Study Assigment

profileMandia04
SaundersComprehensiveReviewfortheNCLEX-RNExaminationPDFDrive.pdf

Evolve Student Resources for Silvestri: Saunders Comprehensive Review for the NCLEX-RN® Examination, Seventh Edition, include the following:

How to Use the Online Practice Questions: Customize your study session for your time and your own unique needs. • Pre-test of 7 5 questions evaluates your current

knowledge. These results feed into a personalized Study Calendar to help guide you in your preparation for the NCLEX-RN examination.

• Study Mode: Receive immediate feedback after each question. Select questions by Client Needs, Integrated Process, Alternate Item Format Type, Priority Concept, or specific Content Area. The answer, rationale, test-taking strategy, question codes, priority concepts, and reference sources for further remediation appear immediately after you answer each question.

• Exam Mode: Take a practice exam, and receive your results and feedback at the end. Select questions by Client Needs, Integrated Process, Alternate Item Format Type, Priority Concept, or specific Content Area. Then select the number of questions you'd like to take in your exam—1 0 , 2 5 , 5 0 , or 1 0 0 . When you've finished the exam, the percentage of questions you answered correctly will be shown in a table, and you can go back to review the correct answers—as well as rationales, test-taking strategies, question codes, priority concepts, and reference(s)—for each question.

• Post-test of 7 5 questions simulating the NCLEX Client Needs percentages helps you evaluate your progress.

Activate the complete learning experience that comes with each NEW textbook purchase by registering with your scratch-off access code at

http://evolve.elsevier.com/Silvestri/comprehensiveRN/ If you purchased a used book and the scratch-off code at right has already been revealed, the code may have been used and cannot be re-used for registration. To purchase a new code to access these valuable study resources, simply follow the link above.

*Evolve Student Resources are provided free with each NEW book purchase only.

Instructor of Nursing Salve Regin a Un iversity, Newport, Rh ode Islan d

President Nu rsin g Reviews, In c., Hen derso n , Nevad a Nu rsin g Reviews, In c., Ch arlesto wn , Rh od e Islan d an d Profession al Nursin g Sem in ars, In c., Ch arlestown , Rh ode Islan d

Elsevier Consultant HESI NCLEX-RN ® an d NCLEX-PN® Live Review Courses

Assistant Professor To uro Un iversity Nevad a—Sch o ol of Nu rsin g Hen d erson , Nevad a

3251 Riverport Lan e St. Louis, Missouri 63043

SAUNDERS CO MPREHENSIVE REVIEW FO R THE NCLEX-RN® EXAMINATIO N, SEVENTH EDITIO N

ISBN: 978-0-323-35851-4

Co p yrigh t © 2017 b y Elsevier, In c. All righ ts reserved .

No part of th is publicatio n m ay be reproduced or tran sm itted in an y form or by an y m ean s, electron ic or m ech an ical, in clu din g ph o to copyin g, recordin g, or an y in form ation sto rage an d retrieval system , with out p erm ission in writin g fro m th e pub lish er. Details on h ow to seek perm issio n , fu rth er in form ation about th e Publish er’s perm ission s policies an d our arran gem en ts with organ ization s su ch as th e Copyrigh t Clearan ce Cen ter an d th e Copyrigh t Licen sin g Agen cy can be fo un d at o ur website: www.elsevier.co m / perm ission s.

Th is book an d th e in divid ual con trib ution s con tain ed in it are protected u n der copyrigh t by th e Pub lish er ( oth er th an as m ay be n oted h erein ) .

No tices

Kn owledge an d best practices in th is field are con stan tly ch an gin g. As n ew research an d experien ce broaden our un derstan din g, ch an ges in research m eth o ds, profession al practices, o r m ed ical treatm en t m ay becom e n ecessary.

Practition ers an d research ers m u st always rely on th eir own experien ce an d kn owled ge in evaluatin g an d usin g an y in form ation , m eth ods, com pou n ds, or experim en ts described h erein . In usin g such in form ation or m eth od s, th ey sh ould be m in dful o f th eir own safety an d th e safety of oth ers, in clud in g parties fo r wh om th ey h ave a pro fessio n al respo n sibility.

With respect to an y d rug or ph arm aceutical products iden tified, readers are advised to ch eck th e m ost curren t in form ation p rovided (i) on pro cedures featured or ( ii) by th e m an ufacturer of each product to be adm in istered to verify th e reco m m en ded dose or fo rm ula, th e m eth od an d d uration o f adm in istration , an d con train dication s. It is th e respo n sibility of practition ers, relyin g on th eir own experien ce an d kn owled ge of th eir patien ts, to m ake diagn oses, to determ in e dosages an d th e best treatm en t for each in dividual p atien t, an d to take all app ropriate safety precaution s.

To th e fu llest exten t of th e law, n eith er th e Publish er n or th e auth ors, con tribu tors, o r editors assum e an y liab ility for an y in jury an d/ or d am age to person s or property as a m atter of pro duct liability, n egligen ce or o th erwise, or from an y u se or operation of an y m eth o ds, products, in stru ction s, or id eas con tain ed in th e m aterial h erein .

Previo us edition s copyrigh ted 2014, 2012, an d 2009.

NCLEX®, NCLEX-RN®, an d NCLEX-PN® are registered tradem arks of th e Nation al Coun cil of State Boards of Nursin g, In c.

Lib rary o f Co n gress Catalo gin g-in -Pu b licatio n Data Nam es: Silvestri, Lin da An n e, auth or. Title: Saun ders com preh en sive review for th e NCLEX-RN exam in ation / Lin da An n e Silvestri. O th er titles: Com preh en sive review for th e NCLEX-RN exam in ation Description : Seven th ed ition . j St. Lo uis, Misso uri : Elsevier, [2017] j In cludes b ibliograph ical referen ces an d in d ex. Iden tifiers: LCCN 2016011692 j ISBN 9780323358514 (p bk. : alk. p aper) Subjects: j MESH: Nu rsin g, Practical j Nursin g Care j Nu rsin g Process j Exam in ation Q u estion s Classification : LCC RT62 j NLM WY 18.2 j DDC 610.73076–dc23 LC record available at h ttp:/ / lccn .loc.gov/ 2016011692

Content Strategist: Jam ie Blum Content Development Manager: Laurie Gower Content Development Specialist: Laura Go odrich Publishing Services Manager: Jeff Patterson Book Production Specialist: Bill Dro n e Designer: Ren ee Duen ow

Prin ted in th e Un ited States of Am erica

Last digit is th e p rin t n u m ber: 9 8 7 6 5 4 3 2 1

Contents

UNIT I NCLEX-RN® Exam Preparation, 1 1 Th e NCLEX-RN® Exam in atio n , 2 2 Path ways to Su ccess, 14 3 Th e NCLEX-RN® Exam in atio n fro m

a Grad u ate’s Persp ective, 18 4 Test-Takin g Strategies, 20

UNIT II Professional Standards in Nursing, 30 5 Cu ltu ral Awaren ess an d Health Practices, 32 6 Eth ical an d Legal Issu es, 44 7 Prio ritizin g Clien t Care: Lead ersh ip ,

Delegatio n , an d Em ergen cy Resp o n se Plan n in g, 59

UNIT III Nursing Sciences, 76 8 Flu id s an d Electro lytes, 78 9 Acid -Base Balan ce, 97

10 Vital Sign s an d Lab o rato ry Referen ce In tervals, 108

11 Nu tritio n , 124 12 Paren teral Nu tritio n , 134 13 In traven o u s Th erap y, 144 14 Ad m in istratio n o f Blo o d Pro d u cts, 158

UNIT IV Fundamentals of Care, 169 15 Health an d Ph ysical Assessm en t o f th e Ad u lt

Clien t, 171 16 Pro visio n o f a Safe En viro n m en t, 192 17 Calcu latio n o f Med icatio n an d In traven o u s

Prescrip tio n s, 204 18 Perio p erative Nu rsin g Care, 215 19 Po sitio n in g Clien ts, 230 20 Care o f a Clien t with a Tu b e, 239

UNIT V Growth and Development Across the Life Span, 255 21 Th eo ries o f Gro wth an d Develo p m en t, 257 22 Develo p m en tal Stages, 265 23 Care o f th e O ld er Clien t, 281

UNIT VI Maternity Nursing, 289 24 Rep ro d u ctive System , 291 25 Pren atal Perio d , 299 26 Risk Co n d itio n s Related to Pregn an cy, 314 27 Lab o r an d Birth , 332 28 Pro b lem s with Lab o r an d Birth , 346 29 Po stp artu m Perio d , 356 30 Po stp artu m Co m p licatio n s, 364 31 Care o f th e Newb o rn , 372 32 Matern ity an d Newb o rn Med icatio n s, 393

UNIT VII Pediatric Nursing, 403 33 In tegu m en tary Diso rd ers, 404 34 Hem ato lo gical Diso rd ers, 411 35 O n co lo gical Diso rd ers, 419 36 Metab o lic an d En d o crin e Diso rd ers, 430 37 Gastro in testin al Diso rd ers, 439 38 Eye, Ear, an d Th ro at Diso rd ers, 457 39 Resp irato ry Diso rd ers, 463 40 Card io vascu lar Diso rd ers, 479 41 Ren al an d Urin ary Diso rd ers, 491 42 Neu ro lo gical an d Co gn itive

Diso rd ers, 499 43 Mu scu lo skeletal Diso rd ers, 511 44 In fectio u s an d Co m m u n icab le

Diseases, 520 45 Ped iatric Med icatio n Ad m in istratio n an d

Calcu latio n s, 536

iii

UNIT VIII Integumentary Disorders of the Adult Client, 543 46 In tegu m en tary System , 544 47 In tegu m en tary Med icatio n s, 569

UNIT IX Hematological and Oncological Disorders of the Adult Client, 578 48 Hem ato lo gical an d O n co lo gical Diso rd ers, 580 49 Hem ato lo gical an d O n co lo gical

Med icatio n s, 614

UNIT X Endocrine Disorders of the Adult Client, 625 50 En d o crin e System , 626 51 En d o crin e Med icatio n s, 653

UNIT XI Gastrointestinal Disorders of the Adult Client, 669 52 Gastro in testin al System , 671 53 Gastro in testin al Med icatio n s, 698

UNIT XII Respiratory Disorders of the Adult Client, 706 54 Resp irato ry System , 708 55 Resp irato ry Med icatio n s, 737

UNIT XIII Cardiovascular Disorders of the Adult Client, 754 56 Card io vascu lar System , 755 57 Card io vascu lar Med icatio n s, 797

UNIT XIV Renal and Urinary Disorders of the Adult Client, 815 58 Ren al an d Urin ary System , 817 59 Ren al an d Urin ary Med icatio n s, 850

UNIT XV Eye and Ear Disorders of the Adult Client, 860 60 Th e Eye an d th e Ear, 861 61 Eye an d Ear Med icatio n s, 882

UNIT XVI Neurological Disorders of the Adult Client, 892 62 Neu ro lo gical System , 893 63 Neu ro lo gical Med icatio n s, 923

UNIT XVII Musculoskeletal Disorders of the Adult Client, 936 64 Mu scu lo skeletal System , 937 65 Mu scu lo skeletal Med icatio n s, 958

UNIT XVIII Immune Disorders of the Adult Client, 965 66 Im m u n e Diso rd ers, 966 67 Im m u n o lo gical Med icatio n s, 980

UNIT XIX Mental Health Disorders of the Adult Client, 987 68 Fo u n d atio n s o f Psych iatric Men tal Health

Nu rsin g, 988 69 Men tal Health Diso rd ers, 1000 70 Ad d ictio n s, 1019 71 Crisis Th eo ry an d In terven tio n , 1030 72 Psych iatric Med icatio n s, 1043

UNIT XX Comprehensive Test, 1056

References, 1079

Glossary, 1081

Index, 1090

Priority Nursing Action List, Back of Inside Cover

iv Contents

To my parents—

To my mother, Frances Mary,

and in loving memory of my father, Arnold La wrence,

who taught me to always love, care,

and be the best that I could be.

To All Fu tu re Registered Nu rses,

Con gratulation s to you!

You sh ould be very proud an d pleased with yourself on your m ost recen t well- deserved acco m plish m en t of com pletin g your n ursin g program to becom e a regis- tered n urse. I kn ow th at you h ave worked very h ard to beco m e successful an d th at yo u h ave proven to yourself th at in deed you can ach ieve your go als.

In m y opin io n , you are ab out to en ter th e m ost won derful an d rewardin g profession th at exists. Your willin gn ess, desire, an d ability to assist th o se wh o n eed n ursin g care will brin g great satisfaction to your life. In th e profession of n ursin g, yo ur learn in g will be a lifelon g process. Th is aspect of th e profession m akes it stim - ulatin g an d dyn am ic. Your learn in g process will con tin ue to exp an d an d grow as th e profession con tin ues to evolve. Your n ext very im portan t en deavor will be th e learn in g process in volved to ach ieve success in your exam in ation to beco m e a registered n urse.

I am excited an d pleased to be able to provid e yo u with th e Sau n ders Pyramid to Success produ cts, wh ich will h elp you prepare for yo ur n ext im portan t profession al go al, beco m in g a registered n urse. I wan t to th an k all of m y form er n ursin g studen ts wh om I h ave assisted in th eir studies for th e NCLEX-RN® exam in ation for th eir willin gn ess to offer ideas regardin g th eir n eeds in preparin g for licen su re. Studen t id eas h ave certain ly added a special un iquen ess to all of th e products available in th e Sau n ders Pyramid to Success.

Saun ders Pyramid to Success products provide yo u with everyth in g th at you n eed to ready yourself for th e NCLEX-RN exam in ation . Th ese produ cts in clude m aterial th at is required for th e NCLEX-RN exam in ation for all n ursin g studen ts regardless of edu cation al backgroun d, specific stren gth s, areas in n eed of im provem en t, or clin ical experien ce durin g th e n ursin g program .

So let’s get started an d begin our journ ey th rough th e Saun ders Pyramid to Success, an d welcom e to th e won derful profession of n ursin g!

Sin cerely,

vi

About the Author

Linda Anne Silvestri, PhD, RN ( Photo by Laurent W. Valliere.)

As a ch ild, I always dream edof beco m in g eith er a n urse or a teach er. In itially I ch ose to beco m e a n urse because I really wan ted to h elp oth ers, esp e-

cially th ose wh o were ill. Th en I realized th at both of m y dream s could com e true; I could be both a n urse an d a teach er. So I pursued m y dream s.

I received m y diplom a in n ursin g at Cooley Dickin - son Hospital Sch o ol of Nursin g in North am pton , Mas- sach usetts. Afterward, I worked at Baystate Med ical Cen ter in Sprin gfield, Massach usetts, wh ere I cared for clien ts in acute m edical-surgical un its, th e in ten sive care un it, th e em ergen cy dep artm en t, pediatric un its, an d oth er acu te care un its. Later I received an associate degree from Holyo ke Com m un ity College in Ho lyoke, Massa- ch usetts; m y BSN from Am erican In tern ation al College in Sprin gfield, Massach usetts; an d m y MSN from An n a Maria College in Paxton , Massach usetts, with a dual m ajo r in Nursin g Man agem en t an d Patien t Education . I received m y Ph D in Nu rsin g from th e Un iversity of Nevad a, Las Vegas, an d con d ucted research on self- efficacy an d th e predictors of NCLEX® success. I am also a m em ber of th e Hon o r Society of Nu rsin g, Sigm a Th eta Tau In tern ation al, Ph i Kappa Ph i, th e Am erican Nu rses Asso ciation , th e Nation al League for Nursin g, th e West- ern In stitute of Nursin g, th e Eastern Nu rsin g Research Society, an d th e Golden Key In tern ation al Ho n our Soci- ety. In ad dition , I received th e 2012 Alum n a of th e Year/ Nurse of th e Year Award from th e Un iversity of Nevada, Las Vegas, Sch ool of Nursin g.

As a n ative of Sprin gfield, Massach usetts, I began m y teach in g career as an in structo r of m edical-surgical n urs- in g an d leadersh ip-m an agem en t n ursin g in 1981 at Baystate Med ical Cen ter Sch ool of Nu rsin g. In 1989,

I relocated to Rh od e Islan d an d began teach in g ad- van ced m edical-surgical n ursin g an d psych iatric n ursin g to RN an d LPN studen ts at th e Com m un ity College of Rh ode Islan d. Wh ile teach in g th ere, a group of studen ts approach ed m e for assistan ce in preparin g for th e NCLEX exam in ation . I h ave always h ad a very special in terest in test success for n ursin g studen ts because of m y own person al experien ces with testin g. Takin g tests was n ever easy for m e, an d as a studen t I n eeded to fin d m eth od s an d strategies th at would brin g success. My own difficult experien ces, desire, an d dedication to assist n ursin g studen ts to overcom e th e obstacles associated with testin g in spired m e to develop an d write th e m an y produ cts th at would foster success with testin g. My exp e- rien ces as a studen t, n ursin g edu cator, an d item writer for th e NCLEX exam in ation s aided m e as I developed a com preh en sive review course to prepare n ursin g graduates for th e NCLEX exam in ation .

Later, in 1994, I began teach in g m edical-su rgical n ursin g at Salve Regin a Un iversity in Newport, Rh ode Islan d, an d I rem ain th ere as an ad jun ct faculty m em ber. I also prepare n ursin g studen ts at Salve Regin a Un iversity for th e NCLEX-RN exam in ation .

I establish ed Profession al Nursin g Sem in ars, In c. in 1991 and Nursin g Reviews, In c. in 2000. Th ese com pan ies are located in Ch arlestown , Rh ode Islan d. In 2012, I estab- lish ed an addition al com pan y, Nursin g Reviews, In c. in Hen derson , Nevada. Both com panies are dedicated to h elpin g n ursin g graduates ach ieve th eir goals of becom in g registered n urses, licen sed practical/ vocation al n urses, or both .

Today, I am th e successful auth o r of n um erou s review produ cts. Also, I serve as an Elsevier con sultan t for HESI Live Reviews, th e review courses for th e NCLEX exam in ation s con ducted th rough ou t th e coun try. I am so pleased th at you h ave decided to join m e on your journ ey to success in testin g for n ursin g exam in ation s an d for th e NCLEX-RN exam in ation !

vii

Contributors

Consultants Dia nne E. Fiorent ino Research Co o rd in ato r Nu rsin g Reviews, In c. Hen d erson , Nevad a

Ja mes Guiba ult, Jr., BS, Pha rmD Clin ical Ph arm acist Wilbrah am , Massach usetts

Nichola s L. Silvest ri, BA Ed itorial an d Co m m u n icatio n s An alyst Nu rsin g Reviews, In c. Ch arlesto wn , Rh o de Islan d

Ja ne Tyerma n, RN, MScN, PhD Facu lty Tren t/ Flem in g Sch oo l o f Nu rsin g Peterb oro ugh , O n tario, Can ada

Contributors Ma rilee Aufdenkamp, BSN, MS Assistan t Pro fesso r Sch oo l o f Nu rsin g Creigh to n Un iversity O m ah a, Nebraska

Ja skaranjeet Bhulla r, RN Graduate Sch oo l o f Nu rsin g To uro Un iversity Nevad a Hen d erson , Nevad a

Jea n Burt , BS, BSN, MSN In structor, Nu rsin g City Co lleges o f Ch icago Ch icago , Illin o is

Reit ha Ca ba niss, EdD, MSN Nu rsin g Directo r Bevill State Co m m u n ity College Jasp er, Alab am a

Ba rbara Ca llaha n, MEd, RN, NCC, CHSE Retired Len oir Com m un ity College Kin ston , No rth Carolin a

Na ncy Curry, BSN, MSN Assistan t Pro fessor, Nu rsin g No rth western State Un iversity Co llege o f Nu rsin g an d Sch o ol

o f Allied Health Sh revepo rt, Lou isian a

Ma tt ie Da vis, DNP, MSN, RN Nu rsin g In stru cto r, Health Scien ces J.F. Drake State Tech n ical Co llege Hun tsville, Alabam a

Ma rgie Fra ncisco, EdD, MSN, RN Nu rsin g Professo r Health Division Illin ois Valley Com m un ity College O glesby, Illin o is

Ma rilyn Greer, MS, RN Asso ciate Professo r o f Nu rsin g Ro ckfo rd Co llege Ro ckfo rd , Illin o is

Joyce Ha mmer, RN, MSN Ad ju n ct Facu lty, Nursin g Mon ro e Co un ty Com m un ity College Mon ro e, Mich igan

Donna Russo, MSN, CCRN, CNE Nu rsin g In stru cto r ARIA Health Sch oo l o f Nu rsin g Ph ilad elp h ia, Pen n sylvan ia

Ma ry Scheid, RN, MSN NCMC Breast Cen ter No rth Colo rad o Medical Cen ter Greeley, Colorado

Laurent W. Va lliere, BS, DD Vice Presiden t o f Nu rsin g Reviews, In c. Pro fessio n al Nu rsin g Sem in ars, In c. Ch arlesto wn , Rh o de Islan d

Donna Wilsker, MSN, BSN Assistan t Pro fessor Dish m an Dep artm en t of Nursin g Lam ar Un iversity Beau m on t, Texas

viii

Item Writer and Section Editor Donna Russo, MSN, CCRN, CNE Nursin g In structor ARIA Health Sch o ol of Nursin g Ph iladelph ia, Pen n sylvan ia

Item Writers Amber Ba llard, MSN, RN Registered Nurse Em ergen cy Dep artm en t Sp arrow Health System Lan sin g, Mich igan

Bett y Cheng, MSN Assistan t Professor Sch o ol o f Nursin g MCPHS Un iversity Bosto n , Massach u setts

Christ ina Keller, MSN, RN In stru cto r Sch o ol o f Nursin g Radfo rd Un iversity Radfo rd , Virgin ia

Heidi Monroe, MSN, RN-BC, CAPA Assistan t Professor o f Nu rsin g NCLEX-RN® Co ordin ator Bellin Co llege Green Bay, Wiscon sin

Betha ny Hawes Sykes, EdD, RN, CEN, CCRN Em ergen cy Dep artm en t RN St Lu ke’s Hosp ital New Bed ford, Massach usetts Adju n ct Faculty Departm en t o f Nu rsin g Salve Regin a Un iversity Newp ort, Rh o de Islan d

Linda Turchin, RN, MSN, CNE Assistan t Professo r, Nu rsin g Fairm o n t State Un iversity Fairm o n t, West Virgin ia

Donna Wilsker, MSN, BSN Assistan t Professo r Dish m an Departm en t o f Nu rsin g Lam ar Un iversity Beaum o n t, Texas

Olga Va n Dyke, PhD (c), CAGS, MSN Assistan t Professo r Sch o ol o f Nu rsin g MCPHS Un iversity Bosto n , Massach u setts

The author and publisher would also like to acknowledge the following individuals for contributions to the previous edition of this book:

Marilee Au fd en kam p , RN, MS Hastin gs, Neb raska

Margaret Barn es, MSN, RN Marion , In dian a

Reith a Cab an iss, MSN, RN, CNE Jasp er, Alabam a

Jo an n a E. Cain , BSN, BA, RN Austin , Texas

Barb ara Callah an , MEd , RN, NCC, CHSE

Kin sto n , North Caro lin a

Mary C. Carrico , MS, RN Pad ucah , Ken tu cky

Mary L. Do well, Ph D, RN, BC San An to n io, Texas

Beth B. Gau l, Ph D, RN Des Moin es, Io wa

Su san Go ld en , MSN, RN Ro swell, New Mexico

Marilyn L. Jo h n essee Greer, MS, RN Ro ckfo rd , Illin ois

Jam ie Lyn n Jo n es, MSN, RN, CNE Little Rock, Arkan sas

Lyn n Ko rvick, Ph D, RN, CNE Jop lin , Misso u ri

Tara McMillan -Q u een , RN, MSN, ANP, GNP

Ch arlo tte, North Carolin a

Heid i Mo n ro e, MSN, RN-BC, CPAN, CAPA

Green Bay, Wisco n sin

David Mo rro w, BSN, RN Las Vegas, Nevad a

Deb ra L. Price, RN, MSN, CPNP Fort Worth , Texas

Do n n a Ru sso , RN, MSN, CCRN Ph ilad elp h ia, Pen n sylvan ia

An gela Silvestri, Ph D, RN, CNE Hen d erson , Nevad a

Ch ristin e Su m p , MSN, RN No rfo lk, Virgin ia

Beth an y Hawes Sykes, Ed D, RN, CEN, CCRN

Newpo rt, Rh od e Islan d

Lin d a Tu rch in , RN, MSN, CNE Fairm o n t, West Virgin ia

Lau ren t W. Valliere, BS, DD Ch arlesto wn , Rh o de Islan d

ixContributors

Reviewers

Da nese M. Boob, RN-BC, BSN, MSN/ ED Certification in Perin atal Nu rsin g an d Med ical-Surgical

Nu rsin g Dep artm en t of Nursin g Pen n sylvan ia State Un iversity Hersh ey, Pen n sylvan ia

Jea n Eliza bet h Burt , MS, RN Nu rsin g In stru cto r Wilbu r Wrigh t Co llege Ch icago , Illin o is

Bet ty Cheng, MSN, RN, FNP In structor of Nursin g Sch oo l o f Nu rsin g Q uin cy College Q uin cy, Massach usetts

Ma rguerite C. DeBello, RN, MSN, ACNS-BC, CNE, NP

Assistan t Pro fesso r Sch oo l o f Nu rsin g Eastern Mich igan Un iversity Ypsilan ti, Mich igan

Ma rgie L. Fra ncisco, EdD, MSN, RN Nu rsin g Professo r Nu rsin g/ Health Pro fessio n s Dep artm en t Illin o is Valley Co m m u n ity Co llege O glesb y, Illin o is

Shari Gould, MSN, RN Asso ciate Professor o f Nu rsin g Career, Health an d Tech n ical Profession s Departm en t Victoria Co llege Victoria, Texas

Sheila Grossman, PhD, APRN, FNP-BC, FAAN Pro fessor & Coo rdin ato r, Fam ily Nu rse Practitio n er Track Nu rsin g Departm en t Fairfield Un iversity Sch oo l o f Nu rsin g Fairfield, Co n n ecticut

Joyce Ha mmer, RN, MSN Ad ju n ct Clin ical Facu lty Nu rsin g Departm en t Mon ro e Co u n ty Com m un ity College Mon ro e, Mich igan

Lila h M. Ha rper, RN, CA Presid en t, Harper Con sultin g Services Valley Cen ter, Califo rn ia Lead Nu rse Plan n er, An derso n Con tin u in g Edu catio n Sacram en to, Califo rn ia

Laura Hope, MSN, RN Nu rsin g Faculty Nu rsin g Program Floren ce-Darlin gto n Tech n ical Co llege Floren ce, Sou th Caro lin a

Donna Wa lker Hubba rd, RN, MSN, CNNe Assistan t Pro fessor, Retired Nu rsin g Departm en t Un iversity of Mary Hardin -Baylo r Belton , Texas

Pa ula Celest e Hughes, MSN, RN Nu rsin g Faculty Nu rsin g an d Allied Health Dep artm en t Georgia North western Tech n ical College Ro m e, Geo rgia

Georgina Julious, RN, BSN, MSN BLS In stru cto r; Facility Ad m in istrato r Nu rsin g Departm en t O ut-Patien t Dialysis Hartsville, So uth Caro lin a

Eliza bet h B. McGrat h, MS, APRN, AGACNP-BC, AOCNP, ACHPN

Nu rse Practitio n er Dartm o uth Hitch cock Medical Cen ter—Geisel Sch oo l o f Medicin e at Dartm ou th Leb an o n , New Ham psh ire

Pa t A. Perryma n, MSN, RN, PhD Presid en t Ad m in istration Dallas Nursin g In stitu te Dallas, Texas

Ka ren Robert son, RN, MSN, MBA, PhD(c) Asso ciate Professo r Nu rsin g Departm en t Ro ck Valley Co llege Ro ckfo rd , Illin o isx

Charlot t e D. St ra hm, DNSc, RN, CNS Assistan t Professor Departm en t o f Nu rsin g Pu rd ue Un iversity No rth Cen tral Westville, In d ian a

Christ ine Sump, MSN, RN Nursin g Lectu rer Nursin g Dep artm en t O ld Do m in io n Un iversity Norfolk, Virgin ia

Daryle Wane, PhD, ARNP, FNP-BC RN to BSN Coo rd in ato r Departm en t o f Health O ccu patio n s Pasco-Hern an d o State College New Po rt Rich ey, Florid a

Donna Wilsker, MSN, RN Assistan t Professo r Dish m an Departm en t o f Nu rsin g Lam ar Un iversity Beaum o n t, Texas

Ka ren Winsor, MSN, RN, ACNS-BC APRN for O rth op edic Trau m a Austin , Texas

xiReviewers

Preface

“To laugh often and much, to appreciate beauty, to find the best in others, to leave the world a bit better,

to know that even one life has breathed easier because you have lived, this is to have succeeded.”

—Ralph Waldo Emerson

Welcome to Saunders Pyra mid t o Success! An Essential Resource for Test Success Saunders Comprehensive Review for the NCLEX-RN ® Exam- ination is on e in a series of produ cts design ed to assist you in ach ievin g your go al of beco m in g a registered n urse. Th is text will provide you with a com preh en sive review of all n ursin g con ten t areas specifically related to th e n ew 2016 test plan for th e NCLEX-RN exam in a- tion , wh ich is im plem en ted by th e Nation al Coun cil of State Boards of Nu rsin g. Th is resource will h elp you ach ieve success on your n ursin g exam in ation s dur- in g n ursin g sch o ol an d on th e NCLEX-RN exam in ation .

Organization

Th is book con tain s 20 un its an d 72 ch apters. Th e ch ap- ters are design ed to iden tify specific com pon en ts of n urs- in g con ten t. Th ey con tain practice question s, in cludin g a critical th in kin g question , an d both m ultiple-ch oice an d altern ate item form ats th at reflect th e ch apter con ten t an d th e 2016 test plan for th e NCLEX-RN exam in ation . Th e fin al un it con tain s a 75-question Com p reh en sive Test. All question s in th e book an d on th e Evo lve site are presen ted in NCLEX-style form at.

Th e n ew test plan iden tifies a fram ework based on Client Needs. Th ese Clien t Needs categories in clude Safe an d Effective Care En viron m en t, Health Prom otion and Main ten ance, Psych osocial In tegrity, an d Physiological In tegrity. Integrated Processes are also iden tified as a com - pon en t of th e test plan . Th ese in clude Carin g, Com m un i- cation an d Docum en tation , Culture an d Spirituality, Nursin g Process, an d Teach in g an d Learn in g. All ch apters address th e com pon en ts of th e test plan fram ework.

Special Features of the Book Pyramid Terms Pyramid Terms are im portan t to th e discussion of th e con - ten t in th e ch apters in each un it. Th erefore, th ey are in

bold green type th rou gh out th e con ten t section of each ch apter. Th e defin ition s can be foun d in th e Glossary at th e en d of th e book.

Pyramid to Success Th e Pyramid to Success, a featured part of each un it in - troduction , provides you with an overview, guidan ce, an d direction regardin g th e focus of review in the particular con ten t area, as well as th e con ten t area’s relative im por- tan ce to the 2016 test plan for th e NCLEX-RN exam in a- tion . Th e Pyramid to Success reviews th e Clien t Needs an d provides learn in g objectives as th ey pertain to the con ten t in th at un it. Th ese learn in g objectives iden tify the specific com pon en ts to keep in m in d as you review each ch apter.

Priority Concepts Each ch apter iden tifies two Priority Concepts reflective of its con ten t. Th ese Priority Concepts will assist you to focus on th e im portan t aspects of th e con ten t an d associated n ursin g in terven tion s.

Pyramid Points Pyramid Points ( ) are placed next to specific content through out th e ch apters. Th e Pyramid Points h ighlight con- tent th at is im portan t for preparin g for the NCLEX-RN exam ination and iden tify con ten t that is likely to appear on the NCLEX-RN exam ination .

Pyramid Alerts Pyramid Alerts are th e red text fo u n d th ro u gh o u t th e ch ap ters th at alert yo u to im p o rtan t in fo rm atio n ab o u t n u rsin g co n cep ts. Th ese alerts id en tify co n ten t th at typ ically ap p ears o n th e N CLEX-RN exam in atio n .

Priority Nursing Actions Num erous Priority Nursing Actions boxes h ave been placed th rough out th e ch apters. Th ese boxes presen t a clin ical n ursin g situation an d th e priority action s to take in th e even t of its occurrence. Arationale is provided th at explain s th e correct order of action, alon g with a referen ce for addi- tion al research . A list of th ese boxes can be foun d in th e backm atter of the book for easier location.xii

Critical Thinking: What Should You Do? Questions Each chapter con tain s a Critical Thinking: What Should You Do? question . Th ese question s provide a brief clin ical sce- n ario related to th e con ten t of the ch apter an d ask you what you sh ould do about th e clien t situation presen ted. A n arrative an swer is provided alon g with a referen ce source for research in g furth er in form ation .

Special Features Found on Evolve Pretest and Study Calendar Th e accom panyin g Evolve site con tain s a 75-question pre- test th at provides you with feedback on your stren gth s an d weakn esses. Th e results of your pretest will gen erate an individualized study calen dar to guide you in your prepa- ration for th e NCLEX-RN exam in ation .

Heart, Lung, and Bowel Sound Questions Th e acco m p an yin g Evo lve site co n tain s Audio Q uestions rep resen tative o f co n ten t ad d ressed in th e 2016 test p lan fo r th e N CLEX-RN exam in atio n . Each q u estio n p resen ts an au d io clip as a co m p o n en t o f th e q u estio n .

Video Questions Th e accom pan yin g Evo lve site con tain s Video Questions represen tative of con ten t addressed in th e 2016 test plan for th e NCLEX-RN exam in ation . Each question presen ts a video clip as a com po n en t of th e question .

Testlet Questions Th e acco m pan yin g Evo lve site con tain s testlet question s. Th ese question typ es in clude a clien t scen ario an d sev- eral acco m pan yin g practice question s th at relate to th e con ten t of th e scen ario.

Audio Review Summaries and Animations Th e com pan ion Evolve site in cludes th ree Audio Review Summaries th at cover ch allen gin g subject areas addressed in th e 2016 test plan for th e NCLEX-RN exam in ation , in cludin g Pharmacology, Acid-Base Balance, an d Fluids and Electrolytes. An im ation s th at presen t various con ten t areas are also available for viewin g.

Practice Questions

While preparin g for th e NCLEX-RN exam in ation , it is crucial for studen ts to practice takin g test question s. Th is book con tain s 996 NCLEX-style m ultiple-ch oice an d altern ate item form at questions. Th e accom pan yin g soft- ware in cludes all questions from th e book plus addition al Evolve question s for a total of m ore th an 5200 question s.

Multiple-Choice and Alternate Item Format Questions Startin g with Un it II, each ch apter is followed by a prac- tice test. Each practice test con tain s several question s reflective of th o se presen ted on th e NCLEX-RN exam in a- tion . Th ese question s provide you with practice in

prioritizin g, decision -m akin g, an d critical th in kin g skills. Ch apter 1 of th is book provides a description of each question type an d th e an swer section . Th e an swer section in cludes th e correct an swer, ration ale, test-takin g strategy, question categories, an d referen ce.

In each practice question , th e specific test-takin g strat- egy th at will assist you in an swerin g the question correctly is h igh ligh ted in bold b lu e type. Specific suggestion s for review are iden tified in th e test-takin g strategy and are h igh ligh ted in bold m agen ta type to provide you with direction for locatin g th e specific con ten t in th is book. Th is h igh ligh tin g of th e specific test-takin g strategies an d spe- cific con ten t areas in th e practice question s will provide you with guidan ce on wh at topics to review for furth er rem ediation in both Saunders Strategies for Test Success: Passing Nursing School and the NCLEX® Exam and Saunders Comprehensive Review for the NCLEX-RN® Examination.

Th e categories iden tified in each practice question in clude Level of Cogn itive Ability, Clien t Needs, In tegrat- ed Process, Priority Con cepts, an d th e specific n ursin g Con ten t Area. Every question on th e accom pan yin g Evolve site is organ ized by th ese question codes, so you can cus- tom ize your study session to be as specific or as gen eric as you n eed. Addition ally, n orm al laboratory referen ce in tervals are provided with each laboratory question .

Pharmacology and Medication Calculations Review

Studen ts con sisten tly state th at ph arm acology is an area with wh ich th ey n eed assistan ce. The 2016 NCLEX-RN test plan con tinues to in corporate ph arm acology in th e exam - in ation , but on ly th e gen eric drug n am es will be in cluded. Th erefore, ph arm acology ch apters h ave been in cluded for your review an d practice. Th is book includes 13 ph arm a- cology ch apters, a m edication and in travenous calculation ch apter, an d a pediatric m edication calculation ch apter. Each of th ese ch apters is followed by a practice test th at uses the sam e question form at described earlier. This book con - tain s n um erous ph arm acology questions. Addition ally, m ore th an 900 ph arm acology question s can be foun d on the accom pan yin g Evolve site.

How to Use This Book

SaundersComprehensive Reviewfor theNCLEX-RN® Examina- tion is especially design ed to help you with your successful journ ey to th e peak of th e Saun ders Pyramid to Success: becom in g a registered n urse! As you begin your journey th rough th is book, you will be in troduced to all ofthe im por- tan t points regardin g th e 2016 NCLEX-RN exam in ation, th e process oftestin g, an d un ique an d special tips regardingh ow to prepare yourself for this very im portan t exam ination .

You should begin your process th rough th e Saun ders Pyramid to Success by readin g all of Un it I in this book

xiiiPreface

an d becom in g fam iliar with th e cen tral poin ts regardin g th e NCLEX-RN exam in ation . Read Ch apter 3, written by a n ursing graduate wh o recen tly passed th e exam in ation , an d n ote wh at sh e h as to say about the testin g experien ce. Ch apter 4 will provide you with th e critical testin g strate- gies th at will guide you in selectin g the correct option or assist you in selectin g an answer to a question if you m ust guess. Keep th ese strategies in m in d as you proceed th rough th is book. Con tinue by studyin g th e specific con - ten t areas addressed in Un its II th rough XIX. Review th e defin ition s of th e Pyramid Terms located in th e Glossary an d th e Pyramid to Success n otes, an d iden tify the Clien t Needs an d Learn in g O bjectives specific to the test plan in each area. Read th rough th e ch apters an d focus on th e Pyramid Points and Pyramid Alerts th at identify th e areas m ost likely to be tested on th e NCLEX-RN exam in ation . Pay particular atten tion to th e PriorityNursing Actionsboxes because th ey provide inform ation about th e steps you will take in clin ical situation s requirin g prioritization .

As yo u read each ch apter, iden tify your areas of stren gth an d th ose in n eed of furth er review. High ligh t th ese areas an d test your abilities by an swerin g th e Crit- ical Thinking: What Should You Do? question an d takin g all practice tests provided at th e en d of th e ch apters. Be sure to review all ration ales an d test-takin g strategies.

After reviewin g all ch apters in th e book, turn to Un it XX, th e Com p reh en sive Test. Take th is exam in ation an d th en review each question , an swer, an d ration ale. Iden tify an y areas requirin g furth er review; th en take th e tim e to review those areas in both th e book and th e com pan ion Evolve site. In preparation for th e NCLEX-RN exam in ation , be sure to take th e pretest an d gen erate your study calen dar. Follow the calen dar for your review because th e calen dar represen ts your pretest results an d th e best study path to follow based on your stron g an d weak con ten t areas. Also, be sure to access th e Testlets and th e Audio Review Summaries as part of your preparation for th e NCLEX-RN exam in ation .

Climbing the Pyra mid t o Success

Th e purpose of th is book is to provide a co m p reh en - sive review of the n ursin g con ten t you will be tested on durin g th e NCLEX-RN exam in ation . However, Saunders Comprehensive Review for the NCLEX-RN® Examination is in ten ded to do m ore th an sim ply prepare you for th e rigors of th e NCLEX-RN exam in ation ; th is book is also m ean t to serve as a valuable study tool th at you can refer to th rough - out your n ursin g program , with custom izable Evolve site selections to h elp iden tify an d rein force key con ten t areas.

After using th is book for com preh en sive con ten t review, your n ext step on th e Pyramid to Success is to get addition al practice with a Q &A review product. Saunders Q&A Review for the NCLEX-RN® Examination offers m ore th an 6000 un ique practice question s in th e book an d on th e com pan ion Evolve site. Th e question s are focused on th e Clien t Needs an d Integrated Processes of the NCLEX- RN test plan , m akin g it easy to access your study area of ch oice. For on -th e-go Q &A review, you can pick up Saun- ders Q&A Review Cards for the NCLEX-RN® Examination.

Your fin al step on th e Pyramid to Success is to m aster th e o n lin e review. Saunders Online Review for the NCLEX- RN® Examination provides an in teractive an d in dividual- ized platform to get yo u ready for your fin al licen su re exam . Th is on lin e course provid es 10 h igh -level con ten t m odules, supplem en ted with in struction al videos, an i- m ation s, audio, illustration s, testlets, an d several subject m atter exam s. En d-of-m o dule practice tests are provid ed alon g with several Crossing the Finish Line practice tests. In addition , you can assess your progress with a pretest, Test Yourself quizzes, an d a com preh en sive exam in a com puterized en viron m en t th at prepares you for th e actual NCLEX-RN exam in ation .

At th e base of th e Pyramid to Success are m y test- takin g strategies, which provide a foun dation for under- stan din g an d unpackin g the com plexities of NCLEX-RN exam in ation question s, in cludin g altern ate item form ats. Saunders Strategies for Test Success: Passing Nursing School and the NCLEX® Exam takes a detailed look at all of th e test-takin g strategies you will n eed to kn ow in order to pass an y n ursin g exam in ation , in cludin g th e NCLEX-RN. Spe- cial tips are integrated for n ursing studen ts, an d th ere are m ore th an 1200 practice question s included so you can apply th e testing strategies.

Good luck with your journ ey th rou gh th e Sau n ders Pyramid to Success. I wish you con tin ued success th rough - out your n ew career as a registered n urse!

Linda Anne Silvestri

xiv Preface

Acknowledgments

Sin cere appreciation an d warm est th an ks are exten ded to th e m an y in dividuals wh o in th eir own ways h ave con tributed to th e publication of th is book.

First, I wan t to th an k all of m y n ursin g studen ts at th e Com m un ity College of Rh od e Islan d in Warwick wh o approach ed m e in 1991 an d persu aded m e to h elp th em prepare to take th e NCLEX-RN ® exam in ation . Th eir en th u siasm an d in spiration led to th e com m en cem en t of m y profession al en deavors in con d uctin g review courses for th e NCLEX-RN exam in ation for n ursin g stu- den ts. I also th an k th e n um erou s n ursin g studen ts wh o h ave atten ded m y review courses for th eir willin gn ess to sh are th eir n eeds an d ideas. Th eir in put h as certain ly added a special un iquen ess to th is publication .

I wish to ackn owledge all of th e n ursin g facu lty wh o taugh t in m y review courses for th e NCLEX-RN exam in a- tion . Th eir com m itm en t, ded ication , an d expertise h ave certain ly h elped n ursin g studen ts to ach ieve success with th e exam .

I wan t to exten d a very special th an k you to m y n iece Dr. An gela Silvestri-Elm o re, wh o fun ctio n ed as m y “super-ed itor” for th is book. In m y eyes sh e is defin itely “super,” an d h er trem en d ous th eoretical an d clin ical kn owledge an d exp ertise an d h er con sisten t ideas an d in pu t certain ly added to th e excellen t quality of th is produ ct. Th an k you An gela!

I also wish to offer a very special ackn o wledgm en t an d th an k you to Jan e Tyerm an for reviewin g th is en tire book to en sure th at it in cluded Can adian n ursin g prac- tice an d stan dards. Th an k yo u, Jan e!

I wan t to ackn o wledge an d sin cerely th an k m y h us- ban d , Lauren t W. Valliere, or Larry, for h is con tribu tion to th is publication , for teach in g in m y review co urses for th e NCLEX-RN exam in ation , an d for h is com m itm en t an d ded ication in h elpin g m y n ursin g studen ts prepare for th e NCLEX-RN exam in ation from a n on academ ic poin t of view. Larry h as supp orted m y m an y profes- sion al en deavors an d was so loyal an d lo vin g to m e each an d every m om en t as I worked to ach ieve m y profes- sion al goals. Larry, th an k you so m uch !

An d, a special th an k you also goes to Jaskaran jeet Bh ullar, RN, BSN, for writin g a ch apter for th is book about h er experien ces preparin g for an d takin g th e NCLEX-RN exam in ation .

I sin cerely ackn owledge an d th an k m an y very im por- tan t in dividuals fro m Elsevier wh o are so dedicated to m y work in creatin g NCLEX products for n ursin g stu- den ts. I th an k Yvon n e Alexo poulo s, Sen ior Con ten t Strategist, for h er con tin uous assistan ce, en th usiasm , support, an d expert profession al guidan ce as I prepared th is publication , an d Laurie Gower, Con ten t Develop- m en t Man ager, for h er expert ideas as we plan n ed th e project an d for h er con tin uo us supp ort th rough ou t th e produ ction process.

An d, a special an d sin cere th an k you to Laura Goodrich , Con ten t Developm en t Specialist, for h er trem en d ous am oun t of support an d assistan ce, for prior- itizin g for m e to keep m e on track, for h er id eas for th e produ ct, an d for h er profession al an d exp ert skills in organ izin g an d m ain tain in g an en orm ous am oun t of m an uscript for produ ction . I could n ot h ave com pleted th is project with ou t Laura—th an k you, Laura! I also wan t to ackn owledge Jam ie Ran dall, Con ten t Strategist for all of h er assistan ce in com pletin g th is project— th an k you, Jam ie!

I th an k Elo dia Dian n e Fioren tin o for research in g con ten t an d preparin g referen ces for each practice ques- tion ; Nich olas Silvestri for editin g, form attin g, an d orga- n izin g m an uscript files for m e; Jam es Guilbault for research in g an d updatin g m ed ication s; an d m y perso n al team wh o participated in reviewin g th e Evo lve site th at accom pan ies th is produ ct. A special th an k you to all of yo u for provid in g con tin uo us supp ort an d ded ication to m y work in preparin g th is publication an d m ain tain - in g its excellen t quality.

I wan t to ackn owledge all of th e staff at Elsevier for th eir trem en dous assistan ce th rou gh out th e preparation an d production of th is publication an d all of th e Elsevier staff in volved in th e publication of previous edition s of th is outstan din g NCLEX review product. A special th an k you to all of th em . I th an k all of th e im portan t peo ple in th e produ ction an d m arketin g dep artm en t, in cludin g Bill Dron e, Boo k Produ ction Specialist; Dan ielle LeCom p te, Marketin g Man ager; Jeff Patterso n , Publish in g Services Man ager; Am y Sim pson , Multim edia Produ cer; an d Ren ee Duen ow, Design er.

An d a special th an k you to Loren Wilson , form er Sen ior Vice Presiden t, for h er years of expert guidan ce xv

an d con tin uous supp ort for all of th e products in th e Pyramid to Success.

I would also like to ackn owledge Patricia Mieg, for- m er education al sales represen tative, wh o en couraged m e to subm it m y ideas an d in itial work for th e first edi- tion of th is book to th e W.B. Saun d ers Com pan y.

A very special an d h eartfelt th an k you goes to m y paren ts, wh o open ed th e door of oppo rtun ity in edu ca- tion for m e. I th an k m y m oth er, Fran ces Mary, for all of h er lo ve, supp ort, an d assistan ce as I con tin uo usly worked to ach ieve m y profession al goals. I th an k m y fath er, Arn old Lawren ce, wh o always provid ed in sigh tful words of en couragem en t. My m em ories of h is love an d support will always rem ain in m y h eart. I am certain th at h e would be very proud of m y profession al accom plish m en ts.

I also th an k m y en tire fam ily for bein g con tin uo usly supportive, givin g, an d h elpful durin g m y research an d preparation of th is publication .

I wan t to especially ackn owledge each an d every in dividual wh o con tribu ted to th is publication —th e reviewers, con tributors, item writers, an d updaters— for th eir expert in pu t an d ideas. I also th an k th e m an y faculty an d studen t reviewers of th e m an u script for

th eir th o ugh ts an d id eas. A very special th an k yo u to all of you!

I also n eed to th an k Salve Regin a Un iversity for th e opportun ity to edu cate n ursin g studen ts in th e baccalau- reate n ursin g program an d for its support durin g m y research an d writin g of th is publication . I would like to especially ackn o wledge m y colleagues Dr. Eileen Gray, Dr. Ellen McCarty, an d Dr. Beth an y Sykes for all of th eir en couragem en t an d supp ort.

I wish to ackn owledge th e Com m un ity College of Rh ode Islan d, wh ich provided m e with th e oppo rtun ity to edu cate n ursin g studen ts in th e Associate Degree of Nursin g Program . A special th an k yo u goes to Patricia Miller, MSN, RN, an d Mich elin a McClellan , MS, RN, from Baystate Med ical Cen ter, Sch ool of Nursin g, in Sprin gfield, Massach usetts, wh o were m y first m en tors in n ursin g education .

Fin ally, a very special th an k yo u to all of m y n ursin g studen ts—past, presen t, an d future. All of you ligh t up m y life! Your love an d ded ication to th e profession of n ursin g an d yo ur co m m itm en t to provid in g h ealth care will brin g n ever-en din g rewards!

Linda Anne Silvestri

xvi Acknowledgments

N

C

L

E

X

P

r

e

p

UNIT I

NCLEX-RN® Exam Preparation

C H A P T E R 1 The NCLEX-RN® Examination

The Pyramid to Success

Welcome to the Pyramid to Success Sa unders Comprehensive Review for t he NCLEX-RN® Exa mina t ion Saunders Comprehensive Review for the NCLEX-RN ® Exam- ination is specially design ed to h elp you begin your suc- cessful journ ey to th e peak of th e pyram id, beco m in g a registered n urse. As you begin your jou rn ey, yo u will be in trodu ced to all of th e im portan t poin ts regardin g th e NCLEX-RN exam in ation an d th e process of testin g, an d to th e un ique an d special tip s regardin g h ow to pre- pare yourself for th is im portan t exam in ation . You will read wh at a n ursin g graduate wh o recen tly passed th e NCLEX-RN exam in ation h as to say about th e test. Im portan t test-takin g strategies are detailed. Th ese details will guid e you in selectin g th e correct option or assist yo u in selectin g an an swer to a question at wh ich you m ust guess.

Each un it in th is book begin s with th e Pyram id to Success. Th e Pyram id to Success ad dresses specific poin ts related to th e NCLEX-RN exam in ation . Clien t Needs as iden tified in th e test plan fram ework for th e exam in ation are listed as well as learn in g objectives for th e un it. Pyr- am id Term s are key words th at are defin ed in th e glossary at th e en d of th e book an d set in color th rough ou t each ch apter to direct your atten tion to sign ifican t poin ts for th e exam in ation .

Th rough out each ch apter, you will fin d Pyram id Poin t bullets th at iden tify areas m ost likely to be tested on th e NCLEX-RN exam in ation . Read each ch apter, an d iden tify your stren gth s an d areas th at are in n eed of fur- th er review. Test your stren gth s an d abilities by takin g all practice tests provided in th is book an d on th e accom pa- n yin g Evolve site. Be sure to read all of th e ration ales an d test-takin g strategies. Th e ration ale provides yo u with sign ifican t in form ation regardin g th e co rrect an d in cor- rect option s. Th e test-takin g strategy provides you with th e logical path to selectin g th e correct option . Th e test-takin g strategy also iden tifies th e co n ten t area to review, if required. Th e referen ce source an d page n um - ber are provided so th at yo u can easily fin d th e in form a- tion th at you n eed to review. Each question is coded on th e basis of th e Level of Cogn itive Ability, th e Clien t

Needs category, th e In tegrated Process, Priority Con - cepts, an d th e n ursin g con ten t area.

Sa unders Q&A Review for the NCLEX-RN® Exa mina t ion Followin g th e com pletion of yo ur com preh en sive review in th is book, con tin ue on yo ur journ ey th rou gh th e Pyr- am id to Success with th e com pan ion book, Saunders Q&A Review for the NCLEX-RN® Examination. Th is book provides you with m ore th an 6000 practice question s in th e m ultiple-ch oice an d altern ate item form ats, in clud- in g audio an d video question s. Th e book is design ed based on th e NCLEX-RN exam in ation test plan fram e- work, with a specific focus on Clien t Needs an d In te- grated Processes. In ad dition , each practice question in th is book in cludes a Priority Nu rsin g Tip, wh ich pro- vides you with an im portan t piece of in form ation th at will be h elpful to an swer question s. Th en , you will be ready for HESI/Saunders Online Review for the NCLEX- RN® Examination. Addition al produ cts in Saun ders Pyr- am id to Success in clude Saunders Strategies for Test Suc- cess: Passing Nursing School and the NCLEX® Exam an d Saunders Q&A Review Cards for the NCLEX-RN ® Exam. Th ese products are described n ext.

HESI/ Sa unders Online Review for t he NCLEX-RN® Exa mina t ion Th is product addresses all areas of th e test plan id en tified by th e Nation al Coun cil of State Boards of Nu rsin g (NCSBN). Th e course con tain s a pretest th at provides feedback regardin g your stren gth s an d weakn esses an d gen erates an in dividualized study sch edule in a calen dar form at. Con ten t review is in an outlin e form at an d in cludes self-ch eck practice question s an d testlets (case studies) , figures an d illustration s, a glossary, an d an im a- tion s an d videos. Num erou s on lin e exam s are in cluded. Th ere are 2500 practice question s; th e types of question s in th is course in clude m ultiple-ch oice an d altern ate item form ats.

Sa unders St ra tegies for Test Success: Pa ssing Nursing School a nd t he NCLEX® Exa m Th is produ ct focuses on th e test-takin g strategies th at will h elp you to pass your n ursin g exam in ation s wh ile in n ursin g sch ool an d will prepare yo u for th e NCLEX-RN

N

C

L

E

X

P

r

e

p

2

exam in ation . Th e ch apters describe various test-takin g strategies an d in clude sam ple question s th at illustrate h ow to use th e strategies. Also in cluded in th is book is in form ation on cultural ch aracteristics an d practices, ph arm acology strategies, m edication an d in traven o us calculation s, laborato ry values, position in g guidelin es, an d th erap eutic diets. Th is book h as m ore th an 1200 practice question s, an d each question provid es a tip for th e begin n in g n ursin g studen t. Th e practice question s reflect th e fram ework an d th e con ten t iden tified in th e NCLEX-RN test plan an d in clude m ultiple-ch oice an d altern ate item form at question s, in cludin g audio an d video question s.

Sa unders Q&A Review Ca rds for t he NCLEX-RN® Exa m Th is product is organ ized by con ten t area an d the fram e- work of th e NCLEX-RN test plan . It provides you with 1200 un ique practice test question s on portable and easy-to-use cards. Th e cards h ave th e question on th e fron t of the card, and th e an swer, ration ale, an d test-takin g strategy are on th e back of the card. Th is product includes m ultiple-ch oice question s an d altern ate item form at question s, in cludin g fill-in -th e-blan k, m ultiple-respon se, ordered-respon se, figure, an d ch art/ exh ibit question s.

Sa unders RNt ert a inment for t he NCLEX-RN® Exa m RNtertain m en t: Th e NCLEX® Review Gam e, 2n d Edition is a revolution ary board gam e th at offers n ursin g stu- den ts a fun an d ch allen gin g ch an ge of pace from stan - dard review option s. 800 clin ical question s an d scen arios cover all th e m ajo r n ursin g categories on th e NCLEX® test plan —in cludin g Health Prom o tion an d Main ten an ce, Ph ysiological In tegrity, Psych osocial In tegrity, an d Safe an d Effective Care En viron m en t. Th is com pletely redesign ed secon d edition also features n ew altern ate item form ats, test-takin g tips an d test-takin g traps coverin g h elpful test takin g strategies an d tech - n iqu es, an d a ration ales booklet th at provides justifica- tion for correct an swers.

All produ cts in th e Sau n ders Pyram id to Success can be obtain ed on lin e by visitin g h ttp :/ / elsevierh ealth .com or by callin g 800-545-2522.

Let’s begin our journ ey th rou gh th e Pyram id to Success.

Examination Process

An im portan t step in th e Pyram id to Success is to beco m e as fam iliar as possib le with th e exam in ation process. Can did ates facin g th e ch allen ge of th is exam i- n ation can experien ce sign ifican t an xiety. Kn o win g wh at th e exam in ation is all about an d kn owin g wh at you will en coun ter durin g th e process of testin g will assist in alle- viatin g fear an d an xiety. Th e in form ation con tain ed in th is ch apter was obtain ed from th e NCSBN Web site

(h ttp :/ / www.n csbn .org) an d from th e NCSBN 2016 test plan for th e NCLEX-RN an d in cludes som e procedures related to registerin g for th e exam , testin g procedures, an d th e an swers to th e question s m ost com m on ly asked by n ursin g studen ts an d graduates preparin g to take th e NCLEX. You can obtain ad dition al in form ation regard- in g th e test an d its develo pm en t by accessin g th e NCSBN Web site an d clickin g on th e NCLEX Exam tab or by writ- in g to th e Nation al Coun cil of State Boards of Nursin g, 111 East Wacker Drive, Suite 2900, Ch icago, IL 60601. You are en couraged to access th e NCSBN Web site because th is site provides yo u with valuable in form ation about th e NCLEX an d oth er resou rces available to an NCLEX can didate.

Computer Adaptive Testing

Th e acron ym CAT stan d s for com pu ter adaptive test, wh ich m ean s th at th e exam in ation is created as th e test-taker an swers each question . All th e test question s are categorized on th e basis of th e test plan structure an d th e level of difficu lty of th e question . As you an swer a question , th e com pu ter determ in es your com peten cy based on th e an swer you selected. If you selected a cor- rect an swer, th e com puter scan s th e question ban k an d selects a m ore difficult question . If you selected an in cor- rect an swer, th e com puter scan s th e question ban k an d selects an easier question . Th is process con tin ues un til all test plan requirem en ts are m et an d a reliable pass- or-fail decision is m ade.

Wh en takin g a CAT, on ce an an swer is recorded, all subsequ en t question s adm in istered depen d, to an exten t, on th e an swer selected for th at question . Skip- pin g an d return in g to earlier question s are n ot com pat- ible with th e logical m eth od ology of a CAT. Th e in ability to skip question s or go back to ch an ge previous an swers will n ot be a disadvan tage to you; you will n ot fall in to th at “trap” of ch an gin g a correct an swer to an in correct on e with th e CAT system .

If you are faced with a question th at con tain s un fa- m iliar co n ten t, yo u m ay n eed to guess at th e an swer. Th ere is n o pen alty for gu essin g but you n eed to m ake an educated gu ess. With m ost of th e question s, th e an swer will be righ t th ere in fron t of you. If you n eed to gu ess, use your n ursin g kn owledge an d clin ical exp e- rien ces to th eir fullest exten t an d all of th e test-takin g strategies you h ave practiced in th is review program .

You do n ot n eed an y com pu ter experien ce to take th is exam in ation . A keyb oard tutorial is provided an d adm in istered to all test-takers at th e start of th e exam in a- tion . Th e tutorial will in struct you on th e use of th e on - screen option al calculator, th e use of th e m ouse, an d h ow to record an an swer. Th e tutorial provid es in struc- tion s on h ow to respo n d to all question types on th is exam in ation . Th is tutorial is provided on th e NCSBN Web site, an d you are en couraged to view th e tutorial

3CHAPTER 1 The NCLEX-RN® Examination

N

C

L

E

X

P

r

e

p

wh en you are preparin g for th e NCLEX exam in ation . In addition , at th e testin g site, a test adm in istrator is presen t to assist in explain in g th e use of th e com pu ter to en sure your full un d erstan din g of h ow to proceed.

Development of the Test Plan

Th e test plan for th e NCLEX-RN exam in ation is devel- oped by th e NCSBN. Th e exam in ation is a n ation al exam in ation ; th e NCSBN con siders th e legal scope of n ursin g practice as go vern ed by state laws an d regula- tion s, in cludin g th e Nurse Practice Act, an d uses th ese laws to defin e th e areas on th e exam in ation th at will assess th e com peten ce of th e test-taker for licen sure.

Th e NCSBN also co n ducts an im portan t study every 3 years, kn own as a practice an alysis study, to determ in e th e fram ework for th e test plan for th e exam in ation . Th e participan ts in th is study in clude n ewly licen sed regis- tered n urses from all types of basic n ursin g edu cation program s. From a list of n ursin g care activities provided, th e participan ts are asked ab out th e frequen cy an d im portan ce of perform in g th em in relation to clien t safety an d th e settin g in wh ich th ey are perform ed. A pan el of con ten t experts at th e NCSBN an alyzes th e results of th e study an d m akes decision s regardin g th e test plan fram ework. Th e results of th is recen tly con - ducted study provid ed th e structure for th e test plan im plem en ted in April 2016.

Test Plan

Th e con ten t of th e NCLEX-RN exam in ation reflects th e activities iden tified in th e practice an alysis study con - ducted by th e NCSBN. Th e question s are written to address Level of Cogn itive Ability, Clien t Needs, an d In tegrated Processes as iden tified in th e test plan devel- oped by th e NCSBN.

Level of Cognitive Ability Levels of cogn itive ability in clude kn owledge, under- stan din g, applyin g, analyzin g, syn th esizin g, evaluatin g, an d creatin g. Th e practice of n ursing requires com plex th ought processin g an d critical th in kin g in decision m ak- in g. Th erefore, you will n ot en coun ter an y kn owledge or un derstan din g question s on th e NCLEX. Q uestion s on th is exam in ation are written at th e applyin g level or at h igh er Levels of Cogn itive Ability. Box 1-1 presents an exam ple of a question th at requires you to apply data.

Client Needs Th e NCSBN iden tifies a test plan fram ework based on Clien t Needs, wh ich in cludes 4 m ajor categories. Som e of th ese categories are divided furth er in to subcategories. Th e Clien t Needs categories are Safe an d Effective Care En viron m en t, Health Prom o tion an d Main ten an ce,

Psych osocial In tegrity, an d Ph ysiological In tegrity (Table 1-1).

Sa fe a nd Effective Ca re Environment Th e Safe an d Effective Care En viron m en t category in cludes 2 subcategories: Man agem en t of Care, an d Safety an d In fection Con trol. Accordin g to th e NCSBN, Man agem en t of Care (17% to 23% of question s) addresses prioritizin g con ten t an d con ten t th at will en sure a safe care delivery settin g to protect clien ts, fam - ilies, sign ifican t oth ers, visitors, an d h ealth care perso n - n el. Th e NCSBN in dicates th at Safety an d In fection Con trol (9% to 15% of question s) addresses con ten t th at will protect clien ts, fam ilies, sign ifican t oth ers, vis- itors, an d h ealth care perso n n el from h ealth an d en vi- ron m en tal h azards with in h ealth care facilities an d in com m un ity settin gs. Box 1-2 presen ts exam ples of ques- tion s th at address th ese 2 subcategories.

BOX 1-1 Level of Cognitive Ability: Applying The nurse notes blanching, coolness, and edema at the peripheral intravenous (IV) site. On the basis of these find- ings, the nurse should implement which action? 1. Remove the IV. 2. Apply a warm compress. 3. Check for a blood return. 4. Measure the area of infiltration.

Answer: 1 This question requires that you focus on the data in the ques- tion and determine that the client is experiencing an infiltra- tion. Next, you need to consider the harmful effects of infiltration and determine the action to implement. Because infiltration can be damaging to the surrounding tissue, the appropriate action is to remove the IV to prevent any further damage.

TABLE 1-1 Client Needs Categories and Percentage of Questions on the NCLEX-RN Examination

Client Needs Category Percentage of Questions

Safe and Effective Care Environment Management of Care 17-23

Safety and Infection Control 9-15

Health Promotion and Maintenance 6-12

Psychosocial Integrity 6-12

Physiological Integrity Basic Care and Comfort 6-12

Pharmacological and Parenteral Therapies 12-18

Reduction of Risk Potential 9-15

Physiological Adaptation 11-17

4 UNIT I NCLEX-RN® Exam Preparation

N

C

L

E

X

P

r

e

p

Hea lt h Promot ion a nd Ma intena nce Th e Health Prom o tion an d Main ten an ce category (6% to 12% of question s) addresses th e prin ciples related to growth an d developm en t. Accordin g to th e NCSBN, th is Clien t Needs category also addresses con ten t required to assist th e clien t, fam ily m em bers, an d sign if- ican t oth ers to preven t h ealth problem s; to recogn ize alteration s in h ealth ; an d to develop h ealth practices th at prom o te an d support welln ess. See Box 1-3 for an exam ple of a question in th is Clien t Needs category.

Psychosocia l Int egrit y Th e Psych o social In tegrity category (6% to 12% of ques- tion s) ad dresses co n ten t required to prom o te an d sup- port th e ab ility of th e clien t, clien t’s fam ily, an d clien t’s sign ifican t oth er to cope, adap t, an d problem - solve durin g stressful even ts. Th e NCSBN also in dicates th at th is Clien t Needs category addresses th e em o tion al, m en tal, an d social well-bein g of th e clien t, fam ily, or sig- n ifican t oth er, an d care for th e clien t with an acute or ch ron ic m en tal illn ess. See Box 1-4 for an exam ple of a question in th is Clien t Needs category.

Physiologica l Integrity Th e Ph ysio lo gical In tegrity catego ry in clu d es 4 su b cat- ego ries: Basic Care an d Co m fo rt, Ph arm aco lo gical an d Paren teral Th erap ies, Red u ctio n o f Risk Po ten tial, an d

BOX 1-2 Safe and Effective Care Environment

Management of Care The nurse has received the client assignment for the day. Which client should the nurse assess first? 1. The client who needs to receive subcutaneous insulin

before breakfast 2. The client who has a nasogastric tube attached to intermit-

tent suction 3. The client who is 2 days postoperative and is complaining

of incisional pain 4. The client who has a blood glucose level of 50 mg/ dL

(2.8 mmol/ L) and complaints of blurred vision

Answer: 4 This question addresses the subcategory Management of Care in the Client Needs category Safe and Effective Care Envi- ronment. Note the strategic word, first, so you need to estab- lish priorities by comparing the needs of each client and deciding which need is urgent. The client described in the cor- rect option has a low blood glucose level and symptoms reflec- tive of hypoglycemia. This client should be assessed first so that treatment can be implemented. Although the clients in options 1, 2, and 3 have needs that require assessment, their assessments can wait until the client in the correct option is stabilized.

Safety and Infection Control The nurse prepares to care for a client on contact precautions who has a hospital-acquired infection caused by methicillin- resistant Staphylococcus aureus (MRSA). The client has an abdominal wound that requires irrigation and has a tracheos- tomy attached to a mechanical ventilator, which requires fre- quent suctioning. The nurse should assemble which necessary protective items before entering the client’s room? 1. Gloves and gown 2. Gloves and face shield 3. Gloves, gown, and face shield 4. Gloves, gown, and shoe protectors

Answer: 3 This question addresses the subcategory Safety and Infection Control in the Client Needs category Safe and Effective Care Environment. It addresses content related to protecting one- self from contracting an infection and requires that you con- sider the methods of possible transmission of infection, based on the client’s condition. Because splashes of infective material can occur during the wound irrigation or suctioning of the tracheostomy, option 3 is correct.

BOX 1-3 Health Promotion and Maintenance The nurse is choosing age-appropriate toys for a toddler. Which toy is the best choice for this age? 1. Puzzle 2. Toy soldiers 3. Large stacking blocks 4. A card game with large pictures

Answer: 3 This question addresses the Client Needs category Health Promotion and Maintenance and specifically relates to the principles of growth and development of a toddler. Note the strategic word, best. Toddlers like to master activities indepen- dently, such as stacking blocks. Because toddlers do not have the developmental ability to determine what could be harmful, toys that are safe need to be provided. A puzzle and toy sol- diers provide objects that can be placed in the mouth and may be harmful for a toddler. A card game with large pictures may require cooperative play, which is more appropriate for a school-age child.

BOX 1-4 Psychosocial Integrity A client with coronary artery disease has selected guided imagery to help cope with psychological stress. Which client statement indicates an understanding of this stress reduction measure? 1. “This will help only if I play music at the same time.” 2. “This will work for me only if I am alone in a quiet area.” 3. “I need to do this only when I lie down in case I fall asleep.” 4. “The best thing about this is that I can use it anywhere,

anytime.”

Answer: 4 This question addresses the Client Needs category Psychoso- cial Integrity and the content addresses coping mechanisms. Guided imagery involves the client creating an image in the mind, concentrating on the image, and gradually becoming less aware of the offending stimulus. It can be done anytime and anywhere; some clients may use other relaxation tech- niques or play music with it.

5CHAPTER 1 The NCLEX-RN® Examination

N

C

L

E

X

P

r

e

p

Ph ysio lo gical Ad ap tatio n . Th e NCSBN d escrib es th ese su b catego ries as fo llo ws. Basic Care an d Co m fo rt ( 6% to 12% o f q u estio n s) ad d resses co n ten t fo r p ro vid in g co m fo rt an d assistan ce to th e clien t in th e p erfo rm an ce o f activities o f d aily livin g. Ph arm aco lo gical an d Par- en teral Th erapies (12% to 18% of question s) addresses con ten t for adm in istering m edication s an d paren teral th erapies such as intraven ous th erapies an d paren teral n utrition , an d adm in isterin g blood an d blood products. Reduction of Risk Poten tial (9% to 15% of questions) addresses con ten t for preven tin g com plication s or h ealth problem s related to the clien t’s con dition or

an y prescribed treatm en ts or procedures. Ph ysiological Adaptation (11% to 17% of question s) addresses con ten t for providin g care to clien ts with acute, ch ron ic, or life-th reaten in g con dition s. See Box 1-5 for exam ples of question s in th is Clien t Needs category.

Integrated Processes Th e NCSBN iden tifies 5 processes in th e test plan th at are fun dam en tal to th e practice of n ursin g. Th ese processes are in corpo rated th rough ou t th e m ajor categories of Cli- en t Needs. Th e In tegrated Process subcategories are Car- in g, Com m un ication an d Docum en tation , Nu rsin g

BOX 1-5 Physiological Integrity Basic Care and Comfort Aclient with Parkinson’s disease develops akinesia while ambu- lating, increasing the risk for falls. Which suggestion should the nurse provide to the client to alleviate this problem? 1. Use a wheelchair to move around. 2. Stand erect and use a cane to ambulate. 3. Keep the feet close together while ambulating and use a

walker. 4. Consciously think about walking over imaginary lines on the

floor.

Answer: 4 This question addresses the subcategory Basic Care and Com- fort in the Client Needs category Physiological Integrity, and addresses client mobility and promoting assistance in an activ- ity of daily living to maintain safety. Clients with Parkinson’s dis- ease can develop bradykinesia (slow movement) or akinesia (freezing or no movement). Having these clients imagine lines on the floor to walk over can keep them moving forward while remaining safe.

Pharmacological and Parenteral Therapies The nurse monitors a client receiving digoxin for which early manifestation of digoxin toxicity? 1. Anorexia 2. Facial pain 3. Photophobia 4. Yellow color perception

Answer: 1 This question addresses the subcategory Pharmacological and Parenteral Therapies in the Client Needs category Physiological Integrity. Note the strategic word, early. Digoxin is a cardiac gly- coside that is used to manage and treat heart failure and to con- trol ventricular rates in clients with atrial fibrillation. The most common early manifestations of toxicity include gastrointesti- nal disturbances such as anorexia, nausea, and vomiting. Neu- rological abnormalities can also occur early and include fatigue, headache, depression, weakness, drowsiness, confusion, and nightmares. Facial pain, personality changes, and ocular distur- bances (photophobia, diplopia, light flashes, halos around bright objects, yellow or green color perception) are also signs of toxicity, but are not early signs.

Reduction of Risk Potential A magnetic resonance imaging (MRI) study is prescribed for a client with a suspected brain tumor. The nurse should imple- ment which action to prepare the client for this test? 1. Shave the groin for insertion of a femoral catheter. 2. Remove all metal-containing objects from the client. 3. Keep the client NPO (nil per os; nothing by mouth) for 6 hours

before the test. 4. Instruct the client in inhalation techniques for the adminis-

tration of the radioisotope.

Answer: 2 This question addresses the subcategory Reduction of Risk Potential in the Client Needs category Physiological Integrity, and the nurse’s responsibilities in preparing the client for the diagnostic test. In an MRI study, radiofrequency pulses in a mag- netic field are converted into pictures. All metal objects, such as rings, bracelets, hairpins, and watches, should be removed. In addition, a history should be taken to ascertain whether the client has any internal metallic devices, such as orthopedic hardware, pacemakers, or shrapnel. NPO status is not necessary for an MRI study of the head. The groin may be shaved for an angio- gram, and inhalation of the radioisotope may be prescribed with other types of scans but is not a part of the procedures for an MRI.

Physiological Adaptation A client with renal insufficiency has a magnesium level of 3.5 mEq/ L (1.75 mmol/ L). On the basis of this laboratory result, the nurse interprets which sign as significant? 1. Hyperpnea 2. Drowsiness 3. Hypertension 4. Physical hyperactivity

Answer: 2 This question addresses the subcategory Physiological Adap- tation in the Client Needs category Physiological Integrity. It addresses an alteration in body systems. The normal magnesium level is 1.5 to 2.5 mEq/ L(0.75 to 1.25 mmol/ L). A magnesium level of 3.5 mEq/ L (1.75 mmol/ L) indicates hyper- magnesemia. Neurological manifestations begin to occur when magnesium levels are elevated and are noted as symptoms of neurological depression, such as drowsiness, sedation, leth- argy, respiratory depression, muscle weakness, and areflexia. Bradycardia and hypotension also occur.

6 UNIT I NCLEX-RN® Exam Preparation

N

C

L

E

X

P

r

e

p

Process (Assessm ent, Analysis, Plan n in g, Im plem en tation , and Evaluation ), Culture an d Spirituality, an d Teachin g and Learn in g. See Box 1-6 for an exam ple of a question that in corporates th e In tegrated Process of Carin g.

Types of Questions on the Examination

Th e types of question s that m ay be adm in istered on the exam in ation in clude m ultiple-ch oice; fill-in -the-blan k; m ultiple-respon se; ordered-respon se (also kn own as drag and drop); question s th at con tain a figure, ch art/ exh ibit, or graph ic option item ; an d audio or video item form ats. Som e question s m ay require you to use the m ouse an d cursor on th e com puter. For exam ple, you m ay be pre- sen ted with a picture that displays th e arterial vessels of an adult clien t. In th is picture, you m ay be asked to “poin t and click” (usin g the m ouse) on th e area (h ot spot) where the dorsalis pedis pulse could be felt. In all types of ques- tion s, th e an swer is scored as eith er righ t or wron g. Credit is n ot given for a partially correct an swer. In addition , all question types m ay in clude pictures, graph ics, tables, ch arts, soun d, or video. Th e NCSBN provides specific directions for you to follow with all question types to guide you in your process of testing. Be sure to read th ese directions as they appear on th e com puter screen. Exam - ples of som e of th ese types of question s are n oted in this ch apter. All question types are provided in th is book an d on th e accom pan yin g Evolve site.

Multiple-Choice Questions Man y of th e question s th at you will be asked to an swer will be in th e m ultiple-ch oice form at. Th ese question s

provide you with data about a clien t situation an d 4 an swers, or option s.

Fill-in-the-Blank Questions Fill-in -th e-blan k question s m ay ask you to perform a m edication calculation , determ in e an in traven o us flow rate, or calculate an in take or outp ut record on a clien t. You will n eed to type on ly a n um ber (you r an swer) in th e an swer box. If th e question requires roun din g th e an swer, th is n eeds to be perform ed at th e en d of th e cal- culation . Th e rules for roun din g an an swer are described in th e tutorial provided by th e NCSBN, an d are also pro- vided in th e specific question on th e com puter screen . In addition , you m ust type in a decim al poin t if n ecessary. See Box 1-7 for an exam ple.

Multiple-Response Questions For a m ultiple-respon se question , you will be asked to select or ch eck all of th e options, such as n ursing in terven - tion s, that relate to the in form ation in th e question . In these question types, th ere m ay be 2 or m ore correct an swers. No partial credit is given for correct selection s. You n eed to do exactly as th e question asks, which will be to select all of th e option s th at apply. See Box 1-8 for an exam ple.

Ordered-Response Questions In th is type of question , you will be asked to use th e com - puter m ouse to drag an d drop your n ursin g action s in order of priority. In form ation will be presen ted in a question an d, based on th e data, you n eed to determ in e wh at yo u will do first, secon d, th ird, an d so forth . Th e un ordered option s will be located in boxes on th e left side of th e screen , an d you n eed to m ove all option s in order of prio rity to ordered-respon se boxes on th e

BOX 1-6 Integrated Processes A client is scheduled for angioplasty. The client says to the nurse, “I’m so afraid that it will hurt and will make me worse off than I am.” Which response by the nurse is therapeutic? 1. “Can you tell me what you understand about the

procedure?” 2. “Your fears are a sign that you really should have this

procedure.” 3. “Those are very normal fears, but please be assured that

everything will be okay.” 4. “Try not to worry. This is a well-known and easy procedure

for the health care provider.”

Answer: 1 This question addresses the subcategory Caring in the cate- gory Integrated Processes. The correct option is a therapeutic communication technique that explores the client’s feelings, determines the level of client understanding about the proce- dure, and displays caring. Option 2 demeans the client and does not encourage further sharing by the client. Option 3 does not address the client’s fears, provides false reassurance, and puts the client’s feelings on hold. Option 4 diminishes the client’s feelings by directing attention away from the client and toward the health care provider’s importance.

BOX 1-7 Fill-in-the-Blank Question A prescription reads: acetaminophen liquid, 650 mg orally every 4 hours PRN for pain. The medication label reads: 500 mg/ 15 mL. The nurse prepares how many milliliters to administer 1 dose? Fill in the blank. Record your answer using one decimal place.

Answer: 19.5 mL Formula:

Desired Available

 volume¼ mL

650 mg 500 mg

 15 mL¼ 19:5 mL

In this question, you need to use the formula for calculat- ing a medication dose. When the dose is determined, you will need to type your numeric answer in the answer box. Always follow the specific directions noted on the computer screen. Also, remember that there will be an on-screen calculator on the computer for your use.

7CHAPTER 1 The NCLEX-RN® Examination

N

C

L

E

X

P

r

e

p

righ t side of th e screen . Specific direction s for m ovin g th e option s are provid ed with th e question . See Figure 1-1 for an exam ple. Exam ples of th is question type are located on th e accom pan yin g Evo lve site.

Figure Questions A question with a picture or graph ic will ask you to an swer th e question based on th e picture or graph ic. Th e ques- tion could con tain a ch art, a table, or a figure or illustra- tion . You also m ay be asked to use the com puter m ouse to poin t an d click on a specific area in th e visual. A figure or illustration m ay appear in an y type of question , in cludin g a m ultiple-ch oice question . See Box 1-9 for an exam ple.

Chart/Exhibit Questions In this type of question, you will be presen ted with a problem an d a ch art or exh ibit. You will be provided with 3 tabs or buttons th at you n eed to click to obtain th e in form ation n eeded to an swer th e question . A prom pt or m essage will appear th at will indicate th e n eed to click on a tab or button . See Box 1-10 for an exam ple.

Graphic Option Questions In th is typ e of question , th e option selection s will be pic- tures rath er th an text. Each option will be preceded by a circle, an d you will n eed to use th e co m puter m ou se to click in th e circle th at represen ts your an swer ch oice. See Box 1-11 for an exam ple.

Audio Questions Audio question s will require listenin g to a sound to answer th e question . Th ese question s will prom pt you to use th e h eadset provided an d to click on the soun d icon . You will be able to click on th e volum e button to adjust the volum e to your com fort level, an d you will be able to listen to th e

BOX 1-8 Multiple-Response Question The emergency department nurse is caring for a child sus- pected of acute epiglottitis. Which interventions apply in the care of the child? Select all that apply.

1. Obtain a throat culture. 2. Ensure a patent airway. 3. Prepare the child for a chest x-ray. 4. Maintain the child in a supine position. 5. Obtain a pediatric-size tracheostomy tray. 6. Place the child on an oxygen saturation monitor.

In a multiple-response question, you will be asked to select or check all of the options, such as interventions, that relate to the information in the question. To answer this question, recall that acute epiglottitis is a serious obstructive inflamma- tory process that requires immediate intervention and that air- way patency is a priority. Examination of the throat with a tongue depressor or attempting to obtain a throat culture is contraindicated because the examination can precipitate fur- ther obstruction. A lateral neck and chest x-ray is obtained to determine the degree of obstruction, if present. To reduce respiratory distress, the child should sit upright. The child is placed on an oxygen saturation monitor to monitor oxygena- tion status. Tracheostomy and intubation may be necessary if respiratory distress is severe. Remember to follow the specific directions given on the computer screen.

FIGURE 1-1 Example of an ordered-response question.

8 UNIT I NCLEX-RN® Exam Preparation

N

C

L

E

X

P

r

e

p

soun d as m an y tim es as n ecessary. Con ten t exam ples include, but are n ot lim ited to, various lun g sounds, h eart soun ds, or bowel soun ds. Exam ples of th is question type are located on th e accom pan yin g Evolve site (Fig. 1-2).

Video Questions Video question s will require viewin g of an an im ation or video clip to an swer th e question . Th ese question s will prom p t you to click on th e video icon . Th ere m ay be soun d associated with th e an im ation an d video, in wh ich case yo u will be prom p ted to use th e h ead set.

BOX 1-9 Figure Question A client who experienced a myocardial infarction is being monitored via cardiac telemetry. The nurse notes the sudden onset of this cardiac rhythm on the monitor (refer to figure) and immediately takes which action?

1. Takes the client’s blood pressure 2. Initiates cardiopulmonary resuscitation (CPR) 3. Places a nitroglycerin tablet under the client’s tongue 4. Continues to monitor the client and then contacts the health care provider (HCP)

Answer: 2 This question requires you to identify the cardiac rhythm, and then determine the priority nursing action. Note the strategic word, immediately. This cardiac rhythm identifies a coarse ventricular fibrillation (VF). The goals of treatment are to terminate VF promptly and to convert it to an organized rhythm. The HCP or an Advanced Cardiac Life Support (ACLS)–qualified nurse must immediately defibrillate the client. If a defibrillator is not readily available, CPR is initiated until the defibrillator arrives. Options 1, 3, and 4 are incorrect actions and delay life-saving treatment.

BOX 1-10 Chart/ Exhibit Question Client’s Chart

History and physical Medications

Diagnostic results

Item 1: Has renal calculi Item 2: Had throm- bophlebitis 1 year ago

Item 3: Multivita- min orally daily

Item 4: Electrocar- diogram normal

The nurse reviews the history and physical examination documented in the medical record of a client requesting a pre- scription for oral contraceptives. The nurse determines that oral contraceptives are contraindicated because of which documented item? Refer to chart.

Answer: 2 This chart/ exhibit question provides you with data from the cli- ent’s medical record and asks you to identify the item that is a contraindication to the use of oral contraceptives. Oral contra- ceptives are contraindicated in women with a history of any of the following: thrombophlebitis and thromboembolic disor- ders, cardiovascular or cerebrovascular diseases (including stroke), any estrogen-dependent cancer or breast cancer, benign or malignant liver tumors, impaired liver function, hypertension, and diabetes mellitus with vascular involvement. Adverse effects of oral contraceptives include increased risk of superficial and deep venous thrombosis, pulmonary embolism, thrombotic stroke (or other types of strokes), myocardial infarc- tion, and accelerations of preexisting breast tumors.

BOX 1-11 Graphic Options Question The nurse should place the client in which position to admin- ister an enema? (Refer to the figures in 1 to 4.)

1.

2.

3.

4.

Answer: 2 This question requires you to select the picture that represents your answer choice. To administer an enema, the nurse assists the client into the left side-lying (Sims’) position with the right knee flexed. This position allows the enema solution to flow downward by gravity along the natural curve of the sig- moid colon and rectum, improving the retention of solution. Option 1 is a prone position. Option 3 is a dorsal recumbent position. Option 4 is a supine position.

9CHAPTER 1 The NCLEX-RN® Examination

N

C

L

E

X

P

r

e

p

Con ten t exam ples in clude, but are n ot lim ited to, assess- m en t tech n iques, n ursin g procedures, or com m un ica- tion skills. Exam ples of th is question type are located on th e acco m pan yin g Evolve site (Fig. 1-3).

Registering to Take the Examination

It is im portan t to obtain an NCLEX Exam in ation Can di- date Bulletin from th e NCSBN Web site at www.n csbn . org because th is bulletin provides all of th e in form ation you n eed to register for and sch edule your exam in ation . It also provides you with Web site an d telephon e in form a- tion for NCLEX exam in ation con tacts. Th e in itial step in th e registration process is to subm it an application to th e state board of n ursin g in th e state in wh ich you in ten d to obtain licen sure. You n eed to obtain in form ation from th e board of n ursin g regardin g the specific registration process because th e process m ay vary from state to state. Th en , use th e NCLEX Exam in ation Can didate Bulletin as your guide to com plete th e registration process.

Followin g th e registration in structions an d com plet- in g the registration form s precisely an d accurately are im portan t. Registration form s n ot properly com plet- ed or n ot accom pan ied by the proper fees in the required m eth od of paym en t will be returned to you and will delay testin g. You m ust pay a fee for takin g the exam in ation; you also m ay h ave to pay additional fees to the board of n ursin g in the state in which you are applyin g.

Authorization to Test Form and Scheduling an Appointment

O n ce you are eligible to test, yo u will receive an Auth o- rization to Test (ATT) form . You can n ot m ake an appoin tm en t un til yo u receive an ATT form . Note th e validity dates on th e ATT form , an d sch edule a testin g date an d tim e before th e expiration date on th e ATT form . Th e NCLEX Exam in ation Can did ate Bulletin pro- vides yo u with th e direction s for sch edulin g an appoin t- m en t an d you do n ot h ave to take th e exam in ation in th e sam e state in wh ich you are seekin g licen su re.

Th e ATT form con tain s im portan t in form ation , in cludin g yo ur test auth o rization n um ber, can didate iden tification n um ber, an d validity date. You n eed to take your ATT form to th e testin g cen ter on th e day of your exam in ation . You will n ot be adm itted to th e exam - in ation if yo u do n ot h ave it.

Changing Your Appointment

If for an y reason you n eed to ch an ge your appointm en t to test, you can m ake th e ch an ge on the can didate Web site or by callin g can didate services. Refer to th e NCLEXExam in a- tion Candidate Bulletin for this contact in form ation an d oth er im portan t procedures for can celing an d chan gin g an appoin tm en t. If you fail to arrive for the exam in ation

FIGURE 1-2 Example of an audio question.

10 UNIT I NCLEX-RN® Exam Preparation

N

C

L

E

X

P

r

e

p

or fail to can cel your appoin tm en t to test without provid- in g appropriate n otice, you will forfeit your exam in ation fee and your ATT form will be in validated. Th is in form a- tion will be reported to th e board of n ursin g in th e state in which you h ave applied for licensure, an d you will be required to register and pay th e testin g fees again .

Day of the Examination

It is im portan t th at you arrive at the testin g cen ter at least 30 m in utes before th e test is sch eduled. If you arrive late for th e sch eduled testin g appoin tm en t, you m ay be required to forfeit your exam in ation appoin tm en t. If it is necessary to forfeit your appoin tm en t, you will n eed to reregister for th e exam in ation an d pay an addition al fee. Th e board of n ursin g will be n otified th at you did n ot take th e test. A few days before your sch eduled date of testin g, take th e tim e to drive to th e testin g cen ter to determ in e its exact location, th e len gth of tim e required to arrive at th at des- tin ation , an d an y potential obstacles th at m igh t delay you, such as road con struction , traffic, or parkin g sites.

In ad dition to th e ATT form , you m ust h ave proper iden tification (ID) such as a U.S. driver’s licen se, pass- port, U.S. state ID, or U.S. m ilitary ID to be adm itted to take th e exam in ation . All acceptable iden tification m ust be valid an d n ot expired an d con tain a ph otograph an d sign ature (in En glish ). In addition , th e first an d last n am es on th e ID m ust m atch th e ATT form . Accordin g to th e NCSBN guidelin es, an y n am e discrepan cies require

legal docum en tation , such as a m arriage licen se, divorce decree, or court action legal n am e ch an ge.

Testing Accommodations

If you require testin g accom m odation s, you should con - tact the board of n ursin g before subm ittin g a registration form . Th e board of n ursin g will provide th e procedures for the request. The board of n ursin g m ust auth orize testin g accom m odation s. Followin g board of n ursing approval, the NCSBN reviews th e requested accom m odation s and m ust approve th e request. If th e request is approved, th e can didate will be n otified an d provided th e procedure for registerin g for and sch edulin g the exam in ation .

Testing Center

Th e testin g cen ter is design ed to en sure com plete security of the testin g process. Strict can didate iden tification requirem en ts h ave been establish ed. You will be asked to read the rules related to testin g. A digital fin gerprin t an d palm vein prin t will be taken . A digital signature an d ph o- tograph will also be taken at the testin g cen ter. These iden - tity con firm ation s will accom pan y th e NCLEX exam results. In addition, if you leave th e testin g room for an y rea- son , you m ay be required to perform th ese iden tity confir- m ation procedures again to be readm itted to th e room .

Person al belon gin gs are n ot allowed in th e testin g room ; all electron ic devices m ust be placed in a sealable

FIGURE 1-3 Example of a video question.

11CHAPTER 1 The NCLEX-RN® Examination

N

C

L

E

X

P

r

e

p

bag provided by th e test ad m in istrator an d kept in a locker. An y eviden ce of tam perin g with th e bag could result in an in ciden t an d a result can cellation . A locker an d lo cker key will be provid ed for you; h owever, storage space is lim ited, so you m ust plan acco rdin gly. In addi- tion , th e testin g cen ter will n ot assum e respo n sibility for your perso n al belon gin gs. Th e testin g waitin g areas are gen erally sm all; frien ds or fam ily m em bers wh o accom - pan y you are n ot perm itted to wait in th e testin g cen ter wh ile you are takin g th e exam in ation .

O n ce you h ave com pleted th e adm ission process, th e test adm in istrator will escort you to th e assign ed com - puter. You will be seated at an in dividual workspace area th at includes com puter equipm en t, appropriate ligh tin g, an erasable n ote board, an d a m arker. No item s, in cludin g un auth orized scratch paper, are allowed in to th e testin g room . Eatin g, drin kin g, or th e use of tobacco is n ot allowed in th e testin g room . You will be observed at all tim es by th e test adm in istrator wh ile takin g th e exam in a- tion . In addition , video an d audio recordin gs of all test ses- sions are m ade. Th e testin g cen ter h as n o con trol over th e soun ds m ade by typin g on th e com puter by oth ers. If these soun ds are distractin g, raise your h an d to sum m on th e test adm in istrator. Earplugs are available on request.

You m ust follow th e direction s given by th e testin g cen - ter staff an d m ust rem ain seated durin g th e test except wh en auth orized to leave. If you th in k th at you h ave a problem with the com puter, n eed a clean n ote board, n eed to take a break, or n eed the test adm in istrator for an y rea- son , you m ust raise your h an d. You are also en couraged to access th e NCSBN can didate Web site to obtain addition al in form ation about th e physical en vironm en t of th e testin g cen ter an d to view a virtual tour of th e testin g cen ter.

Testing Time

Th e m axim u m testin g tim e is 6 h ours; th is period in cludes th e tutorial, th e sam ple item s, all breaks, an d th e exam in ation . All breaks are option al. Th e first option al break will be offered after 2 h ours of testin g. Th e secon d option al break is offered after 3.5 h ours of testin g. Rem em b er th at all breaks coun t again st testin g tim e. If you take a break, you m ust leave th e testin g ro om an d, wh en you return , you m ay be required to perform iden tity con firm ation proced ures to be readm itted.

Length of the Examination

Th e m in im um n um ber of question s th at you will n eed to an swer is 75. O f these 75 question s, 60 will be operation al (scored) question s an d 15 will be pretest (un scored) question s. Th e m axim um n um ber of question s in th e test is 265. Fifteen of the total n um ber of question s th at you n eed to an swer will be pretest (un scored) question s.

Th e pretest question s are question s th at m ay be pre- sen ted as scored question s on future exam in ation s.

Th ese pretest question s are n ot iden tified as such . In oth er words, you do n ot kn ow wh ich question s are th e pretest (un sco red) question s; h owever, th ese pretest (un scored) question s will be adm in istered am on g th e first 75 question s in th e test.

Pass-or-Fail Decisions

All exam in ation question s are categorized by test plan area an d level of difficulty. Th is is an im portan t poin t to keep in m in d wh en you con sider h ow th e com puter m akes a pass-or-fail decision because a pass-or-fail decision is n ot based on a percen tage of correctly an swered question s.

Th e NCSBN in dicates th at a pass-or-fail decision is govern ed by 3 differen t scen arios. Th e first scen ario is th e 95% Con fid en ce In terval Rule, in wh ich th e com - puter stops ad m in isterin g test question s wh en it is 95% certain th at th e test-taker’s ability is clearly above th e passin g stan dard or clearly below th e passin g stan - dard. Th e secon d scen ario is kn own as th e Maxim u m - Len gth Exam , in wh ich th e fin al ability estim ate of th e test-taker is con sidered. If th e fin al ability estim ate is above th e passin g stan dard, th e test-taker passes; if it is below th e passin g stan dard, th e test-taker fails.

Th e th ird scen ario is th e Run -O ut-O f-Tim e (R.O.O .T) Rule. If th e exam in ation en ds because the test-taker ran out of tim e, th e com puter m ay n ot h ave en ough in form a- tion with 95% certain ty to m ake a clear pass-or-fail deci- sion . If this is the case, the com puter will review th e test-taker’s perform an ce durin g testin g. If th e test-taker h as n ot an swered th e m in im um n um ber of required ques- tion s, th e test-taker fails. If th e test-taker’s ability estim ate was con sisten tly above the passing stan dard on th e last 60 question s, th e test-taker passes. If th e test-taker’s ability estim ate falls below the passin g stan dard, even on ce, th e test-taker fails. Addition al inform ation about pass- or-fail decision s can be foun d in th e NCLEX Exam in ation Can didate Bulletin located at www.n csbn .org.

Completing the Examination

Wh en th e exam in ation h as en ded, you will co m plete a brief com puter-delivered question n aire about your testin g experien ce. After you com plete th is question - n aire, you n eed to raise your h an d to sum m on th e test adm in istrator. Th e test adm in istrator will collect an d in ven tory all n ote boards an d th en perm it yo u to leave.

Processing Results

Every com puterized exam in ation is scored twice, on ce by th e com puter at th e testin g cen ter an d again after th e exam in ation is tran sm itted to th e test scorin g cen ter. No results are released at th e testin g cen ter; testin g cen ter staff do n ot h ave access to exam in ation results. Th e board of n ursin g receives your result an d yo ur result will

12 UNIT I NCLEX-RN® Exam Preparation

N

C

L

E

X

P

r

e

p

be m ailed to you approxim ately 1 m on th after you take th e exam in ation . In som e states, an un o fficial result can be obtain ed via th e Q uick Resu lts Service 2 busin ess days after takin g th e exam in ation . Th ere is a fee for th is service an d in form ation about obtain in g your NCLEX result by th is m eth od can be obtain ed on th e NCSBN Web site un der can didate services.

Candidate Performance Report

A can didate perform an ce report is provided to a test-taker who failed th e exam in ation . This report provides th e test- taker with in form ation about h er or h is stren gth s and weakn esses in relation to th e test plan fram ework an d pro- vides a guide for studyin g an d retakin g th e exam in ation . If a retake is n ecessary, th e can didate m ust wait 45 to 90 days between exam in ation adm in istration , depen din g on state procedures. Test-takers sh ould refer to th e state board of n ursin g in th e state in wh ich licen sure is sough t for proce- dures regardin g when th e exam in ation can be taken again .

Interstate Endorsement

Becau se th e NCLEX-RN exam in ation is a n ation al exam - in ation , you can apply to take th e exam in ation in an y state. Wh en licen su re is received, you can apply for in ter- state en dorsem en t, wh ich is obtain in g an oth er licen se in an oth er state to practice n ursin g in th at state. Th e pro- cedu res an d requirem en ts for in terstate en dorsem en t m ay vary from state to state, an d th ese procedures can be obtain ed from th e state board of n ursin g in th e state in wh ich en dorsem en t is sough t.

Nurse Licensure Compact

It m ay be possible to practice n ursin g in an oth er state un der th e m utual recogn ition m odel of n ursin g licen sure if th e state h as en acted a Nurse Licen sure Com pact. To obtain inform ation about th e Nurse Licen sure Com pact and th e states th at are part of th is in terstate com pact, access the NCSBN Web site at h ttp:/ / www.ncsbn .org.

The Foreign-Educated Nurse

An im portan t first step in th e process of obtain in g infor- m ation about becom in g a registered n urse in the Un ited States is to access the NCSBN Web site at h ttp:/ / www. n csbn .org an d obtain in form ation provided for in tern a- tion al n urses in th e NCLEX Web site lin k. Th e NCSBN provides inform ation about som e of th e docum en ts you n eed to obtain as an intern ational n urse seekin g licen sure in th e Un ited States an d about creden tialin g agen cies. Refer to Box 1-12 for a listin g of som e of th ese

docum ents. Th e NCSBN also provides in form ation regardin g the requirem en ts for education and En glish proficien cy, an d im m igration requirem en ts such as visas an d VisaScreen . You are en couraged to access th e NCSBN Web site to obtain th e m ost curren t in form ation about seekin g licen sure as a registered n urse in th e Un ited States.

An im portan t factor to con sider as you pursue th is process is th at som e requirem en ts m ay vary from state to state. You n eed to con tact th e board of n ursin g in th e state in wh ich yo u are plan n in g to obtain licen su re to determ in e th e specific requirem en ts an d docum en ts th at yo u n eed to subm it.

Boards of n ursin g can decide eith er to use a creden tial- in g agency to evaluate your docum en ts or to review your docum ents at th e specific state board, kn own as in-house evaluation . When you contact the board of n ursin g in th e state in wh ich you in ten d to work as a n urse, in form them that you were educated outside of the United States an d ask that th ey sen d you an application to apply for licen sure by exam in ation. Be sure to specify that you are applyin g for registered n urse (RN) licensure. You sh ould also ask about the specific docum en ts n eeded to becom e eligible to take th e NCLEX exam . You can obtain contact in form a- tion for each state board of n ursin g through the NCSBN Web site at h ttp:/ / www.ncsbn .org. In addition , you can write to th e NCSBN regardin g the NCLEX exam . Th e address is 111 East Wacker Drive, Suite 2900, Ch icago, IL 60601. Th e telephon e n um ber for the NCSBN is 1-866-293-9600; in tern ational teleph on e is 011 1 312 525 3600; the fax n um ber is 1-312-279-1032.

BOX 1-12 Foreign-Educated Nurse: Some Documents Needed to Obtain Licensure

1. Proof of citizenship or lawful alien status 2. Work visa 3. VisaScreen certificate 4. Commission on Graduates of Foreign Nursing Schools

(CGFNS) certificate 5. Criminal background check documents 6. Official transcripts of educational credentials sent directly

to credentialing agency or board of nursing from home country school of nursing

7. Validation of a comparable nursing education as that pro- vided in U.S. nursing programs; this may include theoretical instruction and clinical practice in a variety of nursing areas, including, but not limited to, medical nursing, surgical nurs- ing, pediatric nursing, maternityand newborn nursing, com- munityand public health nursing, and mentalhealth nursing

8. Validation of safe professional nursing practice in home country

9. Copy of nursing license or diploma or both 10. Proof of proficiency in the English language 11. Photograph(s) 12. Social Security number 13. Application and fees

13CHAPTER 1 The NCLEX-RN® Examination

N

C

L

E

X

P

r

e

p

C H A P T E R 2 Pathways to Success Laurent W. Valliere, BS, DD

The Pyramid to Success

Preparin g to take th e NCLEX-RN® exam in ation can pro- duce a great deal of an xiety. You m ay be th in kin g th at th is exam is th e m ost im portan t on e you will ever h ave to take an d th at it reflects th e culm in ation of everyth in g you h ave worked so h ard for. Th is is an im portan t exam - in ation because receivin g your n ursin g licen se m ean s th at you can begin your career as a registered n urse. Your success on th is exam in volves gettin g rid of all th o ugh ts th at allow th is exam in ation to appear overwh elm in g an d in tim idatin g. Such th ough ts can take com plete con tro l over your destin y. A stron g positive attitu de, a structured plan for preparatio n , an d m ain tain in g con - trol in your path way to success en sure reach in g th e peak of th e Pyram id to Success ( Fig. 2-1).

Pathways to Success ( Box 2-1) Foundation Th e foun dation of path ways to success begin s with a stron g positive attitude, the belief th at you will ach ieve success, and developin g con trol. It also in cludes develop- in g a list of your person al short-term an d lon g-term goals an d a plan for preparation . With out th ese com pon en ts, your path way to success leads to n owh ere an d h as n o en dpoin t. You will expen d en ergy an d valuable tim e in your journ ey, lack con trol over wh ere you are h eadin g, an d experien ce exh austion with out an y accom plish m en t.

Wh ere do yo u start? To begin , fin d a lo cation th at offers solitude. Sit or lie in a com fo rtable position , clo se your eyes, relax, in h ale deeply, h old yo ur breath to a coun t of 4, exh ale slowly, an d, again , relax. Repeat th is breath in g exercise several tim es un til you feel relaxed, free from an xiety, an d in con trol of your destin y. Allow your m in d to beco m e vo id of all m in d ch atter; n ow you are in con trol an d your m in d’s eye can see for m iles. Next, reflect on all th at you h ave acco m plish ed an d th e path th at brough t yo u to wh ere you are today. Keep a journ al of your reflection s as you plan th e order of your journ ey th rough th e Pyram id to Success.

List It is tim e to create th e “List.” Th e List is your set of sh o rt- term an d lon g-term go als. Begin by develo pin g th e go als th at you wish to acco m plish today, tom o rrow, over th e n ext m on th , an d in th e future. Allow yourself th e oppo r- tun ity to list all th at is flo win g from your m in d . Write your goals in your person al jou rn al. Wh en th e List is com plete, put it away for 2 or 3 days. After th at tim e, retrieve an d review th e List an d begin th e process of plan n in g to prepare for th e NCLEX-RN exam .

Plan for Preparation Now th at you h ave th e List in order, lo ok at th e go als th at relate to studyin g for th e licen sin g exam . Th e first task is to decide wh at study pattern works best for you. Th in k about wh at h as worked m ost successfully for you in th e past. Q uestion s th at m ust be addressed to develop your plan for study are listed in Box 2-2.

Th e plan m ust in clude a sch edule. Use a calen dar to plan an d docum en t th e daily tim es an d n ursin g con ten t areas for your study session s. Establish a realistic sch ed- ule th at in cludes yo ur daily, weekly, an d future goals, an d stick to your plan of study. Th is con sisten cy will provide advan tages to you an d th e people supportin g you. You will develo p a rh yth m th at can en h an ce yo ur reten tion an d positive m om en tum . Th e people wh o are supportin g you will sh are th is rh yth m an d be able to sch edule th eir activities an d lives better wh en you are con sisten t with yo ur study sch edule.

Th e len gth of th e study session depen ds on your abil- ity to focus an d con cen trate. You n eed to th in k about quality rath er th an quan tity wh en you are decidin g on a realistic am oun t of tim e for each session . Plan to sch ed- ule at least 2 h ours of quality study tim e daily. If you can spen d m ore th an 2 h ours, by all m ean s do so.

You m ay ask, “Wh at do yo u m ean by quality study tim e?” Q uality study tim e m ean s spen d in g un in ter- rupted quiet tim e at your study session . Th is m ay m ean th at you h ave to isolate yo urself for th ese study session s. Th in k again about wh at h as worked for yo u durin g n urs- in g sch ool wh en yo u studied for exam in ation s; select a study place th at h as worked for yo u in th e past. If you

N

C

L

E

X

P

r

e

p

14

h ave a special study room at h om e th at you h ave always used, plan your study session s in th at special room . If you h ave always studied at a library, plan yo ur study ses- sion s at th e library. Som etim es it is difficu lt to balan ce your study tim e with your fam ily obligation s an d possi- bly a work sch edule, but, if yo u can , plan your study tim e wh en you kn ow th at you will be at h om e alon e. Try to elim in ate an yth in g th at m ay be distractin g durin g your study tim e. Silen ce your cellph on e appropriately so th at you will n ot be disturbed. If yo u h ave sm all ch ildren , plan yo ur study tim e durin g th eir n ap tim e or durin g th eir sch ool h ours.

Your plan m ust in clude h ow you will m an age your study n eeds with your oth er obligation s. Your fam ily an d frien d s are key players in your life an d are goin g to becom e part of your Pyram id to Success. After you h ave establish ed your study n eeds, com m un icate your n eeds an d th e im portan ce of yo ur study plan to your fam ily an d frien ds.

A difficult part of th e plan m ay be h ow to deal with fam ily m em bers an d frien ds wh o ch oo se n ot to partici- pate in your plan for success. For exam ple, wh at do you do if a frien d asks you to go to a m ovie an d it is yo ur sch eduled study tim e? Your frien d m ay say, “Take som e tim e off. You h ave plen ty of tim e to study. Study later wh en we get back!” You are faced with a decision . You m ust weigh all facto rs carefully. You m ust keep your goals in m in d an d rem em ber th at yo ur n eed for positive m om en tum is critical. Your decision m ay n ot be an easy on e, but it m ust be on e th at will en sure th at your goal of becom in g a registered n urse is ach ieved.

Positive Pampering

Positive pampering m ean s th at yo u m ust con tin ue to care for yourself h olistically. Positive m om en tum can be m ain tain ed on ly if you are properly balan ced. Proper exercise, diet, an d positive m en tal stim ulation are crucial to ach ievin g your goal of beco m in g a registered n urse. Just as yo u h ave developed a sch edule for study, you sh ould h ave a sch edule th at in cludes fun an d ph ysical

Control

S tructure d s tudy pla n

S trong pos itive a ttitude

Re g is te re d Nurs e !

FIGURE 2-1 Pyramid to Success.

BOX 2-1 Pathways to Success

Foundation Maintaining a strong positive attitude Thinking about short-term and long-term realistic goals Developing a plan for preparation Maintaining control

List Writing short-term and long-term realistic goals in a journal

Plan for Preparation Developing a study plan and schedule Deciding on the place to study Balancing personal and work obligations with the study

schedule Sharing the study schedule and personal needs with others Implementing the study plan

Positive Pampering Planning time for exercise and fun activities Establishing healthy eating habits Including activities in the schedule that provide positive men-

tal stimulation

Final Preparation Reviewing and identifying goals achieved Remaining focused to complete the plan of study Writing down the date and time of the examination and post-

ing it next to your name with the letters “RN” following, and the word “YES!”

Planning a test drive to the testing center Engaging in relaxing activities on the day before the

examination

Day of the Examination Grooming yourself for success Eating a nutritious breakfast Maintaining a confident and positive attitude Maintaining control—breathe and focus Meeting the challenges of the day Reaching the peak of the Pyramid to Success

BOX 2-2 Developing a Plan for Study Do I work better alone or in a study group? If I work best in a group, how many study partners should I

have? Who are these study partners? How long should my study sessions last? Does the time of day that I study make a difference? Do I retain more if I study in the morning? How does my work schedule affect my study pattern? How do I balance my family obligations with my need to

study? Do I have a comfortable study area at home or should I find

another environment that is conducive to my study needs?

15CHAPTER 2 Pathways to Success

N

C

L

E

X

P

r

e

p

activity. It is yo ur ch oice—aero bics, walkin g, weigh t lift- in g, bowlin g, or wh atever m akes you feel good about yourself. Tim e spen t away from th e h ard study sch edule an d devoted to som e fun an d ph ysical exercise pays you back a h un dredfold. You will be m ore en ergetic with a sch edule th at in cludes th ese activities.

Establish h ealth y eatin g h abits. Be sure to drin k plen ty of water, wh ich will flush an d clean your body cells. Stay away from fatty foods because th ey slow you down . Eat ligh ter m eals an d eat m ore frequen tly. In clude com plex carbo h ydrates such as oatm eal or wh ole grain food s in your diet for en ergy, an d be careful n ot to in clude too m uch caffein e in your daily diet.

Take th e tim e to pam per yourself with activities th at m ake you feel even better about wh o you are. Make din - n er reservation s at yo ur favorite restauran t with som e- on e wh o is special an d is supportin g your goal. Take walks in a place th at h as a particular tran quility th at en ables yo u to reflect on th e positive m om en tum th at you h ave ach ieved an d m ain tain ed. Wh atever it is, wh er- ever it takes you, allow yo urself th e tim e to do som e pos- itive pam perin g.

Final Preparation

You h ave establish ed th e foun dation of your Pyram id to Success. You h ave developed yo ur list of goals an d your study plan , an d you h ave m ain tain ed yo ur positive m om en tum . You are m ovin g forward, an d in con trol. Wh en you receive yo ur date an d tim e for th e NCLEX- RN exam in ation , yo u m ay im m ediately th in k, “I am n ot ready!” Stop! Reflect on all you h ave ach ieved. Th in k about your goal ach ievem en t an d th e organ ization of th e positive life m om en tum with wh ich yo u h ave sur- roun ded yourself. Th in k about all of th e people wh o love an d support yo ur effort to beco m e a registered n urse. Believe th at th e ch allen ge th at awaits yo u is on e th at you h ave successfully prepared for an d will lead you to your go al of becom in g a registered n urse.

Take a deep breath an d organ ize th e rem ain in g days so th at th ey supp ort your education al an d perso n al n eeds. Supp ort your positive m om en tum with a visu al tech n iqu e. Write your n am e in large letters, an d write th e letters “RN” after it. Post 1 or m ore of th ese visual rein fo rcem en ts in areas th at you frequen t. Th is is a visu al m otivation al tech n iqu e th at works for m an y n ursin g graduates preparin g for th is exam in ation .

It is im perative th at you n ot fall in to th e trap of expectin g too m uch of yourself. Th e idea of perfectio n m ust n ot drive you to a poin t th at cau ses your positive m om en tum to falter. You m ust believe an d stay focused on your goal. Th e date an d tim e are at h an d. Write th e date an d tim e, an d un dern eath write th e word “YES!” Post th is n ext to your n am e plus “RN.”

En sure th at yo u h ave com m an d over h ow to get to th e testin g cen ter. A test run is a m ust. Tim e th e drive,

an d allow for road con struction or wh atever m igh t occur to slow traffic down . O n th e test ru n , wh en you arrive at th e test facility, walk in to it an d beco m e fam iliar with th e lobby an d th e surroun din gs. Th is m ay h elp to alleviate som e of th e periph eral n ervousn ess associated with en terin g an un kn own buildin g. Rem em ber th at you m ust do wh atever it takes to keep yourself in con trol. If fam iliarizin g yo urself with th e facility will h elp you to m ain tain positive m om en tum , by all m ean s be sure to do so.

It is tim e to ch eck your study plan an d m ake th e n ec- essary ad justm en ts n ow th at a firm date an d tim e are set. Adjust your review so th at your study plan en ds 2 days before th e exam in ation . Th e m in d is like a m uscle. If it is overworked, it h as n o stren gth or stam in a. Your strat- egy is to rest th e body an d m in d on th e day befo re th e exam in ation . Your strategy is to stay in con tro l an d allow yourself th e opportun ity to be ab solutely fresh an d atten tive on th e day of th e exam in ation . Th is will h elp you to con trol th e n ervousn ess th at is n atural, ach ieve th e clear th ough t processes required , an d feel con fiden t th at you h ave don e all th at is n ecessary to prepare for an d con quer th is ch allen ge. Th e day befo re th e exam in a- tion is to be on e of pleasure. Treat yourself to wh at you en joy th e m ost.

Relax! Take a deep breath , h old to a coun t of 4, an d exh ale slowly. You h ave prepared yourself well for th e ch allen ge of tom o rrow. Allow yourself a restful n igh t’s sleep, an d wake up on th e day of th e exam in ation kn ow- in g th at you are absolutely prepared to succeed. Loo k at your n am e with “RN” after it an d th e word “YES!”

Day of the Examination (Bo x 2-3)

Wake up believin g in yourself an d th at all you h ave accom plish ed is about to propel you to th e profession al level of registered n urse. Allow yourself plen ty of tim e, eat a n utritious breakfast, an d groo m yo urself for suc- cess. You are ready to m eet th e ch allen ges of th e day an d overcom e an y obstacle th at m ay face you. Today will soon be h isto ry, an d tom o rrow will brin g you th e en ve- lope on wh ich you read your n am e with th e words “Reg- istered Nu rse” after it.

Be proud an d con fiden t of your ach ievem en ts. You h ave worked h ard to ach ieve your goal of beco m in g a

BOX 2-3 Day of the Examination Breathe: Inhale deeply, hold your breath to a count of 4, exhale

slowly Believe: Have positive thoughts today and keep those

thoughts focused on your achievements Control: You are in command Believe: This is your day Visualize: “RN” with your name

16 UNIT I NCLEX-RN® Exam Preparation

N

C

L

E

X

P

r

e

p

registered n urse. If you believe in yo urself an d your goals, n o on e person or obstacle can m ove you off th e path way th at leads to success! Con gratulation s, an d I wish you th e very best in your career as a registered n urse!

This Is Not a Test

1. Wh at are th e facto rs n eeded to en sure a produ ctive study en viron m en t? Select all th at ap p ly. 1. Secure a location th at offers solitude. 2. Plan breaks durin g yo ur study session . 3. Establish a realistic study sch edule th at in cludes

your goals. 4. Con tin ue with th e study pattern th at h as worked

best for you. Answers: 1, 2, 3, 4 Ra tiona le: A lo cation of solitude h elps to en sure con cen - tration . Takin g breaks durin g your study session h elps to clear your m in d an d in crease your ab ility to con cen trate an d focus. Establish in g a realistic study pattern will keep you in con trol. Do n ot vary yo ur study pattern . It h as been successful for you, so wh y ch an ge n ow? 2. Wh at are key factors in your fin al preparation ? Select

all th at ap p ly. 1. Rem ain focused on th e study plan . 2. Visualize th e “RN” after your n am e. 3. Avoid studyin g on th e day before th e exam

an d relax. 4. Kn ow wh ere th e testin g cen ter is an d h ow lon g it

takes to get th ere. Answers: 1, 2, 3, 4

Ra tiona le: Focus on your plan of study an d success will follow. Positive rein forcem en t: Write your n am e in large letters on a piece of paper with “RN” after your n am e an d post it wh ere you will see it often . Allow yo urself a day of pam perin g befo re th e test. Wake up on th e day of th e test refresh ed an d ready to succeed. En sure th at you kn ow wh ere th e testin g cen ter is; m ap out your route an d th e average tim e it takes to arrive. 3. Wh at key poin ts do th e “Path ways to Success” em ph a-

size to h elp en sure your success? Select all th at app ly. 1. A stron g positive attitu de 2. Believin g in yo ur ability to succeed 3. Bein g proud an d con fiden t in your ach ievem en ts 4. Main tain in g co n trol of yo ur m in d, surroun din g

en viron m en t, an d ph ysical bein g Answers: 1, 2, 3, 4 Ra tiona le: A stron g positive attitude leads to success. Believe in wh o yo u are an d th e goals you h ave set for yourself. Be “proud and confident.” If you believe in your- self, you will ach ieve success. Maintain control an d all of your goals are attain ab le.

Your grade: A+ Continue to “Believe” and you will succeed. RN belongs to you!

17CHAPTER 2 Pathways to Success

N

C

L

E

X

P

r

e

p

C H A P T E R 3 The NCLEX-RN® Examination from a Graduate’s Perspective Jaskaranjeet “Jessica” Bhullar, BSN, RN

Graduatin g from n ursin g sch ool is a h uge accom plish - m en t. After earn in g m y Bach elor of Scien ce in Nu rsin g (BSN), I reflected on all of th e work th at h ad led to th at m om en t. Th e past 16 m on th s h ad been a wh irlwin d. Mem ories of preparin g for sim ulation s an d late n igh ts studyin g for exam s an d com pletin g detailed care plan s flooded m y m in d . Th ou gh I was don e with sch o ol, I kn ew th ere was on e m ore test I would h ave to pass before I could call m yself a registered n urse. Th e NCLEX® is a n ation al licen sin g exam th at is adm in is- tered to every n ursin g sch ool graduate. Passin g th is exam gives graduates a licen se to practice. I kn ew it would be th e m ost im portan t exam of m y life an d I was deter- m in ed to pass it.

In addition to studyin g, a few th in gs m ust be don e in preparation for th e NCLEX. Approxim ately 1 m on th before I graduated, I subm itted th e required paperwo rk an d fees to m y State Board of Nursin g. It is im portan t to do th is well in advan ce, as it can poten tially take m on th s for your state board to process th e paperwo rk. Your sch ool will n otify th e board on ce your degree is con - firm ed. Th en it is a m atter of waitin g for your Auth oriza- tion to Test (ATT). An ATT en ab les you to sch edule your test date. Sin ce I h ad don e everyth in g on m y part to en sure th at th ere would be n o delays, I expected to receive m y ATT with in a few weeks after graduation . Wh ile I waited, I packed up m y apartm en t an d m oved from Nevad a to m y h om e state of Californ ia. I also spen t som e tim e catch in g up with frien d s I h ad n ot seen in m on th s. With in a few days of arrivin g h om e, I received m y ATT. I wan ted to take the exam as soon as possible, so I expan ded m y search for testin g cen ters to n eigh borin g cit- ies. I did n ot m in d drivin g a bit farth er if it m ean t that I could take th e exam soon er. I foun d that th e earliest avail- able test date was 3 weeks later in a city about 45 m in utes away. Th e on ly available tim e was 2:00 p.m ., wh ich I gladly accepted as it m ean t I could get a good n igh t’s rest an d avoid early m orn in g traffic. I felt th at I h ad a solid kn owledge base fro m sch ool, an d 3 weeks would be m ore th an en ough tim e to review co n cepts an d

practice m ore question s. You will n eed to assess your person al kn owledge level an d con fiden ce to gauge h ow m uch tim e yo u require to study. It is recom m en ded to take th e exam with in a m axim u m of 3 m on th s to en sure th at yo u are n ot losin g th e kn owledge you learn ed wh ile in sch ool.

Now th at I h ad a date m arked in m y calen dar, I felt em powered to create a study plan . I ch ose to use 1 or 2 resources at th e m ost in order to stay focused an d m as- ter con ten t realistically. Based on m y research , I ch ose Saunders Comprehensive Review for the NCLEX-RN ® Exam- ination. I used th is text in n ursin g sch o ol an d kn ew it would ben efit m e durin g m y NCLEX preparation . Be th ough tful an d selective wh en ch oosin g study tools an d fin d wh at works best for yo u. Wh at works for som e people m ay n ot work for oth ers. I set a go al to practice 150 to 200 question s a day. Th e NCLEX can ask as few as 75 question s an d as m an y as 265. I wan ted to build up m y test-takin g en duran ce, wh ich is wh y I ch ose to practice so m an y question s. Wh en I an swered question s, I would read th e en tire ration ales regardless of wh eth er I an swered correctly or n ot. A wealth of in form ation is in cluded in each ration ale. You will gain a better un der- stan din g of n ot on ly con ten t, but also why you selected an in correct or correct an swer. It is also im portan t to read th e Test-Takin g Strategy, because th is will provide you with a logical way of an swerin g th e question if you were n ot as con fid en t in your m astery of th e m aterial as you would h ave liked. I prefer to study alon e, an d I spen t m ost days practicin g question s at h om e or in a n earby cafe. I m ade sure to take a break every h ou r to stretch an d refresh m y m in d. Kn owin g th at I h ad on ly a few weeks to study m ade m e use m y tim e m ore wisely. I kn ew it was on ly a m atter of tim e before I would be don e with th e NCLEX, an d I wan ted to feel as if I h ad don e everyth in g I could to pass th e exam .

If th ere is an yth in g yo u can do to alleviate test an xi- ety, do it! Two days before th e exam , I drove to th e test- in g cen ter. I left m y h ou se arou n d th e sam e tim e I plan n ed to leave on th e actu al test day, so I could see

N

C

L

E

X

P

r

e

p

18

wh at traffic would be like an d th e parkin g availability. I foun d a m arket n earby wh ere I plan n ed to h ave lun ch before takin g th e exam . Sim ply doin g th is dry ru n h elped to calm m y n erves. I could visualize wh at m y test day would look like. Th e day before th e NCLEX, I ch ose to relax m y m in d , so I didn ’t practice an y question s. I m ade sure to put m y ATT an d id en tification (ID) aside because th ey are required at ch eck-in an d I didn ’t wan t to forget th em . I spen t th e day with m y fam ily an d wen t to bed early. Keep in m in d th at th e exam can take as lon g as 6 h ours, so ad equate sleep is a m ust!

O n th e day of th e NCLEX, I left m y h ou se a few h ours early so I would h ave a ch an ce to eat lun ch an d practice a few question s, just to get in to test-takin g m od e. I believe th at a positive m en tal attitu de is im portan t in life an d especially in poten tially stressful situation s. I kn ew th at in a m atter of h ours, th e exam would be over. It does n ot m atter at wh at question n um ber yo ur com pu ter turn s off, but rath er th at you an swered each question th o ugh t- fully an d to th e best of your ability. I arrived at th e testin g cen ter 30 m in u tes early. I was aware th at lockers are pro- vided, but I brough t as little as possible with m e. Th e ch eck-in process in volves sh owin g your ATT an d ID, h avin g your fin gers an d palm s scan n ed, an d h avin g your ph oto taken . You will also be given a form with in struc- tion s about th e exam , wh ich yo u will be required to sign . It is all very straigh tforward. I was directed to a com puter

in th e testin g room . I took a deep breath an d began th e exam . I treated each question as if it was th e last on e I h ad to an swer. Before I kn ew it, I was on question n um ber 75 an d I clicked subm it. Th e com pu ter sh ut down an d I felt a wave of relief. I was don e with th e NCLEX!

I left th e testin g cen ter feelin g con fiden t. Th e ques- tion s h ad beco m e difficu lt very quickly, an d I took th at as an in dication th at I was doin g well. I replayed th e question s in m y m in d on th e drive h om e, an d began to dwell on a couple I h ad been un sure ab out. I didn ’t allow m yself to becom e con sum ed by self-do ubt because th e exam was over an d th ere was n oth in g I could do but wait! A couple of days later, I foun d out I was officially a registered n urse! My lifelon g dream was n ow a reality. I h ad worked so h ard for th is, an d felt th at n ow I could celebrate with m y frien ds an d fam ily.

Th e NCLEX is th e last h urdle you will h ave to jum p over before you begin your profession al career. It m ay be tem p tin g to put off takin g th e test un til you feel 100% prepared, but th e lo n ger yo u wait th e m ore likely it is th at yo u will forget con ten t you learn ed durin g sch ool. Believe in yo urself an d your edu cation ! Use your tim e wisely an d reduce an xiety h owever you can . I h op e th ese suggestion s will ben efit you. Co n gratu latio n s fo r all yo u h ave an d will acco m p lish , an d th e b est o f lu ck in yo u r n ew career!

19CHAPTER 3 The NCLEX-RN® Examination from a Graduate’s Perspective

N

C

L

E

X

P

r

e

p

N

C

L

E

X

P

r

e

p

C H A P T E R 4 Test-Taking Strategies

If you would like to read m ore about test-takin g strate- gies after com pletin g th is ch apter, Saunders Strategies for Test Success: Passing Nursing School and the NCLEX®

Exam focuses on th e test-takin g strategies th at will h elp you to pass your n ursin g exam in ation s wh ile in n ursin g sch ool an d will prepare you for th e NCLEX-RN®

exam in ation .

I. Key Test-Taking Strategies (Box 4-1)

II. How to Avoid Reading into the Question (Box 4-2) A. Pyram id Poin ts

1. Avoid askin g yourself th e forbidden words, “Well, what if …?” because th is will lead you to the “for- bidden ” area: readin g in to the question.

2. Focus on ly on th e data in th e question , read every word, an d m ake a decision ab out wh at th e ques- tion is askin g. Reread th e question m ore th an 1 tim e; ask yourself, “Wh at is th is question ask- in g?” an d “Wh at con ten t is th is question test- in g?” (see Box 4-2).

3. Loo k for th e strategic words in th e question , such as immediate, initial, first, priority, initial, best, need for follow-up, or need for further teaching; strategic words m ake a differen ce regardin g wh at th e question is askin g.

4. In m ultiple-ch oice question s, m ultiple-respon se question s, or question s th at require you to arran ge n ursin g in terven tion s or oth er data in order of priority, read every ch oice or option pre- sen ted before an swerin g.

5. Always use th e process of elim in ation wh en ch oices or option s are presen ted; after you h ave elim in ated option s, reread th e question before selectin g your fin al ch oice or ch oices. Focus on th e data in both th e question an d th e option s to assist in th e process of elim in ation an d direct- in g you to th e correct an swer (see Box 4-2).

6. With question s th at require you to fill in th e blan k, focus on th e data in th e question an d determ in e wh at th e question is askin g; if th e question requires you to calculate a m edication dose, an in traven ous flow rate, or in take an d out- put am oun ts, rech eck your work in calculatin g

an d always use th e on -screen calculator to verify th e an swer.

B. In gredien ts of a question ( Box 4-3) 1. Th e in gredien ts of a question in clude th e even t,

wh ich is a clien t or clin ical situation ; th e even t query; an d th e option s or an swers.

2. Th e even t provid es yo u with th e con ten t about th e clien t or clin ical situation th at you n eed to th in k about wh en an swerin g th e question .

3. Th e even t query asks som eth in g specific about th e con ten t of th e even t.

4. Th e option s are all of th e an swers provided with th e question .

5. In a m ultiple-ch oice question , th ere will be 4 option s an d you m ust select one; read every option carefully an d thin k about th e even t an d th e even t query as you use th e process of elim in ation.

6. In a m ultiple-respon se question , th ere will be several option s an d you m ust select all option s th at ap ply to th e even t in th e question . Each option provided is a true or false statem en t; ch oose th e true statem en ts. Also, visu alize th e even t an d use your n ursin g kn owledge an d clin - ical experien ces to an swer th e question .

7. In an ordered-respon se (prioritizin g)/ drag-an d- drop question , you will be required to arran ge in order of priority n ursin g in terven tion s or oth er data; visu alize th e even t an d use your n ursin g kn owledge an d clin ical experien ces to an swer th e question .

8. A fill-in-the-blan k question will n ot con tain option s, an d som e figure/ illustration questions an d audio or video item form ats m ay or m ay n ot con tain option s. A graph ic option item will con tain option s in the form of a picture or graph ic.

9. A ch art/ exh ibit question will m ost likely con tain option s; read th e question carefully an d all of th e in form ation in th e ch art or exh ibit befo re select- in g an an swer. In th is question type, th ere will be in form ation th at is pertin en t to h ow th e question is an swered, an d th ere m ay also be in form ation th at is n ot pertin en t. It is n ecessary to discern wh at in form ation is im portan t an d wh at th e “distractors” are.20

10. A Testlet is also kn own as a Case Study. In form a- tio n about a clien t or even t is presen ted in th e testlet follo wed by several question s th at relate to th e in form ation . Th ese question s can be in a m ultiple ch oice form at or an altern ate item for- m at. It is im portan t to read all of th e data in th e question an d lo ok for abn orm alities in th e in form ation presen ted befo re an swerin g th e acco m pan yin g question s.

III. Strategic Words (Boxes 4-4 and 4-5) A. Strategic words focus your atten tion on a critical

poin t to con sider wh en an swerin g th e question an d will assist you in elim in atin g th e in correct option s. Th ese words can be located in eith er th e even t or th e query of th e question .

N

C

L

E

X

P

r

e

p

BOX 4-1 Key Test-Taking Strategies ▪ The Question ▪ Focus on the data, read every word, and make a deci-

sion about what the question is asking. ▪ Note the subject and determine what content is being

tested. ▪ Visualize the event; note if an abnormality exists in the

data provided. ▪ Look for the strategic words; strategic words make a dif-

ference regarding what the question is asking about. ▪ Determine if the question presents a positive or nega-

tive event query. ▪ Avoid asking yourself, “Well, what if…?” because this

will lead you to reading into the question. ▪ The Options ▪ Always use the process of elimination when choices or

options are presented and always read each option care- fully; once you have eliminated options, reread the ques- tion before selecting your final choice or choices.

▪ Look for comparable or alike options and eliminate these.

▪ Determine if there is an umbrella option; if so, this could be the correct option.

▪ Identify any closed-ended words; if present, the option is likely incorrect.

▪ Use the ABCs, airway, breathing, and circulation, Maslow’s Hierarchy of Needs, and the steps of the Nursing Process to answer questions that require prioritizing.

▪ Use therapeutic communication techniques to answer communication questions and remember to focus on the client’s thoughts, feelings, concerns, anxieties, and fears.

▪ Use delegating and assignment-making guidelines to match the client’s needs with the scope of practice of the health care provider.

▪ Use pharmacology guidelines to select the correct option if the question addresses a medication.

▪ Determine whether the question is a positive or nega- tive event query.

BOX 4-2 Practice Question: Avoiding the “What if …?” Syndrome and Reading into the Question

The nurse is caring for a hospitalized client with a diagnosis of heart failure who suddenly complains of shortness of breath and dyspnea. The nurse should take which immediate action?

1. Administer oxygen to the client 2. Prepare to administer furosemide 3. Elevate the head of the client’s bed 4. Call the health care provider (HCP)

Answer: 3 Test-Ta king St ra t egy: You mayimmediatelythink that the client has developed pulmonary edema, a complication of heart fail- ure, and needs a diuretic. Although pulmonary edema is a com- plication of heart failure, the question does not specifically state that pulmonary edema has developed, and the client could be experiencing shortness of breath or dyspnea as a symptom of heart failure exacerbation. This is why it is important to base your answer only on the information presented, without assum- ing something else could be occurring. Read the question care- fully. Note the strategic word, immediate, and focus on the data in the question, the client’s complaints. An HCP’s prescription is needed to administer oxygen. Although the HCP may need to be notified, this is not the immediate action. Furosemide is a diuretic and may or may not be prescribed for the client; further data would be needed in order to make this determination. Because there are no data in the question that indicate the pres- ence of pulmonary edema, option 3 is correct. Additionally, focus on what the question is asking. The question is asking you for a nursing action, so that is what you need to look for as you eliminate the incorrect options. Use nursing knowledge and test-taking strategies to assist in answering the question. Remember to focus on the data in the question, focus on what the question is asking, and avoid the “What if …?” syndrome and reading into the question.

BOX 4-3 Ingredients of a Question: Event, Event Query, and Options

Event: The nurse is caring for a client with terminal cancer. Event Query: The nurse should consider which factor when planning opioid pain relief? Opt ions:

1. Not all pain is real. 2. Opioid analgesics are highly addictive. 3. Opioid analgesics can cause tachycardia. 4. Around-the-clock dosing gives better pain relief than as-

needed dosing.

Answer: 4 Test-Ta king St ra tegy: Focus on what the question is asking and consider the client’s diagnosis of terminal cancer. Around-the- clock dosing provides increased pain relief and decreases stressors associated with pain, such as anxiety and fear. Pain is what the client describes it as, and any indication of pain should be perceived as real for the client. Opioid analgesics may be addictive, but this is not a concern for a client with ter- minal cancer. Not all opioid analgesics cause tachycardia. Remember to focus on what the question is asking.

21CHAPTER 4 Test-Taking Strategies

B. Som e strategic words m ay in dicate th at all option s are correct an d th at it will be n ecessary to prio ritize to select th e correct option ; words th at reflect th e process of assessm en t are also im portan t to n ote (see Box 4-4). Words th at reflect assessm en t usually in dicate th e n eed to look for an option th at is a first step, sin ce assessm en t is th e first step in th e n ursin g process.

C. As you read th e question , look for th e strategic words; strategic words m ake a differen ce regardin g th e focus of th e question . Th rough out th is book,

strategic words presen ted in th e question , such as th ose th at in dicate th e n eed to prioritize, are bolded. If th e test-takin g strategy is to focus on strategic words, th en strategic words is h igh ligh ted in b lu e wh ere it appears in th e test-takin g strategy.

IV. Subject of the Question (Box 4-6) A. Th e subject of th e question is th e specific topic th at

th e question is askin g ab out. B. Iden tifyin g th e subject of th e question will assist in

elim in atin g th e in correct option s an d direct you in selectin g th e correct option . Th rough out th is book, if th e subject of th e question is a specific strategy to use in an swerin g th e question correctly, it is h igh ligh ted in b lu e in th e test-takin g strategy. Also, th e specific con ten t area to review, such as heart fail- ure, is bold in m agen ta wh ere it appears in th e test- takin g strategy.

C. Th e h igh ligh tin g of th e strategy an d specific con ten t areas will provide yo u with guid an ce on wh at strat- egies to review in Saunders Strategies for Test Success: Passing Nursing School and the NCLEX® Exam an d th e con ten t areas in n eed of furth er rem ediation in Saunders Comprehensive Review for the NCLEX-RN ®

Examination.

V. Positive and Negative Event Queries (Boxes 4-7 and 4-8)

A. A positive even t query uses strategic words th at ask you to select an option th at is correct; for exam ple, th e even t query m ay read, “Wh ich statem en t by a cli- en t indicates an understanding of th e side effects of th e prescribed m edication ?”

B. A n egative even t query uses strategic words th at ask you to select an option th at is an in correct item or statem en t; for exam ple, th e even t query m ay read,

N

C

L

E

X

P

r

e

p

BOX 4-4 Common Strategic Words: Words That Indicate the Need to Prioritize and Words That Reflect Assessment

Words That Indicate the Need to Prioritize Best Early or late Essential First Highest priority Immediate Initial Most Most appropriate Most important Most likely Next Primary Vital

Words That Reflect Assessment Ascertain Assess Check Collect Determine Find out Gather Identify Monitor Observe Obtain information Recognize

BOX 4-5 Practice Question: Strategic Words The nurse is caring for a client who just returned from the recovery room after undergoing abdominal surgery. The nurse should monitor for which early sign of hypovolemic shock?

1. Sleepiness 2. Increased pulse rate 3. Increased depth of respiration 4. Increased orientation to surroundings

Answer: 2 Test-Ta king Stra tegy: Note the strategic word, early, in the query and the word just in the event. Think about the patho- physiology that occurs in hypovolemic shock to direct you to the correct option. Restlessness is one of the earliest signs followed by cardiovascular changes (increased heart rate and a decrease in blood pressure). Sleepiness is expected in a cli- ent who has just returned from surgery. Although increased depth of respirations occurs in hypovolemic shock, it is not an early sign. Rather, it occurs as the shock progresses. This is why it is important to recognize the strategic word, early, when you read the question. It requires the ability to discern between early and late signs of impending shock. Increased orientation to surroundings is expected and will occur as the effects of anesthesia resolve. Remember to look for stra- tegic words, in both the event and the query of the question.

BOX 4-6 Practice Question: Subject of the Question

The nurse is teaching a client in skeletal leg traction about measures to increase bed mobility. Which item would be most helpful for this client?

1. Television 2. Fracture bedpan 3. Overhead trapeze 4. Reading materials

Answer: 3 Test -Ta king Stra tegy: Focus on the subject, increasing bed mobility. Also note the strategic word, most. The use of an overhead trapeze is extremely helpful in assisting a client to move about in bed and to get on and off the bedpan. Televi- sion and reading materials are helpful in reducing boredom and providing distraction and a fracture bedpan is useful in reducing discomfort with elimination; these items are helpful for a client in traction, but they are not directly related to the subject of the question. Remember to focus on the subject.

22 UNIT I NCLEX-RN® Exam Preparation

“Wh ich statem en t by a clien t indicates a need for fur- ther teaching about th e side effects of th e prescribed m edication ?”

VI. Questions That Require Prioritizing A. Man y question s in th e exam in ation will require you

to use th e skill of prioritizin g n ursin g action s. B. Look for th e strategic words in th e question th at in di-

cate th e n eed to prio ritize (see Box 4-4). C. Rem em b er th at wh en a question requires prioritiza-

tion , all option s m ay be correct an d yo u n eed to determ in e th e correct order of action .

D. Strategies to use to prioritize in clude th e ABCs (air- way–breath in g–circulation ), Maslow’s Hierarch y of Needs th eory, an d th e step s of th e n ursin g process.

E. Th e ABCs (Box 4-9) 1. Use th e ABCs—airway–breath in g–circulation —

wh en selectin g an an swer or determ in in g th e order of priority.

2. Rem em ber the order of priority: airway–breath ing– circulation .

3. Airway is always the first priority. Note that an exception occurs wh en cardiopulm on ary resusci- tation is perform ed; in th is situation, the n urse fol- lows th e CAB (com pressions–airway–breath in g) guidelin es.

F. Maslow’s Hierarch y of Needs th eory ( Box 4-10; Fig. 4-1) 1. Accordin g to Maslow’s Hierarch y of Needs th e-

ory, ph ysiological n eeds are th e priority, fol- lowed by safety an d security n eeds, love an d belon gin g n eeds, self-esteem n eeds, an d, fin ally, self-actualization n eeds; select th e option or determ in e th e order of priority by addressin g ph ysiological n eeds first.

N

C

L

E

X

P

r

e

p

BOX 4-7 Practice Question: Positive Event Query The nurse provides medication instructions to a client about digoxin. Which statement by the client indicates an under- standing of its adverse effects?

1. “Blurred vision is expected.” 2. “If I am nauseated or vomiting, I should stay on liquids

and take some liquid antacids.” 3. “This medication may cause headache and weakness

but that is nothing to worry about.” 4. “If my pulse rate drops below 60 beats per minute I

should let my health care provider know.”

Answer: 4 Test -Ta king Stra tegy: This question is an example of a positive event queryquestion. Note the words indicates an understanding, and focus on the subject, adverse effects. Additionally, focus on the data provided in the options. Digoxin is a cardiac glycoside and works by increasing contractility of the heart. This medica- tion has a narrow therapeutic range and a major concern is tox- icity. Currently, it is considered second-line treatment for heart failure because of its narrow therapeutic range and potential for adverse effects. Adverse effects that indicate toxicity include gastrointestinal disturbances, neurological abnormalities, bra- dycardia or other cardiac irregularities, and ocular disturbances. If any of these occur, the health care provider (HCP) is notified. Additionally, the client should notify the HCP if the pulse rate drops below 60 beats per minute because serious dysrhythmias are another potential adverse effect of digoxin therapy. Remem- ber to focus on the data provided and note positive event queries.

BOX 4-8 Practice Question: Negative Event Query

The nurse has reinforced discharge instructions to a client who has undergone a right mastectomy with axillary lymph node dissection. Which statement by the client indicates a need for further teaching regarding home care measures?

1. “I should use a straight razor to shave under my arms.” 2. “I need to be sure that I do not have blood pressures or

blood drawn from my right arm.” 3. “I should inform all of my other health care providers

that I have had this surgical procedure.” 4. “I need to be sure to wear thick mitt hand covers or use

thick pot holders when I am cooking and touching hot pans.”

Answer: 1 Test -Ta king Stra tegy: This question is an example of a negative event query. Note the strategic words, need for further teaching. These strategic words indicate that you need to select an option that identifies an incorrect client statement. Recall that edema and infection are concerns with this client due to the removal of lymph nodes in the surgical area. Lymphadenopathy can result and the client needs to be instructed in the measures that will avoid trauma to the affected arm. Recalling that trauma to the affected arm could potentially result in edema and/ or infection will direct you to the correct option. Remember to watch for negative event queries.

BOX 4-9 Practice Question: Use of the ABCs A client with a diagnosis of cancer is receiving morphine sul- fate for pain. The nurse should employ which priority action in the care of the client?

1. Monitor stools. 2. Encourage fluid intake. 3. Monitor urine output. 4. Encourage the client to cough and deep breathe.

Answer: 4 Test-Ta king Stra tegy: Use the ABCs—airway–breathing– circulation—as a guide to direct you to the correct option and note the strategic word, priority. Recall that morphine sul- fate suppresses the cough reflex and the respiratory reflex, and a common adverse effect is respiratory depression. Coughing and deep breathing can assist with ensuring adequate oxygen- ation since the number of respirations per minute can poten- tially be decreased in a client receiving this medication. Although options 1, 2, and 3 are components of the plan of care, the correct option addresses airway. Remember to use the ABCs—airway–breathing–circulation—to prioritize.

23CHAPTER 4 Test-Taking Strategies

2. Wh en a ph ysiological n eed is n ot addressed in th e question or n oted in on e of th e option s, con - tin ue to use Maslow’s Hierarch y of Needs th eory seq uen tially as a guid e an d look for th e option th at addresses safety.

G. Steps of th e n ursin g process 1. Use th e step s of th e n ursin g process to prioritize. 2. Th e steps in clude assessm en t, an alysis, plan n in g,

im plem en tation , an d evaluatio n (AAPIE) an d are follo wed in th is order.

3. Assessm en t a . Assessm en t question s address th e process of

gath erin g subjective an d objective data rela- tive to th e clien t, con firm in g th e data, an d com m un icatin g an d docum en tin g th e data.

b . Rem em b er th at assessm en t is th e first step in th e n ursin g process.

c. Wh en you are asked to select your first, im m e- diate, or in itial n ursin g action , follow th e steps of th e n ursin g process to prioritize wh en selectin g th e correct option .

d . Look for words in th e option s th at reflect assessm en t (see Box 4-4).

e. If an option con tain s th e con cept of assess- m en t or th e collectio n of clien t data, th e best ch oice is to select th at option (Box 4-11).

f. If an assessm en t action is n ot on e of th e option s, follow th e steps of th e n ursin g process as your guide to select your n ext best action .

g. Possib le exception to th e guidelin e—if th e question presen ts an em ergen cy situation , read carefully; in an em ergen cy situation , an in terven tion m ay be th e priority rath er th an takin g th e tim e to assess furth er.

N

C

L

E

X

P

r

e

p

BOX4-10 Practice Question: Maslow’s Hierarchy of Needs Theory

The nurse caring for a client experiencing dystocia determines that the priority is which action?

1. Position changes and providing comfort measures 2. Explanations to family members about what is happen-

ing to the client 3. Monitoring for changes in the physical condition of the

mother and fetus 4. Reinforcement of breathing techniques learned in child-

birth preparatory classes

Answer: 3 Test-Ta king Stra tegy: All the options are correct and would be implemented during the care of this client. Note the strategic word, priority, and use Maslow’s Hierarchy of Needs theory to prioritize, remembering that physiological needs come first. Also, the correct option is the only one that addresses both the mother and the fetus. Remember to use Maslow’s Hierar- chy of Needs theory to prioritize.

Nurs ing Prio ritie s fro m

Mas lo w's Hie rarc hy o f Ne e ds The o ry

S e lf- Ac tualizatio n

Hope S piritua l we ll-be ing Enha nce d growth

S e lf-Es te e m Control

Compe te nce Pos itive re ga rd

Acce pta nce /worthine s s

Lo ve and Be lo ng ing Ma inta in s upport s ys te ms

P rote ct from is ola tion

S afe ty and S e c urity P rote ction from injury

P romote fe e ling of s e curity Trus t in nurs e -clie nt re la tions hip

Bas ic Phys io lo g ic al Ne e ds Airwa y

Re s pira tory e ffort He a rt ra te , rhythm, a nd s tre ngth of contra ction

Nutrition Elimina tion

FIGURE 4-1 Use Maslow’s Hierarchyof Needs theoryto establish priorities.

BOX 4-11 Practice Question: The Nursing Process—Assessment

A client who had an application of a right arm cast complains of pain at the wrist when the arm is passively moved. What action should the nurse take first?

1. Elevate the arm. 2. Document the findings. 3. Medicate with an additional dose of an opioid. 4. Check for paresthesias and paralysis of the right arm.

Answer: 4 Test -Ta king Stra tegy: Note the strategic word, first. Based on the data in the question, determine if an abnormality exists. The question event indicates that the client complains of pain at the wrist when the arm is passively moved. This could indi- cate an abnormality; therefore, further assessment or inter- vention is required. Use the steps of the nursing process, remembering that assessment is the first step. The only option that addresses assessment is the correct option. Options 1, 2, and 3 address the implementation step of the nursing process. Also, these options are inaccurate first actions. The arm in a cast should have already been elevated. The client may be experiencing compartment syndrome, a complication following trauma to the extremities and applica- tion of a cast. Additional data need to be collected to deter- mine whether this complication is present. Remember that assessment is the first step in the nursing process.

24 UNIT I NCLEX-RN® Exam Preparation

4. An alysis (Box 4-12) a. An alysis question s are th e m ost difficult ques-

tio n s because th ey require un derstan din g of th e prin ciples of ph ysiological respon ses an d require in terp retatio n of th e assessm en t data.

b . An alysis question s require critical th in kin g an d determ in in g th e ration ale for th erapeutic prescription s or in terven tion s th at m ay be ad dressed in th e question .

c. Analysis questions m ay address the form ulation of a statem ent that iden tifies a clien t n eed or problem . Analysis question s m ay also in clude the com m un ication an d docum entation of th e results from the process of the an alysis.

d . O ften , th ese typ es of question s require assim - ilation of m ore th an on e piece of in form ation an d application to a clien t scen ario.

5. Plan n in g (Box 4-13) a. Plan n in g question s require prioritizin g clien t

problem s, determ in in g goals an d outcom e criteria for go als of care, developin g th e plan of care, an d co m m un icatin g an d docum en t- in g th e plan of care.

b . Rem em ber th at actual clien t problem s rath er th an poten tial clien t problem s will m ost likely be th e prio rity.

6. Im p lem en tation (Box 4-14) a. Im p lem en tation question s address th e pro-

cess of organ izin g an d m an agin g care, coun selin g an d teach in g, provid in g care to

ach ieve establish ed goals, supervisin g an d coordin atin g care, an d co m m un icatin g an d docum en tin g n ursin g in terven tion s.

b . Focus on a n ursin g action rath er th an on a m ed ical action wh en you are an swerin g a question , un less th e question is askin g you wh at prescribed m ed ical action is an ticipated.

N

C

L

E

X

P

r

e

p

BOX 4-12 Practice Question: The Nursing Process—Analysis

The nurse reviews the arterial blood gas results of a client and notes the following: pH 7.45, PCO2 30 mm Hg, and HCO3 22 mEq/ L (22 mmol/ L). The nurse analyzes these results as indicating which condition?

1. Metabolic acidosis, compensated 2. Respiratory alkalosis, compensated 3. Metabolic alkalosis, uncompensated 4. Respiratory acidosis, uncompensated

Answer: 2 Test -Ta king Stra t egy: Use the steps of the nursing process and analyze the values. The question does not require further assessment; therefore, it is appropriate to move to the next step in the nursing process, analysis. The normal pH is 7.35 to 7.45. In a respiratory condition, an opposite effect will be seen between the pH and the PCO2. In this situation, the pH is at the high end of the normal value and the PCO2 is low. So, you can eliminate options 1 and 3. In an alkalytic condition, the pH is elevated. The values identified indicate a respiratory alkalosis. Compensation occurs when the pH returns to a nor- mal value. Because the pH is in the normal range at the high end, compensation has occurred. Remember that analysis is the second step in the nursing process.

BOX 4-13 Practice Question: The Nursing Process—Planning

The nurse developing a plan of care for a client with a cataract understands that which problem is the priority?

1. Concern about the loss of eyesight 2. Altered vision due to opacity of the ocular lens 3. Difficulty moving around because of the need for glasses 4. Becoming lonely because of decreased community

immersion

Answer: 2 Test-Ta king St ra tegy: Note the strategic word, priority, and use the steps of the nursing process. This question relates to plan- ning nursing care and asks you to identify the priority problem. Use Maslow’s Hierarchy of Needs theory to answer the ques- tion, remembering that physiological needs are the priority. Concern and becoming lonely are psychosocial needs and would be the last priorities. Note that the correct option directly addresses the client’s problem. Remember that plan- ning is the third step of the nursing process.

BOX 4-14 Practice Question: The Nursing Process—Implementation

The nurse is caring for a hospitalized client with angina pec- toris who begins to experience chest pain. The nurse admin- isters a nitroglycerin tablet sublingually as prescribed, but the pain is unrelieved. The nurse should take which action next?

1. Reposition the client. 2. Call the client’s family. 3. Contact the health care provider. 4. Administer another nitroglycerin tablet.

Answer: 4 Test-Ta king St ra t egy: Note the strategic word, next, and use the steps of the nursing process. Implementation questions address the process of organizing and managing care. This question also requires that you prioritize nursing actions. Additionally, focus on the data in the question to assist in avoiding reading into the question. You may think it is neces- sary to check the blood pressure before administering another tablet, which is correct. However, there are no data in the question indicating that the blood pressure is abnormal and could not sustain normality if another tablet were given. In addition, checking the blood pressure is not one of the options. Recalling that the nurse would administer 3 nitroglyc- erin tablets 5 minutes apart from each other to relieve chest pain in a hospitalized client will assist in directing you to the correct option. Remember that implementation is the fourth step of the nursing process.

25CHAPTER 4 Test-Taking Strategies

c. O n th e NCLEX-RN exam , th e on ly clien t th at you n eed to be con cern ed ab out is th e clien t in th e question th at you are an swerin g; avoid th e “Wh at if …?” syn drom e an d rem em ber th at th e clien t in th e question on th e com - puter screen is your only assign ed clien t.

d . An swer th e question from a textbook an d ideal poin t of view; rem em ber th at th e n urse h as all of th e tim e an d all of th e equ ipm en t n eeded to care for th e clien t readily available at th e bedside; rem em ber th at you do n ot n eed to run to th e supp ly room to obtain , for exam ple, sterile gloves because th e sterile gloves will be at th e clien t’s bedside.

7. Evaluation ( Box 4-15) a . Evaluation question s focus on com parin g th e

actu al outcom es of care with th e exp ected outcom es an d on com m un icatin g an d docu- m en tin g fin din gs.

b . Th ese question s focus on assistin g in deter- m in in g th e clien t’s respon se to care an d iden - tifyin g facto rs th at m ay in terfere with ach ievin g expected outcom es.

c. In an evaluation question , watch for n egative even t queries because th ey are frequen tly used in evaluatio n -type question s.

H. Determ in e if an Abn orm ality Exists (Box 4-16) 1. In th e even t, th e clien t scen ario will be described.

Use yo ur n ursin g kn owledge to determ in e if an y of th e in form ation presen ted is in dicatin g an abn o rm ality.

2. If an abn o rm ality exists, eith er furth er assess- m en t or furth er in terven tion will be required . Th erefore, con tin uin g to m on itor or docum en t- in g will n ot be a correct an swer; don ’t select th ese option s if th ey are presen ted!

VII. Client Needs A. Safe an d Effective Care En viron m en t

1. Accordin g to th e Nation al Coun cil of State Boards of Nu rsin g (NCSBN), th ese question s test th e con cepts of providin g safe n ursin g care an d collabo ratin g with oth er h ealth care team m em - bers to facilitate effective clien t care; th ese ques- tion s also focus on th e protectio n of clien ts, sign ifican t oth ers, an d h ealth care perso n n el from en viron m en tal h azards.

2. Focus on safety with th ese types of question s, and rem em ber th e im portan ce of h an d wash in g, call ligh ts or bells, bed position in g, appropriate use of side rails, asepsis, use of stan dard an d oth er precaution s, triage, an d em ergen cy respon se plan n in g.

N

C

L

E

X

P

r

e

p

BOX 4-15 Practice Question: The Nursing Process—Evaluation

The nurse is evaluating the client’s response to treatment of a pleural effusion with a chest tube. The nurse notes a respira- tory rate of 20 breaths per minute, fluctuation of the fluid level in the water seal chamber, and a decrease in the amount of drainage by 30 mL since the previous shift. Based on this information, which interpretation should the nurse make?

1. The client is responding well to treatment. 2. Suction should be decreased to the system. 3. The system should be assessed for an air leak. 4. Water should be added to the water seal chamber.

Answer: 1 Test-Ta king St ra tegy: Use the steps of the nursing process and note that the nurse needs to evaluate the client’s response to treatment. Focus on the subject and the data in the ques- tion. Also, determine if an abnormality exists based on these data. Remember that fluctuation in the water seal chamber is a normal and expected finding with a chest tube. Since the client is being treated for a pleural effusion, it can be determined that he or she is responding well to treatment if the amount of drainage is gradually decreasing because the fluid from the pleural effusion is being effectively removed. If the drain- age were to stop suddenly, the chest tube should be assessed for a kink or blockage. There is no indication based on the data in the question to decrease suction to the system; in fact, it is unclear as to whether the client is on suction at all. There are also no data in the question indicating an air leak. Lastly, there are no data in the question indicating the need to add water to the water seal chamber; again, it is unclear as to whether the client has this type of chest tube versus a dry suction chest tube. Remember that evaluation is the fifth step of the nursing process.

BOX 4-16 Practice Question: Determine If an Abnormality Exists

The nurse is caring for a client being admitted to the emer- gency department with a chief complaint of anorexia, nausea, and vomiting. The nurse asks the client about the home med- ications being taking. The nurse would be most concerned if the client stated that which medication was being taken at home?

1. Digoxin 2. Captopril 3. Losartan 4. Furosemide

Answer: 1 Test -Ta king Stra tegy: Note the strategic word, most. The first step in approaching the answer to this question is to deter- mine if an abnormality exists. The client is complaining of anorexia, nausea, and vomiting; therefore, an abnormality does exist. This tells you that this could be an adverse or toxic effect of one of the medications listed. Although gastrointes- tinal distress can occur as an expected side effect of many medications, anorexia, nausea, and vomiting are hallmark signs of digoxin toxicity. Therefore, the nurse would be most concerned with this medication if taken at home by the client. Remember to first determine if an abnormality exists in the event before choosing the correct option.

26 UNIT I NCLEX-RN® Exam Preparation

B. Ph ysiological In tegrity 1. Th e NCSBN in dicates th at th ese question s test

th e con cepts th at th e n urse provides care as it relates to com fort an d assistan ce in th e perfor- m an ce of activities of daily livin g as well as care related to th e adm in istration of m edication s an d paren teral th erapies.

2. Th ese question s also address th e n urse’s ability to reduce th e clien t’s poten tial for developin g co m - plication s or h ealth problem s related to treat- m en ts, procedures, or existin g con d ition s an d to provide care to clien ts with acute, ch ron ic, or life-th reaten in g ph ysical h ealth con dition s.

3. Focus on Maslow’s Hierarch y of Needs th eory in th ese types of question s an d rem em ber th at ph ysiological n eeds are a prio rity an d are ad dressed first.

4. Use th e ABCs—airway–breath in g–circulation — an d th e step s of th e n ursin g process wh en select- in g an option addressin g Ph ysiological In tegrity.

C. Psych o social In tegrity 1. Th e NCSBN n otes th at th ese question s test th e

con cepts of n ursin g care th at prom o te an d sup- port th e em otion al, m en tal, an d social well- bein g of th e clien t an d sign ifican t oth ers.

2. Con tent addressed in th ese question s relates to supportin g an d prom otin g the client’s or sign ifi- can t oth ers’ability to cope, adapt, or problem -solve in situation s such as illn esses; disabilities; or stress- ful even ts in cludin g abuse, n eglect, or violen ce.

3. In th is Clien t Needs category, you m ay be asked com m un ication -typ e question s th at relate to h ow you would respo n d to a clien t, a clien t’s fam ily m em ber or sign ifican t oth er, or oth er h ealth care team m em bers.

4. Use th erapeutic com m un ication tech n iques to an swer com m un ication question s because of th eir effectiven ess in th e com m un ication process.

5. Rem em ber to select th e option th at focuses on th e th ough ts, feelin gs, con cern s, an xieties, or fears of th e clien t, clien t’s fam ily m em ber, or sig- n ifican t oth er (Box 4-17).

D. Health Prom o tion an d Main ten an ce 1. Accordin g to th e NCSBN, th ese question s test th e

con cepts th at th e n urse provides an d assists in directin g n ursin g care to prom o te an d m ain tain h ealth .

2. Con ten t ad dressed in th ese question s relates to assistin g th e clien t an d sign ifican t oth ers durin g th e n orm al expected stages of growth an d devel- opm en t, an d providin g clien t care related to th e preven tion an d early detection of h ealth problem s.

3. Use th e Teach in g an d Learn in g th eory if th e ques- tio n addresses clien t teach in g, rem em berin g th at th e clien t’s willin gn ess, desire, an d readin ess to learn is th e first priority.

4. Watch for n egative even t queries because th ey are frequen tly used in question s th at ad dress Health Prom o tion an d Main ten an ce an d clien t edu cation .

VIII. Eliminate Comparable or Alike Options (Box 4-18) A. Wh en readin g th e option s in m ultiple-ch oice or

m ultiple-respon se question s, lo ok for option s th at are com parable or alike.

B. Com p arable or alike option s can be elim in ated as possib le an swers because it is n ot likely for both option s to be correct.

N

C

L

E

X

P

r

e

p

BOX 4-17 Practice Question: Communication A client scheduled for bowel surgery states to the nurse, “I’m not sure if I should have this surgery.” Which response by the nurse is appropriate?

1. “It’s your decision.” 2. “Don’t worry. Everything will be fine.” 3. “Why don’t you want to have this surgery?” 4. “Tell me what concerns you have about the surgery.”

Answer: 4 Test-Ta king Stra tegy: Use therapeutic communication tech- niques to answer communication questions and remember to focus on the client’s thoughts, feelings, concerns, anxieties, and fears. The correct option is the only one that addresses the client’s concern. Additionally, asking the client about what specific concerns he or she has about the surgery will allow for further decisions in the treatment process to be made. Option 1 is a blunt response and does not address the client’s concern. Option 2 provides false reassurance. Option 3 can make the client feel defensive and uses the nontherapeutic communication technique of asking “why.” Remember to use therapeutic communication techniques and focus on the client.

BOX 4-18 Practice Question: Eliminate Comparable or Alike Options

The nurse is caring for a group of clients. On review of the cli- ents’ medical records, the nurse determines that which client is at risk for excess fluid volume?

1. The client taking diuretics 2. The client with an ileostomy 3. The client with kidney disease 4. The client undergoing gastrointestinal suctioning

Answer: 3 Test-Ta king Stra t egy: Focus on the subject, the client at risk for excess fluid volume. Think about the pathophysiology associated with each condition identified in the options. The only client who retains fluid is the client with kidney dis- ease. The client taking diuretics, the client with an ileostomy, and the client undergoing gastrointestinal suctioning all lose fluid; these are comparable or alike options. Remember to eliminate comparable or alike options.

27CHAPTER 4 Test-Taking Strategies

IX. Eliminate Options Containing Closed-Ended Words (Box 4-19)

A. Som e clo sed-en ded words are all, always, every, must, none, never, an d only.

B. Elim in ate option s th at con tain clo sed-en ded words because th ese words im ply a fixed or extrem e m ean - in g; th ese typ es of option s are usually in correct.

C. O ption s th at con tain open -en ded words, such as may, usually, normally, commonly, or generally, sh ould be con sidered as possible correct option s.

X. Look for the Umbrella Option (Box 4-20) A. Wh en an swerin g a question , look for th e um b rella

option .

B. Th e um b rella option is on e th at is a broad or un iver- sal statem en t an d th at usually con tain s th e con cepts of th e oth er option s with in it.

C. Th e um b rella option will be th e correct an swer.

XI. Use the Guidelines for Delegating and Assignment Making (Box 4-21)

A. You m ay be asked a question th at will require you to decide h ow you will delegate a task or assign clien ts to oth er h ealth care providers (HCPs).

B. Focus on th e in form ation in th e question an d wh at task or assign m en t is to be delegated.

C. Wh en yo u h ave determ in ed wh at task or assign m en t is to be delegated, con sider th e clien t’s n eeds an d m atch th e clien t’s n eeds with th e scope of practice of th e HCPs iden tified in th e question .

D. Th e Nu rse Practice Act an d an y practice lim itation s defin e wh ich aspects of care can be delegated an d wh ich m ust be perform ed by a registered n urse. Use n ursin g scope of practice as a guide to assist in an swerin g question s. Rem em b er th at th e NCLEX is a n ation al exam an d n ation al stan d ards rath er th an agen cy-sp ecific stan dard s m ust be followed wh en delegatin g.

E. In gen eral, n on in vasive in terven tion s, such as skin care, ran ge-of-m otion exercises, am bulation , groom - in g, an d h ygien e m easu res, can be assign ed to an un licen sed assistive perso n n el (UAP).

F. A licen sed practical n urse (LPN) can perform th e tasks th at a UAP can perform an d can usually per- form certain in vasive tasks, such as dressin gs, suc- tion in g, urin ary cath eterization , an d adm in isterin g m edication s orally or by th e subcutan eous or

N

C

L

E

X

P

r

e

p

BOX 4-19 Practice Question: Eliminate Options That Contain Closed-Ended Words

A client is to undergo a computed tomography (CT) scan of the abdomen with oral contrast, and the nurse provides pre- procedure instructions. The nurse instructs the client to take which action in the preprocedure period?

1. Avoid eating or drinking after midnight before the test. 2. Limit self to only 2 cigarettes on the morning of the test. 3. Have a clear liquid breakfast only on the morning of the

test. 4. Take all routine medications with a glass of water on the

morning of the test.

Answer: 1 Test-Ta king Stra t egy: Note the closed-ended words only in options 2 and 3 and all in option 4. Eliminate options that con- tain closed-ended words because these options are usually incorrect. Also, note that options 2, 3, and 4 are comparable or alike options in that they all involve taking in something on the morning of the test. Remember to eliminate options that contain closed-ended words.

BOX 4-20 Practice Question: Look for the Umbrella Option

A client admitted to the hospital is diagnosed with urethritis caused by chlamydial infection. The nurse should implement which precaution to prevent contraction of the infection dur- ing care?

1. Enteric precautions 2. Contact precautions 3. Standard precautions 4. Wearing gloves and a mask

Answer: 3 Test-Ta king St ra tegy: Focus on the client’s diagnosis and recall that this infection is sexually transmitted. Also, note that the correct option is the umbrella option. Remember to look for the umbrella option, a broad or universal option that includes the concepts of the other options in it.

BOX 4-21 Practice Question: Use Guidelines for Delegating and Assignment Making

The nurse in charge of a long-term care facility is planning the client assignments for the day. Which client should be assigned to the unlicensed assistive personnel (UAP)?

1. A client on strict bed rest 2. A client with dyspnea who is receiving oxygen therapy 3. Aclient scheduled for transfer to the hospital for surgery 4. Aclient with a gastrostomy tube who requires tube feed-

ings every 4 hours

Answer: 1 Test -Ta king St ra t egy: Note the subject of the question, the assignment to be delegated to the UAP. When asked ques- tions about delegation, think about the role description and scope of practice of the employee and the needs of the client. A client with dyspnea who is receiving oxygen therapy, a client scheduled for transfer to the hospital for surgery, or a client with a gastrostomy tube who requires tube feedings every 4 hours has both physiological and psychosocial needs that require care by a licensed nurse. The UAP has been trained to care for a client on bed rest. Remember to match the client’s needs with the scope of practice of the health care provider.

28 UNIT I NCLEX-RN® Exam Preparation

in tram uscular route; som e selected piggyback in tra- ven o us m ed ication s m ay also be adm in istered.

G. A registered n urse can perform th e tasks th at an LPN can perform an d is respo n sible for assessm en t an d plan n in g care, an alyzin g clien t data, im plem en t- in g an d evaluatin g clien t care, supervisin g care, in iti- atin g teach in g, an d adm in isterin g m ed ication s in traven ously.

XII. Answering Pharmacology Questions (Box 4-22) A. If you are fam iliar with th e m ed ication , use n ursin g

kn owledge to an swer th e question . B. Rem em ber th at th e question will iden tify th e gen eric

n am e of th e m edication on m ost occasion s. C. If th e question iden tifies a m ed ical diagn osis, try to

form a relation sh ip between th e m edication an d th e diagn osis; for exam ple, you can determ in e th at cyclop h osph am ide is an an tin eoplastic m ed ication if th e question refers to a clien t with breast can cer wh o is takin g th is m edication .

D. Try to determ in e th e classification of th e m ed ication bein g addressed to assist in an swerin g th e question . Iden tifyin g th e classification will assist in determ in - in g a m ed ication ’s action or side effects or both .

E. Recogn ize th e com m on side effects an d adverse effects associated with each m ed ication classification an d relate th e appropriate n ursin g in terven tion s to each effect; for exam ple, if a side effect is h yperten - sion , th e associated n ursin g in terven tion would be to m on itor th e blood pressure.

F. Focus on wh at th e question is askin g or th e subject of th e question ; for exam ple: in ten ded effect, side effect, ad verse effect, or toxic effect.

G. Learn m edication s th at belon g to a classification by com m on alities in th eir m edication n am es; for exam ple, m ed ication s th at act as beta blockers en d with “-lol” (e.g., aten o lol).

H. If th e question requires a m edication calculation , rem em ber th at a calculator is available on th e co m - puter; talk yourself th rough each step to be sure th e an swer m akes sen se, an d rech eck th e calculation befo re an swerin g th e question , particularly if th e an swer seem s like an un usual dosage.

I. Ph arm acology: Pyram id Poin ts to rem em ber 1. In gen eral, th e clien t sh ould n ot take an an tacid

with m ed ication because th e an tacid will affect th e absorption of th e m edication .

2. En teric-coated an d sustain ed-release tablets sh ould n ot be crush ed; also, cap sules sh ould n ot be open ed.

3. Th e clien t sh ould n ever ad just or ch an ge a m ed- ication dose or abruptly stop takin g a m ed ication .

4. Th e n urse n ever adjusts or ch an ges th e clien t’s m ed ication dosage an d n ever discon tin ues a m ed ication .

5. Th e clien t n eeds to avoid takin g an y over-th e- coun ter m ed ication s or an y oth er m ed ication s, such as h erbal preparation s, un less th ey are approved for use by th e HCP.

6. Th e clien t n eeds to avoid con sum in g alcoh ol. 7. Med ication s are n ever adm in istered if th e

prescription is difficult to read, is un clear, or iden tifies a m edication dose th at is n ot a n orm al on e.

8. Addition al strategies for an swerin g ph arm acol- ogy question s are presen ted in Saunders Strategies for Test Success: Passing Nursing School and the NCLEX® Exam.

N

C

L

E

X

P

r

e

p

BOX 4-22 Practice Question: Answering Pharmacology Questions

Quinapril hydrochloride is prescribed as adjunctive therapy in the treatment of heart failure. After administering the first dose, the nurse should monitor which item as the priority?

1. Weight 2. Urine output 3. Lung sounds 4. Blood pressure

Answer: 4 Test-Ta king Stra t egy: Focus on the name of the medication and note the strategic word, priority. Recall that the medica- tion names of most angiotensin-converting enzyme (ACE) inhibitors end with “-pril” and one of the indications for use of these medications is hypertension. Excessive hypotension (“first-dose syncope”) can occur in clients with heart failure or in clients who are severely sodium-depleted or volume- depleted. Although weight, urine output, and lung sounds would be monitored, monitoring the blood pressure is the pri- ority. Remember to use pharmacology guidelines to assist in answering questions about medications and note the strate- gic words.

29CHAPTER 4 Test-Taking Strategies

UNIT II

Professional Standards in Nursing

Pyramid to Success

Nurses often care for clien ts wh o com e from eth n ic, cul- tural, or religious backgroun ds th at are differen t from th eir own . In th e past 10 years, th e Hispan ic popu lation in th e Un ited States h as in creased by 43%, th e African Am erican population by 12.3%, an d th e Asian popula- tion by 43% (U.S. Cen sus Bureau , 2010). It is projected th at m in o rity groups will m ake up a m ajo rity of th e U.S. population by 2042 (U.S. Departm en t of State, 2008). Awaren ess of an d sen sitivity to th e un iq ue h ealth an d illn ess beliefs an d practices of peo ple of differen t backgroun ds are essen tial for th e delivery of safe an d effective care. Ackn owledgm en t an d acceptan ce of cul- tural differen ces with a n on judgm en tal attitude are essen tial to providin g culturally sen sitive care. Th e NCLEX-RN® exam test plan is un iq ue an d in dividual- ized to th e clien t’s culture an d beliefs. Th e n urse n eeds to avoid stereotypin g an d n eeds to be aware th at th ere are several subcultures with in cultures an d th ere are sev- eral dialects with in lan guages. In n ursin g practice, th e n urse sh ould assess th e clien t’s perceived n eeds before plan n in g an d im plem en tin g a plan of care.

Across all settin gs in th e practice of n ursin g, n urses fre- quen tly are con fron ted with eth ical an d legal issues related to clien t care. Th e profession al n urse h as th e respon sibility to be aware of th e eth ical prin ciples, laws, an d guidelin es related to providing safe an d quality care to clien ts. In the Pyram id to Success, focus on eth ical prac- tices; the Nurse Practice Act an d clien ts’righ ts, particularly con fiden tiality, in form ation security an d con fiden tiality, an d in form ed con sen t; advocacy, docum en tation , and advan ce directives; an d cultural, religious, an d spiritual issues. Kn owledgeable use of inform ation techn ology, such as an electron ic h ealth record, is also an im portan t role of th e n urse.

Th e Nation al Coun cil of State Boards of Nu rsin g (NCSBN) defin es m an agem en t of care as th e n urse

directin g n ursin g care to en h an ce th e care delivery set- tin g to protect th e clien t an d h ealth care person n el. As described in th e NCLEX-RN exam test plan , a profes- sion al n urse n eeds to provid e in tegrated , cost-effective care to clien ts by coordin atin g, supervisin g, an d collab- oratin g or con sultin g with m em bers of th e in terp rofes- sion al h ealth care team . A prim ary Pyram id Poin t focuses on th e skills required to prio ritize clien t care activities. Pyram id Poin ts also focus on con cepts of lead- ersh ip an d m an agem en t, th e process of delegation , em ergen cy respo n se plan n in g, an d triagin g clien ts.

Client Needs: Learning Objectives Safe and Effective Care Environment Actin g as a clien t advocate In tegratin g advan ce directives in to th e plan of care Becom in g fam iliar with th e em ergen cy respo n se plan Delegatin g clien t care activities an d providin g con tin uity

of care En surin g th at eth ical practices are im plem en ted En surin g th at in form ed con sen t h as been obtain ed En surin g th at legal righ ts an d respo n sibilities are

m ain tain ed Collaboratin g with in terp rofessio n al team s Establish in g priorities related to clien t care activities In stitutin g quality im provem en t proced ures In tegratin g case m an agem en t con cepts Main tain in g con fid en tiality an d in form ation security

issues related to th e clien t’s h ealth care Supervisin g th e delivery of clien t care Triagin g clien ts Uph oldin g clien t righ ts Usin g in form ation tech n ology in a con fiden tial m an n er Usin g lead ersh ip an d m an agem en t skills effectively

F

u

n

d

a

m

e

n

t

a

l

s

30

Health Promotion and Maintenance Con siderin g cultural an d spiritual issues related to fam -

ily system s an d fam ily plan n in g Iden tifyin g ch an ges related to th e agin g process Iden tifyin g h igh -risk beh aviors of th e clien t Perform in g ph ysical assessm en t tech n iqu es Prom o tin g h ealth an d preven tin g disease Prom o tin g th e clien t’s ability to perform self-care Provid in g h ealth screen in g an d h ealth prom otio n

program s Resp ectin g cu ltural preferen ces an d lifestyle ch oices

Psychosocial Integrity Addressin g en d-of-life care based on th e clien t’s prefer-

en ces an d beliefs Assessin g th e use of effective copin g m ech an ism s Becom in g aware of cultural an d spiritu al preferen ces an d

in corpo ratin g th ese preferen ces wh en plan n in g an d im plem en tin g care

Iden tifyin g ab use an d n eglect issues Iden tifyin g clien ts wh o do n ot speak or un d erstan d

En glish an d determ in in g h ow lan guage n eeds will be m et by th e use of agen cy-appro ved in terp reters

Iden tifyin g en d-of-life care issues Iden tifyin g fam ily dyn am ics as th ey relate to th e clien t’s

culture

Iden tifyin g supp ort system s for th e clien t Providin g a th erap eutic en viron m en t an d buildin g a

relation sh ip based on trust Respectin g religious an d spiritual in fluen ces on h ealth

(see Box 5-1)

Physiological Integrity En surin g th at em ergen cies are h an dled usin g a prioriti-

zation procedure Iden tifyin g cultural an d spiritual differen ces for provid-

in g h olistic clien t care Iden tifyin g cultural issues related to altern ative an d com -

plem en tary th erap ies Iden tifyin g cultural issues related to receivin g blood an d

blood products Im plem en tin g th erapeutic procedures con sid erin g cul-

tural preferen ces Providin g n on ph arm aco logical co m fort in terven tion s Providin g n utrition an d oral h ydration , con siderin g cul-

tural preferen ces (see Box 5-1) En surin g th at palliative an d com fo rt care is provided to

th e clien t Mon itorin g for alteration s in body system s or un ex-

pected respo n ses to th erap y

31UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 5 Cultural Awareness and Health Practices

PRIORITY CONCEPTS Culture; Health Promotion

CRITICAL THINKING What Should You Do? The nurse is preparing a client for an echocardiogram and notes that the client is wearing a religious medal on a chain around the neck. What should the nurse do with regard to removing this personal item from the client? Answer located on p. 40.

For referen ce th rou gh out th e ch apter, see Figure 5-1 an d Box 5-1.

Cultural awareness includes learning about the cultures of clients with whom you will be working; also, ask clients about their health care practices and preferences.

I. African Americans A. Description : Citizen s or residen ts of th e Un ited

States wh o m ay h ave origin s in an y of th e black population s in Africa.

B. Com m un ication 1. Mem bers are com peten t in stan dard En glish . 2. Head n oddin g does n ot always m ean agreem en t. 3. Prolon ged eye con tact m ay be in terp reted as

ruden ess or aggressive beh avio r. 4. No n verbal com m un ication m ay be im portan t. 5. Perso n al question s asked on in itial con tact with

a perso n m ay be viewed as in trusive. C. Tim e orien tation an d perso n al space preferen ces

1. Tim e orien tation varies accordin g to age, socio- econ om ics, an d subcultures an d m ay in clude past, presen t, or future orien tation .

2. Mem bers m ay be late for an appoin tm en t because relation sh ips an d even ts th at are occur- rin g m ay be deem ed m ore im portan t th an bein g on tim e.

3. Mem bers are com fo rtable with clo se perso n al space wh en in teractin g with fam ily an d frien ds.

D. Social roles 1. Large exten ded-fam ily n etworks are im portan t;

older adults are respected.

2. Man y h ouseh olds m ay be h eaded by a sin gle- paren t wom an .

3. Religiou s beliefs an d ch urch affiliation are sources of stren gth .

E. Health an d illn ess 1. Religiou s beliefs profou n dly affect ideas about

h ealth an d illn ess. 2. Food preferen ces in clude such item s as fried

food s, ch icken , pork, green s such as collard green s, an d rice; som e pregn an t African Am erican wom en en gage in pica.

F. Health risks 1. Sickle cell an em ia 2. Hyperten sion 3. Heart disease 4. Can cer 5. Lactose in toleran ce 6. Diabetes m ellitus 7. O besity

G. In terven tion s 1. Assess th e m ean in g of th e clien t’s verbal an d

n on verbal beh avio r. 2. Be flexible an d avoid rigidity in sch edulin g care. 3. En cou rage fam ily in volvem en t. 4. Altern ative m odes of h ealin g in clude h erbs,

prayer, an d layin g on of h an ds practices.

Assess each individual for cultural preferences because there are many individual and subculture variations.

II. Amish A. Descrip tion

1. Th e Am ish are kn own for sim ple livin g, plain dress, an d reluctan ce to adopt m odern con ve- n ien ce an d can be con sidered a distin ct ethnic group ; th e various Am ish ch urch fellowsh ips are Ch ristian religious den om in ation s th at form a very tradition al subgrou pin g of Men n on ite ch urch es.

2. Cultural beliefs an d preferen ces vary dep en din g on specific Am ish com m un ity m em bersh ip.32

F

u

n

d

a

m

e

n

t

a

l

s

• S umma rize da ta obta ine d

Nurs ing as s e s s me nt

• Clie nt's cultura l a nd ra cia l ide ntifica tion

• P la ce of birth • Time in country

Culturally unique individual • La ngua ge s poke n • Voice qua lity • P ronuncia tion • Us e of s ile nce • Us e of nonve rba ls

Co mmunic atio n

• De gre e of comfort obs e rve d (conve rs a tion)

• P roximity to othe rs • Body move me nt • P e rce ption of s pa ce

S pac e

• Culture • Ra ce • Ethnicity • Fa mily Role Function

S o c ial o rie ntatio n

• Work • Le is ure • Church • Frie nds

• Us e of • Me a s ure s • De finition • S ocia l time • Work time • Time orie nta tion Future P re s e nt P a s t

Time

• Cultura l he a lth pra ctice s Effica cious Ne utra l Dys functiona l Unce rta in • Va lue s • De finition of he a lth a nd illne s s

Enviro nme ntal c o ntro l

• Body s tructure • S kin color • Ha ir color • Othe r phys ica l dime ns ions • Enzyma tic a nd ge ne tic e xis te nce of dis e a s e s s pe cific to popula tions • S us ce ptibility to illne s s a nd dis e a s e • Nutritiona l pre fe re nce s a nd de ficie ncie s • P s ychologica l cha ra cte ris tics , coping, a nd s ocia l s upport

Bio lo g ic al variatio ns

FIGURE 5-1 Giger and Davidhizar’s Transcultural Assessment Model.

BOX 5-1 Religions and Dietary Preferences

Buddhism Alcohol is usually prohibited. Many are lacto-ovo vegetarians. Some eat fish, and some avoid only beef.

Church of Jesus Christ of Latter-day Saints (Mormon) Alcohol, coffee, and tea are usually prohibited. Consumption of meat is limited. The first Sunday of the month is optional for fasting.

Eastern Orthodox During Lent, all animal products, including dairy products, are

forbidden. Fasting occurs during Advent. Exceptions from fasting include illness and pregnancy; children

may also be exempt.

Hinduism Manyare vegetarians; those who eat meat do not eat beef or pork. Fasting rituals vary. Children are not allowed to participate in fasting.

Islam Pork, birds of prey, alcohol, and any meat product not ritually

slaughtered are prohibited. During the month of Ramadan, fasting occurs during the day-

time; some individuals, such as pregnant women, may be exempt from fasting.

Jehovah’s Witnesses Any foods to which blood has been added are prohibited. They can eat animal flesh that has been drained.

Judaism Orthodox believers need to adhere to dietary kosher laws: ▪ Meats allowed include animals that are vegetable eaters,

cloven-hoofed animals (deer, cattle, goats, sheep), and animals that are ritually slaughtered.

▪ Fish that have scales and fins are allowed. ▪ Any combination of meat and milk is prohibited; fish and

milk are not eaten together. During Yom Kippur, 24-hour fasting is observed. Pregnant women, children, and ill individuals are exempt from

fasting. During Passover, only unleavened bread is eaten.

Pentecostal (Assembly of God) Alcohol is usually prohibited. Members avoid consumption of anything to which blood has

been added. Some individuals avoid pork.

Roman Catholicism They avoid meat on Ash Wednesday and Fridays of Lent. They practice optional fasting during Lent season. Children, pregnant women, and ill individuals are exempt from

fasting.

Seventh-Day Adventist (Church of God) Alcohol and caffeinated beverages are usually prohibited. Many are lacto-ovo vegetarians; those who eat meat avoid pork. Overeating is prohibited; 5 to 6 hours between meals without

snacking is practiced.

33CHAPTER 5 Cultural Awareness and Health Practices

F

u

n

d

a

m

e

n

t

a

l

s

3. In gen eral, th ey h ave fewer risk factors for disease th an th e gen eral population because of th eir practice of m an u al labor, diet, an d rare use of tobacco an d alcoh ol; risk of certain gen etic dis- orders is in creased because of in term arriage (sexu al abuse of wom en is a problem in som e com m un ities).

4. Diabetes m ellitus can beco m e a h ealth issue later in life an d is related to th e obesity th at can occur.

B. Com m un ication : Usually speak a Germ an dialect called Pen n sylvan ia Dutch ; Germ an lan guage is usu- ally used durin g worsh ip an d En glish is usually learn ed in sch o ol.

C. Tim e orien tation an d perso n al space preferen ces 1. Mem bers gen erally rem ain separate from oth er

com m un ities, ph ysically an d socially. 2. Th ey often work as farm ers, builders, quilters,

an d h om em akers. D. Social roles

1. Wom en are n ot allowed to h old position s of power in th e co n gregation al organ ization .

2. Roles of wom en are con sidered equally im por- tan t to th ose of m en but are very un equ al in term s of au th ority.

3. Fam ily life h as a patriarch al structure. 4. Marriage outsid e th e faith is n ot usually allowed;

un m arried wom en rem ain un der th e auth o rity of th eir fath ers.

E. Health an d illn ess 1. Most Am ish n eed to h ave ch urch (bish op an d

com m un ity) perm ission to be h ospitalized because th e com m un ity will com e togeth er to h elp pay th e costs.

2. Usually, Am ish do n ot h ave h ealth in suran ce because it is a “worldly produ ct” an d m ay sh ow a lack of faith in God.

3. Som e of th e barriers to m odern h ealth care in clude distan ce, lack of tran sportation , cost, an d lan guage (m ost do n ot un derstan d scien tific jargon ).

F. Health risks 1. Gen etic disorders because of in term arriage

(in breedin g) 2. No n im m un ization 3. Sexual abuse of wom en

G. In terven tion s 1. Speak to both th e h usban d an d th e wife or th e

un m arried wom an an d h er fath er regardin g h ealth care decision s.

2. Health in struction s m ust be given in sim ple, clear lan guage.

3. Teach in g sh ould be focused on h ealth im plica- tion s associated with n on im m un ization , in ter- m arriage, an d sexual abuse issues.

Be alert to cues regarding eye contact, personal space, time concepts, and understanding of the recom- mended plan of care.

III. Asian Americans A. Descrip tion : Am erican s of Asian descen t; can in clude

ethnic groups such as Ch in ese Am erican s, Filipin o Am erican s, In dian Am erican s, Vietn am ese Am eri- can s, Korean Am erican s, Japan ese Am erican s, an d oth ers wh o se n ation al origin is th e Asian co n tin en t.

B. Com m un ication 1. Lan gu ages in clude Ch in ese, Japan ese, Korean ,

Filipin o, Vietn am ese, an d En glish . 2. Silen ce is valued. 3. Eye con tact m ay be con sid ered in approp riate or

disresp ectful (som e Asian cultures in terp ret direct eye con tact as a sexual in vitation ).

4. Criticism or disagreem en t is n ot exp ressed verbally.

5. Head n od din g does n ot always m ean agreem en t. 6. Th e word “n o” m ay be in terp reted as disrespect

for oth ers. C. Tim e orien tation an d perso n al space preferen ces

1. Tim e orien tation reflects respect for th e past, but in cludes em p h asis on th e presen t an d future.

2. Form al perso n al space is preferred, except with fam ily an d close frien ds.

3. Mem bers usually do n ot touch oth ers durin g con versation .

4. For som e cultures , touch in g is un acceptable between m em bers of th e oppo site sex.

5. Th e h ead is con sid ered to be sacred in som e cultures; touch in g som eon e on th e h ead m ay be disrespectful.

D. Social roles 1. Mem bers are devoted to tradition . 2. Large exten ded-fam ily n etworks are com m on . 3. Loyalty to im m ediate an d exten ded fam ily an d

h on or are valued. 4. Th e fam ily un it is structured an d h ierarch ical. 5. Men h ave th e power an d auth o rity, an d wom en

are expected to be obedien t. 6. Education is viewed as im portan t. 7. Religion s in clude Taoism , Bud dh ism , Con fu-

cian ism , Sh in toism , Hin duism , Islam , an d Ch ristian ity.

8. Social organ ization s are stron g with in th e com m un ity.

E. Health an d illn ess 1. Health is a state of ph ysical an d spiritu al h ar-

m on y with n ature an d a balan ce between posi- tive an d n egative en ergy forces (yin an d yan g).

2. A h ealth y body m ay be viewed as a gift from th e an cestors.

3. Illn ess m ay be viewed as an im balan ce between yin an d yan g.

4. Illn ess m ay also be attributed to prolon ged sit- tin g or lyin g or to overexertion .

5. Food preferen ces in clude raw fish , rice, an d vegetables.

34 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

Yin foods are cold and yang foods are hot; one eats cold foods when one has a hot illness, and one eats hot foods when one has a cold illness.

F. Health risks 1. Hyperten sion 2. Heart disease 3. Can cer 4. Lactose in toleran ce 5. Th alassem ia

G. In terven tion s 1. Be aware of an d respect ph ysical boun daries;

request perm ission to touch th e clien t before doin g so.

2. Lim it eye con tact. 3. Avo id gesturin g with h an ds. 4. A fem ale clien t usually prefers a fem ale h ealth

care provider (HCP). 5. Clarify respo n ses to question s an d expectation s

of th e HCP. 6. Be flexible an d avoid rigidity in sch edulin g care. 7. En cou rage fam ily in volvem en t. 8. Altern ative m od es of h ealin g in clude h erbs, acu-

pun cture, restoration of balan ce with food s, m as- sage, an d offerin g of prayers an d in cen se.

If health care recommendations, interventions, or treatments do not fit within the client’s cultural values, they will not be followed.

IV. Hispanic and Latino Americans A. Description : Am erican s of origin s in Latin coun tries;

Mexican Am erican s, Cuban Am erican s, Colom bian Am erican s, Dom in ican Am erican s, Puerto Rican Am er- ican s, Span ish Am erican s, an d Salvadoran Am erican s are som e Hispan ic an d Latin o Am erican subgroups.

B. Com m un ication 1. Lan gu ages in clude prim arily En glish an d

Span ish . 2. Mem bers ten d to be verbally expressive, yet con-

fidentiality is im portan t. 3. Avo idin g eye con tact with a person in au th ority

m ay in dicate respect an d atten tiven ess. 4. Direct con fron tation is usually disresp ectful an d

th e expression of n egative feelin gs m ay be im polite.

5. Dram atic body lan guage, such as gestures or facial exp ression s, m ay be used to express em o- tio n or pain .

C. Tim e orien tation an d perso n al space preferen ces 1. Mem bers are usually orien ted m ore to th e

presen t. 2. Mem bers m ay be late for an ap poin tm en t

because relation sh ips an d even ts th at are occur- rin g are valued m ore th an bein g on tim e.

3. Mem bers are co m fortable in clo se proxim ity with fam ily, frien d s, an d acquain tan ces.

4. Mem bers are very tactile an d use em b races an d h an dsh akes.

5. Mem bers value th e ph ysical presen ce of oth ers. 6. Politen ess an d m od esty are im portan t.

D. Social roles 1. Th e n uclear fam ily is th e basic un it; also , large

exten ded-fam ily n etworks are co m m on . 2. Th e exten ded fam ily is h igh ly regarded. 3. Needs of th e fam ily take preced en ce over th e

n eeds of an in dividual fam ily m em ber. 4. Depen din g on age an d acculturation facto rs, m en

are usually th e decision m akers an d wage earn ers, an d wom en are th e caretakers an d h om em akers.

5. Religion is usually Cath olicism , but m ay vary dep en din g on origin .

6. Mem bers usually h ave stron g ch urch affiliation s. 7. Social organ ization s are stron g with in th e

com m un ity. E. Health an d illn ess

1. Health m ay be viewed as a reward fro m God or a result of good lu ck.

2. Som e m em bers believe th at h ealth results from a state of ph ysical an d em otion al balan ce.

3. Illn ess m ay be viewed by som e m em bers to be a result of God’s pun ish m en t for sin s.

4. Som e m em bers m ay ad h ere to n on tradition al h ealth m easu res such as folk m ed icin e.

5. Food preferen ces in clude bean s, fried food s, an d spicy food s.

F. Health risks 1. Hyperten sion 2. Heart disease 3. Diabetes m ellitus 4. O besity 5. Lactose in toleran ce 6. Parasites

G. In terven tion s 1. Allow tim e for th e clien t to discuss treatm en t

option s with fam ily m em bers. 2. Protect privacy. 3. O ffer to call clergy because of th e sign ifican ce of

religious preferen ces related to illn esses. 4. Ask perm issio n before touch in g a ch ild wh en

plan n in g to exam in e or care for h im or h er; som e believe th at touch in g th e ch ild is im portan t wh en speakin g to th e ch ild to preven t “evil-eye.”

5. Be flexible regardin g tim e of arrival for ap poin t- m en ts an d avoid rigidity in sch edulin g care.

6. Altern ative m odes of h ealin g in clude h erbs, con sul- tation with lay h ealers, restoration of balan ce with h ot or cold foods, prayer, an d religious m edals.

Treat each client and individuals accompanying the client with respect and be aware of the differences and diversity of beliefs about health, illness, and treatment modalities.

35CHAPTER 5 Cultural Awareness and Health Practices

F

u

n

d

a

m

e

n

t

a

l

s

V. Native Americans A. Description : Term th at th e U.S. govern m en t uses to

describe in digen ous peoples from th e region s of North Am erica en com p assed by th e con tin en tal Un ited States, in cludin g parts of Alaska, an d th e islan d state of Hawaii; com prises a large n um ber of distin ct tribes, states, an d ethnic groups, m an y of wh ich survive as in tact political com m un ities.

B. Com m un ication 1. Th ere is m uch lin guistic diversity, depen din g on

origin . 2. Use of a profession al in terp reter is im portan t

because of privacy con cern s an d because accu- racy of com m un ication is m ade clearer.

3. Silen ce in dicates respect for th e speaker for som e grou ps.

4. Som e m em bers m ay speak in a lo w ton e of voice an d expect oth ers to be atten tive.

5. Eye con tact m ay be viewed as a sign of disresp ect. 6. Body lan guage is im portan t.

C. Tim e orien tation an d perso n al space preferen ces 1. Mem bers are orien ted prim arily to th e presen t. 2. Perso n al space is im portan t. 3. Mem bers m ay ligh tly touch an oth er person ’s

h an d durin g greetin gs. 4. Massage m ay be used for th e n ewborn to pro-

m ote bon din g between th e in fan t an d m oth er. 5. Som e grou ps m ay proh ibit touch in g of a

dead body. D. Social roles

1. Mem bers are fam ily orien ted. 2. Th e basic fam ily un it is th e exten ded fam ily,

wh ich often in cludes person s fro m several h ouseh old s.

3. In som e groups, gran dparen ts are viewed as fam - ily leaders.

4. Eld ers are h on ored. 5. Ch ildren are taugh t to respect tradition s. 6. Th e fath er usually does all work outside th e

h om e, an d th e m oth er assum es respon sibility for dom estic duties.

7. Sacred m yth s an d legen ds provide spiritu al guid- an ce for som e groups.

8. Most m em bers adh ere to som e form of Ch ris- tian ity, an d religion an d h ealin g practices are usually in tegrated.

9. Com m un ity social organ ization s are im portan t. E. Health an d illn ess

1. Health is usually con sid ered a state of h arm on y between th e in dividual, fam ily, an d en viron m en t.

2. Som e groups believe th at illn ess is cau sed by supern atural forces an d disequilibrium between th e perso n an d en viron m en t.

3. Tradition al h ealth an d illn ess beliefs m ay con - tin ue to be observed by som e grou ps, in cludin g n atural an d religious folk m edicin e tradition .

4. For som e groups, food preferen ces in clude corn - m eal, fish , gam e, fruits, an d berries.

F. Health risks 1. Alcoh o l abuse 2. O besity 3. Heart disease 4. Diabetes m ellitus 5. Tuberculosis 6. Arth ritis 7. Lactose in toleran ce 8. Gallbladder disease

G. In terven tion s 1. Clarify com m un ication . 2. Un derstan d th at th e clien t m ay be atten tive, even

wh en eye con tact is absen t. 3. Be atten tive to your own use of body lan gu age

wh en carin g for th e clien t or fam ily. 4. O btain in pu t fro m m em bers of th e exten ded

fam ily. 5. En cou rage th e clien t to perso n alize space in

wh ich h ealth care is delivered; for exam ple, en courage th e clien t to brin g perso n al item s or objects to th e h ospital.

6. In th e h om e, assess for th e availability of run n in g water, an d m od ify in fectio n co n trol an d h ygien e practices as n ecessary.

7. Altern ative m od es of h ealin g in clude h erbs, resto- ration of balan ce between th e perso n an d th e un i- verse, an d co n sultatio n with tradition al h ealers.

If language barriers pose a problem, seek a qualified medical interpreter; avoid using ancillary staff or family members as interpreters.

VI. White Americans A. Descrip tion : Term used to in clude U.S. citizen s or

residen ts h avin g origin s in an y of th e origin al people of Eu rope, th e Middle East, or North Africa; th e term is in terch an geab le with Cau casian Am erican .

B. Com m un ication 1. Lan gu ages in clude lan gu age of origin (e.g., Ital-

ian , Polish , Fren ch , Russian ) an d En glish . 2. Silen ce can be used to sh ow respect or disrespect

for an oth er, depen din g on th e situation . 3. Eye con tact is usually viewed as in dicatin g

trustworth in ess in m ost origin s. C. Tim e orien tation an d perso n al space preferen ces

1. Mem bers are usually future orien ted. 2. Tim e is valued; m em bers ten d to be on tim e an d

to be im patien t with people wh o are n ot on tim e. 3. Som e m em bers m ay ten d to avoid clo se ph ysical

con tact. 4. Han dsh akes are usually used for form al

greetin gs. D. Social roles

1. Th e n uclear fam ily is th e basic un it; th e exten ded fam ily is also im portan t.

36 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

2. Th e m an is usually th e dom in an t figure, but a variation of gen d er roles exists with in fam ilies an d relation sh ips.

3. Religion s are varied, dep en din g on origin . 4. Com m un ity social organ ization s are im portan t.

E. Health an d illn ess 1. Health is usually viewed as an absen ce of disease

or illn ess. 2. Man y m em bers usually h ave a ten den cy to be

stoic wh en expressin g ph ysical con cern s. 3. Mem bers usually rely prim arily on th e m od ern

Western h ealth care delivery system . 4. Food preferen ces are based on origin ; m an y

m em bers prefer food s con tain in g carboh ydrates an d m eat item s.

F. Health risks 1. Can cer 2. Heart disease 3. Diabetes m ellitus 4. O besity 5. Hyperten sion 6. Th alassem ia

G. In terven tion s 1. Assess th e m ean in g of th e clien t’s verbal an d

n on verbal beh avior. 2. Resp ect th e clien t’s person al space an d tim e. 3. Be flexible an d avoid rigidity in sch edulin g care. 4. En cou rage fam ily in volvem en t.

Some cultures believe that eye contact gives the other person an opening to see into, or to take, the soul.

VII. End-of-Life Care (Box 5-2) A. People in th e Jewish faith gen erally oppose prolon g-

in g life after irreversib le brain dam age. B. Som e m em bers of Eastern O rth odox religion s,

Muslim s, an d O rth odox Jews m ay proh ibit, oppo se, or discourage au topsy.

C. Muslim s perm it organ tran splan t for th e purpo se of savin g h um an life.

D. Th e Am ish perm it organ don atio n with th e exception of h eart tran splan ts (th e h eart is th e soul of th e body).

E. Buddh ists in th e Un ited States en courage organ don ation an d con sider it an act of m ercy.

BOX 5-2 Religion and End-of-Life Care Christianity Amish Funerals are conducted in the home without a eulogy, flower

decorations, or any other display; caskets are plain and simple, without adornment.

At death, a woman is usually buried in her bridal dress. One is believed to live on after death, with either eternal reward

in heaven or punishment in hell.

Ca t holic and Ort hodox A priest anoints the sick. Other sacraments before death include reconciliation and Holy

Communion.

Church of Jesus Christ of Lat ter-da y Sa int s (Mormons) A sacrament may be administered if the client requests it.

Prot esta nt No last rites are provided (anointing of the sick is accepted by

some groups). Prayers are given to offer comfort and support.

Jehova h’s Wit nesses Members are not allowed to receive a blood transfusion. Members believe that the soul cannot live after the body has

died.

Islam Second-degree male relatives such as cousins or uncles should

be the contact people and determine whether the client or family should be given information about the client.

The client may choose to face Mecca (west or southwest in the United States).

The head should be elevated above the body. Discussions about death usually are not welcomed. Stopping medical treatment is against the will of Allah (Arabic

word for God). Grief may be expressed through slapping or hitting the body. If possible, only a same-sex Muslim should handle the body

after death; if not possible, non-Muslims should wear gloves so as not to touch the body.

Judaism A client placed on life support should remain so until death. A dying person should not be left alone (a rabbi’s presence is

desired). Autopsy and cremation are usually not allowed.

Hinduism Rituals include tying a thread around the neck or wrist of the

dying person, sprinkling the person with special water, and placing a leaf of basil on the person’s tongue.

After death, the sacred threads are not removed, and the body is not washed.

Buddhism A shrine to Buddha may be placed in the client’s room. Time for meditation at the shrine is important and should be

respected. Clients may refuse medications that may alter their awareness

(e.g., opioids). After death, a monk may recite prayers for 1 hour (need not be

done in the presence of the body).

37CHAPTER 5 Cultural Awareness and Health Practices

F

u

n

d

a

m

e

n

t

a

l

s

F. Som e m em bers of Morm on , Eastern O rth o dox, Islam ic, an d Jewish (Con servative an d O rth odox) faith s discourage, oppo se, or proh ib it crem ation .

G. Hin dus usually prefer crem ation an d desire to cast th e ash es in a h oly river.

H. African Am erican s 1. Mem bers discuss issues with th e spouse or older

fam ily m em ber (elders are h eld in h igh respect). 2. Fam ily is h igh ly valued an d is cen tral to th e care

of term in ally ill m em bers. 3. O pen displays of em otion are com m on an d

accepted. 4. Mem bers prefer to die at h om e.

I. Asian Am erican s 1. Fam ily m em bers m ay m ake decision s about care

an d often do n ot tell th e clien t th e diagn osis or progn osis.

2. Dyin g at h om e m ay be co n sidered bad lu ck. 3. O rgan don ation m ay n ot be allowed in som e

eth n ic grou ps. J. Hispan ic an d Latin o groups

1. Th e fam ily gen erally m akes decision s an d m ay request to with h old th e diagn osis or progn osis from th e clien t.

2. Exten ded-fam ily m em bers often are in volved in en d-of-life care (pregn an t wom en m ay be pro- h ibited from carin g for dyin g clien ts or atten din g fun erals).

3. Several fam ily m em bers m ay be at th e dyin g clien t’s bed side.

4. Vocal exp ression of grief an d m ou rn in g is accept- able an d expected.

5. Mem bers m ay refuse proced ures th at alter th e body, such as autopsy.

6. Dyin g at h om e m ay be co n sidered bad lu ck. K. Native Am erican s

1. Fam ily m eetin gs m ay be h eld to m ake decision s about en d-of-life care an d th e type of treatm en ts th at sh ould be pursued.

2. Som e groups avoid con tact with th e dyin g (m ay prefer to die in th e h ospital).

Provide individualized end-of-life care to the client and families.

VIII. Complementary and Alternative Medicine (CAM) A. Description

1. Th erapies are used in addition to con ven tion al treatm en t to provid e h ealin g resources an d focus on th e m in d -bod y con n ection .

2. High -risk th erap ies (th erapies th at are in vasive) an d low-risk th erap ies (th ose th at are n on in va- sive) are in cluded in CAM.

3. Th e Nation al Cen ter for Com plem en tary an d Altern ative Medicin e (NCCAM) h as propo sed a classification system th at in cludes 5 categories of co m plem en tary an d altern ative types of th er- apy ( Box 5-3).

B. Wh ole m ed ical system s 1. Tradition al Ch in ese m ed icin e (TCM): Focuses

on restorin g an d m ain tain in g a balan ced flo w of vital en ergy; in terven tion s in clude acupres- sure, acupun cture, h erbal th erap ies, diet, m edita- tion , tai ch i, an d qigon g (exercise th at focuses on breath in g, visualization , an d m ovem en t).

2. Ayurveda: Focuses on th e balan ce of m in d, body, an d spirit; in terven tion s in clude diet, m ed icin al h erbs, deto xification , m assage, breath in g exer- cises, m ed itation , an d yoga.

3. Hom eopath y: Focuses on h ealin g an d in terven - tion s con sistin g of sm all doses of specially pre- pared plan t an d m in eral extracts th at assist in th e in n ate h ealin g process of th e body.

4. Naturop ath y: Focuses on en h an cin g th e n atural h ealin g respon ses of th e body; in terven tion s in clude n utrition , h erbology, h ydroth erapy, acu- pun cture, ph ysical th erapies, an d coun selin g.

C. Min d-bod y m ed icin e 1. Min d -body m ed icin e focuses on th e in teraction s

am on g th e brain , m in d , body, an d beh avior an d on th e powerfu l ways in wh ich em otion al, m en - tal, social, spiritual, an d beh avioral factors can directly affect h ealth .

2. In terven tion s in clude biofeedb ack, h ypn osis, relaxation th erap y, m editation , visu al im agery, yoga, tai ch i, qigon g, cogn itive-beh avioral th era- pies, group supp orts, autogen ic train in g, an d spiritu ality.

D. Biologically based practices (Box 5-4) 1. Biologically based th erap ies in CAM use sub-

stan ces foun d in n ature, such as h erb s, foods, an d vitam in s.

2. Th erapies in clude botan icals, prebiotics an d pro- biotics, wh o le-food diets, fun ction al foods, an im al-derived extracts, vitam in s, m in erals, fatty acids, am in o acids, an d protein s.

E. Man ipu lative an d body-b ased practices 1. In terven tion s in volve m an ipulation an d m ove-

m en t of th e body by a th erap ist. 2. In terven tion s in clude practices such as ch iro-

practic an d osteopath ic m an ipulation , m assage th erap y, an d reflexology.

F. En ergy m ed icin e 1. En ergy th erap ies focus on en ergy origin atin g

with in th e body or on en ergy fro m oth er sources.

BOX 5-3 Categories of Complementary and Alternative Medicine

▪ Whole medical systems ▪ Mind-body medicine ▪ Biologically based practices ▪ Manipulative and body-based practices ▪ Energy medicine

38 UNIT II Professional Standards in Nursing

2. In terven tion s in clude soun d en ergy th erapy, ligh t th erapy, acu pun cture, qigon g, Reiki an d Joh re, th erap eutic touch , in tercessory prayer, wh ole m edical system s, an d m agn etic th erap y.

IX. Herbal Therapies (Box 5-5) A. Herbal th erapy is th e use of h erbs (plan t or a plan t

part) for th eir th erap eutic value in prom o tin g h ealth . B. Som e h erb s h ave been determ in ed to be safe, but

som e h erb s, even in sm all am oun ts, can be toxic. C. If th e clien t is takin g prescription m ed ication s, th e

clien t sh ould con sult with th e HCP regardin g th e use of h erbs because serious h erb-m edication in ter- action s can occur.

D. Clien t teach in g poin ts 1. Discuss h erb al th erap ies with th e HCP

befo re use. 2. Con tact th e HCP if an y side effects of th e h erb al

substan ce occur.

3. Con tact th e HCP before stoppin g th e use of a prescription m ed ication .

4. Avoid usin g h erbs to treat a serious m edical con - ditio n , such as h eart disease.

5. Avoid takin g h erbs if pregn an t or attem p tin g to get pregn an t or if n ursin g.

6. Do n ot give h erbs to in fan ts or youn g ch ildren . 7. Purch ase h erbal supp lem en ts on ly from a repu-

table m an ufacturer; th e label sh ould con tain th e scien tific n am e of th e h erb, n am e an d address of th e m an u facturer, batch or lot n um - ber, date of m an u facture, an d expiration date.

8. Adh ere to th e recom m en ded dose; if h erbal preparation s are taken in h igh doses, th ey can be toxic.

9. Moistu re, sun ligh t, an d h eat m ay alter th e com - pon en ts of h erbal preparation s.

10. If surgery is plan n ed, th e h erbal th erap y m ay n eed to be discon tin ued 2 to 3 weeks before surgery.

Some herbs have been determined to be safe, but some herbs, even in small amounts, can be toxic. Ask the client to discuss herbal therapies with the HCP before use.

X. Low-Risk Therapies A. Low-risk th erapies are th erap ies th at h ave n o adverse

effects an d, wh en im plem en tin g care, can be used by th e n urse wh o h as train in g an d experien ce in th eir use.

B. Com m on low-risk th erapies 1. Med itation 2. Relaxation tech n iques 3. Im agery 4. Music th erap y 5. Massage 6. Touch 7. Laugh ter an d h um or 8. Spiritu al m easu res, such as prayer

F

u

n

d

a

m

e

n

t

a

l

s

BOX 5-4 Biologically Based Practices

Aromatherapy The use of topical or inhaled oils (plant extracts) that promote

and maintain health

Herbal Therapies The use of herbs derived mostly from plant sources that main-

tain and restore balance and health

Macrobiotic Diet Diet high in whole-grain cereals, vegetables, beans, sea vege-

tables, and vegetarian soups Elimination of meat, animal fat, eggs, poultry, dairy products,

sugars, and artificially produced food from the diet

Orthomolecular Therapy Focus on nutritional balance, including use of vitamins,

essential amino acids, essential fats, and minerals

BOX 5-5 Commonly Used Herbs and Health Products Aloe: Antiinflammatory and antimicrobial effect; accelerates

wound healing Black cohosh: Produces estrogen-like effects Chamomile: Antispasmodic and antiinflammatory; produces

mild sedative effect Dehydroepiandrosterone (DHEA): Converts to androgens and estro-

gen; slows the effects of aging; used for erectile dysfunction Echinacea: Stimulates the immune system Garlic: Antioxidant; used to lower cholesterol levels Ginger: Antiemetic; used for nausea and vomiting Ginkgo biloba: Antioxidant; used to improve memory Ginseng: Increases physical endurance and stamina; used for

stress and fatigue

Glucosamine: Amino acid that assists in the synthesis of cartilage

Melatonin: A hormone that regulates sleep; used for insomnia Milk thistle: Antioxidant; stimulates the production of new liver

cells, reduces liver inflammation; used for liver and gallblad- der disease

Peppermint oil: Antispasmodic; used for irritable bowel syndrome

Saw palmetto: Antiestrogen activity; used for urinary tract infec- tions and benign prostatic hypertrophy

St. John’s wort: Antibacterial, antiviral, antidepressant Valerian: Used to treat nervous disorders such as anxiety,

restlessness, and insomnia

39CHAPTER 5 Cultural Awareness and Health Practices

F

u

n

d

a

m

e

n

t

a

l

s

CRITICAL THINKING What Should You Do? Answer: Before certain diagnostic procedures, it is typical to have a client remove personal objects that are worn on the body. The nurse should ask the client about the significance of such an item and its removal because it may have cultural or spiritual significance. The nurse should also determine whether the item will compromise client safety or the test results. If so, the nurse should ask the client if the item can be either removed temporarily or placed on another part of the body during the procedure.

Reference: Lewis et al. (2014), p. 25.

P R A C T I C E Q U E S T I O N S 1. The am bulatory care nurse is discussing preoperative

procedures with a Japanese Am erican client who is sched- uled for surgery the following week. During the discus- sion, the client con tinually sm iles an d nods th e h ead. How should th e nurse interpret this non verbal behavior? 1. Reflectin g a cultural value 2. An acceptan ce of th e treatm en t 3. Clien t agreem en t to th e required proced ures 4. Clien t un derstan din g of th e preoperative procedures

2. Wh en com m un icatin g with a clien t wh o speaks a dif- feren t lan guage, wh ich b est practice sh ould th e n urse im plem en t? 1. Speak lo udly an d slowly. 2. Arran ge for an in terp reter to tran slate. 3. Speak to th e clien t an d fam ily togeth er. 4. Stan d clo se to th e clien t an d speak loudly.

3. Th e n urse educator is providin g in -service education to th e n ursin g staff regarding tran scultural n ursin g care; a staff m em ber asks th e n urse educator to provide an exam ple of th e con cept of acculturation . Th e n urse edu- cator should m ake wh ich m o st app ro p riate respon se? 1. “A grou p of in dividuals id en tifyin g as a part of th e

Iroqu ois tribe am on g Native Am erican s.” 2. “A perso n wh o m oves from Ch in a to th e Un ited

States (U.S.) an d learn s ab out an d adapts to th e culture in th e U.S.”

3. “A group of in dividuals livin g in th e Azores th at id en tify auton om o usly but are a part of th e larger popu lation of Portugal.”

4. “A perso n wh o h as grown up in th e Ph ilippin es an d ch ooses to stay th ere because of th e sen se of belon gin g to h is or h er cultural group.”

4. Th e n urse is providin g disch arge in struction s to a Ch i- n ese Am erican clien t regardin g prescribed dietary m od ification s. Durin g th e teach in g session , th e clien t con tin uously turn s away from th e n urse. Th e n urse sh ould im plem en t wh ich b est action ?

1. Con tin ue with th e in struction s, verifyin g clien t un derstan din g.

2. Walk aroun d th e clien t so th at th e n urse con stan tly faces th e clien t.

3. Give th e clien t a dietary booklet an d return later to con tin ue with th e in struction s.

4. Tell th e clien t about th e im portan ce of th e in struc- tion s for th e m ain ten an ce of h ealth care.

5. A critically ill Hisp an ic clien t tells th e n urse th rough an in terp reter th at sh e is Rom an Cath olic an d firm ly believes in th e rituals an d tradition s of th e Cath olic faith . Based on th e clien t’s statem en ts, wh ich action s by th e n urse dem on strate cu ltural sen sitivity an d spir- itual supp ort? Select all th at ap p ly.

1. En sures th at a clo se kin stays with th e clien t. 2. Makes a referral for a Cath olic priest to visit th e

clien t. 3. Rem o ves th e cru cifix from th e wall in th e

clien t’s room . 4. Adm in isters th e sacram en t of th e sick to th e cli-

en t if death is im m in en t. 5. O ffers to provide a m ean s for prayin g th e rosary

if th e clien t wish es. 6. Rem in ds th e dietary departm en t th at m eals

served on Fridays durin g Len t do n ot con tain m eat.

6. Wh ich clien ts h ave a h igh risk of obesity an d diabetes m ellitus? Select all th at ap p ly.

1. Latin o Am erican m an 2. Native Am erican m an 3. Asian Am erican wom an 4. Hisp an ic Am erican m an 5. African Am erican wom an

7. Th e n urse is preparin g a plan of care for a clien t, an d is askin g th e clien t ab out religious preferen ces. Th e n urse con siders th e clien t’s religious preferen ces as bein g ch aracteristic of a Jeh ovah ’s Witn ess if wh ich clien t statem en t is m ade? 1. “I can n ot h ave surgery.” 2. “I can n ot h ave an y m ed icin e.” 3. “I believe th e soul lives on after death .” 4. “I can n ot h ave an y food con tain in g or prepared

with blood.”

8. Wh ich m eal tray sh o uld th e n urse deliver to a clien t of O rth odox Judaism faith wh o follows a kosh er diet? 1. Pork ro ast, rice, vegetables, m ixed fruit, m ilk 2. Crab salad on a cro issan t, vegetables with dip,

potato salad, m ilk 3. Sweet an d sour ch icken with rice an d vegetables,

m ixed fru it, juice 4. Noodles an d cream sauce with sh rim p an d vegeta-

bles, salad, m ixed fruit, iced tea

40 UNIT II Professional Standards in Nursing

9. An Asian Am erican clien t is experien cin g a fever. Th e n urse plan s care so th at th e clien t can self-treat th e disorder usin g wh ich m eth od ? 1. Prayer 2. Magn etic th erap y 3. Foods con sid ered to be yin 4. Food s con sidered to be yan g

10. Wh ich is th e b est n ursin g in terven tion regardin g com plem en tary an d altern ative m edicin e? 1. Advisin g th e clien t about “good ” versus “bad”

th erapies 2. Discouragin g th e clien t from usin g an y altern a-

tive th erap ies 3. Educatin g th e clien t about th erap ies th at h e or

sh e is usin g or is in terested in usin g 4. Iden tifyin g h erbal rem edies th at th e clien t sh ould

request from th e h ealth care provider

11. An an tih yp erten sive m edication h as been prescribed for a clien t with h yperten sio n . Th e clien t tells th e clin ic n urse th at h e would like to take an h erb al sub- stan ce to h elp lower h is blood pressure. Th e n urse sh o uld take wh ich action ?

1. Advise th e clien t to read th e labels of h erbal th er- apies closely.

2. Tell th e clien t th at h erbal substan ces are n ot safe an d sh ould n ever be used.

3. En cou rage th e clien t to discuss th e use of an h erb al substan ce with th e h ealth care provid er (HCP).

4. Tell th e clien t th at if h e takes th e h erbal substan ce h e will n eed to h ave h is blood pressure ch ecked frequen tly.

12. Th e n urse edu cator asks a studen t to list th e 5 m ain categories of com plem en tary an d altern ative m ed i- cin e (CAM), develo ped by th e Nation al Cen ter for Com p lem en tary an d Altern ative Med icin e. Wh ich statem en t, if m ade by th e n ursin g studen t, in dicates a n eed fo r fu rth er teach in g regardin g CAM categories? 1. “CAM in cludes biologically based practices.” 2. “Wh ole m ed ical system s are a com pon en t

of CAM.” 3. “Min d-bod y m ed icin e is part of th e CAM

ap proach .” 4. “Magn etic th erap y an d m assage th erapy are a

focus of CAM.”

A N S W E R S 1. 1 Ra t ion a le: Nod din g o r sm ilin g b y a Jap an ese Am erican clien t m ay reflect o n ly th e cultural value of in terp erso n al h arm o n y. Th is n on verb al b eh avio r m ay n o t be an in d icatio n of accep - tan ce of th e treatm en t, agreem en t with th e sp eaker, o r u n d er- stan din g o f th e proced ure. Test -Ta kin g St r a tegy: Elim in ate op tion s 2 an d 3 first b ecau se th ey are co m p a r a b le o r a lik e an d are in co rrect. From th e rem ain in g option s, n ote th at th e clien t is Japan ese Am erican an d th in k abo ut th e ch aracteristics of th is grou p . Th is will direct yo u to op tion 1. In add itio n , o p tion 4 is an in correct in terpretation o f th e clien t’s n o n verb al b eh avio r. Review: Th e cultu ral ch aracteristics o f Asia n Am er ica n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Com m un icatio n ; Cu lture Refer en ces: Giger (2013), p. 317; Jarvis (2016), p . 35.

2. 2 Ra t ion a le: Arran gin g for an in terpreter wo u ld be th e b est prac- tice wh en co m m u n icatin g with a clien t wh o sp eaks a d ifferen t lan guage. O ptio n s 1 an d 4 are in ap p ro priate an d in effective ways to com m un icate. O ption 3 is in ap prop riate b ecause it vio - lates privacy an d d o es n o t en su re co rrect tran slatio n . Test -Ta kin g St r a t egy: No te th e st r a t egic wo r d , best, in th e qu estio n an d n ote th e su b ject , co m m u n icatin g with a clien t of a d ifferen t cu lture. Elim in ate op tio n 3 first because th is actio n can con stitute a vio lation o f th e clien t’s righ t to p rivacy, an d d oes n ot rep resen t b est practice. Next, elim in ate o p tion s 1

an d 4, n o tin g th e wo rd loudly in th ese op tio n s an d becau se th ey are n o n th erap eutic action s an d also are n o t best practices. Review: Co m m u n ica t io n t ech n iq u es for a clien t wh o speaks a differen t lan gu age Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Fun d am en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Com m un icatio n ; Cu lture Refer en ce: Jarvis (2016), p p. 45–46.

3. 2 Ra t ion a le: Acculturation is a p rocess o f learn in g a d ifferen t cul- tu re to adap t to a n ew or ch an gin g en viron m en t. O p tion s 1 an d 3 describe a subculture. O ption 4 describes eth n ic iden tity. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d s, most appropri- ate. Fo cus o n th e su b ject , accu lturation . No te th e wo rd s a per- son who moves an d adapts in th e correct o ptio n an d relate th is to th e defin itio n of acculturation . Review: Th e defin itio n o f a ccu lt u r a t io n Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun d am en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Cultu re; Pro fession alism Refer en ce: Jarvis (2016), p p. 14–15.

4. 1 Ra t ion a le: Most Ch in ese Am erican s m ain tain a fo rm al dis- tan ce with oth ers, wh ich is a fo rm o f resp ect. Man y Ch in ese Am erican s are un co m fo rtab le with face-to-face co m m u n ica- tion s, especially wh en eye co n tact is direct. If th e clien t turn s away fro m th e n u rse d u rin g a con versatio n , th e b est action is

F

u

n

d

a

m

e

n

t

a

l

s

41CHAPTER 5 Cultural Awareness and Health Practices

to con tin u e with th e con versatio n . Walkin g aro un d th e clien t so th at th e n u rse faces th e clien t is in direct co n flict with th is cultu ral practice. Th e clien t m ay con sid er it a ru de gestu re if th e n u rse return s later to co n tin ue with th e explan ation . Tellin g th e clien t abo ut th e im p ortan ce of th e in stru ctio n s fo r th e m ain ten an ce o f h ealth care m ay be viewed as d egrad in g. Test-Ta kin g St r a t egy: No te th e st r a t egic wo r d , best. Fo cus on th e su b ject , th e b eh avio r o f a Ch in ese Am erican clien t. Elim - in ate op tio n s 3 an d 4 first becau se th ese actio n s are n o n th era- p eutic. To select fro m th e rem ain in g o ption s, th in k ab ou t th e cultu ral p ractices o f Ch in ese Am erican s an d recall th at d irect eye con tact m ay be u n co m fortable for th e clien t. Review: Th e co m m u n ication p ractices of Asia n Am er ica n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Cultu ral Awaren ess Pr ior it y Con cept s: Clien t Ed ucation ; Culture Refer en ce: Jarvis (2016), p. 36.

5. 1, 2, 5 Ra tion a le: In tim es of illn ess, a Rom an Catho lic clien t m ay turn to prayer for spiritual sup port. Th is m ay in clu de ro sary prayers o r visits fro m a p riest, who is th e spiritual leader in the Rom an Cath o lic faith . Close fam ily m em b ers usually wan t to stay with a d yin g fam ily m em b er in o rd er to h ear th e wishes of th e clien t, allowin g th e sou l to leave in p eace. A p riest, n ot a n urse, wou ld adm in ister th e sacram en t o f th e sick. Rom an Catho lics would n ot ask for th e cru cifix to b e rem oved . Mem b ers o f oth er reli- gio us gro ups such as Islam or Jud aism m ay req uest th e rem oval o f the cru cifix. Dietary rituals are n ot a con cern at th is tim e. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject , th e Ro m an Cath - o lic religion . Co n sid er th e role o f th e sp iritual leader an d fam - ily in th e Cath olic faith . Th is will assist in selectin g o p tion s 2 an d 5. Fo r th e rem ain in g op tion s, recall th at th e presen ce of fam ily is a sou rce of sup po rt. Review: Sp iritual an d religiou s Hisp a n ic clien t s Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Cultu ral Awaren ess Pr ior it y Con cept s: Care Co o rd in atio n ; Cu lture Refer en ce: Po tter et al. (2015), p p . 111–112, 702–703.

6. 1, 2, 4, 5 Ra tion a le: Because of th eir h ealth an d d ietary p ractices, Latin o Am erican s, Native Am erican s, Hisp an ic Am erican s, an d Afri- can Am erican s h ave a h igh risk o f o besity an d diab etes m elli- tu s. O win g to d ietary practices, Asian Am erican s h ave a lo wer risk for o besity an d diabetes m ellitu s. Test-Ta king Stra tegy: Focus on the su b ject, those with a high risk for diabetes m ellitus and obesity. Think about the health and dietary practices of each cultural group in the options to answer correctly. Review: Th e h ea lt h r isk s for vario us eth n ic grou ps Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n d am en tals o f Care—Cultu ral Awaren ess Pr ior it y Con cept s: Cu lture; Health Pro m o tio n Refer en ce: Lewis et al. (2014), p p . 908, 1170.

7. 4 Ra tion a le: Am o n g Jeh o vah ’s Witn esses, surgery is n ot p ro h ib - ited , bu t th e ad m in istration o f bloo d an d b loo d prod ucts is fo r- b idd en . For a Jeh o vah ’s Witn ess, ad m in istratio n of m edicatio n is an acceptab le practice excep t if th e m edication is derived fro m b loo d prod ucts. Th is religio u s gro up believes th at th e so ul can n ot live after d eath . Jeh o vah ’s Witn esses avo id fo od s p rep ared with o r co n tain in g b loo d. Test-Ta kin g Str a tegy: Focus o n th e su b ject , beliefs of Jeh o- vah ’s Witn esses. Rem em b er th at th e ad m in istration of blo od an d an y associated b loo d p ro du cts is forbid d en am o n g Jeh o - vah ’s Witn esses. Even fo od s prepared with b lo od o r con tain in g b loo d are avo id ed. Review: Th e cu ltural preferen ces o f Jeh o va h ’s Wit n esses Level of Cogn itive Ability: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Cultu ral Awaren ess Pr ior it y Con cept s: Care Co ord in atio n ; Cu lture Refer en ce: Lewis et al. (2014), p . 677.

8. 3 Ra tion a le: Mem bers of O rth od o x Ju d aism ad h ere to d ietary ko sh er laws. In th is religio n , th e dairy-m eat com bin atio n is u n accep tab le. O n ly fish th at h ave scales an d fin s are allo wed ; m eats th at are allowed in clu de an im als th at are vegetable eaters, clo ven h o ofed , an d ritually slau gh tered. Test-Ta kin g St r a t egy: Focus on th e su b ject , dietary kosh er laws, an d recall th at th e d airy-m eat co m b in ation is u n accep t- able in th e O rth o do x Ju d aism grou p. Elim in ate o ption 1 b ecau se th is op tio n co n tain s p ork roast an d m ilk. Next, elim - in ate o p tion s 2 an d 4 b ecau se b o th o ptio n s con tain sh ellfish . Review: Th e d ietary ru les o f m em bers o f th e Or t h o d o x Ju d a - ism religio u s gro up Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Cultu ral Awaren ess Pr ior it y Con cept : Cu lture; Nu trition Refer en ces: Giger (2013), pp. 516–517; Nix (2013), p p. 266–267.

9. 3 Ra tion a le: In th e Asian Am erican cu ltu re, h ealth is believed to b e a state o f ph ysical an d spiritu al h arm on y with n atu re an d a b alan ce b etween po sitive an d n egative en ergy forces (yin an d yan g). Yin fo o ds are co ld an d yan g foo ds are h o t. Co ld fo od s are eaten wh en o n e h as a h ot illn ess (fever), an d h o t fo o ds are eaten wh en o n e h as a co ld illn ess. O p tion s 1 an d 2 are n o t h ealth practices sp ecifically asso ciated with th e Asian Am erican cultu re or th e yin an d yan g th eo ry. Test-Ta kin g Str a tegy: Focus on th e su b ject , an Asian Am eri- can , an d th e clien t’s diagn o sis, fever. Rem em b er th at co ld fo od s (yin fo od s) are eaten wh en o n e h as a h o t illn ess, an d h o t fo od s ( yan g fo od s) are eaten wh en on e h as a cold illn ess. Review: Th e h ealth practices o f th e Asia n Am er ica n cu ltu re Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nu rsin g Pro cess—Plan n in g Con ten t Ar ea : Fun dam en tals o f Care—Cultu ral Awaren ess

F

u

n

d

a

m

e

n

t

a

l

s

42 UNIT II Professional Standards in Nursing

Pr ior ity Con cept: Cultu re; Th erm oregulation Refer en ce: Jarvis (2016), p p. 18, 20.

10. 3 Ra t ion a le: Co m plem en tary an d altern ative th erap ies in clud e a wid e variety of treatm en t m od alities th at are used in add itio n to co n ven tion al th erap y to treat a d isease or illn ess. Ed u catin g th e clien t abo u t th erap ies th at h e o r sh e uses o r is in terested in usin g is th e n urse’s ro le. O ptio n s 1, 2, an d 4 are in ap p ro priate actio n s fo r th e n u rse to take becau se th ey provid e ad vice to th e clien t. Test -Ta kin g Str a tegy: Note th e st r a t egic wo r d , best. Use t h er - a p eu t ic co m m u n ica t io n t ech n iq u es. Elim in ate op tio n s 1, 2, an d 4 because th ey are n o n th erapeu tic. Also n o te th at th ey are co m p a r a b le o r a lik e in th at th ey provid e advice to th e clien t. Reco m m en din g an h erb al rem ed y or disco uragin g a clien t fro m do in g so m eth in g is n o t with in th e role p ractices of th e n urse. In ad d itio n , it is n o n th erapeu tic to advise a clien t to do so m eth in g. Review: Th er a p eu t ic co m m u n ica t io n t ech n iq u es an d th e n urse’s role in ed ucatin g clien ts ab ou t co m p lem en t a r y a n d a lt er n a t ive m ed icin e Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Clien t Edu catio n ; Cu ltu re Refer en ces: Lewis et al. (2014), pp . 85–86; Perry, Potter, O sten - do rf (2014), p . 31.

11. 3 Ra t ion a le: Alth ou gh h erb al sub stan ces m ay h ave so m e b en e- ficial effects, n o t all h erb s are safe to use. Clien ts wh o are b ein g treated with co n ven tion al m edicatio n th erap y sh o uld b e en cou raged to avoid h erb al su b stan ces b ecau se th e co m b in a- tion m ay lead to an excessive reactio n or to u n kn own

in teractio n effects. Th e n u rse sh ou ld advise th e clien t to d iscu ss th e u se of th e h erb al sub stan ce with th e HCP. Th erefore, o p tion s 1, 2, an d 4 are in ap prop riate n u rsin g actio n s. Test -Ta kin g St r a t egy: Elim in ate o ption 2 first b ecause o f th e clo sed -en d ed wo r d never. Next, elim in ate op tion s 1 an d 4 b ecause th ey are co m p a r a b le o r a lik e an d in d icate accep tan ce o f u sin g an h erb al sub stan ce. Review: Th e lim itatio n s asso ciated with th e u se of h er b a l su b st a n ces Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Lewis et al. (2014), pp . 81, 85–86.

12. 4 Ra t ion a le: Th e 5 m ain catego ries o f CAM in clu d e wh o le m ed- ical system s, m in d-b od y m ed icin e, b io logically b ased p rac- tices, m an ip ulative an d b od y-based practices, an d en ergy m ed icin e. Magn etic th erapy an d m assage th erap y are th erap ies with in specific categories of CAM. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d s, need for fur- ther teaching. Th ese wo rd s in dicate a n ega t ive even t q u er y an d th e n eed to select th e in correct o ption . Also , focus o n th e su b ject of th e qu estio n , th e 5 m ain categories of CAM. No t- in g th at th e q uestion asks ab ou t m ain categories, n o t specific th erap ies, will assist in d irectin g you to th e co rrect op tion . Review: Th e categories of co m p lem en t a r y a n d a lt er n a t ive m ed icin e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun d am en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Lewis et al. (2014), p. 80.

F

u

n

d

a

m

e

n

t

a

l

s

43CHAPTER 5 Cultural Awareness and Health Practices

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 6 Ethical and Legal Issues

PRIORITY CONCEPTS Ethics; Health Care Law

CRITICAL THINKING What Should You Do? While preparing a client for surgery scheduled in 1 hour, the client states to the nurse: “I have changed my mind. I don’t want this surgery.” What should the nurse do? Answer located on p. 54.

I. Ethics A. Description : Th e bran ch of ph ilosoph y con cern ed

with th e distin ction between righ t an d wro n g on th e basis of a body of kn owledge, n ot on ly on th e basis of opin ion s

B. Morals: Beh avior in acco rdan ce with custom s or tra- dition , usually reflectin g perso n al or religious beliefs

C. Ethical principles: Codes th at direct or govern n ursin g action s (Box 6-1)

D. Values: Beliefs an d attitu des th at m ay in fluen ce beh avior an d th e process of decision m akin g

E. Values clarification : Process of an alyzin g on e’s own values to un derstan d on eself m ore com pletely regardin g wh at is truly im portan t

F. Eth ical codes 1. Eth ical codes provide broad prin ciples for deter-

m in in g an d evaluatin g clien t care. 2. Th ese codes are n ot legally bin d in g, but th e

board of n ursin g h as auth o rity in m ost states to reprim an d n urses for un profession al con duct th at results from violation of th e eth ical codes.

3. Specific eth ical codes are as follo ws: a . Th e Code of Eth ics for Nurses developed by

th e In tern ation al Coun cil of Nurses; Web site: h ttp :/ / www.icn .ch / abo ut-icn / co de-of-eth ics- for-n u rses/ .

b . Th e Am erican Nu rses Asso ciation Code of Eth ics can be viewed on th e Am erican Nu rses Asso ciation Web site: h ttp :/ / www. n ursin gworld.org/ codeofeth ics.

G. Eth ical dilem m a 1. An eth ical dilem m a occurs wh en th ere is a co n -

flict between 2 or m ore ethical principles.

2. No correct decision exists, an d th e n urse m ust m ake a ch oice between 2 altern atives th at are equally un satisfactory.

3. Such dilem m as m ay occur as a result of differ- en ces in cultural or religious beliefs.

4. Eth ical reason ing is th e process of th in king th rough what on e should do in an orderly and system atic m an n er to provide justification for action s based on prin ciples; th e n urse sh ould gath er all in form a- tion to determ in e wheth er an eth ical dilem m a exists, exam in e his or h er own values, verbalize th e prob- lem , con sider possible courses of action , n egotiate th e outcom e, an d evaluate th e action taken .

H. Advocate 1. An ad vocate is a person wh o speaks up for or acts

on th e beh alf of th e clien t, protects th e clien t’s righ t to m ake h is or h er own decision s, an d uph olds th e prin ciple of fidelity.

2. An advocate represen ts th e clien t’s viewpoin t to oth ers.

3. An advo cate avoids lettin g perso n al values in flu- en ce advocacy for th e clien t an d supports th e cli- en t’s decision , even wh en it con flicts with th e advocate’s own preferen ces or ch oices.

I. Eth ics com m ittees 1. Eth ics com m ittees take an in terp rofession al

approach to facilitate dialogu e regardin g eth ical dilem m as.

2. Th ese com m ittees develop an d establish policies an d proced ures to facilitate th e preven tion an d resolutio n of dilem m as.

An important nursing responsibility is to act as a client advocate and protect the client’s rights.

II. Regulation of Nursing Practice A. Nurse Practice Act

1. A n urse practice act is a series of statutes th at h ave been en acted by each state legislature to regulate th e practice of n ursin g in th at state.

2. Nurse practice acts set education al requirem en ts for th e n urse, distin guish between n ursin g44

F

u

n

d

a

m

e

n

t

a

l

s

practice an d m ed ical practice, an d defin e th e scope of n ursin g practice.

3. Addition al issues covered by n urse practice acts in clude licen su re requirem en ts for protection of th e public, groun ds for disciplin ary action , righ ts of th e n urse licen see if a disciplin ary action is taken , an d related topics.

4. All n urses are respo n sible for kn owin g th e provi- sion s of th e act of th e state or provin ce in wh ich th ey work.

B. Stan dards of care 1. Stan dards of care are guidelin es th at iden tify

wh at th e clien t can exp ect to receive in term s of n ursin g care.

2. Th e gu idelin es determ in e wh eth er n urses h ave perform ed duties in an ap propriate m an n er.

3. If th e n urse does n ot perform duties with in accepted stan d ards of care, th e n urse places h im - self or h erself in jeopardy of legal action .

4. If th e n urse is n am ed as a defen dant in a malprac- tice lawsuit an d proceedin gs sh ow th at th e n urse followed n either th e accepted stan dards of care outlin ed by th e state or provin ce n urse practice act n or th e policies of th e em ployin g institution, th e n urse’s legal liability is clear; h e or she is liable.

C. Em ployee guidelin es 1. Resp on deat superior: Th e em plo yer is h eld liable

for an y n egligen t acts of an em plo yee if th e alleged n egligen t act occurred durin g th e em p loym en t relation sh ip an d was with in th e scope of th e em p loyee’s respon sibilities.

2. Con tracts a. Nu rses are respo n sible for carryin g out th e

term s of a con tractual agreem en t with th e em p loyin g agen cy an d th e clien t.

b . Th e n urse-em ployee relation sh ip is govern ed by establish ed em p loyee h an dbo oks an d cli- en t care policies an d proced ures th at create obligation s, righ ts, an d duties between th o se parties.

3. In stitution al policies a. Written policies an d proced ures of th e

em p loyin g in stitutio n detail h ow n urses are to perform th eir duties.

b . Policies an d proced ures are usually specific an d describe th e expected beh avior on th e part of th e n urse.

c. Alth ou gh policies are n ot laws, courts gen er- ally ru le again st n urses wh o violate policies.

d . If th e n urse practices n ursin g accord in g to cli- en t care policies an d procedures establish ed by th e em plo yer, fun ction s with in th e job respo n sibility, an d provides care con sisten tly in a n on n egligen t m an n er, th e n urse m in i- m izes th e poten tial for liability.

The nurse must follow the guidelines identified in the Nurse Practice Act and agency policies and proce- dures when delivering client care.

D. Hospital staffin g 1. Ch arges of ab an don m en t m ay be m ade again st

n urses wh o “walk out” wh en staffin g is in adeq uate.

2. Nu rses in sh o rt staffin g situation s are obligated to m ake a report to th e n ursin g ad m in istration .

E. Floatin g 1. Floatin g is an acceptable practice used by h ealth

care facilities to alleviate un derstaffin g an d overstaffin g.

2. Legally, th e n urse can n ot refuse to float un less a un io n co n tract guaran tees th at n urses can work on ly in a specified area or th e n urse can prove lack of kn owledge for th e perform an ce of assign ed tasks.

3. Nu rses in a floatin g situation m ust n ot assum e respo n sibility beyon d th eir level of exp erien ce or qualification .

4. Nu rses wh o float sh o uld in form th e supervisor of an y lack of experien ce in carin g for th e type of clien ts on th e n ew n ursin g un it.

5. A resou rce n urse wh o is skilled in th e care of clien ts on th e un it sh ould also be assign ed to th e float n urse; in addition , th e float n urse sh ould be given an orien tation of th e un it an d th e stan d ards of care for th e un it sh o uld be reviewed (th e float n urse can care for “overflow” clien ts wh o se acu ity level m ore clo sely m atch th e n urses’ experien ce).

F. Disciplin ary action 1. Boards of n ursin g m ay den y, revoke, or suspen d

an y licen se to practice as a registered n urse, acco rdin g to th eir statutory auth ority.

2. Som e causes for disciplin ary action are as follo ws: a. Un profession al con d uct b . Con duct th at could affect th e h ealth an d wel-

fare of th e public adversely

BOX 6-1 Ethical Principles Autonomy: Respect for an individual’s right to self-determi-

nation Nonmaleficence: The obligation to do or cause no harm to

another Beneficence: The duty to do good to others and to maintain a

balance between benefits and harms; paternalism is an undesirable outcome of beneficence, in which the health care provider decides what is best for the client and encourages the client to act against his or her own choices

Justice: The equitable distribution of potential benefits and tasks determining the order in which clients should be cared for

Veracity: The obligation to tell the truth Fidelity: The duty to do what one has promised

45CHAPTER 6 Ethical and Legal Issues

c. Breach of clien t confidentiality d . Failure to use sufficien t kn owled ge, skills, or

n ursin g judgm en t e. Ph ysically or verbally abusin g a clien t f. Assum in g duties with out sufficien t preparation g. Kn o win gly delegatin g to un licen sed perso n -

n el n ursin g care th at places th e clien t at risk for in jury

h . Failure to m ain tain an accu rate record for each clien t

i. Falsifyin g a clien t’s record j. Leavin g a n ursin g assign m en t with out prop-

erly n otifyin g appropriate person n el

III. Legal Liability A. Laws

1. Nu rses are govern ed by civil an d crim in al law in roles as providers of services, em plo yees of in sti- tution s, an d private citizen s.

2. Th e n urse h as a perso n al an d legal obligation to provide a stan dard of clien t care expected of a reason ably com peten t profession al n urse.

3. Profession al n urses are h eld respon sible (liab le) for h arm resultin g from th eir n egligen t acts or th eir failure to act.

B. Types of laws (Box 6-2; Fig. 6-1) C. Negligence an d malpractice (Box 6-3)

1. Negligen ce is con d uct th at falls below th e stan - dard of care.

2. Negligen ce can in clude acts of com m ission an d acts of om ission .

3. Th e n urse wh o does n ot m eet appropriate stan - dard s of care m ay be h eld liable.

4. Malpractice is n egligen ce on th e part of th e n urse.

5. Malpractice is determ in ed if th e n urse owed a duty to th e clien t an d did n ot carry out th e duty an d th e clien t was in jured because th e n urse failed to perform th e duty.

6. Proof of liability a . Duty: At th e tim e of in jury, a duty existed

between th e plain tiff an d th e defen dan t. b . Breach of duty: Th e defen dan t breach ed duty

of care to th e plain tiff. c. Proxim ate cau se: Th e breach of th e duty was

th e legal cause of in jury to th e clien t.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 6-2 Types of Law

Contract Law Contract law is concerned with enforcement of agreements among private individuals.

Civil Law Civil law is concerned with relationships among persons and the protection of a person’s rights. Violation may cause harm to an individual or property, but no grave threat to society exists.

Criminal Law Criminal law is concerned with relationships between individ- uals and governments, and with acts that threaten society and its order; a crime is an offense against society that violates a law and is defined as a misdemeanor (less serious nature) or felony (serious nature).

Tort Law A tort is a civil wrong, other than a breach in contract, in which the law allows an injured person to seek damages from a per- son who caused the injury.

The Co ns titutio n

Type s o f law applic able to nurs e s

S ta tutory la w Common la w P riva te la w

Adminis tra tive la w

Le gis la tive bra nch

Inte ntiona l (a ction is s ubs ta ntia lly

ce rta in to ca us e a n e ffe ct) • Fra ud • De fa ma tion • As s a ult a nd ba tte ry • Fa ls e impris onme nt • Inva s ion of priva cy

• Ne glige nce • Ma lpra ctice

Uninte ntiona l (viola tion of

s ta nda rd of ca re )

J udicia l bra nch

S ta nda rd of proof is pre ponde ra nce of the e vide nce

S ta nda rd of proof is guilt be yond a re a s ona ble doubt

Civil

• Nurs e -pa tie nt re la tions hip

Contra cts

Torts

• Ma ns la ughte r • As s a ult a nd ba tte ry • Fra ud

Fe lony

Mis de me a nor

Crimina l

Exe cutive bra nch

S o urc e s o f Law (the balanc e o f po we r)

• P roce dura l la w • P ublic la w • S ubs ta ntive la w

FIGURE 6-1 Sources of law for nursing practice.

46 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

d . Dam age or in ju ry: Th e plain tiff experien ced in ju ry or dam ages or both an d can be com - pen sated by law.

The nurse must meet appropriate standards of care when delivering care to the client; otherwise the nurse would be held liable if the client is harmed.

D. Profession al liability in suran ce 1. Nu rses n eed th eir own liability in suran ce for pro-

tection again st m alpractice lawsuits. 2. Havin g th eir own in suran ce provides n urses pro-

tection as in dividuals; th is allows th e n urse to h ave an attorn ey, wh o h as on ly th e n urse’s in ter- ests in m in d , presen t if n ecessary.

E. Good Sam aritan laws 1. State legislatures pass Good Sam aritan laws,

wh ich m ay vary fro m state to state. 2. Th ese laws en courage h ealth care profession als

to assist in em ergen cy situation s an d lim it liabil- ity an d offer legal im m un ity for person s h elpin g in an em ergen cy, provided th at th ey give reason able care.

3. Im m un ity from suit applies on ly wh en all con di- tio n s of th e state law are m et, such as th at th e h ealth care provid er (HCP) receives n o com pen - sation for th e care provid ed an d th e care given is n ot in ten tion ally n egligen t.

F. Con trolled substan ces 1. Th e n urse sh ould adh ere to facility policies an d

procedures con cern in g ad m in istration of con - tro lled substan ces, wh ich are go vern ed by federal an d state laws.

2. Con trolled substan ces m ust be kep t locked securely, an d on ly au th orized person n el sh ould h ave access to th em .

3. Con trolled substan ces m ust be properly sign ed out for adm in istration an d a correct in ven tory m ust be m ain tain ed.

IV. Collective Bargaining A. Collective bargain in g is a form alized decision -

m akin g process between represen tatives of m an age- m en t an d represen tatives of labor to n egotiate wages an d co n dition s of em p loym en t.

B. Wh en collective bargain in g breaks down because th e parties can n ot reach an agreem en t, th e em ployees m ay call a strike or take oth er work action s.

C. Strikin g presen ts a moral dilem m a to m an y n urses because n ursin g practice is a service to peo ple.

V. Legal Risk Areas A. Assault

1. Assault occurs wh en a person puts an oth er per- son in fear of a h arm fu l or offen sive con tact.

2. Th e victim fears an d believes th at h arm will result because of th e th reat.

B. Battery is an in ten tion al touch in g of an oth er’s body with ou t th e oth er’s consent.

C. In vasion of privacy in cludes violating confidentiality, intrudin g on private clien t or fam ily m atters, an d shar- ing clien t in form ation with un auth orized person s.

D. False im prison m en t 1. False im prison m en t occurs wh en a clien t is n ot

allowed to leave a h ealth care facility wh en th ere is n o legal justification to detain th e clien t.

2. False im prison m en t also occurs wh en restrain in g devices are used with ou t an appropriate clin ical n eed.

3. A clien t can sign an Again st Medical Advice form wh en th e clien t refuses care an d is co m peten t to m ake decision s.

4. Th e n urse sh o uld docum en t circum stan ces in th e m ed ical record to avoid allegation s by th e clien t th at can n ot be defen ded.

E. Defam ation is a false com m un ication th at cau ses dam age to som eon e’s reputation , eith er in writin g (libel) or verbally (slan der) .

F. Frau d results from a deliberate deception in ten ded to produ ce un lawful gain s.

G. Th ere m ay be exception s to certain legal risks areas, such as assault, battery, an d false im prison m en t, wh en carin g for a clien t with a m en tal h ealth disor- der experien cin g acute distress wh o poses a risk to h im self or h erself or oth ers. In th is situation , th e n urse m ust assess th e clien t to determ in e loss of con - trol an d in terven e accordin gly; th e n urse sh ould use th e least restrictive m eth od s in itially, but th en use in terven tion s such as restrain t if th e clien t’s beh avior in dicates th e n eed for th is in terven tion .

VI. Client’s Rights A. Description

1. Th e clien t’s righ ts docum en t, also called the Cli- ent’s (Patient’s) Bill of Rights, reflects ackn owledg- m en t of a client’s righ t to participate in h er or h is h ealth care with an em ph asis on clien t auton om y.

BOX 6-3 Examples of Negligent Acts ▪ Medication errors that result in injury to the client ▪ Intravenous administration errors, such as incorrect flow

rates or failure to monitor a flow rate, that result in injury to the client

▪ Falls that occur as a result of failure to provide safety to the client

▪ Failure to use sterile technique when indicated ▪ Failure to check equipment for proper functioning ▪ Burns sustained by the client as a result of failure to mon-

itor bath temperature or equipment ▪ Failure to monitor a client’s condition ▪ Failure to report changes in the client’s condition to the

health care provider ▪ Failure to provide a complete report to the oncoming nurs-

ing staff

Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

47CHAPTER 6 Ethical and Legal Issues

2. Th e docum en t provid es a list of th e righ ts of th e clien t an d respo n sibilities th at th e h ospital can - n ot violate ( Box 6-4).

3. Th e clien t’s righ ts protect th e clien t’s ability to determ in e th e level an d typ e of care received; all h ealth care agen cies are required to h ave a Client’s Bill of Rights posted in a visible area.

4. Several laws an d stan dard s pertain to clien t’s righ ts ( Box 6-5).

B. Righ ts for th e m en tally ill ( Box 6-6) 1. Th e Men tal Health System s Act created righ ts for

m en tally ill peo ple. 2. Th e Join t Com m ission h as developed policy

statem en ts on th e righ ts of m en tally ill people.

3. Psych iatric facilities are required to h ave a Cli- en t’s Bill of Righ ts posted in a visible area.

C. O rgan don ation an d tran splan tation 1. A clien t h as th e righ t to decide to becom e an

organ don or an d a righ t to refuse organ tran s- plan tation as a treatm en t option .

2. An in dividual wh o is at least 18 years old m ay in dicate a wish to beco m e a don or on h is or h er driver’s licen se (state-specific) or in an advance directive.

3. Th e Un ifo rm An atom ical Gift Act provid es a list of in dividuals wh o can provide informed consent for th e don ation of a deceased in dividual’s organ s.

4. Th e Un ited Network for O rgan Sh arin g sets th e criteria for organ don ation s.

5. Som e organ s, such as th e h eart, lu n gs, an d liver, can be obtain ed on ly fro m a perso n wh o is on m ech an ical ven tilation an d h as suffered brain death , wh ereas oth er organ s or tissues can be rem oved several h ours after death .

6. A don or m ust be free of in fectio us disease an d can cer.

7. Requ ests to th e deceased ’s fam ily for organ don a- tion usually are don e by th e HCP or n urse spe- cially train ed for m akin g such requests.

8. Don ation of organ s does n ot delay fun eral arran gem en ts; n o obvious eviden ce th at th e organ s were rem oved from th e body sh ows wh en

F

u

n

d

a

m

e

n

t

a

l

s

BOX 6-4 Client’s Rights When Hospitalized ▪ Right to considerate and respectful care ▪ Right to be informed about diagnosis, possible treatments,

and likely outcome, and to discuss this information with the health care provider

▪ Right to know the names and roles of the persons who are involved in care

▪ Right to consent or refuse a treatment ▪ Right to have an advance directive ▪ Right to privacy ▪ Right to expect that medical records are confidential ▪ Right to review the medical record and to have information

explained ▪ Right to expect that the hospital will provide necessary

health services ▪ Right to know if the hospital has relationships with outside

parties that may influence treatment or care ▪ Right to consent or refuse to take part in research ▪ Right to be told of realistic care alternatives when hospital

care is no longer appropriate ▪ Right to know about hospital rules that affect treatment,

and about charges and payment methods

From Christensen B, Kockrow E: Foundations of nursing, ed 6, St. Louis, 20 10, Mosby; and adapted from American Hospital Association: The patient care partnership: understanding expectations, rights and responsibilities. Available at www.aha.org/ content/ 0 0 -10/ pcp_english_0 30 730 .pdf.

BOX 6-5 Laws and Standards

American Hospital Association Issued Patient’s Bill of Rights

American Nurses Association Developed the Code of Ethics for Nurses, which defines the nurse’s responsibility for upholding client’s rights

Mental Health Systems Act Developed rights for mentally ill clients

The Joint Commission Developed policy statements on the rights of mentally ill individuals

BOX 6-6 Rights for the Mentally Ill ▪ Right to be treated with dignity and respect ▪ Right to communicate with persons outside the hospital ▪ Right to keep clothing and personal effects with them ▪ Right to religious freedom ▪ Right to be employed ▪ Right to manage property ▪ Right to execute wills ▪ Right to enter into contractual agreements ▪ Right to make purchases ▪ Right to education ▪ Right to habeas corpus (written request for release from

the hospital) ▪ Right to an independent psychiatric examination ▪ Right to civil service status, including the right to vote ▪ Right to retain licenses, privileges, or permits ▪ Right to sue or be sued ▪ Right to marry or divorce ▪ Right to treatment in the least restrictive setting ▪ Right not to be subject to unnecessary restraints ▪ Right to privacy and confidentiality ▪ Right to informed consent ▪ Right to treatment and to refuse treatment ▪ Right to refuse participation in experimental treatments or

research

Adapted from Stuart G: Principles and practice of psychiatric nursing, ed 10 , St. Louis, 20 13, Mosby.

48 UNIT II Professional Standards in Nursing

th e body is dressed; an d th e fam ily in curs n o cost for rem oval of th e organ s don ated.

D. Religiou s beliefs: O rgan don ation an d tran splan - tatio n 1. Cath olic Ch u rch : O rgan don ation an d tran s-

plan ts are acceptable. 2. O rth odox Ch u rch : Ch u rch discourages organ

don ation . 3. Islam (Muslim ) beliefs: Body parts m ay n ot be

rem oved or don ated for tran splan tatio n . 4. Jeh ovah ’s Witn ess: An organ tran splan t m ay be

accepted, but th e organ m ust be clean sed with a n on blood solution befo re tran splan tatio n .

5. O rth odox Judaism a. All body parts rem oved durin g au topsy m ust

be buried with th e body because it is believed th at th e en tire body m ust be return ed to th e earth ; organ don ation m ay n ot be con sidered by fam ily m em bers.

b . O rgan tran splan tation m ay be allowed with th e rabb i’s approval.

6. Refer to Ch apter 5 for addition al in form ation regardin g en d-of-life care.

VII. Informed Consent A. Description

1. In form ed con sen t is th e clien t’s approval (or th at of th e clien t’s legal represen tative) to h ave h is or h er body touch ed by a specific in dividual.

2. Consents, or releases, are legal docum en ts th at in dicate th e clien t’s perm ission to perform sur- gery, perform a treatm en t or proced ure, or give in form ation to a th ird party.

3. Th ere are differen t types of con sen ts (Box 6-7). 4. In form ed con sen t in dicates th e clien t’s participa-

tio n in th e decision regardin g h ealth care. 5. Th e clien t m ust be in form ed, in un derstan dable

term s, of th e risks an d ben efits of th e surgery or treatm en t, wh at th e con sequ en ces are for n ot h avin g th e surgery or procedure perform ed, treat- m en t option s, an d th e n am e of th e h ealth care provider perform in g th e surgery or procedure.

6. A clien t’s question s about th e surgery or proce- dure m ust be an swered befo re sign in g th e con sen t.

7. A con sen t m ust be sign ed freely by th e clien t with out th reat or pressure an d m ust be witn essed (th e witn ess m ust be an ad ult).

8. A clien t wh o h as been m ed icated with sed atin g m ed ication s or an y oth er m ed ication s th at can affect th e clien t’s cogn itive abilities m ust n ot be asked to sign a con sen t.

9. Legally, th e clien t m ust be m en tally an d em o- tio n ally com peten t to give con sen t.

10. If a clien t is declared m en tally or em otion ally in com peten t, th e n ext of kin , appoin ted guard- ian (appoin ted by th e court), or durable power

of atto rn ey for h ealth care h as legal au th ority to give con sen t (Box 6-8).

11. A com peten t clien t 18 years of age or older m ust sign th e con sen t.

12. In m ost states, wh en th e n urse is in volved in th e in form ed con sen t process, th e n urse is witn es- sin g on ly th e sign ature of th e clien t on th e in form ed co n sen t form .

F

u

n

d

a

m

e

n

t

a

l

s

BOX 6-7 Types of Consents

Admission Agreement Admission agreements are obtained at the time of admission and identify the health care agency’s responsibility to the client.

Immunization Consent An immunization consent may be required before the admin- istration of certain immunizations; the consent indicates that the client was informed of the benefits and risks of the immunization.

Blood Transfusion Consent A blood transfusion consent indicates that the client was informed of the benefits and risks of the transfusion. Some cli- ents hold religious beliefs that would prohibit them from receiving a blood transfusion, even in a life-threatening situation.

Surgical Consent Surgical consent is obtained for all surgical or invasive proce- dures or diagnostic tests that are invasive. The health care pro- vider, surgeon, or anesthesiologist who performs the operative or other procedure is responsible for explaining the procedure, its risks and benefits, and possible alternative options.

Research Consent The research consent obtains permission from the client regarding participation in a research study. The consent informs the client about the possible risks, consequences, and benefits of the research.

Special Consents Special consents are required for the use of restraints, photo- graphing the client, disposal of body parts during surgery, donating organs after death, or performing an autopsy.

BOX 6-8 Mentally or Emotionally Incompetent Clients

▪ Declared incompetent ▪ Unconscious ▪ Under the influence of chemical agents such as alcohol or

drugs ▪ Chronic dementia or other mental deficiency that impairs

thought processes and ability to make decisions

49CHAPTER 6 Ethical and Legal Issues

13. An in form ed con sen t can be waived for urgen t m ed ical or surgical in terven tion as lon g as in sti- tution al policy so in dicates.

14. A clien t h as th e righ t to refuse in form ation an d waive th e in form ed con sen t an d un dergo treat- m en t, but th is decision m ust be docum en ted in th e m ed ical record.

15. A clien t m ay with draw con sen t at an y tim e.

An informed consent is a legal document, and the client must be informed by the HCP (i.e., physician, sur- geon), in understandable terms, of the risks and benefits of surgery, treatments, procedures, and plan of care. The client needs to be a participant in decisions regarding health care.

B. Min o rs 1. A m in or is a clien t un der legal age as defin ed by

state statute (usually youn ger th an 18 years). 2. A m in o r m ay n ot give legal co n sen t, an d con sen t

m ust be obtain ed fro m a paren t or th e legal guardian ; assen t by th e m in o r is im portan t because it allows for com m un ication of th e m in o r’s th o ugh ts an d feelin gs.

3. Paren tal or gu ardian con sen t sh o uld be obtain ed befo re treatm en t is in itiated for a m in or except in th e followin g cases: in an em ergen cy; in situation s in wh ich th e con sen t of th e m in o r is sufficien t, in cludin g treatm en t related to sub- stan ce abuse, treatm en t of a sexually tran sm itted in fectio n , h um an im m un od eficien cy virus (HIV) testin g an d acq uired im m un od eficien cy syn - drom e (AIDS) treatm en t, birth con trol services, pregn an cy, or psych iatric services; th e m in o r is an em an cipated m in o r; or a court order or oth er legal auth o rization h as been obtain ed. Refer to th e Guttm ach er Report on Public Policy for addi- tion al in form ation : h ttp:/ / www.guttm ach er.org/ pubs/ tgr/ 03/ 4/ gr030404.h tm l.

C. Em an cipated m in o r 1. An em an cipated m in o r h as establish ed in depen -

den ce from h is or h er paren ts th rough m arriage, pregn an cy, or service in th e arm ed forces, or by a court order.

2. An em an cipated m in or is con sidered legally cap able of sign in g an in form ed con sen t.

VIII. Health Insurance Portability and Accountability Act A. Description

1. Th e Health In suran ce Portability an d Accoun t- ability Act (HIPAA) describes h ow perso n al h ealth in form ation (PHI) m ay be used an d h ow th e clien t can obtain access to th e in form ation .

2. PHI in cludes in dividually iden tifiable in form a- tion th at relates to th e clien t’s past, presen t, or future h ealth ; treatm en t; an d paym en t for h ealth care services.

3. Th e act requires h ealth care agen cies to keep PHI private, provid es in form ation to th e clien t about th e legal respo n sibilities regardin g privacy, an d explain s th e clien t’s righ ts with respect to PHI.

4. Th e clien t h as various righ ts as a con sum er of h ealth care un d er HIPAA, an d an y clien t requests m ay n eed to be placed in writin g; a fee m ay be attach ed to certain clien t requests.

5. Th e clien t m ay file a com plain t if th e clien t believes th at privacy righ ts h ave been violated.

B. Clien t’s righ ts in clude th e righ t to do th e followin g: 1. In spect a copy of PH I. 2. Ask th e h ealth care agen cy to am en d th e PHI

th at is con tain ed in a record if th e PHI is in accurate.

3. Requ est a list of disclosures m ade regardin g th e PHI as specified by HIPAA.

4. Req u est to restrict h o w th e h ealth care agen cy u ses o r d isclo ses PH I regard in g treatm en t, p aym en t, o r h ealth care services, u n less in fo r- m atio n is n eed ed to p ro vid e em ergen cy treatm en t.

5. Requ est th at th e h ealth care agen cy com m un i- cate with th e clien t in a certain way or at a certain location ; th e request m ust specify h ow or wh ere th e clien t wish es to be con tacted.

6. Requ est a paper copy of th e HIPAA n otice. C. Health care agen cy use an d disclosure of PHI

1. Th e h ealth care agen cy obtain s PH I in th e course of providin g or adm in isterin g h ealth in suran ce ben efits.

2. Use or disclosure of PHI m ay be don e for th e followin g: a . Health care paym en t purpo ses b . Health care operation s purpo ses c. Treatm en t purpo ses d . Provid in g in form ation about h ealth care

services e. Data aggregation purpo ses to m ake h ealth

care ben efit decision s f. Adm in isterin g h ealth care ben efits

3. Th ere are ad dition al uses or disclosures of PHI (Box 6-9).

IX. Confidentiality/ Information Security A. Descrip tion

1. In th e h ealth care system , confidentiality/ informa- tion security refers to th e protectio n of privacy of th e clien t’s PHI.

2. Clien ts h ave a righ t to privacy in th e h ealth care system .

3. A special relation sh ip exists between th e clien t an d n urse, in wh ich in form ation discussed is n ot sh ared with a th ird party wh o is n ot directly in volved in th e clien t’s care.

4. Violation s of privacy occur in various ways (Box 6-10).

F

u

n

d

a

m

e

n

t

a

l

s

50 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

B. Nurse’s respo n sibility 1. Nu rses are boun d to protect clien t confidentiality

by m ost n urse practice acts, by ethical principles an d stan d ards, an d by in stitutio n al an d agen cy policies an d proced ures.

2. Disclosure of con fiden tial in form ation exposes th e n urse to liability for in vasion of th e clien t’s privacy.

3. Th e n urse n eeds to protect th e clien t fro m in dis- crim in ate disclosure of h ealth care in form ation th at m ay cau se h arm (Box 6-11).

C. Social n etworks an d h ealth care ( Box 6-12) D. Medical records

1. Med ical records are con fid en tial. 2. Th e clien t h as th e righ t to read th e m ed ical record

an d h ave copies of th e record. 3. O n ly staff m em bers directly in volved in care

h ave legitim ate access to a clien t’s record; th ese m ay in clude HCPs an d n urses carin g for th e cli- en t, tech n ician s, th erap ists, social workers, un it secretaries, clien t advo cates, an d adm in istrators (e.g., for statistical an alysis, staffin g, quality care review). O th ers m ust ask perm ission fro m th e clien t to review a record.

BOX 6-9 Uses or Disclosures of Personal Health Information

▪ Compliance with legal proceedings or for limited law enforcement purposes

▪ To a family member or significant other in a medical emergency

▪ To a personal representative appointed by the client or des- ignated by law

▪ For research purposes in limited circumstances ▪ To a coroner, medical examiner, or funeral director about a

deceased person ▪ To an organ procurement organization in limited

circumstances ▪ To avert a serious threat to the client’s health or safety or

the health or safety of others ▪ To a governmental agency authorized to oversee the health

care system or government programs ▪ To the Department of Health and Human Services for the

investigation of compliance with the Health Insurance Por- tability and Accountability Act or to fulfill another lawful request

▪ To federal officials for lawful intelligence or national secu- rity purposes

▪ To protect health authorities for public health purposes ▪ To appropriate military authorities if a client is a member

of the armed forces ▪ In accordance with a valid authorization signed by the

client

Adapted from U.S. Department of Health and Human Services Office for Civil Rights: Health information privacy. Available at http:/ / www.hhs.gov/ ocr/ privacy/ .

BOX 6-10 Violations and Invasion of Client Privacy

▪ Taking photographs of the client ▪ Release of medical information to an unauthorized person,

such as a member of the press, family, friend, or neighbor of the client, without the client’s permission

▪ Use of the client’s name or picture for the health care agency’s sole advantage

▪ Intrusion by the health care agency regarding the client’s affairs

▪ Publication of information about the client or photographs of the client, including on a social networking site

▪ Publication of embarrassing facts ▪ Public disclosure of private information ▪ Leaving the curtains or room door open while a treatment

or procedure is being performed ▪ Allowing individuals to observe a treatment or procedure

without the client’s consent ▪ Leaving a confused or agitated client sitting in the nursing

unit hallway ▪ Interviewing a client in a room with only a curtain between

clients or where conversation can be overheard ▪ Accessing medical records when unauthorized to do so

BOX 6-11 Maintenance of Confidentiality ▪ Not discussing client issues with other clients or staff unin-

volved in the client’s care ▪ Not sharing health care information with others without

the client’s consent (includes family members or friends of the client and social networking sites)

▪ Keeping all information about a client private, and not revealing it to someone not directly involved in care

▪ Discussing client information only in private and secluded areas

▪ Protecting the medical record from all unauthorized readers

BOX 6-12 Social Networking and Health Care ▪ Specific social networking sites can be beneficial to health

care providers (HCPs) and clients; misuse of social net- working sites by the HCP can lead to Health Insurance Por- tability and Accountability Act (HIPAA) violations and subsequent termination of the employee.

▪ Nurses need to adhere to the code of ethics, confidentiality rules, and social media rules. Additional information about these codes and rules can be located at the American Nurses Association Web site at http:/ / www.nursingworld. org/ FunctionalMenuCategories/ AboutANA/ Social-Media/ Social-Networking-Principles-Toolkit.

▪ Standards of professionalism need to be maintained and any information obtained through any nurse-client rela- tionship cannot be shared in any way.

▪ The nurse is responsible for reporting any identified breach of privacy or confidentiality.

51CHAPTER 6 Ethical and Legal Issues

4. Th e m ed ical record is stored in th e records or th e h ealth in form ation dep artm en t after disch arge of th e clien t from th e h ealth care facility.

E. In form ation tech n ology/ co m pu terized m ed ical records 1. Health care em ployees sh ould h ave access on ly

to th e clien t’s records in th e n ursin g un it or work area.

2. Con fiden tiality/ in form ation security can be pro- tected by th e use of special com puter access codes to lim it wh at em plo yees h ave access to in com - puter system s.

3. Th e use of a password or iden tification code is n eeded to en ter an d sign off a com pu ter system .

4. A passwo rd or iden tification co de sh ould n ever be sh ared with an oth er person .

5. Perso n al passwo rds sh o uld be ch an ged periodi- cally to preven t un au th orized com pu ter access.

F. Wh en con ductin g research , an y in form ation pro- vided by th e clien t is n ot to be reported in an y m an - n er th at iden tifies th e clien t an d is n ot to be m ade accessible to an yon e outsid e th e research team .

The nurse must always protect client confidentiality.

X. Legal Safeguards A. Risk m an agem en t

1. Risk m an agem en t is a plan n ed m eth od to iden - tify, an alyze, an d evaluate risks, followed by a plan for reducin g th e frequen cy of acciden ts an d in juries.

2. Program s are based on a system atic reportin g sys- tem for in ciden ts or un usual occurren ces.

B. In cid en t reports ( Box 6-13) 1. Th e in ciden t report is used as a m ean s of id en ti-

fyin g risk situation s an d im provin g clien t care. 2. Follo w specific docum en tation guidelin es. 3. Fill out th e report com pletely, accu rately, an d

factu ally. 4. Th e report form sh o uld n ot be copied or placed

in th e clien t’s record. 5. Make n o referen ce to th e in ciden t report form in

th e clien t’s record.

6. Th e report is n ot a substitute for a com plete en try in th e clien t’s record regardin g th e in ciden t.

7. If a clien t in jury or error in care occurred, assess th e clien t frequen tly.

8. Th e h ealth care provider m ust be n otified of in ci- den t an d th e clien t’s con ditio n .

C. Safeguardin g valuables 1. Clien t’s valuables sh ould be given to a fam ily

m em ber or secured for safekeep in g in a stored an d locked design ated location , such as th e agen cy’s safe; th e location of th e clien t’s valu- ables sh ould be docum en ted per agen cy policy.

2. Man y h ealth care agen cies require a clien t to sign a release to free th e agen cy of th e respo n sibility for lost valuables.

3. A clien t’s weddin g ban d can be taped in place un less a risk exists for swellin g of th e h an ds or fin gers.

4. Religiou s item s, such as m edals, m ay be pin n ed to th e clien t’s gown if allowed by agen cy policy.

D. HCP’s prescription s 1. Th e n urse is obligated to carry out an HCP’s pre-

scrip tion except wh en th e n urse believes a pre- scrip tion to be in approp riate or in accurate.

2. Th e n urse carryin g out an in accurate prescription m ay be legally respo n sible for an y h arm suffered by th e clien t.

3. If n o resolutio n occurs regardin g th e prescription in question , th e n urse sh ould con tact th e n urse m an ager or supervisor.

4. Th e n urse sh ould follow specific gu idelin es for telep h on e prescription s ( Box 6-14).

5. Th e n urse sh ould en sure th at all com po n en ts of a m edication prescription are docum en ted (Box 6-15).

The nurse should never carry out a prescription if it is unclear or inappropriate. The HCP should be con- tacted immediately.

E. Docum en tation 1. Docum en tation is legally required by accreditin g

agen cies, state licen sin g laws, an d state n urse an d m edical practice acts.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 6-13 Examples of Incidents That Need to Be Reported

▪ Accidental omission of prescribed therapies ▪ Circumstances that led to injury or a risk for client injury ▪ Client falls ▪ Medication administration errors ▪ Needle-stick injuries ▪ Procedure-related or equipment-related accidents ▪ A visitor injury that occurred on the health care agency

premises ▪ Avisitor who exhibits symptoms of a communicable disease

BOX 6-14 Telephone Prescription Guidelines ▪ Date and time the entry. ▪ Repeat the prescription to the health care provider (HCP),

and record the prescription. ▪ Sign the prescription; begin with “t.o.” (telephone order),

write the HCP’s name, and sign the prescription. ▪ If another nurse witnessed the prescription, that nurse’s

signature follows. ▪ The HCP needs to countersign the prescription within a

timeframe according to agency policy.

52 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

2. Th e n urse sh ould follow agen cy guidelin es an d procedures ( Box 6-16).

3. Refer to Th e Join t Com m ission Web site for acceptable abbreviation s an d docum en tation gu idelin es: h ttp:/ / www.join tcom m ission .org/ stan dards_in form ation / n psgs.aspx.

F. Clien t an d fam ily teach in g 1. Provide com plete in struction s in a lan guage th at

th e clien t or fam ily can un derstan d. 2. Do cum en t clien t an d fam ily teach in g, wh at was

tau gh t, evalu ation of un derstan din g, an d wh o was presen t durin g th e teach in g.

3. In form th e clien t of wh at could h appen if in for- m ation sh ared durin g teach in g is n ot followed.

XI. Advance Directives A. Clien t (Patien t) Self-Determ in ation Act

1. Th e Clien t (Patien t) Self-Determ in ation Act is a law th at in dicates clien ts m ust be provided with in form ation ab out th eir righ ts to iden tify written direction s about th e care th at th ey wish to receive in th e even t th at th ey beco m e in capacitated an d are un ab le to m ake h ealth care decision s.

2. O n adm ission to a h ealth care facility, th e clien t is asked about th e existen ce of an advan ce direc- tive, an d if on e exists, it m ust be docum en ted an d in cluded as part of th e m ed ical record; if th e cli- en t sign s an ad van ce directive at th e tim e of adm ission , it m ust be docum en ted in th e clien t’s m ed ical record.

3. Th e 2 basic typ es of advan ce directives in clude in struction al directives an d durable power of attorn ey for h ealth care. a. In struction al directives: Lists th e m ed ical

treatm en t th at a clien t ch oo ses to om it or refuse if th e clien t becom es un ab le to m ake decision s an d is term in ally ill.

b . Du rable power of attorn ey for h ealth care: Appo in ts a person (h ealth care proxy) ch osen by th e clien t to m ake h ealth care decision s on th e clien t’s beh alf wh en th e clien t can n o lon - ger m ake decision s.

B. Do n ot resuscitate (DNR) orders 1. A DNR order sh ould be written if th e clien t an d

h ealth care provider h ave m ade th e decision th at th e clien t’s h ealth is deterioratin g an d th e clien t ch oo ses n ot to un dergo cardiop ulm on ary resus- citation if n eeded.

2. Th e clien t or h is or h er legal represen tative m ust provide informed consent for th e DNR status.

3. Th e DNR order m ust be defin ed clearly so th at oth er treatm en t, n ot refused by th e clien t, will be con tin ued.

4. Som e states offer DNR Com fo rt Care an d DNR Com fo rt Care Arrest protoco ls; th ese protoco ls list specific action s th at HCPs will take wh en pro- vidin g cardiop ulm on ary resuscitation (CPR).

5. All h ealth care person n el m ust kn ow wh eth er a clien t h as a DNR order; if a clien t does n ot h ave a DNR order, HCPs n eed to m ake every effort to revive th e clien t.

6. A DNR order n eeds to be reviewed regularly acco rdin g to agen cy policy an d m ay n eed to be ch an ged if th e clien t’s status ch an ges.

7. DNR protoco ls m ay vary from state to state, an d it is im portan t for th e n urse to kn ow h is or h er state’s protoco ls.

C. Th e n urse’s role 1. Discussin g advan ce directives with th e clien t opens

th e com m un ication ch an n el to establish what is im portan t to the clien t an d what the clien t m ay view as prom otin g life versus prolon gin g dyin g.

BOX 6-15 Components of a Medication Prescription

▪ Date and time prescription was written ▪ Medication name ▪ Medication dosage ▪ Route of administration ▪ Frequency of administration ▪ Health care provider’s signature

BOX 6-16 Do’s and Don’ts Documentation Guidelines: Narrative and Information Technology

▪ Use a black-colored ink pen for narrative documentation. ▪ Date and time entries. ▪ Provide objective, factual, and complete documentation. ▪ Document care, medications, treatments, and procedures

as soon as possible after completion. ▪ Document client responses to interventions. ▪ Document consent for or refusal of treatments. ▪ Document calls made to other health care providers. ▪ Use quotes as appropriate for subjective data. ▪ Use correct spelling, grammar, and punctuation. ▪ Sign and title each entry. ▪ Follow agency policies when an error is made (i.e., draw 1

line through the error, initial, and date). ▪ Follow agency guidelines regarding late entries. ▪ Use only the user identification code, name, or password

for computerized documentation. ▪ Maintain privacy and confidentiality of documented infor-

mation printed from the computer. ▪ Do not document for others or change documentation for

other individuals. ▪ Do not use unacceptable abbreviations. ▪ Do not use judgmental or evaluative statements, such as

“uncooperative client.” ▪ Do not leave blank spaces on documentation forms. ▪ Do not lend access identification computer codes to

another person; change password at regular intervals.

53CHAPTER 6 Ethical and Legal Issues

F

u

n

d

a

m

e

n

t

a

l

s

2. Th e n urse n eeds to en sure th at th e clien t h as been provided with in form ation about th e righ t to iden tify written direction s about th e care th at th e clien t wish es to receive.

3. O n ad m ission to a h ealth care facility, th e n urse determ in es wh eth er an advan ce directive exists an d en sures th at it is part of th e m ed ical record; th e n urse also offers in form ation about advan ce directives if th e clien t in dicates h e or sh e wan ts m ore in form ation .

4. Th e n urse en sures th at th e HCP is aware of th e presen ce of an advan ce directive.

5. All h ealth care workers n eed to follow th e direc- tion s of an advan ce directive to be safe from liability.

6. Som e agen cies h ave specific policies th at pro- h ibit th e n urse from sign in g as a witn ess to a legal docum en t, such as an in struction al directive.

7. If allowed by th e agen cy, when th e n urse acts as a witness to a legal docum en t, th e n urse m ust docu- m en t th e even t an d th e factual circum stan ces sur- roun din g th e sign in g in th e m edical record; docum en tation as a witn ess sh ould in clude wh o was presen t, an y sign ifican t com m en ts by th e cli- en t, an d th e n urse’s observation s of the clien t’s con duct durin g this process.

XII. Reporting Responsibilities A. Nurses are required to report certain com m un icable

diseases or crim in al activities such as ch ild or elder abuse or dom estic violen ce; dog bite or oth er an im al bite, gun sh ot or stab woun ds, assaults, an d h om icides; an d suicides to th e appropriate auth o rities.

B. Im paired n urse 1. If th e n urse susp ects th at a co-worker is abusin g

ch em icals an d poten tially jeopardizin g a clien t’s safety, th e n urse m ust report th e in dividual to th e n ursin g supervisor/ n ursin g ad m in istration in a con fiden tial m an n er. (Clien t safety is always th e first priority.)

2. Nu rsin g adm in istration n otifies th e board of n ursin g regardin g th e n urse’s beh avior.

3. Man y in stitution s h ave policies th at allow for drug testin g if im pairm en t is suspected.

C. O ccupation al Safety an d Health Act (O SHA) 1. O SHA requires th at an em ployer provide a safe

workplace for em ployees accordin g to regulation s. 2. Em ployees can con fiden tially report workin g

con d ition s th at violate regulatio n s. 3. An em ployee wh o reports un safe workin g con di-

tion s can n ot be retaliated again st by the em ployer. D. Sexual h arassm en t

1. Sexual h arassm en t is proh ib ited by state an d federal laws.

2. Sexual h arassm en t in cludes un welcom e con duct of a sexual n ature.

3. Follow agen cy policies an d proced ures to h an dle reportin g a con cern or com plain t.

CRITICAL THINKING What Should You Do? Answer: If the client indicates that he or she does not want a prescribed therapy, treatment, or procedure such as surgery, the nurse should further investigate the client’s request. If the client indicates that he or she has changed his or her mind about surgery, the nurse should assess the client and explore with the client his or her concerns about not wanting the surgery. The nurse would then withhold further surgical preparation and contact the surgeon to report the client’s request so that the surgeon can discuss the conse- quences of not having the surgery with the client. Under no circumstances would the nurse continue with surgical preparation if the client has indicated that he or she does not want the surgery. Further assessment and follow-up related to the client’s request need to be done. In addition, it is the client’s right to refuse treatment.

References: Lewis et al. (20 14), p. 326. Perry, Potter, Ostendorf (2014), p. 882.

P R A C T I C E Q U E S T I O N S 13. Th e n urse h ears a clien t callin g out for h elp, h urries

down th e h allway to th e clien t’s room , an d fin ds th e clien t lyin g on th e flo or. Th e n urse perform s an assessm en t, assists th e clien t back to bed, n otifies th e h ealth care provid er of th e in ciden t, an d com - pletes an in ciden t report. Wh ich statem en t sh ould th e n urse docum en t on th e in ciden t report? 1. Th e clien t fell out of bed . 2. Th e clien t clim bed over th e side rails. 3. Th e clien t was foun d lyin g on th e flo or. 4. Th e clien t becam e restless an d tried to get out

of bed .

14. A clien t is brough t to th e em ergen cy departm en t by em ergen cy m edical services (EMS) after bein g h it by a car. Th e n am e of th e clien t is un kn own , an d th e clien t h as sustain ed a severe h ead in jury an d m ulti- ple fractures an d is un con scious. An em ergen cy cra- n ioto m y is required. Regard in g in form ed con sen t for th e surgical proced ure, wh ich is th e b est action ? 1. O btain a court order for th e surgical procedure. 2. Ask th e EMS team to sign th e in form ed con sen t. 3. Tran sport th e victim to th e operatin g ro om for

surgery. 4. Call th e police to iden tify th e clien t an d locate th e

fam ily.

15. Th e n urse h as just assisted a clien t back to bed after a fall. Th e n urse an d h ealth care provider h ave assessed the clien t an d h ave determ in ed th at th e clien t is n ot

54 UNIT II Professional Standards in Nursing

in jured. After com pletin g th e in ciden t report, the n urse should im plem ent wh ich action n ext? 1. Reassess th e clien t. 2. Con duct a staff m eetin g to describe th e fall. 3. Docum en t in th e n urse’s n otes th at an in ciden t

report was com pleted. 4. Con tact th e n ursin g supervisor to update in for-

m ation regardin g th e fall.

16. Th e n urse arrives at work an d is told to report (float) to th e in ten sive care un it (ICU) for th e day because th e ICU is un d erstaffed an d n eeds addition al n urses to care for th e clien ts. Th e n urse h as n ever worked in th e ICU. Th e n urse sh ould take wh ich b est action ? 1. Refuse to float to th e ICU based on lack of un it

orien tation . 2. Clarify with th e team leader to m ake a safe ICU

clien t assign m en t. 3. Ask th e n ursin g supervisor to review th e h ospital

policy on floatin g. 4. Subm it a written protest to n ursin g adm in istra-

tion , an d th en call th e h ospital lawyer.

17. Th e n urse wh o works on the n igh t sh ift en ters the m edication room an d fin ds a co-worker with a tourn i- quet wrapped aroun d the upper arm . Th e co-worker is about to in sert a n eedle, attach ed to a syrin ge con tain - in g a clear liquid, in to th e an tecubital area. Which is the m o st ap p ro p riate action by th e n urse? 1. Call security. 2. Call th e police. 3. Call th e n ursin g supervisor. 4. Lock th e co-worker in th e m ed ication room un til

h elp is obtain ed.

18. A h ospitalized clien t tells th e n urse th at an in struc- tio n al directive is bein g prepared an d th at th e lawyer will be brin gin g th e docum en t to th e h os- pital today for witn ess sign atures. Th e clien t asks th e n urse for assistan ce in obtain in g a witn ess to th e will. Wh ich is th e m o st ap p ro p riate respon se to th e clien t? 1. “I will sign as a witn ess to yo ur sign ature.” 2. “You will n eed to fin d a witn ess on your own .” 3. “Wh oever is available at th e tim e will sign as a

witn ess for you.” 4. “I will call th e n ursin g supervisor to seek assis-

tan ce regardin g your request.”

19. Th e n urse h as m ade an error in a n arrative docu- m en tation of an assessm en t fin din g on a clien t an d obtain s th e clien t’s record to co rrect th e error. Th e n urse sh ould take wh ich action s to correct th e error? Select all th at ap p ly.

1. Do cum en t a late en try in th e clien t’s record. 2. Draw 1 lin e th rou gh th e error, in itialin g an d

datin g it.

3. Try to erase th e error for space to write in th e correct data.

4. Use wh iteout to delete th e erro r to write in th e correct data.

5. Write a con cise statem en t to explain wh y th e correction was n eeded.

6. Do cum en t th e correct in form ation an d en d with th e n urse’s sign ature an d title.

20. Wh ich iden tifies accurate n ursin g docum en tatio n n otatio n s? Select all th at ap p ly.

1. Th e clien t slept th rough th e n igh t. 2. Abdo m in al woun d dressin g is dry an d in tact

with ou t drain age. 3. Th e clien t seem ed an gry wh en awaken ed for

vital sign m easu rem en t. 4. Th e clien t ap pears to becom e an xiou s wh en it

is tim e for respiratory treatm en ts. 5. Th e clien t’s left lower m edial leg woun d is 3 cm

in len gth with out redn ess, drain age, or edem a.

21. A n ursin g in structor delivers a lecture to n ursin g stu- den ts regardin g th e issue of clien t’s righ ts an d asks a n ursin g studen t to iden tify a situation th at repre- sen ts an exam ple of invasion of client privacy. Wh ich situation , if id en tified by th e studen t, in dicates an un derstan din g of a violation of th is clien t righ t? 1. Perform in g a procedure with ou t con sen t 2. Th reaten in g to give a clien t a m ed ication 3. Tellin g th e clien t th at h e or sh e can n ot leave th e

h ospital 4. O bservin g care provid ed to th e clien t with ou t th e

clien t’s perm ission

22. Nursin g staff m em bers are sitting in th e loun ge takin g th eir m orn in g break. An un licen sed assistive person - n el (UAP) tells th e group th at sh e th inks th at the un it secretary h as acquired im m un odeficien cy syn drom e (AIDS) and proceeds to tell th e n ursin g staff th at th e secretary probably con tracted th e disease from h er h usban d, who is supposedly a drug addict. The registered n urse sh ould in form th e UAP that m akin g th is accusation h as violated wh ich legal tort? 1. Libel 2. Slan der 3. Assault 4. Negligen ce

23. An 87-year-o ld wom an is brough t to th e em ergen cy dep artm en t for treatm en t of a fractured arm . O n ph ysical assessm en t, th e n urse n otes old an d n ew ecch ym otic areas on th e clien t’s ch est an d legs an d asks th e clien t h ow th e bruises were sustain ed. Th e clien t, alth ough relu ctan t, tells th e n urse in con fi- den ce th at h er son frequen tly h its h er if supp er is n ot prepared on tim e wh en h e arrives h om e from

F

u

n

d

a

m

e

n

t

a

l

s

55CHAPTER 6 Ethical and Legal Issues

work. Wh ich is th e m o st ap p ro p riate n ursin g respo n se? 1. “O h , really? I will discuss th is situation with

your son .” 2. “Let’s talk ab out th e ways you can m an age your

tim e to preven t th is from h app en in g.” 3. “Do you h ave an y frien d s wh o can h elp yo u out

un til you resolve th ese im portan t issues with yo ur son ?”

4. “As a n urse, I am legally boun d to report abuse. I will stay with you wh ile you give th e report an d h elp fin d a safe place for you to stay.”

24. Th e n urse calls th e h eath care provider (HCP) regardin g a n ew m ed ication prescription because th e dosage prescribed is h igh er th an th e recom - m en ded dosage. Th e n urse is un able to lo cate th e HCP, an d th e m edication is due to be adm in istered. Wh ich action sh ould th e n urse take?

1. Con tact th e n ursin g supervisor. 2. Adm in ister th e dose prescribed. 3. Ho ld th e m ed ication un til th e HCP can be

con tacted. 4. Adm in ister th e recom m en ded dose un til th e

HCP can be located.

25. Th e n urse em p loyed in a h ospital is waitin g to receive a report fro m th e labo ratory via th e facsim ile (fax) m ach in e. Th e fax m ach in e activates an d th e n urse expects th e report, but in stead receives a sexu- ally orien ted ph otograph . Wh ich is th e m o st ap p ro - p riate in itial n ursin g action ? 1. Call th e police. 2. Cut up th e ph o tograp h an d th row it away. 3. Call th e n ursin g supervisor an d report the in ciden t. 4. Call th e labo ratory an d ask for th e n am e of th e

in dividual wh o sen t th e ph otograph .

A N S W E R S 13. 3 Ra tion a le: Th e in cid en t repo rt sh o uld con tain a factual d escrip tion o f th e in cid en t, an y in juries exp erien ced b y th ose in vo lved , an d th e o u tco m e of th e situatio n . Th e correct op tio n is th e on ly o n e th at d escribes th e facts as o b served b y th e n u rse. O ptio n s 1, 2, an d 4 are in terp retatio n s of th e situatio n an d are n o t factu al in fo rm atio n as o bserved b y th e n u rse. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject , d ocum en tatio n of even ts, an d n ote t h e d a t a in t h e q u est io n to select th e correct o ptio n . Rem em ber to focus o n factual in fo rm atio n wh en d o c- u m en tin g, an d avoid in clud in g in terp retation s. Th is will d irect yo u to th e correct o ptio n . Review: Do cum en tatio n prin ciples related to in cid en t r ep o r t s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Com m un icatio n an d Docum en tation Con ten t Ar ea : Leadersh ip/ Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Co m m u n ication ; Health Care Law Refer en ce: Hub er (2014), p p. 318–319.

14. 3 Ra tion a le: In gen eral, th ere are two situ ation s in wh ich in form ed co n sen t o f an ad ult clien t is n o t n eed ed . O n e is wh en an em ergen cy is presen t an d delayin g treatm en t for th e pu rp ose o f o btain in g in form ed con sen t wou ld resu lt in in ju ry o r d eath to th e clien t. Th e secon d is wh en th e clien t waives th e righ t to give in fo rm ed con sen t. O p tio n 1 will d elay em ergen cy treat- m en t, an d o p tion 2 is in app ro priate. Alth o ugh op tion 4 m ay b e p ursued , it is n o t th e best actio n because it delays n ecessary em ergen cy treatm en t. Test-Ta kin g Str a tegy: No te th e st r a t egic wo r d , best. Recallin g th at wh en an em ergen cy is presen t an d a d elay in treatm en t fo r th e pu rp ose o f ob tain in g in fo rm ed con sen t co uld resu lt in in ju ry or death will direct yo u to th e co rrect o ptio n .

Review: Th e issues su rrou n d in g in fo r m ed co n sen t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Eth ics; Health Care Law Refer en ces: Po tter et al. (2013), p p. 302–303; Zerwekh , Zer- wekh Garn eau (2015), pp. 475–476.

15. 1 Ra tion a le: After a clien t’s fall, th e n u rse m ust freq u en tly reas- sess th e clien t b ecau se po ten tial com p lication s d o n o t always app ear im m ediately after th e fall. Th e clien t’s fall sh o u ld b e treated as p rivate in form atio n an d sh ared o n a “n eed to kn o w” b asis. Co m m u n icatio n regardin g th e even t sh o u ld in volve o n ly th e in d ivid uals p articipatin g in th e clien t’s care. An in ciden t report is a problem -solvin g d ocum en t; h o wever, its co m ple- tio n is n o t do cum en ted in th e n urse’s n o tes. If th e n u rsin g su pervisor h as been m ad e aware o f th e in ciden t, th e sup ervisor will con tact th e n urse if status update is n ecessary. Test-Ta kin g Str a tegy: Note th e st r a t egic wo r d , next. Usin g th e st ep s o f t h e n u r sin g p r o cess will direct you to th e co rrect o ptio n . Rem em ber th at assessm en t is th e first step. Add itio n - ally, use Ma slo w’s Hier a r ch y o f Need s t h eo r y, recallin g th at p h ysio logical n eeds are th e priority. Th e co rrect op tio n is th e o n ly op tio n th at ad dresses a p oten tial p h ysio lo gical n eed of th e clien t. Review: Gu idelin es related to in cid en t r ep o r t s an d care to th e clien t after su stain in g a fa ll Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Safety Pr ior it y Con cept s: Co m m u n ication ; Safety Refer en ces: Lewis et al. (2014), p. 1682; Zerwekh , Zerwekh Garn eau (2015), pp. 479–480.

F

u

n

d

a

m

e

n

t

a

l

s

56 UNIT II Professional Standards in Nursing

16. 2 Ra t ion a le: Floatin g is an acceptab le practice used b y h o spitals to so lve u n d erstaffin g prob lem s. Legally, th e n u rse can n o t refuse to flo at un less a un ion co n tract guaran tees th at n urses can work on ly in a specified area or th e n urse can p ro ve th e lack of kn o wledge fo r th e p erform an ce of assign ed tasks. Wh en en cou n terin g th is situ atio n , th e n u rse sh ou ld set prio rities an d id en tify po ten tial areas o f h arm to th e clien t. Th at is wh y clarifyin g th e clien t assign m en t with th e team lead er to en su re th at it is a safe o n e is th e best op tion . Th e n ursin g sup er- visor is called if th e n urse is exp ected to p erform tasks th at h e o r sh e can n o t safely perform . Su bm ittin g a written p ro test an d callin g th e h osp ital lawyer is a prem atu re action . Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d , best. Elim in ate op tion 1 first becau se o f th e word refuse. Next, elim in ate op tion s 3 an d 4 b ecau se th ey are p rem atu re actio n s. Review: Nu rsin g resp on sibilities related to flo a t in g Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Lead ersh ip / Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Care Co ordin ation ; Pro fessio n alism Refer en ce: Zerwekh , Zerwekh Garn eau (2015), pp . 589–591.

17. 3 Ra t ion a le: Nu rse p ractice acts req uire repo rtin g im p aired n urses. Th e b oard of n ursin g h as ju risd iction o ver th e practice of n u rsin g an d m ay develop plan s fo r treatm en t an d sup ervi- sion o f th e im paired n urse. Th is in ciden t n eeds to b e rep orted to th e n ursin g sup ervisor, wh o will th en rep ort to th e b oard o f n ursin g an d o th er au th o rities, su ch as th e p o lice, as req uired . Th e n urse m ay call security if a d isturban ce o ccu rs, b ut n o in fo rm ation in th e qu estio n su p po rts th is n eed , an d so th is is n o t th e app ro p riate action . O p tion 4 is an in ap pro priate an d un safe action . Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d s, most appro- priate. Elim in ate op tio n 4 first b ecau se th is is an in ap p ro priate an d un safe actio n . Recall th e lin es of organ izatio n al stru ctu re to assist in d irectin g you to th e co rrect op tio n . Review: Th e n urse’s respo n sib ilities wh en d ealin g with an im p a ir ed n u r se Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Lead ersh ip / Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Eth ics; Profession alism Refer en ce: Zerwekh , Zerwekh Garn eau (2015), pp . 452–453.

18. 4 Ra tion a le: In struction al directives (livin g wills) are req uired to be in writin g and sign ed by th e clien t. Th e clien t’s sign atu re m ust be witn essed b y specified in divid uals o r n otarized . Laws an d guidelin es regard in g in struction al d irectives vary from state to state, an d it is th e respo n sib ility of th e n urse to kn ow th e laws. Man y states p roh ibit any em p lo yee, in clu din g th e n urse o f a facility wh ere th e clien t is receivin g care, fro m b ein g a witn ess. O ption 2 is n on th erapeu tic an d n ot a h elpfu l respon se. Th e n urse sh o uld seek th e assistance o f the n ursin g sup ervisor. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d s, most appropri- ate. O p tion s 1 an d 3 are co m p a r a b le o r a lik e an d sh o uld b e

elim in ated first. O p tion 2 is elim in ated becau se it is a n o n th er- ap eu tic resp o n se. Review: Legal im p licatio n s associated with in st r u ct io n a l d ir ect ives Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Lead ersh ip/ Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Health Care Law; Profession alism Refer en ce: Zerwekh , Zerwekh Garn eau (2015), pp. 420, 476–477.

19. 2, 6 Ra t ion a le: If th e n u rse m akes an error in n arrative do cum en - tatio n in th e clien t’s reco rd , th e n urse sh o uld fo llo w agen cy p o licies to correct th e erro r. Th is in clud es d rawin g o n e lin e th ro ugh th e erro r, in itialin g an d d atin g th e lin e, an d th en do c- u m en tin g th e correct in form atio n . A late en try is used to d o cu m en t ad dition al in fo rm atio n n o t rem em b ered at th e in i- tial tim e of d ocum en tation , n o t to m ake a co rrection of an error. Do cu m en tin g th e co rrect in fo rm atio n with th e n u rse’s sign ature an d title is co rrect. Erasin g data from th e clien t’s record an d th e u se of wh iteou t are proh ibited. Th ere is n o n eed to write a statem en t to explain wh y th e correction was n ecessary. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject , co rrectin g a d oc- u m en tatio n error, an d u se prin cip les related to d ocum en ta- tion . Recallin g th at alteration s to a clien t’s record are to b e avo id ed will assist in elim in atin g op tio n s 3 an d 4. From th e rem ain in g o p tion s, fo cu sin g on th e su b ject of th e q u estion an d usin g kn owled ge regard in g th e prin cip les related to do cu- m en tation will direct you to th e correct op tio n . Review: Th e p rin cip les an d gu idelin es related to d o cu m en - t a t io n Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Lead ersh ip/ Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Com m un icatio n ; Pro fession alism Refer en ces: Perry, Potter, O sten d orf (2014), p. 51; Zerwekh , Zerwekh Garn eau (2015), p . 466.

20. 1, 2, 5 Ra t ion a le: Factu al d ocum en tatio n co n tain s descriptive, o bjec- tive in form ation abo ut wh at th e n urse sees, h ears, feels, o r sm ells. Th e use of in feren ces with o u t su pp o rtin g factu al data is n o t accep table b ecau se it can be m isu n d erstoo d. Th e u se o f vagu e term s, su ch as seemed o r appears, is n o t acceptab le b ecau se th ese word s su ggest th at th e n u rse is statin g an op in io n . Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject , accurate do cu- m en tation n o tation s. Elim in ate o ptio n s 3 an d 4 b ecause th ey are co m p a r a b le o r a lik e an d in clu d e vague term s (seem ed, ap pears). Review: Do cu m en t a t io n gu idelin es Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Lead ersh ip/ Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Com m un icatio n ; Pro fession alism Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 50–51.

F

u

n

d

a

m

e

n

t

a

l

s

57CHAPTER 6 Ethical and Legal Issues

21. 4 Ra tion a le: In vasion of privacy o ccurs with un reaso n able in tru- sio n in to an in d ivid ual’s p rivate affairs. Perfo rm in g a p ro ce- d ure with o u t con sen t is an exam p le of b attery. Th reaten in g to give a clien t a m ed icatio n co n stitu tes assault. Tellin g th e cli- en t th at th e clien t can n o t leave th e h o sp ital con stitutes false im p riso n m en t. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject , in vasion of p rivacy. No tin g th e wo rd s without the client’s permission will d irect yo u to th is o ptio n . Review: Situ ation s th at in clud e in va sio n o f p r iva cy Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Leadersh ip/ Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Eth ics; Pro fessio n alism Refer en ce: Zerwekh, Zerwekh Garneau (2015), p p. 447, 473– 474.

22. 2 Ra tion a le: Defam ation is a false com m un ication o r a careless d isregard fo r th e tru th th at cau ses d am age to som eo n e’s rep u- tatio n , eith er in writin g (lib el) o r verb ally (slan der). An assault o ccurs wh en a perso n p uts an o th er person in fear of a h arm fu l o r offen sive co n tact. Negligen ce in vo lves th e actio n s of profes- sio n als th at fall belo w th e stan d ard of care fo r a sp ecific p ro fessio n al gro u p. Test-Ta kin g Str a tegy: Note th e su b ject , th e legal tort violated. Focus on th e d a t a in t h e q u est io n and elim in ate o ptio ns 3 and 4 first b ecau se th eir d efin ition s are un related to th e data. Recallin g th at slander con stitutes verb al defam atio n will d irect you to th e correct o ption fro m th e rem ain in g o ption s. Review: Th e defin ition s of lib el, sla n d er , a ssa u lt , an d n egligen ce Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip/ Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Health Care Law; Pro fessio n alism Refer en ce: Zerwekh , Zerwekh Garn eau (2015), p p. 448, 473.

23. 4 Ra tion a le: Th e n u rse m u st repo rt situatio n s related to ch ild or eld er ab u se, gu n sh ot wou n d s an d o th er crim in al acts, an d cer- tain in fectiou s d iseases. Co n fid en tial issues are n o t to be d is- cussed with n o n m ed ical perso n n el or th e clien t’s fam ily or frien d s with ou t th e clien t’s p erm ission . Clien ts sh o uld be assu red th at in fo rm ation is kep t con fid en tial, un less it p laces th e n u rse u n der a legal o b ligation . O ption s 1, 2, an d 3 d o n o t ad d ress th e legal im p licatio n s o f th e situ ation an d d o n o t en su re a safe en viro n m en t for th e clien t. Test-Ta kin g St r a t egy: Note th e st r a t egic wo r d s, most appropri- ate. Fo cus on th e d a t a in t h e q u est io n an d n ote th at an 87- year-o ld wo m an is receivin g p h ysical ab u se b y h er so n . Recall th e n u rsin g resp on sibilities related to clien t safety an d rep ort- in g ob ligatio n s. O p tio n s 1, 2, an d 3 sh o uld be elim in ated b ecau se th ey are co m p a r a b le o r a lik e in th at th ey do n o t p ro - tect th e clien t from in ju ry.

Review: Th e n u rsin g respo n sib ilities related to r ep o r t in g r esp o n sib ilit ies Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Health Care Law; In terperson al Violen ce Refer en ces: Lewis et al. ( 2014), p p. 68–69; Zerwekh , Zerwekh Garn eau (2015), p. 472.

24. 1 Ra tion a le: If th e HCP writes a prescrip tion th at requ ires clari- fication , th e n urse’s resp on sibility is to con tact th e HCP. If th ere is n o resolutio n regardin g th e p rescriptio n because th e HCP can n o t b e lo cated o r b ecau se th e p rescriptio n rem ain s as it was written after talkin g with th e HCP, th e n u rse sh o u ld con tact th e n urse m an ager o r n u rsin g sup erviso r for furth er clarificatio n as to wh at th e n ext step sh ou ld be. Un der n o cir- cum stan ces sh o u ld th e n u rse pro ceed to carry ou t th e p rescrip- tio n un til ob tain in g clarification . Test-Ta kin g Str a tegy: Elim in ate o ptio n s 2 an d 4 first b ecause th ey are co m p a r a b le o r a lik e an d are u n safe action s. Ho ld in g th e m ed ication can resu lt in clien t in jury. Th e n u rse n eed s to take actio n . Th e co rrect o p tion clearly iden tifies th e req uired action in th is situ ation . Review: Nursin g resp on sib ilities related to th e HCP’s p r escr ip t io n s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), p. 489.

25. 3 Ra tion a le: En surin g a safe workp lace is a respo n sibility of an em ployin g in stitu tion . Sexual h arassm en t in th e wo rkplace is p ro h ib ited b y state an d fed eral laws. Sexu ally suggestive jo kes, to uch in g, p ressu rin g a co -wo rker fo r a d ate, an d o p en d isplays o f o r tran sm ittin g sexually o rien ted ph oto grap h s or p osters are exam ples of con du ct th at co uld be co n sidered sexual h arass- m en t b y an o th er worker. If th e n u rse b elieves th at h e o r sh e is bein g sub jected to un welco m e sexu al co n du ct, th ese con - cern s sh ou ld be rep o rted to th e n u rsin g su perviso r im m edi- ately. O p tio n 1 is u n n ecessary at th is tim e. O p tion s 2 an d 4 are in ap prop riate in itial actio n s. Test-Ta kin g St r a t egy: Note th e st r a t egic wo r d s, most appropri- ate initial. Rem em ber th at usin g th e o rgan ization al ch an n els of com m un icatio n is best. Th is will assist in d irectin g yo u to th e correct op tio n . Review: Nu rsin g respo n sibilities wh en sexu a l h a r a ssm en t o ccurs in th e wo rkp lace Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Health Care Law; Pro fessio n alism Refer en ce: Zerwekh , Zerwekh Garn eau (2015), p p. 474–475.

F

u

n

d

a

m

e

n

t

a

l

s

58 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 7 Prioritizing Client Care: Leadership,

Delegation, and Emergency Response Planning

PRIORITY CONCEPTS Leadership; Health Care Organizations

CRITICAL THINKING What Should You Do? The nurse notes that there has been an increase in the number of intravenous (IV) site infections that developed in the clients being cared for on the nursing unit. How should the nurse proceed to implement a quality improvement program? Answer located on p. 71.

I. Health Care Delivery Systems A. Man aged care

1. Managed care is a broad term used to describe strategies used in th e h ealth care delivery system th at reduce th e costs of h ealth care.

2. Clien t care is outcom e driven an d is m an aged by a case management process.

3. Man aged care em p h asizes th e prom o tion of h ealth , clien t education an d respon sible self- care, early iden tification of disease, an d th e use of h ealth care resources.

B. Case m an agem en t 1. Case m an agem en t is a h ealth care delivery strat-

egy th at supports m an aged care; it uses an in ter- profession al h ealth care delivery approach th at provides com preh en sive clien t care th rou gh out th e clien t’s illn ess, usin g available resources to prom ote h igh -quality an d cost-effective care.

2. Case m an agem en t in cludes assessm en t an d developm en t of a plan of care, co ordin ation of all services, referral, an d follow-up.

3. Critical path ways are used, an d variatio n an alysis is con d ucted.

Case management involves consultation and collab- oration with an interprofessional health care team.

C. Case m an ager 1. A case m an ager is a profession al n urse wh o

assum es respo n sibility for coordin atin g th e cli- en t’s care at adm ission an d after disch arge.

2. Th e case m an ager establish es a plan of care with th e clien t, coordin ates an y in terp rofession al con sultation s an d referrals, an d facilitates disch arge.

D. Critical path way 1. A critical path way is a clin ical m an agem en t

care plan for providin g clien t-cen tered care an d for plan n in g an d m on itorin g th e clien t’s progress with in an establish ed tim e fram e; interprofes- sional collaboration an d team wo rk en sure sh ared decision m akin g an d quality clien t care.

2. Variation an alysis is a con tin uous process th at th e case m an ager an d oth er caregivers con duct by com parin g th e specific clien t outcom es with th e expected outcom es described on th e critical path way.

3. Th e goal of a critical path way is to an ticipate an d recogn ize n egative varian ce (i.e., clien t prob- lem s) early so th at appropriate action can be taken an d positive clien t outcom es can result.

E. Nursin g care plan 1. A n ursin g care plan is a written guidelin e an d

com m un ication tool th at iden tifies th e clien t’s pertin en t assessm en t data, problem s an d n ursin g diagn oses, go als, in terven tion s, an d exp ected outcom es.

2. Th e plan en h an ces in terpro fession al con tin uity of care by id en tifyin g specific n ursin g action s n ecessary to ach ieve th e go als of care.

3. Th e clien t an d fam ily are in volved in developin g th e plan of care, an d th e plan id en tifies sh o rt- term an d lo n g-term goals.

59

4. Clien t problem s, goals, in terven tion s, an d expected outcom es are docum en ted in th e care plan , wh ich provides a fram ework for evaluation of th e clien t’s respo n se to n ursin g action s.

II. Nursing Delivery Systems A. Fun ction al n ursin g

1. Fun ction al n ursin g in volves a task approach to clien t care, with tasks bein g delegated by th e ch arge n urse to in dividual m em bers of th e team .

2. Th is type of system is task-o rien ted, an d th e team m em ber focuses on th e delegated task rath er th an th e total clien t; th is results in fragm en tation of care an d lack of accountability by th e team m em ber.

B. Team n ursin g 1. Th e team gen erally is led by a registered n urse

(team leader) wh o is respo n sible for assessin g cli- en ts, an alyzin g clien t data, plan n in g, an d evalu- atin g each clien t’s plan of care.

2. Th e team leader determ in es th e work assign - m en t; each staff m em ber works fully with in th e realm of h is or h er edu cation al an d clin ical expertise an d job description .

3. Each staff m em ber is acco un table for clien t care an d outcom es of care delivered in accordan ce with th e licen sin g an d practice scope as deter- m in ed by h ealth care agen cy policy an d state law.

4. Mod ular n ursin g is sim ilar to team n ursin g, but takes in to accoun t th e structure of th e un it; th e un it is divided in to m od ules, allowin g n urses to care for a group of clien ts wh o are geograph i- cally clo se by.

C. Relation sh ip-b ased practice (prim ary n ursin g) 1. Relation sh ip-b ased practice (prim ary n ursin g) is

con cern ed with keepin g th e n urse at th e bed side, actively in volved in clien t care, wh ile plan n in g goal-d irected, in dividualized care.

2. O n e (prim ary) n urse is respon sible for m an agin g an d co ordin atin g th e clien t’s care wh ile in th e h ospital an d for disch arge, an d an associate n urse cares for th e clien t wh en th e prim ary n urse is off-du ty.

D. Clien t-focused care 1. Th is is also kn own as th e total care or case

m eth od ; th e registered n urse assum es total respo n sibility for plan n in g an d deliverin g care to a clien t.

2. Th e clien t m ay h ave differen t n urses assign ed dur- in g a 24-h our period; th e n urse provides all n eces- sary care n eeded for th e assign ed tim e period.

III. Professional Responsibilities A. Accountability

1. Th e process in wh ich in dividuals h ave an obliga- tion (or duty) to act an d are an swerable for th eir action s.

2. In volves assum in g on ly th e respo n sibilities th at are with in on e’s scope of practice an d n ot assum - in g respo n sibility for activities in wh ich co m pe- ten ce h as n ot been ach ieved.

3. In volves adm ittin g m istakes rath er th an blam in g oth ers an d evalu atin g th e outcom es of on e’s own action s.

4. In clu des a respon sibility to th e clien t to be com - peten t, providin g n ursin g care in acco rdan ce with stan d ards of n ursin g practice an d adh erin g to th e profession al eth ics codes.

Accountability is the acceptance of responsibility for one’s actions. The nurse is always responsible for his or her actions when providing care to a client.

B. Leadership an d management 1. Lead ersh ip is th e in terp erson al process th at

in volves in fluen cin g oth ers (followers) to ach ieve goals.

2. Man agem en t is th e accom plish m en t of tasks or goals by on eself or by directin g oth ers.

C. Th eories of leadersh ip an d m an agem en t ( Box 7-1) D. Leader an d m an ager approach es

1. Autocratic a . Th e leader or m an ager is focused an d m ain -

tain s stron g con trol, m akes decision s, an d addresses all problem s.

b . Th e leader or m an ager dom in ates th e group an d com m an ds rath er th an seeks suggestion s or in pu t.

2. Dem ocratic a . Th is is also called participative management. b . It is based on th e belief th at every grou p m em -

ber sh o uld h ave in put in to problem solvin g an d th e developm en t of goals; lead er obtain s participation from grou p an d th em m akes best decision for th e organ ization , based upon th e in put from grou p.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 7-1 Theories of Leadership and Management

Cha risma tic: Based on personal beliefs and characteristics Qua ntum: Based on the concepts of chaos theory; maintain-

ing a balance between tension and order prevents an unstable environment and promotes creativity

Rela tiona l: Based on collaboration and teamwork Serva nt : Based on a desire to serve others; the leader emerges

when another’s needs assume priority Sha red: Based on the belief that several individuals share the

responsibility for achieving the health care agency’s goals Tra nsa ctiona l: Based on the principles of social exchange

theory Tra nsforma t iona l: Based on the individual’s commitment to

the health care agency’s vision; focuses on promoting change

60 UNIT II Professional Standards in Nursing

c. Th e dem ocratic style is a m ore “talk with th e m em bers” style an d m uch less auth o ritarian th an th e au tocratic style.

3. Laissez-faire a. A laissez-faire leader or m an ager assum es a

passive, n on directive, an d in active approach an d relin qu ish es part or all of th e respon sibil- ities to th e m em bers of th e grou p.

b . Decision m akin g is left to th e group, with th e laissez-faire leader or m an ager providin g lit- tle, if an y, guidan ce, support, or feedback.

4. Situ ation al a. Situ ation al style uses a com bin ation of styles

based on th e curren t circum stan ces an d even ts.

b . Situ ation al styles are assum ed acco rdin g to th e n eeds of th e grou p an d th e tasks to be ach ieved.

5. Bureaucratic a. Th e leader or m an ager believes th at in divid-

uals are m otivated by extern al forces. b . Th e leader or m an ager relies on organ iza-

tio n al policies an d procedures for decision m akin g.

E. Effective leader an d m an ager beh aviors an d qualities ( Box 7-2)

F. Fun ction s of m an agem en t (Box 7-3) G. Problem -solvin g process an d decision m akin g

1. Problem solvin g in volves obtain in g in form ation an d usin g it to reach an acceptable solution to a problem .

2. Decision m akin g in volves iden tifyin g a problem an d decidin g wh ich altern atives can best ach ieve objectives.

3. Steps of th e problem -solvin g process are sim ilar to th e steps of th e n ursin g process ( Table 7-1).

H. Types of m an agers 1. Fron tlin e m an ager

a. Fron tlin e m an agers fun ctio n in supervisory roles of th o se in volved with delivery of clien t care.

b . Fron tlin e ro les usually in clude ch arge n urse, team leader, an d clien t care co ordin ato r.

c. Fron tlin e m an agers coordin ate th e activity of all staff wh o provide clien t care an d supervise team m em bers durin g th e m an ager’s period of accoun tability.

2. Middle m an ager a. Middle m an ager roles usually in clude un it

m an ager an d supervisor. b . A m iddle m an ager’s respo n sibilities m ay

in clude supervisin g staff, preparin g budgets, preparin g work sch edules, writin g an d im ple- m en tin g policies th at guide clien t care an d un it operation s, an d m ain tain in g th e quality of clien t services.

3. Nu rse executive a. Th e n urse executive is a top-level n urse m an -

ager an d m ay be th e director of n ursin g ser- vices or th e vice presiden t for clien t care services.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 7-2 Effective Leader and Manager Behaviors and Qualities

Behaviors Treats employees as unique individuals Inspires employees and stimulates critical thinking Shows employees how to think about old problems in new

ways and assists with adapting to change Is visible to employees; is flexible; and provides guidance,

assistance, and feedback Communicates a vision, establishes trust, and empowers

employees Motivates employees to achieve goals

Qualities Effective communicator; promotes interprofessional collabo-

ration Credible Critical thinker Initiator of action Risk taker Is persuasive and influences employees

Adapted from Huber D: Leadership and nursing care management, ed 5, Philadelphia, 20 14, Saunders.

BOX 7-3 Functions of Management Pla nning: Determining objectives and identifying methods

that lead to achievement of objectives Orga nizing: Using resources (human and material) to achieve

predetermined outcomes Direct ing: Guiding and motivating others to meet expected

outcomes Controlling: Using performance standards as criteria for mea-

suring success and taking corrective action

TABLE 7-1 Similarities of the Problem-Solving Process and the Nursing Process

Problem-Solving Process Nursing Process

Identifying a problem and collecting data about the problem

Assessment

Determining the exact nature of the problem Analysis

Deciding on a plan of action Planning

Carrying out the plan Implementation

Evaluating the plan Evaluation

61CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

b . Th e n urse executive supervises n um erous dep artm en ts an d works clo sely with th e adm in istrative team of th e organ ization .

c. Th e n urse executive en sures th at all clien t care provided by n urses is con sisten t with th e objectives of th e h ealth care organ ization .

IV. Power A. Power is th e ability to do or act to ach ieve desired

results. B. Powerful people are ab le to m od ify beh avior an d

in fluen ce oth ers to ch an ge, even wh en oth ers are resistan t to ch an ge.

C. Effective n urse lead ers use power to im prove th e delivery of care an d to en h an ce th e profession .

D. Th ere are differen t types of power (Box 7-4).

V. Empowerment A. Em po werm en t is an in terperson al process of

en ablin g oth ers to do for th em selves. B. Em po werm en t occurs wh en in dividuals are able to

in fluen ce wh at h appen s to th em m ore effectively. C. Em po werm en t in volves open co m m un ication ,

m utu al goal settin g, an d decision m akin g. D. Nurses can em power clien ts th rou gh teach in g an d

advocacy.

VI. Formal Organizations A. An organ ization ’s m ission statem en t com m un icates

in broad term s its reason for existen ce; th e geograph - ical area th at th e organ ization serves; an d attitu des, beliefs, an d values from wh ich th e organ ization fun ction s.

B. Goals an d objectives are m easu rable activities spe- cific to th e develo pm en t of design ated services an d program s of an organ ization .

C. Th e organ ization al ch art dep icts an d com m un icates h ow activities are arran ged, h ow au th ority relation - sh ips are defin ed , an d h ow com m un ication ch an - n els are establish ed.

D. Policies, proced ures, an d protoco ls 1. Policies are guid elin es th at defin e th e organ iza-

tion ’s stan d poin t on courses of action .

2. Proced ures are based on policy an d defin e m eth od s for tasks.

3. Protoco ls prescribe a specific course of action for a specific typ e of clien t or problem . a . Cen tralization is th e m akin g of decision s by a

few in dividuals at th e top of th e organ ization or by m an agers of a dep artm en t or un it, an d decision s are com m un icated th ereafter to th e em plo yees.

b . Decen tralization is th e distribution of auth o r- ity th rou gh ou t th e organ ization to allow for in creased respon sibility an d delegation in decision m akin g; decen tralization tries to m ove th e decision -m akin g as clo se to th e clien t as possible.

The nurse must follow policies, procedures, and protocols of the health care agency in which he or she is employed.

VII. Evidence-Based Practice A. Research is an im portan t ro le of th e profession al

n urse. Research provides a foun dation for im prove- m en t in n ursin g practice.

B. Eviden ce-based practice is an ap proach to clien t care in wh ich th e n urse in tegrates th e clien t’s preferen ces, clin ical exp ertise, an d th e best research eviden ce to deliver quality care.

C. Determ in in g th e clien t’s perso n al, social, cultural, an d religious preferen ces en sures in dividualization an d is a com po n en t of im plem en tin g eviden ce- based practice.

D. Th e n urse n eeds to be an observer an d iden tify an d question situation s th at require ch an ge or result in a less th an desirable outcom e.

E. Use of in form ation tech n ology such as on lin e resources, in cludin g research publication s, provid es curren t research fin din gs related to areas of practice.

F. Th e n urse n eeds to follo w eviden ce-based practice protoco ls developed by th e in stitution an d question th e ration ale for n ursin g approach es id en tified in th e protoco ls as n ecessary. Th e n urse sh o uld use appro- priate evaluation criteria wh en determ in in g areas in n eed of research ( Table 7-2).

Evidence-based practice requires that the nurse base nursing practice on the best and most applicable evidence from clinical research studies. The nurse should also be alert to clinical issues that warrant inves- tigation and develop a researchable problem about the issue.

VIII. Quality Improvement A. Also kn own as perform an ce im provem en t, quality

im provem en t focuses on processes or system s th at sign ifican tly con tribu te to clien t safety an d effective clien t care outcom es; criteria are used to m on itor

F

u

n

d

a

m

e

n

t

a

l

s

BOX 7-4 Types of Power Rewa rd: Ability to provide incentives Coercive: Ability to punish Referent : Based on attraction Expert: Based on having an expert knowledge foundation and

skill level Legit ima t e: Based on a position in society Persona l: Derived from a high degree of self-confidence Informa tiona l: When one person provides explanations why

another should behave in a certain way

62 UNIT II Professional Standards in Nursing

outcom es of care an d to determ in e th e n eed for ch an ge to im prove th e quality of care.

B. Q uality im provem en t processes or system s m ay be n am ed quality assuran ce, con tin uous quality management, or con tin uo us quality im provem en t.

C. When quality im provem en t is part of th e ph ilosoph y of a h ealth care agen cy, every staff m em ber becom es in volved in ways to im prove clien t care an d outcom es.

D. A retrospective (“lookin g back”) audit is an evalua- tion m eth od used to in spect th e m edical record after th e clien t’s disch arge for docum en tation of com pli- an ce with th e stan dards.

E. A con curren t (“at th e sam e tim e”) audit is an evalu- ation m eth od used to in spect com plian ce of n urses with predeterm in ed stan d ards an d criteria wh ile th e n urses are providin g care durin g th e clien t’s stay.

F. Peer review is a process in wh ich n urses em ployed in an organ ization evalu ate th e quality of n ursin g care delivered to th e clien t.

G. Th e quality im provem en t process is sim ilar to th e n ursin g process an d in volves an in terp rofession al approach .

H. An outcom e describes th e m ost positive respon se to care; com parison of clien t respon ses with the expected outcom es in dicates wh eth er th e in terven tion s are effective, wh eth er th e clien t h as progressed, h ow well stan dards are m et, an d wheth er ch an ges are n ecessary.

I. Th e n urse is respon sible for recogn izin g tren ds in n urs- in g practice, iden tifyin g recurren t problem s, an d in iti- atin g opportunities to im prove the quality of care.

Quality improvement processes improve the quality of care delivery to clients and the safety of health care agencies.

IX. Change Process A. Ch an ge is a dyn am ic process th at leads to an alter-

ation in beh avior. 1. Lewin ’s basic con cept of th e ch an ge process

in cludes 3 elem en ts for successful ch an ge: un freezin g, m ovin g an d ch an gin g, an d refreezin g (Fig. 7-1). a. Un freezin g is th e first ph ase of th e process,

durin g wh ich th e problem is iden tified an d in dividuals in volved gath er facts an d evi- den ce supportin g a basis for ch an ge.

b . Du rin g th e m ovin g an d ch an gin g ph ase, ch an ge is plan n ed an d im plem en ted.

c. Refreezin g is th e last ph ase of th e process, durin g wh ich th e ch an ge beco m es stabilized.

2. Leadership style in fluen ces th e approach to in iti- atin g th e ch an ge process.

B. Types of ch an ge 1. Plan n ed ch an ge: A deliberate effort to im prove a

situation 2. Un plan n ed ch an ge: Ch an ge th at is un predictable

but is ben eficial an d m ay go un n oticed C. Resistan ce to ch an ge ( Box 7-5)

1. Resistan ce to ch an ge occurs wh en an in dividual rejects propo sed n ew ideas with ou t critically th in kin g about th e propo sal.

2. Ch an ge requires en ergy. 3. Th e ch an ge process does n ot guaran tee positive

outcom es. D. O vercom in g barriers

1. Create a flexible an d ad aptable en viron m en t. 2. En cou rage th e peo ple in volved to plan an d set

goals for ch an ge. 3. In clude all in volved in th e plan for ch an ge. 4. Focus on th e ben efits of th e ch an ge in relation to

im provem en t of clien t care. 5. Delin eate th e drawb acks from failin g to m ake th e

ch an ge in relation to clien t care. 6. Evaluate th e ch an ge process on an on go in g basis,

an d keep everyon e in form ed of progress. 7. Provide positive feed back to all in volved. 8. Com m it to th e tim e it takes to ch an ge.

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 7-2 Evaluation Criteria for Evidence for Clinical Questions

Level Definition

Level I Evidence comes from a review of a number of randomized controlled trials (RCTs) or from clinical practice guidelines that are based on such a review.

Level II Evidence comes from at least one well-designed RCT.

Level III Evidence comes from well-designed controlled studies that are not randomized.

Level IV Evidence comes from well-designed case-controlled and cohort studies.

Level V Evidence comes from a number of descriptive or qualitative studies.

Level VI Evidence comes from a single descriptive or qualitative study.

Level VII Evidence comes from the opinion of authorities and/ or reports of expert committees.

From Zerwekh J, Zerwekh Garneau A: Nursing today: transition and trends, ed 8, Philadelphia, 20 15, Saunders. Data from Sackett D et al.: Evidence-based medicine: how to practice and teach EBM, London, 200 0 , Churchill Livingstone.

Unfreezing

R

e

f r

e

e z i n

g

Movin g/C ha

ng in

g

FIGURE 7-1 Elements of a successful change.

63CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

F

u

n

d

a

m

e

n

t

a

l

s

X. Conflict A. Con flict arises from a percep tion of in com patibility

or differen ce in beliefs, attitu des, values, goals, prior- ities, or decision s.

B. Types of co n flict 1. In trap erson al: O ccurs with in a person 2. In terperson al: O ccurs between an d am on g cli-

en ts, n urses, or oth er staff m em bers 3. O rgan ization al: O ccurs wh en an em ployee con -

fron ts th e policies an d proced ures of th e organ ization

C. Mod es of co n flict resolutio n 1. Avoidan ce

a . Avoiders are un assertive an d un cooperative. b . Avoiders do n ot pursue th eir own n eeds,

goals, or con cern s, an d th ey do n ot assist oth ers to pursue th eirs.

c. Avoiders postp on e dealin g with th e issue. 2. Accom m odation

a . Accom m odators n eglect th eir own n eeds, goals, or con cern s (un assertive) wh ile tryin g to satisfy th o se of oth ers.

b . Accom m odators obey an d serve oth ers an d often feel resen tm en t an d disappo in tm en t because th ey “get n oth in g in return .”

3. Com p etition a . Com p etitors pursue th eir own n eeds an d

goals at th e expen se of oth ers. b . Com p etitors also m ay stan d up for righ ts an d

defen d im portan t prin ciples. 4. Com p rom ise

a . Com p rom isers are assertive an d cooperative. b . Com p rom isers work creatively an d open ly to

fin d th e solution th at m ost fully satisfies all im portan t goals an d con cern s to be ach ieved.

XI. Roles of Health Care Team Members A. Nurse roles are as follows:

1. Prom o te h ealth an d preven t disease 2. Provid e com fo rt an d care to clien ts 3. Make decision s 4. Act as clien t advocate 5. Lead an d m an age th e n ursin g team 6. Serve as case m an ager 7. Fun ction as a reh abilitator 8. Com m un icate effectively 9. Educate clien ts, fam ilies, an d co m m un ities an d

h ealth care team m em bers 10. Act as a resou rce person 11. Allocate resources in a cost-effective m an n er

B. Health care provider (HCP): An HCP diagn oses an d treats disease.

C. HCP assistan t 1. An HCP assistan t (also kn own as ph ysician assis-

tan t) acts to a lim ited exten t in th e ro le of th e HCP durin g th e HCP’s ab sen ce.

2. Th e HCP assistan t con ducts ph ysical exam in a- tion s, perform s diagn ostic proced ures, assists in th e operatin g room an d em ergen cy departm en t, an d perform s treatm en ts.

3. Certified an d licen sed HCP assistan ts in som e states h ave prescriptive powers.

D. Nurse practition er: an advan ced practice registered n urse (APRN) wh o is edu cated to diagn ose an d treat acute illn ess an d ch ron ic con dition s; h ealth prom o - tion an d m ain ten an ce is a focus.

E. Ph ysical th erapist: A ph ysical th erapist assists in exam in in g, testin g, an d treatin g ph ysically disabled clien ts.

F. O ccupation al th erap ist: An occupation al th erap ist develo ps ad aptive devices th at h elp ch ron ically ill or h an dicap ped clien ts to perform activities of daily livin g.

G. Respiratory th erapist: A respiratory th erapist delivers treatm en ts design ed to im prove th e clien t’s ven tila- tion an d oxygen ation status.

H. Speech th erapist: A speech th erapist evaluates a cli- en t’s ability to swallow safely an d effectively an d com m un icates a plan to im prove a clien t’s swallow- in g ability.

I. Nutrition ist: A n utrition ist or dietitian assists in plan n in g dietary m easures to im prove or m ain tain a clien t’s n utrition al status.

J. Con tin uin g care n urse: Th is n urse coordin ates dis- ch arge plan s for th e clien t.

K. Assistive perso n n el, in cludin g un licen sed assistive person n el an d clien t care tech n ician s, h elp th e regis- tered n urse with specified tasks an d fun ctio n s.

L. Ph arm acist: A ph arm acist form ulates an d dispen ses m edication s.

M. Social worker: A social worker coun sels clien ts an d fam ilies ab out h om e care services an d assists th e con - tin uin g care n urse with plan n in g disch arge.

BOX 7-5 Reasons for Resisting Change

Conformity One goes along with others to avoid conflict.

Dissimilar Beliefs and Values Differences can impede positive change.

Habit Routine, set behaviors are often hard to change.

Secondary Gains Benefits or payoff are present, so there is no incentive to change.

Threats to Satisfying Basic Needs Change may be perceived as a threat to self-esteem, security, or survival.

Fear One fears failure or has fear of the unknown.

64 UNIT II Professional Standards in Nursing

N. Ch aplain : A ch aplain (or train ed layperson ) offers spiritual support an d guid an ce to clien ts an d fam ilies.

O. Adm in istrative staff: Adm in istrative or support staff m em bers organ ize an d sch edule diagn ostic tests an d procedures an d arran ge for services n eeded by th e clien t an d fam ily.

XII. Interprofessional Collaboration A. Clien t care plan n in g can be accom plish ed th rough

referrals to or con sultatio n s or interprofessional col- laborations with oth er h ealth care specialists an d th rou gh clien t care con feren ces, wh ich in volve m em - bers from all h ealth care disciplin es. Th is approach h elp s to en sure con tin uity of care.

B. Repo rts 1. Repo rts sh ould be factu al, accurate, curren t,

com plete, an d organ ized. 2. Repo rts sh ould in clude essen tial backgroun d

in form ation , subjective data, objective data, an y ch an ges in th e clien t’s status, clien t problem s or n ursin g diagn oses as appropriate, treatm en ts an d procedures, m edication adm in istration , cli- en t teach in g, disch arge plan n in g, fam ily in for- m ation , th e clien t’s respon se to treatm en ts an d procedures, an d th e clien t’s prio rity n eeds.

3. Ch an ge of sh ift report a. Th e report facilitates co n tin uity of care

am on g n urses wh o are respon sible for a clien t.

b . Th e report m ay be written , oral, au diotaped, or provid ed durin g walkin g roun ds at th e cli- en t’s bedside.

c. Th e report describes th e clien t’s h ealth status an d in form s th e n urse on th e n ext sh ift ab out th e clien t’s n eeds an d priorities for care.

4. Teleph on e reports a. Purpo ses in clude in form in g an HCP of a cli-

en t’s ch an ge in status, com m un icatin g in for- m ation about a clien t’s tran sfer to or from an oth er un it or facility, an d obtain in g results of laborato ry or diagn ostic tests.

b . Th e teleph o n e report sh ould be docum en ted an d sh ould in clude wh en th e call was m ade, wh o m ade th e call, wh o was called, to wh o m in form ation was given , wh at in form ation was given , an d wh at in form ation was received.

5. Tran sfer reports a. Tran sferrin g n urse reports provide con tin uity

of care an d m ay be given by telep h on e or in perso n ( Box 7-6).

b . Receivin g n urse sh o uld repeat tran sfer in for- m ation to en sure clien t safety an d ask ques- tio n s to clarify in form ation about th e clien t’s status.

6. Situ ation , Backgrou n d, Assessm en t, Recom m en - dation (SBAR)

a. SBAR is a structured an d stan dard ized com - m un ication tech n iqu e th at im proves com - m un ication am on g team m em bers wh en sh arin g in form ation on a clien t.

b . SBAR in cludes up-to -date in form ation ab out th e clien t’s situation , associated backgroun d in form ation , assessm en t data, an d recom - m en dation s for care, such as treatm en ts, m ed- ication s, or services n eeded.

XIII. Interprofessional Consultation A. Con sultation is a process in wh ich a specialist is

sough t to iden tify m eth od s of care or treatm en t plan s to m eet th e n eeds of a clien t.

B. Con sultation is n eeded wh en th e n urse en coun ters a problem th at can n ot be solved usin g n ursin g kn owl- edge, skills, an d available resources.

C. Con sultation also is n eeded wh en th e exact problem rem ain s un clear; a con sultan t can objectively an d m ore clearly assess an d iden tify th e exact n ature of th e problem .

D. Rapid respo n se team s are bein g developed with in h ospitals to provide n ursin g staff with in tern al con - sultative services provided by expert clin ician s.

E. Rapid respon se team s are used to assist n ursin g staff with early detection an d resolution of clien t problem s.

F. Medication recon ciliation in cludes collabo ration am on g th e clien t, HCPs, n urses, an d ph arm acists to en sure m ed ication accuracy wh en clien ts experi- en ce ch an ges in h ealth care settin gs or levels of care or are tran sferred fro m on e care un it to an oth er, an d upon disch arge ( Box 7-7).

F

u

n

d

a

m

e

n

t

a

l

s

BOX 7-6 Transfer Reports ▪ Client’s name, age, health care provider, and diagnoses ▪ Current health status and plan of care ▪ Client’s needs and priorities for care ▪ Any assessments or interventions that need to be per-

formed after transfer, such as laboratory tests, medication administration, or dressing changes

▪ Need for any special equipment ▪ Additional considerations such as allergies, resuscitation

status, precautionary considerations, cultural or religious issues, or family issues

BOX 7-7 Process for Medication Reconciliation 1. Obtain a list of current medications from the client. 2. Develop an accurate list of newly prescribed medications. 3. Compare new medications to the list of current medications. 4. Identify and investigate any discrepancies and collaborate

with the health care provider as necessary. 5. Communicate the finalized list with the client, caregivers,

health care provider, and other team members.

From Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 2013, Mosby.

65CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

F

u

n

d

a

m

e

n

t

a

l

s

XIV. Discharge Planning A. Disch arge plan n in g begin s wh en th e clien t is adm it-

ted to th e h ospital or h ealth care facility. B. Disch arge plan n in g is an in terprofession al process that

en sures that th e clien t h as a plan for con tin uin g care after leavin g the h ealth care facility an d assists in th e clien t’s tran sition from on e en viron m en t to an oth er.

C. All caregivers n eed to be in volved in disch arge plan - n in g, an d referrals to oth er HCPs or agen cies m ay be n eeded. An HCP’s prescription m ay be n eeded for th e referral, an d th e referral n eeds to be approved by th e clien t’s h ealth care in surer.

D. Th e n urse sh o uld an ticipate th e clien t’s disch arge n eeds an d m ake th e referral as soon as possible (in vo lvin g th e clien t an d fam ily in th e referral process).

E. Th e n urse n eeds to educate th e clien t an d fam ily regardin g care at h om e ( Box 7-8).

XV. Delegation and Assignments A. Delegation

1. Delegation is a process of tran sferrin g perfor- m an ce of a selected n ursin g task in a situation to an in dividual wh o is com peten t to perform th at specific task.

2. Delegation in volves ach ievin g outcom es an d sh arin g activities with oth er in dividuals wh o h ave th e auth ority to acco m plish th e task.

3. Th e n urse practice act an d an y practice lim ita- tion s (in stitution al policies an d procedures, an d job description s of person n el provided by th e in stitutio n ) defin e wh ich aspects of care can be delegated an d wh ich m ust be perform ed by a registered n urse.

4. Even th o ugh a task m ay be delegated to som e- on e, th e n urse wh o delegates m ain tain s account- ability for th e task.

5. O n ly th e task, n ot th e ultim ate accoun tability, m ay be delegated to an oth er.

6. Th e 5 righ ts of delegation in clude th e righ t task, righ t circum stan ces, righ t perso n , righ t direction / com m un ication , an d righ t supervision / evaluation .

The nurse delegates only tasks for which he or she is responsible. The nurse who delegates is accountable for the task; the person who assumes responsibility for the task is also accountable.

B. Prin ciples an d gu idelin es of delegatin g ( Box 7-9) C. Assign m en ts

1. Assign m en t is th e tran sfer of perform an ce of cli- en t care activities to specific staff m em bers.

2. Guidelin es for clien t care assign m en ts a . Always en sure clien t safety. b . Be aware of in dividual variatio n s in work

abilities. c. Determ in e wh ich tasks can be delegated an d

to wh om . d . Match th e task to th e delegatee on th e basis of

th e n urse practice act an d an y practice lim ita- tion s (in stitution al policies an d procedures, an d job description s of perso n n el provided by th e in stitutio n ).

e. Provid e direction s th at are clear, con cise, accu rate, an d com plete.

f. Validate th e delegatee’s un derstan din g of th e direction s.

g. Com m un icate a feelin g of con fiden ce to th e delegatee, an d provide feedback prom ptly after th e task is perform ed.

BOX 7-8 Discharge Teaching ▪ How to administer prescribed medications ▪ Side and adverse effects of medications that need to be

reported to the health care provider (HCP) ▪ Prescribed dietary and activity measures ▪ Complications of the medical condition that need to be

reported to the HCP ▪ How to perform prescribed treatments ▪ How to use special equipment prescribed for the client ▪ Schedule for home care services that are planned ▪ How to access available community resources ▪ When to obtain follow-up care

BOX 7-9 Principles and Guidelines of Delegating

▪ Delegate the right task to the right delegatee. Be familiar with the experience of the delegatees, their scopes of prac- tice, their job descriptions, agency policy and procedures, and the state nurse practice act.

▪ Provide clear directions about the task and ensure that the delegatee understands the expectations.

▪ Determine the degree of supervision that may be required. ▪ Provide the delegatee with the authority to complete the

task; provide a deadline for completion of the task. ▪ Evaluate the outcome of care that has been delegated. ▪ Provide feedback to the delegatee regarding his or her

performance. ▪ In general, noninvasive interventions, such as skin care,

range-of-motion exercises, ambulation, grooming, and hygiene measures, can be assigned to the unlicensed assistive personnel (UAP).

▪ In general, a licensed practical nurse (LPN) or licensed vocational nurse (LVN) can perform not only the tasks that a UAP can perform, but also certain invasive tasks, such as dressing changes, suctioning, urinary catheterization, and medication administration (oral, subcutaneous, intramus- cular, and selected piggyback medications), according to the education and job description of the LPN or LVN. The LPN or LVN can also review with the client teaching plans that were initiated by the registered nurse.

▪ A registered nurse can perform the tasks that an LPN or LVN can perform and is responsible for assessment and planning care, initiating teaching, and administering med- ications intravenously.

66 UNIT II Professional Standards in Nursing

h . Main tain con tin uity of care as m uch as possi- ble wh en assign in g clien t care.

XVI. Time Management A. Description

1. Tim e m an agem en t is a tech n iqu e design ed to assist in co m pletin g tasks with in a defin ite tim e period.

2. Learn in g h ow, wh en , an d wh ere to use on e’s tim e an d establish in g person al go als an d tim e fram es are part of tim e m an agem en t.

3. Tim e m an agem en t requires an ability to an tici- pate th e day’s activities, to com bin e activities wh en possible, an d to n ot be in terrup ted by n on - essen tial activities.

4. Tim e m an agem en t in volves efficien cy in com - pletin g tasks as quickly as possible an d effective- n ess in decidin g on th e m ost im portan t task to do (i.e., prioritizing) an d doin g it correctly.

B. Prin ciples an d guidelin es 1. Iden tify tasks, obligation s, an d activities an d

write th em down . 2. O rgan ize th e workday; iden tify wh ich tasks m ust

be com pleted in specified tim e fram es. 3. Prioritize clien t n eeds acco rdin g to im portan ce. 4. An ticipate th e n eeds of th e day an d provide tim e

for un exp ected an d un plan n ed tasks th at m ay arise.

5. Focus on begin n in g th e daily tasks, workin g on th e m ost im portan t first wh ile keepin g goals in m in d; look at th e fin al goal for th e day, wh ich h elps in th e breakd own of tasks in to m an ageable parts.

6. Begin clien t roun ds at th e begin n in g of th e sh ift, collectin g data on each assign ed clien t.

7. Delegate tasks wh en appropriate. 8. Keep a daily h our-by-h our lo g to assist in provid-

in g structure to th e tasks th at m ust be accom - plish ed, an d cross tasks off th e list as th ey are acco m plish ed.

9. Use h ealth care agen cy resources wisely, an tici- patin g resource n eeds, an d gath er th e n ecessary supp lies before begin n in g th e task.

10. O rgan ize paperwo rk an d co n tin uou sly docu- m en t task com pletion an d n ecessary clien t data th rou gh ou t th e day (i.e., docum en tation sh ould be con cu rren t with com pletion of a task or obser- vation of pertin en t clien t data).

11. At th e en d of th e day, evaluate th e effectiven ess of tim e m an agem en t.

XVII. Prioritizing Care A. Prio ritizin g is decidin g wh ich n eeds or problem s

require im m ediate action an d wh ich on es could tol- erate a delay in respon se un til a later tim e because th ey are n ot urgen t.

B. Guidelin es for prioritizin g (Box 7-10)

C. Settin g priorities for clien t teach in g 1. Determ in e th e clien t’s im m ediate learn in g n eeds. 2. Review th e learn in g objectives establish ed for th e

clien t. 3. Determ in e wh at th e clien t perceives as

im portan t. 4. Assess th e clien t’s an xiety level an d th e tim e avail-

able to teach . D. Prioritizin g wh en carin g for a group of clien ts

1. Iden tify th e problem s of each clien t. 2. Review th e problem s an d an y n ursin g diagn oses. 3. Determ in e wh ich clien t problem s are m ost

urgen t based on basic n eeds, th e clien t’s ch an g- in g or un stable status, an d com plexity of th e cli- en t’s problem s.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 7-10 Guidelines for Prioritizing ▪ The nurse and the client mutually rank the client’s needs in

order of importance based on the client’s preferences and expectations, safety, and physical and psychological needs; what the client sees as his or her priority needs may be dif- ferent from what the nurse sees as the priority needs.

▪ Priorities are classified as high, intermediate, or low. ▪ Client needs that are life-threatening or that could result in

harm to the client if they are left untreated are high priorities.

▪ Nonemergency and non–life-threatening client needs are intermediate priorities.

▪ Client needs that are not related directly to the client’s ill- ness or prognosis are low priorities.

▪ When providing care, the nurse needs to decide which needs or problems require immediate action and which ones could be delayed until a later time because they are not urgent.

▪ The nurse considers client problems that involve actual or life-threatening concerns before potential health- threatening concerns.

▪ When prioritizing care, the nurse must consider time con- straints and available resources.

▪ Problems identified as important by the client must be given high priority.

▪ The nurse can use the ABCs—airway–breathing–circula- tion—as a guide when determining priorities; client needs related to maintaining a patent airway are always the priority.

▪ If cardiopulmonary resuscitation (CPR) is necessary, the order of priority is CAB—compressions–airway–breath- ing—this is the exception to using the ABCs when determin- ing priorities.

▪ The nurse can use Maslow’s Hierarchy of Needs theory as a guide to determine priorities and to identify the levels of physiological needs, safety, love and belonging, self- esteem, and self-actualization (basic needs are met before moving to other needs in the hierarchy).

▪ The nurse can use the steps of the nursing process as a guide to determine priorities, remembering that assess- ment is the first step of the nursing process.

67CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

F

u

n

d

a

m

e

n

t

a

l

s

4. An ticipate th e tim e th at it m ay take to care for th e prio rity n eeds of th e clien ts.

5. Com b in e activities, if possib le, to resolve m ore th an 1 problem at a tim e.

6. In vo lve th e clien t in h is or h er care as m uch as possible (see Prio rity Nu rsin g Actio n s).

Use the ABCs (airway–breathing–circulation), Maslow’s Hierarchy of Needs theory, and the steps of the nursing process (assessment is first) to prioritize. Also consider the acuity level of clients when applying these guidelines. If cardiopulmonary resuscitation (CPR) needs to be initiated, use CAB (compressions– airway–breathing) as the priority guideline.

XVIII. Disasters and Emergency Response Planning A. Description

1. A disaster is an y h um an -m ade or n atural even t th at cau ses destructio n an d devastation th at can - n ot be alleviated with ou t assistan ce ( Box 7-11).

2. In tern al disasters are disasters th at occur with in a h ealth care agen cy (e.g., h ealth care agen cy fire, structural collapse, radiation spill), wh ereas

extern al disasters are disasters th at occur outside th e h ealth care agen cy (e.g., m ass tran sit acciden t th at could sen d h un dreds of victim s to em er- gen cy departm en ts) .

3. A multi-casualty even t in volves a lim ited n um ber of victim s or casualties an d can be m an aged by a h ospital with available resou rces; a mass casualty event in volves a n um ber of casualties th at exceed s th e resou rce capab ilities of th e h ospital, an d is also kn own as a disaster.

4. An em ergen cy respon se plan is a form al plan of action for coordin atin g th e respon se of the h ealth care agen cy staff in th e event of a disaster in th e h ealth care agen cy or surroun din g com m un ity.

B. Am erican Red Cross (ARC) 1. Th e ARC h as been given auth o rity by th e federal

govern m en t to provide disaster relief. 2. All ARC disaster relief assistan ce is free, an d local

offices are located across th e Un ited States. 3. Th e ARC participates with th e govern m en t in

developin g an d testin g com m un ity disaster plan s.

4. Th e ARC iden tifies an d train s person n el for em ergen cy respon se.

5. Th e ARC works with busin esses an d labor orga- n ization s to iden tify resou rces an d in dividuals for disaster work.

6. Th e ARC edu cates th e public about ways to pre- pare for a disaster.

PRIORITY NURSING ACTIONS Assessing a Group of Clients in Order of Priority The nurse is assigned to the following clients. The order of priority in assessing the clients is as follows:

1. A client with heart failure who has a 4-lb weight gain since yesterday and is experiencing shortness of breath

2. A24-hour postoperative client who had a wedge resection of the lung and has a closed chest tube drainage system

3. A client admitted to the hospital for observation who has absent bowel sounds

4. A client who is undergoing surgery for a hysterectomy on the following day

The nurse determines the order of priority by considering the needs of the client. The nurse also uses guidelines for pri- oritizing, such as the ABCs—airway–breathing–circulation— Maslow’s Hierarchy of Needs theory, and the steps of the nursing process. Clients 1 and 2 have conditions that relate to the cardiac system or respiratory system. These clients are the high priorities. Client 1 is the first priority because this cli- ent is experiencing shortness of breath (life-threatening). There is no indication that client 2 is experiencing any diffi- culty. Because client 4 is scheduled for surgery on the follow- ing day, this client would be the last priority (low priority), and the nurse would assess this client and prepare this client for surgery after other clients are assessed. Because absent bowel sounds could be an indication of a bowel obstruction (intermediate priority), client 3 would be the nurse’s third priority.

References Potter et al. (20 13), pp. 237–238; Zerwekh, Zerwekh Garneau (2015),

pp. 35–36.

BOX 7-11 Types of Disasters

Human-Made Disasters Dam failures resulting in flooding Hazardous substance accidents such as pollution, chemical

spills, or toxic gas leaks Accidents involving release of radioactive material Resource shortages such as food, water, and electricity Structural collapse, fire, or explosions Terrorist attacks such as bombing, riots, and bioterrorism Mass transportation accidents

Natural Disasters Avalanches Blizzards Communicable disease epidemics Cyclones Droughts Earthquakes Floods Forest fires Hailstorms Hurricanes Landslides Mudslides Tidal waves Tornadoes Volcanic eruptions

68 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

7. Th e ARC operates sh elters, provides assistan ce to m eet im m ediate em ergen cy n eeds, an d provides disaster h ealth services, in cludin g crisis coun selin g.

8. Th e ARC h an dles in qu iries fro m fam ily m em bers.

9. Th e ARC coordin ates relief activities with oth er agen cies.

10. Nu rses are in volved directly with th e ARC an d assum e fun ction s such as m an agers, supervisors, an d edu cators of first aid; th ey also participate in em ergen cy respo n se plan s an d disaster relief pro- gram s an d provide services, such as blood collec- tio n drives an d im m un ization program s.

C. HAZMAT (Hazardous Materials) Team 1. HAZMAT team s are typically com po sed of em er-

gen cy departm en t h ealth care providers an d n ursin g staff because th ey will be th e first in di- vidu als to en coun ter th e poten tial exposu re.

2. Mem bers of HAZMAT team s h ave been educated on h ow to recogn ize pattern s of illn ess th at m ay be in dicative of n uclear, biological, an d ch em ical exp osure; protocols for ph arm acological treat- m en t of in fectio us disease agen ts; availability of deco n tam in ation facilities an d perso n al pro- tective gear; safety m easu res; an d th e m eth ods of respo n din g to an exposu re.

D. Ph ases of disaster management 1. Th e Federal Em ergen cy Man agem en t Agen cy

(FEMA) iden tifies 4 disaster m an agem en t ph ases: m itigation , preparedn ess, respon se, an d recovery.

2. Mitigation en com passes th e followin g: a. Action s or m easu res th at can preven t th e

occurren ce of a disaster or reduce th e dam ag- in g effects of a disaster

b . Determ in atio n of th e com m un ity h azards an d com m un ity risks (actual an d poten tial th reats) befo re a disaster occurs

c. Awaren ess of available co m m un ity resources an d com m un ity h ealth perso n n el to facilitate m ob ilization of activities an d m in im ize ch aos an d con fusion if a disaster occurs

d . Determ in atio n of th e resources available for care to in fan ts, older adults, disabled in divid- uals, an d in dividuals with ch ron ic h ealth problem s

3. Preparedn ess en com passes th e followin g: a. Plan s for rescue, evacuation , an d carin g for

disaster victim s b . Plan s for train in g disaster person n el an d

gath erin g resources, equip m en t, an d oth er m aterials n eeded for dealin g with th e disaster

c. Iden tificatio n of specific respo n sibilities for various em ergen cy respon se perso n n el

d . Establish m en t of a com m un ity em ergen cy respo n se plan an d an effective public com - m un ication system

e. Developm en t of an em ergen cy m edical sys- tem an d a plan for activation

f. Verification of proper fun ction in g of em er- gen cy equip m en t

g. Collection of an ticipatory provision s an d cre- ation of a location for providin g food , water, clo th in g, sh elter, oth er supp lies, an d n eeded m ed icin e

h . In ven tory of supplies on a regular basis an d replen ish m en t of outd ated supp lies

i. Practice of com m un ity em ergen cy respo n se plan s (m ock disaster drills)

4. Resp on se en com passes th e followin g: a. Puttin g disaster plan n in g services in to action

an d th e action s taken to save lives an d preven t furth er dam age

b . Prim ary con cern s in clude safety, ph ysical h ealth , an d m en tal h ealth of victim s an d m em bers of th e disaster respon se team

5. Recovery en com p asses th e followin g: a. Actio n s taken to return to a n orm al situation

after th e disaster b . Preven tin g debilitatin g effects an d restorin g

perso n al, econ om ic, an d en viron m en tal h ealth an d stability to th e com m un ity

E. Levels of disaster 1. FEMA iden tifies 3 levels of disaster with FEMA

respo n se (Box 7-12). 2. Wh en a federal em ergen cy h as been declared, th e

federal respo n se plan m ay take effect an d activate em ergen cy support fun ction s.

3. Th e em ergen cy support fun ction s of th e ARC in clude perform in g em ergen cy first aid, sh elter- in g, feed in g, providin g a disaster welfare in for- m ation system , an d coordin atin g bulk distribution of em ergen cy relief supplies.

4. Disaster m edical assistan t team s (team s of spe- cially train ed personn el) can be activated an d sen t to a disaster site to provide triage an d m edical care to victim s un til th ey can be evacuated to a h ospital.

BOX 7-12 Federal Emergency Management Agency (FEMA) Levels of Disaster

Level I Disaster Massive disaster that involves significant damage and results in a presidential disaster declaration, with major federal involvement and full engagement of federal, regional, and national resources

Level II Disaster Moderate disaster that is likely to result in a presidential dec- laration of an emergency, with moderate federal assistance

Level III Disaster Minor disaster that involves a minimal level of damage, but could result in a presidential declaration of an emergency

69CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

F

u

n

d

a

m

e

n

t

a

l

s

F. Nurse’s ro le in disaster plan n in g 1. Perso n al an d profession al preparedn ess

a . Make person al an d fam ily preparation s ( Box 7-13).

b . Be aware of th e disaster plan at th e place of em p loym en t an d in th e com m un ity.

c. Main tain certification in disaster train in g an d in CPR.

d . Participate in m ock disaster drills, in cludin g a bom b th reat drill.

e. Prepare profession al em ergency response item s, such as a copy of n ursing licen se, personal h ealth care equipm en t such as a steth oscope, cash , warm cloth in g, record-keepin g m aterials, an d other n ursin g care supplies.

2. Disaster respon se a . In th e h ealth care agen cy settin g, if a disaster

occurs, th e agen cy disaster prepared n ess plan (em ergen cy respon se plan ) is activated im m e- diately, an d th e n urse respo n ds by follo win g th e direction s iden tified in th e plan .

b . In th e com m un ity settin g, if th e n urse is th e first respo n der to a disaster, th e n urse cares for th e victim s by atten din g to th e victim s with life-th reaten in g problem s first; wh en res- cue workers arrive at th e scen e, im m ediate plan s for triage sh ould begin .

In the event of a disaster, activate the emergency response plan immediately.

G. Triage 1. In a disaster or war, triage con sists of a brief

assessm en t of victim s th at allows th e n urse to classify victim s acco rdin g to th e severity of th e in jury, urgen cy of treatm en t, an d place for treat- m en t (see Priority Nursin g Actio n s).

BOX 7-13 Emergency Plans and Supplies Plan a meeting place for family members. Identify where to go if an evacuation is necessary. Determine when and how to turn off water, gas, and electricity

at main switches. Locate the safe spots in the home for each type of disaster. Replace stored water supply every 3 months and stored food

supply every 6 months. Include the following supplies:

▪ Backpack, clean clothing, sturdy footwear ▪ Pocket-knife or multi-tool ▪ A 3-day supply of water (1 gallon per person per day) ▪ A 3-day supply of nonperishable food ▪ Blankets/ sleeping bags/ pillows ▪ First-aid kit with over-the-counter medications and

vitamins ▪ Adequate supply of prescription medication ▪ Battery-operated radio ▪ Flashlight and batteries ▪ Credit card, cash, or traveler’s checks ▪ Personal ID card, list of emergency contacts, allergies,

medical information, list of credit card numbers and bank accounts (all sealed in water-tight package)

▪ Extra set of car keys and a full tank of gas in the car ▪ Sanitation supplies for washing, toileting, and dispos-

ing of trash; hand sanitizer ▪ Extra pair of eyeglasses/ sunglasses ▪ Special items for infants, older adults, or disabled

individuals ▪ Items needed for a pet such as food, water, and leash ▪ Paper, pens, pencils, maps ▪ Cell phone ▪ Work gloves ▪ Rain gear ▪ Roll of duct tape and plastic sheeting ▪ Radio and extra batteries ▪ Toiletries (basic daily needs, sunscreen, insect repel-

lent, toilet paper) ▪ Plastic garbage bags and resealable bags ▪ Household bleach for disinfection ▪ Whistle ▪ Matches in a waterproof container

From Ignatavicius D, Workman M: Medical surgical nursing: patient-centered collab- orative care, ed 7, Philadelphia, 2013, Saunders.

PRIORITY NURSING ACTIONS Triaging Victims at the Site of an Accident The nurse is the first responder at the scene of a school bus accident. The nurse triages the victims from highest to low- est priority as follows:

1. Confused child with bright red blood pulsating from a leg wound

2. Child with a closed head wound and multiple compound fractures of the arms and legs

3. Child with a simple fracture of the arm complaining of arm pain

4. Sobbing child with several minor lacerations on the face, arms, and legs

Triage systems identify which victims are the priority and should be treated first. Rankings are based on immediacy of needs, including victims with immediate threat to life requiring immediate treatment (emergent), victims whose injuries are not life-threatening provided that they are treated within 30 minutes to 2 hours (urgent), and victims with sustained local injuries who do not have immediate complications and can wait at least 2 hours for medical treatment (nonurgent). Victim 1 has a wound that is pulsating bright red blood; this indicates arterial puncture. The child is also confused, which indicates the presence of hypoxia and shock (emergent). Victim 2 has sustained multiple traumas, so this victim is also classi- fied as emergent and would require immediate treatment; how- ever, victim 1 is the higher priority because of the arterial puncture. Victim 3 has sustained injuries that are not life- threatening provided that the injuries can be treated in 30 minutes to 2 hours (urgent). Victim 4 has sustained minor injuries that can wait at least 2 hours for treatment (nonurgent).

Reference Perry, Potter, Ostendorf (2014), pp. 327–328.

70 UNIT II Professional Standards in Nursing

F

u

n

d

a

m

e

n

t

a

l

s

2. In an em ergen cy departm en t, triage co n sists of a brief assessm en t of clien ts th at allows th e n urse to classify clien ts accord in g to th eir n eed for care an d establish prio rities of care; th e typ e of illn ess or in jury, th e severity of th e problem , an d th e resou rces available govern th e process.

H. Em ergen cy dep artm en t triage system 1. A com m on ly used ratin g system in an em ergen cy

dep artm en t is a 3-tier system th at uses th e catego- ries of em ergen t, urgen t, an d n on urgen t; th ese categories m ay be id en tified by color codin g or n um bers ( Box 7-14).

2. Th e n urse n eeds to be fam iliar with th e triage sys- tem of th e h ealth care agen cy.

3. Wh en carin g for a clien t wh o h as died, th e n urse n eeds to recogn ize th e im portan ce of fam ily an d cultural an d religious rituals an d provide support to loved on es.

4. O rgan don ation procedures of th e h ealth care agen cy n eed to be addressed if appropriate.

Think survivability. If you are the first responder to a scene of a disaster, such as a train crash, a priority victim is one whose life can be saved.

I. Clien t assessm en t in th e em ergen cy dep artm en t 1. Prim ary assessm en t

a. Th e purpo se of prim ary assessm en t is to iden - tify an y clien t problem th at poses an im m edi- ate or poten tial th reat to life.

b . Th e n urse gath ers in form ation prim arily th rou gh objective data an d, on fin din g an y abn o rm alities, im m ediately in itiates in terven tion s.

c. Th e n urse uses th e ABCs—airway–breath in g– circulation —as a gu ide in assessin g a clien t’s n eeds an d assesses a clien t wh o h as sustain ed a traum atic in ju ry for sign s of a h ead in jury or cervical spin e in jury. If CPR n eeds to be in itiated, use CAB (com pressio n s–airway– breath in g) as th e priority guidelin e.

2. Secon dary assessm en t a. Th e n urse perform s secon dary assessm en t

after th e prim ary assessm en t an d after treat- m en t for an y prim ary problem s iden tified.

b . Secon dary assessm en t iden tifies an y oth er life-th reaten in g problem s th at a clien t m igh t be exp erien cin g.

c. Th e n urse obtain s subjective an d objective data, in cludin g a h isto ry, gen eral overview, vital sign m easu rem en ts, n eurological assess- m en t, pain assessm en t, an d com plete or focused ph ysical assessm en t.

CRITICAL THINKING What Should You Do? Answer: Quality improvement, also known as performance improvement, focuses on processes or systems that signifi- cantly contribute to client safety and effective client care out- comes; criteria are used to monitor outcomes of care and to determine the need for change to improve the quality of care. If the nurse notes a particular problem, such as an increase in the number of intravenous (IV) site infections, the nurse should collect data about the problem. This should include information such as the primary and secondary diagnoses of the clients developing the infection, the type of IV catheters being used, the site of the catheter, IV site dressings being used, frequency of assessment and methods of care to the IV site, and length of time that the IV catheter was inserted. Once these data are collected and analyzed, the nurse should examine evidence-based practice protocols to identify the best practices for care to IV sites to prevent infection. These practices can then be implemented and followed by evaluation of results based on the evidence-based practice protocols used.

Reference: Zerwekh, Zerwekh Garneau (20 15), pp. 511, 514.

BOX 7-14 Emergency Department Triage

Emergent (Red): Priority 1 (Highest) This classification is assigned to clients who have life- threatening injuries and need immediate attention and con- tinuous evaluation, but have a high probability for survival when stabilized.

Such clients include trauma victims, clients with chest pain, clients with severe respiratory distress or cardiac arrest, clients with limb amputation, clients with acute neurological deficits, and clients who have sustained chemical splashes to the eyes.

Urgent (Yellow): Priority 2 This classification is assigned to clients who require treatment and whose injuries have complications that are not life- threatening, provided that they are treated within 30 minutes to 2 hours; these clients require continuous evaluation every 30 to 60 minutes thereafter.

Such clients include clients with an open fracture with a distal pulse and large wounds.

Nonurgent (Green): Priority 3 This classification is assigned to clients with local injuries who do not have immediate complications and who can wait at least 2 hours for medical treatment; these clients require eval- uation every 1 to 2 hours thereafter. Such clients include cli- ents with conditions such as a closed fracture, minor lacerations, sprains, strains, or contusions.

Note: Some triage systems include tagging a client “Black” if the victim is dead or who soon will be deceased because of severe injuries; these are victims that would not benefit from any care because of the severity of injuries.

From Ignatavicius D, Workm an M: Medical surgical nursing: patient-centered collab- orative care, ed 7, Philadelphia, 20 13, Saunders.

71CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

P R A C T I C E Q U E S T I O N S 26. Th e n urse is assign ed to care for four clien ts. In plan -

n in g clien t roun ds, wh ich clien t sh o uld th e n urse assess first? 1. A postoperative clien t preparin g for disch arge

with a n ew m ed ication 2. A clien t requirin g daily dressin g ch an ges of a

recen t surgical in cision 3. A clien t sch eduled for a ch est x-ray after in sertio n

of a n aso gastric tube 4. A clien t with asth m a wh o requested a breath in g

treatm en t durin g th e previous sh ift

27. Th e n urse em ployed in an em ergen cy departm en t is assign ed to triage clien ts com in g to the em ergen cy departm en t for treatm en t on the even in g shift. Th e n urse sh ould assign p rio rity to wh ich clien t? 1. A clien t co m plain in g of m uscle ach es, a h ead-

ach e, an d h isto ry of seizures 2. A clien t wh o twisted h er an kle wh en rollerblad-

in g an d is requestin g m ed ication for pain 3. A clien t with a m in or laceration on th e in dex fin -

ger sustain ed wh ile cuttin g an eggplan t 4. A clien t with ch est pain wh o states th at h e just ate

pizza th at was m ade with a very spicy sauce

28. A n ursin g graduate is atten din g an agen cy orien tation regardin g the n ursin g m odel of practice im plem en ted in th e h ealth care facility. The n urse is told th at th e n ursin g m odel is a team n ursin g approach . Th e n urse determ in es that which scen ario is ch aracteristic of th e team -based m odel of n ursin g practice? 1. Each staff m em ber is assign ed a specific task for a

grou p of clien ts. 2. A staff m em ber is assign ed to determ in e th e cli-

en t’s n eeds at h om e an d begin disch arge plan n in g.

3. A sin gle registered n urse (RN) is respo n sible for providin g care to a group of 6 clien ts with th e aid of an un licen sed assistive perso n n el (UAP) .

4. An RN leads 2 licen sed practical n urses (LPNs) and 3 UAPs in providin g care to a group of 12 clien ts.

29. Th e n urse h as received th e assign m en t for th e day sh ift. After m akin g in itial ro un ds an d ch eckin g all of th e assign ed clien ts, wh ich clien t sh ould th e n urse plan to care for first? 1. A clien t wh o is am bulatory dem on stratin g

steady gait 2. A postoperative clien t wh o h as just received an

opioid pain m ed ication 3. A clien t sch eduled for ph ysical th erapy for th e

first crutch -walkin g session 4. A clien t with a wh ite blood cell coun t of

14,000 m m 3 (14Â109/ L) an d a tem perature of 38.4 °C

30. Th e n urse is givin g a bed bath to an assign ed clien t wh en an un licen sed assistive perso n n el (UAP) en ters th e clien t’s room an d tells th e n urse th at an oth er assign ed clien t is in pain an d n eeds pain m ed ication . Wh ich is th e m o st ap p ro p riate n ursin g action ? 1. Fin ish th e bed bath an d th en adm in ister th e pain

m edication to th e oth er clien t. 2. Ask th e UAP to fin d out wh en th e last pain m ed-

ication was given to th e clien t. 3. Ask th e UAP to tell th e clien t in pain th at m edica-

tio n will be adm in istered as soon as th e bed bath is com plete.

4. Cover th e clien t, raise th e side rails, tell th e clien t th at you will return sh ortly, an d adm in ister th e pain m edication to th e oth er clien t.

31. Th e n urse m an ager h as im plem en ted a ch an ge in th e m eth od of th e n ursin g delivery system from fun c- tion al to team n ursin g. An un licen sed assistive per- son n el (UAP) is resistan t to th e ch an ge an d is n ot takin g an active part in facilitatin g th e process of ch an ge. Wh ich is th e b est approach in dealin g with th e UAP? 1. Ign ore th e resistan ce. 2. Exert coercion on th e UAP. 3. Provide a positive reward system for th e UAP. 4. Con fron t th e UAP to en courage verbalization of

feelin gs regardin g th e ch an ge.

32. Th e registered n urse is plan n in g th e clien t assign - m en ts for th e day. Wh ich is th e m o st ap p ro p riate assign m en t for an un licen sed assistive perso n n el (UAP)? 1. A clien t requirin g a colostom y irrigation 2. A clien t receivin g con tin uo us tube feedin gs 3. A clien t wh o requires urin e specim en collectio n s 4. A clien t with difficu lty swallowin g food an d

fluids

33. Th e n urse m an ager is discussin g th e facility protoco l in th e even t of a torn ado with th e staff. Wh ich in struction s sh ould th e n urse m an ager in clude in th e discussion ? Select all th at ap p ly.

1. O pen doors to clien t room s. 2. Move beds away from win do ws. 3. Clo se win do w sh ades an d curtain s. 4. Place blan kets over clien ts wh o are con fin ed

to bed . 5. Relocate am bulatory clien ts from th e h all-

ways back in to th eir room s.

34. Th e n urse em p loyed in a lon g-term care facility is plan n in g assign m en ts for th e clien ts on a n ursin g un it. Th e n urse n eeds to assign four clien ts an d h as a licen sed practical (vocation al) n urse an d 3 un licen sed assistive perso n n el (UAPs) on a n ursin g

F

u

n

d

a

m

e

n

t

a

l

s

72 UNIT II Professional Standards in Nursing

team . Wh ich clien t would th e n urse m o st ap p ro p ri- ately assign to th e licen sed practical (vocation al) n urse? 1. A clien t wh o requires a bed bath 2. An older clien t requirin g frequen t am bulation 3. A clien t wh o requires h ou rly vital sign

m easu rem en ts 4. A clien t requirin g ab dom in al woun d irrigation s

an d dressin g ch an ges every 3 h ou rs

35. Th e ch arge n urse is plan n in g th e assign m en t for th e day. Wh ich facto rs sh ould th e n urse rem ain m in dful of wh en plan n in g th e assign m en t? Select all th at ap p ly.

1. Th e acu ity level of th e clien ts 2. Specific requests from th e staff 3. Th e clusterin g of th e room s on th e un it 4. Th e n um ber of an ticip ated clien t disch arges 5. Clien t n eeds an d workers’ n eeds an d abilities

A N S W E R S 26. 4 Ra t ion a le: Airway is always th e h igh est prio rity, an d th e n u rse wo uld atten d to th e clien t with asth m a wh o req u ested a breath - in g treatm en t du rin g th e p revio us sh ift. Th is cou ld in d icate th at th e clien t was experien cin g d ifficulty b reath in g. Th e clien ts described in o ption s 1, 2, an d 3 h ave n eed s th at wou ld be id en - tified as in term ed iate p riorities. Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d , first. Use th e ABCs—a ir wa y, b r ea t h in g, a n d cir cu la t io n —to an swer th e qu estio n . Rem em b er th at airway is always th e h igh est p rio rity. Th is will direct yo u to th e correct o ptio n . Review: Pr io r it izin g gu id elin es Level of Cogn it ive Ability: An alyzin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Lead ersh ip / Man agem en t—Prio ritizin g Pr ior ity Con cepts: Care Co ordin ation ; Clin ical Jud gm en t Refer en ces: Jarvis (2016), p p. 4–5; Po tter et al. (2013), pp . 838–840.

27. 4 Ra t ion a le: In an em ergen cy d ep artm en t, triage in volves brief clien t assessm en t to classify clien ts accordin g to th eir n eed for care an d in cludes establish in g p riorities o f care. Th e type o f ill- n ess o r in jury, th e severity o f th e problem , an d th e resou rces availab le govern th e p ro cess. Clien ts with traum a, ch est p ain , severe respirato ry d istress or card iac arrest, lim b am putation , an d acu te n eu ro lo gical deficits, or wh o h ave sustain ed ch em ical splash es to th e eyes, are classified as em ergen t and are th e n um ber-1 p riority. Clien ts with con dition s such as a sim p le frac- ture, asth m a with out respiratory distress, fever, h yp erten sion , abd om in al p ain , o r a ren al ston e h ave urgen t n eeds and are clas- sified as a n um b er-2 priority. Clien ts with con dition s such as a m in o r laceration , sprain , o r cold sym p tom s are classified as n on - urgen t an d are a n um ber-3 priority. Test -Ta kin g St r a t egy: No te th e st r a t egic wo r d , priority. Use th e ABCs—a ir wa y, b r ea t h in g, a n d cir cu la t io n —to direct yo u to th e co rrect op tion . A clien t experien cin g ch est p ain is always classified as Prio rity 1 u n til a m yo cardial in farctio n h as been ruled o ut. Review: Th e t r ia ge classificatio n system Level of Cogn it ive Ability: An alyzin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Lead ersh ip / Man agem en t—Triage Pr ior ity Con cepts: Care Co ordin ation ; Clin ical Jud gm en t Refer en ce: Jarvis (2016), p p. 4–5.

28. 4 Ra t ion a le: In team n u rsin g, n ursin g p erso n n el are led b y a reg- istered n urse lead er in p ro vidin g care to a grou p o f clien ts. O p tion 1 id en tifies fu n ctio n al n ursin g. O p tion 2 id en tifies a co m p on en t o f case m an agem en t. O ption 3 iden tifies prim ary n ursin g (relation sh ip -based practice). Test -Ta kin g St r a t egy: Focus o n th e su b ject , team n ursin g. Keep th is su b ject in m in d an d select th e op tio n th at b est d escrib es a team app ro ach . Th e co rrect op tion is th e on ly o n e th at iden tifies th e con cep t of a team app ro ach . Review: Th e vario u s types of n u r sin g d eliver y syst em s Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Lead ersh ip/ Man agem en t—Delegatin g Pr ior ity Con cepts: Care Coo rd in ation ; Co llab oration Refer en ce: Hu ber (2014), pp . 263, 265–266.

29. 4 Ra tion a le: Th e n urse sh ould p lan to care for th e clien t wh o h as an elevated white b lood cell coun t an d a fever first b ecau se this cli- ent’s n eeds are the p riority. Th e clien t wh o is am bulatory with stead y gait an d the clien t sch ed uled for ph ysical th erapy for a cru tch -walkin g session do n ot h ave priority n eeds. Waitin g for p ain m edication to take effect b efore providin g care to th e p ost- o perative clien t is b est. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d , first, an d use p rin ciples related to prioritizin g. Recallin g th e n o rm al wh ite b lo od cell co un t is 5000–10,000 m m 3 (5–10 Â 109/ L) an d th e n orm al tem p eratu re ran ge 97.5 °F to 99.5 °F ( 36.4 °C to 37.5 °C) will direct yo u to th e correct o ptio n . Review: Th e prin cip les related to p r io r it izin g gu id elin es Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Lead ersh ip/ Man agem en t—Prio ritizin g Pr ior ity Con cepts: Care Coo rd in ation ; Clin ical Ju d gm en t Refer en ces: Po tter et al. (2013), pp . 838–840; Zerwekh , Zer- wekh Garn eau (2015), pp. 35–36.

30. 4 Ra t ion a le: Th e n urse is resp on sible for th e care p ro vided to assign ed clien ts. Th e ap pro priate actio n in th is situatio n is to p ro vid e safety to th e clien t wh o is receivin g th e bed b ath an d p repare to adm in ister th e pain m edicatio n . O ption s 1 an d 3 d elay th e ad m in istration o f m ed ication to th e clien t in p ain . O p tion 2 is n ot a resp on sibility of th e UAP. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d s, most appropri- ate, an d u se prin cip les related to prio rities of care. O ption s 1

F

u

n

d

a

m

e

n

t

a

l

s

73CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

an d 3 are co m p a r a b le o r a lik e an d d elay th e adm in istratio n o f p ain m edication , an d o p tion 2 is n ot a respo n sib ility o f th e UAP. Th e m ost app rop riate actio n is to p lan to ad m in ister th e m edicatio n . Review: Prin ciples related to p r io r it izin g ca r e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip/ Man agem en t—Prioritizin g Pr ior it y Con cept s: Care Co o rd in atio n ; Clin ical Ju dgm en t Refer en ce: Po tter et al. (2013), p . 784.

31. 4 Ra tion a le: Con fron tatio n is an im portan t strategy to m eet resis- tan ce h ead-on . Face-to -face m eetin gs to con fron t th e issue at h an d will allow verbalizatio n of feelin gs, iden tificatio n of pro b- lem s and issu es, an d developm en t o f strategies to solve the pro b- lem . O ption 1 will n ot add ress th e p ro blem . O ption 2 m ay p ro du ce add itio n al resistan ce. O ptio n 3 m ay p ro vide a tem po - rary solu tion to th e resistan ce, b ut will n ot address th e con cern specifically. Test-Ta kin g Str a tegy: No te th e st r a t egic wo r d , best. O ptio n s 1 an d 2 can be elim in ated first b ecau se of th e words ignore in o ptio n 1 an d coercion in o ption 2. From th e rem ain in g o ptio n s, select th e correct o ption o ver o ptio n 3 b ecause th e correct o ptio n sp ecifically ad dresses p ro blem -so lvin g m easures. Review: Resist a n ce t o ch a n ge Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip/ Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Lead ersh ip ; Pro fessio n alism Refer en ce: Hub er (2014), p p. 38, 46–47.

32. 3 Ra tion a le: Th e n u rse m ust determ in e th e m o st ap prop riate assign m en t b ased o n th e skills of th e staff m em b er an d th e n eeds o f th e clien t. In th is case, th e m o st ap prop riate assign - m en t fo r th e UAP wo uld b e to care for th e clien t wh o req uires u rin e specim en co llection s. Th e UAP is skilled in th is p ro ce- d ure. Co losto m y irrigation s an d tub e feed in gs are n ot per- fo rm ed b y UAPs b ecau se th ese are in vasive proced ures. Th e clien t with d ifficulty swallowin g foo d an d flu id s is at risk fo r asp iratio n . Test-Ta kin g St r a t egy: Note th e st r a t egic wo r d s, most appropri- ate, an d n o te th e su b ject , an assign m en t to th e UAP. Elim in ate o ptio n 4 first because o f th e wo rd s difficulty swallowing. Next, elim in ate o ption s 1 an d 2 b ecause th ey are co m p a r a b le o r a lik e an d are b oth in vasive p rocedu res an d as su ch a UAP can - n o t perform th ese p ro cedu res. Review: Delega t io n gu id elin es Level of Cogn it ive Abilit y: Creatin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Leadersh ip/ Man agem en t—Delegatin g Pr ior it y Con cept s: Care Co o rd in atio n ; Clin ical Ju dgm en t Refer en ces: Hu ber ( 2014) , p p . 147–148; Zerwekh , Zerwekh Garn eau (2015), p. 305.

33. 2, 3, 4 Ra tion a le: In th is weath er even t, th e appropriate n ursin g action s focu s o n p ro tectin g clien ts from flyin g d eb ris o r glass. Th e n u rse sh o uld clo se do ors to each clien t’s roo m an d m o ve b eds away fro m win d o ws, an d close win do w sh ades an d cur- tain s to p ro tect clien ts, visitors, an d staff fro m sh atterin g glass an d flyin g d eb ris. Blan kets sh o u ld be placed over clien ts con - fin ed to b ed. Am b ulato ry clien ts sh o uld be m oved in to th e h allways from th eir ro om s, away fro m win do ws. Test-Ta kin g Str a tegy: Focus on th e su b ject , p ro tectin g th e cli- en t in th e even t o f a torn ad o. Visu alize each of th e action s in th e op tion s to determ in e if th ese action s wo uld assist in pro - tectin g th e clien t an d p reven tin g an accid en t o r in ju ry. Review: Th e vario us typ es of safety m easures in th e even t of a d isa st er Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Prioritizin g Pr ior it y Con cept s: Lead ersh ip ; Pro fessio n alism Refer en ce: Po tter et al. (2013), p p. 366–367, 387.

34. 4 Ra tion a le: Wh en d elegatin g n u rsin g assign m en ts, th e n urse n eeds to co n sid er th e skills an d ed u catio n al level of th e n u rsin g staff. Givin g a b ed b ath , assistin g with freq uen t am b u- latio n , an d takin g vital sign s can b e provid ed m o st app ro p ri- ately b y UAP. Th e licen sed p ractical (vo cation al) n u rse is skilled in wo un d irrigatio n s an d d ressin g ch an ges an d m o st app rop riately wou ld b e assign ed to th e clien t wh o n eeds th is care. Test-Ta kin g Str a t egy: Fo cu s o n th e su b ject , assign m en t to a licen sed practical (vo catio n al) n u rse, an d n o te th e st r a t egic wo r d s, most appropriately. Recall th at education an d job posi- tio n as described by th e n u rse p ractice act an d em p lo yee gu id e- lin es n eed to be co n sid ered wh en d elegatin g activities an d m akin g assign m en ts. O ption s 1, 2, an d 3 can b e elim in ated b ecau se th ey are n on in vasive tasks th at th e UAP can perform . Review: Th e prin cip les an d gu id elin es o f d elega t io n a n d a ssign m en t s Level of Cogn itive Ability: Creatin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Leadersh ip / Man agem en t—Delegatin g Pr ior it y Con cept s: Care Co ord in atio n ; Clin ical Ju dgm en t Refer en ce: Zerwekh , Zerwekh Garn eau (2015), p p. 305, 308.

35. 1, 5 Ra tion a le: Th ere are gu id elin es th at th e n urse sh o uld use wh en d elegatin g an d plan n in g assign m en ts. Th ese in clud e th e follow- in g: en su re clien t safety; b e aware of in dividu al variatio n s in work abilities; determ in e wh ich tasks can be delegated an d to wh om ; m atch th e task to th e delegatee on th e basis of th e n urse p ractice act an d ap p ro priate po sitio n descriptio n s; p rovid e d irectio n s th at are clear, con cise, accu rate, an d co m p lete; vali- d ate th e d elegatee’s u n d erstan din g of th e direction s; com m un i- cate a feelin g of con fiden ce to th e delegatee an d provid e feed back prom p tly after th e task is p erfo rm ed ; an d m ain tain

F

u

n

d

a

m

e

n

t

a

l

s

74 UNIT II Professional Standards in Nursing

co n tin u ity o f care as m u ch as p ossible wh en assign in g clien t care. Staff requ ests, con ven ien ce as in clusterin g clien t ro om s, an d an ticipated ch an ges in u n it cen su s are n o t specific guide- lin es to use wh en delegatin g an d plan n in g assign m en ts. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject , gu id elin es to u se wh en d elegatin g an d plan n in g assign m en ts. Read each o ptio n carefully an d u se Ma slo w’s Hier a r ch y o f Need s t h eo r y. No te th at th e correct op tio n s d irectly relate to th e clien t’s n eed s an d clien t safety.

Review: Th e p rin ciples an d guidelin es o f d elega t io n a n d a ssign m en t s. Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Lead ersh ip/ Man agem en t—Delegatin g Pr ior ity Con cepts: Clin ical Jud gm en t; Pro fessio n alism Refer en ces: Hub er (2014) , pp . 150–151; Zerwekh , Zerwekh Garn eau (2015), p. 510. F

u

n

d

a

m

e

n

t

a

l

s

75CHAPTER 7 Prioritizing Client Care: Leadership, Delegation, and Emergency Response Planning

UNIT III

Nursing Sciences Pyramid to Success

Pyram id Poin ts focus on fluids an d electrolytes, acid- base balan ce, laborato ry referen ce in tervals, n utrition , in traven ous (IV) th erapy, an d blood adm in istration . Fluids an d electrolytes an d acid-base balan ce con stitute a con ten t area th at is som etim es com plex an d difficult to un derstan d. For a clien t wh o is exp erien cin g th ese im bal- an ces, it is im portan t to rem em ber th at m ain ten an ce of a paten t airway is a priority an d th e n urse n eeds to m on - itor vital sign s, ph ysio logical status, in take an d output, laborato ry referen ce in tervals, an d arterial blood gas values. It is also im portan t to rem em ber th at n orm al lab- oratory referen ce levels m ay vary sligh tly, depen din g on th e laborato ry settin g an d equipm en t used in testin g. If you are fam iliar with th e n orm al referen ce in tervals, you will be able to determ in e wh eth er an ab n orm ality exists wh en a laborato ry value is presen ted in a question . Th e specific labo ratory referen ce levels iden tified in th e NCLEX® test plan th at yo u n eed to kn ow in clude arterial blood gases kn own as ABGs (pH, PO 2, PCO 2, SaO 2, HCO 3), blood urea n itrogen (BUN), ch olestero l (total), glucose, h em atocrit, h em oglobin , glycosylated h em o- globin (HgbA1C) , platelets, potassium , sodium , wh ite blood cell (WBC) coun t, creatin in e, proth rom bin tim e (PT), activated partial th rom boplastin tim e (aPTT), an d in tern ation al n orm alized ratio (INR). Th e question s on th e NCLEX-RN exam in ation related to labo ratory referen ce in tervals will require you to iden tify wh eth er th e labo ratory value is n orm al or abn orm al, an d th en you will be required to th in k critically ab out th e effects of th e labo ratory value in term s of th e clien t. Note th e disorder presen ted in th e question an d th e associated body organ affected as a result of th e disorder. Th is pro- cess will assist you in determ in in g th e correct an swer.

Nutrition is a basic n eed th at m ust be m et for all cli- en ts. Th e NCLEX-RN exam in ation addresses th e dietary m easures required for basic n eeds an d for particular body system alteration s an d addresses paren teral n utri- tion (PN) , both partial paren teral n utrition (PPN) an d total paren teral n utrition (TPN) . Wh en presen ted with

a question related to n utrition , con sider th e clien t’s diag- n osis an d th e particular requirem en t or restrictio n n eces- sary for treatm en t of th e disorder. With regard to IV th erapy, assessm en t of th e clien t for allergies, in cludin g latex sen sitivity, before in itiation of an IV lin e an d m on - itorin g for com plication s are critical n ursin g respo n sibil- ities. Likewise, th e proced ure for adm in isterin g blood com pon en ts, th e sign s an d sym ptom s of tran sfusio n reaction , an d th e im m ediate in terven tion s if a tran sfu- sion reaction occurs are a focus.

Client Needs: Learning Objectives Safe and Effective Care Environment Applyin g prin ciples of in fectio n con trol Collaboratin g with in terp rofessio n al team s En surin g th at in form ed con sen t h as been obtain ed for

in vasive proced ures an d for th e adm in istration of blood produ cts

Establish in g priorities for care Han dlin g h azardo us an d in fectio us m aterials to preven t

in jury to h ealth care person n el an d oth ers Iden tifyin g th e clien t with at least 2 form s of iden tifiers

(e.g., n am e an d iden tification n um ber) prior to th e adm in istration of a blood product

In itiatin g h om e h ealth care referrals Main tain in g con tin uity of care an d providin g close

supervisio n durin g a blood tran sfusion Main tain in g asepsis an d preven tin g in fectio n in th e cli-

en t wh en sam ples for labo ratory studies are obtain ed or wh en IV solution s are ad m in istered

Main tain in g stan dard , tran sm ission -b ased, an d oth er precaution s to preven t tran sm issio n of in fectio n to self an d oth ers

Preven tin g acciden ts an d en surin g safety of th e clien t wh en a fluid or electrolyte im balan ce exists, particu- larly wh en ch an ges in cardiovascular, respiratory, gastroin testin al, n eurom u scular, ren al, or cen tral n er- vous system s occur, or wh en th e clien t is at risk for com plication s such as seizu res, respiratory depres- sion , or dysrh yth m ias

F

u

n

d

a

m

e

n

t

a

l

s

76

Provid in g in form ation to th e clien t about com m un ity classes for n utrition edu cation

Provid in g safety for th e clien t durin g im plem en tatio n of treatm en ts

Usin g equipm en t such as electron ic IV in fusion devices safely

Uph oldin g clien t righ ts

Health Promotion and Maintenance Assessin g th e clien t’s ab ility to perform self-care Con siderin g lifestyle ch oices related to h om e care of th e

IV lin e Evaluatin g th e clien t’s h om e en viron m en t for self-care

m od ification s Iden tifyin g clien ts at risk for an acid-b ase im balan ce Iden tifyin g com m un ity resou rces available for follow-up Iden tifyin g lifestyle ch oices related to receivin g a blood

tran sfusion Im plem en tin g h ealth screen in g an d m on itorin g for th e

poten tial risk for a fluid an d electrolyte im balan ce Perform in g ph ysical assessm en t tech n iqu es Provid in g clien t an d fam ily education regardin g th e

adm in istration of PN at h om e Provid in g edu cation related to m edication an d diet

m an agem en t Provid in g education related to th e poten tial risk for a

fluid an d electrolyte im balan ce, m easu res to preven t an im balan ce, sign s an d sym pto m s of an im balan ce, an d action s to take if sign s an d sym pto m s develop

Teach in g th e clien t an d fam ily about preven tion , early detection , an d treatm en t m easures for h ealth disorders

Teach in g th e clien t to m on itor for sign s an d sym pto m s th at in dicate th e n eed to n otify th e h ealth care provid er

Teach in g th e clien t an d fam ily ab out care of th e IV lin e

Psychosocial Integrity Assessin g th e clien t’s em o tion al respo n se to treatm en t Con siderin g cultural an d spiritual preferen ces related to

n utrition al pattern s an d lifestyle ch oices Discussin g role ch an ges an d alteration s in lifestyle

related to th e clien t’s n eed to receive PN En surin g th erap eutic in teraction s with th e clien t regard-

in g th e proced ure for blood adm in istration Iden tifyin g co pin g m ech an ism s

Iden tifyin g religious, spiritu al, an d cultural con sider- ation s related to blood adm in istration

Iden tifyin g support system s in th e h om e to assist with carin g for an IV an d th e ad m in istration of PN

Providin g em o tion al supp ort to th e clien t durin g testin g Providin g reassuran ce to th e clien t wh o is experien cin g a

fluid or electrolyte im balan ce Providin g supp ort an d con tin uo usly in form in g th e cli-

en t of th e purpo ses for prescribed in terven tion s

Physiological Integrity Adm in isterin g an d m on itorin g m ed ication s, IV fluid s,

an d oth er th erapeutic in terven tion s Adm in isterin g blood products safely Assessin g an d carin g for cen tral ven ous access devices Assessin g for exp ected an d un exp ected respo n ses to th er-

apeutic in terven tion s an d docum en tin g fin din gs Assessin g ven ous access devices for blood adm in istration Assistin g with obtain in g an ABG specim en an d an alyz-

in g th e results Iden tifyin g clien ts wh o are at risk for a fluid or electrolyte

im balan ce Main tain in g IV th erap y Man agin g m ed ical em ergen cies if a tran sfusio n reaction

or oth er com plication occurs Mon itorin g for com plication s related to blood

adm in istration Mon itorin g for com plication s related to a body system

alteration Mon itorin g for ch an ges in status an d for com plication s;

takin g action s if a com plication arises Mon itorin g for clin ical m an ifestation s associated with

an ab n orm al laborato ry value Mon itorin g of en teral feedin gs an d th e clien t’s ability to

tolerate feedin gs Mon itorin g for expected effects of ph arm aco logical an d

paren teral th erap ies Mon itorin g labo ratory referen ce in tervals; determ in in g

th e sign ifican ce of an abn o rm al labo ratory value an d th e n eed to im plem en t specific action s based on th e laborato ry results

Mon itorin g of n utrition al in take an d oral h ydration Providin g woun d care wh en blood is obtain ed for an

ABG study Reducin g th e likelih oo d th at an acid-b ase im balan ce

will occur

77UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 8 Fluids and Electrolytes

PRIORITY CONCEPTS Cellular Regulation; Fluid and Electrolytes

CRITICAL THINKING What Should You Do? The nurse notes the presence of U waves on a client’s cardiac monitor screen. What actions should the nurse take? Answer located on p. 91.

I. Concepts of Fluid and Electrolyte Balance A. Electro lytes

1. Description : An electrolyte is a substan ce th at, on dissolvin g in solution , ion izes; th at is, som e of its m olecu les split or dissociate in to electrically ch arged ato m s or ion s ( Box 8-1).

2. Measu rem en t a . Th e m etric system is used to m easu re vo lum es

of fluids—liters (L) or m illiliters (m L). b . Th e un it of m easu re th at expresses th e com -

bin in g activity of an electrolyte is th e m illieq uivalen t (m Eq).

c. O n e m illieq uivalen t (1 m Eq) of an y cation always reacts ch em ically with 1 m Eq of an an ion .

d . Millieq uivalen ts provide in form ation about th e n um ber of an ion s or cation s available to com bin e with oth er an ion s or cation s.

B. Body flu id com partm en ts (Fig. 8-1) 1. Description

a . Fluid in each of th e body co m partm en ts con - tain s electrolytes.

b . Each co m partm en t h as a particular com po si- tion of electrolytes, wh ich differs from th at of oth er com partm en ts.

c. To fun ction n orm ally, body cells m ust h ave fluid s an d electrolytes in th e righ t com part- m en ts an d in th e righ t am oun ts.

d . Wh en ever an electrolyte m oves out of a cell, an oth er electrolyte m oves in to take its place.

e. Th e n um bers of cation s an d an ion s m ust be th e sam e for homeostasis to exist.

f. Com p artm en ts are separated by sem iperm e- able m em bran es.

2. In travascular com partm en t: Refers to fluid in side a blood vessel

3. In tracellular com partm en t a . Th e in tracellular com partm en t refers to all

fluid in side th e cells. b . Most bodily fluids are in side th e cells.

4. Extracellular com partm en t a . Refers to fluid outsid e th e cells. b . Th e extracellular com partm en t in cludes th e

in terstitial fluid , wh ich is flu id between cells (som etim es called th e third space), blood, lym ph , bon e, con n ective tissue, water, an d tran scellular flu id.

C. Th ird-spacin g 1. Th ird-spacin g is th e accu m ulation an d sequestra-

tion of trapp ed extracellular fluid in an actu al or poten tial body space as a result of disease or in jury.

2. Th e trapped fluid represen ts a vo lum e lo ss an d is un available for n orm al ph ysiological processes.

3. Fluid m ay be trapped in body spaces such as th e pericardial, pleural, periton eal, or join t cavities; th e bowel; or th e abdom en , or with in soft tissues after traum a or burn s.

4. Assessin g th e in travascular fluid loss caused by th ird-sp acin g is difficu lt. Th e loss m ay n ot be reflected in weigh t ch an ges or in take an d output records, an d m ay n ot beco m e apparen t un til after organ m alfun ction occurs.

D. Edem a 1. Edem a is an excess accu m ulation of fluid in

th e in terstitial space; it occurs as a result of alteration s in on cotic pressure, h ydrostatic pres- sure, cap illary perm eability, an d lym p h atic obstru ction .

2. Localized edem a occurs as a result of traum atic in jury from acciden ts or surgery, local in flam m a- tory processes, or burn s.

3. Gen eralized edem a, also called anasarca, is an excessive accu m ulation of fluid in th e in terstitial78

space th rough ou t th e body an d occurs as a result of con dition s such as cardiac, ren al, or liver failure.

E. Body fluid 1. Description

a. Bod y fluid s tran spo rt nutrients to th e cells an d carry waste products from th e cells.

b . To tal body fluid (in tracellular an d extracellu- lar) am oun ts to about 60% of body weigh t in th e adult, 55% in th e older ad ult, an d 80% in th e in fan t.

c. Th us in fan ts an d older adults are at a h igh er risk for fluid-related problem s th an yo un ger ad ults; ch ildren h ave a greater propo rtion of body water th an adults an d th e older adult h as th e least propo rtion of body water.

2. Con stituen ts of body fluids a. Body fluids con sist of water an d dissolved

substan ces. b . Th e largest sin gle fluid co n stituen t of th e

body is water. c. Som e substan ces, such as gluco se, urea, an d

creatin in e, do n ot dissociate in solution ; th at is, th ey do n ot separate from th eir com plex form s in to sim pler substan ces wh en th ey are in solution .

d . O th er substan ces do dissociate; for exam ple, wh en sodium ch loride is in a solution , it dis- sociates, or separates, in to 2 parts or elem en ts.

Infants and older adults need to be monitored closely for fluid imbalances.

F. Body flu id tran sport 1. Diffusion

a. Diffusion is th e process wh ereby a solute (substan ce th at is dissolved ) m ay spread th rou gh a solution or solven t (solution in wh ich th e solute is dissolved).

b . Diffusion of a solute spreads th e m olecules from an area of h igh er con cen tration to an area of lower co n cen tration .

c. A perm eable m em bran e allows substan ces to pass th rough it with ou t restriction .

d . A selectively perm eable m em bran e allows som e solutes to pass th rou gh with out restric- tion but preven ts oth er solutes from passin g freely.

e. Diffusion occurs with in flu id com partm en ts an d from on e com partm en t to an oth er if th e barrier between th e com partm en ts is per- m eable to th e diffusin g substan ces.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 8-1 Properties of Electrolytes and Their Components Atom An atom is the smallest part of an element that still has the

properties of the element. The atom is composed of particles known as the proton (posi-

tive charge), neutron (neutral), and electron (negative charge).

Protons and neutrons are in the nucleus of the atom; therefore, the nucleus is positively charged.

Electrons carry a negative charge and revolve around the nucleus.

As long as the number of electrons is the same as the number of protons, the atom has no net charge; that is, it is neither pos- itive nor negative.

Atoms that gain, lose, or share electrons are no longer neutral.

Molecule A molecule is 2 or more atoms that combine to form a

substance.

Ion An ion is an atom that carries an electrical charge because it has

gained or lost electrons. Some ions carry a negative electrical charge and some carry a

positive charge.

Cation A cation is an ion that has given away or lost electrons and

therefore carries a positive charge. The result is fewer electrons than protons, and the result is a

positive charge.

Anion An anion is an ion that has gained electrons and therefore

carries a negative charge. When an ion has gained or taken on electrons, it assumes a neg-

ative charge and the result is a negatively charged ion.

Intrac e llular fluid

Extrac e llular fluid

Inte rs titia l

Intra va s cula r

Tra ns ce llula r (ce re bros pina l ca na ls , lympha tic tis s ue s , s ynovia l joints , a nd the e ye )

(70%)

(30%)

(22%)

(6%)

(2%)

FIGURE 8-1 Distribution of fluid by compartments in the average adult.

79CHAPTER 8 Fluids and Electrolytes

F

u

n

d

a

m

e

n

t

a

l

s

2. O sm o sis a . O sm o tic pressure is th e force th at draws th e

solven t fro m a less con cen trated solute th rou gh a selectively perm eable m em bran e in to a m ore con cen trated solute, th us ten din g to equalize th e con cen tration of th e solven t.

b . If a m em bran e is perm eable to water but n ot to all solutes presen t, th e m em bran e is a selec- tive or sem iperm eable m em bran e.

c. O sm osis is the m ovem en t of solvent m ole- cules across a m em bran e in respon se to a con - cen tration gradien t, usually from a solution of lower to on e of h igh er solute con cen tration .

d . Wh en a m ore con cen trated solution is on on e side of a selectively perm eable m em bran e an d a less con cen trated solution is on th e oth er side, a pull called osmotic pressure draws th e water th rough th e m em bran e to th e m ore con cen trated side, or th e side with m ore solute.

3. Filtration a . Filtration is th e m ovem en t of solutes an d sol-

ven ts by h ydrostatic pressure. b . Th e m ovem en t is from an area of h igh er pres-

sure to an area of lower pressure. 4. Hydro static pressure

a . Hydro static pressure is th e force exerted by th e weigh t of a solution .

b . Wh en a differen ce exists in th e h ydrostatic pressure on two sides of a m em bran e, water an d diffusible solutes m ove out of th e solu- tion th at h as th e h igh er h ydrostatic pressure by th e process of filtration .

c. At th e arterial en d of th e cap illary, th e h ydro- static pressure is h igh er th an th e osm o tic pres- sure; th erefore, fluids an d diffusible solutes m ove out of th e capillary.

d . At th e ven ous en d, th e osm o tic pressure, or pull, is h igh er th an th e h ydrostatic pressure, an d fluid s an d som e solutes m ove in to th e cap illary.

e. Th e excess fluid an d solutes rem ain in g in th e in terstitial spaces are return ed to th e in travas- cular com partm en t by th e lym p h ch an n els.

5. O sm o lality a . O sm o lality refers to th e n um ber of osm o ti-

cally active particles per kilogram of water; it is th e con cen tration of a solution .

b . In th e body, osm o tic pressure is m easu red in m illiosm oles (m O sm ).

c. Th e n orm al osm o lality of plasma is 275- 295 m O sm / kg (275-295 m m o l/ kg).

G. Movem en t of body fluid 1. Description

a . Cell m em bran es separate th e in terstitial fluid from th e in travascular fluid .

b . Cell m em bran es are selectively perm eable; th at is, th e cell m em bran e an d th e cap illary

wall allow water an d som e solutes free pas- sage th rou gh th em .

c. Several forces affect th e m ovem en t of water an d solutes th rough th e walls of cells an d cap- illaries; for exam ple, th e greater th e n um ber of particles with in th e cell, th e m ore pressure exists to force th e water th rou gh th e cell m em - bran e out of th e cell.

d . If th e body loses m ore electrolytes th an fluids, as can h app en in diarrh ea, th en th e extracel- lular fluid con tain s fewer electrolytes or less solute th an th e in tracellu lar flu id.

e. Fluids an d electrolytes m ust be kept in bal- an ce for h ealth ; wh en th ey rem ain out of bal- an ce, death can occur.

2. Isoton ic solution s a . Wh en th e solution s on both sides of a selec-

tively perm eable m em bran e h ave establish ed equilibrium or are equ al in con cen tration , th ey are isoton ic.

b . Isoton ic solution s are isoton ic to h um an cells, an d th us very little osm o sis occurs; iso- ton ic solution s h ave th e sam e osm olality as body fluids.

c. Refer to Ch apter 13, Table 13-1, for a list of isoton ic solution s.

3. Hypoton ic solution s a . Wh en a solution con tain s a lower co n -

cen tration of salt or solute th an an oth er, m ore con cen trated solution , it is con sidered h ypo ton ic.

b . A h ypoton ic solution h as less salt or m ore water th an an isoton ic solution ; th ese solu- tion s h ave lower osm o lality th an body fluids.

c. Hypoton ic solution s are h ypo ton ic to th e cells; th erefore, osm osis would co n tin ue in an attem p t to brin g about balan ce or equ ality.

d . Refer to Ch apter 13, Table 13-1, for a list of h ypo ton ic solution s.

4. Hyperton ic solution s a . A solution th at h as a h igh er con cen tration of

solutes th an an oth er, less con cen trated solu- tion is h yperton ic; th ese solution s h ave a h igh er osm olality th an body flu ids.

b . Refer to Ch apter 13, Table 13-1, for a list of h yperton ic solution s.

5. O sm o tic pressure a . Th e am oun t of osm o tic pressure is determ in ed

by th e con cen tration of solutes in solution . b . Wh en th e solution s on each side of a selec-

tively perm eable m em bran e are equal in con - cen tration , th ey are isoton ic.

c. A h ypo ton ic solution h as less solute th an an isoton ic solution , wh ereas a h yperton ic solu- tion co n tain s m ore solute.

d . A solven t m oves from th e less con cen trated solute side to th e m ore con cen trated solute side to equ alize con cen tration .

80 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

6. Active tran spo rt a. If an ion is to m ove th rough a m em bran e

fro m an area of lower con cen tration to an area of h igh er con cen tration , an active tran s- port system is n ecessary.

b . An active tran sport system m oves m olecules or ion s again st con cen tration an d osm o tic pressure.

c. Metab olic processes in th e cell supply th e en ergy for active tran spo rt.

d . Substan ces th at are tran spo rted actively th rou gh th e cell m em bran e in clude ion s of sodium, potassium, calcium, iron , an d h ydro- gen ; som e of th e sugars; an d th e am in o acids.

H. Body fluid in take an d output (Fig. 8-2) 1. Bod y fluid in take

a. Water en ters th e body th rou gh 3 sources— orally in gested liquid s, water in food s, an d water form ed by oxidation of food s.

b . Abou t 10 m L of water is released by th e metabolism of each 100 calories of fat, carbo- h ydrates, or protein s.

2. Bod y fluid output a. Water lost th rou gh th e skin is called insensible

loss (th e in dividual is un aware of losin g th at water).

b . Th e am oun t of water lost by perspiration varies accordin g to th e tem perature of th e en viron - m en t an d of th e body, but th e average am ount of loss by perspiration alon e is 100 m L/ day.

c. Water lost from th e lu n gs is called insensible loss an d is lost th rough exp ired air th at is sat- urated with water vapo r.

d . Th e am oun t of water lost from th e lun gs var- ies with th e rate an d th e depth of respiration .

e. Large quan tities of water are secreted in to th e gastro in testin al tract, but alm o st all of th is flu id is reabsorbed.

f. Alarge volum e of electrolyte-con tain in g liquids m oves in to th e gastroin testin al tract an d th en returns again to th e extracellular fluid.

g. Severe diarrh ea results in th e lo ss of large quan tities of flu ids an d electrolytes.

h . Th e kidn eys play a m ajor role in regulatin g fluid an d electrolyte balan ce an d excrete th e largest quan tity of fluid.

i. No rm al kidn eys can ad just th e am oun t of water an d electrolytes leavin g th e body.

j. Th e quan tity of fluid excreted by the kidn eys is determ in ed by th e am oun t of water ingested an d th e am oun t of waste and solutes excreted.

k . As lon g as all organ s are fun ctio n in g n or- m ally, th e body is able to m ain tain balan ce in its fluid con ten t.

The client with diarrhea is at high risk for a fluid and electrolyte imbalance.

I. Main tain in g flu id an d electrolyte balan ce 1. Description

a. Homeostasis is a term th at in dicates th e rela- tive stability of th e in tern al en viron m en t.

b . Con cen tration an d com po sition of body fluid s m ust be n early con stan t.

c. Wh en on e of th e substan ces in a clien t is defi- cien t—eith er fluids or electrolytes—th e sub- stan ce m ust be replaced n orm ally by th e in take of food an d water or by th erapy such as in traven ous (IV) solution s an d m edication s.

d . Wh en th e clien t h as an excess of fluid or elec- trolytes, th erapy is directed toward assistin g th e body to elim in ate th e excess.

2. Th e kidn eys play a m ajor ro le in con trollin g bal- an ce in fluid an d electrolytes.

3. Th e ad ren al glan ds, th rou gh th e secretio n of aldo steron e, also aid in con tro llin g extracellular fluid vo lum e by regulatin g th e am oun t of sodium reabsorb ed by th e kidn eys.

4. An tidiu retic h orm on e from th e pituitary glan d regulates th e osm otic pressure of extracellular fluid by regulatin g th e am oun t of water reab- sorbed by th e kidn eys.

II. Fluid Volume Deficit A. Description

1. Deh ydration occurs wh en th e fluid in take of th e body is n ot sufficien t to m eet th e fluid n eeds of th e body.

2. Th e goal of treatm en t is to restore fluid vo lum e, replace electrolytes as n eeded, an d elim in ate th e cau se of th e flu id volum e deficit.

B. Types of flu id volum e deficits 1. Iso ton ic deh ydratio n

a. Water an d dissolved electrolytes are lost in equ al propo rtion s.

b . Kn o wn as hypovolemia, isoton ic deh ydratio n is th e m ost com m on typ e of deh ydration .

c. Iso ton ic deh ydration results in decreased cir- culatin g blood volu m e an d in adeq uate tissue perfusion .

Fluid intake

Inge s te d wa te r Inge s te d food Me ta bolic oxida tion

TOTAL

1200-1500 mL

800-1100 mL

300 mL

2300-2900 mL

Fluid o utput

Kidne ys Ins e ns ible los s through s kin Ins e ns ible los s through lungs Ga s trointe s tina l tra ct

TOTAL

1500 mL

600-800 mL

400-600 mL 100 mL

2600-3000 mL

FIGURE 8-2 Sources of fluid intake and fluid output.

81CHAPTER 8 Fluids and Electrolytes

F

u

n

d

a

m

e

n

t

a

l

s

2. Hyperton ic deh ydration a . Water loss exceeds electrolyte loss. b . Th e clin ical problem s th at occur result from

alteration s in th e con cen tration s of specific plasm a electrolytes.

c. Fluid m oves fro m th e in tracellular com part- m en t in to th e plasma an d in terstitial fluid spaces, causin g cellular deh ydration an d sh rin kage.

3. Hypo ton ic deh ydratio n a . Electrolyte loss exceed s water loss. b . Th e clin ical problem s th at occur result from

fluid sh ifts between com partm en ts, causin g a decrease in plasm a volum e.

c. Fluid m oves from th e plasm a an d in terstitial fluid spaces in to th e cells, causin g a plasm a volu m e deficit an d causin g th e cells to swell.

C. Causes of fluid volum e deficits 1. Isoton ic deh ydration

a . In adequ ate in take of fluids an d solutes b . Fluid sh ifts between com partm en ts c. Excessive losses of isoton ic body fluids

2. Hyperton ic deh ydration —con dition s th at in crease fluid loss, such as excessive perspiration , h yperventilation , ketoacidosis, prolon ged fevers, diarrh ea, early-stage kidn ey disease, an d diabetes in sipidus

3. Hypoton ic deh ydration a . Ch ron ic illn ess b . Excessive fluid replacem en t (h ypoton ic) c. Kidn ey disease d . Ch ron ic malnutrition

D. Assessm en t (Table 8-1) E. In terven tion s

TABLE 8-1 Assessment Findings: Fluid Volume Deficit and Fluid Volume Excess Fluid Volume Deficit Fluid Volume Excess

Cardiovascular ▪ Thready, increased pulse rate ▪ Bounding, increased pulse rate ▪ Decreased blood pressure and orthostatic (postural)

hypotension ▪ Elevated blood pressure

▪ Flat neck and hand veins in dependent positions ▪ Distended neck and hand veins ▪ Diminished peripheral pulses ▪ Elevated central venous pressure ▪ Decreased central venous pressure ▪ Dysrhythmias ▪ Dysrhythmias Respiratory ▪ Increased rate and depth of respirations ▪ Increased respiratory rate (shallow respirations) ▪ Dyspnea ▪ Dyspnea

▪ Moist crackles on auscultation Neuromuscular ▪ Decreased central nervous system activity, from

lethargy to coma ▪ Altered level of consciousness

▪ Fever, depending on the amount of fluid loss ▪ Headache ▪ Skeletal muscle weakness ▪ Visual disturbances

▪ Skeletal muscle weakness ▪ Paresthesias

Renal ▪ Decreased urine output ▪ Increased urine output if kidneys can compensate; decreased urine output if kidney

damage is the cause

Integumentary ▪ Dry skin ▪ Pitting edema in dependent areas ▪ Poor turgor, tenting ▪ Pale, cool skin ▪ Dry mouth Gastrointestinal ▪ Decreased motility and diminished bowel sounds ▪ Increased motility in the gastrointestinal tract ▪ Constipation ▪ Diarrhea ▪ Thirst ▪ Increased body weight ▪ Decreased body weight ▪ Liver enlargement

▪ Ascites Laboratory Findings ▪ Increased serum osmolality ▪ Decreased serum osmolality ▪ Increased hematocrit ▪ Decreased hematocrit ▪ Increased blood urea nitrogen (BUN) level ▪ Decreased BUN level ▪ Increased serum sodium level ▪ Decreased serum sodium level ▪ Increased urinary specific gravity ▪ Decreased urine specific gravity

82 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

1. Mon itor cardiovascu lar, respiratory, n eurom us- cular, ren al, in tegu m en tary, an d gastroin testin al status.

2. Preven t furth er fluid losses an d in crease fluid com partm en t volum es to n orm al ran ges.

3. Provide oral reh ydration th erap y if possible an d IV fluid replacem en t if th e deh ydration is severe; m on itor in take an d output.

4. In gen eral, isoton ic deh ydration is treated with isoton ic flu id solution s, h yperton ic deh ydration with h ypo ton ic flu id solution s, an d h ypoton ic deh ydratio n with h yperton ic flu id solution s.

5. Adm in ister m edication s, such as an tidiarrh eal, an tim icrobial, an tiem etic, an d an tipyretic m edi- cation s, as prescribed to correct th e cau se an d treat an y sym ptom s.

6. Mon itor electrolyte values an d prepare to ad m in - ister m ed ication to treat an im balan ce, if presen t.

III. Fluid Volume Excess A. Description

1. Flu id in take or fluid reten tion exceeds th e fluid n eeds of th e body.

2. Flu id volum e excess is also called overhydration or fluid overload.

3. Th e goal of treatm en t is to restore fluid balan ce, correct electrolyte im balan ces if presen t, an d elim in ate or con trol th e un d erlyin g cau se of th e overload.

B. Types 1. Iso ton ic overh ydration

a. Kn o wn as hypervolemia, isoton ic overh yd ra- tio n results from excessive fluid in th e extra- cellular fluid com partm en t.

b . On ly th e extracellular fluid com partm en t is expan ded, an d fluid does n ot sh ift between th e extracellular an d in tracellular com partm en ts.

c. Iso ton ic overh ydration causes circulatory overload an d in terstitial edem a; wh en severe or wh en it occurs in a clien t with poor cardiac fun ction , h eart failure an d pulm on ary edem a can result.

2. Hyperton ic overh yd ration a. Th e occurren ce of h yperton ic overh yd ration

is rare an d is caused by an excessive sodium in take.

b . Flu id is drawn fro m th e in tracellular fluid com partm en t; th e extracellular flu id vo lum e exp an ds, an d th e in tracellular fluid vo lum e con tracts.

3. Hypo ton ic overh ydration a. Hypo ton ic overh yd ration is kn own as water

intoxication. b . Th e excessive fluid m oves in to th e in tracellu-

lar space, an d all body fluid com partm en ts exp an d.

c. Electrolyte im balan ces occur as a result of dilution .

C. Causes 1. Iso ton ic overh ydration

a. In ad equately con trolled IV th erap y b . Kidn ey disease c. Lon g-term corticosteroid th erap y

2. Hyperton ic overh ydration a. Excessive sodium in gestion b . Rap id in fusion of h yperton ic salin e c. Excessive sodium bicarbon ate th erapy

3. Hypo ton ic overh ydration a. Early kidn ey disease b . Heart failure c. Syn drom e of in approp riate an tidiuretic h or-

m on e secretio n d . In ad equately con trolled IV th erap y e. Replacem en t of isoton ic fluid lo ss with h ypo-

ton ic fluids f. Irrigation of woun ds an d body cavities with

h ypo ton ic flu ids D. Assessm en t (see Table 8-1) E. In terven tion s

1. Mon itor cardiovascular, respiratory, n eurom us- cular, ren al, in tegu m en tary, an d gastro in testin al status.

2. Preven t furth er fluid overload an d restore n or- m al flu id balan ce.

3. Adm in ister diuretics; osm o tic diuretics m ay be prescribed in itially to preven t severe electrolyte im balan ces.

4. Restrict fluid an d sodium in take as prescribed. 5. Mon itor in take an d output; m on itor weigh t. 6. Mon itor electrolyte values, an d prepare to adm in is-

ter m edication to treat an im balan ce if presen t.

A client with acute kidney injury or chronic kidney disease is at high risk for fluid volume excess.

IV. Hypokalemia A. Description

1. Hypo kalem ia is a serum potassium level lower th an 3.5 m Eq/ L (3.5 m m ol/ L) ( Box 8-2).

2. Potassium deficit is poten tially life-th reaten in g because every body system is affected .

BOX 8-2 Potassium

Normal Value 3.5 to 5.0 mEq/ L (3.5 to 5.0 mmol/ L)

Common Food Sources Avocado, bananas, cantaloupe, oranges, strawberries,

tomatoes Carrots, mushrooms, spinach Fish, pork, beef, veal Potatoes Raisins

83CHAPTER 8 Fluids and Electrolytes

F

u

n

d

a

m

e

n

t

a

l

s

B. Causes 1. Actual total body potassium lo ss

a . Excessive use of m ed ication s such as diuretics or corticosteroid s

b . In creased secretio n of aldostero n e, such as in Cush in g’s syn dro m e

c. Vom itin g, diarrh ea d . Woun d drain age, particularly gastro in testin al e. Prolon ged n asogastric suction f. Excessive diaph o resis g. Kidn ey disease im pairin g reabsorp tio n of

potassium 2. In ad equate potassium in take: Fastin g; n oth in g

by m ou th status 3. Movem en t of potassium from th e extracellular

fluid to th e in tracellular fluid a . Alkalosis b . Hyperin sulin ism

4. Dilution of serum potassium a . Water in toxication b . IV th erapy with potassiu m -deficien t solution s

C. Assessm en t (Tables 8-2 an d 8-3) D. In terven tion s

1. Mon itor cardiovascular, respiratory, n eurom us- cular, gastro in testin al, an d ren al status, an d place th e clien t on a cardiac m on itor.

2. Mon itor electrolyte values. 3. Adm in ister potassiu m supplem en ts orally or

in traven ously, as prescribed. 4. O ral potassium supplem en ts

a . O ral potassium supplem en ts m ay cause n ausea an d vom itin g an d th ey sh ould n ot be taken on an em pty stom ach ; if th e clien t com plain s of abdom in al pain, disten tion , n ausea, vom itin g, diarrh ea, or gastroin testin al bleedin g, the sup- plem en t m ay n eed to be discon tin ued.

b . Liquid potassium ch loride h as an un pleasan t taste an d sh ould be taken with juice or an oth er liqu id.

5. In traven ously adm in istered potassium (Box 8-3) 6. In stitute safety m easures for th e clien t experien c-

in g m uscle weakn ess. 7. If th e clien t is takin g a potassium -losin g diuretic,

it m ay be discon tin ued; a potassiu m -retain in g diuretic m ay be prescribed.

8. In struct th e clien t about food s th at are h igh in potassium con ten t (see Box 8-2).

Potassium is never administered by IV push, intra- muscular, or subcutaneous routes. IV potassium is always diluted and administered using an infusion device!

V. Hyperkalemia A. Description

1. Hyperkalem ia is a serum potassium level th at exceed s 5.0 m Eq/ L (5.0 m m o l/ L) (see Box 8-2).

2. Pseudo h yperkalem ia: a con d ition th at can occur due to m eth od s of blood specim en collection an d cell lysis; if an in creased serum value is obtain ed in th e absen ce of clin ical sym pto m s, th e speci- m en sh ould be redrawn an d evaluated.

B. Causes 1. Excessive potassiu m in take

a . O verin gestion of potassium -con tain in g foods or m edication s, such as potassium ch loride or salt substitutes

b . Rapid in fusio n of potassium -con tain in g IV solution s

2. Decreased potassium excretio n

TABLE 8-2 Assessment Findings: Hypokalemia and Hyperkalemia

Hypokalemia Hyperkalemia

Cardiovascular ▪ Thready, weak, irregular pulse ▪ Slow, weak, irregular heart rate ▪ Weak peripheral pulses ▪ Decreased blood pressure ▪ Orthostatic hypotension Respiratory ▪ Shallow, ineffective

respirations that result from profound weakness of the skeletal muscles of respiration

▪ Profound weakness of the skeletal muscles leading to respiratory failure

▪ Diminished breath sounds Neuromuscular ▪ Anxiety, lethargy, confusion,

coma ▪ Early: Muscle twitches,

cramps, paresthesias (tingling and burning followed by numbness in the hands and feet and around the mouth)

▪ Skeletal muscle weakness, leg cramps

▪ Late: Profound weakness, ascending flaccid paralysis in the arms and legs (trunk, head, and respiratory muscles become affected when the serum potassium level reaches a lethal level)

▪ Loss of tactile discrimination ▪ Paresthesias ▪ Deep tendon hyporeflexia Gastrointestinal ▪ Decreased motility, hypoactive

to absent bowel sounds ▪ Increased motility,

hyperactive bowel sounds ▪ Nausea, vomiting,

constipation, abdominal distention

▪ Diarrhea

▪ Paralytic ileus Laboratory Findings ▪ Serum potassium level lower

than 3.5 mEq/ L (3.5 mmol/ L) ▪ Serum potassium level that

exceeds 5.0 mEq/ L (5.0 mmol/ L)

▪ Electrocardiogram changes: ST depression; shallow, flat, or inverted T wave; and prominent U wave

▪ Electrocardiographic changes: Tall peaked T waves, flat P waves, widened QRS complexes, and prolonged PR intervals

84 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

a. Potassium -retain in g diuretics b . Kid n ey disease c. Adren al in sufficien cy, such as in Addison ’s

disease 3. Movem en t of potassium from th e in tracellular

flu id to th e extracellular fluid a. Tissue dam age b . Acidosis c. Hyperuricem ia d . Hypercatabo lism

C. Assessm en t (see Tables 8-2 an d 8-3)

Monitor the client closely for signs of a potassium imbalance. A potassium imbalance can cause cardiac dysrhythmias that can be life-threatening!

D. In terven tion s 1. Mon itor cardiovascular, respiratory, n eurom us-

cular, ren al, an d gastroin testin al status; place th e clien t on a cardiac m on itor.

2. Discon tin ue IVpotassium (keep th e IVcath eter pat- en t), and with h old oral potassium supplem en ts.

3. In itiate a potassium -restricted diet. 4. Prepare to adm in ister potassium -excretin g

diuretics if ren al fun ction is n ot im paired. 5. If ren al fun ction is im paired, prepare to adm in ister

sodium polystyren e sulfon ate (oral or rectal route), a cation -exch ange resin th at prom otes gastroin testi- nal sodium absorption an d potassium excretion .

6. Prepare th e clien t for dialysis if potassiu m levels are critically h igh .

7. Prepare for th e adm in istration of IV calcium if h yperkalem ia is severe, to avert m yocardial excitability.

8. Prepare for th e IV ad m in istration of h yperton ic gluco se with regular in sulin to m ove excess potassium in to th e cells.

9. Wh en blood tran sfusion s are prescribed for a cli- en t with a potassiu m im balan ce, th e clien t sh ould receive fresh blood , if possible; tran sfu- sion s of stored blood m ay elevate th e potassium level because th e breakd own of older blood cells releases potassium .

10. Teach th e clien t to avoid foods h igh in potassium (see Box 8-2).

11. In struct th e clien t to avoid th e use of salt substi- tutes or oth er potassium -con tain in g substan ces.

Monitor the serum potassium level closely when a client is receiving a potassium-retaining diuretic!

VI. Hyponatremia A. Description

1. Hypo n atrem ia is a serum sodium level lower th an 135 m Eq/ L (135 m m o l/ L) ( Box 8-4).

TABLE 8-3 Electrocardiographic Changes in Electrolyte Imbalances

Electrolyte Imbalance Electrocardiographic Changes

Hypocalcemia Prolonged ST segment Prolonged QT interval

Hypercalcemia Shortened ST segment Widened T wave

Hypokalemia ST depression Shallow, flat, or inverted T wave Prominent U wave

Hyperkalemia Tall peaked T waves Flat P waves Widened QRS complexes Prolonged PR interval

Hypomagnesemia Tall T waves Depressed ST segment

Hypermagnesemia Prolonged PR interval Widened QRS complexes

BOX 8-3 Precautions with Intravenously Administered Potassium

▪ Potassium is never given by intravenous (IV) push or by the intramuscular or subcutaneous route.

▪ A dilution of no more than 1 mEq/ 10 mL (1 mmol/ 10 mL) of solution is recommended.

▪ Many health care agencies supply prepared IVsolutions con- taining potassium; before administering and frequently dur- ing infusion of the IV solution, rotate and invert the bag to ensure that the potassium is distributed evenly throughout the IV solution.

▪ Ensure that the IV bag containing potassium is properly labeled.

▪ The maximum recommended infusion rate is 5 to 10 mEq/ hour (5 to 10 mmol/ hour), never to exceed 20 mEq/ hour (20 mmol/ hour) under any circumstances.

▪ A client receiving more than 10 mEq/ hour (10 mmol/ hour) should be placed on a cardiac monitor and monitored for cardiac changes, and the infusion should be controlled by an infusion device.

▪ Potassium infusion can cause phlebitis; therefore, the nurse should assess the IV site frequently for signs of phlebitis or infiltration. If either occurs, the infusion should be stopped immediately.

▪ The nurse should assess renal function before administering potassium, and monitor intake and output during administration.

85CHAPTER 8 Fluids and Electrolytes

2. Sodium im balan ces usually are associated with fluid vo lum e im balan ces.

B. Causes 1. In creased sodium excretion

a . Excessive diaph o resis b . Diuretics c. Vom itin g d . Diarrh ea e. Woun d drain age, especially gastroin testin al f. Kidn ey disease g. Decreased secretio n of aldo steron e

2. In ad equate sodium in take a . Fastin g; n oth in g by m ou th status b . Low-salt diet

3. Dilution of serum sodium a . Excessive in gestion of h ypoton ic flu ids or irri-

gation with h ypo ton ic fluids b . Kidn ey disease c. Fresh water drown in g d . Syn drom e of in approp riate an tidiuretic h or-

m on e secretio n e. Hyperglycem ia f. Heart failure

C. Assessm en t (Table 8-4) D. In terven tion s

1. Mon itor cardiovascular, respiratory, n eurom us- cular, cerebral, ren al, an d gastro in testin al status.

2. If h ypo n atrem ia is acco m pan ied by a fluid vol- ume deficit (h ypovolem ia), IV sodium ch loride in fusion s are ad m in istered to restore sodium con ten t an d fluid vo lum e.

3. If h ypon atrem ia is acco m pan ied by fluid volume excess (h ypervolem ia), osm o tic diuretics m ay be prescribed to prom ote th e excretion of water rath er th an sodium .

4. If caused by in approp riate or excessive secretio n of an tidiuretic h orm on e, m ed ication s th at an tagon ize an tidiuretic h orm on e m ay be adm in istered.

5. In struct th e clien t to in crease oral sodium in take as prescribed an d in form th e clien t about th e food s to in clude in th e diet (see Box 8-4).

6. If th e clien t is takin g lith ium , m on itor th e lith ium level, because h ypon atrem ia can cause dim in - ish ed lithium excretion , resultin g in toxicity.

Hyponatremia precipitates lithium toxicity in a client taking lithium.

VII. Hypernatremia A. Description : Hypern atrem ia is a serum sodium level

that exceeds 145 m Eq/ L (145 m m ol/ L) (see Box 8-4). B. Causes

1. Decreased sodium excretion a . Corticostero ids b . Cush in g’s syn dro m e c. Kidn ey disease d . Hyperaldostero n ism

2. In creased sodium in take: Excessive oral sodium in gestion or excessive adm in istration of sodium -con tain in g IV fluid s

3. Decreased water in take: Fastin g; n oth in g by m ou th status

4. In creased water loss: In creased rate of metabo- lism, fever, h yperven tilatio n , in fectio n , excessive diaph o resis, watery diarrh ea, diabetes in sipidus

C. Assessm en t (see Table 8-4) D. In terven tion s

1. Mo n ito r card io vascu lar, resp irato ry, n eu ro - m u scu lar, cereb ral, ren al, an d in tegu m en tary statu s.

2. If th e cau se is fluid lo ss, prepare to adm in ister IV in fusion s.

3. If th e cause is in adequate ren al excretion of sodium , prepare to ad m in ister diuretics th at pro- m ote sodium loss.

4. Restrict sodium an d fluid in take as prescribed (see Box 8-4).

VIII. Hypocalcemia A. Descrip tion : Hypo calcem ia is a serum calcium level

lower th an 9.0 m g/ dL (2.25 m m o l/ L) (Box 8-5). B. Causes

1. In h ibition of calcium absorption from th e gas- troin testin al tract a . In adequ ate oral in take of calcium b . Lactose in toleran ce c. Malab sorption syn dro m es such as celiac

sprue or Cro h n ’s disease d . In adequ ate in take of vitam in D e. En d-stage kidn ey disease

2. In creased calcium excretion a . Kidn ey disease, polyuric ph ase b . Diarrh ea c. Steatorrh ea d . Woun d drain age, especially gastro in testin al

F

u

n

d

a

m

e

n

t

a

l

s

BOX 8-4 Sodium

Normal Value 135 to 145 mEq/ L (135 to 145 mmol/ L)

Common Food Sources Bacon, frankfurters, lunch meat Butter, cheese Canned food Ketchup, mustard Milk Processed food Snack foods Soy sauce Table salt

86 UNIT III Nursing Sciences

3. Con dition s th at decrease th e ion ized fraction of calcium a. Hyperprotein em ia b . Alkalosis c. Med ication s such as calcium ch elato rs or

bin d ers d . Acute pan creatitis e. Hyperph osph atem ia f. Im m obility g. Rem o val or destruction of th e parath yroid

glan d s C. Assessm en t (Table 8-5 an d Fig. 8-3; also see

Table 8-3) D. In terven tion s

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 8-4 Assessment Findings: Hyponatremia and Hypernatremia Hyponatremia Hypernatremia

Cardiovascular ▪ Symptoms vary with changes in vascular volume ▪ Heart rate and blood pressure respond to vascular

volume status ▪ Normovolemic: Rapid pulse rate, normal blood pressure ▪ Hypovolemic: Thready, weak, rapid pulse rate; hypotension; flat neck veins; normal or

low central venous pressure ▪ Hypervolemic: Rapid, bounding pulse; blood pressure normal or elevated; normal or

elevated central venous pressure

Respiratory ▪ Shallow, ineffective respiratory movement is a late manifestation related to skeletal

muscle weakness ▪ Pulmonary edema if hypervolemia is present

Neuromuscular ▪ Generalized skeletal muscle weakness that is worse in the extremities ▪ Early: Spontaneous muscle twitches; irregular muscle

contractions ▪ Diminished deep tendon reflexes ▪ Late: Skeletal muscle weakness; deep tendon reflexes

diminished or absent

Central Nervous System ▪ Headache ▪ Altered cerebral function is the most common

manifestation of hypernatremia ▪ Personality changes ▪ Normovolemia or hypovolemia: Agitation, confusion,

seizures ▪ Confusion ▪ Hypervolemia: Lethargy, stupor, coma ▪ Seizures ▪ Coma Gastrointestinal ▪ Increased motility and hyperactive bowel sounds ▪ Extreme thirst ▪ Nausea ▪ Abdominal cramping and diarrhea Renal ▪ Increased urinary output ▪ Decreased urinary output Integumentary ▪ Dry mucous membranes ▪ Dry and flushed skin

▪ Dry and sticky tongue and mucous membranes ▪ Presence or absence of edema, depending on fluid

volume changes

Laboratory Findings ▪ Serum sodium level less than 135 mEq/ L (135 mmol/ L) ▪ Serum sodium level that exceeds 145 mEq/ L (145 mmol/ L) ▪ Decreased urinary specific gravity ▪ Increased urinary specific gravity

BOX 8-5 Calcium

Normal Value 9.0 to 10 .5 mg/ dL (2.25 to 2.75 mmol/ L)

Common Food Sources Cheese Collard greens Kale Milk and soy milk Rhubarb Sardines Tofu Yogurt

87CHAPTER 8 Fluids and Electrolytes

F

u

n

d

a

m

e

n

t

a

l

s

1. Mon itor cardiovascular, respiratory, n eurom us- cular, an d gastro in testin al status; place th e clien t on a cardiac m on itor.

2. Adm in ister calcium supplem en ts orally or cal- ciu m in traven ously.

3. Wh en adm in isterin g calcium in traven ously, warm th e in jection solution to body tem perature before adm in istration an d adm in ister slowly; m on itor for electrocardiograph ic ch an ges, observe for infiltra- tion, an d m on itor for h ypercalcem ia.

4. Adm in ister m edication s th at in crease calcium absorption .

a . Alum in um h ydroxide reduces phosphorus levels, causin g th e coun tereffect of in creasin g calcium levels.

b . Vitam in D aids in th e absorption of calcium from th e in testin al tract.

5. Provid e a quiet en viron m en t to reduce en viron - m en tal stim uli.

6. In itiate seizure precaution s. 7. Move th e clien t carefully, an d m on itor for sign s

of a path olo gical fracture. 8. Keep 10% calcium gluco n ate available for treat-

m en t of acu te calcium deficit.

TABLE 8-5 Assessment Findings: Hypocalcemia and Hypercalcemia Hypocalcemia Hypercalcemia

Cardiovascular ▪ Decreased heart rate ▪ Increased heart rate in the early phase; bradycardia that

can lead to cardiac arrest in late phases ▪ Hypotension ▪ Increased blood pressure ▪ Diminished peripheral pulses ▪ Bounding, full peripheral pulses Respiratory ▪ Not directly affected; however, respiratory failure or arrest can result from decreased

respiratory movement because of muscle tetany or seizures ▪ Ineffective respiratory movement as a result of profound

skeletal muscle weakness

Neuromuscular ▪ Irritable skeletal muscles: Twitches, cramps, tetany, seizures ▪ Profound muscle weakness ▪ Painful muscle spasms in the calf or foot during periods of inactivity ▪ Diminished or absent deep tendon reflexes ▪ Paresthesias followed by numbness that may affect the lips, nose, and ears in

addition to the limbs ▪ Disorientation, lethargy, coma

▪ Positive Trousseau’s and Chvostek’s signs ▪ Hyperactive deep tendon reflexes ▪ Anxiety, irritability Renal ▪ Urinary output varies depending on the cause ▪ Urinary output varies depending on the cause Gastrointestinal ▪ Increased gastric motility; hyperactive bowel sounds ▪ Decreased motility and hypoactive bowel sounds ▪ Cramping, diarrhea ▪ Anorexia, nausea, abdominal distention, constipation Laboratory Findings ▪ Serum calcium level less than 9.0 mg/ dL (2.25 mmol/ L) ▪ Serum calcium level that exceeds 10.5 mg/ dL

(2.75 mmol/ L) ▪ Electrocardiographic changes: Prolonged ST interval, prolonged QT interval ▪ Electrocardiographic changes: Shortened ST segment,

widened T wave

A B C FIGURE 8-3 Tests for hypocalcemia. A, Chvostek’s sign is contraction of facial muscles in response to a light tap over the facial nerve in front of the ear. B, Trousseau’s sign is a carpal spasm induced by inflating a blood pressure cuff (C) above the systolic pressure for a few minutes.

88 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

9. In struct th e clien t to con sum e foods h igh in cal- ciu m (see Box 8-5).

IX. Hypercalcemia A. Description : Hypercalcem ia is a serum calcium level

th at exceeds 10.5 m g/ dL (2.75 m m ol/ L) (see Box 8-5). B. Causes

1. In creased calcium absorption a. Excessive oral in take of calcium b . Excessive oral in take of vitam in D

2. Decreased calcium excretion a. Kid n ey disease b . Use of th iazide diuretics

3. In creased bon e resorptio n of calcium a. Hyperparath yroidism b . Hyperth yroidism c. Malign an cy (bo n e destruction from m eta-

static tum ors) d . Im m obility e. Use of gluco cortico ids

4. Hem o con cen tration a. Deh ydration b . Use of lith iu m c. Adren al in sufficien cy

C. Assessm en t (see Tables 8-3 an d 8-5) D. In terven tion s

1. Mon itor cardiovascu lar, respiratory, n eurom us- cular, ren al, an d gastro in testin al status; place th e clien t on a cardiac m on itor.

2. Discon tin ue IV in fusio n s of solution s con tain in g calcium an d oral m ed ication s con tain in g cal- ciu m or vitam in D.

3. Th iazide diuretics m ay be discon tin ued an d replaced with diuretics th at en h an ce th e excre- tio n of calcium .

4. Adm in ister m ed ication s as prescribed th at in h ibit calcium resorption from th e bon e, such as ph osph orus, calciton in , bisph osp h on ates, an d prostaglan din syn th esis in h ibitors (acetylsa- licylic acid, n on steroidal an tiin flam m ato ry m ed ication s) .

5. Prepare th e clien t with severe h ypercalcem ia for dialysis if m edication s fail to reduce th e serum calcium level.

6. Move th e clien t carefully an d m on itor for sign s of a path ological fracture.

7. Mon itor for flan k or abdom in al pain , an d strain th e urin e to ch eck for th e presen ce of urin ary ston es.

8. In struct th e clien t to avoid food s h igh in calcium (see Box 8-5).

A client with a calcium imbalance is at risk for a pathological fracture. Move the client carefully and slowly; assist the client with ambulation.

X. Hypomagnesemia A. Description : Hypom agnesem ia is a serum magnesium

level lower th an 1.3 m Eq/L (0.65 m m ol/ L) (Box 8-6).

B. Causes 1. In sufficien t m agn esium in take

a. Maln utrition an d starvation b . Vom itin g or diarrh ea c. Malab sorption syn drom e d . Celiac disease e. Croh n ’s disease

2. In creased m agn esium excretio n a. Med ication s such as diuretics b . Ch ron ic alcoh olism

3. In tracellular m ovem en t of m agn esium a. Hyperglycem ia b . In sulin adm in istration c. Sepsis

C. Assessm en t ( Table 8-6; also see Table 8-3) D. In terven tion s

1. Mon itor cardiovascular, respiratory, gastro in tes- tin al, n eurom uscular, an d cen tral n ervou s sys- tem status; place th e clien t on a cardiac m on itor.

2. Because h ypo calcem ia frequen tly acco m pan ies h ypo m agn esem ia, in terven tion s also aim to restore n orm al serum calcium levels.

3. O ral preparatio n s of m agn esium m ay cau se diar- rh ea an d in crease m agn esium loss.

4. Magn esium sulfate by th e IV route m ay be pre- scribed in ill clien ts wh en the m agn esium level is low (in tram uscular injection s cause pain an d tis- sue dam age); in itiate seizure precaution s, m on itor serum m agn esium levels frequen tly, an d m on itor for dim in ish ed deep ten don reflexes, suggestin g hyperm agn esem ia, durin g th e adm in istration of m agn esium .

5. In struct th e clien t to in crease th e in take of foods th at con tain m agn esium (see Box 8-6).

XI. Hypermagnesemia A. Description : Hyperm agn esem ia is a serum magne-

sium level th at exceeds 2.1 m Eq/ L (1.05 m m ol/ L) (see Box 8-6).

BOX 8-6 Magnesium

Normal Value 1.3 to 2.1 mEq/ L (0.65 to 1.0 5 mmol/ L)

Common Food Sources Avocado Canned white tuna Cauliflower Green leafy vegetables, such as spinach and broccoli Milk Oatmeal, wheat bran Peanut butter, almonds Peas Pork, beef, chicken, soybeans Potatoes Raisins Yogurt

89CHAPTER 8 Fluids and Electrolytes

B. Causes 1. In creased m agn esium in take

a . Magn esium -co n tain in g an tacids an d laxatives b . Excessive adm in istration of m agn esium

in traven ously 2. Decreased ren al excretion of m agn esium as a

result of ren al in sufficien cy C. Assessm en t (see Tables 8-3 an d 8-6) D. In terven tion s

1. Mon itor cardiovascular, respiratory, n eurom us- cular, an d cen tral n ervou s system status; place th e clien t on a cardiac m on itor.

2. Diuretics are prescribed to in crease ren al excre- tion of m agn esium .

3. In traven o u sly ad m in istered calciu m ch lo rid e o r calciu m glu co n ate m ay b e p rescrib ed to reverse th e effects o f m agn esiu m o n card iac m u scle.

4. In struct th e clien t to restrict dietary in take of m agn esium -co n tain in g food s (see Box 8-6).

5. In struct th e clien t to avoid th e use of laxatives an d an tacids con tain in g m agn esium .

Calcium gluconate is the antidote for magnesium overdose.

XII. Hypophosphatemia A. Descrip tion

1. Hypoph osph atem ia is a serum phosphorus (ph osph ate) level lower th an 3.0 m g/ dL (0.97 m m o l/ L) (Box 8-7).

2. A decrease in th e serum ph osph orus level is acco m pan ied by an in crease in th e serum calcium level.

B. Causes 1. In sufficien t ph o sph orus in take: Malnutrition an d

starvation 2. In creased ph osph orus excretion

a . Hyperparath yroidism b . Malign an cy c. Use of magnesium-based or alum in um

h ydroxide–based an tacids 3. In tracellular sh ift

a . Hyperglycem ia b . Respiratory alkalosis

C. Assessm en t 1. Card iovascular

a . Decreased con tractility an d cardiac output b . Slowed periph eral pulses

2. Resp iratory: Sh allow respiration s 3. Neurom u scular

a . Weakn ess b . Decreased deep ten don reflexes c. Decreased bon e den sity th at can cause frac-

tures an d alteration s in bon e sh ape d . Rh abd om yolysis

4. Cen tral n ervou s system a . Irritability b . Con fusion c. Seizu res

5. Hem atological a . Decreased platelet aggregation an d in creased

bleedin g b . Im m un osuppression

D. In terven tion s 1. Mon itor cardiovascular, respiratory, n eurom u s-

cular, cen tral n ervous system , an d h em atological status.

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 8-6 Assessment Findings: Hypomagnesemia and Hypermagnesemia

Hypomagnesemia Hypermagnesemia

Cardiovascular ▪ Tachycardia ▪ Bradycardia, dysrhythmias ▪ Hypertension ▪ Hypotension Respiratory ▪ Shallow respirations ▪ Respiratory insufficiency

when the skeletal muscles of respiration are involved

Neuromuscular ▪ Twitches, paresthesias ▪ Diminished or absent deep

tendon reflexes ▪ Positive Trousseau’s and

Chvostek’s signs ▪ Skeletal muscle weakness

▪ Hyperreflexia ▪ Tetany, seizures Central Nervous System ▪ Irritability ▪ Drowsiness and lethargy that

progresses to coma ▪ Confusion Laboratory Findings ▪ Serum magnesium level

less than 1.3 mEq/ L (0.65 mmol/ L)

▪ Serum magnesium level that exceeds 2.1 mEq/ L (1.05 mmol/ L)

▪ Electrocardiographic changes: Tall T waves, depressed ST segments

▪ Electrocardiographic changes: Prolonged PR interval, widened QRS complexes

BOX 8-7 Phosphorus (Phosphate)

Normal Value 3.0 to 4.5 mg/ dL (0 .97 to 1.45 mmol/ L)

Common Food Sources Dairy products Fish Nuts Pork, beef, chicken, organ meats Pumpkin, squash Whole-grain breads and cereals

90 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

2. Discon tin ue m edication s th at con tribu te to h ypo ph osph atem ia.

3. Adm in ister ph o sph orus orally alon g with a vita- m in D supp lem en t.

4. Prepare to adm in ister ph osph orus in traven ously wh en serum ph o sph orus levels fall below 1 m g/ dL an d wh en th e clien t exp erien ces critical clin i- cal m an ifestation s.

5. Adm in ister IV ph osph orus slowly because of th e risks associated with h yperph osph atem ia.

6. Assess th e ren al system before adm in isterin g ph o sph orus.

7. Move th e clien t carefully, an d m on itor for sign s of a path o logical fracture.

8. In struct th e clien t to in crease th e intake of the ph osph orus-con tain in g foods while decreasin g th e in take of any calcium -con tain in g foods (see Boxes 8-5 an d 8-7).

A decrease in the serum phosphorus level is accom- panied by an increase in the serum calcium level, and an increase in the serum phosphorus level is accompanied by a decrease in the serum calcium level. This is called a reciprocal relationship.

XIII. Hyperphosphatemia A. Description

1. Hyperph osph atem ia is a serum phosphorus level th at exceed s 4.5 m g/ dL (1.45 m m o l/ L) (see Box 8-7).

2. Most body system s tolerate elevated serum ph o s- ph o rus levels well.

3. An in crease in th e serum ph o sph orus level is acco m pan ied by a decrease in th e serum calcium level.

4. Th e problem s th at occur in h yperph osph atem ia cen ter on th e h ypo calcem ia th at results wh en serum ph osph orus levels in crease.

B. Causes 1. Decreased ren al excretion resultin g from ren al

in sufficien cy 2. Tu m or lysis syn d rom e 3. In creased in take of ph osph orus, in cludin g die-

tary in take or overuse of ph o sph ate-con tain in g laxatives or en em as

4. Hypo parath yroidism C. Assessm en t: Refer to assessm en t of h ypo calcem ia. D. In terven tion s

1. In terven tion s en tail th e m an agem en t of h ypo calcem ia.

2. Adm in ister ph osph ate-bin din g m edication s th at in crease fecal excretion of ph osph orus by bin din g ph osph orus from food in th e gastroin testin al tract.

3. In struct the clien t to avoid ph osph ate-con tainin g- m edication s, in cludin g laxatives an d en em as.

4. In struct th e clien t to decrease th e in take of food th at is h igh in ph osph orus (see Box 8-7).

5. In struct th e clien t in m ed ication adm in istration : Take ph osph ate-bin din g m ed ication s, em ph asiz- in g th at th ey sh ould be taken with m eals or im m ediately after m eals.

CRITICAL THINKING What Should You Do? Answer: Cardiac changes in hypokalemia include impaired repolarization, resulting in a flattening of the T wave and eventually the emergence of a U wave. Therefore, the nurse should suspect hypokalemia. The incidence of potentially lethal ventricular dysrhythmias is increased in hypokalemia. The nurse should immediately assess the client’s vital signs and cardiac status for signs of hypokalemia. The nurse should also check the client’s most recent serum potassium level and then contact the health care provider to report the findings and obtain prescriptions to treat the hypokalemic state.

Reference: Lewis et al. (20 14), pp. 297–298.

P R A C T I C E Q U E S T I O N S

36. Th e n urse is carin g for a clien t with h eart failure. O n assessm en t, th e n urse n otes th at the clien t is dys- pn eic, an d crackles are audible on auscultation . Wh at additional m an ifestation s would th e n urse expect to n ote in th is clien t if excess fluid volum e is presen t? 1. Weigh t loss an d dry skin 2. Flat n eck an d h an d vein s an d decreased urin ary

outp ut 3. An in crease in blood pressure an d in creased

respiratio n s 4. Weakn ess an d decreased cen tral ven o us

pressure (CVP)

37. Th e n urse is preparin g to care for a clien t with a potassium deficit. Th e n urse reviews th e clien t’s record an d determ in es th at th e clien t is at risk for developin g th e potassium deficit because of wh ich situation ? 1. Sustain ed tissue dam age 2. Requ ires n aso gastric suction 3. Has a h isto ry of Addison ’s disease 4. Uric acid level of 9.4 m g/ dL (559 µm ol/ L)

38. Th e n urse reviews a clien t’s electrolyte laboratory report an d n otes th at the potassium level is 2.5 m Eq/ L (2.5 m m ol/ L). Wh ich patterns sh ould th e nurse watch for on th e electrocardiogram (ECG) as a result of th e laboratory value? Select all th at ap p ly.

1. U waves 2. Absen t P waves 3. In verted T waves 4. Depressed ST segm en t 5. Widen ed Q RS com plex

91CHAPTER 8 Fluids and Electrolytes

F

u

n

d

a

m

e

n

t

a

l

s

39. Potassium ch loride in traven o usly is prescribed for a clien t with h ypo kalem ia. Wh ich action s sh ould th e n urse take to plan for preparatio n an d ad m in istra- tion of th e potassium ? Select all th at ap p ly.

1. O btain an in traven o us (IV) in fusio n pum p. 2. Mon itor urin e output durin g adm in istration . 3. Prepare th e m edication for bolus

ad m in istration . 4. Mon itor th e IV site for sign s of in filtration or

ph lebitis. 5. En sure th at th e m edication is diluted in th e

appropriate vo lum e of fluid. 6. En su re th at th e bag is labeled so th at it reads

th e vo lum e of potassium in th e solution .

40. Th e n urse provides in struction s to a clien t with a low potassium level about th e foods th at are h igh in potassium an d tells th e clien t to con sum e wh ich food s? Select all th at ap p ly.

1. Peas 2. Raisin s 3. Potatoes 4. Can taloup e 5. Cauliflower 6. Strawberries

41. Th e n u rse is reviewin g lab o rato ry resu lts an d n o tes th at a clien t’s seru m so d iu m level is 150 m Eq / L ( 150 m m o l/ L) . Th e n u rse rep o rts th e seru m so d iu m level to th e h ealth care p ro vid er ( H CP) an d th e H CP p rescrib es d ietary in stru ctio n s b ased o n th e so d iu m level. Wh ich accep tab le fo o d item s d o es th e n u rse in stru ct th e clien t to co n su m e? Select all th at ap p ly.

1. Peas 2. Nu ts 3. Ch eese 4. Cauliflower 5. Processed oat cereals

42. Th e n urse is assessin g a clien t with a suspected diag- n osis of h ypocalcem ia. Wh ich clin ical m an ifestation would th e n urse expect to n ote in th e clien t? 1. Twitch in g 2. Hypo active bowel soun ds 3. Negative Trousseau’s sign 4. Hypoactive deep ten don reflexes

43. Th e n urse is carin g for a clien t with h ypo calcem ia. Wh ich pattern s would th e n urse watch for on th e electrocardiogram as a result of th e labo ratory value? Select all th at ap p ly.

1. U waves 2. Widen ed T wave 3. Prom in en t U wave 4. Prolon ged Q T in terval 5. Prolon ged ST segm en t

44. Th e n urse reviews th e electrolyte results of an assign ed clien t an d n otes th at th e potassium level is 5.7 m Eq/ L (5.7 m m o l/ L). Wh ich pattern s would th e n urse watch for on th e cardiac m on itor as a result of th e labo ratory value? Select all th at ap p ly.

1. ST depression 2. Prom in en t U wave 3. Tall peaked T waves 4. Prolon ged ST segm en t 5. Widen ed Q RS co m plexes

45. Wh ich clien t is at risk for th e developm en t of a sodium level at 130 m Eq/ L (130 m m ol/ L)? 1. Th e clien t wh o is takin g diuretics 2. Th e clien t with h yperaldosteron ism 3. Th e clien t with Cush in g’s syn d rom e 4. Th e clien t wh o is takin g corticosteroid s

46. Th e n urse is carin g for a clien t with h eart failure wh o is receivin g h igh doses of a diuretic. O n assessm en t, th e n urse n otes th at th e clien t h as flat n eck vein s, gen eralized m uscle weakn ess, an d dim in ish ed deep ten don reflexes. Th e n urse suspects h ypon atrem ia. Wh at ad dition al sign s would th e n urse expect to n ote in a clien t with h ypo n atrem ia? 1. Muscle twitch es 2. Decreased urin ary outp ut 3. Hyperactive bowel soun ds 4. In creased specific gravity of th e urin e

47. Th e n urse reviews a clien t’s labo ratory report an d n otes th at th e clien t’s serum ph osph orus (ph os- ph ate) level is 1.8 m g/ dL (0.45 m m o l/ L). Wh ich con d ition m o st likely caused th is serum ph osph o- rus level? 1. Maln utrition 2. Ren al in sufficien cy 3. Hypo parath yroidism 4. Tum or lysis syn drom e

48. Th e n urse is readin g a h ealth care provider’s (HCP’s) progress n otes in th e clien t’s record an d reads th at th e HCP h as docum en ted “in sen sible flu id loss of approxim ately 800 m L daily.” Th e n urse m akes a n otatio n th at in sen sible fluid loss occurs th rough wh ich type of excretion ? 1. Urin ary outp ut 2. Woun d drain age 3. In tegum en tary outp ut 4. Th e gastro in testin al tract

49. Th e n urse is assign ed to care for a grou p of clien ts. O n review of th e clien ts’ m edical records, th e n urse determ in es th at wh ich clien t is m o st likely at risk for a fluid vo lum e deficit? 1. A clien t with an ileostom y 2. A clien t with h eart failure

92 UNIT III Nursing Sciences

3. A clien t on lo n g-term corticosteroid th erap y 4. A clien t receivin g frequen t woun d irrigation s

50. Th e n urse carin g for a clien t wh o h as been receivin g in traven ous (IV) diuretics susp ects th at th e clien t is exp erien cin g a flu id volum e deficit. Wh ich assess- m en t fin din g would th e n urse n ote in a clien t with th is con dition ? 1. Weigh t loss an d poor skin turgor 2. Lun g con gestion an d in creased h eart rate 3. Decreased h em atocrit an d in creased urin e outp ut 4. In creased respiration s an d in creased blood

pressure

51. O n review of th e clien ts’ m ed ical records, th e n urse determ in es th at wh ich clien t is at risk for flu id vol- um e excess?

1. Th e clien t takin g diuretics an d h as ten tin g of th e skin

2. Th e clien t with an ileostom y fro m a recen t ab dom in al surgery

3. Th e clien t wh o requires in term itten t gastro in tes- tin al suction in g

4. Th e clien t with kidn ey disease an d a 12-year h is- tory of diabetes m ellitus

52. Wh ich clien t is at risk for th e developm en t of a potassium level of 5.5 m Eq/ L (5.5 m m o l/ L)? 1. Th e clien t with colitis 2. Th e clien t with Cush in g’s syn d rom e 3. Th e clien t wh o h as been overusin g laxatives 4. Th e clien t wh o h as sustain ed a traum atic burn

A N S W E R S 36. 3 Ra t ion a le: A flu id volu m e excess is also kn o wn as overhydration or fluid overload an d o ccurs wh en fluid in take o r fluid reten tion exceeds th e fluid n eeds of th e bo dy. Assessm en t fin d in gs asso- ciated with flu id vo lu m e excess in clud e co ugh , d ysp n ea, crackles, tach ypn ea, tach ycard ia, elevated blo od p ressure, bo un din g p ulse, elevated CVP, weigh t gain , edem a, n eck an d h an d vein d isten tio n , altered level o f co n scio usn ess, an d decreased h em atocrit. Dry skin , flat n eck an d h an d vein s, decreased urin ary o utp ut, an d decreased CVP are n oted in fluid vo lu m e d eficit. Weakn ess can be p resen t in eith er flu id volum e excess o r d eficit. Test -Ta kin g St r a t egy: Focu s on th e su b ject , flu id vo lum e excess. Rem em b er th at wh en th ere is m ore th an on e part to an op tion , all p arts n eed to be correct in o rd er fo r th e o ptio n to be co rrect. Th in k ab ou t th e path o ph ysiology asso ciated with a flu id vo lum e excess to assist in directin g you to th e co rrect op tion . Also, n o te th at th e in correct o p tion s are co m p a r a b le o r a lik e in th at each in clud es m an ifestatio n s th at reflect a decrease. Review: Th e assessm en t fin din gs n o ted in flu id vo lu m e excess Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Fluids & Electro lytes Pr ior ity Con cepts: Flu id an d Electrolytes; Perfusion Refer en ces: Ign ataviciu s, Wo rkm an (2016), p p. 158–159; Lewis et al. (2014), p p. 292–293.

37. 2 Ra t ion a le: Th e n o rm al serum p otassium level is 3.5 to 5.0 m Eq / L ( 3.5 to 5.0 m m ol/ L) . A p otassiu m d eficit is kn own as hypokalemia. Po tassium -rich gastroin testin al fluids are lost th ro ugh gastroin testin al su ctio n , placin g th e clien t at risk for h ypo kalem ia. Th e clien t with tissue dam age o r Ad dison ’s dis- ease an d th e clien t with h yp eru ricem ia are at risk for h yperkale- m ia. Th e n o rm al uric acid level for a fem ale is 2.7 to 7.3 m g/ dL (0.16 to 0.43 m m o l/ L) an d fo r a m ale is 4.0 to 8.5 m g/ dL ( 0.24 to 0.51 m m ol/ L) . Hyp eru ricem ia is a cau se o f h yp erkalem ia.

Test -Ta kin g Str a tegy: No te th at th e su b ject o f th e qu estio n is p o tassium deficit. First recall th e n orm al uric acid levels an d th e causes of h yp okalem ia to assist in elim in atin g o p tion 4. Fo r th e rem ain in g op tio n s, n o te th at th e correct o p tion is th e on ly o n e th at iden tifies a loss o f bo dy fluid . Review: Th e cau ses of h yp o k a lem ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Fluid s & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), pp . 296, 1211.

38. 1, 3, 4 Ra t ion a le: Th e n orm al serum potassium level is 3.5 to 5.0 m Eq/ L (3.5 to 5.0 m m ol/ L). Aserum potassium level lower th an 3.5 m Eq/ L (3.5 m m ol/ L) in dicates h ypokalem ia. Potassium deficit is an electrolyte im balan ce th at can be poten tially life-th reaten in g. Elec- trocardiograph ic ch an ges in clude sh allow, flat, or in verted Twaves; STsegm ent depression ;and prom inent U waves.Absent P wavesare n ot a characteristicofh ypokalem ia but m aybe n oted in a client with atrial fibrillation , jun ction al rh yth m s, or ven tricular rh yth m s. A widen ed Q RS com plex m ay be n oted in h yperkalem ia an d in h yperm agnesem ia. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject , th e ECG pattern s th at m ay be n oted with a clien t with a p o tassium level o f 2.5 m Eq / L ( 2.5 m m ol/ L) . From th e in fo rm atio n in th e q ues- tion , you n eed to d eterm in e th at th e clien t is exp erien cin g severe h ypo kalem ia. Fro m th is po in t, you m u st kn ow th e elec- trocard io grap h ic ch an ges th at are exp ected wh en severe h yp o - kalem ia exists. Review: Th e electrocard io graph ic ch an ges th at o ccu r in h yp o k a lem ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Fluid s & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ces: Ign ataviciu s, Wo rkm an (2016), p p. 163–164; Lewis et al. ( 2014) , p . 298.

F

u

n

d

a

m

e

n

t

a

l

s

93CHAPTER 8 Fluids and Electrolytes

39. 1, 2, 4, 5, 6 Ra tion a le: Potassium ch lo rid e ad m in istered in traven ou sly m ust always b e diluted in IV flu id an d in fu sed via an in fusio n p um p . Po tassium ch loride is n ever given b y bo lus (IV p u sh ). Givin g po tassiu m ch lo ride by IV push can result in cardiac arrest. Th e n u rse sh ou ld en su re th at th e p o tassium is d ilu ted in th e ap pro priate am ou n t of diluen t or fluid. Th e IV b ag con - tain in g th e po tassium ch lo rid e sh ou ld always b e lab eled with th e volum e o f p otassiu m it co n tain s. Th e IV site is m on itored closely becau se p otassium ch lo rid e is irritatin g to th e vein s an d th ere is risk o f p h lebitis. In ad d itio n , th e n u rse sh o uld m o n ito r fo r in filtration . Th e n u rse m on itors urin ary o utp ut du rin g ad m in istratio n an d co n tacts th e h ealth care pro vider if th e u ri- n ary ou tpu t is less th an 30 m L/ h o u r. Test-Ta kin g St r a tegy: Fo cu s on th e su b ject , th e prep aratio n an d adm in istratio n o f po tassiu m ch lo ride in traven o usly. Th in k ab ou t th is proced ure an d th e effects o f p otassiu m . No te th e wo rd bolus in op tion 3 to assist in elim in atin g th is o ption . Review: Th e precaution s with in traven ously adm in istered p o t a ssiu m Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm aco logy—Card iovascular Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Gah art, Nazaren o ( 2015) , p p. 1009–1011; Lewis et al. ( 2014), p. 298.

40. 2, 3, 4, 6 Ra tion a le: Th e n o rm al p otassiu m level is 3.5 to 5.0 m Eq/ L (3.5 to 5.0 m m ol/ L). Com m on fo od sou rces of p otassiu m in clu d e avo cad o , ban an as, can talo up e, carrots, fish , m ush - roo m s, oran ges, p otato es, p ork, beef, veal, raisin s, sp in ach , strawb erries, an d tom atoes. Peas an d cauliflo wer are h igh in m agn esiu m . Test-Ta kin g Str a tegy: Focus on th e su b ject , foo d s h igh in p otassiu m . Read each fo od item an d use kn o wled ge ab ou t n u trition an d co m p o n en ts o f fo od . Recall th at peas an d cauli- flo wer are h igh in m agn esium . Review: Th e fo o d item s h igh in p o t a ssiu m co n ten t Level of Cogn it ive Abilit y: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n d am en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clien t Ed ucation ; Nutritio n Refer en ces: Lewis et al. (2014), pp . 296, 1115; Nix (2013), p . 138.

41. 1, 2, 4 Ra tion a le: Th e n orm al serum sod iu m level is 135 to 145 m Eq/ L (135 to 145 m m ol/ L). A serum sod ium level of 150 m Eq/ L (150 m m o l/ L) in d icates h yp ern atrem ia. O n th e b asis o f th is fin din g, th e n u rse wou ld in stru ct th e clien t to avoid fo od s h igh in so diu m . Peas, n u ts, an d cau liflo wer are goo d foo d sou rces of p h o sph orus an d are n o t h igh in sod iu m (u n less th ey are can n ed o r salted ) . Peas are also a go od sou rce of m agn esium . Pro cessed foo d s su ch as ch eese an d p ro cessed o at cereals are h igh in sod iu m co n ten t. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject , fo o ds accep tab le to be con sum ed b y a clien t with a so dium level o f 150 m Eq/ L (150 m m o l/ L). First, yo u m u st d eterm in e th at th e clien t h as

h yp ern atrem ia. Select peas an d cauliflower first b ecau se th ese are vegetables. From th e rem ain in g o ptio n s, n o te th e word pro- cessed in o ptio n 5 an d recall th at ch eese is h igh in so d ium . Rem em ber th at processed fo od s ten d to b e h igh er in sod iu m con ten t. Review: Fo od s h igh in so d iu m con ten t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fun dam en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clien t Ed ucation ; Nu trition Refer en ces: Lewis et al. (2014), p . 295; Nix (2013), p. 141.

42. 1 Ra tion a le: Th e n o rm al serum calcium level is 9 to 10.5 m g/ d L (2.25 to 2.75 m m ol/ L). A seru m calciu m level lower th an 9 m g/ dL (2.25 m m o l/ L) in dicates h yp ocalcem ia. Sign s of h yp ocalcem ia in clu de p aresth esias fo llo wed by n u m b n ess, h yp eractive d eep ten d o n reflexes, an d a po sitive Trou sseau’s o r Ch vo stek’s sign . Ad ditio n al sign s o f h ypo calcem ia in clud e in creased n eu ro m uscular excitab ility, m u scle cram ps, twitch - in g, tetan y, seizu res, irritability, an d an xiety. Gastro in testin al sym pto m s in clu d e in creased gastric m otility, h yperactive b owel so un ds, ab do m in al cram p in g, an d d iarrh ea. Test-Ta kin g St r a t egy: No te th at th e th ree in correct op tion s are co m p a r a b le o r a lik e in th at th ey reflect a h ypo activity. Th e o ptio n th at is d ifferen t is th e co rrect op tio n . Review: Th e m an ifestation s o f h yp o ca lcem ia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clin ical Ju dgm en t; Flu id an d Electrolytes Refer en ce: Lewis et al. (2014), p p. 299–300.

43. 4, 5 Ra tion a le: Th e n o rm al serum calcium level is 9 to 10.5 m g/ d L (2.25 to 2.75 m m ol/ L). A seru m calciu m level lower th an 9 m g/ dL (2.25 m m o l/ L) in dicates h yp o calcem ia. Electrocar- d iograph ic ch an ges th at o ccu r in a clien t with h ypo calcem ia in clu de a p ro lo n ged Q T in terval an d p ro lo n ged ST segm en t. A sh orten ed ST segm en t an d a widen ed T wave occur with h yp ercalcem ia. ST d epressio n an d p ro m in en t U waves occu r with h ypokalem ia. Test-Ta kin g Str a tegy: Focu s o n th e su b ject , th e electro card io- grap h ic pattern s th at o ccur in a calciu m im b alan ce. It is n eces- sary to kn ow th e electrocard io graph ic ch an ges th at o ccu r in h yp ocalcem ia. Rem em b er th at h ypo calcem ia cau ses a pro - lo n ged ST segm en t an d prolo n ged Q T in terval. Review: Th e electrocardiograph ic ch an ges th at occur in h yp o ca lcem ia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clin ical Ju dgm en t; Flu id an d Electrolytes Refer en ce: Lewis et al. (2014), p . 299.

44. 3, 5 Ra tion a le: Th e n o rm al po tassiu m level is 3.5 to 5.0 m Eq / L (3.5 to 5.0 m m ol/ L). A seru m p otassium level greater th an

F

u

n

d

a

m

e

n

t

a

l

s

94 UNIT III Nursing Sciences

5.0 m Eq / L ( 5.0 m m o l/ L) in dicates h yp erkalem ia. Electro car- dio grap h ic ch an ges asso ciated with h yperkalem ia in clu de flat P waves, p ro lo n ged PR in tervals, widen ed Q RS com plexes, an d tall peaked T waves. ST d ep ressio n an d a p ro m in en t U wave occurs in h yp o kalem ia. A p ro lo n ged ST segm en t occurs in h ypo calcem ia. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject , th e electro card io - graph ic ch an ges th at occur in a p otassiu m im b alan ce. Fro m th e in fo rm ation in th e qu estio n , you n eed to d eterm in e th at th is co n d ition is a h yp erkalem ic on e. Fro m th is p oin t, yo u m u st kn o w th e electrocard io grap h ic ch an ges th at are exp ected wh en h yperkalem ia exists. Rem em b er th at tall peaked T waves, flat P waves, widen ed Q RS co m p lexes, an d p ro lon ged PR in terval are asso ciated with h yperkalem ia. Review: Th e electrocard io grap h ic ch an ges th at o ccu r in h yp er k a lem ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Fluids & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p . 296.

45. 1 Ra t ion a le: Th e n o rm al seru m so dium level is 135 to 145 m Eq / L (135 to 145 m m ol/ L) . A serum sodium level of 130 m Eq/ L (130 m m ol/ L) in dicates h yp on atrem ia. Hyp on atrem ia can occu r in th e clien t takin g diu retics. Th e clien t takin g corticoste- ro ids an d th e clien t with h yperaldosteron ism or Cush in g’s syn - drom e are at risk fo r h ypern atrem ia. Test -Ta kin g Str a tegy: Focus o n th e su b ject , th e cau ses of a sod ium level o f 130 m Eq / L (130 m m o l/ L). First, d eterm in e th at th e clien t is exp erien cin g h yp o n atrem ia. Next, yo u m ust kn o w th e cau ses of h ypo n atrem ia to direct yo u to th e co rrect op tion . Also , recall th at wh en a clien t takes a d iu retic, th e clien t loses flu id an d electro lytes. Review: Th e n o rm al seru m so diu m level an d th e cau ses o f h yp o n a t r em ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Fluids & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p p. 295–296.

46. 3 Ra t ion a le: Th e n orm al seru m sod iu m level is 135 to 145 m Eq / L (135 to 145 m m o l/ L) . Hyp on atrem ia is evid en ced by a seru m sod ium level lower th an 135 m Eq/ L (135 m m o l/ L). Hyperac- tive bo wel sou n d s in d icate h yp on atrem ia. Th e rem ain in g op tion s are sign s of h ypern atrem ia. In h ypo n atrem ia, m uscle weakn ess, in creased urin ary o utp ut, an d decreased sp ecific gravity of th e urin e wou ld be n o ted. Test -Ta kin g Str a tegy: Fo cu s o n th e d a t a in t h e q u es t io n an d th e s u b ject o f th e q u estio n , sign s o f h yp o n atrem ia. It is n ecessary to kn o w th e sign s o f h yp o n atrem ia to an swer co rrectly. Also , th in k ab o u t th e actio n an d effects o f so d iu m o n th e b o d y to an swer co rrectly. Rem em b er th at in creased b o wel m o tility an d h yp eractive b o wel so u n d s in d icate h yp o n atrem ia.

Review: Th e sign s associated with h yp o n a t r em ia an d h yp er n a t r em ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Fluid s & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p. 295.

47. 1 Ra t ion a le: Th e n o rm al seru m p h o sph orus (p h o sph ate) level is 3.0 to 4.5 m g/ d L ( 0.97 to 1.45 m m o l/ L). Th e clien t is experien cin g h ypo ph osp h atem ia. Causative factors relate to m aln utrition o r starvatio n an d th e u se o f alu m in u m h yd ro x- ide–b ased o r m agn esiu m -b ased an tacid s. Ren al in sufficien cy, h ypo parath yro id ism , an d tu m or lysis syn dro m e are cau sative factors o f h yp erp h o sp h atem ia. Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d s , most likely. Fo cu s on th e su b ject , a serum ph osp h o ru s level of 1.8 m g/ d L (0.45 m m ol/ L). First, you m u st d eterm in e th at th e clien t is experien cin g h ypo ph osp h atem ia. Fro m th is p oin t, th in k ab ou t th e effects o f ph osp h o ru s on th e b o dy an d recall th e causes o f h yp o ph o sp h atem ia in order to an swer correctly. Review: Th e causative facto rs asso ciated with h yp o p h o - sp h a t em ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Fluid s & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p. 301.

48. 3 Ra t ion a le: In sen sible lo sses m ay o ccur with ou t th e perso n ’s awaren ess. In sen sib le lo sses o ccur daily th rou gh th e skin an d th e lu n gs. Sen sible lo sses are th ose o f wh ich th e person is aware, such as th ro u gh urin atio n , wo un d drain age, an d gastro- in testin al tract lo sses. Test -Ta kin g Str a tegy: No te th at th e su b ject o f th e qu estio n is in sen sible flu id loss. No te th at u rin ation , wo u n d drain age, an d gastroin testin al tract lo sses are co m p a r a b le o r a lik e in th at th ey can be m easured fo r accu rate o utp ut. Fluid lo ss th rou gh th e skin can n o t be m easured accurately; it can on ly b e ap pro xim ated. Review: Th e d ifferen ce b etween sen sib le a n d in sen sib le flu id lo ss Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Fun d am en tals of Care—Fluid s & Electro lytes Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ces: Lewis et al. (2014) , pp . 290, 293; Perry, Po tter, O sten do rf (2014), p . 810.

49. 1 Ra t ion a le: A fluid volu m e d eficit o ccurs wh en th e flu id in take is n o t sufficien t to m eet th e flu id n eed s o f th e b od y. Causes of a fluid volu m e deficit in clud e vo m itin g, diarrh ea, con dition s th at cause in creased resp iration s or in creased u rin ary ou tpu t, in su fficien t in traven o u s flu id rep lacem en t, d rain in g fistu las,

F

u

n

d

a

m

e

n

t

a

l

s

95CHAPTER 8 Fluids and Electrolytes

an d th e presen ce o f an ileo stom y o r co losto m y. A clien t with h eart failu re o r on lo n g-term co rtico stero id th erap y o r a clien t receivin g frequ en t wo un d irrigatio n s is m ost at risk fo r flu id vo lum e excess. Test-Ta kin g St r a t egy: No te th e st r a t egic wo r d s, most likely. Read th e qu estio n carefully, n otin g th e su b ject , th e clien t at risk for a d eficit. Read each o ption an d th in k ab o ut th e flu id im b alan ce th at can o ccur in each . Th e clien ts with h eart failu re, on lo n g-term cortico steroid th erap y, an d receivin g frequ en t wou n d irrigatio n s retain flu id . Th e on ly co n d itio n th at can cause a d eficit is th e co n dition n o ted in th e co rrect o ptio n . Review: Th e cau ses o f a flu id vo lu m e d eficit Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n d am en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clin ical Ju dgm en t; Fluid an d Electrolytes Refer en ce: Lewis et al. (2014), p . 292.

50. 1 Ra tion a le: A flu id vo lu m e deficit occu rs wh en th e fluid in take is n ot sufficien t to m eet th e flu id n eeds o f th e b od y. Assessm en t fin din gs in a clien t with a flu id volu m e d eficit in clud e in creased resp iratio n s an d h eart rate, d ecreased cen tral ven o us p ressu re (CVP) (n orm al CVP is between 4 an d 11 cm H 2O ), weigh t lo ss, poor skin turgor, dry m ucous m em bran es, d ecreased u rin e vo lum e, in creased specific gravity o f th e urin e, in creased h em atocrit, an d altered level o f co n sciou sn ess. Lun g con gestion , in creased u rin ary o utp ut, an d in creased bloo d p ressu re are all associated with flu id vo lu m e excess. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject , flu id vo lu m e def- icit. Th in k ab ou t th e path op h ysio logy fo r flu id vo lum e d eficit an d flu id vo lu m e excess to an swer co rrectly. No te th at op tion s 2, 3, an d 4 are co m p a r a b le o r a lik e an d are m an ifestation s asso ciated with flu id vo lu m e excess. Review: Th e assessm en t fin d in gs n o ted in flu id vo lu m e d eficit Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n d am en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clin ical Ju dgm en t; Fluid an d Electrolytes Refer en ce: Lewis et al. (2014), p . 292.

51. 4 Ra tion a le: A fluid vo lum e excess is also kn o wn as overhydration o r fluid overload an d occu rs wh en flu id in take o r flu id reten tio n

exceed s th e flu id n eed s of th e bo dy. Th e causes o f fluid vo lu m e excess in clud e decreased kidn ey fu n ction , h eart failure, u se of h yp oto n ic fluid s to rep lace iso ton ic fluid lo sses, excessive irri- gation of wou n d s an d bo dy cavities, an d excessive in gestio n of so diu m . Th e clien t takin g d iu retics, th e clien t with an ileos- to m y, an d th e clien t wh o requ ires gastro in testin al suctio n in g are at risk for fluid vo lum e d eficit. Test-Ta kin g Str a tegy: Focus on th e su b ject , fluid volum e excess. Th in k abo ut th e path o p h ysio logy associated with flu id volum e excess. Read each o ptio n an d th in k abo ut th e flu id im balan ce th at can o ccur in each . Clien ts takin g d iu retics or h avin g ileo sto m ies o r gastro in testin al suctio n in g all lo se fluid . Th e o n ly co n dition th at can cau se an excess is th e co n d itio n n o ted in th e co rrect op tion . Review: Th e causes o f flu id vo lu m e excess Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clin ical Ju dgm en t; Flu id an d Electrolytes Refer en ce: Lewis et al. (2014), p p. 292, 299–300.

52. 4 Ra tion a le: Th e n o rm al po tassiu m level is 3.5 to 5.0 m Eq / L (3.5 to 5.0 m m ol/ L). A serum p otassiu m level h igh er th an 5.0 m Eq/ L (5.0 m m ol/ L) in d icates h yperkalem ia. Clien ts wh o experien ce cellular sh iftin g of potassium in th e early stages o f m assive cell destru ctio n , su ch as with traum a, b urn s, sepsis, o r m etabo lic or respiratory acid osis, are at risk for h yperkale- m ia. Th e clien t with Cush in g’s syn drom e or colitis an d th e clien t wh o h as been o veru sin g laxatives are at risk fo r h yp okalem ia. Test-Ta kin g St r a t egy: Elim in ate th e clien t with colitis an d th e clien t overu sin g laxatives first b ecause th ey are co m p a r a b le o r a lik e, with bo th reflectin g a gastroin testin al loss. Fro m th e rem ain in g option s, recallin g th at cell destructio n causes p otas- siu m sh ifts will assist in directin g you to th e co rrect o ptio n . Also , rem em ber th at Cush in g’s syn d ro m e p resen ts a risk fo r h yp okalem ia an d th at Add iso n ’s disease presen ts a risk fo r h yp erkalem ia. Review: Th e risk facto rs asso ciated with h yp er k a lem ia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Flu id s & Electrolytes Pr ior it y Con cept s: Clin ical Ju dgm en t; Flu id an d Electrolytes Refer en ce: Lewis et al. (2014), p . 296.

F

u

n

d

a

m

e

n

t

a

l

s

96 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 9 Acid-Base Balance

PRIORITY CONCEPTS Acid-Base Balance; Oxygenation

CRITICAL THINKING What Should You Do? The nurse performs an Allen’s test on a client scheduled for an arterial blood gas draw from the radial artery. On release of pressure from the ulnar artery, color in the hand returns after 20 seconds. The nurse should take which actions? Answer located on p. 103.

I. Hydrogen Ions, Acids, and Bases A. Hydro gen io n s

1. Vital to life an d expressed as pH. 2. Circulate in th e body in 2 form s:

a. Volatile h ydrogen of carbo n ic acid b . Non volatile form of h ydrogen an d organ ic acids

B. Acid s 1. Acids are produ ced as en d produ cts of

metabolism. 2. Acids con tain h ydrogen ion s an d are h ydrogen

io n don ors, wh ich m ean s th at acids give up h ydrogen ion s to n eutralize or decrease th e stren gth of an acid or to form a weaker base.

3. Th e stren gth of an acid is determ in ed by th e n um ber of h ydrogen ion s it con tain s.

4. Th e n um ber of h ydrogen ion s in body fluid determ in es its acidity, alkalin ity, or n eutrality.

5. Th e lun gs excrete 13,000 to 30,000 m Eq/ d ay of vo latile h ydrogen in th e form of carbo n ic acid as carbo n dioxide (CO 2).

6. Th e kidn eys excrete 50 m Eq/ d ay of n on volatile acids.

C. Bases 1. Con tain n o h ydrogen ion s. 2. Are h ydrogen io n acceptors; th ey accept h ydro-

gen ion s from acids to n eutralize or decrease th e stren gth of a base or to form a weaker acid.

II. Regulatory Systems for Hydrogen Ion Concentration in the Blood

A. Buffers 1. Buffers are th e fastest actin g regulato ry system .

2. Buffers provide im m ediate protection again st ch an ges in h ydrogen ion con cen tration in th e extracellular fluid.

3. Buffers are reactors th at fun ction on ly to keep th e pH with in th e n arrow lim its of stability wh en too m uch acid or base is released in to th e system , an d buffers absorb or release h ydrogen ion s as n eeded.

4. Buffers serve as a tran spo rt m ech an ism th at carries excess h ydrogen ion s to th e lun gs.

5. O n ce th e prim ary buffer system s react, th ey are co n sum ed, leavin g th e body less able to with stan d furth er stress un til th e buffers are replaced.

B. Prim ary buffer system s in extracellular fluid 1. Hem o globin system

a. System m ain tain s acid-base balan ce by a pro- cess called chloride shift.

b . Ch loride sh ifts in an d out of th e cells in respo n se to th e level of oxygen (O 2) in th e blood .

c. For each ch loride ion th at leaves a red blood cell, a bicarbon ate ion en ters.

d . For each ch loride ion th at en ters a red blood cell, a bicarbon ate ion leaves.

2. Plasma protein system a. Th e system fun ction s alon g with th e liver to

vary th e am oun t of h ydrogen ion s in th e ch em ical structure of plasm a protein s.

b . Plasm a protein s h ave th e ability to attract or release h ydrogen ion s.

3. Carb on ic acid –bicarbon ate system a. Prim ary buffer system in th e body. b . Th e system m ain tain s a pH of 7.4 with a ratio

of 20 parts bicarbon ate (HCO 3 À ) to 1 part carbo n ic acid (H 2CO 3) (Fig. 9-1).

c. Th is ratio (20:1) determ in es th e h ydrogen ion con cen tration of body fluid.

d . Carb on ic acid con cen tration is con trolled by th e excretio n of CO 2 by th e lun gs; th e rate an d dep th of respiration ch an ge in respon se to ch an ges in th e CO 2. 97

F

u

n

d

a

m

e

n

t

a

l

s

e. Th e kidn eys con trol th e bicarbo n ate con cen - tration an d selectively retain or excrete bicar- bon ate in respo n se to bodily n eeds.

4. Ph osph ate buffer system a . System is presen t in th e cells an d body fluids

an d is especially active in th e kidn eys. b . System acts like bicarbon ate an d n eutralizes

excess h ydrogen ion s. C. Lun gs

1. Th e lun gs are th e secon d defen se of th e body an d in teract with th e buffer system to m ain tain acid- base balan ce.

2. In acido sis, th e pH decreases an d th e respiratory rate an d dep th in crease in an attem p t to exh ale acids. Th e carbon ic acid created by th e n eutraliz- in g action of bicarbo n ate can be carried to th e lun gs, wh ere it is reduced to CO 2 an d water an d is exh aled; th u s h ydrogen ion s are in acti- vated an d exh aled.

3. In alkalosis, th e pH in creases an d th e respiratory rate an d dep th decrease; CO 2 is retain ed an d car- bon ic acid in creases to n eutralize an d decrease th e stren gth of excess bicarbon ate.

4. Th e action of th e lu n gs is reversible in co n trollin g an excess or deficit.

5. Th e lun gs can h old h ydrogen ion s un til th e deficit is corrected or can in activate h ydrogen ion s, chan g- in g the ion s to water m olecules to be exh aled alon g with CO 2, th us correctin g th e excess.

6. Th e process of correctin g a deficit or excess takes 10 to 30 secon ds to com plete.

7. Th e lun gs are capable of in activatin g on ly h ydro- gen ion s carried by carbon ic acid; excess h ydro- gen ion s created by oth er m ech an ism s m ust be excreted by th e kidn eys.

Monitor the client’s respiratory status closely. In acidosis, the respiratory rate and depth increase in an attempt to exhale acids. In alkalosis, the respiratory rate and depth decrease; CO2 is retained to neutralize and decrease the strength of excess bicarbonate.

D. Kidn eys 1. Th e kidn eys provide a m ore in clusive corrective

respo n se to acid-b ase disturban ces th an oth er corrective m ech an ism s, even th ough th e ren al excretion of acids an d alkalis occurs m ore slowly.

2. Compensation requires a few h ours to several days; h owever, th e com pen sation is m ore th o r- ough an d selective th an th at of oth er regulators, such as th e buffer system s an d lu n gs.

3. In acido sis, th e pH decreases an d excess h ydro- gen ion s are secreted in to th e tubules an d com - bin e with buffers for excretion in th e urin e.

4. In alkalo sis, th e p H in creases an d excess b icarb o n ate io n s m o ve in to th e tu b u les, co m b in e with s odium , an d are excreted in th e u rin e.

5. Selective regulation of bicarbon ate occurs in th e kidn eys. a . Th e kidn eys restore bicarbo n ate by excre-

tin g h ydrogen ion s an d retain in g bicarbo - n ate io n s.

b . Excess h ydrogen io n s are excreted in th e urin e in th e form of ph osph oric acid.

c. Th e alteration of certain am in o acids in th e ren al tubules results in a diffusion of am m o- n ia in to th e kidn eys; th e am m on ia com bin es with excess h ydrogen io n s an d is excreted in th e urin e.

E. Potassium (K+) 1. Potassium plays an exch an ge role in m ain tain in g

acid-b ase balan ce. 2. Th e b o d y ch an ges th e p o tassiu m level b y d raw-

in g h yd ro gen io n s in to th e cells o r b y p u sh in g th em o u t o f th e cells ( p o tassiu m m o vem en t acro ss cell m em b ran es is facilitated b y tran s- cellu lar sh iftin g in resp o n se to acid -b ase p attern s) .

3. Th e potassium level ch an ges to com pen sate for h ydrogen io n level ch an ges ( Fig. 9-2). a . In acido sis, th e body protects itself from th e

acidic state by m ovin g h ydrogen ion s in to th e cells. Th erefore, potassium m oves out to m ake room for h ydrogen ion s an d th e potas- sium level in creases.

b . In alkalosis, th e cells release h ydrogen ion s in to th e blood in an attem pt to in crease th e acidity of th e blood ; th is forces th e potas- sium in to th e cells an d potassium levels decrease.

When the client experiences an acid-base imbal- ance, monitor the potassium level closely because the potassium moves in or out of the cells in an attempt to maintain acid-base balance. The resulting hypokale- mia or hyperkalemia predisposes the client to associated complications.

7.35 7.45

7.806.80

Acidos is

Norma l Alka los is

De a thDe a th

1 pa rt ca rbonic a cid

20 pa rts bica rbona te

FIGURE 9-1 Acid-base balance. In the healthy state, a ratio of 1 part car- bonic acid to 20 parts bicarbonate provides a normal serum pH between 7.35 and 7.45. Any deviation to the left of 7.35 results in an acidotic state. Any deviation to the right of 7.45 results in an alkalotic state.

98 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

III. Respiratory Acidosis A. Description : Th e total con cen tration of buffer base is

lower th an n orm al, with a relative in crease in h ydro- gen ion con cen tration ; th us a greater n um ber of h ydrogen ion s is circulatin g in th e blood th an can be ab sorbed by th e buffer system .

B. Causes (Box 9-1) 1. Resp iratory acido sis is cau sed by prim ary defects

in th e fun ction of th e lu n gs or ch an ges in n orm al respiratory pattern s.

2. An y con dition th at causes an obstru ction of th e airway or depresses th e respiratory system can cau se respiratory acido sis.

If the client has a condition that causes an obstruc- tion of the airway or depresses the respiratory system, monitor the client for respiratory acidosis.

C. Assessm en t: In an attem pt to com pen sate, th e kid- n eys retain bicarbo n ate an d excrete excess h ydrogen ion s in to th e urin e ( Table 9-1).

D. In terven tion s 1. Mon itor for sign s of respiratory distress. 2. Adm in ister O 2 as prescribed . 3. Place th e clien t in a sem i-Fowler’s position . 4. En cou rage an d assist th e clien t to turn , co ugh ,

an d deep-breath e. 5. En cou rage h ydration to th in secretio n s.

K+K+

K+

K+

K+ K+

K+

K+

K+

K+

K+

K+

K+

K+ K+

K+

K+ K+

K+

K+

K+

K+

K+ K+

K+

K+

H+

In a lka los is , more hydroge n ions a re pre s e nt in the intra ce llula r fluid tha n in the e xtra ce llula r fluid. Hydroge n ions move from the intra ce llula r fluid into the e xtra ce llula r fluid. To ke e p the intra ce llula r fluid e le ctrica lly ne utra l, pota s s ium ions move from the e xtra ce llula r fluid into the intra ce llula r fluid, cre a ting a re la tive hypoka le mia .

In a cidos is , the e xtra ce llula r hydroge n ion conte nt incre a s e s , a nd the hydroge n ions move into the intra ce llula r fluid. To ke e p the intra ce llula r fluid e le ctrica lly ne utra l, a n e qua l numbe r of pota s s ium ions le a ve the ce ll, cre a ting a re la tive hype rka le mia .

Unde r norma l conditions , the intra ce llula r pota s s ium conte nt is much gre a te r tha n tha t of the e xtra ce llula r fluid. The conce ntra tion of hydroge n ions is low in both compa rtme nts .

H+

H+

H+

H+

H+ H+

H+

H+

H+

H+

H+

H+

H+ H+

H+

H+

H+ H+

H+

K+

K+

K+

K+ K+

K+

K+

K+

K+

K+

K+

K+

H+ H+

H+

FIGURE 9-2 Movement of potassium in response to changes in the extracellular fluid hydrogen ion concentration.

BOX 9-1 Causes of Respiratory Acidosis

▪ Asthma: Spasms resulting from allergens, irritants, or emo- tions cause the smooth muscles of the bronchioles to con- strict, resulting in ineffective gas exchange.

▪ Atelectasis: Excessive mucus collection, with the collapse of alveolar sacs caused by mucous plugs, infectious drainage, or anesthetic medications, results in ineffective gas exchange.

▪ Brain trauma: Excessive pressure on the respiratory center or medulla oblongata depresses respirations.

▪ Bronchiectasis: Bronchi become dilated as a result of inflam- mation, and destructive changes and weakness in the walls of the bronchi occur.

▪ Bronchitis: Inflammation causes airway obstruction, result- ing in inadequate gas exchange.

▪ Central nervous system depressants: Depressants such as sedatives, opioids, and anesthetics depress the respiratory center, leading to hypoventilation (excessive sedation from medications may require reversal by opioid antagonist med- ications); carbon dioxide (CO2) is retained and the hydrogen ion concentration increases.

▪ Emphysema and COPD: Loss of elasticity of alveolar sacs restricts air flow in and out, primarily out, leading to an increased CO2 level.

▪ Administering high oxygen levels per nasal cannula to cli- ents who are CO2 retainers (i.e., emphysema and COPD).

▪ Hypoventilation: Carbon dioxide is retained and the hydro- gen ion concentration increases, leading to the acidotic state; carbonic acid is retained and the pH decreases.

▪ Pneumonia: Excess mucus production and lung congestion cause airway obstruction, resulting in inadequate gas exchange.

▪ Pulmonary edema: Extracellular accumulation of fluid in pul- monary tissue causes disturbances in alveolar diffusion and perfusion.

▪ Pulmonary emboli: Emboli cause obstruction in a pulmo- nary artery resulting in airway obstruction and inadequate gas exchange.

99CHAPTER 9 Acid-Base Balance

F

u

n

d

a

m

e

n

t

a

l

s

6. Redu ce restlessn ess by im provin g ven tilation rath er th an by adm in isterin g tran quilizers, sed a- tives, or opioids because th ese m ed ication s fur- th er dep ress respiration s.

7. Prepare to adm in ister respiratory treatm en ts as prescribed.

8. Suction th e clien t’s airway, if n ecessary. 9. Mon itor electrolyte values, particularly th e potas-

sium level an d arterial blood gas (ABG) levels. 10. Adm in ister an tibiotics for respiratory in fectio n

or oth er m ed ication s as prescribed.

11. Prepare for endotracheal intubation and m echanical ventilation if CO2 levels rise above 50 m m Hg and if signs of acute respiratory distress are present.

Clients with a historyofemphysema or chronic obstruc- tive pulmonarydisease (COPD) usuallyare not given oxygen greater than 2 liters bycannula since high levels of oxygen in the blood may decrease the stimulus to breathe leading to CO2 retention and respiratory acidosis.

IV. Respiratory Alkalosis A. Descrip tion : A deficit of carbon ic acid an d a decrease

in h ydrogen io n con cen tration th at results from th e accum ulation of base or fro m a lo ss of acid with ou t a com parable lo ss of base in th e body flu ids.

B. Causes: Resp iratory alkalosis results fro m con dition s th at cause overstim ulation of th e respiratory system (Box 9-2).

If the client has a condition that causes overstimu- lation of the respiratory system, monitor the client for respiratory alkalosis.

C. Assessm en t: In itially th e h yperven tilatio n an d respi- ratory stim ulation cause abn o rm al rapid respiratio n s (tach yp n ea); in an attem p t to com pen sate, th e kid- n eys excrete excess circulatin g bicarbon ate in to th e urin e ( Table 9-2).

D. In terven tion s 1. Mon itor for sign s of respiratory distress. 2. Provid e em otion al support an d reassuran ce to

th e clien t. 3. En cou rage appropriate breath in g pattern s. 4. Assist with breath in g tech n iqu es an d breath in g

aids as prescribed. a . En cou rage volun tary h old in g of th e breath if

appropriate. b . Provid e use of a rebreath in g m ask as

prescribed. c. Provid e CO 2 breath s as prescribed (rebreath -

in g in to a paper bag). 5. Provid e cau tious care with ven tilator clien ts so

th at th ey are n ot forced to take breath s too deeply or rapidly.

6. Mon itor electrolyte values, particularly potas- sium an d calcium levels; m on itor ABG levels.

TABLE 9-1 Clinical Manifestations of Acidosis Respiratory (" PaCO2) Metabolic (# HCO32 )

Neurological Drowsiness Drowsiness

Disorientation Confusion

Dizziness Headache

Headache Coma

Coma

Cardiovascular Decreased blood pressure Decreased blood pressure

Dysrhythmias (related to hyperkalemia from compensation)

Dysrhythmias (related to hyperkalemia from compensation)

Warm, flushed skin (related to peripheral vasodilation)

Warm, flushed skin (related to peripheral vasodilation)

Gastrointestinal No significant findings Nausea, vomiting, diarrhea,

abdominal pain

Neuromuscular Seizures No significant findings

Respiratory Hypoventilation with hypoxia (lungs are unable to compensate when there is a respiratory problem)

Deep, rapid respirations (compensatory action by the lungs); known as Kussmaul’s respirations

From Lewis S, Dirksen S, Heitkemper M, Bucher L, Camera I: Medical-surgical nursing: assessment and management of clinical problems, ed 9, St. Louis, 20 14, Mosby.

BOX 9-2 Causes of Respiratory Alkalosis

▪ Fever: Causes increased metabolism, resulting in overstimu- lation of the respiratory system.

▪ Hyperventilation: Rapid respirations cause the blowing off of carbon dioxide (CO2), leading to a decrease in carbonic acid.

▪ Hypoxia: Stimulates the respiratory center in the brainstem, which causes an increase in the respiratory rate in order to increase oxygen (O2); this causes hyperventilation, which results in a decrease in the CO2 level.

▪ Hysteria: Often is neurogenic and related to a psychoneuro- sis; however, this condition leads to vigorous breathing and excessive exhaling of CO2.

▪ Overventilation by mechanical ventilators: The administra- tion of O2 and the depletion of CO2 can occur from mechan- ical ventilation, causing the client to be hyperventilated.

▪ Pain: Overstimulation of the respiratory center in the brain- stem results in a carbonic acid deficit.

100 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

7. Prepare to adm in ister calcium gluco n ate for tet- an y as prescribed.

V. Metabolic Acidosis A. Description : A total con cen tration of buffer base th at is

lower than n orm al, with a relative in crease in th e h ydro- gen ion con cen tration , resultin g from loss of too m uch base an d/ or reten tion of too m uch acid.

B. Causes (Box 9-3)

An insufficient supply of insulin in a client with diabetes mellitus can result in metabolic acidosis known as diabetic ketoacidosis.

C. Assessm en t: To com pen sate for th e acido sis, deep an d rapid respiration s, kn own as Kussm aul’s respira- tion s, occur as th e lun gs attem p t to exh ale th e excess CO 2 (see Table 9-1).

D. In terven tion s 1. Mon itor for sign s of respiratory distress. 2. Assess level of con scio usn ess for cen tral n ervou s

system depression .

3. Mon itor in take an d outp ut an d assist with fluid an d electrolyte replacem en t as prescribed.

4. Prepare to adm in ister solution s in traven ously as prescribed to in crease th e buffer base.

5. In itiate safety an d seizu re precaution s. 6. Mon itor th e ABG levels an d th e potassium level

clo sely; as m etab olic acido sis resolves, potassium m oves back in to th e cells an d th e potassium level decreases.

E. In terven tion s in diabetes m ellitus an d diabetic ketoacidosis 1. Give in sulin as prescribed to h asten th e m ove-

m en t of gluco se in to th e cells, th ereby decreasin g th e con cu rren t ketosis.

2. Wh en gluco se is bein g properly m etabolized, th e body will stop con vertin g fats to glucose.

3. Mon itor for circulatory collapse caused by poly- uria, wh ich m ay result from th e h yperglycem ic state; osm o tic diuresis m ay lead to extracellular volu m e deficit.

Monitor the client experiencing severe diarrhea for manifestations of metabolic acidosis.

F. In terven tion s in kidn ey disease 1. Dialysis m ay be used to rem ove protein an d waste

produ cts, th ereby lessen in g th e acidotic state. 2. A diet low in protein an d h igh in calories

decreases th e am oun t of protein waste products, wh ich in turn lessen s th e acido sis.

VI. Metabolic Alkalosis A. Descrip tio n : A d eficit o f carb o n ic acid an d a

d ecrease in h yd ro gen io n co n cen tratio n th at resu lts fro m th e accu m u latio n o f b ase o r fro m a lo ss o f acid

TABLE 9-2 Clinical Manifestations of Alkalosis Respiratory (# PaCO2) Metabolic (" HCO32 )

Neurological Lethargy Drowsiness

Lightheadedness Dizziness

Confusion Nervousness

Confusion

Cardiovascular Tachycardia Tachycardia

Dysrhythmias (related to hypokalemia from compensation)

Dysrhythmias (related to hypokalemia from compensation)

Gastrointestinal Nausea Anorexia

Vomiting Nausea

Epigastric pain Vomiting

Neuromuscular Tetany Tremors

Numbness Hypertonic muscles

Tingling of extremities Muscle cramps

Hyperreflexia Tetany

Seizures Tingling of extremities

Seizures

Respiratory Hyperventilation (lungs are unable to compensate when there is a respiratory problem)

Hypoventilation (compensatory action by the lungs)

From Lewis S, Dirksen S, Heitkemper M, Bucher L, Camera I: Medical-surgical nursing: assessment and management of clinical problems, ed 9, St. Louis, 2014, Mosby.

BOX 9-3 Causes of Metabolic Acidosis ▪ Diabetes mellitus or diabetic ketoacidosis: An insufficient

supply of insulin causes increased fat metabolism, leading to an excess accumulation of ketones or other acids; the bicarbonate then ends up being depleted.

▪ Excessive ingestion of acetylsalicylic acid: Causes an increase in the hydrogen ion concentration.

▪ High-fat diet: Causes a much too rapid accumulation of the waste products of fat metabolism, leading to a buildup of ketones and acids.

▪ Insufficient metabolism of carbohydrates: When the oxy- gen supply is not sufficient for the metabolism of carbohy- drates, lactic acid is produced and lactic acidosis results.

▪ Malnutrition: Improper metabolism of nutrients causes fat catabolism, leading to an excess buildup ofketones and acids.

▪ Renal insufficiency, acute kidney injury, or chronic kidney disease: Increased waste products of protein metabolism are retained; acids increase, and bicarbonate is unable to maintain acid-base balance.

▪ Severe diarrhea: Intestinal and pancreatic secretions are normally alkaline; therefore, excessive loss of base leads to acidosis.

101CHAPTER 9 Acid-Base Balance

F

u

n

d

a

m

e

n

t

a

l

s

with o u t a co m p arab le lo ss o f b ase in th e b o d y flu id s.

B. Causes: Metabolic alkalosis results from a dysfun c- tion of metabolism th at cau ses an in creased am oun t of available base solution in th e blood or a decrease in available acids in th e blood (Box 9-4).

C. Assessm en t: To com pen sate, respiratory rate an d depth decrease to con serve CO 2 (see Table 9-2).

Monitor the client experiencing excessive vomiting or the client with gastrointestinal suctioning for manifes- tations of metabolic alkalosis.

D. In terven tion s 1. Mon itor for sign s of respiratory distress. 2. Mon itor ABGs an d potassium an d calcium levels. 3. In stitute safety precaution s. 4. Prepare to adm in ister m edication s an d in trave-

n ous fluids as prescribed to prom ote th e kidn ey excretion of bicarbo n ate.

5. Prepare to replace potassium as prescribed. 6. Treat th e un derlyin g cause of th e alkalosis.

VII. Arterial Blood Gases (ABGs) (Table 9-3) A. Collection of an ABG specim en

1. O btain vital sign s. 2. Determ in e wh eth er th e clien t h as an arterial lin e

in place (allo ws for arterial blood sam plin g with - out furth er pun cture to th e clien t) .

3. Perform th e Allen’s test to determ in e th e presen ce of collateral circulation (see Priority Nursin g Actions).

PRIORITY NURSING ACTIONS Performing the Allen’s Test Before Radial Artery Puncture 1. Explain the procedure to the client. 2. Apply pressure over the ulnar and radial arteries

simultaneously. 3. Ask the client to open and close the hand repeatedly. 4. Release pressure from the ulnar artery while compressing

the radial artery. 5. Assess the color of the extremity distal to the

pressure point. 6. Document the findings.

The Allen’s test is performed before obtaining an arterial blood specimen from the radial artery to determine the pres- ence of collateral circulation and the adequacy of the ulnar artery. Failure to determine the presence of adequate collateral circulation could result in severe ischemic injury to the hand if damage to the radial artery occurs with arterial puncture. The nurse first would explain the procedure to the client. To per- form the test, the nurse applies direct pressure over the client’s ulnar and radial arteries simultaneously. While applying pres- sure, the nurse asks the client to open and close the hand repeatedly; the hand should blanch. The nurse then releases pressure from the ulnar artery while compressing the radial artery and assesses the color of the extremity distal to the pres- sure point. If pinkness fails to return within 6 to 7 seconds, the ulnar artery is insufficient, indicating that the radial artery should not be used for obtaining a blood specimen. Finally, the nurse documents the findings. Other sites, such as the brachial or femoral artery, can be used if the radial artery is not deemed adequate.

Reference Perry, Potter, Ostendorf (2014), pp. 1091–10 92.

4. Assess facto rs th at m ay affect th e accuracy of th e results, such as ch an ges in th e O 2 settin gs, suc- tion in g with in th e past 20 m in u tes, an d clien t’s activities.

5. Provid e em o tion al support to th e clien t. 6. Assist with th e specim en draw; prepare a h epa-

rin ized syrin ge (if n ot already prepackaged). 7. Apply pressure im m ediately to th e pun cture site

followin g th e blood draw; m ain tain pressure for 5 m in utes or for 10 m in utes if th e clien t is takin g an an ticoagulan t.

8. Approp riately label th e specim en an d tran spo rt it on ice to th e laborato ry.

9. O n th e laborato ry form , record th e clien t’s tem - perature an d th e typ e of supp lem en tal O 2 th at th e clien t is receivin g.

BOX 9-4 Causes of Metabolic Alkalosis ▪ Diuretics: The loss of hydrogen ions and chloride from

diuresis causes a compensatory increase in the amount of bicarbonate in the blood.

▪ Excessive vomiting or gastrointestinal suctioning: Leads to an excessive loss of hydrochloric acid.

▪ Hyperaldosteronism: Increased renal tubular reabsorption of sodium occurs, with the resultant loss of hydrogen ions.

▪ Ingestion of and/ or infusion of excess sodium bicarbon- ate: Causes an increase in the amount of base in the blood.

▪ Massive transfusion of whole blood: The citrate anticoagulant used for the storage of blood is metabolized to bicarbonate.

TABLE 9-3 Normal Arterial Blood Gas Values Normal Range

Laboratory Test Conventional Units SI Units

pH 7.35-7.45 7.35-7.45

PaCO2 35-45 mm Hg 35-45 mm Hg

Bicarbonate (HCO3À ) 21-28 mEq/ L 21-28 mmol/ L

PaO2 80-100 mm Hg 80-100 mm Hg

kPa, Kilopascal; mmol, millimole (10 À3 mole); PaCO2, partial pressure of carbon dioxide in arterial blood; PaO2, partial pressure of oxygen in arterial blood. Note: Because arterial blood gases are influenced by altitude, the value for PaO2 decreases as altitude increases.

102 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

B. Resp iratory acid-b ase im balan ces (Table 9-4) 1. Rem em ber th at th e respiratory fun ctio n in dica-

tor is th e PaCO 2. 2. In a respiratory im balan ce, you will fin d an

oppo site relation sh ip between th e pH an d th e PaCO 2; in oth er words, th e pH will be elevated with a decreased PaCO 2 (alkalosis) or th e pH will be decreased with an elevated PaCO 2 (acidosis).

3. Loo k at th e pH an d th e PaCO 2 to determ in e wh eth er th e con d ition is a respiratory problem .

4. Respiratory acidosis: Th e pH is decreased; th e PaCO 2 is elevated .

5. Respiratory alkalosis: Th e pH is elevated ; th e PaCO 2 is decreased.

C. Metab olic acid-b ase im balan ces (see Table 9-4) 1. Rem em ber, th e m etab olic fun ctio n in dicator is

th e bicarbon ate io n (HCO 3 À ). 2. In a m etab olic im balan ce, th ere is a correspo n d-

in g relation sh ip between th e pH an d th e HCO 3 À ; in oth er words, th e pH will be elevated an d HCO 3 À will be elevated (alkalosis), or th e pH will be decreased an d HCO 3 À will be decreased (acidosis).

3. Look at the pH an d the HCO 3 À to determ in e wh eth er th e con dition is a m etabolic problem .

4. Metabolic acidosis: Th e pH is decreased; th e HCO 3 À is decreased.

5. Metabolic alkalosis: Th e pH is elevated ; th e HCO 3 À is elevated.

In a respiratory imbalance, the ABG result indicates an opposite relationship between the pH and the PaCO2. In a metabolic imbalance, the ABG result indicates a cor- responding relationship between the pH and the HCO3À .

D. Compensation (see Table 9-4) 1. Com pen sation refers to the body processes th at

occur to coun terbalan ce th e acid-base disturban ce. 2. Wh en full com pen sation h as occurred, th e pH is

with in n orm al lim its. E. Steps for an alyzin g ABG results ( Box 9-5) F. Mixed acid-b ase disorders

1. O ccurs wh en 2 or m ore disorders are presen t at th e sam e tim e.

2. Th e pH will depen d on th e typ e an d severity of th e disorders in volved, in cludin g an y com pen sa- tory m ech an ism s at work, e.g., respiratory acido- sis com bin ed with m etab olic acido sis will result in a greater decrease in pH th an eith er im balan ce occurrin g alon e.

3. Exam ple: Mixed alkalosis can occur if a clien t begin s to h yperven tilate due to postoperative pain (respiratory alkalosis) and is also losin g acid due to gastric suction in g (m etabolic alkalosis).

CRITICAL THINKING What Should You Do? Answer: Failure to determine the presence of adequate col- lateral circulation before drawing an arterial blood gas spec- imen could result in severe ischemic injury to the hand if damage to the radial artery occurs with arterial puncture. Upon release of pressure on the ulnar artery, if pinkness fails to return within 6 to 7 seconds, the ulnar artery is insufficient, indicating that the radial artery should not be used for obtain- ing a blood specimen. Another site needs to be selected for the arterial puncture and the health care provider needs to be notified of the finding.

Reference: Perry, Potter, Ostendorf (20 14), p. 1091.

TABLE 9-4 Acid-Base Imbalances: Usual Laboratory Value Changes Imbalance pH HCO3À PaO2 PaCO2 K

+

Respiratory acidosis

U: Decreased PC: Decreased C: Normal

U: Normal PC: Increased C: Increased

Usually decreased U: Increased PC: Increased C: Increased

Increased

Respiratory alkalosis

U: Increased PC: Increased C: Normal

U: Normal PC: Decreased C: Decreased

Usually normal but depends on other accompanying conditions

U: Decreased PC: Decreased C: Decreased

Decreased

Metabolic acidosis U: Decreased PC: Decreased C: Normal

U: Decreased PC: Decreased C: Decreased

Usually normal but depends on other accompanying conditions

U: Normal PC: Decreased C: Decreased

Increased

Metabolic alkalosis

U: Increased PC: Increased C: Normal

U: Increased PC: Increased C: Increased

Usually normal but depends on other accompanying conditions

U: Normal PC: Increased C: Increased

Decreased

U, uncompensated; PC, partially compensated; C, compensated.

103CHAPTER 9 Acid-Base Balance

F

u

n

d

a

m

e

n

t

a

l

s

P R A C T I C E Q U E S T I O N S 53. Th e n urse reviews th e arterial blood gas results of a

clien t an d n otes th e followin g: pH 7.45, PaCO 2 of 30 m m Hg (30 m m Hg), an d HCO 3 À of 20 m Eq/ L (20 m m o l/ L). Th e n urse an alyzes th ese results as in dicatin g wh ich co n dition ? 1. Metab olic acido sis, com pen sated 2. Resp iratory alkalosis, com pen sated 3. Metab olic alkalosis, un co m pen sated 4. Resp iratory acido sis, un co m pen sated

54. Th e n urse is carin g for a clien t with a n aso gastric tube th at is attach ed to lo w suction . Th e n urse m on - itors th e clien t for m an ifestation s of wh ich disorder th at th e clien t is at risk for? 1. Metab olic acido sis 2. Metab olic alkalosis 3. Resp iratory acidosis 4. Resp iratory alkalosis

55. A clien t with a 3-day h istory of n ausea an d vom itin g presen ts to the em ergen cy departm en t. Th e clien t is h ypoven tilatin g an d h as a respiratory rate of 10 breaths/m in ute. Th e electrocardiogram (ECG) m oni- tor displays tach ycardia, with a h eart rate of 120 beats/ m in ute. Arterial blood gases are drawn and the n urse reviews the results, expectin g to n ote wh ich fin din g? 1. A decreased pH an d an in creased PaCO 2 2. An in creased pH an d a decreased PaCO 2 3. A decreased pH an d a decreased HCO 3 À 4. An in creased pH an d an in creased HCO 3 À

56. Th e n urse is carin g for a clien t h avin g respiratory distress related to an an xiety attack. Recen t arterial blood gas values are pH ¼7.53, PaO2 ¼72 m m Hg (72 m m Hg), PaCO2 ¼32 m m Hg (32 m m Hg), an d HCO 3 À ¼28 m Eq/ L (28 m m ol/ L). Wh ich con clusion about the clien t sh ould th e n urse m ake? 1. Th e clien t h as acidotic blood. 2. Th e clien t is probably overreactin g. 3. Th e clien t is flu id volum e overloaded . 4. Th e clien t is probably h yperven tilatin g.

57. Th e n urse is carin g for a clien t with diab etic ketoaci- dosis an d docum en ts th at th e clien t is experien cin g Kussm aul’s respiration s. Wh ich pattern s did th e n urse observe? Select all th at ap p ly.

1. Respiration s th at are sh allow 2. Resp iration s th at are in creased in rate 3. Resp iration s th at are abn o rm ally slow 4. Respiration s th at are abn orm ally deep 5. Resp iration s th at cease for several secon ds

58. A clien t wh o is foun d un respon sive h as arterial blood gases drawn an d th e results in dicate th e followin g: pH is 7.12, PaCO2 is 90 m m Hg (90 m m Hg), an d HCO 3 À is 22 m Eq/ L (22 m m ol/ L). Th e n urse in terprets the results as in dicatin g wh ich con dition ? 1. Metab olic acido sis with com pen sation 2. Resp iratory acido sis with com pen sation 3. Metab olic acidosis with ou t com pen sation 4. Respiratory acido sis with out com pen satio n

BOX 9-5 Analyzing Arterial Blood Gas Results If you can remember the following Pyramid Points and Pyramid Steps, you will be able to analyze any blood gas report.

Pyramid Points In acidosis, the pH is decreased. In alkalosis, the pH is elevated. The respiratory function indicator is the PaCO2. The metabolic function indicator is the bicarbonate ion (HCO3À ).

Pyramid Steps Pyra mid Step 1 Look at the blood gas report. Look at the pH. Is the pH elevated or decreased? If the pH is elevated, it reflects alkalosis. If the pH is decreased, it reflects acidosis.

Pyra mid Step 2 Look at the PaCO2. Is the PaCO2 elevated or decreased? If the PaCO2 reflects an opposite relationship to the pH, the condition

is a respiratory imbalance. If the PaCO2 does not reflect an oppo- site relationship to the pH, go to Pyramid Step 3.

Pyra mid Step 3 Look at the HCO3À . Does the HCO3À reflect a corresponding relationship with the pH? If it does, the condition is a metabolic imbalance.

Pyra mid Step 4 Full compensation has occurred if the pH is in a normal range of 7.35 to 7.45. If the pH is not within normal range, look at the respiratory or metabolic function indicators.

If the condition is a respiratory imbalance, look at the HCO3À to determine the state of compensation.

If the condition is a metabolic imbalance, look at the PaCO2 to determine the state of compensation.

104 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

59. Th e n urse n otes th at a clien t’s arterial blood gas (ABG) results reveal a pH of 7.50 an d a PaCO 2 of 30 m m Hg (30 m m Hg) . Th e n urse m on itors th e clien t for wh ich clin ical m an ifestation s associated with th ese ABG results? Select all th at ap p ly.

1. Nausea 2. Con fusion 3. Bradypn ea 4. Tach ycardia 5. Hyperkalem ia 6. Ligh th eadedn ess

60. Th e n urse reviews th e blood gas results of a clien t with atelectasis. Th e n urse an alyzes th e results an d determ in es th at th e clien t is experien cin g respi- ratory acido sis. Wh ich result validates th e n urse’s fin din gs? 1. pH 7.25, PaCO 2 50 m m Hg (50 m m Hg) 2. pH 7.35, PaCO 2 40 m m Hg (40 m m Hg) 3. pH 7.50, PaCO 2 52 m m Hg (52 m m Hg) 4. pH 7.52, PaCO 2 28 m m Hg (28 m m Hg)

61. Th e n urse is carin g for a clien t wh o is on a m ech an - ical ven tilator. Bloo d gas results in dicate a pH of 7.50 an d a PaCO 2 of 30 m m Hg (30 m m Hg). Th e n urse h as determ in ed th at th e clien t is experien cin g respiratory alkalosis. Wh ich labo ratory value would m o st likely be n oted in th is con d ition ? 1. Sodium level of 145 m Eq/ L (145 m m ol/ L) 2. Potassium level of 3.0 m Eq/ L (3.0 m m o l/ L) 3. Magn esium level of 1.3 m Eq/ L (0.65 m m o l/ L) 4. Ph osph orus level of 3.0 m g/ dL (0.97 m m ol/ L)

62. Th e n urse is carin g for a clien t with several broken ribs. Th e clien t is m o st likely to exp erien ce wh at type of acid-b ase im balan ce? 1. Resp iratory acido sis from in adeq uate ven tilation 2. Resp iratory alkalosis from an xiety an d

h yperven tilation 3. Metab olic acido sis from calcium loss due to

broken bon es 4. Metab olic alkalosis from takin g an algesics co n -

tain in g base produ cts

A N S W E R S 53. 2 Ra t ion a le: Th e n orm al p H is 7.35 to 7.45. In a resp irato ry co n - ditio n , an o pp o site effect will b e seen between th e pH an d th e PaCO 2. In th is situ ation , th e pH is at th e h igh en d o f th e n o rm al value an d th e PCO 2 is low. In an alkalotic co n d itio n , th e p H is elevated. Th erefo re, th e values id en tified in th e qu estio n in di- cate a resp irato ry alkalo sis th at is com pen sated by th e kid n eys th ro ugh th e ren al excretio n o f b icarb on ate. Becau se th e pH h as retu rn ed to a n orm al value, com pen sation h as occurred. Test -Ta kin g Str a tegy: Focus o n th e su b ject , arterial blo o d gas results. Rem em ber th at in a respiratory im balan ce you will fin d an o pp osite respo n se b etween th e pH an d th e PCO 2 as in d icated in th e q uestion . Th erefo re, you can elim in ate th e o ptio n s reflective of a prim ary m etabolic problem . Also, rem em ber th at th e pH in creases in an alkalotic co n d ition an d co m pen sation can be evid en ced by a n orm al p H. Th e correct o ptio n reflects a resp irato ry alkalotic co n d itio n an d com pen satio n an d describes th e blo o d gas values as in d icated in th e q uestion . Review: Th e step s related to a n a lyzin g a r t er ia l b lo o d ga s r esu lt s an d th e fin din gs n o ted in r esp ir a t o r y a lk a lo sis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Acid-Base Pr ior ity Con cepts: Acid -Base Balan ce; Clin ical Ju dgm en t Refer en ce: Lewis et al. (2014), p . 304.

54. 2 Ra t ion a le: Metab olic alkalo sis is d efin ed as a deficit or lo ss o f h ydrogen io n s or acids o r an excess of b ase ( bicarbo n ate) th at results fro m th e accum ulatio n of base or from a loss of acid with ou t a co m parable lo ss of base in th e bo d y fluid s. Th is occu rs in con dition s resu ltin g in h yp o vo lem ia, th e loss of gas- tric fluid , excessive b icarbo n ate in take, th e m assive tran sfusion

o f wh o le b lo od , an d h yp eraldo stero n ism . Lo ss o f gastric fluid via n aso gastric suction o r vom itin g cau ses m etab o lic alkalo sis as a resu lt o f th e loss of h yd roch lo ric acid. Th e rem ain in g o p tion s are in co rrect in terp retatio n s. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject , a clien t with a n asogastric tub e attach ed to suctio n . Rem em berin g th at a clien t receivin g n aso gastric su ction loses h ydroch lo ric acid will direct yo u to th e o ptio n iden tifyin g an alkalo tic co n d ition . Becau se th e q u estion ad dresses a situ atio n o th er th an a respirato ry o n e, th e acid-b ase d iso rd er wou ld be a m etab olic co n d ition . Review: Th e ca u ses o f m et a b o lic a lk a lo sis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Acid-Base Pr ior ity Con cepts: Acid -Base Balan ce; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), pp . 304–305.

55. 4 Ra t ion a le: Clien ts exp erien cin g n au sea an d vom itin g wo uld m o st likely p resen t with m etabo lic alkalo sis resu ltin g fro m lo ss o f gastric acid, th u s causin g th e pH an d HCO 3 À to in crease. Sym pto m s experien ced b y th e clien t wo uld in clud e h yp oven ti- lation an d tach ycard ia. O ption 1 reflects a respiratory acid otic co n dition . O ptio n 2 reflects a respiratory alkalotic co n d itio n , an d op tion 3 reflects a m etabo lic acido tic con d itio n . Test -Ta kin g Str a tegy: Focus on th e su b ject , exp ected arterial b lo od gas fin d in gs. Note th e data in th e q uestion an d th at th e clien t is vo m itin g. Recallin g th at vom itin g m ost likely causes m etab o lic alkalo sis will assist in d irectin g you to th e co r- rect op tio n . Review: Th e ca u ses o f m et a b o lic a lk a lo sis Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t

105CHAPTER 9 Acid-Base Balance

Con ten t Ar ea : Fu n d am en tals o f Care—Acid -Base Pr ior it y Con cept s: Acid-Base Balan ce; Clin ical Jud gm en t Refer en ces: Ign atavicius, Workm an (2016), pp. 183–184; Lewis et al. (2014), pp . 303–305.

56. 4 Ra tion a le: Th e ABG values are ab n o rm al, wh ich su pp orts a p h ysio logical prob lem . Th e ABGs in d icate respiratory alkalosis as a resu lt o f h yperven tilatin g, n ot acid osis. Con clu din g th at th e clien t is o verreactin g is an in su fficien t an alysis. No co n clu - sio n can b e m ade abo u t a clien t’s flu id vo lu m e statu s from th e in form atio n provid ed . Test-Ta kin g St r a t egy: Fo cu s o n th e d a t a in t h e q u e s t io n . No te th e ABG valu es an d u se kn o wled ge to in terp ret th em . No te th at th e p H is elevated an d th e PaCO 2 is d ecreased fro m n o rm al. Th is will assist yo u in d eterm in in g th at th e clien t is exp erien cin g resp irato ry alkalo sis. Next, th in k ab o u t th e cau ses o f resp irato ry alkalo sis to an swer co rrectly. Review: Th e ca u ses o f r esp ir a t o r y a lk a lo sis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Fu n d am en tals o f Care—Acid-Base Pr ior it y Con cept s: Acid-Base Balan ce; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), p p . 304–305.

57. 2, 4 Ra tion a le: Kussm au l’s respiratio n s are abn orm ally d eep an d in creased in rate. Th ese occu r as a resu lt o f th e co m p en sato ry action b y th e lu n gs. In bradyp n ea, resp iratio n s are regular b ut ab n o rm ally slo w. Ap n ea is d escrib ed as respiratio n s th at cease fo r several seco n d s. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject , th e ch aracteristics o f Kussm au l’s resp iratio n s. Use kn o wled ge of th e d escrip tion o f Kussm aul’s respiration s. Recallin g th at th is type o f resp ira- tio n occurs in d iab etic keto acid osis will assist you in an swerin g correctly. Review: Th e ch aracteristics o f Ku ssm a u l’s r esp ir a t io n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n d am en tals o f Care—Acid -Base Pr ior it y Con cept s: Acid-Base Balan ce; Clin ical Jud gm en t Refer en ce: Perry, Po tter, O sten d orf (2014), p. 89.

58. 4 Ra tion a le: Th e acid-b ase d isturb an ce is respiratory acid osis with out com p en sation . Th e n o rm al pH is 7.35 to 7.45. Th e n o rm al PaCO 2 is 35 to 45 m m Hg ( 35 to 45 m m Hg) . In resp i- rato ry acido sis th e pH is d ecreased an d th e PCO 2 is elevated . Th e n o rm al b icarbo n ate ( HCO 3 À ) level is 21 to 28 m Eq/ L (21 to 28 m m o l/ L) . Because th e b icarbo n ate is still with in n orm al lim its, th e kidn eys h ave n o t h ad tim e to ad ju st fo r th is acid - b ase disturban ce. In add itio n , th e pH is n ot with in n orm al lim its. Th erefo re, th e con d itio n is with ou t co m pen sation . Th e rem ain in g o ptio n s are in co rrect in terpretation s. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject , in terpretation of arterial b lo od gas resu lts. Rem em ber th at in a respiratory im b alan ce yo u will fin d an op po site resp on se between th e p H an d th e PaCO 2. Also, rem em ber th at th e pH is decreased

in an acido tic con d itio n an d th at co m p en satio n is reflected b y a n o rm al pH. Review: Th e p rocedu re for a n a lyzin g b lo o d ga s r esu lt s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Acid -Base Pr ior it y Con cept s: Acid-Base Balan ce; Clin ical Ju d gm en t Refer en ce: Lewis et al. (2014), p . 304.

59. 1, 2, 4, 6 Ra tion a le: Resp iratory alkalo sis is defin ed as a deficit o f car- b on ic acid o r a d ecrease in h ydrogen io n co n cen tration th at results from th e accum u lation o f base o r from a loss of acid with out a com parable loss of base in th e body fluids. Th is o ccurs in co n d itio n s th at cause o verstim u lation of th e resp ira- to ry system . Clin ical m an ifestatio n s o f resp irato ry alkalo sis in clu de leth argy, ligh th ead ed n ess, con fu sio n , tach ycard ia, d ys- rh yth m ias related to h ypokalem ia, n au sea, vo m itin g, epigastric p ain , an d n um b n ess an d tin glin g o f th e extrem ities. Hyperven - tilatio n (tach yp n ea) occu rs. Brad ypn ea d escrib es resp iratio n s th at are regu lar b u t abn o rm ally slo w. Hyp erkalem ia is asso ci- ated with acido sis. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject , th e in terp retation o f ABG valu es. No te th e data in th e q u estion to determ in e th at th e clien t is exp erien cin g resp irato ry alkalosis. Next, it is n eces- sary to th in k ab ou t th e p ath op h ysio lo gy th at o ccurs in th is con - d ition an d recall th e m an ifestation s th at occu r. Review: Th e clin ical m an ifestation s o f r esp ir a t o r y a lk a lo sis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Acid -Base Pr ior it y Con cept s: Acid-Base Balan ce; Clin ical Ju d gm en t Refer en ce: Lewis et al. (2014), p . 305.

60. 1 Ra tion a le: Atelectasis is a con dition ch aracterized by th e col- lap se of alveoli, p reven tin g th e respiratory exch an ge of o xygen an d carb on dio xid e in a p art of th e lun gs. Th e n orm al pH is 7.35 to 7.45. Th e n o rm al PaCO 2 is 35 to 45 m m Hg ( 35 to 45 m m Hg) . In respiratory acido sis, th e pH is decreased an d th e PaCO 2 is elevated . O p tion 2 id en tifies n orm al valu es. O ptio n 3 iden tifies an alkalo tic con dition , an d o p tion 4 id en - tifies resp irato ry alkalo sis. Test-Ta kin g Str a t egy: Focu s on th e su b ject , th e arterial bloo d gas resu lts in a clien t with atelectasis. Rem em ber th at in a respi- ratory im balan ce you will fin d an o pp o site respo n se b etween th e p H an d th e PaCO 2. Also, rem em b er th at th e p H is d ecreased in an acido tic co n d itio n . First elim in ate o ption 2 b ecau se it reflects a n orm al blood gas result. O p tion s 3 an d 4 iden tify an elevated pH, in dicatin g an alkalotic co n dition . Th e co rrect o ptio n is th e on ly o n e th at reflects an acido tic co n d itio n . Review: Blo od gas fin d in gs in r esp ir a t o r y a cid o sis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysiological In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Acid -Base Pr ior it y Con cept s: Acid-Base Balan ce; Clin ical Ju d gm en t Refer en ce: Lewis et al. (2014), p p. 305, 550.

F

u

n

d

a

m

e

n

t

a

l

s

106 UNIT III Nursing Sciences

61. 2 Ra t ion a le: Resp irato ry alkalosis is d efin ed as a d eficit of car- bo n ic acid or a decrease in h yd rogen io n co n cen tratio n th at results fro m th e accum ulatio n of base or from a loss of acid with ou t a co m parable lo ss of base in th e bo d y fluid s. Th is occu rs in con dition s th at cau se overstim ulatio n o f th e respira- to ry system . Clin ical m an ifestation s o f respiratory alkalo sis in clud e leth argy, ligh th ead edn ess, co n fu sion , tach ycardia, dys- rh yth m ias related to h ypokalem ia, n ausea, vom itin g, epigastric pain , an d n u m bn ess an d tin glin g of th e extrem ities. All th ree in correct o ptio n s iden tify n o rm al lab o rato ry valu es. Th e co r- rect option iden tifies th e presen ce of h ypokalem ia. Test -Ta kin g St r a tegy: Note th e st r a t egic wo r d s , most likely. Fo cu s on th e d a t a in t h e q u est io n an d use kn o wledge abo u t th e in terp retatio n o f arterial bloo d gas values to determ in e th at th e clien t is experien cin g resp irato ry alkalosis. Next, recall th e m an ifestation s th at o ccur in th is con dition an d th e n o rm al lab - orato ry valu es. Th e on ly ab n o rm al labo rato ry value is th e po tassium level, th e correct o ptio n . Review: Th e clin ical m an ifestatio n s of r esp ir a t o r y a lk a lo sis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Acid-Base

Pr ior ity Con cepts: Acid -Base Balan ce; Clin ical Ju dgm en t Refer en ce: Lewis et al. (2014), p. 305.

62. 1 Ra t ion a le: Respiratory acido sis is m o st often caused b y h ypo - ven tilatio n . Th e clien t with b ro ken ribs will h ave d ifficu lty with b reath in g adequ ately an d is at risk for h yp oven tilatio n an d resu ltan t resp irato ry acid osis. Th e rem ain in g op tio n s are in co r- rect. Respiratory alkalosis is asso ciated with h yperven tilatio n . Th ere are n o data in th e q u estion th at in dicate calciu m lo ss o r th at th e clien t is takin g an algesics co n tain in g b ase prod ucts. Test -Ta kin g St r a t egy: Focus on th e d a t a in t h e q u est io n . Th in k ab ou t th e location of th e rib s to d eterm in e th at th e clien t will h ave difficulty breath in g adequately. Th is will assist in d irectin g yo u to th e co rrect o ptio n . Rem em b erin g th at h yp o - ven tilatio n resu lts in resp irato ry acido sis will d irect you to th e co rrect o p tion . Review: Ca u ses o f r esp ir a t o r y a cid o sis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Acid-Base Pr ior ity Con cepts: Acid -Base Balan ce; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), pp . 305, 598.

F

u

n

d

a

m

e

n

t

a

l

s

107CHAPTER 9 Acid-Base Balance

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 10 Vital Signs and Laboratory Reference Intervals

PRIORITY CONCEPTS Cellular Regulation; Perfusion

CRITICAL THINKING What Should You Do? The nurse has just received a client from the postanesthesia care unit (PACU) and is monitoring the client’s vital signs. On arrival to the unit, the client’s temperature was 37.2 °C (98.9 °F) orally, the blood pressure was 142/ 78 mm Hg, the heart rate was 98 beats per minute, the respiratory rate was 14 breaths per minute, and the oxygen saturation was 95% on 3 L of oxygen via nasal cannula. The nurse returns to the room 30 minutes later to find the client’s temperature to be 36.8 °C (98.2 °F) orally, the blood pressure 95/ 54 mm Hg, the heart rate 118 beats per minute, the respiratory rate 18 breaths per minute, and the oxygen saturation 92% on 3 L of oxygen via nasal cannula. On the basis of these data, what actions should the nurse take? Answer located on p. 119.

I. Vital Signs A. Description : Vital sign s in clude tem p erature, pulse,

respiration s, blood pressure (BP) , oxygen saturation (pulse oxim etry), an d pain assessm en t.

B. Guidelin es for m easu rin g vital sign s 1. In itial m easu rem en t of vital sign s provides base-

lin e data on a clien t’s h ealth status an d is used to h elp iden tify ch an ges in th e clien t’s h ealth status.

2. Som e vital sign m easurem en ts (tem perature, pulse, respiration s, BP, pulse oxim etry) m ay be delegated to un licen sed assistive perso n n el (UAP), but th e n urse is respo n sible for in terp ret- in g th e fin din gs.

3. Th e n urse collabo rates with th e h ealth care pro- vider (HCP) in determ in in g th e frequen cy of vital sign assessm en t an d also m akes in depen - den t decision s regardin g th eir frequen cy on th e basis of th e clien t’s status.

The nurse always documents vital sign measure- ments and reports abnormal findings to the HCP.

C. Wh en vital sign s are m easured 1. O n in itial con tact with a clien t (e.g., wh en a cli-

en t is adm itted to a h ealth care facility) 2. Durin g ph ysical assessm en t of a clien t 3. Before an d after an in vasive diagn ostic procedure

or surgical procedure 4. Durin g th e adm in istration of m ed ication th at

affects th e cardiac, respiratory, or tem p erature- con trollin g fun ction s (e.g., in a clien t wh o h as a fever) ; m ay be required before, durin g, an d after adm in istration of th e m ed ication

5. Before, durin g, an d after a blood tran sfusion 6. Wh en ever a clien t’s con d ition ch an ges 7. Wh en ever an in terven tion (e.g., am bulation )

m ay affect a clien t’s con dition 8. Wh en a fever or kn own in fection is presen t

(every 2 to 4 h ours)

II. Temperature A. Descrip tion

1. Norm al body tem p erature ran ges from 36.4° to 37.5° Celsius (C) (97.5° to 99.5° Fah ren h eit [F]); th e average in a h ealth y yo un g adult is 37.0 °C (98.6 °F).

2. Com m on m easu rem en t sites are th e m ou th , rec- tum , axilla, ear, an d across th e foreh ead (tem po - ral artery site); various types of electron ic m easu rin g devices are com m on ly used.

3. Rectal tem p eratures are usually 1 °F (0.5 °C) h igh er an d axillary tem peratures about 1 °F (0.5 °C) lower th an th e n orm al oral tem p erature.

4. Kn ow h ow to con vert a tem p erature to a Fah ren - h eit or Celsius value ( Box 10-1).

B. Nursin g con sideration s 1. Tim e of day

a . Tem perature is gen erally in th e low-n orm al ran ge at th e tim e of awaken in g as a result of m uscle in activity.

b . Aftern oon body tem p erature m ay be h igh - n orm al as a result of th e m etab olic process, activity, an d en viron m en tal tem p erature.

108

2. En viron m en tal tem perature: Body tem p erature is lower in cold weath er an d h igh er in warm weath er.

3. Age: Tem perature m ay fluctuate durin g th e first year of life because th e in fan t’s h eat-regulatin g m ech an ism is n ot fully developed.

4. Ph ysical exercise: Use of th e large m uscles creates h eat, cau sin g an in crease in body tem p erature.

5. Men strual cycle: Tem perature decreases sligh tly just befo re ovulation but m ay in crease to 1 °F ab ove n orm al durin g ovulation .

6. Pregn an cy: Bod y tem perature m ay con sisten tly stay at h igh -n orm al because of an in crease in th e wom an ’s m etab olic rate.

7. Stress: Em otion s in crease h orm on al secretio n , lead in g to in creased h eat produ ction an d a h igh er tem perature.

8. Illn ess: In fective agen ts an d th e in flam m ato ry respo n se m ay cau se an in crease in tem perature.

9. Th e in ability to obtain a tem perature sh ould n ot be ign ored because it could represen t a con dition of h ypoth erm ia, a life-th reaten in g con d ition in very youn g an d older clien ts.

C. Meth od s of m easu rem en t 1. O ral

a. If th e client h as recently con sum ed h ot or cold foods or liquids or h as sm oked or ch ewed gum , th e n urse m ust wait 15 to 30 m in utes before takin g the tem perature orally.

b . The th erm om eter is placed un der th e ton gue in 1 of th e posterior sublingual pockets; ask th e cli- en t to keep th e ton gue down and th e lips closed an d to not bite down on th e th erm om eter.

2. Rectal a. Place th e clien t in th e Sim s position . b . Th e tem perature is taken rectally wh en an

accu rate tem p erature can n ot be obtain ed orally or wh en th e clien t h as n asal con ges- tio n , h as un dergon e n asal or oral surgery or h ad th e jaws wired, h as a n asogastric tube in place, is un ab le to keep th e m outh closed , or is at risk for seizu res.

c. Th e th erm om eter is lubricated an d in serted in to th e rectum , toward th e um b ilicus, ab out 1.5 in ch es (3.8 cm ) (n o m ore th an 0.5 in ch [1.25 cm ] in an in fan t).

The temperature is not taken rectally in cardiac cli- ents; the client who has undergone rectal surgery; or the client with diarrhea, fecal impaction, or rectal bleeding or who is at risk for bleeding.

3. Axillary a. Th is m eth od of takin g th e tem p erature is used

wh en th e oral or rectal tem p erature m easure- m en t is con train dicated.

b . Axillary m easu rem en t is n ot as accu rate as th e oral, rectal, tym pan ic, or tem poral artery m eth od but is used wh en oth er m eth od s of m easu rem en t are n ot possible.

c. Th e th erm om eter is placed in th e clien t’s dry axilla an d th e clien t is asked to h old th e arm tigh tly again st th e ch est, restin g th e arm on th e ch est; follow th e in struction s accom pan y- in g th e m easurem en t device for th e am oun t of tim e th e th erm om eter sh ould rem ain in th e axillary area.

4. Tym pan ic a. Th e au ditory can al is ch ecked for th e presen ce

of redn ess, swellin g, disch arge, or a foreign body befo re th e probe is in serted; th e probe sh ould n ot be in serted if th e clien t h as an in flam m ato ry con d ition of th e auditory can al or if th ere is disch arge fro m th e ear.

b . Th e readin g m ay be affected by an ear in fec- tion or excessive wax blockin g th e ear can al.

5. Tem po ral artery a. En su re th at th e clien t’s foreh ead is dry. b . Th e th erm om eter probe is placed flush

again st th e skin an d slid across th e foreh ead or placed in th e area of th e tem poral artery an d h eld in place.

c. If th e clien t is diaph o retic, th e tem poral artery th erm om eter probe m ay be placed on th e n eck, just beh in d th e earlobe.

III. Pulse A. Description

1. Th e average adult pulse (h eart) rate is 60 to 100 beats/ m in .

2. Ch an ges in pulse rate are used to evalu ate th e cli- en t’s toleran ce of in terven tion s such as am bula- tion , bath in g, dressin g, an d exercise.

3. Ped al pulses are ch ecked to determ in e wh eth er th e circulation is blocked in th e artery up to th at pulse poin t.

4. Wh en th e pedal pulse is difficult to locate, a Do ppler ultrasoun d steth oscope (ultrason ic steth oscope) m ay be n eeded to am plify th e soun ds of pulse waves.

B. Nursin g con sideration s 1. Th e h eart rate slows with age. 2. Exercise in creases th e h eart rate. 3. Em otion s stim ulate th e sym path etic n ervou s sys-

tem , in creasin g th e h eart rate.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 10-1 Body Temperature Conversion To convert Fahrenheit to Celsius: Degrees Fahrenheit –

32 Â 5/ 9 ¼Degrees Celsius Example: 98.2 °F – 32 Â 5/ 9 ¼36.7 °C

To convert Celsius to Fahrenheit: Degrees Celsius  9/ 5 + 32¼Degrees Fahrenheit Example: 38.6 °C 9/ 5+ 32¼101.5 °F

109CHAPTER 10 Vital Signs and Laboratory Reference Intervals

4. Pain in creases th e h eart rate. 5. In creased body tem perature causes th e h eart rate

to in crease. 6. Stim ulan t m ed ication s in crease th e h eart rate;

dep ressan ts an d m edication s affectin g th e car- diac system slow it.

7. Wh en th e BP is lo w, th e h eart rate is usually in creased.

8. Hem o rrh age in creases th e h eart rate. C. Assessin g pulse qualities

1. Wh en th e pulse is bein g co un ted, n ote th e rate, rh yth m , an d stren gth (force or am plitude).

2. O n ce yo u h ave ch ecked th ese param eters, use th e gradin g scale for pulses to assess th e in form ation you h ave elicited (Box 10-2).

D. Pulse poin ts an d location s 1. Th e tem poral artery can be palp ated an terior to

or in th e fron t of th e ear. 2. Th e carotid artery is located in th e groove

between th e trach ea an d th e stern ocleidom as- toid m uscle, m edial to an d alon gside th e m uscle.

3. Th e apical pulse m ay be detected at th e left m id- clavicular, fifth in tercostal space.

4. Th e brach ial pulse is located above th e elbow at th e an tecu bital fossa, between th e biceps an d tri- ceps m uscles.

5. Th e radial pulse is located in th e groo ve alon g th e radial or th u m b side of th e clien t’s in n er wrist.

6. Th e fem oral pulse is located below th e in guin al ligam en t, m idway between th e sym ph ysis pubis an d th e an terosuperior iliac spin e.

7. Th e popliteal pulse is located beh in d th e kn ee. 8. Th e posterior tibial pulse is lo cated on th e in n er

side of th e an kle, beh in d an d below th e m edial m alleolus (an kle bon e).

9. Th e dorsalis pedis pulse is located on th e top of th e foot, in lin e with th e groo ve between th e exten sor ten don s of th e great an d first toes.

The apical pulse is counted for 1 full minute and is assessed in clients with an irregular radial pulse or a heart condition, before the administration of cardiac medications such as digoxin and beta blockers, and in children younger than 2 years.

E. Pulse deficit 1. In th is con dition , th e periph eral pulse rate

(radial pulse) is less th an th e ven tricular con trac- tion rate (apical pulse).

2. A pulse deficit in dicates a lack of peripheral perfu- sion ; can be an in dication of cardiac dysrh yth m ias.

3. O n e-exam in er tech n iqu e: Auscultate an d coun t th e apical pulse first an d th en im m ediately coun t th e radial pulse.

4. Two-exam in er tech n iqu e: O n e perso n coun ts th e apical pulse an d th e oth er coun ts th e radial pulse sim ultan eously.

5. A pulse deficit in dicates th at cardiac con traction s are in effective, failin g to sen d pulse waves to th e periph ery.

6. If a differen ce in pulse rate is n oted, th e HCP is n otified.

IV. Respirations A. Descrip tion

1. Resp iratory rates vary with age. 2. Th e n orm al adult respiratory rate is 12 to 20

breath s/ m in . B. Nursin g con sideration s

1. Man y of th e facto rs th at affect th e pulse rate also affect th e respiratory rate.

2. An in creased level of carbo n dioxide or a lower level of oxygen in th e blood results in an in crease in respiratory rate.

3. Head in jury or in creased in tracran ial pressure will depress th e respiratory cen ter in th e brain , result- in g in sh allow respiratio n s or slowed breath in g.

4. Medication s such as opioid an algesics depress respiration s.

C. Assessin g respiratory rate 1. Coun t th e clien t’s respiration s after m easurin g

th e radial pulse. (Co n tin ue h old in g th e clien t’s wrist wh ile coun tin g th e respiration s or position th e h an d on th e clien t’s ch est.)

2. O n e respiration in cludes both in spiration an d expiration .

3. Th e rate, dep th , pattern , an d soun ds are assessed.

The respiratory rate may be counted for 30 seconds and multiplied by 2, except in a client who is known to be very ill or is exhibiting irregular respirations, in which case respirations are counted for 1 full minute.

V. Blood Pressure A. Descrip tion

1. BP is th e force on th e walls of an artery exerted by th e pulsatin g blood un der pressure fro m th e h eart.

2. Th e h eart’s con traction forces blood un d er h igh pressure in to th e ao rta; th e peak of m axim u m pressure wh en ejection occurs is th e systolic pres- sure; th e blood rem ain in g in th e arteries wh en th e ven tricles relax exerts a force kn own as th e diastolic pressure.

3. Th e differen ce between th e systolic an d diastolic pressures is called th e pulse pressure.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 10-2 Grading Scale for Pulses 4 +¼Strong and bounding 3+¼Full pulse, increased 2 +¼Normal, easily palpable 1+¼Weak, barely palpable 0 ¼Absent, not palpable

110 UNIT III Nursing Sciences

4. For an ad ult (age 18 an d older) , a n orm al BP is a systolic pressure below 120 m m Hg an d a dia- stolic pressure below 80 m m Hg.

5. Classification s in clude preh yperten sion an d stage 1 an d stage 2 h yperten sion ( Box 10-3).

6. In postu ral (orth ostatic) h ypo ten sion , a n orm o- ten sive clien t exh ibits sym pto m s an d low BP on risin g to an uprigh t position .

7. To obtain orth ostatic vital sign m easurem en ts, ch eck th e BP an d pulse with th e clien t supin e, sit- tin g, an d stan din g; readin gs are obtain ed 1 to 3 m in u tes after th e clien t ch an ges position .

B. Nu rsin g con sideration s 1. Facto rs affectin g BP

a. BP ten ds to in crease as th e agin g process progresses.

b . Stress results in sym path etic stim ulation th at in creases th e BP.

c. Th e in ciden ce of h igh BP is h igh er am on g African Am erican s th an am on g Am erican s of European descen t.

d . An tih yperten sive m ed ication s an d opioid an algesics can decrease BP.

e. BP is typ ically lowest in th e early m orn in g, gradually in creases durin g th e day, an d peaks in th e late aftern oon an d even in g.

f. After puberty, m ales ten d to h ave h igh er BP th an fem ales; after m en op ause, wom en ten d to h ave h igh er BP th an m en of th e sam e age.

2. Guidelin es for m easurin g BP a. Determ in e th e best site for assessm en t. b . Avo id applyin g a cuff to an extrem ity in to

wh ich in traven ous (IV) fluids are in fusin g, wh ere an arterioven o us sh un t or fistula is presen t, on th e side on wh ich breast or axil- lary surgery h as been perform ed, or on an extrem ity th at h as been traum atized or is diseased.

c. Th e leg m ay be used if th e brach ial artery is in accessible; th e cuff is wrapp ed arou n d th e th igh an d th e steth oscope is placed over th e popliteal artery.

d . En su re th at th e clien t h as n ot sm oked or exer- cised in th e 30 m in u tes befo re m easurem en t because both activities can yield falsely h igh readin gs.

e. Have th e clien t assum e a sittin g (with feet flat on flo or) or lyin g position an d th en rest for 5 m in utes befo re th e m easurem en t; ask th e clien t n ot to speak durin g th e m easu rem en t.

f. En su re th at th e cuff is fully deflated , th en wrap it even ly an d sn ugly arou n d th e extrem ity.

g. En su re th at th e steth oscope bein g used fits th e exam in er an d does n ot im pair h earin g.

h . Do cum en t th e first Korotkoff soun d at ph ase 1 (h eard as th e blood pulsates th rou gh th e vessel wh en air is released from th e BP cuff an d pressure on th e artery is reduced) as th e systolic pressure an d th e begin n in g of th e fifth Korotkoff soun d at ph ase 5 as th e dia- stolic pressure.

i. BP readin gs obtain ed electron ically with a vital sign m on itorin g m ach in e sh o uld be ch ecked with a m an u al cuff if th ere is an y con - cern about th e accu racy of th e readin g.

When taking a BP, select the appropriate cuff size; a cuff that is too small will yield a falsely high reading, and a cuff that is too large will yield a falsely low one.

VI. Pulse Oximetry A. Description

1. Pulse oxim etry is a n on in vasive test th at registers th e oxygen saturation of th e clien t’s h em oglobin .

2. Th e capillary oxygen saturation (SaO 2) is recorded as a percen tage.

3. Th e n orm al value is 95% to 100%. 4. After a h ypo xic clien t uses up th e readily avail-

able oxygen (m easured as th e arterial oxygen pressure, PaO 2, on arterial blood gas [ABG] test- in g), th e reserve oxygen , th at oxygen attach ed to th e h em oglobin (SaO 2), is drawn on to pro- vide oxygen to th e tissues.

5. A pulse oxim eter readin g can alert th e n urse to h ypo xem ia befo re clin ical sign s occur.

6. If pulse oxim etry readin gs are below n orm al, in struct th e clien t in deep breath in g tech n ique an d rech eck th e pulse oxim etry.

B. Proced ure 1. A sen sor is placed on th e clien t’s fin ger, toe, n ose,

earlobe, or foreh ead to m easu re oxygen satura- tion , wh ich th en is displayed on a m on itor.

2. Main tain th e tran sducer at h eart level. 3. Do n ot select an extrem ity with an im ped im en t

to blood flo w.

A usual pulse oximetry reading is between 95% and 10 0%. A pulse oximetry reading lower than 90% neces- sitates HCP notification; values below 90 % are accept- able only in certain chronic conditions. Agency procedures and HCP prescriptions are followed regard- ing actions to take for specific readings.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 10-3 Hypertension Classifications Prehypertension: A systolic blood pressure (BP) of 120 to

139 mm Hg or a diastolic pressure of 80 to 89 mm Hg Stage 1: A systolic BP of 140 to 159 mm Hg or a diastolic pres-

sure of 90 to 99 mm Hg Stage 2: A systolic BP equal to or greater than 160 mm Hg or a

diastolic pressure equal to or greater than 10 0 mm Hg

111CHAPTER 10 Vital Signs and Laboratory Reference Intervals

F

u

n

d

a

m

e

n

t

a

l

s

VII. Pain A. Types of pain

1. Acute: Usually associated with an in jury, m edical con d ition , or surgical procedure; lasts h ours to a few days

2. Ch ron ic: Usually associated with lo n g-term or ch ron ic illn esses or disorders; m ay con tin ue for m on th s or even years

3. Ph an tom : O ccurs after th e loss of a body part (am p utation ); m ay be felt in th e am putated part for years after th e am putation

B. Assessm en t 1. Pain is a h igh ly in dividual exp erien ce. 2. Ask th e clien t to describe pain in term s of degree,

quality, area, an d frequen cy. 3. Ask th e clien t about th e use of com plem en tary

an d altern ative th erapies to alleviate pain . 4. Pain experien ced by th e older clien t m ay be m an -

ifested differen tly th an pain exp erien ced by m em bers of oth er age groups (e.g., sleep distur- ban ces, ch an ges in gait an d m ob ility, decreased socialization , depression ).

5. Clien ts with cogn itive disorders (e.g., a clien t with dem en tia, a com atose clien t) m ay n ot be able to describe th eir pain experien ces.

6. Th e n urse sh ould be alert to n on verbal in dicators of pain ( Box 10-4).

7. Ask th e clien t to use a n um ber-based pain scale (a picture-based scale m ay be used in ch ildren or clien ts wh o can n ot verbally describe th eir pain ) to rate th e degree of pain (Fig. 10-1).

8. Evaluate clien t respon se to n on ph arm acolo gical in terven tion s.

Consider the client’s culture in assessing pain; some cultures, including many Asian cultures, frown on the outward expression of pain.

C. Con ven tion al n on ph arm aco logical in terven tion s 1. Cutan eous stim ulation

a . Tech n iques in clude h eat, cold, an d pressure an d vibration . Therapeutic touch an d m assage are also cutan eous stim ulation an d m ay be con sidered com plem en tary an d altern ative tech n iques.

b . Such treatm en ts m ay require an HCP’s prescription .

2. Tran scutan eou s electrical n erve stim ulation (TENS) a . TENS is also referred to as percutan eous elec-

trical n erve stim ulation (PENS) . b . Th is tech n iqu e, wh ich m ay require an HCP’s

prescription , in volves th e application of a battery-operated device th at delivers a low electrical curren t to th e skin an d un derlyin g tissues to block pain .

3. Bin ders, slin gs, an d oth er supp ortive devices a . Cloth s or oth er m aterials or devices, wrapp ed

aroun d a lim b or body part, can ease th e pain of strain s, sprain s, an d surgical in cision s.

b . Such devices m ay require an HCP’s prescription . c. Elevation of th e affected body part is an oth er

in terven tion th at can reduce swellin g; sup- portin g an extrem ity on a pillow m ay lessen discom fort.

4. Heat an d cold a . Th e application of h eat an d cold or altern at-

in g ap plication of th e two can sooth e pain resultin g from m uscle strain .

b . Such treatm en t m ay require an HCP’s pre- scrip tion .

BOX 10-4 Nonverbal Indicators of Pain ▪ Moaning ▪ Crying ▪ Irritability ▪ Restlessness ▪ Grimacing or frowning ▪ Inability to sleep ▪ Rigid posture ▪ Increased blood pressure, heart rate, or respiratory rate ▪ Nausea ▪ Diaphoresis

0 No hurt

1 or 2 Hurts

little bit

2 or 4 Hurts

little more

3 or 6 Hurts

e ve n more

4 or 8 Hurts

whole lot

5 or 10 Hurts wors t

B

A

No pa in 0 1 2 3 4 5 6 7 8 9 10

S e ve re pa in

Nume ric al

De s c riptive

No pa in Mild pa in Mode ra te pa in

Unbe a ra ble pa in

S e ve re pa in

Vis ual analo g

No pa in Unbe a ra ble pa in

Clie nts de s igna te a point on the s ca le corre s ponding to the ir pe rce ption of the pa in’s s e ve rity a t the time of a s s e s s me nt.

FIGURE 10-1 Pain assessment scales. A, Numerical, descriptive, and visual analog scales. B, Wong-Baker FACES® Pain Rating Scale. (B, Copy- right 1983, Wong-Baker FACES® Foundation, www.WongBakerFACES.org. Used with permission. Originally published in Whaley & Wong’s Nursing Care of Infants and Children. ©Elsevier Inc.)

112 UNIT III Nursing Sciences

c. Heat application s m ay in clude warm -water com presses, warm blan kets, th erm al pads, an d tub an d wh irlpool bath s.

d . Th e tem p erature of th e application m ust be m on itored carefully to h elp preven t burn s; th e skin of very yo un g an d older clien ts is extra sen sitive to h eat.

e. Th e application of cold can reduce swellin g an d m uscle spasm s an d ease pain in join ts an d m uscles.

f. Th e clien t sh ould be advised to rem ove th e source of h eat or cold if ch an ges in sen sation or discom fort occur. If th e ch an ge in sen sa- tio n or discom fort is n ot relieved after rem oval of th e application , th e HCP sh ould be n otified.

Ice or heat should be applied with a towel or other barrier between the pack and the skin, but should not be left in place for more than 15 to 30 minutes.

D. Com p lem en tary an d altern ative th erap ies 1. Description : Th erapies are used in addition

to con ven tion al treatm en t to provid e h ealin g resou rces an d focus on th e m in d -body con n ec- tio n (Box 10-5).

2. Nu rsin g con sid eration s a. Som e com plem en tary an d altern ative th era-

pies require an HCP’s prescription . b . Herbal rem edies are con sidered ph arm aco -

lo gical th erap y by som e HCPs; because of th e risk for in teraction with prescription m ed- ication s, it is im portan t th at th e n urse ask th e clien t about th e use of such th erap ies.

c. If spiritu al m easu res are to be em plo yed, th e n urse m ust elicit fro m th e clien t th e preferred form s of spiritual expressio n an d learn wh en th ey are practiced so th at th ey m ay be in te- grated in to th e plan of care.

VIII. Pharmacological Interventions A. Non o pioid an algesics

1. No n steroidal an tiin flam m ato ry drugs (NSAIDs) an d acetylsalicylic acid (Aspirin ) ( Box 10-6) a. Th ese m ed ication types are con train dicated if

th e clien t h as gastric irritatio n or ulcer disease or an allergy to th e m edication .

b . Bleedin g is a con cern with th e use of th ese m ed ication types.

c. In struct th e clien t to take oral doses with m ilk or a sn ack to reduce gastric irritatio n .

d . NSAIDs can am plify th e effects of an ticoagulan ts.

e. Hypo glycem ia m ay result for th e clien t takin g ibuprofen if th e clien t is con cu rren tly takin g an oral h ypo glycem ic agen t.

f. A h igh risk of toxicity exists if th e clien t is tak- in g ibuprofen con curren tly with a calcium ch an n el blocker.

2. Acetam in oph en a. Acetam in oph en , com m on ly kn own as Tyle-

n ol, is co n train d icated in clien ts with h epatic or ren al disease, alcoh olism , or h ypersen sitivity.

b . Assess th e clien t for a h isto ry of liver dys- fun ction .

c. Mon itor th e clien t for sign s of h epatic dam age (e.g., n ausea an d vom itin g, diarrh ea, abdom in al pain ).

d . Mon itor liver fun ction param eters. e. Tell th e clien t th at self-m edication sh o uld n ot

con tin ue lon ger th an 10 days in an adult or 5 days in a ch ild because of th e risk of h epatotoxicity.

f. Th e an tidote to acetam in oph en is acetylcys- tein e.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 10-5 Complementary and Alternative Therapies

Acupuncture and acupressure Biofeedback Chiropractic manipulation Distraction techniques Guided imagery and meditation techniques Herbal therapies Hypnosis Laughter and humor Massage Relaxation and repositioning techniques Spiritual measures (e.g., prayer, use of a rosary or prayer

beads, reading of scripture) Therapeutic touch

BOX 10-6 Side and Adverse Effects of NSAIDs and Acetylsalicylic Acid

NSAIDs ▪ Gastric irritation ▪ Hypotension ▪ Sodium and water retention ▪ Blood dyscrasias ▪ Dizziness ▪ Tinnitus ▪ Pruritus Acetylsalicylic Acid ▪ Gastric irritation ▪ Flushing ▪ Tinnitus ▪ Drowsiness ▪ Headaches ▪ Vision changes

113CHAPTER 10 Vital Signs and Laboratory Reference Intervals

The major concern with acetaminophen is hepatotoxicity.

B. O pioid an algesics 1. Description

a . Th ese m ed ication s suppress pain im pulses but can also suppress respiration an d co ugh - in g by actin g on th e respiratory an d cough cen ter, located in th e m edulla of th e brain stem .

b . Review th e clien t’s h isto ry an d n ote th at cli- en ts with im paired ren al or liver fun ctio n m ay on ly be able to tolerate low doses of opioid an algesics.

c. In traven ous route adm in istration produ ces a faster effect th an oth er routes but th e effect lasts sh o rter to relieve pain

d . O pioids, wh ich produ ce euph o ria an d sed a- tion , can cau se ph ysical depen den ce.

e. Adm in ister th e m edication 30 to 60 m in u tes befo re pain ful activities.

f. Mon itor th e respiratory rate; if it is slower th an 12 breath s/ m in in an adult, with h old th e m ed ication an d n otify th e HCP.

g. Mon itor th e pulse; if bradycardia develo ps, with h old th e m ed ication an d n otify th e HCP.

h Mon itor th e BP for h ypo ten sion an d assess befo re adm in isterin g pain m ed ication s to decrease th e risk of adverse effects.

i. Auscu ltate th e lun gs for n orm al breath soun ds.

j. En cou rage activities such as turn in g, deep breath in g, an d in cen tive spirom etry to h elp preven t atelectasis an d pn eum on ia.

k . Mon itor th e clien t’s level of con scio usn ess. l. In itiate safety precaution s. m . Mon itor in take an d outp ut an d assess th e cli-

en t for urin e reten tion . n . In struct th e clien t to take oral doses with m ilk

or a sn ack to reduce gastric irritatio n . o . In struct th e clien t to avoid activities th at

require alertn ess. p . Assess th e effectiven ess of th e m edication

30 m in utes after ad m in stration . q . Have an opioid an tagon ist (e.g., n aloxo n e),

oxygen , an d resuscitation equipm en t avail- able.

An electronic infusion device is always used for con- tinuous or dose-demand IV infusion of opioid analgesics.

2. Codein e sulfate a . Th is m edication is also used in low doses as a

cough suppressan t. b . It m ay cause con stipation . c. Com m on m edication s in th is class are h ydro-

codon e an d oxycodon e (syn th etic form s) .

3. Hydro m orph on e a . Th e prim ary con cern is respiration depres-

sion . b . O th er effects in clude drowsin ess, dizzin ess,

an d orth ostatic h ypoten sion . c. Mon itor vital sign s, especially th e respiratory

rate an d BP. 4. Morph in e sulfate

a . Morph in e sulfate is used to ease acute pain resultin g from m yocardial in farctio n or can - cer, for dyspn ea resultin g fro m pulm on ary edem a, an d as a preoperative m edication .

b . Th e m ajo r con cern is respiratory dep ression , but postu ral h ypoten sion , urin e reten tion , con stipation , an d pupillary con striction m ay also occur; m on itor th e clien t for adverse effects.

c. Morph in e m ay cause n ausea an d vom itin g by in creasin g vestibular sen sitivity.

d . It is con train dicated in severe respiratory dis- orders, h ead in juries, severe ren al disease, or seizure activity, an d in th e presen ce of in creased in tracran ial pressure.

e. Mon itor th e clien t for urin e reten tion . f. Mon itor bowel soun ds for decreased peristal-

sis; con stipation m ay occur. g. Mon itor th e pupil for ch an ges; pin poin t

pupils m ay in dicate overdose.

IX. Laboratory Reference Intervals For referen ce th rou gh out th e ch apter, see

Figure 10-2. A. Meth od s for drawin g blood (Table 10-1) B. Serum sodium

1. A m ajor cation of extracellular fluid. 2. Main tain s osm otic pressure an d acid-b ase bal-

an ce, an d assists in th e tran sm ission of n erve im pulses.

3. Is absorbed from th e sm all in testin e an d excreted in th e urin e in am oun ts depen den t on dietary in take.

4. Norm al referen ce in terval: 135 to 145 m Eq/ L (135 to 145 m m o l/ L).

Drawing blood specimens from an extremity in which an IV solution is infusing can produce an inaccu- rate result, depending on the test being performed and the type of solution infusing. Prolonged use of a tourni- quet before venous sampling can increase the blood level of potassium, producing an inaccurate result.

C. Serum potassium 1. A m ajor in tracellular cation , potassium regulates

cellular water balan ce, electrical con duction in m uscle cells, an d acid-b ase balan ce.

2. Th e body obtain s potassium th rou gh dietary in gestion an d th e kidn eys preserve or excrete potassium , depen din g on cellu lar n eed.

F

u

n

d

a

m

e

n

t

a

l

s

114 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

TOTAL BODY WEIGHT

WHOLE BLOOD (pe rce nta ge by volume )

PLAS MA (pe rce nta ge by we ight)

Blood 8%

Othe r fluids a nd

tis s ue s 92%

Ce ntrifuge d s a mple of blood

Buffy coa t

PLAS MA 55%

Albumins Globulins Fibrinoge n P rothrombin

54% 38%

4% 1%

PROTEINS

Ga s e s Ions Nutrie nts

Re gula tory s ubs ta nce s Wa s te products

OTHER S OLUTES

LEUKOCYTES

FORMED ELEMENTS 45%

P la te le ts

P rote ins

Wa te r

Othe r s olute s

7%

91%

2%

Ne utrophils 60-70%

Lymphocyte s 20-25%

Monocyte s 3-8%

Eos inophils 2-4%

Ba s ophils 0.5-1%

150,000-400,000 mm3

(150-400 × 109/L)

White blood ce lls

5000-10,000 mm3

(5.0-10.0 × 109/L)

FORMED ELEMENTS

FIGURE 10-2 Approximate values for the components of blood in a normal adult.

TABLE 10-1 Obtaining a Blood Sample Venipuncture Peripheral Intravenous Line Central Intravenous Line

Check health care provider’s (HCP’s) prescription.

Check HCP’s prescription. Check HCP’s prescription.

Identify foods, medications, or other factors that may affect the procedure or results.

Identify foods, medications, or other factors such as the type of solution infusing that may affect the procedure or results.

Identify foods, medications, or other factors such as the type of solution infusing that may affect the procedure or results.

Gather needed supplies, including gloves, needle (appropriate gauge and size), transfer/ collection device per agency policy, specimen containers per agency policy, tourniquet, antiseptic swabs, 2 Â 2 inch gauze, tape, tube label(s), biohazard bag, requisition form or bar code per agency policy.

Gather needed supplies, including gloves, tourniquet, transparent dressing or other type of dressing, tape, 2 Â 2 inch gauze, antiseptic agent, extension set (optional), two 5- or 10-mL normal saline flushes, one empty 5- or 10 -mL syringe (depending on the amount of blood needed), transfer/ collection device per agency policy, specimen containers per agency policy, alcohol- impregnated intravenous (IV) line end caps, tube labels, biohazard bag, requisition form or bar code per agency policy.

Gather needed supplies, including gloves, transfer/ collection device per agency policy, specimen containers per agency policy, two 5- or 10-mL normal saline flushes, one empty 5- or 10-mL syringe (depending on the amount of blood needed), antiseptic swabs, alcohol- impregnated IV line end caps, 2 masks, biohazard bag, requisition form or bar code per agency policy.

Perform hand hygiene. Identify the client with at least 2 accepted identifiers.

Perform hand hygiene. Identify the client with at least 2 accepted identifiers.

Perform hand hygiene. Identify the client with at least 2 accepted identifiers.

Explain the purpose of the test and procedure to the client.

Explain the purpose of the test and procedure to the client.

Explain the purpose of the test and procedure to the client.

Apply clean gloves. Place the client in a lying position or a semi-Fowler’s position. Place a small pillow or towel under the extremity.

Prepare extension set if being used by priming with normal saline. Attach syringe to extension set. Place extension set within reach while maintaining aseptic technique and keeping it in the package.

Place mask on self and client or ask client to turn the head away. Stop any running infusions for at least 1 minute.

Apply tourniquet 5 to 10 cm above the venipuncture site so it can be removed in 1 motion.

Apply tourniquet 10 to 15 cm above intravenous site. Clamp all ports. Scrub port to be used with antiseptic swab.

Ask the client to open and close the fist several times, then clench the fist.

Apply gloves. Scrub tubing insertion port with antiseptic solution or per agency policy.

Attach 5- or 10-mL normal saline flush and unclamp line. Flush line with appropriate amount per agency policy and withdraw 5- 10 mL of blood to discard (per agency policy). Clamp line and detach flush.

Continued

115CHAPTER 10 Vital Signs and Laboratory Reference Intervals

3. Potassium levels are used to evaluate cardiac fun ction , ren al fun ction , gastro in testin al fun c- tion , an d th e n eed for IV replacem en t th erapy.

4. If th e clien t is receivin g a potassium supplem en - tatio n , th is n eeds to be n oted on th e labo ratory form .

5. Clien ts with elevated wh ite blood cell (WBC) coun ts an d platelet coun ts m ay h ave falsely ele- vated potassium levels.

6. No rm al referen ce in terval: 3.5 to 5.0 m Eq/ L (3.5 to 5.0 m m o l/ L)

D. Activated partial th rom boplastin tim e (aPTT) 1. Th e aPTT evaluates h ow well th e coagu lation

seq uen ce (in trin sic clottin g system ) is fun ctio n - in g by m easu rin g th e am oun t of tim e it takes in secon ds for recalcified citrated plasma to clot after partial th rom bop lastin is added to it.

2. Th e test screen s for deficien cies an d in h ibitors of all factors, except facto rs VII an d XIII.

3. Usually, th e aPTT is used to m on itor th e effec- tiven ess of h eparin th erapy an d screen for coag- ulatio n disorders.

4. No rm al referen ce in terval: 28 to 35 secon ds (con ven tion al an d SI un its), depen din g on th e type of activator used.

5. If th e clien t is receivin g in term itten t h eparin th er- apy, draw th e blood sam ple 1 h our before th e n ext sch eduled dose.

6. Do n ot draw sam ples from an arm in to wh ich h eparin is in fusin g.

7. Tran sport specim en to th e laborato ry im m e- diately.

8. Provid e direct pressure to th e venipuncture site for 3 to 5 m in utes.

9. Th e aPTT sh ould be between 1.5 an d 2.5 tim es n orm al wh en th e clien t is receivin g h eparin th erap y.

If the aPTT value is prolonged (longer than 87.5 sec- onds or per agency policy) in a client receiving IVheparin therapy or in any client at risk for thrombocytopenia, initiate bleeding precautions.

E. Proth ro m bin tim e (PT) an d in tern ation al n orm al- ized ratio (INR) 1. Proth rom bin is a vitam in K–depen den t glyco-

protein produced by th e liver th at is n ecessary for fibrin clo t form ation .

2. Each labo ratory establish es a n orm al or con tro l value based on th e m eth od used to perform th e PT test.

3. The PT m easures th e am ount of tim e it takes in secon ds for clot form ation an d is used to m on itor respon se to warfarin sodium th erapy or to screen for dysfun ction of th e extrin sic clottin g system resultin g from liver disease, vitam in K deficien cy, or dissem in ated in travascular coagulation .

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 10-1 Obtaining a Blood Sample—cont’d Venipuncture Peripheral Intravenous Line Central Intravenous Line

Inspect to determine the vein to be used for venipuncture. Select the vein based on size and quality. Use the most distal site in the nondominant arm if possible. Palpate the vein with the index finger for resilience.

Attach 5- or 10-mL normal saline flush and unclamp line. Flush line with appropriate amount per agency policy and withdraw 5-10 mL of blood to discard (per agency policy). Clamp line and detach flush syringe.

Scrub port with antiseptic swab. Attach 5- or 10-mL syringe or transfer/ collection device to port (depending on available equipment), unclamp line, and withdraw needed sample or attach specimen container to withdraw using vacuum system. Clamp line and detach syringe or transfer/ collection device.

Clean site with antiseptic swabs or per agency policy, using a circular scrubbing motion, inward to outward for 30 seconds. Insert the needle bevel up at a 15- to 30- degree angle. Collect blood in collection device per agency policy.

Scrub tubing insertion port. Attach 5- or 10-mL syringe, extension set, or transfer/ collection device to port (depending on available equipment), unclamp line, and withdraw needed sample or attach specimen container to withdraw using vacuum system. Clamp line and detach syringe or transfer/ collection device.

Scrub port with antiseptic swab. Attach a 5- or 10-mL normal saline flush. Unclamp line and flush with amount per agency policy. Clamp line, remove flush, and place end cap on IV line. Remove masks.

Release tourniquet. Apply 2 Â 2 inch gauze over insertion site. Remove needle and engage safety on needle. Apply pressure for 2 minutes. If the client is on anticoagulants, apply pressure for several minutes. Perform hand hygiene.

Remove tourniquet and flush with normal saline to ensure patency.

Transfer specimen to collection device per agency policy if not previously collected.

Send specimen to the laboratory in biohazard bag with associated requisition forms or bar codes per agency policy.

Send specimen to the laboratory in biohazard bag with associated requisition forms or bar codes per agency policy.

Send specimen to the laboratory in biohazard bag with associated requisition forms or bar codes per agency policy.

116 UNIT III Nursing Sciences

4. A PT value with in 2 secon ds (plus or m in us) of th e con trol is con sidered n orm al.

5. Th e INR is a frequen tly used test to m easu re th e effects of som e an ticoagulan ts.

6. Th e INR stan dardizes th e PT ratio an d is calcu- lated in th e laborato ry settin g by raisin g th e observed PT ratio to th e power of th e in tern a- tio n al sen sitivity in dex specific to th e th rom bo- plastin reagen t used.

7. If a PT is prescribed , baselin e specim en sh ould be drawn before an ticoagulation th erap y is started; n ote th e tim e of collectio n on th e labo ra- tory form .

8. Provide direct pressure to th e ven ipu n cture site for 3 to 5 m in utes.

9. Con curren t warfarin th erap y with h eparin th er- ap y can len gth en th e PT for up to 5 h ours after dosin g.

10. Diets h igh in green leafy vegetables can in crease th e ab sorption of vitam in K, wh ich sh orten s th e PT.

11. O rally adm in istered an ticoagulation th erap y usually m ain tain s th e PT at 1.5 to 2 tim es th e lab- oratory con trol value.

12. No rm al referen ce in tervals a. PT: 11 to 12.5 secon ds (con ven tion al an d

SI un its) b . INR: 2 to 3 for stan d ard warfarin th erap y c. INR: 3 to 4.5 for h igh -d ose warfarin th erap y

Ifthe PT value is longer than 32 seconds and the INRis greater than 3.0 in a client receiving standard warfarin ther- apy (or per agency policy), initiate bleeding precautions.

F. Platelet coun t 1. Platelets fun ction in h em ostatic plug form ation ,

clo t retraction , an d coagulation factor activation . 2 Platelets are produced by th e bon e m arro w to

fun ction in h em ostasis. 3. Norm al referen ce in terval: 150,000-400,000 m m 3

(150–400 Â 109/ L) 4. Mon itor th e ven ipu n ctu re site for bleedin g in cli-

en ts with kn own th rom bocytopen ia. 5. High altitud es, ch ron ic cold weath er, an d exer-

cise in crease platelet coun ts. 6. Bleedin g precaution s sh ould be in stituted in cli-

en ts wh en th e platelet co un t falls sufficien tly below th e n orm al level; th e specific value for im plem en tin g bleedin g precaution s usually is determ in ed by agen cy policy.

Monitor the platelet count closely in clients receiv- ing chemotherapy because of the risk for thrombocyto- penia. In addition, any client who will be having an invasive procedure (such as a liver biopsy or thoracen- tesis) should have coagulation studies and platelet counts done before the procedure.

G. Hem o globin an d h em atocrit 1. Hem o globin is th e m ain com po n en t of eryth ro-

cytes an d serves as th e veh icle for tran spo rtin g oxygen an d carbo n dioxide.

2. Hem atocrit represen ts red blood cell (RBC) m ass an d is an im portan t m easu rem en t in th e pres- en ce of an em ia or polycyth em ia ( Table 10-2).

3. Fastin g is n ot required for th is test. H. Lipids

1. Bloo d lipids con sist prim arily of ch olestero l, tri- glycerides, an d ph o sph olipids.

2. Lipid assessm en t in cludes total ch olestero l, h igh - den sity lipoprotein (HDL), low-den sity lipopro- tein (LDL), an d triglycerides.

3. Ch o lesterol is presen t in all body tissues an d is a m ajo r com pon en t of LDLs, brain an d n erve cells, cell m em bran es, an d som e gallblad der ston es.

4. Triglycerides con stitute a m ajor part of very low- den sity lipoprotein s an d a sm all part of LDLs.

5. Triglycerides are syn th esized in th e liver from fatty acids, protein , an d glucose, an d are obtain ed fro m th e diet.

6. In creased ch olestero l levels, LDL levels, an d tri- glyceride levels place th e clien t at risk for coro- n ary artery disease.

7. HDL h elps to protect again st th e risk of coron ary artery disease.

8. O ral co n tracep tives m ay in crease th e lipid level. 9. In struct th e clien t to abstain from food an d fluid,

except for water, for 12 to 14 h ours an d from alcoh ol for 24 h ou rs before th e test.

10. In struct th e clien t to avoid con sum in g h igh - ch olesterol food s with th e even in g m eal before th e test.

11. No rm al referen ce in tervals ( Table 10-3). I. Fastin g blood glucose

1. Glu cose is a m on osacch aride foun d in fruits an d is form ed from th e digestion of carbo h ydrates an d th e con versio n of glycogen by th e liver.

2. Glu cose is th e m ain source of cellular en ergy for th e body an d is essen tial for brain an d eryth ro- cyte fun ction .

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 10-2 Hemoglobin and Hematocrit: Reference Intervals

Blood Component Reference Interval

Hemoglobin (altitude dependent) Male adult 14-18 g/ dL (140-180 mmol/ L) Female adult 12-16 g/ dL (120-160 mmol/ L)

Hematocrit (altitude dependent) Male adult 42%-52% (0.42-0.52) Female adult 37%-47% (0.37-0.47)

117CHAPTER 10 Vital Signs and Laboratory Reference Intervals

F

u

n

d

a

m

e

n

t

a

l

s

3. Fastin g blood glucose levels are used to h elp diagn ose diabetes m ellitus an d h ypo glycem ia.

4. In struct th e clien t to fast for 8 to 12 h ours before th e test.

5. In struct a clien t with diabetes m ellitus to with - h old m orn in g in sulin or oral h ypoglycem ic m ed- ication un til after th e blood is drawn .

6. No rm al referen ce in terval: gluco se (fastin g) 70-110 m g/ dL (4-6 m m ol/ L)

J. Glycosylated h em oglobin (HgbA1C) 1. HgbA1C is blood gluco se boun d to h em oglobin . 2. Hem o globin A1c (glycosylated h em oglobin A;

HbA1c) is a reflection of h ow well blood gluco se levels h ave been con trolled for th e past 3 to 4 m on th s.

3. Hyperglycem ia in clien ts with diabetes is usually a cau se of an in crease in th e HbA1c.

4. Fastin g is n ot required befo re th e test. 5. No rm al referen ce in tervals: 4.0%–6.0% (4.0%–

6.0%)

6. HgbA1C an d estim ated average gluco se (eAG) referen ce in tervals (Table 10-4).

K. Ren al fun ctio n studies 1. Serum creatin in e

a . Creatin in e is a specific in dicator of ren al fun ction .

b . In creased levels of creatin in e in dicate a slow- in g of th e glom erular filtration rate.

c. In struct th e clien t to avoid excessive exercise for 8 h ours an d excessive red m eat in take for 24 h ours befo re th e test.

d . Norm al referen ce in terval: 0.6–1.3 m g/ dL (53–115 µm ol/ L)

2. Bloo d urea n itrogen (BUN) a . Urea n itrogen is th e n itrogen portion of urea,

a substan ce form ed in th e liver th rough an en zym atic protein breakdown process.

b . Urea is n orm ally freely filtered th rough th e ren al glom eruli, with a sm all am oun t reab- sorbed in th e tubu les an d th e rem ain der excreted in th e urin e.

c. Elevated levels in dicate a slowin g of th e glo- m erular filtration rate.

d . BUN an d creatin in e ratios sh ould be an alyzed wh en ren al fun ctio n is evaluated.

e. Norm al referen ce in terval: 6–20 m g/ dL (2.1– 7.1 m m o l/ L)

L. Wh ite blood cell (WBC) coun t 1. WBCs fun ction in th e im m un e defen se system of

th e body. 2. Th e WBC differen tial provides specific in form a-

tion on WBC types. 3. A “sh ift to th e left” (in th e differen tial) m ean s

th at an in creased n um ber of im m ature n eutro- ph ils is presen t in th e blood.

4. A low total WBC coun t with a left sh ift in dicates a recovery from bon e m arrow depression or an in fec- tion of such in ten sity th at th e dem an d for n eutro- ph ils in the tissue is high er th an th e capacity of the bon e m arrow to release th em in to the circulation .

5. A h igh total WBC coun t with a left sh ift in dicates an in creased release of n eutroph ils by th e bon e m arro w in respo n se to an overwh elm in g in fec- tion or in flam m ation .

6. An in creased n eutroph il coun t with a left sh ift is usually associated with bacterial in fectio n .

7. A “sh ift to th e righ t” m ean s th at cells h ave m ore th an th e usual n um ber of n uclear segm en ts; foun d in liver disease, Down syn drom e, an d m egaloblastic an d pern iciou s an em ia.

8. Norm al referen ce in terval: 5000–10,000 m m 3

(5.0–10.0 Â 109/ L)

Monitor the WBC count and differential closely in cli- ents receiving chemotherapy because of the risk for neu- tropenia; neutropenia places the client at risk for infection.

TABLE 10-3 Lipids: Reference Intervals Blood Component Reference Interval

Cholesterol < 200 mg/ dL (< 5.2 mmol/ L)

High-density lipoproteins (HDLs)

Male: > 40 mg/ dL (> 1.04 mmol/ L) Female: > 50 mg/ dL (> 1.3 mmol/ L)

Low-density lipoproteins (LDLs)

Recommended: < 10 0 mg/ dL (< 2.6 mmol/ L) Near optimal: 100-129 mg/ dL (2.6-3.34 mmol/ L) Moderate risk for coronary artery disease (CAD): 130-159 mg/ dL (3.37-4.12 mmol/ L) High risk for CAD: > 160 mg/ dL (> 4.14 mmol/ L)

Triglycerides < 150 mg/ dL (< 1.7 mmol/ L)

TABLE 10-4 Glycosylated Hemoglobin (HgbA1C) and Estimated Average Glucose (eAG)

HgbA1C % eAG mg/ dL eAG mmol/ L

6 126 7.0

6.5 140 7.8

7 154 8.6

7.5 169 9.4

8 183 10.1

8.5 197 10.9

9 212 11.8

9.5 226 12.6

10 240 13.4

American Diabetes Association, DiabetesPro: Estimated average glucose, eAG/ A1C Conversion Calculator (website): http:/ / professional.diabetes.org/ diapro/ glucose_calc.

118 UNIT III Nursing Sciences

CRITICAL THINKING What Should You Do? Answer: The client’s vital signs are showing a significant change, particularly the blood pressure, heart rate, and oxy- gen saturation levels. The nurse should first compare the vital signs to the set of baseline vital signs obtained when the client arrived to the unit. This provides information about how much of a change has occurred in these parameters. The nurse should quickly consider the following when determin- ing the next action: (1) Is the equipment working properly? (2) Is the correct equipment being used? (3) Is there a con- dition or procedure in the client’s history that can be attrib- uted to this change? (4) Are there environmental factors that could influence the change in the client’s vital signs? (5) Does this change necessitate contacting the surgeon? Given the significant change from the baseline vital signs, and after checking equipment to ensure it is working properly, the nurse should then determine that it is necessary to contact the surgeon to inform him or her of this change, especially considering that the client recently had surgery and there is a potential for bleeding. The nurse should determine if there is any sign of bleeding, ie, drainage on the dressing, bloody output in a surgical drain, swelling in the surgical area suggestive of hematoma. The charge nurse should also be informed of the change in client status.

References: Lewis et al. (2014), pp. 350 , 354; Potter et al. (20 15), p. 272.

P R A C T I C E Q U E S T I O N S 63. A clien t with atrial fibrillatio n wh o is receivin g

m ain ten an ce th erap y of warfarin sodium h as a pro- th rom bin tim e (PT) of 35 (35) secon ds an d an in ter- n ation al n orm alized ratio (INR) of 3.5. O n th e basis of th ese labo ratory values, th e n urse an ticipates wh ich prescription ? 1. Addin g a dose of h eparin sodium 2. Holdin g th e n ext dose of warfarin 3. In creasin g th e n ext dose of warfarin 4. Adm in isterin g th e n ext dose of warfarin

64. A staff n urse is preceptin g a n ew graduate n urse an d th e n ew graduate is assign ed to care for a clien t with ch ron ic pain . Wh ich statem en t, if m ade by th e n ew graduate n urse, in dicates th e n eed fo r fu rth er teach in g regardin g pain m an agem en t? 1. “I will be sure to ask m y clien t wh at h is pain level

is on a scale of 0 to 10.” 2. “I kn ow th at I sh ould follo w up after givin g m ed-

ication to m ake sure it is effective.” 3. “I kn ow th at pain in th e older clien t m igh t m an -

ifest as sleep disturban ces or depression .” 4. “I will be sure to cue in to an y in dicators th at th e

clien t m ay be exaggeratin g th eir pain .”

65. A clien t h as been adm itted to th e h ospital for urin ary tract in fectio n an d deh ydratio n . Th e n urse determ in es th at th e clien t h as received ad equate volu m e replacem en t if th e blood urea n itrogen (BUN) level drops to wh ich value? 1. 3 m g/ dL (1.05 m m ol/ L) 2. 15 m g/ dL (5.25 m m o l/ L) 3. 29 m g/ dL (10.15 m m ol/ L) 4. 35 m g/ dL (12.25 m m o l/ L)

66. Th e n urse is explain in g th e appropriate m eth od s for m easu rin g an accu rate tem perature to an un licen sed assistive person n el (UAP) . Wh ich m eth od , if n oted by th e UAP as bein g an appropriate m eth od , in di- cates th e n eed fo r fu rth er teach in g? 1. Takin g a rectal tem p erature for a clien t wh o h as

un dergon e n asal surgery 2. Takin g an oral tem p erature for a clien t with a

co ugh an d n asal con gestion 3. Takin g an axillary tem perature for a clien t wh o

h as just con sum ed h ot coffee 4. Takin g a tem poral tem perature on th e n eck

beh in d th e ear for a clien t wh o is diaph o retic

67. A clien t is receivin g a con tin uo us in traven ous in fu- sion of h eparin sodium to treat deep vein th rom bo- sis. Th e clien t’s activated partial th rom boplastin tim e (aPTT) is 65 secon ds (65 secon ds). Th e n urse an ticipates th at wh ich action is n eeded? 1. Discon tin uin g th e h eparin in fusio n 2. In creasin g th e rate of th e h eparin in fusion 3. Decreasin g th e rate of th e h eparin in fusion 4. Leavin g th e rate of th e h eparin in fusion as is

68. A clien t with a h istory of cardiac disease is due for a m orn in g dose of furosem ide. Wh ich serum potas- sium level, if n oted in th e clien t’s laborato ry report, sh ould be reported before ad m in isterin g th e dose of furosem ide? 1. 3.2 m Eq/ L (3.2 m m o l/ L) 2. 3.8 m Eq/ L (3.8 m m ol/ L) 3. 4.2 m Eq/ L (4.2 m m ol/ L) 4. 4.8 m Eq/ L (4.8 m m o l/ L)

69. Several labo ratory tests are prescribed for a clien t, an d th e n urse reviews th e results of th e tests. Wh ich laborato ry test results sh o uld th e n urse report? Select all th at ap p ly.

1. Platelets 35,000 m m 3 (35 Â 109/ L) 2. Sodium 150 m Eq/ L (150 m m o l/ L) 3. Potassium 5.0 m Eq/ L (5.0 m m o l/ L) 4. Segm en ted n eutroph ils 40% (0.40) 5. Serum creatin in e, 1 m g/ dL (88.3 µm ol/ L) 6. Wh ite b lo o d cells, 3000 m m 3

( 3.0 Â 109/ L)

F

u

n

d

a

m

e

n

t

a

l

s

119CHAPTER 10 Vital Signs and Laboratory Reference Intervals

F

u

n

d

a

m

e

n

t

a

l

s

70. Th e n urse is carin g for a clien t wh o takes ibuprofen for pain . Th e n urse is gath erin g in form ation on th e clien t’s m edication h isto ry, an d determ in es it is n ec- essary to con tact th e h ealth care provider (HCP) if th e clien t is also takin g wh ich m ed ication s? Select all th at ap p ly.

1. Warfarin 2. Glim epirid e 3. Am lodipin e 4. Sim vastatin 5. Hydroch loroth iazide

71. A clien t with diabetes m ellitus h as a glycosylated h em oglobin A1c level of 9%. O n th e basis of th is test result, th e n urse plan s to teach th e clien t about th e n eed for wh ich m easu re? 1. Avoidin g in fectio n 2. Takin g in adequate fluids 3. Preven tin g an d recogn izin g h ypoglycem ia 4. Preven tin g an d recogn izin g h yperglycem ia

72. Th e n urse is carin g for a clien t with a diagn osis of can cer wh o is im m un osuppressed. Th e n urse would con sider im plem en tin g n eutropen ic precaution s if th e clien t’s wh ite blood cell co un t was wh ich value? 1. 2000 m m 3 (2.0 Â 109/ L) 2. 5800 m m 3 (5.8 Â 109/ L) 3. 8400 m m 3 (8.4 Â 109/ L) 4. 11,500 m m 3 (11.5 Â 109/ L)

73. A clien t brough t to th e em ergen cy dep artm en t states th at h e h as acciden tally been takin g 2 tim es h is pre- scrib ed dose of warfarin for th e past week. After n ot- in g th at th e clien t h as n o evid en ce of obvious bleed in g, th e n urse plan s to take wh ich action ? 1. Prepare to adm in ister an an tidote. 2. Draw a sam ple for type an d cro ssm atch an d

tran sfuse th e clien t. 3. Draw a sam ple for an activated partial th rom bo-

plastin tim e (aPTT) level.

4. Draw a sam ple for proth rom bin tim e (PT) an d in tern ation al n orm alized ratio (INR).

74. Th e n urse is carin g for a postoperative clien t wh o is receivin g dem an d-dose h ydrom orph on e via a patien t-con trolled an algesia (PCA) pum p for pain con trol. Th e n urse en ters th e clien t’s room an d fin ds th e clien t drowsy an d records th e follo win g vital sign s: tem p erature 97.2 °F (36.2 °C) orally, pulse 52 beats per m in u te, blood pressure 101/ 58 m m Hg, respiratory rate 11 breath s per m in u te, an d SpO 2 of 93% on 3 liters of oxygen via n asal can n ula. Wh ich action sh ould th e n urse take n ext? 1. Docum en t th e fin din gs. 2. Attem pt to arou se th e clien t. 3. Con tact th e h ealth care provid er (HCP)

im m ediately. 4. Ch eck th e m ed ication adm in istration h isto ry on

th e PCA pum p.

75. An adult fem ale clien t h as a h em oglobin level of 10.8 g/ d L (108 m m ol/ L). Th e n urse in terp rets th at th is result is m o st likely caused by wh ich con ditio n n oted in th e clien t’s h istory? 1. Deh ydration 2. Heart failure 3. Iron deficien cy an em ia 4. Ch ron ic obstru ctive pulm o n ary disease

76. A clien t with a h istory of gastroin testin al bleedin g h as a platelet coun t of 300,000 m m 3 (300 Â 109/ L). Th e n urse sh ould take wh ich action after seein g th e laboratory results? 1. Repo rt th e abn orm ally low coun t. 2. Repo rt th e abn o rm ally h igh coun t. 3. Place th e clien t on bleedin g precaution s. 4. Place th e n orm al report in th e clien t’s m edical

record.

A N S W E R S 63. 2 Ra tion a le: Th e n o rm al PT is 11 to 12.5 secon ds (co n ven tion al th erapy an d SI u n its). Th e n o rm al INR is 2 to 3 for stan d ard warfarin th erapy, wh ich is used for th e treatm en t of atrial fibril- latio n , an d 3 to 4.5 fo r h igh -do se warfarin th erap y, wh ich is u sed for clien ts with m ech an ical h eart valves. A th erap eutic PT level is 1.5 to 2 tim es h igh er th an th e n orm al level. Becau se th e values of 35 seco n d s an d 3.5 are h igh , th e n urse sh ou ld an ticip ate th at th e clien t wo uld n ot receive furth er do ses at th is tim e. Th erefore, th e p rescrip tio n s n o ted in th e rem ain in g o ptio n s are in co rrect. Test-Ta kin g Str a t egy: Fo cu s o n th e su b ject , a PT o f 35 seco n d s an d an INR of 3.5. Recall th e n o rm al ran ges for th ese valu es

an d rem em ber th at a PT greater th an 32 seco n ds an d an INR greater th an 3 fo r stan dard warfarin th erap y places th e clien t at risk fo r bleedin g; th is will direct yo u to th e correct o ptio n . Review: Th e n o r m a l p r o t h r o m b in t im e a n d INR levels Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Fu n dam en tals o f Care—Labo rato ry Valu es Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ces: Lewis et al. ( 2014) , p . 627; Ro sen jack Bu rch u m , Ro sen th al (2016), p p. 622–623.

64. 4 Ra tion a le: Pain is a h igh ly in dividual experien ce, an d th e n ew grad uate n u rse sh o u ld n o t assu m e th at th e clien t is

120 UNIT III Nursing Sciences

exaggeratin g h is p ain . Rath er, th e n urse sh ou ld freq uen tly assess th e pain an d in terven e acco rd in gly th ro ugh th e use o f bo th n on ph arm aco logical an d p h arm aco lo gical in terven tio n s. Th e n urse sh ou ld assess p ain u sin g a n um b er-b ased scale o r a picture-b ased scale fo r clien ts wh o can n o t verbally d escrib e th eir p ain to rate th e d egree o f p ain . Th e n urse sh o uld fo llo w up with th e clien t after givin g m ed ication to en su re th at th e m ed ication is effective in m an agin g th e pain . Pain exp erien ced by th e older clien t m ay be m an ifested d ifferen tly th an p ain experien ced by m em b ers o f o th er age grou p s, an d th ey m ay h ave sleep d istu rb an ces, ch an ges in gait an d m ob ility, decreased so cializatio n , an d d epressio n ; th e n u rse sh ou ld b e aware o f th is attrib u te in th is po p ulatio n . Test-Ta kin g Str a tegy: Note th e st r at egic wo r d s, need for further teaching. These words in dicate a n egat ive even t q u er y an d the n eed to select th e in correct statem en t as th e an swer. Recall that pain is a h igh ly in dividual exp erien ce, an d th e n urse sh o uld n ot assum e th at th e clien t is exaggeratin g pain . Review: Ma n a gem en t o f p a in Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun dam en tals of Care—Pain Pr ior ity Con cepts: Clin ical Jud gm en t; Pain Refer en ce: Lewis et al. (2014), p p. 122, 134.

65. 2 Ra t ion a le: Th e n orm al BUN level is 6 to 20 m g/ d L ( 2.1 to 7.1 m m o l/ L) . Values o f 29 m g/ d L (10.15 m m o l/ L) an d 35 m g/ d L (12.25 m m o l/ L) reflect co n tin u ed deh ydration . A value of 3 m g/ dL (1.05 m m ol/ L) reflects a lower th an n o rm al value, wh ich m ay o ccur with fluid volu m e overlo ad, am on g oth er co n dition s. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject , ad equ ate fluid rep lacem en t an d th e n orm al BUN level. Th e correct option is th e on ly o ptio n th at iden tifies a n orm al value. Review: Th e n o rm al b lo o d u r ea n it r o gen level Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Fun dam en tals of Care—Lab oratory Valu es Priority Concepts: Clin ical Ju dgm en t; Fluid an d Electrolyte Balan ce Refer en ces: Lewis et al. (2014), p. 1057; Pagan a, Pagan a (2014) , p p. 511–514.

66. 2 Ra t ion a le: An o ral tem perature sh ou ld b e avoided if th e clien t h as n asal con gestion . O n e of th e o th er m eth o d s o f m easu rin g th e tem perature sh ou ld b e used accordin g to th e eq uipm en t availab le. Takin g a rectal tem perature fo r a clien t wh o h as u n d er- go n e n asal su rgery is ap prop riate. O th er, less in vasive m easu res sh ou ld be u sed if available; if n ot availab le, a rectal tem p eratu re is accep table. Takin g an axillary tem perature o n a clien t wh o ju st co n su m ed co ffee is also acceptab le; h o wever, th e axillary m eth od o f m easu rem en t is th e least reliable, an d o th er m eth od s sh ou ld b e used if available. If tem p oral eq uipm en t is availab le an d th e clien t is diap h o retic, it is accep table to m ea- sure th e tem p eratu re o n th e n eck b eh in d th e ear, avoid in g th e fo reh ead .

Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d s, need for fur- ther teaching. Th ese words in dicate a n ega t ive even t q u er y an d th e n eed to select th e in correct actio n as th e an swer. Recall th at n asal co n gestio n is a reaso n to avo id takin g an oral tem - p eratu re, as th e n asal con gestion will cause p ro b lem s with b reath in g wh ile th e tem perature is bein g taken . Review: Tem p er a t u r e m ea su r em en t m et h o d s Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun d am en tals of Care—Vital Sign s Pr ior ity Con cepts: Teach in g an d Learn in g; Th erm o regu lation Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 68–69, 76.

67. 4 Ra t ion a le: Th e n o rm al aPTT varies b etween 28 an d 35 secon ds (28 an d 35 seco n d s), d ep en d in g on th e type of activator used in testin g. Th e th erapeu tic do se of h ep arin for treatm en t o f d eep vein th rom bo sis is to keep th e aPTT b etween 1.5 (42 to 52.5) an d 2.5 ( 70 to 87.5) tim es n o rm al. Th is m ean s th at th e clien t’s value sh ou ld n o t b e less th an 42 seco n d s or greater th an 87.5 seco n d s. Th us th e clien t’s aPTT is with in th e th erap eu tic ran ge an d th e do se sh ou ld rem ain u n ch an ged . Test-Ta king Stra tegy: Fo cu s o n th e su b ject, th e exp ected aPTT fo r a clien t receivin g a h ep arin so d iu m in fu sio n . Rem em b er th at th e n o rm al ran ge is 28 to 35 seco n d s an d th at th e aPTT sh o u ld b e b etween 1.5 an d 2.5 tim es n o rm al wh en th e clien t is receivin g h ep arin th erap y. Sim p le m u ltip licatio n o f 1.5 an d 2.5 b y 28 an d 35 will yield a ran ge o f 42 to 87.5 seco n d s) . Th is clien t’s valu e is 65 seco n d s Review: Th e a PTT level an d th e expected level if th e clien t is receivin g h ep a r in Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Fun d am en tals of Care—Lab oratory Values Pr ior ity Con cepts: Clin ical Jud gm en t; Clottin g Refer en ce: Lewis et al. (2014), p. 627.

68. 1 Ra t ion a le: Th e n orm al seru m p otassiu m level in th e ad ult is 3.5 to 5.0 m Eq/ L ( 3.5 to 5.0 m m ol/ L) . Th e co rrect op tio n is th e o n ly value th at falls below th e th erapeu tic ran ge. Ad m in is- terin g furosem id e to a clien t with a low p otassium level an d a h isto ry of card iac prob lem s co uld p recip itate ven tricular dys- rh yth m ias. Th e rem ain in g o p tion s are with in th e n orm al ran ge. Test -Ta kin g Str a tegy: N o te th e s u b ject o f th e q u estio n , th e level th at sh o u ld b e rep o rted . Th is in d icates th at yo u are lo o kin g fo r an ab n o rm al level. Rem em b er, th e n o rm al seru m p o tassiu m level in th e ad u lt is 3.5 to 5.0 m Eq / L ( 3.5 to 5.0 m m o l/ L) . Th is will d irect yo u to th e co rrect o p tio n . Review: Th e n o rm al ser u m p o t a ssiu m level Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Lab orato ry Values Pr ior ity Con cept s: Clin ical Ju d gm en t; Flu id an d Electrolyte Balan ce

F

u

n

d

a

m

e

n

t

a

l

s

121CHAPTER 10 Vital Signs and Laboratory Reference Intervals

Refer en ces: Lewis et al. (2014), p . 296; Pagan a, Pagan a (2014), p . 409.

69. 1, 2, 4, 6 Ra tion a le: Th e n orm al values in clud e th e followin g: p latelets 150,000–400,000 m m 3 (150–400 Â 109/ L); sodium 135– 145 m Eq / L (135–145 m m ol/ L) ; p otassiu m 3.5–5.0 m Eq/ L (3.5–5.0 m m ol/ L); segm en ted n eu tro ph ils 60%–70% (0.60– 0.70); seru m creatin in e 0.6–1.3 m g/ d L ( 53–115 µm o l/ L); an d wh ite b lo od cells 5000–10,000 m m 3 (5.0–10.0 Â 109/ L). Th e p latelet level n oted is low; th e sod iu m level n o ted is h igh ; th e p otassiu m level n oted is n orm al; th e segm en ted n eu tro ph il level n o ted is lo w; th e seru m creatin in e level n o ted is n o rm al; an d th e wh ite b lo od cell level is lo w. Test-Ta kin g St r a t egy: Focus o n th e su b ject , th e abn o rm al lab- o rato ry values th at n eed to b e rep orted. Recallin g th e n orm al lab oratory values for th e bloo d stu dies iden tified in th e op tion s will assist in an swerin g th is q uestion . Review: Th e n orm al la b o r a t o r y va lu es Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Labo rato ry Valu es Pr ior it y Con cept s: Clin ical Ju dgm en t; Co llabo ration Refer en ce: Lewis et al. (2014), p p . 626, 661, 1702–1703

70. 1, 2, 3 Ra tion a le: Non stero id al an tiin flam m ato ry drugs (NSAIDs) can am p lify th e effects of an tico agulan ts; th erefo re, th ese m ed - ication s sh o uld n o t b e taken togeth er. Hyp oglycem ia m ay result fo r th e clien t takin g ib u profen if th e clien t is co n curren tly takin g an oral h ypo glycem ic agen t su ch as glim ep iride; th ese m edicatio n s sh o uld n ot b e com b in ed . A h igh risk of toxicity exists if th e clien t is takin g ibu p ro fen con cu rren tly with a cal- cium ch an n el blo cker su ch as am lod ip in e; th erefo re, th is com - b in atio n sh ou ld b e avoid ed . Th ere is n o kn o wn in teractio n b etween ibu profen an d sim vastatin o r h yd ro ch lo ro th iazid e. Test-Ta kin g Str a tegy: Note th e su b ject of th e question , data p ro vided by th e clien t n ecessitatin g co n tactin g th e HCP. Deter- m in in g th at ibu profen is classified as an NSAID will h elp you to d eterm in e th at it sh ou ld n o t be com b in ed with an ticoagu - lan ts. Also recallin g th at h ypo glycem ia can o ccu r as an adverse effect will h elp yo u to recall th at th ese m ed icatio n s sh o uld n o t b e com b in ed . Fro m th e rem ain in g o p tion s, it is n ecessary to rem em b er th at toxicity can result if NSAIDs are co m b in ed with calciu m ch an n el blockers. Review: Med icatio n in teractio n s for NSAIDs, sp ecifically ib u p r o fen Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Pain Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Rosen jack Bu rch um , Ro sen th al (2016), p p. 861, 866–868.

71. 4 Ra tion a le: Th e n orm al referen ce ran ge fo r th e glyco sylated h em o glob in A1c is 4.0% to 6.0%. Th is test m easures th e am ou n t o f glu cose th at h as b ecom e perm an en tly bo un d to

th e red bloo d cells from circu latin g gluco se. Eryth rocytes live fo r ab o ut 120 days, givin g feed back abo ut b lo od glu co se fo r p ast 120 days. Elevation s in th e bloo d glu cose level will cause elevatio n s in th e am ou n t of glycosylatio n . Th us th e test is use- fu l in id en tifyin g clien ts wh o h ave p erio d s of h yp erglycem ia th at are un d etected in oth er ways. Th e estim ated average glu - cose fo r a glyco sylated h em oglo b in A1c o f 9% is 212 m g/ d L (11.8 m m ol/ L). Elevation s in dicate co n tin ued n eed fo r teach - in g related to th e preven tio n o f h yperglycem ic ep isod es. Test-Ta kin g Str a tegy: Focus on th e su b ject , a glyco sylated h em o glob in A1c level of 9%. Recallin g th e n o rm al valu e an d th at an elevated valu e in dicates h yperglycem ia will assist in d irectin g yo u to th e correct o ptio n . Review: Glyco syla t ed h em o glo b in A1c Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n dam en tals o f Care—Labo rato ry Valu es Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regulation Refer en ces: Lewis et al. (2014), p p. 1150, 1175; Pagan a, Pagan a (2014), p . 266.

72. 1 Ra tion a le: Th e n o rm al WBC co un t ran ges fro m 5000– 10,000 m m 3 (5–10 Â 109/ L). Th e clien t wh o h as a d ecrease in th e n u m ber o f circu latin g WBCs is im m u n o sup pressed . Th e n urse im p lem en ts n eu tro p en ic p recautio n s wh en th e cli- en t’s values fall sufficien tly below th e n orm al level. Th e sp ecific valu e fo r im plem en tin g n eutrop en ic p recaution s u sually is d eterm in ed b y agen cy p olicy. Th e rem ain in g op tion s are n or- m al valu es. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject , th e n eed to im ple- m en t n eutrop en ic p recautio n s. Recallin g th at th e n o rm al WBC cou n t is 5000–10,000 m m 3 (5–10 Â 109/ L) will d irect yo u to th e correct o ptio n . Review: Th e n orm al ad ult wh it e b lo o d cell d iffer en t ia l co u n t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Fu n dam en tals o f Care—Labo rato ry Valu es Pr ior it y Con cept s: Clin ical Ju dgm en t; In fectio n Refer en ces: Lewis et al. (2014), p p . 625–626.

73. 4 Ra tion a le: Th e actio n th at th e n u rse sh o u ld take is to d raw a sam p le fo r PT an d INR level to d eterm in e th e clien t’s an ti- co agu latio n statu s an d risk fo r b leed in g. Th ese resu lts will p ro vid e in fo rm atio n as to h o w to b est treat th is clien t (e.g., if an an tid o te su ch as vitam in K o r a b lo o d tran sfu sio n is n eed ed ) . Th e aPTT m o n ito rs th e effects o f h ep arin th erap y. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject , a clien t wh o h as taken an excessive do se o f warfarin . Elim in ate th e o ptio n with aPTT first because it is un related to warfarin th erap y an d relates to h ep arin th erapy. Next, elim in ate th e op tion s in d icatin g to adm in ister an an tido te an d to tran sfuse th e clien t because th ese th erapies wou ld n o t be im plem en ted un less th e PT an d INR levels were kn own . Review: Care to th e clien t receivin g wa r fa r in th erap y Level of Cogn itive Ability: Ap plyin g

F

u

n

d

a

m

e

n

t

a

l

s

122 UNIT III Nursing Sciences

Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Fun dam en tals of Care—Lab oratory Valu es Pr ior ity Con cepts: Clin ical Jud gm en t; Clottin g Refer en ce: Lewis et al. (2014), p . 627.

74. 2 Ra t ion a le: Th e p rim ary con cern with op ioid an algesics is resp i- ratory depression an d h ypoten sion . Based on th e assessm en t fin d in gs, th e n urse sh ou ld su spect o p ioid o verd ose. Th e n u rse sh ou ld first attem p t to arou se th e clien t an d th en reassess th e vital sign s. Th e vital sign s m ay begin to n o rm alize on ce th e cli- en t is aro used becau se sleep can also cause decreased h eart rate, blo od p ressu re, respirato ry rate, an d oxygen saturation . Th e n urse sh ou ld also ch eck to see h ow m u ch m ed ication h as been taken via th e PCA p um p , an d sh o uld co n tin ue to m o n ito r th e clien t clo sely to d eterm in e if fu rth er action is n eed ed . Th e n u rse sh ou ld con tact th e HCP an d d ocum en t th e fin din gs after all data are co llected , after th e clien t is stab ilized, an d if an abn or- m ality still exists after arou sin g th e clien t. Test -Ta kin g St r a tegy: First, n ote th e st r a t egic wo r d , n ext. Fo cu s o n t h e d a t a in t h e q u est io n an d d et er m in e if a n a b n o r m a lit y exist s. It is clear th at an ab n o rm ality exists because th e clien t is d rowsy an d th e vital sign s are ou tside o f th e n o rm al ran ge. Recall th at attem p tin g to arou se th e clien t sh ou ld com e b efore fu rth er assessm en t o f th e pu m p . Th e clien t sh ou ld always be assessed befo re th e equ ip m en t, b efore co n - tactin g th e HCP, an d befo re do cum en tatio n . Review: Man agem en t o f p o ten tial o p io id o ver d o se. Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Pain Pr ior ity Con cepts: Clin ical Jud gm en t; Pain Refer en ce: Lewis et al. (2014), p . 164.

75. 3 Ra t ion a le: Th e n o rm al h em oglobin level for an adult fem ale clien t is 12–16 g/ dL (120–160 m m o l/ L). Iron deficien cy

an em ia can result in lower h em o glo bin levels. Deh yd ratio n m ay in crease th e h em o glob in level b y h em ocon cen tratio n . Heart failu re an d ch ron ic ob stru ctive pu lm on ary d isease m ay in crease th e h em o glob in level as a result o f th e bo dy’s n eed fo r m ore o xygen -carryin g cap acity. Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d s , most likely. Evalu ate each o f th e co n dition s in th e o ptio n s in term s of th eir p ath o ph ysiology an d wh eth er each is likely to raise or lower th e h em o glob in level. Also , n o te th e relation sh ip between h em oglo bin level in th e qu estio n an d th e correct op tio n . Review: Th e n o rm al h em o glo b in level Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Lab orato ry Values Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), pp . 628, 638.

76. 4 Ra t ion a le: A n o rm al platelet co un t ran ges from 150,000 to 400,000 m m 3 (150 to 400 Â 109/ L). Th e n urse sh o u ld place th e repo rt co n tain in g th e n orm al labo rato ry valu e in th e clien t’s m edical record. A p latelet co un t o f 300,000 m m 3

(300 Â 109/ L) is n o t an elevated cou n t. Th e co u n t also is n ot low; th erefo re, b leed in g p recautio n s are n ot n eeded . Test -Ta kin g Str a tegy: Fo cu s on th e su b ject , a platelet coun t of 300,000 m m 3 (300 Â 109/ L). Rem em ber th at op tio n s th at are co m p a r a b le o r a lik e are n ot likely to b e co rrect. With th is in m in d, elim in ate op tio n s in dicatin g to repo rt th e abn orm ally low co un t an d p lacin g th e clien t on bleedin g precau tio n s first. From th e rem ain in g o ptio n s, recallin g th e n orm al ran ge fo r th is lab o ratory test will direct you to th e co rrect op tion . Review: Th e n o rm al p la t elet co u n t Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Lab oratory Values Pr ior ity Con cepts: Clin ical Jud gm en t; Clottin g Refer en ce: Lewis et al. (2014), p. 626.

F

u

n

d

a

m

e

n

t

a

l

s

123CHAPTER 10 Vital Signs and Laboratory Reference Intervals

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 11 Nutrition

PRIORITY CONCEPT Health Promotion; Nutrition

CRITICAL THINKING What Should You Do? A client has been placed on a fluid restriction due to acute kidney injury. The client complains of thirst and asks what can be done to relieve this discomfort. What measures should the nurse tell the client to take to relieve thirst while adhering to the fluid restriction? Answer located on p. 130.

I. Nutrients A. Carb oh ydrates

1. Carb oh ydrates are th e preferred source of en ergy. 2. Sugars, starch es, an d cellulose provide 4 cal/ g. 3. Carb oh ydrates prom o te n orm al fat metabolism,

spare protein , an d en h an ce lower gastro in testi- n al fun ction .

4. Majo r food sources of carboh ydrates in clude m ilk, grain s, fru its, an d vegetables.

5. In ad equate carbo h ydrate in take affects m etab olism .

B. Fats 1. Fats provide a con cen trated source an d a stored

form of en ergy. 2. Fats protect in tern al organ s an d m ain tain body

tem p erature. 3. Fats en h an ce absorption of th e fat-solub le

vitam in s. 4. Fats provide 9 cal/ g. 5. In ad equate in take of essen tial fatty acids leads to

clin ical m an ifestatio n s of sen sitivity to cold, skin lesion s, in creased risk of in fectio n , an d am en or- rh ea in wom en .

6. Diets h igh in fat can lead to obesity an d in crease th e risk of cardiovascular disease an d som e can cers.

C. Protein s 1. Am in o acids, wh ich m ake up protein s, are critical

to all aspects of growth an d developm en t of body tissues, an d provide 4 cal/ g.

2. Protein s build an d repair body tissues, regulate fluid balan ce, m ain tain acid-b ase balan ce, pro- duce an tibod ies, provide en ergy, an d produce en zym es an d h orm on es.

3. Essen tial am in o acids are required in th e diet because th e body can n ot m an u facture th em .

4. Com p lete protein s con tain all essen tial am in o acids; in com plete protein s lack som e of th e essen tial fatty acids.

5. In adequ ate protein can cau se protein en ergy malnutrition an d severe wastin g of fat an d m uscle tissue.

Major stages of the lifespan with specific nutritional needs are pregnancy, lactation, infancy, childhood, and adolescence. Adults and older adults may experience physiological aging changes, which influence individual nutritional needs.

D. Vitam in s ( Box 11-1) 1. Vitam in s facilitate m etab olism of protein s, fats,

an d carboh ydrates an d act as catalysts for m eta- bolic fun ction s.

2. Vitam in s prom ote life an d growth processes, an d m ain tain an d regulate body fun ctio n s.

3. Fat-solub le vitam in s A, D, E, an d K can be stored in th e body, so an excess can cause toxicity.

4. Th e B vitam in s an d vitam in C are water-solub le vitam in s, are n ot stored in th e body, an d can be excreted in th e urin e.

E. Min erals (Box 11-2) 1. Min erals are co m pon en ts of h orm on es, cells, tis-

sues, an d bon es. 2. Min erals act as catalysts for ch em ical reactio n s

an d en h an cers of cell fun ction . 3. Alm ost all foods con tain som e form of m in erals. 4. A deficien cy of m in erals can develo p in ch ron i-

cally ill or h ospitalized clien ts. 5. Electro lytes play a m ajor role in osm olality

an d body water regulation , acid-b ase balan ce, en zym e reaction s, an d n eurom u scular activity (see Ch apter 8 for addition al in form ation regardin g electrolytes).124

Always assess the client’s ability to eat and swallow and promote independence in eating as much as is possible.

II. MyPlate (Fig. 11-1) A. Provid es a description of a balan ced diet th at in cludes

grain s, vegetables, fruits, dairy produ cts, an d protein food s (see h ttp :/ / www.ch oosem yplate.gov/ )

B. A n utrition ist sh o uld be con sulted for in dividualized dietary recom m en dation s.

C. Guidelin es 1. Avoid eatin g oversized portion s of food s. 2. Fill h alf of th e plate with fru its an d vegetables. 3. Vary th e type of vegetables an d fruits eaten . 4. Select at least h alf of th e grain s as wh o le grain s. 5. En su re th at food s fro m th e dairy grou p are h igh

in calcium. 6. Drin k m ilk th at is fat-free or low fat (1%).

F

u

n

d

a

m

e

n

t

a

l

s

BOX 11-1 Food Sources of Vitamins Water-Soluble Vitamins Folic acid: Green leafy vegetables; liver, beef, and fish; legumes;

grapefruit and oranges Niacin: Meats, poultry, fish, beans, peanuts, grains Vitamin B1 (thiamine): Pork and nuts, whole-grain cereals, and

legumes Vitamin B2 (riboflavin): Milk, lean meats, fish, grains Vitamin B6 (pyridoxine): Yeast, corn, meat, poultry, fish Vitamin B12 (cobalamin): Meat, liver Vitamin C (ascorbic acid): Citrus fruits, tomatoes, broccoli,

cabbage

Fat-Soluble Vitamins Vitamin A: Liver, egg yolk, whole milk, green or orange vegeta-

bles, fruits Vitamin D: Fortified milk, fish oils, cereals Vitamin E: Vegetable oils; green leafy vegetables; cereals; apri-

cots, apples, and peaches Vitamin K: Green leafy vegetables; cauliflower and cabbage

BOX 11-2 Food Sources of Minerals

Calcium Cheese Collard greens Milk and soy milk Rhubarb Sardines Tofu Yogurt

Chloride Salt

Iron Breads and cereals Dark green vegetables Dried fruits Egg yolk Legumes Liver Meats

Magnesium Avocado Canned white tuna Cauliflower Cooked rolled oats Green leafy vegetables Milk Peanut butter Peas Pork, beef, chicken Potatoes Raisins Yogurt

Phosphorus Fish Nuts Organ meats Pork, beef, chicken Whole-grain breads and

cereals

Potassium Avocado Bananas Cantaloupe Carrots Fish Mushrooms Oranges Pork, beef, veal Potatoes Raisins Spinach Strawberries Tomatoes

Sodium Bacon Butter Canned food Cheese Cured pork Hot dogs Ketchup Lunch meat Milk Mustard Processed food Snack food Soy sauce Table salt White and whole-wheat

bread

Zinc Eggs Leafy vegetables Meats Protein-rich foods

FIGURE 11-1 MyPlate. (From U.S. Department of Agriculture. Available at http:/ / www.choosemyplate.gov.)

125CHAPTER 11 Nutrition

F

u

n

d

a

m

e

n

t

a

l

s

7. Eat protein food s th at are lean . 8. Select fresh food s over fro zen or can n ed food s. 9. Drin k water rath er th an liquids th at con tain

sugar.

Always consider the client’s cultural and personal choices when planning nutritional intake.

III. Therapeutic Diets A. Clear liquid diet

1. In dication s a . Clear liqu id diet provid es flu ids an d som e

electrolytes to preven t deh ydratio n . b . Clear liquid diet is used as an in itial feedin g

after com plete bowel rest. c. Clear liquid diet is used in itially to feed a m al-

n ourish ed person or a person wh o h as n ot h ad an y oral in take for som e tim e.

d . Clear liqu id diet is used for bowel preparation for surgery or diagn ostic tests, as well as post- operatively an d in clien ts with fever, vom it- in g, or diarrh ea.

e. Clear liquid diet is used in gastro en teritis. 2. Nu rsin g con sideration s

a . Clear liquid diet is deficien t in en ergy (calo- ries) an d m an y nutrients.

b . Clear liquid diet is easily digested an d absorbed.

c. Min im al residue is left in th e gastro in testin al tract.

d . Clien ts m ay fin d a clear liquid diet un ap petiz- in g an d borin g.

e. As a tran sition diet, clear liquids are in ten ded for sh ort-term use.

f. Clear liquid s an d food s th at are relatively tran sparen t to ligh t an d are liquid at body tem p erature are con sidered “clear liquid s,” such as water, bouillon , clear broth , carbo n - ated beverages, gelatin , h ard can dy, lem on - ade, ice pops, an d regular or decaffein ated coffee or tea.

g. By lim itin g caffein e in take, an upset stom ach an d sleeplessn ess m ay be preven ted.

h . Th e clien t m ay con sum e salt an d sugar. i. Dairy produ cts an d fru it juices with pulp are

n ot clear liquid s.

Monitor the client’s hydration status by assessing intake and output, assessing weight, monitoring for edema, and monitoring for signs of dehydration. Each kilogram (2.2 lb) of weight gained or lost is equal to 1liter of fluid retained or lost.

B. Full liqu id diet 1. In dication : May be used as a tran sition diet after

clear liqu ids followin g surgery or for clien ts wh o h ave difficu lty ch ewin g, swallowin g, or tolerat- in g solid food s

2. Nursin g con sideration s a . A full liqu id diet is n utrition ally deficien t in

en ergy (calories) an d m an y n utrien ts. b . Th e diet in cludes clear an d opaqu e liqu id

food s, an d th ose th at are liquid at body tem perature.

c. Food s in clude all clear liqu ids an d item s such as plain ice cream , sh erbet, breakfast drin ks, m ilk, pudd in g an d custard, soup s th at are strain ed , refin ed cooked cereals, fruit juices, an d strain ed vegetable juices.

d . Use of a com plete n utrition al liqu id supp le- m en t is often n ecessary to m eet n utrien t n eeds for clien ts on a full liquid diet for m ore th an 3 days.

Provide nutritional supplements such as those high in protein, as prescribed, for the client on a liquid diet.

C. Mech an ical soft diet 1. In dication s

a . Provid es foods th at h ave been m ech an ically altered in texture to require m in im al ch ewin g

b . Used for clien ts wh o h ave difficulty ch ewin g but can tolerate m ore variety in texture th an a liqu id diet offers

c. Used for clien ts wh o h ave den tal problem s, surgery of th e h ead or n eck, or dysph agia (requires swallowin g evalu ation an d m ay require th icken ed liquid s if th e clien t h as swallowin g difficu lties)

2. Nursin g con sideration s a . Degree of texture m od ification depen ds on

in dividual n eed, in cludin g pureed, m ash ed, groun d , or ch op ped.

b . Foods to be avoided in m ech an ically altered diets in clude n uts; dried fruits; raw fruits an d vegetables; fried foods; tough , sm oked, or salted m eats; an d foods with coarse textures.

D. Soft diet 1. In dication s

a . Used for clien ts wh o h ave difficulty ch ewin g or swallowin g

b . Used for clien ts wh o h ave ulceration s of th e m ou th or gum s, oral surgery, broken jaw, plastic surgery of th e h ead or n eck, or dysph a- gia, or for th e clien t wh o h as h ad a stroke

2. Nursin g con sideration s a . Clien ts with m ou th sores sh ould be served

food s at cooler tem p eratures. b . Clien ts wh o h ave difficulty ch ewin g an d swal-

lowin g because of dry m ou th can in crease sal- ivary flow by suckin g on sour can dy.

c. En cou rage th e clien t to eat a variety of foods. d . Provid e plen ty of fluids with m eals to ease

ch ewin g an d swallowin g of food s. e. Drin kin g flu ids th rou gh a straw m ay be easier

th an drin kin g fro m a cup or glass; a straw m ay

126 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

n ot be allowed for clien ts with dysph agia (because of th e risk of aspiration ) .

f. All food s an d season in gs are perm itted; h owever, liqu id, ch op ped, or pureed foods or regular food s with a soft con sisten cy are tolerated best.

g. Food s th at con tain n uts or seeds, wh ich easily can beco m e trapped in th e m ou th an d cau se discom fort, sh ould be avoided.

h . Raw fru its an d vegetables, fried foods, an d wh ole grain s sh o uld be avoided.

Consider the client’s disease or illness and how it may affect nutritional status.

E. Low-fib er (low-residue) diet 1. In dication s

a. Supp lies foods th at are least likely to form an obstru ctio n wh en th e in testin al tract is n ar- ro wed by in flam m ation or scarrin g or wh en gastro in testin al m otility is slowed

b . Used for in flam m atory bowel disease, partial obstruction s of th e in testin al tract, gastroen ter- itis, diarrh ea, or oth er gastroin testin al disorders

2. Nu rsin g con sid eration s a. Foods th at are low in fiber in clude white bread,

refin ed cooked cereals, cooked potatoes with - out skin s, wh ite rice, and refin ed pasta.

b . Food s to lim it or avoid are raw fruits (except ban an as), vegetables, n uts an d seeds, plan t fib er, an d wh ole grain s.

c. Dairy produ cts sh ould be lim ited to 2 serv- in gs a day.

F. High -fiber (h igh -residue) diet 1. In dication : Used for con stipatio n , irritable bowel

syn drom e wh en th e prim ary sym pto m is alter- n atin g con stipatio n an d diarrh ea, an d asym p- tom atic diverticu lar disease

2. Nu rsin g con sid eration s a. High -fiber diet provides 20 to 35 g of dietary

fib er daily. b . Volum e an d weigh t are ad ded to th e stool,

speedin g th e m ovem en t of un digested m ate- rials th rou gh th e in testin e.

c. High -fiber food s are fruits an d vegetables an d wh ole-grain produ cts.

d . In crease fiber gradually an d provide adequate flu ids to reduce possible un d esirable side effects such as ab dom in al cram ps, bloatin g, diarrh ea, an d deh ydratio n .

e. Gas-form in g food s sh o uld be lim ited (Box 11-3).

G. Card iac diet ( Box 11-4) 1. In dication s

a. In dicated for ath erosclerosis, diabetes m ellitus, h yperlipidem ia, h yperten sion , m yocardial in farction , n eph rotic syn drom e, an d ren al failure

b . Redu ces th e risk of h eart disease c. Dietary Approach es to Stop Hyperten sion

(DASH ) diet: recom m en ded to preven t an d con trol h yperten sion , h yperch olesterolem ia, an d obesity

d . Th e DASH diet in cludes fruits, vegetables, wh o le grain s, an d low-fat dairy food s; m eat, fish , poultry, n uts, an d bean s; an d is lim ited in sugar-sweeten ed food s an d beverages, red m eat, an d added fats.

2. Nu rsin g con sideration s a. Restrict total am oun ts of fat, in cludin g satu-

rated, tran s, polyun saturated, an d m on oun - saturated; ch olesterol; an d sodium.

b . Teach th e clien t about th e DASH diet or oth er prescribed diet.

H. Fat-restricted diet 1. In dication s

a. Used to reduce sym pto m s of abdom in al pain , steato rrh ea, flatu len ce, an d diarrh ea associ- ated with h igh in takes of dietary fat, an d to decrease n utrien t losses caused by in gestion of dietary fat in in dividuals with m alabsorp- tion disorders

b . Used for clien ts with m alab sorption disor- ders, pan creatitis, gallblad der disease, an d gastro esoph ageal reflux

2. Nu rsin g con sideration s a. Restrict total am oun t of fat, in cludin g saturated,

tran s, polyun saturated, an d m on oun saturated. b . Clien ts with m alab sorption m ay also h ave

difficu lty toleratin g fiber an d lactose.

BOX 11-3 Gas-Forming Foods

Apples Artichokes Barley Beans Bran Broccoli Brussels sprouts Cabbage Celery Figs

Melons Milk Molasses Nuts Onions Radishes Soybeans Wheat Yeast

BOX 11-4 Sodium-Free Spices and Flavorings

Allspice Almond extract Bay leaves Caraway seeds Cinnamon Curry powder Garlic powder or garlic

Ginger Lemon extract Maple extract Marjoram Mustard powder Nutmeg

127CHAPTER 11 Nutrition

F

u

n

d

a

m

e

n

t

a

l

s

c. Vitam in an d m in eral deficien cies m ay occur in clien ts with diarrh ea or steato rrh ea.

d . A fecal fat test m ay be prescribed an d in di- cates fat m alab sorption with excretion of m ore th an 6 to 8 g of fat (or m ore th an 10% of fat con sum ed) per day durin g th e 3 days of specim en collectio n .

I. High -calorie, h igh -protein diet 1. In d icatio n : Used fo r severe stress, b u rn s, wo u n d

h ealin g, can cer, h u m an im m u n o d eficien cy viru s, acq u ired im m u n o d eficien cy syn d ro m e, ch ro n ic o b stru ctive p u lm o n ary d isease, resp ira- to ry failu re, o r an y o th er typ e o f d eb ilitatin g d isease

2. Nu rsin g con sideration s a . En cou rage n utrien t-d en se, h igh -calorie, h igh -

protein food s such as wh o le m ilk an d m ilk produ cts, pean ut butter, n uts an d seeds, beef, ch icken , fish , pork, an d eggs.

b . En cou rage sn acks between m eals, such as m ilksh akes, in stan t breakfasts, an d n utri- tion al supp lem en ts.

Calorie counts assist in determining the client’s total nutritional intake and can identifya deficit or excess intake.

J. Carb oh ydrate-con sisten t diet 1. In dication : Used for clien ts with diabetes m elli-

tus, h ypo glycem ia, h yperglycem ia, an d obesity 2. Nu rsin g con sideration s

a . Th e Exch an ge System for Meal Plan n in g, developed by th e Academ y of Nu trition an d Dietetics an d th e Am erican Diabetes Asso ciation , is a food guide th at m ay be recom m en ded .

b . Th e Exch an ge System grou ps food s acco rdin g to th e am oun ts of carboh ydrates, fats, an d protein s th ey con tain ; m ajor food groups in clude th e carboh ydrate, m eat an d m eat sub- stitute, an d fat grou ps.

c. Acarboh ydrate con sisten t diet focuses on m ain - tain in g a con sisten t am oun t of carboh ydrate in take each day an d with each m eal; also kn own as “carb coun tin g.” For addition al in form ation, refer to: h ttp:/ / www.livestron g.com / article/ 436101-th e-consistent-carboh ydrate-diet-for- diabetics/

d . Th e MyPlate diet m ay also be recom m en ded. K. Sodium -restricted diet (see Box 11-4)

1. In dication : Used for h yperten sio n , h eart failure, ren al disease, cardiac disease, an d liver disease

2. Nu rsin g con sideration s a . In dividualized; can in clude 4 g of sodium

daily (n o-add ed-salt diet), 2 to 3 g of sodium daily (m oderate restriction ), 1 g of sodium daily (strict restriction ), or 500 m g of sodium daily (severe restriction an d sel- dom prescribed)

b . En cou rage in take of fresh food s, rath er th an processed food s, wh ich con tain h igh er am oun ts of sodium .

c. Can n ed , fro zen , in stan t, sm o ked , p ickled , an d b o xed fo o d s u su ally co n tain h igh er am o u n ts o f so d iu m . Lu n ch m eats, so y sau ce, salad d ressin gs, fast fo o d s, so u p s, an d sn acks su ch as p o tato ch ip s an d p ret- zels also co n tain large am o u n ts o f so d iu m ; teach p atien ts to read n u tritio n al facts o n p ro d u ct p ackagin g regard in g so d iu m co n - ten t p er servin g.

d . Certain m ed ication s con tain sign ifican t am oun ts of sodium .

e. Salt substitutes m ay be used to im prove palat- ability; m ost salt substitutes con tain large am oun ts of potassium an d sh ould n ot be used by clien ts with ren al disease.

L. Protein -restricted diet 1. In dication : Used for ren al disease an d en d-stage

liver disease 2. Th e n utrition al status of critically ill clien ts with

protein -losin g ren al diseases, m alabsorption syn d rom es, an d co n tin uou s ren al replacem en t th erap y or dialysis sh ould h ave th eir protein n eeds assessed by estim atin g th e protein equiva- len t of n itrogen appearan ce (PNA); a n utrition ist sh ould be con sulted.

3. Nursin g con sideration s a . Provid e en ough protein to m ain tain n utri-

tion al status but n ot an am oun t th at will allow th e buildup of waste produ cts from protein m etab olism (40 to 60 g of protein daily).

b . The less protein allowed, the m ore im portan t it becom es th at all protein in th e diet be of h igh biological value (con tain all essen tial am in o acids in recom m en ded proportion s).

c. An adequ ate total en ergy in take from food s is critical for clien ts on protein -restricted diets (pro tein will be used for en ergy, rath er th an for protein syn th esis).

d . Special lo w-protein produ cts, such as pastas, bread, cookies, wafers, an d gelatin m ade with wh eat starch , can im prove en ergy in take an d add variety to th e diet.

e. Carb oh ydrates in powdered or liquid form s can provide addition al en ergy.

f. Vegetables an d fruits con tain som e protein an d, for very low-protein diets, th ese food s m ust be calculated in to th e diet.

g. Food s are lim ited from th e m ilk, m eat, bread, an d starch groups.

M. Gluten -free diet: A treatm en t for celiac disease an d gluten sen sitivity for clien ts n eedin g th e protein fraction “glu ten ” elim in ated from th eir diet. See Ch apter 37 for in form ation on th is diet.

128 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

Fluid restrictions may be prescribed for clients with hyponatremia, severe extracellular cellular volume excess, and renal disorders. Ask specifically about client preferences regarding types of oral fluids and tempera- ture preference of fluids.

N. Ren al diet (see Box 11-2) 1. In dication : Used for th e clien t with acu te kidn ey

in ju ry or ch ron ic kidn ey disease an d th o se requirin g h em od ialysis or periton eal dialysis

2. Nu rsin g con sid eration s a. Con trolled am oun ts of protein , sodium ,

phosphorus, calcium , potassium , an d fluids m ay be prescribed; m ay also n eed m od ifica- tio n in fib er, ch olesterol, an d fat based on in dividual requirem en ts; clien ts on perito- n eal dialysis usually h ave diets prescribed th at are less restrictive with fluid an d protein in take th an th ose on h em od ialysis.

b . Most clien ts receivin g dialysis n eed to restrict flu ids ( Box 11-5).

c. Mon itor weigh t daily as a prio rity because weigh t is an im portan t in dicator of fluid status.

An initial assessment includes identifying allergies and food and medication interactions.

O. Potassium -m o dified diet (see Box 11-2) 1. In dication s

a. Low-p otassium diet is in dicated for h yperka- lem ia, wh ich m ay be caused by im paired ren al fun ction , h ypo aldo steron ism , Addi- son ’s disease, an gioten sin -con vertin g en zym e in h ibitor m ed ication s, im m un osuppressive m ed ication s, potassium -retain in g diuretics, an d ch ron ic h yperkalem ia.

b . High -potassium diet is in dicated for h ypo- kalem ia, wh ich m ay be cau sed by ren al tubu lar acido sis, gastroin testin al losses (diarrh ea, vom itin g), in tracellular sh ifts, potassium -losin g diuretics, an tibiotics, m in eraloco rticoid or gluco cortico id excess resultin g from prim ary or secon dary aldo ste- ro n ism , Cush in g’s syn dro m e, or exogen ous corticosteroid use.

2. Nu rsin g con sid eration s a. Food s th at are low in potassium in clude

ap plesauce, green bean s, cabbage, lettuce, pep pers, grapes, blueberries, cooked sum m er

squash , cooked turn ip green s, pin eapple, an d rasp berries.

b . Box 11-2 lists food s th at are h igh in potassium .

P. High -calcium diet 1. In dication : Calcium is n eeded durin g bon e

growth an d in adulth o od to preven t osteo- porosis an d to facilitate vascular con traction , vaso dilation , m uscle con traction , an d n erve tran sm ission .

2. Nu rsin g con sideration s a. Prim ary dietary sources of calcium are dairy

produ cts (see Box 11-2 for food item s h igh in calcium ).

b . Lactose-in toleran t clien ts sh ould in corpo rate n on dairy sources of calcium in to th eir diet regularly.

Q. Low-p urin e diet 1. In dication : Used for go ut, kidn ey ston es, an d ele-

vated uric acid levels 2. Nu rsin g con sideration s

a. Purin e is a precurso r for uric acid, wh ich form s ston es an d crystals.

b . Food s to restrict in clude an ch ovies, h errin g, m ackerel, sard in es, scallop s, organ m eats, gravies, m eat extracts, wild gam e, goose, an d sweetbreads.

R. High -iron diet 1. In dication : Used for clien ts with an em ia 2. Nu rsin g con sideration s

a. Th e h igh -iron diet replaces iron deficit from in adeq uate in take or loss.

b . Th e diet in cludes organ m eats, m eat, egg yolks, wh ole-wh eat products, dark green leafy vegetables, dried fruit, an d legum es.

c. In form th e clien t th at con curren t in take of Vitam in C with iron food s en h an ces absorp- tion of iron .

IV. Vegan and Vegetarian Diets A. Vegan

1. Vegan s follow a strict vegetarian diet an d con - sum e n o an im al food s.

2. Eat on ly foods of plan t origin (e.g., wh ole or en rich ed grain s, legum es, n uts, seeds, fruits, vegetables).

3. Th e use of soybean s, soy m ilk, soybean curd (to fu), an d processed soy protein produ cts en h an ce th e n utrition al value of th e diet.

B. Lacto-vegetarian 1. Lacto-vegetarian s eat m ilk, ch eese, an d

dairy food s but avoid m eat, fish , poultry, an d eggs.

2. A diet of wh o le or en rich ed grain s, legum es, n uts, seeds, fruits, an d vegetables in sufficien t quan tities to m eet en ergy n eeds provides a balan ced diet.

BOX 11-5 Measures to Relieve Thirst ▪ Chew gum or suck hard candy. ▪ Freeze fluids so they take longer to consume. ▪ Add lemon juice to water to make it more refreshing. ▪ Gargle with refrigerated mouthwash.

129CHAPTER 11 Nutrition

C. Lacto-o vo-vegetarian 1. Lacto-o vo-vegetarian s follo w a food pattern th at

allows for th e con sum ptio n of dairy produ cts an d eggs.

2. Con sum ption of adequate plan t an d an im al food sources th at exclud es m eat, poultry, pork, an d fish poses n o n utrition al risks.

D. O vo-vegetarian s: Th e on ly an im al foods th at th e ovo-vegetarian con sum es are eggs, wh ich are an excellen t source of com plete protein s.

E. Nursin g con sideration s 1. Vegan an d vegetarian diets are n ot usually pre-

scrib ed but are a diet ch oice m ade by a clien t. 2. En su re th at th e clien t eats a sufficien t am oun t

of varied food s to m eet n utrien t an d en ergy n eeds.

3. Clien ts sh ould be edu cated about con sum in g com plem en tary protein s over th e course of each day to en sure th at all essen tial am in o acids are provided.

4. Poten tial deficien cies in vegetarian diets in clude en ergy, protein , vitam in B12, zin c, iron , calcium, om ega-3 fatty acids, an d vitam in D (if lim ited exposu re to sun ligh t).

5. To en h an ce absorption of iron , vegetarian s sh ould con sum e a good source of iron an d vita- m in C with each m eal.

6. Food s eaten m ay in clude tofu, tem peh , soy m ilk an d soy produ cts, m eat an alo gs, legum es, n uts an d seeds, sprouts, an d a variety of fru its an d vegetables.

7. Soy protein is con sidered equ ivalen t in quality to an im al protein .

Body mass index (BMI) can be calculated by dividing the client’s weight in kilograms by height in meters squared. For example, a client who weighs 75 kg (165 pounds) and is 1.8 m (5 feet, 9 inches) tall has a BMI of 23.15 (75 divided by 1.82¼23.15). From: Potter et al. (2013), p. 100 8.

V. Enteral Nutrition A. Description : Provides liqu efied food s in to th e gastro -

in testin al tract via a tube B. In dication s

1. Wh en th e gastro in testin al tract is fun ction al but oral in take is n ot m eetin g estim ated n utrien t n eeds

2. Used for clien ts with swallowin g problem s, burn s, m ajor traum a, liver or oth er organ failure, or severe malnutrition

C. Nursin g con sideration s 1. Clien ts with lactose in toleran ce n eed to be

placed on lactose-free form ulas. 2. See Ch apter 20 for in form ation regardin g th e

adm in istration of gastroin testin al tube feedin gs an d associated com plication s.

CRITICAL THINKING What Should You Do? Answer: The client with acute kidney injury may be placed on fluid restriction because of decreased renal function and glomerular filtration rate, resulting in fluid volume excess. To allow the kidneys to rest, decreased fluid consumption may be indicated. When a client is placed on this restriction, increased thirst may be a problem. The nurse should instruct the client in measures to relieve thirst in order to promote adherence to the fluid restriction. These measures include chewing gum or sucking hard candy, freezing fluids so they take longer to consume, adding lemon juice to water to make it more refreshing, and gargling with refrigerated mouthwash.

References: Lewis et al. (20 14), p. 1115; Potter et al. (20 13), p. 904.

P R A C T I C E Q U E S T I O N S 77. Th e n urse is teach in g a clien t wh o h as iron defi-

cien cy an em ia about food s sh e sh o uld in clude in th e diet. Th e n urse determ in es th at th e clien t un der- stan d s th e dietary m odification s if wh ich item s are selected from th e m en u? 1. Nuts an d m ilk 2. Coffee an d tea 3. Cooked rolled oats an d fish 4. O ran ges an d dark green leafy vegetables

78. Th e n urse is plan n in g to teach a clien t with m alab- sorption syn drom e about th e n ecessity of follo win g a low-fat diet. Th e n urse develops a list of h igh -fat foods to avoid an d sh ould in clude wh ich food item s on th e list? Select all th at ap p ly.

1. O ran ges 2. Broccoli 3. Margarin e 4. Cream ch eese 5. Lun ch eon m eats 6. Broiled h add ock

79. Th e n urse in structs a clien t with ch ron ic kidn ey dis- ease wh o is receivin g h em od ialysis about dietary m od ification s. Th e n urse determ in es th at th e clien t un derstan ds th ese dietary m odification s if th e clien t selects wh ich item s from th e dietary m en u? 1. Cream of wh eat, blueb erries, coffee 2. Sau sage an d eggs, ban an a, oran ge juice 3. Bacon , can taloupe m elon , tom ato juice 4. Cured pork, grits, strawberries, oran ge juice

80. Th e n urse is con d uctin g a dietary assessm en t on a clien t wh o is on a vegan diet. Th e n urse provid es die- tary teach in g an d sh o uld focus on foods h igh in wh ich vitam in th at m ay be lackin g in a vegan diet?

F

u

n

d

a

m

e

n

t

a

l

s

130 UNIT III Nursing Sciences

1. Vitam in A 2. Vitam in B12 3. Vitam in C 4. Vitam in E

81. A clien t with h yperten sion h as been told to m ain - tain a diet lo w in sodium . Th e n urse wh o is teach in g th is clien t about foods th at are allowed sh ould in clude wh ich food item in a list provided to th e clien t? 1. To m ato soup 2. Boiled sh rim p 3. In stan t oatm eal 4. Sum m er squash

82. A postoperative clien t h as been placed on a clear liq- uid diet. Th e n urse sh ould provid e th e clien t with wh ich item s th at are allowed to be con sum ed on th is diet? Select all th at ap p ly.

1. Broth 2. Coffee 3. Gelatin 4. Puddin g 5. Vegetable juice 6. Pureed vegetables

83. Th e n urse is in structin g a clien t with h yperten sion on th e im portan ce of ch oosin g food s low in sodium . Th e n urse sh o uld teach th e clien t to lim it in take of wh ich food ? 1. Apples 2. Ban an as 3. Sm oked sausage 4. Steam ed vegetables

84. A clien t wh o is recoverin g from surgery h as been advan ced from a clear liquid diet to a full liqu id diet. Th e clien t is lookin g forward to th e diet ch an ge because h e h as been “bored” with th e clear liqu id diet. Th e n urse sh ould offer wh ich full liquid item to th e clien t? 1. Tea 2. Gelatin 3. Custard 4. Ice pop

85. A clien t is recoverin g from abdom in al surgery an d h as a large abdom in al woun d. Th e n urse should encour- age th e clien t to eat which food item th at is n aturally h igh in vitam in C to prom ote woun d h ealing? 1. Milk 2. O ran ges 3. Ban an as 4. Ch icken

86. Th e n urse is carin g for a clien t with cirrh osis of th e liver. To m in im ize th e effects of th e disorder, th e n urse teach es th e clien t about food s th at are h igh in th iam in e. Th e n urse determ in es th at th e clien t h as th e b est un derstan din g of th e dietary m easures to follow if th e clien t states an in ten tion to in crease th e in take of wh ich food? 1. Milk 2. Ch icken 3. Broccoli 4. Legu m es

A N S W E R S 77. 4 Ra t ion a le: Dark green leafy vegetab les are a go od so urce o f iro n an d o ran ges are a goo d sou rce of vitam in C, wh ich en h an ces iro n abso rptio n . All o th er o ption s are n ot foo d sou rces th at are h igh in iro n an d vitam in C. Test -Ta kin g St r a t egy: Focus on th e s u b ject , d iet ch o ices for a clien t with an em ia. Th in k ab ou t th e p ath o ph ysiology o f an e- m ia an d d eterm in e th at th e clien t n eeds foo ds h igh in iro n an d recall th at vitam in C en h an ces iron ab so rp tion . Use kn o wledge of fo o ds h igh in iron an d vitam in C. Rem em ber th at green leafy vegetables are h igh in iro n an d oran ges are h igh in vitam in C. Review: Foo d so urces o f vit a m in C an d ir o n Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Fu n d am en tals of Care—Nutritio n Pr ior ity Con cepts: Clien t Edu catio n ; Nu tritio n Refer en ces: Lewis et al. (2014), p. 889; Nix (2013), pp . 108, 144.

78. 3, 4, 5 Ra t ion a le: Fruits an d vegetab les ten d to b e lo wer in fat becau se th ey do n ot co m e fro m an im al so urces. Bro iled h add ock is also n aturally lower in fat. Margarin e, cream ch eese, an d lu n ch eo n m eats are h igh -fat foo ds. Test -Ta kin g Str a t egy: Fo cus on th e su b ject of th e qu estio n , th e h igh -fat foo ds. O ran ges an d b ro cco li (fruit an d vegetable) can be elim in ated first. Next elim in ate h ad do ck because it is a b ro iled foo d. Rem em b er th at m argarin e, ch eese, an d lu n ch eo n m eats are h igh in fat co n ten t. Review: High -fa t fo o d s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun d am en tals of Care—Nu tritio n Pr ior ity Con cepts: Clien t Ed u catio n ; Nu tritio n Refer en ce: Nix (2013), p. 38.

79. 1 Ra tion a le: Th e diet for a client with ch ron ic kid n ey disease wh o is receivin g h em odialysis sh ould in clud e con tro lled am o un ts o f sodium , p h osp h orus, calcium , p otassium , and fluids, wh ich

F

u

n

d

a

m

e

n

t

a

l

s

131CHAPTER 11 Nutrition

is in d icated in th e correct o ption . Th e food item s in th e rem ain - in g option s are h igh in sodiu m , ph osph o ru s, or p otassium . Test-Ta kin g St r a tegy: Focu s on th e su b ject , dietary m od ifica- tio n for a clien t with ch ro n ic kid n ey d isease. Th in k ab ou t th e p ath op h ysio lo gy of th is disorder to recall th at so dium n eeds to b e lim ited . Notin g th e item s sausage, b aco n , an d cu red po rk will assist in elim in atin g th ese optio n s. Review: Diet a r y gu id elin es fo r th e clien t with ch r o n ic k id - n ey d isea se Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Fu n dam en tals o f Care—Nu trition Pr ior it y Con cept s: Clien t Ed ucation ; Nutritio n Refer en ce: Lewis et al. (2014), p p . 1114–1115.

80. 2 Ra tion a le: Vegan s d o n o t co n sum e an y an im al prod ucts. Vita- m in B12 is fo un d in an im al p rod ucts an d th erefore wou ld m ost likely be lackin g in a vegan d iet. Vitam in s A, C, an d E are fou n d in fresh fru its an d vegetab les, wh ich are co n su m ed in a vegan d iet. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject , a vegan diet an d th e vitam in lackin g in th is d iet. Recallin g th e fo o d item s eaten an d restricted in th is d iet will direct you to th e correct o ption . Rem em ber th at vegan s d o n ot con sum e an y an im al prod ucts an d as a resu lt m ay b e d eficien t in vitam in B12. Review: Th e vega n d iet an d sou rces of vit a m in s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n dam en tals o f Care—Nu trition Pr ior it y Con cept s: Health Pro m otio n ; Nu trition Refer en ces: Lewis et al. (2014), p. 889; Nix (2013), p . 55.

81. 4 Ra tion a le: Fo ods th at are lower in sodium in clude fruits an d vegetab les (su m m er squ ash ), b ecau se th ey do n o t con tain p h ysio logical salin e. High ly p ro cessed o r refin ed fo od s (tom ato so up , in stan t oatm eal) are h igh er in so dium un less th eir foo d lab els sp ecifically state “low so diu m .” Saltwater fish an d sh ellfish are h igh in so d ium . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject , foods low in so diu m . Begin to an swer th is qu estio n b y elim in atin g b oiled sh rim p, recallin g th at saltwater fish an d sh ellfish are h igh in so diu m . Next, elim in ate to m ato so up an d in stan t oatm eal b ecau se th ey are p ro cessed fo od s. Review: Fo od s h igh in so d iu m Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n dam en tals o f Care—Nu trition Pr ior it y Con cept s: Health Pro m otio n ; Nu trition Refer en ce: Nix (2013), p p. 141, 389.

82. 1, 2, 3 Ra tion a le: A clear liq u id diet co n sists o f foo d s th at are rela- tively tran sparen t to ligh t an d are clear an d liqu id at ro o m an d bo dy tem peratu re. Th ese fo od s in clud e item s su ch as water, bouillon , clear broth , carb on ated beverages, gelatin ,

h ard can dy, lem on ade, ice p o ps, an d regular o r d ecaffein ated coffee o r tea. Th e in co rrect foo d item s are item s th at are allo wed o n a full liqu id diet. Test-Ta king Str a tegy: Focus o n th e s u b ject , a clear liquid d iet. Recallin g th at a clear liq uid d iet con sists o f foo ds th at are rela- tively tran sparen t to ligh t and are clear will assist in an swerin g th e q uestio n. Review: Clea r liq u id d iet an d fu ll liq u id d iet Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fun dam en tals o f Care—Nu trition Pr ior it y Con cept s: Health Pro m o tio n ; Nu tritio n Refer en ce: Perry, Potter, O sten dorf (2014), p. 765.

83. 3 Ra tion a le: Sm o ked fo o ds are h igh in sod iu m , wh ich is n oted in th e co rrect op tion . Th e rem ain in g op tion s are fru its an d veg- etab les, wh ich are low in sod iu m . Test-Ta kin g St r a t egy: Note th e su b ject , th e foo d item th at is h igh in sod iu m . Rem em ber th at sm o ked foo d s are h igh in so diu m . Also elim in ate o ptio n s 1, 2, an d 4 becau se th ey are co m p a r a b le o r a lik e an d are n o n p ro cessed fo od s. Review: Fo od item s h igh in so d iu m Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n dam en tals o f Care—Nu trition Pr ior it y Con cept s: Health Pro m otio n ; Nu trition Refer en ce: Nix (2013), p . 389.

84. 3 Ra tion a le: Full liquid food item s in clude item s such as plain ice cream , sh erb et, breakfast drin ks, m ilk, p ud din g an d custard, so up s th at are strain ed, refin ed co o ked cereals, an d strain ed vegetable juices. A clear liq uid diet con sists o f fo od s th at are rel- atively tran sparen t. Th e foo d item s in th e in correct o ptio n s are clear liq uids. Test-Ta kin g Str a t egy: Focu s o n th e su b ject , a fu ll liq uid item . Rem em ber th at a clear liq u id diet con sists of fo o ds th at are rel- atively tran sparen t. Th is will assist yo u in elim in atin g tea, gela- tin , an d ice p op s; in ad ditio n , th ese are co m p a r a b le o r a lik e o ptio n s. Review: Clea r liq u id d iet an d fu ll liq u id d iet Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Nu trition Pr ior it y Con cept s: Health Pro m otio n ; Nu trition Refer en ce: Perry, Potter, O sten d orf ( 2014), p . 765.

85. 2 Ra tion a le: Citrus fruits an d juices are especially h igh in vitam in C. Ban an as are h igh in p otassium . Meats an d d airy prod ucts are two fo od gro u ps th at are h igh in th e B vitam in s. Test-Ta kin g St r a tegy: Note th e su b ject , fo od item s n atu rally h igh in vitam in C. It is n ecessary to recall th at citrus fruits an d ju ices are h igh in vitam in C; th is will d irect yo u to th e cor- rect option .

F

u

n

d

a

m

e

n

t

a

l

s

132 UNIT III Nursing Sciences

Review: Foo d item s h igh in vit a m in C Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fu n d am en tals of Care—Nutritio n Pr ior ity Con cepts: Nutrition ; Tissu e In tegrity Refer en ce: Nix (2013), pp . 108, 451.

86. 4 Ra t ion a le: Th e clien t with cirrh o sis n eeds to con sum e foo ds h igh in th iam in e. Th iam in e is p resen t in a variety of foo ds o f plan t an d an im al o rigin . Legu m es are especially rich in th is vitam in . O th er go od foo d sou rces in clu de n uts, wh o le-grain cereals, an d po rk. Milk co n tain s vitam in s A, D, an d B2. Pou ltry

co n tain s n iacin . Bro ccoli con tain s vitam in s C, E, an d K an d fo lic acid. Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d , best. Th is m ay in d icate th at m o re th an o n e op tion m ay b e a foo d th at co n tain s th iam in e. Rem em b erin g th at legu m es are especially rich in th iam in e will d irect yo u to th e co rrect o ption . Review: Foo d item s h igh in t h ia m in e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Fun d am en tals of Care—Nu tritio n Pr ior ity Con cepts: Health Prom o tion ; Nutritio n Refer en ces: Lewis et al. (2014), p p. 1023–1024; Nix (2013), p . 109.

F

u

n

d

a

m

e

n

t

a

l

s

133CHAPTER 11 Nutrition

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 12 Parenteral Nutrition

PRIORITY CONCEPTS Fluids and Electrolytes; Nutrition

CRITICAL THINKING What Should You Do? A client has a triple-lumen central venous catheter that is being used for the administration of parenteral nutrition, medications, and laboratory draws. The nurse is preparing to administer medication through the catheter, and the port being used for medication administration is sluggish and not flushing properly. What should the nurse do? Answer located on p. 138.

I. Parenteral Nutrition (PN) A. Description

1. Paren teral n utrition (also term ed h yperalim en ta- tion ) supp lies n utrien ts via th e vein s.

2. PN con sists of both partial parenteral nutrition (PPN) an d total parenteral nutrition (TPN) . Th e in dication of th e type used dep en ds on th e cli- en t’s n utrition al n eeds.

3. PN supp lies carboh ydrates in th e form of dex- trose, fats in an em ulsified form , protein s in th e form of am in o acids, vitam in s, m in erals, electrolytes, an d water.

4. PN preven ts subcutan eous fat an d m uscle protein from bein g catabolized by th e body for en ergy.

5. PN solution s are h yperton ic due to th e h igh er con cen tration s of glucose an d addition of am in o acids.

B. In dication s 1. Clien ts with severely dysfun ction al or n on fun c-

tion al gastroin testinal tracts who are un able to process n utrien ts m ay ben efit from PN.

2. Clien ts wh o can take som e oral n utrition , but n ot en ough to m eet th eir n utrien t requirem en ts, m ay ben efit from PN.

3. Clien ts with m ultiple gastroin testin al surgeries, gastro in testin al traum a, severe in toleran ce to en teral feedin gs, or in testin al obstru ction s, or wh o n eed to rest th e bowel for h ealin g, m ay ben - efit from PN.

4. Clien ts with severe n utrition ally deficien t con d i- tion s such as acquired im m un od eficien cy syn - drom e, can cer, burn in juries, or malnutrition, or clien ts receivin g ch em oth erapy, m ay ben efit from PN.

PN is a form of nutrition and is used when there is no other nutritional alternative. Administering nutrition orally or through a nasogastric tube is usually initiated first, before PN is initiated.

C. Adm in istration of PN (Fig. 12-1) 1. Partial paren teral n utrition

a . PPN: Usually adm in istered through a large dis- tal vein in the arm with a stan dard periph eral in traven ous (IV) cath eter or m idlin e or through a peripherally in serted cen tral cath eter (PICC). A m idlin e is placed in an upper arm vein such as th e brachial or cephalic vein with the tip en d- in g below th e level of the axillary lin e.

b . If a PICC can n ot be establish ed, th e subcla- vian vein or in tern al or extern al jugular vein s can be used for PPN.

2. TPN: Adm in istered th rough a cen tral vein ; th e use of a PICC is acceptable. O th er sites th at can be used in clude th e subclavian vein an d th e in tern al or extern al jugu lar vein s.

3. If th e bag of in traven o us solution is em pty an d th e n urse is waitin g for th e delivery of a n ew bag of solution from th e ph arm acy, a 10 % dex- trose in water solution sh ould be in fused at prescribed rate to preven t h ypo glycem ia; th e pre- scrib ed solution sh o uld be obtain ed as soon as possib le.

The delivery of hypertonic solutions into peripheral veins can cause sclerosis, phlebitis, or swelling. Monitor closely for these complications.

II. Components of Parenteral Nutrition A. Carboh ydrates

1. Th e stren gth of th e dextrose solution depen ds on th e clien t’s n utrition al n eeds, th e ro ute of134

ad m in istration (cen tral or periph eral), an d agen cy protoco ls.

2. Carb oh yd rates typically provide 60% to 70% of calorie (en ergy) n eeds.

B. Am in o acids (pro tein ) 1. Con cen tration s ran ge fro m 3.5% to 20%; lower

con cen tration s are m ost com m on ly used for periph eral vein ad m in istration an d h igh er con - cen tration s are m ost often adm in istered th rou gh a cen tral vein .

2. Abou t 15% to 20% of total en ergy n eeds sh ould com e from protein .

C. Fat emulsion (lipids) 1. Lipids provid e up to 30% of calorie (en ergy)

n eeds. 2. Lipids provide n on protein calories an d preven t

or correct fatty acid deficien cy. 3. Lipid solution s are isoton ic an d th erefore can be

ad m in istered th rou gh a periph eral or cen tral vein ; th e solution m ay be adm in istered th rou gh a separate IV lin e below th e filter of th e m ain IV ad m in istration set by a Y-con n ector or as an ad m ixture to th e PN solution (3-in -1 ad m ixture con sistin g of dextrose, am in o acids, an d lipids).

4. Most fat em u lsion s are prepared fro m soybean or safflower oil, with egg yolk to provid e em u lsifica- tio n ; th e prim ary com pon en ts are lin oleic, oleic, palm itic, lin olen ic, an d stearic acids (assess th e clien t for allergies).

5. Glucose-in toleran t clien ts or clien ts with diabe- tes m ellitus m ay ben efit from receivin g a larger percen tage of th eir PN fro m lipids, wh ich h elps to con tro l blood glucose levels an d lower in sulin requirem en ts cau sed by in fused dextrose.

6. Exam in e th e bottle for sep aration of em ulsio n in to layers or fat glob ules or for th e accum ulation of froth ; if observed, do n ot use an d return th e solution to th e ph arm acy.

7. Additives sh ould n ot be put in to th e fat em ulsion solution .

8. Follo w agen cy policy regardin g th e filter size th at sh ould be used; usually a 1.2-µm filter or larger sh ould be used because th e lipid particles are too large to pass th rough a 0.22-µm filter.

9. In fuse solution at th e flo w rate prescribed— usually slowly at 1 m L/ m in ute in itially— m on itor vital sign s every 10 m in utes, an d observe for adverse reaction s for th e first 30 m in utes of th e in fusion . If sign s of an adverse reaction occur, stop th e in fusion an d n otify th e h ealth care provider (HCP) ( Box 12-1).

10. If n o adverse reaction occurs, adju st th e flow rate to th e prescribed rate.

11. Mon itor serum lipids 4 h ours after discon tin uin g th e in fusion .

Fat emulsions (lipids) contain egg yolk phospho- lipids and should not be given to clients with egg allergies.

D. Vitam in s 1. PN solution s usually con tain a stan d ard m ultivi-

tam in preparation to m eet m ost vitam in n eeds an d preven t deficien cies.

2. In dividual vitam in preparation s can be added , as n eeded an d as prescribed.

E. Min erals an d trace elem en ts: Com m ercial m in eral and trace elem en t preparation s are available in various con cen tration s to prom ote n orm al metabolism.

F

u

n

d

a

m

e

n

t

a

l

s

Incis ionFrom IV fe e de r

S ubcla via n ve in

Ca the te r ins ide s upe rior ve na ca va

B

S upe rior ve na ca va

Ce pha lic ve in

A

P ICC s ite s

Pe riphe ra lly ins e rte d ce ntra l ca the te r

Ba s ilic ve in

FIGURE 12-1 A, Placement of peripherally inserted central catheter through antecubital fossa. B, Placement of central venous catheter inserted into subclavian vein. IV, Intravenous; PICC, peripherally inserted central catheter.

BOX 12-1 Signs and Symptoms of an Adverse Reaction to Lipids

▪ Chest and back pain ▪ Chills ▪ Cyanosis ▪ Diaphoresis ▪ Dyspnea ▪ Fever

▪ Flushing ▪ Headache ▪ Nausea and vomiting ▪ Pressure over the eyes ▪ Thrombophlebitis ▪ Vertigo

135CHAPTER 12 Parenteral Nutrition

F

u

n

d

a

m

e

n

t

a

l

s

F. Electro lytes: Electrolyte requirem en ts for in dividuals receivin g PN th erap y vary, depen din g on body weigh t, presen ce of m aln utrition or catabo lism , degree of electrolyte depletion , ch an ges in organ fun ction , on go in g electrolyte losses, an d th e disease process.

G. Water: Th e am oun t of water n eeded in a PN solution is determ in ed by electrolyte balan ce an d fluid requirem en ts.

H. Regular in sulin : May be added to con trol th e blood gluco se level because of th e h igh con cen tration of gluco se in th e PN solution .

I. Heparin : May be ad ded to reduce th e buildup of a fibrin ous clot at th e cath eter tip.

III. Administration and Discontinuation A. Types of ad m in istration

1. Con tin uous PN a . In fused con tin uo usly over 24 h ours b . Most com m on ly used in a h ospital settin g

2. In term itten t or cyclic PN a . In gen eral, th e n utrien t solution in fusion reg-

im en varies an d is com m on ly ad m in istered overn igh t.

b . Allows clien ts requirin g PN on a lon g-term basis to participate in activities of daily livin g durin g th e day with out th e in con ven ien ce of an IV bag an d pum p set

c. Mon itor gluco se levels closely because of th e risk of h ypoglycem ia due to lack of gluco se durin g n on -in fusion tim es.

B. Discon tin uin g PN th erapy 1. Evaluation of n utrition al status by a n utrition ist

or ph arm acist is don e befo re PN is discon tin u ed. 2. If discon tin uation is prescribed, gradually

decrease th e flo w rate for 1 to 2 h ou rs wh ile in creasin g oral in take (th is assists in preven tin g h ypo glycem ia).

3. After rem oval of th e IV cath eter, ch an ge th e dress- in g daily un til th e in sertion site h eals. No te th at cen tral lin es sh ould n ot be left in with out a rea- son due to risk of in fectio n , but in som e situa- tion s are left in place an d used for oth er n ecessary reason (ven ou s access, m edication adm in istration ).

4. En cou rage oral n utrition . 5. Record oral in take, body weigh t, an d labo ratory

results of serum electrolyte an d glucose levels.

Abrupt discontinuation of a PN solution can result in hypoglycemia. The flow rate should be decreased gradually when the PN is discontinued.

IV. Complications (Table 12-1) A. Pn eum oth orax an d air embolism are associated with

cen tral lin e placem en t; air em bolism is also associ- ated with tubin g ch an ges.

B. O th er com plication s in clude in fectio n (cath eter- related) , h ypervo lem ia, an d m etab olic alteration s such as h yperglycem ia an d h ypoglycem ia; th ese com plication s are usually caused by th e PN solution itself (see Priority Nursin g Actio n s).

V. Additional Nursing Considerations A. Ch eck th e PN solution with th e HCP’s prescription

to en sure th at th e prescribed com pon en ts are con - tain ed in th e solution ; som e h ealth care agen cies require validation of th e prescription by 2 registered n urses.

B. To preven t in fectio n an d solution in com patib ility, IV m ed ication s an d blood are n ot given th rou gh th e PN lin e.

C. Blood for testin g m ay be drawn from th e cen tral ven ous access site; a port oth er th an th e port used to in fuse th e PN is used for blood draws after th e PN h as been stopp ed for several m in utes

PRIORITY NURSING ACTIONS Central Venous Catheter Site with a Suspected Infection 1. Notify the health care provider (HCP). 2. Prepare to remove the catheter and for possible restart at

a different location. 3. Remove the tip of the catheter and send it to the labora-

tory for culture if prescribed by the HCP. 4. Prepare the client for obtaining blood cultures. 5. Prepare for antibiotic administration. 6. Document the occurrence, the actions taken, and the cli-

ent’s response.

Signs of infection at the catheter site include redness or drainage. The client will also exhibit chills, fever, and an ele- vated white blood cell count. If the nurse suspects infection, the HCP is notified because of the risk for sepsis. The cath- eter is removed and the client is prepared for a possible restart at a different location as prescribed. A central line may be removed by a nurse who has been trained in approved protocol to remove a central line. If requested, the catheter tip may be sent to the laboratory for culture to identify the bacteria present so that the effective antibiotic is prescribed. Intravenous (IV) antibiotics may be prescribed and an IV site will be needed for administration. Blood cul- tures are also performed to determine the presence of bacte- ria in the blood. Antibiotics are not started until blood cultures are obtained; otherwise the results of the cultures may not be accurate. Finally, the nurse documents the occur- rence, actions taken, and the client’s response. Additionally, per agency protocol, pictures of the infected catheter site may be taken and added to the documentation.

References Lewis et al. (2014), p. 311; Perry, Potter, Ostendorf (2014), pp. 798, 801.

136 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 12-1 Complications of Parenteral Nutrition Complication Possible Cause Signs or Symptoms Intervention Prevention

Air embolism ▪ Catheter system opened or IV tubing disconnected ▪ Air entry on IV

tubing changes

▪ Apprehension ▪ Chest pain ▪ Dyspnea ▪ Hypotension ▪ Loud churning sound

heard over pericardium on auscultation ▪ Rapid and weak pulse ▪ Respiratory distress

▪ Clamp all ports of the IV catheter ▪ Place the client in a left

side-lying position with the head lower than the feet ▪ Notify the HCP ▪ Administer oxygen

▪ Make sure all catheter connections are secure (use tape per agency protocol) ▪ Clamp the catheter when not in use and

when changing caps (follow agency protocol for flushing and clamping the catheter and cap changes) ▪ Instruct the client in the Valsalva maneuver

for tubing and cap changes ▪ For tubing and cap changes, place the

client in the Trendelenburg position (if not contraindicated) with the head turned in the opposite direction of the insertion site; client should hold breath and bear down

Hyperglycemia ▪ High concentration of dextrose in solution ▪ Client receiving

solution too quickly ▪ Not enough insulin ▪ Infection

▪ Restlessness ▪ Confusion ▪ Weakness ▪ Diaphoresis ▪ Elevated blood glucose

level > 200 mg/ dL (10 .9 mmol/ L) ▪ Excessive thirst ▪ Fatigue ▪ Kussmaul respirations ▪ Coma (when severe)

▪ Notify the HCP ▪ The infusion rate may

need to be slowed ▪ Monitor blood

glucose levels ▪ Administer regular

insulin as prescribed

▪ Assess the client for a history of glucose intolerance ▪ Assess the client’s medication history

(corticosteroids increase blood glucose) ▪ Begin infusion at a slow rate as prescribed

(usually 40-60 mL/ h) ▪ Monitor blood glucose levels per agency

protocol ▪ Administer regular insulin as prescribed ▪ Use strict aseptic technique to prevent

infection

Hypervolemia ▪ Excessive fluid administration or administration of fluid too rapidly ▪ Renal dysfunction ▪ Heart failure ▪ Hepatic failure

▪ Bounding pulse ▪ Crackles on lung

auscultation ▪ Headache ▪ Increased blood pressure ▪ Jugular vein distention ▪ Weight gain greater than

desired

▪ Slow or stop IV infusion ▪ Notify the HCP ▪ Restrict fluids ▪ Administer diuretics ▪ Use dialysis (in

extreme cases)

▪ Assess client’s history for risk for hypervolemia ▪ Administer via an electronic infusion device

and ensure proper function of the device ▪ Never increase the rate of infusion of the

device to “catch up” if the infusion gets behind ▪ Monitor intake and output ▪ Monitor weight daily (ideal weight gain is

1-2 lb per week)

Hypoglycemia ▪ PN abruptly discontinued ▪ Too much insulin

being administered

▪ Anxiety ▪ Diaphoresis ▪ Hunger ▪ Low blood glucose level

< 70 mg/ dL (4 mmol/ L) ▪ Shakiness ▪ Weakness

▪ Notify the HCP ▪ Administer IV

dextrose ▪ Monitor blood

glucose level

▪ Gradually decrease PN solution when discontinued ▪ Infuse 10% dextrose at same rate as the

PN to prevent hypoglycemia for 1-2 hours after the PN solution is discontinued ▪ Monitor glucose levels and check the level

1 hour after discontinuing the PN

Infection ▪ Poor aseptic technique ▪ Catheter

contamination ▪ Contamination of

solution

▪ Chills ▪ Fever ▪ Elevated white blood cell

count ▪ Redness or drainage at

insertion site

▪ Notify the HCP ▪ Remove catheter ▪ Send catheter tip to

the laboratory for culture ▪ Prepare to obtain

blood cultures ▪ Prepare for antibiotic

administration

▪ Use strict aseptic techniques (PN solution has a high concentration of glucose and is a medium for bacterial growth) ▪ Monitor temperature (fever could indicate

infection) ▪ Assess IV site for signs of infection

(redness, swelling, drainage) ▪ Change site dressing, solution, and tubing

as specified by agency policy ▪ Do not disconnect tubing unnecessarily

Pneumothorax ▪ Inexact catheter placement resulting in puncture of the pleural space

▪ Chest or shoulder pain ▪ Sudden shortness of

breath ▪ Cyanosis ▪ Tachycardia ▪ Absence of breath sounds

on affected side

▪ Notify the HCP ▪ Prepare to obtain a

chest x-ray ▪ Small pneumothorax

may resolve ▪ Larger pneumothorax

may require chest tube

▪ Monitor for signs of pneumothorax ▪ Obtain a chest x-ray after insertion of

the catheter to ensure proper catheter placement ▪ PN is not initiated until correct catheter

placement is verified and the absence of pneumothorax is confirmed

HCP, Health care provider; IV, intravenous; PN, parenteral nutrition. Adapted from Ignatavicius D, Workman M: Medical-surgical nursing: patient-centered collaborative care, ed 7, St. Louis, 20 13, Saunders.

137CHAPTER 12 Parenteral Nutrition

(per agen cy proced ure) because th e PN solution can alter th e results of th e sam ple. Th e clien t with a cen - tral ven ous access site receivin g PN sh ould still h ave a ven ipu n cture site.

D. Mon itor partial th rom boplastin tim e an d proth rom - bin tim e for clien ts receivin g an ticoagulan ts.

E. Mon itor electrolyte an d album in levels an d liver an d ren al fun ction studies, as well as an y oth er prescribed laborato ry studies. Bloo d studies for blood ch em is- tries are n orm ally don e every oth er day or 3 tim es per week (per agen cy procedures) wh en th e clien t is receivin g PN; th e results are th e basis for th e HCP con tin uin g or ch an gin g th e PN solution or rate.

F. Mon itor blood gluco se levels as prescribed (usually every 4 h ours) because of th e risk for h yperglycem ia from th e PN solution com po n en ts.

G. In severely deh ydrated clien ts, th e album in level m ay drop in itially after in itiatin g PN, because th e treat- m en t restores h ydration .

H. With severely m aln ou rish ed clien ts, m on itor for “refeedin g syn dro m e” (a rapid drop in potassium, magnesium, an d ph osph ate serum levels) .

I. Th e electrolyte sh ift th at occurs in “refeedin g syn - drom e” can cau se cardiovascular, respiratory, an d n eurological problem s; m on itor for sh allow respira- tion s, con fusion , weakn ess, bleed in g ten den cies, an d seizures. If n oted, th e HCP is n otified im m ediately.

J. Abn orm al liver fun ction values m ay in dicate in toler- an ce to or an excess of fat em u lsion or problem s with m etab olism with glucose an d protein .

K. Abn orm al ren al fun ctio n tests m ay in dicate an excess of am in o acids.

L. PN solution s sh ould be stored un der refrigeration an d ad m in istered with in 24 h ours fro m th e tim e th ey are prepared (rem ove from refrigerator 0.5 to 1 h our befo re use).

M. PN solution s th at are cloudy or darken ed sh ould n ot be used an d sh ould be return ed to th e ph arm acy.

N. Addition s of substan ces such as n utrien ts to PN solu- tion s sh ould be m ade in th e ph arm acy an d n ot on th e n ursin g un it.

O. Con sultation with th e n utrition ist sh o uld be don e on a regular basis (as prescribed or per agen cy protoco l).

VI. Home Care Instructions (Box 12-2)

P R A C T I C E Q U E S T I O N S 87. A clien t is bein g wean ed from paren teral n utrition

(PN) an d is expected to begin takin g solid food today. Th e on goin g solution rate h as been 100 m L/ h ou r. Th e n urse an ticipates th at wh ich

F

u

n

d

a

m

e

n

t

a

l

s

BOX 12-2 Home Care Instructions Teach the client and caregiver how to obtain, administer, and

maintain parenteral nutrition fluids. Teach the client and caregiver how to change a sterile

dressing. Obtain a daily weight at the same time of day in the same

clothes. Stress that if a weight gain of more than 3 lb/ week is noted,

this may indicate excessive fluid intake and should be reported.

Monitor the blood glucose level and report abnormalities immediately. Teach the client how to monitor for and man- age hypoglycemia and hyperglycemia.

Teach the client and caregiver about the signs and symptoms of side effects or adverse effects such as infection, throm- bosis, air embolism, and catheter displacement.

Teach the client and caregiver the actions to take if a compli- cation arises and about the importance of reporting com- plications to the health care provider.

For signs and symptoms of thrombosis, the client should report edema of the arm or at the catheter insertion site, neck pain, and jugular vein distention.

Leaking of fluid from the insertion site or pain or discomfort as the fluids are infused may indicate displacement of the catheter; this must be reported immediately.

Encourage the client and caregiver to contact the health care provider if they have questions about administration or any other questions.

Inform the client and caregiver about the importance of follow-up care.

Teach the client to keep electronic infusion devices fully charged in case of electrical power failure.CRITICAL THINKING What Should You Do?

Answer: Difficulty with flushing the catheter indicates that the catheter is partially or fully blocked. Possible causes of a blockage include a clamped or kinked catheter, the tip of the catheter against the vein wall, thrombosis, or a precipi- tate buildup in the lumen. The nurse should not try to force the flushing because this could dislodge a clot or disrupt the integrity of the catheter. If the catheter becomes fully

blocked, it may not be usable. The nurse should assess for and alleviate clamping or kinking. The nurse should also instruct the client to change position, raise the arm, and cough. If the blockage is due to a positional issue, this inter- vention will correct it. The nurse should attempt to flush again to see if the problem has been corrected. If it has not, this difficulty should be reported to the necessary per- sonnel (i.e., health care provider or intravenous nurse) so that full functionality can be regained. Fluoroscopy may be performed to determine the cause of the blockage and anti- coagulant or thrombolytic medications may be instilled into the catheter as prescribed to alleviate blockage.

References: Lewis et al. (20 14), p. 312; Perry, Potter, Ostendorf (2014), p. 50 4.

138 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

prescription regardin g th e PN solution will accom - pan y th e diet prescription ? 1. Discon tin ue th e PN. 2. Decrease PN rate to 50 m L/ h ou r. 3. Start 0.9% n orm al salin e at 25 m L/ h our. 4. Con tin ue curren t in fusio n rate prescription s

for PN.

88. Th e n u rse is p rep arin g to ch an ge th e p aren teral n u tritio n ( PN) so lu tio n b ag an d tu b in g. Th e clien t’s cen tral ven o u s lin e is lo cated in th e righ t su b clavian vein . Th e n u rse asks th e clien t to take wh ich essen tial actio n d u rin g th e tu b in g ch an ge? 1. Breath e n orm ally. 2. Turn th e h ead to th e righ t. 3. Exh ale slowly an d even ly. 4. Take a deep breath , h old it, an d bear down .

89. A clien t with paren teral n utrition (PN) in fusin g h as discon n ected th e tubin g from th e cen tral lin e cath - eter. Th e n urse assesses th e clien t an d suspects an air em b olism . Th e n urse sh ould im m ed iately place th e clien t in wh ich position ? 1. O n th e left side, with th e h ead lo wer th an th e feet 2. O n th e left side, with th e h ead h igh er th an

th e feet 3. O n th e righ t side, with th e h ead lower th an th e feet 4. O n th e righ t side, with th e h ead h igh er th an the feet

90. Wh ich n ursin g action is essen tial prior to in itiatin g a n ew prescription for 500 m L of fat em ulsio n (lipids) to in fuse at 50 m L/ h ou r? 1. En su re th at th e clien t does n ot h ave diabetes. 2. Determ in e wh eth er th e clien t h as an allergy

to eggs. 3. Add regular in sulin to th e fat em ulsio n , usin g

aseptic tech n iqu e. 4. Con tact th e h ealth care provider (HCP) to h ave a

cen tral lin e in serted for fat em u lsion in fusion .

91. Th e n urse m on itors th e clien t receivin g paren teral n utrition (PN) for com plication s of th e th erap y an d sh ould assess th e clien t for wh ich m an ifesta- tio n s of h yperglycem ia? 1. Fever, weak pulse, an d th irst 2. Nausea, vom itin g, an d oliguria 3. Sweatin g, ch ills, an d abdom in al pain 4. Weakn ess, th irst, an d in creased urin e outp ut

92. Th e n urse is ch an gin g th e cen tral lin e dressin g of a clien t receivin g paren teral n utrition (PN) an d n otes th at th e cath eter in sertion site appears redden ed. Th e n urse sh ould n ext assess wh ich item ? 1. Clien t’s tem p erature 2. Expiration date on th e bag 3. Tim e of last dressin g ch an ge 4. Tigh tn ess of tubin g con n ection s

93. Th e n urse is preparin g to h an g fat em u lsion (lipids) an d n otes th at fat globules are visible at th e top of th e solution . Th e n urse sh ould take wh ich action ? 1. Roll th e bottle of solution gen tly. 2. O btain a differen t bottle of solution . 3. Sh ake th e bottle of solution vigorou sly. 4. Run th e bottle of solution un der warm water.

94. A clien t receivin g paren teral n utrition (PN) suddenly develops a fever. Th e n urse n otifies th e h ealth care provider (HCP), an d the HCP in itially prescribes that th e solution an d tubin g be chan ged. Wh at sh ould th e n urse do with th e discon tin ued m aterials? 1. Discard th em in th e un it trash . 2. Return th em to th e h ospital ph arm acy. 3. Save th em for return to th e m an ufacturer. 4. Prepare to sen d th em to th e labo ratory for culture.

95. A clien t h as been disch arged to h om e on paren teral n utrition (PN). With each visit, th e h om e care n urse sh ould assess wh ich param eter m o st closely in m on - itorin g th is th erapy? 1. Pulse an d weigh t 2. Tem peratu re an d weigh t 3. Pulse an d blood pressure 4. Tem perature an d blood pressure

96. Th e n urse, carin g for a group of adult clien ts on an acute care m edical-surgical n ursing un it, determ ines th at wh ich clien ts would be th e m o st likely can didates for paren teral n utrition (PN)? Select all th at ap p ly.

1. A clien t with exten sive burn s 2. A clien t with can cer wh o is sep tic 3. A clien t wh o h as h ad an open ch olecystectom y 4. A clien t with severe exacerbation of Cro h n ’s

disease 5. A clien t with persisten t n ausea an d vo m itin g

from ch em oth erapy

97. Th e n urse is preparin g to h an g th e first bag of paren - teral n utrition (PN) solution via th e cen tral lin e of an assign ed clien t. Th e n urse sh ould obtain wh ich m o st essen tial piece of equ ipm en t before h an gin g th e solution ? 1. Urin e test strips 2. Bloo d glucose m eter 3. Electron ic in fusion pum p 4. Non in vasive blood pressure m on itor

98. Th e n urse is m akin g in itial roun ds at th e begin n in g of th e sh ift an d n otes th at th e paren teral n utrition (PN) bag of an assign ed clien t is em p ty. Wh ich solu- tion sh ould th e n urse h an g un til an oth er PN solu- tion is m ixed an d delivered to th e n ursin g un it? 1. 5% dextrose in water 2. 10% dextrose in water 3. 5% dextrose in Rin ger’s lactate 4. 5% dextrose in 0.9% sodium ch loride

139CHAPTER 12 Parenteral Nutrition

F

u

n

d

a

m

e

n

t

a

l

s

99. Th e n urse is m on itorin g th e status of a client’s fat em ulsion (lipid) in fusion an d n otes th at th e in fusion is 1 h our beh in d. Wh ich action should th e n urse take? 1. Adjust th e in fusion rate to catch up over th e

n ext h our. 2. In crease th e in fusio n rate to catch up over th e

n ext 2 h ours. 3. En su re th at th e fat em ulsion in fusio n rate is in fus-

in g at th e prescribed rate. 4. Adjust th e in fusion rate to run wid e open un til

th e solution is back on tim e.

100. A clien t receivin g paren teral n utrition (PN) in th e h om e settin g h as a weigh t gain of 5 lb in 1 week. Th e n urse sh ould n ext assess th e clien t for th e pres- en ce of wh ich con d ition ? 1. Th irst 2. Polyuria 3. Decreased blood pressure 4. Crackles on auscultation of th e lun gs

101. Th e n urse is carin g for a restless clien t wh o is begin - n in g n utrition al th erapy with paren teral n utrition (PN) . Th e n urse sh ould plan to en sure th at wh ich action is taken to preven t th e clien t from sustain in g in ju ry? 1. Calculate daily in take an d outp ut. 2. Mon itor th e tem p erature on ce daily. 3. Secure all con n ection s in th e PN system . 4. Mon itor blood gluco se levels every 12 h ours.

102. A clien t receivin g paren teral n utrition (PN) com - plain s of a h eadach e. Th e n urse n otes th at th e cli- en t h as an in creased blood pressure, boun din g pulse, jugu lar vein disten tion , an d crackles bilater- ally. Th e n urse determ in es th at th e clien t is experien cin g wh ich com plication of PN th erapy? 1. Sepsis 2. Air em bolism 3. Hypervolem ia 4. Hyperglycem ia

A N S W E R S 87. 2 Ra tion a le: Wh en a clien t b egin s eatin g a regular d iet after a p erio d o f receivin g PN, th e PN is decreased gradu ally. PN th at is d iscon tin u ed ab ru ptly can cau se h yp oglycem ia. Clien ts often h ave an o rexia after bein g with ou t foo d fo r som e tim e, an d th e d igestive tract also is n o t u sed to p ro d ucin g th e digestive en zym es th at will be n eed ed. Gradu ally decreasin g th e in fu sio n rate allo ws th e clien t to rem ain adeq uately n o urish ed du rin g th e tran sition to a n o rm al diet an d p reven ts th e o ccurren ce o f h yp o glycem ia. Even b efore clien ts are started o n a so lid d iet, th ey are given clear liq uids fo llo wed by fu ll liq u ids to furth er ease th e tran sitio n . A solu tio n of n o rm al salin e d oes n ot p ro - vid e th e glu cose n eed ed du rin g th e tran sitio n o f d isco n tin uin g th e PN an d co uld cau se th e clien t to exp erien ce h yp oglycem ia. Test-Ta kin g Str a tegy: Focu s on th e su b ject, wean in g th e clien t fro m th e PN. Recallin g th e effects o f PN an d th e com p lication s th at o ccu r will direct yo u to th e co rrect op tio n . If you can recall th at a clien t can exp erien ce hyperglycem ia wh en started o n PN, it m ay h elp yo u to rem em b er th at hypoglycem ia can occu r if th e PN is discontinued ab rup tly. Review: Paren teral n u tritio n Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Critical Care—Paren teral Nutrition Pr ior it y Con cept s: Glucose Regulatio n ; Nu tritio n Refer en ces: Lewis et al. (2014), p . 902; Perry, Po tter, O sten d orf (2014), pp . 799, 802.

88. 4 Ra tion a le: The clien t should be asked to perform the Valsalva m an euver d urin g tu bin g ch an ges. Th is h elp s avoid air em bo lism d urin g tubin g chan ges. Th e n urse asks th e clien t to take a deep b reath, h old it, an d b ear d own . If th e in traven ous lin e is o n th e righ t, th e clien t turn s h is o r h er h ead to th e left. Th is positio n in creases in trath o racic p ressure. Breath in g n orm ally and

exh alin g slo wly an d even ly are in appropriate an d could enh an ce th e poten tial for an air em b olism d urin g th e tubin g ch ange. Test-Ta kin g St r a tegy: No te th e strategic wo rd , essential. Recal- lin g th at air em bo lism is a co m p licatio n th at can o ccu r du rin g tub in g ch an ges an d th in kin g abo ut th e m easu res th at will p re- ven t th is com p licatio n will d irect yo u to th e co rrect o p tion . Review: Th e procedure for p aren teral n u tritio n bag an d tub- in g ch an ge an d air em b o lism Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Ign ataviciu s, Wo rkm an ( 2013) , p. 225; Perry, Potter, O sten do rf (2014), p . 798.

89. 1 Ra tion a le: Air em bo lism o ccu rs wh en air en ters th e cath eter system , such as wh en th e system is o pen ed fo r in traven ou s (IV) tub in g ch an ges o r wh en th e IV tub in g d isco n n ects. Air em bo lism is a critical situatio n ; if it is su spected , th e clien t sh o u ld b e p laced in a left sid e-lyin g p osition . Th e h ead sh o u ld b e lower th an th e feet. Th is po sitio n is used to m in im ize th e effect of th e air travelin g as a bo lu s to th e lun gs b y trap pin g it in th e righ t side o f th e h eart. Th e p o sition s in th e rem ain in g o ptio n s are in ap prop riate if an air em b o lism is su sp ected . Test-Ta kin g Str a tegy: No te th e strategic wo rd , immediately. Focus o n th e su b ject, th e o ccurren ce of an air em b olism . Recall th at th e goal in th is em ergen cy situ ation is to trap air in th e righ t side of th e h eart. Th in k about th e p osition th at will ach ieve th is goal; th is will d irect you to th e correct op tio n . Review: Actio n s to take if an air em b o lism is susp ected Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nu rsin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Perry, Po tter, O sten d orf (2014), p. 798.

140 UNIT III Nursing Sciences

90. 2 Ra t ion a le: Th e clien t b egin n in g in fu sion s o f fat em ulsion s m u st b e first assessed fo r kn o wn allergies to eggs to preven t an aph ylaxis. Egg yo lk is a com p on en t o f th e so lu tion an d pro- vides em ulsificatio n . Th e rem ain in g o ptio n s are u n n ecessary an d are n ot related sp ecifically to th e ad m in istration o f fat em u lsio n . Test -Ta kin g St r a t egy: Focu s o n th e strategic wo rd , essential, wh en exam in in g each op tion an d recall kn owled ge o f fat em u l- sion s. Recall th e co m p on en ts of fat em u lsio n to direct yo u to th e co rrect op tion . Review: Fat em u lsio n an d p aren teral n u tritio n Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Lewis et al. (2014), p. 901; Gah art, Nazaren o (2015) , p . 527.

91. 4 Ra t ion a le: Th e h igh glu cose co n cen tration in PN p laces th e cli- en t at risk for h yp erglycem ia. Sign s o f h yp erglycem ia in clu de excessive th irst, fatigu e, restlessn ess, co n fu sio n , weakn ess, Kussm aul resp iratio n s, diuresis, an d co m a wh en h yp erglyce- m ia is severe. If th e clien t h as th ese sym pto m s, th e b lo od glu - co se level sh o uld b e ch ecked im m ed iately. Th e rem ain in g op tion s do n ot id en tify sign s sp ecific to h yperglycem ia. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, sign s of h yp ergly- cem ia. Fo r an op tio n to b e correct, all o f th e p arts of th at o ptio n m u st b e co rrect. Begin to an swer th is qu estio n b y elim in atin g op tion s th at in clu de fever an d ch ills b ecau se th ey are in dicative of in fectio n . Ch oo se th e correct op tion o ver th e o ption th at in clud es oligu ria b ecau se th e clien t with h yp erglycem ia h as in creased urin e o u tp u t rath er th an d ecreased u rin e o utp ut. Review: Sign s of h yp erglycem ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Glu co se Regu lation ; Nu trition Refer en ce: Perry, Potter, O sten do rf (2014), p . 798.

92. 1 Ra t ion a le: Red n ess at th e cath eter in sertio n site is a p ossible in d icatio n o f in fectio n . Th e n urse wo uld n ext assess for o th er sign s of in fectio n . O f th e o ption s given , th e tem perature is th e n ext item to assess. Th e tigh tn ess o f tu bin g con n ection s sh ou ld be assessed each tim e th e PN is ch ecked ; lo ose con n ec- tion s wo uld resu lt in leakage, n o t skin redn ess. Th e exp iration date o n th e bag is a viab le op tio n , b ut th is also sh o uld b e ch ecked at th e tim e th e solutio n is h u n g an d with each sh ift ch an ge. Th e tim e o f th e last d ressin g ch an ge sh o uld be ch ecked with each sh ift ch an ge. Test -Ta kin g Str a tegy: No te th e strategic wo rd , next. Th is q ues- tion requ ires th at you p rio ritize based on th e in form ation pro- vided in th e qu estio n . Also n ote th e relatio n sh ip between site appears reddened in th e q u estio n an d th e word temperature in th e correct op tion . Fo cusin g o n th e su b ject of in fection will direct yo u to th e correct o ptio n . Review: Sign s of in fectio n an d p aren teral n u tritio n

Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; In fectio n Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 798, 800.

93. 2 Ra t ion a le: Fat em ulsion ( lip id s) is a wh ite, op aq ue solutio n ad m in istered in traven ou sly d urin g p aren teral n u tritio n th er- ap y to p reven t fatty acid deficien cy. Th e n urse sh o uld exam in e th e b ottle of fat em u lsio n fo r sep aratio n o f em ulsion in to layers o f fat glo bu les o r for th e accu m ulation of fro th . Th e n u rse sh ou ld n ot h an g a fat em u lsio n if an y o f th ese are o bserved an d sh o uld retu rn th e so lu tion to th e ph arm acy. Th erefore, th e rem ain in g op tion s are in ap prop riate actio n s. Test -Ta kin g Str a tegy: Rem em b er th at op tio n s th at are co m p a- rab le o r alike are n ot likely to be correct. With th is in m in d, elim in ate ro llin g th e b o ttle an d sh akin g th e bo ttle first. Select b etween th e rem ain in g op tio n s by recallin g th e sign ifican ce o f fat glo b ules in th e so lu tion . Also, th in k ab o ut th e po ten tial ad verse effect of fat glo bu les en terin g th e clien t’s bloo dstream . Review: Ad m in istratio n o f fat em u lsio n Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Gah art, Nazaren o (2015), p . 525.

94. 4 Ra t ion a le: Wh en th e clien t wh o is receivin g PN develop s a fever, a cath eter-related in fectio n sh ou ld be susp ected. Th e so lu tio n an d tu bin g sh ou ld b e ch an ged, an d th e d iscon tin u ed m aterials sh o uld be cu ltured fo r in fectiou s organ ism s p er HCP p rescription . Th e o th er o ptio n s are in co rrect. Becau se cu lture fo r in fectio us o rgan ism s is n ecessary, th e d iscon tin u ed m ate- rials are n o t d iscarded o r retu rn ed to th e ph arm acy o r m an u factu rer. Test -Ta kin g St r a t egy: Id en tifyin g th e su b ject o f th e qu estio n , in fection , an d co rrelatin g th e fever with in fectio n asso ciated with th e in traven ous lin e sh ould direct you to th e correct o p tion . Rem em b er th at th e d iscon tin u ed m aterials n eed to b e cu ltured . Review: Paren teral n u tritio n an d in fectio n Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; In fectio n Refer en ces: Lewis et al. (2014), p . 899; Perry, Po tter, O sten d o rf (2014), p . 804

95. 2 Ra t ion a le: Th e clien t receivin g PN at h o m e sh ou ld h ave h er o r h is tem p eratu re m o n ito red as a m ean s o f detectin g in fec- tion , wh ich is a po ten tial co m p lication o f th is th erap y. An in fection also co u ld result in sepsis because th e cath eter is in a bloo d vessel. Th e clien t’s weigh t is m o n ito red as a m ea- su re o f th e effectiven ess of th is n u tritio n al th erapy an d to d etect h ypervolem ia. Th e p ulse an d blo od p ressure are

F

u

n

d

a

m

e

n

t

a

l

s

141CHAPTER 12 Parenteral Nutrition

im p ortan t p aram eters to assess, bu t th ey d o n ot relate sp ecif- ically to th e effects of PN. Test-Ta kin g Str a tegy: Note th e strategic wo rd , most, wh ich tells yo u th at m ore th an 1 or all of th e op tio n s m ay be p artially o r totally correct. Rem em ber also th at wh en th ere are m u ltip le p arts to an op tio n , all p arts m u st b e correct fo r th at o p tion to be correct. Recallin g th at in fection an d h yp ervo lem ia are co m p li- cation s of PN an d th at weigh t is m on itored as a m easu re o f th e effectiven ess o f th is n u tritio n al th erap y will direct yo u to th e correct o ptio n . Review: Paren teral n u tritio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Clin ical Ju dgm en t; In fection Refer en ces: Lewis et al. (2014), p . 902; Perry, Po tter, O sten d orf (2014), pp . 800, 804.

96. 1, 2, 4, 5 Ra tion a le: PN is in d icated in clien ts wh ose gastro in testin al tracts are n ot fu n ction al or m u st be rested, can n ot take in a diet en terally fo r exten d ed p eriod s, o r h ave in creased m etab olic n eed. Exam p les o f th ese con d itio n s in clu de th o se clien ts with b urn s, exacerbation o f Cro h n ’s d isease, an d persisten t n ausea an d vo m itin g d ue to ch em oth erap y. O th er clien ts wou ld be th o se wh o h ave h ad exten sive su rgery, h ave m u ltip le fractu res, are sep tic, o r h ave ad van ced can cer or acqu ired im m u n o defi- cien cy syn drom e. Th e clien t with th e o p en ch o lecystecto m y is n o t a can didate because th is clien t wo uld resu m e a regular d iet with in a few days followin g su rgery. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, most likely, wh ich tell yo u th at th e correct option s are th e clien ts wh o requ ire th is typ e of n utritio n al su pp ort. Use n u rsin g kn owled ge o f th ese variou s co n d ition s in th e o ption s an d baselin e kn owl- ed ge o f th e p urp oses of PN to m ake you r selectio n . Review: Paren teral n u tritio n Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Nutritio n Refer en ce: Perry, Po tter, O sten d orf (2014), p. 797.

97. 3 Ra tion a le: Th e n urse ob tain s an electro n ic in fu sion p u m p b efore h an gin g a PN so lu tion . Becau se o f th e h igh glu co se con - ten t, u se o f an in fu sio n p um p is n ecessary to en su re th at th e so lution d oes n ot in fuse to o rap idly o r fall b eh in d. Because th e clien t’s bloo d glucose level is m on itored every 4 to 6 h o urs d urin g ad m in istration of PN, a blo o d glu co se m eter also will b e n eeded , b u t th is is n o t th e m o st essen tial item n eed ed befo re h an gin g th e so lu tion because it is n o t directly related to ad m in - isterin g th e PN. Urin e test strip s (to m easu re glu co se) rarely are u sed because of th e ad ven t o f b lo od glu cose m on itorin g. Alth ou gh th e blo o d p ressure will be m o n ito red, a n o n in vasive b loo d p ressure m on itor is n ot th e m ost essen tial p iece of eq uipm en t n eeded fo r th is p ro ced ure. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most essential. Th ey tell yo u th at th e co rrect op tio n iden tifies th e item n eed ed to start th e in fu sio n . Visu alizin g th e p ro cedu re fo r in itiatin g PN

an d fo cu sin g o n th e strategic wo rd s will d irect you to th e cor- rect option . Review: Paren teral n u tritio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 801, 803.

98. 2 Ra tion a le: Th e clien t is at risk for h ypo glycem ia; th erefo re, th e so lutio n co n tain in g th e h igh est am o u n t of gluco se sh o uld be h u n g u n til th e n ew PN solutio n beco m es availab le. Because PN solu tio n s co n tain h igh glu co se con cen tratio n s, th e 10% d extro se in water solutio n is th e b est o f th e ch o ices presen ted . Th e solutio n selected sh ou ld be on e th at m in im izes th e risk of h yp oglycem ia. Th e rem ain in g op tio n s will n o t b e as effective in m in im izin g th e risk of h yp oglycem ia. Test-Ta kin g St r a t egy: Focu s on th e su b ject, th at th e clien t is at risk for h ypoglycem ia. With th is in m in d, yo u wou ld th en select th e solutio n th at m in im izes th is risk to th e clien t. Also , rem em ber th at option s th at are co m p arab le o r alike are n o t likely to b e correct. Each of th e in co rrect op tio n s represen ts a so lutio n th at co n tain s 5% d extro se. Review: Th e n ursin g actio n s to p reven t h yp o glycem ia in th e clien t receivin g p aren teral n u tritio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Glucose Regu latio n ; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), p. 802.

99. 3 Ra tion a le: Th e n urse sh o uld n o t in crease th e rate o f a fat em u l- sio n to m ake up th e differen ce if th e in fu sion tim in g falls b eh in d. Doin g so cou ld p lace th e clien t at risk fo r fat overlo ad. In ad dition , in creasin g th e rate sud den ly can cause flu id o ver- lo ad. Th e sam e prin ciple (n o t in creasin g th e rate) ap plies to p aren teral n utritio n o r an y in traven o us in fu sio n . Th erefo re, th e rem ain in g o ptio n s are in co rrect. Test-Ta kin g St r a t egy: Focu s o n th e data in th e q uestion . Rem em ber also th at o ptio n s th at are co m p arab le o r alike are n o t likely to b e co rrect. Th is gu id es yo u to elim in ate th e o ptio n s referrin g to catching up. Ch o ose th e co rrect op tio n o ver run n in g th e in fusion wide op en , recallin g th at th e n urse n ever in creases th e in fu sio n rate or adjusts an in fu sio n rate if an in fu- sio n is b eh in d. Review: Safety prin ciples related to in traven o u s th erap y Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Paren teral Nutritio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Gah art, Nazaren o ( 2015) , pp . 526–527; Lewis et al. ( 2014) , p. 901.

100. 4 Ra tion a le: O ptim al weigh t gain wh en th e clien t is receivin g PN is 1 to 2 lb/ week. Th e clien t wh o h as a weigh t gain o f 5 lb / week

F

u

n

d

a

m

e

n

t

a

l

s

142 UNIT III Nursing Sciences

wh ile receivin g PN is likely to h ave fluid reten tion . Th is can result in h ypervolem ia. Sign s of h ypervolem ia in clude in creased b loo d p ressu re, crackles o n lun g auscultation , a bo un din g p ulse, ju gular vein disten tio n , h ead ach e, p eriph eral edem a, an d weigh t gain m o re th an d esired. Th irst an d p o lyuria are associated with h yp erglycem ia. A d ecreased b lo od pressu re is likely to b e n oted in deficien t fluid vo lu m e. Test -Ta kin g St r a tegy: Fo cus on th e su b ject of th e qu estio n , a weigh t gain of 5 lb in 1 week, an d n o te th e strategic wo rd , next. Th is sh ou ld d irect you r th in kin g to th e po ten tial fo r h yp er- vo lem ia. With th is in m in d , select th e op tio n th at id en tifies th e sign o f h yp ervolem ia. Review: Sign s an d sym pto m s o f h yp ervo lem ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p . 292.

101. 3 Ra tion a le: Th e n urse sh o uld p lan to secure all con n ection s in th e tub in g (con n ection s are used per agency p ro to co l). This h elps to p reven t th e restless clien t fro m p ullin g th e con n ection s apart acciden tally. Th e n urse should also m on itor in take an d o utp ut, b ut th is does n ot relate specifically to a risk for in jury as p resen ted in th e question . Also, m on ito r- in g th e tem perature an d b lood glu cose levels d oes n ot relate to a risk fo r in jury as p resen ted in the q uestion . In add i- tion , th e clien t’s tem p eratu re and b lood glu co se levels are m o n itored m ore frequen tly th an th e tim e fram es iden tified in th e o ption s to detect sign s of in fectio n and h yp erglycem ia, resp ectively.

Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, safety, an d n o te th e wo rd s restless, ensure, prevent, an d injury. Th is will direct yo u to th e co rrect o ption . Review: Precautio n s related to p aren teral n u tritio n Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Lewis et al. (2014), pp . 899, 901.

102. 3 Ra t ion a le: Hyp ervo lem ia is a critical situatio n an d occurs fro m excessive flu id adm in istration o r adm in istratio n o f flu id too rap - id ly. Clien ts with card iac, ren al, o r h ep atic dysfu nction are also at in creased risk. Th e clien t’s sign s an d sym pto m s presented in th e question are con sisten t with h yp ervolem ia. Th e in creased in travascu lar volum e in creases the blood p ressure, wh ereas th e pulse rate in creases as th e h eart tries to pum p th e extra fluid volum e. Th e in creased volum e also cau ses n eck vein d isten tio n an d sh iftin g o f flu id in to th e alveo li, resultin g in lun g crackles. Th e signs an d sym ptom s presen ted in the q uestion d o n ot in d i- cate sepsis, air em bolism , or h yperglycem ia. Test -Ta kin g Str a tegy: Focus o n th e su b ject, a co m plicatio n o f PN, an d o n th e d ata in th e q u estio n . Recallin g th e sign s of h ypervolem ia will direct you to th e correct op tio n . Review: Sign s of h yp ervo lem ia Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Critical Care—Paren teral Nu tritio n Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p. 292.

F

u

n

d

a

m

e

n

t

a

l

s

143CHAPTER 12 Parenteral Nutrition

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 13 Intravenous Therapy

PRIORITY CONCEPTS Fluids and Electrolytes; Safety

CRITICAL THINKING What Should You Do? A client with a peripherally inserted central catheter (PICC) in the right upper extremity suddenly exhibits chest pain, dys- pnea, hypotension, and tachycardia. The nurse suspects an embolism related to the PICC line. What should the nurse do? Answer located on p. 153.

I. Intravenous Therapy A. Purpo se an d uses

1. Used to sustain clien ts wh o are un able to take substan ces orally

2. Replaces water, electrolytes, an d nutrients m ore rapidly th an oral adm in istration

3. Provides im m ediate access to th e vascu lar system for th e rapid delivery of specific solution s with - out th e tim e required for gastro in testin al tract absorption

4. Provides a vascu lar route for th e ad m in istration of m edication or blood com po n en ts

B. Types of solution s (Table 13-1) 1. Iso ton ic solution s

a . Have th e sam e osm o lality as body fluids b . In crease extracellular fluid volum e c. Do n ot en ter th e cells because n o osm o tic

force exists to sh ift th e flu ids 2. Hypo ton ic solution s

a . Are m ore dilute solution s an d h ave a lower osm o lality th an body fluid s

b . Cause th e m ovem en t of water in to cells by osm o sis

c. Sh o uld be adm in istered slowly to preven t cellu lar edem a

3. Hyperton ic solution s a . Are m ore con cen trated solution s an d h ave a

h igh er osm olality th an body fluids b . Cause m ovem en t of water from cells in to th e

extracellular fluid by osm osis

4. Colloids a . Also called plasm a expan d ers b . Pull flu id from th e in terstitial com partm en t

in to th e vascu lar com partm en t c. Used to in crease th e vascu lar volum e rapidly,

such as in h em orrh age or severe h ypovolem ia

Administration ofan intravenous (IV) solution or med- ication provides immediate access to the vascular system. This is a benefit of administering solutions or medications via this route but can also present a risk. Therefore, it is critical to ensure that the health care provider’s (HCP’s) prescriptions are checked carefully and that the correct solution or medication is administered as prescribed. Always follow the 6 rights for medication administration.

II. Intravenous Devices A. IV can n ulas

1. Butterfly sets a . Th e set is a win g-tip n eedle with a m etal can -

n ula, plastic or rubber win gs, an d a plastic cath eter or h ub.

b . Th e n eedle is 0.5 to 1.5 in ch es in len gth , with n eedle gauge sizes from 16 to 26.

c. Infiltration is m ore com m on with th ese devices. d . Th e butterfly in fusion set is used com m on ly

in ch ildren an d older clien ts, wh ose vein s are likely to be sm all or fragile.

2. Plastic can n ulas a . Plastic can n ulas m ay be an over-th e-n eedle

device or an in -n eedle cath eter an d are used prim arily for sh ort-term th erapy.

b . The over-th e-n eedle device is preferred for rapid in fusion an d is m ore com fortable for th e clien t.

c. Th e in -n eedle cath eter can cause catheter embolism if th e tip of th e can n ula breaks.

B. IV gauges 1. Th e gauge refers to th e diam eter of th e lu m en of

th e n eedle or can n ula. 2. Th e sm aller th e gauge n um ber, th e larger th e

diam eter of th e lum en ; th e larger th e gauge n um - ber, th e sm aller th e diam eter of th e lum en .144

F

u

n

d

a

m

e

n

t

a

l

s

3. Th e size of th e gauge used depen ds on th e solu- tio n to be adm in istered an d th e diam eter of th e available vein .

4. Large-diam eter lum en s (sm aller gauge n um bers) allow a h igh er fluid rate th an sm aller diam eter lu m en s an d allow th e adm in istration of h igh er con cen tration s of solution s.

5. For rapid em ergen cy flu id adm in istration , blood products, or an esth etics, preoperative an d post- operative clien ts, large-diam eter lum en n eedles or can n ulas are used, such as an 18- or 19-gauge lu m en or can n ula.

6. For periph eral fat emulsion (lipids) in fusio n s, a 20- or 21-gauge lum en or can n ula is used.

7. For stan dard IV fluid an d clear liquid IV m edica- tion s, a 22- or 24-gauge lum en or can n ula is used.

8. If th e clien t h as very sm all vein s, a 24- to 25- gauge lum en or can n ula is used.

C. IV con tain ers 1. Con tain er m ay be glass or plastic. 2. Squeeze th e plastic bag to en sure intactn ess and

assess th e glass bottle for an y cracks before h an gin g. 3. Recon stitute an y m ed ication s per agen cy proto-

col an d ph arm acy in struction .

Do not write on a plastic IV bag with a marking pen because the ink may be absorbed through the plastic into the solution. Use a label and a ballpoint pen for writ- ing on the label, placing the label onto the bag.

D. IV tubin g ( Fig. 13-1) 1. IV tubin g co n tain s a spike en d for th e bag or bot-

tle, drip ch am b er, roller clam p , Y site, an d ad apter en d for attach m en t to th e can n ula or n eedle th at is in serted in to th e clien t’s vein .

2. Sh o rter, secon dary tubin g is used for piggyback solution s, con n ectin g th em to th e in jection sites n earest to th e drip ch am b er (Fig. 13-2).

3. Special tubin g is used for m ed ication th at absorbs in to plastic (ch eck specific m edication adm in istration guid elin es wh en ad m in isterin g IV m edication s).

4. Ven ted an d n on ven ted tubin g are available. a. A ven t allows air to en ter th e IV con tain er as

th e fluid leaves. b . A ven ted adapter can be used to add a ven t to

a n on ven ted IV tubin g system . c. Use n on ven ted tubin g for flexible con tain ers.

TABLE 13-1 Types of Intravenous Solutions Solution and Type Uses

0.9% saline (NS): Isotonic Extracellular fluid deficits in clients with low serum levels of sodium or chloride and metabolic acid-base imbalances. Used before or after the infusion of blood products.

Ringer’s lactate solution: Isotonic Extracellular fluid deficits, such as fluid loss from burns, bleeding, and dehydration from loss of bile or diarrhea.

5% dextrose in water (D5W): Isotonic at the time of administration; within a short time after administration, dextrose is metabolized and the tonicity decreases in proportion to the osmolarity or tonicity of the nondextrose components (electrolytes) within the water (may become hypotonic).

Replaces deficits of total body water. Not used alone to expand extracellular fluid volume because dilution of electrolytes can occur.

5% dextrose in 0.225% saline (5% D/ 1/ 4 NS): Isotonic at the time of administration; within a short time after administration, dextrose is metabolized and the tonicity decreases in proportion to the osmolarity or tonicity of the nondextrose components (electrolytes) within the water (may become hypertonic).

Used as initial fluid for hydration because it provides more water than sodium. Commonly used as maintenance fluid.

5% dextrose in 0.9% saline (5% D/ NS): Hypertonic Extracellular fluid deficits in clients with low serum levels of sodium or chloride and metabolic alkalosis.

5% dextrose in 0.45% saline (5% D/ 1/ 2 NS): Hypertonic Used as initial fluid for hydration because it provided more water than sodium. Commonly used as maintenance fluid.

5% dextrose in Ringer’s lactate solution: Hypertonic Extracellular fluid deficits, such as fluid loss from burns, bleeding, and dehydration from loss of bile or diarrhea.

S pike e nd for IV ba g or bottle

Drip cha mbe r

Rolle r cla mp

Ada pte r e nd of tubing to ne e dle

Y s ite

FIGURE 13-1 Intravenous (IV) tubing.

145CHAPTER 13 Intravenous Therapy

F

u

n

d

a

m

e

n

t

a

l

s

d . Use ven ted tubin g for glass or rigid plastic con tain ers to allow air to en ter an d displace th e flu id as it leaves; fluid will n ot flow from a rigid IV con tain er un less it is ven ted.

Extension tubing can be added to an IVtubing set to provide extra length to the tubing. Add extension tubing to the IV tubing set for children, clients who are restless, or clients who have special mobility needs.

E. Drip ch am b ers (Fig. 13-3) 1. Macrodrip ch am b er

a . Th e ch am b er is used if th e solution is th ick or is to be in fused rapidly.

b . Th e drop factor varies from 10 to 20 drops (gtt) / m L, depen din g on th e m an ufactu rer.

c. Read th e tubin g package to determ in e h ow m an y drops per m illiliter are delivered (drop facto r).

2. Micro drip ch am b er a . Norm ally, th e ch am b er h as a sh ort vertical

m etal piece (stylet) wh ere th e drop form s. b . Th e ch am b er delivers about 60 gtt/ m L. c. Read th e tubin g package to determ in e th e

drop factor (gtt/ m L). d . Micro drip ch am b ers are used if flu id will be

in fused at a slow rate (less th an 50 m L/ h our) or if th e solution con tain s poten t m edication th at n eeds to be titrated, such as in a critical care settin g or in ped iatric clien ts.

F. Filters 1. Filters provide protectio n by preven tin g particles

from en terin g th e clien t’s vein s. 2. Th ey are used in IV lin es to trap sm all particles

such as un dissolved substan ces, or m edication s th at h ave precipitated in solution .

3. Ch eck the agency policy regardin g th e use of filters. 4. A 0.22-µm filter is used for m ost solution s; a 1.2-

µm filter is used for solution s con tain in g lipids or album in ; an d a special filter is used for blood com po n en ts.

5. Ch an ge filters every 24 to 72 h ou rs (depen d in g on agen cy policy) to preven t bacterial growth .

G. Needleless in fusion devices 1. Needleless in fusio n devices in clude recessed n ee-

dles, plastic can n ulas, an d 1-way valves; th ese system s decrease th e exposu re to con tam in ated n eedles.

2. Do n ot adm in ister parenteral nutrition or blood produ cts th rough a 1-way valve.

H. In term itten t in fusion devices 1. In term itten t in fusion devices are used wh en

in travascular accessibility is desired for in term it- ten t adm in istration of m edication s by IV push or IV piggyback.

2. Paten cy is m ain tain ed by periodic flush in g with n orm al salin e solution ( sodium chloride an d nor- mal saline are in terch an geab le n am es).

3. Depen din g on agen cy policy, wh en adm in ister- in g m ed ication , flush with 1 to 2 m L of n orm al salin e to con firm placem en t of th e IV can n ula; adm in ister th e prescribed m ed ication an d th en flush th e can n ula again with 1 to 2 m L of n orm al salin e to m ain tain paten cy.

I. Electro n ic IV in fusion devices 1. IV in fusion pum ps con tro l th e am oun t of flu id

in fusin g an d sh o uld be used with cen tral ven ous lin es, arterial lin es, solution s con tain in g m edica- tion , an d paren teral n utrition in fusion s. Most agen cies use IV pum ps for th e in fusio n of an y IV solution .

2. A syrin ge pum p is used wh en a sm all volum e of m edication is adm in istered; th e syrin ge th at con - tain s th e m ed ication an d solution fits in to a pum p an d is set to deliver th e m ed ication at a con trolled rate.

3. Patien t-con tro lled an algesia (PCA)

IV ba g with me dica tion

FIGURE 13-2 Secondary bag with medication. IV, Intravenous.

Ma crodrip 10-20 gtt/mL

Microdrip 60 gtt/mL

FIGURE 13-3 Macrodrip and microdrip sizes.

146 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

a. A device th at allows th e clien t to self- ad m in ister IV m ed ication , such as an an alge- sic; th e clien t can adm in ister doses at set in ter- vals an d th e pum p can be set to lock out doses th at are n ot with in th e preset tim e fram e to preven t overdose.

b . Th e PCA regim en m ay in clude a basal rate of in fusion alon g with th e dem an d dosin g, basal rate in fusion alon e, or dem an d dosin g alon e.

c. A bolus dose can be given prio r to an y of th e settin gs an d sh ould be set based on th e HCP’s prescription .

d . PCAs are always kept locked an d setup requires th e witn ess of an oth er registered n urse (RN).

Check electronic IV infusion devices frequently. Although these devices are electronic, this does not ensure that they are infusing solutions and medications accurately.

III. Latex Allergy A. Assess th e clien t for an allergy to latex. B. IV supplies, in cludin g IV cath eters, IV tubin g, IV

ports (particularly IV rubber in jection ports), ru bber stopp ers on m ultidose vials, an d adh esive tape, m ay con tain latex.

C. Latex-safe IV supplies n eed to be used for clien ts with a latex allergy; m ost agen cies carry th ese n ow, but th is still n eeds to be ch ecked.

D. See Ch apter 66 for ad dition al in form ation regardin g latex allergy.

IV. Selection of a Peripheral IV Site A. Vein s in th e h an d, forearm , an d an tecubital fossa are

suitable sites (Fig. 13-4). B. Vein s in th e lower extrem ities (legs an d feet) are n ot

suitable for an adult clien t because of th e risk of th rom - bus form ation an d th e possible poolin g of m edication in areas of decreased ven ous return (Box 13-1).

C. Vein s in th e scalp an d feet m ay be suitable sites for in fan ts.

D. Assess th e vein s of both arm s clo sely befo re selectin g a site.

E. Start th e IV in fusion distally to provide th e option of proceedin g up th e extrem ity if th e vein is ruptured or infiltration occurs; if in filtration occurs from th e an te- cubital vein , th e lo wer vein s in th e sam e arm usually sh ould n ot be used for furth er pun cture sites.

F. Determ in e th e clien t’s dom in an t side, an d select th e opposite side for a venipuncture site.

G. Ben d in g th e elbow on th e arm with an IV m ay easily obstru ct th e flo w of solution , cau sin g in filtration th at could lead to th rom boph leb itis.

H. Avoid ch eckin g th e blood pressure on th e arm receiv- in g th e IV in fusion if possible.

I. Do n ot place restrain ts over th e ven ipun ctu re site. J. Use an arm board as n eeded wh en th e ven ipu n cture

site is located in an area of flexion .

In an adult, the most frequently used sites for insert- ing an IV cannula or needle are the veins of the forearm because the bones of the forearm act as a natural sup- port and splint.

V. Initiation and Administration of IV Solutions A. Ch eck th e IVsolution again st the HCP’s prescription for

the type, am oun t, percentage of solution , an d rate of flow; follow th e 6 righ ts for m edication adm in istration.

B. Assess th e h ealth status an d m ed ical disorders of th e clien t an d iden tify clien t con d ition s th at con train d i- cate use of a particular IV solution or IV equipm en t, such as an allergy to clean sin g solution , ad h esive m aterials, or latex. Ch eck com patibility of IV solu- tion s as appropriate.

C. Ch eck clien t’s iden tification an d explain th e proce- dure to th e clien t; assess clien t’s previous exp erien ce with IV th erapy an d preferen ce for in sertio n site.

D. Wash h an ds th orough ly before in sertin g an IV lin e an d befo re workin g with an IV lin e; wear gloves.

E. Use sterile tech n iqu e wh en in sertin g an IV lin e an d wh en ch an gin g th e dressin g over th e IV site.

F. Ch an ge th e ven ipun cture site every 72 to 96 h ours in accordan ce with Cen ters for Disease Con trol an d Pre- ven tion (CDC) recom m en dation s an d agen cy policy.

G. Ch an ge th e IV dressin g wh en th e dressin g is wet or con tam in ated , or as specified by th e agen cy policy.

H. Ch an ge th e IV tubin g every 96 h ours in acco rdan ce with CDC recom m en dation s an d agen cy policy or with ch an ge of ven ipu n cture site.

Ce pha lic ve in

Ce pha lic ve in

Ra dia l ve in

A

Ba s ilic ve in

Ba s ilic ve in

Me dia n ve in of fore a rm

Me dia n cubita l ve in

Ce pha lic ve in B Ba s ilic ve in

Dors a l ve nous a rch

S upe rficia l dors a l ve ins

FIGURE 13-4 Common intravenous sites. A, Inner arm. B, Dorsal surface of hand.

BOX 13-1 Peripheral Intravenous Sites to Avoid ▪ Edematous extremity ▪ An arm that is weak, traumatized, or paralyzed ▪ The arm on the same side as a mastectomy ▪ An arm that has an arteriovenous fistula or shunt for

dialysis ▪ A skin area that is infected

147CHAPTER 13 Intravenous Therapy

I. Do n ot let an IV bag or bottle of solution h an g for m ore th an 24 h ours to dim in ish th e poten tial for bacterial con tam in ation an d possibly sepsis.

J. Do n ot allow th e IV tubin g to touch th e floor to pre- ven t poten tial bacterial co n tam in ation .

K. See Prio rity Nursin g Action s for in struction s on in sertin g an IV.

L. See Prio rity Nursin g Action s for in struction s on rem ovin g an IV.

F

u

n

d

a

m

e

n

t

a

l

s

PRIORITY NURSING ACTIONS Inserting a Peripheral Intravenous Line 1. Check the health care provider’s (HCP’s) prescription,

determine the type and size of infusion device, and prepare intravenous (IV) tubing or extension set and solution; prime IV tubing or extension set to remove air from the system; explain procedure to the client.

2. Select the vein for insertion based on vein quality, client size, and indication of IV therapy; apply tourniquet and pal- pate the vein for resilience (see Fig. 13-4).

3. Clean the skin with an antimicrobial solution, using an inner to outer circular motion, or as specified bythe Centers for Disease Control and Prevention (CDC) guidelines and agency policy.

4. Stabilize the vein below the insertion site and puncture the skin and vein, observing for blood in the flashback chamber; when observed, lower the catheter so that it is flush with the skin and advance the catheter into the vein (if unsuccessful, a new sterile device is used for the next attempt at insertion).

5. Remove the tourniquet. Apply pressure above the insertion site with the middle finger of the nondominant hand and retract the stylet from the catheter; connect the end of the IV tubing or extension set to the catheter tubing, secure it, and begin IV flow. Ask the client about comfort at the site and assess site for adequate flow.

6. Tape and secure insertion site with a transparent dressing as specified by agency procedure; label the tubing, dressing, and solution bags clearly, indicating the date and time.

7. Document the specifics about the procedure such as num- ber of attempts at insertion; the insertion site, type and size of device, solution and flow rate, and time; and the client’s response. In addition, follow agency procedure for docu- mentation of procedure.

The nurse checks the HCP’s prescription for the IV line and then determines the type and size of infusion device. The type and size are important to ensure adequate flow of the prescribed solution. For example, if a blood product is prescribed, the nurse would need to insert an appropriate catheter gauge size for blood delivery. The nurse also considers the client’s size, age, mobility, and other factors in selecting the type and size of the infusion device. The nurse prepares the appropriate IV tubing or extension set and primes the IV tubing or extension set to remove air from the system. The appropriate vein is selected, the tourniquet is applied, and the vein is checked and palpated for resilience. Strict surgical asepsis is employed and the skin is cleaned with an antimicrobial solution (as specified by agency policy), using an inner to outer circular motion. The vein is stabilized to prevent its movement and the skin is punctured. Blood in the flashback chamber indicates that the device is in the vein and when noted the catheter is carefully advanced to avoid puncture of the back wall of the vein. The tourniquet is removed, the stylet is removed from the catheter device, the IVtubing or extension set is connected, and the IVflow is started. Following assessment of the client and site, the nurse tapes and secures the site and labels the tubing, dressing, and solution bag appropriately and according to agency policy. The nurse checks the site and ensures that the solution is flowing. Finally, the nurse documents the specifics about the procedure.

Reference Perry, Potter, Ostendorf (2014), pp. 697, 701-703.

PRIORITY NURSING ACTIONS Removing a Peripheral Intravenous Line 1. Check the health care provider’s (HCP’s) prescription and

explain the procedure to the client; ask the client to hold the extremity still during cannula or needle removal.

2. Turn off the intravenous (IV) tubing clamp and remove the dres- sing and tape covering the site, while stabilizing the catheter.

3. Apply light pressure with sterile gauze or other material as specified by agency procedure over the site and withdraw the catheter using a slow, steady movement, keeping the hub parallel to the skin.

4. Apply pressure for 2 to 3 minutes, using dry sterile gauze (apply pressure for a longer period of time if the client has a bleeding disorder or is taking anticoagulant medication).

5. Inspect the site for redness, drainage, or swelling; check the catheter for intactness.

6. Apply dressing as needed per agency policy. 7. Document the procedure and the client’s response.

The nurse checks for an HCP’s prescription to remove the IV line and then explains the procedure to the client. The nurse asks the client to hold the extremitystill during removal. The IVtubing clamp is placed in the off position and the dressing and tape are removed. The nurse is careful to stabilize the catheter so that it is not pulled, resulting in vein trauma. Light pressure is applied over the site to stabilize the catheter and it is removed using a slow, steady movement, keeping the hub parallel to the skin. Pressure is applied until hemostasis occurs. The site is inspected for redness, drainage, or swelling and the catheter is checked for intactness to ensure that no part of it has broken off. A dressing is applied as needed per agency policy. Finally, the nurse documents the procedure and the client’s response.

Reference Perry, Potter, Ostendorf (2014), pp. 723-724.

148 UNIT III Nursing Sciences

VI. Precautions for IV Lines A. O n in sertio n , an IV lin e can cause in itial pain an d

discom fort for th e clien t. B. An IV pun cture provides a route of en try for m icro-

organ ism s in to th e body. C. Med ication s adm in istered by th e IV route en ter th e

blood im m ediately, an d an y ad verse reaction s or allergic respo n ses can occur im m ediately.

D. Fluid (circulatory) overload or electrolyte im bal- an ces can occur from excessive or too rapid in fusion of IV flu ids.

E. In com patibilities between certain solution s an d m ed ication s can occur.

A client with heart failure or renal failure usually is not given a solution containing saline because this type of fluid promotes the retention of water and would there- fore exacerbate heart failure or renal failure by increasing the fluid overload.

VII. Complications (Table 13-2) A. Air embolism

1. Description : A bolus of air en ters th e vein th rou gh an in adeq uately prim ed IV lin e, from a lo ose con n ection , durin g tubin g ch an ge, or durin g rem oval of th e IV.

2. Preven tion an d in terven tion s a. Prim e tubin g with fluid befo re use, an d m on -

ito r for an y air bubb les in th e tubin g. b . Secure all con n ection s. c. Replace th e IV fluid befo re th e bag or bottle

is em p ty. d . Mon itor for sign s of air em b olism ; if sus-

pected, clam p th e tubin g, turn th e clien t on th e left side with th e h ead of th e bed lo wered (Tren delen b urg position ) to trap th e air in th e righ t atrium , an d n otify th e HCP.

B. Catheter embolism 1. Description : An obstruction th at results from

breakage of th e cath eter tip durin g IV lin e in ser- tio n or rem oval

2. Preven tion an d in terven tion s a. Rem o ve th e cath eter carefully. b . In spect th e cath eter wh en rem oved. c. If th e cath eter tip h as broken off, place a tour-

n iqu et as proxim ally as possible to th e IV site on th e affected lim b , n otify th e HCP im m edi- ately, prepare to obtain a radiograph , an d pre- pare th e clien t for surgery to rem ove th e cath eter piece(s) , if n ecessary.

C. Circulatory overload 1. Description : Also kn own as fluid overload; results

fro m th e adm in istration of fluids too rapidly, esp ecially in a clien t at risk for fluid overload

2. Preven tion an d in terven tion s

a. Iden tify clien ts at risk for circulatory overload.

b . Calculate an d m on itor th e drip (flow) rate frequen tly.

c. Use an electron ic IV in fusion device an d fre- quen tly ch eck th e drip rate or settin g (at least every h ou r for an ad ult).

d . Add a tim e tape (label) to th e IV bag or bottle n ext to th e vo lum e m arkin gs. Mark on th e tape th e expected h ou rly decrease in volu m e based on th e m L/ h ou r calculation (Fig. 13-5).

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 13-2 Signs of Complications of Intravenous Therapy

Complication Signs

Air embolism Tachycardia Chest pain and dyspnea Hypotension Cyanosis Decreased level of consciousness

Catheter embolism Decrease in blood pressure Pain along the vein Weak, rapid pulse Cyanosis of the nail beds Loss of consciousness

Circulatory overload Increased blood pressure Distended jugular veins Rapid breathing Dyspnea Moist cough and crackles

Electrolyte overload Signs depend on the specific electrolyte overload imbalance

Hematoma Ecchymosis, immediate swelling and leakage of blood at the site, and hard and painful lumps at the site

Infection Local—redness, swelling, and drainage at the site Systemic—chills, fever, malaise, headache, nausea, vomiting, backache, tachycardia

Infiltration Edema, pain, numbness, and coolness at the site; may or may not have a blood return

Phlebitis Heat, redness, tenderness at the site Not swollen or hard Intravenous infusion sluggish

Thrombophlebitis Hard and cordlike vein Heat, redness, tenderness at site Intravenous infusion sluggish

Tissue damage Skin color changes, sloughing of the skin, discomfort at the site

149CHAPTER 13 Intravenous Therapy

e. Mon itor for sign s of circulatory overload. If circulatory overload occurs, decrease th e flow rate to a m in im u m , at a keep-vein -open rate; elevate th e h ead of th e bed ; keep th e clien t warm ; assess lun g soun ds; assess for edem a; an d n otify th e HCP.

Clients with respiratory, cardiac, renal, or liver dis- ease; older clients; and very young persons are at risk for circulatory overload and cannot tolerate an excessive fluid volume.

D. Electro lyte overload 1. Description : An electrolyte im balan ce is cau sed

by too rapid or excessive in fusio n or by use of an in approp riate IV solution .

2. Preven tion an d in terven tion s a . Assess labo ratory value reports. b . Verify th e correct solution . c. Calculate an d m on itor th e flo w rate. d . Use an electron ic IV in fusion device an d fre-

quen tly ch eck th e drip rate or settin g (at least every h ou r for an ad ult).

e. Add a tim e tape (label) to th e IV bag or bottle (see Fig. 13-5).

f. Place a red m ed ication sticker on th e bag or bottle if a m edication h as been added to th e IV solution (see Fig. 13-5).

g. Mon itor for sign s of an electrolyte im balan ce, an d n otify th e HCP if th ey occur.

Lactated Ringer’s solution contains potassium and should not be administered to clients with acute kidney injury or chronic kidney disease.

E. Hem atom a 1. Description : Th e collection of blood in th e tis-

sues after an un successful ven ipun ctu re or after th e ven ipu n ctu re site is discon tin ued an d blood con tin ues to ooze in to th e tissue

2. Preven tion an d in terven tion s a . Wh en startin g an IV, avoid piercin g th e poste-

rior wall of th e vein . b . Do not apply a tourniquet to the extrem ity im -

m ediately after an unsuccessful venipuncture. c. Wh en discon tin uin g an IV, apply pressure to

th e site for 2 to 3 m in u tes an d elevate th e extrem ity; apply pressure lon ger for clien ts with a bleedin g disorder or wh o are takin g an ticoagulan ts.

d . If a h em atom a develops, elevate th e extrem ity an d ap ply pressure an d ice as prescribed.

e. Docum en t acco rdin gly, in cludin g takin g pictures of th e IV site if in dicated by agen cy policy.

F. In fection 1. Description

a . In fection occurs from th e en try of m icroor- gan ism s in to th e body th rough th e ven ipun c- ture site.

b . Venipuncture in terrupts th e in tegrity of th e skin , th e first lin e of defen se again st in fectio n .

c. Th e lon ger th e th erapy con tin ues, th e greater th e risk for in fectio n .

d . In fection can occur locally at th e IV in sertio n site or system ically fro m th e en try of m icroor- gan ism s in to th e body.

2. At-risk clien ts a . Im m un ocom p rom ised clien ts with diseases

such as can cer, h um an im m un od eficien cy virus or acquired im m un odeficien cy syn - drom e, th ose receivin g biologic m odifier respo n se m edication s for treatm en t of auto- im m un e co n dition s, or status post organ tran splan t are at risk for in fectio n .

b . Clien ts receivin g treatm en ts such as ch em o- th erap y wh o h ave an altered or lo wered wh ite blood cell coun t are at risk for in fectio n .

c. O lder clien ts, because agin g alters th e effec- tiven ess of th e im m un e system , are at risk for in fectio n .

d . Clien ts with diab etes m ellitus are at risk for in fectio n .

3. Preven tion an d in terven tion s a . Assess th e clien t for predisposition to or risk

for in fectio n . b . Main tain strict asepsis wh en carin g for th e

IV site. c. Mon itor for sign s of local or system ic

in fectio n .

F

u

n

d

a

m

e

n

t

a

l

s

FIGURE 13-5 Intravenous fluid bag with medication label and time- tape. (From Potter et al., 2013.)

150 UNIT III Nursing Sciences

d . Mon itor wh ite blood cell coun ts. e. Ch eck fluid con tain ers for cracks, leaks, clo ud-

in ess, or oth er eviden ce of con tam in ation . f. Ch an ge IV tubin g every 96 h ours in acco r-

dan ce with CDC recom m en dation s or acco rdin g to agen cy policy; ch an ge IV site dressin g wh en soiled or con tam in ated an d acco rdin g to agen cy policy.

g. Label th e IV site, bag or bottle, an d tubin g with th e date an d tim e to en sure th at th ese are ch an ged on tim e acco rdin g to agen cy policy.

h . En su re th at th e IV solution is n ot h an gin g for m ore th an 24 h ours.

i. If in fectio n occurs, th e HCP is n otified; dis- con tin ue th e IV, an d place th e ven ipu n cture device in a sterile con tain er for possible culture.

j. Prepare to obtain blood cultures as pre- scrib ed if in fection occurs an d docum en t acco rdin gly.

k . Restart an IV in th e opposite arm to differen - tiate sepsis (system ic in fection ) fro m local in fectio n at th e IV site.

l. Do cum en t accordin gly, in cludin g takin g pictures of th e IV site if in dicated by agen cy policy.

A client with diabetes mellitus usually does not re- ceive dextrose (glucose) solutions because the solution can increase the blood glucose level.

G. Infiltration 1. Description

a. In filtration is seepage of th e IV fluid out of th e vein an d in to th e surroun din g in terstitial spaces.

b . In filtration occurs wh en an access device h as beco m e dislodged or perforates th e wall of th e vein or wh en ven o us backpressure occurs because of a clo t or ven o spasm .

2. Preven tion an d in terven tion s a. Avo id ven ipun ctu re over an area of flexion . b . An ch or th e can n ula an d a loop of tubin g

securely with tap e. c. Use an arm board or splin t as n eeded if th e cli-

en t is restless or active. d . Mon itor th e IV rate for a decrease or a cessa-

tio n of flo w. e. Evaluate th e IV site for in filtration by occlu d-

in g th e vein proxim al to th e IV site. If th e IV flu id con tin ues to flo w, th e can n ula is proba- bly outside th e vein (in filtrated); if th e IV flow stops after occlu sion of th e vein , th e IV device is still in th e vein .

f. Lower th e IV flu id con tain er below th e IV site, an d m on itor for th e appearan ce of blood in

th e IV tubin g; if blood ap pears, th e IV device is m ost likely in th e vein .

g. If infiltration h as occurred, rem ove th e IV device im m ediately; elevate th e extrem ity an d apply com presses (warm or cool, depen d- in g on th e IV solution that was in fusin g an d the HCP’s prescription ) over th e affected area.

h . Do n ot ru b an in filtrated area, wh ich can cau se h em atom a.

i. Do cum en t accord in gly, in cludin g takin g pic- tures of th e IV site if in dicated by agen cy policy.

H. Phlebitis an d th rom boph leb itis 1. Description

a. Ph lebitis is an in flam m ation of the vein that can occur from m ech an ical or ch em ical (m ed- ication ) traum a or from a local in fection .

b . Ph lebitis can cause th e developm en t of a clot (th rom boph lebitis).

2. Preven tion an d in terven tion s a. Use an IV can n ula sm aller th an th e vein , an d

avoid usin g very sm all vein s wh en adm in is- terin g irritatin g solution s.

b . Avoid usin g th e lower extrem ities (legs an d feet) as an access area for th e IV.

c. Avoid ven ipu n ctu re over an area of flexion . d . An ch or th e can n ula an d a loop of tubin g

securely with tape. e. Use an arm board or splin t as n eeded if th e cli-

en t is restless or active. f. Ch an ge th e ven ipun ctu re site every 72 to

96 h ou rs in accord an ce with CDC recom - m en dation s an d agen cy policy.

g. If ph lebitis occurs, rem ove th e IV device im m ediately an d restart it in th e opposite extrem ity; n otify th e HCP if ph lebitis is sus- pected, an d apply warm , m oist com presses, as prescribed.

h . If th rom bop h lebitis occurs, do n ot irrigate th e IV cath eter; rem ove th e IV, n otify th e HCP, an d restart th e IV in th e opposite extrem ity.

i. Do cum en t accord in gly, in cludin g takin g pic- tures if in dicated by agen cy policy.

I. Tissue dam age 1. Description

a. Tissues m ost co m m on ly dam aged in clude th e skin , vein s, an d subcu tan eous tissue.

b . Tissue dam age can be un com fo rtable an d can cau se perm an en t n egative effects.

c. Extravasation is a form of tissue dam age cau sed by th e seepage of vesican t or irritan t solution s in to th e tissues; th is occurren ce requires im m ediate HCP n otification so th at treatm en t can be prescribed to preven t tissue n ecrosis.

F

u

n

d

a

m

e

n

t

a

l

s

151CHAPTER 13 Intravenous Therapy

F

u

n

d

a

m

e

n

t

a

l

s

2. Preven tion an d in terven tion s a . Use a careful an d gen tle approach wh en

applyin g a tourn iquet. b . Avoid tappin g th e skin over th e vein wh en

startin g an IV. c. Mon itor for ecch ym osis wh en pen etratin g th e

skin with th e can n ula. d . Assess for allergies to tape or dressin g adhesives. e. Mon itor for skin color ch an ges, slough in g of

th e skin , or discom fort at th e IV site. f. No tify th e HCP if tissue dam age is susp ected. g. Do cum en t accord in gly, in cludin g takin g pic-

tures if in dicated by agen cy policy.

Always document the occurrence of a complication, assessment findings, actions taken, and the client’s response according to agency policy.

VIII. Central Venous Catheters A. Description

1. Cen tral ven o us cath eters (Fig. 13-6) are used to deliver h yperosm o lar solution s, m easu re cen tral ven o us pressure, in fuse paren teral n utrition , or in fuse m ultiple IV solution s or m ed ication s.

2. Cath eter position is determ in ed by radiograph y after in sertion .

3. Th e cath eter m ay h ave a sin gle, doub le, or triple lu m en .

4. Th e cath eter m ay be in serted periph erally an d th read ed th rou gh th e basilic or ceph alic vein in to th e superio r ven a cava, in serted cen trally th rough th e in tern al jugular or subclavian vein s, or surgi- cally tun n eled th rough subcu tan eous tissue.

5. With m ultilum en cath eters, m ore th an 1 m edica- tion can be ad m in istered at th e sam e tim e with - out in com patibility problem s, an d on ly 1 in sertio n site is presen t.

For central line insertion, tubing change, and line removal, place the client in the Trendelenburg position if not contraindicated or in the supine position, and instruct the client to perform the Valsalva maneuver to increase pressure in the central veins when the IV system is open.

B. Tun n eled cen tral ven ous cath eters 1. A m ore perm an en t typ e of cath eter, such as th e

Hickm an , Broviac, or Grosh on g cath eter, is used for lon g-term IV th erapy.

2. The cath eter m ay be sin gle lum en or m ultilum en. 3. Th e cath eter is in serted in th e operatin g room ,

an d th e cath eter is th read ed in to th e lower part of th e ven a cava at th e en tran ce of th e righ t atrium (en tran ce site), an d tun n eled un d er th e

S ubcla via n ca the te r s ite A B

Pe riphe ra lly ins e rte d ce ntra l ca the te r (P ICC) C

Fe mora l ca the te r s ite

D Hickma n ca the te r s ite

E F S ubcla via n ca the te r with

impla nta ble va s cula r a cce s s port Impla nta ble

va s cula r a cce s s port

S e lf-s e a ling s e ptum

S kin line

S uture Fluid flow

Ca the te r

FIGURE 13-6 Central venous access sites. A, Subclavian catheter. B, Peripherally inserted central catheter (PICC). C, Femoral catheter. D, Hickman catheter. E, Subclavian catheter with implantable vascular access port. F, Implantable vascular access port.

152 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

skin to th e exit site wh ere th e cath eter com es out of th e ch est; th e cath eter at th e exit site is secured by m ean s of a "cuff" just un der th e skin at th e exit site.

4. Th e cath eter is fitted with an in term itten t in fu- sion device to allow access as n eeded an d to keep th e system closed an d in tact.

5. Paten cy is m ain tain ed by flush in g with a diluted h eparin solution or n orm al salin e solution , dep en din g on th e type of cath eter, per agen cy policy.

C. Vascular access ports (im p lan table port) 1. Surgically im planted un der th e skin , ports such as a

Port-a-Cath , Mediport, or In fusaport are used for lon g-term adm in istration of repeated IV therapy.

2. For access, th e port requires palpation an d in jec- tion th rough th e skin in to th e self-sealin g port with a n oncorin g n eedle, such as a Huber poin t n eedle.

3. Paten cy is m ain tain ed by periodic flush in g with a diluted h eparin solution as prescribed an d as per agen cy policy.

D. PICC lin e 1. Th e cath eter is used for lo n g-term IV th erap y, fre-

quen tly in th e h om e. 2. Th e basilic vein usually is used, but th e m edian

cubital an d ceph alic vein s in th e an tecubital area also can be used.

3. Th e cath eter is th read ed so th at th e cath eter tip m ay term in ate in th e subclavian vein or superior ven a cava.

4. A sm all am oun t of bleed in g m ay occur at th e tim e of in sertio n an d m ay con tin ue for 24 h ours, but bleedin g th ereafter is n ot expected.

5. Phlebitis is a com m on com plication .

IX. Epidural Catheter (Fig. 13-7) A. Cath eter is placed in th e epidu ral space for th e

adm in istration of an algesics; th is m eth od of ad m in - istration reduces th e am oun t of m edication n eeded to co n trol pain ; th erefore, th e clien t experien ces fewer side effects.

B. Assess clien t’s vital sign s, level of con sciousn ess, an d m oto r an d sen sory fun ctio n of lo wer extrem ities.

C. Mon itor in sertio n site for sign s of in fectio n an d be sure th at th e cath eter is secured to th e clien t’s skin an d th at all con n ection s are tap ed to preven t discon n ection .

D. Ch eck HCP’s prescription regardin g solution an d m edication adm in istration .

E. For con tin uo us in fusion , m on itor th e electron ic in fusion device for proper rate of flo w.

F. For bolus dose adm in istration , follow th e procedure for ad m in isterin g bolus doses th rou gh th e cath eter an d follow agen cy proced ure.

G. Aspiration is don e before in jectin g m edication ; if m ore th an 1 m L of clear fluid or blood return s, the m edication is n ot in jected an d the HCP or an esth esi- ologist is n otified im m ediately (cath eter m ay h ave m igrated in to the subarach n oid space or a blood vessel).

Contraindications to an epidural catheter and administration of epidural analgesia include skeletal and spinal abnormalities, bleeding disorders, use of anti- coagulants, history of multiple abscesses, and sepsis.

CRITICAL THINKING What Should You Do? Answer: When a client has any type of central venous cath- eter, there is a risk for breaking of the catheter, dislodgement of a thrombus, or entry of air into the circulation, all of which can lead to an embolism. Signs and symptoms that this com- plication is occurring include sudden chest pain, dyspnea, tachypnea, hypoxia, cyanosis, hypotension, and tachycardia. If this occurs, the nurse should clamp the catheter, place the client on the left side with the head lower than the feet (to trap the embolism in the right atrium of the heart), adminis- ter oxygen, and notify the health care provider.

Reference: Ignatavicius, Workman (20 16), p. 20 7.

P R A C T I C E Q U E S T I O N S 103. A clien t h ad a 1000-m L bag of 5% dextrose in

0.9% sodium ch loride h un g at 1500. Th e n urse m akin g roun ds at 1545 fin ds th at th e clien t is com plain in g of a poun din g h eadach e an d is dys- pn eic, experien cin g ch ills, an d ap preh en sive, with an in creased pulse rate. Th e in traven ous (IV) bag h as 400 m L rem ain in g. Th e n urse sh ould take wh ich action first? 1. Slo w th e IV in fusion . 2. Sit th e clien t up in bed. 3. Rem ove th e IV cath eter. 4. Call th e h ealth care provider (HCP).

104. Th e n urse h as a prescription to h an g a 1000-m L in traven ous (IV) bag of 5% dextrose in water with 20 m Eq of potassium ch loride. Th e n urse also n eeds to h an g an IV in fusion of piperacillin /

S ke le ta l ve rte bra

Epidura l ca the te r

FIGURE 13-7 Tunneled epidural catheter.

153CHAPTER 13 Intravenous Therapy

F

u

n

d

a

m

e

n

t

a

l

s

tazobactam . Th e clien t h as on e IV site. Th e n urse sh o uld plan to take wh ich action first? 1. Start a secon d IV site. 2. Ch eck com patibility of th e m ed ication an d IV

fluids. 3. Mix th e prepackaged piperacillin / tazobactam

per agen cy policy. 4. Prim e th e tubin g with th e IV solution , an d back-

prim e th e m edication .

105. Th e n urse is com pletin g a tim e tape for a 1000-m L in traven ous (IV) bag th at is sch eduled to in fuse over 8 h ours. Th e n urse h as just placed th e 1100 m arkin g at th e 500-m L level. Th e n urse would place th e m ark for 1200 at wh ich n um erical level (m L) on th e tim e tap e? Fill in th e b lan k. An swer: ______ m L

106. Th e n urse is m akin g in itial ro un ds on th e n ursin g un it to assess th e con dition of assign ed clien ts. Wh ich assessm en t fin din gs are con sisten t with in filtration ? Select all th at ap p ly.

1. Pain an d eryth em a 2. Pallor an d cooln ess 3. Nu m bn ess an d pain 4. Edem a an d blan ch ed skin 5. Form ation of a red streak an d purulen t

drain age

107. Th e n urse is in sertin g an in traven ous (IV) lin e in to a clien t’s vein . After th e in itial stick, th e n urse would con tin ue to ad van ce th e cath eter in wh ich situation ? 1. Th e cath eter advan ces easily. 2. Th e vein is disten ded un der th e n eedle. 3. Th e clien t does n ot com plain of discom fort. 4. Bloo d return sh ows in th e backflash ch am b er of

th e cath eter.

108. Th e n urse is assessin g a clien t’s periph eral in trave- n ou s (IV) site after co m pletio n of a van com ycin in fusion an d n otes th at th e area is redden ed, warm , pain ful, an d sligh tly edem atous proxim al to th e in sertion poin t of th e IV cath eter. At th is tim e, wh ich action by th e n urse is b est? 1. Ch eck for th e presen ce of blood return . 2. Rem ove th e IV site an d restart at an oth er site. 3. Docum en t th e fin din gs an d con tin ue to m on i-

tor th e IV site. 4. Call th e h ealth care provider (HCP) an d request

th at th e van com ycin be given orally.

109. Th e n urse is preparin g a con tin uous in traven ous (IV) in fusion at th e m ed ication cart. As th e n urse go es to in sert th e spike en d of th e IV tubin g in to th e IV bag, th e tubin g drops an d th e spike en d h its th e top of th e m ed ication cart. Th e n urse sh ould take wh ich action ?

1. O btain a n ew IV bag. 2. O btain n ew IV tubin g. 3. Wipe th e spike en d of th e tubin g with povidon e

io din e. 4. Scrub th e spike en d of th e tubin g with an alco-

h ol swab.

110. A h ealth care provider h as written a prescription to discon tin ue an in traven o us (IV) lin e. Th e n urse sh ould obtain wh ich item from th e un it supply area for applyin g pressure to th e site after rem ovin g th e IV cath eter? 1. Elastic wrap 2. Povidon e iodin e swab 3. Adh esive ban dage 4. Sterile 2 Â 2 gauze

111. A clien t rin gs th e call ligh t an d com plain s of pain at th e site of an in traven o us (IV) in fusion . Th e n urse assesses th e site an d determ in es th at ph lebi- tis h as developed. Th e n urse sh ould take wh ich action s in th e care of th is clien t? Select all th at ap p ly.

1. Rem o ve th e IV cath eter at th at site. 2. Apply warm m oist packs to th e site. 3. No tify th e h ealth care provider (HCP) . 4. Start a n ew IV lin e in a proxim al portion of

th e sam e vein . 5. Docum en t th e occurren ce, action s taken ,

an d th e clien t’s respo n se.

112. A clien t in volved in a m otor veh icle crash presen ts to th e em ergen cy departm en t with severe in tern al bleed in g. Th e clien t is severely h ypo ten sive an d un respon sive. Th e n urse an ticip ates th at wh ich in traven ous (IV) solution will m o st likely be pre- scrib ed for th is clien t? 1. 5% dextrose in lactated Rin ger’s solution 2. 0.33% sodium ch loride (1/ 3 n orm al salin e) 3. 0.45% sodium ch loride (1/ 2 n orm al salin e) 4. 0.225% sodium ch loride (1/ 4 n orm al salin e)

113. Th e n urse provid es a list of in struction s to a clien t bein g disch arged to h om e with a periph erally in serted cen tral cath eter (PICC) . Th e n urse deter- m in es th at th e clien t n eed s fu rth er in stru ctio n s if th e clien t m ade wh ich statem en t? 1. “I n eed to wear a MedicAlert tag or bracelet.” 2. “I n eed to restrict m y activity wh ile th is cath eter

is in place.” 3. “I n eed to keep th e in sertio n site protected wh en

in th e sh ower or bath .” 4. “I n eed to ch eck th e m arkin gs on th e cath eter

each tim e th e dressin g is ch an ged.”

114. A clien t h as just un dergon e in sertion of a cen tral ven o us cath eter at th e bedside un der ultraso un d. Th e n urse would be sure to ch eck wh ich results

154 UNIT III Nursing Sciences

before in itiatin g th e flow rate of th e clien t’s in trave- n ous (IV) solution at 100 m L/ h ou r? 1. Serum osm o lality 2. Serum electrolyte levels 3. In take an d outp ut record 4. Ch est radiolo gy results

115. In traven ou s (IV) fluid s h ave been in fusin g at 100 m L/ h ou r via a cen tral lin e cath eter in th e righ t in tern al jugular for approxim ately 24 h ours to in crease urin e output an d m ain tain th e clien t’s

blood pressure. Upo n en terin g th e clien t’s ro om , th e n urse n otes th at th e clien t is breath in g rapidly an d cough in g. For wh ich addition al sign s of a com - plication sh ould th e n urse assess based on th e pre- viou sly kn own data? 1. Excessive bleedin g 2. Crackles in th e lun gs 3. In com p atibility of th e in fusion 4. Ch est pain radiatin g to th e left arm

A N S W E R S 103. 1 Ra t ion a le: Th e clien t’s sym pto m s are co m patib le with circula- to ry overload . Th is m ay b e verified by n otin g th at 600 m L h as in fu sed in th e co urse of 45 m in u tes. Th e first action o f th e n u rse is to slo w th e in fusion . O th er actio n s m ay fo llo w in rap id seq uen ce. Th e n u rse m ay elevate th e h ead o f th e bed to aid th e clien t’s breath in g, if n ecessary. Th e n u rse also n otifies th e HCP. Th e IV cath eter is n ot rem o ved; it m ay b e n eed ed for th e ad m in istration o f m ed ication s to resolve th e co m p lication . Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d , first. Th is tells yo u th at m o re th an 1 or all of th e o ptio n s are likely to be co rrect actio n s an d th at th e n u rse n eeds to p rio ritize th em acco rdin g to a tim e seq uen ce. You m u st b e able to reco gn ize th e sign s o f cir- cu latory o verload . From th is p oin t, select th e o ptio n th at pro- vides th e in terven tio n sp ecific to circu lato ry overload . Review: Nu rsin g actio n s for cir cu la t o r y o ver lo a d Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Med icatio n s an d In traven o us Th erap y Pr ior ity Con cepts: Flu id an d Electrolytes; Perfusion Refer en ce: Ign atavicius, Workm an (2016), p . 207.

104. 2 Ra t ion a le: Wh en h an gin g an IV an tibio tic, th e n urse sh o uld first ch eck co m p atibility o f th e m ed ication an d th e IV fluid s cu rren tly p rescribed . If th e fluid s an d m ed icatio n are in com - patib le, it wou ld th en b e ap prop riate to start a secon d IV site. If th ey are com p atible, th e n u rse sh ou ld h an g th em to geth er so as to avoid h avin g to start an o th er IV site. After th is, th e n u rse sh ou ld p repare th e p rep ackaged pip eracillin / tazo b actam per agen cy po licy, th en prim e th e tub in g with th e IV so lu tion , an d th en back-p rim e th e m edicatio n . Back-prim in g p reven ts an y m edicatio n from bein g lo st d urin g th e p rim in g p ro cess. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d , first. Th is im p lies a co rrect tim e sequ en ce, an d you n eed to prioritize. Visualize an d th in k th ro ugh th e step s o f h an gin g an IV an tibi- otic o r secon dary m ed ication , an d m ake yo ur ch o ice accordin gly. Review: Ad m in ist r a t io n o f a n IV m ed ica t io n Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity

In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Critical Care—Med icatio n s an d In traven o us Th erap y Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten d orf ( 2014) , pp . 568, 573-574.

105. 375 Ra t ion a le: If th e IV is sch edu led to run o ver 8 h ou rs, th e h ou rly rate is 125 m L/ h o ur. Usin g 500 m L as th e referen ce p oin t, th e n ext h ou rly m arkin g wou ld be at 375 m L, wh ich is 125 m L less th an 500. Test -Ta kin g Str a tegy: Focus o n th e su b ject , in traven o us in fu - sion calcu latio n s. Use basic prin cip les related to do sage calcu- lation an d IV adm in istratio n to an swer th is q u estio n . Sub tract 125 fro m 500 to yield 375. Review: Ad m in istratio n o f in t r a ven o u s m ed ica t io n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity Integra ted Process: Nursin g Pro cess—Im p lem en tatio n Con t en t Ar ea : Fun d am en tal of Care—Medication / IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 710-711.

106. 2, 3, 4 Ra t ion a le: An in filtrated in traven o us (IV) lin e is o n e th at h as d islo d ged fro m th e vein an d is lyin g in sub cu tan eo u s tissue. Pallo r, co oln ess, edem a, pain , n u m b n ess, an d b lan ch ed skin are th e resu lts of IV fluid bein g dep o sited in th e sub cutan eo u s tissue. Wh en th e pressu re in th e tissu es exceeds th e pressu re in th e tu b in g, th e flo w of th e IV solutio n will sto p, an d if an elec- tron ic p um p is b ein g u sed , it will alarm . Eryth em a can b e asso- ciated with in fectio n , p h leb itis, or th ro m bo sis. Fo rm atio n of a red streak an d p urulen t drain age is asso ciated with p h leb itis an d in fection . Test -Ta kin g Str a tegy: Focu s on th e su b ject , clin ical m an ifes- tatio n s at th e IV site. Rem em b er th at p allo r, co oln ess, p ain , n um b n ess, an d swellin g are sign s o f in filtratio n , an d th at in fec- tion , p h lebitis, an d th ro m bo sis are asso ciated with warm th at th e IV site. Review: Sign s of in filt r a t io n Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Critical Care—Medicatio n s an d In traven ou s Th erap y

F

u

n

d

a

m

e

n

t

a

l

s

155CHAPTER 13 Intravenous Therapy

Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 204.

107. 4 Ra tion a le: Th e IV cath eter h as en tered th e lum en of th e vein su ccessfu lly wh en blo od b ackflash sh o ws in th e IV cath eter. Th e vein sh o uld h ave been d isten d ed b y th e tou rn iq uet befo re th e vein was can n ulated, an d if fu rth er d isten tio n occurs after ven ipu n cture, th is cou ld m ean th e n eed le wen t th ro u gh th e vein an d in to th e tissu e; th erefo re, th e cath eter sh ou ld n o t be ad van ced . Clien t d iscom fort varies with th e clien t, th e site, an d th e n u rse’s in sertion tech n iq ue an d is n ot a reliable m easure of cath eter placem en t. Th e n u rse sh o uld n ot advan ce th e cath eter un til p lacem en t in th e vein is verified by bloo d return . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject o f th e q u estion , correct placem en t o f an IV cath eter. Notin g th e wo rd s blood return in th e correct o ption will direct you to th is option b ecau se a bloo d retu rn is exp ected if th e cath eter is in a vein . Review: In sertio n o f an in t r a ven o u s ca t h et er Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Medication s an d In traven ous Th erap y Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 703-704.

108. 2 Ra tion a le: Ph leb itis at an IV site can b e d istin gu ish ed b y cli- en t discom fo rt at th e site an d by red n ess, warm th , an d swell- in g p ro xim al to th e cath eter. If ph lebitis occu rs, th e n urse sh o u ld rem ove th e IV lin e an d in sert a n ew IV lin e at a d iffer- en t site, in a vein oth er th an th e on e th at h as d evelo p ed p h le- b itis. Ch eckin g for th e presen ce of b loo d return sh o uld be d on e b efo re th e ad m in istratio n o f van co m ycin b ecau se th is m edicatio n is a vesican t. Docu m en tin g th e fin din gs an d con - tin uin g to m o n ito r th e IV site an d callin g th e HCP an d requ estin g th at th e van co m ycin be given orally d o n o t ad d ress th e im m ed iate prob lem . Ad dition ally, th ere cou ld b e in d ica- tio n s for th e prescrip tion of IV as op p osed to oral van co m ycin fo r th e clien t. Th e HCP sh o uld b e n otified o f th e co m p lica- tio n s with th e IV site, b ut n o t asked fo r a prescrip tion fo r oral van com ycin . Test-Ta kin g St r a t egy: Note th e st r a t egic wo r d , best. Also, d et er m in e if a n a b n o r m a lit y exist s. Based on th e assessm en t fin din gs n o ted in th e qu estio n , it is clear th at an abn orm ality d oes exist, so elim in ate do cu m en tin g an d co n tin u in g to m o n - ito r. Next, recallin g th e ap p ro priate n u rsin g in terven tio n fo r p h leb itis will direct yo u to th e correct o ptio n . Review: Sign s an d sym ptom s of p h leb it is an d th e associated n u rsin g in terven tio n s Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Medication s an d In traven ous Th erap y Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 205.

109. 2 Ra tion a le: Th e n urse sh ou ld ob tain n ew IV tub in g b ecause con tam in ation h as o ccu rred an d cou ld cau se system ic in fec- tio n to th e clien t. Th ere is n o n eed to o btain a n ew IV b ag b ecau se th e bag was n o t co n tam in ated . Wipin g with p ovido n e io din e or alcoh o l is in sufficien t an d is con train d icated b ecause th e sp ike will b e in serted in to th e IV bag. Test-Ta kin g Str a tegy: Focus o n th e su b ject , th at th e tubin g was co n tam in ated . Use kn o wledge o f basic in fectio n con tro l m easures an d IV th erap y co n cep ts to an swer th is q uestion . Rem em ber th at if an item is con tam in ated, discard it an d o btain a n ew sterile item . Review: Su r gica l a sep t ic t ech n iq u e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Medication s an d In traven ous Th erapy Pr ior it y Con cept s: Clin ical Ju dgm en t; In fectio n Refer en ce: Perry, Po tter, O sten d orf (2014), p. 700.

110. 4 Ra tion a le: A d ry sterile dressin g such as a sterile 2 Â 2 gauze is u sed to app ly pressu re to th e disco n tin u ed IV site. Th is m aterial is ab sorben t, sterile, an d n o n irritatin g. A p o vido n e iod in e swab wo u ld irritate th e op en ed p un ctu re site an d wo uld n ot sto p th e b loo d flow. An adh esive b an d age o r elastic wrap m ay be u sed to cover th e site o n ce h em o stasis h as occurred . Test-Ta king Stra tegy: Fo cu s on th e su b ject, care to th e IV site after rem o val o f th e cath eter, an d n ote th e words applying pressure. Visu alize th is proced ure, th in kin g abo u t each o f th e item s id en tified in th e o p tion s to d irect you to th e co rrect o ptio n . Review: In t r a ven o u s ca t h et er r em o va l Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Medication s an d In traven ous Th erapy Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Perry, Po tter, O sten d orf (2014), p. 723.

111. 1, 2, 3, 5 Ra tion a le: Ph leb itis is an in flam m atio n o f th e vein th at can o ccur from m ech an ical o r ch em ical (m edicatio n ) trau m a or fro m a lo cal in fectio n an d can cause th e develop m en t o f a clot ( th rom b op h leb itis) . Th e n urse sh o uld rem o ve th e IV at th e p h leb itic site an d ap ply warm m o ist co m p resses to th e area to sp eed resolu tio n o f th e in flam m ation . Becau se ph lebitis h as occurred , th e n urse also n otifies th e HCP ab ou t th e IV com plicatio n . Th e n u rse sh o u ld restart th e IV in a vein oth er th an th e on e th at h as d evelo ped p h lebitis. Fin ally, th e n urse d ocum en ts th e occurren ce, actio n s taken , an d th e clien t’s respon se. Test-Ta king Stra tegy: Focus on th e su b ject, action s to take if p h leb itis o ccu rs. Recall th at ph lebitis is an in flam m atio n of th e vein . Th is will assist in elim in atin g th e op tio n th at in d icates to u se th e sam e vein becau se an IV sh o uld b e restarted in a vein o th er th an th e o n e th at h as d evelo ped ph leb itis. Review: P h leb it is

F

u

n

d

a

m

e

n

t

a

l

s

156 UNIT III Nursing Sciences

Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Med icatio n s an d In traven o us Th erap y Pr ior ity Con cepts: Clin ical Jud gm en t; In flam m ation Refer en ce: Ign atavicius, Workm an (2016), p . 205.

112. 1 Ra t ion a le: Fo r th is clien t, th e go al of th erap y is to exp an d in tra- vascu lar vo lum e as qu ickly as p ossible. In th is situatio n , th e cli- en t will likely experien ce a d ecrease in in travascular volum e fro m b lo od loss, resu ltin g in decreased bloo d p ressu re. Th ere- fo re, a so lu tion th at in creases in travascular volu m e, rep laces im m ed iate bloo d loss vo lum e, an d in creases b lo od p ressu re is n eed ed . Th e 5% d extrose in lactated Rin ger’s (h yp erto n ic) solu tio n wou ld in crease in travascu lar vo lu m e an d im m ed i- ately rep lace lo st flu id vo lu m e un til a tran sfu sio n co uld b e ad m in istered , resu ltin g in an in crease in th e clien t’s b loo d pres- sure. Th e so lu tion s in th e rem ain in g op tio n s wo uld n o t b e given to th is clien t b ecause th ey are h yp oto n ic so lutio n s an d, in stead of in creasin g in travascular sp ace, th e so lutio n s wo uld m o ve in to th e cells via o sm o sis. Test -Ta kin g St r a t egy: Focu s on th e su b ject , th at th e clien t h as been in a trau m atic accid en t. Also, n o te th e st r a t egic wo r d s , most likely. Also n o te th at th e in co rrect o p tion s are co m p a r a b le o r alike an d in clu d e a % o f n o rm al salin e. Determ in in g th at th is clien t will likely experien ce d ecreased in travascular volum e an d blo o d pressure du e to bloo d loss an d recallin g IV fluid typ es an d h ow h ypo ton ic an d h yp erto n ic so lu tion s fu n ction with in th e in travascu lar space will d irect yo u to th e co rrect op tion . Review: In t r a ven o u s flu id s Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Critical Care—Med icatio n s an d In traven o us Th erap y Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Perry, Potter, O sten do rf (2014), p . 694.

113. 2 Ra t ion a le: Th e clien t sh o uld be taugh t th at o n ly m in or activity restriction s apply with th is type of cath eter. Th e clien t sh ould carry or wear a Med icAlert id en tificatio n an d sh ou ld protect th e site d urin g b ath in g to p reven t in fectio n . Th e clien t sh o uld ch eck th e m arkin gs on th e cath eter du rin g each d ressin g ch an ge to assess fo r cath eter m igratio n o r d islo dgem en t. Test -Ta kin g St r a t egy: No te th e st r a t egic wo r d s , needs further instructions. Th ese wo rd s in d icate a n ega t ive even t q u er y an d th e n eed to select th e in correct clien t statem en t. Recallin g th at th e PICC is fo r lon g-term u se will assist in directin g yo u to th e co rrect op tio n . To restrict activity with su ch a cath eter is un reaso n able. Review: Per ip h er a lly in ser t ed in t r a ven o u s ca t h et er s Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g

Con t en t Ar ea : Critical Care—Med icatio n s an d In traven o us Th erap y Pr ior ity Con cepts: Clien t Ed u catio n ; Fun ctio n al Ab ility Refer en ce: Perry, Po tter, O sten do rf (2014), p . 735.

114. 4 Ra t ion a le: Befo re begin n in g ad m in istratio n o f IV so lutio n , th e n urse sh o uld assess wh eth er th e ch est rad iology resu lts reveal th at th e cen tral cath eter is in th e p ro per p lace. Th is is n ecessary to p reven t in fusion of IV flu id in to pu lm on ary o r sub cutan eo u s tissues. Th e o th er op tio n s rep resen t item s th at are u sefu l fo r th e n urse to be aware o f in th e gen eral care o f th is clien t, b ut th ey d o n o t relate to th is proced ure. Test -Ta kin g St r a t egy: Note th e su b ject , care to th e clien t with a cen tral ven o u s cath eter. No te th e wo rd s insertion of a central venous catheter at the bedside. Recallin g th e p o ten tial co m plica- tion s asso ciated with th e in sertio n o f cen tral ven o us cath eters will direct you to th e correct option . Review: Nursin g actio n s related to cen t r a l ven o u s ca t h et er s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Critical Care—Medicatio n s an d In traven ou s Th erap y Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Ign atavicius, Wo rkm an (2016), pp . 190-191, 193; Perry, Potter, O sten do rf (2014), p . 735.

115. 2 Ra t ion a le: Circu latory (flu id ) overlo ad is a com p lication o f IV th erap y. Sign s in clud e rapid b reath in g, d ysp n ea, a m oist co ugh , an d crackles. Bloo d pressure an d h eart rate also in crease if circu latory overlo ad is p resen t. Th erefo re, sin ce th e n u rse pre- viou sly n o ted rapid breath in g an d cou gh in g, th e n u rse sh o uld th en assess fo r a m o ist co u gh an d crackles. Hem ato m a is an oth er po ten tial co m plicatio n an d is ch aracterized by ecch y- m o sis, swellin g, an d leakage at th e IV in sertio n site, as well as h ard an d p ain fu l lum ps at th e site. Allergic reactio n is a co m - p licatio n of adm in istratio n o f IV fluids o r m ed ication an d is ch aracterized b y ch ills, fever, m alaise, h ead ach e, n ausea, vo m itin g, backach e, an d tach ycardia; th is typ e o f reactio n co uld also occu r if th e IV so lution s in fu sed are in com p atible; h owever, th ere was n o in d ication o f m ultiple solu tio n s b ein g in fused sim u ltan eo u sly in th is qu estio n . Ch est pain radiatin g to th e left arm is a classic sign of card iac co m prom ise an d is n ot sp ecifically related to a co m plicatio n o f IV th erapy. Test -Ta kin g St r a t egy: Fo cus on t h e d a t a in t h e q u est io n an d n ote th e su b ject , a co m plicatio n . No tin g th at th e clien t is experien cin g rapid b reath in g an d is co u gh in g will assist in d irectin g you to th e co rrect op tio n . Review: Sign s of cir cu la t o r y o ver lo a d Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Critical Care—Medicatio n s an d In traven ou s Th erap y Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 207.

F

u

n

d

a

m

e

n

t

a

l

s

157CHAPTER 13 Intravenous Therapy

C H A P T E R 14 Administration of Blood Products

PRIORITY CONCEPTS Perfusion; Safety

CRITICAL THINKING What Should You Do? The nurse is administering 1 unit of packed red blood cells (PRBCs) to a client who has never received a blood transfu- sion. The client suddenly becomes apprehensive and com- plains of back pain after the first 10 minutes of administration. What should the nurse do? Answer located on p. 163.

I. Types of Blood Components A. Packed red blood cells (PRBCs)

1. PBRCs are a blood product used to replace eryth - rocytes; in fusion tim e for 1 un it is usually between 2 an d 4 h ours.

2. Each un it in creases th e h em oglobin level by 1 g/ dL (10 m m ol/ L) an d h em atocrit by 3% (0.03); th e ch an ge in laborato ry values takes 4 to 6 h ours after com pletion of th e blood tran sfusion .

3. Evaluation of an effective respo n se is based on th e resolution of th e sym pto m s of an em ia an d an in crease in th e eryth rocyte, h em oglobin , an d h em atocrit coun t.

4. Leukocyte-poor or leukocyte-depleted units are unitsin wh ich leukocytes, protein s, an d plasm a have been reduced. They are used to restore oxygen- carryingcapacityofblood an d in travascular volum e.

Washed red blood cells (depleted of plasma, plate- lets, and leukocytes) may be prescribed for a client with a history of allergic transfusion reactions or those who underwent hematopoietic stem cell transplant. Leuko- cyte depletion (leukoreduction) by filtration, washing, or freezing is the process used to decrease the amount of white blood cells (WBCs) in a unit of packed cells.

B. Platelet transfusion 1. Platelets are used to treat th rom bocytop en ia an d

platelet dysfun ction s. a . Clien ts receivin g m ultiple un its of platelets

can becom e “alloim m un ized” to differen t

platelet an tigen s. Th ese clien ts m ay ben efit from receivin g on ly platelets th at m atch th eir specific h um an leuko cyte an tigen (HLA).

2. Crossmatching is n ot required but usually is don e (platelet con cen trates con tain few red blood cells [RBCs]).

3. Th e volum e in a un it of platelets m ay vary; always ch eck th e bag for th e vo lum e of th e blood com po n en t (in m illiliters).

4. Platelets are ad m in istered im m ediately upon receipt fro m th e blood ban k an d are given rap- idly, usually over 15 to 30 m in u tes.

5. Evaluation of an effective respo n se is based on im provem en t in th e platelet coun t, an d platelet coun ts n orm ally are evalu ated 1 h ou r an d 18 to 24 h ours after th e tran sfusio n ; for each un it of platelets ad m in istered, an in crease of 5000 to 10,000 m m 3 (5 to 10 Â 109/ L) is exp ected.

C. Fresh-frozen plasma 1. Fresh -frozen plasm a m ay be used to provide clot-

tin g factors or volum e expan sion ; it con tain s n o platelets.

2. Fresh -frozen plasm a is in fused with in 2 h ou rs of th awin g, wh ile clo ttin g factors are still viable, an d is in fused over a period of 15 to 30 m in u tes.

3. Rh compatibility an d ABO com patibility are required for th e tran sfusion of plasma products.

4. Evaluation of an effective respon se is assessed by m on itorin g coagu lation studies, particularly th e proth rom bin tim e an d th e partial th rom bo- plastin tim e, an d resolutio n of h ypo volem ia.

D. Cryoprecipitates 1. Prepared from fresh -frozen plasm a, cryoprecipi-

tates can be stored for 1 year. O n ce th awed, th e produ ct m ust be used; 1 un it is adm in istered over 15 to 30 m in utes.

2. Used to replace clo ttin g facto rs, especially facto r VIII an d fib rin ogen

3. Evaluation of an effective respon se is assessed by m on itorin g coagulation studies an d fibrin ogen levels.

F

u

n

d

a

m

e

n

t

a

l

s

158

E. Gran ulocytes 1. May be used to treat a clien t with sep sis or a n eu-

tro pen ic clien t with an in fection th at is un re- spon sive to an tibiotics

2. Evaluation of an effective respo n se is assessed by m on itorin g th e WBC an d differen tial coun ts.

Document the necessary information about the blood transfusion in the client’s medical record (follow agency guidelines). Include the client’s tolerance and response to the transfusion and the effectiveness of the transfusion.

II. Types of Blood Donations A. Autologous

1. A don ation of th e clien t’s own blood before a sch eduled proced ure is an autologous don ation ; it reduces th e risk of disease tran sm issio n an d poten tial tran sfusion co m plication s.

2. Autologous don ation is n ot an option for a clien t with leukem ia or bacterem ia.

3. A don ation can be m ade every 3 days as lon g as th e h em oglobin rem ain s with in a safe ran ge.

4. Do n ation s sh ould begin with in 5 weeks of th e tran sfusion date an d en d at least 3 days before th e date of tran sfusio n .

B. Bloo d salvage 1. Bloo d salvage is an autologous don ation th at

in volves suction in g blood fro m body cavities, join t spaces, or oth er closed body sites.

2. Bloo d m ay n eed to be “wash ed,” a special pro- cess th at rem oves tissue deb ris before rein fu sion .

C. Design ated don or 1. Design ated don ation occurs wh en recipien ts

select th eir own com patible don ors. 2. Do n ation does n ot reduce th e risk of con tractin g

in fectio n s tran sm itted by th e blood ; h owever, recipien ts feel m ore com fo rtable iden tifyin g th eir don ors.

III. Compatibility (Table 14-1) A. Clien t (th e recipien t) blood sam ples are drawn an d

labeled at th e clien t’s bed side at th e tim e th e blood sam ples are drawn ; th e clien t is asked to state h is or h er n am e, wh ich is com pared with th e n am e on th e clien t’s id en tification ban d or bracelet.

B. Th e recip ien t’s ABO typ e an d Rh typ e are id en tified .

C. An an tibody screen is don e to determ in e th e pres- en ce of an tibodies oth er th an an ti-A an d an ti-B.

D. To determ in e com patibility, crossmatching is don e, in wh ich don or red blood cells are com bin ed with th e recipien t’s serum an d Coom bs’serum ; the crossm atch is com patible if n o RBC agglutin ation occurs.

E. Th e un iversal RBC don or is O n egative; th e un iversal recip ien t is AB positive.

F. Clien ts with Rh -positive blood can receive RBC tran sfusion from an Rh -n egative don or if n ecessary; h owever, an Rh -n egative clien t sh ould n ot receive Rh -p ositive blood .

The donor’s blood and the recipient’s blood must be tested for compatibility. If the blood is not compatible, a life-threatening transfusion reaction can occur.

IV. Infusion Pumps A. In fusion pum ps m ay be used to ad m in ister blood

produ cts if th ey are design ed to fun ction with opaqu e solution s; special in traven ous (IV) tubin g is used specifically for blood produ cts to preven t h em olysis of red blood cells.

B. Always con sult m an ufacturer guidelin es for h ow to use th e pum p an d compatibility for use with blood tran sfusion s.

C. Special m an u al pressure cuffs design ed specifically for blood produ ct adm in istration m ay be used to in crease th e flow rate, but it sh ould n ot exceed 300 m m Hg.

D. Stan d ard sp h ygm o m an o m eter cu ffs are n o t to b e u sed to in crease th e flo w rate b ecau se th ey d o n o t exert u n ifo rm p ressu re again st all p arts o f th e b ag.

V. Blood Warmers A. Bloo d warm ers m ay be used to preven t h ypo th erm ia

an d ad verse reaction s wh en several un its of blood are bein g ad m in istered.

B. Special warm ers h ave been design ed for th is pur- pose, an d on ly devices specifically approved for th is use can be used.

If blood warming is necessary, use only warming devices specifically designed and approved for warming blood products. Do not warm blood products in a micro- wave oven or in hot water.

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 14-1 Compatibility Chart for Red Blood Cell Transfusions

Recipient

Donor A B AB O

A X X

B X X

AB X

O X X X X

The ABO type of the donor should be compatible with the recipient’s. Type A can receive from type Aor O; type B from type B or O; type AB can receive from type A, B, AB, or O; type O only from type O. From Ignatavicius D, Workm an ML: Medical-surgical nursing: patient-centered collaborative care, ed 7, Philadelphia, 20 13, Saunders.

159CHAPTER 14 Administration of Blood Products

VI. Precautions and Nursing Responsibilities (Box 14-1)

Check the client’s identity before administering a blood product. Be sure to check the health care pro- vider’s (HCP’s) prescription, that the client has an appropriate venous access site, that crossmatching pro- cedures have been completed, that an informed consent has been obtained, and that the correct client is receiving the correct type of blood. Use barcode scanning systems per agency policy to ensure client safety.

VII. Complications (Box 14-2) A. Transfusion reactions

1. Description a . A tran sfusion reaction is an adverse reactio n

th at h appen s as a result of receivin g a blood tran sfusion .

b . Types of tran sfusion reactio n s in clude h em o- lytic, allergic, febrile or bacterial reactio n s ( septicemia), or tran sfusion -associated graft- versus-h ost disease (GVH D).

F

u

n

d

a

m

e

n

t

a

l

s

BOX 14-1 Precautions and Nursing Responsibilities General Precautions A large volume of refrigerated blood infused rapidly through a

central venous catheter into the ventricle of the heart can cause cardiac dysrhythmias.

No solution other than normal saline should be added to blood components.

Medications are never added to blood components or piggy- backed into a blood transfusion.

To avoid the risk of septicemia, infusions (1 unit) should not exceed the prescribed time for administration (2 to 4 hours for packed red blood cells); follow evidence-based practice guidelines and agency procedure.

The blood administration set should be changed with each unit of blood, or according to agency policy, to reduce the risk of septicemia.

Check the blood bag for the date of expiration; components expire at midnight on the day marked on the bag unless oth- erwise specified.

Inspect the blood bag for leaks, abnormal color, clots, and bubbles.

Blood must be administered as soon as possible (within 20 to 30 minutes) after being received from the blood bank, because this is the maximal allowable time out of monitored storage.

Never refrigerate blood in refrigerators other than those used in blood banks; if the blood is not administered within 20 to 30 minutes, return it to the blood bank.

The recommended rate of infusion varies with the blood com- ponent being transfused and depends on the client’s condi- tion; generally blood is infused as quickly as the client’s condition allows.

Components containing few red blood cells (RBCs) and plate- lets may be infused rapidly, but caution should be taken to avoid circulatory overload.

The nurse should measure vital signs and assess lung sounds before the transfusion and again after the first 15 minutes and every 30 minutes to 1 hour (per agency policy) until 1 hour after the transfusion is completed.

Client Assessment Assess for any cultural or religious beliefs regarding blood

transfusions. A Jehovah’s Witness cannot receive blood or blood products;

this group believes that receiving a blood transfusion has eternal consequences.

Ensure that an informed consent has been obtained.

Explain the procedure to the client and determine whether the client has ever received a blood transfusion or experienced any previous reactions to blood transfusions.

Check the client’s vital signs; assess renal, circulatory, and respiratory status and the client’s ability to tolerate intrave- nously administered fluids.

If the client’s temperature is elevated, notify the health care pro- vider (HCP) before beginning the transfusion; a fever may be a cause for delaying the transfusion in addition to masking a possible symptom of an acute transfusion reaction.

Blood Bank Precautions Blood will be released from the blood bank only to personnel

specified by agency policy. The name and identification number of the intended recipient

must be provided to the blood bank, and a documented permanent record of this information must be maintained.

Blood should be transported from the blood bank to only 1client at a time to prevent blood delivery to the wrong client.

Only 1 unit of blood should be transported at a time, even if the client is prescribed to have more than 1 unit transfused.

Client Identity and Compatibility Check the HCP’s prescription for the administration of the

blood product. The most critical phase of the transfusion is confirming product

compatibility and verifying client identity. Universal barcode systems for blood transfusions should be

used to confirm product compatibility, client identity, and expiration.

Two licensed nurses (follow agency policy) need to check the HCP’s prescription, the client’s identity, and the client’s identification band or bracelet and number, verifying that the name and number are identical to those on the blood component tag.

At the bedside, the nurse asks the client to state his or her name, and the nurse compares the name with the name on the identification band or bracelet.

The nurs e checks the blood bag tag, label, and blood requi- sition form to ensure that ABO and Rh types are com pat- ible. The nurse uses the barcode scanning system per agency policy.

If the nurse notes any inconsistencies when verifying client identity and compatibility, the nurse notifies the blood bank immediately.

160 UNIT III Nursing Sciences

2. Sign s of an im m ediate tran sfusion reactio n a. Ch ills an d diaph o resis b . Muscle ach es, back pain , or ch est pain c. Rash es, h ives, itch in g, an d swellin g d . Rap id, th ready pulse e. Dysp n ea, cough , or wh eezin g

f. Pallor an d cyan osis g. Appreh en sion h . Tin glin g an d n um bn ess i. Headach e j. Nausea, vom itin g, abdom in al cram p in g, an d

diarrh ea 3. Sign s of a tran sfusion reactio n in an un co n scious

clien t a. Weak pulse b . Fever c. Tach ycardia or brad ycardia d . Hypo ten sion e. Visible h em oglob in uria f. O liguria or an uria

F

u

n

d

a

m

e

n

t

a

l

s

BOX 14-1 Precautions and Nursing Responsibilities—cont’d

Administration of the Transfusion Maintain standard and transmission-based precautions and

surgical asepsis as necessary. Insert an intravenous (IV) line and infuse normal saline; main-

tain the infusion at a keep-vein-open rate. An 18- or 19-gauge IV needle will be needed to achieve a maxi-

mum flow rate of blood products and to prevent damage to RBCs; if a smaller gauge needle must be used, RBCs may be diluted with normal saline (check agency procedure).

Acentral venous catheter is an acceptable venous access option for blood transfusions; for a multilumen catheter, use the largest catheter port available or check the port size to ensure that it is adequate for blood administration.

Always check the bag for the volume of the blood component. Blood products should be infused through administration sets

designed specifically for blood; use a Y-tubing or straight tubing blood administration set that contains a filter designed to trap fibrin clots and other debris that accumu- late during blood storage (Fig. 14-1).

Premedicate the client with acetaminophen or diphenhydra- mine, as prescribed, if the client has a history of adverse reactions; if prescribed, oral medications should be admin- istered 30 minutes before the transfusion is started, and intravenously administered medications may be given immediately before the transfusion is started.

Instruct the client to report anything unusual immediately. Determine the rate of infusion by the HCP’s prescription or, if

not specified, by agency policy. Begin the transfusion slowly under close supervision; if no reac-

tion is noted within the first 15 minutes, the flow can be increased to the prescribed rate.

During the transfusion, monitor the client for signs and symp- toms of a transfusion reaction; the first 15 minutes of the transfusion are the most critical, and the nurse must stay with the client.

If an ABO incompatibility exists or a severe allergic reaction occurs, the reaction is usually evident within the first 50 mL of the transfusion.

Document the client’s tolerance to the administration of the blood product.

Monitor appropriate laboratory values and document effective- ness of treatment related to the specific type of blood product.

Reactions to the Transfusion If a transfusion reaction occurs, stop the transfusion, change

the IV tubing down to the IV site, keep the IV line open with normal saline, notify the HCP and blood bank, and return the blood bag and tubing to the blood bank.

Do not leave the client alone, and monitor the client’s vital signs and monitor for any life-threatening signs or symptoms.

Obtain appropriate laboratory samples, such as blood and urine samples (free hemoglobin indicates that RBCs were hemo- lyzed), according to agency policies.

FIGURE 14-1 Tubing for blood administration has an in-line filter. (From Potter et al., 2013.)

BOX 14-2 Complications of a Blood Transfusion

▪ Transfusion reactions ▪ Circulatory overload ▪ Septicemia ▪ Iron overload

▪ Disease transmission ▪ Hypocalcemia ▪ Hyperkalemia ▪ Citrate toxicity

161CHAPTER 14 Administration of Blood Products

F

u

n

d

a

m

e

n

t

a

l

s

4. Delayed tran sfusion reaction s a . Reaction s can occur days to years after a

tran sfusion . b . Sign s in clude fever, m ild jaun dice, an d a

decreased h em atocrit level.

Stay with the client for the first 15 minutes of the infu- sion of blood and monitor the client for signs and symp- toms of a transfusion reaction; the first 15 minutes of the transfusion are the most critical, and the nurse must stay with the client. Vital signs are monitored every 30 minutes to one hour according to institutional protocol.

5. In terven tion s (see Priority Nu rsin g Action s)

Stop the transfusion immediately if a blood transfu- sion reaction is suspected.

PRIORITY NURSING ACTIONS Transfusion Reaction: Nursing Interventions 1. Stop the transfusion. 2. Change the intravenous (IV) tubing down to the IV site

and keep the IV line open with normal saline. 3. Notify the health care provider (HCP) and blood bank. 4. Stay with the client, observing signs and symptoms and

monitoring vital signs as often as every 5 minutes. 5. Prepare to administer emergency medications as

prescribed. 6. Obtain a urine specimen for laboratory studies (perform

any other laboratory studies as prescribed). 7. Return blood bag, tubing, attached labels, and transfu-

sion record to the blood bank. 8. Document the occurrence, actions taken, and the client’s

response.

If the client exhibits signs of a transfusion reaction, the nurse immediately stops the transfusion and changes the IV tubing down to the IV site to prevent the entrance of addi- tional blood solution into the client. Normal saline solution is hung and infused to keep the IV line open in the event that emergency medications need to be administered. The HCP is notified and the nurse also notifies the blood bank of the occurrence. The nurse stays with the client and monitors the client closely while other personnel obtain needed sup- plies to treat the client. As prescribed by the HCP, the nurse administers emergency medications such as antihistamines, vasopressors, fluids, and corticosteroids. The nurse then obtains a urine specimen for laboratory studies and any other laboratory studies as prescribed to check for free hemoglobin indicating that red blood cells were hemolyzed. The blood bag, tubing, attached labels, and transfusion record are returned to the blood bank so that the blood bank can check the items to determine the reason that the reaction occurred. Finally the nurse documents the occurrence, actions taken, and the client’s response.

Reference Ignatavicius, Workman (2016), pp. 824-825.

B. Circulatory overload 1. Description : Caused by th e in fusion of blood at a

rate too rapid for th e clien t to tolerate 2. Assessm en t

a . Cough , dyspn ea, ch est pain , an d wh eezin g on auscultation of th e lun gs

b . Headach e c. Hyperten sion d . Tach ycardia an d a boun din g pulse e. Disten d ed n eck vein s

3. In terven tion s a . Slow th e rate of in fusion . b . Place th e clien t in an uprigh t position , with

th e feet in a depen den t position . c. Notify th e HCP. d . Adm in ister oxygen , diuretics, an d m orph in e

sulfate, as prescribed. e. Mon itor for dysrh yth m ias. f. Ph leboto m y also m ay be a m eth od of pre-

scrib ed treatm en t in a severe case.

If circulatory overload is suspected, immediately slow the rate of infusion and place the client in an upright position, with the feet in a dependent position.

C. Septicemia 1. Description : O ccurs with th e tran sfusio n of

blood th at is con tam in ated with m icro organ ism s 2. Assessm en t

a . Rapid on set of ch ills an d a h igh fever b . Vom itin g c. Diarrh ea d . Hypoten sion e. Sh ock

3. In terven tion s a . Notify th e HCP. b . O btain blood cultures an d cultures of th e

blood bag. c. Adm in ister oxygen , IV fluids, antibiotics, vaso-

pressors, an d corticosteroids as prescribed. D. Iron overload

1. Description : A delayed tran sfusion com plication th at occurs in clien ts wh o receive m ultiple blood tran sfusion s, such as clien ts with an em ia or th rom bocytop en ia

2. Assessm en t a . Vom itin g b . Diarrh ea c. Hypoten sion d . Altered h em atological values

3. In terven tion s a . Deferoxam in e, adm in istered in traven ously or

subcu tan eously, rem oves accu m ulated iron via th e kidn eys.

b . Urin e turn s red as iron is excreted after the ad- m in istration of deferoxam in e; treatm en t is dis- con tin ued wh en serum iron levels return to n orm al.

162 UNIT III Nursing Sciences

F

u

n

d

a

m

e

n

t

a

l

s

Contact the HCP immediately if a transfusion reac- tion or a complication of blood administration arises.

E. Disease tran sm issio n 1. Th e disease m ost com m on ly tran sm itted is h ep-

atitis C, wh ich is m an ifested by an orexia, n ausea, vo m itin g, dark urin e, an d jaun dice; th e sym p- tom s usually occur with in 4 to 6 weeks after th e tran sfusion .

2. O th er in fectio us agen ts an d diseases tran sm itted by blood tran sfusion in clude h epatitis B virus, h um an im m un od eficien cy virus (HIV), h um an h erpes virus type 6, Epstein -Barr virus, h um an T-cell leukem ia, cytom egalovirus, an d m alaria.

3. Do n or screen in g h as greatly reduced th e risk of tran sm issio n of in fectio us agen ts; in addition , an tibody testin g of don ors for HIV h as greatly reduced th e risk of tran sm ission .

F. Hypo calcem ia 1. Citrate in tran sfused blood bin d s with calcium

an d is excreted. 2. Assess serum calcium level befo re an d after th e

tran sfusion . 3. Mon itor for sign s of h ypo calcem ia (h yperactive

reflexes, paresth esias, tetan y, m uscle cram p s, positive Trousseau’s sign , positive Ch vostek’s sign ) .

4. Slo w th e tran sfusion an d n otify th e HCP if sign s of h ypo calcem ia occur.

G. Hyperkalem ia 1. Stored blood liberates potassium th rough

h em olysis. 2. Th e older th e blood, th e greater th e risk of h yper-

kalem ia; th erefore, clien ts at risk for h yperkale- m ia, such as th ose with ren al in sufficien cy or ren al failure, sh ould receive fresh blood.

3. Assess th e date on th e blood an d th e serum potassium level befo re an d after th e tran sfusion .

4. Mon itor th e potassiu m level an d for sign s an d sym ptom s of h yperkalem ia (paresth esias, weak- n ess, abdom in al cram p s, diarrh ea, an d dysrh yth m ias).

5. Slo w th e tran sfusion an d n otify th e HCP if sign s of h yperkalem ia occur.

H. Citrate toxicity 1. Citrate, th e an ticoagulan t used in blood prod-

ucts, is m etab olized by th e liver. 2. Rap id ad m in istratio n o f m u ltip le u n its o f

sto red b lo o d m ay cau se h yp o calcem ia an d h yp o m agn esem ia wh en citrate b in d s calciu m an d magnesium; th is resu lts in citrate to xicity, cau sin g m yo card ial d ep ressio n an d co agu lo p ath y.

3. Th ose m ost at risk in clude in dividuals with liver dysfun ction or n eon ates with im m ature liver fun ction .

4. Treatm en t in cludes slowin g or stopp in g th e tran sfusion to allow th e citrate to be m etabo- lized; h ypo calcem ia an d h ypom agn esem ia are also treated with replacem en t th erapy.

CRITICAL THINKING What Should You Do? Answer: Signs of an immediate transfusion reaction include the following: chills and diaphoresis; muscle aches, back pain, or chest pain; rash, hives, itching, and swelling; rapid, thready pulse; dyspnea, cough, or wheezing; pallor and cyanosis; apprehension; tingling and numbness; headache; and nausea, vomiting, abdominal cramping, and diarrhea. In the event that a transfusion reaction is suspected, the nurse should first stop the infusion. The nurse should then change the intravenous (IV) tubing down to the IVsite, keep the IVline open with nor- mal saline, notify the health care provider and the blood bank, and return the blood bag and the tubing to the blood bank. The nurse should also collect a urine specimen. The nurse imple- ments prescriptions, stays with the client, and monitors the client closely until the client is stabilized.

Reference: Ignatavicius, Workman (20 16), pp. 824-825.

P R A C T I C E Q U E S T I O N S 116. Packed red blood cells h ave been prescribed for a

fem ale clien t with a h em oglobin level of 7.6 g/ d L (76 m m o l/ L) an d a h em atocrit level of 30% (0.30) . Th e n urse takes th e clien t’s tem p erature befo re h an gin g th e blood tran sfusion an d records 100.6 °F (38.1 °C) orally. Wh ich action sh ould th e n urse take? 1. Begin th e tran sfusio n as prescribed. 2. Adm in ister an an tih istam in e an d begin th e

tran sfusion . 3. Delay h an gin g th e blood an d n otify th e h ealth

care provid er (HCP) . 4. Adm in ister 2 tablets of acetam in oph en an d

begin th e tran sfusion .

117. Th e n urse h as received a prescription to tran sfuse a clien t with a un it of packed red blood cells. Before exp lain in g th e proced ure to th e clien t, th e n urse sh o uld ask wh ich in itial question ? 1. “H ave you ever h ad a tran sfusion befo re?” 2. “Wh y do you th in k th at you n eed th e

tran sfusion ?” 3. “Have you ever gon e in to sh ock for an y reason

in th e past?” 4. “Do you kn ow th e com plication s an d risks of a

tran sfusion ?”

118. A clien t receivin g a tran sfusion of packed red blood cells (PRBCs) begin s to vom it. Th e clien t’s blood pressure is 90/ 50 m m Hg fro m a baselin e of 125/ 78 m m Hg. Th e clien t’s tem perature is 100.8 °F

163CHAPTER 14 Administration of Blood Products

(38.2 °C) orally from a baselin e of 99.2 °F (37.3 °C) orally. Th e n urse determ in es th at th e clien t m ay be experien cin g wh ich com plication of a blood tran sfusion ? 1. Septicem ia 2. Hyperkalem ia 3. Circulatory overload 4. Delayed tran sfusion reaction

119. Th e n urse determ in es th at a clien t is h avin g a tran s- fusion reaction . After th e n urse stops th e tran sfu- sion , wh ich action sh ould be taken n ext? 1. Rem o ve th e in traven o us (IV) lin e. 2. Run a solution of 5% dextrose in water. 3. Run n orm al salin e at a keep-vein -open rate. 4. O btain a culture of th e tip of th e cath eter device

rem oved from th e clien t.

120. Th e n urse h as just received a un it of packed red blood cells from th e blood ban k for tran sfusion to an assign ed clien t. Th e n urse is careful to select tubin g especially m ade for blood produ cts, kn ow- in g th at th is tubin g is m an u factured with wh ich item ? Refer to figu res 1-4. 1.

2.

3.

4.

121. A clien t h as received a tran sfusion of platelets. Th e n urse evaluates th at th e clien t is ben efitin g m ost fro m th is th erap y if th e clien t exh ibits wh ich fin din g?

1. In creased h em atocrit level 2. In creased h em oglobin level 3. Declin e of elevated tem perature to n orm al 4. Decreased oozin g of blood from pun cture sites

an d gu m s

122. Th e n urse h as obtain ed a un it of blood from th e blood ban k an d h as ch ecked th e blood bag prop- erly with an oth er n urse. Just before begin n in g th e tran sfusion , th e n urse sh ould assess wh ich p ri- o rity item ? 1. Vital sign s 2. Skin color 3. Urin e outp ut 4. Latest h em atocrit level

123. Th e n urse h as just received a prescription to tran s- fuse a un it of packed red blood cells for an assign ed clien t. Wh at action sh ould th e n urse take n ext? 1. Ch eck a set of vital sign s. 2. O rder th e blood from th e blood ban k. 3. O btain Y-site blood adm in istration tubin g. 4. Ch eck to be sure th at con sen t for th e tran sfusio n

h as been sign ed .

124. Follo win g in fusion of a un it of packed red blood cells, th e clien t h as developed n ew on set of tach y- cardia, boun din g pulses, crackles, an d wh eezes. Wh ich action sh ould th e n urse im plem en t first? 1. Main tain bed rest with legs elevated . 2. Place th e clien t in h igh -Fowler’s position . 3. In crease th e rate of in fusion of in traven ous fluids. 4. Con sult with th e h ealth care provider (HCP)

regardin g in itiation of oxygen th erapy.

125. Th e n urse, listen in g to th e m orn in g report, learn s th at an assign ed clien t received a un it of gran ulo- cytes th e previous even in g. Th e n urse m akes a n ote to assess th e results of wh ich daily serum labora- tory studies to assess th e effectiven ess of th e tran sfusion ? 1. Hem atocrit level 2. Eryth rocyte coun t 3. Hem oglobin level 4. Wh ite blood cell coun t

126. A clien t is brough t to th e em ergen cy dep artm en t h avin g experien ced blood loss related to an arterial laceration . Wh ich blood com po n en t sh ould th e n urse expect th e h ealth care provider to prescribe? 1. Platelets 2. Gran ulocytes 3. Fresh -frozen plasm a 4. Packed red blood cells

127. Th e n urse wh o is about to begin a blood tran sfu- sion kn ows th at blood cells start to deterio rate after

F

u

n

d

a

m

e

n

t

a

l

s

164 UNIT III Nursing Sciences

a certain period of tim e. Th e n urse takes wh ich action s in order to preven t a com plication of th e blood tran sfusion as it relates to deterio ration of blood cells? Select all th at ap p ly.

1. Ch ecks th e expiration date 2. In spects for th e presen ce of clo ts 3. Ch ecks th e blood grou p an d type 4. Ch ecks th e blood iden tification n um ber 5. Han gs th e blood with in th e specified tim e

fram e per agen cy policy

128. A clien t requirin g surgery is an xious about th e possible n eed for a blood tran sfusio n durin g or after th e proced ure. Th e n urse suggests to th e cli- en t to take wh ich action s to reduce th e risk of pos- sible tran sfusio n com plication s? Select all th at ap p ly.

1. Ask a fam ily m em ber to don ate blood ah ead of tim e.

2. Give an autologous blood don atio n before th e surgery.

3. Take iron supp lem en ts before surgery to boost h em oglobin levels.

4. Requ est th at an y don ated blood be screen ed twice by th e blood ban k.

5. Take ad equate am oun ts of vitam in C several days prio r to th e surgery date.

129. A clien t with severe blood lo ss resultin g fro m m ul- tiple traum a requires rapid tran sfusion of several un its of blood. Th e n urse asks an oth er h ealth team m em ber to obtain wh ich device for use durin g th e

tran sfusion proced ure to h elp reduce th e risk of cardiac dysrh yth m ias? 1. In fusion pum p 2. Pulse oxim eter 3. Cardiac m on itor 4. Bloo d-warm in g device

130. A clien t h as a prescription to receive a un it of packed red blood cells. Th e n urse sh ould obtain wh ich in traven ous (IV) solution fro m th e IV stor- age area to h an g with th e blood produ ct at th e clien t’s bedside? 1. Lactated Rin ger’s 2. 0.9% sodium ch loride 3. 5% dextrose in 0.9% sodium ch loride 4. 5% dextrose in 0.45% sodium ch loride

131. Th e n urse is carin g for a clien t wh o is receivin g a blood tran sfusion an d is com plain in g of a cough . Th e n urse ch ecks th e clien t’s vital sign s, wh ich in clude tem p erature of 97.2 °F (36.2 °C), pulse of 108 beats per m in ute, blood pressure of 152/ 76 m m Hg, respiratory rate of 24 breath s per m in ute, an d an oxygen saturatio n level of 95% on room air. Th e clien t den ies pain at th is tim e. Based on th is in form ation , wh at in itial action sh o uld th e n urse take? 1. Collect a urin e sam ple for an alysis. 2. Place th e clien t in an uprigh t position . 3. Com pare cu rren t data to baselin e data. 4. Slow th e rate of th e blood tran sfusion .

A N S W E R S 116. 3 Ra t ion a le: If th e clien t h as a tem perature h igh er th an 100 °F (37.8 °C), th e u n it o f bloo d sh ou ld n ot b e h u n g un til th e HCP is n o tified an d h as th e op po rtu n ity to give furth er p re- scription s. Th e HCP likely will p rescribe th at th e bloo d b e ad m in istered regard less of th e tem perature, o r m ay in stru ct th e n u rse to ad m in ister prescrib ed acetam in o ph en an d wait un til th e tem p eratu re h as decreased b efo re ad m in istration , bu t th e d ecisio n is n o t with in th e n u rse’s scop e of p ractice to m ake. Th e n urse n eed s an HCP’s prescrip tion to ad m in ister m ed ication s to th e clien t. Test -Ta kin g St r a t egy: Elim in ate all op tio n s th at in d icate to begin th e tran sfusio n , n o tin g th at th ey are co m p a r a b le o r a lik e. In add itio n , th e op tion s in clud in g an tih istam in e an d acetam in o ph en in dicate adm in isterin g m edicatio n to th e cli- en t, wh ich is n ot d on e with ou t an HCP’s prescrip tion . Review: Nu rsin g respo n sib ilities related to b lo o d t r a n sfu sio n Level of Cogn it ive Ability: Syn th esizin g An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Blo od Ad m in istration

Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Lewis et al (2014), p . 677.

117. 1 Ra t ion a le: Askin g the clien t about person al experien ce with tran sfusion th erapy pro vides a good startin g poin t for clien t teach in g about th is p ro cedure. Q uestio n in g abo ut p revio us h is- tory of sh o ck an d kn o wledge o f com plication s an d risks o f tran s- fusion is n ot h elpfu l b ecause it m ay elicit a fearful respon se fro m th e clien t. Altho ugh d eterm in in g wh eth er th e clien t kn ows th e reason for th e tran sfusion is im p ortan t, it is n ot an appropriate statem en t in term s o f elicitin g in fo rm ation fro m th e clien t regard in g an u n derstan d in g of th e n eed for th e tran sfu sion . Test -Ta kin g St r a t egy: No te th e st r a t egic wo r d , initial. Th is tells yo u th at th e co rrect o p tion is th e best startin g p o in t fo r d iscus- sion abo ut th e tran sfusio n th erapy. Elim in ate th e op tion s th at h ave em o tio n ally lad en trigger wo rd s, in clud in g gone into shock an d risks, wh ich m ake th em in co rrect. Fro m th e rem ain in g o p tion s, focus o n th e st r a t egic wo r d an d use t h er a p eu t ic co m - m u n ica t io n t ech n iq u es to d irect you to th e co rrect o p tion . Review: Blo o d t r a n sfu sio n proced ures Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Ph ysio lo gical In tegrity

F

u

n

d

a

m

e

n

t

a

l

s

165CHAPTER 14 Administration of Blood Products

In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Ign ataviciu s, Wo rkm an (2016), p . 117; Perry, Po tter, O sten d o rf (2014), p . 31.

118. 1 Ra tion a le: Sep ticem ia o ccu rs with th e tran sfusion o f bloo d con tam in ated with m icro organ ism s. Sign s in clu de ch ills, fever, vo m itin g, d iarrh ea, h yp oten sion , an d th e d evelop m en t of sh o ck. Hyperkalem ia cau ses weakn ess, p aresth esias, ab do m i- n al cram ps, diarrh ea, an d d ysrh yth m ias. Circulato ry o verload causes co ugh , d yspn ea, ch est pain , wh eezin g, tach ycardia, an d h yp erten sio n . A d elayed tran sfusion reaction can occur d ays to years after a tran sfusion . Sign s in clu d e fever, m ild jau n d ice, an d a decreased h em ato crit level. Test-Ta kin g Str a tegy: Fo cus on th e su b ject , a com plicatio n of a bloo d tran sfu sion . No tin g th at th e clien t’s tem perature is ele- vated will direct yo u to th e correct o ptio n . Review: Co m p lica t io n s o f b lo o d t r a n sfu sio n s Level of Cogn it ive Abilit y: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; In fection Refer en ce: Perry, Po tter, O sten d orf, (2014), p . 742.

119. 3 Ra tion a le: If th e n urse su spects a tran sfusio n reaction , th e n u rse sto ps th e tran sfusion an d in fu ses n orm al salin e at a keep-vein -op en rate p en d in g fu rth er h ealth care provid er pre- scrip tio n s. Th is m ain tain s a p aten t IV access lin e an d aids in m ain tain in g th e clien t’s in travascu lar vo lum e. Th e n urse wou ld n o t rem ove th e IV lin e b ecause th en th ere wo uld b e n o IV access rou te. O b tain in g a cu ltu re of th e tip of th e cath eter d evice rem oved fro m th e clien t is in co rrect. First, th e cath eter sh o u ld n o t b e rem oved . Seco n d , cultu res are p erfo rm ed wh en in fectio n , n o t tran sfu sio n reactio n , is susp ected. Norm al salin e is th e solutio n of ch o ice over solutio n s co n tain in g dextro se b ecau se salin e do es n o t cau se red bloo d cells to clu m p. Test-Ta kin g St r a tegy: Note the st r at egic wo r d , next. Knowin g th at th e IV lin e should n ot be rem o ved assists in elim in atin g th e o ptio n s d irectin g th e n urse to d isco ntin ue th e d evice. Recallin g th at n orm al salin e, n ot dextrose, is used wh en adm in isterin g a u n it o f b lood will direct you to th e correct option . Review: Tr a n sfu sio n r ea ct io n s Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), p. 741.

120. 3 Ra tion a le: Th e tub in g u sed fo r blo od adm in istratio n h as an in - lin e filter. Th e filter h elps to en sure th at an y p articles larger th an th e size o f the filter are caught in th e filter an d are n ot in fu sed in to th e clien t. Tin ted tubin g (o ptio n 2) is in correct because b lood does n ot n eed to b e pro tected fro m ligh t. The tub in g

sho uld b e m acro drip , n ot m icro drip (option 4), to allow blood to flow freely th rou gh th e drip ch am b er. An air ven t ( op tio n 1) is u nn ecessary because the b lo od b ag is n ot m ade of glass. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject , in traven o us tub - in g used to adm in ister bloo d. Lo o k at each op tio n carefully an d visualize th e pro cess of b lo od adm in istratio n . Rem em ber th at tu bin g u sed for b lo od ad m in istration h as an in -lin e filter. Review: Blo o d a d m in ist r a t io n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Ign ataviciu s, Wo rkm an (2016), p . 822; Perry, Po tter, O sten d orf (2014), p . 744.

121. 4 Ra tion a le: Platelets are n ecessary fo r p ro per b loo d clo ttin g. Th e clien t with in sufficien t p latelets m ay exh ib it fran k bleedin g o r o o zin g of blo od fro m pu n cture sites, wou n d s, an d m ucou s m em bran es. In creased h em oglo bin an d h em ato crit levels would occur wh en th e clien t h as received a tran sfusion of red blood cells. An elevated tem p eratu re wo uld declin e to n or- m al after in fusion of gran u lo cytes b ecau se th ese cells were in stru m en tal in figh tin g in fectio n in th e b od y. Test-Ta kin g Str a tegy: Use kn owled ge regardin g th e p oten tial u ses an d b en efits o f th e variou s types o f b loo d p ro du ct tran s- fu sion s. Elim in ate in creased h em ato crit an d in creased h em o- glo bin first b ecause th ey are co m p a r a b le o r a lik e. From th e rem ain in g option s, recallin g th at p latelets are n ecessary for p ro per b lo od clo ttin g will direct yo u to th e correct o ptio n . Review: Typ es o f b lo o d p r o d u ct s Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 824.

122. 1 Ra tion a le: A ch an ge in vital sign s d urin g th e tran sfu sion from b aselin e m ay in dicate th at a tran sfusion reactio n is occu rrin g. Th is is wh y th e n urse assesses vital sign s befo re th e p ro cedu re an d again after th e first 15 m in utes an d th ereafter per agen cy p olicy. Th e o th er o ptio n s d o n ot id en tify assessm en ts th at are a p rio rity ju st before b egin n in g a tran sfusion . Test-Ta king Str a t egy: Note th e st r at egic wo r d , priority. Th is tells you that m o re th an on e o f th e o ptio n s m ay b e partially o r totally correct an d th at th e correct o ptio n n eeds to be assessed fo r possible com pariso n d urin g th e tran sfu sion . Use th e ABCs— air way, b r ea th in g, a n d cir cu la tio n —to d irect you to th e cor- rect optio n . Review: Blo o d t r a n sfu sio n s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Lewis et al. (2014), p p . 677-679; Perry, Po tter, O sten d orf (2014), p . 744.

F

u

n

d

a

m

e

n

t

a

l

s

166 UNIT III Nursing Sciences

123. 4 Ra t ion a le: After receivin g a prescrip tion fo r a b lo od tran sfu - sion , th e first actio n th e n u rse sh o uld take sh ou ld b e to ch eck to b e su re th at co n sen t fo r th e tran sfusion h as been sign ed by th e clien t. If th e clien t h as co n sen ted, th e n urse sh o uld th en ch eck a set of vital sign s to be sure th ere is n o con train dicatio n fo r a tran sfu sio n at th at tim e, su ch as an elevatio n in tem per- atu re. If th e vital sign s are acceptab le, th e n u rse can th en gath er sup plies to ad m in ister th e tran sfusio n an d ord er th e b lo od fro m th e b loo d b an k. Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d , next. Th is wo rd tells yo u th at all op tio n s m ay b e p artially or to tally co r- rect, an d you n eed to ch oose th e best next ch o ice. Th e n u rse sh ou ld n o t take an y p ro cedu ral step s u n til th e clien t h as co n - sen ted to th e b loo d tran sfusion . Review: Blo o d t r a n sfu sio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Critical Care—Blo od Ad m in istration Pr ior ity Con cepts: Care Co ordin ation ; Health Care Law Refer en ce: Ign atavicius, Workm an (2016), p p. 226, 822.

124. 2 Ra t ion a le: New on set of tach ycardia, b ou n d in g p u lses, an d crackles an d wh eezes p o sttran sfu sio n is eviden ce of fluid over- load , a co m plicatio n asso ciated with blo o d tran sfusio n s. Plac- in g th e clien t in a h igh -Fowler’s (up righ t) p osition will facilitate b reath in g. Measu res th at in crease b loo d return to th e h eart, su ch as leg elevation an d ad m in istration of IV flu id s, sh ou ld be avo ided at th is tim e. In ad dition , adm in istratio n o f fluid s can n ot b e in itiated with ou t a prescrip tio n . Con sultin g with th e HCP regardin g adm in istratio n o f o xygen m ay b e n ec- essary, b ut p o sitio n al ch an ges take a sh ort am o u n t o f tim e to do an d sh ou ld be in itiated first. Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d , first. Ap p ly kn o wledge of sign s an d sym pto m s of circu latory overlo ad an d u se th e ABCs—a ir wa y, b r ea t h in g, a n d cir cu la t io n —to assist yo u with selectin g th e priority actio n . Rem em ber th at placin g th e clien t in a h igh -Fowler’s (up righ t) po sitio n will facilitate b reath in g. Review: Sign s o f cir cu la t o r y o ver lo a d an d associated n u rsin g actio n s Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Blo od Ad m in istration Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Perry, Potter, O sten do rf (2014), p . 742.

125. 4 Ra t ion a le: Th e clien t wh o h as n eutrop en ia m ay receive a tran sfu sio n of gran u lo cytes, o r WBCs. Th ese clien ts o ften h ave severe in fection s an d are u n respo n sive to an tib io tic th erap y. Th e n u rse n o tes th e results of follow-up WBC cou n ts an d differen tial to evaluate th e effectiven ess of th e th erapy. Th e n urse also co n tin ues to m on itor th e clien t fo r sign s an d sym p- to m s of in fection . Eryth ro cyte cou n t an d h em o glob in an d h em atocrit levels are d eterm in ed after tran sfusion of packed red bloo d cells.

Test -Ta kin g St r a t egy: Note th e st r a t egic wo r d , effectiveness. Recallin g th at gran u locytes are a com p on en t o f WBCs will assist in d irectin g yo u to th e co rrect o p tion . In add itio n , n o te th at th e rem ain in g o p tion s are co m p a r a b le o r a lik e in th at th ese o p tion s all refer to red blo o d cells. Review: Typ es o f b lo o d p r o d u ct s an d gr a n u lo cyt es Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Critical Care—Blo od Ad m in istration Pr ior ity Con cepts: Evid en ce; In fectio n Refer en ce: Lewis et al. (2014), p. 676.

126. 3 Ra t ion a le: Fresh -fro zen p lasm a is o ften u sed for volum e expan sion as a result of flu id an d b lo od lo ss. It is rich in clo t- tin g facto rs an d can b e th awed qu ickly an d tran sfu sed qu ickly. Platelets are used to treat th ro m b ocytop en ia an d p latelet dys- fu n ctio n . Gran u lo cytes m ay b e used to treat a clien t with sepsis o r a n eu tro p en ic clien t with an in fectio n th at is u n respo n sive to an tibiotics. Packed red blo od cells are a b lo od p ro du ct used to rep lace eryth ro cytes. Test -Ta kin g Str a t egy: Fo cus o n th e s u b ject , th e type of tran s- fu sio n th erap y for th e clien t experien cin g b loo d lo ss. Note th e relatio n sh ip between th e wo rd s experienced blood loss an d th e word plasma co rrect o p tion . Review: Fr esh -fr o zen p la sm a Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Critical Care—Blo od Ad m in istration Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p. 676.

127. 1, 5 Ra t ion a le: Th e n u rse n otes th e exp iration d ate o n th e u n it o f b lo od to en sure th at th e b lo od is fresh . Bloo d cells begin to d eteriorate o ver tim e, so safe sto rage usu ally is lim ited to 35 days. Carefu l n otatio n o f th e expiratio n d ate by th e n u rse is an essen tial p art of th e verification process befo re h an gin g a u n it o f b loo d. Th e n urse also n eeds to h an g th e b lo od with in th e specified tim e fram e after receivin g it fro m th e b loo d b an k p er agen cy po licy to en sure th at th e b loo d bein g tran sfu sed is fresh . Th e blo o d b an k keep s th e bloo d regulated at a specific tem p eratu re, an d th erefo re it m u st b e in fu sed with in a sp eci- fied tim e fram e o n ce received o n th e u n it. Th e n u rse also n otes th e bloo d id en tificatio n (u n it) n u m b er, b lo od gro up an d typ e, an d clien t’s n am e, bu t th is is n o t sp ecifically related to th e degradatio n of b loo d cells. Th e n urse also in sp ects th e u n it of b lo od for leaks, ab n o rm al co lo r, clo ts, an d b ub b les an d return s th e u n it to th e b lo od b an k if clots are n oted . Again , th is is n o t related to th e d egrad ation o f b lo od cells o ver tim e. Test -Ta kin g Str a tegy: Focu s on th e su b ject , m easures to verify p rior to blo o d ad m in istration . Note th e wo rd deteriorate. To an swer th is q u estion co rrectly, yo u m u st kn o w wh ich part o f th e p retran sfu sio n verification p rocedu re relates to th e freshness o f th e un it of b lo od . Keepin g th is in m in d sh o uld d irect you to th e co rrect o p tion s. Review: Blo o d t r a n sfu sio n

F

u

n

d

a

m

e

n

t

a

l

s

167CHAPTER 14 Administration of Blood Products

Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 744-745.

128. 1, 2 Ra tion a le: A don atio n of th e clien t’s own blood before a sch ed uled proced ure is au tolo go us. Don atin g au to logo us b loo d to be rein fu sed as n eeded du rin g or after su rgery redu ces th e risk of d isease tran sm ission an d p oten tial tran sfu sio n com - p lication s. Th e n ext m o st effective way is to ask a fam ily m em - b er to do n ate b lo od before su rgery. Blo od ban ks d o n o t p ro vide extra screen in g on req uest. Preo perative iron su p ple- m en ts are h elp fu l fo r iron d eficien cy an em ia b ut are n ot h elp - fu l in replacin g b loo d lo st d urin g th e su rgery. Vitam in C en h an ces iro n ab sorption , bu t also is n o t h elp fu l in replacin g b loo d lo st d u rin g surgery. Test-Ta kin g Str a tegy: Fo cus on th e su b ject , red ucin g th e risk o f p ossible tran sfu sion co m p licatio n s. Recallin g th at an au to l- o gou s tran sfu sion is th e collectio n o f th e clien t’s own bloo d an d also th at fam ily do n atio n of blo o d is u sually effective will d irect yo u to th e co rrect o p tion s. Review: Blo o d d o n a t io n p r o ced u r es Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: An xiety; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 825-826.

129. 4 Ra tion a le: If several un its o f blo o d are to b e ad m in istered rap- id ly, a b loo d warm er sh ou ld b e u sed. Rap id tran sfusio n of coo l b loo d p laces th e clien t at risk fo r card iac d ysrh yth m ias. To pre- ven t th is, th e n urse warm s th e b loo d with a b lo od -warm in g d evice. Pulse oxim etry an d card iac m o n ito rin g equ ip m en t are u sefu l fo r th e early assessm en t of com p lication s b u t d o n o t red uce th e o ccurren ce of cardiac d ysrh yth m ias. Electro n ic in fusio n d evices are n ot h elp ful in th is case b ecause th e in fu- sio n m u st be rap id , an d in fusion d evices gen erally are u sed to con tro l th e flo w rate. In add itio n , n ot all in fu sio n d evices are m ad e to h an d le b lo od o r b lo od p rod ucts. Test-Ta kin g St r a t egy: No te th e wo rd s rapid an d reduce the risk. Th ese words tell you th at th e b loo d will in fu se q uickly an d th at th e correct o ptio n is th e on e th at will m in im ize th e risk o f car- d iac d ysrh yth m ias. Elim in ate th e pu lse oxim eter an d card iac m on itor first b ecau se th ese item s are co m p a r a b le o r a lik e an d are u sed to assess fo r rath er th an red uce th e risk o f co m p li- cation s. Fro m th e rem ain in g op tion s, use kn owled ge related to th e com p lication s of tran sfu sio n th erap y an d n ote th e relation - sh ip b etween th e words several units of blood in th e q uestion an d blood-warming device in th e co rrect o p tion . Review: Blo o d t r a n sfu sio n s Level of Cogn it ive Abilit y: Ap p lyin g

Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Perfu sion ; Th erm oregulatio n Refer en ce: Lewis et al. (2014), p . 679.

130. 2 Ra tion a le: So diu m ch lo ride 0.9% (n orm al salin e) is a stan - d ard iso ton ic solutio n u sed to p reced e an d follow in fu sio n o f b loo d prod u cts. Dextro se is n o t used b ecau se it cou ld result in clu m p in g an d su bseq u en t h em o lysis o f red blo od cells (RBCs). Lactated Rin ger’s is n o t th e so lutio n o f ch o ice with th is p ro ced ure. Test-Ta kin g St r a t egy: Elim in ate op tio n s th at con tain dextro se first because th ey are co m p a r a b le o r a lik e. Fro m th e rem ain - in g op tio n s, rem em ber th at n orm al salin e is an iso ton ic so lu- tio n an d th e so lu tion co m p atib le with RBCs. Review: Blo o d t r a n sfu sio n p ro cedu res Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 825.

131. 3 Ra tion a le: Fo r th e clien t receivin g a b loo d tran sfusio n , th e n u rse sh o uld m on itor fo r po ten tial co m p licatio n s of a tran sfu- sio n . O n e of th e co m p lication s is circulato ry overlo ad . Sign s an d sym pto m s o f circulato ry overlo ad in clu de cou gh , dysp n ea, ch est pain , wh eezin g o n auscu ltation o f th e lu n gs, h ead ach e, h yp erten sio n , tach ycard ia an d a bo u n d in g p ulse, an d d is- ten d ed n eck vein s. Based o n th e d ata in th e q uestion , th e n urse sh o u ld com p are cu rren t data to b aselin e d ata. Th e n urse sh o u ld also furth er assess th e clien t for o th er sign s an d sym p - to m s o f circulatory o verlo ad. If th e n urse still su sp ects th is com plicatio n after co m p arin g to baselin e data, th e n urse sh o u ld th en p lace th e clien t in an up righ t p osition with th e feet in a dep en d en t po sitio n an d slo w th e rate of th e in fu sio n . Co l- lectio n of a urin e sam ple sh o uld o ccu r if th e n u rse susp ects a tran sfusio n reactio n , such as a h em o lytic reaction . Test-Ta kin g St r a t egy: No te th e st r a t egic wo r d , initial. Th is wo rd in d icates th at so m e o r all o f th e o ptio n s m ay b e p artially o r to tally co rrect, b ut th e n urse n eed s to p rio ritize. Also , d et er - m in e if a n a b n o r m a lit y exist s . No tin g th at th e clien t is com - p lain in g o f cou gh an d th e vital sign s are sligh tly abn orm al sh o u ld h elp you to determ in e th at fu rth er assessm en t is n eed ed at th is tim e. Review: Actio n s to take if a b lo o d t r a n sfu sio n co m p lica t io n is susp ected Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Bloo d Adm in istratio n Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 825.

F

u

n

d

a

m

e

n

t

a

l

s

168 UNIT III Nursing Sciences

UNIT IV

Fundamentals of Care

Pyramid to Success

O n th e NCLEX-RN®, safety an d infection con trol con - cepts, includin g stan dard precaution s and tran sm ission- based precaution s, related to clien t care are a priority focus. Medication or in traven ous (IV) calculation ques- tion s are also a focus on th e NCLEX-RN exam in ation . Fill-in -th e-blan k question s m ay require that you calculate a m edication dose or an IV flow rate. Use th e on -screen calculator for th ese m edication and IV problem s an d then rech eck the calculation before selectin g an option or typ- ing th e an swer.

Th e Pyram id to Success also focuses on th e proce- dures for perform in g a h ealth an d ph ysical assessm en t of th e ad ult clien t an d collectin g both subjective an d objective data. Perioperative n ursin g care an d m on itor- in g for posto perative com plication s is a prio rity. Clien t safety related to position in g an d am bulation , an d care to th e clien t with a tube such as a gastro in testin al tube or ch est tube are im portan t con cepts ad dressed on th e NCLEX. Because m an y surgical proced ures are per- form ed th rou gh am bulatory care un its (1-day-stay un its), Pyram id Poin ts also focus on preparin g th e clien t for disch arge, teach in g related to th e prescribed treat- m en ts an d m edication s, follow-up care, an d th e m obili- zation of h om e care supp ort services.

Client Needs: Learning Objectives Safe and Effective Care Environment Actin g as an advocate regardin g th e clien t’s wish es Collaboratin g with in terprofession al h ealth care m em bers En surin g en viron m en tal, perso n al, an d h om e safety En surin g th at th e clien t’s righ ts, in cludin g in form ed con -

sen t, are uph eld Establish in g priorities of assessm en ts an d in terven tion s Followin g advan ce directives regardin g th e clien t’s docu-

m en ted requests

Fo llo win g gu id elin es regard in g th e u se o f safety d evices

Han dlin g h azardous an d in fectio us m aterials safely In form in g th e clien t of th e surgical process an d en surin g

th at in form ed con sen t for a surgical proced ure an d oth er proced ures h as been obtain ed

Kn owin g th e em ergen cy respon se plan an d action s to take for exposure to biological an d chem ical warfare agen ts

Main tain in g con fiden tiality Main tain in g con tin uity of care an d in itiatin g referrals to

h om e care an d oth er support services Main tain in g precaution s to preven t errors, acciden ts,

an d in ju ry Position in g th e clien t ap propriately an d safely Preparin g an d adm in isterin g m edication s, usin g th e

righ ts of m edication adm in istration Preven tin g a surgical in fectio n Protectin g th e m edicated clien t fro m in jury Uph oldin g th e clien t’s righ ts Usin g equ ipm en t safely Usin g ergon om ic prin ciples an d body m ech an ics wh en

m ovin g a clien t Usin g stan dard an d tran sm ission -based precaution s an d

surgical asepsis proced ures

Health Promotion and Maintenance Assistin g clien ts an d fam ilies to id en tify en viron m en tal

h azards in th e h om e Perform in g h om e safety assessm en ts Perform in g th e tech n iqu es associated with th e h ealth

an d ph ysical assessm en t of th e clien t Providin g h ealth an d welln ess teach in g to preven t

com plication s Discussin g h igh -risk beh aviors an d lifestyle ch oices Respectin g lifestyle ch oices an d h ealth care beliefs an d

preferen ces Teach in g clien ts an d fam ilies about acciden t preven tion Teach in g clien ts an d fam ilies about m easu res to be

im plem en ted in an em ergen cy or disaster

F

u

n

d

a

m

e

n

t

a

l

s

169

Teach in g clien ts an d fam ilies about preven tin g th e spread of in fectio n an d preven tin g diseases

Teach in g th e clien t about prescribed m edication (s) or IV th erap y

Psychosocial Integrity Assessin g an d m an agin g th e clien t with sen sory an d per-

ception alteration s Discussin g expected body im age ch an ges an d situation al

role ch an ges Facilitatin g clien t an d fam ily copin g Iden tifyin g supp ort system s Iden tifyin g th e cultural, religious, an d spiritual facto rs

in fluen cin g h ealth Keepin g th e fam ily in form ed of clien t progress Provid in g em o tion al supp ort to sign ifican t oth ers

Physiological Integrity Adm in isterin g m edication s an d IV th erapy safely Assessin g for expected an d un expected effects of ph ar-

m acological th erap y Assessin g th e m obility an d im m ob ility level of th e clien t Assistin g th e clien t with activities of daily livin g Calculatin g m ed ication doses an d IV flow rates Docum en tin g th e clien t’s respo n se to basic life supp ort

(BLS) m easu res Han dlin g m ed ical em ergen cies Iden tifyin g clien t allergies an d sen sitivities

Iden tifyin g th e adverse effects of an d con train dication s to m ed ication or IV th erap y

Im plem en tin g priority n ursin g action s in an em ergen cy or disaster

In itiatin g n ursin g in terven tion s wh en surgical com plication s arise

Man agin g an d providin g care to clien ts with in fectio us diseases

Mon itorin g for alteration s in body system s Mon itorin g for surgical com plication s Mon itorin g for woun d in fectio n Preparin g for diagn ostic tests to con firm accu rate place-

m en t of a tube Preven tin g th e com plication s of im m ob ility Prom otin g an en viron m en t th at will allow th e clien t to

express con cern s Providin g com fo rt an d assistan ce to th e clien t Providin g n utrition an d oral in take Providin g in terven tion s com patible with th e clien t’s age;

cultural, religious, spiritual an d h ealth care beliefs; education level; an d lan guage

Providin g perso n al h ygien e as n eeded Recogn izin g ch an ges in th e clien t’s con dition th at in di-

cate a poten tial com plication an d in terven in g appropriately

Usin g assistive devices to preven t in ju ry Usin g special equipm en t

170 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 15 Health and Physical Assessment

of the Adult Client PRIORITY CONCEPTS Clinical Judgment; Health Promotion

CRITICAL THINKING What Should You Do? The nurse is performing a cardiovascular assessment and notes the presence of a blowing, swishing sound over the carotid artery. What should the nurse do? Answer located on p. 188.

I. Environment/ Setting A. Establish a relation sh ip an d explain th e proced ure to

th e clien t. B. En su re privacy an d m ake th e clien t feel com fo rtable

(com fortable room tem p erature, sufficien t ligh tin g, rem ove distraction s such as n oise or objects, an d avoid in terrup tion s).

C. Sit down for th e in terview (avoid barriers such as a desk), m ain tain an ap propriate social distan ce, an d m ain tain eye level.

D. Use th erapeutic com m un ication tech n iqu es an d open -en ded question s to obtain in form ation about th e clien t’s sym pto m s an d con cern s; allow tim e for th e clien t to ask question s.

E. Co n sid er religio u s an d cu ltu ral ch aracteristics su ch as lan gu age ( th e n eed fo r an in terp reter) , valu es an d b eliefs, h ealth p ractices, eye co n tact, an d to u ch .

F. Keep n ote-takin g to a m in im u m so th e clien t is th e focus of atten tion .

G. Types of h ealth an d ph ysical assessm en ts ( Box 15-1)

II. Health History A. Gen eral state of h ealth : Body features an d ph ysical

ch aracteristics, body m ovem en ts, body posture, level of con scio usn ess, n utrition al status, speech

B. Ch ief com plain t an d h isto ry of presen t illn ess (doc- um en t direct clien t quotes) th at leads th e clien t to seek care

C. Fam ily h isto ry: Th e h ealth status of direct blood rel- atives as well as th e clien t’s spouse

D. Social h istory 1. Data ab out th e clien t’s lifestyle, with a focus on

facto rs th at m ay affect h ealth 2. In form ation ab out alcoh ol, drug, an d tobacco

use; sexual practices; tattoos; body piercin g; travel h istory; an d work settin g to iden tify occu- patio n al h azards

E. Dom estic violen ce screen in g 1. Do n e to determ in e wh eth er th e clien t is

experien cin g an y form of dom estic violen ce 2. Con ducted durin g a 1-to-1 in terview with

th e clien t wh ile obtain in g th e h ealth h isto ry

III. Mental Status Exam A. Th e m en tal status can be assessed wh ile obtain in g

subjective data fro m th e clien t durin g th e h ealth h is- tory in terview.

B. Appearan ce 1. No te appearan ce, in cludin g postu re, body m ove-

m en ts, dress, an d h ygien e an d groo m in g. 2. An in approp riate ap pearan ce an d poor h ygien e

m ay be in dicative of dep ression , m an ic disorder, dem en tia, organ ic brain disease, or an oth er disorder.

C. Beh avior 1. Level of con scio usn ess: Assess alertn ess an d

awaren ess an d th e clien t’s ability to in teract appropriately with th e en viron m en t.

2. Facial exp ression an d body lan guage: Ch eck for appropriate eye con tact an d determ in e wh eth er facial expressio n an d body lan guage are appro- priate to th e situation ; th is assessm en t also pro- vides in form ation regardin g th e clien t’s m ood an d affect.

3. Speech : Assess speech pattern for articulation an d appropriaten ess of con versation .

D. Cogn itive level of fun ction in g ( Box 15-2)

F

u

n

d

a

m

e

n

t

a

l

s

171

IV. Physical Exam A. O verview

1. Gath er equ ipm en t n eeded for th e exam in ation . 2. Use th e sen ses of sigh t, sm ell, touch , an d h earin g

to collect data. 3. Assessm en t in cludes inspection, palpation, per-

cussion, an d auscultation; th ese skills are per- form ed on e at a tim e, in th is order (except th e abdom in al assessm en t) .

B. Assessm en t tech n iqu es 1. In spection

a . Th e first assessm en t tech n iqu e, wh ich uses vision an d sm ell sen ses wh ile observin g th e clien t

b . Requ ires go od ligh tin g, adequ ate body exposu re, an d possibly th e use of certain in strum en ts such as an otosco pe or oph th al- m osco pe

2. Palp ation a . Uses th e sen se of touch ; warm th e h an ds

befo re touch in g th e clien t.

b . Iden tify ten der areas an d palpate th em last. c. Start with ligh t palp ation to detect surface

ch aracteristics, an d th en perform deeper palpation .

d . Ligh t palpation is don e with 1 h an d by pressin g th e skin gen tly with th e tips of 2 or 3 fingers h eld close togeth er; deep palpation is don e by placin g 1 h an d on top of th e oth er an d pressin g down with th e fin gertips of both h an ds.

e. Assess texture, tem perature, an d m oistu re of th e skin , as well as organ lo cation an d size an d sym m etry if appropriate.

f. Assess for swellin g, vibration or pulsation , rigidity or spasticity, an d crepitation .

g. Assess for th e presen ce of lum ps or m asses, as well as th e presen ce of ten dern ess or pain .

3. Percussion a . In volves tappin g th e clien t’s skin to assess

un derlyin g structures an d to determ in e th e presen ce of vibration s an d soun ds an d, if pre- sen t, th eir in ten sity, duration , pitch , quality, an d lo cation

b . Provid es in form ation related to th e presen ce of air, fluid, or solid m asses as well as organ size, sh ap e, an d position

c. Description s of fin din gs in clude reson an ce, h yperreson an ce, tym pan y, dulln ess, or flatn ess

4. Auscu ltation : In vo lves listen in g to soun ds pro- duced by th e body for presen ce an d quality, such as h eart, lu n g, or bowel soun ds

C. Vital sign s 1. In clu des tem perature, radial pulse (apical pulse

m ay be m easu red durin g th e cardiovascular assessm en t), respiration s, blood pressure, pulse oxim etry, an d presen ce of pain (refer to Ch apter 10 for in form ation on vital sign s, pulse oxim etry, an d pain )

2. Heigh t, weigh t, an d n utrition al status are also assessed.

V. Body Systems Assessment A. In tegum en tary system : In vo lves in spection an d pal-

pation of skin , h air, an d n ails. 1. Subjective data: Self-care beh aviors, h istory of

skin disease, m edication s bein g taken , en viron - m en tal or occupation al h azards an d exposu re to toxic substan ces, ch an ges in skin color or pig- m en tation , ch an ge in a m ole or a sore th at does n ot h eal

2. Objective data: Color, tem p erature (h ypoth erm ia or h yperth erm ia); excessive dryn ess or m oistu re; skin turgor; texture (sm ooth n ess, firm n ess); excessive bruisin g, itch in g, rash ; h air loss (alope- cia) or n ail abn o rm alities such as pittin g; lesion s (m ay be in spected with a m agn ifier an d ligh t or with th e use of a Wood ’s ligh t [u ltraviolet ligh t

F

u

n

d

a

m

e

n

t

a

l

s

BOX 15-1 Types of Health and Physical Assessments

Complete Assessment: Includes a complete health history and physical examination and forms a baseline database.

Focused Assessment : Focuses on a limited or short-term prob- lem, such as the client’s complaint.

Episodic/ Follow-up Assessment: Focuses on evaluating a cli- ent’s progress.

Emergency Assessment: Involves the rapid collection of data, often during the provision of life-saving measures.

BOX 15-2 The Mental Status Examination: Cognitive Level of Functioning

Orienta t ion: Assess client’s orientation to person, place, and time.

At tention Spa n: Assess client’s ability to concentrate. Recent Memory: Assessed by asking the client to recall a

recent occurrence (e.g., the means of transportation used to get to the health care agency for the physical assessment).

Remote Memory: Assessed by asking the client about a verifi- able past event (e.g., a vacation).

New Lea rning: Used to assess the client’s ability to recall unre- lated words identified by the nurse; the nurse selects 4 words and asks the client to recall the words 5, 10, and 30 minutes later.

Judgment: Determine whether the client’s actions or decisions regarding discussions during the interview are realistic.

Thought Processes a nd Perceptions: The way the client thinks and what the client says should be logical, coherent, and relevant; the client should be consistently aware of reality.

172 UNIT IV Fundamentals of Care

used in a darken ed room ]); scars or birth m arks; edem a; cap illary fillin g tim e (Boxes 15-3 an d 15-4; Table 15-1)

3. Dark-skin n ed clien t a. Cyan osis: Ch eck lips an d ton gue for a gray

color; n ail bed s, palm s, an d soles for a blue color; an d con jun ctivae for pallor.

b . Jau n dice: Ch eck oral m ucou s m em bran es for a yellow color; ch eck th e sclera n earest to th e iris for a yello w color.

c. Bleedin g: Look for skin swellin g an d darken - in g an d com pare th e affected side with th e un affected side.

d . In flam m ation : Ch eck for warm th or a sh in y or taut an d pittin g skin area, an d com pare with th e un affected side.

4. Refer to Ch apter 46 for diagn ostic tests related to th e in tegu m en tary system

To test skin turgor, pinch a large fold of skin and assess the ability of the skin to return to its place when released. Poor turgor occurs in severe dehydration or extreme weight loss.

5. Clien t teach in g a. Provide in form ation ab out facto rs th at can be

h arm ful to th e skin , such as sun exposu re.

b . En cou rage perform in g self-exam in ation of th e skin m on th ly.

B. Head, n eck, an d lym p h n odes: In volves in spection an d palpatio n of th e h ead, n eck, an d lym ph n od es 1. Ask th e clien t about h eadach es; episo des of diz-

zin ess (ligh th eadedn ess) or vertigo (spin n in g sen sation ); h istory of h ead in jury; loss of con - sciousn ess; seizures; episo des of n eck pain ; lim i- tatio n s of ran ge of m otion ; n um bn ess or tin glin g in th e sh oulders, arm s, or h an ds; lum ps or swell- in g in th e n eck; difficu lty swallowin g; m edica- tion s bein g taken ; an d h istory of surgery in th e h ead an d n eck region .

2. Head a. In spect an d palpate: Size, sh ape, m asses or

ten dern ess, an d sym m etry of th e sku ll b . Palp ate tem poral arteries, lo cated above th e

ch eekbon e between th e eye an d th e top of th e ear.

c. Tem po rom an d ibular join t: Ask th e clien t to open h is or h er m ou th ; n ote an y crepitation , ten dern ess, or lim ited ran ge of m otion .

d . Face: In spect facial structures for sh ape, sym - m etry, in volun tary m ovem en ts, or swellin g, such as periorbital edem a (swellin g arou n d th e eyes).

3. Neck a. In spect for sym m etry of accessory n eck

m uscles. b . Assess ran ge of m otion . c. Test cran ial n erve XI (spin al accesso ry n erve)

to assess m uscle stren gth : Ask th e clien t to push again st resistan ce applied to th e side of th e ch in (tests stern ocleidom astoid m us- cle); also ask th e clien t to sh rug th e sh oulders again st resistan ce (tests trapezius m uscle).

d . Palp ate th e trach ea: It sh o uld be m idlin e, with ou t an y deviatio n s.

e. Th yroid glan d: In spect th e n eck as th e clien t takes a sip of water an d swallows (th yroid tissue m oves up with a swallow); palp ate usin g an an terior-po sterior approach

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 15-1 Pitting Edema Scale Scale Description “Measurement”*

1+ A barely perceptible pit 2 mm (3=32 in)

2+ 4

mm

1+ 2

mm

3+ 6

mm

4+ 8

mm

2 + A deeper pit, rebounds in a few seconds

4 mm (6

32 in)

3+ A deep pit, rebounds in 10 -20 sec 6 mm (1=4 in)

4 + A deeper pit, rebounds in > 30 sec 8 mm (5=16 in)

*“Measurement” is in quotation marks because depth of edema is rarely actually measured but is included as a frame of reference. Data from Wilson AF, Giddens JF: Health assessment for nursing practice, ed 5, St. Louis, 20 13, Mosby. Description column data from Kirton C: Assessing edema, Nursing 96 26(7):54, 1996.

BOX 15-4 Assessing Capillary Filling Time 1. Depress the nail bed to produce blanching. 2. Release and observe for the return of color. 3. Color will return within 3 seconds if arterial capillary perfu-

sion is normal.

BOX 15-3 Characteristics of Skin Color Cya nosis: Mottled bluish coloration Eryt hema : Redness Pa llor: Pale, whitish coloration Ja undice: Yellow coloration

173CHAPTER 15 Health and Physical Assessment of the Adult Client

(usually th e n orm al adult th yroid can n ot be palp ated); if it is en larged, auscultate for a bruit.

4. Lym ph n od es a . Palp ate usin g a gen tle pressure an d a circular

m otion of th e fin ger pads. b . Begin with th e preauricular lym p h n odes (in

fron t of th e ear); m ove to th e posterio r auric- ular lym ph n odes an d th en down ward toward th e supraclavicular lym p h n odes.

c. Palp ate with both h an ds, com parin g th e 2 sides for sym m etry.

d . If n od es are palpated, n ote th eir size, sh ap e, location , m ob ility, con sisten cy, an d ten dern ess.

5. Clien t teach in g: In struct th e clien t to n otify th e h ealth care provider (HCP) if persisten t h ead- ach e, dizzin ess, or n eck pain occurs; if swellin g or lum ps are n oted in th e h ead an d n eck region ; or if a n eck or h ead in ju ry occurs.

Neck movements are never performed if the client has sustained a neck injury or if a neck injury is suspected.

C. Eyes: In cludes in spection , palpation , vision -testin g procedures, an d the use of an oph th alm oscope 1. Subjective data: Difficulty with vision (e.g.,

decreased acuity, double vision , blurrin g, blin d spots); pain , redn ess, swellin g, watery or oth er disch arge from th e eye; use of glasses or con tact len ses; m ed ication s bein g taken ; h isto ry of eye problem s

2. O bjective data a . In spect th e extern al eye structures, in cludin g

eyeb rows, for sym m etry; eyelash es for even distribution ; eyelids for ptosis (dro opin g); eyeb alls for exoph th alm o s (protru sion ) or en oph th alm o s (recession in to th e orbit; sun ken eye).

b . In spect th e con jun ctiva (sh ould be clear), sclera (sh ould be wh ite), an d lacrim al appara- tus (ch eck for excessive tearin g, redn ess, ten - dern ess, or swellin g) ; corn ea an d len s (sh ou ld be sm ooth an d clear) ; iris (sh ou ld be flat, with a roun d regular sh ape an d even coloration ); eyelids; an d pupils

3. Sn ellen eye ch art a . Th e Sn ellen eye ch art is a sim ple tool used to

m easu re distan ce vision . b . Position th e clien t in a well-lit spot 20 feet (6

m eters) from th e ch art, with th e ch art at eye level, an d ask th e clien t to read th e sm allest lin e th at h e or sh e can discern .

c. In struct th e clien t to leave on glasses or leave in con tact len ses; if th e glasses are for readin g on ly, th ey are rem oved because th ey blur dis- tan ce vision .

d . Test 1 eye at a tim e. e. Record th e result usin g th e fraction at th e en d

of th e last lin e successfully read on th e ch art. f. Norm al visual acuity is 20/ 20 (distan ce in feet

at wh ich th e clien t is stan din g fro m th e ch art/ distan ce in feet at wh ich a n orm al eye could h ave read th at particular lin e) .

4. Near vision a . Use a h an d-h eld vision screen er (h eld about

14 in ch es [35.5 cen tim eters] from th e eye) th at con tain s various sizes of prin t or ask th e clien t to read fro m a m agazin e.

b . Test each eye sep arately with th e clien t’s glasses on or con tact len ses in .

c. Norm al result is 14/ 14 (distan ce in inch es at wh ich the subject h olds th e card from th e eye/ distan ce in inch es at wh ich a n orm al eye could h ave read th at particular lin e).

5. Con fron tatio n test a . A crude but rapid test used to m easu re periph -

eral vision an d com pare th e clien t’s periph - eral vision with th e n urse’s (assum in g th at th e n urse’s periph eral vision is n orm al)

b . Th e clien t covers 1 eye an d looks straigh t ah ead ; th e n urse, position ed 2 feet away (60 cen tim eters), covers h is or h er eye opposite th e clien t’s covered eye.

c. Th e n urse advan ces a fin ger or oth er sm all object from th e periph ery from several direc- tion s; th e clien t sh ould see th e object at th e sam e tim e th e n urse does.

6. Corn eal ligh t reflex a . Used to assess for parallel align m en t of th e

axes of th e eyes b . Clien t is asked to gaze straigh t ah ead as th e

n urse h old s a ligh t about 12 in ch es (30 cen ti- m eters) from th e clien t.

c. Th e n urse looks for reflection of the ligh t on the corn eas in exactly th e sam e spot in each eye.

7. Cover test a . Used to ch eck for sligh t degrees of deviated

align m en t b . Each eye is tested sep arately. c. Th e n urse asks th e clien t to gaze straigh t

ah ead an d cover 1 eye. d . Th e n urse exam in es th e un co vered eye,

expectin g to n ote a steady, fixed gaze. 8. Extraocular m uscle fun ction (6 cardin al posi-

tion s of gaze) (Fig. 15-1) a . Th e 6 m uscles th at attach th e eyeball to its

orbit an d serve to direct th e eye to poin ts of in terest are tested.

b . Clien t h old s h ead still an d is asked to m ove h is or h er eyes an d follow a sm all object.

c. Th e exam in er n otes an y parallel m ovem en ts of th e eye or n ystagm u s, an in volun tary, rh yth m ic, rapid twitch in g of th e eyeb alls.

F

u

n

d

a

m

e

n

t

a

l

s

174 UNIT IV Fundamentals of Care

9. Color vision a. Tests for color vision in volve pickin g n um -

bers or letters out of a co m plex an d colorful picture.

b . Th e Ish ih ara ch art is used for testin g an d con - sists of n um bers com po sed of colored dots lo cated with in a circle of colored dots.

c. Th e clien t is asked to read th e n um bers on th e ch art.

d . Each eye is tested separately. e. Readin g th e n um bers correctly in dicates n or-

m al color vision . f. Th e test is sen sitive for th e diagn osis of red-

green blin dn ess but can n ot detect discrim in a- tio n of blue.

The first slide on the Ishihara chart is one that every- one can discriminate; failure to identify numbers on this slide suggests a problem with performing the test, not a problem with color vision.

10. Pupils ( Box 15-5) a. Th e pupils are roun d an d of equal size. b . Increasin g ligh t causes pupillary con striction .

c. Decreasin g ligh t cau ses pupillary dilation . d . Con striction of both pupils is a n orm al

respo n se to direct ligh t. 11. Sclera an d corn ea

a. No rm al sclera color is wh ite. b . A yellow color to th e sclera m ay in dicate jaun -

dice or system ic problem s. c. In a dark-skin n ed perso n , th e sclera m ay n or-

m ally appear yellow; pigm en ted dots m ay be presen t.

d . Th e co rn ea is tran sparen t, sm ooth , sh in y, an d brigh t.

e. Cloudy areas or specks on th e corn ea m ay be th e result of an acciden t or eye in jury.

12. O ph th alm o scopy a. Th e oph th alm oscop e is an in strum en t used to

exam in e th e extern al structures an d th e in te- rior of th e eye.

b . Th e ro om is darken ed so th at th e pupil will dilate.

c. Th e in strum en t is h eld with th e righ t h an d wh en exam in in g th e righ t eye an d with th e left h an d wh en exam in in g th e left eye.

d . Th e clien t is asked to look straigh t ah ead at an object on th e wall.

e. Th e exam in er sh ould approach th e clien t’s eye from about 12 to 15 in ch es (30.5 to 38 cen tim eters) away an d 15 degrees lateral to th e clien t’s lin e of vision .

f. As th e in strum en t is directed at th e pupil, a red glare (red reflex) is seen in th e pupil.

g. Th e red reflex is th e reflection of ligh t on th e vascu lar retin a.

h . Absen ce of th e red reflex m ay in dicate opacity of th e len s.

i. Th e retin a, optic disc, optic vessels, fun dus, an d m acula can be exam in ed .

13. Refer to Ch apter 60 for diagn ostic tests related to th e eye.

14. Clien t teach in g a. In struct th e clien t to n otify th e HCP

if alteration s in vision occur or an y red- n ess, swellin g, or drain age from th e eye is n oted.

b . In form th e clien t of th e im portan ce of regular eye exam in ation s.

D. Ears: In cludes in spection , palpatio n , h earin g tests, vestibular assessm en t, an d th e use of an otosco pe 1. Subjective data: Difficulty h earin g, earach es,

drain age from th e ears, dizzin ess, rin gin g in th e ears, exp osure to en viron m en tal n oise, use of a h earin g aid, m edication s bein g taken , h istory of ear problem s or in fection s

2. O bjective data a. In spect an d palpate th e extern al ear, n otin g

size, sh ap e, sym m etry, skin color, an d th e presen ce of pain .

F

u

n

d

a

m

e

n

t

a

l

s

BOX 15-5 Assessing and Documenting Pupillary Responses

Pupillary Light Reflex 1. Darken the room (to dilate the client’s pupils) and ask the

client to look forward. 2. Test each eye. 3. Advance a light in from the side to note constriction of the

same-side pupil (direct light reflex) and simultaneous con- striction of the other pupil (consensual light reflex).

Accommodation 1. Ask the client to focus on a distant object (dilates the pupil). 2. Ask the client to shift gaze to a near object held about

3 inches (7.5 centimeters) from the nose. 3. Normal response includes pupillary constriction and

convergence of the axes of the eyes.

Documenting Normal Findings: PERRLA P¼pupils E¼equal R¼round RL¼reactive to light A¼reactive to accommodation

III

III

III

III

VI

IVIII

III

VI

FIGURE 15-1 Checking extraocular muscles in the 6 cardinal positions. This indicates the functioning of cranial nerves III, IV, and VI.

175CHAPTER 15 Health and Physical Assessment of the Adult Client

F

u

n

d

a

m

e

n

t

a

l

s

b . In spect the extern al auditory m eatus for size, swellin g, redn ess, disch arge, an d foreign bod- ies; som e cerum en (earwax) m ay be presen t.

3. Auditory assessm en t a . Soun d is tran sm itted by air con duction an d

bon e con duction . b . Air con duction takes 2 or 3 tim es lon ger th an

bon e con duction . c. Hearin g loss is categorized as co n ductive, sen -

sorin eural, or m ixed con d uctive an d sen sorin eural.

d . Con ductive h earin g loss is cau sed by an y ph ysical obstru ction to th e tran sm ission of soun d waves.

e. Sen sorin eural h earin g loss is cau sed by a defect in th e coch lea, eigh th cran ial n erve, or th e brain itself.

f. A m ixed h earin g loss is a com bin ation of a con d uctive an d sen sorin eural h earin g lo ss; it results from problem s in both th e in n er ear an d th e outer ear or m iddle ear.

4. Voice (Wh isper) test a . Used to determ in e wh eth er h earin g loss h as

occurred b . O n e ear is tested at a tim e (th e ear n ot bein g

tested is occluded by th e clien t). c. Th e n urse stan ds 1 to 2 feet (30 to 60 cen tim e-

ters) from th e clien t, covers his or h er m outh so th at th e clien t can n ot read th e lips, exh ales fully, an d softly whispers 2-syllable words in th e direction of th e un occluded ear; the clien t poin ts a fin ger up durin g the test wh en th e n urse’s voice is h eard (a ticking watch m ay also be used to test h earin g acuity).

d . Failure to h ear th e soun ds could in dicate pos- sible fluid collection an d/ o r con solidation , requirin g furth er assessm en t.

5. Watch test a . A tickin g watch is used to test for h igh -

frequen cy soun ds. b . Th e exam in er h old s a tickin g watch about 5

in ch es (12.5 cen tim eters) from each ear an d asks th e clien t if th e tickin g is h eard.

6. Tun in g fork tests a . Used to m easure h earin g on th e basis of air

con d uction or bon e con duction ; in cludes th e Weber an d Rin n e tests

b . To activate th e tun in g fork, th e n urse h olds th e base an d ligh tly taps th e tin es again st th e oth er h an d, settin g th e fork in vibration .

7. Weber test a . Determ in es wh eth er th e clien t h as a con duc-

tive or sen sorin eural h earin g loss b . Stem of th e vibratin g tun in g fork is placed in

th e m idlin e of th e clien t’s sku ll an d th e clien t is asked if th e ton e soun ds th e sam e in both ears or better in 1 ear.

c. Th e clien t h ears th e ton e by bon e con duction an d th e soun d sh o uld be h eard equ ally in both ears.

d . In con d uctive loss, th e soun d travels toward th e im paired ear.

e. In sen sorin eural lo ss, th e soun d travels toward th e go od ear.

8. Rin n e test a . Stem of th e vibratin g tun in g fork is placed on

th e clien t’s m astoid process. b . Wh en th e clien t n o lo n ger h ears th e soun d,

th e tun in g fork is quickly in verted an d placed n ear th e ear can al; th e clien t sh o uld still h ear a soun d.

c. Norm ally th e soun d is h eard twice as lon g by way of air con duction (AC) (n ear th e ear can al) th an by way of bon e con duction (BC) (at th e m astoid process); AC > BC.

d . In sen sorin eural h earin g loss, air con duction is h eard lon ger th an bon e con d uction , but it is n ot h eard to be twice as lon g.

e. In con d uctive h earin g loss, th e bon e con duc- tion soun d is lon ger th an or equal to th e air con duction soun d.

9. Vestibu lar assessm en t ( Box 15-6) 10. O tosco pic exam

Before performing an otoscopic exam and inserting the speculum, check the auditory canal for foreign bod- ies. Instruct the client not to move the head during the examination to avoid damage to the canal and tympanic membrane.

a . Th e clien t’s h ead is tilted sligh tly away an d th e otoscope is h eld upside down as if it were a large pen ; th is perm its th e exam in er’s h an d to lay again st th e clien t’s h ead for support.

b . In an adult, pull th e pin n a up an d back to straigh ten th e extern al can al.

c. Visualize th e extern al can al wh ile slowly in sertin g th e speculum .

d . Th e n orm al extern al can al is pin k an d in tact, with ou t lesion s an d with varyin g am oun ts of cerum en an d fin e little h airs.

e. Assess th e tym pan ic m em bran e for in tactn ess; th e n orm al tym pan ic m em bran e is in tact, with ou t perforation s, an d sh ould be free from lesion s.

f. Th e tym pan ic m em bran e is tran sparen t, o- paque, pearly gray, an d sligh tly con cave.

g. A fluid lin e or th e presen ce of air bubbles is n ot n orm ally visible.

h . If th e tym pan ic m em bran e is bulgin g or retractin g, th e edges of th e ligh t reflex will be fuzzy (diffu se) an d m ay spread over th e tym pan ic m em bran e.

176 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

The otoscope is never introduced blindly into the external canal because of the risk of perforating the tym- panic membrane.

11. Refer to Ch apter 60 for diagn ostic tests related to th e ear.

12. Clien t teach in g a. In struct th e clien t to n otify th e HCP if an

alteration in h earin g or ear pain or rin gin g in th e ears occurs, or if redn ess, swellin g, or drain age from th e ear is n oted.

b . In struct th e clien t in th e proper m eth od of clean in g th e ear can al.

c. Th e client should clean se th e ear can al with the corn er of a m oisten ed wash cloth an d sh ould n ever in sert sh arp objects or cotton -tipped applicators in to th e ear can al.

E. No se, m ou th , an d th roat: In cludes in spection an d palp ation

1. Subjective data a. No se: Ask about disch arge or n oseb leed (epi-

staxis) , facial or sin us pain , h isto ry of fre- quen t colds, altered sen se of sm ell, allergies, m ed ication s bein g taken , h istory of n ose traum a or surgery.

b . Mou th an d th roat: Ask ab out th e presen ce of sores or lesion s; bleed in g from th e gum s or elsewh ere; altered sen se of taste; tooth ach es; use of den tures or oth er applian ces; tooth an d m outh care h ygien e h abits; at-risk beh av- iors (e.g., sm okin g, alcoh ol con sum p tion ); an d h istory of in fection , traum a, or surgery.

2. O bjective data a. Extern al n ose sh ould be m idlin e an d in pro-

portion to oth er facial features. b . Paten cy of th e n ostrils can be tested by push -

in g each n asal cavity closed an d askin g th e cli- en t to sn iff in ward th rough th e oth er n ostril.

c. A n asal speculum and penlight or a sh ort, wide- tipped speculum attach ed to an otoscope h ead is used to in spect for redn ess, swellin g, dis- ch arge, bleedin g, or foreign bodies; th e n asal septum is assessed for deviation .

d . Th e n u rse p resses th e fro n tal sin u ses ( lo cated b elo w th e eyeb ro ws) an d o ver th e m axillary sin u ses ( lo cated b elo w th e ch eek- b o n es) ; th e clien t sh o u ld feel firm p ressu re b u t n o p ain .

e. Th e extern al an d in n er surfaces of th e lips are assessed for color, m oistu re, crackin g, or lesion s.

f. Th e teeth are in spected for con d ition an d n um ber (sh ou ld be wh ite, spaced even ly, straigh t, an d clean , free of debris an d decay).

g. Th e align m en t of th e upper an d lo wer jaw is assessed by h avin g th e clien t bite down .

h . Th e gum s are in spected for swellin g, bleed- in g, discoloration , an d retraction of gin gival m argin s (gum s n orm ally appear pin k).

i. Th e ton gue is in spected for color, surface ch aracteristics, m oistu re, wh ite patch es, n od- ules, an d ulceration s (do rsal surface is n or- m ally rough ; ven tral surface is sm oo th an d glisten in g, with visible vein s).

j. Th e n urse retracts th e ch eek with a ton gue dep ressor to ch eck th e buccal m ucosa for color an d th e presen ce of n odules or lesion s; n orm al m ucosa is glisten in g, pin k, soft, m oist, an d sm oo th .

k . Usin g a pen ligh t an d ton gue dep ressor, th e n urse in spects th e h ard an d soft palates for color, sh ap e, texture, an d defects; th e h ard palate (roof of th e m outh ) , wh ich is located an teriorly, sh ould be wh ite an d dom e- sh ap ed, an d th e soft palate, wh ich exten ds posteriorly, sh ould be ligh t pin k an d sm oo th .

BOX 15-6 Vestibular Assessment

Test for Falling 1. The examiner asks the client to stand with the feet together,

arms hanging loosely at the sides, and eyes closed. 2. The client normally remains erect, with only slight swaying. 3. A significant sway is a positive Romberg sign.

Test for Past Pointing 1. The client sits in front of the examiner. 2. The client closes the eyes and extends the arms in front,

pointing both index fingers at the examiner. 3. The examiner holds and touches his or her own extended

index fingers under the client’s extended index fingers to give the client a point of reference.

4. The client is instructed to raise both arms and then lower them, attempting to return to the examiner’s extended index fingers.

5. The normal test response is that the client can easily return to the point of reference.

6. The client with a vestibular function problem lacks a nor- mal sense of position and cannot return the extended fin- gers to the point of reference; instead, the fingers deviate to the right or left of the reference point.

Gaze Nystagmus Evaluation 1. The client’s eyes are examined as the client looks straight

ahead, 30 degrees to each side, upward and downward. 2. Any spontaneous nystagmus—an involuntary, rhythmic,

rapid twitching of the eyeballs—represents a problem with the vestibular system.

Dix-Hallpike Maneuver 1. The client starts in a sitting position; the examiner lowers

the client to the exam table and rather quickly turns the cli- ent’s head to the 45-degree position.

2. If after about 30 seconds there is no nystagmus, the client is returned to a sitting position and the test is repeated on the other side.

177CHAPTER 15 Health and Physical Assessment of the Adult Client

l. Th e uvula is in spected for m idlin e location ; th e n urse asks th e clien t to say “ah h h ” an d watch es for th e soft palate an d uvula to rise in th e m idlin e (th is tests 1 fun ction of cran ial n erve X, th e vagus n erve).

m . Usin g a pen ligh t an d ton gue dep ressor, th e n urse in spects th e th roat for color, presen ce of ton sils, an d th e presen ce of exudate or lesion s; 1 tech n ique to test cran ial n erve XII (th e h ypo glossal n erve) is askin g th e clien t to stick out th e ton gue (sh ou ld protrude in th e m idlin e).

n . To test th e gag reflex, touch th e posterior ph aryn x with th e en d of a ton gue blade; th e clien t sh ould gag m om en tarily (th is tests th e fun ctio n of cran ial n erve IX, th e glossoph aryn geal n erve).

3. Clien t teach in g a . Em ph asize th e im portan ce of h ygien e an d

tooth care, as well as regular den tal exam in a- tion s an d th e use of fluorid ated water or fluo- ride supp lem en ts.

b . En cou rage th e clien t to avoid at-risk beh av- iors (e.g., sm okin g, alcoh ol con sum p tion ).

c. Stress th e im portan ce of reportin g pain or abn o rm al occurren ce (e.g., n odules, lesion s, sign s of in fection ).

F. Lun gs 1. Su b jective d ata: Co u gh ; exp ecto ratio n o f sp u -

tu m ; sh o rtn ess o f b reath o r d ysp n ea; ch est p ain o n b reath in g; sm o kin g h isto ry; en viro n - m en tal exp o su re to p o llu tio n o r ch em icals; m ed icatio n s b ein g taken ; h isto ry o f resp irato ry d isease o r in fectio n ; last tu b ercu lo sis test, ch est rad io grap h , p n eu m o n ia, an d an y in flu - en za im m u n izatio n s. Reco rd th e sm o kin g h is- to ry in p ack-years ( th e n u m b er o f p acks p er d ay tim es th e n u m b er o f years sm o ked ) . Fo r exam p le, a clien t wh o h as sm o ked o n e-h alf p ack a d ay fo r 20 years h as a 10 –p ack-year sm o kin g h isto ry.

2. O bjective data: In cludes in spection , palpation , percussion , an d auscultation

3. In spection of th e an terior an d posterio r ch est: No te skin color an d con d ition an d th e rate an d quality of respiration s, look for lum ps or lesion s, n ote th e sh ap e an d con figuration of th e ch est wall, an d n ote th e position th e clien t takes to breath e.

4. Palp ation : Palpate th e en tire ch est wall, n otin g skin tem p erature an d m oistu re an d lo okin g for areas of ten dern ess an d lum ps, lesion s, or m asses; assess ch est excu rsion an d tactile or vocal frem itus (Box 15-7).

5. Percussion a . Startin g at th e apices, percuss across th e top of

th e sh oulders, m ovin g to th e in tersp aces,

m akin g a side-to -side com parison all th e way down th e lun g area ( Fig. 15-2).

b . Determ in e th e predom in an t n ote; reson an ce is n oted in h ealth y lun g tissue.

c. Hyperreson an ce is n oted wh en excessive air is presen t an d a dull n ote in dicates lun g den sity.

6. Auscu ltation a . Usin g th e flat diaph ragm en dpiece of th e

steth oscope, h old it firm ly again st th e ch est wall, an d listen to at least 1 full respiration in each location (an terior, posterior, an d lateral).

b . Posterior: Start at th e apices an d m ove side to side for co m parison (see Fig. 15-2).

c. An terior: Auscu ltate th e lu n g fields from th e apices in th e supraclavicular area down to th e 6th rib; avoid percussion an d au scultatio n over fem ale breast tissue (disp lace th is tissue) because a dull soun d will be produ ced (see Fig. 15-2).

d . Com p are fin din gs on each side. 7. Norm al breath soun ds: Th ree types of breath

soun ds are con sidered n orm al in certain parts of th e th orax, in cludin g vesicular, bron ch ovesicular, and bron ch ial; breath soun ds sh ould be clear to auscultation (Fig. 15-3).

8. Abn orm al breath soun ds: Also kn own as adven- titious sounds (Table 15-2)

9. Voice soun ds (Box 15-8) a . Perform ed wh en a path o logical lun g con d i-

tion is susp ected

F

u

n

d

a

m

e

n

t

a

l

s

BOX 15-7 Palpation of the Chest

Chest Excursion Posterior: The nurse places the thumbs along the spinal pro-

cesses at the 10 th rib, with the palms in light contact with the posterolateral surfaces.

The nurse’s thumbs should be about 2 inches (5 centimeters) apart, pointing toward the spine, with the fingers pointing laterally.

Anterior: The nurse places the hands on the anterolateral wall with the thumbs along the costal margins, pointing toward the xiphoid process.

The nurse instructs the client to take a deep breath after exhaling.

The nurse should note movement of the thumbs and chest excursion should be symmetrical, separating the thumbs approximately 2 inches (5 centimeters).

Tactile or Vocal Fremitus The nurse places the ball or lower palm of the hand over the

chest, starting at the lung apices and palpating from side to side.

The nurse asks the client to repeat the words “ninety-nine.” Symmetrical palpable vibration should be felt by the nurse.

178 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

1

4

5

8 7

6

3

4

5

8

9

7

10

6

3

2 1 2

1

4

5 7

6

3

2

C

A B

FIGURE 15-2 Landmarks for chest auscultation and percussion. A, Posterior view. B, Anterior view. C, Lateral views.

Bronchove s icula r ove r ma in bronchi Ke y:

Ve s icula r ove r le s s e r bronchi, bronchiole s , a nd lobe s

Bronchia l ove r tra che a

A B FIGURE 15-3 Auscultatory sounds. A, Anterior thorax. B, Posterior thorax.

179CHAPTER 15 Health and Physical Assessment of the Adult Client

b . Auscu ltate over th e ch est wall; th e clien t is asked to vocalize words or a ph rase wh ile th e n urse listen s to th e ch est.

c. Norm al voice tran sm ission is soft an d m uffled; th e n urse can h ear th e sound but is un able to distin guish exactly wh at is bein g said.

When auscultating breath sounds, instruct the cli- ent to breathe through the mouth and monitor the client for dizziness.

10. Refer to Ch apter 54 for diagn ostic tests related to th e respiratory system .

11. Clien t teach in g a . En courage th e clien t to avoid exposu re to

en viron m en tal h azards, in cludin g sm okin g

(discuss sm okin g cessation program s as appropriate).

b . Clien t sh ould un dergo periodic exam in ation s as prescribed (e.g., ch est x-ray study, tuberculo- sis skin testin g; refer to Chapter 54).

c. En courage th e clien t to obtain pn eum on ia an d in fluen za im m un ization s.

d . HCP sh o uld be n otified if clien t exp erien ces persisten t cough , sh ortn ess of breath , or oth er respiratory sym pto m s.

G. Heart an d periph eral vascu lar system 1. Subjective data: Ch est pain , dyspn ea, cough ,

fatigue, edem a, n octuria, leg pain or cram p s (claudication ), ch an ges in skin color, obesity, m edication s bein g taken , cardiovascular risk fac- tors, fam ily h isto ry of cardiac or vascular prob- lem s, perso n al h isto ry of cardiac or vascu lar problem s

2. O bjective data: May in clude in spection , palp a- tion , percussion , an d auscultation

3. In spection : In spect th e an terior ch est for pulsa- tion s (apical im pulse) created as th e left ven tricle rotates again st th e ch est wall durin g systole; n ot always visible.

4. Palpation a . Palpate th e apical im pulse at th e fourth or

fifth in terspace, or m edial to th e m idclavicu- lar lin e (n ot palp able in obese clien ts or cli- en ts with th ick ch est walls).

b . Palpate th e apex, left stern al border, an d base for pulsation s; n orm ally n on e are presen t.

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 15-2 Characteristics of Adventitious Sounds Adventitious Sound Characteristics Clinical Examples

Crackles (previously called rales)

Fine crackles High-pitched crackling and popping noises (discontinuous sounds) heard during the end of inspiration. Not cleared by cough

May be heard in pneumonia, heart failure, asthma, and restrictive pulmonary diseases

Medium crackles Medium-pitched, moist sound heard about halfway through inspiration. Not cleared by cough

Same as above, but condition is worse

Coarse crackles Low-pitched, bubbling or gurgling sounds that start early in inspiration and extend into the first part of expiration

Same as above, but condition is worse or may be heard in terminally ill clients with diminished gag reflex. Also heard in pulmonary edema and pulmonary fibrosis

Wheeze (also called sibilant wheeze)

High-pitched, musical sound similar to a squeak. Heard more commonly during expiration, but may also be heard during inspiration. Occurs in small airways

Heard in narrowed airway diseases such as asthma

Rhonchi (also called sonorous wheeze)

Low-pitched, coarse, loud, low snoring or moaning tone. Actually sounds like snoring. Heard primarily during expiration, but may also be heard during inspiration. Coughing may clear

Heard in disorders causing obstruction of the trachea or bronchus, such as chronic bronchitis

Pleural friction rub

A superficial, low-pitched, coarse rubbing or grating sound. Sounds like 2 surfaces rubbing together. Heard throughout inspiration and expiration. Loudest over the lower anterolateral surface. Not cleared by cough

Heard in individuals with pleurisy (inflammation of the pleural surfaces)

Data from Wilson AF, Giddens JF: Health assessment for nursing practice, ed 5, St. Louis, 20 13, Mosby.

BOX 15-8 Voice Sounds

Bronchophony 1. Ask the client to repeat the words “ninety-nine.” 2. Normal voice transmission is soft, muffled, and indistinct.

Egophony 1. Ask the client to repeat a long “ee-ee-ee” sound. 2. Normally the nurse would hear the “ee-ee-ee” sound.

Whispered Pectoriloquy 1. Ask the client to whisper the word “ninety-nine.” 2. Normal voice transmission is faint, muffled, and almost

inaudible.

180 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

5. Percussion : May be perform ed to outlin e th e h eart’s borders an d to ch eck for cardiac en large- m en t (den oted by reson an ce over th e lun g an d dull n otes over th e h eart) .

6. Auscu ltation a. Areas of th e h eart (Fig. 15-4) b . Auscu ltate h eart rate an d rh yth m ; ch eck for a

pulse deficit (auscu ltate th e apical h eartbeat wh ile palpatin g an artery) if an irregularity is n oted.

c. Assess S1 (“lub ”) an d S2 (“dub”) soun ds, an d listen for extra h eart soun ds, as well as th e presen ce of m urm urs (blowin g or swoosh in g n oise th at can be fain t or lo ud with a h igh , m ed ium , or lo w pitch ).

7. Periph eral vascu lar system a. Assess ad equacy of blood flow to th e extrem -

ities by palpatin g arterial pulses for equ ality an d sym m etry an d ch eckin g th e con dition of th e skin an d n ails.

b . Ch eck for pretibial edem a an d m easu re calf circum feren ce (see Table 15-1).

c. Measu re blood pressure. d . Palpate superficial in guin al n od es (usin g firm

but gen tle pressure) , begin n in g in th e in gui- n al area an d m ovin g down toward th e in n er th igh .

e. An ultrason ic steth oscope m ay be n eeded to am plify th e soun ds of a pulse wave if th e pulse can n ot be palp ated.

f. Caro tid artery: Located in th e groo ve between th e trach ea an d stern ocleidom astoid m uscle, m ed ial to an d alon gside th e m uscle

g. Palpate 1 carotid artery at a tim e to avoid com pro m isin g blood flow to th e brain .

h . Auscu ltate each carotid artery for th e presen ce of a bruit (a blowin g, swish in g, or buzzin g, h um m in g soun d), wh ich in dicates blood

flow turbulen ce; n orm ally a bruit is n ot presen t.

i. Palp ate th e arteries in th e extrem ities (Box 15-9).

8. Refer to Ch apter 56 for diagn ostic tests related to th e cardiovascular system .

9. Clien t teach in g a. Advise clien t to m od ify lifestyle for risk factors

associated with h eart an d vascu lar disease. b . En cou rage th e clien t to seek regular ph ysical

exam in ation s. c. Clien t sh o uld seek m edical assistan ce for

sign s of h eart or vascu lar disease. H. Breasts

1. Subjective data: Pain or ten dern ess, lum ps or th icken in g, swollen axillary lym p h n odes, n ipple disch arge, rash or swellin g, m edication s bein g taken , person al or fam ily h isto ry of breast dis- ease, traum a or in jury to th e breasts, previous surgery on th e breasts, breast self-exam in ation (BSE) com plian ce, m am m ogram s as prescribed

2. O bjective data: In spection an d palpation 3. In spection

a. Perform ed with th e clien t’s arm s raised above the h ead, th e h an ds pressed again st th e h ips, an d th e arm s exten ded straigh t ah ead wh ile the clien t sits and lean s forward

b . Assess size an d sym m etry (1 breast is often larger th an th e oth er); m asses, flatten in g,

Ba s e

A P E T

MApe x

2nd RICS (a ortic)

2nd LICS (pulmonic)

3rd LICS (Erb’s point)

4th LICS (tricus pid)

5th LMCL (mitra l)

FIGURE 15-4 Auscultation areas of the heart. LICS, Left intercostal space; LMCL, left midclavicular line; RICS, right intercostal space.

BOX 15-9 Arterial Pulse Points and Grading the Force of Pulses

Arteries in the Arms and Hands Ra dia l Pulse: Located at the radial side of the forearm at the

wrist Ulna r Pulse: Located on the opposite side of the location of the

radial pulse at the wrist Bra chia l Pulse: Located above the elbow at the antecubital

fossa, between the biceps and triceps muscles

Arteries in the Legs Femora l Pulse: Located below the inguinal ligament, midway

between the symphysis pubis and the anterosuperior iliac spine

Poplitea l Pulse: Located behind the knee Dorsa lis Pedis Pulse: Located at the top of the foot, in line with

the groove between the extensor tendons of the great and first toes

Post erior Tibia l Pulse: Located on the inside of the ankle, behind and below the medial malleolus (ankle bone)

Grading the Force 4 +¼Strong and bounding 3+¼Full pulse, increased 2 +¼Normal, easily palpable 1+¼Weak, barely palpable

181CHAPTER 15 Health and Physical Assessment of the Adult Client

retraction , or dim plin g; color an d ven o us pat- tern ; size, color, sh ape, an d disch arge in th e n ipp le an d areola; an d th e direction in wh ich n ipp les poin t.

4. Palp ation a . Clien t lies supin e, with th e arm on th e side

bein g exam in ed beh in d th e h ead an d a sm all pillow un der th e sh oulder.

b . Th e n urse uses th e pads of th e first 3 fin gers to com press th e breast tissue gen tly again st th e ch est wall, n otin g tissue con sisten cy.

c. Palp ation is perform ed system atically, en sur- in g th at th e en tire breast an d tail are palp ated.

d . Th e n urse n otes th e con sisten cy of th e breast tissue, wh ich n orm ally feels den se, firm , an d elastic.

e. Th e n urse gen tly palpates th e n ipple an d are- ola an d com presses th e n ipp le, n otin g an y disch arge.

5. Axillary lym ph n od es a . Th e n urse faces th e clien t an d stan ds on th e

side bein g exam in ed , supp ortin g th e clien t’s arm in a sligh tly flexed position , an d ab ducts th e arm away from th e ch est wall.

b . Th e n urse places th e free h an d again st th e cli- en t’s ch est wall an d h igh in th e axillary h ol- low, th en , with th e fin gertips, gen tly presses down , rollin g soft tissue over th e surface of th e ribs an d m uscles.

c. Lym ph n od es are n orm ally n ot palpab le. 6. Clien t teach in g

a . En cou rage an d teach th e clien t to perform BSE (refer to Ch apter 48 for in form ation on perform in g BSE) .

b . Clien t sh ould report lu m ps or m asses to th e HCP im m ediately.

c. Regular ph ysical exam in ation s an d m am m o- gram s sh ould be obtain ed as prescribed .

I. Abdo m en 1. Subjective data: Ch an ges in appetite or weigh t,

difficu lty swallowin g, dietary in take, in toleran ce to certain food s, n ausea or vom itin g, pain , bowel h abits, m edication s curren tly bein g taken , h is- tory of abdom in al problem s or abdom in al surgery

2. O bjective data a . Ask th e clien t to em pty th e bladder. b . Be sure to warm th e h an ds an d th e en dpiece

of th e steth oscope. c. Exam in e pain ful areas last.

When performing an abdominal assessment, the specific order for assessment techniques is inspection, auscultation, percussion, and palpation.

3. In spection a . Con tour: Look down at th e ab dom en an d

th en across th e abdom en from th e rib m argin

to th e pubic bon e; describe as flat, roun ded, con cave, or protub eran t.

b . Sym m etry: No te an y bulgin g or m asses. c. Um b ilicus: Sh o uld be m idlin e an d in verted d . Skin su rface: Sh o u ld b e sm o o th an d even e. Pulsation s from th e aorta m ay be n oted in th e

epigastric area, an d peristaltic waves m ay be n oted across th e abdom en .

4. Auscu ltation a . Perform ed befo re percussion an d palpatio n ,

wh ich can in crease peristalsis. b . Hold th e steth oscope ligh tly again st th e skin

an d listen for bowel soun ds in all 4 quad- ran ts; begin in th e righ t lo wer quadran t (bowel soun ds are n orm ally h eard h ere).

c. Note th e ch aracter an d frequen cy of n orm al bowel soun ds: h igh -pitch ed gurglin g soun ds occurrin g irregularly from 5 to 30 tim es a m in u te.

d . Iden tify as n orm al, h ypo active, or h yperactive (borborygm us) .

e. Absen t soun ds: Auscu ltate for 5 m in utes before determ in in g th at soun ds are absen t.

f. Auscu ltate over th e ao rta, ren al arteries, iliac arteries, an d fem o ral arteries for vascu lar soun ds or bruits.

5. Percussion a . All 4 quadran ts are percussed ligh tly. b . Bord ers of th e liver an d spleen are percussed. c. Tym pan y sh ould predo m in ate over th e abdo-

m en , with dulln ess over th e liver an d spleen . d . Percussion over th e kidn ey at th e 12th rib

(costovertebral an gle) sh ould produce n o pain .

6. Palpation a . Begin with ligh t palpation of all 4 quadran ts,

usin g th e fin gers to dep ress th e skin about 1 cm ; n ext perform deep palpation , depress- in g 5 to 8 cm .

b . Palpate th e liver an d spleen (spleen m ay n ot be palpable).

c. Palpate th e ao rtic pulsation in th e upper abdom en sligh tly to th e left of m idlin e; n or- m ally it pulsates in a forward direction (pu l- sation expan ds laterally if an an eurysm is presen t).

7. Refer to Ch apter 52 for diagn ostic tests related to th e gastro in testin al system .

8. Clien t teach in g a . En cou rage th e clien t to con sum e a balan ced

diet; obesity n eeds to be preven ted . b . Substan ces th at can cause gastric irritation

sh ould be avoided. c. Th e regular use of laxatives is discouraged. d . Lifestyle beh aviors th at can cause gastric irri-

tatio n (e.g., spicy food s) sh ould be m od ified. e. Regular ph ysical exam in ation s are im portan t.

F

u

n

d

a

m

e

n

t

a

l

s

182 UNIT IV Fundamentals of Care

f. Th e clien t sh o uld report gastro in testin al problem s to th e HCP.

J. Muscu loskeletal system 1. Subjective data: Join t pain or stiffn ess; redn ess,

swellin g, or warm join ts; lim ited m otion of join ts; m uscle pain , cram p s, or weakn ess; bon e pain ; lim itation s in activities of daily livin g; exercise pattern s; exposu re to occupation al h azards (e.g., h eavy liftin g, prolon ged stan din g or sittin g); m ed ication s bein g taken ; h istory of join t, m uscle, or bon e in juries; h isto ry of surgery of th e join ts, m uscles, or bon es

2. O bjective data: In spection an d palpation 3. In spection : In spect gait an d posture, an d for

cervical, th o racic, an d lum bar curves (Box 15-10).

4. Palpation : Palpate all bon es, join ts, an d surroun din g m uscles.

5. Ran ge of m otion a. Perform active an d passive ran ge-of-m otion

exercises of each m ajor join t. b . Ch eck for pain , lim ited m ob ility, spastic

m ovem en t, join t in stability, stiffn ess, an d con tractures.

c. No rm ally join ts are n on ten d er, with out swellin g, an d m ove freely.

6. Muscle ton e an d stren gth a. Assess durin g m easurem en t of ran ge of m otion . b . Ask clien t to flex th e m uscle to be exam in ed

an d th en to resist wh ile applyin g opposin g force again st th e flexion .

c. Assess for in creased ton e (h yperto n icity) or little ton e (h ypoto n icity).

7. Gradin g m uscle stren gth ( Table 15-3) 8. Refer to Ch apter 64 for diagn ostic tests related to

th e m uscu loskeletal system . 9. Clien t teach in g

a. Th e clien t sh ould con sum e a balan ced diet, in cludin g foods con tain in g calcium an d vitam in D.

b . Activities th at cause m uscle strain or stress to th e join ts sh ould be avoided.

c. En cou rage th e clien t to m ain tain a n orm al weigh t.

d . Participation in a regular exercise program is ben eficial.

e. Th e client sh ould con tact th e HCP if join t or m uscle pain or problem s occur or if lim itation s in range of m otion or m uscle stren gth develop.

K. Neurological system 1. Subjective data: Headach es, dizzin ess or vertigo,

trem o rs, weakn ess, in coord in ation , n um bn ess or tin glin g in an y area of th e body, difficu lty speak- in g or swallowin g, m ed ication s bein g taken , h is- tory of seizures, h istory of h ead in jury or surgery, exposu re to en viron m en tal or occupation al h az- ards (e.g., ch em icals, alcoh ol, drugs)

2. O bjective data: Assessm en t of cran ial n erves, level of con sciousn ess, pupils, m oto r fun ction , cerebellar fun ctio n , coordin ation , sen sory fun c- tion , an d reflexes

3. No te m en tal an d em o tion al status, beh avior an d appearan ce, lan guage ability, an d in tellectual fun ction in g, in cludin g m em ory, kn owledge, abstract th in kin g, association , an d judgm en t.

4. Vital sign s: Ch eck tem perature, pulse, respira- tion s, an d blood pressure; m on itor for blood pressure or pulse ch an ges, wh ich m ay in dicate in creased in tracran ial pressure (see Ch apter 62 for abn o rm al respiratory pattern s).

5. Cran ial n erves ( Table 15-4) 6. Level of con sciousn ess

a. Assess th e clien t’s beh avior to determ in e level of co n sciousn ess (e.g., alertn ess, con fusion , delirium , un con sciousn ess, stupor, co m a); assessm en t beco m es in creasin gly in vasive as th e clien t is less respo n sive.

b . Speak to clien t. c. Assess appropriaten ess of beh avior an d

con versation . d . Ligh tly touch th e clien t (as culturally

appropriate) .

F

u

n

d

a

m

e

n

t

a

l

s

BOX 15-10 Common Postural Abnormalities Lordosis (Swa yba ck): Increased lumbar curvature Kyphosis (Hunchba ck): Exaggeration of the posterior curva-

ture of the thoracic spine Scoliosis: Lateral spinal curvature

TABLE 15-3 Criteria for Grading and Recording Muscle Strength

Functional Level Lovett Scale Grade

Percentage of Normal

No evidence of contractility

Zero (0) 0 0

Evidence of slight contractility

Trace (T) 1 10

Complete range of motion with gravity eliminated

Poor (P) 2 25

Complete range of motion with gravity

Fair (F) 3 50

Complete range of motion against gravity with some resistance

Good (G) 4 75

Complete range of motion against gravity with full resistance

Normal (N) 5 10 0

Data from Wilson AF, Giddens JF: Health assessment for nursing practice, ed 5, St. Louis, 20 13, Mosby.

183CHAPTER 15 Health and Physical Assessment of the Adult Client

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 15-4 Assessment of the Cranial Nerves Cranial Nerve Test

Cranial Nerve I: Olfactory ▪ Sensory ▪ Controls the sense of smell

▪ Have the client close the eyes and occlude 1 nostril with a finger ▪ Ask the client to identify nonirritating and familiar odors (e.g., coffee, tea, cloves, soap,

chewing gum, peppermint) ▪ Repeat the test on the other nostril

Cranial Nerve II: Optic ▪ Sensory ▪ Controls vision

▪ Assess visual acuity with a Snellen chart and perform an ophthalmoscopic exam ▪ Check peripheral vision by confrontation ▪ Check color vision

Cranial Nerves III, IV, and VI Cra nia l Nerve III: Oculomotor ▪ Motor ▪ Controls pupillary constriction, upper-

eyelid elevation, and most eye movement

▪ The motor functions of cranial nerves III, IV, and VI overlap; therefore, they should be tested together ▪ Inspect the eyelids for ptosis (drooping); then assess ocular movements and note any eye

deviation ▪ Test accommodation and direct and consensual light reflexes

Cra nia l Nerve IV: Trochlea r ▪ Motor ▪ Controls downward and inward eye

movement Crania l Nerve VI: Abducens ▪ Motor ▪ Controls lateral eye movement Cranial Nerve V: Trigeminal ▪ Sensory and motor ▪ Controls sensation in the cornea, nasal

and oral mucosa, and facial skin, as well as mastication

▪ To test motor function, ask the client to clench the teeth and assess the muscles of mastication; then try to open the client’s jaws after asking the client to keep them tightly closed ▪ The corneal reflex may be tested by the health care provider; this is done by lightly touching

the client’s cornea with a cotton wisp (this test may be omitted if the client is alert and blinking normally) ▪ Check sensory function by asking the client to close the eyes; lightly touch forehead, cheeks,

and chin, noting whether the touch is felt equally on the 2 sides

Cranial Nerve VII: Facial ▪ Sensory and motor ▪ Controls movement of the face and taste

sensation

▪ Test taste perception on the anterior two thirds of the tongue; the client should be able to taste salty and sweet tastes ▪ Have the client smile, frown, and show the teeth ▪ Ask the client to puff out the cheeks ▪ Attempt to close the client’s eyes against resistance

Cranial Nerve VIII: Acoustic or Vestibulocochlear ▪ Sensory ▪ Controls hearing and vestibular function

▪ Assessing the client’s ability to hear tests the cochlear portion ▪ Assessing the client’s sense of equilibrium tests the vestibular portion ▪ Check the client’s hearing, using acuity tests ▪ Observe the client’s balance and watch for swaying when he or she is walking or standing ▪ Assessment of sensorineural hearing loss may be done with the Weber or Rinne test

Cranial Nerves IX and X Cra nia l Nerve IX: Glossopha ryngeal ▪ Sensory and motor ▪ Controls swallowing ability, sensation in

the pharyngeal soft palate and tonsillar mucosa, taste perception on the posterior third of the tongue, and salivation

▪ Usually cranial nerves IX and X are tested together ▪ Test taste perception on the posterior one third of the tongue or pharynx; the client should be

able to taste bitter and sour tastes ▪ Inspect the soft palate and watch for symmetrical elevation when the client says “aaah” ▪ Touch the posterior pharyngeal wall with a tongue depressor to elicit the gag reflex

Cra nia l Nerve X: Va gus ▪ Sensory and motor ▪ Controls swallowing and phonation,

sensation in the exterior ear’s posterior wall, and sensation behind the ear ▪ Controls sensation in the thoracic and

abdominal viscera

Continued

184 UNIT IV Fundamentals of Care

7. Pupils a. Assess size, equ ality, an d reaction to ligh t

(brisk, slow, or fixed ) an d n ote an y un usual eye m ovem en ts (ch eck direct ligh t an d con - sen sual ligh t reflex); refer to Ch apter 62 for ab n orm al pupillary fin din gs

b . Th is co m pon en t of th e n eurological exam in a- tio n m ay be perform ed durin g assessm en t of th e eye.

8. Moto r fun ction a. Assess m uscle ton e, in cludin g stren gth an d

equ ality. b . Assess for volun tary an d in volun tary m ove-

m en ts an d purpo seful an d n on purposeful m ovem en ts.

c. Th is co m pon en t of th e n eurological exam in a- tio n m ay be perform ed durin g assessm en t of th e m uscu loskeletal system .

9. Cereb ellar fun ctio n a. Mon itor gait as th e clien t walks in a straigh t

lin e, h eel to toe (tan dem walkin g). b . Rom b erg test: Clien t is asked to stan d with

th e feet togeth er an d th e arm s at th e sides an d to close th e eyes an d h old th e position ; n orm ally th e clien t can m ain tain posture an d balan ce.

c. If ap propriate, ask th e clien t to perform a sh allow kn ee ben d or to h op in place on 1 leg an d th en th e oth er.

10. Coordin ation a. Assess by askin g th e clien t to perform rapid

altern atin g m ovem en ts of th e h an ds (e.g., turn in g th e h an ds over an d pattin g th e kn ees con tin uously).

b . Th e n urse asks th e clien t to touch th e n urse’s fin ger, th en h is or h er own n ose; th e clien t keeps th e eyes open an d th e n urse m oves th e fin ger to differen t spots to en sure th at th e clien t’s m ovem en ts are sm ooth an d accu rate.

c. Heel-to -sh in test: Assist th e clien t in to a supin e position , th en ask th e clien t to place th e h eel on th e opposite kn ee an d run it

down th e sh in ; n orm ally th e clien t m oves th e h eel down th e sh in in a straigh t lin e.

11. Sen sory fun ction a. Pain : Assess by applyin g an object with a

sh arp poin t an d on e with a dull poin t to th e clien t’s body in ran dom order; ask th e cli- en t to id en tify th e sh arp an d dull feelin gs.

b . Ligh t touch : Brush a piece of cotton over th e clien t’s skin at various location s in a ran dom order an d ask th e clien t to say wh en th e touch is felt.

c. Vibration : Use a tun in g fork to test th e cli- en t’s ability to feel vibration s over bon y prom in en ces; ask th e clien t to an n oun ce wh en th e vibration starts an d stops.

d . Position sen se (kin esth esia): Move th e cli- en t’s fin ger or toe up or down an d ask th e cli- en t wh ich way it h as been m oved; th is tests th e clien t’s ability to perceive passive m ovem en t.

e. Stereogn osis: Tests th e clien t’s ability to rec- ogn ize objects placed in h is or h er h an d

f. Graph esth esia: Tests th e clien t’s ability to iden tify a num ber traced on th e clien t’s h an d

g. Two-poin t discrim in ation : Tests th e clien t’s ability to discrim in ate 2 sim ultan eous pin - pricks on th e skin

12. Deep ten don reflexes a. Includes testin g th e followin g reflexes: biceps,

triceps, brach ioradialis, patella, Ach illes b . Lim b sh o uld be relaxed. c. Th e ten don is tap ped quickly with a reflex

h am m er, wh ich sh o uld cause con traction of m uscle.

d . Scorin g deep ten don reflex activity (Box 15-11) 13. Plan tar reflex

a. A cutan eous (su perficial) reflex is tested with a poin ted but n ot sh arp object.

b . Th e sole of th e clien t’s foot is stroked from th e h eel, up th e lateral side, an d th en across th e ball of th e foot to th e m ed ial side.

c. Th e n orm al respon se is plan tar flexion of all toes.

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 15-4 Assessment of the Cranial Nerves—cont’d Cranial Nerve Test

Cranial Nerve XI: Spinal Accessory ▪ Motor ▪ Controls strength of neck and shoulder

muscles

▪ The nurse palpates and inspects the sternocleidomastoid muscle as the client pushes the chin against the nurse’s hand ▪ The nurse palpates and inspects the trapezius muscle as the client shrugs the shoulders

against the nurse’s resistance

Cranial Nerve XII: Hypoglossal ▪ Motor ▪ Controls tongue movements involved in

swallowing and speech

▪ Observe the tongue for asymmetry, atrophy, deviation to 1 side, and fasciculations (uncontrollable twitching); ask the client to stick out the tongue (tongue should be midline) ▪ Ask the client to push the tongue against a tongue depressor, and then have the client move

the tongue rapidly in and out and from side to side

185CHAPTER 15 Health and Physical Assessment of the Adult Client

Dorsiflexion of the great toe and fanning of the other toes (Babinski’s sign) is abnormal in anyone older than 2 years and indicates the presence of central nervous sys- tem disease indicating an upper motor neuron lesion.

14. Testin g for m en in geal irritation a . A positive Brudzin ski’s sign or Kern ig’s sign

in dicates m en in geal irritation . b . Brudzin ski’s sign is tested with th e clien t in

th e supin e position . Th e n urse flexes th e cli- en t’s h ead (gen tly m oves th e h ead to th e ch est) an d th ere sh ould be n o reports of pain or resistan ce to th e n eck flexion ; a positive Brudzin ski’s sign is observed if th e clien t pas- sively flexes th e h ip an d kn ee in respo n se to n eck flexion an d reports pain in th e vertebral colum n .

c. Kern ig’s sign is positive wh en th e clien t flexes th e legs at th e h ip an d kn ee an d com plain s of pain alon g th e vertebral colum n wh en th e leg is exten ded .

15. Refer to Ch apter 62 for ad dition al n eurological assessm en ts an d diagn ostic tests.

16. Clien t teach in g a . Clien t sh ould avoid exposu re to en viron -

m en tal h azards (e.g., in secticides, lead). b . High -risk beh aviors th at can result in h ead

an d spin al cord in ju ries sh ould be avoided. c. Protective devices (e.g., a h elm et, body pads)

sh ould be worn wh en participatin g in h igh - risk beh aviors.

d . Seat belts sh ould always be worn . L. Fem ale gen italia an d reproductive tract

1. Su b jective d ata: Urin ary d ifficu lties o r sym p - to m s su ch as freq u en cy, u rgen cy, o r b u rn in g; vagin al d isch arge; p ain ; m en stru al an d o b stetri- cal h isto ries; o n set o f m en o p au se; m ed icatio n s b ein g taken ; sexu al activity an d th e u se o f co n - tracep tives; h isto ry o f sexu ally tran sm itted in fectio n s

2. O bjective data a . Use a calm an d relaxin g approach ; th e

exam in ation is em barrassin g for m an y wom en an d m ay be a difficult exp erien ce for an adolescen t.

b . Con sider th e clien t’s cultural backgroun d an d h er beliefs regardin g exam in ation of th e gen italia.

c. A com plete exam in ation will in clude th e extern al gen italia an d a vagin al exam in ation .

d . Th e n urse’s role is to prepare th e clien t for th e exam in ation an d to assist th e HCP, n urse practition er, or n urse m idwife.

e. Th e clien t is asked to em p ty h er bladder before th e exam in ation .

f. Th e clien t is placed in th e lith otom y position , an d a drape is placed across th e clien t.

3. Extern al gen italia a . Q uan tity an d distribution of h air b . Ch aracteristics of labia m ajo ra an d m in ora

(m ake n ote of an y in flam m ation , edem a, lesion s, or laceration s)

c. Ureth ral orifice is observed for color an d position .

d . Vagin al orifice (in tro itus) is in spected for in flam m ation , edem a, discoloration , dis- ch arge, an d lesion s.

e. Th e exam in er m ay ch eck Sken e’s an d Barth o- lin ’s glan ds for ten dern ess or disch arge (if dis- ch arge is presen t, color, odor, an d con sisten cy are n oted an d a culture of th e disch arge is obtain ed).

f. Th e clien t is assessed for th e presen ce of a cystocele (in wh ich a portion of th e vagin al wall an d blad der prolapse, or fall, in to th e orifice an teriorly) or a rectocele (bulgin g of th e posterior wall of th e vagin a caused by pro- lapse of th e rectum ).

4. Specu lum exam in ation of th e in tern al gen italia a . Perform ed by th e HCP, n urse practition er, or

n urse m idwife b . Perm its visu alization of th e cervix an d vagin a c. Papan icolaou (Pap ) sm ear (test): A pain less

screen in g test for cervical can cer is don e; th e specim en is obtain ed durin g th e speculum exam in ation , an d th e n urse h elps to prepare th e specim en for laborato ry an alysis.

5. Clien t teach in g a . Stress th e im p o rtan ce o f p erso n al h ygien e. b . Explain th e purpo se an d recom m en ded fre-

quen cy of Pap tests. c. Explain th e sign s of sexually tran sm itted

in fectio n s. d . Educate th e clien t on m easu res to preven t a

sexually tran sm itted in fectio n . e. In form th e clien t with a sexually tran sm itted

in fectio n th at sh e m ust in form h er sexual partn er(s) of th e n eed for an exam in ation .

M. Male gen italia 1. Subjective data: Urin ary difficulty (e.g., fre-

quen cy, urgen cy, h esitan cy or strain in g, dysuria, n octuria); pain , lesion s, or disch arge on or from

F

u

n

d

a

m

e

n

t

a

l

s

BOX 15-11 Scoring Deep Tendon Reflex Activity 0 ¼No response 1+¼Sluggish or diminished 2 +¼Active or expected response 3+¼Slightly hyperactive, more brisk than normal; not neces-

sarily pathological 4 +¼Brisk, hyperactive with intermittent clonus associated

with disease

Data from Wilson AF, Giddens JF: Health assessment for nursing practice, ed 5, St. Louis, 20 13, Mosby.

186 UNIT IV Fundamentals of Care

th e pen is; pain or lesion s in th e scrotum ; m edi- cation s bein g taken ; sexual activity an d th e use of con tracep tives; h istory of sexually tran sm itted in fectio n s

2. O bjective data a. In cludes assessm en t (in spection an d palpa-

tio n ) of th e extern al gen italia an d in guin al rin g an d can al

b . Clien t m ay stan d or lie down for th is exam in ation .

c. Gen italia are m an ipu lated gen tly to avoid cau sin g erection or discom fort.

d . Sexual m aturity is assessed by n otin g th e size an d sh ap e of th e pen is an d testes, th e color an d texture of th e scrotal skin , an d th e ch arac- ter an d distribution of pubic h air.

e. Th e pen is is ch ecked for th e presen ce of lesion s or disch arge; a culture is obtain ed if a disch arge is presen t.

f. Th e scrotum is in spected for size, sh ape, an d sym m etry (n orm ally th e left testicle h an gs lo wer th an th e righ t) an d is palpated for th e presen ce of lum ps.

g. In guin al rin g an d can al; in spection (askin g th e clien t to bear down ) an d palp ation are per- form ed to assess for th e presen ce of a h ern ia.

3. Clien t teach in g a. Stress th e im portan ce of perso n al h ygien e. b . Teach th e clien t h ow to perform testicular self-

exam ination (TSE); a day of the m on th is selected an d th e exam is perform ed on the sam e day each m on th after a shower or bath wh en th e h an ds are warm and soapy and the scrotum is warm . (Refer to Ch apter 48 for in form ation on perform in g TSE.)

c. Explain th e sign s of sexually tran sm itted in fectio n s.

d . Educate th e clien t on m easures to preven t sex- ually tran sm itted in fectio n s.

e. In form th e clien t with a sexually tran sm itted in fectio n th at h e m ust in form h is sexual part- n er(s) of th e n eed for an exam in ation .

N. Rectum an d an us 1. Subjective data: Usual bowel pattern ; an y ch an ge

in bowel h abits; rectal pain , bleedin g from th e rectum , or black or tarry stools; dietary h abits; problem s with urin ation ; previous screen in g for colorectal can cer; m edication s bein g taken ; h isto ry of rectal or colon problem s; fam ily h is- tory of rectal or colon problem s

2. O bjective data a. Exam in ation can detect colorectal can cer in

its early stages; in m en , th e rectal exam in ation can also detect prostate tum o rs.

b . Wom en m ay be exam in ed in th e lith otom y position after exam in ation of th e gen italia.

c. A m an is best exam in ed by h avin g th e clien t ben d forward with h is h ips flexed an d upper body restin g over th e exam in ation table.

d . A n on am bulatory clien t m ay be exam in ed in th e left lateral (Sim s’) position .

e. Th e extern al an us is in spected for lum ps or lesion s, rash es, in flam m ation or excoriation , scars, or h em orrh oid s.

f. Digital exam in ation will m ost likely be per- form ed by th e HCP or n urse practition er.

g. Digital exam in ation is perform ed to assess sph in cter ton e; to ch eck for ten dern ess, irreg- ularities, polyps, m asses, or n odules in th e rectal wall; an d to assess th e prostate glan d.

h . Th e prostate glan d is n orm ally firm , with out boggin ess, ten dern ess, or n odules (h ardn ess or n odules m ay in dicate th e presen ce of a can - cerous lesion ).

3. Clien t teach in g a. Diet sh ould in clude h igh -fiber an d lo w-fat

food s an d plen ty of liquid s. b . Th e clien t sh ould obtain regular digital

exam in ation s. c. Th e clien t sh o uld be able to iden tify th e

sym pto m s of colorectal can cer or prostatic can cer (m en ).

d . Th e clien t sh ould follow th e Am erican Can cer Society’s gu idelin es for screen in g for colorectal can cer.

VI. Documenting Health and Physical Assessment Findings

A. Docum en tation of fin din gs m ay be eith er written or recorded electron ically (depen d in g on agen cy protoco l).

B. Wh eth er written or electron ic, th e docum en tatio n is a legal docum en t an d a perm an en t record of th e cli- en t’s h ealth status.

C. Prin ciples of docum en tatio n n eed to be followed an d data n eed to be recorded accurately, con cisely, com pletely, legibly, an d objectively with ou t bias or opin ion s; always follow agen cy protoco l for docum en tatio n .

D. Docum en tation fin din gs serve as a source of clien t in form ation for oth er h ealth care providers; proce- dures for m ain tain in g con fiden tiality are always followed.

E. Record fin din gs ab out th e clien t’s h ealth h isto ry an d ph ysical exam in ation as soon as possible after com - pletion of th e h ealth assessm en t.

F. Refer to Ch apter 6 for addition al in form ation ab out docum en tatio n guidelin es.

F

u

n

d

a

m

e

n

t

a

l

s

187CHAPTER 15 Health and Physical Assessment of the Adult Client

F

u

n

d

a

m

e

n

t

a

l

s

CRITICAL THINKING What Should You Do? Answer: The carotid arteries are located in the groove between the trachea and sternocleidomastoid muscle, medial to and alongside the muscle. On assessment, the nurse should palpate 1 carotid artery at a time to avoid compromising blood flow to the brain. On auscultation, the nurse listens for the presence of a bruit (a blowing, swish- ing sound), which indicates blood flow turbulence. Normally a bruit is not present, so this finding necessitates the need for follow-up. Both carotid arteries should be auscultated. The nurse should notify the health care provider if a bruit is detected. The nurse should also document the findings.

Reference: Ignatavicius, Workman (20 16), p. 639.

P R A C T I C E Q U E S T I O N S 132. A Span ish -sp eakin g clien t arrives at th e triage desk

in th e em ergen cy dep artm en t an d states to th e n urse, “No speak En glish , n eed in terp reter.” Wh ich is th e b est action for th e n urse to take? 1. Have on e of th e clien t’s fam ily m em bers in terpret. 2. Have th e Span ish -speakin g triage reception ist

in terpret. 3. Page an in terpreter from th e h ospital’s in ter-

preter services. 4. O btain a Span ish -En glish diction ary an d

attem p t to triage th e clien t.

133. Th e n urse is perform in g a n eurological assessm en t on a clien t an d elicits a positive Rom b erg’s sign . Th e n urse m akes th is determ in ation based on wh ich observation ? 1. An in volun tary rh yth m ic, rapid, twitch in g of th e

eyeb alls 2. A dorsiflexion of th e an kle an d great toe with

fan n in g of th e oth er toes 3. A sign ifican t sway wh en th e clien t stan d s erect

with feet togeth er, arm s at th e side, an d th e eyes closed

4. A lack of n orm al sen se of position wh en th e cli- en t is un able to return exten ded fin gers to a poin t of referen ce

134. Th e n urse n otes docum en tation th at a clien t is exh ibitin g Ch eyn e-Stokes respiratio n s. O n assess- m en t of th e clien t, th e n urse sh o uld expect to n ote wh ich fin din g? 1. Rh yth m ic respiration s with periods of ap n ea 2. Regular rapid an d deep, sustain ed respiratio n s 3. Totally irregular respiration in rh yth m an d dep th 4. Irregular respiration s with pauses at th e en d of

in spiration an d expiration

135. A clien t diagn osed with con d uctive h earin g loss asks th e n urse to explain th e cau se of th e h earin g problem . Th e n urse plan s to explain to th e clien t th at th is con d ition is caused by wh ich problem ? 1. A defect in th e coch lea 2. A defect in cran ial n erve VIII 3. A ph ysical obstru ction to th e tran sm ission of

soun d waves 4. A defect in th e sen sory fib ers th at lead to th e

cerebral cortex

136. Wh ile perform in g a cardiac assessm en t on a clien t with an in com peten t h eart valve, th e n urse auscul- tates a m urm u r. Th e n urse docum en ts th e fin din g an d describes th e soun d as wh ich ? 1. Lub -dub soun ds 2. Scratch y, leath ery h eart n oise 3. A blowin g or swoosh in g n oise 4. Abrupt, h igh -pitch ed sn appin g n oise

137. Th e n urse is testin g th e extraocu lar m ovem en ts in a clien t to assess for m uscle weakn ess in th e eyes. Th e n urse sh ould im plem en t wh ich assess- m en t tech n iqu e to assess for m uscle weakn ess in th e eye? 1. Test th e corn eal reflexes. 2. Test th e 6 cardin al position s of gaze. 3. Test visu al acuity, usin g a Sn ellen eye ch art. 4. Test sen sory fun ction by askin g th e clien t to

close th e eyes an d th en ligh tly touch in g th e fore- h ead, ch eeks, an d ch in .

138. Th e n urse is in structin g a clien t h ow to perform a testicular self-exam in ation (TSE). Th e n urse sh ould explain th at wh ich is th e b est tim e to perform th is exam ? 1. After a sh ower or bath 2. Wh ile stan din g to void 3. After h avin g a bowel m ovem en t 4. Wh ile lyin g in bed befo re arisin g

139. Th e n urse is assessin g a clien t for m en in geal irrita- tion an d elicits a positive Brud zin ski’s sign . Wh ich fin din g did th e n urse observe? 1. Th e clien t rigidly exten ds th e arm s with

pron ated forearm s an d plan tar flexion of th e feet.

2. Th e clien t flexes a leg at th e h ip an d kn ee an d reports pain in th e vertebral colum n wh en th e leg is exten ded .

3. Th e clien t passively flexes th e h ip an d kn ee in respon se to n eck flexion an d reports pain in th e vertebral colum n .

4. Th e clien t’s upper arm s are flexed an d h eld tigh tly to th e sides of th e body an d th e legs are exten ded an d in tern ally rotated.

188 UNIT IV Fundamentals of Care

140. A clien t with a diagn osis of asth m a is adm itted to th e h ospital with respiratory distress. Wh ich typ e of adven titious lun g soun ds sh ould th e n urse expect to h ear wh en perform in g a respiratory assessm en t on th is clien t? 1. Stridor 2. Crackles 3. Wh eezes 4. Dim in ish ed

141. Th e clin ic n urse prepares to perform a focused assessm en t on a clien t wh o is com plain in g of

sym pto m s of a cold, a cough , an d lu n g con gestion . Wh ich sh ould th e n urse in clude for th is type of assessm en t? Select all th at ap p ly.

1. Auscu ltatin g lun g soun ds 2. O btain in g th e clien t’s tem p erature 3. Assessin g th e stren gth of periph eral pulses 4. O btain in g in form ation about th e clien t’s

respiratio n s 5. Perform in g a m usculoskeletal an d n eurolog-

ical exam in ation 6. Askin g th e clien t about a fam ily h istory of

an y illn ess or disease

A N S W E R S 132. 3 Ra t ion a le: Th e best actio n is to h ave a p ro fessio n al h osp ital- based in terpreter tran slate for th e clien t. En glish -sp eakin g fam - ily m em bers m ay n ot ap prop riately u n derstan d wh at is asked of th em an d m ay paraph rase wh at th e clien t is actually sayin g. Also, clien t con fiden tiality as well as accu rate in fo rm atio n m ay be co m prom ised wh en a fam ily m em ber o r a n on –h ealth care provid er acts as in terp reter. Test -Ta kin g St r a t egy: No te th e st r a t egic wo r d , best. In i- tially focus o n wh at th e clien t n eed s. In th is case th e clien t n eed s an d asks fo r an in terpreter. Next keep in m in d th e issue of co n fiden tiality an d m akin g sure th at in fo rm ation is ob tain ed in th e m o st efficien t an d accurate way. Th is will assist in elim in atin g o ptio n s 1, 2, an d 4. Review: Action s to take to ad dress la n gu a ge b a r r ier s Level of Cogn it ive Abilit y: Applyin g Clien t Needs: Psych o social In tegrity In t egr a t ed Pr ocess: Co m m u n icatio n an d Do cum en tatio n Con t en t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Com m un ication ; Culture Refer en ce: Jarvis (2016), p p. 45-46.

133. 3 Ra t ion a le: In Ro m berg’s test, th e clien t is asked to stan d with th e feet to geth er an d th e arm s at th e sid es, an d to clo se th e eyes an d h o ld th e p osition ; n orm ally th e clien t can m ain tain p os- tu re an d balan ce. A po sitive Ro m berg’s sign is a vestibu lar n eu - ro logical sign th at is foun d wh en a clien t exh ibits a loss of balan ce wh en clo sin g th e eyes. Th is m ay occur with cerebellar ataxia, lo ss of p ro prio cep tio n , an d loss o f vestibu lar fu n ctio n . A lack of n o rm al sen se of p osition cou pled with an in ability to retu rn exten ded fin gers to a p oin t of referen ce is a fin din g th at in d icates a prob lem with coo rd in ation . A po sitive gaze n ystag- m u s evalu ation results in an in volu n tary rh yth m ic, rap id twitch in g of th e eyeballs. A p ositive Bab in ski’s test results in do rsiflexio n o f th e an kle an d great to e with fan n in g o f th e o th er to es; if th is occu rs in an yo n e o ld er th an 2 years it in dicates th e presen ce o f cen tral n ervo u s system d isease. Test-Ta king Stra tegy: No te th e su b ject, Rom b erg’s sign . Yo u can easily an swer th is q uestio n if yo u can recall th at th e clien t’s balan ce is tested in th is test. Review: Ro m b er g’s t est

Level of Cogn it ive Abilit y: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a t ed Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clin ical Judgm en t; Mobility Refer en ces: Ign atavicius, Workm an (2016), p . 842; Jarvis (2016), p . 650.

134. 1 Ra tion a le: Ch eyn e-Sto kes respiration s are rh yth m ic respira- tion s with perio ds of ap n ea an d can in d icate a m etabo lic dys- fu n ctio n in th e cerebral h em isp h ere o r basal gan glia. Neurogen ic h yp erven tilatio n is a regular, rap id an d deep, sus- tain ed resp iratio n th at can in d icate a d ysfun ctio n in th e lo w m id brain an d m id dle po n s. Ataxic respiratio n s are to tally irreg- u lar in rh yth m an d d ep th an d in dicate a dysfu n ctio n in th e m ed ulla. Apn eu stic resp iratio n s are irregu lar respiratio n s with p auses at th e en d o f in sp iration an d expiratio n an d can in dicate a dysfu n ction in th e m idd le o r caud al p on s. Test -Ta kin g Str a t egy: Focus on th e su b ject , th e ch aracteris- tics of Ch eyn e-Stokes resp iratio n s. Recallin g th at p erio d s o f ap n ea o ccur with th is type of respiratio n will h elp d irect yo u to th e co rrect an swer. Review: Ch eyn e-St o k es r esp ir a t io n s Level of Cogn it ive Abilit y: Applyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a t ed Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clin ical Judgm en t; Gas Exch an ge Refer en ce: Jarvis (2016), p. 444.

135. 3 Ra tion a le: A co n d uctive h earin g loss occu rs as a result of a p h ysical ob stru ction to th e tran sm issio n o f sou n d waves. A sen - so rin eu ral h earin g loss o ccu rs as a result of a path olo gical pro- cess in th e in n er ear, a d efect in cran ial n erve VIII, or a defect o f th e sen so ry fib ers th at lead to th e cereb ral cortex. Test -Ta kin g St r a tegy: Focu s o n th e su b ject , a con ductive h earin g lo ss. Notin g th e relation sh ip o f th e word conductive in th e q uestion an d transmission in th e correct op tio n will direct yo u to th is o ptio n . Review: Co n d u ct ive h ea r in g lo ss an d s en s o r in eu r a l h ea r - in g lo ss

F

u

n

d

a

m

e

n

t

a

l

s

189CHAPTER 15 Health and Physical Assessment of the Adult Client

Level of Cogn itive Ability: Ap plyin g Clien t Needs: Ph ysio lo gical In tegrity In tegr a ted Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo pm en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior ity Con cepts: Clien t Ed ucatio n ; Sen sory Perceptio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1009.

136. 3 Ra tion a le: A h eart m urm u r is an ab n o rm al h eart so un d an d is d escrib ed as a fain t or lo ud blo win g, swo o sh in g sou n d with a h igh , m ed ium , o r lo w p itch . Lu b-d ub so un ds are n o rm al an d represen t th e S1 (first) h eart so un d an d S2 (secon d) h eart so un d, resp ectively. A p ericardial frictio n ru b is described as a scratch y, leath ery h eart soun d. A click is described as an ab ru pt, h igh -p itch ed sn app in g sou n d . Test-Ta king Stra tegy: Fo cu s o n th e su b ject, ch aracteristics o f a m u rm u r. Elim in ate o p tio n 1 b ecau se it d escrib es n o rm al h eart so u n d s. Next recall th at a m u rm u r o ccu rs as a resu lt o f th e m an - n er in wh ich th e b lo o d is flo win g th ro u gh th e card iac ch am - b ers an d valves. Th is will d irect yo u to th e co rrect o p tio n . Review: Hea r t m u r m u r Level of Cogn itive Ability: Ap plyin g Clien t Needs: Ph ysio lo gical In tegrity In tegr a ted Pr ocess: Com m un ication an d Docum en tation Con ten t Ar ea : Develo pm en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior ity Con cepts: Clin ical Ju d gm en t; Perfu sion Refer en ces: Ign ataviciu s, Wo rkm an (2016), p . 640; Jarvis (2016), p p. 464, 506.

137. 2 Ra tion a le: Testin g th e 6 card in al p o sition s of gaze is do n e to assess for m uscle weakn ess in th e eyes. Th e clien t is asked to h o ld th e h ead stead y, an d th en to fo llo w m o vem en t of an o bject th ro ugh th e po sitio n s o f gaze. Th e clien t sh o uld follow th e o bject in a p arallel m an n er with th e 2 eyes. A Sn ellen eye ch art assesses visual acu ity an d cran ial n erve II (o p tic) . Testin g sen sory fun ction b y h avin g th e clien t clo se h is or h er eyes an d th en ligh tly to uch in g areas o f th e face an d testin g th e corn eal reflexes assess cran ial n erve V (trigem in al). Test -Ta kin g Str a t egy: Fo cu s on th e su b ject , assessin g fo r m uscle weakn ess in th e eyes. No te th e relatio n sh ip b etween th e words extraocular movements in th e q uestion an d positions of gaze in th e co rrect o p tion . Review: Ph ysical assessm en t tech n iq ues fo r m u scle wea k n ess in t h e eyes Level of Cogn itive Ability: Ap plyin g Clien t Needs: Ph ysio lo gical In tegrity In tegr a ted Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Develo pm en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior ity Con cepts: Clin ical Ju d gm en t; Sen so ry Percep tion Refer en ces: Ign ataviciu s, Wo rkm an (2016), p p. 972-973; Jarvis (2016), p . 313.

138. 1 Ra tion a le: Th e n u rse n eed s to teach th e clien t h ow to p erfo rm a TSE. Th e n urse sh ou ld in stru ct th e clien t to p erfo rm th e exam o n th e sam e day each m o n th . Th e n u rse sh o uld also in stru ct th e

clien t th at th e b est tim e to perfo rm a TSE is after a sh ower o r bath wh en th e h an ds are warm an d soapy an d th e scrotum is warm . Palpatio n is easier an d th e clien t will b e b etter ab le to id en tify an y ab n o rm alities. Th e clien t wo u ld stan d to p erfo rm th e exam , b ut it wou ld b e d ifficult to p erfo rm th e exam wh ile vo id in g. Havin g a bo wel m o vem en t is un related to perform in g a TSE. Test-Ta kin g St r a t egy: Note th e st r a t egic wo r d , best. Th in k abo u t th e p urpo se of th is test an d visu alize th is assessm en t tech n iq u e to an swer correctly. Review: Test icu la r self-exa m in a t io n Level of Cogn itive Abilit y: Ap plyin g Clien t Needs: Health Pro m otio n an d Main ten an ce In tegr a ted Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo pm en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior ity Con cepts: Clien t Ed ucation ; Sexu ality Refer en ces: Ign ataviciu s, Wo rkm an (2016), p. 1513; Jarvis (2016), pp . 704-705.

139. 3 Ra t ion a le: Bru dzin ski’s sign is tested with th e clien t in th e su pin e p ositio n . Th e n u rse flexes th e clien t’s h ead (gen tly m o ves th e h ead to th e ch est) an d th ere sh o u ld be n o rep orts of pain or resistan ce to th e n eck flexion . A positive Bru dzin ski’s sign is o bserved if th e clien t passively flexes th e h ip an d kn ee in respon se to n eck flexion an d reports pain in th e vertebral col- u m n . Kern ig’s sign also tests fo r m en in geal irritatio n an d is p o s- itive wh en th e clien t flexes th e legs at th e h ip an d kn ee an d com plain s of pain alon g th e verteb ral colu m n wh en th e leg is exten ded . Deco rticate po sturin g is abn o rm al flexion an d is n o ted wh en th e clien t’s up per arm s are flexed an d h eld tigh tly to th e sides of th e bo dy an d th e legs are exten d ed an d in tern ally rotated. Decerebrate po sturin g is abn orm al exten sio n an d o ccurs wh en th e arm s are fu lly exten d ed, fo rearm s pron ated, wrists an d fin gers flexed, jaws clen ch ed, n eck exten ded, an d feet p lan tar-flexed. Test-Ta kin g St r a tegy: Fo cus on th e su b ject , a positive Brud- zin ski’s sign . Recallin g th at a p ositive sign is elicited if th e clien t reports pain will assist in elim in atin g op tion s 1 an d 4. Next it is n ecessary to kn o w th at a po sitive Bru d zin ski’s sign is ob served if th e clien t p assively flexes th e h ip an d kn ee in respo n se to n eck flexion an d rep orts p ain in th e verteb ral co lu m n . Review: Br u d zin sk i’s sign Level of Cogn itive Abilit y: Ap plyin g Clien t Needs: Ph ysio lo gical In tegrity In tegr a ted Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Develo pm en tal Stages—Health Assessm en t/ Ph ysical Exam Pr iority Con cepts: Clin ical Ju dgm en t; In tracran ial Regulation Refer en ce: Jarvis (2016), p . 688.

140. 3 Ra t ion a le: Asth m a is a respiratory d isord er ch aracterized b y recurrin g episo des of d yspn ea, con strictio n of th e b ro n ch i, and wheezin g. Wheezes are described as h igh-pitch ed m usical sounds h eard when air p asses th rough an obstru cted or n arro wed lum en o f a respiratory passageway. Strido r is a h arsh soun d n oted with an u pp er airway obstruction and o ften sign als a life-th reaten in g em ergen cy. Crackles are p ro du ced b y air passin g over retain ed air- way secretions or fluid, or the sudden open in g of collapsed

F

u

n

d

a

m

e

n

t

a

l

s

190 UNIT IV Fundamentals of Care

airways. Dim in ish ed lun g sou n ds are h eard o ver lun g tissue wh ere poor o xygen exch an ge is occurrin g. Test -Ta kin g Str a tegy: Note th e su b ject, assessm en t of abn or- m al lun g soun ds. Note the client’s diagn osis and th ink about the path oph ysiology th at occurs in th is disorder. Recallin g th at bron - ch ial con striction occurs will assist in directin g you to th e correct option . Also, th in kin g about th e defin ition of each adven titious lun g soun d iden tified in th e option s will direct you to th e correct option . Review: Ad ven t it io u s lu n g so u n d s Level of Cogn it ive Abilit y: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a t ed Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clin ical Judgm en t; Gas Exch an ge Refer en ces: Ign atavicius, Workm an (2016), p p . 506-507; Jarvis (2016), p . 447.

141. 1, 2, 4 Ra t ion a le: A focused assessm en t focuses o n a lim ited or sh ort-term p ro blem , such as th e clien t’s com plain t. Because the clien t is com plain in g o f sym ptom s of a cold , a cou gh , and lu n g

con gestio n, th e n urse wou ld focu s o n th e respiratory system an d th e presen ce of an in fectio n. A com plete assessm en t in clu des a com plete h ealth h isto ry an d p h ysical exam in atio n an d form s a b aselin e d atab ase. Assessin g the stren gth o f p eriph eral p ulses relates to a vascular assessm en t, wh ich is n ot related to th is clien t’s com plain ts. A m u sculoskeletal an d n euro logical exam in atio n also is n ot related to th is clien t’s com p lain ts. However, stren gth o f p eriph eral p ulses and a m uscu lo skeletal an d n eu ro lo gical exam in ation would b e in clu ded in a com plete assessm en t. Likewise, askin g th e clien t about a fam ily h istory o f any illn ess o r d isease wou ld b e in clu ded in a com plete assessm en t. Test -Ta kin g St r a t egy: Focus o n th e su b ject an d n o te th e words focused assessment. Notin g th at th e clien t’s sym pto m s relate to th e resp irato ry system an d th e presen ce o f an in fection will direct you to th e correct option s. Review: Fo cu sed a ssessm en t s Level of Cogn it ive Abilit y: An alyzin g Clien t Needs: Health Pro m o tion an d Main ten an ce In t egr a t ed Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clin ical Judgm en t; Gas Exch an ge Refer en ces: Jarvis (2016), p . 7; Lewis et al. (2014), p p . 44-45.

F

u

n

d

a

m

e

n

t

a

l

s

191CHAPTER 15 Health and Physical Assessment of the Adult Client

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 16 Provision of a Safe Environment

PRIORITY CONCEPTS Infection, Safety

CRITICAL THINKING What Should You Do? The nurse is working in a long-term care facility that has a “no restraint policy.” An assigned client is disoriented and unsteady and continually attempts to climb out of bed. What should the nurse do with regard to instituting safety precau- tions for this client? Answer located on p. 199.

I. Environmental Safety A. Fire safety (see Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Event of a Fire 1. Rescue clients who are in immediate danger. 2. Activate the fire alarm. 3. Confine the fire. 4. Extinguish the fire.

a . Obtain the fire extinguisher. b . Pull the pin on the fire extinguisher. c. Aim at the base of the fire. d . Squeeze the extinguisher handle. e. Sweep the extinguisher from side to side to coat the

area of the fire evenly. Remember the mnemonic RACE to prioritize in the event of a fire. R is rescue clients in immediate danger, A is alarm (sound the alarm), C is confine the fire by closing all doors, and E is extinguish. To properly use the fire extinguisher, remember the mnemonic PASS to prioritize in the use of a fire extinguisher. P is pull the pin, A is aim at the base of the fire, S is squeeze the handle, and S is sweep from side to side to coat the area evenly.

Reference Perry, Potter, Ostendorf (2014), pp. 313-314.

1. Keep open spaces free of clu tter. 2. Clearly m ark fire exits. 3. Kn ow th e lo cation s of all fire alarm s, exits, an d

extin guish ers (Table 16-1; also see Priority Nursin g Action s).

4. Kn ow th e telep h on e n um ber for reportin g fires. 5. Kn ow th e fire drill an d evacuatio n plan of th e

agen cy. 6. Never use th e elevator in th e even t of a fire. 7. Turn off oxygen an d applian ces in th e vicin ity of

th e fire. 8. In th e even t of a fire, if a clien t is on life support,

m ain tain respiratory status m an ually with an Am bu bag (resuscitation bag) un til th e clien t is m oved away from th e th reat of th e fire an d can be placed back on life supp ort.

9. In th e even t of a fire, am bulatory clien ts can be directed to walk by th em selves to a safe area an d, in som e cases, m ay be ab le to assist in m ov- in g clien ts in wh eelch airs.

10. Bedrid den clien ts gen erally are m oved from th e scen e of a fire by stretch er, th eir bed, or wh eelch air.

11. If a clien t m ust be carried from th e area of a fire, appropriate tran sfer tech n iqu es n eed to be used.

12. If fire departm en t person n el are at th e scen e of th e fire, th ey will h elp to evacu ate clien ts.

Remember the mnemonic RACE (Rescue clients, Activate the fire alarm, Confine the fire, Extinguish the fire) to set priorities in the event of a fire and the mne- monic PASS (Pull the pin, Aim at the base of the fire, Squeeze the handle, Sweep from side to side) to use a fire extinguisher.

B. Electrical safety 1. Electrical equ ipm en t m ust be m ain tain ed in

good workin g order an d sh ould be groun d ed; oth erwise, it presen ts a physical hazard.

2. Use a 3-pron ged electrical cord.

192

F

u

n

d

a

m

e

n

t

a

l

s

3. In a 3-pron ged electrical cord, th e th ird, lon ger pron g of th e cord is th e grou n d; th e oth er 2 pron gs carry th e power to th e piece of electrical equ ipm en t.

4. Ch eck electrical cords an d outlets for exposed, frayed , or dam aged wires.

5. Avo id overloadin g an y circuit. 6. Read warn in g labels on all equip m en t; n ever

operate un fam iliar equ ipm en t. 7. Use safety exten sion cords on ly wh en absolutely

n ecessary, an d tape th em to th e flo or with electrical tape.

8. Never run electrical wirin g un d er carpets. 9. Never pull a plug by usin g th e cord; always grasp

th e plug itself. 10. Never use electrical applian ces n ear sin ks, bath -

tubs, or oth er water sources. 11. Always discon n ect a plug from th e outlet before

clean in g equ ipm en t or applian ces. 12. If a clien t receives an electrical sh o ck, turn off th e

electricity before touch in g th e clien t.

Any electrical equipment that the client brings into the health care facility must be inspected for safety before use.

C. Rad iation safety 1. Kn o w th e protoco ls an d gu idelin es of th e h ealth

care agen cy. 2. Label poten tially radioactive m aterial. 3. To reduce exposu re to radiation , do th e

followin g. a. Lim it th e tim e spen t n ear th e source. b . Make th e distan ce from th e source as great as

possible. c. Use a sh ieldin g device such as a lead ap ron .

4. Mon itor radiation exp osure with a film (do sim eter) badge.

5. Place th e clien t wh o h as a radiation im plan t in a private room .

6. Never touch dislodged radiation im plan ts. 7. Keep all lin en s in th e clien t’s room un til th e

im plan t is rem oved. D. Disp osal of in fectio us wastes

1. Han dle all in fectio us m aterials as a h azard. 2. Disp ose of waste in design ated areas on ly, usin g

proper con tain ers for disposal. 3. En su re th at in fectio us m aterial is labeled

properly.

4. Disp ose of all sh arps im m ediately after use in clo sed, pun cture-resistan t disposal con tain ers th at are leak-proo f an d labeled or color-coded.

Needles (sharps) should not be recapped, bent, or broken because of the risk of accidental injury (needle stick).

E. Ph ysiological ch an ges in th e older clien t th at in crease th e risk of acciden ts ( Box 16-1)

F. Risk for falls assessm en t 1. Sh o uld be clien t-cen tered an d in clude th e use of

a fall risk scale per agen cy proced ures 2. In clude th e clien t’s own percep tion s of th eir risk

facto rs for falls an d th eir m eth od to adapt to th ese factors. Areas of con cern m ay in clude gait stability, m uscle stren gth an d coordin ation , bal- an ce, an d vision .

3. Assess for an y previous acciden ts. 4. Assess with th e clien t an y co n cern s ab out th eir

im m ediate en viron m en t, in cludin g stairs, use of th row ru gs, grab bars, or a raised toilet seat.

5. Review th e m ed ication s th at th e clien t is takin g th at could h ave a side or adverse effect or side/ adverse effects th at could place th e clien t at risk for a fall.

6. Determ in e an y sch eduled proced ures th at pose risks to th e clien t.

G. Measu res to preven t falls (Box 16-2) H. Measu res to prom o te safety in am bulation for th e

clien t

TABLE 16-1 Types of Fire Extinguishers Type Class of Fire

A Wood, cloth, upholstery, paper, rubbish, plastic

B Flammable liquids or gases, grease, tar, oil-based paint

C Electrical equipment

BOX 16-1 Physiological Changes in Older Clients That Increase the Risk of Accidents

Musculoskeletal Changes Strength and function of muscles decrease. Joints become less mobile and bones become brittle. Postural changes and limited range of motion occur.

Nervous System Changes Voluntary and autonomic reflexes become slower. Decreased ability to respond to multiple stimuli occurs. Decreased sensitivity to touch occurs.

Sensory Changes Decreased vision and lens accommodation and cataracts

develop. Delayed transmission of hot and cold impulses occurs. Impaired hearing develops, with high-frequency tones less

perceptible.

Genitourinary Changes Increased nocturia and occurrences of incontinence may

occur.

Adapted from Potter A, Perry P, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby; and Touhy T, Jett K: Ebersole and Hess’ toward healthy aging, ed 8, St. Louis, 20 12, Mosby.

193CHAPTER 16 Provision of a Safe Environment

1. Gait belt m ay be used to keep th e cen ter of gravity m idlin e. a . Place th e belt on th e clien t prior to

am bulation . b . En circle th e clien t’s waist with th e belt. c. Hold on to th e side or back of th e belt so th at

th e clien t does n ot lean to 1 side. d . Return th e clien t to bed or a n earby ch air if

th e clien t develops dizzin ess or beco m es un steady.

I. Steps to preven t in jury to th e h ealth care worker (Box 16-3)

J. Restraints (safety devices) 1. Restrain ts (safety devices) are protective devices

used to lim it th e ph ysical activity of a clien t or to im m ob ilize a clien t or an extrem ity. a . Th e agen cy policy sh o uld be ch ecked wh en

applyin g side rails. b . Th e use of side rails is n ot con sidered a

restrain t wh en th ey are used to preven t a sed ated clien t from fallin g out of bed .

c. Th e clien t m ust be able to exit th e bed easily in case of an em ergen cy wh en usin g side rails. O n ly th e top 2 side rails sh ould be used.

d . Th e bed m ust be kept th e in th e lowest posi- tion wh en usin g side rails.

2. Physical restraints restrict clien t m ovem en t th rou gh th e application of a device.

3. Chemical restraints are m edication s given to in h ib it a specific beh avior or m ovem en t.

4. In terven tion s a . Use altern ative devices, such as pressure-

sen sitive bed s or ch air pads with alarm s or oth er types of bed or ch air alarm s, wh en ever possib le.

b . If restrain ts are n ecessary, th e h ealth care pro- vider’s (HCP’s) prescription s sh ould state th e type of restrain t, id en tify specific clien t beh av- iors for wh ich restrain ts are to be used, an d iden tify a lim ited tim e fram e for use.

c. Th e HCP’s prescription s for restrain ts sh ould be ren ewed with in a specific tim e fram e acco rdin g to agen cy policy.

d . Restrain ts are n ot to be prescribed PRN (as n eeded) .

e. Th e reason for th e safety device sh ould be given to th e clien t an d th e fam ily, an d th eir perm ission sh o uld be sough t.

f. Restrain ts sh ould n ot in terfere with an y treat- m en ts or affect th e clien t’s h ealth problem .

g. Use a h alf-bo w or safety kn ot (quick release tie) or a restrain t with a quick release buckle to secure th e device to th e bed fram e or ch air, n ot to th e side rails.

h . En sure th at th ere is en ough slack on th e straps to allow som e m ovem en t of th e body part.

i. Assess skin in tegrity an d n eurovascular an d circulatory status every 30 m in utes an d rem ove th e safety device at least every 2 h ours to perm it m uscle exercise an d to prom ote cir- culation (fo llow agen cy policies).

j. Con tin ually assess an d docum en t th e n eed for safety devices (Box 16-4).

k . O ffer fluids if clin ically in dicated every 2 h ours.

l. O ffer bedpan or toiletin g every 2 h ours.

An HCP’s prescription for use of a safety device (restraint) is needed. Alternative measures for safety devices should always be used first.

5. Altern atives to safety devices a . O rien t th e clien t an d fam ily to th e

surroun din gs. b . Explain all proced ures an d treatm en ts to th e

clien t an d fam ily. c. En cou rage fam ily an d frien d s to stay with th e

clien t, an d use sitters for clien ts wh o n eed supervision .

F

u

n

d

a

m

e

n

t

a

l

s

BOX 16-2 Measures to Prevent Falls ▪ Assess the client’s risk for falling. ▪ Assign the client at risk for falling to a room near the

nurses’ station. ▪ Alert all personnel to the client’s risk for falling. ▪ Assess the client frequently. ▪ Orient the client to physical surroundings. ▪ Instruct the client to seek assistance when getting up. ▪ Explain the use of the nurse call system. ▪ Use safety devices such as floor pads, and bed or chair

alarms that alert health care personnel of the person get- ting out of bed or a chair.

▪ Keep the bed in the low position with side rails adjusted to a safe position (follow agency policy).

▪ Lock all beds, wheelchairs, and stretchers. ▪ Keep clients’ personal items within their reach. ▪ Eliminate clutter and obstacles in the client’s room. ▪ Provide adequate lighting. ▪ Reduce bathroom hazards. ▪ Maintain the client’s toileting schedule throughout the

day.

BOX 16-3 Steps to Prevent Injury to the Health Care Worker When Moving a Client

▪ Use available safety equipment. ▪ Keep the weight to be lifted as close to the body as

possible. ▪ Bend at the knees. ▪ Tighten abdominal muscles and tuck the pelvis. ▪ Maintain the trunk erect and knees bent so that multiple

muscle groups work together in a coordinated manner.

Adapted from Potter A, Perry P, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

194 UNIT IV Fundamentals of Care

d . Assign con fused an d disorien ted clien ts to ro om s n ear th e n urses’ station .

e. Provide ap propriate visu al an d auditory stim - uli, such as a n igh t ligh t, clo cks, calen dars, television , an d a radio, to th e clien t.

f. Place fam iliar item s, such as fam ily pictures, n ear th e clien t’s bed side.

g. Main tain toiletin g routin es. h . Elim in ate both erso m e treatm en ts, such as

n aso gastric tube feedin gs, as soon as possib le. i. Evaluate all m edication s th at th e clien t is

receivin g. j. Use relaxation tech n iqu es with th e clien t. k . In stitute exercise an d am bulation sch edules

as th e clien t’s co n dition allows. l. Collaborate with th e HCP to evalu ate oxygen -

ation status, vital sign s, electrolyte/ laboratory values, an d oth er pertin en t assessm en t fin d- in gs th at m ay provide in form ation ab out th e cau se of th e clien t’s con fusion .

K. Poison s 1. A poison is an y substan ce th at im pairs h ealth or

destroys life wh en in gested, in h aled, or oth er- wise absorbed by th e body.

2. Specific an tidotes or treatm en ts are available on ly for som e types of poison s.

3. Th e cap acity of body tissue to recover from a poi- son determ in es th e reversibility of th e effect.

4. Poison can im pair th e respiratory, circulatory, cen tral n ervous, h epatic, gastro in testin al, an d ren al system s of th e body.

5. Th e toddler, th e presch oo ler, an d th e yo un g sch o ol-age ch ild m ust be protected from acciden - tal poison in g.

6. In older adults, dim in ish ed eyesigh t an d im paired m em ory m ay result in acciden tal in ges- tio n of poison ous substan ces or an overdose of prescribed m ed ication s.

7. A Poison Con trol Cen ter ph on e n um ber sh ould be visible on th e telep h on e in h om es with sm all ch ildren ; in all cases of susp ected poison in g, th e n um ber sh o uld be called im m ediately.

8. In terven tion s a. Rem o ve an y obvious m aterials from th e

m ou th , eyes, or body area im m ediately.

b . Iden tify th e type an d am oun t of substan ce in gested.

c. Call th e Poison Con trol Cen ter before attem p tin g an in terven tion .

d . If th e victim vom its or vo m itin g is in du ced, save th e vom itus if requested to do so, an d deliver it to th e Poison Con trol Cen ter.

e. If in structed by th e Poison Con trol Cen ter to take th e person to th e em ergen cy dep artm en t, call an am bulan ce.

f. Never in du ce vom itin g followin g in gestio n of lye, h ouseh old clean ers, grease, or petroleum produ cts.

g. Never in du ce vom itin g in an un co n scious victim .

The Poison Control Center should be called first before attempting an intervention.

II. Health Care–Associated (Nosocomial) Infections A. Health care–associated (n osocom ial) in fectio n s also

are referred to as hospital-acquired infections. B. Th ese in fectio n s are acquired in a h ospital or oth er

h ealth care facility an d were n ot presen t or in cubat- in g at th e tim e of a clien t’s adm ission .

C. Clostridium difficile is spread m ain ly by h an d-to-h an d con tact in a h ealth care settin g. Clien ts takin g m ultiple an tibiotics for a prolon ged period are m ost at risk.

D. Com m on drug-resistan t in fectio n s: Van com ycin - resistan t en terococci, m eth icillin -resistan t Staphylo- coccus aureus, m ultidrug-resistan t tuberculosis, carbapen em -resistan t En terobacteriaceae (CRE)

E. Illn ess an d som e m ed ication s such as im m un osup- pressan ts im pair th e n orm al defen se m ech an ism s.

F. Th e h ospital en viron m en t provides exposure to a variety of virulen t organ ism s th at th e clien t h as n ot been exposed to in th e past; th erefore, th e clien t h as n ot developed resistan ce to th ese organ ism s.

G. In fection s can be tran sm itted by h ealth care perso n - n el wh o fail to practice proper h an d-wash in g proce- dures or fail to ch an ge gloves between clien t con tacts.

H. At m an y h ealth care agen cies, dispen sers con tain in g an alcoh ol-based solution for h an d san itization are m ou n ted at th e en tran ce to each clien t’s room ; it is im portan t to n ote th at alcoh ol-based san itizers are n ot effective again st som e in fectio us agen ts such as Clostridium difficile spores.

III. Standard Precautions A. Description

1. Nu rses m ust practice stan dard precaution s with all clien ts in an y settin g, regardless of th e diagn o- sis or presu m ed in fectiven ess.

2. Stan dard precaution s in clude h an d wash in g an d th e use of gloves, m asks, eye protection , an d gown s, wh en appropriate, for clien t con tact.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 16-4 Documentation Points with Use of a Safety Device (Restraint)

▪ Reason for safety device ▪ Method of use for safety device ▪ Date and time of application of safety device ▪ Duration of use of safety device and client’s response ▪ Release from safety device with periodic exercise and circu-

latory, neurovascular, and skin assessment ▪ Assessment of continued need for safety device ▪ Evaluation of client’s response

195CHAPTER 16 Provision of a Safe Environment

F

u

n

d

a

m

e

n

t

a

l

s

3. Th ese precaution s apply to blood , all body fluids (wh eth er or n ot th ey con tain blood ), secretio n s an d excretion s, n on in tact skin , an d m ucous m em bran es.

B. In terven tion s 1. Wash h an ds between clien t con tacts; after con -

tact with blood , body flu ids, secretio n s or excre- tion s, n on in tact skin , or m ucou s m em bran es; after co n tact with equipm en t or co n tam in ated articles; an d im m ediately after rem ovin g gloves.

2. Wear gloves wh en touch in g blood, body fluids, secretion s, excretion s, n onin tact skin , m ucous m em bran es, or con tam in ated item s; rem ove gloves an d wash h an ds between clien t care contacts.

3. For ro utin e deco n tam in ation of h an ds, use alcoh ol-based h an d rubs wh en h an ds are n ot vis- ibly soiled. For m ore in form ation on h an d h ygien e from th e Cen ters for Disease Con trol an d Preven tion (CDC), see www.cdc.gov/ h an dh ygien e/

4. Wear m asks an d eye protectio n , or face sh ield s, if clien t care activities m ay gen erate splash es or sprays of blood or body flu id.

5. Wear gown s if soilin g of cloth in g is likely from blood or body fluid ; wash h an ds after rem ovin g a gown .

6. Steps for don n in g an d rem ovin g person al protec- tive equ ipm en t (PPE) (Table 16-2)

7. Clean an d reprocess clien t care equ ipm en t prop- erly an d discard sin gle-u se item s.

8. Place con tam in ated lin en s in leak-proo f bags an d lim it h an dlin g to preven t skin an d m ucous m em bran e exposu re.

9. Use n eedleless devices or special n eedle safety devices wh en ever possible to reduce th e risk of n eedle sticks an d sh arps in juries to h ealth care workers.

10. Discard all sh arp in strum en ts an d n eedles in a pun cture-resistan t con tain er; dispose of n eedles un cap ped or en gage th e safety m ech an ism on th e n eedle if available.

11. Clean spills of blood or body flu ids with a solu- tion of bleach an d water (diluted 1:10) or agen cy-appro ved disin fectan t.

Handle all blood and body fluids from all clients as if they were contaminated.

IV. Transmission-Based Precautions A. Tran sm issio n -based precaution s in clude airborn e,

droplet, an d con tact precaution s. B. Airborn e precaution s

1. Diseases a . Measles b . Ch icken pox (varicella) c. Dissem in ated varicella zoster d . Pulm o n ary or laryn geal tubercu losis

2. Barrier protectio n a . Sin gle room is m ain tain ed un der n egative

pressure; door rem ain s closed except upon en terin g an d exitin g.

b . Negative airflow pressure is used in th e room , with a m in im um of 6 to 12 air exch an ges per h our via h igh -efficien cy particulate air (HEPA) filtration m ask or accordin g to agen cy protocol.

c. Ultraviolet germ icide irradiation or HEPA fil- ter is used in th e ro om .

d . Health care workers wear a respiratory m ask (N95 or h igh er level). A surgical m ask is placed on th e clien t wh en th e clien t n eeds to leave th e room ; th e clien t leaves th e room on ly if n ecessary.

C. Droplet precaution s 1. Diseases

a . Aden ovirus b . Diph th eria (ph aryn geal) c. Epiglottitis d . In fluen za (flu) e. Men in gitis f. Mum ps g. Mycoplasm al pn eum on ia or m en in go coccal

pn eum on ia

TABLE 16-2 Steps for Donning and Removing Personal Protective Equipment (PPE)

Donning of PPE Removal of PPE*

Gown Gloves Fully cover front of body from neck to knees and upper arms to end of wrist Fasten in the back at neck and waist, wrap around the back

Grasp outside of glove with opposite hand with glove still on and peel off Hold on to removed glove in gloved hand Slide fingers of ungloved hand under clean side of remaining glove at wrist and peel off

Mask or Respirator Goggles/ Face Shield Secure ties or elastic band at neck and middle of head Fit snug to face and below chin Fit to nose bridge Respirator fit should be checked per agency policy

Remove by touching clean band or inner part

Goggles/ Face Shield Gown Adjust to fit according to agency policy

Unfasten at neck, then at waist Remove using a peeling motion, pulling gown from each shoulder toward the hands Allow gown to fall forward, and roll into a bundle to discard

Gloves Mask or Respirator Select appropriate size and extend to cover wrists of gown

Grasp bottom ties then top ties to remove

*Note: All equipment is considered contaminated on the outside.

196 UNIT IV Fundamentals of Care

h . Parvovirus B19 i. Pertussis j. Pn eum on ia k . Rubella l. Scarlet fever m . Sepsis n . Strepto coccal ph aryn gitis

2. Barrier protectio n a. Private ro om or coh o rt clien t (a clien t

wh ose body cultures con tain th e sam e organ ism )

b . Wear a surgical m ask wh en with in 3 feet of a clien t.

c. Place a m ask on th e clien t wh en th e clien t n eeds to leave th e ro om .

D. Con tact precaution s 1. Diseases

a. Colon izatio n or in fectio n with a m ultidrug- resistan t organ ism

b . En teric in fectio n s, such as Clostridium difficile c. Resp iratory in fectio n s, such as respiratory

syn cytial virus d . In fluen za: In fection can occur by touch in g

som eth in g with flu viruses on it an d th en touch in g th e m outh or n ose.

e. Woun d in fection s f. Skin in fectio n s, such as cutan eous diph th eria,

h erpes sim plex, im petigo, ped iculo sis, sca- bies, staph yloco cci, an d varicella zoster

g. Eye in fectio n s, such as co n jun ctivitis h . In direct con tact tran sm ission m ay occur

wh en con tam in ated object or in strum en t, or h an ds, are en coun tered.

2. Barrier protectio n a. Private room or coh ort clien t b . Use gloves an d a go wn wh en ever en terin g th e

clien t’s room .

V. Emergency Response Plan and Disasters A. Kn o w th e em ergen cy respo n se plan of th e agen cy. B. Internal disasters are th o se th at occur with in th e

h ealth care facility. C. External disasters occur in th e com m un ity, an d vic-

tim s are brough t to th e h ealth care facility for care. D. Wh en th e h ealth care facility is n otified of a disaster,

th e n urse sh o uld follo w th e guidelin es specified in th e em ergen cy respon se plan of th e facility.

E. See Ch apter 7 for ad dition al in form ation on disaster plan n in g.

In the event of a disaster, the emergency response plan is activated immediately.

VI. Biological Warfare Agents A. A warfare agen t is a biological or ch em ical substan ce

th at can cause m ass destru ction or fatality. B. An th rax (Fig. 16-1)

1. Th e disease is cau sed by Bacillus anthracis an d can be con tracted th rou gh th e digestive system , ab ra- sion s in th e skin , or in h alation th rough th e lun gs.

2. An th rax is tran sm itted by direct con tact with bac- teria an d spores; spores are dorm an t en capsulated bacteria th at becom e active when th ey enter a liv- ing h ost (n o person -to-person spread) (Box 16-5).

3. Th e in fection is carried to th e lym p h n odes an d th en spreads to th e rest of th e body by way of th e blood an d lym ph ; h igh levels of toxin s lead to sh ock an d death .

4. In th e lu n gs, an th rax can cause buildup of fluid, tissue decay, an d death (fatal if un treated).

5. A blood test is available to detect an th rax (detects an d am plifies Bacillus anthracis DNA if presen t in th e blood sam ple).

6. An th rax is usually treated with an tibiotics such as cip rofloxacin , doxycyclin e, or pen icillin .

7. Th e vaccin e for an th rax h as lim ited availability.

F

u

n

d

a

m

e

n

t

a

l

s

FIGURE 16-1 Anthrax. (From Swartz, 2010.)

BOX 16-5 Anthrax: Transmission and Symptoms

Skin Spores enter the skin through cuts and abrasions and are con-

tracted by handling contaminated animal skin products. Infection starts with an itchy bump like a mosquito bite that

progresses to a small liquid-filled sac. The sac becomes a painless ulcer with an area of black, dead

tissue in the middle. Toxins destroy surrounding tissue.

Gastrointestinal Infection occurs following the ingestion of contaminated

undercooked meat. Symptoms begin with nausea, loss of appetite, and vomiting. The disease progresses to severe abdominal pain, vomiting of

blood, and severe diarrhea.

Inhalation Infection is caused by the inhalation of bacterial spores, which

multiply in the alveoli. The disease begins with the same symptoms as the flu, includ-

ing fever, muscle aches, and fatigue. Symptoms suddenly become more severe with the develop-

ment of breathing problems and shock. Toxins cause hemorrhage and destruction of lung tissue.

197CHAPTER 16 Provision of a Safe Environment

C. Sm allpox ( Fig. 16-2) 1. Sm allpox is tran sm itted in air droplets an d by

h an dlin g con tam in ated m aterials an d is h igh ly con tagious.

2. Sym pto m s begin 7 to 17 days after exp osure an d in clude fever, back pain , vom itin g, m alaise, an d h ead ach e.

3. Papules develop 2 days after sym ptom s develop an d progress to pustu lar vesicles th at are ab un - dan t on th e face an d extrem ities in itially.

4. A vaccin e is available to th o se at risk for exp osure to sm allpox.

D. Botulism 1. Botulism is a serious paralytic illn ess caused by a

n erve toxin produced by th e bacterium Clostrid- ium botulinum (death can occur with in 24 h ou rs).

2. Its spores are foun d in th e soil an d can spread th rou gh th e air or food (im pro perly can n ed food ) or via a con tam in ated woun d.

3. Botulism can n ot be spread from person to person . 4. Sym pto m s in clude abdom in al cram ps, diarrh ea,

n ausea an d vom itin g, double vision , blurred vision , droop in g eyelids, difficulty swallowin g or speakin g, dry m outh , an d m uscle weakn ess.

5. Neurological sym pto m s begin 12 to 36 h ours after in gestion of food -born e botu lism an d 24 to 72 h ours after in h alation an d can progress to paralysis of th e arm s, legs, trun k, or respiratory m uscles (m ech an ical ven tilation is n ecessary).

6. If diagn osed early, food -born e an d woun d botu- lism can be treated with an an titoxin th at blocks th e action of toxin circulatin g in th e blood.

7. O th er treatm en ts in clude in ductio n of vom itin g, en em as, an d pen icillin .

8. No vaccin e is available. E. Plague

1. Plague is caused by Yersinia pestis, a bacteria foun d in roden ts an d fleas.

2. Plague is con tracted by bein g bitten by a roden t or flea th at is carryin g th e plague bacterium , by th e in gestio n of con tam in ated m eat, or by h an - dlin g an an im al in fected with th e bacteria.

3. Tran sm ission is by direct person -to-person spread. 4. Form s in clude bubon ic (m ost com m on ), pn eu-

m on ic, an d septicem ic (m ost deadly) . 5. Sym pto m s usually begin with in 1 to 3 days an d

in clude fever, ch est pain , lym ph n ode swellin g, an d a productive cough (h em optysis) .

6. Th e disease rapidly progresses to dyspn ea, stri- dor, an d cyan osis; death occurs from respiratory failure, sh ock, an d bleedin g.

7. An tibio tics are effective on ly if adm in istered im m ediately; th e usual m ed ication s of ch oice in clude streptom ycin or gen tam icin .

8. A vaccin e is available. F. Tularem ia

1. Tularem ia (also called deer fly fever or rabbit fever) is an in fectio us disease of an im als caused by th e bacillus Francisella tularensis.

2. Th e disease is tran sm itted by ticks, deer flies, or con tact with an in fected an im al.

3. Sym pto m s in clude fever, h ead ach e, an d an ulcer- ated skin lesion with localized lym p h n ode en largem en t, eye in fectio n s, gastro in testin al ulceration s, or pn eum on ia.

4. Treatm en t is with an tibiotics. 5. Recovery produces lifelon g im m un ity (a vaccin e

is available). G. Hem o rrh agic fever

1. Hem o rrh agic fever is cau sed by several viruses, in cludin g Marb urg, Lassa, Jun in , an d Ebola.

2. Th e virus is carried by roden ts an d m osq uitoes. 3. Th e disease can be tran sm itted directly by

perso n -to-person spread via body flu ids. 4. Sym ptom s include fever, h eadach e, m alaise, con -

jun ctivitis, n ausea, vom itin g, h ypoten sion , h em - orrh age of tissues an d organ s, an d organ failure.

5. No kn own specific treatm en t is available; treat- m en t is sym pto m atic.

H. Ebola Virus Disease (EVD) 1. Previously kn own as Ebola h em orrh agic fever 2. Caused by in fectio n with a virus of th e fam ily

Filoviridae, gen us Ebolavirus 3. First discovered in 1976 in the Dem ocratic Republic

of th e Con go. O utbreaks h ave appeared in Africa. 4. The n atural reservoir h ost of Ebolavirus rem ain s

un kn own . It is believed th at th e virus is an im al- born e an d th at bats are th e m ost likely reservoir.

5. Spread of th e virus is th rou gh con tact with objects (such as clo th es, beddin g, n eedles, syrin - ges/ sh arps, or m edical equ ipm en t) th at h ave been co n tam in ated with th e virus.

6. Sym pto m s sim ilar to h em orrh agic fever m ay appear from 2 to 21 days after exposu re.

7. Assessm en t: Ask th e clien t if h e or sh e traveled to an area with EVD such as Guin ea, Liberia, or Sierra Leo n e with in th e last 21 days or if h e or sh e h as h ad con tact with som eon e with EVD an d h ad an y of th e followin g sym pto m s:

F

u

n

d

a

m

e

n

t

a

l

s

FIGURE 16-2 Smallpox. (Courtesy Centers for Disease Control and Pre- vention [CDC]: Evaluating patients for smallpox. Atlanta, 2002, CDC.)

198 UNIT IV Fundamentals of Care

a. Fever at h om e or a curren t tem perature of 38 °C (100.4 °F) or greater

b . Severe h eadach e c. Muscle pain d . Weakn ess e. Fatigue f. Diarrh ea g. Vom itin g h . Abdo m in al pain i. Un explain ed bleedin g or bruisin g

8. In terven tion s a. If th e assessm en t in dicates possible in fection

with EVD, th e clien t n eeds to be isolated in a private room with a private bath room or a cov- ered bedside com m ode with th e door closed.

b . Health care workers n eed to wear th e proper PPE an d follow updated procedures design ated by th e Cen ters for Disease Con trol an d Preven tion for don n in g (puttin g on ) an d doffin g (rem ov- in g) PPE. Refer to th e followin g Web site for updated inform ation: http:/ / www.cdc.gov/ vh f/ ebola/ h ealthcare-us/ ppe/ guidan ce.h tm l

c. Th e n um ber of health care workers en terin g th e room sh ould be lim ited an d a log of everyon e wh o en ters an d leaves th e room sh ould be kept.

d . O n ly n ecessary tests an d proced ures sh ould be perform ed, an d aerosol-gen eratin g proce- dures sh ould be avoided.

e. Refer to th e CDC guidelin es for clean in g, dis- in fectin g, an d m an agin g waste (www.cdc. go v/ vh f/ ebola/ h ealth care-us/ clean in g/ h ospitals.h tm l).

f. Th e agen cy’s in fection con trol program sh ould be n otified, and state an d local public h ealth auth orities sh ould be n otified. Alist of th e state an d local h ealth departm en t n um bers is avail- able at www.cdc.gov/ vh f/ ebola/ outbreaks/ state-local-h ealth -departm en t-con tacts.h tm l

Anthrax is transmitted by direct contact with bacteria and spores and can be contracted through the digestive system, abrasions in the skin, or inhalation through the lungs.

VII. Chemical Warfare Agents A. Sarin

1. Sarin is a h igh ly toxic n erve gas th at can cau se death with in m in u tes of exposu re.

2. It en ters th e body th rou gh th e eyes an d skin an d acts by paralyzin g th e respiratory m uscles.

B. Ph osgen e is a colorless gas n orm ally used in chem ical m an ufacturin g th at if in h aled at h igh con cen tration s for a lon g en ough period will lead to severe respira- tory distress, pulm on ary edem a, and death .

C. Mustard gas is yellow to brown an d h as a garliclike odor th at irritates th e eyes an d cau ses skin burn s an d blisters.

D. Ion izin g radiation 1. Acute radiation exposu re develops after a sub-

stan tial exposu re to radiation . 2. Expo sure can occur from extern al radiation or

in tern al absorption . 3. Sym p to m s d ep en d o n th e am o u n t o f exp o su re

to th e rad iatio n an d ran ge fro m n au sea an d vo m itin g, d iarrh ea, fever, electro lyte im b al- an ces, an d n eu ro lo gical an d card io vascu lar im p airm en t to leu ko p en ia, p u rp u ra, h em o r- rh age, an d d eath .

VIII. Nurse’s Role in Exposure to Warfare Agents A. Be aware th at, in itially, a bioterrorism attack m ay

resem ble a n aturally occurrin g outb reak of an in fec- tious disease.

B. Nurses an d oth er h ealth care workers m ust be pre- pared to assess an d determ in e wh at type of even t occurred, th e n um ber of clien ts wh o m ay be affected, an d h ow an d wh en clien ts will be exp ected to arrive at th e h ealth care agen cy.

C. It is essen tial to d eterm in e an y ch an ges in th e m icro o rgan ism th at m ay in crease its viru len ce o r m ake it resistan t to co n ven tio n al an tib io tics o r vaccin es.

D. See Ch apter 7 for addition al in form ation on disas- ters an d em ergen cy respon se plan n in g.

F

u

n

d

a

m

e

n

t

a

l

s

CRITICAL THINKING What Should You Do? Answer: Many facilities implement a “no restraint policy,” which requires health care workers to implement other safety strategies for clients who pose a risk for falls. These strategies include orienting the client and family to the surroundings; explaining all procedures and treatments to the client and fam- ily; encouraging family and friends to stay with the client as appropriate and using sitters for clients who need supervision; assigning confused and disoriented clients to rooms near the nurses’station; providing appropriate visual and auditorystim- uli to the client, such as a night light, clocks, calendars, televi- sion, and a radio; maintaining toileting routines; eliminating bothersome treatments, such as tube feedings, as soon as pos- sible; evaluating all medications that the client is receiving; using relaxation techniques with the client; and instituting exer- cise and ambulation schedules as the client’s condition allows. Some agencies are instituting certain policies, such as hourly rounding, to ensure client safety. With hourlyrounding, nurses and unlicensed assistive personnel are required to check the client to address the 5 Ps—problem, pain, positioning, potty, and possessions—every hour. This helps to eliminate the need to call for assistance and ensures that the client’s basic needs are being met in a timely manner.

Reference: Perry, Potter, Ostendorf (20 14), pp. 304, 307.

199CHAPTER 16 Provision of a Safe Environment

P R A C T I C E Q U E S T I O N S 142. Th e n urse is preparin g to in itiate an in traven ous

(IV) lin e con tain in g a h igh dose of potassium ch lo- ride an d plan s to use an IV in fusio n pum p. Th e n urse brin gs th e pum p to th e bedside, prepares to plug th e pum p cord in to th e wall, an d n otes th at n o receptacle is available in th e wall socket. Th e n urse sh o uld take wh ich action ? 1. In itiate th e IV lin e with out th e use of a pum p. 2. Con tact th e electrical m ain ten an ce departm en t

for assistan ce. 3. Plug in th e pum p cord in th e available plug

above th e room sin k. 4. Use an exten sion cord from th e n urses’ lo un ge

for th e pum p plug.

143. Th e n urse obtain s a prescription from a h ealth care provider to restrain a client an d in structs an un licen sed assistive person n el (UAP) to apply th e safety device to th e client. Wh ich observation of un safe application of the safety device would indi- cate th at fu rth er in stru ctio n is req u ired by th e UAP? 1. Placin g a safety kn ot in th e safety device straps 2. Safely securin g th e safety device straps to th e

side rails 3. Applyin g safety device straps th at do n ot tigh ten

wh en force is applied again st th em 4. Securin g so th at 2 fin gers can slide easily

between th e safety device an d th e clien t’s skin

144. Th e com m un ity h ealth n urse is providin g a teach - in g session ab out an th rax to m em bers of th e com - m un ity an d asks th e participan ts about th e m eth od s of tran sm ission . Wh ich an swers by th e participan ts would in dicate th at teach in g was effec- tive? Select all th at ap p ly.

1. Bites fro m ticks or deer flies 2. In h alatio n of bacterial spores 3. Th rough a cut or abrasio n in th e skin 4. Direct con tact with an in fected in dividual 5. Sexual con tact with an in fected in dividual 6. In gestion of con tam in ated un dercooked m eat

145. Th e n urse is givin g a report to an un licen sed assis- tive perso n n el (UAP) wh o will be carin g for a clien t wh o h as h an d restrain ts (safety devices). Th e n urse in structs th e UAP to ch eck th e skin in tegrity of th e restrain ed h an ds h ow frequen tly? 1. Every 2 h ours 2. Every 3 h ou rs 3. Every 4 h ou rs 4. Every 30 m in u tes

146. Th e n urse is reviewin g a plan of care for a clien t with an in tern al radiation im plan t. Wh ich in ter- ven tio n , if n oted in th e plan , in d icates th e n eed fo r revisio n of th e plan ? 1. Wearin g gloves wh en em p tyin g th e clien t’s

bed pan 2. Keepin g all lin en s in th e room un til th e im plan t

is rem oved 3. Wearin g a lead ap ron wh en providin g direct care

to th e clien t 4. Placin g th e clien t in a sem iprivate room at th e

en d of th e h allway

147. Con tact precaution s are in itiated for a clien t with a h ealth care–associated (n oso com ial) in fection cau sed by m eth icillin -resistan t Staphylococcus aureus. Th e n urse prepares to provide colosto m y care an d sh o uld obtain wh ich protective item s to perform th is procedure? 1. Glo ves an d gown 2. Gloves an d goggles 3. Gloves, go wn , an d sh o e protecto rs 4. Gloves, gown , goggles, an d a m ask or face sh ield

148. Th e n urse en ters a clien t’s ro om an d fin ds th at th e wastebasket is on fire. Th e n urse im m ediately assists th e clien t out of th e room . Wh at is th e n ext n ursin g action ? 1. Call for h elp. 2. Extin guish th e fire. 3. Activate th e fire alarm . 4. Con fin e th e fire by closin g th e room door.

149. A m oth er calls a n eigh bor wh o is a n urse an d tells th e n urse th at h er 3-year-o ld ch ild h as just in gested liqu id furn iture polish . Th e n urse would direct th e m oth er to take wh ich im m ed iate action ? 1. In duce vom itin g. 2. Call an am bulan ce. 3. Call th e Poison Con trol Cen ter. 4. Brin g th e ch ild to th e em ergen cy departm en t.

150. Th e em ergen cy departm en t (ED) n urse receives a telep h on e call an d is in form ed th at a torn ado h as h it a local residen tial area an d th at n um erou s casualties h ave occurred. Th e victim s will be brough t to th e ED. Th e n urse sh ould take wh ich in itial action ? 1. Prepare th e triage room s. 2. Activate th e em ergen cy respon se plan . 3. O btain addition al supplies from th e cen tral sup-

ply departm en t. 4. O btain ad dition al n ursin g staff to assist in treat-

in g th e casualties.

F

u

n

d

a

m

e

n

t

a

l

s

200 UNIT IV Fundamentals of Care

151. Th e n urse is carin g for a clien t with m en in gitis an d im plem en ts wh ich tran sm issio n -based precau- tion s for th is clien t? 1. Private room or coh ort clien t 2. Person al respiratory protectio n device 3. Private room with n egative airflow pressure 4. Mask worn by staff wh en th e clien t n eeds to

leave th e ro om

152. Th e n urse workin g in th e em ergen cy departm en t (ED) is assessin g a clien t wh o recen tly return ed fro m Liberia an d presen ted com plain in g of a fever at h om e, fatigue, m uscle pain , an d abdom in al pain . Wh ich action sh ould th e n urse take n ext? 1. Ch eck th e clien t’s tem p erature. 2. Con tact th e h ealth care provid er. 3. Isolate th e clien t in a private ro om . 4. Ch eck a com plete set of vital sign s.

A N S W E R S 142. 2 Ra t ion a le: Electrical equipm en t m ust be m ain tain ed in goo d workin g o rder an d should b e gro un ded; o th erwise, it p resents a p h ysical h azard. An IV lin e th at con tain s a d ose o f p otassiu m ch loride sho uld be adm in istered b y an in fusio n p um p. Th e n urse n eeds to u se h ospital reso urces for assistance. A regular exten sion cord sh ould n ot b e u sed because it poses a risk for fire. Use o f electrical app lian ces n ear a sin k also p resen ts a h azard . Test -Ta kin g Str a t egy: Note th e su b ject, electrical safety. Recal- lin g safety issu es will d irect yo u to th e co rrect o ption . Con tact- in g th e m ain ten an ce d ep artm en t is th e on ly correct o ptio n sin ce th e oth er op tio n s are n o t co n sidered safe practice wh en im p lem en tin g electrical actio n s. In ad d itio n , sin ce po tassium ch loride is in th e IV solu tio n , a p um p m u st b e used . Review: Electrical safety Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p . 314.

143. 2 Ra t ion a le: Th e safety d evice straps are secu red to th e b ed fram e an d n ever to th e sid e rails to avo id accid en tal in jury in th e even t th at th e sid e rails are released . A h alf-b ow o r safety kn o t o r device with a qu ick release bu ckle sh o uld b e u sed to ap ply a safety device b ecau se it d oes n o t tigh ten wh en force is ap plied again st it an d it allows qu ick an d easy rem oval of th e safety device in case o f an em ergen cy. Th e safety device sh o uld b e secu re, an d 1 or 2 fin gers sh o u ld slid e easily b etween th e safety device an d th e clien t’s skin . Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e un safe in ter- ven tio n . Also n ote th e strategic wo rd s, further instruction is required. Th ese words in dicate a n egative even t query an d th e n eed to select th e in co rrect op tion . Read each o ptio n carefully. Th e wo rd s securing the safety device straps to the side rails in op tion 2 sh ou ld direct yo u r atten tion to th is as an in correct an d un safe action . Review: Safety d evice ap p licatio n Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Health Care Q uality; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p . 310.

144. 2, 3, 6 Ra t ion a le: An th rax is cau sed b y Bacillus anthracis an d can b e co n tracted th rou gh th e d igestive system or ab rasio n s in th e skin , o r in h aled th ro ugh th e lu n gs. It can n ot b e sp read fro m p erson to p erson , an d it is n ot con tracted via b ites from ticks o r d eer flies. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject, rou tes o f tran sm is- sion o f an th rax. Kn o wledge regardin g th e m eth od s o f co n tract- in g an th rax is n eed ed to an swer th is qu estio n . Rem em ber th at it is n o t spread b y p erso n -to -perso n con tact o r con tracted via tick or deer fly b ites. Review: An th rax Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun d am en tals of Care—In fection Con tro l Pr ior ity Con cepts: Clien t Teach in g; In fectio n Refer en ce: Ign atavicius, Workm an (2016), p . 411.

145. 4 Ra t ion a le: Th e n urse sh o uld in struct th e UAP to ch eck safety d evices an d skin in tegrity every 30 m in u tes. Th e n eurovascular an d circu latory status of th e extrem ity sh o u ld also be ch ecked every 30 m in u tes. In add itio n , th e safety d evice sh o uld b e rem oved at least every 2 h o urs to p erm it m uscle exercise an d to pro m o te circu latio n . Agen cy guidelin es regard in g th e use o f safety d evices sh o uld always b e fo llo wed . Test -Ta kin g Str a tegy: Focus on th e su b ject, ch eckin g skin in tegrity o f a clien t with safety d evices. In th is situatio n , select- in g th e op tio n th at id en tifies th e m o st frequ en t tim e fram e is b est. Review: Safety d evice gu idelin es Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Lead ersh ip/ Man agem en t—Delegatin g Pr ior ity Con cepts: Health Care Q uality; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p . 311.

146. 4 Ra t ion a le: A private ro om with a p rivate b ath is essen tial if a clien t h as an in tern al radiatio n im plan t. Th is is n ecessary to p reven t accid en tal expo sure of o th er clien ts to rad iatio n . Th e rem ain in g o ptio n s id en tify accu rate in terven tio n s fo r a clien t with an in tern al radiation im plan t an d protect th e n urse from expo sure. Test -Ta kin g Str a t egy: No te th e strategic wo rd s, indicates the need for revision. Th ese word s in d icate a n egative even t q u ery

F

u

n

d

a

m

e

n

t

a

l

s

201CHAPTER 16 Provision of a Safe Environment

an d th e n eed to select th e in co rrect n u rsin g in terven tio n . Rem em ber th at th e clien t with an in tern al rad iatio n im plan t n eeds to be p laced in a p rivate ro om . Review: Rad iatio n safety p rin ciples Level of Cogn it ive Abilit y: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Fu n d am en tals o f Care—Safety Pr ior it y Con cept s: Health Care Q u ality; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 376.

147. 4 Ra tion a le: Sp lash es of bo dy secretio n s can occu r wh en provid - in g colosto m y care. Goggles an d a m ask or face sh ield are wo rn to protect th e face an d m u co us m em bran es o f th e eyes du rin g in terven tion s th at m ay prod uce splash es o f b lo od , b od y flu id s, secretion s, o r excretion s. In add itio n , co n tact p recau- tio n s req uire th e use of glo ves, an d a go wn sh o uld b e wo rn if d irect clien t co n tact is an ticipated . Sh oe p ro tectors are n o t n ecessary. Test-Ta kin g St r a tegy: Fo cu s on th e su b ject, protective item s n eeded to p erfo rm co lo stom y care. Also, n ote th e wo rd s contact precautions. Visu alize care for th is clien t to d eterm in e th e n ec- essary item s req u ired for self-p ro tectio n . Th is will d irect you to th e correct o ptio n . Review: Tran sm issio n -b ased p recau tio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—In fectio n Con trol Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 403-404, 453.

148. 3 Ra tion a le: Th e o rd er of priority in th e even t o f a fire is to rescue th e clien ts wh o are in im m ed iate d an ger. Th e n ext step is to activate th e fire alarm . Th e fire th en is co n fin ed by closin g all do o rs an d , fin ally, th e fire is extin guish ed. Test-Ta kin g St r a t egy: No te th e strategic wo rd , next. Rem em - b er th e m n em o n ic RACE to p rioritize in th e even t of a fire. R is rescu e clien ts in im m ediate dan ger, A is alarm ( so un d th e alarm ), C is co n fin e th e fire by closin g all d o ors, an d E is extin - gu ish or evacu ate. Review: Fire safety Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Safety Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 313-314.

149. 3 Ra tion a le: If a p o ison in g o ccu rs, th e Poison Con tro l Cen ter sh o u ld b e con tacted im m ediately. Vom itin g sh ou ld n ot be in du ced if th e victim is u n con scio us o r if th e sub stan ce in gested is a stro n g corro sive o r petro leum pro du ct. Brin gin g th e ch ild to th e em ergen cy d ep artm en t or callin g an am bu lan ce wou ld n o t be th e in itial actio n b ecau se th is wou ld d elay treatm en t. Th e Poison Co n trol Cen ter m ay advise th e m oth er to b rin g

th e ch ild to th e em ergen cy dep artm en t; if th is is th e case, th e m oth er sh ou ld call an am bu lan ce. Test-Ta kin g St r a t egy: Note th e strategic wo rd , immediate. Callin g th e Poison Co n tro l Cen ter is th e first actio n sin ce it will d irect th e m o th er o n th e n ext step to take based o n th e type of p oiso n in g. Th e o th er op tion s are un safe or co uld cau se a d elay in treatm en t. Review: Po iso n co n tro l m easures Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Safety Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Hocken b erry, Wilso n (2015), pp . 545, 548.

150. 2 Ra tion a le: In an extern al d isaster (a d isaster th at occu rs o utside o f th e in stitu tio n o r agen cy), m an y victim s m ay b e brou gh t to th e ED fo r treatm en t. Th e in itial n ursin g action m u st b e to acti- vate th e em ergen cy resp on se p lan . O n ce th e em ergen cy respon se plan is activated , th e action s in th e oth er option s will occur. Test-Ta kin g Str a tegy: No te th e strategic wo rd , initial, an d d eterm in e th e p rio rity actio n . Note th at th e correct o ptio n is th e u m b rella o p tio n . Th e em ergen cy resp on se plan in clud es all of th e o th er o ptio n s. Review: Disaster p rep ared n ess Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Safety Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 140-143.

151. 1 Ra tion a le: Men in gitis is tran sm itted b y d ro plet in fectio n . Pre- cau tio n s fo r th is d isease in clu de a p rivate roo m o r co h o rt clien t an d u se o f a stan dard p recautio n m ask. Private n egative airflow p ressu re ro om s an d person al resp irato ry p ro tectio n d evices are required for clien ts with airborn e disease such as tub erculosis. Wh en ap p ro priate, a m ask m ust b e worn b y th e clien t an d n o t th e staff wh en th e clien t leaves th e ro om . Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e co rrect p recau- tio n n eeds fo r a clien t with m en in gitis. Recallin g th at m en in gi- tis is tran sm itted by drop lets will d irect yo u to th e co rrect o ptio n . Review: Tran sm issio n -b ased p recau tio n s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—In fectio n Co n trol Pr ior it y Con cept s: In fection ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 403-404.

152. 3 Ra tion a le: Th e n u rse sh o uld su spect th e po ten tial for Eb ola virus disease (EVD) because o f th e clien t’s recen t travel to Lib e- ria. Th e n urse n eeds to co n sid er th e sym pto m s th at th e clien t is reportin g, an d clien ts wh o m eet th e expo su re criteria sh o u ld b e

F

u

n

d

a

m

e

n

t

a

l

s

202 UNIT IV Fundamentals of Care

isolated in a private roo m befo re o th er treatm en t m easu res are taken . Expo su re criteria in clu de a fever repo rted at h om e o r in th e ED of 38.0 °C (100.4 °F) or h ead ach e, fatigue, weakn ess, m u scle p ain , vo m itin g, d iarrh ea, ab d om in al pain , or sign s o f bleedin g. Th is clien t is repo rtin g a fever an d is sh o win g o th er sign s of EVD, an d th erefore sh o uld be isolated . After iso latin g th e clien t, it wou ld be acceptab le to th en collect fu rth er d ata an d n otify th e h ealth care p rovid er an d o th er state an d lo cal au th o rities of th e clien t’s sign s an d sym pto m s. Test -Ta kin g St r a t egy: Note th e strategic wo rd, next. Th is in dicates th at som e o r all of th e o th er option s m ay b e partially o r totally correct, b ut th e n urse n eeds to prioritize. Elim in ate optio ns 1 and 4 first becau se th ey are co m p arab le

o r alike. Next n ote th at th e client recen tly traveled to Liberia. Recall th at isolation to preven t tran sm ission o f an in fectio n is th e im m ed iate priority in th e care of a clien t with suspected EVD. Review: Care o f th e clien t with Eb o la viru s d isease. Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Safety Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Lewis et al. (2014), p. 228. www.cdc.gov/ vh f/ ebola/ h ealth care-us/ em ergen cy-services/ em ergen cy-dep artm en ts.h tm l

F

u

n

d

a

m

e

n

t

a

l

s

203CHAPTER 16 Provision of a Safe Environment

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 17 Calculation of Medication and Intravenous Prescriptions

PRIORITY CONCEPTS Clinical Judgment, Safety

CRITICAL THINKING What Should You Do? The nurse is preparing to administer 30 milliliters (mL) of a liquid medication to an assigned client. What should the nurse do when preparing this medication? Answer located on p. 209.

I. Medication Administration (Box 17-1)

II. Medication Measurement Systems A. Metric system (Box 17-2)

1. Th e basic un its of m etric m easures are th e m eter, liter, an d gram .

2. Meter m easu res len gth ; liter m easu res volu m e; gram m easu res m ass.

B. Apoth ecary an d h ouseh o ld system s 1. Th e apoth ecary an d h ou seh old system s are th e

oldest of th e m ed ication m easu rem en t system s. 2. Apoth ecary m easu res such as grain , dram ,

m in im , an d oun ce are n ot com m on ly used in th e clin ical settin g.

3. Com m on ly used h ou seh old m easures in clude drop, teaspo on , tablespo on , oun ce, pin t, an d cup.

The NCLEX® will not present questions that require you to convert from the apothecary system of measurement to the metric system; however, this system is still important to know because, although it is not common, you may encounter it in the clinical setting.

C. Addition al com m on m ed ication m easu res 1. Millieq uivalen t

a . Millieq uivalen t is ab breviated m Eq. b . Th e m illiequivalen t is an exp ression of th e

n um ber of gram s of a m edication con tain ed in 1 m L of a solution .

c. For exam ple, th e m easu re of serum potassium is given in m illiequivalen ts.

2. Un it a . Un it m easu res a m edication in term s of its

action , n ot its ph ysical weigh t. b . For exam ple, pen icillin , h eparin sodium , an d

in sulin are m easured in un its.

III. Conversions A. Con version between m etric un its ( Box 17-3)

1. Th e m etric system is a decim al system ; th erefore, con version s between th e un its in th is system can be don e by dividin g or m ultiplyin g by 1000 or by m ovin g th e decim al poin t 3 places to th e righ t or 3 places to th e left.

2. In th e m etric system , to con vert larger to sm aller, m ultiply by 1000 or m ove th e decim al poin t 3 places to th e righ t.

3. In th e m etric system , to con vert sm aller to larger, divide by 1000 or m ove th e decim al poin t 3 places to th e left.

B. Con version between h ouseh old an d m etric system s 1. Househ old an d m etric m easures are equivalen t

an d n ot equal m easu res. 2. Con version to equivalen t m easu res between

system s is n ecessary wh en a m ed ication prescrip- tion is written in on e system but th e m edication label is stated in an oth er.

3. Medication s are n ot always prescribed an d prepared in th e sam e system of m easu rem en t; th erefore, con versio n of un its from on e system to an oth er is n ecessary. However, th e m etric system is th e m ost com m on ly used system in th e clin ical settin g.

4. Calculatin g equivalen ts between 2 system s m ay be don e by usin g th e m eth od of ratio an d pro- portion (Boxes 17-4 an d 17-5).

Conversion is the first step in the calculation of dosages.204

IV. Medication Labels A. A m edication label always con tain s th e generic name

an d m ay co n tain th e trade name of th e m ed ication .

The NCLEX now only tests you on generic names of medications. Trade names will not be available for most medications, so be sure to learn medications by their generic names for the examination. However, you will likely still encounter the trade names in the clinical setting.

B. Always ch eck expiration dates on m ed ication labels.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 17-1 Medication Administration Assess the medication prescription. Compare the client’s medication prescription with all medi-

cations that the client was previously taking (medication reconciliation).

Ask the client about a history of allergies. Assess the client’s current condition and the purpose for the

medication or intravenous (IV) solution. Determine the client’s understanding of the purpose of

the prescribed medication or need for IV solution. Teach the client about the medication and about self-

administration at home. Identify and address concerns (social, cultural, religious) that

the client may have about taking the medication. Assess the need for conversion when preparing a dose of

medication for administration to the client. Assess the 6 rights of medication administration: right med-

ication, right dose, right client, right route, right time, and right documentation.

Assess the vital signs, check significant laboratory results, and identify any potential interactions (food or medication interactions) before administering medication, when appropriate.

Document the administration of the prescribed therapy and the client’s response to the therapy.

BOX 17-2 Metric System Abbreviations meter: m liter: L milliliter: mL kilogram: kg gram: g milligram: mg microgram: mcg

Equivalents 1 mcg¼0 .0 00 0 01 g 1 mg¼10 0 0 mcg or 0 .0 0 1 g 1 g¼100 0 mg 1 kg¼10 00 g 1 kg¼2.2 lb 1 mL¼0 .00 1 L

BOX 17-3 Conversion Between Metric Units Problem 1 Convert 2 g to milligrams.

Solut ion Change a larger unit to a smaller unit:

2 g¼200 0 mg (moving decimal point 3 places to the right)

Problem 2 Convert 250 mL to liters.

Solut ion Change a smaller unit to a larger unit:

250 mL¼0.25 L (moving decimal point 3 places to the left)

BOX 17-4 Ratio and Proportion Ratio: The relationship between 2 numbers, separated by a

colon; for example, 1:2 (1 to 2). Proportion: The relationship between 2 ratios, separated by a

double colon (::) or an equal sign (¼).

Formula: H on handð Þ : V vehicleð Þ :: ¼ð Þ desired doseð Þ : X unknownð Þ

To solve a ratio and proportion problem: The middle numbers (means) are multiplied and the end numbers (extremes) are multiplied.

Sample Problem H ¼1 V¼2 Desired dose¼3 X¼unknown Set up the formula: 1 : 2 :: 3 : X Solve: Multiply means and extremes: 1X¼6 X¼6

BOX 17-5 Calculating Equivalents Between Two Systems

Calculating equivalents between 2 systems may be done by using the method of ratio and proportion.

Problem The health care provider prescribes nitroglycerin 1150 grain (gr). The medication label reads 0 .4 milligrams (mg) per tablet. The

nurse prepares to administer how manytablets to the client? If you knew that 1150 gr was equal to 0.4 mg, you would know

that you need to administer 1 tablet. Otherwise, use the ratio and proportion formula.

Ratio and Proportion Formula

H on handð Þ : V vehicleð Þ :: ¼ð Þ desired doseð Þ : X unknownð Þ

1gr : 60 mg :: 1 150

gr : Xmg

60 Â 1 150 ¼ X

X ¼ 0 :4 mg 1tabletð Þ

205CHAPTER 17 Calculation of Medication and Intravenous Prescriptions

V. Medication Prescriptions (Box 17-6) A. In a m ed ication prescription , th e n am e of th e m ed-

ication is written first, followed by th e dosage, route, an d frequen cy (depen d in g on th e frequen cy of th e prescription , tim es of adm in istration are usually establish ed by th e h ealth care agen cy an d written in an agen cy policy).

B. Medication prescription s n eed to be written usin g accepted abbreviation s, acron ym s, an d sym bo ls approved by Th e Join t Com m ission ; also follow agen cy guid elin es.

If the nurse has any questions about or sees incon- sistencies in the written prescription, the nurse must contact the person who wrote the prescription immedi- ately and must verify the prescription.

VI. Oral Medications A. Scored tablets con tain an in den ted m ark to be used

for possib le breakage in to partial doses; wh en n eces- sary, scored tablets (th ose m arked for division ) can be divided in to h alves or quarters acco rdin g to agen cy policy.

B. En teric-coated tab lets an d sustain ed-released cap- sules delay absorption un til th e m ed ication reach es th e sm all in testin e; th ese m edication s sh ould n ot be cru sh ed.

C. Capsules con tain a powdered or oily m edication in a gelatin cover.

D. O rally adm in istered liqu ids are supp lied in solution form an d con tain a specific am oun t of m ed ication in a given am oun t of solution , as stated on th e label.

E. Th e m ed icin e cup 1. Th e m ed icin e cup h as a capacity of 30 m L or 1

oun ce (oz) an d is used for orally ad m in istered liqu ids.

2. Th e m edicin e cup is calibrated to m easure tea- spoo n s, tablespo on s, an d oun ces.

3. To pour accurately, place th e m edication cup on a level surface at eye level an d th en pour th e liq- uid wh ile readin g th e m easu rin g m arkin gs.

F. Volum es of less th an 5 m L are m easu red usin g a syrin ge with th e n eedle rem oved.

A calibrated syringe is used for giving medicine to children.

VII. Parenteral Medications A. Paren teral always m ean s an in jection route an d par-

en teral m edication s are adm in istered by in traven ous (IV), in tram uscular, subcutan eous, or in traderm al in jection (see Fig. 17-1 for an gles of in jection ).

B. Paren teral m edication s are packaged in sin gle-use am pules, in sin gle- an d m ultiple-use rubber-stoppered vials, an d in prem easured syrin ges an d cartridges.

C. Th e n urse sh ould n ot adm in ister m ore th an 3 m L per in tram uscular in jection site (2 m L for th e deltoid) or 1 m L per subcutan eous in jection site; larger volum es are difficult for an in jection site to absorb an d, if pre- scribed, n eed to be verified. Variation s for pediatric clien ts are discussed in th e pediatric sections of th is text.

D. Th e stan d ard 3-m L syrin ge is used to m easu re m ost in jectable m edication s an d is calibrated in ten th s (0.1) of a m illiliter.

E. Th e syrin ge is filled by drawin g in solution un til th e top rin g on th e plun ger (i.e., th e rin g closest to th e n eedle), n ot th e m iddle section or th e botto m rin g of th e plun ger, is align ed with th e desired calibratio n (Fig. 17-2).

F

u

n

d

a

m

e

n

t

a

l

s

BOX 17-6 Medication Prescriptions Name of client Date and time when prescription is written Name of medication to be given Dosage of medication Medication route Time and frequency of administration Signature of person writing the prescription

1010°–15–15°

9090° 9090°

S kin

45°

S ubcuta ne ous tis s ue

Mus cle

S ubcuta ne ous tis s ue

Mus cle

Epide rmis De rmis

S kin

Ble b Intrade rmal

Intramus c ular S ubc utane o us

10°–15°

90° 90°

FIGURE 17-1 Angles of injection.

Tip (Hub)

Ba rre l

Re a d from this point

Rubbe r s toppe r P lunge r

FIGURE 17-2 Parts of a syringe.

206 UNIT IV Fundamentals of Care

Always question and verify excessively large or small volumes of medication.

F. Prefilled m ed ication cartridge 1. Th e m edication cartridge slips in to th e cartridge

h old er, wh ich provides a plun ger for in jection of th e m ed ication .

2. Th e cartridge is design ed to provid e sufficien t cap acity to allow for th e addition of a secon d m ed ication wh en com bin ed dosages are prescribed.

3. Th e prefilled m ed ication cartridge is to be used on ce an d discard ed; if th e n urse is to give less th an th e full sin gle dose provid ed, th e n urse n eeds to discard th e extra am oun t before givin g th e clien t th e in jection , in accordan ce with agen cy policies an d procedures.

G. In gen eral, stan d ard m ed ication doses for adults are to be roun ded to th e n earest ten th (0.1 m L) of a m il- liliter an d m easured on th e m illiliter scale; for exam - ple, 1.28 m L is roun ded to 1.3 m L (follow agen cy policy for roun din g m ed ication doses).

H. Wh en volu m es larger th an 3 m L are required, th e n urse m ay use a 5-m L syrin ge; th ese syrin ges are cal- ibrated in fifth s (0.2 m L) ( Fig. 17-3).

I. O th er syrin ge sizes m ay be available (10, 20, an d 50 m L) an d m ay be used for m ed ication ad m in istra- tion requirin g dilu tion .

J. Tuberculin syrin ge (Fig. 17-4) 1. Th e tubercu lin syrin ge h old s 1 m L an d is used to

m easu re sm all or critical am oun ts of m ed ication , such as allergen extract, vaccin e, or a ch ild’s m ed ication .

2. Th e syrin ge is calibrated in h un dredth s (0.01) of a m illiliter, with each on e ten th (0.1) m arked on th e m etric scale.

K. In sulin syrin ge ( Fig. 17-5) 1. Th e stan d ard 100-un it in sulin syrin ge is cali-

brated for 100 un its of in sulin (100 un its¼1 m L) ;

low-dose in sulin syrin ges ( 12 - an d 3 10-m L sizes)

m ay also be used wh en adm in isterin g sm aller in sulin doses.

2. In sulin sh ould n ot be m easu red in an y oth er typ e of syrin ge.

If the insulin prescription states to administer regular and NPH insulin, combine both types ofinsulin in the same syringe. Use the mnemonic RN: Draw Regular insulin into the insulin syringe first, and then draw the NPH insulin.

L. Safety n eedles con tain sh ield in g devices th at are attach ed to th e n eedle an d slip ped over th e n eedle to reduce th e in ciden ce of n eedle-stick in ju ries.

VIII. Injectable Medications in Powder Form A. Som e m ed ication s beco m e un stable wh en stored in

solution form an d are th erefore packaged in powder form .

B. Powders m ust be dissolved with a sterile diluen t before use; usually, sterile water or n orm al salin e is used. Th e dissolvin g procedure is called recon stitu- tion (Box 17-7).

IX. Calculating the Correct Dosage (see Box 17-8 for the standard formula)

A. Wh en calculatin g dosages of oral m edication s, ch eck th e calculation an d question th e prescription if th e calculation calls for m ore th an 3 tablets.

F

u

n

d

a

m

e

n

t

a

l

s1 2 3 4 5

FIGURE 17-3 Five-milliliter syringe.

.10

4m 8m 12m 16m

.20 .30 .40 .50 .60 .70 .80 .90 1.0

FIGURE 17-4 Tuberculin syringe.

5 15 25 35 45 55 65 75 85 95

Units

10 20 30 40 50 60 70 80 90 100

FIGURE 17-5 A 100 -unit insulin syringe.

BOX 17-7 Reconstitution In reconstituting a medication, locate the instructions on the

label or in the vial package insert, and read and follow the directions carefully.

Instructions will state the volume of diluent to be used and the resulting volume of the reconstituted medication.

Often, the powdered medication adds volume to the solution in addition to the amount of diluent added.

The total volume of the prepared solution will exceed the vol- ume of the diluent added.

When reconstituting a multiple-dose vial, label the medication vial with the date and time of preparation, your initials, and the date of expiration.

Indicating the strength per volume on the medication label also is important.

207CHAPTER 17 Calculation of Medication and Intravenous Prescriptions

F

u

n

d

a

m

e

n

t

a

l

s

B. Wh en calculatin g dosages of paren teral m ed ication s, ch eck th e calculation an d question th e prescription if th e am oun t to be given is too large a dose.

C. Be sure th at all m easures are in th e sam e system , and th at all un its are in th e sam e size, con vertin g wh en n ec- essary; carefully con sider wh at th e reason able am oun t of th e m edication th at sh ould be adm in istered is.

D. Roun d stan dard in jection doses to ten th s an d m ea- sure in a 3-m L syrin ge (follow agen cy policy).

E. Roun d sm all, critical am oun ts or ch ildren ’s doses to h un dredth s an d m easu re in a 1-m L tuberculin syrin ge (fo llow agen cy policy).

F. In addition to usin g th e stan d ard form ula (see Box 17-8), calculation s can be don e usin g dim en - sion al an alysis, a m eth od th at uses con version fac- tors to m ove from on e un it of m easu rem en t to an oth er; th e required elem en ts of th e equatio n in clude th e desired an swer un its, con version for- m ula th at in cludes th e desired an swer un its an d th e un its th at n eed to be con verted, an d th e origin al factors to con vert in cludin g quan tity an d un its.

Regardless of the source or cause of a medication error, if the nurse gives an incorrect dose, the nurse is legally responsible for the action.

X. Percentage and Ratio Solutions A. Percen tage solution s

1. Express th e n um ber of gram s (g) of th e m edica- tion per 100 m L of solution .

2. For exam ple, calcium gluco n ate 10% is 10 g of pure m edication per 100 m L of solution .

B. Ratio solution s 1. Express th e n um ber of gram s of th e m edication

per total m illiliters of solution . 2. For exam ple, epin eph rin e 1:1000 is 1 g of pure

m ed ication per 1000 m L of solution .

XI. Intravenous Flow Rates (Box 17-9) A. Mon itor IVflow rate frequen tly even if th e IVsolution

is bein g adm in istered th rou gh an electron ic in fusion device (fo llow agen cy policy regardin g frequen cy).

B. If an IV is ru n n in g beh in d sch edule, collabo rate with th e h ealth care provider to determ in e th e clien t’s ability to tolerate an in creased flo w rate, particularly for older clien ts an d th ose with cardiac, pulm o n ary, ren al, or n eurological con ditio n s.

The nurse should never increase the rate of (i.e., speed up) an IV infusion to catch up if the infusion is running behind schedule.

C. Wh en ever a prescribed IV rate is in creased, th e n urse sh ould assess th e clien t for in creased h eart rate, in creased respiration s, an d in creased lun g con gestion , wh ich could in dicate flu id overload.

D. In traven ou sly ad m in istered fluids are prescribed m ost frequen tly based on m illiliters per h our to be adm in istered.

E. Th e vo lum e per h our prescribed is adm in istered by settin g th e flow rate, wh ich is coun ted in drops per m in ute.

F. Most flow rate calculation s in volve ch an gin g m illili- ters per h our to drops per m in ute.

G. In traven ou s tubin g 1. IV tubin g sets are calibrated in drops per m illili-

ter; th is calibration is n eeded for calculatin g flow rates.

2. A stan d ard or m acrodrip set is used for ro utin e adult IV ad m in istration s; depen din g on th e m an - ufacturer an d type of tubin g, th e set will require 10, 15, or 20 drops (gtt) to equ al 1 m L.

3. A m in idrip or m icrodrip set is used wh en m ore exact m easu rem en ts are n eeded, such as in in ten - sive care un its an d ped iatric un its.

4. In a m in idrip or m icrodrip set, 60 gtt is usually equal to 1 m L.

5. Th e calibratio n , in drops per m illiliter, is written on th e IV tubin g package.

XII. Calculation of Infusions Prescribed by Unit Dosage per Hour

A. Th e m ost com m on m edication s th at will be prescribed by un it dosage per h our an d run by con tinuous in fu- sion are h eparin sodium and regular in sulin .

BOX 17-8 Standard Formula for Calculating a Medication Dosage

D A

 Q ¼ X

D (desired) is the dosage that the health care provider prescribed.

A (available) is the dosage strength as stated on the medica- tion label.

Q (quantity) is the volume or form in which the dosage strength is available, such as tablets, capsules, or milliliters.

BOX 17-9 Formulas for Intravenous Calculations Flow Rates

Total volume  Drop factor Time in minutes

¼ Drops per minute

Infusion Time Total volume to infuse

Milliliters per hour being infused ¼ Infusion time

Number of Milliliters per Hour Total volume in milliliters

Number of hours ¼ Number of milliliters per hour

208 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

B. Calculation of th ese in fusion s can be don e usin g a 2-step process (Box 17-10). 1. Determ in e th e am oun t of m ed ication per 1 m L. 2. Determ in e th e in fusion rate or m illiliters

per h our.

CRITICAL THINKING What Should You Do? Answer: When preparing to administer a liquid medication, the nurse should use a medicine cup, pouring the liquid into it after placing it on a flat surface at eye level with the thumbnail at the medicine cup line indicating the desired amount. Liquids should not be mixed with tablets or with other liquids in the same container. The nurse should be sure not to return poured medication to its container and should properly discard poured medication if not used. The nurse should pour liquids from the side opposite the bottle’s label to avoid spilling medicine on the label. Medications that irri- tate the gastric mucosa, such as potassium products, should be diluted or taken with meals. Ice chips should be offered before administering unpleasant-tasting medications in order to numb the client’s taste buds.

Reference: Perry, Potter, Ostendorf (2014), pp. 486, 496-498.

P R A C T I C E Q U E S T I O N S

153. A h ealth care provid er’s prescription reads 1000 m L of n orm al salin e (NS) to in fuse over 12 h ou rs. Th e drop factor is 15 drops (gtt) / 1 m L. Th e n urse prepares to set th e flow rate at h ow m an y drops per m in u te? Fill in th e b lan k. Reco rd yo u r an swer to th e n earest wh o le n u m b er. An swer: _______ drops per m in u te

154. A h ealth care provid er’s prescription reads to adm in ister an in traven o us (IV) dose of 400,000 un its of pen icillin G ben zath in e. Th e label on th e 10-m L am pule sen t from th e ph arm acy reads pen - icillin G ben zath in e, 300,000 un its/ m L. Th e n urse prepares h ow m uch m edication to ad m in ister th e correct dose? Fill in th e b lan k. Reco rd yo u r an swer u sin g 1 d ecim al p lace. An swer: _______ m L

155. A h ealth care provid er’s prescription reads potas- sium ch loride 30 m Eq to be added to 1000 m L n orm al salin e (NS) an d to be adm in istered over a 10-h our period. Th e label on th e m edication bottle reads 40 m Eq/ 20 m L. Th e n urse prepares

BOX 17-10 Infusions Prescribed by Unit Dosage per Hour Calculation of these problems can be done using a 2-step process.

1. Determine the amount of medication per 1 mL. 2. Determine the infusion rate or milliliters per hour.

Problem 1 Prescription: Continuous heparin sodium by IVat 10 00 units per

hour Available: IV bag of 500 mL D5W with 20 ,00 0 units of heparin

sodium

How many milliliters per hour are required to administer the correct dose?

Solut ion Step 1: Calculate the amount of medication (units) per

milliliter (mL).

Known amount of medication in solution Total volume of diluent

¼ Amount of medication per milliliter

20, 000 units 500 mL

¼ 40 units=1mL

Step 2: Calculate milliliters per hour.

Dose per hour desired Concentration per milliliter

¼ Infusion rate, or mL=hour

10 00 units 40 units

¼ 25mL=hour

Problem 2 Prescription: Continuous regular insulin by IV at 10 units per

hour Available: IV bag of 100 mL NS with 50 units regular insulin

How many milliliters per hour are required to administer the correct dose?

Solut ion Step 1: Calculate the amount of medication (units) per milliliter.

Known amount of medication in solution Total volume of diluent

¼ Amount of medication per milliliter

50 units 100 mL

¼ 0:5units=1mL

Step 2: Calculate milliliters per hour.

Dose per hour desired Concentration per milliliter

¼ Infusion rate, or mL=hour

10 units 0:5units=mL

¼ 20 mL=hour

209CHAPTER 17 Calculation of Medication and Intravenous Prescriptions

F

u

n

d

a

m

e

n

t

a

l

s

h ow m an y m illiliters of potassiu m ch loride to adm in ister th e correct dose of m edication ? Fill in th e b lan k. An swer: _______ m L

156. A h ealth care provider’s prescription reads clin da- m ycin ph o sph ate 0.3 g in 50 m L n orm al salin e (NS) to be adm in istered in traven o usly over 30 m in utes. Th e m edication label reads clin dam y- cin ph osph ate 900 m g in 6 m L. Th e n urse prepares h ow m an y m illiliters of th e m ed ication to ad m in - ister th e correct dose? Fill in th e b lan k. An swer: _______ m L

157. A h ealth care provid er’s prescription reads ph en y- toin 0.2 g orally twice daily. Th e m ed ication label states th at each cap sule is 100 m g. Th e n urse pre- pares h ow m an y capsule( s) to ad m in ister 1 dose? Fill in th e b lan k. An swer: _______ capsule( s)

158. A h ealth care provid er prescribes 1000 m L of n or- m al salin e 0.9% to in fuse over 8 h ours. Th e drop facto r is 15 drops (gtt) / 1 m L. Th e n urse sets th e flow rate at h ow m an y drops per m in ute? Fill in th e b lan k. Reco rd yo u r an swer to th e n earest wh o le n u m b er. An swer: _______ drops per m in u te

159. A h ealth care provider prescribes h eparin sodium , 1300 un its/ h our by con tinuous in traven ous (IV) in fusion . The ph arm acy prepares th e m edication an d delivers an IV bag labeled h eparin sodium 20,000 un its/ 250 m L D5W. An in fusion pum p m ust be used to adm in ister th e m edication . The n urse sets the in fusion pum p at h ow m an y m illiliters per h our to deliver 1300 un its/h our? Fill in th e b lan k. Reco rd yo u r an swer to th e n earest wh o le n u m b er. An swer: _______ m L per h our

160. A h ealth care provider prescribes 3000 m L of D5W to be adm in istered over a 24-h o ur period. Th e n urse determ in es th at h ow m an y m illiliters per h our will be ad m in istered to th e clien t? Fill in th e b lan k. An swer: _______ m L per h our

161. Gen tam icin sulfate, 80 m g in 100 m L n orm al salin e (NS) , is to be ad m in istered over 30 m in u tes. Th e drop facto r is 10 drops (gtt)/ 1 m L. Th e n urse sets th e flo w rate at h ow m an y drops per m in ute?

Fill in th e b lan k. Reco rd yo u r an swer to th e n ear- est wh o le n u m b er. An swer: _______ drops per m in ute

162. A h ealth care provider’s prescription reads levoth yroxin e, 150 m cg orally daily. Th e m edica- tion label reads levoth yroxin e, 0.1 m g/ tablet. Th e n urse adm in isters h ow m an y tablet( s) to th e cli- en t? Fill in th e b lan k. An swer: _______ tablet(s)

163. Cefu roxim e sodium , 1 g in 50 m L n orm al salin e (NS) , is to be adm in istered over 30 m in utes. Th e drop facto r is 15 drops (gtt) / 1 m L. Th e n urse sets th e flow rate at h ow m an y drops per m in ute? Fill in th e b lan k. An swer: _______ drops per m in ute

164. A h ealth care provid er prescribes 1000 m L D5W to in fuse at a rate of 125 m L/ h ou r. Th e n urse deter- m in es th at it will take h ow m an y h ours for 1 L to in fuse? Fill in th e b lan k. An swer: _______ h our(s)

165. A h ealth care provider prescribes 1 un it of packed red blood cells to in fuse over 4 h ours. Th e un it of blood con tain s 250 m L. Th e drop factor is 10 drops (gtt)/ 1 m L. Th e n urse prepares to set th e flow rate at h ow m an y drops per m in u te? Fill in th e b lan k. Reco rd yo u r an swer to th e n earest wh o le n u m b er. An swer: _______ drops per m in ute

166. A h ealth care provider’s prescription reads m or- ph in e sulfate, 8 m g stat. Th e m edication am pule reads m orph in e sulfate, 10 m g/ m L. Th e n urse pre- pares h ow m an y m illiliters to adm in ister th e cor- rect dose? Fill in th e b lan k. An swer: _______ m L

167. A h ealth care provider prescribes regular in sulin , 8 un its/ h our by con tin uo us in traven o us (IV) in fu- sion . Th e ph arm acy prepares th e m edication an d th en delivers an IV bag labeled 100 un its of regular in sulin in 100 m L n orm al salin e (NS). An in fusio n pum p m ust be used to ad m in ister th e m ed ication . Th e n urse sets th e in fusio n pum p at h ow m an y m illiliters per h our to deliver 8 un its/ h o ur? Fill in th e b lan k. An swer: _______ m L/ h ou r

210 UNIT IV Fundamentals of Care

A N S W E R S : A L T E R N A T E I T E M F O R M A T ( F I L L - I N - T H E - B L A N K ) 153. 21 Ra t ion a le: Use th e in traven ou s (IV) flo w rate fo rm u la. For mu la :

To tal Vo lu m e  Drop factor Tim e in m in u tes

¼ Dro ps p er m in u te

1000 m LÂ 15 gtt 720 m in u tes

¼ 15, 000

720 ¼ 20:8, or 21 gtt=m in

Test -Ta kin g St r a t egy: Focus on th e su b ject, IVflow rates. Use th e form u la for calculatin g IVflow rates wh en an swerin g th e question . On ce you h ave perform ed th e calcu lation , verify you r an swer usin g a calculator and m ake sure th at th e answer m akes sen se. Rem em ber to round th e an swer to th e n earest whole n um ber. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med ication s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p p. 710-711.

154. 1.3 Ra t ion a le: Use th e m ed ication d ose form u la. For mu la :

Desired  m L Availab le

¼ Milliliters p er d ose

400, 000 un its  1 m L 300, 000 u n its

¼ Milliliters per dose

400, 000 300, 000

¼ 1:33 ¼ 1:3 m L

Test -Ta kin g St r a t egy: Focus on th e sub ject, a dosage calculatio n. Follow the form ula for the calculation of th e co rrect m edication do se. O n ce yo u h ave p erfo rm ed the calculation , verify your answer usin g a calculator and m ake sure th at th e an swer m akes sen se. Rem em ber to record you r an swer usin g 1 decim al place. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med ication s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p p. 486-487.

155. 15 Ra t ion a le: In m o st facilities, p o tassium ch lorid e is p rem ixed in th e in traven ou s solu tio n an d th e n u rse will n eed to verify th e co rrect d ose before ad m in istratio n . In so m e cases th e n u rse will n eed to add th e po tassiu m ch lo rid e an d will u se th e m ed ica- tion calculatio n form ula to determ in e th e m L to b e add ed. For mu la :

Desired  m L Available

¼ Milliliters per do se

30 m Eq  20 m L 40 m Eq

¼ 15 m L

Test -Ta kin g Str a tegy: Focus o n th e su b ject, a do sage calcula- tion . Fo llo w th e fo rm u la fo r th e calculatio n o f th e co rrect m ed- icatio n d ose. O n ce yo u h ave p erfo rm ed th e calcu lation , verify yo ur an swer u sin g a calculato r an d m ake sure th at th e an swer m akes sen se. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tal of Care—Med icatio n s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Reference: Perry, Po tter, O sten d orf (2014), p p. 486-487.

156. 2 Ra t ion a le: Yo u m u st con vert 0.3 g to m illigram s. In th e m etric system , to co n vert larger to sm aller, m u ltip ly b y 1000 o r m ove th e decim al 3 p laces to th e righ t. Th erefore, 0.3 g¼300 m g. Fo llo win g co n version fro m gram s to m illigram s, u se th e fo r- m u la to calcu late th e co rrect do se. For mu la :

Desired  m L Available

¼ Milliliters per do se

300 m g  6 m L 900 m g

¼ 1800 900

¼ 2 m L

Test -Ta kin g Str a tegy: Focus o n th e su b ject, a do sage calcula- tion . In th is m ed icatio n calculation p ro blem , first yo u m ust co n vert gram s to m illigram s. O n ce yo u h ave p erform ed th e cal- cu lation , verify you r an swer u sin g a calculato r an d m ake su re th at th e an swer m akes sen se. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med icatio n s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 486-487.

157. 2 Ra t ion a le: Yo u m u st con vert 0.2 g to m illigram s. In th e m etric system , to co n vert larger to sm aller, m u ltip ly b y 1000 o r m ove th e decim al p o in t 3 places to th e righ t. Th erefore, 0.2 g equ als 200 m g. After con versio n from gram s to m illigram s, use th e fo rm u la to calcu late th e correct do se. For mu la :

Desired  Cap sule sð Þ Available

¼ Cap su le sð Þp er d ose

200 m g  1 Capsule 100 m g

¼ 2 Capsules

Test -Ta kin g Str a tegy: Focus o n th e su b ject, a do sage calcula- tion . In th is m ed icatio n calculatio n prob lem , first yo u m u st con vert gram s to m illigram s. O n ce yo u h ave d on e th e co n version an d reread th e m ed ication calcu latio n prob lem , yo u will kn o w th at 2 cap sules is th e co rrect an swer. Rech eck

F

u

n

d

a

m

e

n

t

a

l

s

211CHAPTER 17 Calculation of Medication and Intravenous Prescriptions

yo ur wo rk usin g a calculato r an d m ake su re th at th e an swer m akes sen se. Review: Med icatio n calcu latio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Content Area : Fun dam en tals of Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 486-487.

158. 31 Ra tion a le: Use th e in traven o us (IV) flow rate fo rm ula. For mu la :

To tal vo lum e  Drop facto r Tim e in Min utes

¼ Dro p p er m in u te

1000 m LÂ 15 gtt 480 m in u tes

¼ 15, 000

480 ¼ 31:2, o r 31 gtt=m in

Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, an IV flo w rate. Use th e form u la fo r calcu latin g IV flo w rates wh en an swerin g th e q u estion . O n ce you h ave perfo rm ed th e calcu lation , verify yo ur an swer usin g a calcu lator an d m ake su re th at th e an swer m akes sen se. Rem em ber to rou n d th e an swer to th e n earest wh ole n um ber. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 710-711.

159. 16 Ra tion a le: Calcu latio n o f th is p ro blem can be do n e usin g a 2- step process. First, yo u n eed to determ in e th e am o un t of h ep - arin sod iu m in 1 m L. Th e n ext step is to determ in e th e in fu sio n rate, or m illiliters per h o ur. St ep 1:

Kn o wn am ou n t of m edicatio n in so lu tio n Total vo lu m e of diluen t

¼ Am o un t o f m ed ication p er m illim eter

20, 000 u n its 250 m L

¼ 80 u n its=m L

St ep 2:

Do se per h o ur desired Co n cen tration per m illileter

¼ In fu sion rate, o r m L=h r

1300 u n its 80 u n its=m L

¼ 16:25, o r 16 m L=h r

Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, an IV flo w rate. Read th e qu estio n carefu lly, n otin g th at 2 step s can be u sed to so lve th is m ed icatio n prob lem . Follo w th e fo rm ula, verify yo ur an swer u sin g a calcu lator, an d m ake su re th at th e an swer m akes sen se. Rem em ber to rou n d th e an swer to th e n earest wh ole n um ber.

Review: In traven o u s in fu sio n calcu latio n s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 710-711.

160. 125 Ra tion a le: Use th e in traven o u s (IV) fo rm u la to d eterm in e m il- liliters per h o ur. For mu la :

To tal vo lum e in m illiliters Nu m b er o f h ou rs

¼ Milliliters per h ou r

3000 m L 24 h ou rs

¼ 125 m L=h r

Test-Ta kin g St r a t egy: Focus on th e su b ject, an IV in fu sion cal- culatio n . Read th e q uestion carefu lly, n o tin g th at th e qu estio n is askin g ab ou t m illiliters p er h ou r to b e ad m in istered to th e clien t. Use th e form ula fo r calcu latin g m illiliters p er h ou r. O n ce you h ave p erfo rm ed th e calcu latio n , verify yo ur an swer u sin g a calcu lato r an d m ake sure th at th e an swer m akes sen se. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Reference: Perry, Potter, O sten do rf (2014), pp . 710-711.

161. 33 Ra tion a le: Use th e in traven o us (IV) flow rate form ula. For mu la :

To tal volum e  Drop factor Tim e in m in u tes

¼ Dro ps p er m in u te

100 m LÂ 10 gtt 30 m in u tes

¼ 1000

30 ¼ 33:3, or 33 gtt=m in

Test-Ta kin g St r a t egy: Focus on th e su b ject, an IV in fu sion cal- culatio n . Use th e form u la for calculatin g IV flow rates wh en an swerin g th e qu estio n . O n ce you h ave p erform ed th e calcu la- tio n , verify yo ur an swer usin g a calcu lator an d m ake su re th at th e an swer m akes sen se. Rem em b er to rou n d th e an swer to th e n earest wh ole n u m ber. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 710-711.

162. 1.5 Ra tion a le: You m u st co n vert 150 m cg to m illigram s. In th e m etric system , to con vert sm aller to larger, d ivid e b y 1000 or

F

u

n

d

a

m

e

n

t

a

l

s

212 UNIT IV Fundamentals of Care

m o ve th e decim al 3 p laces to th e left. Th erefo re, 150 m cg equ als 0.15 m g. Next, use th e fo rm u la to calcu late th e co rrect d o se. For mu la :

Desired Available

 Tab let ¼ Tablets per dose

0:15 m g 0:1 m g

 1 tablet ¼ 1:5 tablets

Test -Ta kin g Str a tegy: Focu s o n th e su b ject, a do sage calcula- tion . In th is m ed icatio n calcu lation p ro blem , first you m ust co n vert m icro gram s to m illigram s. Next, fo llo w th e fo rm u la fo r th e calcu latio n o f th e correct d o se, verify you r an swer usin g a calcu lator, an d m ake su re th at th e an swer m akes sen se. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Content Area : Fu n d am en tals o f Care—Med ication s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p p. 486-487.

163. 25 Ra tiona le: Use th e in traven o us (IV) flo w rate fo rm ula. Formula :

To tal vo lu m e  Dro p facto r Tim e in m in u tes

¼ Drop s per m in u te

50 m LÂ 15 gtt 30 m in u tes

¼ 750 30

¼ 25 gtt=m in

Test -Ta kin g Str a t egy: Fo cus o n th e su b ject, an IV in fusion cal- cu lation . Use th e fo rm ula fo r calculatin g IV flo w rates wh en an swerin g th e qu estio n . O n ce yo u h ave p erfo rm ed th e calcula- tion , verify yo u r an swer u sin g a calcu lato r an d m ake sure th at th e an swer m akes sen se. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med ication s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p p. 710-711.

164. 8 Ra t ion a le: You m u st d eterm in e th at 1 L equ als 1000 m L. Next, use th e fo rm ula for d eterm in in g in fu sio n tim e in h ou rs. For mu la :

Total vo lu m e to in fu se Milliliters per h ou r b ein g in fu sed

¼ In fu sion tim e

1000 m L 125 m L

¼ 8 h ours

Test -Ta kin g St r a t egy: Focu s o n th e su b ject, an in traven o u s in fu sion calcu latio n . Read th e qu estio n carefully, n o tin g th at th e qu estio n is askin g abo u t in fusio n tim e in h o urs. First, co n - vert 1 L to m illiliters. Next, u se th e fo rm u la for d eterm in in g

in fu sion tim e in h o urs. Verify you r an swer u sin g a calcu lator an d m ake sure th at th e an swer m akes sen se. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med icatio n s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Perry, Potter, O sten do rf (2014), p p. 710-711.

165. 10 Ra t ion a le: Use th e in traven ou s (IV) flo w rate fo rm u la. For mu la :

Total vo lu m e  Dro p facto r Tim e in m in u te

¼ Drop s per m in ute

250 m L Â 10 gtt 240 m in u tes

¼ 2500 240

¼ 10:4, or 10 gtt=m in

Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, an IV in fusion cal- cu lation . Use th e fo rm ula fo r calcu latin g IV flo w rates wh en an swerin g th e q uestion . O n ce yo u h ave perfo rm ed th e calcula- tion , verify yo u r an swer u sin g a calcu lato r an d m ake su re th at th e an swer m akes sen se. Rem em ber to ro un d th e an swer to th e n earest wh o le n u m b er. Review: In traven o u s in fu sio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med icatio n s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 710-711.

166. 0.8 Ra t ion a le: Use th e fo rm u la to calcu late th e correct do se. For mu la :

Desired  m L Availab le

¼ Milliliters p er h ou r

8 m g  1 m L 10 m g

¼ 0:8 m L

Test -Ta kin g Str a tegy: Focus o n th e su b ject, a do sage calcula- tion . Fo llo w th e fo rm u la fo r th e calcu latio n of th e correct d ose. O n ce yo u h ave perform ed th e calculatio n , verify you r an swer u sin g a calculato r an d m ake su re th at th e an swer m akes sen se. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med icatio n s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 486-487.

167. 8 Ra t ion a le: Calcu latio n o f th is pro blem can be d o n e usin g a 2-step process. First, you n eed to d eterm in e th e am o un t o f

F

u

n

d

a

m

e

n

t

a

l

s

213CHAPTER 17 Calculation of Medication and Intravenous Prescriptions

regular in su lin in 1 m L. Th e n ext step is to d eterm in e th e in fu- sio n rate, o r m illiliters p er h o ur. For mu la : St ep 1:

Kn o wn am ou n t of m edicatio n in so lu tio n Total vo lu m e of diluen t

¼ Am o un t o f m ed ication p er m illiliter

100 un its 100 m L

¼ 1 un it=m L

St ep 2: Dose p er h o u r d esired

Co n cen tration per m illiliter ¼ In fusio n rate, o r m illiliters p er h o u r

8 un its 1 un it=m L

¼ 8 m L=h ou r

Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, an IV flow rate. Read th e qu estio n carefu lly, n otin g th at 2 step s can be u sed to solve th is m edicatio n p ro blem . O n ce yo u h ave p erfo rm ed th e calculatio n , verify yo u r an swer u sin g a calcu lator an d m ake su re th at th e an swer m akes sen se. Th ese steps can be used fo r sim ilar m edication prob lem s related to th e ad m in istratio n of h ep arin so diu m or regu lar in sulin by IV in fu sio n . Review: Med icatio n calcu latio n s Level of Cogn itive Ability: An alyzin g Clien t Need : Ph ysiological In tegrity Integra ted Process: Nu rsin g Process—Im plem en tation Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Perry, Po tter, O sten d orf (2014), pp . 486-487.

F

u

n

d

a

m

e

n

t

a

l

s

214 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 18 Perioperative Nursing Care

PRIORITY CONCEPT Infection; Safety

CRITICAL THINKING What Should You Do? The nurse is assisting the surgeon in obtaining informed con- sent from a client for a scheduled surgical procedure. The cli- ent signs the consent and after the surgeon leaves the nursing unit the client informs the nurse that he is unclear about certain aspects of the surgical procedure. What should the nurse do? Answer located on p. 225.

I. Preoperative Care

A client may return home shortly after having a sur- gical procedure because many surgical procedures are done through ambulatory care or 1-day stay surgical units. Perioperative care procedures apply even when the client returns home on the same day of the surgical procedure.

A. O btain in g in form ed con sen t 1. Th e surgeon is respo n sible for explain in g th e sur-

gical procedure to th e clien t an d an swerin g th e clien t’s question s. O ften , th e n urse is respo n sible for obtain in g th e clien t’s sign ature on th e con - sen t form for surgery, wh ich in dicates th e clien t’s agreem en t to th e proced ure based on th e surgeon ’s explan ation .

2. Th e n urse m ay witn ess th e clien t’s sign in g of th e con sen t form , but th e n urse m ust be sure th at th e clien t h as un dersto od th e surgeon ’s explan ation of th e surgery.

3. Th e n urse n eeds to docum en t th e witn essin g of th e sign in g of th e con sen t form after th e clien t ackn owledges un derstan din g th e proced ure.

4. Min ors (clien ts yo un ger th an 18 years) m ay n eed a paren t or legal guardian to sign th e con sen t form .

5. O ld er clien ts m ay n eed a legal guardian to sign th e con sen t form .

6. Psych iatric clien ts h ave a righ t to refuse treatm en t un til a court h as legally determ in ed th at th ey are un ab le to m ake decision s for th em selves.

7. No sedation sh o uld be adm in istered to th e clien t befo re th e clien t sign s th e con sen t form .

8. O btain in g teleph o n e con sen t from a legal gu ard- ian or power of atto rn ey for h ealth care is an acceptable practice if clien ts are un ab le to give con sen t th em selves. Th e n urse m ust en gage an oth er n urse as a witn ess to th e con sen t given over th e telep h on e.

B. Nutrition 1. Review th e surgeon ’s prescription s regardin g th e

NPO (n oth in g by m outh ) status before surgery. 2. With h old solid food s an d liquid s as prescribed

to avoid aspiration , usually for 6 to 8 h ours befo re gen eral an esth esia an d for approxim ately 3 h ours before surgery with local an esth esia (as prescribed).

3. In sert an in traven o us (IV) lin e an d ad m in ister IV fluid s, if prescribed; per agen cy policy, th e IV cath eter size sh ould be large en ough to adm in is- ter blood products if th ey are required .

C. Elim in ation 1. If th e clien t is to h ave in testin al or abdom in al

surgery, per surgeon ’s preferen ce an en em a, lax- ative, or both m ay be prescribed for th e day or n igh t before surgery.

2. Th e clien t sh ould void im m ediately before surgery.

3. In sert an in dwellin g urin ary cath eter, if pre- scrib ed; urin ary cath eter collection bags sh ould be em p tied im m ediately befo re surgery, an d th e n urse sh ould docum en t th e am oun t an d ch aracteristics of th e urin e.

D. Surgical site 1. Clean th e surgical site with a m ild an tiseptic or

an tibacterial soap on th e n igh t before surgery, as prescribed.

2. Sh ave th e operative site, as prescribed; sh avin g m ay be don e in th e operative area.

215

Hair on the head or face (including the eyebrows) should be shaved only if prescribed.

E. Preop erative clien t teach in g 1. In form th e clien t about wh at to expect

posto peratively. 2. In form th e clien t to n otify th e n urse if th e clien t

experien ces an y pain posto peratively an d th at pain m ed ication will be prescribed an d given as th e clien t requests. Th e clien t sh o uld be in form ed th at som e degree of pain sh ould be expected an d is n orm al.

3. In form th e clien t th at requestin g an opioid after surgery will n ot m ake th e clien t a drug ad dict.

4. Dem on strate th e use of a patien t-con tro lled an al- gesia (PCA) pum p if prescribed.

5. In struct th e clien t h ow to use n on in vasive pain - relief tech n iqu es such as relaxation , distractio n tech n iques, an d guided im agery before th e pain occurs an d as soon as th e pain is n oticed.

6. Th e n urse sh ould in struct th e clien t n ot to sm oke (fo r at least 24 h ours before surgery); discuss sm okin g cessation treatm en ts an d program s.

7. In struct th e clien t in deep-breath in g an d co ugh - in g tech n iqu es, use of in cen tive spirom etry, an d th e im portan ce of perform in g th e tech n iqu es posto peratively to preven t th e develo pm en t of pn eum on ia an d atelectasis ( Box 18-1).

8. In struct th e clien t in leg an d foot exercises to pre- ven t ven o us stasis of blood an d to facilitate ven o us blood return ( Fig. 18-1; see Box 18-1).

9. In struct th e clien t in h ow to splin t an in cision , turn , an d reposition (Fig. 18-2; see Box 18-1).

10. In form th e clien t of an y in vasive devices th at m ay be n eeded after surgery, such as a n aso gastric tube, drain , urin ary cath eter, epidu ral cath eter, or IV or subclavian lin es.

11. In struct th e clien t n ot to pull on an y of th e in va- sive devices; th ey will be rem oved as soon as possible.

F. Psych o social preparatio n 1. Be alert to th e clien t’s level of an xiety. 2. An swer an y question s or con cern s th at th e clien t

m ay h ave regardin g surgery. 3. Allow tim e for privacy for th e clien t to prepare

psych o logically for surgery. 4. Provide supp ort an d assistan ce as n eeded. 5. Take cultural aspects in to con sideration wh en

providin g care ( Box 18-2). G. Preop erative ch ecklist

1. En su re th at th e clien t is wearin g an iden tification bracelet.

2. Assess for allergies, in cludin g an allergy to latex (see Ch apter 66 for in form ation on latex allergy).

3. Review th e preoperative ch ecklist to be sure th at each item is addressed before th e clien t is tran s- ported to surgery.

4. Follow agen cy policies regardin g preoperative proced ures, in cludin g in form ed con sen ts, preop- erative ch ecklists, prescribed laborato ry or radio- logical tests, an d an y oth er preoperative proced ure.

5. En sure th at in form ed con sen t form s h ave been sign ed for th e operative procedure, an y blood tran sfusion s, disposal of a lim b , or surgical ster- ilization procedures.

6. En sure th at a h isto ry an d ph ysical exam in ation h ave been com pleted an d docum en ted in th e cli- en t’s record ( Box 18-3).

7. En sure th at con sultation requests h ave been com pleted an d docum en ted in th e clien t’s record.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 18-1 Client Teaching

Deep-Breathing and Coughing Exercises Instruct the client that a sitting position gives the best lung

expansion for coughing and deep-breathing exercises. Instruct the client to breathe deeply 3 times, inhaling through

the nostrils and exhaling slowly through pursed lips. Instruct the client that the third breath should be held for 3 sec-

onds; then the client should cough deeply 3 times. The client should perform this exercise every 1 to 2 hours.

Incentive Spirometry Instruct the client to assume a sitting or upright position. Instruct the client to place the mouth tightly around the

mouthpiece. Instruct the client to inhale slowly to raise and maintain the

flow rate indicator, usually between the 600 and 900 marks on the device.

Instruct the client to hold the breath for 5 seconds and then to exhale through pursed lips.

Instruct the client to repeat this process 10 times every hour.

Leg and Foot Exercises Gastrocnemius (calf) pumping: Instruct the client to move

both ankles by pointing the toes up and then down. Quadriceps (thigh) setting: Instruct the client to press the

back of the knees against the bed and then to relax the knees; this contracts and relaxes the thigh and calf muscles to prevent thrombus formation.

Foot circles: Instruct the client to rotate each foot in a circle. Hip and knee movements: Instruct the client to flex the knee

and thigh and to straighten the leg, holding the position for 5 seconds before lowering (not performed if the client is having abdominal surgery or if the client has a back problem).

Splinting the Incision If the surgical incision is abdominal or thoracic, instruct the

client to place a pillow, or 1 hand with the other hand on top, over the incisional area.

During deep breathing and coughing, the client presses gently against the incisional area to splint or support it.

216 UNIT IV Fundamentals of Care

8. En su re th at prescribed labo ratory results are docum en ted in th e clien t’s record.

9. En su re th at electrocardiogram an d ch est radiog- raph y reports are docum en ted in th e clien t’s record.

10. En su re th at a blood type, screen , an d cro ssm atch are perform ed an d docum en ted in th e clien t’s record with in th e establish ed tim e fram e per agen cy policy.

11. Rem o ve jewelry, m akeup, den tures, h airp in s, n ail polish (depen din g on agen cy proced ures), glasses, an d prosth eses.

F

u

n

d

a

m

e

n

t

a

l

sGa s trocne mius (ca lf) pumping

Qua drice ps (thigh) s e tting

Hip a nd kne e move me nts

Foot circle s

De s irable

Es s e ntial

FIGURE 18-1 Postoperative leg exercises.

FIGURE 18-2 Techniques for splinting a wound when coughing.

BOX 18-2 Cultural Aspects of Perioperative Nursing Care

Cultural assessment includes questions related to: ▪ Primary language spoken ▪ Feelings related to surgery and pain ▪ Pain management ▪ Expectations ▪ Support systems ▪ Feelings toward self ▪ Cultural practices and beliefs Allow a family member to be present if appropriate. Secure the help of a professional interpreter to communicate

with non–English-speaking clients. Use pictures or phrase cards to communicate and assess the

non–English-speaking client’s perception of pain or other feelings.

Provide preoperative and postoperative educational materials in the appropriate language.

Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

BOX 18-3 Medical Conditions That Increase Risk During Surgery

▪ Bleeding disorders such as thrombocytopenia or hemophilia

▪ Diabetes mellitus ▪ Chronic pain ▪ Heart disease, such as a recent myocardial infarction, dys-

rhythmia, heart failure, or peripheral vascular disease ▪ Obstructive sleep apnea ▪ Upper respiratory infection ▪ Liver disease ▪ Fever ▪ Chronic respiratory disease, such as emphysema, bronchi-

tis, or asthma ▪ Immunological disorders, such as leukemia, infection with

human immunodeficiency virus, acquired immunodefi- ciency syndrome, bone marrow depression, or use of chemotherapy or immunosuppressive agents

▪ Abuse of street drugs Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

217CHAPTER 18 Perioperative Nursing Care

12. Do cum en t th at valuables h ave been given to th e clien t’s fam ily m em bers or locked in th e h ospital safe.

13. Do cum en t th e last tim e th at th e clien t ate or dran k.

14. Do cum en t th at th e clien t vo ided befo re surgery. 15. Do cum en t th at th e prescribed preop erative m ed-

ication s were given ( Box 18-4). 16. Mon itor an d docum en t th e clien t’s vital sign s.

H. Preop erative m ed ication s 1. Prepare to ad m in ister preoperative m ed ication s

as prescribed before surgery. 2. In struct th e clien t about th e desired effects of th e

preop erative m ed ication .

After administering the preoperative medications, keep the client in bed with the side rails up (per agency pol- icy). Place the call bell next to the client; instruct the client not to get out of bed and to call for assistance if needed.

I. Arrival in th e operatin g room 1. Guidelin es to preven t wron g site an d wron g pro-

cedu re surgery a . Th e surgeon m eets with th e clien t in th e pre-

operative area an d uses in delible in k to m ark th e operative site.

b . In th e operatin g room , th e n urse an d surgeon en sure an d recon firm th at th e operative site h as been appropriately m arked.

c. Just before startin g th e surgical proced ure, a tim e-o ut is con d ucted with all m em bers of th e operative team presen t to iden tify th e correct clien t an d ap propriate surgical site again .

2. Wh en th e clien t arrives in th e operatin g room , th e operatin g room n urse will verify th e iden tifi- cation bracelet with th e clien t’s verbal respo n se an d will review th e clien t’s ch art.

3. Th e clien t’s record will be ch ecked for co m plete- n ess an d reviewed for in form ed con sen t form s, h isto ry an d ph ysical exam in ation , an d allergic reaction in form ation .

4. Th e surgeon ’s prescription s will be verified an d im plem en ted.

5. Th e IV lin e m ay be in itiated at th is tim e (or in th e preop erative area), if prescribed.

6. Th e an esth esia team will ad m in ister th e pre- scrib ed an esth esia.

Verification of the client and the surgical operative site is critical.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 18-4 Substances That Can Affect the Client in Surgery Antibiotics Antibiotics potentiate the action of anesthetic agents.

Anticholinergics Medications with anticholinergic effects increase the potential

for confusion, tachycardia, and intestinal hypotonicity and hypomotility.

Anticoagulants, antiplatelets, and thrombolytics These medications alter normal clotting factors and increase

the risk of hemorrhaging. Acetylsalicylic acid (Aspirin), clopidogrel, and nonsteroidal anti-

inflammatory drugs are commonly used medications that can alter platelet aggregation.

These medications should be discontinued at least 48 hours before surgery or as specified by the surgeon; clopidogrel usually has to be discontinued 5 days before surgery.

Anticonvulsants Long-term use of certain anticonvulsants can alter the metabo-

lism of anesthetic agents.

Antidepressants Antidepressants may lower the blood pressure during anesthesia.

Antidysrhythmics Antidysrhythmic medications reduce cardiac contractility and

impair cardiac conduction during anesthesia.

Antihypertensives Antihypertensive medications can interact with anesthetic

agents and cause bradycardia, hypotension, and impaired circulation.

Corticosteroids Corticosteroids cause adrenal atrophy and reduce the ability of

the body to withstand stress. Before and during surgery, dosages may be increased

temporarily.

Diuretics Diuretics potentiate electrolyte imbalances after surgery.

Herbal Substances Herbal substances can interact with anesthesia and cause a

variety of adverse effects. These substances may need to be stopped at a specific time before surgery. During the pre- operative period, the client needs to be asked if he or she is taking an herbal substance.

Insulin The need for insulin after surgery in a diabetic may be reduced

because the client’s nutritional intake is decreased, or the need for insulin may be increased because of the stress response and intravenous administration of glucose solutions.

Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

218 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

II. Postoperative Care A. Description

1. Posto perative care is th e m an agem en t of a clien t after surgery an d in cludes care given durin g th e im m ediate postoperative period as well as durin g th e days followin g surgery.

2. Th e goal of postoperative care is to prevent com - plication s, to prom ote h ealin g of th e surgical inci- sion , an d to return th e clien t to a h ealth y state.

B. Resp iratory system

Assess breath sounds; stridor, wheezing, or a crow- ing sound can indicate partial obstruction, broncho- spasm, or laryngospasm, while crackles or rhonchi may indicate pulmonary edema.

1. Mon itor vital sign s. 2. Mon itor airway paten cy an d en sure adequate

ven tilation (prolo n ged m ech an ical ven tilation durin g an esth esia m ay affect posto perative lun g fun ction ).

3. Rem em ber th at extubated clien ts wh o are leth ar- gic m ay n ot be able to m ain tain an airway.

4. Mon itor for secretio n s; if th e clien t is un ab le to clear th e airway by cough in g, suction th e secre- tio n s from th e clien t’s airway.

5. O bserve ch est m ovem en t for sym m etry an d th e use of accesso ry m uscles.

6. Mon itor oxygen adm in istration if prescribed. 7. Mon itor pulse oxim etry an d en d title carbo n

dioxide (CO 2) as prescribed . 8. En cou rage deep-breath in g an d cough in g exer-

cises as soon as possible after surgery. 9. No te th e rate, dep th , an d quality of respiration s;

th e respiratory rate sh ould be greater th an 10 an d less th an 30 breath s/ m in ute.

10. Mon itor for sign s of respiratory distress, atelecta- sis, or oth er respiratory com plication s.

C. Card iovascu lar system 1. Mon itor circulatory status, such as skin color,

periph eral pulses, an d cap illary refill, an d for th e absen ce of edem a, n um bn ess, an d tin glin g.

2. Mon itor for bleedin g. 3. Assess th e pulse for rate an d rh yth m (a boun din g

pulse m ay in dicate h yperten sio n , fluid overload, or clien t an xiety).

4. Mon itor for sign s of h yperten sio n an d h ypo ten sion .

5. Mon itor for cardiac dysrh yth m ias. 6. Mon itor for sign s of th rom boph lebitis, particu-

larly in clien ts wh o were in th e lith otom y posi- tio n durin g surgery.

7. En cou rage th e use of an tiem bolism stockin gs or seq uen tial com pression devices (Fig. 18-3), if prescribed, to prom ote ven ous return , stren gth en m uscle ton e, an d preven t poolin g of blood in th e extrem ities.

D. Muscu loskeletal system 1. Assess th e clien t for m ovem en t of th e extrem ities. 2. Review th e surgeon ’s prescription s regardin g cli-

en t position in g or restriction s. 3. En cou rage am bulation if prescribed; before

am bulation , in struct th e clien t to sit at th e edge of th e bed with h is or h er feet supported to assum e balan ce.

4. Un less con train dicated, place th e clien t in a low Fowler’s position after surgery to in crease th e size of th e th orax for lun g expan sion .

5. Avoid position in g th e posto perative clien t in a supin e position un til ph aryn geal reflexes h ave return ed; if th e clien t is com atose or sem icom a- tose, position on th e side (in ad dition , an oral airway m ay be n eeded).

6. If th e clien t is un ab le to get out of bed, turn th e clien t every 1 to 2 h ours.

E. Neurological system 1. Assess level of con scio usn ess. 2. Make frequen t periodic attem pts to awaken th e

clien t un til th e clien t awaken s. 3. O rien t th e clien t to th e en viron m en t. 4. Speak in a soft ton e; filter out extran eous n oises

in th e en viron m en t. 5. Main tain th e clien t’s body tem p erature an d pre-

ven t h eat loss by providin g th e clien t with warm blan kets an d raisin g th e ro om tem p erature as n ecessary.

F. Tem perature con trol 1. Mon itor tem perature. 2. Mon itor for sign s of h ypoth erm ia th at m ay result

from an esth esia, a cool operatin g room , or expo- sure of th e skin an d in tern al organ s durin g surgery.

3. Apply warm blan kets, con tin ue oxygen , an d adm in ister m ed ication as prescribed if th e clien t experien ces postoperative sh iverin g.

G. In tegum en tary system 1. Assess th e surgical site, drain s, an d woun d dress-

in gs (serous drain age m ay occur from an in ci- sion , but n otify th e surgeon if excessive bleed in g occurs from th e site).

2. Assess th e skin for redn ess, ab rasion s, or break- down th at m ay h ave resulted fro m surgical position in g.

FIGURE 18-3 Sequential compression device.

219CHAPTER 18 Perioperative Nursing Care

3. Mon itor body tem p erature an d woun d for sign s of in fectio n .

4. Main tain a dry, in tact dressin g. 5. Ch an ge dressin gs as prescribed, n otin g th e

am oun t of bleedin g or drain age, odor, and in tact- n ess of sutures or staples; com m on ly used dress- in gs in clude 4 Â 4 in ch gauze, n on adh eren t pads, abdom in al pads, gauze rolls, an d split gauze th at are com m on ly referred to as drain spon ges.

6. Woun d drain s sh ould be paten t; prepare to assist with th e rem oval of drain s (as prescribed by th e surgeon ) wh en th e drain age am oun t beco m es in sign ifican t.

7. An ab dom in al bin der m ay be prescribed for obese an d deb ilitated in dividuals to preven t deh iscen ce of th e in cision .

H. Fluid an d electrolyte balan ce 1. Mon itor IV flu id adm in istration as prescribed. 2. Record in take an d outp ut. 3. Mon itor for sign s of flu id or electrolyte im bal-

an ces. I. Gastro in testin al system

1. Mon itor in take an d outp ut an d for n ausea an d vom itin g.

2. Main tain paten cy of th e n aso gastric tube if pre- sen t an d m on itor placem en t an d drain age per agen cy procedure.

3. Mon itor for abdom in al disten tion . 4. Mon itor for passage of flatu s an d return of bowel

soun ds. 5. Adm in ister frequen t oral care, at least every

2 h ours. 6. Main tain th e NPO status un til th e gag reflex an d

peristalsis return . 7. Wh en oral fluids are perm itted, start with ice

ch ips an d water. 8. En su re th at th e clien t advan ces to clear liquids

an d th en to a regular diet, as prescribed an d as th e clien t can tolerate.

To prevent aspiration, turn the client to a side-lying position if vomiting occurs; have suctioning equipment available and ready to use.

J. Ren al system 1. Assess th e bladder for disten tion . 2. Mon itor urin e outp ut (urin ary output sh ould be

at least 30 m L/ h ou r). 3. If th e clien t does n ot h ave a urin ary cath eter, th e

clien t is expected to void with in 6 to 8 h ours posto peratively depen din g on th e typ e of an es- th esia adm in istered; en sure th at th e am oun t is at least 200 m L.

K. Pain m an agem en t 1. Assess th e type of an esth etic used an d preop era-

tive m edication th at th e clien t received, an d n ote wh eth er th e clien t received an y pain m ed ication s in th e postan esth esia period.

2. Assess for pain an d in quire about th e type an d location of pain ; ask th e clien t to rate th e degree of pain on a scale of 1 to 10, with 10 bein g th e m ost severe.

3. If th e clien t is un ab le to rate th e pain usin g a n um erical pain scale, use a descripto r scale th at lists words th at describe differen t levels of pain in ten sity, such as no pain, mild pain, moderate pain, an d severe pain, or oth er available pain rat- in g scales.

4. Mon itor for objective data related to pain , such as facial expressio n s, body gestures, in creased pulse rate, in creased blood pressure, an d in creased respiration s.

5. In quire about th e effectiven ess of th e last pain m edication .

6. Adm in ister pain m edication as prescribed . 7. En sure th at th e clien t with a PCA pum p un der-

stan d s h ow to use it. 8. If an opioid h as been prescribed, after adm in is-

tration assess th e clien t every 30 m in utes for respiratory rate an d pain relief.

9. Use n on in vasive m easu res to relieve posto pera- tive pain , in cludin g provision of distractio n , relaxation tech n iques, gu ided im agery, com fo rt m easu res, position in g, backrubs, an d a quiet an d restful en viron m en t.

10. Docum en t effectiven ess of th e pain m edication an d n on in vasive pain -relief m easu res.

Consider cultural practices and beliefs when plan- ning pain management.

III. Pneumonia and Atelectasis A. Descrip tion ( Box 18-5 an d Fig. 18-4)

1. Pn eum on ia: An in flam m ation of th e alveoli caused by an in fectio us process th at m ay develop 3 to 5 days postoperatively as a result of in fec- tion , aspiration , or im m ob ility

2. Atelectasis: A collapsed or airless state of th e lun g th at m ay be th e result of airway obstru ctio n

F

u

n

d

a

m

e

n

t

a

l

s

BOX 18-5 Postoperative Complications

▪ Pneumonia and atelectasis ▪ Hypoxemia ▪ Pulmonary embolism ▪ Hemorrhage ▪ Shock ▪ Thrombophlebitis ▪ Urinary retention ▪ Constipation ▪ Paralytic ileus ▪ Wound infection ▪ Wound dehiscence ▪ Wound evisceration

220 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

cau sed by accu m ulated secretio n s or failure of th e clien t to deep-breath e or am bulate after sur- gery; a postoperative com plication th at usually occurs 1 to 2 days after surgery

B. Assessm en t 1. Dysp n ea an d in creased respiratory rate 2. Crackles over in volved lun g area 3. Elevated tem perature 4. Productive co ugh an d ch est pain

C. In terven tion s 1. Assess lun g soun ds. 2. Repo sition th e clien t every 1 to 2 h ours. 3. En cou rage th e clien t to deep-breath e, cough , an d

use th e in cen tive spirom eter as prescribed. 4. Provide ch est ph ysioth erapy an d postu ral drain -

age, as prescribed. 5. En cou rage flu id in take an d early am bulation . 6. Use suction to clear secretio n s if th e clien t is

un ab le to cough .

IV. Hypoxemia A. Description : An in adequate con cen tration of oxygen

in arterial blood ; in th e postoperative clien t, h ypo x- em ia can be due to sh allow breath in g from th e effects of an esth esia or m edication s.

B. Assessm en t 1. Restlessn ess 2. Dysp n ea 3. Diaph oresis 4. Tach ycardia 5. Hyperten sion

6. Cyan osis 7. Low pulse oxim etry readin gs

C. In terven tion s 1. Mon itor for sign s of h ypo xem ia. 2. No tify th e surgeon . 3. Mon itor lun g soun ds an d pulse oxim etry. 4. Adm in ister oxygen as prescribed. 5. En cou rage deep breath in g an d cough in g an d use

of th e in cen tive spirom eter. 6. Turn an d reposition th e clien t frequen tly;

en courage am bulation .

V. Pulmonary Embolism A. Description : An em bolus blockin g th e pulm o n ary

artery an d disruptin g blood flo w to 1 or m ore lobes of th e lun g

B. Assessm en t 1. Sudd en dyspn ea 2. Sudd en sh arp ch est or upper abdom in al pain 3. Cyan osis 4. Tach ycardia 5. A drop in blood pressure

C. In terven tion s 1. No tify th e surgeon im m ediately because pulm o -

n ary em b olism m ay be life-th reaten in g an d requires em ergen cy action .

2. Mon itor vital sign s. 3. Adm in ister oxygen an d m edication s as prescribed.

VI. Hemorrhage A. Description : Th e loss of a large am oun t of blood

extern ally or in tern ally in a sh o rt tim e period B. Assessm en t

1. Restlessn ess 2. Weak an d rapid pulse 3. Hypo ten sion 4. Tach ypn ea 5. Cool, clam m y skin 6. Redu ced urin e output

C. In terven tion s 1. Provide pressure to th e site of bleedin g. 2. No tify th e surgeon . 3. Adm in ister oxygen , as prescribed. 4. Adm in ister IV flu ids an d blood , as prescribed . 5. Prepare th e clien t for a surgical procedure, if

n ecessary.

VII. Shock A. Description : Loss of circulatory fluid volum e, wh ich

usually is caused by h em orrh age B. Assessm en t: Sim ilar to assessm en t fin din gs in

h em orrh age C. In terven tion s

1. If sh ock develops, elevate th e legs. 2. No tify th e surgeon . 3. Determ in e an d treat th e cau se of sh ock. 4. Adm in ister oxygen , as prescribed. 5. Mon itor level of con sciousn ess.

Alve oli line d by fla tte ne d e pithe lium

to a llow ga s e xcha nge

Mucous plug

A

B C

Mucous plugs

a ccumula ting

Air a bs orbe d from a lve oli;

lung s e gme nt colla ps e s

FIGURE 18-4 Postoperative atelectasis. A, Normal bronchiole and alveoli. B, Mucous plug in bronchiole. C, Collapse of alveoli caused by atelectasis following absorption of air.

221CHAPTER 18 Perioperative Nursing Care

6. Mon itor vital sign s for in creased pulse or decreased blood pressure.

7. Mon itor in take an d output. 8. Assess color, tem perature, turgor, an d m oistu re

of th e skin an d m ucou s m em bran es. 9. Adm in ister IV fluids, blood, an d collo id solu-

tion s, as prescribed.

If the client had spinal anesthesia, do not elevate the legs any higher than placing them on the pillow; other- wise, the diaphragm muscles needed for effective breathing could be impaired.

VIII. Thrombophlebitis A. Description

1. Th rom b oph lebitis is an in flam m ation of a vein , often acco m pan ied by clot form ation .

2. Vein s in th e legs are affected m ost com m on ly. B. Assessm en t

1. Vein in flam m ation 2. Ach in g or cram p in g pain 3. Vein feels h ard an d cordlike an d is ten der to touch. 4. Elevated tem p erature

C. In terven tion s 1. Mon itor legs for swellin g, in flam m ation , pain,

ten dern ess, ven ous disten tion , an d cyan osis; n otify th e surgeon if an y of these sign s are presen t.

2. Elevate th e extrem ity 30 degrees with out allow- in g an y pressure on th e popliteal area.

3. En cou rage th e use of an tiem bolism stockin gs as prescribed; rem ove stockin gs twice a day to wash an d in spect th e legs.

4. Use a sequen tial com pression device as pre- scrib ed (see Fig. 18-3).

5. Perform passive ran ge-of-m otion exercises every 2 h ours if th e clien t is con fin ed to bed rest.

6. En cou rage early am bulation , as prescribed. 7. Do n ot allow th e clien t to dan gle th e legs. 8. In struct th e clien t n ot to sit in 1 position for an

exten ded period of tim e. 9. Adm in ister an ticoagulan ts such as h eparin

sodium or en oxap arin , as prescribed.

IX. Urinary Retention A. Description

1. Urin ary reten tion is an in volun tary accu m ula- tion of urin e in th e bladder as a result of loss of m uscle ton e.

2. It is cau sed by th e effects of an esth etics or opioid an algesics an d appears 6 to 8 h ours after surgery.

B. Assessm en t 1. In ab ility to vo id 2. Restlessn ess an d diaph o resis 3. Lower abdom in al pain 4. Disten ded bladder 5. Hyperten sion 6. O n percussion , bladder soun ds like a drum .

C. In terven tion s 1. Mon itor for voidin g. 2. Assess for a disten ded bladder by palpation an d

bladder scan n in g if in dicated . 3. En cou rage am bulation wh en prescribed. 4. En cou rage fluid in take un less con train d icated. 5. Assist th e clien t to void by h elpin g th e clien t

to stan d. 6. Provid e privacy. 7. Pour warm water over th e perin eum or allow th e

clien t to h ear ru n n in g water to prom o te voidin g. 8. Con tact th e surgeon an d cath eterize th e clien t as

prescribed after all n on in vasive tech n iqu es h ave been attem pted.

X. Constipation A. Descrip tion

1. Con stipation is an abn orm al in freq uen t passage of stool.

2. Wh en th e clien t resum es a solid diet posto pera- tively, failure to pass stool with in 48 h ours m ay in dicate con stipation .

B. Assessm en t 1. Absen ce of bowel m ovem en ts 2. Abdo m in al disten tion 3. An orexia, h eadach e, an d n ausea

C. In terven tion s 1. Assess bowel soun ds. 2. En cou rage fluid in take up to 3000 m L/ day un less

con train dicated. 3. En cou rage early am bulation . 4. En cou rage con sum p tion of fib er food s un less

con train dicated. 5. Provid e privacy an d adequ ate tim e for bowel

elim in ation . 6. Adm in ister stool soften ers an d laxatives, as

prescribed.

XI. Paralytic Ileus A. Descrip tion

1. Paralytic ileus is failure of appropriate forward m ovem en t of bowel con ten ts.

2. Th e con dition m ay occur as a result of an esth etic m edication s or of m an ipulation of th e bowel durin g th e surgical procedure.

B. Assessm en t 1. Vom itin g posto peratively 2. Abdo m in al disten tion 3. Absen ce of bowel soun ds, bowel m ovem en t, or

flatu s C. In terven tion s

1. Mon itor in take an d outp ut. 2. Main tain NPO status un til bowel soun ds return . 3. Main tain p aten cy o f a n aso gastric tu b e if in

p lace; assess p aten cy an d d rain age p er agen cy p ro ced u re.

4. En cou rage am bulation .

F

u

n

d

a

m

e

n

t

a

l

s

222 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

5. Adm in ister IV fluids or paren teral n utrition , as prescribed.

6. Adm in ister m ed ication s as prescribed to in crease gastro in testin al m otility an d secretion s.

7. If ileus occurs, it is treated first n on su rgically with bowel deco m pression by in sertion of a n aso gas- tric tube attach ed to in term itten t or con stan t suction .

Vomiting postoperatively, abdominal distention, and absence of bowel sounds may be signs of paralytic ileus.

XII. Wound Infection A. Description

1. Woun d in fectio n m ay be caused by poor aseptic tech n ique or a con tam in ated woun d befo re sur- gical exploration ; existin g clien t con ditio n s such as diab etes m ellitus or im m un ocom prom ise m ay place th e clien t at risk.

2. In fection usually occurs 3 to 6 days after surgery.

3. Purulen t m aterial m ay exit fro m th e drain s or sep arated woun d edges.

B. Assessm en t 1. Fever an d ch ills 2. Warm , ten der, pain ful, an d in flam ed in cision site 3. Edem atous skin at th e in cision an d tigh t skin

sutures 4. Elevated wh ite blood cell coun t

C. In terven tion s 1. Mon itor tem perature. 2. Mon itor in cision site for approxim ation of

suture lin e, edem a, or bleed in g, an d sign s of in fectio n ( REEDA: redn ess, eryth em a, ecch ym o - sis, drain age, approxim atio n of th e woun d edges); n otify th e surgeon if sign s of woun d in fectio n are presen t.

3. Main tain paten cy of drain s, an d assess drain age am oun t, color, an d con sisten cy.

4. Main tain asepsis, ch an ge th e dressin g, an d per- form woun d irrigation , if prescribed (Box 18-6).

5. Adm in ister an tibiotics, as prescribed.

BOX 18-6 Procedure for Sterile Dressing Change and Wound Irrigation* Verify the prescription for the procedure in the medical record. Anticipate supplies that will be needed and gather supplies,

including personal protective equipment (PPE) and addi- tional equipment needed for protection (i.e., gown, face shield, clean gloves), a sterile dressing change kit if avail- able, and any anticipated additional supplies such as gauze pads, drain sponges, cotton tipped applicators, tape, an abdominal pad, a measuring tool, syringe for irrigation, irri- gation basin, extra pair of sterile gloves, and underpad.

Introduce self to client, identify the client with 2 accepted iden- tifiers and compare against medical record, provide privacy, and explain the procedure.

Assess the client’s pain level using an appropriate pain scale and medicate as necessary.

Assess the client for allergies, particularly to tape or latex. Perform hand hygiene and don PPE. Position the client appropriately, apply clean gloves, and place

the underpad underneath the client. Remove the soiled dressing, assess and characterize drainage

noted on the dressing, and discard the removed dressing in the biohazard waste; note: if a moist-to-dry dressing adheres to the wound, gently free the dressing and warn the client of the discomfort; if a dry dressing adheres to the wound that is not to be debrided, moisten the dressing with normal saline and remove.

Assess the wound and periwound for size (length, width, depth; measure using measuring tool), appearance, color, drain- age, edema, approximation, granulation tissue, presence and condition of drains, and odor; and palpate edges for ten- derness or pain.

Cover the wound with sterile gauze by opening a sterile gauze pack and lightly placing the gauze on the wound without touching the dressing material; remove gloves and perform hand hygiene.

Set up the sterile field: prepare sterile equipment using sterile tech- nique on an overbed table. If irrigation is prescribed, pour any prescribed irrigation solution into a sterile basin and draw solu- tion into the irrigating syringe. Gently irrigate the wound with the prescribed solution from the least contaminated area to the most contaminated area. Use an approved irrigation basin to collect solution from the irrigating procedure.

Cleanse the wound with sterile gauze from the least contaminated area to the most contaminated area, using single-stroke motions. Discard the gauze from each stroke and use a new one for the next stroke. If drains are present, use cotton tipped applicators to hold drains up and clean around drain sites using circular strokes, starting near the drain and moving outward from the insertion site using cotton tipped applicators or sterile gauze. Dry sites in the same manner using sterile gauze.

Apply any prescribed wound antiseptic with a cotton-tipped applicator or sterile gauze, using the same technique as when cleansing the wound.

Dress the wound with the prescribed dressings using sterile technique and secure in place.

Date/ time/ initial the dressing and discard supplies as indicated per agency procedures, and remove gloves.

Assist the client to a comfortable position and ensure safety; assess pain level.

Document the procedure, any related assessments, client response, and any additional procedural responses.

Adapted from Perry A, Potter P, Ostendorf W: Clinical nursing skills and techniques, ed 8, St. Louis, 20 14, Mosby. *Note: Adapt procedure if irrigation is not prescribed or if the client does not have drains or tubes in place. Always follow agency procedures for dressing changes and wound irrigations.

223CHAPTER 18 Perioperative Nursing Care

XIII. Wound Dehiscence and Evisceration (Fig. 18-5) A. Description

1. Woun d deh iscen ce is sep aration of th e woun d edges at th e suture lin e; it usually occurs 6 to 8 days after surgery.

2. Woun d evisceratio n is protrusion of th e in tern al organ s th rough an in cision ; it usually occurs 6 to 8 days after surgery.

3. Evisceration is m ost com m on am on g obese cli- en ts, clien ts wh o h ave h ad abdom in al surgery, or th o se wh o h ave poor woun d-h ealin g ability.

4. Woun d evisceration is an em ergen cy. B. Assessm en t: Deh iscen ce

1. In creased drain age 2. O pen ed woun d edges 3. Appearan ce of un derlyin g tissues th rough

th e woun d C. Assessm en t: Evisceration

1. Disch arge of serosan guin eous fluid from a previ- ously dry woun d

2. Th e appearan ce of loops of bowel or oth er abdom in al con ten ts th rough th e woun d

3. Clien t reports feelin g a popp in g sen sation after cough in g or turn in g.

D. In terven tion s (see Priority Nursin g Action s)

XIV. Ambulatory Care or 1-Day Stay Surgical Units A. Gen eral criteria for clien t disch arge

1. Is alert an d orien ted. 2. Has vo ided. 3. Has n o respiratory distress. 4. Is ab le to am bulate, swallow, an d cough . 5. Has m in im al pain . 6. Is n ot vom itin g. 7. Has m in im al, if an y, bleed in g from th e in cision

site.

8. Has a respo n sible adult available to drive th e clien t h om e.

9. Th e surgeon h as sign ed a release form . B. Disch arge teach in g (Box 18-7)

1. Disch arge teach in g sh ould be perform ed befo re th e date of th e sch eduled proced ure.

2. Provid e written in struction s to th e clien t an d fam ily regardin g th e specifics of care.

3. In struct th e clien t an d fam ily ab out posto pera- tive com plication s th at can occur.

4. Provid e appropriate resources for h om e care support.

5. In struct th e clien t n ot to drive, m ake im portan t decision s, or sign an y legal docum en ts for 24 h ours after receivin g gen eral an esth esia.

6. In struct th e clien t to call th e surgeon , am bulatory cen ter, or em ergen cy dep artm en t if postoperative problem s occur.

7. In struct th e clien t to keep follow-up appoin t- m en ts with th e surgeon .

F

u

n

d

a

m

e

n

t

a

l

s

PRIORITY NURSING ACTIONS Evisceration in a Wound 1. Call for help; ask that the surgeon be notified and that

needed supplies be brought to the client’s room. 2. Stay with the client. 3. While waiting for supplies to arrive, place the client in a

low Fowler’s position with the knees bent. 4. Cover the wound with a sterile normal saline dressing and

keep the dressing moist. 5. Take vital signs and monitor the client closely for signs

of shock. 6. Prepare the client for surgery as necessary. 7. Document the occurrence, actions taken, and the client’s

response.

Wound evisceration is protrusion of the internal organs through an incision; it usually occurs 6 to 8 days after sur- gery. Evisceration is most common among obese clients, cli- ents who have had abdominal surgery, or those who have poor wound-healing ability. Wound evisceration is an emer- gency. The nurse immediately calls for help and asks that the surgeon be notified and that needed supplies (vital sign mea- surement devices, sterile normal saline, and dressings) be brought to the client’s room. The nurse stays with the client and while waiting for supplies to arrive, places the client in a low Fowler’s position with the knees bent to prevent abdom- inal tension on the abdominal suture line. The nurse covers the wound with a sterile normal saline dressing as soon as supplies are available and keeps the dressing moist. Vital signs are monitored closely, and the client is monitored for signs of shock. The client is prepared for surgery if neces- sary. The nurse also documents the occurrence, actions taken, and client’s response.

Reference Perry, Potter, Ostendorf (2014), pp. 925–926.

De his ce nce

Evis ce ra tion

FIGURE 18-5 Complications of wound healing.

224 UNIT IV Fundamentals of Care

CRITICAL THINKING What Should You Do? Answer: Nursing responsibilities with regard to informed consent for a surgical procedure include witnessing the client’s signing of the consent form, but the nurse must be sure that the client has understood the surgeon’s explanation of the surgery. The nurse needs to document the witnessing of the signing of the consent form after the cli- ent acknowledges understanding the procedure. If the client informs the nurse that the explanation was not fully under- stood, the nurse must notify the surgeon and the surgeon will need to clarify anything that was not understood by the client.

Reference: Lewis et al. (20 14), pp. 325–326.

P R A C T I C E Q U E S T I O N S 168. Th e n urse h as just reassessed the con dition of a post-

operative clien t who was adm itted 1 h our ago to the surgical un it. Th e n urse plan s to m on itor wh ich param eter m o st carefully durin g the n ext h our?

1. Urin ary outp ut of 20 m L/ h our 2. Tem perature of 37.6 °C (99.6 °F) 3. Blood pressure of 100/ 70 m m Hg 4. Serous drain age on th e surgical dressin g

169. Th e n urse is teach in g a clien t about cough in g an d deep-breath in g tech n iques to preven t posto pera- tive co m plication s. Wh ich statem en t is m o st ap p ro p riate for th e n urse to m ake to th e clien t at th is tim e as it relates to th ese tech n iqu es? 1. “Use of an in cen tive spirom eter will h elp pre-

ven t pn eum on ia.” 2. “Close m on itorin g of yo ur oxygen saturatio n

will detect h ypoxem ia.” 3. “Adm in istration of in traven o us fluids will pre-

ven t or treat fluid im balan ce.” 4. “Early am bulation an d adm in istration of blood

th in n ers will preven t pulm o n ary em b olism .”

170. Th e n urse is creatin g a plan of care for a clien t sch eduled for surgery. Th e n urse sh ould in clude wh ich activity in th e n ursin g care plan for th e clien t on th e day of surgery? 1. Avoid oral h ygiene an d rin sin g with m outh wash. 2. Verify th at th e clien t h as n ot eaten for th e last

24 h ours. 3. Have th e clien t vo id im m ediately before goin g

in to surgery. 4. Repo rt im m ediately an y sligh t in crease in blood

pressure or pulse.

171. A clien t with a gastric ulcer is sch eduled for surgery. Th e clien t can n ot sign th e operative con sen t form because of sedation from opioid an algesics th at h ave been adm in istered. Th e n urse should take which m ost ap p ro p riate action in the care of this clien t? 1. O btain a court order for th e surgery. 2. Have th e ch arge n urse sign th e in form ed con -

sen t im m ediately. 3. Sen d th e clien t to surgery with ou t th e con sen t

form bein g sign ed . 4. O btain a teleph on e con sen t fro m a fam ily m em -

ber, followin g agen cy policy.

172. A preop erative clien t expresses an xiety to th e n urse ab out upcom in g surgery. Wh ich respon se by th e n urse is m o st likely to stim ulate furth er discussion between th e clien t an d th e n urse? 1. “If it’s an y h elp, everyon e is n ervou s before

surgery.” 2. “I will be h app y to exp lain th e en tire surgical

procedure to you.” 3. “Can yo u sh are with m e wh at you’ve been told

about yo ur surgery?” 4. “Let m e tell you about th e care you’ll receive

after surgery an d th e am oun t of pain yo u can an ticipate.”

F

u

n

d

a

m

e

n

t

a

l

s

BOX 18-7 Postoperative Discharge Teaching Assess the client’s readiness to learn, educational level, and

desire to change or modify lifestyle. Assess the need for resources needed for home care. Demonstrate care of the incision and how to change the

dressing. Instruct the client to cover the incision with plastic if shower-

ing is allowed. Ensure that the client is provided with a 48-hour supply of

dressings for home use. Instruct the client on the importance of returning to the sur-

geon’s office for follow-up. Instruct the client that sutures usually are removed in the sur-

geon’s office 7 to 10 days after surgery. Inform the client that staples are removed 7 to 14 days after

surgery and that the skin may become slightly reddened when staples are ready to be removed.

Sterile adhesive strips (e.g., Steri-Strips®) may be applied to provide extra support after the sutures are removed.

Instruct the client on the use of medications, their purpose, dosages, administration, and side effects or adverse effects.

Instruct the client on diet and to drink 6 to 8 glasses of liquid a day.

Instruct the client about activity levels and to resume normal activities gradually.

Instruct the client to avoid lifting for 6 weeks if a major surgi- cal procedure was performed.

Instruct the client with an abdominal incision not to lift any- thing weighing 10 pounds or more and not to engage in any activities that involve pushing or pulling.

The client usually can return to work in 6 to 8 weeks depending on the procedure and as prescribed by the surgeon.

Instruct the client about the signs and symptoms of compli- cations and when to call the surgeon.

225CHAPTER 18 Perioperative Nursing Care

173. Th e n urse is con ductin g preop erative teach in g with a clien t about th e use of an in cen tive spirom eter. Th e n urse sh ould in clude wh ich piece of in form a- tio n in discussio n s with th e clien t? 1. In h ale as rapidly as possible. 2. Keep a loose seal between th e lips an d th e

m outh p iece. 3. After m axim um in spiration , h old th e breath for

15 secon ds an d exh ale. 4. Th e best results are achieved wh en sittin g up or

with th e head of th e bed elevated 45 to 90 degrees.

174. Th e n urse h as con d ucted preop erative teach in g for a clien t sch eduled for surgery in 1 week. Th e clien t h as a h istory of arth ritis an d h as been takin g ace- tylsalicylic acid. Th e n urse determ in es th at th e cli- en t n eed s ad d itio n al teach in g if th e clien t m akes wh ich statem en t? 1. “Asp irin can cau se bleedin g after surgery.” 2. “Aspirin can cau se m y ability to clot blood to be

abn orm al.” 3. “I n eed to con tin ue to take th e aspirin un til th e

day of surgery.” 4. “I n eed to ch eck with m y h ealth care provider

about th e n eed to stop th e aspirin befo re th e sch eduled surgery.”

175. Th e n urse assesses a clien t’s surgical in cision for sign s of in fection . Which fin din g by the n urse would be in terpreted as a n orm al fin din g at the surgical site? 1. Red, h ard skin 2. Serous drain age 3. Purulen t drain age 4. Warm , ten der skin

176. Th e n urse is m on itorin g th e status of a postoperative clien t in th e im m ediate postoperative period. Th e n urse would becom e m o st con cern ed with wh ich sign th at could indicate an evolvin g com plication ? 1. In creasin g restlessn ess 2. A pulse of 86 beats/ m in ute 3. Blood pressure of 110/ 70 m m Hg 4. Hypo active bowel soun ds in all 4 quadran ts

177. A clien t wh o h as h ad abdom in al surgery com plain s of feelin g as th ough “som eth in g gave way” in th e in cision al site. Th e n urse rem oves th e dressin g

an d n otes th e presen ce of a loop of bowel protrud- in g th rou gh th e in cision . Wh ich in terven tion s sh ould th e n urse take? Select all th at ap p ly.

1. Con tact th e surgeon . 2. In struct th e clien t to rem ain quiet. 3. Prepare th e clien t for woun d clo sure. 4. Docum en t th e fin din gs an d action s taken . 5. Place a sterile salin e dressin g an d ice packs

over th e woun d. 6. Place th e clien t in a supin e position with ou t

a pillow un d er th e h ead.

178. A clien t wh o h as un dergon e preadm ission testin g h as h ad blood drawn for serum laborato ry studies, in cludin g a com plete blood coun t, coagu lation studies, an d electrolytes an d creatin in e levels. Wh ich labo ratory result sh ould be reported to th e surgeon ’s office by th e n urse, kn owin g th at it could cau se surgery to be postp on ed? 1. Hem o globin , 8.0 g/ dL (80 m m ol/ L) 2. Sodium , 145 m Eq/ L (145 m m o l/ L) 3. Serum creatin in e, 0.8 m g/ dL (70.6 µm ol/ L) 4. Platelets, 210,000 cells/ m m 3 (210 Â 103/ µL/

210 Â 109/ L)

179. Th e n urse receives a telep h on e call from th e post- an esth esia care un it statin g th at a clien t is bein g tran sferred to th e surgical un it. Th e n urse plan s to take wh ich action first on arrival of th e clien t? 1. Assess th e paten cy of th e airway. 2. Ch eck tubes or drain s for paten cy. 3. Ch eck th e dressin g to assess for bleedin g. 4. Assess th e vital sign s to com pare with preop era-

tive m easu rem en ts.

180. Th e n urse is reviewin g a surgeon ’s prescription sh eet for a preoperative clien t th at states th at th e clien t m ust be n oth in g by m ou th (NPO ) after m id- n igh t. Th e n urse sh ould call th e surgeon to clarify th at wh ich m edication sh ould be given to th e clien t an d n ot with h eld? 1. Predn ison e 2. Ferrous sulfate 3. Cycloben zaprin e 4. Con ju gated estrogen

A N S W E R S 168. 1 Ra tion a le: Urin e outpu t should be m ain tain ed at a m in im um o f 30 m L/ h our for an adu lt. An o utpu t o f less th an 30 m L for 2 con secu tive h ours sho uld b e reported to the h ealth care pro - vid er. A tem perature h igh er th an 37.7 °C (100 °F) or lower th an

36.1 °C (97 °F) and a fallin g systolic b lo od pressure, lo wer th an 90 m m Hg, are usually con sidered rep ortable im m ediately. Th e clien t’s p reop erative o r b aselin e b lood p ressure is used to m ake in form ed p ostoperative com p arison s. Mo derate o r light sero us d rain age from the surgical site is co n sidered n orm al. Test-Ta kin g Str a t egy: No te th e strategic wo rd , most. Fo cu s on th e su b ject, expected po sto perative assessm en t fin din gs. To

F

u

n

d

a

m

e

n

t

a

l

s

226 UNIT IV Fundamentals of Care

an swer th is q uestio n correctly, yo u m ust kn ow th e n o rm al ran ges fo r tem perature, blood pressure, urin ary output, an d wo un d drain age. No te th at th e u rin ary ou tpu t is th e on ly ob servatio n th at is n ot with in th e n o rm al ran ge. Review: Po sto p erative assessm en t Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Fun dam en tals of Care—Perio perative Care Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 262.

169. 1 Ra t ion a le: Po stop erative respiratory prob lem s are atelectasis, pn eum on ia, an d p u lm on ary em b oli. Pn eum o n ia is th e in flam - m atio n of lu n g tissu e th at cau ses prod uctive cou gh , d ysp n ea, an d lu n g crackles an d can b e cau sed b y retain ed p ulm o n ary secretio n s. Use o f an in cen tive spiro m eter h elps to preven t pn eum on ia an d atelectasis. Hypo xem ia is an in adeq uate co n - cen tratio n of oxygen in arterial b lo od . Wh ile close m on ito rin g of th e oxygen satu ratio n will h elp to d etect h yp oxem ia, m o n ito rin g is n o t directly related to cou gh in g an d deep- breath in g tech n iqu es. Flu id im b alan ce can b e a d eficit or excess related to fluid loss o r overload, an d surgical clien ts are often given in traven ou s flu ids to preven t a d eficit; h owever, th is is n ot related to co ugh in g an d d eep b reath in g. Pu lm on ary em b o - lus occu rs as a resu lt of a blo ckage of th e pu lm on ary artery th at disrup ts bloo d flow to 1 or m o re lo bes o f th e lun g; th is is u su- ally d ue to clo t fo rm atio n . Early am b ulation an d adm in istra- tion o f b lo od th in n ers h elps to p reven t th is co m p lication ; h owever, it is n ot related to cou gh in g an d d eep -breath in g tech n iq ues. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Fo cu s o n th e su b ject, clien t in stru ctio n s related to co ugh - in g an d deep -b reath in g tech n iqu es. Also , fo cu s on th e d ata in th e q u estio n an d n ote th e relation sh ip between th e words coughing an d deep-breathing in th e q uestion an d pneumonia in th e co rrect op tion . Review: Po sto p erative co m p licatio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun dam en tals of Care—Perio perative Care Pr ior ity Con cepts: Clien t Edu catio n ; Gas Exch an ge Refer en ce: Perry, Potter, O sten d orf ( 2014) , pp . 597-599, 893.

170. 3 Ra t ion a le: Th e n urse wo uld assist th e clien t to void im m edi- ately befo re surgery so th at th e blad der will b e em pty. O ral h ygien e is allo wed , b u t th e clien t sh ou ld n o t swallow an y water. Th e clien t u su ally h as a restrictio n o f foo d an d fluid s fo r 6 to 8 h ou rs ( or lon ger as prescrib ed) befo re surgery in stead of 24 h o urs. A sligh t in crease in bloo d p ressu re an d pu lse is co m m o n d urin g th e preop erative period an d is usu ally th e result of an xiety. Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, p reo perative care m easu res. Th in k abo ut th e m easu res th at m ay b e h elpfu l an d prom ote co m fort. O ral h ygien e sh ou ld be ad m in istered sin ce it m ay m ake th e clien t feel m o re co m fo rtab le. A clien t sh o uld be n oth in g b y m o u th (NPO ) fo r 6 to 8 h o u rs befo re surgery

rath er th an 24 h ou rs. A sligh t in crease in b loo d pressu re o r p u lse is in sign ifican t in th is situ ation . Review: Preo p erative care Level of Cogn it ive Ability: Creatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Clin ical Jud gm en t; Palliatio n Refer en ce: Ign atavicius, Workm an (2016), p . 234.

171. 4 Ra t ion a le: Every effort sh ou ld b e m ad e to o btain perm ission from a respo n sib le fam ily m em b er to perform su rgery if th e cli- en t is u n able to sign th e co n sen t form . A teleph o n e con sen t m u st be witn essed b y 2 p erson s wh o h ear th e fam ily m em b er’s o ral co n sen t. Th e 2 witn esses th en sign th e co n sen t with th e n am e o f th e fam ily m em b er, n otin g th at an oral co n sen t was o b tain ed . Con sen t is n o t in fo rm ed if it is o btain ed fro m a clien t wh o is con fused, un con scious, m en tally in com peten t, or un der th e in fluen ce of sedatives. In an em ergen cy, a clien t m ay b e u n ab le to sign an d fam ily m em b ers m ay n o t be available. In th is situatio n , a h ealth care provid er is p erm itted legally to p er- fo rm su rgery with ou t con sen t, b ut th e d ata in th e q u estion do n ot in dicate an em ergen cy. O p tion s 1, 2, an d 3 are n ot ap pro- p riate in th is situatio n . Also, agen cy p o licies regardin g in form ed con sen t sh ou ld always be followed . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Focu s o n th e d ata in th e q u estio n . Elim in ate op tion s 1 an d 3 first. O ptio n 1 will delay n ecessary surgery an d op tio n 3 is in app ro p riate. O p tio n 2 is n o t an accep tab le an d legal role o f a ch arge n u rse. Select o ptio n 4 sin ce it is th e o n ly legally acceptab le o p tion : to ob tain a teleph on e perm issio n from a fam ily m em b er if it is witn essed by 2 p erson s. Review: Th e pro ced ures fo r ob tain in g in fo rm ed co n sen t Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Eth ics; Health Care Law Refer en ce: Lewis et al. (2014), pp . 325-326, 784.

172. 3 Ra t ion a le: Explan ation s sh ou ld b egin with th e in fo rm ation th at th e clien t kn o ws. By p ro vidin g th e clien t with in dividu al- ized explan ation s of care an d pro ced ures, th e n u rse can assist th e clien t in h an dlin g an xiety an d fear for a sm o oth p reo p era- tive exp erien ce. Clien ts wh o are calm an d em otion ally p re- p ared for surgery with stan d an esth esia b etter an d exp erien ce fewer po stop erative com p lication s. O ptio n 1 d oes n ot focus o n th e clien t’s an xiety. Exp lain in g th e en tire surgical proced ure m ay in crease th e clien t’s an xiety. O p tion 4 avo id s th e clien t’s an xiety an d is focused on p osto perative care. Test -Ta kin g St r a t egy: Note th at th e clien t expresses an xiety. Use kn o wled ge of th erap eu tic co m m u n icatio n tech n iq u es. No te th at th e qu estio n co n tain s strategic wo rd s, most likely, an d also n o te th e wo rd s stimulate further discussion. Also u se th e step s o f th e n u rsin g p ro cess. Th e co rrect o p tion ad dresses assessm en t an d is th e on ly th erap eutic respo n se. Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: App lyin g

F

u

n

d

a

m

e

n

t

a

l

s

227CHAPTER 18 Perioperative Nursing Care

Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Com m un icatio n an d Docum en tation Con ten t Ar ea : Fu n d am en tals o f Care—Periop erative Care Pr ior it y Con cept s: An xiety; Co m m u n icatio n Refer en ces: Lewis et al. (2014), p . 319; Perry, Po tter, O sten d orf (2014), p. 31.

173. 4 Ra tion a le: Fo r o p tim al lu n g expan sion with th e in cen tive sp i- rom eter, th e clien t sh ou ld assum e th e sem i-Fo wler’s o r h igh Fowler’s p ositio n . Th e m ou th p iece sh ou ld be covered com pletely an d tigh tly wh ile th e clien t in h ales slo wly, with a con stan t flo w th ro u gh th e un it. Th e breath sh ou ld b e h eld fo r 5 seco n d s befo re exh alin g slowly. Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, co rrect u se o f an in cen tive spiro m eter, an d visu alize th e proced ure. No te th e words rapidly, loose, an d 15 seconds in th e in correct o ptio n s. O ptio n s 1, 2, an d 3 are in correct steps regard in g in cen tive sp iro m eter use. Review: In cen tive sp iro m etry Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n d am en tals o f Care—Periop erative Care Pr ior it y Con cept s: Clien t Ed ucation ; Gas Exch an ge Refer en ce: Perry, Potter, O sten d o rf (2014), pp . 597–599, 893.

174. 3 Ra tion a le: An tip latelets alter n orm al clottin g factors an d in crease th e risk of bleedin g after su rgery. Aspirin h as prop er- ties th at can alter platelet aggregation an d sh o u ld be d iscon tin - u ed at least 48 h ou rs before surgery. Ho wever, th e clien t sh ou ld always ch eck with h is o r h er h ealth care p rovid er regard in g wh en to stop takin g th e aspirin wh en a surgical procedure is sch ed uled. O p tion s 1, 2, an d 4 are accurate clien t statem en ts. Test-Ta kin g Str a tegy: Note th e strategic wo rd s, needs additional teaching. Th ese words indicate a n egative even t qu ery an d th at you n eed to select th e in correct clien t statem en t. Elim in ate option s 1 an d 2 first because th ey are co m p arab le o r alike. From th e rem ain in g option s, recallin g th at aspirin h as properties th at can alter platelet aggregation will direct you to th e correct option . Review: An tip latelet m ed icatio n s in th e preop erative period Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n d am en tals o f Care—Periop erative Care Pr ior it y Con cept s: Clien t Ed ucation ; Clo ttin g Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 228.

175. 2 Ra tion a le: Sero us d rain age is an exp ected fin din g at a su rgical site. Th e oth er op tio n s in dicate sign s o f wou n d in fection . Sign s an d sym p tom s o f in fectio n in clud e warm , red, an d ten d er skin aro u n d th e in cision . Wo u n d in fectio n u sually ap pears 3 to 6 d ays after surgery. Th e clien t also m ay h ave a fever an d ch ills. Purulen t m aterial m ay exit fro m d rain s or from sep arated woun d edges. In fection m ay be caused by poor aseptic tech - n iqu e o r a con tam in ated wou n d befo re su rgical exp lo ratio n ; existin g clien t co n d ition s su ch as d iab etes m ellitu s or im m u n o- com pro m ise m ay p lace th e clien t at risk.

Test-Ta kin g Str a tegy: Focus o n th e su b ject, n orm al fin din gs in th e po sto perative p eriod . Elim in ate op tio n s 1, 3, an d 4 b ecause th ey are co m p arab le o r alike an d are m an ifestatio n s of in fectio n . Review: Po sto p erative assessm en t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Periop erative Care Pr ior it y Con cept s: In fection ; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 264.

176. 1 Ra tion a le: In creasin g restlessn ess is a sign th at req uires co n tin - u ou s an d close m on itorin g because it cou ld in d icate a p oten tial com plicatio n , su ch as h em orrh age, sh ock, o r pu lm on ary em bo lism . A b lo od pressure o f 110/ 70 m m Hg with a p ulse o f 86 b eats/ m in u te is with in n orm al lim its. Hypo active bo wel so un ds h eard in all 4 qu adran ts are a n o rm al o ccurren ce in th e im m ediate p o stop erative perio d. Test-Ta kin g Str a t egy: No te th e strategic wo rd , most. Fo cu s on th e su b ject, a m an ifestation o f an evolvin g com plicatio n in th e im m ediate po stop erative period . Elim in ate each o f th e in co r- rect option s because th ey are co m p arab le o r alike an d are n o r- m al expected fin d in gs, esp ecially given th e tim e fram e n o ted in th e q uestion . Review: Po sto p erative assessm en t Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Fu n dam en tals o f Care—Periop erative Care Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 260-261, 741.

177. 1, 2, 3, 4 Ra tion a le: Wo u n d deh iscen ce is th e sep aratio n o f th e wo un d ed ges. Wou n d evisceration is p ro tru sion o f th e in tern al organ s th rou gh an in cisio n . If wou n d deh iscen ce or evisceration o ccurs, th e n urse sh o uld call fo r h elp , stay with th e clien t, an d ask an o th er n u rse to co n tact th e surgeon an d ob tain n eeded sup p lies to care for th e clien t. Th e n urse p laces th e clien t in a lo w Fo wler’s p osition , an d th e clien t is kep t qu iet an d in stru cted n o t to co ugh . Protrud in g o rgan s are covered with a sterile salin e dressin g. Ice is n ot applied because of its vaso con strictive effect. Th e treatm en t fo r evisceration is u sually im m ed iate wo un d clo su re u n d er lo cal o r gen eral an esth esia. Th e n u rse also do cum en ts th e fin d in gs an d action s taken . Test-Ta kin g Str a tegy: Focus on th e su b ject, th at th e clien t is exp erien cin g wo un d evisceration . Visualizin g th is o ccurren ce will assist you in determ in in g th at th e clien t would n ot be p laced su pin e an d th at ice p acks wo uld n ot be p laced o n th e in cisio n . Review: Evisceratio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Periop erative Care Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 264.

F

u

n

d

a

m

e

n

t

a

l

s

228 UNIT IV Fundamentals of Care

178. 1 Ra t ion a le: Ro utin e screen in g tests in clud e a co m p lete b lo od co un t, serum electro lyte an alysis, co agulation stud ies, an d a seru m creatin in e test. Th e co m plete blo o d co un t in clud es th e h em oglo b in an alysis. All o f th ese values are with in n o rm al ran ge except for h em oglobin . If a clien t h as a low h em oglobin level, th e surgery likely co uld be p ostp on ed b y th e surgeon . Test -Ta kin g St r a t egy: Focus o n th e su b ject, an abn orm al lab - orato ry result th at n eed s to be repo rted . Use kn owled ge of th e n orm al referen ce in tervals to assist in an swerin g co rrectly. Th e h em oglo bin valu e is th e on ly ab n o rm al lab orato ry fin d in g. Review: No rm al lab o rato ry referen ce levels Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Perio perative Care Pr ior ity Con cepts: Clin ical Jud gm en t; Collab o ratio n Refer en ce: Lewis et al. (2014), p p. 325, 626.

179. 1 Ra t ion a le: The first actio n of th e n urse is to assess th e paten cy o f th e airway an d respiratory fun ction . If the airway is n ot p aten t, th e n urse m ust take im m ediate m easu res for th e survival o f th e clien t. Th e n urse then takes vital signs followed by ch eckin g th e dressin g an d the tub es o r drain s. Th e o th er n ursin g action s sh ould b e perform ed after a p aten t airway h as b een establish ed. Test -Ta kin g St r a t egy: No te th e strategic wo rd , first. Use th e prin ciples o f prioritizatio n to an swer th is q u estion . Use th e ABCs—airway, b reath in g, an d circu latio n . En su rin g airway paten cy is th e first action to b e taken , directin g yo u to th e co r- rect option . Review: Po sto p erative care

Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Care Coo rd in ation ; Clin ical Ju d gm en t Refer en ce: Ign atavicius, Workm an (2016), p . 258.

180. 1 Ra t ion a le: Predn ison e is a cortico stero id . With p ro lon ged u se, co rticostero ids cau se adren al atrop h y, wh ich redu ces th e ab il- ity of th e b od y to with stan d stress. Wh en stress is severe, co rti- co stero id s are essen tial to life. Before an d d urin g su rgery, d o sages m ay b e in creased tem po rarily an d m ay b e given p aren - terally rath er th an o rally. Ferro us su lfate is an oral iro n prepa- ratio n u sed to treat iron d eficien cy an em ia. Cyclo b en zap rin e is a skeletal m u scle relaxan t. Con ju gated estro gen is an estro gen u sed fo r h o rm on e replacem en t th erap y in po stm en o pau sal wom en . Th ese last 3 m edication s m ay be with h eld before sur- gery with o ut u n d u e effects o n th e clien t. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e m ed ication th at sh ou ld b e ad m in istered in th e p reo p erative perio d. Use kn o wled ge ab ou t m edicatio n s th at m ay h ave sp ecial im plica- tion s fo r th e su rgical clien t. Pred n iso n e is a corticosteroid. Recall th at wh en stress is severe, such as with su rgery, co rtico - stero ids are essen tial to life. Review: Co rtico stero id s in th e preop erative perio d Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Clin ical Jud gm en t; Co llab oratio n Refer en ce: Lewis et al. (2014), pp . 320–321.

F

u

n

d

a

m

e

n

t

a

l

s

229CHAPTER 18 Perioperative Nursing Care

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 19 Positioning Clients

PRIORITY CONCEPT Mobility; Safety

CRITICAL THINKING What Should You Do? The nurse is caring for a client who is receiving intermittent tube feedings via a nasogastric tube. In maintaining proper position- ing for this client, what actions should the nurse take? Answer located on p. 234.

For referen ce th rou gh ou t th e ch apter, please see Figures 19-1, Figure 19-2, Figure 19-3, an d Figure 19-4.

I. Guidelines for Positioning A. Clien t safety an d com fo rt

1. Position clien t in a safe an d appropriate m an n er to provide safety an d com fo rt.

2. Select a position th at will preven t th e develop- m en t of com plication s related to an existin g con d ition , prescribed treatm en t, or m ed ical or surgical procedure.

B. Ergonomic principles related to body mechanics (Box 19-1)

Always review the health care provider’s (HCP’s) prescription, especially after treatments or procedures, and take note of instructions regarding positioning and mobility.

II. Positions to Ensure Safety and Comfort A. In tegum en tary system

1. Autograft: After surgery, th e site is im m ob ilized usually for 3 to 7 days to provide th e tim e n eeded for th e graft to adh ere an d attach to th e woun d bed .

2. Burn s of th e face an d h ead: Elevate th e h ead of th e bed to preven t or reduce facial, h ead , an d trach eal edem a.

3. Circum feren tial burn s of th e extrem ities: Elevate th e extrem ities above th e level of th e h eart to pre- ven t or reduce depen den t edem a.

4. Skin graft: Elevate an d im m ob ilize th e graft site to preven t m ovem en t an d sh earin g of th e graft an d disruption of tissue; avoid weigh t-b earin g.

B. Reprod uctive system 1. Mastectom y

a . Position th e clien t with th e h ead of th e bed elevated at least 30 degrees ( semi-Fowler’s

Tre nde le nburg’s Fowle r’s

Re ve rs e Tre nde le nburg’s

Fla t

S e mi-Fowle r’s

FIGURE 19-1 Bed positions.

BOX 19-1 Body Mechanics (Ergonomic Principles) for Health Care Workers

When planning to move a client, arrange for adequate help. Use mechanical aids if help is unavailable.

Encourage the client to assist as much as possible. Keep the back, neck and pelvis, and feet aligned. Avoid twisting. Flex knees, and keep feet wide apart. Raise the client’s bed so that the client’s weight is at the level

of the nurse’s center of gravity. Position self close to the client (or object being lifted). Use arms and legs (not back). Slide client toward yourself, using a pull sheet. When transferring

a client onto a stretcher, a slide board is more appropriate. Set (tighten) abdominal and gluteal muscles in preparation

for the move. Person with the heaviest load coordinates efforts of the team

involved by counting to 3.

Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 2013, Mosby. Perry, Potter, Ostendorf (20 14), pp. 197-198. St. Louis: Mosby.

230

position), with th e affected arm elevated on a pillow to prom o te lym ph atic flu id return after th e rem oval of axillary lym p h n odes.

b . Turn th e clien t on ly to th e back an d un affected side.

2. Perin eal an d vagin al procedures: Place th e clien t in th e lithotomy position.

F

u

n

d

a

m

e

n

t

a

l

s

La te ra l (s ide -lying) pos ition

S e miprone (S ims ’ or forwa rd s ide -lying) pos ition

S upine pos ition

P rone pos ition. The clie nt’s a rms a nd s houlde rs ma y be pos itione d in inte rna l or e xte rna l rota tion.

FIGURE 19-3 Client positions.

FIGURE 19-2 Lithotomy position for examination.

FIGURE 19-4 Pressure points in lying and sitting positions.

231CHAPTER 19 Positioning Clients

F

u

n

d

a

m

e

n

t

a

l

s

C. En docrin e system 1. Hypo ph ysectom y: Elevate th e h ead of th e bed to

preven t in creased in tracran ial pressure. 2. Th yroidecto m y

a . Place th e clien t in th e sem i-Fowler’s to Fowler’s position to reduce swellin g an d edem a in th e n eck area.

b . San db ags or pillows or oth er stabilization devices m ay be used to supp ort th e clien t’s h ead or n eck.

c. Avoid n eck exten sion to decrease ten sion on th e suture lin e.

D. Gastro in testin al system 1. Hem o rrh oidectom y: Assist th e clien t to a lateral

(side-lying) position to preven t pain an d bleedin g. 2. Gastroesoph ageal reflux disease: Reverse Trende-

lenburg’s position m ay be prescribed to prom o te gastric em p tyin g an d preven t esoph ageal reflux.

3. Liver biopsy (see Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Liver Biopsy 1. Explain the procedure to the client. 2. Ensure that informed consent has been obtained. 3. Position the client supine, with the right side of the upper

abdomen exposed; the client’s right arm is raised and extended behind the head and over the left shoulder.

4. Remain with the client during the procedure. 5. After the procedure, assist the client into a right lateral

(side-lying) position and place a small pillow or folded towel under the puncture site.

6. Monitor vital signs closely after the procedure and mon- itor for signs of bleeding.

7. Document appropriate information about the procedure, client’s tolerance, and postprocedure assessment findings.

For the client undergoing liver biopsy (or any invasive pro- cedure), the procedure is explained to the client and informed consent is obtained by the health care provider performing the procedure. Since the liver is located on the right side of the upper abdomen, the client is positioned supine, with the right side of the upper abdomen exposed. In addition, the right arm is raised and extended behind the head and over the left shoul- der. This position provides for maximal exposure of the right intercostal spaces. The nurse remains with the client during the procedure to provide emotional support and comfort. After the procedure, the client is assisted into a right lateral (side- lying) position and a small pillow or folded towel is placed under the puncture site for at least 3 hours or as prescribed, to provide pressure to the site and prevent bleeding. Vital signs are monitored closely after the procedure and the client is monitored for signs of bleeding. The nurse documents appro- priate information about the procedure, the client’s tolerance, and postprocedure assessment findings.

Reference Lewis et al. (20 14), pp. 882–883.

4. Paracen tesis: Client is usually positioned in a sem i- Fowler’s position in bed, or sittin g uprigh t on the side of th e bed or in a ch air with the feet supported; clien t is assisted to a position of com fort followin g th e procedure.

5. Naso gastric tube a . In sertion

( 1) Position th e clien t in a high Fowler’s posi- tion with th e h ead tilted forward.

( 2) Th is position will h elp to close th e tra- ch ea an d open th e eso ph agus.

b . Irrigation s an d tube feedin gs ( 1) Elevate th e h ead of th e bed (sem i-

Fowler’s to Fowler’s position ) to preven t aspiration .

( 2) Main tain h ead elevation for 30 m in u tes to 1 h our (per agen cy proced ure) after an in term itten t feed in g.

( 3) Th e h ead of th e bed sh ould rem ain ele- vated for co n tin uou s feedin gs.

If the client receiving a continuous tube feeding needs to be placed in a supine position when providing care, such as when giving a bed bath or changing linens, shut off the feeding to prevent aspiration. Remember to turn the feeding back on and check the rate of flow when the client is placed back into the semi-Fowler’s or Fowler’s position.

6. Rectal en em a an d irrigation s: Place th e clien t in th e left Sims’ position to allow th e solution to flow by gravity in th e n atural direction of th e colon .

7. Sen gstaken -Blakem ore an d Min n esota tubes a . Not com m on ly used because th ey are un com -

fortable for th e clien t an d can cau se com plica- tion s, but th eir use m ay be n ecessary wh en oth er in terven tion s are n ot feasible.

b . If prescribed, m ain tain elevation of th e h ead of th e bed to en h an ce lun g expan sion an d reduce portal blood flow, perm ittin g effective esoph agogastric balloon tam pon ade.

E. Respiratory system 1. Ch ro n ic o b stru ctive p u lm o n ary d isease: In

ad van ced d isease, p lace th e clien t in a sittin g p o sitio n , lean in g fo rward , with th e clien t’s arm s o ver several p illo ws o r an o verb ed tab le; th is p o sitio n will assist th e clien t to b reath e easier.

2. Laryn gectom y (radical n eck dissectio n ): Place th e clien t in a sem i-Fowler’s or Fowler’s position to m ain tain a paten t airway an d m in im ize edem a.

3. Bron ch oscop y postp rocedu re: Place th e clien t in a sem i-Fowler’s position to preven t ch okin g or aspiration resultin g fro m an im paired ab ility to swallow.

232 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

4. Postu ral drain age: Th e lu n g segm en t to be drain ed sh o uld be in th e upperm ost position ; Trendelenburg’s position m ay be used.

5. Th oracen tesis a. Du rin g th e proced ure, to facilitate rem oval

of fluid from th e pleural space, position th e clien t sittin g on th e edge of th e bed an d lean - in g over th e bed side table with th e feet sup- ported on a stool, or lyin g in bed on th e un affected side with th e clien t in Fowler’s position .

b . After th e procedure, assist th e clien t to a posi- tio n of com fo rt.

Always check the HCP’s prescription regarding posi- tioning for the client who had a thoracotomy, lung wedge resection, lobectomy of the lung, or pneumonectomy.

F. Card iovascu lar system 1. Abdo m in al an eu rysm resectio n

a. After surgery, lim it elevation of th e h ead of th e bed to 45 degrees to avoid flexion of th e graft.

b . Th e clien t m ay b e tu rn ed fro m sid e to sid e.

2. Am pu tatio n of th e lo wer extrem ity a. Du rin g th e first 24 h ou rs after am putation ,

elevate th e foot of th e bed (th e residual lim b is supp orted with pillows but n ot elevated because of th e risk of flexion con tractures) to reduce edem a.

b . Con sult with th e HCP an d, if prescribed , position th e clien t in a prone position twice a day for a 20- to 30-m in ute period to stretch m uscles an d preven t flexion con tractures of th e h ip.

3. Arterial vascular graftin g of an extrem ity a. To prom o te graft paten cy after th e proced ure,

bed rest usually is m ain tain ed for approxi- m ately 24 h ours an d th e affected extrem ity is kep t straigh t.

b . Lim it m ovem en t an d avoid flexion of th e h ip an d kn ee.

4. Card iac cath eterization a. If th e fem oral vessel was accessed for th e proce-

dure, th e clien t is m ain tain ed on bed rest for 4 to 6 h ours (tim e for bed rest m ay vary depen d- in g on HCP preferen ce an d if a vascular closure device was used); the clien t m ay turn from side to side.

b . Th e affected extrem ity is kept straigh t an d th e h ead is elevated n o m ore th an 30 degrees (so m e HCPs prefer a lo wer h ead position or th e flat position ) un til h em ostasis is ad e- quately ach ieved .

5. Heart failure an d pulm o n ary edem a: Position th e clien t uprigh t, preferably with th e legs dan glin g over th e side of th e bed, to decrease ven ous return an d lun g con gestion .

Most often, clients with respiratory and cardiac dis- orders should be positioned with the head of the bed elevated.

6. Periph eral arterial disease a. O btain th e HCP’s prescription for

position in g. b . Because swellin g can preven t arterial blood

flow, clien ts m ay be advised to elevate th eir feet at rest, but th ey sh o uld n ot raise th eir legs above th e level of th e h eart because extrem e elevation slows arterial blood flow; som e cli- en ts m ay be advised to m ain tain a sligh tly dep en den t position to prom o te perfusion .

7. Deep vein th rom bosis a. If th e extrem ity is red, edem atous, an d pain -

ful, tradition al h eparin sodium th erap y m ay be in itiated. Bed rest with leg elevation m ay also be prescribed for th e clien t.

b . Clien ts receivin g low-m olecular-weigh t h epa- rin usually can be out of bed after 24 h ours if pain level perm its.

8. Varicose vein s: Leg elevation above h eart level usually is prescribed; th e clien t also is advised to m in im ize prolon ged sittin g or stan d in g durin g daily activities.

9. Ven ous in sufficien cy an d leg ulcers: Leg elevation usually is prescribed.

G. Sen sory system 1. Cataract surgery: Postoperatively, elevate th e

h ead of th e bed (sem i-Fowler’s to Fowler’s posi- tion ) an d position th e clien t on th e back or th e n on op erative side to preven t th e developm en t of edem a at th e operative site.

2. Retin al detach m en t a. If th e detach m en t is large, bed rest an d bilat-

eral eye patch in g m ay be prescribed to m in i- m ize eye m ovem en t an d preven t exten sion of th e detach m en t.

b . Restriction s in activity an d position in g fol- lowin g repair of th e detach m en t depen ds on th e HCP’s preferen ce an d th e surgical pro- cedu re perform ed.

H. Neurological system 1. Auton om ic dysreflexia: Elevate th e h ead of th e

bed to a h igh Fowler’s position to assist with ad e- quate ven tilation an d assist in th e preven tion of h yperten sive stroke.

If autonomic dysreflexia occurs, immediately place the client in a high Fowler’s position.

233CHAPTER 19 Positioning Clients

F

u

n

d

a

m

e

n

t

a

l

s

2. Cereb ral an eu rysm : Bed rest is m ain tain ed with th e h ead o f th e b ed elevated 30 to 4 5 d egrees to p reven t p ressu re o n th e an eu rysm site.

3. Cereb ral an giograph y a . Main tain bed rest for th e len gth of tim e as

prescribed. b . Th e extrem ity in to wh ich th e con trast

m ed ium was in jected is kept straigh t an d im m ob ilized for about 6 to 8 h ou rs.

4. Stroke (brain attack) a . In clien ts with h em orrh agic strokes, th e h ead

of th e bed is usually elevated to 30 degrees to reduce in tracran ial pressure an d to facilitate ven o us drain age.

b . For clien ts with isch em ic strokes, th e h ead of th e bed is usually kept flat.

c. Main tain th e h ead in a m idlin e, n eutral posi- tion to facilitate ven o us drain age from th e h ead .

d . Avoid extrem e h ip an d n eck flexion ; extrem e h ip flexion m ay in crease in trath o- racic pressure, wh ereas extrem e n eck flexion proh ibits ven ous drain age fro m th e brain .

5. Cran iotom y a . Th e clien t sh ould n ot be position ed on th e

site th at was operated on , esp ecially if th e bon e flap h as been rem oved, because th e brain h as n o bon y coverin g on th e affected site.

b . Elevate th e h ead of th e bed 30 to 45 degrees an d m ain tain th e h ead in a m idlin e, n eutral position to facilitate ven ous drain age from th e h ead .

c. Avoid extrem e h ip an d n eck flexion . 6. Lam in ectom y an d oth er vertebral surgery

a . Logroll th e clien t. b . Wh en th e clien t is out of bed , th e clien t’s back

is kept straigh t (th e clien t is placed in a straigh t-backed ch air) with th e feet restin g com fo rtably on th e floor.

7. In creased in tracran ial pressure a . Elevate th e h ead of th e bed 30 to 45 degrees

an d m ain tain th e h ead in a m idlin e, n eutral position to facilitate ven ous drain age from th e h ead .

b . Avoid extrem e h ip an d n eck flexion .

Do not place a client with a head injury in a flat or Trendelenburg’s position because of the risk of increased intracranial pressure.

8. Lum bar pun cture a . Du rin g th e proced ure, assist th e clien t to th e

lateral (side-lyin g) position , with th e back

bowed at th e edge of th e exam in in g table, th e kn ees flexed up to th e abdom en , an d th e n eck flexed so th at th e ch in is restin g on th e ch est.

b . After th e proced ure, place th e clien t in th e supine position for 4 to 12 h ours, as prescribed.

9. Spin al cord in ju ry a . Im m obilize th e clien t on a spin al back-

board, with th e h ead in a n eutral position , to preven t in com plete in ju ry from beco m in g com plete.

b . Preven t h ead flexion , rotatio n , or exten sion ; th e h ead is im m ob ilized with a firm , padded cervical collar.

c. Logroll th e clien t; n o part of th e body sh ould be twisted or turn ed, n or sh ould th e clien t be allowed to assum e a sittin g position .

I. Musculoskeletal system 1. Total h ip replacem en t

a. Position in g dep en ds on th e surgical tech n iques used (an terior or posterio r approach ), th e m eth od of im plan tation , th e prosth esis, an d sur- geon ’s preferen ce.

b . Avoid extrem e in tern al an d extern al rotation . c. Avoid adduction ; in m ost cases side-lyin g is per-

m itted as lo n g as an abduction pillow is in place; som e surgeon s allow turn in g to on ly 1 side.

d . Main tain abduction wh en th e clien t is in a supin e position or position ed on th e n on op era- tive side.

e. Place a wedge (abd uction ) pillow between th e clien t’s legs to m ain tain abduction ; in struct th e clien t n ot to cross th e legs

f. Ch eck th e HCP’s prescription s regardin g eleva- tion of th e h ead of th e bed an d h ip flexion .

2. Devices used to prom ote proper position in g (Box 19-2)

CRITICAL THINKING What Should You Do? Answer: For the client receiving intermittent tube feedings via a nasogastric tube, the nurse should position the client in an upright (semi-Fowler’s or high Fowler’s) position during the feeding and for 30 minutes to 1 hour following the feeding, per agency procedure. Positioning the client in an upright position prevents aspiration of the formula. For the client receiving a continuous tube feeding, an upright position should be maintained at all times.

Reference: Perry, Potter, Ostendorf (2014), p. 778.

234 UNIT IV Fundamentals of Care

P R A C T I C E Q U E S T I O N S 181. A clien t is bein g prepared for a th oracen tesis. Th e

n urse sh o uld assist th e clien t to wh ich position for th e procedure? 1. Lyin g in bed on th e affected side 2. Lyin g in bed on th e un affected side 3. Sim s’ position with th e h ead of th e bed flat 4. Pron e with th e h ead turn ed to th e side an d sup-

ported by a pillow

182. Th e n urse is caring for a clien t followin g a cran iotom y, in wh ich a large tum or was rem oved from the left side. In which position can th e nurse safely place th e clien t? Refer to th e figu res in op tio n s 1 to 4.

1.

2.

3.

4.

183. Th e n urse creates a plan of care for a clien t with deep vein th rom bosis. Wh ich clien t position or activity in th e plan sh ould be in cluded? 1. O ut-o f-bed activities as desired 2. Bed rest with th e affected extrem ity kep t flat 3. Bed rest with elevation of th e affected extrem ity 4. Bed rest with th e affected extrem ity in a depen -

den t position

184. Th e n urse is carin g for a clien t who is 1 day postop- erative for a total h ip replacem en t. Wh ich is th e b est position in which th e n urse sh ould place th e clien t? 1. Sid e-lyin g on th e operative side 2. O n th e n on operative side with th e legs abducted 3. Side-lyin g with th e affected leg in tern ally rotated 4. Side-lyin g with th e affected leg extern ally

rotated

F

u

n

d

a

m

e

n

t

a

l

s

BOX 19-2 Devices Used for Proper Positioning Bed Boards These plywood boards are placed under the entire surface area of the mattress and are useful for increasing back support and body alignment.

Foot Boots Foot boots are made of rigid plastic or heavy foam and keep the foot flexed at the proper angle. They should be removed 2 or 3 times a day to assess skin integrity and joint mobility.

Hand Rolls Hand rolls maintain the fingers in a slightly flexed and func- tional position and keep the thumb slightly adducted in oppo- sition to the fingers.

Hand-Wrist Splints These splints are individually molded for the client to maintain proper alignment of the thumb in slight adduction and the wrist in slight dorsiflexion.

Pillows Pillows provide support, elevate body parts, splint incisional areas, and reduce postoperative pain during activity, coughing, or deep breathing. They should be of the appropriate size for the body part to be positioned.

Sandbags Sandbags are soft devices filled with a substance that can be shaped to body contours to provide support. They immobilize extremities and maintain specific body alignment.

Side Rails These bars, positioned along the sides of the length of the bed, ensure client safety and are useful for increasing mobility. They also provide assistance in rolling from side to side or sitting up in bed. Laws regarding the use of side rails vary state to state and these laws must be followed; therefore, agency policies must be followed.

Trapeze Bar This bar descends from a securely fastened overhead bar attached to the bed frame. It allows the client to use the upper extremities to raise the trunk off the bed, assists in transfer from the bed to a wheelchair, and helps the client to perform upper arm–strengthening exercises.

Trochanter Rolls These rolls prevent external rotation of the legs when the client is in the supine position. To form a roll, use a cotton bath blan- ket or a sheet folded lengthwise to a width extending from the greater trochanter of the femur to the lower border of the pop- liteal space.

Wedge Pillow This triangular pillow is made of heavy foam and is used to maintain the legs in abduction following total hip replacement surgery.

Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

235CHAPTER 19 Positioning Clients

185. Th e n urse is providin g in struction s to a clien t an d th e fam ily regardin g h om e care after righ t eye cataract rem oval. Wh ich statem en t by th e clien t would in dicate an un derstan din g of th e in struc- tio n s? 1. “I sh ould sleep on m y left side.” 2. “I sh ould sleep on m y righ t side.” 3. “I sh ould sleep with m y h ead flat.” 4. “I sh o uld n ot wear m y glasses at an y tim e.”

186. Th e n urse is adm in isterin g a clean sin g en em a to a clien t with a fecal im paction . Before adm in isterin g th e en em a, th e n urse sh ould place th e clien t in wh ich position ? 1. Left Sim s’ position 2. Righ t Sim s’ position 3. O n th e left side of th e body, with th e h ead of th e

bed elevated 45 degrees 4. O n th e righ t side of th e body, with th e h ead of

th e bed elevated 45 degrees

187. A clien t h as just return ed to a n ursin g un it after an ab ove-kn ee am putation of th e righ t leg. Th e n urse sh o uld place th e clien t in wh ich position ? 1. Pron e 2. Reverse Tren delen burg’s 3. Supin e, with th e residual lim b flat on th e bed 4. Supin e, with th e residual lim b supp orted with

pillows

188. Th e n urse is carin g for a clien t with a severe burn wh o is sch eduled for an autograft to be placed on th e lower extrem ity. Th e n urse creates a posto- perative plan of care for th e clien t an d sh ould in clude wh ich in terven tion in th e plan ? 1. Main tain th e clien t in a pron e position . 2. Elevate an d im m obilize th e grafted extrem ity. 3. Main tain th e grafted extrem ity in a flat position . 4. Keep th e grafted extrem ity covered with a blan ket.

189. Th e n urse is preparin g to care for a clien t wh o h as return ed to th e n ursin g un it followin g cardiac cath eterization perform ed th rough th e fem oral vessel. Th e n urse ch ecks th e h ealth care provid er’s (HCP’s) prescription an d plan s to allow wh ich cli- en t position or activity followin g th e proced ure? 1. Bed rest in h igh Fowler’s position 2. Bed rest with bath roo m privileges on ly 3. Bed rest with h ead elevation at 60 degrees 4. Bed rest with h ead elevation n o greater th an 30

degrees

190. Th e n urse is preparin g to in sert a n asogastric tube in to a clien t. Th e n urse sh o uld place th e clien t in wh ich position for in sertion ? 1. Righ t side 2. Low Fowler’s 3. High Fowler’s 4. Supin e with th e h ead flat

A N S W E R S 181. 2 Ra tion a le: To facilitate rem o val o f fluid fro m th e ch est, th e cli- en t is po sitio n ed sittin g at th e ed ge o f th e b ed lean in g o ver th e b edside table, with th e feet su pp orted on a sto ol; or lyin g in bed o n th e un affected side with th e h ead of th e b ed elevated 30 to 45 d egrees. Th e pron e an d Sim s’ po sitio n s are in app ro p riate p osition s fo r th is p ro ced u re. Test-Ta kin g Str a tegy: Focus on th e su b ject, positio nin g for th oracen tesis. To p erform a th oracen tesis safely, the site m u st b e visible to th e h ealth care p ro vid er (HCP) p erform in g th e pro - ced ure. Th e clien t should be p laced in a position wh ere h e o r sh e is as com fo rtable as p ossible with access to th e affected sid e. A p ro n e p ositio n would n ot give th e HCP access to the chest. Lyin g o n th e affected sid e would preven t access to th e site. Review: Po sitio n in g for th o racen tesis Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Diagn ostic Tests Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Lewis et al. (2014), p p. 493, 550; Perry, Potter, O sten d orf (2014), p. 1110.

182. 1 Ra tion a le: Clien ts wh o h ave un dergon e crain oto m y sh o u ld h ave th e h ead of th e bed elevated 30 to 45 d egrees to p ro m ote ven o u s drain age fro m th e h ead . Th e clien t is po sitio n ed to avoid extrem e h ip or n eck flexio n an d th e h ead is m ain tain ed in a m id lin e n eutral p osition . Th e clien t sh ou ld n o t b e p osi- tio n ed o n th e site th at was op erated on , esp ecially if th e bo n e flap was rem oved , because th e brain h as n o b on y co verin g on th e affected site. A flat p ositio n or Tren delen b urg’s p osition would in crease in tracran ial pressure. A reverse Tren delen burg’s p ositio n wou ld n ot b e h elp fu l an d m ay be u n co m fo rtab le fo r th e clien t. Test-Ta kin g Str a tegy: Focus o n th e su b ject, position in g fol- lo win g cran io to m y. Rem em ber th at a prim ary con cern is th e risk for in creased in tracran ial pressu re. Th erefo re, use co n cep ts related to gravity an d preven tin g edem a an d in creased in tracra- n ial p ressure to an swer th is qu estio n . Review: Po sition in g follo win g cran io to m y Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Safety Pr ior it y Con cept s: In tracran ial Regu lation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 960.

F

u

n

d

a

m

e

n

t

a

l

s

236 UNIT IV Fundamentals of Care

183. 3 Ra t ion a le: Fo r th e clien t with d eep vein th rom bo sis, elevatio n of th e affected leg facilitates b lo od flow b y th e force of gravity an d also decreases ven ou s p ressure, wh ich in turn relieves edem a an d pain . A flat o r dep en d en t p ositio n o f th e leg wo uld n ot ach ieve th is goal. Bed rest is in dicated to preven t em bo li an d to p reven t pressu re flu ctu atio n s in th e ven o us system th at occu r with walkin g. Test -Ta kin g Str a t egy: Focus on th e su b ject, th e safe p ositio n or activity for th e clien t with d eep vein th ro m bo sis. Th in k ab o ut th e p ath o ph ysiolo gy asso ciated with th is d iso rd er an d th e prin cip les related to gravity flow an d ed em a to an swer th e qu estio n . Review: Positio n in g fo r a ven o u s d iso rd er Level of Cogn it ive Ability: Creatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Perfusio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 731.

184. 2 Ra t ion a le: Po sitio n in g followin g a to tal h ip replacem en t dep en d s o n th e surgical tech n iq ues used , th e m eth o d o f im p lan tatio n , th e prosth esis, an d th e h ealth care provider’s (HCP’s) preferen ce. Abd u ctio n is m ain tain ed wh en th e clien t is in a sup in e po sitio n or p osition ed o n th e n o n o perative sid e. In tern al an d extern al ro tatio n , ad du ction , o r sid e-lyin g on th e op erative sid e (un less specifically prescrib ed b y th e HCP) is avo id ed to preven t d isp lacem en t of th e p ro sth esis. Test -Ta kin g Str a tegy: Fo cu s o n th e strategic wo rd , best. Use kn o wledge regardin g care o f clien ts followin g total h ip replace- m en t to an swer th is q uestion . After a to tal h ip replacem en t, th e clien t sh o u ld n ever h ave th e extrem ity in tern ally or extern ally ro tated. Lyin g o n th e surgical side can cause dam age to th e sur- gical rep lacem en t site. Review: Positio n in g after to tal h ip rep lacem en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Im p lem en tatio n Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Mo bility; Safety Refer en ce: Lewis et al. (2014), p . 1526.

185. 1 Ra t ion a le: After cataract su rgery, th e clien t sh o u ld n o t sleep o n th e side o f th e b od y th at was o perated o n to p reven t edem a fo r- m atio n an d in traocu lar pressu re. Th e clien t also sh ou ld b e placed in a sem i-Fo wler’s po sitio n to assist in m in im izin g edem a an d in trao cu lar p ressu re. Du rin g th e day, th e clien t m ay wear glasses o r a p ro tective sh ield ; at n igh t, th e p ro tective sh ield alon e is su fficien t. Test -Ta kin g St r a t egy: Focus on th e su b ject, righ t cataract sur- gery. Use o f th e prin ciples o f gravity an d ed em a fo rm atio n will assist in an swerin g th is q uestion . Rem em ber to in struct th e cli- en t to rem ain o ff th e o p erative sid e an d to rest with th e h ead elevated to m in im ize ed em a fo rm ation . Th is will assist yo u wh en an swerin g q uestion s related to cataract su rgery. Review: Positio n in g fo llo win g cataract su rgery Level of Cogn it ive Ability: Evaluatin g

Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Fun d am en tals of Care—Safety Pr ior ity Con cepts: Clien t Teach in g; Sen so ry Percep tion Refer en ce: Lewis et al. (2014), pp . 393-394.

186. 1 Ra t ion a le: Fo r ad m in isterin g an en em a, th e clien t is p laced in a left Sim s’ po sitio n so th at th e en em a solu tio n can flow by grav- ity in th e n atural directio n o f th e colo n . Th e h ead o f th e b ed is n ot elevated in th e Sim s’ po sitio n . Test -Ta kin g St r a t egy: Focus on th e su b ject, p osition in g for en em a adm in istratio n . Use kn o wled ge regard in g th e an ato m y o f th e bo wel to an swer th e q u estion . Th e descen din g colon is located on th e lo wer left sid e o f th e b o dy. Th e h ead of th e bed sh ou ld b e flat d urin g en em a ad m in istration . Review: En em a adm in istratio n Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Skills Pr ior ity Con cepts: Elim in atio n ; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 853-854.

187. 4 Ra t ion a le: Th e residual lim b is usually supported on pillows fo r th e first 24 h o urs fo llo win g su rgery to prom o te ven o u s retu rn an d decrease edem a. After th e first 24 h ou rs, th e residu al lim b u sually is placed flat o n th e b ed to red uce h ip co n tracture. Ed em a also is co n trolled b y lim b -wrapp in g tech n iqu es. In ad dition , it is im po rtan t to ch eck h ealth care p ro vider p rescrip - tion s regard in g po sitio n in g followin g am pu tation . Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, position in g fol- lowin g am p utatio n , an d n o te th at th e clien t h as ju st return ed from surgery. Usin g basic prin cip les related to im m ed iate p ost- o p erative care an d p reven tin g ed em a will assist in d irectin g yo u to th e co rrect op tion . Review: Po sitio n in g fo llo win g am p u tatio n Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Perfusio n ; Tissue In tegrity Refer en ce: Lewis et al. (2014), p. 1532.

188. 2 Ra t ion a le: Au tografts p laced over jo in ts or o n lower extrem i- ties are elevated an d im m o bilized fo llo win g surgery for 3 to 7 d ays, d ep en d in g on th e surgeon ’s preferen ce. Th is p eriod o f im m o bilizatio n allo ws th e au tograft tim e to adh ere an d attach to th e wou n d b ed , an d th e elevatio n m in im izes ed em a. Keepin g th e clien t in a pron e p ositio n an d co verin g th e extrem - ity with a blan ket can d isrup t th e graft site. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, position in g fol- lowin g au tograft. Use gen eral p osto perative p rin ciples; elevat- in g th e graft site will d ecrease ed em a to th e graft. Th e clien t sh ou ld n ot b e placed in a p ro n e po sitio n o r h ave it co vered after su rgery sin ce it can d isru pt a graft easily. Review: Po sitio n in g fo llo win g au to graft Level of Cogn it ive Ability: Creatin g

F

u

n

d

a

m

e

n

t

a

l

s

237CHAPTER 19 Positioning Clients

Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Fu n d am en tals o f Care—Periop erative Care Pr ior it y Con cept s: Perfu sio n ; Tissu e In tegrity Refer en ces: Ign ataviciu s, Wo rkm an (2016), p . 484. Lewis et al. (2014), pp . 466–467.

189. 4 Ra tion a le: After cardiac cath eterizatio n , th e extrem ity in to wh ich th e cath eter was in serted is kept straigh t for 4 to 6 h ours. Th e clien t is m ain tain ed o n b ed rest for 4 to 6 h o urs (tim e fo r b ed rest m ay vary d ep en d in g on th e HCP’s preferen ce an d on wh eth er a vascular closu re device was used) an d th e clien t m ay tu rn from side to sid e. Th e h ead is elevated n o m ore th an 30 degrees (alth ou gh som e HCPs p refer a lower po sitio n or th e flat p osition ) u n til h em o stasis is adeq uately ach ieved . Test-Ta kin g Str a tegy: Focus o n th e su b ject, position in g fol- lo win g card iac cath eterization . Th in k ab o ut th is d iagn o stic p ro ced u re an d wh at it en tails. Un d erstan din g th at th e h ead o f th e b ed is n ever elevated m o re th an 30 degrees an d b ath - roo m privileges are restricted in th e im m ediate p ostcath eteriza- tio n perio d will assist in an swerin g th is q uestion . Review: Po sitio n in g followin g card iac cath eterizatio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity

In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Fu n dam en tals o f Care—Diagn ostic Tests Pr ior it y Con cept s: Perfu sion ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 644.

190. 3 Ra tion a le: Durin g in sertion of a n aso gastric tub e, th e clien t is p laced in a sittin g o r h igh Fo wler’s p osition to facilitate in ser- tio n of th e tub e an d red uce th e risk of pu lm on ary aspiratio n if th e clien t sh ou ld vo m it. Th e righ t sid e, an d low Fo wler’s an d su pin e p osition s place th e clien t at risk for asp iration ; in ad di- tio n , th ese p o sition s d o n ot facilitate in sertio n of th e tu be. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, in sertion o f a n aso gastric tu be. Visu alize each p osition an d th in k ab ou t h o w it m ay facilitate in sertion o f th e tu be. Also , recall th at a con cern with in sertion o f a n aso gastric tu be is p ulm o n ary asp i- ration . Placin g th e clien t in a h igh Fowler’s p osition with h is or h er ch in to th e ch est will decrease th e risk of aspiratio n . Review: Po sition in g for n aso gastric tu b e in sertion Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nu rsin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fun dam en tals o f Care—Skills Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), p. 778.

F

u

n

d

a

m

e

n

t

a

l

s

238 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 20 Care of a Client with a Tube

PRIORITY CONCEPTS Caregiving, Safety

CRITICAL THINKING What Should You Do? The nurse assesses a client with a closed chest tube drainage system. On inspection, the nurse notes that the system is cracked. What should the nurse do? Answer located on p. 251.

I. Nasogastric Tubes A. Description

1. Th ese are tubes used to in tub ate th e stom ach . 2. Th e tube is in serted from th e n ose to th e

stom ach . B. Purpo se

1. To deco m press th e stom ach by rem ovin g fluid s or gas to prom o te ab dom in al com fo rt

2. To allow surgical an astom oses to h eal with out disten tion

3. To decrease th e risk of aspiration 4. To adm in ister m ed ication s to clien ts wh o are

un ab le to swallow 5. To provid e n utrition by actin g as a tem porary

feed in g tube 6. To irrigate th e stom ach an d rem ove toxic sub-

stan ces, such as in poison in g C. Types of tubes

1. Levin tube (Fig. 20-1) a. Sin gle-lum en n asogastric tube b . Used to rem ove gastric con ten ts via in term it-

ten t suction or to provide tube feedin gs 2. Salem sum p tube: A Salem sum p is a double-

lu m en n aso gastric tube with an air ven t (pigtail) used for deco m pression with in term itten t con - tin uo us suction (see Fig. 20-1).

The air vent on a Salem sump tube is not to be clamped and is to be kept above the level of the stomach. If leakage occurs through the air vent, instill 30 mL of air into the air vent and irrigate the main lumen with normal saline (NS).

D. In tubation proced ures (Box 20-1) E. Irrigation

1. Assess placem en t before irrigatin g (see Box 20-1). 2. Perform irrigation every 4 h ou rs to assess an d

m ain tain th e paten cy of th e tube. 3. Gen tly in still 30 to 50 m L of water or NS

(depen din g on agen cy policy) with an irrigation syrin ge.

4. Pull back on th e syrin ge plun ger to with draw th e fluid to ch eck paten cy; repeat if th e tube flow is sluggish .

F. Rem o val of a n asogastric tube: Ask th e clien t to take a deep breath an d h old it; rem ove th e tube slowly an d even ly over th e course of 3 to 6 secon ds (coil th e tube aroun d th e h an d wh ile rem ovin g it).

II. Gastrointestinal Tube Feedings A. Types of tubes an d an atom ical placem en t

1. Naso gastric: Nose to stom ach 2. Naso duoden al-n asojejun al: Nose to duoden um

or jejun um 3. Gastrostom y: Stom ach 4. Jejun ostom y: Jejun um

B. Types of ad m in istration 1. Bolu s

a. A bolus resem bles n orm al m eal feedin g pattern s.

b . Form ula is adm in istrated over a 30- to 60- m in u te period every 3 to 6 h ours; th e am oun t of form ula an d frequen cy can be recom - m en ded by th e dietitian an d is prescribed by th e h ealth care provider (HCP).

2. Con tin uous a. Feedin g is adm in istered con tin ually for

24 h ou rs. b . An in fusion feedin g pum p regulates th e flow.

3. Cyclical a. Feedin g is adm in istered in th e daytim e or

n igh ttim e for approxim ately 8 to 16 h ours. b . An in fusion feedin g pum p regulates th e flow. c. Feedin gs at n igh t allow for m ore freedom

durin g th e day. 239

C. Adm in istration of feedin gs 1. Check the HCP’s prescription an d agen cy policy

regardin g residual am oun ts; usually, if th e residual is less th an 100 m L, feedin g is adm in istered; large- volum e aspirates in dicate delayed gastric em ptyin g an d place th e clien t at risk for aspiration .

2. Assess bowel soun ds; h old th e feedin g an d n otify th e HCP if bowel soun ds are absen t.

3. Position th e clien t in a h igh Fowler’s position ; if com atose, place in h igh Fowler’s an d on th e righ t side.

4. Assess tube placem en t by aspiratin g gastric con ten ts an d m easurin g th e pH (sh ould be 3.5 or lower).

5. Aspirate all stom ach con ten ts (resid ual), m ea- sure th e am oun t, an d return th e con ten ts to

th e stom ach to preven t electrolyte im balan ces (un less th e color or ch aracteristics of th e residual is abn orm al or th e am oun t is greater th an 250 m L).

6. Warm th e feed in g to room tem perature to pre- ven t diarrh ea an d cram p s.

7. Use an in fusion feedin g pum p for con tin uo us or cyclic feed in gs.

8. For bolus feedin g, m ain tain th e clien t in a h igh Fowler’s position for 30 m in utes after th e feed- in g. Use an in fusion pum p or allow th e feedin g to in fuse via gravity. Do n ot plun ge th e feedin g in to th e stom ach .

9. For a con tin uous feedin g, keep th e clien t in a sem i-Fowler’s position at all tim es.

F

u

n

d

a

m

e

n

t

a

l

s

Lavac uato r tube An oroga s tric tube with a la rge s uction lume n a nd a s ma lle r la va ge /ve nt lume n tha t provide s continuous s uction be ca us e irriga ting s olution e nte rs the la va ge lume n while s toma ch conte nts a re re move d through the s uction lume n. Us e d to re move toxic s ubs ta nce s from the s toma ch. An e wa ld tube is s imila r but ha s a s ingle lume n.

Canto r tube A s ingle -lume n long tube with a s ma ll infla ta ble ba g a t the dis ta l e nd. A s pe cia l s ubs ta nce (tungs te n) is inje cte d with a ne e dle (ga uge 21 or s ma lle r or ba lloon ma y le a k) a nd s yringe into the ba g of the tube .

S e ng s take n-Blake mo re tube A thre e -lume n tube . Two ports infla te a n e s opha ge a l a nd a ga s tric ba lloon for ta mpona de , a nd the third is us e d for na s oga s tric s uction. This tube doe s not provide e s opha ge a l s uction, but a na s oga s tric tube ma y be ins e rte d in the oppos ite na ris or the mouth a nd a llowe d to re s t on top of the e s opha ge a l ba lloon. Es opha ge a l s uction is the n pos s ible , re ducing the ris k of a s pira tion.

We ig hte d fle xible fe e ding tube with s tyle t Acce s s port with irriga tion a da ptor a llows ma inte na nce of the tube without dis conne cting the fe e ding s e t.

Le vin tube A pla s tic or rubbe r s ingle -lume n tube with a s olid tip tha t ma y be ins e rte d into the s toma ch via the nos e or mouth. Us e d to dra in fluid a nd ga s from the s toma ch.

S ale m s ump tube A double -lume n tube . The s ma ll ve nt tube within the la rge s uction tube pre ve nts mucos a l s uction da ma ge by ma inta ining the pre s s ure in ope n e ye s a t the dis ta l e nd of the tube a t le s s tha n 25 mm Hg.

Mille r-Abbo tt tube A long double -lume n tube us e d to dra in a nd de compre s s the s ma ll inte s tine . One lume n le a ds to a ba lloon tha t is fille d with a s pe cia l s ubs ta nce (tungs te n) once it is in the s toma ch; the s e cond is for irriga tion a nd dra ina ge .

Ope n e ye s La rge s uction lume n

La va ge /ve nt lume n

Ope n e ye s a long tube

S olid tip

Ope n e ye s

S ma ll ve nt tube

La rge s uction tube

Ope n e ye for dra ina ge

Ba lloon fille d with a s pe cia l s ubs ta nce

Two lume ns

Le ngth ma rkings

Ga s tric ba lloon infla tion lume n

Ga s tric a s pira tion lume n

Es opha ge a l ba lloon

Es opha ge a l ba lloon infla tion lume n

Ga s tric ba lloon

Acce s s port

S tyle t

Exit port

We ighte d tip

FIGURE 20-1 Comparison of design and function of selected gastrointestinal tubes.

240 UNIT IV Fundamentals of Care

D. Precaution s

Always assess the placement of a gastrointestinal tube before instilling feeding solutions, medications, or any other solution. If the tube is incorrectly placed, the client is at risk for aspiration.

1. Ch an ge th e feedin g con tain er an d tubin g every 24 h ou rs or per agen cy policy.

2. Do n ot h an g m ore solution th an is required for a 4-h our period; th is preven ts bacterial growth .

3. Ch eck th e expiration date on th e form ula before ad m in isterin g.

4. Sh ake th e form ula well before pourin g it in to th e con tain er (feedin g bag). Som e feedin gs require th e use of a bag in wh ich form ula is added , or require th e use of bottles th at feed in g tubin g can be attach ed to directly. Th e tubin g som e- tim es h as a Y-site con n ection so a regular flush can be program m ed usin g th e pum p rath er th an usin g a piston syrin ge.

5. Always assess bowel soun ds; do n ot adm in ister an y feed in gs if bowel soun ds are absen t.

6. Adm in ister th e feedin g at th e prescribed rate or via gravity flow (in term itten t bolus feed in gs) with a 50- to 60-m L syrin ge with th e plun ger rem oved.

7. Gen tly flush with 30 to 50 m L of water or NS (depen din g on agen cy policy) usin g th e irriga- tion syrin ge after th e feedin g.

E. Preven tion of com plication s 1. Diarrh ea

a. Assess th e clien t for lactose in toleran ce. b . Use fib er-con tain in g feed in gs. c. Adm in ister feed in g slowly an d at room

tem p erature. 2. Aspiration

a. Verify tube placem en t. b . Do n ot adm in ister th e feedin g if residual is

m ore th an 100 m L (ch eck HCP’s prescription an d agen cy policy).

c. Keep th e h ead of th e bed elevated. d . If aspiration occurs, suction as n eeded, assess

respiratory rate, auscultate lun g soun ds, m oni- tor tem perature for aspiration pneum on ia, an d prepare to obtain a ch est radiograph .

F

u

n

d

a

m

e

n

t

a

l

s

BOX 20-1 Nasogastric Tubes: Intubation Procedures 1. Follow agency procedures. 2. Explain the procedure and its potential discomfort to the

client. 3. Position the client in a high Fowler’s position with pillows

behind the shoulders. 4. Determine which nostril is more patent. 5. Measure the length of the tube from the bridge of the nose to

the earlobe to the xiphoid process and indicate this length with a piece of tape on the tube (remember the abbreviation NEX, which stands for nose, earlobe, and xiphoid process).

6. If the client is conscious and alert, have him or her swallow or drink water (follow agency procedure).

7. Lubricate the tip of the tube with water-soluble lubricant. 8. Gently insert the tube into the nasopharynx and advance

the tube. 9. When the tube nears the back of the throat (first black mea-

surement on the tube), instruct the client to swallow or drink sips of water (unless contraindicated). If resistance is met, slowly rotate and aim the tube downward and toward the closer ear; in the intubated or semiconscious cli- ent, flex the head toward the chest while passing the tube.

10. Immediately withdraw the tube if any change is noted in the client’s respiratory status.

11. Following insertion, obtain an abdominal x-ray study to confirm placement of the tube.

12. Connect the tube to suction, to either the intermittent or the continuous suction setting, as prescribed if the purpose of the tube is for decompression.

13. Secure the tube to the client’s nose with adhesive tape and to the client’s gown (follow agency procedure and check for client allergy to tape).

14. Observe the client for nausea, vomiting, abdominal full- ness, or distention and monitor gastric output.

15. Check residual volumes every 4 hours, before each feeding, and before giving medications. Aspirate all stomach con- tents (residual) and measure the amount. Reinstill residual contents to prevent excessive fluid and electrolyte losses, unless the residual contents appear abnormal or the vol- ume is large (greater than 250 mL). Always follow agency procedure. Withhold a feeding if the residual amount is more than 10 0 mL or according to agency or nutritional consult recommendations.

16. Before the instillation of any substance through the tube (i.e., irrigation solution, feeding, medications), aspirate stomach contents and test the pH (a pH of 3.5 or lower indi- cates that the tip of the tube is in a gastric location).

17. If irrigation is indicated, use normal saline solution (check agency procedure).

18. Observe the client for fluid and electrolyte balance. 19. Instruct the client about movement to prevent nasal irrita-

tion and dislodgment of the tube. 20. On a daily basis, remove the adhesive tape that is securing

the tube to the nose and clean and dry the skin, assessing for excoriation; then reapply the tape.

Note: Gastrostomy or jejunostomy tubes are surgically inserted. A dressing is placed at the site of insertion. The dressing needs to be removed, the skin needs to be cleansed (with a solution determined by the health care provider or agency procedure), and a new sterile dressing needs to be applied every 8 hours (or as specified by agency policy). The skin at the insertion site is checked for signs of excoriation, infection, or other abnormalities, such as leakage of the feeding solution. Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

241CHAPTER 20 Care of a Client with a Tube

F

u

n

d

a

m

e

n

t

a

l

s

3. Clogged tube a . Use liqu id form s of m ed ication , if possib le. b . Flush th e tube with 30 to 50 m L of water or

NS (depen din g on agen cy policy) before an d after m ed ication adm in istration an d befo re an d after bolus feedin g.

c. Flush with water every 4 h ours for con tin uo us feedin g.

4. Vom itin g a . Adm in ister feedin gs slowly an d, for bolus feed-

in gs, m ake feedin g last for at least 30 m in utes. b . Measu re abdom in al girth . c. Do n ot allow th e feed in g bag to em pty. d . Do n ot allow air to en ter th e tubin g. e. Adm in ister th e feed in g at room tem perature. f. Elevate th e h ead of th e bed . g. Adm in ister an tiem etics as prescribed.

If the client vomits, stop the tube feeding and place the client in a side-lying position; suction the client as needed.

F. Adm in istration of m edication s (see Prio rity Nu rsin g Action s)

III. Intestinal Tubes A. Description

1. Th e in testin al tube is passed n asally in to th e sm all in testin e.

2. It m ay be used to deco m press th e bowel or to rem ove accu m ulated in testin al secretion s wh en oth er in terven tion s to decom press th e bowel are n ot effective.

3. Th e tu b e en ters th e sm all in testin e th ro u gh th e p ylo ric sp h in cter b ecau se o f th e weigh t o f a sm all b ag co n tain in g tu n gsten at th e en d .

B. Types of tubes in clude th e Can tor tube (sin gle lum en ) an d th e Miller-Abbott tube (double lum en ) (see Fig. 20-1).

C. In terven tion s 1. Assess th e HCP’s prescription s an d agen cy policy

for advan cem en t an d rem oval of th e tube an d tun gsten .

2. Position th e clien t on th e righ t side to facilitate passage of th e weigh ted bag in th e tube th rough th e pylorus of th e stom ach an d in to th e sm all in testin e.

3. Do n ot secure th e tube to th e face with tape un til it h as reach ed fin al placem en t (m ay take several h ours) in th e in testin es.

4. Assess th e abdom en durin g th e proced ure by m on itorin g drain age fro m th e tube an d th e abdom in al girth .

5. If th e tube becom es blocked, n otify th e HCP. 6. To rem ove th e tube, th e tun gsten is rem oved

from th e balloo n portion of th e tube with a

PRIORITY NURSING ACTIONS Administering Medications via a Nasogastric, Gastrostomy, or Jejunostomy Tube 1. Check the health care provider’s (HCP’s) prescription. 2. Prepare the medication for administration. 3. Ensure that the medication prescribed can be crushed or is

a capsule that can be opened; use elixir forms of medica- tions if available.

4. Dissolve crushed medication or capsule contents in 15 to 30 mL of water.

5. Verify the client’s identity and explain the procedure to the client.

6. Check tube placement and residual contents before instil- ling the medication; check for bowel sounds.

7. Pour medication into a catheter tip syringe that is attached to clamped tubing. Unclamp tubing immediately and allow medication to infuse via gravity.

8. Flush with 30 to 50 mL of water or normal saline (NS), depending on agency policy.

9. Clamp the tube for 30 to 60 minutes, depending on med- ication and agency policy.

10. Document the administration of the medication and any other appropriate information.

The nurse always checks the HCP’s prescription before administering any medication to a client. Once the prescription is verified, the medication is prepared for administration. The nurse determines the reason for administration, checks for any contraindications to administering the medication, and checks for any potential interactions. When preparing medications

for administration through a nasogastric, gastrostomy, or jeju- nostomytube, the nurse needs to ensure that the medication pre- scribed can be crushed or is a capsule that can be opened. Whole tablets or capsules cannot be administered through a tube because they can cause a tube blockage. Elixir forms of medica- tions can also be used if available. The nurse then dissolves the crushed medication or capsule contents in 15 to 30 mL of water. Client identity is always verified before medication administra- tion and the procedure is explained to the client. The nurse checks tube placement and residual contents before instilling the medication and checks for bowel sounds. The nurse also per- forms any additional assessments, such as checking the apical heart rate for cardiac medications or checking the blood pressure for antihypertensives. The medication is poured into a catheter tip syringe that is attached to clamped tubing. The tubing is unclamped immediately and the medication is allowed to infuse via gravity. The tube is flushed with 30 to 50 mL of water or NS (depending on agency policy) to ensure that all medication has been instilled. The tube is then clamped for 30 to 60 minutes (depending on the medication and agency policy) to ensure that it is absorbed (if the tube is not clamped and is reattached to suc- tion, the medication will be aspirated out with the suction). The nurse then documents the administration of the medication and any other appropriate information.

Reference Perry, Potter, Ostendorf (2014), pp. 501-503. St. Louis, Mosby.

242 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

syrin ge; th e tube is rem oved gradually (6 in ch es [15 cm ] every h ou r) as prescribed by th e HCP.

IV. Esophageal and Gastric Tubes A. Description

1. May be used to ap ply pressure again st bleedin g eso ph ageal vein s to con trol th e bleed in g wh en oth er in terven tion s are n ot effective or th ey are con train dicated

2. No t used if th e clien t h as ulceration or n ecrosis of th e eso ph agus or h as h ad previous eso ph ageal surgery because of th e risk of ru pture

B. Sen gstaken -Blakem ore tube an d Min n esota tube (see Fig. 20-1) 1. Th e Sen gstaken -Blakem ore tube, used on ly occa-

sion ally, is a triple-lum en gastric tube with an in flatable esoph ageal balloon (com presses esoph- ageal varices), an in flatable gastric balloon (applies pressure at th e cardioesoph ageal junction ), an d a gastric aspiration lum en . A n asogastric tube also is in serted in th e opposite n aris to collect secretions that accum ulate above th e esoph ageal balloon .

2. More com m on ly used is the Min n esota tube, wh ich is a m odified Sen gstaken -Blakem ore tube with an addition al lum en (a 4-lum en gastric tube) for aspiratin g esoph agoph aryn geal secretion s.

3. A radiograph of th e upper abdom en an d ch est con firm s placem en t.

C. In terven tion s 1. Ch eck paten cy an d in tegrity of all balloo n s

befo re in sertio n . 2. Label each lum en . 3. Place th e clien t in th e uprigh t or Fowler’s posi-

tio n for in sertio n . 4. Im m ediately after in sertio n , prepare for radiog-

raph y to verify placem en t. 5. Main tain h ead elevation once th e tube is in place. 6. Do uble-clam p th e balloo n ports to preven t

air leaks. 7. Keep scissors at th e bedside at all tim es; m on itor

for respiratory distress, an d if it occurs, cut th e tubes to deflate th e balloon s.

8. To preven t ulceration or n ecrosis of th e eso ph a- gu s, release esoph ageal pressure at in tervals as prescribed an d per agen cy policy.

9. Mon itor for in creased blood y drain age, wh ich m ay in dicate persisten t bleed in g an d rupture of th e varices.

10. Mon itor for sign s of esoph ageal rupture, wh ich in clude a drop in blood pressure, in creased h eart rate, an d back an d upper abdom in al pain . (Eso ph ageal rupture is an em ergen cy, an d sign s of esoph ageal rupture m ust be reported to th e HCP im m ediately.)

V. Lavage Tubes A. Description : Used to rem ove toxic substan ces from

th e stom ach

B. Types of tubes 1. Lavacuator (see Fig. 20-1)

a. Th e Lavacu ator is an orogastric tube with a large suction lu m en an d a sm aller lavage– ven t lum en th at provides con tin uo us suction .

b . Irrigation solution en ters th e lavage lum en wh ile stom ach con ten ts are rem oved th rough th e suction lum en .

2. Ewald tube: A sin gle-lum en large tube used for rapid 1-tim e irrigation an d evacuation

VI. Urinary and Renal Tubes A. Types of urin ary cath eters

1. Sin gle lum en : Usually used for straigh t cath eter- ization to em p ty th e clien t’s bladder, obtain ster- ile urin e specim en s, or ch eck th e residual am oun t of urin e after th e clien t voids

2. Do uble lum en : Used wh en an in dwellin g cath e- ter is n eeded for con tin uous bladder drain age; on e lu m en is for drain age an d th e oth er is for bal- loon in flation .

3. Triple lum en : Used wh en bladder irrigation an d drain age is n ecessary; 1 lum en is for in stillin g th e blad der irrigan t solution , 1 lum en is for con tin - uous bladder drain age, an d 1 lum en is for bal- loon in flation .

4. Strict aseptic tech n ique is n ecessary for in sertio n an d care of th e cath eter.

B. Routin e urin ary cath eter care 1. Use gloves an d wash th e perin eal area with warm

soapy water. 2. With th e n on dom in an t h an d, pull back th e

labia or foreskin to exp ose th e m eatus (in th e adult m ale, return th e foreskin to its n orm al position ).

3. Clean se alon g th e cath eter with soap an d water. 4. An ch or th e cath eter to th e th igh . 5. Main tain th e cath eter bag below th e level of th e

blad der. C. Ureteral an d n eph rostom y tubes (Fig. 20-2)

1. Never clam p th e tube.

FIGURE 20-2 Ureteral and nephrostomy tubes.

243CHAPTER 20 Care of a Client with a Tube

2. Main tain paten cy. 3. Irrigate on ly if prescribed by th e HCP, usin g strict

aseptic tech n ique; a m axim u m of 5 m L of sterile NS is in stilled slowly an d gen tly.

4. If paten cy can n ot be establish ed with th e pre- scrib ed irrigation , n otify th e HCP im m ediately.

D. Cath eter in sertion an d rem oval (Box 20-2)

If the client has a ureteral or nephrostomy tube, monitor output closely; urine output of less than 30 mL/ hour or lack of output for more than 15 minutes should be reported to the HCP immediately.

F

u

n

d

a

m

e

n

t

a

l

s

BOX 20-2 Urinary Catheters: Insertion and Removal Procedures Urinary Catheters: Insertion Procedure

1. Follow agency procedures. 2. Explain the procedure and its potential discomfort to the

client. 3. Place the client in position for catheterization:

Female: Assist to dorsal recumbent position (supine with knees flexed). Support legs with pillows to reduce mus- cle tension and promote comfort.

Male: Assist to supine position with thighs slightly abducted.

4. Wearing clean gloves, wash perineal area with soap and water as needed; dry thoroughly. Remove and discard gloves; perform hand hygiene.

5. Open outer wrapping of the catheter kit, remembering that all components of the catheterization tray are sterile (all supplies are arranged in the box in order of sequence of use).

6. Apply waterproof sterile drape (when packed as first item in tray).

7. Urinary catheter procedure with specifics for male and female: a. Place a sterile drape with plastic side down under the cli-

ent’s buttocks. b. Don sterile gloves using sterile technique. c. Pick up fenestrated drape from tray. Allow it to unfold

without touching nonsterile surface. Apply drape over perineum, exposing labia or penis.

d. While maintaining sterility, open packet of lubricant and squeeze out on sterile field. Lubricate catheter tip by dip- ping it into water-soluble gel, 2.5 to 5 cm (1 to 2 inches) for women and 12.5 to 17.5 cm (5 to 7 inches) for men. Attach prefilled syringe to balloon port. Prepare cotton balls or swab sticks for cleansing perineal area.

e. Remember with a sterile technique, the sterile field and gloved hands must be maintained above the level of the waist, the 1-inch (2.5 cm) border on the field is consid- ered contaminated, and the nurse cannot turn his or her back to the field at any time.

f. Catheter insertion Female: The female should be positioned in a dorsal

recumbent position with the legs open to allow for full visualization and maintenance of the sterile field. With nondominant hand, fully expose urethral mea- tus by spreading labia, taking care to not allow the labia to close. Using forceps in sterile dominant hand, pick up cotton ball or swab sticks saturated with anti- septic solution, wiping from front to back (from clito- ris toward anus). Using a new cotton ball or swab for each area you clean, wipe far labial fold, near labial

fold, and directly over center of urethral meatus. Pick up and hold catheter 7.5 to 10 cm (3 to 4 inches) from catheter tip. Advance catheter a total of 7.5 cm (3 inches) in adult or until urine flows out of catheter end. When urine appears, advance catheter another 2.5 to 5 cm (1 to 2 inches). Do not use force to insert catheter.

Male: Use of square sterile drape is optional; you may apply fenestrated drape with fenestrated slit resting over penis. Grasp penis at shaft just below glans. (If client is not circumcised, retract foreskin with non- dominant hand.) With dominant hand, pick up antiseptic-soaked cotton ball with forceps or swab stick and clean penis. Move cotton ball or swab in cir- cular motion from urethral meatus down to base of glans. Repeat cleaning 2 more times, using clean cot- ton ball/ stick each time. Pick up catheter with gloved dominant hand and insert catheter by lifting penis to position perpendicular to client’s body and apply light traction. Advance catheter 17.5 to 22.5 cm (7 to 9 inches) in adult or until urine flows out of catheter end. Advance an additional 2.5 to 5 cm (1 to 2 inches) after urine appears. Lower penis and hold catheter securely in nondominant hand.

8. Inflate balloon fully per manufacturer’s directions and gently pull back on the catheter until resistance is felt.

9. Secure catheter tubing to inner thigh with agency-approved securing device, such as a StatLock®.

10. Record type and size of catheter inserted, amount of fluid used to inflate the balloon, characteristics and amount of urine, specimen collection if appropriate, client’s response to procedure, and that teaching was completed.

Urinary Catheters: Removal Procedure 1. Follow agency procedures. 2. Explain the procedure and its potential discomfort to the

client. 3. Position the client in the same position as during

catheterization. 4. Remove the securing device and place the towel between a

female client’s thighs or over a male client’s thighs. 5. Insert a 10 -mL syringe into the balloon injection port. Slowly

withdraw all of the solution to deflate the balloon totally. 6. After deflation, explain to the client that he or she may feel a

burning sensation as the catheter is withdrawn. Pull the cath- eter out smoothly and slowly.

7. Assess the client’s urinary function by noting the first voiding after catheter removal and documenting the time and amount of voiding for the next 24 hours.

Adapted from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby.

244 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

VII. Respiratory System Tubes A. En do trach eal tubes (Fig. 20-3)

1. Description a. Th e en dotrach eal tube is used to m ain tain a

paten t airway. b . En do trach eal tubes are in dicated wh en th e

clien t n eeds m ech an ical ven tilation . c. If th e clien t requires an artificial airway for

lo n ger th an 10 to 14 days, a trach eostom y m ay be created to avoid m ucosal an d vocal cord dam age th at can be caused by th e en dotrach eal tube.

d . Th e cuff (located at th e distal en d of th e tube), wh en in flated, produ ces a seal between th e trach ea an d th e cuff to preven t aspiration an d en sure delivery of a set tidal volu m e wh en m ech an ical ven tilation is used; an in flated cuff also preven ts air fro m passin g to th e vocal cords, n ose, or m ou th .

e. Th e pilot balloon perm its air to be in serted in to th e cu ff, preven ts air from escapin g, an d is used as a guid elin e for determ in in g th e presen ce or absen ce of air in th e cuff.

f. Th e un iversal adap ter en ables attach m en t of th e tube to m ech an ical ven tilation tubin g or oth er types of oxygen delivery system s.

g. Types of tubes: orotrach eal an d n aso trach eal 2. O ro trach eal tubes

a. In serted th rou gh th e m ou th ; allows use of a larger diam eter tube an d reduces th e work of breath in g

b . In dicated wh en th e clien t h as a n asal obstru c- tio n or a predisp osition to epistaxis

c. Un com fo rtable an d can be m an ipulated by th e ton gu e, cau sin g airway obstruction ; an oral airway m ay be n eeded to keep th e clien t fro m bitin g on th e tube.

3. Naso trach eal tubes a. In serted th rou gh a n ostril; th is sm aller tube

in creases resistan ce an d th e clien t’s work of breath in g.

b . Its use is avoided in clien ts with bleedin g disorders.

c. It is m ore com fo rtable for th e clien t, an d th e clien t is un ab le to m an ipulate th e tube with th e ton gue.

4. In terven tion s a. Placem en t is con firm ed by ch est x-ray film (cor-

rect placem en t is 1 to 2 cm above th e carin a). b . Assess placem en t by auscultatin g both sides

of th e ch est wh ile m an ually ven tilatin g with a resuscitation (Am bu) bag (if breath soun ds an d ch est wall m ovem en t are absen t in th e left side, th e tube m ay be in th e righ t m ain stem bron ch us).

c. Perform auscultation over th e stom ach to rule out esoph ageal in tub ation .

d . If th e tube is in th e stom ach , louder breath soun ds will be h eard over th e stom ach th an over th e ch est, an d ab dom in al disten tion will be presen t.

e. Secure th e tube with adh esive tape im m edi- ately after in tubation .

f. Mon itor th e position of th e tube at th e lip or n ose.

g. Mon itor skin an d m ucou s m em bran es. h . Suction th e tube on ly wh en n eeded. i. Th e oral tube n eeds to be m oved to th e oppo-

site side of th e m ou th daily to preven t pres- sure an d n ecrosis of th e lip an d m ou th area, preven t n erve dam age, an d facilitate in spec- tion an d clean in g of th e m ou th ; m ovin g th e tube to th e oppo site side of th e m ou th sh ould be don e by 2 HCPs.

BA

Infla te d cuff

FIGURE 20-3 A, Endotracheal (ET) tube with inflated cuff. B, ET tubes with uninflated and inflated cuffs and syringe for inflation.

245CHAPTER 20 Care of a Client with a Tube

j. Preven t dislodgm en t an d pullin g or tuggin g on th e tube; suction , co ugh in g, an d speakin g attem p ts by th e clien t place extra stress on th e tube an d can cause dislodgm en t.

k . Assess th e pilot balloo n to en sure th at th e cuff is in flated; m ain tain cuff in flation , wh ich cre- ates a seal an d allows com plete m ech an ical con trol of respiration .

l. Mon itor cuff pressures at least every 8 h ours per agen cy procedure to ensure th at th ey do not exceed 20 m m Hg (an an eroid pressure m an om eter is used to m easure cuff pressures); m inim al leak an d occlusive tech niques are used for cuff in flation to ch eck cuff pressures.

A resuscitation (Ambu) bag needs to be kept at the bedside of a client with an endotracheal tube or a tracheostomy tube at all times.

5. Min im al leak tech n iqu e a . This is used for cuff inflation and ch eckin g cuff

pressures for cuffs with out pressure relief valves. b . In flate th e cuff un til a seal is establish ed; n o

h arsh soun d sh ould be h eard th rough a steth oscope placed over the trach ea wh en th e client breathes in , but a sligh t air leak on peak in spiration is presen t an d can be h eard.

c. Th e clien t can n ot m ake verbal soun ds, an d n o air is felt com in g out of th e clien t’s m ou th .

6. O cclusive tech n iqu e a . Th is is used for cuff in flation an d ch ecking cuff

pressures for cuffs with pressure relief valves. b . Provides an ad equate seal in th e trach ea at th e

lowest possib le cuff pressure. c. Uses sam e proced ure as m in im al leak tech -

n iqu e, with ou t an air leak. 7. Extub ation

a . Hyperoxygen ate th e clien t an d suction th e en dotrach eal tube an d th e oral cavity.

b . Place th e clien t in a sem i-Fowler’s position . c. Deflate th e cuff; h ave th e clien t in h ale an d, at

peak in spiration , rem ove th e tube, suction in g th e airway th rou gh th e tube wh ile pullin g it out.

d . After rem oval, in struct th e clien t to cough an d deep-breath e to assist in rem ovin g accum u- lated secretio n s in th e th roat.

e. Apply oxygen th erap y, as prescribed . f. Mon itor for respiratory difficulty; con tact th e

HCP if respiratory difficulty occurs. g. In form th e clien t th at h oarsen ess or a sore

th roat is n orm al an d th at th e clien t sh ould lim it talkin g if it occurs.

B. Trach eostom y 1. Description

a . A trach eo stom y is an open in g m ade surgically directly in to th e trach ea to establish an air- way; a trach eo stom y tube is in serted in to

th e open in g an d th e tube attach es to th e m ech an ical ven tilator or an oth er type of oxy- gen delivery device ( Fig. 20-4).

b . Th e trach eostom y can be tem p orary or per- m an en t. (See Box 20-3 for types of trach eo s- tom y tubes.)

2. In terven tion s a . Assess respiration s an d for bilateral breath

soun ds. b . Mon itor arterial blood gases an d pulse

oxim etry. c. En cou rage cough in g an d deep breath in g. d . Main tain a sem i-Fowler’s to h igh Fowler’s

position . e. Mon itor for bleed in g, difficulty with breath -

in g, absen ce of breath soun ds, an d crepitus (subcutan eous em ph ysem a), wh ich are in di- cation s of h em orrh age or pn eum oth orax.

f. Provid e respiratory treatm en ts as prescribed . g. Suction fluids as n eeded; h yperoxygen ate th e

clien t before suction in g. h . If th e clien t is allowed to eat, sit th e clien t up

for m eals an d en sure th at th e cuff is in flated (if th e tube is n ot cap ped) for m eals an d for 1 h our after m eals to preven t aspiration .

i. Mon itor cuff pressures as prescribed. j. Assess th e stom a an d secretio n s for blood or

purulen t drain age. k . Follow th e HCP’s prescription s an d agen cy

policy for clean in g th e trach eostom y site an d in n er can n ula (m an y in n er can n ulas are disposable); usually, h alf-stren gth h ydro- gen peroxide is used.

l. Adm in ister h um idified oxygen as prescribed, because th e n orm al h um idification process is bypassed in a clien t with a trach eo stom y.

m . O btain assistan ce in ch an gin g trach eo stom y ties; after placin g th e n ew ties, cut an d rem ove th e old ties h old in g th e trach eostom y in place (som e securin g devices are soft an d m ade with Velcro to h old th e tube in place).

n . Keep a resuscitation (Am bu) bag, obturato r, clam p s, an d spare trach eo stom y tube of th e sam e size at th e bedside.

3. Com p lication s of a trach eo stom y ( Table 20-1)

Never insert a plug (cap) into a tracheostomy tube until the cuff is deflated and the inner cannula is removed; prior insertion prevents airflow to the client.

VIII. Chest Tube Drainage System A. Descrip tion

1. Th e ch est tube drain age system return s n egative pressure to th e in trapleural space.

2. Th e system is used to rem ove abn o rm al accum u- lation s of air an d fluid from th e pleural space (Fig. 20-5).

F

u

n

d

a

m

e

n

t

a

l

s

246 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

A

Dis pos a ble inne r ca nnula

S lots for tube tie s

Cuff (infla te d)P ilot

ba lloon

Obtura tor

Va lve us e d for cuff infla tion,

de fla tion, a nd pre s s ure

me a s ure me nt

Fa ce pla te

Oute r ca nnula

C

Fe ne s tra tions

B

Cuff (infla te d)

P ilot ba lloon

Obtura tor Va lve us e d

to infla te a nd de fla te cuff

a nd me a s ure cuff pre s s ure

Cuff infla tion tube

S lots for a tta chme nt of tube tie s

Fa ce pla te

Oute r ca nnula

FIGURE 20-4 Tracheostomy tubes. A, Double-lumen cuffed tracheostomy tube with disposable inner cannula. B, Single-lumen cannula cuffed tracheostomy tube. C, Double-lumen cuffed fenestrated tracheostomy tube with plug (red cap).

BOX 20-3 Some Types of Tracheostomy Tubes Double-Lumen Tube The double-lumen tube has the following parts:

Outer cannula—fits into the stoma and keeps the airway open. The face plate indicates the size and type of tube and has small holes on both sides for securing the tube with trache- ostomy ties or another device.

Inner cannula—fits snugly into the outer cannula and locks into place. It provides the universal adaptor for use with the ven- tilator and other respiratory therapy equipment. Some may be removed, cleaned, and reused; others are disposable.

Obturator—a stylet with a smooth end used to facilitate the direc- tion of the tube when inserting or changing a tracheostomy tube. The obturator is removed immediately after tube place- ment and is always kept with the client and at the bedside in case of accidental decannulation.

Cuff—when inflated, seals the airway. The cuffed tube is used for mechanical ventilation, preventing aspiration of oral or gas- tric secretions, or for the client receiving a tube feeding to prevent aspiration. A pilot balloon attached to the outside of the tube indicates the presence or absence of air in the cuff.

Single-Lumen Tube The single-lumen tube is similar to the double-lumen tube except that there is no inner cannula. More intensive nursing care is required with this tube because there is no inner cannula to ensure a patent lumen.

Fenestrated Tube The fenestrated tube has a precut opening (fenestration) in the upper posterior wall of the outer cannula. The tube is used to wean the client from a tracheostomy by ensuring that the client can tolerate breathing through his or her natural airway before the entire tube is removed. This tube allows the client to speak.

Cuffed Fenestrated Tube The cuffed fenestrated tube facilitates mechanical ventilation and speech and often is used for clients with spinal cord paral- ysis or neuromuscular disease who do not require ventilation at all times. When not on the ventilator, the client can have the cuff deflated and the tube capped (see Fig. 20 -4 for cuffed fenes- trated tube with red cap) for speech. A cuffed fenestrated tube is never used in weaning from a tracheostomy because the cuff, even fully deflated, may partially obstruct the airway.

247CHAPTER 20 Care of a Client with a Tube

F

u

n

d

a

m

e

n

t

a

l

s

TABLE 20-1 Complications of a Tracheostomy Complication and Description Manifestations Management Prevention

Tracheomalacia: Constant pressure exerted by the cuff causes tracheal dilation and erosion of cartilage

▪ An increased amount of air is required in the cuff to maintain the seal ▪ A larger tracheostomy tube is

required to prevent an air leak at the stoma ▪ Food particles are seen in

tracheal secretions ▪ The client does not receive

the set tidal volume on the ventilator

▪ Monitor client; no special management is needed unless bleeding or airway problems occur

▪ Use an uncuffed tube as soon as possible ▪ Monitor cuff pressure and

air volume closely to detect changes

Tracheal stenosis: Narrowed tracheal lumen is the result of scar formation from irritation of tracheal mucosa by the cuff

▪ Stenosis is usually seen after the cuff is deflated or the tracheostomy tube is removed ▪ The client has increased

coughing, inability to expectorate secretions, or difficulty breathing and talking

▪ Tracheal dilation or surgical intervention is used

▪ Prevent pulling of and traction on the tracheostomy tube ▪ Properly secure the tube

in the midline position ▪ Maintain cuff pressure ▪ Minimize oronasal

intubation time

Tracheoesophageal fistula (TEF): Excessive cuff pressure causes erosion of the posterior wall of the trachea. A hole is created between the trachea and the anterior esophagus. The client at highest risk also has a nasogastric tube present

Similar to tracheomalacia: ▪ Food particles are seen in

tracheal secretions ▪ Increased air in cuff is

needed to achieve a seal ▪ The client has increased

coughing and choking while eating ▪ The client does not receive

the set tidal volume on the ventilator

▪ Suction; manually administer oxygen by mask to prevent hypoxemia ▪ Use a small soft feeding tube instead of a

nasogastric tube for tube feedings ▪ A gastrostomy or jejunostomy may be

performed ▪ Monitor the client with a nasogastric

tube closely; assess for TEF and aspiration

▪ Maintain cuff pressure ▪ Monitor the amount of

air needed for inflation to detect changes ▪ Progress to a deflated or

cuffless tube as soon as possible

Trachea–innominate artery fistula: A malpositioned tube causes its distal tip to push against the lateral wall of the trachea. Continued pressure causes necrosis and erosion of the innominate artery. This is a medical emergency

▪ The tracheostomy tube pulsates in synchrony with the heartbeat ▪ There is heavy bleeding from

the stoma ▪ This is a life-threatening

complication

▪ Remove the tracheostomy tube immediately ▪ Apply direct pressure to the innominate

artery at the stoma site ▪ Prepare the client for immediate repair

surgery

▪ Use the correct tube size and length, and maintain the tube in midline position ▪ Prevent pulling or tugging

of the tracheostomy tube ▪ Immediately notify the

health care provider (HCP) of a pulsating tube

Tube obstruction ▪ Difficulty breathing ▪ Noisy respirations ▪ Difficulty inserting the

suction catheter ▪ Thick, dry secretions ▪ Unexplained peak pressures

if client is on a mechanical ventilator

▪ The HCP repositions or replaces the tube if obstruction occurs as a result of cuff prolapse over the end of the tube

▪ Assist the client to cough and deep-breathe ▪ Provide humidification

and suctioning ▪ Clean the inner cannula

regularly

Tube dislodgment ▪ Difficulty breathing ▪ Noisy respirations ▪ Restlessness ▪ Excessive coughing ▪ Audible wheeze or stridor

▪ Be familiar with institutional policy regarding replacement of a tracheostomy tube as a nursing procedure ▪ During the first 72 hours following

surgical placement of the tracheostomy, the nurse manually ventilates the client by using a manual resuscitation (Ambu) bag while another nurse calls the Rapid Response Team for help

▪ Secure the tube in place ▪ Minimize manipulation of

and traction on the tube ▪ Ensure that the client

does not pull on the tube ▪ Ensure that a

tracheostomy tube of the same type and size is at the client’s bedside

248 UNIT IV Fundamentals of Care

F

u

n

d

a

m

e

n

t

a

l

s

B. Drain age collection ch am ber ( Fig. 20-6) 1. Th e drain age collection ch am b er is located

wh ere th e ch est tube from th e clien t con n ects to th e system .

2. Drain age fro m th e tube drain s in to an d collects in a series of calibrated co lum n s in th is ch am ber.

C. Water seal ch am b er (see Fig. 20-6) 1. Th e tip of th e tube is un d erwater, allowin g fluid

an d air to drain from th e pleural space an d pre- ven tin g air from en terin g th e pleural space.

2. Water oscillates (m oves up as th e clien t in h ales an d m oves down as th e clien t exh ales).

3. Excessive bubb lin g in dicates an air leak in th e ch est tube system .

D. Suction con trol ch am ber (see Fig. 20-6) 1. Th e suction con trol ch am b er provides th e suc-

tion , wh ich can be con trolled to provide n egative pressure to th e ch est.

2. Th is ch am b er is filled with various levels of water to ach ieve th e desired level of suction ; with ou t th is con trol, lu n g tissue could be sucked in to th e ch est tube.

3. Gen tle bubb lin g in th is ch am ber in dicates th at th ere is suction an d does n ot in dicate th at air is escapin g from th e pleural space.

E. Dry suction system (see Fig. 20-6) 1. Th is is an oth er type of ch est drain age system .

Because this is a dry suction system , absen ce of bubblin g is n oted in th e suction con trol ch am ber.

2. A kn ob on th e collection device is used to set th e prescribed am oun t of suction ; th en th e wall suction source dial is turn ed un til a sm all oran ge floater valve ap pears in th e win do w on th e device (wh en th e oran ge floater valve is in th e win dow, th e correct am oun t of suction is applied) .

Vis ce ra l ple ura

Air dra ina ge tube

Air dra ina ge tube

Lung

P le ura l s pa ce

Rib ca ge

Dia phra gm

Blood dra ina ge tube

Blood dra ina ge tube

Pa rie ta l ple ura

FIGURE 20-5 Chest tube placement.

TABLE 20-1 Complications of a Tracheostomy—cont’d Complication and Description Manifestations Management Prevention

▪ 72 hours following surgical placement of the tracheostomy: ▪ Extend the client’s neck and open the

tissues of the stoma to secure the airway ▪ Grasp the retention sutures (if they

are present) to spread the opening ▪ Use a tracheal dilator (curved clamp)

to hold the stoma open ▪ Prepare to insert a tracheostomy

tube; place the obturator into the tracheostomy tube, replace the tube, and remove the obturator ▪ Maintain ventilation by resuscitation

(Ambu) bag ▪ Assess airflow and bilateral breath

sounds ▪ If unable to secure an airway, call the

Rapid Response Team and the anesthesiologist

From Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 7, Philadelphia, 20 13, Saunders.

249CHAPTER 20 Care of a Client with a Tube

F. Portable ch est drain age system : Sm all an d portable ch est drain age system s are also available an d are dry system s th at use a con tro l flutter valve to preven t th e backflow of air in to th e clien t’s lu n g. Prin ciples of gravity an d pressure, an d th e n ursin g care in volved, are th e sam e for all types of system s, an d th ese sys- tem s allow greater am bulation an d allow th e clien t to go h om e with th e ch est tubes in place.

G. In terven tion s 1. Collection ch am b er

a . Mon itor drain age; n otify the HCP if drain age is m ore th an 70 to 100 m L/ h our or if drain - age becom es brigh t red or in creases sudden ly.

b . Mark th e ch est tube drain age in th e collec- tion ch am b er at 1- to 4-h our in tervals, usin g a piece of tap e.

2. Water seal ch am ber a . Mon itor for fluctuation of th e fluid level in

th e water seal ch am ber. b . Fluctuation in th e water seal ch am b er stops

if th e tube is obstru cted, if a depen den t lo op

exists, if th e suction is n ot workin g properly, or if th e lun g h as reexpan ded.

c. If th e clien t h as a kn own pn eum oth o rax, in term itten t bubblin g in th e water seal ch am b er is expected as air is drain ed from th e ch est, but con tin uous bubb lin g in dicates an air leak in th e system .

d . Notify th e HCP if th ere is con tin uo us bub- blin g in th e water seal ch am b er.

3. Suction con trol ch am b er: Gen tle (n ot vigorou s) bubblin g sh ould be n oted in th e suction con - trol ch am b er of a wet suction system .

4. An occlusive sterile dressin g is m ain tain ed at th e in sertio n site.

5. A chest radiograph assesses th e position of th e tube an d determ ines wheth er th e lung h as reexpan ded.

6. Assess respiratory status an d au scultate lun g soun ds. Assess ch est tube dressin g for drain age an d palpate surroun din g tissue for crepitus.

7. Mon itor for sign s of exten ded pn eum oth orax or h em oth orax.

8. Keep th e drain age system below th e level of th e ch est an d th e tubes free of kin ks, dep en den t loops, or oth er obstruction s.

9. En sure th at all con n ection s are secure. 10. En cou rage cough in g an d deep breath in g. 11. Ch an ge th e clien t’s position frequen tly to pro-

m ote drain age an d ven tilation . 12. Do n ot strip or m ilk a ch est tube un less specif-

ically directed to do so by th e HCP an d if agen cy policy allows it.

13. Keep a clam p (m ay be n eeded if th e system n eeds to be ch an ged) an d a sterile occlusive dressin g at th e bedside at all tim es.

14. Never clam p a ch est tube with ou t a written pre- scrip tion fro m th e HCP; also , determ in e agen cy policy for clam pin g a ch est tube.

15. If th e drain age system cracks or breaks, in sert th e ch est tube in to a bottle of sterile water, rem ove th e cracked or broken system , an d replace it with a n ew system .

16. Dep en d in g o n th e H CP’s p referen ce, wh en th e ch est tu b e is rem o ved , th e clien t m ay b e asked to take a d eep b reath an d h o ld it, an d th e tu b e is rem o ved . O r, th e clien t m ay b e asked to take a d eep b reath , exh ale, an d b ear d o wn ( Valsalva m an eu ver) . A d ry sterile d ressin g, p etro leu m gau ze d ressin g, o r Telfa d ressin g ( d ep en d in g o n th e H CP’s p referen ce) is tap ed in p lace after rem o val o f th e ch est tu b e.

If the chest tube is pulled out of the chest acci- dentally, pinch the skin opening together, apply an occlu- sive sterile dressing, cover the dressing with overlapping pieces of 2-inch (5 cm) tape, and call the HCP immediately.

F

u

n

d

a

m

e

n

t

a

l

s

Wa te r-fille d s uction control

cha mbe r

Wa te r s e a l cha mbe r

Colle ction cha mbe r

Wa te r s e a l cha mbe r

Colle ction cha mbe r

Dry s uction control

re gula tion

A

B FIGURE 20-6 Chest drainage system. A, Wet system. B, Dry system. (From Lewis et al., 2011. From Atrium Medical Corporation, Hudson, N.H.)

250 UNIT IV Fundamentals of Care

CRITICAL THINKING What Should You Do? Answer: If the nurse notes that the chest tube drainage system is cracked, the chest tube should be disconnected from the system and submerged in a bottle of sterile water in order to maintain the water seal. The system will then need to be replaced. A clamp should be kept at the bedside in case the system needs to be changed. However, the nurse should never clamp a chest tube without a written prescription from the health care provider and per agency policy. The drainage sys- tem (chest tube and bottle of sterile water) should also be maintained below the level of the chest if this complication occurs.

Reference: Ignatavicius, Workman, (2016), p. 579.

P R A C T I C E Q U E S T I O N S 191. Th e n urse is preparin g to adm in ister m ed ication

usin g a clien t’s n aso gastric tube. Wh ich action s sh o uld th e n urse take before adm in isterin g th e m ed ication ? Select all th at ap p ly.

1. Ch eck th e residual volum e. 2. Aspirate th e stom ach con ten ts. 3. Turn off th e suction to th e n asogastric tube. 4. Rem o ve th e tube an d place it in th e oth er

n ostril. 5. Test th e stom ach con ten ts for a pH in dicat-

in g acidity.

192. Th e n urse is preparin g to ad m in ister m ed ication th rough a n aso gastric tube th at is con n ected to suc- tion . To ad m in ister th e m edication , th e n urse sh ould take wh ich action ? 1. Position th e clien t supin e to assist in m ed ication

ab sorption . 2. Aspirate th e n asogastric tube after m ed ication

adm in istration to m ain tain paten cy. 3. Clam p th e n aso gastric tube for 30 to 60 m in u tes

followin g ad m in istration of th e m edication . 4. Ch an ge th e suction settin g to low in term itten t

suction for 30 m in u tes after m ed ication ad m in istration .

193. Th e n urse is assessin g for correct placem en t of a n asogastric tube. Th e n urse aspirates th e stom ach con ten ts, ch ecks th e gastric pH, an d n otes a pH of 7.35. Based on th is in form ation , wh ich action sh ould th e n urse take at th is tim e? 1. Retest th e pH usin g an oth er strip. 2. Docum en t th at th e n aso gastric tube is in th e

correct place. 3. Ch eck for placem en t by auscultatin g for air

in jected in to th e tube. 4. Call th e h ealth care provid er to request a pre-

scrip tion for a ch est radiograph .

194. Th e n urse carin g for a clien t with a ch est tube turn s th e clien t to th e side an d th e ch est tube acciden tally discon n ects from th e water seal ch am b er. Wh ich in itial action sh ould th e n urse take? 1. Call th e h ealth care provider (HCP) . 2. Place th e tube in a bottle of sterile water. 3. Replace th e ch est tube system im m ediately. 4. Place a sterile dressin g over th e discon n ection site.

195. Th e registered n urse is preparin g to in sert a n asogas- tric tube in an adult clien t. To determ in e th e accu- rate m easurem ent of th e len gth of the tube to be in serted, the n urse should take wh ich action ? 1. Mark th e tube at 10 in ch es (25.5 cm ). 2. Mark th e tube at 32 in ch es (81 cm ). 3. Place th e tube at th e tip of th e n ose an d m easure

by exten din g th e tube to th e earlo be an d th en down to th e xiph oid process.

4. Place th e tube at th e tip of th e n ose an d m easure by exten din g th e tube to th e earlo be an d th en down to th e top of th e stern um .

196. Th e n urse is assessin g th e fun ction in g of a ch est tube drain age system in a clien t who h as just return ed from the recovery room followin g a th oracotom y with wedge resection . Wh ich are th e expected assess- m en t fin din gs? Select all th at ap p ly.

1. Excessive bubb lin g in th e water seal ch am b er 2. Vigorous bubb lin g in th e suction con trol

ch am ber 3. Drain age system m ain tain ed below th e

clien t’s ch est 4. 50 m L of drain age in th e drain age collection

ch am b er 5. O cclusive dressin g in place over th e ch est

tube in sertio n site 6. Fluctuation of water in th e tube in th e

water seal ch am b er durin g in h alation an d exh alatio n

197. Th e n urse is assistin g a h ealth care provider with th e rem oval of a ch est tube. Th e n urse sh ould in struct th e clien t to take wh ich action ? 1. Stay very still. 2. Exh ale very quickly. 3. In h ale an d exh ale quickly. 4. Perform th e Valsalva m an euver.

198. Wh ile ch an gin g th e tapes on a n ewly in serted tra- ch eostom y tube, th e clien t cough s an d th e tube is dislodged. Wh ich is th e in itial n ursin g action ? 1. Call th e h ealth care provider to rein sert th e tube. 2. Grasp the retention sutures to spread the openin g. 3. Call th e respiratory th erap y departm en t to rein -

sert th e trach eotom y. 4. Cover th e trach eostom y site with a sterile dress-

in g to preven t in fectio n .

F

u

n

d

a

m

e

n

t

a

l

s

251CHAPTER 20 Care of a Client with a Tube

199. Th e n urse is carin g for a clien t im m ediately after rem oval of th e en dotrach eal tube. Th e n urse sh o uld report wh ich sign im m ed iately if exp eri- en ced by th e clien t? 1. Strid or 2. O ccasio n al pin k-tin ged sputum 3. Respiratory rate of 24 breath s/ m in ute 4. A few basilar lun g crackles on th e righ t

200. Th e n urse ch ecks for residual before adm in isterin g a bolus tube feed in g to a clien t with a n aso gastric tube an d obtain s a residual am oun t of 150 m L. Wh at is th e m o st ap p ro p riate action for th e n urse to take? 1. Ho ld th e feedin g an d rein still th e residual

am oun t. 2. Rein still th e am oun t an d con tin ue with adm in -

isterin g th e feedin g. 3. Elevate th e clien t’s h ead at least 45 degrees an d

adm in ister th e feedin g. 4. Discard th e residual am oun t an d proceed with

adm in isterin g th e feed in g.

201. Th e n urse carin g for a clien t with a pn eum oth orax an d wh o h as h ad a ch est tube in serted n otes con - tin uo us gen tle bubblin g in th e water seal ch am b er. Wh at action is m o st ap p ro p riate? 1. Do n oth in g, because th is is an exp ected fin din g. 2. Ch eck for an air leak, because th e bubblin g

sh o uld be in term itten t. 3. In crease th e suction pressure so th at th e bub-

blin g becom es vigorous. 4. Clam p th e ch est tube an d n otify th e h ealth care

provid er im m ediately.

202. Th e n urse is in sertin g a n aso gastric tube in an adult clien t. Durin g th e proced ure, th e clien t begin s to cough an d h as difficulty breath in g. Wh at is th e m o st ap p ro p riate action ? 1. In sert th e tube quickly. 2. No tify th e h ealth care provid er im m ediately. 3. Rem o ve th e tube an d rein sert it wh en th e respi-

ratory distress subsides. 4. Pull back on th e tube an d wait un til th e respira-

tory distress subsid es.

A N S W E R S 191. 1, 2, 3, 5 Ra tion a le: By asp iratin g sto m ach co n ten ts, th e residu al vo l- u m e can be d eterm in ed an d th e p H ch ecked . A p H less th an 3.5 verifies gastric placem en t. Th e suctio n sh o uld be turn ed o ff before th e tu b in g is discon n ected to ch eck fo r residu al vo l- u m e; in ad dition , su ctio n sh o uld rem ain o ff for 30 to 60 m in u tes fo llo win g m ed ication ad m in istration to allow fo r m edicatio n abso rp tio n . Th ere is n o n eed to rem ove th e tub e an d place it in th e o th er n o stril in order to ad m in ister a feed in g; in fact, th is is an in vasive procedu re an d is un n ecessary. Test-Ta kin g St r a tegy: Focu s on th e su b ject, in stillin g m edica- tio n in to th e n aso gastric tu b e, an d visu alize th e p rocedu re wh en an swerin g th is question . Read each option carefully an d elim in ate o ptio n 4 becau se it is n o t n ecessary an d is an in vasive procedu re. Review: Med ication ad m in istration via a n aso gastric tu b e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Skills Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 502, 786-788.

192. 3 Ra tion a le: If a clien t h as a n asogastric tu be con n ected to suc- tio n , th e n urse sh ou ld wait 30 to 60 m in utes befo re reco n n ect- in g th e tub e to th e suctio n ap p aratus to allo w ad eq uate tim e fo r m edicatio n abso rp tio n . Th e clien t sh ou ld n o t b e placed in th e su pin e p osition becau se o f th e risk fo r aspiratio n . Aspiratin g th e n aso gastric tu be will rem ove th e m edicatio n just adm in is- tered. Low in term itten t su ction also will rem o ve th e m edica- tio n ju st ad m in istered.

Test-Ta kin g Str a tegy: Elim in ate o ptio n s 2 an d 4 first b ecause th ese action s are co m p arab le o r alike an d will prod uce th e sam e effect o f rem ovin g m edicatio n ad m in istered . Th e clien t sh o u ld n o t b e placed in a su p in e po sitio n d ue to th e risk of reflux an d aspiration . Review: Med ication ad m in istration via a n aso gastric tu b e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Skills Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), pp . 501-502.

193. 4 Ra tion a le: If th e n asogastric tu b e is in th e sto m ach , th e p H of th e co n ten ts will b e acidic. Gastric aspirates h ave acidic p H valu es an d sh o uld b e 3.5 o r lower. A p H o f 7.35 in d icates a n eu- tral p H, wh ich m ay in dicate th at th e tub e is n o lo n ger in th e sto m ach . Based o n th is in fo rm atio n , th e n urse sh ou ld call th e h ealth care p ro vider to req uest a p rescrip tio n fo r a ch est radiograph to determ in e if placem en t is accu rate. Retestin g th e pH usin g an o th er strip is un n ecessary an d ch eckin g fo r p lacem en t b y auscu ltatin g fo r air in jected in to th e tu be is n o t a d efin itive m eth o d o f ch eckin g for tu be p lacem en t. Th e n u rse sh o uld n ot d o cu m en t th at th e tu be is in th e correct p lace b ecau se th e data in d icate th is m ay n o t be th e case. Test-Ta kin g Str a tegy: No te th e su b ject, verifyin g correct tub e p lacem en t. Recallin g th at gastric con ten ts are acid ic an d th e d efin itive m eth o ds of assessin g for accurate tu be placem en t will d irect you to th e correct op tio n . Review: Assessin g p lacem en t o f a n aso gastric tu b e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t

F

u

n

d

a

m

e

n

t

a

l

s

252 UNIT IV Fundamentals of Care

Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p . 784.

194. 2 Ra t ion a le: If th e ch est drain age system is disco n n ected , th e en d of th e tu be is p laced in a b o ttle o f sterile water h eld below th e level of th e ch est. Th e HCP m ay n eed to b e n otified, b ut th is is n ot th e in itial actio n . Th e system is replaced if it breaks o r cracks or if th e collectio n ch am b er is fu ll. Placin g a sterile dress- in g o ver th e d iscon n ection site will n o t preven t co m plicatio n s resultin g fro m th e discon n ection . Test -Ta kin g St r a t egy: No te th e strategic wo rd , initial. Th is in d icates th at a n u rsin g action is req uired th at will p reven t a serio u s com p lication as a result o f th e disco n n ectio n . Elim in ate op tion s 1 an d 3 b ecau se th ese actio n s d elay req uired an d im m ed iate in terven tio n . From th e rem ain in g o ptio n s, recallin g th e com plicatio n s th at can o ccu r fro m a d iscon n ection an d th e pu rp ose of a ch est tub e system will d irect yo u to o ption 2. Review: Nu rsin g actio n s related to ch est tu b e co m plicatio n s Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con tent Ar ea : Critical Care: Em ergen cy Situation s/ Man agem ent Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Perry, Potter, O sten do rf (2014), p . 665.

195. 3 Ra t ion a le: Measu rin g th e len gth of a n aso gastric tu b e n eeded is do n e by placin g th e tu be at th e tip o f th e clien t’s n o se an d exten d in g th e tub e to th e earlo be an d th en d own to th e xip h o id process. Th e average len gth fo r an adu lt is abo ut 22 to 26 in ch es (56 to 66 cm ) . Th e rem ain in g o ption s id en tify in correct proce- du res fo r m easurin g th e len gth o f th e tu be. Test -Ta kin g Str a tegy: Focus o n th e su b ject, in sertio n of a n asogastric tu b e, an d visu alize th is p ro cedu re. Elim in ate op tion s 1 an d 2 first b ecau se 10 in ch es (25.5 cm ) is sh o rt an d 32 in ch es (81 cm ) is to o lo n g. Also , rem em b er th e abb re- viation NEX, wh ich stan ds fo r n ose, earlo be, an d xip h o id pro- cess, to assist in an swerin g q uestion s sim ilar to th is on e. Review: Naso gastric tu b e in sertion p ro cedu re Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Fun dam en tals of Care—Skills Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry, Potter, O sten do rf (2014), p . 778.

196. 3, 4, 5, 6 Ra t ion a le: Th e bu bb lin g o f water in th e water seal ch am ber in d icates air d rain age from th e clien t an d u sually is seen wh en in trath oracic p ressu re is h igh er th an atm osp h eric p ressure, an d m ay occur d urin g exh alation , co ugh in g, o r sn eezin g. Excessive bu bb lin g in th e water seal ch am b er m ay in d icate an air leak, an un expected fin d in g. Fluctuatio n o f water in th e tub e in th e water seal ch am b er du rin g in h alation an d exh alatio n is expected . An absen ce of flu ctu atio n m ay in d icate th at th e ch est tu b e is ob stru cted or th at th e lun g h as reexpan d ed an d th at n o m o re air is leakin g in to th e p leural space. Gen tle (n o t vigorou s) bu bb lin g sh ou ld be n oted in th e su ction con tro l ch am ber. A

to tal o f 50 m L o f d rain age is n o t excessive in a clien t return in g to th e n ursin g un it from th e recovery roo m . Drain age th at is m o re th an 70 to 100 m L/ h o ur is con sidered excessive an d req uires n o tification o f th e h ealth care p ro vid er. Th e ch est tu be in sertion site is covered with an occlusive (airtigh t) dressin g to p reven t air from en terin g th e pleural space. Position in g th e d rain age system b elo w th e clien t’s ch est allows gravity to d rain th e pleural sp ace. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, exp ected fin d in gs asso ciated with ch est tu b e drain age system s. Th in kin g abo ut th e p h ysio logy associated with th e fun ctio n in g o f a ch est tu be d rain age system will assist in an swerin g th is q uestion . Th e words excessive bubbling an d vigorous bubbling will assist in elim - in atin g th ese assessm en t fin d in gs. Review: Ch est tu b es Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health / Resp irato ry Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Ign atavicius, Workm an (2016), p . 579.

197. 4 Ra t ion a le: Wh en th e ch est tub e is rem o ved , th e clien t is asked to perfo rm th e Valsalva m an euver (take a d eep breath , exh ale, an d b ear do wn ). Th e tu be is q uickly with drawn , an d an airtigh t d ressin g is tap ed in place. An altern ative in structio n is to ask th e clien t to take a deep breath an d h old th e breath wh ile th e tub e is rem oved . Test -Ta kin g St r a t egy: Focus on th e su b ject, rem oval o f a ch est tu b e. Elim in ate o ptio n s 2 an d 3 becau se th ey are co m p arab le o r alike. Next, visu alize th e procedu re, clien t in struction s, an d th e effect o f each of th e action s in th e op tio n s to an swer co rrectly. Review: Ch est tu b e rem o val Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health / Resp irato ry Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Perry, Po tter, O sten do rf (2014), p p. 669-670.

198. 2 Ra t ion a le: If th e tu be is d islo dged accid en tally, th e in itial n u rs- in g actio n is to grasp th e reten tio n sutu res an d sp read th e op en - in g. If agen cy po licy perm its, th e n u rse th en attem p ts to rep lace th e tu be im m ediately. Callin g an cillary services o r th e h ealth care p ro vid er will delay treatm en t in th is em ergen cy situatio n . Coverin g th e trach eo stom y site will b lo ck th e airway. Test -Ta kin g St r a t egy: No te th e strategic wo rd , initial. Elim i- n ate op tio n s 1 an d 3 first b ecau se th ey are co m p arab le o r alike an d will delay th e im m ediate in terven tio n n eed ed . Co verin g th e trach eo stom y o p en in g will blo ck th e airway. Review: Man agem en t o f com p lication s of trach eo sto m y Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Critical Care: Em ergen cy Situation s/ Man agem ent Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), p. 510.

F

u

n

d

a

m

e

n

t

a

l

s

253CHAPTER 20 Care of a Client with a Tube

199. 1 Ra tion a le: Fo llo win g rem oval o f th e en do trach eal tub e th e n u rse m on itors th e clien t fo r respirato ry distress. Th e n urse repo rts strido r to th e h ealth care p ro vid er (HCP) im m ed iately. Th is is a h igh -pitch ed , coarse so u n d th at is h eard with th e steth o scop e over th e trach ea. Strido r in dicates airway ed em a an d p laces th e clien t at risk fo r airway o bstructio n . Alth o u gh th e fin d in gs id en tified in th e rem ain in g o ptio n s req uire m o n - ito rin g, th ey d o n ot req uire im m ed iate n o tification of th e HCP. Test-Ta kin g Str a tegy: No te th e strategic wo rd , immediately. Recall th at th e prim ary con cern after rem o val o f an artificial air- way is th e clien t’s in ability to m ain tain a paten t airway an d b reath e in dep en d en tly. Becau se strid or in d icates laryn geal ed em a an d p o ssible airway o bstruction , it is th e sym pto m th at m ust b e repo rted im m ediately. Review: En d o trach eal tu b e rem oval Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Conten t Ar ea : Critical Care: Em ergen cy Situations/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 622.

200. 1 Ra tion a le: Un less sp ecifically in d icated , resid ual am ou n ts greater th an 100 m L requ ire h old in g th e feedin g, b ut th is is in divid u alized an d each agen cy’s p olicy sh o uld b e ch ecked. Th e residu al am ou n t sh o uld b e rein stilled un less it is greater th an 250 m L o r per agen cy p olicy. In ad d itio n , th e feedin g is n o t d iscarded u n less its co n ten ts are ab n orm al in colo r or ch aracteristics. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. No te th at th e residu al am ou n t is 150 m L. Also n ote th at o ptio n s 2, 3, an d 4 are co m p arab le o r alike an d in dicate ad m in isterin g th e feedin g. Review: Naso gastric tu b es Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Safety Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Perry, Po tter, O sten d o rf (2014), p p. 790, 792.

201. 2 Ra tion a le: Flu ctuation with in spiratio n an d expiration , n ot con tin u ou s bu bb lin g, sh o uld b e n o ted in th e water seal ch am - b er. In term itten t b ub blin g m ay b e n o ted if th e clien t h as a kn own pn eum o th o rax, b u t th is sh o uld decrease as tim e go es o n an d as th e p n eu m o th o rax begin s to reso lve. Th erefo re, th e n u rse sh ou ld ch eck for an air leak. If a wet ch est d rain age

system is u sed, b ub b lin g wou ld b e co n tin uo us in th e suction con tro l ch am ber an d n ot in term itten t. In a d ry system , th ere is n o bu bb lin g. In creasin g th e suction pressure on ly in creases th e rate o f evap oration of water in th e d rain age system ; in ad di- tio n , in creasin g th e suctio n can b e h arm fu l an d is n o t do n e with out a specific prescription to do so if usin g a wet system . Dry system s will allo w for o n ly a certain am o un t o f suction to b e app lied ; an o ran ge b ello w will ap pear in th e su ctio n win - d ow, in dicatin g th at th e p ro p er am ou n t o f su ction h as b een app lied. Ch est tub es sh o uld be clam p ed on ly with a h ealth care p ro vider’s p rescrip tion . Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Th in k ab ou t th e p h ysio lo gy asso ciated with each ch am b er o f th e ch est tub e d rain age system . Rem em ber th at co n tin uo us gen tle bu b blin g in th e suctio n co n trol ch am b er is exp ected if a wet system is used, b ut th is fin d in g is n o t n o rm al in th e water seal ch am ber. Review: Exp ected assessm en t fin din gs asso ciated with ch est tu b es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health / Respiratory Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), p . 546.

202. 4 Ra tion a le: Durin g th e in sertion of a n aso gastric tub e, if th e cli- en t experien ces d ifficulty breath in g o r an y respiratory d istress, with draw th e tube sligh tly, stop th e tube advan cem en t, an d wait un til th e distress subsides. It is n ot n ecessary to n otify th e h ealth care provid er im m ed iately or rem o ve th e tub e com pletely. Q u ickly in sertin g th e tub e is n ot an ap prop riate action becau se, in th is situatio n , it is likely th at th e tub e h as en tered th e b ron ch u s. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Elim in ate op tio n 1 b ecau se of th e word quickly. Visu alizin g th e p ro ced ure an d an ticip atin g po ten tial co m plicatio n s will assist in elim in atin g op tio n s 2 an d 3 as n ecessary actio n s at th is tim e. If a clien t h as resp irato ry d istress, th e tub e h as en tered th e b ro n ch us an d in sertio n sh ou ld n o t b e co n tin ued . It is n ot n ec- essary to rem o ve th e tub e co m p letely at th is tim e. Review: Naso gastric tu b es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Skills Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry, Po tter, O sten d orf (2014), p. 780.

F

u

n

d

a

m

e

n

t

a

l

s

254 UNIT IV Fundamentals of Care

UNIT V

Growth and Development Across the Life Span

Pyramid to Success

Norm al growth an d developm en t proceed in an orderly, system atic, an d predictable pattern , wh ich provides a basis for iden tifyin g an d assessin g an in dividual’s abili- ties. Un derstan din g th e n orm al path of growth an d developm en t across th e life span assists th e n urse in iden tifyin g ap propriate an d expected h um an beh avior. Th e Pyram id to Success focuses on Sigm un d Freud’s th e- ory of psych osexual developm en t, Jean Piaget’s th eory of cogn itive developm en t, Erik Erikson ’s psych o social th e- ory, an d Lawren ce Koh lberg’s th eory of m oral develop- m en t. Gro wth an d developm en t con cepts also focus on th e agin g process; an d on ph ysical ch aracteristics, n utrition al beh aviors, skills, play, an d specific safety m easu res relevan t to a particular age grou p th at will en sure a safe an d h azard-free en viron m en t. Wh en a question is presen ted on th e NCLEX-RN ® exam in ation , if an age is iden tified in th e question , n ote th e age an d th in k about th e associated growth an d develo pm en tal con cepts to an swer th e question correctly.

Client Needs: Learning Objectives Safe and Effective Care Environment Actin g as a clien t advo cate Com m un icatin g with th e in terp rofession al h ealth

care team En surin g h om e safety an d security plan s En surin g th at in form ed con sen t h as been obtain ed for

in vasive treatm en ts or proced ures Establish in g priorities of care Main tain in g con fiden tiality

Preven tin g acciden ts an d errors Providin g care in acco rdan ce with eth ical an d legal

stan dard s Providin g care usin g a n on judgm en tal approach Respectin g clien t an d fam ily n eeds, based on th eir

preferen ces Im plem en tin g stan dard precaution s an d oth er

tran sm ission -b ased precaution s as appropriate Uph oldin g th e clien t’s righ ts

Health Promotion and Maintenance Discussin g h igh -risk beh aviors an d lifestyle ch oices Iden tifyin g ch an ges th at occur as a result of th e agin g

process Iden tifyin g developm en tal stages an d tran sition s Main tain in g h ealth an d welln ess an d self-care

m easu res Mon itorin g growth an d developm en t Perform in g th e n ecessary h ealth an d ph ysical assess-

m en t tech n iqu es Providin g clien t an d fam ily education Respectin g h ealth care beliefs an d preferen ces

Psychosocial Integrity Assessin g for abuse an d n eglect Con siderin g grief an d lo ss issues an d en d-of-life care Iden tifyin g copin g m ech an ism s Iden tifyin g cultural practices an d beliefs of th e clien t an d

appropriate support system s Iden tifyin g loss of quan tity an d quality of relation sh ips

with th e older clien t Mon itorin g for adju stm en t to poten tial deterioration in

ph ysical an d m en tal h ealth an d well-bein g in th e older clien t

F

u

n

d

a

m

e

n

t

a

l

s

255

Mon itorin g for ch an ges an d adjustm en t in role fun ction in th e older clien t (th reat to in depen dent fun ction in g)

Mon itorin g for sen sory an d perceptual alteration s Provid in g resources for th e clien t an d fam ily

Physiological Integrity Adm in isterin g m ed ication safely an d teach in g th e clien t

about prescribed m ed ication s

Iden tifyin g practices or restriction s related to procedures an d treatm en ts

Mon itorin g for alteration s in body system s an d th e related risks associated with th e clien t’s age

Providin g basic care an d co m fort n eeds Providin g in terven tion s com patible with th e clien t’s age;

cultural, spiritual, religious, an d h ealth care beliefs; education level; an d lan guage

256 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 21 Theories of Growth and Development

PRIORITY CONCEPT Development, Health Promotion

CRITICAL THINKING What Should You Do? The mother of a 4-year-old child calls the clinic nurse and expresses concern because the child has been masturbating. Using Freud’s psychosexual stages of development, what should the nurse do to alleviate the mother’s concerns? Answer located on p. 261.

I. Psychosocial Development: Erik Erikson A. Th e th eory

1. Erikson ’s th eory of psych osocial developm en t describes th e h um an life cycle as a series of 8 ego developm en tal stages from birth to death .

2. Each stage presen ts a psych o social crisis, th e goal of wh ich is to in tegrate ph ysical, m aturation , an d societal dem an ds.

3. Th e result of 1 stage m ay n ot be perm an en t, but can be ch an ged by experien ce(s) later in life.

4. Th e th eory focuses on psych osocial tasks th at are acco m plish ed th rou gh out th e life cycle.

B. Psych o social develo pm en t: O ccurs th rou gh a life- lon g series of crises affected by social an d cultural facto rs

According to Erikson’s theory of psychosocial development, each psychosocial crisis must be resolved for the child or adult to progress emotionally. Unsuc- cessful resolution can leave the person emotionally disabled.

C. Stages of psych osocial developm en t (Table 21-1) D. In terven tion s to assist th e clien t in ach ievin g

Erikson ’s stages of developm en t (Box 21-1)

II. Cognitive Development: Jean Piaget A. Th e th eory

1. Piaget’s th eory of cogn itive develo pm en t defin es cogn itive acts as ways in wh ich th e m in d orga- n izes an d adapts to its en viron m en t (i.e., “m en - tal m appin g”).

2. Sch em a refers to an in dividual’s cogn itive struc- ture or fram ework of th ough t.

3. Sch em ata a. Sch em ata are categories th at an in dividual

form s in h is or h er m in d to organ ize an d un derstan d th e world .

b . A youn g ch ild h as on ly a few sch em ata with wh ich to un d erstan d th e world, an d gradually th ese are in creased.

c. Adults use a wide variety of sch em ata to un derstan d th e world .

4. Assim ilation a. Assim ilation is th e ability to in corporate n ew

ideas, objects, an d exp erien ces in to th e fram e- work of on e’s th ough ts.

b . Th e growin g ch ild will perceive an d give m ean in g to n ew in form ation acco rdin g to wh at is already kn own an d un dersto od.

5. Accom m odation a. Accom m odation is th e ability to ch an ge a

sch em a to in troduce n ew ideas, objects, or experien ces.

b . Accom m odation ch an ges th e m en tal struc- ture so th at n ew experien ces can be added.

B. Stages of cogn itive developm en t 1. Sen sorim otor stage

a. Birth to 2 years b . Developm en t proceeds from reflex activity to

im agin in g an d solvin g problem s th rough th e sen ses an d m ovem en t.

c. Th e in fan t or todd ler learn s about reality an d h ow it works.

d . Th e in fan t or todd ler does n ot recogn ize th at objects con tin ue to be in existen ce, even if out of th e visual field.

2. Preop eration al stage a. 2 to 7 years b . Th e ch ild learn s to th in k in term s of past, pre-

sen t, an d future. c. Th e ch ild m oves from kn owin g th e world

through sen sation an d m ovem en t to prelogical thin kin g an d fin din g solution s to problem s.

F

u

n

d

a

m

e

n

t

a

l

s

257

TABLE 21-1 Erik Erikson’s Stages of Psychosocial Development Resolution of Crisis

Age Psychosocial Crisis Task Successful Unsuccessful

Infancy (birth to 18 mo)

Trust versus mistrust Attachment to the mother

Trust in persons; faith and hope about the environment and future

General difficulties relating to persons effectively; suspicion; trust-fear conflict, fear of the future

Early childhood (18 mo to 3 yr)

Autonomy versus shame and doubt

Gaining some basic control over self and environment

Sense of self-control and adequacy; willpower

Independence-fear conflict; severe feelings of self-doubt

Late childhood (3-6 yr)

Initiative versus guilt Becoming purposeful and directive

Ability to initiate one’s own activities; sense of purpose

Aggression-fear conflict; sense of inadequacy or guilt

School age (6-12 yr)

Industry versus inferiority

Developing social, physical, and learning skills

Competence; ability to learn and work

Sense of inferiority; difficulty learning and working

Adolescence (12-20 yr)

Identity versus role confusion

Developing sense of identity

Sense of personal identity Confusion about who one is; identity submerged in relationships or group memberships

Early adulthood (20-35 yr)

Intimacy versus isolation

Establishing intimate bonds of love and friendship

Ability to love deeply and commit oneself

Emotional isolation, egocentricity

Middle adulthood (35-65 yr)

Generativity versus stagnation

Fulfilling life goals that involve family, career, and society

Ability to give and care for others

Self-absorption; inability to grow as a person

Later adulthood (65 yr to death)

Integrity versus despair

Looking back over one’s life and accepting its meaning

Sense of integrity and fulfillment

Dissatisfaction with life

Modified from Varcarolis E: Foundations of psychiatric mental health nursing, ed 6, St. Louis, 2010 , Saunders.

BOX 21-1 Interventions to Assist the Client in Achieving Erikson’s Stages of Development Infancy Hold the infant often Offer comfort after painful procedures Meet the infant’s needs for food and hygiene Encourage parents to room in while hospitalized

Early Childhood Allow self-feeding opportunities Encourage child to remove and put on own clothes Allow for choice

Late Childhood Offer medical equipment for play Accept the child’s choices and expressions of feelings

School Age Encourage the child to continue schoolwork while hospi-

talized Encourage the child to bring favorite pastimes to the hospital

Adolescence Take the health history and perform examinations without par-

ents present Introduce the adolescent to other teens with the same health

condition

Early Adulthood Include support from client’s partner or significant other Assist with rehabilitation and contacting support services as

needed before returning to work

Middle Adulthood Assist in choosing creative ways to foster social development Encourage volunteer activities

Later Adulthood Listen attentively to reminiscent stories about his or her life’s

accomplishments Assist with making changes to living arrangements

258 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

d . Th e ch ild is egocen tric. e. Th e ch ild is un ab le to con ceptualize an d

requires con crete exam ples. 3. Con crete operation al

a. 7 to 11 years b . Th e ch ild is able to classify, order, an d

sort facts. c. Th e ch ild m oves from prelogical th o ugh t to

solvin g con crete problem s th rough logic. d . Th e ch ild begin s to develop abstract th in kin g.

4. Form al operation s a. 11 years to ad ulth ood b Th e person is able to th in k abstractly an d

lo gically. c. Logical th in kin g is expan d ed to in clude solv-

in g ab stract an d con crete problem s.

III. Moral Development: Lawrence Kohlberg A. Moral develo pm en t

1. Moral develo pm en t is a com plicated process in volvin g th e acceptan ce of th e values an d ru les of society in a way th at sh ap es beh avior.

2. Moral develo pm en t is classified in a series of levels an d beh aviors.

3. Moral develo pm en t is sequen tial but people do n ot autom atically go fro m 1 stage or level to th e n ext as th ey m ature.

4. Stages or levels of m oral developm en t can n ot be skipp ed.

B. Levels of m oral develo pm en t (Box 21-2)

IV. Psychosexual Development: Sigmund Freud A. Com p on en ts of th e th eory ( Box 21-3) B. Levels of awaren ess

1. Un con scio us level of awaren ess a. Th e un con scious is n ot logical an d is gov-

ern ed by th e Pleasure Prin ciple, wh ich refers to seekin g im m ediate ten sion reduction .

b . Mem ories, feelin gs, th ough ts, or wish es are repressed an d are n ot available to th e con scious m in d.

c. Th ese repressed m em ories, th ough ts, or feel- in gs, if m ade prem atu rely con scious, can cau se an xiety.

2. Precon scious level of awaren ess a. Th e precon scious is called th e subconscious. b . Th e precon scious in cludes experien ces,

th o ugh ts, feelin gs, or desires th at m igh t n ot be in im m ediate awaren ess but can be recalled to con sciousn ess.

c. Th e subcon scious can h elp to repress un p leasan t th o ugh ts or feelin gs an d can exam in e an d cen sor certain wish es an d th in kin g.

3. Con scious level of awaren ess a. Th e con scio us m in d is logical an d is regulated

by th e Reality Prin ciple.

b . Con sciousn ess in cludes all exp erien ces th at are with in an in dividual’s awaren ess an d th at th e in dividual is ab le to con tro l, an d in cludes all in form ation th at is rem em bered easily an d is im m ediately available to an in dividual.

C. Agen cies of th e m in d : Id, ego, an d superego

The id, ego, and superego are the 3 systems of per- sonality. These psychological processes follow different operating principles. In a mature and well-adjusted per- sonality, they work together as a team under the leader- ship of the ego.

1. Th e id a. Source of all drives, presen t at birth , operates

acco rdin g to th e Pleasure Prin ciple b . Do es n ot tolerate un co m fortable states an d

seeks to disch arge th e ten sion an d return to a m ore com fo rtable, con stan t level of en ergy

c. Acts im m ediately in an im pulsive, irration al way an d pays n o atten tion to th e con se- quen ces of its action s; th erefore, often beh aves in ways h arm ful to self an d oth ers

d . Th e prim ary process is a psych ological activity in wh ich th e id attem p ts to reduce ten sion .

e. Th e prim ary process by itself is n ot capable of reducin g ten sion ; th erefore, a secon dary psy- ch ological process m ust develop if th e in di- vidu al is to survive. Wh en th is occurs, th e structure of th e secon d system of th e perso n - ality, th e ego, begin s to take form .

2. Th e ego a. Fun ction s in clude reality testin g an d problem

solvin g; follows th e Reality Prin ciple b . Begin s its developm en t durin g th e fourth or

fifth m on th of life c. Em erges out of th e id an d acts as an in term e-

diary between th e id an d th e extern al world d . Em erges because th e n eeds, wish es, an d

dem an ds of th e id require appropriate exch an ges with th e outside world of reality

e. Th e ego distin guish es between th in gs in th e m in d an d th in gs in th e extern al world.

3. Th e superego a. Necessary part of socialization th at develops

durin g th e ph allic stage at 3 to 6 years of age b . Develops from in teraction s with th e ch ild’s

paren ts durin g th e exten ded period of ch ild- h ood depen den cy

c. In cludes in tern alization of th e values, ideals, an d m oral stan d ards of paren ts an d society

d . Superego con sists of th e con scien ce an d th e ego ideal.

e. Con scien ce refers to capacity for self- evaluation an d criticism ; wh en m oral codes are violated , th e con scien ce pun ish es th e in dividual by in stillin g guilt.

259CHAPTER 21 Theories of Growth and Development

F

u

n

d

a

m

e

n

t

a

l

s

D. An xiety an d defen se m ech an ism s 1. Th e ego develops defen ses or defen se m ech a-

n ism s to figh t off an xiety. 2. Defen se m ech an ism s operate on an un co n scious

level, except for suppressio n , so th e in dividual is n ot aware of th eir operation .

3. Defen se m ech an ism s den y, falsify, or distort real- ity to m ake it less th reaten in g.

BOX 21-2 Moral Development: Lawrence Kohlberg Level One: Preconventional Morality Sta ge 0 (Birth t o 2 Yea rs): Egocent ric Judgment The infant has no awareness of right or wrong.

Sta ge 1(2 to 4 Years): Punishment -Obedience Orient at ion At this stage, children cannot reason as mature members ofsociety. Children view the world in a selfish way, with no real under-

standing of right or wrong. The child obeys rules and demonstrates acceptable behavior to

avoid punishment and to avoid displeasing those who are in power, and because the child fears punishment from a supe- rior force, such as a parent.

A toddler typically is at the first substage of the preconventional stage, involving punishment and obedience orientation, in which the toddler makes judgments based on avoiding pun- ishment or obtaining a reward.

Physical punishment and withholding privileges tend to give the toddler a negative view of morals.

Withdrawing love and affection as punishment leads to feelings of guilt in the toddler.

Appropriate discipline includes providing simple explanations of why certain behaviors are unacceptable, praising appro- priate behavior, and using distractions when the toddler is headed for an unsafe action.

Sta ge 2 (4 t o 7 Years): Instrument al Rela tivist Orienta t ion The child conforms to rules to obtain rewards or have favors

returned. The child’s moral standards are those of others, and the child

observes them either to avoid punishment or obtain rewards. A preschooler is in the preconventional stage of moral

development. In this stage, conscience emerges and the emphasis is on exter-

nal control.

Level Two: Conventional Morality The child conforms to rules to please others. The child has increased awareness of others’ feelings. A concern for social order begins to emerge. A child views good behavior as that which those in authority will

approve. If the behavior is not acceptable, the child feels guilty.

Sta ge 3 (7 t o 10 Yea rs): Good Boy or Nice Girl Orienta t ion Conformity occurs to avoid disapproval or dislike by others.

This stage involves living up to what is expected by individuals close to the child or what individuals generally expect of others in their roles such as daughter, son, brother, sister, and friend.

Being good is important and is interpreted as having good motives and showing concern about others.

Being good also means maintaining mutual relationships, such as trust, loyalty, respect, and gratitude.

Sta ge 4 (10 to 12 Years): La w a nd Order Orient at ion The child has more concern with society as a whole. Emphasis is on obeying laws to maintain social order. Moral reasoning develops as the child shifts the focus of living

to society. The school-age child is at the conventional level of the confor-

mity stage and has an increased desire to please others. The child observes and to some extent internalizes the stan-

dards of others. The child wants to be considered “good” by those individuals

whose opinions matter to her or him.

Level Three: Postconventional Morality The individual focuses on individual rights and principles of

conscience. The focus is on concerns regarding what is best for all.

Sta ge 5: Socia l Cont ract a nd Legalistic Orient at ion The person is aware that others hold a variety of values and

opinions and that most values and rules are relative to the group.

The adolescent in this stage gives and takes and does not expect to get something without paying for it.

Sta ge 6: Universal Et hica l Principles Orient at ion Conformity is based on universal principles of justice and

occurs to avoid self-condemnation. This stage involves following self-chosen ethical principles. The development of the postconventional level of morality

occurs in the adolescent at about age 13 years, marked by the development of an individual conscience and a defined set of moral values.

The adolescent can now acknowledge a conflict between 2 socially accepted standards and try to decide between them.

Control of conduct is now internal in standards observed and in reasoning about right and wrong.

BOX 21-3 Components of Sigmund Freud’s Psychosexual Development Theory

▪ Levels of awareness ▪ Agencies of the mind (id, ego, superego) ▪ Concept of anxiety and defense mechanisms ▪ Psychosexual stages of development

260 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

4. An in dividual can n ot survive with out defen se m ech an ism s; h owever, if the in dividual becom es too extrem e in distortin g reality, in terferen ce with h ealth y adjustm en t an d person al growth m ay occur.

E. Psych o sexual stages of developm en t ( Box 21-4) 1. Hu m an develo pm en t proceeds th rou gh a series

of stages from in fan cy to ad ulth ood. 2. Each stage is ch aracterized by th e in born ten -

den cy of all in dividuals to reduce ten sion an d seek pleasure.

3. Each stage is associated with a particular con flict th at m ust be resolved befo re th e ch ild can m ove successfully to th e n ext stage.

4. Experien ces durin g th e early stages determ in e an in dividual’s adju stm en t pattern s an d th e perso n - ality traits th at th e in dividual h as as an adult.

CRITICAL THINKING What Should You Do? Answer: According to Freud’s psychosexual stages of devel- opment, between the ages of 3 and 6 the child is in the phallic stage. At this time, the child devotes much energyto examining genitalia, masturbating, and expressing interest in sexual con- cerns. Therefore, the nurse should alleviate the mother’s con- cern by telling the mother that this behavior is normal.

Reference: Hockenberry, Wilson (20 15), pp. 525, 570–571.

P R A C T I C E Q U E S T I O N S 203. Th e clin ic n urse is preparin g to exp lain th e con -

cepts of Koh lb erg’s th eory of m oral developm en t with a paren t. Th e n urse sh ould tell th e paren t th at wh ich factor m otivates go od an d bad action s for th e ch ild at th e precon ven tion al level? 1. Peer pressure 2. Social pressure 3. Paren ts’ beh avio r 4. Pun ish m en t an d reward

204. Th e m atern ity n urse is providin g in struction s to a n ew m oth er regardin g th e psych osocial develop- m en t of th e n ewborn in fan t. Usin g Erikson ’s psy- ch osocial develo pm en t th eory, th e n urse in structs th e m oth er to take wh ich m easu re? 1. Allow th e n ewborn in fan t to sign al a n eed. 2. An ticipate all n eeds of th e n ewborn in fan t. 3. Atten d to th e n ewborn in fan t im m ediately

wh en cryin g. 4. Avoid th e n ewborn in fan t durin g th e first

10 m in u tes of cryin g.

205. Th e n urse n otes th at a 6-year-old ch ild does n ot recogn ize th at objects exist even wh en th e objects are outside of th e visual field. Based on th is observation , wh ich action sh ould th e n urse take?

BOX 21-4 Freud’s Psychosexual Stages of Development Oral Stage (Birth to 1 Year) During this stage, the infant is concerned with self-gratification. The infant is all id, operating on the Pleasure Principle and striv-

ing for immediate gratification of needs. When the infant experiences gratification of basic needs, a

sense of trust and security begins. The ego begins to emerge as the infant begins to see self as sep-

arate from the mother; this marks the beginning of the devel- opment of a sense of self.

Anal Stage (1 to 3 Years) Toilet training occurs during this period, and the child gains

pleasure from the elimination of the feces and from their retention.

The conflict of this stage is between those demands from soci- ety and the parents and the sensations of pleasure associ- ated with the anus.

The child begins to gain a sense of control over instinctive drives and learns to delay immediate gratification to gain a future goal.

Phallic Stage (3 to 6 Years) The child experiences pleasurable and conflicting feelings asso-

ciated with the genital organs. The pleasures of masturbation and the fantasy life of children

set the stage for the Oedipus complex.

The child’s unconscious sexual attraction to and wish to pos- sess the parent of the opposite sex, the hostility and desire to remove the parent of the same sex, and the subsequent guilt about these wishes is the conflict the child faces.

The conflict is resolved when the child identifies with the parent of the same sex.

The emergence of the superego is the solution to and the result of these intense impulses.

Latency Stage (6 to 12 Years) The latency stage is a tapering off of conscious biological and

sexual urges. The sexual impulses are channeled and elevated into a more

culturally accepted level of activity. Growth of ego functions and the ability to care about and relate

to others outside the home is the task of this stage of development.

Genital Stage (12 Years and Beyond) The genital stage emerges at adolescence with the onset of

puberty, when the genital organs mature. The individual gains gratification from his or her own body. During this stage, the individual develops satisfying sexual and

emotional relationships with members of the opposite sex. The individual plans life goals and gains a strong sense of per-

sonal identity.

261CHAPTER 21 Theories of Growth and Development

F

u

n

d

a

m

e

n

t

a

l

s

1. Repo rt th e observation to th e h ealth care provider.

2. Move th e objects in th e ch ild’s direct field of vision .

3. Teach th e ch ild h ow to visu ally scan th e en viron m en t.

4. Provid e addition al ligh tin g for th e ch ild durin g play activities.

206. A n ursin g studen t is presen tin g a clin ical co n fer- en ce to peers regardin g Freud’s psych osexual stages of developm en t, specifically th e an al stage. Th e stu- den t explain s to th e group th at wh ich ch aracteristic relates to th is stage of developm en t? 1. Th is stage is associated with toilet train in g. 2. Th is stage is ch aracterized by th e gratification

of self. 3. Th is stage is ch aracterized by a taperin g off of

con scio us biological an d sexual urges. 4. Th is stage is associated with pleasurable an d

con flictin g feelin gs ab out th e gen ital organ s.

207. Th e n urse is describin g Piaget’s cogn itive develop- m en tal th eory to pediatric n ursin g staff. Th e n urse sh o uld tell th at staff th at wh ich ch ild beh avior is ch aracteristic of th e form al operation s stage? 1. Th e ch ild h as th e ability to th in k abstractly. 2. Th e ch ild begin s to un d erstan d th e en viron -

m en t. 3. Th e ch ild is able to classify, order, an d sort facts. 4. Th e ch ild learn s to th in k in term s of past, pre-

sen t, an d future.

208. Th e m oth er of an 8-year-o ld ch ild tells th e clin ic n urse th at sh e is con cern ed about th e ch ild because th e ch ild seem s to be m ore atten tive to frien ds th an an yth in g else. Usin g Erikson ’s psych osocial devel- opm en t th eory, th e n urse sh ould m ake wh ich respo n se? 1. “You n eed to be con cern ed.” 2. “You n eed to m on itor th e ch ild’s beh avior

closely.”

3. “At th is age, th e ch ild is develo pin g h is own perso n ality.”

4. “You n eed to provide m ore praise to th e ch ild to stop th is beh avior.”

209. Th e n urse educator is preparin g to con duct a teach - in g session for th e n ursin g staff regardin g th e th e- ories of growth an d developm en t an d plan s to discuss Koh lberg’s th eory of m oral developm en t. Wh at in form ation sh ould th e n urse in clude in th e session ? Select all th at ap p ly.

1. In divid uals m ove th rou gh all 6 stages in a sequen tial fash ion .

2. Moral developm en t progresses in relation - sh ip to cogn itive developm en t.

3. A perso n ’s ab ility to m ake m oral jud gm en ts develops over a period of tim e.

4. Th e th eory provid es a fram ework for un der- stan din g h ow in dividuals determ in e a m oral code to guide th eir beh avior.

5. In stage 1 (pu n ish m en t-obedien ce orien ta- tio n ), ch ildren are expected to reason as m ature m em bers of society.

6. In stage 2 (in strum en tal-relativist orien ta- tio n ), th e ch ild con form s to rules to obtain rewards or h ave favors return ed.

210. A paren t of a 3-year-old tells a clin ic n urse th at th e ch ild is rebellin g con stan tly an d h avin g tem per tan trum s. Usin g Erikson ’s psych osocial developm en t th eory, wh ich in struction s sh ould th e n urse provide to th e paren t? Select all th at ap p ly.

1. Set lim its on th e ch ild’s beh avior. 2. Ign o re th e ch ild wh en th is beh avio r occurs. 3. Allow th e beh avior, because th is is n orm al at

th is age period. 4. Provide a sim ple exp lan ation of wh y th e

beh avio r is un acceptable. 5. Pun ish th e ch ild every tim e th e ch ild says

“n o ” to ch an ge th e beh avior.

A N S W E R S 203. 4 Ra tion a le: In th e p reco n ven tion al stage, m orals are th ou gh t to b e m otivated by p un ish m en t an d reward . If th e ch ild is ob ed i- en t an d is n ot pu n ish ed, th en th e ch ild is bein g m o ral. Th e ch ild sees actio n s as goo d o r b ad . If th e ch ild’s action s are go o d, th e ch ild is praised. If th e ch ild ’s actio n s are b ad, th e ch ild is p un ish ed . O p tion s 1, 2, an d 3 are n o t asso ciated facto rs fo r th is stage o f m o ral d evelo pm en t. Test-Ta kin g Str a tegy: Elim in ate o ptio n s 1 an d 2; th ey are co m p arab le o r alike because peer p ressu re is th e sam e as social p ressu re. To select fro m th e rem ain in g o ptio n s, recallin g th at

th e p recon ven tio n al stage occurs b etween b irth an d 7 years will assist in directin g yo u to th e correct o ptio n . Review: Ko h lb erg’s th eo ry o f m o ral d evelo p m en t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo p m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Clien t Ed ucation ; Develop m en t Refer en ce: Hocken b erry, Wilso n (2015), p. 575.

204. 1 Ra tion a le: Acco rd in g to Erikso n , th e caregiver sh ou ld n ot try to an ticip ate th e n ewbo rn in fan t’s n eeds at all tim es b ut m u st

262 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

allow th e n ewbo rn in fan t to sign al n eed s. If a n ewbo rn in fan t is n ot allo wed to sign al a n eed, th e n ewb orn will n o t learn h o w to co n tro l th e en viron m en t. Erikson believed th at a d elayed o r prolo n ged resp on se to a n ewbo rn in fan t’s sign al wo uld in h ibit th e develop m en t of tru st an d lead to m istru st o f o th ers. Test -Ta kin g St r a t egy: Elim in ate o p tion s 2, 3, an d 4 because o f th e clo sed -en d ed wo rd s, all, immediately, an d avoid, in th ese op tion s. Review: Erikso n ’s stage o f p sych o so cial d evelo p m en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develo pm en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Clien t Edu catio n ; Develo p m en t Refer en ce: Ho cken berry, Wilson (2015), p . 420.

205. 1 Ra t ion a le: Acco rd in g to Jean Piaget’s th eo ry o f co gn itive devel- op m en t, it is n orm al fo r th e in fan t o r to d dler n ot to reco gn ize th at ob jects co n tin ue to be in existen ce, even if ou t of th e visu al field ; h owever, th is is abn orm al fo r th e 6-year-o ld . If a 6-year- old ch ild d o es n o t reco gn ize th at o bjects still exist even wh en ou tside th e visu al field , th e ch ild is n ot p ro gressin g n orm ally th ro ugh th e d evelop m en tal stages. Th e n u rse sh o uld repo rt th is fin d in g to th e h ealth care p ro vider. O p tion s 2, 3, an d 4 delay n ecessary follow-up an d treatm en t. Test -Ta kin g Str a tegy: Fo cu s o n th e d ata in th e q u estio n . Also, n ote th e age of th e ch ild an d th in k abo u t develop m en tal co n - cep ts related to th is age. No tin g th at th e ch ild is n ot ab le to rec- ogn ize th at o bjects co n tin u e to b e in existen ce, even if ou t o f th e visu al field, will d irect yo u to th e correct op tio n . Also , n o te th at o p tion s 2, 3, an d 4 are co m p arab le o r alike an d are in ter- ven tio n s th at will delay follow-up fo r an ab n o rm al ob servatio n . Review: Jean Piaget’s th eo ry o f co gn itive d evelo p m en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Develo pm en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Clin ical Jud gm en t; Develop m en t Refer en ce: Ho cken berry, Wilson (2015), p p. 525–526, 573.

206. 1 Ra t ion a le: In gen eral, toilet train in g o ccu rs d urin g th e an al stage. Acco rd in g to Freud , th e ch ild gain s pleasure fro m th e elim in atio n o f feces an d from th eir reten tion . O ptio n 2 relates to th e o ral stage. O p tion 3 relates to th e laten cy p eriod . O ptio n 4 relates to th e p h allic stage. Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e an al stage. Note th e relation sh ip between th e words anal in th e q u estio n an d toilet training in th e co rrect op tion . Review: Freu d ’s p sych o so cial stages o f d evelo p m en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develo pm en t Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Develop m en t; Health Prom o tion Refer en ce: McKin n ey et al. (2013), p . 74.

207. 1 Ra t ion a le: In th e form al o p eratio n s stage, th e ch ild h as th e ab ility to th in k ab stractly an d lo gically. O ptio n 2 id en tifies th e sen sorim oto r stage. O ptio n 3 iden tifies th e co n crete op er- atio n al stage. O ption 4 iden tifies th e p reo peratio n al stage. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e form al op era- tion s stage of Piaget’s cogn itive develop m en tal th eo ry, an d n ote th e relation sh ip between th e su b ject an d th e descriptio n in th e co rrect o ptio n . Rem em b er th at in th e fo rm al op eratio n s stage, th e ch ild h as th e ability to th in k ab stractly an d lo gically. Review: Piaget’s co gn itive d evelo p m en tal th eo ry Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develop m en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Clien t Ed u catio n ; Develo p m en t Refer en ce: Ho cken berry, Wilson (2015), p p. 525–526.

208. 3 Ra t ion a le: Accordin g to Erikson , d urin g sch oo l-age years ( 6 to 12 years o f age) , th e ch ild begin s to m o ve toward p eers an d frien ds an d away fro m th e paren ts fo r su pp ort. Th e ch ild also b egin s to d evelop sp ecial in terests th at reflect h is o r h er own d evelo p in g p erson ality in stead o f th e paren ts. Th erefo re o p tion s 1, 2, an d 4 are in correct respo n ses. Test -Ta kin g Str a tegy: Use kn owled ge o f Erikso n ’s psych o so- cial develop m en t th eory related to m idd le ch ildh oo d . O p tio n s 1 an d 2 can b e elim in ated first becau se th ey are co m p arab le o r alike an d in dicate th at th e m o th er sh o uld b e con cern ed abo ut th e ch ild. Elim in ate o p tion 4 n ext b ecau se alth ou gh praisin g th e ch ild fo r accom p lish m en ts is im p ortan t at th is age, th e b eh avio r th at th e ch ild is exh ibitin g is n o rm al. Review: Erik Erikso n ’s stages o f p sych o so cial d evelo p m en t Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Develop m en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Develop m en t; Health Prom o tion Refer en ce: Ho cken berry, Wilson (2015), p . 571.

209. 2, 3, 4, 6 Ra t ion a le: Koh lb erg’s th eory states th at in d ivid uals m ove th ro ugh stages o f develop m en t in a seq u en tial fash ion b ut th at n ot everyon e reach es stages 5 an d 6 in h is o r h er d evelo pm en t o f p erso n al m orality. Th e th eo ry p ro vides a fram ewo rk for u n d erstan din g h o w in dividu als d eterm in e a m o ral cod e to gu id e th eir beh avior. It states th at m o ral d evelo p m en t p ro - gresses in relation sh ip to co gn itive d evelo pm en t an d th at a per- so n ’s ability to m ake m o ral ju dgm en ts develop s over a p erio d o f tim e. In stage 1, ages 2 to 3 years (pu n ish m en t-o bed ien ce o rien tatio n ), ch ild ren can n ot reaso n as m atu re m em b ers o f so ciety. In stage 2, ages 4 to 7 years (in strum en tal-relativist o ri- en tation ), th e ch ild co n fo rm s to ru les to ob tain rewards or h ave favo rs retu rn ed. Test -Ta kin g Str a tegy: Read each option carefully. Recallin g th at th e th eo ry p ro vid es a fram ewo rk fo r u n d erstan din g h ow in d ividu als d eterm in e a m o ral cod e to gu ide th eir b eh avio r an d recallin g th e ages associated with each stage will assist in

263CHAPTER 21 Theories of Growth and Development

F

u

n

d

a

m

e

n

t

a

l

s

an swerin g th e qu estio n . Also n o tin g th e clo sed -en d ed wo rd all in o p tion 1 an d th e wo rd mature in op tio n 5 will assist in elim - in atin g th ese op tio n s. Review: Ko h lb erg’s th eo ry o f m o ral d evelo p m en t Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develop m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Clien t Ed ucation ; Develo pm en t Refer en ce: Hocken b erry, Wilso n (2015), pp . 526, 575.

210. 1, 4 Ra tion a le: Accord in g to Erikson , th e ch ild focuses o n gain in g som e b asic con trol over self an d th e en viro nm en t an d in depen - d en ce between ages 1 an d 3 years. Gain in g in depend en ce often m ean s th at th e ch ild h as to rebel again st th e paren ts’wish es. Say- in g th in gs like “n o ” o r “m in e” an d h avin g tem per tan trum s are com m on d urin g th is p eriod of d evelop m en t. Bein g con sisten t

and settin g lim its on th e ch ild’s b eh avior are n ecessary elem en ts. Pro vidin g a sim ple explanation o f wh y certain beh avio rs are u naccep table is an appropriate actio n . O ptio ns 2 an d 3 d o n ot add ress th e child ’s b eh avio r. O ption 5 is likely to p ro du ce a n egative resp on se durin g th is n orm al developm en tal p attern . Test-Ta kin g St r a t egy: O ption s 2 an d 3 can b e elim in ated first b ecau se th ey are co m p arab le o r alike, in dicatin g th at th e m oth er sh ou ld n ot add ress th e ch ild’s beh avior. Next, elim i- n ate o ption 5 because th is actio n is likely to prod uce a n egative respon se durin g th is n orm al develo pm en tal pattern . Also , n ote th e clo sed -en d ed wo rd every in o ptio n 5. Review: Erik Erikso n ’s stages o f p sych o so cial d evelo p m en t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo p m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Clien t Ed ucation ; Develop m en t Refer en ce: Hocken b erry, Wilso n (2015), pp . 490-491.

264 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 22 Developmental Stages

PRIORITY CONCEPTS Development, Family Dynamics

CRITICAL THINKING What Should You Do? The nurse is caring for a hospitalized preschool-age child who is very apprehensive. What should the nurse do to assist in promoting comfort in the child? Answer located on p. 276.

I. The Hospitalized Infant and Toddler A. Separation an xiety

1. Protest a. Cryin g, scream in g, search in g for a paren t;

avoidan ce an d rejection of con tact with stran gers

b . Verbal attacks on oth ers c. Ph ysical figh tin g: Kickin g, bitin g, h ittin g,

pin ch in g 2. Despair

a. With drawn , depressed, un in terested in th e en viron m en t

b . Loss of n ewly learn ed skills 3. Detach m en t

a. Detach m en t is un com m on an d occurs on ly after len gth y sep aration s from th e paren t.

b . Superficially, th e toddler appears to h ave ad justed to th e loss.

c. Du rin g th e detach m en t ph ase, th e todd ler again beco m es m ore in terested in th e en vi- ro n m en t, plays with oth ers, an d seem s to form n ew relation sh ips; th is beh avior is a form of resign ation an d is n ot a sign of con ten tm en t.

d . Th e toddler detach es from th e paren t in an effort to escape th e em otion al pain of desirin g th e paren t’s presen ce.

e. Du rin g th e detach m en t ph ase, th e todd ler copes by form in g sh allow relation sh ips with oth ers, beco m in g in creasin gly self-cen tered ,

an d attach in g prim ary im portan ce to m aterial objects.

f. Detach m en t is th e m ost serious ph ase because reversal of th e poten tial adverse effects is less likely to occur on ce detach m en t is establish ed.

g. In m ost situation s, th e tem porary separation im posed by h ospitalization does n ot cau se such prolon ged paren tal absen ce th at th e tod- dler en ters in to detach m en t.

B. Fear of in ju ry an d pain : Affected by previous experi- en ces, separation from paren ts, an d preparation for th e experien ce

C. Loss of con trol 1. Hospitalization , with its own set of rituals an d

routin es, can severely disrupt th e life of a todd ler. 2. Th e lack of con trol often is exh ibited in beh av-

iors related to feedin g, toiletin g, playin g, an d bed tim e.

3. Th e todd ler m ay dem on strate regression . D. In terven tion s

1. Provide cu ddlin g an d touch an d talk softly to th e in fan t.

2. Provide opportun ities for suckin g and oral stim - ulation for th e in fan t, usin g a pacifier if the in fan t is NPO (not to receive an yth in g by m outh ).

3. Provide stim ulation , if appropriate, for th e in fan t, usin g objects of con trastin g colors an d textures.

4. Provide ch oices as m uch as possib le to th e tod- dler to en able h im or h er to h ave som e con trol.

5. Approach th e todd ler with a positive attitude. 6. Allow th e toddler to express feelin gs of protest. 7. En cou rage th e todd ler to talk about paren ts or

oth ers in th eir lives. 8. Accept regressive beh avior with ou t ridiculin g

th e todd ler. 9. Provide th e todd ler with favorite an d com fo rt-

in g objects. 10. Allow th e toddler as m uch m obility as possible.

F

u

n

d

a

m

e

n

t

a

l

s

265

11. An ticipate tem per tan trum s from th e todd ler, an d m ain tain a safe en viron m en t for ph ysical actin g out.

12. Em ploy pain reduction tech n iqu es, as appropriate.

For the hospitalized toddler, provide routines and rituals as close as possible to what he or she is used to at home.

II. The Hospitalized Preschooler A. Separation an xiety

1. Separation an xiety is gen erally less obvious an d less serious th an in th e todd ler.

2. As stress in creases, th e presch oo ler’s ability to sep arate from th e paren ts decreases.

3. Protest a . Protest is less direct an d aggressive th an in th e

todd ler. b . Th e presch ooler m ay displace feelin gs on to

oth ers. 4. Despair

a . Th e presch oo ler reacts in a m an n er sim ilar to th at of th e todd ler.

b . Th e presch oo ler is quietly with drawn , dep ressed, an d un in terested in th e en viron m en t.

c. Th e ch ild exh ibits lo ss of n ewly learn ed skills. d . Th e presch ooler beco m es gen erally un co-

operative, refusin g to eat or take m ed ication . e. Th e presch ooler repeatedly asks wh en th e

paren ts will be visitin g. 5. Detach m en t: Sim ilar to th e todd ler

B. Fear of in jury an d pain 1. Th e presch ooler h as a gen eral lack of un d erstan d-

in g of body in tegrity. 2. Th e ch ild fears in vasive proced ures an d

m utilation . 3. Th e ch ild im agin es th in gs to be m uch worse th an

th ey are. 4. Presch oolers believe th at th ey are ill because of

som eth in g th ey did or th o ugh t. C. Loss of con trol

1. Th e presch ooler likes fam iliar routin es an d rit- uals an d m ay sh ow regression if n ot allowed to m ain tain som e con trol.

2. Presch oolers’ egocen tric an d m agical th in kin g lim its th eir ability to un derstan d even ts because th ey view all exp erien ces from th eir own self- referen ced (egocen tric) persp ective.

3. Th e ch ild h as attain ed a good deal of in depen - den ce an d self-care at h om e an d m ay exp ect th at to con tin ue in th e h ospital.

D. In terven tion s 1. Provid e a safe an d secure en viron m en t. 2. Take tim e for com m un ication . 3. Allow th e presch oo ler to express an ger.

4. Ackn owledge fears an d an xieties. 5. Accept regressive beh avior; assist th e pre-

sch ooler in m ovin g from regressive to appropri- ate beh avio rs accord in g to age.

6. En cou rage room in g-in or leavin g a favorite toy. 7. Allow m ob ility an d provide play an d diversion al

activities. 8. Place th e presch ooler with oth er ch ildren of th e

sam e age if possible. 9. En cou rage th e presch ooler to be in depen den t.

10. Explain proced ures sim ply, on th e presch ooler’s level.

11. Avoid in trusive procedures wh en possible. 12. Allow th e wearin g of un derpan ts.

III. The Hospitalized School-Age Child A. Separation an xiety

1. Th e sch ool-age ch ild is accu stom ed to periods of separation from th e paren ts, but as stressors are added , th e sep aration beco m es m ore difficult.

2. Th e ch ild is m ore con cern ed with m issin g sch o ol an d th e fear th at frien ds will forget h er or h im .

3. Usually, th e stages of beh avior of protest, despair, an d detach m en t do n ot occur with sch ool-age ch ildren .

B. Fear of in jury an d pain 1. Th e sch o ol-age ch ild fears bodily in jury

an d pain . 2. Th e ch ild fears illn ess itself, disability, death , an d

in trusive proced ures in gen ital areas. 3. Th e ch ild is un co m fortable with an y type of sex-

ual exam in ation . 4. Th e ch ild groan s or wh in es, h olds rigidly still,

an d co m m un icates about pain . C. Loss of con trol

1. Th e ch ild is usually h igh ly social, in depen den t, an d in volved with activities.

2. Th e ch ild seeks in form ation an d asks relevan t ques- tion s about tests an d procedures an d the illn ess.

3. Th e ch ild associates h is or h er action s with th e cause of th e illn ess.

4. Th e ch ild m ay feel h elpless an d depen den t if ph ysical lim itation s occur.

D. In terven tion s 1. En cou rage room in g-in . 2. Focus on th e sch o ol-age ch ild’s abilities

an d n eeds. 3. En cou rage th e sch ool-age ch ild to becom e

in volved with h is or h er own care. 4. Accept regression but en courage in depen den ce. 5. Provid e ch oices to th e sch o ol-age ch ild. 6. Allow expressio n of feelin gs verbally an d

n on verbally. 7. Ackn owledge fears an d con cern s an d allow for

discussion . 8. Explain all proced ures, usin g body diagram s or

outlin es.

266 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

9. Provide privacy. 10. Avo id in trusive proced ures if possible. 11. Allow th e sch ool-age ch ild to wear un derpan ts. 12. In volve th e sch ool-age ch ild in activities appro-

priate to th e developm en tal level an d illn ess. 13. En cou rage th e sch ool-age ch ild to con tact

frien ds. 14. Provide for edu cation al n eeds. 15. Use ap propriate in terven tion s to relieve pain .

IV. The Hospitalized Adolescent A. Separation an xiety

1. Adolescen ts are n ot sure wh eth er th ey wan t th eir paren ts with th em wh en th ey are h ospitalized.

2. Adolescen ts beco m e upset if frien ds go on with th eir lives, exclud in g th em .

For the hospitalized adolescent, separation from friends is a source of anxiety.

B. Fear of in jury an d pain 1. Adolescen ts fear bein g differen t from oth ers an d

th eir peers. 2. Adolescen ts m ay give th e im pressio n th at

th ey are n ot afraid, even th ough th ey are terrified. 3. Adolescen ts beco m e guarded wh en an y areas

related to sexual developm en t are exam in ed. C. Loss of con tro l

1. Beh aviors exh ibited in clude an ger, with drawal, an d un cooperativen ess.

2. Adolescen ts seek h elp an d th en reject it. D. In terven tion s

1. En cou rage question s about appearan ce an d effects of th e illn ess on th e future.

2. Explore feelin gs about th e h ospital an d th e sig- n ifican ce th at th e illn ess m igh t h ave for relation sh ips.

3. En cou rage adolescen ts to wear th eir own cloth es an d carry out n orm al groom in g activities.

4. Allow favorite food s to be brough t in to th e h os- pital if possible.

5. Provide privacy. 6. Use body diagram s to prepare for proced ures. 7. In troduce th em to oth er ad olescen ts in th e

n ursin g un it. 8. En cou rage m ain tain in g con tact with peer

grou ps. 9. Provide for edu cation al n eeds.

10. Iden tify form ation of future plan s. 11. Help to develop positive copin g m ech an ism s.

V. Communication Approaches A. Gen eral guid elin es (Box 22-1) B. In fan t

1. In fan ts respon d to n on verbal com m un ication beh aviors of ad ults, such as h oldin g, rockin g, pattin g, cuddlin g, an d touch in g.

2. Use a slow approach an d allow th e in fan t to get to kn ow th e n urse.

3. Use a calm , soft, sooth in g voice. 4. Be respo n sive to cries. 5. Talk an d read to in fan ts. 6. Allow security objects such as blan kets an d pac-

ifiers if th e in fan t h as th em . C. Toddler

1. Approach th e todd ler cautiously. 2. Rem em ber th at todd lers accept th e verbal com -

m un ication s of oth ers literally. 3. Learn th e todd ler’s words for co m m on item s

an d use th em in con versation s. 4. Use sh o rt, con crete term s. 5. Prepare th e toddler for proced ures im m ediately

befo re th e even t. 6. Repeat explan ation s an d description s. 7. Use play for dem on stratio n s. 8. Use visual aids such as picture books, pupp ets,

an d dolls. 9. Allow th e toddler to h an dle th e equip m en t or

in strum en ts; explain wh at th e equipm en t or in strum en t does an d h ow it feels.

10. En cou rage th e use of com fo rt objects. D. Presch oo ler

1. Seek opportun ities to offer ch oices. 2. Speak in sim ple sen ten ces. 3. Be con cise an d lim it th e len gth of explan ation s. 4. Allow askin g question s. 5. Describe proced ures as th ey are about to be

perform ed. 6. Use play to explain proced ures an d activities. 7. Allow h an dlin g of equipm en t or in strum en ts,

wh ich will ease fear an d h elp to an swer question s.

E. Sch o ol-age ch ild 1. Establish lim its. 2. Provide reassuran ce to h elp in alleviatin g fears

an d an xieties. 3. En gage in con versation s th at en courage

th in kin g. 4. Use m ed ical play tech n iques. 5. Use ph o tograph s, books, dolls, an d videos to

explain proced ures. 6. Explain in clear term s. 7. Allow tim e for com po sure an d privacy.

BOX22-1 General Guidelines for Communication Allow the child to feel comfortable with the nurse. Communicate through the use of objects. Allow the child to express fears and concerns. Speak clearly and in a quiet, unhurried voice. Offer choices when possible. Be honest with the child. Set limits with the child as appropriate.

267CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

F. Adolescen t 1. Rem em ber th at th e adolescen t m ay be preoccu -

pied with body im age. 2. En cou rage an d support in depen den ce. 3. Provide privacy. 4. Use ph otograph s, books, an d videos to exp lain

proced ures. 5. En gage in con versation s about th e ad olescen t’s

in terests. 6. Avoid beco m in g too ab stract, too detailed, an d

too tech n ical. 7. Avoid respon d in g by pryin g, con fron tin g, con -

descen din g, or expressin g judgm en tal attitu des.

VI. Car Safety Seats and Guidelines A. Th e safest place for all ch ildren to ride, regardless of

age, is in th e back seat of th e car. B. Lock th e car doors; 4-door cars sh o uld be equ ipped

with ch ild safety locks on th e back doors. C. Th ere are differen t types of car safety seats an d th e

m an u facturer’s guidelin es n eed to be followed . D. For specific in form ation regardin g car safety, refer to

Car seats: information for families for 2016 (copyrigh t © 2016 Am erican Academ y of Ped iatrics), foun d at www.h ealth ych ildren .org/ En glish / safety- preven tion / on -th e-go/ Pages/ Car-Safety-Seats- In form ation -for-Fam ilies.aspx.

VII. Developmental Characteristics A. In fan t

1. Ph ysical a . Heigh t in creases by 1 in ch per m on th in th e

first 6 m on th s, an d by 1 year th e len gth h as in creased by 50%.

b . Weigh t is doubled at 5 to 6 m on th s an d tri- pled at 12 m on th s.

c. At birth , h ead circum feren ce is 33 to 35 cm (13.2 to 14 in ch es), approxim ately 2 to 3 cm m ore th an ch est circum feren ce.

d . By 1 to 2 years of age, h ead circum feren ce an d ch est circum feren ce are equ al.

e. An terior fon tan el (soft an d flat in a n orm al in fan t) clo ses by 12 to 18 m on th s of age.

f. Posterior fon tan el (soft an d flat in a n orm al in fan t) closes by the en d of th e secon d m on th.

g. Th e first prim ary teeth to erupt are th e lower cen tral in cisors at approxim ately 6 to 10 m on th s of age.

h . Sleep pattern s vary am on g in fan ts; in gen eral, by 3 to 4 m on th s of age, m ost in fan ts h ave developed a n octurn al pattern of sleep th at lasts 9 to 11 h ours.

2. Vital sign s (Box 22-2) 3. Nu trition

a . Th e in fan t m ay breast-feed or bottle-feed (with iron -fortified form ula), dep en din g on th e m oth er’s ch oice; h owever, breast m ilk is

th e preferred form of n utrition for all in fan ts, especially durin g th e first 6 m on th s.

b . Exclusively breast-fed in fan ts an d in fan ts in gestin g less th an 1000 m L of vitam in D– fortified form ula or m ilk per day sh ould receive daily vitam in D supp lem en tation (400 IU) startin g in th e first few days of life to preven t rickets an d vitam in D deficien cy.

c. Iron stores from birth are dep leted by 4 m on th s of age; if th e in fan t is bein g breast-fed on ly, iron supp lem en tation , usu- ally with iron -fortified cereal, is n eeded.

d . Wh o le m ilk, low-fat m ilk, skim m ilk, oth er an im al m ilk, or im itation m ilk sh ould n ot be given to in fan ts as a prim ary source of n utrition because th ese food sources lack th e n ecessary com po n en ts n eeded for growth an d h ave lim ited digestibility.

e. Fluoride supp lem en tation m ay be n eeded at about 6 m on th s of age, depen din g on th e in fan t’s in take of fluorid ated tap water.

f. Solid food s (strain ed, pureed, or fin ely m ash ed) are in trodu ced at about 5 to 6 m on th s of age; in trodu ce solid food s on e at a tim e, usually at in tervals of 4 to 5 days, to iden tify food allergen s.

g. Sequen ce of the in troduction of solid foods var- ies depen din g on h ealth care provider’s prefer- en ce an d usually is as follows: iron -fortified rice cereal, fruits, vegetables, th en m eats.

h . At 12 m on th s of age, eggs can be given (in tro- duce egg wh ites in sm all quan tities to detect an allergy); ch eese m ay be used as a substitute for m eat.

i. Avoid solid food s th at place th e in fan t at risk for ch okin g, such as n uts, foods with seeds, raisin s, popco rn , grapes, an d h ot dog pieces.

j. Avoid m icrowavin g baby bottles an d baby food because of th e poten tial for uneven h eatin g.

k . Never m ix food or m ed ication s with form ula. l. Avoid addin g h on ey to form ula, water, or

oth er fluid to preven t botu lism .

BOX 22-2 Vital Signs: Newborn and 1-Year-Old Infant

Newborn Tempera ture: Axillary, 96.8°F to 99.0 °F (36°C to 37.2°C) Apica l Hea rt Ra t e: 120 to 160 beats/ minute Respira tions: 30 to 60 (average 40 ) breaths/ minute Blood Pressure: 80 -90 / 40-50 mm Hg

1-Year-Old Infant Tempera ture: Axillary, 97°F to 99°F (36.1°C to 37.2°C) Apica l Hea rt Ra t e: 90 to 130 beats/ minute Respira tions: 20 to 40 breaths/ minute Blood Pressure: 90 / 56 mm Hg

268 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

m . O ffer fruit juice from a cup (12 to 13 m on th s or at a prescribed age) rath er th an a bottle to preven t n ursin g (bo ttle-m outh ) caries; fruit juice is lim ited because of its h igh sugar con ten t.

4. Skills (Box 22-3) 5. Play

a. Solitary b . Birth to 3 m on th s: Verbal, visual, an d tactile

stim uli

c. 4 to 6 m on th s: In itiation of action s an d recog- n ition of n ew exp erien ces

d . 6 to 12 m on th s: Awaren ess of self, im itation , repetition of pleasurable action s

e. En joym en t of soft stuffed an im als, crib m ob iles with con trastin g colors, squeeze toys, rattles, m usical toys, water toys durin g th e bath , large picture books, an d push toys after th e in fan t begin s to walk

6. Safety a. Paren ts m ust baby-proof th e h om e. b . Guard th e in fan t wh en on a bed or

ch an gin g table. c. Use gates to protect th e in fan t from stairs. d . Be sure th at bath water is n ot h ot; do n ot leave

th e in fan t un atten ded in th e bath . e. Do n ot h old th e in fan t wh ile drin kin g or

workin g n ear h ot liquids or item s such as a stove.

f. Cool vapo rizers in stead of steam sh o uld be used if n eeded, to preven t burn in ju ries.

g. Avoid offerin g food th at is roun d an d sim ilar to th e size of th e airway to preven t ch okin g.

h . Be sure th at toys h ave n o sm all pieces. i. Toys or m ob iles h an gin g over th e crib sh ould

be well out of reach , to preven t stran gulation . j. Avoid placin g large toys in th e crib because an

older in fan t m ay use th em as steps to clim b . k . Crib s sh ould be position ed away fro m cur-

tain s an d blin d cords. l. Cover electrical outlets. m . Rem o ve h azardous objects from lo w, reach -

able places. n . Rem o ve ch em icals such as clean in g or oth er

h ouseh old products, m ed ication s, poison s, an d plan ts fro m th e in fan t’s reach .

o . Keep th e Poison Con trol Cen ter n um ber available.

Never shake an infant because of the risk of causing a closed head injury known as shaken baby syndrome, which is a life-threatening injury.

B. Toddler 1. Ph ysical

a. Heigh t an d weigh t in crease in ph ases, reflect- in g growth spurts an d lags.

b . Head circum feren ce in creases about 1 in ch (25.5 m m ) between ages 1 an d 2; th ereafter h ead circum feren ce in creases about ½ in ch (12.5 m m ) per year un til age 5.

c. An terior fon tan el closes between ages 12 an d 18 m on th s.

d . Weigh t gain is slower th an in in fan cy; by age 2, th e average weigh t is 22 to 27 poun ds (10 to 12 kg).

e. No rm al h eigh t ch an ges in clude a growth of about 3 in ch es (7.5 cm ) per year; th e average

BOX 22-3 Infant Skills

2 to 3 Months ▪ Smiles ▪ Turns head side to side ▪ Cries ▪ Follows objects ▪ Holds head in midline 4 to 5 Months ▪ Grasps objects ▪ Switches objects from hands ▪ Rolls over for the first time ▪ Enjoys social interaction ▪ Begins to show memory ▪ Aware of unfamiliar surroundings 6 to 7 Months ▪ Creeps ▪ Sits with support ▪ Imitates ▪ Exhibits fear of strangers ▪ Holds arms out ▪ Frequent mood swings ▪ Waves “bye-bye” 8 to 9 Months ▪ Sits steadily unsupported ▪ Crawls ▪ May stand while holding on ▪ Begins to stand without help 10 to 11 Months ▪ Can change from prone to sitting position ▪ Walks while holding on to furniture ▪ Stands securely ▪ Entertains self for periods of time 12 to 13 Months ▪ Walks with 1 hand held ▪ Can take a few steps without falling ▪ Can drink from a cup 14 to 15 Months ▪ Walks alone ▪ Can crawl up stairs ▪ Shows emotions such as anger and affection ▪ Will explore away from mother in familiar surroundings

269CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

h eigh t of th e todd ler is 34 in ch es (86 cm ) at age 2 years.

f. Lordo sis (pot belly) is n oted. g. Th e toddler sh ould see a den tist soon after th e

first teeth erupt, usually aroun d 1 year of age, an d oral h ygien e m easures sh ould be in stituted; regular den tal care is essen tial, an d th e toddler will require assistan ce with brush in g an d floss- in g of teeth (fluoride supplem en ts m ay be n ec- essary if th e water is n ot fluoridated).

h . A todd ler sh ould n ever be allowed to fall asleep with a bottle con tain in g m ilk, juice, soda pop, sweeten ed water, or an y oth er sweet liquid because of th e risk of n ursin g (bottle-m outh ) caries.

i. Typically, th e todd ler sleep s th rou gh th e n igh t an d h as 1 daytim e n ap; th e daytim e n ap is n orm ally discon tin ued at about age 3.

j. A con sisten t bed tim e ritual h elps to prepare th e todd ler for sleep.

k . Security objects at bedtim e m ay assist in sleep.

2. Vital sign s (Box 22-4) 3. Nu trition

a . Th e MyPlate food guide (see Fig. 11-1) pro- vides dietary gu idelin es an d ap plies to ch il- dren as youn g as 2 years of age (see www. ch oo sem yplate.gov).

b . Th e todd ler sh o uld average an in take of 2 to 3 servin gs of m ilk daily (24 to 30 oz [700 to 800 m L]) to en sure an adequate am oun t of calcium an d ph osph orus (low-fat m ilk m ay be given after 2 years of age).

c. Tran s-fatty acids an d saturated fats n eed to be restricted; oth erwise fat restriction is n ot appropriate for a todd ler (m oth ers sh ould be taugh t about th e types of food th at con - tain fat th at sh ould be selected).

d . Iron -fortified cereal an d a h igh -iron diet, adequ ate am oun ts of calcium an d vitam in D, an d vitam in C (4 to 6 oz [120 to 180 m L] of juice daily) are essen tial com po- n en ts for th e todd ler’s diet.

e. Most todd lers prefer to feed th em selves. f. Th e toddler gen erally does best by eatin g sev-

eral sm all n utritious m eals each day rath er th an 3 large m eals.

g. O ffer a lim ited n um ber of foods at an y on e tim e.

h . O ffer fin ger food s an d avoid con cen trated sweets an d em p ty calories.

i. Th e todd ler is at risk for aspiration of sm all food s th at are n ot ch ewed easily, such as n uts, food s with seeds, raisin s, popcorn , grapes, an d h ot dog pieces.

j. Ph ysiological an orexia m ay occur an d is n or- m al because of th e altern atin g stages of fast an d slow growth .

k . Sit th e toddler in a h igh ch air at th e fam ily table for m eals.

l. Allow sufficien t tim e to eat, but rem ove food wh en th e toddler begin s to play with it.

m . Th e todd ler drin ks well fro m a cup h eld with both h an ds.

n . Avoid usin g food as a reward or pun ish m en t. 4. Skills

a . Th e todd ler begin s to walk with 1 h an d h eld by age 12 to 13 m on th s.

b . Th e todd ler run s by age 2 years an d walks backward an d h op s on 1 foot by age 3 years.

c. Th e toddler usually can n ot altern ate feet wh en clim bin g stairs.

d . Th e todd ler begin s to m aster fin e m oto r skills for buildin g, un dressin g, an d drawin g lin es.

e. Th e youn g todd ler often uses “n o” even wh en h e or sh e m ean s “yes” to assert in depen den ce.

f. Th e todd ler begin s to use sh o rt sen ten ces an d h as a vocab ulary of about 300 words by age 2.

5. Bowel an d bladder con trol a . Certain sign s in dicate th at a todd ler is ready

for toilet train in g (Box 22-5). b . Bowel con trol develops before bladder con trol. c. By age 3, th e toddler ach ieves fairly good

bowel an d blad der con trol. d . Th e toddler m ay stay dry durin g th e day but

m ay n eed a diaper at n igh t un til about age 4. 6. Play

a . The m ajor socializing m ech an ism is parallel play, an d therapeutic play can begin at th is age.

b . Th e todd ler h as a sh ort atten tion span , caus- in g th e todd ler to ch an ge toys often .

c. Th e todd ler exp lores body parts of self an d oth ers.

BOX 22-4 The Toddler’s Vital Signs Tempera ture: Axillary, 97.5°F to 98.6°F (36.4°C to 37°C) Apica l Hea rt Ra t e: 80 to 120 beats/ minute Respira tions: 20 to 30 breaths/ minute Blood Pressure: Average, 92/ 55 mm Hg

BOX 22-5 Signs of Readiness for Toilet Training Child is able to stay dry for 2 hours. Child is waking up dry from a nap. Child is able to sit, squat, and walk. Child is able to remove clothing. Child recognizes the urge to defecate or urinate. Child expresses willingness to please a parent. Child is able to sit on the toilet for 5 to 10 minutes without

fussing or getting off.

Data from Hockenberry M, Wilson D: Nursing care of infants and children, ed 9, St. Louis, 2011, Mosby.

270 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

d . Typical toys in clude push -pull toys, blocks, san d, fin ger pain ts an d bubb les, large balls, crayon s, trucks an d dolls, con tain ers, Play- Do h , toy telep h on es, cloth books, an d wooden puzzles.

7. Safety

Toddlers are eager to explore the world around them; they need to be supervised at play to ensure safety.

a. Use back burn ers on th e stove to prepare a m eal; turn pot h an dles in ward an d toward th e m iddle of th e stove.

b . Keep dan glin g cords from sm all applian ces or oth er item s away from th e todd ler.

c. Place in accessible locks on win dows an d doors, an d keep furniture away from win dows.

d . Secure screen s on all win do ws. e. Place safety gates at stairways. f. Do n ot allow th e todd ler to sleep or play in an

upper bun k bed . g. Never leave th e todd ler alon e n ear a bath tu b,

pail of water, swim m in g pool, or an y oth er body of water.

h . Keep toilet lids closed. i. Keep all m ed icin es, poison s, h ouseh old

plan ts, an d toxic produ cts in h igh areas an d lo cked out of reach .

j. Keep th e Poison Con trol Cen ter n um ber available.

C. Presch ooler 1. Ph ysical

a. Th e presch ooler grows 2½ to 3 in ch es (6.5 to 7.5 cm ) per year.

b . Average h eigh t is 37 in ch es (94 cm ) at age 3, 40½ in ch es (103 cm ) at age 4, an d 43 in ch es (110 cm ) at age 5.

c. Th e presch ooler gain s approxim ately 5 poun ds (2.25 kg) per year; average weigh t is 40 poun ds (18 kg) at age 5.

d . Th e presch ooler requires about 12 h ou rs of sleep each day.

e. A security object an d a n igh tligh t h elp with sleepin g.

f. At th e begin n in g of th e presch ool period, th e eruptio n of th e deciduous (prim ary) teeth is com plete.

g. Regular den tal care is essen tial, an d th e pre- sch ooler m ay require assistan ce with brush in g an d flossin g of teeth ; fluoride supplem en ts m ay be n ecessary if the water is n ot fluoridated.

2. Vital sign s ( Box 22-6) 3. Nu trition

a. Nu trition al n eeds are sim ilar to th o se required for th e todd ler alth ough th e daily am oun ts of m in erals, vitam in s, an d protein m ay in crease with age.

b . Th e MyPlate food guid e is ap propriate for presch oolers (see www.ch oosem yplate.gov).

c. Th e presch ooler exh ibits food fads an d certain taste preferen ces an d m ay exh ibit fin icky eatin g.

d . By 5 years old, th e ch ild ten ds to focus on social aspects of eatin g, table con versation s, m an n ers, an d willin gn ess to try n ew food s.

4. Skills a. Th e presch ooler h as go od postu re. b . Th e ch ild develops fin e m oto r coordin ation . c. Th e ch ild can h op, skip, an d run m ore

sm oo th ly. d . Ath letic abilities begin to develop. e. Th e presch oo ler dem on strates in creased skills

in balan cin g. f. Th e ch ild altern ates feet wh en clim b in g stairs. g. Th e ch ild can tie sh oelaces by age 6. h . Th e ch ild m ay talk con tin uo usly an d ask

m an y “wh y” question s. i. Vocabulary in creases to about 900 words by

age 3 an d to 2100 words by age 5. j. By age 3, th e presch oo ler usually talks in 3- or

4-word sen ten ces an d speaks in sh ort ph rases. k . By age 4, th e presch ooler speaks 5- or 6-word

sen ten ces, an d by age 5, speaks in lon ger sen - ten ces th at con tain all parts of speech .

l. Th e ch ild can be un dersto od readily by oth ers an d can un d erstan d clearly wh at oth ers are sayin g.

5. Bowel an d bladder con trol a. By age 4, th e presch oo ler h as daytim e con trol

of bowel an d blad der but m ay exp erien ce bed -wettin g acciden ts at n igh t.

b . By age 5, th e presch oo ler ach ieves bowel an d blad der con trol, alth ough acciden ts m ay occur in stressful situation s.

6. Play a. Th e presch ooler is cooperative. b . Th e presch ooler h as im agin ary playm ates. c. Th e ch ild likes to build an d create th in gs, an d

play is sim ple an d im agin ative. d . Th e ch ild un derstan ds sh arin g an d is able to

in teract with peers. e. Th e ch ild requires regular socialization with

m ates of sim ilar age. f. Play activities in clude a large space for ru n -

n in g an d jum pin g. g. Th e presch oo ler likes dress-up cloth es, pain ts,

paper, an d crayon s for creative exp ression .

BOX 22-6 The Preschooler’s Vital Signs Tempera t ure: Axillary, 97.5°F to 98.6°F (36.4°C to 37°C) Apica l Hea rt Ra te: 70 to 110 beats/ minute Respira t ions: 16 to 22 breaths/ minute Blood Pressure: Average, 95/ 57 mm Hg

271CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

h . Swim m in g an d sports aid in growth developm en t.

i. Puzzles an d toys aid with fin e m oto r developm en t.

7. Safety a . Presch oolers are active an d in quisitive. b . Because of th eir m agical th in kin g, th ey m ay

believe th at darin g feats seen in cartoo n s are possible an d m ay attem pt th em .

c. Th e p resch o o ler can learn sim p le safety p ractices b ecau se th ey can fo llo w sim p le verb al d irectio n s an d th eir atten tio n sp an is lo n ger.

d . Teach th e presch ooler basic safety ru les to en sure safety wh en playin g in a playgroun d such as n ear swin gs an d ladd ers.

e. Teach th e presch ooler n ever to play with m atch es or ligh ters.

f. Th e presch ooler sh o uld be taugh t wh at to do in th e even t of a fire or if cloth es catch fire; fire drills sh ould be practiced with th e presch ooler.

g. Gun s sh ould be stored un lo aded an d secured un der lock an d key (am m un ition sh ould be locked in a sep arate place).

h . Teach th e presch ooler h is or h er full n am e, address, paren ts’ n am es, and teleph on e n um ber.

i. Teach th e presch oo ler h ow to dial 911 in an em ergen cy situation .

j. Keep th e Poison Con trol Cen ter n um ber available.

Teach a preschooler and school-age child to leave an area immediately if a gun is visible and to tell an adult. The preschooler should also be taught never to point a toy gun at another person.

D. Sch o ol-age ch ild 1. Ph ysical

a . Girls usually grow faster th an boys. b . Gro wth is about 2 in ch es (5 cm ) per year

between ages 6 an d 12. c. Heigh t ran ges from 45 in ch es (115 cm ) at age

6 to 59 in ch es (150 cm ) at age 12. d . Sch o ol-age ch ildren gain weigh t at a rate

of ab out 4½ to 6½ poun ds (2 to 3 kg) per year.

e. Average weigh t is 46 poun ds (21 kg) at age 6 an d 88 poun ds (40 kg) at age 12.

f. Th e first perm an en t (secon dary) teeth erupt arou n d age 6, an d deciduous teeth are lost gradually.

g. Regular den tist visits are n ecessary, an d th e sch o ol-age ch ild n eeds to be supervised with brush in g an d flo ssin g teeth ; fluorid e supple- m en ts m ay be n ecessary if th e water is n ot fluoridated.

h . For sch ool-age ch ildren with prim ary an d per- m an en t den tition , th e best tooth brush is on e with soft n ylon bristles an d an overall len gth of about 6 in ch es (15 cm ).

i. Sleep requirem en ts ran ge from 10 to 12 h ours a n igh t.

2. Vital sign s (Box 22-7) 3. Nutrition

a . Sch o ol-age ch ildren will h ave in creased growth n eeds as th ey approach adolescen ce.

b . Ch ildren require a balan ced diet from food s in th e MyPlate food guide; h ealth y sn acks sh ould con tin ue to be em ph asized to preven t ch ildh ood obesity (see www. ch oosem yplate.gov).

c. Ch ildren still m ay be picky eaters but are usu- ally willin g to try n ew foods.

4. Skills a . Sch o ol-age ch ildren exh ibit refin em en t of

fin e m oto r skills. b . Developm en t of gross m oto r skills con tin ues. c. Stren gth an d en duran ce in crease.

5. Play a . Play is m ore com petitive. b . Rules an d rituals are im portan t aspects of play

an d gam es. c. Th e sch o ol-age ch ild en jo ys drawin g, collect-

in g item s, dolls, pets, guessin g gam es, board gam es, listen in g to th e radio, TV, readin g, watch in g videos or DVDs, an d com pu ter gam es.

d . Th e ch ild participates in team sports. e. Th e ch ild m ay participate in secret clubs,

group peer activities, an d scout organ ization s. 6. Safety

a . Th e sch ool-age ch ild experien ces less fear in play activities an d frequen tly im itates real life by usin g tools an d h ouseh old item s.

b . Major causes of injuries in clude bicycles, skate- boards, an d team sports as th e ch ild in creases in m otor abilities an d in depen den ce.

c. Ch ildren sh o uld always wear a h elm et wh en ridin g a bike or usin g in -lin e skates or skateboards.

d . Teach th e ch ild water safety ru les. e. In struct th e ch ild to avoid teasin g or playin g

rough ly with an im als. f. Teach th e ch ild n ever to play with m atch es or

ligh ters.

BOX 22-7 The School-Age Child’s Vital Signs Tempera ture: Oral, 97.5°F to 98.6°F (36.4°C to 37°C) Apica l Hea rt Ra t e: 60 to 100 beats/ minute Respira tions: 18 to 20 breaths/ minute Blood Pressure: Average, 10 7/ 64 mm Hg

272 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

g. Th e ch ild sh ould be taugh t wh at to do in th e even t of a fire or if cloth es catch fire; fire drills sh o uld be practiced with th e ch ild.

h . Gun s sh ould be stored un lo aded an d secured un d er lock an d key (am m un ition sh ould be lo cked in a sep arate place).

i. Teach th e ch ild traffic safety ru les. j. Teach th e ch ild h ow to dial 911 in an em er-

gen cy situation . k . Keep th e Poison Con trol Cen ter n um ber

available.

Teach the preschooler and school-age child that if another person touches his or her body in an inappropri- ate way, an adult should be told. Also teach the child to avoid speaking to strangers and never to accept a ride, toys, or gifts from a stranger.

E. Adolescen t 1. Ph ysical

a. Puberty is th e m aturatio n al, h orm on al, an d growth process th at occurs wh en th e repro- ductive organ s begin to fun ction an d th e sec- on d ary sex ch aracteristics develo p.

b . Bod y m ass in creases to adult size. c. Sebaceous an d sweat glan ds beco m e active

an d fully fun ction al. d . Bod y h air distrib ution occurs. e. In creases in h eigh t, weigh t, breast develop-

m en t, an d pelvic girth occur in girls. f. Men strual periods occur about 2½ years after

th e on set of puberty. g. In boys, in creases in h eigh t, weigh t, m uscle

m ass, an d pen is an d testicle size occur. h . Th e voice deepen s in boys. i. No rm al weigh t gain durin g puberty: Girls

gain 15 to 55 poun ds (7 to 25 kg); boys gain 15 to 65 poun ds (7 to 30 kg).

j. Careful brush in g an d care of th e teeth are im portan t, an d m an y adolescen ts n eed to wear braces.

k . Sleep pattern s in clude a ten den cy to stay up late; th erefore, in an attem p t to catch up on m issed sleep , adolescen ts sleep late wh en ever possible; an overall average of 8 h ou rs per n igh t is recom m en ded.

2. Vital sign s ( Box 22-8) 3. Nu trition

a. Teach in g about th e MyPlate food guid e is im portan t (see www.ch oosem yplate.gov).

b . Adolescen ts typically eat wh en ever th ey h ave a break in activities.

c. Calcium , zin c, iron , folic acid, an d protein are esp ecially im portan t n utrition al n eeds.

d . Adolescen ts ten d to sn ack on em pty calories, an d th e im portan ce of adequate an d h ealth y n utrition n eeds to be stressed.

e. Body im age is im portan t. 4. Skills

a. Gro ss an d fin e m oto r skills are well developed.

b . Stren gth an d en duran ce in crease. 5. Play

a. Gam es an d ath letic activities are th e m ost com m on form s of play.

b . Com p etition an d strict ru les are im portan t. c. Adolescen ts en joy activities such as sports,

videos, m ovies, readin g, parties, dan cin g, h obbies, com pu ter gam es, m usic, com m un i- catin g via th e In tern et, an d experim en tin g, such as with m akeup an d h airstyles.

d . Frien ds are im portan t, an d adolescen ts like to gath er in sm all grou ps.

6. Safety a. Adolescen ts are risk takers. b . Adolescen ts h ave a n atural urge to exp erim en t

an d to be in depen den t. c. Rein fo rce in struction s about th e dan gers

related to cigarette sm okin g, caffein e in ges- tion , alcoh ol, an d drugs.

d . Help adolescen ts to recogn ize th at th ey h ave ch oices wh en difficult or poten tially dan ger- ous situation s arise.

e. En su re th at th e adolescen t uses a seat belt. f. In struct adolescen ts in th e con sequen ces

of in ju ries th at m oto r veh icle acciden ts can cause.

g. In struct adolescen ts in water safety an d em p h asize th at th ey sh ould en ter th e water feet first as oppo sed to divin g, especially wh en th e depth of th e water is un kn own .

h . In struct adolescen ts about th e dan gers associ- ated with gun s, violen ce, an d gan gs.

i. In struct ad olescen ts about th e com plication s associated with body piercin g, tattooin g, an d sun tan n in g.

Discuss issues such as acquaintance rape, sexual relationships, and transmission of sexually transmitted infections with the adolescent. Also discuss the dangers of the Internet and social media related to communicat- ing and setting up meetings (dates) with unknown persons.

F. Early ad ulth ood 1. Description : Period between th e late teen s an d

m id to late 30s 2. Ph ysical ch an ges

BOX 22-8 The Adolescent’s Vital Signs Tempera t ure: Oral, 97.5°F to 98.6°F (36.4°C to 37°C) Apica l Hea rt Ra te: 55 to 90 beats/ minute Respira t ions: 12 to 20 breaths/ minute Blood Pressure: Average, 121/ 70 mm Hg

273CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

a . Perso n h as com pleted ph ysical growth by th e age of 20.

b . Perso n is active. c. Severe illn esses are less com m on th an in

older age grou ps. d . Perso n ten ds to ign ore ph ysical sym ptom s

an d postpon e seekin g h ealth care. e. Lifestyle h abits such as sm oking, stress, lack of

exercise, poor person al h ygien e, an d fam ily h is- tory of disease in crease the risk of future illn ess.

3. Cogn itive ch an ges a . Perso n h as ration al th in kin g h abits. b . Con ceptual, problem -solvin g, an d m oto r

skills in crease. c. Perso n id en tifies preferred occupation al

areas. 4. Psych o social ch an ges

a . Perso n sep arates from fam ily of origin . b . Perso n gives m uch atten tion to occupation al

an d social pursuits to im prove socioeco- n om ic status.

c. Perso n m akes decision s regardin g career, m arriage, an d paren th ood.

d . Perso n n eeds to adap t to n ew situation s. 5. Sexuality

a . Perso n h as th e em otion al m aturity to develop m ature sexual relation sh ips.

b . Perso n is at risk for sexually tran sm itted in fectio n s.

G. Middle adulth o od 1. Description : Period between th e m id to late 30s

an d m id 60s 2. Ph ysical ch an ges

a . Ph ysical ch an ges occur between 40 an d 65 years of age.

b . In dividual becom es aware th at ch an ges in reprodu ctive an d ph ysical ab ilities sign ify th e begin n in g of an oth er stage in life.

c. Men op ause occurs in wom en an d clim acteric occurs in m en .

d . Ph ysiological ch an ges often h ave an im pact on self-con cept an d body im age.

e. Ph ysiological con cern s in clude stress, level of welln ess, an d th e form ation of positive h ealth h abits.

3. Cogn itive ch an ges a . Perso n m ay be in terested in learn in g n ew

skills. b . Perso n m ay becom e in volved in education al

or vocation al program s for en terin g th e job m arket or for ch an gin g careers.

4. Psych o social ch an ges a . Ch an ges m ay in clude expected even ts, such as

ch ildren m ovin g away from h om e (po stpar- en tal fam ily stage) , or un exp ected even ts, such as th e death of a clo se frien d .

b . Tim e an d fin an cial dem an ds decrease as ch il- dren m ove away fro m h om e, an d couples face redefin in g th eir relation sh ip.

c. Adults m ay beco m e gran dparen ts. d . Adults are ach ievin g gen erativity.

5. Sexuality a . Man y couples ren ew th eir relation sh ips

an d fin d in creased m arital an d sexual satisfaction .

b . Th e on set of m en op ause an d clim acteric m ay affect sexual h ealth .

c. Stress, h ealth , an d m ed ication s can affect sexuality.

H. Later adulth ood (perio d between 65 years an d death ): Refer to Ch apter 23.

VIII. Gender Dysphoria Across the Lifespan A. Th e followin g section was adapted from Keltn er,

Steele (2015) , pp. 371-372, DSM-5 Criteria B. Ch ildren

1. Description : An in con gruen ce between on e’s experien ced an d expressed gen d er an d assign ed gen der of a duration of at least 6 m on th s an d at least two of th e followin g assessm en t fin din gs; results in clin ically sign ifican t distress in social, sch ool, or oth er im portan t areas of fun ction in g.

2. Assessm en t a . A stron g desire or in sisten ce th at on e is th e

oth er gen d er b . A stron g preferen ce for cross-dressin g in

fem ale attire for boys; a stron g preferen ce for wearin g m asculin e attire for girls

c. A stron g preferen ce for cross-gen der roles in m ake-believe play

d . A stron g preferen ce for toys, gam es, or activi- ties used stereotypically by th e oth er gen d er

e. A stron g preferen ce for playm ates of th e oth er gen d er

f. Avoidan ce of rough play an d m asculin e toys for boys, an d avoidan ce of fem in in e toys for girls

C. Adolescen ts an d Adults 1. Description : An in con gruen ce between on e’s

experien ced an d expressed gen d er an d assign ed gen der of a duration of at least 6 m on th s an d at least two of th e followin g assessm en t fin din gs. Resu lts in clin ically sign ifican t distress in social, occupation al, or oth er im portan t areas of fun ction in g.

2. Assessm en t a . In con gruen ce between exp ressed gen d er an d

sex ch aracteristics b . A stron g desire to be rid of on e’s sex ch aracter-

istics because of in con gruen ce with expressed gen der

274 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

c. A stron g desire for sex ch aracteristics of th e oth er gen der

d . A stron g desire to be of th e oth er gen d er e. A stron g desire to be treated as th e

oth er gen der f. A stron g con viction th at on e h as th e typical

feelin gs an d reaction s of th e oth er gen d er D. Posttran sition

1. Th e in dividual h as tran sition ed to full-tim e liv- in g in th e desired gen d er

2. Th e in dividual h as un d ergon e or is preparin g to un d ergo at least on e cross-sex m ed ical proced ure or treatm en t regim en .

IX. End-of-Life Care A. Description : En d-of-life care relates to death

an d dyin g. B. Cultural an d religious issues (see Ch apter 5 an d

Box 5-2 for in form ation regardin g cultural an d reli- giou s issues)

C. Legal an d eth ical issues 1. O utcom es related to care durin g illn ess an d th e

dyin g exp erien ce sh ould be based on th e clien t’s wish es.

2. Issu es for con sideration m ay in clude organ an d tissue don atio n s, advan ce directives or oth er legal docum en ts, with h oldin g or with drawin g treatm en t, an d cardiop ulm on ary resuscitation .

D. Palliative care 1. Palliative care focuses on carin g in terven tion s

an d sym pto m m an agem en t rath er th an cure for diseases or con d ition s th at n o lon ger respo n d to treatm en t.

2. Pain an d sym ptom s are con trolled; th e dyin g cli- en t sh ould be as pain -free an d as com fo rtable as possible.

3. Ho spice care provid es supp ort an d care for cli- en ts in th e last ph ases of in curable diseases so th at th ey m igh t live as fully an d as com fo rtably as possible; clien t an d fam ily n eeds are th e focus of an y in terven tion .

E. Near-d eath ph ysiological m an ifestation s 1. As death approach es, m etab olism is reduced,

an d th e body gradually slows down un til all fun ction s en d.

2. Sen sory: Th e clien t experien ces blurred vision , decreased sen se of taste an d sm ell, decreased pain an d touch percep tion , an d lo ss of blin k reflex, an d appears to stare (h earin g is believed to be th e last sen se lost).

3. Resp iration s a. Resp iration s m ay be rapid or slow, sh allow,

an d irregular. b . Resp iration s m ay be n oisy an d wet soun din g

(“d eath rattle”).

c. Ch eyn e-Stokes respiratio n is altern atin g periods of ap n ea an d deep, rapid breath in g.

4. Circulation a. Heart rate slows, an d blood pressure falls

progressively. b . Skin is cool to th e touch , an d th e extrem ities

beco m e pale, m ottled, an d cyan otic. c. Skin is waxlike very n ear death .

5. Urin ary outp ut decreases; in con tin en ce m ay occur.

6. Gastroin testin al m otility an d peristalsis dim in - ish , leadin g to con stipatio n , gas accu m ulation , an d disten tion ; in con tin en ce m ay occur.

7. Muscu loskeletal system : Th e clien t gradually loses ability to m ove, h as difficu lty speakin g an d swallowin g, an d loses th e gag reflex.

F. Death 1. Death occurs wh en all vital organ s an d body sys-

tem s cease to fun ction . 2. In gen eral, respiration s cease first, an d th en th e

h eartb eat stops a few m in utes th ereafter. 3. Brain death occurs wh en th e cerebral cortex stops

fun ction in g or is irreversibly dam aged. G. Nursin g care

1. Frequen cy of assessm en t dep en ds on th e clien t’s stability (at least every 4 h ours); as ch an ges occur, assessm en t n eeds to be don e m ore frequen tly.

2. Ph ysical care ( Box 22-9) 3. Psych o social care

a. Mon itor for an xiety an d depression. b . Mon itor for fear (Box 22-10). c. En cou rage th e clien t an d fam ily to express

feelin gs. d . Provide supp ort an d ad vocacy for th e clien t

an d fam ily. e. Provide privacy for th e clien t an d fam ily. f. Provide a private room for th e clien t.

4. Postm ortem care (Box 22-11) a. Main tain respect an d dign ity for th e clien t. b . Determ in e wh eth er th e clien t is an organ

don or; if so, follo w appropriate procedures related to th e don atio n .

c. Con sider cultural rituals, state laws, an d agen cy proced ures wh en perform in g post- m ortem care.

d . Prepare th e body for im m ediate viewin g by th e fam ily.

e. Provide privacy an d tim e for th e fam ily to be with th e deceased perso n .

f. Medical exam in er jurisdiction guidelin es are determ in ed by each state an d usually in clude n on n atural, traum atic, or question of crim inal in volvem en t death s; any foren sic eviden ce is preserved an d th e body is n ot clean ed or pre- pared prior to transfer to th e m orgue.

275CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

CRITICAL THINKING What Should You Do? Answer: When caring for a child who is apprehens ive, the nurs e s hould provide a s afe and s ecure environm ent. The nurs e s hould als o take tim e for com m unication with the child; allow the child to expres s feelings s uch as anxi- ety, fear, or anger; accept any regres s ive behavior and as s is t the pres chooler in m oving from regres s ive to appro- priate behaviors . Additional interventions include encour- aging room ing-in with the parents or leaving a favorite toy; allowing m obility and providing play and diversional activities ; placing the pres chooler with other children of the s am e age if pos s ible; and encouraging the child to be independent. The nurs e s hould als o explain procedures s im ply, on the child’s level; avoid intrus ive procedures when pos s ible; and allow the child to wear his or her underpants .

Reference: Hockenberry, Wilson (20 15), pp. 537, 871-872.

P R A C T I C E Q U E S T I O N S 211. A 4-year-old ch ild diagn osed with leukem ia is h os-

pitalized for ch em oth erapy. Th e ch ild is fearful of th e h ospitalization . Wh ich n ursin g in terven tion sh ould be im plem en ted to alleviate th e ch ild’s fears? 1. En cou rage th e ch ild’s paren ts to stay with

th e ch ild.

BOX 22-9 Physical Care of the Dying Client Pain Administer pain medication. Do not delay or deny pain medication.

Dyspnea Elevate the head of the bed or position the client on his or her

side. Administer supplemental oxygen for comfort. Suction fluids from the airway as needed. Administer medications as prescribed.

Skin Assess color and temperature. Assess for breakdown. Implement measures to prevent breakdown.

Dehydration Maintain regular oral care. Encourage taking ice chips and sips of fluid. Do not force the client to eat or drink. Use moist cloths to provide moisture to the mouth. Apply lubricant to the lips and oral mucous membranes.

Anorexia, Nausea, and Vomiting Provide antiemetics before meals. Have family members provide the client’s favorite foods. Provide frequent small portions of favorite foods.

Elimination Monitor urinary and bowel elimination. Place absorbent pads under the client and check frequently.

Weakness and Fatigue Provide rest periods. Assess tolerance for activities. Provide assistance and support as needed for maintaining bed

or chair positions.

Restlessness Maintain a calm, soothing environment. Do not restrain. Limit the number of visitors at the client’s bedside (consider

cultural practices). Allow a family member to stay with the client.

BOX 22-10 Fear Associated with Dying

Fear of Pain Fear of pain may occur, based on anxieties related to dying. Do not delay or deny pain-relief measures to a terminally ill

client.

Fear of Loneliness and Abandonment Allow family members to stay with the client. Holding hands, touching (if culturally acceptable), and listen-

ing to the client are important.

Fear of Being Meaningless Client may feel hopeless and powerless. Encourage life reviews and focus on the positive aspects of the

client’s life.

Adapted from Lewis S, Dirksen S, Heitkemper M, Bucher L, Camera I: Medical- surgical nursing: assessment and management of clinical problems, ed 8, St. Louis, 20 11, Mosby.

BOX 22-11 General Postmortem Procedures Close the client’s eyes. Replace dentures. Wash the body and change bed linens if needed. Place pads under the perineum. Remove tubes and dressings. Straighten the body and place a pillow under the head in prep-

aration for family viewing.

276 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

2. En courage play with oth er ch ildren of th e sam e age.

3. Advise th e fam ily to visit on ly durin g th e sch ed- uled visitin g h ou rs.

4. Provide a private room , allowin g th e ch ild to brin g favorite toys from h om e.

212. A 16-year-o ld clien t is adm itted to th e h ospital for acute appen dicitis an d an appen dectom y is per- form ed. Wh ich n ursin g in terven tion is m o st ap p ro p riate to facilitate n orm al growth an d devel- opm en t posto peratively? 1. En cou rage th e clien t to rest an d read. 2. En courage th e paren ts to room in with th e

clien t. 3. Allow th e fam ily to brin g in th e clien t’s favorite

com pu ter gam es. 4. Allow th e clien t to in teract with oth ers in h is o r

h er ( Ad o lescen t) sam e age group.

213. Wh ich car safety device sh ould be used for a ch ild wh o is 8 years old an d 4 feet tall? 1. Seat belt 2. Booster seat 3. Rear-facin g con vertible seat 4. Fro n t-facin g con vertible seat

214. Th e n urse assesses th e vital sign s of a 12-m on th -old in fan t with a respiratory in fection an d n otes th at th e respiratory rate is 35 breath s/ m in ute. O n th e basis of th is fin din g, wh ich action is m o st ap p ro p riate? 1. Adm in ister oxygen . 2. Docum en t th e fin din gs. 3. Notify th e h ealth care provider. 4. Reassess th e respiratory rate in 15 m in utes.

215. Th e n urse is m on itorin g a 3-m on th -old in fan t for sign s of in creased in tracran ial pressure. O n palpa- tion of th e fon tan els, the n urse n otes that th e an te- rior fon tanel is soft an d flat. O n th e basis of this fin din g, which n ursin g action is m o st ap p ro p riate? 1. In crease oral fluid s. 2. Docum en t th e fin din g. 3. Notify th e h ealth care provider (HCP). 4. Elevate th e h ead of th e bed to 90 degrees.

216. Th e n urse is evaluatin g th e developm en tal level of a 2-year-o ld. Wh ich does th e n urse exp ect to observe in th is ch ild? 1. Uses a fork to eat 2. Uses a cup to drin k 3. Pours own m ilk in to a cup 4. Uses a kn ife for cuttin g food

217. A 2-year-old ch ild is treated in the em ergen cy departm en t for a burn to the ch est an d abdom en . Th e ch ild sustain ed th e burn by grabbin g a cup of

h ot coffee th at was left on th e kitch en coun ter. Th e n urse reviews safety prin ciples with the paren ts before disch arge. Which statem en t by th e paren ts in dicates an un derstan din g of m easures to provide safety in th e h om e? 1. “We will be sure n ot to leave h ot liquids

un atten ded.” 2. “I guess our ch ildren n eed to un derstan d wh at

th e word hot m ean s.” 3. “We will be sure th at th e ch ildren stay in th eir

room s wh en we work in th e kitch en .” 4. “We will in stall a safety gate as soon as we get

h om e so th e ch ildren can n ot get in to th e kitch en .”

218. A m oth er arrives at a clin ic with h er todd ler an d tells th e n urse th at sh e h as a difficult tim e gettin g th e ch ild to go to bed at n igh t. Wh at m easu re is m o st ap p ro p riate for th e n urse to suggest to th e m oth er? 1. Allow th e ch ild to set bedtim e lim its. 2. Allow th e ch ild to h ave tem per tan trum s. 3. Avoid lettin g th e ch ild n ap durin g th e day. 4. In form th e ch ild of bed tim e a few m in u tes

befo re it is tim e for bed.

219. Th e m oth er of a 3-year-old is con cern ed because h er ch ild still is in sistin g on a bottle at n ap tim e an d at bedtim e. Wh ich is th e m o st ap p ro p riate suggestion to th e m oth er? 1. Allow th e bottle if it con tain s juice. 2. Allow th e bottle if it con tain s water. 3. Do n ot allow th e ch ild to h ave th e bottle. 4. Allow th e bottle durin g n aps but n ot at bedtim e.

220. Th e n urse is preparin g to care for a 5-year-old wh o h as been placed in traction followin g a fracture of th e fem ur. Th e n urse plan s care, kn owin g th at wh ich is th e m o st ap p ro p riate activity for th is ch ild? 1. A radio 2. A sports video 3. Large picture books 4. Crayon s an d a colorin g book

221. Th e m oth er of a 3-year-old asks a clin ic n urse ab out ap propriate an d safe toys for th e ch ild. Th e n urse sh o uld tell th e m oth er th at th e m o st ap p ro p riate toy for a 3-year-old is wh ich ? 1. A wagon 2. A go lf set 3. A farm set 4. A jack set with m arbles

222. Wh ich in terven tion s are appropriate for th e care of an in fan t? Select all th at ap p ly.

1. Provid e swaddlin g. 2. Talk in a lo ud voice.

277CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

3. Provide th e in fan t with a bottle of juice at n ap tim e.

4. Han g m obiles with black an d wh ite con trast design s.

5. Caress th e in fan t wh ile bath in g or durin g dia- per ch an ges.

6. Allow th e in fan t to cry for at least 10 m in u tes befo re respon d in g.

223. Th e n urse is preparin g to care for a dyin g clien t, an d several fam ily m em bers are at th e clien t’s bed- side. Wh ich th erapeutic tech n iqu es sh ould th e

n urse use wh en co m m un icatin g with th e fam ily? Select all th at ap p ly.

1. Discou rage rem in iscin g. 2. Make th e decision s for th e fam ily. 3. En cou rage expressio n of feelin gs, con cern s,

an d fears. 4. Explain everyth in g th at is h app en in g to all

fam ily m em bers. 5. To uch an d h old th e clien t’s or fam ily m em -

ber’s h an d if appropriate. 6. Be h on est an d let th e clien t an d fam ily kn ow

th ey will n ot be aban do n ed by th e n urse.

A N S W E R S 211. 1 Ra tion a le: Alth o ugh th e presch ooler already m ay be spen din g som e tim e away from paren ts at a day care cen ter or presch ool, ill- n ess adds a stressor th at m akes separation m ore difficult. The child m ay ask repeatedly when paren ts will be com ing for a visit or m ay con stantly want to call th e paren ts. O p tions 3 and 4 in crease stress related to separation an xiety. O ption 2 is un related to th e sub ject of the questio n an d , in addition , m ay n ot be appropriate for a ch ild who m ay be im m unocom p rom ised and at risk fo r in fectio n. Test-Ta kin g Str a tegy: No te th at th e su b ject relates to th e ch ild ’s fear. O ptio n s 3 an d 4 will in crease an xiety an d fear fur- th er an d sh o uld be elim in ated . Bearin g th e su b ject o f th e qu es- tio n in m in d an d co n sid erin g th e ch ild’s d iagn o sis will assist yo u in elim in atin g o p tion 2. Review: Measu res to alleviate sep aratio n an xiety Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Develop m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: An xiety; Develo p m en t Refer en ce: Hocken b erry, Wilso n (2015), p. 871.

212. 4 Ra tion a le: Ad o lescen ts o ften are n o t su re wh eth er th ey wan t th eir p aren ts with th em wh en th ey are h o sp italized . Because o f th e im p o rtan ce of th eir p eer grou p , separation from frien ds is a so u rce o f an xiety. Id eally, th e m em bers o f th e p eer grou p will support th eir ill frien d. O ption s 1, 2, an d 3 isolate th e cli- en t from th e peer grou p. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Co n sid er th e p sych oso cial n eed s o f th e ado lescen t an d rem em b er th at th e p eer gro u p is very im p o rtan t. O p tion s 1, 2, an d 3 are co m p arab le o r alike in th at th ey iso late th e clien t fro m h is or h er own p eer gro up . Review: Psych o social n eed s o f th e ad o lescen t Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Develop m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Develo p m en t; Health Pro m otio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 874-875.

213. 2 Ra tion a le: All ch ildren wh o se weigh t or h eigh t is abo ve th e forward -facin g lim it for th eir car safety seat sh o uld u se a b elt- p ositio nin g b oo ster seat u ntil th e veh icle seat b elt fits p roperly,

typically wh en th ey h ave reach ed 4 feet, 9 in ch es in h eigh t (145 cm ) an d are between 8 an d 12 years o f age. In fan ts sh ould ride in a car in a sem ireclin ed , rear-facin g p ositio n in an in fan t- o nly seat or a con vertible seat un til th ey weigh at least 20 p ou nd s (9 kg) an d are at least 1 year of age. Th e tran sitio n poin t for switch in g to th e forward -facin g p osition is d efin ed by th e m an u - factu rer o f th e con vertib le car safety seat b ut is gen erally at a b od y weight of 9 kilogram s (20 pounds) and 1 year of age. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, car safety, an d n o te th e age an d h eigh t o f th e ch ild to id en tify th e ap prop riate safety device. Rem em b er th at ch ild ren sh ou ld rem ain in a b oo ster seat u n til th ey are 8 to 12 years o ld an d at least 4 feet, 9 in ch es (145 cm ) tall. Review: Car safety Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Develo p m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Hocken b erry, Wilso n (2015) , p . 601; www. h ealth ych ild ren .o rg

214. 2 Ra tion a le: Th e n orm al respiratory rate in a 12-m on th -old in fan t is 20 to 40 breath s/ m in ute. Th e n orm al ap ical h eart rate is 90 to 130 b eats/ m in u te, an d th e average b loo d pressu re is 90/ 56 m m Hg. Th e n urse wo u ld do cu m en t th e fin din gs. Test-Ta kin g Str a tegy: Focu s o n th e d ata in th e qu estio n an d n o te th e strategic wo rd s, most appropriate. Recallin g th e n orm al vital sign s of an in fan t an d n o tin g th at th e resp irato ry rate id en - tified in th e qu estio n is with in th e n orm al ran ge will d irect you to th e correct o ptio n . Review: No rm al vital sign s fo r th e in fan t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Develo p m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Hocken b erry, Wilso n (2015), p. 254.

215. 2 Ra tion a le: Th e an terio r fon tan el is d iam o n d -sh ap ed an d lo cated on th e to p o f th e h ead . Th e fo n tan el sh o uld b e so ft an d flat in a n o rm al in fan t, an d it n orm ally closes b y 12 to 18 m o n th s o f age. Th e n u rse wou ld d ocum en t th e fin d in g b ecau se it is n o rm al. Th ere is n o usefu l reason to in crease oral flu ids, n o tify th e HCP, o r elevate th e h ead o f th e b ed to 90 d egrees.

278 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate, an d th e wo rd s soft an d flat. Th is sh ou ld pro vide yo u with th e clu e th at th is is a n orm al fin d in g. A b ulgin g or ten se fo n ta- n el m ay resu lt from cryin g or in creased in tracran ial p ressu re. Review: Assessm en t o f th e fo n tan els Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Develo pm en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Develop m en t; In tracran ial Regulatio n Refer en ce: Ho cken berry, Wilson (2015), p . 255, 261.

216. 2 Ra t ion a le: By age 2 years, th e ch ild can u se a cu p an d sp oo n co rrectly b ut with som e spillin g. By age 3 to 4, th e ch ild b egin s to use a fo rk. By th e en d o f th e p resch o o l p eriod , th e ch ild sh ou ld b e able to p ou r m ilk in to a cup an d begin to u se a kn ife fo r cuttin g. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e d evelo pm en tal level o f a 2-year-o ld . O ption 4 can b e elim in ated first becau se of th e wo rd knife. Next, th in k ab o ut th e fin e m o tor skills th at n eed to be d evelo ped in selectin g th e co rrect op tio n . With th is in m in d, elim in ate o ption s 1 an d 3. Review: Develo p m en tal skills o f th e to d d ler Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Develo pm en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Clin ical Jud gm en t; Develop m en t Refer en ce: Ho cken berry, Wilson (2015), p p. 492, 497.

217. 1 Ra t ion a le: To dd lers, with th eir in creased m o bility an d devel- op m en t o f m oto r skills, can reach h o t water or h o t o bjects placed o n cou n ters an d sto ves an d can reach o pen fires o r sto ve bu rn ers ab ove th eir eye level. Th e n urse sh ou ld en cou rage par- en ts to rem ain in th e kitch en wh en p rep arin g a m eal, use th e back b urn ers on th e stove, an d tu rn p ot h an dles in ward an d to ward th e m id d le of th e sto ve. Ho t liq u ids sh ou ld n ever b e left un atten ded or with in th e ch ild ’s reach , an d th e to dd ler sh o uld always b e su pervised . Th e statem en ts in o ption s 2, 3, an d 4 do n ot in dicate an u n d erstan d in g of th e p rin ciples o f safety. Test -Ta kin g Str a tegy: No te th e wo rd s indicates an understand- ing. O ption 2 can be elim in ated b ecause it is m an datin g th at th e tod d ler un derstan d wh at is an d is n o t safe. Th e tod dler is n ot d evelo pm en tally able to un derstan d dan ger. O ptio n s 3 an d 4 are co m p arab le o r alike in th at th ey isolate th e ch ild fro m th e en viro n m en t. Th e correct o ptio n is th e on ly o n e th at reflects an u n derstan din g of safety prin ciples by th e paren ts. Review: Safety m easures for th e to d d ler Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Develo pm en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Develop m en t; Safety Refer en ce: Ho cken berry, Wilson (2015), p p. 515-516.

218. 4 Ra t ion a le: To d dlers o ften resist go in g to bed . Bed tim e p ro tests m ay be redu ced b y establish in g a con sisten t b efo re-b ed tim e ro utin e an d en fo rcin g co n sisten t lim its regardin g th e ch ild’s bed tim e b eh avio r. In fo rm in g th e ch ild of bedtim e a few

m in utes b efo re it is tim e fo r b ed is th e m ost ap p ro priate o p tion . Most tod d lers take an aftern o on n ap an d , u n til th eir seco n d birth d ay, also m ay req uire a m o rn in g n ap. Firm , co n - sisten t lim its are n eeded fo r tem per tan trum s o r wh en to dd lers try stallin g tactics. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate, an d focu s on th e su b ject, th e to dd ler. Elim in ate op tio n s 1, 2, an d 3 by u sin g co n cep ts related to growth an d develop m en t. Rem em b er th at prep arin g th e tod dler fo r an even t will m in i- m ize resistive beh avior. Review: Sleep p attern s fo r th e to d d ler Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develop m en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Clien t Ed u catio n ; Develo p m en t Refer en ce: Ho cken berry, Wilson (2015), p . 509.

219. 2 Ra t ion a le: A tod dler sh ou ld n ever b e allowed to fall asleep with a bottle con tain in g m ilk, juice, soda pop, sweeten ed water, or an y oth er sweet liquid because of th e risk of n ursin g (b ottle-m o uth ) caries. If a bo ttle is allo wed at n ap tim e or b ed - tim e, it sh o uld con tain on ly water. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Elim in ate o ptio n s 3 an d 4 first b ecause th ey are co m p ara- b le o r alike statem en ts. From th e rem ain in g op tion s, recallin g th at n u rsin g (b ottle-m o uth ) caries is a co n cern in a ch ild will assist in d irectin g yo u to th e co rrect o p tion . Review: In stru ction s for th e ch ild wh o is b o ttle-feed in g Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develop m en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Develop m en t; Safety Refer en ce: Ho cken berry, Wilson (2015), p p. 511-512.

220. 4 Ra t ion a le: In th e presch oo ler, p lay is sim ple an d im agin ative, an d in clud es activities such as crayon s an d co lo rin g bo o ks, p u pp ets, felt an d m agn etic b oards, an d Play-Do h . A rad io o r a sp orts vid eo is m o st ap prop riate fo r th e ado lescen t. Large p ic- tu re bo oks are m o st ap prop riate for th e in fan t. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Note th e age of th e ch ild, an d th in k ab ou t th e age-related activity th at wo uld be m o st ap prop riate. Elim in ate o ptio n s 1 an d 2, kn owin g th at th ey are m o st ap prop riate fo r th e ado les- cen t. Fro m th e rem ain in g o ptio n s, th e word large in o ptio n 3 sh ou ld p ro vid e yo u with th e clu e th at th is activity wou ld b e m o re app ro priate fo r a ch ild you n ger th an age 5. Review: Age-ap p ro p riate activities Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Develop m en tal Stages—In fan cy to Ad o lescen ce Pr ior ity Con cepts: Cop in g; Develo pm en t Refer en ce: Ho cken berry, Wilson (2015), p . 875.

221. 1 Ra t ion a le: Toys for th e toddler m ust be stron g, safe, an d too large to swallow or p lace in th e ear or n o se. Tod dlers n eed

279CHAPTER 22 Developmental Stages

F

u

n

d

a

m

e

n

t

a

l

s

su pervisio n at all tim es. Pu sh -p ull to ys, large b alls, large crayon s, large tru cks, an d do lls are som e of th e ap prop riate to ys. A farm set, a golf set, an d jacks with m arbles m ay con tain item s th at th e ch ild co uld swallo w. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate, an d fo cu s on th e su b ject, th e ap prop riate to y fo r a 3-year- o ld. O p tion s 2, 3, an d 4 can be elim in ated becau se th ey are co m p arab le o r alike an d co uld co n tain item s th at th e ch ild cou ld swallow. Rem em ber th at large an d stron g toys are safest fo r th e tod dler. Review: Age-ap p ro p riate activities Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develop m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Develo p m en t; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 497.

222. 1, 4, 5 Ra tion a le: Holdin g, caressin g, an d swadd lin g pro vide warm th and tactile stim u latio n for th e in fan t. To provide aud itory stim - u lation , th e n urse sh ould talk to th e in fan t in a soft voice and sho uld in struct th e m oth er to do so also. Add itio n al in terven - tio n s in clud e playin g a m u sic b ox, radio , or televisio n , o r h avin g a tickin g clock o r m etro n om e n earby. Han gin g a b righ t sh in y o bject in m idlin e with in 20 to 25 cm o f th e in fan t’s face an d h an gin g m o biles with con trastin g co lo rs, such as b lack an d white, p rovide visual stim ulation . Cryin g is an infan t’s way of com m un icatin g; th erefo re, th e n urse would respo nd to th e in fan t’s cryin g. Th e m oth er is tau gh t to d o so also. An in fan t o r ch ild sh ould n ever b e allowed to fall asleep with a b ottle con - tain in g m ilk, juice, sod a pop, sweeten ed water, o r an oth er sweet liquid b ecau se of th e risk of n ursin g ( bottle-m outh ) caries.

Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, care o f th e in fan t. No tin g th e wo rd loud an d th e words at least 10 minutes before responding will assist in elim in atin g th ese in terven tion s. Also , recallin g th e con cern s related to den tal caries will assist in elim - in atin g op tion 3. Review: Care of an in fan t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Develo p m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Develo pm en t; Safety Refer en ce: Lowd erm ilk et al. (2016), pp . 503-504.

223. 3, 5, 6 Ra tion a le: Th e n u rse m ust d eterm in e wh eth er th ere is a sp okesperson for th e fam ily an d h ow m uch th e clien t an d fam - ily wan t to kn o w. Th e n urse n eeds to allo w th e fam ily an d cli- en t th e o pp o rtu n ity for in form ed ch o ices an d assist with th e d ecision -m akin g process if asked . Th e n urse sh o uld en co urage exp ression of feelin gs, co n cern s, an d fears an d rem in iscin g. Th e n u rse n eeds to be h on est an d let th e clien t an d fam ily kn ow th ey will n ot be aban do n ed . Th e n u rse sh ou ld tou ch an d h old th e clien t’s or fam ily m em b er’s h an d , if app ro priate. Test-Ta kin g St r a t egy: Use th erap eu tic co m m u n icatio n tech - n iq u es an d recall clien t an d fam ily righ ts to assist in d irectin g you to th e correct op tio n s. Review: En d -o f-life care Level of Cogn itive Ability: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Develop m en tal Stages—En d -of-Life Care Pr ior it y Con cept s: Fam ily Dyn am ics; Palliation Refer en ce: Perry, Po tter, O sten d orf, (2014), p p. 31, 388.

280 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

C H A P T E R 23 Care of the Older Client

PRIORITY CONCEPTS Development, Safety

CRITICAL THINKING What Should You Do? The home care nurse is caring for an older female client who lives with her son and is physically and financially dependent on him. The nurse notes multiple bruises on the client’s arms and asks the client how these bruises occurred. The client confides in the nurse that her son takes out his anger on her sometimes. What should the nurse do? Answer located on p. 285.

I. Aging and Gerontology A. Agin g is th e biopsych osocial process of ch an ge th at

occurs in a perso n between birth an d death . B. Geron tology is th e study of th e agin g process.

II. Physiological Changes A. In tegum en tary system

1. Loss of pigm en t in h air an d skin 2. Wrin klin g of th e skin 3. Th in n in g of th e epiderm is an d easy bruisin g an d

tearin g of th e skin 4. Decreased skin turgo r, elasticity, an d subcu tan e-

ous fat 5. In creased n ail th ickn ess an d decreased n ail

growth 6. Decreased persp iration 7. Dry, itch y, scaly skin 8. Sebo rrh eic derm atitis an d keratosis form ation

(overgrowth an d th icken in g of th e skin ) B. Neurological system

1. Slo wed reflexes 2. Sligh t trem o rs an d difficulty with fin e m oto r

m ovem en t 3. Loss of balan ce 4. In creased in ciden ce of awaken in g after sleep

on set 5. In creased susceptibility to h ypo th erm ia an d

h yperth erm ia 6. Sh o rt-term m em ory declin e possible 7. Lon g-term m em ory usually m ain tain ed

C. Muscu loskeletal system 1. Decreased m uscle m ass an d stren gth an d atroph y

of m uscles 2. Decreased m obility, ran ge of m otion , flexibility,

coordin ation , an d stability 3. Ch an ge of gait, with sh orten ed step an d wider

base 4. Postu re an d stature ch an ges causin g a decrease in

h eigh t ( Fig. 23-1) 5. In creased brittlen ess of th e bon es 6. Deterioratio n of join t capsule co m pon en ts 7. Kyph o sis of th e dorsal spin e (in creased con vexity

in th e curvatu re of th e spin e)

The older client is at risk for falls because of the changes that occur in the neurological and musculoskel- etal systems.

D. Card iovascular system 1. Dim in ish ed en ergy an d en duran ce, with lowered

toleran ce to exercise 2. Decreased com plian ce of th e h eart m uscle,

with h eart valves beco m in g th icker an d m ore rigid

3. Decreased cardiac outp ut an d decreased effi- cien cy of blood return to th e h eart

4. Decreased com pen satory respo n se, so less ab le to respo n d to in creased dem an ds on th e cardiovas- cular system

5. Decreased restin g h eart rate 6. Weak periph eral pulses 7. In creased blood pressure but susceptibility to

postu ral h ypo ten sion E. Resp iratory system

1. Decreased stretch an d com plian ce of th e ch est wall

2. Decreased stren gth an d fun ction of respiratory m uscles

3. Decreased size an d n um ber of alveoli 4. Resp iratory rate usually un ch an ged 5. Decreased depth of respiratio n s an d oxygen

in take 6. Decreased ability to cough an d expecto rate

sputu m

F

u

n

d

a

m

e

n

t

a

l

s

281

F. Hem atological system 1. Hem o globin an d h em atocrit levels average

toward th e low en d of n orm al 2. Pron e to in creased blood clottin g 3. Decreased protein available for protein -bou n d

m ed ication s G. Im m un e system

1. Ten d en cy for lym p h ocyte coun ts to be lo w with altered im m un oglobulin produ ction

2. Decreased resistan ce to in fection an d disease H. Gastro in testin al system

1. Decreased n eed for calories because of lowered basal m etab olic rate

2. Decreased appetite, th irst, an d oral in take 3. Decreased lean body weigh t 4. Decreased stom ach em ptyin g tim e 5. In creased ten den cy toward con stipatio n 6. In creased susceptibility for deh ydration 7. Tooth loss 8. Difficulty in ch ewin g an d swallowin g food

I. En docrin e system 1. Decreased secretio n of h orm on es, with specific

ch an ges related to each h orm on e’s fun ction 2. Decreased m etab olic rate 3. Decreased glucose toleran ce, with resistan ce to

in sulin in periph eral tissues J. Ren al system

1. Decreased kidn ey size, fun ction , an d ab ility to con cen trate urin e

2. Decreased glom erular filtration rate 3. Decreased capacity of th e bladder 4. In creased residual urin e an d in creased in ciden ce

of in fectio n an d possibly in con tin en ce 5. Im paired m edication excretio n

K. Reprod uctive system 1. Decreased testo steron e production an d

decreased size of th e testes 2. Ch an ges in th e prostate glan d, leadin g to urin ary

problem s 3. Decreased secretio n of h orm on es with th e cessa-

tion of m en ses 4. Vagin al ch an ges, in cludin g decreased m uscle

ton e an d lu brication 5. Im poten ce or sexual dysfun ction for both sexes;

sexual fun ction varies an d dep en ds on gen eral ph ysical con dition , m en tal h ealth status, an d m edication s

L. Special sen ses 1. Decreased visual acuity 2. Decreased accom m o dation in eyes, requirin g

in creased adjustm en t tim e to ch an ges in ligh t 3. Decreased periph eral vision an d in creased sen si-

tivity to glare 4. Presb yopia an d cataract form ation 5. Possib le loss of h earin g ability; low-pitch ed

ton es are h eard m ore easily 6. In ability to discern taste of food 7. Decreased sen se of sm ell 8. Ch an ges in touch sen sation 9. Decreased pain awaren ess

III. Psychosocial Concerns A. Adjustm en t to deterioration in ph ysical an d m en tal

h ealth an d well-bein g B. Th reat to in depen den t fun ction in g an d fear of

becom in g a burden to loved on es C. Adjustm en t to retirem en t an d lo ss of in com e D. Loss of skills an d com peten cies developed early

in life E. Copin g with ch an ges in role fun ctio n an d social life F. Dim in ish ed quan tity an d quality of relation sh ips

an d copin g with loss G. Depen den ce on govern m en tal an d social system s H. Access to social support system s I. Costs of h ealth care an d m edication s

IV. Mental Health Concerns A. Depression: Th e in creased dep en den cy th at older

adults m ay experien ce can lead to h op elessn ess, h elplessn ess, lowered sen se of self-con trol, an d decreased self-esteem an d self-worth ; th ese ch an ges can in terfere with daily fun ction in g an d lead to depression .

B. Grief: Clien t reacts to th e percep tion of loss, in clud- in g ph ysical, psych ological, social, an d spiritual aspects.

H

e

i

g

h

t

Age 40 60 70

5'6"

5'0"

4'6"

4'0"

3'6"

3'0"

2'6"

2'0"

1'6"

1'0"

0'6"

0'0"

FIGURE 23-1 A normal spine at age 40 years of age and osteoporotic changes at 60 and 70 years of age. These changes can cause a loss of as much as 6 inches (15 cm) in height and can result in the so-called dow- ager’s hump (far right) in the upper thoracic vertebrae.

282 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

C. Iso lation : Clien t is alon e an d desires con tact with oth ers but is un able to m ake th at con tact.

D. Suicide: Depression can lead to th ough ts of self-h arm .

E. Depression differs from delirium an d dementia ( Table 23-1).

Any suicide threat made by an older client should be taken seriously.

V. Pain A. Description

1. Pain can occur from n um erou s causes an d m ost often occurs fro m degen erative ch an ges in th e m uscu loskeletal system .

2. Th e n urse n eeds to m on itor th e older clien t clo sely for sign s of pain ; failure to alleviate pain in th e older clien t can lead to fun ction al lim ita- tio n s affectin g h is or h er ability to fun ction in depen den tly.

B. Assessm en t 1. Restlessn ess 2. Verbal reportin g of pain 3. Agitation 4. Moan in g 5. Cryin g

C. In terven tion s 1. Mon itor th e clien t for sign s of pain . 2. Iden tify th e pattern of pain .

3. Iden tify th e precipitatin g facto r(s) for th e pain . 4. Mon itor th e im pact of th e pain on activities of

daily livin g. 5. Provide pain relief th rough m easures such as dis-

traction , relaxation , m assage, an d biofeedback. 6. Adm in ister pain m ed ication as prescribed, an d

in struct th e clien t in its use. 7. Evaluate th e effects of pain -red ucin g m easu res.

VI. Infection (Box 23-1) A. Con fusion is a com m on sign of in fectio n in th e older

adult, especially in fectio n of th e urin ary tract.

TABLE 23-1 Differentiating Delirium, Depression, and Dementia Characteristic Delirium Depression Dementia

Onset Sudden, abrupt Recent, may relate to life change Insidious, slow, over years and often unrecognized until deficits are obvious

Course over 24 hr

Fluctuating, often worse at night Fairly stable, may be worse in the morning

Fairly stable, may see changes with stress; sundowning may occur

Consciousness Reduced Clear Clear

Alertness Increased, decreased, or variable Normal Generally normal

Psychomotor activity

Increased, decreased, or mixed Variable; agitation or retardation Normal; may have apraxia or agnosia; agitation can occur

Duration Hours to weeks Variable and may be chronic Years

Attention Disordered, fluctuates Little impairment Generally normal but may have trouble focusing; overwhelmed with multiple stimuli

Orientation Usually impaired, fluctuates Usually normal, may answer “I don’t know” to questions or may not try to answer

Often impaired, may make up answers or answer close to the right thing, or may confabulate, but tries to answer

Speech Often incoherent, slow or rapid, may call out repeatedly or repeat the same phrase

May be slow Difficulty finding word, perseveration

Affect Variable but may look disturbed, frightened

Flat Slowed response, may be labile

Adapted from Sendelbach S, Guthrie PF, Schoenfelder DP: Acute confusion/ delirium, J Gerontol Nurse 35(11):11–18, 20 0 9.

BOX 23-1 Nonspecific Symptoms That Possibly Indicate Illness or Infection

▪ Anorexia ▪ Apathy ▪ Changes in functional status ▪ Confusion ▪ Dyspnea ▪ Falling ▪ Fatigue ▪ Incontinence ▪ Self-neglect ▪ Shortness of breath ▪ Tachypnea ▪ Vital sign changes

283CHAPTER 23 Care of the Older Client

F

u

n

d

a

m

e

n

t

a

l

s

B. Carefully m on itor th e older adult with in fectio n because of th e dim in ish ed an d altered im m un e respo n se.

C. Non sp ecific sym pto m s m ay in dicate illn ess or in fec- tion (see Box 23-1).

VII. Medications A. Majo r problem s with prescriptive m ed ication s

in clude adverse effects, m ed ication in teraction s, m edication erro rs, n on com plian ce, polyph arm acy, an d cost. See Box 23-2 for in form ation on m edication s to avoid in th e older adult clien t. Th is in form ation is based on Beers Criteria from th e Am erican Geriatrics Society. In form ation on th is criteria an d a full list of m ed ication s to avoid can be located at h ttp:/ / www.am erican geriatrics. org/ files/ docum en ts/ beers/ BeersCriteriaPublicTran slation .pdf

B. Determ in e th e use of over-th e-cou n ter m ed ication s. C. Polypharmacy

1. Routin ely m on itor th e n um ber of prescription an d n on prescrip tion m edication s used an d determ in e wh eth er an y can be elim in ated or com bin ed.

2. Keep th e use of m edication s to a m in im u m . 3. O verprescribin g m edication s leads to in creased

problem s with m ore side an d adverse effects, in creased in teraction between m edication s, duplication of m ed ication treatm en t, dim in - ish ed quality of life, an d in creased costs.

D. Medication dosages n orm ally are prescribed at on e th ird to on e h alf of n orm al adult dosages.

E. Closely m on itor th e clien t for adverse effects an d respon se to th erapy because of th e in creased risk for m edication toxicity (see Box 23-2).

F. Assess for m ed ication in teraction s in th e clien t tak- in g m ultiple m edication s.

G. Advise th e clien t to use 1 ph arm acy an d n otify th e con sultin g h ealth care provider( s) of th e m edica- tion s taken .

A common sign of an adverse reaction to a medi- cation in the older client is a sudden change in mental status.

H. Safety m easu res for m edication adm in istration ( See Prio rity Nu rsin g Actio n s Bo x) 1. Th e clien t sh o uld be in a sittin g position wh en

takin g m ed ication . 2. Th e m ou th is ch ecked for dryn ess because m ed-

ication m ay stick an d dissolve in th e m outh . 3. Liquid preparation s can be used if th e clien t h as

difficu lty swallowin g tab lets. 4. Tablets can be crush ed if n ecessary an d given

with textured food (n ectar, applesau ce) if n ot con train dicated.

5. En teric-coated tablets are n ot crush ed an d cap- sules are n ot open ed.

6. If adm in isterin g a supp ository, avoid in sertin g th e suppository im m ediately after rem ovin g it from th e refrigerator; a supp ository m ay take a wh ile to dissolve because of decreased body core tem perature.

7. Wh en adm in isterin g paren teral solution or m edication , m on itor th e site, because it m ay ooze or bleed due to decreased tissue elasticity; an im m ob ile lim b is n ot used for adm in isterin g paren teral m ed ication .

8. Mon itor clien t com plian ce with takin g pre- scrib ed m edication s.

9. Mon itor the client for safety in correctly takin g m edication s, includin g an assessm en t of h is or h er ability to read th e in struction s an d discrim i- n ate am on g the pills an d th eir colors an d sh apes.

10. Use a m ed ication cassette to facilitate proper adm in istration of m ed ication .

BOX 23-2 Medications to Avoid in the Older Client

Analgesics ▪ Indomethacin ▪ Ketorolac ▪ Nonsteroidal antiinflammatory drugs (NSAIDs) ▪ Meperidine Antidepressants ▪ First-generation tricyclic antidepressants Antihistamines ▪ First-generation antihistamines Antihypertensives ▪ Alpha1-blockers ▪ Centrally acting alpha2-agonists Urge Incontinence Medications ▪ Oxybutynin ▪ Tolterodine Muscle Relaxants ▪ Carisoprodol ▪ Cyclobenzaprine ▪ Metaxolone ▪ Methocarbamol Sedative-Hypnotics ▪ Barbiturates ▪ Benzodiazepines

284 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

VIII. Abuse of the Older Adult A. Do m estic m istreatm en t takes place in th e h om e of

th e older adult an d is usually carried out by a fam ily m em ber or sign ifican t oth er; th is can in clude ph ysi- cal m altreatm en t, neglect, or ab an don m en t.

B. In stitution al m istreatm en t takes place wh en an older adult exp erien ces abuse wh en h ospitalized or livin g som ewh ere oth er th an h om e (e.g., lo n g-term care facility).

C. Self-neglect is th e ch oice by a m en tally com peten t in dividual to avoid m edical care or oth er services th at could im prove optim al fun ction , to n ot care for on e- self, an d to en gage in action s th at n egatively affect h is or h er person al safety; un less declared legally in com - peten t, an in dividual h as the righ t to refuse care.

Individuals at most risk for abuse include those who are dependent because of their immobility or altered mental status.

D. For addition al in form ation on abuse of th e older clien t, see Ch apter 71.

CRITICAL THINKING What Should You Do? Answer: If the nurse suspects or knows for certain that elder abuse is occurring, the nurse s hould report this abuse to the appropriate authorities and follow s tate and agency guide- lines in doing so. The nurse should then perform a thorough asses sm ent of physical injuries, while providing confiden- tiality during the assessm ent with an empathetic and non- judgm ental approach. The nurse should reassure the victim that he or she has done nothing wrong. The nurse should als o as sist the victim in developing s elf-protective and problem -solving skills . Even if the victim is not ready to leave the situation, encourage the victim to develop a spe- cific safety plan (a fast escape if the violence returns) and know where to obtain help (hotlines , safe houses, and shel- ters); an abused person is usually reluctant to call the police.

Reference: Lewis, Dirksen, Heitkemper, Bucher (20 14), pp. 68–69.

PRIORITY NURSING ACTIONS Administering Oral Medications to a Client at Risk for Aspiration 1. Check the medication prescription and compare against

the medical record. Clarify any incomplete prescriptions prior to administration. Check the 6 rights of medication administration.

2. Review pertinent information related to the medication and any related nursing considerations, such as laboratory parameters.

3. Assess for any contraindications to the administration of oral medications, such as NPO (nothing by mouth) status or decreased level of consciousness.

4. Place the client in a high Fowler’s position. Assess aspira- tion risk using a screening tool or per agency policy. Check for an ability to swallow and cough on command. Check for the presence of a gag reflex. Following this assessment, if aspiration is a serious concern, the nurse would collaborate with the health care provider and speech therapist before administering the medication.

5. Prepare the medication in the form that is easiest to swallow, checking the 6 rights of medication administration again. Mix medications whole or crush medications and mix with applesauce or pudding if indicated (use sugar- free products for clients with diabetes). Do not crush sustained-release tablets, and use liquid preparations when possible. Thicken liquids when indicated, and avoid the use of straws.

6. Check the 6 rights of medication administration for the last time, and administer the medications 1 at a time in the pre- pared form, ensuring that the client has effectively swallowed everything. Ensure that the client is comfortable and safe, and document the medications given using an electronic sys- tem or per agency policy.

If a client is determined to be at risk for aspiration, there are specific actions the nurse should take to ensure client safetywhen administering oral medications. As with the administration of any medication, the nurse checks the medication prescription and compares it against the medical record clarifying any incomplete prescriptions; checks the 6 rights of medication administration: right client, right medication, right time, right route, right fre- quency, and right purpose; reviews any pertinent information related to medication administration, such as the international normalized ratio for the client taking warfarin; and assesses for any contraindications for administration of oral medications, such as NPO status. Next, the nurse places the client in a high Fowler’s position and assesses for the client’s aspiration risk using the agency-approved screening tool to determine if it is safe to administer oral medications, checking for the abilityto swallow and cough on command and checking for the presence of a gag reflex. If the client is unable to swallow or does not have a gag reflex then the nurse would not administer the medications and would collaborate with the health care provider. If the client is able to swallow and cough and has a gag reflex then the nurse checks the 6 rights of medication administration again and pre- pares the medications and anyliquids used in the most appropri- ate form based on the outcome of the swallow screen. Next, the nurse checks the 6 rights of medication administration immedi- atelybefore administration for the last time, administers the med- ications 1 at a time in the prepared form, and ensures that the client has effectively swallowed each medication. The nurse then ensures that the client is comfortable and safe and documents the medications given per agency policy.

Reference Potter, Perry, Ostendorf (2014), pp. 495–500 .

285CHAPTER 23 Care of the Older Client

F

u

n

d

a

m

e

n

t

a

l

s

P R A C T I C E Q U E S T I O N S 224. Th e n urse is provid in g m ed ication in struction s to

an older clien t wh o is takin g digo xin daily. Th e n urse explain s to th e clien t th at decreased lean body m ass an d decreased glom erular filtration rate, wh ich are age-related body ch an ges, could place th e clien t at risk for wh ich com plication with m ed ication th erapy? 1. Decreased ab sorption of digoxin 2. In creased risk for digoxin toxicity 3. Decreased th erap eutic effect of digoxin 4. In creased risk for side effects related to digo xin

225. Th e n urse is carin g for an older clien t in a lon g-term care facility. Wh ich action con tribu tes to en courag- in g au ton om y in th e clien t? 1. Plan n in g m eals 2. Decoratin g th e room 3. Sch edulin g h aircu t appoin tm en ts 4. Allowin g th e clien t to ch oo se social activities

226. Th e h om e care n urse is visitin g an older clien t wh ose spouse died 6 m on th s ago. Wh ich beh aviors by th e clien t in dicates effective copin g? Select all th at ap p ly. 1. Neglectin g perso n al groom in g 2. Lookin g at old sn apsh o ts of fam ily 3. Participatin g in a sen ior citizen s program 4. Visitin g th e spouse’s grave on ce a m on th 5. Decoratin g a wall with th e spou se’s pictures an d

awards received

227. Th e n urse is provid in g in struction s to th e un li- cen sed assistive person n el (UAP) regardin g care of an older clien t with h earin g loss. Wh at sh ould th e n urse tell th e UAP about older clien ts with h earin g lo ss? 1. Th ey are often distracted. 2. Th ey h ave m iddle ear ch an ges. 3. Th ey respo n d to low-pitch ed ton es. 4. Th ey develo p m oist cerum en produ ction .

228. Th e n urse is provid in g an edu cation al session to n ew em p loyees, an d th e topic is abuse of th e older clien t. Th e n urse h elps th e em plo yees to iden tify wh ich clien t as m o st typically a victim of ab use? 1. A m an wh o h as m od erate h yperten sion 2. A m an wh o h as n ewly diagn osed cataracts 3. A wom an wh o h as advan ced Parkin son ’s disease 4. A wom an wh o h as early diagn osed Lym e disease

229. Th e n urse is perform in g an assessm en t on an older clien t wh o is h avin g difficulty sleep in g at n igh t. Wh ich statem en t by th e clien t in dicates th e n eed fo r fu rth er teach in g regardin g m easures to im prove sleep?

1. “I swim 3 tim es a week.” 2. “I h ave stopp ed sm okin g cigars.” 3. “I drin k h ot ch oco late befo re bedtim e.” 4. “I read for 40 m in utes befo re bedtim e.”

230. Th e visitin g n urse observes th at th e older m ale cli- en t is con fin ed by h is daugh ter-in -law to h is ro om . Wh en th e n urse suggests th at h e walk to th e den an d join th e fam ily, h e says, “I’m in everyon e’s way; m y daugh ter-in -law n eeds m e to stay h ere.” Wh ich is th e m o st im p o rtan t action for th e n urse to take? 1. Say to th e daugh ter-in -law, “Con fin in g yo ur

fath er-in -law to h is room is in h um an e.” 2. Suggest to th e clien t an d daugh ter-in -law th at

th ey con sid er a n ursin g h om e for th e clien t. 3. Say n oth in g, because it is best for th e n urse to

rem ain n eutral an d wait to be asked for h elp. 4. Suggest appropriate resou rces to th e clien t an d

daugh ter-in -law, such as respite care an d a sen ior citizen s cen ter.

231. Th e n urse is perform in g an assessm en t on an older adult clien t. Wh ich assessm en t data would in dicate a poten tial com plication associated with th e skin ? 1. Crustin g 2. Wrin klin g 3. Deepen in g of expression lin es 4. Th in n in g an d loss of elasticity in th e skin

232. Th e h om e h ealth n urse is visitin g a clien t for th e first tim e. Wh ile assessin g th e clien t’s m edication h isto ry, it is n oted th at th ere are 19 prescription s an d several over-th e-coun ter m edication s th at th e clien t h as been takin g. Wh ich in terven tion sh ould th e n urse take first? 1. Ch eck for m edication in teraction s. 2. Determ in e wh eth er th ere are m edication

duplication s. 3. Call th e prescribin g h ealth care provider (HCP)

an d report polyph arm acy. 4. Determ in e wh eth er a fam ily m em ber supervises

m edication adm in istration .

233. Th e lon g-term care n urse is perform in g assess- m en ts on several of th e residen ts. Wh ich are n or- m al age-related ph ysiological ch an ges th e n urse sh ould expect to n ote? Select all th at ap p ly.

1. In creased h eart rate 2. Declin e in visual acuity 3. Decreased respiratory rate 4. Declin e in lon g-term m em ory 5. In creased susceptibility to urin ary tract

in fectio n s 6. In creased in ciden ce of awaken in g after

sleep on set

286 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

A N S W E R S 224. 2 Ra t ion a le: Th e o lder clien t is at risk fo r m edicatio n to xicity because o f decreased lean bo d y m ass an d an age-associated decreased glom erular filtratio n rate. Th is age-related ch an ge is n ot sp ecifically asso ciated with d ecreased abso rp tio n , decreased th erapeu tic effect, or in creased risk for side effects. Toxicity, o r toxic effects, o ccurs as a result o f excessive accu m u - lation of th e m edicatio n in th e b od y. Test -Ta kin g St r a t egy: Focus on th e su b ject, age-related body ch an ges th at co uld place th e clien t at risk fo r m edicatio n tox- icity. Recall th at toxicity o ccurs as a result o f m edicatio n accu - m u latio n in th e b od y, wh ich usu ally o ccurs as a resu lt o f decreased ren al fu n ctio n . Note th at th e correct o ption is th e on ly on e th at add resses ren al excretio n . Review: Risks for m ed icatio n to xicity in th e o ld er clien t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develop m en tal Stages—Early Ad u lth o od to Later Adu lth o o d Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Lewis et al. (2014), p p. 73-74, 112.

225. 4 Ra t ion a le: Auton om y is th e person al freedom to direct on e’s own life as lon g as it does n ot im pin ge on th e righ ts of oth ers. An auton - om ous person is capable of ration al th ough t. Th is in dividual can iden tify problem s, search for altern atives, an d select solution s th at allow con tin ued person al freedom as lon g as oth ers an d th eir righ ts an d property are n ot h arm ed. Loss of auton om y, an d th ere- fore in depen den ce, is a real fear of older clien ts. Th e correct option is th e on ly on e th at allows th e clien t to be a decision m aker. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, en cou ragin g au to n om y. Recallin g th e defin itio n o f au to n o m y will direct yo u to th e co rrect o ption . Rem em ber th at givin g th e clien t ch o ices is essen tial to p ro m o te in depen den ce. Review: Au to n o m y Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Develop m en tal Stages—Early Ad u lth o od to Later Adu lth o o d Pr ior ity Con cepts: Health Care Q uality; Professio n alism Refer en ce: Zerwekh , Zerwekh Garn eau (2015), p. 421.

226. 2, 3, 4, 5 Ra t ion a le: Copin g m ech an ism s are beh avio rs u sed to d ecrease stress an d an xiety. In respo n se to a death , in effective copin g is m an ifested by an extrem e b eh avior that in som e cases m ay b e h arm ful to th e in dividual ph ysically or p sych ologically. Neglect- in g p erson al gro om in g is in d icative o f a beh avio r that iden tifies in effective copin g in th e grievin g p ro cess. Th e rem ain in g o ption s id en tify app ro priate and effective copin g m echan ism s. Test -Ta kin g St r a t egy: No te th e strategic wo rd , effective, an d fo cus o n th e su b ject, effective cop in g b eh avio rs. No te th at op tion s 2, 3, 4, an d 5 are co m p arab le o r alike an d are po sitive activities in wh ich th e in d ivid ual is en gagin g to get o n with h is or h er life.

Review: Co p in g m ech an ism s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Cop in g; Fam ily Dyn am ics Refer en ces: Lewis et al. (2014), p. 144 Varcarolis (2013) , pp . 491-492.

227. 3 Ra t ion a le: Presbycusis refers to the age-related irreversible degen - erative ch anges of th e in n er ear that lead to decreased h earin g abil- ity. As a result of th ese ch anges, th e o lder clien t h as a decreased response to h igh-frequen cy soun ds. Low-pitch ed voice ton es are h eard m ore easily an d can be in terpreted by the older clien t. O ption s 1, 2, and 4 are n ot accurate characteristics related to agin g. Test-Ta kin g Str a tegy: Focus on th e su b ject, age-related ch an ges related to h earin g. Th in k about th e physiological ch an ges associ- ated with aging. Recallin g th at th e clien t with a h earin g loss respon ds to low-pitch ed ton es will direct you to th e correct option . Review: Presb ycu sis an d h earin g lo ss Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Develop m en tal Stages—Early Ad ulth o od to Later Adu lth o o d Pr ior ity Con cepts: Develop m en t; Sen sory Percep tio n Refer en ce: Lewis et al. (2014), pp . 410-411.

228. 3 Ra t ion a le: Eld er ab use in clu des p h ysical, sexu al, or psych o log- ical abu se; m isu se o f prop erty; an d violation of righ ts. Th e typ - ical ab use victim is a wo m an o f ad van ced age with few so cial co n tacts an d at least 1 p h ysical o r m en tal im p airm en t th at lim its h er ab ility to perfo rm activities o f daily livin g. In add i- tion , th e clien t u sually lives alo n e or with th e abu ser an d d ep en d s o n th e ab u ser for care. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, eld er abu se. No te th e strategic wo rd , most. Read each o ptio n carefu lly an d id en - tify th e clien t wh o is m o st defen seless as th e resu lt o f th e dis- ease p rocess. Th is will d irect you to th e co rrect op tio n . Review: Eld er ab u se Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Develop m en tal Stages—Early Ad ulth o od to Later Adu lth o o d Pr ior ity Con cepts: In terp erso n al Violen ce; Safety Refer en ces: Lewis et al. (2014), pp . 68-69 Perry, Potter, O sten do rf (2014), p p . 112, 115.

229. 3 Ra t ion a le: Man y n on ph arm acological sleep aids can be used to in fluen ce sleep. Ho wever, th e clien t sh o uld avoid caffein - ated b everages an d stim u lan ts such as tea, cola, an d ch ocolate. Th e clien t sh ou ld exercise regularly, b ecau se exercise prom o tes sleep b y bu rn in g o ff ten sio n th at accum u lates du rin g th e day. A 20- to 30-m in ute walk, swim , o r b icycle rid e 3 tim es a week is h elp ful. Sm o kin g an d alcoh ol sh o uld b e avoided . Read in g is also a h elpfu l m easu re an d is relaxin g.

287CHAPTER 23 Care of the Older Client

F

u

n

d

a

m

e

n

t

a

l

s

Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further teaching. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an o ption th at is an in co rrect statem en t. O p tion s 1, 2, an d 4 are po sitive statem en ts in dicatin g th at th e clien t u n d erstan d s th e m eth o ds o f im provin g sleep . Rem em b er th at ch o co late co n tain s caffein e. Review: Sleep in th e o ld er clien t Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo p m en tal Stages—Early Ad ulth oo d to Later Ad u lth o od Pr ior it y Con cept s: Clien t Ed ucation ; Palliation Refer en ce: Lewis et al. (2014), p p . 75, 109-110.

230. 4 Ra tion a le: Assistin g clien ts an d fam ilies to b ecom e aware of availab le com m un ity sup p ort system s is a ro le an d respo n sib il- ity o f th e n u rse. O b servin g th at th e clien t h as begu n to b e con - fin ed to h is roo m m akes it n ecessary fo r th e n u rse to in terven e legally an d eth ically, so op tio n 3 is n o t ap p ro priate an d is p as- sive in term s o f ad vocacy. O ptio n 2 suggests com m ittin g th e cli- en t to a n ursin g h om e an d is a p rem ature actio n o n th e n urse’s p art. Alth ough th e d ata provided tell th e n urse th at th is clien t requires n ursin g care, th e n urse d oes n ot kn o w th e exten t o f th e n ursin g care req uired. O ption 1 is in correct an d judgm en tal. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most impor- tant. Usin g p rin ciples related to th e eth ical an d legal resp on si- b ility o f th e n u rse an d kn o wledge of th e n u rse’s ro le will d irect yo u to th e correct o ptio n . O p tion 1 is a n o n th erapeutic state- m en t, op tio n 2 is a prem ature actio n , an d op tio n 3 avo ids th e situ ation . Review: Eth ical an d legal p rin cip les related to th e o ld er ad u lt Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Develo p m en tal Stages—Early Ad ulth oo d to Later Ad u lth o od Pr ior it y Con cept s: Eth ics; Health Care Law Refer en ce: Lewis et al. (2014), p p . 68, 70-71.

231. 1 Ra tion a le: Th e n orm al ph ysiolo gical ch an ges th at o ccu r in th e skin o f older ad ults in clu de th in n in g o f th e skin , lo ss of elastic- ity, deepen in g o f exp ression lin es, an d wrin klin g. Cru stin g n o ted o n th e skin wou ld in d icate a p oten tial co m p licatio n . Test-Ta kin g Str a tegy: No te th e su b ject, a p oten tial co m p lica- tio n . Th in k ab o ut th e n orm al ph ysiolo gical ch an ges th at occu r in th e agin g p ro cess in th e in tegum en tary system to d irect you to th e correct o ptio n . Review: Age-related skin ch an ges Level of Cogn it ive Abilit y: An alyzin g

Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Develo p m en tal Stages—Early Adu lth oo d to Later Ad ulth o od Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ces: Jarvis (2016), p. 230 Lewis et al. (2014), pp . 416-417.

232. 2 Ra tion a le: Polyp h arm acy is a con cern in th e o lder clien t. Du plicatio n of m edicatio n s n eed s to b e id en tified befo re m ed - ication in teractio n s can b e determ in ed , because th e n urse n eeds to kn o w wh at th e clien t is takin g. Askin g ab ou t m edica- tio n ad m in istration su p ervision m ay be part o f th e assessm en t b ut is n ot a first actio n . Th e p h on e call to th e HCP is th e in ter- ven tio n after all oth er in fo rm atio n h as been collected . Test-Ta kin g St r a t egy: No te th e strategic wo rd , first. Also n ote th at th e n u rse is visitin g th e clien t for th e first tim e. O ptio n s 1, 3, an d 4 sh o uld b e do n e after po ssib le m ed ication d up lication h as b een iden tified . Review: Po lyp h arm acy Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—Safety Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign atavicius, Workm an (2016), p p. 13-14.

233. 2, 5, 6 Ra tion a le: An ato m ical ch an ges to th e eye affect th e in divid- u al’s visu al ab ility, leadin g to p o ten tial prob lem s with activities o f d aily livin g. Ligh t ad aptatio n an d visual field s are red uced . Alth ou gh lun g fu n ctio n m ay d ecrease, th e resp irato ry rate u su - ally rem ain s u n ch an ged. Heart rate decreases an d h eart valves th icken . Age-related ch an ges th at affect th e u rin ary tract in crease an o ld er clien t’s suscep tibility to urin ary tract in fec- tio n s. Sh ort-term m em o ry m ay d eclin e with age, bu t lo n g-term m em ory u sually is m ain tain ed. Ch an ge in sleep pattern s is a con sisten t, age-related ch an ge. O lder p erso n s exp erien ce an in creased in ciden ce of awaken in g after sleep o n set. Test-Ta kin g St r a tegy: Focu s on th e su b ject, n o rm al age- related ch an ges. Read each ch aracteristic carefully an d th in k abo u t th e ph ysio logical ch an ges th at o ccu r with agin g to select th e correct item s. Review: No rm al age-related ch an ges Level of Cogn itive Ability: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Develo p m en tal Stages—Early Adu lth oo d to Later Ad ulth o od Pr ior it y Con cept s: Develo pm en t; Sen so ry Perception Refer en ce: Lewis et al. (2014), p . 65.

288 UNIT V Growth and Development Across the Life Span

F

u

n

d

a

m

e

n

t

a

l

s

UNIT VI

Maternity Nursing

Pyramid to Success

Th e Pyram id to Success focuses on th e ph ysiological an d psych o social aspects related to th e exp erien ce of preg- n an cy, birth , an d th e postp artum period. Pyram id Poin ts begin with th e assessm en t an d kn owledge of expected fin din gs of th e pregn an t clien t an d fetus durin g th e an tep artum period. In structin g th e pregn an t clien t in m easu res th at prom ote a h ealth y en viron m en t for th e m oth er an d th e fetus is in cluded. Th e focus is on th e im portan ce of an tepartum follow-up, n utrition , an d in terven tion s for com m on discom forts th at occur durin g pregn an cy. Kn owledge of th e purpose of th e co m m on ly prescribed diagn ostic tests an d proced ures in th e an te- partum period is also part of th e Pyram id to Success. Th e focus is on disorders th at can occur durin g preg- n an cy, particularly gestation al h yperten sion an d diab e- tes m ellitus. Th e labor an d birth process an d th e im m ediate in terven tion s for con d ition s in wh ich th e m atern al or fetal status is com pro m ised , such as pro- lapsed cord or altered fetal h eart rate, are part of th e Pyr- am id to Success. Review of th e fetus of a m oth er with h um an im m un od eficien cy virus or acquired im m un o- deficien cy syn d rom e or a substan ce-abusin g m oth er is recom m en ded . Th e Pyram id to Success also in cludes a focus on th e n orm al expectation s of th e postp artum period an d th e com plication s th at can occur durin g th is tim e. Th e n ext Pyram id Poin t focuses on th e n orm al ph ysical assessm en t fin din gs an d early iden tification of disorders in th e n eon ate. Th e last Pyram id Poin t in this un it focuses on m atern ity an d n ewborn m edication s.

Client Needs: Learning Objectives Safe and Effective Care Environment Con sultin g with th e in terp rofession al h ealth care team En surin g th at in form ed con sen t for diagn ostic tests an d

proced ures h as been obtain ed

Establish in g prio rities of care Han dlin g h azardous an d in fectio us m aterials safely Main tain in g con fiden tiality Providin g co n tin uity of clien t care Prom o tin g a safe en viron m en t fro m poten tial terato-

gen ic th reats Uph oldin g clien t’s righ ts Usin g surgical asepsis wh en providin g care Usin g stan d ard an d tran sm ission -based precaution s

wh en providin g care

Health Promotion and Maintenance Assessin g for growth an d developm en t Discussin g expected body im age ch an ges with th e clien t Discussin g fam ily plan n in g an d birth in g an d paren tin g

issues Iden tifyin g at-risk clien ts durin g pregn an cy Iden tifyin g h ealth an d welln ess con cepts an d providin g

h ealth care screen in g Iden tifyin g lifestyle ch oices an d h igh -risk beh aviors Perform in g tech n iqu es of ph ysical assessm en t Providin g an tepartum , in trapartum , postp artum , an d

n ewborn care Teach in g regardin g an tep artum , in trapartum , an d post-

partum care, an d care to th e n ewborn

Psychosocial Integrity Con siderin g cultural, religious, an d spiritual in fluen ces

regardin g birth an d m oth erh ood Discussin g situation al role ch an ges in th e fam ily En surin g th erapeutic in teraction s with in th e fam ily Iden tifyin g available supp ort system s Iden tifyin g copin g m ech an ism s

Physiological Integrity In structin g th e clien t about prescribed diagn ostic tests

an d procedures Mon itorin g for exp ected outcom es an d effects related to

ph arm aco logical an d paren teral th erap ies

M

a

t

e

r

n

i

t

y

289

Mon itorin g for n orm al expectation s durin g pregn an cy Mon itorin g for side effects an d adverse effects related to

prescribed ph arm acological an d paren teral th erapies Mon itorin g th e clien t durin g th e labo r an d birth

process Provid in g in terven tion s for un expected even ts durin g

pregn an cy

Providin g n on ph arm aco logical com fo rt in terven tion s an d ph arm acological pain m an agem en t durin g labo r

Supportin g fam ilies wh o are experien cin g fertility issues Teach in g th e clien t about n utrition durin g pregn an cy

an d in th e postpartum period Teach in g th e clien t about th e ph ysio logical ch an ges th at

occur durin g pregn an cy

290 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

C H A P T E R 24 Reproductive System

PRIORITY CONCEPTS Reproduction, Sexuality

CRITICAL THINKING What Should You Do? The nurse is conducting an intake assessment on a pregnant adolescent who reports consuming small amounts of alcohol on a daily basis. On the basis of the information provided, what should the nurse do? Answer located on p. 295.

I. Female Reproductive Structures A. O varies

1. Form an d expel ova 2. Secrete estrogen an d progesteron e

B. Fallop ian tubes 1. Muscu lar tubes (oviducts) lyin g n ear th e ovaries

an d con n ected to th e uterus 2. Tu bes th at propel th e ova from th e ovaries to th e

uterus C. Uterus

1. Muscu lar, pear-sh aped cavity in wh ich th e fetus develops

2. Cavity from wh ich m en struation occurs D. Cervix

1. Th e in tern al os of th e cervix open s in to th e body of th e uterin e cavity.

2. Th e cervical can al is located between th e in tern al os an d th e extern al os.

3. Th e extern al cervical os open s in to th e vagin a. E. Vagina

1. Muscu lar tube th at exten ds from th e cervix to th e vagin al open in g in th e perin eum

2. Kn o wn as th e birth canal 3. Passageway for m en strual blood flo w, for pen is

for in tercou rse, an d for th e fetus

II. Male Reproductive Structures A. Pen is

1. Stru ctures in clude th e body or sh aft, glan s pen is, an d ureth ra.

2. Prim ary fun ction s in clude path way for urin ation an d th e organ used for in tercou rse.

B. Scrotum 1. Structures in clude th e testes, epididym is, an d vas

deferen s. 2. No rm al tem p erature is sligh tly cooler th an body

tem p erature. C. Prostate glan d

1. Secretes a m ilky alkalin e flu id 2. En h an ces sperm m ovem en t an d n eutralizes

acidic vagin al secretio n s

III. Menstrual Cycle (Box 24-1) A. O varian h orm on es

1. O varian h orm on es, released by th e an terior pitu- itary glan d, in clude follicle-stim ulatin g h orm on e (FSH) an d lutein izin g h orm on e (LH).

2. Th e h orm on es produ ce ch an ges in th e ovaries an d in th e en dom etrium .

3. Th e m en strual cycle, th e regularly recurrin g ph ys- iolo gical ch an ges in th e en dom etrium th at cul- m in ate in its sh edd in g, m ay vary in len gth , with th e average len gth bein g about 28 days.

B. O varian an d uterin e ph ases (see Box 24-1)

IV. Female Pelvis and Measurements A. True pelvis

1. Lies below th e pelvic brim 2. Con sists of th e pelvic in let, m idpelvis, an d pelvic

outlet B. False pelvis

1. Th e sh allow portion ab ove th e pelvic brim 2. Supp orts th e abdom in al viscera

C. Types of pelvis 1. Gyn eco id

a. No rm al fem ale pelvis b . Tran sversely roun ded or blun t

The gynecoid pelvis is most favorable for successful labor and birth. If cephalopelvic disproportion (CPD) exists, the normal labor process will be delayed and most likely result in a cesarean delivery.

M

a

t

e

r

n

i

t

y

291

2. An th ropoid a . O val sh ap e b . Adeq uate outlet, with a n arrow pubic arch

3. An d roid a . Heart-sh aped or an gulated b . Resem bles a m ale pelvis c. No t favorable for labor an d vagin al birth d . Narrow pelvic plan es can cause slow descen t

an d m idpelvic arrest. 4. Platyp elloid

a . Flat with an oval in let b . Wid e tran sverse diam eter, but sh ort an tero -

posterior diam eter, m akin g labor an d vagin al birth difficu lt

D. Pelvic in let diam eters 1. An teroposterior diam eters

a . Diagon al co n jugate: Distan ce fro m th e lower m argin of th e sym ph ysis pubis to th e sacral prom o n tory

b . True con jugate or con jugate vera: Distan ce from th e upper m argin of th e sym ph ysis pubis to th e sacral prom on to ry

c. O bstetric con jugate: Exten ds from th e sacral prom o n tory to th e top of th e sym ph ysis pubis. It is th e sm allest fron t-to-back distan ce th rou gh wh ich th e fetal h ead m ust pass in m ovin g th rou gh th e pelvic in let.

2. Tran sverse diam eter: Th e largest of th e pelvic in let diam eters; lo cated at righ t an gles to th e tru e con jugate

3. O blique (diagon al) diam eter: Not clin ically m easu rable

4. Posterior sagittal diam eter: Distan ce fro m th e poin t wh ere th e an teroposterior an d tran sverse diam eters cross each oth er to th e m iddle of th e sacral prom o n tory

E. Pelvic m idplan e diam eters 1. Tran sverse (in terspin ous diam eter) 2. Midplan e n orm ally is th e largest plan e an d h as

th e lon gest diam eter. F. Pelvic outlet diam eters

1. Tran sverse (in tertuberous diam eter) 2. O utlet presen ts th e sm allest plan e of th e pelvic

can al.

V. Fertilization and Implantation A. Fertilization

1. Fertilization occurs in th e am pulla of th e fallo- pian (uterin e) tube wh en sperm an d ovum un ite.

2. Wh en fertilized, th e m em bran e of th e ovum un dergoes ch an ges th at preven t en try of oth er sperm .

3. Each rep ro d u ctive cell carries 23 ch ro m o - so m es.

4. Sperm carry an X or a Ych rom oso m e—XY, m ale; XX, fem ale.

B. Implantation 1. Th e zygote is propelled toward th e uterus an d

im plan ts 6 to 8 days after ovulation .

BOX 24-1 Menstrual Cycle Ovarian Changes Preovulat ory Pha se Hypothalamus releases gonadotropin-releasing hormone

through the portal system to the anterior pituitary system. Secretion of follicle-stimulating hormone (FSH) by the anterior

lobe of the pituitary gland stimulates growth of follicles. Most follicles die, leaving 1 to mature into a large graafian follicle. Estrogen produced by the follicle stimulates increased secre-

tions of luteinizing hormone (LH) by the anterior lobe of the pituitary gland.

The follicle ruptures and releases an ovum into the peritoneal cavity.

Lutea l Pha se Begins with ovulation. Body temperature decreases and then increases by 0 .5 °F to 1 °F

around the time of ovulation. Corpus luteum is formed from follicle cells that remain in the

ovary after ovulation. Corpus luteum secretes estrogen and progesterone during the

remaining 14 days of the cycle. Corpus luteum degenerates if the ovum is not fertilized, and

secretion of estrogen and progesterone declines. Decline of estrogen and progesterone stimulates the anterior

pituitary to secrete more FSH and LH, initiating a new repro- ductive cycle.

Uterine Changes Menstrua l Phase Consists of 4 to 6 days of bleeding as the endometrium breaks

down because of the decreased levels of estrogen and progesterone.

The level of FSH increases, enabling the beginning of a new cycle.

Prolifera tive Pha se Lasts about 9 days. Estrogen stimulates proliferation and growth of the endome-

trium. As estrogen increases, it suppresses secretion of FSH and

increases secretion of LH. Secretion of LH stimulates ovulation and the development of

the corpus luteum. Ovulation occurs between days 12 and 16. Estrogen level is high, and progesterone level is low.

Secret ory Pha se Lasts about 12 days and follows ovulation. This phase is initiated in response to the increase in LH level. The graafian follicle is replaced by the corpus luteum. The corpus luteum secretes progesterone and estrogen. Progesterone prepares the endometrium for pregnancy if a

fertilized ovum is implanted.

292 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

2. Th e blastocyst secretes ch orion ic go n adotropin to en sure th at th e corpus luteum rem ain s viable an d secretes estrogen an d progesteron e for th e first 2 to 3 m on th s of gestation .

VI. Fetal Development (Box 24-2)

VII. Fetal Environment A. Am n io n

1. En closes th e am n iotic cavity 2. Is th e in n er m em bran e th at form s about th e sec-

on d week of em bryo n ic develo pm en t 3. Form s a flu id-filled sac th at surroun ds th e

embryo an d later th e fetus

BOX 24-2 Fetal Development Preembryonic Period First 2 weeks after conception

Embryonic Period Beginning day 15 through approximately week 8 after conception

Fetal Period Week 9 after conception to birth

Week 1 Blastocyst is free-floating.

Weeks 2 to 3 Embryo is 1.5 to 2 mm in length. Lung buds appear. Blood circulation begins. Heart is tubular and begins to beat. Neural plate becomes brain and spinal cord.

Week 5 Embryo is 0.4 to 0 .5 cm in length. Embryo is 0.4 g. Double heart chambers are visible. Heart is beating. Limb buds form.

Week 8 Embryo is 3 cm in length. Embryo is 2 g. Eyelids begin to fuse. Circulatory system through umbilical cord is well established. Every organ system is present.

Week 12 Fetus is 6 to 9 cm in length. Fetus is 19 g. Face is well formed. Limbs are long and slender. Kidneys begin to form urine. Spontaneous movements occur. Heartbeat is detected by Doppler transducer between 10 and

12 weeks. Sex of fetus is visually recognizable.

Week 16 Fetus is 11.5 to 13.5 cm in length. Fetus is 100 g. Active movements are present. Fetal skin is transparent. Lanugo hair begins to develop. Skeletal ossification occurs.

Week 20 Fetus is 16 to 18.5 cm in length. Fetus is 300 g. Lanugo covers the entire body. Fetus has nails. Muscles are developed. Enamel and dentin are depositing. Heartbeat is detected by regular (nonelectronic) fetoscope.

Week 24 Fetus is 23 cm in length. Fetus is 60 0 g. Hair on head is well formed. Skin is reddish and wrinkled. Reflex hand grasp functions are present. Vernix caseosa covers entire body. Fetus has ability to hear.

Week 28 Fetus is 27 cm in length. Fetus is 110 0 g. Limbs are well flexed. Brain is developing rapidly. Eyelids open and close. Lungs are developed sufficiently to provide gas exchange

(lecithin forming). If born, neonate can breathe at this time.

Week 32 Fetus is 31 cm in length. Fetus is 180 0 to 2100 g. Bones are fully developed. Subcutaneous fat has collected. Lecithin-to-sphingomyelin (L/ S) ratio is 1.2:1.

Week 36 Fetus is 35 cm in length. Fetus is 2200 to 2900 g. Skin is pink and body is rounded. Skin is less wrinkled. Lanugo is disappearing. L/ S ratio is greater than 2:1.

Week 40 Fetus is 40 cm in length. Fetus is more than 3200 g. Skin is pinkish and smooth. Lanugo is present on upper arms and shoulders. Vernix caseosa decreases. Fingernails extend beyond fingertips. Sole (plantar) creases run down to the heel. Testes are in the scrotum. Labia majora are well developed.

293CHAPTER 24 Reproductive System

M

a

t

e

r

n

i

t

y

B. Ch orion 1. Is th e outer m em bran e en closin g th e am n iotic

cavity 2. Becom es vascu larized an d form s th e fetal part of

th e placen ta C. Amniotic fluid

1. Con sists of 800 to 1200 m L by th e en d of pregn an cy

2. Surro un ds, cush ion s, an d protects th e fetus an d allows for fetal m ovem en t

3. Main tain s th e body tem perature of th e fetus 4. Con tain s fetal urin e an d is a m easure of fetal kid-

n ey fun ction 5. Th e fetus m odifies th e am n iotic fluid th rough

th e processes of swallowin g, urin atin g, an d m ovem en t of fluid th rou gh th e respiratory tract.

D. Placen ta 1. Th e placenta provides for exch an ge of n utrien ts

an d waste products between the fetus an d m oth er. 2. Th e placen ta begin s to form at im plan tation ; th e

structure is com plete by week 12. 3. It produces h orm on es to m ain tain pregn an cy and

assum es full respon sibility for th e production of th ese h orm on es by th e twelfth week of gestation .

4. In the th ird trim ester, tran sfer of m atern al im m u- n oglobulin provides the fetus with passive

im m un ity to certain diseases for th e first few m on th s after birth .

5. By week 10 to 12, gen etic testin g can be don e via ch orion ic villus sam plin g (CVS) .

Large particles such as bacteria cannot pass through the placenta, but nutrients, medications, alco- hol, antibodies, and viruses can pass through the placenta.

VIII. Fetal Circulation A. Um bilical cord

1. It con tain s 2 arteries an d 1 vein . 2. Th e arteries carry deo xygen ated blood an d waste

produ cts from th e fetus. 3. Th e vein carries oxygen ated blood an d provid es

oxygen an d n utrien ts to th e fetus. B. Fetal h eart rate (FHR)

1. FHR dep en ds on gestation al age; FH R is 160 to 170 beats/ m in ute in th e first trim ester, but slows with fetal growth to 110 to 160 beats/ m in ute n ear or at term .

2. FHR is about twice th e m atern al h eart rate. C. Fetal circulation bypass ( Fig. 24-1)

1. Fetal circulation bypass is presen t because of n on fu n ction in g lu n gs.

P la ce nta

Umbilica l a rte rie s

Urina ry bla dde r

Inte rna l ilia c a rte ry

To le gs

S upe rior ve na ca va

Aortic a rch

Ductus a rte rios us

Le ft a trium

P ulmona ry ve ins

Noninfla te d lung

Right a trium

Fora me n ova le (ope n)

Infe rior ve na ca va

Live r

Umbilica l ve in AortaPorta l ve in

Ductus ve nos us

Umbilica l cord

Fe ta l circula tion

High

Ke y to oxyge n s a tura tion of blood:

Me dium

Low

FIGURE 24-1 Fetal circulation. Three shunts (ductus venosus, ductus arteriosus, and foramen ovale) allow most blood from the placenta to bypass the fetal lungs and liver.

294 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

2. Bypasses m ust close after birth to allow blood to flow th rough th e lun gs an d th e liver.

3. Th e ductus arteriosus co n n ects th e pulm o n ary artery to th e aorta, bypassin g th e lu n gs.

4. Th e ductus ven osus con n ects th e um bilical vein an d th e in ferior ven a cava, bypassin g th e liver.

5. Th e foram en ovale is th e open in g between th e righ t an d left atria of th e h eart, bypassin g th e lu n gs.

IX. Family Planning A. Description

1. In volves ch oosin g wh en to h ave ch ildren 2. In cludes con tracep tion , preven tion of preg-

n an cy, an d m eth ods to ach ieve pregn an cy B. Birth con tro l

1. Th e focus of coun selin g on con tracep tion m ust m eet th e n eeds an d feelin gs of th e wom an an d h er partn er.

2. Several factors sh ould be con sidered wh en ch oo sin g a m eth od of birth con tro l, in cludin g effectiven ess, safety, an d perso n al preferen ce.

3. Th e wom an ’s preferen ces are m ost im portan t, an d cultural practices an d beliefs an d religious or oth er perso n al beliefs m ay affect th e ch oice of con traceptives.

4. O th er factors th at bear on selectio n of a con tra- ceptive m eth od in clude fam ily plan n in g goals, age, frequen cy of in tercou rse, an d th e in divid- ual’s capacity for com plian ce.

5. If fam ily plan n in g goals h ave already been m et, sterilization of eith er th e m ale or th e fem ale part- n er m ay be desirable (it is im portan t for th e cou- ple to un d erstan d th at tubal recon struction m ay be un successful).

6. For wom en wh o frequen tly en gage in coitus, oral con traceptives or a lo n g-term m eth od such as im plan ts or an in trauterin e device (IUD) m ay be con sidered .

7. Wh en sexual activity is lim ited, use of sperm i- cid e, con d om s, or a diaph ragm m ay be m ost ap propriate.

8. Because som e m eth od s h ave adverse effects, a sign ed in form ed con sen t form m ay be n eeded.

9. For addition al in form ation on th e use of con tra- ceptives, see Ch apter 51.

C. In fertility 1. In fertility is th e in volun tary in ability to con ceive

wh en desired. 2. Som e factors con tribu tin g to in fertility in m en

in clude abn o rm alities of th e sperm , abn orm al erection s or ejaculation s, or abn o rm alities of th e sem in al fluid .

3. Som e factors th at con tribu te to in fertility in wom en in clude disorders of ovulation or ab n or- m alities of th e fallopian tubes or cervix.

4. Several diagn ostic tests are available to determ in e th e probable cau se of in fertility, an d th e th erapy

recom m en ded m ay dep en d on th e cau se of th e in fertility.

5. In fertility option s a. O ption s in clude m edication , surgical proce-

dures, an d th erap eutic in sem in ation . b . O th er th erapies are available, such as in vitro

fertilization , surrogate m oth ers, an d em b ryo h osts.

c. Adop tion m ay also be an option . 6. Th e n urse n eeds to provide supp ort to th e couple

in th eir decision -m akin g process an d durin g th erap y.

CRITICAL THINKING What Should You Do? Answer: Adolescent pregnancies are considered high risk due to the immaturity of the reproductive system, as well as the high-risk behaviors that some adolescents engage in. The nurse should provide information to the adolescent regard- ing the risks associated with drug and alcohol consumption during pregnancy. The nurse should explain to the adoles- cent that large particles such as bacteria cannot pass through the placenta, but nutrients, medications, alcohol, antibodies, and viruses can pass through; therefore, measures should be taken to minimize exposure to substances that can cross the placental barrier and affect the health of the fetus. Follow-up regarding this high-risk behavior is also necessary.

Reference: Lowdermilk, Perry, Cashion, Alden (2016), pp. 326, 332–333.

P R A C T I C E Q U E S T I O N S 234. Th e n urse is preparin g to teach a pren atal class

about fetal circulation . Wh ich statem en ts sh ould be in cluded in th e teach in g plan ? Select all th at ap p ly.

1. “Th e ductus arteriosus allows blood to bypass th e fetal lun gs.”

2. “O n e vein carries oxygen ated blood from th e placen ta to th e fetus.”

3. “Th e n orm al fetal h eart ton e ran ge is 140 to 160 beats per m in ute in early pregn an cy.”

4. “Two arteries carry deo xygen ated blood an d waste produ cts away from th e fetus to th e placen ta.”

5. “Two vein s carry blood th at is h igh in carbo n dioxide an d oth er waste products away from th e fetus to th e placen ta.”

235. Th e n ursin g in structo r asks th e studen t to describe fetal circulation , specifically th e ductus ven o sus. Wh ich statem en t by th e studen t in dicates an un d erstan din g of th e ductus ven o sus? 1. “It con n ects th e pulm on ary artery to th e aorta.” 2. “It is an open in g between th e righ t an d

left atria.”

295CHAPTER 24 Reproductive System

M

a

t

e

r

n

i

t

y

3. “It con n ects th e um b ilical vein to th e in ferior ven a cava.”

4. “It con n ects th e um b ilical artery to th e in ferior ven a cava.”

236. A pregn an t clien t tells th e clin ic n urse th at sh e wan ts to kn ow th e sex of h er baby as soon as it can be determ in ed. Th e n urse in form s th e clien t th at sh e sh ould be able to fin d out th e sex at 12 weeks’ gestation because of wh ich facto r? 1. Th e appearan ce of th e fetal extern al gen italia 2. Th e begin n in g of differen tiation in th e

fetal groin 3. Th e fetal testes are descen ded in to th e scrotal sac 4. Th e in tern al differen ces in m ales an d fem ales

beco m e apparen t

237. Th e n urse is perform in g an assessm en t on a clien t wh o is at 38 weeks’ gestation an d n otes th at th e fetal h eart rate (FHR) is 174 beats/ m in u te. O n th e basis of th is fin din g, wh at is th e p rio rity n urs- in g action ? 1. Do cum en t th e fin din g. 2. Ch eck th e m oth er’s h eart rate. 3. Notify th e h ealth care provider (HCP). 4. Tell th e clien t th at th e fetal h eart rate is n orm al.

238. Th e n urse is con ductin g a pren atal class on th e fem ale reproductive system . Wh en a clien t in th e class asks wh y th e fertilized ovum stays in th e fal- lo pian tube for 3 days, wh at is th e n urse’s b est respo n se? 1. “It prom otes th e fertilized ovum ’s ch an ces of

survival.” 2. “It prom o tes th e fertilized ovum ’s exposure to

estrogen an d progesteron e.” 3. “It prom o tes th e fertilized ovum ’s n orm al

im plan tation in th e top portion of th e uterus.” 4. “It prom otes th e fertilized ovum ’s exposure to

lutein izin g h orm on e an d follicle-stim ulatin g h orm on e.”

239. Th e n ursin g in structor asks a n ursin g studen t to explain th e ch aracteristics of th e am n iotic fluid. Th e studen t respo n ds correctly by explain in g wh ich as ch aracteristics of am n iotic flu id? Select all th at ap p ly.

1. Allows for fetal m ovem en t 2. Surroun ds, cush ion s, an d protects th e fetus 3. Main tain s th e body tem p erature of th e fetus

4. Can be used to m easu re fetal kidn ey fun ctio n 5. Preven ts large particles such as bacteria from

passin g to th e fetus 6. Provides an exch an ge of n utrien ts an d waste

products between th e m oth er an d th e fetus

240. A couple com es to th e fam ily plan n in g clin ic an d asks about sterilization proced ures. Wh ich ques- tion by th e n urse sh o uld determ in e wh eth er th is m eth od of fam ily plan n in g would be m o st ap p ro p riate? 1. “Did yo u ever h ad surgery?” 2. “Do yo u plan to h ave an y oth er ch ildren ?” 3. “Do eith er of yo u h ave diabetes m ellitus?” 4. “Do eith er of you h ave problem s with h igh

blood pressure?”

241. Th e n urse sh ould m ake wh ich statem en t to a preg- n an t clien t foun d to h ave a gyn ecoid pelvis? 1. “You r type of pelvis h as a n arrow pubic arch .” 2. “You r type of pelvis is th e m ost favorable for

labo r an d birth .” 3. “You r type of pelvis is a wide pelvis, but it h as a

sh o rt diam eter.” 4. “You will n eed a cesarean section because th is

type of pelvis is n ot favorable for a vagin al delivery.”

242. Wh ich purposes of placen tal fun ction in g sh ould th e n urse in clude in a pren atal class? Select all th at ap p ly.

1. It cush ion s an d protects th e baby. 2. It m ain tain s th e tem perature of th e baby. 3. It is th e way th e baby gets food an d oxygen . 4. It preven ts all an tibodies an d viruses from

passin g to th e baby. 5. It provid es an exch an ge of n utrien ts an d

waste produ cts between th e m oth er an d developin g fetus.

243. A 55-year-o ld m ale clien t con fid es in th e n urse th at h e is con cern ed about h is sexual fun ction . Wh at is th e n urse’s b est respo n se? 1. “How often do you h ave sexual relation s?” 2. “Please sh are with m e m ore about your

co n cern s.” 3. “You are still youn g an d h ave n oth in g to be

co n cern ed about.” 4. “You sh ould n ot h ave a declin e in testosteron e

un til you are in yo ur 80s.”

296 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

A N S W E R S 234. 1, 2, 4 Ra t ion a le: Th e du ctus arterio su s is a un iqu e fetal circu latio n stru ctu re th at allows th e n o n fun ction in g lun gs to receive on ly a m in im al am ou n t o f o xygen ated bloo d fo r tissue m ain te- n an ce. O xygen ated bloo d is tran sp orted to th e fetu s b y o n e um bilical vein . Th e n orm al fetal h eart to n e ran ge is co n sid ered to b e 110 to 160 beats per m in u te. Arteries carry d eoxygen ated blo od an d waste p ro du cts fro m th e fetus, an d th e u m b ilical vein carries o xygen ated blo od an d provid es oxygen an d n utri- en ts to th e fetu s. Blo od p um ped b y th e em b ryo ’s h eart leaves th e em bryo th ro ugh two u m b ilical arteries. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, fetal circulatio n . Recall th at th ree u m b ilical vessels are with in th e u m b ilical cord (two arteries an d on e vein ) an d th at th e vein carries o xygen ated blo od an d th e arteries carry d eo xygen ated blo od . Review: Fetal circu latio n Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clien t Edu catio n ; Perfu sio n Refer en ce: Lo wderm ilk et al. (2016), p p . 273-274.

235. 3 Ra t ion a le: Th e d uctus ven o su s co n n ects th e u m b ilical vein to th e in ferior ven a cava. Th e fo ram en o vale is a tem p orary op en - in g between th e righ t an d left atria. Th e d u ctu s arteriosus jo in s th e aorta an d th e p ulm o n ary artery. Test -Ta kin g Str a tegy: Focu s o n th e su b ject, th e descriptio n o f th e d u ctu s ven o sus. No te th e relation sh ip o f th e wo rd venosus in th e qu estio n an d vein in th e co rrect op tion . Review: Fetal circu latio n Level of Cogn it ive Ability: Evaluatio n Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process/ Evalu ation Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Perfusio n ; Reprod uctio n Refer en ce: Lo wderm ilk et al. (2016), p . 273.

236. 1 Ra t ion a le: By th e en d o f th e twelfth week, th e extern al gen italia of th e fetus h ave develop ed to such a d egree th at th e sex o f th e fetus can be d eterm in ed visually. Differen tiation o f th e extern al gen italia occu rs at th e en d o f th e n in th week. Testes descen d in to th e scro tal sac at th e en d o f th e th irty-eigh th week. In tern al differen ces in th e m ale an d fem ale occu r at th e en d o f th e seven th week. Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, sex o f th e fetu s. Rem em b er th at th e sex of th e fetu s can be reco gn izab le visually by th e app earan ce o f th e extern al gen italia by gestatio n al week 12. Review: Fetal d evelo p m en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Develop m en t; Sexu ality Refer en ce: Lo wderm ilk et al. (2016), p . 278.

237. 3 Ra t ion a le: Th e FHR dep en d s on gestatio n al age an d ran ges from 160 to 170 b eats/ m in u te in th e first trim ester, bu t slows with fetal growth to 110 to 160 beats/ m in ute n ear or at term . At o r n ear term , if th e FHR is less th an 110 b eats/ m in u te or m o re th an 160 b eats/ m in u te with th e u teru s at rest, th e fetu s m ay b e in distress. Becau se th e FHR is in creased fro m th e referen ce ran ge, th e n urse sh ou ld n o tify th e HCP. O ption s 2 an d 4 are in app ro p riate action s b ased o n th e in form atio n in th e q ues- tion . Alth ou gh th e n u rse do cum en ts th e fin din gs, b ased o n th e in form atio n in th e qu estio n , th e HCP n eed s to be n otified. Test -Ta kin g Str a tegy: No te th e strategic wo rd , priority. Th en , n o te if an ab n o rm ality exists. Also n o te th e FHR an d th at th e clien t is at 38 weeks o f gestation . Rem em b er th at th e n o r- m al FHR at or n ear term is 110 to 160 b eats/ m in u te. Review: Norm al fetal h eart rate Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p . 417.

238. 3 Ra t ion a le: Th e tub al isth m us rem ain s con tracted un til 3 d ays after con cep tion to allow th e fertilized o vum to d evelop within th e tube. This in itial growth o f th e fertilized ovum prom o tes its n orm al im plan tation in th e fun dal portio n o f th e u terin e cor- p us. Estro gen is a h orm on e pro duced b y th e o varian follicles, corp us luteu m , adren al cortex, an d placen ta durin g p regn an cy. Progestero ne is a h orm on e secreted b y th e corp us luteum o f th e o vary, adren al glan ds, an d p lacen ta d urin g p regn an cy. Lutein iz- in g h orm o ne an d follicle-stim ulatin g h orm on e are excreted by th e anterior pituitary glan d. The survival o f the fertilized o vu m d oes n ot d ep en d o n it stayin g in th e fallo pian tube for 3 d ays. Test -Ta kin g Str a t egy: Note th e strategic wo rd , best, an d u se kn o wled ge of th e an ato m y an d ph ysiology of th e fem ale repro- d u ctive system . Rem em b er th at fertilizatio n occu rs in th e fallo - p ian tub e an d th e fertilized o vum rem ain s in th e fallo pian tu be fo r abo u t 3 d ays. Th is prom otes its n orm al im plan tation . Review: An atom y an d p h ysio logy of th e rep ro d u ctive system Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Develop m en t; Reprod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 266-267.

239. 1, 2, 3, 4 Ra t ion a le: The am n io tic flu id surro un ds, cush io n s, an d p rotects th e fetu s. It allows th e fetus to m o ve freely an d m ain tain s th e b od y tem perature of th e fetu s. In additio n , th e am n io tic fluid con tain s urin e from th e fetus an d can be used to assess fetal kid- n ey fu n ction . Th e p lacen ta p reven ts large particles such as bacte- ria from passin g to the fetu s an d p ro vid es an exch an ge o f n utrien ts an d waste products between th e m other and th e fetus. Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e ch aracteristics o f am n iotic flu id . Visualizin g th e lo cation of th e am n iotic fluid will assist in an swerin g th is question .

297CHAPTER 24 Reproductive System

M

a

t

e

r

n

i

t

y

Review: Ch aracteristics of th e am n io tic flu id Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess/ Evaluatio n Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clien t Ed ucation ; Reprod u ctio n Refer en ce: Lo wd erm ilk et al. (2016), p. 270.

240. 2 Ra tion a le: Sterilizatio n is a m eth o d o f con tracep tio n fo r co u- p les wh o h ave com p leted th eir fam ilies. It sh ou ld be co n sid - ered a p erm an en t en d to fertility b ecau se reversal su rgery is n o t always successful. Th e n urse wo uld ask th e cou ple ab ou t th eir plan s fo r h avin g ch ildren in th e fu ture. O p tio n s 1, 3, an d 4 are u n related to th is pro ced ure. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Focus o n th e su b ject, sterilizatio n proced ure. No tin g th e relation sh ip b etween th e wo rd sterilization an d th e words plan to have any other children in th e co rrect o ption . Review: Effects o f sterilizatio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Health Pro m otio n ; Reprod uctio n Refer en ce: Lo wd erm ilk et al. (2016), pp . 189-190.

241. 2 Ra tion a le: A gyn eco id pelvis is a n o rm al fem ale p elvis an d is th e m o st favo rab le fo r su ccessfu l labo r an d birth . An an droid p elvis (resem blin g a m ale p elvis) wou ld b e u n favorable fo r lab or because o f th e n arro w p elvic p lan es. An an th ro po id pel- vis h as an ou tlet th at is adequ ate, with a n o rm al o r m o derately n arro w pu b ic arch . A p latypello id pelvis ( flat pelvis) h as a wid e tran sverse diam eter, bu t th e an tero po sterio r d iam eter is sh o rt, m akin g th e o utlet in ad eq uate. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, fem ale p elvis types. Recallin g th at th e gyn eco id pelvis is th e n o rm al fem ale p elvis will d irect you to th e correct op tio n . Review: Fem ale p elvic typ es Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g

Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Health Pro m otio n ; Rep rod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p. 371.

242. 3, 5 Ra tion a le: Th e placen ta p ro vides an exch an ge o f o xygen , n u tri- en ts, an d waste p ro du cts between th e m o th er an d th e fetu s. Th e am n io tic fluid su rrou n d s, cush ion s, an d protects th e fetu s an d m ain tain s th e bo dy tem perature o f th e fetu s. Nutrien ts, m edi- cation s, an tibo dies, an d viru ses can pass th ro u gh th e p lacen ta. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e pu rp ose o f th e p lacen ta. Rem em ber th at th e placen ta provid es oxygen an d n u trien ts. Review: Structure an d fun ctio n of th e p lacen ta an d am n io tic flu id Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Develo pm en t; Rep ro du ction Refer en ce: Lowd erm ilk et al. (2016), pp . 270, 272-273.

243. 2 Ra tion a le: Th e n u rse n eed s to establish trust wh en discu ssin g sexu al relatio n sh ips with m en . Th e n urse sh o u ld op en th e con - versation with bro ad statem en ts to determ in e th e tru e n atu re of th e clien t’s con cern s. Th e freq uen cy o f in terco urse is n ot a rel- evan t first q u estion to estab lish trust. Testostero n e declin es with th e agin g process. Test-Ta kin g Str a tegy: No te th e strategic wo rd , best. Determ in e wh eth er furth er assessm en t or valid ation is n eed ed. In th is case, m o re in fo rm atio n is n eed ed to determ in e th e n ature of th e clien t’s co n cern s. Keepin g th ese co n cepts in m in d an d u sin g th erap eu tic co m m u n icatio n tech n iq u es will assist in d irectin g yo u to th e correct o ptio n . Review: Sexu al fu n ctio n in th e m ale clien t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Ad u lt Health —Reprod u ctive Pr ior it y Con cept s: Co m m u n ication ; Sexu ality Refer en ce: Lewis et al. (2014), p . 1229.

298 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

C H A P T E R 25 Prenatal Period

PRIORITY CONCEPTS Development, Reproduction

CRITICAL THINKING What Should You Do? The pregnant client at 8 weeks of gestation tells the nurse that she is experiencing morning sickness upon awakening. By lunchtime, she no longer has issues with nausea and vomiting. What should the nurse instruct the client to do to assist in relief of this common morning discomfort? Answer located on p. 310.

I. Gestation A. Tim e from fertilization of th e ovum un til th e esti-

m ated date of delivery B. Abou t 280 days C. Nägele’s rule for estim atin g th e date of delivery, also

kn own as date of birth (Box 25-1) 1. Use of Nägele’s rule requires th at th e wom an

h ave a regular 28-day m en strual cycle. 2. Subtract 3 m on th s an d add 7 days to th e first day

of th e last m en strual period; th en add 1 year if ap propriate. Altern atively, add 7 days to th e last m en strual period an d coun t forward 9 m on th s.

II. Gravidity and Parity A. Gravidity

1. Gravida refers to a pregn an t wom an . 2. Gravidity refers to th e n um ber of pregn an cies. 3. A n ulligravida is a wom an wh o h as n ever been

pregn an t. 4. A prim igravida is a wom an wh o is pregn an t for

th e first tim e. 5. A m ultigravid a is a wom an in at least h er secon d

pregn an cy. B. Parity

1. Parity is th e n um ber of birth s (n ot th e n um ber of fetuses, e.g., twin s) carried past 20 weeks of ges- tatio n , wh eth er or n ot th e fetus was born alive.

2. A n ullipara is a wom an wh o h as n ot h ad a birth at m ore th an 20 weeks of gestation .

3. A prim ipara is a wom an wh o h as h ad 1 birth th at occurred after th e twen tieth week of gestation .

4. A m ultipara is a wom an wh o h as h ad 2 or m ore pregn an cies to th e stage of fetal viability.

C. Use of GTPAL: Pregn an cy outcom es can be described with th e acron ym GTPAL (Box 25-2). 1. G is gravid ity, th e n um ber of pregn an cies, in clud-

in g th e presen t on e. 2. T is term birth s, th e n um ber born at term (lon ger

th an 37 weeks of gestation ). 3. P is preterm birth s, th e n um ber born before

37 weeks of gestation . 4. A is abortion s or m iscarriages, th e n um ber of

abortion s or m iscarriages (in clu ded in gravida if befo re 20 weeks of gestation ; in cluded in parity if past 20 weeks of gestation ). A term in ation of th e pregn an cy after 20 weeks is referred to as a “th erapeutic term in ation .”

5. L is th e n um ber of curren t livin g ch ildren .

III. Pregnancy Signs A. Presu m ptive sign s

1. Am en orrh ea 2. Nausea an d vom itin g 3. In creased size an d in creased feelin g of fulln ess in

breasts 4. Pron oun ced n ipples 5. Urin ary frequen cy 6. Quickening: Th e first perception of fetal m ove-

m en t by th e m oth er m ay occur at th e sixteen th to twen tieth week of gestation .

7. Fatigue 8. Discolo ration of th e vagin al m ucosa

B. Probable sign s 1. Uterin e en largem en t 2. Hegar’s sign: Com pressibility an d soften in g of

th e lo wer uterin e segm en t th at occurs at about week 6

3. Goodell’s sign: Soften in g of th e cervix th at occurs at th e begin n in g of th e secon d m on th

M

a

t

e

r

n

i

t

y

299

4. Chadwick’s sign: Vio let coloratio n of th e m ucous m em bran es of th e cervix, vagina, an d vulva th at occurs at ab out week 6

5. Ballottement: Reboun din g of th e fetus again st th e exam in er’s fin gers on palpation

6. Braxto n Hicks con traction s (irregular pain less con traction s th at m ay occur in term itten tly th rou gh out pregn an cy)

7. Positive pregn an cy test for determ in ation of th e presen ce of h um an ch orion ic go n adotropin

C. Positive sign s (diagn o stic) 1. Fetal h eart rate detected by electron ic device

(Dopp ler tran sducer) at 10 to 12 weeks an d by n on electron ic device (fetosco pe) at 20 weeks of gestation

2. Active fetal m ovem en ts palpable by exam in er 3. O utlin e of fetus via radiograph y or

ultraso n ograph y

IV. Fundal Height (Box 25-3) A. Fun dal h eigh t is m easured to evaluate th e gestation al

age of th e fetus. B. Durin g th e secon d an d th ird trim esters (weeks 18 to

30), fun dal h eigh t in cen tim eters approxim ately equals fetal age in weeks Æ2 cm (Fig. 25-1).

C. At 16 weeks, th e fun dus can be foun d approxim ately h alfway between th e sym ph ysis pubis an d th e um bilicus.

D. At 20 to 22 weeks, th e fun dus is approxim ately at th e location of th e um bilicus.

E. At 36 weeks, th e fun dus is at th e xiph oid process.

When assessing fundal height, monitor the client closely for supine hypotension when placed in the supine position.

V. Physiological Maternal Changes

Culture often determines health beliefs, values, and family expectations. Therefore, it is important to assess cultural beliefs during care of the maternity client.

A. Cardio vascular system 1. Circulatin g blood volum e in creases, plasm a

in creases, an d total red blood cell volum e in creases (to tal volum e in creases by approxi- m ately 40% to 50%).

BOX 25-1 Nägele’s Rule for Estimating the Date of Delivery

First da y of la st menstrua l period: September 12, 20 18 Subtra ct 3 mont hs: June 12, 20 18 Add 7 da ys: June 19, 20 18 Add 1 yea r: June 19, 2019 Est ima t ed da te of delivery: June 19, 20 19

BOX 25-2 Describing Pregnancy Outcome with GTPAL

G¼Gravidity T¼Term births P¼Preterm births A¼Abortions or miscarriages L¼Current living children

Exa mple: A woman is pregnant for the fourth time. She had 1 elective abortion in the first trimester, a daughter who was born at 40 weeks of gestation, and a son who was born at 36 weeks of gestation. She is gravida (G), 4; term (T), 1 (the daughter born at 40 weeks); preterm (P), 1 (the son born at 36 weeks); abortion (A), 1 (the abortion is counted in the gra- vidity, but is not included in the parity because it occurred before 20 weeks); living children (L), 2. Parity is the number of births (not the number of fetuses) carried past 20 weeks of gestation, whether or not the fetus was born alive. There- fore, the parity for this woman is 2.

GTPAL¼ 4, 1, 1, 1, 2

BOX 25-3 Measuring Fundal Height 1. Place the client in the supine position. 2. Place the end of the tape measure at the level of the sym-

physis pubis. 3. Stretch the tape to the top of the uterine fundus. 4. Note and record the measurement.

36

32

28

24

20

16

12

40

FIGURE 25-1 Height of fundus by weeks of normal gestation with a sin- gle fetus. Dashed line, Height after lightening (descent of the fetus toward the pelvic inlet before labor).

300 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

2. Ph ysiological an em ia occurs as th e plasm a in crease exceeds th e in crease in productio n of red blood cells.

3. Iron requirem en ts are in creased. 4. Heart size in creases, an d th e h eart is elevated

sligh tly upward an d to th e left because of dis- placem en t of th e diaph ragm as th e uterus en larges ( Fig. 25-2).

5. Reten tion of sodium an d water m ay occur. B. Resp iratory system

1. O xygen con sum p tion in creases by approxi- m ately 15% to 20%.

2. Diaph ragm is elevated because of th e en larged uterus (see Fig. 25-2).

3. Sh o rtn ess of breath m ay be experien ced.

During pregnancy, a woman’s pulse rate may increase about 10 to 15 beats/ minute; the blood pressure slightly decreases in the second trimester, then increases in the third trimester, but not above the pre- pregnancy level; and the respiratory rate remains unchanged or slightly increases.

C. Gastroin testin al system 1. Nausea an d vom itin g m ay occur as a result of th e

secretio n of h um an ch orion ic gon ado tropin ; it typ ically subsides by th e th ird m on th .

2. Poor appetite m ay occur because of decreased gastric m otility.

3. Alteration s in taste an d sm ell m ay occur. 4. Con stipation m ay occur because of an in crease

in progesteron e produ ction or pressure of th e uterus resultin g in decreased gastro in testin al m otility.

5. Flatu len ce an d h eartburn m ay occur because of decreased gastro in testin al m otility an d slowed em p tyin g of th e stom ach caused by an in crease in progesteron e produ ction .

6. Hem o rrh oids m ay occur because of in creased ven o us pressure.

7. Gum tissue m ay becom e swollen an d easily bleed because of in creasin g levels of estrogen .

8. Ptyalism (excessive secretio n of saliva) m ay occur because of in creasin g levels of estrogen .

D. Ren al system 1. Frequen cy of urin ation in creases in th e first an d

th ird trim esters because of in creased bladder sen - sitivity an d pressure of th e en largin g uterus on th e blad der.

2. Decreased bladder ton e m ay occur an d is cau sed by an in crease in progesteron e an d estrogen levels; bladder capacity in creases in respo n se to in creasin g levels of progesteron e.

3. Ren al th resh o ld for glucose m ay be reduced. E. En docrin e system

1. Basal m etab olic rate in creases an d m etabolic fun ction in creases.

2. Th e an terior lobe of th e pituitary glan d en larges an d produces serum prolactin n eeded for th e lac- tatio n process.

3. Th e posterior lo be of th e pituitary glan d pro- duces oxytocin , wh ich stim ulates uterin e con traction s.

4. Th e th yroid en larges sligh tly, an d th yroid activity in creases.

5. Th e parath yro id in creases in size. 6. Aldosteron e levels gradually in crease. 7. Body weigh t in creases. 8. Water reten tion is in creased, wh ich can con trib-

ute to weigh t gain . F. Reprod uctive system

1. Uterus a. Uterus en larges, in creasin g in m ass from

approxim ately 60 to 1000 g as a result of h yperplasia (in fluen ce of estrogen ) an d h ypertroph y.

b . Size an d n um ber of blood vessels an d lym - ph atics in crease.

c. Irregular con traction s occur, typically begin - n in g after 16 weeks of gestation .

2. Cervix a. Cervix becom es sh orter, m ore elastic, an d

larger in diam eter. b . En do cervical glan ds secrete a th ick m ucous

plug, wh ich is expelled fro m th e can al wh en dilation begin s.

c. In creased vascu larization an d an in crease in estrogen cau se soften in g an d a violet discolor- ation kn own as Chadwick’s sign, wh ich occurs at about 6 weeks of gestation .

FIGURE 25-2 Changes in position of heart, lungs, and thoracic cage in pregnancy. Broken line, Nonpregnant state. Solid line, Change that occurs in pregnancy.

301CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

3. O varies a . A m ajor fun ction of th e ovaries is to secrete

progesteron e for th e first 6 to 7 weeks of pregn an cy.

b . Th e m aturatio n of n ew follicles is blocked. c. Th e ovaries cease ovum productio n .

4. Vagina a . Hypertroph y an d th icken in g of th e m uscle

occur. b . An in crease in vagin al secretio n s is exp eri-

en ced; secretio n s are usually th ick, wh ite, an d acidic.

5. Breasts: Breast ch an ges occur because of th e in creasin g effects of estrogen an d progesteron e. a . Breast size in creases, an d breasts m ay

be ten der. b . Nipp les beco m e m ore pron oun ced . c. Th e areolae beco m e darker in color. d . Superficial vein s beco m e prom in en t. e. Hypertroph y of Mon tgom ery’s follicles occurs. f. Colostrum m ay leak from th e breast.

G. Skin 1. Som e ch an ges occur because th e levels of

m elan ocyte-stim ulating h orm on e in crease as a result of an in crease in estrogen an d progesterone levels; th ese ch an ges in clude th e followin g: a . In creased pigm en tatio n b . Dark streak down th e m idlin e of th e abdo-

m en (lin ea n igra) c. Ch loasm a (m ask of pregn an cy)—a blotch y

brown ish h yperp igm en tation , over th e fore- h ead , ch eeks, an d n ose

d . Redd ish purple stretch m arks (striae gravi- daru m ) on th e abdom en , breasts, th igh s, an d upper arm s

2. Vascular spider n evi m ay occur on th e n eck, ch est, face, arm s, an d legs.

3. Rate of h air growth m ay in crease. H. Muscu loskeletal system

1. Ch an ges in th e cen ter of gravity begin in th e sec- on d trim ester an d are cau sed by th e h orm on es relaxin an d progesteron e.

2. Th e lu m brosacral curve in creases. 3. Ach in g, n um bn ess, an d weakn ess m ay result;

walkin g beco m es m ore difficult, an d th e wom an develops a waddlin g gait an d is at risk for falls.

4. Relaxation an d in creased m ob ility of pelvic join ts occur, wh ich perm it en largem en t of pelvic dim en sion s.

5. Abdo m in al wall stretch es with loss of ton e th rou gh out pregn an cy, regain ed postp artum .

6. Um b ilicus flatten s or protrudes.

During pregnancy, postural changes occur as the increased weight of the uterus causes a forward pull of the bony pelvis. It is important for the nurse to encour- age the client to implement measures that maintain safety and correct posture to prevent a backache.

VI. Psychological Maternal Changes A. Am bivalen ce

1. Am bivalen ce occurs early in pregn an cy, even wh en th e pregn an cy is plan n ed.

2. Th e m oth er m ay experien ce a dep en den ce- in depen den ce con flict an d am bivalen ce related to role ch an ges.

3. Th e partn er m ay experien ce am bivalen ce related to th e n ew role bein g assum ed, in creased fin an - cial respo n sibilities, an d sh arin g th e m oth er’s atten tion with th e ch ild.

B. Acceptan ce: Facto rs th at m ay be related to acceptan ce of th e pregn an cy are th e wom an ’s readin ess for th e experien ce an d h er iden tification with th e m oth er- h ood role. Specific developm en tal tasks m ust be accom plish ed successfully for positive m atern al role adaptation . Th ese tasks in clude acceptin g th e preg- n an cy, iden tifyin g with th e m oth erin g ro le, solidify- in g h er relation sh ip with h er partn er, establish in g a relation sh ip with h er un born in fan t, an d preparin g for h er birth experien ce.

C. Em otion al lability 1. Em otion al lability m ay be m an ifested by fre-

quen t ch an ges of em otion al states or extrem es in em otion al states.

2. Th ese em otion al ch an ges are com m on , but th e m oth er m ay th in k th at th ese ch an ges are abn o rm al.

D. Body im age ch an ges 1. Th e ch an ges in a wom an ’s perception of h er

im age durin g pregn an cy occur gradually an d m ay be positive or n egative.

2. Th e ph ysical ch an ges an d sign s an d sym pto m s th at th e wom an experien ces durin g pregn an cy con tribute to h er body im age.

E. Relatio n sh ip with th e fetus 1. Th e wom an m ay daydream to prepare for m oth -

erh ood an d th in k about th e m atern al qualities th at sh e would like to possess.

2. Th e wom an first accepts th e biological fact th at sh e is pregn an t.

3. Th e wom an n ext accepts th e growin g fetus as dis- tin ct from h erself an d a perso n to n urtu re.

4. Fin ally, th e wom an prepares realistically for th e birth an d paren tin g of th e ch ild.

VII. Discomforts of Pregnancy A. Nausea an d vom itin g

1. O ccurs in th e first trim ester an d usually subsid es by th e th ird m on th

2. Caused by elevated levels of h um an ch orion ic gon ado tropin an d oth er pregn an cy h orm on es as well as ch an ges in carbo h ydrate m etab olism

3. In terven tion s a . Eatin g dry crackers befo re arisin g b . Avoidin g brush in g teeth im m ediately after

arisin g

302 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

c. Eatin g sm all, frequen t, low-fat m eals durin g th e day

d . Drin kin g liqu ids between m eals rath er th an at m eals

e. Avo idin g fried foods an d spicy food s f. Askin g th e h ealth care provider (HCP) ab out

acu pressure (som e types m ay require a prescription )

g. Askin g th e HCP about th e use of h erb al rem edies

h . Takin g an tiem etic m edication s as prescribed B. Syn cop e

1. Usually occurs in th e first trim ester; supin e h ypo- ten sion occurs particularly in th e secon d an d th ird trim esters.

2. May be triggered h orm on ally or caused by th e in creased blood vo lum e, an em ia, fatigue, sud- den position ch an ges, or lyin g supin e

3. In terven tion s a. Sittin g with th e feet elevated b . Risk for falls; teach to ch an ge position s slowly

The nurse needs to instruct the pregnant woman to avoid lying in the supine position, particularly in the second and third trimesters. The supine position places the woman at risk for supine hypotension, which occurs as a result of pressure of the uterus on the inferior vena cava.

C. Urin ary urgen cy an d frequen cy 1. Usually occurs in th e first an d th ird trim esters 2. Cau sed by pressure of th e uterus on th e blad der 3. In terven tion s

a. Drin kin g n o less th an 2000 m L of fluid dur- in g th e day

b . Lim itin g fluid in take in th e even in g c. Voidin g at regular in tervals d . Sleep in g side-lyin g at n igh t e. Wearin g perin eal pads, if n ecessary f. Perform in g Kegel exercises

D. Breast ten dern ess 1. Can occur in th e first th rough th e th ird trim esters 2. Cau sed by in creased levels of estrogen an d

progesteron e 3. In terven tion s

a. Wearin g a supportive bra b . Avo idin g th e use of soap on th e n ipp les an d

areolar area to preven t dryin g of skin E. In creased vagin al disch arge

1. Can occur in th e first th rough th e th ird trim esters 2. Cau sed by h ypertro ph y an d th icken in g of th e

vagin al m ucosa an d in creased m ucus production 3. In terven tion s

a. Usin g proper clean sin g an d h ygien e tech n iques

b . Wearin g cotton un derwear c. Avo idin g douch in g d . Con sultin g th e HCP if in fectio n is susp ected

F. Nasal stuffin ess 1. O ccurs in th e first th rou gh th ird trim esters 2. Resu lts from in creased estrogen , wh ich cau ses

edem a of th e n asal tissues an d dryn ess 3. In terven tion s

a. En cou ragin g th e use of a h um idifier b . Avoidin g th e use of n asal sprays or an tih ista-

m in es (th e HCP sh ould be con sulted ab out th eir use)

G. Fatigue 1. O ccurs usually in th e first an d th ird trim esters 2. Usually results from h orm on al ch an ges 3. In terven tion s

a. Arran gin g frequen t rest periods th rou gh out th e day

b . Usin g correct postu re an d body m ech an ics c. O btain in g regular exercise d . Perform in g m uscle relaxation an d stren gth -

en in g exercises for th e legs an d h ip join ts e. Avoidin g eatin g an d drin kin g food s con tain -

in g stim ulan ts th rou gh out th e pregn an cy H. Heartb urn

1. O ccurs in th e secon d an d th ird trim esters 2. Resu lts fro m in creased progesteron e levels,

decreased gastroin testin al m otility, eso ph ageal reflux, an d displacem en t of th e stom ach by th e en largin g uterus

3. In terven tion s a. Eatin g sm all, frequen t m eals b . Sittin g uprigh t for 30 m in utes after a m eal c. Drin kin g m ilk between m eals d . Avoidin g fatty an d spicy food s e. Perform in g tailor-sittin g exercises f. Con sultin g with th e HCP ab out th e use of

an tacids I. An kle edem a

1. Usually occurs in th e secon d an d th ird trim esters 2. Resu lts fro m vasodilation , ven o us stasis, an d

in creased ven ous pressure below th e uterus 3. In terven tion s

a. Elevatin g th e legs at least twice a day an d wh en restin g

b . Sleep in g in a side-lyin g position c. Wearin g supportive stockin gs or support h ose d . Avoidin g sittin g or stan din g in 1 position for

lon g periods J. Varicose vein s

1. Usually occur in th e secon d an d th ird trim esters 2. Resu lt from weaken in g walls of th e vein s or

valves an d ven o us con gestion 3. In terven tion s

a. Wearin g supportive stockin gs or support h ose b . Elevatin g th e feet wh en sittin g c. Lyin g with th e feet an d h ips elevated d . Avoidin g lon g periods of stan din g or sittin g e. Movin g about wh ile stan d in g to im prove

circulation

303CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

f. Avoidin g leg crossin g g. Avoidin g con strictin g articles of cloth in g such

as kn ee-h igh stockin gs 4. Th rom b oph lebitis is rare, but it m ay occur.

a . Teach in g leg exercises b . Avoidin g airlin e travel

K. Headach es 1. Usually con sidered ben ign in th e first trim ester.

May n eed furth er in vestigation if occurrin g in th e secon d an d th ird trim esters

2. Resu lt from ch an ges in blood volum e an d vascu lar ton e

3. In terven tion s a . Ch an gin g position slowly b . Applyin g a cool cloth to th e foreh ead c. Eatin g a sm all sn ack d . Usin g acetam in oph en on ly if prescribed by

th e HCP L. Hem o rrh oids

1. Usually occur in th e secon d an d th ird trim esters 2. Resu lt fro m in creased ven o us pressure an d

con stipation 3. In terven tion s

a . Soakin g in a warm sitz bath b . Sittin g on a soft pillow c. Eatin g h igh -fiber food s an d drin kin g suffi-

cien t fluids to avoid con stipation d . In creasin g exercise, such as walkin g e. Applyin g oin tm en ts, suppositories, or com -

presses as prescribed by th e HCP M. Con stipation

1. Usually occurs in th e secon d an d th ird trim esters 2. Resu lts from an in crease in progesteron e produ c-

tion , decreased in testin al m otility, displacem en t of th e in testin es, pressure of th e uterus, an d tak- in g iron supplem en ts

3. In terven tion s a . Eatin g h igh -fiber food s such as wh o le grain s,

fruits, an d vegetables b . Drin kin g n o less th an 2000 m L per day c. Exercisin g regularly, such as a daily 20-

m in u te walk d . Con sultin g with th e HCP about in terven tion s

such as th e use of stool soften ers, laxatives, or en em as

N. Backach e 1. Usually occurs in th e secon d an d th ird trim esters 2. Caused by an exaggerated lum bo sacral curve

resultin g fro m an en larged uterus 3. Risk for falls; teach to m ove about slowly 4. In terven tion s

a . O btain in g rest b . Usin g correct postu re an d body m ech an ics c. Wearin g lo w-h eeled , com fo rtable, an d sup-

portive sh o es d . Perform in g pelvic tilt (rock) exercises an d

con scious relaxation exercises e. Sleep in g on a firm m attress

O. Leg cram p s 1. Usually occur in th e secon d an d th ird trim esters 2. Resu lt from an altered calcium -p h osph orus bal-

an ce an d pressure of th e uterus on n erves or from fatigue

3. In terven tion s a . Gettin g regular exercise, esp ecially walkin g b . Dorsiflexin g th e foot of th e affected leg c. In creasin g calcium in take

P. Sh ortn ess of breath 1. Can occur in th e secon d an d th ird trim esters 2. Resu lts from pressure on th e diap h ragm from th e

en larged uterus 3. In terven tion s

a . Takin g frequen t rest periods b . Sittin g an d sleepin g with th e h ead elevated or

on th e side c. Avoidin g overexertion

VIII. Maternal Risk Factors A. Matern al age: Wom en youn ger th an 20 years an d

older th an 35 years are at risk for adverse perin atal outcom es.

B. Adolescen t pregn an cy 1. Factors th at result in adolescen t pregn an cy

in clude th e early on set of m en arch e, ch an gin g sexual beh aviors in th is age group, problem s with fam ily relation sh ips, poverty, an d lack of kn owledge of reprodu ction an d birth con trol.

2. Majo r con cern s related to adolescen t pregn an cy in clude poor n utrition al status; em otion al an d beh avioral difficu lties; lack of support system s; in creased risk of stillbirth ; low-birth -weigh t infants; fetal m ortality; ceph alopelvic disprop or- tion ; an d in creased risk of m atern al com plica- tion s, such as h yperten sion , an em ia, prolon ged labor, an d in fectio n s.

3. Th e ro le of th e n urse in reducin g risks an d con - sequen ces of adolescen t pregn an cy is twofold— first, to en courage early an d con tin ued pren atal care, an d secon d, to refer th e adolescen t, if n eces- sary, for appropriate assistan ce, wh ich can h elp to coun ter th e effects of a n egative socioeco- n om ic en viron m en t. a . Nutrition : Adequate n utrition is n ecessary for

n orm al fetal growth an d develo pm en t. Nutri- tion n eeds are determ in ed by th e stage of pregn an cy an d n utrition sh ould supp ort recom m en ded weigh t gain durin g th e various stages.

Women of childbearing age should take folic acid supplements to prevent neural tube defects and orofa- cial clefts in the fetus.

b . Gen etic con sideration s: Gen etic abn o rm ali- ties such as defective gen es or tran sm issible in h erited disorders can result in con gen ital an om alies; th e n urse sh ould perform a

304 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

gen etic risk assessm en t to determ in e an in h eritable risk.

c. Health care: Failure to seek an d obtain pren a- tal care, in cludin g den tal care, in creases th e risk for preterm birth an d low birth weigh t.

d . Abuse an d violen ce: Ph ysical ab use an d vio- len ce can in crease th e risk for abruptio pla- cen tae, preterm birth , an d in fectio n s from un wan ted an d forced sex.

e. Med ical con d ition s: Con curren t m ed ical con - dition s, such as but n ot lim ited to diabetes m ellitus, h yperten sive disorder, or cardiac disease, in crease th e risk of pregn an cy.

C. Germ an m easles (rubella): Matern al in fectio n dur- in g th e first 8 weeks of gestation carries th e h igh est rate of fetal in fectio n .

D. Sexually tran sm itted in fectio n s 1. Syp h ilis

a. O rgan ism m ay cro ss th e placenta. b . In fection usually leads to spon tan eous abor-

tio n s an d in creases th e in ciden ce of m en tal subn orm ality an d ph ysical deform ities.

2. Con dylom a acum in atu m (h um an papillom a- virus) a. Tran sm issio n m ay occur durin g vagin al birth . b . In fection is associated with th e developm en t

of epith elial tum o rs of th e m ucou s m em - bran es of th e laryn x in ch ildren .

3. Gon orrh ea a. Fetus is co n tam in ated at th e tim e of birth . b . Matern al in fectio n m ay result in postp artum

in fectio n of th e neonate. c. Risks to th e n eon ate in clude oph th alm ia n eo-

n atorum , pn eum on ia, an d sepsis. 4. Ch lam ydial in fectio n

a. Tran sm issio n m ay occur durin g vagin al birth an d can result in n eon atal con jun ctivitis or pn eum on itis.

b . In fection can cause prem atu re rupture of th e m em bran es, prem ature labor, an d postp ar- tum en dom etritis.

5. Trich om on iasis: Asso ciated with prem atu re ru p- ture of th e m em bran es an d postp artum en dom e- tritis

6. Gen ital h erpes sim plex virus a. Ch aracterized by pain ful lesion s, fever, ch ills,

m alaise, an d severe dysuria an d m ay last 2 to 3 weeks

b . Assessm en t includes question in g all wom en about sign s an d sym ptom s an d in spectin g the vulvar, perin eal, an d vagin al areas for vesicles or areas of ulceration or crustin g; th is is don e durin g pregn an cy an d at th e on set of labor.

c. Vagin al birth m ay be acceptable; cesarean birth is recom m en ded if visible lesion s are present.

d . In fan ts wh o are born th rough an in fected vagin a sh o uld be observed carefully, an d sam ples sh ould be taken for culture.

E. Hum an im m un od eficien cy virus (HIV) 1. HIV is tran sm itted th rough blood ; blood

produ cts; an d oth er bodily fluids, such as urin e, sem en , an d vagin al secretio n s; th e virus is also tran sm itted th rough exposu re to in fected secre- tion s durin g birth an d th rou gh breast m ilk.

2. Repeated exposure to th e virus durin g pregn an cy th rou gh un safe sex practices or in traven ous drug use can in crease th e risk of tran sm issio n to th e fetus.

3. Perin atal ad m in istration of zidovud in e m ay be recom m en ded to decrease th e risk of tran sm is- sion of HIV from m oth er to fetus.

F. Substan ce abuse 1. Substan ce abuse th reaten s n orm al fetal growth

an d successful term com pletion of the pregn an cy. 2. Substan ce abuse places th e pregn an cy at risk for

fetal growth restriction , abru ptio placen tae, an d fetal bradycardia.

3. Man y substan ces cross th e placen ta an d can be teratogen ic (dru gs, tobacco, alcoh ol, m edica- tion s, certain food s such as raw fish ) ; n o over- th e-coun ter m edication s sh ould be taken un less prescribed by th e HCP.

4. Sm okin g (tobacco) can result in low birth weigh t, a h igh er in ciden ce of birth defects, an d stillbirth s.

5. Ph ysical sign s of drug ab use m ay in clude dilated or co n tracted pupils, fatigue, track (n eedle) m arks, skin abscesses, in flam ed n asal m ucosa, an d in approp riate beh avior by th e m oth er.

6. Con sum ption of alcoh ol durin g pregn an cy m ay lead to fetal alcoh ol syn d rom e an d can cause jit- terin ess, ph ysical abn orm alities, con gen ital an om alies, an d growth deficits in th e newborn.

G. Viral h epatitis (see Ch apter 26 an d Ch apter 52 for in form ation regardin g h epatitis B in fectio n )

IX. Antepartum Diagnostic Testing

The usual schedule for antepartum health care visits is every 4 weeks for the first 28 to 32 weeks, every 2 weeks from 32 to 36 weeks, and every week from 36 to 40 weeks.

A. Bloo d type an d Rh factor 1. ABO typ in g is perform ed to determ in e th e

wom an ’s blood type in th e ABO an tigen system . 2. Rh typ in g is don e to determ in e th e wom an ’s

blood typ e in th e rh esus an tigen system . ( Rh pos- itive in dicates th e presen ce of th e an tigen ; Rh neg- ative in dicates th e absen ce of th e an tigen .)

3. If th e clien t is Rh n egative an d h as a n egative an ti- body screen , sh e will n eed repeat an tibod y screen s an d sh ould receive Rh o(D) im m un e glob ulin (Rh oGAM) at 28 weeks of gestation .

B. Rubella titer 1. If th e clien t h as a n egative titer (less th an 1:8),

in dicatin g susceptibility to th e rubella virus,

305CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

sh e sh o uld receive th e appropriate im m un iza- tion postpartum .

2. Th e clien t m ust be usin g effective birth con tro l at th e tim e of th e im m un ization an d m ust be coun - seled n ot to beco m e pregn an t for 1 to 3 m on th s after im m un ization (as specified by th e HCP) an d to avoid con tact with an yon e wh o is im m un ocom prom ised.

3. If th e rubella vaccin e is adm in istered at th e sam e tim e as Rh o(D) im m un e glob ulin , it m ay n ot be effective.

4. Rubella vaccin e is adm in istered postp artum (before disch arge) via th e subcutan eous ro ute if th e titer is less th an 1:8; in qu ire about sen sitiv- ity to eggs.

Rubella vaccine is not given during pregnancy because the live attenuated virus may cross the placenta and present a risk to the developing fetus.

C. Hem o globin an d h em atocrit levels 1. Hem o globin an d h em atocrit levels declin e dur-

in g gestation as a result of in creased plasm a volu m e.

2. A decrease in th e h em oglobin level to less th an 10 g/ d L (100 m m ol/ L) or in th e h em atocrit level to less th an 30% in dicates an em ia.

D. Papan icolaou’s sm ear is don e durin g th e in itial pre- n atal exam in ation to screen for cervical n eoplasia.

E. Sexually tran sm itted in fectio n s (Table 25-1) F. Sickle cell screen in g

1. Screen in g is in dicated for clien ts at risk for sickle cell disease.

2. A positive test m ay in dicate a n eed for furth er screen in g.

G. Tuberculin skin test 1. Th e HCP m ay prefer to perform th is skin test

after birth. 2. A positive skin test in dicates th e n eed for a ch est

radiograph (usin g an ab dom in al lead sh ield) to rule out active disease; in a pregn an t clien t, ch est radiograph y would n ot be perform ed un til after 20 weeks of gestation (after th e fetal organ s are form ed).

3. Con verters to positive m ay be referred for treat- m en t with m edication after birth .

H. Hepatitis B surface an tigen s 1. Testin g for h epatitis an tigen s is recom m en ded

for all wom en because of th e prevalen ce of th e disease in th e gen eral popu lation .

2. Vaccin ation for h epatitis B an tigen m ay be specif- ically in dicated for th e followin g: a . Health care workers b . In traven ous drug users c. Clien ts born in Asia, Africa, Haiti, or th e

Pacific islan ds d . Clien ts with previously un diagn osed jaun -

dice or ch ron ic liver disease e. Clien ts with tattoos f. Clien ts with h isto ries of blood tran sfusion s g. Clien ts with h istories of m ultiple episodes of

sexually tran sm itted in fectio n s h . Clien ts wh o h ave been rejected previously as

blood don ors i. Clien ts with h istories of dialysis or ren al

tran splan tation j. Clien ts from h ou seh olds h avin g m em bers

in fected with h epatitis B or h em odialysis clien ts

TABLE 25-1 Monitoring for Sexually Transmitted Infections Disease Laboratory Test

Gonorrhea Vaginal culture is done during initial prenatal examination to screen for gonorrhea. Culture may be repeated during third trimester in high-risk clients.

Syphilis Culture of lesions (if present) is done during initial prenatal examination to screen for syphilis. Diagnosis depends on microscopic examination of primary and secondary lesion tissue and serology (Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test) during latency and late infection. Culture may be repeated during third trimester in high-risk clients.

Condyloma acuminatum (human papillomavirus)

Culture is indicated for clients with positive history or with active lesions. Test is performed to determine route of delivery. Weekly cultures may be done at week 35 or 36 of pregnancy until birth.

Chlamydia Vaginal culture is indicated for all pregnant clients if client is in a high-risk group or if infants from previous pregnancies have developed neonatal conjunctivitis or pneumonia.

Trichomoniasis Normal saline wet smear of vaginal secretions is checked for presence of protozoa. Associated with premature rupture of membranes and postpartum endometritis.

Genital herpes simplex virus (HSV-2)

Culture is done of lesions (if present) during initial prenatal examination to screen for HSV. Microscopic examination is done to determine presence of virus. Additional screening may be necessary as pregnancy progresses.

HIV Testing may be done for high-risk client. Common tests to determine the presence of antibodies include ELISA, Western blot, and immunofluorescence assay (IFA).

ELISA, Enzyme-linked immunosorbent assay; HIV, human immunodeficiency virus.

306 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

3. Hepatitis B vaccin e is n ot con train d icated durin g pregn an cy an d m ay be recom m en ded by th e HCP.

4. See Ch apter 52 for ad dition al in form ation ab out h epatitis.

I. Urin alysis an d urin e culture 1. A urin e specim en for gluco se an d protein deter-

m in ation s sh o uld be obtain ed at every an tep artum visit.

2. Glycosuria is a co m m on result of decreased ren al th resh old th at occurs durin g pregn an cy.

3. If glycosu ria persists, it m ay in dicate diabetes. 4. Wh ite blood cells in th e urin e m ay in dicate

in fectio n . 5. Keto n uria m ay result from in sufficien t food

in take or vom itin g. 6. Levels of 2 + to 4 + protein in th e urin e m ay in di-

cate in fectio n or preeclam p sia. J. Ultrason ograph y

1. O utlin es an d iden tifies fetal an d m atern al structures

2. Assists in con firm in g gestation al age an d esti- m ated date of delivery an d evaluatin g amniotic fluid volu m e (am n iotic fluid in dex) , wh ich is don e via special m easu rem en ts

3. May be don e abdom in ally or tran svagin ally dur- in g pregn an cy

4. Can be used to determ in e th e presen ce of pre- m ature dilation of th e cervix (in com peten t cervix). A tran svagin al ultraso un d is used durin g th e first trim ester to ch eck th e len gth of th e cervix.

5. In terven tion s a. If an abdom in al ultraso un d is bein g per-

form ed, th e wom an m ay n eed to drin k water to fill th e bladder before th e proced ure to obtain a better im age of th e fetus.

b . If a tran svagin al ultraso un d is bein g per- form ed, a lubricated probe is in serted in to th e vagina.

c. Th e clien t sh ould be in form ed th at th e test presen ts n o kn own risks to th e clien t or th e fetus.

K. Biop h ysical profile 1. No n in vasive assessm en t of th e fetus th at

in cludes fetal breath in g m ovem en ts, fetal m ove- m en ts, fetal ton e, am n iotic flu id in dex, an d fetal h eart rate pattern s via a n on stress test

2. No rm al fetal bioph ysical activities in dicate th at th e cen tral n ervou s system is fun ctio n al an d th at th e fetus is n ot h ypoxem ic.

L. Do ppler blood flow an alysis: Non in vasive (ultraso- n ograph y) m eth od of studyin g th e blood flow in th e fetus an d placenta

M. Percutan eous um b ilical blood sam plin g 1. Percutan eous um b ilical blood sam plin g is per-

form ed if fetal blood sam plin g is n ecessary; it

in volves in sertio n of a n eedle directly in to th e fetal um b ilical vessel un der ultraso un d guid an ce.

2. Fetal h eart rate m on itorin g is n ecessary for 1 h our after th e procedure, an d a follow-up ultraso un d to ch eck for bleedin g or h em atom a form ation is don e 1 h our after th e proced ure.

N. α-Feto protein screen in g 1. Assesses th e quan tity of fetal serum protein s;

abn o rm al protein levels are associated with open n eural tube an d abdom in al wall defects

2. Assists in screen in g for spin a bifid a an d Down syn d rom e

3. If abn orm al, repeat test; false positive is com m on . 4. In terven tion s

a. α-Fetoprotein level is determ in ed by a m ater- n al blood sam ple drawn between 16 an d 18 weeks of gestation .

b . If th e level is abn orm al an d th e gestation is less th an 18 weeks, a secon d sam ple is drawn an d screen ed.

c. An ultraso un d is perform ed for elevated levels to rule out fetal abn orm alities or m ultiple gestation .

O. Deoxyribon ucleic acid (DNA) gen etic testin g 1. Can be used to detect abn o rm alities related to an

in h erited con d ition 2. Assists in determ in in g if th e wom an is at risk for

h avin g a fetus with Do wn syn d rom e (trisom y 21), Edwards syn drom e (trisom y 18), or Patau syn d rom e (trisom y 13).

3. In terven tion s: Th is typ e of testin g can be don e as early as 7 weeks of gestation an d a blood sam ple is used.

P. Ch orion ic villus sam plin g 1. Perform ed for th e purpo se of detectin g gen etic

abn o rm alities; th e HCP aspirates a sm all sam ple of ch orion ic villus tissue at 10 to 13 weeks of gestation .

2. In terven tion s a. En su re in form ed con sen t was obtain ed. b . Th e clien t m ay n eed to drin k water to fill th e

blad der before th e procedure to aid in th e visu alization of th e uterus for cath eter in sertion .

c. O btain baselin e vital sign s an d fetal h eart rate; m on itor frequen tly after th e procedure.

d . Rh -n egative wom en m ay be given Rh o(D) im m un e globulin because ch orion ic villus sam plin g in creases th e risk of Rh sen siti- zation .

Q. Am n io cen tesis 1. Aspiration of am n iotic fluid; best perform ed

between 15 an d 20 weeks of pregn an cy because am n iotic flu id vo lum e is adequate an d m an y via- ble fetal cells are presen t in th e fluid by th is tim e

2. Perform ed to determ in e gen etic disorders, m eta- bolic defects, an d fetal lun g m aturity

307CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

3. Risks a . Matern al h em orrh age b . In fection c. Rh isoim m u n ization d . Abruptio placen tae e. Am n iotic fluid em b oli f. Prem atu re rupture of th e m em bran es

4. In terven tion s a . En su re in form ed con sen t was obtain ed. b . If less th an 20 weeks of gestation , th e clien t

sh ould h ave a full bladder to support th e uterus; if perform ed after 20 weeks of gesta- tion , th e clien t sh ould h ave an em p ty bladder to m in im ize th e ch an ce of pun cture.

c. Prepare th e clien t for ultrason o graph y, wh ich is perform ed to locate th e placen ta an d avoid pun cture.

d . O btain baselin e vital sign s an d fetal h eart rate; m on itor every 15 m in u tes.

e. Position th e clien t supin e durin g th e exam i- n ation an d on th e left side after th e proced ure.

After chorionic villus sampling and amniocentesis, instruct the client that if chills, fever, bleeding, leakage of fluid at the needle insertion site, decreased fetal move- ment, uterine contractions, or cramping occurs, she must notify the HCP.

R. Kick coun ts (fetal m ovem en t co un tin g) 1. Th e clien t sits quietly or lies down on h er side

an d coun ts fetal kicks as in structed. 2. In struct th e clien t to n otify th e HCP if th ere are

fewer th an 10 kicks in 2 con secutive 2-h our periods or as in structed by th e HCP.

S. Fern test 1. Th e fern test is a m icroscopic slide test to deter-

m in e th e presen ce of am n iotic fluid leakage. 2. Usin g sterile tech n ique, a specim en is obtain ed

from th e extern al os of th e cervix an d vagin al pool an d is exam in ed on a slide un d er a m icroscope.

3. A fern like pattern produced by th e effects of salts of th e am n iotic flu id in dicates th e presen ce of am n iotic flu id.

4. In terven tion s a . Position th e clien t in th e dorsal lith otom y

position . b . In struct th e clien t to cough , wh ich cau ses th e

am n iotic fluid to leak fro m th e uterus if th e m em bran es are ruptured.

T. Nitrazin e test 1. A n itrazin e test strip is used to detect th e presen ce

of am n iotic fluid in vagin al secretio n s. 2. Vagin al secretion s h ave a pH of 4.5 to 5.5 an d do

n ot affect th e n itrazin e strip or swab. 3. Am n iotic fluid h as a pH of 7.0 to 7.5 an d turn s

th e n itrazin e strip or swab blue.

4. In terven tion s a . Position th e clien t in th e dorsal lith otom y

position . b . Touch th e test tape to th e fluid . c. Assess th e test tap e for a blue-green , blue-gray,

or deep blue color, wh ich in dicates th at th e m em bran es are ruptured, cau sin g leakage of am n iotic flu id.

U. Fibron ectin test 1. Sam plin g of cervical an d vagin al secretio n s for

fetal fibro n ectin (a protein presen t in fetal tissues n orm ally foun d in cervical an d vagin al secretio n s un til 16 to 20 weeks of gestation an d again at or n ear term )

2. Positive results m ay in dicate th e on set of labor in 1 to 3 weeks; n egative test results are m ore pre- dictive th at preterm labor will n ot begin .

3. Test used if at risk for preterm labor, befo re 37 weeks of gestation

4. In terven tion s a . Clien t is placed in lith otom y position for ster-

ile speculum exam . b . Cervical secretio n s are obtain ed with

cotton swab. c. Laboratory tests are don e for th e presen ce of

fibron ectin . V. Non stress test ( Box 25-4) W. Con traction stress test (Box 25-5)

X. Nutrition A. Gen eral guidelin es

1. Guidelin es for h ealth an d n utrition in form ation for breast-feed in g an d pregn an t wom en are located at th e U.S. Departm en t of Agriculture Ch ooseMyPlate website at www. ch oosem yplate.gov/ m om s-pregn an cy- breastfeedin g. Th e wom an sh ould be assisted with accessin g th is site an d preparin g a n utrition al plan .

2. Th e average exp ected weigh t gain durin g preg- n an cy is 25 to 35 lb (11 to 16 kg) for wom en with a n orm al prepregn an cy weigh t.

3. An in crease of about 300 calories/ day is n eeded durin g pregn an cy.

4. Calo rie n eeds are greater in th e last 2 trim esters th an in th e first.

5. An in crease of about 500 calories/ day is n eeded durin g lactation .

6. A diet h igh in folic acid or folic acid supplem en ts is n ecessary for all wom en of ch ildbearin g age to preven t n eural tube defects an d orofacial clefts in th e fetus.

7. At least 8 to 10 ( 8-o z) glasses o f flu id are n eed ed each d ay, o f wh ich 4 to 6 glasses sh o u ld b e water.

8. Sodium is n ot restricted un less specifically pre- scrib ed by th e HCP.

308 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

B. Vegan an d Vegetarian Diets (see Ch apter 11) 1. En su re th at th e clien t eats a sufficien t am oun t of

varied food s to m eet n orm al n utrien t an d en ergy n eeds.

2. Clien ts sh ould be educated about con sum in g com plem en tary protein s over th e course of each day to en sure th at all essen tial am in o acids are provided.

3. Poten tial deficien cies in vegetarian diets in clude en ergy, protein , vitam in B12, zin c, iron , calcium , om ega-3 fatty acids, an d vitam in D (if lim ited exp osure to sun ligh t).

4. Protein con sum p tion can be in creased by con - sum p tion of a variety of vegetable protein sources based on wh ole grain s, legum es, seeds, n uts, an d vegetables com bin ed to provide all essen tial am in o acids.

5. To en h an ce absorption of iron , vegetarian s sh ould in clude a good source of iron an d vita- m in C with each m eal.

6. Food s com m on ly eaten in clude tofu, tem peh , soy m ilk an d soy products, m eat an alogs, legum es, n uts an d seeds, sprouts, an d a variety of fruits an d vegetables.

C. Lactose in toleran ce 1. Lactose con sum ed by an in dividual with lactose

in toleran ce can cause ab dom in al disten tion , dis- com fo rt, n ausea, vom itin g, cram p s, an d lo ose stools.

2. Clien ts with lactose in toleran ce n eed to in corpo- rate sources of calcium oth er th an dairy products in to th eir dietary pattern s regularly.

BOX 25-4 Nonstress Test

Description ▪ Test is performed to assess placental function and

oxygenation. ▪ Test determines fetal well-being. ▪ Test evaluates the fetal heart rate (FHR) response to fetal

movement.

Interventions ▪ An external ultrasound transducer and tocodynamometer

are applied to the client, and a tracing of at least 20 minutes’ duration is obtained so that the FHR and uter- ine activity can be observed.

▪ Baseline blood pressure is obtained, and blood pressure is monitored frequently.

▪ The client is placed in the lateral (side-lying) position to avoid vena cava compression.

▪ The client may be asked to press a button every time she feels fetal movement; the monitor records a mark at each point of fetal movement, which is used as a reference point to assess the FHR response.

Results Rea ct ive Nonst ress Test (Norma l, Nega t ive) “Reactive” indicates a healthy fetus. The result requires 2 or more FHR accelerations of at least 15

beats/ minute, lasting at least 15 seconds from the begin- ning of the acceleration to the end, in association with fetal movement, during a 20-minute period.

Nonreact ive Nonst ress Test (Abnorma l) No accelerations or accelerations of less than 15 beats/ minute

or lasting less than 15 seconds in duration occur during a 40 -minute observation.

Unsa t isfa ctory The result cannot be interpreted because of the poor quality of

the FHR tracing.

BOX 25-5 Contraction Stress Test

Description ▪ Test assesses placental oxygenation and function. ▪ Test determines fetal ability to tolerate labor and deter-

mines fetal well-being. ▪ Fetus is exposed to the stress of contractions to assess the

adequacy of placental perfusion under simulated labor conditions.

▪ Test is performed if nonstress test is abnormal. Interventions ▪ External fetal monitor is applied to the client, and a 20- to

30 -minute baseline strip is recorded. ▪ The uterus is stimulated to contract by the administration

of a dilute dose of oxytocin or by having the client use nipple stimulation until 3 palpable contractions with a duration of 40 seconds or more in a 10 -minute period have been achieved.

▪ Frequent maternal blood pressure readings are done, and the mother is monitored closely while increasing doses of oxytocin are given.

Results Nega tive Cont ra ct ion Stress Test (Norma l) A negative result is represented by no late decelerations of the fetal heart rate (FHR).

Positive Cont ra ct ion Stress Test (Abnorma l) A positive result is represented by late decelerations of the

FHR, with 50 % or more of the contractions in the absence of hyperstimulation of the uterus.

Equivocal An equivocal result contains decelerations, but with less than

50 % of the contractions, or uterine activity shows a hyper- stimulated uterus.

Unsa t isfact ory An unsatisfactory result means that adequate uterine contrac-

tions cannot be achieved, or the FHR tracing is of insuffi- cient quality for adequate interpretation.

309CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

3. Milk m ay be tolerated in cooked form , such as in custards or ferm en ted dairy produ cts.

4. Ch eese an d yogurt som etim es are tolerated. 5. Lactase, an en zym e, m ay be prescribed an d is

taken befo re in gestin g m ilk or m ilk produ cts. 6. Lactase-treated m ilk or lactose-free products are

also available com m ercially. D. Pica

1. Pica refers to eatin g n on fo od substan ces, such as dirt, clay, starch , an d freezer frost.

2. Th e cau se is un kn own ; cultural values, such as beliefs regardin g th e effect of a m aterial on th e m oth er or fetus, m ay m ake pica a com m on practice.

3. Iron deficien cy an em ia m ay occur as a result of pica.

E. Cultural con sideratio n s: See Ch apter 5 for in form a- tion on cultural con sideration s in n utrition .

CRITICAL THINKING What Should You Do? Answer: Interventions for nausea and vom iting in the pregnant client include eating dry crackers before arising; avoiding brushing teeth im m ediately after arising; eating sm all, frequent, low-fat m eals during the day; drinking liq- uids between m eals rather than at m eals; avoiding fried foods and spicy foods; asking the health care provider (HCP) about acupressure (som e types m ay require a pre- scription); and as king the HCP about the us e of herbal rem edies.

Reference: Lowdermilk, Perry, Cashion, Alden (20 16), p. 362.

P R A C T I C E Q U E S T I O N S 244. Th e n urse is providin g in struction s to a pregn an t

clien t wh o is sch eduled for an am n iocen tesis. Wh at in struction sh ould th e n urse provide? 1. Strict bed rest is required after th e proced ure. 2. Hospitalization is n ecessary for 24 h ou rs after

th e proced ure. 3. An in form ed con sen t n eeds to be sign ed before

th e procedure. 4. A fever is expected after th e procedure because

of th e traum a to th e abdom en .

245. A pregn an t clien t in th e first trim ester calls th e n urse at a h ealth care clin ic an d reports th at sh e h as n oticed a th in , colorless vagin al drain age. Th e n urse sh ould m ake wh ich statem en t to th e clien t? 1. “Com e to th e clin ic im m ediately.” 2. “Th e vagin al disch arge m ay be both erso m e, but

is a n orm al occurren ce.” 3. “Report to th e em ergen cy departm en t at th e

m atern ity cen ter im m ediately.”

4. “Use tam pon s if th e disch arge is both erso m e, but be sure to ch an ge th e tam pon s every 2 h ours.”

246. A n on stress test is perform ed on a clien t wh o is pregn an t, an d th e results of th e test in dicate n on - reactive fin din gs. Th e h ealth care provid er pre- scrib es a con traction stress test, an d th e results are docum en ted as n egative. How sh ould th e n urse docum en t th is fin din g? 1. A n orm al test result 2. An abn orm al test result 3. A h igh risk for fetal dem ise 4. Th e n eed for a cesarean section

247. A ru bella titer result of a 1-day postp artum clien t is less th an 1:8, an d a rubella virus vaccin e is pre- scrib ed to be adm in istered befo re disch arge. Th e n urse provides wh ich in form ation to th e clien t about th e vaccin e? Select all th at ap p ly.

1. Breast-feedin g n eeds to be stopped for 3 m on th s.

2. Pregn an cy n eeds to be avoided for 1 to 3 m on th s.

3. Th e vaccin e is adm in istered by th e subcu ta- n eous route.

4. Exposure to im m un osu ppressed in dividuals n eeds to be avoided.

5. A h ypersen sitivity reaction can occur if th e clien t h as an allergy to eggs.

6. Th e area of th e in jection n eeds to be covered with a sterile gauze for 1 week.

248. Th e n urse in a h ealth care clin ic is in structin g a pregn an t clien t h ow to perform “kick coun ts.” Wh ich statem en t by th e clien t in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I will record th e n um ber of m ovem en ts or kicks.” 2. “I n eed to lie flat on m y back to perform th e

procedure.” 3. “If I coun t fewer th an 10 kicks in a 2-h o ur

period, I sh ould coun t th e kicks again over th e n ext 2 h ours.”

4. “I sh ould place m y h an ds on th e largest part of m y abdom en an d con cen trate on th e fetal m ovem en ts to coun t th e kicks.”

249. Th e n urse is perform in g an assessm en t of a preg- n an t clien t wh o is at 28 weeks of gestation . Th e n urse m easu res th e fun dal h eigh t in cen tim eters an d n otes th at th e fun dal h eigh t is 30 cm . How sh ould th e n urse in terp ret th is fin din g? 1. Th e clien t is m easurin g large for gestation al age. 2. Th e clien t is m easu rin g sm all for gestation al age. 3. Th e clien t is m easurin g n orm al for gestation al age. 4. More evid en ce is n eeded to determ in e size for

gestation al age.

310 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

250. Th e n urse is perform in g an assessm en t on a clien t wh o susp ects th at sh e is pregn an t an d is ch eckin g th e clien t for probable sign s of pregn an cy. Th e n urse sh ould assess for wh ich probable sign s of pregn an cy? Select all th at ap p ly.

1. Ballo ttem en t 2. Ch adwick’s sign 3. Uterin e en largem en t 4. Positive pregn an cy test 5. Fetal h eart rate detected by a n on electron ic

device 6. O utlin e of fetus via radiograph y or

ultrason o graph y

251. A pregn an t clien t is seen for a regular pren atal visit an d tells th e n urse th at sh e is exp erien cin g irregular con traction s. Th e n urse determ in es th at sh e is experien cin g Braxto n Hicks con traction s. O n th e basis of th is fin din g, wh ich n ursin g action is appropriate? 1. Con tact th e h ealth care provider. 2. In struct th e clien t to m ain tain bed rest for th e

rem ain d er of th e pregn an cy. 3. In form th e clien t th at th ese con traction s are

com m on an d m ay occur th rou gh ou t th e pregn an cy.

4. Call th e m atern ity un it an d in form th em th at th e clien t will be adm itted in a preterm labo r con d ition .

252. Aclien t arrives at th e clinic for th e first prenatal assess- m en t. Sh e tells th e n urse th at th e first day of h er last n orm al m en strual period was O ctober 19, 2018. Using Nägele’s rule, wh ich expected date of delivery sh ould th e n urse docum en t in th e clien t’s ch art? 1. July 12, 2019 2. July 26, 2019 3. August 12, 2019 4. August 26, 2019

253. Th e n urse is collectin g data durin g an adm ission assessm en t of a clien t wh o is pregn an t with twin s. Th e clien t h as a h ealth y 5-year-old ch ild wh o was delivered at 38 weeks an d tells th e n urse th at sh e does n ot h ave a h isto ry of an y typ e of abortion or fetal dem ise. Usin g GTPAL, wh at sh ould th e n urse docum en t in th e clien t’s ch art? 1. G¼3, T¼2, P¼0, A¼0, L¼1 2. G¼2, T¼1, P¼0, A¼0, L¼1 3. G¼1, T¼1, P¼1, A¼0, L¼1 4. G¼2, T¼0, P¼0, A¼0, L¼1

A N S W E R S 244. 3 Ra t ion a le: Because am n iocen tesis is an in vasive procedure, in fo rm ed con sen t n eeds to be ob tain ed b efo re th e p rocedu re. After th e p ro ced ure, th e clien t is in stru cted to rest, bu t m ay resum e ligh t activity after th e cram pin g subsides. Th e clien t is in structed to keep th e pu n cture site clean an d to rep ort an y com p lication s, su ch as ch ills, fever, b leed in g, leakage o f fluid at th e n eed le in sertio n site, d ecreased fetal m ovem en t, uterin e co n tractio n s, or cram pin g. Am n io cen tesis is an o utp a- tien t pro ced ure an d m ay be d on e in th e h ealth care provider’s office or in a special p ren atal testin g un it. Hosp italizatio n is n o t n ecessary after th e p ro ced u re. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, n u rsin g im plica- tion s related to am n iocen tesis. Recallin g th at th is p ro ced u re is in vasive will d irect you to th e co rrect op tion . Review: Am n io cen tesis Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clien t Edu catio n ; Health Care Law Refer en ces: Lowderm ilk et al. (2016), p . 642; Pagan a, Pagan a, Pagan a (2015), p. 52.

245. 2 Ra t ion a le: Leu korrh ea b egin s du rin g th e first trim ester. Man y clien ts n o tice a th in , colo rless or yellow vagin al d isch arge th ro ugh ou t p regn an cy. Som e clien ts b ecom e d istressed abo u t th is co n d itio n , bu t it d oes n ot req uire th at th e clien t rep ort to

th e h ealth care clin ic or em ergen cy d ep artm en t im m ed iately. If vagin al disch arge is p ro fu se, th e clien t m ay u se pan ty lin ers, b ut sh e sh o u ld n ot wear tam p on s b ecau se o f th e risk o f in fectio n . If th e clien t u ses pan ty lin ers, sh e sh ou ld ch an ge th em frequ en tly. Test -Ta kin g St r a t egy: Elim in ate op tion s 1 an d 3 first b ecau se th ey are co m p arab le o r alike, in d icatin g th at th e clien t requ ires m ed ical atten tio n . From th e rem ain in g op tion s, recallin g th at th is m an ifestation is a n orm al ph ysiolo gical o ccu rren ce or th at tam p on s sh ou ld be avoided will assist in directin g you to th e co rrect o ption . Review: No rm al assessm en t fin d in gs in p regn an cy Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Health Prom o tion ; Repro du ctio n Refer en ce: Lo wd erm ilk et al. (2016), p . 298.

246. 1 Ra t ion a le: Con traction stress test resu lts m ay be in terpreted as n egative (n orm al), p ositive (abn orm al), o r equ ivo cal. A n ega- tive test result in dicates th at n o late d eceleratio n s o ccu rred in th e fetal h eart rate, alth ou gh th e fetu s was stressed b y 3 con trac- tion s o f at least 40 seco n d s’ d uration in a 10-m in u te perio d. O p tion s 2, 3, an d 4 are in correct in terp retation s. Test -Ta kin g Str a tegy: No te th at o ptio n s 2, 3, an d 4 are co m - p arab le o r alike in th at th ey in dicate an abn orm al test result fin din g. Review: Th e in terp retatio n o f th e resu lts o f a co n tractio n stress test

311CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Perfu sio n ; Rep ro du ction Refer en ces: Lo wd erm ilk et al. (2016), p. 651; Pagan a, Pagan a, Pagan a (2015), p p . 432-433.

247. 2, 3, 4, 5 Ra tion a le: Ru bella vaccin e is adm in istered to wo m en wh o h ave n o t h ad ru b ella o r wo m en wh o are n ot sero lo gically im m un e. Th e vaccin e m ay b e adm in istered in th e im m ed iate p ostp artu m perio d to preven t th e p ossib ility of co n tractin g rub ella in futu re pregn an cies. Th e live atten uated rub ella viru s is n o t co m m u n icable in b reast m ilk; b reast-feed in g d o es n o t n eed to be stop ped . Th e clien t is cou n seled n o t to b eco m e p reg- n an t fo r 1 to 3 m on th s after im m un izatio n o r as sp ecified by th e h ealth care provid er b ecau se o f a po ssib le risk to a fetu s from th e live viru s vaccin e; th e clien t m ust be usin g effective b irth con tro l at th e tim e o f th e im m u n izatio n . Th e clien t sh o u ld avoid co n tact with im m u n o su pp ressed in d ivid uals b ecause o f th eir low im m u n ity toward live viruses an d b ecause th e viru s is sh ed in th e u rin e an d o th er bo dy fluids. Th e vaccin e is ad m in - istered b y th e su b cu tan eo us ro ute. A h ypersen sitivity reaction can o ccu r if th e clien t h as an allergy to eggs becau se th e vaccin e is m ad e from d u ck eggs. Th ere is n o u seful o r n ecessary reason fo r coverin g th e area of th e in jection with a sterile gauze. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, clien t in structio n s regard in g th e rub ella vaccin e. Recallin g th at th e rub ella vac- cin e is a live virus vaccin e will assist in selectin g op tio n s 2 an d 5. Next, recallin g th e rou te o f ad m in istration an d th e con - train dicatio n s asso ciated with its u se will assist in selectin g o ptio n s 3 an d 4. Review: Clien t in struction s regardin g th e ru b ella vaccin e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Clien t Ed ucation ; Im m un ity Refer en ce: Lo wd erm ilk et al. (2016), p. 493.

248. 2 Ra tion a le: Th e clien t sh ou ld sit o r lie q uietly o n h er side to per- fo rm kick co un ts. Lyin g flat o n th e back is n o t n ecessary to per- fo rm th is proced ure, can cause d isco m fort, an d presen ts a risk o f ven a cava (su pin e h ypo ten sive) syn drom e. Th e clien t is in stru cted to place h er h an ds o n th e largest p art o f th e ab do - m en an d co n cen trate on th e fetal m ovem en ts. Th e clien t reco rd s th e n um b er of m ovem en ts felt du rin g a specified tim e p erio d . Th e clien t n eeds to n o tify th e h ealth care p ro vider (HCP) if sh e feels fewer th an 10 kicks o ver two con secu tive 2-h o u r in tervals o r as in stru cted b y th e HCP. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in co rrect statem en t. If yo u are un fam iliar with th is p ro cedu re, recallin g th at th e risk o f ven a cava (su pin e h ypo ten sive) syn drom e exists wh en th e clien t lies o n h er b ack will d irect yo u to th e correct o ptio n . Review: Procedu re for kick co u n ts Level of Cogn it ive Abilit y: Evalu atin g

Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clien t Ed ucation ; Perfusio n Refer en ce: Lo wd erm ilk et al. (2016), pp . 635-636.

249. 3 Ra tion a le: Du rin g th e seco n d an d th ird trim esters ( weeks 18 to 30) , fu n d al h eigh t in cen tim eters ap proxim ately equ als th e fetu s’s age in weeks Æ2 cm . Th erefore, if th e clien t is at 28 weeks gestatio n , a fu n d al h eigh t o f 30 cm wo uld in d icate th at th e clien t is m easurin g n orm al for gestatio n al age. At 16 weeks, th e fu n du s can be lo cated h alfway between th e sym ph ysis p ub is an d th e um bilicus. At 20 to 22 weeks, th e fu n d us is at th e u m b ilicu s. At 36 weeks, th e fun d u s is at th e xiph oid p ro cess. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e lo catio n of fun dal h eigh t. Rem em b er th at du rin g th e seco n d an d th ird tri- m esters (weeks 18 to 30), fu n d al h eigh t in cen tim eters ap prox- im ately eq uals th e fetu s’s age in weeks Æ2 cm . Review: Measu rem en t o f fu n d al h eigh t Level of Cogn itive Ability: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Develo pm en t; Rep ro du ction Refer en ces: Lo wd erm ilk et al. (2016), p p. 287, 315-319.

250. 1, 2, 3, 4 Ra tion a le: Th e p ro bab le sign s of p regn an cy in clud e u terin e en largem en t, Hegar’s sign ( co m p ressibility an d soften in g of th e lo wer uterin e segm en t th at occurs at abo ut week 6), Go od - ell’s sign ( soften in g o f th e cervix th at o ccurs at th e b egin n in g of th e seco n d m o n th ), Ch ad wick’s sign (violet colo ratio n o f th e m ucou s m em b ran es of th e cervix, vagin a, an d vu lva th at o ccu rs at ab o ut week 4), b allo ttem en t (rebo un din g o f th e fetu s again st th e exam in er’s fin gers o n palp ation ), Braxton Hicks co n trac- tio n s, an d a p ositive pregn an cy test fo r th e p resen ce o f h um an ch orio n ic go n ad otrop in . Positive sign s of p regn an cy in clud e fetal h eart rate d etected by electro n ic device (Dop pler tran s- d ucer) at 10 to 12 weeks an d b y n on electro n ic d evice (feto- scop e) at 20 weeks o f gestatio n , active fetal m ovem en ts p alpab le by th e exam in er, an d an o utlin e of th e fetu s by rad i- o graph y o r ultraso n o graph y. Test-Ta kin g Str a t egy: Fo cu sin g o n th e su b ject, p ro bab le sign s o f p regn an cy, will assist in an swerin g th is qu estio n . Rem em b er th at d etection o f th e fetal h eart rate an d an o u tlin e o f th e fetu s via rad io grap h y o r u ltraso n o grap h y are p ositive sign s of p regn an cy. Review: Pro b ab le sign s o f p regn an cy Level of Cogn itive Ability: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Develo pm en t; Rep ro du ction Refer en ce: Lowd erm ilk et al. (2016), pp . 286, 302.

251. 3 Ra tion a le: Braxto n Hicks co n tractio n s are irregular, p ain less con traction s th at m ay occu r in term itten tly th rou gh o ut

312 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

pregn an cy. Because Braxto n Hicks co n tractio n s m ay o ccu r an d are n orm al in so m e pregn an t wo m en d urin g pregn an cy, th ere is n o reason to n o tify th e h ealth care p ro vid er. Th is clien t is n o t in p reterm lab o r an d, th erefore, d o es n o t n eed to b e placed o n bed rest o r b e ad m itted to th e h o sp ital to be m on itored. Test -Ta kin g St r a t egy: O ptio n s 1 an d 4 are co m p arab le o r alike an d can be elim in ated first. Fro m th e rem ain in g op tion s, kn o win g th at Braxton Hicks co n tractio n s are com m on an d n orm al an d can o ccur th ro ugh o u t pregn an cy will assist in directin g you to th e co rrect op tio n . Review: Ph ysiology associated with Braxto n Hicks co n tractio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Reprod uctio n Refer en ce: Lo wderm ilk et al. (2016), p . 287.

252. 2 Ra t ion a le: Accu rate u se o f Nägele’s rule requ ires th at th e wo m an h ave a regu lar 28-d ay m en strual cycle. Sub tract 3 m on th s an d ad d 7 days to th e first d ay o f th e last m en strual period , an d th en add 1 year to th at d ate: first d ay of th e last m en stru al p eriod , O ctob er 19, 2018; su b tract 3 m o n th s, July 19, 2018; ad d 7 d ays, July 26, 2018; add 1 year, Ju ly 26, 2019. Test -Ta kin g Str a tegy: Focus o n th e su b ject an d use kn o wledge regard in g Nägele’s rule to an swer th is question . Th is rule req uires additio n an d su btraction , so read all option s carefully, n otin g th e d ates an d years in th e op tio n s, b efore selectin g an an swer. Review: Nägele’s ru le

Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Develop m en t; Reprod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p . 302.

253. 2 Ra t ion a le: Pregn an cy ou tco m es can b e d escrib ed with th e acro n ym GTPAL. G is gravidity, th e n u m ber o f p regn an cies; T is term birth s, th e n um ber b orn at term (lon ger th an 37 weeks) ; P is p reterm b irth s, th e n u m ber b orn b efore 37 weeks o f gestation ; A is abo rtion s o r m iscarriages, th e n u m - b er of ab ortio n s or m iscarriages (in clud ed in gravid a if b efore 20 weeks o f gestation ; in clu ded in p arity [n u m b er o f birth s] if p ast 20 weeks o f gestation ); an d L is th e n um ber o f cu rren t liv- in g ch ildren . A wo m an wh o is pregn an t with twin s an d h as a ch ild h as a gravida o f 2. Becau se th e ch ild was d elivered at 38 weeks, th e n u m ber o f term birth s is 1, an d th e n u m b er o f p reterm b irth s is 0. Th e n um b er o f ab ortion s is 0, an d th e n u m - b er o f livin g ch ild ren is 1. Test -Ta kin g St r a t egy: Fo cus on th e su b ject o f th e qu estio n . Recallin g th e m ean in g of th e acron ym GTPAL an d focu sin g o n th e in fo rm atio n in th e qu estio n will d irect yo u to th e co rrect o p tion . Review: GTPAL Level of Cogn it ive Ability: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Rep rod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p . 284.

313CHAPTER 25 Prenatal Period

M

a

t

e

r

n

i

t

y

C H A P T E R 26 Risk Conditions Related to Pregnancy

PRIORITY CONCEPTS Reproduction, Safety

CRITICAL THINKING What Should You Do? A pregnant client with diabetes mellitus asks the nurse about insulin needs during pregnancy. What information should the nurse provide to the client? Answer located on p. 327.

I. Abortion A. Description : A pregn an cy th at en ds before 20 weeks’

gestation , spon tan eously or electively B. Types (Box 26-1) C. Assessm en t

1. Spon tan eous vagin al bleedin g 2. Low uterin e cram p in g or con traction s 3. Bloo d clo ts or tissue th rough th e vagin a 4. Hem o rrh age an d sh ock can result if bleed in g is

excessive. D. In terven tion s

1. Main tain bed rest as prescribed. 2. Mon itor vital sign s. 3. Mon itor for cram pin g an d bleedin g. 4. Coun t perin eal pads to evaluate blood loss, an d

save expelled tissues an d clots. 5. Main tain in traven ous (IV) flu ids as prescribed;

m on itor for sign s of h em orrh age or sh o ck. 6. Prepare th e clien t for dilation an d curettage as

prescribed for in com plete abortion . 7. Adm in ister Rh o(D) im m un e globulin , as pre-

scrib ed, for an Rh -n egative wom an . 8. Provide psych ological support.

II. Anemia A. Description

1. Iron deficien cy an em ia is a con dition th at develops as a result of an in adequate am oun t of serum iron .

2. An em ia predisposes th e clien t to postp artum in fectio n .

B. Assessm en t 1. Fatigue 2. Headach e 3. Pallor 4. Tach ycardia 5. Hem o globin value is usually less th an 10 g/ dL

(100 m m o l/ L); h em atocrit value is usually less th an 30%.

C. In terven tion s 1. Mon itor h em oglobin an d h em atocrit levels every

2 weeks. 2. Adm in ister an d in struct th e clien t about iron an d

folic acid supplem en ts. 3. In struct th e clien t to take iron with a source of

vitam in C to in crease its absorption an d to avoid takin g iron with tea, m ilk products, or caffein e. Iron is absorbed best if taken between m eals.

4. In struct th e clien t to eat food s h igh in iron , folic acid, an d protein .

5. Teach th e clien t to m on itor for sign s an d sym p- tom s of in fectio n .

6. Prepare to ad m in ister paren teral iron or blood tran sfusion s; th is m ay be prescribed for severe an em ia.

7. Prepare for th e ad m in istration of oxytocic m ed i- cation s in th e postpartum period if excessive bleedin g is a co n cern .

III. Cardiac Disease A. Descrip tion : A pregn an t clien t with cardiac disease

m ay be un ab le ph ysiologically to cope with th e added plasm a volum e an d in creased cardiac output th at occur durin g pregn an cy; blood volu m e peaks at weeks 32 to 34 an d th en declin es sligh tly to week 40.

B. Matern al cardiac disease risk groups (Box 26-2) C. Assessm en t

1. Sign s an d sym pto m s of cardiac deco m pen sation a . Cough an d respiratory con gestion b . Dysp n ea an d fatigue c. Palpitation s an d tach ycardia d . Periph eral edem a e. Ch est pain

M

a

t

e

r

n

i

t

y

314

2. Sign s of respiratory in fectio n 3. Sign s of h eart failure an d pulm o n ary edem a

D. In terven tion s 1. Mon itor vital sign s, fetal h eart rate, an d con d i-

tio n of th e fetus. 2. Lim it ph ysical activities, an d stress th e n eed for

sufficien t rest. 3. Mon itor for sign s of cardiac stress an d deco m -

pen sation , such as cough , fatigue, dyspn ea, ch est pain , an d tach ycardia; also m on itor for sign s of h eart failure an d pulm o n ary edem a.

4. En cou rage ad equate n utrition to preven t an em ia, wh ich would worsen th e cardiac status; in addi- tion , a low-sod ium diet m ay be prescribed to pre- ven t flu id reten tion an d h eart failure.

5. Avoid excessive weigh t gain . 6. Du rin g labor, prepare to do th e follo win g:

a. Mon itor vital sign s frequen tly. b . Place th e clien t on a cardiac m on itor an d on

an extern al fetal m on itor. c. Main tain bed rest, with th e clien t lyin g on h er

side with h er h ead an d sh o ulders elevated. d . Adm in ister oxygen as prescribed. e. Man age pain early in labo r. f. Use con trolled push in g efforts to decrease

cardiac stress.

Excessive weight gain places stress on the heart. In addition, obesity places the client at increased risk for complications during pregnancy.

IV. Chorioamnionitis A. Description

1. Bacterial in fectio n of th e am n iotic cavity; can result from prem ature or prolon ged rupture of th e m em bran es, vagin itis, am n iocen tesis, or in trauterin e proced ures

2. May result in th e developm en t of postp artum en dom etritis an d n eon atal sep sis

B. Assessm en t 1. Uterin e ten dern ess an d con traction s 2. Elevated tem p erature 3. Matern al or fetal tach ycardia 4. Foul odor to amniotic fluid 5. Leuko cytosis

C. In terven tion s 1. Mon itor m atern al vital sign s an d fetal h eart rate. 2. Mon itor for uterin e ten dern ess, con traction s,

an d fetal activity. 3. Mon itor results of blood cultures. 4. Prepare for am n iocen tesis to obtain am n iotic

fluid for Gram stain an d leuko cyte coun t. 5. Adm in ister an tibiotics as prescribed after cul-

tures are obtain ed. 6. Adm in ister oxytocic m edication s as prescribed to

in crease uterin e ton e. 7. Prepare to obtain n eon atal cultures after birth .

V. Diabetes Mellitus A. Description

1. Pregn an cy places dem an ds on carbo h ydrate m etab olism an d cau ses in sulin requirem en ts to ch an ge.

2. Matern al gluco se crosses th e placenta, but in sulin does n ot.

3. Th e fetus produ ces its own in sulin an d pulls glu- cose from th e m oth er, wh ich predisp oses th e m oth er to h ypoglycem ic reaction s.

BOX 26-1 Types of Abortions Sponta neous: Pregnancy ends because of natural causes. Induced: Therapeutic or elective reasons exist for terminating

pregnancy. Threa tened: Spotting and cramping occur without cervical

change. Inevita ble: Spotting and cramping occur and cervix begins to

dilate and efface. Incomplete: Loss of some of the products of conception

occurs, with part of the products retained (most often pla- centa is retained).

Complet e: Loss of all products of conception. Missed: Products of conception are retained in utero after fetal

death. Ha bit ua l: Spontaneous abortions occur in 3 or more succes-

sive pregnancies.

BOX 26-2 Maternal Cardiac Disease Risk Groups

Group I (Mortality Rate, 1%) ▪ Corrected tetralogy of Fallot ▪ Pulmonic or tricuspid disease ▪ Mitral stenosis (classes I and II) ▪ Patent ductus arteriosus ▪ Ventricular septal defect ▪ Atrial septal defect ▪ Porcine valve Group II (Mortality Rate, 5% to 15%) ▪ Mitral stenosis with atrial fibrillation ▪ Artificial heart valves ▪ Mitral stenosis (classes III and IV) ▪ Uncorrected tetralogy ▪ Aortic coarctation (uncomplicated) ▪ Aortic stenosis Group III (Mortality Rate, 25% to 50%) ▪ Aortic coarctation (complicated) ▪ Myocardial infarction ▪ Marfan syndrome ▪ True cardiomyopathy ▪ Pulmonary hypertension

From Lowdermilk D, Cashion MC, Perry S: Maternity & women’s health care, ed 10 , St. Louis, 20 12, Mosby.

315CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

4. Th e newborn of a diabetic m oth er m ay be large in size, but h as fun ction s related to gestation al age rath er th an size.

5. Th e n ewborn of a diabetic m oth er is at risk for h ypo glycem ia, h yperbilirubin em ia, respiratory distress syn d rom e, h ypocalcem ia, an d con gen i- tal an om alies.

During the first trimester, maternal insulin needs decrease. During the second and third trimesters, increases in placental hormones cause an insulin- resistant state, requiring an increase in the client’s insu- lin dose. After placental delivery, placental hormone levels abruptly decrease and insulin requirements decrease.

B. Gestation al diabetes m ellitus 1. Gestation al diabetes occurs in pregn an cy (du rin g

th e secon d or th ird trim ester) in clien ts n ot pre- viou sly diagn osed as diabetic an d occurs wh en th e pan creas can n ot respo n d to th e dem an d for m ore in sulin .

2. Pregn an t wom en sh o uld be screen ed for gesta- tion al diabetes between 24 an d 28 weeks of gestation .

3. A 3-h our oral gluco se toleran ce test is perform ed to con firm gestation al diab etes m ellitus.

4. Gestation al diab etes frequen tly can be treated by diet alon e; h owever, som e clien ts m ay n eed in sulin .

5. Most wom en with gestation al diab etes return to a euglycem ic state after birth ; h owever, th ese in dividuals h ave an in creased risk of developin g diab etes m ellitus in th eir lifetim es.

C. Predisp osin g con ditio n s to gestation al diabetes 1. O lder th an 35 years 2. O besity 3. Multiple gestation 4. Fam ily h isto ry of diabetes m ellitus 5. Large for gestation al age fetus

D. Assessm en t 1. Excessive th irst 2. Hun ger 3. Weigh t loss 4. Frequen t urin ation 5. Blurred vision 6. Recurren t urin ary tract in fection s an d vagin al

yeast in fectio n s 7. Glycosuria an d keton uria 8. Sign s of gestation al h yperten sion 9. Polyh ydram n ios 10. Large for gestation al age fetus

E. In terven tion s 1. Em ploy diet, m edication s (if diet can n ot con trol

blood gluco se levels), exercise, an d blood glu- cose determ in ation s to m ain tain blood gluco se levels between 65 m g/ dL (3.7 m m ol/ L) an d 130 m g/ dL (7.4 m m o l/ L) as prescribed.

2. O bserve for sign s of h yperglycem ia, glycosu ria an d keton uria, an d h ypo glycem ia.

3. Mon itor weigh t. 4. In crease calorie in take as prescribed, with ade-

quate in sulin th erap y so th at gluco se m oves in to th e cells.

5. Assess for sign s of m atern al com plication s such as preeclam psia (h yperten sion an d protein uria).

6. Mon itor for sign s of in fectio n . 7. In struct th e clien t to report burn in g an d pain on

urin ation , vagin al disch arge or itch in g, or an y oth er sign s of in fectio n to th e h ealth care provid er (HCP) .

8. Assess fetal status an d m on itor for sign s of fetal com pro m ise.

F. In terven tion s durin g labor 1. Mon itor fetal status con tin uo usly for sign s of dis-

tress an d, if n oted, prepare th e clien t for im m edi- ate cesarean section .

2. Carefully regulate in sulin an d provide glucose in traven ously as prescribed because labo r depletes glycogen .

G. In terven tion s durin g th e postp artum period 1. O bserve th e m oth er closely for a h ypo glycem ic

reaction because a precipitous declin e in in sulin requirem en ts n orm ally occurs (th e m oth er m ay n ot require in sulin for th e first 24 h ours).

2. Reregulate in sulin n eeds as prescribed after th e first day, acco rdin g to blood gluco se testin g.

3. Assess dietary n eeds, based on blood gluco se test- in g an d in sulin requirem en ts.

4. Mon itor for sign s of in fection or postpartum h em orrh age.

VI. Disseminated Intravascular Coagulation (DIC) A. Descrip tion : DIC is a m atern al con dition in

wh ich th e clottin g cascade is activated, resultin g in th e form ation of clots in th e m icro circulation (Fig. 26-1).

The rapid and extensive formation of clots that occurs in DIC causes the platelets and clotting factors to be depleted; this results in bleeding and the potential vascu- lar occlusion of organs from thromboembolus formation.

B. Predisp osin g con d ition s (Box 26-3) C. Assessm en t

1. Un con trolled bleed in g 2. Bruisin g, purpu ra, petech iae, an d ecch ym osis 3. Presen ce of occult blood in excretio n s such

as stool 4. Hem aturia, h em atem esis, or vagin al bleedin g 5. Sign s of sh o ck 6. Decreased fibrin ogen level, platelet coun t, an d

h em atocrit level 7. In creased proth rom bin tim e an d partial th rom -

boplastin tim e, clo ttin g tim e, an d fibrin degrada- tion products

316 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

D. In terven tion s 1. Rem o ve un derlyin g cause. 2. Mon itor vital sign s; assess for bleed in g an d sign s

of sh ock. 3. Prepare for oxygen th erap y, volum e replacem en t,

blood com po n en t th erapy, an d possibly h eparin th erapy.

4. Mon itor for com plication s associated with fluid an d blood replacem en t an d h eparin th erap y.

5. Mon itor urin e output an d m aintain at least 30 m L/ h our (ren al failure is a com plication of DIC).

VII. Ectopic Pregnancy A. Description

1. Implantation of th e fertilized ovum outsid e of th e uterin e cavity

2. Most com m on location is th e am pulla of th e fal- lopian tube ( Fig. 26-2).

B. Assessm en t 1. Missed m en strual period 2. Abdo m in al pain 3. Vagin al spottin g to bleedin g th at is dark red

or brown 4. Ruptu re: In creased pain , referred sh oulder pain ,

sign s of sh o ck C. In terven tion s

1. O btain assessm en t data an d vital sign s. 2. Mon itor bleed in g an d in itiate m easu res to pre-

ven t ru pture an d sh ock. 3. Meth otrexate, a folic acid an tagon ist, m ay be pre-

scrib ed to in h ibit cell division in th e developin g embryo.

4. Prepare th e clien t for laparoto m y an d rem oval of th e pregn an cy an d tube, if n ecessary, or repair of th e tube.

5. Adm in ister an tibiotics; Rh o(D) im m un e globu- lin is prescribed for Rh -n egative wom en .

VIII. Endometritis A. Description

1. En do m etritis is an in fection of th e lin in g of th e uterus occurrin g in th e postp artum period an d cau sed by bacteria th at in vade th e uterus at th e placen tal site.

2. Th e in fectio n m ay spread an d in volve th e en tire en dom etrium an d cau se periton itis or pelvic th rom boph leb itis.

B. Assessm en t 1. Ch ills an d fever 2. In creased pulse 3. Decreased appetite 4. Headach e 5. Backach e 6. Prolon ged, severe afterpain s 7. Ten der, large uterus

P la s minoge n a ctiva tion

S timulus

Tis s ue de s truction Endothe lia l injury

Tis s ue fa ctor Endotoxin Endotoxin

Fa ctor XII a ctiva tion (intrins ic pa thwa y)

Thrombin ge ne ra tion

Intra va s cula r fibrin de pos ition

P la s min ge ne ra tionThrombos is

He molytic a ne mia

Tis s ue is che mia

Thrombocytope nia

P la te le t cons umption

(Extrins ic(Extrins ic pa thwa y)pa thwa y) (Extrins ic pa thwa y)

Fibrinolys is

Fibrin de gra da tion products (inhibit

thrombin a nd pla te le t a ggre ga tion)

Clotting fa ctor

de gra da tion

Ble e ding

FIGURE 26-1 Pathophysiology of disseminated intravascular coagulation.

BOX 26-3 Predisposing Conditions for Disseminated Intravascular Coagulation

▪ Abruptio placentae ▪ Amniotic fluid embolism ▪ Gestational hypertension ▪ HELLP syndrome ▪ Intrauterine fetal death ▪ Liver disease ▪ Sepsis

Inte rs titia lIs thmicAmpulla r

Fimbria l

1 43

2

FIGURE 26-2 Sites of tubal ectopic pregnancy. Numbers indicate the order of prevalence.

317CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

8. Foul odor to lochia or reddish brown loch ia 9. Ileus 10. Elevated wh ite blood cell co un t, with left sh ift of

im m ature cells C. In terven tion s

1. Mon itor vital sign s. 2. Position th e clien t in Fowler’s position to facili-

tate drain age of loch ia. 3. Provid e a private room for th e m oth er; in form

th e m oth er th at isolation of th e n ewborn from th e m oth er is un n ecessary.

4. In struct th e m oth er in proper h an d-wash in g tech n iqu es.

5. In itiate con tact precaution s as n ecessary. 6. Mon itor in take an d outp ut an d en courage fluid

in take. 7. Adm in ister an tibiotics as prescribed. 8. Adm in ister com fo rt m easu res such as back ru bs

an d position ch an ges an d pain m edication s as prescribed.

9. Adm in ister oxytocic m ed ication s as prescribed to im prove uterin e ton e.

10. Provid e psych o logical supp ort.

IX. Fetal Death in Utero A. Description

1. Fetal death in utero refers to th e death of a fetus after th e twen tieth week of gestation an d befo re birth .

2. Th e clien t can develop DIC if th e dead fetus is retain ed in th e uterus for 3 to 4 weeks or lo n ger.

B. Assessm en t 1. Absen ce of fetal m ovem en t 2. Absen ce of fetal h eart ton es 3. Matern al weigh t lo ss 4. Lack of fetal growth or decrease in fun dal h eigh t 5. No evid en ce of fetal cardiac activity 6. O th er ch aracteristics suggestive of fetal death

n oted on ultraso un d C. In terven tion s

1. Prepare for th e birth of th e fetus. 2. Supp ort th e clien t’s decision about labor, birth ,

an d th e postpartu m period. 3. Accept beh aviors such as an ger an d h ostility

from th e paren ts. 4. Refer the paren ts to an appropriate support group.

Cultural, spiritual, and religious practices and beliefs are important to consider when caring for the par- ents of a fetus who has died. Be aware of the cultural, spiritual, and religious practices and beliefs of the client.

X. Hepatitis B A. Description

1. Th e risks of prem aturity, low birth weigh t, an d n eon atal death in crease if th e m oth er h as h epa- titis B in fectio n .

2. Hepatitis is tran sm itted th rough blood , saliva, vagin al secretio n s, sem en , an d breast m ilk an d across th e placen tal barrier.

B. In terven tion s 1. Min im ize th e risk for in trapartum ascen din g

in fectio n s (lim it th e n um ber of vagin al exam in ation s).

2. Rem o ve m atern al blood from th e n eon ate im m ediately after birth .

3. Suction th e flu ids from th e n eon ate im m ediately after birth .

4. Bath e th e n eon ate befo re an y in vasive proced ures.

5. Clean an d dry th e face an d eyes of th e n eon ate before in stillin g eye proph ylaxis.

6. In fectio n o f th e n eo n ate can b e p reven ted b y th e ad m in istratio n o f h ep atitis B im m u n e glo b u lin an d h ep atitis B vaccin e so o n after b irth .

7. Discou rage th e m oth er from kissin g th e n eon ate un til th e n eon ate h as received th e vaccin e.

8. In form th e m oth er th at th e h epatitis B vaccin e will be adm in istered to th e n eon ate an d th at a secon d dose sh ould be ad m in istered at 1 m on th after birth an d a th ird dose at 6 m on th s after birth .

Support breast-feeding after neonatal treatment for hepatitis B; breast-feeding is not contraindicated if the neonate has been vaccinated.

XI. Hematoma A. Descrip tion

1. Hem atom a occurs followin g th e escape of blood in to th e m atern al tissue after birth .

2. Predisp osin g con dition s in clude operative deliv- ery with forceps or in ju ry to a blood vessel.

B. Assessm en t (Box 26-4) C. In terven tion s

1. Mon itor vital sign s. 2. Mon itor clien t for abn o rm al pain , especially

wh en forceps delivery h as been perform ed. 3. Apply ice to th e h em atom a site. 4. Adm in ister an algesics as prescribed.

BOX 26-4 Hematoma: Assessment Findings ▪ Abnormal, severe pain ▪ Pressure in perineal area (client states that she feels like

she has to have a bowel movement) ▪ Palpable, sensitive swelling in the perineal area, with discol-

ored skin ▪ Inability to void ▪ Decreased hemoglobin and hematocrit levels ▪ Signs of shock, such as pallor, tachycardia, and hypoten-

sion, if significant blood loss has occurred

318 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

5. Mon itor in take an d output. 6. En cou rage fluid s an d void in g; prepare for uri-

n ary cath eterization if th e clien t is un able to void.

7. Adm in ister blood replacem en ts as prescribed. 8. Mon itor for sign s of in fectio n , such as in creased

tem p erature, pulse rate, an d wh ite blood cell co un t.

9. Adm in ister an tibiotics as prescribed because in fectio n is com m on after h em atom a form ation .

10. Prepare for in cision an d evacuation of th e h em atom a if n ecessary.

XII. Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)

A. Description 1. HIV is th e cau sative agen t of AIDS. 2. Wom en in fected with HIV m ay first sh ow sign s

an d sym pto m s at th e tim e of pregn an cy or pos- sibly develop life-th reaten in g in fectio n s because n orm al pregn an cy in volves som e supp ression of th e m atern al im m un e system .

3. Repeated exposu re to th e virus durin g pregn an cy th rou gh un safe sex practices or IV drug use can in crease th e risk of tran sm ission to th e fetus.

4. Zido vudin e is recom m en ded for th e preven tion of m atern al-to-fetal HIV tran sm ission an d is ad m in istered orally begin n in g after 14 weeks of gestation , in traven o usly durin g labo r, an d in th e form of syrup to th e n ewborn for 6 weeks after birth .

B. Tran sm issio n 1. Sexual exposu re to gen ital secretio n s of an

in fected perso n 2. Paren teral exposure to in fected blood an d tissue 3. Perin atal exposure of an infant to in fected m ater-

n al secretio n s th rou gh birth or breast-feed in g C. Risks to th e m oth er: A m oth er with HIV is m an aged

as h igh risk because sh e is vuln erable to in fection s. D. Diagn osis

1. Tests used to determ in e th e presen ce of an ti- bodies to HIV in clude en zym e-lin ked im m un o- sorben t assay (ELISA) , Western blot, an d im m un ofluo rescen ce assay (IFA).

2. A sin gle reactive ELISA test by itself can n ot be used to diagn ose HIV, an d th e test sh ould be repeated with th e sam e blood sam ple; if th e result is again reactive, follo w-up tests usin g Western blot or IFA sh ould be don e.

3. A positive Western blot or IFA is con sidered con - firm ato ry for HIV.

4. A positive ELISA th at fails to be con firm ed by Western blot or IFA sh o uld n ot be con sidered n egative, an d repeat testin g sh ould be don e in 3 to 6 m on th s.

5. See Ch apter 10 for addition al laborato ry tests.

E. Assessm en t (see Ch apter 66) F. In terven tion s

1. Pren atal period a. Preven t oppo rtun istic in fectio n s. b . Avoid proced ures th at in crease th e risk of

perin atal tran sm issio n , such as am n iocen tesis an d fetal scalp sam plin g.

2. In trap artum period a. If th e fetus h as n ot been exposed to HIV

in utero, th e h igh est risk exists durin g delivery th rou gh th e birth can al.

b . Avoid th e use of in tern al scalp electrod es for m on itorin g of th e fetus.

c. Avoid episioto m y to decrease th e am oun t of m atern al blood in an d aroun d th e birth can al.

d . Avoid th e adm in istration of oxytocin because con traction s in du ced by oxytocin can be stron g, causin g vagin al tears or n ecessitatin g an episioto m y.

e. Place h eavy absorben t pads un der th e m oth er’s h ips to ab sorb am n iotic flu id an d m atern al blood.

f. Min im ize th e n eon ate’s exposu re to m atern al blood an d body fluids; prom p tly rem ove th e n eon ate from th e m oth er’s blood after delivery.

g. Suction fluids from th e n eon ate prom p tly. h . Prepare to adm in ister zidovud in e as pre-

scrib ed to th e m oth er durin g labor an d delivery.

3. Postp artum period a. Mon itor for sign s of in fectio n . b . Place th e m oth er in protective isolatio n if sh e

is im m un osuppressed. c. Restrict breast-feed in g. d . In struct th e m oth er to m on itor for sign s of

in fectio n an d report an y sign s if th ey occur. G. Th e newborn an d HIV

1. Description a. Neon ates born to HIV-positive clien ts m ay

test positive because an tibodies received from th e m oth er m ay persist for 18 m on th s after birth ; all n eon ates acquire m atern al an tibod y to HIV in fection , but n ot all acq uire in fectio n .

b . Th e use of an tiviral m ed ication , reduced exposu re of th e n eon ate to m atern al blood an d body fluids, an d early id en tification of HIV in pregn an cy reduce th e risk of tran sm is- sion to th e n eon ate.

2. In terven tion s a. Bath e th e neonate carefully befo re an y in va-

sive proced ure, such as th e ad m in istration of vitam in K, h eel sticks, or ven ipu n ctures; clean th e um b ilical cord stum p m eticulo usly every day un til h ealed.

b . Th e n ewborn can room with th e m oth er.

319CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

c. Adm in ister zidovud in e to th e n ewborn as prescribed for th e first 6 weeks of life.

d . All HIV-exposed n ewborn s sh ould be treated with m ed ication to preven t in fectio n by Pneu- mocystis jiroveci.

e. HIV culture is recom m en ded at 1 an d 4 m on th s after birth ; in fan ts at risk for HIV in fectio n sh o uld be seen by th e HCP at birth an d at 1 week, 2 weeks, 1 m on th , 2 m on th s, an d 4 m on th s of age.

f. Th e ch ild m ay be asym ptom atic for th e first several years of life an d sh o uld be m on itored for early sign s of im m un od eficien cy

Infants at risk for HIV infection need to receive all recommended immunizations on the regular schedule; however, no live vaccines should be administered.

XIII. Hydatidiform Mole A. Description

1. Hydatidiform m ole is a form of gestation al tro- ph oblastic disease th at occurs wh en th e troph o- blasts, wh ich are th e periph eral cells th at attach th e fertilized ovum to th e uterin e wall, develop abn o rm ally.

2. Th e m ole m an ifests as an edem atous grapelike clu ster th at m ay be n on m align an t or m ay develop in to ch oriocarcin om a.

B. Assessm en t 1. Fetal h eart rate n ot detectable 2. Vagin al bleed in g, wh ich m ay occur by th e fourth

week or n ot un til th e secon d trim ester; m ay be brigh t red or dark brown in color an d m ay be sligh t, profuse, or in term itten t

3. Signs of preeclam psia (elevated blood pressure an d protein uria) before th e twentieth week of gestation

4. Fun dal h eigh t greater th an expected for gestation al date

5. Elevated h um an ch orion ic go n adotro pin levels 6. Ch aracteristic sn o wstorm pattern sh own on

ultraso un d C. In terven tion s

1. Prepare th e clien t for uterin e evacuation (before evacuation , diagn ostic tests are don e to detect m etastatic disease).

2. Evacuation of th e m ole is don e by vacuu m aspi- ration ; oxytocin is adm in istered after evacuation to con tract th e uterus.

3. Mon itor for postp rocedu re h em orrh age an d in fectio n .

4. Tissue is sen t to th e labo ratory for evaluatio n , an d follow-up is im portan t to detect ch an ges suggestive of m align an cy.

5. Hum an ch orion ic gon ado tropin levels are m on - itored every 1 to 2 weeks un til n orm al prepreg- n an cy levels are attain ed; levels are ch ecked every 1 to 2 m on th s for 1 year.

6. In struct th e clien t an d h er partn er ab out birth con trol m easu res so th at pregn an cy can be pre- ven ted durin g th e 1-year follow-up period.

XIV. Hyperemesis Gravidarum A. Descrip tion : In tractable n ausea an d vom itin g durin g

th e first trim ester th at cau ses disturban ces in n utri- tion an d fluid an d electrolyte balan ce

B. Assessm en t 1. Nausea m ost pron oun ced on arisin g; m ay occur

at oth er tim es durin g th e day 2. Persisten t vom itin g 3. Weigh t loss 4. Sign s of deh ydration 5. Fluid an d electrolyte im balan ces

C. In terven tion s 1. In itiate m easu res to alleviate n ausea, in cludin g

m edication th erap y; if un successful, an d weigh t loss an d fluid an d electrolyte im balan ces occur, in traven ously ad m in istered flu id an d electrolyte replacem en t or paren teral n utrition m ay be n ecessary.

2. Mon itor vital sign s, in take an d output, weigh t, an d calorie coun t.

3. Mon itor laborato ry data an d for sign s of deh y- dratio n an d electrolyte im balan ces.

4. Mon itor urin e for keton es. 5. Mon itor fetal h eart rate, activity, an d growth . 6. En cou rage in take of sm all portion s of food (low-

fat, easily digestible carboh ydrates, such as cereals, rice, an d pasta).

7. En cou rage th e in take of liquids between m eals to avoid disten din g th e stom ach an d triggerin g vom itin g.

8. En cou rage th e clien t to sit uprigh t after m eals.

XV. Gestational Hypertension A. Descrip tion an d types: Hyperten sion can be m ild or

severe, leadin g to preeclam p sia an d th en eclam psia (seizures) ( Table 26-1).

Signs of preeclampsia are hypertension and proteinuria.

B. Assessm en t (Table 26-2) C. Predisp osin g con d ition s

1. Prim igravida 2. Wom en youn ger th an 19 years or older th an

40 years 3. Ch ron ic ren al disease 4. Ch ron ic h yperten sion 5. Diabetes m ellitus 6. Rh in com patibility 7. History of or fam ily h istory of gestation al

h yperten sion D. Com plication s of gestation al h yperten sion

1. Abruptio placen tae 2. Dissem in ated in travascu lar coagu lation

320 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

3. Th rom b ocytopen ia 4. Placen tal in sufficien cy 5. In trau terin e growth restriction 6. In trau terin e fetal death 7. HELLP syn drom e (a laborato ry diagn osis for

severe preeclam psia ch aracterized by hem olysis, elevated liver en zym e levels, an d low platelet coun t)

E. In terven tion s for m ild h yperten sio n 1. Mon itor blood pressure. 2. Mon itor fetal activity an d fetal growth . 3. En cou rage frequen t rest periods, in structin g th e

clien t to lie in th e lateral position . 4. Adm in ister an tih yp erten sive m ed ication s as pre-

scrib ed; teach clien t about th e im portan ce of th e m ed ication s.

5. Mon itor in take an d output. 6. Evaluate ren al fun ction th rough prescribed stud-

ies such as blood urea n itrogen , serum creati- n in e, an d 24-h o ur urin e levels for creatin in e clearan ce an d protein .

F. In terven tion s for m ild preeclam p sia 1. Provide bed rest an d place th e clien t in th e lateral

position . 2. Mon itor blood pressure an d weigh t. 3. Mon itor n eurological status because ch an ges can

in dicate cerebral h ypo xia or im pen din g seizure.

TABLE 26-1 Classification of Hypertensive Stages of Pregnancy

Type Description

Gestational Hypertensive Disorders Gestational hypertension Blood pressure elevation detected

first time after mid-pregnancy without proteinuria

Preeclampsia Pregnancy-specific syndrome that usually occurs after 20 wk of gestation and is determined by gestational hypertension plus proteinuria

Eclampsia Occurrence of seizures in a preeclamptic woman

Chronic Hypertensive Disorders Chronic hypertension Hypertension that is present and

observable before pregnancy or that is diagnosed before week 20 of gestation

Preeclampsia superimposed on chronic hypertension

Chronic hypertension with new proteinuria or exacerbation of hypertension (previously well controlled) or proteinuria, thrombocytopenia, or increases in hepatocellular enzymes

From Lowderm ilk D, Perry S, Cashion K, Alden K: Maternity & women’s health care, ed 10 , St. Louis, 2012, Mosby.

TABLE 26-2 Mild Versus Severe Preeclampsia Parameter Evaluated Mild Severe

Systolic blood pressure 140 but < 160 mm Hg 160 mm Hg (two readings, 6 hr apart, while on bed rest)

Diastolic blood pressure 90 but < 110 mm Hg 110 mm Hg

Proteinuria (24-hr specimen is preferred to eliminate hour-to-hour variations)

0.3 but < 2 g in 24-hr specimen (1+ on random dipstick)

5 g in 24-hr specimen ( 3+ on random dipstick sample)

Creatinine, serum (renal function) Normal Elevated (> 1.0 mg/ dL [> 76.3 mcmol/ L])

Platelets Normal Decreased (< 100,000 mm 3 [< 100 x 10 9/ L])

Liver enzymes (alanine aminotransferase or aspartate aminotransferase)

Normal or minimal increase in levels

Elevated levels

Urine output Normal Oliguria common, often < 50 0 mL/ day

Severe, unrelenting headache not attributable to other cause; mental confusion (cerebral edema)

Absent Often present

Persistent right upper quadrant or epigastric pain or pain penetrating to back (distention of liver capsule); nausea and vomiting

Absent May be present and often precedes seizure

Visual disturbances (spots or “sparkles”; temporary blindness; photophobia)

Absent to minimal Common

Pulmonary edema; heart failure; cyanosis Absent May be present

Fetal growth restriction Normal growth Growth restriction; reduced amniotic fluid volume

Modified from Lowdermilk D, Cashion MC, Perry S, Alden K: Maternity & women’s health care, ed 10 , St. Louis, 20 12, Mosby.

321CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

4. Mon itor deep ten don reflexes an d for th e pres- en ce of h yperreflexia or clon us, because h yperre- flexia in dicates in creased cen tral n ervou s system irritability ( Box 26-5).

5. Provide adequ ate fluids. 6. Mo n ito r in take an d o u tp u t; a u rin ary o u tp u t

o f 3 0 m L/ h o u r in d icates ad eq u ate ren al p erfu sio n .

7. In crease dietary protein an d carbo h ydrates with n o ad ded salt.

8. Adm in ister m ed ication s as prescribed to reduce blood pressure; blood pressure sh ould n ot be reduced drastically because placen tal perfusio n can be com pro m ised.

9. Mon itor for HELLP syn drom e. G. In terven tion s for severe preeclam p sia

1. Main tain bed rest.

2. Adm in ister m agn esium sulfate (use a con trolled in fusion device) as prescribed to preven t sei- zures; m agn esium sulfate m ay be con tin ued for 24 to 48 h ours postp artum .

3. Mon itor for sign s of m agn esium toxicity, in clud- in g flu sh in g, sweatin g, h ypoten sion , dep ressed deep ten don reflexes, urin e outp ut, an d cen tral n ervou s system depression in cludin g respiratory depression ; keep an tidote (calcium gluco n ate) available for im m ediate use, if n ecessary.

4. Adm in ister an tih yp erten sives as prescribed. 5. Prepare for th e in duction of labor.

H. Eclam p sia 1. Assessm en t: Ch aracterized by gen eralized sei-

zures (Box 26-6) 2. In terven tion s (see Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Eclampsia Event 1. Remain with the client and call for help. 2. Ensure an open airway, turn the client on her side, and

administer oxygen by face mask at 8 to 10 L/ minute. 3. Monitor fetal heart rate patterns. 4. Administer medications to control the seizures as

prescribed. 5. After the seizure has ended, insert an oral airway and suc-

tion the client’s mouth as needed. 6. Prepare for delivery of the fetus after stabilization of the

client, if warranted. 7. Document occurrence, client’s response, and outcome.

Eclampsia refers to the occurrence of a s eizure. It is a potentially preventable extens ion of severe preeclam ps ia; early identification of preeclam ps ia in a pregnant client allows intervention before the condition reaches the s ei- zure s tate. If eclam ps ia occurs , the nurs e rem ains with the client and calls for help. The nurs e ens ures an open air- way. If the client is not on her s ide already, the nurs e attem pts to turn the client on her s ide. The s ide-lying pos i- tion perm its greater circulation through the placenta and m ay help to prevent as piration. The nurs e adm inis ters oxy- gen by face m as k at 8 to 10 L/ m inute to ens ure adequate placental oxygenation. The nurs e als o notes the tim e the s eizure began and the duration of the s eizure and protects the client from injury during the event. The nurs e m onitors fetal heart rate patterns clos ely and adm inis ters m edica- tions as pres cribed (m agnes ium s ulfate m ay be pre- s cribed). After the s eizure has ended, the nurse ins erts an oral airway to m aintain airway patency and s uctions the client’s m outh as needed. If warranted, the nurs e pre- pares for the delivery of the fetus after stabilization of the client. The nurse docum ents the occurrence, the client’s res pons e, and the outcom e.

Reference Lowdermilk et al. (2016), p. 667.

BOX 26-5 Assessment of Reflexes

Biceps Position thumb over client’s biceps tendon, supporting cli-

ent’s elbow with the palm of the hand. Strike a downward blow over the thumb with percussion

hammer. Normal response: Flexion of the arm at the elbow

Patellar Position client with her legs dangling over the edge of the

examining table or lying on her back with her legs slightly flexed.

Strike patellar tendon just below kneecap with percussion hammer.

Normal response: Extension or kicking out of the leg

Clonus Position client with her legs dangling over the edge of exam-

ining table. Support the leg with 1 hand and sharply dorsiflex client’s foot

with the other hand. Maintain the dorsiflexed position for a few seconds and then

release foot. Normal response (negative clonus response):

Foot remains steady in dorsiflexed position. No rhythmic oscillations or jerking of foot is felt. When released, foot drops to plantar-flexed position with

no oscillations. Abnormal response (positive clonus response):

Rhythmic oscillations occur when foot is dorsiflexed. Similar oscillations are noted when foot drops to plantar-

flexed position.

Grading Response 0 Reflex absent 1+ Reflex present but hypoactive 2 + Normal reflex 3+ Hyperactive reflex 4 + Hyperactive reflex with clonus present

322 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

XVI. Incompetent Cervix A. Description

1. Incompetent cervix refers to prem ature dilation of th e cervix, wh ich occurs m ost often in th e fourth or fifth m on th of pregn an cy an d is associated with structural or fun ction al defects of th e cervix.

2. Treatm en t in volves surgical placem en t of a cervi- cal cerclage.

B. Assessm en t 1. Vagin al bleedin g 2. Fetal m em bran es visible th rou gh th e cervix

C. In terven tion s 1. Provide bed rest, h ydration , an d tocolysis, as pre-

scrib ed, to in h ibit uterin e con traction s. 2. Prepare for cervical cerclage (at 10 to 14 weeks of

gestation ), in wh ich a ban d of fascia or n on ab- sorbable ribbon is placed aroun d th e cervix ben eath th e m ucosa to con strict th e in tern al os.

3. After cervical cerclage, th e clien t is told to refrain fro m in tercou rse an d to avoid prolon ged stan d- in g an d h eavy liftin g.

4. Th e cervical cerclage is rem oved at 37 weeks of gestation or left in place an d a cesarean birth is perform ed; if rem oved, cerclage m ust be repeated with each successive pregn an cy.

5. After placem en t of th e cervical cerclage, m on itor for con traction s, rupture of th e m em bran es, an d sign s of in fectio n .

6. In struct th e clien t to report to th e HCP im m edi- ately an y postprocedure vagin al bleedin g or in creased uterin e con traction s.

XVII. Infections (TORCH Complex Acronym) A. Toxop lasm osis (“T”)

1. Cau sed by in fectio n with th e in tracellular proto- zoan parasite Toxoplasma gondii

2. Produces a rash an d sym ptom s of acu te, flulike in fectio n in th e m oth er

3. Tran sm itted to th e m oth er th rough raw m eat or h an dlin g of cat litter of in fected cats

4. O rgan ism is tran sm itted to th e fetus across th e placen ta

5. Can cause spon tan eous ab ortion in th e first trim ester

B. O th er In fection s (“O ,” in cludes HIV—discussed ear- lier, syph ilis—d iscussed un d er Sexually Tran sm itted In fection s, parvovirus, h epatitis B virus [HBV], West Nile, etc.)

C. Rubella (Germ an m easles) (“R”) 1. Teratogen ic in th e first trim ester 2. O rgan ism is tran sm itted to th e fetus across th e

placen ta. 3. Causes con gen ital defects of th e eyes, h eart, ears,

an d brain 4. If n ot im m un e (titer less th an 1:8), th e clien t

sh ould be vaccin ated in th e postpartu m period; th e clien t m ust wait 1 to 3 m on th s (as specified by th e HCP) before becom in g pregn an t.

D. Cytom egalovirus (“C”) 1. O rgan ism is tran sm itted th rough close perso n al

con tact; it is tran sm itted across th e placen ta to th e fetus, or th e fetus m ay be in fected th rough th e birth can al.

2. Th e m oth er m ay be asym ptom atic; m ost in fan ts are asym ptom atic at birth .

3. Cytom egalovirus causes low birth weigh t, in tra- uterin e growth restriction , en larged liver an d spleen , jaun dice, blin dn ess, h earin g loss, an d seizu res.

4. An tiviral m edication s m ay be prescribed for severe in fection s in th e m oth er, but th ese m ed i- cation s are toxic an d m ay on ly tem p orarily sup- press sh eddin g of th e virus.

E. Herpes sim plex virus (“H”) 1. Herpes sim plex virus affects th e extern al gen ita-

lia, vagin a, an d cervix an d cau ses drain in g, pain - ful vesicles.

2. Acyclovir can be used to treat recurren t outbreaks durin g pregn an cy or used as supp ressive th erap y late in pregn an cy to preven t an outbreak durin g labo r an d birth .

3. Virus usually is tran sm itted to th e fetus durin g birth th rough th e in fected vagin a or via an ascen din g in fectio n after rupture of th e m em bran es.

4. No vagin al exam in ation s are don e in th e pres- en ce of active vagin al h erpetic lesion s.

5. Herpes can cau se death or severe n eurological im pairm en t in th e n ewborn .

6. Delivery of th e fetus is usually by cesarean sec- tion if active lesion s are presen t in th e vagin a; delivery m ay be perform ed vagin ally if th e lesion s are in th e an al, perin eal, or in n er th igh area (strict precaution s are n ecessary to protect th e fetus durin g delivery).

7. Main tain con tact precaution s. F. Group B Streptococcus (GBS) (m ay be in cluded as an

“O ” un d er TO RCH com plex) 1. GBS is a leadin g cause of life-th reaten in g perin a-

tal in fectio n s.

BOX 26-6 Eclampsia 1. Seizure typically begins with twitching around the mouth. 2. Body then becomes rigid in a state of tonic muscular con-

tractions that last 15 to 20 seconds. 3. Facial muscles and then all body muscles alternately con-

tract and relax in rapid succession (clonic phase may last about 1 minute).

4. Respiration ceases during seizure because diaphragm tends to remain fixed (breathing resumes shortlyafter the seizure).

5. Postictal sleep occurs.

323CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

2. Th e gram -p ositive bacterium colon izes th e rec- tum , vagin a, cervix, an d ureth ra of pregn an t an d n on pregn an t wom en .

3. Men in gitis, fasciitis, an d in traab dom in al abscess can occur in th e pregn an t clien t if sh e is in fected at th e tim e of birth .

4. Tran sm issio n occurs durin g vagin al delivery. 5. Early-on set n ewborn GBS occurs with in th e first

week after birth , usually with in 48 h ou rs, an d can in clude in fectio n s such as sepsis, pn eum o- n ia, or m en in gitis; perm an en t n eurological dis- ability can result.

6. Diagn o sis o f th e m o th er is d o n e via vagin al an d rectal cu ltu res at 35 to 37 weeks o f gestatio n .

7. An tibio tics such as pen icillin m ay be prescribed for th e m oth er durin g labo r an d birth ; IV an tibi- otics m ay be prescribed for in fected in fan ts.

XVIII. Multiple Gestation A. Description

1. Multiple gestation results from fertilization of 2 ova (fratern al or dizygotic) or a splittin g of 1 fer- tilized ovum (iden tical or m on ozygotic).

2. Com p lication s in clude spon tan eous abortion , an em ia, con gen ital an om alies, h yperem esis gravidarum , in trauterin e growth restriction , ges- tatio n al h yperten sio n , polyh ydram n ios, postp ar- tum h em orrh age, prem atu re rupture of m em bran es, an d preterm labor an d delivery.

B. Assessm en t 1. Excessive fetal activity 2. Uterus large for gestation al age 3. Palp ation of 3 or 4 large parts in th e uterus 4. Auscu ltation of m ore th an 1 fetal h eart rate 5. Excessive weigh t gain

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor fetal h eart rates, activity, an d growth . 3. Mon itor for cervical ch an ges. 4. Prepare th e clien t for ultraso un d as prescribed. 5. Mon itor for an em ia; adm in ister supplem en tal

vitam in s as prescribed. 6. Mon itor for preterm labor, an d treat preterm

labo r prom p tly. 7. Prepare for cesarean delivery for abn orm al

presen tation s. 8. Prepare to adm in ister oxytocic m ed ication s after

delivery to preven t postpartum h em orrh age from uterin e overdisten tion .

XIX. Pyelonephritis A. Description

1. Resu lts from bacterial in fectio n s th at exten d upward fro m th e bladder th rou gh th e blood ves- sels an d lym p h atics

2. Freq u en tly fo llo ws u n treated u rin ary tract in fectio n s an d is asso ciated with in creased in cid en ce o f an em ia, lo w b irth weigh t, ges- tatio n al h yp erten sio n , p rem atu re lab o r an d d elivery, an d p rem atu re ru p tu re o f th e m em b ran es

B. Assessm en t an d In terven tion s (refer to Ch apter 58)

XX. Sexually Transmitted Infections A. Chlamydia

1. Description a . Sexually tran sm itted path ogen associated

with an in creased risk for prem atu re birth , stillbirth , n eon atal con jun ctivitis, an d n ew- born ch lam ydial pn eum on ia

b . Can cause salpin gitis, pelvic abscesses, ectop ic pregn an cy, ch ron ic pelvic pain , an d in fertility

c. Diagn ostic test is culture for Chlamydia trachomatis.

2. Assessm en t a . Usually asym ptom atic b . Bleedin g between periods or after coitus c. Mucoid or purulen t cervical disch arge d . Dysu ria an d pelvic pain

3. In terven tion s a . Screen th e clien t to determ in e wh eth er sh e is

h igh risk; a vagin al cu lture is in dicated for all pregn an t clien ts if th e clien t is in a h igh -risk group or if in fan ts fro m previous pregn an cies h ave developed n eon atal con jun ctivitis or pn eum on ia.

b . Instruct the clien t in th e im portance of rescreen- in g because reinfection can occur as the client n ears term .

c. En sure th at th e sexual partn er is treated. B. Syph ilis

1. Description a . Syph ilis is a ch ron ic in fectio us disease cau sed

by th e organ ism Treponema pallidum. b . Tran sm ission is by ph ysical con tact with syph -

ilitic lesion s, which usually are foun d on th e skin, m ucous m em bran es of th e m outh , or gen itals.

c. Th e in fectio n m ay cause abortion or prem a- ture labo r an d is passed to th e fetus after th e fourth m on th of pregn an cy as con gen ital syph ilis.

2. Assessm en t ( Box 26-7) 3. In terven tion s

a . O btain a serum test (Ven ereal Disease Research Laboratory or rapid plasm a reagin ) for syph ilis on th e first pren atal visit; prepare to repeat th e test at 36 weeks of gestation because th e disease m ay be acq uired after th e in itial visit.

324 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

b . If th e test result is positive, treatm en t with an an tibiotic such as pen icillin m ay be n ecessary.

c. In struct th e clien t th at treatm en t of h er part- n er is n ecessary if in fectio n is presen t.

C. Gon orrh ea 1. Description

a. Gon orrh ea is an in fectio n cau sed by Neisseria gonorrhoeae, wh ich cau ses in flam m ation of th e m ucou s m em bran es of th e gen ital an d urin ary tracts.

b . Tran sm issio n of th e organ ism is by sexual in tercou rse.

c. In fection m ay be tran sm itted to th e n ew- born ’s eyes durin g delivery, causin g blin dn ess (op h th alm ia n eon ato rum ).

2. Assessm en t: Usually asym ptom atic; vagin al dis- ch arge, urin ary frequen cy, an d lower abdom in al pain possible

3. In terven tion s a. O btain a vagin al culture durin g th e in itial

pren atal exam in ation to screen for go n or- rh ea; th e culture m ay be repeated durin g th e th ird trim ester in h igh -risk clien ts.

b . In struct th e clien t th at treatm en t of h er part- n er is n ecessary if in fectio n is presen t.

D. Con dylom a acum in atum (h um an papillom avirus) 1. Description

a. Con dylom a acum in atum is cau sed by h um an papillom avirus.

b . In fection affects th e cervix, ureth ra, an us, pen is, an d scrotum .

c. A culture is in dicated for clien ts with a posi- tive h isto ry or with active lesion s, an d weekly

cultures m ay be don e startin g at week 35 or 36 of pregn an cy un til delivery; th e test is perform ed to determ in e th e route of delivery.

d . Hum an papillom avirus is transm itted th rough sexual con tact.

2. Assessm en t a. In fection produces sm all to large wartlike

growth s on th e gen itals. b . Cervical cell ch an ges m ay be n oted because

h um an papillom avirus is associated with cer- vical m align an cies.

3. In terven tion s a. Lesio n s are rem oved by th e use of cyto-

toxic agents, cryoth erapy, electrocautery, and laser.

b . En cou rage an n ual Papan icolaou test. c. Sexual con tact sh ould be avoided until lesions

are h ealed (con dom s reduce tran sm ission ). E. Trich o m on iasis

1. Description a. Trich o m on iasis is cau sed by Trichomonas vagi-

nalis an d is tran sm itted via sexual con tact. b . A n orm al salin e wet sm ear of vagin al secre-

tion s in dicates th e presen ce of protozoa. c. In fection is associated with prem atu re rup-

ture of th e m em bran es an d postp artum en dom etritis.

2. Assessm en t a. Yellowish to green ish , froth y, m ucop urulen t,

copious, m alodorou s vagin al disch arge b . In flam m ation of vu lva, vagin a, or both

m ay occur. 3. In terven tion s

a. Metro n idazo le m ay be prescribed. b . Sexual partn er m ay n eed to be treated.

F. Bacterial vagin o sis 1. Description

a. Caused by Haemophilus vaginalis ( Gardnerella vaginalis) an d tran sm itted via sexual con tact

b . Asso ciated with prem atu re labor an d birth 2. Assessm en t

a. Clien t com plain s of “fish y odor” to vagin al secretion s and in creased odor after in tercourse.

b . Microscopic exam in ation of vagin al secre- tion s id en tifies th e in fectio n .

3. In terven tion s a. O ral m etro n idazo le m ay be prescribed. b . Sexual partn er m ay n eed to be treated.

G. Vagin al can didiasis 1. Description

a. Candida albicans is th e m ost com m on cau sa- tive organ ism .

b . Predisp osin g facto rs in clude use of an tibi- otics, diabetes m ellitus, an d obesity.

c. Vagin al can didiasis is diagn osed by iden tify- in g spores of Candida albicans.

BOX 26-7 Stages of Syphilis

Primary Stage ▪ Most infectious stage ▪ Appearance of ulcerative, painless lesions produced by spi-

rochetes at point of entry into the body

Secondary Stage ▪ Highly infectious stage ▪ Appearance of lesions about 6 weeks to 6 months after pri-

mary stage; located anywhere on the skin and mucous membranes

▪ Generalized lymphadenopathy Tertiary Stage ▪ Entrance of spirochetes into internal organs, causing per-

manent damage; symptoms occur 10 to 30 years after untreated primary lesion

▪ Invasion of central nervous system, causing meningitis, ataxia, general paresis, and progressive mental deterioration

▪ Deleterious effects on aortic valve and aorta

325CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

2. Assessm en t a . Vulvar an d vagin al pruritus b . Wh ite, lum py, cottage ch eese–like disch arge

from vagin a 3. In terven tion s

a . An an tifun gal vagin al preparation such as m icon azole m ay be prescribed .

b . For exten sive irritatio n an d swellin g, sitz bath s m ay be prescribed.

c. Sexual partn er m ay n eed to be treated.

XXI. Tuberculosis A. Description

1. High ly co m m un icable disease cau sed by Myco- bacterium tuberculosis

2. Tran sm itted by th e airborn e ro ute 3. Multidrug-resistan t strain s of tuberculosis can

result fro m im proper com plian ce, n on com pli- an ce with treatm en t program s, or developm en t of m utation s in tubercle bacillus.

B. Tran sm issio n 1. Tran splacen tal tran sm ission is rare. 2. Tran sm issio n can occur durin g birth th rough

aspiration of in fected am n iotic fluid. 3. Th e n ewborn can beco m e in fected from con tact

with in fected in dividuals. C. Risk to m oth er: Active disease durin g pregn an cy h as

been associated with an in crease in h yperten sive dis- orders of pregn an cy.

D. Diagn osis: If a ch est radiograph is required for th e m oth er, it is don e on ly after 20 weeks of gestation , an d a lead sh ield for th e abdom en is required .

Tuberculin skin testing is safe during pregnancy; however, the HCP may want to delay testing until after delivery.

E. Assessm en t 1. Moth er

a . Possibly asym ptom atic b . Fever an d ch ills c. Nigh t sweats d . Weigh t loss e. Fatigue f. Cough with h em op tysis or green or yello w

sputu m g. Dysp n ea h . Pleural pain

2. Neonate a . Fever b . Leth argy c. Poor feedin g d . Failure to th rive e. Resp iratory distress f. Hepatosplen o m egaly

g. Men in gitis h . Disease m ay spread to all m ajor organ s

F. In terven tion s 1. Pregn an t clien t

a . Adm in istration of ison iazid , pyrazin am ide, an d rifam p in daily for 9 m on th s (as pre- scrib ed); eth am buto l is added if m edication resistan ce is likely.

b . Pyrido xin e sh ould be ad m in istered with iso- n iazid to th e pregn an t clien t to preven t fetal n eurotoxicity caused by ison iazid .

c. Prom o te breast-feedin g on ly if th e clien t is n on in fectious.

2. Newborn a . Man agem en t focuses on preven tin g disease

an d treatin g early in fectio n . b . Skin testin g is perform ed on th e n ewborn at

birth , an d th e n ewborn m ay be placed on iso- n iazid th erap y; th e skin test is repeated in 3 to 4 m on th s, an d ison iazid m ay be stopped if th e skin test results rem ain n egative.

c. If th e skin test result is positive, th e n ewborn sh ould receive ison iazid for at least 6 m on th s (as prescribed ).

d . If th e m oth er’s sputu m is free of organ ism s, th e n ewborn does n ot n eed to be isolated from th e m oth er wh ile in th e h ospital.

XXII. Urinary Tract Infection A. Descrip tion : A urin ary tract in fectio n can occur dur-

in g pregn an cy (pregn an cy is a predisposin g factor); if un treated, th e clien t can develop pyelon eph ritis.

B. Predisp osin g con d ition s 1. History of urin ary tract in fectio n s 2. Sickle cell trait 3. Poor h ygien e 4. An em ia 5. Diabetes m ellitus

C. Assessm en t an d In terven tion s (refer to Ch apter 58)

XXIII. Obesity in Pregnancy A. Descrip tion : O besity in every population , in cludin g

adults an d ch ildren , is a problem in th e Un ited States. O besity in pregn an cy places th e clien t at risk for com plication s durin g pregn an cy, in cludin g ven ous th rom boem bo lism an d in creased n eed for cesarean birth .

B. O besity in pregn an cy can h ave n egative effects on th e n ewborn , in cludin g stillbirth , con gen ital an om alies, future obesity, an d h eart disease.

C. Com plication s in n ursin g care 1. Difficulty obtain in g IV access, epidu ral access,

an d in tub ation if n eeded 2. Mob ility an d tran sfer difficu lties 3. Bed size an d equipm en t acco m m odation s

326 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

D. Poten tial posto perative com plication s an d associ- ated in terven tion s 1. Th rom boem bolism stockin gs (TEDs), sequen tial

com pression devices (SCDs), an d ph arm acological ven ous th rom boem bolism proph ylaxis such as h eparin are used postoperatively.

2. Early am bulation is encouraged to preven t venous throm boem bolism form ation .

3. Vigilan t m on itorin g an d clean in g of surgical in ci- sion s to preven t in fectio n due to excess ab dom in al fat

CRITICAL THINKING What Should You Do? Answer: The nurse should begin by explaining to the client that pregnancy places demands on carbohydrate metabolism and causes insulin requirements to change. The nurse should inform the client that maternal glucose crosses the placenta, but insulin does not. During the first trimester, maternal insulin needs decrease. During the second and third trimesters, increases in placental hormones cause an insulin-resistant state, requiring an increase in the client’s insulin dose. After placental delivery, placental hormone levels abruptly decrease and insulin requirements decrease. In addition, the fetus produces its own insulin and pulls glu- cose from the mother, which predisposes the mother to hypoglycemic reactions.

Reference: Lowdermilk et al. (20 16), pp. 694–695.

P R A C T I C E Q U E S T I O N S 254. Th e n urse is providin g in struction s to a pregn an t

clien t with h um an im m un od eficien cy virus (HIV) in fectio n regardin g care to th e n ewborn after delivery. Th e clien t asks th e n urse about th e feedin g option s th at are available. Wh ich respo n se sh ould th e n urse m ake to th e clien t? 1. “You will n eed to bottle-feed your n ewborn .” 2. “You will n eed to feed yo ur n ewborn by n aso-

gastric tube feed in g.” 3. “You will be able to breast-feed for 6 m on th s

an d th en will n eed to switch to bottle-feedin g.” 4. “You will be able to breast-feed for 9 m on th s

an d th en will n eed to switch to bottle-feedin g.”

255. The h om e care nurse visits a pregn ant client wh o h as a diagn osis of m ild preeclam psia. Wh ich assessm en t findin g in dicates a worsen ing of the preeclam psia and th e need to notify th e h ealth care provider (HCP)? 1. Urin ary outp ut h as in creased. 2. Depen den t edem a h as resolved . 3. Blood pressure readin g is at the prenatal baselin e. 4. Th e clien t com plain s of a h eadach e an d blurred

vision .

256. A stillborn baby was delivered in th e birth in g suite a few h ours ago. After th e delivery, th e fam ily rem ain ed togeth er, h oldin g an d touch in g th e baby. Wh ich statem en t by th e n urse would assist th e fam - ily in th eir period of grief? 1. “Wh at can I do for you?” 2. “Now you h ave an an gel in h eaven .” 3. “Don ’t worry, th ere is n oth in g you could h ave

don e to preven t th is from h appen in g.” 4. “We will see to it th at you h ave an early dis-

ch arge so th at yo u don ’t h ave to be rem in ded of th is experien ce.”

257. Th e n u rse im p lem en ts a teach in g p lan fo r a p reg- n an t clien t wh o is n ewly d iagn o sed with gesta- tio n al d iab etes m ellitu s. Wh ich statem en t m ad e b y th e clien t in d icates a n eed fo r fu rth er teach in g? 1. “I sh ould stay on th e diab etic diet.” 2. “I sh ould perform gluco se m on itorin g

at h om e.” 3. “I sh ould avoid exercise because of th e n egative

effects on in sulin production .” 4. “I sh ould be aware of an y in fectio n s an d report

sign s of in fectio n im m ediately to m y h ealth care provider (HCP).”

258. Th e n urse is perform in g an assessm en t on a preg- n an t clien t in th e last trim ester with a diagn osis of severe preeclam psia. Th e n urse reviews th e assessm en t fin din gs an d determ in es th at wh ich fin din g is m o st clo sely associated with a com plica- tio n of th is diagn osis? 1. En largem en t of th e breasts 2. Com p lain ts of feelin g h ot wh en th e room

is cool 3. Periods of fetal m ovem en t followed by quiet

periods 4. Eviden ce of bleedin g, such as in th e gu m s, pete-

ch iae, an d purpu ra

259. Th e n urse in a m atern ity un it is reviewin g th e cli- en ts’ records. Wh ich clien ts sh ould th e n urse iden - tify as bein g at th e m o st risk for developin g dissem in ated in travascular coagulation (DIC) ? Select all th at ap p ly.

1. A prim igravida with m ild preeclam p sia 2. A prim igravida wh o delivered a 10-lb in fan t

3 h ou rs ago 3. A gravida II wh o h as just been diagn osed

with dead fetus syn d rom e 4. A gravida IV wh o delivered 8 h ours ago an d

h as lo st 500 m L of blood 5. A prim igravida at 29 weeks of gestation

wh o was recen tly diagn osed with severe preeclam p sia

327CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

260. Th e h om e care n urse is m on itorin g a pregn an t cli- en t with gestation al h yperten sio n wh o is at risk for preeclam psia. At each h om e care visit, th e n urse assesses th e clien t for wh ich classic sign s of pre- eclam psia? Select all th at ap p ly.

1. Protein uria 2. Hyperten sion 3. Low-grade fever 4. Gen eralized edem a 5. In creased pulse rate 6. In creased respiratory rate

261. Th e n u rse is assessin g a p regn an t clien t with typ e 1 d iab etes m ellitu s ab o u t h er u n d erstan d in g regard in g ch an gin g in su lin n eed s d u rin g p regn an cy. Th e n u rse d eterm in es th at fu rt h er t ea ch in g is n eed ed if th e clien t m akes wh ich statem en t? 1. “I will n eed to in crease m y in sulin dosage durin g

th e first 3 m on th s of pregn an cy.” 2. “My in sulin dose will likely n eed to be in creased

durin g th e secon d an d th ird trim esters.” 3. “Episod es of h ypo glycem ia are m ore likely to

occur durin g th e first 3 m on th s of pregn an cy.” 4. “My in sulin n eeds sh ould return to prepregn an t

levels with in 7 to 10 days after birth if I am bottle-feedin g.”

262. A p regn an t clien t rep o rts to a h ealth care clin ic, co m p lain in g o f lo ss o f ap p etite, weigh t lo ss, an d fatigu e. After assessm en t o f th e clien t, tu b ercu lo sis is su sp ected . A sp u tu m cu ltu re is o b tain ed an d iden tifies Mycobacterium tuberculosis. Wh ich in struc- tion sh ould th e n urse in clude in th e clien t’s teach in g plan ? 1. Th erapeutic ab ortion is required. 2. Ison iazid plus rifam pin will be required for

9 m on th s. 3. Sh e will h ave to stay at h om e un til treatm en t is

com pleted. 4. Med ication will n ot be started un til after deliv-

ery of th e fetus.

263. Th e n urse is providin g in struction s to a pregn an t clien t with a h istory of cardiac disease regardin g ap propriate dietary m easu res. Wh ich statem en t, if m ade by th e clien t, in dicates an un derstan din g of th e in form ation provided by th e n urse? 1. “I sh ould in crease m y sodium in take durin g

pregn an cy.” 2. “I sh ould lower m y blood volu m e by lim itin g

m y fluids.” 3. “I sh ould m ain tain a low-calorie diet to preven t

an y weigh t gain .” 4. “I sh o uld drin k adequate fluid s an d in crease m y

in take of h igh -fiber food s.”

264. Th e clin ic n urse is perform in g a psych o social assessm en t of a clien t wh o h as been told th at sh e is pregn an t. Wh ich assessm en t fin din gs in dicate to th e n urse th at th e clien t is at risk for con tractin g h um an im m un od eficien cy virus (HIV) ? Select all th at ap p ly.

1. Th e clien t h as a h isto ry of in traven ous drug use.

2. Th e clien t h as a sign ifican t oth er wh o is h eterosexu al.

3. Th e clien t h as a h isto ry of sexually tran sm it- ted in fectio n s.

4. Th e clien t h as h ad on e sexual partn er for th e past 10 years.

5. Th e clien t h as a previous h istory of gesta- tion al diabetes m ellitus.

265. Th e n urse in a m atern ity un it is providin g em o - tion al supp ort to a clien t an d h er sign ifican t oth er wh o are preparin g to be disch arged from th e h os- pital after th e birth of a dead fetus. Wh ich state- m en t m ade by th e clien t in dicates a com po n en t of th e n orm al grievin g process? 1. “We wan t to atten d a supp ort group.” 2. “We n ever wan t to try to h ave a baby again .” 3. “We are goin g to try to adopt a ch ild

im m ediately.” 4. “We are okay, an d we are goin g to try to h ave

an oth er baby im m ediately.”

266. Th e n urse evaluates th e ability of a h epatitis B–positive m oth er to provid e safe bottle-feedin g to h er n ewborn durin g postpartum h ospitaliza- tion . Wh ich m atern al action b est exem p lifies th e m oth er’s kn owled ge of poten tial disease tran sm is- sion to th e n ewborn ? 1. Th e m oth er requests th at th e win do w be clo sed

befo re feed in g. 2. Th e m oth er h old s th e n ewborn properly durin g

feed in g an d burpin g. 3. Th e m oth er tests th e tem perature of th e form ula

befo re in itiatin g feedin g. 4. Th e m oth er wash es an d dries h er h an ds before

an d after self-care of th e perin eum an d asks for a pair of gloves befo re feedin g.

267. A client in the first trim ester of pregnan cy arrives at a health care clin ic an d reports that she h as been experien cing vaginal bleeding. A th reaten ed abortion is suspected, an d the nurse in structs th e clien t regard- in g m anagem en t of care. Wh ich statem en t m ade by th e client indicates a n eed for fu rth er in stru ction ? 1. “I will watch for th e eviden ce of th e passage of

tissue.” 2. “I will m ain tain strict bed rest th rou gh out th e

rem ain der of th e pregn an cy.”

328 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

3. “I will coun t th e n um ber of perin eal pads used on a daily basis an d n ote th e am oun t an d color of blood on th e pad.”

4. “I will avoid sexual in tercou rse un til th e bleed- in g h as stopped , an d for 2 weeks followin g th e last evid en ce of bleed in g.”

268. Th e n urse is plan n in g to ad m it a pregn an t clien t wh o is obese. In plan n in g care for th is clien t, wh ich poten tial clien t n eeds sh o uld th e n urse an ticipate? Select all th at ap p ly.

1. Bed rest as a n ecessary preven tive m easu re m ay be prescribed.

2. Ro utin e adm in istration of subcu tan eo us h eparin m ay be prescribed.

3. An overbed lift m ay be n ecessary if th e clien t requires a cesarean section .

4. Less frequen t clean sin g of a cesarean in ci- sion , if presen t, m ay be prescribed .

5. Th rom b oem bolism stockin gs or seq uen tial com pression devices m ay be prescribed.

A N S W E R S 254. 1 Ra t ion a le: Perin atal tran sm issio n o f HIV can o ccu r d urin g th e an tepartum p erio d , du rin g labo r an d birth , o r in th e po stpar- tu m p erio d if th e m oth er is breast-feedin g. Clien ts wh o h ave HIV are ad vised n ot to breast-feed . Th ere is n o ph ysiolo gical reason wh y th e n ewborn n eeds to be fed by n asogastric tube. Test -Ta kin g Str a tegy: Use kn o wled ge regardin g th e tran sm is- sion o f HIV. Elim in ate op tio n s 3 an d 4 first because th ese op tion s are co m p arab le o r alike in th at th ey b o th address breast-feedin g. Fro m th e rem ain in g op tio n s, select th e co rrect op tion , kn owin g th at it is u n n ecessary to feed th e n ewb orn by n asogastric tub e. Review: Feedin g o ption s fo r a n ewbo rn with a m oth er wh o h as h u m an im m u n o d eficien cy viru s ( HIV) Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Clien t Edu catio n ; In fection Refer en ce: Lo wderm ilk et al. (2016), p . 603.

255. 4 Ra t ion a le: If th e clien t com plain s of a h eadach e an d blurred vision , th e HCP sh o uld be n otified, because th ese are sign s of wo rsen in g preeclam p sia. O ptio n s 1, 2, an d 3 are n o rm al fin d in gs. Test -Ta kin g St r a t egy: No te th e word worsening in th e q uestio n . Elim in ate op tio n s 1, 2, an d 3 b ecau se th ese op tion s are co m - p arab le o r alike an d in dicate n orm al fin d in gs. Review: Sign s of worsen in g p reeclam p sia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wderm ilk et al. (2016), p p . 654, 660.

256. 1 Ra t ion a le: Wh en a loss o r death o ccurs, th e n urse sh o uld en su re th at paren ts h ave b een h on estly told abo ut th e situ atio n by th eir h ealth care pro vider o r oth ers o n th e h ealth care team . It is im p ortan t fo r th e n u rse to be with th e paren ts at th is tim e an d to use th erapeutic co m m u n icatio n tech n iqu es. Th e n u rse

m u st also co n sid er cu ltu ral an d religiou s p ractices an d beliefs. Th e correct o ptio n p ro vides a sup po rtive, givin g, an d carin g resp on se. O ptio n s 2, 3, an d 4 are b lo cks to co m m u n icatio n an d devalu e th e p aren ts’ feelin gs. Test -Ta kin g Str a tegy: Use kn o wledge o f th erap eu tic co m m u - n icatio n tech n iq u es to an swer th e qu estio n . Th e co rrect o p tion is th e on ly op tio n th at reflects u se of th erap eu tic co m - m u n icatio n tech n iq u es. Review: Grief associated with p erin atal d eath Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Com m un icatio n ; Co pin g Refer en ce: Lo wd erm ilk et al. (2016), p p. 911, 918.

257. 3 Ra t ion a le: Exercise is safe fo r a clien t with gestation al d iabetes m ellitus an d is h elp ful in lowerin g th e b lo od glu co se level. Die- tary m od ification s are th e m ain stay o f treatm en t, an d th e clien t is p laced o n a stan d ard d iabetic diet. Man y clien ts are tau gh t to p erform b loo d glu co se m o n ito rin g. If th e clien t is n ot p erfo rm - in g th e b loo d glu co se m on itorin g at h om e, it is p erform ed at th e clin ic or HCP’s office. Sign s o f in fectio n n eed to be rep orted to th e HCP. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further teaching. Th ese words in dicate a n egative even t q u ery an d th e n eed to select an in correct clien t statem en t. Notin g th ese stra- tegic word s an d th e clo sed -en d ed wo rd avoid in th e correct o p tion will assist in an swerin g th e q uestio n . Review: Teach in g po in ts fo r gestatio n al d iab etes Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clien t Ed u catio n ; Glucose Regu latio n Refer en ce: Lo wd erm ilk et al. (2016), p . 703.

258. 4 Ra t ion a le: Severe preeclam p sia can trigger dissem in ated in tra- vascular co agulation (DIC) because of th e wid espread dam age to vascular in tegrity. Bleed in g is an early sign of DIC an d sh ou ld be repo rted to th e h ealth care p ro vider if n o ted o n assessm en t. O ption s 1, 2, an d 3 are n o rm al o ccu rren ces in th e last trim ester o f p regn an cy.

329CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

Test-Ta kin g St r a t egy: No te th e strategic wo rd , most. Fo cus on th e su b ject, a com plicatio n o f severe preeclam psia. Elim in ate o ptio n s 1, 2, an d 3 becau se th ey are co m p arab le o r alike an d are n orm al o ccu rren ces in th e last trim ester of p regn an cy. Review: Assessm en t fin din gs in d issem in ated in travascu lar co agu latio n ( DIC) Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Lo wd erm ilk et al. (2016), pp . 663, 685.

259. 3, 5 Ra tion a le: In a pregn an t clien t, DIC is a co n dition in wh ich th e clottin g cascade is activated , resu ltin g in th e form ation of clo ts in th e m icro circu latio n . Dead fetus syn drom e is co n sid ered a risk factor for DIC. Severe p reeclam psia is co n sid ered a risk fac- to r fo r DIC; a m ild case is n o t. Deliverin g a large n ewbo rn is n o t con sidered a risk facto r fo r DIC. Hem o rrh age is a risk facto r fo r DIC; h owever, a lo ss of 500 m L is n ot con sid ered h em o rrh age. Test-Ta kin g St r a t egy: No te th e strategic wo rd , most. Fo cus on th e su b ject, th e clien t at m ost risk for DIC. Th in k abo u t th e p ath op h ysio lo gy associated with DIC an d recall th at d ead fetu s syn d ro m e is a risk facto r. Th is will direct yo u to th e correct o ptio n . Review: Risk factors for d issem in ated in travascu lar co agu latio n Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Matern ity—In trapartum Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Lo wd erm ilk et al. (2016), pp . 662, 685.

260. 1, 2 Ra tion a le: Th e two classic sign s o f p reeclam p sia are h yp erten - sio n an d p ro tein u ria. A lo w-grad e fever, in creased pu lse rate, or in creased resp irato ry rate is n o t asso ciated with p reeclam p sia. Gen eralized edem a m ay occur, but is n o lon ger in cluded as a classic sign o f preeclam psia b ecau se it can occur in m an y con ditio n s. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e classic sign s of p reeclam psia. Th in kin g ab ou t th e p ath op h ysio lo gy asso ciated with preeclam p sia will direct you to th e correct option s. Rem em ber th at th e two classic sign s of p reeclam psia are h yp er- ten sion an d p ro tein uria. Review: Sign s o f p reeclam p sia Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Lo wd erm ilk et al. (2016), p. 654.

261. 1 Ra tion a le: In su lin n eeds d ecrease in th e first trim ester of p reg- n an cy b ecau se o f in creased in su lin p ro du ction b y th e p an creas an d in creased perip h eral sen sitivity to in su lin . Th e statem en ts in op tio n s 2, 3, an d 4 are accurate an d sign ify th at th e clien t u n d erstan d s con tro l of h er diab etes du rin g pregn an cy. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, further teach- ing is needed. Th ese wo rd s in dicate a n egative even t q u ery

an d th e n eed to select an in co rrect clien t statem en t. Elim in ate o ptio n s 2, 3, an d 4 b ecause th ey are co m p arab le o r alike an d are accu rate statem en ts. Rem em ber th at in su lin n eeds d ecrease in th e first trim ester of pregn an cy. Review: In sulin n eed s of th e p regn an t clien t with d iab etes m ellitu s Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regulation Refer en ce: Lowd erm ilk et al. (2016), pp . 694–695.

262. 2 Ra tion a le: Mo re th an 1 m edication m ay b e used to preven t th e gro wth of resistan t o rgan ism s in a pregn an t clien t with tub er- culo sis. Treatm en t m ust co n tin ue for a pro lon ged p eriod . Th e p referred treatm en t fo r th e p regn an t clien t is ison iazid plus rifam pin daily for 9 m o n th s. Eth am bu tol is ad ded in itially if m edicatio n resistan ce is susp ected. Pyrido xin e (vitam in B6) o ften is adm in istered with iso n iazid to preven t fetal n euroto x- icity. Th e clien t d o es n o t n eed to stay at h om e du rin g treat- m en t, an d th erap eu tic ab ortion is n ot requ ired. Test-Ta kin g Str a tegy: Focus on th e su b ject, th erapeutic m an - agem en t fo r a clien t with tub ercu losis. Recallin g th e p ath o- p h ysio logy associated with tub ercu losis an d its treatm en t will assist in elim in atin g op tio n s 1, 3, an d 4. Review: Treatm en t m easu res fo r th e p regn an t clien t with tu b ercu lo sis Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: McKin n ey et al. (2013), p. 631.

263. 4 Ra tion a le: Co n stip ation can cause th e clien t to use th e Valsalva m an eu ver. Th e Valsalva m an eu ver sh o u ld be avoid ed in clien ts with cardiac disease because it can cause blood to rush to th e h eart an d overload th e cardiac system . Con stipatio n can be p reven ted b y th e ad d ition of fluid s an d a h igh -fiber d iet. A lo w-calorie d iet is n o t reco m m en ded d urin g p regn an cy an d cou ld be h arm fu l to th e fetu s. So diu m sh o u ld be restricted as p rescribed b y th e h ealth care provid er becau se excess sod iu m would cause an overload to th e circulatin g blood volum e an d con trib ute to cardiac co m p lication s. Diets low in fluid can cau se a d ecrease in b lo od vo lu m e, wh ich cou ld d ep rive th e fetu s of n utrien ts. Test-Ta kin g Str a t egy: Focu s o n th e sub ject, the pregn an t clien t with h eart d isease. Th in k abo ut th e ph ysiology o f th e card iac sys- tem , m atern al an d fetal n eed s, an d th e factors that in crease th e worklo ad o n th e h eart. Th is will d irect you to th e correct o ption . Review: Nu rsin g m easures fo r th e p regn an t clien t with h eart d isease Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ces: Lowderm ilk et al. (2016), p . 352; McKin n ey et al. (2013), p. 619.

330 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

264. 1, 3 Ra t ion a le: HIV is tran sm itted by in tim ate sexual con tact an d th e exch an ge of bo dy flu ids, exp osu re to in fected b loo d , an d passage fro m an in fected wo m an to h er fetu s. Clien ts wh o fall in to th e h igh -risk category for HIV in fectio n in clu de in d ivid - uals wh o h ave used in traven ou s drugs, in dividu als wh o exp e- rien ce persisten t an d recurren t sexually tran sm itted in fection s, an d in d ivid uals wh o h ave a h isto ry of m u ltip le sexu al p artn ers. Gestatio n al diabetes m ellitu s d oes n o t p red isp ose th e clien t to HIV. A clien t with a h etero sexu al partn er, p articularly a clien t wh o h as h ad on ly on e sexual partn er in 10 years, d o es n o t h ave a h igh risk fo r co n tractin g HIV. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, risk factors for HIV. Recallin g th at exch an ge o f b lo od an d bo d y flu ids places th e clien t at h igh risk fo r HIV in fectio n will d irect yo u to th e co rrect o p tion . Review: Risk factors associated with h u m an im m u n o d efi- cien cy viru s ( HIV) Level of Cogn it ive Ability: An alyzin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: In fectio n ; Sexuality Refer en ce: Lo wderm ilk et al. (2016), p . 161.

265. 1 Ra t ion a le: A su pp ort grou p can h elp th e p aren ts to wo rk th ro ugh th eir p ain b y n on jud gm en tal sh arin g of feelin gs. Th e correct op tion id en tifies a statem en t th at in d icates p ositive, n orm al grievin g. Alth o ugh th e o th er op tion s m ay in d icate reac- tion s o f th e clien t an d sign ifican t o th er, th ey are n o t sp ecifically a p art of th e n o rm al grievin g p rocess. Test -Ta kin g St r a t egy: Read all op tio n s carefully b efo re select- in g an an swer an d fo cu s o n th e su b ject, th e n orm al grievin g process. Note th at op tion s 2, 3, an d 4 are co m p arab le o r alike in th at th ey relate to ch ildb earin g. Review: No rm al grievin g p ro cess Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Cop in g; Fam ily Dyn am ics Refer en ce: Lo wderm ilk et al. (2016), p . 918.

266. 4 Ra t ion a le: Hepatitis B virus is high ly con tagious an d is transm it- ted by direct con tact with blood an d body fluids of infected per- son s. Th e ration ale for iden tifyin g ch ildbearin g clien ts with th is disease is to provide adequate protection of the fetus and th e n ew- born , to m in im ize tran sm ission to oth er in dividuals, an d to reduce m aternal com plication s. Th e correct option provides th e best evaluation of m atern al un derstan din g of disease transm is- sion. O ption 1 will n ot affect disease tran sm ission sin ce h epatitis B does not spread th rough airborn e transm ission . O ption s 2 an d 3 are appropriate feeding techn iques for bottle-feedin g, but do not m in im ize disease transm ission for h epatitis B. Test -Ta kin g St r a tegy: Note th e strategic wo rd , best. Fo cu s o n th e su b ject, d isease tran sm issio n to th e n ewbo rn . Th is focu s will d irect yo u to th e co rrect o p tion . Review: Measures to preven t tran sm issio n of h ep atitis

Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Clien t Ed u catio n ; In fection Refer en ce: Lo wd erm ilk et al. (2016), p p. 159, 862.

267. 2 Ra t ion a le: Strict bed rest th ro ugh ou t th e rem ain d er o f th e p regn an cy is n o t requ ired fo r a th reaten ed abo rtion . Th e clien t sh ou ld watch fo r th e eviden ce o f th e passage of tissu e. Th e cli- en t is in structed to cou n t th e n um b er o f p erin eal p ads used d aily an d to n o te th e q uan tity an d co lor of b lo od o n th e p ad. Th e clien t is ad vised to cu rtail sexu al activities u n til b leed - in g h as ceased an d fo r 2 weeks after th e last evid en ce o f b leed - in g or as reco m m en ded by th e h ealth care p ro vid er. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further instruction. Th ese words in dicate a n egative even t q u ery an d th e n eed to select an in co rrect clien t statem en t. Notin g th e word strict in th e co rrect o p tion will assist in directin g yo u to th is o ption . Review: Th erapeu tic m an agem en t for th reaten ed ab o rtio n Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clien t Ed u catio n ; Rep ro du ction Refer en ce: Lo wd erm ilk et al. (2016), p . 671.

268. 2, 3, 5 Ra t ion a le: Th e ob ese p regn an t clien t is at risk for co m p lica- tion s su ch as ven ou s th rom b oem b olism an d in creased n eed fo r cesarean sectio n . Ad dition ally, th e o bese clien t requ ires sp e- cial con sideration s p ertain in g to n u rsin g care. To preven t ven ou s th ro m b o em b o lism , p articu larly in th e clien t wh o req uired cesarean sectio n , frequ en t an d early am b u lation (n ot b ed rest), prio r to an d after surgery, is recom m en d ed . Ro u- tin e ad m in istration of p ro p h ylactic ph arm aco lo gical ven o u s th ro m b o em b o lism m ed ication s su ch as h ep arin is also com - m o n ly p rescrib ed. An overbed lift m ay be n eed ed to tran sfer a clien t fro m a bed to an o peratin g tab le if cesarean sectio n is n ecessary. In creased m o n ito rin g an d clean sin g o f a cesarean in cisio n , if p resen t, will likely be p rescribed du e to th e in creased risk for in fectio n seco n d ary to in creased ab d om in al fat. Th rom b oem b olism sto ckin gs or seq u en tial com p ression d evices will likely b e p rescrib ed becau se of th e clien t’s in creased risk o f b loo d clots. Test -Ta kin g Str a tegy: No te th e su b ject, p lan n in g care for th e p regn an t clien t wh o is o bese. If yo u can recall th e gen eral com - p licatio n s associated with o b esity, th is will h elp you to ch o ose th e correct op tio n s. Recall th at p reven tive m easures n eed to be taken to preven t bloo d clots an d in fectio n in clien ts at h igh er risk for th ese com p lication s. Review: Care o f th e p regn an t clien t wh o is o b ese Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: In fectio n ; Perfusion Refer en ce: Lo wd erm ilk et al. (2016), p . 778.

331CHAPTER 26 Risk Conditions Related to Pregnancy

M

a

t

e

r

n

i

t

y

M

a

t

e

r

n

i

t

y

C H A P T E R 27 Labor and Birth

PRIORITY CONCEPTS Perfusion, Reproduction

CRITICAL THINKING What Should You Do? A client at 39 weeks of gestation is in active labor. The nurse is monitoring the fetal heart rate and notes that the heart rate is 180 beats/ minute, lasting for longer than 10 minutes. What should the nurse do? Answer located on p. 341.

I. Process of Labor—4 P’s A. Description

1. Labor: Coordin ated sequen ce of in volun tary, in term itten t uterin e con traction s

2. Birth: Actual even t of birth B. Four m ajor facto rs (4 P’s) in teract durin g n orm al

ch ildbirth ; th e 4 P’s are in terrelated an d depen d on each oth er for a safe birth an d are Powers, Passage- way, Passen ger, an d Psych e.

C. Powers: Uterin e con traction s 1. Forces actin g to expel th e fetus 2. Effacem en t: Sh o rten in g an d th in n in g of th e cer-

vix durin g th e first stage of labo r 3. Dilation : En largem en t of cervical os an d cervical

can al durin g th e first stage of labor 4. Push in g efforts of m oth er durin g th e secon d

stage D. Passageway: Th e m oth er’s rigid bon y pelvis an d th e

soft tissues of th e cervix, pelvic flo or, vagina, an d in troitus (extern al open in g to th e vagin a)

E. Passen ger: Th e fetus, m em bran es, an d placenta F. Psych e: A wom an ’s em otion al structure th at can

determ in e h er en tire respon se to labo r an d in fluen ce ph ysiological an d psych o logical fun ction in g; th e m oth er m ay exp erien ce an xiety or fear.

G. Attitude 1. Attitude is th e relation sh ip of th e fetal body parts

to on e an oth er. 2. No rm al in trauterin e attitu de is flexion , in wh ich

th e fetal back is roun ded, th e h ead is forward on th e ch est, an d th e arm s an d legs are folded in

again st th e body. Th e oth er attitu de, exten sion , ten ds to presen t larger fetal diam eters.

H. Lie 1. Relation sh ip of th e spin e of th e fetus to th e spin e

of th e m oth er 2. Lon gitudin al or vertical ( Fig. 27-1)

a . Fetal spin e is parallel to th e m oth er’s spin e. b . Fetus is in ceph alic or breech presen tation .

3. Tran sverse or h orizo n tal (see Fig. 27-1) a . Fetal spin e is at a righ t an gle, or perpen d icu-

lar, to th e m oth er’s spin e. b . Presen tin g part is th e sh o ulder. c. Delivery by cesarean section is n ecessary.

I. Presen tation 1. Portion of th e fetus th at en ters th e pelvic

in let first 2. Ceph alic: Head first

a . Ceph alic is th e m ost com m on presen tation . b . Ceph alic presen tation h as 4 variatio n s: ver-

tex, m ilitary, brow, an d face. 3. Breech : Buttocks presen t first.

a . Delivery by cesarean section m ay be required, alth ough vagin al birth is often possible.

b . Breech presen tation h as 3 variation s: fran k, full (com plete), an d footlin g.

4. Sh oulder a . Fetus is in a tran sverse lie, or th e arm , back,

abdom en , or side could presen t. b . If th e fetus does n ot spon tan eously rotate, or

if it is im possible to turn th e fetus m an u ally, a cesarean section m ay n eed to be perform ed.

J. Presen tin g part: Th e specific fetal structure lyin g n earest to th e cervix

K. Position : Relatio n sh ip of assign ed area of th e pre- sen tin g part or lan dm ark to th e m atern al pelvis (Fig. 27-2 an d Box 27-1)

L. Station 1. Th e m easu rem en t of th e progress of descen t in

cen tim eters above or below th e m idplan e from th e presen tin g part to th e isch ial spin e

2. Statio n 0: At isch ial spin e 3. Min u s statio n : Above isch ial spin e332

M

a

t

e

r

n

i

t

y

Longitudina l lie Tra ns ve rs e lieBA FIGURE 27-1 Fetal lie. A, In a longitudinal lie, the long axis of the fetus is parallel to the long axis of the mother. B, In a transverse lie, the long axis of the fetus is at a right angle to the long axis of the mother. The mother’s abdomen has a wide, short appearance.

ROP Right occipitopos te rior

Right Le ft

Ante rior

ROT Right occipitotra ns ve rs e

ROA Right occipitoa nte rior

LOA Le ft occipitoa nte rior

LOT Le ft occipitotra ns ve rs e

LOP Le ft occipitopos te rior

Pos te rior

Lie : Longitudina l or ve rtica l P re s e nta tion: Ve rte x

Re fe re nce point: Occiput Attitude : Comple te fle xion

FIGURE 27-2 Fetal vertex (occiput) presentations in relation to the front, back, or side of the maternal pelvis.

BOX 27-1 Fetal Positions

Vertex Presentations ROA: Right occipitoanterior LOA: Left occipitoanterior ROP: Right occipitoposterior LOP: Left occipitoposterior ROT: Right occipitotransverse LOT: Left occipitotransverse

Face Presentations RMA: Right mentoanterior LMA: Left mentoanterior RMP: Right mentoposterior

Breech Presentations LSA: Left sacroanterior LSP: Left sacroposterior

Other Presentations Brow presentation Shoulder presentation

333CHAPTER 27 Labor and Birth

M

a

t

e

r

n

i

t

y

4. Plus station : Below isch ial spin e 5. En gagem en t: Wh en th e widest diam eter of th e

presen tin g part h as passed th e in let; correspo n ds to a 0 station

II. Mechanisms of Labor (Box 27-2) A. Assessm en t

1. Ligh ten in g or dropp in g: Is also kn own as engage- ment an d occurs wh en th e fetus descen ds in to th e pelvis about 2 weeks befo re birth ; ligh ten in g or dropp in g is m ost n oticeable in first pregn an cies.

2. Braxto n Hicks co n traction s in crease. 3. Th e vagin al m ucosa is con gested , an d vagin al

disch arge in creases. 4. Brown ish or blood-tin ged cervical m ucus is

passed.

5. Cervix ripen s, beco m es soft an d partly effaced, an d m ay begin to dilate.

6. Th e m oth er h as a sudd en burst of en ergy, also kn own as “n estin g,” often 24 to 48 h ours before on set of labo r.

7. Weigh t loss of 1 to 3 lb results from fluid sh ifts pro- duced by th e ch an ges in progesteron e an d estrogen levels 24 to 48 h ours before th e on set of labor.

8. Spon tan eous rupture of m em bran es occurs. a . True labor: Con traction s m ay m an ifest as back

pain in som e wom en ; con traction s often resem - ble m en strual cram ps durin g early labor (Box 27-3).

b . False labo r: Also kn own as prodromal labor, con traction s are felt in th e abdom en an d groin an d m ay be m ore an n oyin g th an pain - ful (see Box 27-3).

In true labor, contractions increase in duration and intensity and cervical dilation and effacement are progressive, with engagement and descent of the fetus. In false labor, contractions are irregular and do not produce dilation, effacement, or descent.

III. Leopold’s Maneuvers A. Descrip tion : Meth od s of palp ation to determ in e pre-

sen tation an d position of th e fetus an d aid in loca- tion of fetal h eart soun ds

B. If th e h ead is in th e fun dus, a h ard, roun d, m ov- able object is felt. Th e buttocks feel soft an d h ave an irregular sh ap e an d are m ore difficult to m ove.

C. Th e fetus’s back, wh ich is a sm ooth , h ard surface, sh ould be felt on 1 side of th e abdom en .

D. Irregular kn obs an d lum ps, wh ich m ay be th e h an ds, feet, elbows, an d kn ees, are felt on th e opposite side of th e ab dom en .

BOX 27-2 Mechanisms of Labor Engagement ▪ Engagement is the mechanism whereby the fetus nestles

into the pelvis. ▪ Engagement occurs when the presenting part reaches the

level of the ischial spines.

Descent ▪ Descent is the process that the fetal head undergoes as it

begins its journey through the pelvis. ▪ Descent is a continuous process from prior to engagement

until birth and is assessed by the measurement called station.

Flexion ▪ Flexion is a process of nodding of the fetal head forward

toward the fetal chest.

Internal Rotation ▪ Internal rotation of the fetus occurs most commonly from

the occipitotransverse position, assumed at engagement into the pelvis, to the occipitoanterior position while contin- uously descending.

Extension ▪ Extension enables the head to emerge when the fetus is in a

cephalic position. ▪ Extension begins after the head crowns. ▪ Extension is complete when the head passes under the sym-

physis pubis and occiput, and the anterior fontanel, brow, face, and chin pass over the sacrum and coccyx and are over the perineum.

Restitution ▪ Restitution is realignment of the fetal head with the body

after the head emerges.

External Rotation ▪ The shoulders externally rotate after the head emerges and

restitution occurs, so that the shoulders are in the antero- posterior diameter of the pelvis.

Expulsion ▪ Expulsion is the birth of the entire body.

BOX 27-3 True Labor Versus False Labor

True Labor ▪ Contractions occur regularly, become stronger, last longer,

and occur closer together. ▪ Cervical dilation and effacement are progressive. ▪ The fetus usually becomes engaged in the pelvis and

begins to descend.

False Labor ▪ False labor does not produce dilation, effacement, or

descent. ▪ Contractions are irregular, without progression. ▪ Activity, such as walking, often relieves false labor.

Exa mple: If a woman has been sleeping and wakes up with contractions, gets up, and moves around, and her contrac- tions become stronger and closer together, this is true labor. If the contractions go away, this is false labor.

334 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

IV. Breathing Techniques (Box 27-4) A. Provide a focus durin g con traction s, in terferin g with

pain sen sory tran sm issio n . B. Prom o te relaxation an d oxygen ation . C. Begin with sim ple breath in g pattern s an d progress to

m ore com plex on es as n eeded.

V. Fetal Monitoring A. Description

1. Th e fetal m onitor displays th e fetal h eart rate (FHR). 2. Th e device m on itors uterin e activity. 3. Th e m on itor assesses frequen cy, duration , an d

in ten sity of con traction s. 4. Th e m on itor assesses FHR in relation to m atern al

con traction s. 5. Baselin e FHR is m easured between con traction s;

th e n orm al FHR at term is 110 to 160 beats/ m in ute. B. Extern al fetal m on itorin g

1. Extern al fetal m on itorin g is n on in vasive an d is perform ed with a tocotran sducer or Doppler ultrason ic tran sdu cer.

2. Leo pold’s m an euvers are perform ed to deter- m in e on wh ich side th e fetal back is located, an d th e ultraso un d tran sducer is placed over th is area (fasten with a belt or stockin g tubin g).

3. Th e tocotran sducer is placed over th e fun dus of th e uterus, wh ere con traction s feel th e stron gest (fasten with a belt or stockin g tubin g).

4. Th e clien t is allowed to assum e a com fo rtable position , avoidin g ven a cava com pression (m atern al supin e h ypo ten sive syn d rom e).

5. Th e preferred position is to h ave th e clien t lie on h er side to in crease perfusion .

C. In tern al fetal m on itorin g 1. In tern al fetal m on itorin g is in vasive an d requires

ru pturin g of th e m em bran es an d attach in g an electrode to th e presen tin g part of th e fetus.

2. Th e clien t m ust be dilated 2 to 3 cm to perform in tern al m on itorin g.

D. Periodic pattern s in FH R 1. Fetal bradycardia an d tach ycardia

a. Bradycardia: FHR is less th an 110 beats/ m in u te for 10 m in utes or lon ger.

b . Tach ycardia: FHR is m ore th an 160 beats/ m in u te for 10 m in utes or lon ger.

If fetal bradycardia or tachycardia occurs, change the position of the mother, administer oxygen, and assess the mother’s vital signs. Notify the health care provider (HCP) as soon as possible.

2. Variability (Box 27-5) a. Fluctuation s in baselin e FH R b . Absen t or un detected variab ility is con sid ered

n on reassurin g. c. Decreased variability can result from fetal

h ypo xem ia, acido sis, or certain m edication s. d . A tem porary decrease in variab ility can occur

wh en th e fetus is in a sleep state (sleep states do n ot usually last lon ger th an 30 m in u tes).

3. Acceleration s a. Brief, tem p orary in creases in FH R of at least

15 beats/ m in u te m ore th an baselin e an d last- in g at least 15 secon ds

b . Usually are a reassurin g sign , reflectin g a respo n sive, n on acidotic fetus

c. Usually occur with fetal m ovem en t d . May be n on periodic (h avin g n o relation to

con traction s) or periodic (with con traction s)

BOX 27-4 Breathing Techniques First-Stage Breathing Clea nsing Brea t h Each contraction begins and ends with a deep inspiration and

expiration.

Slow-Paced Brea thing Slow-paced breathing promotes relaxation. Slow-paced breathing is used for as long as possible during

labor.

Modified-Pa ced Breat hing Modified-paced breathing is used when slow-paced breathing is

no longer effective. Breathing is shallow and fast.

Pat t ern-Paced Brea thing Pattern-paced breathing sometimes is referred to as pant-blow.

After a certain number of breaths (modified-paced breathing), the woman exhales with a slight blow, and then begins modified-paced breathing again.

Brea thing to Prevent Pushing The woman blows repeatedly, using short puffs, when the urge

to push is strong.

Second-Stage Breathing Several variations of breathing can be used in the pushing stage

of labor, and the woman may grunt, groan, sigh, or moan as she pushes. Prolonged breath holding while pushing with a closed glottis may result in a decrease in cardiac output. If breath holding while pushing is used, the open glottis method or limiting breath holding to less than 6 to 8 seconds should be done.

BOX 27-5 Variability in Fetal Heart Rate Absent Va ria bilit y: Undetected variability Minima l Va ria bilit y: Greater than undetected but not more

than 5 beats/ minute Modera t e Va ria bilit y: Fetal heart rate fluctuations are 6 to 25

beats/ minute Ma rked Va ria bility: Fetal heart rate fluctuations are greater

than 25 beats/ minute

335CHAPTER 27 Labor and Birth

M

a

t

e

r

n

i

t

y

e. May occur with uterin e con traction s, vagin al exam in ation s, or m ild cord com pression , or wh en th e fetus is in a breech presen tation

4. Early deceleration s ( Fig. 27-3) a . Early deceleration s are decreases in FHR

below baselin e; th e rate at th e lo west poin t of th e deceleration usually rem ain s greater th an 100 beats/ m in ute.

b . Early deceleration s occur durin g con traction s as th e fetal h ead is pressed again st th e m oth er’s pelvis or soft tissues, such as th e cer- vix, an d return to baselin e FHR by th e en d of th e con traction .

c. Tracin g sh o ws a un ifo rm sh ape an d m irror im age of uterin e con traction s.

d . Early deceleration s are n ot associated with fetal com prom ise an d require n o in terven tion .

5. Late deceleration s (see Fig. 27-3) a . Late deceleration s are n on reassurin g pattern s

th at reflect im paired placen tal exch an ge or uterop lacen tal in sufficien cy.

b . Th e pattern s look sim ilar to early decelera- tion s, but begin well after th e con traction begin s an d return to baselin e after th e con - traction en ds.

c. Th e degree of declin e in FHR from baselin e is n ot related to th e am oun t of uteroplacen tal in sufficien cy.

Interventions for late decelerations include imme- diately improving placental blood flow and fetal oxygenation.

6. Variable deceleration s (see Fig. 27-3). a . Variable deceleration s are cau sed by con d i-

tion s th at restrict flo w th rou gh th e um bilical cord.

b . Variable deceleration s do n ot h ave th e un ifo rm appearan ce of early an d late deceleration s.

c. Th e sh ap e, duration , an d degree of declin e below baselin e FHR are variable; th ese fall an d rise abruptly with th e on set an d relief of cord com pression .

d . Variable decelerations also m ay be n on periodic, occurrin g at tim es un related to con traction s.

e. Baselin e rate an d variability are con sidered wh en evaluatin g variable deceleration s.

f. Variable deceleration s are sign ifican t wh en FHR repeatedly declin es to less th an 70 beats/ m in ute an d persists at th at level for at least 60 secon ds befo re return in g to baselin e.

If variable decelerations occur, discontinue oxytocin if infusing, change the position of the mother, administer oxygen, and assess the mother’s vital signs. Notify the HCP. Assist with amnioinfusion (intrauterine instillation of warmed saline to decrease compression on the umbilical cord) if prescribed.

7. Hyperton ic uterin e activity a . Assessm en t of uterin e activity in cludes fre-

quen cy, duration , in ten sity of con traction s, an d uterin e restin g ton e; assessm en t is per- form ed eith er by palpatin g by h an d or with an in tern al uterin e pressure cath eter (IUPC).

b . Th e uterus sh ould relax between con traction s for 60 secon ds or lon ger.

c. Uterin e con traction in ten sity is about 50 to 75 m m Hg (with an IUPC) durin g labo r an d m ay reach 110 m m Hg with push in g dur- in g th e secon d stage.

d . Th e average restin g ton e is 5 to 15 m m Hg. e. In h yperton ic uterin e activity, th e uterin e rest-

in g ton e between con traction s is h igh , reduc- in g uterin e blood flow an d decreasin g fetal oxygen supp ly.

8. Non reassurin g FH R pattern s ( Box 27-6) 9. In terven tion s for n on reassurin g pattern s (see

Priority Nu rsin g Action s)

434241

ECG dir.ECG dir. ECG a bd.ECG a bd. P HONOP HONO USUS

A

3:30 FECG IUP

50178177 50179 50180

B

C

240 210210 180180 150150 120120 9090 6060 30

100 8080 6060 4040 2020 0

240 210 180 150 120 90 60 30

100 80 60 40 20 0

240 210210 180180 150150 120120 9090 6060 30

100 7575 5050 2525 0

240 210 180 150 120 90 60 30

100 75 50 25 0

ECG dir. ECG a bd. P HONO US

TOCO int.TOCO int. TOCO e xt.TOCO e xt. TOCO int. TOCO e xt.

FHR 240 bpm 210210 180180 150150 120120 9090 6060 30

FHR 240 bpm 210 180 150 120 90 60 30

UA mm HgkPa

1212

8

4

0

100 7575 5050 2525 0UA mm HgkPa

12

8

4

0

100 75 50 25 0

FIGURE 27-3 Deceleration patterns. Top graphs in each pair: Fetal heart rate. Bottom graphs in each pair: Uterine contractions. A, Early decelera- tions caused by head compression. B, Late decelerations caused by uter- oplacental insufficiency. C, Variable decelerations caused by cord compression.

336 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

PRIORITY NURSING ACTIONS Nonreassuring Fetal Heart Rate Pattern 1. Identify the cause. 2. Discontinue oxytocin infusion. 3. Change the mother’s position. 4. Administer oxygen by face mask at 8 to 10 L/ minute and

infuse intravenous (IV) fluids as prescribed. 5. Prepare to initiate continuous electronic fetal monitoring

with internal devices if not contraindicated. 6. Prepare for cesarean delivery if necessary. 7. Document the event, actions taken, and the mother’s

response.

Nonreassuring fetal heart rate (FHR) patterns include bradycardia, tachycardia, late decelerations, prolonged decel- erations, hypertonic uterine activity, decreased or absent var- iability, or variable decelerations falling to less than 70 beats/ minute for longer than 60 seconds. If a nonreassuring FHR pattern is noted, the health care provider (HCP) or nurse- midwife is notified as soon as possible (the nurse stays with the client and asks another nurse to contact the HCP). The nurse needs to identify the cause of the pattern immediately. This includes checking for a prolapsed umbilical cord and checking maternal vital signs to identify hypotension, hyper- tension, or fever that can contribute to the fetal response associated with the nonreassuring pattern. If the mother is receiving an oxytocin infusion, it is stopped because oxytocin causes uterine stimulation, which can worsen the nonreas- suring pattern. A tocolytic may be prescribed. The mother is repositioned because this may improve placental perfu- sion (avoid the supine position). Oxygen is administered by face mask at 8 to 10 L/ minute to increase maternal blood oxygen saturation, making more oxygen available to the fetus, and IV fluids are infused to expand the mother’s blood volume and improve placental perfusion. If not contraindi- cated, the nurse prepares to initiate continuous electronic fetal monitoring with internal devices. Cesarean delivery may be necessary, and the nurse should prepare for this pro- cedure. Birth preparation should also include neonatal resus- citation. The nurse documents the event, actions taken, the mother’s response, and any other pertinent data.

Reference Lowdermilk et al. (2016), p. 423.

VI. Four Stages of Labor (Table 27-1) A. Stage 1: Laten t ph ase

1. Description : Stage 1 is th e lo n gest. A labor curve, such as th e Friedman curve, m ay be used to iden - tify wh eth er a wom an ’s cervical dilation is pro- gressin g at th e exp ected rate (Fig. 27-4).

2. Assessm en t a. Cervical dilation is 1 to 4 cm . b . Uterin e con traction s occur every 15 to

30 m in utes, are 15 to 30 secon ds in duration , an d are of m ild in ten sity.

3. In terven tion s a. En cou rage m oth er an d partn er to participate

in care. b . Assist with com fo rt m easures, ch an ges of

position , an d am bulation . c. Keep m other an d partn er in form ed of progress. d . O ffer fluids an d ice ch ips. e. En cou rage vo idin g every 1 to 2 h ou rs.

B. Stage 1: Active ph ase 1. Assessm en t

a. Cervical dilation is 4 to 7 cm . b . Uterin e con traction s occur every 3 to

5 m in utes, are 30 to 60 secon ds in duration , an d are of m od erate in ten sity.

2. In terven tion s a. En cou rage m ain ten an ce of effective breath in g

pattern s. b . Provide a quiet en viron m en t. c. Keep m other an d partn er in form ed of progress. d . Prom o te com fo rt with back rubs, sacral pres-

sure, pillow supp ort, an d position ch an ges. e. In struct partn er in effleurage (ligh t strokin g of

abdom en ). f. O ffer fluids an d ice ch ips an d oin tm en t for

dry lips. g. En cou rage vo idin g every 1 to 2 h ou rs.

C. Stage 1: Tran sition ph ase 1. Assessm en t

a. Cervical dilation is 8 to 10 cm . b . Uterin e con traction s occur every 2 to

3 m in utes, are 45 to 90 secon ds in duration , an d are of stron g in ten sity.

2. In terven tion s a. En cou rage rest between co n traction s. b . Wake m oth er at begin n in g of con traction so

sh e can begin breath in g pattern . c. Keep m o th er an d p artn er in fo rm ed o f

p ro gress. d . Provide privacy. e. O ffer fluids an d ice ch ips an d oin tm en t for

dry lips. f. En cou rage vo idin g every 1 to 2 h ou rs.

D. In terven tion s th rou gh ou t stage 1 1. Mon itor m atern al vital sign s. 2. Mon itor FH R via ultrasoun d Doppler, fetoscope,

or electron ic fetal m on itor.

BOX 27-6 Nonreassuring Fetal Heart Rate Patterns

• Bradycardia • Tachycardia • Late decelerations • Prolonged decelerations • Hypertonic uterine activity • Decreased or absent variability • Variable decelerations falling to less than 70 beats/ minute

for longer than 60 seconds

337CHAPTER 27 Labor and Birth

3. Assess FHR befo re, durin g, an d after a con trac- tion , n otin g th at th e n orm al FH R is 110 to 160 beats/ m in u te.

4. Mon itor uterin e con traction s by palpatio n or tocodyn am om eter, determ in in g frequen cy, duration , an d in ten sity.

5. Assess status of cervical dilation an d effacem en t. 6. Assess fetal station presen tation an d position by

Leopold’s m an euvers. 7. Assist with pelvic exam in ation an d prepare for a

fern test.

If the membranes have ruptured, assess the FHR because of the risk of prolapsed umbilical cord, and assess the color of the amniotic fluid because meconium-stained fluid can indicate fetal distress.

E. Stage 2 1. Assessm en t

a . Cervical dilation is com plete. b . Progress of labor is m easu red by descen t of

fetal h ead th rou gh th e birth can al (ch an ge in fetal station ).

c. Uterin e con traction s occur every 2 to 3 m in utes, lastin g 60 to 75 secon ds, an d are of stron g in ten sity.

d . In crease in blood y sh ow occurs. e. Moth er feels urge to bear down ; assist m oth er

in push in g efforts. 2. In terven tion s

a . Perform assessm en ts every 5 m in u tes. b . Mon itor m atern al vital sign s. c. Mon itor FH R via ultrasoun d Doppler, feto-

scope, or electron ic fetal m on itor. d . Assess FHR befo re, durin g, an d after a co n -

traction , n otin g th at th e n orm al FHR is 110 to 160 beats/ m in ute.

M

a

t

e

r

n

i

t

y

TABLE 27-1 Four Stages of Labor First Stage Second Stage Third Stage Fourth Stage

Effacement and dilation of cervix Expulsion of fetus Separation of placenta Physical recovery

Three stages– latent, active, and transition Pushing stage Latent phase– known as “laboring down” Active phase– pushing

Expulsion of placenta 1–4 hr after expulsion of placenta

Mother is talkative and eager in latent phase, becoming tired, restless, and anxious as labor intensifies and contractions become stronger

Mother has intense concentration on pushing with contractions; may fall asleep between contractions

Mother is relieved after birth of newborn; mother is usually very tired

Mother is tired, but is eager to become acquainted with her newborn

Multipa rous (compos ite )Multipa rous (compos ite )

Nullipa rous (compos ite )Nullipa rous (compos ite )Nullipa rous (compos ite )

Multipa rous (compos ite )

10

4 5 6 7 8 9 10 11 12 13

11 12 1 2 3 4 5 6 7 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AM 15 30 45 00

AMP M P M P M P M P M P M P M P M P M P M 15 30 45

Time

9

Effa ce me nt % a nd/or pos ition Hour of la bor

8

7

6

5

4

3

2

–4

–3

–2

–1

0

+1

+2

+3

S

t

a

t

i

o

n

Co mpo s ite no rmal dilatio n c urve s

C

e

r

v

i

c

a

l

d

i

l

a

t

i

o

n

FIGURE 27-4 Alabor curve, often referred to as a partogram or Friedman’s curve, may be used to identify whether a woman’s cervical dilation and descent are progressing at the expected rate. The symbol for station (X), which represents descent, may be added to the labor curve. Typical labor curves for a multiparous woman and a nulliparous woman are illustrated for comparison of patterns.

338 UNIT VI Maternity Nursing

e. Mon itor uterin e con traction s by palpation or tocodyn am om eter, determ in in g frequen cy, duration , an d in ten sity.

f. Provide m oth er with en couragem en t an d praise an d provid e for rest between con traction s.

g. Keep m oth er an d partn er in form ed of progress.

h . Main tain privacy. i. Provide ice ch ips an d oin tm en t for dry lips. j. Assist m oth er in to a position th at prom o tes

com fo rt an d facilitates push in g efforts, such as lith otom y, sem isittin g, kn eelin g, side- lyin g, or squattin g.

k . Mon itor for sign s of ap proach in g birth , such as perin eal bulgin g or visu alization of th e fetal h ead.

l. Prepare for birth (expu lsion of th e fetus). F. Stage 3

1. Assessm en t a. Con traction s occur un til th e placen ta is

exp elled. b . Placen tal separation an d exp ulsion occur. c. Expu lsion of th e placen ta occurs 5 to

30 m in utes after th e birth of th e in fan t. d . Sch ultze m ech an ism : Cen ter portion of th e

placen ta sep arates first, an d its sh in y fetal sur- face em erges from th e vagin a.

e. Du n can m ech an ism : Margin of th e placen ta sep arates, an d th e dull, red, rough m atern al surface em erges from th e vagin a first.

f. Meth od of placen tal presen tation is of n o clin ical sign ifican ce.

2. In terven tion s a. Assess m atern al vital sign s. b . Assess uterin e status. c. Provide paren ts with an explan ation regard-

in g exp ulsion of th e placen ta. d . After exp ulsion of th e placen ta, uterin e fun -

dus rem ain s firm an d is located 2 fin ger- breadth s below th e um b ilicus.

e. Exam in e placen ta for cotyledon s an d m em - bran es to verify th at it is in tact.

f. Assess m oth er for sh iverin g an d provid e warm th .

g. Prom ote paren tal-n eon atal attach m en t. G. Stage 4

1. Description : Period 1 to 4 h ours after birth 2. Assessm en t

a. Bloo d pressure return s to prelabor level. b . Pulse is sligh tly lower th an durin g labor. c. Fun dus rem ain s con tracted, in th e m idlin e, 1

or 2 fin gerbreadth s below th e um bilicus.

Monitor lochia discharge. Lochia may be moderate in amount and red in color in stage 4.

3. In terven tion s a. Perform m atern al assessm en ts every

15 m in utes for 1 h our, every 30 m in u tes for 1 h ou r, an d h ourly for 2 h ours (or as per agen cy policy).

b . Provide warm blan kets. c. Apply ice packs to th e perin eum . d . Massage th e uterus if n eeded, an d teach th e

m oth er to m assage th e uterus. e. Provide breast-feedin g support as n eeded. f. See Ch apter 31 for in form ation on carin g for

th e newborn.

VII. Anesthesia A. Local an esth esia

1. Local an esth esia is used for blockin g pain durin g episioto m y.

2. Local an esth esia is adm in istered just befo re th e birth of th e in fan t.

3. Th e an esth etic h as n o effect on th e fetus. B. Lum bar epidural block

1. In jection site is in epidu ral space at L3 to L4. 2. Th e block is adm in istered after labo r is estab-

lish ed or just befo re a sch eduled cesarean birth . 3. Th e an esth etic relieves pain from con traction s

an d n um bs th e vagin a an d perin eum . 4. Th e block m ay cause h ypo ten sion , blad der dis-

ten tion , an d a prolon ged secon d stage. 5. Th e an esth etic does n ot cau se a h eadach e

because th e dura m ater is n ot pen etrated. 6. Assess m atern al blood pressure an d assess blad-

der frequen tly. 7. Main tain th e m oth er in a side-lyin g position or

place a rolled blan ket ben eath th e righ t h ip to displace th e uterus from th e ven a cava.

8. Adm in ister in traven ous (IV) fluids as prescribed. 9. In crease fluids as prescribed if h ypoten sion

occurs. 10. O bserve for an y ad verse effects from opioid epi-

durals, such as n ausea an d vom itin g, pruritu s, or respiratory dep ression .

C. In trath ecal opioid an algesics 1. Th e m ed ication is in jected in to th e subarach n oid

space an d h as a rapid on set of action . 2. It m ay be used in com bin ation with a lu m bar

epidu ral block. D. Subarach n oid (spin al) block

1. In jection site is in th e spin al subarach n oid space at L3 to L5.

2. Th e block is adm in istered just before birth . 3. Th e an esth etic relieves uterin e an d perin eal pain

an d n um bs th e vagin a, perin eum , an d lower extrem ities.

4. Th e an esth etic m ay cause m atern al h ypo - ten sion .

5. Th e an esth etic m ay cause postpartum h ead ach e.

M

a

t

e

r

n

i

t

y

339CHAPTER 27 Labor and Birth

6. Th e m oth er m ust lie flat for 8 to 12 h ou rs after spin al in jection .

7. Adm in ister IV flu ids as prescribed . E. Gen eral an esth esia

1. Gen eral an esth esia m ay be used for som e surgical in terven tion s.

2. Th e m oth er is n ot awake.

General anesthesia presents a maternal danger of respiratory depression, vomiting, and aspiration.

VIII. Obstetrical Procedures A. Bish op score ( Table 27-2)

1. Th e Bish op score is used to determ in e m atern al readin ess for labo r an d evaluates cervical status an d fetal position .

2. Th e Bish op score is in dicated befo re th e in du c- tion of labo r.

3. Th e 5 factors are assign ed a score of 0 to 3, an d th e total score is calculated.

4. A score of 6 or m ore in dicates a readin ess for labo r in duction .

B. In duction 1. In duction is a deliberate in itiation of uterin e

con traction s th at stim ulates labor. 2. Elective in ductio n m ay be acco m plish ed by oxy-

tocin in fusio n . 3. O btain a baselin e tracin g of uterin e con traction s

an d FHR. 4. In crease th e IV dosage of oxytocin as prescribed

on ly after assessin g con traction s, FHR, an d m atern al blood pressure an d pulse.

5. Do n ot in crease th e rate of oxytocin wh en th e desired con traction pattern is obtain ed (con trac- tion frequen cy of 2 to 3 m in utes an d lastin g 60 secon ds).

An oxytocin infusion is discontinued if uterine contraction frequency is less than 2 minutes or duration is longer than 90 seconds, or if fetal distress is noted.

C. Am n iotom y 1. Artificial rupture of th e m em bran es is perform ed

by th e HCP or n urse-m idwife to stim ulate labo r. 2. Am n io tom y is perform ed if th e fetus is at 0 or a

plus station . 3. Am n io tom y in creases th e risk of prolapsed cord

an d in fection . 4. Mon itor FHR before an d after am n iotom y. 5. Record tim e of am n iotom y, FHR, an d ch aracter-

istics of th e fluid. 6. Meco n ium -stain ed amniotic fluid m ay be associ-

ated with fetal distress. 7. Bloo dy am n iotic flu id m ay in dicate abruptio pla-

cen tae or fetal traum a. 8. An un p leasan t odor to am n iotic flu id is associ-

ated with in fection . 9. Polyh ydram n ios is associated with m atern al dia-

betes an d certain con gen ital disorders. 10. O ligoh ydram n ios is associated with in trauterin e

growth restriction an d con gen ital disorders. 11. Expect m ore variable deceleration s after rupture

of th e m em bran es as a result of possible cord com pression durin g con traction s.

12. Lim it clien t activity if prescribed. D. Extern al version

1. Extern al version is th e m an ipu lation of th e fetus from an un favorable presen tation in to a favor- able presen tation for birth

2. Extern al version is in dicated for an abn orm al pre- sen tation that exists after th e th irty-fourth week.

3. Mon itor vital sign s. 4. If th e m oth er is Rh -n egative, ensure th at Rh o(D)

im m un e globulin was given at 28 weeks of gestation .

5. Prepare for a n on stress test to evalu ate fetal well- bein g.

6. IV fluids an d tocolytic th erap y m ay be adm in is- tered to relax th e uterus an d perm it easier m an ip- ulatio n of th e fetus.

7. Ultrasoun d is used durin g th e procedure to eval- uate fetal position an d placen tal placem en t an d guide direction of th e fetus.

8. Th e abdom in al wall is m an ipu lated to direct th e fetus in to a ceph alic presen tation if possible.

9. Mon itor blood pressure to iden tify ven a cava com pression .

10. Mon itor for un usual pain . 11. After th e proced ure, do th e followin g:

a . Perform a n on stress test to evalu ate fetal well- bein g.

b . Mon itor for uterin e activity, bleedin g, rup- tured m em bran es, an d decreased fetal activity.

c. With Rh -n egative clien ts, perform Kleih auer- Betke test as prescribed to detect th e presen ce an d am oun t of fetal blood in th e m atern al cir- culation an d to iden tify clien ts wh o n eed addition al Rh o(D) im m un e glob ulin .

M

a

t

e

r

n

i

t

y

TABLE 27-2 Factors of the Bishop Score Score

0 1 2 3

Dilation of cervix (cm)

0 1-2 3-4 > 5

Effacement of cervix (%)

0-30 40-50 60-70 > 80

Consistency of cervix Firm Medium Soft –

Position of cervix Posterior Midposition Anterior –

Station of presenting part

–3 –2 –1 +1, +2

340 UNIT VI Maternity Nursing

E. Episiotom y 1. An episioto m y is an in cision m ade in to th e per-

in eum to en large th e vagin al outlet an d facilitate birth .

2. Th e use of th is procedure h as declin ed dram at- ically in recen t years.

3. Ch eck th e episioto m y site. 4. In stitute m easures to relieve pain . 5. Provide ice packs durin g th e first 24 h ours. 6. In struct th e clien t in th e use of an ice pack for

th e first 24 h ou rs, an d th en sitz bath s th ereafter. 7. Apply an algesic spray or oin tm en t as prescribed . 8. Provide perin eal care, usin g clean tech n iqu e. 9. In struct th e client in th e proper care of th e

in cision . 10. In struct th e clien t to dry th e perin eal area fro m

fron t to back an d to blot th e area rath er th an wipe it.

11. In struct th e clien t to sh ower rath er th an bath e in a tub.

12. Apply a perin eal pad with ou t touch in g th e in side surface of th e pad.

13. Report an y bleed in g or disch arge from th e epi- siotom y site to th e HCP.

F. Forceps delivery 1. Two double-crossed, spoon like articulated blades

are used to assist in th e delivery of th e fetal h ead. 2. Reassure th e m oth er an d exp lain th e n eed for

forceps. 3. Mon itor th e m oth er an d fetus durin g delivery. 4. Ch eck th e n eon ate an d m oth er after delivery for

an y possible in jury. 5. Assist with repair of an y laceration s.

G. Vacu um extraction 1. A cap like suction device is applied to th e fetal

h ead to facilitate extraction . 2. Suction is used to assist in delivery of th e

fetal h ead. 3. Traction is ap plied durin g uterin e con traction s

un til descen t of th e fetal h ead is ach ieved . 4. Th e suction device sh o uld n ot be kept in place

an y lon ger th an 25 m in utes. 5. Mon itor FHR every 5 m in u tes if extern al fetal

m on itorin g is n ot used. 6. Assess infant at birth an d th rough ou t th e postp ar-

tum period for sign s of cerebral traum a. 7. Mon itor for developin g ceph alh em atom a. 8. Cap ut succedan eum is n orm al an d resolves in

24 h ou rs. H. Cesarean delivery

1. Cesarean section is delivery of th e fetus usually th rou gh a tran sabdom in al, lo w-segm en t in cision of th e uterus.

2. Preoperative a. If plan n ed, prepare th e m oth er an d partn er. b . If an em ergen cy, quickly explain th e n eed an d

procedure to th e m oth er an d partn er.

c. O btain in form ed con sen t. d . En su re th at th e preoperative diagn ostic tests

are don e, in cludin g Rh factor determ in ation . e. Prepare to in sert an IV lin e an d an in dwellin g

urin ary cath eter. f. Prepare th e abdom en as prescribed. g. Mon itor th e m oth er an d fetus con tin uo usly. h . Provide em o tion al support. i. Adm in ister preoperative m ed ication s as

prescribed. 3. Posto perative

a. Mon itor vital sign s. b . Perform a fun dal assessm en t; evaluate

in cision . c. Provide pain relief. d . En cou rage turn in g, cough in g, an d deep

breath in g. e. En cou rage am bulation . f. En cou rage bon din g an d attach m en t with

n ewborn . g. Provide psych ological support. h . Mon itor for sign s of in fectio n an d bleedin g. i. Burn in g an d pain on urin ation m ay in dicate a

blad der in fectio n . j. A ten der uterus an d foul-sm ellin g lochia m ay

in dicate en dom etritis. k . A produ ctive cough or ch ills m ay in dicate

pn eum on ia. l. Pain , redn ess, or edem a of an extrem ity m ay

in dicate th rom boph leb itis.

CRITICAL THINKING What Should You Do? Answer: Near or at term, the normal fetal heart rate (FHR) is 110 to 160 beats/ minute. If fetal tachycardia or bradycardia occurs, the nurse should change the position of the mother, administer oxygen, and assess the mother’s vital signs. In addition, the nurse should notify the health care provider as soon as possible. A FHR of 180 in the early first trimester of pregnancy (6 to 8 weeks) may be a normal finding. Later in pregnancy, it would be deemed as tachycardia.

Reference: Lowdermilk, Perry, Cashion, Alden (2016), p. 422.

P R A C T I C E Q U E S T I O N S

269. Th e n urse is carin g for a clien t in labor. Wh ich assessm en t fin din gs in dicate to th e n urse th at th e clien t is begin n in g th e secon d stage of labo r? Select all th at ap p ly.

1. Th e con traction s are regular. 2. Th e m em bran es h ave ru ptured. 3. Th e cervix is dilated com pletely. 4. Th e clien t begin s to exp el clear vagin al fluid. 5. Th e spon tan eous urge to push is in itiated

from perin eal pressure.

M

a

t

e

r

n

i

t

y

341CHAPTER 27 Labor and Birth

M

a

t

e

r

n

i

t

y

270. Th e n urse in th e labor ro om is carin g for a clien t in th e active stage of th e first ph ase of labor. Th e n urse is assessin g th e fetal pattern s an d n otes a late decel- eration on th e m on itor strip. Wh at is th e m o st ap p ro p riate n ursin g action ? 1. Adm in ister oxygen via face m ask. 2. Place th e m oth er in a supin e position . 3. In crease th e rate of th e oxytocin in traven ous

in fusio n . 4. Do cum en t th e fin din gs an d con tin ue to m on i-

tor th e fetal pattern s.

271. Th e n urse is perform in g an assessm en t of a clien t wh o is sch eduled for a cesarean delivery at 39 weeks of gestation . Wh ich assessm en t fin din g in dicates th e n eed to con tact th e h ealth care provider (HCP) ? 1. Hem o glob in of 11 g/ dL ( 110 mmol/L) 2. Fetal h eart rate of 180 beats/ m in ute 3. Matern al pulse rate of 85 beats/ m in u te 4. Wh ite blood cell coun t of 12,000 m m 3

(12.0 Â 109/ L)

272. Th e n urse is reviewin g th e record of a clien t in th e labo r room an d n otes th at th e h ealth care provider h as docum en ted th at th e fetal presen tin g part is at th e –1 station . Th is docum en ted fin din g in dicates th at th e fetal presen tin g part is lo cated at wh ich area? Refer to figu re.

1. 2.

4.

3.

1. 1 2. 2 3. 3 4. 4

273. A clien t arrives at a birth in g cen ter in active labor. Follo win g exam in ation , it is determ in ed th at h er m em bran es are still in tact an d sh e is at a –2 station . Th e h ealth care provider prepares to perform an am n iotom y. Wh at will th e n urse relay to th e clien t as th e m o st likely outcom es of th e am n iotom y? Select all th at ap p ly.

1. Less pressure on h er cervix 2. Decreased n um ber of con traction s 3. In creased efficien cy of con traction s 4. Th e n eed for in creased m atern al blood pres-

sure m on itorin g 5. Th e n eed for frequen t fetal h eart rate m on itor-

in g to detect the presen ce of a prolapsed cord

274. Th e n urse is m on itorin g a clien t in labor. Th e n urse susp ects um bilical cord com pression if wh ich is n oted on th e extern al m on itor tracin g durin g a con traction ? 1. Variability 2. Acceleratio n s 3. Early deceleration s 4. Variable deceleration s

275. A clien t in labor is tran sported to th e delivery room an d prepared for a cesarean delivery. After th e cli- en t is tran sferred to th e delivery ro om tab le, th e n urse sh o uld place th e clien t in wh ich position ? 1. Supin e position with a wedge un der th e

righ t h ip 2. Tren delen burg’s position with th e legs in

stirrups 3. Pron e position with th e legs separated an d

elevated 4. Sem i-Fo wler’s position with a pillow un der

th e kn ees

276. Th e n urse is m on itorin g a clien t in active labor an d n otes that th e clien t is h avin g con traction s every 3 m in utes that last 45 secon ds. Th e n urse n otes th at the fetal h eart rate between con tractions is 100 beats/ m in ute. Which nursin g action is m o st ap p ro p riate? 1. No tify th e h ealth care provider (HCP). 2. Con tin ue m on itorin g th e fetal h eart rate. 3. En cou rage th e clien t to con tin ue push in g with

each con traction . 4. In struct th e clien t’s coach to con tin ue to en cour-

age breath in g tech n iqu es.

277. Th e n urse is carin g for a clien t in labor an d is m on - itorin g th e fetal h eart rate pattern s. Th e n urse n otes th e presen ce of episo dic acceleration s on th e elec- tron ic fetal m on itor tracin g. Wh ich action is m o st ap p ro p riate? 1. No tify th e h ealth care provider of th e fin din gs. 2. Repo sitio n th e m oth er an d ch eck th e m on itor

for ch an ges in th e fetal tracin g. 3. Take th e m oth er’s vital sign s an d tell th e m oth er

th at bed rest is required to con serve oxygen . 4. Docum en t th e fin din gs an d tell th e m oth er th at

th e pattern on th e m on itor in dicates fetal well- bein g.

278. Th e n urse is adm ittin g a pregn an t clien t to th e labo r room an d attach es an extern al electron ic fetal m on itor to th e clien t’s abdom en . After attach m en t of th e electron ic fetal m on itor, wh at is th e n ext n ursin g action ? 1. Iden tify th e typ es of acceleratio n s. 2. Assess th e baselin e fetal h eart rate. 3. Determ in e th e in ten sity of th e con traction s. 4. Determ in e th e frequen cy of th e con traction s.

342 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

279. Th e n urse is reviewin g true an d false labor sign s with a m ultiparous clien t. Th e n urse determ in es th at th e clien t un derstan ds th e sign s of true labor if sh e m akes wh ich statem en t? 1. “I won ’t be in labor un til m y baby drops.” 2. “My con traction s will be felt in m y abdom in al

area.” 3. “My con traction s will n ot be as pain ful if I

walk arou n d.” 4. “My con traction s will in crease in duration an d

in ten sity.”

280. Wh ich assessm en t followin g an am n iotom y sh ould be con ducted first? 1. Cervical dilation 2. Bladder disten tion 3. Fetal h eart rate pattern 4. Matern al blood pressure

281. Th e n urse h as been workin g with a labo rin g clien t an d n otes th at sh e h as been push in g effectively for

1 h our. Wh at is th e clien t’s p rim ary ph ysiolo gical n eed at th is tim e? 1. Am bu lation 2. Rest between con traction s 3. Ch an ge position s frequen tly 4. Con sum e oral food an d fluid s

282. Th e n urse is assistin g a clien t un dergoin g in duction of labor at 41 weeks of gestation . The clien t’s con - traction s are m oderate an d occurrin g every 2 to 3 m in utes, with a duration of 60 secon ds. An in ter- n al fetal h eart rate m on itor is in place. Th e baselin e fetal h eart rate h as been 120 to 122 beats/ m in ute for th e past h our. Wh at is th e p rio rity n ursin g action ? 1. No tify th e h ealth care provider. 2. Discon tin ue th e in fusion of oxytocin . 3. Place oxygen on at 8 to 10 L/ m in ute via

face m ask. 4. Con tact th e clien t’s prim ary supp ort perso n (s) if

n ot curren tly presen t.

A N S W E R S 269. 3, 5 Ra t ion a le: Th e secon d stage of lab or b egin s wh en th e cervix is dilated com p letely an d en d s with b irth of th e n eo n ate. Th e wo m an h as a stro n g u rge to pu sh in stage 2 fro m p erin eal pres- sure. O p tio n s 1, 2, an d 4 are n ot specific assessm en t fin din gs o f th e seco n d stage of lab or an d occu r in stage 1. Test -Ta kin g St r a tegy: Elim in ate op tion s 2 an d 4 first b ecau se th ey are co m p arab le o r alike. Fro m th e rem ain in g op tion s, recallin g th at regular con traction s occur before th e secon d stage of labo r will direct yo u to th e correct o ptio n . Review: Stages o f lab o r Level of Cogn it ive Ability: An alyzin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Reprod uctio n Refer en ce: Lo wderm ilk et al. (2016), p p . 376, 454.

270. 1 Ra t ion a le: Late deceleration s are d ue to u terop lacen tal in suffi- cien cy an d o ccu r because o f decreased blo od flo w an d oxygen to th e fetu s d urin g th e uterin e con traction s. Hyp oxem ia results; oxygen at 8 to 10 L/ m in ute via face m ask is n ecessary. Th e sup in e p osition is avoid ed b ecau se it d ecreases u terin e b lo od flow to th e fetus. Th e clien t sh o uld b e turn ed on to h er sid e to d isp lace p ressure of th e gravid u teru s on th e in ferio r ven a cava. An in traven ou s o xytocin in fusion is d iscon tin u ed wh en a late deceleration is n o ted. Th e o xytocin wo uld cause fu rth er h ypo xem ia b ecause of in creased uterop lacen tal in su fficien cy resultin g from stim ulation of con traction s by th is m edication . Alth o ugh th e n urse wo u ld d o cu m en t th e o ccurren ce, o ptio n 4 wo uld d elay n ecessary treatm en t. Test-Ta kin g Str a tegy: Note th e strategic wo rds, most appropriate. Use the ABCs—airway, b reath in g, an d circu latio n —an d

kn owled ge related to th e sign ifican ce of a late deceleratio n to an swer th is q uestion . Review: Nu rsin g actio n s related to late d eceleratio n s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p . 422.

271. 2 Ra t ion a le: An orm al fetal h eart rate is 110 to 160 beats/m in ute. A fetal h eart rate of 180 beats/ m in ute could in dicate fetal distress an d would warran t im m ediate n otification of th e HCP. By full term , a n orm al m atern al hem oglobin range is 11 – 13 g/dL (110 – 130 m m ol/L) because of th e h em odilution caused by an in crease in plasm a volum e durin g pregn an cy. Th e m atern al pulse rate dur- in g pregn an cy in creases 10 to 15 beats/ m in ute over prepregn an cy readin gs to facilitate in creased cardiac output, oxygen tran sport, an d kidn ey filtration . Wh ite blood cell coun ts in a n orm al preg- n an cy begin to increase in the secon d trim ester an d peak in th e th ird trim ester, with a n orm al ran ge of 11,000 to 15,000 m m 3

(11 to 15 Â 109/ L), up to 18,000 m m 3 (18 Â 109/L). During th e im m ediate postpartum period, th e wh ite blood cell coun t m ay be 25,000 to 30,000 m m 3 (25 to 30 Â 109/ L) because of in creased leukocytosis th at occurs durin g delivery. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, n orm al assess- m en t an d labo rato ry fin din gs an d th o se th at in d icate th e n eed to co n tact th e HCP. Kn o wledge regardin g th e n orm al an d ab n o rm al fin din gs in a p regn an t clien t an d fetu s will direct yo u to th e co rrect o ption . Review: Norm al an d ab n o rm al lab o rato ry fin d in gs an d n o r- m al fetal h eart rate Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis

343CHAPTER 27 Labor and Birth

Con ten t Ar ea : Matern ity—In trapartum Pr ior it y Con cept s: Co llab oration ; Perfusio n Refer en ce: Lo wd erm ilk et al. (2016), pp . 411, 788.

272. 3 Ra tion a le: Statio n is th e m easu rem en t o f th e progress of d escen t in cen tim eters abo ve o r b elo w th e m id p lan e from th e p resen tin g p art to th e isch ial sp in e. It is m easured in cen - tim eters, an d n oted as a n egative n u m b er ab ove th e lin e an d as a po sitive n u m ber below th e lin e. At th e n egative 1 ( –1) sta- tio n , th e fetal p resen tin g p art is 1 cm abo ve th e isch ial sp in e. O ptio n 1 is at th e n egative 5 ( –5) station an d th e fetal presen t- in g p art is 5 cm abo ve th e isch ial spin e. O ption 2 is at th e n eg- ative 2 (–2) statio n an d th e fetal presen tin g p art is 2 cm ab ove th e isch ial sp in e. O ptio n 4 is at th e po sitive 3 (+3) an d th e fetal p resen tin g part is 3 cm b elo w th e isch ial sp in e. Test-Ta kin g Str a tegy: Recallin g th at statio n is m easu red in cen - tim eters an d u ses th e isch ial sp in e as a referen ce po in t will assist in an swerin g th is qu estio n . Fo cu s o n th e d ata in th e q u estio n an d n o te th e locatio n o f th e isch ial sp in e, an d th at th e station s ran ge fro m –5 cm to +5 cm above or below th is referen ce poin t. Review: Statio n s o f th e p resen tin g p art Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—In trapartum Pr ior it y Con cept s: Clin ical Ju dgm en t; Rep ro du ction Refer en ce: Lo wd erm ilk et al. (2016), p. 370.

273. 3, 5 Ra tion a le: Am n io tom y (artificial ru ptu re o f th e m em b ran es) can b e used to in d uce labo r wh en th e co n d ition of th e cervix is favo rab le (ripe) or to au gm en t lab o r if th e p ro gress begin s to slow. Ru ptu rin g o f th e m em b ran es allo ws th e fetal h ead to co n tact th e cervix m o re directly an d m ay in crease th e effi- cien cy o f con traction s. In creased m o n itorin g of m atern al b loo d p ressu re is u n n ecessary fo llo win g th is p ro ced ure. Th e fetal h eart rate n eed s to b e m o n ito red frequ en tly, as th ere is an in creased likelih oo d of a p ro lapsed co rd with ru ptu red m em bran es an d a h igh p resen tin g part. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, most likely. Focus o n th e su b ject, an am n ioto m y. Recallin g th at am n iot- o m y is perform ed to augm en t lab or if th e p ro gress begin s to slo w will d irect yo u to th e co rrect o p tion . Review: Pu rp ose of am n io to m y Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—In trapartum Pr ior it y Con cept s: Clien t Ed ucation ; Reprod u ctio n Refer en ce: Lo wd erm ilk et al. (2016), p. 783.

274. 4 Ra tion a le: Variable d eceleration s occur if th e um b ilical cord b ecom es com pressed , redu cin g blood flow b etween th e placen ta and th e fetu s. Variability refers to fluctuation s in th e b aselin e fetal h eart rate. Acceleration s are a reassurin g sign an d usually o ccur with fetal m ovem en t. Early d eceleration s result fro m p res- sure o n the fetal h ead durin g a con traction . Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, um bilical cord com pressio n . Recallin g th at variable d eceleratio n s o ccu r if

th e u m b ilical cord b ecom es com p ressed will d irect you to th e correct o ptio n . Review: Fin din gs th at o ccu r in u m b ilical co rd co m p ressio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—In trapartu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lowd erm ilk et al. (2016), pp . 421, 423.

275. 1 Ra tion a le: Ven a cava an d descen d in g ao rta com p ression b y th e pregn an t u teru s im p edes b loo d retu rn fro m th e lower tru n k an d extrem ities. Th is lead s to d ecreasin g card iac return , card iac o utp ut, an d bloo d flo w to th e u teru s an d sub seq uen tly th e fetu s. Th e b est p osition to preven t th is wou ld be sid e-lyin g, with th e uterus displaced off th e abdom in al vessels. Position - in g fo r abd om in al su rgery n ecessitates a sup in e po sitio n , h o wever; a wed ge placed u n d er th e righ t h ip provid es d isp lace- m en t o f th e uterus. Tren d elen bu rg’s p osition p laces p ressure fro m th e p regn an t uterus on th e diaph ragm an d lun gs, d ecreas- in g respirato ry cap acity an d oxygen ation . A p ro n e or sem i- Fowler’s po sitio n is n ot p ractical fo r th is typ e o f abd o m in al su rgery. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, p osition in g th e p regn an t wo m an . Visualizin g each of th e po sitio n s iden tified in th e o ptio n s an d con sid erin g th e effect th at th e p o sition m ay h ave o n th e m o th er an d th e fetu s will d irect you to th e correct op tio n . Review: Care for th e m o th er requ irin g cesarean d elivery Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—In trapartu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lowd erm ilk et al. (2016), p. 791.

276. 1 Ra tion a le: A n o rm al fetal h eart rate is 110 to 160 beats/ m in u te, an d th e fetal h eart rate sh ou ld be with in th is ran ge b etween con traction s. Fetal b rad ycard ia b etween co n tractio n s m ay in dicate th e n eed fo r im m ediate m ed ical m an agem en t, an d th e HCP o r n u rse-m id wife n eeds to be n o tified . O p tion s 2, 3, an d 4 are in app ro priate n u rsin g action s in th is situatio n an d d elay n ecessary in terven tion . Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Fo cu s o n th e d ata in th e q u estio n . Kn o wledge th at th e n o rm al fetal h eart rate is 110 to 160 beats/ m in ute will assist you to recogn ize th at fetal bradycard ia is presen t. Review: Expected an d un exp ected fin d in gs d u rin g th e lab o r p ro cess Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—In trapartu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lowd erm ilk et al. (2016), p. 411.

277. 4 Ra tion a le: Acceleratio n s are tran sien t in creases in th e fetal h eart rate th at often accom p an y con traction s o r are caused

M

a

t

e

r

n

i

t

y

344 UNIT VI Maternity Nursing

by fetal m ovem en t. Episod ic acceleratio n s are th ou gh t to b e a sign of fetal well-b ein g an d ad eq uate o xygen reserve. O ptio n s 1, 2, an d 3 are in accu rate n u rsin g action s an d are un n ecessary. Test-Ta kin g Str a tegy: Note th e strategic wo rd s, most appropriate. Option s 1, 2, an d 3 are co m p arab le o r alike in th at th ey in dicate th e n eed for furth er in terven tion . Also, kn owin g th at accelera- tion s in dicate fetal well-bein g will direct you to th e correct option . Review: Th e sign ifican ce of ep iso d ic acceleratio n s Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wderm ilk et al. (2016), p . 420.

278. 2 Ra t ion a le: Assessin g th e b aselin e fetal h eart rate is im p ortan t so th at ab n o rm al variatio n s of th e b aselin e rate can b e id en ti- fied if th ey o ccu r. Th e in ten sity o f con traction s is assessed by an in tern al fetal m on itor, n ot an extern al fetal m on ito r. O ptio n s 1 an d 4 are im p ortan t to assess, bu t n ot as th e first p rio rity. Fetal h eart rate is evaluated by assessin g baselin e an d p erio dic ch an ges. Perio dic ch an ges o ccur in respo n se to th e in term itten t stress of u terin e con traction s an d th e b aselin e beat-to -beat var- iability of th e fetal h eart rate. Test -Ta kin g Str a tegy: No te th e strategic wo rd , next. Use th e ABCs—airway–b reath in g–circu latio n . Fetal h eart rate reflects th e ABCs. Review: Co n cepts related to extern al fetal m o n ito rin g Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wderm ilk et al. (2016), p p . 414-416.

279. 4 Ra t ion a le: Tru e lab or is presen t wh en con traction s in crease in du ratio n an d in ten sity. Ligh ten in g or drop p in g lead s to engage- ment (presen tin g p art reach es th e level o f th e isch ial sp in e) an d occu rs wh en th e fetu s descen ds in to th e p elvis abo u t 2 weeks befo re d elivery. Co n tractio n s felt in th e abd om in al area an d co n tractio n s th at ease with walkin g are sign s of false labo r. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, th e sign s o f true labo r. Notin g th e word true in th e q u estion an d its relation sh ip to th e word s increase in duration and intensity in th e co rrect op tion will d irect yo u to th is o ption . Review: Sign s of tru e an d false lab o r Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Reprod uctio n Refer en ce: Lo wderm ilk et al. (2016), p . 431.

280. 3 Ra t ion a le: Fetal h eart rate is assessed im m ediately after am n ioto m y to d etect an y ch an ges th at m ay in dicate co rd co m - pressio n or pro lapse. Wh en th e m em b ran es are ru ptu red ,

m in im al vagin al exam in atio n s wo u ld be d on e b ecau se of th e risk o f in fectio n . Blad d er d isten tion o r m atern al b lo od pressu re would n ot be th e first th in g to ch eck after an am n iotom y. Test -Ta kin g Str a tegy: No te th e strategic wo rd , first. Becau se o f th e risk of a prolap sed cord after an am n io to m y, th e first action is to ch eck th e fetal h eart rate for sign s o f n o n reassu rin g fetal h eart rate pattern s. Review: Nursin g care fo llo win g am n io to m y Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p . 783.

281. 2 Ra t ion a le: Th e b irth process expen ds a great d eal o f en ergy, p articu larly du rin g th e tran sition stage. En co uragin g rest b etween co n tractio n s con serves m atern al en ergy, facilitatin g vo lu n tary p ush in g efforts with co n tractio n s. Utero placen tal p erfusio n also is en h an ced, wh ich p ro m o tes fetal to leran ce o f th e stress o f lab or. Am b ulation is en cou raged du rin g early labo r. Ice ch ip s sh o uld be p ro vided . Ch an gin g po sitio n s fre- q u en tly is n o t th e p rim ary p h ysio lo gical n eed . Foo d an d fluid s are likely to be with h eld at th is tim e. Test -Ta kin g Str a tegy: Note th e strategic wo rd , primary. Also, n otin g th e words pushing effectively will assist in d irectin g yo u to th e co rrect o p tion . Review: Care fo r th e clien t in th e tran sitio n stage o f lab o r Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Rep rod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 386, 405.

282. 2 Ra t ion a le: Th e prio rity n ursin g actio n is to sto p th e in fusion o f o xyto cin . O xytocin can cause fo rcefu l u terin e co n tractio n s an d d ecrease o xygen atio n to th e placen ta, resu ltin g in decreased variability. After sto pp in g th e o xytocin , th e n urse sh ou ld rep o - sition th e lab o rin g m o th er. No tifyin g th e h ealth care p ro vider, ap plyin g oxygen , an d in creasin g th e rate o f th e in traven o us (IV) fluid (th e so lu tion with o ut th e o xytocin ) are also action s th at are in dicated in th is situ ation , bu t n ot th e prio rity actio n . Con tactin g th e clien t’s prim ary sup po rt person (s) is n ot th e p riority action at th is tim e. Test -Ta kin g St r a tegy: Focus o n th e strategic wo rd , priority. Fo cu s o n th e d ata in th e q uestion an d n ote th e relation sh ip o f th e wo rds undergoing induction an d th e co rrect o ptio n . Also recall th at ph ysio logical n eeds are prioritized o ver psych o social n eed s. Review: Care to th e clien t receivin g o xyto cin Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p . 784.

M

a

t

e

r

n

i

t

y

345CHAPTER 27 Labor and Birth

C H A P T E R 28 Problems with Labor and Birth

PRIORITY CONCEPTS Reproduction, Safety

CRITICAL THINKING What Should You Do? The nurse is caring for a pregnant client in labor who sud- denly experiences a hypotensive episode. What should the nurse do? Answer located on p. 351.

I. Premature Rupture of the Membranes A. Description

1. Prem atu re rupture of th e m em bran es refers to spon tan eous rupture of th e am n iotic m em - bran es before th e on set of labor.

2. Gestation al age usually determ in es th e plan an d in terven tion .

3. Wh en th e rupture of m em bran es is before term an d birth will be delayed, in fection becom es a risk.

B. Assessm en t 1. Presen ce of fluid poolin g in vagin al vault; n itra-

zin e test is positive. 2. Am ou n t, color, con sisten cy, an d odor of fluid

n eed to be assessed . 3. Vital sign s are m on itored; an elevated tem p era-

ture m ay in dicate in fectio n . 4. Fetal m on itorin g is n ecessary; tach ycardia in th e

fetus m ay in dicate m atern al in fectio n . C. In terven tion s

1. Assist with tests to assess gestation al age. 2. Avoid vagin al exam in ation s because of th e risk of

in fectio n . 3. Mon itor m atern al an d fetal status for sign s of

com pro m ise or in fectio n . 4. Adm in ister an tibiotics as prescribed.

II. Prolapsed Umbilical Cord A. Description : Th e um b ilical cord is displaced between

th e presen tin g part an d th e am n ion or protrudin g th rou gh th e cervix, causin g com pression of th e cord an d co m prom isin g fetal circulation ( Fig. 28-1).

B. Assessm en t 1. Th e clien t h as a feelin g th at som eth in g is com in g

th rou gh th e vagina. 2. Um b ilical cord is visible or palpable. 3. Fetal h eart rate is irregular an d slow. 4. Fetal h eart m on itor sh ows variable deceleration s

or bradycardia after rupture of th e m em bran es. 5. If fetal h ypoxia is severe, violen t fetal activity m ay

occur an d th en cease. C. In terven tion s (see Priority Nursin g Action s)

III. Placenta Previa A. Descrip tion

1. Placen ta previa is an im properly im plan ted pla- centa in th e lower uterin e segm en t n ear or over th e in tern al cervical os (Fig. 28-2).

2. Total (com plete): Th e in tern al cervical os is cov- ered en tirely by th e placen ta wh en th e cervix is dilated fully.

3. Partial: Th e lo wer border of th e placen ta is with in 3 cm of th e in tern al cervical os, but does n ot fully cover it.

4. Margin al (low-lyin g): Th e placen ta is im plan ted in th e lo wer uterus, but its lo wer border is m ore th an 3 cm from th e in tern al cervical os.

5. Man agem en t dep en ds on th e classification of th e placen ta previa an d gestation al age of th e fetus.

B. Assessm en t 1. Sudden onset of pain less, brigh t red vagin al bleed-

in g occurs in th e last h alf of pregn an cy. 2. Uterus is soft, relaxed, an d n on ten d er. 3. Fun dal h eigh t m ay be m ore th an expected for

gestation al age. C. In terven tion s

1. Mon itor m atern al vital sign s, fetal h eart rate, an d fetal activity.

2. Prepare for ultraso un d to con firm th e diagn osis. 3. Vagin al exam in ation s or an y oth er action s th at

would stim ulate uterin e activity are avoided. 4. Main tain bed rest in a side-lyin g position as

prescribed.

M

a

t

e

r

n

i

t

y

346

PRIORITY NURSING ACTIONS Umbilical Cord Prolapse 1. Elevate the fetal presenting part that is lying on the cord by

applying finger pressure with a gloved hand. 2. Place the client into extreme Trendelenburg or modified

Sims’ position or a knee-chest position. 3. Administer oxygen, 8 to 10 L/ minute, by face mask to the

client. 4. Monitor fetal heart rate and assess the fetus for hypoxia. 5. Prepare to start intravenous fluids or increase the rate of

administration of an existing solution. 6. Prepare for immediate birth. 7. Document the event, actions taken, and the client’s

response.

If umbilical cord prolapse occurs, the cord is lying alongside or below the presenting part of the fetus and can be seen or felt in or protruding from the vagina. The nurse stays with the client and asks another nurse to call the health care provider imme- diately. The nurse must relieve cord pressure immediately so that the fetus receives adequate oxygenation. The nurse can

relieve cord pressure by elevating the fetal presenting part that is lying on the cord; the nurse does this by quickly gloving the hand and inserting 2 fingers into the vagina to the cervix and exerting upward pressure on the presenting part. The nurse also relieves cord pressure by placing the client into an extreme Trendelenburg or modified Sims’ position or a knee-chest posi- tion (a rolled towel is placed under the client’s hip). The nurse administers oxygen, 8 to 10 L/ minute, by face mask to the cli- ent, monitors the fetal heart rate and fetal heart rate patterns, and assesses the fetus for hypoxia. The client is prepared for immediate birth (vaginal or cesarean). The nurse documents the event, actions taken, the client’s response, and any addi- tional pertinent information. The nurse never attempts to push the cord into the uterus. If the umbilical cord is protruding from the vagina, the cord is wrapped loosely in a sterile towel satu- rated with warm sterile normal saline.

Reference Lowdermilk et al. (2016), pp. 797–798.

A B C D FIGURE 28-1 Prolapse of umbilical cord. Note the pressure of the presenting part on the umbilical cord, which endangers fetal circulation. A, Occult (hidden) prolapse of cord. B, Complete prolapse of cord. Membranes are intact. C, Cord presenting in front of the fetal head may be seen in the vagina. D, Frank breech presentation with prolapsed cord.

A B C

P la ce nta is impla nte d in lowe r ute rus but its lowe r borde r is >3 cm

from inte rna l ce rvica l os .

Ma rgina l

Lowe r borde r of pla ce nta is within 3 cm of inte rna l

ce rvica l os but doe s not fully cove r it.

P a rtia l

P la ce nta comple te ly cove rs inte rna l ce rvica l os .

Tota l

FIGURE 28-2 Three classifications of placenta previa.

347CHAPTER 28 Problems with Labor and Birth

M

a

t

e

r

n

i

t

y

5. Mon itor am oun t of bleedin g (treat sign s of sh ock).

6. Adm in ister in traven ous (IV) fluid s, blood prod- ucts, or tocolytic m edication s as prescribed; Rh o(D) im m un e globulin m ay be prescribed.

7. If bleedin g is h eavy, a cesarean delivery m ay be perform ed.

Vaginal exams are contraindicated if the client is suspected of having or has a known placenta previa.

IV. Abruptio Placentae A. Description : Prem atu re sep aration of th e placen ta

from th e uterin e wall after th e twen tieth week of ges- tatio n an d befo re th e fetus is delivered (Fig. 28-3)

B. Assessm en t 1. Dark red vagin al bleedin g. If th e bleed in g is h igh

in th e uterus or is m in im al, th ere can be an absen ce of visible blood.

2. Uterin e pain or ten dern ess or both 3. Uterin e rigidity 4. Severe abdom in al pain 5. Sign s of fetal distress 6. Sign s of m atern al sh ock if bleedin g is excessive

C. In terven tion s 1. Mon itor m atern al vital sign s an d fetal h eart rate. 2. Assess for excessive vagin al bleed in g, abdom in al

pain , an d an in crease in fun dal h eigh t. 3. Main tain bed rest; adm in ister oxygen , IV fluid s,

an d blood produ cts as prescribed. 4. Place th e clien t in Tren delen burg position if

in dicated to decrease th e pressure of th e fetus on th e placen ta, or place in th e lateral position with th e h ead of th e bed flat if h ypovo lem ic sh ock occurs.

5. Mon itor an d report an y uterin e activity. 6. Prepare for delivery of th e fetus as quickly as pos-

sible, with vagin al delivery preferable if th e fetus is h ealth y an d stable an d th e presen tin g part is in th e pelvis; em ergen cy cesarean delivery is per- form ed if th e fetus is alive but sh ows sign s of distress.

7. Mon itor for sign s of dissem in ated in travascular coagulation in th e postpartu m period.

Know the differences between placenta previa and abruptio placentae. In placenta previa, there is painless, bright red vaginal bleeding, and the uterus is soft, relaxed, and nontender. In abruptio placentae, there is dark red vaginal bleeding, uterine pain or tenderness or both, and uterine rigidity.

V. Supine Hypotension (Vena Cava Syndrome) A. Description

1. Supin e h ypo ten sion (also kn own as ven a cava syn d rom e) occurs wh en th e ven o us return to th e h eart is im paired by th e weigh t of th e uterus on th e ven a cava.

2. Th e syn d rom e results in partial occlusion of th e ven a cava an d ao rta an d in reduced cardiac return , cardiac output, an d blood pressure.

B. Assessm en t 1. Pallor 2. Fain tn ess, dizzin ess, breath lessn ess 3. Tach ycardia, h ypo ten sion 4. Sweatin g, cool an d dam p skin 5. Fetal distress

C. In terven tion s 1. Position th e client on h er side to sh ift the weigh t of

th e fetus off th e vena cava un til th e clien t’s sign s an d sym ptom s subside an d vital sign s stabilize.

2. Mon itor vital sign s an d fetal h eart rate.

To prevent supine hypotension, avoid the supine position; position the client by placing a pillow or wedge under the client’s hip to displace the gravid uterus off the vena cava.

VI. Placental Abnormalities A. Descrip tion : Placenta accreta is an abn orm ally

adh eren t placen ta; placen ta in creta occurs wh en th e placen ta pen etrates th e uterin e m uscle itself; pla- cen ta percreta occurs wh en th e placen ta go es all th e way th rou gh th e uterus.

A

B C

Ma rgina l a bruption with e xte rna l ble e ding

Pa rtia l a bruption with conce a le d ble e ding

Comple te a bruption with conce a le d ble e ding

FIGURE 28-3 Types of abruptio placentae.

348 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

B. Assessm en t: May cause h em orrh age im m ediately after birth because the placen ta does n ot separate clean ly

C. In terven tion 1. Mon itor for h em orrh age an d sh ock. 2. Prepare th e clien t for a h ysterectom y if a

large portion of th e placen ta is abn o rm ally ad h eren t.

VII. Preterm Labor A. Description

1. Preterm labo r occurs after th e twen tieth week but befo re th e th irty-seven th week of gestation .

2. Risk factors in clude a h isto ry of m ed ical con d i- tio n s; presen t an d past obstetric problem s; in fec- tio n ; an d social an d en viron m en tal factors, in cludin g substan ce ab use.

3. Addition al risk facto rs in clude a m ultifetal preg- n an cy, wh ich con tributes to overdisten tion of th e uterus; an em ia, wh ich decreases oxygen sup- ply to th e uterus; an d age youn ger th an 18 years or first pregn an cy an d age older th an 40 years.

B. Assessm en t 1. Uterin e con traction s (pain ful or pain less) 2. Abdo m in al cram p in g (m ay be acco m pan ied by

diarrh ea) 3. Low back pain 4. Pelvic pressure or h eavin ess 5. Ch an ge in ch aracter an d am oun t of usual dis-

ch arge—m ay be th icker or th in n er, blood y, brown or colorless, odoro us

6. Ruptu re of am n iotic m em bran es 7. Presen ce of fetal fibron ectin in cervical can al 8. Sh o rten in g of cervical len gth

C. In terven tion s 1. Focus on stopp in g th e labo r: Iden tify an d treat

in fectio n , restrict activity, an d en sure h ydration . 2. Main tain bed rest an d a lateral position . 3. Mon itor fetal status. 4. Adm in ister fluids. 5. Adm in ister m ed ication s as prescribed an d m on -

ito r for side effects of tocolytics (see Table 32-1 for a description of m edication s used to treat preterm labor).

6. Use of 17 alph a-h ydroxyprogesteron e caproate kn own as 17P in jection to decrease risk of pre- term delivery.

VIII. Precipitous Labor and Delivery A. Description : Labor lastin g less th an 3 h ou rs B. In terven tion s

1. Have a precipitou s delivery tray available (h em o- stats, scissors, an d cord clam p ).

2. Stay with th e clien t at all tim es. 3. Provide em otion al supp ort an d keep th e

clien t calm . 4. En cou rage th e clien t to pan t between

con traction s.

5. Prepare for ru pturin g m em bran es wh en th e h ead cro wn s, if th ey are n ot already ruptured.

6. Do n ot try to preven t th e fetus from bein g delivered.

7. If delivery is n ecessary befo re th e arrival of th e h ealth care provider, do th e followin g: a. Apply gen tle pressure to th e fetal h ead

upward toward th e vagin a to preven t dam age to th e fetal h ead an d vagin al laceration s; sup- port th e perin eal area. Both action s con stitute th e Ritgen m an euver.

b . Supp ort th e in fan t’s body durin g delivery. c. Deliver th e infant between con traction s,

ch eckin g for th e cord arou n d th e n eck. d . Use restitution to deliver th e posterior

sh oulder. e. Use gen tle down ward pressure to m ove

th e an terior sh oulder un der th e pubic sym ph ysis.

f. Bulb suction th e in fan t’s m ou th first an d th en suction each n aris.

g. Dry an d cover th e in fan t to keep th e body warm .

h . Allow th e placen ta to sep arate n aturally. i. Place th e in fan t on th e m oth er’s ab dom en or

breast to in duce uterin e con traction s.

IX. Dystocia A. Description

1. Dysto cia is difficu lt labor th at is prolon ged or m ore pain ful.

2. O ccurs because of problem s cau sed by uterin e con traction s, th e fetus, or th e bon es an d tissues of th e m atern al pelvis.

3. Th e fetus m ay be excessively large, m alposi- tion ed, or in an abn o rm al presen tation .

4. Con traction s m ay be h ypoton ic or h yperton ic. 5. Hypo ton ic con traction s are sh ort, irregular, an d

weak; am n iotom y an d oxytocin in fusion m ay be treatm en t m easures.

6. Hyperton ic con traction s are pain ful, occur fre- quen tly, an d are un co ordin ated; treatm en t dep en ds on th e cause an d in cludes pain relief m easu res an d rest.

7. Can result in m atern al deh ydration , in fectio n , fetal in ju ry, or death .

B. Assessm en t 1. Excessive abdom in al pain 2. Abn orm al con traction pattern 3. Fetal distress 4. Matern al or fetal tach ycardia 5. Lack of progress in labor

C. In terven tion s 1. Assess fetal h eart rate; m on itor for fetal distress. 2. Mon itor uterin e con traction s. 3. Mon itor m atern al tem p erature an d h eart rate. 4. Assist with pelvic exam in ation , m easurem en ts,

ultraso un d, an d oth er procedures.

349CHAPTER 28 Problems with Labor and Birth

M

a

t

e

r

n

i

t

y

5. Adm in ister proph ylactic an tibiotics as prescribed to preven t in fectio n .

6. Adm in ister IV flu ids as prescribed . 7. Mon itor in take an d output. 8. Main tain h ydration . 9. In struct th e clien t in breath in g tech n iqu es an d

relaxation exercises. 10. Perform fetal m on itorin g if oxytocin is pre-

scrib ed for h ypoton ic uterin e con traction s (oxy- tocin is n ot prescribed for h yperton ic uterin e con traction s) .

11. Mon itor color of amniotic fluid. 12. Provide rest an d com fo rt as with a n orm al deliv-

ery, such as back rubs an d position ch an ges. 13. Assess clien t’s fatigue an d pain , an d adm in ister

sed atives an d pain m ed ication s as prescribed. 14. Assess for prolapse of th e cord after m em bran es

rupture.

X. Amniotic Fluid Embolism A. Description

1. Am n iotic flu id em bolism is th e escape of am n i- otic flu id in to th e m atern al circulation .

2. Th e debris-co n tain in g am n iotic fluid deposits in th e pulm o n ary arterioles an d is usually fatal to th e m oth er.

B. Assessm en t 1. Abrupt on set of respiratory distress an d

ch est pain 2. Cyan osis 3. Fetal bradycardia an d distress if delivery h as n ot

occurred at th e tim e of th e em bolism C. In terven tion s

1. In stitute em ergen cy m easu res to m ain tain life. 2. Adm in ister oxygen , 8 to 10 L/ m in ute, by face

m ask or resuscitation bag deliverin g 100% oxygen .

3. Prepare for in tub ation an d m ech an ical ven tilation .

4. Position th e clien t on h er side. 5. Adm in ister IV flu ids, blood products, an d m ed i-

cation s to correct coagulation failure. 6. Mon itor fetal status. 7. Prepare for em ergen cy delivery wh en th e clien t is

stabilized. 8. Provide em o tion al support to th e clien t, partn er,

an d fam ily.

XI. Fetal Distress A. Assessm en t

1. Fetal h eart rate less th an 110 beats/ m in ute or greater th an 160 beats/ m in u te

2. Meco n ium -stain ed am n iotic fluid 3. Fetal h ypo activity or h yperactivity 4. Progressive decrease in baselin e variability 5. Severe variable deceleration s 6. Late deceleration s

B. In terven tion s 1. Discon tin ue oxytocin if in fusin g. 2. Place th e clien t in a lateral position . 3. Adm in ister oxygen , 8 to 10 L/ m in ute, via face

m ask. 4. Mon itor m atern al an d fetal status.

In the event of fetal distress, prepare the client for emergency cesarean delivery.

XII. Intrauterine Fetal Demise A. Assessm en t

1. Loss of fetal m ovem en t 2. Absen ce of fetal h eart ton es 3. Dissem in ated in travascular coagulation (DIC)

screen (m on ito r for coagulation abn o rm alities because DIC is a com plication related to in tra- uterin e fetal dem ise)

4. Low h em oglob in an d h em atocrit; lo w platelet coun t; prolon ged bleedin g an d clottin g tim e

5. Bleedin g from pun cture sites (cou ld in dicate DIC)

B. In terven tion s 1. En cou rage th e clien t an d h er fam ily to verbalize

feelin gs; provide em otion al supp ort. 2. In corporate religious an d cultural h ealth care

beliefs an d practices in th e plan of care. 3. Allow th e clien t ch oices relatin g to labor an d

delivery. 4. Adm in ister IV flu ids, m edication s, an d blood

an d blood produ cts as prescribed if DIC occurs.

XIII. Rupture of the Uterus A. Descrip tion

1. Com p lete or in com plete sep aration of th e uter- in e tissue as a result of a tear in th e wall of th e uterus fro m th e stress of labor

2. Com p lete: Direct com m un ication between th e uterin e an d periton eal cavities

3. In com p lete: Ru pture in to th e periton eum coverin g th e uterus, but n ot in to th e periton eal cavity

4. Man ifestation s vary with th e degree of ru pture. 5. Risk facto rs: Labor after previous cesarean sec-

tion , overdisten ded uterus (e.g., m ultiple fetuses or h ydram n ios) after cesarean section , abdom i- n al traum a

B. Assessm en t 1. Abdo m in al pain or ten dern ess 2. Ch est pain 3. Con traction s m ay stop or fail to progress 4. Rigid abdom en 5. Absen t fetal h eart rate 6. Sign s of m atern al sh ock 7. Fetus palpated outsid e th e uterus (com plete

rupture)

350 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

C. In terven tion s 1. Mon itor for an d treat sign s of sh ock (adm in ister

oxygen , IV fluids, an d blood produ cts). 2. Prepare clien t for cesarean delivery (possible h ys-

terecto m y m ay be n ecessary). 3. Provide em otion al supp ort for th e clien t an d

partn er.

XIV. Uterine Inversion A. Description

1. Uterus com pletely or partly turn s in side out. 2. Th is can occur durin g delivery or after delivery of

th e placenta. 3. Risk factors: Fun dal im plan tation of th e pla-

cen ta, m an u al extraction of th e placen ta, sh ort um b ilical co rd, uterin e aton y, leiom yom as, an d ab n orm ally ad h eren t placen tal tissue

B. Assessm en t 1. A depression in th e fun dal area of th e uterus

is n oted. 2. Th e in terior of th e uterus m ay be seen th rough

th e cervix or protrudin g th rough th e vagina. 3. Th e clien t h as severe pain . 4. Hem o rrh age is eviden t. 5. Th e clien t sh o ws sign s of sh ock.

C. In terven tion s 1. Mon itor for h em orrh age an d sign s of sh ock, an d

treat sh o ck. 2. Prepare th e clien t for a return of th e uterus to th e

correct position via th e vagin a; if un successful, laparotom y with replacem en t to th e correct posi- tio n is don e.

CRITICAL THINKING What Should You Do? Answer If a pregnant client experiences a hypotensive epi- sode, the nurse should position the client on her side to shift the weight of the fetus off the vena cava until the client’s signs and symptoms subside, and should monitor vital signs until stable. The nurse should also monitor the fetal heart rate. To reposition the client, a pillow or wedge should be placed under the client’s hip to displace the gravid uterus off the vena cava, and the supine position should be avoided.

Reference: Lowdermilk et al. (20 16), pp. 313, 40 0.

P R A C T I C E Q U E S T I O N S

283. Th e n urse is assessin g a pregn an t client in th e secon d trim ester of pregn an cy wh o was adm itted to the m atern ity un it with a suspected diagn osis of abruptio placen tae. Wh ich assessm ent fin din g should the n urse expect to n ote if th is con dition is present? 1. Soft abdom en 2. Uterin e ten dern ess 3. Absen ce of abdom in al pain 4. Pain less, brigh t red vagin al bleed in g

284. Th e m atern ity n u rse is p rep arin g fo r th e ad m is- sio n o f a clien t in th e th ird trim ester o f p reg- n an cy wh o is exp erien cin g vagin al b leed in g an d h as a su sp ected d iagn o sis o f p lacen ta p re- via. Th e n u rse reviews th e h ealth care p ro vid er’s p rescrip tio n s an d sh o u ld q u estio n wh ich p rescrip tio n ? 1. Prepare th e clien t for an ultrasoun d. 2. O btain equip m en t for a m an u al pelvic

exam in ation . 3. Prepare to draw a h em oglobin an d h em atocrit

blood sam ple. 4. O btain equipm en t for extern al electron ic fetal

h eart rate m on itorin g.

285. An ultrasoun d is perform ed on a clien t at term ges- tatio n wh o is experien cin g m oderate vagin al bleed- in g. Th e results of th e ultraso un d in dicate th at ab ruptio placen tae is presen t. O n th e basis of th ese fin din gs, th e n urse sh ould prepare th e clien t for wh ich an ticip ated prescription ? 1. Delivery of th e fetus 2. Strict m on itorin g of in take an d output 3. Com plete bed rest for th e rem ain der of th e

pregn an cy 4. Th e n eed for weekly m on itorin g of coagulation

studies un til th e tim e of delivery

286. Th e n urse is perform in g an assessm en t on a clien t wh o h as just been told th at a pregn an cy test is pos- itive. Wh ich assessm en t fin din g in dicates th at th e clien t is at risk for preterm labor? 1. Th e clien t is a 35-year-o ld prim igravida. 2. Th e clien t h as a h isto ry of cardiac disease. 3. Th e clien t’s h em oglob in level is 13.5 g/ dL

(135 m m ol/ L) . 4. Th e clien t is a 20-year-o ld prim igravida of aver-

age weigh t an d h eigh t.

287. Th e n urse is m on itorin g a clien t wh o is in th e active stage of labo r. Th e n urse docum en ts th at th e clien t is exp erien cin g labor dystocia. Th e n urse deter- m in es th at wh ich risk factors in th e clien t’s h isto ry placed h er at risk for th is com plication ? Select all th at ap p ly.

1. Age 54 2. Bod y m ass in dex of 28 3. Previous difficulty with fertility 4. Adm in istration of oxytocin for in du ction 5. Potassium level of 3.6 m Eq/ L (3.6 m m o l/ L)

288. Th e n urse in a birth in g room is m on itorin g a clien t with dysfun ction al labor for sign s of fetal or m ater- n al com prom ise. Wh ich assessm en t fin din g sh ould alert th e n urse to a com pro m ise? 1. Matern al fatigue 2. Coordin ated uterin e co n traction s

351CHAPTER 28 Problems with Labor and Birth

M

a

t

e

r

n

i

t

y

3. Progressive ch an ges in th e cervix 4. Persisten t n on reassurin g fetal h eart rate

289. Th e n urse in a labor ro om is preparin g to care for a clien t with h yperton ic uterin e con traction s. Th e n urse is told th at th e clien t is experien cin g un coor- din ated con traction s th at are erratic in th eir fre- quen cy, duration , an d in ten sity. Wh at is th e p rio rity n ursin g action ? 1. Provide pain relief m easu res. 2. Prepare th e clien t for an am n iotom y. 3. Prom o te am bulation every 30 m in utes. 4. Mon itor th e oxytocin in fusion closely.

290. Th e n urse is reviewin g th e h ealth care provid er’s (HCP’s) prescription s for a clien t ad m itted for pre- m ature rupture of th e m em bran es. Gestation al age of th e fetus is determ in ed to be 37 weeks. Wh ich prescription sh o uld th e n urse question ? 1. Mon itor fetal h eart rate con tin uously. 2. Mon itor m atern al vital sign s frequen tly. 3. Perform a vagin al exam in ation every sh ift. 4. Adm in ister an an tibiotic per HCP prescription

an d per agen cy protoco l.

291. Th e n urse h as created a plan of care for a clien t exp erien cin g dystocia an d in cludes several n ursin g action s in th e plan of care. Wh at is th e p rio rity n ursin g action ? 1. Providin g com fo rt m easu res 2. Mon itorin g th e fetal h eart rate 3. Ch an gin g th e clien t’s position frequen tly 4. Keepin g th e sign ifican t oth er in form ed of th e

progress of th e labor

292. Fetal distress is occurrin g with a laborin g clien t. As th e n urse prepares th e clien t for a cesarean birth , wh at is th e m o st im p o rtan t n ursin g action ? 1. Slo w th e in traven o us flow rate. 2. Con tin ue th e oxytocin drip if in fusin g.

3. Place th e clien t in a h igh Fowler’s position . 4. Adm in ister oxygen , 8 to 10 L/ m in ute, via face

m ask.

293. Th e n urse in th e postpartum un it is carin g for a cli- en t wh o h as just delivered a n ewborn in fan t fol- lowin g a pregn an cy with placen ta previa. Th e n urse reviews th e plan of care an d prepares to m on - itor th e clien t for wh ich risk associated with pla- cen ta previa? 1. In fection 2. Hem orrh age 3. Ch ron ic h yperten sion 4. Dissem in ated in travascu lar coagu lation

294. Th e n urse is perform in g an assessm en t on a clien t diagn osed with placen ta previa. Wh ich assessm en t fin din gs sh ould th e n urse exp ect to n ote? Select all th at ap p ly.

1. Uterin e rigidity 2. Uterin e ten dern ess 3. Severe abdom in al pain 4. Brigh t red vagin al bleedin g 5. Soft, relaxed, n on ten d er uterus 6. Fun dal h eigh t m ay be greater th an exp ected

for gestation al age

295. Th e n urse in a labo r ro om is perform in g a vagin al assessm en t on a pregn an t clien t in labor. Th e n urse n otes th e presen ce of th e um b ilical co rd protrudin g from th e vagin a. Wh at is th e first n ursin g action with th is fin din g? 1. Gen tly push th e cord in to th e vagin a. 2. Place th e clien t in Tren delen burg position . 3. Fin d th e closest telep h on e an d page th e h ealth

care provid er stat. 4. Call th e delivery ro om to n otify th e staff th at th e

clien t will be tran spo rted im m ediately.

A N S W E R S 283. 2 Ra tion a le: Abruptio placen tae is th e prem ature separation of th e p lacen ta from th e u terin e wall after th e twen tieth week o f gestatio n an d befo re th e fetus is d elivered . In ab ru ptio p la- cen tae, acute ab do m in al p ain is p resen t. Uterin e ten d ern ess acco m p an ies p lacen tal abrup tio n , esp ecially with a cen tral ab ru ptio n an d trap ped blo od b eh in d th e p lacen ta. Th e ab do - m en feels h ard an d bo ard like o n p alpatio n as th e b lo od p en - etrates th e m yo m etriu m an d cau ses u terin e irritability. A so ft ab do m en an d p ain less, b righ t red vagin al bleedin g in th e sec- o n d or th ird trim ester o f p regn an cy are sign s of placen ta p revia. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, abruptio placen - tae. Rem em ber th at th e d ifferen ce b etween p lacen ta previa

an d abru ptio p lacen tae in vo lves th e p resen ce of uterin e p ain an d ten d ern ess with abrup tio placen tae, as op p osed to p ain less b leed in g with p lacen ta p revia. Review: Sign s o f ab ru p tio p lacen tae Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—In trapartu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lowd erm ilk et al. (2016), p. 683.

284. 2 Ra tion a le: Placen ta p revia is an im pro perly im p lan ted p la- cen ta in th e lo wer u terin e segm en t n ear or o ver th e in tern al cer- vical o s. Man u al p elvic exam in ation s are co n train d icated wh en

352 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

vagin al bleed in g is apparen t u n til a d iagn osis is m ade and pla- cen ta p revia is ruled out. Digital exam in ation of th e cervix can lead to h em orrh age. A diagn osis o f p lacen ta p revia is m ade b y ultrasoun d. Th e h em oglobin an d h em atocrit levels are m o ni- tored, and extern al electron ic fetal h eart rate m on itorin g is in iti- ated. Electron ic fetal m o nitorin g (extern al) is crucial in evalu atin g th e status o f th e fetu s, wh o is at risk fo r severe h yp oxia. Test -Ta kin g Str a tegy: Focu s on th e su b ject, n u rsin g care o f th e clien t with p lacen ta p revia. Use kn o wledge of th e path o ph ysi- olo gy associated with placen ta previa. No te th e words question which prescription in th e even t qu ery. Also , n ote th at th e co rrect op tion is th e on ly p ro ced u re th at is in vasive to th e p regn an cy an d en dan gers th e p h ysio lo gical safety of th e clien t an d th e fetus. Review: Care o f th e clien t with p lacen ta p revia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Collabo ratio n ; Safety Refer en ce: Lo wderm ilk et al. (2016), p p . 680-682.

285. 1 Ra t ion a le: Abruptio placen tae is th e p rem ature separation of th e p lacen ta fro m th e uterin e wall after th e twen tieth week of gestatio n an d befo re th e fetus is delivered . Th e go al o f m an - agem en t in abrup tio placen tae is to con tro l th e h em o rrh age an d d eliver th e fetu s as so on as po ssib le. Delivery is th e treat- m en t of ch oice if th e fetus is at term gestation o r if th e b leed in g is m o derate to severe an d th e clien t o r fetus is in jeo pardy. Becau se delivery o f th e fetu s is n ecessary, op tio n s 2, 3, an d 4 are in co rrect regard in g m an agem en t of a clien t with ab ru ptio placen tae. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, m an agem en t of ab ru p tio placen tae. Use kn o wledge regard in g th e m an agem en t of ab ru ptio p lacen tae to an swer th e q uestion . No te th e words term gestation an d moderate vaginal bleeding. Kn owin g th at th e go al is to d eliver th e fetus will direct yo u easily to th e co rrect op tion . Review: Nu rsin g m an agem en t of ab ru p tio p lacen tae Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con ten t Ar ea : Critical Care: Em ergen cy Situation s/ Man agem en t Pr ior ity Con cepts: Perfusio n ; Safety Refer en ce: Lo wderm ilk et al. (2016), p p . 682-684.

286. 2 Ra t ion a le: Preterm labo r o ccu rs after th e twen tieth week b ut befo re th e th irty-seven th week o f gestation . Several facto rs are associated with preterm lab or, in clud in g a h istory o f m ed- ical co n dition s, presen t an d past o bstetric prob lem s, so cial an d en viron m en tal factors, an d su bstan ce abu se. O th er risk facto rs in clud e a m ultifetal p regn an cy, wh ich con trib u tes to o verd is- ten tio n o f th e u terus; an em ia, wh ich d ecreases o xygen su pp ly to th e u terus; an d age yo un ger th an 18 years o r first p regn an cy at age o lder th an 40 years. Test -Ta kin g St r a tegy: O p tio n s 1, 3, an d 4 are co m p arab le o r alike an d are average an d n orm al fin d in gs. Also n o te th at th e

co rrect o ptio n is th e on ly o ptio n th at iden tifies an ab n o rm al co n d ition . Review: Risk facto rs fo r p reterm lab o r Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 760-761.

287. 1, 2, 3 Ra t ion a le: Risk facto rs th at in crease a wo m an ’s risk fo r d ys- fu n ctio n al lab o r in clu d e th e fo llo win g: ad van ced m atern al age, b ein g o verweigh t, electro lyte im b alan ces, p revio u s d iffi- cu lty with fertility, u terin e o verstim u latio n with o xyto cin , sh o rt statu re, p rio r versio n , m ascu lin e ch aracteristics, u terin e ab n o rm alities, m alp resen tatio n s an d p o sitio n o f th e fetu s, cep h alo p elvic d isp ro p o rtio n , m atern al fatigu e, d eh y- d ratio n , fear, ad m in istratio n o f an an algesic early in lab o r, an d u se o f ep id u ral an algesia. Age 54 is co n sid ered ad van ced m atern al age, an d a b o d y m ass in d ex o f 28 is co n sid ered o verweigh t. Previo u s d ifficu lty with in fertility is an o th er risk facto r fo r lab o r d ysto cia. A p o tassiu m level o f 3.6 m Eq / L ( 3.6 m m o l/ L) is n o rm al an d ad m in istratio n o f o xyto cin alo n e is n o t a risk facto r; risk exists o n ly if u terin e h yp erstim - u latio n o ccu rs. Test -Ta kin g St r a tegy: Fo cus on th e su b ject, risk factors for labo r d ystocia. Add itio n ally, fo cu s o n th e d ata in th e q u es- tio n , lo o k at each o ption , an d determ in e if th ese are n o rm al assessm en t fin d in gs. Review: Dysto cia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Com m un icatio n ; Perfu sion Refer en ce: Lowderm ilk et al. ( 2016), p. 773.

288. 4 Ra t ion a le: Sign s o f fetal or m atern al co m p rom ise in clud e a p ersisten t, n on reassu rin g fetal h eart rate, fetal acido sis, an d th e passage o f m econ ium . Matern al fatigu e an d in fectio n can o ccu r if th e lab or is p ro lo n ged , bu t d o n o t in d icate fetal o r m atern al com pro m ise. Co ordin ated uterin e con traction s an d p ro gressive ch an ges in th e cervix are a reassu rin g pattern in labo r. Test -Ta kin g Str a t egy: Focus on th e su b ject, sign s of fetal o r m atern al co m p rom ise. Elim in ate op tio n s 1, 2, an d 3 becau se th ey are co m p arab le o r alike an d are n orm al expectation s d u rin g lab o r. Review: Assessm en t fin d in gs th at in d icate fetal or m atern al co m p ro m ise Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 773-774.

353CHAPTER 28 Problems with Labor and Birth

M

a

t

e

r

n

i

t

y

289. 1 Ra tion a le: Hyp erto n ic uterin e con traction s are pain ful, occu r frequ en tly, an d are u n coo rd in ated. Man agem en t of h yp erto n ic lab or d epen d s on th e cau se. Relief of pain is th e p rim ary in ter- ven tion to prom ote a n orm al lab or pattern . An am n io tom y an d o xytocin in fu sio n are n ot treatm en t m easu res fo r h yp er- to n ic con traction s; h o wever, th ese treatm en ts m ay be u sed in clien ts with h yp o to n ic d ysfun ctio n . A clien t with h yp erto n ic u terin e con tractio n s wou ld n o t be en cou raged to am b ulate every 30 m in utes, b ut wo uld b e en co uraged to rest. Test-Ta kin g St r a t egy: Fo cu s o n th e strategic wo rd , priority. Also n o te th at op tion s 2, 3, an d 4 are co m p arab le o r alike an d are th erapeu tic m easu res fo r h ypo to n ic d ysfu n ction . Review: Man agem en t of h yp erto n ic u terin e co n tractio n s Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—In trapartum Pr ior it y Con cept s: Clin ical Ju dgm en t; Pain Refer en ce: Lo wd erm ilk et al. (2016), pp . 774, 799.

290. 3 Ra tion a le: Vagin al exam in atio n s sh o uld n ot be do n e rou tin ely o n a clien t with prem atu re rup ture of th e m em b ran es b ecause o f th e risk o f in fectio n . Th e n u rse wou ld expect to m o n ito r fetal h eart rate, m on itor m atern al vital sign s, an d ad m in ister an an tib io tic. Test-Ta kin g St r a tegy: No te th e word question. Th is word in d i- cates th e activity th at th e n urse sh ou ld n o t im p lem en t with ou t clarificatio n . O p tion s 1, 2, an d 4 are co m p arab le o r alike an d are expected activities for th e n urse to p erfo rm fo r a clien t with p rem ature rup ture of th e m em b ran es. Perform in g a vagin al exam in atio n every sh ift sh o uld n o t b e d o n e o n a clien t with p rem ature ru ptu re o f th e m em b ran es becau se o f th e risk of in fectio n , so th e n urse wo uld q uestion th is p rescriptio n . Review: Care of th e clien t with p rem atu re ru p tu re o f th e m em b ran es Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—In trapartum Pr ior it y Con cept s: Co llab oration ; Safety Refer en ces: Lo wd erm ilk et al. (2016), p p. 770-771.

291. 2 Ra tion a le: Dystocia is d ifficu lt lab or th at is p ro lo n ged o r m o re p ain fu l th an exp ected. Th e p riority is to m on itor th e fetal h eart rate. Alth o ugh provid in g co m fo rt m easures, ch an gin g th e cli- en t’s po sitio n freq uen tly, an d keepin g th e sign ifican t o th er in form ed of th e progress o f th e lab or are co m po n en ts of th e p lan o f care, th e fetal statu s wo uld b e th e priority. Test-Ta kin g Str a tegy: No te th e strategic wo rd , priority. Use Maslo w’s Hierarch y o f Need s th eo ry an d th e ABCs—airway– b reath in g–circu latio n —to assist in an swerin g th e qu estio n . Review: Priority n ursin g in terven tion s fo r th e clien t with d ysto cia Level of Cogn it ive Abilit y: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Matern ity—In trapartum

Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lo wd erm ilk et al. (2016), pp . 775, 777-778.

292. 4 Ra tion a le: O xygen is adm in istered, 8 to 10 L/ m in u te, via face m ask to o ptim ize oxygen ation o f th e circu latin g b loo d . O p tion 1 is in co rrect because th e in traven ou s in fu sion sh ou ld be in creased (p er h ealth care p ro vider p rescriptio n ) to in crease th e m atern al bloo d vo lum e. O ption 2 is in co rrect b ecau se oxy- to cin stim ulatio n o f th e uterus is d iscon tin u ed if fetal h eart rate p attern s ch an ge fo r an y reaso n . O p tion 3 is in correct b ecause th e clien t is p laced in th e lateral p osition with h er legs raised to in crease m atern al b lo od volu m e an d im prove fetal p erfu sion . Test-Ta kin g St r a t egy: Note th e strategic wo rd s, most impor- tant. Use th e ABCs—airway–b reath in g–circu latio n . O xygen is th e o n ly o ptio n th at wou ld im p ro ve card iac o utp ut an d im prove p erfu sio n to th e fetu s. Th e o th er o ptio n s wo uld n o t im prove perfu sion to th e fetu s. Review: Care o f th e lab o rin g clien t exp erien cin g fetal d istress Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care: Em ergen cy Situation s/ Man agem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lowd erm ilk et al. (2016), p. 399.

293. 2 Ra tion a le: In p lacen ta p revia, th e placen ta is im plan ted in th e lo wer uterin e segm en t. Th e lo wer uterin e segm en t d oes n o t con tain th e sam e in tertwin in g m u sculatu re as th e fun du s of th e u teru s, an d th is site is m ore p ro n e to b leed in g. O p tion s 1, 3, an d 4 are n o t risks th at are related sp ecifically to p lacen ta p revia. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e risks asso ci- ated with placen ta p revia. Th in kin g abo ut th e p ath op h ysio lo gy asso ciated with th is d iso rd er an d recallin g th at b leed in g is a pri- m ary con cern in th is clien t will d irect yo u easily to th e co rrect o ptio n . Review: Placen ta p revia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lowd erm ilk et al. (2016), p. 682.

294. 4, 5, 6 Ra tion a le: Placen ta p revia is an im pro perly im p lan ted p la- cen ta in th e lo wer u terin e segm en t n ear or o ver th e in tern al cer- vical os. Pain less, brigh t red vagin al b leed in g in th e seco n d or th ird trim ester o f p regn an cy is a sign o f p lacen ta previa. Th e cli- en t h as a so ft, relaxed , n on ten d er u teru s, an d fu n d al h eigh t m ay b e m ore th an exp ected for gestatio n al age. In ab ru ptio p la- cen tae, severe ab do m in al p ain is p resen t. Uterin e ten d ern ess acco m p an ies p lacen tal ab ru p tion . In add itio n , in abru ptio p la- cen tae, th e abd o m en feels h ard an d bo ard like o n p alp ation as th e blo od pen etrates th e m yom etrium an d cau ses u terin e irritab ility.

354 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

Test -Ta kin g Str a tegy: First, elim in ate o p tion s 1 an d 2 b ecau se th ey are co m p arab le o r alike. Next, rem em ber th at th e differ- en ce b etween p lacen ta p revia an d ab ru ptio placen tae in vo lves th e presen ce o f u terin e pain an d ten d ern ess with abrup tio pla- cen tae, as o pp o sed to pain less b righ t red bleedin g with p la- cen ta previa. Review: Sign s of p lacen ta p revia an d ab ru p tio p lacen tae Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—In trap artu m Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wderm ilk et al. (2016), p p . 680-681.

295. 2 Ra t ion a le: Wh en co rd p ro lapse occurs, p ro m p t action s are taken to relieve co rd co m pressio n an d in crease fetal oxygen a- tion . Th e clien t sh o u ld be p osition ed with th e h ips h igh er th an th e h ead to sh ift th e fetal presen tin g p art toward th e dia- ph ragm . Th e n urse sh o uld pu sh th e call ligh t to sum m on h elp , an d o th er staff m em bers sh o uld call th e h ealth care provid er

an d n o tify th e delivery ro o m . If th e co rd is p ro tru din g fro m th e vagin a, n o attem p t sh ou ld b e m ade to replace it becau se to d o so cou ld trau m atize it an d redu ce b lo od flo w furth er. Also as a first actio n , th e exam in er sh ou ld p lace a gloved h an d in to th e vagin a an d h o ld th e p resen tin g part off th e u m b ilical co rd . O xygen , 8 to 10 L/ m in u te, b y face m ask is ad m in istered to th e clien t to in crease fetal o xygen atio n . Test -Ta kin g St r a t egy: Note th e strategic wo rd , first, an d th at th e u m b ilical co rd is p ro tru din g fro m th e vagin a. O p tion s 3 an d 4 can b e elim in ated first b ecau se th ese actio n s d elay n ec- essary an d im m ed iate treatm en t. Recallin g th at th e goal is to relieve cord co m p ression an d to in crease fetal o xygen atio n will d irect you to th e correct op tio n . Also rem em ber th at th e cord sh ou ld n o t be pu sh ed b ack in to th e vagin a. Review: Prio rity n ursin g m easu res for p ro lap sed co rd Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con ten t Area : Critical Care: Em ergen cy Situation s/ Man agem ent Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p . 798.

355CHAPTER 28 Problems with Labor and Birth

M

a

t

e

r

n

i

t

y

M

a

t

e

r

n

i

t

y

C H A P T E R 29 Postpartum Period

PRIORITY CONCEPTS Health Promotion, Reproduction

CRITICAL THINKING What Should You Do? The nurse is caring for a postpartum client on her third day following birth. When entering the new mother’s room, she finds the client in tears. The new mother states, “I do not know why I am acting like such a baby. I feel prepared for my new role.” How should the nurse respond to the new mother? Answer located on p. 360.

I. Postpartum A. Description : Period wh en th e reprodu ctive tract

return s to th e n orm al, n on pregn an t state B. Th e postpartum period starts im m ediately after birth

an d is usually com pleted by week 6 follo win g birth .

II. Physiological Maternal Changes A. In volu tion

1. Description a . In vo lution is th e rapid decrease in th e size of

th e uterus as it return s to th e n on pregn an t state.

b . Clien ts wh o breast-feed m ay experien ce a m ore rapid in volution because of th e release of oxytocin durin g breast-feed in g.

2. Assessm en t a . Th e weigh t of th e uterus decreases from

approxim ately 2 lb (900 g) to 2 oz (57 g) in 6 weeks.

b . Th e en dom etrium regen erates. c. Th e fun dus steadily descen ds in to th e pelvis. d . Fun dal h eigh t decreases ab out 1 cm / day

( Fig. 29-1). e. By 10 days postpartu m , th e uterus can n ot be

palp ated ab dom in ally. f. A flaccid fun dus in dicates uterin e aton y, an d

it sh o uld be m assaged un til firm ; a ten der fun dus in dicates an in fectio n .

g. Afterpain s decrease in frequen cy after th e first few days.

B. Lochia 1. Description : Disch arge fro m th e uterus th at con -

sists of blood fro m th e vessels of th e placen tal site an d deb ris from th e decidu a

2. Assessm en t ( Box 29-1) a . Rubra is brigh t red disch arge th at occurs from

day of birth to day 3. b . Serosa is brown ish pin k disch arge th at occurs

from days 4 to 10. c. Alba is wh ite disch arge th at occurs from days

11 to 14. d . Th e disch arge sh ould sm ell like n orm al

m en strual flow. e. Disch arge decreases daily in am oun t. f. Disch arge m ay in crease with am bulation .

To determine most accurately the amount of lochial flow, weigh the perineal pad before and after use and identify the amount of time between pad changes.

C. Cervix: Cervical in volution occurs, an d th e m uscle begin s to regen erate after 1 week.

D. Vagina: Vagin al disten tion decreases, alth ough m us- cle ton e is n ever restored com pletely to th e pregravid state.

E. O varian fun ction an d m en struation 1. O varian fun ction dep en ds on th e rapidity with

wh ich pituitary fun ctio n is restored. 2. Men strual flow resum es with in 1 to 2 m on th s in

n on –breast-feedin g m oth ers. 3. Men strual flow usually resum es with in 3 to

6 m on th s in breast-feedin g m oth ers. 4. Breast-feedin g m oth ers m ay experien ce am en or-

rh ea durin g th e en tire period of lactation .

Women mayovulate without menstruating, so breast- feeding should not be considered a form of birth control.

F. Breasts 1. Breasts con tin ue to secrete co lostrum for th e first

48 to 72 h ours after birth . 2. A decrease in estrogen an d progesteron e levels

after birth stim ulates in creased prolactin levels, wh ich prom ote breast m ilk produ ction .356

M

a

t

e

r

n

i

t

y

3. Breasts becom e disten ded with m ilk on th e th ird day.

4. En gorgem en t occurs on approxim ately day 4 in both breast-feedin g an d n on –breast-feedin g m oth ers. Box 29-2 sum m arizes care of breasts for n on –breast-feedin g m oth ers.

5. Breast-feedin g relieves en gorgem en t. G. Urin ary tract

1. Th e clien t m ay h ave urin ary reten tion as a result of lo ss of elasticity an d ton e an d loss of sen sation in th e bladder from traum a, m edication s, an es- th esia, an d lack of privacy.

2. Diuresis usually begin s with in th e first 12 h ours after birth .

H. Gastro in testin al tract 1. Clien ts are usually h un gry after birth . 2. Con stipation can occur, with bowel m ovem en t

(soft, form ed stool) by th e secon d or th ird postp artum day.

3. Hem o rrh oids are com m on . I. Vital sign s ( Table 29-1)

III. Postpartum Interventions A. Assessm en t

1. Mon itor vital sign s. 2. Assess pain level. 3. Assess h eigh t, con sisten cy, an d location of th e

fun dus (h ave clien t em pty th e bladder before fun dal assessm en t) (Fig. 29-2).

Da y 1 Da y 2 Da y 3 Da y 4 Da y 5 Da y 6 Da y 7 Da y 8 Da y 9

FIGURE 29-1 Involution of the uterus. The height of the uterine fundus decreases by approximately 1 cm/ day.

BOX 29-1 Amount of Lochia Sca nt: Less than 2.5 cm (< 1 inch) on menstrual pad in 1 hour Light: Less than 10 cm (< 4 inches) on menstrual pad in 1 hour Moderate: Less than 15 cm (< 6 inches) on menstrual pad in 1hour Hea vy: Saturated menstrual pad in 1 hour Excessive: Menstrual pad saturated in 15 minutes

From Murray S, McKinney E: Foundations of maternal-newborn and women’s health nursing, ed 5, Philadelphia, 2010 , Saunders.

BOX 29-2 Breast Care for Non–Breast-Feeding Mothers

Avoid nipple stimulation. Apply a breast binder, wear a snug-fitting bra, apply ice packs,

or take a mild analgesic for engorgement. Engorgement usually resolves within 24 to 36 hours after it

begins.

TABLE 29-1 Normal Postpartum Vital Signs Vital Sign Description

Temperature May increase to 10 0.4°F (38.0°C) during the first 24 hr postpartum because of dehydrating effects of labor. Any higher elevation may be caused by infection and must be reported.

Pulse May decrease to 50 beats/ min (normal puerperal bradycardia). Pulse > 100 beats/ min may indicate excessive blood loss or infection.

Blood pressure

Should be normal; suspect hypovolemia if it decreases.

Respirations Rarely change; if respirations increase significantly, suspect pulmonary embolism, uterine atony, or hemorrhage.

Fundus

Bla dde r

FIGURE 29-2 A full bladder displaces and prevents contraction of the uterus.

357CHAPTER 29 Postpartum Period

M

a

t

e

r

n

i

t

y

4. Mon itor color, am oun t, an d odor of loch ia. 5. Assess breasts for en gorgem en t. 6. Mon itor perin eum for swellin g or discoloration . 7. Mon itor for perin eal laceration s or episioto m y

for h ealin g. 8. Assess in cision s or dressin gs of clien t wh o h ad a

cesarean birth . 9. Mon itor bowel status.

10. Mon itor in take an d output. 11. En cou rage frequen t void in g. 12. En cou rage am bulation . 13. Assess extrem ities for th rom boph leb itis (red-

n ess, ten dern ess, or warm th of th e leg). 14. Adm in ister Rh o(D) im m un e globulin if pre-

scrib ed with in 72 h ours postpartum to Rh - n egative clien t wh o h as given birth to Rh -p ositive newborn.

15. Evaluate rubella im m un ity. If n ot im m un e, adm in ister rubella im m un ization .

16. Assess bon din g with th e newborn. 17. Assess em o tion al status.

B. Clien t teach in g 1. Dem on strate n ewborn care skills as n ecessary. 2. Provide th e opportun ity for th e clien t to bath e

th e n ewborn . 3. In struct in feedin g tech n ique. 4. In struct th e clien t to avoid h eavy liftin g for at

least 3 weeks. 5. In struct th e clien t to plan at least 1 rest period

per day. 6. In struct th e clien t th at con tracep tion sh ould

begin after birth or with th e in itiation of in ter- course (in tercourse sh o uld be postp on ed at least un til loch ia ceases). With ru bella im m un ization , avoid con ception for 1 to 3 m on th s based on h ealth care provider (HCP) recom m en dation .

7. In struct th e clien t in th e im portan ce of follow- up, wh ich sh ould be sch eduled at 4 to 6 weeks.

8. In struct th e clien t to report an y sign s of ch ills, fever, in creased loch ia, or depressed feelin gs to th e HCP im m ediately.

IV. Postpartum Discomforts A. Afterbirth pain s

1. O ccur as a result of con traction s of th e uterus 2. Are m ore com m on in m ultiparas, breast-feed in g

m oth ers, clien ts treated with oxytocin , an d cli- en ts wh o h ad an overdisten ded uterus durin g pregn an cy, such as with carryin g twin s

B. Perin eal discom fort 1. Apply ice packs to th e perin eum durin g th e first

24 h ou rs to reduce swellin g. 2. After th e first 24 h ours, apply warm th by

sitz bath s. C. Episiotom y

1. If don e, in struct th e clien t to adm in ister perin eal care after each void in g.

2. En cou rage th e use of an an algesic spray as prescribed.

3. Adm in ister an algesics as prescribed if com fo rt m easu res are un successful.

D. Perin eal laceration s 1. Care as for an episiotom y; adm in ister perin eal care

and use an algesic spray an d an algesics for com fort. 2. Rectal supp ositories an d en em as m ay be con tra-

in dicated (to avoid in jury to sutures). E. Breast discom fort fro m en go rgem en t

1. En cou rage th e clien t to wear a support bra at all tim es, even wh ile sh e is sleepin g.

2. En cou rage th e use of ice packs between feedin gs if th e clien t is breast-feedin g.

3. En courage th e use of warm soaks or a warm sh ower before feedin g for th e breast-feedin g m other.

4. Adm in ister an algesics as prescribed if com fo rt m easu res are un successful.

F. Con stipation 1. En cou rage adequ ate in take of fluids

(2000 m L/ d ay). 2. En cou rage diet h igh in fiber. 3. En cou rage am bulation . 4. Adm in ister stool soften er, laxative, en em a, or

suppository if n eeded an d prescribed. G. Postpartum em otion al ch an ges ( Box 29-3)

1. Ackn owledge th e clien t’s feelin gs an d dem on - strate a carin g attitu de.

2. Determ in e availability of fam ily supp ort an d oth er supp ort system s an d resou rces as n eeded.

3. En cou rage an d assist th e clien t to verbalize h er feelin gs.

4. Mon itor th e n ewborn for appropriate growth an d developm en t expectation s.

5. Assist th e sign ifican t oth er an d oth er appropriate fam ily m em bers to discuss feelin gs an d iden tify ways to assist th e clien t.

All clients should be assessed for depression during pregnancy and in the postpartum period.

V. Nutritional Counseling A. Discuss caloric in take with breast-feed in g an d n on –

breast-feedin g m oth ers. B. Nutrition al n eeds dep en d on prepregn an cy weigh t,

ideal weigh t for h eigh t, an d wh eth er th e clien t is breast-feedin g.

C. If th e clien t is breast-feed in g, calorie n eeds in crease by 200 to 500 calories/ day, an d th e clien t m ay require in creased fluid s an d th e con tin uan ce of pre- n atal vitam in s an d m in erals.

VI. Breast-Feeding A. In terven tion s

1. Put th e n ewborn to th e m oth er’s breast as soon as th e m oth er’s an d n ewborn ’s con dition s are stable (on delivery tab le, if possible).

358 UNIT VI Maternity Nursing

2. Stay with th e clien t each tim e sh e n urses un til sh e feels secure an d con fid en t with th e n ewborn an d h er feelin gs.

3. Assess LATCH (latch ach ieved by n ewborn ; audi- ble swallowin g; typ e of n ipple; com fo rt of m oth er; hold or position of baby).

4. Uterin e cram pin g m ay occur th e first day after birth wh ile th e clien t is n ursin g, wh en oxytocin stim ulation causes th e uterus to con tract.

5. In struct th e clien t to use gen eral h ygien e an d wash th e breasts on ce daily.

6. If en gorgem en t occurs, breast-feed frequen tly, ap ply warm packs before feedin g, apply ice packs between feedin gs, an d m assage th e breasts.

7. Th e clien t sh o uld n ot use soap on th e breasts because it ten ds to rem ove n atural oils, wh ich in creases th e ch an ce of cracked n ipp les.

8. If cracked n ipp les develop, th e clien t sh o uld expose th e n ipp les to air for 10 to 20 m in u tes after feed in g, rotate th e position of th e baby for each feedin g, an d en sure th at th e baby is latch ed on to th e areola, n ot just th e n ipp le.

9. Th e bra sh ould be well fitted an d supp ortin g; avoid an un d erwire bra.

10. Breasts m ay leak between feedin gs or durin g coi- tus; place breast pad in bra.

11. Calo ries sh o uld be in creased by 200 to 500 calories/ day, an d th e diet sh ould in clude addi- tio n al fluid s; pren atal vitam in s sh ould be taken as prescribed.

12. Newborn ’s stools are usually ligh t yellow, seedy, watery, an d frequen t.

13. Med ication s, in cludin g over-th e-cou n ter m edica- tion s, n eed to be avoided un less prescribed because th ey m ay be un safe wh en breast-feedin g.

14. Gas-producin g food s an d caffein e sh ould be avoided.

15. O ral con traceptives con tain in g estrogen are n ot recom m en ded for breast-feedin g m oth ers; progestin -on ly birth con trol pills are less likely to in terfere with th e m ilk supp ly.

16. Th e in fan t will develop h is or h er own feedin g sch edule.

B. Breast-feedin g proced ure for th e m oth er (Box 29-4)

M

a

t

e

r

n

i

t

y

BOX 29-3 Signs and Symptoms of Emotional Changes Postpartum Blues ▪ Anger ▪ Anxiety ▪ Cries easily for no apparent reason ▪ Emotionally labile ▪ Expresses a let-down feeling ▪ Fatigue ▪ Headache ▪ Insomnia ▪ Restlessness ▪ Sadness Postpartum Depression ▪ Anxiety ▪ Appetite changes ▪ Crying, sadness

▪ Difficulty concentrating or making decisions ▪ Fatigue, unable to sleep ▪ Feelings of guilt ▪ Irritability and agitation ▪ Lack of energy ▪ Less responsive to the infant ▪ Loss of pleasure in normal activities ▪ Suicidal thoughts Postpartum Psychosis ▪ Break with reality ▪ Confusion ▪ Delirium ▪ Delusions ▪ Hallucinations ▪ Panic

Data from Lowdermilk D, Cashion MC, Perry S: Maternity &women’s health care, ed 9, St. Louis, 20 11, Mosby; Lowderm ilk D, Perry S, Cashion MC, Alden K: Maternity & women’s health care, ed 10, St. Louis, 20 12, Mosby; and Perry S, Hockenberry M, Lowderm ilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 13, Mosby.

BOX 29-4 Breast-Feeding Procedure for the Mother

1. Wash hands and assume a comfortable position. 2. Start with the breast with which the last feeding ended. 3. Brush the newborn’s lower lip with nipple. 4. Tickle the lips to have the newborn open the mouth wide. 5. Guide the nipple and surrounding areola into the new-

born’s mouth. 6. Encourage the newborn to nurse on each breast for 15 to

20 minutes. 7. After the newborn has nursed, release suction by depress-

ing the newborn’s chin or inserting a clean finger into the newborn’s mouth.

8. Burp the newborn after the first breast. 9. Repeat the procedure on the second breast until the new-

born stops nursing. 10. Burp the newborn again. 11. Listen for audible sucking and swallowing.

359CHAPTER 29 Postpartum Period

M

a

t

e

r

n

i

t

y

CRITICAL THINKING What Should You Do? Answer: The nurse should recognize that the new mother is experiencing a normal phenomenon, postpartum blues, and explain to the new mother what she is experiencing along with ways to minimize the “blues” (e.g., adequate nutrition, rest, diversional activity). In addition, this is an ideal oppor- tunity for the nurse to address signs and symptoms of post- partum depression so if a more serious situation develops, the new mother understands when to seek help.

Reference: Lowdermilk et al. (2016), pp. 50 9, 749.

P R A C T I C E Q U E S T I O N S 296. Th e postp artum n urse is takin g th e vital sign s of a

clien t wh o delivered a h ealth y n ewborn 4 h ours ago. Th e n urse n otes th at th e clien t’s tem p erature is 100.2°F. Wh at is th e p rio rity n ursin g action ? 1. Do cum en t th e fin din gs. 2. Retake th e tem p erature in 15 m in utes. 3. Notify th e h ealth care provider (HCP). 4. In crease h ydration by en couragin g oral fluid s.

297. Th e n urse is assessin g a clien t wh o is 6 h ours post- partum after deliverin g a full-term h ealth y n ew- born . Th e clien t com plain s to th e n urse of feelin gs of fain tn ess an d dizzin ess. Wh ich n ursin g action is m o st ap p ro p riate? 1. Raise th e h ead of th e clien t’s bed. 2. O btain h em oglob in an d h em atocrit levels. 3. In struct th e clien t to request h elp wh en gettin g

out of bed. 4. In form th e n ursery ro om n urse to avoid brin g-

in g th e n ewborn to th e clien t un til th e clien t’s sym pto m s h ave subsided.

298. Th e postpartum n urse is providin g in struction s to a clien t after birth of a h ealth y n ewborn . Wh ich tim e fram e sh o uld th e n urse relay to th e clien t regardin g th e return of bowel fun ction ? 1. 3 days postpartu m 2. 7 days postpartum 3. O n th e day of birth 4. With in 2 weeks postpartum

299. Th e n urse is plan n in g care for a postp artum clien t wh o h ad a vagin al delivery 2 h ou rs ago. Th e clien t required an episioto m y an d h as several h em or- rh oids. Wh at is th e p rio rity n ursin g con sideration for th is clien t? 1. Clien t pain level 2. In adequ ate urin ary outp ut

3. Clien t percep tion of body ch an ges 4. Poten tial for im balan ced body fluid volum e

300. Th e n urse is providin g postp artum in struction s to a clien t wh o will be breast-feed in g h er n ewborn . Th e n urse determ in es th at th e clien t h as un dersto od th e in struction s if sh e m akes wh ich statem en ts? Select all th at ap p ly.

1. “I sh ould wear a bra th at provid es support.” 2. “Drin kin g alcoh ol can affect m y m ilk supply.” 3. “Th e use of caffein e can decrease m y m ilk

supp ly.” 4. “I will start m y estrogen birth con trol pills

again as soon as I get h om e.” 5. “I kn ow if m y breasts get en gorged, I will

lim it m y breast-feed in g an d supp lem en t th e baby.”

6. “I plan on h avin g bottled water available in th e refrigerator so I can get addition al fluids easily.”

301. Th e n urse is teach in g a postpartum clien t about breast-feedin g. Wh ich in struction sh ould th e n urse in clude? 1. Th e diet sh ould in clude addition al fluids. 2. Pren atal vitam in s sh o uld be discon tin ued. 3. Soap sh o uld be used to clean se th e breasts. 4. Birth con trol m easu res are un n ecessary wh ile

breast-feedin g.

302. Th e n urse is preparin g to assess th e uterin e fun dus of a clien t in th e im m ediate postp artum period. After locatin g th e fun dus, th e n urse n otes th at th e uterus feels soft an d boggy. Wh ich n ursin g in terven tion is appropriate? 1. Elevate th e clien t’s legs. 2. Massage th e fun dus un til it is firm . 3. Ask th e clien t to turn on h er left side. 4. Push on th e uterus to assist in expressin g clots.

303. Th e n urse is carin g for four 1-day postp artum cli- en ts. Wh ich clien t assessm en t requires th e n eed fo r fo llo w-u p ? 1. Th e clien t with m ild afterpain s 2. Th e clien t with a pulse rate of 60 beats/ m in ute 3. Th e clien t with colostrum disch arge from both

breasts 4. Th e clien t with loch ia th at is red an d h as a foul-

sm ellin g odor

304. Wh en perform in g a postp artum assessm en t on a clien t, th e n urse n otes th e presen ce of clo ts in th e loch ia. Th e n urse exam in es th e clots an d n otes th at th ey are larger th an 1 cm . Wh ich n ursin g action is m o st ap p ro p riate?

360 UNIT VI Maternity Nursing

1. Do cum en t th e fin din gs. 2. Reassess th e clien t in 2 h ou rs. 3. Notify th e h ealth care provider (HCP). 4. En cou rage in creased oral in take of fluids.

305. Th e n urse is m on itorin g th e am oun t of loch ia drain age in a clien t wh o is 2 h ours postp artum an d n otes th at th e clien t h as saturated a perin eal pad in 15 m in utes. Ho w sh ould th e n urse respo n d to th is fin din g in itially? 1. Do cum en t th e fin din g. 2. En courage th e clien t to am bulate. 3. En courage th e clien t to in crease fluid in take. 4. Con tact th e h ealth care provider (HCP) an d

in form th e HCP of th is fin din g.

306. Th e n urse h as provided disch arge in struction s to a clien t wh o delivered a h ealth y n ewborn by cesar- ean delivery. Wh ich statem en t m ade by th e clien t in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I will begin abdom in al exercises im m ediately.”

2. “I will n otify th e h ealth care provider if I develop a fever.”

3. “I will turn on m y side an d push up with m y arm s to get out of bed .”

4. “I will lift n oth in g h eavier th an m y n ewborn baby for at least 2 weeks.”

307. After a precipitous delivery, th e n urse n otes th at th e n ew m oth er is passive an d touch es h er n ewborn in fan t on ly briefly with h er fin gertips. Wh at sh ould th e n urse do to h elp th e wom an process th e delivery? 1. En cou rage th e m oth er to breast-feed soon

after birth . 2. Support th e m oth er in h er reaction to th e n ew-

born in fan t. 3. Tell th e m oth er th at it is im portan t to h old th e

n ewborn in fan t. 4. Do cum en t a com plete accoun t of th e m oth er’s

reaction on th e birth record.

A N S W E R S 296. 4 Ra t ion a le: Th e clien t’s tem p eratu re sh o uld b e taken every 4 h o urs wh ile sh e is awake. Tem p eratu res u p to 100.4°F (38°C) in th e first 24 h ou rs after birth often are related to th e d eh ydratin g effects o f lab or. Th e ap p ro priate action is to in crease h ydration b y en co uragin g o ral flu id s, wh ich sh o uld brin g th e tem p eratu re to a n o rm al read in g. Alth ou gh th e n u rse also wo u ld d ocum en t th e fin d in gs, th e ap prop riate action wo uld b e to in crease h yd ratio n . Takin g th e tem peratu re in an oth er 15 m in utes is an u n n ecessary action . Con tactin g th e HCP is n o t n ecessary. Test -Ta kin g St r a t egy: Note th e strategic wo rd , priority, an d use kn o wled ge regardin g th e ph ysiolo gical fin d in gs in th e im m ed iate p ostp artu m perio d to an swer th is qu estio n . Recal- lin g th at a tem p erature elevatio n often is related to th e deh y- dratin g effects o f labo r will d irect yo u to th e correct op tio n . Also, in creasin g h yd ratio n relates to a ph ysiolo gical clien t n eed. Review: No rm al p o stp artu m assessm en t fin d in gs Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Reprod uctio n ; Th erm o regu latio n Refer en ce: Lo wderm ilk et al. (2016), p p . 484-485.

297. 3 Ra t ion a le: O rth o static h ypo ten sio n m ay b e eviden t d urin g th e first 8 h o urs after b irth . Feelin gs o f fain tn ess o r dizzin ess are sign s th at cau tio n th e n u rse to fo cu s in terven tio n s o n th e cli- en t’s safety. Th e n u rse sh ou ld advise th e clien t to get h elp th e first few tim es sh e gets ou t of b ed. O ptio n 1 is n o t a h elp ful actio n in th is situ ation an d wou ld n o t relieve th e

sym p tom s. O p tio n 2 requ ires a h ealth care provider’s p rescrip - tion . O p tio n 4 is un n ecessary. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Fo cu s o n th e su b ject, clien t safety. O p tio n 4 is in ap prop ri- ate an d sh o uld be elim in ated first. Elevatin g th e clien t’s h ead is n ot a h elp ful in terven tio n . To select from th e rem ain in g o p tion s, recall th at safety is a p rim ary issu e. Review: Po stp artu m n u rsin g in terven tio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Perfusio n ; Safety Refer en ce: Lo wd erm ilk et al. (2016), p . 490.

298. 1 Ra t ion a le: After b irth , th e n urse sh ou ld au scu ltate th e clien t’s ab do m en in all 4 q u adran ts to d eterm in e th e return o f b owel so u n d s. Norm al b owel elim in ation u su ally retu rn s 2 to 3 d ays p o stpartu m . Surgery, an esth esia, an d th e u se o f o pio id s an d p ain co n trol agen ts also con trib ute to th e lo n ger perio d o f altered bo wel fun ctio n s. O p tio n s 2, 3, an d 4 are in co rrect. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject an d use gen eral p rin ciples related to po stpartum care. Elim in ate o ption s 2 an d 4 first b ecau se o f th e len gth of tim e stated in th ese o p tion s. From th e rem ain in g op tio n s, elim in ate op tio n 3 becau se it would seem un reason able th at bowel fun ction would return th at qu ickly in th e p ostp artu m wo m an . Review: No rm al gastro in testin al fun ctio n in th e p o stp artu m clien t Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Po stpartum

M

a

t

e

r

n

i

t

y

361CHAPTER 29 Postpartum Period

Pr ior it y Con cept s: Clien t Ed ucation ; Elim in atio n Refer en ce: Lo wd erm ilk et al. (2016), p. 491.

299. 1 Ra tion a le: Th e priority n ursin g con sideratio n fo r a clien t wh o d elivered 2 h ou rs ago an d wh o h as an ep isio tom y an d h em o r- rh oids is clien t p ain level. Most clien ts h ave so m e d egree o f d is- com fort d u rin g th e im m ed iate p o stpartu m p eriod . Th ere are n o d ata in th e q uestion th at in d icate in adeq uate u rin ary o ut- p ut, th e p resen ce o f clien t p erception o f b od y ch an ges, an d p oten tial for im b alan ced b o dy flu id volum e. Test-Ta kin g Str a tegy: No te th e strategic wo rd , priority. Use Maslo w’s Hierarch y o f Need s th eo ry to elim in ate op tio n 3 b ecau se th is is a p sych oso cial, n o t a p h ysio lo gical, n eed. To select fro m th e rem ain in g o ptio n s, fo cu s o n th e d ata in th e q u estio n . Review: Disco m forts in th e p o stp artu m clien t Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Pain ; Rep ro du ction Refer en ce: Lo wd erm ilk et al. (2016), pp . 488-489.

300. 1, 2, 3, 6 Ra tion a le: Th e p o stp artu m clien t sh ou ld wear a b ra th at is well fitted an d su pp ortive. Co m m o n cau ses o f decreased m ilk sup - p ly in clu de form u la u se; in adeq uate rest or diet; sm okin g b y th e m o th er or o th ers in th e h om e; an d use o f caffein e, alco h o l, o r o th er m edicatio n s. Breast-feed in g clien ts sh o uld in crease th eir daily fluid in take; h avin g b ottled water available in d icates th at th e p o stpartu m clien t un d erstan ds th e im po rtan ce of in creasin g flu id s. If en gorgem en t occurs, th e clien t sh ou ld n o t lim it breast-feedin g, bu t sh ou ld b reast-feed freq uen tly. O ral co n tracep tives con tain in g estrogen are n ot recom m en d ed fo r breast-feedin g m oth ers. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject an d n o te th e wo rds understood the instructions. Th in k about th e p h ysiology associ- ated with m ilk p ro du ction an d th e co m plicatio n s o f breast- feed in g to an swer co rrectly. Review: Po stpartum in stru ctio n s fo r a b reast-feed in g clien t Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Health Pro m otio n ; Reprod uctio n Refer en ce: Lo wd erm ilk et al. (2016), pp . 620-621.

301. 1 Ra tion a le: Th e diet for a breast-feedin g clien t sh ould in clude ad ditio n al flu id s. Pren atal vitam in s sh o u ld b e taken as pre- scrib ed , an d so ap sh o u ld n ot be used o n th e breasts b ecause it ten ds to rem o ve n atural o ils, wh ich in creases th e ch an ce of cracked n ipp les. Breast-feed in g is n ot a m eth o d of con tracep- tio n , so b irth con tro l m easures sh ou ld be resum ed . Test-Ta kin g Str a tegy: No te th e su b ject, teach in g for th e breast- feed in g clien t. Rem em b er th at flu ids an d calo ries sh ou ld be in creased wh en th e clien t is breast-feed in g.

Review: Breast-feed in g Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Clien t Ed ucation ; Nu trition Refer en ce: Lowd erm ilk et al. (2016), p. 612.

302. 2 Ra tion a le: If th e u teru s is n o t co n tracted firm ly, th e in itial in terven tion is to m assage th e fu n d us u n til it is firm an d to exp ress clots th at m ay h ave accu m ulated in th e uterus. Elevat- in g th e clien t’s legs an d p osition in g th e clien t on th e sid e wou ld n o t assist in m an agin g uterin e ato n y. Push in g on an u n con - tracted u teru s can in vert th e u teru s an d cau se m assive h em o rrh age. Test-Ta kin g St r a tegy: Focus on th e su b ject, a soft an d boggy u teru s. Visualize th e p ro ced ure an d recall th e th erap eutic m an - agem en t fo r u terin e aton y. Rem em ber th at a full blad d er d is- p laces th e uteru s. Review: Fu n d al assessm en t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Health Pro m otio n ; Rep ro d uction Refer en ce: Lowd erm ilk et al. (2016), pp . 487-488.

303. 4 Ra tion a le: Loch ia, th e disch arge presen t after birth , is red for th e first 1 to 3 d ays an d grad ually decreases in am ou n t. No rm al lo ch ia h as a flesh y od o r or an od or sim ilar to m en stru al flo w. Fou l-sm ellin g o r p urulen t loch ia u su ally in dicates in fection , an d th ese fin din gs are n o t n o rm al. Th e o th er op tion s are n or- m al fin din gs fo r a 1-d ay p ostp artu m clien t. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for follow- up. Th ese wo rd s in d icate a n egative even t q u ery an d th e n eed to select th e ab n o rm al assessm en t fin d in g. Note th e wo rd s foul- smelling in th e co rrect op tion . Review: No rm al assessm en t fin din gs in th e p o stp artu m clien t Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity Integra ted Process: Nu rsin g Process—An alysis Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: In fection ; Rep ro d uction Refer en ce: Lowd erm ilk et al. (2016), pp . 486, 810.

304. 3 Ra tion a le: Norm ally, a few sm all clo ts m ay b e n o ted in th e lo ch ia in th e first 1 to 2 d ays after birth fro m p oo lin g of bloo d in th e vagin a. Clots larger th an 1 cm are con sidered ab n o rm al. Th e cau se o f th ese clo ts, such as u terin e ato n y or retain ed p la- cen tal fragm en ts, n eeds to be determ in ed an d treated to p re- ven t fu rth er b lo od loss. Alth o u gh th e fin d in gs wou ld be d ocum en ted, th e app ro p riate actio n is to n otify th e HCP. Reas- sessin g th e clien t in 2 h o urs wou ld d elay n ecessary treatm en t. In creasin g o ral in take of flu ids wo uld n o t be a h elpfu l actio n in th is situation .

M

a

t

e

r

n

i

t

y

362 UNIT VI Maternity Nursing

Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Focus o n th e wo rd s larger than 1 cm. Th in k ab ou t th e sig- n ifican ce of loch ial clo ts in th e p o stpartum perio d to an swer co rrectly. Review: No rm al fin din gs in th e p o stp artu m clien t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Clin ical Jud gm en t; Clottin g Refer en ce: Lo wderm ilk et al. (2016), p p . 486-487.

305. 4 Ra t ion a le: Lo ch ia is th e d isch arge fro m th e uterus in th e p o st- partu m p erio d ; it co n sists of bloo d fro m th e vessels of th e p la- cen tal site an d d ebris from th e decid ua. Th e fo llowin g can b e used as a guide to d eterm in e th e am ou n t of flo w: scan t¼ less th an 2.5 cm (< 1 in ch ) o n m en strual pad in 1 h o ur; ligh t ¼ less th an 10 cm (< 4 in ch es) on m en strual pad in 1 h our; m oderate¼ less th an 15 cm (< 6 in ch es) on m en strual pad in 1 h our; h eavy¼ saturated m en stru al pad in 1 h our; an d excessive¼m en strual pad saturated in 15 m in utes. If th e clien t is experien cin g excessive bleedin g, th e n urse sho uld con tact th e HCP in th e even t th at postpartu m h em orrh age is occurrin g. It m ay be appropriate to en courage in creased fluid in take, but th is is n ot th e in itial action . It is n ot appropriate to encou rage am bu lation at th is tim e. Docu m en tation shou ld occur on ce th e clien t h as been stab ilized. Test -Ta kin g St r a t egy: Note th e strategic wo rd , initially. Focus on th e d ata in th e q u estio n , a satu rated perin eal pad in 15 m in u tes. Next, d eterm in e if an ab n o rm ality exists. Th e data an d th e use of gu idelin es to determ in e th e am ou n t o f loch ial flow will h elp yo u to determ in e th at th is is ab n o rm al an d warran ts n otificatio n of th e HCP. Review: Assessm en t o f th e am o u n t o f lo ch ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con ten t Ar ea : Critical Care: Em ergen cy Situation s/ Man agem en t Pr ior ity Con cepts: Clottin g; Reprod uctio n Refer en ce: Lo wderm ilk et al. (2016), p . 487.

306. 1 Ra t ion a le: A cesarean d elivery requ ires an in cisio n m ade th ro ugh th e ab do m in al wall an d in to th e uterus. Abd om in al exercises sh o u ld n ot start im m ed iately after abd om in al su rgery; th e clien t sh ou ld wait at least 3 to 4 weeks p osto peratively to allow for h ealin g o f th e in cision . O p tio n s 2, 3, an d 4 are ap pro- p riate in stru ctio n s fo r th e clien t after a cesarean d elivery. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further instruction. Th ese words in dicate a n egative even t q u ery an d ask yo u to select an o ption th at is an in co rrect statem en t. Keep- in g in m in d th at th e clien t h ad a cesarean delivery an d n o tin g th e wo rd immediately in th e co rrect op tion will assist in d irect- in g you to th is o p tion . Review: Hom e care in stru ctio n s fo r a clien t after cesarean d elivery Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Clien t Ed u catio n ; Rep ro du ction Refer en ce: Lo wd erm ilk et al. (2016), p p. 793-794.

307. 2 Ra t ion a le: Precip ito us lab or is labo r th at lasts 3 h ou rs or less. Wom en wh o h ave experien ced precipitous labor often describe feelin gs o f d isb elief th at th eir lab o r p ro gressed so rapidly. To assist th e clien t to process wh at h as h ap p en ed , th e b est o ptio n is to su pp ort th e clien t in h er reactio n to th e n ewb orn in fan t. O p tion s 1, 3, an d 4 d o n o t ackn o wledge th e clien t’s feelin gs. Test -Ta kin g Str a tegy: Use th erap eu tic co m m u n icatio n tech - n iq u es. Th e co rrect o p tion is th e on ly op tio n th at ackn o wl- edges th e clien t’s feelin gs. Review: Use of th erap eu tic co m m u n icatio n tech n iq u es fo l- lowin g delivery Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Caregivin g; Reprod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 79, 774-775.

M

a

t

e

r

n

i

t

y

363CHAPTER 29 Postpartum Period

M

a

t

e

r

n

i

t

y

C H A P T E R 30 Postpartum Complications

PRIORITY CONCEPTS Caregiving, Reproduction

CRITICAL THINKING What Should You Do? The nurse caring for a client who is 28 hours postpartum notes a temperature of 101.2 °F (38.4 °C). What should the nurse do? Answer located on p. 368.

I. Cystitis A. Description : Cystitis, an in fection of the bladder, can

occur in th e postpartum period, an d th e postpartum wom an sh ould be en couraged to con sum e adequate fluids and void frequen tly to avoid bladder disten tion.

B. Assessm en t an d in terven tion s (refer to Ch apter 58)

If a urine specimen for culture and sensitivity is pre- scribed, obtain the specimen before initiating antibiotic therapy.

II. Hematoma A. Description

1. A h em atom a is a lo calized co llection of blood in th e tissues an d can occur in tern ally, in volvin g th e vagin al sulcus or oth er organ s; vulvar h em ato- m as are th e m ost co m m on ( Fig. 30-1).

2. Predisposin g con dition s in clude operative delivery with forceps an d in jury to a blood vessel.

3. A h em atom a can be a life-th reaten in g con dition . B. Assessm en t

1. Abn orm al, severe pain 2. Pressure in th e perin eal area 3. Sen sitive, bulgin g m ass in th e perin eal area with

discolored skin 4. In ab ility to vo id 5. Decreased h em oglobin an d h em atocrit levels 6. Ch an ges in vital sign s in dicatin g sh ock such as

tach ycardia an d h ypo ten sion C. In terven tion s

1. Mon itor clien t for abn orm al pain or perin eal pressure, especially wh en forceps delivery h as occurred.

2. Mon itor vital sign s an d for sign s of sh o ck. 3. Place ice at th e h em atom a site. 4. Adm in ister an algesics as prescribed. 5. Prepare for urin ary cath eterization if th e clien t is

un ab le to void. 6. Adm in ister blood produ cts as prescribed. 7. Mon itor for sign s of in fection, such as in creased

tem perature, pulse rate, an d white blood cell coun t. 8. Adm in ister an tibiotics as prescribed because

in fectio n is com m on after h em atom a form ation . 9. Prepare for in cision an d evacu ation of h em a-

tom a if n ecessary.

III. Uterine Atony A. Descrip tion : A poorly con tracted uterus th at does

n ot adequ ately co m press large open vessels at th e placen tal site; th is can result in h em orrh age.

B. Assessm en t: A soft (boggy) uterus n oted on palp a- tion of th e uterin e fun dus

C. In terven tion s 1. Massage th e uterus un til firm ( Fig. 30-2). 2. Em pty the wom an’s bladder (by voiding or catheter-

ization) if that is contributing to the uterine atony. 3. Notify th e h ealth care provider (HCP) if in ter-

ven tio n s do n ot resolve th e aton y, because th is could be an in dication of h em orrh age.

IV. Hemorrhage and Shock A. Descrip tion

1. Bleedin g of 500 m L or m ore after delivery 2. Can occur early durin g th e first 24 h ours after

delivery, or later after th e first 24 h ours follo win g delivery

3. Causes an d predisp osin g factors (Box 30-1) B. Assessm en t

1. Persisten t sign ifican t bleedin g: Perin eal pad is soaked with in 15 m in u tes.

2. Restlessn ess, in creased pulse rate, decrease in blood pressure, cool an d clam m y skin , ash en or grayish color

3. Com p lain ts of weakn ess, ligh th ead edn ess, dyspn ea364

M

a

t

e

r

n

i

t

y

C. In terven tion s: See Prio rity Nu rsin g Actio n s

V. Infection A. Description : An y in fection of th e reproductive organ s

th at occurs with in 28 days of delivery or abortion B. Assessm en t

1. Fever 2. Ch ills

FIGURE 30-1 A vulvar hematoma is caused by rapid bleeding into soft tissue. It causes severe pain and feelings of pressure.

BOX 30-1 Postpartum Hemorrhage

Causes ▪ Uterine atony ▪ Laceration of the cervix or vagina ▪ Hematoma development in the cervix, perineum, or labia ▪ Retained placental fragments Predisposing Factors ▪ Previous history of postpartum hemorrhage ▪ Placenta previa ▪ Abruptio placentae ▪ Overdistention of the uterus—polyhydramnios, multiple

gestation, large neonate ▪ Infection ▪ Multiparity ▪ Dystocia or labor that is prolonged ▪ Operative delivery—cesarean or forceps delivery, intrauterine

manipulation

PRIORITY NURSING ACTIONS Hemorrhage and Shock in the Postpartum Client

1. Notify primary health care provider (stay with the client and ask another nurse to contact the health care provider).

2. If uterus is atonic, massage gently to cause it to contract. 3. Tilt the woman to her side or elevate the right hip;

elevate her legs to at least a 30 -degree angle. 4. Administer oxygen by nonrebreather face mask or nasal

cannula at 8 to 10 L/ min. 5. Monitor vital signs. 6. Administer uterotonic medications (e.g., oxytocin, pros-

taglandins) as prescribed to increase uterine tone. 7. Provide additional or maintain existing intravenous (IV)

infusion of lactated Ringer’s solution or normal saline solution to restore circulatory volume (woman should have 2 patent IV lines; insert second IV infusion using 16- to 18-gauge IV catheter).

8. Administer blood or blood products as prescribed. 9. Insert an indwelling urinary catheter to monitor perfu-

sion of kidneys. 10. Administer emergency medications as prescribed. 11. Prepare for possible surgery or other emergency treat-

ments or procedures. 12. Record event, interventions instituted, and woman’s

response to interventions.

In the postpartum client, if bleeding is excessive and signs of shock are evident, the nurse immediatelycontacts the health care provider (HCP) because this is a life-threatening situation. The nurse never leaves a client who is unstable or experiencing a life-threatening condition and would ask another nurse to con- tact the HCP. The nurse should quickly attempt to determine the cause of the hemorrhage, and if the client is experiencing uterine atony, the nurse should massage the uterus gently to cause it to contract (do not push on an uncontracted uterus). The nurse positions the client to assist in perfusion of body organs, implements prescriptions including oxygen adminis- tration, and monitors vital signs. Medications to contract the uterus, fluids to restore circulating blood volume, and blood replacement therapy may be prescribed in addition to other emergency medications. Surgical intervention maybe required if the bleeding is caused by a laceration or retained placental fragments. The nurse then records the event, the interventions instituted, and the woman’s response to interventions.

Reference Lowdermilk, Perry, Cashion, Alden (2016), pp. 439, 486, 808–809.

The othe r ha nd is cuppe d to ma s s a ge a nd ge ntly

compre s s the fundus towa rd the lowe r ute rine s e gme nt.

One ha nd re ma ins cuppe d a ga ins t the ute rus a t the le ve l of the s ymphys is

pubis to s upport the ute rus .

FIGURE 30-2 Technique for fundal massage.

365CHAPTER 30 Postpartum Complications

M

a

t

e

r

n

i

t

y

3. An o rexia 4. Pelvic discom fort or pain 5. Vagin al disch arge th at is m alodorou s; n orm al

vagin al disch arge h as a flesh y odor or an odor sim ilar to a m en strual period.

6. Elevated wh ite blood cell coun t

A temperature of 100 .4 °F (38 °C) is normal during the first 24 hours postpartum because of dehydration; a temperature of 100.4 °F (38 °C) or greater after 24 hours postpartum indicates infection.

C. In terven tion s 1. Mon itor vital sign s an d tem p erature every 2 to

4 h ours. 2. Make th e clien t as com fortab le as possib le; posi-

tion th e clien t to prom o te vagin al drain age. 3. Keep th e clien t warm , if ch illed. 4. Iso late th e newborn from th e clien t on ly if th e cli-

en t can in fect th e n ewborn . 5. Provide a n utritious, high -calorie, high -protein diet. 6. En cou rage fluids to 3000 to 4000 m L/ d ay, if n ot

con train dicated. 7. En cou rage frequen t void in g an d m on itor in take

an d output. 8. Mon itor cu lture results if cultures were

prescribed. 9. Adm in ister an tibiotics acco rdin g to id en tified

organ ism , as prescribed.

VI. Mastitis A. Description

1. Mastitis is in flam m ation of th e breast as a result of in fectio n .

2. Mastitis occurs prim arily in breast-feed in g m oth ers 2 to 3 weeks after delivery, but m ay occur at an y tim e durin g lactation .

B. Assessm en t (Fig. 30-3) 1. Localized h eat an d swellin g

2. Pain ; ten der axillary lym ph n od es 3. Elevated tem p erature 4. Com p lain ts of flu like sym ptom s

C. In terven tion s 1. In struct th e clien t in go od h an d-wash in g an d

breast h ygien e tech n iques. 2. Prom o te com fo rt. 3. Apply h eat or co ld to th e site as prescribed. 4. Main tain lactation in breast-feed in g m oth ers. 5. En cou rage m an u al exp ression of breast m ilk or

use of a breast pum p every 4 h ours. 6. En cou rage th e clien t to supp ort th e breasts by

wearin g a supp ortive bra; avoid wearin g an un derwire bra.

7. Adm in ister an algesics as prescribed. 8. Adm in ister an tibiotics as prescribed.

VII. Pulmonary Embolism A. Descrip tion : Passage of a th rom bus, often origin at-

in g in a uterin e or oth er pelvic vein , in to th e lun gs, wh ere it disrupts th e circulation of th e blood

B. Assessm en t 1. Sudd en dyspn ea an d ch est pain 2. Tach ypn ea an d tach ycard ia 3. Cough an d lun g crackles 4. Hem o ptysis 5. Feelin g of im pen din g doom

C. In terven tion s 1. Adm in ister oxygen . 2. Position th e clien t with th e h ead of th e bed

elevated . 3. Mon itor vital sign s frequen tly, especially respira-

tory an d h eart rate an d breath soun ds. 4. Mon itor for sign s of respiratory distress an d for

sign s of in creasin g h ypoxem ia. 5. Adm in ister in traven o us fluid s as prescribed. 6. Adm in ister an ticoagulan ts as prescribed . 7. Prepare to assist th e HCP to ad m in ister m edica-

tion s to dissolve th e clot, if prescribed.

VIII. Subinvolution A. Descrip tion : In com plete in volution or failure of th e

uterus to return to its n orm al size an d con d ition B. Assessm en t

1. Uterin e pain on palp ation 2. Uterus larger th an expected 3. More th an n orm al vagin al bleed in g

C. In terven tion s 1. Assess vital sign s. 2. Assess uterus an d fun dus. 3. Mon itor for uterin e pain an d vagin al bleedin g. 4. Elevate legs to prom o te ven o us return . 5. En cou rage frequen t voidin g. 6. Mon itor h em oglob in an d h em atocrit. 7. Prepare to ad m in ister m eth ylergon ovin e m ale-

ate, wh ich provid es sustain ed con traction of th e uterus, as prescribed.FIGURE 30-3 Mastitis.

366 UNIT VI Maternity Nursing

IX. Thrombophlebitis A. Description

1. A clo t form s in a vessel wall as a result of in flam - m ation of th e vessel wall.

2. A partial obstru ction of th e vessel can occur. 3. In creased blood -clottin g facto rs in th e postpar-

tum period place th e clien t at risk. 4. Early am bulation in th e postoperative period

after cesarean section is a preven tive m easu re. B. Types

1. Superficial th rom bop h lebitis 2. Fem o ral th rom bop h lebitis 3. Pelvic th rom boph leb itis

C. Assessm en t ( Box 30-2) D. In terven tion s

1. Specific th erap ies m ay depen d on th e location of th rom boph leb itis.

2. Assess th e lower extrem ities for edem a, ten der- n ess, varices, an d in creased skin tem perature.

3. Main tain bed rest. 4. Elevate th e affected leg. 5. Apply a bed cradle an d keep bedcloth es off th e

affected leg. 6. Never m assage th e leg. 7. Mon itor for m an ifestatio n s of pulm o n ary

em b olism . 8. Apply h ot packs or m oist h eat to th e affected site

as prescribed to alleviate discom fort. 9. Apply elastic stockin gs (suppo rt h ose) if

prescribed. 10. Adm in ister an algesics an d an tibiotics as

prescribed. 11. Heparin sodium in traven ously m ay be pre-

scrib ed for fem oral or pelvic th rom boph leb itis to preven t furth er th rom bus form ation .

E. Clien t education ( Box 30-3)

X. Perinatal Loss A. Description

1. Perin atal loss is associated with m iscarriage, n eo- n atal death , stillbirth , an d th erap eutic abortion .

2. Loss an d grief also m ay occur with th e birth of a preterm baby, a newborn with com plication s of birth , or a n ewborn with con gen ital an om alies; it also m ay occur in a clien t wh o is givin g up a ch ild for adoption .

B. In terven tion s

Not all interventions are appropriate for every woman and her family who has experienced perinatal loss. It is crucial to consider religious, spiritual, and cul- tural health care practices and beliefs when planning care for a woman and family who have experienced perinatal loss.

1. Com m un icate th erapeutically an d actively listen , providin g paren ts tim e to grieve.

2. No tify th e h ospital ch aplain or oth er religious perso n .

3. Discuss with th e paren ts option s such as seein g, h old in g, bath in g, or dressin g th e deceased in fan t; visitation by oth er fam ily m em bers or frien ds; religious, spiritual, or cultural rituals; an d fun eral arran gem en ts.

4. Prepare a special m em ories box with keepsakes such as footprin ts, h an dprin ts, locks of h air, an d pictures, if ap propriate.

5. Adm it th e m oth er to a private room ; if possible, m ark th e door to th e room with a special card (per agen cy proced ure an d m ain tain in g con fi- den tiality) th at den otes to h ospital staff th at th is fam ily h as experien ced a loss.

6. See Ch apter 28 for addition al in form ation on in trauterin e fetal dem ise.

M

a

t

e

r

n

i

t

y

BOX 30-2 Assessment of Types of Thrombophlebitis

Superficial ▪ Palpable thrombus that feels bumpy and hard ▪ Tenderness and pain in affected lower extremity ▪ Warm and pinkish red color over the thrombus area Femoral ▪ Malaise ▪ Chills and fever ▪ Diminished peripheral pulses ▪ Shiny white skin over affected area ▪ Pain, stiffness, and swelling of affected leg Pelvic ▪ Severe chills ▪ Dramatic body temperature changes ▪ Pulmonary embolism may be the first sign

BOX 30-3 Client Education for Thrombophlebitis Never massage the leg. Avoid crossing the legs. Avoid prolonged sitting. Avoid constrictive clothing. Avoid pressure behind the knees. Know how to apply elastic stockings (support hose) if

prescribed. Understand the importance of compliance with anticoagulant

therapy if prescribed. Understand the importance of follow-up with the health care

provider.

367CHAPTER 30 Postpartum Complications

M

a

t

e

r

n

i

t

y

CRITICAL THINKING What Should You Do? Answer: A temperature of 10 0 .4 °F (38 °C) is normal during the first 24 hours postpartum because of dehydration; a tem- perature of 10 0.4 °F (38 °C) or greater after 24 hours postpar- tum indicates infection. Therefore, if the temperature is 101.2 °F (38.4 °C) 28 hours postpartum, the nurse should report the finding to the health care provider (HCP) and immediately implement any prescriptions from the HCP.

Reference: Lowdermilk et al. (2016), pp. 478, 486.

P R A C T I C E Q U E S T I O N S 308. Th e n urse is m on itorin g a clien t in th e im m ediate

postp artum period for sign s of h em orrh age. Wh ich sign , if n oted, would be an early sign of excessive blood loss? 1. A tem p erature of 100.4 °F (38 °C) 2. An in crease in th e pulse rate from 88 to 102

beats/ m in ute 3. A blood pressure ch an ge from 130/ 88 to

124/ 80 m m Hg 4. An in crease in th e respiratory rate fro m 18 to 22

breath s/ m in ute

309. Th e n urse is preparin g a list of self-care in struction s for a postpartum clien t wh o was diagn osed with m astitis. Wh ich in struction s sh ould be in cluded on th e list? Select all th at ap p ly.

1. Wear a supportive bra. 2. Rest durin g th e acute ph ase. 3. Main tain a fluid in take of at least

3000 m L/ day. 4. Con tin ue to breast-feed if th e breasts are n ot

too sore. 5. Take th e prescribed an tibiotics un til th e sore-

n ess subsides. 6. Avoid decom pression of th e breasts by

breast-feedin g or breast pum p.

310. Th e n urse is providing in struction s about m easures to preven t postpartum m astitis to a clien t wh o is breast-feedin g h er n ewborn. Wh ich clien t statem en t would in dicate a n eed fo r furth er in stru ctio n ? 1. “I sh ould breast-feed every 2 to 3 h ours.” 2. “I sh ould ch an ge th e breast pads frequen tly.” 3. “I sh ould wash m y h an ds well before breast-

feedin g.” 4. “I sh ould wash m y n ipp les daily with soap

an d water.”

311. Th e postpartu m n urse is assessin g a clien t wh o delivered a h ealth y in fan t by cesarean section for

sign s an d sym pto m s of superficial ven o us th rom - bosis. Wh ich sign sh ould th e n urse n ote if superfi- cial ven o us th rom bosis were presen t? 1. Palen ess of th e calf area 2. Cooln ess of th e calf area 3. En larged, h arden ed vein s 4. Palpab le dorsalis ped is pulses

312. A clien t in a postp artum un it com plain s of sudd en sh arp ch est pain an d dyspn ea. Th e n urse n otes th at th e clien t is tach ycardic an d th e respiratory rate is elevated. Th e n urse susp ects a pulm on ary em bo- lism . Wh ich sh ould be th e in itial n ursin g action ? 1. In itiate an in traven o us lin e. 2. Assess th e clien t’s blood pressure. 3. Prepare to adm in ister m orph in e sulfate. 4. Adm in ister oxygen , 8 to 10 L/ m in ute, by face

m ask.

313. Th e n urse is assessin g a clien t in th e fourth stage of labo r an d n otes th at th e fun dus is firm , but th at bleed in g is excessive. Wh ich sh o uld be th e in itial n ursin g action ? 1. Record th e fin din gs. 2. Massage th e fun dus. 3. No tify th e h ealth care provid er (HCP) . 4. Place th e clien t in Tren delen burg’s position .

314. Th e n urse is preparin g to care for four assign ed clien ts. Wh ich clien t is at m o st risk for h em or- rh age? 1. A prim iparous clien t wh o delivered 4 h ours ago 2. A m ultiparous clien t wh o delivered 6 h ours ago 3. A m ultiparous clien t wh o delivered a large baby

after oxytocin in du ction 4. A prim iparous clien t wh o delivered 6 h ours ago

an d h ad epidu ral an esth esia

315. A postpartu m clien t is diagn osed with cystitis. Th e n urse sh o uld plan for wh ich p rio rity action in th e care of th e clien t? 1. Providin g sitz bath s 2. En cou ragin g fluid in take 3. Placin g ice on th e perin eum 4. Mon itorin g h em oglobin an d h em atocrit levels

316. Th e n urse is m on itorin g a postpartum clien t wh o received epidu ral an esth esia for delivery for th e presen ce of a vulvar h em atom a. Wh ich assessm en t fin din g would b est in dicate th e presen ce of a h em atom a? 1. Ch an ges in vital sign s 2. Sign s of h eavy bruisin g 3. Com plain ts of in ten se pain 4. Com p lain ts of a tearin g sen sation

368 UNIT VI Maternity Nursing

317. Th e n urse is creatin g a plan of care for a postp artum clien t with a sm all vu lvar h em atom a. Th e n urse sh ould in clude wh ich specific action durin g th e first 12 h ours after delivery? 1. En cou rage am bulation h ourly. 2. Assess vital sign s every 4 h ours. 3. Measure fun dal h eigh t every 4 h ou rs. 4. Prepare an ice pack for application to th e area.

318. O n assessm en t of a postp artum clien t, th e n urse n otes th at th e uterus feels soft an d boggy. Th e n urse sh o uld take wh ich in itial action ? 1. Do cum en t th e fin din gs. 2. Elevate th e clien t’s legs. 3. Massage th e fun dus un til it is firm . 4. Push on th e uterus to assist in exp ressin g clo ts.

A N S W E R S 308. 2 Ra t ion a le: Durin g th e fo urth stage o f lab or, th e m atern al blo od pressu re, pu lse, an d resp iratio n sh o uld be ch ecked every 15 m in u tes d urin g th e first h ou r. An in creasin g pu lse is an early sign of excessive b lo od lo ss b ecau se th e h eart pu m ps faster to co m p en sate for redu ced b lo od vo lum e. A sligh t in crease in tem p eratu re is n orm al. Th e bloo d p ressure decreases as th e blo od volum e dim in ish es, bu t a d ecreased b lo od pressu re wo uld n o t be th e earliest sign of h em orrh age. Th e resp irato ry rate is sligh tly in creased from n orm al. Test-Ta king Stra tegy: Note th e strategic wo rd , early. Th in k ab o ut th e p h ysio lo gical occurren ces of h em o rrh age an d sh o ck an d th e exp ected fin d in gs in th e po stpartum p erio d . Th is sh ou ld assist in d irectin g yo u to th e co rrect o ption . Review: Early sign s of h em o r r h a ge Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Clottin g; Perfu sio n Refer en ce: Lo wderm ilk et al. (2016), p p . 487, 809.

309. 1, 2, 3, 4 Ra t ion a le: Mastitis is an in flam m ation of th e lactatin g breast as a result of in fectio n . Clien t in structio n s in clu de restin g du r- in g th e acu te ph ase, m ain tain in g a flu id in take o f at least 3000 m L/ day ( if n o t co n train d icated) , an d takin g an algesics to relieve disco m fo rt. An tib io tics m ay b e p rescribed an d are taken u n til th e com p lete prescrib ed co urse is fin ish ed . Th ey are n ot stop p ed wh en th e so ren ess sub sid es. Ad dition al su p- po rtive m easu res in clu de th e use o f m o ist h eat o r ice p acks an d wearin g a su pp ortive b ra. Co n tin ued d ecom pressio n o f th e breast by b reast-feedin g or breast pu m p is im p ortan t to em p ty th e b reast an d p reven t th e fo rm ation o f an ab scess. Test -Ta kin g St r a t egy: Focus on th e su b ject , treatm en t m easu res fo r m astitis. Th in k abo u t th e p ath o ph ysiology asso ciated with m astitis to an swer co rrectly. Recallin g th at su p- po rtive m easu res in clu d e rest, m o ist h eat o r ice p acks, an tibi- otics, an algesics, in creased flu id in take, breast su p po rt, an d decom p ression of th e breasts will assist in an swerin g th e qu estio n . Review: Treatm en t m easu res for m a st it is Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Clien t Edu catio n ; In flam m ation Refer en ce: Lo wderm ilk et al. (2016), p p . 490, 625.

310. 4 Ra t ion a le: Mastitis is in flam m atio n o f th e b reast as a result o f in fection . It gen erally is cau sed b y an o rgan ism th at en ters th ro ugh an in ju red area o f th e n ipp les, su ch as a crack o r blis- ter. Measures to p reven t th e d evelo pm en t o f m astitis in clu de ch an gin g n ursin g p ad s wh en th ey are wet an d avoidin g con tin - u o us pressure o n th e b reasts. So ap is d ryin g an d cou ld lead to crackin g o f th e n ip ples, an d th e clien t sh ou ld be in stru cted to avo id u sin g so ap on th e n ipp les. Th e m oth er is tau gh t abo ut th e im p ortan ce o f h an d wash in g an d th at sh e sh o uld breast- feed every 2 to 3 h o urs. Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d s, need for fur- ther instruction. Th ese words in dicate a n ega t ive even t q u er y an d th e n eed to select th e op tion th at id en tifies th e in correct clien t statem en t. Recallin g th at th e u se o f so ap is d ryin g to th e skin an d co u ld cau se crackin g an d p ro vid e an en try p oin t fo r o rgan ism s will d irect yo u easily to th e correct op tio n . Review: Preven tion m easu res for m a st it is Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Clien t Ed u catio n ; In flam m ation Refer en ce: Lo wd erm ilk et al. (2016), p p. 489, 624–625.

311. 3 Ra t ion a le: Th rom b osis o f sup erficial vein s usu ally is accom p a- n ied by sign s an d sym pto m s o f in flam m ation , in clu din g swellin g, red n ess, ten d ern ess, an d warm th o f th e in vo lved extrem ity. It also m ay b e po ssib le to palp ate th e en larged , h ard vein . Clien ts so m etim es experien ce p ain wh en th ey walk. Palp able d o rsalis p ed is p ulses is a n o rm al fin d in g. Test -Ta kin g Str a tegy: Elim in ate op tion 4 first, because th is is a n orm al an d expected fin d in g. Next, elim in ate o ptio n s 1 an d 2 b ecause th ey are co m p a r a b le o r a lik e. Review: Su p er ficia l ven o u s t h r o m b o sis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Clottin g: Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 811–812.

312. 4 Ra t ion a le: If p ulm o n ary em b olism is susp ected, o xygen sh ou ld b e ad m in istered , 8 to 10 L/ m in u te, b y face m ask. O xy- gen is used to d ecrease h yp oxia. Th e clien t also is kept o n b ed rest with th e h ead of th e b ed sligh tly elevated to redu ce dys- p n ea. Morph in e sulfate m ay b e p rescribed for th e clien t, bu t th is wo u ld n o t b e th e in itial n u rsin g action . An in traven o us

M

a

t

e

r

n

i

t

y

369CHAPTER 30 Postpartum Complications

lin e also will b e req uired , an d vital sign s n eed to b e m o n ito red , b ut th ese action s wo uld follow th e ad m in istration of oxygen . Test-Ta kin g St r a t egy: No te th e st r a t egic wo r d , initial. Use th e ABCs—a ir wa y–b r ea t h in g–cir cu la t io n —to assist in d irectin g yo u to th e correct o ptio n . Review: Th erap eu tic m an agem en t o f a clien t with p u lm o n a r y em b o lism Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care: Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Lo wd erm ilk et al. (2016), p. 811.

313. 3 Ra tion a le: If bleedin g is excessive, th e cau se m ay be laceration o f th e cervix o r b irth can al. Massagin g th e fu n du s if it is firm would n o t assist in con tro llin g th e bleedin g. Tren delen burg’s p osition sh ou ld b e avo ided b ecau se it m ay in terfere with car- d iac an d respiratory fu n ctio n . Alth o ugh th e n urse wo uld record th e fin din gs, th e in itial n ursin g action wou ld be to n otify th e HCP. Test-Ta kin g Str a tegy: No te th e st r a t egic wo r d , initial. Focus o n th e d a t a in t h e q u est io n , n otin g th e clin ical m an ifestation s id en tified in th e qu estio n . Elim in ate op tio n 2 first because, if th e u teru s is firm , it wo uld n o t be n ecessary to p erfo rm fun dal m assage. Kn o win g th at Tren d elen bu rg’s p o sitio n in terferes with cardiac an d respiratory fun ctio n will assist in elim in atin g o ptio n 4. Fro m th e rem ain in g o ptio n s, n otin g th e wo rd s bleed- ing is excessive will assist in d irectin g you to th e correct o ption . Review: Nursin g in terven tion s fo r p o st p a r t u m h em o r r h a ge Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care: Em ergen cy Situ ation s/ Man age- m en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Lo wd erm ilk et al. (2016), pp . 486, 803.

314. 3 Ra tion a le: Th e causes of po stpartum h em o rrh age in clu de uter- in e ato n y; laceration o f th e vagin a; h em atom a d evelo pm en t in th e cervix, perin eum , o r labia; an d retain ed placen tal frag- m en ts. Pred isp osin g facto rs for h em orrh age in clu de a p reviou s h istory o f p o stpartu m h em o rrh age, p lacen ta p revia, ab ru p tio p lacen tae, overdisten tio n of th e u teru s from p olyh ydram n ios, m ultiple gestation , a large n eo n ate, in fection , m u ltip arity, d ys- to cia or lab or th at is p ro lo n ged, op erative delivery such as a cesarean or forceps delivery, an d in trau terin e m an ip u lation . Th e m u ltiparou s clien t wh o delivered a large fetu s after o xyto- cin in du ction h as m o re risk factors associated with p ostp artu m h em o rrh age th an th e oth er clien ts. In add itio n , th ere are n o sp ecific d ata in th e clien t descriptio n s in o p tion s 1, 2, an d 4 th at p resen t th e risk fo r h em o rrh age. Test-Ta kin g St r a t egy: Note th e st r a t egic wo r d , most. Fo cus on th e su b ject , th e clien t at m o st risk for h em orrh age. Read th e clien t d escription in each o ption . No tin g th e wo rd s large an d oxytocin in th e co rrect o p tion will direct yo u to th is o ptio n . Review: Hem o r r h a ge an d p o st p a r t u m clien t

Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Lowd erm ilk et al. (2016), pp . 486, 810.

315. 2 Ra tion a le: Cystitis is an in fectio n o f th e blad der. Th e clien t sh o u ld co n su m e 3000 m L o f fluid s per d ay if n o t co n train d i- cated. Sitz bath s an d ice wou ld b e app ro priate in terven tio n s fo r p erin eal disco m fo rt. Hem o glob in an d h em ato crit levels would be m on itored with h em orrh age. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject , m easu res to treat cystitis, an d n o te th e st r a t egic wo r d , priority. Rem em ber th at in creased fluid s are a p rio rity in terven tion . Review: In terven tion s fo r a clien t with cyst it is Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Elim in ation ; In fection Refer en ce: Lowd erm ilk et al. (2016), pp . 813–814.

316. 1 Ra tion a le: Because th e clien t h as h ad ep id ural an esth esia an d is an esth etized , sh e can n ot feel p ain , pressu re, o r a tearin g sen - satio n . Ch an ges in vital sign s in d icate h yp ovo lem ia in an an es- th etized p ostp artu m clien t with vulvar h em ato m a. O ptio n 2 (h eavy b ru isin g) m ay b e seen , b ut vital sign ch an ges in d icate h em ato m a caused by b lo od collection in th e perin eal tissu es. Test-Ta kin g St r a t egy: No te th e st r a t egic wo r d , best. Also n ote th at th e clien t received ep id ural an esth esia. With th is in m in d , elim in ate o p tion s 3 an d 4. Fro m th e rem ain in g o ption s, u se th e ABCs—a ir wa y–b r ea t h in g–cir cu la t io n —to direct yo u to th e correct o ptio n . Review: Sign s o f a vu lva r h em a t o m a Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—Postp artu m Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Lowd erm ilk et al. (2016), pp . 804, 809.

317. 4 Ra tion a le: A h em ato m a is a localized collection o f blo od in th e tissues o f th e rep ro d uctive sac after delivery. Vulvar h em a- to m a is th e m ost co m m o n . App licatio n o f ice redu ces swellin g cau sed by h em atom a fo rm ation in th e vu lvar area. O p tio n s 1, 2, an d 3 are n o t in terven tion s th at are sp ecific to th e plan of care fo r a clien t with a sm all vu lvar h em ato m a. Am b ulatio n h o urly in creases th e risk fo r b leed in g. Clien t assessm en t every 4 h o urs is to o in frequ en t. Test-Ta kin g St r a tegy: Focus on the su b ject , a sm all vulvar h em atom a. Th in k abo ut th e effect o f each action in th e option s; th is focus will assist in directin g you to th e correct option . Review: Nu rsin g care of th e clien t with a h em a t o m a Level of Cogn itive Ability: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g

M

a

t

e

r

n

i

t

y

370 UNIT VI Maternity Nursing

Con t en t Ar ea : Matern ity—Po stp artum Pr ior ity Con cepts: Clin ical Jud gm en t; Clottin g Refer en ce: Lo wderm ilk et al. (2016), p p . 488–489.

318. 3 Ra t ion a le: If th e u terus is n ot con tracted firm ly (i.e., it is soft an d boggy), th e in itial in terven tio n is to m assage th e fun d us un til it is firm and to exp ress clots th at m ay h ave accum u lated in th e uterus. Elevatin g th e clien t’s legs wou ld n ot assist in m an agin g uterin e aton y. Docum en tin g th e fin din gs is an appropriate actio n , but is n ot th e in itial actio n . Pushin g o n an u ncon tracted u teru s can in vert th e uterus an d cau se m assive h em o rrh age.

Test -Ta kin g Str a tegy: No te th e st r a t egic wo r d , initial, in th e q u estion . Focus o n th e su b ject , th at th e uteru s is so ft an d b o ggy. Recallin g th e th erapeu tic m an agem en t fo r uterin e ato n y will assist in directin g you to th e correct option . Review: Th erapeu tic m an agem en t of th e clien t with u terin e ato n y Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Clin ical Jud gm en t; Rep rod uctio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 486, 803.

M

a

t

e

r

n

i

t

y

371CHAPTER 30 Postpartum Complications

M

a

t

e

r

n

i

t

y

C H A P T E R 31 Care of the Newborn

PRIORITY CONCEPTS Development, Health Promotion

CRITICAL THINKING What Should You Do? The nurse is performing an initial assessment on a newborn and notes that the newborn is experiencing tremors. What should the nurse do? Answer located on p. 388.

I. Initial Care of the Newborn A. Assessm en t

1. O bserve or assist with in itiation of respiration s. 2. Assess Apgar score. 3. Note ch aracteristics of cry. 4. Mon itor for n asal flarin g, grun tin g, retraction s,

an d abn o rm al respiration s, such as a seesaw respiratory pattern (rise an d fall of th e ch est an d abdom en do n ot occur togeth er) .

5. Assess for cen tral cyan osis an d acrocyan osis. 6. O btain vital sign s. 7. O bserve th e newborn for sign s of h ypo th erm ia or

h yperth erm ia. 8. Assess for gross an om alies.

B. In terven tion s 1. Suction th e m ou th first an d th en th e n ares with

a bulb syrin ge. 2. Dry th e n ewborn an d stim ulate cryin g by rub-

bin g th e back. 3. Main tain tem p erature stability; wrap th e n ew-

born in warm blan kets an d place a stockin ette cap on th e n ewborn ’s h ead.

4. Keep th e n ewborn with th e m oth er to facilitate bon din g.

5. Place th e n ewborn at th e m oth er’s breast if breast-feedin g is plan n ed, or place th e n ewborn on th e m oth er’s abdom en .

6. Place th e n ewborn in a radian t warm er. 7. Position th e n ewborn on th e side with a rolled

blan ket at th e back to facilitate drain age of m ucus.

8. En sure th e n ewborn ’s proper iden tification . 9. Footp rin t th e n ewborn an d fin gerprin t th e

m oth er on th e iden tification sh eet per agen cy policies an d proced ures; in itiate oth er agen cy iden tification an d safety proced ures.

10. Place m atch in g id en tification bracelets on th e m oth er an d th e n ewborn .

C. Apgar scorin g system 1. Assess each of 5 item s to be scored an d ad d th e

poin ts to determ in e th e n ewborn ’s total score. 2. Five vital in dicators ( Table 31-1) 3. In terven tion s: Apgar score ( Table 31-2)

The newborn’s Apgar score is routinely assessed and recorded at 1 minute and 5 minutes after birth, and at 10 minutes if needed.

II. Initial Physical Examination A. Gen eral guidelin es

1. Keep th e newborn warm durin g th e exam in ation . 2. Begin with gen eral observation s, an d th en per-

form assessm en ts th at are least disturbin g to th e n ewborn first.

3. In itiate n ursin g in terven tion s for ab n orm al fin d- in gs an d docum en t fin din gs.

4. Th e Ballard Scale m ay be used for gestation al age assessm en t; in th is scale, scores are assign ed to ph ysical an d n eurological criteria.

The phases of newborn instability occur during the first 6 to 8 hours after birth and are known as the tran- sition period between intrauterine and extrauterine exis- tence. These phases include the first period of reactivity, period of decreased responsiveness, and second period of reactivity.

B. Vital sign s 1. Heart rate (restin g): 120 to 160 beats/ m in ute

(apical), 80 to 100 beats/ m in ute (if sleepin g), up to 180 beats/ m in u te (if cryin g) ; au scultate at th e fourth in tercostal space for 1 full m in ute to detect abn o rm alities.

372

2. Respiration s: 30 to 60 breath s/ m in ute; assess for 1 full m in ute.

3. Assess h eart rate an d respiratory rate first before assessin g oth er vital sign s wh ile th e n ewborn is restin g or sleepin g.

4. Axillary tem perature: 96.8 °F (37 °C) to 99 °F (37.2 °C)

5. Blood pressure: Usually n ot don e in term n ew- born , 80–90/ 40–50 m m Hg

C. Bod y m easurem en ts (app roxim ate) 1. Len gth : 18 to 22 in ch es (45 to 55 cm ) 2. Weigh t: 2500 to 4000 g (5.5 to 8.75 lb) 3. Head circum feren ce: 33 to 35 cm (13.2 to

14 in ch es) D. Head

1. Head sh ould be on e fourth of th e body len gth (ceph alocaudal develo pm en t).

2. Bon es of th e sku ll are n ot fused. 3. Sutures (con nective tissue between the skull bones)

are palpable an d m ay be overlappin g because of h ead m oldin g, but sh ould n ot be widen ed.

4. Fon tan els are un ossified m em bran ous tissue at th e jun ction of th e sutures (Table 31-3).

5. Moldin g is asym m etry of th e h ead resultin g from pressure in th e birth can al; m oldin g disappears in about 72 h ours ( Fig. 31-1).

6. Masses from birth traum a a . Caput succed an eum is edem a of th e soft tis-

sue over bon e (crosses over suture lin e); it subsides with in a few days.

b . Ceph alh em atom a is swellin g cau sed by bleedin g in to an area between th e bon e an d its periosteum (does n ot cross over suture lin e); it usually is absorbed with in 6 weeks with n o treatm en t.

M

a

t

e

r

n

i

t

y

TABLE 31-1 Five Vital Indicators of Apgar Scoring Indicator 0 Points 1 Point 2 Points

Heart rate Absent < 100 beats/ min ! 100 beats/ min

Respiratory rate and effort Absent Slow, irregular breathing, weak cry Good rate and effort, vigorous cry

Muscle tone Flaccid, limp Minimal flexion of extremities Good flexion, active motion

Reflex irritability No response Minimal response (grimace) to suction or to gentle slap on soles

Responds promptly with a cry or active movement

Skin color Pallor or cyanosis Body skin color normal, extremities blue Body and extremity skin color normal

TABLE 31-2 Apgar Score Interventions Score Intervention

8-10 No intervention required except to support newborn’s spontaneous efforts

4-7 Stimulate; rub newborn’s back; administer oxygen to newborn; rescore at specific intervals

0-3 Newborn requires full resuscitation; rescore at specific intervals

TABLE 31-3 Fontanels Fontanel Characteristics Closure

Anterior Soft, flat, diamond-shaped; 3-4 cm wide  2-3 cm long

Between 12 and 18 mo of age

Posterior Triangular; 0.5-1 cm wide Located between occipital and parietal bones

Between birth and 2-3 mo of age

B

A

FIGURE 31-1 Molding. A, Significant molding after vaginal birth. B, Sche- matic of bones of skull when molding is present. (A, From Perry et al, 20 10. Courtesy Kim Molloy, Knoxville, Iowa.)

373CHAPTER 31 Care of the Newborn

7. Head lag a . Com m on wh en pullin g th e n ewborn to a sit-

tin g position b . Wh en pron e, th e n ewborn sh ould be able to

lift th e h ead sligh tly an d turn th e h ead from side to side.

E. Eyes 1. Slate gray (ligh t skin ), dark blue, or brown -gray

(dark skin ) 2. Sym m etrical an d clear 3. Pupils equal, roun d, react to ligh t an d accom -

m od ation 4. Blin k reflex presen t 5. Eyes cro ss because of weak extraocu lar m uscles 6. Ability to track an d fixate m om en tarily 7. Red reflex presen t 8. Eyelids often edem atou s as a result of pressure

durin g th e birth process an d th e effects of eye m ed ication

F. Ears 1. Sym m etrical 2. Firm cartilage with recoil 3. To p of pin n a on or above lin e drawn from outer

can th us of eye 4. Low-set ears associated with Down syn dro m e,

ren al an om alies, or oth er gen etic or ch rom o- som al syn drom es

G. No se 1. Flat, broad, in cen ter of face 2. O bligatory n ose breath in g 3. O ccasion al sn eezin g to rem ove obstru ction s 4. Nares are paten t an d sh ould n ot flare (flarin g is

an in dication of respiratory distress). H. Mou th

1. Pin k, m oist gum s 2. Soft an d h ard palates in tact 3. Epstein ’s pearls (sm all, wh ite cysts) m ay be pre-

sen t on h ard palate. 4. Uvula in m idlin e 5. Freely m ovin g ton gue, sym m etrical, h as sh ort

fren u lum 6. Suckin g an d cryin g m ovem en ts sym m etrical 7. Able to swallow 8. Ro ot an d gag reflexes presen t

When assessing the newborn’s mouth, look for the presence of thrush (Candida albicans), which are white patchy areas on the tongue or gums that cannot be removed with a washcloth; these may be painful.

I. Neck 1. Sh o rt an d th ick 2. Head h eld in m idlin e 3. Trach ea m idlin e 4. Good ran ge of m otion an d ability to flex

an d exten d

5. Assess for torticollis (h ead in clin ed to 1 side as a result of con traction of m uscles on that side of th e n eck)

J. Ch est 1. Circular appearan ce because an tero posterio r

an d lateral diam eters are about equ al (app roxi- m ately 30 to 33 cm [12 to 13.2 in ch es] at birth )

2. Diaph ragm atic respiration s—ch est an d abdo- m en sh ould rise an d fall in syn ch ron y, n ot in seesaw pattern

3. Bron ch ial soun ds h eard on au scultatio n 4. Nipp les prom in en t an d often edem atous; m ilky

secretio n (witch ’s m ilk) com m on 5. Breast tissue presen t 6. Clavicles n eed to be palp ated to assess for

fractures. K. Skin

1. Pin kish red (ligh t-skin n ed n ewborn ) to pin kish brown or pin kish yellow (dark-skin n ed n ewborn )

2. Vern ix caseosa, a ch eesy wh ite substan ce, on en tire body in preterm n ewborn s, but is m ore prom in en t between folds closer to term ; m ay be absen t after 42 weeks of gestation

3. Lan ugo, fin e body h air, m igh t be seen , espe- cially on th e back.

4. Milia, sm all wh ite sebaceous glan d s, appear on th e foreh ead, n ose, an d ch in .

5. Dry, peelin g skin , in creased in postm ature n ewborn s

6. Dark red color (pleth oric) com m on in prem a- ture n ewborn s

7. Cyan osis m ay be n oted with h ypo th erm ia, in fectio n , an d h ypo glycem ia an d with cardiac, respiratory, or n eurological abn orm alities.

8. Acrocyan osis (perip h eral cyan osis of h an ds an d feet) is n orm al in th e first few h ours after birth an d m ay be n oted in term itten tly for th e n ext 7 to 10 days (Fig. 31-2).

9. Assess for ecch ym osis an d petech iae resultin g from traum a of birth .

10. Assess skin turgor over th e abdom en to deter- m in e h ydration status.

M

a

t

e

r

n

i

t

y

FIGURE 31-2 Acrocyanosis. (From McKinney et al., 2013. Courtesy Todd Shiros, Santa Fe Springs, California.)

374 UNIT VI Maternity Nursing

11. O bserve for forceps m arks. 12. Harlequ in sign

a . Deep pin k or red color develo ps over 1 side of n ewborn ’s body wh ile th e oth er side rem ain s pale or of n orm al color.

b . Harlequ in sign m ay in dicate sh un tin g of blood th at occurs with a cardiac problem or m ay in dicate sep sis.

13. Birth m arks (Table 31-4) L. Abdo m en

1. Um bilical cord a . Um bilical cord sh ould have 3 vessels—2 arter-

ies an d 1 vein; if fewer th an 3 vessels are n oted, n otify the h ealth care provider (HCP).

b . Wh ile a 2-vessel cord (1 artery, 1 vein ) m ay presen t n o problem s or con cern s, th ere is a h igh er correlation to in trauterin e growth restrictio n (IUGR) an d gen etic or ch rom o- som al problem s.

c. Sm all, th in cord m ay be associated with poor fetal growth .

d . Assess for in tact cord, an d en sure th at th e cord clam p is secured.

e. Cord sh ould be clam ped for at least th e first 24 h ou rs after birth ; clam p can be rem oved wh en th e cord is dried an d occluded an d is n o lon ger bleedin g.

f. Note an y bleedin g or drain age from th e cord. g. Clean sin g of th e cord n eeds to be don e; h os-

pital protoco l an d HCP’s preferen ce deter- m in e th e frequen cy, tech n iqu e, an d skin preparatio n used for cord care.

h . If sign s of in fectio n , such as m oistn ess, ooz- in g, disch arge, an d a redden ed base, occur, an tibiotic treatm en t is prescribed .

2. Gastroin testin al a . Mon itor cord for m eco n ium stain in g. b . Assess for um b ilical h ern ia. c. Assess for abdom in al dep ression associated

with diap h ragm atic h ern ia. d . Assess for abdom in al disten tion associated

with obstru ctio n , m ass, or sep sis. e. Mon itor bowel soun ds (presen t with in th e

first h our after birth ). 3. An u s

a . En su re th at th e an al open in g is presen t. b . First stool m econ ium sh ould pass with in

first 24 h ours. M. Gen itals

1. Fem ale a . Labia m ay be swollen ; clitoris m ay be

en larged. b . Sm egm a m ay be presen t (th ick, wh ite

m ucus disch arge). c. Pseudom en struation , cau sed by th e with -

drawal of th e m atern al h orm on e estrogen , is possible (blood-tin ged m ucus).

d . Hym en tag m ay be visible. e. First void in g sh ould occur with in 24 h ours.

2. Male a . Prepuce (foreskin ) covers glan s pen is. b . Scrotum m ay be edem atous. c. Verify m eatu s at tip of pen is. d . Testes are descen ded , but m ay retract

with cold. e. Assess for h ern ia or h ydrocele. f. First void in g sh ould occur with in 24 h ours.

N. Spin e 1. Straigh t 2. Postu re flexed 3. Supp ortive of h ead m om en tarily wh en pron e 4. Ch in flexed on upper ch est 5. Well-coordin ated, sporadic m ovem en ts 6. A degree of h ypo ton icity or h yperton icity m ay

in dicate cen tral n ervous system dam age. 7. Assess for h air tufts an d dim ples alon g th e

spin al colum n (m ay be in dicative of a possible open in g).

M

a

t

e

r

n

i

t

y

TABLE 31-4 Birthmarks Birthmark Characteristics

Telangiectatic nevi (stork bites)

Pale pink or red, flat, dilated capillaries

On eyelids, nose, lower occipital bone, and nape of neck

Blanch easily

More noticeable during crying periods

Disappear by age 2 yr

Nevus flammeus (port-wine stain)

Capillary angioma directly below epidermis

Nonelevated, sharply demarcated, red to purple, dense areas of capillaries

Commonly appear on face

No fading with time

May require future surgery

Nevus vasculosus (strawberry mark)

Capillary hemangioma

Raised, clearly delineated, dark red, with rough surface

Common in head region

Disappears by age 7-9 yr

Mongolian spots Bluish black pigmentation

On lumbar dorsal area and buttocks

Gradually fade during first and second years of life

Common in Asian and dark-skinned individuals

375CHAPTER 31 Care of the Newborn

O. Extrem ities 1. Flexed 2. Full ran ge of m otion ; sym m etrical m ovem en ts 3. Fists clen ch ed 4. Ten fin gers an d 10 toes, all separate 5. Legs bowed 6. Majo r gluteal folds even 7. Creases on soles of feet 8. Assess for fractures (especially clavicle) or

dislocation s (h ip). 9. Assist HCP to assess for developm en tal dyspla-

sia of th e h ip; wh en th igh s are rotated outward, n o clicks sh o uld be h eard (O rtolan i’s sign an d Barlow’s sign are th e 2 assessm en t tools for developm en tal dysplasia of th e h ip).

10. Pulses palp able (radial, brach ial, fem o ral)

Slight tremors noted in the newborn may be a com- mon finding, but could also be a sign of hypoglycemia, hypocalcemia, or drug withdrawal.

III. Body Systems Assessment and Interventions A. Card iovascu lar system

1. Keep th e newborn warm . 2. Measu re th e apical h eart rate for 1 full m in u te. 3. Listen for m urm u rs; assess oxygen saturatio n via

pulse oxim etry if a m urm u r is h eard. 4. Palpate pulses. 5. Assess for cyan osis; blan ch th e skin on th e trun k

an d extrem ities to assess circulation . 6. O bserve for cardiac distress wh en th e n ewborn is

feed in g. B. Resp iratory system

1. Suction th e airway as n ecessary: Use a bulb syrin ge for upper airway suction in g (com press bulb before in sertio n ) an d a Fren ch cath eter for deeper suction in g.

2. O bserve for respiratory distress an d h ypoxem ia. a. Nasal flarin g b . In creasin gly severe retraction s c. Grun tin g d . Cyan osis e. Bradycardia an d periods of apn ea lastin g

lon ger th an 15 secon ds 3. Adm in ister oxygen if n ecessary an d as prescribed.

C. Hepatic system 1. Norm al or ph ysiological jaun dice appears after

the first 24 h ours in full-term n ewborn s an d after the first 48 h ours in prem ature n ewborn s; jaun - dice occurrin g before th is tim e (path ological jaun dice) m ay in dicate early h em olysis of red blood cells an d m ust be reported to th e HCP.

2. Ph ysiological jaun dice peaks on ab out th e fifth day of life (in direct bilirubin levels 6 to 7 m g/ dL [90 to 105 m cm o l/ L).

3. Feed early to stim ulate in testin al activity an d to keep th e bilirubin level lo w.

4. Preven t ch illin g because h ypo th erm ia can cau se acidosis th at in terferes with bilirubin con juga- tion an d excretio n .

5. Liver stores th e iron passed from th e m oth er for 5 to 6 m on th s.

6. Glycogen storage occurs in th e liver. 7. Th e n ewborn is at risk for h em orrh agic disor-

ders; coagulation facto rs syn th esized in th e liver depen d on vitam in K, wh ich is n ot syn th esized un til in testin al bacteria are presen t.

8. Han dle th e n ewborn carefully an d m on itor for an y bruisin g or bleedin g episo des.

9. Watch for m eco n ium stool an d subsequ en t stools.

10. Adm in ister in tram uscular dose of ph yto n a- dion e to th e n ewborn as prescribed to preven t h em orrh agic disorders (usually 0.5 to 1 m g is prescribed); adm in ister in lateral aspect of th e m iddle th ird of th e vastus lateralis m uscle (see Ch apter 32).

11. Assess th e n ewborn ’s h em oglob in an d blood glucose levels.

D. Ren al system 1. Th e im m ature kidn eys are un ab le to con cen trate

urin e. 2. A weigh t loss of 5% to 10% durin g th e first week

of life occurs as a result of water lo ss an d lim ited in take; birth weigh t sh ould be regain ed by 10 to 14 days after birth .

3. Weigh th e n ewborn daily. 4. Mon itor in take an d outp ut; weigh diapers if n ec-

essary (1 g of diap er weigh t equ als 1 m L of urin e).

5. If th e diaper requires weigh in g, record th e weigh t befo re puttin g it on th e n ewborn ; after th e n ewborn voids, reweigh th e diap er an d sub- tract th e prevoided weigh t.

6. Assess for sign s of deh ydration (dry m ucou s m em bran es, sun ken eyeballs, poor skin turgo r, sun ken fon tan els).

E. Im m un e system 1. Newborn receives passive im m un ity via th e

placenta (im m un oglobulin G). 2. Newborn receives passive im m un ity from

colostrum (im m un oglobulin A). 3. Elevation s in im m un oglobulin M in dicate

in fectio n in utero. 4. Use aseptic tech n iqu e an d stan dard precaution s

wh en carin g for th e n ewborn . 5. En sure m eticulo us h an d wash in g. 6. En sure th at an in fectio n -free staff cares for th e

n ewborn . 7. Mon itor th e n ewborn ’s tem perature. 8. O bserve for an y cracks or open in gs in th e skin . 9. Adm in ister eye m edication with in 1 h ou r after

birth to preven t oph th alm ia n eon atoru m (see Ch apter 32).

M

a

t

e

r

n

i

t

y

376 UNIT VI Maternity Nursing

10. Provid e cord care. a. Um b ilical clam p can be rem oved after

24 h ours if cord is dried an d occluded an d is n ot bleedin g.

b . Teach th e m oth er h ow to perform cord care. c. Keep th e cord clean an d dry; soap an d water

m ay be prescribed for clean in g th e cord. d . Keep th e diaper fro m coverin g th e cord; fold

th e diaper below th e cord. e. Assess cord for odor, edem a, or disch arge. f. Th e n ewborn is typically wash ed via a

spon ge bath un til th e cord falls off (with in 2 weeks) . Follow altern ate in struction s if provided by HCP.

11. Provid e circum cisio n care. a. Apply petroleum jelly gauze to th e pen is

except wh en a PlastiBell is used. b . Rem ove petroleum jelly gauze, if applied,

after th e first voidin g followin g circum cision . c. O bserve for edem a, in fectio n , or bleedin g

fro m th e circum cisio n site. d . Teach th e m oth er h ow to care for th e

circum cisio n site. e. Clean th e pen is after each voidin g by

squeezin g warm water over th e pen is. f. A m ilky coverin g over th e glan s pen is is n or-

m al an d sh ould n ot be disrupted. g. Mon itor for urin ary reten tion .

F. Metab olic system an d gastroin testin al system 1. Newborn s are able to digest sim ple carboh y-

drates, but are un ab le to digest fats because of th e lack of lipase.

2. Protein s m ay be broken down on ly partially, so th ey m ay serve as an tigen s an d provoke an aller- gic reactio n .

3. Th e n ewborn h as a sm all stom ach cap acity (less th an 10 m L at birth , in creasin g to about 90 m L by day 10), with rapid in testin al peristalsis (bowel em p tyin g tim e is 2.5 to 3 h ou rs).

4. Breast-feedin g usually can begin im m ediately after birth ; based on HCP preferen ce an d agen cy protoco ls, bottle-fed n ewborn s m ay be in itially offered n o m ore th an 30 m L of form ula.

5. O bserve feedin g reflexes, such as ro otin g, suck- in g, an d swallowin g.

6. Assist th e m oth er with breast-feedin g or for- m ula feedin g; breast-feedin g sh ould be don e every 2 to 3 h ours, an d form ula feed in g (m in i- m um of 30 m L, or 1 oz by day 3) sh ould be don e every 3 to 4 h ours (or per HCP preferen ce or agen cy protoco ls).

7. Burp th e n ewborn durin g an d after feedin g. 8. Assess for regurgitation or vom itin g. 9. Position th e n ewborn on th e righ t side after

feedin g; h owever, th e side-lyin g position is n ot recom m en ded for sleep because th is posi- tion m akes it easy for th e n ewborn to roll to

th e pron e position (pro n e position is con train - dicated because th e pron e position in creases th e risk of sudd en in fan t death syn dro m e).

10. O bserve for n orm al stool an d th e passage of m eco n ium . a . Meco n ium stool, wh ich is green ish black

with a th ick, sticky, tarlike con sisten cy, usu- ally is passed with in th e first 24 h ou rs of life.

b . Tran sition al stool, th e secon d typ e of stool excreted by th e n ewborn , is green ish brown an d of looser con sisten cy th an m eco n ium .

c. Seedy, yellow stools are usually n oted in breast-fed n ewborn s; pale yellow to ligh t brown stools are usually seen in form ula- fed n ewborn s.

11. Perform a n ewborn screen in g test (in clu din g th e test for ph en ylketon uria [PKU]) as prescribed before disch arge after sufficien t protein in take occurs; th e n ewborn sh ould be on form ula or breast m ilk for 24 h ours befo re screen in g.

G. Neurological system 1. Newborn h ead size is propo rtion ally larger

th an th at of an adult because of ceph alocaud al develo pm en t.

2. Myelin ization of n erve fib ers is in com plete, so prim itive reflexes are presen t.

3. Fon tan els are open to allow for brain growth . 4. Assess for abn orm al h ead size an d a bulgin g or

depressed an terior fon tan el. 5. Measu re an d graph th e h ead circum feren ce in

relation to ch est circum feren ce an d len gth . 6. Assess th e n ewborn ’s m ovem en ts, n otin g sym -

m etry, posture, an d ab n orm al m ovem en ts. 7. O bserve for jitterin ess, m arked trem ors, an d

seizures. 8. Test th e n ewborn ’s reflexes. 9. Assess for leth argy.

10. Assess pitch of cry. H. Th erm al regulatory system

1. Preven t cold stress ( Fig. 31-3). 2. Newborn s do n ot sh iver to produ ce h eat. 3. Newborn s h ave brown fat deposits, wh ich

produce h eat. 4. Preven t h eat loss resultin g from evaporation by

keepin g th e n ewborn dry an d well wrapped with a blan ket.

5. Preven t h eat loss resultin g from radiation by keepin g th e n ewborn away from cold objects an d outsid e walls.

6. Preven t h eat lo ss resultin g fro m co n vectio n by sh ieldin g th e n ewborn from drafts.

7. Preven t h eat loss resultin g from con duction by perform in g all treatm en ts on a warm , padded surface.

8. Keep th e ro om tem p erature warm . 9. Take th e n ewborn ’s axillary tem p erature every

h ou r for th e first 4 h ou rs of life, every 4 h ours

M

a

t

e

r

n

i

t

y

377CHAPTER 31 Care of the Newborn

for th e rem ain d er of th e first 24 h ours, an d th en every sh ift (as per agen cy protocol).

Cold stress causes oxygen consumption and energy to be diverted from maintaining normal brain cell func- tion and cardiac function, resulting in serious metabolic and physiological conditions.

I. Reflexes 1. Suckin g an d rootin g

a . Touch th e n ewborn ’s lip, ch eek, or corn er of th e m ou th with a n ipp le.

b . Th e n ewborn turn s th e h ead toward th e n ip- ple, open s th e m outh , takes h old of th e n ip- ple, an d sucks.

c. Rootin g reflex usually disappears after 3 to 4 m on th s, but m ay persist for 1 year.

2. Swallowin g reflex a . Swallowin g reflex occurs spon tan eously

after suckin g an d obtain in g flu ids. b . Newborn swallows in coordin ation with

suckin g with out gaggin g, cough in g, or vom itin g.

3. Ton ic n eck or fen cin g a . Wh ile th e n ewborn is fallin g asleep or sleep-

in g, gen tly an d quickly turn th e h ead to 1 side.

b . As th e n ewborn faces th e left side, th e left arm an d leg exten d outward wh ile th e righ t arm an d leg flex.

c. Wh en th e h ead is turn ed to th e righ t side, th e righ t arm an d leg exten d outward wh ile th e left arm an d leg flex.

d . Resp on se usually disappears with in 3 to 4 m on th s.

4. Palm ar-plan tar grasp a . Place a fin ger in th e palm of th e n ewborn ’s

h an d an d th en place a fin ger at th e base of th e toes.

b . Th e n ewborn ’s fin gers curl aroun d th e exam in er’s fin gers, an d th e n ewborn ’s toes curl down ward.

c. Palm ar respon se lessen s within 3 to 4 m on th s. d . Plan tar respon se lessen s with in 8 m on th s.

5. Moro reflex (also kn own as th e startle reflex) a . Hold th e n ewborn in a sem isittin g position

an d th en allow th e h ead an d trun k to fall backward to at least a 30-degree an gle.

b . The n ewborn assum es sharp exten sion an d abduction of th e arm s with the thum bs an d forefin gers in a “C” position ; th is is followed by flexion an d adduction to an “em brace” position (legs follow a sim ilar pattern ).

c. Th e Moro reflex is presen t at birth an d is absen t by 6 m on th s of age if n eurological m aturation is n ot delayed.

d . A body jerk m otion m ay be th e respo n se between 8 an d 18 weeks.

e. A persisten t respon se lastin g m ore th an 6 m on th s m ay in dicate a n eurological abn o rm ality.

6. Startle reflex (often con sid ered th e sam e as th e Moro reflex) a . Th e respo n se is best elicited if th e n ewborn

is at least 24 h ours old. b . Th e exam in er m akes a loud n oise or claps

h an ds to elicit th e respo n se. c. Th e n ewborn ’s arm s ad duct wh ile th e

elbows flex. d . Th e h an ds stay clen ch ed . e. The reflex sh ould disappear within 4 m on th s.

7. Pull-to-sit respo n se a . Pull th e n ewborn up by th e wrist wh ile th e

n ewborn is in th e supin e position . b . Th e h ead lags un til th e n ewborn is in an

uprigh t position , an d th en th e h ead is level with th e ch est an d sh o ulders m om en tarily before fallin g forward.

c. Th e h ead th en lifts for a few m in u tes. d . Th e respo n se depen ds on th e n ewborn ’s

gen eral m uscle ton e an d con dition an d on m aturity level.

8. Babin ski sign : Plan tar reflex a . Begin n in g at th e h eel of th e foot, use a fin ger

to stroke gen tly upward alon g th e lateral aspect of th e sole, an d th en m ove th e fin ger alon g th e ball of th e foot.

M

a

t

e

r

n

i

t

y P ulmona ry va s ocons triction

↑ Re s pira tory ra te

Pe riphe ra l va s ocons triction

↓ O2 upta ke by lungs

↑ O2 cons umption

Me ta bolic a cidos is

↑ Ana e robic glycolys is

↓ in P O2 a nd pH

↓ O2 to tis s ue s

Cold

FIGURE 31-3 Effects of cold stress. When a newborn is stressed by cold, oxygen (O2) consumption increases and pulmonary and peripheral vaso- constriction occur, decreasing O2 uptake by the lungs and O2 delivery to the tissues; anaerobic glycolysis increases; and there is a decrease in par- tial pressure of oxygen (PO2) and pH, leading to metabolical acidosis.

378 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

b . Th e n ewborn ’s toes h yperexten d wh ile th e big toe dorsiflexes.

c. Th e reflex disappears after th e n ewborn is 1 year old.

d . Absen ce of th is reflex in dicates th e n eed for a n eurological exam in ation .

9. Stepp in g or walkin g a . Ho ld th e n ewborn in a vertical position ,

allowin g 1 foot to touch a table surface. b . Th e n ewborn sim ulates walkin g, altern ately

flexin g an d exten din g th e feet. c. Th e reflex is usually present for 3 to 4 m on th s.

10. Crawlin g a . Place th e n ewborn on th e ab dom en . b . Th e n ewborn begin s to m ake crawlin g

m ovem en ts with th e arm s an d legs. c. Th e reflex usually disappears after ab out

6 weeks.

IV. Newborn Safety A. Newborn iden tification

1. In form ation bracelets are applied to th e m oth er an d n ewborn im m ediately after birth an d before th e m oth er an d n ewborn are sep arated; in addi- tio n , iden tification pictures of th e n ewborn an d footp rin ts from th e n ewborn m ay be obtain ed befo re th e n ewborn leaves th e m oth er’s side in th e delivery room .

2. Th e bracelets in clude n am e, sex, date, tim e of birth , an d id en tification n um bers.

3. Som e agencies use iden tification bracelets th at h ave radiofrequen cy transm itters that set off alarm s if th e newborn is rem oved from a certain area.

4. Agen cies also con d uct un it an d h ospital-wide drills to preven t n ewborn abduction s.

B. Newborn abduction 1. Th e m oth er is taugh t to ch eck th e iden tification

of an y person wh o com es to rem ove th e in fan t fro m h er room an d is taugh t oth er precaution s to preven t n ewborn abduction (n urses m ust be wearin g ph oto id en tification or som e oth er secu- rity badge) (Box 31-1).

2. Clo sed-circuit television s, code-alert ban d s, com pu ter m on itorin g system s, or oth er m on itor- in g system s m ay be used in som e agen cies.

3. Th e n ewborn is wh eeled in a bassin ette, n ot carried in a staff m em ber’s arm s.

V. Parent Teaching A. Form ula feedin g

1. Teach sterilization tech n iqu es if th e water supp ly is located in areas wh ere th e purification process of th e water is question ab le.

2. Rem in d th e m oth er n ot to h eat th e bottle of for- m ula in a m icrowave oven .

3. In form th e m oth er th at form ula is a sufficien t diet for th e first 4 to 6 m on th s.

4. Assess th e m oth er’s ab ility to burp th e n ewborn .

B. Breast-feedin g 1. Assess th e n ewborn ’s ab ility to attach to th e

m oth er’s breast an d suck ( Fig. 31-4). 2. Teach th e m oth er h ow to pum p h er breasts an d

h ow to store breast m ilk properly. 3. In form th e m oth er th at breast m ilk is a sufficien t

diet for th e first 4 to 6 m on th s. 4. Give th e m oth er th e ph on e n um bers of local

organ ization s th at offer support to breast-feed in g m oth ers.

C. Bath in g 1. Bath e th e n ewborn in a warm room before

feed in g. 2. Have all equipm en t for bath in g available. 3. Use a m ild soap (n ot on th e face). 4. Proceed from th e clean est area to th e dirtiest. 5. Clean eyes fro m th e in n er can th us outward. 6. Special care sh ould be taken to clean un der th e

folds of th e n eck, un derarm s, groin , an d gen itals.

BOX 31-1 Precautions to Prevent Infant Abduction

All personnel must wear identification that is easily visible at all times.

Teach parents to allow only hospital staff with proper identi- fication to take their infants from them.

Question anyone with a newborn near an exit or in an unusual part of the facility.

Never leave a newborn unattended. Teach the parents that the newborn must be observed at all

times. When the newborn is in the mother’s room, position the crib

away from the doorway. Teach the parents home safety precautions; suggest that the

parents not place announcements in the paper or signs in their yard that might alert an abductor that a new infant is in the home.

Bre a s t

Are ola a nd bre a s t tis s ue with unde rlying milk ducts

Es opha gus NippleP a la te

Gum

Tongue

Lowe r lip

FIGURE 31-4 Correct attachment (latch-on) of a newborn at breast.

379CHAPTER 31 Care of the Newborn

M

a

t

e

r

n

i

t

y

7. Make bath tim e en joyable for th e n ewborn an d th e m oth er.

D. Cloth in g 1. Assess diaper an d clo th in g n eeds for th e n ewborn

with th e m oth er. 2. In struct the m oth er th at th e newborn’s head sh ould

be covered in cold weather to prevent heat loss. 3. In struct th e m oth er to layer th e n ewborn ’s clo th -

in g in cooler weath er. 4. To be com fo rtable, th e n ewborn sh o uld be

dressed in 1 m ore layer of cloth in g th an wh at th e paren ts are wearin g.

E. Cord care: See earlier for cord care, “Body System s Assessm en t an d In terven tion s.”

F. Circum cision : See earlier for circum cisio n care, “Body System s Assessm en t an d In terven tion s.”

G. Un circum cised n ewborn 1. In form th e m oth er th at th e foreskin an d glan s are

2 sim ilar layers of cells th at separate from each oth er an d th at th e sep aration process n orm ally is com plete by 3 years of age, alth ough th e layers can rem ain adh ered un til puberty.

2. In struct th e m oth er n ot to pull back th e foreskin , but to allow n atural separation to occur.

3. In form th e m oth er th at as th e process of separa- tio n occurs, slough ed cells build up between th e layers of th e foreskin an d th e glan s, an d th at wh en retraction occurs, daily gen tle wash in g of th e glan s with soap an d water is sufficien t to m ain tain ad equate clean lin ess.

4. Providin g stim ulation to th e n ewborn such as touch in g, cu ddlin g, or talkin g is an im portan t in terven tion .

VI. Preterm Newborn A. Description

1. An in fan t born befo re 37 weeks of gestation 2. Prim ary con cern relates to im m aturity of all body

system s B. Assessm en t

1. Respiration s are irregular with periods of apn ea. 2. Body tem p erature is below n orm al. 3. Th e n ewborn h as poor suck an d swallow reflexes. 4. Bowel soun ds are dim in ish ed. 5. Urin ary output is in creased or decreased. 6. Extrem ities are th in , with m in im al creasin g on

soles an d palm s. 7. Th e n ewborn exten ds extrem ities an d does n ot

m ain tain flexion . 8. Lan ugo, on skin an d in th e h air on th e n ew-

born ’s h ead, is presen t in woolly patch es. 9. Skin is th in , with visible blood vessels an d m in -

im al subcu tan eo us fat pads. 10. Skin m ay ap pear jaun diced . 11. Testes are un descen ded in boys. 12. Labia are n arrow in girls.

C. In terven tion s 1. Mon itor vital sign s every 2 to 4 h ou rs.

2. Main tain airway and cardiopulm on ary fun ction s. 3. Adm in ister oxygen an d h um idification as

prescribed. 4. Mon itor in take an d outp ut an d electrolyte

balan ce. 5. Mon itor daily weigh t. 6. Main tain th e n ewborn in a warm in g device. 7. Avoid exp osure to in fectio n s.

VII. Postterm Newborn A. Descrip tion : In fan t born after 42 weeks of gestation B. Assessm en t

1. Hypoglycem ia 2. Parch m en t-like skin (dry an d cracked) with ou t

lan ugo 3. Lon g fin gern ails, exten ded over en ds of fin gers 4. Profuse scalp h air 5. Lon g an d th in body 6. Wastin g of fat an d m uscle in extrem ities 7. Meco n ium stain in g possibly presen t on n ails an d

um b ilical cord C. In terven tion s

1. Provid e n orm al n ewborn care. 2. Mon itor for h ypoglycem ia. 3. Main tain n ewborn ’s tem p erature. 4. Mon itor for m econ ium aspiration .

VIII. Small for Gestational Age A. Descrip tion : Newborn wh o is plotted at or below th e

10th percen tile on th e in trauterin e growth curve B. Assessm en t

1. Fetal distress 2. Decreased or elevated body tem p erature 3. Ph ysical abn orm alities 4. Hypoglycem ia 5. Sign s of polycyth em ia

a. Ruddy appearan ce b . Cyan osis c. Jau n dice

6. Sign s of in fection 7. Sign s of aspiration of m econ ium

C. In terven tion s 1. Main tain airway an d cardiopulm on ary fun ction . 2. Main tain body tem perature. 3. O bserve for sign s of respiratory distress. 4. Mon itor for in fectio n an d in itiate m easu res to

preven t sep sis. 5. Mon itor for h ypoglycem ia. 6. In itiate early feedin gs an d m on itor for sign s of

aspiration .

IX. Large for Gestational Age A. Descrip tion : Newborn wh o is plotted at or above th e

90th percen tile on th e in trauterin e growth curve B. Assessm en t

1. Birth traum a or in jury 2. Resp iratory distress 3. Hypoglycem ia

380 UNIT VI Maternity Nursing

C. In terven tion s 1. Mon itor vital sign s an d for respiratory distress. 2. Mon itor for h ypo glycem ia. 3. In itiate early feedin gs. 4. Mon itor for in fectio n an d in itiate m easu res to

preven t sepsis. 5. Provide stim ulation , such as touch an d cuddlin g.

X. Respiratory Distress Syndrome A. Description : Serious lun g disorder caused by im m a-

turity an d in ability to produce surfactant, resultin g in h ypo xia an d acido sis

B. Assessm en t 1. Resp iratory distress; can in clude tach ypn ea,

n asal flarin g, expiratory grun tin g, retraction s, seesaw respiratio n s, decreased breath soun ds, an d apn ea

2. Pallor an d cyan osis 3. Hypo th erm ia 4. Poor m uscle ton e

C. In terven tion s 1. Mon itor color, respiratory rate, an d degree of

effort in breath in g. 2. Main tain airway an d cardiop ulm on ary fun ction

an d supp ort respiration s as prescribed. 3. Mon itor arterial blood gases an d oxygen satura-

tion levels as prescribed (arterial blood gases from um bilical artery); en sure th at oxygen adm in istered to th e n ewborn is at th e lo west possible con cen tration n ecessary to m ain tain adequate arterial oxygen ation .

4. An y prem ature newborn wh o required oxygen support sh ould be sch eduled for an eye exam in a- tion before disch arge to assess for retin al dam age.

5. Suction every 2 h ours or m ore often as n ecessary. 6. Position th e n ewborn on th e side or back, with

th e n eck sligh tly exten ded . 7. Adm in ister respiratory th erapy (percussion an d

vibration ) as prescribed ; use padded sm all plas- tic cup or sm all oxygen m ask for percussion ; use padded electric tooth brush for vibration .

8. Provide n utrition . 9. Support bon din g.

10. Prepare paren ts for sh ort-term to lo n g-term period of oxygen dep en den cy if n ecessary.

11. En courage th e m oth er to pum p th e breasts for future breast-feed in g if sh e so desires.

12. En courage as m uch paren tal participation in th e n ewborn ’s care as th e con d ition allows.

Prepare to administer surfactant replacement ther- apy (instilled into the endotracheal tube) to a newborn with respiratory distress syndrome.

XI. Meconium Aspiration Syndrome A. Description

1. O ccurs in term or postterm newborns

2. Exact etiology is un kn own , but th e release of m eco n ium in to th e amniotic fluid is th ough t to be related to a stressful fetal even t in itiatin g a bio- ch em ical ch ain of even ts.

3. Aspiration can occur in utero or with th e first breath .

B. Assessm en t 1. Resp iratory distress is presen t at birth ; tach ypn ea,

cyan osis, retraction s, n asal flarin g, grun tin g, crackles, an d rh on ch i m ay be presen t.

2. Th e n ewborn ’s n ails, skin , an d um bilical cord m ay be stain ed a yello w-green color.

C. In terven tion s 1. If th e n ewborn is delivered in an active, cryin g

state with n o eviden ce of respiratory distress, n o in terven tion is n ecessary.

2. If th e n ewborn is delivered an d exh ibits in activity an d lack of cry, en dotrach eal suction in g is per- form ed. If th e n ewborn also exh ibits lack of respiratory effort an d a low h eart rate, ad dition al in terven tion s will occur.

3. Newborn s with severe m econ ium aspiration syn drom e m ay ben efit from extracorporeal m em - bran e oxygen ation ; th is th erapy uses a m odified h eart-lun g m ach in e an d provides oxygen to th e circulation , allowin g the lun gs to rest an d decreas- ing pulm on ary h yperten sion an d h ypoxem ia.

XII. Bronchopulmonary Dysplasia A. Description

1. Th is ch ron ic pulm o n ary con dition affects new- borns wh o h ave exp erien ced respiratory failure or h ave been oxygen -depen den t for m ore th an 28 days.

2. X-ray fin din gs are abn o rm al, in dicatin g areas of overin flation an d atelectasis.

B. Assessm en t 1. Tach ypn ea 2. Tach ycardia 3. Retraction s 4. Nasal flarin g 5. Labored breath in g 6. Crackles an d decreased air m ovem en t 7. O ccasion al expiratory wh eezin g

C. In terven tion s 1. Mon itor airway an d cardiopulm on ary fun ction ;

provide oxygen th erapy. 2. Fluid restriction m ay be prescribed. 3. Medication s in clude surfactant at birth , bron ch odi-

lators, an d possibly diuretics an d corticosteroids.

XIII. Transient Tachypnea of the Newborn A. Description

1. Resp iratory co n dition th at results from in com - plete reabsorp tion of fetal lun g flu id in full-term newborns

2. Usually disappears with in 24 to 48 h ours

M

a

t

e

r

n

i

t

y

381CHAPTER 31 Care of the Newborn

B. Assessm en t 1. Tach ypn ea 2. Expiratory grun tin g 3. Retraction s 4. Nasal flarin g 5. Fluid breath soun ds per auscultation 6. Cyan osis

C. In terven tion s 1. Supp ortive care 2. O xygen adm in istration

XIV. Intraventricular Hemorrhage A. Description

1. Bleedin g with in th e ven tricles of th e brain 2. Risk factors in clude prem aturity, respiratory dis-

tress syn dro m e, traum a, an d asph yxia. B. Assessm en t: Dim in ish ed or absen t Moro reflex, leth -

argy, apn ea, poor feedin g, h igh -pitch ed sh rill cry, sei- zure activity

C. In terven tion s: Supp ortive treatm en t

XV. Retinopathy of Prematurity A. Description

1. Vascu lar d iso rd er in vo lvin g grad u al rep lace- m en t o f retin a b y fib ro u s tissu e an d b lo o d vessels

2. Prim arily caused by prem atu rity an d use of sup- plem en tal oxygen ( > 30 days)

B. Assessm en t: Leu kocoria (wh ite tissue on th e retro- len tal space), vitreo us h em orrh age, strab ism us, cata- racts (ch eck for red reflex)

C. In terven tion s: Laser ph otocoagulation surgery

XVI. Necrotizing Enterocolitis (NEC) A. Description

1. Acute in flam m ato ry disease of th e gastroin testi- n al tract

2. Usually occurs 4 to 10 days after birth , an d is m ost frequen tly seen in preterm n ewborn s

B. Assessm en t: In creased abdom in al girth , decreased or absen t bowel soun ds, bowel loop disten tion , vom it- in g, bile-stain ed em esis, ab dom in al ten dern ess, occult blood in stool

C. Preven tion 1. With h old feedin gs for 24 to 48 h ours from

in fan ts believed to h ave suffered birth asph yxia. Breast m ilk is th e preferred n utrien t after th is tim e period.

2. Th e use of probiotics with en teral feedin gs an d breast m ilk h as sh own eviden ce of preven tion of NEC.

3. Adm in istration of corticostero ids to th e m oth er prior to birth by prom o tin g early gut closure an d m aturation of th e gut m ucosa

D. In terven tion s 1. Ho ld oral feedin gs. 2. Insert oral gastric tube to decom press the abdom en .

3. In traven ous an tibiotics 4. In traven ous fluid s to correct flu id, electrolyte,

an d acid-base im balan ces 5. Surgery if in dicated

XVII. Hyperbilirubinemia A. Description

1. Elevated serum bilirubin level 2. Evaluation is in dicated wh en serum levels are

greater th an 12 m g/ dL (180 m cm ol/ L) in a term newborn.

3. Th erapy is aim ed at preven tin g kern icterus, wh ich results in perm an en t n eurological dam age resultin g from th e deposition of bilirubin in th e brain cells.

B. Assessm en t 1. Jaun d ice 2. Elevated serum bilirubin levels 3. En larged liver 4. Poor m uscle ton e 5. Leth argy 6. Poor suckin g reflex

C. In terven tion s 1. Mon itor for th e presen ce of jaun dice; assess skin

an d sclera for jaun dice. a . Exam in e th e n ewborn ’s skin color in

n atural ligh t. b . Press a fin ger over a bon y prom in en ce or tip

of th e n ewborn ’s n ose to press out cap illary blood from th e tissues.

c. No te th at jaun dice starts at th e h ead first an d spreads to th e ch est, abdom en , arm s an d legs, an d h an ds an d feet, wh ich are th e last to be jaun diced.

2. Keep th e n ewborn well h ydrated to m ain tain blood volum e.

3. Facilitate early, frequen t feedin g to h asten pas- sage of m eco n ium an d en courage excretion of bilirubin .

4. Repo rt to th e HCP an y sign s of jaun dice in th e first 24 h ou rs of life an d an y abn orm al sign s an d sym ptom s.

5. Prepare for ph ototh erapy (bili-ligh t or bili- blan ket), an d m on itor th e n ewborn clo sely dur- in g th e treatm en t.

At any serum bilirubin level, the appearance of jaundice during the first day of life indicates a pathological process.

D. Ph ototh erapy 1. Description

a . Ph o toth erapy is use of ligh t to reduce serum bilirubin levels in th e n ewborn .

b . Adverse effects from treatm en t, such as eye dam age, deh ydration , or sen sory dep riva- tio n , can occur.

2. In terven tion s

M

a

t

e

r

n

i

t

y

382 UNIT VI Maternity Nursing

a . Expo se as m uch of th e n ewborn ’s skin as possible.

b . Cover th e gen ital area, an d m on itor th e gen - ital area for skin irritatio n or breakd own .

c. Cover th e n ewborn ’s eyes with eye sh ield s or patch es; en sure th at th e eyelids are clo sed wh en sh ields or patch es are ap plied.

d . Rem o ve th e sh ields or patch es at least on ce per sh ift (durin g a feedin g tim e) to in spect th e eyes for in fectio n or irritation an d to allow for eye con tact an d bon din g with th e paren ts.

e. Measu re th e lam p en ergy output to en sure efficacy of th e treatm en t (don e with a special device kn own as a photometer).

f. Mon itor skin tem perature clo sely. g. In crease flu ids to com pen sate for water loss. h . Expect lo ose green stools. i. Mon itor th e n ewborn ’s skin color with th e

fluorescen t ligh t turn ed off, every 4 to 8 h ours.

j. Mon itor th e skin for bron ze baby syn d rom e, a grayish brown discoloration of th e skin ; n otify th e HCP because th is m ay in dicate a com plication of ph o toth erapy.

k . Repo sition th e n ewborn every 2 h ours; m on - itor th e n ewborn clo sely.

l. Provide stim ulation . m . If treatm en t is don e at h om e, teach th e par-

en ts about care an d in dication s of th e n eed to n otify th e HCP.

n . After treatm en t, con tin ue m on itorin g for sign s of h yperbilirubin em ia, because rebou n d elevation s can occur after th erap y is discon tin ued.

o . Turn off th e ph ototh erapy ligh ts before drawin g a blood specim en for serum

bilirubin levels, an d do n ot leave th e blood specim en un covered un d er flu orescen t ligh ts (to preven t th e breakd own of bilirubin in th e blood specim en ).

XVIII. Erythroblastosis Fetalis A. Description

1. Eryth roblastosis fetalis is th e destructio n of red blood cells th at results from an an tigen -an tibo dy reaction .

2. Th e disorder is ch aracterized by h em olytic an e- m ia or h yperbilirubin em ia.

3. Exch an ge of fetal an d m atern al blood occurs pri- m arily wh en th e placen ta separates at birth (Fig. 31-5).

4. An tibo dies are h arm less to th e m oth er, but attach to th e eryth rocytes in th e fetus an d cause h em olysis.

5. Sen sitization is rare with th e first pregn an cy. 6. ABO in com patibility is usually less severe.

B. Assessm en t 1. An em ia 2. Jaun d ice th at develops rapidly after birth an d

befo re 24 h ou rs 3. Edem a

C. In terven tion s 1. Adm in ister Rh o(D) im m un e glob ulin to th e

m oth er durin g th e first 72 h ours after birth if th e Rh -n egative m oth er delivers an Rh -p ositive fetus but rem ain s un sen sitized.

2. Assist with exch an ge tran sfusion after birth or in trauterin e tran sfusion as prescribed.

3. Th e newborn’s blood is replaced with Rh -n egative blood to stop th e destruction of th e n ewborn ’s red blood cells; the Rh-n egative blood is replaced with the n ewborn’s own blood gradually.

4. Provide supp ort to th e paren ts.

M

a

t

e

r

n

i

t

y

FIRS T PREGNANCY

A

S ECOND PREGNANCY

B

Rh-ne ga tive mothe r

– ––

+

+

– –

– –

+

+

+

+

+

+

Norma l Rh-pos itive infa nt S e ns itiza tion S e ns itize d mothe r Erythrobla s tos is fe ta lis

Antibodie s

+

FIGURE 31-5 Development of maternal sensitization to Rh antigens. A, Fetal Rh-positive erythrocytes enter the maternal system. Maternal anti-Rh anti- bodies are formed. B, Anti-Rh antibodies cross the placenta and attack fetal erythrocytes.

383CHAPTER 31 Care of the Newborn

XIX. Sepsis A. Description : Gen eralized in fectio n resultin g from

th e presen ce of bacteria in th e blood, such as Gro up B strepto coccal in fectio n

B. Assessm en t 1. Pallor 2. Tach ypn ea, tach ycardia 3. Poor feedin g 4. Abdo m in al disten tion 5. Tem perature in stability

C. In terven tion s 1. Assess for periods of apn ea or irregular

respiratio n s. 2. If apn ea is presen t, stim ulate by gen tly rubbin g

th e ch est or foot. 3. Adm in ister oxygen as prescribed. 4. Mon itor vital sign s; assess for fever. 5. Main tain warm th in a radian t warm er. 6. Provide isolatio n as n ecessary. 7. Mon itor in take an d outp ut, an d obtain daily

weigh t. 8. Mon itor for diarrh ea. 9. Assess feedin g an d suckin g reflex, wh ich m ay

be poor. 10. Assess for jaun dice. 11. Assess for irritability an d leth argy. 12. Adm in ister an tibiotics as prescribed, an d

observe carefully for toxicity because a n ew- born ’s liver an d kidn eys are im m ature.

XX. TORCH Infections (see Chapter 26)

XXI. Syphilis A. Description

1. Syph ilis is a sexually tran sm itted in fectio n . 2. Con gen ital syph ilis can result in prem atu re birth ,

skin lesions, an d abn orm al skeletal developm en t. 3. Th e causative organ ism , Treponema pallidum,

a spiroch ete, is able to cross th e placenta th rou gh out pregn an cy an d in fect th e fetus, usu- ally after 18 weeks’ gestation .

4. Risks in clude preterm birth , stillbirth , an d low birth weigh t.

5. Con gen ital effects are irreversible an d m ay in clude cen tral n ervous system dam age an d h ear- in g loss.

B. Assessm en t 1. Hepatosplen om egaly 2. Join t swellin g 3. Palm ar rash an d lesion s (Fig. 31-6) 4. An em ia 5. Jaun d ice 6. Sn u ffles 7. Ascites 8. Pn eum on itis 9. Cereb rospin al fluid ch an ges

C. In terven tion s 1. Mon itor th e n ewborn for sign s of syph ilis. 2. Prepare th e n ewborn for serological testin g if

prescribed. 3. Adm in ister an tibiotic th erapy as prescribed. 4. Use stan dard precaution s an d drain age an d

secretio n (con tact) precaution s with susp ected con gen ital syph ilis.

5. Wear gloves wh en h an dlin g th e n ewborn un til an tibiotic th erap y h as been adm in istered for 24 h ours.

6. Provid e psych ological supp ort to th e m oth er, an d provide in struction s regardin g follow-up care to th e n ewborn .

XXII. Addicted Newborn A. Descrip tion

1. A n ewborn can beco m e passively addicted to drugs th at h ave passed th rough th e placenta.

2. Assessm en t fin din gs an d with drawal tim es m ay vary dep en din g on th e specific addictin g drug.

3. See also Fetal Alcoh ol Spectrum Disorders (FASDs) below.

B. Assessm en t 1. Irritability 2. Trem ors 3. Hyperactivity an d h yperton icity 4. Resp iratory distress 5. Vo m itin g 6. High -pitch ed cry 7. Sn eezin g 8. Fever 9. Diarrh ea

10. Excessive sweatin g 11. Poor feedin g 12. Extrem e suckin g of fists 13. Seizures

M

a

t

e

r

n

i

t

y

FIGURE 31-6 Neonatal syphilitic lesions on hands and feet. (From Low- dermilk et al., 2012. Courtesy Mahesh Kotwal, MD, Phoenix, Arizona.)

384 UNIT VI Maternity Nursing

C. In terven tion s 1. Mon itor respiratory an d cardiac status

frequen tly. 2. Mon itor tem p erature an d vital sign s. 3. Hold n ewborn firm ly an d clo se to th e body dur-

in g feedin g an d wh en givin g care. 4. Initiate seizure precaution s (pad sides of th e crib). 5. Provide sm all frequen t feedin gs an d allow a lon -

ger period for feedin g. 6. Mon itor in take an d outp ut. 7. Adm in ister in traven o us h ydration if prescribed . 8. Protect th e n ewborn ’s skin from in ju ry th at can

be caused by th e co n stan t ru bbin g from h yper- active jitters.

9. Swaddle th e n ewborn . 10. Place th e n ewborn in a quiet room an d reduce

stim ulation . 11. Allow th e m oth er to express feelin gs such as

an xiety an d guilt. 12. Refer th e m oth er for treatm en t of th e substan ce

abuse problem .

XXIII. Fetal Alcohol Spectrum Disorders (FASDs) A. Description

1. FASDs are a grou p of con dition s caused by m atern al alcoh ol use durin g pregn an cy.

2. Th e disorders are a result of teratogen esis. 3. FASDs cause cogn itive an d ph ysical delays. 4. Fetal alcoh ol syn dro m e is th e m ost severe of th e

FASDs. Th e oth er disorders in cluded in th is cat- egory are alcoh ol-related n eurodevelopm en tal disorder (ARND) an d alcoh ol-related birth defects (ARBDs).

B. Assessm en t 1. Facial ch an ges (Fig. 31-7)

a. Sh o rt palpebral fissures b . Hypo plastic ph iltrum c. Sh o rt, upturn ed n ose d . Flat m idface e. Th in upper lip f. Low n asal bridge

2. Abn orm al palm ar creases 3. Resp iratory distress (apn ea, cyan osis) 4. Con gen ital h eart disorders 5. Irritability an d h ypersen sitivity to stim uli 6. Trem ors 7. Poor feedin g 8. Seizu res

C. In terven tion s 1. Mon itor for respiratory distress. 2. Position th e n ewborn on th e side to facilitate

drain age of secretio n s. 3. Keep resuscitation equip m en t at th e bed side. 4. Mon itor for h ypo glycem ia. 5. Assess suck an d swallow reflex. 6. Adm in ister sm all feedin gs an d burp well. 7. Suction as n ecessary.

8. Mon itor in take an d outp ut. 9. Mon itor weigh t an d h ead circum feren ce.

10. Decrease en viron m en tal stim uli. 11. Make referral to local early in terven tion system .

XXIV. Newborn of a Mother with Human Immunodefi- ciency Virus (HIV)

A. Description 1. Th e fetus of a m oth er wh o is positive for HIV

an tibody sh o uld be m on itored closely th rough - out th e pregn an cy.

2. Serial ultrasoun d screen in gs sh ould be don e dur- in g pregn an cy to iden tify IUGR.

3. Weekly n on stress testin g after 32 weeks of gesta- tion an d bioph ysical profiles m ay be n ecessary durin g pregn an cy.

4. Newborn s born to HIV-po sitive m oth ers m ay test positive because th e m oth er’s an tibodies m ay persist in th e n ewborn for 18 m on th s after birth .

5. Th e use of an tiviral m ed ication , th e reduction of n ewborn exp osure to m atern al blood an d body fluid s, an d th e early iden tification of HIV in preg- n an cy reduce th e risk of tran sm ission to th e n ewborn .

6. All n ewborn s born to HIV-po sitive m oth ers acq uire m atern al an tibod y to HIV in fectio n , but n ot all acquire th e in fectio n .

7. Th e n ewborn m ay be asym ptom atic for th e first several m on th s to years of life.

B. Tran sm issio n 1. Acro ss placen tal barrier 2. Du rin g labor an d birth

M

a

t

e

r

n

i

t

y

FIGURE 31-7 Infant with fetal alcohol syndrome. (From Markiewicz, Abrahamson, 1999.)

385CHAPTER 31 Care of the Newborn

3. Breast m ilk (breast-feedin g n ot don e if th e m oth er is HIV-positive)

C. Assessm en t 1. Possibly n o outward sign s at birth 2. Sign s of im m un od eficien cy 3. Hepatom egaly 4. Splen om egaly 5. Lym ph aden opath y 6. Im p airm en t in growth an d developm en t

D. In terven tion s 1. Clean th e n ewborn ’s skin carefully befo re an y

in vasive procedure, such as th e ad m in istration of ph yto n adion e, h eel sticks, or ven ipu n ctures.

2. Circum cisio n s are n ot don e on n ewborn s with HIV-positive m oth ers un til th e n ewborn ’s status is determ in ed.

3. Newborn can room with m oth er. 4. All HIV-exposed n ewborn s sh ould be treated

with m ed ication to preven t in fection by Pneumo- cystis jiroveci.

5. An tiretroviral m ed ication s m ay be ad m in istered as prescribed for th e first 6 weeks of life or lon ger if prescribed .

6. Mon itor for early sign s of im m un odeficien cy, such as en larged spleen or liver, lym ph aden opathy, and im pairm en t in growth an d developm en t.

7. Newborn s at risk for HIV in fectio n sh o uld be seen by th e HCP at birth an d at 1 week, 2 weeks, 1 m on th , an d 2 m on th s of age.

8. In form th e m oth er th at HIV culture is recom - m en ded at 1 m on th an d after 4 m on th s of age.

E. Im m un izatio n s 1. Im m un ization s with live vaccin es, such as

m easles-m u m ps-ru bella an d varicella, sh ould n ot be don e un til th e n ewborn ’s, in fan t’s, or ch ild’s status is con firm ed.

2. If in fected, live vaccin e will n ot be given .

Newborns at risk for HIV infection need to receive all recommended immunizations at the regular sched- ule; live vaccines are not administered until HIV status is determined.

XXV. Newborn of a Diabetic Mother A. Description

1. In fan t born to m oth er with typ e 1 or type 2 dia- betes or gestation al diabetes

2. Hypo glycem ia, h yperbilirubin em ia, respiratory distress syn d rom e, h ypo calcem ia, birth traum a, an d con gen ital an om alies m ay be presen t.

B. Assessm en t 1. Excessive size an d weigh t as a result of excess fat

an d glycogen in th e tissues 2. Edem a or puffin ess in th e face an d ch eeks 3. Sign s of h ypoglycem ia, such as twitch in g, apn ea,

difficulty in feedin g, leth argy, seizures, an d cyan osis

4. Hyperbilirubin em ia 5. Sign s of respiratory distress, such as tach ypn ea,

cyan osis, retraction s, grun tin g, an d n asal flarin g C. In terven tion s

1. Mon itor for sign s of respiratory distress, birth traum a, an d con gen ital an om alies.

2. Mon itor bilirubin an d blood gluco se levels. 3. Mon itor weigh t. 4. Feed th e n ewborn soon after birth with glucose

in water, breast m ilk, or form ula as prescribed. 5. Adm in ister gluco se in traven ously to treat h ypo -

glycem ia if n ecessary an d as prescribed. 6. Mon itor for edem a. 7. Mon itor for respiratory distress, trem ors, or

seizu res.

XXVI. Hypoglycemia A. Description

1. Hypo glycem ia is an abn orm ally low level of glu- cose in th e blood ( < 40 m g/ dL [< 2.3 m m ol/ L] in th e first 72 h ou rs of life or < 45 m g/ dL [< 2.6 m m o l/ L] after th e first 3 days of life).

2. Norm al blood glucose referen ce in terval is 40 to 60 m g/ dL (2.3 to 3.4 m m ol/ L) in a 1-day-old n ewborn an d 50 to 90 m g/ dL (2.9 to 5.1 m m ol/ L) in a n ewborn older th an 1 day (in sti- tution al values for n orm al n ewborn blood glu- cose levels vary).

B. Assessm en t 1. In creased respiratory rate 2. Twitch in g, n ervousn ess, or trem o rs 3. Un stable tem p erature 4. Leth argy, apn ea, seizu res, cyan osis

C. In terven tion s 1. Preven t low blood gluco se level th rou gh early

feedin gs. 2. Adm in ister form ula orally or gluco se in trave-

n ously as prescribed. 3. Mon itor blood gluco se levels as prescribed. 4. Mon itor for feedin g problem s. 5. Mon itor for apn eic periods. 6. Assess for sh rill or in term itten t cries. 7. Evaluate leth argy an d poor m uscle ton e.

XXVII. Hypothyroidism A. Description : Hypoth yroidism is a decrease in th e

produ ction of th yroid h orm on e. B. Assessm en t

1. Protrudin g or th ick ton gue 2. Du ll look 3. Swollen face 4. Decreased m uscle ton e

C. In terven tion s: Focus on th yroid replacem en t

XXVIII. Relief of Choking in an Infant A. Description : Ch okin g is also kn own as foreign body

airway obstru ction (FBAO ) .

M

a

t

e

r

n

i

t

y

386 UNIT VI Maternity Nursing

B. Assessm en t 1. Sign s of m ild airway obstru ction in clude good air

exch an ge, ability to cough forcefully, an d wh eez- in g between cough s.

2. Sign s of severe airway obstruction in clude poor or n o air exch an ge, weak or in effective cough or n o cough , a h igh -p itch ed n oise wh ile in h alin g or n o n oise, in creased respiratory difficu lty, cya- n osis, an d in ability to cry.

C. In terven tion s 1. For m ild obstru ction , do n ot in terfere with th e

in fan t’s own attem p ts to expel th e object. Stay with th em an d con tin ue to m on itor. If th e obstru ctio n persists, activate th e em ergen cy respo n se system an d relieve th e obstru ction .

2. Severe obstruction m ust be relieved as soon as possible (see Priority Nursin g Action s).

XXIX. Cardiopulmonary Resuscitation (CPR) Guide- lines for Infants

A. Description : In fan ts in clude in dividuals wh o are 1 year of age or less. Th e basic life support (BLS) sequen ce for in fan ts is very sim ilar to th at used for ch ild an d ad ult CPR. Th e m ain differen ces in clude th e followin g: 1. Location of th e pulse ch eck is th e brach ial artery

in in fan ts. 2. Com p ression tech n iqu e is to use 2 fin gers for a

sin gle rescuer an d to use a 2 th um b-en circlin g tech n ique for 2 rescuers.

3. Com p ression dep th sh o uld be on e th ird of th e ch est depth , wh ich is approxim ately 1½ in ch es or 4 cm .

4. Th e com pression to ven tilation ratio for 1 rescuer is 30:2; 2 rescuers is 15:2.

M

a

t

e

r

n

i

t

y

PRIORITY NURSING ACTIONS Choking Infant 1. Sit or kneel with the infant in your lap. 2. Remove clothing from the infant’s chest if easily removed. 3. Hold the infant face down with the head lower than the

chest while resting on your forearm. The infant’s head and jaw should be supported with the hand. The forearm is rested on the thigh to support the infant (Fig. 31-8).

4. Deliver 5 back slaps between the infant’s shoulder blades using the heel of the other hand with sufficient force. Place free hand on infant’s back while supporting the back of the infant’s head with the palm of the hand. Cradle the infant between the 2 forearms. Turn the infant as a unit while sup- porting the head and neck.

5. Rest the forearm on the thigh while holding the infant face up. Deliver 5 chest thrusts in the middle of the chest over the lower half of the sternum at a rate of 1 per second with enough force to dislodge the foreign body.

6. Repeat the sequence until the object is removed or the infant becomes unresponsive.

7. If the infant becomes unresponsive, call for help and acti- vate the emergency response system.

8. Begin cardiopulmonary resuscitation (CPR) while checking for a foreign body each time the airway is opened. Do not perform blind finger sweeps.

The interventions to relieve choking in an infant are different than the interventions for an adult. First, the rescuer sits or kneels with the infant in the lap and removes the clothing if it is easy to do so. Next, the infant is held face down with the head lower than the chest on the rescuer’s forearm. The res- cuer must remember to support the head and jaw throughout this process, and rests the forearm on the thigh (see Fig. 31-8). The rescuer delivers up to 5 back slaps forcefully between the infant’s shoulder blades using the heel of the hand with suffi- cient force to dislodge the foreign body. Next, the rescuer’s free hand is placed on the infant’s back and cradles the infant between their 2 forearms while supporting the infant’s head and neck. The infant is turned as a unit and the head is kept lower than the trunk. The rescuer delivers up to 5 chest thrusts in the middle of the chest over the lower half of the sternum at a rate of 1 per second with enough force to dislodge the foreign body. This sequence is repeated until the object is removed or the infant becomes unresponsive. If the infant becomes unre- sponsive, the rescuer should call for help and ask someone to activate the emergency response system. CPR is started and each time the airway is opened, the rescuer checks for a foreign body. Blind finger sweeps are not performed because this may push the foreign body further back into the airway. If the emer- gency response system could not be activated by another per- son, the single rescuer would activate it after 2 minutes of CPR.

Reference American Heart Association (20 11), pp. 55–56. Hockenberry, Wilson (2015), pp. 1200-1202.

FIGURE 31-8 Relief of choking in the newborn infant.

387CHAPTER 31 Care of the Newborn

M

a

t

e

r

n

i

t

y

5. Th e em ergen cy respo n se system sh o uld be acti- vated if th e arrest is n ot witn essed an d th e rescuer is alon e after providin g 2 m in utes of CPR; after 2 m in u tes th e sin gle rescuer can activate th e em ergen cy respon se system an d get an auto- m ated extern al defibrillator.

6. Th e em ergen cy respon se system sh ould be acti- vated an d th e autom ated extern al defibrillator sh ould be retrieved before begin n in g CPR if th e arrest is sudden and witn essed.

B. Refer to Ch apter 56 for detailed in form ation on th e Am erican Heart Association ’s recom m en dation s for th e CPR sequen ce.

CRITICAL THINKING What Should You Do? Answer: Slight tremors noted in the newborn may be a common finding, but could also be a sign of hypoglycemia, hypocalcemia, or drug withdrawal. The nurse should deter- mine the presence of tremors so that treatment can be initi- ated immediately. This finding should also be reported to the health care provider immediately.

Reference: Hockenberry, Wilson (20 15), p. 393.

P R A C T I C E Q U E S T I O N S

319. Th e n urse assisted with th e birth of a n ewborn . Wh ich n ursin g action is m o st effective in preven t- in g h eat loss by evaporation ? 1. Warm in g th e crib pad 2. Closin g th e doors to th e room 3. Dryin g th e in fan t with a warm blan ket 4. Turn in g on th e overh ead radian t warm er

320. Th e m oth er of a n ewborn calls th e clin ic an d reports th at wh en clean in g th e um b ilical cord, sh e n oticed th at th e cord was m oist an d th at dis- ch arge was presen t. Wh at is th e m o st ap p ro p riate n ursin g in struction for th is m oth er? 1. Brin g th e in fan t to th e clin ic. 2. Th is is a n orm al occurren ce an d n o furth er

action is n eeded. 3. In crease th e n um ber of tim es th at th e cord is

clean ed per day. 4. Mon itor th e cord for an oth er 24 to 48 h ours an d

call th e clin ic if th e disch arge con tin ues.

321. Th e n urse in a n eon atal in ten sive care un it (NICU) receives a telep h on e call to prepare for th e adm is- sion of a 43-week gestation n ewborn with Apgar scores of 1 an d 4. In plan n in g for adm ission of th is n ewborn , wh at is th e n urse’s h igh est p rio rity? 1. Turn on th e apn ea and cardiorespiratory m on itors. 2. Con n ect th e resuscitation bag to th e oxygen

outlet.

3. Set up th e in traven o us lin e with 5% dextrose in water.

4. Set th e radian t warm er con trol tem p erature at 36.5 °C (97.6 °F).

322. Th e n urse is assessin g a n ewborn after circum cisio n an d n otes th at th e circum cised area is red with a sm all am oun t of bloody drain age. Wh ich n ursin g action is m o st ap p ro p riate? 1. Apply gen tle pressure. 2. Rein force th e dressin g. 3. Do cum en t th e fin din gs. 4. Con tact th e h ealth care provider (HCP).

323. Th e n urse in a n ewborn n ursery is m on itorin g a preterm n ewborn for respiratory distress syn - drom e. Wh ich assessm en t fin din gs sh ould alert th e n urse to th e possibility of th is syn d rom e? Select all th at ap p ly.

1. Cyan osis 2. Tach ypn ea 3. Hypo ten sion 4. Retraction s 5. Audible grun ts 6. Presen ce of a barrel ch est

324. Th e postp artum n urse is providin g in struction s to th e m oth er of a n ewborn with h yperbilirubin em ia wh o is bein g breast-fed. Th e n urse sh o uld provide wh ich in struction to th e m oth er? 1. Feed th e n ewborn less frequen tly. 2. Con tin ue to breast-feed every 2 to 4 h ours. 3. Switch to bottle-feedin g th e in fan t for 2 weeks. 4. Stop breast-feed in g an d switch to bottle-feedin g

perm an en tly.

325. Th e n urse is assessin g a n ewborn wh o was born to a m oth er wh o is ad dicted to drugs. Wh ich fin din gs sh ould th e n urse expect to n ote durin g th e assess- m en t of th is n ewborn ? Select all th at ap p ly.

1. Leth argy 2. Sleep in ess 3. Irritability 4. Con stan t cryin g 5. Difficult to com fo rt 6. Cudd les wh en bein g h eld

326. Th e n urse n otes h ypo ton ia, irritab ility, an d a poor suckin g reflex in a full-term n ewborn on adm ission to th e n ursery. Th e n urse susp ects fetal alcoh ol syn - drom e an d is aware th at wh ich addition al sign would be con sisten t with th is syn drom e? 1. Len gth of 19 in ch es 2. Abn orm al palm ar creases 3. Birth weigh t of 6 lb, 14 oz (3120 g) 4. Head circum feren ce ap propriate for gesta-

tion al age

388 UNIT VI Maternity Nursing

327. Th e n urse is creatin g a plan of care for a n ewborn diagn osed with fetal alcoh ol syn d rom e. Th e n urse sh ould in clude wh ich p rio rity in terven tion in th e plan of care? 1. Allow th e n ewborn to establish own sleep-rest

pattern . 2. Main tain th e n ewborn in a brigh tly ligh ted area

of th e n ursery. 3. En courage frequen t h an dlin g of th e n ewborn by

staff an d paren ts. 4. Mon itor th e n ewborn ’s respon se to feedin gs

an d weigh t gain pattern .

328. Th e n urse adm in isters eryth rom ycin oin tm en t (0.5%) to th e eyes of a n ewborn an d th e m oth er asks th e n urse wh y th is is perform ed. Wh ich exp la- n ation is b est for th e n urse to provide about n eo- n atal eye proph ylaxis? 1. Protects th e n ewborn ’s eyes fro m possible in fec-

tio n s acquired wh ile h ospitalized. 2. Preven ts cataracts in th e n ewborn born to a

wom an wh o is susceptible to rubella. 3. Min im izes th e spread of m icro organ ism s to th e

n ewborn from in vasive procedures durin g labor.

4. Preven ts an in fection called oph th alm ia n eon a- torum from occurrin g after birth in a n ewborn born to a wom an with an un treated gon ococcal in fectio n .

329. Th e n urse is preparin g to care for a n ewborn receiv- in g ph ototh erapy. Wh ich in terven tion s sh ould be in cluded in th e plan of care? Select all th at ap p ly.

1. Avo id stim ulation . 2. Decrease fluid in take. 3. Expose all of th e n ewborn ’s skin . 4. Mon itor skin tem perature clo sely. 5. Repo sition th e n ewborn every 2 h ou rs. 6. Cover th e n ewborn ’s eyes with eye sh ields or

patch es.

330. Th e n urse creates a plan of care for a wom an with h um an im m un odeficien cy virus (HIV) in fectio n an d h er n ewborn . Th e n urse sh ould in clude wh ich in terven tion in th e plan of care? 1. Mon itorin g th e n ewborn ’s vital sign s ro utin ely

2. Main tain in g stan dard precaution s at all tim es wh ile carin g for th e n ewborn

3. In itiatin g referral to evaluate for blin dn ess, deaf- n ess, learn in g problem s, or beh avioral problem s

4. In structin g th e breast-feed in g m oth er regardin g th e treatm en t of th e n ipples with n ystatin oin tm en t

331. Th e n urse is plan n in g care for a n ewborn of a m oth er with diab etes m ellitus. Wh at is th e p rio rity n ursin g con sid eration for th is n ewborn ? 1. Developm en tal delays because of excessive size 2. Main tain in g safety because of low blood glu-

cose levels 3. Ch okin g because of im paired suck an d swallow

reflexes 4. Elevated body tem perature because of excess fat

an d glycogen

332. Wh ich statem en t reflects a n ew m oth er’s un der- stan din g of th e teach in g about th e preven tion of n ewborn abduction ? 1. “I will place m y baby’s crib close to th e door.” 2. “Som e h ealth care perso n n el won ’t h ave n am e

badges.” 3. “I will ask th e n urse to atten d to m y in fan t if I am

n appin g an d m y h usban d is n ot h ere.” 4. “It’s okay to allow th e n urse assistan t to carry m y

n ewborn to th e n ursery.”

333. Th e n urse prepares to ad m in ister a ph yto n adion e (vitam in K) in jection to a n ewborn , an d th e m oth er asks th e n urse wh y h er in fan t n eeds th e in jection . Wh at b est respon se sh o uld th e n urse provide? 1. “You r n ewborn n eeds th e m edicin e to develop

im m un ity.” 2. “Th e m ed icin e will protect your n ewborn from

bein g jaun diced.” 3. “Newbo rn s h ave sterile bowels, an d th e m ed i-

cin e prom o tes th e growth of bacteria in th e bowel.”

4. “Newbo rn s are deficien t in vitam in K, an d th is in jection preven ts your n ewborn from bleed in g.”

A N S W E R S 319. 3 Ra t ion a le: Evapo ratio n o f m o isture fro m a wet bo dy dissipates h eat alo n g with th e m o isture. Keepin g th e n ewb orn dry by dry- in g th e wet n ewb o rn at b irth preven ts h ypo th erm ia via evap o- ration . Hypoth erm ia caused by con duction occurs wh en th e n ewbo rn is o n a co ld surface, su ch as a co ld p ad or m attress,

an d h eat fro m th e n ewbo rn ’s b o dy is tran sferred to th e colder o b ject (direct co n tact). Warm in g th e crib p ad assists in preven t- in g h ypo th erm ia b y co n d u ctio n . Co n vectio n o ccurs as air m o ves across th e n ewb orn ’s skin fro m an op en do o r an d h eat is tran sferred to th e air. Rad iation occu rs wh en h eat fro m th e n ewb o rn rad iates to a co lder surface (in d irect con tact). Test -Ta kin g St r a t egy: No te th e strategic wo rd s, most effective. Recallin g th at evap oration o f m oistu re fro m a wet b od y

M

a

t

e

r

n

i

t

y

389CHAPTER 31 Care of the Newborn

d issip ates h eat alon g with th e m o isture will assist in d irectin g yo u to th e correct o ptio n . Review: Meth od s of h eat lo ss in a n ewb orn Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—Newb orn Pr ior it y Con cept s: Caregivin g; Th erm oregulation Refer en ce: Hocken b erry, Wilso n (2015), p. 267.

320. 1 Ra tion a le: Sign s o f u m bilical cord in fection are m o istn ess, o ozin g, d isch arge, an d a red den ed base aro un d th e co rd . If sign s o f in fectio n occu r, th e clien t sh o u ld b e in stru cted to n o tify a h ealth care provid er ( HCP) . If th ese sym p tom s o ccur, an tib io tics m ay b e n ecessary. O ptio n s 2, 3, an d 4 are n ot th e m ost ap prop riate n u rsin g in terven tion s fo r an u m b ilical co rd in fectio n as given in th e q uestio n . Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Fo cu s o n th e clin ical m an ifestation s provid ed in th e qu es- tio n to assist in an swerin g. No tin g th e wo rd discharge in th e q uestion will assist in directin g yo u to th e o p tion th at in d icates th at th e n ewbo rn n eeds to be seen b y th e HCP. Review: In terven tion s related to co rd care Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—Newb orn Pr ior it y Con cept s: Clin ical Ju dgm en t; In fection Refer en ce: Hocken b erry, Wilso n (2015), pp . 271-272.

321. 2 Ra tion a le: The h igh est priority on adm ission to th e n ursery for a n ewbo rn with a lo w Apgar sco re is th e airway, wh ich wou ld in vo lve p rep arin g resp iratory resu scitation equ ipm ent an d oxy- gen . Th e rem ain in g o ptio n s are also im portan t, alth o ugh th ey are o f lower prio rity. Th e n ewborn would be p laced on an apn ea and cardioresp iratory m o n itor. Settin g u p an in traven ou s lin e with 5% d extrose in water would p rovide circulatory support. Th e rad ian t warm er would p ro vide an extern al h eat source, wh ich is n ecessary to p reven t furth er respiratory d istress. Test-Ta kin g Str a t egy: No te th e strategic wo rd s, highest priority. Th is q u estio n asks you to p rio ritize care o n th e b asis o f in fo r- m ation abo u t a n ewb orn ’s co n d itio n . Use th e ABCs—airway– b reath in g–circu latio n . A m eth o d o f p lan n in g fo r airway sup - p ort is to h ave th e resu scitatio n bag co n n ected to an o xygen so urce. Review: Care of th e n ewb orn with lo w Ap gar sco res Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Critical Care: Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Hocken b erry, Wilso n (2015), p. 247.

322. 3 Ra tion a le: Th e pen is is n orm ally red du rin g th e h ealin g p ro - cess after circum cision . A yellow exud ate m ay be n oted in 24 h o u rs, an d th is is part of n orm al h ealin g. Th e n urse wou ld exp ect th at th e area wou ld be red with a sm all am ou n t of

b loo dy d rain age. O n ly if th e b leed in g were excessive wou ld th e n u rse app ly gen tle p ressure with a sterile gau ze. If bleedin g can n o t b e co n trolled, th e b loo d vessel m ay n eed to be ligated , an d th e n urse wou ld n otify th e HCP. Because th e fin d in gs id en - tified in th e qu estio n are n o rm al, th e n u rse wo uld d ocu m en t th e assessm en t fin d in gs. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate, an d focus on th e assessm en t fin d in gs in th e qu estio n . Th is sh o u ld assist in d irectin g yo u to th e correct op tio n , b ecau se th is is a n o rm al occu rren ce after circu m cisio n . Review: Expected fin din gs after circu m cisio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—Newbo rn Pr ior it y Con cept s: Clin ical Ju dgm en t; Develo pm en t Refer en ce: Hocken b erry, Wilso n (2015), p. 274.

323. 1, 2, 4, 5 Ra tion a le: A n ewborn in fan t with respiratory distress syn - d ro m e m ay presen t with clin ical sign s o f cyan o sis, tach yp n ea o r ap n ea, n asal flarin g, ch est wall retraction s, or au dib le gru n ts. Hypo ten sion an d a b arrel ch est are n ot clin ical m an ifestatio n s asso ciated with respiratory d istress syn d ro m e. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, sign s o f resp irato ry d istress syn d ro m e. Elim in ate h yp oten sion , as th is is n ot a fin d- in g associated with resp irato ry d istress syn drom e. Also, resp ira- to ry distress syn drom e is an acu te occu rren ce an d a barrel ch est d evelop s with a ch ro n ic con ditio n . In ad dition , n o te th e rela- tio n sh ip between th e d iagn o sis an d th e sign s n oted in th e cor- rect option s. Review: Sign s o f resp irato ry d istress syn d ro m e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Matern ity—Newbo rn Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Hocken b erry, Wilso n (2015), p. 371.

324. 2 Ra tion a le: Hyperb ilirub in em ia is an elevated serum b ilirub in level. At an y serum bilirub in level, th e ap pearan ce o f jaun dice d urin g th e first d ay of life in d icates a p ath o logical p ro cess. Early an d frequ en t feed in g h asten s th e excretion o f biliru b in . Breast-feed in g sh ou ld be in itiated with in 2 h o u rs after b irth an d every 2 to 4 h ou rs th ereafter. Th e in fan t sh ou ld n o t be fed less freq uen tly. Switch in g to bo ttle-feed in g fo r 2 weeks or sto pp in g b reast-feedin g perm an en tly is u n n ecessary. Test-Ta kin g Str a tegy: Elim in ate o ptio n s 3 an d 4 are co m p ara- b le o r alike. Th ese op tio n s d iscou rage th e con tin u ation of b reast-feed in g an d sh ou ld be elim in ated . Fro m th e rem ain in g o ptio n s, recallin g th e p ath o ph ysiolo gy asso ciated with h yp er- b ilirub in em ia will assist yo u in elim in atin g op tio n 1. Review: Hyp erb iliru b in em ia in th e n ewb orn Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—Newbo rn Pr ior it y Con cept s: Cellular Regulation ; Clien t Ed u catio n Refer en ce: Ho cken b erry, Wilso n (2015), p. 321.

M

a

t

e

r

n

i

t

y

390 UNIT VI Maternity Nursing

325. 3, 4, 5 Ra t ion a le: A n ewb orn of a wom an wh o u ses d rugs is irritable. Th e in fan t is o verlo aded easily by sen sory stim ulation . Th e in fan t m ay cry in cessan tly an d b e difficu lt to con sole. Th e in fan t wo uld h yp erexten d an d po sture rath er th an cu dd le wh en b ein g h eld . Th is in fan t is n ot leth argic o r sleepy. Test -Ta kin g St r a t egy: Leth argy an d sleep in ess are co m p arab le o r alike in th at th ey in dicate h yp oactivity of th e n ewb o rn , an d th erefore can be elim in ated . From th e rem ain in g op tion s, recallin g th e path oph ysiology associated with an in fan t born to a d ru g-add icted m o th er an d th at th e n ewb o rn is irritab le will assist yo u in elim in atin g th at th is in fan t will be easily co m - fo rted an d cu dd le wh en h eld. Review: Assessm en t fin din gs fo r th e n ewb o rn o f a d ru g- ad d icted m o th er Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—Newbo rn Pr ior ity Con cepts: Add iction ; Clin ical Jud gm en t Refer en ce: Ho cken berry, Wilson (2015), p . 396.

326. 2 Ra tion a le: Fetal alcoh ol syn dro m e, a d iagn ostic category o f fetal alcoh ol spectrum d isorders (FASDs), is caused b y m atern al alco- h ol u se d urin g p regn an cy. Features of n ewborn s diagn osed with fetal alcoh ol syn drom e in clude cran io facial abn orm alities, in tra- uterin e gro wth restriction , card iac abn orm alities, abn orm al palm ar creases, an d respirato ry d istress. O ptio ns 1, 3, an d 4 are n orm al assessm en t fin din gs in th e fu ll-term n ewbo rn in fan t. Test -Ta kin g Str a tegy: Use kn owled ge regard in g n orm al assess- m en t fin d in gs in th e full-term n ewbo rn in fan t to an swer th is qu estio n . Len gth , b irth weigh t, an d h ead circum feren ce are co m p arab le o r alike in th at all are p h ysical m easurem en ts assessed o n a n ewbo rn an d rep resen t n orm al fin d in gs in a fu ll-term n ewb orn . Review: Norm al n ewbo rn assessm en t fin din gs an d fetal alco - h o l syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Matern ity—Newbo rn Pr ior ity Con cepts: Add iction ; Clin ical Jud gm en t Refer en ce: Ho cken berry, Wilson (2015), p . 401.

327. 4 Ra t ion a le: Fetal alco h o l syn d ro m e, a d iagn o stic catego ry delin eated u n d er fetal alcoh ol sp ectrum disorders (FASDs), is caused b y m atern al alcoh ol u se du rin g pregn an cy. A prim ary n ursin g go al fo r th e n ewb orn diagn osed with fetal alco h o l syn - drom e is to establish n utritio n al b alan ce after b irth . Th ese n ew- bo rn s m ay exh ibit h yp erirritability, vom itin g, d iarrh ea, or an un co ordin ated su ckin g an d swallowin g ab ility. A q uiet en vi- ro n m en t with m in im al stim uli an d h an dlin g would h elp to establish ap p ro priate sleep-rest cycles in th e n ewbo rn as well. O p tion s 1, 2, an d 3 are in ap prop riate in terven tion s. Test -Ta kin g Str a t egy: Note th e strategic wo rd , priority. Thin k about th e path oph ysiology th at occurs in a n ewborn with th is con - dition . Also, use Maslo w’s Hierarch y of Need s th eo ry to direct you to the correct option . Rem em ber that n utrition is a priority.

Review: Care o f a n ewbo rn with fetal alco h o l syn d ro m e Level of Cogn it ive Ability: Creatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Matern ity—Newb o rn Pr ior ity Con cepts: Ad d iction ; Clin ical Jud gm en t Refer en ce: Ho cken berry, Wilson (2015), p . 401.

328. 4 Ra t ion a le: Eryth rom ycin o ph th alm ic o in tm en t 0.5% is u sed as a proph ylactic treatm en t for oph th alm ia n eon atorum , wh ich is caused b y th e bacterium Neisseria gonorrhoeae. Preven tive treat- m en t of go n o rrh ea is req uired b y law. O p tio n s 1, 2, an d 3 are n ot th e pu rp oses fo r adm in isterin g th is m ed ication to a n ew- b o rn in fan t. Test -Ta kin g St r a t egy: Note th e strategic wo rd , best. Use kn o wled ge o f th e pu rpo se o f adm in isterin g eryth ro m ycin o p h - th alm ic o in tm en t to a n ewbo rn in fan t. Rem em b er th at th is is d o n e to p reven t o ph th alm ia n eo n ato ru m . Review: In itial eye p ro p h ylaxis fo r th e n ewb orn in fan t Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Newb o rn Pr ior ity Con cepts: Health Prom o tion ; In fection Refer en ce: Ho cken berry, Wilson (2015), p . 268.

329. 4, 5, 6 Ra t ion a le: Ph o to th erap y (bili-ligh t o r b ili-b lan ket), is th e use o f in ten se fluo rescen t ligh t to redu ce serum b ilirub in levels in th e n ewb orn . Ad verse effects fro m treatm en t, such as eye d am - age, d eh yd ratio n , or sen so ry deprivation , can occur. In terven - tion s in clu d e expo sin g as m u ch o f th e n ewb orn ’s skin as p o ssible; h owever, th e gen ital area is co vered . Th e n ewbo rn ’s eyes are also covered with eye sh ield s o r p atch es, en su rin g th at th e eyelid s are clo sed wh en sh ields o r patch es are app lied . Th e sh ield s o r patch es are rem o ved at least on ce per sh ift to in sp ect th e eyes fo r in fectio n o r irritation an d to allo w eye con tact. Th e n urse m easu res th e lam p en ergy o utp ut to en sure efficacy o f th e treatm en t (d on e with a sp ecial d evice kn o wn as a photometer), m o n ito rs skin tem p eratu re closely, an d in creases flu ids to com - p en sate for water lo ss. Th e n ewbo rn m ay h ave loo se green sto o ls an d green -colo red urin e. Th e n ewb orn ’s skin co lo r is m o n ito red with th e fluo rescen t ligh t turn ed o ff every 4 to 8 h o urs an d is m o n ito red fo r b ro n ze bab y syn d ro m e, a grayish b ro wn d iscolo ration o f th e skin . Th e n ewb o rn is rep osition ed every 2 h o u rs, an d stim u latio n is p ro vided . After treatm en t, th e n ewb o rn is m on itored fo r sign s o f h yperbiliru b in em ia becau se reb ou n d elevatio n s can o ccur after th erapy is disco n tin ued . Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, p h o toth erapy. Recallin g th at ad verse effects fro m treatm en t, su ch as eye d am - age, d eh yd ratio n , or sen so ry d eprivation , can o ccur will assist in d eterm in in g th e correct in terven tion s. Review: In terven tio n s for th e n ewb o rn receivin g p h o to th erap y Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Matern ity—Newb o rn Pr ior ity Con cepts: Cellu lar Regu latio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p . 320.

M

a

t

e

r

n

i

t

y

391CHAPTER 31 Care of the Newborn

330. 2 Ra tion a le: An in fan t b o rn to a m o th er in fected with HIV m ust b e cared for with strict atten tion to stan dard precau tio n s. Th is p reven ts th e tran sm issio n of HIV fro m th e n ewbo rn , if in fected , to o th ers an d preven ts tran sm issio n o f o th er in fec- tio us agen ts to th e po ssib ly im m u n oco m p ro m ised n ewbo rn . O ptio n s 1 an d 3 are n o t asso ciated sp ecifically with th e care o f a po ten tially HIV-in fected n ewbo rn . Moth ers in fected with HIV sh ou ld n o t b reast-feed. Test-Ta kin g St r a t egy: Elim in ate o ptio n s 1 an d 3 first because th ey are co m p arab le o r alike an d are n o t associated sp ecifi- cally with th e care of a po ten tially HIV-in fected n ewbo rn . Recallin g th at HIV-in fected m o th ers sh o uld n o t breast-feed will direct you to th e correct option . Review: Care o f an in fan t b orn to a h u m an im m u n o d eficien cy viru s ( HIV) –in fected m oth er Level of Cogn it ive Abilit y: Creatin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Matern ity—Newb orn Pr ior it y Con cept s: In fection ; Safety Refer en ce: Hocken b erry, Wilso n (2015), pp . 193-194.

331. 2 Ra tion a le: Th e n ewb orn of a d iabetic m o th er is at risk fo r h yp oglycem ia, so m ain tain in g safety because o f lo w b lo od glu - cose levels wo uld b e a priority. Th e n ewb o rn wou ld also b e at risk fo r h yperbiliru b in em ia, respiratory distress, h yp ocalcem ia, an d co n gen ital an om alies. Develo pm en tal delays, ch o kin g, an d an elevated b od y tem p eratu re are n o t exp ected p ro b lem s. Test-Ta kin g St r a t egy: No te th e strategic wo rd , priority. Read each o ptio n th o ro ugh ly an d elim in ate op tio n s 1, 3, an d 4 b ecau se th ey are co m p arab le o r alike in th at n ewb orn s of d ia- b etic m oth ers are n o t at risk fo r th ese prob lem s. Also , n ote th e relation sh ip o f th e words diabetes mellitus in th e q uestio n an d th e word glucose in th e correct op tio n . Review: Nursin g in terven tion s for n ewb o rn s o f d iab etic m o th ers Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Matern ity—Newb orn Pr ior it y Con cept s: Clin ical Ju dgm en t; Glucose Regu latio n Refer en ce: Hocken b erry, Wilso n (2015), p. 328.

332. 3 Ra tion a le: Precaution s to preven t in fan t abd u ction in clude p lacin g a n ewb orn ’s crib away from th e d oo r, tran sp o rtin g a

n ewb orn on ly in th e crib an d n ever carryin g th e n ewbo rn , exp ectin g h ealth care p erso n n el to wear iden tification th at is easily visib le at all tim es, an d askin g th e n urse to atten d to th e n ewbo rn if th e m o th er is n app in g an d n o fam ily m em b er is available to watch th e n ewb orn (th e n ewb orn is n ever left u n atten d ed). If th e m o th er states th at sh e will ask th e n urse to watch th e n ewb orn wh ile sh e is sleepin g, sh e h as u n d ersto od th e teach in g. O p tio n s 1, 2, an d 4 are in co rrect an d in d icate th at th e m oth er n eed s fu rth er teach in g. Test-Ta kin g Str a tegy: Focus on th e su b ject, th at th e clien t u n derstan d s precautio n s to p reven t in fan t ab d uction . Read each op tion carefully an d select th e o p tion th at provid es p ro - tection to th e in fan t. Th is will direct you to th e correct o ptio n . Review: Precau tion s to p reven t n ewb o rn ab d u ctio n Level of Cogn itive Ability: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Matern ity—Newbo rn Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 268.

333. 4 Ra tion a le: Phyton adion e is n ecessary for th e b od y to syn th esize coagulation factors. It is adm in istered to th e n ewbo rn to p reven t b leedin g disord ers. It also p rom otes liver form ation of th e clo t- tin g factors II, VII, IX, and X. Newborn s are vitam in K–deficien t b ecause the b owel d oes n ot h ave th e bacteria n ecessary to syn - th esize fat-soluble vitam in K. The n orm al flora in th e in testin al tract produces vitam in K. The n ewborn ’s bowel d oes n ot support th e n orm al p ro du ctio n o f vitam in K u n til b acteria adequately colon ize it. Th e b owel b ecom es colo n ized by bacteria as foo d is in gested. Vitam in K d oes n ot p rom o te th e d evelo pm en t of im m u nity or p reven t the in fan t from b ecom in g jau n diced. Test-Ta king Str a tegy: Note th e strategic wo rd, best. Because im m un ity an d jau n dice are n ot related to th e action o f vitam in K, elim in ate option s 1 an d 2. From th e rem ain in g o ption s, recall th e action of vitam in K to d irect you to th e correct o ption . Rem em ber th at vitam in K does n ot prom o te th e growth of b acteria, b ut is adm in istered to p reven t bleed in g. Review: Th e p urpo se o f ad m in isterin g a p h yto n ad io n e in jec- tio n to a n ewb orn Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Matern ity—Newbo rn Pr ior it y Con cept s: Clien t Ed ucation ; Clottin g Refer en ce: Hocken b erry, Wilso n (2015), p. 269.

M

a

t

e

r

n

i

t

y

392 UNIT VI Maternity Nursing

C H A P T E R 32 Maternity and Newborn Medications

PRIORITY CONCEPTS Health Promotion, Safety

CRITICAL THINKING What Should You Do? The nurse notes that a pregnant client who has undergone amniocentesis is Rh-negative. What should the nurse do? Answer located on p. 399.

I. Tocolytics A. Description : To colytics are m ed ication s th at produ ce

uterin e relaxatio n an d suppress uterin e activity ( Table 32-1).

B. Uses: To h alt uterin e co n traction s an d preven t pre- term birth ; dih ydrop yridin e calcium ch an n el blockers such as n ifedipin e an d m agn esium sulfate m ay be prescribed to ach ieve th is goal.

C. Adverse effects an d co n train d ication s 1. See Table 32-1 for a description of ad verse effects. 2. Matern al co n train d ication s in clude severe pre-

eclam psia an d eclam psia, active vagin al bleed- in g, in trauterin e in fectio n , cardiac disease, an d m ed ical or obstetric con d ition s th at con train di- cate con tin uation of pregn an cy.

3. Fetal con train dication s in clude estim ated gesta- tio n al age greater th an 37 weeks, cervical dilation greater th an 4 cm , fetal dem ise, leth al fetal an om aly, ch orioam n ion itis, acute fetal distress, an d ch ron ic in trauterin e growth restrictio n .

D. In terven tion s for th e clien t receivin g tocolytic th erap y 1. Position the clien t on h er side to enh an ce placental

perfusion an d reduce pressure on the cervix. 2. Mon itor m atern al vital sign s, fetal status, an d

labor status frequen tly acco rdin g to agen cy protocol.

3. Mon itor for sign s of ad verse effects to th e m ed ication .

4. Mon itor daily weigh t an d in pu t an d output sta- tus, an d provide fluid in take as prescribed.

5. O ffer com fo rt m easu res an d provide psych o so- cial supp ort to th e clien t an d fam ily.

6. See Table 32-1 for in terven tion s specific to each tocolytic m ed ication .

II. Magnesium Sulfate A. Description (see Table 32-1)

1. Magn esium sulfate is a cen tral n ervou s system dep ressan t an d an tiseizure m edication .

2. Th e m edication causes sm ooth m uscle relaxation. 3. Th e an tidote is calcium glucon ate.

B. Uses 1. Stopp in g preterm labor to preven t preterm birth 2. Preven tin g an d con tro llin g seizures in pre-

eclam ptic an d eclam ptic clien ts C. Adverse effects an d con train dication s

1. Magn esium sulfate can cau se respiratory depres- sion , depressed reflexes, flush in g, h ypoten sion , extrem e m uscle weakn ess, decreased urin e out- put, pulm o n ary edem a, an d elevated serum m ag- n esium levels.

2. Con tin uous in traven ous (IV) in fusion in creases th e risk of m agn esium toxicity in th e newborn.

3. IV adm in istration sh ould n ot be used for 2 h ours preced in g birth.

4. Magn esium sulfate m ay be prescribed for th e first 12 to 24 h ou rs postpartu m if it is used for preeclam psia.

5. High doses can cause loss of deep ten don reflexes, h eart block, respiratory paralysis, an d cardiac arrest.

6. Th e m edication is con train dicated in clien ts with h eart block, m yocardial dam age, or kidn ey failure.

7. Th e m edication is used with cau tion in clien ts with kidn ey im pairm en t.

D. In terven tion s 1. Mon itor m atern al vital sign s, esp ecially respira-

tion s, every 30 to 60 m in utes. 2. Assess ren al fun ction an d electrocardiogram for

cardiac fun ction . 3. Mon itor m agn esium levels—th e target ran ge

wh en used as a tocolytic agen t is 4 to 7.5 m Eq/ L (2 to 3.75 m m ol/ L); if the m agn esium level increases, n otify th e h ealth care provider (HCP).

M

a

t

e

r

n

i

t

y

393

4. Always adm in ister by IV in fusion via an in fusion m on itorin g device; carefully m on itor th e dose bein g adm in istered, an d follo w agen cy protoco l for adm in istration .

5. Keep calcium glucon ate readily accessible in case of a m agn esium sulfate overdose because cal- ciu m gluco n ate an tagon izes th e effect of m agn e- sium sulfate.

6. Mon itor deep ten don reflexes h ourly for sign s of developin g toxicity.

7. Test th e patellar reflex or kn ee jerk reflex before adm in isterin g a repeat paren teral dose (used as an in dicator of cen tral n ervous system depres- sion ; supp ressed reflex m ay be a sign of im pen d- in g respiratory arrest) ( Table 32-2).

8. Patellar reflex m ust be presen t an d respiratory rate m ust be greater th an 12 breath s/ m in ute (or as design ated by agen cy protocol) before each paren teral dose.

9. Mon itor in take an d output h ourly; output should be m ain tain ed at 25 to 30 m L/ hour because th e m edication is elim inated th rough th e kidn eys.

Monitor a client receiving magnesium sulfate intra- venously closely for signs of toxicity. Call the HCP if res- pirations are less than 12 breaths/ minute, indicating respiratory depression, or if any other adverse effects occur.

III. Betamethasone and Dexamethasone A. Descrip tion : Corticostero ids th at in crease th e pro-

duction of surfactant to accelerate fetal lun g m aturity an d reduce th e in ciden ce or severity of respiratory distress syn drom e

B. Use: For a clien t in preterm labor between 28 an d 32 weeks’ gestation wh ose labo r can be in h ibited for 48 h ou rs with ou t jeopardizin g th e m oth er or fetus

C. Adverse effects an d con train dication s 1. May decrease th e m oth er’s resistan ce to in fectio n 2. Pulm o n ary edem a secon dary to sodium an d

fluid reten tion can occur. 3. Elevated blood glucose levels can occur in a

clien t with diabetes m ellitus.

TABLE 32-1 Tocolytics Medication, Classification, and Actions Adverse Effects Nursing Interventions

Magnesium sulfate—central nervous system depressant; relaxes smooth muscle, including the uterus; used to halt preterm labor contractions; used for preeclamptic clients to prevent seizures

Maternal—depressed respirations, depressed DTRs, hypotension, extreme muscle weakness, flushing, decreased urine output, pulmonary edema, serum magnesium levels > 7.5 mEq/ L (3.75 mmol/ L)

Always use intravenous controller device for administration

Newborn—hypotonia and sleepiness Follow agency protocol for administration

Discontinue infusion and notify HCP if adverse effects occur

Monitor for respirations < 12/ min, urine output < 100 mL/ 4 hr (25-30 mL/ hr)

Monitor DTRs

Monitor magnesium levels and report values outside therapeutic range of 4 to 7.5 mEq/ L(2 to 3.75 mmol/ L)

Keep calcium gluconate readily accessible (antidote)

Nifedipine-calcium channel blocker; relaxes smooth muscles, including the uterus, by blocking calcium entry; in some health care agencies, this may be the first-line agent to halt preterm labor contractions

Maternal—tachycardia, hypotension, dizziness, headache, nervousness, facial flushing, fatigue, nausea Newborn—hypotension

Follow agency protocol for administration Use with magnesium sulfate is avoided because severe hypotension can occur Monitor for adverse effects

DTRs, Deep tendon reflexes; HCP, health care provider.

TABLE 32-2 Assessing Deep Tendon Reflexes Grade Deep Tendon Reflex Response

0 No response

1 Sluggish or diminished

2 Active or expected response

3 More brisk than expected, slightly hyperactive

4 Brisk, hyperactive, with intermittent or transient clonus

Data from Seidel H, Ball J, Dains J, Flynn J, Solomon B, Stewart R: Mosby’s guide to physical examination, ed 6, St. Louis, 20 11, Mosby.

394 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

D. In terven tion s 1. Mon itor m atern al vital sign s an d lun g soun ds,

an d for edem a. 2. Mon itor m oth er for sign s of in fectio n . 3. Mon itor wh ite blood cell coun t. 4. Mon itor blood gluco se levels. 5. Adm in ister by deep in tram uscular in jection .

IV. Opioid Analgesics A. Description

1. Used to relieve m oderate to severe pain associ- ated with labor

2. Adm in istered by in tram uscular or IV route 3. Regular use of opioids durin g pregn an cy m ay

produce with drawal sym ptom s in th e n ewborn (irritability, excessive cryin g, trem o rs, h yperac- tive reflexes, fever, vom itin g, diarrh ea, yawn in g, sn eezin g, an d seizu res).

4. An tido tes for opioids a. Naloxon e is usually th e treatm en t of ch oice

because it rapidly reverses opioid toxicity; th e dose m ay n eed to be repeated every few h ou rs un til opioid con cen tration s h ave decreased to n on to xic levels.

b . Th ese m ed ication s can cause with drawal in opioid-depen den t clien ts.

B. Hydro m orph on e h ydroch loride an d m ep eridin e h ydroch loride 1. Can cau se dizzin ess, n ausea, vom itin g, sedation ,

decreased blood pressure, decreased respiration s, diaph oresis, flush ed face, an d urin ary reten tion

2. May be prescribed to be adm in istered with an an tiem etic such as prom eth azin e to preven t n ausea

3. High dosages m ay result in respiratory depres- sion , skeletal m uscle flaccidity, cold clam m y skin , cyan osis, an d extrem e som n olen ce progres- sin g to seizures, stupor, an d com a.

4. Used cau tiously in clien ts deliverin g preterm n ewborn s

5. No t ad m in istered in early labor because it m ay slow th e labo r process

6. No t adm in istered in advan ced labor (with in 1 to 4 h ours of expected birth ) ; if th e m ed ication is n ot adequ ately rem oved fro m th e fetal circula- tio n , respiratory depression can occur.

7. Mep eridin e is used less frequen tly th an h ydro- m orph on e h ydroch loride because of th e risk of ab n orm al fetal h eart rate in n ewborn s as well as th e poten tial for seizures in th e m oth er.

C. Fen tan yl an d sufen tan il can cause respiratory dep res- sion , dizzin ess, drowsin ess, h ypo ten sion , urin ary reten tion , an d fetal n arcosis an d distress; sufen tan il is used less com m on ly th an fen tan yl.

D. Butorph an ol tartrate an d n albuph in e 1. May be prescribed dep en din g on HCP preferen ce 2. Can cau se con fusion , sed ation , sweatin g, n ausea,

vo m itin g, h ypo ten sion , an d sin usoidal-like fetal h eart rh yth m

3. Use with caution in a clien t with preexistin g opi- oid dep en den cy, because th ese m edication s can precipitate with drawal sym ptom s in th e clien t an d th e n ewborn .

E. In terven tion s 1. Mon itor vital sign s, particularly respiratory

status; if respiration s are 12 breath s/ m in ute or less, with h old th e m ed ication an d con tact th e HCP.

2. Mon itor th e fetal h eart rate an d ch aracteristics of uterin e con traction s.

3. Mon itor for blood pressure ch an ges (h ypoten - sion ); m ain tain th e clien t in a recum ben t posi- tion (elevate th e h ip with a wedge pillow or oth er device).

4. Record th e level of pain relief. 5. Mon itor th e blad der for disten tion an d

reten tion . 6. Have th e an tidote n aloxo n e readily accessible,

esp ecially if delivery is expected to occur durin g peak m ed ication ab sorption tim e.

Obtain a medication history before the administra- tion of an opioid analgesic. Some medications may be contraindicated if the client has a history of opioid dependency, because these medications can precipitate withdrawal symptoms in the client and newborn.

V. Prostaglandins (Box 32-1) A. Description

1. Rip en th e cervix, m akin g it softer an d cau sin g it to begin to dilate an d efface

2. Stim ulate uterin e con traction s 3. Adm in istered vagin ally

B. Uses 1. Prein d uction cervical ripen in g (ripen in g of th e

cervix before th e in ductio n of labo r wh en th e Bish op score is 4)

2. In duction of labo r 3. In duction of ab ortion (abo rtifacien t agen t)

C. Adverse effects an d con train dication s 1. Gastroin testin al effects, in cludin g diarrh ea, n au-

sea, vom itin g, an d stom ach cram p s 2. Fever, ch ills, flush in g, h ead ach e, an d

h ypo ten sion 3. Uterin e tach ysystole ( ! 12 uterin e con traction s

in 20 m in utes with ou t an alteration in th e fetal h eart rate pattern )

4. Hyperstim ulation of th e uterus 5. Fetal passage of m eco n ium 6. Con train dication s (Box 32-2)

D. In terven tion s

BOX 32-1 Prostaglandins Prosta gla ndin E1: Misoprostol intravaginal tablet Prostaglandin E2: Dinoprostone vaginal gel, insert, or suppository

395CHAPTER 32 Maternity and Newborn Medications

M

a

t

e

r

n

i

t

y

1. Mon itor m atern al vital sign s, fetal h eart rate pat- tern , ad verse effects, an d status of pregn an cy, in cludin g in dication s for cervical ripen in g or th e in du ction of labor, sign s of labor or im pen d- in g labor, an d th e Bish op score (see Ch apter 27, Table 27-2 for in form ation about th e Bish op score).

2. Have th e clien t vo id before adm in istration of m ed ication an d th en h ave h er m ain tain a supin e with lateral tilt or side-lyin g position for 30 to 60 m in u tes (gel) up to 2 h ours (in sert) after adm in istration , depen din g on th e m ed ication adm in istered.

3. Treatm en t is discon tin u ed wh en th e Bish op score is 8 or m ore (cervix ripen s) or an effective con traction pattern is establish ed (3 or m ore con traction s in a 10-m in ute period); in addition , sign s of ad verse effects in dicate th at th e treat- m en t n eeds to be discon tin u ed.

4. Follo w agen cy protoco l for th e in duction of labo r if cervical ripen in g h as occurred an d labo r h as n ot begun ; oxytocin can be in itiated if n eeded 6 to 12 h ou rs after discon tin uation of prostaglan din th erapy.

VI. Uterine Stimulants (Oxytocics): Oxytocin A. Description

1. O xytocin stim ulates th e sm ooth m uscle of th e uterus an d in creases th e force, frequen cy, an d duration of uterin e con traction s.

2. O xytocin also prom o tes m ilk letdown . 3. For in duction of labor, oxytocin is ad m in istered

by th e IV route (oth er route of ad m in istration is in tram uscular); if in jectin g in tram uscularly, aspiration is n ecessary to avoid in jection in to a blood vessel.

4. Magn esium sulfate should be readily accessible in case relaxation of th e m yom etrium is n ecessary.

5. Min im al cervical ch an ge usually is n oted un til th e active ph ase of labo r is ach ieved .

B. Uses 1. In duces or au gm en ts labor 2. Con trols postpartu m bleedin g 3. Man ages an in com plete abortion

C. Adverse effects an d con train dication s 1. Adverse effects in clude allergies, dysrh yth m ias,

ch an ges in blood pressure, uterin e rupture, an d water in toxication .

2. O xytocin m ay produce uterin e h yperton icity, resultin g in fetal or m atern al adverse effects.

3. High doses m ay cause h ypo ten sion , with rebou n d h yperten sion .

4. Postpartum h em orrh age can occur an d sh ould be m on itored for because th e uterus m ay beco m e aton ic wh en th e m edication wears off.

5. O xytocin sh ould n ot be used in a clien t wh o can - n ot deliver vagin ally or in a clien t with h yperton ic uterin e con traction s; it is also con train dicated in a client with active gen ital h erpes.

D. In terven tion s 1. Mon itor m atern al vital sign s (every 15 m in utes),

esp ecially th e blood pressure an d h eart rate, weigh t, in take an d output, level of con scious- n ess, an d lu n g soun ds.

2. Mon itor frequen cy, duration , an d force of co n - traction s an d restin g uterin e ton e every 15 m in utes.

3. Mon itor fetal h eart rate every 15 m in u tes, an d n otify th e HCP if sign ifican t ch an ges occur; use of an in tern al fetal scalp electrod e m ay be prescribed .

4. Adm in istered by IV in fusio n via an in fusion m on itorin g device (m ost com m on route); pre- scrib ed additive solution is piggybacked at th e port n earest th e poin t of ven ous in sertion (pre- scrib ed additive solution m ay be n orm al salin e, lactated Rin ger’s, or 5% dextrose in water).

5. Carefully m on itor th e dose bein g ad m in istered; do n ot leave th e clien t un atten ded wh ile th e oxytocin is in fusin g.

6. Adm in ister oxygen if prescribed . 7. Mon itor for h yperton ic con traction s or a n on -

reassurin g fetal h eart rate an d n otify th e HCP if th ese occur (see Priority Nursin g Action s).

8. Stop the m edication if uterine hyperstim ulation or a non reassurin g fetal h eart rate occurs; turn the client on her side, in crease th e IV rate of the n or- m al salin e, an d adm in ister oxygen via face m ask.

9. Mon itor for sign s of water in toxication . 10. Have em ergen cy equ ipm en t readily accessible. 11. Do cum en t th e dose of th e m ed ication an d th e

tim e th e m edication was started, in creased, m ain tain ed, an d discon tin ued; docum en t th e clien t’s respon se.

BOX 32-2 Contraindications to the Use of Prostaglandins

▪ Active cardiac, hepatic, pulmonary, or kidney disease ▪ Acute pelvic inflammatory disease ▪ Clients in whom vaginal delivery is not indicated ▪ Fetal malpresentation ▪ History of cesarean section or major uterine surgery ▪ History of difficult labor or traumatic labor ▪ Hypersensitivity to prostaglandins ▪ Maternal fever or infection ▪ Nonreassuring fetal heart rate pattern ▪ Placenta previa or unexplained vaginal bleeding ▪ Regular progressive uterine contractions ▪ Significant cephalopelvic disproportion

396 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

12. Keep th e clien t an d fam ily in form ed of th e cli- en t’s progress.

13. Calculatin g an oxytocin drip ( Box 32-3)

VII. Medications Used to Manage Postpartum Hemorrhage (Box 32-4)

A. Ergot alkaloid 1. Description

a. Meth ylergon ovin e m aleate is an ergot alkaloid. b . Directly stim ulates uterin e m uscle, in creases

th e force an d frequen cy of con traction s, an d produces a firm tetan ic con traction of th e uterus

c. Can produce arterial vaso con striction an d vaso spasm of th e coron ary arteries

d . An ergot alkaloid is adm in istered postp artum an d is n ot adm in istered befo re th e birth of th e placen ta.

2. Uses a. Postp artum h em orrh age b . Postab ortal h em orrh age resultin g fro m aton y

or in volution 3. Adverse effects an d co n train d ication s

a. Can cause n ausea, uterin e cram pin g, brad y- cardia, dysrh yth m ias, m yocardial in farction , an d severe h yperten sion

BOX 32-3 Calculating an Oxytocin Dose Prescription: Oxytocin 2 milliunits (mU)/ minute Available: 20 units (U) in 100 0 mL 5% dextrose in Water (D5W)

How many mL per hour? Steps for calculating:

1. Do you need to convert? Yes, you need to change mU to U 2. What has been prescribed? Oxytocin 2 mU/ minute 3. What do you have available? 10 00 mL D5W containing

20 U oxytocin 4. Set up formula:

Convert: How many mU are in 1 U? There are 100 0 mU in 1 U. If there are 10 00 mU in 1 U, how many U in 2 mU?

10 00 mU = 1U ¼ 2 mU = X

Answer: 0.0 02 U in 2 mU Now use the standard formula for calculation.

Prescribed = Available  Volume

0:00 2 U = 20 U Â 10 00 mL ¼ 0:1mL

Now, determine how many mL should be given in 1 hour if the prescription is for 0 .1 mL/ minute. 0 .1 mL/ minute  60 minutes/ 1 hour¼6 mL/ hr

Reference: Gahart B, Nazareno A: 2015 intravenous medications, ed 31, St. Louis, 2015, Mosby. Note: Many electronic pumps allow for programming in units or milliunits per minute, eliminating the need to calculate the mL per hour, and this practice is recommended if available because medications are programmed in the pumps with dosage safeguards. If a dose that is too low or too high is programmed into the pump, the pump will flag or will not allow the nurse to proceed with administration.

BOX 32-4 Medications Used to Manage Postpartum Hemorrhage

▪ Methylergonovine ▪ Oxytocin ▪ Prostaglandin F2α: Carboprost tromethamine

PRIORITY NURSING ACTIONS Hypertonic Contractions or a Nonreassuring Fetal Heart Rate during Oxytocin Infusion 1. Stop the oxytocin infusion. 2. Turn the client on her side, stay with the client, and ask

another nurse to contact the health care provider (HCP). 3. Increase the flow rate of the intravenous (IV) solution that

does not contain the oxytocin. 4. Administer oxygen, 8 to 10 L/ minute, by snug face mask. 5. Assess maternal vital signs; fetal heart rate and patterns;

and frequency, duration, and force of contractions. 6. Document the event, actions taken, and the response.

Oxytocin is a uterine stimulant and stimulates the smooth muscle of the uterus and increases the force, fre- quency, and duration of uterine contractions. It is adminis- tered to induce or augment labor. The presence of hypertonic contractions or a nonreassuring fetal heart rate indicates the need to institute emergency measures to reduce uterine stimulation and increase fetal oxygenation. The nurse would always follow the agency’s protocol regard- ing the procedure to follow in this event. Keeping the emer- gency goals of care in mind (to reduce uterine stimulation and increase fetal oxygenation) guides the nurse’s actions. The oxytocin infusion needs to be stopped to reduce uterine contractions. The nurse turns the client on her side to increase placental oxygenation. The nurse never leaves a cli- ent if an emergency situation is present; the nurse asks another nurse to contact the HCP. The flow rate of the IV solution that does not contain the oxytocin is increased, and oxygen is administered. These actions also facilitate the goals of care. When these emergency actions are taken, the nurse assesses and continuously monitors maternal vital signs; fetal heart rate and patterns; and frequency, duration, and force of contractions. The nurse also implements any additional prescriptions and documents the event, actions taken, and the response.

Reference Lowdermilk et al. (2016), p. 799.

397CHAPTER 32 Maternity and Newborn Medications

M

a

t

e

r

n

i

t

y

b . High doses are associated with periph eral vaso spasm or vaso con striction , an gin a, m io- sis, con fusion , respiratory depression , sei- zures, or un co n sciousn ess; uterin e tetan y can occur.

c. Co n train d icated d u rin g p regn an cy an d in clien ts with sign ifican t card io vascu lar d is- ease, p erip h eral vascu lar d isease, o r h yp er- ten sio n

4. In terven tion s a . Mon itor m atern al vital sign s, weigh t, in take

an d outp ut, level of con sciousn ess, an d lun g soun ds.

b . Mon itor th e blood pressure clo sely; th e m ed- ication produ ces vaso con striction , an d if an in crease in blood pressure is n oted, with h old th e m ed ication an d n otify th e HCP.

c. Mon itor uterin e con traction s (freq uen cy, stren gth , an d duration ).

d . Assess for ch est pain , h eadach e, sh ortn ess of breath , itch in g, pale or cold h an ds or feet, n ausea, diarrh ea, an d dizzin ess.

e. Assess th e extrem ities for color, warm th , m ovem en t, an d pain .

f. Assess vagin al bleedin g. g. No tify th e HCP if ch est pain or oth er adverse

effects occur. h . Adm in ister an algesics as prescribed ; th ey m ay

be required because th e m ed ication produ ces pain ful uterin e con traction s.

Check the client’s blood pressure before administer- ing methylergonovine maleate. This medication can cause severe hypertension and is contraindicated in a cli- ent with hypertension.

B. Prostaglan din F2α: carbo prost trom eth am in e 1. Description : Con tracts th e uterus 2. Uses: Postp artum h em orrh age 3. Adverse effects an d co n train d ication s

a . Can cause h ead ach e, n ausea, vom itin g, diar- rh ea, fever, tach ycardia, an d h yperten sio n

b . Con train dicated if th e clien t h as asth m a 4. In terven tion s

a . Mon itor vital sign s. b . Mon itor vagin al bleed in g an d uterin e ton e.

C. O xytocin : See Section VI on uterin e stim ulan ts.

VIII. Rho(D) Immune Globulin A. Description

1. Preven tion of an ti-Rh o(D) an tibody form ation is m ost successful if th e m edication is ad m in istered twice, at 28 weeks’ gestation an d again with in 72 h ou rs after delivery.

2. Rh o(D) im m un e globulin also sh ould be ad m in - istered with in 72 h ours after poten tial or actual exposu re to Rh -p ositive blood an d m ust be given with each subsequ en t exp osure or poten tial exposu re to Rh -p ositive blood.

B. Use: To preven t isoim m un ization in Rh -n egative cli- en ts wh o are n egative for Rh an tibod ies an d exposed or poten tially exp osed to Rh -p ositive red blood cells by am n iocen tesis, ch orion ic villus sam plin g, tran sfu- sion , term in ation of pregn an cy, abdom in al traum a, or bleedin g durin g pregn an cy or th e birth process

C. Adverse effects an d con train dication s 1. Elevated tem p erature 2. Ten dern ess at th e in jection site 3. Con train dicated for Rh -p ositive clien ts 4. Con train dicated in clien ts with a h isto ry of sys-

tem ic allergic reactio n s to preparation s con tain - in g h um an im m un oglobulin s

5. Note: Not adm in istered to a n ewborn D. In terven tion s

1. Adm in ister to th e clien t by in tram uscu lar in jec- tion at 28 weeks’ gestation an d with in 72 h ours after delivery.

2. Never ad m in ister by th e IV route. 3. Mon itor for tem perature elevation . 4. Mon itor in jection site for ten dern ess.

Rho(D) immune globulin is of no benefit when the client has developed a positive antibody titer to the Rh antigen.

IX. Rubella Vaccine A. Given subcu tan eo usly before h ospital disch arge to a

n on im m un e postpartum clien t B. Adm in istered if th e rubella titer is less th an 1:8 C. Adverse effects: Tran sien t rash , h ypersen sitivity D. Con train dicated in a clien t with a h ypersen sitivity to

eggs (ch eck with th e HCP regardin g adm in istration ) E. In terven tion s

1. Assess for allergy to duck eggs an d n otify th e HCP before adm in istration if an allergy exists.

2. Do n ot adm in ister if th e clien t or oth er fam ily m em bers are im m un ocom prom ised.

The client should avoid pregnancy for 1 to 3 months (or as prescribed) after immunization with rubella vac- cine. Inform the client about the need to use a contracep- tion method during this time.

X. Lung Surfactants A. Descrip tion

1. Replen ish surfactan t an d restore surface activity to th e lun gs to preven t an d treat respiratory dis- tress syn drom e.

2. Adm in istered to th e n ewborn by th e in tratra- ch eal route.

B. Use: To preven t or treat respiratory distress syn - drom e in prem atu re n ewborn s

C. Adverse effects an d con train dication s 1. Adverse effects in clude tran sien t bradycardia an d

oxygen desatu ration ; pulm on ary h em orrh age, m ucus pluggin g, an d en dotrach eal tube reflux can also occur.

398 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

2. Surfactan ts are adm in istered with cau tion in n ewborn s at risk for circulatory overload.

D. In terven tion s 1. In still surfactan t th rough th e cath eter in serted

in to th e n ewborn ’s en dotrach eal tube; avoid suction in g for at least 2 h ours after adm in is- tration .

2. Mon itor for bradycardia an d decreased oxygen saturation durin g adm in istration .

3. Mon itor respiratory status an d lun g soun ds an d for sign s of adverse effects.

XI. Eye Prophylaxis for the Newborn A. Description

1. Preven tive eye treatm en t again st oph th alm ia n eon atorum in th e n ewborn is required by law in th e Un ited States.

2. O ph th alm ic form s of eryth rom ycin are pre- scrib ed because it is bacteriostatic an d bacteri- cid al an d provides proph ylaxis again st Neisseria gonorrhoeae an d Chlamydia trachomatis.

B. Use: As a proph ylactic m easure to protect again st N. gonorrhoeae an d C. trachomatis

C. In terven tion s 1. Clean th e n ewborn ’s eyes befo re in stillin g th e

m ed ication . 2. Do n ot flush th e eyes after in stillation .

Instillation of eye medication can be delayed for 1 hour after birth to facilitate eye contact and parent- newborn attachment and bonding.

XII. Phytonadione A. Description

1. Th e newborn is at risk for h em orrh agic disorders; coagulation factors syn th esized in th e liver dep en d on ph yton adio n e (also kn own as vita- m in K), wh ich is n ot syn th esized un til in testin al bacteria are presen t.

2. Newborn s are deficien t in ph yton adion e for th e first 5 to 8 days of life because of th e lack of in tes- tin al bacteria.

B. Use: Proph ylaxis an d treatm en t of h em orrh agic dis- ease of th e n ewborn

C. Adverse effect: Can cause h yperb ilirubin em ia in th e n ewborn (occu rren ce is rare).

D. In terven tion s 1. Protect th e m edication from ligh t. 2. Adm in ister durin g th e early n ewborn period. 3. Adm in ister by th e in tram uscular route in th e lat-

eral aspect of th e m iddle th ird of th e vastus later- alis m uscle of th e th igh .

4. Mon itor for bruisin g at th e in jection site an d for bleedin g from th e cord.

5. Mon itor for jaun dice an d m on itor th e bilirubin level because, alth ough rare, th e m ed ication can cau se h yperb ilirubin em ia in th e n ewborn .

XIII. Hepatitis B Vaccine, Recombinant A. Description : Given in tram uscu larly to th e n ewborn

before disch arge h om e B. Use: Recom m en ded for all n ewborn s to preven t

h epatitis B C. Adverse effects: Rash , fever, eryth em a, an d pain at

in jection site D. In terven tion s

1. Paren tal con sen t m ust be obtain ed. 2. Adm in ister in tram uscularly in th e lateral aspect

of th e m iddle th ird of th e vastu s lateralis m uscle. 3. If th e in fan t was born to a m oth er positive for

h epatitis B surface an tigen , h epatitis B im m un e glob ulin sh ould be given with in 12 h ou rs of birth in addition to h epatitis B vaccin e. Th en fol- low th e regularly sch eduled h epatitis B vaccin a- tion sch edule.

4. Do cum en t im m un ization adm in istration on a vaccin ation card so th at th e paren ts h ave a record th at th e vaccin e was ad m in istered.

CRITICAL THINKING What Should You Do? Answer: The nurse should seek a prescription from the health care provider for the administration of Rho(D) immune glob- ulin. Rho(D) immune globulin is administered to prevent iso- immunization in Rh-negative clients who are negative for Rh antibodies and exposed or potentially exposed to Rh-positive red blood cells from the fetus by amniocentesis or chorionic villus sampling, transfusion, termination of pregnancy, abdominal trauma, or bleeding during pregnancy or the birth process. It is administered to the Rh-negative client by intra- muscular injection at 28 weeks’ gestation and within 72 hours after delivery. The indirect Coombs’ test or antibody screen- ing test must be negative (absence of any Rh antibodies).

Reference: Lowdermilk et al. (20 16), pp. 884–885.

P R A C T I C E Q U E S T I O N S

334. Th e n urse is m on itorin g a clien t wh o is receivin g oxytocin to in duce labo r. Wh ich assessm en t fin d- in gs sh o uld cause th e n urse to im m ed iately dis- con tin ue th e oxytocin in fusion ? Select all th at ap p ly.

1. Fatigue 2. Drowsin ess 3. Uterin e h yperstim ulation 4. Late deceleration s of th e fetal h eart rate 5. Early deceleration s of th e fetal h eart rate

335. A pregn an t clien t is receivin g m agn esium sulfate for th e m an agem en t of preeclam p sia. Th e n urse determ in es th at th e clien t is exp erien cin g toxicity from th e m edication if wh ich fin din gs are n oted on assessm en t? Select all th at ap p ly.

1. Protein uria of 3 + 2. Resp iration s of 10 breath s/ m in ute

399CHAPTER 32 Maternity and Newborn Medications

M

a

t

e

r

n

i

t

y

3. Presen ce of deep ten don reflexes 4. Urin e outp ut of 20 m L in an h our 5. Serum m agn esium level of 4 m Eq/ L

(2 m m o l/ L)

336. Th e n urse asks a n ursin g studen t to describe the pro- cedure for adm in isterin g eryth rom ycin oin tm en t to th e eyes of a n ewborn . Which studen t statem en t in dicates th at fu rth er teach in g is n eed ed about adm in istration of the eye m edication ? 1. “I will flush the eyes after in stillin g the oin tm en t.” 2. “I will clean th e n ewborn ’s eyes before in stillin g

oin tm en t.” 3. “I n eed to adm in ister th e eye oin tm en t with in

1 h our after delivery.” 4. “I will in still th e eye oin tm en t in to each of th e

n ewborn ’s con jun ctival sacs.”

337. A clien t in preterm labor (31 weeks) wh o is dilated to 4 cm h as been started on m agn esium sulfate an d con traction s h ave stopp ed. If th e clien t’s labor can be in h ib ited for th e n ext 48 h ours, th e n urse an tic- ip ates a prescription for wh ich m edication ? 1. Nalbuph in e 2. Betam eth ason e 3. Rh o(D) im m un e glob ulin 4. Din oproston e vagin al in sert

338. Meth ylergon ovin e is prescribed for a wom an to treat postpartum h em orrh age. Before adm in istration of m eth ylergon ovin e, what is the p rio rity assessm en t? 1. Uterin e ton e 2. Blood pressure 3. Am oun t of loch ia 4. Deep ten don reflexes

339. Th e n urse is preparin g to adm in ister exogen ous surfactan t to a prem atu re in fan t wh o h as respira- tory distress syn d rom e. Th e n urse prepares to ad m in ister th e m ed ication by wh ich route? 1. In traderm al 2. In tratrach eal 3. Subcutan eous 4. In tram uscular

340. An opioid an algesic is ad m in istered to a clien t in labo r. Th e n urse assign ed to care for th e clien t en sures th at wh ich m ed ication is readily accessible sh ould respiratory depression occur? 1. Naloxon e 2. Morph in e sulfate 3. Betam eth ason e 4. Hydro m orph on e h ydroch loride

341. Rh o(D) im m un e globulin is prescribed for a clien t after delivery an d th e n urse provid es in form ation to th e clien t about th e purpo se of th e m ed ication . Th e n urse determ in es th at th e wom an un d erstan ds th e purpo se if th e wom an states th at it will protect h er n ext baby fro m wh ich con dition ? 1. Havin g Rh -p ositive blood 2. Developin g a rubella in fectio n 3. Developin g ph ysiological jaun dice 4. Bein g affected by Rh in com patib ility

342. Meth ylergon o vin e is prescribed for a clien t with postp artum h em orrh age. Before ad m in isterin g th e m edication , th e n urse sh ould con tact th e h ealth care provider wh o prescribed th e m edica- tion if wh ich con d ition is docum en ted in th e cli- en t’s m edical h isto ry? 1. Hypo ten sion 2. Hypo th yroidism 3. Diabetes m ellitus 4. Periph eral vascu lar disease

343. Th e n urse is m on itorin g a clien t in preterm labo r wh o is receivin g in traven ous m agn esium sulfate. Th e n urse sh ould m on itor for wh ich adverse effects of th is m ed ication ? Select all th at ap p ly.

1. Flush in g 2. Hyperten sion 3. In creased urin e output 4. Depressed respiration s 5. Extrem e m uscle weakn ess 6. Hyperactive deep ten don reflexes

A N S W E R S

334. 3, 4 Ra tion a le: O xyto cin stim u lates u terin e co n tractio n s an d is a p h arm acolo gical m eth od to in d uce labo r. Late d eceleration s, a n o n reassurin g fetal h eart rate pattern , is an om in ou s sign in dicatin g fetal d istress. O xytocin in fusion m u st b e sto p ped wh en an y sign s of uterin e h yperstim ulation , late deceleration s, o r o th er ad verse effects o ccu r. So m e h ealth care p ro vid ers pre- scrib e th e ad m in istration of oxyto cin in 10-m in ute p ulsed in fu- sio n s rath er th an as a co n tin u ou s in fu sion . Th is p ulsed

m eth o d, wh ich is m o re like en d ogen ou s secretion of o xyto cin , is rep o rted to b e effective fo r lab or in d uction an d req u ires sig- n ifican tly less oxyto cin u se. Dro wsin ess an d fatigu e m ay be cau sed by th e lab or exp erien ce. Early d eceleratio n s o f th e fetal h eart rate are a reassu rin g sign an d d o n ot in d icate fetal d istress. Test-Ta kin g Str a tegy: Note th e strategic word , immediately. Focus on th e su b ject, an adverse effect of oxytocin . Option s 1 an d 2 are co m p arab le o r alike an d can be elim in ated first. From the rem ain in g option s, recallin g th at early deceleration s of th e fetal h eart rate are a reassurin g sign will direct you to th e correct option .

400 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

Review: Nu rsin g resp on sib ilities associated with th e ad m in is- tratio n of o xyto cin Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Rep ro du ctive/ Matern ity/ New- bo rn Med icatio n s Pr ior ity Con cepts: Perfusio n ; Reprod uctio n Refer en ces: Lowderm ilk et al. (2016), p. 784; Bu rch u m , Rosen th al (2016), pp . 786–787.

335. 2, 4 Ra t ion a le: Magn esium toxicity can o ccur fro m m agn esium sul- fate th erap y. Sign s of m agn esiu m su lfate toxicity relate to th e cen tral n ervo us system dep ressan t effects o f th e m ed ication an d in clud e respiratory dep ression , loss o f deep ten do n reflexes, an d a sudden declin e in fetal h eart rate an d m atern al h eart rate an d b lo od p ressure. Resp irato ry rate below 12 breath s per m in u te is a sign o f toxicity. Urin e ou tpu t sh o uld be at least 25 to 30 m L p er h ou r. Protein uria o f 3 + is an expected fin d in g in a clien t with p reeclam p sia. Presen ce o f deep ten d o n reflexes is a n o rm al an d exp ected fin din g. Th era- peu tic seru m levels o f m agn esiu m are 4 to 7.5 m Eq / L (2 to 3.75 m m ol/ L) . Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, m agn esiu m toxic- ity. Elim in ate o ptio n 3 first b ecause it is a n o rm al fin d in g. Next, elim in ate o p tion 5, kn owin g th at th e th erapeutic serum level o f m agn esium is 4 to 7.5 m Eq/ L (2 to 3.75 m m o l/ L). Fro m th e rem ain in g o ptio n s, recallin g th at protein uria of 3 + would be n oted an d expected in a clien t with preeclam p sia will direct yo u to th e co rrect o p tion s. Review: Ad verse effects of m agn esiu m su lfate Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Rep ro du ctive/ Matern ity/ Newb orn Medicatio n s Pr ior ity Con cepts: Perfusio n ; Reprod uctio n Refer en ce: Lo wderm ilk et al. (2016), p . 664.

336. 1 Ra t ion a le: Eye prop h ylaxis protects th e n ewbo rn again st Neis- seria gonorrhoeae an d Chlamydia trachomatis. Th e eyes are n o t flush ed after in stillation of th e m ed ication b ecause th e flu sh wo uld wash away th e adm in istered m ed ication . O p tio n s 2, 3, an d 4 are correct statem en ts regardin g th e proced ure for ad m in isterin g eye m ed ication to th e n ewbo rn . Test -Ta kin g Str a tegy: Note th e strategic wo rd s, further teach- ing is needed. Th ese words in d icate a n egative even t q u ery an d ask you to select an op tio n th at is an in co rrect statem en t. Elim in ate op tio n s 3 an d 4 first because th ey are co m p arab le o r alike an d relate to in stillin g th e eye m ed ication . Fro m th e rem ain in g option s, visualize th e effect of each . Th is will direct yo u to th e co rrect o p tion . Review: Proced ure for ad m in isterin g eye p ro p h ylaxis to th e n ewbo rn Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g

Con t en t Ar ea : Ph arm acology—Reproductive/ Matern ity/ New- b o rn Medicatio n s Pr ior ity Con cepts: Health Prom o tion ; In fection Refer en ce: Lo wd erm ilk et al. (2016), p . 569.

337. 2 Ra t ion a le: Betam eth aso n e, a glu co cortico id , is given to in crease th e p ro d uction o f surfactan t to stim u late fetal lu n g m atu ratio n . It is adm in istered to clien ts in p reterm labo r at 28 to 32 weeks o f gestatio n if th e labo r can be in h ib ited for 48 h o urs. Nalb up h in e is an o p ioid an algesic. Rh o(D) im m u n e glob ulin is given to Rh -n egative clien ts to p reven t sen sitization . Din o prosto n e vagin al in sert is a prostaglan din given to rip en an d soften th e cervix an d to stim ulate uterin e con traction s. Test -Ta kin g Str a tegy: Focu s on th e su b ject, a clien t at 31 weeks’ gestation . Recall th at th e p reterm in fan t is at risk fo r resp irato ry d istress syn drom e because o f im m aturity an d th e in ab ility to prod uce surfactan t. Next, recallin g th e action s o f th e m ed icatio n s in th e op tio n s an d th at b etam eth aso n e is u sed to in crease th e prod u ctio n o f surfactan t will d irect yo u to th e co rrect op tion . Review: Betam eth aso n e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ph arm acology—Reproductive/ Matern ity/ New- b o rn Medicatio n s Pr ior ity Con cepts: Gas Exch an ge; Perfu sio n Refer en ce: Lo wd erm ilk et al. (2016), p . 769.

338. 2 Ra t ion a le: Meth ylergon o vin e, an ergot alkalo id , is u sed to p re- ven t o r co n trol po stpartum h em o rrh age b y co n tractin g th e u terus. Meth ylergo n o vin e cau ses co n tin u ou s u terin e con trac- tion s an d m ay elevate th e blo od p ressure. A p riority assessm en t b efo re th e ad m in istration of th e m ed ication is to ch eck th e b lo od pressure. Th e h ealth care p ro vider n eeds to b e n o tified if h yp erten sio n is presen t. Alth ou gh o ptio n s 1, 3, an d 4 m ay b e co m po n en ts o f th e p ostp artu m assessm en t, b lo od pressu re is related specifically to th e ad m in istration of th is m edicatio n . Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority. Elim i- n ate op tion s 1 an d 3 first becau se th ey are co m p arab le o r alike an d related to on e an o th er. To ch oo se fro m th e rem ain in g o p tion s, u se th e ABCs—airway–b reath in g–circu latio n . Blo o d p ressure is a m eth o d o f assessin g circulatio n . Review: Ad verse effects o f m eth ylergo n o vin e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm acology—Reproductive/ Matern ity/ New- b o rn Medicatio n s Pr ior ity Con cepts: Clottin g; Rep rod uctio n Refer en ce: Bu rch u m , Rosen th al (2016), p. 787.

339. 2 Ra t ion a le: Resp irato ry d istress syn drom e is a serio us lun g dis- o rd er caused b y im m atu rity an d th e in ability to p ro du ce surfac- tan t, resultin g in h ypo xia an d acid osis. It is co m m o n in p rem atu re in fan ts an d m ay b e d ue to lun g im m aturity as a

401CHAPTER 32 Maternity and Newborn Medications

M

a

t

e

r

n

i

t

y

result o f surfactan t deficien cy. Th e m ain stay o f treatm en t is th e ad m in istratio n of exo gen o us su rfactan t, wh ich is adm in istered b y th e in tratrach eal ro u te. O ptio n s 1, 3, an d 4 are n o t ro u tes of ad m in istratio n fo r th is m ed ication . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, ro u te of adm in is- tration for exo gen ou s su rfactan t. Note th e relatio n sh ip b etween th e d iagn osis, respiratory distress syndrome, an d th e cor- rect o ption , intratracheal. Review: Su rfactan t Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm aco logy—Reprod uctive/ Matern ity/ New- b orn Med ication s Pr ior it y Con cept s: Develo p m en t; Gas Exch an ge Refer en ces: Lo wderm ilk et al. (2016), p. 825; Burch um , Ro sen th al (2016), p p. 1305–1306.

340. 1 Ra tion a le: O pioid an algesics m ay be p rescribed to relieve m od erate to severe pain asso ciated with labo r. O p io id toxicity can occu r an d cause respirato ry dep ression . Naloxo n e is an o pio id an tago n ist, wh ich reverses th e effects of o pio id s an d is given fo r respiratory d ep ressio n . Mo rp h in e sulfate an d h yd ro m orph on e h ydroch lo ride are op io id an algesics. Beta- m eth aso n e is a co rtico stero id ad m in istered to en h an ce fetal lu n g m atu rity. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e an tid ote fo r respiratory depressio n . Elim in ate op tio n s 2 an d 4 first b ecause th ey are co m p arab le o r alike an d are o pio id an algesics. Next, elim in ate o ption 3, kn o win g th at th is m ed icatio n is a cortico steroid . Review: An tid o te fo r o p io id to xicity Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm aco logy—Reprod uctive/ Matern ity/ New- b orn Med ication s Pr ior it y Con cept s: Gas Exch an ge; Safety Refer en ces: Lo wderm ilk et al. (2016), p. 395; Burch um , Ro sen th al (2016), p . 266.

341. 4 Ra tion a le: Rh in com patib ility can o ccur wh en an Rh -n egative m oth er b ecom es sen sitized to th e Rh an tigen . Sen sitization m ay d evelo p wh en an Rh -n egative wom an b ecom es p regn an t with a fetus wh o is Rh po sitive. Durin g pregn an cy an d at deliv- ery, so m e of th e fetu s’s Rh -p ositive blo o d can en ter th e m ater- n al circu latio n , cau sin g th e m o th er’s im m u n e system to fo rm an tib o dies again st Rh -po sitive b lo od . Ad m in istration of Rh o(D) im m u n e glo bu lin p reven ts th e m oth er from develop - in g an tib od ies again st Rh -p ositive b loo d by pro vidin g passive an tib o dy p ro tection again st th e Rh an tigen . Test-Ta kin g St r a t egy: Note th e su b ject, th e p urpo se o f Rh o(D) im m un e glo b ulin . Notin g th e relatio n sh ip between th e n am e

o f th e m ed ication , Rh o(D) im m u n e glo bu lin , an d th e word incompatibility in th e correct option will direct you to th is o ptio n . Review: Th e p u rp ose of Rh o ( D) im m u n e glo b u lin Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm acology—Rep rod uctive/ Matern ity/ New- b orn Med ication s Pr ior it y Con cept s: Health Pro m otio n ; Rep ro d uction Refer en ce: Lowd erm ilk et al. (2016), p. 494.

342. 4 Ra tion a le: Meth ylergon ovin e is an ergot alkalo id used to treat p ostp artu m h em o rrh age. Ergo t alkalo id s are con train dicated in clien ts with sign ifican t card io vascu lar d isease, perip h eral vas- cular d isease, h yp erten sio n , p reeclam psia, or eclam p sia. Th ese con d itio n s are wo rsen ed b y th e vaso co n strictive effects o f th e ergo t alkaloid s. O ption s 1, 2, an d 3 are n o t co n train dicatio n s related to th e use of ergot alkaloids. Test-Ta kin g Str a tegy: Focus o n th e su b ject, th e purpose, action , an d co n train dicatio n s of m eth ylergo n ovin e. Recallin g th at ergo t alkalo id s p ro d uce vaso co n strictio n will direct you to th e correct o ptio n . Review: Th e p u rp ose an d actio n of m eth ylergo n o vin e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm acology—Rep rod uctive/ Matern ity/ New- b orn Med ication s Pr ior it y Con cept s: Co llab oration ; Safety Refer en ce: Lowd erm ilk et al. (2016), p. 668.

343. 1, 4, 5 Ra tion a le: Magn esium sulfate is a cen tral n ervou s system d epressan t an d relaxes sm oo th m uscle, in clu d in g th e uterus. It is u sed to h alt preterm lab or co n tractio n s an d is u sed for p re- eclam p tic clien ts to p reven t seizures. Adverse effects in clud e flu sh in g, dep ressed respiration s, d epressed d eep ten d on reflexes, h ypoten sion , extrem e m uscle weakn ess, decreased u rin e ou tp ut, p ulm o n ary edem a, an d elevated seru m m agn e- siu m levels. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, ad verse effects of m agn esiu m sulfate. Recallin g th at th is m edication is a cen tral n ervou s system dep ressan t an d relaxes sm oo th m u scle will assist you in ch o o sin g th e correct op tio n s. Review: Ad verse effects o f m agn esiu m su lfate Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acology—Rep rod uctive/ Matern ity/ New- b orn Med ication s Pr ior it y Con cept s: Perfu sion ; Rep ro du ction Refer en ces: Lowd erm ilk et al. (2016), p p. 663–664; Burch um , Ro sen th al (2016), p . 780.

402 UNIT VI Maternity Nursing

M

a

t

e

r

n

i

t

y

P

e

d

i

a

t

r

i

c

s

UNIT VII

Pediatric Nursing

Pyramid to Success

Pyram id Poin ts focus on growth an d developm en t, safety, an d age-appropriate m easu res to en sure a safe an d h azard-free en viron m en t for th e ch ild; on protec- tion of th e ch ild an d th e preven tion of acciden ts; an d on acu te disorders th at can occur in ch ildren . Th e focus is on n utrition , specific feedin g tech n iqu es, position in g tech n iqu es, an d in terven tion s th at will provide an d m ain tain adequ ate airway, breath in g, an d circulation pattern s in th e ch ild. In addition , n eglect an d/ o r abuse of th e ch ild is a focus. O n th e NCLEX-RN ® exam in ation , be alert to th e age of th e ch ild if th e age is presen ted in a question . If an age is presen ted in th e question , th in k about th e specific growth an d develo pm en t ch aracteris- tics of th e age group to an swer th e question correctly.

Client Needs: Learning Objectives Safe and Effective Care Environment Com m un icatin g with in terp rofession al h ealth care team

m em bers Con siderin g issues related to in form ed con sen t regard-

in g m in o rs Delegatin g care safely En surin g en viron m en tal safety, in cludin g h om e safety

an d perso n al safety, related to th e develo pm en tal age of th e ch ild

Establish in g priorities In stitutin g m easu res related to th e spread an d con tro l of

in fectio us agen ts, particularly com m un icable diseases Main tain in g con fiden tiality Preven tin g errors an d acciden ts Protectin g th e ch ild an d oth er con tacts to preven t illn ess Provid in g con tin uity of care Provid in g protective m easures Uph oldin g paren t an d ch ild righ ts

Health Promotion and Maintenance En surin g th at im m un ization sch edules are up to date Focusin g on develo pm en tal stages wh en plan n in g care Perform in g ph ysical assessm en t tech n iqu es specific to

th e pediatric clien t Preven tin g disease in th e ped iatric popu lation Providin g h ealth prom o tion program s for th e pediatric

clien t Providin g in struction s to th e ch ild an d paren ts regardin g

care at h om e

Psychosocial Integrity Assessin g th e ch ild for n eglect an d/ o r abuse Com m un icatin g with th e pediatric clien t Con siderin g con cepts of fam ily dyn am ics wh en

plan n in g care Con siderin g cultural, religious, an d spiritual beliefs

wh en plan n in g care Con siderin g en d-of-life issues an d grief an d loss in th e

pediatric population Iden tifyin g fam ily an d support system s for th e ch ild Providin g play th erap ies

Physiological Integrity Followin g m ed ication ad m in istration proced ures Followin g n utrition al guidelin es for th e pediatric

population Id en tifyin g co m fo rt m easu res ap p ro p riate fo r th e ch ild Main tain in g sen sitivity for in trusive procedures n eeded

for th e pediatric clien t Man agin g ch ildh ood illn esses Mon itorin g elim in ation pattern s Mon itorin g for age-appropriate n orm al body structure

an d fun ction Mon itorin g for in fectio us diseases of th e ped iatric clien t Mon itorin g for respon ses to treatm en ts Providin g for con sisten t rest an d sleep pattern s Respon din g to m ed ical em ergen cies

403

P

e

d

i

a

t

r

i

c

s

C H A P T E R 33 Integumentary Disorders

PRIORITY CONCEPTS Infection; Tissue Integrity

CRITICAL THINKING What Should You Do? A child being admitted to the pediatric unit is suspected of having impetigo. In order to prevent the spread of this infec- tious disease, what should the nurse do? Answer located on p. 407.

I. Eczema (Atopic Dermatitis) A. Description

1. Superficial in flam m ato ry process in volvin g pri- m arily th e epiderm is

2. Asso ciated with fam ily h istory of th e disorder, allergies, asth m a, or allergic rh in itis

3. Th e m ajor goals of m an agem en t are to relieve pruritus, lubricate th e skin , reduce in flam m a- tion , an d preven t or con trol secon dary in fectio n s.

B. Form s of eczem a (Box 33-1) C. Assessm en t

1. Redn ess 2. Scalin ess 3. Itch in g 4. Min u te papules (firm , elevated , circum scrib ed

lesion s < 1 cm in diam eter) an d vesicles (sim ilar to papules, but fluid-filled)

5. Weep in g, oozin g, an d cru stin g of lesion s 6. Adolescen t an d early adult form s: Com m on ly

occur in an tecu bital an d popliteal areas D. In terven tion s

1. Avoid exposu re to skin irritan ts such as soaps, detergen ts, fabric soften ers, diap er wipes, an d powder.

2. Avoid excessive bath in g an d wash in g of affected areas; bath in g water sh ould be tepid, an d th e skin sh o uld be lubricated im m ediately after th e bath .

3. In term itten tly apply cool, wet com presses for sh ort periods to sooth e th e skin an d alleviate itch in g; pat skin dry between coolin g treatm en ts.

4. Adm in ister an tih istam in es an d topical cortico- steroids as prescribed; cortico steroids are applied in a th in layer an d are rubbed in to th e area th oro ugh ly.

5. Adm in ister m edication s as prescribed . 6. Adm in ister prescribed an tibiotics if secon dary

in fectio n s occur. 7. Preven t or m in im ize scratch in g; keep n ails sh o rt

an d clean , an d place gloves or cotton socks over th e h an ds.

8. Elim in ate con ditio n s th at in crease itch in g, such as wet diap ers, excessive bath in g, am bien t h eat, woolen clo th es or blan kets, an d ro ugh fabrics or furry stuffed an im als; exposu re to latex sh ould also be avoided.

9. In struct paren ts to wash cloth in g in a m ild deter- gen t an d rin se th orough ly; puttin g th e cloth es th rou gh a secon d com plete wash cycle with ou t detergen t m in im izes th e residue rem ain in g on th e fabric.

10. In struct paren ts about m easu res to preven t skin in fectio n s.

11. In struct paren ts to m on itor lesion s for sign s of in fectio n (h on ey-colored crusts with surroun d- in g eryth em a) an d to seek im m ediate m ed ical in terven tion if such sign s are n oted.

A child with an integumentary disorder needs to be monitored for signs of either a skin infection or a systemic infection.

II. Impetigo A. Descrip tion

1. Im petigo is a con tagious bacterial in fectio n of th e skin cau sed by β-h em olytic strepto cocci or staph ylococci, or both ; it occurs m ost com m on ly durin g h ot, h um id m on th s.

2. Im petigo can occur because of poor h ygien e; it can be a prim ary infection or occur secon darily at a site th at h as been in jured or sustain ed an in sect bite, or at a site th at was origin ally a rash , such as atopic derm atitis or poison ivy or poison oak.404

3. Th e m ost com m on sites of in fectio n are on th e face an d arou n d th e m outh , an d th en on th e h an ds, n eck, an d extrem ities.

4. Th e lesion s begin as vesicles or pustu les sur- ro un ded by edem a an d redn ess (a pustule is sim - ilar to a vesicle except th at its fluid co n ten t is purulen t).

5. Th e lesion s progress to an exudative an d crustin g stage; after th e crustin g of th e lesion s, th e in itially serou s vesicular flu id beco m es cloudy, an d th e vesicles rupture, leavin g h on ey-colo red cru sts coverin g ulcerated bases.

B. Assessm en t ( Fig. 33-1) 1. Lesion s 2. Eryth em a 3. Pruritus 4. Burn in g 5. Secon dary lym p h n ode in volvem en t

C. In terven tion s 1. In stitute con tact isolatio n ; use stan d ard precau-

tio n s an d im plem en t agen cy-sp ecific isolatio n procedures for th e h ospitalized ch ild; strict h ygien e practices are im portan t because im pe- tigo is a h igh ly con tagious con dition .

2. Allow lesion s to dry by air exposu re. 3. Assist th e ch ild with daily bath in g with an tibac-

terial soap, as prescribed.

4. Apply warm salin e or oth er prescribed com - presses to th e lesion s 2 or 3 tim es daily, followed by m ild soap an d water to soften cru sts for rem oval an d prom ote h ealin g; Burow’s solution m ay also be prescribed to soften th e cru sts.

5. Apply topical an tibiotic oin tm en ts with a clean / sterile cotton swab with out touch in g th e tube open in g with fin gers or skin , an d in struct paren ts in th e oin tm en t an d swab use; th e in fection is still com m un icable for 48 h ou rs beyon d in itia- tion of an tibiotic treatm en t.

6. Adm in ister oral an tibiotics, wh ich m ay be pre- scrib ed if th ere is n o respo n se to topical an tibi- otic treatm en t; it is extrem ely im portan t to com ply with th e prescribed an tibiotic regim en because secon dary in fectio n s such as glom erulo- n eph ritis m ay result if th e in fectio us agen t is of a strepto coccal type th at can affect th e n eph ron s.

7. To preven t skin crackin g, ap ply em ollien ts an d in struct paren ts in th e use of em ollien ts.

8. In struct paren ts in th e m eth ods to preven t th e spread of th e in fection , esp ecially careful h an d- wash in g.

9. In form paren ts th at th e ch ild n eeds to use sep a- rate towels, lin en s, an d dish es.

10. In form paren ts th at all lin en s an d cloth in g used by th e ch ild sh ould be wash ed with detergen t in h ot water sep arately fro m th e lin en s an d cloth in g of oth er h ouseh old m em bers.

III. Pediculosis Capitis (Lice) A. Description

1. Pediculosis capitis refers to an in festation of th e h air an d scalp with lice.

2. The m ost com m on sites of in volvem en t are th e occipital area, beh in d th e ears at th e n ape of th e neck, an d occasion ally the eyebrows an d eyelash es.

3. Th e fem ale louse lays h er eggs (n its) on th e h air sh aft, close to th e scalp; th e in cubation period is 7 to 10 days.

4. Lice can survive for 48 h ours away fro m th e h ost; n its sh ed in th e en viron m en t can h atch in 7 to 10 days.

5. Head lice live an d reprodu ce on ly on h um an s an d are tran sm itted by direct an d in direct co n - tact, such as sh arin g of brush es, h ats, towels, an d beddin g.

6. All con tacts of th e in fested ch ild, especially sib- lin gs, sh o uld be exam in ed for lice in festatio n an d referred for treatm en t as appropriate.

B. Assessm en t ( Box 33-2) C. In terven tion s

1. Use a ped iculicide produ ct as prescribed ; follow package in struction s for tim in g th e application an d for con train d ication s for use in ch ildren .

2. Daily rem oval of n its with an extra–fin e-tooth m etal n it com b sh ould be don e as a con trol

P

e

d

i

a

t

r

i

c

s

FIGURE 33-1 Impetigo contagiosa. (From Weston, Lane, 200 7.)

BOX 33-1 Forms of Eczema Infa nt ile: Usually begins at 2 to 6 months of age and

decreases in incidence with aging; spontaneous remission may occur by 3 years

Childhood: May follow the infantile form; occurs at 2 to 3 years of age

Prea dolescent a nd Adolescent : Begins at about 12 years of age and may continue into the early adult years or indefinitely

405CHAPTER 33 Integumentary Disorders

m easu re after use of th e ped iculicide produ ct (gloves sh ould be worn for rem oval of n its); h air- brush es or com bs sh ould be discarded or soaked in boilin g water for 10 m in utes or in a com m er- cially available lice-killin g produ ct for 1 h our.

3. In struct paren ts th at siblin gs m ay also n eed treat- m en t; groo m in g item s sh ould n ot be sh ared , an d a sin gle com b or brush sh ould be used for each in dividual ch ild.

4. In struct paren ts th at bed din g an d cloth in g used by th e ch ild sh ould be ch an ged daily, laun dered in h ot water with detergen t, an d dried in a h ot dryer for 20 m in utes; th is process sh ould con - tin ue for 1 week.

5. In struct paren ts th at n on essen tial bed din g an d clo th in g can be stored in a tigh tly sealed plastic bag for 2 weeks an d th en wash ed.

6. In struct paren ts to seal toys th at can n ot be wash ed or dry-clean ed in a plastic bag for 2 weeks.

7. In struct paren ts th at furn iture an d carpets n eed to be vacuu m ed frequen tly an d th at th e dust bag from th e vacuu m sh ould be discarded after vacuu m in g.

8. Teach th e ch ild n ot to sh are clo th in g, h eadwear, brush es, an d com bs.

9. Lice on th e eyelash es or eyebrows m ay n eed to be rem oved m an ually.

IV. Scabies A. Description

1. Scab ies is a parasitic skin disorder cau sed by an in festation of Sarcoptes scabiei (itch m ite) (see Ch apter 47).

2. Scab ies is en dem ic am on g sch oolch ildren an d in stitution alized population s as a result of clo se perso n al con tact.

3. In cubation period a. Th e fem ale m ite burrows in to th e epiderm is,

lays eggs, an d dies in th e burrow after 4 to 5 weeks.

b . Th e eggs h atch in 3 to 5 days, an d larvae m ature an d com plete th eir life cycle.

4. In fectious period: Durin g th e en tire course of th e in festation

B. Assessm en t (Box 33-3 an d Fig. 33-2)

Scabies is transmitted by close personal contact with an infected person. Household members and contacts of an infected child need to be treated simultaneously.

C. In terven tion s 1. Topical application of a scabicide such as per-

m eth rin kills th e m ites. 2. Lin dan e sh am poo, on e product th at m ay be pre-

scrib ed, sh ould n ot be used in ch ildren youn ger th an 2 years because of th e risk of n eurotoxicity an d seizu res.

3. In struct paren ts in th e application of th e scabicide.

4. Wh en perm eth rin is used, it is applied to cool dry skin at least 30 m in u tes after bath in g; th e cream is m assaged th orough ly an d gen tly in to all skin surfaces (n ot just th e areas th at h ave th e rash ) from th e h ead to th e soles of th e feet (avoid con - tact with th e eyes), left on th e skin for 8 to 14 h ours, an d th en rem oved by bath in g; a repeat treatm en t m ay be n ecessary.

5. In struct th e paren ts ab out th e im portan ce of fre- quen t h an d wash in g.

6. In struct th e paren ts th at all clo th in g, beddin g, an d pillowcases used by th e ch ild n eed to be ch an ged daily, wash ed in h ot water with deter- gen t, dried in a h ot dryer, an d iron ed befo re reuse; th is process sh ould con tin ue for 1 week.

7. In struct paren ts th at n on wash able toys an d oth er item s sh ould be sealed in plastic bags for at least 4 days.

8. An ti-itch topical treatm en t m ay be n ecessary, an d an tibiotics m ay be prescribed if a secon dary in fectio n develops.

P

e

d

i

a

t

r

i

c

s

BOX 33-2 Assessment Findings: Pediculosis Capitis

Child scratches scalp excessively. Pruritus is caused by the crawling insect and insect saliva on

the skin. Nits (white eggs) are observable on the hair shaft (it is impor-

tant to differentiate nits from lint or dandruff, which flakes away easily).

Adult lice are difficult to see and appear as small tan or grayish specks, which may crawl quickly.

FIGURE 33-2 Scabies rash on an infant. (From Calen et al., 1993. Courtesy Dr. Steve Estes.)

BOX 33-3 Assessment Findings: Scabies ▪ Pruritic papular rash ▪ Burrows into the skin (fine grayish red lines that may be

difficult to see)

406 UNIT VII Pediatric Nursing

V. Burn Injuries (see Priority Nursing Actions)

PRIORITY NURSING ACTIONS A Major Burn Injury in the Child 1. Stop the burning process. 2. Assess the ABCs—airway–breathing–circulation. 3. Begin resuscitation measures if necessary. 4. Remove burned clothing and jewelry. 5. Cover the wound(s) with a clean cloth. 6. Keep the child warm. 7. Transport the child to the emergency department.

The initial management of the burn injury begins at the scene of the injury. The first priority is to stop the burning process; this must be done before other interventions. To stop the burning process, flames should be smothered. The child should be placed in a horizontal position because a vertical position may cause the hair to ignite or the inhala- tion of flames, heat, or smoke. The child should be rolled in a blanket or other article, taking care not to cover the face and head because of the danger of inhaling smoke and fumes. As soon as the flames are extinguished, the child is assessed for adequate airway, breathing, and circulation. Measures are taken immediately if resuscitation is necessary. Burned cloth- ing and jewelry are removed to prevent further burning of the skin and disruption of skin integrity, and then the burn is cov- ered with a clean cloth, which prevents contamination of the wound, reduces pain by eliminating air contact, and prevents hypothermia. The child is also kept warm to prevent hypo- thermia and is immediately transported to the nearest emer- gency facility.

Reference Hockenberry, Wilson (2015), p. 977.

A. Ped iatric con sid eration s 1. Very youn g ch ildren wh o h ave been burn ed

severely h ave a h igh er m ortality rate th an older ch ildren an d ad ults with com parable burn s.

2. Lower burn tem peratures an d sh orter exp osure to h eat can cau se a m ore severe burn in a ch ild th an in an adult because a ch ild’s skin is th in n er.

3. Th e degree of pain experien ced by th e ch ild an d th e ability to com m un icate it are differen t th an in an adult with th e sam e exp osure.

4. Severely burn ed ch ildren are at in creased risk for flu id an d h eat loss, deh ydration , an d m etabolic acido sis com pared with ad ults.

5. Th e h igh er proportion of body fluid to body m ass in ch ildren in creases th e risk of cardiovas- cular problem s.

6. Burn s in volvin g m ore th an 10% of th e total body surface area require som e form of fluid resuscitation .

7. In fan ts an d ch ildren are at in creased risk for pro- tein an d calorie deficien cy because th ey h ave

sm aller m uscle m ass an d less body fat th an adults.

8. Scarrin g is m ore severe in a ch ild; disturbed body im age is a distin ct issue for a ch ild or adolescen t, esp ecially as growth con tin ues.

9. An im m ature im m un e system presen ts an in creased risk of in fectio n for in fan ts an d youn g ch ildren .

10. A delay in growth m ay occur after a burn . B. Exten t of burn in jury

1. Th e rule of n in es, used for adults with burn in ju- ries, gives an in accurate estim ate in ch ildren because of th e differen ce in body proportion s between ch ildren an d adults.

2. In a ped iatric clien t, th e exten t of th e burn is expressed as a percen tage of th e total body sur- face area, usin g age-related ch arts (Fig. 33-3).

C. Fluid replacem en t th erapy

To determine adequacy of fluid resuscitation, vital signs (especially heart rate), urine output, adequacy of capillary filling, and sensorium status are assessed.

1. Fluid replacem en t is n ecessary durin g th e in itial 24-h our period after burn in jury because of th e fluid sh ifts th at occur as a result of th e in jury.

2. Several form ulas are available to calculate th e ch ild’s fluid n eeds, an d th e form ula used dep en ds on th e h ealth care provid er’s preferen ce.

3. Crystalloid solution s are used durin g th e in itial ph ase of th erap y; colloid solution s such as albu- m in , Plasm a-Lyte (com bin ed electrolyte solu- tion ), or fresh -frozen plasm a are useful in m ain tain in g plasm a volum e.

4. See also Ch apter 47.

CRITICAL THINKING What Should You Do? Answer: For a child suspected of having impetigo, the nurse should institute strict contact precautions and use standard precautions. The nurse should also implement agency- specific isolation procedures for the hospitalized child. Strict hygiene practices are important because impetigo is a highly contagious condition. The nurse should ensure that all health care workers and visitors are aware of the necessary precautions in order to prevent the spread of infection. For the nonhospitalized child, the nurse needs to instruct par- ents in the methods to prevent the spread of the infection, especially hand-washing technique. The nurse should also inform parents that the child needs to use separate towels, linens, and dishes and that all linens and clothing used by the child should be washed with detergent in hot water sep- arately from the linens and clothing of other household members.

Reference: Hockenberry, Wilson (20 15), pp. 227, 902-903.

P

e

d

i

a

t

r

i

c

s

407CHAPTER 33 Integumentary Disorders

P R A C T I C E Q U E S T I O N S 344. Th e n urse is m on itorin g a ch ild with burn s durin g

treatm en t for burn sh ock. Wh ich assessm en t pro- vides th e m o st accu rate guid e to determ in e th e ad e- quacy of flu id resuscitation ? 1. Skin turgor 2. Level of edem a at burn site 3. Adequacy of cap illary fillin g 4. Am ou n t of fluid tolerated in 24 h ours

345. Th e m oth er of a 3-year-old ch ild arrives at a clin ic an d tells th e n urse th at th e ch ild h as been scratch - in g th e skin con tin uously an d h as develo ped a rash . Th e n urse assesses th e ch ild an d suspects th e presen ce of scabies. Th e n urse bases th is susp i- cio n on wh ich fin din g n oted on assessm en t of th e ch ild’s skin ? 1. Fin e grayish red lin es 2. Purple-colored lesion s 3. Th ick, h on ey-colo red cru sts 4. Clusters of fluid-filled vesicles

346. Perm eth rin is prescribed for a ch ild with a diagn o- sis of scabies. Th e n urse sh ould give wh ich in struc- tion to th e paren ts regardin g th e use of th is treatm en t? 1. Apply th e lo tion to areas of th e rash on ly. 2. Apply th e lotion an d leave it on for 6 h ou rs. 3. Avoid puttin g cloth es on th e ch ild over th e

lo tion . 4. Apply th e lotion to cool, dry skin at least

30 m in u tes after bath in g.

347. Th e sch ool n urse h as provided an in struction al ses- sion about im petigo to paren ts of th e ch ildren atten din g th e sch ool. Wh ich statem en t, if m ade by a paren t, in dicates a n eed fo r fu rth er in stru ctio n ? 1. “It is extrem ely con tagious.” 2. “It is m ost com m on in h um id weath er.” 3. “Lesion s m ost often are located on th e arm s

an d ch est.” 4. “It m igh t sh o w up in an area of broken skin ,

such as an in sect bite.”

P

e

d

i

a

t

r

i

c

s

RELATIVE P ERCENTAGES OF AREAS AFFECTED BY GROWTH

AREA

A = B = C =

½ of he a d ½ of one thigh ½ of one le g

BIRTH

9½ 2¾ 2½

AGE 1 YR

8½ 3¼ 2½

AGE 5 YR

6½ 4 2¾

RELATIVE P ERCENTAGES OF AREAS AFFECTED BY GROWTH

AREA

A = B = C =

½ of he a d ½ of one thigh ½ of one le g

AGE 10 YR

5½ 4½ 3

AGE 15 YR

4½ 4½ 3¼

YOUNG ADULT

3½ 4¾ 3½

B

C

A B

B

C

11

1 1 1 1

1

13 132 2 2

22

2

B

C

B

C

A A

1¼ 1¼ 1¼1¼

A

B B

CC

1

1 3 22

1¼ 1¼

1¾1¾

1½1½

A

B B

CC

1

1

1 3 22

1¼ 1¼

1¾1¾

1½1½

2½ 2½

1

1

FIGURE 33-3 Estimation of distribution of burns in children. A, Children from birth to age 5 years. B, Older children.

408 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

348. Th e clin ic n urse is reviewin g th e h ealth care pro- vider’s prescription for a ch ild wh o h as been diag- n osed with scabies. Lin dan e h as been prescribed for th e ch ild. Th e n urse question s th e prescription if wh ich is n oted in th e ch ild’s record? 1. Th e ch ild is 18 m on th s old. 2. Th e ch ild is bein g bottle-fed. 3. A siblin g is usin g lin dan e for th e treatm en t of

scabies. 4. Th e ch ild h as a h istory of frequen t respiratory

in fectio n s.

349. A topical cortico steroid is prescribed by th e h ealth care provid er for a ch ild with atopic derm atitis (eczem a). Wh ich in struction sh o uld th e n urse give th e paren t about applyin g th e cream ? 1. Apply th e cream over th e en tire body. 2. Apply a thick layer of cream to affected areas only. 3. Avoid clean sin g th e area before application of

th e cream . 4. Apply a th in layer of cream an d rub it in to th e

area th orough ly.

350. Th e sch ool n urse is perform in g pedicu losis cap itis (h ead lice) assessm en ts. Wh ich assessm en t fin din g in dicates th at a ch ild h as a “positive” h ead ch eck? 1. Maculopapu lar lesion s beh in d th e ears 2. Lesion s in th e scalp th at exten d to th e h airlin e

or n eck

3. Wh ite flaky particles th rou gh out th e en tire scalp region

4. Wh ite sacs attach ed to th e h air sh afts in th e occip ital area

351. Th e n urse carin g for a ch ild wh o sustain ed a burn in jury plan s care based on wh ich pediatric con sid- eration s associated with th is in jury? Select all th at ap p ly.

1. Scarrin g is less severe in a ch ild th an in an adult.

2. A delay in growth m ay occur after a burn in ju ry.

3. An im m ature im m un e system presen ts an in creased risk of in fectio n for in fan ts an d yo un g ch ildren .

4. Fluid resuscitation is un n ecessary un less th e burn ed area is m ore th an 25% of th e total body surface area.

5. Th e lower propo rtion of body fluid to body m ass in a ch ild in creases th e risk of cardio- vascular problem s.

6. In fan ts an d youn g ch ildren are at in creased risk for protein an d calorie deficien cy because th ey h ave sm aller m uscle m ass an d less body fat th an adults.

A N S W E R S 344. 3 Ra t ion a le: Param eters such as vital sign s (especially h eart rate), urin ary o utp u t vo lu m e, adeq uacy of capillary fillin g, an d state of sen soriu m d eterm in e ad equ acy o f flu id resu scitatio n . Alth o ugh op tion s 1, 2, an d 4 m ay provide so m e in fo rm ation related to flu id volum e, in a b urn in jury, an d from th e option s provid ed , ad eq uacy o f capillary fillin g is m o st accu rate. Test -Ta kin g St r a t egy: Note th e strategic wo rd , most. Use th e ABCs—airway–b reath in g–circu latio n —to assist in d irectin g yo u to th e co rrect o p tion . Review: Flu id resu scitatio n an d b u rn sh o ck Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Pediatrics—In tegum en tary Pr ior ity Con cepts: Eviden ce; Flu id an d Electrolyte Balan ce Refer en ce: Ho cken berry, Wilson (2015), p p. 978-979.

345. 1 Ra t ion a le: Scabies is a parasitic skin diso rd er cau sed b y an in festatio n of Sarcoptes scabiei (itch m ite). Scab ies app ears as bu rrows o r fin e, grayish red, th read like lin es. Th ey m ay b e d if- ficu lt to see if th ey are o b scu red by exco riation an d in flam m a- tion . Pu rp le-colored lesio n s m ay in dicate variou s disorders, in clud in g system ic con dition s. Th ick, h on ey-co lored cru sts are ch aracteristic of im petigo or seco n d ary in fection in eczem a. Clusters o f flu id -filled vesicles are seen in h erp esviru s in fectio n .

Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, clin ical m an ifesta- tion s o f scab ies. Th in k ab ou t th e ch aracteristic of th is parasitic skin diso rd er. Recallin g th at scab ies in festatio n p ro du ces b u r- rows will assist in d irectin g you to th e correct op tio n . Review: Scab ies Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—In tegum en tary Pr ior ity Con cepts: In fectio n ; Tissu e In tegrity Refer en ce: Ho cken berry, Wilson (2015), p p. 232-233.

346. 4 Ra t ion a le: Perm eth rin is m assaged th orou gh ly an d gen tly in to all skin su rfaces (n ot just th e areas th at h ave th e rash ) from th e h ead to th e so les o f th e feet. Care sh o uld b e taken to avo id co n - tact with th e eyes. Th e lo tion sh ou ld n o t b e ap p lied un til at least 30 m in u tes after b ath in g an d sh o uld be ap plied o n ly to co ol, dry skin . Th e lo tion sh o uld b e kep t o n fo r 8 to 14 h o urs, an d th en th e ch ild sh o uld be given a bath . Th e ch ild sh o uld b e clo th ed d urin g th e 8 to 14 h ou rs o f treatm en t co n tact tim e. Test -Ta kin g St r a t egy: O p tion 3 can b e elim in ated b ecau se th e ch ild sh o uld b e cloth ed. Elim in ate op tio n 1 n ext b ecau se o f th e clo sed -en d ed wo rd , only, in th is o p tion . Fro m th e rem ain in g o p tion s, recallin g th e p ro cedu re fo r th e ap plicatio n of th is lotio n will d irect yo u to th e co rrect o p tion . Review: Perm eth rin Level of Cogn it ive Ability: App lyin g

409CHAPTER 33 Integumentary Disorders

Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—In tegu m en tary Pr ior it y Con cept s: Clien t Ed ucation ; Tissue In tegrity Refer en ces: Bu rch u m , Ro sen th al (2016) p . 1202. Hocken berry, Wilson ( 2015) , p p. 232-233.

347. 3 Ra tion a le: Im p etigo is a con tagio us bacterial in fection of th e skin caused by β-h em o lytic strepto co cci or staph ylococci, or b oth . Im p etigo is m ost com m on du rin g h o t, h u m id sum m er m on th s. Im p etigo m ay b egin in an area o f broken skin , such as an in sect b ite or atop ic d erm atitis. Im p etigo is extrem ely con tagiou s. Lesio n s u su ally are located aro u n d th e m o uth an d n ose, bu t m ay b e p resen t o n th e h an d s an d extrem ities. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d ask you to select an op tio n th at is an in correct statem en t. Th in k ab ou t th e p ath op h ysio lo gy asso ciated with im petigo . Kn o wl- ed ge regard in g th e cause an d m an ifestation s o f im petigo will d irect yo u to th e co rrect o ption . Review: Im p etigo Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—In tegu m en tary Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: Hocken b erry, Wilso n (2015), p. 311.

348. 1 Ra tion a le: Lin dan e is a p ed icu licid e prod u ct th at m ay be pre- scrib ed to treat scabies. It is con train d icated for ch ild ren you n - ger th an 2 years becau se th ey h ave m o re perm eable skin , an d h igh system ic ab sorption m ay o ccur, p lacin g th e ch ild ren at risk fo r cen tral n ervo us system to xicity an d seizures. Lin d an e also is u sed with cautio n in ch ild ren b etween th e ages of 2 an d 10 years. Siblin gs an d o th er h ou seh o ld m em b ers sh ou ld b e treated sim ultan eou sly. O ptio n s 2 an d 4 are u n related to th e u se of lin dan e. Lin d an e is n o t reco m m en ded fo r u se b y a b reast-feed in g wo m an b ecause th e m ed ication is secreted in to b reast m ilk. Test-Ta kin g St r a t egy: Focus o n th e su b ject, co n train d icatio n s o f lin d an e. Recall th e con cepts related to th e bo d y su rface area o f ch ildren an d an 18-m on th -old, an d m edicatio n ad m in istratio n . Th ese co n cepts will d irect yo u to th e correct o ptio n . Review: Lin d an e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ped iatrics—In tegu m en tary Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1204.

349. 4 Ra tion a le: Atop ic derm atitis is a su perficial in flam m atory p ro - cess in vo lvin g prim arily th e epiderm is. A to pical co rticosteroid m ay b e prescrib ed an d sh ou ld be ap plied sparin gly (th in layer) an d rub bed in to th e area th o ro ugh ly. Th e affected area sh ou ld b e clean ed gen tly b efo re ap plicatio n . A top ical co rticosteroid

sh o u ld n ot b e ap plied o ver exten sive areas. System ic ab so rp - tio n is m o re likely to occu r with exten sive app licatio n . Test-Ta kin g Str a tegy: Focus o n th e su b ject, ap plicatio n of a to pical co rtico stero id . Elim in ate o p tion 3 first b ecause it d oes n o t m ake sen se n o t to clean an affected area. Elim in ate o ptio n 1 b ecau se m ed icated cream sh o uld b e ap plied o n ly to areas th at are affected. Elim in ate o ptio n 2 because of th e wo rd thick. Review: To p ical co rtico stero id s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—In tegu m en tary Pr ior it y Con cept s: Clien t Ed ucation ; Tissue In tegrity Refer en ce: Hocken b erry, Wilso n (2015), pp . 468, 614-615.

350. 4 Ra tion a le: Pediculosis cap itis is an in festatio n o f th e h air an d scalp with lice. Th e n its are visib le an d attach ed firm ly to th e h air sh aft n ear th e scalp. Th e o ccip ut is an area in wh ich n its can b e seen . Macu lo pap ular lesio n s b eh in d th e ears o r lesion s th at exten d to th e h airlin e or n eck are in d icative of an in fec- tio us process, n ot p edicu losis. Wh ite flaky particles are in d ica- tive o f d an druff. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, th e ch aracteristics o f ped iculo sis capitis. O ptio n 3 can be elim in ated first b ecause wh ite flaky particles are in d icative of d an d ru ff. Recallin g th at in th is in festatio n n it sacs attach to th e h air sh aft will direct you to th e correct o ptio n . Review: Ped icu lo sis cap itis Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—In tegu m en tary Pr ior it y Con cept s: Clin ical Ju dgm en t; In fectio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 233-234.

351. 2, 3, 6 Ra tion a le: Ped iatric co n sid eratio n s in th e care o f a bu rn victim in clu de th e fo llo win g: Scarrin g is m o re severe in a ch ild th an in an adu lt. A d elay in gro wth m ay occu r after a bu rn in ju ry. An im m atu re im m un e system p resen ts an in creased risk of in fec- tio n fo r in fan ts an d you n g ch ildren . Th e h igh er prop o rtio n of b od y fluid to b o dy m ass in a ch ild in creases th e risk of cardio - vascu lar prob lem s. Burn s in vo lvin g m ore th an 10% of total b od y su rface area req uire so m e fo rm of flu id resu scitation . In fan ts an d you n g ch ildren are at in creased risk for protein an d calorie deficien cies b ecau se th ey h ave sm aller m uscle m ass an d less bo dy fat th an ad u lts. Test-Ta kin g Str a tegy: Focu s o n th e su b ject, ped iatric co n sid er- atio n s in th e care of a ch ild wh o h as sustain ed a b urn in ju ry. To an swer correctly, read each o ptio n carefu lly an d th in k ab ou t th e p h ysio lo gy o f a ch ild related to bo d y size. Review: Bu rn in ju ries in th e ch ild Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—In tegu m en tary Pr ior it y Con cept s: Develo pm en t; Tissu e In tegrity Refer en ce: Hocken b erry, Wilso n (2015), pp . 989-991.

P

e

d

i

a

t

r

i

c

s

410 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 34 Hematological Disorders

PRIORITY CONCEPTS Perfusion; Safety

CRITICAL THINKING What Should You Do? A child with hemophilia who has been in a motor vehicle crash is admitted to the pediatric unit. What should the nurse do in the care of this child? Answer located on p. 415.

I. Sickle Cell Anemia A. Descrip tion

1. Sickle cell an em ia con stitutes a grou p of diseases term ed hemoglobinopathies, in wh ich h em oglobin A is partly or com pletely replaced by abn orm al sickle h em oglob in S.

2. It is cau sed by th e in h eritan ce of a gen e for a struc- turally abn orm al portion of the h em oglobin ch ain .

3. Risk facto rs in clude h avin g paren ts h eterozygou s for h em oglobin S or bein g of African Am erican descen t.

4. For screen in g purpo ses th e sickle-turb idity test (Sickledex) is frequen tly used because it can be perform ed on blood from a fin gerstick an d yields accu rate results in 3 m in u tes. Ho wever, if th e test result is positive, h em oglobin (Hgb) electrop h oresis is n ecessary to distin guish between ch ildren with th e trait an d th ose with th e disease.

5. Hem o globin S is sen sitive to ch an ges in th e oxy- gen con ten t of th e red blood cell.

6. In sufficien t oxygen causes th e cells to assum e a sickle sh ap e, an d th e cells beco m e rigid an d clum ped togeth er, obstru ctin g capillary blood flow (Fig. 34-1).

7. Th e clin ical m an ifestation s occur prim arily as a result of obstru ction caused by sickled red blood cells an d in creased red blood cell destruction .

8. Situation s th at precipitate sicklin g in clude fever, deh ydration , an d em otion al or ph ysical stress;

an y con dition th at in creases th e n eed for oxygen or alters th e tran spo rt of oxygen can result in sickle cell crisis (acute exacerbation ) .

9. Sickle cell crises are acu te exacerbatio n s of th e dis- ease, wh ich vary con siderably in severity an d fre- quen cy; th ese in clude vaso -occlusive crisis, splen ic sequestration , h yperh em olytic crisis, an d aplastic crisis.

10. Th e sicklin g respo n se is reversible un der con d i- tion s of ad equate oxygen ation an d h ydration ; after repeated sicklin g, th e cell becom es perm a- n en tly sickled.

11. An in terp rofessio n al ap proach to care is n eeded, an d care focuses on th e preven tion (preven tin g exposu re to in fectio n an d m ain tain in g n orm al h ydration ) an d treatm en t (h ydration , oxygen , pain m an agem en t, an d bed rest) of th e crisis.

B. Assessm en t of th e crisis ( Box 34-1) C. In terven tion s

1. Main tain adequ ate h ydration an d blood flow th rough oral an d in traven o usly (IV) adm in is- tered fluids. Electro lyte replacem en t is also pro- vided as n eeded; with out ad equate h ydration , pain will n ot be con trolled.

2. Adm in ister oxygen an d blood tran sfusio n s as prescribed to in crease tissue perfusion ; exch an ge tran sfusion s, wh ich reduce th e n um ber of circu- latin g sickle cells an d th e risk of com plication s, m ay also be prescribed .

3. Adm in ister an algesics as prescribed (aroun d th e clock) .

4. Assist th e ch ild to assum e a com fortable position so that th e ch ild keeps the extrem ities exten ded to prom ote ven ous return ; elevate th e h ead of th e bed n o m ore than 30 degrees, avoid puttin g strain on pain ful join ts, an d do n ot raise th e kn ee gatch of th e bed.

5. En courage con sum p tion of a h igh -calorie, h igh - protein diet, with folic acid supp lem en tation .

6. Adm in ister an tibiotics as prescribed to preven t in fectio n .

411

7. Mon itor for sign s of com plication s, in cludin g in creasin g an em ia, decreased perfusion, an d sh ock (m en tal status ch an ges, pallor, vital sign ch an ges).

8. In struct th e ch ild an d paren ts about th e early sign s an d sym ptom s of crisis an d th e m easures to preven t crisis.

9. En sure th at th e ch ild receives pn eum ococcal an d m en in go coccal vaccines an d an an n ual in fluen za vaccin e because of susceptibility to in fectio n sec- on dary to fun ction al asplen ia.

10. A splen ecto m y m ay be n ecessary for clien ts wh o experien ce recurren t splen ic seq uestration .

11. In form paren ts of th e hereditary aspects of th e disorder.

Administration of meperidine for pain is avoided because of the risk of normeperidine-induced seizures.

II. Iron Deficiency Anemia A. Descriptio n

1. Iron stores are dep leted, resultin g in a decreased supply of iron for th e m an ufacture of h em oglo- bin in red blood cells.

2. Com m on ly results from blood loss, in creased m etabolic dem an ds, syn d rom es of gastro in testi- n al m alabsorption , an d dietary in adeq uacy.

B. Assessm en t 1. Pallor 2. Weakn ess an d fatigue 3. Low h em oglobin an d h em atocrit levels 4. Red blood cells th at are m icrocytic an d h ypo -

ch rom ic C. In terven tion s

1. In crease oral in take of iron ; iron -fortified for- m ula is n eeded for an in fan t.

P

e

d

i

a

t

r

i

c

s

Chronic ulce rs (ra re in childre n)

P a in Os te omye litis

Abdomina l pa in

He ma turia Hypos the nuria (dilute urine )

Ava s cula r ne cros is (hip)

S ple nome ga ly S ple nic s e que s tra tion Autos ple ne ctomy

He pa tome ga ly Ga lls tone s

Ava s cula r ne cros is (s houlde r)

Infa rction P ne umonia Che s t s yndrome P ulmona ry hype rte ns ion Ate le cta s is

Re tinopa thy Blindne s s He morrha ge

S troke P a ra lys is De a th

He molys is

Ane mia

He a rt fa ilure

Da ctylitis (ha nd-foot s yndrome )

P ria pis m

A

B

FIGURE 34-1 Differences between effects of (A) normal red blood cells and (B) sickled red blood cells on circulation, with related complications.

BOX 34-1 Sickle Cell Crisis

Vaso-Occlusive Crisis Caused by stasis of blood with clumping of cells in the micro-

circulation, ischemia, and infarction Manifestations: Fever; painful swelling of hands, feet, and

joints; and abdominal pain

Splenic Sequestration Caused by pooling and clumping of blood in the spleen

(hypersplenism) Manifestations: Profound anemia, hypovolemia, and shock

Hyperhemolytic Crisis An accelerated rate of red blood cell destruction Manifestations: Anemia, jaundice, and reticulocytosis

Aplastic Crisis Caused by diminished production and increased destruction of

red blood cells, triggered by viral infection or depletion of folic acid

Manifestations: Profound anemia and pallor

412 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

2. In struct th e ch ild an d paren ts in food ch oices th at are h igh in iron (Box 34-2).

3. Adm in ister iron supp lem en ts as prescribed. 4. In tram uscular in jection s of iron (usin g Z-track

m eth od ) or IV adm in istration of iron m ay be pre- scribed in severe cases of an em ia.

5. Teach paren ts h ow to adm in ister th e iron supplem en ts. a. Give between m eals for m axim um absorption . b . Give with a m ultivitam in or fruit juice

because vitam in C in creases absorption . c. Do n ot give with m ilk or an tacids because

th ese item s decrease absorption . 6. In struct th e ch ild an d paren ts about th e side

effects of iron supp lem en ts (black stools, con sti- pation , an d foul aftertaste).

Liquid iron preparation stains the teeth. Teach the parents and child that liquid iron should be taken through a straw and that the teeth should be brushed after administration.

III. Aplastic Anemia A. Descrip tion

1. Aplastic an em ia is a deficien cy of circulatin g eryth rocytes an d all oth er form ed elem en ts of blood , resultin g fro m th e arrested developm en t of cells with in th e bon e m arro w.

2. It can be prim ary (presen t at birth ) or secon dary (acquired ).

3. Several possible cau ses exist, in cludin g ch ron ic exposu re to m yelotoxic agen ts, viruses, in fectio n , autoim m un e disorders, an d allergic states.

4. Th e defin itive diagn osis is determ in ed by bon e m arro w aspiration (sh ows con version of red bon e m arrow to fatty bon e m arro w).

5. Th erapeutic m an agem en t focuses on restorin g fun ctio n to th e bon e m arro w an d in volves im m un osuppressive th erap y an d bon e m arro w tran splan tation (treatm en t of ch oice if a suitable don or exists).

6. If th e cau se is a m yelotoxic m ed ication th at is bein g adm in istered for an oth er purpose, th e m edication m ay be discon tin ued to im prove bon e m arrow fun ction .

B. Assessm en t 1. Pan cytop en ia (deficien cy of eryth rocytes, leuko-

cytes, an d th rom bocytes) 2. Petech iae, purpura, bleedin g, pallor, weakn ess,

tach ycardia, an d fatigue C. In terven tion s

1. Prepare th e ch ild for bon e m arrow tran splan ta- tion if plan n ed.

2. Adm in ister im m un osu ppressive m ed ication s as prescribed; an ti-lym ph ocyte glob ulin or an ti- th ym ocyte globulin m ay be prescribed to sup- press th e autoim m un e respo n se.

3. Colon y-stim ulatin g facto rs m ay be prescribed to en h an ce bon e m arro w productio n .

4. Corticosteroids an d cyclosporin e m ay be prescribed.

5. Adm in ister blood tran sfusion s if prescribed an d m on itor for tran sfusion reactio n s.

IV. Hemophilia A. Description

1. Hemophilia refers to a group of bleedin g disorders resultin g from a deficien cy of specific coagulation protein s.

2. Iden tifyin g th e specific coagu lation deficien cy is im portan t so th at defin itive treatm en t with th e specific replacem en t agen t can be im plem en ted; aggressive replacem en t th erap y is in itiated to preven t th e ch ron ic cripp lin g effects fro m join t bleedin g.

3. Th e m ost com m on types are factor VIII deficien cy (h em oph ilia A or classic h em oph ilia) an d factor IX deficien cy (h em oph ilia B or Ch ristm as disease).

4. Hem o ph ilia is tran sm itted as an X-lin ked reces- sive disorder (it m ay also occur as a result of a gen e m utation ).

5. Carrier fem ales pass on th e defect to affected m ales; fem ale offsp rin g are rarely born with th e disorder, but m ay be if th ey in h erit an affected gen e from th eir m oth er an d are offsp rin g of a fath er with h em op h ilia.

6. Th e prim ary treatm en t is replacem en t of th e m issin g clo ttin g facto r; addition al m ed ication s, such as agen ts to relieve pain or co rticosteroids, m ay be prescribed depen din g on th e source of bleedin g from th e disorder.

B. Assessm en t 1. Abn orm al bleedin g in respon se to traum a or sur-

gery (som etim es is detected after circum cision ) 2. Epistaxis (n osebleeds) 3. Join t bleed in g causin g pain , ten dern ess, swellin g,

an d lim ited ran ge of m otion 4. Ten den cy to bruise easily

BOX 34-2 Iron-Rich Foods

▪ Breads and cereals ▪ Dark green, leafy

vegetables ▪ Dried fruits ▪ Egg yolks ▪ Iron-enriched infant for-

mula and cereal ▪ Kidney beans ▪ Legumes ▪ Liver

▪ Meats ▪ Molasses ▪ Nuts ▪ Potatoes ▪ Prune juice ▪ Raisins ▪ Seeds ▪ Shellfish ▪ Tofu ▪ Whole grains

413CHAPTER 34 Hematological Disorders

P

e

d

i

a

t

r

i

c

s

5. Results of tests th at m easu re platelet fun ctio n are n orm al; results of tests th at m easu re clo ttin g fac- tor fun ctio n m ay be ab n orm al.

C. In terven tion s 1. Mon itor for bleedin g an d m ain tain bleedin g

precaution s. 2. Prepare to adm in ister factor VIII con cen trates,

eith er produced th rou gh gen etic en gin eerin g (recom bin an t) or derived from pooled plasm a, as prescribed.

3. DDAVP (1-deam in o-8-D-argin in e vaso pressin ), a syn th etic form of vasopressin , in creases plasm a factor VIII an d m ay be prescribed to treat m ild h em op h ilia.

4. Mon itor for join t pain ; im m ob ilize th e affected extrem ity if join t pain occurs.

5. Assess n eurological status (ch ild is at risk for in tracran ial h em orrh age).

6. Mon itor urin e for h em aturia. 7. Con trol join t bleedin g by im m obilization , eleva-

tion , an d ap plication of ice; apply pressure (15 m in utes) for superficial bleed in g.

8. In struct th e ch ild an d paren ts about th e sign s of in tern al bleedin g.

9. In struct paren ts in h ow to con trol th e bleedin g. 10. In struct paren ts regardin g activities for th e ch ild,

em ph asizin g th e avoidan ce of con tact sports an d th e n eed for protective devices wh ile learn in g to walk; assist in developin g an appropriate exercise plan .

11. In struct th e ch ild to wear protective devices such as h elm ets an d kn ee an d elbow pads wh en partic- ipatin g in sports such as bicyclin g an d skatin g.

V. von Willebrand’s Disease A. Description

1. von Willebran d’s disease is a hereditary bleedin g disorder th at is ch aracterized by a deficien cy of or a defect in a protein term ed von Willebrand factor.

2. Th e disorder cau ses platelets to adh ere to dam - aged en doth elium ; th e von Willeb ran d facto r protein also serves as a carrier protein for facto r VIII.

3. It is ch aracterized by an in creased ten den cy to bleed fro m m ucou s m em bran es.

B. Assessm en t 1. Epistaxis 2. Gum bleedin g 3. Easy bruisin g 4. Excessive m en strual bleedin g

C. In terven tion s 1. Treatm en t an d care are sim ilar to m easures

im plem en ted for h em op h ilia, in cludin g ad m in - istration of clo ttin g factors.

2. Provide em o tion al supp ort to th e ch ild an d par- en ts, esp ecially if th e ch ild is experien cin g an epi- sode of bleedin g.

A child with a bleeding disorder needs to wear a MedicAlert bracelet.

VI. β-Thalassemia Major A. Descriptio n ( Box 34-3)

1. β-Th alassem ia m ajo r is an autoso m al recessive disorder ch aracterized by th e reduced productio n of 1 of th e globin ch ain s in th e syn th esis of h em oglob in (both paren ts m ust be carriers to produce a ch ild with β-th alassem ia m ajor).

2. Th e in ciden ce is h igh est in in dividuals of Med i- terran ean descen t, such as Italian s, Greeks, Syr- ian s, an d th eir offsp rin g.

3. Treatm en t is supp ortive; th e go al of th erap y is to m ain tain n orm al h em oglobin levels by th e adm in istration of blood tran sfusion s.

4. Bon e m arrow tran splan tation m ay be offered as an altern ative th erap y.

5. A splen ectom y m ay be perform ed in a ch ild with severe splen om egaly wh o requires repeated tran sfusio n s (assists in relievin g abdom in al pres- sure an d m ay in crease th e life span of supp lem en - tal red blood cells).

B. Assessm en t 1. Fron tal bossin g 2. Maxillary prom in en ce 3. Wide-set eyes with a flatten ed n ose 4. Green ish yellow skin ton e 5. Hepatosplen om egaly 6. Severe an em ia 7. Microcytic, h ypo ch rom ic red blood cells

C. In terven tion s 1. Adm in ister blood tran sfusion s as prescribed;

m on itor for tran sfusion reaction s. 2. Mon itor for iron overload; ch elation th erap y

with deferasirox or deferoxam in e m ay be pre- scribed to treat iron overload an d to preven t organ dam age from th e elevated levels of iron caused by th e m ultiple tran sfusion th erapy.

3. If th e ch ild h as h ad a splen ecto m y, in struct par- en ts to report an y sign s of in fectio n because of th e risk of sep sis.

4. En sure th at paren ts un d erstan d th e im portan ce of th e ch ild receivin g pn eum ococcal an d m en in - gococcal vaccin es in addition to an an n ual in flu- en za vaccin e and th e regularly sch eduled vaccin es.

5. Provide gen etic coun selin g to paren ts.

BOX 34-3 Types of β-Thalassemia Tha la ssemia Minor: Asymptomatic silent carrier case Tha la ssemia Tra it: Produces mild microcytic anemia Tha la ssemia Intermedia : Manifested as splenomegaly and

moderate to severe anemia Tha la ssemia Ma jor: Results in severe anemia requiring transfu-

sion support to sustain life (also known as Cooley’s anemia)

414 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

CRITICAL THINKING What Should You Do? Answer: The child with hemophilia is at risk for bleeding. If the child experienced recent trauma, the nurse should place the child on bleeding precautions and monitor for bleeding. This is the priority intervention. The nurse should monitor vital signs and monitor for joint pain. Joint bleeding should be controlled by immobilization, elevation, and application of ice. Pressure should be applied for 15 minutes for any superficial bleeding. The neurological status should be checked because the child is at risk for intracranial hemor- rhage, and the nurse should monitor the urine for hematuria. Blood replacement factors may be prescribed.

Reference: Hockenberry, Wilson (20 15), pp. 1360 -1361.

P R A C T I C E Q U E S T I O N S 352. Th e n urse an alyzes th e laborato ry results of a ch ild

with h em oph ilia. Th e n urse un derstan ds th at wh ich result will m o st likely be abn o rm al in th is ch ild? 1. Platelet coun t 2. Hem atocrit level 3. Hem o globin level 4. Partial th rom bop lastin tim e

353. Th e n urse is providin g h om e care in struction s to th e paren ts of a 10-year-old ch ild with h em op h ilia. Wh ich sport activity sh ould th e n urse suggest for th is ch ild? 1. Soccer 2. Basketb all 3. Swim m in g 4. Field h ockey

354. Th e n ursin g studen t is presen tin g a clin ical con fer- en ce an d discusses th e cause of β-th alassem ia. Th e n ursin g studen t in form s th e group th at a ch ild at greatest risk of developin g th is disorder is wh ich of th ese? 1. A ch ild of Mexican descen t 2. A ch ild of Med iterran ean descen t 3. A ch ild wh ose in take of iron is extrem ely poor 4. A breast-fed ch ild of a m oth er with ch ron ic

an em ia

355. A ch ild with β-th alassem ia is receivin g lon g-term blood tran sfusio n th erapy for th e treatm en t of th e disorder. Ch elation th erapy is prescribed as a result of too m uch iron fro m th e tran sfusion s. Wh ich m ed ication sh ould th e n urse an ticipate to be prescribed? 1. Fragm in 2. Meropen em

3. Metoprolol 4. Deferoxam in e

356. Th e clin ic n urse in structs paren ts of a ch ild with sickle cell an em ia about th e precipitatin g factors related to sickle cell crisis. Wh ich , if iden tified by th e paren ts as a precipitatin g facto r, in dicates th e n eed fo r fu rth er in stru ctio n ? 1. Stress 2. Traum a 3. In fection 4. Fluid overload

357. A 10-year-old ch ild with h em op h ilia A h as slipped on th e ice an d bum ped h is kn ee. Th e n urse sh ould prepare to adm in ister wh ich prescription ? 1. In jection of facto r X 2. In traven ou s in fusion of iron 3. In traven ou s in fusion of facto r VIII 4. In tram uscular in jection of iron usin g th e Z-track

m ethod

358. Th e n urse is in structin g th e paren ts of a ch ild with iron deficien cy an em ia regardin g th e ad m in istration of a liqu id oral iron supplem en t. Wh ich in struction sh ould th e n urse tell th e paren ts? 1. Adm in ister th e iron at m ealtim es. 2. Adm in ister th e iron th rou gh a straw. 3. Mix th e iron with cereal to adm in ister. 4. Add th e iron to form ula for easy adm in istra-

tion .

359. Laboratory studies are perform ed for a ch ild sus- pected to h ave iron deficien cy an em ia. Th e n urse reviews th e labo ratory results, kn owin g th at wh ich result in dicates th is type of an em ia? 1. Elevated h em oglob in level 2. Decreased reticulocyte coun t 3. Elevated red blood cell co un t 4. Red blood cells th at are m icrocytic an d

h ypo ch rom ic

360. Th e n urse is reviewin g a h ealth care provid er’s prescription s for a ch ild with sickle cell an em ia wh o was adm itted to th e h ospital for th e treatm en t of vaso -occlusive crisis. Wh ich prescription s docu- m en ted in th e ch ild’s record sh ould th e n urse ques- tion ? Select all th at ap p ly.

1. Restrict fluid in take. 2. Position for com fo rt. 3. Avo id strain on pain ful join ts. 4. Apply n asal oxygen at 2 L/ m in ute. 5. Provide a h igh -calorie, h igh -protein diet. 6. Give m ep eridin e, 25 m g in traven o usly,

every 4 h ours for pain .

415CHAPTER 34 Hematological Disorders

361. Th e n urse is con ductin g staff in -service train in g on von Willeb ran d’s disease. Wh ich sh o uld th e n urse in clude as ch aracteristics of von Willeb ran d’s dis- ease? Select all th at ap p ly.

1. Easy bruisin g occurs. 2. Gum bleed in g occurs. 3. It is a h ereditary bleed in g disorder.

4. Treatm en t an d care are sim ilar to th at for h em op h ilia.

5. It is ch aracterized by extrem ely h igh creati- n in e levels.

6. Th e disorder cau ses platelets to adh ere to dam aged en doth elium .

A N S W E R S 352. 4 Ra tion a le: Hem o ph ilia refers to a gro up o f b leedin g disorders resultin g from a d eficien cy o f specific coagu lation pro tein s. Resu lts of tests th at m easu re p latelet fun ctio n are n orm al; results o f tests th at m easure clottin g factor fun ctio n m ay b e abn orm al. Abn orm al laborato ry results in h em oph ilia in d icate a prolon ged p artial throm b oplastin tim e. Th e platelet coun t, h em o glob in level, an d h em atocrit level are n orm al in h em o ph ilia. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, lab o rato ry tests u sed to m on itor h em op h ilia, an d n ote th e strategic wo rd s, most likely. Recallin g th e path o ph ysio logy asso ciated with th is d isorder an d recallin g th at it resu lts fro m a d eficien cy o f spe- cific co agu latio n p ro tein s will d irect you to th e correct o ptio n . Review: Labo rato ry tests used to m o n ito r h em o p h ilia Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Hem ato logical Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Hocken b erry, Wilso n (2015), p. 1358.

353. 3 Ra tion a le: Hem o ph ilia refers to a grou p of bleedin g d isorders resultin g fro m a d eficien cy of sp ecific coagu latio n p ro tein s. Ch ild ren with h em o ph ilia n eed to avo id con tact spo rts an d to take p recaution s such as wearin g elb o w an d kn ee pad s an d h elm ets with oth er spo rts. Th e safe activity for th em is swim m in g. Test-Ta kin g Str a tegy: Focu s on th e su b ject, a safe activity. Recallin g th at b leed in g is a m ajo r con cern in th is co n dition , elim in ate op tion s 1, 2, an d 4 because th ese activities are co m - p arab le o r alike in th at th ey p resen t th e p o ten tial for in ju ry. Review: Ho m e care an d safety in structio n s for h em o p h ilia Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Hem ato logical Pr ior it y Con cept s: Clo ttin g; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 1360.

354. 2 Ra tion a le: β-Th alassem ia is an auto som al recessive d isord er ch aracterized b y th e redu ced p rod uctio n o f 1 o f th e glo bin ch ain s in th e syn th esis o f h em oglob in ( bo th p aren ts m u st be carriers to prod u ce a ch ild with β-th alassem ia m ajor). Th is

d isorder is fo un d prim arily in in d ivid uals of Med iterran ean d escen t. O p tio n s 1, 3, an d 4 are in co rrect. Test-Ta kin g St r a t egy: Focus on th e su b ject, th e ch ild at great- est risk fo r β-th alassem ia m ajo r. Th in k abo u t th e p ath op h ysi- o logy o f th e d iso rd er. Rem em ber th at th is diso rd er o ccu rs p rim arily in in divid u als o f Med iterran ean d escen t. Review: β-Th alassem ia Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Hem atolo gical Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Hocken b erry, Wilso n (2015), p. 1349.

355. 4 Ra tion a le: β-Th alassem ia is an au tosom al recessive d isorder ch aracterized by th e redu ced p ro d uction of 1 o f th e glo bin ch ain s in th e syn th esis o f h em oglo b in ( b oth p aren ts m u st b e carriers to pro du ce a ch ild with β-th alassem ia m ajor). Th e m ajo r com p lication o f lo n g-term tran sfusio n th erap y is h em o- sid ero sis. To p reven t o rgan dam age fro m too m uch iro n , ch e- latio n th erap y with eith er Exjad e or defero xam in e m ay be p rescrib ed . Defero xam in e is classified as an an tido te for acu te iron to xicity. Fragm in is an an tico agu lan t used as p ro p h ylaxis fo r p osto p erative deep vein th rom b osis. Mero pen em is an an ti- b iotic. Metop ro lol is a beta blo cker u sed to treat h yp erten sio n . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, ch elation th erap y. Specific kn o wledge regard in g th e an tid o te fo r iron to xicity is n eeded to an swer th is qu estio n . O n e way to rem em ber th is is to lo ok at th e prefix in th e gen eric n am e o f th e m edicatio n u sed to treat iro n o verd o se. Rem em ber to associate defer- an d rem o val of iron . Review: Ch elatio n th erap y Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—Hem atolo gical Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Hocken b erry, Wilso n (2015), pp . 1352-1353.

356. 4 Ra tion a le: Sickle cell crises are acute exacerb ation s of th e d is- ease, wh ich vary con siderably in severity an d freq uen cy; th ese in clu de vaso-o cclu sive crisis, splen ic sequ estratio n , h yperh e- m olytic crisis, an d aplastic crisis. Sickle cell crisis m ay b e p re- cipitated by in fectio n , d eh yd ratio n , h ypo xia, trau m a, or p h ysical or em otion al stress. Th e m o th er o f a ch ild with sickle

P

e

d

i

a

t

r

i

c

s

416 UNIT VII Pediatric Nursing

cell d isease sh ou ld en co urage flu id in take o f 1½ to 2 tim es th e daily req uirem en t to preven t d eh yd ratio n . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further instruction. Th ese words in d icate a n egative even t q u ery an d ask you to select an o ptio n th at is an in co rrect statem en t. Recal- lin g th at fluid s are a m ain com p on en t of treatm en t in sickle cell an em ia to p reven t crisis will direct you to th e correct op tio n . Rem em b er th at fluid s are req uired to p reven t deh ydration . Review: Precipitatin g factors of sickle cell crisis Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Hem ato lo gical Pr ior ity Con cepts: Clien t Edu catio n ; Gas Exch an ge Refer en ces: Ho cken b erry, Wilso n (2015), p . 1343.

357. 3 Ra t ion a le: Hem oph ilia refers to a group of bleedin g d isord ers resu ltin g fro m a deficien cy of specific coagulation p ro tein s. The prim ary treatm en t is rep lacem en t o f th e m issin g clo ttin g fac- tor; add ition al m ed icatio ns, such as agen ts to relieve p ain , m ay be p rescribed d epen din g o n th e sou rce of bleed in g from the dis- order. A ch ild with h em o ph ilia A is at risk for join t b leedin g after a fall. Factor VIII would b e p rescribed in traven ously to replace th e m issin g clo ttin g facto r an d m in im ize th e bleedin g. Factor X and iron are n ot u sed to treat child ren with h em oph ilia A. Test -Ta kin g St r a t egy: Focu s o n th e ch ild’s d iagn osis. Elim in ate op tion s 2 an d 4 becau se th ey are co m p arab le o r alike. Recal- lin g th at a ch ild with h em o ph ilia A is m issin g clo ttin g facto r VIII will d irect you to th e co rrect o ptio n from th o se rem ain in g. Review: Hem o p h ilia A Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Pediatrics—Hem ato lo gical Pr ior ity Con cepts: Clin ical Jud gm en t; Clottin g Refer en ce: Ho cken berry, Wilson (2015), p . 1357.

358. 2 Ra t ion a le: In iron deficien cy an em ia, iro n sto res are d ep leted , resultin g in a decreased supply of iron for th e m an ufacture of h em oglo b in in red b loo d cells. An o ral iron su pp lem en t sh o uld be adm in istered th ro ugh a straw o r m edicin e d ro pp er placed at th e b ack o f th e m ou th because th e iro n stain s th e teeth . Th e par- en ts sh ou ld be in stru cted to b ru sh or wip e th e ch ild’s teeth o r h ave th e ch ild b ru sh th e teeth after ad m in istration . Iro n is ad m in istered b etween m eals b ecause ab so rp tion is decreased if th ere is fo od in th e sto m ach . Iron requ ires an acid en viron - m en t to facilitate its ab sorption in th e du od en um . Iro n is n ot ad d ed to fo rm u la or m ixed with cereal or o th er foo d item s. Test -Ta kin g St r a tegy: Elim in ate op tion s 3 an d 4 first b ecau se th ey are co m p arab le o r alike an d because m ed ication sh o uld n ot be ad ded to fo rm ula an d fo od . Next, n ote th e wo rd liquid in th e qu estio n . Th is sh ou ld assist you in recallin g th at iron in liq - uid fo rm stain s teeth . Review: Ad m in istration o f o ral liq uid iro n

Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Hem ato lo gical Pr ior ity Con cepts: Clien t Ed u catio n ; Health Pro m otio n Refer en ce: Bu rch u m , Rosen th al (2016), pp . 652-653.

359. 4 Ra t ion a le: In iro n d eficien cy an em ia, iron stores are d epleted, resu ltin g in a decreased su pp ly o f iron fo r th e m an ufacture o f h em oglo bin in red b lo od cells. Th e resu lts of a co m p lete b lo od cell cou n t in ch ild ren with iron deficien cy an em ia sh ow d ecreased h em o glo bin levels an d m icro cytic an d h yp och rom ic red b loo d cells. Th e red blo o d cell co u n t is d ecreased . Th e retic- u lo cyte co un t is u sually n orm al o r sligh tly elevated. Test -Ta kin g Str a t egy: Fo cus o n th e su b ject, labo rato ry fin d - in gs. Elim in ate o ptio n s 1 an d 3 first, kn o win g th at th e h em o - glob in an d red bloo d cell cou n ts wou ld be decreased. From th e rem ain in g o ptio n s, select th e correct op tio n over o ption 2 b ecause of th e relation sh ip b etween an em ia an d red b lo od cells. Review: Labo rato ry fin din gs asso ciated with iro n d eficien cy an em ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Hem ato lo gical Pr ior ity Con cepts: Cellu lar Regu latio n ; Gas Exch an ge Refer en ce: Ho cken berry, Wilson (2015), p p. 1329, 1336.

360. 1, 6 Ra t ion a le: Sickle cell an em ia is o n e of a grou p of diseases term ed hemoglobinopathies, in wh ich h em o glob in A is p artly o r com pletely rep laced by ab n orm al sickle h em oglob in S. It is cau sed by th e in h eritan ce o f a gen e for a stru ctu rally abn or- m al p ortion o f th e h em o glo bin ch ain . Hem oglo bin S is sen si- tive to ch an ges in th e o xygen co n ten t o f th e red b lo od cell; in su fficien t o xygen causes th e cells to assum e a sickle sh ape, an d th e cells b eco m e rigid an d clum ped to geth er, ob stru ctin g capillary b lo od flo w. O ral an d in traven ou s fluid s are an im po r- tan t p art o f treatm en t. Mep erid in e is n o t reco m m en d ed fo r a ch ild with sickle cell d isease because of th e risk for n orm eperid in e-in du ced seizu res. No rm ep eridin e, a m etab olite o f m ep erid in e, is a cen tral n ervo us system stim u lan t th at pro- d u ces an xiety, trem o rs, m yoclo n u s, an d gen eralized seizu res wh en it accum ulates with repetitive dosin g. Th e n urse would q u estion th e p rescriptio n fo r restricted flu ids an d m ep erid in e fo r p ain co n trol. Position in g fo r co m fo rt, avo idin g strain o n p ain fu l join ts, oxygen , an d a h igh -calorie an d h igh -protein d iet are also im po rtan t p arts of th e treatm en t plan . Test -Ta kin g St r a tegy: Focus o n th e su b ject, iden tifyin g th e p rescription s th at n eed to be q uestion ed an d o n th e path o - p h ysio lo gy th at occu rs in sickle cell disease. Recallin g th at fluid s are an im po rtan t com p on en t of th e treatm en t plan will assist in id en tifyin g th at a flu id restrictio n prescrip tion wo uld n eed to b e q uestio n ed . Also, recallin g th e effects o f m ep eridin e

P

e

d

i

a

t

r

i

c

s

417CHAPTER 34 Hematological Disorders

will assist in iden tifyin g th at th is prescription n eeds to be q uestion ed. Review: Sickle cell crisis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Hem ato logical Pr ior it y Con cept s: Co llab oration ; Safety Refer en ce: Hocken b erry, Wilso n (2015), pp . 1347, 1350.

361. 1, 2, 3, 4, 6 Ra tion a le: vo n Willeb ran d’s d isease is a h ereditary bleedin g d isord er ch aracterized b y a d eficien cy of or a d efect in a protein term ed von Willebrand factor. Th e disorder cau ses platelets to ad h ere to dam aged en do th eliu m . It is ch aracterized b y an

in creased ten den cy to bleed fro m m u cou s m em bran es. Assess- m en t fin d in gs in clu de epistaxis, gum bleedin g, easy bru isin g, an d excessive m en strual bleedin g. An elevated creatin in e level is n o t asso ciated with th is d iso rd er. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, assessm en t fin d- in gs, an d on th e ch ild’s diagn o sis. Recallin g th at th is d isorder is ch aracterized b y an in creased ten den cy to b leed from m ucou s m em b ran es will direct yo u to th e correct o ptio n s. Review: vo n Willeb ran d ’s d isease Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Hem atolo gical Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Hocken b erry, Wilso n (2015), p. 1362.

P

e

d

i

a

t

r

i

c

s

418 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 35 Oncological Disorders

PRIORITY CONCEPTS Cellular Regulation; Safety

CRITICAL THINKING What Should You Do? The nurse caring for a child with a diagnosis of leukemia receives a report from the laboratory indicating that the white blood cell count is 20 00 mm 3 (2.0 Â 10 9/ L) and the absolute neutrophil count is 40 % (0 .40 ). What should the nurse do? Answer located on p. 425.

I. Leukemia A. Description

1. Leu kem ia is a m align an t in crease in th e n um ber of leuko cytes, usually at an im m ature stage, in th e bon e m arro w.

2. In leukem ia, proliferatin g im m ature wh ite blood cells (WBCs) depress th e bon e m arro w, causin g an em ia fro m decreased eryth rocytes, in fectio n fro m n eutropen ia, an d bleedin g from decreased platelet production (th rom bocytopen ia).

3. Th e cau se is un kn own ; it seem s to in volve gen etic dam age of cells, leadin g to th e tran sform ation of cells from a n orm al state to a m align an t state.

4. Risk facto rs in clude gen etic, viral, im m un ologi- cal, an d en viron m en tal facto rs an d exp osure to radiation , ch em icals, an d m edication s.

5. Acute lym ph o cytic leukem ia is th e m ost frequen t typ e of can cer in ch ildren .

6. Leu kem ia is m ore com m on in boys th an girls after 1 year of age.

7. Progn osis depen ds on various facto rs such as age at diagn osis, in itial WBC co un t, type of cell in volved, an d sex of th e ch ild.

8. Treatm en t in volves ch em oth erapy an d possib ly radiation an d h em atopo ietic stem cell tran splan tation .

9. Th e ph ases of ch em oth erapy in clude in duction , wh ich ach ieves a com plete rem ission or disap- pearan ce of leukem ic cells; in ten sification or con solidation th erapy, wh ich decreases th e

tum o r burden furth er; cen tral n ervou s system proph ylactic th erapy, wh ich preven ts leukem ic cells fro m in vadin g th e cen tral n ervou s system ; an d m ain ten an ce, wh ich serves to m ain tain th e rem ission ph ase.

B. Assessm en t 1. In filtration of th e bon e m arro w by m align an t

cells causes fever, pallor, fatigue, an orexia, h em orrh age (usually petech iae), an d bon e an d join t pain ; path o logical fractures can occur as a result of bon e m arro w in vasion with leukem ic cells.

2. Sign s of in fectio n occur as a result of n eutro- pen ia.

3. Th e ch ild experien ces h epatosp len om egaly an d lym p h aden o path y.

4. Th e ch ild h as a n orm al, elevated, or low WBC coun t, depen din g on th e presen ce of in fectio n or of im m ature versus m ature WBCs.

5. Th e ch ild h as decreased h em oglobin an d h em at- ocrit levels.

6. Th e ch ild h as a decreased platelet coun t. 7. A positive bon e m arro w biopsy specim en iden -

tifies leukem ic blast (im m ature)–ph ase cells. 8. Sign s of in creased in tracran ial pressure (ICP)

occur as a result of cen tral n ervou s system in volvem en t (Box 35-1).

9. Th e ch ild sh o ws sign s of cran ial n erve (cran ial n erve VII, or th e facial n erve, is m ost com m on ly affected) or spin al n erve in volvem en t; clin ical m an ifestatio n s relate to th e area in volved.

10. Clin ical m an ifestation s in dicate th e in vasion of leukem ic cells to th e kidn eys, testes, prostate, ovaries, gastro in testin al tract, an d lu n gs.

C. In fection ( Box 35-2) 1. In fection can occur th rou gh self-con tam in ation

or cro ss-con tam in ation . 2. Th e m ost com m on sites for in fection are th e

skin (an y break in th e skin is a poten tial site of in fectio n ), respiratory tract, an d gastro in testin al tract.

419

D. Bleedin g ( Box 35-3) 1. Platelet tran sfusion s are gen erally reserved for

active bleedin g episo des th at do n ot respon d to lo cal treatm en t an d th at m ay occur durin g in du c- tio n or relapse th erap y.

2. Packed red blood cells m ay be prescribed for a ch ild with severe blood loss.

E. Fatigue an d n utrition 1. Assist th e paren ts an d ch ild in selectin g a well-

balan ced diet. 2. Provide sm all m eals th at require little ch ewin g

an d are n ot irritatin g to th e oral m ucosa. 3. If th e ch ild can n ot take oral feedin gs, paren teral

n utrition or en teral feed in gs m ay be prescribed.

P

e

d

i

a

t

r

i

c

s

BOX 35-1 Manifestations of Increased Intracranial Pressure in Infants and Children

Infants ▪ Tense, bulging fontanel ▪ Separated cranial sutures ▪ Macewen’s sign (cracked-pot sound on percussion) ▪ Irritability ▪ High-pitched cry ▪ Increased head circumference ▪ Distended scalp veins ▪ Poor feeding ▪ Crying when disturbed ▪ Setting sun sign (eyes appear to look only downward, with

the sclera prominent over the iris)

Children ▪ Headache ▪ Nausea ▪ Forceful vomiting ▪ Diplopia; blurred vision ▪ Seizures

Personality and Behavior Signs ▪ Irritability, restlessness ▪ Indifference, drowsiness ▪ Decline in school performance ▪ Diminished physical activity and motor performance ▪ Increased sleeping ▪ Inability to follow simple commands ▪ Lethargy Late Signs ▪ Bradycardia ▪ Decreased motor response to command ▪ Decreased sensory response to painful stimuli ▪ Alterations in pupil size and reaction ▪ Decerebrate (extension) or decorticate (flexion) posturing ▪ Cheyne-Stokes respirations ▪ Papilledema ▪ Decreased consciousness ▪ Coma

From Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 10, Mosby.

BOX 35-2 Protecting the Child from Infection

Initiate protective isolation procedures. Maintain frequent and thorough hand washing. Maintain the child in a private room with high-efficiency partic-

ulate air filtration or laminar air flow system if possible. Ensure that the child’s room is cleaned daily. Use strict aseptic technique for all nursing procedures. Limit the number of caregivers entering the child’s room, and

ensure that anyone entering the child’s room wears a mask. Keep supplies for the child separate from supplies for other

children. Reduce exposure to environmental organisms by eliminating

raw fruits and vegetables from the diet, by not allowing fresh flowers in the child’s room, and by not leaving standing water in the child’s room.

Assist the child with daily bathing, using antimicrobial soap. Assist the child to perform oral hygiene frequently. Assess for signs and symptoms of infection. Monitor temperature, pulse, and blood pressure. Change wound dressings daily, and inspect wounds for red-

ness, swelling, or drainage. Assess urine for color and cloudiness. Assess the skin and oral mucous membranes for signs of

infection. Auscultate lung sounds.

Encourage the child to cough and deep-breathe. Monitor white blood cell and neutrophil counts. Notify the health care provider if signs of infection are present,

and prepare to obtain specimens for culture of open lesions, urine, and sputum.

Initiate a bowel program to prevent constipation and rectal trauma.

Avoid invasive procedures such as injections, rectal tempera- tures, and urinary catheterization.

Administer antibiotic, antifungal, and antiviral medications as prescribed.

Administer granulocyte colony-stimulating factor as prescribed. Instruct parents to keep the child away from crowds and individ-

uals with infections. Instruct parents that the child should not receive immunization

with a live virus (measles, mumps, rubella, polio) because if the immune system is depressed, the attenuated virus can result in a life-threatening infection; also, the child should not receive the varicella vaccine.

The Salk (inactivated) vaccine for poliomyelitis may be administered.

Instruct parents to inform the teacher that they should be noti- fied immediately if a case of a communicable disease occurs in another child at school.

420 UNIT VII Pediatric Nursing

4. Assist th e ch ild in self-care an d m obility activities. 5. Allow adequ ate rest periods durin g care. 6. Do n ot perform n ursin g care activities un less

th ey are essen tial. F. Ch em oth erapy

1. Mon itor for severe bon e m arro w supp ression ; durin g th e period of greatest bon e m arrow sup- pression (th e n adir), blood cell coun ts are extrem ely low.

2. Mon itor for in fectio n an d bleedin g. 3. Protect th e ch ild from life-th reaten in g in fectio n s. 4. Mon itor for n ausea, vom itin g, an d alteration in

bowel fun ction . 5. Adm in ister stool softeners as prescribed an d if

n eeded to preven t strain in g if con stipation occurs. 6. Provide rectal h ygien e gen tly as n eeded. 7. Adm in ister an tiem etics before begin n in g ch em o-

th erapy as prescribed. 8. Mon itor for sign s of deh ydratio n . 9. Mon itor for sign s of h em orrh agic cystitis. 10. Mon itor for sign s of periph eral n europath y. 11. Assess oral m ucou s m em bran es for m ucositis;

ad m in ister frequen t m ou th rin ses per agen cy procedure an d as prescribed to prom o te h ealin g or preven t in fectio n (local oral an esth etics m ay also be prescribed).

12. Instruct th e parents and ch ild in the signs and sym ptom s to watch for after ch em otherapy and when to notify th e h ealth care provider (HCP).

13. In form th e paren ts an d ch ild th at h air loss m ay occur from ch em oth erapy (h air regrows in ab out 3 to 6 m on th s an d m ay be a sligh tly differen t color or texture) .

14. In struct th e paren ts an d ch ild about th e care of a cen tral ven ous access device, as n ecessary (see Ch apter 13).

15. Listen to th e ch ild an d fam ily, an d en courage th em to verbalize th eir feelin gs an d express th eir con cern s.

16. In tro duce th e fam ily to oth er fam ilies of ch ildren with can cer.

17. Con sult social services an d ch aplain s as n ecessary.

Monitor a child receiving chemotherapy closely for signs of infection. Infection is a major cause of death in the immunosuppressed child.

II. Hodgkin’s Disease A. Description

1. Ho dgkin ’s disease (a type of lym p h om a) is a m align an cy of th e lym ph n od es th at origin ates in a sin gle lym p h n od e or a sin gle ch ain of n od es ( Fig. 35-1).

P

e

d

i

a

t

r

i

c

s

Wa lde ye r ring

Axilla ry

Live r

Ilia c

P a ra -a ortic a nd me s e nte ric

S ple e n

Me dia s tina l

Ce rvica l a nd s upra cla vicula r

FIGURE 35-1 Main areas of lymphadenopathy and organ involvement in Hodgkin’s disease.

BOX 35-3 Protecting the Child from Bleeding

Examine the child for signs and symptoms of bleeding. Handle the child gently. Measure abdominal girth; an increase can indicate internal

hemorrhage. Instruct the child to use a soft toothbrush and avoid dental

floss. Provide soft foods that are cool to warm in temperature. Avoid injections, if possible, to prevent trauma to the skin and

bleeding. Apply firm and gentle pressure to a needle-stick site for at least

10 minutes. Pad side rails and sharp corners of the bed and furniture. Discourage the child from engaging in activities involving the

use of objects that can be harmful.

Instruct the child to avoid constrictive or tight clothing. Use caution when taking the blood pressure to prevent skin

injury. Instruct the child to avoid blowing his or her nose. Avoid the use of rectal suppositories, enemas, and rectal

thermometers. Examine all body fluids and excrement for the presence of

blood. Count the number of pads or tampons used if the adolescent

girl is menstruating. Instruct the child about the signs and symptoms of bleeding. Instruct parents to avoid administering nonsteroidal antiin-

flammatory drugs and products that contain aspirin to the child.

421CHAPTER 35 Oncological Disorders

P

e

d

i

a

t

r

i

c

s

2. Th e disease predictably m etastasizes to n on n odal or extralym ph atic sites, especially th e spleen , liver, bon e m arro w, lun gs, an d m ediastin um .

3. Hodgkin ’s disease is ch aracterized by th e pres- en ce of Reed -Stern berg cells n oted in a lym p h n ode biopsy specim en .

4. Peak in ciden ce is in m id-adolescen ce. 5. Possible causes in clude viral in fectio n s an d previ-

ous exposu re to alkylatin g ch em ical agen ts. 6. Th e progn osis is excellen t, with lon g-term sur-

vival rates dep en din g on th e stage of th e disease. 7. Th e prim ary treatm en t m odalities are radiation

an d ch em oth erapy; each m ay be used alon e or in com bin ation , depen din g on th e clin ical stage of th e disease.

B. Assessm en t 1. Pain less en largem en t of lym ph n odes 2. En larged, firm , n on ten der, m ovable n odes in th e

supraclavicular area; in ch ildren , th e “sen tin el” n ode lo cated n ear th e left clavicle m ay be th e first en larged n od e

3. Non pro ductive cough as a result of m ed iastin al lym ph ad en opath y

4. Abdom in al pain as a result of en larged retroperito n eal n odes

5. Advan ced lym p h n ode an d extralym ph atic in volvem en t th at m ay cause system ic sym pto m s, such as a low-grade or in term itten t fever, an orexia, n ausea, weigh t loss, n igh t sweats, an d pruritus

6. Positive biopsy specim en of a lym p h n od e (pres- en ce of Reed-Stern berg cells) an d positive bon e m arrow biopsy specim en

7. Com puted tom o graph y scan of th e liver, spleen , an d bon e m arro w m ay be don e to detect m etastasis.

C. In terven tion s 1. For early stages with ou t m ed iastin al n od e

in volvem en t, th e treatm en t of ch oice is exten sive extern al radiation of th e in volved lym p h n od e region s.

2. With m ore exten sive disease, radiation an d m ul- tidrug ch em oth erapy are used.

3. Mon itor for m edication -in duced pan cytopen ia an d an abn o rm al dep ression of all cellular com - pon en ts of th e blood , wh ich in creases th e risk for in fectio n , bleedin g, an d an em ia.

4. Mon itor for sign s of in fection an d bleed in g. 5. Protect th e ch ild fro m in fectio n . 6. Mon itor for adverse effects related to ch em oth er-

apy or radiation ; th e m ost com m on adverse effect of exten sive irradiatio n is m alaise, wh ich can be difficu lt for older ch ildren an d adoles- cen ts to tolerate ph ysically an d psych o logically (Table 35-1).

7. Mon itor for n ausea an d vom itin g, an d adm in is- ter an tiem etics as prescribed.

III. Nephroblastoma (Wilms’ Tumor) A. Description

1. Wilm s’ tum o r is th e m ost com m on in traabdom - in al an d kidn ey tum o r of ch ildh ood; it m ay m an - ifest un ilaterally an d localized or bilaterally, som etim es with m etastasis to oth er organ s.

TABLE 35-1 Adverse Effects of Radiation Therapy and Nursing Interventions

Body Area and Adverse Effects Interventions

Ga strointest ina l Tra ct Anorexia Encourage fluids and foods as best tolerated

Provide small, frequent meals

Monitor for weight loss

Nausea, vomiting Administer antiemetics around the clock

Monitor for dehydration

Mucosal ulceration Provide soothing oral hygiene and prescribed mouth rinses

Topical anesthetic may be prescribed

Diarrhea Administer antispasmodics and antidiarrheal preparations as prescribed

Monitor for dehydration

Skin Alopecia (hair loss) Introduce idea of a wig or head wraps to

child

Provide scalp hygiene

Stress the need for head covering in cold weather

Dry or moist desquamation

Keep skin clean

Wash skin daily, using a mild soap sparingly

Do not remove skin markings for radiation

Avoid exposure to the sun and other extreme temperature changes

For dryness, apply lubricant as prescribed

Urinary Bla dder Cystitis Encourage fluid intake and frequent voiding

Monitor for hematuria

Bone Ma rrow Myelosuppression Monitor for fever

Administer antibiotics as prescribed

Avoid use of suppositories, enemas, and rectal temperatures

Institute neutropenic or bleeding precautions as needed

Monitor for signs of anemia

Adapted from Hockenberry M, Wilson D: Wong’s nursing care of infants and children, ed 9, St. Louis, 20 13, Mosby; and McKinney E, James S, Murray S, Ashwill J: Maternal-child nursing, ed 4, St. Louis, 20 13, Saunders.

422 UNIT VII Pediatric Nursing

2. Th e peak in ciden ce is 3 years of age. 3. O ccurren ce is associated with a gen etic in h eri-

tan ce an d with several con gen ital an om alies. 4. Th erapeutic m an agem en t in cludes a com bin ed

treatm en t of surgery (partial to total n eph rec- tom y) an d ch em oth erapy with or with out radia- tio n , dep en din g on th e clin ical stage an d th e h isto logical pattern of th e tum or.

B. Assessm en t 1. Swellin g or m ass with in th e abdom en (m ass is

ch aracteristically firm , n on ten d er, con fin ed to 1 side, an d deep with in th e flan k)

2. Urin ary reten tion or h em aturia, or both 3. An em ia (caused by h em orrh age with in

th e tum o r) 4. Pallor, an orexia, an d leth argy (resultin g from

an em ia) 5. Hyperten sion (caused by secretio n of excess

am oun ts of ren in by th e tum o r) 6. Weigh t lo ss an d fever 7. Sym ptom s of lun g in volvem en t, such as dys-

pn ea, sh o rtn ess of breath , an d pain in th e ch est, if m etastasis h as occurred

C. Preop erative in terven tion s 1. Mon itor vital sign s, particularly blood pressure. 2. Avo id palp ation of th e abdom en ; place a sign at

bed side th at reads, Do Not Palp ate Abdo m en . 3. Measu re abdom in al girth at least on ce daily.

D. Posto perative in terven tion s 1. Mon itor tem perature an d blood pressure closely. 2. Mon itor for sign s of h em orrh age an d in fectio n . 3. Mon itor strict in take an d urin e outp ut clo sely. 4. Mon itor for abdom in al disten tion ; m on itor

bowel soun ds an d oth er sign s of gastroin testin al activity because of th e risk for in testin al obstru ctio n .

Avoid palpation of the abdomen in a child with Wilms’ tumor and be cautious when bathing, moving, or handling the child. It is important to keep the encap- sulated tumor intact. Rupture of the tumor can cause the cancer cells to spread throughout the abdomen, lymph system, and bloodstream.

IV. Neuroblastoma A. Description

1. Neuroblastom a is a tum o r th at origin ates from th e em b ryon ic n eural crest cells th at n orm ally give rise to th e adren al m ed ulla an d th e sym pa- th etic gan glia.

2. Most tum o rs develop in th e adren al glan d or th e retroperito n eal sym path etic ch ain ; oth er sites m ay be with in th e h ead, n eck, ch est, or pelvis.

3. Most ch ildren presen t with n euroblastom a befo re 10 years of age.

4. Most presen tin g sign s are caused by th e tum o r com pressin g adjacen t n orm al tissue an d organ s.

5. Diagn ostic evaluation is aim ed at locatin g th e prim ary site of th e tum o r; an alyzin g th e break- down produ cts excreted in th e urin e, n am ely van illylm an delic acid, h om ovan illic acid, dopa- m in e, an d n orepin eph rin e, perm its detection of suspected tum or befo re an d after m ed ical- surgical in terven tion .

6. Th e progn osis is poor because of th e frequen cy of in vasiven ess of th e tum o r an d because, in m ost cases, a diagn osis is n ot m ade un til after m etasta- sis h as occurred; th e youn ger th e ch ild at diagn o- sis, th e better th e survival rate.

7. Th erapeutic m an agem en t a . Surgery is perform ed to rem ove as m uch of

th e tum o r as possible an d to obtain biopsy specim en s; in th e early stages, com plete surgi- cal rem oval of th e tum o r is th e treatm en t of ch oice.

b . Surgery usually is lim ited to biopsy in th e later stages because of exten sive m etastasis.

c. Radiation is used com m on ly with later-stage disease an d provides palliation for m etastatic lesion s in bon es, lun gs, liver, an d brain .

d . Ch em o th erap y is used for exten sive local or dissem in ated disease.

B. Assessm en t 1. Firm , n on ten der, irregular m ass in th e abdom en

th at crosses th e m idlin e 2. Urin ary frequen cy or reten tion from co m pres-

sion of th e kidn ey, ureter, or bladder 3. Lym ph aden opath y, especially in th e cervical an d

supraclavicular areas 4. Bon e pain if skeletal in volvem en t 5. Supraorbital ecch ym osis, periorbital edem a, an d

exo ph th alm os as a result of in vasion of retrobu l- bar soft tissue

6. Pallor, weakn ess, irritability, an orexia, weigh t loss 7. Sign s of respiratory im pairm en t (th oracic lesion ) 8. Sign s of n eurological im pairm en t (in tracran ial

lesion ) 9. Paralysis from com pression of th e spin al cord

C. Preop erative in terven tion s 1. Mon itor for sign s an d sym ptom s related to th e

location of th e tum o r. 2. Provide em otion al supp ort to th e ch ild an d

paren ts. D. Posto perative in terven tion s

1. Mon itor for posto perative com plication s related to th e location (organ ) of th e surgery.

2. Mon itor for com plication s related to ch em oth er- apy or radiation if prescribed .

3. Provide supp ort to th e paren ts an d en courage th em to express th eir feelin gs; m an y paren ts feel guilt for n ot h avin g recogn ized sign s in th e ch ild earlier.

4. Refer paren ts to ap propriate com m un ity services.

P

e

d

i

a

t

r

i

c

s

423CHAPTER 35 Oncological Disorders

P

e

d

i

a

t

r

i

c

s

V. Osteosarcoma (Osteogenic Sarcoma) A. Description

1. Th e m ost com m on bon e can cer in ch ildren ; it is also kn own as osteogenic sarcoma.

2. Can cer usually is foun d in th e m etap h ysis of lon g bon es, esp ecially in th e lower extrem ities, with m ost tum o rs occurrin g in th e fem u r.

3. Th e peak age of in ciden ce is between 10 an d 25 years.

4. Sym pto m s in th e earliest stage are alm o st always attribu ted to extrem ity in ju ry or n orm al growin g pain s.

5. Treatm en t m ay in clude surgical resectio n (lim b salvage procedure) to save a lim b or rem ove affected tissue, or am putation .

6. Ch em o th erap y is used to treat th e can cer an d m ay be used befo re an d after surgery.

B. Assessm en t 1. Localized pain at th e affected site (m ay be severe

or dull) th at m ay be attribu ted to traum a or th e vague com plain t of “growin g pain s”; pain often is relieved by a flexed position .

2. Palpable m ass 3. Lim pin g if weigh t-b earin g lim b is affected 4. Progressive lim ited ran ge of m otion an d th e

ch ild’s curtailin g of ph ysical activity 5. Ch ild m ay be un ab le to h old h eavy objects

because of th eir weigh t an d resultan t pain in th e affected extrem ity.

6. Path olo gical fractures occur at th e tum or site. C. In terven tion s

1. Prepare th e ch ild an d fam ily for prescribed treat- m en t m odalities, wh ich m ay in clude surgical resectio n by lim b salvage to rem ove affected tis- sue, am putation , an d ch em oth erapy.

2. Com m un icate h on estly with th e ch ild an d fam ily an d provide supp ort.

3. Prepare for prosth etic fittin g as n ecessary. 4. Assist th e ch ild in dealin g with problem s of self-

im age. 5. In struct th e ch ild an d paren ts ab out th e poten tial

develo pm en t of ph an tom lim b pain th at m ay occur after am putation , ch aracterized by tin glin g, itch in g, an d a pain ful sen sation in th e area wh ere th e lim b was am putated.

VI. Brain Tumors A. Description

1. An in fraten torial (below th e ten torium cerebelli) tum o r, th e m ost com m on brain tum o r, is located in th e posterior th ird of th e brain (prim arily in th e cerebellum or brain stem ) an d acco un ts for th e frequen cy of sym pto m s resultin g from in creased ICP.

2. A supraten torial tum or is located with in th e an terior two th irds of th e brain —m ain ly th e cerebrum .

3. Th e sign s an d sym pto m s of a brain tum o r dep en d on its an atom ical location an d size an d, to som e exten t, on th e age of th e ch ild; a n um ber of tests m ay be used in th e n eurological evaluation , but th e m ost com m on diagn ostic proced ure is m agn etic reson an ce im agin g (MRI), wh ich determ in es th e location an d exten t of th e tum or.

4. Th erapeutic m an agem en t in cludes surgery, radi- ation , an d ch em oth erapy; th e treatm en t of ch oice is total rem oval of th e tum or with ou t residual n eurological dam age.

B. Assessm en t 1. Headach e th at is worse on awaken in g an d

im proves durin g th e day 2. Vom itin g th at is un related to feedin g or eatin g 3. Ataxia 4. Seizu res 5. Beh avioral ch an ges 6. Clum sin ess; awkward gait or difficulty walkin g 7. Diplop ia 8. Facial weakn ess

Monitor for signs of increased ICP in a child with a brain tumor and after a craniotomy. If signs of increased ICP occur, notify the HCP immediately.

C. Preop erative in terven tion s 1. Perform a n eurological assessm en t at least every

4 h ours. 2. In stitute seizu re precaution s an d safety m ea-

sures. 3. Assess weigh t loss an d n utrition al status. 4. Sh ave th e ch ild’s h ead as prescribed (provide a

favorite cap or h at for th e ch ild) ; sh avin g th e h ead m ay also be don e in th e surgical suite.

5. Prepare th e ch ild as m uch as possib le; tell th e ch ild th at h e or sh e will wake up with a large h ead dressin g.

D. Postoperative in terven tion s 1. Assess n eurological an d m oto r fun ction an d level

of con scio usn ess. 2. Mon itor tem perature closely, wh ich m ay be ele-

vated because of h ypo th alam us or brain stem in volvem en t durin g surgery; m ain tain a co olin g blan ket by th e bed side.

3. Mon itor for sign s of respiratory in fectio n . 4. Mon itor for sign s of m en in gitis (opisth oton os,

Kern ig’s an d Brud zin ski’s sign s). 5. Mon itor for sign s of in creased ICP (see Box 35-1;

see also Ch apter 42). 6. Mon itor for h em orrh age, ch eckin g th e back of

th e h ead dressin g for posterior poolin g of blood; m ark drain age edges with m arker, rein fo rce dressin g if n eeded, an d do n ot ch an ge dressin g with ou t a specific HCP prescription .

7. Assess pupillary respo n se; sluggish , dilated, or un equ al pupils are reported im m ediately

424 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

because th ey m ay in dicate in creased ICP an d poten tial brain stem h ern iation .

8. Mon itor for colorless drain age on th e dressin g or fro m th e ears or n ose, wh ich in dicates cerebro - spin al fluid an d sh ould be reported im m ediately; assess for th e presen ce of glucose in th e drain age (dipstick).

9. Assess the HCP’s prescription for position in g, in cludin g th e degree of n eck flexion (Box 35-4).

10. Mon itor in traven ous fluids closely. 11. Prom ote m easu res th at preven t vom itin g (vom it-

in g in creases ICP an d th e risk for in cision al ru pture).

12. Provide a quiet en viron m en t. 13. Adm in ister an algesics as prescribed. 14. Provide em otion al support to th e ch ild an d par-

en ts, an d prom ote optim al growth an d developm en t.

CRITICAL THINKING What Should You Do? Answer: A white blood cell count of 20 00 mm 3 (2.0 Â 10 9/ L) and an absolute neutrophil count of 800 mm3 are indicative of a neutropenic state, and the child should be placed on neu- tropenic precautions. The absolute neutrophil count (ANC) is the standard of care in determining whether a child is in a neutropenic state and the need for protective isolation. If the ANC is less than 50 % (0 .50 ), a severe infection risk is pre- sent. Interventions include a private room; good hand- washing technique or use of alcohol-based hand rub before entering the child’s room and before touching the client or any belongings; ensuring that the child’s room and bathroom are cleaned a minimum of once per day; limiting the number of people entering the child’s room (no sick persons should enter the room); using strict aseptic technique for all invasive procedures; keeping fresh flowers and potted plants out of the room; and implementing a low-bacteria diet (no fresh fruits or vegetables or undercooked meats).

References: Burchum, Rosenthal (20 16), pp. 1214-1215. Hockenberry, Wilson (20 15), pp. 1364-1365.

P R A C T I C E Q U E S T I O N S 362. Th e n urse is m on itorin g a ch ild for bleedin g after

surgery for rem oval of a brain tum o r. Th e n urse ch ecks th e h ead dressin g for th e presen ce of blood an d n otes a colorless drain age on th e back of th e dressin g. Wh ich in terven tion sh ould th e n urse per- form im m ed iately? 1. Rein force th e dressin g. 2. Notify th e h ealth care provider (HCP). 3. Docum en t th e fin din gs an d con tin ue to

m on itor. 4. Circle th e area of drain age an d con tin ue

to m on itor.

363. A ch ild un dergoes surgical rem oval of a brain tum o r. Durin g th e postoperative period, th e n urse n otes th at th e ch ild is restless, th e pulse rate is ele- vated, an d th e blood pressure h as decreased sign if- ican tly from th e baselin e value. Th e n urse susp ects th at th e ch ild is in sh ock. Wh ich is th e m o st ap p ro - p riate n ursin g action ? 1. Place th e ch ild in a supin e position . 2. Notify th e h ealth care provider (HCP). 3. Place th e ch ild in Tren delen burg position . 4. In crease th e flow rate of th e in traven ous

fluid s.

364. Th e m oth er of a 4-year-old ch ild tells th e ped iatric n urse th at th e ch ild’s ab dom en seem s to be swol- len . Du rin g furth er assessm en t, th e m oth er tells th e n urse th at th e ch ild is eatin g well an d th at th e activity level of th e ch ild is un ch an ged. Th e n urse, susp ectin g th e possibility of Wilm s’ tum o r, sh o uld avoid wh ich durin g th e ph ysical assessm en t? 1. Palpatin g th e abdom en for a m ass 2. Assessin g th e urin e for th e presen ce of

h em aturia 3. Mon itorin g th e tem p erature for th e presen ce

of fever 4. Mon itorin g th e blood pressure for th e presen ce

of h yperten sion

365. Th e n urse provides a teach in g session to th e n urs- in g staff regardin g osteosarcom a. Wh ich statem en t by a m em ber of th e n ursin g staff in dicates a n eed fo r in fo rm atio n ? 1. “Th e fem ur is th e m ost com m on site of th is

sarcom a.” 2. “Th e ch ild does n ot exp erien ce pain at th e pri-

m ary tum o r site.” 3. “Lim pin g, if a weigh t-b earin g lim b is affected , is

a clin ical m an ifestation .” 4. “Th e sym ptom s of th e disease in th e early stage

are alm ost always attribu ted to n orm al growin g pain s.”

BOX 35-4 Positioning After Craniotomy Assess the health care provider’s prescription for positioning,

including the degree of neck flexion. If a large tumor has been removed, the child is not placed on

the operative side because the brain may shift suddenly to that cavity.

In an infratentorial procedure, the child usually is positioned flat and on either side.

In a supratentorial procedure, the head usually is elevated above the heart level to facilitate cerebrospinal fluid drain- age and to decrease excessive blood flow to the brain to prevent hemorrhage.

Never place the child in Trendelenburg position because it increases intracranial pressure and the risk of hemorrhage.

425CHAPTER 35 Oncological Disorders

366. Th e n urse an alyzes th e laborato ry values of a ch ild with leukem ia wh o is receivin g ch em oth erapy. Th e n urse n otes th at th e platelet coun t is 19,500 m m 3

(19.5 Â 109/ L). O n th e basis of th is labo ratory result, wh ich in terven tion sh ould th e n urse in clude in th e plan of care? 1. In itiate bleed in g precaution s. 2. Mon itor clo sely for sign s of in fectio n . 3. Mon itor th e tem p erature every 4 h ours. 4. In itiate protective isolation precaution s.

367. Th e n urse is m on itorin g a 3-year-old ch ild for sign s an d sym pto m s of in creased in tracran ial pressure (ICP) after a cran io tom y. Th e n urse plan s to m on - ito r for wh ich early sign or sym ptom of in creased ICP? 1. Vom itin g 2. Bulgin g an terior fon tan el 3. In creasin g h ead circum feren ce 4. Com p lain ts of a fron tal h eadach e

368. A 4-year-old ch ild is adm itted to th e h ospital for ab dom in al pain . Th e m oth er reports th at th e ch ild h as been pale an d excessively tired an d is bruisin g easily. O n ph ysical exam in ation , lym ph ad en opa- th y an d h epatosp len om egaly are n oted. Diagn o stic studies are bein g perform ed because acute lym p h o- cytic leukem ia is susp ected. Th e n urse determ in es th at wh ich laborato ry result con firm s th e diagn osis? 1. Lum bar pun cture sh o win g n o blast cells 2. Bon e m arro w biopsy sh owin g blast cells 3. Platelet coun t of 350,000 m m 3 (350 Â 109/ L) 4. Wh ite blood cell coun t 4500 m m 3 (4.5 Â 109/ L)

369. A 6-year-old ch ild with leukem ia is h ospitalized an d is receivin g com bin ation ch em oth erapy. Lab- oratory results in dicate th at th e ch ild is n eutrope- n ic, an d protective isolation proced ures are in itiated. Th e gran dm o th er of th e ch ild visits an d brin gs a fresh bouq uet of flowers picked from h er garden , an d asks th e n urse for a vase for th e flo wers. Wh ich respo n se sh ould th e n urse provid e to th e gran dm oth er?

1. “I h ave a vase in th e utility ro om , an d I will get it for you.”

2. “I will get th e vase an d wash it well before you put th e flowers in it.”

3. “Th e flo wers fro m your garden are beautifu l, but sh o uld n ot be placed in th e ch ild’s room at th is tim e.”

4. “Wh en you brin g th e flowers in to th e room , place th em on th e bed side stan d as far away from th e ch ild as possible.”

370. A diagn osis of Hodgkin ’s disease is susp ected in a 12-year-old ch ild. Several diagn ostic studies are perform ed to determ in e th e presen ce of th is dis- ease. Wh ich diagn ostic test result will con firm th e diagn osis of Hodgkin ’s disease? 1. Elevated van illylm an delic acid urin ary levels 2. Th e presen ce of blast cells in th e bon e m arro w 3. Th e presen ce of Epstein -Barr virus in th e blood 4. Th e presen ce of Reed-Stern berg cells in th e

lym ph n odes

371. Wh ich specific n ursin g in terven tion s are im ple- m en ted in th e care of a ch ild with leukem ia wh o is at risk for in fectio n ? Select all th at ap p ly.

1. Main tain th e ch ild in a sem iprivate room . 2. Reduce exposure to en viron m en tal organ ism s. 3. Use strict aseptic tech n ique for all procedures. 4. En sure th at an yon e en terin g th e ch ild’s room

wears a m ask. 5. Apply firm pressure to a n eedle-stick area for

at least 10 m in utes.

372. Th e n urse is perform in g an assessm en t on a 10- year-o ld ch ild suspected to h ave Hodgkin ’s disease. Wh ich assessm en t fin din gs are specifically ch arac- teristic of th is disease? Select all th at ap p ly.

1. Abdo m in al pain 2. Fever an d m alaise 3. An o rexia an d weigh t lo ss 4. Pain ful, en larged in guin al lym p h n odes 5. Pain less, firm , an d m ovable aden opath y in

th e cervical area

A N S W E R S

362. 2 Ra tion a le: Colorless drain age on th e dressin g in a ch ild after cran ioto m y in d icates th e presen ce of cereb ro spin al flu id an d sh o u ld b e repo rted to th e HCP im m ediately. O ptio n s 1, 3, an d 4 are n ot th e im m ed iate n ursin g in terven tion b ecau se th ey d o n ot ad dress th e n eed fo r im m ed iate in terven tion to p reven t com plicatio n s.

Test-Ta kin g Str a tegy: No te th e strategic wo rd , immediately. Elim in ate op tion s 3 an d 4 b ecause th ey are co m p arab le o r alike an d d elay n ecessary in terven tio n . Also, n ote th e wo rd s colorless drainage. Th is sh o u ld alert yo u q uickly to th e po ssib il- ity of th e presen ce of cereb ro sp in al flu id an d d irect yo u to th e correct op tio n . Review: Assessm en t of cereb ro sp in al flu id Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity

P

e

d

i

a

t

r

i

c

s

426 UNIT VII Pediatric Nursing

In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Pediatrics—O n co lo gical Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ho cken berry, Wilson (2015), p . 1409.

363. 2 Ra t ion a le: In th e even t of sh o ck, th e HCP is n o tified im m ed i- ately befo re th e n u rse ch an ges th e ch ild’s p o sition or in creases in traven ou s fluid s. After cran io tom y, a ch ild is n ever placed in th e su p in e o r Tren d elen bu rg po sitio n because it in creases in tra- cran ial pressu re (ICP) an d th e risk of b leed in g. Th e h ead of th e bed sh o uld be elevated . In creasin g in traven o us fluid s can cau se an in crease in ICP. Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, care for th e ch ild fo llo win g cran io tom y, an d n o te th e strategic wo rd s, most appropriate. Elim in ate o p tion s 1 an d 3 because th ese po sitio n s co uld in crease ICP. Elim in ate op tio n 4 becau se in creasin g th e flo w rate co uld also in crease ICP. In add itio n , th e n u rse sh ou ld n o t in crease in traven o u s fluid s with o ut an HCP’s prescrip tion . Review: Care followin g surgical rem oval of a b rain tu m o r or cran io to m y Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con ten t Ar ea : Critical Care: Em ergen cy Situation s/ Man agem en t Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ho cken berry, Wilson (2015), p p. 960, 962.

364. 1 Ra t ion a le: Wilm s’ tum o r is th e m ost com m on in traab d om in al an d kid n ey tu m o r of ch ild h o od . If Wilm s’ tu m or is susp ected, th e tu m o r m ass sh ou ld n ot be p alp ated b y th e n u rse. Excessive m an ipu latio n can cause seed in g of th e tum o r an d sp read o f th e can cerou s cells. Hem aturia, fever, an d h yp erten sio n are clin ical m an ifestation s asso ciated with Wilm s’ tu m o r. Test -Ta ki n g Str a t egy: Fo cu s o n th e su b ject, th e actio n to avo id . Kn o wled ge th at th is tu m o r is an in traab d o m in al an d kid n ey tu m o r will assist in elim in atin g o p tio n s 2 an d 4 b ecau se o f th e relatio n sh ip o f th ese o p tio n s to ren al fu n c- tio n . Next, th in kin g ab o u t th e effect o f p alp atin g th e tu m o r will d irect yo u to th e co rrect o p tio n fro m th e rem ain in g o p tio n s. Review: Wilm s’ tu m o r Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Pediatrics—O n co lo gical Pr ior ity Con cepts: Cellu lar Regu latio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p . 1416.

365. 2 Ra t ion a le: O steosarco m a is th e m ost co m m o n b o n e can cer in ch ildren . Can cer u sually is fo un d in th e m etaph ysis of lo n g bo n es, especially in th e lower extrem ities, with m o st tum o rs occu rrin g in th e fem u r. O steo sarco m a is m an ifested clin ically by p ro gressive, in sidiou s, an d in term itten t p ain at th e tum o r site. By th e tim e th ese ch ildren receive m edical atten tio n , th ey

m ay be in con siderable pain from th e tum o r. O p tio n s 1, 3, an d 4 are accurate regardin g osteosarcom a. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for infor- mation. Th ese words in d icate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in co rrect statem en t. Kn owl- edge th at osteosarco m a is a m align an t tum o r of th e b on e will d irect you to th e co rrect op tio n . Review: O steo gen ic sarco m a Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—O n co lo gical Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Ho cken berry, Wilson (2015), p p. 1413-1414.

366. 1 Ra t ion a le: Leu kem ia is a m align an t in crease in th e n u m ber o f leukocytes, u sually at an im m atu re stage, in th e bo n e m arro w. It affects th e bo n e m arro w, cau sin g an em ia fro m decreased eryth rocytes, in fection fro m n eu tro pen ia, an d b leed in g fro m d ecreased platelet p ro du ction (th rom bo cyto p en ia). If a ch ild is severely th rom bo cyto p en ic an d h as a platelet cou n t less th an 20,000 m m 3 (20.0 Â 109/ L), b leed in g p recaution s n eed to b e in itiated b ecau se of th e in creased risk o f b leed in g o r h em or- rh age. Precau tion s in clu de lim itin g activity th at co uld resu lt in h ead in jury, usin g soft too th b ru sh es, ch eckin g u rin e an d sto o ls fo r b lo od , an d adm in isterin g stoo l so ften ers to preven t strain in g with co n stipatio n . In add itio n , su pp ositories, en em as, an d rectal tem peratu res are avo ided. O ption s 2, 3, an d 4 are related to th e p reven tion o f in fection rath er th an b leed in g. Test -Ta kin g Str a tegy: Note th at th e p latelet cou n t is low an d recall th at a low p latelet co un t places th e ch ild at risk for b leed - in g. In ad dition , n ote th at o ptio n s 2, 3, an d 4 are co m p arab le o r alike because th ey relate to preven tio n of an d m on itorin g fo r in fectio n . Review: In terven tio n s fo r ch ild at risk fo r b leed in g an d leu kem ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Pediatrics—O n co lo gical Pr ior ity Con cepts: Cellu lar Regu latio n ; Clo ttin g Refer en ce: Ho cken berry, Wilson (2015), p p. 1326, 1398.

367. 1 Ra t ion a le: Th e brain , alth ou gh well protected by th e so lid b o n y cran iu m , is h igh ly suscep tible to p ressu re th at m ay accu- m u late with in th e en clo sure. Vo lum e an d p ressure m ust rem ain co n stan t with in th e b rain . Ach an ge in th e size of th e brain , su ch as occu rs with ed em a or in creased vo lum e of in tracran ial b lo od o r cereb ro sp in al flu id with ou t a co m pen satory ch an ge, leads to an in crease in ICP, wh ich m ay be life-th reaten in g. Vo m itin g, an early sign o f in creased ICP, can b ecom e excessive as pressu re b u ild s u p an d stim u lates th e m ed ulla in th e b rain stem , wh ich h ou ses th e vo m itin g cen ter. Ch ild ren with o pen fo n tan els (p os- terio r fon tan el closes at 2 to 3 m on th s; an terio r fo n tan el clo ses at 12 to 18 m on th s) co m pen sate fo r ICP ch an ges b y sku ll

P

e

d

i

a

t

r

i

c

s

427CHAPTER 35 Oncological Disorders

exp an sio n an d su bsequ en t bu lgin g fo n tan els. Wh en th e fon ta- n els h ave clo sed , n au sea, excessive vo m itin g, d ip lop ia, an d h ead ach es b ecom e pron ou n ced , with h ead ach es beco m in g m ore p revalen t in o ld er ch ild ren . Test-Ta kin g St r a tegy: No te th e strategic wo rd , early; fo cu s on th e age o f th e ch ild, an d u se age as th e key to prin cip les of gro wth an d d evelo pm en t. Kn owin g wh en th e fon tan els clo se an d focu sin g on th e ch ild’s age as 3 years elim in ates op tion s 2 an d 3. Th e su b jective sym p to m o f h ead ach e in o ption 4 is u n reliable in a 3 year o ld, so elim in ate th is o ption . Review: In creased in tracran ial p ressu re Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—O n co logical Pr ior it y Con cept s: Develo p m en t; In tracran ial Regu lation Refer en ce: Hocken b erry, Wilso n (2015), p. 1410.

368. 2 Ra tion a le: Leukem ia is a m align an t in crease in th e n um ber o f leukocytes, usu ally at an im m ature stage, in the b on e m arrow. Th e con firm atory test for leu kem ia is m icroscop ic exam in atio n o f b on e m arrow o btain ed by bon e m arrow asp irate an d b io psy, which is con sidered positive if blast cells are present. An altered p latelet cou n t occurs as a resu lt of the disease, but also m ay o ccur as a result of ch em oth erap y and d oes n ot con firm th e d iagn osis. Th e wh ite blo od cell cou nt m ay be n orm al, h igh , o r low in leu - kem ia. A lum b ar p un cture m ay be d on e to loo k for b last cells in th e spin al flu id th at in dicate cen tral n ervous system disease. Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, bo n e m arro w b iop sy an d leukem ia, an d n ote th e word confirms in th e qu es- tio n . Th is wo rd an d kn owled ge th at th e bo n e m arro w is affected in leu kem ia will direct yo u to th e correct o ptio n . Review: Con firm atory diagn ostic tests for leu kem ia Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—O n co logical Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ce: Hocken b erry, Wilso n (2015), pp . 1400-1401.

369. 3 Ra tion a le: Leu kem ia is a m align an t in crease in th e n u m b er of leu ko cytes, usu ally at an im m ature stage, in th e b o n e m arrow. It affects th e bo n e m arrow, causin g an em ia from d ecreased eryth ro cytes, in fectio n fro m n eutrop en ia, an d bleedin g from d ecreased platelet prod uctio n (th ro m bo cyto pen ia). Fo r a h o s- p italized n eu tro p en ic ch ild , flowers o r p lan ts sh o uld n o t b e kep t in th e roo m becau se stan d in g water an d d am p soil h arb o r Asper- gillus an d Pseudomonas aeruginosa, to wh ich th e ch ild is suscep - tib le. In ad dition , fresh fru its an d vegetables h arbo r m o ld s an d sh o u ld be avoid ed un til th e wh ite blo od cell co u n t in creases. Test-Ta kin g Str a tegy: No te th at o ptio n s 1 an d 2 are co m p ara- b le o r alike an d sh ou ld be elim in ated first; th ese o ptio n s in d i- cate th at it is acceptab le to p lace th e flo wers in th e ch ild’s ro om . Fro m th e rem ain in g o ption s, select th e co rrect op tio n o ver o ptio n 4 b ecause th is resp on se m ain tain s th e p rotective iso la- tio n proced ures requ ired.

Review: Pro tective iso latio n p ro ced u res an d n eu tro p en ia Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—O n colo gical Pr ior it y Con cept s: In fection ; Safety Refer en ce: McKin n ey et al. (2013). p. 1276.

370. 4 Ra tion a le: Ho dgkin ’s d isease ( a type of lym ph om a) is a m align an cy of th e lym ph n od es. Th e p resen ce o f gian t, m ulti- n u cleated cells ( Reed -Stern b erg cells) is th e classic ch aracteris- tic o f th is d isease. Elevated levels of van illylm an delic acid in th e u rin e m ay b e fou n d in ch ild ren with n eu ro blasto m a. Th e presen ce o f blast cells in th e b on e m arro w in dicates leu - kem ia. Epstein -Barr viru s is associated with in fectio u s m on on ucleo sis. Test-Ta kin g Str a tegy: Focus o n th e su b ject, con firm atory diag- n o stic tests fo r Hod gkin ’s disease. Th in k abo ut th e p ath op h ys- io logy associated with Ho dgkin ’s disease. Rem em ber th at th e Reed -Stern b erg cell is ch aracteristic of Hod gkin ’s disease. Review: Ho d gkin ’s d isease Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—O n colo gical Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: McKin n ey et al. (2013), pp . 1285-1286.

371. 2, 3, 4 Ra tion a le: Leukem ia is a m align an t in crease in th e n u m b er of leu ko cytes, usu ally at an im m ature stage, in th e b on e m arrow. It affects th e b o n e m arrow, causin g an em ia from d ecreased eryth ro cytes, in fectio n from n eutrop en ia, an d bleedin g from d ecreased platelet prod u ctio n (th rom bo cyto p en ia). A co m - m on co m plicatio n o f treatm en t for leukem ia is o verwh elm in g in fectio n seco n d ary to n eutrop en ia. Measures to preven t in fec- tio n in clud e th e u se of a private ro o m , strict asep tic tech n iqu e, restriction of visitors an d h ealth care perso n n el with active in fectio n , strict h an d wash in g, en su rin g th at an yo n e en terin g th e ch ild ’s roo m wears a m ask, an d redu cin g exp osu re to en vi- ron m en tal organ ism s by elim in atin g raw fru its an d vegetables fro m th e diet an d fresh flowers fro m th e ch ild ’s ro o m an d b y n o t leavin g stan din g water in th e ch ild’s roo m . App lyin g firm p ressu re to a n eedle-stick area for at least 10 m in utes is a m ea- su re to preven t bleedin g. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, p reven tin g in fec- tio n . Readin g each in terven tion carefu lly an d keepin g th is su b - ject in m in d will assist in an swerin g th e q uestio n . A sem ip rivate room places th e ch ild at risk fo r in fectio n . Applyin g firm pres- su re to a n eed le-stick area is related to p reven tin g bleedin g. Review: Leu kem ia an d risk fo r in fectio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—O n colo gical Pr ior it y Con cept s: In fection ; Safety Refer en ce: Hocken berry, Wilson (2015) , pp . 1392-1393, 1401.

P

e

d

i

a

t

r

i

c

s

428 UNIT VII Pediatric Nursing

372. 1, 5 Ra t ion a le: Ho dgkin ’s d isease ( a typ e o f lym p h o m a) is a m alig- n an cy o f th e lym ph n o d es. Sp ecific clin ical m an ifestation s associated with Ho dgkin ’s disease in clu de p ain less, firm , an d m o vable ad en o path y in th e cervical an d su p raclavicu lar areas an d abd o m in al pain as a result of en larged retrop eriton eal n od es. Hepato splen o m egaly also is n oted . Alth ou gh fever, m alaise, an orexia, an d weigh t lo ss are asso ciated with Ho dg- kin ’s disease, th ese m an ifestatio n s are seen in m an y disorders. Test -Ta kin g St r a t egy: Note th e wo rds specifically characteristic in th e qu estio n . Elim in ate o p tion s 2 an d 3 first b ecau se th ese

sym p tom s are co m p arab le o r alike in th at th ey are gen eral an d vagu e. Recallin g th at p ain less aden op ath y is asso ciated with Ho dgkin ’s d isease an d ab do m in al p ain will direct you to th e co rrect o ption s. Review: Ho d gkin ’s d isease Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—O n co lo gical Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Ho cken berry, Wilson (2015), p . 1403.

P

e

d

i

a

t

r

i

c

s

429CHAPTER 35 Oncological Disorders

P

e

d

i

a

t

r

i

c

s

C H A P T E R 36 Metabolic and Endocrine Disorders

PRIORITY CONCEPTS Glucose Regulation; Thermoregulation

CRITICAL THINKING What Should You Do? A child is diagnosed with phenylketonuria. What interven- tions should the nurse include in the plan of care? Answer located on p. 435.

I. Fever A. Description

1. Fever is an abn o rm al body tem p erature elevation .

2. A ch ild’s tem p erature can vary dep en din g on activity, em o tion al stress, disease processes, m ed- ication s, type of cloth in g th e ch ild is wearin g, an d tem perature of th e en viron m en t.

3. Assessm en t fin din gs associated with th e fever provide im portan t in dication s of th e seriousn ess of th e fever.

B. Assessm en t 1. Tem perature elevation : No rm al tem p erature

ran ge for a ch ild is 36.4 °C to 37.0 °C (97.5 °F to 98.6 °F); 38.0 °C (100.4 °F) is con sidered to be fever.

2. Flu sh ed skin , warm to touch 3. Diaph oresis 4. Ch ills 5. Restlessn ess or leth argy

C. In terven tion s 1. Mon itor vital sign s; take th e tem perature via th e

electron ic ro ute or per agen cy proced ures. 2. Rem o ve excess cloth in g an d blan kets, reduce th e

ro om tem perature, an d in crease th e air circula- tio n ; use oth er coolin g m easures such as th e ap plication of a cool com press to th e foreh ead if ap propriate.

3. Adm in ister a spon ge bath with tepid water for 20 to 30 m in u tes an d gen tly squeeze water fro m a facecloth over th e back an d ch est. Rech eck th e tem p erature 30 m in utes after th e bath . Do n ot

use alcoh ol because it can cause periph eral vaso con striction .

4. Adm in ister an tipyretics such as ibuprofen as prescribed.

5. Aspirin sh ould n ot be adm in istered, un less spe- cifically prescribed, because of th e risk of Reye’s syn d rom e.

6. Retake th e tem perature 30 to 60 m in utes after th e an tipyretic is adm in istered.

7. Provide ad equate fluid in take as tolerated an d as prescribed.

8. Mon itor for sign s an d sym pto m s th at in dicate deh ydration an d electrolyte im balan ces; m on itor labo ratory values.

9. In struct th e paren ts in h ow to take th e tem perature, h ow to m edicate th e ch ild safely, an d wh en it is n ecessary to call th e h ealth care provider (HCP).

II. Dehydration A. Description

1. Deh ydration is a com m on fluid an d electrolyte im balan ce in in fan ts an d ch ildren .

2. In in fan ts an d ch ildren , th e organ s th at con serve water are im m ature, placin g th em at risk for fluid volu m e deficit.

3. Causes can in clude decreased fluid in take, dia- ph oresis, vom itin g, diarrh ea, diabetic ketoacido- sis, an d exten sive burn s or oth er serious in juries.

Infants and children are more vulnerable to fluid vol- ume deficit because more of their body water is in the extracellular fluid compartment.

B. Assessm en t ( Table 36-1) C. In terven tion s

1. Treat an d elim in ate th e cause of th e deh ydration . 2. Mon itor vital sign s. 3. Mon itor weigh t an d m on itor for ch an ges, in clud-

in g fluid gain s an d losses. 4. Mon itor in take an d output an d urin e for specific

gravity. 5. Mon itor level of con sciousn ess.

430

6. Mon itor skin turgo r an d m ucou s m em bran es for dryn ess.

7. For m ild to m od erate deh ydration , provid e oral reh ydration th erap y with Ped ialyte® or a sim ilar reh ydration solution as prescribed ; avoid car- bon ated beverages, because th ey are gas- producin g, an d fluids th at con tain h igh am oun ts of sugar, such as apple juice.

8. For severe deh ydration , m ain tain NPO (n oth in g by m ou th ) status to place th e bowel at rest an d provide fluid an d electrolyte replacem en t by th e in traven ous (IV) ro ute as prescribed; if potas- sium is prescribed for IV ad m in istration , en sure th at th e ch ild h as vo ided before adm in isterin g an d h as ad equate ren al fun ction .

9. Rein troduce a n orm al diet wh en reh ydration is ach ieved.

10. Provide in struction s to th e paren ts ab out th e typ es an d am oun ts of fluid to en courage, sign s of deh ydration , an d in dication s of th e n eed to n otify th e HCP.

III. Phenylketonuria A. Description

1. Ph en ylketon uria is a gen etic disorder (auto som al recessive disorder) th at results in cen tral n ervou s system dam age fro m toxic levels of ph en ylala- n in e (an essen tial am in o acid) in th e blood .

2. It is ch aracterized by blood ph en ylalan in e levels greater th an 20 m g/ dL (12.1 m cm ol/ L) ; n orm al level is 0 to 2 m g/ dL (0 to 121 m cm o l/ L).

3. All 50 states require routin e screen in g of all n ewborn s for ph en ylketon uria.

B. Assessm en t 1. In all ch ildren

a . Digestive problem s an d vom itin g b . Seizures c. Musty odor of th e urin e d . Men tal retardation

2. In older ch ildren a . Eczem a b . Hyperton ia c. Hypopigm en tation of th e h air, skin , an d

irises d . Hyperactive beh avior

C. In terven tion s 1. Screen in g of n ewborn in fan ts for ph en ylke-

ton uria: Th e in fan t sh ould h ave begun for- m ula or breast m ilk feeding before specim en collection .

2. If in itial screen in g is positive, a repeat test is per- form ed, an d furth er diagn ostic evaluatio n is required to verify th e diagn osis.

3. Rescreen n ewborn s by 14 days of age if th e in itial screen in g was don e befo re 48 h ours of age.

4. If ph en ylketon uria is diagn osed, prepare to im plem en t th e followin g:

P

e

d

i

a

t

r

i

c

s

TABLE 36-1 Evaluating the Extent of Dehydration Level of Dehydration

Clinical Signs Mild Moderate Severe

Weight loss—infants 3%-5% 6%-9% 10%

Weight loss—children 3%-4% 6%-8% 10%

Pulse Normal Slightly increased Very increased

Respiratory rate Normal Slight tachypnea (rapid) Hyperpnea (deep and rapid)

Blood pressure Normal Normal to orthostatic (> 10 mm Hg change) Orthostatic to shock

Behavior Normal Irritable, more thirsty Hyperirritable to lethargic

Thirst Slight Moderate Intense

Mucous membranes* Normal Dry Parched

Tears Present Decreased Absent; sunken eyes

Anterior fontanel Normal Normal to sunken Sunken

External jugular vein Visible when supine Not visible except with supraclavicular pressure Not visible even with supraclavicular pressure

Skin* Capillary refill > 2 sec Slowed capillary refill (2-4 sec [decreased turgor]) Very delayed capillary refill (> 4 sec) and tenting; skin cool, acrocyanotic or mottled

Urine specific gravity > 1.0 20 > 1.020; oliguria Oliguria or anuria

*These signs are less prominent in the child who has hypernatremia. Data from Jospe N, Forbes G: Fluids and electrolytes—clinical aspects, Pediatr Rev 17:395–403, 1996; and Steiner MJ, DeWalt DA, Byerley JS: Is this child dehydrated? JAMA 291:2746–2754, 20 0 4. Table from Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 10 , Mosby.

431CHAPTER 36 Metabolic and Endocrine Disorders

P

e

d

i

a

t

r

i

c

s

a. Restrict ph en ylalan in e in take; h igh -protein food s (m eats an d dairy products) an d aspar- tam e are avoided because th ey con tain large am oun ts of ph en ylalan in e.

b . Mon itor ph ysical, n eurological, an d in tellec- tual developm en t.

c. Stress th e im portan ce of follow-up treatm en t. d . En cou rage th e paren ts to exp ress th eir feelin gs

about th e diagn osis an d discuss th e risk of ph en ylketon uria in future ch ildren .

e. Educate th e paren ts ab out th e use of special preparation form ulas an d about th e foods th at con tain ph en ylalan in e.

f. Con sult with social care services to assist th e paren ts with th e fin an cial burden s of pur- ch asin g special prepared form ulas.

IV. Diabetes Mellitus A. Descriptio n ( Fig. 36-1)

1. Type 1 diabetes m ellitus is ch aracterized by th e destruction of th e pan creatic beta cells, wh ich produce in sulin ; th is results in ab solute in sulin deficien cy.

2. Type 2 diabetes m ellitus usually arises because of in sulin resistan ce, in wh ich th e body fails to use in sulin properly, com bin ed with relative (rath er th an absolute) in sulin deficien cy.

3. In sulin deficien cy requires th e use of exogen ous in sulin to prom o te ap propriate glucose use an d to preven t com plication s related to elevated

blood glucose levels, such as h yperglycem ia, dia- betic ketoacidosis, an d death .

4. Diagn osis is based on th e presen ce of classic sym ptom s an d an elevated blood gluco se level (n orm al blood gluco se level is 70 to 110 m g/ dL [4 to 6 m m o l/ L]); based on HCP preferen ce, n or- m al level m ay be a lower ran ge).

5. Ch ildren m ay n eed to be ad m itted directly to th e ped iatric in ten sive care un it because of th e m an - ifestation s of diabetic ketoacidosis, wh ich m ay be th e in itial occurren ce leadin g to diagn osis of diab etes m ellitus.

B. Assessm en t 1. Polyuria, polydipsia, polyph agia 2. Hyperglycem ia 3. Weigh t lo ss 4. Un explain ed fatigue or leth argy 5. Headach es 6. O ccasion al en uresis in a previously toilet-

train ed ch ild 7. Vagin itis in adolescen t girls (caused by Candida,

wh ich th rives in h yperglycem ic tissues) 8. Fru ity odor to breath 9. Deh ydration 10. Blurred vision 11. Slo w woun d h ealin g 12. Ch an ges in level of con sciousn ess

C. Lon g-term effects 1. Failure to grow at a n orm al rate 2. Delayed m aturation 3. Recurren t in fectio n s 4. Neuropath y 5. Cardiovascu lar disease 6. Retin al m icrovascular disease 7. Ren al m icrovascu lar disease

D. Com p lication s 1. Hypo glycem ia 2. Hyperglycem ia 3. Diabetic ketoacid osis 4. Com a 5. Hypo kalem ia 6. Hyperkalem ia 7. Microvascu lar ch an ges 8. Cardiovascu lar ch an ges

For a child with diabetes mellitus, plan to initiate a consultation with the diabetic specialist to plan the child’s care.

E. Diet 1. No rm al h ealth y n utrition is en couraged, an d th e

total n um ber of calories is in dividualized based on th e ch ild’s age an d growth expectation s.

2. As prescribed by th e HCP, ch ildren with diabetes n eed n o special food s or supplem en ts. Th ey n eed sufficien t calories to balan ce daily exp en di- ture for en ergy an d to satisfy th e requirem en t for growth an d developm en t.

Impa ire d me ta bolis m of fa ts , prote ins , ca rbohydra te s

Ins ulin de fic ie nc y

Hype rg lyc e mia Fa tigue Hunge r

We ight los s

Ke tone s , produce d in re s pons e to ce llula r s ta rva tion, ca nnot nouris h ce ll be ca us e of a bs e nce of ins ulin.

Ke to ac ido s is

Polyuria , ce llula r s ta rva tion

FIGURE 36-1 Insulin deficiency leading to ketoacidosis.

432 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

3. Dietary in take sh o uld in clude 3 well-balan ced m eals per day, eaten at regular in tervals, plus a m id-aftern oon sn ack an d a bedtim e sn ack; a con sisten t in take of th e prescribed protein , fats, an d carbo h ydrates at each m eal an d sn ack is n eeded (con cen trated sweets are discouraged; fat is reduced to 30% or less of th e total caloric requirem en t).

4. In struct ch ildren an d paren ts to carry a source of glucose, such as gluco se tablets, with th em at all tim es to treat h ypo glycem ia if it occurs.

5. In corporate th e diet in to th e in dividual ch ild’s n eeds, likes an d dislikes, lifestyle, an d cultural an d socioecon o m ic pattern s.

6. Allow th e ch ild to participate in m akin g food ch oices to provid e a sen se of con trol.

F. Exercise 1. In struct th e ch ild in dietary adjustm en ts wh en

exercisin g. 2. Extra food n eeds to be con sum ed for in creased

activity, usually 10 to 15 g of carboh ydrates for every 30 to 45 m in u tes of activity.

3. In struct th e ch ild to m on itor th e blood gluco se level before exercisin g.

4. Plan an appropriate exercise regim en with th e ch ild, takin g th e developm en tal stage in to accoun t.

G. In sulin 1. Diluted in sulin m ay be required for som e in fan ts

to provide sm all en ough doses to avoid h ypogly- cem ia; diluted in sulin sh ould be labeled clearly to avoid dosage errors.

2. Laboratory evalu ation of glycosylated h em oglo- bin (HgbA1c) sh ould be perform ed every 3 m on th s. Referen ce in terval for HgbA1c is less th an 6%.

3. Illn ess, in fectio n , an d stress in crease th e n eed for in sulin , an d in sulin sh ould n ot be with h eld dur- in g illn ess, in fection , or stress because h ypergly- cem ia an d ketoacid osis can result.

4. Wh en th e ch ild is n ot receivin g an yth in g by m outh for a special procedure, verify with th e HCP the n eed to withh old th e m orn in g in sulin , an d when food, fluids, an d in sulin are to be resum ed.

5. In struct th e ch ild an d paren ts in th e ad m in istra- tion of in sulin .

6. In struct th e ch ild an d paren ts to recogn ize sym p- tom s of h ypoglycem ia an d h yperglycem ia.

7. In struct th e paren ts in th e ad m in istration of glu- cagon in tram uscularly or subcutan eously if th e ch ild h as a h ypoglycem ic reaction an d is un able to con sum e an yth in g orally (if sem ico n sciou s or un con scious).

8. In struct th e ch ild an d paren ts always to h ave a spare bottle of in sulin available.

9. Advise th e paren ts to obtain a MedicAlert brace- let in dicatin g th e typ e an d daily in sulin dosage prescribed for th e ch ild.

10. See Ch apter 51 for in form ation on in sulin types, adm in istration sites, an d ad m in istration procedure.

H. Bloo d glucose m on itorin g 1. Results provide in form ation n eeded to m ain tain

good glycem ic co n trol. 2. Blood gluco se m on itorin g is m ore accurate th an

urin e testin g. 3. Mon itorin g requires th at th e ch ild prick h im self

or h erself several tim es a day as prescribed (Box 36-1).

4. In stru ct th e ch ild an d p aren ts ab o u t th e p ro p er p ro ced u re fo r o b tain in g th e b lo o d glu co se level.

5. In fo rm th e ch ild an d p aren ts th at th e p ro ced u re m u st b e d o n e p recisely to o b tain accu rate resu lts.

6. Stress th e im portan ce of h an d wash in g before an d after perform in g th e proced ure to preven t in fectio n .

7. Stress th e im portan ce of followin g th e m an u fac- turer’s in struction s for th e blood gluco se m on i- torin g device.

8. In struct th e ch ild an d paren ts to calibrate th e m on itor as in structed by th e m an ufacturer.

9. In struct th e ch ild an d paren ts to ch eck th e expi- ration date on th e test strip s used for blood glu- cose m on itorin g.

10. In struct th e ch ild an d paren ts th at if th e blood glucose results do n ot seem reason able, th ey sh ould reread th e in struction s, reassess tech - n ique, ch eck th e expiration date of th e test strip s, an d perform th e procedure again to verify results.

I. Urin e testin g 1. In struct th e paren ts an d ch ild in th e procedure

for testin g urin e for keton es an d gluco se. 2. Teach th e ch ild th at th e secon d voided urin e

specim en is m ost accurate. 3. Th e presen ce of keton es m ay in dicate im pen din g

ketoacid osis.

BOX 36-1 Lessening the Pain of Blood Glucose Monitoring

Hold the finger under warm water for a few seconds before puncture (enhances blood flow to the finger).

Use the ring finger or thumb to obtain a blood sample because blood flows more easily to these areas; puncture the finger just to the side of the finger pad because there are more blood vessels in this area and fewer nerve endings.

Press the lancet device lightly against the skin to prevent a deep puncture.

Use glucose monitors that require very small blood samples for measurement.

Adapted from Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nursing care, ed 3, St. Louis, 2010 , Mosby.

433CHAPTER 36 Metabolic and Endocrine Disorders

P

e

d

i

a

t

r

i

c

s

Urine glucose testing is an unreliable method of mon- itoring the glucose level; however, the urine should be tested for ketones when the child is ill or when the blood glucose level is consistently greater than 200 mg/ dL (greater than 11.4 mmol/ L) or as specified by the HCP.

J. Hypo glycem ia 1. Descrip tion

a . Hypo glycem ia is a blood glucose level less th an 70 m g/ dL (4 m m o l/ L) (or as specified by th e HCP).

b . Hypo glycem ia results from too m uch in su- lin , n ot en ough food , or excessive activity.

2. Sign s in clude h eadach e, n ausea, sweatin g, trem ors, leth argy, h un ger, con fusion , slurred speech , tin glin g aroun d th e m ou th , an d an xiety.

3. In terven tion s (Boxes 36-2 an d 36-3; see also Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Hypoglycemia in a Hospitalized Child with Diabetes Mellitus

1. Check the child’s blood glucose level. 2. Give the child ½ cup of fruit juice or other acceptable item. 3. Take the child’s vital signs. 4. Retest the blood glucose level. 5. Give the child a small snack of carbohydrate and protein. 6. Document the child’s complaints, actions taken, and

outcome.

If a child with diabetes mellitus experiences hypoglycemia, the nurse first would check the child’s blood glucose level to verify that the child is experiencing hypoglycemia. When this is verified, the nurse gives the child 10 to 15 g of carbohy- drates. The nurse retests the blood glucose level in 15minutes. In the meantime, the nurse checks the child’s vital signs. If the child’s symptoms of hypoglycemia do not resolve, the nurse gives the child another 10- to 15-g carbohydrate food item. Otherwise, the nurse provides a small snack of carbohydrates and protein if the child’s next scheduled meal is more than 1 hour away from the time of the occurrence. After treatment and resolution of the hypoglycemic event, the nurse docu- ments the occurrence, actions taken, and outcome.

Reference Hockenberry, Wilson (2015), pp. 1529, 1537.

K. Hyperglycem ia 1. Descrip tion : Elevated blood glucose level

(> 200 m g/ dL [11.4 m m o l/ L], or as specified by th e HCP)

2. Signs include polydipsia, polyuria, polyphagia, blurred vision , weakn ess, weigh t loss, and syn cope.

3. In terven tion s (Box 36-4) 4. Sick day rules (Box 36-5)

L. Diabetic ketoacid osis 1. Descriptio n

a . Diabetic ketoacidosis is a com plication of diab etes m ellitus th at develops wh en a severe in sulin deficien cy occurs.

b . Diabetic ketoacidosis is a life-th reaten in g con d ition .

c. Hyperglycem ia th at progresses to m etab olic acido sis occurs.

d . Diabetic ketoacidosis develops over several h ours to days.

BOX 36-2 Interventions for Hypoglycemia If possible, confirm hypoglycemia with a blood glucose

reading. Administer glucose immediately; rapid-releasing glucose is

followed by a complex carbohydrate and protein, such as a slice of bread or a peanut butter cracker.

Give an extra snack if the next meal is not planned for more than 30 minutes or if activity is planned.

If the child becomes unconscious, squeeze cake frosting or glucose paste onto the gums and retest the blood glucose level in 15 minutes (monitor the child closely); if the read- ing remains low, administer additional glucose.

If the child remains unconscious, the administration of gluca- gon may be necessary.

In the hospital, prepare to administer dextrose intravenously if the child is unable to consume an oral glucose product.

BOX 36-3 Food Items to Treat Hypoglycemia ▪ ½ cup of orange juice or sugar-sweetened carbonated

beverage ▪ 8 oz of milk ▪ 1 small box of raisins ▪ 3 or 4 hard candies ▪ 4 sugar cubes (1 Tbsp of sugar) ▪ 3 or 4 Life Savers candies ▪ 1 candy bar ▪ 1 tsp honey ▪ 2 or 3 glucose tablets

BOX 36-4 Interventions for Hyperglycemia Instruct the parents to notify the health care provider when the following occur:

▪ Blood glucose results remain elevated (usually > 200 mg/ dL (> 11.4 mmol/ L)

▪ Moderate or high ketonuria is present ▪ Child is unable to take food or fluids ▪ Child vomits more than once ▪ Illness persists

434 UNIT VII Pediatric Nursing

e. Th e blood glucose level is greater th an 300 m g/ dL (greater th an 17.14 m m ol/ L), an d urin e an d serum keton e tests are positive.

Manifestations of diabetic ketoacidosis include signs of hyperglycemia, Kussmaul respirations, acetone (fruity) breath odor, increasing lethargy, and decreasing level of consciousness.

2. In terven tion s a . Resto re circulatin g blood vo lum e, an d pro-

tect again st cerebral, coron ary, or ren al h ypo perfusio n .

b . Correct deh ydration with IV in fusion s of 0.9% or 0.45% salin e as prescribed.

c. Correct h yperglycem ia with IV regular in sulin adm in istration as prescribed .

d . Mon itor vital sign s, urin e outp ut, an d m en tal status closely.

e. Correct acidosis an d electrolyte im balan ces as prescribed.

f. Adm in ister oxygen as prescribed. g. Mon itor blood gluco se level frequen tly. h . Mon itor potassium level clo sely because

wh en th e ch ild receives in sulin to reduce th e blood gluco se level, th e serum potassium level ch an ges; if th e potassium level decreases, potassium replacem en t m ay be required.

i. Th e ch ild sh ould be void in g adequ ately before adm in isterin g potassium ; if th e ch ild does n ot h ave an adequ ate outp ut, h yperkale- m ia m ay result.

j. Mon itor th e ch ild clo sely for sign s of fluid overload.

k . IV dextrose is added as prescribed wh en th e blood glucose reach es an appropriate level.

l. Treat th e cause of h yperglycem ia.

CRITICAL THINKING What Should You Do? Answer: Interventions for phenylketonuria include restricting phenylalanine intake. High-protein foods (meats and dairy products) and products that contain aspartame are avoided because they contain large amounts of phenylalanine. Mon- itoring physical, neurological, and intellectual development is important to detect any abnormalities. The nurse should stress the importance of follow-up treatment with the par- ents, encourage the parents to express their feelings about the diagnosis and discuss the risk of phenylketonuria in future children, educate the parents about the use of special preparation formulas and about the foods that contain phe- nylalanine, and consult with social care services to assist the parents with any financial burdens.

Reference: Hockenberry, Wilson (20 15), pp. 70 -72.

P R A C T I C E Q U E S T I O N S 373. A sch o ol-age ch ild with type 1 diabetes m ellitus h as

soccer practice an d th e sch ool n urse provid es in struction s regardin g h ow to preven t h ypoglyce- m ia durin g practice. Wh ich sh ould th e sch o ol n urse tell th e ch ild to do? 1. Eat twice th e am oun t n orm ally eaten at

lu n ch tim e. 2. Take h alf th e am oun t of prescribed in sulin on

practice days. 3. Take th e prescribed in sulin at n oon tim e rath er

th an in th e m orn in g. 4. Eat a sm all box of raisin s or drin k a cup of

oran ge juice befo re soccer practice.

374. Th e m oth er of a 6-year-o ld ch ild wh o h as type 1 diabetes m ellitus calls a clin ic n urse an d tells th e n urse th at th e ch ild h as been sick. Th e m oth er reports th at sh e ch ecked th e ch ild’s urin e an d it was positive for keton es. Th e n urse sh ould in struct th e m oth er to take wh ich action ? 1. Ho ld th e n ext dose of in sulin . 2. Com e to th e clin ic im m ediately. 3. En courage th e ch ild to drin k liquid s. 4. Adm in ister an addition al dose of regular

in sulin .

375. A h ealth care provider prescribes an in traven ous (IV) solution of 5% dextrose an d h alf-n orm al salin e (0.45%) with 40 m Eq of potassium ch loride for a ch ild with h ypoton ic deh ydration . Th e n urse perform s wh ich p rio rity assessm en t befo re adm in - isterin g th is IV prescription ? 1. O btain s a weigh t 2. Takes th e tem p erature 3. Takes th e blood pressure 4. Ch ecks th e am oun t of urin e outp ut

P

e

d

i

a

t

r

i

c

s

BOX 36-5 Sick Day Rules for a Diabetic Child Always give insulin, even if the child does not have an appetite,

or contact the health care provider (HCP) for specific instructions.

Test blood glucose levels at least every 4 hours. Test for urinary ketones with each voiding. Notify the HCP if moderate or large amounts of urinary

ketones are present. Follow the child’s usual meal plan. Encourage liquids to aid in clearing ketones. Encourage rest, especially if urinary ketones are present. Notify the HCP if vomiting, fruity odor to the breath, deep

rapid respirations, decreasing level of consciousness, or persistent hyperglycemia occurs.

Adapted from Hockenberry M, Wilson D: Nursing care of infants and children, ed 9, St. Louis, 20 11, Mosby.

435CHAPTER 36 Metabolic and Endocrine Disorders

376. An adolescen t clien t with type 1 diabetes m ellitus is ad m itted to th e em ergen cy departm en t for treatm en t of diab etic ketoacidosis. Wh ich assess- m en t fin din gs sh ould th e n urse expect to n ote? 1. Sweatin g an d trem o rs 2. Hun ger an d h yperten sion 3. Cold, clam m y skin an d irritab ility 4. Fruity breath odor an d decreasin g level of

con sciousn ess

377. A m oth er brin gs h er 3-week-old in fan t to a clin ic for a ph en ylketon uria rescreen in g blood test. Th e test in dicates a serum ph en ylalan in e level of 1 m g/ dL (60.5 m cm ol/ L). Th e n urse reviews th is result an d m akes wh ich in terpretation ? 1. It is positive. 2. It is n egative. 3. It is in con clusive. 4. It requires rescreen in g at age 6 weeks.

378. A ch ild with typ e 1 d iab etes m ellitu s is b ro u gh t to th e em ergen cy d ep artm en t b y th e m o th er, wh o states th at th e ch ild h as b een co m p lain in g o f ab d o m in al p ain an d h as b een leth argic. D iab etic keto acid o sis is d iagn o sed . An ticip atin g th e p lan o f care, th e n u rse p rep ares to ad m in ister wh ich typ e o f in traven o u s ( IV) in fu sio n ? 1. Potassium in fusion 2. NPH in sulin in fusio n 3. 5% dextrose in fusion 4. No rm al salin e in fusion

379. Th e n urse h as just adm in istered ibuprofen to a ch ild with a tem p erature of 102 °F (38.8 °C). Th e n urse sh o uld also take wh ich action ? 1. With h old oral flu ids for 8 h ou rs. 2. Spon ge th e ch ild with co ld water. 3. Plan to adm in ister salicylate in 4 h ours. 4. Rem ove excess cloth in g an d blankets from th e

child.

380. A ch ild h as fluid volum e deficit. Th e n urse per- form s an assessm en t an d determ in es th at th e ch ild is im provin g an d th e deficit is resolvin g if wh ich fin din g is n oted? 1. Th e ch ild h as n o tears. 2. Urin e specific gravity is 1.035. 3. Capillary refill is less th an 2 secon ds. 4. Urin e output is less th an 1 m L/ kg/ h our.

381. Th e n urse sh o uld im plem en t wh ich in terven tion s for a ch ild older th an 2 years with type 1 diabetes m ellitus wh o h as a blood gluco se level of 60 m g/ dL (3.4 m m ol/ L) ? Select all th at ap p ly.

1. Adm in ister regular in sulin . 2. En cou rage th e ch ild to am bulate. 3. Give th e ch ild a teaspoon of h on ey. 4. Provide electrolyte replacem en t th erap y

in traven o usly. 5. Wait 30 m in u tes an d con firm th e blood glu-

cose readin g. 6. Prepare to adm in ister glucagon subcutan e-

ously if un con sciousn ess occurs.

A N S W E R S 373. 4 Ra tion a le: Hypo glycem ia is a b lo od glu co se level less th an 70 m g/ dL (4 m m o l/ L) an d results from to o m u ch in sulin , n o t en o ugh fo od , or excessive activity. An extra sn ack o f 15 to 30 g of carb oh yd rates eaten befo re activities such as soccer p ractice wo u ld preven t h ypo glycem ia. A sm all bo x o f raisin s o r a cu p o f o ran ge juice p ro vides 15 to 30 g o f carb oh ydrates. Th e ch ild o r p aren ts sh o uld n o t be in structed to ad ju st th e am ou n t o r tim e o f in su lin ad m in istratio n . Meal am ou n ts sh o u ld n o t b e do ub led . Test-Ta kin g St r a t egy: Use gen eral m edicatio n gu id elin es to elim in ate op tio n s 2 an d 3 first, n otin g th at th ey are co m p ara- b le o r alike an d in d icate ch an gin g th e am o un t o f in su lin or tim e of adm in istratio n . Fro m th e rem ain in g o ptio n s, recallin g th e d efin ition of h yp oglycem ia an d its m an ifestation s an d asso ciated treatm en t will direct yo u to th e correct o ptio n . Review: Preven tio n o f h yp o glycem ia Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Metab olic/ En do crin e

Pr ior it y Con cept s: Glucose Regu latio n ; Health Pro m o tio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1537.

374. 3 Ra tion a le: Wh en th e ch ild is sick, th e m oth er sh ould test for u rin ary keton es with each void in g. If keto n es are p resen t, liq- u ids are essen tial to aid in clearin g th e keto n es. Th e ch ild sh o u ld be en cou raged to d rin k liq uids. Brin gin g th e ch ild to th e clin ic im m ed iately is u n n ecessary. In sulin do ses sh o u ld n o t be adjusted o r ch an ged . Test-Ta kin g Str a tegy: Use gen eral m edication guidelin es. Elim in ate op tion s 1 an d 4, n otin g th at th ey are co m p arab le o r alike. Recall th at in sulin do ses sh ou ld n o t b e ad ju sted or ch an ged . Fro m th e rem ain in g o p tion s, n o te th e wo rd s positive for ketones in th e qu estio n . Recallin g th at liqu id s are essen tial to aid in clearin g th e keto n es will d irect yo u to th e correct o ptio n . Review: Sick d ay ru les fo r th e d iab etic ch ild Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Metabo lic/ En do crin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Glu co se Regu latio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 1529, 1536.

P

e

d

i

a

t

r

i

c

s

436 UNIT VII Pediatric Nursing

375. 4 Ra t ion a le: In h ypo ton ic deh ydration , electrolyte loss exceeds water loss. Th e prio rity assessm en t b efo re adm in isterin g p otas- sium ch lorid e in traven o u sly wou ld b e to assess th e statu s o f th e urin e ou tpu t. Potassiu m ch loride sh o u ld n ever b e ad m in is- tered in th e p resen ce of oligu ria o r an u ria. If th e u rin e o utp ut is less th an 1 to 2 m L/ kg/ h ou r, po tassiu m ch lo ride sh o u ld n o t be ad m in istered . Alth ou gh op tio n s 1, 2, an d 3 are app ro priate assessm en ts for a ch ild with deh ydratio n , th ese assessm en ts are n ot related specifically to th e IV ad m in istration o f po tassium ch loride. Test -Ta kin g Str a tegy: No te th e strategic wo rd , priority. Focus on th e IV prescrip tio n . Recallin g th at th e kid n eys p lay a key role in th e excretion an d reabso rp tion o f p o tassium will direct yo u to th e co rrect op tio n . Review: Nu rsin g con sid eratio n s fo r th e adm in istratio n o f p o tassiu m ch lo rid e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Metabo lic/ En d ocrin e Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Ho cken berry, Wilson (2015), p p. 952-953.

376. 4 Ra t ion a le: Diab etic keto acid o sis is a co m p licatio n o f d iab e- tes m ellitu s th at d evelo p s wh en a severe in su lin d eficien cy o ccu rs. Hyp erglycem ia o ccu rs with d iab etic keto acid o sis. Sign s o f h yp erglycem ia in clu d e fru ity b reath o d o r an d a d ecreasin g level o f co n scio u sn ess. H u n ger can b e a sign o f h yp o glycem ia o r h yp erglycem ia, b u t h yp erten sio n is n o t a sign o f d iab etic keto acid o sis. H yp o ten sio n o ccu rs b ecau se o f a d ecrease in b lo o d vo lu m e related to th e d eh yd rated state th at o ccu rs d u rin g d iab etic keto acid o sis. Co ld clam m y skin , irritab ility, sweatin g, an d trem o rs all are sign s o f h yp o glycem ia. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, th e sign s o f dia- betic keto acid osis, an d recall th at in th is co n d itio n th e b lo od glucose level is elevated. Elim in ate op tion s 1, 2, an d 3 b ecau se th ese sign s d o n o t occur with h yperglycem ia. Recall th at fru ity breath od or an d a ch an ge in th e level o f co n scio usn ess can occu r du rin g diab etic keto acido sis. Review: Sign s an d sym p tom s of h yp erglycem ia, h yp o glyce- m ia, an d d iab etic keto acid o sis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Metabo lic/ En d ocrin e Pr ior ity Con cepts: Clin ical Jud gm en t; Glu co se Regulatio n Refer en ce: Ho cken berry, Wilson (2015), p . 1528.

377. 2 Ra t ion a le: Ph en ylketo n u ria is a gen etic (au toso m al recessive) diso rd er th at results in cen tral n ervou s system d am age fro m to xic levels o f p h en ylalan in e ( an essen tial am in o acid) in th e b loo d . It is ch aracterized b y b loo d p h en ylalan in e levels greater th an 20 m g/ dL (12.1 m cm ol/ L); n o rm al level is 0 to 2 m g/ d L (0 to 121 m cm o l/ L). A resu lt o f 1 m g/ dL is a n egative test result.

Test -Ta kin g St r a t egy: Elim in ate op tion s 3 an d 4 first b ecau se th ey are co m p arab le o r alike, in d icatin g n o d efin itive fin d in g. No te th at th e level iden tified in th e qu estio n is a lo w level; th is sh ou ld assist in directin g yo u to th e correct o ptio n . Review: Ph en ylketo n u ria Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Metab o lic/ En d ocrin e Pr ior ity Con cepts: Clin ical Jud gm en t; Health Prom otion Refer en ce: Ho cken berry, Wilson (2015), p . 71.

378. 4 Ra t ion a le: Diab etic ketoacido sis is a com p lication of d iabetes m ellitus th at d evelo ps wh en a severe in sulin d eficien cy o ccu rs. Hyp erglycem ia o ccu rs with d iabetic keto acid osis. Reh ydration is th e in itial step in resolvin g d iabetic keto acido sis. Norm al salin e is th e in itial IV reh yd ratio n flu id. NPH in sulin is n ever ad m in istered b y th e IV rou te. Dextrose so lution s are ad d ed to th e treatm en t wh en th e b lo od glu co se level decreases to an accep table level. In traven o usly adm in istered p o tassium m ay be requ ired, depen din g o n th e po tassiu m level, b u t wo uld n ot b e p art o f th e in itial treatm en t. Test -Ta kin g Str a tegy: Focus on th e su b ject, treatm en t fo r dia- b etic ketoacid osis. Elim in ate o ption 3, kn owin g th at d extro se would n ot be adm in istered in a h yperglycem ic state. Elim in ate o p tion 2 n ext, kn o win g th at NPH in su lin is n ot ad m in is- tered by th e IV rou te. Recallin g th at h ydration is th e in itial treatm en t in d iabetic ketoacid osis will d irect yo u to th e co rrect o p tion . Review: Diab etic keto acid o sis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Pediatrics—Metab o lic/ En d ocrin e Pr ior ity Con cepts: Clin ical Jud gm en t; Glu co se Regulatio n Refer en ce: Ho cken berry, Wilson (2015), p . 1530.

379. 4 Ra t ion a le: After adm in isterin g ibu profen , excess cloth in g an d b lan kets sh ou ld be rem o ved. Th e ch ild can b e spo n ged with tepid water bu t n o t cold water, becau se th e co ld water can cause sh iverin g, wh ich in creases m etabo lic requ irem en ts ab o ve th ose alread y cau sed by th e fever. Asp irin is n ot ad m in istered to a ch ild with fever because o f th e risk o f Reye’s syn drom e. Flu id s sh o u ld be en cou raged to p reven t deh ydration , so oral fluid s sh ou ld n o t b e with h eld . Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, in terven tio n s for an elevated tem p eratu re. Rem em b er th at co olin g m easu res su ch as rem ovin g excess cloth in g an d b lan kets sh ou ld be d o n e wh en a ch ild h as a fever. O ption s 1, 2, an d 3 are n ot in terven - tion s fo r a ch ild with a fever. Review: In terven tio n s for fever Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Pediatrics—Metab o lic/ En d ocrin e Pr ior ity Con cepts: Clin ical Jud gm en t; Th erm oregu lation Refer en ce: Ho cken berry, Wilson (2015), p . 899.

P

e

d

i

a

t

r

i

c

s

437CHAPTER 36 Metabolic and Endocrine Disorders

380. 3 Ra tion a le: In dicators th at flu id vo lu m e d eficit is reso lvin g would be capillary refill less th an 2 secon ds, specific gravity o f 1.003 to 1.030, urin e ou tpu t o f at least 1 m L/ kg/ h ou r, an d ad equ ate tear p ro d uction . A capillary refill tim e less th an 2 seco n d s is th e on ly in d icato r th at th e ch ild is im p ro vin g. Urin e ou tpu t of less th an 1 m L/ kg/ h o ur, a specific gravity of 1.035, an d n o tears wo uld in dicate th at th e deficit is n o t resolvin g. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, assessm en t fin d - in gs in dicatin g th at fluid vo lum e d eficit is reso lvin g. Recall th e p aram eters th at in dicate adeq uate h ydration statu s. Th e o n ly o ptio n th at in dicates an im provin g fluid b alan ce is op tio n 3. Th e oth er op tion s in d icate fluid im b alan ce. Review: Flu id vo lu m e d eficit an d flu id vo lu m e excess Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ped iatrics—Metab olic/ En do crin e Pr ior it y Con cept s: Evid en ce; Fluid an d Electro lyte Balan ce Refer en ce: Hocken b erry, Wilso n (2015), p. 958.

381. 3, 6 Ra tion a le: Hyp oglycem ia is d efin ed as a blo o d gluco se level less th an 70 m g/ dL (4 m m ol/ L). Hypo glycem ia o ccurs as a result of too m u ch in sulin , n ot en ou gh foo d, or excessive activ- ity. If p ossib le, th e n u rse sh ou ld co n firm h yp oglycem ia with a b lo od glu co se read in g. Glu cose is ad m in istered o rally

im m ediately; rapid -releasin g glu cose is followed by a co m plex carb oh yd rate an d p ro tein , su ch as a slice of b read or a p ean u t b utter cracker. An extra sn ack is given if th e n ext m eal is n o t p lan n ed for m ore th an 30 m in utes or if activity is p lan n ed. If th e ch ild b ecom es u n co n scio us, cake frostin g o r glu co se p aste is sq ueezed o n to th e gu m s, an d th e b lo od glucose level is retested in 15 m in u tes; if th e read in g rem ain s low, add itio n al glu co se is ad m in istered . If th e ch ild rem ain s un co n sciou s, adm in istratio n o f glu cago n m ay b e n ecessary, an d th e n urse sh o u ld b e p rep ared for th is in terven tio n . En co uragin g th e ch ild to am bu late an d adm in isterin g regular in su lin wou ld result in a lowered blood glucose level. Pro vidin g electrolyte replace- m en t th erapy in traven o u sly is an in terven tio n to treat d iab etic keto acido sis. Waitin g 30 m in utes to con firm th e bloo d glu co se level d elays n ecessary in terven tio n . Test-Ta kin g St r a t egy: Focus on th e su b ject, a lo w b lo od glu - cose level, an d on th e in form atio n in th e qu estio n . Th in k ab ou t th e path o ph ysio logy associated with h yp oglycem ia an d h ow it is treated. Recallin g th at a blo o d glu cose level o f 60 m g/ d L (3.4 m m o l/ L) in d icates h yp oglycem ia will assist in determ in - in g th e co rrect in terven tion s. Review: In terven tion s fo r h yp o glycem ia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Metabo lic/ En do crin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Glu co se Regu latio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 1528-1529.

P

e

d

i

a

t

r

i

c

s

438 UNIT VII Pediatric Nursing

C H A P T E R 37 Gastrointestinal Disorders

PRIORITY CONCEPTS Elimination; Nutrition

CRITICAL THINKING What Should You Do? A child suddenly vomits. What should the nurse do to pre- vent aspiration? Answer located on p. 453.

I. Vomiting A. Description

1. Th e m ajor concern s when a ch ild is vom itin g are the risk of deh ydration , th e loss of fluid an d electrolytes, an d th e developm ent of m etabolic alkalosis.

2. Addition al co n cern s in clude aspiration an d th e developm en t of atelectasis or pn eum on ia.

3. Cau ses of vom itin g in clude acute in fectio us dis- eases, in creased in tracran ial pressure, toxic in ges- tio n s, food in toleran ce, m ech an ical obstruction of th e gastro in testin al tract, m etab olic disorders, an d psych o gen ic disorders.

B. Assessm en t 1. Ch aracter of vom itus 2. Sign s of aspiration 3. Presen ce of pain an d abdom in al cram p in g 4. Sign s of deh ydration an d fluid an d electrolyte

im balan ces 5. Sign s of m etab olic alkalosis

C. In terven tion s 1. Main tain a paten t airway. 2. Position the ch ild on th e side to preven t aspiration. 3. Mon itor th e ch aracter, am oun t, an d frequen cy of

vo m itin g. 4. Assess th e force of th e vo m itin g; projectile vom it-

in g m ay in dicate pylo ric stenosis or in creased in tracran ial pressure.

5. Mon itor strict in take an d outp ut. 6. Mon itor for sign s an d sym ptom s of deh ydration ,

such as a sun ken fon tan el (age-app ropriate), n on elastic skin turgo r, dry m ucous m em bran es, decreased tear produ ction , an d oliguria.

7. Mon itor electrolyte levels. 8. Provide oral reh ydration th erapy as tolerated an d

as prescribed; begin feedin g slowly, with sm all am oun ts of fluid at frequen t in tervals.

9. Adm in ister an tiem etics as prescribed. 10. Assess for abdom in al pain or diarrh ea. 11. Advise th e paren ts to in form th e h ealth care pro-

vider (HCP) if sign s of deh ydratio n , blood in th e vom itus, forceful vom itin g, or ab dom in al pain are presen t.

II. Diarrhea A. Description

1. Acute diarrh ea is a cause of deh ydration , particu- larly in ch ildren youn ger th an 5 years.

2. Cau ses of acute diarrh ea in clude acu te in fectious disorders of th e gastroin testin al tract, an tibiotic th erapy, rotavirus, an d parasitic in festation .

3. Cau ses of ch ron ic diarrh ea in clude m alabsorp- tion syn drom es, in flam m ato ry bowel disease, im m un odeficien cies, food in toleran ces, an d n on sp ecific facto rs.

4. Rotavirus is a cause of serious gastroen teritis an d is a n osocom ial (hospital-acquired) path ogen th at is m ost severe in ch ildren 3 to 24 m on th s old; ch il- dren youn ger than 3 m on th s h ave som e protection because of m atern ally acquired antibodies.

B. Assessm en t 1. Ch aracter of stools 2. Presen ce of pain an d abdom in al cram p in g 3. Sign s of deh ydration an d fluid an d electrolyte

im balan ces 4. Sign s of m etab olic acido sis

C. In terven tion s 1. Mon itor ch aracter, am oun t, an d frequen cy of

diarrh ea. 2. Provide en teric isolatio n as required ; in struct th e

paren ts in effective h an d-wash in g tech n iqu e (ch ildren sh ould be taugh t th is tech n iqu e also ).

3. Mon itor skin in tegrity. 4. Mon itor strict in take an d outp ut.

P

e

d

i

a

t

r

i

c

s

439

P

e

d

i

a

t

r

i

c

s

5. Mon itor electrolyte levels. 6. Mon itor for sign s an d sym pto m s of deh ydra-

tio n . 7. For m ild to m od erate deh ydration , provide oral

reh ydration th erap y with Ped ialyte® or a sim ilar reh ydration solution as prescribed; avoid car- bon ated beverages, because th ey are gas- producin g, an d flu ids th at con tain h igh am oun ts of sugar, such as ap ple juice.

8. For severe deh ydration , m ain tain NPO (n oth in g by m ou th ) status to place th e bowel at rest an d provide fluid an d electrolyte replacem en t by th e in traven ous (IV) ro ute as prescribed; if potas- sium is prescribed for IV adm in istration , en sure th at th e ch ild h as vo ided before adm in isterin g an d h as adequ ate ren al fun ctio n .

9. Rein troduce a n orm al diet wh en reh ydration is ach ieved.

The major concerns when a child is having diarrhea are the risk of dehydration, the loss of fluid and electro- lytes, and the development of metabolic acidosis.

III. Cleft Lip and Cleft Palate A. Description

1. Cleft lip an d cleft palate are con gen ital an om alies that occur as a result of failure of soft tissue or bon y structure to fuse durin g em bryon ic developm en t.

2. Th e defects in volve abn o rm al open in gs in th e lip an d palate th at m ay occur un ilaterally or bilater- ally an d are readily apparen t at birth .

3. Causes in clude hereditary an d en viron m en tal fac- tors—exposure to radiation or ru bella virus, ch rom osom e ab n orm alities, an d teratogen ic facto rs.

4. Closure of a cleft lip defect precedes clo sure of th e cleft palate an d is usually perform ed by age 3 to 6 m on th s.

5. Cleft palate repair is usually perform ed between 6 an d 24 m on th s of age to allow for th e palatal ch an ges th at occur with n orm al growth; a cleft palate is closed as early as possible to facilitate speech develo pm en t.

6. A ch ild with cleft palate is at risk for developin g frequen t otitis m ed ia; th is can result in h earin g loss.

7. An in terp rofession al team approach , in cludin g audiologists, orth odon tists, plastic surgeon s, an d occupation al an d speech th erap ists, is taken to address th e m an y n eeds of th e ch ild.

B. Assessm en t ( Fig. 37-1) 1. Cleft lip can ran ge from a sligh t n otch to a com -

plete sep aration from th e flo or of th e n ose. 2. Cleft palate can in clude n asal distortion , m id-

lin e or bilateral cleft, an d variable exten sion from th e uvula an d soft an d h ard palate.

BA

C D FIGURE 37-1 Variations in clefts of lip and palate at birth. A, Notch in vermilion border. B, Unilateral cleft lip and palate. C, Bilateral cleft lip and palate. D, Cleft palate.

440 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C. In terven tion s 1. Assess th e ab ility to suck, swallow, h an dle n or-

m al secretio n s, an d breath e with out distress. 2. Assess flu id an d calorie in take daily. 3. Mon itor daily weigh t. 4. Mod ify feed in g tech n iqu es; plan to use special-

ized feedin g tech n iqu es, obtu rators, an d special n ipp les an d feeders.

5. Ho ld th e in fan t in an uprigh t position an d direct th e form ula to th e side an d back of th e m ou th to preven t aspiration .

6. Feed sm all am oun ts gradually an d burp frequen tly.

7. Keep suction equ ipm en t an d a bulb syrin ge at th e bed side.

8. Teach th e paren ts special feedin g or suction in g tech n iqu es.

9. Teach th e paren ts th e ESSR m eth od of feedin g— en large th e n ipple, stim ulate th e suckin g reflex, swallow, rest to allow th e in fan t to fin ish swal- lo win g wh at h as been placed in th e m ou th .

10. En cou rage paren ts to express th eir feelin gs ab out th e disorder.

11. En cou rage paren tal bon din g with th e in fan t, in cludin g h old in g th e in fan t an d callin g th e in fan t by n am e.

D. Posto perative in terven tion s 1. Cleft lip repair

a . Provide lip protection ; a m etal ap plian ce or adh esive strips m ay be taped securely to th e ch eeks to preven t traum a to th e suture lin e.

b . Avoid position in g th e in fan t on th e side of th e repair or in th e pron e position because th ese position s can cause rubbin g of th e sur- gical site on th e m attress (position on th e back uprigh t an d position to preven t airway obstru ction by secretio n s, blood , or th e ton gue).

c. Keep th e surgical site clean an d dry; after feed- in g, gen tly clean se th e suture lin e of form ula or serosan guin eous drain age with a solution such as n orm al salin e or as design ated by agen cy procedure.

d . Apply an tibiotic oin tm en t to th e site as prescribed.

e. Elb ow restrain ts sh o uld be used to preven t th e in fan t from in jurin g or traum atizin g th e surgical site.

f. Mon itor for sign s an d sym pto m s of in fectio n at th e surgical site.

2. Cleft palate repair a . Feedin gs are resum ed by bottle, breast, or cup

per surgeon preferen ce; som e surgeon s pre- scrib e th e use of an Asepto ® syrin ge for feed- in g or a soft cup such as a sippy cup.

b . O ral packin g m ay be secured to th e palate (usually rem oved in 2 to 3 days).

c. Do n ot allow th e ch ild to brush h is or h er teeth . d . In struct th e paren ts to avoid offerin g h ard food

item s to th e ch ild, such as toast or cookies. 3. Soft elbow or jacket restrain ts m ay be used

(ch eck agen cy policies an d proced ures) to keep th e ch ild fro m touch in g th e repair site; rem ove restrain ts at least every 2 h ou rs (or per agen cy procedure) to assess skin in tegrity an d circula- tion an d to allow for exercisin g th e arm s.

4. Avo id th e use of oral suction or placin g objects in th e m outh such as a ton gue depresso r, th erm om - eter, straws, spoon s, forks, or pacifiers.

5. Provide an algesics for pain as prescribed. 6. In struct th e paren ts in feed in g tech n iqu es an d in

th e care of th e surgical site. 7. In struct th e paren ts to m on itor for sign s of in fec-

tion at th e surgical site, such as redn ess, swellin g, or drain age.

8. En cou rage th e paren ts to h old th e ch ild. 9. In itiate appropriate referrals such as a den tal

referral an d speech th erapy referral.

IV. Esophageal Atresia and Tracheoesophageal Fistula (Fig. 37-2)

A. Description 1. Th e esoph agus term in ates befo re it reach es th e

stom ach , en din g in a blin d pouch , or a fistula is presen t th at form s an un n atural con n ection with th e trach ea.

2. Th e con ditio n causes oral in take to en ter th e lun gs or a large am oun t of air to en ter th e stom - ach , presen tin g a risk of cough in g an d ch okin g; severe abdom in al disten tion can occur.

3. Aspiration pn eum on ia an d severe respiratory distress m ay develop, an d death is likely to occur with ou t surgical in terven tion .

4. Treatm en t in cludes m ain ten an ce of a paten t air- way, preven tion of aspiration pn eum on ia, gastric or blin d pouch deco m pression , supportive th er- apy, an d surgical repair.

B. Assessm en t 1. Fro th y saliva in th e m ou th an d n ose an d exces-

sive droolin g 2. Th e “3 Cs”—cough in g an d ch okin g durin g feed-

in gs an d un explain ed cyanosis 3. Regurgitation an d vom itin g 4. Abdo m in al disten tion 5. In creased respiratory distress durin g an d after

feed in g C. Preop erative in terven tion s

1. Th e in fan t m ay be placed in a radian t warm er in wh ich h um idified oxygen is adm in istered (in tu- bation an d m ech an ical ven tilation m ay be n eces- sary if respiratory distress occurs) .

2. Main tain NPO status. 3. Main tain IV fluids as prescribed. 4. Mon itor respiratory status closely.

441CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

5. Suction accum ulated secretio n s fro m th e m ou th an d ph aryn x.

6. Main tain in a supin e uprigh t position (at least 30 degrees uprigh t) to facilitate drain age an d pre- ven t aspiration of gastric secretio n s.

7. Keep th e blin d pouch em p ty of secretio n s by in term itten t or con tin uo us suction as prescribed; m on itor its paten cy clo sely because cloggin g fro m m ucus can occur easily.

8. If a gastro stom y tube is in serted, it m ay be left open so th at air en terin g th e stom ach th rough th e fistula can escape, m in im izin g th e risk of regurgitation of gastric con ten ts in to th e trach ea.

9. Broad-spectrum an tibiotics m ay be prescribed because of th e h igh risk for aspiration pn eum on ia.

D. Posto perative in terven tion s 1. Mon itor vital sign s an d respiratory status. 2. Main tain IV fluids, an tibiotics, an d paren teral

n utrition as prescribed. 3. Mon itor strict in take an d outp ut. 4. Mon itor daily weigh t; assess for deh ydration an d

possible fluid overload. 5. Assess for sign s of pain . 6. Main tain ch est tube if presen t. 7. In spect th e surgical site for sign s an d sym ptom s

of in fectio n . 8. Mon itor for an astom otic leaks as evid en ced by

purulen t drain age from th e ch est tube, in creased tem p erature, an d in creased wh ite blood cell coun t.

9. If a gastro stom y tube is presen t, it is usually attach ed to gravity drain age un til th e in fan t can tolerate feedin gs an d th e an astom osis is h ealed (usually posto perative day 5 to 7); th en feedin gs are prescribed .

10. Before oral feedin gs an d rem oval of th e ch est tube, prepare for an eso ph agogram as prescribed to ch eck th e in tegrity of th e eso ph ageal an astom osis.

11. Before feed in g, elevate th e gastro stom y tube an d secure it above th e level of th e stom ach to allow gastric secretio n s to pass to th e duoden um an d swallowed air to escape th rou gh th e open gastro stom y tube.

12. Adm in ister oral feedin gs with sterile water, fol- lowed by frequen t sm all feedin gs of form ula as prescribed.

13. Assess th e cervical esoph agostom y site, if presen t, for redn ess, breakdown , or exu date; rem ove accu m ulated drain age frequen tly, an d apply pro- tective oin tm en t, barrier dressin g, or a collectio n device as prescribed.

14. Provide n on n utritive suckin g, usin g a pacifier for in fan ts wh o rem ain NPO for exten ded periods (a pacifier sh ould n ot be used if th e in fan t is un ab le to h an dle secretio n s).

15. In struct th e paren ts in th e tech n iqu es of suction - in g, gastro stom y tube care an d feedin gs, an d skin site care as appropriate.

16. In struct th e paren ts to iden tify beh aviors th at in dicate th e n eed for suction in g, sign s of respi- ratory distress, an d sign s of a con stricted eso ph - agus (e.g., poor feedin g, dysph agia, droolin g, cough in g durin g feedin gs, regurgitated un digested food ).

V. Gastroesophageal Reflux Disease A. Description

1. Gastroesoph ageal reflux is backflow of gastric con ten ts in to th e esoph agus as a result of relaxa- tion or in com peten ce of th e lower esoph ageal or cardiac sph in cter.

2. Most in fan ts with gastro esoph ageal reflux h ave a m ild problem th at im proves in about 1 year an d requires m edical th erapy on ly.

3. Gastroesoph ageal reflux disease occurs wh en gas- tric con ten ts reflux in to th e esoph agus or oro- ph aryn x an d produ ce sym ptom s.

A B C D E FIGURE 37-2 Congenital atresia of esophagus and tracheoesophageal fistula. A, Upper and lower segments of esophagus end in blind sac (occurring in 5% to 8% of such infants). B, Upper segment of esophagus ends in atresia and connects to trachea by fistulous tract (occurring rarely). C, Upper segment of esophagus ends in blind pouch; lower segment connects with trachea by small fistulous tract (occurring in 80% to 95% of such infants). D, Both segments of esophagus connect by fistulous tracts to trachea (occurring in less than 1% of such infants). Infant may aspirate with first feeding. E, Esoph- agus is continuous, but connects by fistulous tract to trachea (known as H-type).

442 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

B. Assessm en t 1. Passive regurgitation or em esis 2. Poor weigh t gain 3. Irritability 4. Hem atem esis 5. Heartburn (in older ch ildren ) 6. An em ia from blood lo ss

C. In terven tion s 1. Assess am oun t an d ch aracteristics of em esis. 2. Assess th e relation sh ip of vom itin g to th e tim es

of feedin gs an d in fan t activity. 3. Mon itor breath soun ds before an d after feedin gs. 4. Assess for sign s of aspiration , such as droolin g,

cough in g, or dyspn ea, after feed in g. 5. Place suction equ ipm en t at th e bedside. 6. Mon itor in take an d outp ut. 7. Mon itor for sign s an d sym ptom s of deh ydration . 8. Main tain IV fluid s as prescribed.

Complications of gastroesophageal reflux disease include esophagitis, esophageal strictures, aspiration of gastric contents, and aspiration pneumonia.

D. Position in g 1. Th e in fan t is placed in th e supin e position durin g

sleep (to reduce th e in ciden ce of sudden in fan t death syn drom e) un less th e risk of death from aspiration or oth er serious co m plication s of gas- tro esoph ageal reflux disease greatly outweigh s th e risks associated with th e pron e position (ch eck th e HCP’s prescription ); oth erwise, th e pron e position is acceptable on ly wh ile th e in fan t is awake an d can be m on itored .

2. In ch ildren older th an 1 year, position with th e h ead of th e bed elevated.

E. Diet 1. Provide sm all, frequen t feed in gs with predi-

gested form ula to decrease th e am oun t of regurgitation .

2. Nu trition via n aso gastric tube feed in gs m ay be prescribed if severe regurgitation an d poor growth are presen t.

3. For in fan ts, form ula m ay be th icken ed by addin g rice cereal to th e form ula (follow agen cy proce- dure); cro ss-cut th e n ipp le.

4. Breast-feedin g m ay con tin ue, an d th e m oth er m ay provide m ore frequen t feedin g tim es or exp ress m ilk for th icken in g with rice cereal.

5. Burp th e in fan t frequen tly wh en feedin g an d h an dle th e in fan t m in im ally after feed in gs; m on - ito r for cough in g durin g feed in g an d oth er sign s of aspiration .

6. Fo r to d d lers, feed so lid s first, fo llo wed b y liq u id s.

7. In struct th e paren ts to avoid feed in g th e ch ild fatty foods, ch ocolate, tom ato produ cts, carbo n - ated liqu ids, fruit juices, citrus produ cts, an d spicy foods.

8. In struct th e paren ts th at th e ch ild sh o uld avoid vigorous play after feedin g an d avoid feedin g just befo re bed tim e.

F. Med ication s 1. An tacids for sym pto m relief 2. Proton pum p in h ib itors an d h istam in e

H 2-receptor an tagon ists to decrease gastric acid secretio n

VI. Hypertrophic Pyloric Stenosis (Fig. 37-3) A. Description

1. Hypertroph y of th e circular m uscles of th e pylo- rus cau ses n arrowin g of th e pyloric can al between th e stom ach an d th e duoden um .

2. Th e stenosis usually develops in th e first few weeks of life, causin g projectile vom itin g, deh ydratio n , m etab olic alkalosis, an d failure to th rive.

B. Assessm en t 1. Vom itin g th at progresses from m ild regurgitation

to forceful an d projectile vom itin g; it usually occurs after a feedin g.

2. Vom itus con tain s gastric con ten ts such as m ilk or form ula, m ay con tain m ucus, m ay be blood- tin ged, an d does n ot usually con tain bile.

B

A

FIGURE 37-3 Hypertrophic pyloric stenosis. A, Enlarged muscular area nearly obliterates pyloric channel. B, Longitudinal surgical division of muscle down to submucosa establishes adequate passageway.

443CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

3. Th e ch ild exh ibits h un ger an d irritability. 4. Peristaltic waves are visible from left to righ t

across th e epigastriu m durin g or im m ediately after a feedin g.

5. An olive-sh aped m ass is in th e epigastrium just righ t of th e um b ilicus.

6. Sign s of deh ydration an d m aln utrition 7. Sign s of electrolyte im balan ces 8. Metab olic alkalosis

C. In terven tion s 1. Mon itor strict in take an d outp ut. 2. Mon itor vom itin g episo des an d stools. 3. O btain daily weigh ts. 4. Mon itor for sign s of deh ydration an d electrolyte

im balan ces. 5. Prepare th e ch ild an d paren ts for pylorom yot-

om y if prescribed. D. Pylo rom yoto m y

1. Description : An in cision th rough th e m uscle fib ers of th e pylorus; m ay be perform ed by laparoscopy

2. Preoperative in terven tion s a. Mon itor h ydration status by daily weigh ts,

in take an d outp ut, an d urin e for specific gravity.

b . Correct fluid an d electrolyte im balan ces; adm in ister flu ids in traven o usly as prescribed for reh ydration .

c. Main tain NPO status as prescribed. d . Mon itor th e n um ber an d ch aracter of stools. e. Main tain paten cy of th e n aso gastric tube

placed for stom ach decom pression . 3. Posto perative in terven tion s

a. Mon itor in take an d output. b . Begin sm all, frequen t feedin gs posto pera-

tively as prescribed. c. Gradu ally in crease am oun t an d in terval

between feedin gs un til a full feedin g sch edule h as been rein stated.

d . Feed th e in fan t slowly, burpin g frequen tly, an d h an dle th e in fan t m in im ally after feedin gs.

e. Mon itor for abdom in al disten tion . f. Mon itor th e surgical woun d an d for sign s of

in fectio n . g. In struct th e paren ts ab out woun d care an d

feedin g.

VII. Lactose Intolerance A. Description : In ab ility to tolerate lactose as a result of

an ab sen ce or deficien cy of lactase, an en zym e foun d in th e secretio n s of th e sm all in testin e th at is required for th e digestion of lactose

B. Assessm en t 1. Sym ptom s occur after th e in gestion of m ilk or

oth er dairy products. 2. Abdo m in al disten tion

3. Cram py, abdom in al pain ; co lic 4. Diarrh ea an d excessive flatu s

C. In terven tion s 1. Elim in ate th e offen din g dairy produ ct, or adm in -

ister an en zym e tab let replacem en t. 2. Provide in form ation to th e paren ts about

en zym e tablets th at predigest th e lactose in dairy produ cts or supplem en t th e body’s own lactase.

3. Substitute soy-based form ulas for cow’s m ilk for- m ula or h um an m ilk.

4. Lim it m ilk con sum ptio n to 1 glass at a tim e. 5. In struct th e ch ild an d fam ily th at th e ch ild

sh ould drin k m ilk with oth er foods rath er th an by itself.

6. En cou rage co n sum ption of h ard ch eese, cottage ch eese, an d yogu rt, wh ich con tain th e in active lactase en zym e.

7. En cou rage con sum p tion of sm all am oun ts of dairy foods daily to h elp colon ic bacteria ad apt to in gested lactose.

8. In struct th e paren ts about th e food s th at con tain lactose, in cludin g h idd en sources.

Achild with lactose intolerance can develop calcium and vitamin D deficiency. Instruct the parents about the importance of providing these supplements.

VIII. Celiac Disease A. Description

1. Celiac disease is also kn own as gluten en terop a- th y or celiac sprue.

2. In toleran ce to gluten , th e protein com pon en t of wh eat, barley, rye, an d oats, is ch aracteristic.

3. Celiac disease results in th e accu m ulation of th e am in o acid glutam in e, wh ich is toxic to in testin al m ucosal cells.

4. In testin al villous atroph y occurs, wh ich affects absorption of in gested n utrien ts.

5. Sym pto m s of th e disorder occur m ost often between th e ages of 1 an d 5 years.

6. Th ere is usually an in terval of 3 to 6 m on th s between th e in troduction of gluten in th e diet an d th e on set of sym pto m s.

7. Strict dietary avoidan ce of gluten m in im izes th e risk of develo pin g m align an t lym p h om a of th e sm all in testin e an d oth er gastro in testin al m align an cies.

B. Assessm en t 1. Acute or in sidiou s diarrh ea 2. Steatorrh ea 3. An o rexia 4. Abdo m in al pain an d disten tion 5. Muscle wastin g, particularly in th e butto cks an d

extrem ities 6. Vom itin g 7. An em ia 8. Irritability

444 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C. Celiac crisis 1. Precipitated by fastin g, in fection , or in gestion of

gluten 2. Cau ses profuse watery diarrh ea an d vom itin g 3. Can lead to rapid deh ydration , electrolyte im bal-

an ce, an d severe acidosis D. In terven tion s

1. Main tain a gluten -free diet, substitutin g corn , rice, an d m illet as grain sources.

2. In struct th e paren ts an d ch ild about lifelon g elim in ation of gluten sources such as wh eat, rye, oats, an d barley.

3. Adm in ister m in eral an d vitam in supplem en ts, in cludin g iron , folic acid, an d fat-solub le vita- m in s A, D, E, an d K.

4. Teach th e ch ild an d paren ts about a gluten -free diet an d about readin g food labels carefully for h idd en sources of gluten (Box 37-1).

5. In struct th e paren ts in m easu res to preven t celiac crisis.

6. In form th e paren ts about th e Celiac Sprue Asso ciation .

IX. Appendicitis A. Description

1. In flam m ation of th e appen dix 2. Wh en th e appen dix beco m es in flam ed or

in fected, perforation m ay occur with in a m atter of h ou rs, leadin g to periton itis, sepsis, sep tic sh o ck, an d poten tially death .

3. Treatm en t is surgical rem oval of th e appen dix befo re perforation occurs.

B. Assessm en t 1. Pain in perium bilical area th at descen ds to th e

righ t lower quadran t 2. Abdo m in al pain th at is m ost in ten se at

McBurn ey’s poin t 3. Referred pain in dicatin g th e presen ce of perito-

n eal irritation 4. Rebo un d ten dern ess an d ab dom in al rigidity 5. Elevated wh ite blood cell coun t

6. Sid e-lyin g position with ab dom in al guardin g (legs flexed) to relieve pain

7. Difficulty walkin g an d pain in th e righ t h ip 8. Low-grade fever 9. An o rexia, n ausea, an d vom itin g after pain

develops 10. Diarrh ea

C. Periton itis 1. Description : Resu lts from a perforated appen dix 2. Assessm en t

a . In creased fever b . Progressive ab dom in al disten tion c. Tach ycardia an d tach ypn ea d . Pallor e. Ch ills f. Restlessn ess an d irritability

An indication of a perforated appendix is the sudden relief of pain and then a subsequent increase in pain accompanied by right guarding of the abdomen.

D. Appen dectom y 1. Description : Surgical rem oval of th e ap pen dix 2. In terven tion s preoperatively

a . Main tain NPO status. b . Adm in ister IV fluid s an d electrolytes as pre-

scrib ed to preven t deh ydration an d co rrect electrolyte im balan ces.

c. Mon itor for ch an ges in th e level of pain . d . Mon itor for sign s of a ruptured appen dix an d

periton itis. e. Avoid th e use of pain m ed ication s so as n ot to

m ask pain ch an ges associated with perforation .

f. Adm in ister an tibiotics as prescribed. g. Mon itor bowel soun ds. h . Position in a righ t side-lyin g or lo w to sem i-

Fowler’s position to prom o te com fo rt. i. Apply ice packs to th e ab dom en for 20 to

30 m in u tes every h ou r if prescribed. j. Avoid th e application of h eat to th e

abdom en . k . Avoid laxatives or en em as.

3. Posto perative in terven tion s a . Mon itor vital sign s, particularly tem perature. b . Main tain NPO status un til bowel fun ctio n

h as return ed, ad van cin g th e diet gradually as tolerated an d as prescribed wh en bowel soun ds return .

c. Assess th e in cision for sign s of in fection , such as redn ess, swellin g, drain age, an d pain .

d . Mon itor drain age from th e drain , wh ich m ay be in serted if perforation occurred.

e. Position th e ch ild in a righ t side-lyin g or low to sem i-Fowler’s position with th e legs sligh tly flexed to facilitate drain age.

f. Ch an ge th e dressin g as prescribed , an d record th e type an d am oun t of drain age.

BOX 37-1 Basics of a Gluten-Free Diet

Foods Allowed Meat such as beef, pork, poultry, and fish; eggs; milk and some dairy products; vegetables, fruits, rice, corn, gluten-free flour, puffed rice, cornflakes, cornmeal, and precooked gluten- free cereals are allowed.

Foods Prohibited Commercially prepared ice cream; malted milk; prepared puddings; and grains, including anything made from wheat, rye, oats, or barley, such as breads, rolls, cookies, cakes, crack- ers, cereal, spaghetti, macaroni noodles, beer, and ale, are prohibited.

445CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

g. Perform woun d irrigation s if prescribed. h . Main tain n asogastric tube suction an d

paten cy of th e tube if presen t. i. Adm in ister an tibiotics an d an algesics as

prescribed.

X. Hirschsprung’s Disease (Fig. 37-4) A. Description

1. Hirsch sprun g’s disease is a con gen ital an om aly also kn own as co n gen ital agan glion osis or agan - glion ic m egacolon .

2. Th e disease occurs as th e result of an absen ce of gan glion cells in th e rectum an d oth er areas of th e affected in testin e.

3. Mech an ical obstru ction results because of in ade- quate m otility in an in testin al segm en t.

4. Th e disease m ay be a fam ilial con gen ital defect or m ay be associated with oth er an om alies, such as Down syn drom e an d gen itourin ary abn orm alities.

5. A rectal biopsy specim en sh ows h istolo gical evi- den ce of th e absen ce of gan glion ic cells.

6. Th e m ost serious com plication is en terocolitis; sign s in clude fever, severe prostration , gastro in - testin al bleed in g, an d explo sive watery diarrh ea.

7. Treatm en t for m ild or m oderate disease is based on relievin g th e ch ron ic con stipation with stool soften ers an d rectal irrigation s; h owever, m an y ch ildren require surgery.

8. Treatm en t for m oderate to severe disease in volves a 2-step surgical procedure. a. In itially, in th e n eon atal period, a tem porary

colosto m y is created to relieve obstru ctio n an d allow th e n orm ally in n ervated, dilated bowel to return to its n orm al size.

b . Wh en th e bowel return s to its n orm al size, a com plete surgical repair is perform ed via a pull-th rough procedure to excise portion s of th e bowel; at th is tim e, th e colosto m y is closed .

B. Assessm en t 1. Newborn s

a . Failure to pass m eco n ium stool b . Refusal to suck c. Abdom in al disten tion d . Bile-stain ed vom itus

2. Ch ildren a . Failure to gain weigh t an d delayed growth b . Abdom in al disten tion c. Vom itin g d . Con stipation altern atin g with diarrh ea e. Ribbon -like an d foul-sm ellin g stools

C. In terven tion s: Med ical m an agem en t 1. Main tain a lo w-fiber, h igh -calorie, h igh -protein

diet; paren teral n utrition m ay be n ecessary in extrem e situation s.

2. Adm in ister stool soften ers as prescribed. 3. Adm in ister daily rectal irrigation s with n orm al

salin e to prom o te adequate elim in ation an d pre- ven t obstru ction as prescribed.

D. Surgical m an agem en t: Preoperative in terven tion s 1. Assess bowel fun ctio n . 2. Adm in ister bowel preparation as prescribed. 3. Main tain NPO status. 4. Mon itor h ydration an d fluid an d electrolyte sta-

tus; provide fluids in traven ously as prescribed for h ydration .

5. Adm in ister an tibiotics or colon ic irrigation s with an an tibiotic solution as prescribed to clear th e bowel of bacteria.

6. Mon itor strict in take an d outp ut. 7. O btain daily weigh t. 8. Measu re abdom in al girth daily 9. Avoid takin g th e tem p erature rectally. 10. Mon itor for respiratory distress associated with

abdom in al disten tion . E. Surgical m an agem en t: Posto perative in terven tion s

1. Mon itor vital sign s, avoidin g takin g th e tem p er- ature rectally.

2. Measu re abdom in al girth daily an d PRN (as n eeded).

3. Assess th e surgical site for redn ess, swellin g, an d drain age.

4. Assess th e stom a if presen t for bleedin g or skin breakd own (sto m a sh ould be red an d m oist) .

5. Assess th e an al area for th e presen ce of stool, red- n ess, or disch arge.

6. Main tain NPO status as prescribed an d un til bowel soun ds return or flatu s is passed, usually with in 48 to 72 h ours.

7. Main tain n aso gastric tube to allow in term itten t suction un til peristalsis return s.

8. Main tain IV fluids un til th e ch ild tolerates appro- priate oral in take, advan cin g th e diet from clear liqu ids to regular as tolerated an d as prescribed.

9. Assess for deh ydration an d fluid overload. 10. Mon itor strict in take an d outp ut.

Dis te nde d s igmoid colon

Aga nglionic portion

Re ctum

FIGURE 37-4 Hirschsprung’s disease.

446 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

11. O btain daily weigh t. 12. Assess for pain an d provide co m fort m easu res as

required. 13. Provide th e paren ts with in struction s regardin g

colostom y care an d skin care. 14. Teach th e paren ts ab out th e appropriate diet an d

th e n eed for adequ ate flu id in take.

XI. Intussusception (Fig. 37-5) A. Description

1. Telescopin g of on e portion of th e bowel in to an oth er portion

2. Th e con d ition results in obstru ction to th e pas- sage of in testin al con ten ts.

B. Assessm en t 1. Colicky abdom in al pain th at causes th e ch ild to

scream an d draw th e kn ees to th e abdom en , sim - ilar to th e fetal position

2. Vo m itin g of gastric con ten ts 3. Bile-stain ed fecal em esis 4. Curran t jelly–like stools con tain in g blood

an d m ucus 5. Hypo active or h yperactive bowel soun ds 6. Ten d er disten ded abdom en , possibly with a

palpable sausage-sh aped m ass in th e upper righ t quadran t

C. In terven tion s 1. Mon itor for sign s of perforation an d sh ock as

evid en ced by fever, in creased h eart rate, ch an ges in level of co n sciousn ess or blood pressure, an d respiratory distress, an d report im m ediately.

2. An tibiotics, IV fluids, an d decom pression via n aso gastric tube m ay be prescribed.

3. Mon itor for th e passage of n orm al, brown stool, wh ich in dicates th at th e in tussusception h as reduced itself.

4. Prepare for h ydrostatic reduction as prescribed, if n o sign s of perforation or sh ock occur (in h ydro- static reduction , air or fluid is used to exert pres- sure on area in volved to lessen , dim in ish , or rid th e in testin e of prolapse).

5. Posth ydrostatic reduction a . Mon itor for th e return of n orm al bowel

soun ds, for th e passage of barium , an d th e ch aracteristics of stool.

b . Adm in ister clear fluids, an d advan ce th e diet gradually as prescribed.

6. If surgery is required, postoperative care is sim ilar to care after an y ab dom in al surgery; procedure m ay be don e via laparoscope.

XII. Abdominal Wall Defects A. O m ph alocele

1. Omphalocele refers to h ern iation of th e abdom i- n al con ten ts th rough th e um bilical rin g, usually with an in tact periton eal sac.

2. Th e protrusion is covered by a tran slucen t sac th at m ay con tain bowel or oth er abdom in al organ s.

3. Ruptu re of th e sac results in evisceration of th e abdom in al co n ten ts.

4. Im m ediately after birth , th e sac is covered with sterile gauze soaked in n orm al salin e to preven t dryin g of abdom in al con ten ts; a layer of plastic wrap is placed over th e gauze to provide addi- tion al protection again st m oisture loss.

5. Mon itor vital sign s frequen tly (every 2 to 4 h ours), particularly tem p erature, because th e in fan t can lose h eat th rou gh th e sac.

6. Preop eratively: Main tain NPO status, adm in ister IV flu ids as prescribed to m ain tain h ydration an d electrolyte balan ce, m on itor for sign s of in fec- tion , an d h an dle th e in fan t carefully to preven t rupture of th e sac.

7. Posto peratively: Con trol pain , preven t in fectio n , m ain tain fluid an d electrolyte balan ce, an d en sure adequ ate n utrition .

B. Gastrosch isis 1. Gastrosch isis occurs wh en th e h ern iation of th e

in testin e is lateral to th e um bilical rin g. 2. No m em bran e co vers th e exp osed bowel. 3. Th e exposed bowel is covered loosely in salin e-

soaked pads, an d th e abdom en is loosely wrapp ed in a plastic drap e or bowel bag; wrap- pin g directly aroun d th e exposed bowel is con tra- in dicated because if th e exposed bowel expan d s, wrapp in g could cause pressure an d n ecrosis.

4. Preop eratively: Care is sim ilar to th at for om ph a- locele; surgery is perform ed with in several h ours after birth because n o m em bran e is coverin g th e sac.

He pa tic fle xure

Intus s us ce ptum

Ile ocolic va lve

Ile um

Blood ve s s e ls dra wn in be twe e n la ye rs

Appe ndix

FIGURE 37-5 Ileocolic intussusception.

447CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

5. Posto peratively: Most in fan ts develop prolon ged ileu s, require m ech an ical ven tilation , an d n eed paren teral n utrition ; oth erwise, care is sim ilar to th at for om ph alocele.

XIII. Umbilical Hernia A. Description

1. A h ern ia is a protrusion of th e bowel th rou gh an ab n orm al open in g in th e abdom in al wall.

2. In ch ildren , h ern ias m ost com m on ly occur at th e um b ilicus an d th rou gh th e in guin al can al.

3. A h ydrocele is th e presen ce of abdom in al flu id in th e scro tal sac.

B. Assessm en t 1. Um b ilical h ern ia: Soft swellin g or protrusion

arou n d th e um b ilicus th at is usually reducible with th e fin ger

2. In guin al h ern ia a. In guin al h ern ia refers to a pain less in guin al

swellin g th at is reducible. b . Swellin g m ay disappear durin g periods of rest

an d is m ost n oticeable wh en th e in fan t cries or cough s.

3. In carcerated h ern ia a. In carcerated h ern ia occurs wh en the descended

portion of the bowel becom es tigh tly caugh t in the h ernial sac, com prom isin g blood supply.

b . Th is represen ts a m ed ical em ergen cy requir- in g surgical repair.

c. Assessm en t fin din gs in clude irritab ility, ten - dern ess at site, an orexia, ab dom in al disten - tion , an d difficu lty defecatin g.

d . Com p lete in testin al obstru ction an d gan - gren e m ay occur.

4. No n com m u n icatin g h ydrocele a. Non com m un icatin g h ydrocele occurs wh en

residual periton eal fluid is trapped with n o com m un ication to th e periton eal cavity.

b . Hydro cele usually disappears by age 1 year. 5. Com m un icatin g h ydrocele

a. Com m un icatin g h ydrocele is associated with a h ern ia th at rem ain s open from th e scro tum to th e abdom in al cavity.

b . Assessm en t in cludes a bulge in th e in guin al area or th e scrotum th at in creases with cryin g or strain in g an d decreases wh en th e in fan t is at rest.

C. Posto perative in terven tion s (h ern ia) 1. Mon itor vital sign s. 2. Assess for woun d in fectio n . 3. Mon itor for redn ess or drain age. 4. Mon itor in pu t an d output an d h ydration status. 5. Advan ce th e diet as tolerated . 6. Adm in ister an algesics as prescribed.

D. Posto perative in terven tion s (h ydrocele) 1. Provide ice bags an d a scro tal support to relieve

pain an d swellin g.

2. In struct th e ch ild an d paren ts to avoid tub bath - in g un til th e in cision h eals.

3. In struct th e ch ild an d paren ts to avoid stren uous ph ysical activities.

XIV. Constipation and Encopresis A. Description

1. Con stipation is th e in freq uen t an d difficu lt pas- sage of dry, h ard stools.

2. En cop resis is co n stipatio n with fecal in con ti- n en ce; ch ildren often com plain th at soilin g is in volun tary an d occurs with ou t warn in g.

3. If th e ch ild does n ot h ave a n eurological or an a- tom ical disorder, en copresis is usually th e result of fecal im paction an d an en larged rectum cau sed by ch ron ic con stipation .

B. Assessm en t 1. Con stipation

a . Abdo m in al pain an d cram p in g with ou t disten tion

b . Palp able m ovable fecal m asses c. No rm al or decreased bowel soun ds d . Malaise an d h eadach e e. An o rexia, n ausea, an d vo m itin g

2. En cop resis a . Eviden ce of soilin g of clo th in g b . Scratch in g or rubbin g of th e an al area c. Fecal odor d . Social with drawal

C. In terven tion s 1. Main tain a diet h igh in fiber an d fluid s to pro-

m ote bowel elim in ation ( Box 37-2). 2. Mon itor treatm en t regim en for severe en copresis

for 3 to 6 m on th s. 3. Decrease sugar an d m ilk in take. 4. Adm in ister en em as as prescribed un til im pac-

tio n is cleared. 5. Mon itor for h ypern atrem ia or h yperph o sph ate-

m ia wh en ad m in isterin g repeated en em as. a . Sign s of h ypern atrem ia in clude in creased

th irst; dry, sticky m ucou s m em bran es; flush ed skin ; in creased tem p erature; n ausea an d vom itin g; oliguria; an d leth argy.

b . Sign s of h yperph osph atem ia in clude tetan y, m uscle weakn ess, dysrh yth m ias, an d h ypo ten sion .

6. Adm in ister stool soften ers or laxatives as prescribed .

7. En cou rage th e ch ild to sit on th e toilet for 5 to 10 m in utes approxim ately 20 to 30 m in utes after breakfast an d din n er to assist with defecation .

XV. Irritable Bowel Syndrome A. Description

1. Irritable bowel syn d rom e results from in creased m otility, wh ich can lead to spasm an d pain .

448 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

2. Th e diagn osis is based on th e elim in ation of path olo gical con d ition s.

3. Th e syn dro m e is a self-lim itin g, in term itten t problem with n o defin itive treatm en t.

4. Stress an d em o tion al factors m ay con tribu te to its occurren ce.

B. Assessm en t 1. Diffuse abdom in al pain un related to m eals or

activity 2. Altern atin g con stipation an d diarrh ea with th e

presen ce of un d igested food an d m ucus in th e stool

C. In terven tion s 1. Reassu re th e paren ts an d ch ild th at th e

problem is self-lim itin g an d in term itten t an d will resolve.

2. An tich olin ergics m ay be prescribed (an tidepres- san ts m ay be n eeded in severe cases).

3. En courage th e m ain ten an ce of a h ealth y, well- balan ced , m oderate-fiber, an d low-fat diet.

4. En courage h ealth prom o tion activities such as exercise an d sch ool activities.

5. In form th e paren ts of psych o social resou rces if required .

XVI. Imperforate Anus A. Descrip tion : In com plete developm en t or ab sen ce of

th e an us in its n orm al position in th e perin eum B. Types

1. A m em bran e is n oted over th e an al open in g, with a n orm al an us just above th e m em bran e.

2. Th ere is com plete absen ce of th e an us (an al agen esis) with a rectal pouch en din g som e distan ce above.

3. Rectum en ds blin dly or h as a fistula co n n ection to th e perin eum , ureth ra, bladder, or vagin a.

C. Assessm en t ( Box 37-3) D. Preoperative in terven tion s

1. Determ in e presen ce of an an al open in g. 2. Mon itor for th e presen ce of stool in th e urin e

an d vagin a (in dicates a fistula) an d report im m ediately.

3. Adm in ister IV fluids as prescribed. 4. Prepare th e ch ild an d paren ts for th e surgical

procedures, in cludin g th e poten tial for colosto m y.

E. Posto perative in terven tion s 1. Mon itor th e skin for sign s of in fectio n . 2. Th e preferred position is a side-lyin g pron e posi-

tion with th e h ips elevated or a supin e position with th e legs susp en ded at a 90-degree an gle to th e trun k to reduce edem a an d pressure on th e surgical site.

3. Keep th e an al surgical in cision clean an d dry, an d m on itor for redn ess, swellin g, or drain age.

4. Main tain NPO status an d n asogastric tube if in place.

5. Main tain IV fluid s un til gastro in testin al m otility return s.

6. Provide care for colostom y, if presen t, as prescribed.

7. A n ew colostom y stom a m ay be red an d edem a- tous, but th is sh ould decrease with tim e.

8. In struct th e paren ts to perform an al dilation if prescribed to ach ieve an d m ain tain bowel paten cy.

9. In struct th e paren ts to use on ly dilato rs supplied by th e HCP an d a water-solub le lu brican t an d to in sert th e dilato r n o m ore th an 1 to 2 cm in to th e an us to preven t dam age to th e m ucosa.

XVII. Hepatitis A. Th is section con tain s specific in form ation regardin g

h epatitis as it relates to in fan ts an d ch ildren ; see also Ch apters 26 an d 52.

B. Descriptio n : An acu te or ch ron ic in flam m ation of th e liver th at m ay be cau sed by a virus, a m ed ication reaction , or an oth er disease process

BOX 37-2 High-Fiber Foods

Bread and Grains ▪ Whole-grain bread or rolls ▪ Whole-grain cereals ▪ Bran ▪ Pancakes, waffles, and muffins with fruit or bran ▪ Unrefined (brown) rice Vegetables ▪ Raw vegetables, especially broccoli, cabbage, carrots, cau-

liflower, celery, lettuce, and spinach ▪ Cooked vegetables, including those listed above and

asparagus, beans, Brussels sprouts, corn, potatoes, rhu- barb, squash, string beans, and turnips

Fruits ▪ Prunes, raisins, or other dried fruits ▪ Raw fruits, especially those with skins or seeds, other than

ripe banana or avocado

Miscellaneous ▪ Legumes (beans), popcorn, nuts, and seeds ▪ High-fiber snack bars

Data from Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 10 , Mosby.

BOX 37-3 Assessment Findings: Imperforate Anus

▪ Failure to pass meconium stool ▪ Absence or stenosis of the anal rectal canal ▪ Presence of an anal membrane ▪ External fistula to the perineum

449CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

C. Hepatitis A (HAV) 1. High est in ciden ce of HAV in fectio n occurs

am on g presch oo l or sch ool-age ch ildren yo un - ger th an 15 years.

2. Man y in fected ch ildren are asym ptom atic, but m ild n ausea, vom itin g, an d diarrh ea m ay occur.

3. In fected ch ildren wh o are asym ptom atic still can spread HAV to oth ers.

D. Hepatitis B (HBV) 1. Most HBV in fectio n in ch ildren is acquired

perin atally. 2. Newborn s are at risk if th e m oth er is in fected with

HBV or was a carrier of HBV durin g pregn an cy. 3. Possible routes of m atern al-fetal (n ewb orn )

tran sm ission in clude leakage of th e virus across th e placen ta late in pregn an cy or durin g labo r, in gestio n of am n iotic fluid or m atern al blood, an d breast-feedin g, esp ecially if th e m oth er h as cracked n ipples.

4. Th e severity in th e in fan t varies fro m n o liver dis- ease to fulm in an t (severe acu te co urse) or ch ron ic active disease.

5. In ch ildren an d adolescen ts, HBV occurs in spe- cific h igh -risk groups, in cludin g ch ildren with h em op h ilia or oth er disorders requirin g m ulti- ple blood tran sfusion s, ch ildren or adolescen ts in volved in IV drug abuse, in stitutio n alized ch il- dren , presch oo l ch ildren in en dem ic areas, an d ch ildren wh o h ave h ad h eterosexual activity or sexual activity with h om osexual m en .

6. In fection with HBV can cause a carrier state an d lead to even tual cirrh osis or h epatocellular carci- n om a in adulth o od.

E. Hepatitis C (HCV) 1. Tran sm issio n of HCV is prim arily by th e

paren teral route. 2. Som e ch ildren m ay be asym ptom atic, but HCV

often beco m es a ch ron ic con dition an d can cause cirrh osis an d h epatocellular carcin o m a.

F. Hepatitis D 1. In fection occurs in ch ildren already in fected

with HBV. 2. Acute an d ch ron ic form s ten d to be m ore severe

th an HBV an d can lead to cirrh osis. 3. Ch ildren with h em oph ilia are m ore likely to be

in fected, as are ch ildren wh o are IV drug users. G. Hepatitis E

1. In fection is un co m m on in ch ildren . 2. In fection is n ot a ch ron ic con d ition , does n ot

cause ch ron ic liver disease, an d h as n o carrier state.

H. Assessm en t ( Box 37-4) I. Laboratory diagn ostic evalu ation : See Ch apter 52. J. Preven tion

1. Im m un oglobulin provides passive immunity an d m ay be effective for preexpo sure proph ylaxis to preven t HAV in fectio n .

2. Hepatitis B im m un oglobulin provides passive im m un ity an d m ay be effective in preven tin g in fection after a 1-tim e exp osure (sh ou ld be given im m ediately after exposu re), such as an acciden tal n eedle pun cture or oth er con tact of co n tam in ated m aterial with m ucou s m em - bran es; im m un oglobulin sh ould also be given to n ewborn s wh o se m oth ers are positive for h ep- atitis B surface an tigen .

3. Hepatitis A vaccine an d h epatitis B vaccin e: See Ch apter 44.

Proper hand washing and standard precautions, as well as enteric precautions, can prevent the spread of viral hepatitis.

K. In terven tion s 1. Strict h an d wash in g is required. 2. Ho spitalization is required in th e even t of coagu-

lo path y or fulm in an t h epatitis. 3. Stan dard precaution s an d en teric precaution s are

followed durin g h ospitalization . 4. Provide en teric precaution s for at least 1 week

after th e on set of jaun dice with HAV. 5. Th e h ospitalized ch ild usually is n ot isolated in a

sep arate ro om un less h e or sh e is fecally in con ti- n en t an d item s are likely to beco m e con tam i- n ated with feces.

6. Ch ildren are discouraged from sh arin g toys. 7. In struct th e ch ild an d paren ts in effective h an d-

wash in g tech n iqu es. 8. In struct th e paren ts to disin fect diaper-ch an gin g

surfaces th oro ugh ly with a solution of ¼ cup (60 m L) bleach in 1 gallon (3.8 L) of water.

9. Main tain com fort, an d provide adequate rest an d sleep.

10. Provide a low-fat, well-balan ced diet. 11. In form th e paren ts th at because HAV is n ot in fec-

tio us 1 week after th e on set of jaun dice, th e ch ild

BOX 37-4 Assessment Findings: Hepatitis

Prodromal or Anicteric Phase ▪ Lasts 5 to 7 days ▪ Absence of jaundice ▪ Anorexia, malaise, lethargy, easy fatigability ▪ Fever (especially in adolescents) ▪ Nausea and vomiting ▪ Epigastric or right upper quadrant abdominal pain ▪ Arthralgia and rashes (more likely with hepatitis B virus) ▪ Hepatomegaly Icteric Phase ▪ Jaundice, which is best assessed in the sclera, nail beds,

and mucous membranes ▪ Dark urine and pale stools ▪ Pruritus

450 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

m ay return to sch o ol at th at tim e if h e or sh e feels well en ough .

12. In form th e paren ts th at jaun dice m ay appear worse before it resolves.

13. Caution th e paren ts about adm in isterin g an y m edication s to th e ch ild; explain th e role of th e liver in detoxification an d excretio n of m ed- ication s in un derstan dable term s.

14. In struct th e paren ts about th e sign s of th e ch ild’s con dition worsen in g, such as ch an ges in n euro- logical status, bleedin g, an d fluid reten tion .

XVIII. Ingestion of Poisons (see Priority Nursing Actions)

PRIORITY NURSING ACTIONS Poisoning Treatment in the Emergency Department

1. Assess the child. 2. Terminate exposure to the poison. 3. Identify the poison. 4. Take measures to prevent absorption of the poison. 5. Document the occurrence, assessment findings, poison

ingested, treatment measures, and the child’s response.

In the event of a poisoning, the nurse treats the child first, not the poison. The ABCs—airway–breathing–circulation— and vital signs are assessed. Cardiopulmonary resuscitation is initiated immediately if necessary. Exposure to the poison is terminated next, such as emptying the mouth of pills or other materials or flushing the skin or other body area. Then, the poison is identified by questioning the parents or wit- nesses of the event to determine the appropriate treatment. The nurse administers the antidote or takes other measures as prescribed by the health care provider, such as administer- ing activated charcoal. The nurse documents the occurrence, assessment findings, poison ingested, treatment measures, and the child’s response.

Reference Hockenberry, Wilson (2015), p. 548.

A. Lead poison in g 1. Descriptio n : Excessive accu m ulation of lead in

th e blood 2. Cau ses

a . Th e path way for exposu re m ay be food , air, or water.

b . Du st an d soil co n tam in ated with lead m ay be a source of exp osure.

c. Lead en ters th e ch ild’s body th rou gh in ges- tion or in h alation or th rou gh placen tal tran s- m ission to an un b orn ch ild wh en th e m oth er is exposed; th e m ost com m on ro ute is h an d to m ou th from con tam in ated objects, such

as loose pain t ch ips, pottery, or ceram ic ware coupled with th e in h alation of lead dust in th e en viron m en t.

d . Wh en lead en ters th e body, it affects th e eryth rocytes, bon es an d teeth , an d organ s an d tissues, in cludin g th e brain an d n ervous system ; th e m ost serious con sequen ces are th e effects on th e cen tral n ervous system .

3. Un iversal screen in g a . Screen in g is recom m en ded for ch ildren 1 to

2 years old; ch ildren at h igh risk sh ould be screen ed earlier.

b . An y ch ild between th e ages of 3 an d 6 years wh o h as n ot been screen ed sh ould be tested.

4. Targeted screen in g a . Targeted screen in g is acceptable in low-

risk areas. b . A ch ild at th e age of 1 to 2 years (or a ch ild

between th e ages of 3 an d 6 years wh o h as n ot been screen ed) m ay be targeted for screen in g if determ in ed to be at risk.

5. Bloo d lead level test: Used for screen in g an d diag- n osis ( Table 37-1)

6. Eryth rocyte protop orph yrin test a . In dicator of an em ia b . Norm al value for a ch ild: 35 m cg/ 100 m L of

wh o le blood or lower

TABLE 37-1 Blood Lead Level Test Results and Interventions

Level (mcg/ dL) Intervention

< 5 Reassess or rescreen in 1 yr or sooner if exposure status changes

5-14 Provide family lead education, follow-up testing, and social service referral for home assessment if necessary

15-19 Provide family education about lead, follow-up testing, and social service referral if necessary; on follow-up testing, initiate actions for blood lead level of 20-44 mcg/ dL (9.7-2.1 mcmol/ L)

20 -44 Provide coordination of care and clinical management, including treatment, environmental investigation, and lead-hazard control

45-69 Provide coordination of care and clinical management within 48 hr, including treatment, environmental investigation, and lead-hazard control (the child must not remain in a lead-hazardous environment if resolution is necessary)

70 Medical treatment is provided immediately, including coordination of care, clinical management, environmental investigation, and lead-hazard control

Data from Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 10 , Mosby; and Centers for Disease Control and Prevention: Blood lead levels in children (website): www.cdc.gov/ nceh/ lead/ acclpp/ lead_levels_ in_children_fact_sheet.pdf. Accessed September 28, 2015.

451CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

7. Ch elation th erap y a. Ch elation th erap y rem oves lead from th e cir-

culatin g blood an d from som e organ s an d tissues.

b . Th erapy does n ot coun teract an y effects of th e lead.

c. Medication s in clude calcium disodium ede- tate, an d succim er, an oral preparation ; Brit- ish an ti-Lewisite is used in con jun ction with EDTA.

d . British an ti-Lewisite is adm in istered via th e IV route or th e deep in tram uscular ro ute an d is con train d icated in ch ildren with an allergy to pean uts because th e m ed ication is prepared in a pean ut oil solution ; it is also con train dicated in ch ildren with glucose-6- ph osph ate deh ydrogen ase (G6PD) deficien cy an d sh ould n ot be given with iron .

e. Th e fun ction of th e ren al, h epatic, an d h em atological system s m ust be m on itored closely.

f. En sure ad equate urin ary outp ut before adm in isterin g th e m edication , an d m on itor th e outp ut an d pH of th e urin e closely durin g an d after th erap y.

g. Provid e adequ ate h ydration an d m on itor kid- n ey fun ction for n eph rotoxicity wh en th e m edication is given because th e m edication is excreted via th e kidn eys.

h . Follo w-up of lead levels n eeds to be don e to m on itor progress.

i. Provid e in struction s to paren ts about safety from lead h azards, m edication adm in istra- tion , an d th e n eed for follow-up.

j. Con firm th at th e ch ild will be disch arged to a h om e with ou t lead h azards.

B. Acetam in oph en 1. Description

a. Seriousn ess of in gestion is determ in ed by th e am oun t in gested an d th e len gth of tim e before in terven tion .

b . Toxic dose is 150 m g/ kg or h igh er in ch ildren . 2. Assessm en t

a. First 2 to 4 h ours: Malaise, n ausea, vom itin g, sweatin g, pallor, weakn ess

b . Laten t period: 24 to 36 h ou rs; ch ild im proves c. Hepatic in volvem en t: May last 7 days an d

m ay be perm an en t; righ t upper quadran t pain , jaun dice, con fusion , stupor, elevated liver en zym e an d bilirubin levels, prolon ged proth rom bin tim e

3. In terven tion s a. Adm in ister an tidote: N-Acetylcystein e. b . Dilute an tidote in juice or soda because of its

offen sive odor. c. Loadin g dose is followed by m ain ten an ce

doses.

d . In an un co n sciou s ch ild, prepare to adm in is- ter gastric lavage with activated ch arcoal to decrease th e ab sorption of acetam in o ph en .

e. If usin g activated ch arcoal with lavage, do n ot also use N-acetylcystein e because activated ch arcoal in activates th e an tidote.

C. Acetylsalicylic acid (aspirin ) 1. Description

a . O verdose m ay be cau sed by acu te in gestion or ch ron ic in gestio n .

b . Acute: Severe toxicity with 300 to 500 m g/ kg c. Ch ron ic: In gestion of m ore th an 100 m g/ kg

per day for 2 days or m ore, wh ich can be m ore serious th an acute in gestion

2. Assessm en t a . Gastro in testin al effects: Nausea, vo m itin g,

an d th irst from deh ydration b . Cen tral n ervous system effects: Hyperpn ea,

con fusion , tin n itu s, seizu res, com a, respira- tory failure, circulatory collapse

c. Ren al effects: O liguria d . Hem atop oietic effects: Bleedin g ten den cies e. Metab olic effects: Diaph oresis, fever, h ypon a-

trem ia, h ypo kalem ia, deh ydration , h ypo gly- cem ia, m etab olic acido sis

3. In terven tion s a . Prepare to adm in ister activated ch arcoal to

decrease ab sorption of salicylate. b . Em esis or cath artic m easu res m ay be

prescribed. c. Adm in ister IVfluids; sodium bicarbon ate m ay

be prescribed to correct m etab olic acido sis. d . O th er in terven tion s in clude extern al coolin g,

an ticon vulsan ts, vitam in K (if bleed in g), an d oxygen .

e. Prepare th e ch ild for dialysis as prescribed if th e ch ild is un respo n sive to th e th erap y.

D. Corrosives 1. Description

a . Item s th at can cau se poison in g in clude h ouseh old clean ers, detergen ts, bleach , pain t or pain t th in n ers, an d batteries.

b . Liquid corrosives can cau se m ore dam age to th e victim th an oth er typ es of corrosives, such as gran ular.

2. Assessm en t a . Severe burn in g in th e m ou th , th roat, or

stom ach b . Edem a of the m ucous m em bran es, lips, ton gue,

an d pharyn x c. Vom itin g d . Droolin g an d in ability to clear secretio n s

3. In terven tion s a . Dilute corrosive with water or m ilk as pre-

scribed (usually n o m ore th an 4 oz [120 m L]) b . In ducin g vo m itin g is con train d icated because

vom itin g redam ages th e m ucous m em bran es.

452 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

c. Neutralization of th e in gested corrosive is n ot don e because it can cau se a reaction produc- in g h eat an d burn s.

Educate parents to call the Poison Control Center immediately in the event of poisoning. The parents need to post the Poison Control Center telephone number near each phone in the house and have it in their mobile phones.

XIX. Intestinal Parasites A. Description : Com m on in fectio n s in ch ildren are

giardiasis an d pin worm in festatio n . 1. Giardiasis is cau sed by protozoa an d is prevalen t

am on g ch ildren in cro wded en viron m en ts, such as classroom s or day care cen ters.

2. Pin worm s (en terobiasis) are un iversally presen t in tem perate clim ate zon es an d are easily tran s- m itted in crowded en viron m en ts.

B. Assessm en t 1. Giardiasis

a . Diarrh ea an d vom itin g b . An o rexia c. Failure to th rive d . Abdo m in al cram p s with in term itten t loose

stools an d con stipatio n e. Steatorrh ea f. Stool specim en s fro m 3 or m ore collection s

are used for diagn osis. 2. Pin worm s

a . In ten se perian al itch in g b . Irritability, restlessn ess c. Poor sleepin g d . Bed wettin g

C. In terven tion s 1. Giardiasis

a . Med ication s th at kill th e parasites m ay be pre- scrib ed; m ed ication s are n ot usually pre- scrib ed for ch ildren youn ger th an 2 years.

b . Caregivers sh o uld wash h an ds m eticulo usly. c. Provide edu cation to fam ily an d caregivers

regardin g san itary practices. 2. Pin worm s

a . Perform a visu al in spection of th e an us with a flash ligh t 2 to 3 h ours after sleep.

b . Th e tape test is th e m ost com m on diagn ostic test.

c. Educate th e fam ily an d caregivers regardin g th e tape test. A loop of tran sparen t tape is placed firm ly again st th e ch ild’s perian al area; it is rem oved in th e m orn in g an d placed in a glass jar or plastic bag an d tran spo rted to th e labo ratory for an alysis.

d . Med ication s th at kill th e parasites m ay be pre- scrib ed; m ed ication s are n ot usually pre- scrib ed for ch ildren youn ger th an 2 years.

e. Th e m edication regim en m ay be repeated in 2 weeks to preven t rein fection .

f. All m em bers of th e fam ily are treated for th e in fectio n .

g. Teach th e fam ily an d caregivers ab out th e im portan ce of m eticulous h an d wash in g an d ab out wash in g all clo th es an d bed lin en s in h ot water.

CRITICAL THINKING What Should You Do? Answer: If a child suddenly vomits, the nurse must maintain a patent airway. The child should be positioned upright or on the side to prevent aspiration. Suctioning equipment should be obtained and kept at the bedside. The nurse should check the character and amount of the vomitus. The force of the vomiting should be assessed because projectile vomiting may indicate pyloric stenosis or increased intracranial pres- sure. The nurse should also monitor intake and output and for signs of dehydration.

References: Hockenberry, Wilson (20 15), p. 1068. McKinney et al. (20 13), pp. 10 0 4-10 05.

P R A C T I C E Q U E S T I O N S 382. Th e clin ic n urse reviews th e record of an in fan t an d

n otes th at th e h ealth care provider h as docum en - ted a diagn osis of suspected Hirsch sprun g’s dis- ease. Th e n urse reviews th e assessm en t fin din gs docum en ted in th e record, kn owin g th at wh ich sign m o st likely led th e m oth er to seek h ealth care for th e in fan t? 1. Diarrh ea 2. Projectile vo m itin g 3. Regurgitation of feed in gs 4. Foul-sm ellin g ribb on -like stools

383. An in fan t h as just return ed to th e n ursin g un it after surgical repair of a cleft lip on th e righ t side. Th e n urse sh ould place th e in fan t in wh ich b est posi- tio n at th is tim e? 1. Pron e position 2. O n th e stom ach 3. Left lateral position 4. Righ t lateral position

384. Th e n urse reviews th e record of a n ewborn in fan t an d n otes th at a diagn osis of eso ph ageal atresia with trach eo esoph ageal fistula is susp ected. Th e n urse expects to n ote wh ich m o st likely sign of th is con d ition docum en ted in th e record? 1. In cessan t cryin g 2. Cough in g at n igh ttim e 3. Ch okin g with feedin gs 4. Severe projectile vo m itin g

453CHAPTER 37 Gastrointestinal Disorders

P

e

d

i

a

t

r

i

c

s

385. Th e n urse provid es feedin g in struction s to a paren t of an in fan t diagn osed with gastro eso ph ageal reflux disease. Wh ich in struction sh ould th e n urse give to th e paren t to assist in reducin g th e episo des of em esis? 1. Provide less frequen t, larger feedin gs. 2. Burp th e in fan t less frequen tly durin g feedin gs. 3. Th in th e feedin gs by ad din g water to th e

form ula. 4. Th icken th e feed in gs by ad din g rice cereal to th e

form ula.

386. A ch ild is h ospitalized because of persisten t vom it- in g. Th e n urse sh ould m on itor th e ch ild clo sely for wh ich problem ? 1. Diarrh ea 2. Metab olic acido sis 3. Metabolic alkalosis 4. Hyperactive bowel soun ds

387. Th e n urse is carin g for a n ewborn with a susp ected diagn osis of im perfo rate an us. Th e n urse m on itors th e in fan t, kn owin g th at wh ich is a clin ical m an i- festation associated with th is disorder? 1. Bile-stain ed fecal em esis 2. Th e passage of curran t jelly–like stools 3. Failure to pass m econ ium stool in th e first

24 h ours after birth 4. Sausage-sh aped m ass palpated in th e upper

righ t abdom in al quadran t

388. Th e n urse ad m its a ch ild to th e h ospital with a diagn osis of pyloric sten osis. O n assessm en t, wh ich data would th e n urse expect to obtain wh en askin g th e paren t about th e ch ild’s sym pto m s? 1. Watery diarrh ea 2. Projectile vo m itin g

3. In creased urin e outp ut 4. Vom itin g large am oun ts of bile

389. Th e n urse provid es h om e care in struction s to th e paren ts of a ch ild with celiac disease. Th e n urse sh ould teach th e paren ts to in clude wh ich food item in th e ch ild’s diet? 1. Rice 2. O atm eal 3. Rye toast 4. Wh eat bread

390. Th e n urse is preparin g to care for a ch ild with a diagn osis of in tussusception . Th e n urse reviews th e ch ild’s record an d expects to n ote wh ich sign of th is disorder docum en ted? 1. Watery diarrh ea 2. Rib bon -like stools 3. Profuse projectile vo m itin g 4. Brigh t red blood an d m ucus in th e stools

391. Wh ich in terven tion s sh ould th e n urse in clude wh en creatin g a care plan for a ch ild with h epatitis? Select all th at ap p ly.

1. Providin g a low-fat, well-balan ced diet. 2. Teach in g th e ch ild effective h an d-wash in g

tech n iqu es. 3. Sch edulin g playtim e in th e playroo m with

oth er ch ildren . 4. No tifyin g th e h ealth care provider (HCP) if

jaun dice is presen t. 5. In structin g th e paren ts to avoid adm in ister-

in g m edication s un less prescribed. 6. Arran gin g for in defin ite h om e sch o olin g

because th e ch ild will n ot be ab le to return to sch ool.

A N S W E R S 382. 4 Ra tion a le: Hirsch sp ru n g’s d isease is a con gen ital an om aly also kn own as co n gen ital agan glio n o sis or agan glion ic m egaco lo n . It occu rs as th e result of an ab sen ce of gan glion cells in th e rectu m an d oth er areas o f th e affected in testin e. Ch ron ic con - stip ation b egin n in g in th e first m o n th of life an d resultin g in p ellet-like or rib b on -like sto o ls th at are fo u l-sm ellin g is a clin - ical m an ifestation of th is disorder. Delayed p assage o r ab sen ce o f m eco n iu m stoo l in th e n eon atal p eriod is also a sign . Bowel o bstructio n , esp ecially in th e n eon atal perio d; ab d om in al p ain an d disten tion ; an d failu re to th rive are also clin ical m an ifesta- tio n s. O p tio n s 1, 2, an d 3 are n ot asso ciated sp ecifically with th is d isorder. Test-Ta kin g Str a tegy: Note th e strategic wo rd s, most likely. Use kn owled ge regardin g th e p ath o ph ysiolo gy asso ciated with Hirsch sprun g’s d isease to d irect yo u to th e correct o ption . Rem em ber th at ch ron ic co n stip ation b egin n in g in th e first

m on th o f life an d resu ltin g in pellet-like or ribb o n -like, fou l- sm ellin g sto ols is a clin ical m an ifestatio n o f th is d iso rd er. Review: Hirsch sp ru n g’s d isease Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1074.

383. 3 Ra tion a le: A cleft lip is a co n gen ital an o m aly th at o ccu rs as a result of failure of soft tissu e or bon y structu re to fuse durin g em bryon ic develop m en t. After cleft lip rep air, th e n u rse avo id s p ositio n in g an in fan t on th e sid e o f th e rep air or in th e p ro n e p ositio n because th ese po sitio n s can cau se ru bb in g o f th e su r- gical site on th e m attress. Th e n urse p ositio n s th e in fan t o n th e sid e lateral to th e rep air or on th e back u p righ t an d p osition s

454 UNIT VII Pediatric Nursing

th e in fan t to p reven t airway o bstruction b y secretion s, bloo d, or th e ton gue. From th e o ptio n s provided , p lacin g th e in fan t on th e left side im m ed iately after surgery is best to preven t th e risk o f aspiratio n if th e in fan t vo m its. Test -Ta kin g Str a tegy: No te th e strategic wo rd , best. Elim in ate op tion s 1 an d 2 b ecau se th ey are com parable or alike p osition s. Con sider th e an ato m ical location o f th e surgical site an d n o te th e words right side in th e qu estio n to d irect you to th e co rrect op tion fro m th o se rem ain in g. Review: Positio n in g gu idelin es follo win g cleft lip rep air Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Pediatrics—Gastroin testin al Pr ior ity Con cepts: Safety; Tissu e In tegrity Refer en ce: Ho cken berry, Wilson (2015), p p. 305, 309.

384. 3 Ra t ion a le: In esoph ageal atresia an d trach eoeso p h ageal fis- tu la, th e esop h agu s term in ates b efo re it reach es th e sto m ach , en d in g in a b lin d p ou ch , an d a fistu la is p resen t th at form s an u n n atu ral co n n ectio n with th e trach ea. An y ch ild wh o exh ib its th e “3 Cs”—co u gh in g an d ch o kin g with feed in gs an d u n exp lain ed cyan o sis—sh o uld b e su spected to h ave tra- ch eoeso ph ageal fistu la. O ption s 1, 2, an d 4 are n o t sp ecifically associated with trach eoesop h ageal fistula. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most likely. Fo cu s o n th e d iagn o sis an d th in k ab ou t th e path o ph ysiology of th e d iso rd er. Recallin g th e “3 Cs” asso ciated with th is d iso r- der will assist in d irectin g you to th e correct op tio n . Review: Trach eo eso p h ageal fistu la Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Gastroin testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ho cken berry, Wilson (2015), p . 1108.

385. 4 Ra t ion a le: Gastro esop h ageal reflux is b ackflow of gastric co n - ten ts in to th e eso ph agu s as a resu lt o f relaxatio n or in co m p e- ten ce of th e lo wer eso ph ageal or card iac sp h in cter. Sm all, m o re freq uen t feed in gs with frequ en t bu rp in g o ften are p re- scribed in th e treatm en t o f gastro esop h ageal reflux. Feedin gs th icken ed with rice cereal m ay red uce episod es o f em esis. If th icken ed fo rm u la is used, cro ss-cu ttin g o f th e n ipp le m ay b e req uired. Test -Ta kin g St r a t egy: No te th e su b ject, gastroeso p h ageal reflu x disease. Use basic prin ciples related to feedin g an in fan t to assist in elim in atin g o p tion s 1 an d 2. No tin g th e word s reducing the episodes of emesis in th e q uestion will assist in d irect- in g you to select th e co rrect o p tion o ver o ption 3. Review: Gastro eso p h ageal reflu x d isease Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Gastroin testin al Pr ior ity Con cepts: Clien t Edu catio n ; Nu tritio n Refer en ce: Ho cken berry, Wilson (2015), p p. 1076-1077.

386. 3 Ra t ion a le: Vom itin g cau ses th e loss of h ydroch lo ric acid an d sub sequen t m etabolic alkalosis. Metabo lic acid osis would occur in a ch ild experien cin g d iarrh ea b ecau se of th e loss of b icarbo n- ate. Diarrh ea m igh t o r m igh t n ot accom pan y vom itin g. Hyperac- tive bowel sou n ds are n ot associated with vom itin g. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, co m plicatio n s related to vom itin g. Recallin g th at gastric fluid s are acidic an d th at th e lo ss of th ese fluid s lead s to alkalo sis will assist yo u in an swerin g th e qu estio n . No d ata in th e qu estio n su pp ort o p tion s 1 an d 4. Review: Flu id an d electro lyte b alan ce an d vo m itin g Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Gastroin testin al Pr ior ity Con cepts: Acid-Base Balan ce; Fluid an d Electrolyte Balan ce Refer en ce: Ho cken berry, Wilson (2015), p . 1132.

387. 3 Ra t ion a le: Im p erfo rate an u s is th e in co m p lete d evelo pm en t o r ab sen ce of th e an u s in its n o rm al po sitio n in th e perin eum . Du rin g th e n ewb orn assessm en t, th is d efect sh ou ld be id en ti- fied easily on sigh t. Ho wever, a rectal th erm om eter or tu be m ay b e n ecessary to determ in e p aten cy if m econ ium is n o t passed in th e first 24 h ou rs after birth . O th er assessm en t fin din gs in clu de ab sen ce or sten osis of th e an al rectal can al, p resen ce of an an al m em b ran e, an d an extern al fistula to th e perin eum . O ption s 1, 2, an d 4 are fin d in gs n o ted in in tussu sceptio n . Test -Ta kin g St r a t egy: Note th e su b ject, m an ifestation s of im p erfo rate an u s. Use th e defin itio n o f th e word imperforate to assist in an swerin g th is q u estion . Th is sh o u ld d irect yo u to th e co rrect op tion . Review: Im p erfo rate an u s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Gastroin testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in ation Refer en ce: Ho cken berry, Wilson (2015), p . 1117.

388. 2 Ra t ion a le: In p yloric sten o sis, h ypertrop h y of th e circu lar m us- cles o f th e p ylorus cau ses n arro win g o f th e pylo ric can al b etween th e sto m ach an d th e d u od en u m . Clin ical m an ifesta- tion s o f p ylo ric sten o sis in clu d e projectile vom itin g, irritab ility, h un ger an d cryin g, con stipatio n , an d sign s o f deh ydration , in clud in g a d ecrease in urin e o utp ut. Test -Ta kin g Str a tegy: Fo cus on th e su b ject, th e m an ifestation s o f pylo ric sten osis. Co n sid erin g th e an ato m ical locatio n o f th is d iso rd er an d its p oten tial effects will assist in elim in atin g o p tion s 1 an d 3. Th in kin g abo ut th e p ath o ph ysiolo gy of th e d iso rd er an d recallin g th at a m ajo r clin ical m an ifestation is p ro jectile vo m itin g will assist in directin g you to th e co rrect o p tion from th o se rem ain in g. Review: Pylo ric sten o sis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity

P

e

d

i

a

t

r

i

c

s

455CHAPTER 37 Gastrointestinal Disorders

In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; Nutritio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1091.

389. 1 Ra tion a le: Celiac disease also is kn o wn as gluten en terop ath y o r celiac sprue an d refers to in to leran ce to glu ten , th e protein com po n en t o f wh eat, b arley, rye, an d oats. Th e im po rtan t fac- to r to rem em ber is th at all wh eat, rye, barley, an d o ats sh ou ld b e elim in ated fro m th e diet an d replaced with corn , rice, or m illet. Vitam in su pp lem en ts—esp ecially th e fat-solu ble vita- m in s, iro n , an d folic acid—m ay be n eed ed to co rrect deficien - cies. Dietary restrictio n s are likely to b e lifelo n g. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, h o m e care in struc- tio n s for th e ch ild with celiac disease. Recallin g th at co rn , rice, an d m illet are su b stitute foo d replacem en ts in th is d isease will d irect yo u to th e co rrect o p tion . Review: Celiac d isease Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clien t Ed ucation ; Nutritio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1096.

390. 4 Ra tion a le: In tussu sceptio n is a telescop in g of 1 po rtion o f th e b owel in to an o th er. Th e co n d itio n resu lts in an o bstructio n to th e passage of in testin al con ten ts. A ch ild with in tussu scep tio n typically h as severe ab do m in al pain th at is cram p y an d in ter- m itten t, causin g th e ch ild to draw in th e kn ees to th e ch est. Vo m itin g m ay be p resen t, b ut is n ot p ro jectile. Brigh t red bloo d an d m ucus are p assed th ro u gh th e rectu m an d co m m o n ly are d escrib ed as cu rran t jelly–like sto o ls. Watery diarrh ea an d ribb on -like stoo ls are n o t m an ifestatio n s of th is d iso rd er. Test-Ta kin g Str a tegy: Focus on the su b ject, the m anifestations of intussusception. Th in k about th e path oph ysiology associated with th is con dition . Recallin g th at a classic m an ifestation is curran t jelly–like stools will assist in directin g you to th e correct option. Review: In tu ssu scep tio n

Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce:Ho cken b erry, Wilso n (2015) , p . 1094.

391. 1, 2, 5 Ra tion a le: Hep atitis is an acu te o r ch ro n ic in flam m atio n of th e liver th at m ay b e cau sed b y a viru s, a m edicatio n reactio n , or an o th er d isease p ro cess. Becau se h ep atitis can be viral, stan - d ard p recautio n s sh ou ld be in stitu ted in th e h o spital. Th e ch ild sh o u ld be d isco u raged fro m sh arin g to ys, so p laytim e in th e p layro om with o th er ch ild ren is n ot p art o f th e p lan of care. Th e ch ild will b e allo wed to retu rn to sch o ol 1 week after th e o n set of jau n d ice, so in defin ite h o m e sch oo lin g wou ld n o t n eed to be arran ged. Jaun dice is an exp ected fin d in g with h ep atitis an d wou ld n o t warran t n otificatio n of th e HCP. Pro - visio n o f a lo w-fat, well-b alan ced d iet is reco m m en ded . Paren ts are cau tio n ed abo u t adm in isterin g an y m ed ication to th e ch ild b ecau se n o rm al do ses o f m an y m ed icatio n s m ay b eco m e dan - gero u s owin g to th e liver’s in ability to detoxify an d excrete th em . Han d wash in g is th e m o st effective m easu re fo r con tro l o f h ep atitis in an y settin g, an d effective h an d wash in g can p re- ven t th e im m un ocom p ro m ised ch ild fro m co n tractin g an o pp ortun istic type of in fectio n . Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, care for a ch ild with h epatitis. Th in kin g about th e path oph ysiology associated with h epatitis an d th e m eth od of tran sm ission will assist you in an swerin g th e q uestion . Becau se th e in fection can b e tran sm it- ted to o th ers, playin g with o th er ch ild ren in th e playroo m is n o t an ap prop riate in terven tio n . Sin ce jau n d ice is an expected fin d in g, n otifyin g th e HCP is u n n ecessary. Plan n in g for an in defin ite perio d of h o m e sch o olin g is n ot n ecessary. Review: Hep atitis Level of Cogn itive Ability: Creatin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; In fectio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1104.

P

e

d

i

a

t

r

i

c

s

456 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 38 Eye, Ear, and Throat Disorders

PRIORITY CONCEPTS Safety; Sensory Perception

CRITICAL THINKING What Should You Do? An adolescent has just been diagnosed with bacterial con- junctivitis. What should the nurse do? Answer located on p. 459.

I. Strabismus A. Description

1. Called “squin t” or “cross-eye” 2. Con dition in wh ich th e eyes are n ot align ed

because of lack of coordin ation of th e extraocular m uscles

3. Most often results fro m m uscle im balan ce or paralysis of extraocu lar m uscles, but also m ay result fro m a con gen ital defect

4. Am blyopia (reduced visual acuity) m ay occur if n ot treated early because th e brain receives 2 m es- sages as a result of the n on parallel visual axes.

5. Perm an en t loss of vision can occur if n ot treated early.

6. Th is con d ition , con sidered a n orm al fin din g in a yo un g in fan t, sh o uld n ot be presen t after ab out age 4 m on th s.

7. Treatm en t of th e con dition dep en ds on th e cau se.

B. Assessm en t 1. Cro ssed eyes 2. Squin tin g; tilts th e h ead or clo ses 1 eye to see 3. Loss of bin o cular vision 4. Im p airm en t of dep th percep tion 5. Frequen t h ead ach es 6. Diplopia; ph otop h obia

C. In terven tion s 1. Corrective len ses m ay be in dicated. 2. In struct th e paren ts regardin g patch in g (occlu-

sion th erap y) of th e “good ” eye to stren gth en th e weak eye.

3. Prepare for surgery to realign th e weak m uscles as prescribed if n on su rgical in terven tion s are

un successful; th is is usually perform ed before age 2 years.

4. In struct th e paren ts about th e n eed for follow-up visits.

II. Conjunctivitis A. Description

1. Also kn own as “pin k eye”; an in flam m ation of th e con jun ctiva

2. Con jun ctivitis usually is caused by allergy, in fec- tion , or traum a.

3. Bacterial or viral con jun ctivitis is extrem ely con tagious.

B. Assessm en t 1. Itch in g, burn in g, or scratch y eyelids 2. Redn ess 3. Edem a 4. Disch arge

Chlamydial conjunctivitis is rare in older children; if diagnosed in a child who is not sexually active, the child should be assessed for possible sexual abuse.

C. In terven tion s 1. In struct in in fectio n co n trol m easu res such as

good h an d wash in g an d n ot sh arin g towels an d wash cloth s.

2. Adm in ister an tibiotic or an tiviral eye drops or oin tm en t as prescribed if in fectio n is presen t (severe in fectio n m ay require th erapy with sys- tem ic an tibiotics).

3. In struct th e ch ild an d paren ts about th e adm in is- tration of th e prescribed m edication s.

4. In struct th e paren ts th at th e ch ild sh ould be kept h om e fro m sch ool or day care un til an tibiotics h ave been ad m in istered for 24 h ours.

5. In struct th e ch ild to avoid rubbin g th e eye to pre- ven t in jury.

6. In struct a ch ild wh o is wearin g co n tact len ses to discon tin ue wearin g th em an d to obtain n ew len ses to elim in ate th e ch an ce of rein fection th at can occur fro m use of th e old len ses.

457

P

e

d

i

a

t

r

i

c

s

7. In struct an adolescen t th at eye m akeup sh ould be discarded an d replaced.

III. Otitis Media A. Description

1. An in flam m ato ry disorder usually caused by an in fectio n of th e m iddle ear occurrin g as a result of a blocked eustach ian tube, wh ich preven ts n orm al drain age; can be acute or ch ron ic.

2. O titis m edia is a com m on com plication of an acu te respiratory in fectio n (m ost com m on ly fro m respiratory syn cytial virus or in fluen za).

3. In fan ts an d ch ildren h ave eustach ian tubes th at are sh o rter, wider, an d straigh ter, wh ich m akes th em m ore pron e to otitis m edia.

B. Preven tion 1. Feed in fan ts in uprigh t position , to preven t

reflux. 2. Main tain ro utin e im m un ization s. 3. En cou rage breast-feedin g for at least th e first

6 m on th s of life. 4. Avo id exp osure to tobacco sm oke an d allergen s.

C. Assessm en t 1. Fever 2. Acute on set of ear pain 3. Cryin g, irritab ility, leth argy 4. Loss of appetite 5. Rollin g of h ead from side to side 6. Pullin g on or rubbin g th e ear 7. Purulen t ear drain age m ay be presen t 8. Red, opaqu e, bulgin g, im m obile tym pan ic m em -

bran e on otosco pic exam in ation 9. Sign s of h earin g loss (in dicative of ch ron ic

otitis m ed ia) D. In terven tion s

1. En cou rage fluid in take (m ay be difficult if th e ch ild is in pain ) .

2. In struct th e ch ild to avoid ch ewin g as m uch as possible durin g th e acute period because ch ew- in g in creases pain .

3. Provide lo cal h eat or cold as prescribed to relieve discom fort, an d h ave th e ch ild lie with th e affected ear down .

4. In struct th e paren ts in th e appropriate procedure to clean drain age from th e extern al ear can al with sterile swabs or gauze; frequen t clean sin g an d th e ap plication of m oistu re barriers m ay be pre- scrib ed to preven t ear exco riation from th e drain age.

5. In struct th e paren ts in th e adm in istration of an al- gesics or an tipyretics such as acetam in o ph en or ib uprofen as prescribed to decrease fever an d pain .

6. In struct th e paren ts in th e adm in istration of an ti- biotics if prescribed , em p h asizin g th at th e

prescribed period of adm in istration is n ecessary to elim in ate in fective organ ism s.

7. In h ealth y in fan ts over 6 m on th s an d ch ildren , careful use of an tibiotics is recom m en ded because of co n cern s about m edication -resistan t Streptococcus pneumoniae; usually, waitin g up to 72 h ours for spon tan eous resolutio n is a safe an d appropriate m an agem en t of acute otitis m ed ia.

8. In struct th e paren ts th at screen in g for h earin g loss m ay be n ecessary.

9. In struct th e paren ts about th e procedure for adm in isterin g ear m edication s such as topical pain -relief drops, if prescribed.

To administer ear medications in a child younger than age 3 years, pull the earlobe down and back. In a child older than 3 years, pull the pinna up and back.

E. Myrin gotom y 1. Description

a . A surgical in cision in to th e tym pan ic m em - bran e to provid e drain age of th e purulen t m iddle ear fluid ; m ay be don e by a laser- assisted procedure

b . Tym pan oplasty tubes, wh ich are sm all cylin d er-sh aped tubes, m ay be in serted in to th e m iddle ear to allow con tin ued drain age an d to equalize pressure an d allow ven tila- tion of th e m iddle ear.

2. Posto perative in terven tion s a . In struct th e paren ts an d ch ild to keep th e

ears dry. b . Th e clien t sh ould wear earplugs wh ile bath -

in g, sh am pooin g, an d swim m in g (divin g an d subm ergin g un der water are n ot allowed).

c. Paren ts can adm in ister an an algesic such as acetam in oph en or ibuprofen to relieve discom fort after in sertion of tym pan oplasty tubes.

d . Paren ts sh ould be taugh t th at th e ch ild sh ould n ot blow h is or h er n ose for 7 to 10 days after surgery.

e. In struct th e paren ts th at if th e tubes fall out, it is n ot an em ergen cy, but th e h ealth care pro- vider (HCP) sh o uld be n otified; in form th e paren ts of th e appearan ce of th e tubes (tin y, wh ite, spoo l-sh aped tubes) .

IV. Tonsillitis and Adenoiditis A. Description

1. Tonsillitis refers to in flam m ation an d in fectio n of th e ton sils, wh ich is lym ph o id tissue located in th e ph aryn x (Fig. 38-1).

458 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

2. Adenoiditis refers to in flam m ation an d in fectio n of th e aden oids (ph aryn geal ton sils), located on th e posterior wall of th e n aso ph aryn x.

3. To n sillectom y (su rgical rem oval of th e ton sils) an d aden oidecto m y (surgical rem oval of th e ad e- n oid s) m ay be n ecessary.

B. Assessm en t 1. Persisten t or recurren t sore th roat 2. En larged, brigh t red ton sils th at m ay be covered

with wh ite exudate 3. Difficulty in swallowin g 4. Mou th breath in g an d an un pleasan t m ou th odor 5. Fever 6. Cough 7. En larged aden oids m ay cause n asal quality of

speech , m ou th breath in g, h earin g difficu lty, sn o rin g, or obstru ctive sleep apn ea.

C. Preop erative in terven tion s 1. Assess for sign s of active in fectio n . 2. Assess bleedin g an d clo ttin g studies because th e

th roat is vascu lar. 3. Prepare th e ch ild for a sore th roat postopera-

tively, an d in form th e ch ild th at h e or sh e will n eed to drin k liqu ids.

4. Assess for an y loose teeth to decrease th e risk of aspiration durin g surgery.

D. In terven tion s postoperatively 1. Position th e ch ild pron e or side-lyin g to facilitate

drain age. 2. Have suction equipm en t available, but do n ot

suction un less th ere is an airway obstru ction . 3. Mon itor for sign s of bleedin g (frequen t swallow-

in g m ay in dicate bleedin g); if bleedin g occurs, turn th e ch ild to th e side an d n otify th e HCP.

4. Discou rage cough in g, clearin g th e th roat, or n ose blowin g to preven t bleedin g.

5. Provide an ice collar or an algesics (rectally or in traven ously) for discom fort.

6. Adm in ister an tiem etics to preven t vom itin g if prescribed.

7. Provide clear, cool, n on citrus an d n on carbo- n ated flu ids (crush ed ice, ice pops).

8. Avo id red, purple, or brown liquid s, wh ich sim - ulate th e appearan ce of blood if th e ch ild vom its.

9. Avo id m ilk products such as m ilk, ice cream , an d pudd in g in itially because th ey coat th e th roat, cau sin g th e ch ild to cough to clear th e th roat.

10. Soft food s m ay be prescribed 1 to 2 days posto peratively.

11. Do n ot give th e ch ild an y straws, forks, or sh arp objects th at can be put in to th e m outh .

12. Mouth odor, sligh t ear pain , and a low-grade fever m ay occur for a few days postoperatively, but th e paren ts sh ould be in structed to n otify the HCP if bleedin g, persisten t earach e, or fever occurs.

13. In struct th e paren ts to keep th e ch ild away from cro wds un til h ealin g h as occurred; usually th e ch ild is able to resum e n orm al activities 1 to 2 weeks posto peratively.

V. Epistaxis (Nosebleed) A. Description

1. Th e n ose, esp ecially th e sep tum , is a h igh ly vas- cular structure, an d bleedin g usually results from direct traum a, foreign bodies, an d n ose pickin g or from m ucosal in flam m ation .

2. Recurren t epistaxis an d severe bleed in g m ay in di- cate an un derlyin g disease.

B. In terven tion s 1. See Priority Nursin g Action s. 2. If bleedin g can n ot be con trolled, packin g or caute-

rization of th e bleedin g vessel m ay be prescribed.

CRITICAL THINKING What Should You Do? Answer: Bacterial conjunctivitis is contagious, so the nurs e should im m ediately ins titute m easures to prevent the spread of the infection to others. The nurs e should als o teach the adolescent about m easures to prevent the spread of infection. Thes e and other m easures include good infec- tion control m easures such as hand washing and not shar- ing towels and washcloths, the procedure for adm inistering antibiotic eye drops or ointm ent as pres cribed, staying hom e from school until antibiotics have been adm inistered for 24 hours, wearing dark glasses if photophobia occurs, avoiding rubbing the eye to prevent injury, discontinuing wearing eye contacts and obtaining new lenses to elim inate the chance of reinfection, and dis carding and replacing eye m akeup.

Reference: Hockenberry, Wilson (20 15), p. 221.

P ha rynge a l tons il (a de noids )

Tuba l tons il

P a la tine (fa ucia l) tons il

Lingua l tons il

FIGURE 38-1 Location of various tonsillar masses.

459CHAPTER 38 Eye, Ear, and Throat Disorders

P

e

d

i

a

t

r

i

c

s

PRIORITY NURSING ACTIONS A Child Has a Nosebleed 1. Remain calm and keep the child calm and quiet. 2. Have the child sit up and lean forward (not lie down). 3. Apply continuous pressure to the nose with the thumb

and forefinger for at least 10 minutes. 4. Insert cotton or wadded tissue into each nostril, and apply

ice or a cold cloth to the bridge of the nose if bleeding persists.

If a nosebleed occurs in a child, it is important for the nurse to remain calm; otherwise, the child becomes agitated and it is difficult to get the child to cooperate with the neces- sary interventions. The child should be assisted to a sitting up and leaning forward position to prevent aspiration of blood. The child should not be placed in a lying down position because of the risk of aspiration. Nosebleeds usually origi- nate in the anterior part of the nasal septum and can be con- trolled by applying pressure to the soft lower portion of the nose with the thumb and forefinger for at least 10 minutes. If bleeding persists, cotton or wadded tissue should be placed into each nostril, and ice or a cold cloth should be applied to the bridge of the nose. In addition, if bleeding persists, the health care provider (HCP) needs to be notified, and the nose may require packing by the HCP. After the nosebleed has been stopped, petroleum or a water-soluble jelly may be inserted into each nostril to prevent crusting of old blood and to lessen the likelihood of the child picking at the crusted lesions and restarting the bleeding. Repeated bleeding episodes that last longer than 30 minutes may be an indica- tion of the need for evaluation of a bleeding disorder.

Reference Hockenberry, Wilson (2015), p. 1362.

P R A C T I C E Q U E S T I O N S 392. After a ton sillectom y, a ch ild begin s to vom it brigh t

red blood . Th e n urse sh ould take wh ich in itial action ? 1. Tu rn th e ch ild to th e side. 2. Adm in ister th e prescribed an tiem etic. 3. Notify th e h ealth care provider (HCP). 4. Main tain NPO (n oth in g by m ou th ) status.

393. Th e m oth er of a 6-year-old ch ild arrives at a clin ic because th e ch ild h as been exp erien cin g itch y, red, an d swollen eyes. Th e n urse n otes a disch arge from th e eyes an d sen ds a culture to th e labo ratory for an alysis. Ch lam ydial co n jun ctivitis is diagn osed. O n th e basis of th is diagn osis, th e n urse determ in es th at wh ich requires furth er in vestigation ? 1. Possible traum a 2. Possible sexual abuse 3. Presen ce of an allergy 4. Presen ce of a respiratory in fectio n

394. Th e n urse prepares a teach in g plan for th e m oth er of a ch ild diagn osed with bacterial con jun ctivitis. Wh ich , if stated by th e m oth er, in dicates a n eed fo r fu rth er teach in g? 1. “I n eed to wash m y h an ds frequen tly.” 2. “I n eed to clean th e eye as prescribed.” 3. “It is okay to sh are towels an d wash cloth s.” 4. “I n eed to give th e eye drops as prescribed.”

395. Th e n urse is reviewin g th e laborato ry results for a ch ild sch eduled for a ton sillectom y. Th e n urse determ in es th at wh ich laborato ry value is m o st sig- n ifican t to review? 1. Creatin in e level 2. Proth rom bin tim e 3. Sedim en tation rate 4. Bloo d urea n itrogen level

396. Th e n urse is preparin g to care for a ch ild after a ton - sillecto m y. Th e n urse docum en ts on th e plan of care to place th e ch ild in wh ich position ? 1. Supin e 2. Side-lyin g 3. High Fowler’s 4. Tren d elen burg

397. After a ton sillectom y, th e n urse reviews th e h ealth care provider’s (HCP’s) postoperative prescrip- tion s. Wh ich prescription sh ould th e n urse question ? 1. Mon itor for bleedin g. 2. Suction every 2 h ours. 3. Give n o m ilk or m ilk produ cts. 4. Give clear, cool liquid s wh en awake an d alert.

398. Th e n urse is carin g for a ch ild after a ton sillectom y. Th e n urse m on itors th e ch ild, kn owin g th at wh ich fin din g in dicates th e ch ild is bleedin g? 1. Frequen t swallowin g 2. A decreased pulse rate 3. Com plain ts of discom fort 4. An elevation in blood pressure

399. An tibio tics are prescribed for a ch ild with otitis m ed ia wh o un derwen t a m yrin gotom y with in ser- tion of tym pan ostom y tubes. Th e n urse provides disch arge in struction s to th e paren ts regardin g th e adm in istration of th e an tibiotics. Wh ich state- m en t, if m ade by th e paren ts, in dicates un der- stan d in g of th e in struction s provid ed? 1. “Adm in ister th e an tibiotics un til th ey are gon e.” 2. “Adm in ister th e an tibiotics if th e ch ild h as

a fever.” 3. “Adm in ister th e an tibiotics un til th e ch ild

feels better.” 4. “Begin to taper th e an tibiotics after 3 days of a

full course.”

460 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

400. Th e day care n urse is observin g a 2-year-o ld ch ild an d suspects th at th e ch ild m ay h ave strab ism us. Wh ich observation m ade by th e n urse in dicates th e presen ce of th is con d ition ? 1. Th e ch ild h as difficu lty h earin g. 2. Th e ch ild con sisten tly tilts th e h ead to see. 3. Th e ch ild does n ot respo n d wh en spoken to. 4. Th e ch ild con sisten tly turn s th e h ead to h ear.

401. A ch ild h as been diagn osed with acu te otitis m ed ia of th e righ t ear. Wh ich in terven tion s sh o uld th e

n urse in clude in th e plan of care? Select all th at ap p ly.

1. Provide a soft diet. 2. Position th e ch ild on th e left side. 3. Adm in ister an an tih istam in e twice daily. 4. Irrigate th e righ t ear with n orm al salin e every

8 h ours. 5. Adm in ister ibuprofen for fever every 4 h ours

as prescribed an d as n eeded. 6. In struct th e paren ts about th e n eed to adm in -

ister th e prescribed an tibiotics for th e full course of th erapy.

A N S W E R S 392. 1 Ra tion a le: After ton sillectom y, if b leed in g o ccurs, th e n urse im m ediately turn s th e ch ild to th e side to p reven t aspiratio n an d th en n otifies th e HCP. NPO statu s wo u ld b e m ain tain ed, an d an an tiem etic m ay b e p rescribed ; h o wever, th e in itial n urs- in g action wou ld be to tu rn th e ch ild to th e sid e. Test-Ta kin g Str a tegy: Note th e strategic wo rd , initial. Alth ou gh all of th e op tio n s m ay b e app ro priate to m ain tain p h ysio logical in tegrity, th e in itial action is to turn th e ch ild to th e side to preven t aspiration . Review: To n sillecto m y Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: McKin n ey et al. (2013), p. 1158.

393. 2 Ra tion a le: Con jun ctivitis is an in flam m ation of th e con jun c- tiva. A d iagn osis o f ch lam yd ial co n ju n ctivitis in a ch ild wh o is n o t sexu ally active sh ou ld sign al th e h ealth care p ro vider to assess th e ch ild for p ossible sexu al abu se. Traum a, allergy, an d in fection can cause con jun ctivitis, b u t th e cau sative o rgan - ism is n ot likely to be Chlamydia. Test-Ta kin g Str a tegy: No te th e age of th e ch ild an d th e o rgan - ism th at is id en tified in th e q uestio n . Also n o te th at o ption s 1, 3, an d 4 are co m p arab le o r alike in th at th ey can be recogn ized as th e co m m o n causes of co n ju n ctivitis an d th ey relate to a p h ysio logical prob lem . Review: Causes of ch lam yd ial co n ju n ctivitis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Pediatrics—In fectiou s an d Com m un icab le Diseases Pr ior it y Con cept s: Clin ical Ju dgm en t; In fection Refer en ces: Hocken berry, Wilso n (2015), p. 562. McKin n ey et al. ( 2013) , p p. 1508-1509.

394. 3 Ra tion a le: Con jun ctivitis is an in flam m ation of th e con jun c- tiva. Bacterial con ju n ctivitis is h igh ly con tagiou s, an d th e n urse sh o u ld teach in fection con tro l m easu res. Th ese in clu de goo d h an d wash in g an d n o t sh arin g to wels an d wash clo th s. O p tion s 1, 2, an d 4 are correct treatm en t m easu res.

Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further teaching. Th ese wo rd s in d icate a n egative even t q u ery an d ask you to select an o ptio n th at is an in correct statem en t. O p tion s 1, 2, an d 4 can b e elim in ated b y recallin g th at b acterial con - ju n ctivitis is h igh ly co n tagio us. Review: Infection con tro l m easures for b acterial con ju n ctivitis Level of Cogn itive Ability: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Eye/ Ear Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: McKin n ey et al. (2013), p. 1509.

395. 2 Ra tion a le: A ton sillectom y is th e su rgical rem o val o f th e to n - sils. Becau se th e to n sillar area is so vascular, p osto perative b leed in g is a con cern . Proth ro m b in tim e, partial th ro m b op las- tin tim e, p latelet co u n t, h em o glob in an d h em atocrit, wh ite b loo d cell cou n t, an d u rin alysis are p erfo rm ed p reo peratively. Th e proth ro m b in tim e results wo uld iden tify a po ten tial fo r b leed in g. Creatin in e level, sed im en tatio n rate, an d bloo d urea n itro gen wo uld n o t determ in e th e p oten tial for b leed in g. Test-Ta kin g Str a t egy: No te th e strategic wo rd , most. Fo cu s on th e su rgical p ro cedu re an d th e su b ject o f th e q uestio n . Th e su b ject o f th e qu estio n relates to th e po ten tial for b leed in g. O ptio n s 1 an d 4 can b e elim in ated b ecau se th ey relate to kid- n ey fun ctio n . O ptio n 3 can be elim in ated b ecau se it is un re- lated to th e su b ject of th e q uestion . Review: To n sillecto m y Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ces: Hocken berry, Wilso n (2015), p. 1358. McKin n ey et al. ( 2013) , p . 1158.

396. 2 Ra tion a le: A ton sillectom y is th e su rgical rem o val o f th e to n - sils. Th e ch ild sh ou ld be p laced in a p ro n e or sid e-lyin g p osi- tio n after th e surgical proced ure to facilitate d rain age. O ptio n s 1, 3, an d 4 wo uld n o t ach ieve th is go al. Test-Ta kin g St r a tegy: Focus on th e su b ject, p osition in g after ton sillecto m y. Fo cu s o n th e su rgical proced ure an d visu alize each o f th e po sitio n s d escrib ed in th e o ptio n s. Keepin g in m in d th at th e go al is to facilitate d rain age will direct you to th e cor- rect option . Review: Po sitio n in g gu id elin es fo llo win g to n sillecto m y

461CHAPTER 38 Eye, Ear, and Throat Disorders

Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Caregivin g; Safety Refer en ce: McKin n ey et al. (2013), p. 1158.

397. 2 Ra tion a le: A ton sillecto m y is th e su rgical rem o val o f th e ton - sils. After ton sillectom y, suction eq u ipm en t sh ou ld b e avail- ab le, b ut suction in g is n ot p erfo rm ed u n less th ere is an airway o b stru ctio n b ecau se o f th e risk of trau m a to th e su rgical site. Mon itorin g fo r bleedin g is an im p o rtan t n u rsin g in terven - tio n after an y type o f surgery. Milk an d m ilk p ro d ucts are avoided in itially b ecau se th ey co at th e th ro at, cause th e ch ild to clear th e th ro at, an d in crease th e risk of bleedin g. Clear, coo l liq u ids are en co uraged. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e prescrip tio n th at th e n u rse q uestion s. O p tion 1 can b e elim in ated first b ecau se th is is a n ursin g action , n ot a m edical p rescriptio n . Fro m th e rem ain in g o ption s, co n sid er th e an atom ical location o f th e su rgery. Th is sh ou ld direct yo u to th e co rrect o ption . Review: Po stop erative care followin g to n sillecto m y Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Co llab oration ; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 1157.

398. 1 Ra tion a le: A ton sillecto m y is th e su rgical rem o val o f th e ton - sils. Frequ en t swallo win g, restlessn ess, a fast an d th read y pu lse, an d vo m itin g b righ t red bloo d are sign s o f b leed in g. An ele- vated bloo d pressure an d co m plain ts of d iscom fo rt are n o t in dicatio n s o f b leed in g. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, a sign of b leed in g, an d u se th e con cep ts related to th e sign s o f sh o ck. Th ese con - cepts sh o uld assist in elim in atin g op tion s 2 an d 4. Fro m th e rem ain in g o p tion s, recallin g th at disco m fo rt is exp ected an d d oes n ot in dicate b leed in g will direct yo u to th e co rrect o ption . Review: Sign s o f b leed in g followin g to n sillecto m y Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Hocken b erry, Wilso n (2015), p. 1175.

399. 1 Ra tion a le: A m yrin goto m y is th e in sertion of tym p an o plasty tu bes in to th e m idd le ear to p ro m o te drain age o f p urulen t m id- d le ear fluid , equ alize p ressu re, an d keep th e ear aerated . Th e n u rse m ust in stru ct paren ts regardin g th e adm in istratio n of an tib io tics. An tibio tics n eed to be taken as p rescribed, an d th e full cou rse n eed s to b e co m p leted . O ptio n s 2, 3, an d 4 are in correct. An tib io tics are n o t tap ered , b ut are adm in istered fo r th e full cou rse o f th erap y. Test-Ta kin g St r a tegy: Focu s on th e su b ject, un d erstan d in g o f th e in structio ns about an tib io tics. Recall that an tib iotics m ust

b e taken for th e full cou rse, regardless of wh eth er th e child is feel- in g b etter. Th is will assist in d irectin g you to th e correct o ptio n . Review: Adm in istratio n of an tib io tics Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ped iatrics—Eye/ Ear Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 1181.

400. 2 Ra tion a le: Strab ism us is a co n d itio n in wh ich th e eyes are n o t align ed b ecau se of lack o f co ordin atio n o f th e extrao cu lar m u s- cles. Th e n urse m ay su spect strab ism us in a ch ild wh en th e ch ild com p lain s of freq uen t h ead ach es, squ in ts, or tilts th e h ead to see. O th er m an ifestatio n s in clu de crossed eyes, closin g o n e eye to see, d ip lop ia, p h o top h o bia, loss o f b in o cular vision , o r im pairm en t o f dep th perception . O p tion s 1, 3, an d 4 are n o t in dicative o f th is con ditio n . Test-Ta kin g Str a tegy: Elim in ate o ptio n s 1 an d 4 first b ecause th ey are co m p arab le o r alike an d relate to h earin g. To select fro m th e rem ain in g op tio n s, recall th at th is is a con d itio n in wh ich th e eyes are n o t align ed b ecause of lack o f coo rd in atio n o f th e extraocu lar m u scles. Review: Strab ism u s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Eye/ Ear Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen sory Perceptio n Refer en ce: Hocken b erry, Wilso n (2015), p. 846.

401. 1, 5, 6 Ra tion a le: Acute otitis m edia is an in flam m atory disorder cau sed by an in fectio n o f th e m id dle ear. Th e ch ild o ften h as fever, p ain , lo ss of ap p etite, an d p ossible ear d rain age. Th e ch ild also is irritable an d leth argic an d m ay roll th e h ead o r pu ll o n o r ru b th e affected ear. O toscop ic exam in ation m ay reveal a red, opaque, bulgin g, an d im m obile tym pan ic m em b ran e. Hearin g loss m ay be n oted p articu larly in ch ron ic o titis m edia. Th e ch ild’s fever sh o uld b e treated with ib up ro fen . Th e ch ild is p ositio n ed o n h is o r h er affected side to facilitate drain age. A so ft d iet is recom m en d ed du rin g th e acute stage to avoid p ain th at can occu r with ch ewin g. An tib io tics are prescrib ed to treat th e b acterial in fection an d sh ou ld b e adm in istered for th e fu ll p rescrib ed cou rse. Th e ear sh o u ld n ot b e irrigated with n orm al salin e b ecau se it can exacerb ate th e in flam m atio n furth er. An ti- h istam in es are n o t usu ally recom m en d ed as a p art of th erapy. Test-Ta kin g Str a tegy: Focu s o n th e su b ject, care fo r th e ch ild with acu te o titis m edia, an d o n th e ch ild’s d iagn osis an d n ote th e words acute an d right ear. Th in k ab ou t th e p ath op h ysio lo gy asso ciated with th e diso rder an d th e asso ciated m an ifestatio n s to select th e correct op tio n s. Review: Acu te o titis m ed ia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—Eye/ Ear Pr ior it y Con cept s: Clin ical Ju dgm en t; In fectio n Refer en ce: McKin n ey et al. (2013), pp . 1152-1153.

P

e

d

i

a

t

r

i

c

s

462 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 39 Respiratory Disorders

PRIORITY CONCEPTS Gas Exchange; Health Promotion

CRITICAL THINKING What Should You Do? A child with pneumonia complains of pain in the pleural area on the affected side. What should the nurse do? Answer located on p. 474.

I. Epiglottitis A. Descrip tion

1. Bacterial form of cro up 2. In flam m ation of th e epiglottis occurs, wh ich m ay

be caused by Haemophilus influenzae type b or Streptococcus pneumoniae; ch ildren im m un ized with H. influenzae type b (Hib vaccine) are at less risk for epiglottitis.

3. O ccurs m ost frequen tly in ch ildren 2 to 8 years old, but can occur from in fan cy to adulth o od

4. O n set is abrupt, an d th e con dition occurs m ost often in win ter.

5. Con sidered an em ergen cy situation because it can progress rapidly to severe respiratory distress

B. Assessm en t 1. High fever 2. Sore, red, an d in flam ed th roat (large, ch erry red,

edem atou s epiglottis) an d pain on swallowin g (Fig. 39-1)

3. Absen ce of spon tan eous cough 4. Dysp h on ia (m uffled vo ice), dysph agia, dyspn ea,

an d droolin g 5. Agitation 6. Retractions as th e ch ild struggles to breath e 7. In spiratory stridor aggravated by th e supin e

position 8. Tach ycardia 9. Tach ypn ea progressin g to m ore severe respiratory

distress (h ypoxia, h ypercapn ia, respiratory acido- sis, decreased level of con scio usn ess)

10. Tripod position in g: Wh ile supp ortin g th e body with th e h an ds, th e ch ild lean s forward, th rusts

th e ch in forward an d open s th e m ou th in an attem p t to widen th e airway.

C. In terven tion s 1. Main tain a paten t airway. 2. Assess respiratory status an d breath soun ds, n ot-

in g nasal flaring, th e use of accesso ry m uscles, retraction s, an d th e presen ce of stridor (Fig. 39-2).

3. Do n ot m easure the tem perature by th e oral route. 4. Mon itor pulse oxim etry. 5. Prepare th e ch ild for lateral n eck film s to con firm

th e diagn osis (accom pan y th e ch ild to th e radiol- ogy departm en t).

6. Main tain NPO (n oth in g by m ou th ) status. 7. Do n ot leave th e ch ild un atten ded. 8. Avoid placin g th e ch ild in a supin e position

because th is position would affect th e respiratory status furth er.

9. Do n ot restrain th e ch ild or take an y oth er m ea- sure th at m ay agitate th e ch ild.

10. Adm in ister in traven o us (IV) fluid s as prescribed; in sertio n of an IV lin e m ay n eed to be delayed un til an adequ ate airway is establish ed because th is proced ure m ay agitate th e ch ild.

11. Adm in ister IV an tibiotics as prescribed; th ese are usually followed by oral an tibiotics.

12. Adm in ister an algesics an d an tipyretics (acet- am in op h en or ibuprofen ) to reduce fever an d th roat pain as prescribed .

13. Adm in ister cortico steroids to decrease in flam m a- tion an d reduce th roat edem a as prescribed.

14. Nebulized epin eph rin e (racem ic epin eph rin e) m ay be prescribed for severe cases (causes m uco- sal vasocon striction an d reduces edem a) ; h eliox (m ixture of h elium an d oxygen ) m ay also be pre- scribed to reduce m ucosal edem a.

15. Provide cool m ist oxygen th erap y as prescribed; h igh h um idification cools th e airway an d decreases swellin g.

16. Have resuscitation equip m en t available, an d pre- pare for en dotrach eal in tub ation or trach eotom y for severe respiratory distress.

463

17. En sure th at th e ch ild is up to date with im m un i- zation s, in cludin g Hib con jugate vaccin e (see Ch apter 44).

If epiglottitis is suspected, no attempts should be made to visualize the posterior pharynx, obtain a throat culture, or take an oral temperature. Otherwise, spasm of the epiglottis can occur, leading to complete airway occlusion.

II. Laryngotracheobronchitis A. Description

1. In flam m ation of th e laryn x, trach ea, an d bron ch i 2. Most co m m on type of croup; m ay be viral or bac-

terial an d m ost frequen tly occurs in ch ildren youn ger th an 5 years

3. Com m on cau sative organ ism s in clude parain - fluen za virus types 2 an d 3, respiratory syn cytial virus (RSV) , Mycoplasma pneumoniae, an d in flu- en za A an d B.

4. Ch aracterized by gradual on set th at m ay be pre- ceded by an upper respiratory in fectio n

B. Assessm en t ( Box 39-1) C. In terven tion s

1. Main tain a paten t airway. 2. Assess respiratory status an d m on itor pulse oxim -

etry; m on itor for nasal flaring, stern al retraction , an d in spiratory stridor (see Fig. 39-2).

3. Mon itor for adequ ate respiratory exch an ge; m on - itor for pallor or cyanosis.

4. Elevate th e h ead of th e bed an d provide rest. 5. Provide h um idified oxygen via a cool air or m ist

ten t as prescribed for a h ospitalized ch ild (Table 39-1).

6. In struct th e paren ts to use a cool air vaporizer at h om e; oth er m easu res in clude h avin g th e ch ild breath e in th e cool n igh t air or th e air from an open freezer or takin g th e ch ild to a cool base- m en t or garage.

7. Provide an d en courage fluid in take; IV fluids m ay be prescribed to m ain tain h ydration status if th e ch ild is un ab le to take fluid s orally.

8. Adm in ister an algesics as prescribed to reduce fever.

9. Teach th e paren ts to avoid adm in isterin g cough syrups or cold m edicin es, wh ich m ay dry an d th icken secretio n s.

10. Adm in ister cortico steroids if prescribed to reduce in flam m ation an d edem a.

11. Adm in ister n ebulized epin eph rin e (racem ic epi- n eph rin e) as prescribed; th is m ay be prescribed for ch ildren with severe disease exp erien cin g stri- dor at rest, retraction s, or difficu lty breath in g.

P

e

d

i

a

t

r

i

c

s

A B

Fa ls e cords

True cords

Tra che a

S ubglottic tis s ue

Epiglottis

FIGURE 39-1 A, Normal larynx. B, Obstruction and narrowing resulting from edema of croup.

Inte rcos ta l

S ubs te rna l

S ubcos ta l

S upra s te rna l

Cla vicula r

FIGURE 39-2 Location of retractions.

BOX 39-1 Progression of Symptoms in Laryngotracheobronchitis

Stage I ▪ Low-grade fever ▪ Hoarseness ▪ Seal bark and brassy cough (croup cough) ▪ Inspiratory stridor ▪ Fear ▪ Irritability and restlessness Stage II ▪ Continuous respiratory stridor ▪ Retractions ▪ Use of accessory muscles ▪ Crackles and wheezing ▪ Labored respirations Stage III ▪ Continued restlessness ▪ Anxiety ▪ Pallor ▪ Diaphoresis ▪ Tachypnea ▪ Signs of anoxia and hypercapnia Stage IV ▪ Intermittent cyanosis progressing to permanent cyanosis ▪ Apneic episodes progressing to cessation of breathing

Adapted from Perry S, Hockenberry M, Lowderm ilk D, Wilson D: Maternal-child nurs- ing care, ed 4, St. Louis, 20 10 , Mosby.

464 UNIT VII Pediatric Nursing

12. Adm in ister an tibiotics as prescribed , n otin g th at th ey are n ot in dicated un less a bacterial in fectio n is presen t.

13. Helio x (m ixture of h elium an d oxygen ) m ay be prescribed; th is m ed ication reduces th e work of breath in g, reduces airway turbulen ce, an d h elp s to relieve airway obstru ction .

14. Have resuscitation equ ipm en t available. 15. Provid e appropriate reassuran ce an d education

to th e paren ts or caregivers.

Isolation precautions should be implemented for a hospitalized child with an upper respiratory infection until the cause of the infection is known.

III. Bronchitis A. Descrip tion

1. In flam m ation of th e trach ea an d bron ch i; m ay be referred to as trach eobron ch itis

2. Usually occurs in association with an upper respi- ratory in fectio n

3. Is usually a m ild disorder; causative agen t is m ost often viral

B. Assessm en t 1. Fever 2. Dry, h ackin g, an d n on pro ductive cough th at is

worse at n igh t an d beco m es produ ctive in 2 to 3 days

C. In terven tion s 1. Treat sym ptom s as n ecessary. 2. Mon itor for respiratory distress.

3. Provide cool, h um idified air to th e ch ild. 4. En courage in creased fluid in take; ch ild m ay

drin k beverages th at h e or sh e likes as lo n g as th e respiratory status is stable.

5. Adm in ister an tipyretics for fever as prescribed. 6. A cough suppressan t m ay be prescribed to

prom o te rest.

IV. Bronchiolitis and Respiratory Syncytial Virus (RSV) A. Description

1. Bron ch iolitis is an in flam m ation of th e bron ch i- oles th at causes produ ction of th ick m ucus th at occlu des bron ch iole tubes an d sm all bron ch i.

2. RSV causes an acu te viral in fection an d is a com - m on cau se of bron ch iolitis (oth er organ ism s th at cau se bron ch iolitis in clude aden oviruses, parain - fluen za viruses, an d h um an m etap n eum o virus).

3. RSV, alth ough n ot airborn e, is h igh ly com m un i- cab le an d is usually tran sferred by direct con tact with respiratory secretio n s.

4. RSV occurs prim arily in th e win ter an d sprin g. 5. RSV is rarer in ch ildren older th an 2 years, with a

peak in ciden ce at ap proxim ately 6 m on th s of age.

6. At-risk ch ildren in clude ch ildren older th an 1 year of age wh o h ave a ch ron ic or disablin g con d ition .

7. Iden tification of th e virus is don e via testin g of n asal or n aso ph aryn geal secretion s.

8. Preven tion m easures in clude en couragin g breast- feedin g; avoidin g tobacco sm oke exposure; usin g

P

e

d

i

a

t

r

i

c

s

TABLE 39-1 Oxygen Delivery Systems: Advantages and Disadvantages System Advantages Disadvantages

Oxygen mask Various sizes available; delivers higher O2 concentration than cannula Able to provide a predictable concentration of oxygen if Venturi mask is used, whether child breathes through nose or mouth

Skin irritation Fear of suffocation Accumulation of moisture on face Possibility of aspiration of vomitus Difficulty in controlling O2 concentrations (except with Venturi mask)

Nasal cannula Provides low-moderate O2 concentration (22%-40 %) Child is able to eat and talk while getting O2 Possibility of more complete observation of child because nose and mouth remain unobstructed

Must have patent nasal passages May cause abdominal distention and discomfort or vomiting Difficulty controlling O2 concentrations if child breathes through mouth Inability to provide mist if desired

Oxygen tent Provides lower O2 concentrations (FIO2 up to 0 .3-0.5) Child is able to receive desired inspired O2 concentrations, even while eating

Necessity for tight fit around bed to prevent leakage of oxygen Cool and wet tent environment Poor access to child; inspired O2 levels fall when tent is entered

Oxygen hood, face tent

Provides high O2 concentrations (FIO2 up to 1.00) Free access to child’s chest for assessment

High-humidity environment Need to remove child for feeding and care

Data from Hockenberry M, Wilson D: Wong’s nursing care of infants and children, ed 9, St. Louis, 2011, Mosby. FIO2, Fraction of inspired oxygen; O2, oxygen.

465CHAPTER 39 Respiratory Disorders

P

e

d

i

a

t

r

i

c

s

good h an d-wash in g tech n iques; an d adm in ister- in g palivizum ab, a m on oclon al an tibody, to h igh -risk in fan ts. Palivizum ab is adm in istered via in tram uscular in jection m on th ly for a 5- m on th period (usually from Novem ber to March ).

B. Assessm en t (Box 39-2) C. In terven tion s

1. For a ch ild with bron ch iolitis, in terven tion s are aim ed at treatin g sym pto m s an d in clude airway m ain ten an ce, cool h um idified air an d oxygen , adequ ate fluid in take, an d m edication s.

2. For a h ospitalized ch ild with RSV, isolate th e ch ild in a sin gle room or place in a room with an oth er ch ild with RSV.

3. En su re th at n urses carin g for a ch ild with RSV do n ot care for oth er h igh -risk ch ildren .

4. Use con tact an d stan d ard precaution s durin g care; usin g good h an d-wash in g tech n iques an d wearin g gloves an d go wn s are n ecessary.

5. Mon itor airway status an d m ain tain a paten t airway.

6. For m ost effective airway m ain ten an ce, position th e ch ild at a 30- to 40-degree an gle with th e n eck sligh tly exten ded to m ain tain an open airway an d decrease pressure on th e diaph ragm .

7. Provide cool, h um idified oxygen as prescribed. 8. Mon itor pulse oxim etry levels. 9. En cou rage fluid s; fluids adm in istered in trave-

n ously m ay be n ecessary un til th e acute stage h as passed.

10. Periodic suction in g m ay be n ecessary if n asal secretio n s are copious; use of a bulb syrin ge for suction in g m ay be effective. Suction in g sh ould be don e before feed in g to prom o te com fo rt an d ad equate in take.

11. Adm in ister ribavirin , an an tiviral m edication , as prescribed,

Cough suppressants are administered with caution because they can interfere with the clearance of respira- tory secretions.

V. Pneumonia A. Description

1. In flam m ation of th e pulm o n ary paren ch ym a or alveo li or both , caused by a virus, m ycoplasm al agen ts, bacteria, or aspiration of foreign substan ces.

2. Th e cau sative agen t usually is in trodu ced in to th e lun gs th rou gh in h alation or from th e blood stream .

3. Viral pn eum on ia occurs m ore frequen tly th an bacterial pn eum on ia, is seen in ch ildren of all ages, an d often is associated with a viral upper respiratory in fectio n .

4. Prim ary atypical pn eum on ia, usually cau sed by Mycoplasma pneumoniae or Chlamydia pneumo- niae, occurs m ost often in th e fall an d win ter m on th s an d is m ore com m on in crowded livin g con d ition s; it is m ost often seen in ch ildren 5 to 12 years old.

5. Bacterial pn eum on ia is often a serious in fection requirin g h ospitalization wh en pleural effusio n or em pyem a acco m pan ies th e disease; h ospitali- zation is also n ecessary for ch ildren with staph y- lococcal pn eum on ia ( Streptococcus pneumoniae is a com m on cau se).

6. Aspiration pn eum on ia occurs wh en food , secre- tion s, liquids, or oth er m aterials en ter th e lun g an d cause in flam m ation an d a ch em ical pn eu- m on itis. Classic sym ptom s in clude an in creasin g cough or fever with foul-sm ellin g sputu m , dete- rioratin g results on ch est x-rays, an d oth er sign s of airway in volvem en t.

7. Preven tion of viral an d bacterial pn eum on ia in cludes im m un ization of in fan ts an d ch ildren with h eptavalen t pn eum ococcal con jugate vac- cine (see Ch apter 44).

B. Viral pn eum on ia 1. Assessm en t

a . Acute or in sidious on set b . Sym pto m s ran ge from m ild fever, sligh t

cough , an d m alaise to h igh fever, severe cough , an d diaph o resis.

c. Non p roductive or produ ctive cough of sm all am oun ts of wh itish sputu m

d . Wh eezes or fin e crackles

BOX 39-2 Assessment: Respiratory Syncytial Virus

Initial Manifestations ▪ Rhinorrhea ▪ Eye or ear drainage ▪ Pharyngitis ▪ Coughing ▪ Sneezing ▪ Wheezing ▪ Intermittent fever Manifestations as Disease Progresses ▪ Increased coughing and wheezing ▪ Signs of air hunger ▪ Tachypnea and retractions ▪ Periods of cyanosis Manifestations in Severe Illness ▪ Tachypnea more than 70 breaths/ minute ▪ Decreased breath sounds and poor air exchange ▪ Listlessness ▪ Apneic episodes

Adapted from Perry S, Hockenberry M, Lowderm ilk D, Wilson D: Maternal-child nurs- ing care, ed 4, St. Louis, 20 10 , Mosby.

466 UNIT VII Pediatric Nursing

2. In terven tion s a . Treatm en t is sym ptom atic. b . Adm in ister oxygen with cool h um idified air

as prescribed. c. In crease fluid in take. d . Adm in ister an tipyretics for fever as

prescribed. e. Adm in ister ch est ph ysioth erapy an d postural

drain age as prescribed . C. Prim ary atypical pn eum on ia

1. Assessm en t a . Acute or in sidious on set b . Fever (lastin g several days to 2 weeks) , ch ills,

an orexia, h ead ach e, m alaise, an d m yalgia (m uscle pain )

c. Rh in itis; sore th roat; an d dry, h ackin g cough d . Non p roductive cough in itially, progressin g

to produ ction of serom ucoid sputum th at beco m es m ucopurulen t or blood -streaked

2. In terven tion s a . Treatm en t is sym ptom atic. b . Recovery gen erally occurs in 7 to 10 days.

D. Bacterial pn eum on ia 1. Assessm en t

a . Acute on set b . In fan t: Irritability, leth argy, poor feedin g;

abrupt fever (m ay be acco m pan ied by sei- zures); respiratory distress (air h un ger, tach ypn ea, an d circum oral cyan osis)

c. O lder ch ild: Headach e, ch ills, abdom inal pain , ch est pain , m en in geal sym ptom s (m en in gism )

d . Hackin g, n on productive cough e. Dim in ish ed breath soun ds or scattered

crackles f. With con solidation , decreased breath

soun ds are m ore pron oun ced . g. As th e in fectio n resolves, th e cough beco m es

produ ctive an d th e ch ild expecto rates puru- len t sputum ; coarse crackles an d wheezing are n oted.

2. In terven tion s a . An tibio tic th erap y is in itiated as soon as th e

diagn osis is susp ected; in a h ospitalized in fan t or ch ild, IV an tibiotics are usually prescribed.

b . Adm in ister oxygen for respiratory distress as prescribed, an d m on itor oxygen saturation via pulse oxim etry.

c. Place th e ch ild in a cool m ist ten t as pre- scrib ed; cool h um idification m oisten s th e airways an d assists in tem p erature reduction .

d . Suction m ucus from th e in fan t, usin g a bulb syrin ge, to m ain tain a paten t airway if th e in fan t is un ab le to h an dle secretion s.

e. Adm in ister ch est ph ysioth erapy an d postural drain age every 4 h ours as prescribed.

f. Prom o te bed rest to con serve en ergy.

g. En courage th e ch ild to lie on th e affected side (if pn eum on ia is un ilateral) to splin t th e ch est an d reduce th e discom fort cau sed by pleural ru bbin g.

h . En courage fluid in take (adm in ister cau- tiously to preven t aspiration ) ; in traven o usly adm in istered flu ids m ay be n ecessary.

i. Adm in ister an tipyretics for fever an d bron - ch odilators as prescribed.

j. Mon itor tem perature frequen tly because of th e risk for febrile seizures.

k . In stitute isolatio n precaution s with pn eum o- coccal or staph ylococcal pn eum on ia (accordin g to agen cy policy).

l. Adm in ister cough suppressan t as prescribed before rest tim es an d m eals if th e cough is disturbin g.

m . Con tin uo us closed ch est drain age m ay be in stituted if purulen t fluid is presen t (usually n oted in Staphylococcus in fectio n s).

n . Fluid accu m ulation in th e pleural cavity m ay be rem oved by th o racen tesis; th oracen tesis also provides a m ean s for obtain in g fluid for culture an d for in stillin g an tibiotics directly in to th e pleural cavity.

Children with a respiratory disorder should be mon- itored for weight loss and for signs of dehydration. Signs of dehydration include a sunken fontanel (infants), none- lastic skin turgor, decreased and concentrated urinary output, dry mucous membranes, and decreased tear production.

VI. Asthma A. Description

1. Asth m a is a ch ron ic in flam m ato ry disease of th e airways (see Ch apter 54).

2. Asth m a is classified on th e basis of disease sever- ity; m an agem en t in cludes m ed ication s, en viron - m en tal con trol of allergen s, an d ch ild an d fam ily edu cation .

3. Th e allergic reaction in th e airways cau sed by th e precipitan t can result in an im m ediate reaction with obstru ction occurrin g, an d it can result in a late bron ch ial obstru ctive reactio n several h ours after th e in itial exposu re to th e precipitan t.

4. Mast cell release of h istam in e leads to a bron ch o- con strictive process, bron ch ospasm , an d obstru ctio n .

5. Diagn osis is m ade on th e basis of th e child’s sym ptom s, h istory an d ph ysical exam in ation , chest radiograph , and laboratory tests (Box 39-3).

6. Precipitan ts m ay trigger an asth m a attack (Box 39-4).

7. Status asth m aticus is an acute asth m a attack, an d th e ch ild displays respiratory distress despite

P

e

d

i

a

t

r

i

c

s

467CHAPTER 39 Respiratory Disorders

vigorous treatm en t m easures; th is is a m ed ical em ergen cy th at can result in respiratory failure an d death if n ot treated.

B. Assessm en t 1. Ch ild h as episodes of dyspn ea, wheezing, breath -

lessn ess, ch est tigh tn ess, an d cough , particularly at n igh t or in th e early m orn in g or both .

2. Acute asth m a attacks a . Episodesin clude progressivelyworsen in gsh ort-

ness ofbreath, cough, wheezing, chest tightn ess, decreases in expiratory airflow secondary to bronch ospasm , m ucosal edem a, an d m ucus pluggin g; air is trapped beh in d occluded or n ar- row airways, an d hypoxem ia can occur.

b . Th e attack begin s with irritab ility, restless- n ess, h eadach e, feelin g tired, or ch est tigh t- n ess; just befo re th e attack, th e ch ild m ay presen t with itch in g localized at th e fro n t of th e n eck or over th e upper part of th e back.

c. Respiratory sym pto m s in clude a h ackin g, irritable, n on productive cough caused by bron ch ial edem a.

d . Accum ulated secretions stim ulate th e cough ; th e cough becom es rattlin g, an d th ere is production of froth y, clear, gelatin ous sputum .

e. Th e ch ild experien ces retraction s. f. Hyperreson an ce on percussion of th e ch est

is n oted. g. Breath soun ds are coarse an d loud, with

crackles, coarse rh on ch i, an d in spiratory an d expiratory wh eezin g; expiration is prolon ged.

h . Ch ild m ay be pale or flush ed, an d the lips m ay h ave a deep, dark red color th at m ay pro- gress to cyanosis (also observed in th e n ail beds an d skin , especially aroun d the m outh ).

i. Restlessn ess, appreh en sion , an d diaphoresis occur.

j. Ch ild speaks in sh o rt, broken ph rases. k . Youn ger ch ildren assum e th e tripod sittin g

position ; older ch ildren sit uprigh t, with th e sh oulders in a h un ch ed -over position , th e h an ds on th e bed or a ch air, an d th e arm s braced to facilitate th e use of th e accessory m uscles of breath in g (ch ild avoids a lyin g- down position ).

l. Exercise-in duced attack: Cough , shortn ess of breath , ch est pain or tigh tness, wheezin g, an d en duran ce problem s occur durin g exercise.

m . Severe spasm or obstru ctio n : Breath soun ds an d wh eezin g can n ot be h eard (silen t ch est), an d cough is in effective (rep resen ts a lack of air m ovem en t).

n . Ven tilatory failure an d asph yxia: Sh o rtn ess of breath , with air m ovem en t in th e ch est restricted to th e poin t of absen t breath soun ds, is n oted; th is is acco m pan ied by a sudden in crease in th e respiratory rate.

C. In terven tion s: Acute episo de (see Priority Nursin g Action s)

P

e

d

i

a

t

r

i

c

s

BOX 39-3 Laboratory Tests to Assist in Diagnosing Asthma

Pulmona ry Funct ion Test s: Spirometry testing assesses the presence and degree of disease and can determine the response to treatment.

Pea k Expira tory Flow Ra te Mea surement: Measures maxi- mum flow of air that can be forcefully exhaled in 1 second; child uses a peak expiratory flowmeter to determine a “per- sonal best” value that can be used for comparison at other times, such as during and after an asthma attack.

Bronchoprovoca t ion Test ing: Testing that is done to identify inhaled allergens; mucous membranes are directly exposed to suspected allergen in increasing amounts.

Skin Test ing: Done to identify specific allergens. Exercise Cha llenges: Exercise is used to identify the occurrence

of exercise-induced bronchospasm. Ra dioa llergosorbent Test: Blood test used to identify a specific

allergen. Chest Ra diogra ph: May show hyperexpansion of the airways.

Note: Some tests place the child at risk for an asthma attack; testing should be done under close supervision.

BOX 39-4 Precipitants Triggering an Asthma Attack Allergens

Outdoor: Trees, shrubs, weeds, grasses, molds, pollen, air pollution, spores

Indoor: Dust, dust mites, mold, cockroach antigen Irrita nts: Tobacco smoke, wood smoke, odors, sprays Exposure t o Occupa tiona l Irrit a nt s Exercise Cold Air Cha nges in Wea t her or Tempera t ure Environmenta l Cha nge: Moving to a new home, starting a new

school

Colds a nd Infect ions Anima ls: Cats, dogs, rodents, horses Medica tions: Aspirin, nonsteroidal antiinflammatory drugs,

antibiotics, beta blockers St rong Emotions: Fear, anger, laughing, crying Conditions: Gastroesophageal reflux disease, tracheoesopha-

geal fistula Food Addit ives: Sulfite preservatives Foods: Nuts, milk, other dairy products Endocrine Fa ctors: Menses, pregnancy, thyroid disease

Data from Perry S, Hockenberry M, Lowderm ilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 10 , Mosby.

468 UNIT VII Pediatric Nursing

PRIORITY NURSING ACTIONS Acute Asthma Attack 1. Assess airway patency and respiratory status. 2. Administer humidified oxygen by nasal cannula or

face mask. 3. Administer quick-relief (rescue) medications. 4. Initiate an intravenous (IV) line. 5. Prepare the child for a chest radiograph if prescribed. 6. Prepare to obtain a blood sample for determining arterial

blood gas levels if prescribed.

In the event of an acute asthma attack, several interven- tions are necessary. First, the nurse assesses airway status to ensure airway patency. If the airway is not patent, emer- gency interventions such as endotracheal intubation may be necessary. The nurse also quickly assesses the child’s respiratory status. If the airway is patent, the nurse adminis- ters oxygen by nasal cannula or mask as prescribed. Quick- relief (rescue) medications are administered as prescribed to treat the symptoms. An IV line is initiated so that IV med- ications can be administered if prescribed. The nurse pre- pares the child for a chest x-ray to assess airway status and to assist in ruling out a respiratory infection. Blood sam- ples are obtained, and an arterial blood gas may be obtained. When the laboratory results are obtained, the nurse admin- isters medications as prescribed to correct dehydration, aci- dosis, or electrolyte imbalances. During the episode and during treatment, the nurse continuously monitors respira- tory status, pulse oximetry, and color. The nurse also needs to be alert to decreased wheezing or a silent chest, which may signal the inability to move air.

Reference Hockenberry, Wilson (2015), p. 1228.

D. Med ication s 1. Q uick-relief m edication s (rescue m edication s):

Used to treat sym pto m s an d exacerbatio n s (Box 39-5)

2. Lon g-term co n trol m ed ication s (preven ter m edi- cation s): Used to ach ieve an d m ain tain con trol of in flam m ation ( Box 39-6)

3. Nebulizer, m etered-dose in h aler (MDI): May be used to ad m in ister m ed ication s; if th e ch ild h as difficulty usin g th e MDI, m edication can be ad m in istered by n ebulization (m edication is m ixed with salin e an d th en n ebulized with co m - pressed air by a m ach in e).

4. If an MDI is used to adm in ister a corticosteroid , a spacer sh ould be used to preven t yeast in fectio n s in th e ch ild’s m ou th .

5. Th e ch ild’s growth pattern s n eed to be m on itored wh en cortico steroids are prescribed.

E. Ch est ph ysioth erap y 1. In cludes breath ing exercises an d ph ysical train in g. 2. Ch est ph ysioth erapy stren gth en s th e respiratory

m uscu lature an d produ ces m ore efficien t breath - in g pattern s.

3. Ch est ph ysioth erapy is n ot recom m en ded durin g an acute exacerb ation .

F. Allergen con trol 1. Testin g m ay be don e to iden tify allergen s. 2. Teach th e ch ild an d paren ts about m easures to

preven t an d reduce exposu re to allergen s (see Box 39-4)

G. Hom e care m easu res 1. In struct th e fam ily in m easures to elim in ate en vi-

ron m en tal allergen s. 2. Avo id extrem es of en viron m en tal tem perature;

in cold tem peratures, in struct th e ch ild to breath e th rou gh th e n ose, n ot th e m outh , an d to cover th e n ose an d m ou th with a scarf.

3. Avo id exposu re to in dividuals with a respiratory in fectio n .

4. In struct th e ch ild an d fam ily in h ow to recogn ize early sym pto m s of an asth m a attack.

5. Teach th e ch ild an d fam ily h ow to adm in ister m ed ication s as prescribed.

6. Teach th e ch ild an d fam ily h ow to use a n ebu- lizer, MDI, or peak exp iratory flowm eter.

7. In struct th e ch ild an d fam ily about th e im por- tan ce of h om e m on itorin g of th e peak exp iratory flow rate; a decrease in th e expiratory flow rate m ay in dicate im pen din g in fectio n or exacerbatio n .

8. In struct th e ch ild in the clean in g of devices used for in h aled m edication s (yeast in fection s can occur with th e use of aerosolized corticosteroids).

9. En cou rage adequate rest, sleep , an d a well- balan ced diet.

P

e

d

i

a

t

r

i

c

s

BOX 39-5 Quick-Relief Medications (Rescue Medications)

▪ Short-acting β2 agonists (for bronchodilation) ▪ Anticholinergics (for relief of acute bronchospasm) ▪ Systemic corticosteroids (for antiinflammatory action to

treat reversible airflow obstruction)

BOX 39-6 Long-Term Control (Medications to Prevent Attacks)

▪ Corticosteroids (for antiinflammatory action) ▪ Antiallergy medications (to prevent an adverse response

on exposure to an allergen) ▪ Nonsteroidal antiinflammatory drugs (for antiinflamma-

tory action) ▪ Long-acting β2 agonists (for long-acting bronchodilation) ▪ Leukotriene modifiers (to prevent bronchospasm and

inflammatory cell infiltration) ▪ Monoclonal antibody (blocks binding of immunoglobulin

E [IgE] to mast cells to inhibit inflammation)

469CHAPTER 39 Respiratory Disorders

10. In struct th e ch ild in th e im portan ce of adequate flu id in take to liqu efy secretio n s.

11. Assist in developin g an exercise program . 12. In struct th e ch ild in th e procedure for respiratory

treatm en ts an d exercises as prescribed. 13. En cou rage th e ch ild to cough effectively. 14. En cou rage th e paren ts to keep im m un ization s

up to date; an n ual in fluen za vaccin ation s are recom m en ded for ch ildren 6 m on th s of age an d older.

15. In form oth er h ealth care providers (HCPs) an d sch o ol person n el of th e asth m a con ditio n .

16. Allow th e ch ild to take con trol of self-care m ea- sures, based on age appropriaten ess.

VII. Cystic Fibrosis A. Description (Fig. 39-3)

1. A ch ron ic m ultisystem disorder (auto som al recessive trait disorder) ch aracterized by exo- crin e glan d dysfun ction

2. Th e m ucus produ ced by th e exocrin e glan ds is ab n orm ally th ick, ten acio us, an d copious, caus- in g obstru ction of th e sm all passageways of th e affected organ s, particularly in th e respiratory, gastro in testin al, an d reproductive system s.

3. Com m on sym ptom s are associated with pan cre- atic en zym e deficien cy an d pan creatic fibrosis cau sed by duct blockage, progressive ch ron ic lu n g disease as a result of in fectio n , an d sweat glan d dysfun ction resultin g in in creased sodium an d ch loride sweat con cen tration s.

4. An in crease in sodium an d ch loride in sweat an d saliva form s th e basis for on e diagn ostic test, th e sweat ch loride test (Box 39-7).

5. Cystic fibrosis is a progressive an d in curable dis- order, an d respiratory failure is a com m on cau se of death ; organ tran splan tation s m ay be an option to in crease survival rates.

B. Resp iratory system 1. Sym ptom s are produ ced by th e stagn ation of

m ucus in th e airway, leadin g to bacterial colon i- zation an d destruction of lu n g tissue.

2. Em ph ysem a an d atelectasis occur as th e airways beco m e in creasin gly obstru cted.

3. Ch ron ic h ypo xem ia cau ses con traction an d h ypertroph y of th e m uscle fibers in pulm on ary

P

e

d

i

a

t

r

i

c

s

Ba s ic de fe ct

Exocrine gla nd dys function

Bronchi

Ge ne ra lize d obs tructive

e mphys e ma

Chronic bronchia l

pne umonia

Pa ncre a tic ductsBile ducts

Bronchia l obs truction

S e conda ry de ge ne ra tion of pa ncre a s

Foca l bilia ry fibros is with concre tions

Pa ncre a tic a chylia

Bilia ry cirrhos is

Abnorma l mucus s e cre tion a nd obs truction

Ma la bs orption s yndrome

Porta l hype rte ns ion

S ma ll inte s tine

Inte s tina l obs truction of ne wborn

Ins pis s a te d me conium

FIGURE 39-3 Various effects of exocrine gland dysfunction in cystic fibrosis.

BOX 39-7 Quantitative Sweat Chloride Test Production of sweat is stimulated (pilocarpine iontophoresis),

sweat is collected, and sweat electrolytes are measured (more than 75 mg of sweat is needed).

Normally, the sweat chloride concentration is less than 40 mEq/ L (40 mmol/ L).

Chloride concentration greater than 60 mEq/ L (60 mmol/ L) is a positive test result (higher than 40 mEq/ L (40 mmol/ L) is diagnostic in infants younger than 3 months of age).

Chloride concentrations of 40 to 60 mEq/ L (40 to 60 mmol/ L) are highly suggestive of cystic fibrosis and require a repeat test.

470 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

arteries an d arterioles, lead in g to pulm o n ary h yperten sion an d even tual cor pulm o n ale.

4. Pn eum oth orax from ruptured bullae an d h em optysis from erosion of th e bron ch ial wall occur as th e disease progresses.

5. O th er respiratory sym pto m s a. Wheezing an d cough b . Dysp n ea c. Cyanosis d . Clu bbin g of th e fin gers an d toes e. Barrel ch est f. Repeated episodes of bron ch itis an d

pn eum on ia C. Gastroin testin al system

1. Mecon ium ileus in th e n ewborn is th e earliest m an ifestation .

2. In testin al obstru ction (distal in testin al obstru c- tive syn d rom e) cau sed by th ick in testin al secre- tion s can occur; sign s in clude pain , abdom in al disten tion , n ausea, an d vom itin g.

3. Stools are fro th y an d foul-sm ellin g. 4. Deficien cy of th e fat-soluble vitam in s A, D, E,

an d K, wh ich can result in easy bruisin g, bleed- in g, an d an em ia, occurs.

5. Maln utrition an d failure to th rive is a con cern . 6. Dem on stration of h ypo album in em ia can occur

from dim in ish ed absorption of protein , result- in g in gen eralized edem a.

7. Rectal prolap se can result from th e large, bulky stools an d in creased in traabdom in al pressure.

8. Pan creatic fib rosis can occur an d places th e ch ild at risk for diabetes m ellitus.

D. In tegum en tary system 1. Abn orm ally h igh co n cen tration s of sodium an d

ch loride in sweat are n oted. 2. Paren ts report th at th e in fan t tastes “salty”

wh en kissed. 3. Deh ydration and electrolyte im balan ces can

occur, especially durin g h yperth erm ic con ditions. E. Reproductive system

1. Cystic fibro sis can delay puberty in girls. 2. Fertility can be in h ibited by th e h igh ly visco us

cervical secretio n s, wh ich act as a plug an d block sperm en try.

3. Males are usually sterile (but n ot im poten t), caused by th e blockage of th e vas deferen s by abn orm al secretio n s or by failure of n orm al developm en t of duct structures.

F. Diagn ostic tests 1. Q uan titative sweat ch loride test is positive (see

Box 39-7). 2. Newborn screen in g m ay be don e in som e states

an d m ay con sist of im m un oreactive trypsin ogen an alysis an d direct DNA an alysis for m utan t gen es.

3. Ch est x-ray reveals atelectasis an d obstru ctive em ph ysem a.

4. Pulm o n ary fun ction tests provide eviden ce of ab n orm al sm all airway fun ction .

5. Stool, fat, en zym e an alysis: A 72-h o ur stool sam - ple is collected to ch eck th e fat or en zym e (tryp- sin ) con ten t, or both (food in take is recorded durin g th e co llection ).

G. In terven tion s: Resp iratory system 1. Goals of treatm en t in clude preven tin g an d treat-

in g pulm o n ary in fectio n by im provin g aeration , rem ovin g secretio n s, an d adm in isterin g an tibi- otic m edication s.

2. Mon itor respiratory status, in cludin g lun g soun ds an d th e presen ce an d ch aracteristics of a co ugh .

3. Ch est ph ysioth erapy (percussio n an d postural drain age) on awaken in g an d in th e even in g (m ore frequen tly durin g pulm o n ary in fectio n ) n eeds to be don e every day to m ain tain pulm o - n ary h ygien e; ch est ph ysioth erapy sh ould n ot be perform ed before or im m ediately after a m eal.

4. A Flutter m ucus clearan ce device (a sm all, h an d- h eld plastic pipe with a stain less steel ball on th e in side) facilitates th e rem oval of m ucus an d m ay be prescribed; store away fro m sm all ch ildren because if th e device separates, th e steel ball poses a ch okin g h azard.

5. Han d-h eld percussors or a special vest device th at provides h igh -frequen cy ch est wall oscilla- tio n m ay be prescribed to h elp lo osen secretio n s.

6. A positive expiratory pressure m ask m ay be pre- scrib ed; use of th is m ask forces secretio n to th e upper airway for expecto ration .

7. Th e ch ild sh ould be tau gh t th e forced exp iratory tech n ique (h uffin g) to m ob ilize secretion s for exp ectoration .

8. Bron ch odilator m ed ication by aerosol m ay be prescribed ; th e m edication open s th e bron ch i for easier expectoration (adm in istered before ch est physiotherapy when the ch ild h as reactive airway disease or is wheezin g). Medication s that decrease the viscosity of m ucus m ay also be prescribed.

9. A ph ysical exercise program with th e aim of stim - ulatin g m ucus expecto ration an d establish in g an effective breath in g pattern sh o uld be in stituted.

10. Aeroso lized or IV an tibiotics m ay be prescribed an d adm in istered at h om e th rough a cen tral ven o us access device.

11. O xygen m ay be prescribed durin g acute epi- sodes; m on itor closely for oxygen n arcosis (sign s in clude n ausea an d vom itin g, m alaise, fatigue, n um bn ess an d tin glin g of extrem ities, substern al distress) because a ch ild with cystic fibrosis m ay h ave ch ron ic carbo n dioxide reten tion .

12. Lun g tran splan tation is occasion ally perform ed. H. In terven tion s: Gastroin testin al system

1. A ch ild with cystic fibrosis requires a h igh - calorie, h igh -p rotein , an d well-balan ced diet to

471CHAPTER 39 Respiratory Disorders

m eet en ergy an d growth n eeds; m ultivitam in s an d vitam in s A, D, E, an d K are also adm in is- tered ; for th ose with severe lun g disease, en ergy requirem en ts m ay be as h igh as 20% to 50% or m ore of th e recom m en ded daily allowan ce.

2. Mon itor weigh t an d for failure to th rive. 3. Mon itor stool pattern s an d for sign s of in testin al

obstru ctio n . 4. Th e go al of treatm en t for pan creatic in suffi-

cien cy is to replace pan creatic en zym es; pan cre- atic en zym es are adm in istered with in 30 m in u tes of eatin g an d adm in istered with all m eals an d all sn acks (en zym es sh o uld n ot be given if th e ch ild is NPO ).

5. Th e am oun t of pan creatic en zym es ad m in istered dep en ds on th e HCP’s preferen ce an d usually is ad justed to ach ieve n orm al growth an d a decrease in th e n um ber of stools to 2 or 3 daily (add ition al en zym es are n eeded if th e ch ild is con sum in g h igh -fat foods).

6. En teric-coated pan creatic en zym es sh ould n ot be crush ed or ch ewed; cap sules can be taken ap art an d th e con ten ts can be sprin kled on a sm all am oun t of food for adm in istration .

7. Mon itor for con stipatio n , in testin al obstruction , an d rectal prolapse.

8. Mon itor for sign s of gastro esoph ageal reflux; place th e in fan t in an uprigh t position after eat- in g, an d teach th e ch ild to sit uprigh t after eatin g.

I. Addition al in terven tion s 1. Mon itor blood glucose levels an d for sign s of

diabetes m ellitus. 2. En su re adequ ate salt in take an d fluids th at pro-

vide an adequ ate supply of electrolytes durin g extrem ely h ot weath er an d wh en th e ch ild h as a fever.

3. Mon itor bon e growth in th e ch ild. 4. Mon itor for sign s of retin opath y or n eph ropath y. 5. Provide em otion al support to th e paren ts, par-

ticu larly wh en th e ch ild is diagn osed; paren ts will be fearful an d un certain about th e disorder an d th e care in volved.

6. Provide supp ort to th e ch ild as h e or sh e tran si- tio n s th rough th e stages of growth .

7. Teach th e ch ild an d paren ts about th e care in volved an d en courage in depen den ce in th e ch ild for self-care as age appropriate.

J. Ho m e care 1. Ho m e care in volves educatin g th e paren ts an d

th e ch ild ab out all aspects of care for th e disorder.

2. In form th e paren ts an d ch ild about th e sign s of com plication s an d action s to take an d th at th e im portan ce of follow-up care is cru cial.

3. In struct th e paren ts to en sure th at th e ch ild receives th e recom m en ded im m un ization s on sch edule; in ad dition , an n ual in fluen za

vaccin ation s are recom m en ded for ch ildren 6 m on th s of age an d older.

4. In form th e ch ild an d paren ts about th e Cystic Fib rosis Foun dation .

An alteration in respiratory status can be a frighten- ing experience for the child and parents. Acalm and reas- suring nursing approach assists in reducing fear.

VIII. Sudden Infant Death Syndrome (SIDS) A. Descriptio n

1. SIDS refers to un expected death of an ap paren tly h ealth y in fan t youn ger th an 1 year for wh om an in vestigation of th e death an d a th orough autopsy fail to sh ow an adequ ate cau se of death .

2. Several th eories are propo sed regardin g th e cau se of SIDS, but th e exact cau se is un kn own .

3. SIDS m ost frequen tly occurs durin g win ter m on th s.

4. Death usually occurs durin g sleep periods, but n ot n ecessarily at n igh t.

5. SIDS m ost frequen tly affects in fan ts 2 to 3 m on th s of age.

6. In ciden ce is h igh er in boys. 7. In ciden ce is h igh er in Native Am erican s, African

Am erican s, an d Hisp an ics an d in lo wer socioeco- n om ic grou ps.

8. In ciden ce h as been foun d to be lower in breast- fed in fan ts an d in fan ts sleep in g with a pacifier.

9. High -risk con d ition s for SIDS: a . Pron e position b . Use of soft beddin g, sleepin g in a n on in fan t

bed such as a sofa c. O verh eatin g (th erm al stress) d . Cosleepin g e. Moth er wh o sm oked cigarettes or abused sub-

stan ces durin g pregn an cy f. Expo sure to tobacco sm oke after birth

B. Assessm en t 1. In fan t is ap n eic, blue, an d lifeless. 2. Froth y blood -tin ged flu id is in th e n ose

an d m ou th . 3. In fan t m ay be foun d in an y position , but typ i-

cally is foun d in a dish eveled bed, with blan kets over th e h ead, an d h uddled in a corn er.

4. In fan ts m ay appear to h ave been clu tch in g beddin g.

5. Diaper m ay be wet an d full of stool. C. Preven tion an d in terven tion s

1. In fan ts sh ould be placed in th e supin e position for sleep.

2. Moth er n eeds to be taugh t ab out th e risk factors: cigarette sm okin g an d substan ce abuse durin g pregn an cy; use of soft beddin g, sleep in g in a n on - in fan t bed such as a sofa; overh eatin g (th erm al stress); cosleepin g; exposu re to tobacco sm oke after birth . Stuffed an im als or oth er toys sh ould

P

e

d

i

a

t

r

i

c

s

472 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

be rem oved from th e crib wh ile th e in fan t is sleepin g.

3. Teach th e paren ts to m on itor for position al pla- gioceph aly cau sed by th e supin e sleepin g posi- tion ; sign s in clude flatten ed posterior occiput an d developm en t of a bald spot in th e posterior occiput area.

4. To assist in preven tin g position al plagioceph aly, teach th e paren ts to alter h ead position durin g sleep, avoid excessive tim e in in fan t seats an d boun cers, an d place th e in fan t in a pron e posi- tion wh ile awake (m on ito r th e in fan t wh en in th e pron e position ).

5. If SIDS occurs, th e paren ts n eed a great deal of support as th ey grieve an d m ou rn , esp ecially because th e even t was sudden , un exp ected, an d un exp lain ed.

IX. Foreign Body Aspiration A. Description (Fig. 39-4)

1. Swallowin g an d aspiration of a foreign body in to th e air passages

2. Most in h aled foreign bodies lodge in th e m ain stem or lobar bron ch us.

3. Most com m on offen din g food s are ro un d in sh ap e an d in clude item s such as h ot dogs, can dy, pean uts, popco rn , or grapes.

B. Assessm en t 1. In itially, ch okin g, gaggin g, cough in g, an d retrac-

tio n s are gen eral fin din gs. 2. If th e con dition worsen s, cyanosis m ay occur. 3. Laryn gotrach eal obstru ction leads to dyspn ea,

stridor, cough , an d h oarsen ess. 4. Bron ch ial obstru ctio n produ ces paroxysm al

cough , wheezing, asym m etrical breath soun ds, an d dyspn ea.

5. If an y obstru ction progresses, un co n sciousn ess an d asph yxiation m ay occur.

6. Partial obstru ction s m ay occur with out symptoms.

7. Distressed ch ild can n ot speak, beco m es cyan otic, an d collapses.

C. In terven tion s 1. Em ergen cy care

a . In terven tion s for th e rem oval of a foreign body (or relief of ch okin g) in a ch ild (1 year of age or older) are th e sam e as for th e adult clien t. See Ch apter 54 for th is in form ation .

2. After in stitutin g em ergen cy care m easures, rem oval by en doscopy m ay be n ecessary. a . After en doscopy, th e ch ild receives h igh -

h um idity air. b . O bserve for sign s an d sym pto m s of

airway edem a. 3. Preven tion

a . Keep sm all objects, in cludin g rubber bal- loon s, out of reach of sm all ch ildren .

b . Avoid givin g sm all ch ildren sm all, roun d food item s.

4. Paren t, day care provider, an d babysitter education a . Teach about th e h azards of aspiration . b . Discuss poten tial situation s in wh ich sm all

item s m ay be aspirated. c. Teach about th e sym ptom s of aspiration . d . Teach h ow to perform em ergen cy care

m easu res.

X. Tuberculosis A. Description

1. Tuberculosis is a con tagious disease cau sed by Mycobacterium tuberculosis, an acid-fast bacillus (see Ch apter 54).

Ins pira tion Expira tion

Obs truction a llows pa s s a ge of a ir in both dire ctions

FIRS T-DEGREE OBS TRUCTION

Air una ble to move in e ithe r dire ction. FB a nd e de ma tous mucos a oblite ra te pa s s a ge .

COMP LETE OBS TRUCTION

Air a ble to move pa s t the obs truction in one dire ction only. Air pa s s a ge s e nla rge during ins pira tion a nd diminis h during e xpira tion.

S ECOND-DEGREE OBS TRUCTION

FIGURE 39-4 Mechanisms of airway obstruction by a foreign body (FB).

473CHAPTER 39 Respiratory Disorders

P

e

d

i

a

t

r

i

c

s

2. Multidrug-resistan t strain s of M. tuberculosis occur because of ch ild or fam ily n on com plian ce with th erap eutic regim en s.

3. Th e route of tran sm ission of M. tuberculosis is th rou gh in h alation of droplets from an in divid- ual with active tuberculosis.

4. Th ere is an in creased in ciden ce in urban low- in com e areas, n on wh ite racial or eth n ic grou ps, an d first-gen eration im m igran ts from en dem ic coun tries.

5. Most ch ildren are in fected by a fam ily m em ber or by an oth er in dividual with wh om th ey h ave fre- quen t con tact, such as a babysitter.

B. Assessm en t 1. Ch ild m ay be asym ptom atic or develop sym p-

tom s such as m alaise, fever, cough , weigh t lo ss, an orexia, an d lym ph ad en opath y.

2. Specific sym ptom s related to th e site of in fectio n , such as th e lun gs, brain , or bon e, m ay be presen t.

3. With in creased tim e, asym m etrical exp an sion of th e lun gs, decreased breath soun ds, crackles, an d dulln ess to percussion develop.

C. Tuberculin skin test (TST) or Man toux test (Box 39-8) 1. Th e test produces a positive reactio n 2 to

10 weeks after th e in itial in fectio n . 2. Th e test d eterm in es wh eth er a ch ild h as

b een in fected an d h as d evelo p ed a sen sitivity to th e p ro tein o f th e tu b ercle bacillus; a p o sitive reactio n d o es n o t co n firm th e p res- en ce o f active d isease ( exp o su re versu s p resen ce) .

3. After a ch ild reacts p o sitively, th e ch ild will always react p o sitively; a p o sitive reactio n in a p revio u sly n egative ch ild in d icates th at th e ch ild h as b een in fected sin ce th e last test.

4. Tu berculosis testin g sh ould n ot be don e at th e sam e tim e as m easles im m un ization (viral in ter- feren ce from th e m easles vaccine m ay cau se a false-n egative result).

D. Sputu m culture 1. A defin itive diagn osis is m ade by sh owin g th e

presen ce of m ycobacteria in a culture. 2. Ch est x-rays are supplem en tal to sputu m cultures

an d are n ot defin itive alon e. 3. Because an in fan t or yo un g ch ild often swallows

sputu m rath er th an expecto rates it, gastric wash - in gs (aspiration of lavaged co n ten ts fro m th e fastin g stom ach ) m ay be don e to obtain a speci- m en ; th e specim en is obtain ed in th e early m orn - in g befo re breakfast.

E. In terven tion s 1. Med ication s

a . A 9-m on th course of ison iazid m ay be pre- scribed to preven t a laten t in fectio n from pro- gressin g to clin ically active tuberculosis an d to preven t in itial in fectio n in ch ildren in h igh -risk situation s; a 12-m on th course m ay be prescribed for a ch ild in fected with h um an im m un od eficien cy virus (HIV).

b . Recom m en dation for a ch ild with clin ically active tubercu losis m ay in clude com bin ation adm in istration of ison iazid , rifam p in , an d pyrazin am ide daily for 2 m on th s, an d th en ison iazid an d rifam pin twice weekly for 4 m on th s.

c. In form th e paren ts an d ch ild th at bodily fluids, in cludin g urin e, m ay turn an oran ge- red color with som e tubercu losis m ed ication s.

d . Directly observed th erapy m ay be n ecessary for som e ch ildren .

2. Place ch ildren with active disease wh o are con ta- giou s on respiratory isolation un til m edication s h ave been in itiated, sputum cultures sh ow a dim in ish ed n um ber of organ ism s, an d cough is im provin g; th is in cludes use of a perso n ally fitted air-pu rifyin g N95 or N100 respirator (m ask) by th e n urse carin g for th e ch ild.

3. Stress th e im portan ce of adequate rest an d adequ ate diet.

4. In struct th e ch ild an d fam ily about m easu res to preven t th e tran sm issio n of tuberculo sis.

5. Case fin din g an d follo w-up with kn own con tacts is crucial to decrease th e n um ber of cases of in di- vidu als with active tuberculo sis.

CRITICAL THINKING What Should You Do? Answer: For a child with pneumonia, in order to reduce the discomfort in the pleural area, the nurse should encourage the child to lie on the affected side (if pneumonia is unilat- eral) to splint the chest. This position reduces the discomfort associated with pleural rubbing. A mild analgesic may be administered if prescribed.

Reference: Hockenberry, Wilson (20 15), p. 1195.

BOX 39-8 Tuberculin Skin Test (MantouxTest) Interpretation

Induration measuring 15 mm or more is considered to be a positive reaction in children 4 years or older who do not have any risk factors.

Induration measuring 10 mm or more is considered to be a positive reaction in children younger than 4 years and in children with chronic illness or at high risk for exposure to tuberculosis.

Induration measuring 5 mm or more is considered to be pos- itive for the highest risk groups, such as children with immunosuppressive conditions or human immunodefi- ciency virus (HIV) infection.

474 UNIT VII Pediatric Nursing

P R A C T I C E Q U E S T I O N S 402. A 10-year-old ch ild with asth m a is treated for acu te

exacerbation in th e em ergen cy departm en t. Th e n urse carin g for th e ch ild sh ould m on itor for wh ich sign , kn owin g th at it in dicates a worsen in g of th e con d ition ? 1. Warm , dry skin 2. Decreased wh eezin g 3. Pulse rate of 90 beats/ m in u te 4. Resp iration s of 18 breath s/ m in ute

403. Th e m oth er of an 8-year-o ld ch ild bein g treated for righ t lower lobe pn eum on ia at h om e calls th e clin ic n urse. Th e m oth er tells th e n urse th at th e ch ild com plain s of discom fort on th e righ t side an d th at ibuprofen is n ot effective. Wh ich in struction sh ould th e n urse provide to th e m oth er? 1. In crease th e dose of ibuprofen . 2. In crease th e frequen cy of ibuprofen . 3. En courage th e ch ild to lie on th e left side. 4. En cou rage th e ch ild to lie on th e righ t side.

404. A n ew paren t expresses con cern to th e n urse regard- in g sudd en in fan t death syn drom e (SIDS). Sh e asks th e n urse h ow to position h er n ew in fan t for sleep . In wh ich position sh ould th e n urse tell th e paren t to place th e in fan t? 1. Sid e or pron e 2. Back or pron e 3. Stom ach with th e face turn ed 4. Back rath er th an on th e stom ach

405. Th e clin ic n urse is providin g in struction s to a par- en t of a ch ild with cystic fib rosis regardin g th e im m un ization sch edule for th e ch ild. Wh ich state- m en t sh o uld th e n urse m ake to th e paren t? 1. “Th e im m un ization sch edule will n eed to be

altered.” 2. “Th e ch ild sh ould n ot receive an y h epatitis

vaccin es.” 3. “Th e ch ild will receive all of th e im m un ization s

except for th e polio series.” 4. “Th e ch ild will receive th e recom m en ded basic

series of im m un ization s alon g with a yearly in fluen za vaccin ation .”

406. Th e em ergen cy dep artm en t n urse is carin g for a ch ild diagn osed with epiglottitis. In assessin g th e ch ild, th e n urse sh o uld m on itor for wh ich in dica- tion th at th e ch ild m ay be exp erien cin g airway obstruction ? 1. Th e ch ild exh ibits n asal flarin g an d brad ycardia. 2. Th e ch ild is lean in g forward , with th e ch in

th rust out.

3. Th e ch ild h as a low-grade fever an d com plain s of a sore th roat.

4. Th e ch ild is lean in g backward, supportin g h im - self or h erself with th e h an ds an d arm s.

407. A ch ild with laryn gotrach eobro n ch itis (croup) is placed in a cool m ist ten t. Th e m oth er beco m es con cern ed because th e ch ild is frigh ten ed, con sis- ten tly cryin g an d tryin g to clim b out of th e ten t. Wh ich is th e m o st ap p ro p riate n ursin g action ? 1. Tell th e m oth er th at th e ch ild m ust stay in

th e ten t. 2. Place a toy in th e ten t to m ake th e ch ild feel

m ore com fo rtable. 3. Call th e h ealth care provider an d obtain a pre-

scriptio n for a m ild sedative. 4. Let th e m oth er h old th e ch ild an d direct th e

cool m ist over th e ch ild’s face.

408. Th e clin ic n urse reads th e results of a tubercu lin skin test (TST) on a 3-year-o ld ch ild. Th e results in dicate an area of in duration m easu rin g 10 m m . Th e n urse sh o uld in terp ret th ese results as wh ich fin din g? 1. Positive 2. Negative 3. In con clu sive 4. Defin itive an d requirin g a repeat test

409. Th e m oth er of a h ospitalized 2-year-old ch ild with viral laryn gotrach eobro n ch itis (croup) asks th e n urse wh y th e h ealth care provid er did n ot pre- scrib e an tibiotics. Wh ich respo n se sh ould th e n urse m ake? 1. “Th e ch ild m ay be allergic to an tibiotics.” 2. “Th e ch ild is too youn g to receive an tibiotics.” 3. “An tibiotics are n ot in dicated un less a bacterial

in fectio n is presen t.” 4. “Th e ch ild still h as th e m atern al an tibodies

from birth an d does n ot n eed an tibiotics.”

410. Th e n urse is carin g for an in fan t with bron ch iolitis, an d diagn ostic tests h ave co n firm ed respiratory syn cytial virus (RSV) . O n th e basis of th is fin din g, wh ich is th e m o st ap p ro p riate n ursin g action ? 1. In itiate strict en teric precaution s. 2. Move th e in fan t to a room with an oth er ch ild

with RSV. 3. Leave th e in fan t in th e presen t room because

RSV is n ot con tagious. 4. In form th e staff th at th ey m ust wear a m ask,

gloves, an d a gown wh en carin g for th e ch ild.

411. Th e n urse is preparin g for th e adm ission of an in fan t with a diagn osis of bron ch iolitis caused by

P

e

d

i

a

t

r

i

c

s

475CHAPTER 39 Respiratory Disorders

respiratory syn cytial virus (RSV) . Wh ich in terven - tion s sh ould th e n urse in clude in th e plan of care? Select all th at ap p ly.

1. Place th e in fan t in a private ro om . 2. En su re th at th e in fan t’s h ead is in a flexed

position . 3. Wear a m ask at all tim es wh en in con tact

with th e in fan t.

4. Place th e in fan t in a ten t th at delivers warm h um idified air.

5. Position th e in fan t on th e side, with th e h ead lower th an th e ch est.

6. En su re th at n urses carin g for th e in fan t with RSV do n ot care for oth er h igh -risk ch ildren .

A N S W E R S 402. 2 Ra tion a le: Asth m a is a ch ro n ic in flam m atory d isease of th e air- ways. Decreased wh eezin g in a ch ild with asth m a m ay be in ter- p reted in correctly as a po sitive sign wh en it m ay actu ally sign al an in ability to m o ve air. A “silen t ch est” is an om in ou s sign d urin g an asth m a ep iso de. With treatm en t, in creased wh eezin g actu ally m ay sign al th at th e ch ild’s con dition is im p ro vin g. Warm , d ry skin in dicates an im p ro vem en t in th e ch ild’s co n d i- tio n because th e ch ild is n o rm ally diap h o retic d urin g exacerb a- tio n . Th e n orm al pu lse rate in a 10-year-old is 70 to 110 beats/ m in u te. Th e n o rm al resp irato ry rate in a 10-year-o ld is 16 to 20 b reath s/ m in u te. Test-Ta kin g Str a tegy: No te th e wo rd worsening in th e qu estio n . O ptio n s 3 an d 4 can b e elim in ated becau se th ey are co m p ara- b le o r alike in th at th ey are n orm al vital sign s. From th e rem ain in g o ption s, recall th at a “silen t ch est” is an o m in o us sign d urin g an asth m a ep iso de an d in dicates severe b ro n ch ial sp asm or ob stru ction . Review: Bro n ch ial sp asm an d care o f th e ch ild with asth m a Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Hocken b erry, Wilso n (2015), p. 1226.

403. 4 Ra tion a le: Pn eu m on ia is an in flam m ation of th e pulm on ary p aren ch ym a o r alveoli, or b oth , cau sed by a viru s, m yco p las- m al agen ts, b acteria, o r asp iratio n o f fo reign su bstan ces. Splin tin g o f th e affected sid e b y lyin g on th at sid e m ay d ecrease disco m fo rt. It wou ld b e in ap prop riate to ad vise th e m oth er to in crease th e d ose o r freq uen cy o f th e ib up ro fen . Lyin g on th e left sid e wo u ld n o t be h elpfu l in alleviatin g d isco m fort. Test-Ta kin g Str a tegy: O p tion s 1 an d 2 can be elim in ated b ecau se th ey are co m p arab le o r alike. Recall th at th e n urse d oes n ot adjust th e do se o r freq uen cy o f m ed icatio n s. Recallin g th e p rin cip les related to sp lin tin g an in cisio n in th e p o stop er- ative clien t will assist in d irectin g you to th e co rrect op tio n b ecau se th ese p rin ciples can be app lied in th is situatio n . Review: Care of a ch ild with p n eu m o n ia Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clien t Ed ucation ; Pain Refer en ce: Hocken b erry, Wilso n (2015), p. 1195.

404. 4 Ra tion a le: SIDS is th e un expected death of an apparen tly h ealth y in fan t you n ger th an 1 year fo r wh om an in vestigation o f th e death an d a th o ro ugh au top sy fail to sh ow an adeq uate cau se o f death . Several th eo ries are prop o sed regardin g th e cau se, b ut th e exact cau se is un kn o wn . Nurses sh o uld en cou r- age p aren ts to place th e in fan t o n th e b ack (su p in e) for sleep . In fan ts in th e pron e po sitio n ( on th e sto m ach ) m ay be un ab le to m o ve th eir h ead s to th e side, in creasin g th e risk o f suffo ca- tio n . Th e in fan t m ay h ave th e ab ility to tu rn to a p ro n e p osition fro m th e side-lyin g po sitio n . Test-Ta kin g St r a t egy: Elim in ate op tion s 1, 2, an d 3 b ecau se th ey are co m p arab le o r alike. Rem em b er th at th e in fan t n eeds to b e p laced on h is o r h er b ack. Review: Po sitio n in g gu id elin es to preven t su d d en in fan t d eath syn d ro m e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 475.

405. 4 Ra t ion a le: Cystic fib ro sis is a ch ro n ic m u ltisystem d iso rd er (au to so m al recessive trait d iso rd er) ch aracterized b y exo - crin e glan d d ysfu n ctio n . Th e m u cu s p ro d u ced b y th e exo - crin e glan d s is ab n o rm ally th ick, ten acio u s, an d co p io u s, cau sin g o b stru ctio n o f th e sm all p assageways o f th e affected o rgan s, p articu larly in th e resp irato ry, gastro in testin al, an d rep ro d u ctive system s. Ad eq u ately p ro tectin g ch ild ren with cystic fib ro sis fro m co m m u n icab le d iseases b y im m u n iza- tio n is essen tial. In ad d itio n to th e b asic series o f im m u n i- zatio n s, a yearly in flu en za im m u n izatio n is reco m m en d ed fo r ch ild ren with cystic fib ro sis. O p tio n s 1, 2, an d 3 are in co rrect. Test-Ta kin g St r a t egy: Elim in ate op tion s 1, 2, an d 3 b ecau se th ey are co m p arab le o r alike, in d icatin g th at th e im m u n iza- tio n sch edu le will b e ad ju sted in so m e way. Recallin g th e im po rtan ce o f p ro tectio n from com m un icab le diseases, p artic- u larly in ch ild ren with a d iso rd er su ch as cystic fib ro sis, will assist in directin g yo u to th e correct o ptio n . Review: Im m u n ization sch ed u le fo r th e ch ild with cystic fib ro sis Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Clien t Ed ucation ; Health Prom o tion Refer en ce: Hocken b erry, Wilso n (2015), p. 1243.

P

e

d

i

a

t

r

i

c

s

476 UNIT VII Pediatric Nursing

406. 2 Ra t ion a le: Ep iglottitis is a bacterial form o f cro up . A prim ary co n cern is th at it can progress to acu te resp irato ry distress. Clin - ical m an ifestatio n s suggestive of airway ob stru ction in clu de tri- po d p o sitio n in g (lean in g forward wh ile sup po rted b y arm s, ch in th rust o ut, m o uth op en ), n asal flarin g, th e use of acces- sory m uscles for breath in g, an d th e p resen ce o f strid o r. O ptio n 4 is an in correct po sitio n . O ption s 1 an d 3 are in co rrect b ecau se epiglottitis cau ses tach ycardia an d a h igh fever. Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, m an ifestatio n s o f airway o bstructio n in a ch ild with ep iglo ttitis. Elim in ate o ptio n 1 first b ecau se tach ycardia rath er th an bradycard ia wo u ld o ccur in a ch ild exp erien cin g respirato ry d istress. Elim in ate o ptio n 3 n ext, kn owin g th at a h igh fever o ccu rs with ep iglo ttitis. Fro m th e rem ain in g o p tion s, visualize th e d escrip tio n s in each an d determ in e wh ich p o sition wo uld best assist a ch ild exp erien c- in g resp irato ry distress. Review: Man ifestatio n s of ep iglo ttitis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Th roat/ Respiratory Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Ho cken berry, Wilson (2015), p . 1187.

407. 4 Ra t ion a le: Laryn go trach eob ron ch itis (crou p ) is th e in flam m a- tion o f th e laryn x, trach ea, an d b ro n ch i an d is th e m o st co m - m o n type o f crou p . Co ol m ist th erap y m ay be p rescribed to liqu efy secretio n s an d to assist in b reath in g. If th e u se o f a ten t or h o od is cau sin g distress, treatm en t m ay b e m o re effective if th e ch ild is h eld by th e paren t an d a coo l m ist is d irected to ward th e ch ild’s face ( blo w-by) . A m ild sedative wo uld n ot b e adm in istered to th e ch ild. Cryin g wou ld in crease h ypo xia an d aggravate laryn go spasm , wh ich m ay cau se airway ob stru ctio n . O ptio n s 1 an d 2 wo u ld n o t alleviate th e ch ild’s fear. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Fo cu s o n th e su b ject, th e ch ild ’s fear. O ptio n s 1, 2, an d 3 are co m p arab le o r alike in th at th ey do n ot address th e fear. Th e co rrect o p tion is th e o n e th at ad dresses th e su b ject o f th e qu estio n . Review: Nu rsin g care fo r th e clien t in a m ist ten t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Pediatrics—Th roat/ Respiratory Pr ior ity Con cepts: Caregivin g; Clin ical Jud gm en t Refer en ce: Ho cken berry, Wilson (2015), p . 1187.

408. 1 Ra t ion a le: In du ration m easurin g 10 m m or m o re is con sid- ered to be a p ositive result in ch ildren yo un ger th an 4 years of age an d in ch ildren with ch ro n ic illn ess or at h igh risk for expo su re to tu berculo sis. A reactio n of 5 m m o r m o re is con sid- ered to be a p ositive result fo r th e h igh est risk gro up s, su ch as a ch ild with an im m un osu pp ressive co n d itio n o r a ch ild with h um an im m u n o deficien cy viru s (HIV) in fectio n . A reactio n of 15 m m o r m ore is p ositive in ch ild ren 4 years o r older with - ou t an y risk factors.

Test -Ta kin g St r a t egy: O p tio n s 3 an d 4 are co m p arab le o r alike an d can be elim in ated first. Fro m th e rem ain in g o p tion s, fo cus o n th e d ata in th e qu estio n an d n ote th e ch ild ’s age to assist in d irectin g yo u to th e co rrect o p tion . Review: An alysis o f th e tu b ercu lin skin test in ch ild ren Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Pediatrics—Th roat/ Respiratory Pr ior ity Con cepts: Evid en ce; In fectio n Refer en ce: McKin n ey et al. (2013), p . 1192.

409. 3 Ra t ion a le: Laryn gotrach eob ro n ch itis (crou p ) is th e in flam m a- tion o f th e laryn x, trach ea, an d b ro n ch i an d is th e m o st co m - m o n typ e of cro up . It can be viral o r bacterial. An tibiotics are n ot in dicated in th e treatm en t o f cro u p un less a bacterial in fec- tion is presen t. O p tio n s 1, 2, an d 4 are in co rrect. In ad dition , n o su pp o rtin g d ata in th e q uestion in d icate th at th e ch ild m ay b e allergic to an tib io tics. Test -Ta kin g Str a tegy: Focu s on th e su b ject, in dicatio n s fo r th e u se of an tib io tics. Elim in ate o p tion 1 because th ere are n o sup - p o rtin g d ata in th e qu estio n regardin g th e p o ten tial fo r aller- gies. Notin g th e wo rd viral in th e question an d n otin g th e age of th e ch ild will assist in elim in atin g o p tion s 2 an d 4. Review: Treatm en t fo r cro u p Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Th roat/ Respiratory Pr ior ity Con cepts: Im m un ity; In flam m ation Refer en ce: McKin n ey et al. (2013), p . 1161.

410. 2 Ra t ion a le: RSV is a h igh ly co m m u n icab le disorder an d is n ot tran sm itted via th e airbo rn e ro u te. Th e viru s usu ally is tran s- ferred b y th e h an d s. Use of con tact an d stan dard precau tion s d u rin g care is n ecessary. Usin g goo d h an d -wash in g tech n iqu e an d wearin g gloves an d gown s are also n ecessary. Masks are n ot req uired . An in fan t with RSV is isolated in a sin gle ro o m o r p laced in a ro om with an o th er ch ild with RSV. En teric precau - tion s are u n n ecessary. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Focus o n th e su b ject, th e m eth o d of tran sm issio n o f RSV. Rem em b er th at th e viru s is n ot tran sm itted via th e airbo rn e rou te an d is usu ally tran sferred by th e h an ds. An in fan t with RSV is iso lated in a sin gle ro om o r p laced in a roo m with an oth er ch ild with RSV. Review: Th e n u rsin g care for an in fan t with resp irato ry syn cy- tial viru s Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Pediatrics—Th roat/ Respiratory Pr ior ity Con cepts: In fectio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p . 1191.

411. 1, 6 Ra t ion a le: RSV is a h igh ly co m m u n icab le disorder an d is n ot tran sm itted via th e airbo rn e rou te. Th e viru s u sually is

P

e

d

i

a

t

r

i

c

s

477CHAPTER 39 Respiratory Disorders

tran sferred b y th e h an ds. Use o f co n tact an d stan d ard p recau- tio n s d urin g care (wearin g gloves an d a go wn ) redu ces n o soco- m ial tran sm issio n o f RSV. A m ask is un n ecessary. In ad dition , it is im po rtan t to en su re th at n u rses carin g fo r a ch ild with RSV d o n ot care fo r o th er h igh -risk ch ild ren to preven t th e tran sm is- sio n o f th e in fection . An in fan t with RSV sh ou ld be isolated in a p rivate ro om o r in a ro om with an oth er in fan t with RSV in fec- tio n . Th e in fan t sh o uld be po sitio n ed with th e h ead an d ch est at a 30- to 40-d egree an gle an d th e n eck sligh tly exten d ed to m ain tain an o pen airway an d d ecrease p ressu re on th e d ia- p h ragm . Coo l h um id ified oxygen is delivered to relieve d ys- p n ea, h ypo xem ia, an d in sen sib le water loss fro m tach ypn ea.

Test-Ta kin g Str a tegy: Fo cus on th e su b ject, care o f th e ch ild with bron ch iolitis an d RSV. Recallin g th e m od e o f tran sm is- sio n o f RSV will assist in an swerin g co rrectly. Rem em b er th at RSV is h igh ly co m m u n icable an d is tran sm itted via con tact su ch as by th e h an d s. Review: Bro n ch io litis an d resp irato ry syn cytial viru s ( RSV) Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—Th ro at/ Resp irato ry Pr ior it y Con cept s: Care Co ord in atio n ; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 1191.

P

e

d

i

a

t

r

i

c

s

478 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 40 Cardiovascular Disorders

PRIORITY CONCEPTS Gas Exchange; Perfusion

CRITICAL THINKING What Should You Do? A child diagnosed with a congenital heart defect suddenly develops difficulty breathing. What should the nurse do? Answer located on p. 487.

I. Heart Failure (HF) A. Description

1. HF (Box 40-1) is th e in ability of th e h eart to pum p a sufficien t am oun t of blood to m eet th e m etab olic an d oxygen n eeds of th e body.

2. In in fan ts an d ch ildren , in adequate cardiac out- put m ost com m on ly is caused by con gen ital h eart defects (shunt, obstru ction , or a com bin a- tio n of both ) th at produ ce an excessive volu m e or pressure load on th e m yocardium .

3. In in fan ts an d ch ildren , a com bin ation of left- sided an d righ t-sided HF is usually presen t.

4. Th e go als of treatm en t are to im prove cardiac fun ction , rem ove accu m ulated fluid an d sodium , decrease cardiac dem an ds, im prove tissue oxy- gen ation , an d decrease oxygen con sum p tion .

B. Assessm en t of early sign s 1. Tach ycardia, esp ecially durin g rest an d sligh t

exertion 2. Tach ypn ea 3. Profuse scalp diaph o resis, especially in in fan ts 4. Fatigue an d irritability 5. Sudd en weigh t gain 6. Resp iratory distress

C. In terven tion s 1. Mon itor for early sign s of HF. 2. Mon itor for respiratory distress (cou n t respira-

tio n s for 1 m in ute). 3. Mon itor apical pulse (cou n t apical pulse for

1 m in u te), an d m on itor for dysrh yth m ias. 4. Mon itor tem perature for h yperth erm ia an d for

oth er sign s of in fectio n , particularly respiratory in fectio n .

5. Mon itor strict in take an d output; weigh diapers as appropriate for m ost accu rate outp ut.

6. Mon itor daily weigh t to assess for flu id reten tion ; a weigh t gain of 0.5 kg (1 lb ) in 1 day is cau sed by th e accu m ulation of flu id.

7. Mon itor for facial or periph eral dep en den t edem a, au scultate lun g soun ds, an d report abn o rm al fin din gs in dicatin g excessive fluid in th e body.

8. Elevate th e h ead of th e bed in a sem i-Fowler’s position .

9. Main tain a n eutral th erm al en viron m en t to pre- ven t co ld stress in in fan ts.

10. Provide rest an d decrease en viron m en tal stim uli. 11. Adm in ister cool h um idified oxygen as prescribed,

usin g an oxygen h ood for youn g in fan ts and a n asal can n ula or face m ask for older in fan ts an d children .

12. O rgan ize n ursin g activities to allow for un in ter- rupted sleep.

13. Main tain adequ ate n utrition al status. 14. Feed wh en h un gry an d soon after awaken in g,

con servin g en ergy an d oxygen supp ly. 15. Provide sm all, frequen t feed in gs, con servin g

en ergy an d oxygen supply. 16. Adm in ister sedation as prescribed durin g th e

acu te stage to prom ote rest. 17. Adm in ister digoxin as prescribed.

a. Assess apical h eart rate for 1 m in ute before adm in istration .

b . With h old digoxin if th e apical pulse is less th an 90 to 110 beats/ m in ute in in fan ts an d youn g ch ildren an d less th an 70 beats/ m in u te in older ch ildren , as prescribed.

c. Be aware th at in fan ts rarely receive m ore th an 1 m L (50 m cg or 0.05 m g) of digo xin in 1 dose.

18. Mon itor digoxin levels an d for sign s of digo xin toxicity, in cludin g an orexia, poor feed in g, n au- sea, vom itin g, bradycardia, an d dysrh yth m ias. a. Th e optim al th erap eutic digoxin level ran ge is

0.5 to 0.8 n g/ m L (0.64-1.02 n m ol/ L). 479

b . Digoxin toxicity is presen t wh en level is greater th an 0.8 n g/ m L (1.02 n m ol/ L).

19. Adm in ister an gioten sin -con vertin g en zym e in h i- bitors as prescribed. a. Mon itor for h ypo ten sion , ren al dysfun ction ,

an d cough wh en an gioten sin -con vertin g en zym e in h ibitors are ad m in istered.

b . Assess blood pressure; serum protein , albu- m in , blood urea n itrogen , an d creatin in e levels; wh ite blood cell coun t; urin e output; urin ary specific gravity; an d urin ary protein level.

20. Adm in ister diuretics such as furosem ide as prescribed. a. Mon itor for sign s an d sym pto m s of h ypo ka-

lem ia (serum potassium level < 3.5 m Eq/ L [3.5 m m o l/ L]), in cludin g m uscle weakn ess an d cram p in g, con fusion , irritability, restless- n ess, an d in verted T waves or prom in en t U waves on th e electrocardiogram .

b . If sign s an d sym ptom s of h ypo kalem ia are presen t an d th e ch ild is also bein g adm in is- tered digo xin , m on itor clo sely for digoxin toxicity because h ypo kalem ia poten tiates digoxin toxicity.

21. Adm in ister potassium supp lem en ts an d provide dietary sources of potassium as prescribed . a . Supplem en tal potassium sh ould be given on ly

if in dicated by serum potassium levels an d if adequate ren al fun ction is eviden t an d is usually n ecessary when adm in isterin g a potassium - wastin g diuretic such as furosem ide.

b . En courage food s th at th e ch ild will eat th at are h igh in potassium , as appropriate, such as ban an as, baked potato skin s, an d pean ut butter.

22. Mon itor serum electrolyte levels, particularly th e potassium level (n orm al level is 3.5 to 5.0 m Eq/ L [3.5-5.0 m m ol/ L]).

23. Lim it fluid in take as prescribed in th e acu te stage. 24. Mon itor for sign s an d sym ptom s of deh ydration ,

in cludin g sun ken fon tan el (in fan t), n on elastic skin turgor, dry m ucou s m em bran es, decreased tear produ ction , decreased urin e output, an d con cen trated urin e.

25. Mon itor sodium levels as prescribed. a . Norm al level is 135 to 145 m Eq/ L (135-

145 m m o l/ L). b . Man y in fan t form ulas h ave sligh tly m ore

sodium th an breast m ilk. 26. In struct th e paren ts regardin g adm in istration of

digoxin (Box 40-2). 27. In struct th e paren ts in cardiop ulm on ary resusci-

tatio n (CPR). Th e guidelin es for CPR for th e ch ild older th an 1 year of age are th e sam e as th e adult. See Ch apter 56 for m ore in form ation .

The parents should be provided with a medication guide for any medication prescribed for the infant or child. In addition, the nurse needs to review the instruc- tions in the guide and provide an opportunity for the parents to demonstrate medication administration procedures.

P

e

d

i

a

t

r

i

c

s

BOX 40-1 Signs and Symptoms of Heart Failure

Left-Sided Failure ▪ Crackles and wheezes ▪ Cough ▪ Dyspnea ▪ Grunting (infants) ▪ Head bobbing (infants) ▪ Nasal flaring ▪ Orthopnea ▪ Periods of cyanosis ▪ Retractions ▪ Tachypnea Right-Sided Failure ▪ Ascites ▪ Hepatosplenomegaly ▪ Jugular vein distention ▪ Oliguria ▪ Peripheral edema, especially dependent edema, and

periorbital edema ▪ Weight gain

BOX 40-2 Home Care Instructions for Administering Digoxin Administer as prescribed. Use an accurate measuring device as provided by the pharmacist. Administer 1 hour before or 2 hours after feedings. Use a calendar to mark off the dose administered. Do not mix medication with foods or fluid. If a dose is missed and more than 4 hours has elapsed, withhold

the dose and give the next dose at the scheduled time; if less than 4 hours has elapsed, administer the missed dose.

If the child vomits, do not administer a second dose. (Follow the health care provider’s [HCP’s] prescription.)

If more than 2 consecutive doses have been missed, notify the HCP; do not increase or double the dose for missed doses.

If the child has teeth, give water after the medication; if possible, brush the teeth to prevent tooth decay from the sweetened liquid.

Monitor for signs of toxicity, such as poor feeding or vomiting. If the child becomes ill, notify the HCP. Keep the medication in a locked cabinet. Call the Poison Control Center immediately if accidental over-

dose occurs.

480 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

II. Defects with Increased Pulmonary Blood Flow A. Description

1. In tracardiac com m un ication alon g th e septum or an abn orm al con n ection between th e great arteries allows blood to flow from th e h igh - pressure left side of th e h eart to th e lo w-pressure righ t side of th e h eart.

2. Th e in fan t typ ically sh ows sign s an d sym pto m s of HF.

B. Atrial sep tal defect (ASD) 1. ASD is an abn o rm al open in g between th e atria

th at causes an in creased flow of oxygen ated blood in to th e righ t side of th e h eart.

2. Righ t atrial an d ven tricular en largem en t occurs. 3. In fan t m ay be asym ptom atic or m ay develop HF. 4. Sign s an d sym ptom s of decreased cardiac outp ut

m ay be presen t (Box 40-3). 5. Types

a . ASD 1 (ostium prim um ) : O pen in g is at th e lower en d of th e septum .

b . ASD 2 (ostium secun du m ): O pen in g is n ear th e cen ter of th e septum .

c. ASD 3 (sin us ven o sus defect): O pen in g is n ear th e jun ction of th e superior ven a cava an d th e righ t atrium .

6. Man agem en t a . Defect m ay be closed durin g a cardiac

cath eterization . b . O pen repair with cardiop ulm on ary bypass

m ay be perform ed an d usually is perform ed before sch o ol age.

C. Atrioven tricular can al defect 1. Th e defect results fro m in com plete fusion of th e

en docardial cush io n s. 2. Th e defect is th e m ost com m on cardiac defect in

Do wn syn d rom e. 3. A ch aracteristic m urm u r is presen t. 4. Th e in fan t usually h as m ild to m od erate HF, with

cyanosis in creasin g with cryin g. 5. Sign s an d sym ptom s of decreased cardiac outp ut

m ay be presen t. 6. Man agem en t can in clude pulm on ary artery

ban din g for in fan ts with severe sym ptom s (palli- ative) or com plete repair via cardiop ulm on ary bypass.

D. Paten t ductus arteriosus

1. Paten t ductus arteriosus is failure of th e fetal duc- tus arteriosus ( shunt co n n ectin g th e aorta an d th e pulm o n ary artery) to close with in th e first weeks of life.

2. A ch aracteristic m ach in ery-like m urm ur is presen t.

3. An in fan t m ay be asym ptom atic or m ay sh ow sign s of HF.

4. A widen ed pulse pressure an d boun din g pulses are presen t.

5. Sign s an d sym ptom s of decreased cardiac output m ay be presen t.

6. Man agem en t a . In dom eth acin , a prostaglan din in h ib itor,

m ay be ad m in istered to close a paten t ductus in prem atu re in fan ts an d som e n ewborn s.

b . Th e defect m ay be clo sed durin g cardiac cath - eterization , or th e defect m ay require surgical m an agem en t.

E. Ven tricular septal defect (VSD) 1. VSD is an abn o rm al open in g between th e righ t

an d left ven tricles. 2. Man y VSDs close spon tan eously durin g th e first

year of life in ch ildren h avin g sm all or m oderate defects.

3. A ch aracteristic m urm ur is presen t. 4. Sign s an d sym pto m s of HF are com m on ly

presen t. 5. Sign s an d sym ptom s of decreased cardiac output

m ay be presen t. 6. Man agem en t

a. Closure durin g cardiac cath eterization m ay be possible.

b . O pen repair m ay be don e with cardiopulm o- n ary bypass.

III. Obstructive Defects A. Description

1. Bloo d exitin g a portion of th e h eart m eets an area of an atom ical n arrowin g ( stenosis), causin g obstru ction to blood flow.

2. Th e location of n arrowin g is usually n ear th e valve of th e obstructive defect.

3. In fan ts an d ch ildren exh ibit sign s of HF. 4. Ch ildren with m ild obstru ction m ay be

asym ptom atic. B. Aortic sten osis

1. Aortic sten osis is a n arrowin g or stricture of th e aortic valve, causin g resistan ce to blood flow from th e left ven tricle in to the aorta, resultin g in decreased cardiac output, left ven tricular h yper- troph y, an d pulm on ary vascular con gestion .

2. Valvular sten osis is th e m ost com m on type an d usually is cau sed by m alform ed cusps, resultin g in a bicuspid rath er th an a tricuspid valve, or fusion of th e cusps.

3. A ch aracteristic m urm ur is presen t.

BOX 40-3 Signs and Symptoms of Decreased Cardiac Output

▪ Decreased peripheral pulses

▪ Exercise intolerance ▪ Feeding difficulties ▪ Hypotension

▪ Irritability, restlessness, lethargy

▪ Oliguria ▪ Pale, cool extremities ▪ Tachycardia

481CHAPTER 40 Cardiovascular Disorders

4. In fan ts with severe defects sh ow sign s of decreased cardiac outp ut.

5. Ch ildren sh ow sign s of exercise in toleran ce, ch est pain , an d dizzin ess wh en stan d in g for lon g periods.

6. Man agem en t a. Dilation of th e n arrowed valve m ay be don e

durin g cardiac cath eterization . b . Surgical aortic valvotom y (palliative) m ay be

don e; a valve replacem en t m ay be required at a secon d proced ure.

C. Coarctation of th e ao rta 1. Coarctation of th e aorta is lo calized n arro win g

n ear th e in sertio n of th e ductus arteriosus. 2. Bloo d pressure is h igh er in th e upper extrem ities

th an in th e lower extrem ities; boun din g pulses in th e arm s, weak or ab sen t fem oral pulses, an d cool lower extrem ities m ay be presen t.

3. Sign s of HF m ay occur in in fan ts. 4. Sign s an d sym ptom s of decreased cardiac output

m ay be presen t. 5. Ch ildren m ay experien ce h eadach es, dizzin ess,

fain tin g, an d epistaxis resultin g from h yperten sion .

6. Man agem en t of th e defect m ay be don e via balloo n an gioplasty in ch ildren ; resten osis can occur.

7. Surgical m an agem en t a. Mech an ical ven tilation an d m edication s to

im prove cardiac outp ut are often n ecessary before surgery.

b . Resection of th e coarcted portion with en d- to-en d an astom osis of th e aorta or en large- m en t of th e con stricted section , usin g a graft, m ay be required.

c. Becau se th e defect is outsid e th e h eart, cardio- pulm o n ary bypass is n ot required , an d a th o- racoto m y in cision is used.

With coarctation of the aorta, the blood pressure is higher in the upper extremities than in the lower extrem- ities. In addition, bounding pulses in the arms, weak or absent femoral pulses, and cool lower extremities may be present.

D. Pulm o n ary sten osis 1. Pulm o n ary sten osis is n arro win g at th e en tran ce

to th e pulm o n ary artery. 2. Resistan ce to blood flow causes righ t ven tricular

h ypertroph y an d decreased pulm o n ary blood flow; th e righ t ven tricle m ay be h ypo plastic.

3. Pulm o n ary atresia is th e extrem e form of pulm o- n ary sten osis in th at th ere is total fusion of th e com m issures an d n o blood flow to th e lun gs.

4. A ch aracteristic m urm ur is presen t. 5. In fan ts or ch ildren m ay be asym ptom atic. 6. Newborn s with severe n arro win g are cyan otic.

7. If pulm o n ary sten osis is severe, HF occurs. 8. Sign s an d sym pto m s of decreased cardiac output

m ay occur. 9. Man agem en t: Dilation of th e n arrowed valve

m ay be don e durin g cardiac cath eterization . 10. Surgical m an agem en t:

a . In in fan ts: Tran sven tricular (closed) valvot- om y procedure

b . In ch ildren : Pulm o n ary valvotom y with car- diopu lm on ary bypass

IV. Defects with Decreased Pulmonary Blood Flow A. Descrip tion

1. O bstructed pulm o n ary blood flo w an d an an a- tom ical defect (ASD or VSD) between th e righ t an d left sides of th e h eart are presen t.

2. Pressure on th e righ t side of th e h eart in creases, exceed in g pressure on th e left side, wh ich allows desatu rated blood to shunt righ t to left, cau sin g desatu ration in th e left side of th e h eart an d in th e system ic circulation .

3. Typically h ypo xem ia an d cyanosis appear. B. Tetralogy of Fallot

1. Tetralogy of Fallot in cludes 4 defects—VSD, pul- m on ary stenosis, overridin g ao rta, an d righ t ven - tricular h ypertro ph y.

2. If pulm o n ary vascu lar resistan ce is h igh er th an system ic resistan ce, th e sh un t is from righ t to left; if system ic resistan ce is h igh er th an pulm on ary resistan ce, th e sh u n t is from left to righ t.

3. In fan ts a . An in fan t m ay be acutely cyan otic at birth or

m ay h ave m ild cyan osis th at progresses over th e first year of life as th e pulm o n ic sten osis worsen s.

b . A ch aracteristic m urm u r is presen t. c. Acute episodes of cyan osis an d h ypoxia

(h ypercyan otic spells), called blue spells or tet spells, occur wh en th e in fan t’s oxygen require- m en ts exceed the blood supply, such as durin g periods of cryin g, feedin g, or defecatin g.

4. Ch ildren : With in creasin g cyan osis, squattin g, clubbin g of th e fin gers, an d poor growth m ay occur. a . Squattin g is a com pen sato ry m ech an ism to

facilitate in creased return of blood flow to th e h eart for oxygen ation .

b . Clubbin g is an abn o rm al en largem en t in th e distal ph alan ges; seen in th e fin gers.

5. Surgical m an agem en t: Palliative sh u n t a . Th e sh un t in creases pulm o n ary blood flow

an d in creases oxygen saturatio n in in fan ts wh o can n ot un d ergo prim ary repair.

b . Th e sh un t provid es blood flow to th e pulm o - n ary arteries from th e left or righ t subclavian artery.

P

e

d

i

a

t

r

i

c

s

482 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

6. Surgical m an agem en t: Com p lete repair a . Com p lete repair usually is perform ed in th e

first year of life. b . Th e repair requires a m ed ian stern otom y an d

cardiop ulm on ary bypass. C. Tricusp id atresia

1. Tricuspid atresia is failure of th e tricuspid valve to develop.

2. No com m un ication exists from th e righ t atrium to th e righ t ven tricle.

3. Bloo d flows th rough an ASD or a paten t foram en ovale to th e left side of th e h eart an d th rou gh a VSD to th e righ t ven tricle an d out to th e lun gs.

4. Th e defect often is associated with pulm o n ic ste- n osis an d tran spo sition of th e great arteries.

5. Th e defect results in com plete m ixin g of un oxy- gen ated an d oxygen ated blood in th e left side of th e h eart, resultin g in system ic desaturation , pulm o n ary obstru ction , an d decreased pulm o- n ary blood flow.

6. Cyan osis, tach ycardia, an d dyspn ea are seen in th e n ewborn .

7. O ld er ch ildren exh ibit sign s of ch ron ic h ypo x- em ia an d clubbin g.

8. Man agem en t: If th e ASD is sm all, th e defect m ay be clo sed durin g cardiac cath eterization ; oth er- wise, surgery is n eeded.

Clubbing is symptomatic of chronic hypoxia. Periph- eral circulation is diminished and oxygenation of vital organs and tissues is compromised.

V. Mixed Defects A. Description

1. Fully saturated system ic blood flo w m ixes with th e desaturated blood flow, causin g desaturation of th e system ic blood flow.

2. Pulm on ary con gestion occurs an d cardiac outp ut decreases.

3. Sign s of HF are presen t; sym ptom s vary with th e degree of desaturation .

B. Hypo plastic left h eart syn d rom e 1. Un derdevelopm en t of th e left side of th e h eart

occurs, resultin g in a h ypo plastic left ven tricle an d aortic atresia.

2. Mild cyanosis an d sign s of HF occur un til th e ductus arteriosus clo ses; th en progressive deteri- oration with cyan osis an d decreased cardiac out- put are seen , lead in g to cardiovascular collapse.

3. Th e defect is fatal in th e first few m on th s of life with out in terven tion .

4. Surgical treatm en t a . Surgical treatm en t is necessary; tran splantation

in the n ewborn period m ay be con sidered. b . In th e preoperative period, the n ewborn

requires m echan ical ventilation an d a con tin u- ous in fusion of prostaglan din E1 to m ain tain

ductal paten cy, ensuring adequate system ic blood flow.

C. Tran sposition of th e great arteries or tran spo sition of th e great vessels 1. Th e pulm on ary artery leaves th e left ven tricle,

an d th e aorta exits from th e righ t ven tricle. 2. No com m un ication exists between th e system ic

an d pulm o n ary circulation . 3. In fan ts with m in im al com m un ication are

severely cyan otic an d dep ressed at birth . 4. In fan ts with large sep tal defects or a paten t duc-

tus arteriosus m ay be less severely cyan otic, but m ay h ave sym pto m s of HF.

5. Card iom egaly is eviden t a few weeks after birth . 6. No n surgical m an agem en t

a . Prostaglan din E1 m ay be in itiated to keep th e ductus arteriosus open an d to im prove blood m ixin g tem porarily.

b . Balloon atrial sep tostom y durin g cardiac cath eterization m ay be perform ed to in crease m ixin g an d to m ain tain cardiac outp ut over a lon ger period.

7. Surgical m an agem en t: Th e arterial switch proce- dure reestab lish es n orm al circulation with th e left ven tricle actin g as th e system ic pum p an d cre- ation of a n ew aorta.

D. Total an om alo us pulm on ary ven ous con n ection 1. Th e defect is a failure of th e pulm o n ary vein s to

join th e left atrium . 2. Th e defect results in m ixed blood bein g return ed

to th e righ t atrium an d sh un ted fro m th e righ t to th e left th rou gh an ASD.

3. Th e righ t side of th e h eart h ypertroph ies, wh ereas th e left side of th e h eart m ay rem ain sm all.

4. Sign s an d sym ptom s of HF develo p. 5. Cyan osis worsen s with pulm o n ary vein obstru c-

tion ; wh en obstru ction occurs, th e in fan t’s con d i- tion deterio rates rapidly.

6. Surgical m an agem en t a . Corrective repair is perform ed in early in fan cy. b . The pulm on ary vein is an astom osed to th e left

atrium , th e ASD is closed, an d th e an om alous pulm on ary ven ous con n ection is ligated.

E. Trun cus arteriosus 1. Trun cus arteriosus is failure of n orm al septation

an d division of th e em bryo n ic bulbar trun k in to th e pulm o n ary artery an d th e aorta, resultin g in a sin gle vessel th at overrides both ven tricles.

2. Bloo d fro m both ven tricles m ixes in th e com m on great artery, causin g desaturation an d h ypo xem ia.

3. A ch aracteristic m urm u r is presen t. 4. Th e in fan t exh ibits m od erate to severe HF an d

variable cyan osis, poor growth, an d activity in toleran ce.

5. Surgical m an agem en t: Corrective surgical repair is perform ed in th e first few m on th s of life.

483CHAPTER 40 Cardiovascular Disorders

VI. Interventions: Cardiovascular Defects A. Mon itor for sign s of a defect in th e in fan t or ch ild

(see previous description s of defects) . B. Mon itor vital sign s closely. C. Mon itor respiratory status for th e presen ce of nasal

flaring, use of accesso ry m uscles, an d oth er sign s of im pen din g respiratory distress, an d n otify th e h ealth care provid er (HCP) if an y ch an ges occur.

D. Auscu ltate breath soun ds for crackles, rh on ch i, or wheezes.

E. If respiratory effort is in creased, place th e ch ild in a reverse Tren d elen burg position , elevatin g th e h ead an d upper body, to decrease th e work of breath in g.

F. Adm in ister h um idified oxygen as prescribed. G. Provide en dotrach eal tube an d ven tilator care as

prescribed. H. Mon itor for h ypercyan otic spells an d in terven e

im m ediately if th ey occur (see Priority Nu rsin g Action s).

PRIORITY NURSING ACTIONS Hypercyanotic Spell Occuring in an Infant 1. Place the infant in a knee-chest position. 2. Administer 10 0 % oxygen. 3. Administer morphine sulfate. 4. Administer fluids intravenously. 5. Document occurrence, actions taken, and the infant’s

response.

Hypercyanotic spells are also known as tet spells or blue spells and occur in infants or children with certain types of heart defects. The infant or child becomes acutely cyanotic and hyperpneic because of the sudden infundibular spasm. These spells may occur as a result of stressful procedures or from feeding, crying, or defecation. If a spell occurs, the nurse needs to provide a calm and comforting approach while immediately placing the infant in the knee-chest posi- tion; this assists breathing and increases oxygenation to body tissues. Oxygen is administered by face mask or blow-by. Morphine sulfate is administered as prescribed sub- cutaneously or through an existing intravenous line (mor- phine sulfate helps to reduce the infundibular spasm). Intravenous fluids are administered to replace fluids and to keep the infant well hydrated and to keep the hematocrit and blood viscosity within acceptable limits. Depending on the infant’s response, a repeated dose of morphine sulfate may be prescribed. Finally, the nurse documents the occur- rence, actions taken, and the infant’s response.

Reference Hockenberry, Wilson (2015), p. 1273.

I. Assess for sign s of HF, such as periorbital edem a or dep en den t edem a in th e h an ds an d feet.

J. Assess periph eral pulses. K. Main tain flu id restrictio n if prescribed.

L. Mon itor in take an d output, an d n otify th e HCP if a decrease in urin e output occurs.

M. O btain daily weigh t. N. Provide adequate n utrition (h igh calorie require-

m en ts) as prescribed. O. Adm in ister m edication s as prescribed . P. Plan in terven tion s to allow m axim al rest for th e

ch ild; keep th e ch ild as stress-free as possible. Q. Prepare th e ch ild an d paren ts for cardiac cath eteriza-

tion , if appropriate.

VII. Cardiac Catheterization A. Descrip tion

1. In vasive diagn ostic procedure to determ in e car- diac defects.

2. Provid es in form ation ab out oxygen saturation of blood in great vessels an d h eart ch am b ers.

3. May be don e for diagn ostic, in terven tion al, or electrop h ysiological reason s.

4. May be carried out on an outpatien t basis. 5. Risks in clude h em orrh age from th e en try site,

clot form ation an d subsequ en t blockage distally, an d tran sien t dysrh yth m ias.

6. Gen eral an esth esia is usually un n ecessary. 7. See Ch apter 56.

B. Preprocedure n ursin g in terven tion s 1. Assess accurate h eigh t an d weigh t because th is

h elps with th e selectio n of th e correct cath eter size.

2. O btain a h isto ry of th e presen ce of allergic reac- tion s to iodin e.

3. Assess for sym pto m s of in fectio n , in cludin g a diaper rash .

4. Assess an d m ark bilateral pulses, such as th e dor- salis ped is an d posterior tib ial.

5. Assess baselin e oxygen saturatio n . 6. Fam iliarize th e paren ts an d ch ild with h ospital

proced ures an d equip m en t. 7. Educate th e ch ild, if age appropriate, an d th e par-

en ts about th e procedure. 8. Allow th e paren ts an d ch ild to verbalize feelin gs

an d con cern s regardin g th e procedure an d th e disorder.

C. Postprocedure n ursin g in terven tion s 1. Mon itor fin din gs on th e cardiac m on itor an d

oxygen saturation for 4 h ou rs after proced ure. 2. Assess pulses below th e cath eter site for equ ality

an d sym m etry. 3. Assess th e tem p erature an d color of th e affected

extrem ity an d report cooln ess, wh ich m ay in di- cate arterial obstruction .

4. Mon itor vital sign s frequen tly, usually every 15 m in utes 4 tim es, every h alf-h our 4 tim es, an d th en every h our 4 tim es.

5. Assess th e pressure dressin g for in tactn ess an d sign s of h em orrh age.

P

e

d

i

a

t

r

i

c

s

484 UNIT VII Pediatric Nursing

6. Ch eck th e bed sh eets un der th e extrem ity for blood, wh ich m ay in dicate bleedin g from th e en try site.

7. If bleed in g is presen t, apply con tin uous, direct pressure at th e cardiac cath eter en try site an d report it im m ediately.

8. Im m obilize th e affected extrem ity in a flat position for at least 4 to 6 h ours for ven ous en try site an d 6 to 8 h ours for arterial en try site as prescribed.

9. Hydrate th e ch ild via th e oral or in traven o us ro ute or both routes as prescribed.

10. Adm in ister acetam in o ph en or ib uprofen for pain or discom fort as prescribed.

11. Prepare th e paren ts an d ch ild, if appropriate, for surgery.

D. Disch arge teach in g for th e ch ild an d paren ts 1. Rem o ve th e dressin g on th e day after th e proce-

dure an d cover it with a ban dage for 2 or 3 days as prescribed.

2. Keep th e site clean an d dry. 3. Avo id tub bath s for 2 to 3 days. 4. O bserve for redn ess, edem a, drain age, bleedin g,

an d fever, an d report an y of th ese sign s im m ediately.

5. Avo id stren uou s activity, if applicable. 6. Th e ch ild m ay return to sch o ol, if appropriate. 7. Provide a diet as tolerated. 8. Adm in ister acetam in o ph en or ib uprofen for

pain , discom fort, or fever. 9. Keep follow-up appoin tm en t with prim ary care

provider.

VIII. Cardiac Surgery A. Posto perative in terven tion s

1. Mon itor vital sign s frequen tly, esp ecially tem per- ature, an d n otify th e HCP if fever occurs.

2. Mon itor for sign s of sepsis, such as fever, ch ills, diaph o resis, leth argy, an d altered levels of con scio usn ess.

3. Main tain strict aseptic tech n ique. 4. Mon itor lin es, tubes, or cath eters th at are in

place, an d m on itor for sign s an d sym pto m s of in fection .

5. Assess for sign s of discom fort, such as irritability, restlessn ess, ch an ges in h eart rate, respiratory rate, an d blood pressure.

6. Adm in ister pain m edication s as prescribed. 7. Adm in ister an tibiotics an d an tipyretics as

prescribed . 8. Prom ote rest an d sleep periods. 9. Facilitate paren t-ch ild con tact as soon as

possible. B. Posto perative h om e care ( Box 40-4)

IX. Rheumatic Fever A. Description

1. Rh eum atic fever is an in flam m ato ry autoim - m un e disease th at affects th e con n ective tissues of th e h eart, join ts, skin (su bcutan eous tissues), blood vessels, an d cen tral n ervous system .

2. Th e m ost serious com plication is rh eum atic h eart disease, wh ich affects th e cardiac valves, particularly th e m itral valve.

3. Rh eum atic fever m an ifests 2 to 6 weeks after an un treated or partially treated grou p A β-h em olytic streptococcal in fectio n of th e upper respiratory tract.

4. Jon es criteria are used to h elp determ in e th e diag- n osis ( Box 40-5).

B. Assessm en t ( Fig. 40-1) 1. Fever: Low-grade fever th at spikes in th e late

aftern oon 2. Elevated an ti–streptolysin O titer 3. Elevated eryth rocyte sedim en tation rate 4. Elevated C-reactive protein level 5. Asch off bodies (lesion s): Foun d in th e h eart,

blood vessels, brain , an d serou s surfaces of th e join ts an d pleura

P

e

d

i

a

t

r

i

c

s

BOX 40-4 Home Care after Cardiac Surgery Omit play outside for several weeks as prescribed. Avoid activities in which the child could fall and be injured, such

as bike riding, for 2 to 4 weeks. Avoid crowds for 2 weeks after discharge. Follow a no-added-salt diet, if prescribed. Do not add any new foods to the infant’s diet (if an allergy exists

to the new food, the manifestations may be interpreted as a postoperative complication).

Do not place creams, lotions, or powders on the incision until completely healed.

The child may return to school usually the third week after dis- charge, starting with half-days.

The child should not participate in physical education for 2 months.

Discipline the child normally. The 2-week follow-up is important. Avoid immunizations, invasive procedures, and dental visits for

2 months; following this time period, the immunization schedule and dental visits need to be resumed.

The child should have a dental visit every 6 months after age 3 years and inform the dentist of the cardiac problem so that antibiotics can be prescribed if necessary.

Call the health care provider if coughing, tachypnea, cyanosis, vomiting, diarrhea, anorexia, pain, or fever occur, or any swelling, redness, or drainage occurs at the site of the incision.

485CHAPTER 40 Cardiovascular Disorders

Assessment of a child with suspected rheumatic fever includes inquiring about a recent sore throat because rheumatic fever manifests 2 to 6 weeks after an untreated or partially treated group A β-hemolytic streptococcal infection of the upper respiratory tract.

C. In terven tion s 1. Assess vital sign s. 2. Con trol join t pain an d in flam m ation with m as-

sage an d altern atin g h ot an d cold application s as prescribed.

3. Provid e bed rest durin g th e acute febrile ph ase. 4. Lim it ph ysical exercise in a ch ild with carditis. 5. Adm in ister an tibiotics as prescribed. 6. Adm in ister salicylates an d an tiin flam m ato ry

agen ts as prescribed; th ese m edication s sh ould n ot be adm in istered before th e diagn osis is con firm ed because th e m ed ication s m ask th e polyarth ritis.

7. In itiate seizure precaution s if th e ch ild is experien cin g ch orea.

8. In struct th e paren ts about th e im portan ce of follow-up an d th e n eed for an tibiotic proph y- laxis for den tal work, in fectio n , an d in vasive proced ures.

9. Advise th e ch ild to inform th e paren ts if an yon e in sch ool develops a streptococcal th roat in fection.

X. Kawasaki Disease A. Descrip tion

1. Kawasaki disease, also kn own as mucocutaneous lymph node syndrome, is an acute system ic in flam - m atory illn ess.

2. Th e cause is un kn own , but m ay be associated with an in fection from an organ ism or toxin .

3. Card iac in volvem en t is th e m ost serious com pli- cation ; an eurysm s can develop.

B. Assessm en t 1. Acute stage

a . Fever b . Con ju n ctival h yperem ia c. Red th roat d . Swollen h an ds, rash , an d en largem en t of cer-

vical lym p h n odes 2. Subacute stage

a . Crackin g lips an d fissures b . Desqu am ation of th e skin on th e tip s of th e

fin gers an d toes c. Join t pain d . Cardiac m an ifestation s e. Th rom b ocytosis

3. Con valescen t stage: Ch ild appears n orm al, but sign s of in flam m ation m ay be presen t.

C. In terven tion s 1. Mon itor tem perature frequen tly. 2. Assess h eart soun ds an d h eart rate an d rh yth m .

P

e

d

i

a

t

r

i

c

s

BOX 40-5 Jones Criteria for Diagnosis of Rheumatic Fever

Major Criteria ▪ Carditis ▪ Arthralgia ▪ Chorea ▪ Erythema marginatum ▪ Subcutaneous nodules Minor Criteria ▪ Fever ▪ Arthralgia ▪ Elevated erythrocyte sedimentation rate or positive

C-reactive protein level ▪ Prolonged PR interval on electrocardiogram

Note: For making a diagnosis, 2 major or 1 major and 2 minor manifestations must be accompanied by supporting evidence of a preceding streptococcal infection (pos- itive throat culture for group A Streptococcus and an elevated or increasing anti– streptolysin O titer).

Involunta ry move me nts of e xtre mitie s a nd fa ce ; a ffe cts s pe e ch

Cho re a

With his tory of s ore throa t

Fe ve r

Infla mma tion of a ll pa rts of the he a rt, prima rily

the mitra l va lve s

Carditis

Re d s kin le s ions s ta rting on the trunk a nd s pre a ding

pe riphe ra lly

Erythe ma marg inatum

S ma ll, nonte nde r s we llings ofte n ove r the joints

S ubc utane o us no dule s

Te nde r, pa inful joints (e lbows , kne e s , a nkle s , wris ts )

Po lyarthritis

Occurs in s ome ca s e s

Abdo minal pain

FIGURE 40-1 Clinical manifestations of rheumatic fever.

486 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

3. Assess extrem ities for edem a, redn ess, an d desquam ation .

4. Exam in e eyes for con jun ctivitis. 5. Mon itor m ucou s m em bran es for in flam m ation . 6. Mon itor strict in take an d outp ut. 7. Adm in ister soft food s an d liqu ids th at are n eith er

too h ot n or too cold. 8. Weigh ch ild daily. 9. Provide passive ran ge-of-m otion exercises to

facilitate join t m ovem en t. 10. Adm in ister acetylsalicylic acid as prescribed for

its an tipyretic an d an tiplatelet effects (add ition al an ticoagulation m ay be n ecessary if an eurysm s are presen t).

11. Adm inister im m un oglobulin in traven ously as pre- scribed to reduce the duration of the fever and th e in cidence of coronary artery lesions an d an eu- rysm s; in traven ous im m un oglobulin is a blood product, so blood precautions when adm in isterin g it are warranted.

12. Paren t education ( Box 40-6)

CRITICAL THINKING What Should You Do? Answer: The nurse should monitor respiratory status closely in a child who has a congenital heart defect. If respiratory effort is increased, the nurse should place the child in a reverse Trendelenburg position, elevating the head and upper body, to decrease the work of breathing. In addition, the child should sleep with the head elevated on several pil- lows and should remain in a semi- or high Fowler’s position during waking hours.

Reference: Hockenberry, Wilson (20 15), pp. 1267, 1270.

P R A C T I C E Q U E S T I O N S 412. Th e n urse is m on itorin g an in fan t with con gen ital

h eart disease closely for sign s of h eart failure (HF). Th e n urse sh o uld assess th e in fan t for wh ich early sign of HF? 1. Pallor 2. Cough 3. Tach ycardia 4. Slow an d sh allow breath in g

413. Th e n urse reviews th e laborato ry results for a ch ild with a suspected diagn osis of rh eu m atic fever, kn owin g th at wh ich laborato ry study would assist in con firm in g th e diagn osis? 1. Im m un oglo bulin 2. Red blood cell coun t 3. Wh ite blood cell coun t 4. An ti–strepto lysin O titer

414. O n assessm en t of a ch ild adm itted with a diagn osis of acute-stage Kawasaki disease, th e n urse expects to n ote wh ich clin ical m an ifestation of th e acute stage of th e disease? 1. Cracked lips 2. Norm al appearan ce 3. Con jun ctival h yperem ia 4. Desqu am ation of th e skin

415. Th e n urse provides h om e care in struction s to th e paren ts of a ch ild with h eart failure regardin g th e procedure for adm in istration of digoxin . Wh ich statem en t m ade by th e paren t in dicates th e n eed fo r fu rth er in stru ctio n ? 1. “I will n ot m ix th e m ed ication with food .” 2. “I will take m y ch ild’s pulse before adm in ister-

in g th e m edication .” 3. “If m ore th an 1 dose is m issed, I will call th e

h ealth care provider.” 4. “If m y ch ild vom its after m edication adm in is-

tration , I will repeat th e dose.”

BOX 40-6 Parent Education for Kawasaki Disease Follow-up care is essential to recovery. Signs and symptoms of Kawasaki disease include the

following: Irritability that may last for 2 months after the onset of

symptoms Peeling of the hands and feet Pain in the joints that may persist for several weeks Stiffness in the morning, after naps, and in cold temperatures

Record the temperature (because fever is expected) until the child has been afebrile for several days.

Notify the health care provider if the temperature is 101 °F (38.3 °C) or higher.

Salicylates such as acetylsalicylic acid (aspirin) may be prescribed.

Signs of aspirin toxicity include tinnitus, headache, vertigo, and bruising; do not administer aspirin or aspirin- containing products if the child has been exposed to chick- enpox or the flu.

Signs and symptoms of bleeding include epistaxis (nose- bleeds), hemoptysis (coughing up blood), hematemesis (vomiting up blood), hematuria (blood in urine), melena (blood in stool), and bruises on the body.

Signs and symptoms of cardiac complications include chest pain or tightness (older children), cool and pale extremi- ties, abdominal pain, nausea and vomiting, irritability, rest- lessness, and uncontrollable crying.

The child should avoid contact sports, if age appropriate, if taking aspirin or anticoagulants.

Avoid administration of measles, mumps, and rubella (MMR) or varicella vaccine to the child for 11 months after intrave- nous immunoglobulin therapy, if appropriate.

487CHAPTER 40 Cardiovascular Disorders

416. Th e n urse is clo sely m on itorin g th e in take an d out- put of an in fan t with h eart failure wh o is receivin g diuretic th erap y. Th e n urse sh ould use wh ich m o st ap p ro p riate m eth od to assess th e urin e outp ut? 1. Weigh in g th e diapers 2. In sertin g a urin ary cath eter 3. Com parin g in take with outp ut 4. Measu rin g th e am oun t of water added to

form ula

417. Th e clin ic n urse reviews th e record of a ch ild just seen by a h ealth care provider an d diagn osed with susp ected aortic sten osis. Th e n urse expects to n ote docum en tation of wh ich clin ical m an ifestatio n specifically foun d in th is disorder? 1. Pallor 2. Hyperactivity 3. Exercise in toleran ce 4. Gastroin testin al disturban ces

418. Th e n urse h as provided h om e care in struction s to th e paren ts of a ch ild wh o is bein g disch arged after cardiac surgery. Wh ich statem en t m ade by th e par- en ts in dicates a n eed fo r fu rth er in stru ctio n ? 1. “A balan ce of rest an d exercise is im portan t.” 2. “I can apply lotion or powder to th e in cision if it

is itch y.” 3. “Activities in wh ich m y ch ild could fall n eed to

be avoided for 2 to 4 weeks.” 4. “Large cro wds of peo ple n eed to be avoided for

at least 2 weeks after surgery.”

419. A ch ild with rh eum atic fever will be arrivin g to th e n ursin g un it for ad m ission . O n adm ission assess- m en t, th e n urse sh ould ask th e paren ts wh ich ques- tio n to elicit assessm en t in form ation specific to th e developm en t of rh eum atic fever? 1. “H as th e ch ild com plain ed of back pain ?” 2. “Has th e ch ild com plain ed of h ead ach es?” 3. “Has th e ch ild h ad an y n ausea or vom itin g?”

4. “Did th e ch ild h ave a sore th roat or fever with in th e last 2 m on th s?”

420. A h ealth care provider h as prescribed oxygen as n eeded for an in fan t with h eart failure. In wh ich situation sh ould th e n urse adm in ister th e oxygen to th e in fan t? 1. Du rin g sleep 2. Wh en ch an gin g th e in fan t’s diap ers 3. Wh en th e m oth er is h old in g th e in fan t 4. Wh en drawin g blood for electrolyte level testin g

421. Assessm en t fin din gs of an in fan t adm itted to th e h ospital reveal a m ach in ery-like m urm u r on aus- cultatio n of th e h eart an d sign s of h eart failure. Th e n urse reviews con gen ital cardiac an om alies an d iden tifies th e in fan t’s con dition as wh ich dis- order? Refer to figu re (th e circled area) to deter- m in e th e con d ition .

1. Aortic sten osis 2. Atrial sep tal defect 3. Paten t ductus arteriosus 4. Ven tricular septal defect

A N S W E R S 412. 3 Ra tion a le: HF is th e in ab ility o f th e h eart to p um p a sufficien t am ou n t of b lo od to m eet th e o xygen an d m etab olic n eeds of th e b od y. Th e early sign s o f HF in clu d e tach ycard ia, tach ypn ea, p ro fuse scalp sweatin g, fatigue an d irritab ility, su dd en weigh t gain , an d resp irato ry distress. A cou gh m ay o ccur in HF as a result o f m ucosal swellin g an d irritatio n , bu t is n o t an early sign . Pallor m ay b e n o ted in an in fan t with HF, bu t is n o t an early sign . Test-Ta kin g Str a tegy: No te th e strategic wo rd , early. Th in k ab ou t th e ph ysiology an d th e effects o n th e h eart wh en flu id o verlo ad o ccu rs. Th ese con cep ts will assist in directin g you to th e correct o ptio n .

Review: Early sign s of h eart failu re in th e in fan t Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Cardiovascu lar Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Hocken b erry, Wilso n (2015), p. 1268.

413. 4 Ra tion a le: Rh eum atic fever is an in flam m ato ry au toim m un e d isease th at affects th e co n n ective tissues o f th e h eart, join ts, skin (su bcutan eou s tissu es), blo o d vessels, an d cen tral n ervou s system . A d iagn o sis of rh eu m atic fever is co n firm ed b y th e p res- en ce o f 2 m ajor m an ifestatio n s or 1 m ajo r an d 2 m in o r m an - ifestatio n s fro m th e Jon es criteria. In add itio n , evid en ce of a

P

e

d

i

a

t

r

i

c

s

488 UNIT VII Pediatric Nursing

recen t streptococcal in fection is con firm ed by a positive an ti– strep tolysin O titer, Strep tozym e assay, o r an ti-DNase B assay. O p tion s 1, 2, an d 3 wo uld n ot h elp to co n firm th e d iagn osis o f rh eu m atic fever. Test -Ta kin g Str a tegy: Focus o n th e su b ject, d efin itive d iagn o - sis of rh eu m atic fever. Recallin g th at rh eu m atic fever ch aracter- istically is associated with strep to co ccal in fection will direct yo u to th e co rrect o p tion . Review: Rh eu m atic fever Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Pediatrics—Card io vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; In flam m ation Refer en ce: Ho cken berry, Wilson (2015), p p. 1296-1297

414. 3 Ra t ion a le: Kawasaki disease, also kn o wn as mucocutaneous lymph node syndrome, is an acute system ic in flam m atory illn ess. In th e acute stage, th e ch ild h as a fever, co n ju n ctival h yp er- em ia, red th ro at, swo llen h an ds, rash , an d en largem en t o f th e cervical lym ph n od es. In th e su bacute stage, crackin g lips an d fissures, desqu am atio n of th e skin on th e tip s o f th e fin gers an d to es, jo in t pain , cardiac m an ifestation s, an d th ro m bo cyto - sis o ccur. In th e con valescen t stage, th e ch ild ap pears n orm al, bu t sign s o f in flam m atio n m ay be p resen t. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, th e acute stage o f Kawasaki d isease. O ptio n 2 can b e elim in ated first because a n orm al ap pearan ce is n o t likely in th e acu te stage. From th e rem ain in g option s, focusin g on th e words acute stage in th e qu estio n will assist in directin g yo u to th e correct o ptio n . Review: Acute stage o f Kawasaki d isease Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Card io vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; In flam m ation Refer en ce: Ho cken berry, Wilson (2015), p p. 1298-1299.

415. 4 Ra t ion a le: Digoxin is a card iac glycoside. Th e paren ts n eed to be in structed th at if th e ch ild vom its after digo xin is ad m in is- tered , th ey are n o t to rep eat th e do se. O p tion s 1, 2, an d 3 are accurate in stru ction s regardin g th e adm in istratio n o f th is m ed- icatio n . In add itio n , th e p aren ts sh o u ld be in structed th at if a do se is m issed an d is n o t iden tified un til 4 h o urs later, th e do se sh ou ld n o t be adm in istered. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further instruction. Th ese words in d icate a n egative even t q u ery an d ask you to select an op tion th at is an in correct statem en t. Gen - eral kn o wledge regardin g digo xin ad m in istration will assist in elim in atin g op tio n 3. Prin cip les related to adm in isterin g m ed- icatio n s to ch ild ren will assist in elim in atin g o p tion 1. Fro m th e rem ain in g o ption s, select th e co rrect o ptio n b ecau se if th e ch ild vo m its, it wo uld be difficu lt to determ in e wh eth er th e m edicatio n also was vo m ited or was ab sorbed by th e b od y. Review: Gu id elin es for ad m in istration of d igo xin Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g

Con t en t Ar ea : Pediatrics—Card io vascu lar Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p . 1270.

416. 1 Ra t ion a le: Heart failu re is th e in ab ility of th e h eart to p um p a su fficien t am ou n t o f bloo d to m eet th e o xygen an d m etabo lic n eed s o f th e b od y. Th e m o st ap prop riate m eth o d for assessin g u rin e ou tpu t in an in fan t receivin g diu retic th erap y is to weigh th e diap ers. Co m parin g in take with o utp ut wo u ld n ot pro vide an accurate m easure of u rin e ou tpu t. Measu rin g th e am ou n t o f water added to form ula is un related to th e am oun t of output. Alth o ugh u rin ary cath eter d rain age is m o st accu rate in deter- m in in g ou tpu t, it is n ot th e m o st app ro priate m eth od in an in fan t an d places th e in fan t at risk for in fection . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Elim in ate o p tion s 3 an d 4 first because th ey are co m p ara- b le o r alike an d will n o t provid e an in dicatio n o f u rin e ou tpu t. No tin g th e strategic wo rd s will direct you to th e correct option from th e rem ain in g o ptio n s. Review: Care o f an in fan t receivin g d iu retic th erap y Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Card io vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ho cken berry, Wilson (2015), p p. 957-958, 1271.

417. 3 Ra t ion a le: Ao rtic sten o sis is a n arrowin g o r strictu re o f th e ao r- tic valve, causin g resistan ce to b lo od flo w in th e left ven tricle, d ecreased card iac ou tpu t, left ven tricu lar h ypertro ph y, an d pu l- m o n ary vascu lar co n gestio n . A ch ild with ao rtic sten osis sh ows sign s o f exercise in to leran ce, ch est p ain , an d d izzin ess wh en stan din g fo r lo n g p erio d s. Pallor m ay be n o ted, bu t is n ot sp e- cific to th is typ e of d iso rd er alon e. O p tio n s 2 an d 4 are n ot related to th is diso rd er. Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e ch aracteristics o f aortic sten osis. O ptio n s 2 an d 4 can b e elim in ated first b ecause th ey are n o t associated with a cardiac d iso rd er. Fro m th e rem ain in g op tio n s, n o tin g th e wo rd specifically in th e q ues- tion will direct yo u to th e correct o ptio n . Review: Ao rtic sten o sis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Card io vascu lar Pr ior ity Con cepts: Elim in atio n ; Perfusio n Refer en ce: Ho cken berry, Wilson (2015), p . 1291.

418. 2 Ra t ion a le: Th e m oth er sh ould be in structed th at lotion s an d p o wd ers sh ou ld n ot b e app lied to th e in cisio n site after cardiac su rgery. Lotio n s an d p owders can irritate th e su rrou n d in g skin , wh ich could lead to skin b reakdown an d subsequen t in fection o f th e in cisio n site. O p tion s 1, 3, an d 4 are accu rate in stru ctio n s regard in g h o m e care after cardiac su rgery. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further instruction. Th ese words in dicate a n egative even t q u ery an d ask you to select an op tion th at is an in correct statem en t. Usin g

P

e

d

i

a

t

r

i

c

s

489CHAPTER 40 Cardiovascular Disorders

gen eral prin cip les related to p osto perative in cision al site care will direct you to th e correct option . Review: Ho m e care in structio n s fo llo win g card iac su rgery Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Card iovascular Pr ior it y Con cept s: Clien t Ed ucation ; Health Pro m o tion Refer en ce: Hocken b erry, Wilso n (2015), p. 1224.

419. 4 Ra tion a le: Rh eum atic fever is an in flam m ato ry au toim m u n e d isease th at affects th e co n n ective tissues o f th e h eart, join ts, skin (su bcu tan eou s tissu es), bloo d vessels, an d cen tral n ervo us system . Rh eu m atic fever ch aracteristically m an ifests 2 to 6 weeks after an u n treated o r p artially treated grou p A β-h em olytic strep to co ccal in fectio n of th e up per resp irato ry tract. In itially, th e n u rse d eterm in es wh eth er th e ch ild h ad a so re th ro at or an u n exp lain ed fever with in th e past 2 m on th s. O ptio n s 1, 2, an d 3 are u n related to rh eu m atic fever. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e p ath op h ysio l- o gy an d etio lo gy asso ciated with rh eum atic fever. Also, n ote th e sim ilarity b etween th e words rheumatic fever in th e q uestio n an d th e wo rd fever in th e co rrect op tio n . Review: Etiolo gy related to rh eu m atic fever Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Card iovascular Pr ior it y Con cept s: Clin ical Ju dgm en t; In flam m atio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 1296-1297.

420. 4 Ra tion a le: Heart failu re (HF) is th e in ability of th e h eart to p um p a su fficien t am o un t of b loo d to m eet th e oxygen an d m etabo lic n eeds o f th e b od y. Cryin g exh au sts th e lim ited en ergy su pp ly, in creases th e wo rkload of th e h eart, an d in creases th e o xygen dem an d s. O xygen ad m in istration m ay

b e p rescribed fo r stressfu l p erio d s, esp ecially d u rin g b ou ts of cryin g or in vasive p ro ced ures. O p tio n s 1, 2, an d 3 are n ot likely to p ro du ce cryin g in th e in fan t. Test-Ta kin g St r a t egy: Focu s on th e su b ject, th e n eed to adm in ister o xygen to th e in fan t with HF, an d recall th e situa- tio n s th at wou ld place stress an d an in creased wo rklo ad on th e h eart; th is sh ou ld d irect you to th e co rrect op tio n . Drawin g b loo d is an in vasive proced ure, wh ich wo uld likely cau se th e in fan t to cry. Review: Care of th e ch ild with h eart failu re Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Cardiovascular Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Hocken b erry, Wilso n (2015), p. 1267.

421. 3 Ra tion a le: A paten t d uctus arterio su s is failu re o f th e fetal d u c- tu s arteriosus (artery con n ectin g th e ao rta an d th e pu lm on ary artery) to close. A ch aracteristic m ach in ery-like m u rm ur is p re- sen t, an d th e in fan t m ay sh ow sign s o f h eart failure. Aortic ste- n o sis is a n arrowin g or strictu re o f th e ao rtic valve. Atrial septal d efect is an ab n o rm al op en in g b etween th e atria. Ven tricular sep tal d efect is an ab n o rm al o pen in g b etween th e righ t an d left ven tricles. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e co n gen ital car- d iac an om aly an d th e lo catio n o f th e defect. Recallin g th e an a- tom ical lo catio n s in th e h eart will direct you to th e co rrect o ptio n . Review: Co n gen ital h eart d efects Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Cardiovascular Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Hocken b erry, Wilso n (2015), p. 1278.

P

e

d

i

a

t

r

i

c

s

490 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 41 Renal and Urinary Disorders

PRIORITY CONCEPTS Elimination; Inflammation

CRITICAL THINKING What Should You Do? The nurse notes that there has been no urinary output for 1 hour in an infant who underwent surgical repair of hypospa- dias. What should the nurse do? Answer located on p. 495.

I. Glomerulonephritis A. Description

1. Glomerulonephritis refers to a group of kidn ey dis- orders ch aracterized by in flam m ato ry in ju ry in th e glom erulus, m ost of wh ich are cau sed by an im m un ological reaction .

2. Th e disorder results in proliferative an d in flam - m atory ch an ges with in th e glom erular structure.

3. Destruction , in flam m ation , an d sclerosis of th e glom eruli of th e kidn eys occur.

4. In flam m ation of th e glom eruli results from an an tigen -an tibody reaction produ ced by an in fec- tio n elsewh ere in th e body.

5. Loss of kidn ey fun ction develops. B. Cau ses

1. Im m un ological diseases 2. Autoim m un e diseases 3. An teceden t grou p A β-h em olytic streptococcal

in fection of th e ph aryn x or skin 4. Histo ry of ph aryn gitis or ton sillitis 2 to 3 weeks

befo re sym pto m s C. Types

1. Acute: O ccurs 2 to 3 weeks after a streptococcal in fection

2. Ch ron ic: May occur after th e acute ph ase or slowly over tim e

D. Com p lication s 1. Kid n ey failure 2. Hyperten sive en ceph alo path y 3. Pulm on ary edem a 4. Heart failure

E. Assessm en t 1. Periorbital an d facial edem a th at is m ore prom -

in en t in th e m orn in g

2. An o rexia 3. Decreased urin ary outp ut 4. Cloudy, sm oky, brown -colored urin e (h em aturia) 5. Pallor, irritab ility, leth argy 6. In an older ch ild: Headach es, abdom in al or flan k

pain , dysuria 7. Hyperten sion 8. Protein uria th at produces a persisten t an d exces-

sive foam in th e urin e 9. Azotem ia 10. In creased blood urea n itrogen an d creatin in e

levels 11. In creased anti–streptolysin O titer (used to diag-

n ose disorders caused by streptococcal in fection s) F. In terven tion s (see Priority Nu rsin g Action s box)

PRIORITY NURSING ACTIONS Fluid Volume Overload in a Child with Glomerulonephritis

1. Assess airway patency, vital signs, and weight. 2. Assess for bounding, increased pulse. 3. Assess for distended hand and neck veins. 4. Assess for elevated central venous pressure (CVP) and for

dysrhythmias. 5. Notify the health care provider (HCP) and carry out pre-

scriptions, including water and sodium restriction and administration of diuretics.

The client with glomerulonephritis is at risk for fluid volume overload and usually has peripheral and periorbital edema during the acute phase. If the child has developed fluid volume overload, actions should be taken to prevent cardiovas- cular and pulmonary edema. The nurse should assess airway patency, vital signs, and weight and compare to baseline data. The nurse should also look for other signs of fluid volume over- load, including a bounding increased pulse, distended hand and neck veins, elevated CVP, and dysrhythmias. If anyof these occur, the nurse should notify the HCP and carry out any pre- scriptions, which may include water and sodium restriction and the administration of diuretics.

Reference Hockenberry, Wilson (20 15), pp. 10 13-10 15, 1028.

491

P

e

d

i

a

t

r

i

c

s

1. Mon itor vital sign s, in take an d outp ut, an d ch ar- acteristics of urin e.

2. Measu re daily weigh ts at th e sam e tim e of day, usin g th e sam e scale, an d wearin g th e sam e clo th in g.

3. Lim it activity; provid e safety m easu res. 4. Diet restrictio n s of sodium depen d on th e stage

an d severity of th e disease, esp ecially th e exten t of th e edem a; in ad dition , potassium m ay be restricted durin g periods of oliguria.

5. Mon itor for com plication s (e.g., kidn ey failure, h yperten sive en ceph alopath y, seizures, pulm o - n ary edem a, h eart failure).

6. Adm in ister diuretics (if sign ifican t edem a an d flu id overload are presen t), an tih yp erten sives (fo r h yperten sion ), an d an tibiotics (to a ch ild with eviden ce of persisten t strepto coccal in fec- tio n s) as prescribed.

7. In itiate seizure precaution s an d adm in ister an ti- con vu lsan ts as prescribed for seizu res associated with h yperten sive en ceph alopath y.

8. In struct paren ts to report sign s of bloody urin e, h eadach e, or edem a.

9. In struct paren ts th at th e ch ild n eeds to obtain ap propriate treatm en t for in fectio n s, specifically for sore th roats, upper respiratory in fectio n s, an d skin in fection s.

Measuring the daily weight and assessing for changes is the most useful and effective measure for determining fluid balance.

II. Nephrotic Syndrome A. Descriptio n

1. Neph rotic syn drom e is a kidn ey disorder ch arac- terized by m assive protein uria, h ypoalbum in em ia (h ypoprotein em ia), an d edem a (Fig. 41-1).

2. Th e prim ary objectives of th erapeutic m an agem en t are to reduce th e excretion of urin ary protein , m ain - tain protein -free urin e, reduce edem a, preven t in fection , an d m in im ize com plication s.

B. Assessm en t ( Box 41-1)

The classic manifestations of nephrotic syndrome are massive proteinuria, hypoalbuminemia, and edema.

C. In terven tion s 1. Mon itor vital sign s, in take an d output, an d daily

weigh ts. 2. Mon itor urin e for specific gravity an d protein . 3. Mon itor for edem a. 4. Nutrition : A regular diet with ou t added salt m ay

be prescribed if th e ch ild is in rem ission ; sodium is restricted durin g periods of m assive edem a (fluids m ay also be restricted).

De cre a s e d oncotic pre s s ure

De cre a s e d re na l blood

flow

Incre a s e d s e cre tion of

ADH a nd a ldos te rone

Re nin re le a s e

Va s ocons triction

Na + a nd wa te r re a bs orption

Incre a s e d hydros ta tic pre s s ure

Incre a s e d he pa tic s ynthe s is of prote ins

a nd lipids

Re na l glome rula r da ma ge

P rote inuria (ma s s ive )

Hypoprote ine mia

Ede ma

Hypovole mia Hype rlipide mia

FIGURE 41-1 Sequence of events in nephrotic syndrome. ADH, Antidiuretic hormone; Na+, sodium.

492 UNIT VII Pediatric Nursing

5. Corticosteroid th erap y is prescribed as soon as th e diagn osis h as been determ in ed; m on itor th e ch ild clo sely for sign s of in fectio n an d oth er ad verse effects of corticostero ids (see Ch apter 51).

6. Im m un osuppressan t th erap y m ay be prescribed to reduce th e relap se rate an d in duce lon g-term rem ission , or, if th e ch ild is un respon sive to cor- ticosteroid th erapy, th erap y m ay be adm in istered alon g with th e cortico steroid.

7. Diuretics m ay be prescribed to reduce edem a. 8. Plasm a expanders such as salt-poor h um an album in

m ay be prescribed for a severely edem atous child. 9. In struct paren ts about testin g th e urin e for pro-

tein , m ed ication adm in istration , side effects of m edication s, an d gen eral care of th e ch ild.

10. In struct paren ts on th e sign s of in fectio n an d th e n eed to avoid con tact with oth er ch ildren wh o m ay be in fectious.

III. Hemolytic-Uremic Syndrome A. Description

1. Hem olytic-urem ic syn drom e is th ough t to be associated with bacterial toxin s, ch em icals, an d viruses th at cau se acute kidn ey in ju ry in ch ildren .

2. It occurs prim arily in in fan ts an d sm all ch ildren 6 m on th s to 5 years old.

3. Clin ical features in clude acq uired h em olytic an e- m ia, th rom bocytopen ia, kidn ey in jury, an d cen - tral n ervou s system sym pto m s.

B. Assessm en t 1. Triad of an em ia, th rom bocytop en ia, an d kidn ey

failure ( Box 41-2) 2. Protein uria, h em aturia, an d presen ce of

urin ary casts 3. Bloo d urea n itrogen an d serum creatin in e levels

elevated; h em oglobin an d h em atocrit levels decreased

C. In terven tion s 1. Hem odialysis or periton eal dialysis m ay be pre-

scrib ed if a ch ild is an uric (dialysate solution is prescribed to m eet th e ch ild’s electrolyte n eeds).

2. Strict m on itorin g of flu id balan ce is n ecessary; fluid restriction s m ay be prescribed if th e ch ild is an uric.

3. In stitute m easu res to preven t in fectio n . 4. Provide ad equate n utrition . 5. O th er treatm en ts in clude m ed ication s to treat

m an ifestatio n s an d th e adm in istration of blood produ cts to treat severe an em ia (adm in istered with cau tion to preven t fluid overload).

IV. Enuresis A. Description

1. Enuresis refers to a co n dition in wh ich a ch ild is un ab le to con tro l blad der fun ction , even th o ugh th e ch ild h as reach ed an age at wh ich con trol of void in g is expected or th e ch ild h as successfully com pleted a bladder con tro l program .

2. By age 5, m ost ch ildren are aware of bladder full- n ess an d are able to con trol void in g.

B. Prim ary n octurn al en uresis 1. Prim ary n octurn al en uresis is bed -wettin g in a

ch ild wh o h as n ever been dry for exten ded periods.

2. Th e con dition is com m on in ch ildren , an d m ost ch ildren even tually outgrow bed -wettin g with - out th erap eutic in terven tion .

3. Th e ch ild is un ab le to sen se a full blad der an d does n ot awaken to void.

4. Th e ch ild m ay h ave delayed m aturation of th e cen tral n ervous system .

5. Th e ch ild sh ould be evaluated for an y path o log- ical causes befo re th e diagn osis of prim ary n oc- turn al en uresis is m ade.

C. Secon dary or acquired en uresis 1. Th e on set of wettin g occurs after a period of

establish ed urin ary con tin en ce. 2. Secon dary en uresis m ay occur durin g n igh ttim e

sleep (n octurn al), on ly durin g th e wakin g h ours (diurn al), or durin g daytim e an d n igh ttim e.

3. Th e ch ild m ay co m plain of dysuria, urgen cy, or frequen cy.

4. Th e ch ild sh o uld be assessed for urin ary tract in fectio n s.

P

e

d

i

a

t

r

i

c

s

BOX 41-1 Assessment Findings in Nephrotic Syndrome

▪ Child gains weight ▪ Periorbital and facial edema most prominent in the morning ▪ Leg, ankle, labial, or scrotal edema ▪ Urine output decreases; urine dark and frothy ▪ Ascites (fluid in abdominal cavity) ▪ Blood pressure normal or slightly decreased ▪ Lethargy, anorexia, and pallor ▪ Massive proteinuria ▪ Decreased serum protein (hypoproteinemia) and elevated

serum lipid levels

BOX 41-2 Manifestations of Hemolytic-Uremic Syndrome

▪ Vomiting ▪ Irritability ▪ Lethargy ▪ Marked pallor ▪ Hemorrhagic manifestations: bruising, petechiae, jaun-

dice, bloody diarrhea ▪ Oliguria or anuria ▪ Central nervous system involvement: seizures, stupor,

coma

493CHAPTER 41 Renal and Urinary Disorders

D. Assessm en t: History of bed -wettin g with n o exten ded period of dryn ess in a ch ild older th an age 5 years

E. In terven tion s 1. Perform urin alysis an d urin e culture as pre-

scrib ed to rule out in fectio n or an existin g disorder.

2. Assist th e fam ily with iden tifyin g a treatm en t plan th at best fits th e n eeds of th e ch ild.

3. Lim it fluid in take at n igh t, an d en courage th e ch ild to void just befo re go in g to bed .

4. In volve th e ch ild in carin g for th e wet sh eets an d ch an gin g th e bed to assist th e ch ild to take own - ersh ip of th e problem .

5. Provide reward system s as appropriate for th e ch ild.

6. In corporate beh avioral con d ition in g tech n iqu es. 7. Med ication s m ay be prescribed (such as tricyclic

an tidepressan ts, an tidiuretics, an d an tispas- m od ics) to treat en uresis.

8. En cou rage follow-up to determ in e th e effective- n ess of th e treatm en t.

V. Cryptorchidism A. Description : Cryp torch idism is a con d ition in wh ich

1 or both testes fail to descen d th rough th e in guin al can al in to th e scrotal sac.

B. Assessm en t: Testes are n ot palp able or easily gu ided in to th e scrotum .

C. In terven tion s 1. Mon itor durin g th e first 12 m on th s of life to

determ in e wh eth er spon tan eous descen t occurs. 2. After age 1 year, m ed ical or surgical treatm en t

m ay be in stituted. 3. Hum an ch orion ic gon adotropin , a pituitary h or-

m on e th at stim ulates th e production of testoster- on e, m ay be prescribed for an older ch ild.

4. Surgical correction , if n eeded, is don e by orch io- pexy before th e ch ild’s secon d birth day (prefera- bly between 1 an d 2 years of age) if th e testes do n ot descen d spon tan eously.

5. Mon itor for bleedin g an d in fectio n postoper- atively.

6. In struct paren ts in posto perative h om e care m ea- sures, in cludin g preven tin g in fectio n , pain con - trol, an d activity restriction s.

7. Provide an oppo rtun ity for paren tal coun selin g if th e paren ts are con cern ed about th e future fertil- ity of th e ch ild.

VI. Epispadias and Hypospadias (Fig. 41-2) A. Description

1. Epispadias an d h ypospadias are con gen ital defects in volvin g abn orm al placem en t of th e ure- th ral orifice of th e pen is.

2. Th ese an atom ical defects can lead to th e easy en try of bacteria in to th e urin e.

B. Assessm en t 1. Epispadias: Ureth ral orifice is located on th e dor-

sal surface of th e pen is; th e con dition often occurs with exstroph y of th e bladder.

2. Hypo spadias: Ureth ral orifice is located below th e glan s pen is alon g th e ven tral surface.

C. Surgical in terven tion s: Surgery is don e before th e age of toilet train in g, preferably between 16 an d 18 m on th s of age.

Circumcision may not be performed on a newborn with epispadias or hypospadias. Although there are other surgical techniques used to repair these defects, the pediatrician may prefer using the foreskin for surgi- cal reconstruction.

D. Postoperative in terven tion s 1. Th e ch ild h as a pressure dressin g an d m ay h ave

som e type of urin ary diversion or a urin ary sten t (used to m ain tain paten cy of th e ureth ral open - in g) wh ile th e m eatu s is h ealin g.

2. Mon itor vital sign s. 3. En cou rage flu id in take to m ain tain ad equate

urin e output an d m ain tain paten cy of th e sten t. 4. Mon itor in take an d output an d th e urin e for

clo udin ess or a foul odor.

P

e

d

i

a

t

r

i

c

s

Dors a l pla ce me nt of ure thra l ope ning

Ve ntra l pla ce me nt of ure thra l ope ning

Epis padias

Hypo s padias

FIGURE 41-2 Epispadias and hypospadias are genital anomalies in which the urethral opening is above or below its normal location on the glans of the penis.

494 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

5. No tify th e h ealth care provider (HCP) if th ere is n o urin ary output for 1 h our because th is m ay in dicate kin ks in th e urin ary diversion or sten t or obstruction by sedim en t.

6. Provide pain m ed ication or m ed ication to relieve bladder spasm s (an tich olin ergic) as prescribed.

7. Adm in ister an tibiotics as prescribed. 8. In struct paren ts in th e care of th e ch ild wh o h as a

urin ary diversion or sten t. 9. In struct paren ts to avoid givin g the ch ild a tub bath

until the sten t, if presen t, is rem oved. 10. In struct parents about fluid in take, m edication

adm in istration , sign s an d sym ptom s of in fection, an d n eed for HCP follow-up for dressin g rem oval after surgery as prescribed.

VII. Bladder Exstrophy A. Description

1. Bladder exstroph y is a con gen ital an om aly ch ar- acterized by extru sion of th e urin ary bladder to th e outsid e of th e body th rough a defect in th e lo wer abdom in al wall.

2. Th e cause is un kn own . 3. Treatm en t requires surgical m an agem en t an d

occurs in a series of staged recon struction s. 4. In itial surgery for clo sure of th e abdom in al

defect sh ould occur with in th e first few days of life.

5. Th e goal of subsequ en t surgeries is to recon struct th e blad der an d gen italia an d en ab le th e ch ild to ach ieve urin ary con tin en ce.

B. Assessm en t 1. Expo sed blad der m ucosa 2. Widen ed sym ph ysis pubis 3. Defects of th e extern al gen italia

C. In terven tion s 1. Mon itor urin ary outp ut. 2. Mon itor for sign s of urin ary tract or woun d

in fection . 3. Main tain th e in tegrity of th e exposed bladder

m ucosa. 4. Preven t th e blad der tissue fro m dryin g, wh ile

allowin g th e drain age of urin e, un til surgical clo- sure is perform ed; im m ediately after birth , as pre- scrib ed, th e exp osed blad der is covered with a sterile, n on adh eren t dressin g to protect it un til clo sure can be perform ed.

5. Mon itor laborato ry values an d urin alysis to assess ren al fun ctio n .

6. Adm in ister an tibiotics as prescribed. 7. Provide em otion al support to th e paren ts, an d

en courage verbalization of th eir fears an d con cern s.

Applying petroleum jelly to the bladder mucosa is avoided because it tends to dry out, adhere to the blad- der mucosa, and damage the delicate tissues when the dressing is removed.

CRITICAL THINKING What Should You Do? Answer: Following surgical repair for hypospadias, the uri- nary output is monitored closely. The nurse should notify the health care provider if there is no urinary output for 1 hour because this may indicate kinks in the urinary diversion or stent placed during the surgical procedure or an obstruction caused by sediment.

Reference: Hockenberry, Wilson (20 15), pp. 1043-10 44.

P R A C T I C E Q U E S T I O N S 422. Th e n urse reviews th e record of a ch ild wh o is sus-

pected to h ave glom erulon eph ritis. Wh ich state- m en t by th e ch ild’s paren t sh ould th e n urse exp ect th at is associated with th is diagn osis? 1. “I’m so glad th ey didn ’t fin d an y protein in

h is urin e.” 2. “I n oticed h is urin e was th e co lor of coca-cola

lately.” 3. “His h ealth care provider said h is kidn eys are

workin g well.” 4. “Th e n urse wh o adm itted m y ch ild said h is

blood pressure was low.”

423. Th e n urse perform in g an adm ission assessm en t on a 2-year-old ch ild wh o h as been diagn osed with n eph rotic syn drom e n otes th at wh ich m o st com - m on characteristic is associated with th is syn drom e? 1. Hyperten sion 2. Gen eralized edem a 3. In creased urin ary output 4. Fran k, brigh t red blood in th e urin e

424. Th e n urse is plan n in g care for a ch ild with h em olytic-urem ic syn d rom e wh o h as been an uric an d will be receivin g periton eal dialysis treatm en t. Th e n urse sh ould plan to im plem en t wh ich m easu re? 1. Restrict fluids as prescribed. 2. Care for th e arterioven ous fistula. 3. En courage foods h igh in potassium . 4. Adm in ister an algesics as prescribed .

425. A 7-year-o ld ch ild is seen in a clin ic, an d th e h ealth care provider docum en ts a diagn osis of prim ary n octurn al en uresis. Th e n urse sh o uld provid e wh ich in form ation to th e paren ts? 1. Prim ary n octurn al en uresis does n ot respo n d to

treatm en t. 2. Prim ary n octurn al en uresis is cau sed by a psy-

ch iatric problem . 3. Prim ary n octurn al en uresis requires surgical

in terven tion to im prove th e problem . 4. Prim ary n octurn al en uresis is usually outgrown

with ou t th erap eutic in terven tion .

495CHAPTER 41 Renal and Urinary Disorders

426. Th e n urse provided disch arge in struction s to th e paren ts of a 2-year-old ch ild wh o h ad an orch io- pexy to correct crypto rch idism . Wh ich statem en t by th e paren ts in dicates th e n eed fo r fu rth er in stru ctio n ? 1. “I’ll ch eck h is tem p erature.” 2. “I’ll give h im m ed ication so h e’ll be

com fo rtable.” 3. “I’ll ch eck h is voidin g to be sure th ere’s n o

problem .” 4. “I’ll let h im decide wh en to return to h is play

activities.”

427. Th e n urse is reviewin g a treatm en t plan with th e paren ts of a n ewborn with h ypo spadias. Wh ich statem en t by th e paren ts in dicates th eir un der- stan din g of th e plan ? 1. “Caution sh ould be used wh en straddlin g th e

in fan t on a h ip.” 2. “Vital sign s sh ould be taken daily to ch eck for

bladder in fectio n .” 3. “Cath eterization will be n ecessary wh en th e

in fan t does n ot vo id.” 4. “Circu m cision h as been delayed to save tissue

for surgical repair.”

428. Th e n urse is carin g for an in fan t with a diagn osis of bladder exstroph y. To protect th e exp osed bladder tissue, th e n urse sh ould plan wh ich in terven tion ? 1. Cover th e bladder with petroleum jelly gauze. 2. Cover th e bladder with a n on adh erin g

plastic wrap. 3. Apply sterile distilled water dressin gs over th e

bladder m ucosa. 4. Keep th e bladder tissue dry by coverin g it with

dry sterile gauze.

429. Wh ich question sh ould th e n urse ask th e paren ts of a ch ild susp ected of h avin g glom erulon eph ritis? 1. “Did your ch ild fall off a bike on to th e

h an dlebars?” 2. “H as th e ch ild h ad persisten t n ausea an d

vo m itin g?” 3. “H as th e ch ild been itch in g or h ad a rash an y-

tim e in th e last week?” 4. “Has th e ch ild h ad a sore th roat or a th roat

in fectio n in th e last few weeks?”

430. Th e n urse co llects a urin e specim en preop eratively from a ch ild with episp adias wh o is sch eduled for surgical repair. Wh en an alyzin g th e results of th e urin alysis, wh ich sh ould th e n urse m o st likely expect to n ote? 1. Hem aturia 2. Protein uria 3. Bacteriuria 4. Glucosuria

431. Th e n urse is perform in g an assessm en t on a ch ild adm itted to th e h ospital with a probable diagn osis of n eph ro tic syn d rom e. Wh ich assessm en t fin d- in gs sh o uld th e n urse expect to observe? Select all th at ap p ly.

1. Pallor 2. Edem a 3. An o rexia 4. Protein uria 5. Weigh t lo ss 6. Decreased serum lipids

A N S W E R S

422. 2 Ra tion a le: Glom erulo n ep h ritis refers to a grou p o f kid n ey d is- o rd ers ch aracterized b y in flam m atory in ju ry in th e glo m eru lus. Gro ss h em aturia, resultin g in d ark, sm oky, cola-colored or b ro wn -co lored u rin e, is a classic sym p tom of glom eru lo n ep h ri- tis. Blo od urea n itro gen levels an d seru m creatin in e levels m ay b e elevated, in d icatin g th at kidn ey fu n ctio n is co m prom ised . A m ild to m od erate elevatio n in p ro tein in th e urin e is asso ciated with glom erulo n eph ritis. Hyp erten sion is also com m on due to flu id vo lu m e o verload seco n d ary to th e kid n eys n o t workin g p ro perly. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, th e m an ifestatio n s o f glo m eru lon eph ritis. Elim in ate o ption s 1 an d 3 first b ecause h yp erten sio n fro m flu id vo lu m e o verload an d p ro tein uria are m ost likely to occur in th is kid n ey d isorder. Recallin g th at th is is a ren al d isorder an d th at blo o d u rea n itrogen levels an d serum creatin in e levels in crease in th ese typ e of diso rd ers will assist in directin g yo u to th e correct o ptio n .

Review: Clin ical m an ifestatio n s of glo m eru lo n ep h ritis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1013.

423. 2 Ra tion a le: Neph rotic syn d ro m e is defin ed as m assive p ro tein - u ria, h yp oalb um in em ia, h yperlip em ia, an d edem a. O th er m an ifestatio n s in clud e weigh t gain ; p eriorbital an d facial ed em a th at is m o st p ro m in en t in th e m o rn in g; leg, an kle, lab ial, o r scro tal ed em a; d ecreased u rin e ou tpu t an d u rin e th at is dark an d fro th y; ab do m in al swellin g; an d b loo d p ressure th at is n o rm al o r sligh tly d ecreased . Test-Ta kin g St r a t egy: Note th e strategic wo rd , most. Recall th e p ath op h ysio lo gy asso ciated with n eph ro tic syn drom e. Asso ci- ate ed em a with n eph ro tic syn d ro m e. Th is will h elp you to an swer q uestio n s sim ilar to th is o n e.

P

e

d

i

a

t

r

i

c

s

496 UNIT VII Pediatric Nursing

Review: Clin ical m an ifestation s o f n ep h ro tic syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Ren al an d Urin ary Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in atio n Refer en ce: Ho cken berry, Wilson (2015), p p. 1017, 1020.

424. 1 Ra t ion a le: Hem olytic-u rem ic syn dro m e is th ou gh t to be asso- ciated with bacterial toxin s, ch em icals, an d viru ses th at resu lt in acu te kidn ey in ju ry in ch ild ren . Clin ical m an ifestation s o f th e d isease in clu de acq uired h em o lytic an em ia, th ro m bo cyto - pen ia, ren al in ju ry, an d cen tral n ervou s system sym pto m s. A ch ild with h em olytic-u rem ic syn d ro m e un d ergoin g p erito n eal dialysis because o f an u ria wou ld b e on flu id restrictio n . Pain is n ot asso ciated with h em o lytic-u rem ic syn dro m e, an d p otas- sium wou ld be restricted, n o t en co u raged , if th e ch ild is an u ric. Periton eal d ialysis do es n o t requ ire an arterio ven o u s fistu la (o n ly h em od ialysis) . Test -Ta kin g St r a t egy: Note th e su b ject, an u ria. Focus on th e ch ild’s d iagn o sis an d recall kn o wled ge abo ut th e care of a clien t with acu te kidn ey in jury. Also fo cu s o n th e d ata in th e q u es- tio n . Notin g th e word peritoneal will assist in elim in atin g op tion 2. Fro m th e rem ain in g op tio n s, rem em b er th at b ecau se th e ch ild is an u ric, flu id s will b e restricted. Review: Hem o lytic-u rem ic syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Pediatrics—Ren al an d Urin ary Pr ior ity Con cepts: Elim in atio n ; Flu id an d Electrolyte Balan ce Refer en ce: Ho cken berry, Wilson (2015), p . 1023.

425. 4 Ra t ion a le: Prim ary n octurn al en u resis occurs in a ch ild wh o h as n ever b een d ry at n igh t for exten ded p eriod s. Th e co n d ition is com m o n in ch ildren , an d m o st ch ildren even tually ou tgro w bed -wettin g with o ut th erapeu tic in terven tio n . Th e ch ild is un ab le to sen se a fu ll b lad der an d d oes n ot awaken to void. Th e ch ild m ay h ave d elayed m atu ration o f th e cen tral n ervo u s system . Th e con ditio n is n o t cau sed b y a p sych iatric p ro blem . Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e ch aracteristics of p rim ary n octurn al en uresis. Recall th at th e word enuresis refers to u rin atin g, an d th e word nocturnal refers to n igh ttim e. Review: En u resis Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Pediatrics—Ren al an d Urin ary Pr ior ity Con cepts: Develop m en t; Elim in atio n Refer en ce: Ho cken berry, Wilson (2015), p p. 636-637.

426. 4 Ra t ion a le: Crypto rch id ism is a con d itio n in wh ich 1 o r bo th testes fail to descen d th ro ugh th e in guin al can al in to th e scro tal sac. Su rgical co rrectio n m ay b e n ecessary. All vigo ro u s activities sh ou ld b e restricted fo r 2 weeks after su rgery to p ro m ote h eal- in g an d preven t in ju ry. Th is p reven ts d islo dgin g o f th e su ture, wh ich is in tern al. Norm ally, 2-year-o ld s wan t to be active;

allowin g th e ch ild to d ecide wh en to retu rn to h is p lay activities m ay p reven t h ealin g an d cau se in jury. Th e paren ts sh ou ld b e tau gh t to m o n ito r th e tem p eratu re, p ro vide an algesics as n eed ed, an d m o n ito r th e urin e o utp ut. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further instruction. Th ese words in dicate a n egative even t q u ery an d ask you to select an o ptio n th at is an in co rrect statem en t. O p tion 1 is an im p ortan t action to reco gn ize sign s of in fectio n . O p tion 2 is app ro priate to keep pain to a m in im u m . O ptio n 3 m o n ito rs void in g pattern , wh ich is also im p ortan t after th is typ e o f su rgery. Review: Proced ures fo r th e correctio n of cryp to rch id ism Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Ren al an d Urin ary Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p . 1042.

427. 4 Ra t ion a le: Hyp osp adias is a co n gen ital d efect in vo lvin g abn or- m al placem en t of th e ureth ral o rifice of th e pen is. In h yp osp a- d ias, th e ureth ral o rifice is located b elo w th e glan s pen is alon g th e ven tral su rface. Th e in fan t sh ou ld n o t be circum cised b ecause th e d orsal fo reskin tissu e will b e u sed fo r su rgical rep air o f th e h ypo spad ias. O p tion s 1, 2, an d 3 are u n related to th is d iso rd er. Test -Ta kin g St r a tegy: Fo cus on th e su b ject, treatm en t for h ypo spad ias. No te th e words indicates their understanding. Recallin g th at h yp osp adias is a con gen ital defect in vo lvin g ab n o rm al p lacem en t of th e u reth ral orifice o f th e pen is will d irect you to th e co rrect op tio n . Review: Treatm en t p lan related to repair o f h yp o sp ad ias Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Pediatrics—Ren al an d Urin ary Pr ior ity Con cepts: Clien t Ed u catio n ; Elim in ation Refer en ce: Ho cken berry, Wilson (2015), p . 1043.

428. 2 Ra t ion a le: In blad der exstrop h y, th e b ladd er is exp osed an d extern al to th e b od y. In th is d isord er, o n e m u st take care to pro- tect th e expo sed bladd er tissu e fro m d ryin g, wh ile allo win g th e d rain age of u rin e. Th is is accom p lish ed b est by co verin g th e b lad der with a n on ad h erin g plastic wrap . Th e use o f p etro leu m jelly gau ze sh ou ld b e avoided b ecause th is type o f dressin g can d ry ou t, ad h ere to th e m ucosa, an d d am age th e d elicate tissu e wh en rem oved. Dry sterile dressin gs an d dressin gs soaked in so lu tio n s (th at can dry o ut) also d am age th e m u co sa wh en rem oved . Test -Ta kin g St r a t egy: Focu s o n th e su b ject, treatm en t for blad - d er exstrop h y, an d visu alize th is d isord er. No tin g th e word nonadhering in th e correct o p tion will d irect yo u to select th is o n e. Review: Care fo r th e in fan t with b lad d er exstro p h y Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Pediatrics—Ren al an d Urin ary

P

e

d

i

a

t

r

i

c

s

497CHAPTER 41 Renal and Urinary Disorders

Pr ior it y Con cept s: Safety; Tissu e In tegrity Refer en ce: Hocken b erry, Wilso n (2015), pp . 1044-1045.

429. 4 Ra tion a le: Glom erulo n ep h ritis refers to a grou p o f kid n ey d is- o rd ers ch aracterized b y in flam m atory in ju ry in th e glo m eru lus. Gro up A β-h em olytic strep toco ccal in fection is a cause o f glo - m eru lo n ep h ritis. O ften , a ch ild b eco m es ill with strepto co ccal in fectio n of th e u pp er resp irato ry tract an d th en d evelo ps sym pto m s of acute po ststrep toco ccal glom erulo n ep h ritis after an in terval o f 1 to 2 weeks. Th e assessm en t d ata in o p tion s 1, 2, an d 3 are u n related to a d iagn o sis of glom erulo n ep h ritis. Test-Ta kin g St r a t egy: No te th e su b ject, a question th at will elicit in fo rm atio n sp ecific to th e diagn osis of glom eru lo n ep h ri- tis. O p tio n 1 relates to a kid n ey in jury, n o t an in fectiou s p ro - cess. Fro m th e rem ain in g op tion s, recallin g th at a strepto co ccal in fectio n 1 to 2 weeks before th e d evelop m en t of glom erulo n e- p h ritis is th e classic assessm en t fin d in g will assist in d irectin g yo u to th e correct o ptio n . Review: Causes of glo m eru lo n ep h ritis Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; In fection Refer en ce: Hocken b erry, Wilso n (2015), pp . 1012-1013.

430. 3 Ra tion a le: Ep isp ad ias is a co n gen ital defect in volvin g ab n o r- m al p lacem en t of th e u reth ral orifice of th e p en is. Th e u reth ral o pen in g is lo cated an ywh ere o n th e d orsum o f th e p en is. Th is an ato m ical ch aracteristic facilitates en try o f bacteria in to th e

u rin e. O ptio n s 1, 2, an d 4 are n o t ch aracteristically n o ted in th is co n d itio n . Test-Ta kin g St r a t egy: Note th e strategic wo rd s, most likely. Visu alize th e an atom ical ch aracteristics o f episp adias to an swer th e qu estio n . O p tio n s 1, 2, an d 4 d o n o t relate to th e p oten tial for in fection , wh ich can b e asso ciated with epispad ias. Review: Ep isp ad ias Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 1044-1045.

431. 1, 2, 3, 4 Ra tion a le: Neph ro tic syn d ro m e is a kidn ey d iso rd er ch aracter- ized b y m assive p ro tein u ria, h yp oalb um in em ia, edem a, ele- vated serum lipids, an o rexia, an d pallor. Th e ch ild gain s weigh t. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, th e ch aracteristics o f n ep h rotic syn d rom e. Th in kin g abo ut th e p ath op h ysio lo gy asso ciated with th is diso rd er an d recallin g th e assessm en t fin d- in gs fo r n ep h rotic syn drom e will d irect you to th e co rrect o ptio n s. Review: Clin ical m an ifestation s asso ciated with n ep h ro tic syn d ro m e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 1016-1018.

P

e

d

i

a

t

r

i

c

s

498 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 42 Neurological and Cognitive Disorders

PRIORITY CONCEPTS Intracranial Regulation; Safety

CRITICAL THINKING What Should You Do? The nurse notes signs of increased intracranial pressure (ICP) in a child who has undergone insertion of a ventriculo- peritoneal shunt for the treatment of hydrocephalus. What should the nurse do? Answer located on p. 506.

I. Cerebral Palsy A. Descrip tion

1. Disord er ch aracterized by im paired m ovem en t an d postu re resultin g from an abn o rm ality in th e extrapyram idal or pyram id al m oto r system

2. Th e m ost com m on clin ical type is spastic cerebral palsy, wh ich represen ts an upper m otor n euron type of m uscle weakn ess.

3. Less com m on types of cerebral palsy are ath etoid, ataxic, an d m ixed.

B. Assessm en t 1. Extrem e irritability an d cryin g 2. Feedin g difficu lties 3. Abn orm al m oto r perform an ce 4. Alteration s of m uscle ton e; stiff an d rigid arm s

or legs 5. Delayed developm en tal m ilesto n es 6. Persisten ce of prim itive in fan tile reflexes (Moro,

ton ic n eck) after 6 m on th s (m ost prim itive reflexes disappear by 3 to 4 m on th s of age)

7. Abn orm al posturin g, such as opisth oto n os (exag- gerated arch in g of th e back) (Fig. 42-1)

8. Seizu res m ay occur. C. In terven tion s

1. Th e goal of m an agem en t is early recogn ition an d in terven tion s to m axim ize th e ch ild’s abilities.

2. An in terp rofession al team approach is im ple- m en ted to m eet th e m an y n eeds of th e ch ild.

3. Th erapeutic m an agem en t in cludes ph ysical th er- apy, occupation al th erap y, speech th erapy, edu- cation , an d recreation .

4. Assess th e ch ild’s developm en tal level an d in telligen ce.

5. En courage early in terven tion an d participation in sch ool program s.

6. Prepare for usin g m obilizin g devices to h elp pre- ven t or reduce defo rm ities.

7. En courage com m un ication an d in teraction with th e ch ild on h is or h er develo pm en tal level, rath er th an chronological age level.

8. Provide a safe en viron m en t by rem ovin g sh arp objects, usin g a protective h elm et if th e ch ild falls frequen tly, an d im plem en tin g seizu re precau- tion s if n ecessary.

9. Provide safe, appropriate toys for th e ch ild’s age an d developm en tal level.

10. Position th e ch ild uprigh t after m eals. 11. Medication s m ay be prescribed to relieve m uscle

spasm s, wh ich cau se in ten se pain ; an tiseizure m edication s m ay also be prescribed.

12. Provide th e paren ts with in form ation about th e disorder an d treatm en t plan ; en courage supp ort groups for paren ts.

II. Head Injury A. Description

1. Head in jury is th e path olo gical result of an y m ech an ical force to th e sku ll, scalp , m en in ges, or brain ( Fig. 42-2). a. O pen h ead in jury occurs wh en th ere is a frac-

ture of th e sku ll or pen etration of th e skull by an object.

b . Closed h ead in jury is the result of blun t traum a (th is is m ore serious th an an open h ead in jury because of th e ch an ce of in creased ICP in a “closed” vault); this type of in jury can also be caused by sh aken baby syn drom e.

2. Man ifestation s dep en d on th e type of in ju ry an d th e subsequen t am oun t of in creased ICP.

499

B. Assessm en t: In creased ICP

The child’s level of consciousness provides the ear- liest indication of an improvement or deterioration of the neurological condition.

1. Early sign s a. Sligh t ch an ge in vital sign s b . Sligh t ch an ge in level of con sciousn ess c. In fan t: Irritability, h igh -pitch ed cry, bulgin g

fon tan el, in creased h ead circum feren ce, dilated scalp vein s, Macewen ’s sign (cracked- pot soun d on percussion of th e h ead), settin g sun sign (sclera visible above th e iris)

d . Ch ild: Headach e, n ausea, vom itin g, visu al disturban ces (diplo pia), seizu res

2. Late sign s a. Sign ifican t decrease in level of con scio usn ess b . Bradycardia c. Decreased m oto r an d sen sory respo n ses d . Alteration in pupil size an d reactivity

e. Decorticate (flexion ) postu rin g: Addu ction of th e arm s at th e sh oulders; arm s are flexed on th e ch est with th e wrists flexed an d th e h an ds fisted, an d th e lower extrem ities are exten ded an d adducted; seen with severe dysfun ction of cerebral cortex ( Fig. 42-3)

f. Decereb rate (exten sion ) postu rin g: Rigid exten sion an d pron atio n of th e arm s an d th e legs; sign of dysfun ction at th e level of th e m idbrain (see Fig. 42-3)

g. Ch eyn e-Stokes respiratio n s h . Com a

Immobilize the neck and spine after a head injury if a cervical or other spinal injury is suspected. When a spi- nal cord injury is ruled out, elevate the head of the bed 15 to 30 degrees, if not contraindicated and as prescribed, to facilitate venous drainage.

C. In terven tion s 1. Mon itor th e airway; ad m in ister oxygen as

prescribed. 2. Assess in juries. (See Ch apter 62 for in form ation

on spin al cord in juries.) 3. Position th e clien t so th at th e h ead is m ain tain ed

m idlin e to avoid jugu lar vein com pression , wh ich can in crease ICP.

4. Mon itor vital sign s an d n eurological fun ction (assess level of con sciousn ess closely).

5. Notify th e h ealth care provider if sign s of in creased ICP occur.

6. Keep stim uli to a m in im u m ; attem p t to m in i- m ize cryin g in an in fan t.

7. With h old sedatin g m edication s durin g th e acute ph ase of th e in ju ry so th at ch an ges in levels of con sciousn ess can be assessed.

8. In itiate seizure precaution s ( Box 42-1). 9. Mon itor for decreased respo n siven ess to pain

(a significan t sign of altered level of con sciousn ess). 10. Main tain NPO (n oth in g by m ou th ) status or

provid e clear liquid s, if prescribed, un til it is determ in ed th at vo m itin g will n ot occur.

11. Mon itor prescribed in traven o us fluid s carefully to avoid in creasin g an y cerebral edem a an d to m in im ize th e possibility of overh yd ration .

P

e

d

i

a

t

r

i

c

s

FIGURE 42-1 Abnormal posturing: opisthotonos.

Torn s ubdura l ve s s e ls

P re injury contour of s kull

Imme dia te pos tinjury contour of s kull

S he a ring force sS he a ring force s

Tra uma from conta ct with floor of cra nium

S he a ring force s

FIGURE 42-2 Mechanical distortion of cranium during closed head injury.

A

B

FIGURE 42-3 A, Decorticate (flexion) posturing. B, Decerebrate (exten- sion) posturing.

500 UNIT VII Pediatric Nursing

12. Mon itor for a flu id or electrolyte alteration (cou ld in dicate in ju ry to th e h ypo th alam us or posterior pituitary).

13. Assess woun ds an d dressin gs for th e presen ce of drain age, an d m on itor for n ose or ear drain age, wh ich could in dicate leakage of cerebro spin al flu id (CSF).

14. Adm in ister tepid spon ge bath s or place th e ch ild on a h ypoth erm ia blan ket as prescribed if h yper- th erm ia occurs.

15. Avo id suction in g th rou gh th e n ares because of th e possibility of th e cath eter en terin g th e brain th rou gh a fracture, wh ich places th e ch ild at h igh risk for a secon dary in fectio n .

16. As prescribed, adm in ister acetam in oph en for h eadach e, an ticon vu lsan ts for seizures, an d an ti- biotics if a laceration is presen t; prepare to ad m in ister proph ylactic tetan us toxoid.

17. A corticostero id or osm o tic diuretic m ay be pre- scrib ed to reduce cerebral edem a.

18. Mon itor for sign s of brain stem in volvem en t (Box 42-2).

19. Mon itor for sign s of epidural h em atom a: Asym - m etrical pupils (on e dilated, n on reactive pupil) m ay in dicate a n eurosurgical em ergen cy th at requires evacuation of th e h em atom a.

Drainage from the nose or ear needs to be tested for the presence of glucose. Drainage that is positive for glu- cose (as tested with reagent strips) indicates leakage of CSF. The health care provider must be notified immedi- ately if the drainage tests positive for glucose.

III. Hydrocephalus A. Description

1. An im balan ce of CSF absorption or productio n cau sed by m alform atio n s, tum ors, h em orrh age, in fectio n s, or traum a

2. Resu lts in h ead en largem en t an d in creased ICP B. Types

1. Com m un icatin g a . Hydroceph alus occurs as a result of im paired

absorption with in th e subarach n oid space. b . In terferen ce of th e cerebro spin al fluid in th e

ven tricular system does n ot occur. 2. Non com m un icatin g: O bstruction of cerebrospi-

n al fluid flow in th e ven tricular system does occur. C. Assessm en t

1. In fan t a . In creased h ead circum feren ce b . Th in , widely sep arated bon es of th e h ead th at

produce a cracked-pot soun d (Macewen ’s sign ) on percussion

c. An terior fon tan el ten se, bulgin g, an d n on - pulsatin g; sutures will sep arate prior to fon ta- n el bulgin g

d . Dilated scalp vein s e. Fron tal bossin g f. “Settin g sun ” eyes

2. Ch ild a . Beh avior ch an ges, such as irritability an d

leth argy b . Headach e on awaken in g c. Nausea an d vo m itin g d . Ataxia e. Nystagm u s

3. Late sign s: High , sh rill cry an d seizu res D. Surgical in terven tion s

1. Th e go al of surgical treatm en t is to preven t fur- th er CSF accu m ulation by bypassin g th e block- age an d drain in g th e flu id from th e ven tricles to a location wh ere it m ay be reabsorbed.

2. In a ven triculoperiton eal shunt, th e CSF drain s in to th e periton eal cavity fro m th e lateral ven tri- cle (Fig. 42-4).

3. In a ven triculoatrial sh u n t, CSF drain s in to th e righ t atrium of th e h eart from th e lateral ven tri- cle, bypassin g th e obstru ctio n (used in older ch il- dren an d in ch ildren with path olo gical con d ition s of th e abdom en ).

4. Sh u n t revision m ay be n ecessary as th e ch ild grows.

5. An altern ative to sh un t placem en t is en doscopic th ird ven triculostom y, in wh ich a sm all open in g in th e floor of th e th ird ven tricle is m ade th at allows CSF to bypass th e fourth ven tricle an d return to th e circulation to be ab sorbed; th is treatm en t m ay n ot be appropriate for som e typ es of h ydroceph alus.

P

e

d

i

a

t

r

i

c

s

BOX 42-1 Seizure Precautions Raise side rails when child is sleeping or resting. Pad side rails and other hard objects. Place waterproof mattress or pad on bed or crib. Instruct child to wear or carry medical identification. Instruct child in precautions to take during potentially hazard-

ous activities. Instruct child to swim with a companion. Instruct child to use a protective helmet and padding when

engaged in bicycle riding, skateboarding, and in-line skating.

Alert caregivers to need for any special precautions.

BOX 42-2 Signs of Brainstem Involvement

▪ Deep, rapid, or intermittent and gasping respirations ▪ Wide fluctuations or noticeable slowing of pulse ▪ Widening pulse pressure or extreme fluctuations in blood

pressure ▪ Sluggish, dilated, or unequal pupils

Notify the health care provider immediately if these signs develop!

501CHAPTER 42 Neurological and Cognitive Disorders

E. Preop erative in terven tion s 1. Mon itor in take an d outp ut; give sm all, frequen t

feed in gs as tolerated un til preoperative NPO sta- tus is prescribed.

2. Repo sition th e h ead frequen tly an d use special devices such as an egg crate m attress un d er th e h ead to preven t pressure sores.

3. Prepare th e ch ild an d fam ily for diagn ostic pro- cedu res an d surgery.

F. Posto perative in terven tion s 1. Mon itor vital sign s an d n eurological sign s. 2. Position th e ch ild on th e un operated side to pre-

ven t pressure on th e sh un t valve. 3. Keep th e ch ild flat as prescribed to avoid rapid

reduction of in tracran ial flu id. 4. O bserve for in creased ICP; if in creased ICP occurs,

elevate th e h ead of th e bed to 15 to 30 degrees to en h an ce gravity flow th rough the sh un t.

5. Measu re h ead circum feren ce. 6. Mon itor for sign s of in fectio n an d assess dress-

in gs for drain age. 7. Mon itor in take an d output. 8. Provide com fo rt m easures an d adm in ister m ed i-

cation s as prescribed. 9. In struct paren ts on h ow to recogn ize sh u n t in fec-

tio n or m alfun ction . 10. In an in fan t, irritability; a h igh , sh rill cry; leth -

argy; an d feed in g poorly m ay in dicate sh un t m al- fun ction or in fection .

11. In a toddler, h ead ach e an d a lack of appetite are th e earliest com m on sign s of sh u n t m alfun ction .

12. In older ch ildren , an in dicator of sh un t m alfun c- tio n is an alteration in th e ch ild’s level of con sciousn ess.

A high, shrill cry in an infant can be a sign of increased ICP.

IV. Meningitis A. Descrip tion

1. Men in gitis is an in fectious process of th e cen tral n ervou s system cau sed by bacteria or viruses th at m ay be acquired as a prim ary disease or as a result of com plication s of n eurosu rgery, traum a, in fectio n of th e sin uses or ears, or system ic in fectio n s.

2. Diagn osis of bacterial m en in gitis is m ade by test- in g CSF obtain ed by lum bar pun cture; th e fluid is cloudy with in creased pressure, in creased wh ite blood cell coun t, elevated protein , an d decreased gluco se levels.

3. Bacterial m en in gitis can be caused by various organ ism s, m ost com m on ly Haemophilus influen- zae typ e b, Streptococcus pneumoniae, or Neisseria meningitidis; m en in go coccal m en in gitis occurs in epidem ic form an d can be tran sm itted by droplets from n aso ph aryn geal secretio n s.

4. Viral m en in gitis is associated with viruses such as m um ps, param yxovirus, h erpesvirus, an d en terovirus.

B. Assessm en t 1. Sign s an d sym ptom s vary, depen din g on th e

type, th e age of th e ch ild, an d th e duration of th e preced in g illn ess.

2. Fever, ch ills, h eadach e 3. Vom itin g, diarrh ea 4. Poor feedin g or an orexia 5. Nuch al rigidity 6. Poor or h igh , sh rill cry 7. Altered level of con sciousn ess, such as leth argy or

irritab ility 8. Bulgin g an terior fon tan el in an in fan t 9. Positive Kern ig’s sign (in ability to exten d th e leg

wh en th e th igh is flexed an teriorly at th e h ip) an d Brud zin ski’s sign (n eck flexion causes adduction

P

e

d

i

a

t

r

i

c

s

Extra tubing is coile d to a llow for growth

Tubing continue s to be thre a de d s ubcuta ne ous ly until it e nte rs the pe ritone a l ca vity

S hunt tube conne ction

Enla rge d le ft ve ntricle

Va lve (be hind the e a r)

Ca the te r pa s s e s unde r the s kin be hind the e a r, through the cra nium, a nd into e nla rge d la te ra l ve ntricle

Entry into cra nium

FIGURE 42-4 Ventriculoperitoneal shunt.

502 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

an d flexion m ovem en ts of th e lower extrem ities) in ch ildren an d adolescen ts

10. Muscle or join t pain (m en in gococcal in fectio n an d H. influenzae in fection )

11. Petech ial or purpu ric rash es (m en in gococcal in fectio n )

12. Ear th at ch ron ically drain s (pn eum o coccal m en in gitis)

C. In terven tion s 1. Provide respiratory isolatio n precaution s an d

m ain tain it for at least 24 h ours after an tibiotics are in itiated.

2. Adm in ister an tibiotics an d an tipyretics as pre- scrib ed (adm in ister an tibiotics as soon as th ey are prescribed after lum bar pun cture); an tisei- zure m edication s m ay also be prescribed.

3. Perform n eurological assessm en t an d m on itor for seizu res; assess for th e com plication of in ap- propriate an tidiuretic h orm on e secretio n , caus- in g flu id reten tion (cerebral edem a) an d dilu tion al h ypo n atrem ia.

4. Assess for ch an ges in level of con sciousn ess an d irritability.

5. Mon itor for a purpu ric or petech ial rash an d for sign s of th rom boem boli.

6. Assess n utrition al status; m on itor in take an d outp ut.

7. Mon itor for h earin g loss. 8. Determ in e close con tacts of th e ch ild with m en -

in gitis because th e con tacts n eed proph ylactic treatm en t.

9. Pn eum ococcal con jugate vaccine is recom - m en ded for all ch ildren begin n in g at age 2 m on th s to protect again st m en in gitis; strepto- coccal pn eum ococci can cause m an y bacterial in fection s, includin g m en in gitis (see Ch apter 44 for inform ation on vaccin es).

V. Submersion Injury A. Description

1. Survival of at least 24 h ou rs after subm ersion in a fluid m ed ium

2. Hypo xia/ asph yxiation is th e prim ary problem because it results in exten sive cell dam age; cere- bral cells sustain irreversible dam age after 4 to 6 m in u tes of subm ersion .

3. Addition al problem s in clude aspiration an d h ypo th erm ia.

4. O utcom e is predicted on th e basis of th e len gth of subm ersion in n on -icy water; outcom e m ay be good if subm ersion was for less th an 5 m in u tes an d th e ch ild exh ibits n eurological respo n sive- n ess, reactive pupils, an d a n orm al cardiac rh yth m .

5. A ch ild wh o was subm erged for m ore th an 10 m in utes an d does n ot respo n d to cardiop ul- m on ary life supp ort m easu res with in 25 m in u tes

h as an extrem ely poor progn osis (severe n euro- logical im pairm en t or death ).

B. In terven tion s 1. Provide ven tilatory an d circulatory support; if

th e ch ild h as h ad a severe cerebral in sult, en do- trach eal in tub ation an d m ech an ical ven tilation m ay be required .

2. Mon itor respiratory status because respiratory com pro m ise an d cerebral edem a m ay occur 24 h ours after th e in ciden t.

3. Mon itor for aspiration pn eum on ia. 4. Mon itor n eurological status clo sely; if spon tan e-

ous purpo seful m ovem en t an d n orm al brain - stem fun ction are n ot apparen t 24 h ou rs after th e even t, th e ch ild m ost likely h as sustain ed severe n eurological deficits.

5. Teach paren ts to provide adequate supervision of in fan ts an d sm all ch ildren aroun d water to pre- ven t acciden ts.

VI. Reye’s Syndrome A. Description

1. Reye’s syn d rom e is an acute en ceph alo path y th at follo ws a viral illn ess an d is ch aracterized path o- logically by cerebral edem a an d fatty ch an ges in th e liver; a defin itive diagn osis is m ade by liver biopsy.

2. Th e exact cau se is un clear; it m ost com m on ly fol- lows a viral illn ess such as in fluen za or varicella.

3. Adm in istration of aspirin an d aspirin -con tain in g produ cts is n ot recom m en ded for ch ildren with a febrile illn ess or ch ildren with varicella or in flu- en za because of its association with Reye’s syn d rom e.

4. Acetam in oph en or ibuprofen are con sidered th e m ed ication s of ch oice.

5. Early diagn osis an d aggressive treatm en t are im portan t; th e go al of treatm en t is to m ain tain effective cerebral perfusion an d con trol in creas- in g ICP.

B. Assessm en t 1. Histo ry of system ic viral illn ess 4 to 7 days before

th e on set of sym ptom s 2. Fever 3. Nausea an d vom itin g 4. Sign s of altered h epatic fun ctio n such as leth argy 5. Progressive n eurological deterioration 6. In creased blood am m on ia levels

C. In terven tion s 1. Provide rest an d decrease stim ulation in th e

en viron m en t. 2. Assess n eurological status. 3. Mon itor for altered level of con sciousn ess an d

sign s of in creased ICP. 4. Mon itor for sign s of altered h epatic fun ction an d

results of liver fun ction studies. 5. Mon itor in take an d output.

503CHAPTER 42 Neurological and Cognitive Disorders

P

e

d

i

a

t

r

i

c

s

6. Mon itor for sign s of bleedin g an d sign s of im paired coagulation , such as a prolon ged bleed in g tim e.

VII. Seizure Disorders A. Description (see Ch apter 62 for addition al in form a-

tion on seizures) 1. Excessive an d un o rgan ized n euron al disch arges

in th e brain th at activate associated m oto r an d sen sory organ s

2. Classified as gen eralized, partial, or un classified, dep en din g on th e area of th e brain in volved

3. Types of gen eralized seizu res in clude ton ic- clon ic, absen ce, m yoclon ic, an d aton ic.

4. Partial seizu res arise fro m a specific area in th e brain an d cau se lim ited sym pto m s; types in clude sim ple partial an d com plex partial.

B. Assessm en t 1. O btain in form ation fro m th e paren ts about th e

tim e of on set, precipitatin g even ts, an d beh avior befo re an d after th e seizure.

2. Determ in e th e ch ild’s h isto ry related to seizu res. 3. Ask th e ch ild about th e presen ce of an aura (a

warn in g sign of im pen din g seizu re). 4. Mon itor for apn ea an d cyanosis. 5. Postseizure: Th e ch ild is disorien ted an d sleepy.

C. Seizu re precaution s (see Box 42-1) D. In terven tion s ( Box 42-3) E. An tiseizure m edication s (see Ch apter 63 for in for-

m ation on m edication s)

Never place anything, including an airway device, into the mouth of a child experiencing a seizure.

VIII. Neural Tube Defects A. Descrip tion

1. Th is cen tral n ervous system defect results from failure of th e n eural tube to clo se durin g em bry- on ic developm en t.

2. Folic acid is recom m en ded durin g pregn an cy to reduce th e occurren ce of th ese con d ition s.

3. Asso ciated deficits in clude sen sorim o tor distur- ban ce, dislocated h ips, talipes equin ovarus (clubfoot), an d h ydroceph alus.

4. Defect closure is perform ed soon after birth . B. Types

1. Spin a bifida occulta a. Posterio r vertebral arch es fail to close in th e

lum bosacral area. b . Spin al cord rem ain s in tact an d usually is n ot

visible. c. Men in ges are n ot exposed on th e skin surface. d . Neurological deficits are n ot usually presen t.

2. Spin a bifida cystica a. Protrusion of th e spin al cord or its m en in ges

or both occurs. b . Defect results in in com plete clo sure of th e

vertebral an d n eural tubes, resultin g in a sac- like protrusion in th e lum bar or sacral area, with varyin g degrees of n ervous tissue in volvem en t.

c. Defect can in clude m en in go cele, m yelom e- n in gocele, lipo m en in go cele, an d lipom en in - gom yelocele.

3. Men in go cele a. Protrusion in volves m en in ges an d a saclike

cyst th at co n tain s CSF in th e m idlin e of th e back, usually in th e lum bo sacral area.

b . Spin al cord is n ot in volved. c. Neurological deficits are usually n ot presen t.

4. Myelom en in gocele a. Protrusion of th e m en in ges, CSF, n erve ro ots,

an d a portion of th e spin al co rd occurs. b . Th e sac (defect) is covered by a th in m em -

bran e pron e to leakage or rupture. c. Neurological deficits are eviden t.

C. Assessm en t 1. Depen ds on th e spin al cord in volvem en t 2. Visib le spin al defect 3. Flaccid paralysis of th e legs 4. Altered bladder an d bowel fun ction 5. Hip an d join t deform ities 6. Hydro ceph alu s

D. In terven tion s 1. Evaluate th e sac an d m easu re th e lesion . 2. Perform n eurological assessm en t. 3. Mon itor for in creased ICP, wh ich m igh t in dicate

developin g h ydroceph alus. 4. Measu re h ead circum feren ce; assess an terior fon -

tan el for bulgin g.

BOX 42-3 Interventions for Seizures Ensure airway patency. Have suction equipment and oxygen available. Time the seizure episode. If the child is standing or sitting, ease the child down to the

floor and place the child in a side-lying position. Place a pillow or folded blanket under the child’s head; if no

bedding is available, place your own hands under the child’s head or place the child’s head in your own lap.

Loosen restrictive clothing. Remove eyeglasses from the child if present. Clear the area of any hazards or hard objects. Allow the seizure to proceed and end without interference. If vomiting occurs, turn the child to one side as a unit. Do not restrain the child, place anything in the child’s mouth,

or give any food or liquids to the child. Prepare to administer medications as prescribed. Remain with the child until the child recovers fully. Observe for incontinence, which may have occurred during

the seizure. Document the occurrence.

504 UNIT VII Pediatric Nursing

5. Protect th e sac; as prescribed, cover with a sterile, m oist (n orm al salin e), n on adh eren t dressin g to m ain tain th e m oistu re of th e sac an d con ten ts.

6. Ch an ge th e dressin g coverin g th e sac on a regular sch edule or wh en ever it beco m es soiled because of th e risk of in fectio n ; diaperin g m ay be con tra- in dicated un til th e defect h as been repaired.

7. Use aseptic tech n iqu e to preven t in fectio n . 8. Assess th e sac for redn ess, clear or purulen t drain -

age, abrasio n s, irritation , an d sign s of in fectio n . 9. Early sign s of in fectio n in clude elevated tem per-

ature (axillary) , irritability, leth argy, an d n uch al rigidity.

10. Place in a pron e position to m in im ize ten sion on th e sac an d th e risk of traum a; th e h ead is turn ed to 1 side for feed in g.

11. Assess for ph ysical im pairm en ts such as h ip an d join t defo rm ities.

12. Prepare th e ch ild an d fam ily for surgery. 13. Adm in ister an tibiotics preop eratively an d post-

operatively, as prescribed, to preven t in fectio n . 14. Teach th e paren ts an d even tually th e ch ild ab out

lon g-term h om e care. a . Position in g, feedin g, skin care, an d ran ge-of-

m otion exercises b . In stitutin g a blad der elim in ation program

an d perform in g clean in term itten t cath eteri- zation tech n ique if n ecessary

c. Adm in isterin g an tispasm odics (th at act on th e sm ooth m uscle of th e bladder) as pre- scribed to in crease bladder cap acity an d im prove con tin en ce

d . Im plem en t a bowel program , in cludin g a h igh -fiber diet, in creased fluids, an d supp os- itories as n eeded.

e. Th e ch ild is at h igh risk for allergy to latex an d rubber products because of th e frequen t exposu re to latex durin g im plem en tatio n of care m easu res.

IX. Attention-Deficit/ Hyperactivity Disorder A. Description

1. Beh avior disorder ch aracterized by developm en - tally in approp riate degrees of in atten tion , over- activity, an d im pulsivity

2. Ch ildh ood problem s in clude lo wered in tellec- tual developm en t, som e m in or ph ysical ab n or- m alities, sleepin g disturban ces, beh avio ral or em o tion al disorders, an d difficu lty in social relation sh ips.

3. Early diagn osis is im portan t to preven t im paired em o tion al an d psych ological develo pm en t.

4. Diagn osis is establish ed on th e basis of self- reports, paren t an d teach er reports, an d use of assessm en t tools.

B. Assessm en t 1. Fidgets with h an ds or feet or squirm s in th e seat

2. Easily distracted with extern al or in tern al stim uli 3. Difficulty with followin g th rough on

in struction s 4. Poor atten tio n span 5. Sh ifts from 1 un co m pleted activity to an oth er 6. Talks excessively 7. In terrupts or in trudes on oth ers 8. En gages in ph ysically dan gerous activities with -

out con siderin g th e possible con sequ en ces C. In terven tion s

1. Provide paren ts with in form ation about th e dis- order an d treatm en t plan ; en courage supp ort grou ps for paren ts.

2. Treatm en t in cludes beh avioral th erap y, m edica- tion , m ain tain in g a con sisten t en viron m en t, an d appropriate classroom placem en t.

3. Beh avioral th erapy focuses on preven tin g un de- sirable beh avio r.

4. Main tain a con sisten t h om e an d classro om en vi- ron m en t, an d provide en viron m en tal an d ph ys- ical safety m easu res.

5. Prom o te self-esteem . 6. Stim ulan t m ed ication s m ay be prescribed ; possi-

ble side effects in clude appetite suppressio n an d weigh t loss, n ervou sn ess, tics, in som n ia, an d in creased blood pressure.

7. In struct th e ch ild an d paren ts about m edica- tion adm in istration an d th e n eed for regular follo w-up.

X. Autism Spectrum Disorders A. Description

1. Autism spectrum disorders (ASDs) are com plex n eurodevelopm en tal disorders of un kn own etiol- ogy com posed of qualitative alteration s in social interaction and verbal im pairm en t with repetitive, restricted, an d stereotype beh avioral pattern s.

2. Autism spectrum disorder im pairm en ts ran ge from m ild to severe; types in clude autism , Asper- ger syn d rom e, Rett syn d rom e.

3. Sym pto m s are usually n oticed by th e paren ts by 3 years of age.

4. Th e cau se of th e disorder is n ot specifically kn own ; h owever, it h as been lin ked to a wid e ran ge of an tep artum , in trapartum , an d n ewborn con d ition s an d exposure to h azardo us ch em i- cals; gen etic predisp osition is also lin ked to th e disorder.

5. Th e disorder is accom pan ied by in tellectual an d social beh avioral deficits, an d th e ch ild exh ibits pecu liar an d bizarre ch aracteristics with social in teraction s, com m un ication , an d beh aviors.

6. Despite th eir relatively m od erate to severe dis- ability, som e ch ildren with autism (kn own as savants) excel in particular areas, such as art, m usic, m em ory, m ath em atics, or percep tual skills such as puzzle buildin g.

P

e

d

i

a

t

r

i

c

s

505CHAPTER 42 Neurological and Cognitive Disorders

P

e

d

i

a

t

r

i

c

s

7. Diagn osis is establish ed on th e basis of sym ptom s and the use of several screen in g tools.

B. Assessm en t 1. Social

a. Abn orm al or lack of com fort-seekin g beh aviors b . Abn orm al or lack of social play c. Im pairm en t in peer relation sh ips d . Lack of awaren ess of th e existen ce or feelin gs

of oth ers e. Abn orm al or lack of im itation of oth ers

2. Com m un ication a. Lack of, im paired, or ab n orm al speech , such

as produ cin g a m on oto n e voice or ech olalia b . Abn orm al n on verbal com m un ication (do es

n ot use gestures to com m un icate) c. Lack of im agin ative play

3. Beh avior a. Persisten t preoccu pation or attach m en t to

objects; ran ge of in terests restricted b . Self-in jurious beh aviors c. Must m ain tain routin e; an y en viron m en tal

ch an ge produ ces m arked distress d . Produ ces repetitive body m ovem en ts such as

rockin g or h ead ban gin g C. In terven tion s

1. Determ in e th e ch ild’s routin es, h abits, an d pref- eren ces an d m ain tain con sisten cy as m uch as possible.

2. Determ in e th e specific ways in wh ich th e ch ild com m un icates an d use th ese m eth od s.

3. Avoid placin g dem an ds on th e ch ild. 4. Im p lem en t safety precaution s as n ecessary for

self-in juriou s beh aviors such as h ead ban gin g. 5. In itiate referrals to special program s as required. 6. Provide supp ort to paren ts.

Ensuring a safe environment for a child with autism is a priority.

XI. Intellectual Disability A. Descrip tion

1. In in tellectual disability, a ch ild m an ifests sub- average in tellectu al fun ction in g alon g with defi- cits in adaptive skills.

2. Down syn drom e is a co n gen ital con d ition th at results in m od erate to severe in tellectual disabil- ities an d h as been lin ked to an extra group G ch rom osom e, ch rom osom e 21 (trisom y 21).

B. Assessm en t 1. Deficits in cogn itive skills an d level of adap tive

fun ctio n in g 2. Delays in fin e an d gross m oto r skills 3. Speech delays 4. Decreased spon tan eous activity 5. Non respon siven ess 6. Irritability 7. Poor eye con tact durin g feedin g

C. In terven tion s 1. Medical strategies are focused on correctin g

structural deform ities an d treatin g associated beh aviors.

2. Im plem en t com m un ity an d education al ser- vices, usin g a m ultidiscip lin ary approach .

3. Prom o te care skills as m uch as possible. 4. Assist with com m un ication an d socialization

skills. 5. Facilitate appropriate play tim e. 6. In itiate safety precaution s as n ecessary. 7. Assist th e fam ily with decision s regardin g care. 8. Provide in form ation regardin g supp ort services

an d com m un ity agen cies.

CRITICAL THINKING What Should You Do? Answer: Following insertion of a ventriculoperitoneal shunt for the treatment of hydrocephalus, the nurse should moni- tor the child for signs of increased ICP. In the child, early signs include a change of level of consciousness, headache, nausea, vomiting, visual disturbances (diplopia), and sei- zures. Normally, the surgeon prescribes that the child be kept flat to avoid rapid reduction of intracranial fluid. If increased ICP occurs, the nurse should elevate the head of the bed to 15 to 30 degrees to enhance gravity flow through the shunt. The surgeon is also notified immediately.

Reference: Hockenberry, Wilson (20 15), p. 1489.

P R A C T I C E Q U E S T I O N S 432. Th e paren ts of a ch ild recen tly diagn osed with cere-

bral palsy ask th e n urse ab out th e lim itation s of th e disorder. Th e n urse respo n ds by exp lain in g th at th e lim itation s occur as a result of wh ich path oph ysi- ological process? 1. An in fectious disease of th e cen tral n ervous system 2. An in flam m ation of th e brain as a result of a

viral illn ess 3. A ch ron ic disability ch aracterized by im paired

m uscle m ovem en t an d postu re 4. A con gen ital con dition th at results in m od erate

to severe in tellectu al disabilities

433. Th e n urse n otes docum en tation th at a ch ild is exh i- bitin g an in ability to flex th e leg wh en th e th igh is flexed an teriorly at th e h ip. Wh ich con d ition does th e n urse susp ect? 1. Men in gitis 2. Spin al cord in jury 3. In tracran ial bleedin g 4. Decreased cerebral blood flow

434. A m oth er arrives at th e em ergen cy departm en t with h er 5-year-old ch ild and states th at the ch ild fell off a bun k bed. A h ead injury is suspected. Th e n urse

506 UNIT VII Pediatric Nursing

ch ecks the child’s airway status an d assesses th e child for early an d late signs of in creased intracran ial pres- sure (ICP). Wh ich is a late sign of in creased ICP? 1. Nausea 2. Irritability 3. Headach e 4. Bradycardia

435. Th e n urse is assign ed to care for an 8-year-o ld ch ild with a diagn osis of a basilar skull fracture. Th e n urse reviews th e h ealth care provider’s (HCP’s) prescription s an d sh o uld con tact th e HCP to ques- tion wh ich prescription ? 1. O btain daily weigh t. 2. Provide clear liquid in take. 3. Nasotrach eal suction as n eeded. 4. Main tain a paten t in traven o us lin e.

436. Th e n urse is reviewin g th e record of a ch ild with in creased in tracran ial pressure an d n otes th at th e ch ild h as exh ibited sign s of decerebrate postu rin g. O n assessm en t of th e ch ild, th e n urse expects to n ote wh ich ch aracteristic of th is type of posturin g? 1. Flaccid paralysis of all extrem ities 2. Adduction of th e arm s at th e sh oulders 3. Rigid exten sion an d pron ation of th e arm s

an d legs 4. Abn orm al flexion of th e upper extrem ities an d

exten sion an d ad duction of th e lo wer extrem ities

437. A ch ild is diagn osed with Reye’s syn d rom e. Th e n urse creates a n ursin g care plan for th e ch ild an d sh ould in clude wh ich in terven tion in th e plan ? 1. Assessin g h earin g loss 2. Mon itorin g urin e outp ut 3. Ch an gin g body position every 2 h ours 4. Providin g a quiet atm osp h ere with dim m ed

ligh tin g

438. Th e n urse creates a plan of care for a ch ild at risk for ton ic-clon ic seizu res. In th e plan of care, th e n urse iden tifies seizu re precaution s an d docum en ts th at wh ich item ( s) n eed to be placed at th e ch ild’s bedside? 1. Em ergen cy cart 2. Trach eoto m y set 3. Padded ton gue blad e 4. Suction in g equ ipm en t an d oxygen

439. A lum bar pun cture is perform ed on a ch ild sus- pected to h ave bacterial m en in gitis, an d cerebro - spin al fluid (CSF) is obtain ed for an alysis. Th e n urse reviews th e results of th e CSF an alysis an d determ in es th at wh ich results would verify th e diagn osis? 1. Clear CSF, decreased pressure, an d elevated

protein level 2. Clear CSF, elevated protein , an d decreased glu-

cose levels 3. Cloudy CSF, elevated protein , an d decreased

glucose levels 4. Cloudy CSF, decreased protein , an d decreased

gluco se levels

440. Th e n urse is plan n in g care for a ch ild with acu te bacterial m en in gitis. Based on th e m od e of tran s- m ission of th is in fectio n , wh ich precaution ary in terven tion sh ould be in cluded in th e plan of care? 1. Main tain en teric precaution s. 2. Main tain n eutropen ic precaution s. 3. No precaution s are required as lo n g as an tibi-

otics h ave been started. 4. Main tain respiratory isolatio n precaution s for at

least 24 h ours after th e in itiation of an tibiotics.

441. An in fan t with a diagn osis of h ydroceph alus is sch eduled for surgery. Wh ich is th e p rio rity n urs- in g in terven tion in th e preop erative period? 1. Test th e urin e for protein . 2. Reposition th e in fan t frequen tly. 3. Provide a stim ulatin g en viron m en t. 4. Assess blood pressure every 15 m in u tes.

442. Th e n urse is creatin g a plan of care for a ch ild wh o is at risk for seizu res. Wh ich in terven tion s apply if th e ch ild h as a seizure? Select all th at ap p ly.

1. Tim e th e seizu re. 2. Restrain th e ch ild. 3. Stay with th e ch ild. 4. Place th e ch ild in a pron e position . 5. Move furn iture away from th e ch ild. 6. In sert a padded ton gue blade in th e ch ild’s

m outh .

A N S W E R S 432. 3 Ra t ion a le: Cereb ral palsy is a ch ron ic disab ility ch aracterized by im p aired m ovem en t an d po sture resu ltin g fro m an abn or- m ality in th e extrap yram idal or p yram id al m o tor system .

Men in gitis is an in fectiou s p ro cess of th e cen tral n ervou s sys- tem . En ceph alitis is an in flam m atio n of th e b rain th at occurs as a resu lt o f viral illn ess or cen tral n ervo us system in fectio n . Down syn d rom e is an exam p le o f a con gen ital co n d ition th at resu lts in m o derate to severe in tellectu al d isabilities.

P

e

d

i

a

t

r

i

c

s

507CHAPTER 42 Neurological and Cognitive Disorders

Test-Ta kin g Str a tegy: Elim in ate o ptio n s 1 an d 2 first, n otin g th at th ey are co m p arab le o r alike. Next, n ote th e relatio n sh ip b etween th e word s palsy in th e q uestion an d impaired muscle movement in th e correct o ptio n . Review: Cereb ral p alsy Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Neurolo gical Pr ior it y Con cept s: In tracran ial Regu lation ; Mo bility Refer en ce: Hocken b erry, Wilso n (2015), pp . 1618-1619.

433. 1 Ra tion a le: Men in gitis is an in fectiou s p ro cess o f th e cen tral n ervou s system cau sed by b acteria an d viruses. Th e in ability to exten d th e leg wh en th e th igh is flexed an terio rly at th e h ip is a p ositive Kern ig’s sign , n o ted in m en in gitis. Kern ig’s sign is n o t seen specifically with spin al co rd in ju ry, in tracran ial b leed in g, or d ecreased cereb ral b lo od flo w. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, th e ch aracteristics o f Kern ig’s sign . Kn owled ge regardin g th is sign is n eed ed to an swer correctly. Th in k abo u t th e n eu ro lo gical exam an d ph ys- ical assessm en t fin din gs to an swer correctly. Review: Ch aracteristics of Kern ig’s sign Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Neurolo gical Pr ior it y Con cept s: Clin ical Ju dgm en t; In tracran ial Regulation Refer en ces: Hocken berry, Wilso n (2015), p. 1456; Jarvis (2016), p . 688.

434. 4 Ra tion a le: Head in jury is th e p ath olo gical resu lt of an y m ech an ical force to th e sku ll, scalp , m en in ges, o r b rain . A h ead in ju ry can cause b leed in g in th e brain an d result in in creased ICP. In a ch ild , early sign s in clud e a sligh t ch an ge in level of con scio u sn ess, h ead ach e, n ausea, vom itin g, visu al d istur- b an ces (d ip lo pia), an d seizures. Late sign s o f in creased ICP in clu d e a sign ifican t d ecrease in level o f co n scio usn ess, brady- card ia, d ecreased m o to r an d sen so ry resp on ses, alteration s in p up il size an d reactivity, p ostu rin g, Ch eyn e-Sto kes resp ira- tio n s, an d co m a. Test-Ta kin g Str a tegy: No te th e age o f th e ch ild an d th e strate- gic wo rd , late. Th in k about th e p ath oph ysiology th at occurs wh en pressure in creases in th e cran ial vault to assist in an swer- in g correctly. Review: Early an d late sign s o f in creased in tracran ial p ressu re ( ICP) Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Neurolo gical Pr ior it y Con cept s: Clin ical Ju dgm en t; In tracran ial Regulation Refer en ce: Hocken b erry, Wilso n (2015), p. 1428.

435. 3 Ra tion a le: A basilar sku ll fracture is a type of h ead in jury. Naso trach eal su ction in g is con train d icated in a ch ild with a b asilar sku ll fracture: Becau se o f th e n ature o f th e in jury, th ere

is a p ossibility th at th e cath eter will en ter th e b rain th ro ugh th e fracture, creatin g a h igh risk o f seco n d ary in fectio n . Flu id b al- an ce is m on itored closely by d aily weigh t d eterm in ation , in take an d o utp ut m easurem en t, an d serum osm olality d eter- m in atio n to detect early sign s o f water reten tio n , excessive d eh yd ratio n , an d states of h yperton icity or h yp oto n icity. Th e ch ild is m ain tain ed on NPO ( n o th in g b y m o u th ) status or restricted to clear liquids u n til it is determ in ed th at vom itin g will n ot occur. An in traven ous lin e is m ain tain ed to adm in ister flu ids or m ed ication s, if n ecessary. Test-Ta kin g Str a t egy: No te th e wo rd s question which prescrip- tion. Elim in ate op tio n s 1, 2, an d 4 because th ey are co m p ara- b le o r alike in th at th ey add ress th e su bject of fluid s. Rem em ber th at n asotrach eal su ction in g is co n train d icated in a ch ild with a sku ll fracture b ecau se of th e risk o f in fection . Review: Care of th e ch ild with a sku ll fractu re Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Neu ro lo gical Pr ior it y Con cept s: Co llab oration ; In tracran ial Regu latio n Refer en ce: Hocken berry, Wilson (2015), p p. 1445, 1450- 1451.

436. 3 Ra tion a le: Decerebrate (exten sion ) po stu rin g is ch aracterized b y th e rigid exten sio n an d pron ation o f th e arm s an d legs. O ptio n 1 is in co rrect. O p tio n s 2 an d 4 d escrib e decorticate (flexio n ) po sturin g. Test-Ta kin g Str a tegy: Focus on th e su b ject, ch aracteristics of d ecereb rate (exten sion ) po sturin g. Recallin g th e clin ical m an - ifestatio n s associated with decerebrate p o sturin g will direct you to th e co rrect op tio n . Rem em ber th at decerebrate po sturin g is ch aracterized by th e rigid exten sio n an d p ro n atio n o f th e arm s an d legs. Review: Ch aracteristics of d eco rticate an d d ecereb rate p o stu rin g Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Neu ro lo gical Pr ior it y Con cept s: Clin ical Ju dgm en t; In tracran ial Regulation Refer en ce: Hocken b erry, Wilso n (2015), p. 1434.

437. 4 Ra tion a le: Reye’s syn d ro m e is an acu te en cep h alo path y th at fo llows a viral illn ess an d is ch aracterized path o lo gically b y cereb ral ed em a an d fatty ch an ges in th e liver. In Reye’s syn d ro m e, sup po rtive care is d irected to ward m o n ito rin g an d m an agin g cereb ral edem a. Decreasin g stim uli in th e en viro n m en t b y p ro vid in g a q uiet en viron m en t with dim m ed ligh tin g wo uld decrease th e stress o n th e cereb ral tissue an d n eu ron respo n ses. Hearin g lo ss an d urin e ou tpu t are n o t affected. Ch an gin g th e b od y po sitio n every 2 h o urs wou ld n o t affect th e cerebral edem a directly. Th e ch ild sh o uld be p ositio n ed with th e h ead elevated to d ecrease th e p ro gressio n o f th e cerebral ed em a an d p ro m ote d rain age o f cerebrosp in al flu id. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, n ursin g care for th e ch ild with Reye’s syn drom e. Th in k ab o ut th e

P

e

d

i

a

t

r

i

c

s

508 UNIT VII Pediatric Nursing

path o ph ysiology asso ciated with Reye’s syn d ro m e. Recallin g th at cereb ral edem a is a co n cern fo r a ch ild with Reye’s syn - drom e will direct you to th e correct op tio n . Review: Care o f th e ch ild with Reye’s syn d ro m e Level of Cogn it ive Ability: Creatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Pediatrics—Neu ro logical Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ho cken berry, Wilson (2015), p p. 1462-1463.

438. 4 Ra t ion a le: A seizu re resu lts fro m th e excessive an d u n o rga- n ized n eu ro n al d isch arges in th e b rain th at activate asso ci- ated m o to r an d sen so ry o rgan s. A typ e o f gen eralized seizu re is a to n ic-clo n ic seizu re. Th is typ e o f seizu re cau ses rigid ity o f all b o d y m u scles, fo llo wed b y in ten se jerkin g m o vem en ts. Becau se in creased o ral secretio n s an d ap n ea can o ccu r d u rin g an d after th e seizu re, o xygen an d su ctio n - in g eq u ip m en t are p laced at th e b ed sid e. A trach eo to m y is n o t p erfo rm ed d u rin g a seizu re. No o b ject, in clu d in g a p ad - d ed to n gu e b lad e, is p laced in to th e ch ild ’s m o u th d u rin g a seizu re. An em ergen cy cart wo u ld n o t b e left at th e b ed sid e, b u t wo u ld b e availab le in th e treatm en t ro o m o r n earb y o n th e n u rsin g u n it. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, seizu re precau - tion s. Note th e words need to be placed at the child’s bedside. Elim - in ate o p tion 2, kn o win g th at a trach eoto m y is n ot p erfo rm ed . Next, recallin g th at n o o bject is placed in to th e m o uth of a ch ild experien cin g a seizu re assists in elim in atin g op tio n 3. From th e rem ain in g op tio n s, focu s on th e p rim ary con cern du rin g seizu re activity. Th is will direct you to th e co rrect op tion . Review: Seizu re p recau tio n s Level of Cogn it ive Ability: Creatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Pediatrics—Neu ro logical Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ho cken berry, Wilson (2015), p p. 1476-1477.

439. 3 Ra t ion a le: Men in gitis is an in fectio u s process of th e cen tral n ervo u s system caused by b acteria an d viru ses; it m ay b e acq uired as a p rim ary d isease or as a resu lt of co m plicatio n s of n eurosu rgery, trau m a, in fectio n o f th e sin us o r ears, o r sys- tem ic in fection s. Men in gitis is d iagn o sed b y testin g CSF ob tain ed by lum bar pu n cture. In th e case o f b acterial m en in - gitis, fin d in gs usu ally in clud e an elevated p ressu re; tu rb id o r clo ud y CSF; an d elevated leu kocyte, elevated protein , an d decreased glu co se levels. Test -Ta ki n g St r a t egy: Use kn o wled ge regard in g th e d iagn o s- tic fin d in gs in m en in gitis. Elim in ate o p tio n s 1 an d 2 first b ecau se th ey are co m p arab le o r alike; recall th at clear CSF is n o t likely to b e fo u n d in an in fectio u s p ro cess su ch as m en - in gitis. Fro m th is p o in t, recall th at an elevated p ro tein level in d icates a p o ssib le d iagn o sis o f m en in gitis to d irect yo u to th e co rrect o p tio n . Review: Diagn o stic fin d in gs associated with m en in gitis Level of Cogn it ive Ability: An alyzin g

Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Pediatrics—Neu ro logical Pr ior ity Con cepts: In fectio n ; In tracran ial Regulation Refer en ce: Ho cken berry, Wilson (2015), p . 1460.

440. 4 Ra t ion a le: Men in gitis is an in fectio u s p ro cess o f th e cen tral n ervo u s system cau sed b y b acteria an d viru ses; it m ay b e acq u ired as a p rim ary d isease o r as a resu lt o f co m p licatio n s o f n eu ro su rgery, trau m a, in fectio n o f th e sin u s o r ears, o r sys- tem ic in fectio n s. A m ajo r p rio rity o f n u rsin g care fo r a ch ild su sp ected to h ave m en in gitis is to ad m in ister th e an tib io tic as so o n as it is p rescrib ed . Th e ch ild also is p laced o n resp i- rato ry iso latio n p recau tio n s fo r at least 24 h o u rs wh ile cu l- tu re resu lts are o b tain ed an d th e an tib io tic is h avin g an effect. En teric p recau tio n s an d n eu tro p en ic p recau tio n s are n o t asso ciated with th e m o d e o f tran sm issio n o f m en in gitis. En teric p recau tio n s are in stitu ted wh en th e m o d e o f tran s- m issio n is th ro u gh th e gastro in testin al tract. Neu tro p en ic p recau tio n s are in stitu ted wh en a ch ild h as a lo w n eu tro p h il co u n t. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e m ode of tran s- m ission of m en in gitis. Elim in ate o p tion s 1 an d 2 first becau se th ey are co m p arab le o r alike, an d are u n related to th e m o de o f tran sm issio n . Recallin g th at it takes ab o ut 24 h o urs for an tibi- o tics to reach a th erap eu tic b lo od level will assist in directin g yo u to th e co rrect o ption . Review: Mod e of tran sm ission o f m en in gitis Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Pediatrics—Neu ro logical Pr ior ity Con cepts: In fectio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p . 1459.

441. 2 Ra t ion a le: Hyd ro ceph alus o ccu rs as a resu lt of an im b alan ce o f cerebrosp in al fluid ab sorptio n o r p ro du ction th at is cau sed by m alfo rm atio n s, tum o rs, h em orrh age, in fectio n s, o r traum a. It resu lts in h ead en largem en t an d in creased in tracran ial pressu re (ICP). In in fan ts with h yd ro ceph alus, th e h ead grows at an ab n o rm al rate, an d if th e in fan t is n o t repo sitio n ed frequ en tly, p ressure ulcers can o ccur o n th e back an d side o f th e h ead. An egg crate m attress un der th e h ead is also a n u rsin g in terven tio n th at can h elp to preven t skin b reakdo wn . Pro tein u ria is n ot sp ecific to h ydro cep h alu s. Stim u lu s sh o uld b e kept at a m in i- m u m b ecau se o f th e in crease in ICP. It is n o t n ecessary to ch eck th e blo o d pressu re every 15 m in u tes. Test -Ta kin g Str a tegy: No te th e strategic wo rd , priority. Focus o n th e ch ild ’s diagn osis. Elim in ate op tio n 4 b ecau se o f th e words 15 minutes. Fro m th e rem ain in g o ption s, recall th at b ecause o f th e severe h ead en largem en t, th e n u rsin g in terven - tion th at h as prio rity is to repo sitio n th e in fan t freq u en tly to p reven t th e d evelo pm en t o f p ressure areas. Review: Co m p lication s associated with h yd ro cep h alu s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Pediatrics—Neu ro logical

P

e

d

i

a

t

r

i

c

s

509CHAPTER 42 Neurological and Cognitive Disorders

Pr ior it y Con cept s: In tracran ial Regu lation ; Tissue In tegrity Refer en ce: Hocken b erry, Wilso n (2015), pp . 1488-1489.

442. 1, 3, 5 Ra tion a le: A seizure is a d isord er th at o ccurs as a result o f exces- sive an d u n o rgan ized n eu ro n al disch arges in th e b rain th at activate associated m o tor an d sen so ry o rgan s. Du rin g a seizu re, th e ch ild is placed o n h is o r h er side in a lateral po sitio n . Posi- tio n in g o n th e sid e preven ts asp iratio n b ecause saliva drain s o ut th e corn er of th e ch ild’s m o uth . Th e ch ild is n o t restrain ed b ecau se th is cou ld cause in jury to th e ch ild . Th e n u rse wou ld lo osen clo th in g aro u n d th e ch ild’s n eck an d en su re a p aten t air- way. Noth in g is placed in to th e ch ild’s m outh durin g a seizure b ecau se th is actio n m ay cau se in ju ry to th e ch ild’s m ou th ,

gum s, or teeth . Th e n urse wo uld stay with th e ch ild to redu ce th e risk o f in jury an d allow fo r o b servatio n an d tim in g of th e seizu re. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject an d visu alize th is clin ical situ atio n . Recallin g th at airway paten cy an d safety is th e prio rity will assist in d eterm in in g th e ap prop riate in terven tion s. Review: Care of th e ch ild experien cin g seizu res Level of Cogn itive Ability: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Neu ro lo gical Pr ior it y Con cept s: In tracran ial Regu lation ; Safety Refer en ce: Hocken b erry, Wilso n (2015), pp . 1476, 1478.

P

e

d

i

a

t

r

i

c

s

510 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C H A P T E R 43 Musculoskeletal Disorders

PRIORITY CONCEPTS Development; Mobility

CRITICAL THINKING What Should You Do? The nurse is assessing an infant with clubfoot who is in a cast. The nurse notes that the tissue distal to the cast is pale and edematous and the infant shows signs of pain with pas- sive movement. What should the nurse do? Answer located on p. 516.

I. Developmental Dysplasia of the Hip A. Description

1. Diso rders related to abn o rm al develo pm en t of th e h ip th at m ay develop durin g fetal life, in fan cy, or ch ildh ood; in th ese disorders, th e h ead of th e fem ur is seated im properly in th e ace- tabulum , or h ip socket, of th e pelvis.

2. Degrees of developm en tal dysplasia of th e h ip (Box 43-1)

B. Assessm en t ( Fig. 43-1) 1. Neon ate: Laxity of th e ligam en ts arou n d th e h ip 2. In fan t

a. Sh o rten in g of th e lim b on th e affected side (Galeazzi sign , Allis sign )

b . Restricted abduction of th e h ip on th e affected side wh en th e in fan t is placed supin e with kn ees an d h ips flexed (lim ited ran ge of m otion in th e affected h ip)

c. Un equal gluteal folds wh en th e in fan t is pron e an d legs are exten ded again st th e exam in in g table

d . Positive O rtolan i’s test: O rtolan i’s m an euver is a test to assess for h ip in stability. Th e exam - in er abducts th e th igh an d applies gen tle pres- sure forward over th e greater troch an ter. A “clickin g” sen sation in dicates a dislocated fem o ral h ead m ovin g in to th e acetabulum .

e. Positive Barlow’s test: Th e exam in er adducts th e h ips an d applies gen tle pressure down an d back with th e th um bs. In h ip dysplasia,

th e exam in er can feel th e fem oral h ead m ove out of th e acetabulum .

3. O ld er in fan t an d ch ild a . Affected leg is sh orter th an th e oth er. b . Th e h ead of th e fem u r can be felt to m ove up

an d down in th e butto ck wh en th e exten ded th igh is push ed first toward th e ch ild’s h ead an d th en pulled distally.

c. Positive Tren d elen burg’s sign : Th e ch ild stan ds on on e foot an d th en th e oth er foot, h old in g on to a supp ort an d bearin g weigh t on th e affected h ip; th e pelvis tilts down ward on th e n orm al side in stead of upward, as it would with n orm al stability.

d . Greater troch an ter is prom in en t. e. Marked lo rdosis or waddlin g gait is n oted in

bilateral dislocation s. C. In terven tion s

1. Birth to 6 m on th s of age: Splin tin g of th e h ips with a Pavlik h arn ess to m ain tain flexion an d ab duction an d extern al rotation (worn con tin u- ously un til h ip is stable in ab out 3 to 6 m on th s) ( Fig. 43-2)

2. Age 6 to 18 m on th s: Gradual reduction by trac- tio n followed by closed reduction or open reduc- tio n (if n ecessary) un d er gen eral an esth esia; ch ild is th en placed in a h ip spica cast for 2 to 4 m on th s un til th e h ip is stable, an d th en a flexion -abduction brace is applied for approxi- m ately 3 m on th s

3. O ld er ch ild: O perative reduction an d recon struc- tio n is usually required .

4. Paren ts are in structed regardin g proper care of a Pavlik h arn ess, spica cast, or abduction brace.

II. Congenital Clubfoot A. Description

1. Com p lex deform ity of th e an kle an d foot th at in cludes forefo ot adduction , m idfoot supin a- tio n , h in dfoo t varus, an d an kle equin us; defect m ay be un ilateral or bilateral

511

2. Th e go al of treatm en t is to ach ieve a pain less plan tigrade (able to walk on th e sole of th e foot with th e h eel on th e grou n d) an d stable foot.

3. Lon g-term in terval follo w-up care is required un til th e ch ild reach es skeletal m aturity.

B. Assessm en t: Deform ities are described on th e basis of th e position of th e an kle an d foot (Fig. 43-3). 1. Talipes varus: In version or ben din g in ward

2. Talipes valgus: Eversion or ben din g outward 3. Talipes equ in us: Plan tar flexion in wh ich th e toes

are lo wer th an th e h eel 4. Talipes calcan eus: Dorsiflexion in wh ich th e toes

are h igh er th an th e h eel C. In terven tion s

1. Treatm en t b egin s as so o n after b irth as p o ssib le.

2. Man ip u latio n an d castin g are p erfo rm ed weekly fo r ab o u t 8 to 1 2 weeks b ecau se o f th e rap id growth o f early in fan cy; a sp lin t is th en ap p lied if castin g an d m an ip u latio n are su ccessfu l.

3. Surgical in terven tion m ay be n ecessary if n orm al align m en t is n ot ach ieved by ab out 6 to 12 weeks of age.

4. Mon itor for pain , an d m on itor th e n eurovascular status of th e toes.

Contact the health care provider (HCP) immediately if signs of neurovascular impairment are noted in a child with a cast or brace.

III. Idiopathic Scoliosis A. Description

1. Th ree-dim en sion al spin al defo rm ity th at usually in volves lateral curvatu re, spin al rotatio n result- in g in rib asym m etry, an d h ypokyph osis of th e th o rax

P

e

d

i

a

t

r

i

c

s

BOX43-1 Degrees of Developmental Dysplasia of the Hip

Acetabular Dysplasia (Preluxation) ▪ Mildest form ▪ Neither subluxation nor dislocation ▪ Delay in acetabular development occurs ▪ Femoral head remains in acetabulum Subluxation ▪ Incomplete dislocation of the hip ▪ Femoral head remains in acetabulum ▪ Stretched capsule and ligamentum teres causes head of

the femur to be partially displaced

Dislocation ▪ Femoral head loses contact with acetabulum and is dis-

placed posteriorly and superiorly over fibrocartilaginous rim ▪ Ligamentum teres is elongated and taut

A B C

D E

FIGURE 43-1 Signs of developmental dysplasia of the hip. A, Asymmetry of gluteal and thigh folds. B, Limited hip abduction, as seen in flexion. C, Apparent shortening of the femur, as indicated by the level of the knees in flexion. D, Ortolani click (if infant is younger than 4 weeks old). E, Positive Trendelenburg’s sign or gait (if child is weight-bearing).

512 UNIT VII Pediatric Nursing

2. Idiop ath ic scoliosis usually is diagn osed durin g th e preadolescen t growth spurt; screen in gs are im portan t wh en growth spurts occur.

3. Surgical (spin al fusion , wh ich m ay be don e by th oracoscopic surgery, placem en t of an in stru- m en tation system , or use of m etallic staples placed in to vertebral bodies) an d n on surgical (bracin g) in terven tion s are used; th e type of treatm en t dep en ds on th e location an d degree of th e curvatures, th e age of th e ch ild, th e am oun t of growth th at is yet an ticipated, an d an y un der- lyin g disease processes.

4. Lon g-term m on itorin g is essen tial to detect an y progression of th e curve.

B. Assessm en t 1. Asym m etry of th e ribs an d flan ks is n oted wh en

th e ch ild ben ds forward at th e waist an d h an gs th e arm s down toward th e feet (Ad am ’s test).

2. Hip h eigh t, rib position in g, an d sh oulder h eigh t are asym m etrical (can be n oted wh en stan din g beh in d an un dressed ch ild) ; leg-len gth discrep- an cy is also apparen t.

3. Rad iograph s are obtain ed to con firm th e diagn osis.

C. In terven tion s 1. Mon itor progression of th e curvatures. 2. Prepare th e ch ild an d paren ts for th e use of a

brace if prescribed. 3. Prepare th e ch ild an d paren ts for surgery (sp in al

fusion , placem en t of in tern al in strum en tatio n system s) if prescribed.

The potential for altered role performance, body image disturbance, fear, anger, and isolation exists for a child with a disabling condition and a condition that requires wearing a body brace.

D. Braces 1. Braces are n ot curative, but m ay slow th e progres-

sion of th e curvature to allow skeletal growth an d m aturity.

2. Braces usually are prescribed to be worn 16 to 23 h ou rs a day.

3. In spect th e skin for sign s of redn ess or breakdown .

4. Keep th e skin clean an d dry, an d avoid lotio n s an d powders because th ese cake an d lead to skin breakdown .

5. Advise th e ch ild to wear soft n on irritatin g clo th - in g un d er th e brace.

6. In struct in prescribed exercises (exercises h elp m ain tain an d stren gth en spin al an d abdom in al m uscles durin g treatm en t).

7. En cou rage verbalization ab out body im age an d oth er psych osocial issues.

E. Posto perative in terven tion s 1. Main tain proper align m en t; avoid twistin g

m ovem en ts. 2. Logroll th e ch ild wh en turn in g to m ain tain

align m en t. 3. Assess extrem ities for adequ ate n eurovascular

status. 4. En cou rage cough in g an d deep breath in g an d th e

use of in cen tive spirom etry. 5. Assess p ain an d ad m in ister p rescrib ed

an algesics. 6. Mon itor for in con tin en ce. 7. Mon itor for sign s an d sym pto m s of in fectio n . 8. Mon itor for superior m esen teric artery syn dro m e

(caused by m ech an ical ch an ges in th e position of th e ch ild’s abdom in al con ten ts durin g surgery) an d n otify th e HCP if it occurs; sym pto m s in clude em esis an d abdom in al disten tion sim ilar to wh at occurs with in testin al obstru ction or paralytic ileu s.

9. In struct in activity restriction s.

P

e

d

i

a

t

r

i

c

s

Front Ba ck

FIGURE 43-2 Child in Pavlik harness.

Talipe s varusTalipe s valg us

Talipe s e quinusTalipe s c alc ane us

FIGURE 43-3 Talipes clubfoot deformity positions.

513CHAPTER 43 Musculoskeletal Disorders

10. In struct th e ch ild h ow to roll from a side-lyin g position to a sittin g position , an d assist with am bulation .

11. Address a body im age disturban ce wh en form u- latin g a plan of n ursin g care.

IV. Juvenile Idiopathic Arthritis A. Description

1. Autoim m un e in flam m ato ry disease affectin g th e join ts an d oth er tissues, such as articular carti- lage; occurs m ost often in girls.

2. Treatm en t is supportive (th ere is n o cure) an d directed toward preservin g join t fun ction , co n - tro llin g in flam m ation , m in im izin g deform ity, an d reducin g th e im pact th at th e disease m ay h ave on th e developm en t of th e ch ild.

3. Treatm en t in cludes m edication s, ph ysical an d occupation al th erapies, an d ch ild an d fam ily edu cation .

4. Surgical in terven tion m ay be im plem en ted if th e ch ild h as problem s with join t con tractures an d un equ al growth of extrem ities.

B. Assessm en t ( Box 43-2) 1. Th ere are n o defin itive tests to diagn ose juven ile

id iopath ic arth ritis. 2. Som e laborato ry tests, such as an elevated eryth -

ro cyte sed im en tation rate or determ in ation of th e presen ce of leuko cytosis, m ay support evi- den ce of th e disease.

3. Rad iograph s m ay sh ow soft tissue swellin g an d join t space widen in g fro m in creased syn o vial flu id in th e join t.

C. In terven tion s 1. Facilitate social an d em o tion al develo pm en t. 2. In struct paren ts an d ch ild in th e ad m in istration

of m edication s; m ed ication s m ay be given alon e or in com bin ation an d are prescribed in a step- like m an n er depen din g on th e disease respo n se to each level (Box 43-3).

3. Assist th e ch ild with ran ge-of-m otion exercises an d in struct in prescribed exercises.

4. En cou rage n orm al perform an ce of activities of daily livin g.

5. In struct paren ts an d ch ild in th e use of h ot or cold packs, splin tin g, an d position in g th e affected joint in a n eutral position durin g pain ful episodes.

6. En cou rage an d supp ort prescribed ph ysical an d occupation al th erap y.

7. In struct in th e im portan ce of preven tive eye care an d reportin g visual disturban ces.

8. Assess th e ch ild’s an d fam ily’s perception s regardin g th e ch ron ic illn ess; plan to discuss th e n ature of a ch ron ic illn ess an d th e associated life alteration s th at result from th e ch ron ic pro- gression of th e disorder.

V. Marfan Syndrome A. Description

1. Disorder of con n ective tissue th at affects th e skel- etal system , cardiovascular system , eyes, an d skin.

2. Marfan syn drom e is cau sed by defects in th e fibrillin -1 gen e, wh ich serves as a buildin g block for elastic tissue in th e body; also, th e disorder m ay be in h erited.

3. Th ere is n o cure for th e disorder. B. Assessm en t

1. Tall an d th in body structure: slen der fin gers, lon g arm s an d legs, curvatu re of th e spin e

2. Presen ce of visu al problem s 3. Presen ce of cardiac problem s

P

e

d

i

a

t

r

i

c

s

BOX 43-2 Assessment Findings: Juvenile Idiopathic Arthritis

Stiffness, swelling, and limited motion occur in affected joints. Affected joints are warm to touch, tender, and painful. Joint stiffness is present on arising in the morning and after

inactivity. Uveitis (inflammation of structures in the uveal tract) can

occur and cause blindness.

BOX 43-3 Medications Used in Juvenile Idiopathic Arthritis

Nonsteroidal Antiinflammatory Drugs (NSAIDs) ▪ First medications used ▪ May cause gastrointestinal irritation and easy bruising Methotrexate ▪ Used if NSAIDs are ineffective ▪ Complete blood cell counts and liver function studies are

monitored closely

Corticosteroids ▪ Potent immunosuppressives used for life-threatening

complications, incapacitating arthritis, and uveitis ▪ Administered at lowest effective dose for the shortest time

period; discontinued on a tapering schedule ▪ Prolonged use can cause Cushing’s syndrome, osteoporo-

sis, increased infection risk, glucose intolerance, hypokale- mia, cataracts, and growth suppression

Tumor Necrosis Factor Receptor Inhibitors ▪ Etanercept ▪ Infliximab ▪ Adverse effects include allergic reaction at injection site,

increased risk for infection, demyelinating disease, and pancytopenia

Slower Acting Antirheumatic Drugs ▪ Usually prescribed in combination with NSAIDs ▪ Sulfasalazine, hydroxychloroquine, gold sodium thioma-

late, penicillamine

514 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C. In terven tion s 1. Mon itor for vision problem s an d obtain visu al

exam in ation s on a regular sch edule. 2. Mon itor for curvature of th e spin e, esp ecially

durin g adolescen ce. 3. Cardiac m ed ication s m ay be prescribed to slow

th e h eart rate, to decrease stress on th e aorta. 4. In struct paren ts th at th e ch ild sh ould avoid par-

ticipatin g in com petitive ath letics an d con tact sports to avoid in ju rin g th e h eart.

5. In struct paren ts to in form th e den tist of th e con - dition ; an tibiotics sh ould be taken befo re den tal procedures to preven t en docarditis.

6. Surgical replacem en t of th e aortic ro ot an d valve m ay be n ecessary.

VI. Legg-Calve-Perthes Disease A. Description

1. A con dition affectin g th e h ip wh ere th e fem u r an d pelvis m eet in th e join t

2. Bloo d supp ly is tem p orarily in terrup ted to th e fem oral h ead an d begin s to die

B. Assessm en t 1. Lim pin g 2. Pain or stiffn ess in th e h ip, groin , th igh , or kn ee 3. Lim ited ran ge of m otion in th e affected join t

C. In terven tion s 1. Ph ysical th erap y, particularly stretch in g exercises 2. Use of cru tch es to avoid bearin g weigh t on th e

affected h ip 3. Bed rest an d traction if pain is severe 4. Castin g to keep th e fem oral h ead with in its

socket 5. Use of a n igh ttim e brace 6. Hip replacem en t surgery

VII. Fractures A. Description (see also Ch apter 64)

1. A break in th e con tin uity of th e bon e as a result of traum a, twistin g, or bon e decalcification

2. Fractures in ch ildren usually occur as a result of in creased m obility an d in adequate or im m ature m oto r an d cogn itive skills; th ey m ay result fro m traum a or bon e diseases such as con gen ital bon e disease or bon e tum ors.

Fractures in infancy are generally rare and warrant further investigation to rule out the possibility of child abuse and to identify bone structure defects.

B. Assessm en t 1. Pain or ten dern ess over th e in volved area 2. O bvious defo rm ity 3. Ed em a 4. Ecch ym osis 5. Muscle spasm 6. Loss of fun ction 7. Crepitation

C. In itial care of a fracture (see Priority Nu rsin g Actio n s)

PRIORITY NURSING ACTIONS Extremity Fracture in a Child 1. Assess extent of injury and immobilize the affected

extremity. 2. If a compound fracture exists, cover the wound with a

sterile dressing (apply a clean dressing if a sterile dressing is unavailable).

3. Elevate the injured extremity. 4. Apply cold to injured area. 5. Continue to monitor neurovascular status. 6. Transport to the nearest emergency department.

If a child sustains a fracture, the extent of the injury is immediately assessed using the 5 “P’s”—pain and point of tenderness, pulses distal to fracture site, pallor, paresthesia (sensation) distal to the fracture site, and paralysis (move- ment distal to fracture site). The extremity is immobilized to prevent movement and further injury to soft tissues. If an open wound is present, it is covered to reduce the risk of infection. The extremity is elevated to reduce swelling, and cold packs are applied to assist in reducing the swelling and to reduce the pain. The neurovascular status is moni- tored closely, and the child is transported to the nearest emergency facility.

Reference Hockenberry, Wilson (20 15), p. 1573.

D. In terven tion s 1. Redu ction

a . Resto rin g th e bon e to proper align m en t b . Clo sed reduction : Accom p lish ed by m an u al

align m en t of th e fragm en ts, followed by im m obilization

c. O pen reduction : Surgical in sertio n of in tern al fixation devices, such as rods, wires, or pin s, th at h elp m ain tain align m en t wh ile h ealin g occurs

2. Reten tion : Application of traction or a cast to m ain tain align m en t un til h ealin g occurs

E. Traction (see Ch apter 64) 1. Russell skin traction

a . Used to stabilize a fractured fem ur before surgery

b . Sim ilar to Buck’s traction , but provides a dou- ble pull usin g a kn ee slin g th at pulls at th e kn ee an d foot

2. Balan ced suspen sion a . Used with skin or skeletal traction to approx-

im ate fractures of th e fem u r, tibia, or fib ula b . Balan ced suspen sion is produ ced by a coun -

terforce oth er th an th e ch ild. c. Provide pin care if pin s are used with th e skel-

etal traction .

515CHAPTER 43 Musculoskeletal Disorders

3. 90-degree–90-degree traction a . Th e lower leg is supported by a boot cast or a

calf slin g. b . A skeletal Stein m an n pin or Kirsch n er wire is

placed in th e distal fragm en t of th e fem u r, allowin g 90-degree flexion at th e h ip an d th e kn ee.

4. In terven tion s a . Main tain correct am oun t of weigh t as

prescribed. b . En su re th at weigh ts h an g freely. c. Ch eck all ro pes for frayin g an d all kn ots for

tigh tn ess; be sure th at th e ro pes are ap propri- ately trackin g in th e grooves of th e pulley wh eels.

d . Mon itor n eurovascular status of th e in volved extrem ity.

e. Protect th e skin from breakd own . f. Mon itor for sign s an d sym pto m s of com plica-

tio n s of im m ob ilization , such as con stipa- tio n , skin breakdown , lun g con gestion , ren al com plication s, an d disuse syn dro m e of un affected extrem ities.

g. Provide th erapeutic an d diversion al play. F. Casts (see Ch apter 64)

1. Description a . Made of plaster or fiberglass to provide

im m obilization of bon e an d join ts after a fracture or in jury

b . Fractu res of th e h ip or kn ee m ay require a spica cast.

2. In terven tion s a . Exam in e th e cast for pressure areas. b . En su re th at n o rough castin g m aterial rem ain s

in con tact with th e skin ; petal th e cast edges with waterproof adh esive tape as n ecessary to en sure a sm ooth cast edge.

c. If a h ip spica cast is placed, th e cast edges arou n d th e perin eum an d butto cks m ay n eed to be taped with waterproof tape.

d . Mo n ito r th e extrem ity fo r circu lato ry im p airm en t, su ch as p ain greater th an th at exp ected fo r th e typ e o f in ju ry, ed em a, ru b o r, p allo r, n u m b n ess an d tin glin g, co o l- n ess, d ecreased sen satio n o r m o b ility, o r d im in ish ed p u lse.

e. No tify th e HCP if circulatory im pairm en t occurs.

f. Prepare for bivalvin g or cuttin g th e cast if circulatory im pairm en t occurs; prepare for em ergen cy fasciotom y if cast rem oval does n ot im prove th e n eurocircu latory com pro m ise.

g. In struct paren ts an d ch ild n ot to stick objects down th e cast.

h . Teach paren ts an d ch ild to keep th e cast clean an d dry.

i. In struct paren ts an d ch ild in isom etric exer- cises to preven t m uscle atrop h y.

CRITICAL THINKING What Should You Do? Answer: Compartment syndrome is a condition in which pressure increases in a confined anatomical space, leading to decreased blood flow, ischemia, and dysfunction of these tissues. This complication can occur with casts. Signs of this complication include unrelieved or increased pain in the limb; pale, dusky, or edematous tissue distal to the involved area; pain with passive movement; loss of sensation (pares- thesia); and pulselessness (a late sign). The nurse should contact the health care provider (HCP) immediately if signs of neurovascular impairment are noted in a child with a cast or brace because of the risk of tissue ischemia and necrosis.

Reference: Hockenberry, Wilson (20 15), pp. 1573-1574.

P R A C T I C E Q U E S T I O N S 443. A ch ild h as a righ t fem u r fracture caused by a m oto r

veh icle crash an d is placed in skin traction tem po- rarily un til surgery can be perform ed. Durin g assessm en t, th e n urse n otes th at th e dorsalis ped is pulse is ab sen t on th e righ t foot. Wh ich action sh ould th e n urse take? 1. Adm in ister an an algesic. 2. Release th e skin traction . 3. Apply ice to th e extrem ity. 4. Notify th e h ealth care provider (HCP).

444. A ch ild is placed in skeletal traction for treatm en t of a fractured fem u r. Th e n urse creates a plan of care an d sh ould in clude wh ich in terven tion ? 1. En su re th at all ropes are outsid e th e pulleys. 2. En su re th at th e weigh ts are restin g ligh tly on

th e flo or. 3. Restrict diversion al an d play activities un til th e

ch ild is out of traction . 4. Ch eck th e h ealth care provid er’s (HCP’s) pre-

scrip tion s for th e am oun t of weigh t to be applied.

445. A 4-year-old ch ild sustain s a fall at h om e. After an x-ray exam in ation , th e child is determ in ed to h ave a fractured arm an d a plaster cast is applied. Th e n urse provides in struction s to th e paren ts regardin g care for th e ch ild’s cast. Wh ich statem en t by th e par- en ts in dicates a n eed for fu rth er in stru ctio n ? 1. “Th e cast m ay feel warm as th e cast dries.” 2. “I can use lotio n or powder arou n d th e cast

edges to relieve itch in g.” 3. “A sm all am oun t of wh ite sh o e polish can touch

up a soiled wh ite cast.” 4. “If th e cast beco m es wet, a blow drier set on th e

cool settin g m ay be used to dry th e cast.”

P

e

d

i

a

t

r

i

c

s

516 UNIT VII Pediatric Nursing

446. Th e paren ts of a ch ild with juven ile id iopath ic arth ritis call th e clin ic n urse because th e ch ild is experien cin g a pain ful exacerb ation of th e disease. Th e paren ts ask th e n urse if th e ch ild can perform ran ge-of-m otion exercises at th is tim e. Th e n urse sh ould m ake wh ich respon se? 1. “Avoid all exercise durin g pain ful periods.” 2. “Ran ge-of-m o tion exercises m ust be perform ed

every day.” 3. “Have th e ch ild perform sim ple isom etric exer-

cises durin g th is tim e.” 4. “Adm in ister addition al pain m ed ication before

perform in g ran ge-of-m otion exercises.”

447. A ch ild wh o h as un dergon e spin al fusion for scoli- osis com plain s of ab dom in al discom fort an d begin s to h ave episodes of vom itin g. O n furth er assessm en t, th e n urse n otes abdom in al disten tion . O n th e basis of th ese fin din gs, th e n urse sh ould take wh ich action ? 1. Adm in ister an an tiem etic. 2. In crease th e in traven ous flu ids. 3. Place th e ch ild in a Sim s’ position . 4. No tify th e h ealth care provider (HCP) .

448. Th e n urse is providin g in struction s to th e paren ts of a ch ild with scoliosis regardin g th e use of a brace. Wh ich statem en t by th e paren ts in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I will en courage m y ch ild to perform prescribed

exercises.” 2. “I will h ave m y ch ild wear soft fabric clo th in g

un der th e brace.” 3. “I sh ould apply lotion un d er th e brace to pre-

ven t skin breakdown .” 4. “I sh ould avoid th e use of powder because it will

cake un der th e brace.”

449. Th e n urse is assistin g a h ealth care provider (HCP) exam in in g a 3-week-old in fan t with developm en - tal dysplasia of th e h ip. Wh at test or sign sh ould th e n urse expect th e HCP to assess? 1. Babin ski’s sign 2. Th e Moro reflex 3. O rtolan i’s m an euver 4. Th e palm ar-p lan tar grasp

450. A 1-m on th -old in fan t is seen in a clin ic an d is diag- n osed with develo pm en tal dysplasia of th e h ip. O n assessm en t, th e n urse un derstan ds th at wh ich fin d- in g sh o uld be n oted in th is con ditio n ? 1. Lim ited ran ge of m otion in th e affected h ip 2. An apparen t len gth en ed fem u r on th e

affected side 3. Asym m etrical ad duction of th e affected h ip

wh en th e in fan t is placed supin e with th e kn ees an d h ips flexed

4. Sym m etry of th e gluteal skin folds wh en th e in fan t is placed pron e an d th e legs are exten ded again st th e exam in in g table

451. Paren ts brin g th eir 2-week-old in fan t to a clin ic for treatm en t after a diagn osis of clubfoo t m ade at birth . Wh ich statem en t by th e paren ts in dicates a n eed fo r fu rth er teach in g regardin g th is disorder? 1. “Treatm en t n eeds to be started as soon as

possible.” 2. “I realize m y in fan t will require follo w-up care

un til fully grown .” 3. “I n eed to brin g m y in fan t back to th e clin ic in

1 m on th for a n ew cast.” 4. “I n eed to com e to th e clin ic every week with m y

in fan t for th e castin g.”

452. Th e n urse prepares a list of h om e care in struction s for th e paren ts of a ch ild wh o h as a plaster cast applied to th e left forearm . Wh ich in struction s sh ould be in cluded on th e list? Select all th at ap p ly.

1. Use th e fin gertips to lift th e cast wh ile it is dryin g.

2. Keep sm all toys an d sh arp objects away from th e cast.

3. Use a padded ruler or an oth er padded object to scratch th e skin un der th e cast if it itch es.

4. Place a h eatin g pad on th e lower en d of th e cast an d over the fin gers if th e fin gers feel cold.

5. Elevate th e extrem ity on pillows for th e first 24 to 48 h ours after castin g to preven t swellin g.

6. Con tact th e h ealth care provid er (HCP) if th e ch ild com plain s of n um bn ess or tin glin g in th e extrem ity.

A N S W E R S 443. 4 Ra t ion a le: An ab sen t p ulse to an extrem ity o f th e affected lim b after a b on e fractu re cou ld m ean th at th e ch ild is develop in g o r experien cin g com partm en t syn drom e. Th is is an em ergen cy situatio n , an d th e HCP sh o uld b e n otified im m ediately.

Adm in isterin g an algesics wou ld n ot im prove circulation . Th e skin tractio n sh ou ld n ot b e released with o ut an HCP’s p rescrip - tion . Ap plyin g ice to an extrem ity with ab sen t perfu sion is in correct. Ice m ay be prescrib ed wh en p erfu sio n is ad equ ate to decrease swellin g. Test -Ta kin g Str a tegy: Use th e ABCs—airway–b reath in g– circu latio n . Fo cu sin g o n th e d ata in th e q u estio n in dicates

P

e

d

i

a

t

r

i

c

s

517CHAPTER 43 Musculoskeletal Disorders

th at circulatio n is im p aired. Th is sh o uld direct you to th e cor- rect o ption . Review: Care of th e ch ild in tractio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Mu scu lo skeletal Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Hocken b erry, Wilso n (2015), p. 1573.

444. 4 Ra t ion a le: Wh en a ch ild is in tractio n , th e n u rse wo u ld ch eck th e HCP’s p rescrip tio n to verify th e p rescrib ed am o u n t o f tractio n weigh t. Th e n u rse wo u ld m ain tain th e co rrect am o u n t o f weigh t as p rescrib ed , en su re th at th e weigh ts h an g freely, ch eck th e ro p es fo r frayin g an d en su re th at th ey are o n th e p u lleys ap p ro p riately, m o n ito r th e n eu ro vascu lar statu s o f th e in vo lved extrem ity, an d m o n ito r fo r sign s an d sym p - to m s o f im m o b ilizatio n . Th e n u rse wo u ld p ro vid e th erap eu - tic an d d iversio n al p lay activities fo r th e ch ild . Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, care o f th e ch ild in tractio n . Elim in ate o ptio n 3 first because o f th e word restrict. Next recall th e gen eral p rin cip les related to traction , recallin g th at weigh ts sh ou ld h an g freely an d ro pes sh o u ld rem ain in th e p ulleys. Review: Care of th e ch ild in tractio n Level of Cogn it ive Abilit y: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ped iatrics—Mu scu lo skeletal Pr ior it y Con cept s: Mob ility; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 1561.

445. 2 Ra tion a le: Teach in g abo ut cast care is essen tial to preven t com - p lication s fro m th e cast. Th e paren ts n eed to be in stru cted n o t to use lo tion or p o wd ers on th e skin arou n d th e cast ed ges or in side th e cast. Lo tio n s or p o wd ers can b ecom e sticky or caked an d cause skin irritatio n . O p tion s 1, 3, an d 4 are ap prop riate statem en ts. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an op tio n th at is an in correct statem en t. Rem em ber th at lotio n s o r po wd ers can b eco m e sticky o r caked an d cause skin irritatio n . Review: Ho m e care in structio n s regardin g cast care Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Mu scu lo skeletal Pr ior it y Con cept s: Clien t Ed ucation ; Skin In tegrity Refer en ce: Hocken b erry, Wilso n (2015), pp . 1557, 1559.

446. 3 Ra tion a le: Ju ven ile idio p ath ic arth ritis is an au toim m u n e in flam m atory d isease affectin g th e jo in ts an d oth er tissu es, su ch as articu lar cartilage. Du rin g p ain fu l ep iso des o f ju ven ile id io path ic arth ritis, h o t or co ld packs an d splin tin g an d p osi- tio n in g th e affected join t in a n eu tral po sitio n h elp redu ce

th e pain . Alth o ugh restin g th e extrem ity is ap p ro priate, b egin - n in g sim p le isom etric o r ten sin g exercises as so on as th e ch ild is able is im p ortan t. Th ese exercises d o n o t in volve jo in t m ovem en t. Test-Ta kin g Str a tegy: Focus on th e su b ject, exercise d urin g an acu te exacerbatio n of th e d isease. Elim in ate op tio n s 1 an d 2, b ecau se of th e clo sed -en d ed wo rd s all an d must, an d op tio n 4 becau se o f th e wo rd additional. Review: Ju ven ile id io p ath ic arth ritis Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ped iatrics—Muscu loskeletal Pr ior it y Con cept s: Mob ility; Pain Refer en ces: Hocken berry, Wilso n (2015), p. 1605; McKin n ey et al. ( 2013) , p . 1370.

447. 4 Ra tion a le: Scoliosis is a th ree-d im en sio n al spin al defo rm ity th at usu ally in volves lateral cu rvature, spin al ro tation resultin g in rib asym m etry, an d h yp okyp h o sis o f th e th orax. A co m p li- cation after su rgical treatm en t of sco lio sis is su perio r m esen - teric artery syn d ro m e. Th is d iso rd er is caused b y m ech an ical ch an ges in th e p osition o f th e ch ild’s ab do m in al co n ten ts, resultin g from len gth en in g of th e ch ild’s b od y. Th e disorder results in a syn drom e of em esis an d abd o m in al disten tion sim - ilar to th at wh ich o ccurs with in testin al o bstructio n or p aralytic ileu s. Posto perative vom itin g in ch ild ren with b od y casts or ch ild ren wh o h ave un dergon e sp in al fusion warran ts atten tion b ecau se of th e p ossib ility o f sup erior m esen teric artery syn - d ro m e. O ptio n s 1, 2, an d 3 are in co rrect. Test-Ta kin g St r a t egy: Focus on th e su b ject, com plication s fol- lo win g surgical treatm en t fo r sco lio sis. Elim in ate o ptio n 2 first b ecau se it sh o uld n ot be im p lem en ted u n less p rescribed by th e HCP. Elim in ate o p tion 3 n ext b ecause th is ch ild requ ires lo g- rollin g, an d Sim s’position m ay cause in jury after surgery. Fro m th e rem ain in g op tio n s, n o te th e assessm en t sign s an d sym p - to m s in th e q uestion . Th ese sh o uld alert yo u th at n otificatio n o f th e HCP is n ecessary. Review: Man ifestation s of su p erio r m esen teric artery syn d ro m e Level of Cogn itive Ability: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Muscu loskeletal Pr ior it y Con cept s: Clin ical Ju dgm en t; Mo bility Refer en ces: Hocken berry, Wilso n (2015), p. 1589; McKin n ey et al. ( 2013) , p p. 1357-1358.

448. 3 Ra tion a le: A brace m ay be p rescribed to treat sco lio sis. Braces are n ot cu rative, b ut m ay slo w th e pro gressio n o f th e cu rvature to allow skeletal growth an d m atu rity. Th e u se o f lo tion s or p owders un der a b race sh ou ld b e avoided becau se th ey can b eco m e sticky an d cake un der th e b race, cau sin g irritation . O ptio n s 1, 2, an d 4 are ap prop riate in terven tio n s in th e care o f a ch ild with a brace. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d

P

e

d

i

a

t

r

i

c

s

518 UNIT VII Pediatric Nursing

ask yo u to select an op tio n th at is an in correct statem en t. Care- fu l readin g o f th e o ptio n s will assist in d irectin g yo u to th e co r- rect optio n . Also, applyin g th e prin ciples associated with cast care will direct yo u to th e co rrect o ption . Review: Hom e care in stru ction s fo r a ch ild in a b race Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Musculoskeletal Pr ior ity Con cepts: Clien t Edu catio n ; Mob ility Refer en ces: Ho cken b erry, Wilso n (2015), p p . 1587-1588; McKin n ey et al. (2013), pp . 1535, 1537.

449. 3 Ra t ion a le: In d evelo p m en tal d ysp lasia o f th e h ip , th e h ead o f th e fem u r is seated im p ro p erly in th e acetab u lu m o r h ip so cket o f th e p elvis. O rto lan i’s m an eu ver is a test to assess fo r h ip in stab ility an d can b e d o n e o n ly b efo re 4 weeks o f age. Th e exam in er ab d u cts th e th igh an d ap p lies gen tle p res- su re fo rward o ver th e greater tro ch an ter. A “clickin g” sen sa- tio n in d icates a d islo cated fem o ral h ead m o vin g in to th e acetab u lu m . Bab in ski’s sign is ab n o rm al in an yo n e o ld er th an 2 years o f age an d in d icates cen tral n ervo u s system ab n o rm al- ity. Th e Mo ro reflex is n o rm ally p resen t at b irth b u t is ab sen t b y 6 m o n th s; if still p resen t at 6 m o n th s, th ere is an in d icatio n o f n eu ro lo gical ab n o rm ality. Th e p alm ar-p lan tar grasp is p re- sen t at b irth an d lessen s with in 8 m o n th s. Test -Ta kin g St r a t egy: O p tio n s 1 an d 2 can be elim in ated first because th ey are co m p arab le o r alike an d are bo th tests o f n eu - ro logical fu n ction . To select from th e rem ain in g option s, rem em ber th at O rtolan i’s m an euver is an assessm en t tech - n iq ue fo r h ip dysp lasia th at m u st b e d on e before 4 weeks o f age. Th is will direct yo u to th e correct o ptio n . Review: Th e p urpo se o f O rto lan i’s m an eu ver Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Pediatrics—Musculoskeletal Pr ior ity Con cepts: Clin ical Jud gm en t; Mo bility Refer en ce: Ho cken berry, Wilson (2015), p p. 258, 1592.

450. 1 Ra t ion a le: In d evelo p m en tal d ysp lasia o f th e h ip , th e h ead o f th e fem u r is seated im p ro p erly in th e acetab u lu m o r h ip so cket o f th e p elvis. Asym m etrical an d restricted ab d u ctio n o f th e affected h ip , wh en th e ch ild is p laced su p in e with th e kn ees an d h ip s flexed , wo u ld b e an assessm en t fin d in g in d evelo p m en tal d ysp lasia o f th e h ip in in fan ts b eyo n d th e n ewb o rn p erio d . O th er fin d in gs in clu d e an ap p aren t sh o rt fem u r o n th e affected sid e, asym m etry o f th e glu teal skin fo ld s, an d lim ited ran ge o f m o tio n in th e affected extrem ity. Test -Ta kin g Str a tegy: No te th e su b ject, assessm en t fin din gs in develo p m en tal d ysplasia of th e h ip . Also , n o te th e age o f th e in fan t an d fo cu s o n th e in fan t’s diagn o sis. Visu alizin g each of th e assessm en t fin d in gs d escrib ed in th e o ptio n s will direct yo u to th e co rrect o p tion .

Review: Hip d ysp lasia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Mu sculo skeletal Pr ior ity Con cepts: Develop m en t; Mo bility Refer en ce: Ho cken berry, Wilson (2015), p p. 1591-1592.

451. 3 Ra t ion a le: Clubfoot is a com plex deform ity of th e an kle an d fo o t th at in clu d es fo refo ot ad du ctio n , m id foo t sup in atio n , h in d foo t varus, an d an kle equ in u s; th e defect m ay be un ilateral o r bilateral. Treatm en t for club foo t is started as soo n as p o ssi- b le after b irth . Serial m an ip ulatio n an d castin g are perform ed at least weekly. If sufficien t correctio n is n ot ach ieved in 3 to 6 m on th s, surgery usu ally is in d icated . Becau se clu bfo ot can recur, all ch ild ren with club foo t requ ire lo n g-term in terval fo llo w-u p u n til th ey reach skeletal m atu rity to en sure an o pti- m al ou tco m e. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further teaching. Th ese wo rd s in dicate a n egative even t q u ery an d ask yo u to select an o p tion th at is an in co rrect statem en t. Th is will assist yo u in elim in atin g o p tion s 1 an d 2. Recallin g th at serial m an ipu lation s an d castin g are requ ired weekly will assist in d irectin g you to th e co rrect op tion . Review: Treatm en t fo r clu b fo o t Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Mu sculo skeletal Pr ior ity Con cepts: Clien t Ed u catio n ; Mob ility Refer en ce: Ho cken berry, Wilson (2015), p p. 1596-1597.

452. 2, 5, 6 Ra t ion a le: Wh ile th e cast is d ryin g, th e palm s o f th e h an ds are u sed to lift th e cast. If th e fin gertips are used, in den tation s in th e cast cou ld occu r an d cause con stan t p ressu re on th e u n d er- lyin g skin . Sm all toys an d sh arp o bjects are kept away from th e cast, an d n o o bjects (in clud in g p ad d ed o bjects) are placed in sid e th e cast because o f th e risk o f altered skin in tegrity. Th e extrem ity is elevated to preven t swellin g, an d th e HCP is n otified im m ediately if an y sign s of n eurovascular im p airm en t d evelo p . A h eatin g pad is n ot ap plied to th e cast or fin gers. Cold fin gers co uld in dicate n eurovascular im p airm en t, an d th e HCP sh ou ld b e n otified. Test -Ta kin g Str a tegy: Use o f th e ABCs—airway, b reath in g, an d circu latio n —an d safety prin cip les related to care of a ch ild with a cast will assist in an swerin g th is question . Review: Cast care Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Mu sculo skeletal Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ces: Ho cken b erry, Wilson (2015), p p. 1559, 1573.

P

e

d

i

a

t

r

i

c

s

519CHAPTER 43 Musculoskeletal Disorders

P

e

d

i

a

t

r

i

c

s

C H A P T E R 44 Infectious and Communicable Diseases

PRIORITY CONCEPTS Infection; Safety

CRITICAL THINKING What Should You Do? The nurse is admitting a child with a diagnosis of mumps to the pediatric unit. What should the nurse do to prevent the transmission of mumps to others? Answer located on p. 531.

I. Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome

A. Description 1. Acquired im m un od eficien cy syn dro m e (AIDS) is

a disorder cau sed by h um an im m un od eficien cy virus (HIV) an d ch aracterized by gen eralized dys- fun ction of th e im m un e system (Fig. 44-1).

2. Th e diagn osis of AIDS is associated with certain illn esses or con ditio n s.

3. HIV in fects CD4+ T cells; a gradual decrease in CD4+ T-cell coun t occurs, an d th is results in a progressive im m un od eficien cy; th e risk for oppo rtun istic in fectio n s is presen t (Box 44-1).

4. HIV is tran sm itted th rou gh blood , sem en , vagi- n al secretio n s, an d breast m ilk; th e in cubation period is m on th s to years.

5. Ho rizon tal tran sm issio n occurs th rou gh in ti- m ate sexual con tact or paren teral exposure to blood or body fluids th at con tain th e virus.

6. Vertical (perin atal) tran sm issio n occurs from an HIV-in fected pregn an t wom an to h er fetus (see Ch apter 26).

7. Th e m ost com m on oppo rtun istic in fectio n th at occurs in ch ildren in fected with HIV is Pneumo- cystis jiroveci pn eum on ia; P. jiroveci pn eum on ia m ost frequen tly occurs between th e ages of 3 an d 6 m on th s.

An infant or child infected with HIV is at risk for developing a life-threatening opportunistic infection. Monitor the infant or child closely for signs of infection and report these signs immediately if they occur.

B. Assessm en t (see Box 44-1 an d Box 44-2) C. Diagn ostic tests: Before testin g, coun selin g sh ould be

provid ed to paren ts; issues th at sh ould be addressed in clude th e causes of HIV, reason s for testin g, im plication s of positive test results, con fiden tiality issues, an d ben eficial effects of early in terven tion (Table 44-1).

II. Care of the Child with HIV Infection or AIDS A. A m ultidisciplin ary h ealth care approach is taken ;

prim ary goals are to decelerate th e replication of th e virus, preven t opportun istic in fectio n s, provide n utrition al supp ort, treat sym pto m s, an d treat opportun istic in fectio n s.

B. Proph ylaxis (P. jiroveci pn eum on ia an d oth er oppo r- tun istic in fectio n s) 1. Provide proph ylaxis as prescribed again st P. jiro-

veci pn eum on ia an d oth er opportun istic in fec- tion s, particularly durin g th e first year of life of an in fan t born to an HIV-in fected m oth er.

2. After 1 year of age, th e n eed for proph ylaxis is determ in ed on th e basis of th e presen ce an d severity of im m un osu ppression or a h isto ry of P. jiroveci pn eum on ia.

3. Con tin uin g proph ylaxis is based on th e ch ild’s HIV status, h isto ry of oppo rtun istic in fectio n s, an d CD4+ coun ts.

C. An tiretro viral m edication s (refer to Ch apter 67)

Before administering an antiretroviral medication, ensure that the medication is safe for pediatric adminis- tration. Also check the contraindications for use and the adverse effects.

1. Th e goal of an tiretroviral m edication s is to supp ress viral replication to slow th e declin e in th e n um ber of CD4+ cells, preserve im m un e fun ction , reduce th e in ciden ce an d severity of oppo rtun istic in fectio n s, an d delay disease progression .

520

2. Th e m ed ication s affect differen t stages of th e HIV life cycle to preven t reprodu ction of n ew virus particles.

3. Com b in ation th erap y m ay be prescribed an d in cludes th e use of m ore th an 1 an tiretroviral m ed ication .

D. Im m un ization s

Immunization against childhood diseases is recom- mended for all children exposed to and infected with HIV.

1. If a ch ild h as sym ptom atic HIV in fection or h as severe im m un osuppression , gu idelin es are as follo ws: a . O n ly th e in activated in fluen za vaccine th at is

given in tram uscu larly sh o uld be used (in flu- en za vaccin e sh o uld be given yearly).

b . Measles vaccin e sh ould n ot be given ; im m u- n oglob ulin m ay be prescribed after m easles exposu re.

c. O n ly th e in activated polio vaccin e th at is given in tram uscularly sh ould be used.

P

e

d

i

a

t

r

i

c

s

Immune s ys te m

Nons pe cificS pe cific

Ce ll me dia te d

T-lymphocyte Comple me nt B-lymphocyte

T-he lpe r T-s uppre s s or

T-cytotoxic Lymphokine s

De a th of a ntige n

Antibodie s

IgA IgD

Humora l Monocyte s

Ma cropha ge s Ne utrophils

P ha gocytos is S kin a nd mucous me mbra ne s

Che mica l ba rrie r Infla mma tory re s pons e

Inte rfe ron

Vira l, funga l, protozoa n, a nd s ome ba cte ria l prote ction

Gra ft re je ction S kin hype rs e ns itivity Immune s urve illa nce Vira l

prote ction Function unknown

IgE

Involve d in a lle rgy

a nd pa ra s itic infe s ta tion

IgG

S e conda ry a ntibody

prote ction

IgM

P rima ry a ntibody

prote ction

FIGURE 44-1 Components of the immune system. Ig, Immunoglobulin.

BOX 44-1 Common Acquired Immunodeficiency Syndrome (AIDS)–Defining Conditions in Children

▪ Candidal esophagitis ▪ Cryptosporidiosis ▪ Cytomegalovirus disease ▪ Herpes simplex disease ▪ Human immunodeficiency virus encephalopathy ▪ Lymphoid interstitial pneumonitis ▪ Mycobacterium avium-intracellulare infection ▪ Pneumocystis jiroveci pneumonia ▪ Pulmonary candidiasis ▪ Recurrent bacterial infections ▪ Wasting syndrome

Data from Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nursing care, ed 4, St. Louis, 20 10 , Mosby.

BOX 44-2 Common Assessment Findings in Children with Human ImmunodeficiencyVirus (HIV) Infection

▪ Chronic cough ▪ Chronic or recurrent diarrhea ▪ Developmental delay or regression of developmental

milestones ▪ Failure to thrive ▪ Hepatosplenomegaly ▪ Lymphadenopathy ▪ Malaise and fatigue ▪ Night sweats ▪ Oral candidiasis ▪ Parotitis ▪ Weight loss

Adapted from Perry S, Hockenberry M, Lowdermilk D, Wilson D: Maternal-child nurs- ing care, ed 4, St. Louis, 20 10 , Mosby.

521CHAPTER 44 Infectious and Communicable Diseases

d . Rotavirus vaccin e sh o uld n ot be given . e. Varicella-zoster virus vaccin e sh ould

n ot be given ; varicella-zoster im m un oglob- ulin m ay be prescribed after ch icken p ox exposu re.

f. Tetan u s im m un oglobulin m ay be prescribed for tetan us-pron e woun ds.

E. Caregiver in struction s 1. Wash h an ds frequen tly. 2. Assess th e ch ild for fever, m alaise, fatigue, weigh t

lo ss, vo m itin g, diarrh ea, altered activity level, an d oral lesion s; n otify th e h ealth care provider if an y of th ese occur.

3. Assess th e ch ild for sign s an d sym pto m s of oppo rtun istic in fectio n s, such as pn eum on ia.

4. Adm in ister an tiretroviral m edication s an d oth er m ed ication s to th e ch ild as prescribed.

5. Th e ch ild n eeds to be restricted from h avin g con tact with perso n s wh o h ave in fectio n s or oth er con tagious or poten tially con tagious illn esses.

6. Keep th e ch ild’s im m un ization s up to date. 7. Keep th e ch ild h om e wh en sick. 8. Avo id direct un protected con tact with th e ch ild’s

body fluids. 9. Mon itor th e ch ild’s weigh t. 10. Provide a h igh -calorie an d h igh -p rotein diet to

th e ch ild. 11. Adm in ister ap petite stim ulan ts to th e ch ild as

prescribed an d as n eeded. 12. Do n ot sh are eatin g uten sils with th e ch ild. 13. Wash all eatin g uten sils in th e dish wash er. 14. Cover an y of th e ch ild’s un u sed food an d for-

m ula an d refrigerate (discard un u sed refrigerated form ula an d food after 24 h ours).

15. Do n ot allow th e ch ild to eat fresh fruits or veg- etables or raw m eat or fish (n eu tropen ic diet if im m un osuppressed).

16. Wear gloves wh en carin g for th e ch ild, especially wh en in con tact with body fluid s an d ch an gin g diap ers.

17. Ch an ge th e ch ild’s diap ers frequen tly, away from food areas.

18. Fold th e ch ild’s soiled disposable diapers in ward, clo se with th e tabs, an d dispose in a tigh tly cov- ered plastic-lin ed con tain er.

19. Disp ose of trash daily. 20. Clean up an y of th e ch ild’s body fluid spills

with a bleach solution (10:1 ratio of water to bleach ).

F. Education for an adolescen t in fected with HIV 1. High -risk beh aviors an d th e im portan ce of

avoidin g h igh -risk beh aviors 2. Meth od s of tran sm ission of HIV 3. Th e im portan ce of abstin en ce from sexual con -

tact, such as in tercourse 4. Th e im portan ce of usin g safe con d om s if in ter-

course is plan n ed 5. Reso u rces availab le fo r su p p o rt an d o th er

issu es

III. Rubeola (Measles) A. Description

1. Agen t: Param yxovirus 2. In cubation period: 10 to 20 days 3. Com m un icable period: From 4 days befo re to

5 days after rash appears, m ain ly durin g th e pro- dromal stage (pertain in g to early sym pto m s th at m ay m ark th e on set of disease)

4. Source: Resp iratory tract secretio n s, blood , or urin e of in fected perso n

5. Tran sm issio n : Airbo rn e particles or direct con tact with in fectio us droplets; tran splacen tal

B. Assessm en t ( Fig. 44-2) 1. Fever 2. Malaise

P

e

d

i

a

t

r

i

c

s

TABLE 44-1 Diagnostic Tests for Human Immunodeficiency Virus (HIV)

Test Age-Appropriate Use Test Determines Special Considerations

Enzyme-linked immunosorbent assay

18 mo Response of antibodies to HIV

If used and found to be positive in infants < 18 mo, indicates only that mother is infected because maternal antibodies are transmitted transplacentally; use another diagnostic test

Western blot 18 mo Presence of HIV antibodies Same as above

Polymerase chain reaction

< 18 mo Presence of proviral DNA Very accurate for diagnosing infants 1-4 mo of age

p24 antigen < 18 mo HIV antigen specific Very accurate for diagnosing infants 1-4 mo of age

CD4+ lymphocyte count, T-lymphocyte count

Infant–13 yr Immune system status related specifically to suppression

Age adjustment is essential because normal counts are relatively high in infants and steadily decline until 6 yr of age. Severe suppression in all age groups is < 15% total lymphocytes (< 750 cells/ L in infant < 12 mo, < 500 cells/ L in child 1-5 yr, < 200 cells/ L in child 6-12 yr)

From Branson BM, Handsfield HH, Lampe MA, et al.; Centers for Disease Control and Prevention: Revised recom mendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006, 55(RR14):1–17. Available at http:/ / www.cdc.gov/ mm wr/ preview/ mmwrhtml/ rr5514a1.htm .

522 UNIT VII Pediatric Nursing

3. Th e 3 “C’s”—co ryza, cough , con jun ctivitis 4. Rash ap pears as red, eryth em atou s m aculopapu-

lar eruptio n startin g on th e face an d spreadin g down ward to th e feet; blan ch es easily with pres- sure an d gradually turn s a brown ish color (lasts 6 to 7 days); m ay h ave desquam ation

5. Koplik’s spots: Sm all red spots with a bluish wh ite cen ter an d a red base; located on th e buccal m ucosa an d last 3 days

C. In terven tion s 1. Use airborn e droplet an d con tact precaution s if

th e ch ild is h ospitalized. 2. Restrict ch ild to quiet activities an d bed rest. 3. Use a cool m ist vapo rizer for cough an d coryza. 4. Dim ligh ts if ph o toph ob ia is presen t. 5. Adm in ister an tipyretics for fever. 6. Adm in ister vitam in A supplem en tation as

prescribed .

IV. Roseola (Exanthema Subitum) A. Description

1. Agen t: Hum an h erpesvirus type 6 2. In cubation period: 5 to 15 days 3. Com m un icable period: Un kn own , but th o ugh t

to exten d from th e febrile stage to th e tim e th e rash first appears

4. Source: Un kn own 5. Tran sm ission : Un kn own

B. Assessm en t ( Fig. 44-3) 1. Sudd en h igh ( > 38.8°C [> 102° F]) fever of 3 to

5 days’ duration in a ch ild wh o appears well, fol- lo wed by a rash (rose-pin k m acules th at blan ch with pressure); febrile seizu res m ay occur.

2. Rash ap pears several h ours to 2 days after th e fever subsides an d lasts 1 to 2 days.

C. In terven tion s: Supp ortive

V. Rubella (German Measles) A. Description

1. Agen t: Rubella virus

2. In cubation period: 14 to 21 days 3. Com m un icable period: From 7 days befo re to

about 5 days after rash appears 4. Source: Nasoph aryn geal secretio n s; virus is also

presen t in blood, stool, an d urin e 5. Tran sm issio n

a . Airborn e or direct con tact with in fectious droplets

b . In directly via articles fresh ly con tam in ated with n aso ph aryn geal secretio n s, feces, or urin e

c. Tran splacen tal B. Assessm en t ( Fig. 44-4)

1. Low-grade fever 2. Malaise 3. Pin kish red m aculopapular rash th at begin s on

th e face an d spreads to th e en tire body with in 1 to 3 days

4. Petech iae (red , pin p oin t spots) m ay occur on th e soft palate.

P

e

d

i

a

t

r

i

c

s

FIGURE 44-2 Rubeola (measles). (From Hockenberry, Wilson, 2012.)

FIGURE 44-3 Roseola (exanthema subitum). (From Habif, 2004.)

FIGURE 44-4 Rubella (German measles). (From Zitelli, Davis, 2007. Courtesy Dr. Michael Sherlock, Lutherville, MD.)

523CHAPTER 44 Infectious and Communicable Diseases

C. In terven tion s 1. Use airborne droplet and contact precautions if the

child is hospitalized; provide supportive treatm ent. 2. Iso late th e in fected ch ild fro m pregn an t wom en .

VI. Mumps A. Description

1. Agen t: Param yxovirus 2. In cubation period: 14 to 21 days 3. Com m un icable period: Im m ediately befo re an d

after parotid glan d swellin g begin s 4. Source: Saliva of in fected person an d

possibly urin e 5. Tran sm issio n : Direct con tact or droplet spread

fro m an in fected perso n B. Assessm en t

1. Fever 2. Headach e an d m alaise 3. An o rexia 4. Jaw or ear pain aggravated by ch ewin g, follo wed

by paro tid glan dular swellin g 5. O rch itis m ay occur 6. Asep tic m en in gitis m ay occur

C. In terven tion s 1. In stitute airborn e droplet an d con tact

precaution s. 2. Provide bed rest un til th e paro tid glan d swellin g

subsides. 3. Avo id foods th at require ch ewin g. 4. Apply h ot or cold com presses as prescribed to

th e n eck. 5. Apply warm th an d local support with sn u g-

fittin g un derpan ts to relieve orch itis. 6. Mon itor for sign s of aseptic m en in gitis (see

Ch apters 42 an d 62 for in form ation on m en in gitis)

VII. Chickenpox (Varicella) A. Description

1. Agen t: Varicella-zoster (VCZ) virus 2. In cubation period: 13 to 17 days 3. Com m un icable period: From 1 to 2 days before

th e on set of th e rash to 6 days after th e first crop of vesicles, wh en crusts h ave form ed

4. Source: Respiratory tract secretio n s of in fected perso n ; skin lesion s

5. Tran sm issio n : Direct con tact, droplet (airborn e) spread, an d con tam in ated objects

B. Assessm en t ( Fig. 44-5) 1. Sligh t fever, m alaise, an d an orexia are followed

by a m acular rash th at first ap pears on th e trun k an d scalp an d m oves to th e face an d extrem ities.

2. Lesion s beco m e pustules, begin to dry, an d develop a crust.

3. Lesion s m ay appear on th e m ucou s m em bran es of th e m ou th , th e gen ital area, an d th e rectal area.

C. In terven tion s 1. In th e h ospital, en sure strict isolatio n (con tact

an d droplet [airborn e] precaution s) . 2. At h om e, isolate th e in fected ch ild un til th e ves-

icles h ave dried. 3. Th e an tiviral agen t acyclovir m ay be used to treat

varicella in fectio n s in susceptible im m un oco m - prom ised perso n s to decrease th e n um ber of lesion s; sh o rten th e duration of fever; an d decrease itch in g, leth argy, an d an orexia.

4. Th e use of VCZ im m un e glob ulin or in traven ous im m un e globulin (IVIG) is recom m en ded for ch ildren wh o are im m un ocom prom ised, wh o h ave n o previous h isto ry of varicella, an d wh o are likely to con tract th e disease an d h ave com - plication s as a result.

5. Provide supp ortive care.

Isolate high-risk children, such as children who have immunosuppressive disorders, from a child with a com- municable disease.

VIII. Pertussis (Whooping Cough) A. Description

1. Agen t: Bord etella pertussis 2. In cubation period: 5 to 21 days (usually 10 days) 3. Com m un icable period: Greatest durin g th e

catarrh al stage (wh en disch arge fro m respiratory secretio n s occurs)

4. Source: Disch arge from th e respiratory tract of th e in fected perso n

5. Tran sm issio n : Direct con tact or droplet spread from in fected perso n ; in direct con tact with fresh ly con tam in ated articles

B. Assessm en t 1. Sym pto m s of respiratory in fectio n followed by

in creased severity of cough , with a loud wh oop- in g in spiration

2. May exp erien ce cyanosis, respiratory distress, an d ton gue protrusion

3. Listlessn ess, irritability, an orexia

P

e

d

i

a

t

r

i

c

s

FIGURE 44-5 Chickenpox (varicella). (From Habif, 2004.)

524 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

C. In terven tion s 1. Iso late ch ild durin g th e catarrh al stage; if th e

ch ild is h ospitalized, in stitute airborn e droplet an d con tact precaution s.

2. Adm in ister an tim icrobial th erap y as prescribed. 3. Redu ce en viron m en tal factors th at cau se cough -

in g spasm s, such as dust, sm oke, an d sudden ch an ges in tem p erature.

4. En su re adequate h ydration an d n utrition . 5. Provide suction an d h um idified oxygen

if n eeded. 6. Mon itor cardiop ulm on ary status (via m on itor as

prescribed ) an d pulse oxim etry. 7. In fan ts do n ot receive m atern al im m un ity to per-

tussis; th e tetan us-diph th eria–acellular pertussis (Tdap) vaccin e sh o uld be adm in istered to wom en in th e postp artum period an d th o se in clo se con tact with th e in fan t to preven t th e spread of pertussis to in fan ts.

IX. Diphtheria A. Description

1. Agen t: Coryn ebacterium diph th eriae 2. In cubation period: 2 to 5 days 3. Com m un icable period: Variable, un til virulen t

bacilli are n o lo n ger presen t (3 n egative cultures of disch arge fro m th e n ose an d n aso ph aryn x, skin , an d oth er lesion s) ; usually 2 weeks, but can be 4 weeks

4. Source: Disch arge from th e m ucou s m em bran e of th e n ose an d n aso ph aryn x, skin , an d oth er lesion s of th e in fected perso n

5. Tran sm ission : Direct con tact with in fected per- son , carrier, or co n tam in ated articles

B. Assessm en t 1. Low-grade fever, m alaise, sore th roat 2. Foul-sm ellin g, m ucopurulen t n asal disch arge 3. Den se pseudo m em bran e form ation in th e th roat

th at m ay in terfere with eatin g, drin kin g, an d breath in g

4. Lym ph aden itis, n eck edem a, “bull n eck” C. In terven tion s

1. En su re strict isolatio n for th e h ospitalized ch ild. 2. Adm in ister diph th eria an titoxin as prescribed

(after a skin or con jun ctival test to rule out sen - sitivity to h orse serum ).

3. Provide bed rest. 4. Adm in ister an tibiotics as prescribed. 5. Provide suction an d h um idified oxygen as n eeded. 6. Provide trach eostom y care if a trach eo tom y is

n ecessary.

X. Poliomyelitis A. Description

1. Agen t: En teroviruses 2. In cubation period: 7 to 14 days

3. Com m un icable period: Un kn own ; th e virus is presen t in th e th roat an d feces sh o rtly after in fec- tion an d persists for ab out 1 week in th e th roat an d 4 to 6 weeks in th e feces

4. Source: O roph aryn geal secretio n s an d feces of th e in fected perso n

5. Tran sm issio n : Direct con tact with in fected per- son ; fecal-oral an d oroph aryn geal routes

B. Assessm en t 1. Fever, m alaise, an orexia, n ausea, h ead ach e, sore

th roat 2. Ab d o m in al p ain fo llo wed b y so ren ess an d

stiffn ess o f th e tru n k, n eck, an d lim b s th at m ay p ro gress to cen tral n ervo u s system p aralysis

C. In terven tion s 1. En teric an d con tact precaution s 2. Supp ortive treatm en t 3. Bed rest 4. Mon itorin g for respiratory paralysis 5. Ph ysical th erap y

XI. Scarlet Fever A. Description

1. Agen t: Group A β-h em olytic streptococci 2. In cubation period: 1 to 7 days 3. Com m un icable period: Abou t 10 days durin g th e

in cubation period an d clin ical illn ess; durin g th e first 2 weeks of th e carrier stage, alth ough m ay persist for m on th s

4. Source: Nasoph aryn geal secretion s of in fected perso n an d carriers

5. Tran sm issio n : Direct con tact with in fected per- son or droplet spread; in directly by con tact with con tam in ated articles, in gestion of con tam i- n ated m ilk, or oth er foods

B. Assessm en t ( Fig. 44-6) 1. Abrupt h igh fever, flush ed ch eeks, vo m itin g,

h ead ach e, en larged lym p h n od es in th e n eck, m alaise, abdom in al pain

2. A red, fin e san d paper–like rash develops in th e axilla, groin , an d n eck th at spreads to cover th e en tire body except th e face.

3. Rash blan ch es with pressure (Sch ultz-Ch arlton reaction ) except in areas of deep creases an d folds of th e join ts (Pastia’s sign ) .

4. Desqu am ation , sh eetlike slough in g of th e skin on palm s an d soles, appears by weeks 1 to 3.

5. Th e ton gue is in itially coated with a wh ite, furry coverin g with red projectin g papillae (wh ite strawb erry ton gue); by th e th ird to fifth day, th e wh ite coat slough s off, leavin g a red swollen ton gue (red strawberry ton gue) .

6. Ton sils are redden ed, edem atous, an d covered with exudate.

7. Ph aryn x is edem atou s an d beefy red.

525CHAPTER 44 Infectious and Communicable Diseases

P

e

d

i

a

t

r

i

c

s

C. In terven tion s 1. In stitute con tact precaution s an d respiratory pre-

cau tion s un til 24 h ou rs after in itiation of an tibiotics.

2. Provide supp ortive th erapy. 3. Provide bed rest. 4. En cou rage flu id in take.

XII. Erythema Infectiosum (Fifth Disease) A. Description

1. Agen t: Hum an parvovirus B19 2. In cubation period: 4 to 14 days; m ay be 20 days 3. Com m un icable period: Un certain , but befo re th e

on set of sym ptom s in m ost ch ildren 4. Source: In fected perso n 5. Tran sm issio n : Un kn own ; possibly respiratory

secretio n s an d blood B. Assessm en t

1. Before rash : Asym ptom atic or m ild fever, m al- aise, h ead ach e, run n y n ose

2. Stages of rash a . Eryth em a of th e face (slapp ed-ch eek ap pear-

an ce) develo ps an d disappears by 1 to 4 days (Fig. 44-7).

b . About 1 day after th e rash appears on th e face, m aculopapular red spots ap pear, sym m etri- cally distributed on th e extrem ities; th e rash progresses from proxim al to distal surfaces an d m ay last a week or m ore.

c. Th e rash subsid es, but m ay reappear if th e skin beco m es irritated by th e sun , h eat, cold, exercise, or friction .

C. In terven tion s 1. Ch ild is n ot usually h ospitalized. 2. Pregn an t wom en sh o uld avoid th e in fected

in dividual. 3. Provide supp ortive care. 4. Adm in ister an tipyretics, an algesics, an d an tiin -

flam m atory m ed ication s as prescribed.

XIII. Infectious Mononucleosis A. Description

1. Agen t: Epstein -Barr virus 2. In cubation period: 4 to 6 weeks 3. Com m un icable period: Un kn own 4. Source: O ral secretio n s 5. Tran sm issio n : Direct in tim ate con tact

B. Assessm en t 1. Fever, m alaise, h eadach e, fatigue, n ausea,

abdom in al pain , sore th roat, en larged red ton sils 2. Lym ph aden op ath y an d h epatosplen o m egaly 3. Discrete m acular rash m ost prom in en t over th e

trun k m ay occur. C. In terven tion s

1. Provide supp ortive care. 2. Mon itor for sign s of splen ic rupture.

Teach the parents of a child with mononucleosis to monitor for signs of splenic rupture, which include abdom- inal pain, left upper quadrant pain, and left shoulder pain.

Firs t day o f ras h Third day o f ras h

Firs t day Third day

Circumora l pa llorFlus he d che e ks

Re d s tra wbe rry tongue (s e e be low)

White s tra wbe rry tongue (s e e be low)

Incre a s e d de ns ity in a xilla

Incre a s e d de ns ity on ne ck

Incre a s e d de ns ity in groin

Tra ns ve rs e line s (Pa s tia ’s s ign)

Pos itive bla nching te s t (S chultz-Cha rlton)

White s tra wbe rry tongue Re d s tra wbe rry tongue

FIGURE 44-6 Scarlet fever.

FIGURE 44-7 Erythema infectiosum (fifth disease): Slapped-face appear- ance. (From Habif, 200 4.)

526 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

XIV. Rocky Mountain Spotted Fever A. Description

1. Agen t: Rickettsia rickettsii 2. In cubation period: 2 to 14 days 3. Source: Tick from a m am m al, m ost often fro m

wild roden ts an d dogs 4. Tran sm ission : Bite of in fected tick

B. Assessm en t 1. Fever, m alaise, an orexia, vom itin g, h eadach e,

m yalgia 2. Maculopapu lar or petech ial rash prim arily on th e

extrem ities (an kles an d wrists), but m ay spread to oth er areas, ch aracteristically on th e palm s an d soles

C. In terven tion s 1. Provide vigorou s supp ortive care. 2. Adm in ister an tibiotics as prescribed. 3. Teach th e ch ild an d paren ts about protection

fro m tick bites (Box 44-3).

XV. Community-Associated Methicillin-Resistant St a ph- ylococcus a ureus (CA-MRSA)

A. Description (also see Ch apter 16) 1. Staphylococcus aureus is a bacterium th at is n or-

m ally located on th e skin or in th e n ose of h ealth y people; wh en presen t with ou t sym p- tom s, it is called colonization, an d wh en sym p- tom s are presen t, it is called an infection.

2. MRSA is a strain of S. aureus th at is resistan t to m eth icillin an d m ost often occurs in people wh o were h ospitalized or treated at a h ealth care facility (h osp ital-acquired MRSA) .

3. CA-MRSA is an MRSA in fection th at occurs in a h ealth y person wh o h as n ot been h ospitalized or h ad a m ed ical proced ure don e with in th e past year.

4. Perso n s at risk for CA-MRSA in clude ath letes, prison ers, day care atten dees, m ilitary recruits, perso n s wh o abuse in traven ous drugs, perso n s livin g in crowded settin gs, perso n s with poor h ygien e practices, person s wh o use con tam i- n ated item s, perso n s wh o get tattoos, an d per- son s with a com pro m ised im m un e system .

5. CA-MRSA is spread th rou gh perso n -to-person con tact, th rough co n tact with con tam in ated item s, or th rough in fectio n of a preexistin g cut or woun d th at is n ot protected by a dressin g.

6. Th e bacteria can enter th e bloodstream th rough th e cut or woun d an d cause sepsis, cellulitis, en do- carditis, osteom yelitis, septic arth ritis, toxic sh ock syn drom e, pn eum on ia, organ failure, an d death .

B. Preven tion m easu res 1. Han d wash in g an d practicin g good perso n al

h ygien e 2. Avo idin g sh arin g of perso n al item s 3. Regular clean in g of sh ared equipm en t such as

ath letic equipm en t, wh irlp ools, or saun as 4. Clean in g a cut or woun d th o rough ly

C. Assessm en t 1. Appearan ce of a skin in fection : Red, swollen

area; warm th aroun d th e area; drain age of pus; pain at th e site; fever

2. Sym ptom s of a m ore serious in fectio n : Ch est pain , cough , fatigue, ch ills, fever, m alaise, h ead- ach e, m uscle ach es, sh o rtn ess of breath , rash

D. In terven tion s 1. Assess skin lesion s. 2. Prepare to drain an in fected skin site an d culture

th e woun d an d woun d drain age. 3. Prepare to obtain blood cultures, sputum cul-

tures, an d urin e cultures. 4. Prepare to adm in ister an tibiotics as prescribed. 5. Educate the ch ild an d fam ily about th e causes and

m odes of tran sm ission , sign s an d sym ptom s, and im portan ce of treatm en t m easures prescribed.

XVI. Influenza A. Description

1. Various strain s of in fluen za can occur. 2. It is a viral in fectio n th at affects th e respiratory

system an d is h igh ly con tagious. 3. Ch ildren , pregn an t wom en , person s with preex-

istin g h ealth con dition s, an d perso n s with a com pro m ised im m un e system are at h igh risk for developin g com plication s.

BOX 44-3 Measures to Protect Children from Tick Bites

▪ Wearing long-sleeved shirts, long pants tucked into long socks (socks should be pulled up over the pant legs), and a hat when walking in tick-infested areas

▪ Wearing light-colored clothing to make ticks more visible if they get onto the child

▪ Checking children for the presence of ticks after being in high-risk or tick-infested areas

▪ Following paths rather than walking in tall grass and shrub areas, because these are the places where most ticks are found

▪ Applying insect repellents containing diethyltoluamide (DEET) and permethrin before possible exposure to areas where ticks are found (use with caution in infants and small children)

▪ Keeping yards at home trimmed and free of accumulating leaves and other brush

▪ Applying tick repellent to dogs ▪ Saving the tick for later identification if it is removed from

the child’s body ▪ To remove the tick, grasp the tick at the point of closest

contact to the skin with tweezers and pull straight up with steady, even pressure; remove any remaining parts with a sterile needle; if using bare hands, use a tissue during removal; wash hands with soap and water.

527CHAPTER 44 Infectious and Communicable Diseases

P

e

d

i

a

t

r

i

c

s

4. It is cau sed by con tact with an in fected person or by touch in g som eth in g such as a toy or tissue th at th e in fected perso n h as touch ed.

B. Preven tion 1. Flu vaccine 2. Wash th e ch ild’s h an ds frequen tly an d teach

h an d-wash in g tech n iqu es. 3. Avo id ch ildren wh o are ill. 4. Keep th e ch ild h om e fro m sch o ol or away from

oth ers un til th e ch ild h as been fever-free (with - out th e use of an tipyretics) for at least 24 h ours.

5. For addition al in form ation , refer to Cen ters for Disease Con trol an d Preven tion (CDC) Web site: h ttp :/ / www.cd c.gov/ vaccin es/ sch ed ules/ in dex. h tm l.

The signs and symptoms of flu usually last a week. If they last longer, the presence of complications should be suspected.

C. Assessm en t 1. Fever th at occurs sudden ly an d is h igh 2. Headach e, body ach es, fatigue, ch ills, cough ,

con gestion , sore th roat, loss of ap petite, vom it- in g, diarrh ea

D. In terven tion s 1. An tiviral m edication s if prescribed, fluids, rest,

pain relievers such as acetam in oph en or ibuprofen 2. Fam ily an d ch ild teach in g about preven tion

m easu res

XVII. Immunizations A. Guidelin es (see Prio rity Nu rsin g Actio n s)

1. In th e Un ited States, th e recom m en ded age for begin n in g prim ary im m un ization s of in fan ts is at birth .

2. Ch ildren wh o began prim ary im m un ization s at th e recom m en ded age but failed to receive all required doses do n ot n eed to begin th e series again ; th ey n eed to receive on ly th e m issed doses.

3. If th ere is suspicion th at th e paren t will n ot brin g th e ch ild to th e ped iatrician or h ealth care clin ic for follow-up im m un ization s accord in g to th e optim al im m un ization sch edule, an y of th e recom m en ded vaccin es can be adm in istered sim ultan eously.

B. Gen eral con train dication s an d precaution s 1. A vaccin e is con train dicated if th e ch ild exp eri-

en ced an an aph ylactic reaction to a previously adm in istered vaccin e or a com po n en t in th e vaccin e.

2. Live virus vaccin es gen erally are n ot adm in istered to in dividuals with severely deficien t im m un e system s, in dividuals with a severe sen sitivity to gelatin , or pregn an t wom en .

3. A vaccin e is adm in istered with caution to an in di- vidu al with a m od erate or severe acute illn ess, with or with ou t fever.

4. See Section XVIII, Recom m en ded Ch ildh ood an d Adolescen t Im m un ization s, for specific in form ation for each type of vaccin e.

C. Guidelin es for ad m in istration (Box 44-4)

Children born preterm should receive the full dose of each vaccine at the appropriate chronological age.

XVIII. Recommended Childhood and Adolescent Immunizations (Box 44-5)

A. For th e m ost up-to -date in form ation , refer to CDC Web site: h ttp:/ / www.cdc.gov/ vaccin es/ sch edules/ in dex.h tm l.

PRIORITY NURSING ACTIONS Administering a Parenteral Vaccine 1. Verify the prescription for the vaccine. 2. Obtain an immunization history from the parents and

assess for allergies. 3. Provide information to the parents about the vaccine. 4. Obtain parental consent. 5. Check the lot number and expiration date and prepare the

injection. 6. Select the appropriate site for administration. 7. Administer the vaccine. 8. Document the administration and site of

administration and lot number and expiration date of the vaccine.

9. Provide a vaccination record to the parents.

The nurse should first verify the prescription and then obtain an immunization history from the parents to ensure that the

immunizations are up to date. The nurse should also question the parents about the presence of any allergies in the child because some vaccines contain components to which the child may be allergic. The nurse next provides information to the par- ents about the vaccine and obtains consent. The expiration date and the lot number (located on the medication vial) of the vaccine should be checked before preparing the vaccine for administra- tion. When the vaccine is prepared, the nurse prepares the child for the procedure, selects an appropriate site, and administers the vaccine. The nurse documents that the vaccination has been administered and provides an updated immunization record to the parents.

Reference Hockenberry, Wilson (2015), pp. 208-209.

528 UNIT VII Pediatric Nursing

B. Hepatitis B vaccin e (HepB) 1. Adm in istered by th e in tram uscular route 2. Con train dication s: Severe allergic reaction to

previous dose or vaccin e com po n en t (com po- n en ts in clude alum in um h ydroxide, yeast protein )

3. Precaution s: An in fan t weigh in g less th an 2000 g or an in fan t with m oderate or severe acute illn ess with or with out fever

4. HBsAg (h ep atitis B surface an tigen )-p ositive m oth ers a. In fan t sh ould receive HepB vaccin e an d h ep-

atitis B im m un oglobulin (HBIG) with in 12 h ours of birth .

b . In fan t sh o uld be tested for HBsAg an d an ti- body to HBsAg after com pletion of HepB series (9 to 18 m on th s of age).

5. Moth er wh ose HBsAg status is un kn own a . In fan t sh ould receive th e first dose of h epati-

tis vaccin e series with in 12 h ou rs of birth . b . Matern al blood sh ould be drawn as soon as pos-

sible to determ in e the m oth er’s HBsAg status. c. If th e m oth er’s HBsAg test result is positive,

th e in fan t sh o uld receive HBIG as soon as possible (n o later th an 1 week of age).

C. Ro tavirus vaccin e (RV) 1. Rotavirus is a cause of serious gastroenteritis and is

a n osocom ial (h ospital-acquired) path ogen th at is m ost severe in ch ildren 3 to 24 m on th s of age; ch il- dren youn ger th an 3 m on th s h ave som e protec- tion because of m atern ally acquired an tibodies.

2. Two vaccin es are available (RotaTeq an d Rotarix) an d are ad m in istered by th e oral route because th e vaccin e m ust replicate in th e in fan t’s gut.

P

e

d

i

a

t

r

i

c

s

BOX 44-4 Guidelines for Administration of Vaccines Follow manufacturer’s recommendations for route of adminis-

tration, storage, and reconstitution of the vaccine. If refrigeration is necessary, store on a central shelf and not on

the door; frequent temperature changes from opening the refrigerator door can alter the vaccine’s potency.

A vaccine information statement needs to be given to the par- ents or individual, and informed consent for administration needs to be obtained.

Check the expiration date on the vaccine bottle. Parenteral vaccines are given in separate syringes in different

injection sites. Vaccines administered intramuscularly are given in the vastus

lateralis muscle (best site) or ventrogluteal muscle (the del- toid can be used for children 36 months of age and older).

Vaccines administered subcutaneously are given in the fatty areas in the lateral upper arms and anterior thighs.

Adequate needle length and gauge are as follows: intramuscu- lar, 1 inch, 23–25 gauge; subcutaneous, ⅝ inch, 25 gauge (needle length may vary depending on the child’s size).

Mild side effects include fever, soreness, swelling, or redness at injection site.

A topical anesthetic may be applied to injection site before the injection.

For painful or red injection sites, advise the parent to apply cool compresses for the first 24 hours, and then use warm or cold compresses as long as needed.

An age-appropriate dose of acetaminophen or ibuprofen, per health care provider’s preference, may be administered every 4 to 6 hours for vaccine-associated discomfort.

Maintain an immunization record—document day, month, year of administration; manufacturer and lot number of vaccine; name, address, title of person administering the vaccine; and site and route of administration.

A vaccine adverse event report needs to be filed and the health department needs to be notified if an adverse reaction to an immunization occurs.

BOX 44-5 Recommended Childhood and Adolescent Immunizations: 2016* Birt h: Hepatitis B vaccine (HepB) 1 month: HepB 2 months: Inactivated poliovirus vaccine (IPV); diphtheria, teta-

nus, acellular pertussis (DTaP) vaccine; Haemophilus influ- enzae type b conjugate vaccine (Hib); pneumococcal conjugate vaccine (PCV), rotavirus (RV)

4 months: DTaP, Hib, IPV, PCV, RV 6 months: DTaP, Hib, HepB, IPV, PCV, RV(dose may be needed

depending on type of vaccine used for first and second doses)

12–15 months: Hib; PCV; measles, mumps, rubella (MMR) vac- cine; hepatitis A, first dose (second dose is given 6– 18 months after the first dose); varicella vaccine

15–18 months: DTaP 18–33 months: Hepatitis A (second dose given 6–18 months

after the first dose) 4–6 yea rs: DTaP, IPV, MMR, varicella vaccine 11–12 yea rs: MMR (if not administered at 4–6 years); diphtheria,

tetanus, acellular pertussis adolescent preparation (Tdap); meningococcal vaccine (MCV4) with a booster at age 16; human papillomavirus (HPV) (first dose to girls at age 11 to 12 years, second dose 2 months after first dose, and third dose 6 months after first dose)

*Updated yearly. See Centers for Disease Control and Prevention (CDC) Web site at http:/ / www.cdc.gov/ vaccines/ s chedules/ index.html for current schedule. Note: Influenza vaccine is recommended annually for children beginning at age 6 months. From Centers for Disease Control and Prevention (CDC): Immunization schedules, Atlanta, 20 12, CDC. Available at http:/ / www.cdc.gov/ vaccines/ schedules / index.html.

529CHAPTER 44 Infectious and Communicable Diseases

3. Vaccin e m ay be with h eld if an in fan t is experien cin g severe vom itin g an d diarrh ea; it is adm in istered as soon as th e in fan t recovers.

D. Diph th eria, tetan us, acellular pertussis (DTaP); teta- n us toxoid ; reduced diph th eria toxoid an d acellular pertussis vaccin e (Tdap adolescen t preparation ) 1. Adm in istered by in tram uscular route 2. Th e Tdap (adolescen t preparation ) is recom -

m en ded at 11 to 12 years of age for ch ildren wh o h ave com pleted th e recom m en ded ch ild- h ood DTaP series but h ave n ot received a tetan us an d diph th eria toxoid (Td) booster dose; ch il- dren 13 to 18 years old wh o h ave n ot received Tdap sh ould receive a dose.

3. Td does n ot provide protectio n again st pertussis; Td is used as a booster every 10 years after Tdap is adm in istered at 11 to 18 years of age.

4. En ceph alopath y is a com plication . 5. Con train dication s: En ceph alop ath y with in

7 days of a previous dose or a severe allergic reac- tion to a previous dose or to a vaccin e com po n en t

E. Haemophilus influenzae type b (Hib) con jugate vac- cin e (Hib) 1. Protects again st n um erou s serious in fectio n s

caused by H. influenzae type b, such as bacterial m en in gitis, epiglottitis, bacterial pn eum on ia, septic arth ritis, an d sepsis

2. Adm in istered by th e in tram uscular route 3. Con train dication s: Severe allergic reaction to a

previous dose or vaccin e com po n en t F. In fluen za vaccin e: Vaccin e is recom m en ded an n u-

ally for ch ildren begin n in g at age 6 m on th s. G. In activated polioviru s vaccin e (IPV)

1. IPVis adm in istered by th e subcutan eous route (it m ay also be given by th e in tram uscular route).

2. Con train dication s: Severe allergic reaction to a previous dose or vaccin e com po n en t; com po- n en ts m ay in clude form alin , n eom ycin , strepto- m ycin , or polym yxin B

H. Measles, m um ps, rubella (MMR) vaccin e 1. Vaccin e is adm in istered by th e subcu tan eous

route. 2. Con train dication s: Severe allergic reaction to a

previous dose or vaccin e com pon en t (gelatin , n eom ycin , eggs), pregn an cy, kn own im m un od e- ficien cy

3. If th e ch ild received im m un oglobulin , th e MMR vaccin e sh ould be postpon ed for at least 3 to 6 m on th s (im m un oglobulin can in h ib it th e im m un e respon se to th e MMR vaccin e).

I. Varicella vaccin e 1. It is adm in istered by th e subcutan eous route. 2. Ch ildren receivin g th e vaccin e sh ould avoid

aspirin or aspirin -con tain in g products because of th e risk of Reye’s syn d rom e.

3. Con train dication s: Severe allergic reaction to a previous dose or vaccin e com pon en t (gelatin ,

bovin e albu m in , n eom ycin ), sign ifican t sup- pression of cellu lar im m un ity, pregn an cy

J. Pn eum ococcal con jugate vaccin e (PCV) 1. PCV preven ts in fectio n with Streptococcus pneu-

moniae, wh ich m ay cau se m en in gitis, pn eum o- n ia, sep ticem ia, sin usitis, an d otitis m edia.

2. It is adm in istered by th e in tram uscu lar ro ute. 3. Con train dication s: Severe allergic reactio n to a

previous dose or vaccin e com po n en t K. Hepatitis A vaccin e (Hep A)

1. It is adm in istered by th e in tram uscu lar ro ute. 2. Con train dication s: Severe allergic reactio n to a

previous dose or vaccin e com po n en t L. Men in goco ccal vaccin e (MCV)

1. Vaccin e protects again st Neisseria meningitidis. 2. MCV4 is th e preferred typ e of vaccin e an d is

given in tram uscu larly. 3. MCV4 sh ould be adm in istered to all ch ildren at

age 11 to 12 years an d to un vaccin ated adoles- cen ts at h igh sch ool en try (age 15 years); all col- lege fresh m en livin g in dorm itories sh ould be vaccin ated.

4. Revaccin atio n is recom m en ded for ch ildren wh o rem ain at in creased risk after 3 years (if th e first dose was ad m in istered at age 2 to 6 years) or after 5 years (if th e first dose was adm in istered at age 7 years or older) .

5. It is con train d icated in ch ildren with a h istory of Guillain -Barré syn d rom e.

M. Hu m an papillom avirus vaccin e (HPV) 1. Depen din g on th e type of vaccin e used (HPV2 or

HPV4), th e HPV vaccin e guards again st diseases th at are cau sed by HPV types 6, 11, 16, an d 18, such as cervical can cer, cervical abn o rm alities th at can lead to cervical can cer, an d gen ital warts.

2. Th e vaccin e is m ost effective for boys an d girls if ad m in istered before exposu re to h um an papillo- m avirus th rou gh sexual con tact.

3. Th e vaccin e is adm in istered as 3 in jection s over 6 m on th s—first dose to girls at age 11 to 12 years, th e secon d dose 2 m on th s after th e first dose, an d th e th ird dose 6 m on th s after th e first dose.

4. A 3-dose series m ay be adm in istered to boys 9 to 18 years old to reduce th eir likelih ood of acq uir- in g gen ital warts.

5. Th e vaccin e can cause pain , swellin g, itch in g, an d redn ess at th e in jection site; fever; n ausea; an d dizzin ess.

6. Th e vaccin e is con train dicated in in dividuals with a reactio n to a previous in jection an d in pregn an t wom en .

XIX. Reactions to a Vaccine A. Local reaction s

1. Ten d ern ess, eryth em a, swellin g at in jection site 2. Low-grade fever

P

e

d

i

a

t

r

i

c

s

530 UNIT VII Pediatric Nursing

P

e

d

i

a

t

r

i

c

s

3. Beh avioral ch an ges such as drowsin ess, un usual cryin g, decreased appetite

B. Min im izin g lo cal reaction s 1. Select a n eedle of adequ ate len gth to dep osit vac-

cin e deep in to th e m uscle or subcu tan eous m ass. 2. In ject in to th e appropriate recom m en ded site.

C. An aph ylactic reaction s 1. Goals of treatm en t are to secure an d protect th e

airway, restore adequ ate circulation , an d preven t furth er exposu re to th e an tigen .

2. For a m ild reaction with n o eviden ce of respira- tory distress or cardiovascular com prom ise, a subcu tan eo us in jection of an an tih istam in e, such as diph en h ydram in e, an d epin eph rin e m ay be ad m in istered.

3. For m oderate or severe distress, establish an air- way; provide cardiop ulm on ary resuscitation if th e ch ild is n ot breath in g; elevate th e h ead; ad m in ister epin eph rin e, fluid s, an d vaso pressors as prescribed; m on itor vital sign s; an d m on itor urin e outp ut.

CRITICAL THINKING What Should You Do? Answer: Airborne droplet and contact precautions should be instituted for the child with mumps to prevent its transmis- sion. It is transmitted by direct contact or droplet spread from an infected person. Transmission-based precautions of this type indicate the use of a negative pressure room with at least 12 exchanges per hour. All health care personnel should wear an N95 respirator mask. Additional precautions include wearing gowns and gloves, and performing hand hygiene before and after client contact.

Reference: Hockenberry, Wilson (20 15), pp. 20 3, 214.

P R A C T I C E Q U E S T I O N S 453. An in fan t of a m oth er in fected with h um an im m u-

n odeficien cy virus (HIV) is seen in th e clin ic each m on th an d is bein g m on itored for sym pto m s in dicative of HIV in fectio n . With kn owled ge of th e m o st co m m on oppo rtun istic in fectio n of ch il- dren in fected with HIV, th e n urse assesses th e in fan t for wh ich sign ? 1. Cough 2. Liver failure 3. Watery stool 4. Nu ch al rigidity

454. Th e n urse provides h om e care in struction s to th e paren t of a ch ild with acq uired im m un od eficien cy syn drom e (AIDS). Wh ich statem en t by th e paren t in dicates th e n eed fo r fu rth er teach in g? 1. “I will wash m y h an ds frequen tly.” 2. “I will keep m y ch ild’s im m un ization s up

to date.”

3. “I will avoid direct un protected con tact with m y ch ild’s body fluids.”

4. “I can sen d m y ch ild to day care if h e h as a fever, as lon g as it is a low-grade fever.”

455. Th e clin ic n urse is in structin g th e paren t of a ch ild with h um an im m un od eficien cy virus (HIV) in fec- tio n regardin g im m un ization s. Th e n urse sh ould provide wh ich in struction to th e paren t? 1. Th e h epatitis B vaccin e will n ot be given to

th e ch ild. 2. Th e in activated in fluen za vaccin e will be given

yearly. 3. Th e varicella vaccin e will be given before

6 m on th s of age. 4. A Western blot test n eeds to be perform ed an d

th e results evalu ated befo re im m un ization s.

456. A h ealth care provider prescribes labo ratory studies for an in fan t of a wom an positive for h um an im m un od eficien cy virus (HIV). Th e n urse an tici- pates th at wh ich laborato ry study will be pre- scrib ed for th e in fan t? 1. Ch est x-ray 2. Western blot 3. CD4+ cell coun t 4. p24 an tigen assay

457. Th e m oth er with h um an im m un od eficien cy virus (HIV) in fectio n brin gs h er 10-m on th -old in fan t to th e clin ic for a routin e ch eckup . Th e h ealth care provider h as docum en ted th at th e in fan t is asym p- tom atic for HIV in fection . After th e ch eckup, th e m oth er tells th e n urse th at sh e is so pleased th at th e in fan t will n ot get HIV in fectio n . Th e n urse sh o uld m ake wh ich m o st ap p ro p riate respo n se to th e m oth er? 1. “I am so pleased also th at everyth in g h as turn ed

out fin e.” 2. “Because sym ptom s h ave n ot developed , it is

un likely th at yo ur in fan t will develop HIV in fectio n .”

3. “Everyth in g looks great, but be sure to return with your in fan t n ext m on th for th e sch eduled visit.”

4. “Mo st ch ildren in fected with HIV develop sym pto m s with in th e first 9 m on th s of life, an d som e becom e sym ptom atic som etim e befo re th ey are 3 years old.”

458. A 6-year-old ch ild with h um an im m un odeficien cy virus (HIV) in fection h as been adm itted to th e h os- pital for pain m an agem ent. Th e ch ild asks the n urse if the pain will ever go away. Th e n urse sh ould m ake which b est respon se to th e ch ild? 1. “Th e pain will go away if you lie still an d let th e

m ed icin e work.”

531CHAPTER 44 Infectious and Communicable Diseases

P

e

d

i

a

t

r

i

c

s

2. “Try n ot to th in k about it. Th e m ore you th in k it h urts, th e m ore it will h urt.”

3. “I kn ow it m ust h urt, but if you tell m e wh en it does, I will try to m ake it h urt a little less.”

4. “Every tim e it h urts, press on th e call butto n an d I will give you som eth in g to m ake th e pain go all away.”

459. Th e n urse is carin g for a 4-year-old ch ild with h um an im m un od eficien cy virus (HIV) in fectio n . Th e n urse sh ould expect wh ich statem en t th at is align ed with th e psych o social expectation s of th is age? 1. “Bein g sick is scary.” 2. “I kn ow it h urts to die.” 3. “I kn ow I will be h ealth y soon .” 4. “I kn ow I am differen t th an oth er kids.”

460. Th e h om e care n urse provides in struction s regard- in g basic in fectio n con trol to th e paren t of an in fan t with h um an im m un od eficien cy virus (HIV) in fectio n . Wh ich statem en t, if m ade by th e paren t, in dicates th e n eed fo r fu rth er in stru ctio n ? 1. “I will clean up an y spills from th e diaper with

diluted alcoh ol.” 2. “I will wash baby bottles, n ipp les, an d pacifiers

in th e dish wash er.” 3. “I will be sure to prepare food s th at are h igh in

calories an d h igh in protein .” 4. “I will be sure to wash m y h an ds carefully before

an d after carin g for m y in fan t.”

461. Wh ich h om e care in struction s sh ould th e n urse provide to th e paren t of a ch ild with acquired im m un odeficien cy syn d rom e (AIDS)? Select all th at ap p ly.

1. Mon itor th e ch ild’s weigh t. 2. Frequen t h an d wash in g is im portan t. 3. Th e ch ild sh ould avoid exp osure to oth er

illn esses. 4. Th e ch ild’s im m un ization sch edule will n eed

revisio n . 5. Clean up body fluid spills with bleach solu-

tion (10:1 ratio of water to bleach ). 6. Fever, m alaise, fatigue, weigh t loss, vom itin g,

an d diarrh ea are expected to occur an d do n ot require special in terven tion .

462. Th e n urse provides h om e care in struction s to th e paren ts of a ch ild h ospitalized with pertussis wh o is in th e con valescen t stage an d is bein g pre- pared for disch arge. Wh ich statem en t by a paren t in dicates a n eed fo r fu rth er in stru ctio n ? 1. “We n eed to en courage our ch ild to drin k

flu ids.” 2. “Cough in g spells m ay be triggered by dust

or sm oke.”

3. “Vom itin g m ay occur wh en our ch ild h as cough - in g episo des.”

4. “We n eed to m ain tain droplet precaution s an d a quiet en viron m en t for at least 2 weeks.”

463. An in fan t receives a diph th eria, tetan us, an d acellu lar pertussis (DTaP) im m un ization at a well-baby clin ic. Th e paren t return s h om e an d calls th e clin ic to report th at th e in fan t h as devel- oped swellin g an d redn ess at th e site of in jection . Wh ich in terven tion sh ould th e n urse suggest to th e paren t? 1. Mon itor th e in fan t for a fever. 2. Brin g th e in fan t back to th e clin ic. 3. Apply a h ot pack to th e in jection site. 4. Apply a cold pack to th e in jection site.

464. A ch ild is receivin g a series of th e h epatitis B vaccin e an d arrives at th e clin ic with h is paren t for th e sec- on d dose. Before adm in isterin g th e vaccin e, th e n urse sh ould ask th e ch ild an d paren t about a h is- tory of a severe allergy to wh ich substan ce? 1. Eggs 2. Pen icillin 3. Sulfon am ides 4. A previous dose of h epatitis B vaccin e or

com po n en t

465. A paren t brin gs h er 4-m on th -old in fan t to a well- baby clin ic for im m un ization s. Th e ch ild is up to date with th e im m un ization sch edule. Th e n urse sh ould prepare to adm in ister wh ich im m un iza- tion s to th is in fan t? 1. Varicella, h epatitis B vaccin e (Hep B) 2. Diph th eria, tetan us, acellular pertussis (DTaP);

m easles, m um ps, rubella (MMR); in activated poliovirus vaccin e (IPV)

3. MMR, Haemophilus influenzae type b (Hib), DTaP 4. DTaP, Hib, IPV, pn eum ococcal vaccin e (PCV),

rotavirus vaccin e (RV)

466. Th e clin ic n urse is assessin g a ch ild wh o is sch ed- uled to receive a live virus vaccin e (im m un ization ). Wh at are th e gen eral con train d ication s associated with receivin g a live virus vaccin e? Select all th at ap p ly.

1. Th e ch ild h as sym pto m s of a cold. 2. Th e ch ild h ad a previous an aph ylactic reac-

tion to th e vaccin e. 3. Th e m oth er reports th at th e ch ild is h avin g

in term itten t episo des of diarrh ea. 4. Th e m oth er reports th at th e ch ild h as n ot h ad

an appetite an d h as been fussy. 5. Th e ch ild h as a disorder th at cau sed a severely

deficien t im m un e system . 6. Th e m other reports th at the ch ild h as recen tly

been exposed to an in fectious disease.

532 UNIT VII Pediatric Nursing

A N S W E R S 453. 1 Ra t ion a le: Acqu ired im m u n o deficien cy syn drom e ( AIDS) is a diso rd er caused by HIV an d ch aracterized b y gen eralized dys- fu n ctio n of th e im m u n e system . Th e m ost com m on op po rtu - n istic in fectio n of ch ild ren in fected with HIV is Pneumocystis jiroveci p n eu m on ia, wh ich o ccu rs m ost frequ en tly between th e ages of 3 an d 6 m on th s, wh en HIV status m ay b e in d eter- m in ate. Co ugh is a co m m o n sign of th is op p ortun istic in fec- tion . Cyto m egalovirus in fection is also ch aracteristic of HIV in fection ; h owever, it is n o t th e m ost com m on op po rtu n istic in fection . Liver failure is a com m on sign of th is co m p lication . Alth o ugh gastro in testin al distu rb an ces an d n eu rolo gical ab n o rm alities m ay occu r in a ch ild with HIV in fectio n , o ptio n s 3 an d 4 are n ot specific opportun istic in fection s n oted in th e HIV-in fected ch ild . Watery stoo l is n o ted with gastro en teritis an d n u ch al rigid ity is seen in m en in gitis. Test -Ta kin g St r a t egy: No te th e strategic wo rd , most. Th is will direct yo u to th e correct o p tion . Rem em b er th at th e m ost co m - m o n o pp ortun istic in fection o f ch ild ren in fected with HIV is P. jiroveci pn eum o n ia, an d th at cou gh is a com m on sign with th is co m p lication . Review: Co m p lication s associated with h u m an im m u n o d efi- cien cy viru s ( HIV) in an in fan t or ch ild Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Pediatrics—Im m u n e Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ce: Ho cken berry, Wilson (2015), p p. 1368-1369.

454. 4 Ra t ion a le: AIDS is a d iso rd er cau sed b y h um an im m un od efi- cien cy viru s (HIV) an d ch aracterized by gen eralized dysfu n c- tion o f th e im m un e system . A ch ild with AIDS wh o is sick o r h as a fever sh ou ld b e kept h o m e an d n o t b ro ugh t to a d ay care cen ter. O p tion s 1, 2, an d 3 are co rrect statem en ts an d wo uld b e actio n s a caregiver sh ou ld take wh en th e ch ild h as AIDS. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further teaching. Th ese wo rds in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in co rrect statem en t. Notin g th e wo rd fever in th e correct option will d irect you to th is op tion . Review: Teach in g po in ts an d h o m e care in structio n s for th e ch ild with acq u ired im m u n o d eficien cy syn d ro m e ( AIDS) Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Im m u n e Pr ior ity Con cepts: Clien t Edu catio n ; Im m u n ity Refer en ce: Ho cken berry, Wilson (2015), p . 1372.

455. 2 Ra tion a le: Im m u n izatio n s again st com m on ch ildh oo d illn esses are reco m m en ded for all ch ildren exp osed to o r in fected with HIV. Th e in activated in fluenza vaccin e th at is given in tram uscu- larly will b e adm in istered (in fluen za vaccin e should be given yearly). Th e h ep atitis B vaccin e is adm in istered accordin g to th e recom m en ded im m un ization sch edule. Varicella-zoster virus vaccin e sho uld n ot b e given becau se it is a live viru s vaccin e;

varicella-zoster im m u n o glo bulin m ay b e p rescribed after ch ick- enp ox exposure. O ptio n 4 is un n ecessary an d in accurate. Test -Ta kin g St r a t egy: Focus on th e su b ject, im m u n ization s fo r th e ch ild with HIV. O p tio n 4 can b e elim in ated first becau se th e Western blot is a d iagn ostic test, n ot an evalu ative test. From th e rem ain in g o ptio n s, recallin g th at th e ch ild in fected with HIV is at risk for opportun istic in fection s an d th at live viru s vaccin es are n ot ad m in istered to an im m u n o deficien t ch ild will assist in d irectin g yo u to th e co rrect o p tion . Review: Im m u n izatio n s in th e im m u n o deficien t ch ild Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Im m un e Pr ior ity Con cepts: Clien t Ed u catio n ; Im m u n ity Refer en ce: Ho cken berry, Wilson (2015), p . 1371.

456. 4 Ra t ion a le: In fan ts b orn to HIV-in fected m oth ers n eed to b e screen ed fo r th e HIV an tigen . Th e d etectio n o f HIV in in fan ts is con firm ed by a p24 an tigen assay, viru s culture of HIV, o r p o lym erase ch ain reaction . A Western b lo t test co n firm s th e p resen ce of HIV an tibo dies. Th e CD4+ cell co u n t in dicates h ow well th e im m u n e system is wo rkin g. A ch est x-ray evalu - ates th e presen ce o f o th er m an ifestation s o f HIV in fectio n , such as p n eu m o n ia. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, laboratory study to determ in e th e p resen ce o f HIV an tigen , an d n o te th e word infant. Recall th e labo rato ry tests used to determ in e th e pres- en ce of HIV in fectio n in th e in fan t to an swer th is q uestion . Review: En zym e-lin ked im m u n o so rb en t assay, Western b lo t, CD4 + cell co u n t, an d p 24 an tigen assay Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Pediatrics—Im m un e Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ce: Lo wd erm ilk et al. (2016), p . 863.

457. 4 Ra t ion a le: Acqu ired im m u n o deficien cy syn d ro m e (AIDS) is caused b y HIV in fection an d ch aracterized by gen eralized dys- fu n ctio n of th e im m un e system . Mo st ch ild ren in fected with HIV d evelo p sym pto m s with in th e first 9 m on th s of life. Th e rem ain in g in fected ch ildren beco m e sym p tom atic som etim e b efo re age 3 years. With th eir im m atu re im m u n e system s, ch il- d ren h ave a m uch sh o rter in cub ation perio d th an adu lts. O p tion s 1, 2, an d 3 are in co rrect. Add itio n ally, th ese o ptio n s o ffer false reassu ran ce. Test-Ta kin g Str a tegy: Note th e strategic word s, most appropriate. Elim in ate o ptio n s 1, 2, and 3 because th ey are co m p arab le o r alike in con tent. Th e correct o ptio n is th e on ly o ne th at p rovid es specific an d accurate d ata regardin g HIV in fectio n in an in fan t. Review: Assessm en t fin d in gs asso ciated with h u m an im m u n o - d eficien cy viru s ( HIV) in an in fan t Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Pediatrics—Im m un e Pr ior ity Con cepts: Clien t Ed u catio n ; Im m u n ity Refer en ce: Ho cken berry, Wilson (2015), p p. 1369-1370.

P

e

d

i

a

t

r

i

c

s

533CHAPTER 44 Infectious and Communicable Diseases

458. 3 Ra tion a le: Th e m ultiple co m plicatio n s associated with HIV are acco m p an ied b y a h igh level o f p ain . Aggressive p ain m an age- m en t is essen tial fo r th e ch ild to h ave an accep table q u ality of life. Th e n urse m ust ackn owled ge th e ch ild’s p ain an d let th e ch ild kn o w th at everyth in g will b e d o n e to d ecrease th e p ain . Tellin g th e ch ild th at m ovem en t o r lack th ereof wou ld elim i- n ate th e p ain is in accu rate. Allowin g a ch ild to th in k th at h e o r sh e can con tro l th e p ain sim ply b y th in kin g or n ot th in kin g ab ou t it o versim p lifies th e p ain cycle asso ciated with HIV. Givin g false h o pe by tellin g th e ch ild th at th e pain will be taken “all away” is n eith er truth fu l n o r realistic. Test-Ta kin g St r a t egy: Note th e strategic wo rd , best. Recall th e gen eral con cep t of pain an d gro wth an d d evelo pm en t con cep ts o f a 6-year-o ld ch ild. Givin g th e ch ild in form ation ab o ut th e p ain in wo rd s th at h e o r sh e can u n d erstan d, bu t with o ut p ro - vid in g false h o pe o r n o t tellin g th e truth , sh o u ld gu id e yo u to th e co rrect o p tion . O p tion s 1 an d 2 provid e in accurate in fo r- m ation abo ut p ain m an agem en t. O ptio n 4 p ro vides false h o pe th at th e pain can b e alleviated co m p letely. Review: Con cep ts asso ciated with p ain m an agem en t in a ch ild Level of Cogn it ive Abilit y: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Im m un e Pr ior it y Con cept s: Im m u n ity; Pain Refer en ce: Hocken b erry, Wilso n (2015), p. 1372.

459. 2 Ra tion a le: A presch oo l-age ch ild begin s to con ceptu alize th e d eath p ro cess as in volvin g p h ysical h arm . An ad olescen t exp resses fear, with drawal, an d d en ial, n oted in op tio n 1. A ch ild from birth to 2 years o f age is un ab le to grasp th e con - cept of illn ess an d d eath , wh ich is reflected in th e statem en t in o ptio n 3. A sch o ol-age ch ild begin s to u n derstan d th at so m e- th in g is wro n g, wh ich is n o ted in op tion 4. Test-Ta kin g St r a t egy: Focus o n th e su b ject, a p resch o oler, an d u se con cep ts of gro wth an d develop m en t an d related psych o - so cial issu es to an swer th e q uestion . No tin g th e age o f th e ch ild will assist in d irectin g you to th e correct option . Review: Gro wth an d d evelo p m en t Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Develop m en tal Stages—In fan cy to Ad olescen ce Pr ior it y Con cept s: Develo p m en t; Im m u n ity Refer en ce: Hocken b erry, Wilso n (2015), pp . 1371-1372

460. 1 Ra tion a le: HIV is transm itted through blood, sem en, vaginal secretions, and breast m ilk. The m other of an infant with HIV should be instructed to use a bleach solution for disinfecting contam inated objects or cleaning up spills from the child’s diaper. Alcohol would not be effective in destroying the virus. Options 2, 3, and 4 are accurate instructions related to basic infection control. Test-Ta kin g Str a t egy: Note th e strategic word s, need for further instruction. Th ese words in dicate a n egative even t q uery an d ask you to select an option th at is an in co rrect statem en t. Recall- in g b asic in fection con trol m easures and th e m easures to p reven t th e spread o f HIV will d irect you to th e correct option .

Review: Hom e care m easu res to preven t th e tran sm ission of h u m an im m u n o d eficien cy viru s ( HIV) Level of Cogn itive Ability: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Pediatrics—In fectiou s an d Co m m u n icab le Diseases Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: Hocken b erry, Wilso n (2015), p. 1372.

461. 1, 2, 3, 5 Ra tion a le: AIDS is a d isord er caused b y h um an im m un od efi- cien cy virus ( HIV) in fectio n an d is characterized b y a gen eralized d ysfu nction o f th e im m u n e system . Hom e care in structio ns in clud e th e followin g: frequ en t h an d wash in g; m o n itorin g for fever, m alaise, fatigue, weigh t loss, vom itin g, and d iarrh ea and n otifyin g th e h ealth care pro vider if th ese o ccur; m o n itorin g fo r sign s an d sym p tom s of o pportu n istic in fection s; adm in ister- in g an tiretroviral m edicatio n s an d oth er m edication s as p re- scribed; avo id in g exposure to o th er illn esses; keep in g im m u nization s u p to d ate; m on itorin g weigh t an d p ro vid in g a h igh-calorie, h igh-protein diet; washing eating uten sils in th e d ishwash er; an d avoidin g sharin g eatin g u ten sils. Gloves are worn for care, especially wh en in co n tact with b od y flu id s and ch an gin g d iapers; d iapers are chan ged frequ en tly an d away from food areas, an d soiled d isposable d iapers are folded in ward, clo sed with th e tab s, an d dispo sed of in a tightly covered p lastic-lin ed con tain er. An y b od y flu id spills are clean ed with a b leach solution (10:1 ratio of water to b leach). Test-Ta kin g Str a tegy: Fo cus on th e su b ject, care o f th e ch ild with AIDS. Recallin g th at AIDS is ch aracterized b y a gen eral- ized dysfu n ction o f th e im m u n e system an d recallin g th e m od es of tran sm issio n o f th e viru s will assist in selectin g th e correct h o m e care in stru ctio n s. Review: Hom e care in stru ction s th at will preven t th e tran sm is- sio n o f acq u ired im m u n o d eficien cy syn d ro m e ( AIDS) Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Pediatrics—In fectiou s an d Co m m u n icab le Diseases Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: Hocken b erry, Wilso n (2015), pp . 194, 902-903.

462. 4 Ra tion a le: Pertu ssis is tran sm itted by d irect co n tact or resp ira- to ry drop lets from co ugh in g. Th e co m m un icab le p eriod o ccu rs p rim arily d urin g th e catarrh al stage. Respiratory p recautio n s are n ot req u ired du rin g th e co n valescen t ph ase. O ptio n s 1, 2, an d 3 are accu rate com po n en ts o f h om e care in stru ction s. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an op tio n th at is an in correct statem en t. Also , n o te th e word convalescent in th e qu estio n . O ptio n s 1 an d 3 can b e elim in ated because th ey are gen erally associated with con - valescen ce. Kn o win g th at 2 weeks o f respirato ry p recautio n s is n o t req uired du rin g th e con valescen t p eriod will d irect you to th is op tion . Review: Ho m e care in structio n s for th e clien t with p ertu ssis Level of Cogn itive Ability: Evalu atin g

P

e

d

i

a

t

r

i

c

s

534 UNIT VII Pediatric Nursing

Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ped iatrics—In fectio us an d Co m m u n icable Diseases Pr ior ity Con cepts: Clien t Edu catio n ; In fection Refer en ce: Ho cken berry, Wilson (2015), p . 216.

463. 4 Ra tion a le: O n o ccasion , ten dern ess, red ness, or swellin g m ay occur at th e site o f th e DTaP in jection . Th is can be relieved with cold p acks for th e first 24 h ours, follo wed by warm or cold com p resses if the in flam m ation p ersists. Brin gin g th e in fant back to th e clin ic is un n ecessary. O ption 1 m ay b e an app ro pri- ate in terven tion , but is n ot specific to th e subject o f th e question , a localized reaction at th e in jection site. Hot packs are n ot app lied and can be h arm ful b y cau sin g burn in g of th e skin . Test -Ta kin g Str a tegy: Focu s o n th e su b ject, a localized reaction at th e in jectio n site. O ption 1 can b e elim in ated first b ecau se it does n ot relate specifically to th e sub ject of th e q uestion . Elim - in ate option 2 n ext as an u nn ecessary in terven tion . Fro m th e rem ain in g option s, gen eral p rin ciples related to the effects o f h eat an d cold will direct you to th e correct o ptio n . Also n otin g th e word hot in o ptio n 3 will assist in elim in atin g this option . Review: Follow-up care after im m u n izatio n Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ped iatrics—In fectio us an d Co m m u n icable Diseases Pr ior ity Con cepts: Clien t Edu catio n ; Health Pro m otio n Refer en ces: Cen ters fo r Disease Co n trol an d Preven tio n (CDC) , h ttp :/ / www.cdc.gov/ vaccin es/ sch ed ules/ in dex.h tm l; Ho cken b erry, Wilso n (2015), p p . 195-196; 207-208.

464. 4 Ra t ion a le: A co n train dicatio n to receivin g th e h ep atitis B vac- cin e is a previo us an aph ylactic reaction to a p reviou s d ose o f h ep atitis B vaccin e or to a com po n en t (alu m in u m h yd ro xid e or yeast protein ) of th e vaccin e. An allergy to eggs, pen icillin , an d su lfon am id es is u n related to th e con train d ication to receivin g th is vaccin e. Test -Ta kin g Str a tegy: Focus on th e su bject, a con train dication to receivin g th e h epatitis B vaccin e. Note th e relation sh ip of th e words hepatitis B vaccine in th e question an d th e correct option . Review: Hep atitis B vaccin e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ped iatrics—In fectio us an d Co m m u n icable Diseases Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Cen ters fo r Disease Co n trol an d Preven tio n (CDC) , h ttp :/ / www.cdc.gov/ vaccin es/ sch ed ules/ in d ex.h tm l; Ho cken b erry, Wilso n (2015), p . 206.

465. 4 Ra t ion a le: DTaP, Hib , IPV, PCV, an d RV are ad m in istered at 4 m o n th s o f age. DTaP is ad m in istered at 2, 4, an d 6 m o n th s

o f age; at 15 to 18 m on th s o f age; an d at 4 to 6 years of age. Hib is adm in istered at 2, 4, an d 6 m o n th s o f age an d at 12 to 15 m o n th s o f age. IPV is adm in istered at 2, 4, an d 6 m on th s o f age an d at 4 to 6 years o f age. PCV is ad m in istered at 2, 4, an d 6 m o n th s o f age an d at 12 to 15 m on th s o f age. Th e first d o se of MMR vaccin e is ad m in istered at 12 to 15 m on th s o f age; th e seco n d d ose is ad m in istered at 4 to 6 years o f age (if th e seco n d do se was n ot given b y 4 to 6 years o f age, it sh ou ld b e given at th e n ext visit). Th e first do se o f Hep B is ad m in istered at birth , th e seco n d d o se is adm in istered at 1 m o n th o f age, an d th e th ird do se is ad m in istered at 6 m on th s o f age. Varicella-zo ster vaccin e is ad m in istered at 12 to 15 m on th s o f age an d again at 4 to 6 years of age. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject, im m un izatio n sch edu le fo r a 4-m o n th -o ld in fan t, an d u se kn o wledge regard - in g th e im m un izatio n sch edu le to an swer th is q uestion . Not- in g th e age o f th e in fan t will assist in directin g yo u to th e co rrect o ption . Review: Im m u n izatio n sch ed u le for in fan ts, ch ildren , an d ad olescen ts Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ped iatrics—In fectio us an d Com m un icab le Diseases Pr ior ity Con cepts: Develop m en t; Health Prom o tion Refer en ces: Cen ters for Disease Co n tro l an d Preven tio n (CDC), h ttp :/ / www.cdc.gov/ vaccin es/ sch ed ules/ in d ex.h tm l; Ho cken b erry, Wilso n (2015) , p p. 195-196.

466. 2, 5 Ra t ion a le: Th e gen eral co n train d ication s for receivin g live viru s vaccin es in clud e a p reviou s an aph ylactic reactio n to a vac- cin e or a com p on en t of a vaccin e. In ad d ition , live viru s vac- cin es gen erally are n o t ad m in istered to in divid u als with a severely d eficien t im m u n e system , in d ividu als with a severe sen sitivity to gelatin , o r pregn an t wo m en . A vaccin e is ad m in - istered with cau tion to an in dividu al with a m o derate or severe acute illn ess, with or with o ut fever. O ption s 1, 3, 4, an d 6 are n ot con train d ication s to receivin g a vaccin e. Test -Ta kin g Str a tegy: Focu s on th e su b ject, con train d ication s fo r a live virus vaccin e. Th is in dicates th at you n eed to select th e situatio n s in wh ich a live viru s vaccin e can n o t be given becau se d o in g so can cause h arm to th e ch ild. No tin g th e wo rd anaphy- lactic in o ptio n 2 an d th e words severely deficient in o p tion 5 will d irect you to th ese op tio n s. Review: Co n train dicatio n s to receivin g a live viru s vaccin e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ped iatrics—In fectio us an d Com m un icab le Diseases Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Burch um , Rosen th al (2016), p. 817; Cen ters for Disease Con trol an d Preven tio n (CDC), h ttp://www. cdc.gov/ vaccin es/ sch ed ules/ in dex.h tm l; Hocken berry, Wilson (2015), p p. 207-208.

P

e

d

i

a

t

r

i

c

s

535CHAPTER 44 Infectious and Communicable Diseases

P

e

d

i

a

t

r

i

c

s

C H A P T E R 45 Pediatric Medication Administration and Calculations

PRIORITY CONCEPTS Development; Safety

CRITICAL THINKING What Should You Do? The nurse is preparing to administer a medication that has an unpleasant taste to an infant. What should the nurse do to minimize this unpleasant effect? Answer located on p. 540.

I. Oral Medications A. Most oral ped iatric m edication s are in liqu id or sus-

pen sion form because ch ildren usually are un able to swallow a tablet.

B. Solution s m ay be m easu red by usin g an oral plastic syrin ge or oth er acceptable m easu rem en t or ad m in - istration device; th e device used dep en ds on th e developmental age of th e ch ild ( Fig. 45-1).

C. Medication s in susp en sion settle to th e botto m of th e bottle between uses, an d th orough m ixin g is required before pourin g th e m edication .

D. Susp en sion s m ust be adm in istered im m ediately after m easu rem en t to preven t settlin g an d resultan t adm in istration of an in com plete dose.

E. Adm in ister oral m edication s with a ch ild sittin g in an uprigh t position an d with th e h ead elevated to preven t aspiration if th e ch ild cries or resists.

F. Place a sm all ch ild sideways on the lap; th e ch ild’s clos- est arm sh ould be placed un der the adult’s arm an d beh in d th e adult’s back; cradle the ch ild’s h ead, h old th e ch ild’s h an d, an d adm in ister th e m edication slowly with a plastic spoon, sm all plastic cup, or syrin ge.

G. If a tablet or cap sule h as been adm in istered, ch eck th e ch ild’s m ou th to en sure th at it h as been swallowed; if swallowin g is a problem , som e tablets can be crush ed an d given in sm all am oun ts of puréed food or fla- vored syrup (en teric-coated tab lets, tim ed-release tablets, an d capsules sh ould n ot be crush ed) .

H. Follow gen erally accepted m edication adm in istra- tion gu idelin es for ch ildren (Box 45-1).

Newborns and infants have an immature liver and immature kidneys; therefore, metabolism and elimina- tion of medications is delayed.

II. Parenteral Medications A. Subcu tan eously an d in tram uscularly adm in istered

m edication s 1. Medication s m ost often given via th e subcutan e-

ous route are in sulin an d som e im m un ization s. 2. An y site with sufficien t subcu tan eous tissue m ay

be used for subcu tan eous in jection s; com m on sites in clude th e cen tral th ird of th e lateral aspect of th e upper arm , th e abdom en , an d th e cen tral th ird of th e an terior th igh .

3. Th e safe use of in jection sites is based on n orm al m uscle develo pm en t an d th e size of th e ch ild; th e preferred site for in tram uscu lar in jection s in in fan ts is th e vastu s lateralis, but agen cy poli- cies an d proced ures n eed to be followed (Table 45-1 an d Fig. 45-2).

4. Th e usual n eedle len gth an d gauge for pediatric clien ts are ½ to 1 in ch (1.25 to 2.5 cm ) an d 22 to 25 gauge; n eedle len gth also can be estim ated by graspin g th e m uscle between th e th u m b an d forefin ger—h alf th e resultin g distan ce would be th e n eedle len gth .

5. Pediatric dosages for subcutan eous an d in tram us- cular adm in istration are calculated to th e n earest h un dredth an d m easured by usin g a tuberculin syrin ge; always follow agen cy guidelin es.

6. Place a plain or deco rated adh esive ban d age over th e pun cture site to h elp th e ch ild view th e expe- rien ce in a pleasan t way.

B. In traven ou sly ad m in istered m edication s 1. In traven ou s (IV) m edication s are diluted for

adm in istration . 2. Wh en an in fan t or ch ild is receivin g an IV m ed-

ication , th e IV site n eeds to be assessed for sign s of in flam m ation an d in filtration or extravasatio n536

P

e

d

i

a

t

r

i

c

s

im m ediately before, durin g, an d after co m ple- tion of each m edication .

3. IV m ed ication s m ay be prescribed in a m an n er th at requires a con tin uo us in fusion th rough a prim ary in fusion lin e.

4. IV m edication s m ay be adm in istered in term it- ten tly; several doses m ay be adm in istered in a 24-h o ur period.

5. Medication s for IV adm in istration are diluted ac- cording to th e direction s accom pan yin g th e m edi- cation an d accordin g to the health care provider’s (HCP’s) prescription s an d agency procedures.

6. In fusion tim e for IV m edication s is determ in ed on th e basis of th e direction s acco m pan yin g th e m ed ication , th e HCP’s prescription , an d agen cy procedures.

7. Determ in e agen cy proced ures related to th e vol- um e of flush (n orm al salin e) for periph eral IV lin es an d for cen tral lin es.

8. Th e flu sh volum e (3 to 20 m L) m ust be in cluded in th e ch ild’s in take; th e flush is usually adm in - istered before adm in isterin g an IV m ed ication an d after th e IV m edication is co m pleted an d is in fused at th e sam e rate as th e m edication .

C. In term itten t IV m ed ication adm in istration 1. Ch ildren receivin g IV m ed ication s in term itten tly

m ay or m ay n ot h ave a prim ary IV solution in fusin g.

2. If a prim ary IV solution is in fusin g, th e m edica- tion m ay be ad m in istered by IV piggyback via a secon dary lin e.

3. If a prim ary IVsolution does n ot exist, an in dwell- in g in fusion cath eter is used for m edication adm in istration , an d th e m ed ication m ay be adm in istered by push or piggyback; m edication adm in istration in struction s m ust be ch ecked for dilution an d in fusion tim e proced ures.

4. All interm itten t m edication adm in istrations are preceded an d followed by a norm al saline flush to ensure th at th e m edication h as cleared th e IVtub- in g an d that th e total dose h as been adm inistered.

5. Electron ic devices such as co n trollers or pum ps are used to regulate an d adm in ister IV fluids an d in term itten t IV m ed ication s.

D. Special IV adm in istration sets 1. Special IV adm in istration sets, such as a burette,

m ay be used for m ed ication preparation an d adm in istration via piggyback.

2. Th ese special sets are all m icrodrip sets calibrated to deliver 60 drops (gtt)/ m L.

3. Th e total cap acity of th ese special IV ad m in istra- tion sets is 100 to 150 m L, calibrated in 1-m L in crem en ts so th at exact m easu rem en ts of sm all volu m es are possib le.

4. Th e m edication is m ixed with th e appropriate am oun t of diluen t, added to th e special IV adm in istration set, an d allowed to in fuse at th e prescribed rate.

5. Th e special IV ad m in istration set n eeds to be labeled clearly to iden tify th e m edication an d fluid dosage added .

6. Durin g m edication in fusion tim e, a label is attach ed that in dicates th at th e m edication is infusin g.

FIGURE 45-1 Acceptable devices for measuring and administering oral medication to children (clockwise from bottom left): Measuring spoon, plas- tic syringes, calibrated nipple, plastic medicine cup, calibrated dropper, hollow-handled medicine spoon. (From Hockenberry, Wilson, 2005.)

BOX 45-1 Medication Administration Guidelines for Children

Two identifiers are required before medication administration— such as name, medicalrecord number, and birth date. Bar code scanning systems are commonly used as an additional safe- guard to ensure that medications are given to the correct client.

Obtain information from parents about successful methods for administering medications to their children.

Ask parents about any known allergies. To avoid aspiration, liquid forms of medication are safer to

swallow than other forms. Straws often help older children to swallow pills. Avoid putting medications in foods such as milk, cereal, or baby

food because it may cause an unpleasant taste to the food, and the child may refuse to accept the same food in the future. In addition, the child maynot consume the entire serv- ing and would not receive the required medication dosage.

If the taste of the medication is unpleasant, it is acceptable to have the child pinch the nose and drink the medication through a straw.

Offer juice, a soft drink, or a frozen juice bar after the child swallows a medication.

Always read the pharmacological indications for administra- tion. Some items such as fruit syrups can be acidic and should not be used with medications that react negatively in an acid medium.

Record the most successful method of administering medica- tions and pertinent nursing prescriptions on the child’s care plan for other nursing staff to follow; this notation also saves the child frustration, fear, and anxiety.

Data from Potter P, Perry A, Stockert P, Hall A: Fundamentals of nursing, ed 8, St. Louis, 20 13, Mosby; and Perry S, Hockenberry M, Lowdermilk D, Wilson D: Mater- nal-child nursing care, ed 4, St. Louis, 2010 , Mosby.

537CHAPTER 45 Pediatric Medication Administration and Calculations

7. Durin g th e flush in fusion tim e, a label is attach ed in dicatin g th at th e flu sh is in fusin g.

E. Syrin ge pum p for IV m ed ication adm in istration 1. A syrin ge con tain in g th e m edication is fitted in to

a pum p th at is con n ected to th e IV tubin g th rou gh a Y con n ector.

2. Th e m edication is adm in istered over th e pre- scrib ed tim e.

The 24-hour fluid intake must be monitored closely, and all IVfluid amounts including the amount of flush vol- ume need to be documented accurately to prevent over- hydration. For children, the maximum amount of IV fluid administered in a 24-hour period varies and is usually based on body weight and other factors. Check the HCP’s prescription and agency guidelines for the procedures for the administration of IV fluids and medications.

III. Calculation of Medication Dosage by Body Weight A. Con version of body weigh t ( Box 45-2) B. Calculation of daily dosages

1. Abbreviation s (Box 45-3) 2. Dosages are expressed in term s of m illigram s per

kilogram per day, m illigram s per poun d per day, or m illigram s per kilogram per dose.

3. Th e total daily dosage usually is ad m in istered in divided (m ore th an 1) doses per day.

4. Express the ch ild’s body weigh t in kilogram s or poun ds to correlate with the dosage specification s.

5. Calculate th e total daily dosage.

6. Divide th e total daily dosage by th e n um ber of doses to be adm in istered in 1 day.

IV. Calculation of Body Surface Area (BSA) A. Th e BSA is determ in ed by com parin g body weigh t

an d h eigh t with averages or n orm s on a graph called a nomogram.

B. Not all ch ildren are th e sam e size at th e sam e age; th e n om ogram is used to determ in e th e BSA of a ch ild.

P

e

d

i

a

t

r

i

c

s

TABLE 45-1 Intramuscular Injections: Amount of Medication (mL) by Muscle Group Muscle Neonate Infant (1-12 mo old) Toddler (1-2 yr old) Preschool to Child (3-12 yr old) Adolescent (12-18 yr old)

Vastus lateralis 0.5 0.5-1 0.5-2 2 2

Rectus femoris Not safe Not safe 0.5-1 2 2

Ventrogluteal Not safe Not safe Not safe 0.5-3 2-3

Deltoid Not safe Not safe 0.5-1 0.5-1 1-1.5

Data from Kee J, Marshall S: Clinical calculations: with applications to general and specialty areas, ed 7, St. Louis, 20 13, Saunders.

GREATER TROCHANTER*

S cia tic ne rve

Re ctus fe moris

KNEE J OINT*

Fe mora l a rte ry

S ite o f inje c tio n (va s tus la te ra lis )

FIGURE 45-2 Intramuscular injection site—vastus lateralis. Landmarks are indicated by asterisks.

BOX 45-2 Conversion of Body Weight Measurements

1lb ¼ 16 oz

2:2 lb ¼ 1kg

Pounds to Kilograms

2:2 lb ¼ 1kg

When converting from pounds to kilograms, divide by 2.2. Kilograms are expressed to the nearest tenth.

Kilograms to Pounds

1kg ¼ 2:2 lb

When converting from kilograms to pounds, multiply by 2.2. Pounds are expressed to the nearest tenth.

BOX 45-3 Common Measurement Abbreviations Abbreviation Meaning BSA Body surface area g Gram(s) gr Grain(s) kg Kilogram(s) lb Pound(s) m2 Square meters mcg Microgram(s) mg Milligram(s) mL Milliliter(s) SA Surface area

538 UNIT VII Pediatric Nursing

C. Look at th e n om ogram ( Fig. 45-3), an d n ote th at th e h eigh t is on th e left-h an d side of th e ch art an d th e weigh t is on th e righ t-h an d side of th e ch art.

D. Place a ru ler across th e ch art. E. Lin e up th e left side of th e ruler on th e h eigh t an d th e

righ t side of th e ruler on th e weigh t; read th e BSA at th e poin t wh ere th e straigh t edge of th e ruler in ter- sects th e surface area (SA) colum n .

F. Th e estim ated SA is given in square m eters (m 2). G. Box 45-4 gives a sam ple practice question usin g th e

n om ogram .

V. Calculation Based on BSA A. Wh en dosage recom m endation s for children specify

m illigram s, m icrogram s, or un its per square m eter, cal- culatin g th e dosage is sim ple m ultiplication (Box 45-5).

B. Wh en dosage recom m en dation s are specified on ly for adults, a form ula is used to calculate a ch ild’s dos- age from th e adult dosage ( Box 45-6).

VI. Developmental Considerations for Administering Medications

A. Wh en adm in isterin g m edication s to ch ildren , devel- opmental age m ust be taken in to con sideration to en sure safe an d effective adm in istration .

B. Gen eral in terven tion s 1. Always be prepared for th e proced ure with all

n ecessary equipm en t an d assistan ce.

P

e

d

i

a

t

r

i

c

s

No mo g ram

S A m 2

2.0 1.9 1.8 1.7 1.6 1.5 1.4 1.3 1.2 1.1 1.0 0.9

0.8

0.7

0.6

0.5

0.4

0.3

0.2

0.1

We ight lb kg

180 160 140 130 120 110 100

90 80 70 60

50 45 40 35 30

25

20 18 16 14

12

10 9 8 7 6

5

4

3

80 70 60

50

40

30

25

20

10 9.0 8.0 7.0 6.0

5.0

4.0

3.0

2.0

2.5

1.5

1.0

15

For childre n of norma l he ight

for we ight

W

e

i

g

h

t

(

l

b

)

S

u

r

f

a

c

e

a

r

e

a

(

s

q

u

a

r

e

m

e

t

e

r

s

)

90 80 70

60

50

40

30

20

10

15

9 8 7

6

5

4

3

2 0.10

0.15

0.20

0.30

0.25

0.35

0.45

0.55 0.50

0.60

0.80

0.90

1.00 1.10

1.30 1.20

0.70

0.40

He ight

240 90 85 80 75

65

55

45

35

70

60

50

40

30 28 26 24

22

20 19 18 17 16 15 14 13

12

220

200 190 180 170 160 150 140 130 120

110

100

90

80

70

60

50

40

30

cm in

FIGURE 45-3 West nomogram for estimation of surface areas in infants and children. First, find height; next, find weight; finally, draw a straight line connecting the height and weight. The body surface area (in square meters [m2]) is indicated where a straight line connecting the height and weight intersects the surface area (SA) column or, if the child is approx- imately of normal proportion, from weight alone (darker blue area).

BOX 45-4 How to Use the Nomogram Exa mple: Use the nomogram (see Fig. 45-3) and calculate the body surface area (BSA) for a child whose height is 58 inches (147 cm) and weight is 12 kg.

1. Look at the nomogram chart and note that the height is on the left-hand side of the chart and the weight is on the right- hand side.

2. Place a ruler on the chart and line up the left side of the ruler on the height and the right side of the ruler on the weight; read the BSA at the point where the straight edge of the ruler intersects the surface area (SA) column.

3. The estimated SA is given in square meters.

Answer: 0 :66 m2

BOX 45-5 Calculating Medication Dosage When dosage recommendations for children specify milli- grams, micrograms, or units per square meter, calculating the dosage is simple multiplication.

Exa mple: The dosage recommendation is 4 mg/ m 2. The child has a body surface area of 1.1 m2. What is the dosage to be administered?

Answer: 1:1Â 4 mg ¼ 4:4 mg

BOX 45-6 Calculating a Child’s Dosage from the Adult Dosage

When dosages are specified only for adults, a formula is used to calculate a child’s dosage from the adult dosage. The adult dosage is based on a standardized body surface area (BSA) of 1.73 m 2.

Exa mple: A health care provider has prescribed an antibi- otic for a child. The average adult dose is 250 mg. The child has a BSA of 0.41 m2. What is the dose for the child?

Answer: 59.24 mg Formula :

BSAof a child m2ð Þ 1:73m2

 Adult dose ¼ Child’s dose

0 :41 1:73

 250 mg ¼ 59:24 mg

539CHAPTER 45 Pediatric Medication Administration and Calculations

P

e

d

i

a

t

r

i

c

s

2. For a h ospitalized ch ild, ask th e paren t or ch ild or both if th e paren t sh ould or sh ould n ot rem ain for th e proced ure.

3. Determ in e appropriate preadm in istration an d postad m in istration com fo rt m easu res.

4. Try to m ake th e even t as pleasan t as possible. C. Box 45-7 lists developm en tal con sideration s wh en

givin g m edication s.

CRITICAL THINKING What Should You Do? Answer: When administering a medication with an unpleasant taste to an infant, the nurse should draw the required dose into a syringe used for oral medication admin- istration and place the syringe into the side and toward the back of the infant’s mouth; the medication should be admin- istered slowly, allowing the infant to swallow.

Reference: Hockenberry, Wilson (20 15), pp. 915-916.

P R A C T I C E Q U E S T I O N S 467. Th e n urse is providin g m edication in struction s to a

paren t. Wh ich statem en t by th e paren t in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I sh ould cu ddle m y ch ild after givin g th e

m ed ication .” 2. “I can give m y ch ild a frozen juice bar after h e

swallows th e m ed ication .” 3. “I sh ould m ix th e m edication in th e baby food

an d give it wh en I feed m y ch ild.” 4. “If m y ch ild does n ot like th e taste of th e m ed-

icin e, I sh ould en courage h im to pin ch h is n ose an d drin k th e m edication th rou gh a straw.”

468. A h ealth care provider’s prescription reads “am pi- cillin sodium 125 m g IV every 6 h ou rs.” Th e m ed- ication label reads “wh en recon stituted with 7.4 m L of bacteriostatic water, th e fin al con cen tra- tion is 1 g/ 7.4 m L.” Th e n urse prepares to draw up h ow m an y m illiliters to adm in ister 1 dose? 1. 1.1 m L 2. 0.54 m L 3. 7.425 m L 4. 0.925 m L

469. A ped iatric clien t with ven tricular sep tal defect repair is placed on a m ain ten an ce dosage of digo xin . Th e dosage is 8 m cg/ kg/ day, an d th e clien t’s weigh t is 7.2 kg. Th e h ealth care provider (HCP) prescribes th e digoxin to be given twice daily. Th e n urse pre- pares h ow m an y m cg of digoxin to ad m in ister to th e clien t at each dose? 1. 12.6 m cg 2. 21.4 m cg 3. 28.8 m cg 4. 32.2 m cg

470. Sulfisoxazole, 1 g orally twice daily, is prescribed for an adolescen t with a urin ary tract in fectio n . Th e m edication label reads “500-m g tablets.” Th e n urse h as determ in ed th at th e dosage prescribed is safe. Th e n urse adm in isters h ow m an y tablets per dose to th e ad olescen t?

BOX 45-7 Developmental Considerations for Administering Medications

Infants Perform procedure quickly, allowing the infant to swallow;

then offer comfort measures, such as holding, rocking, and cuddling.

Allow self-comforting measures, such as the use of a pacifier.

Toddlers Offer a brief, concrete explanation of the procedure and then

perform it. Accept aggressive behavior, within reasonable limits, as a

healthy response, and provide outlets for the toddler. Provide comfort measures immediately after the procedure,

such as touch, holding, cuddling, and providing a favorite toy.

Preschoolers Offer a brief, concrete explanation of the procedure and then

perform it. Accept aggressive behavior, within reasonable limits, as a

healthy response, and provide outlets for the child. Provide comfort measures after the procedure, such as touch,

holding, or providing a favorite toy.

School-Age Children Explain the procedure, allowing for some control over the body

and situation. Explore feelings and concepts through therapeutic play, draw-

ings of own body and self in the hospital, and the use of books and realistic hospital equipment.

Set appropriate behavior limits, such as it is all right to cry or scream, but not to bite.

Provide activities for releasing aggression and anger. Use the opportunity to teach about how medication helps the

disorder.

Adolescents Explain the procedure, allowing for some control over body

and situation. Explore concepts of self, hospitalization, and illness, and cor-

rect any misconceptions. Encourage self-expression, individuality, and self-care needs. Encourage participation in the procedure.

Data from McKenry L, Salerno E: Mosby’s pharmacology in nursing, St. Louis, 200 3, Mosby.

540 UNIT VII Pediatric Nursing

1. ½ tab let 2. 1 tablet 3. 2 tablets 4. 3 tablets

471. Pen icillin G procain e, 1,000,000 un its IM (in tra- m uscularly), is prescribed for a ch ild with an in fec- tion . Th e m ed ication label reads “1,200,000 un its per 2 m L.” Th e n urse h as determ in ed th at th e dose prescribed is safe. Th e n urse adm in isters h ow m an y m illiliters per dose to th e ch ild? 1. 0.8 m L 2. 1.2 m L 3. 1.4 m L 4. 1.7 m L

472. Th e n urse prepares to adm in ister an in tram uscular in jection to a 4-m on th -old in fan t. Th e n urse selects wh ich b est site to adm in ister th e in jection ? 1. Ven troglu teal

2. Lateral deltoid 3. Rectus fem o ris 4. Vastus lateralis

473. Atropin e sulfate, 0.6 m g in tram uscularly, is pre- scrib ed for a ch ild preop eratively. Th e n urse h as determ in ed th at th e dose prescribed is safe an d pre- pares to adm in ister h ow m an y m illiliters to th e ch ild? Fill in th e b lan k ( refer to figu re) .

An swer: ________ m L

A N S W E R S 467. 3 Ra t ion a le: Th e n u rse wou ld teach th e p aren t to avoid pu ttin g m ed ication s in fo od s b ecau se it m ay give an un p leasan t taste to th e fo od , an d th e ch ild m ay refu se to accep t th e sam e fo od in th e futu re. In ad dition , th e ch ild m ay n o t co n su m e th e en tire servin g an d wo u ld n o t receive th e req uired m edicatio n d osage. Th e m oth er sh o u ld p ro vide com fort m easu res im m ed iately after m ed icatio n adm in istratio n , su ch as tou ch in g, h oldin g, cu dd lin g, an d provid in g a favorite to y. Th e m o th er sh o uld offer juice, a so ft drin k, or a fro zen juice b ar to th e ch ild after th e ch ild swallo ws th e m edicatio n . If th e taste of th e m ed ica- tion is u n p leasan t, th e ch ild sh ou ld pin ch th e n o se an d drin k th e m edicatio n th ro ugh a straw. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for fur- ther instruction. Th ese words in d icate a n egative even t q u ery an d th e n eed to select th e in correct statem en t m ad e by th e m o th er. Read each statem en t carefully an d th in k abo ut th e statem en t th at m ay b e u n safe an d m ay n o t p ro vide an accu rate d o se to th e ch ild . Th is will d irect yo u to th e co rrect o p tion . Review: Med icatio n ad m in istratio n gu id elin es for ch ildren Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun dam en tals of Care—Med ication s/ IV Calcu latio n s Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Ho cken berry, Wilson (2015), p p. 915-916.

468. 4 Ra t ion a le: Con vert 1 g to m illigram s. In th e m etric system , to co n vert larger to sm aller, m ultiply by 1000 or m o ve th e d eci- m al po in t 3 places to th e righ t:

1 g ¼ 1000 m g

For mu la :

Desired Available

 Volume¼ 125 mg 1000 mg

 7:4 mL¼ 0:925 mLper dose

Test -Ta kin g St r a t egy: Focus on th e su b ject, m illiliters per d o se. Con vert gram s to m illigram s first. Next, u se th e fo rm u la to determ in e th e co rrect d ose, kn o win g th at wh en recon sti- tu ted , 1000 m g¼7.4 m L. Verify th e an swer u sin g a calculato r. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med icatio n s/ IV Calcu latio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry et al. (2014), p . 480.

469. 3 Ra t ion a le: Calculate th e d aily d osage b y weigh t first:

8 m cg=d ay  7:2 kg ¼ 57:6 m cg=day

Th e HCP p rescribes d igoxin twice d aily; 2 do ses in 24 h ou rs will be adm in istered:

57:6 mcg=day 2 doses

¼ 28:8 mcg for each dose

Test -Ta kin g St r a t egy: Focus on th e su b ject, m g per do se, an d n ote th at th e q uestion states twice daily an d each dose. Calcu late th e d osage per day b y weigh t first, an d th en d eterm in e th e m icro gram s p er each d ose by divid in g th e to tal daily do se by 2. Verify th e an swer usin g a calcu lator. Review: Med icatio n calcu latio n s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Med icatio n s/ IV Calcu latio n s

P

e

d

i

a

t

r

i

c

s

541CHAPTER 45 Pediatric Medication Administration and Calculations

Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Hocken b erry, Wilso n (2015), p. 914.

470. 3 Ra tion a le: Ch an ge 1 g to m illigram s, kn owin g th at 1000 m g¼1 g. Also, wh en con vertin g from gram s to m illigram s (larger to sm aller), m o ve th e d ecim al p oin t 3 places to th e righ t:

1 g ¼ 1000 m g

Next, u se th e fo rm ula to calcu late th e co rrect d o se. For mu la :

Desired Available

 Tablet ¼ 1000 mg 500 mg

 Tablet ¼ 2 tablets

Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, tab lets per dose. Co n vert gram s to m illigram s first. Next, u se th e fo rm u la to d eter- m in e th e co rrect d o se an d verify th e an swer usin g a calculato r. Review: Med icatio n calcu latio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), p. 487.

471. 4 Ra tion a le: Use th e m ed icatio n calcu lation fo rm u la. For mu la :

Desired Available

 Volume¼ 1, 000, 000 1, 200, 000

 2 mL¼ 1:7 mLper dose

Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, m illiliters p er d ose. Use th e fo rm u la to determ in e th e co rrect do se, an d verify th e an swer u sin g a calcu lato r. Review: Med icatio n calcu latio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals of Care—Med ication s/ IV Calcu- latio n s

Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), p. 487.

472. 4 Ra tion a le: In tram uscular in jection sites are selected on th e b asis o f th e ch ild ’s age an d m u scle develop m en t o f th e ch ild . Th e vastu s lateralis is th e o n ly safe m u scle grou p to u se for in tra- m uscular in jection in a 4-m o n th -o ld in fan t. Th e sites iden tified in o ptio n s 1, 2, an d 3 are un safe fo r a ch ild of th is age. Test-Ta kin g St r a t egy: Note th e strategic wo rd , best, an d fo cus o n th e age of th e ch ild iden tified in th e q uestion . Th in kin g abo u t th e p h ysio lo gical d evelo pm en t of th e m u scle grou ps in an in fan t at 4 m on th s o f age will assist in directin g yo u to th e correct o ptio n . Review: Ped iatric m ed icatio n ad m in istratio n gu id elin es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), p. 487.

473. 1.5 mL Ra tion a le: Use th e form ula for calculatin g th e m edication d ose. For mu la :

Desired Available

 Volume¼ 0:6 mg 0:4 mg

 1 mL¼ 1:5 mL

Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, th e m illiliters to be adm in istered. Note th at th e m ed icatio n lab el in dicates th at th ere is 0.4 m g/ m L. Use th e fo rm u la to determ in e th e co rrect d ose, an d verify th e an swer usin g a calcu lator. Review: Med icatio n ad m in istratio n gu id elin es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Medicatio n s/ IV Calculation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), pp . 485-487.

P

e

d

i

a

t

r

i

c

s

542 UNIT VII Pediatric Nursing

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

UNIT VIII

Integumentary Disorders of the Adult Client

Pyramid to Success

Th e Pyram id to Success focuses on th e con cept th at th e in tegu m en tary system provid es th e first lin e of defen se again st in fectio n s. Focus is on th e protective m easures n ecessary to preven t in fectio n , in cludin g in fection fro m colon ization with a m ultidrug resistan t organ ism , such as m eth icillin -resistan t Staphylococcus aureus (MRSA). Pyram id Poin ts address th e risk factors related to th e developm en t of in tegu m en tary disorders, an d th e pre- ven tive m easures related to skin can cer. Also described are th e em ergen cy m easu res related to bites an d stin gs, an d for a clien t wh o sustain ed a burn in ju ry. Psych o so- cial issues relate to th e body im age disturban ces th at can occur as th e result of an in tegu m en tary disorder.

Client Needs: Learning Objectives Safe and Effective Care Environment Con sultin g with in terp rofession al h ealth care team

m em bers regardin g treatm en ts En surin g th at in form ed con sen t h as been obtain ed for

treatm en ts an d proced ures Establish in g priorities of care Han dlin g of h azardo us an d in fectio us m aterials In stitutin g stan dard an d oth er precaution s Main tain in g con fiden tiality related to th e disorder

Makin g referrals to appropriate h ealth care providers Practicin g asepsis tech n iqu es an d preven tin g in fectio n

Health Promotion and Maintenance Im plem en tin g disease preven tion m easu res Perform in g ph ysical assessm en t tech n iques for th e in teg-

um en tary system Prom o tin g h ealth screen in g an d h ealth prom o tion pro-

gram s to preven t skin disorders Providin g in struction s to th e clien t regardin g preven tion

m easures an d care for an in tegum en tary disorder

Psychosocial Integrity Addressin g en d-of-life issues Discussin g un exp ected body im age ch an ges Iden tifyin g copin g m ech an ism s Iden tifyin g situation al role ch an ges Iden tifyin g supp ort system s

Physiological Integrity Assessin g for alteration s in body system s Providin g ad equate n utrition for h ealin g Providin g basic care an d com fo rt Providin g em ergen cy care Mon itorin g for expected effects of treatm en ts Mon itorin g for fluid an d electrolyte im balan ces an d

oth er com plication s Mon itorin g laborato ry referen ce in tervals

543

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

C H A P T E R 46 Integumentary System

PRIORITY CONCEPTS Infection; Tissue Integrity

CRITICAL THINKING What Should You Do? Aburn client undergoes autograft to the lower right leg. What should the nurse do when caring for the graft site? Answer located on p. 562.

I. Anatomy and Physiology A. Th e skin is th e largest sen sory organ of th e body, with

a surface area of 15 to 20 square feet (1.4 to 1.9 square m eters) an d a weigh t of about 9 lb (4 kg).

B. Fun ction s 1. Acts as th e first lin e of defen se again st in fectio n s 2. Protects un derlyin g tissues an d organ s from injury 3. Receives stim uli from th e extern al en viron m en t;

detects touch , pressure, pain , an d tem p erature stim uli; relays in form ation to th e n ervou s system

4. Regulates n orm al body tem p erature 5. Excretes salts, water, an d organ ic wastes 6. Protects th e body from excessive water loss 7. Syn th esizes vitam in D3, wh ich con verts to calci-

triol, for n orm al calcium m etab olism 8. Stores n utrien ts

C. Layers 1. Epiderm is 2. Derm is 3. Hypo derm is (subcutan eous fat)

D. Epiderm al appen dages 1. Nails 2. Hair 3. Glan ds

a. Sebaceous b . Sweat

E. No rm al bacterial flora 1. Types of n orm al bacterial flora in clude:

a. Gram -positive an d gram -negative staphylococci b . Pseudomonas sp. c. Streptococcus sp.

2. O rgan ism s are sh ed with n orm al exfo liation . 3. A pH of 4.2 to 5.6 h alts th e growth of bacteria.

II. Risk Factors for Integumentary Disorders A. Expo sure to ch em ical an d en viron m en tal pollutan ts B. Expo sure to radiation C. Race an d age D. Expo sure to th e sun or use of in door tan n in g E. Lack of person al h ygien e h abits F. Use of h arsh soaps or oth er h arsh products G. Som e m edication s, such as lon g-term gluco cortico id

use or h erbal preparation s H. Nu trition al deficien cies I. Mod erate to severe em otion al stress J. In fection , with in jured areas as th e poten tial en try

poin ts for in fection K. Repeated in ju ry an d irritatio n L. Gen etic predisp osition

M. System ic illn esses

III. Psychosocial Impact A. Ch an ge in body im age, decreased gen eral well-

bein g, an d decreased self-esteem B. Social isolatio n an d fear of rejection (because of

em b arrassm en t about ch an ges in skin appearan ce) C. Restriction s in ph ysical activity D. Pain E. Disrup tion or loss of em plo ym en t F. Cost of m edication s, h ospitalization s, an d follow-

up care, in cludin g dressin g supplies

IV. Phases of Wound Healing A. Ph ases

1. In flam m atory: Begin s at th e tim e of in jury an d lasts 3 to 5 days; m an ifestation s in clude local edem a, pain , redn ess, an d warm th .

2. Fib roblastic: Begin s th e fourth day after in jury an d lasts 2 to 4 weeks; scar tissue form s an d gran - ulation tissue form s in th e tissue bed.

3. Maturatio n : Begin s as early as 3 weeks after th e in jury an d m ay last for 1 year; scar tissue beco m es th in n er an d is firm an d in elastic on palpatio n .

544

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

B. Healin g by in ten tion 1. First in ten tion : Woun d edges are approxim ated

an d h eld in place (i.e., with sutures) un til h eal- in g occurs; woun d is easily clo sed an d dead space is elim in ated .

2. Secon d in ten tion : Th is type of h ealin g occurs with in juries or woun ds th at h ave tissue loss an d require gradual fillin g in of th e dead space with con n ective tissue.

3. Th ird in ten tion : Th is type of h ealin g in volves delayed prim ary closure an d occurs with woun ds th at are in ten tion ally left open for several days for irrigation or rem oval of deb ris an d exudates; on ce deb ris h as been rem oved an d in flam m a- tion resolves, th e woun d is clo sed by first in ten tion .

C. Types of woun d drain age: Refer to Box 46-1.

V. Diagnostic Tests A. Skin biopsy

1. Descriptio n a . Skin biopsy is th e collection of a sm all piece

of skin tissue for h isto path o logical study. b . Meth od s in clude pun ch , excision al, an d

sh ave. 2. Preprocedure in terven tion s

a . Verify in form ed con sen t h as been obtain ed. b . Clean se site as prescribed.

3. Postp rocedu re in terven tion s a . Place specim en in th e appropriate co n tain er

an d sen d to path olo gy labo ratory for an alysis.

b . Use surgically aseptic tech n iqu e for biopsy site dressin gs.

c. Assess th e biopsy site for bleedin g an d in fectio n .

d . In struct th e clien t to keep dressin g in place for at least 8 h ours, an d th en clean daily an d use an tibiotic oin tm en t as prescribed (su tures are usually rem oved in 7 to 10 days).

e. In struct th e clien t to report sign s of exces- sive drain age, or redn ess, or oth er sign s of in fectio n .

B. Skin / woun d cultures 1. A sm all skin culture sam ple is obtain ed with a

sterile applicato r an d th e appropriate type of cul- ture tube (e.g., bacterial or viral). Meth od s in clude scrapin g, pun ch biopsy, an d collectin g fluid . Local an esth esia m ay be used.

2. A n asal swab is also com m on ly don e to deter- m in e previous exposu re to certain types of bacteria.

3. Postp rocedu re in terven tion a . Viral culture is placed im m ediately on ice. b . Sam ple is sen t to labo ratory to iden tify an

existin g organ ism .

Obtain skin culture samples or any other type of culture specimens before instituting antibiotic therapy.

C. Wood ’s ligh t exam in ation 1. Description : Skin is viewed un der ultraviolet

ligh t th rough a special glass (Wo od’s glass) to iden tify superficial in fectio n s of th e skin .

2. Preprocedure in terven tion : Explain procedure to clien t an d reassure h im or h er th at ligh t is n ot h arm ful to th e skin or th e eyes. Darken th e ro om befo re th e exam in ation .

3. Postp rocedu re in terven tion : Assist th e clien t dur- in g adju stm en t from th e darken ed ro om .

D. Diascop y 1. Tech n ique allows clearer in spection of lesion s by

elim in atin g th e eryth em a caused by in creased blood flow to th e area.

2. A glass slide is pressed over th e lesion , caus- in g blan ch in g an d revealin g th e lesion m ore clearly.

E. Skin assessm en t: See Ch apter 15.

VI. Ca ndida albicans A. Description

1. A superficial fun gal in fectio n of th e skin an d m ucou s m em bran es

2. Also kn own as a yeast in fectio n (oral can didia- sis), or thrush wh en it occurs in th e m ou th

3. Risk facto rs in clude im m un osuppression , lon g- term an tibiotic th erapy, diab etes m ellitus, an d obesity.

4. Com m on areas of occurren ce in clude skin folds, perin eum , vagin a, axilla, an d un der th e breasts.

BOX 46-1 Types of Exudate from Wounds

Serous ▪ Clear or straw colored ▪ Occurs as a normal part of the healing process Serosanguineous ▪ Pink colored due to the presence of a small amount of

blood cells mixed with serous drainage ▪ Occurs as a normal part of the healing process Sanguineous ▪ Red drainage from trauma to a blood vessel ▪ May occur with wound cleansing or other trauma to the

wound bed ▪ Sanguineous drainage is abnormal in wounds Hemorrhaging ▪ Frank blood from a leaking blood vessel ▪ May require emergency treatment to control bleeding ▪ Hemorrhage is an abnormal wound exudate Purulent ▪ Yellow, gray, or green drainage due to infection in the

wound

545CHAPTER 46 Integumentary System

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

B. Assessm en t 1. Skin : Red an d irritated appearan ce th at itch es

an d stin gs 2. Mucou s m em bran es of th e m ou th : Red an d wh it-

ish patch es C. In terven tion s

1. Teach th e clien t to keep skin fold areas clean an d dry.

2. For th e h ospitalized clien t, in spect skin fold areas frequen tly, turn an d repositio n th e clien t fre- quen tly, an d keep th e skin an d bed lin en s clean an d dry.

3. Provide frequen t m outh care as prescribed an d avoid irritatin g products.

4. Provide food an d fluid s th at are tepid in tem per- atu re an d n on irritatin g to m ucou s m em bran es.

5. An tifu n gal m ed ication s m ay be prescribed.

VII. Herpes Zoster (Shingles) A. Description

1. With a h isto ry of ch icken pox, sh in gles is cau sed by reactivation of th e varicella-zoster virus; sh in gles can occur durin g an y im m un oco m - prom ised state in a clien t with a h isto ry of ch icken pox.

2. Th e dorm an t virus is located in th e dorsal n erve ro ot gan glia of th e sen sory cran ial an d spin al n erves.

3. Herpes zoster eruptio n s occur in a segm en tal dis- tribu tion on th e skin area alon g th e in fected n erve an d sh ow up after several days of discom - fort in th e area.

4. Diagn osis is determ in ed by visual exam in ation , an d by Tzan ck sm ear to verify a h erpes in fectio n an d viral culture to iden tify th e organ ism .

5. Posth erpetic n euralgia (severe pain ) can rem ain after th e lesion s resolve.

6. Herpes zoster is con tagious to in dividuals wh o n ever h ad ch icken pox an d wh o h ave n ot been vaccin ated again st th e disease.

7. Herpes sim plex virus is an oth er type of virus; typ e 1 in fectio n typically cau ses a cold sore (usu- ally on th e lip) an d type 2 causes gen ital h erp es typ ically below th e waist (both types are con ta- giou s an d m ay be presen t togeth er).

B. Assessm en t 1. Un ilaterally clu stered skin vesicles alon g periph -

eral sen sory n erves on th e tru n k, th o rax, or face 2. Fever, m alaise 3. Burn in g an d pain 4. Paresth esia 5. Pruritus

C. In terven tion s 1. Isolate the clien t because exudate from th e lesions

con tain s th e virus (m ain tain stan dard an d oth er precaution s as appropriate, such as con tact pre- caution s as lon g as vesicles are presen t).

2. Assess for sign s an d sym ptom s of in fectio n , in cludin g skin in fection s an d eye in fectio n s; skin n ecrosis can also occur.

3. Assess n eurovascular status an d seven th cran ial n erve fun ction ; Bell’s palsy is a com plication .

4. Use an air m attress an d bed cradle on th e clien t’s bed if h ospitalized, an d keep th e en vi- ron m en t cool; warm th an d touch aggravate th e pain .

5. Preven t th e clien t from scratch in g an d rubbin g th e affected area.

6. In struct th e clien t to wear ligh tweigh t, loose cot- ton cloth in g an d to avoid wool an d syn th etic clo th in g.

7. Teach th e clien t about th e prescribed th erapies; astrin gen t co m presses m ay be prescribed to relieve irritation an d pain an d to prom o te crust form ation an d h ealin g.

8. Teach th e clien t about m easu res to keep th e skin clean to preven t in fectio n .

9. Teach th e clien t about topical treatm en t an d an ti- viral m ed ication s; an tiviral th erapies begun with in 3 days of rash reduce pain an d lessen like- lih ood of posth erpetic n euralgia.

10. Th e zoster vaccin e (live), th e vaccin ation for sh in gles, is recom m en ded for adults 60 years of age an d older to reduce th e risk of occurren ce an d th e associated lon g-term pain .

11. An tiviral m ed ication s m ay be prescribed; refer to - Ch apter 67 for in form ation on an tiviral m ed ication s.

VIII. Methicillin-Resistant Staphylococcus a ureus (MRSA) A. Description

1. Skin or woun d becom es in fected with m ethicillin - resistan t Staphylococcus aureus (MRSA). MRSA can be com m un ity acquired, such as through sports when skin -to-skin con tact and sh arin g of equip- m en t occurs. It can also be h ospital acquired, such as in th e case of a surgical site in fection (SSI). See Ch apter 16 for addition al types of h ealth care– associated in fection s.

2. An MRSA screen in g with a n asal swab m ay be don e for clien ts wh o are h avin g surgery, wh o h ave been previously h ospitalized, or wh o live in grou p settin gs. Clien ts with positive cultures or with a h isto ry of a positive cu lture are isolated.

3. In fection can ran ge from m ild to severe an d can presen t as folliculitis or furun cles.

4. Folliculitis is a superficial in fectio n of th e follicle cau sed by Staphylococcus an d presen ts as a raised red rash an d pustu les; furun cles are also caused by Staphylococcus an d occur deep in th e follicle, presen tin g as very pain ful large, raised bum ps th at m ay or m ay n ot h ave a pustu le.

5. If MRSA in fects th e blood, sep sis, organ dam age, an d death can occur.

546 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

MRSA is contagious and is spread to others by direct contact with infected skin or infected articles; for the client with MRSA, the infection can also be spread to other parts of the body.

B. Assessm en t: A culture an d sen sitivity test of th e skin or woun d con firm s th e presen ce of MRSA an d lead s to ch oice of appropriate an tibiotic th erapy.

C. In terven tion s 1. Main tain stan dard precaution s an d con tact pre-

cau tion s as ap propriate to preven t spread of in fection to oth ers.

2. Mon itor th e clien t closely for sign s of furth er in fection , wh ich m ay result in system ic illn ess or organ dam age.

3. Adm in ister an tibiotic th erap y as prescribed. 4. For addition al in form ation on MRSA, refer to

Ch apters 16 an d 44.

IX. Erysipelas and Cellulitis A. Description

1. Erysipelas is an acute, superficial, rapidly spread- in g in flam m ation of th e derm is an d lym ph atics caused by group A Streptococcus, which en ters th e tissue via an abrasion , bite, traum a, or woun d.

2. Cellulitis is an in fectio n of th e derm is an d un der- lyin g h ypo derm is; th e causative organ ism is usu- ally group A Streptococcus or Staphylococcus aureus.

B. Assessm en t 1. Pain an d ten dern ess 2. Eryth em a an d warm th 3. Edem a 4. Fever

C. In terven tion s 1. Prom ote rest of th e affected area. 2. Apply warm com presses as prescribed to pro-

m ote circulation an d to decrease discom fort, ery- th em a, an d edem a.

3. Apply an tibacterial dressin gs, oin tm en ts, or gels as prescribed .

4. Adm in ister an tibiotics as prescribed for an in fec- tio n ; obtain a culture of th e area befo re in itiatin g th e an tibiotics.

X. Poison Ivy, Poison Oak, and Poison Sumac (Fig. 46-1) A. Description : A derm atitis th at develops fro m con tact

with urush iol from poison ivy, oak, or sum ac plan ts B. Assessm en t

1. Papulovesicular lesion s 2. Severe pruritu s

C. In terven tion s 1. Clean se th e skin of th e plan t oils im m ediately. 2. Apply cool, wet com presses to relieve th e itch in g. 3. Apply topical products to relieve th e itch in g an d

discom fort. 4. To pical or oral glucocorticoid s m ay be prescribed

for severe reactio n s.

XI. Bites and Stings A. Spider bites

1. Alm ost all typ es of spider bites are ven om ou s an d m ost are n ot h arm fu l, but bites or stin gs from brown recluse spiders, black widow spiders, an d taran tulas (as well as from scorpion s, bees, an d wasps) can produ ce toxic reaction s in h um an s. Tetan us proph ylaxis sh ould be curren t sin ce spider bites can be con tam in ated with teta- n us spores.

2. Brown recluse spider a . Bite can cau se a skin lesion , a n ecro tic

woun d, or system ic effects from th e toxin (loxoscelism ).

b . Application of ice decreases en zym e activity of th e ven om an d lim its tissue n ecrosis; sh ould be don e im m ediately an d in term it- ten tly for up to 4 days after th e bite.

c. Topical an tiseptics an d an tibiotics m ay be n ecessary if th e site beco m es in fected.

3. Black wid ow spider a . Bite cau ses a sm all red papule. b . Ven om causes n eurotoxicity. c. Ice is applied im m ediately to in h ibit th e

action of th e n eurotoxin . d . System ic toxicity can occur an d th e victim

m ay require supportive th erapy in th e h ospital.

4. Taran tulas a . Bite causes swellin g, redn ess, n um bn ess,

lym ph in flam m ation , an d pain at th e bite site.

b . Th e taran tula laun ch es its barbed h airs, wh ich can pen etrate th e skin an d eyes of th e victim , producin g a severe in flam m ato ry reaction .

c. Taran tu la h airs are rem oved as soon as possi- ble, usin g sticky tap e to pull h airs from th e skin , an d th e skin is th orough ly irrigated; salin e irrigation s are don e for eye exposu re.

FIGURE 46-1 Poison ivy. Note “streaked” blisters surrounding 1 large blister. (From Habif, 2004.)

547CHAPTER 46 Integumentary System

d . Th e in volved extrem ity is elevated an d im m o- bilized to reduce pain an d swellin g.

e. An tih istam in es an d topical or system ic co rti- costeroids m ay be prescribed; tetan us pro- ph ylaxis is n ecessary.

B. Scorpion stin gs 1. Scorpion s in ject ven om in to th e victim th rou gh a

stin gin g ap paratus on th eir tail. 2. Most stin gs cause local pain , in flam m ation ,

an d m ild system ic reaction s th at are treated with an algesics, woun d care, an d supp ortive treatm en t.

3. Th e bark scorpion can in flict a severe an d poten - tially fatal system ic respon se, esp ecially in ch il- dren an d th e elderly; th e ven om is n eurotoxic; th e victim sh ould be taken to th e em ergen cy dep artm en t im m ediately (an an tiven om is ad m in istered for bark scorpion bites).

C. Bees an d wasps 1. Stin gs usually cause a wh eal an d flare reaction . 2. Em ergen cy care in volves quick rem oval of th e

stin ger an d application of an ice pack. 3. Th e stin ger is rem oved by gen tly scrap in g or

brush in g it off with th e edge of a n eedle or sim - ilar object; tweezers are n ot used because th ere is a risk of pin ch in g th e ven o m sac.

4. If th e victim is allergic to th e ven om of a bee or wasp, a severe allergic respo n se can occur (h ives, pruritus, swellin g of th e lips an d ton gue) th at can progress to life-th reaten in g an aph ylaxis; im m e- diate em ergen cy care is required.

5. In dividuals wh o are allergic sh ould carry an epi- n eph rin e au toin jecto r for self-adm in istration of in tram uscu lar epin eph rin e if a bee or wasp stin g occurs. After use of th e epin eph rin e autoin jecto r, th e in dividual sh ould seek em ergen cy m ed ical atten tion . Perso n s sh ould h ave 2 in jectors avail- ab le an d obtain a replacem en t as soon as possible.

D. Sn ake bites 1. Som e sn akes are ven o m ous an d can cause a seri-

ous system ic reaction in th e victim . 2. Th e victim sh ould be im m ediately m oved to a

safe area away from th e sn ake an d sh ould rest to decrease ven om circulation ; th e extrem ity is im m obilized an d kept below th e level of th e h eart.

3. Con strictin g cloth in g an d jewelry are rem oved befo re swellin g occurs.

4. Th e victim is kept warm an d is n ot allowed to con sum e caffein ated or alcoh olic beverages, wh ich m ay speed absorption of th e ven o m .

5. If un able to seek em ergen cy m ed ical atten tio n prom ptly, a con strictin g ban d m ay be applied proxim al to th e woun d to slow th e ven om circu- lation ; m on itor th e circulation frequen tly an d lo osen th e ban d if edem a occurs.

6. Th e woun d is n ot in cised or sucked to rem ove th e ven o m ; ice is n ot applied to th e woun d.

7. Em ergen cy care in a h ospital is required as soon as possible; an an tiven om m ay be adm in istered alon g with supp ortive care. Th e sn ake sh ould n ot be tran spo rted with th e victim for id en tifica- tion purpo ses un less it can be safely placed in a sealed con tain er durin g tran sportation .

For spider bites, scorpion bites, or other stings or bites, the Poison Control Center should be contacted as soon as possible to determine the best initial management.

XII. Frostbite A. Description

1. Frostbite is dam age to tissues an d blood vessels as a result of prolon ged exposu re to cold.

2. Fin gers, toes, face, n ose, an d ears often are affected .

B. Assessm en t 1. First-degree: In vo lves wh ite plaq ue surroun ded

by a rin g of h yperem ia an d edem a 2. Secon d-d egree: Large, clear fluid –filled blisters

with partial-th ickn ess skin n ecrosis 3. Th ird -degree: In volves th e form ation of sm all

h em orrh agic blisters, usually followed by esch ar form ation in volvin g th e h ypo derm is requirin g deb ridem en t

4. Fourth -degree: No blisters or edem a n oted; full- th ickn ess n ecrosis with visible tissue loss exten d- in g in to m uscle an d bon e, wh ich m ay result in gan gren e. Am putation m ay be required .

C. In terven tion s 1. Rewarm th e affected part rapidly an d con tin u-

ously with a warm water bath or towels at 104.0 °F to 107.6 °F (40 °C to 42 °C) to th aw th e frozen part.

2. Han dle th e affected area gen tly an d im m ob ilize. 3. Avoid usin g dry h eat, an d n ever rub or m assage

th e part, wh ich m ay result in furth er tissue dam age.

4. Th e rewarm in g process m ay be pain ful; an alge- sics m ay be n ecessary.

5. Avoid com pression of th e in jured tissues an d apply on ly loose an d n on adh eren t sterile dressin gs.

6. Mon itor for sign s of com partm en t syn drom e. 7. Tetan us proph ylaxis is n ecessary, an d topical an d

system ic an tibiotics m ay be prescribed. 8. Debridem en t of n ecrotic tissue m ay be n ecessary;

am putation m ay be n ecessary if gan gren e develops.

XIII. Actinic Keratoses A. Actin ic keratoses are caused by ch ron ic exposu re to

th e sun an d appear as ro ugh , scaly, red, or brown

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

548 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

lesion s th at are usually foun d on th e face, scalp, arm s, an d backs of th e h an ds.

B. Lesion s are con sidered prem align an t an d th ere is risk for slow progression to squam ous cell carcin om a.

C. Treatm en t in cludes m edication s, excision , cryoth er- apy, curettage, an d laser th erapy.

D. See Ch apter 47 for in form ation on m ed ication s to treat th is disorder.

XIV. Skin Cancer A. Description

1. Skin can cer is a m align an t lesion of th e skin , wh ich m ay or m ay n ot m etastasize.

2. O verexposure to th e sun is a prim ary cause; oth er cau ses an d con dition s th at place th e in dividual at risk in clude ch ron ic skin dam age from repeated in ju ry an d irritation such as tan n in g an d use of tan n in g beds, gen etic predisposition , io n izin g radiation , ligh t-skin n ed race, age older th an 60 years, an outd oor occupation , an d exp osure to ch em ical carcin ogen s.

3. Diagn osis is con firm ed by skin biopsy. B. Types

1. Basal cell: Basal cell can cer arises from th e basal cells con tain ed in th e epiderm is; m etastasis is rare but un derlyin g tissue destruction can pro- gress to organ tissue.

2. Squam ous cell: Squam o us cell can cer is a tum o r of th e epiderm al keratin ocytes an d can in filtrate surroun din g structures an d m etastasize to lym p h n odes.

3. Melan om a: Melan om a m ay occur an y place on th e body, especially wh ere birth m arks or n ew m oles are apparen t; it is h igh ly m etastatic to th e brain , lun gs, bon e, an d liver, with survival dep en din g on early diagn osis an d treatm en t.

C. Assessm en t ( Table 46-1) 1. Ch an ge in color, size, or sh ape of preexistin g

lesion 2. Pruritus 3. Local soren ess

The client needs to be informed about the risks associated with overexposure to the sun and taught about the importance of performing monthly skin self- assessments.

D. In terven tion s 1. In struct th e clien t regardin g th e risk factors an d

preven tive m easu res. 2. In struct th e clien t to perform m on th ly skin self-

assessm en ts an d to m on itor for lesion s th at do n ot h eal or th at ch an ge ch aracteristics.

3. Advise th e clien t to h ave m oles or lesion s th at are subject to ch ron ic irritatio n rem oved.

4. Advise th e clien t to avoid co n tact with ch em ical irritan ts.

5. In struct th e clien t to wear layered cloth in g an d use an d reapply sun screen lotio n s with an appro- priate sun protectio n facto r wh en outd oors.

6. In struct th e clien t to avoid sun exposu re between 10 a.m . an d 4 p.m .

7. Man agem en t m ay in clude surgical or n on su rgi- cal in terven tion s; if m edication is prescribed, provide in struction s about its use.

8. Assist with surgical m an agem en t, wh ich m ay in clude cryosurgery, curettage an d electrod essica- tion , or surgical excision of th e lesion .

TABLE 46-1 Appearance of Skin Cancer Lesions Basal Cell Carcinoma

Waxy nodule with pearly borders Papule, red, central crater Metastasis is rare

Squamous Cell Carcinoma

Oozing, bleeding, crusting lesion Potentially metastatic Larger tumors associated with a higher risk for metastasis

Melanoma

Irregular, circular, bordered lesion with hues of tan, black, or blue Rapid infiltration into tissue, highly metastatic

Figures from Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 8, Philadelphia, 20 16, Saunders.

549CHAPTER 46 Integumentary System

XV. Psoriasis A. Description

1. Psoriasis is a ch ron ic, n on in fectious skin in flam - m ation occurrin g with rem ission s an d exacerba- tio n s, in volvin g keratin syn th esis th at results in psoriatic patch es; m ay lead to an in fection in th e affected area.

2. Various form s exist, with psoriasis vulgaris bein g th e m ost com m on .

3. Possible causes of th e disorder in clude stress, traum a, in fectio n , h orm on al ch an ges, obesity, an autoim m un e reaction , an d clim ate ch an ges; a gen etic predisposition m ay also be a cau se.

4. Th e disorder m ay be exacerbated by th e use of certain m edication s.

5. Koebn er ph en om en on is th e developm en t of psoriatic lesion s at a site of in jury, such as a scratch ed or sun burn ed area. Prom pt cleansin g of th e area m ay preven t or lessen th is ph en om en on .

6. In som e in dividuals with psoriasis, arth ritis develops, wh ich leads to join t ch an ges sim ilar to th ose seen in rh eum atoid arth ritis.

7. Th e goal of th erap y is to reduce cell proliferation an d in flam m ation , an d th e typ e of th erap y pre- scrib ed depen ds on th e exten t of th e disease an d th e clien t’s respo n se to treatm en t.

B. Assessm en t 1. Pruritus 2. Sh eddin g: Silvery-wh ite scales on a raised, red-

den ed , roun d plaque th at usually affects th e scalp, kn ees, elbows, exten sor surfaces of arm s an d legs, an d sacral region s

3. Yellow discoloration , pittin g, an d th icken in g of th e n ails are n oted if th ey are affected .

4. Join t in flam m ation with psoriatic arth ritis C. Ph arm acological th erap y: Refer to Ch apter 47 for

m ed ication s used to treat psoriasis. D. In terven tion s an d clien t education

1. Provide em otion al supp ort to th e clien t with associated altered body im age an d decreased self-esteem .

2. In stru ct th e clien t in th e u se o f p rescrib ed th er- ap ies an d to avo id o ver-th e-co u n ter m ed i- catio n s.

3. In struct th e clien t n ot to scratch th e affected areas an d to keep th e skin lu bricated as prescribed to m in im ize itch in g.

4. Mon itor for an d in struct th e clien t to recogn ize an d report th e sign s an d sym ptom s of secon dary skin problem s, such as in fectio n .

5. In struct th e clien t to wear ligh t cotton cloth in g over affected areas.

6. Assist th e clien t to iden tify ways to reduce stress if stress is a predisp osin g facto r.

XVI. Acne Vulgaris A. Description

1. Acn e is a ch ron ic skin disorder th at usually begin s in puberty an d is m ore com m on in m ales; lesion s develop on th e face, n eck, ch est, sh o ul- ders, an d back.

2. Acn e requires active treatm en t for con tro l un til it resolves.

3. Th e types of lesion s in clude com edon es (open an d closed), pustules, papules, an d n od ules.

4. Th e exact cau se is un kn own but m ay in clude an drogen ic in fluen ce on seb aceous glan ds, in creased sebum productio n , an d proliferation of Propionibacterium acnes, th e organ ism th at co n - verts seb um in to irritan t fatty acids.

5. Exacerbation s coin cide with th e m en strual cycle in fem ale clien ts because of h orm on al activity; oily skin an d a gen etic predisp osition m ay be con tributin g facto rs.

B. Assessm en t 1. Closed co m edon es are wh iteh eads an d n on in -

flam ed lesion s th at develop as follicles en large, with th e reten tion of h orn y cells.

2. O pen com edon es are blackh eads th at result from con tin uin g accu m ulation of h orn y cells an d seb um , wh ich dilates th e follicles.

3. Pustu les an d papules result as th e in flam m atory process progresses.

4. No dules result fro m total disin tegration of a com edon e an d subsequ en t collapse of th e follicle.

5. Deep scarrin g can result fro m n od ules. C. In terven tion s

1. In stru ct th e clien t in p rescrib ed skin -clean sin g m eth o d s, with em p h asis o n n o t scru b b in g th e face an d u sin g o n ly p rescrib ed to p ical agen ts.

2. In struct th e clien t in th e adm in istration of topical or oral m edication s as prescribed .

3. In struct th e clien t n ot to squeeze, prick, or pick at lesion s.

4. In struct th e clien t to use products labeled n on - com edogen ic an d cosm etics th at are water based, an d to avoid co n tact with produ cts with an exces- sive oil base.

5. In struct th e clien t on th e im portan ce of follo w- up treatm en t.

6. Refer to Ch apter 47 for in form ation on th e m ed- ication s used to treat acn e.

XVII. Stevens-Johnson Syndrome A. A m ed ication -in duced skin reaction th at occurs

th rou gh an im m un ological respo n se; com m on m ed- ication s causin g th e reaction in clude an tibiotics (especially sulfon am ides), an tiseizure m edication s an d n on steroidal an tiin flam m atory drugs (NSAIDs).

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

550 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

B. Sim ilar to toxic epiderm al n ecrolysis (TEN), an oth er m ed ication -in duced skin reactio n th at results in dif- fuse eryth em a an d large blister form ation on th e skin an d m ucous m em bran es

C. May be m ild or severe, an d m ay cau se vesicles, ero- sion s, an d crusts on th e skin ; if severe, system ic reac- tion s occur th at in volve th e respiratory system , ren al system , an d eyes, resultin g in blin dn ess, an d it can be fatal. In itial clin ical m an ifestation s in clude flulike sym pto m s an d eryth em a of th e skin an d m ucous m em bran es. Serious system ic sym ptom s an d com - plication s occur wh en th e ulceratio n s in volve th e laryn x, bron ch i, an d eso ph agus.

D. Most com m on ly occurs in clien ts wh o h ave im paired im m un e system s

E. Treatm en t in cludes im m ediate discon tin uation of the m edication causin g th e syn drom e; antibiotics, corti- costeroids, an d supportive therapy m ay be n ecessary.

XVIII. Pressure Ulcer A. Description

1. A pressure ulcer is an im pairm en t of skin in tegrity.

2. A pressure ulcer can occur an ywh ere on th e body; tissue dam age results wh en th e skin an d un derly- in g tissue are com pressed between a bon y prom - in en ce an d an extern al surface for an exten ded period of tim e.

3. Th e tissue com pression restricts blood flow to th e skin , wh ich can result in tissue isch em ia, in flam - m ation , an d n ecro sis; on ce a pressure ulcer form s, it is difficu lt to h eal.

4. Preven tion of skin breakd own in an y part of th e clien t’s body is a m ajo r role for th e n urse.

B. Risk factors 1. Skin pressure 2. Skin sh earin g an d friction 3. Im m obility 4. Maln utrition 5. In con tin en ce 6. Decreased sen sory perception

C. Assessm en t an d stagin g ( Table 46-2) D. In terven tion s

TABLE 46-2 Stages of Pressure Ulcers Stage I Stage III

Skin is intact Area is red and does not blanch with external pressure Area may be painful, firm, soft, warmer, or cooler compared

with adjacent tissue

Full-thickness skin loss extends into the dermis and subcutaneous tissues, and slough may be present

Subcutaneous tissue may be visible Undermining and tunneling may or may not be present

Stage II Stage IV

Skin is not intact Partial-thickness skin loss of the dermis occurs Presents as a shallow open ulcer with a red-pink wound bed or

as intact or open/ ruptured serum-filled blister

Full-thickness skin loss is present with exposed bone, tendon, or muscle Slough or eschar may be present Undermining and tunneling may develop

Continued

551CHAPTER 46 Integumentary System

Avoid direct massage to a reddened skin area because massage can damage the capillary beds and cause tissue necrosis.

1. Iden tify clien ts at risk for developin g a pressure ulcer.

2. In stitute m easu res to preven t pressure ulcers, such as appropriate position in g, usin g pressure relief devices, en surin g adequate n utrition , an d developin g a plan for skin clean sin g an d care.

3. Perform frequen t skin assessm ents and m onitor for an alteration in skin in tegrity (refer to Chapter 15 for m ore in form ation on skin assessm en t).

4. Keep th e clien t’s skin dry an d th e sh eets wrin kle- free; if th e clien t is in con tin en t, ch eck th e clien t frequen tly an d ch an ge pads or an y item s placed un d er th e clien t im m ediately after th ey are soiled.

5. Use cream s an d lotion s to lubricate th e skin an d a barrier protection oin tm en t for th e in con tin en t clien t.

6. Tu rn an d reposition th e im m obile clien t every 2 h ours or m ore frequen tly if n ecessary; provid e

active an d passive ran ge of m otion exercises at least every 8 h ou rs.

7. If a pressure ulcer is presen t, record th e location an d size of th e woun d (len gth , width, depth in cen tim eters), m on itor an d record th e type an d am ount of exudates (a culture of the exudate m ay be prescribed), an d assess for un derm in in g an d tun n elin g.

8. Serosan guin eous exudate (blood-tin ged am ber fluid) is expected for the first 48 h ours; purulen t exudates in dicate colon ization of th e woun d with bacteria.

9. Use agen cy protoco ls for skin assessm en t an d m an agem en t of a woun d.

10. Treatm en t m ay in clude woun d dressin gs an d deb ridem en t; skin graftin g m ay be n ecessary ( Tables 46-3 an d 46-4).

11. O th er treatm ents m ay in clude electrical stim ula- tion to th e woun d area (in creases blood vessel growth an d stim ulates gran ulation ), vacuum - assisted wound closure (rem oves in fectious m ate- rial from th e woun d an d prom otes gran ulation ), h yperbaric oxygen th erapy (adm in istration of

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

TABLE 46-2 Stages of Pressure Ulcers–cont’d

Suspected Deep-Tissue Injury Unstageable

Ischemic subcutaneous tissue injury under intact skin Appears purple or maroon colored May be painful, firm, or boggy

Full-thickness tissue loss in which the wound bed is covered by slough and/ or eschar

The true depth, and therefore stage, of the wound cannot be determined until the slough and/ or eschar is removed to visualize the wound bed

Adapted from Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 8, Philadelphia, 2016, Saunders. Figures from National Pressure Ulcer Advisory Panel (NPUAP), copyright and used with permission.

TABLE 46-3 Types of Dressings and Mechanism of Action for Pressure Ulcers Pressure Ulcer Stage

Dressing Type Mechanism of Action

I None Transparent dressing Hydrocolloid dressing

Slow resolution within 7 to 10 days

II Composite film Hydrocolloid dressing Hydrogel

Heals through reepithelialization

Continued

552 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

TABLE 46-4 Types of Dressing Materials Type Indications, Uses, and Considerations Frequency of Dressing Changes

Alginate Provides hemostasis, debridement, absorption, and protection Can be used as packing for deep wounds and for infected wounds Requires a secondary dressing for securing

When dressing is saturated (every 3 to 5 days) or more frequently

Biological Provides protection, and debridement after eschar removal May be used for dormant and nonhealing wounds that do not

respond to other topical therapies May be used for burns or before pigskin and cadaver skin grafts Conforms to uneven wound surfaces; reduces pain Requires a secondary dressing for securing

Topical growth factors: changed daily Skin substitutes: the need for dressing change varies

Cotton gauze Continuous dry dressing provides absorption and protection Continuous wet dressing provides protection, a means for the

delivery of topical treatment, and debridement Wet to damp dressing provides atraumatic mechanical debridement May be painful on removal

Clean base: every 12 to 24 hr Necrotic base: every 4 to 6 hr

Foam Provides absorption, protection, insulation, and debridement Conforms to uneven wound surfaces Requires a secondary dressing for securing

When dressing is saturated or more frequently; can remain for a maximum of 7 days

Hydrocolloidal Provides absorption, protection, and debridement Is waterproof and painless on removal

Clean base: on leakage of exudates Necrotic base: every 24 hr

Hydrogel Provides absorption, protection, and debridement Conducive to use with topical agents Conforms to uneven wound surfaces but allows only partial wound

visualization Requires a secondary dressing for securing Can promote the growth of Pseudomonas and other microorganisms

Clean base: every 24 hr Necrotic base: every 6 to 8 hr

Adhesive transparent film

Provides protection for partial-thickness lesions, debridement, and serves as a secondary (cover) dressing

Provides good wound visualization Is waterproof and reduces pain Use is limited to superficial lesions Is nonabsorbent, adheres to normal and healing tissue Dressing may be difficult to apply

Clean base: on leakage of exudates Necrotic base: every 24 hr

From Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 8, Philadelphia, 20 16, Saunders.

TABLE 46-3 Types of Dressings and Mechanism of Action for Pressure Ulcers–cont’d Pressure Ulcer Stage

Dressing Type Mechanism of Action

III Hydrocolloid Hydrogel covered with foam dressing Gauze Growth factors

Heals through granulation and reepithelialization

IV Hydrogel covered with foam dressing Calcium alginate Gauze

Heals through granulation, reepithelialization, and scar tissue development

Unstageable Adherent film Gauze with a prescribed solution Enzymes None

Eschar loosens and lifts at edges as healing occurs; surgical debridement may be necessary

Data from Perry, Potter, Ostendorf: Clinical nursing skills & techniques, ed 8, St. Louis, 20 14, Mosby.

553CHAPTER 46 Integumentary System

oxygen un der h igh pressure raises tissue oxygen con cen tration ), an d the use of topical growth fac- tors (biologically active substan ces th at stim ulate cell growth ).

XIX. Burn Injuries (see Priority Nursing Actions)

PRIORITY NURSING ACTIONS Burn Injury: Care in the Emergency Department

1. Assess for airway patency. 2. Administer oxygen as prescribed. 3. Obtain vital signs. 4. Initiate an intravenous (IV) line and begin fluid replace-

ment as prescribed. 5. Elevate the extremities if no fractures are obvious. 6. Keep the client warm and place the client on NPO (noth-

ing by mouth) status.

The primary goal for a burn injury is to maintain a patent airway, administer IVfluids to prevent hypovolemic shock, and preserve vital organ functioning. Therefore, the priority actions are to assess for airway patency and to maintain a patent air- way. The nurse then prepares to administer oxygen. The type of oxygen delivery system is prescribed by the health care pro- vider. Oxygen is necessary to perfuse tissues and organs. Vital signs should be assessed so that a baseline is obtained, which is needed for comparison of subsequent vital signs once fluid resuscitation is initiated. The nurse then initiates an IV line and begins fluid replacement as prescribed. The extremities are elevated (if no obvious fractures are present) to assist in preventing shock. The client is kept warm (using sterile linens) and is placed on NPO status because of the altered gastroin- testinal function that occurs as a result of the burn injury. A Foley catheter may be inserted so that the response to the fluid resuscitation can be carefully monitored. Once these actions are taken, the nurse performs a complete assessment, stays with the client, and monitors the client closely. In addition, tet- anus toxoid may be prescribed for prophylaxis.

Reference Lewis et al. (20 14), pp. 456, 1689.

A. Description : Cell destru ction of th e layers of th e skin cau sed by h eat, friction , electricity, radiation , or ch em icals.

B. Burn size 1. Sm all burn s: Th e respo n se of th e body to in jury is

lo calized to th e in ju red area. 2. Large or exten sive burn s:

a. Majo r or exten sive burn s con sist of 25% or m ore of th e total body surface area for an adult an d 10% or m ore of th e total body sur- face for a ch ild.

b . Th e respo n se of th e body to th e in jury is system ic.

c. Th e burn affects all m ajo r system s of th e body.

d . Electrical burn s often h ave surface in ju ry th at is sm all but in tern al in juries m ay be exten sive

C. Estim atin g th e exten t of in jury ( Fig. 46-2) D. Burn depth

1. Superficial-thickness burn ( Fig. 46-3) a. In volves in ju ry to th e epiderm is; th e blood

supply to th e derm is is still in tact. b . Mild to severe eryth em a (pin k to red) is pre-

sen t, but n o blisters. c. Skin blan ch es with pressure. d . Burn is pain ful, with tin glin g sen sation , an d

th e pain is eased by coolin g. e. Discom fort lasts about 48 h ours; h ealin g

occurs in about 3 to 6 days. f. No scarrin g occurs an d skin grafts are n ot

required . 2. Superficial partial-thickness burn (Fig. 46-4)

a . In volves in jury deeper in to th e derm is; th e blood supp ly is reduced.

b . Large blisters m ay co ver an exten sive area. c. Edem a is presen t.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

4.5% Ante rior 4.5% Pos te rior

4.5% Ante rior 4.5% Pos te rior

4.5% Ante rior 4.5% Pos te rior

1% Pe rine um

9% Ante rior 9% Pos te rior

9% Ante rior 9% Pos te rior

18% Ante rior 18% Pos te rior

FIGURE 46-2 The rule of nines for estimating burn percentage.

554 UNIT VIII Integumentary Disorders of the Adult Client

d . Mottled pin k to red base an d broken epider- m is, with a wet, sh in y, an d weep in g surface, are ch aracteristic.

e. Burn is pain ful an d sen sitive to cold air. f. Heals in 10 to 21 days with n o scarrin g, but

som e m in o r pigm en t ch an ges m ay occur. g. Grafts m ay be used if th e h ealin g process is

prolon ged. 3. Deep partial-thickness burn ( Fig. 46-5)

a . Exten ds deeper in to th e skin derm is b . Blister form ation usually does n ot occur

because th e dead tissue layer is th ick an d sticks to un d erlyin g viable derm is.

c. Woun d surface is red an d dry with wh ite areas in deeper parts.

d . May or m ay n ot blan ch , an d edem a is m od erate.

e. Can con vert to full-th ickn ess burn if tissue dam age in creases with in fectio n , h ypo xia, or isch em ia.

f. Gen erally h eals in 3 to 6 weeks, but scar for- m ation results an d skin graftin g m ay be n ecessary.

4. Full-thickness burn (Fig. 46-6)

a . In volves in jury an d destruction of th e epider- m is an d th e derm is; th e woun d will n ot h eal by reepith elialization an d graftin g m ay be required.

b . Appears as a dry, h ard, leath ery esch ar (burn crust or dead tissue m ust slough off or be rem oved from th e woun d befo re h ealin g can occur)

c. Appears waxy wh ite, deep red, yello w, brown , or black

d . In jured surface ap pears dry. e. Edem a is presen t un d er th e esch ar. f. Sen sation is reduced or absen t because of

n erve en din g destructio n . g. Healin g m ay take weeks to m on th s an d

depen ds on establish in g an adequ ate blood supply.

h . Burn requires rem oval of esch ar an d split- or full-th ickn ess skin graftin g.

i. Scarrin g an d woun d con tractures are likely to develop.

5. Deep full-thickness burn (Fig. 46-7) a . In jury exten ds beyon d th e skin in to un d erly-

in g fascia an d tissues, an d m uscle, bon e, an d ten don s are dam aged.

b . In jured area appears black an d sen sation is com pletely absen t.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

FIGURE 46-3 Tissues involved in superficial burns.

FIGURE 46-4 Typical appearance of superficial partial-thickness burn injury. (From Ignatavicius, Workman, 2016.)

FIGURE 46-5 Typical appearance of deep partial-thickness burn injury. (From Ignatavicius, Workman, 2016.)

FIGURE 46-6 Typical appearance of full-thickness burn injury. (From Ignatavicius, Workman, 2016.)

555CHAPTER 46 Integumentary System

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

c. Esch ar is h ard an d in elastic. d . Th ere is lack of pain because n erve en din gs

h ave been destroyed. e. Healin g takes m on th s an d grafts are required.

E. Age an d gen eral h ealth 1. Mortality rates are h igh er for ch ildren youn ger

th an 4 years of age, particularly for ch ildren from birth to 1 year of age, an d for clien ts older th an 65 years.

2. Debilitatin g disorders, such as cardiac, respira- tory, en docrin e, an d ren al disorders, n egatively in fluen ce th e clien t’s respon se to in jury an d treatm en t.

3. Mortality rate is h igh er wh en th e clien t h as a pre- existin g disorder at th e tim e of th e burn in jury.

F. Burn location 1. Burn s of th e h ead, n eck, an d ch est are associated

with pulm o n ary com plication s. 2. Burn s of th e face are associated with corn eal

ab rasion . 3. Burn s of th e ear are associated with auricular

ch on dritis. 4. Han ds an d join ts require in ten sive th erap y to

preven t disability. 5. Th e perin eal area is pron e to autocon tam in ation

by urin e an d feces. 6. Circum feren tial burn s of th e extrem ities can pro-

duce a tourn iquet-like effect an d lead to vascular com pro m ise (com partm en t syn dro m e).

7. Circum feren tial thorax burn s lead to in adequate ch est wall expan sion an d pulm on ary in sufficien cy.

XX. Inhalation Injuries A. Smoke inhalation injury

1. Description : Resp iratory in ju ry th at occurs wh en th e victim in h ales produ cts of com bu stion dur- in g a fire.

The airway is a priority concern in an inhalation injury.

2. Assessm en t a. Facial burn s b . Eryth em a

c. Swellin g of oroph aryn x an d n aso ph aryn x d . Sin ged n asal h airs e. Flarin g n ostrils f. Stridor, wh eezin g, an d dyspn ea g. Hoarse voice h . Sooty (carbon aceous) sputum an d cough i. Tach ycardia j. Agitation an d an xiety

B. Carbon monoxide poisoning 1. Description

a . Carbon m on oxide is a colorless, odorless, an d tasteless gas th at h as an affin ity for h em o- globin 200 tim es greater th an th at of oxygen .

b . O xygen m olecu les are displaced an d carbon m on oxide reversibly bin d s to h em oglob in to form carbo xyh em o glob in .

c. Tissue h ypoxia occurs. 2. Assessm en t ( Table 46-5)

C. Direct th erm al h eat in jury 1. Description

a . Th erm al h eat in jury can occur to th e lo wer airways by th e in h alation of steam or explo- sive gases or th e aspiration of scald in g liquids.

b . In jury can occur to th e upper airways, wh ich appear eryth em atou s an d edem atous, with m ucosal blisters an d ulceratio n s.

c. Mucosal edem a can lead to upper airway obstru ction , esp ecially durin g th e first 24 to 48 h ours.

d . All clien ts with h ead or n eck burn s sh o uld be m on itored clo sely for th e developm en t of airway obstruction an d are con sidered

FIGURE 46-7 Typical appearance of deep full-thickness burn injury. (From Ignatavicius, Workman, 2016.)

TABLE 46-5 Carbon Monoxide Poisoning Blood Level (%) Clinical Manifestations

1-10 Normal level

11-20 (mild poisoning) Headache Flushing Decreased visual acuity Decreased cerebral functioning Slight breathlessness

21-40 (moderate poisoning)

Headache Nausea and vomiting Drowsiness Tinnitus and vertigo Confusion and stupor Pale to reddish-purple skin Decreased blood pressure Increased and irregular heart rate Depressed ST segment on electrocardiogram

41-60 (severe poisoning) Coma Seizures Cardiopulmonary instability

61-80 (fatal poisoning) Death

Adapted from Ignatavicius D, Workm an ML: Medical-surgical nursing: patient- centered collaborative care, ed 8, Philadelphia, 20 16, Saunders .

556 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

im m ediately for en dotrach eal in tub ation if obstru ction occurs.

2. Assessm en t a . Eryth em a an d edem a of th e upper airways b . Mucosal blisters an d ulceration s

XXI. Pathophysiology of Burns A. Followin g a burn , vasoactive substan ces are released

from th e in ju red tissue, an d th ese substan ces cau se an in crease in cap illary perm eability, allowin g th e plasm a to seep in to th e surroun din g tissues.

B. Th e direct in jury to th e vessels in creases capillary perm eability (capillary perm eability decreases 18 to 26 h ours after th e burn , but does n ot n orm alize un til 2 to 3 weeks followin g in ju ry).

C. Exten sive burn s result in gen eralized body edem a an d a decrease in circulatin g in travascular blood volum e.

D. Th e fluid losses result in a decrease in organ perfusio n .

E. Th e h eart rate in creases, cardiac outp ut decreases, an d blood pressure drops.

F. In itially, h ypon atrem ia an d h yperkalem ia occur. G. Th e h em atocrit level in creases as a result of plasm a

loss; th is in itial in crease falls to below n orm al by th e th ird to fourth day after th e burn as a result of red blood cell dam age an d loss at th e tim e of in jury.

H. In itially, th e body sh un ts blood from th e kidn eys, causin g oliguria; th en th e body begin s to reabsorb fluid, an d diuresis of th e excess flu id occurs over th e n ext days to weeks.

I. Blood flow to th e gastro in testin al tract is dim in - ish ed, lead in g to in testin al ileus an d gastroin testin al dysfun ction .

J. Im m un e system fun ction is dep ressed, resultin g in im m un osuppression an d th u s in creasin g th e risk of in fectio n an d sepsis.

K. Pulm on ary h yperten sio n can develop, resultin g in a decrease in th e arterial oxygen ten sion level an d a decrease in lun g com plian ce.

L. Evaporative fluid losses th rou gh th e burn woun d are greater th an n orm al, an d th e losses con tin ue un til com plete woun d closure occurs.

M. If th e in travascular space is n ot replen ish ed with in traven o usly adm in istered flu ids, h ypo volem ic sh ock an d ultim ately death occur.

XXII. Management of the Burn Injury A. Resu scitation / em ergen t ph ase ( Table 46-6)

1. Preh osp ital care a . Begin s at th e scen e of th e acciden t an d en ds

wh en em ergen cy care is obtain ed b . Rem o ve th e victim from th e source of

th e burn . c. Assess th e ABCs—airway–breath in g–circula-

tion . d . Assess for associated traum a, in cludin g in h a-

lation in ju ry.

e. Con serve body h eat. f. Cover burn s with sterile or clean cloth s. g. Rem o ve co n strictin g jewelry an d clo th in g. h . In sert in traven ous (IV) access. i. Tran sport to th e em ergen cy dep artm en t.

2. Em ergen cy departm en t care is a con tin uation of care adm in istered at th e scen e of th e in jury.

3. Major burn s a. Evaluate th e degree an d exten t of th e burn

an d treat life-th reaten in g con d ition s. b . En sure a paten t airway an d ad m in ister 100%

oxygen as prescribed. c. Mon itor for respiratory distress an d assess

th e n eed for in tub ation . d . Assess th e oroph aryn x for blisters an d ery-

th em a; assess vocal quality an d for sin ged n asal h airs an d auscultate lun g soun ds.

e. Mon itor arterial blood gases an d carbo xyh e- m oglobin levels.

TABLE 46-6 Phases of Management of the Burn Injury Phase Goal

Resuscitation/ Emergent Phase Begins at the time of injury Ends with the restoration of

normal capillary permeability Duration usually 48 to 72 hr Includes prehospital care and

emergency department care

The primary goal is to maintain a patent airway, administer intravenous fluids to prevent hypovolemic shock, and preserve vital organ functioning.

Resuscitative Phase Begins with the initiation of

fluids Ends when capillary integrity

returns to near-normal levels and large fluid shifts have decreased

Amount of fluid administered is based on client’s weight and extent of injury

(Most fluid replacement formulas are calculated from the time of injury and not from the time of arrival at the hospital)

The goal is to prevent shock by maintaining adequate circulating blood volume and maintaining vital organ perfusion.

Acute Phase Begins when the client is

hemodynamically stable, capillary permeability is restored, and diuresis has begun

Usually begins 48 to 72 hr after time of injury

Focus on infection control, wound care, wound closure, nutritional support, pain management, and physical therapy

The emphasis during this phase is placed on restorative therapy, and the phase continues until wound closure is achieved.

Rehabilitative Phase Overlaps acute phase of care Extends beyond hospitalization

The goals of this phase are designed so that the client can gain independence and achieve maximal function.

557CHAPTER 46 Integumentary System

f. For an in h alation in ju ry, adm in ister 100% oxygen via a tigh t-fittin g n on reb reath er face m ask as prescribed un til th e carboxyh em o- globin level falls below 15%.

g. In itiate periph eral IV access to n on bu rn ed skin proxim al to an y extrem ity burn , or pre- pare for th e in sertio n of a cen tral ven ous lin e as prescribed.

h . Assess for h ypovo lem ia an d prepare to adm in ister fluid s in traven o usly to m ain tain fluid balan ce.

i. Mon itor vital sign s clo sely. j. In sert a Foley cath eter as prescribed, an d

m an age fluid resuscitation with goal to m ain tain urin e outp ut at 30 to 50 m L/ h ou r.

k . Main tain NPO (n oth in g by m outh ) status. l. Insert a n asogastric tube as prescribed to rem ove

gastric secretion s and preven t aspiration. m . Adm in ister tetan us proph ylaxis as prescribed. n . Adm in ister pain m edication , as prescribed,

by th e IV ro ute. o . Prepare th e clien t for an esch aro tom y or fas-

ciotom y as prescribed. 4. Min or burn s

a. Adm in ister pain m edication as prescribed. b . In struct th e clien t in th e use of oral an algesics

as prescribed. c. Adm in ister tetan us proph ylaxis as prescribed. d . Adm in ister woun d care as prescribed, wh ich

m ay in clude clean sin g, debridin g loose tis- sue, an d rem ovin g an y dam agin g agen ts, fol- lowed by th e ap plication of topical an tim icrobial cream an d a sterile dressin g.

e. In struct th e clien t in follow-up care, in clud- in g active ran ge-of-m otion exercises an d woun d care treatm en ts.

B. Resu scitative ph ase (see Table 46-6) 1. Flu id resuscitation ( Table 46-7)

a . Th e am oun t of fluid adm in istered depen ds on h ow m uch IV fluid per h our is required to m ain tain a urin ary outp ut of 30 to 50 m L/ h ou r.

b . Successful flu id resuscitation is evaluated by stable vital sign s, an adequ ate urin e output, palpab le periph eral pulses, an d in tact level of co n sciousn ess an d th o ugh t processes.

c. IV fluid replacem en t m ay be titrated (adjusted) on th e basis of urin ary outp ut plus serum electrolyte levels to m eet th e perfusio n n eeds of th e clien t with burn s.

d . If th e h em oglob in an d h em atocrit levels decrease or if th e urin ary outp ut exceeds 50 m L/ h ou r, th e rate of IV flu id adm in istra- tion m ay be decreased.

Urinary output is the most reliable and most sensi- tive noninvasive assessment parameter for cardiac out- put and tissue perfusion.

2. In terven tion s a . Mon itor for trach eal or laryn geal edem a an d

adm in ister respiratory treatm en ts as pre- scribed; in tubation an d m ech an ical ven tila- tion are in stituted with respiratory burn s before com plication s develop, if n eeded.

b . Mon itor pulse oxim etry an d prepare for arte- rial blood gases an d carbo xyh em o globin levels if in h alation in jury is suspected.

c. Elevate th e h ead of th e bed to 30 degrees or m ore for burn s of th e face an d h ead.

d . Mon itor for fluid overload an d pulm on ary edem a.

e. In itiate electrocardiograp h ic m on itorin g. f. Mon itor tem p erature an d assess for in fectio n . g. In itiate protective isolation tech n iqu es;

m ain tain strict h an d wash in g; use sterile sh eets an d lin en s wh en carin g for th e clien t; an d use gloves, cap , m asks, sh oe covers, scrub cloth es, an d plastic apron s.

h . Clip body h air arou n d woun d m argin s. i. Mon itor daily weigh ts, exp ectin g a weigh t

gain of 6 to 9 kilogram s (15 to 20 poun ds) in th e first 72 h ours.

j. Mon itor gastric output an d pH levels an d for gastric discom fort an d bleed in g, in dicatin g a stress ulcer.

k . Adm in ister an tacids, H 2 receptor an tago- n ists, an d an tiulcer m ed ication s as pre- scribed to preven t a stress ulcer.

l. Auscu ltate bowel soun ds for ileus an d m on - itor for abdom in al disten tion an d gastro in - testin al dysfun ction .

m . Mon itor stools for occult blood . n . O btain urin e specim en for m yoglobin an d

h em oglob in levels.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

TABLE 46-7 Common Fluid Resuscitation Formulas for First 24 Hours After a Burn Injury

Formula Solution Amount

Modified Brooke 5% albumin in isotonic

saline Lactated Ringer’s

without dextrose

0.5 mL to 15 mL/ kg/ % TBSA burn

Parkland (Baxter) Crystalloid only (lactated

Ringer’s) 4 mL/ kg/ % TBSA burn

Modified Parkland Crystalloid only (lactated

Ringer’s) 4 mL/ kg/ % TBSA burn

+ 15 mL/ m2 of TBSA

TBSA, Total body surface area. From Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 8, Philadelphia, 2016, Saunders.

558 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

o . Mon itor IV fluids an d h ourly in take an d out- put to determ in e th e adequ acy of fluid replacem en t th erap y; n otify th e h ealth care provider (HCP) if urin e outp ut is less th an 30 or greater th an 50 m L/ h ou r. Mon itor serum labo ratory, in cludin g electrolytes an d com plete blood co un t.

p . Elevate circum feren tial burn s of th e extrem i- ties on pillows above th e level of th e h eart to reduce depen den t edem a if n o obvious frac- tures are presen t; diuretics in crease th e risk of h ypo volem ia an d are gen erally avoided as a m ean s of decreasin g edem a.

q . Mon itor pulses an d capillary refill of the affected extrem ities an d assess perfusion of the distal extrem ity with a circum feren tial burn .

r . Prepare to obtain ch est x-rays an d oth er radiograph s to rule out fractures or associ- ated traum a.

s. Keep th e room tem perature warm . t . Place th e clien t on an air-fluidized bed or

oth er special m attress an d use a bed cradle to keep sh eets off th e clien t’s skin .

3. Pain m an agem en t a. Adm in ister opioid an algesics as prescribed by

th e IV route. b . Avoid ad m in isterin g m edication by th e oral

route because of th e possib ility of gastro in tes- tin al dysfun ction .

c. Med icate th e clien t as prescribed an d before pain ful procedures.

Avoid the intramuscular or subcutaneous medica- tion route for medication administration because absorption through the soft tissue is unreliable when hypovolemia and large fluid shifts occur.

4. Nu trition a . Proper n utrition is essen tial to prom o te

woun d h ealin g an d preven t in fectio n . b . Th e basal m etab olic rate is 40 to 100 tim es

h igh er th an n orm al with a burn in ju ry. c. Main tain NPO status un til bowel soun ds are

h eard, an d th en advan ce to clear liqu ids as prescribed.

d . Dietary con sultation m ay be prescribed. Nutri- tion m ay be provided via en teral tube feedin g or paren teral n utrition th rough a cen tral lin e.

e. Provide a diet h igh in protein , carbo h ydrates, fats, an d vitam in s, with m ajor burn s requir- in g m ore th at 5000 calories daily.

f. Mon itor calorie in take an d daily weigh ts. 5. Esch arotom y

a . A len gth wise in cision is m ade th rou gh th e burn esch ar to relieve con striction an d pres- sure an d to im prove circulation .

b . Esch arotom y is perform ed for circulatory com pro m ise cau sed by circum feren tial burn s.

c. Esch arotom y can be perform ed at th e bedside with ou t an esth esia because n erve en din gs h ave been destroyed by th e burn in jury.

d . Esch arotom y m ay be n ecessary on th e th o rax to im prove ven tilation .

e. Followin g th e esch arotom y, assess pulses, color, m ovem en t, an d sen sation of affected extrem ity an d con tro l an y bleedin g with pressure.

f. Pack th e in cision gen tly with fin e m esh gauze as prescribed after esch arotom y.

g. Apply topical an tim icrobial agen ts to th e area as prescribed.

6. Fasciotom y a . An in cision is m ade exten din g th rou gh th e

subcu tan eous tissue an d fascia. b . Th e proced ure is perform ed if adequate tissue

perfusion does n ot return followin g an esch arotom y.

c. Fasciotom y is perform ed in th e operatin g room with the clien t under gen eral an esth esia.

d . Followin g th e procedure, assess pulses, color, m ovem en t, an d sen sation of affected extrem - ity an d con trol an y bleedin g with pressure.

e. Apply topical an tim icrobial agen ts an d dress- in gs to th e area, as prescribed.

C. Acute ph ase (see Table 46-6) 1. Con tin ue with protective isolatio n tech n iques. 2. Provide woun d care as prescribed an d prepare for

woun d clo sure. 3. Provide pain m an agem en t. 4. Provide ad equate n utrition as prescribed . 5. Prepare th e clien t for reh abilitation .

D. Woun d care ( Table 46-8) 1. Description : Clean sin g, debridem en t, an d dress-

in g of burn woun ds 2. Hydro th erap y

a . Woun ds are clean sed by sh owerin g on a spe- cial table, or wash in g sm all areas of woun d at bedside.

b . Hydro th erap y occurs for 30 m in utes or less to preven t in creased sodium lo ss th rou gh th e burn woun d, h eat loss, pain , an d stress.

c. Clien t sh ould be prem edicated before proced ure.

d . Hydro th erap y is n ot used for clien ts wh o are h em od yn am ically un stable or th o se with n ew skin grafts.

e. Care is taken to m in im ize bleedin g an d m ain tain body tem p erature durin g th e proced ure.

f. Prescribed an tim icrobial agen ts are applied after h ydroth erapy.

3. Debridem en t ( Box 46-2) a . Debrid em en t is rem oval of esch ar or n ecro tic

tissue to preven t bacterial proliferation un der th e esch ar an d to prom o te woun d h ealin g.

559CHAPTER 46 Integumentary System

b . Debrid em en t m ay be m ech an ical, en zym atic, or surgical.

c. Deep partial-th ickn ess burn s or deep full- th ickn ess burn s: Woun d is clean sed an d de- brided, an d topical an tim icrobial agen ts are applied on ce or twice daily.

E. Woun d clo sure 1. Description

a. Woun d closure preven ts in fectio n an d loss of fluid.

b . Closure prom o tes h ealin g. c. Closure preven ts con tractures.

d . Woun d closure is perform ed usually on day 5 to 21 followin g th e in jury, depen din g on th e exten t of th e burn .

2. Woun d coverin gs (Box 46-3) 3. Autograftin g

a . Autograftin g provides perm an en t woun d coverage.

b . Autograftin g is th e surgical rem oval of a th in layer of th e clien t’s own un burn ed skin , wh ich th en is applied to th e excised burn wound.

c. Autograftin g is perform ed in th e operatin g room un der an esth esia.

d . Mon itor for bleedin g follo win g th e graft pro- cedure because bleed in g ben eath an autograft can preven t adh eren ce.

e. If prescribed, sm all am ounts of blood or serum can be rem oved by gen tly rollin g th e fluid from th e cen ter of th e graft to th e periph ery with a sterile gauze pad, wh ere it can be absorbed.

f. For large accu m ulation s of blood , th e HCP m ay aspirate th e blood usin g a sm all-gauge n eedle an d syrin ge.

g. Autografts are im m ob ilized followin g surgery for 3 to 7 days to allow tim e to ad h ere an d attach to th e woun d bed.

h . Position th e clien t for im m obilization an d elevation of th e graft site to preven t m ove- m en t an d sh earin g of th e graft.

4. Care of th e graft site a . Elevate an d im m ob ilize th e graft site. b . Keep th e site free from pressure. c. Avoid weigh t-bearin g. d . Wh en th e graft takes, if prescribed, roll a

cotton -tipped applicator over th e graft to rem ove exudate, because exudate can lead to in fection an d preven t graft adh erence.

e. Mon itor for foul-sm ellin g drain age, in creased tem perature, in creased white blood cell coun t, h em atom a form ation , an d fluid accum ulation .

f. In struct th e clien t to avoid usin g fabric soften ers an d harsh detergents in th e laun dry.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

TABLE 46-8 Open Method Versus Closed Method of Wound Care Method Advantages Disadvantages

Open Antimicrobial cream is applied as prescribed, and wound is

left open to the air without a dressing Visualization of the wound Easier mobility and joint range of motion Simplicity in wound care

Increased chance of hypothermia from exposure

Closed Gauze dressings are carefully wrapped from the distal to the

proximal area of the extremity to ensure that circulation is not compromised

No two burn surfaces should be allowed to touch; touching can promote webbing of digits, contractures, and poor cosmetic outcome

Dressings are changed usually every 8 to 12 hr

Decreases evaporative fluid and heat loss

Aids in debridement

Mobility limitations Prevents effective range-of-motion

exercises Wound assessment limited

BOX 46-2 Debridement

Mechanical ▪ Performed during hydrotherapy; involves use of wash-

cloths or sponges to cleanse and debride eschar and the use of scissors and forceps to lift and trim away loose eschar

▪ May include wet-to-dry or wet-to-wet dressing changes ▪ Painful procedure; may cause bleeding Enzymatic ▪ Application of topical enzyme agents directly to the wound;

the agent digests collagen in necrotic tissue

Surgical ▪ Excision of eschar or necrotic tissue via a surgical proce-

dure in the operating room

Tangential Technique ▪ Very thin layers of the necrotic burn surface are excised

until bleeding occurs (bleeding indicates that a healthy der- mis or subcutaneous fat has been reached).

Fascial Technique ▪ The burn wound is excised to the level of superficial fascia;

this technique is usually reserved for very deep and exten- sive burns.

560 UNIT VIII Integumentary Disorders of the Adult Client

g. In struct th e clien t to lubricate th e h ealin g skin with prescribed agen ts.

h . In struct th e clien t to protect th e affected area from sun ligh t.

i. In struct th e clien t to use splin ts an d support garm en ts as prescribed.

5. Care of th e don or site a. Meth od of care varies, dep en din g on th e

HCP’s preferen ce. b . A n on adh eren t gauze dressin g m ay be

applied at th e tim e of th e surgery to m ain tain pressure an d stop an y oozin g; coverin g th e site decreases discom fort from exposed n erve en din gs; always ch eck th e surgeon ’s preferen ce.

c. Th e HCP m ay prescribe site treatm en t with gauze im pregn ated with petrolatum or with a biosyn th etic dressin g.

d . Keep th e don or site clean , dry, an d free fro m pressure.

e. Preven t th e clien t from scratch in g th e don or site.

f. Apply lubricatin g lotion s to soften th e area an d reduce th e itch in g after th e don or site is h ealed.

g. Don o r site can be reused on ce h ealin g h as occurred (h eals spon tan eously with in 7 to 14 days with proper care).

F. Ph ysical th erap y 1. An in dividualized program of splin tin g, posi-

tion in g, exercises, am bulation , an d activities of daily livin g is im plem en ted early in th e acute ph ase of recovery to m axim ize fun ction al an d cosm etic outcom es.

2. Perform ran ge-of-m otion exercises as prescribed to reduce edem a an d m ain tain stren gth an d join t fun ction .

3. Am bu late th e clien t as prescribed to m ain tain th e stren gth of th e lower extrem ities.

4. Apply splin ts as prescribed to m ain tain proper join t position an d preven t con tractures. a . Static splin ts im m ob ilize th e join t an d are

applied for periods of im m obilization , dur- in g sleepin g, an d for clien ts wh o can n ot m ain tain proper position in g.

b . Dyn am ic splin ts exercise th e affected join t. c. Avoid pressure to skin areas wh en applyin g

splin ts, wh ich could lead to furth er tissue an d n erve dam age.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

BOX 46-3 Wound Coverings Biological Amniot ic Membra nes ▪ Amniotic membrane from human placenta is used; adheres

to the wound. ▪ Effective as a dressing until epithelial cell regrowth occurs ▪ Requires frequent changes because it does not develop a

blood supply and disintegrates in about 48 hours

Allograft or Homograft (Huma n Tissue) ▪ Donated human cadaver skin provided through a skin bank ▪ Monitor for wound exudate and signs of infection. ▪ Rejection—can occur within 24 hours ▪ Risk of transmitting bloodborne infection exists when used Xenogra ft or Heterogra ft (Anima l Tissue) ▪ Pigskin harvested after slaughter is preserved for storage

and use. ▪ Monitor for infection and wound adherence. ▪ Placed over granulation tissue; replaced every 2 to 5 days until

wound heals naturallyor until closure with autograft is complete

Cult ured Skin ▪ Grown in laboratory from a small specimen of epidermal

cells from an unburned portion of the client’s body ▪ Cell sheets are grafted on the client to generate permanent

skin surface. ▪ Cell sheets are not durable; care must be taken when apply-

ing to ensure adherence and prevent sloughing.

Art ificia l Skin ▪ Consists of 2 layers—Silastic epidermis and porous dermis

made from bovine hide collagen and shark cartilage

▪ After application, fibroblasts move into the collagen part of the artificial skin and create a structure similar to normal dermis.

▪ Artificial dermis then dissolves; it is then replaced with nor- mal blood vessels and connective tissue called neodermis.

▪ Neodermis supports the standard autograft placed over it when the Silastic layer is removed.

Biosynthetic ▪ Combination of biosynthetic and synthetic materials ▪ Placed in contact with the wound surface; forms an adherent

bond until epithelialization occurs ▪ Porous substance allows exudate to pass through. ▪ Monitor for wound exudate and signs of infection. Synthetic ▪ Applied directly to the surface of a clean or surgically pre-

pared wound; remains in place until it falls off or is removed ▪ Covering is transparent or translucent; therefore, wound can

be inspected without removing dressing. ▪ Pain at the wound site is reduced because covering prevents

contact of the wound with air.

Autograft ▪ Skin taken from a remote unburned area of the client’s own

body; transplanted to cover burn wound ▪ Graft placed on a clean granulated bed or over surgically

excised area of the burn ▪ Provides for permanent skin coverage

561CHAPTER 46 Integumentary System

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

5. Scarrin g is con tro lled by elastic wraps an d ban - dages th at apply con tin uous pressure to th e h eal- in g skin durin g th e tim e in wh ich th e skin is vu ln erable to sh earin g.

6. An ti–burn scar support garm en ts are usually prescribed to be worn 23 h ours a day un til th e burn scar tissue h as m atured , wh ich takes 18 to 24 m on th s.

G. Reh abilitative ph ase (see Table 46-6) 1. Description : Reh abilitation is th e fin al ph ase of

burn care. 2. Goals

a. Prom o te woun d h ealin g. b . Min im ize deform ities. c. In crease stren gth an d fun ctio n . d . Provid e em o tion al support.

CRITICAL THINKING What Should You Do? Answer: The nurse should elevate and immobilize the graft site, keep the site free from pressure, and not allow the client to bear weight on the extremity. When the graft takes, if pre- scribed, the nurse should roll a cotton-tipped applicator over the graft to remove exudate, because exudate can lead to infection and prevent graft adherence. The nurse should monitor for signs of infection such as foul-smelling drainage, increased temperature, and increased white blood cell count; and monitor for hematoma formation, or fluid accumulation.

Reference: Ignatavicius, Workman (20 16), p. 484.

P R A C T I C E Q U E S T I O N S 474. Th e n urse is con d uctin g a session about th e prin ci-

ples of first aid an d is discussin g th e in terven tion s for a sn akebite to an extrem ity. Th e n urse sh ould in form th o se atten din g th e session th at th e first p rio rity in terven tion in th e even t of th is occur- ren ce is wh ich action ? 1. Im m obilize th e affected extrem ity. 2. Rem ove jewelry an d con strictin g cloth in g from

th e victim . 3. Place th e extrem ity in a position so th at it is

below th e level of th e h eart. 4. Move th e victim to a safe area away from th e

sn ake an d en courage th e victim to rest.

475. A clien t calls th e em ergen cy departm en t an d tells th e n urse that h e cam e directly in to con tact with poison ivy sh rubs. Th e clien t tells th e n urse th at h e cann ot see anyth in g on th e skin an d asks th e n urse wh at to do. Th e n urse sh ould m ake which respon se? 1. “Com e to th e em ergen cy departm en t.” 2. “Apply calam in e lotion im m ediately to th e

exposed skin areas.”

3. “Take a sh ower im m ediately, lath erin g an d rin s- in g several tim es.”

4. “It is n ot n ecessary to do an yth in g if you can n ot see an yth in g on your skin .”

476. A clien t is bein g adm itted to th e h ospital for treat- m en t of acu te cellulitis of th e lower left leg. Du rin g th e adm ission assessm en t, th e n urse expects to n ote wh ich fin din g? 1. An in flam m ation of th e epiderm is on ly 2. A skin in fectio n of th e derm is an d un derlyin g

h ypo derm is 3. An acu te superficial in fection of th e derm is an d

lym p h atics 4. An epiderm al an d lym p h atic in fectio n cau sed

by Staphylococcus

477. Th e clin ic n urse assesses th e skin of a clien t with psoriasis after th e clien t h as used a n ew topical treatm en t for 2 m on th s. Th e n urse iden tifies wh ich ch aracteristics as im provem en t in th e m an ifesta- tion s of psoriasis? Select all th at ap p ly.

1. Presen ce of striae 2. Palp able radial pulses 3. Absen ce of an y ecch ym osis on th e extrem ities 4. Th in n er an d decrease in n um ber of reddish

papules 5. Scarce am oun t of silvery-wh ite scaly patch es

on th e arm s

478. Th e clin ic n urse n otes th at th e h ealth care provider h as docum en ted a diagn osis of h erpes zoster (sh in - gles) in th e clien t’s ch art. Based on an un derstan d- in g of th e cause of th is disorder, th e n urse determ in es th at th is defin itive diagn osis was m ade by wh ich diagn ostic test? 1. Positive patch test 2. Positive culture results 3. Abn orm al biopsy results 4. Wood ’s ligh t exam in ation in dicative of

in fectio n

479. A clien t return s to th e clin ic for follow-up treat- m en t follo win g a skin biopsy of a susp iciou s lesion perform ed 1 week ago. Th e biopsy report in dicates th at th e lesion is a m elan om a. Th e n urse un der- stan d s th at m elan om a h as wh ich ch aracteristics? Select all th at ap p ly.

1. Lesion is pain ful to touch . 2. Lesio n is h igh ly m etastatic. 3. Lesio n is a n evus th at h as ch an ges in color. 4. Skin un der th e lesion is redden ed an d warm

to touch . 5. Lesion occurs in body area exposed to out-

door sun ligh t.

562 UNIT VIII Integumentary Disorders of the Adult Client

480. Wh en assessin g a lesion diagn osed as basal cell carcin om a, th e n urse m o st likely expects to n ote wh ich fin din gs? Select all th at ap p ly.

1. An irregularly sh ap ed lesion 2. A sm all papule with a dry, rough scale 3. A firm , n od ular lesion topped with crust 4. A pearly papule with a cen tral crater an d a

waxy border 5. Location in th e bald spot atop th e h ead th at is

exposed to outdoor sun ligh t

481. A clien t arrivin g at th e em ergen cy departm en t h as experien ced frostbite to th e righ t h an d. Wh ich fin din g would th e n urse n ote on assessm en t of th e clien t’s h an d? 1. A pin k, edem atous h an d 2. Fiery red skin with edem a in th e n ail bed s 3. Black fin gertips surroun ded by an eryth em a-

tous rash 4. A wh ite color to th e skin , wh ich is in sen sitive

to touch

482. Th e even in g n urse reviews th e n ursin g docum en ta- tion in a clien t’s ch art an d n otes th at th e day n urse h as docum en ted th at th e clien t h as a stage II pres- sure ulcer in th e sacral area. Wh ich fin din g would th e n urse expect to n ote on assessm en t of th e cli- en t’s sacral area? 1. In tact skin 2. Full-th ickn ess skin loss 3. Exposed bon e, ten don , or m uscle 4. Partial-th ickn ess skin loss of th e derm is

483. An ad ult clien t was burn ed in an exp losion . Th e burn in itially affected th e clien t’s en tire face (an te- rior h alf of th e h ead ) an d th e upper h alf of th e an te- rior torso, an d th ere were circum feren tial burn s to th e lower h alf of both arm s. Th e clien t’s cloth es caugh t on fire, an d th e clien t ran , cau sin g subse- quen t burn in juries to th e posterio r surface of th e h ead an d th e upper h alf of th e posterior torso. Usin g th e rule of n in es, wh at would be th e exten t of th e burn in ju ry? 1. 18% 2. 24% 3. 36% 4. 48%

484. Th e n urse is preparin g to care for a burn clien t sch eduled for an esch arotom y proced ure bein g perform ed for a th ird-degree circum feren tial arm burn . Th e n urse un d erstan ds th at wh ich fin din g is th e an ticip ated th erap eutic outcom e of th e esch arotom y? 1. Return of distal pulses

2. Brisk bleed in g from th e site 3. Decreasin g edem a form ation 4. Form ation of gran ulation tissue

485. A clien t is un dergoin g fluid replacem en t after bein g burn ed on 20% of h er body 12 h ours ago. Th e n urs- ing assessm en t reveals a blood pressure of 90/ 50 m m Hg, a pulse rate of 110 beats/m in ute, an d a urin e out- put of 20 m L over th e past h our. Th e nurse reports th e fin din gs to th e h ealth care provider (HCP) an d an ticipates wh ich prescription ? 1. Tran sfusin g 1 un it of packed red blood cells 2. Adm in isterin g a diuretic to in crease urin e

output 3. In creasin g th e am oun t of in traven ous (IV) lac-

tated Rin ger’s solution ad m in istered per h our 4. Ch an gin g th e IV lactated Rin ger’s solution to

on e th at con tain s 5% dextrose in water

486. A clien t is brough t to th e em ergen cy departm en t with partial-th ickn ess burn s to h is face, n eck, arm s, an d ch est after tryin g to put out a car fire. Th e n urse sh ould im plem en t wh ich n ursin g action s for th is clien t? Select all th at ap p ly.

1. Restrict flu ids. 2. Assess for airway paten cy. 3. Adm in ister oxygen as prescribed. 4. Place a coolin g blan ket on th e clien t. 5. Elevate extrem ities if n o fractures are presen t. 6. Prepare to give oral pain m ed ication as

prescribed .

487. Th e n urse is carin g for a clien t wh o sustain ed super- ficial partial-th ickn ess burn s on th e an terior lower legs an d an terior th o rax. Wh ich fin din g does th e n urse expect to n ote durin g th e resuscitation / em er- gen t ph ase of th e burn in jury? 1. Decreased h eart rate 2. In creased urin ary output 3. In creased blood pressure 4. Elevated h em atocrit levels

488. Th e n urse m an ager is plan n in g th e clin ical assign - m en ts for th e day. Wh ich staff m em bers can n ot be assign ed to care for a clien t with h erp es zoster? Select all th at ap p ly.

1. Th e n urse wh o n ever h ad roseola 2. Th e n urse wh o n ever h ad m um ps 3. Th e n urse wh o n ever h ad ch icken pox 4. Th e n urse wh o n ever h ad Germ an m easles 5. Th e n urse wh o n ever received th e varicella-

zoster vaccin e

489. A clien t arrives at th e em ergen cy departm en t fol- lo win g a burn in jury th at occurred in th e basem en t

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

563CHAPTER 46 Integumentary System

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

at h om e, an d an in h alation in jury is susp ected. Wh at would th e n urse an ticipate to be prescribed for th e clien t? 1. 100% oxygen via an aerosol m ask 2. O xygen via n asal can n ula at 6 L/ m in ute 3. O xygen via n asal can n ula at 15 L/ m in ute 4. 100% oxygen via a tigh t-fittin g, n on rebreath er

face m ask

490. Th e n urse is adm in isterin g fluid s in traven o usly as prescribed to a clien t wh o sustain ed superficial partial-th ickn ess burn in ju ries of th e back an d legs. In evalu atin g th e adequ acy of fluid resuscitation , th e n urse un derstan ds th at wh ich assessm en t would provide th e m o st reliable in dicator for determ in in g th e adequacy? 1. Vital sign s 2. Urin e outp ut 3. Men tal status 4. Periph eral pulses

491. Th e n urse m an ager is observin g a n ew n ursing grad- uate carin g for a burn clien t in protective isolation. Th e n urse m an ager in tervenes if th e n ew n ursin g graduate plann ed to im plem en t wh ich un safe com - pon en t of protective isolation tech n ique?

1. Usin g sterile sh eets an d lin en s 2. Perform in g strict h an d-wash in g tech n ique 3. Wearin g gloves an d a go wn on ly wh en givin g

direct care to th e clien t 4. Wearin g protective garb, in cludin g a m ask,

gloves, cap , sh oe covers, gown s, an d plastic apron

492. Th e n urse is carin g for a clien t followin g an auto- graft an d graftin g to a burn woun d on th e righ t kn ee. Wh at would th e n urse an ticipate to be pre- scrib ed for th e clien t? 1. O ut-o f-bed activities 2. Bath room privileges 3. Im m obilization of th e affected leg 4. Placin g th e affected leg in a depen den t position

493. Th e n urse is carin g for a clien t wh o suffered an in h alation in ju ry fro m a wood stove. Th e carbo n m on oxide blood report reveals a level of 12%. Based on th is level, th e n urse would an ticipate n ot- in g wh ich sign in th e clien t? 1. Com a 2. Flush in g 3. Dizzin ess 4. Tach ycardia

A N S W E R S 474. 4 Ra tion a le: In th e even t of a sn akeb ite, th e first p rio rity is to m ove th e victim to a safe area away fro m th e sn ake an d en cou r- age th e victim to rest to decrease ven o m circu lation . Next, jew- elry an d co n strictin g cloth in g are rem o ved b efo re swellin g o ccurs. Im m o bilizin g th e extrem ity an d m ain tain in g th e extrem ity at th e h eart level wo uld b e d on e n ext; th ese actio n s lim it th e sp read of th e ven om . Th e victim is kep t warm an d calm . Stim u lan ts su ch as alcoh ol o r caffein ated b everages are n o t given to th e victim b ecause th ese p rod ucts m ay speed th e ab sorption o f th e ven om . Th e victim sh o uld b e tran sp orted to an em ergen cy facility as soo n as po ssib le. Test-Ta kin g Str a tegy: Note th e strategic wo rd s, first priority. Elim in ate o ptio n s 1 an d 3 first becau se th ey are co m p arab le o r alike an d relate to po sitio n in g of th e affected extrem ity. For th e rem ain in g o ption s, th in k abo ut th em an d visu alize each . Movin g th e victim to a safe area is th e prio rity to p reven t fu rth er in jury fro m th e sn ake. Review: Care of th e clien t in th e even t o f a sn akeb ite Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Leadersh ip/ Man agem en t—Prioritizin g Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 124.

475. 3 Ra tion a le: Wh en an in d ivid ual com es in con tact with a p oiso n ivy p lan t, th e sap fro m th e p lan t fo rm s an in visible film on th e h u m an skin . Th e clien t sh ou ld b e in stru cted to clean se th e area b y sh o werin g im m ed iately an d to lath er th e skin several tim es an d rin se each tim e in run n in g water. Rem ovin g th e p oison ivy sap will d ecrease th e likelih o od o f irritatio n . Calam in e lotio n m ay b e o n e p ro d uct reco m m en ded fo r use if d erm atitis d evelop s. Th e clien t do es n ot n eed to be seen in th e em ergen cy d epartm en t at th is tim e. Test-Ta kin g Str a tegy: Focus o n th e su b ject, con tact with p o i- so n ivy. Recallin g th at derm atitis can develop fro m con tact with an allergen an d th at co n tact with p oison ivy resu lts in an in visible film will assist in directin g you to th e co rrect o ptio n . Review: Im m ediate treatm en t fo r co n tact with p o iso n ivy Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —In tegum en tary Pr ior it y Con cept s: Clien t Ed ucation ; Tissue In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 452-453.

476. 2 Ra tion a le: Cellulitis is an in fectio n o f th e d erm is an d u n d erly- in g h yp od erm is th at resu lts in a d eep red eryth em a with o u t sh arp bo rd ers an d spread s widely th rou gh o ut tissue sp aces.

564 UNIT VIII Integumentary Disorders of the Adult Client

Th e skin is eryth em ato us, ed em atou s, ten d er, an d som etim es n od u lar. Erysip elas is an acu te, su perficial, rapid ly sp read in g in flam m ation o f th e derm is an d lym p h atics. Th e in fectio n is n ot su perficial an d exten d s deep er th an th e ep id erm is. Test -Ta kin g Str a tegy: Elim in ate o ptio n s 3 an d 4 b ecause th ey are co m p arab le o r alike an d ad dress th e lym p h atics. Elim in ate op tion 1 because o f th e clo sed -en d ed wo rd only. Review: Ch aracteristics o f cellu litis an d erysip elas Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —In tegu m en tary Pr ior ity Con cepts: Clien t Edu catio n ; Tissu e In tegrity Refer en ce: Lewis et al. (2014), p p. 434-435.

477. 4, 5 Ra t ion a le: Psoriasis skin lesion s in clude th ick redden ed pap- ules o r p laqu es covered by silvery-wh ite p atch es. A decrease in th e severity o f th ese skin lesio n s is n oted as an im p ro vem en t. Th e presen ce of striae (stretch m arks), palp able pu lses, o r lack of ecch ym osis is n ot related to p so riasis. Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, m an ifestatio n s o f pso riasis. Use kn owled ge regardin g th e p ath o ph ysiolo gy an d sign s an d sym p tom s asso ciated with p soriasis. Th is will direct yo u to th e correct o ptio n s d etailin g a decrease in th e pso riatic sign s. Review: Man ifestatio n s associated with p so riasis Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ad ult Health —In tegu m en tary Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 456.

478. 2 Ra t ion a le: With th e classic presen tation of h erpes zoster, th e clin ical exam in atio n is d iagn o stic. Ho wever, a viral cu lture o f th e lesio n provid es th e d efin itive d iagn o sis. Herp es zo ster (sh in gles) is cau sed b y a reactivation o f th e varicella-zoster viru s, th e viru s th at cau ses ch icken po x. A patch test is a skin test th at in vo lves th e ad m in istration of an allergen to th e su rface o f th e skin to id en tify sp ecific allergies. A biop sy wo uld pro vide a cyto logical exam in atio n o f tissue. In a Woo d ’s ligh t exam in a- tion , th e skin is viewed u n d er ultraviolet ligh t to iden tify sup er- ficial in fectio n s o f th e skin . Test -Ta kin g Str a t egy: Fo cus o n th e su b ject, diagn osin g h erpes zoster. Recallin g th at h erpes zo ster is cau sed b y a virus will assist in d irectin g yo u to th e co rrect op tio n . Also rem em ber th at a b iop sy will determ in e tissu e type, wh ereas a cu lture will id en - tify an o rgan ism . Review: Herp es zo ster ( sh in gles) Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —In tegu m en tary Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p p. 450, 452.

479. 2, 3 Ra t ion a le: Melan om as are p igm en ted m align an t lesion s o rig- in atin g in th e m elan in -prod u cin g cells o f th e ep id erm is. Mela- n om as cau se ch an ges in a n evu s (m ole), in clud in g color an d b o rd ers. Th is skin can cer is h igh ly m etastatic, an d a perso n ’s su rvival d epen ds on early d iagn osis an d treatm en t. Melan om as are n o t p ain fu l o r accom pan ied b y sign of in flam m ation . Alth o ugh sun exp osu re in creases th e risk o f m elan om a, lesio n s are m ost com m on ly fou n d on th e up p er back an d legs an d o n th e soles an d p alm s o f p erson s with d ark skin . Test -Ta kin g St r a t egy: Focus on th e su b ject, ch aracteristics of m elan om a skin can cer. It is n ecessary to kn o w th e n o rm al ch ar- acteristics asso ciated with m elan om a in order to an swer th is q u estion correctly. Also , recallin g th at m elan om as are h igh ly m etastatic will assist in d irectin g yo u to th e co rrect o ption s. Review: Ch aracteristics o f m elan o m a Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —In tegu m en tary Pr ior ity Con cepts: Cellu lar Regu latio n ; Tissu e In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 459.

480. 4, 5 Ra t ion a le: Basal cell carcin om a app ears as a p early pap ule with a cen tral crater an d rolled waxy bo rd er. Exp o sure to u ltraviolet su n ligh t is a m ajo r risk facto r. A m elan om a is an irregularly sh aped p igm en ted p apu le o r plaq ue with a red -, wh ite-, o r b lu e-ton ed colo r. Actin ic keratosis, a p rem align an t lesio n , ap pears as a sm all m acule o r pap ule with a d ry, ro ugh , ad h er- en t yello w o r brown scale. Sq uam ou s cell carcin om a is a firm , n od u lar lesion top p ed with a crust o r a cen tral area o f u lceratio n . Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most likely. Recall ch aracteristics an d etio lo gy o f b asal cell can cer to direct yo u to th e co rrect o ption s. Review: Ch aracteristics o f b asal cell carcin o m a Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —In tegu m en tary Pr ior ity Con cepts: Cellu lar Regu latio n ; Tissu e In tegrity Refer en ces: Ign atavicius, Workm an (2016), p . 459; Lewis et al. ( 2014) , p . 432.

481. 4 Ra t ion a le: Assessm en t fin din gs in fro stbite in clud e a wh ite o r b lu e colo r; th e skin will b e h ard , co ld, an d in sen sitive to tou ch . As th awin g occurs, flush in g o f th e skin , th e d evelo pm en t o f b listers or blebs, o r tissue ed em a app ears. O p tio n s 1, 2, an d 3 are in correct. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, assessm en t fin d - in gs in fro stbite. No tin g th e wo rd s insensitive to touch in th e co r- rect op tio n sh o uld d irect you to th is op tion . Review: Ch aracteristics asso ciated with fro stb ite Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

565CHAPTER 46 Integumentary System

Con ten t Ar ea : Adu lt Health —In tegum en tary Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 132-133.

482. 4 Ra tion a le: In a stage II pressu re u lcer, th e skin is n o t in tact. Partial-th ickn ess skin loss o f th e d erm is h as o ccurred. It pre- sen ts as a sh allo w o pen u lcer with a red-p in k wou n d b ed, with - o ut slou gh . It m ay also presen t as an in tact o r o pen / rup tured serum -filled blister. Th e skin is in tact in stage I. Fu ll-th ickn ess skin lo ss o ccurs in stage III. Exp o sed b on e, ten d on , o r m uscle is p resen t in stage IV. Test-Ta kin g Str a tegy: Focus on th e su b ject, assessm en t of a p ressu re ulcer. Fo cusin g o n th e wo rd s stage II an d visualizin g th e app earan ce of a stage II p ressu re ulcer will d irect yo u to th e correct o ptio n . Review: Stages o f p ressu re u lcers Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —In tegum en tary Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 441-442.

483. 3 Ra tion a le: Accordin g to th e rule o f n in es, with th e in itial bu rn , th e an terior h alf o f th e h ead eq uals 4.5%, th e u pp er h alf o f th e an terio r torso equ als 9%, an d th e lower h alf of b oth arm s eq uals 9%. Th e su b sequ en t bu rn in clu ded th e p osterio r h alf o f th e h ead , eq ualin g 4.5%, an d th e u pp er h alf of p o sterio r to rso , equ alin g 9%. Th is totals 36%. Test-Ta kin g St r a t egy: Focu s o n th e su b ject, th e ru le o f n in es. Recallin g th e p ercen tages associated with th e ru le o f n in es an d fo cu sin g on th e bu rn in ju ry described in th e q uestion will d irect yo u to th e co rrect o p tion . Review: Th e ru le o f n in es Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —In tegum en tary Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 476.

484. 1 Ra tion a le: Esch aroto m ies are perform ed to relieve th e com - p artm en t syn d ro m e th at can occu r wh en edem a fo rm s u n d er n o n d isten sible esch ar in a circu m feren tial th ird-d egree bu rn . Th e esch aroto m y releases th e to urn iq u et-like com pressio n aro u n d th e arm . Esch aro to m ies are perform ed th rou gh avascu - lar esch ar to su b cu tan eo us fat. Alth o ugh b leed in g m ay occu r from th e site, it is con sid ered a com p lication rath er th an an an ticip ated th erapeu tic ou tco m e. Usually, d irect p ressu re with a b ulky dressin g an d elevatio n co n trol th e bleedin g, bu t o cca- sio n ally an artery is dam aged an d m ay requ ire ligation . Esch ar- o tom y do es n ot affect th e form atio n o f edem a. Fo rm ation of gran ulatio n tissue is n o t th e in ten t o f an esch aroto m y. Test-Ta kin g Str a tegy: Use th e ABCs—airway, b reath in g, an d circu latio n —to an swer th e qu estio n . Th e co rrect op tion is th e o n ly o n e th at ad dresses circu latio n .

Review: Th e p u rp ose of an esch aro to m y Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ad ult Health —In tegum en tary Pr ior it y Con cept s: Perfu sion ; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 479-480.

485. 3 Ra tion a le: Flu id m an agem en t d urin g th e first 24 h ou rs follow- in g a bu rn in jury gen erally in clud es th e in fusio n o f (u sually) lactated Rin ger’s so lu tion . Lactated Rin ger’s solu tio n is an iso- to n ic so lu tion th at co n tain s electro lytes th at will m ain tain flu id volum e in th e circulation . Flu id resu scitatio n is d eterm in ed b y u rin e o utp ut an d h o urly u rin e o u tp u t sh ou ld be at least 30 m L/ h o ur. Th e clien t’s u rin e ou tpu t is in d icative of in sufficien t flu id resuscitation , wh ich places th e clien t at risk for in adequate p er- fu sion of th e b rain , h eart, kid n eys, an d o th er bo dy o rgan s. Th erefo re, th e HCP wou ld p rescribe an in crease in th e am ou n t o f IV lactated Rin ger’s so lu tion ad m in istered per h o ur. Th ere is n o th in g in th e situ ation th at calls fo r bloo d resp lacem en t, wh ich is n ot used for fluid th erapy for burn in juries. Adm in is- terin g a d iuretic wou ld n o t co rrect th e p ro b lem b ecause flu id replacem en t is n eeded. Diu retics p ro m ote th e rem oval of th e circulatin g volum e, th ereby fu rth er com prom isin g th e in ad e- q uate tissue perfusion . In traven o us 5% d extrose so lutio n is iso- to n ic befo re adm in istered b ut is h yp oto n ic on ce th e d extro se is m etabo lized . Hypo ton ic solutio n s are n o t ap prop riate for flu id resuscitation of a clien t with sign ifican t burn in juries. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, flu id rep lacem en t th erapy, an d th in k ab ou t th e path o p h ysio logy th at occu rs in a b urn in jury. No tin g th at th e bu rn in ju ry o ccu rred 12 h o urs ago an d th at th e clien t’s urin e ou tpu t is 20 m L/ h ou r, in d icative of in sufficien t flu id resuscitatio n , will d irect you to th e co rrect o ptio n . Review: Flu id resu scitatio n in a clien t with a b u rn in ju ry Level of Cogn itive Ability: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Critical Care—Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Perfu sion ; Tissu e In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 478-479.

486. 2, 3, 5 Ra tion a le: Th e prim ary go al for a b urn in jury is to m ain tain a p aten t airway, ad m in ister in traven ou s (IV) fluids to p reven t h yp ovo lem ic sh ock, an d p reserve vital o rgan fu n ction in g. Th erefo re, th e p riority action s are to assess for airway p aten cy an d m ain tain a paten t airway. Th e n urse th en p repares to adm in ister o xygen . O xygen is n ecessary to perfu se vital tissues an d o rgan s. An IV lin e sh ou ld b e o btain ed an d fluid resuscita- tio n started. Th e extrem ities are elevated to assist in p reven tin g sh o ck an d decrease fluid m ovin g to th e extrem ities, esp ecially in th e b urn -in ju red u pp er extrem ities. Th e clien t is kep t warm sin ce th e loss o f skin in tegrity cau ses h eat lo ss. Th e clien t is p laced o n NPO (n oth in g b y m o uth ) status becau se of th e altered gastro in testin al fu n ction th at o ccurs as a result o f a b urn in jury.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

566 UNIT VIII Integumentary Disorders of the Adult Client

Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, action s in a bu rn in ju ry. Th in k abo ut th e p ath o ph ysiolo gy th at o ccurs an d h ow th e b o dy reacts to a m ajor b urn in jury. Th is assists in elim in at- in g op tio n s 1, 4, an d 6. Review: Path op h ysio lo gy associated with b u rn in ju ries Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con ten t Area : Critical Care—Em ergen cy Situation s/Managem en t Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Lewis et al. (2014), p . 455.

487. 4 Ra t ion a le: Th e resuscitatio n / em ergen t ph ase begin s at th e tim e of in ju ry an d en ds with th e resto ratio n of capillary perm eab ility, usu ally at 48 to 72 h ou rs fo llo win g th e in jury. Durin g th e resuscitatio n / em ergen t p h ase, th e h em ato crit level in creases to ab o ve n o rm al b ecau se o f h em o co n cen tration fro m th e large fluid sh ifts. Hem ato crit levels of 50% to 55% ( 0.50 to 0.55) are expected du rin g th e first 24 h o urs after in ju ry, with return to n o rm al by 36 h ours after in jury. In itially, blood is sh un ted away from th e kidn eys an d ren al p erfu sion an d glo- m erular filtration are decreased, resultin g in lo w u rin e ou tpu t. Th e b urn clien t is p ro n e to h yp ovo lem ia an d th e bo dy attem pts to co m pen sate b y in creased pu lse rate an d lowered b lo od pressure. Pulse rates are typ ically h igh er th an n o rm al, an d th e blo o d pressure is d ecreased as a resu lt of th e large fluid sh ifts. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, resuscitatio n / em ergen t ph ase, an d th in k ab ou t h o w th e b od y wou ld react in su ch a traum atizin g even t; th is elim in ates o ptio n s 1 an d 2. Kn o wled ge th at th e b lo od pressu re wo uld decrease as a resu lt of th e d ecrease in circu latin g blo o d volu m e will direct yo u to th e co rrect op tion fro m th e rem ain in g o ption s. Review: Path op h ysio lo gy associated with b u rn in ju ries Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con ten t Area : Adult Health —Integum en tary Pr ior ity Con cepts: Perfusio n ; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 477.

488. 3, 5 Ra t ion a le: Th e n urses wh o h ave n ot h ad ch icken p ox or d id n o t receive th e varicella-zoster vaccin e are susceptible to th e h erpes zoster viru s an d sh ou ld n o t b e assign ed to care fo r th e clien t with h erp es zoster. Nurses wh o h ave n ot con tracted ro seola, m u m ps, or rub ella are n ot n ecessarily suscep tible to h erp es zoster. Herp es zoster ( sh in gles) is cau sed b y a reactivatio n o f th e varicella-zo ster virus, th e cau sative viru s o f ch icken po x. In divid u als wh o h ave n o t been exp osed to th e varicella-zoster viru s o r wh o did n ot receive th e varicella-zoster vaccin e are su s- cep tib le to ch icken po x. Health care workers wh o are u n sure o f th eir im m u n e statu s sh ou ld h ave varicella titers do n e b efore expo su re to a person with h erp es zoster. Test -Ta kin g St r a tegy: Fo cus on th e su b ject, tran sm ission of h erp es zoster. Recallin g th at h erp es zo ster is cau sed b y a reac- tivation of th e varicella-zoster viru s, th e causative virus o f ch icken po x, will d irect yo u to th e co rrect o ption s.

Review: Th e relatio n sh ip b etween h erp es zo ster an d ch icken p o x Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Lead ersh ip/ Man agem en t—Delegatin g Pr ior ity Con cepts: In fectio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 451.

489. 4 Ra t ion a le: If an in h alation in ju ry is susp ected , ad m in istratio n o f 100% o xygen via a tigh t-fittin g n o n rebreath er face m ask is p rescribed u n til carbo xyh em o glob in levels fall (u su ally b elo w 15%) . In in h alation in ju ries, th e o ro ph aryn x is in spected fo r eviden ce o f eryth em a, blisters, o r u lceratio n s. Th e n eed fo r en do trach eal in tu b ation also is assessed. Ad m in istration o f o xygen b y aero sol m ask an d can n u la are in co rrect an d wo uld n ot pro vide th e n ecessary o xygen sup ply n eed ed for ad equ ate tissue perfusion fo r th e clien t with a likely in h alatio n in jury. Test -Ta kin g Str a tegy: Focus on th e su b ject, an in h alation in ju ry. Recallin g th at 100% o xygen is requ ired fo llo win g an in h alatio n in ju ry will assist you in elim in atin g o ption s 2 an d 3. Fro m th e rem ain in g o ptio n s, recall th at a tigh t-fittin g n o n - reb reath er m ask is preferred so th at th e clien t will n o t rebreath e exh aled air. Review: In h alatio n in ju ry Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con ten t Ar ea : Critical Care—Em ergen cy Situations/ Man agem ent Pr ior ity Con cepts: Gas Exch an ge; Perfu sio n Refer en ce: Lewis et al. (2014), p. 456.

490. 2 Ra t ion a le: Successful or adequate fluid resuscitation in th e clien t is sign aled by stable vital sign s, ad equ ate urin e ou tpu t, p alp able p erip h eral p u lses, an d clear sen soriu m . However, th e m ost reliab le in d icator fo r d eterm in in g adeq u acy o f fluid resu scitatio n , esp ecially in a clien t with b urn s, is th e u rin e o ut- p u t. For an adu lt, th e h o urly u rin e vo lu m e sh ou ld be 30 to 50 m L. Test -Ta kin g St r a t egy: Note th e strategic wo rd , most. Also n o te th e su b ject, fluid resuscitation o f a clien t with bu rn s. Urin e o u tpu t is m ost sim ilar to th e su bject of adm in isterin g flu id s. Review: Care o f th e b u rn clien t du rin g flu id resu scitatio n Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ad ult Health —In tegu m en tary Pr ior ity Con cepts: Perfusio n ; Tissue In tegrity Refer en ce: Lewis et al. (2014), pp . 459-461.

491. 3 Ra t ion a le: In protective isolatio n , th e n urse n eed s to p ro tect th e clien t at all tim es from an y po ten tial in fectiou s con tact. Th orou gh h an d wash in g sh o uld b e do n e b efo re an d after each co n tact with th e bu rn -in jured clien t. Sterile sh eets an d lin en s are used b ecau se o f th e clien t’s h igh risk fo r in fectio n . Pro tec- tive garb , in clu d in g glo ves, cap, m asks, sh oe co vers, gown s, an d

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

567CHAPTER 46 Integumentary System

p lastic ap ron , n eed to be wo rn wh en in th e clien t’s roo m an d wh en directly carin g fo r th e clien t. Test-Ta kin g Str a tegy: Note th e wo rd unsafe in th e q u estion . O ptio n s 1 an d 2 can b e elim in ated easily b ecause o f th e wo rds sterile an d strict in th ese o ption s. Next, n o te th e clo sed -en d ed wo rd only in th e co rrect op tio n . Also , th e correct op tion id en - tifies th e least th o rou gh tech n iqu e to p reven t in fectio n . Review: Pro tective iso latio n tech n iqu e wh en carin g fo r th e b u rn clien t Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip/ Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Ign ataviciu s, Wo rkm an (2016), p . 482; Perry et al. (2014), p. 173.

492. 3 Ra tion a le: Auto grafts p laced over join ts o r o n th e lower extrem ities after surgery o ften are elevated an d im m o bilized fo r 3 to 7 d ays. Th is perio d o f im m ob ilizatio n allows th e auto - graft tim e to ad h ere to th e wo un d bed . Gettin g o u t of b ed, go in g to th e b ath ro o m , an d p lacin g th e grafted leg d ep en d en t would put stress on th e grafted woun d. Test-Ta kin g St r a t egy: Elim in ate o ptio n s 1 an d 2 first because th ey are co m p arab le o r alike an d allow out-of-bed activities. Fro m th e rem ain in g op tio n s, n ote th at th e au to graft was p laced o ver a join t. Th is sh ou ld d irect yo u to th e co rrect o ptio n . Elim - in ate op tion s th at p ut an y stress o n th e grafted site. Review: Care of an au to graft p laced over a jo in t

Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ad u lt Health —In tegum en tary Pr ior it y Con cept s: Perfu sion ; Tissu e In tegrity Refer en ce: Lewis et al. (2014), p p. 466-467.

493. 2 Ra tion a le: Carb on m on o xid e levels b etween 11% an d 20% result in flush in g, h eadach e, d ecreased visual activity, d ecreased cereb ral fun ction in g, an d sligh t b reath lessn ess; levels of 21% to 40% result in n au sea, vom itin g, dizzin ess, tin - n itu s, vertigo , con fu sio n , d ro wsin ess, pale to red dish -p urple skin , an d tach ycard ia; levels of 41% to 60% resu lt in seizure an d com a; an d levels h igh er th an 60% result in death . Test-Ta kin g Str a tegy: Fo cus on th e su b ject, a carb on m o n o x- id e level o f 12%. Rem em ber th at flush in g occurs with levels b etween 11% an d 20%; th is will assist you in an swerin g qu es- tio n s sim ilar to th is on e. Note th at 12% carb on m on oxide level is on th e lower sid e an d flu sh in g is th e least seriou s o f th e sign s an d sym pto m s. Review: Effects of an in h alatio n in ju ry, carb o n m o n o xid e levels, an d th e associated clin ical m an ifestation s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Respiratory Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Lewis et al. (2014), p p. 456, 1689.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

568 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

C H A P T E R 47 Integumentary Medications

PRIORITY CONCEPTS Clinical Judgment; Safety

CRITICAL THINKING What Should You Do? Atopical glucocorticoid is prescribed for a hospitalized client to treat an inflammatory skin condition on the neck. What should the nurse do when administering the medication? Answer located on p. 575.

I. Poison Ivy Treatment (Box 47-1) A. Treatm en t of lesion s in cludes calam in e lotion an d

com m ercial produ cts th at sooth e lesion s, alum in um acetate com presses an d solution s th at are astrin gen t an d an tiseptic, an d/ o r collo idal oatm eal bath s to relieve discom fort.

B. Topical corticosteroid s are effective to preven t or relieve in flam m ation , especially wh en used before blisters form .

C. O ral cortico steroids m ay be prescribed for severe reaction s an d an an tih istam in e such as diph en h ydra- m in e m ay be prescribed.

II. Medications to Treat Atopic Dermatitis (Box 47-2) A. Description

1. A ch ron ic in flam m ato ry skin disease th at is also kn own as eczema an d is ch aracterized by dry an d scaly skin

2. May be treated with m oisturizer an d topical gluco corticoids; system ic im m un osuppressan ts m ay also be prescribed if topical treatm en t is in effective.

B. Topical im m un osu ppressan ts 1. Tacrolim us an d pim ecrolim us cream s 2. Sid e an d adverse effects in clude redn ess, burn in g,

an d itch in g; cau ses sen sitization of th e skin to sun ligh t. Treated areas sh ould be protected fro m direct sun ligh t.

3. Tacrolim us m ay in crease th e risk of varicella- zoster in fectio n in ch ildren .

4. Tacrolim us m ay in crease risk of developin g skin cancer an d lym p h om a.

When administering any topical medication or top- ical patches, the nurse and family caregivers should always wear gloves to protect self from absorption of the medication. Caregivers should also be taught to wash hands thoroughly before and after administration.

III. Topical Glucocorticoids A. Description

1. An tiin flam m atory, an tipruritic, an d vasocon - strictive action s

2. Preparation s vary in poten cy an d depen d on th e con cen tration an d type of preparation , an d m eth od of application (occlusive dressin gs en h an ce absorption , in creasin g th e effects).

3. System ic effects are m ore likely to occur with pro- lon ged th erapy an d wh en exten sive skin surfaces are treated.

Topical glucocorticoids can be absorbed into the systemic circulation; absorption is greater in permeable skin areas (scalp, axilla, face and neck, eyelids, peri- neum) and less in areas where permeability is poor (palms, soles, back).

B. Con train dication s 1. Clien ts dem on stratin g previous sen sitivity to

corticosteroid s 2. Clien ts with curren t system ic fun gal, viral, or bac-

terial in fectio n s 3. Clien ts with curren t co m plication s related to glu-

cocorticoid th erap y C. Local side an d ad verse effects

1. Burn in g, dryn ess, irritatio n , itch in g 2. Skin atroph y 3. Th in n in g of th e skin , striae, purpura, telan giectasia 4. Acn eiform eruptio n s 5. Hypo pigm en tation 6. O vergrowth of bacteria, fun gi, an d viruses

569

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

D. System ic adverse effects 1. Gro wth retardatio n in ch ildren 2. Adren al supp ression 3. Cush in g’s syn d rom e 4. Striae, skin atroph y 5. O cular effects (glaucom a an d cataracts)

E. In terven tion s 1. Mon itorin g plasm a cortisol levels m ay be pre-

scrib ed if prolon ged th erap y is n ecessary. 2. Wash th e area just befo re application to in crease

m ed ication pen etration . 3. Apply sparin gly in a th in film , rubbin g gen tly. 4. Avo id use of a dry occlusive dressin g un less

specifically prescribed by th e h ealth care provider (HCP).

5. In struct clien t to report sign s of adverse effects to th e HCP.

In the adult, intact skin is generally impermeable to most topical medications. However, medications should not be applied to denuded areas unless prescribed because undesired absorption can occur.

IV. Medications to Treat Actinic Keratosis (Box 47-3) A. Description

1. Actin ic keratoses are caused by prolon ged expo- sure to th e sun an d appear as rough , scaly, red or brown lesion s usually foun d on th e face, scalp, arm s, an d back of th e h an ds.

2. Lesion s can progress to squam ous cell carcin om a.

3. Treatm en t in cludes m edication s an d th erapies such as excision , cryoth erapy, curettage, an d laser th erapy.

B. Medication s in clude fluorouracil, diclofen ac sodium , im iquim od 5% cream , am in olevulin ic acid, an d in gen ol m ebutate. 1. Fluorouracil

a . A topical m ed ication th at affects DNA an d RNA syn th esis an d causes a seq uen ce of respon ses th at results in h ealin g; results are usually seen in 2 to 6 weeks but m ay take 1 to 2 m on th s lon ger for com plete h ealin g.

b . Side an d adverse effects in clude itch in g, burn - in g, in flam m ation , rash , an d in creased sen si- tivity to sun ligh t.

2. Diclofen ac sodium a . A n on steroidal an tiin flam m ato ry topical

m edication ; it m ay take 3 m on th s to be effective.

b . Side an d adverse effects in clude dry skin , itch - in g, redn ess, an d rash .

3. Im iqu im od 5% cream a . In addition to treatin g actin ic keratoses, th is

topical m edication h as been used to treat ven ereal warts; it m ay take up to 4 m on th s to be effective.

b . Side an d ad verse effects in clude redn ess, skin swellin g, itch in g, burn in g, sores, blisters, scabbin g, an d cru stin g of th e skin .

4. Am in o levulin ic acid a . A topical m edication used in con jun ction

ph otod yn am ic th erap y; th e m ed ication is applied an d 14 to 18 h ou rs later th e m edica- tion is activated by exposin g th e lesion s to special blue ligh t.

b . Side an d adverse effects in clude burn in g, stin gin g, redn ess, an d swellin g of th e skin ; treated areas n eed to be protected from sun - ligh t an d brigh t in do or ligh ts.

5. In gen o l m ebutate a . In dicated for th e topical treatm en t of actin ic

keratosis b . Side an d adverse effects include skin reaction s,

eryth em a, flakin g/ scalin g, crustin g, swellin g, postulation , an d erosion / ulceration .

V. Sunscreens A. Ultraviolet (UV) ligh t can dam age th e skin an d cau se

prem align an t actin ic keratoses an d som e typ es of skin can cer.

BOX 47-1 Poison Ivy Treatment Products ▪ Bentoquatam—for preventive use ▪ Calamine lotion ▪ Hydrocortisone ▪ Zinc acetate; isopropanol ▪ Zinc acetate; isopropanol; benzyl alcohol

BOX 47-2 Medications to Treat Atopic Dermatitis

Systemic Immunosuppressants ▪ Azathioprine ▪ Cyclosporine ▪ Methotrexate ▪ Oral glucocorticoids Topical Immunosuppressants ▪ Pimecrolimus 1% cream ▪ Tacrolimus

BOX 47-3 Medications to Treat Actinic Keratosis ▪ Aminolevulinic acid ▪ Diclofenac sodium 3% gel ▪ Fluorouracil ▪ Imiquimod 5% cream ▪ Ingenol mebutate

570 UNIT VIII Integumentary Disorders of the Adult Client

B. Sun screen s preven t th e pen etration of UV ligh t an d protect th e skin .

C. O rgan ic (ch em ical) sun screen s ab sorb UV ligh t; in organ ic (ph ysical) sun screen s reflect an d scatter UV ligh t.

D. A sun screen th at protects again st both UVB an d UVA rays an d on e th at h as a sun protectio n facto r (SPF) of at least 15 sh ould be used.

E. Sun screen s are m ost effective wh en applied at least 30 m in utes before exposu re to th e sun (su n screen s con tain in g para-am in o ben zoic acid or padim ate O require application 2 h ou rs before sun exposu re).

F. Sun screen sh o uld be reapplied every 2 to 3 h ours an d after swim m in g or sweatin g; oth erwise, th e duration of protection is reduced.

G. Products con tain in g para-am in oben zoic acid n eed to be avoided by in dividuals allergic to ben zocain e, sulfon am ides, or th iazides.

H. Sun screen s can cause con tact derm atitis an d ph o to- sen sitivity reaction s.

The client should be informed that UV light is great- est between the hours of 10 :0 0 a.m. and 4:00 p.m., and that sunglasses, protective clothing, and a hat should be worn to reduce the risk of skin damage from the sun.

VI. Medications to Treat Psoriasis (Box 47-4) A. Descrip tion

1. Psoriasis is a ch ron ic in flam m ato ry disorder th at h as varyin g degrees of severity.

2. Treatm en t is based on th e severity of sym pto m s an d aim s to suppress th e proliferation of keratin o cytes or suppress th e activity of in flam m ato ry cells.

B. To pical m edication s 1. Glucocorticoids

a . Used for m ild psoriasis b . Sh o uld n ot be ap plied to th e face, groin ,

axilla, or gen italia because th e m edication is readily absorbable, m akin g th e skin vuln er- ab le to gluco corticoid -in duced atroph y

2. Tazaroten e a . Is a vitam in A derivative b . Local reaction s in clude itch in g, burn in g,

stin gin g, dry skin , an d redn ess; oth er, less com m on effects in clude rash , desquam ation , con tact derm atitis, in flam m ation , fissurin g, an d bleedin g.

c. Sen sitizatio n to sun ligh t can occur an d th e clien t sh ould be in structed to use sun screen an d wear protective clo th in g.

d . Med ication is usually applied on ce daily in th e even in g to dry skin .

3. Calcipo trien e a . Is an an alo g of vitam in D b . May take up to 1 to 3 weeks to produ ce a

desired effect c. Can cau se local irritatio n ; h igh -d ose applica-

tio n s rarely h ave caused h ypercalcem ia. 4. Coal tar

a . Supp resses DNA syn th esis, m iotic activity, an d cell proliferation

b . Has an un p leasan t odor an d m ay cau se irrita- tio n , burn in g, an d stin gin g; can also stain th e skin an d h air an d in crease sen sitivity to sun

c. May in crease risk for can cer developm en t in h igh doses

5. Keratolytics a . Soften scales an d loosen th e h orn y layer of

th e skin , resultin g in m in im al peelin g to exten sive desquam ation

b . Salicylic acid: Can be absorbed system ically an d can cause salicylism , wh ich is ch aracter- ized by dizzin ess an d tin n itu s, h yperpn ea, an d psych ological disturban ces; salicylic acid is n ot ap plied to large surface areas or open woun ds because of th e risk of system ic effects.

c. Sulfur: Prom o tes peelin g an d dryin g an d is used to treat acn e, dan d ruff, seb orrh eic der- m atitis, an d psoriasis

C. System ic m edication s 1. Meth otrexate

a . Redu ces proliferatio n of epiderm al cells b . Can be toxic; causes gastroin testin al effects such

as diarrh ea an d ulcerative stom atitis an d bone m arrow depression leadin g to blood dyscrasias

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

BOX 47-4 Medications and Treatments for Psoriasis

Topical Medications ▪ Calcipotriene ▪ Coal tar ▪ Glucocorticoids ▪ Keratolytics (topical salicylic acid; sulfur) ▪ Tazarotene Systemic Medications ▪ Acitretin ▪ Cyclosporine ▪ Methotrexate Systemic Biological Medications ▪ Adalimumab ▪ Etanercept ▪ Infliximab ▪ Ustekinumab ▪ Secukinumab Phototherapy ▪ Coal tar and ultraviolet B irradiation ▪ Photochemotherapy (psoralen and ultraviolet A therapy)

571CHAPTER 47 Integumentary Medications

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

c. Can be h epatotoxic; h epatic fun ction sh ould be m on itored durin g th erap y

d . Th is m edication is teratogen ic; wom en of ch ild-bearin g age sh ould wait 3 m on th s after discon tin u ation of th e m ed ication before beco m in g pregn an t.

2. Acitretin a. In h ibits keratin ization , proliferation , an d dif-

feren tiation of cells; h as antiin flam m atory an d im m un om odulator action s; used for severe psoriasis an d reserved for use in th ose wh o h ave n ot respon ded to safer m edication s

b . Is em bryotoxic an d teratogen ic: Medication is con train dicated durin g pregn an cy; pregn an cy m ust be ruled out an d 2 reliable form s of con - traception n eed to be im plem en ted before th e m edication is started (contraception m ust be im plem en ted at least 1 m on th before treat- m en t starts an d be con tin ued for at least 3 years after treatm en t is discon tin ued).

c. If pregn an cy occurs durin g treatm en t with th e m edication , th e m edication is discon tin - ued im m ediately an d possible term in ation of th e pregn an cy is discussed.

d . Derm atological effects in clude h air loss, skin peelin g, dry skin , rash , pruritus, an d n ail dis- orders; oth er effects in clude rh in itis from m ucou s m em bran e irritatio n , in flam m ation of th e lips, dry m ou th , dry eyes, n oseb leed, gin givitis, stom atitis, bon e an d join t pain , an d spin al disorders.

e. Can be h epatotoxic; can elevate triglycerid e levels an d reduce levels of h igh -d en sity lipo- protein ch olestero l

f. Sh o uld n ot be taken with alcoh ol, vitam in A supp lem en tation , or tetracyclin e

3. Cyclosporin e a. An im m un osuppressan t th at in h ibits prolif-

eration of B an d T cells b . Can be toxic an d cause kidn ey dam age c. Used for severe psoriasis an d reserved for use

in th ose wh o h ave n ot respon d ed to safer m ed ication s

D. System ic biological m ed ication s (Clien ts sh ould be tested for tuberculosis befo re in itiation of m ed ication s.) 1. Tum or n ecrosis facto r (TNF) an tagon ists

a . Lowers am oun t of TNF-alph a an d in terrupts in flam m atory process of psoriasis

b . Adalim um ab: Adm in istered by subcu tan e- ous in jection , usually every oth er week. In jec- tio n sites sh o uld be rotated.

c. Etan ercept: Adm in istered by subcu tan eo us in jection twice weekly for 3 m on th s, th en weekly

d . In flixim ab: Adm in istered by in traven ous route 3 tim es over 6 weeks an d th en every 8 weeks

e. Adverse effects, wh ich are gen erally n ot severe, in clude upper respiratory in fectio n s, abdom in al pain , h eadach e, rash , in jection site reaction s, an d urin ary tract in fectio n s; m ay prom o te serious in fectio n s, in cludin g bacterial sepsis, in vasive fun gal in fectio n s, tuberculosis, an d reactivation of h epatitis B

f. Con train dicated for person s with h istory of severe or recurren t in fection s, h eart failure, or dem yelin atin g n eurological diseases; given with caution to person s with n um bn ess or tin glin g

g. In creases risk of develo pin g lym p h om a 2. Ustekin um ab

a . A h um an m on oclon al an tibod y adm in is- tered by subcutan eous route

b . Can decrease th e activity of th e im m un e sys- tem an d in crease th e risk for certain types of can cer

c. Side an d ad verse effects of th e m edication in clude upper respiratory in fectio n s, h ead- ach e, tiredn ess, redn ess at in jection site, back pain , an d fatigue.

d . Con train dicated in clien ts wh o h ave a h istory of can cer; also con train dicated in clien ts with in fectio n or reversible posterior leuko en ce- ph alop ath y syn dro m e (rare con d ition th at affects th e brain an d can cause death )

e. Th e clien t sh o uld n ot receive an y live virus vaccin es because th e viruses used in som e types of vaccin es can cause in fectio n in th o se with a weaken ed im m un e system ; in addi- tion , th e HCP n eeds to be in form ed if an yon e in th e h ouseh old n eeds a vaccin e.

f. Th e clien t sh ould n ot receive th e bacillus Calm ette-Gu erin (BCG) vaccin e durin g th e 1 year befo re takin g or 1 year after takin g th e m ed ication .

g. Th e clien t sh ould in form th e HCP if h e or sh e is receivin g ph ototh erapy, h as an y oth er m ed ical con d ition , is pregn an t or plan s to beco m e pregn an t, or is breast-feed in g or plan s to breast-feed .

3. Secukin um ab a . Hum an in terlukin -17A an tagon ist b . Blocks cytokin es to in terrupt in flam m ato ry

cycle of psoriasis c. Adm in istered by subcu tan eo us route d . Side and adverse effects include cold sym ptom s,

diarrhea, and upper respiratory in fections. e. Safety with pregn an cy h as n ot been

establish ed. E. Ph o toth erapy

1. Coal tar an d ultraviolet B (UVB) irradiation : Treatm ent th at involves th e application of coal tar for 8 to 10 h ours; coal tar is wash ed off an d th e area is exposed to sh ort-wave UV radiation (UVB).

572 UNIT VIII Integumentary Disorders of the Adult Client

2. Ph otoch em oth erapy (psoralen an d ultraviolet A [UVA] th erapy) a. Com bin es th e use of lon g-wave radiation

(UVA) with oral m eth oxsalen (used in very specific cases; ph o tosen sitive m edication )

b . Can cause pruritus, n ausea, eryth em a; m ay accelerate th e agin g process of th e skin ; m ay in crease th e risk of skin can cer.

VII. Acne Products (Box 47-5; Fig. 47-1) A. Description

1. Acn e lesion s th at are m ild m ay be treated with n on ph arm aco logical m easu res such as gen tle clean sin g 2 or 3 tim es daily (oil-based m oistu riz- in g produ cts n eed to be avoided), derm ab rasion , or com edo extraction .

2. Mild acn e is usually treated ph arm acologically with topical agen ts (an tim icrobials an d retin oids).

3. Mod erate acn e is usually treated with oral an tibi- otics an d com edolytics.

4. Severe acn e is usually treated with isotretin oin . 5. Ho rm on al m ed ication s such as oral con tracep-

tives an d spiron olacton e m ay be prescribed to treat acn e in fem ale clien ts.

6. Com b in ation th erap y m ay be prescribed to treat acn e.

7. Actions of th e m edication s m ay in clude suppres- sin g th e growth of Propionibacterium acnes, reducin g in flam m ation , prom otin g keratolysis, un pluggin g

existin g com edon es an d preven tin g th eir develop- m ent, an d n orm alizin g h yperproliferation of epithelial cells within the h air follicles; som e m ed- ications cause thin n in g of th e skin , which facilitates penetration of other m edication s.

8. For topical application s: Site sh ould be wash ed an d allowed to dry com pletely before applica- tion ; h an ds sh o uld be wash ed after ap plication .

9. All topical products are kept away from th e eyes, in side th e n ose, lips, m ucous m em bran es, h air, an d in flam ed or den uded skin .

B. Topical an tibiotic produ cts 1. Ben zoyl peroxide

a . Can produ ce dryin g an d peelin g b . Severe local irritation (burn in g, blisterin g,

scalin g, swellin g) m ay require reducin g th e frequen cy of application s.

c. Som e produ cts m ay con tain sulfites; m on itor for serious allergic reaction s.

2. Clin dam ycin an d eryth rom ycin a . Both products are an tibiotics th at suppress

th e growth of P. acnes. b . Com b in ation th erapy with ben zoyl peroxide

preven ts th e em ergen ce of resistan t bacteria; fixed -dose co m bin ation s in clude clin dam y- cin / ben zoyl peroxide an d eryth rom ycin / ben - zoyl peroxide.

3. Dapson e: Sid e an d adverse effects in clude oili- n ess, peelin g, dryn ess, an d eryth em a of th e skin (oral form of m edication is used to treat leprosy).

C. Topical retin oids 1. Tretin oin

a . A derivative of vitam in A (vitam in A supple- m en ts sh ould be discon tin ued durin g therapy)

b . In addition to treatin g acn e, it m ay be prescribed to reduce fin e wrin kles, skin rough n ess, an d m ottled h yperpigm en tation as with age spots.

c. Can cause lo calized side an d adverse effects such as blisterin g, peelin g, crustin g, burn in g, an d swellin g of th e skin

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

BOX 47-5 Acne Products

Topical Antibiotics ▪ Benzoyl peroxide ▪ Clindamycin and erythromycin ▪ Clindamycin/ tretinoin combination gel ▪ Dapsone ▪ Fixed dose combinations: Clindamycin/ benzoyl peroxide

and erythromycin/ benzoyl peroxide

Topical Retinoids ▪ Adapalene ▪ Azelaic acid ▪ Tazarotene ▪ Tretinoin Oral Medications ▪ Doxycycline ▪ Erythromycin ▪ Isotretinoin ▪ Minocycline ▪ Tetracycline Hormonal Medications ▪ Oral contraceptives ▪ Spironolactone

A B

FIGURE 47-1 Acne vulgaris. A, Comedones with a few inflammatory pustules. B, Papulopustular acne. (From Perry et al., 2010.)

573CHAPTER 47 Integumentary Medications

d . Abrasive produ cts an d keratolytic products are discon tin ued befo re usin g tretin o in to decrease lo calized adverse effects.

e. In struct th e clien t to apply a sun screen with an SPF of 15 or greater an d to wear protective cloth in g wh en outd oors due to sen sitivity to UV ligh t.

2. Adapalen e: Sim ilar to tretin oin an d sen sitizes th e skin to UV ligh t; adverse effects in clude burn in g an d itch in g after application , redn ess, dryn ess, an d scalin g of th e skin . In itially m ay worsen acn e; ben efits seen in 8 to 12 weeks.

3. Tazaroten e a. Is a derivative of vitam in A (vitam in A supple-

m en ts sh ould be discon tin ued durin g th erap y)

b . In addition to acn e, it is used to treat wrin kles an d psoriasis.

c. Can cau se itch in g, burn in g, an d dry skin an d sen sitizes th e skin to UV ligh t.

4. Azelaic acid can cau se burn in g, itch in g, stin gin g, an d redn ess of th e skin ; it can also cause h ypo- pigm en tation of th e skin in clien ts with a dark com plexion .

D. O ral an tibiotics 1. In cludes doxycyclin e, m in ocyclin e, tetracyclin e,

an d eryth rom ycin 2. Im p rovem en t develops slowly with th e use of

oral an tibiotics an d m ay take 3 to 6 m on th s for som e im provem en t to be n oted; follo win g con - tro l of sym pto m s, th e clien t is usually switch ed to a topical an tibiotic.

E. Iso tretin oin 1. Derivative of vitam in A (vitam in A supplem en ts

sh o uld be discon tin ued durin g th erap y); in addi- tio n , th e use of tetracyclin es can in crease th e risk of adverse effects an d sh ould be discon tin ued befo re use of isotretin oin .

2. Used to treat severe cystic acn e; reserved for per- son s wh o h ave n ot respo n ded to oth er th erap ies, in cludin g system ic an tibiotics

3. Side an d adverse effects in clude n osebleeds; in fla- m m ation of the lips or eyes; dryn ess or itch in g of th e skin , n ose, or m outh ; pain , ten dern ess, or stiff- n ess in the join ts, bon es, or m uscles; an d back pain .

4. Less co m m on side an d ad verse effects in clude rash , h air loss, peelin g of th e skin , h eadach e, an d reduction in n igh t vision .

5. Cau ses sen sitization of th e skin to UV ligh t 6. Th e m edication elevates triglyceride levels, wh ich

sh o uld be m easu red before an d durin g th erap y; alcoh ol con sum ptio n sh ould be elim in ated dur- in g th erap y because alcoh ol could poten tiate ele- vation of serum triglyceride levels.

7. Th e m edication m ay cause depression in som e clien ts; if dep ression occurs, th e m ed ication sh o uld be discon tin ued.

Isotretinoin is highly teratogenic and can cause fetal abnormalities. If prescribed, the client needs to follow strict rules of the iPLEDGE program. It must not be used if the client is pregnant.

F. iPLEDGE program 1. A risk m an agem en t program th at en sures th at n o

wom an startin g isotretin oin is pregn an t an d th at n o wom an takin g th is m ed ication beco m es pregn an t

2. Access to th e m ed ication is con trolled th rou gh a cen tral au tom ated system .

3. Strict rules m ust be followed by th e clien t, HCP prescribin g th e m edication , ph arm acist dispen s- in g th e m ed ication , an d wh olesaler of th e m ed i- cation to en sure safety an d to en sure th at n o wom an is pregn an t on in itiation of th erapy or beco m es pregn an t wh ile takin g th e m ed ication .

4. Web site on the iPLEDGE program from the U.S. Food and Drug Adm inistration : http://www.fda. gov/Drugs/DrugSafety/Postm arketDrugSafetyInf orm ationforPatientsandProviders/ucm 094307. htm

G. Horm on al m ed ication s 1. Horm on al m edication s such as oral con tracep-

tives an d spiron olacto n e m ay be prescribed to treat acn e in fem ale clien ts.

2. Th ese m edication s decrease an drogen activity, resultin g in decreased produ ction of seb um .

3. Spiro n olacton e is teratogen ic; th erefore, con tra- ception durin g its use is n ecessary.

4. Side an d ad verse effects of spiron olacto n e in clude breast ten dern ess, m en strual irregulari- ties, an d h yperkalem ia.

VIII. Burn Products (Box 47-6) A. Silver sulfadiazin e

1. Has broad spectrum of activity again st gram - n egative bacteria, gram -positive bacteria, an d yeast

2. Silver is released slowly fro m th e cream , wh ich is selectively toxic to bacteria.

3. Used prim arily to preven t sep sis in clien ts with burn s

4. No t a carbo n ic an h yd rase in h ib itor; does n ot cau se acidosis

5. Apply 1=16 -in ch film (keep burn co vered at all tim es with silver sulfadiazin e).

6. Side an d ad verse effects in clude rash an d itch in g, blue-green or gray skin discoloration , leukope- n ia, an d in terstitial n eph ritis.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

BOX 47-6 Burn Products ▪ Mafenide acetate ▪ Silver sulfadiazine ▪ Bacitracin topical ointment (first-degree burns only) ▪ Povidone-iodine

574 UNIT VIII Integumentary Disorders of the Adult Client

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

7. Mon itor com plete blood cell coun t, particularly th e wh ite blood cells, frequen tly; if leukopen ia develops, the HCP is n otified (m edication is usu- ally discon tin ued).

B. Mafen ide acetate 1. Water-solub le cream th at is bacteriostatic for

gram -n egative an d gram -p ositive organ ism s 2. Used to treat burn s to reduce th e bacteria presen t

in avascular tissues 3. Diffuses th rough th e devascularized areas of th e

skin an d m ay precipitate m etab olic acido sis with th e clien t displayin g h yperven tilation . Mon itor blood gases an d electrolytes.

4. Apply 1=16 -in ch (1.5 m m ) film directly to th e burn .

5. Sid e effects can in clude lo cal pain an d rash . Med- icate for pain before application .

6. Adverse effects in clude bon e m arro w depression , h em olytic an em ia, an d m etab olic acido sis.

7. Keep burn covered with m afen ide acetate at all tim es.

8. No tify th e HCP if h yperven tilation occurs; if aci- dosis develops, m afen ide acetate is wash ed off th e skin an d usually discon tin ued for 1 to 2 days.

CRITICAL THINKING What Should You Do? Answer: Topical glucocorticoids can be absorbed into the systemic circulation; absorption is greater in permeable skin areas (scalp, axilla, face and neck, eyelids, perineum). The nurse should wash the area just before application and apply the medication sparingly in a thin film, rubbing the area gently. The nurse should also monitor the client for signs of systemic absorption.

Reference: Burchum, Rosenthal (20 16), p. 1279.

P R A C T I C E Q U E S T I O N S 494. Salicylic acid is prescribed for a clien t with a diag-

n osis of psoriasis. Th e n urse m on itors th e clien t, kn owin g th at wh ich fin din g in dicates th e presen ce of system ic toxicity from th is m ed ication ? 1. Tin n itus 2. Diarrh ea 3. Con stipation 4. Decreased respiration s

495. Th e h ealth edu cation n urse provides in struction s to a grou p of clien ts regardin g m easures th at will assist in preven tin g skin can cer. Wh ich in struction s sh o uld th e n urse provide? Select all th at ap p ly.

1. Sun screen sh ould be applied every 8 h ou rs. 2. Use sun screen wh en participatin g in out-

door activities.

3. Wear a h at, opaqu e cloth in g, an d sun glasses wh en in th e sun .

4. Avoid sun exp osure in th e late aftern oon an d early even in g h ours.

5. Exam in e yo ur body m on th ly for an y lesion s th at m ay be susp icious.

496. Silver sulfadiazin e is prescribed for a clien t with a burn in jury. Wh ich labo ratory fin din g requires th e n eed fo r fo llo w-u p by th e n urse? 1. Glu cose level of 99 m g/ dL (5.65 m m ol/ L) 2. Magn esium level of 1.5 m Eq/ L (0.75 m m ol/ L) 3. Platelet level of 300,000 m m 3 (300 Â 109/ L) 4. Wh ite blood cell coun t of 3000 m m 3 (3.0

Â109/ L)

497. A burn clien t is receivin g treatm en ts of topical m afen ide acetate to th e site of in ju ry. Th e n urse m on itors th e clien t, kn owin g th at wh ich fin din g in dicates th at a system ic effect h as occurred? 1. Hyperven tilation 2. Elevated blood pressure 3. Local rash at th e burn site 4. Local pain at th e burn site

498. Iso tretin o in is prescribed for a clien t with severe acn e. Before th e adm in istration of th is m ed ication , th e n urse an ticip ates th at wh ich laborato ry test will be prescribed? 1. Potassium level 2. Triglyceride level 3. Hem oglob in A1C 4. Total ch olestero l level

499. A clien t with severe acn e is seen in th e clin ic an d th e h ealth care provider (HCP) prescribes isotreti- n oin . Th e n urse reviews th e clien t’s m edication record an d would con tact th e HCP if th e clien t is also takin g wh ich m ed ication ? 1. Digoxin 2. Ph en yto in 3. Vitam in A 4. Furosem ide

500. Th e n urse is ap plyin g a topical cortico steroid to a clien t with eczem a. Th e n urse sh o uld apply th e m ed ication to wh ich body area? Select all th at ap p ly.

1. Back 2. Axilla 3. Eyelids 4. Soles of th e feet 5. Palm s of th e h an ds

501. Th e clin ic n urse is perform in g an adm ission assess- m en t on a clien t an d n otes th at th e clien t is takin g azelaic acid. Th e n urse determ in es th at wh ich

575CHAPTER 47 Integumentary Medications

clien t com plain t m ay be associated with use of th is m ed ication ? 1. Itch in g 2. Euph oria 3. Drowsin ess 4. Frequen t urin ation

502. Silver sulfadiazin e is prescribed for a clien t with a partial-th ickn ess burn an d th e n urse provid es teach in g about th e m ed ication . Wh ich statem en t m ade by th e clien t in dicates a n eed fo r fu rth er teach in g about th e treatm en ts? 1. “Th e m ed ication is an an tibacterial.” 2. “Th e m edication will h elp h eal th e burn .”

3. “Th e m ed ication is likely to cause stin gin g every tim e it is applied.”

4. “Th e m edication sh ould be applied directly to th e woun d.”

503. Th e cam p n urse asks th e ch ildren preparin g to swim in th e lake if th ey h ave ap plied sun screen . Th e n urse rem in ds th e ch ildren th at ch em ical sun - screen s are m o st effective wh en ap plied at wh ich tim es? 1. Im m ediately befo re swim m in g 2. 5 m in utes befo re exposure to th e sun 3. Im m ediately befo re exposu re to th e sun 4. At least 30 m in u tes before exposu re to th e sun

A N S W E R S 494. 1 Ra tion a le: Salicylic acid is ab sorbed readily th ro ugh th e skin , an d system ic to xicity (salicylism ) can resu lt. Sym pto m s in clud e tin n itu s, d izzin ess, h yp erpn ea, an d psych o logical d istu rb an ces. Co n stip atio n an d d iarrh ea are n ot asso ciated with salicylism . Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, system ic to xicity. No tin g th e n am e of th e m ed icatio n will assist in directin g you to th e correct o ptio n if you can recall th e toxic effects th at occu r with acetylsalicylic acid (aspirin ). Review: Toxic effects o f salicylic acid Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—In tegu m en tary Med ication s Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1279.

495. 2, 3, 5 Ra tion a le: The clien t sho uld b e in stru cted to avoid sun exposure b etween th e h ou rs o f brigh test sun ligh t: 10 a.m . and 4 p .m . Sun screen , a h at, opaqu e clo th in g, an d sun glasses should be worn for outdoor activities. Th e clien t should be instructed to exam in e th e b od y m on th ly for the app earance o f any can cero us o r an y precan cero us lesion s. Sun screen sh ould be reapplied every 2 to 3 h ours and after swim m in g or sweatin g; o th erwise, th e dura- tio n o f protection is red uced. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, m easures to p re- ven t skin can cer. Read each option carefully. Notin g th e tim e fram es in o ption s 1 and 4 will assist in elim in atin g th ese option s. Review: Clien t teach in g p oin ts for th e p reven tion o f skin can cer Level of Cogn it ive Abilit y: Syn th esizin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —In tegum en tary Pr ior it y Con cept s: Clien t Ed ucation ; Health Pro m o tion Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1286.

496. 4 Ra tion a le: Silver sulfadiazin e is used for th e treatm en t of burn in ju ries. Adverse effects o f th is m edication in clude rash an d

itch in g, blue-green or gray skin d iscoloratio n , leuko pen ia, and in terstitial n ep h ritis. Th e n urse sh o uld m on itor a com p lete b lood coun t, particularly th e wh ite b lo od cells, frequen tly for th e clien t takin g th is m edication . If leukopen ia develo ps, th e h ealth care pro vider is n otified an d th e m edication is usu ally d is- con tin ued . Th e white blood cell coun t n oted in o ption 4 is in d ic- ative o f leu ko pen ia. Th e oth er lab oratory valu es are n ot specific to this m edication , an d are also with in n orm al lim its. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for follow- up. Elim in ate o ptio n s 1, 2, an d 3 b ecau se th ey are co m p arab le o r alike an d are with in n o rm al lim its. In ad dition , recall th at leu ko pen ia is an ad verse effect req uirin g discon tin u ation of th e m ed icatio n . Review: Silver su lfad iazin e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm acolo gy—In tegu m en tary Med ication s Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1061.

497. 1 Ra tion a le: Mafen id e acetate is a carb on ic an h yd rase in h ib ito r an d can sup press ren al excretio n of acid , th ereby cau sin g acido - sis. Clien ts receivin g th is treatm en t sh ou ld b e m on itored fo r sign s o f an acid-b ase im b alan ce (h yp erven tilatio n ). If th is o ccurs, th e m ed ication will p ro b ab ly be disco n tin ued fo r 1 to 2 d ays. O ptio n s 3 an d 4 d escrib e local rath er th an system ic effects. An elevated blo o d p ressu re m ay b e expected fro m th e p ain th at occu rs with a bu rn in ju ry. Test-Ta kin g St r a t egy: No te th e words systemic effect. O ption s 3 an d 4 can b e elim in ated b ecause th ey are co m p arab le o r alike an d are local rath er th an system ic effects. Fro m th e rem ain in g o ptio n s, recall th at th e clien t in pain wou ld likely h ave an ele- vated b loo d p ressu re. Th is sh o uld d irect you to th e co rrect o ptio n . Review: System ic effects of m afen id e acetate Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—In tegu m en tary Med ication s Pr ior it y Con cept s: Gas Exch an ge; Tissue In tegrity Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1061.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

576 UNIT VIII Integumentary Disorders of the Adult Client

498. 2 Ra t ion a le: Iso tretin oin can elevate triglycerid e levels. Blo o d triglycerid e levels sh ou ld b e m easu red b efore treatm en t an d period ically th ereafter un til th e effect o n th e triglycerides h as been evalu ated. Th ere is n o in dicatio n th at iso tretin oin affects po tassium , h em o glob in A1C, o r total ch olestero l levels. Test -Ta kin g Str a tegy: No te th e su b ject, labo rato ry valu es th at sh ou ld b e m on ito red sp ecifically fo r th e clien t takin g iso treti- n oin . Recall th at th e m ed ication can affect triglyceride levels in th e clien t. Review: Iso tretin o in Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco logy—In tegum en tary Medicatio n s Pr ior ity Con cepts: Cellu lar Regu latio n ; Tissu e In tegrity Refer en ces: Burch um , Ro sen th al (2016), p . 1283; Ho d gso n , Kizior (2016), p p. 662-663.

499. 3 Ra t ion a le: Isotretin oin is a m etab olite of vitam in A an d can prod uce gen eralized in ten sification of iso tretin oin toxicity. Becau se of th e p o ten tial for in creased to xicity, vitam in A sup plem en ts sh o uld b e d isco n tin ued befo re isotretin o in th er- ap y. Th ere are n o con train dicatio n s asso ciated with d igo xin , ph en ytoin , or furosem ide. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, th e n eed to con tact th e HCP to en sure clien t safety. Recall th at iso tretin oin is a m etab olite o f vitam in A. Vitam in A is a fat-solu b le vitam in an d th erefore it is po ssib le to develop to xic levels. Th is will direct yo u to th e correct o ptio n . Review: Iso tretin o in Level of Cogn it ive Ability: An alyzin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—In tegum en tary Medicatio n s Pr ior ity Con cepts: Collabo ratio n ; Safety Refer en ce: Burch um , Rosen th al (2016), p. 1283.

500. 1, 4, 5 Ra t ion a le: Top ical co rtico stero ids can b e abso rb ed in to th e system ic circu lation . Abso rp tio n is h igh er from regio n s wh ere th e skin is especially perm eable ( scalp , axilla, face, eyelids, n eck, perin eu m , gen italia) , an d lower fro m region s wh ere p er- m eab ility is p oo r (b ack, palm s, so les). Th e n urse sh o uld avo id areas o f h igh er ab so rp tion to preven t system ic ab sorption . Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, p erm eability an d th e p o ten tial for in creased system ic abso rp tio n . Elim in ate op tion s 2 an d 3 b ecau se th ese b od y areas are co m p arab le o r alike in term s of skin su bstan ce. Fro m th e rem ain in g op tion s, th in k abo ut p erm eab ility of th e skin area. Th is sh ou ld direct yo u to th e co rrect o p tion s. Review: Ad m in istration o f to p ical co rtico stero id s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—In tegum en tary Medicatio n s

Pr ior ity Con cepts: Safety; Tissu e In tegrity Refer en ce: Bu rch u m , Rosen th al (2016), p. 1279.

501. 1 Ra t ion a le: Azelaic acid is a to pical m edicatio n u sed to treat m ild to m od erate acn e. Ad verse effects in clud e b urn in g, itch - in g, stin gin g, redn ess of th e skin , an d h yp op igm en tatio n o f th e skin in clien ts with a d ark com p lexio n . Th e effects n o ted in th e o th er op tio n s are n ot specifically associated with th is m ed ication . Test -Ta kin g St r a t egy: Focu s o n th e su b ject, th e purpose an d u se of azelaic acid . Focu sin g on th e n am e of th e m ed ication an d recallin g th at acn e m ed ication s co m m o n ly cau se local irri- tatio n will d irect yo u to th e correct o ptio n . Review: Azelaic acid Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—In tegum en tary Medicatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Bu rch u m , Rosen th al (2016), p. 1283.

502. 3 Ra t ion a le: Silver sulfad iazin e is an an tib acterial th at h as a b ro ad spectru m of activity again st gram -n egative bacteria, gram -p o sitive b acteria, an d yeast. It is app lied d irectly to th e woun d to assist in h ealin g. It does n ot cause stin gin g wh en ap plied . Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further teaching. Th ese wo rd s in dicate a n egative even t q u ery an d ask yo u to select an op tio n th at is an in co rrect statem en t. Recall th e ch aracteristics o f th is m ed icatio n . Review: Silver su lfad iazin e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—In tegum en tary Medicatio n s Pr ior ity Con cepts: Clien t Ed u catio n ; Tissu e In tegrity Refer en ce: Lilley et al. (2014), p. 905.

503. 4 Ra t ion a le: Su n screen s are m ost effective wh en ap plied at least 30 m in u tes befo re exp osu re to th e su n so th at th ey can p en e- trate th e skin . All su n screen s sh o uld be reap plied after swim - m in g o r sweatin g. Test -Ta kin g Str a tegy: Kn o wled ge th at su n screen s n eed to pen - etrate th e skin will assist in elim in atin g o ption s 2 an d 3. Next, n otin g th e strategic wo rd s, most effective, will assist in directin g yo u to th e co rrect o ption . Review: Su n screen an d o th er p ro tective skin m easu res Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—In tegum en tary Medicatio n s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 1286.

A

d

u

l

t

I

n

t

e

g

u

m

e

n

t

a

r

y

577CHAPTER 47 Integumentary Medications

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l UNIT IX

Hematological and Oncological Disorders of the Adult Client

Pyramid to Success

Pyram id Poin ts focus on treatm en t m od alities related to an on co logical disorder, such as pain m an agem en t, in tern al an d extern al radiation , an d ch em oth erapy. In preparation for th e NCLEX®, focus on th e follo win g on colo gical disorders: skin can cer; leukem ia; breast can cer; testicular can cer; stom ach , bowel, an d pan creatic can cers; bladder can cer; prostate can cer; an d lun g can cer. Particular atten tion is given to th e n ursin g care related to th ese disorders an d treatm en t m odalities, clien t adap ta- tion to acceptan ce of diagn osis an d associated lifestyle ch an ges, an d th e im pact of th e treatm en t for th e disorder on daily life. Also, con cen trate on th e co m plication s related to ch em oth erapy, such as h em atological disor- ders, an d th e n ursin g m easu res required in m on itorin g for th ese com plication s an d preven tin g life-th reaten in g con dition s, such as in fectio n an d bleedin g.

Client Needs: Learning Objectives Safe and Effective Care Environment Discussin g on co logy-related con sultation s an d referrals

with th e in terpro fession al h ealth care team En surin g th at advan ce directives are in th e clien t’s

m edical record En surin g advocacy related to th e clien t’s decision s En surin g th at in form ed con sen t for treatm en ts an d pro-

cedures h as been obtain ed Establish in g prio rities Han dlin g h azardo us an d in fectio us m aterials related to

radiation an d ch em oth erapy safely Im plem en tin g protective, stan d ard, an d oth er pre-

cautio n s

Main tain in g m ed ical an d surgical asepsis an d preven tin g in fectio n

Providin g con fiden tiality regardin g diagn osis Uph oldin g clien t righ ts

Health Promotion and Maintenance Discussin g exp ected body im age ch an ges related to ch e-

m oth erapy an d treatm en ts Providin g clien t an d fam ily in struction s regardin g

h om e care Providin g in struction s regardin g regular breast or testic-

ular self-exam in ation s Respectin g th e clien t’s lifestyle ch oices Teach in g about h ealth prom o tion program s regardin g

risks for can cer Teach in g about h ealth screen in g m easu res for can cer

Psychosocial Integrity Assessin g th e clien t’s ability to cope, ad apt, an d/ o r solve

problem s durin g illn ess or stressful even ts Assessin g th e co n cern s o f th e clien t wh o su rvived

can cer Assistin g th e clien t an d fam ily to cope with th e alteration

in body im age Discussin g en d-of-life an d grief an d lo ss issues related to

death an d th e dyin g process Mobilizin g appropriate support an d resource system s Prom otin g a positive en viron m en t to m ain tain optim al

quality of life Respectin g religious, spiritu al, an d cultural preferen ces

Physiological Integrity Adm in isterin g blood an d blood produ cts Carin g for cen tral ven ous access devices an d im plan ted

ports

578

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

Carin g for th e clien t receivin g ch em oth erapy or radia- tion th erapy

Man agin g pain Mon itorin g diagn ostic tests an d laborato ry values, such

as wh ite blood cell an d platelet coun ts

Mon itorin g for expected an d un exp ected respo n ses to radiation an d ch em oth erapy

Protectin g th e clien t from th e life-th reaten in g adverse effects of treatm en ts

Providin g basic care an d com fo rt Providin g n utrition

579UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

C H A P T E R 48 Hematological and Oncological Disorders

PRIORITY CONCEPTS Cellular Regulation; Safety

CRITICAL THINKING What Should You Do? The laboratory reports that a client’s platelet count is 19,00 0 mm3 (19.0 Â 10 9/ L) What should the nurse do? Answer located on p. 606.

I. Cancer A. Description

1. Can cer is a m align an t n eoplastic disorder th at can in volve all body organ s with m an ifestation s th at vary accordin g to th e body system affected an d type of tum o r cells.

2. Cells lose th eir n orm al growth -co n trollin g m ech - an ism , an d th e growth of cells is un co n trolled .

3. Can cer produces serious h ealth problem s such as im paired im m un e an d h em atop oietic (blood- producin g) fun ctio n , altered gastro in testin al tract structure an d fun ction , m oto r an d sen sory deficits, an d decreased respiratory fun ction .

B. Metastasis (Box 48-1) 1. Can cer cells m ove from th eir origin al location to

oth er sites. 2. Routes of m etastasis

a. Local seedin g: Distribution of sh ed can cer cells occurs in th e local area of th e prim ary tum o r.

b . Bloo dborn e m etastasis: Tu m or cells en ter th e blood , wh ich is th e m ost com m on cau se of can cer spread.

c. Lym ph atic spread: Prim ary sites rich in lym ph atics are m ore susceptible to early m etastatic spread.

C. Can cer classification 1. Solid tum o rs: Associated with th e organ s from

wh ich th ey develop, such as breast can cer or lu n g can cer

2. Hem atological can cers: O rigin ate from blood cell–form in g tissues, such as leukemias, lympho- mas, an d m ultiple myeloma

D. Gradin g an d stagin g (Box 48-2) 1. Gradin g an d staging are m eth od s used to

describe th e tum or. 2. Th ese m eth od s describe th e exten t of th e tum o r,

th e exten t to wh ich m align an cy h as in creased in size, th e in volvem en t of region al n odes, an d m et- astatic developm en t.

3. Gradin g a tum o r classifies th e cellular aspects of th e can cer an d is an in dicator of tum or growth rate an d spread.

4. Stagin g classifies th e severity an d clin ical aspects of th e can cer an d degree of m etastasis at diagn osis.

E. Factors th at in fluen ce can cer developm en t 1. En viron m en tal factors

a . Ch em ical carcinogen: Factors in clude in du s- trial ch em icals, m edication s, an d tobacco.

b . Ph ysical carcin o gen : Facto rs in clude ion izin g radiation (diagn o stic an d th erap eutic x-rays) an d ultraviolet radiation (sun , tan n in g beds, an d germ icid al ligh ts), ch ron ic irritatio n , an d tissue traum a.

c. Viral carcin o gen : Viruses cap able of causin g can cer are kn own as on co viruses, such as Epstein -Barr virus, h epatitis B virus, an d h um an papillom avirus.

d . Helicobacter pylori in fectio n is associated with an in creased risk of gastric can cer.

2. O besity an d dietary facto rs, in cludin g preserva- tives, con tam in an ts, additives, alcoh ol, an d n itrates

3. Gen etic predisp osition : Factors in clude an in h er- ited predisposition to specific can cers, in h erited con d ition s associated with can cer, fam ilial clus- terin g, an d ch rom osom al ab erration s.

4. Age: Advan cin g age is a sign ifican t risk factor for th e developm en t of can cer.

5. Im m un e fun ction : Th e in ciden ce of can cer is h igh er in im m un osuppressed in dividuals, such as th ose with acquired im m un odeficien cy syn - drom e an d organ tran splan t recip ien ts wh o are takin g im m un osuppressive m edication s.580

F. Preven tion : Avoidan ce of kn own or poten tial carcin - ogen s an d avoidan ce or m odification of th e factors associated with th e developm en t of can cer cells.

G. Early detection (Box 48-3) 1. Mam m ograph y 2. Papan icolaou (Pap ) test 3. Rectal exam s an d stools for occult blood 4. Sigm oidosco py, colon oscopy 5. Breast self-exam in ation (BSE) an d clin ical breast

exam in ation 6. Testicular self-exam in ation 7. Skin in spection

II. Diagnostic Tests A. Diagn ostic tests to be perform ed depen d on th e sus-

pected prim ary or m etastatic site of th e can cer; in va- sive procedures require in form ed con sen t (Box 48-4).

B. Biop sy 1. Description

a . Biop sy is th e defin itive m ean s of diagn osin g can cer an d provid es h isto logical proof of m align an cy.

b . Biop sy in volves th e surgical in cision to obtain a sm all piece of tissue for m icroscopic exam in ation .

2. Types a . Needle: Aspiration of cells b . In cision al: Rem oval of a wedge of susp ected

tissue fro m a larger m ass c. Excision al: Com p lete rem oval of th e en tire

lesion d . Stagin g: Multiple n eedle or in cision al biop-

sies in tissues wh ere m etastasis is susp ected or likely (see Boxes 48-1 an d 48-2)

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

BOX 48-1 Common Sites of Metastasis Bladder Cancer ▪ Lung ▪ Bone ▪ Liver ▪ Pelvic, retroperitoneal

structures

Brain Tumors ▪ Central nervous system Breast Cancer ▪ Bone ▪ Lung ▪ Brain ▪ Liver Colorectal Cancer ▪ Liver

Lung Cancer ▪ Brain ▪ Liver Prostate Cancer ▪ Bone ▪ Spine ▪ Lung ▪ Liver ▪ Kidneys Testicular Cancer ▪ Lung ▪ Bone ▪ Liver ▪ Adrenal glands ▪ Retroperitoneal lymph

nodes

BOX 48-2 Grading and Staging Grading Gra de I: Cells differ slightly from normal cells and are well dif-

ferentiated (mild dysplasia). Gra de II: Cells are more abnormal and are moderately differ-

entiated (moderate dysplasia). Gra de III: Cells are very abnormal and are poorly differentiated

(severe dysplasia). Gra de IV: Cells are immature (anaplasia) and undifferen-

tiated; cell of origin is difficult to determine.

Staging Sta ge 0: Carcinoma in situ Sta ge I: Tumor limited to the tissue of origin; localized tumor

growth Sta ge II: Limited local spread Sta ge III: Extensive local and regional spread Sta ge IV: Distant metastasis

BOX 48-3 Warning Signs of Cancer—CAUTION ▪ Change in bowel or bladder habits ▪ Any sore that does not heal ▪ Unusual bleeding or discharge ▪ Thickening or lump in breast or elsewhere ▪ Indigestion ▪ Obvious change in wart or mole ▪ Nagging cough or hoarseness

Data from WebMD: Understanding cancer—symptoms (website): www.webmd. com/ cancer/ understanding-cancer-symptoms. Ignatavicius, Workman (20 16), p. 367.

BOX 48-4 Diagnostic Tests ▪ Biopsy ▪ Bone marrow examination (particularly if a hematolym-

phoid malignancy is suspected) ▪ Chest radiograph ▪ Complete blood count (CBC) ▪ Computed tomography (CT) ▪ Cytological studies (Papanicolaou test) ▪ Evaluation of serum tumor markers (e.g., carcinoembryo-

nic antigen and alpha-fetoprotein) ▪ Liver function studies ▪ Magnetic resonance imaging (MRI) ▪ Proctoscopic examination (including guaiac test for occult

blood) ▪ Radiographic studies (mammography) ▪ Radioisotope scanning (liver, brain, bone, lung) ▪ Tumor markers

581CHAPTER 48 Hematological and Oncological Disorders

3. Tissue exam in ation a. Follo win g excision , a frozen section or a per-

m an en t paraffin section is prepared to exam - in e th e specim en .

b . Th e ad van tage of th e frozen section is th e speed with wh ich th e section can be prepared an d th e diagn osis m ade, because on ly m in u tes are required for th is test.

c. Perm an en t paraffin section takes ab out 24 h ours; h owever, it provides clearer details th an th e frozen section .

4. In terven tion s a. Th e procedure usually is perform ed in an out-

patien t surgical settin g. b . Prepare th e clien t for th e diagn ostic proce-

dure, an d provide postp rocedu re in struc- tion s.

c. En sure th at in form ed con sen t h as been obtain ed.

III. Pain Control A. Causes of pain

1. Bon e destruction 2. O bstruction of an organ 3. Com p ression of periph eral n erves 4. In filtration , disten tion of tissue 5. In flam m ation , n ecrosis 6. Psych ological facto rs, such as fear or an xiety; a

distress screen in g tool m ay be used to assess em o tion al h ealth (see h ttp :/ / www.can cer.org/ treatm en t/ treatm en tsan dsideeffects/ em o tion alsideeffects/ distressin peoplewith can cer/ distress-in -people- with -can cer-to ols-to-m easure-distress).

B. In terven tion s 1. Collaborate with oth er m em bers of th e h ealth

care team to develo p a pain m an agem en t program .

2. Adm in ister oral preparation s if possible an d if th ey provid e adequ ate relief of pain ; th e tran sder- m al route m ay also be prescribed.

3. Mild or m od erate pain m ay be treated with salic- ylates, acetam in o ph en , an d n on steroidal an tiin - flam m atory drugs (NSAIDs).

4. Severe pain is treated with opioids, such as codein e sulfate, m orph in e sulfate, m eth ado n e, an d h ydrom orph o n e h ydroch loride. Neuro- path ic pain m ay be treated with a variety of an ti- con vu lsan ts an d an tidepressan ts, as well as opioids.

5. Subcu tan eo us in jection s an d con tin uo us in trave- n ou s (IV) in fusio n s of opioids provide rapid pain con tro l; equ ian algesic com parison ch arts sh o uld be used wh en switch in g routes of ad m in - istration of opioids.

6. Mon itor vital sign s an d for side effects of m ed ication s.

7. Mon itor for effectiven ess of m ed ication s an d col- labo rate with th e h ealth care provider (HCP) if m ed iation is in effective.

8. Provide n on ph arm acological tech n iques of pain con trol, such as relaxatio n , guided im agery, bio- feedback, m assage, an d h eat-cold application .

Assess the client’s pain; pain is what the client describes or says that it is. Do not undermedicate the client with cancer who is in pain.

IV. Surgery A. Description : Surgery is in dicated to diagn ose, stage,

an d treat certain types of cancer. B. Proph ylactic surgery

1. Proph ylactic surgery is perform ed in clien ts with an existin g prem align an t con d ition or a kn own fam ily h isto ry or gen etic m utation th at stron gly predisp oses th e person to th e developm en t of can cer.

2. An attem p t is m ade to rem ove th e tissue or organ at risk an d th us preven t th e developm en t of can cer.

C. Curative surgery: All gross an d m icroscopic tum or is rem oved or destroyed.

D. Con trol (cytored uctive or “debulkin g”) surgery 1. Con trol surgery is a debulkin g proced ure th at

con sists of rem ovin g a large portion of a locally in vasive tum o r, such as ad van ced ovarian can cer.

2. Surgery decreases th e n um ber of can cer cells; th erefore, it m ay in crease th e ch an ce th at oth er th erap ies will be successful.

E. Palliative surgery 1. Palliative surgery is perform ed to im prove qual-

ity of life durin g th e survival tim e. 2. Palliative surgery is perform ed to reduce pain ,

relieve airway obstru ction , relieve obstru ctio n s in th e gastro in testin al or urin ary tract, relieve pressure on th e brain or spin al cord, preven t h em orrh age, rem ove in fected or ulcerated tum o rs, or drain abscesses.

F. Recon structive or reh abilitative surgery is perform ed to im prove quality of life by restorin g m axim al fun c- tion an d appearan ce, such as breast recon struction after m astectom y.

G. Adverse effects of surgery 1. Loss or loss of fun ction of a specific body part 2. Redu ced fun ction as a result of organ loss 3. Scarrin g or disfigurem en t 4. Grievin g ab out altered body im age or im posed

ch an ge in lifestyle 5. Pain , in fectio n , bleedin g, th rom boem bo lism

V. Chemotherapy A. Description

1. Ch em o th erap y kills or in h ibits th e reproductio n of n eoplastic cells an d kills n orm al cells.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

582 UNIT IX Hematological and Oncological Disorders of the Adult Client

2. Th e effects are system ic because ch em oth erapy is usually adm in istered system ically.

3. No rm al cells m ost profou n dly affected in clude th o se of th e skin , h air, an d lin in g of th e gastro in - testin al tract; sperm atocytes; an d h em atop oietic cells.

4. Usually, several ch em oth erapy an d bioth erapy agen ts are used in com bin ation (com bin ation th erapy) to in crease th e th erapeutic respo n se.

5. Com b in ation ch em oth erapy is plan n ed by th e HCP so th at m ed ication s with overlappin g toxic- ities an d nadirs (th e tim e durin g wh ich bon e m arrow activity an d wh ite blood cell coun ts are at th eir lowest) are n ot adm in istered at or n ear th e sam e tim e; th is will m in im ize im m un osu ppression .

6. Ch em oth erapy m ay be com bin ed with oth er treatm en ts, such as surgery an d radiation .

B. Com m on side effects in clude fatigue, alop ecia, n au- sea an d vom itin g, m ucositis, skin ch an ges, an d m yelosuppression (n eu tropen ia, an em ia, an d th rom bocytop en ia) .

C. See Ch apter 49 for in form ation regardin g care of th e clien t receivin g ch em oth erapy.

VI. Radiation Therapy A. Description

1. Rad iation th erap y destro ys can cer cells, with m in im al exp osure of n orm al cells to th e dam ag- in g effects of radiation ; th e dam aged cells die or beco m e un ab le to divide.

2. Rad iation th erapy is effective on tissues directly with in th e path of th e radiation beam .

3. Sid e effects in clude local skin ch an ges an d irrita- tio n , alopecia (h air loss) , fatigue (m ost com m on side effect of radiation ), an d altered taste sen sa- tio n ; th e effects vary accord in g to th e site of treatm en t.

4. Extern al beam radiation (also called teleth erapy) an d in tern al radiation (also called brach yth er- ap y) are th e types of radiation th erap y m ost co m - m on ly used to treat can cer.

B. Extern al beam radiation (teleth erapy): Th e actual radiation source is extern al to th e clien t. 1. In struct th e clien t regardin g self-care of th e skin

(Box 48-5). 2. Th e clien t does n ot em it radiation an d does n ot

pose a h azard to an yon e else. C. Brach yth erapy

1. Th e radiation source com es in to direct, con - tin uo us con tact with tum or tissues for a specific tim e.

2. Th e radiation source is with in th e clien t; for a period of tim e, th e clien t em its radiation an d can pose a h azard to oth ers.

3. Brach yth erapy in cludes an un sealed source or a sealed source of radiation .

4. Un sealed radiation source a . Adm in istration is via th e oral or IV route or by

in stillation in to body cavities. b . Th e source is n ot con fin ed com pletely to on e

body area, an d it en ters body fluids an d even - tually is elim in ated via various excreta, wh ich are radioactive an d h arm ful to oth ers. Most of th e source is elim in ated from th e body with in 48 h ou rs; th en n eith er th e clien t n or th e excreta is radioactive or h arm fu l.

5. Sealed radiation source ( Priority Nu rsin g Action s) ( Box 48-6)

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

BOX 48-5 Client Education Guide: Radiation Therapy for Cancer

Wash the irradiated area gently each day with warm water alone or with mild soap and water.

Use the hand rather than a washcloth to wash the area. Rinse soap thoroughly from the skin. Take care not to remove the markings that indicate exactly

where the beam of radiation is to be focused. Dry the irradiated area with patting motions rather than rub-

bing motions; use a clean, soft towel or cloth. Use no powders, ointments, lotions, or creams on the skin at

the radiation site unless they are prescribed by the radiologist.

Wear soft clothing over the skin at the radiation site. Avoid wearing belts, buckles, straps, or any type of clothing

that binds or rubs the skin at the radiation site. Avoid exposure of the irradiated area to the sun. Avoid heat exposure.

BOX 48-6 Care of the Client with a Sealed Radiation Implant

Place the client in a private room with a private bath. Place a radiation precaution sign on the client’s door. Organize nursing tasks to minimize exposure to the radiation

source. Nursing assignments to a client with a radiation implant

should be rotated. Limit time to 30 minutes per care provider per shift. Wear a dosimeter film badge to measure radiation exposure. Lead shielding may be used to reduce exposure to radiation. The nurse should never care for more than 1 client with a radi-

ation implant at 1 time. Do not allow a pregnant nurse to care for the client. Do not allow children younger than 16 years or a pregnant

woman to visit the client. Limit visitors to 30 minutes per day; visitors should be at least

6 feet from the source. Save bed linens and dressings until the source is removed;

then dispose of the linens and dressings in the usual manner.

Other equipment can be removed from the room at any time.

583CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

PRIORITY NURSING ACTIONS Sealed Radiation Implant that Dislodges 1. Encourage the client to lie still. 2. Use a long-handled forceps to retrieve the radioactive source. 3. Deposit the radioactive source in a lead container. 4. Contact the radiation oncologist. 5. Document the occurrence and the actions taken.

The client with a sealed radiation implant can emit radia- tion. Therefore, the nurse and any other person who is in con- tact with the client needs to take special precautions to protect himself or herself from radiation exposure. In the event that a radiation source becomes dislodged, the nurse would first encourage the client to lie still until the radioactive source has been placed in a safe, closed lead container. The nurse would never touch the dislodged radiation source with his or her hands and would use a long-handled forceps to place the source in the lead container that should be kept in the cli- ent’s room. The nurse calls the radiation oncologist and then documents the occurrence and the actions taken. In the event that the radiation source cannot be located, the nurse ensures that no linens or other articles in the client’s room are disposed of, prohibits visitors, and notifies the radiation oncologist.

Reference Ignatavicius, Workman (2016), p. 376.

a. A sealed , tem p orary or perm an en t radiation source (so lid im plan t) is im plan ted with in th e tum o r target tissues.

b . Th e clien t em its radiation wh ile th e im - plan t is in place, but th e excreta are n ot radioactive.

6. Rem o val of sealed radiation sources a. Th e clien t is n ot radioactive follo win g

rem oval. b . In form th e clien t th at can cer is n ot

con tagious. c. In fo rm th e clien t to fo llo w th e H CPs p re-

scrip tio n regard in g resu m p tio n o f sexu al in terco u rse if th e im p lan t was cervical o r vagin al.

d . Ad vise th e clien t wh o h ad a cervical o r vagi- n al im p lan t to n o tify th e H CP if an y o f th e fo llo win g o ccu rs: severe d iarrh ea, freq u en t u rin atio n , u reth ral b u rn in g fo r m o re th an 24 h o u rs, h em atu ria, h eavy vagin al b leed - in g, extrem e fatigu e, ab d o m in al p ain , fever o ver 100° F ( 38° C) , o r o th er sign s o f in fectio n .

VII. Bone Marrow Transplantation A. Description

1. Bon e m arro w tran splan tation (BMT) an d periph - eral blood stem cell tran splan tatio n (PBSCT) are

proced ures th at replace stem cells th at h ave been destroyed by h igh doses of ch em oth erapy an d/ o r radiation th erap y.

2. BMT an d PBSCT are m ost com m on ly used in th e treatm en t of leukem ia an d lym ph o m a, but are also used to treat oth er can cers, such as n euro- blastom a an d m ultiple m yelom a.

3. Th e go al of treatm en t is to rid th e clien t of all leu- kem ic or oth er malignant cells th rough treatm en t with h igh doses of ch em oth erapy an d wh o le- body irradiation .

4. Because th ese treatm en ts are dam agin g to bon e m arro w cells, with out th e replacem en t of blood -form in g stem cell fun ctio n th rou gh tran s- plan tation , th e clien t would die of in fectio n or h em orrh age.

B. Types of don or stem cells 1. Allogen eic: Stem cell don or is usually a siblin g, a

paren t with a sim ilar tissue type, or a perso n wh o is n ot related to th e clien t (un related don or).

2. Syn gen eic: Stem cells are fro m an iden tical twin . 3. Autologous

a . Autologo us don ation is th e m ost com m on type.

b . Th e clien t receives h is or h er own stem cells. c. Stem cells are h arvested durin g disease rem is-

sion and are stored frozen to be rein fused later. C. Proced ure

1. Harvest a . Th e stem cells used in PBSCT com e from th e

bloodstream in a 4- to 6-h our process called apheresis or leukapheresis (th e blood is rem oved th rough a cen tral ven ous catheter an d an aphe- resis m achine rem oves th e stem cells and return s th e rem ain der of the blood to th e don or).

b . In BMT, m arro w is h arvested th rou gh m ulti- ple aspiration s from th e iliac crest to retrieve sufficien t bon e m arro w for th e tran splan t.

c. Marro w from th e clien t is filtered for residual can cer cells.

d . Allogen eic m arrow is tran sfused im m edi- ately; autologous m arro w is frozen for later use (cryopreservation ).

e. Harvestin g is don e before th e in itiation of th e con dition in g regim en .

2. Conditioning refers to an im m un osuppression th erap y regim en used to eradicate all m align an t cells, provide a state of im m un osuppression , an d create space in th e bon e m arro w for th e en graftm en t of th e n ew m arro w.

3. Tran splan tation a . Stem cells are ad m in istered th rou gh th e cli-

en t’s cen tral lin e in a m an n er sim ilar to th at for a blood tran sfusio n .

b . Stem cells m ay be ad m in istered by IV in fu- sion or by IV push directly in to th e cen tral lin e.

584 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

4. En graftm en t a . Th e tran sfused stem cells m ove to th e m arrow-

form in g sites of the recipien t’s bon es. b . En graftm en t occurs wh en th e wh ite blood

cell (WBC), eryth rocyte, an d platelet coun ts begin to rise.

c. Wh en successful, th e en graftm en t process takes 2 to 5 weeks.

D. Posttran splan tation period: In fection , bleed in g, or n eutropen ia an d th rom bocytopen ia are m ajo r con - cern s un til en graftm en t occurs.

During the posttransplantation period, the client remains without any natural immunity until the donor stem cells begin to proliferate and engraftment occurs.

E. Com p lication s 1. Failure to en graft: If th e tran splan ted stem cells

fail to en graft, th e clien t will die un less an oth er tran splan tation is attem pted an d is successful.

2. Graft-versus-h ost disease in allogen eic tran splan ts a . Alth ou gh th e recipien t can n ot recogn ize th e

don ated stem cells as foreign or n on -self because of th e total im m un osuppression , th e im m un e-co m peten t cells of th e don or recogn ize th e recipien t’s cells as foreign an d m ou n t an im m un e offen se again st th em .

b . Graft-versus-h o st disease is m an aged cau- tiously with im m un osuppressive agen ts to avoid supp ressin g th e n ew im m un e system to such an exten t th at th e clien t beco m es m ore susceptible to in fection , or th e tran s- plan ted cells stop en graftin g.

3. Hepatic ven o -occlusive disease a . Th e disease in volves occlusion of th e h epatic

ven u les by th rom bosis or ph lebitis. b . Sign s in clude righ t upper quadran t abdom i-

n al pain , jaun dice, ascites, weigh t gain , an d h epatom egaly.

c. Early detection is critical because th ere is n o kn own way to open th e h epatic vessels.

d . Th e clien t will be treated with fluid s an d sup- portive th erapy.

VIII. Skin Cancer (see Chapter 46)

IX. Leukemia (Box 48-7) A. Description

1. Leukemias are a group of h em atological m alig- n an cies in volvin g ab n orm al overprod uction of leuko cytes, usually at an im m ature stage, in th e bon e m arro w.

2. Th e 2 m ajo r types of leukem ia are lym p h ocytic (in volvin g abn orm al cells from th e lym p h oid path way) an d m yelocytic or m yelogen ous (in volvin g abn orm al cells from th e m yeloid path ways) .

3. Leu kem ia m ay be acu te, with a sudd en on set, or ch ron ic, with a slow on set an d persisten t sym p- tom s over a period of years.

4. Leu kem ia affects th e bon e m arro w, causin g an e- m ia, leukopen ia, th e production of im m ature cells, th rom bocytop en ia, an d a declin e in im m un ity.

5. Th e cause is un kn own an d appears to in volve gen etically dam aged cells, lead in g to th e tran sfor- m ation of cells from a n orm al state to a m align an t state.

6. Risk factors in clude gen etic, viral, im m un ologi- cal, an d en viron m en tal facto rs an d exposu re to radiation , ch em icals, an d m edication s, such as previous ch em oth erapy.

B. Assessm en t 1. An o rexia, fatigue, weakn ess, weigh t lo ss 2. An em ia 3. O vert bleed in g (n osebleeds, gum bleed in g, rectal

bleed in g, h em aturia, in creased m en strual flow) an d occult bleedin g (e.g., as detected in a fecal occult blood test)

4. Ecch ym oses, petech iae 5. Prolon ged bleed in g after m in or ab rasion s or

laceration s 6. Elevated tem perature 7. En larged lym ph n od es, spleen , liver 8. Palp itation s, tach ycardia, orth o static h ypo ten -

sion 9. Pallor an d dyspn ea on exertion 10. Headach e 11. Bon e pain an d join t swellin g 12. No rm al, elevated, or reduced WBC coun t 13. Decreased h em oglobin an d h em atocrit levels 14. Decreased platelet coun t 15. Positive bon e m arro w biopsy iden tifyin g leuke-

m ic blast–ph ase cells

BOX 48-7 Classification of Leukemia Acute Lymphocytic Leukemia ▪ Mostly lymphoblasts present in bone marrow ▪ Age of onset is younger than 15 years. Acute Myelogenous Leukemia ▪ Mostly myeloblasts present in bone marrow ▪ Age of onset is between 15 and 39 years. Chronic Myelogenous Leukemia ▪ Mostly granulocytes present in bone marrow ▪ Age of onset is in the fourth decade. Chronic Lymphocytic Leukemia ▪ Mostly lymphocytes present in bone marrow ▪ Age of onset is after 50 years.

585CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

C. In fection 1. In fection can occur th rough autocon tam in ation

or cross-con tam in ation . Th e WBC coun t m ay be extrem ely low durin g th e period of greatest bon e m arro w depression , kn own as th e nadir.

2. Com m on sites of in fection are th e skin , respira- tory tract, an d gastroin testin al tract.

3. In itiate protective isolation procedures. 4. En su re frequen t an d th oro ugh h an d wash in g by

th e clien t, fam ily, an d HCPs. 5. Staff an d visitors with kn own in fectio n s or expo-

sure to com m un icable diseases sh o uld avoid con tact with th e clien t un til risk of in fectious spread h as passed.

6. Use strict aseptic tech n iqu e for all procedures. 7. Keep supplies for th e clien t sep arate fro m sup-

plies for oth er clien ts; keep frequen tly used equ ipm en t in th e room for th e clien t’s use on ly.

8. Lim it th e n um ber of staff en terin g th e clien t’s ro om to reduce th e risk of cross-in fection .

9. Main tain th e clien t in a private room with th e door closed .

10. Place th e clien t in a room with h igh -efficien cy particulate air filtration or a lam in ar airflow sys- tem if possible.

11. Redu ce exposu re to en viron m en tal organ ism s by elim in atin g fresh or raw fruits an d vegetables (low-b acteria diet) fro m th e diet; elim in ate fresh flowers an d live plan ts from th e clien t’s ro om an d avoid leavin g stan din g water in th e clien t’s room .

12. Be sure th at th e clien t’s room is clean ed daily. 13. Assist th e clien t with daily bath in g, usin g an

an tim icrobial soap. 14. Assist the clien t to perform oral h ygiene frequently. 15. In itiate a bowel program to preven t co n stipatio n

an d preven t rectal traum a. 16. Avo id in vasive proced ures such as in jection s,

in sertion of rectal th erm om eters, an d urin ary cath eterization .

17. Ch an ge woun d dressin gs daily, an d in spect th e woun ds for redn ess, swellin g, or drain age.

18. Assess th e urin e for cloudin ess an d oth er ch arac- teristics of in fection .

19. Assess skin an d oral m ucou s m em bran es for sign s of in fectio n (Box 48-8).

20. Auscu ltate lun g soun ds, an d en courage th e clien t to cough an d deep-breath e.

21. Mon itor tem p erature, pulse, respiration s, blood pressure, an d for pain .

22. Mon itor WBC an d n eutroph il coun ts. 23. No tify th e HCP if sign s of in fectio n are presen t,

an d prepare to obtain specim en s for culture of th e blood , open lesion s, urin e, an d sputum ; ch est radiograph m ay also be prescribed.

24. Adm in ister prescribed an tibiotic, an tifun gal, an d an tiviral m ed ication s.

25. In struct th e clien t to avoid crowds an d th o se with in fectio n s.

26. In struct th e clien t about a low-bacteria diet. 27. In struct th e clien t to avoid activities th at exp ose

th e clien t to in fectio n , such as ch an gin g a pet’s lit- ter box or workin g with h ouse plan ts or in th e garden .

28. In struct clien ts th at n eith er th ey n or th eir h ou se- h old con tacts sh o uld receive im m un ization with a live virus such as m easles, m um ps, rubella, polio, varicella, sh in gles, an d som e in fluen za, in cludin g th e H1N1 vaccin e.

Infection is a major cause of death in the immuno- suppressed client.

D. Bleedin g 1. Du rin g th e period of greatest bon e m arrow sup-

pression (th e n adir), th e platelet coun t m ay be extrem ely low.

2. Th e clien t is at risk for bleedin g wh en th e plate- let coun t falls below 50,000 m m 3 (50 Â 109/ L), an d spon tan eous bleedin g frequen tly occurs wh en th e platelet coun t is lower th an 20,000 m m 3 (20 Â 109/ L) .

3. Clien ts with platelet coun ts lower th an 20,000 m m 3 (20 Â 109/ L) m ay n eed a platelet tran sfusion .

4. For clien ts with an em ia an d fatigue, packed red blood cells m ay be prescribed .

5. Mon itor laborato ry values. 6. Exam in e th e clien t for sign s an d sym pto m s of

bleed in g, such as petech iae; exam in e all body fluid s an d excrem en t for th e presen ce of blood.

7. Han dle th e clien t gen tly; use caution wh en takin g blood pressures to preven t skin in jury.

8. Mon itor for sign s of in ternal h em orrh age (e.g., pain , rapid an d weak pulse, increased abdom in al girth , abdom en guardin g, ch ange in m en tal status).

9. Provide soft food s th at are co ol to warm to avoid oral m ucosa dam age.

BOX 48-8 Mouth Care for the Client with Mucositis

Inspect the mouth daily. Offer complete mouth care before and after every meal and at

bedtime. Brush the teeth and tongue with a soft-bristled toothbrush or

sponges. Provide mouth rinses every 12 hours with the prescribed

solution. Administer topical anesthetic agents to mouth sores as

prescribed. Avoid the use of alcohol- or glycerin-based mouthwashes or

swabs because they are irritating to the mucosa. Offer soft foods that are cool to warm in temperature rather

than foods that are hard or spicy.

586 UNIT IX Hematological and Oncological Disorders of the Adult Client

10. Avo id in jection s, if possib le, to preven t traum a to th e skin an d bleedin g; apply firm an d gen tle pres- sure to a n eedle-stick site for at least 5 m in u tes, or lo n ger if n eeded.

11. Pad side rails an d sh arp co rn ers of th e bed an d furn iture.

12. Avo id rectal supp ositories, en em as, an d th erm om eters.

13. If th e fem ale clien t is m en struatin g, coun t th e n um ber of pads or tam pon s used.

14. Adm in ister blood produ cts as prescribed. 15. In struct th e clien t to use a soft tooth brush an d

avoid den tal floss. 16. In struct th e clien t to use on ly an electric razor for

sh avin g. 17. In struct th e clien t to avoid blowin g th e n ose. 18. Discou rage th e clien t from en gagin g in activities

in volvin g th e use of sh arp objects; con tact sports also n eed to be avoided.

19. In struct th e clien t to avoid usin g NSAIDs an d products th at con tain aspirin .

E. Fatigue an d n utrition 1. Assist th e clien t in selectin g a well-balan ced diet. 2. Provide sm all, frequent m eals (h igh calorie, h igh

protein , h igh carboh ydrate) th at require little ch ew- ing to reduce en ergy expen diture at m ealtim es.

3. Assist the clien t in self-care an d m obility activities. 4. Allow adequ ate rest periods durin g care. 5. Do n ot perform activities un less th ey are essen -

tial; assist th e clien t in sch edulin g im portan t or pleasurable activities durin g periods of h igh est en ergy.

6. Adm in ister blood produ cts for an em ia as prescribed .

F. Addition al in terven tion s 1. Ch em oth erapy

a . In duction th erap y is aim ed at ach ievin g a rapid, com plete rem ission of all m an ifesta- tion s of th e disease.

b . Con solidation th erap y is ad m in istered early in rem ission with th e aim of curin g.

c. Main ten an ce th erap y m ay be prescribed for m on th s or years followin g successful in du c- tion an d con solidation th erapy; th e aim is to m ain tain rem ission .

2. Adm in ister an tibiotic, an tibacterial, an tiviral, an d an tifun gal m ed ication s as prescribed.

3. Adm in ister colon y-stim ulatin g factors as prescribed .

4. Adm in ister blood replacem en ts as prescribed. 5. Main tain in fectio n an d bleedin g precaution s. 6. Prepare th e clien t for tran splan tation if in dicated. 7. In struct th e clien t in appropriate h om e care

m easu res. 8. Provide psych osocial support an d supp ort ser-

vices for h om e care.

X. Lymphoma: Hodgkin’s Disease A. Description

1. Lymphomas, classified as Hodgkin ’s and n on - Hodgkin ’s depen din g on th e cell type, are ch arac- terized by abn orm al proliferation of lym ph ocytes.

2. Ho dgkin ’s disease is a m align an cy of th e lym p h n od es th at origin ates in a sin gle lym p h n ode or a ch ain of n odes.

3. Metastasis occurs to oth er, adjacen t lym ph struc- tures an d even tually in vades n on lym ph oid tissue.

4. Th e disease usually in volves lym p h n odes, ton - sils, spleen , an d bon e m arro w an d is ch aracter- ized by th e presen ce of Reed -Stern berg cells in th e n od es.

5. Possible cau ses in clude viral in fectio n s; clien ts treated with com bin ation ch em oth erapy for Ho dgkin ’s disease h ave a greater risk of develop- in g acu te leukem ia an d n on –Hodgkin ’s lym - ph o m a, am on g oth er secon dary m align an cies.

6. Progn osis depen ds on th e stage of th e disease. B. Assessm en t

1. Fever 2. Malaise, fatigue, an d weakn ess 3. Nigh t sweats 4. Loss of appetite an d sign ifican t weigh t loss 5. An em ia an d th rom bocytop en ia 6. En larged lym ph n od es, spleen , an d liver 7. Positive biopsy of lym ph n odes, with cervical

n od es m ost often affected first 8. Presen ce of Reed -Stern berg cells in n od es 9. Positive com pu ted tom ograph y (CT) scan of th e

liver an d spleen C. In terven tion s

1. For earlier stages (stages I an d II), with out m ed i- astin al n od e in volvem en t, th e treatm en t of ch oice is exten sive extern al radiation of th e in volved lym p h n ode region s.

2. With m ore exten sive disease, radiation an d m ul- tiagen t ch em oth erapy are used.

3. Mon itor for side effects related to ch em oth erapy or radiation th erap y.

4. Mon itor for sign s of in fectio n an d bleedin g. 5. Main tain in fection an d bleed in g precaution s. 6. Discuss th e possibility of sterility with th e clien t

receivin g ch em oth erapy an d/ or radiation , an d in form th e clien t of fertility option s such as sperm ban kin g.

XI. Multiple Myeloma A. Description

1. A m align an t proliferation of plasm a cells with in th e bon e

2. Excessive n um bers of abn orm al plasm a cells in vade th e bon e m arro w an d ultim ately destroy bon e; in vasion of th e lym ph n odes, spleen , an d liver occurs.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

587CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

3. Th e abn o rm al plasm a cells produ ce an abn orm al an tibody (m yelom a protein or th e Ben ce Jon es protein ) foun d in th e blood an d urin e.

4. Multiple m yelom a causes decreased productio n of im m un oglobulin an d an tibod ies an d in creased levels of uric acid an d calcium , wh ich can lead to kidn ey failure.

5. Th e disease typically develo ps slowly an d th e cau se is un kn own .

B. Assessm en t 1. Bon e (skeletal) pain , especially in th e ribs, spin e,

an d pelvis 2. Weakn ess an d fatigue 3. Recurren t in fectio n s 4. An em ia 5. Urin alysis sh ows Ben ce Jon es protein uria an d

elevated total serum protein level. 6. O steoporo sis (bon e lo ss an d th e developm en t of

path ological fractures) 7. Th rom bocytopen ia an d leukopen ia 8. Elevated calcium an d uric acid levels 9. Kid n ey failure 10. Spin al cord com pression an d paraplegia 11. Bon e m arrow aspiration sh o ws an abn orm al

n um ber of im m ature plasm a cells.

The client with multiple myeloma is at risk for path- ological fractures. Therefore, provide skeletal support during moving, turning, and ambulating and provide a hazard-free environment.

C. In terven tion s 1. Adm in ister ch em oth erapy as prescribed. 2. Provide supportive care to con trol sym ptom s and

preven t com plication s, especially bon e fractures, h ypercalcem ia, kidn ey failure, an d in fection s.

3. Main tain n eutropen ic an d bleed in g precaution s as n ecessary.

4. Mon itor for sign s of bleedin g, in fectio n , an d skeletal fractures.

5. En cou rage th e con sum p tion of at least 2 L of flu ids per day to offset poten tial problem s asso- ciated with h ypercalcem ia, h yperuricem ia, an d protein uria, an d en courage addition al flu id as in dicated an d tolerated .

6. Mon itor for sign s of kidn ey failure. Collect 24- h ou r urin e as prescribed.

7. En cou rage am bulation to preven t ren al prob- lem s an d to slow down bon e resorptio n .

8. Adm in ister IV fluid s an d diuretics as prescribed to in crease ren al excretio n of calcium .

9. Adm in ister blood tran sfusio n s as prescribed for an em ia.

10. Adm in ister an algesics as prescribed an d provid e n on ph arm aco logical th erapies to con trol pain .

11. Adm in ister an tibiotics as prescribed for in fectio n . 12. Prepare th e clien t for local radiation th erapy if

prescribed.

13. In struct th e clien t in h om e care m easu res an d th e sign s an d sym ptom s of in fectio n .

14. Adm in ister bisph osp h on ate m edication s as pre- scrib ed to slow bon e dam age an d reduce pain an d risk of fractures.

XII. Testicular Cancer A. Description

1. Testicular can cer arises from germ in al epith elium from th e sperm -producin g germ cells or from n on germ in al epith elium from oth er structures in th e testicles.

2. Testicular can cer m ost often occurs between th e ages of 15 an d 40 years.

3. Th e cause of testicular can cer is un kn own , but a h isto ry of un descen ded testicle (cryptorch idism ) an d gen etic predisposition h ave been associated with testicular tum or developm en t.

4. Metastasis occurs to th e lu n g, liver, bon e, an d adren al glan d s via th e blood , an d to th e retroper- iton eal lym p h n odes via lym p h atic ch an n els.

B. Early detection : Perform m on th ly testicular self- exam in ation ( Fig. 48-1). 1. Perform in g testicular self-exam in ation : Perform

m on th ly; a day of th e m on th is selected an d th e exam in ation is perform ed on th e sam e day each m on th .

2. Clien t in struction s (see Fig. 48-1) C. Assessm en t

1. Pain less testicular swellin g occurs. 2. “Draggin g” or “pullin g” sen sation is exp erien ced

in th e scrotum . 3. Palp able lym ph ad en opath y, abdom in al m asses,

an d gyn ecom astia m ay in dicate m etastasis. 4. Late sign s in clude back or bon e pain an d respira-

tory sym ptom s. D. In terven tion s

1. Adm in ister ch em oth erapy as prescribed. 2. Prepare th e clien t for radiation th erapy as

prescribed. 3. Prepare th e clien t for un ilateral orch iecto m y, if

prescribed, for diagn osis an d prim ary surgical m an agem en t or radical orch iecto m y (surgical rem oval of th e affected testis, sperm atic cord, an d region al lym p h n odes).

4. Prepare th e clien t for retroperiton eal lym ph n ode dissection , if prescribed, to stage th e disease an d reduce tum o r vo lum e so th at ch em oth erapy an d radiation th erap y are m ore effective.

5. Discuss reprodu ction , sexuality, an d fertility in form ation an d option s with th e clien t.

6. Iden tify reprodu ctive option s such as sperm stor- age, don or in sem in ation , an d adoption .

E. Postoperative in terven tion s 1. Mon itor for sign s of bleedin g an d woun d in fec-

tion ; an tibiotics m ay be ad m in istered to preven t woun d in fectio n .

588 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

2. Mon itor in take an d outp ut. 3. Provide an d explain pain m an agem en t m eth od s;

to reduce swellin g in th e first 48 h ours, ap ply an ice pack with an in terven in g protective layer of cloth .

4. No tify th e HCP if ch ills, fever, in creasin g pain or ten dern ess at th e in cision site, or drain age from th e in cision occurs.

5. After th e orch iecto m y, in struct th e clien t to avoid h eavy liftin g an d stren uou s activity for th e len gth of tim e prescribed by th e HCP.

6. In struct th e clien t to perform a m on th ly testicular self-exam in ation on th e rem ain in g testicle (see Fig. 48-1).

7. In form th e clien t th at sutures will be rem oved ap proxim ately 7 to 10 days after surgery.

XIII. Cervical Cancer A. Descrip tion

1. Prein vasive can cer is lim ited to th e cervix (Box 48-9).

2. In vasive can cer is in th e cervix an d oth er pelvic structures.

3. Metastasis usually is con fin ed to th e pelvis, but distan t m etastasis occurs th rough lym p h atic spread.

4. Prem align an t ch an ges are described on a con tin - uum fro m dysplasia, wh ich is th e earliest prem a- lign an cy ch an ge, to carcinoma in situ, th e m ost advan ced prem align an t ch an ge.

B. Risk facto rs 1. Hum an papillom avirus (HPV) in fectio n (vacci-

n ation again st HPV is effective to avoid HPV in fectio n , an d th u s cervical can cer)

2. Cigarette sm okin g, both active an d passive 3. Reproductive beh avior, in cludin g early first

in tercou rse (before age 17), m ultiple sex part- n ers, or m ale partn ers with m ultiple sex partn ers

4. Screen in g via regular gyn ecological exam in a- tion s an d Pap test, with treatm en t of precan cer- ous abn o rm alities, decreases th e in ciden ce an d m ortality of cervical can cer.

C. Assessm en t 1. Pain less vagin al postm en strual an d postco ital

bleedin g 2. Foul-sm ellin g or serosan guin eous vagin al

disch arge 3. Pelvic, lower back, leg, or groin pain 4. An orexia an d weigh t loss 5. Leakage of urin e an d feces from th e vagin a 6. Dysuria 7. Hem aturia 8. Cytological ch an ges on Pap test

D. In terven tion s ( Box 48-10) E. Laser th erap y

1. Laser th erap y is used wh en all boun daries of th e lesion are visible durin g colposco pic exam in ation .

2. En ergy fro m th e beam is ab sorbed by fluid in th e tissues, causin g th em to vapo rize.

3. Min im al bleedin g is associated with th e procedure.

4. Sligh t vagin al disch arge is exp ected followin g th e procedure, an d h ealin g occurs in 6 to 12 weeks.

FIGURE 48-1 Testicular self-examination. The best time to perform this examination is right after a shower when your scrotal skin is moist and relaxed, making the testicles easy to feel. First, gently lift each testicle. Each one should feel like an egg, firm but not hard, and smooth with no lumps. Then, using both hands, place your middle fingers on the underside of each testicle and your thumbs on top. Gently roll the testicle between the thumb and fingers to feel for any lumps, swelling, or mass. If you notice any changes from 1 month to the next, notify your health care provider.

BOX 48-9 Premalignant Cancers: Stages of Cervical Intraepithelial Neoplasia

Sta ge I: Mild dysplasia Sta ge II: Moderate dysplasia Sta ge III: Severe dysplasia to carcinoma in situ

BOX 48-10 Treatment for Cervical Cancer Nonsurgical ▪ Chemotherapy ▪ Cryosurgery ▪ External radiation ▪ Internal radiation implants (intracavitary) ▪ Laser therapy Surgical ▪ Conization ▪ Hysterectomy ▪ Pelvic exenteration

589CHAPTER 48 Hematological and Oncological Disorders

F. Cryosurgery 1. Cryosurgery in volves freezin g of th e tissues,

usin g a probe, with subsequen t n ecrosis an d slough in g.

2. No an esth esia is required, alth ough cram p in g m ay occur durin g th e procedure.

3. A h eavy watery disch arge will occur for several weeks followin g th e proced ure.

4. In struct th e clien t to avoid in tercou rse an d th e use of tam pon s wh ile th e disch arge is presen t.

G. Con izatio n 1. A con e-sh aped area of th e cervix is rem oved. 2. Con ization allows th e wom an to retain repro-

ductive capacity. 3. Lon g-term follo w-up care is n eeded because n ew

lesion s can develo p. 4. Th e risks of th e proced ure in clude h em orrh age,

uterin e perforation , in com peten t cervix, cervical sten osis, an d preterm labo r in future preg- n an cies.

H. Hysterecto m y 1. Descrip tion

a . Hysterecto m y is perform ed for m icro in va- sive can cer if ch ildbearin g is n ot desired.

b . A vagin al approach is m ost com m on ly used. c. A radical h ysterectom y an d bilateral lym p h

n od e dissectio n m ay be perform ed for can - cer th at h as spread beyon d th e cervix but n ot to th e pelvic wall.

2. Postoperative in terven tion s a . Mon itor vital sign s b . Assist with cough in g an d deep-breath in g

exercises. c. Assist with ran ge-of-m otion exercises an d

provide early am bulation . d . Apply an tiem bolism stockin gs or sequen tial

com pression devices as prescribed. e. Mon itor in take an d outp ut, urin ary cath eter

drain age, an d h ydration status. f. Mon itor bowel soun ds. g. Assess in cision site for sign s of in fectio n . h . Adm in ister pain m edication as prescribed. i. In struct th e clien t to lim it stair clim b in g for

1 m on th as prescribed an d to avoid tub bath s an d sittin g for lo n g periods.

j. Avo id stren uou s activity or liftin g an yth in g weigh in g m ore th an 20 poun ds (9 kg).

k . In struct th e clien t to con sum e food s th at prom ote tissue h ealin g.

l. In struct th e clien t to avoid sexual in tercourse for 3 to 6 weeks as prescribed.

m . In struct th e clien t in th e sign s associated with com plication s.

Monitor vaginal bleeding following hysterectomy. More than 1 saturated pad per hour may indicate exces- sive bleeding.

I. Pelvic exen teration ( Box 48-11) 1. Descriptio n

a . Pelvic exen teratio n , th e rem oval of all pelvic con ten ts, in cludin g bowel, vagin a, an d blad- der, is a radical surgical proced ure perform ed for recurren t can cer if n o evid en ce of tum o r outsid e th e pelvis an d n o lym p h n ode in volvem en t exist.

b . Wh en th e blad der is rem oved, an ileal con - duit is created an d lo cated on th e righ t side of th e abdom en to divert urin e.

c. A colosto m y m ay n eed to be created on th e left side of th e ab dom en for th e passage of feces.

2. Posto perative in terven tion s a. Sim ilar to postoperative in terven tion s fol-

lowin g h ysterectom y. b . Mon itor for sign s of altered respiratory

status. c. Mon itor in cision site for in fectio n . d . Mon itor in take an d outp ut an d for sign s of

deh ydration . e. Mon itor for h em orrh age, sh ock, an d deep

vein th rom bosis. f. Apply an tiem bolism stockin gs or seq uen tial

com pression devices as prescribed. g. Adm in ister proph ylactic h eparin as pre-

scrib ed. h . Adm in ister perin eal irrigation s an d sitz

bath s as prescribed . i. In struct th e clien t to avoid stren uou s activity

for 6 m on th s. j. In struct th e clien t th at th e perin eal open in g,

if presen t, m ay drain for several m on th s. k . In struct th e clien t in th e care of th e ileal con -

duit an d co lostom y, if created. l. Provide sexual coun selin g because vagin al

in tercou rse is n ot possible after an terior an d total pelvic exen teration .

m . In tern al radiation th erap y is used for clien ts for wh o m surgery is n ot an option .

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

BOX 48-11 Types of Pelvic Exenteration Anterior ▪ Removal of the uterus, ovaries, fallopian tubes, vagina,

bladder, urethra, and pelvic lymph nodes

Posterior ▪ Removal of the uterus, ovaries, fallopian tubes, descending

colon, rectum, and anal canal

Total ▪ Combination of anterior and posterior

590 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

XIV. Ovarian Cancer A. Description

1. O varian can cer grows rapidly, spreads fast, an d is often bilateral.

2. Metastasis occurs by direct spread to th e organ s in th e pelvis, by distal spread th rou gh lym ph atic drain age, or by periton eal seedin g.

3. In its early stages, ovarian can cer is often asym p- tom atic; because m ost wom en are diagn osed in ad van ced stages, ovarian can cer h as a h igh er m ortality rate th an an y oth er can cer of th e fem ale reproductive system , particularly am on g wh ite wom en between 55 an d 65 years of age of No rth Am erican or European descen t.

4. An explo ratory laparoto m y is perform ed to diag- n ose an d stage th e tum or.

5. A tran svagin al ultrasoun d can also be used; h ow- ever, th is screen in g does n ot decrease m ortality.

B. Assessm en t 1. Abdo m in al discom fort or swellin g 2. Gastroin testin al disturban ces 3. Dysfu n ction al vagin al bleedin g 4. Abdo m in al m ass 5. Elevated tumor marker (i.e., CA-125)

C. In terven tion s 1. Extern al radiation m ay be used if th e tum or h as

in vaded oth er organ s; in traperiton eal radioiso- topes m ay be in stilled for stage I disease.

2. Ch em oth erapy is used posto peratively for m ost stages of ovarian can cer.

3. In traperiton eal ch em oth erapy in volves th e in stil- lation of ch em oth erapy in to th e abdom in al cavity.

4. To tal abdom in al h ysterectom y an d bilateral salpin go-oo ph orectom y with tum o r debulkin g m ay be n ecessary.

XV. Endometrial (Uterine) Cancer A. Description

1. En do m etrial can cer is a slow-growin g tum o r aris- in g from th e en dom etrial m ucosa of th e uterus, associated with th e m en opausal years.

2. Metastasis occurs th rough th e lym p h atic system to th e ovaries an d pelvis; via th e blood to th e lu n gs, liver, an d bon e; or in traabdom in ally to th e periton eal cavity.

B. Risk facto rs 1. Use of estrogen replacem en t th erap y (ERT) 2. Nu lliparity 3. Polycystic ovary disease 4. In creased age 5. Late m en op ause 6. Fam ily h isto ry of uterin e can cer or h ereditary

n on po lypo sis colorectal can cer 7. O besity 8. Hyperten sion 9. Diabetes m ellitus

C. Assessm en t 1. Abn orm al bleedin g, especially in postm en o-

pausal wom en 2. Vagin al disch arge 3. Low back, pelvic, or abdom in al pain (pain

occurs late in th e disease process) 4. En larged uterus (in ad van ced stages)

D. Non su rgical in terven tion s 1. Extern al or in tern al radiation is used alon e or in

com bin ation with surgery, depen din g on th e stage of can cer.

2. Ch em oth erapy is used to treat advan ced or recur- ren t disease.

3. Progesteron e th erap y with m ed ication m ay be prescribed for estrogen -depen den t tum o rs.

4. Tam oxifen , an an tiestrogen m edication , also m ay be prescribed.

E. Surgical in terven tion s: To tal abdom in al h ysterec- tom y an d bilateral salpin go-ooph orectom y

XVI. Breast Cancer A. Description

1. Breast can cer is classified as in vasive wh en it pen - etrates th e tissue surroun din g th e m am m ary duct an d grows in an irregular pattern .

2. Metastasis occurs via lym p h n odes. 3. Com m on sites of m etastasis are th e bon e an d

lun gs; m etastasis m ay also occur to th e brain an d liver.

4. Diagn osis is m ade by breast biopsy th rou gh a n eedle aspiration or by surgical rem oval of th e tum o r with m icroscopic exam in ation for m alig- n an t cells.

B. Risk factors 1. Age 2. Fam ily h istory of breast can cer due to gen etic

predisp osition 3. Early m en arch e an d late m en op ause 4. Previous can cer of th e breast, uterus, or ovaries 5. Nu lliparity, late first birth 6. O besity 7. High -dose radiation exposu re to ch est

C. Assessm en t 1. Mass felt durin g BSE (usually felt in th e upper

outer quadran t, ben eath th e n ipple, or in axilla) 2. Presen ce of th e lesion on m am m ograph y 3. A fixed, irregular n on en capsu lated m ass; typi-

cally pain less except in th e late stages 4. Asym m etry 5. Bloo dy or clear n ipp le disch arge 6. Nipp le retraction or elevation 7. Skin dim plin g, retraction , or ulceration 8. Skin edem a or peau d’o ran ge skin 9. Axillary lym ph ad en opath y 10. Lym ph edem a of th e affected arm 11. Sym ptom s of bon e or lun g m etastasis in

late stage

591CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

D. Early detection : Regular BSE 1. Perform in g BSE

a. Perform regularly 7 to 10 days after m en ses. b . Postm en opausal clien ts or clien ts wh o h ave

h ad a h ysterectom y sh ould perform BSE reg- ularly as well.

2. Clien t in struction s (Fig. 48-2) E. No n surgical in terven tion s

1. Ch em oth erapy 2. Rad iation th erap y

3. Horm on al m an ipu lation via th e use of m edica- tion in postm en opausal wom en or oth er m edica- tion s for estrogen receptor–positive tum ors

4. Mon oclon al an tibodies such as trastu zum ab for h um an epiderm al growth factor receptor 2- positive (HER-2 +) breast can cer

F. Surgical in terven tion s: Surgical breast procedures, with possible breast recon struction (Box 48-12)

G. Postoperative in terven tion s 1. Mon itor vital sign s. 2. Position th e clien t in a sem i-Fowler’s position ;

turn from th e back to th e un affected side, with th e affected arm elevated ab ove th e level of th e h eart to prom o te drain age an d preven t lym p h edem a.

3. En cou rage cough in g an d deep breath in g. 4. If a drain (usually a Jackson -Pratt) is in place,

m ain tain suction an d record th e am oun t of drain age an d drain age ch aracteristics; teach th e clien t about h om e m an agem en t of th e drain ( Fig. 48-3).

5. Assess operative site for in fectio n , swellin g, or th e presen ce of fluid collection un der th e skin flaps or in th e arm .

6. Mon itor in cision site for restriction of dressin g, im paired sen sation , or color ch an ges of th e skin .

7. If breast recon struction was perform ed, th e clien t will return from surgery usually with a surgical brassiere an d a prosth esis in place.

8. Provide th e use of a pressure sleeve as prescribed if edem a is severe.

9. Main tain fluid an d electrolyte balan ce; adm in is- ter diuretics an d provide a low-salt diet as pre- scrib ed for severe lym p h edem a.

10. Con sult with th e HCP an d ph ysical th erap ist regardin g th e ap propriate exercise program an d assist th e clien t with prescribed exercise.

11. In struct th e clien t ab out h om e care m easu res ( Box 48-13).

1 2

3 4

5

FIGURE 48-2 Breast self-examination and client instructions. 1, While in the shower or bath, when the skin is slippery with soap and water, examine your breasts. Use the pads of your second, third, and fourth fingers to press every part of the breast firmly. Use your right hand to examine your left breast, and use your left hand to examine your right breast. Using the pads of the fingers on your left hand, examine the entire right breast using small circular motions in a spiral or up-and-down motion so that the entire breast area is examined. Repeat the procedure using your right hand to examine your left breast. Repeat the pattern of palpation under the arm. Check for any lump, hard knot, or thickening of the tissue. 2, Look at your breasts in a mirror. Stand with your arms at your side. 3, Raise your arms overhead and check for any changes in the shape of your breasts, dimpling of the skin, or any changes in the nipple. 4, Next, place your hands on your hips and press down firmly, tightening the pectoral mus- cles. Observe for asymmetry or changes, keeping in mind that your breasts probably do not match exactly. 5, While lying down, feel your breasts as described in step 1. When examining your right breast, place a folded towel under your right shoulder and put your right hand behind your head. Repeat the procedure while examining your left breast. Mark your calendar that you have completed your breast self-examination; note any changes or unique characteristics you want to check with your health care provider.

BOX 48-12 Surgical Breast Procedures Lumpectomy ▪ Tumor is excised and removed. ▪ Lymph node dissection may also be performed. Simple Mastectomy ▪ Breast tissue and the nipple are removed. ▪ Lymph nodes are usually left intact. Modified Radical Mastectomy ▪ Breast tissue, nipple, and lymph nodes are removed. ▪ Muscles are left intact.

592 UNIT IX Hematological and Oncological Disorders of the Adult Client

No IVs, no injections, no blood pressure measure- ments, and no venipunctures should be done in the arm on the side of the mastectomy. The arm on the side of the mastectomy is protected, and any intervention that could traumatize the affected arm is avoided because of the risk for lymphedema on this side.

XVII. Esophageal Cancer A. Description

1. Esoph ageal can cer is a m align an cy foun d in th e eso ph ageal m ucosa, form ed by squam ous cell carcin om a (SCC) or adenocarcinoma.

2. Th e cau se is un kn own but m ajor risk factors in clude cigarette sm okin g, alcoh ol con sum p tion , ch ron ic reflux, Barrett’s eso ph agus, an d vitam in deficien cies.

3. Com p lication s in clude dysph agia, pain ful swal- lowin g, loss of appetite, an d m alaise.

4. Th e go al of treatm en t is to in h ibit tum o r growth an d m ain tain n utrition .

B. Assessm en t 1. Dysp h agia 2. O dyn oph agia 3. Epigastric pain or stern al pain

C. In terven tion s 1. Mon itor n utritional status, in cludin g daily weigh t,

in take and output, an d calories con sum ed. 2. In struct th e clien t ab out diet ch an ges th at m ake

eatin g easier. 3. Prepare th e clien t for ch em oth erapy an d radia-

tion as prescribed. 4. Prepare th e clien t for surgical resectio n of th e

tum o r as prescribed.

XVIII. Gastric Cancer A. Description

1. Gastric can cer is a m align an t growth of th e m ucosal cells in th e in n er lin in g of th e stom ach , with in vasion to th e m uscle an d beyon d in advan ced disease.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

A

B

FIGURE 48-3 Jackson-Pratt device. A, Drainage tubes and reservoir. B, Emptying drainage reservoir. (From Potter et al., 2013.)

BOX 48-13 Client Instructions Following Mastectomy Avoid overuse of the arm during the first few months. To prevent lymphedema, keep the affected arm elevated; con-

sultation with lymphedema specialist may be prescribed. Provide incision care with an emollient as prescribed, to soften

and prevent wound contracture. Encourage use of support groups. Encourage the client to perform breast self-examination on the

remaining breast and surgical site once healed. Protect the affected hand and arm. Avoid strong sunlight on the affected arm. Do not let the affected arm hang dependent. Do not carry a pocketbook or anything heavy over the affected

arm.

Avoid trauma, cuts, bruises, or burns to the affected side. Avoid wearing constricting clothing or jewelry on the affected

side. Wear gloves when gardening. Use thick oven mitts when cooking. Use a thimble when sewing. Apply hand cream several times daily. Use cream cuticle remover. Call the health care provider if signs of inflammation occur in

the affected arm. Wear a MedicAlert bracelet stating which arm is at risk for

lymphedema.

593CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

2. No sin gle cau sative agen t h as been iden tified but it is believed th at H. pylori in fectio n an d a diet of sm oked, h igh ly salted, processed, or spiced foods h ave carcin ogen ic effects; oth er risk factors in clude sm okin g, alcoh ol an d n itrate in gestion , an d a h istory of gastric ulcers.

3. Com p lication s in clude h em orrh age, obstru c- tio n , m etastasis, an d dum pin g syn drom e.

4. Th e goal of treatm en t is to rem ove th e tum o r an d provide a n utrition al program .

B. Assessm en t 1. Early:

a. In digestion b . Abdo m in al discom fort c. Full feelin g d . Epigastric, back, or retrostern al pain

2. Late: a. Weakn ess an d fatigue b . An orexia an d weigh t loss c. Nausea an d vom itin g d . A sen sation of pressure in th e stom ach e. Dysp h agia an d obstru ctive sym pto m s f. Iron deficien cy an em ia g. Ascites h . Palpab le epigastric m ass

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor h em oglobin an d h em atocrit an d

ad m in ister blood tran sfusion s as prescribed. 3. Mon itor weigh t. 4. Assess n utrition al status; en courage sm all, blan d,

easily digestible m eals with vitam in an d m in eral supp lem en ts.

5. Adm in ister pain m edication as prescribed. 6. Prepare th e clien t for ch em oth erapy or radiation

th erapy as prescribed. 7. Prepare th e clien t for surgical resectio n of th e

tum o r as prescribed (Box 48-14).

D. Postoperative in terven tion s 1. Mon itor vital sign s. 2. Place in Fowler’s position for com fo rt. 3. Adm in ister an algesics an d an tiem etics, as

prescribed. 4. Mon itor in take an d outp ut; adm in ister fluids

an d electrolyte replacem en t by IV as prescribed; adm in ister paren teral n utrition as in dicated.

5. Main tain NPO (n oth in g by m ou th ) status as pre- scrib ed for 1 to 3 days un til peristalsis return s; assess for bowel soun ds.

6. Mon itor n asogastric suction . Follo win g gastrec- tom y, drain age from th e n aso gastric tube is n or- m ally bloody for 24 h ours posto peratively, ch an ges to brown -tin ged , an d is th en yello w or clear.

7. Do n ot irrigate or rem ove th e n asogastric tube (fo llow agen cy proced ures); assist th e HCP with irrigation or rem oval.

8. Advan ce th e diet fro m NPO to sips of clear water to 6 sm all blan d m eals a day, as prescribed.

9. Mon itor for com plication s such as h em orrh age, dum pin g syn d rom e, diarrh ea, h ypo glycem ia, an d vitam in B12 deficien cy.

XIX. Pancreatic Cancer A. Description

1. Most pan creatic tum o rs are h igh ly m align an t, rapidly growin g aden ocarcin om as origin atin g from th e epith elium of th e ductal system .

2. Pan creatic can cer is associated with in creased age, a h istory of diabetes m ellitus, alcoh ol use, h isto ry of previous pan creatitis, sm okin g, in ges- tion of a h igh -fat diet, an d exposu re to en viron - m en tal ch em icals.

3. Sym pto m s usually do n ot occur un til th e tum o r is large; th erefore, th e progn osis is poor.

4. En do scopic retrograd e ch olan giopan creatogra- ph y for visualization of th e pan creatic duct an d biliary system an d collection of tissue an d secre- tion s m ay be don e.

B. Assessm en t 1. Nausea an d vom itin g 2. Jaun d ice 3. Un explain ed weigh t loss 4. Clay-colored stools 5. Glu cose in toleran ce 6. Abdo m in al pain

C. In terven tion s 1. Rad iation 2. Ch em o th erap y 3. Whipple procedure, which in volves a pan creatico-

duoden ectom y with rem oval of th e distal th ird of th e stom ach , pan creaticojejun ostom y, gastrojeju- n ostom y, an d ch oledoch ojejun ostom y (Fig. 48-4)

4. Posto perative care m easu res an d com plication s are sim ilar to th o se for th e care of a clien t with

BOX 48-14 Surgical Interventions for Gastric Cancer

Subtotal Gastrectomy Billrot h I ▪ Also called gastroduodenostomy ▪ Partial gastrectomy, with remaining segment anasto-

mosed to the duodenum

Billrot h II ▪ Also called gastrojejunostomy ▪ Partial gastrectomy, with remaining segment anasto-

mosed to the jejunum

Total Gastrectomy ▪ Also called esophagojejunostomy ▪ Removal of the stomach, with attachment of the esopha-

gus to the jejunum or duodenum

594 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

pan creatitis an d th e clien t follo win g gastric sur- gery; m on itor blood gluco se levels for tran sien t h yperglycem ia or h ypoglycem ia resultin g from surgical m an ipu lation of th e pan creas.

XX. Intestinal Tumors A. Description

1. In testin al tum ors are m align an t lesion s th at develop in th e cells linin g the bowel wall or develop as aden om atous polyps in th e colon or rectum .

2. Tu m or spread is by direct in vasion an d th rou gh th e lym p h atic an d circulatory system s.

3. Com p lication s in clude bowel perforation with periton itis, ab scess an d fistula form ation , h em or- rh age, an d com plete in testin al obstru ction .

B. Risk facto rs for co lorectal can cer 1. Age older th an 50 years 2. Fam ilial polyposis, fam ily h isto ry of colorectal

can cer 3. Previous colorectal polyps, h isto ry of colorectal

can cer 4. Histo ry of ch ron ic in flam m atory bowel disease 5. Histo ry of ovarian or breast, en dom etrial, an d

stom ach can cers C. Assessm en t

1. Bloo d in stool (m ost com m on m an ifestation ) detected by fecal occult blood testin g, sigm oidos- copy, an d colon o scopy

2. An o rexia, vom itin g, an d weigh t loss 3. An em ia 4. Abn orm al stools

a . Ascen din g colon tum o r: Diarrh ea b . Descen din g colon tum o r: Con stipation or

som e diarrh ea, or flat, ribb on -like stool cau sed by a partial obstru ction

c. Rectal tum o r: Altern atin g con stipation an d diarrh ea

5. Guardin g or abdom in al disten tion , abdom in al m ass (late sign )

6. Cach exia (late sign ) 7. Masses n oted on barium en em a, co lon oscopy,

CT scan , sigm oidoscopy D. Gen eral in terven tion s

1. Mon itor for sign s of com plication s, wh ich in clude bowel perforation with periton itis, abscess or fistula form ation (fever associated with pain ) , h em orrh age (sign s of sh ock), an d com plete in testin al obstru ctio n .

2. Mon itor for sign s of bowel perforation , wh ich in clude low blood pressure, rapid and weak pulse, disten ded abdom en , and elevated tem perature.

3. Mon itor for sign s of in testin al obstru ctio n , wh ich in clude vom itin g (m ay be fecal con ten ts), pain , con stipation , an d abdom in al disten tion ; provide com fo rt m easu res.

4. No te th at an early sign of in testin al obstru ction is in creased peristaltic activity, wh ich produ ces an in crease in bowel soun ds; as th e obstru ction pro- gresses, h ypo active bowel soun ds m ay be h eard.

5. Prepare for radiation preoperatively to facilitate surgical resectio n , an d posto peratively to decrease th e risk of recurren ce or to reduce pain , h em orrh age, bowel obstru ctio n , or m etastasis.

E. No n surgical in terven tion s 1. Preop erative radiation for local con tro l an d post-

operative radiation for palliation m ay be prescribed.

2. Posto perative ch em oth erapy to con tro l sym p- tom s an d th e spread of disease

F. Surgical in terven tion s: Bowel, local lym p h n ode resectio n , an d creatio n of a colosto m y or ileostom y

G. Colosto m y, ileostom y 1. Preop erative in terven tion s

a. Con sult with th e en terostom al th erap ist to assist in id en tifyin g optim al placem en t of th e ostom y.

b . In struct th e clien t in prescribed preoperative diet; bowel preparation (laxatives an d en em as) m ay be prescribed.

c. In testin al an tiseptics an d an tibiotics m ay be prescribed, to decrease th e bacterial con ten t of th e colon an d to reduce th e risk of in fec- tion fro m th e surgical proced ure.

2. Posto perative: Colosto m y a. If a pouch system is n ot in place, ap ply a

petroleum jelly gauze over th e stom a to keep it m oist, covered with a dry sterile dressin g; place a pouch system on th e stom a as soon as possib le.

b . Mon itor th e pouch system for proper fit an d sign s of leakage; em pty th e pouch wh en on e- th ird full.

c. Mon itor th e stom a for size, un usual bleed- in g, color ch an ges, or n ecrotic tissue.

d . Note th at th e n orm al stom a color is red or pin k, in dicatin g h igh vascu larity.

Cys tic duct

J e junum

P a ncre a s

S toma ch

Common duct

He pa tic ducts

FIGURE 48-4 Whipple procedure, or radical pancreaticoduodenectomy.

595CHAPTER 48 Hematological and Oncological Disorders

e. Note th at a pale pin k stom a in dicates low h em oglobin an d h em atocrit levels.

f. Assess th e fun ctio n in g of th e colosto m y. g. Expect th at stool will be liqu id posto pera-

tively but will beco m e m ore solid, dep en din g on th e area of th e colostom y.

h . Expect liquid stool from an ascen din g co lon colosto m y, loose to sem iform ed stool from a tran sverse colon colostom y, or clo se to n or- m al stool from a descen din g colon colosto m y.

i. Fecal m atter sh o uld n ot be allowed to rem ain on th e skin .

j. Adm in ister an algesics an d an tibiotics as prescribed.

k . Irrigate perin eal woun d if presen t an d if pre- scrib ed, an d m on itor for sign s of in fectio n ; provid e com fo rt m easu res for perin eal itch - in g an d pain .

l. In struct th e clien t to avoid food s th at cau se excessive gas form ation an d odor.

m . In struct th e clien t in stom a care an d irriga- tion s as prescribed.

n . In struct th e clien t on h ow to resum e n orm al activities, in cludin g work, travel, an d sexual in tercou rse, as prescribed; provide psych o so- cial support.

3. Posto perative: Ileostom y a. Health y stom a is red in color. b . Postoperative drain age will be dark green an d

progress to yello w as th e clien t begin s to eat. c. Stool is liquid. d . Risk for deh ydratio n an d electrolyte im bal-

an ce exists.

Monitor stoma color. A dark blue, purple, or black stoma indicates compromised circulation, requiring HCP notification.

XXI. Lung Cancer A. Descriptio n

1. Lun g can cer is a m align an t tum or of th e bron ch i an d periph eral lu n g tissue.

2. Th e lun gs are a com m on target for m etastasis from oth er organ s.

3. Bron ch ogen ic can cer (tu m ors origin ate in th e epith elium of th e bron ch us) spreads th rough direct exten sion an d lym p h atic dissem in ation .

4. Classified accordin g to h istological cell type; types in clude sm all cell lun g can cer (SCLC) and n on – sm all cell lun g can cer (NSCLC); epiderm al (squa- m ous cell), aden ocarcin om a, an d large cell an a- plastic carcinoma are classified as NSCLC because of th eir sim ilar respon ses to treatm en t.

5. Diagn osis is m ade by a ch est x-ray study, CT scan, or m agnetic reson an ce im agin g (MRI), wh ich sh ows a lesion or m ass, an d by bron ch oscopy

an d sputum studies, wh ich dem on strate a posi- tive cytological study for can cer cells.

B. Cau ses 1. Cigarette sm okin g; also exposu re to “passive”

tobacco sm oke 2. Expo sure to en viron m en tal an d occupation al

pollutan ts C. Assessm en t

1. Cough 2. Wh eezin g, dyspn ea 3. Ho arsen ess 4. Hem optysis, blood -tin ged or purulen t sputum 5. Ch est pain 6. An o rexia an d weigh t loss 7. Weakn ess 8. Dim in ish ed or ab sen t breath soun ds, respiratory

ch an ges D. In terven tion s

1. Mon itor vital sign s. 2. Mon itor breath in g pattern s an d breath soun ds

an d for sign s of respiratory im pairm en t; m on itor for h em optysis.

3. Assess for trach eal deviation . 4. Adm in ister an algesics as prescribed for pain

m an agem en t. 5. Place in a Fowler’s position to h elp ease breath in g. 6. Adm in ister oxygen as prescribed an d h um idifi-

cation to m oisten an d loosen secretio n s. 7. Mon itor pulse oxim etry. 8. Provide respiratory treatm en ts as prescribed. 9. Adm in ister bron ch od ilators an d corticosteroid s

as prescribed to decrease bron ch ospasm , in flam - m ation , an d edem a.

10. Provide a h igh -calorie, h igh -protein , h igh - vitam in diet.

11. Provide activity as tolerated , rest periods, an d active an d passive ran ge-of-m otion exercises.

E. No n surgical in terven tion s 1. Rad iation th erapy m ay be prescribed for local-

ized in trath oracic lun g can cer an d for palliatio n of h em optysis, obstruction s, dysph agia, superior ven a cava syn d rom e, an d pain .

2. Ch em oth erapy m ay be prescribed for treatm en t of n on resectable tum o rs or as adjuvan t th erap y.

F. Surgical in terven tion s 1. Laser th erapy: To relieve en dobro n ch ial

obstru ction 2. Th oracen tesis an d pleurodesis: To rem ove pleu-

ral fluid an d relieve h ypo xia 3. Th oracotom y (open in g in to th e th oracic cavity)

with pn eum on ectom y: Surgical rem oval of 1 en tire lun g

4. Th oracotom y with lo bectom y: Surgical rem oval of 1 lobe of th e lun g for tum ors con fin ed to a sin gle lo be

5. Th oracotom y with segm en tal resectio n : Surgical rem oval of a lobe segm en t

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

596 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

G. Preoperative in terven tion s 1. Explain th e poten tial postoperative n eed for

ch est tubes. 2. Note th at closed ch est drain age usually is n ot

used for a pn eum on ectom y an d th e serou s fluid th at accu m ulates in th e em p ty th o racic cavity even tually con solidates, preven tin g sh ifts of th e m ediastin um , h eart, an d rem ain in g lu n g.

H. Postoperative in terven tion s 1. Mon itor vital sign s. 2. Assess cardiac an d respiratory status; m on itor

lun g soun ds. 3. Main tain th e ch est tube drain age system , wh ich

drain s air an d blood th at accum ulates in th e pleural space; m on itor for excess bleedin g. (See Ch apter 20 for care of th e clien t with a ch est tube.)

4. Adm in ister oxygen as prescribed. 5. Ch eck th e HCP’s prescription s regardin g clien t

position in g; avoid com plete lateral turn in g. 6. Mon itor pulse oxim etry. 7. Provide activity as tolerated . 8. En courage active ran ge-of-m otion exercises of

th e operative sh oulder as prescribed.

The airway is the priority for a client with lung or laryngeal cancer.

XXII. Laryngeal Cancer A. Descrip tion

1. Laryn geal can cer is a m align an t tum or of th e lar- yn x (Fig. 48-5).

2. Laryn geal can cer presen ts as m align an t ulcera- tion s with un d erlyin g in filtration an d is spread by local exten sion to adjacen t structures in th e th roat an d n eck, an d by th e lym p h atic system .

3. Diagn o sis is m ade by laryn gosco py an d biopsy sh owin g a positive cytological study for can cer cells.

4. Laryn gosco py allows for evaluatio n of th e th roat an d biopsy of tissues; ch est radiograph y, CT, an d MRI are used for stagin g.

B. Risk facto rs 1. Cigarette sm okin g 2. Heavy alcoh ol use an d th e com bin ed use of

tobacco an d alcoh ol 3. Exposure to en viron m en tal pollutan ts (e.g.,

asbestos, wood dust) 4. Exposure to radiation

C. Assessm en t 1. Persisten t h oarsen ess or sore th roat an d ear pain 2. Pain less n eck m ass 3. Feelin g of a lum p in th e th roat 4. Burn in g sen sation in th e th roat 5. Dysph agia 6. Ch an ge in vo ice quality 7. Dyspn ea 8. Weakn ess an d weigh t loss 9. Hem optysis 10. Foul breath odor

D. In terven tion s 1. Place in Fowler’s position to prom o te optim al air

exch an ge. 2. Mon itor respiratory status. 3. Mon itor for sign s of aspiration of food an d fluid. 4. Adm in ister oxygen as prescribed. 5. Provide respiratory treatm en ts as prescribed. 6. Provide activity as tolerated. 7. Provide a h igh -calorie an d h igh -p rotein diet. 8. Provide n utrition al support via paren teral n utri-

tion , n aso gastric tube feed in gs, or gastro stom y or jejun ostom y tube, as prescribed.

9. Adm in ister an algesics as prescribed for pain . 10. En courage clien ts to stop sm okin g an d drin kin g

alcoh ol to in crease effectiven ess of treatm en ts. E. No n surgical in terven tion s

1. Radiation th erapy in specified situation s 2. Ch em o th erap y, wh ich m ay be given in com bin a-

tion with radiation an d surgery F. Surgical in terven tion s

1. Th e go al is to rem ove th e can cer wh ile preservin g as m uch n orm al fun ction as possib le.

2. Surgical in terven tion depen ds on th e tum o r size, location , an d am oun t of tissue to be resected.

3. Types of resection in clude cordal strippin g, cordect- om y, partial laryngectom y, an d total laryn gectom y.

4. A trach eo stom y is perform ed with a total laryn - gectom y; th is airway open in g is perm an en t an d is referred to as a laryngectomy stoma.

G. Preoperative in terven tion s 1. Discuss self-care of th e airway, altern ative

m eth od s of com m un ication , suction in g, pain con trol m eth od s, th e critical care en viron m en t, an d n utrition al supp ort.

2. En courage th e clien t to express feelin gs about ch an ges in body im age an d loss of vo ice.

Epiglottis

Glottic 59%

S ubglottic 1%

S upra glottic 40%

Tra ns glottic

Tra che a

True voca l folds (cords )

Fa ls e voca l folds (cords )

FIGURE 48-5 Sites and incidence of primary laryngeal tumors.

597CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

3. Describ e th e reh abilitation program an d in for- m ation about th e trach eo stom y an d suction in g.

H. Posto perative in terven tion s 1. Mon itor vital sign s. 2. Mon itor respiratory status; m on itor airway

paten cy an d provide frequen t suction in g to rem ove blood y secretio n s.

3. Place th e clien t in a h igh Fowler’s position . 4. Main tain m ech an ical ven tilator supp ort or a tra-

ch eosto m y collar with h um idification , as prescribed.

5. Mon itor pulse oxim etry. 6. Main tain surgical drain s in the n eck area if

presen t. 7. O bserve for h em orrh age an d edem a in th e n eck. 8. Mon itor IV flu ids or paren teral n utrition un til

n utrition is adm in istered via a n asogastric, gas- trostom y, or jejun ostom y tube.

9. Provide oral h ygien e. 10. Assess gag an d cough reflexes an d th e ab ility to

swallow. 11. In crease activity as tolerated. 12. Assess th e color, am oun t, an d co n sisten cy of

sputum . 13. Provide stom a an d laryn gectom y care (Box 48-15). 14. Provide con sultatio n with speech an d lan guage

path olo gist as prescribed. 15. Rein force m eth od of com m un ication estab-

lish ed preop eratively. 16. Prepare th e clien t for reh abilitation an d speech

th erapy (Box 48-16).

XXIII. Prostate Cancer A. Descriptio n

1. Prostate can cer, a slow-growin g m align an cy of th e prostate glan d, is a com m on can cer in Am erican m en ; m ost prostate tum ors are aden ocarcin om as arisin g from an drogen -depen den t epith elial cells.

2. Th e risk in creases in m en with each decade after th e age of 50 years.

3. Prostate can cer can spread via direct in vasion of surroun din g tissues or by m etastasis th rough th e bloodstream an d lym p h atics, to th e bon y pelvis an d spin e.

4. Bon e m etastasis is a con cern , as is spread to th e lu n gs, liver, an d kidn eys.

5. Th e cause of prostate can cer is un clear, but ad van cin g age, h eavy m etal exp osure, sm okin g, an d h isto ry of sexually tran sm itted in fection are con tributin g facto rs; it is m ore com m on am on g m en of African Am erican descen t.

B. Assessm en t 1. Asym ptom atic in early stages 2. Hard, pea-sized n odule or irregularities palpated

on rectal exam in ation 3. Gross, pain less h em aturia 4. Late sym pto m s such as weigh t loss, urin ary

obstru ction , an d bon e pain radiatin g from th e lu m bosacral area down th e leg

5. Th e prostate-specific an tigen level is elevated in various n on can cerous con dition s; th erefore, it sh o uld n ot be used as a screen in g test with ou t a digital rectal exam in ation . It is routin ely used to m on itor respon se to th erap y.

6. Diagn osis is m ade th rou gh biopsy of th e prostate glan d .

C. No n surgical in terven tion s 1. Prepare th e clien t for h orm on e m an ipulation

th erapy (an drogen supp ression th erapy) as

BOX 48-15 Stoma Care Following Laryngectomy Protect the neck from injury. Instruct the client in how to clean the incision and provide

stoma care. Instruct the client to wear a stoma guard to shield the stoma. Demonstrate ways to prevent debris from entering the stoma. Advise the client to wear loose-fitting, high-collared clothing to

cover the stoma. Avoid swimming, showering, and using aerosol sprays. Teach the client clean suctioning technique. Advise the client to increase humidity in the home. Increase fluid intake to 30 00 mL/ day as prescribed. Avoid exposure to persons with infections. Alternate rest periods with activity. Instruct the client in range-of-motion exercises for the arms,

shoulders, and neck as prescribed. Advise the client to wear a MedicAlert bracelet.

BOX 48-16 Speech Rehabilitation Following Laryngectomy

Esophageal Speech The client produces esophageal speech by “burping” the air

swallowed. The voice produced is monotone, cannot be raised or lowered,

and carries no pitch. The client must have adequate hearing because his or her

mouth shapes words as they are heard.

Mechanical Devices One device, the electrolarynx, is placed against the side of the

neck; the air inside the neck and pharynx is vibrated, and the client articulates.

Another device consists of a plastic tube that is placed inside the client’s mouth and vibrates on articulation.

Tracheoesophageal Fistula A fistula is created surgically between the trachea and the

esophagus, with eventual placement of a prosthesis to pro- duce speech.

The prosthesis provides the client with a means to divert air from the trachea into the esophagus, and out of the mouth.

Lip and tongue movement produce the speech.

598 UNIT IX Hematological and Oncological Disorders of the Adult Client

prescribed or active surveillan ce with prostate- specific an tigen (PSA) an d digital rectal exam in ation (DRE).

2. Lutein izin g h orm on e m ay be prescribed to slow th e rate of growth of th e tum o r.

3. Medication adverse effects in clude reduced libido, h ot flash es, breast ten dern ess, osteoporo- sis, loss of m uscle m ass, an d weigh t gain . Th e cli- en t sh ould be in form ed of th ese effects.

4. Pain m edication , radiation th erap y, cortico ste- roids, an d bisph osp h on ates m ay be prescribed for palliatio n of advan ced prostate can cer.

5. Prepare th e clien t for extern al beam radiation or brach yth erapy, wh ich m ay be prescribed alon e or with surgery, preop eratively or postopera- tively, to reduce th e lesion an d lim it m etastasis.

6. Prepare th e client for th e adm in istration of che- m oth erapy in cases of h orm on e-resistan t tum ors.

D. Surgical in terven tion s 1. Prepare th e clien t for orch iectom y (palliative), if

prescribed, wh ich will lim it th e produ ction of testosteron e.

2. Prepare th e clien t for prostatectom y, if prescribed. 3. Th e radical prostatectom y can be perform ed via

a retropu bic, perin eal, or suprapu bic approach . 4. Cryosurgical ablation is a m in im ally in vasive

proced ure th at m ay be an altern ative to radical prostatectom y; liqu id n itrogen freezes th e glan d , an d th e dead cells are absorbed by th e body.

E. Tran sureth ral resection of th e prostate (TURP) m ay be perform ed for palliation in prostate can cer clien ts. 1. Th e procedure in volves in sertio n of a scope in to

th e ureth ra to excise prostatic tissue. 2. Mon itor for h em orrh age; bleed in g is com m on

followin g TURP. 3. Postoperative con tin uous bladder irrigation

(CBI) m ay be prescribed, wh ich preven ts cath e- ter obstruction from clots.

4. Assess for sign s of tran sureth ral resectio n syn - drom e, wh ich in clude sign s of cerebral edem a an d in creased in tracran ial pressure, such as in creased blood pressure, bradycardia, con fu- sion , disorien tation , m uscle twitch in g, visu al disturban ces, an d n ausea an d vom itin g.

5. An tispasm odics m ay be prescribed for bladder spasm .

6. In struct th e clien t to m on itor an d report drib- blin g or in con tin en ce postoperatively an d teach perin eal exercises.

7. Sterility is possible followin g th e surgical proced ure.

F. Suprapub ic prostatectom y 1. Suprapub ic prostatectom y is rem oval of th e

prostate glan d by an abdom in al in cision with a bladder in cision .

2. Th e clien t will h ave an ab dom in al dressin g th at m ay drain copious am oun ts of urin e, an d th e

abdom in al dressin g will n eed to be ch an ged frequen tly.

3. Severe h em orrhage is possible, an d m on itorin g for blood loss is an im portan t n ursing in tervention.

4. An tispasm odics m ay be prescribed for bladder spasm s.

5. CBI is prescribed an d carried out to m ain tain pin k-colored urin e.

6. Sterility occurs with th is procedure. G. Retropubic prostatectom y

1. Retropu bic prostatectom y is rem oval of th e pros- tate glan d by a low abdom in al in cision with out open in g th e bladder.

2. Less bleedin g occurs with th is procedure com - pared with th e suprapu bic procedure, an d th e clien t exp erien ces fewer bladder spasm s.

3. Abdom in al drain age is m in im al. 4. CBI m ay be used. 5. Sterility occurs with th is procedure.

H. Perin eal prostatectom y 1. Th e prostate glan d is rem oved th rou gh an in ci-

sion m ade between th e scrotum an d an us. 2. Min im al bleed in g occurs with th is proced ure. 3. Th e clien t n eeds to be m on itored clo sely for

in fectio n , because th e risk of in fectio n is in creased with th is type of prostatectom y.

4. Urin ary in con tin en ce is com m on . 5. Th e proced ure cau ses sterility. 6. Teach th e clien t h ow to perform perin eal

exercises. I. Posto perative in terven tion s

1. Mon itor vital sign s. 2. Mon itor urin ary output an d urin e for h em or-

rh age or clots. 3. In crease fluids to 2400 to 3000 m L/ d ay, un less

con train d icated. 4. Mon itor for arterial bleed in g as eviden ced by

brigh t red urin e with n um erou s clots; if it occurs, in crease CBI an d n otify th e HCP im m ediately.

5. Mon itor for ven ous bleedin g as eviden ced by burgun dy-colored urin e outp ut; if it occurs, in form th e HCP, wh o m ay apply traction on th e cath eter.

6. Mon itor h em oglobin an d h em atocrit levels. 7. Expect red to ligh t pin k urin e for 24 h ours, turn -

in g to am ber in 3 days. 8. Am bulate th e clien t as early as possible an d as

soon as urin e begin s to clear in color. 9. In form th e clien t th at a con tin uo us feelin g of an

urge to void is n orm al. 10. In struct th e clien t to avoid attem p ts to void

aroun d th e cath eter because th is will cause blad- der spasm s.

11. Adm in ister an tibiotics, an algesics, stool soft- en ers, an d an tispasm odics as prescribed.

12. Mon itor th e 3-way urin ary cath eter, wh ich usu- ally h as a 30- to 45-m L reten tion balloon .

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

599CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

13. Main tain CBI with sterile bladder irrigation solu- tion as prescribed to keep th e cath eter free of obstruction an d keep th e urin e pin k in color (Box 48-17).

Following TURP, monitor for transurethral resection syndrome or severe hyponatremia (water intoxication) caused by the excessive absorption of bladder irrigation during surgery. (Signs include altered mental status, bra- dycardia, increased blood pressure, and confusion.)

J. Posto perative in terven tion s: Suprapubic prostatec- tom y 1. Mon itor suprapu bic an d urin ary cath eter

drain age. 2. Mon itor CBI if prescribed. 3. No te th at th e urin ary cath eter will be rem oved 2

to 4 days posto peratively if th e clien t h as a supra- pubic cath eter.

4. If prescribed, clam p th e suprapubic cath eter after th e urin ary cath eter is rem oved, an d in struct th e clien t to attem p t to void; after th e clien t h as vo ided, assess th e residual urin e in th e bladder by un clam pin g th e suprapubic cath eter an d m easu rin g th e outp ut.

5. Prepare for rem oval of th e suprapubic cath eter wh en th e clien t con sisten tly em pties th e bladder an d residual urin e is 75 m L or less.

6. Mon itor th e suprapu bic in cision dressin g, wh ich m ay becom e saturated with urin e, un til th e in ci- sion h eals; dressin g m ay n eed to be ch an ged frequen tly.

K. Posto perative in terven tion s: Retropu bic prostatec- tom y 1. No te th at because th e blad der is n ot en tered ,

th ere is n o urin ary drain age on th e ab dom in al dressin g; if urin ary or purulen t drain age is n oted on th e dressin g, n otify th e HCP.

2. Mon itor for fever an d in creased pain , wh ich m ay in dicate an in fectio n .

L. Posto perative in terven tion s: Perin eal prostatectom y 1. No te th at th e clien t will h ave an in cision , wh ich

m ay or m ay n ot h ave a drain . 2. Avo id th e use of rectal th erm om eters, rectal

tubes, an d en em as because th ey m ay cause traum a an d bleedin g.

XXIV. Bladder Cancer A. Description

1. Blad d er can cer is a p ap illo m ato u s gro wth in th e b lad d er u ro th eliu m th at u n d ergo es m alig- n an t ch an ges an d th at m ay in filtrate th e b lad d er wall.

2. Predisposin g facto rs in clude cigarette sm okin g, exp osure to in du strial ch em icals, an d exposu re to radiation .

3. Com m on sites of m etastasis in clude th e liver, bon es, an d lu n gs.

4. As th e tum or progresses, it can exten d in to th e rectum , vagin a, oth er pelvic soft tissues, an d ret- ro periton eal structures.

B. Assessm en t 1. Gross or m icroscopic, pain less h em aturia (m ost

co m m on sign ) 2. Frequen cy, urgen cy, dysuria 3. Clot-in duced obstru ction 4. Bladder wash specim en s an d biopsy con firm

diagn osis

BOX 48-17 Continuous Bladder Irrigation (CBI) Description A 3-way (lumen) irrigation is used to decrease bleeding and to

keep the bladder free from clots—1 lumen is for inflating the balloon (30 mL); 1 lumen is for instillation (inflow); 1 lumen is for outflow.

Interventions Maintain traction on the catheter, if applied, to prevent bleed-

ing by pulling the catheter taut and taping it to the abdo- men or thigh.

Instruct the client to keep the leg straight if traction is applied to the catheter and it is taped to the thigh.

Catheter traction is not released without a health care pro- vider’s (HCP’s) prescription; it usually is released after any bright red drainage has diminished.

Use only sterile bladder irrigation solution or prescribed solu- tion to prevent water intoxication.

Run the solution at a rate, as prescribed, to keep the urine pink. Run the solution rapidly if bright red drainage or clots are present; monitor output closely. Run the solution at about 40 drops (gtt)/ minute when the bright red drainage clears.

If the urinary catheter becomes obstructed, turn off the CBI and irrigate the catheter with 30 to 50 mL of normal saline, if prescribed; notify the HCP if obstruction does not resolve.

Discontinue CBI and the urinary catheter as prescribed, usu- ally 24 to 48 hours after surgery.

Monitor for continence and urinary retention when the cathe- ter is removed. Inform the client that some burning, fre- quency, and dribbling may occur following catheter removal.

Inform the client that he should be voiding 150 to 200 mL of clear yellow urine every 3 to 4 hours by 3 days after surgery.

Inform the client that he may pass small clots and tissue debris for several days.

Teach the client to avoid heavy lifting, stressful exercise, driv- ing, the Valsalva maneuver, and sexual intercourse for 2 to 6 weeks to prevent strain, and to call the HCP if bleeding occurs or if there is a decrease in urinary stream.

Instruct the client to drink 2400 to 300 0 mL of fluid each day, preferably before 8 p.m. to avoid nocturia.

Instruct the client to avoid alcohol, caffeinated beverages, and spicy foods, and overstimulation of the bladder.

Instruct the client that if the urine becomes bloody, to rest and increase fluid intake and, if the bleeding does not subside, to notify the HCP.

600 UNIT IX Hematological and Oncological Disorders of the Adult Client

C. Radiation 1. Radiation th erap y is in dicated for advan ced dis-

ease th at can n ot be eradicated by surgery; palli- ative radiation m ay be used to relieve pain an d bowel obstru ction an d con trol poten tial h em or- rh age an d leg edem a caused by ven ous or lym - ph atic obstru ction .

2. In tracavitary radiation m ay be prescribed, wh ich protects ad jacen t tissue.

3. Extern al beam radiation com bin ed with ch em o- th erap y or surgery m ay be prescribed to im prove survival.

4. Com plication s of radiation a. Abacterial cystitis b . Proctitis c. Fistula form ation d . Ileitis or colitis e. Bladder ulceration an d h em orrh age

D. Ch em o th erap y 1. In travesical in stillation

a. An alkylatin g ch em oth erapeutic agen t is in stilled in to th e blad der.

b . Th is m eth od provides a con cen trated topical treatm en t with little system ic absorption .

c. Th e m ed ication is in jected in to a ureth ral cath eter an d retain ed for 2 h ours.

d . Followin g in stillation , th e clien t’s position is rotated every 15 to 30 m in utes, startin g in th e supin e position , to avoid lyin g on a full bladder.

e. After 2 h ours, th e clien t voids in a sittin g posi- tion an d is in structed to in crease flu ids to flush th e bladder.

f. Treat th e urin e as a bioh azard an d sen d to th e radioisotop e laborato ry for m on itorin g.

g. For 6 h ou rs followin g in travesical ch em o- th erapy, disin fect th e toilet with h ouseh old bleach after th e clien t h as voided.

2. System ic ch em oth erapy: Used to treat in op era- ble tum o rs or distan t m etastasis.

3. Com plication s of ch em oth erapy a. Bladder irritation b . Hem orrh agic cystitis

E. Surgical in terven tion s 1. Tran sureth ral resectio n of bladder tum or

a. Local resection an d fulguration (destruction of tissue by electrical curren t th rough elec- trodes placed in direct con tact with th e tissue)

b . Perform ed for early tum o rs for cure or for in operable tum o rs for palliatio n

2. Partial cystectom y a. Partial cystectom y is th e rem oval of up to h alf

th e bladder. b . Th e proced ure is don e for early-stage tum ors

an d for clien ts wh o can n ot tolerate a radical cystectom y.

c. Durin g the initial postoperative period, blad- der capacity is reduced greatly to about 60 m L; h owever, as th e bladder tissue expan ds, the capacity in creases to 200 to 400 m L.

d . Main ten an ce of a con tin uous output of urin e followin g surgery is critical to preven t blad- der disten tion an d stress on th e suture lin e.

e. A ureth ral cath eter an d a suprapu bic cath eter m ay be in place, an d th e suprapubic cath eter m ay be left in place for 2 weeks un til h ealin g occurs.

3. Cystecto m y an d urin ary diversion ( Fig. 48-6) a . Various surgical procedures perform ed to cre-

ate altern ative path ways for urin e collectio n an d excretion

b . Urin ary diversion m ay be perform ed with or with out cystectom y (bladd er rem oval).

c. Th e surgery m ay be perform ed in 2 stages if th e tum o r is exten sive, with th e creation of th e urin ary diversion first an d th e cystectom y several weeks later.

d . If a radical cystectom y is perform ed, lower extrem ity lym p h edem a m ay occur as a result of lym ph n od e dissection , an d m ale im po- ten ce m ay occur.

4. Ileal con duit a . Th e ileal con duit is also called a ureteroileos-

tom y, or Bricker’s procedure. b . Ureters are im plan ted in to a segm en t of th e

ileu m , with th e form ation of an abdom in al stom a.

c. Th e urin e flows in to th e con d uit an d is pro- pelled con tin uo usly out th rough th e stom a by peristalsis.

d . Th e clien t is required to wear an applian ce over th e stom a to collect th e urine (Box 48-18).

e. Com p lication s in clude obstru ction , pyelon e- ph ritis, leakage at th e an astom osis site, sten o- sis, h ydron eph rosis, calculi, skin irritatio n an d ulceration , an d stom al defects.

5. Kock pouch a . Th e Kock pouch is a con tin en t in tern al ileal

reservoir created from a segm en t of th e ileum an d ascen din g colon .

b . Th e ureters are im plan ted in to th e side of th e reservoir, an d a special n ipp le valve is con - structed to attach th e reservoir to th e skin .

c. Posto peratively, th e clien t will h ave a urin ary cath eter in place to drain urin e con tin uo usly un til th e pouch h as h ealed.

d . Th e urin ary cath eter is irrigated gen tly with n orm al salin e to preven t obstru ction from m ucus or clots.

e. Followin g rem oval of th e urin ary cath eter, th e clien t is in structed in h ow to self- cath eterize an d to drain th e reservoir at 4- to 6-h o ur in tervals ( Box 48-19).

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

601CHAPTER 48 Hematological and Oncological Disorders

6. In dian a pouch a . A con tin en t reservoir is created from th e

ascen din g colon an d term in al ileu m , m akin g a pouch larger th an th e Kock pouch (add i- tio n al con tin en t reservoirs in clude th e Main z an d Florid a pouch system s).

b . Posto peratively, care is sim ilar as with th e Kock pouch .

7. Creation of a n eobladder a . Creation of a n eobladder is sim ilar to

creation of an in tern al reservoir, with th e

differen ce bein g th at in stead of em ptyin g th rou gh an abdom in al stom a, th e bladder em p ties th rou gh a pelvic outlet in to th e ureth ra.

b . Th e clien t em pties th e n eobladder by relaxin g th e extern al sph in cter an d creatin g abdom i- n al pressure or by in term itten t self- cath eterization .

8. Percutan eous n eph rostom y or pyelosto m y a . Th ese procedures are used to preven t or treat

obstru ction .

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

Ure te ro s to my Dive rts urine dire ctly to the s kin s urfa ce through a ure te ra l-s kin ope ning (s toma ).

Afte r ure te ros tomy the clie nt mus t we a r a pouch.

Co nduit Colle cts urine in a portion of the inte s tine which is the n ope ne d onto the s kin

s urfa ce a s a s toma . Afte r the cre a tion of a conduit the clie nt mus t we a r a pouch.

Ile al re s e rvo ir Dive rts urine into a s urgica lly cre a te d pouch or pocke t tha t functions a s a bla dde r. The

s toma is contine nt a nd the clie nt re move s urine by re gula r

s e lf-ca the te riza tion.

Ca the te r

Cuta ne ous ure te ros tomy Cuta ne ous ure te roure te ros tomy

Ile a l (Bricke r’s ) conduitColon conduit

Ure te ros igmoidos tomy Ure te roile os igmoidos tomy

Contine nt inte rna l ile a l re s e rvoir (Kock’s pouch)

Bila te ra l cuta ne ous ure te ros igmoidos tomy

S ig mo ido s to my Dive rts urine to the la rge inte s tine s o no s toma is re quire d. The clie nt

e xcre te s urine with bowe l move me nts a nd bowe l incontine nce ma y re s ult.

FIGURE 48-6 Urinary diversion procedures used in the treatment of bladder cancer.

602 UNIT IX Hematological and Oncological Disorders of the Adult Client

b . Th e procedures in volve a percutan eous or surgical in sertion of a n eph rostom y tube in to th e kidn ey for drain age.

c. Nursin g in terven tion s in volve stabilizin g th e tube to preven t dislodgm en t an d m on itorin g output.

9. Uretero stom y a. Ureterostom y m ay be perform ed as a pallia-

tive procedure if th e ureters are obstru cted by th e tum o r.

b . Th e ureters are attach ed to th e surface of th e abdom en , wh ere th e urin e flows directly in to a drain age applian ce with out a con d uit.

c. Poten tial problem s in clude in fectio n , skin irritatio n , an d obstru ction to urin ary flow as a result of strictu res at th e open in g.

10. Vesicostom y a . Th e bladder is sutured to th e abdom en , an d a

stom a is created in th e bladder wall. b . Th e bladder em pties th rou gh th e stom a.

F. Preoperative in terven tion s 1. In struct th e clien t in preop erative, operative, an d

postoperative m an agem en t, in cludin g diet, m edication s, n asogastric tube placem en t, IV lin es, NPO status, pain con tro l, cough in g an d deep breath in g, leg exercises, an d postoperative activity.

2. Dem on strate ap plian ce application an d use for th ose clien ts wh o will h ave a stom a.

3. Arran ge an en terostom al n urse con sult an d for a visit with a perso n wh o h as h ad urin ary diversion .

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

BOX 48-18 Urinary Stoma Care Instruct the client to change the appliance in the morning, when

urinary production is slowest. Collect equipment, remove collection bag, and use water or

commercial solvent to loosen adhesive. Hold a rolled gauze pad against the stoma to collect and absorb

urine during the procedure. Cleanse the skin around the stoma and under the drainage bag

with mild nonresidue soap and water. Inspect the skin for excoriation, and instruct the client to pre-

vent urine from coming into contact with the skin. After the skin is dry, apply skin adhesive around the appliance. Instruct the client to cut the stoma opening of the skin barrier

just large enough to fit over the stoma (no more than 3 mm larger than the stoma).

Instruct the client that the stoma will begin to shrink, requiring a smaller stoma opening on the skin barrier.

Apply skin barrier before attaching the pouch or face plate. Place the appliance over the stoma and secure in place. Encourage self-care; teach the client to use a mirror. Instruct the client that the pouch may be drained by a bedside

bag or leg bag, especially at night.

Instruct the client to empty the urinary collection bag when it is one-third full to prevent pulling of the appliance and leakage.

Instruct the client to check the appliance seal if perspiring occurs.

Instruct the client to leave the urinary pouch in place as long as it is not leaking and to change it every 5 to 7 days.

During appliance changes, leave the skin open to air for as long as possible.

Use a non–karaya gum product, because urine erodes karaya gum.

To control odor, instruct the client to drink adequate fluids, wash the appliance thoroughly with soap and lukewarm water, and soak the collection pouch in dilute white vinegar for 20 to 30 minutes; a special deodorant tablet can also be placed into the pouch while it is being worn.

Instruct the client who takes baths to keep the level of the water below the stoma and to avoid oily soaps.

If the client plans to shower, instruct the client to direct the flow of water away from the stoma.

BOX 48-19 Self-Irrigation and Catheterization of Stoma

Irrigation Instruct the client to wash hands and use clean technique. Instruct the client to use a catheter and syringe, instill 60 mL of

normal saline or water into the reservoir, and aspirate gently or allow to drain.

Instruct the client to irrigate until the drainage remains free of mucus but to be careful not to overirrigate.

Catheterization Instruct the client to wash hands and use clean technique. Initially, instruct the client to insert a catheter every 2 to 3 hours

to drain the reservoir; during each week thereafter, increase the interval by 1 hour until catheterization is done every 4 to 6 hours.

Lubricate the catheter well with water-soluble lubricant, and instruct the client never to force the catheter into the reservoir.

If resistance is met, instruct the client to pause, rotate the cath- eter, and apply gentle pressure to insert.

Instruct the client to notify the health care provider if the client is unable to insert the catheter.

When urine has stopped, instruct the client to take several deep breaths and move the catheter in and out 2 to 3 inches (5 to 7.5 cm) to ensure that the pouch is empty.

Instruct the client to withdraw the catheter slowly and pinch the catheter when withdrawn so that it does not leak urine.

Instruct the client to carry catheterization supplies with him or her.

603CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

4. Adm in ister an tim icrobials for bowel preparation as prescribed.

5. En courage discussion of feelin gs, in cludin g th e effects on sexual activities.

G. Posto perative in terven tion s

Monitor urinary output closely following bladder surgery. Irrigate the ureteral catheter (if present and if prescribed) gently to prevent obstruction. Follow the HCP’s prescriptions and agency policy regarding irrigation.

1. Mon itor vital sign s. 2. Assess in cision site. 3. Assess stom a (sh ou ld be red an d m oist) every

h our for th e first 24 h ou rs. 4. Mon itor for edem a in th e stom a, wh ich m ay

be presen t in th e im m ediate postoperative period.

5. Notify th e HCP if th e stom a ap pears dark an d dusky (in dicates n ecrosis) .

6. Mon itor for prolap se or retraction of th e stom a. 7. Assess bowel fun ctio n ; m on itor for exp ected

return of peristalsis in 3 to 4 days. 8. Main tain NPO status as prescribed un til bowel

soun ds return . 9. Mon itor for con tin uo us urin e flow (30 to

60 m L/ h ou r). 10. Notify th e HCP if th e urin e outp ut is less th an

30 m L/ h ou r or if n o urin e outp ut occurs for m ore th an 15 m in utes.

11. Ureteral sten ts or cath eters, if presen t, m ay be in place for 2 to 3 weeks or un til h ealin g occurs; m ain tain stability with cath eters to preven t dislodgm en t.

12. Mon itor for h em aturia. 13. Mon itor for sign s of periton itis. 14. Mon itor for blad der disten tion follo win g a par-

tial cystectom y. 15. Mon itor for sh o ck, h em orrh age, th rom boph le-

bitis, an d lower extrem ity lym ph edem a after a radical cystectom y.

16. Mon itor th e urin ary drain age pouch for leaks, an d ch eck skin in tegrity (see Box 48-18).

17. Mon itor th e pH of th e urin e (do n ot place th e dipstick in th e stom a) because h igh ly alkalin e or acidic urin e can cause skin irritation an d facil- itate crystal form ation .

18. In stru ct th e clien t regard in g th e p o ten tial fo r u rin ary tract in fectio n o r th e d evelo p m en t o f calcu li.

19. In struct th e clien t to assess th e skin for irritatio n , m on itor th e urin ary drain age pouch , an d report an y leakage.

20. En courage th e clien t to express feelin gs about ch an ges in body im age, em barrassm en t, an d sex- ual dysfun ction .

XXV. Oncological Emergencies A. Sepsis an d dissem in ated in travascular coagu lation

(DIC) 1. Description : Th e clien t with can cer is at in creased

risk for in fectio n , particularly gram -n egative organ ism s, in th e bloodstream (sepsis or sep tice- m ia) an d DIC, a life-th reaten in g problem fre- quen tly associated with sepsis.

2. In terven tion s a . Preven t th e com plication th rou gh early iden -

tification of clien ts at h igh risk for sep sis an d DIC.

b . Main tain strict aseptic tech n ique with th e im m un oco m prom ised clien t an d m on itor closely for in fectio n an d sign s of bleedin g.

c. Adm in ister an tibiotics in traven ously as prescribed.

d . Adm in ister an ticoagulan ts as prescribed dur- in g th e early ph ase of DIC.

e. Adm in ister cryop recipitated clottin g factors, as prescribed, wh en DIC progresses an d h em - orrh age is th e prim ary problem .

Notify the HCP immediately if signs of an oncolog- ical emergency occur.

B. Syn drom e of in approp riate an tidiuretic h orm on e (SIADH) 1. Description

a . Tum ors can produce, secrete, or stim ulate substan ces th at m im ic an tidiuretic h orm on e.

b . Mild sym pto m s in clude weakn ess, m uscle cram p s, loss of appetite, an d fatigue; serum sodium levels ran ge from 115 to 120 m Eq/ L (115-120 m m ol/ L) .

c. More serious sign s an d sym ptom s relate to water in toxication an d in clude weigh t gain , person ality ch an ges, con fusion , an d extrem e m uscle weakn ess.

d . As th e serum sodium level approach es 110 m Eq/ L (110 m m o l/ L), seizures, com a, an d even tually death will occur, un less th e con dition is treated rapidly.

2. In terven tion s a . In itiate flu id restriction an d in creased sodium

in take as prescribed. b . As prescribed, ad m in ister an an tagon ist to

an tidiuretic h orm on e. c. Mon itor serum sodium levels. d . Treat th e un derlyin g cau se with ch em oth er-

apy or radiation to reduce th e tum o r. C. Spin al cord com pression

1. Description a . Spin al cord com pression occurs wh en a

tum or directly en ters th e spin al cord or wh en th e vertebral colum n collapses from tum o r en try, im pin gin g on th e spin al cord.

604 UNIT IX Hematological and Oncological Disorders of the Adult Client

b . Sp in al co rd co m p ressio n cau ses b ack p ain , u su ally b efo re n eu ro lo gical d eficits o ccu r.

c. Neurological deficits relate to th e spin al level of com pression an d in clude n um bn ess; tin - glin g; loss of ureth ral, vagin al, an d rectal sen - satio n ; an d m uscle weakn ess.

2. In terven tion s a . Early recogn ition : Assess for back pain an d

n eurological deficits. b . Adm in ister h igh -d ose cortico steroids to

reduce swellin g aroun d th e spin al cord an d relieve sym ptom s.

c. Prepare th e clien t for im m ediate radiation an d/ o r ch em oth erapy to reduce th e size of th e tum o r an d relieve com pression .

d . Surgery m ay n eed to be perform ed to rem ove th e tum o r an d relieve th e pressure on th e spin al cord.

e. In struct th e clien t in th e use of n eck or back braces if th ey are prescribed.

D. Hypercalcem ia 1. Descriptio n

a . Hypercalcem ia is a late m an ifestation of exten sive m align an cy th at occurs m ost often with bon e m etastasis, wh en th e bon e releases calcium in to th e bloodstream .

b . Decreased ph ysical m ob ility con tribu tes to or worsen s h ypercalcem ia.

c. Early sign s in clude fatigue, an orexia, n ausea, vom itin g, co n stipatio n , an d polyuria.

d . More serious sign s an d sym pto m s in clude severe m uscle weakn ess, dim in - ish ed deep ten don reflexes, paralytic ileu s, deh ydration , an d ch an ges in th e electro- cardiogram .

2. In terven tion s a . Mon itor serum calcium level an d electrocar-

diograph ic ch an ges. b . Adm in ister oral or paren teral flu ids as

prescribed. c. Adm in ister m ed ication s th at lower th e cal-

ciu m level an d con trol n ausea an d vom itin g as prescribed.

d . Prepare th e clien t for dialysis if th e con dition beco m es life-th reaten in g or is acco m pan ied by ren al im pairm en t.

e. En cou rage walkin g to preven t breakd own of bon e.

E. Superior ven a cava syn d rom e 1. Descriptio n

a . Superior ven a cava (SVC) syn drom e occurs wh en th e SVC is com pressed or obstru cted by tum o r growth (com m on ly associated with lun g can cer an d lym ph om a).

b . Sign s an d sym pto m s result fro m blockage of blood flow in th e ven o us system of th e h ead, n eck, an d upper trun k.

c. Early sign s an d sym pto m s gen erally occur in th e m orn in g an d in clude edem a of th e face, especially arou n d th e eyes, an d tigh tn ess of th e sh irt or blouse collar (Stokes’ sign ).

d . As th e con ditio n worsen s, edem a in th e arm s an d h an ds, dyspn ea, eryth em a of th e upper body, swellin g of th e vein s in th e ch est an d n eck, an d epistaxis occur.

e. Life-th reaten in g sign s an d sym ptom s in clude airway obstru ction , h em orrh age, cyan osis, m en tal status ch an ges, decreased cardiac out- put, an d h ypoten sion .

2. In terven tion s a . Assess for early sign s an d sym ptom s of SVC

syn d rom e. b . Place th e clien t in sem i-Fowler’s position an d

adm in ister corticosteroid s an d diuretics as prescribed.

c. Prepare th e clien t for h igh -dose radiation th erap y to th e m ed iastin al area, an d possible surgery to in sert a m etal sten t in th e ven a cava.

F. Tum or lysis syn dro m e 1. Description

a . Tum or lysis syn drom e occurs wh en large quan - tities of tum or cells are destroyed rapidly an d intracellular com pon en ts such as potassium and uric acid are released in to th e bloodstream faster th an the body can elim in ate them .

b . Tum or lysis syn d rom e can in dicate th at can - cer treatm en t is destro yin g tum o r cells; h ow- ever, if left un treated, it can cause severe tissue dam age an d death .

c. Hyperkalem ia, h yperph o sph atem ia with resultan t h ypo calcem ia, an d h yperuricem ia occur; h yperuricem ia can lead to acute kidn ey in jury.

2. In terven tion s a . En cou rage oral h ydration ; IV h ydration m ay

be prescribed; m on itor ren al fun ction an d in take an d output, an d en sure th at th e clien t is on a ren al diet low in potassium an d ph osph orus.

b . Adm in ister diuretics to in crease th e urin e flow th rou gh th e kidn eys as prescribed .

c. Adm in ister m edication s th at in crease th e excretion of purin es, such as allopu rin ol, as prescribed.

d . Prepare to adm in ister IV in fusion of gluco se an d in sulin to treat h yperkalem ia.

e. Prep are th e clien t fo r d ialysis if h yp erkale- m ia an d h yp eru ricem ia p ersist d esp ite treatm en t.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

605CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

CRITICAL THINKING What Should You Do? Answer: The normal platelet count is 150 ,0 0 0-400 ,00 0 mm 3

(150-40 0 Â 10 9/ L). If the count is low, the nurse should place the client on bleeding precautions. The nurse should exam- ine the client for signs of bleeding, including checking all body fluids and excrement and monitoring for signs of inter- nal hemorrhage (e.g., pain, rapid and weak pulse, increased abdominal girth, and abdomen guarding). The nurse should handle the client gently and use caution when taking blood pressures to prevent skin injury. Other interventions include soft foods that are cool to warm to avoid oral mucosa dam- age; avoiding injections to prevent trauma to the skin and bleeding; applying firm and gentle pressure to a needle-stick site for at least 5 minutes, or longer if needed; padding cor- ners of the bed and furniture; and avoiding rectal supposito- ries, enemas, and thermometers. The client should use a soft toothbrush and avoid dental floss, use only an electric razor for shaving, and avoid blowing the nose.

Reference: Ignatavicius, Workman (20 16), pp. 383, 60 9.

P R A C T I C E Q U E S T I O N S 504. Th e n urse is reviewin g th e laborato ry results of a

clien t diagn osed with m ultiple m yelom a. Wh ich would th e n urse exp ect to n ote specifically in th is disorder? 1. In creased calcium level 2. In creased wh ite blood cells 3. Decreased blood urea n itrogen level 4. Decreased n um ber of plasm a cells in th e bon e

m arro w

505. Th e n urse is creatin g a plan of care for th e clien t with m ultiple m yelom a an d in cludes wh ich p rio r- ity in terven tion in th e plan ? 1. En cou ragin g fluid s 2. Providin g frequen t oral care 3. Cough in g an d deep breath in g 4. Mon itorin g th e red blood cell coun t

506. Wh en carin g for a clien t with an in tern al radiation im plan t, th e n urse sh ould observe wh ich prin ci- ples? Select all th at ap p ly.

1. Lim itin g th e tim e with th e clien t to 1 h ou r per sh ift.

2. Keepin g pregn an t wom en out of th e clien t’s ro om .

3. Placin g th e clien t in a private ro om with a private bath .

4. Wearin g a lead sh ield wh en providin g direct clien t care.

5. Rem ovin g th e dosim eter film badge wh en en terin g th e clien t’s room .

6. Allowin g in dividuals yo un ger th an 16 years old in th e room as lon g as th ey are 6 feet away fro m th e clien t.

507. While givin g care to a clien t with an in ternal cervical radiation im plant, th e n urse fin ds the im plan t in th e bed. Th e n urse sh ould take wh ich in itial action ? 1. Call th e h ealth care provider (HCP). 2. Rein sert th e im plan t in to th e vagin a. 3. Pick up th e im plan t with gloved h an ds an d flu sh

it down th e toilet. 4. Pick up th e im plan t with lon g-h an dled forceps

an d place it in a lead co n tain er.

508. Th e n urse sh o uld plan to im plem en t wh ich in ter- ven tio n in th e care of a clien t exp erien cin g n eutro- pen ia as a result of ch em oth erapy? 1. Restrict all visitors. 2. Restrict fluid in take. 3. Teach th e clien t an d fam ily about th e n eed for

h an d h ygien e. 4. In sert an in dwellin g urin ary cath eter to preven t

skin breakd own .

509. Th e h om e h ealth care n urse is carin g for a clien t with can cer wh o is co m plain in g of acute pain . Th e m o st ap p ro p riate determ in ation of th e clien t’s pain sh ould in clude wh ich assessm en t? 1. Th e clien t’s pain ratin g 2. No n verbal cues from th e clien t 3. Th e n urse’s im pression of th e clien t’s pain 4. Pain relief after appropriate n ursing interven tion

510. Th e n urse is carin g for a clien t wh o is postoperative follo win g a pelvic exen teration an d th e h ealth care provider ch an ges th e clien t’s diet from NPO (n oth - in g by m outh ) status to clear liquids. Th e n urse sh ould ch eck wh ich p rio rity item befo re adm in is- terin g th e diet? 1. Bowel soun ds 2. Ability to am bulate 3. In cision appearan ce 4. Urin e specific gravity

511. A clien t is adm itted to th e h ospital with a susp ected diagn osis of Ho dgkin ’s disease. Wh ich assessm en t fin din g would th e n urse expect to n ote specifically in th e clien t? 1. Fatigue 2. Weakn ess 3. Weigh t gain 4. En larged lym p h n odes

512. Du rin g th e adm ission assessm en t of a clien t with advan ced ovarian can cer, th e n urse recogn izes wh ich m an ifestation as typ ical of th e disease?

606 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

1. Diarrh ea 2. Hyperm en orrh ea 3. Abn orm al bleedin g 4. Abdo m in al disten tion

513. Th e n urse is carin g for a clien t with lu n g can cer an d bon e m etastasis. Wh at sign s an d sym ptom s would th e n urse recogn ize as in dication s of a possible on co logical em ergen cy? Select all th at ap p ly.

1. Facial edem a in th e m orn in g 2. Weigh t lo ss of 20 lb (9 kg) in 1 m on th 3. Serum calcium level of 12 m g/dL(3.0 m m ol/ L) 4. Serum sodium level of 136 m g/ dL (136

m m o l/ L) 5. Serum potassium level of 3.4 m g/ dL

(3.4 m m ol/ L) 6. Num bn ess an d tin glin g of th e lower

extrem ities

514. A clien t wh o h as been receivin g radiation th erap y for bladder can cer tells th e n urse th at it feels as if sh e is voidin g th rou gh th e vagin a. Th e n urse in ter- prets th at th e clien t m ay be experien cin g wh ich con ditio n ? 1. Ru pture of th e bladder 2. Th e developm en t of a vesicovagin al fistula 3. Extrem e stress cau sed by th e diagn osis of can cer 4. Altered perin eal sen sation as a side effect of radi-

ation th erap y

515. Th e n urse is in structin g a clien t to perform a testic- ular self-exam in ation (TSE). Th e n urse sh ould pro- vide th e clien t with wh ich in form ation about th e procedure? 1. To exam in e th e testicles wh ile lyin g down 2. Th at th e best tim e for th e exam in ation is after

a sh ower 3. To gen tly feel th e testicle with 1 fin ger to feel for

a growth 4. Th at TSEs should be don e at least every 6 m on th s

516. Th e n urse is con d uctin g a h isto ry an d m on itorin g labo ratory values on a clien t with m ultiple m ye- lo m a. Wh at assessm en t fin din gs sh o uld th e n urse exp ect to n ote? Select all th at ap p ly. 1. Path ological fracture 2. Urin alysis positive for n itrites 3. Hem oglob in level of 15.5 g/ dL (155 m m o l/ L) 4. Calcium level of 8.6 m g/ dL (2.15 m m o l/ L) 5. Serum creatin ine level of 2.0 m g/ dL (176.6

m cm ol/ L)

517. A gastrectom y is perform ed on a clien t with gastric can cer. In th e im m ediate postoperative period, th e n urse n otes blood y drain age from th e n aso gastric tube. Th e n urse sh o uld take wh ich m o st ap p ro p ri- ate action ?

1. Measu re abdom in al girth . 2. Irrigate th e n asogastric tube. 3. Con tin ue to m on itor th e drain age. 4. No tify th e h ealth care provider (HCP).

518. Th e n urse is teach in g a clien t ab out th e risk factors associated with colorectal can cer. Th e n urse deter- m in es th at fu rth er teach in g is n ecessary related to colorectal can cer if th e clien t iden tifies wh ich item as an associated risk facto r? 1. Age youn ger th an 50 years 2. History of colorectal polyps 3. Fam ily h istory of colorectal can cer 4. Ch ron ic in flam m atory bowel disease

519. Th e n urse is assessin g th e perin eal woun d in a cli- en t wh o h as return ed fro m th e operatin g room fol- lo win g an abdom in al perin eal resectio n an d n otes serosan guin eous drain age fro m th e woun d. Wh ich n ursin g in terven tion is m o st ap p ro p riate? 1. Clam p th e surgical drain . 2. Ch an ge th e dressin g as prescribed . 3. Notify th e h ealth care provider (HCP). 4. Rem o ve an d replace th e perin eal packin g.

520. Th e n urse is assessin g th e colostom y of a clien t wh o h as h ad an abdom in al perin eal resectio n for a bowel tum or. Wh ich assessm en t fin din g in dicates th at th e colosto m y is begin n in g to fun ction ? 1. Th e passage of flatu s 2. Absen t bowel soun ds 3. Th e clien t’s ability to tolerate food 4. Bloo dy drain age fro m th e colostom y

521. Th e n urse is reviewin g th e h isto ry of a clien t with bladder can cer. Th e n urse exp ects to n ote docu- m en tation of wh ich m o st com m on sign or sym p- tom of th is type of can cer? 1. Dysu ria 2. Hem aturia 3. Urgen cy on urin ation 4. Frequen cy of urin ation

522. Th e n urse is assessin g a clien t wh o h as a n ew ure- terosto m y. Wh ich statem en t by th e clien t in dicates th e n eed fo r m o re ed u catio n about urin ary stom a care? 1. “I ch an ge m y pouch every week.” 2. “I ch an ge th e ap plian ce in th e m orn in g.” 3. “I em pty th e urin ary collection bag wh en it is

two-th irds full.” 4. “Wh en I’m in th e sh ower I direct th e flow of

water away from m y stom a.”

523. A clien t with carcin o m a of th e lun g develops syn - drom e of in approp riate an tidiuretic h orm on e (SIADH) as a com plication of th e can cer. Th e n urse

607CHAPTER 48 Hematological and Oncological Disorders

an ticipates th at th e h ealth care provider will request wh ich prescription s? Select all th at ap p ly.

1. Rad iation 2. Ch em o th erapy 3. In creased fluid in take 4. Decreased oral sodium in take 5. Serum sodium level determ in ation 6. Medication th at is an tagon istic to an tidiure-

tic h orm on e

524. Th e n urse is m on itorin g a clien t for sign s an d sym ptom s related to superior ven a cava syn d rom e. Wh ich is an early sign of th is on colo gical em ergen cy? 1. Cyan osis 2. Arm edem a 3. Periorbital edem a 4. Men tal status ch an ges

525. Th e n urse m an ager is teach in g th e n ursin g staff ab out sign s an d sym ptom s related to h ypercalce- m ia in a clien t with m etastatic prostate can cer, an d tells th e staff th at wh ich is a late sign or sym p- tom of th is on colo gical em ergen cy? 1. Headach e 2. Dysph agia 3. Con stipation 4. Electrocardio graph ic ch an ges

526. As part of ch em oth erapy education , th e n urse teach es a fem ale clien t about th e risk for bleedin g an d self-care durin g th e period of greatest bon e m arrow suppressio n (th e n adir). Th e n urse un der- stan ds th at fu rth er teach in g is n eed ed if th e clien t m akes wh ich statem en t? 1. “I sh ould avoid blowin g m y n ose.”

2. “I m ay n eed a platelet tran sfusion if m y platelet co un t is too low.”

3. “I’m goin g to take aspirin for m y h eadach e as soon as I get h om e.”

4. “I will coun t th e n um ber of pads an d tam pon s I use wh en m en struatin g.”

527. Th e com m un ity h ealth n urse is in structin g a group of youn g fem ale clien ts about breast self- exam in ation . Th e n urse sh o uld in struct th e clien ts to perform th e exam in ation at wh ich tim e? 1. At th e on set of m en struation 2. Every m on th durin g ovulation 3. Weekly at th e sam e tim e of day 4. 1 week after m en struation begin s

528. A clien t is diagn osed as h avin g a bowel tum o r. Th e n urse sh ould m on itor th e clien t for wh ich com pli- cation s of th is type of tum o r? Select all th at ap p ly.

1. Flatulen ce 2. Periton itis 3. Hem o rrh age 4. Fistula form ation 5. Bowel perforation 6. Lactose in toleran ce

529. Th e n urse is carin g for a clien t followin g a m astec- tom y. Wh ich n ursin g in terven tion would assist in preven tin g lym ph edem a of th e affected arm ? 1. Placin g cool com presses on th e affected arm 2. Elevatin g th e affected arm on a pillow above

h eart level 3. Avoidin g arm exercises in th e im m ediate

posto perative period 4. Main tain in g an in traven ous site below th e an te-

cubital area on th e affected side

A N S W E R S

504. 1 Ra tion a le: Fin din gs in d icative of m u ltip le m yelom a are an in creased n um b er of plasm a cells in th e b on e m arrow, an em ia, h yp ercalcem ia cau sed by th e release o f calcium from th e dete- rioratin g bo n e tissu e, an d an elevated b lo od urea n itro gen level. An in creased wh ite b lo od cell co un t m ay or m ay n o t b e p resen t an d is n o t related specifically to m ultiple m yelo m a. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, lab oratory fin d - in gs in m ultiple m yelom a. No tin g th e n am e o f th e d isord er an d recallin g th e path o ph ysio logy o f th e disease an d th at p ro - liferatio n of plasm a cells in th e b on e occurs will d irect yo u to th e correct o ptio n . Review: Mu ltip le m yelo m a Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —O n co lo gy

Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 818-819.

505. 1 Ra tion a le: Hyp ercalcem ia cau sed b y bo n e d estruction is a p ri- o rity co n cern in th e clien t with m u ltiple m yelo m a. Th e n urse sh o u ld ad m in ister fluid s in ad equ ate am ou n ts to m ain tain a u rin e o utp ut o f 1.5 to 2 L/ d ay; th is req u ires abo ut 3 L o f flu id in take per day. Th e fluid is n eeded n o t on ly to d ilu te th e cal- cium o verlo ad b ut also to preven t p ro tein from p recip itatin g in th e ren al tu bu les. O p tio n s 2, 3, an d 4 m ay be co m p o n en ts o f th e p lan of care b u t are n ot th e p rio rity in th is clien t. Test-Ta kin g Str a tegy: No te th e strategic wo rd , priority. Recal- lin g th e p ath o ph ysiolo gy o f th is d iso rd er an d th at h ypercalce- m ia can o ccu r will d irect you to th e co rrect op tion . Review: Hyp ercalcem ia Level of Cogn itive Ability: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

608 UNIT IX Hematological and Oncological Disorders of the Adult Client

Con t en t Ar ea : Ad ult Health —O n cology Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Ign atavicius, Workm an (2016), p p. 169-170, 819.

506. 2, 3, 4 Ra t ion a le: Th e tim e th at th e n u rse spen ds in th e ro o m o f a cli- en t with an in tern al rad iatio n im p lan t is 30 m in u tes p er 8-h ou r sh ift. Th e clien t m u st b e placed in a p rivate ro om with a private bath . Lead sh ieldin g can be u sed to red uce th e tran sm ission o f radiation . Th e dosim eter film badge m ust be worn wh en in th e clien t’s ro om . Ch ild ren you n ger th an 16 years o f age an d preg- n an t wo m en are n ot allowed in th e clien t’s roo m . Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, radiatio n precau - tion s. Recallin g th e tim e fram e related to expo su re to th e clien t will assist in elim in atin g o ption 1. Fro m th e rem ain in g op tion s, select th e correct op tio n s because of th e p ossible risks associated with expo su re to rad iatio n . Review: Care of th e clien t with an in tern al rad iatio n im p lan t Level of Cogn it ive Ability: An alyzin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Cellu lar Regu latio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 376.

507. 4 Ra t ion a le: In th e even t th at a radiation sou rce beco m es dis- lod ged, th e n u rse wo uld first en cou rage th e clien t to lie still un til th e rad ioactive sou rce h as been p laced in a safe, clo sed co n tain er. Th e n u rse wo uld use lon g-h an dled fo rceps to place th e so urce in th e lead con tain er th at sh o uld b e in th e clien t’s ro om . Th e n urse sh ould th en call th e radiation on cologist an d d o cu m en t th e even t an d th e action s taken . It is n o t with in th e sco pe o f n ursin g practice to in sert a radiatio n im plan t. Test -Ta kin g Str a tegy: Note th e strategic wo rd , initial. Th e in i- tial action wou ld be to p reven t self-con tam in ation fro m radi- ation expo sure. Th is will direct yo u to th e correct o ptio n . Review: Nursin g actio n s to take if a sealed rad iatio n im p lan t becom es d islo d ged Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Safety Pr ior ity Con cepts: Cellu lar Regu latio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 376.

508. 3 Ra t ion a le: In th e n eu tro p en ic clien t, m eticulou s h an d h ygien e edu catio n is im plem en ted fo r th e clien t, fam ily, visitors, an d staff. No t all visitors are restricted , b ut th e clien t is p ro tected fro m p erson s with kn o wn in fection s. Flu ids sh ou ld be en co ur- aged . In vasive m easu res such as an in d wellin g u rin ary cath eter sh ou ld b e avo ided to p reven t in fectio n s. Test -Ta kin g St r a t egy: Elim in ate o ption 1 because o f th e clo sed -en d ed wo rd , all. Next, elim in ate op tio n 2 becau se it is n o t reason able to restrict fluid s in a clien t receivin g ch em o - th erap y wh o is at risk for fluid an d electro lyte im b alan ces. Elim in ate o ptio n 4 b ecau se of th e risk o f in fection th at exists with th is m easure. Review: In terven tio n s for th e clien t with n eu tro p en ia

Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Fun d am en tals of Care—Safety Pr ior ity Con cepts: Caregivin g; In fectio n Refer en ces: Ign atavicius, Workm an (2016), p p . 381-382; Perry et al. (2014), p . 173.

509. 1 Ra t ion a le: Th e clien t’s self-rep o rt is a critical com po n en t o f p ain assessm en t. Th e n u rse sh ou ld ask th e clien t to d escrib e th e pain an d listen carefully to th e words th e clien t uses to d escrib e th e pain . Non verb al cu es from th e clien t are im p ortan t b u t are n o t th e m o st ap prop riate pain assessm en t m easu re. Th e n urse’s im pressio n of th e clien t’s pain is n ot ap prop riate in d eterm in in g th e clien t’s level o f pain . Assessin g pain relief is an im p o rtan t m easu re, b ut th is o ptio n is n o t related to th e sub - ject o f th e q u estion . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Elim in ate o ptio n 3 b ecau se th e n urse is n o t th e clien t o f th e q u estion . Fro m th e rem ain in g op tio n s, th e su b jective data from th e clien t will p ro vide th e m o st accurate d escrip tio n o f th e pain . Review: Pain assessm en t tech n iqu es Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Fun d am en tals of Care—Pain Pr ior ity Con cepts: Caregivin g; Pain Refer en ce: Ign atavicius, Workm an (2016), p p. 30-32.

510. 1 Ra t ion a le: Th e clien t is kept NPO un til p eristalsis retu rn s, usu- ally in 4 to 6 days. Wh en sign s of b owel fun ctio n return , clear fluid s are given to th e clien t. If n o d isten tion o ccu rs, th e diet is ad van ced as tolerated . Th e m ost im p ortan t assessm en t is to assess b owel sou n d s b efore feedin g th e clien t. O p tion s 2, 3, an d 4 are u n related to th e data in th e q uestion . Test -Ta kin g St r a t egy: Note th e strategic wo rd , priority, an d th e words NPO status to clear liquids in th e q uestion . Th e co rrect o p tion is th e on ly o n e th at relates to gastroin testin al fu n ctio n . Review: Pelvic exen teratio n Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Clin ical Jud gm en t; Nu trition Refer en ce: Ign atavicius, Workm an (2016), p . 262.

511. 4 Ra t ion a le: Hod gkin ’s disease is a ch ro n ic progressive n eop las- tic d iso rd er o f lym ph oid tissu e ch aracterized by th e pain less en largem en t o f lym ph n o des with progressio n to extralym p h a- tic sites, such as th e spleen an d liver. Weigh t loss is m o st likely to b e n oted . Fatigue an d weakn ess m ay o ccur b ut are n ot related sign ifican tly to th e d isease. Test -Ta kin g Str a t egy: O p tio n s 1 an d 2 are co m p arab le o r alike an d are rath er vague sym ptom s th at can occur in m an y d iso rd ers. O p tion 3 can b e elim in ated b ecau se, in su ch a

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

609CHAPTER 48 Hematological and Oncological Disorders

d isord er, weigh t lo ss is m ost likely to occu r. Also, recallin g th at Hod gkin ’s disease affects th e lym p h n o des will direct yo u to th e correct op tio n . Review: Man ifestation s asso ciated with Ho d gkin ’s d isease Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —O n co lo gy Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), p p . 670-671.

512. 4 Ra tion a le: Clin ical m an ifestatio n s o f ovarian can cer in clud e ab do m in al d isten tio n , u rin ary frequ en cy an d u rgen cy, pleu ral effu sion , m aln u trition , pain from pressu re caused b y th e grow- in g tum or an d th e effects of u rin ary o r b owel ob stru ction , con - stip ation , ascites with dysp n ea, an d ultim ately gen eral severe p ain . Abn orm al bleedin g, o ften resultin g in h yperm en o rrh ea, is associated with uterin e can cer. Test-Ta kin g St r a t egy: Elim in ate o ptio n s 2 an d 3 first because th ey are co m p arab le o r alike. From th e rem ain in g o ptio n s, con sider th e an atom ical lo catio n o f th e can cer. Th is will assist in d irectin g yo u to th e co rrect o p tion . Review: Man ifestation s asso ciated with o varian can cer Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —O n co lo gy Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1496.

513. 1, 3, 6 Ra tion a le: O n co lo gical em ergen cies in clu de sep sis, dissem i- n ated in travascu lar coagu latio n , syn d ro m e of in app ro p riate an tid iu retic h orm on e, sp in al co rd com p ression , h yp ercalce- m ia, su perio r ven a cava syn drom e, an d tu m or lysis syn d ro m e. Blockage o f b lo od flo w to th e ven o u s system of th e h ead resu lt- in g in facial ed em a is a sign o f su perio r ven a cava syn dro m e. A serum calciu m level of 12 m g/ dL (3.0 m m o l/ L) in d icates h yp ercalcem ia. Num bn ess an d tin glin g o f th e lo wer extrem ities cou ld be a sign of sp in al co rd co m p ression . Mild h ypo kalem ia an d weigh t lo ss are n o t o n co lo gical em ergen cies. A so diu m level o f 136 m g/ dL (136 m m o l/ L) is a n o rm al level. Test-Ta kin g St r a t egy: Note th e su b ject, an o n cological em er- gen cy. Recallin g th e sign s an d sym p tom s of on co lo gical em er- gen cies will h elp yo u to iden tify th e correct op tio n s. Also , recallin g th e n orm al calcium , po tassiu m , an d sod ium levels will direct you to th e correct option s. Review: O n co lo gical em ergen cies Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —O n co lo gy Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 392-393.

514. 2 Ra tion a le: A vesicovagin al fistula is a gen ital fistula th at occurs b etween th e b lad der an d vagin a. Th e fistula is an ab n orm al o pen in g between th ese 2 bo d y parts an d, if th is occu rs, th e

clien t m ay exp erien ce d rain age o f u rin e th ro ugh th e vagin a. Th e clien t’s co m p lain t is n ot associated with op tio n s 1, 3, or 4. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, a co m p lication of b ladd er can cer. Notin g th e wo rd s voiding through the vagina sh o u ld direct you to th e correct op tio n . Review: Vesico vagin al fistu la Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ad ult Health —O n co logy Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), p . 1301.

515. 2 Ra tion a le: Th e TSE is reco m m en ded m on th ly after a warm b ath or sh ower wh en th e scro tal skin is relaxed . Th e clien t sh o u ld stan d to exam in e th e testicles. Usin g b oth h an d s, with fin gers u n der th e scro tu m an d th u m b s o n to p, th e clien t sh o u ld gen tly roll th e testicles, feelin g fo r an y lu m ps. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e proced ure fo r p erfo rm in g TSE. Elim in ate o p tion 4 first b ecau se of th e wo rd s 6 months. Next, elim in ate o p tion 3 b ecause of th e wo rd 1. From th e rem ain in g o ptio n s, elim in ate o ptio n 1 b y tryin g to visu alize th e p ro cess o f th e self-exam in atio n . Review: Testicu lar self-exam in atio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clin ical Ju dgm en t; Health Pro m o tio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1513.

516. 1, 2, 5 Ra tion a le: Multiple m yelom a is a B-cell n eoplastic con dition ch aracterized b y ab n o rm al m align an t p ro liferatio n o f plasm a cells an d th e accu m u latio n of m atu re plasm a cells in th e bo n e m arrow. Th e clien t with m align an t m elan o m a m ay experien ce p ath ologic fractu res, h yp ercalcem ia, an em ia, recu rren t in fec- tio n s, an d ren al failure. A seru m calciu m level o f 8.6 m g/ d L (2.15 m m ol/ L) an d a h em oglo bin level o f 15.5 g/ d L (155 m m o l/ L) are n orm al valu es. Th erefore, th e co rrect an swers are p ath ological fractures, po sitive urin alysis fo r n itrites, an d a serum creatin in e level of 2.0 m g/ dL ( 176.6 m cm o l/ L). Test-Ta kin g Str a tegy: Focus on th e su b ject, ch aracteristics of m align an t m yelo m a. Th in k ab ou t th e p ath o ph ysiolo gy of th e d iso rd er an d an alyze th e values given to direct yo u to th e correct op tio n . Review: Ch aracteristics of m u ltip le m yelo m a Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —O n co logy Pr ior it y Con cept s: Cellular Regulation ; Clien t Edu catio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 818-819.

517. 3 Ra tion a le: Followin g gastrectom y, d rain age fro m th e n asogas- tric tub e is n o rm ally b loo d y fo r 24 h ou rs p osto p eratively,

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

610 UNIT IX Hematological and Oncological Disorders of the Adult Client

ch an ges to brown -tin ged, an d is th en yello w or clear. Because blo od y drain age is expected in th e im m ediate po stop erative period , th e n u rse sh ou ld con tin u e to m on itor th e d rain age. Th e n urse do es n ot n eed to n otify th e HCP at th is tim e. Mea- surin g ab do m in al girth is p erfo rm ed to d etect th e d evelo pm en t of d isten tion . Fo llo win g gastrecto m y, a n aso gastric tu be sh ou ld n ot be irrigated u n less th ere are sp ecific HCP p rescrip- tion s to do so . Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate, an d fo cus on th e su b ject, th e im m ed iate po sto perative period . Th is sh ou ld direct you to th e co rrect o p tion . Rem em b er th at drain age from th e n aso gastric tu be is n orm ally bloo dy for 24 h o urs po stop eratively, ch an ges to brown -tin ged, an d th en to yello w o r clear. Review: Posto perative fin d in gs fo llo win g gastrecto m y Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Fun dam en tals of Care—Perio perative Care Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Lewis et al. (2014), p . 361.

518. 1 Ra t ion a le: Co lorectal can cer risk factors in clu de age o ld er th an 50 years, a fam ily h isto ry o f th e d isease, co lo rectal po lyps, an d ch ron ic in flam m atory bo wel disease. Test -Ta kin g St r a t egy: Note th e strategic wo rd s, further teaching is necessary. Th ese words in dicate a n egative even t q uery and ask you to select an option th at is an in correct statem en t. Notin g th e words younger than in o ption 1 will direct you to this option . Review: Risk facto rs asso ciated with co lo rectal can cer Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —O n cology Pr ior ity Con cepts: Clien t Edu catio n ; Health Pro m otio n Refer en ce: Lewis et al. (2014), p . 986.

519. 2 Ra t ion a le: Im m ediately after surgery, p ro fuse sero san gu in eo us drain age fro m th e perin eal wo un d is exp ected. Th erefo re, th e n urse sh ou ld ch an ge th e d ressin g as prescrib ed. A su rgical d rain sh ou ld n o t b e clam p ed becau se th is action will cau se th e accu - m u latio n o f drain age with in th e tissue. Th e n u rse do es n o t n eed to n otify th e HCP at th is tim e. Drain s an d packin g are rem oved gradually over a period of 5 to 7 days as prescribed. Th e n urse sh o u ld n o t rem ove th e perin eal p ackin g. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Elim in ate op tion s 1 an d 4, kn owin g th at th ese are in ap pro- priate in terven tion s. Recallin g th at sero san gu in eo us d rain age is expected fo llowin g th is type o f su rgery will assist in d irectin g yo u to th e co rrect o p tion . Review: Po stop erative n ursin g care fo llo win g ab d o m in al p er- in eal resectio n Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —O n cology Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign ataviciu s, Workm an (2016), p p. 267-268, 1154.

520. 1 Ra t ion a le: Followin g abd om in al perin eal resectio n , th e n u rse would expect th e colostom y to begin to fun ction with in 72 h ou rs after su rgery, alth o ugh it m ay take up to 5 days. Th e n urse sh o uld assess fo r a retu rn of peristalsis, listen for b o wel so u n d s, an d ch eck for th e p assage o f flatu s. Absen t b o wel sou n d s wou ld n o t in d icate th e retu rn o f p eristalsis. Th e clien t wo uld rem ain NPO (n o th in g by m o uth ) u n til b owel so u n d s return an d th e colo stom y is fun ction in g. Blo od y drain - age is n ot exp ected from a co lo stom y. Test -Ta kin g Str a t egy: Focus on th e su b ject, th e co lo stom y b egin n in g to fu n ction . Th is sh o uld assist in elim in atin g o ptio n 2. Kn owled ge o f gen eral p osto p erative m easu res will assist in elim in atin g o p tion 3. Fo cu s o n th e su b ject to assist in elim in at- in g op tion 4 as a co rrect op tio n . Review: Posto perative care fo llo win g ab d o m in al p erin eal resectio n Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Fun d am en tals of Care—Perio perative Care Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in ation Refer en ce: Ign atavicius, Workm an (2016), p . 1154.

521. 2 Ra t ion a le: Th e m ost co m m o n sign in clien ts with can cer of th e b lad der is h em aturia. Th e clien t also m ay exp erien ce irritative vo id in g sym p tom s su ch as frequ en cy, urgen cy, an d dysu ria, an d th ese sym pto m s often are associated with carcin o m a in situ . Dysu ria, u rgen cy, an d freq uen cy of u rin ation are also sym p tom s o f a b ladd er in fection . Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, b ladd er can cer, an d n ote th e strategic wo rd , most. O ptio n s 1, 3, an d 4 are sym p tom s th at are associated m o st often with b ladd er in fection . Review: Clin ical m an ifestation s asso ciated with b lad d er can cer Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —O n colo gy Pr ior ity Con cepts: Cellu lar Regu latio n ; Elim in atio n Refer en ce: Lewis et al. (2014), p. 1085.

522. 3 Ra t ion a le: Th e u rin ary co llectio n b ag sh o uld b e ch an ged wh en it is o n e-th ird fu ll to preven t pu llin g o f th e ap plian ce an d leak- age. Th e rem ain in g op tio n s iden tify co rrect statem en ts abo ut th e care o f a u rin ary sto m a. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for more education, an d elim in ate th e o p tion s th at in d icate clien t u n d er- stan din g. Notin g th e words two-thirds full will assist in directin g yo u to th e co rrect o ption . Review: Urin ary sto m a care Level of Cogn it ive Abilit y: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —O n colo gy Pr ior ity Con cepts: Clien t Ed u catio n ; Elim in ation Refer en ce: Perry et al. (2014), p . 826.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

611CHAPTER 48 Hematological and Oncological Disorders

523. 1, 2, 5, 6 Ra tion a le: Can cer is a co m m on cause o f SIADH. In SIADH, excessive am ou n ts o f water are reabsorbed b y th e kidn ey an d p ut in to th e system ic circulatio n . Th e in creased water causes h yp on atrem ia ( d ecreased serum so dium levels) an d som e d egree o f fluid reten tio n . Th e syn d ro m e is m an aged b y treatin g th e co n d itio n an d cause an d usu ally in clud es flu id restriction , in creased so d ium in take, an d m ed icatio n with a m ech an ism of action th at is an tago n istic to an tidiuretic h o rm o n e. So dium levels are m on itored closely because h yp ern atrem ia can d evelo p sud den ly as a resu lt o f treatm en t. Th e im m ed iate in sti- tu tion of ap prop riate can cer th erap y, usu ally rad iatio n o r ch e- m oth erap y, can cau se tu m or regression so th at an tidiuretic h o rm o n e syn th esis an d release processes retu rn to n orm al. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, treatm en t fo r SIADH, an d recall th at in SIADH excessive am o un ts o f water are reab sorb ed b y th e kidn ey an d pu t in to th e system ic circu- latio n . Th is will assist in an swerin g th is q u estio n . Review: Syn d ro m e o f in ap p ro p riate an tid iu retic h o rm o n e ( SIADH) Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Adu lt Health —O n co lo gy Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 392-393.

524. 3 Ra tion a le: Su perior ven a cava syn d ro m e occurs wh en th e su perio r ven a cava is co m pressed or o b stru cted by tu m or gro wth . Early sign s an d sym pto m s gen erally o ccu r in th e m orn - in g an d in clud e ed em a o f th e face, esp ecially arou n d th e eyes, an d clien t com p lain ts of tigh tn ess o f a sh irt or b lou se co llar. As th e com pressio n wo rsen s, th e clien t exp erien ces ed em a of th e h an ds an d arm s. Cyan o sis an d m en tal status ch an ges are late sign s. Test-Ta kin g Str a tegy: No te th e strategic wo rd , early. Th in k ab ou t th e path op h ysio lo gy associated with th is disorder an d fo cu s on th e strategic wo rd to assist in elim in atin g o ptio n s 1, 2, an d 4. Review: Su p erio r ven a cava syn d ro m e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —O n co lo gy Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 393-394.

525. 4 Ra tion a le: Hyp ercalcem ia is a m an ifestatio n of bo n e m etasta- sis in late-stage can cer. Head ach e an d dysp h agia are n o t asso - ciated with h yp ercalcem ia. Co n stip ation m ay o ccur early in th e p ro cess. Electro card io gram ch an ges in clu de sh orten ed ST seg- m en t an d a wid en ed T wave. Test-Ta kin g St r a t egy: Note th e strategic wo rd , late. Fo cu s on th e n am e of th e on co lo gical em ergen cy, hypercalcemia, to d irect yo u to th e correct o ptio n . Elim in ate op tion s 1 an d 2 b ecause th ey are n ot sign s o f h yp ercalcem ia. Elim in ate o ptio n 3 b ecau se it is an early sign of h ypercalcem ia. Review: Early an d late sign s o f h yp ercalcem ia

Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —O n co logy Pr ior it y Con cepts: Cellular Regulation ; Fluid an d Electro lyte Balan ce Refer en ce: Lewis et al. (2014), p . 299.

526. 3 Ra tion a le: Durin g th e p eriod o f greatest b on e m arro w su pp res- sio n (th e n ad ir), th e platelet co un t m ay b e low, less th an 20,000 cells m m 3 (20.0 Â 109/ L). Th e correct o p tion describes an in correct statem en t b y th e clien t. Asp irin an d n on stero id al an tiin flam m ato ry drugs an d p ro du cts th at co n tain asp irin sh o uld be avoided b ecau se o f th eir an tip latelet activity. O ptio n s 1, 2, an d 4 are co rrect statem en ts b y th e clien t to p re- ven t an d m o n ito r bleedin g. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, further teach- ing is needed. Recallin g th e effects o f b on e m arro w su p pressio n will d irect you to th e correct op tio n . Review: Bo n e m arro w su p p ressio n an d n ad ir Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —O n co logy Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), p . 299.

527. 4 Ra tion a le: Th e breast self-exam in atio n sh o u ld be p erfo rm ed regularly, 7 days after th e on set of th e m en stru al period. Per- fo rm in g th e exam in atio n weekly is n o t reco m m en ded . At th e o n set o f m en stru ation an d d urin g o vulation , h orm on al ch an ges occu r th at m ay alter breast tissue. Test-Ta kin g Str a tegy: O p tio n 3 can b e elim in ated easily b ecau se o f th e wo rd weekly. Elim in ate o p tion s 1 an d 2 n ext b ecau se th ey are co m p arab le o r alike in th e sim ilarity th at exists regard in g th e h o rm o n al ch an ges th at occur du rin g th ese tim es. Review: Breast self-exam in atio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clien t Ed ucation ; Health Prom o tion Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1468.

528. 2, 3, 4, 5 Ra tion a le: Com p lication s o f b owel tum o rs in clud e b owel p er- fo ratio n , wh ich can resu lt in h em orrh age an d perito n itis. O th er co m plicatio n s in clu de b owel o bstructio n an d fistu la fo r- m ation . Flatu len ce can occu r b u t is n o t a com p licatio n ; lacto se in to leran ce also is n ot a com p lication of in testin al tu m o r. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, co m plicatio n s o f a b owel tu m or. Th in k ab ou t th e locatio n an d path op h ysio lo gy asso ciated with th is type of tum o r to an swer co rrectly. Review: Com plicatio n s asso ciated with in testin al tu m o rs Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

612 UNIT IX Hematological and Oncological Disorders of the Adult Client

In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —O n cology Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Ign atavicius, Workm an (2016), p p. 1138-1139.

529. 2 Ra t ion a le: Fo llo win g m astecto m y, th e arm sh o uld be elevated ab o ve th e level of th e h eart. Sim p le arm exercises sh ou ld b e en cou raged . No b lo od p ressu re read in gs, in jectio n s, in trave- n ou s lin es, or blo o d d raws sh o u ld b e p erfo rm ed o n th e affected arm . Co ol com presses are n o t a su ggested m easure to preven t lym p h ed em a fro m o ccurrin g.

Test -Ta kin g St r a t egy: Fo cus on th e su b ject, preven tin g lym ph - edem a. No te th e relation sh ip between th e wo rd s lymphedema in th e q uestion an d elevating in th e co rrect o ptio n . Also , usin g gen eral p rin cip les related to gravity will direct you to th e co rrect o p tion . Review: Po sto perative care m easures followin g m astecto m y Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —O n colo gy Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1474.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

613CHAPTER 48 Hematological and Oncological Disorders

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

C H A P T E R 49 Hematological and Oncological Medications

PRIORITY CONCEPTS Cellular Regulation; Safety

CRITICAL THINKING What Should You Do? The nurse notes that a client who needs to receive a sched- uled antineoplastic medication has a segmented neutrophil count of 10% conventional units (0.10 SI units). What should the nurse do? Answer located on p. 619.

Note: O n colo gical m ed ication s are prescribed to treat can cer. Hem atological m edication s are prescribed to treat con d ition s an d diseases related to th e blood an d blood -form in g organ s. Blood com po n en ts are affected wh en th e clien t receives on cological m ed ication s. Hem atolo gical m ed ication s specific to treatin g th e effects of on colo gical m edication s on th e body are in cluded in th is ch apter.

I. Antineoplastic Medications A. Description

1. An tin eoplastic m edication s kill or in h ibit th e reproductio n of n eoplastic cells.

2. An tin eoplastic m edication s are used to cure, in crease survival tim e, an d decrease life- th reaten in g co m plication s.

3. Th e effect of an tin eoplastic m ed ication s m ay n ot be lim ited to n eoplastic cells; n orm al cells also are affected by th e m edication .

4. Cell cycle ph ase–specific m edication s affect cells on ly durin g a certain ph ase of th e reprodu ctive cycle (Fig. 49-1).

5. Cell cycle ph ase–n on specific m edication s affect cells in an y ph ase of th e reprodu ctive cycle (see Fig. 49-1).

6. Usually, several m edication s are used in com bi- n ation to in crease th e th erap eutic respon se.

7. An tin eoplastic m ed ication s m ay be com bin ed with oth er treatm en ts, such as surgery an d radiation .

8. Alth ou gh th e in traven o us (IV) route is m ost com m on for adm in istration , an tin eop lastic

m ed ication m ay be given by th e oral, in traarter- ial, isolated lim b perfusion , or in tracavitary route; dosin g is usually based on th e clien t’s body surface area (BSA) an d type of cancer.

9. Ch em o th erap y dosin g is usually based on total BSA, wh ich requires a curren t, accu rate h eigh t an d weigh t for BSA calculation (before each m ed ication adm in istration ) to en sure th at th e clien t receives optim al doses of ch em oth erapy m ed ication s.

Side and adverse effects from chemotherapy result from the effects of the antineoplastic medication on normal cells.

B. Side an d adverse effects 1. Mucositis 2. Alopecia 3. An o rexia, n ausea, an d vo m itin g 4. Diarrh ea 5. An em ia 6. Low wh ite blood cell coun t (n eu tropen ia) 7. Th rom b ocytopen ia 8. In fertility, sexual alteration s 9. Neuropath y

C. Gen eral in terven tion s 1. Ph ysiological in tegrity

a . Mon itor com plete blood cell coun t, wh ite blood cell coun t, platelet coun t, uric acid level, an d electrolytes.

b . In itiate bleedin g precaution s if th rom bocyto- pen ia occurs.

c. Wh en the platelet coun t is less than 50,000 m m 3 (50 Â 109/ L), m in or traum a can lead to episodes of prolon ged bleedin g; wh en less th an 20,000 m m 3 (20 Â 109/ L), spon tane- ous an d uncon trollable bleeding can occur; with h old the m edication if th e platelet count drops (accordin g to agen cy policy) an d notify the health care provider (HCP). Bleeding pre- caution s are initiated.

d . Mon itor for petech iae, ecch ym oses, bleedin g of th e gum s, an d n oseb leeds because th e614

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

decreased platelet coun t can precipitate bleed in g ten den cies.

e. Avoid in tram uscu lar in jection s an d ven i- pun ctures as m uch as possible to preven t bleed in g.

f. Withh old th e m edication an d in itiate n eutro- pen ic precaution s if the segm en ted n eutroph il coun t decreases below 18% con ven tion al un its (0.18 SI un its); n otify th e HCP.

g. Mon itor for fever, sore th roat, un usual bleed- in g, an d sign s an d sym pto m s of in fectio n .

h . In form th e clien t th at loss of appetite also m ay be th e result of taste ch an ges or a bitter taste in th e m ou th fro m th e m ed ication s.

i. Mon itor for n ausea an d vom itin g an d provide a h igh -calorie diet with protein supp lem en ts.

j. Adm in ister an tiem etics several h ours before ch em oth erapy an d for 12 to 48 h ours after as prescribed, because an tin eop lastic m ed ication s stim ulate th e vom itin g cen ter in th e brain .

k . En cou rage h ydration ; IV flu ids are adm in is- tered before an d durin g th erapy.

l. Prom o te a flu id in take of at least 2000 m L/ day to m ain tain adequ ate ren al fun ctio n .

Antineoplastic medication causes the rapid destruc- tion of cells, resulting in the release of uric acid. Allopurinol may be prescribed to lower the serum uric acid level.

2. Safe an d effective care en viron m en t a . Prepare IV ch em oth erapy in an air-ven ted

space (biolo gical safety cab in et). b . Wear appropriate person al protective equip-

m en t (PPE), in cludin g gloves, gown , eye protecto rs, an d m ask as in dicated, to reduce exposu re wh en ever th ere is a risk of h azard- ous m edication s bein g released in to th e en viron m en t.

c. Nurses wh o are pregn an t sh o uld avoid ch e- m oth erapy preparation or th e ad m in istration of ch em oth erapy.

d . Discard IV equ ipm en t in design ated (bioh az- ard) con tain ers.

e. Adm in ister an tin eoplastic m edication precisely as prescribed to m axim ize antin eoplastic effects while allowing n orm al cells to recover.

f. Mon itor for ph lebitis with IV ad m in istration because th ese m edication s m ay irritate th e vein s.

g. Vesican ts sh ould be adm in istered th rou gh a cen tral lin e wh en possible; if a periph eral lin e is used, blood return sh ould be ch ecked prior to adm in istration .

h . As prescribed , reduce IV site pain by alterin g IV rates or warm in g th e in jection site to dis- ten d th e vein an d in crease blood flo w.

i. Mon itor for extravasation (leakage of m edica- tion in to surroun din g skin an d subcu tan eo us tissue, wh ich cau ses tissue n ecrosis) an d n otify th e HCP if th is occurs; h eat or ice is applied dep en din g on th e m ed ication , an d an an tidote m ay be in jected in to th e site.

3. Psych osocial in tegrity a . In struct th e clien t ab out th e possibility of h air

loss an d th at varyin g degrees of h air loss m ay occur after th e first or secon d treatm en t.

b . Discuss th e purch ase of a wig before treat- m en t starts an d con sider cuttin g h air sh o rt.

c. In form th e clien t th at n ew h air growth will occur several m on th s after th e fin al treatm en t.

d . In struct th e clien t ab out th e n eed for con tra- ception because th ese m ed ication s h ave teratogen ic effects.

e. Discuss th e poten tial effect of in fertility, wh ich m ay be irreversible.

f. En cou rage pretreatm en t co un selin g an d en courage sperm ban kin g or preservation of eggs if th e clien t is still of ch ildbearin g age.

4. Health prom otion an d m ain ten an ce a . In struct th e clien t, if diarrh ea is a problem , to

avoid spicy foods, h igh -fib er food s, an d foods th at are h ot in tem perature, wh ich in crease peristalsis.

b . In struct th e clien t to in spect th e oral m ucosa frequen tly for eryth em a an d ulcers, rin se th e m ou th after m eals, an d carry out good oral h ygien e.

c. In struct th e clien t to use m outh rin ses as pre- scrib ed for m ou th sores if n ecessary.

d . In struct th e clien t in th e use of an tifun gal agen ts for m outh sores, if prescribed, for th e developm en t of a fun gal in fectio n .

e. In struct the clien t to avoid crowds an d person s with in fection s and to report sign s of in fection such as a low-grade fever, ch ills, or sore th roat.

Ce ll cycle nons pe cific: • Alkyla ting a ge nts • Antitumor a ntibiotics • Hormona l the ra py

Ce ll cycle s pe cific:

The Ce ll Cyc le

• Antime ta bolic a ge nts (a ffe ct S pha s e ) • Mitotic inhibitors (a ffe ct M pha s e ) • Topois ome ra s e inhibitors (a ffe ct G2 a nd S pha s e s ) • Ta xa ne s

G 2 (

2 n

d g

a p

p

h

a s e

)

G 1 (1

s t g

a p

p

h

a

s

e

)

M

(m itot

ic pha s e )

DNA re p lica

tio

n )

S (s yn th e s is

p h a s e

/

FIGURE 49-1 The cell cycle. G1, the cell is preparing for division; S (syn- thesis phase/ DNA replication), the cell doubles its DNA content through DNA synthesis; G2, the cell produces proteins to be used in cell division and in normal physiological function after cell division is complete; M (mitotic phase), the single cell splits apart into 2 cells.

615CHAPTER 49 Hematological and Oncological Medications

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

f. In struct in dividuals with colds or in fectio n s to wear a m ask wh en visitin g or to avoid vis- itin g th e clien t.

g. In struct th e clien t to use a soft tooth brush an d electric razor to m in im ize th e risk of bleedin g.

h . In struct th e clien t to avoid aspirin -con tain in g produ cts to m in im ize th e risk of bleedin g.

i. In struct th e clien t to con sult th e HCP before receivin g vaccin ation s (live vaccin es sh ould n ot be ad m in istered).

D. An aph ylactic reaction s 1. Precaution s

a. O btain an allergy h isto ry. b . Adm in ister a test dose wh en prescribed by

th e HCP. c. Stay with th e clien t durin g th e adm in istration

of m edication . d . Mon itor vital sign s. e. Have em ergen cy equ ipm en t an d m ed ication s

readily available. f. O btain IV access for th e adm in istration of

em ergen cy m edication s if n eeded. 2. Sign s of an an aph ylactic reaction

a. Dysp n ea b . Ch est tigh tn ess or pain c. Pruritu s or urticaria d . Tach ycardia e. Dizzin ess f. An xiety or agitation g. Flush ed appearan ce h . Hypo ten sion i. Decreased sen sorium j. Cyan osis

3. In terven tion s for an an aph ylactic reaction (see Priority Nursin g Actio n s)

II. Alkylating Medications (Box 49-1) A. Description

1. Break th e DNA h elix, th ereby in terferin g with DNA replication

2. Cell cycle ph ase–n on sp ecific m ed ication s B. Side an d adverse effects

1. An o rexia, n ausea, an d vo m itin g m ay occur. 2. Stom atitis m ay occur. 3. Rash m ay occur. 4. Clien t m ay feel IV site pain durin g IV

adm in istration . 5. Busulfan m ay cause h yperuricem ia. 6. Ch loram bucil an d m ech loreth am in e m ay cause

gon adal suppressio n an d h yperu ricem ia. 7. Cisplatin , a platin um com poun d, m ay cause oto-

toxicity, tin n itus, h ypokalem ia, h ypocalcem ia, h ypom agn esem ia, and n eph rotoxicity.

BOX 49-1 Alkylating Medications

Nitrogen Mustards ▪ Bendamustine ▪ Chlorambucil ▪ Cyclophosphamide ▪ Ifosfamide ▪ Estramustine ▪ Mechlorethamine ▪ Melphalan Nitrosoureas ▪ Carmustine ▪ Lomustine ▪ Streptozocin

Alkylating-Like Medications ▪ Altretamine ▪ Busulfan ▪ Carboplatin ▪ Cisplatin ▪ Dacarbazine ▪ Oxaliplatin ▪ Temozolomide ▪ Thiotepa

PRIORITY NURSING ACTIONS Anaphylactic Reaction Occurring from Medication 1. Assess respiratory status. 2. Stop the medication. 3. Contact the health care provider (HCP) and the Rapid

Response Team if necessary. 4. Administer oxygen. 5. Maintain the intravenous (IV) access with normal saline. 6. Raise the client’s feet and legs, if not contraindicated. 7. Administer prescribed emergency medications, such as

epinephrine. 8. Monitor vital signs. 9. Document the event, actions taken, and the client’s response.

If anaphylaxis occurs, the nurse immediately assesses the client’s respiratory status. The medication is also immediately stopped. If the client’s airway needs to be established or

stabilized, the Rapid Response Team is called. In addition, the HCP is contacted. The IV line is not removed because IV access is needed to administer emergency medications such as diphenhydramine or epinephrine. The client is positioned appropriately. The legs and feet are elevated. The head of the bed is elevated to improve ventilation; elevate the head of the bed 10 degrees if hypotension is present and 45 degrees or higher if the blood pressure is normal. The nurse stays with the client and monitors the client’s status, including the vital signs. The nurse documents the event, actions taken, and the client’s response.

Reference Ignatavicius, Workman (2016), p. 353.

616 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

8. Cycloph osph am ide m ay cause alopecia, gon adal suppression , h em orrh agic cystitis, an d h em aturia.

9. Ifosam ide m ay cau se n eurotoxicity. C. In terven tion s: Refer to Section I, C (An tin eop lastic

Med ication s—Gen eral In terven tion s). 1. Assess results of pulm o n ary fun ction tests. 2. Assess results of ch est radiograph y an d ren al an d

liver fun ction studies. 3. Wh en adm in isterin g cisplatin , assess th e clien t

for dizzin ess, tin n itus, h earin g loss, in coord in a- tio n , an d n um bn ess or tin glin g of extrem ities.

4. Mesna m ay be adm inistered with ifosfam ide to reduce th e potential for ifosfam ide-induced cystitis.

5. In struct th e clien t th at cyclop h osph am ide, wh en prescribed orally, is ad m in istered with ou t food.

6. In struct th e clien t to follow a diet low in purin es to alkalin ize th e urin e an d lower uric acid blood levels.

7. In struct th e clien t about h ow to avoid in fectio n . 8. In struct th e clien t to report sign s of in fectio n or

bleedin g. 9. In struct th e clien t about good oral h ygien e an d

th e use of a soft tooth brush .

Cyclophosphamide and ifosfamide are medications that can cause hemorrhagic cystitis. Encourage the client to drink increased fluids (2 to 3 L/ day) during therapy, unless contraindicated.

III. Antitumor Antibiotic Medications (Box 49-2) A. Description

1. In terfere with DNA an d RNA syn th esis 2. Cell cycle ph ase–n on sp ecific m edication s

B. Sid e an d ad verse effects 1. Nausea an d vo m itin g 2. Fever 3. Bon e m arro w depression 4. Rash 5. Alo pecia 6. Stom atitis 7. Gon adal suppressio n 8. Hyperuricem ia 9. Vesication (blisterin g of tissue at IV site) 10. Daun orubicin m ay cau se h eart failure an d

dysrh yth m ias. 11. Doxorubicin an d idarubicin m ay cause cardiotoxi-

city, cardiom yopath y, an d electrocardiograph ic chan ges (dexrazoxane, which is a cardioprotective

agen t, m ay be adm in istered with doxorubicin to reduce cardiom yopathy).

12. Pulm o n ary toxicity can occur with bleom ycin . C. In terven tion s: Refer to Section I, C (An tin eop lastic

Med ication s—Gen eral In terven tion s). 1. Assess results of pulm on ary fun ctio n tests. 2. Mon itor for electrocardiograph ic ch an ges. 3. Assess lun g soun ds for crackles. 4. Assess for sign s of h eart failure, in cludin g dyspn ea,

crackles, peripheral edem a, an d weigh t gain . 5. Assess results of ch est radiograph y an d ren al an d

liver fun ction studies. 6. Assess for m yocardial toxicity, dyspn ea, dys-

rh yth m ias, h ypo ten sion , an d weigh t gain wh en adm in isterin g doxorubicin or idarub icin .

7. Mon itor pulm o n ary status wh en adm in isterin g bleom ycin .

IV. Antimetabolite Medications (Box 49-3) A. Description

1. An tim etabolite m edication s h alt th e syn th esis of cell protein ; th eir presen ce im pairs cell division .

2. An tim etabolite m edication s are cell cycle ph ase– specific an d affect th e S ph ase.

B. Side an d adverse effects 1. An o rexia, n ausea, an d vom itin g 2. Diarrh ea 3. Alo pecia 4. Stom atitis 5. Depression of bon e m arro w 6. Cytarabin e m ay cause alop ecia, stom atitis,

h yperuricem ia, an d h epatotoxicity. 7. Flu orouracil m ay cau se alop ecia, stom atitis, diar-

rh ea, ph ototo xicity reaction s, an d cerebellar dysfun ction .

8. Mercaptopurin e m ay cause h yperuricem ia an d h epatotoxicity.

9. Meth otrexate m ay cau se alopecia; stom atitis; h yperuricem ia; ph otosen sitivity; h epatotoxicity; an d h em atological, gastro in testin al, an d skin toxicity.

BOX 49-2 Antitumor Antibiotic Medications

▪ Bleomycin sulfate ▪ Dactinomycin ▪ Daunorubicin ▪ Doxorubicin ▪ Epirubicin

▪ Idarubicin ▪ Mitomycin ▪ Mitoxantrone ▪ Valrubicin

BOX 49-3 Antimetabolite Medications

▪ Azacitidine ▪ Capecitabine ▪ Cladribine ▪ Clofarabine ▪ Cytarabine ▪ Decitabine ▪ Floxuridine ▪ Fludarabine ▪ Fluorouracil ▪ Gemcitabine

▪ Hydroxyurea ▪ Mercaptopurine ▪ Methotrexate ▪ Nelarabine ▪ Pemetrexed ▪ Pentostatin ▪ Pralatrexate ▪ Thioguanine ▪ Uracil

617CHAPTER 49 Hematological and Oncological Medications

C. In terven tion s: Refer to Section I, C (An tin eop lastic Med ication s—Gen eral In terven tion s). 1. Mon itor ren al fun ction studies. 2. Mon itor for cerebellar dysfun ction . 3. Assess for ph otosen sitivity. 4. Wh en adm in isterin g flu orouracil, assess for

sign s of cerebellar dysfun ction , such as dizzin ess, weakn ess, an d ataxia, an d assess for stom atitis an d diarrh ea, wh ich m ay n ecessitate m ed ication discon tin u ation .

5. Wh en adm in isterin g fluorouracil or m eth otrexate, in struct th e clien t to use sunscreen an d wear protec- tive cloth in g to preven t ph otosen sitivity reaction s.

When administering methotrexate in large doses, prepare to administer leucovorin as prescribed to pre- vent toxicity. This is known as leucovorin rescue.

V. Mitotic Inhibitor Medications (Vinca Alkaloids) (Box 49-4)

A. Description 1. Mitotic in h ib itors preven t m itosis, causin g cell

death . 2. Mitotic in h ib itors are cell cycle ph ase–specific

an d act on th e M ph ase. B. Side an d ad verse effects

1. Leu kopen ia 2. Neurotoxicity with vin cristin e, m an ifested as

n um bn ess an d tin glin g in th e fin gers an d toes, con stipatio n , an d paralytic ileus

3. Ptosis 4. Ho arsen ess 5. Moto r in stability 6. An o rexia, n ausea, an d vom itin g 7. Periph eral n europath y 8. Alo pecia 9. Stom atitis 10. Hyperuricem ia 11. Ph lebitis at IV site

C. In terven tion s: Refer to Section I, C (An tin eop lastic Med ication s—Gen eral In terven tion s). 1. Mon itor for h oarsen ess. 2. Assess eyes for ptosis. 3. Assess m otor stability an d in itiate safety precau-

tio n s as n ecessary. 4. Mon itor for n eurotoxicity with vin cristin e, m an -

ifested as n um bn ess an d tin glin g in th e fin gers an d toes.

5. Mon itor for con stipation an d paralytic ileus.

VI. Topoisomerase Inhibitors (Box 49-5) A. Description

1. Block an en zym e n eeded for DNA syn th esis an d cell division

2. Cell cycle ph ase–specific; act on th e G2 an d S ph ases

B. Side an d adverse effects 1. Leuko pen ia, th rom bocytop en ia, an d an em ia 2. An o rexia, n ausea, an d vo m itin g 3. Diarrh ea 4. Alopecia 5. O rth ostatic h ypo ten sion 6. Hypersen sitivity reaction

C. In terven tion s: Refer to Section I, C (An tin eoplastic Medication s—Gen eral In terven tion s).

VII. Hormonal Medications and Enzymes (Box 49-6) A. Description

1. Supp ress th e im m un e system an d block n orm al h orm on es in h orm on e-sen sitive tum o rs

2. Ch an ge th e h orm on al balan ce an d slow th e growth rates of certain tum o rs

B. Side an d adverse effects 1. An o rexia, n ausea, an d vo m itin g 2. Leuko pen ia 3. Im p aired pan creatic fun ction with asparagin ase 4. Sex ch aracteristic alteration s

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

BOX 49-4 Mitotic Inhibitors

Vinca Alkaloids ▪ Vinblastine sulfate ▪ Vincristine sulfate ▪ Vinorelbine

Ta xanes ▪ Docetaxel ▪ Paclitaxel

BOX 49-5 Topoisomerase Inhibitors

▪ Etoposide ▪ Irinotecan

▪ Teniposide ▪ Topotecan

BOX 49-6 Hormonal Medications and Enzymes

Estrogens ▪ Estramustine ▪ Ethinyl estradiol Antiestrogens ▪ Anastrozole ▪ Exemestane ▪ Fulvestrant ▪ Letrozole ▪ Raloxifene ▪ Tamoxifen citrate ▪ Toremifene Antiandrogens ▪ Bicalutamide ▪ Flutamide ▪ Goserelin acetate ▪ Histrelin ▪ Nilutamide ▪ Triptorelin

Progestins ▪ Medroxyprogesterone ▪ Megestrol acetate Other Hormonal Antagonists and Enzymes ▪ Asparaginase ▪ Leuprolide acetate ▪ Mitotane

618 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

a . Masculin izin g effect in wom en : Ch est an d facial h air, m en ses stops

b . Fem in in e m an ifestation s in m en : Gyn eco m astia

5. Breast swellin g 6. Ho t flash es 7. Weigh t gain 8. Hem orrh agic cystitis, h ypo uricem ia, an d h yper-

ch olesterolem ia, with m itotan e 9. Hyperten sion 10. Th rom boem bolic disorders 11. Edem a 12. Electrolyte im balan ces 13. Tam oxifen citrate m ay cau se edem a, h ypercalce-

m ia, an d elevated ch olesterol an d triglycerid e levels.

14. Tam oxifen citrate decreases th e effects of estrogen . C. In terven tion s: Refer to Section I, C (An tin eop lastic

Med ication s—Gen eral In terven tion s). 1. Assess m edication s th at the clien t is takin g curren tly. 2. Mon itor serum calcium levels with an drogen s. 3. Mon itor for sign s of alteration s in sexual

ch aracteristics. 4. Mon itor pan creatic fun ctio n with asparagin ase. 5. Mon itor uric acid an d ch olestero l levels. 6. Mon itor for sign s of h em orrh agic cystitis.

VIII. Immunomodulator Agents: Biological Response Modifiers (Box 49-7)

A. Description 1. Im m un om o dulators stim ulate th e im m un e sys-

tem to recogn ize can cer cells an d take action to elim in ate or destroy th em .

2. In terleukin s h elp various im m un e system cells to recogn ize an d destroy abn o rm al body cells.

3. In terferon s slow tum o r cell division , stim ulate proliferatio n , an d cause can cer cells to differen ti- ate in to n on pro liferative form s.

B. Colon y-stim ulatin g factors in duce m ore rapid bon e m arro w recovery after supp ression by ch em oth erapy ( Box 49-8).

IX. Targeted Therapy A. Description

1. Med ication s used as targeted th erap ies are m on o- clo n al an tibod ies an d sm all m olecule in h ibitors th at target a cellular elem en t of th e can cer cell or an tisen se m edication s th at work at th e gen e level.

2. Exam ples of m on oclon al an tibod ies are rituxi- m ab, trastuzu m ab, alem tuzum ab, bevacizum ab, an d cetuxim ab.

B. Adverse effects: Allergic reactio n s (m on oclon al an tibod ies)

X. Other Antineoplastic Medications A. Altretam in e: Cytotoxic agen t used to treat

ovarian can cer B. Den ileukin diftitox: Recom bin an t DNA-derived

m ed ication used to treat cutan eous T-cell lymphoma C. Pegaspargase: Used in com bin ation ch em oth erapies

for acute lym ph o blastic leukemia in clien ts un ab le to take asparagin ase

D. Bexaroten e: Used to treat advan ced -stage cutan eous T-cell lym ph o m a

CRITICAL THINKING What Should You Do? Answer: For the client receiving an antineoplastic medica- tion, the nurse should withhold the medication if the neutro- phil count is less than 18% conventional units (0.18 SI units). The health care provider is notified for further prescriptions and neutropenic precautions are initiated to protect the cli- ent from infection.

References: Burchum, Rosenthal (2016), p. 1214; Lilley et al. (2014), pp. 740 , 745.

BOX 49-7 Immunomodulator Agents

▪ Aldesleukin ▪ Interferon alfa-2a ▪ Interferon alfa-2b ▪ Interferon alfa-n3 ▪ Recombinant interferon

alfa-2a ▪ Recombinant interferon

alfa-2b

Common Monoclonal Antibodies ▪ Bevacizumab ▪ Cetuximab ▪ Ibritumomab ▪ Infliximab ▪ Panitumumab ▪ Rituximab ▪ Trastuzumab

Small Molecule Inhibitors ▪ Bortezomib ▪ Dasatinib ▪ Erlotinib ▪ Gefitinib ▪ Imatinib ▪ Lapatinib ▪ Nilotinib ▪ Sorafenib ▪ Sunitinib ▪ Temsirolimus

BOX 49-8 Colony-Stimulating Factors

Granulocyte-Macrophage Colony-Stimulating Factor ▪ Sargramostim Granulocyte Colony-Stimulating Factor ▪ Filgrastim ▪ Pegfilgrastim Erythropoietin ▪ Epoetin alfa ▪ Darbepoetin alfa Thrombopoietic Growth Factor ▪ Oprelvekin

619CHAPTER 49 Hematological and Oncological Medications

P R A C T I C E Q U E S T I O N S 530. Ch em oth erapy dosage is frequen tly based on total

body surface area (BSA) , so it is im portan t for th e n urse to perform wh ich assessm en t befo re adm in - isterin g ch em oth erapy? 1. Measu re th e clien t’s abdom in al girth . 2. Calculate th e clien t’s body m ass in dex. 3. Measure th e clien t’s curren t weigh t an d h eigh t. 4. Ask th e client about h is or h er weigh t an d h eigh t.

531. A clien t with squam ous cell carcin o m a of th e lar- yn x is receivin g bleom ycin in traven ously. Th e n urse carin g for th e clien t an ticipates th at wh ich diagn ostic study will be prescribed? 1. Ech ocardiograph y 2. Electrocardiograph y 3. Cervical radiograph y 4. Pulm o n ary fun ction studies

532. A clien t with acu te m yelocytic leukem ia is bein g treated with busulfan . Wh ich labo ratory value would th e n urse specifically m on itor durin g treat- m en t with th is m edication ? 1. Clo ttin g tim e 2. Uric acid level 3. Potassiu m level 4. Bloo d gluco se level

533. A clien t with sm all cell lun g can cer is bein g treated with etoposide. Th e n urse m on itors th e clien t durin g adm in istration , kn owin g that wh ich adverse effect is specifically associated with th is m edication ? 1. Alo pecia 2. Ch est pain 3. Pulm o n ary fibrosis 4. O rth ostatic h ypoten sion

534. A clin ic n urse prepares a teach in g plan for a clien t receivin g an an tin eop lastic m ed ication . Wh en im plem en tin g th e plan , th e n urse sh ould m ake wh ich statem en t to th e clien t? 1. “You can take aspirin as n eeded for h eadach e.” 2. “You can drin k beverages con tain in g alcoh ol in

m oderate am oun ts each even in g.” 3. “You n eed to con sult with th e h ealth care pro-

vider (HCP) befo re receivin g im m un ization s.” 4. “It is fin e to receive a flu vaccin e at th e local

h ealth fair with ou t HCP approval because th e flu is so co n tagious.”

535. A clien t with ovarian can cer is bein g treated with vin cristin e. Th e n urse m on itors th e clien t, kn owin g th at wh ich m an ifestation in dicates an adverse effect specific to th is m ed ication ? 1. Diarrh ea 2. Hair loss

3. Ch est pain 4. Periph eral n europath y

536. Th e n urse is reviewin g th e h isto ry an d ph ysical exam in ation of a clien t wh o will be receivin g aspar- agin ase, an an tin eop lastic agen t. Th e n urse con tacts th e h ealth care provider before adm in is- terin g th e m ed ication if wh ich disorder is docu- m en ted in th e clien t’s h isto ry? 1. Pan creatitis 2. Diabetes m ellitus 3. Myocardial in farction 4. Ch ron ic obstructive pulm o n ary disease

537. Tam oxifen citrate is prescribed for a clien t with m et- astatic breast carcin om a. Th e clien t asks th e n urse if h er fam ily m em ber with bladder cancer can also take th is m edication . Th e n urse m o st ap p ro p riately respon ds by m akin g wh ich statem en t? 1. “Th is m edication can be used on ly to treat

breast can cer.” 2. “Yes, your fam ily m em ber can take th is m edica-

tio n for bladder can cer as well.” 3. “Th is m edication can be taken to preven t an d

treat clien ts with breast can cer.” 4. “Th is m edication can be taken by an yon e with

can cer as lon g as th eir h ealth care provider approves it.”

538. A clien t with m etastatic breast can cer is receivin g tam oxifen . Th e n urse specifically m on itors wh ich labo ratory value wh ile th e clien t is takin g th is m ed ication ? 1. Glu cose level 2. Calcium level 3. Potassium level 4. Proth rom bin tim e

539. Megestrol acetate, an an tin eoplastic m edication , is prescribed for a clien t with m etastatic en dom etrial carcin om a. Th e n urse reviews th e clien t’s h istory an d sh o uld con tact th e h ealth care provider if wh ich diagn osis is docum en ted in th e clien t’s h isto ry? 1. Gout 2. Asth m a 3. Myocardial in farction 4. Ven ous th rom boem bo lism

540. Th e n urse is m on itorin g th e in traven o us (IV) in fu- sion of an an tin eoplastic m edication . Durin g th e in fusion , th e clien t com plain s of pain at th e in ser- tion site. O n in spection of th e site, th e n urse n otes redn ess an d swellin g an d th at th e in fusion of th e m edication h as slowed in rate. Th e n urse suspects extravasation an d sh o uld take wh ich action s? Select all th at ap p ly.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

620 UNIT IX Hematological and Oncological Disorders of the Adult Client

1. Stop th e in fusion . 2. Notify th e h ealth care provider (HCP). 3. Prepare to ap ply ice or h eat to th e site. 4. Restart th e IV at a distal part of th e sam e vein . 5. Prepare to adm in ister a prescribed an tidote

in to th e site. 6. In crease th e flo w rate of th e solution to flush

th e skin an d subcutan eous tissue.

541. Th e n urse is an alyzin g th e laborato ry results of a clien t with leukem ia wh o h as received a regim en of ch em oth erapy. Wh ich laborato ry value would th e n urse specifically n ote as a result of th e m assive cell destructio n th at occurred from th e ch em oth erapy? 1. An em ia 2. Decreased platelets 3. In creased uric acid level 4. Decreased leuko cyte coun t

542. Th e n urse is provid in g m edication in struction s to a clien t with breast can cer wh o is receivin g cyclo- ph osph am ide. Th e n urse sh o uld tell th e clien t to take wh ich action ? 1. Take th e m ed ication with food .

2. In crease fluid in take to 2000 to 3000 m L daily. 3. Decrease sodium in take wh ile takin g th e

m edication . 4. In crease potassium in take wh ile takin g th e

m ed ication .

543. A clien t with n on –Hodgkin ’s lym ph o m a is receiv- in g daun orubicin . Wh ich fin din g would in dicate to th e n urse th at th e clien t is experien cin g an ad verse effect related to th e m ed ication ? 1. Fever 2. Sores in th e m outh an d th roat 3. Com plain ts of n ausea an d vom itin g 4. Crackles on auscultation of th e lun gs

544. Th e n urse is m on itorin g th e laborato ry results of a clien t receivin g an an tin eoplastic m ed ication by th e in traven ous route. Th e n urse plan s to in itiate bleedin g precaution s if wh ich labo ratory result is n oted? 1. A clottin g tim e of 10 m in u tes 2. An am m on ia level of 10 m cg/ dL (6 m cm ol/ L) . 3. A platelet co un t of 50,000 m m 3 (50 Â 109/ L) 4. A wh ite blood cell coun t of 5000 m m 3

(5.0 Â 109/ L)

A N S W E R S 530. 3 Ra t ion a le: To en su re th at th e clien t receives o ptim al do ses o f ch em o th erapy, do sin g is usu ally b ased o n th e to tal BSA, wh ich req uires a curren t accurate h eigh t an d weigh t for BSA calcula- tion (b efo re each m ed ication adm in istratio n ) . Askin g th e clien t ab ou t h is or h er h eigh t an d weigh t m ay lead to in accu- racies in determ in in g a true BSA an d dosage. Calculatin g body m ass in dex an d m easu rin g ab do m in al girth will n ot p ro vide th e data n eeded . Test -Ta kin g Str a tegy: Recall th e b asis fo r d o sin g ch em oth er- ap y. Recallin g th at a cu rren t accu rate h eigh t an d weigh t n eed to be o btain ed fo r BSA calcu latio n an d ch em oth erap y do sin g will direct yo u to th e correct op tio n . Elim in ate op tion 4 because it is an u n reliable way o f ob tain in g th e in form atio n . Next, elim in ate o ption s 1 an d 2 b ecau se th ey are co m p arab le o r alike an d do n ot relate to ch em o th erap y do sin g. Review: Bo d y su rface area an d ch em o th erap y d osin g Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medicatio n s Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Burch u m , Rosen th al (2016), p. 26.

531. 4 Ra t ion a le: Bleom ycin is an an tin eoplastic m edication th at can cau se in terstitial pn eum on itis, wh ich can p ro gress to p ulm on ary fibro sis. Pulm o n ary fun ctio n stu dies alon g with h em ato lo gical, h ep atic, an d ren al fun ctio n tests n eed to be m on itored. Th e n urse

n eeds to m on itor lun g sou n d s for dyspn ea and crackles, wh ich in dicate p ulm on ary toxicity. The m edication n eeds to be d isco n- tin ued im m ed iately if p ulm o n ary toxicity occurs. O ption s 1, 2, an d 3 are un related to th e specific u se o f th is m edication . Test -Ta kin g St r a t egy: Elim in ate op tion s 1 an d 2 first b ecau se th ey are cardiac-related an d are th erefore co m p arab le o r alike. From th e rem ain in g o ptio n s, use th e ABCs—airway–b reath in g– circu latio n —to d irect you to th e correct o ption . Review: Bleo m ycin Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medication s Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ces: Burch um , Rosen th al (2016), p. 1232. Gah art, Nazaren o (2015), p. 1232.

532. 2 Ra t ion a le: Bu sulfan can cause an in crease in th e uric acid level. Hyp eru ricem ia can prod uce uric acid n ep h rop ath y, ren al sto n es, an d acu te kidn ey in jury. O p tio n s 1, 3, an d 4 are n o t sp e- cifically related to th is m ed ication . Test -Ta kin g Str a tegy: Focus o n th e su b ject, a specific lab ora- to ry valu e. It is n ecessary to kn ow th e ad verse effects asso ciated with th is m edication . Recallin g th at busulfan in creases th e uric acid level will d irect yo u to th e co rrect o p tion . Review: Ad verse effects o f b u su lfan Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

621CHAPTER 49 Hematological and Oncological Medications

Con ten t Ar ea : Ph arm aco logy—O n co logy Med ication s Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ces: Hod gson , Kizio r (2016), p. 176. Lilley et al. (2014), p . 739.

533. 4 Ra tion a le: An ad verse effect specific to eto po sid e is orth o static h yp oten sio n . Eto po sid e sh o u ld b e adm in istered slowly over 30 to 60 m in u tes to avoid h ypo ten sion . Th e clien t’s blo o d p res- su re is m o n ito red du rin g th e in fu sion . Hair loss occu rs with n early all an tin eo p lastic m ed ication s. Ch est pain an d pu lm o- n ary fibro sis are un related to th is m edicatio n . Test-Ta kin g Str a tegy: Elim in ate op tio n 1 first b ecau se th is ad verse effect is associated with m an y o f th e an tin eo plastic agen ts. Elim in ate o ption s 2 an d 3 n ext b ecau se th ey are co m - p arab le o r alike an d are u n related to etop o side. Note th at th e q uestion asks fo r th e adverse effect specific to th is m edication . Co rrelate h ypo ten sio n with eto po side. Review: Adverse effects o f eto p o sid e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—O n co logy Med ication s Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ces: Bu rch u m , Ro sen th al (2016) p . 1235. Gah art, Nazaren o (2015), p. 513.

534. 3 Ra tion a le: Because an tineoplastic m edication s lower the resis- tan ce of th e b ody, clien ts m u st b e in form ed n ot to receive im m u- n izatio ns with o ut th e HCP’s app roval. Clien ts also n eed to avo id con tact with in divid uals wh o h ave recently received a live viru s vaccin e. Clien ts n eed to avo id asp irin and asp irin -con tain in g p ro du cts to m in im ize th e risk of bleed in g, an d th ey n eed to avo id alcoh o l to m in im ize th e risk o f toxicity an d side/ adverse effects. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, clien t teach in g ab ou t an an tin eo plastic m edicatio n , an d th in k ab ou t th e sid e/ ad verse effects of an tin eo plastic m ed ication s. Recallin g th at an tin eo plastic m ed icatio n s lo wer th e resistan ce o f th e b od y will d irect you to th e correct op tio n . Review: Clien t teach in g p o in ts regard in g an tin eo p lastic m ed icatio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—O n co logy Med ication s Pr ior it y Con cept s: Cellular Regu lation ; Clien t Edu catio n Refer en ces: Bu rch u m , Ro sen th al (2016) p . 817. Lilley et al. (2014), p . 743.

535. 4 Ra tion a le: An adverse effect specific to vin cristin e is perip h eral n europ ath y, wh ich occurs in alm o st every clien t. Perip h eral n europ ath y can b e m an ifested as n u m b n ess an d tin glin g in th e fin gers an d to es. Dep ression o f th e Ach illes ten d on reflex m ay b e th e first clin ical sign in d icatin g perip h eral n europ ath y. Co n stip atio n rath er th an diarrh ea is m ost likely to occu r with th is m ed icatio n , alth o ugh diarrh ea m ay occu r o ccasion ally. Hair lo ss o ccurs with n early all an tin eo p lastic m ed ication s. Ch est p ain is u n related to th is m edicatio n .

Test-Ta kin g Str a tegy: Elim in ate o ptio n s 1 an d 2 first b ecause th ey are co m p arab le o r alike an d are side/ adverse effects asso - ciated with m an y of th e an tin eo p lastic agen ts. No te th at th e q uestio n asks fo r th e adverse effect specific to th is m ed ication . Co rrelate p eriph eral n europ ath y with vin cristin e. Review: Sid e/ ad verse effects o f vin cristin e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—O n colo gy Med icatio n s Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1233.

536. 1 Ra tion a le: Asp aragin ase is con train d icated if h yp ersen sitivity exists, in p an creatitis, o r if th e clien t h as a h istory of pan crea- titis. Th e m edicatio n im pairs p an creatic fun ction an d pan cre- atic fu n ction tests sh o u ld be p erfo rm ed b efo re th erap y b egin s an d wh en a week o r m o re h as elap sed b etween d ose adm in istratio n s. Th e clien t n eeds to be m on itored fo r sign s o f pan creatitis, wh ich in clu d e n au sea, vo m itin g, an d ab do m i- n al p ain . Th e con dition s n oted in op tio n s 2, 3, an d 4 are n o t con train d icated with th is m edicatio n . Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, a co n train d ication o f asp aragin ase. It is n ecessary to kn ow th e co n train dicatio n s asso ciated with th is m edicatio n . Recallin g th at th is m edicatio n affects p an creatic fun ctio n will d irect yo u to th e correct o ptio n . Review: Asp aragin ase Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—O n colo gy Med icatio n s Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1235.

537. 3 Ra tion a le: Tam oxifen is an an tin eoplastic m edication th at com petes with estrad iol fo r bin d in g to estrogen in tissues con - tain in g h igh con cen tratio n s o f recep tors. Tam oxifen is used to treat m etastatic breast carcin o m a in wo m en an d m en . Tam o x- ifen is also effective in d elayin g th e recu rren ce of can cer follow- in g m astectom y an d for preven tin g breast can cer in th ose th at are at h igh risk. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ately. Recallin g th at th is m edicatio n is used for breast can cer will assist you in elim in atin g o ption s 2 an d 4. Note th e clo sed -en d ed wo rd only in o p tion 1 to assist yo u in elim in atin g th is op tion . Also , recall th at th is m ed ication is u sed for bo th p reven tion an d treatm en t o f b reast can cer. Review: Tam o xifen Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acolo gy—O n colo gy Med icatio n s Pr ior it y Con cept s: Cellular Regulation ; Clin ical Jud gm en t Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1239.

538. 2 Ra tion a le: Tam oxifen m ay in crease calcium , ch olesterol, an d triglycerid e levels. Before th e in itiatio n of th erap y, a com p lete

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

622 UNIT IX Hematological and Oncological Disorders of the Adult Client

blo od cou n t, p latelet co u n t, an d serum calcium level sh o uld b e assessed. Th ese b lo od levels, alo n g with ch o lesterol an d triglyc- erid e levels, sh ou ld b e m o n ito red p eriod ically d u rin g th erap y. Th e n urse sh ou ld assess fo r h ypercalcem ia wh ile th e clien t is takin g th is m edicatio n . Sign s of h yp ercalcem ia in clu de in creased urin e volum e, excessive th irst, n ausea, vom itin g, co n stip ation , h yp oto n icity o f m u scles, an d d eep b on e an d flan k p ain . Test -Ta kin g St r a t egy: Focu s o n th e su b ject, th e labo rato ry valu e to m on itor fo r tam o xifen . Th in k abo ut th e actio n o f th is m ed ication . Recallin g th at th is m ed icatio n causes h yp ercalce- m ia will d irect you to th e correct op tio n . Review: Tam o xifen Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medicatio n s Pr ior ity Con cept s: Cellular Regu latio n ; Flu id an d Electrolyte Balan ce Refer en ce: Ho dgso n , Kizior (2016), p p. 1168-1170.

539. 4 Ra t ion a le: Megestro l acetate su p presses th e release o f lu tein iz- in g h o rm o n e fro m th e an terio r pituitary b y in h ibitin g p itu itary fu n ctio n an d regressin g tum o r size. Megestrol is used with cau - tion if th e clien t h as a h istory o f ven ou s th ro m bo em bo lism . O p tion s 1, 2, an d 3 are n o t co n train dicatio n s for th is m ed ication . Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, a co n train dicatio n to m egestro l acetate. It is n ecessary to kn o w th e adverse effects asso ciated with th is m edicatio n . Recallin g th at m egestro l ace- tate is a h o rm o n al an tagon ist en zym e an d th at an ad verse effect is th rom b otic d isord ers will direct you to th e correct op tio n . Review: Megestro l acetate Level of Cogn it ive Ability: An alyzin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medicatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Ho dgso n , Kizior (2016), p p. 758-759.

540. 1, 2, 3, 5 Ra t ion a le: Redn ess an d swellin g an d a slowed in fusion in di- cate sign s of extravasatio n . If th e n u rse susp ects extravasation du rin g th e IV ad m in istration o f an an tin eop lastic m ed icatio n , th e in fu sion is sto p ped an d th e HCP is n otified. Ice o r h eat m ay be p rescrib ed for ap plicatio n to th e site an d an an tid ote m ay b e prescrib ed to b e ad m in istered in to th e site. In creasin g th e flo w rate can in crease dam age to th e tissues. Restartin g an IV in th e sam e vein can in crease d am age to th e site an d vein . Test -Ta kin g St r a t egy: Fo cu s on th e assessm en t sign s in th e qu estio n an d th e words suspects extravasation. Visu alize th e sit- uatio n to iden tify th e n u rsin g action s. Th in k abo ut th e action s th at will cause furth er dam age. Note th at o ptio n s 4 an d 6 are co m p arab le o r alike an d can cause furth er dam age. Review: Nu rsin g actio n s to take if extravasatio n occu rs Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medicatio n s

Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p p. 188, 205

541. 3 Ra t ion a le: Hyperu ricem ia is esp ecially com m on fo llo win g treatm en t for leukem ias an d lym ph om as b ecause ch em o th er- ap y results in m assive cell kill. Alth o ugh op tion s 1, 2, an d 4 also m ay b e n o ted, an in creased u ric acid level is related sp ecif- ically to cell d estru ction . Test -Ta kin g St r a t egy: Focus on th e su b ject, th e lab o ratory valu e th at reflects m assive cell d estru ctio n . Rem em ber th at u ric acid is released wh en cells are destro yed. Th is will d irect you to th e co rrect o p tion . Review: Th e effects of ch em o th erap y Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medication s Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ce: Bu rch u m , Rosen th al (2016), pp . 1216, 1308.

542. 2 Ra t ion a le: Hem o rrh agic cystitis is an ad verse effect th at can o ccu r with th e u se of cyclop h o sph am id e. Th e clien t n eed s to b e in stru cted to d rin k co pio u s am ou n ts of flu id d u rin g th e ad m in istration o f th is m ed ication . Clien ts also sh o uld m on itor u rin e ou tpu t fo r h em aturia. Th e m edicatio n sh ou ld be taken o n an em p ty sto m ach , u n less gastroin testin al up set o ccu rs. Hyp erkalem ia can result fro m th e u se o f th e m edicatio n ; th erefo re, th e clien t wou ld n ot be told to in crease p o tassium in take. Th e clien t wo uld n o t be in stru cted to alter so d ium in take. Test -Ta kin g Str a tegy: Focus o n th e su b ject, clien t teach in g ab ou t cyclo ph o sp h am ide. Recallin g th at cyclo ph o sp h am ide can cau se h em orrh agic cystitis will direct yo u to th e correct o p tion . Review: Ad verse effects asso ciated with cyclo p h o sp h am id e Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—O n co lo gy Medication s Pr ior ity Con cepts: Cellu lar Regu latio n ; Clien t Ed ucation Refer en ce: Bu rch u m , Rosen th al (2016), p. 1225.

543. 4 Ra t ion a le: Cardiotoxicity n oted by abn orm al electrocardio- graph ic fin din gs o r cardio m yop ath y m an ifested as h eart failure (lu n g crackles) is an adverse effect o f dau n o ru bicin . Bo n e m ar- row d ep ressio n is also an adverse effect. Fever is a frequ en t side effect an d so res in th e m ou th an d th ro at can o ccu r occasion - ally. Nausea an d vo m itin g is a freq uen t sid e effect asso ciated with th e m edication th at begin s a few h ours after adm in istra- tion an d lasts 24 to 48 h ou rs. O ption s 1, 2, an d 3 are n ot ad verse effects. Test -Ta kin g Str a tegy: Keep in m in d th at th e qu estio n is askin g ab ou t an ad verse effect. Use o f th e ABCs—airway, b reath in g, an d circu latio n —will d irect you to th e co rrect op tio n . Review: Ad verse effects o f d au n o ru b icin Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

623CHAPTER 49 Hematological and Oncological Medications

In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm aco logy—O n co logy Med ication s Pr ior it y Con cept s: Cellular Regu lation ; Clin ical Jud gm en t Refer en ces: Bu rch u m , Ro sen th al (2016), p. 1231. Hod gso n , Kizio r. (2016) , p p . 333, 335-336.

544. 3 Ra tion a le: Bleedin g p recaution s n eed to b e in itiated wh en th e p latelet cou n t d ecreases. Th e n orm al p latelet coun t is 150,000 to 450,000 m m 3 (150–400 Â 109/ L). Wh en the p latelet coun t d ecreases, th e clien t is at risk for b leedin g. Th e n orm al white b lood cell coun t is 5000 to 10,000 m m 3 (5.0–10.0Â109/ L). Wh en th e wh ite b lood cell cou n t d rops, n eu tropen ic p recau - tio n s n eed to b e im p lem en ted. Th e n orm al clottin g tim e is 8 to 15 m in u tes. The n orm al am m o n ia value is 10 to 80 m cg/ dL (6-47 m cm o l/ L).

Test-Ta kin g Str a tegy: Use kn o wled ge regardin g n o rm al lab o- ratory values. O ption s 1, 2, an d 4 are co m p arab le o r alike an d id en tify n orm al labo rato ry valu es. Rem em b er to co rrelate a lo w platelet co un t with th e n eed for bleedin g p recautio n s an d a lo w wh ite b lo od cell co un t with th e n eed for n eutrop en ic p recautio n s. Review: In d ication s to im p lem en t b leed in g p recau tio n s Level of Cogn itive Ability: Syn th esizin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Fu n dam en tals o f Care—Safety Pr ior it y Con cept s: Cellular Regulation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 1214-1215.

A

d

u

l

t

O

n

c

o

l

o

g

i

c

a

l

624 UNIT IX Hematological and Oncological Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

eUNIT X

Endocrine Disorders of the Adult Client

Pyramid to Success

Th e en docrin e system is m ade up of organ s or glan ds th at secrete h orm on es an d release th em directly in to th e circulation . Th e en docrin e system can be un dersto od easily if you rem em ber th at basically 1 of 2 situation s can occur—h ypersecretion or h ypo secretio n of h orm on es from th e organ or glan d. Wh en an excess of th e h orm on e occurs, treatm en t is aim ed at blockin g th e h orm on e release th rou gh m ed ication or surgery. Wh en a deficit of th e h orm on e exists, treatm en t is aim ed at replacem en t th erap y. Pyram id Poin ts focus on diabetes m ellitus, in cludin g its preven tion , th e preven tion an d treatm en t of com plication s, in sulin th erapy, h ypo glycem ic an d h yperglycem ic reactio n s, an d diab etic ketoacid osis; Addiso n ’s disease an d ad dison ian crisis; Cush in g’s dis- ease or Cush in g’s syn d rom e; th yroid disorders an d th y- roid storm ; an d care of th e clien t after th yroidectom y or adren alectom y.

Client Needs: Learning Objectives Safe and Effective Care Environment Actin g as a clien t advo cate Collab oratin g with th e in terp ro fession al team an d

appropriate care providers regardin g treatm en t En surin g th at in form ed con sen t for treatm en ts an d pro-

cedu res h as been obtain ed Establish in g priorities of care Han dlin g h azardous an d in fectious m aterials Main tain in g con fiden tiality related to th e disorder Preven tin g acciden ts an d clien t in jury Usin g m ed ical an d su rgical asep sis to p reven t

in fectio n

Health Promotion and Maintenance Discussin g exp ected body im age ch an ges Iden tifyin g lifestyle ch oices related to treatm en t Perform in g ph ysical assessm en t of th e en docrin e system Preven tin g disease Providin g h ealth screen in g Teach in g about self-care m easu res

Psychosocial Integrity Discussin g grief an d loss issues related to com plication s

of th e disorder Discussin g situation al role ch an ges related to th e

disorder Discussin g un exp ected body im age ch an ges Iden tifyin g copin g m ech an ism s Mon itorin g for sen sory an d perceptual alteration s as a

result of th e disorder Usin g supp ort system s

Physiological Integrity Mon itorin g for alteration s in body system s as a result of

th e disorder Mon itorin g for com plication s from surgical procedures

an d h ealth alteration s Mon itorin g for com plication s of diagn ostic tests, treat-

m en ts, an d proced ures Mon itorin g for exp ected outcom es an d effects of ph ar-

m acological th erap y Mon itorin g for fluid an d electrolyte im balan ces th at

can occur Mon itorin g for un expected respon se to th erapies Mon itorin g laborato ry values Preparin g th e clien t for diagn ostic tests Providin g em ergen cy care to th e clien t Providin g n on ph arm aco logical co m fort in terven tion s Providin g n utrition an d oral h ydration m easu res

625

A

d

u

l

t

E

n

d

o

c

r

i

n

e

C H A P T E R 50 Endocrine System

PRIORITY CONCEPTS Glucose Regulation; Hormonal Regulation

CRITICAL THINKING What Should You Do? The nurse suspects that a client with pheochromocytoma is developing hypertensive crisis. What should the nurse do? Answer located on p. 644.

I. Anatomy and Physiology of Endocrine Glands (Box 50-1)

A. Fun ction s 1. Main ten an ce an d regulation of vital fun ction s 2. Respon se to stress an d in ju ry 3. Growth an d developm en t 4. En ergy m etab olism 5. Reprod uction 6. Fluid, electrolyte, an d acid-b ase balan ce

B. Risk facto rs for en docrin e disorders ( Box 50-2) C. Hypo th alam us (Box 50-3)

1. Portion of th e dien ceph alon of th e brain , form - in g th e floor an d part of th e lateral wall of th e th ird ven tricle

2. Activates, con trols, an d in tegrates th e periph eral auton om ic n ervou s system , en docrin e processes, an d m an y som atic fun ction s, such as body tem - perature, sleep, an d appetite

D. Pituitary glan d (Box 50-4; Fig. 50-1) 1. Th e m aster glan d; located at th e base of th e brain 2. Influen ced by th e h ypoth alam us; directly affects

th e fun ction of th e oth er endocrin e glan ds 3. Prom o tes growth of body tissue, in fluen ces water

absorption by th e kidn ey, an d con tro ls sexual develo pm en t an d fun ctio n

E. Adren al glan d 1. O n e adren al glan d is on top of each kidn ey. 2. Regulates sodium an d electrolyte balan ce; affects

carboh ydrate, fat, an d protein m etabolism ; in flu- ences the developm en t of sexual ch aracteristics; an d sustain s th e figh t-or-fligh t respon se

3. Adren al co rtex a . Th e cortex is th e outer sh ell of th e ad ren al

glan d . b . Th e cortex syn th esizes glucocorticoids an d

m in eralocorticoids an d secretes sm all am oun ts of sex h orm on es (an drogen s, estro- gen s; Box 50-5)

4. Adren al m ed ulla a . Th e m edulla is th e in n er core of th e ad ren al

glan d . b . Th e m ed ulla works as part of th e sym path etic

n ervou s system an d produces epin eph rin e an d n orepin eph rin e.

F. Th yroid glan d 1. Located in th e an terior part of th e n eck 2. Con trols th e rate of body m etab olism an d

growth an d produ ces th yroxin e (T4), triiodoth y- ro n in e (T3), an d th yrocalciton in

G. Parath yroid glan d s 1. Located on th e th yroid glan d 2. Con trols calcium an d ph o sph orus m etab olism ;

produces parath yroid h orm on e H. Pan creas

1. Located posteriorly to th e stom ach 2. In fluen ces carboh ydrate m etab olism , in directly

in fluen ces fat an d protein m etabolism , an d pro- duces in sulin an d glucagon

I. O varies an d testes 1. Th e ovaries are located in th e pelvic cavity an d

produce estrogen an d progesteron e. 2. Th e testes are located in th e scrotum , con tro l th e

developm en t of th e secon dary sex ch aracteristics, an d produ ce testo steron e.

J. Negative-feed back loop 1. Regulates h orm on e secretio n by th e h ypoth ala-

m us an d pituitary glan d 2. In creased am oun ts of target glan d h orm on es

in th e blood stream decrease secretio n of th e sam e h orm on e an d oth er h orm on es th at stim u- late its release.

626

A

d

u

l

t

E

n

d

o

c

r

i

n

e

II. Diagnostic Tests A. Stim ulation an d suppressio n tests

1. Stim ulation tests a . In th e clien t with suspected un d eractivity of

an en docrin e glan d , a stim ulus m ay be pro- vided to determ in e wh eth er th e glan d is cap a- ble of n orm al h orm on e production .

b . Measured am oun ts of selected h orm on es or substan ces are adm in istered to stim ulate th e target glan d to produ ce its h orm on e.

c. Horm on e levels produ ced by th e target glan d are m easu red.

d . Failure of th e h orm on e level to in crease with stim ulation in dicates h ypo fun ctio n .

2. Supp ression tests a . Suppression tests are used wh en h orm on e

levels are h igh or in th e upper ran ge of n orm al.

b . Agen ts th at n orm ally in du ce a supp ressed respon se are adm in istered to determ in e wh eth er n orm al n egative feedback is in tact.

c. Failure of h orm on e produ ction to be sup- pressed durin g stan dard ized testin g in dicates h yperfun ction .

BOX 50-1 Endocrine Glands ▪ Adrenal ▪ Hypothalamus ▪ Ovaries ▪ Pancreas

▪ Parathyroid ▪ Pituitary ▪ Testes ▪ Thyroid

BOX 50-2 Risk Factors for Endocrine Disorders ▪ Age ▪ Heredity ▪ Congenital factors ▪ Trauma

▪ Environmental factors ▪ Consequence of other

disorders or surgery

BOX 50-3 Hypothalamus Hormones ▪ Corticotropin-releasing hormone (CRH) ▪ Gonadotropin-releasing hormone (GnRH) ▪ Growth hormone–inhibiting hormone (GHIH) ▪ Growth hormone–releasing hormone (GHRH) ▪ Melanocyte-inhibiting hormone (MIH) ▪ Prolactin-inhibiting hormone (PIH) ▪ Thyrotropin-releasing hormone (TRH)

Thyroid

Adre na l corte x

Ma mma ry gla nds

Bone

Ova ry

Oxyto c in

Adre no c o rtic o tro pic ho rmo ne (ACTH)

Gro wth ho rmo ne (GH)

Go nado tro pic ho rmo ne s

(FS H and LH)

Pro lac tin

Thyro id-s timulating ho rmo ne (TS H)

Antidiure tic ho rmo ne (ADH)

Mus cle s of ute rus

Kidne y tubule s

Ne urohypophys is (pos te rior pituita ry)

P ituita ry s ta lk

Optic ne rve

Optic chia s m

Ade nohypophys is (a nte rior pituita ry)

Te s tis

FIGURE 50-1 Pituitary hormones. FSH, Follicle-stimulating hormone; LH, luteinizing hormone.

BOX 50-4 Pituitary Gland Hormones Anterior Lobe Production ▪ Adrenocorticotropic hormone (ACTH) ▪ Follicle-stimulating hormone (FSH) ▪ Growth hormone (GH) ▪ Luteinizing hormone (LH) ▪ Melanocyte-stimulating hormone (MSH) ▪ Prolactin (PRL) ▪ Somatotropic growth-stimulating hormone ▪ Thyroid-stimulating hormone (TSH)

Posterior Lobe These hormones are produced by the hypothalamus, stored in the posterior lobe, and secreted into the blood when needed:

▪ Oxytocin ▪ Vasopressin, antidiuretic hormone (ADH)

627CHAPTER 50 Endocrine System

3. O vern igh t dexam eth ason e suppression test a. Used to distin guish between Cush in g’s syn -

drom e an d Cush in g’s disease. b . In Cush in g’s disease th e source of excess cor-

tisol is th e pituitary glan d rath er th an th e adren al co rtex or exogen ous corticosteroid adm in istration .

c. Dexam eth ason e, a poten t lon g-actin g corti- costero id given at bed tim e, sh ould suppress th e m orn in g cortisol in clien ts with out Cush - in g’s disease by supp ressin g adren ocortico- tropic h orm on e (ACTH) productio n ; in th e clien t with Cush in g’s disease, th is suppres- sion will n ot occur.

B. Radio active io din e uptake 1. Th is th yroid fun ction test m easures th e absorp-

tion of an iodin e isotop e to determ in e h ow th e th yroid glan d is fun ction in g.

2. A sm all dose of radioactive iodin e is given by m ou th or in traven o usly; th e am oun t of radioac- tivity is m easu red in 2 to 4 h ours an d again at 24 h ours.

3. Norm al values are 3% to 10% at 2 to 4 h ours, an d 5% to 30% in 24 h ours.

4. Elevated values in dicate hyperthyroidism, de- creased io din e in take, or in creased io din e excretion .

5. Decreased values in dicate a low T4 level, th e use of an tith yroid m edication s, th yroiditis, m yx- edem a, or hypothyroidism.

6. Th e test is con train d icated in pregn an cy. C. T3 an d T4 resin uptake test

1. Bloo d tests are used to diagn ose th yroid disorders.

2. T3 an d T4 regulate th yroid-stim u latin g h orm on e. 3. Norm al values (n orm al fin din gs vary between

labo ratory settin gs) a. Triiodo th yron in e, total T3: 70–205 n g/ dL

(1.2–3.4 n m ol/ L) b . Th yroxin e, total T4: 5–12 m cg/ dL (64–154

n m ol/ L) c. Th yroxin e, free (FT4): 0.8–2.8 n g/ dL (10–36

pm ol/ L)

4. Th e T4 level is elevated in h yperth yroidism an d decreased in h ypoth yroidism .

D. Th yroid-stim ulatin g h orm on e 1. Bloo d test is used to differen tiate th e diagn osis of

prim ary h ypo th yroidism . 2. Norm al value is 2–10 m cU/ L (2–10 m U/ L). 3. Elevated values in dicate prim ary h ypo th y-

roidism . 4. Decreased values in dicate h yperth yroidism or

secon dary h ypoth yroidism . E. Th yroid scan

1. A th yroid scan is perform ed to iden tify n odules or growth s in th e th yroid glan d.

2. A radioisotope of iodin e or tech n etium is adm in - istered before scan n in g th e th yroid glan d.

3. Reassu re th e clien t th at th e level of radioactive m edication is n ot dan gerous to self or oth ers.

4. Determ in e wh eth er th e clien t h as received radio- graph ic con trast agents with in th e past 3 m on th s, because th ese m ay in validate the scan .

5. Ch eck with th e h ealth care provider (HCP) regardin g discon tin uin g m edication s con tain in g iodin e for 14 days before the test an d th e n eed to discon tin ue th yroid m edication before th e test.

6. In struct th e clien t to m ain tain NPO (n oth in g by m ou th ) status after m idn igh t on th e day befo re th e test; if iodin e is used, th e clien t will fast for an addition al 45 m in utes after in gestion of th e oral isotop e an d th e scan will be perform ed in 24 h ours.

7. If tech n etium is used, it is adm in istered by th e in traven ous (IV) route 30 m in utes before th e scan .

8. Th e test is co n train d icated in pregn an cy. F. Needle aspiration of th yroid tissue

1. Aspiration of th yroid tissue is don e for cytologi- cal exam in ation .

2. No clien t preparation is n ecessary; NPO status m ay or m ay n ot be prescribed.

3. Ligh t pressure is applied to th e aspiration site after th e proced ure.

G. Glycosylated h em oglobin 1. HgbA1C is blood glucose boun d to h em oglobin . 2. Hemoglobin A1c (glyco sylated h em oglobin A;

HbA1c) is a reflection of h ow well blood gluco se levels h ave been co n trolled for th e past 3 to 4 m on th s.

3. Hyperglycem ia in clien ts with diabetes is usually a cause of an in crease in Hb A1c.

4. Fastin g is n ot required befo re th e test. 5. Norm al referen ce in tervals: 4.0%–6.0% (4.0%–

6.0%) 6. HgbA1C an d estim ated average gluco se (eAG)

referen ce in tervals: Refer to Table 10-4 for th ese referen ce in tervals.

Poor glycemic control in a client with diabetes melli- tus is usually the cause of an increase in the HbA1c value.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-5 Adrenal Cortex Glucocorticoids: Cortisol, Cortisone, Corticosterone ▪ Responsible for glucose metabolism, protein metabolism,

fluid and electrolyte balance, suppression of the inflamma- tory response to injury, protective immune response to invasion by infectious agents, and resistance to stress

Mineralocorticoids: Aldosterone ▪ Regulation of electrolyte balance by promoting sodium

retention and potassium excretion

628 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

H. 24-h o ur urin e collection for van illylm an delic acid (VMA) 1. Diagn ostic tests for ph eoch rom ocytom a in clude

a 24-h o ur urin e collectio n for VMA, a produ ct of catech o lam in e m etab olism , m etan ep h rin e, an d catech o lam in es, all of wh ich are elevated in th e presen ce of ph eoch rom ocytom a.

2. Th e n orm al ran ge of urin ary catech olam in es: a . Epin eph rin e: < 20 m cg/ day (< 109 n m ol/ day) b . Norepin eph rin e: 15–80 m cg/ day (89–473

n m ol/ day)

III. Pituitary Gland Disorders ( Box 50-6) A. Hypo pituitarism

1. Description : Hyposecretion of 1 or m ore of th e pituitary h orm on es cau sed by tum o rs, traum a, en ceph alitis, autoim m un ity, or stroke

2. Ho rm on es m ost often affected are growth h orm on e (GH) an d gon ado tropic h orm on es (lutein izin g h orm on e, follicle-stim ulatin g h orm on e) , but th yroid-stim ulatin g h orm on e (TSH ), adren o corticotro pic h orm on e (ACTH), or an tidiuretic h orm on e (ADH) m ay be in volved.

3. Assessm en t a . Mild to m oderate obesity (GH, TSH) b . Redu ced cardiac output (GH, ADH) c. In fertility, sexual dysfun ction (gon adotro-

pin s, ACTH) d . Fatigue, lo w blood pressure (TSH, ADH,

ACTH , GH) e. Tum ors of th e pituitary also m ay cause h ead-

ach es an d visual defects (th e pituitary is located n ear th e optic n erve).

4. In terven tion s a . Clien t m ay n eed h orm on e replacem en t for

th e specific deficien t h orm on es. b . Provid e em otion al supp ort to th e clien t an d

fam ily. c. En cou rage th e clien t an d fam ily to express

feelin gs related to disturbed body im age or sexual dysfun ction .

d . Clien t education is n eeded regardin g th e sign s an d sym pto m s of h ypo fun ction an d

h yperfun ctio n related to in sufficien t or excess h orm on e replacem en t

B. Hyperpituitarism (acrom egaly) 1. Description : Hypersecretion of growth h orm on e

by th e an terior pituitary glan d in an adult; cau sed prim arily by pituitary tum o rs

2. Assessm en t a. Large h an ds an d feet b . Th icken in g an d protrusion of th e jaw c. Arth ritic ch an ges an d join t pain , im pin ge-

m en t syn dro m es d . Visual disturban ces e. Diaph oresis f. O ily, ro ugh skin g. O rgan om egaly h . Hyperten sion , ath erosclerosis, cardiom egaly,

h eart failure i. Dysph agia j. Deepen in g of th e vo ice

k . Th icken in g of th e ton gue, n arrowin g of th e airway, sleep apn ea

l. Hyperglycem ia m . Colon polyps, in creased colon can cer risk

3. In terven tion s a. Provid e ph arm acological in terven tion s to

suppress GH or to block th e action of GH b . Prepare th e clien t for radiation of th e pitui-

tary glan d or for stereotactic radiosurgery if prescribed.

c. Prepare th e clien t for h ypoph ysectom y if plan n ed.

d . Provid e ph arm acological an d n on ph arm aco- logical in terven tion s for join t pain .

e. Provid e em otion al supp ort to th e clien t an d fam ily, an d en courage th e clien t an d fam ily to exp ress feelin gs related to disturbed body im age.

C. Hypoph ysectom y (pitu itary ad en ectom y, sublabial tran ssp h en oid al pituitary surgery) 1. Description

a. Rem o val of a pituitary tum o r via cran iotom y or a sublabial tran ssph en oid al (en doscop ic tran sn asal) approach (th e latter approach is preferred because it is associated with fewer com plication s)

b . Com p lication s for cran io tom y in clude in creased in tracran ial pressure, bleedin g, m en in gitis, an d h ypo pituitarism .

c. Com p lication s for th e sublabial tran ssp h e- n oidal surgery in clude cerebro spin al fluid leak, in fectio n , diab etes in sipidus, an d h ypopituitarism .

d . If th e sublabial approach is used, an in cision is m ade alon g th e gum lin e of th e in n er upper lip.

2. Posto perative in terven tion s a. In itial posto perative care is sim ilar to

cran iotom y care.

BOX 50-6 Pituitary Gland Disorders Anterior Pituitary ▪ Hyperpituitarism ▪ Hypopituitarism Posterior Pituitary These disorders can be caused by damage to the posterior pituitary or hypothalamus:

▪ Diabetes insipidus ▪ Syndrome of inappropriate antidiuretic hormone secretion

(SIADH)

629CHAPTER 50 Endocrine System

A

d

u

l

t

E

n

d

o

c

r

i

n

e

b . Mon itor vital sign s, n eurological status, an d level of con sciousn ess.

c. Elevate th e h ead of th e bed. d . Mon itor for in creased in tracran ial pressure. e. In struct th e clien t to avoid sn eezin g, cough -

in g, an d blowin g th e n ose. f. Mon itor for bleedin g. g. Mon itor for an d report sign s of tem p orary

diabetes insipidus; m on itor in take an d output, an d report excessive urin ary outp ut.

h . If th e en tire pituitary is rem oved, clien ts will require lifelon g replacem en t of ADH, co rti- sol, an d th yroid h orm on e.

i. Mon itor for an d report sign s of in fectio n an d m en in gitis.

j. Adm in ister an tibiotics, an algesics, an d an ti- pyretics as prescribed.

k . Adm in ister oral m outh rin ses as prescribed. Clien ts m ay be in structed to avoid usin g a tooth brush or to brush teeth gen tly with an ultra-soft tooth brush for 10 days to 2 weeks after surgery.

l. In struct th e clien t in th e adm in istration of prescribed m edication s.

Following transsphenoidal hypophysectom y, m onitor for and report postnasal drip or clear nas al drainage, which m ight indicate a cerebros pinal fluid leak. Clear drainage s hould be checked for glucose.

D. Diabetes insipidus 1. Description

a. Hyposecretion of ADH by th e posterior pitu- itary glan d cau sed by stroke, traum a, or sur- gery, or it m ay be idiopath ic

b . Kidn ey tubu les fail to reabsorb water. c. In cen tral diabetes in sipidus th ere is de-

creased ADH productio n . d . In n eph rogen ic diabetes in sipidu s, ADH

produ ction is adequate but th e kidn eys do n ot respo n d appropriately to th e ADH.

2. Assessm en t a. Excretion of large am oun ts of dilute urin e b . Polydipsia c. Deh ydration (decreased skin turgor an d dry

m ucou s m em bran es) d . In ability to con cen trate urin e e. Low urin ary specific gravity; n orm al is 1.003–

1.030 (1.005–1.030) f. Fatigue g. Muscle pain an d weakn ess h . Headach e i. Postural h ypo ten sion th at m ay progress to

vascu lar collapse with ou t reh ydration j. Tach ycardia

3. In terven tion s a. Mon itor vital sign s an d n eurological an d car-

diovascular status.

b . Provide a safe en viron m en t, particularly for th e clien t with postu ral h ypo ten sion .

c. Mon itor electrolyte values an d for sign s of deh ydration .

d . Main tain clien t in take of adequate flu ids; IV h ypo ton ic salin e m ay be prescribed to replace urin ary lo sses.

e. Mon itor in take an d outp ut, weigh t, serum osm o lality, an d specific gravity of urin e for excessive urin ary outp ut, weigh t loss, an d lo w urin ary specific gravity.

f. In struct th e clien t to avoid food s or liqu ids th at produ ce diuresis.

g. Vasopressin or desm op ressin acetate m ay be prescribed ; th ese are used wh en th e ADH deficien cy is severe or ch ron ic.

h . In stru ct th e clien t in th e ad m in istratio n o f m ed icatio n s as p rescrib ed ; d esm o p ressin acetate m ay b e ad m in istered b y su b cu tan e- o u s in jectio n , in traven o u sly, in tran asally, o r o rally; watch fo r sign s o f water in to xica- tio n in d icatin g o vertreatm en t.

i. In struct th e clien t to wear a Med icAlert bracelet.

E. Syndrome of inappropriate antidiuretic hormone secretio n (SIADH) 1. Description

a . Con dition of h yperfun ction in g of th e poste- rior pituitary glan d in wh ich excess ADH is released , but n ot in respo n se to th e body’s n eed for it.

b . Causes in clude traum a, stroke, m align an cies (often in th e lun gs or pan creas), m ed ication s, an d stress.

c. Th e syn drom e results in in creased in travascu - lar volum e, water in toxication , an d dilu tion al h ypon atrem ia.

d . May cause cerebral edem a an d th e clien t is at risk for seizures.

2. Assessm en t a. Sign s of fluid volu m e overload b . Ch an ges in level of con sciousn ess an d m en tal

status ch an ges c. Weigh t gain with ou t edem a d . Hyperten sio n e. Tach ycardia f. An orexia, n ausea, an d vom itin g g. Hypo n atrem ia h . Low urin ary outp ut an d con cen trated urin e

3. In terven tion s a. Mon itor vital sign s an d cardiac an d n eurolog-

ical status. b . Provide a safe en viron m en t, particularly

for th e clien t with ch an ges in level of co n sciousn ess or m en tal status.

c. Mon itor for sign s of in creased in tracran ial pressure.

d . Im p lem en t seizure precaution s.

630 UNIT X Endocrine Disorders of the Adult Client

e. Elevate th e h ead of th e bed a m axim u m of 10 degrees to prom o te ven ous return an d decrease barorecep tor-in duced ADH release.

f. Mon itor in take an d output an d obtain weigh t daily.

g. Mon itor flu id an d electrolyte balan ce. h . Mon itor serum an d urin e osm olality. i. Restrict fluid in take as prescribed. j. Adm in ister IV fluids (usually n orm al salin e

[NS] or h yperton ic salin e) as prescribed; m on itor IV fluids carefully because of th e risk for fluid volum e overload.

k . Loop diuretics m ay be prescribed to prom ote diuresis but on ly if serum sodium is at least 125 m Eq/ L(125 m m ol/ L); potassium replace- m en t m ay be n ecessary if loop diuretics are prescribed.

l. Vasopressin an tagon ists m ay be prescribed to decrease th e ren al respo n se to ADH.

IV. Adrenal Gland Disorders ( Box 50-7) A. Adren al cortex in sufficien cy (Addison ’s disease)

1. Prim ary adren al in sufficien cy a . Also known as Addison’s disease, refers to hypo-

secretion of adrenal cortex horm ones (glucocor- ticoids, m ineralocorticoids, and androgen); autoim m une destruction is a com m on cause.

b . Requ ires lifelon g replacem en t of glucocorti- coids an d possib ly of m in eralocorticoids if sign ifican t h ypo secretio n occurs; th e con di- tion is fatal if left un treated.

2. Secon dary ad ren al in sufficien cy is cau sed by h ypo secretio n of ACTH from th e an terior pitui- tary glan d ; m in eralocorticoid release is spared.

3. Loss of gluco cortico ids in Addison’s disease lead s to decreased vascu lar ton e, decreased vascu lar respon se to th e catech o lam in es epi- n eph rin e an d n orepin eph rin e, an d decreased gluco n eogen esis.

4. In Addison’s disease, loss of th e m in eralocorti- coid aldostero n e leads to deh ydration , h ypoten - sion , h ypo n atrem ia, an d h yperkalem ia.

5. Assessm en t ( Table 50-1) 6. In terven tion s

a . Mon itor vital sign s (particularly for h ypoten - sion ), for weigh t loss, and in take and output.

b . Mon itor wh ite blood cell (WBC) coun t; blood gluco se; an d potassium , sodium , an d calcium levels.

c. Adm in ister gluco corticoid an d/ or m in eralo- cortico id m edication s as prescribed .

d . O bserve for addisonian crisis cau sed by stress, in fectio n , traum a, or surgery.

7. Clien t education a . Need for lifelo n g gluco cortico id replacem en t

an d possibly lifelon g m in eraloco rticoid replacem en t.

b . Corticosteroid replacem en t will n eed to be in creased durin g tim es of stress.

c. Avoid in dividuals with an in fectio n . d . Avoid stren uou s exercise an d stressful

situation s. e. Avoid over-th e-coun ter m edication s. f. Diet should be high in protein and carbohy-

drates; clients taking glucocorticoids should be prescribed calcium and vitam in D supplem ents to protect against corticosteroid-induced oste- oporosis; som e clients taking m in eralocorti- coids m ay be prescribed a diet high in sodium . For inform ation on diet, refer to http:// endocrine.niddk.nih.gov/pubs/addison/ addison.aspx#eating

g. Wear a Med icAlert bracelet. h . Report signs an d sym ptom s of com plication s,

such as un derreplacem en t an d overreplace- m en t of corticosteroid h orm on es.

B. Addisonian crisis 1. Description (Box 50-8) 2. Assessm en t

a. Severe h eadach e b . Severe ab dom in al, leg, an d lower back pain

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-7 Adrenal Gland Disorders Adrenal Cortex ▪ Addison’s disease ▪ Primary hyperaldosteronism (Conn’s syndrome) ▪ Cushing’s disease ▪ Cushing’s syndrome Adrenal Medulla ▪ Pheochromocytoma

TABLE 50-1 Assessment: Addison’s Disease and Cushing’s Disease and Cushing’s Syndrome

Addison’s Disease Cushing’s Disease and Cushing’s Syndrome

Lethargy, fatigue, and muscle weakness

Generalized muscle wasting and weakness

Gastrointestinal disturbances Moon face, buffalo hump

Weight loss Truncal obesity with thin extremities, supraclavicular fat pads; weight gain

Menstrual changes in women; impotence in men

Hirsutism (masculine characteristics in females)

Hypoglycemia, hyponatremia Hyperglycemia, hypernatremia

Hyperkalemia, hypercalcemia Hypokalemia, hypocalcemia

Hypotension Hypertension

Hyperpigmentation of skin (bronzed) with primary disease

Fragile skin that bruises easily Reddish-purple striae on the abdomen and upper thighs

631CHAPTER 50 Endocrine System

c. Gen eralized weakn ess d . Irritability an d con fusion e. Severe h ypo ten sion f. Sh ock

3. In terven tion s a. Prepare to adm in ister gluco corticoids in tra-

ven ously as prescribed . b . Adm in ister IV fluid s as prescribed to replace

fluids an d restore electrolyte balan ce. c. Followin g resolution of th e crisis, adm in ister

gluco corticoid an d m in eraloco rticoid orally as prescribed.

d . Mon itor vital sign s, particularly blood pressure. e. Mon itor n eurological status, n otin g irritabil-

ity an d con fusion . f. Mon itor in take an d outp ut. g. Mon itor laboratory values, particularly

sodium , potassium , an d blood glucose levels. h . Protect th e clien t from in fection . i. Main tain bed rest an d provide a quiet

en viron m en t.

Clients taking exogenous corticosteroids must establish a plan with their HCPs for increasing their cor- ticosteroids during times of stress

C. Cush in g’s syn d rom e an d Cush in g’s disease (h ypercortisolism ) 1. Cushing’s syndrome

a. A m etab olic disorder resultin g fro m th e ch ron ic an d excessive produ ction of cortisol by th e ad ren al co rtex or from th e adm in is- tration of gluco cortico ids in large doses for several weeks or lon ger (exogen o us or iatrogen ic).

b . ACTH secretin g tum o rs (m ost often of th e lun g, pan creas, or gastro in testin al [GI] tract) can cause Cush in g’s syn d rom e.

2. Cushing’s disease is a m etabolic disorder ch arac- terized by abn orm ally in creased secretion (en dog- en ous) of cortisol, caused by in creased am oun ts of ACTH secreted by the pituitary glan d.

3. Assessm en t ( Fig. 50-2; see Table 50-1) 4. In terven tion s

a. Mon itor vital sign s, particularly blood pressure. b . Mon itor in take an d outp ut an d weigh t. c. Mon itor laborato ry values, particularly WBC

coun t an d serum glucose, sodium , potas- sium , an d calcium levels.

d . Prepare th e clien t for radiation as prescribed if th e con d ition results from a pituitary aden om a.

e. Adm in ister ch em oth erapeutic agen ts as pre- scribed for in operable ad ren al tum ors.

f. Prepare th e clien t for rem oval of pituitary tum or (h ypoph ysectom y, sublabial tran s- sph en oidal ad en ectom y) if th e con d ition results from in creased pituitary secretion of ACTH.

g. Prepare th e clien t for adrenalectomy if th e con dition results from an adren al ad en om a; glucocorticoid replacem en t m ay be required followin g ad ren alecto m y.

h . Clien ts requirin g lifelon g gluco cortico id replacem en t followin g ad ren alecto m y sh ould obtain in struction s fro m th eir HCPs about in creasin g th eir gluco corticoid durin g tim es of stress.

i. Assess for an d protect again st postoperative th rom bus form ation ; Cush in g’s syn drom e predisp oses to th rom boem bo li.

j. Allow th e clien t to discuss feelin gs related to body ap pearan ce.

k . In struct th e clien t about th e n eed to wear a MedicAlert bracelet.

Addison’s disease is characterized by the hypose- cretion of adrenal cortex hormones, whereas Cushing’s syndrome and Cushing’s disease are characterized by a hypersecretion of glucocorticoids.

D. Prim ary h yperaldosteron ism (Con n ’s syn d rom e) 1. Description

a . Hypersecretion of m in eralocorticoids (aldo- steron e) from th e adren al cortex of th e adren al glan d

b . Most com m on ly caused by an aden om a

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-8 Addisonian Crisis • A life-threatening disorder caused by acute adrenal

insufficiency • Precipitated by stress, infection, trauma, surgery, or abrupt

withdrawal of exogenous corticosteroid use • Can cause hyponatremia, hyperkalemia, hypoglycemia,

and shock

FIGURE 50-2 Typical appearance of a client with Cushing’s syndrome. Note truncal obesity, moon face, buffalo hump, thinner arms and legs, and abdominal striae. (From Wenig, Heffess, Adair, 1997.)

632 UNIT X Endocrine Disorders of the Adult Client

c. Excess secretion of aldosteron e causes sodium and water reten tion and potassium excretion , leadin g to h yperten sion an d h ypokalem ic alkalosis.

2. Assessm en t a. Sym pto m s related to h ypo kalem ia, h ypern a-

trem ia, an d h yperten sion b . Headach e, fatigue, m uscle weakn ess c. Card iac dysrh yth m ias d . Paresth esias, tetan y e. Visual ch an ges f. Glucose in toleran ce g. Elevated serum aldostero n e levels

3. In terven tion s a. Mon itor vital sign s, particularly blood

pressure. b . Mon itor for sign s of h ypo kalem ia an d h yper-

n atrem ia. c. Mon itor in take an d outp ut an d urin e for spe-

cific gravity. d . Mon itor for h yperkalem ia, particularly for

clien ts with im paired ren al fun ction or exces- sive potassium in take because potassium - retain in g diuretics an d aldostero n e an tago- n ists m ay be prescribed to prom o te fluid balan ce an d con trol h yperten sion .

e. Adm in ister potassium supplem en ts as pre- scribed to treat h ypokalem ia; clien ts takin g potassium -retain in g diuretics and potassium supplem en tation are at risk for h yperkalem ia.

f. Prepare th e clien t for adren alectom y. g. Main tain sodium restriction , if prescribed ,

preop eratively. h . Adm in ister gluco cortico ids preop eratively, as

prescribed, to preven t adren al h ypo fun ctio n an d prepare for stress of surgery.

i. Mon itor th e clien t for ad ren al in sufficien cy posto peratively.

j. In struct the clien t regardin g th e n eed for glu- cocorticoid th erapy followin g adren alectom y.

k . In struct th e clien t ab out th e n eed to wear a MedicAlert bracelet.

E. Ph eoch rom ocytom a 1. Description

a . Catech olam in e-produ cin g tum o r usually foun d in th e adren al m edulla, but extraadre- n al location s in clude th e ch est, bladder, abdom en , an d brain ; typically is a ben ign tum o r but can be m align an t

b . Excessive am oun ts of epin eph rin e an d n or- epin eph rin e are secreted.

c. Diagn ostic test in cludes a 24-h o ur urin e col- lectio n for VMA.

d . Surgical rem oval of th e adren al glan d is th e prim ary treatm en t.

e. Sym pto m atic treatm en t is in itiated if surgical rem oval is n ot possible.

f. Th e com plication s associated with ph eoch ro- m ocytom a in clude h yperten sive crisis; h yper- ten sive retin o path y an d n eph ropath y, cardiac en largem en t, an d dysrh yth m ias; h eart failure; m yocardial in farction ; in creased platelet aggregation ; an d stroke.

g. Death can occur fro m sh ock, stroke, ren al failure, dysrh yth m ias, or dissectin g aortic an eurysm .

2. Assessm en t a. Paroxysm al or sustain ed h yperten sion b . Severe h eadach es c. Palpitation s d . Flush in g an d profuse diap h oresis e. Pain in th e ch est or abdom en with n ausea

an d vo m itin g f. Heat in toleran ce g. Weigh t loss h . Trem ors i. Hyperglycemia

3. In terven tion s a. Mon itor vital sign s, particularly blood pres-

sure an d h eart rate. b . Mon itor for h yperten sive crisis; m on itor for

com plication s th at can occur with h yperten - sive crisis, such as stroke, cardiac dysrh yth - m ias, an d m yocardial in farction .

c. In struct th e clien t n ot to sm oke, drin k caffein e-con tain in g beverages, or ch an ge position sudd en ly.

d . Prepare to adm in ister α-ad ren ergic blockin g agen ts an d β-ad ren ergic blockin g agen ts as prescribed to con trol h yperten sio n . α- Adren ergic blockin g agen ts are started 7 to 10 days befo re β-adren ergic blockin g agen ts.

e. Mon itor serum gluco se level. f. Prom ote rest an d a n on stressful en viron m en t. g. Provid e a diet h igh in calories, vitam in s, an d

m in erals. h . Prepare th e clien t for adren alectom y.

For the client with pheochromocytoma, avoid stimuli that can precipitate a hypertensive crisis, such as increased abdominal pressure and vigorous abdominal palpation.

F. Adren alectom y 1. Description (Box 50-9) 2. Preop erative in terven tion s

a. Mon itor electrolyte levels an d correct electro- lyte im balan ces.

b . Assess for dysrh yth m ias. c. Mon itor for h yperglycem ia. d . Protect th e clien t fro m in fection s. e. Adm in ister glucocorticoids as prescribed.

3. Posto perative in terven tion s a. Mon itor vital sign s. b . Mon itor in take an d output; if the urin ary

output is lower th an 30 m L/ h our, n otify th e

A

d

u

l

t

E

n

d

o

c

r

i

n

e

633CHAPTER 50 Endocrine System

HCP, because th is m ay result in acute kidn ey in jury an d in dicate im pen din g shock.

c. Mon itor weigh t daily. d . Mon itor electrolyte an d serum glucose levels. e. Mon itor for sign s of h em orrh age an d sh o ck,

particularly durin g th e first 24 to 48 h ours. f. Mon itor for m an ifestation s of adren al in suffi-

cien cy (see Table 50-1). g. Assess th e dressin g for drain age. h . Mon itor for paralytic ileu s. i. Adm in ister IV fluids as prescribed to m ain -

tain blood vo lum e. j. Adm in ister gluco cortico ids an d m in eralo-

cortico ids as prescribed . k . Adm in ister pain m ed ication as prescribed. l. Provid e pulm o n ary in terven tion s to preven t

atelectasis (cough in g an d deep breath in g, in cen tive spirom etry, splin tin g of in cision ).

m . In struct the clien t in th e im portan ce of h or- m on e replacem en t th erapy followin g surgery.

n . In struct th e clien t regardin g sign s an d sym p- tom s of com plication s such as un d erreplace- m en t an d overreplacem en t of h orm on es.

o . In struct th e clien t regardin g th e n eed to wear a MedicAlert bracelet.

V. Thyroid Gland Disorders A. Hypothyroidism

1. Description a. Hypoth yroid state resultin g from h yposecre-

tion of th yroid h orm on es an d ch aracterized by a decreased rate of body m etab olism

b . Th e T4 is low an d th e TSH is elevated. c. In prim ary h ypo th yroidism , th e source of

dysfun ction is th e th yroid glan d an d th e th y- roid can n ot produ ce th e n ecessary am oun t of h orm on es. In secon dary h ypo th yroidism , th e th yroid is n ot bein g stim ulated by th e pitui- tary to produce h orm on es.

2. Assessm en t ( Table 50-2) 3. In terven tion s

a. Mon itor vital sign s, in cludin g h eart rate an d rh yth m .

b . Adm in ister th yroid replacem en t; levoth yrox- in e sodium is m ost com m on ly prescribed .

c. In struct th e clien t about th yroid replacem en t th erap y an d about th e clin ical m an ifestatio n s of both h ypo th yroidism an d h yperth yroid- ism related to un derreplacem en t or overre- placem en t of th e h orm on e.

d . In struct th e clien t in a lo w-calorie, low- ch olestero l, lo w–saturated fat diet; discuss a daily exercise program such as walkin g.

e. Assess th e clien t for con stipation ; provide rough age an d fluids to preven t con stipation .

f. Provide a warm en viron m en t for th e clien t. g. Avoid sedatives an d opioid an algesics because

of in creased sen sitivity to th ese m edication s; m ay precipitate m yxedem a com a.

h . Mon itor for overdose of th yroid m edication s, ch aracterized by tach ycardia, ch est pain , rest- lessn ess, n ervousn ess, an d in som n ia.

i. In struct th e clien t to report episo des of ch est pain or oth er sign s of overdose im m ediately.

B. Myxedema coma 1. Description ( Box 50-10) 2. Assessm en t

a . Hypoten sion b . Bradycardia

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-9 Adrenalectomy Surgical removal of an adrenal gland Lifelong glucocorticoid and mineralocorticoid replacement is

necessary with bilateral adrenalectomy. Temporary glucocorticoid replacement, usually up to 2 years,

is necessary after a unilateral adrenalectomy. Catecholamine levels drop as a result of surgery, which can

result in cardiovascular collapse, hypotension, and shock, and the client needs to be monitored closely.

Hemorrhage also can occur because of the high vascularity of the adrenal glands.

TABLE 50-2 Assessment: Hypothyroidism and Hyperthyroidism

Hypothyroidism Hyperthyroidism

Lethargy and fatigue Personality changes such as irritability, agitation, and mood swings

Weakness, muscle aches, paresthesias

Nervousness and fine tremors of the hands

Intolerance to cold Heat intolerance

Weight gain Weight loss

Dry skin and hair and loss of body hair

Smooth, soft skin and hair

Bradycardia Palpitations, cardiac dysrhythmias, such as tachycardia or atrial fibrillation

Constipation Diarrhea

Generalized puffiness and edema around the eyes and face (myxedema)

Protruding eyeballs (exophthalmos) may be present (see Fig. 50-3)

Forgetfulness and loss of memory

Diaphoresis

Menstrual disturbances Hypertension

Goiter may or may not be present Enlarged thyroid gland (goiter)

Cardiac enlargement, tendency to develop heart failure

634 UNIT X Endocrine Disorders of the Adult Client

c. Hypo th erm ia d . Hypo n atrem ia e. Hypoglycemia f. Gen eralized edem a g. Resp iratory failure h . Com a

3. In terven tion s a. Main tain a paten t airway. b . In stitute aspiration precaution s. c. Adm in ister IV fluids (n orm al or h yperton ic

salin e) as prescribed . d . Adm in ister levo th yroxin e sodium in trave-

n ously as prescribed. e. Adm in ister glucose in traven o usly as

prescribed. f. Adm in ister cortico steroids as prescribed. g. Assess th e clien t’s tem p erature h ourly. h . Mon itor blood pressure frequen tly. i. Keep th e clien t warm . j. Mon itor for ch an ges in m en tal status.

k . Mon itor electrolyte an d glucose levels. C. Hyperthyroidism

1. Description a . Hyperth yroid state resultin g fro m h ypersecre-

tion of th yroid h orm on es (T3 an d T4) b . Ch aracterized by an in creased rate of body

m etab olism c. A com m on cause is Graves’ disease, also

kn own as toxic diffuse goiter. d . Clin ical m an ifestatio n s are referred to as

thyrotoxicosis. e. Th e T3 an d T4 are usually elevated an d th e

TSH level is low. 2. Assessm en t (see Table 50-2; Fig. 50-3) 3. In terven tion s

a. Provid e adequ ate rest. b . Adm in ister sedatives as prescribed . c. Provid e a cool an d quiet en viron m en t. d . O btain weigh t daily. e. Provid e a h igh -calorie diet. f. Avoid th e adm in istration of stim ulan ts. g. Adm in ister an tith yroid m ed ication s, such as

m eth im azole or propylth iouracil th at block th yroid syn th esis as prescribed.

h . Adm in ister iodin e preparation s th at inh ibit th e release of thyroid h orm on e as prescribed.

i. Adm in ister propran olol for tach ycardia as prescribed.

j. Prepare the client for radioactive iodin e th er- apy, as prescribed, to destroy thyroid cells.

k . Prepare th e clien t for subto tal thyroidectomy if prescribed.

l. Elevate th e h ead of th e bed of a clien t experien cin g exoph th alm os; in addition , in struct on low-salt diet, adm in ister artificial tears, en courage th e use of dark glasses, an d tape eyelids clo sed at n igh t if n ecessary.

m . Allow th e clien t to express con cern s about body im age ch an ges.

D. Thyroid storm 1. Description (Box 50-11) 2. Assessm en t

a. Elevated tem p erature (fever) b . Tach ycardia c. Systolic h yperten sion d . Nausea, vom itin g, an d diarrh ea e. Agitation , trem o rs, an xiety f. Irritability, agitation , restlessn ess, con fusion ,

an d seizures as th e con dition progresses g. Delirium an d co m a

3. In terven tion s a. Main tain a paten t airway an d ad equate

ven tilation . b . Adm inister an tithyroid m edication s, iodides,

propranolol, an d glucocorticoids as prescribed. c. Mon itor vital sign s.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-10 Myxedema Coma This rare but serious disorder results from persistently low

thyroid production. Coma can be precipitated by acute illness, rapid withdrawal of

thyroid medication, anesthesia and surgery, hypothermia, or the use of sedatives and opioid analgesics.

FIGURE 50-3 Exophthalmos. (From Ignatavicius, Workman, 2016.)

BOX 50-11 Thyroid Storm This acute and life-threatening condition occurs in a client

with uncontrollable hyperthyroidism. It can be caused by manipulation of the thyroid gland during

surgery and the release of thyroid hormone into the blood- stream; it also can occur from severe infection and stress.

Antithyroid medications, beta blockers, glucocorticoids, and iodides may be administered to the client before thyroid surgery to prevent its occurrence.

635CHAPTER 50 Endocrine System

d . Mon itor con tin ually for cardiac dysrh yth m ias. e. Adm in ister n on salicylate an tipyretics as pre-

scrib ed (salicylates in crease free th yroid h or- m on e levels).

f. Use a coolin g blan ket to decrease tem p era- ture as prescribed .

E. Th yroidectom y 1. Description

a. Rem o val of th e th yroid glan d b . Perform ed wh en persisten t h yperth yroidism

exists c. Subto tal th yroidectom y, rem oval of a portion

of th e th yroid glan d, is th e preferred surgical in terven tion .

2. Preop erative in terven tion s a. O btain vital sign s an d weigh t. b . Assess electrolyte levels. c. Assess for h yperglycem ia. d . In struct th e clien t in h ow to perform cough -

in g an d deep-breath in g exercises an d h ow to supp ort th e n eck in th e posto perative period wh en cough in g an d m ovin g.

e. Adm in ister an tith yroid m ed ication s, iodides, propran olol, an d glucocorticoid s as pre- scrib ed to preven t th e occurren ce of th yroid storm .

3. Posto perative in terven tion s a. Mon itor for respiratory distress. b . Have a trach eo tom y set, oxygen , an d suction

at th e bedside. c. Lim it clien t talkin g, an d assess level of

h oarsen ess. d . Avoid n eck flexion an d stress on th e

suture lin e. e. Mon itor for laryn geal n erve dam age, as evi-

den ced by airway obstru ctio n , dysph on ia, h igh -p itch ed voice, stridor, dysph agia, an d restlessn ess.

f. Mon itor for sign s of h ypo calcem ia an d tet- an y, wh ich can be cau sed by traum a to th e parath yroid glan d ( Box 50-12).

g. Prepare to adm in ister calcium gluco n ate as prescribed for tetan y.

h . Mon itor for th yroid storm .

Following thyroidectomy, maintain the client in a semi-Fowler’s position. Monitor the surgical site for edema and for signs of bleeding and check the dressing anteriorly and at the back of the neck.

VI. Parathyroid Gland Disorders A. Hypoparath yroid ism

1. Description a . Con dition caused by h ypo secretio n of

parath yroid h orm on e by th e parath yroid glan d

b . Can occur follo win g thyroidectomy because of rem oval of parath yro id tissue

2. Assessm en t a . Hypocalcem ia an d h yperp h osph atem ia b . Num bn ess an d tin glin g in th e face c. Muscle cram p s an d cram ps in th e abdom en

or in th e extrem ities d . Positive Trousseau’s sign or Chvostek’s sign e. Sign s o f o vert tetan y, su ch as b ro n ch o sp asm ,

laryn go sp asm , carp o p ed al sp asm , d ysp h a- gia, p h o to p h o b ia, card iac d ysrh yth m ias, seizu res

f. Hypoten sion g. An xiety, irritab ility, depression

3. In terven tion s a . Mon itor vital sign s. b . Mon itor for sign s of h ypocalcem ia and tetan y. c. In itiate seizu re precaution s. d . Place a trach eo tom y set, oxygen , an d suction -

in g equipm en t at th e bed side. e. Prepare to adm in ister calcium glucon ate

in traven o usly for h ypo calcem ia. f. Provide a h igh -calcium , low-ph osph orus diet. g. In struct th e clien t in th e adm in istration of

calcium supplem en ts as prescribed. h . In struct th e clien t in th e adm in istration of

vitam in D supplem en ts as prescribed; vita- m in D en h an ces th e absorption of calcium from th e GI tract.

i. In struct th e clien t in th e use of th iazide diuretics if prescribed, to protect th e kidn ey if vitam in D is also taken .

j. In struct th e clien t in th e adm in istration of ph osph ate bin ders as prescribed to prom ote th e excretion of ph osph ate th rou gh th e GI tract.

k . In struct th e clien t to wear a Med icAlert bracelet.

B. Hyperparathyroidism 1. Description : Con dition caused by h ypersecre-

tion of parath yroid h orm on e (PTH) by th e parath yroid glan d

2. Assessm en t a . Hypercalcem ia an d h ypo ph osph atem ia b . Fatigue an d m uscle weakn ess

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-12 Signs of Tetany ▪ Cardiac dysrhythmias ▪ Carpopedal spasm ▪ Dysphagia ▪ Muscle and abdominal cramps ▪ Numbness and tingling of the face and extremities ▪ Positive Chvostek’s sign ▪ Positive Trousseau’s sign ▪ Visual disturbances (photophobia) ▪ Wheezing and dyspnea (bronchospasm, laryngospasm) ▪ Seizures

636 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

c. Skeletal pain an d ten dern ess d . Bon e defo rm ities th at result in path olo gical

fractures e. An orexia, n ausea, vom itin g, epigastric pain f. Weigh t loss g. Con stipation h . Hyperten sion i. Card iac dysrh yth m ias j. Ren al ston es

3. In terven tion s a. Mon itor vital sign s, particularly blood

pressure. b . Mon itor for cardiac dysrh yth m ias. c. Mon itor in take an d outp ut an d for sign s of

ren al ston es. d . Mon itor for skeletal pain ; m ove th e clien t

slowly an d carefully. e. En cou rage fluid in take. f. Adm in ister furosem ide as prescribed to

lower calcium levels. g. Adm in ister NS in traven o usly as prescribed to

m ain tain h ydration . h . Adm in ister ph o sph ates, wh ich in terfere with

calcium reabsorp tion , as prescribed . i. Adm in ister calciton in as prescribed to

decrease skeletal calcium release an d in crease ren al excretion of calcium .

j. Adm in ister IV or oral bisph osph on ates to in h ib it bon e resorption .

k . Mon itor calcium an d ph osph orus levels. l. Prepare th e clien t for parath yroidectom y as

prescribed. m . En cou rage a h igh -fiber, m od erate-calcium

diet. n . Em ph asize th e im portan ce of an exercise

program an d avoidin g prolon ged in activity. C. Parath yroidectom y

1. Description : Rem o val of 1 or m ore of th e para- th yroid glan d s a . En do scopic radioguided parath yroidectom y

with autotran splan tation is th e m ost co m - m on proced ure.

b . Parath yroid tissue is tran splan ted in th e fore- arm or n ear th e stern ocleidom astoid m uscle, allowin g PTH secretio n to co n tin ue.

2. Preoperative in terven tion s a . Mon itor electrolytes, calcium , ph osph ate,

an d m agn esium levels. b . En sure th at calcium levels are decreased to

n ear-n orm al values. c. In form th e clien t th at talkin g m ay be pain ful

for th e first day or two after surgery. 3. Posto perative in terven tion s

a . Mon itor for respiratory distress. b . Place a trach eo tom y set, oxygen , an d suction -

in g equip m en t at th e bedside. c. Mon itor vital sign s. d . Position th e clien t in sem i-Fowler’s position .

e. Assess n eck dressin g for bleed in g. f. Mon itor for h ypo calcem ic crisis, as eviden ced

by tin glin g an d twitch in g in th e extrem ities an d face.

g. Assess for positive Trou sseau’s sign or Ch vos- tek’s sign , wh ich in dicates tetan y.

h . Mon itor for ch an ges in voice pattern an d h oarsen ess.

i. Mon itor for laryn geal n erve dam age. j. In struct th e clien t in th e adm in istration of

calcium an d vitam in D supp lem en ts as pre- scribed.

VII. Disorders of the Pancreas A. Diabetes mellitus

1. Description a . Ch ron ic disorder of im paired carbo h ydrate,

protein , an d lipid m etab olism cau sed by a deficien cy of in sulin

b . An absolute or relative deficien cy of in sulin results in hyperglycemia.

c. Type 1 diabetes m ellitus is a n early ab solute deficien cy of in sulin (prim ary beta cell destruction ); if in sulin is n ot given , fats are m etab olized for en ergy, resultin g in keton e- m ia (acidosis).

d . Type 2 diabetes m ellitus is a relative lack of in sulin or resistan ce to th e action of in sulin ; usually, in sulin is sufficien t to stabilize fat an d protein m etab olism but n ot carboh y- drate m etab olism .

e. Metab olic syn dro m e is also kn own as syn - drom e X an d th e in dividual h as coexistin g risk facto rs for developin g typ e 2 diabetes m ellitus; th ese risk factors in clude abdom in al obesity, h yperglycem ia, h yperten sion , h igh triglyceride level, an d a lo wered HDL (h igh - den sity lipo protein ) ch olestero l level.

f. Diabetes m ellitus can lead to ch ron ic h ealth problem s an d early death as a result of com - plication s th at occur in th e large an d sm all blood vessels in tissues an d organ s.

g. Macrovascular com plication s in clude coron ary artery disease, cardiom yopathy, h ypertension , cerebrovascular disease, an d peripheral vascular disease. (Refer to Ch apter 56 for in form ation on cardiovascular disorders.)

h . Microvascular com plication s in clude reti- n opath y, n eph ropath y, an d n europath y.

i. In fection is also a con cern because of reduced h ealin g ability.

j. Male erectile dysfun ction can also occur as a result of th e disease.

Obesity is a major risk factor for diabetes mellitus.

2. Assessm en t a . Polyuria, polydipsia, polyph agia (m ore com -

m on in typ e 1 diabetes m ellitus)

637CHAPTER 50 Endocrine System

A

d

u

l

t

E

n

d

o

c

r

i

n

e

b . Hyperglycem ia c. Weigh t loss (com m o n in type 1 diabetes m el-

litus, rare in type 2 diabetes m ellitus) d . Blurred vision e. Slow woun d h ealin g f. Vagin al in fectio n s g. Weakn ess an d paresth esias h . Sign s of in adequate circulation to th e feet i. Sign s of accelerated ath ero sclerosis (ren al,

cerebral, cardiac, periph eral) 3. Diet

a. Th e diabetic clien t’s diet sh ould take in to accoun t weigh t, m ed ication , activity level, an d oth er h ealth problem s.

b . Day-to-d ay con sisten cy in tim in g an d am oun t of food in take h elps to con tro l th e blood gluco se level.

c. As prescribed by th e HCP, th e clien t m ay be advised to follow th e recom m en dation s of th e Am erican Diabetic Asso ciation diet or U. S. dietary guidelin es (MyPlate; h ttp :/ / www. ch oosem yplate.gov/ ) issued by th e U.S. Departm en ts of Agriculture an d Health an d Hum an Services.

d . Carboh ydrate coun tin g m ay be a sim pler approach for som e clien ts; it focuses on th e total gram s of carbo h ydrates eaten per m eal. Th e clien t m ay be m ore com plian t with carbo- h ydrate coun tin g, resultin g in better glycem ic con tro l; it is usually n ecessary for clien ts un dergoin g in ten se in sulin th erap y.

e. In corporate th e diet in to in dividual clien t n eeds, lifestyle, an d cultural an d socioeco- n om ic pattern s.

4. Exercise a. Exercise lowers th e blood gluco se level,

en courages weigh t loss, reduces cardiovascu - lar risks, im proves circulation an d m uscle ton e, decreases total ch olestero l an d triglycer- ide levels, an d decreases in sulin resistan ce an d gluco se in toleran ce.

b . In struct th e clien t in dietary adjustm en ts wh en exercisin g; dietary adjustm en ts are in dividualized .

c. If th e clien t requires extra food durin g exer- cise to preven t h ypo glycem ia, it n eed n ot be deducted from th e regular m eal plan .

d . If th e blood gluco se level is h igh er th an 250 m g/ dL (14.2 m m o l/ L) an d urin ary keton es (type 1 diab etes m ellitus) are presen t, th e clien t is in structed n ot to exercise un til th e blood glucose level is closer to n orm al an d urin ary keton es are absen t.

e. Th e clien t sh ould try to exercise at th e sam e tim e each day an d sh o uld exercise wh en glucose from th e m eal is peakin g, n ot wh en in sulin or glucose-lo werin g m edication s are peakin g.

f. In sulin sh ould n ot be in jected in to an area of th e body th at will be exercised followin g in jection , as exercise speeds absorption .

Instruct the client with diabetes mellitus to monitor the blood glucose level before, during, and after exercising.

5. O ral h ypo glycem ic m ed ication s: O ral m edica- tion s are prescribed for clien ts with diabetes m el- litus type 2 wh en diet an d weigh t con trol th erap y h ave failed to m ain tain satisfactory blood glu- cose levels (see Ch apter 51).

6. In sulin (refer to Ch apter 51 for addition al in for- m ation on in sulin ) a. Insulin is used to treat type 1 diabetes m ellitus

an d m ay be used to treat type 2 diabetes m el- litus wh en diet, weigh t con trol th erapy, an d oral h ypoglycem ic agen ts h ave failed to m ain - tain satisfactory blood glucose levels.

b . Illn ess, in fectio n , an d stress in crease th e blood gluco se level an d th e n eed for in sulin ; in sulin sh ould n ot be with h eld durin g tim es of illn ess, in fectio n , or stress because h yperglycem ia an d diabetic ketoacidosis can result.

c. Th e peak action tim e of in sulin is im portan t to explain to th e clien t because of th e possi- bility of h ypoglycem ic reaction s occurrin g durin g th is tim e.

Regular insulin (U-10 0 strength) can be adminis- tered via IV injection (IV push). Regular insulin (U-10 0) and the short-duration insulins (lispro, aspart, and glu- lisine) can be administered via IV infusion.

B. Com plication s of in sulin th erapy 1. Local allergic reaction s

a. Redn ess, swellin g, ten dern ess, an d in dura- tion or a wh eal at th e site of in jection m ay occur 1 to 2 h ou rs after adm in istration .

b . Reaction s usually occur durin g th e early stages of in sulin th erap y.

c. In struct th e clien t to clean se th e skin with alcoh ol before in jection .

2. In sulin lipodystroph y a. Th e developm en t of fibrous fatty m asses at

th e in jection site caused by repeated use of an in jection site; use of h um an in sulin h elps to preven t th is.

b . In struct th e clien t to avoid in jectin g in sulin in to affected sites.

c. In struct th e clien t about th e im portan ce of rotatin g in sulin in jection sites. System atic rotation with in 1 an atom ical area is recom - m en ded to preven t lipodystroph y; th e clien t sh ould be in structed n ot to use th e sam e site m ore th an on ce in a 2 to 3 week period. In jec- tion s sh ould be 1½ in ch es (3.8 cm ) apart with in th e an atom ical area.

638 UNIT X Endocrine Disorders of the Adult Client

3. Dawn phenomenon a . Dawn ph en om en on is ch aracterized by

h yperglycem ia upon m orn in g awaken in g th at results from excessive early m orn in g release of GH an d cortisol.

b . Treatm en t requires an in crease in th e clien t’s in sulin dose or a ch an ge in th e tim e of in sulin adm in istration .

4. Somogyi phenomenon a . Norm al or elevated blood gluco se levels are

presen t at bedtim e; h ypo glycem ia occurs at about 2 to 3 a.m ., wh ich causes an in crease in th e produ ction of coun terregulatory h orm on es.

b . By about 7 a.m ., in respo n se to th e coun terre- gulato ry h orm on es, th e blood gluco se rebou n ds sign ifican tly to th e h yperglycem ic ran ge.

c. Treatm en t in cludes a decrease in th e clien t’s in sulin dose an d in crease in th e bedtim e sn ack, or both .

d . Clien ts experien cin g th e Som o gyi ph o m e- n eon m ay com plain of early m orn in g h ead- ach es, n igh t sweats, or n igh tm ares caused by th e early m orn in g h ypo glycem ia.

C. In sulin adm in istration 1. Subcu tan eo us in jection s an d m ixin g in sulin : See

Ch apter 51. 2. In sulin pum ps

a . Con tin uo us subcu tan eous in sulin in fusion is adm in istered by an extern ally worn device th at con tain s a syrin ge attach ed to a lo n g, th in , n arrow-lum en tube with a n eedle or Tef- lon cath eter attach ed to th e en d.

b . Th e clien t in serts th e n eedle or Teflon cath e- ter in to th e subcu tan eo us tissue (usually on th e abdom en or upper arm ) an d secures it with tap e or a tran sparen t dressin g; th e pum p is worn on a belt or in a pocket; th e n eedle or Teflon cath eter is ch an ged at least every 2 to 3 days.

c. A con tin uous basal rate of in sulin in fuses; in addition , on th e basis of th e blood gluco se level, th e an ticip ated food in take, an d th e activity level, th e clien t delivers a bolus of in sulin before each m eal.

d . Both rapid-actin g an d regular sh ort-actin g in sulin (bu ffered to preven t th e precipitation of in sulin crystals with in th e cath eter) are appropriate for use in th ese pum ps.

3. In sulin pum p an d skin sen sor a . A skin sen sor device can be used th at m on i-

tors th e clien t’s blood gluco se con tin uo usly; th e in form ation is tran sm itted to th e pum p, determ in es th e n eed for in sulin , an d th en th e in sulin is in jected.

b . Th e pum p h old s up to a 3-day supp ly of in su- lin an d can be discon n ected easily for activi- ties such as bath in g.

4. Pan creas tran splan ts a . Th e goal of pan creatic tran splan tation is to

h alt or reverse th e com plication s of diabetes m ellitus.

b . Tran splan tation s are perform ed on a lim ited n um ber of clien ts (in gen eral, th ese are clien ts wh o are un dergoin g kidn ey tran splan tatio n sim ultan eously).

c. Im m un osuppressive th erap y is prescribed to preven t an d treat rejection .

D. Self-m o n itorin g of blood gluco se level 1. Self-m o n itorin g provides th e clien t with th e cur-

ren t blood gluco se level an d in form ation to m ain tain good glycem ic con trol.

2. Mon itorin g requires a fin ger prick to obtain a drop of blood for testin g.

3. Altern ative site testin g (obtain in g blood from th e forearm , upper arm , abdom en, th igh , or calf) is available, usin g specific m easurem en t devices.

4. Tests m ust be used with cau tion in clien ts with diab etic n europath y.

5. Clien t in struction s ( Box 50-13) E. Urin e testin g

1. Urin e testin g for gluco se is n ot a reliable in dica- tor of th e blood glucose level an d is n ot used for m on itorin g purpo ses.

2. In struct th e clien t in th e procedure for testin g for urin e keton es.

3. Th e presen ce of keton es m ay in dicate im pen din g ketoacidosis.

4. Urin e keton e testin g sh ould be perform ed durin g illn ess an d when ever th e clien t with type 1 diabetes m ellitus h as persisten tly elevated blood glucose levels (h igh er th an 240 m g/ dL [13.7 m m ol/ L] or as prescribed for 2 consecutive testin g periods).

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 50-13 Client Instructions: Self-Monitoring of Blood Glucose Level

Use the proper procedure to obtain the sample for determin- ing the blood glucose level.

Perform the procedure precisely to obtain accurate results. Follow the manufacturer’s instructions for the glucometer. Wash hands before and after performing the procedure to pre-

vent infection. If needed, calibrate the monitor as instructed by the

manufacturer. Check the expiration date on the test strips. If the blood glucose level results do not seem reasonable,

reread the instructions, reassess technique, check the expi- ration date of the test strips, and perform the procedure again to verify results.

639CHAPTER 50 Endocrine System

A

d

u

l

t

E

n

d

o

c

r

i

n

e

VIII. Acute Complications of Diabetes Mellitus A. Hypoglycemia

1. Description a. Hypoglycem ia occurs wh en th e blood glu-

cose level falls below 70 m g/ dL (4.0 m m o l/ L), or wh en th e blood gluco se level drops rap- idly from an elevated level.

b . Hypoglycem ia is cau sed by too m uch in sulin or too large an am oun t of an oral h ypo glycem ic agen t, too little food , or exces- sive activity.

c. Th e clien t n eeds to be in structed always to carry som e form of fast-actin g sim ple carbo - h ydrate with h im or h er ( Box 50-14).

d . If th e clien t h as a h yp o glycem ic reactio n an d d o es n o t h ave an y o f th e reco m m en - d ed em ergen cy fo o d s availab le, an y avail- ab le fo o d sh o u ld b e eaten ; h igh -fat fo o d s slo w th e ab so rp tio n o f glu co se an d th e h yp o glycem ic sym p to m s m ay n o t reso lve q u ickly.

e. Clien ts wh o experien ce frequen t episo des of h ypo glycem ia, older clien ts, an d clien ts tak- in g β-adren ergic blockin g agen ts m ay n ot experien ce th e warn in g sign s of h ypo glyce- m ia un til th e blood gluco se level is dan ger- ously low; th is ph en om en o n is term ed h ypo glycem ia un awaren ess.

2. Assessm en t ( Box 50-15) a. Mild h ypoglycem ia: Th e clien t rem ain s fully

awake but displays adren ergic sym pto m s; th e blood gluco se level is lower th an 70 m g/ dL (4.0 m m ol/ L) .

b . Mod erate h ypo glycem ia: Th e clien t displays sym pto m s of worsen in g h ypo glycem ia; th e blood glucose level is usually lower th an 40 m g/ dL (2.2 m m ol/ L) .

c. Severe h ypo glycem ia: Th e clien t displays severe n euroglycopen ic sym pto m s; th e blood gluco se level is usually lower th an 20 m g/ dL (1.1 m m ol/ L) .

3. In terven tion s (see Priority Nu rsin g Action s)

PRIORITY NURSING ACTIONS Suspected Hypoglycemic Reaction (the 15/ 15 rule) 1. If a blood glucose monitor is readily available, check the

client’s blood glucose level. If the client is experiencing symptoms suggestive of hypoglycemia such as diaphore- sis, hunger, pallor, and shakiness, and a blood glucose monitor is not readily available, assume hypoglycemia and treat accordingly.

2. For the client whose blood glucose is below 70 mg/ dL (4.0 mmol/ L), or for the client with an unknown blood glucose who is exhibiting signs of hypoglycemia, admin- ister 15 g of a simple carbohydrate such as ½ cup of fruit juice or 15 g of glucose gel.

3. Recheck the blood glucose level in 15 minutes. 4. If the blood glucose remains below 70 mg/ dL(4.0 mmol/ L),

administer another 15 g of a simple carbohydrate. 5. Recheck the blood glucose level in 15 minutes; if still

below 70 mg/ dL (4.0 mmol/ L), treat with an additional 15 g of a simple carbohydrate.

6. Recheck the blood glucose level in 15 minutes; if still below 70 mg/ dL (4.0 mmol/ L), treat with 25 to 50 mL of 50% dextrose intravenously or, if no intravenous (IV) equipment is present, treat with 1 mg of glucagon subcu- taneously or intramuscularly.

7. After the blood glucose level has recovered, have the cli- ent ingest a snack that includes a complex carbohydrate and a protein.

8. Document the client’s complaints, actions taken, and outcome.

9. Explore the precipitating cause of the hypoglycemia with the client.

10. If the client is experiencing an altered level of conscious- ness, bypass oral treatment and start with injectable gluca- gon or 50% dextrose. If the client is at home and does not have access to injectable glucagon, the client should seek immediate medical care.

In the event of a suspected hypoglycemic reaction, the nurse should first check the client’s blood glucose level. If a blood glucose monitor is not available and the client is experiencing the signs and symptoms of hypoglycemia, hypo- glycemic reaction should be suspected. If the blood glucose level is below 70 mg/ dL (4.0 mmol/ L), the nurse should treat accordingly with 15 g of carbohydrate and recheck the level in 15 minutes. If the level is still below 70 mg/ dL (4.0 mmol/ L), the nurse should treat with an additional 15 g of carbohydrate. One more 15 g of carbohydrate if given if the level remains below 70 mg/ dL (4.0 mmol/ L). The nurse then rechecks the blood glucose level in another 15 minutes; if still below 70 mg/ dL (4.0 mmol/ L), the nurse should treat with an inject- able form of glucose. The nurse should then have the client consume a snack, document the occurrence, and explore the reasons the reaction occurred. If at any point the client becomes unconscious, the nurse should administer an inject- able form of glucose to raise the blood glucose level.

Reference: Ignatavicius, Workman (2016), pp. 1330–1331. American Diabetes Association. The 15/ 15 rule. Retrieved from http:/ /

community.diabetes.org/ t5/ Adults-Living-with-Type-2/ THE-15- 15-RULE/ td-p/ 111545

BOX 50-14 Simple Carbohydrates to Treat Hypoglycemia

▪ Commercially prepared glucose tablets ▪ 6 to 10 Life Savers® or hard candy ▪ 4 tsp of sugar ▪ 4 sugar cubes ▪ 1 Tbsp of honey or syrup ▪ ½ cup of fruit juice or regular (nondiet) soft drink ▪ 8 oz (235 mL) of low-fat milk ▪ 6 saltine crackers ▪ 3 graham crackers

640 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

Do not attempt to administer oral food or fluids to the client experiencing a severe hypoglycemic reaction who is semiconscious or unconscious and is unable to swallow. This client is at risk for aspiration. For this cli- ent, an injection of glucagon is administered subcutane- ously or intramuscularly. In the hospital or emergency department, the client may be treated with an IV injec- tion of 25 to 50 mL of 50% dextrose in water.

B. Diabetic ketoacidosis (DKA) 1. Description (Fig. 50-4)

a . Diabetic ketoacid osis is a life-th reaten in g com plication of type 1 diab etes m ellitus th at develo ps wh en a severe in sulin deficien cy occurs.

b . Th e m ain clin ical m an ifestatio n s in clude h yperglycem ia, deh ydration , ketosis, an d acido sis.

2. Assessm en t ( Table 50-3) 3. In terven tion s

BOX 50-15 Assessment of Hypoglycemia Mild • Hunger • Nervousness • Palpitations • Sweating • Tachycardia • Tremor

Moderate • Confusion • Double vision • Drowsiness • Emotional changes • Headache • Impaired coordination • Inability to concentrate • Irrational or combative behavior • Lightheadedness • Numbness of the lips and tongue • Slurred speech

Severe • Difficulty arousing • Disoriented behavior • Loss of consciousness • Seizures

*Ha llma rks of DKA

Exce s s s e cre tion of glycoge n a nd othe r

counte rre gula tory hormone s

Ina de qua te ins ulin

De cre a s e d glucos e upta ke

Ke toge ne s is

Incre a s e d lipolys is of

a dipos e tis s ue

Infe ction S tre s s

Glycoge nolys is a nd

glucone oge ne s is by the live r

Mis s e d ins ulin dos e Ne w-ons e t dia be te s

*Ke tos is

*Acidos is

Vomiting

*Hype rglyce mia

Os motic diure s is

*De hydra tion

P ota s s ium los s

FIGURE 50-4 Pathophysiology of diabetic ketoacidosis (DKA).

TABLE 50-3 Differences Between Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome

Diabetic Ketoacidosis (DKA)

Hyperosmolar Hyperglycemic Syndrome (HHS)

Onset Sudden Gradual

Precipitating factors

Infection Infection

Other stressors Other stressors

Inadequate insulin dose Poor fluid intake

Manifestations Ketosis: Kussmaul’s respiration, “fruity” breath, nausea, abdominal pain

Altered central nervous system function with neurologic symptoms

Dehydration or electrolyte loss: Polyuria, polydipsia, weight loss, dry skin, sunken eyes, soft eyeballs, lethargy, coma

Dehydration or electrolyte loss: Same as for DKA

Laboratory Findings

Serum glucose > 300 mg/ dL (> 17.1 mmol/ L)

> 800 mg/ dL (> 45.7 mmol/ L)

Osmolarity Variable > 350 mOsm/ L

Serum ketones Positive at 1:2 dilution Negative

Serum pH < 7.35 > 7.4

Serum HCO3 < 15 mEq/ L (15 mmol/ L) > 20 mEq/ L (> 20 mmol/ L)

Serum Na Low, normal, or high Normal or low

Serum K Normal; elevated with acidosis, low following dehydration

Normal or low

BUN > 20 mg/ dL (> 7.1 mmol/ L); elevated because of dehydration

Elevated

Creatinine > 1.5 mg/ dL (> 132.5 mcmol/ L); elevated because of dehydration

Elevated

Urine ketones Positive Negative

BUN, Blood urea nitrogen; HCO3, bicarbonate; K, potassium; Na, sodium. From Ignatavicius D, Workm an M: Medical-surgical nursing: patient-centered collaborative care, ed 7, St. Louis, 2013, Saunders .

641CHAPTER 50 Endocrine System

A

d

u

l

t

E

n

d

o

c

r

i

n

e

a. Resto re circulatin g blood volu m e an d protect again st cerebral, coron ary, an d ren al h ypo perfusion .

b . Treat deh ydration with rapid IV in fusion s of 0.9% or 0.45% NS as prescribed; dextrose is added to IV flu ids wh en th e blood gluco se level reach es 250 to 300 m g/ dL (14.2 to 17.1 m m o l/ L). Too rapid adm in istration of IV flu ids; use of th e in correct types of IV fluids, particularly h ypoton ic solution s; an d correctin g th e blood glucose level too rapidly can lead to cerebral edem a.

c. Treat h yperglycem ia with in sulin adm in is- tered in traven ously as prescribed .

d . Correct electrolyte im balan ces (potassium level m ay be elevated as a result of deh ydra- tion an d acido sis).

e. Mon itor potassium level closely because wh en th e clien t receives treatm en t for th e deh ydration an d acido sis, th e serum potas- sium level will decrease an d potassium replacem en t m ay be required .

f. Card iac m on itorin g sh ould be in place for th e clien t with DKA due to risks associated with abn o rm al serum potassiu m levels.

4. In sulin IV adm in istration a. Use sh ort-duration in sulin on ly. b . An IV bolus dose of sh ort-duration regular U-

100 in sulin (usually 5 to 10 un its) m ay be pre- scribed before a con tin uous in fusion is begun .

c. Th e prescribed IV dose of in sulin for con tin - uous in fusion is prepared in 0.9% or 0.45% NS as prescribed.

d . Always place th e in sulin in fusion on an IV in fusion con troller.

e. In sulin is in fused con tin uously un til subcu ta- n eous adm in istration resum es, to preven t a rebou n d of th e blood gluco se level.

f. Mon itor vital sign s. g. Mon itor urin ary outp ut an d m on itor for

sign s of fluid overload. h . Mon itor potassium an d gluco se levels an d for

sign s of in creased in tracran ial pressure. i. Th e potassium level will fall rapidly with in

th e first h ou r of treatm en t as th e deh ydration an d th e acido sis are treated.

j. Potassium is ad m in istered in traven ously in a diluted solution as prescribed; en sure ade- quate ren al fun ction befo re adm in isterin g potassium .

5. Clien t education ( Box 50-16)

Monitor the client being treated for DKA closely for signs of increased intracranial pressure. If the blood glu- cose level falls too far or too fast before the brain has time to equilibrate, water is pulled from the blood to the cerebrospinal fluid and the brain, causing cerebral edema and increased intracranial pressure.

C. Hyperosmolar hyperglycemic syndrome (HHS) 1. Description

a . Extrem e h yperglycem ia occurs with out keto- sis or acido sis.

b . Th e syn d rom e occurs m ost often in in divid- uals with type 2 diabetes m ellitus.

c. Th e m ajor differen ce between HHS an d DKA is th at ketosis an d acidosis do n ot occur with HHS; en ough in sulin is presen t with HHS to preven t th e breakd own of fats for en ergy, th us preven tin g ketosis.

2. Assessm en t (see Table 50-3) 3. In terven tion s

a . Treatm en t is sim ilar to th at for DKA. b . Treatm en t in cludes fluid replacem en t, correc-

tion of electrolyte im balan ces, an d in sulin adm in istration .

c. Fluid replacem en t in th e older clien t m ust be don e very carefully because of th e poten tial for h eart failure.

d . In sulin plays a less critical role in th e treat- m en t of HHS th an it does in th e treatm en t of DKA because ketosis an d acido sis do n ot occur; reh ydration alon e m ay decrease glu- cose levels.

IX. Chronic Complications of Diabetes Mellitus A. Diabetic retin o path y

1. Description a . Ch ron ic an d progressive im pairm en t of th e

retin al circulation th at even tually cau ses h em orrh age

b . Perm an en t vision ch an ges an d blin dn ess can occur.

c. Th e clien t h as difficulty with carryin g out th e daily tasks of blood gluco se testin g an d in su- lin in jection s.

2. Assessm en t a . A ch an ge in vision is caused by th e rupture of

sm all m icroan eurysm s in retin al blood vessels.

BOX 50-16 Client Education: Guidelines During Illness

Take insulin or oral antidiabetic medications as prescribed. Determine the blood glucose level and test the urine for

ketones every 3 to 4 hours. If the usual meal plan cannot be followed, substitute soft

foods 6 to 8 times a day. If vomiting, diarrhea, or fever occurs, consume liquids every 30

to 60 minutes to prevent dehydration and to provide calories. Notify the health care provider if vomiting, diarrhea, or fever

persists; if blood glucose levels are higher than 250 to 300 mg/ dL (14.2 to 17.1 mmol/ L); when ketonuria is pre- sent for more than 24 hours; when unable to take food or fluids for a period of 4 hours; or when illness persists for more than 2 days.

642 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

b . Blurred vision results from m acular edem a. c. Sudd en loss of vision results from retin al

detach m en t. d . Cataracts result from len s opacity.

3. In terven tion s a . Main tain safety. b . Early preven tion via th e con trol of h yperten -

sion an d blood gluco se levels c. Ph otocoagulation (laser th erapy) m ay be

don e to rem ove h em orrh agic tissue to decrease scarrin g an d preven t progression of th e disease process.

d . Vitrectom y m ay be don e to rem ove vitreous h em orrh ages an d th us decrease ten sion on th e retin a, preven tin g detach m en t.

e. Cataract rem oval with len s im plan tation im proves vision .

B. Diabetic n eph ropath y 1. Description : Progressive decrease in kidn ey

fun ction 2. Assessm en t

a . Micro album in u ria b . Th irst c. Fatigue d . An em ia e. Weigh t loss f. Sign s of m aln utrition g. Frequen t urin ary tract in fection s h . Sign s of a n eurogen ic bladder

3. In terven tion s a . Early preven tion m easures in clude th e

con trol of h yperten sion an d blood gluco se levels.

b . Assess vital sign s. c. Mon itor in take an d output. d . Mon itor th e blood urea n itrogen , creatin in e,

an d urin e albu m in levels. e. Restrict dietary protein , sodium , an d potas-

sium in take as prescribed. f. Avoid n eph rotoxic m edication s. g. Prepare th e clien t for dialysis proced ures

if plan n ed. h . Prepare th e clien t for kidn ey tran splan t

if plan n ed. i. Prepare th e clien t for pan creas tran splan t

if plan n ed. C. Diabetic n europath y

1. Description a . Gen eral deterioration of th e n ervou s system

th rou gh out th e body b . Com p lication s in clude th e developm en t of

n on h ealin g ulcers of th e feet, gastric paresis, an d erectile dysfun ction .

2. Classification s a . Focal n europathy or m on on europath y:

In volves a sin gle n erve or group of n erves, m ost

frequently cran ial n erves III (oculom otor) an d VI (abducen s), resultin g in diplopia

b . Sen sory or periph eral n europath y: Affects dis- tal portion of n erves, m ost frequen tly in th e lower extrem ities

c. Auton om ic n europath y: Sym pto m s vary accord in g to th e organ system in volved.

d . Cardio vascular: Card iac den ervation syn - drom e (h eart rate does n ot respon d to ch an ges in oxygen ation n eeds) an d orth o- static h ypo ten sion occur.

e. Pupillary: Pupil does n ot dilate in respo n se to decreased ligh t.

f. Gastric: Decreased gastric em p tyin g (gastroparesis)

g. Urin ary: Neurogen ic bladder h . Skin : Decreased sweatin g i. Adren al: Hypoglycem ic un awaren ess j. Reprod uctive: Im p oten ce (m ale), pain ful

in tercou rse (fem ale) 3. Assessm en t: Fin din gs dep en d on th e classifica-

tion a. Paresth esias b . Decreased or absen t reflexes c. Decreased sen sation to vibration or ligh t

touch d . Pain , ach in g, an d burn in g in th e lower

extrem ities e. Poor periph eral pulses f. Skin breakd own an d sign s of in fectio n g. Weakn ess or loss of sen sation in cran ial

n erves III (oculo m otor), IV (troch lear), V (trigem in al), an d VI (abducen s)

h . Dizzin ess an d postural h ypo ten sion i. Nausea an d vom itin g j. Diarrh ea or con stipation

k . In con tin en ce l. Dyspareun ia

m . Im poten ce n . Hypoglycem ic un awaren ess

4. In terven tion s a. Early preven tion m easures in clude th e con -

trol of h yperten sio n an d blood gluco se levels. b . Careful foot care is required to preven t

traum a (Box 50-17). c. Adm in ister m edication s as prescribed for

pain relief. d . In itiate bladder train in g program s. e. In struct in th e use of estrogen -con tain in g

lubrican ts for wom en with dyspareun ia. f. Prepare th e m ale clien t with im poten ce for

pen ile in jection s or oth er possible treatm en t option s as prescribed.

g. Prepare for surgical deco m pression of com - pressio n lesion s related to th e cran ial n erves as prescribed.

643CHAPTER 50 Endocrine System

A

d

u

l

t

E

n

d

o

c

r

i

n

e

X. Care of the Diabetic Client Undergoing Surgery A. Preop erative care

1. Ch eck with HCP regardin g with h oldin g oral h ypo glycem ic m edication s or in sulin .

2. Som e long-actin g oral antidiabetic m edication s are discon tin ued 24 to 48 h ours before surgery.

3. Metform in m ay n eed to be discon tin ued 48 h ou rs before surgery an d m ay n ot be restarted un til ren al fun ction is n orm al posto peratively.

4. All oth er oral an tidiabetic m ed ication s are usu- ally with h eld on th e day of surgery.

5. In sulin dose m ay be adju sted or with h eld if IV in sulin adm in istration durin g surgery is plan n ed.

6. Mon itor blood gluco se level. 7. Adm in ister IV flu ids as prescribed .

B. Postoperative care 1. Adm in ister IV gluco se an d in sulin in fusion s as

prescribed un til th e clien t can tolerate oral feedin gs.

2. Adm in ister supp lem en tal sh ort-actin g in sulin as prescribed based on blood gluco se results.

3. Mon itor blood glucose levels frequen tly, espe- cially if th e clien t is receivin g paren teral n utrition .

4. Wh en th e clien t is toleratin g food , en sure th at th e clien t receives an ad equate am oun t of carboh y- drates daily to preven t h ypo glycem ia.

5. Clien t is at h igh er risk for cardiovascular an d ren al com plication s posto peratively.

6. Clien t is also at risk fo r im p aired wo u n d h ealin g.

CRITICAL THINKING What Should You Do? Answer: Hypertensive crisis can occur as a complication of pheochromocytoma. This can result in stroke, cardiac dysrhyth- mias, or myocardial infarction. Manifestations include severe headache, extremely high blood pressure (BP), dizziness, blurred vision, shortness of breath, epistaxis (nosebleed), and severe anxiety. If the nurse suspects a hypertensive crisis, the nurse should place the client in a semi-Fowler’s position. The health care provider should be notified immediately and, as prescribed, the nurse should prepare to administer oxy- gen, start an intravenous (IV) infusion of 0 .9% normal saline (NS) solution and infuse it slowly to prevent fluid overload (which would increase BP), administer IV medications to lower the BP, monitor the BP frequently, and monitor for complications.

Reference: Ignatavicius, Workman (20 16), pp. 718, 1282–1283.

P R A C T I C E Q U E S T I O N S 545. A clien t is brough t to th e em ergen cy dep artm en t

in an un respo n sive state, an d a diagn osis of h yper- osm o lar h yperglycem ic syn d rom e is m ade. Th e n urse would im m ed iately prepare to in itiate wh ich an ticipated h ealth care provider’s prescription ? 1. En do trach eal in tub ation 2. 100 un its of NPH in sulin 3. In traven ou s in fusion of n orm al salin e 4. In traven ous in fusion of sodium bicarbo n ate

546. An extern al in sulin pum p is prescribed for a clien t with diabetes m ellitus. Wh en th e clien t asks th e n urse ab out th e fun ctio n in g of th e pum p, th e n urse bases th e respo n se on wh ich in form ation about th e pum p? 1. It is tim ed to release program m ed doses of eith er

sh ort-duration or NPH in sulin in to th e blood - stream at specific in tervals.

2. It con tin uously in fuses sm all am oun ts of NPH in sulin in to th e bloodstream wh ile regularly m on itorin g blood gluco se levels.

3. It is surgically attach ed to th e pan creas an d in fuses regular in sulin in to th e pan creas. Th is releases in sulin in to th e blood stream .

4. It ad m in isters a sm all con tin uous dose of sh o rt- duration in sulin subcutan eously. Th e clien t can self-adm in ister an addition al bolus dose from th e pum p befo re each m eal.

BOX 50-17 Preventive Foot Care Instructions Provide meticulous skin care and proper foot care. Inspect feet daily and monitor feet for redness, swelling, or

break in skin integrity. Notify the health care provider if redness or a break in the skin

occurs. Avoid thermal injuries from hot water, heating pads, and

baths. Wash feet with warm (not hot) water and dry thoroughly

(avoid foot soaks). Avoid treating corns, blisters, or ingrown toenails. Do not cross legs or wear tight garments that may constrict

blood flow. Apply moisturizing lotion to the feet but not between the toes. Prevent moisture from accumulating between the toes. Wear loose socks and well-fitting (not tight) shoes; do not go

barefoot. Wear clean cotton socks to keep the feet warm and change the

socks daily. Avoid wearing the same pair of shoes 2 days in a row. Avoid wearing open-toed shoes or shoes with a strap that goes

between the toes. Check shoes for cracks or tears in the lining and for foreign

objects before putting them on. Break in new shoes gradually. Cut toenails straight across and smooth nails with an emery

board. Avoid smoking.

644 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

547. A clien t with a diagn osis of diab etic ketoacidosis (DKA) is bein g treated in th e em ergen cy dep art- m en t. Wh ich fin din gs supp ort th is diagn osis? Select all th at ap p ly.

1. In crease in pH 2. Com atose state 3. Deep, rapid breath in g 4. Decreased urin e outp ut 5. Elevated blood glucose level

548. Th e n urse teach es a clien t with diab etes m ellitus ab out differen tiatin g between h ypoglycem ia an d ketoacidosis. Th e clien t dem on strates an un der- stan din g of th e teach in g by statin g th at a form of gluco se sh ould be taken if wh ich sym pto m or sym ptom s develo p? Select all th at ap p ly.

1. Polyuria 2. Sh akin ess 3. Palpitation s 4. Blurred vision 5. Ligh th eadedn ess 6. Fruity breath odor

549. A clien t with d iab etes m ellitu s d em o n strates acu te an xiety wh en ad m itted to th e h o sp ital fo r th e treatm en t o f h yp erglycem ia. Wh at is th e ap p ro p riate in terven tio n to d ecrease th e clien t’s an xiety? 1. Adm in ister a sed ative. 2. Con vey em p ath y, tru st, an d respect toward th e

clien t. 3. Ign ore th e sign s an d sym ptom s of an xiety, an tic-

ipatin g th at th ey will soon disappear. 4. Make sure th at th e clien t is fam iliar with th e cor-

rect m edical term s to prom o te un derstan din g of wh at is h app en in g.

550. Th e n urse provides in struction s to a clien t n ewly diagn osed with type 1 diabetes m ellitus. Th e n urse recogn izes accu rate un d erstan din g of m easures to preven t diabetic ketoacidosis wh en th e clien t m akes wh ich statem en t? 1. “I will stop takin g m y in sulin if I’m too sick

to eat.” 2. “I will decrease m y in sulin dose durin g tim es of

illn ess.” 3. “I will adju st m y in sulin dose accord in g to th e

level of glucose in m y urin e.” 4. “I will n otify m y h ealth care provider (HCP)

if m y blood glucose level is h igh er th an 250 m g/ dL (14.2 m m o l/ L).”

551. A clien t is adm itted to a h ospital with a diagn osis of diabetic ketoacidosis (DKA). The in itial blood glu- cose level is 950 m g/ dL (54.2 m m ol/ L). A con tin u- ous in travenous (IV) in fusion of short-actin g in sulin is in itiated, along with IV rehydration with

n orm al salin e. The serum glucose level is n ow de- creased to 240 m g/ dL (13.7 m m ol/ L). Th e n urse would n ext prepare to adm in ister which m edication ? 1. An am pule of 50% dextrose 2. NPH in sulin subcutan eously 3. IV fluid s con tain in g dextrose 4. Ph en ytoin for th e preven tion of seizu res

552. Th e n urse is m on itorin g a clien t n ewly diagn osed with diabetes m ellitus for sign s of co m plication s. Wh ich sign or sym ptom , if exh ibited in th e clien t, in dicates th at th e clien t is at risk for ch ron ic com - plication s of diab etes if th e blood gluco se is n ot ad equately m an aged ? 1. Polyuria 2. Diaph oresis 3. Pedal edem a 4. Decreased respiratory rate

553. Th e n urse is preparin g a plan of care for a clien t with diabetes m ellitus wh o h as h yperglycem ia. Th e n urse places p rio rity on wh ich clien t problem ? 1. Lack of kn owled ge 2. In adequ ate flu id volum e 3. Com pro m ised fam ily copin g 4. In ad equate con sum p tion of n utrien ts

554. Th e h om e h ealth n urse visits a clien t with a diagn o- sis of type 1 diabetes m ellitus. Th e clien t relates a h isto ry of vom itin g an d diarrh ea an d tells th e n urse th at n o food h as been con sum ed for th e last 24 h ou rs. Wh ich addition al statem en t by th e clien t in dicates a n eed fo r fu rth er teach in g? 1. “I n eed to stop m y in sulin .” 2. “I n eed to in crease m y fluid in take.” 3. “I n eed to m on itor m y blood gluco se every 3 to

4 h ours.” 4. “I n eed to call th e h ealth care provid er (HCP)

because of th ese sym ptom s.”

555. Th e n urse is carin g for a clien t after h ypo ph ysec- tom y an d n otes clear n asal drain age from th e cli- en t’s n ostril. Th e n urse sh o uld take wh ich in itial action ? 1. Lower th e h ead of th e bed. 2. Test th e drain age for gluco se. 3. O btain a culture of th e drain age. 4. Con tin ue to observe th e drain age.

556. Th e n urse is adm ittin g a clien t wh o is diagn osed with syn dro m e of in approp riate an tidiuretic h or- m on e secretio n (SIADH) an d h as serum sodium of 118 m Eq/ L (118 m m ol/ L) . Wh ich h ealth care provider prescription s sh ould th e n urse an ticipate receivin g? Select all th at ap p ly.

1. In itiate an in fusion of 3% NaCl. 2. Adm in ister in traven ous furosem ide.

645CHAPTER 50 Endocrine System

3. Restrict fluids to 800 m L over 24 h ou rs. 4. Elevate th e h ead of th e bed to h igh Fowler’s. 5. Adm in ister a vaso pressin an tagon ist as

prescribed.

557. A clien t is ad m itted to an em ergen cy departm en t, an d a diagn osis of m yxedem a com a is m ade. Wh ich action sh ould th e n urse prepare to carry out in itially? 1. Warm th e clien t. 2. Main tain a paten t airway. 3. Adm in ister th yroid h orm on e. 4. Adm in ister fluid replacem en t.

558. Th e n urse is carin g for a clien t adm itted to th e em ergen cy dep artm en t with diabetic ketoacidosis (DKA). In th e acu te ph ase, th e n urse plan s for wh ich p rio rity in terven tion ? 1. Correct th e acidosis. 2. Adm in ister 5% dextrose in traven ously. 3. Apply a m on itor for an electrocardiogram . 4. Adm in ister sh ort-duration in sulin in traven ously.

559. A clien t with type 1 diabetes m ellitus calls th e n urse to report recurren t episodes of h ypo glycem ia with exercisin g. Wh ich statem en t by th e clien t in dicates an adequ ate un derstan din g of th e peak action of NPH in sulin an d exercise? 1. “I sh ould n ot exercise sin ce I am takin g in sulin .” 2. “Th e best tim e for m e to exercise is after breakfast.” 3. “Th e best tim e for m e to exercise is m id- to late

aftern o on .” 4. “NPH is a basal in sulin , so I sh ould exercise in

th e even in g.”

560. Th e n urse is com pletin g an assessm en t on a clien t wh o is bein g adm itted for a diagn ostic workup for prim ary h yperparath yro idism . Wh ich clien t com - plain t would be ch aracteristic of th is disorder? Select all th at ap p ly.

1. Polyuria 2. Headach e 3. Bon e pain 4. Nervo usn ess 5. Weigh t gain

561. Th e n urse is teach in g a clien t with h yperparath y- ro idism h ow to m an age th e con d ition at h om e. Wh ich respon se by th e clien t in dicates th e n eed fo r ad d itio n al teach in g? 1. “I sh ould lim it m y flu ids to 1 liter per day.” 2. “I sh ould use m y treadm ill or go for

walks daily.” 3. “I sh o uld follow a m od erate-calcium , h igh -

fiber diet.” 4. “My alen dro n ate h elps to keep calcium from

com in g out of m y bon es.”

562. A clien t with a diagn osis of addison ian crisis is bein g adm itted to th e in ten sive care un it. Wh ich fin din gs will th e in terp rofession al h ealth care team focus on ? Select all th at ap p ly.

1. Hypoten sion 2. Leuko cytosis 3. Hyperkalem ia 4. Hypercalcem ia 5. Hypern atrem ia

563. Th e n urse is m on itorin g a clien t wh o was diag- n osed with type 1 diabetes m ellitus an d is bein g treated with NPH an d regular in sulin . Wh ich m an ifestation s would alert th e n urse to th e pres- en ce of a possib le h ypoglycem ic reaction ? Select all th at ap p ly.

1. Trem ors 2. An orexia 3. Irritability 4. Nervousn ess 5. Ho t, dry skin 6. Muscle cram ps

564. Th e n urse is perform in g an assessm en t on a clien t with ph eoch rom ocyto m a. Wh ich assessm en t data would in dicate a poten tial com plication associated with th is disorder? 1. A urin ary output of 50 m L/ h ou r 2. A coagulation tim e of 5 m in utes 3. A h eart rate th at is 90 beats/ m in u te an d irregular 4. A blood urea n itrogen level of 20 m g/ dL

(7.1 m m ol/ L)

565. Th e n urse is m on itorin g a clien t diagn osed with acrom egaly wh o was treated with tran ssp h en oidal h ypo ph ysectom y an d is recoverin g in th e in ten sive care un it. Wh ich fin din gs sh o uld alert th e n urse to th e presen ce of a possible postoperative com plica- tion ? Select all th at ap p ly.

1. An xiety 2. Leuko cytosis 3. Ch vostek’s sign 4. Urin ary outp ut of 800 m L/ h ou r 5. Clear drain age on n asal dripper pad

566. Th e n urse perform s a ph ysical assessm en t on a cli- en t with typ e 2 diabetes m ellitus. Fin din gs in clude a fastin g blood gluco se level of 120 m g/ dL (6.8 m m o l/ L), tem perature of 101 °F (38.3 °C), pulse of 102 beats/ m in ute, respiration s of 22 breath s/ m in u te, an d blood pressure of 142/ 72 m m Hg. Wh ich fin din g would be th e p rio rity con - cern to th e n urse? 1. Pulse 2. Resp iration 3. Tem peratu re 4. Bloo d pressure

A

d

u

l

t

E

n

d

o

c

r

i

n

e

646 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

567. Th e n urse is preparin g a clien t with a n ew diagn osis of h ypoth yroidism for disch arge. Th e n urse deter- m in es th at th e clien t un d erstan ds disch arge in struction s if th e clien t states th at wh ich sign s an d sym pto m s are associated with th is diagn osis? Select all th at ap p ly.

1. Trem ors 2. Weigh t loss 3. Feelin g cold 4. Loss of body h air 5. Persisten t leth argy 6. Puffin ess of th e face

568. A clien t h as just been adm itted to th e n ursin g un it followin g th yroidectom y. Wh ich assessm en t is th e p rio rity for th is clien t?

1. Hypo glycem ia 2. Level of h oarsen ess 3. Respiratory distress 4. Edem a at th e surgical site

569. A clien t h as been diagn osed with h yperth yroidism . Th e n urse m on itors for wh ich sign s an d sym pto m s in dicatin g a com plication of th is disorder? Select all th at ap p ly.

1. Fever 2. Nausea 3. Leth argy 4. Trem ors 5. Con fusion 6. Bradycardia

A N S W E R S 545. 3 Ra t ion a le: Th e p rim ary go al of treatm en t in h yp ero sm olar h yperglycem ic syn d ro m e ( HHS) is to reh ydrate th e clien t to resto re flu id volum e an d to correct electrolyte deficien cy. In tra- ven ou s (IV) flu id replacem en t is sim ilar to th at ad m in istered in diab etic ketoacid osis (DKA) an d b egin s with IV in fu sio n o f n orm al salin e. Regu lar in su lin , n ot NPH in su lin , wo uld b e ad m in istered . Th e u se o f sod ium b icarb on ate to co rrect acid o- sis is avoid ed b ecau se it can precipitate a fu rth er drop in seru m po tassium levels. In tu b ation an d m ech an ical ven tilation are n ot requ ired to treat HHS. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, treatm en t of HHS, an d n ote th e strategic wo rd , immediately. If yo u can recall th e treatm en t for DKA, yo u will b e ab le to an swer th is qu estio n eas- ily. Treatm en t for HHS is sim ilar to th e treatm en t for DKA an d begin s with reh ydratio n . Review: Hyp ero sm o lar h yp erglycem ic syn d ro m e ( HHS) Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Ad ult Health —En do crin e Pr ior ity Con cepts: Clin ical Jud gm en t; Glu co se Regulatio n Refer en ce: Ign atavicius, Workm an (2016), p p. 1335–1337.

546. 4 Ra t ion a le: An in sulin pu m p provid es a sm all co n tin u o us do se of sh o rt-du ration (rap id- o r sh ort-actin g) in su lin sub cu tan e- ou sly th ro ugh o u t th e day an d n igh t. Th e clien t can self- ad m in ister an add itio n al bo lu s d ose fro m th e p u m p b efore each m eal as n eed ed . Sh ort-du ratio n in su lin is u sed in an in su - lin p u m p . An extern al pu m p is n ot attach ed surgically to th e pan creas. Test -Ta kin g Str a tegy: Focu s on th e su b ject, use o f an in sulin pu m p . Recallin g th at sh o rt-d uratio n in su lin is u sed in an in su- lin p um p will assist in elim in atin g o p tion s 1 an d 2. No tin g th e wo rd external in th e question will assist in elim in atin g op tion 3. Review: In su lin p u m p s an d in su lin th erap y Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity

In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cepts: Clien t Ed u catio n ; Glucose Regu latio n Refer en ces: Lewis et al. (2014) , p p. 1161–1162, 1168; Perry, Po tter, O sten d orf (2014), p. 580.

547. 2, 3, 5 Ra t ion a le: Because of th e profoun d deficiency of in sulin associated with DKA, glu co se can no t b e u sed for energy an d th e body breaks d own fat as a secon dary source o f en ergy. Keton es, wh ich are acid b yp ro du cts o f fat m etabolism , b uild u p an d th e clien t exp erien ces a m etabo lic keto acid osis. High seru m glu cose con tributes to an osm o tic diuresis and th e clien t b ecom es severely deh yd rated. If u n treated, th e clien t will b ecom e com atose d ue to severe d eh ydratio n , acidosis, an d elec- tro lyte im balance. Kussm aul’s resp iratio n s, th e d eep rapid b reath in g associated with DKA, is a com pen sato ry m ech anism b y th e body. The b ody attem p ts to correct th e acido tic state b y blowin g o ff carbo n d io xid e (CO 2), wh ich is an acid. In th e absen ce o f in sulin , the clien t will experien ce severe h yp erglyce- m ia. O ption 1 is in correct b ecause in acido sis the p H would b e lo w. O ption 4 is in correct b ecau se a h igh serum glu cose will resu lt in an o sm otic d iu resis an d th e clien t will experien ce p olyuria. Test -Ta kin g Str a tegy: Focus o n th e su b ject, fin d in gs associ- ated with DKA. Recall th at th e p ath op h ysio lo gy o f DKA is th e b reakd o wn of fats for en ergy. Th e b reakd own of fats leads to a state of acido sis. Th e h igh serum glu co se co n tribu tes to an o sm otic d iu resis. Kn o win g th e path o p h ysio logy o f DKA will aid in id en tificatio n o f th e co rrect an swer. Review: Diab etic keto acid o sis ( DKA) Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cepts: Clin ical Jud gm en t; Glu co se Regulatio n Refer en ce: Lewis et al. (2014), p. 1176.

548. 2, 3, 5 Ra t ion a le: Sh akin ess, palpitation s, an d ligh th eadedn ess are sign s/ sym pto m s of h yp o glycem ia an d wo uld in dicate th e n eed

647CHAPTER 50 Endocrine System

fo r fo od o r glu co se. Po lyu ria, blu rred visio n , an d a fru ity breath o do r are m an ifestatio n s of h yp erglycem ia. Test-Ta kin g Str a tegy: Focu s o n th e su b ject, th e treatm en t of h yp oglycem ia. Th in k ab o ut its path o p h ysio logy an d th e m an - ifestatio n s th at occu r. Recallin g th e sign s an d sym p tom s of h yp oglycem ia will d irect yo u to th e co rrect o p tion . Review: Sign s o f h yp o glycem ia Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regu lation Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1330.

549. 2 Ra tion a le: An xiety is a sub jective feelin g o f ap p reh en sio n , u n easin ess, or d read. Th e ap prop riate in terven tion is to ad d ress th e clien t’s feelin gs related to th e an xiety. Adm in isterin g a sed - ative is n o t th e m o st ap pro priate in terven tion an d do es n o t ad dress th e sou rce o f th e clien t’s an xiety. Th e n u rse sh o u ld n o t ign o re th e clien t’s an xio us feelin gs. An xiety n eed s to be m an aged b efore m ean in gful clien t ed ucation can o ccur. Test-Ta kin g St r a t egy: Use th erap eu tic co m m u n icatio n tech - n iq u es to an swer th e q uestion . Rem em b er th at th e clien t’s feel- in gs are th e p riority. Keep in g th is in m in d will d irect you easily to th e correct o ptio n . Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: An xiety; Caregivin g Refer en ces: Lewis et al. (2014), pp . 1185–1186; Perry, Po tter, O sten d orf (2014), p. 31.

550. 4 Ra tion a le: Durin g illn ess, th e clien t with type 1 diabetes m ellitus is at in creased risk of diabetic ketoacidosis, due to h yperglycem ia associated with th e stress respon se an d due to a typically decreased caloric in take. As part of sick day m an agem en t, th e cli- en t with diabetes sh ould m on itor blood glucose levels an d sh ould n otify th e HCP if th e level is h igh er th an 250 m g/ dL (14.2 m m ol/ L). In sulin should n ever be stopped. In fact, in sulin m ay n eed to be in creased durin g tim es of illn ess. Doses sh ould n ot be adjusted with out th e HCP’s advice an d are usually adjusted on th e basis of blood glucose levels, n ot urin ary glucose readin gs. Test-Ta kin g St r a t egy: Use gen eral m edicatio n gu id elin es to an swer th e q uestio n . No te th at op tion s 1, 2, an d 3 are co m p a- rab le o r alike an d all relate to adjustm en t of in sulin d oses. Review: Sick d ay ru les for d iabetic m an agem en t Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regu lation Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1335.

551. 3 Ra tion a le: Em ergen cy m an agem en t o f DKA focu ses on correct- in g flu id an d electro lyte im b alan ces an d n orm alizin g th e

serum gluco se level. If th e co rrectio n s occu r too q u ickly, seri- o us co n seq uen ces, in clu d in g h ypo glycem ia an d cerebral ed em a, can occu r. Du rin g m an agem en t o f DKA, wh en th e b loo d glu co se level falls to 250 to 300 m g/ d L (14.2 to 17.1 m m o l/ L) , th e IV in fu sion rate is red uced an d a dextro se so lution is ad ded to m ain tain a b lo od glu co se level of ab ou t 250 m g/ d L ( 14.2 m m ol/ L) , or un til th e clien t reco vers from keto sis. Fifty p ercen t d extrose is used to treat h ypo glycem ia. NPH in su lin is n o t u sed to treat DKA. Ph en yto in is n o t a usu al treatm en t m easu re for DKA. Test-Ta kin g St r a t egy: No te th e strategic wo rd , next. Fo cu s on th e su b ject, m an agem en t o f DKA. Elim in ate op tio n 2 first, kn owin g th at sh ort-du ratio n (rap id -actin g) in sulin is u sed in th e m an agem en t of DKA. Elim in ate op tio n 1 n ext, kn owin g th at th is is th e treatm en t for h yp o glycem ia. No te th e wo rd s the serum glucose level is now decreased to 240 mg/dL ( 13.7 mmol/L) . Th is sh ould in dicate th at th e IV solution con - tain in g dextrose is th e n ext step in th e m an agem en t o f care. Review: Diab etic keto acid o sis ( DKA) Level of Cogn itive Ability: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad ult Health —En do crin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Glu co se Regu latio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1332–1335.

552. 1 Ra tion a le: Ch ron ic h yp erglycem ia, resu ltin g from p oo r glyce- m ic co n tro l, co n trib utes to th e m icro vascu lar an d m acro vascu - lar co m plicatio n s of d iab etes m ellitus. Classic sym pto m s of h yp erglycem ia in clu de po lydipsia, p o lyuria, an d p olyp h agia. Diap h o resis m ay occu r in h ypo glycem ia. Hyp o glycem ia is an acu te com p lication o f diab etes m ellitu s; h o wever, it d oes n o t p red isp ose a clien t to th e ch ro n ic com plicatio n s o f diab etes m ellitu s. Th erefo re, o p tion 2 can b e elim in ated becau se th is fin d in g is ch aracteristic o f h yp o glycem ia. O ptio n s 3 an d 4 are n ot asso ciated with d iab etes m ellitus. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, ch ron ic com p lica- tio n s of d iabetes m ellitu s. Recall th at po or glycem ic con tro l con trib utes to d evelo pm en t o f th e ch ro n ic com plicatio n s of d iabetes m ellitu s. Rem em ber th e 3 Ps associated with h yp ergly- cem ia—po lyu ria, p olyd ip sia, an d po lyph agia. Review: Sign s o f ch ro n ic co m p licatio n s o f d iab etes m ellitu s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ad ult Health —En do crin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Glu co se Regu latio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1302, 1333.

553. 2 Ra tion a le: An in creased b lo od gluco se level will cau se th e kid- n eys to excrete th e gluco se in th e u rin e. Th is glu co se is accom - p an ied b y flu ids an d electrolytes, cau sin g an osm o tic d iu resis lead in g to d eh yd ratio n . Th is flu id lo ss m ust b e rep laced wh en it b eco m es severe. O ptio n s 1, 3, an d 4 are n o t related specifi- cally to th e in form ation in th e q uestion . Test-Ta kin g Str a tegy: Note th e strategic wo rd , priority, an d fo cu s o n th e in fo rm atio n in th e q u estio n . Use Maslo w’s Hierarch y o f Need s th eo ry. Th e co rrect o ptio n in d icates a

A

d

u

l

t

E

n

d

o

c

r

i

n

e

648 UNIT X Endocrine Disorders of the Adult Client

ph ysiolo gical n eed an d is th e p rio rity. O p tio n s 1, 3, an d 4 are prob lem s th at m ay n eed to be add ressed after p ro vidin g fo r th e priority p h ysio lo gical n eed s. Review: Hyp erglycem ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Co n t en t Ar ea : Ad ult Health —En do crin e Pr ior ity Con cepts: Clin ical Jud gm en t; Glu co se Regulatio n Refer en ce: Ign atavicius, Workm an (2016), p p. 1333–1334.

554. 1 Ra t ion a le: Wh en a clien t with d iabetes m ellitu s is u n able to eat n orm ally b ecau se o f illn ess, th e clien t still sh ou ld take th e p re- scribed in su lin or o ral m ed ication . Th e clien t sh o u ld co n su m e ad d ition al fluid s an d sh o uld n o tify th e HCP. Th e clien t sh o uld m o n ito r th e b loo d glucose level every 3 to 4 h ou rs. Th e clien t sh ou ld also m on itor th e u rin e for keton es du rin g illn ess. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further teaching. Th ese words in dicate a n egative even t q u ery an d th e n eed to select th e in correct statem en t. Rem em berin g th at th e clien t n eed s to take in sulin will d irect yo u easily to th e co rrect op tion . Review: Sick d ay gu id elin es Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —En do crin e Pr ior ity Con cepts: Clien t Edu catio n ; Gluco se Regu latio n Refer en ce: Ign atavicius, Workm an (2016), p . 1335.

555. 2 Ra t ion a le: After h yp op h ysectom y, th e clien t sh o u ld b e m o n i- to red fo r rh in o rrh ea, wh ich cou ld in d icate a cereb ro spin al fluid leak. If th is occu rs, th e d rain age sh o u ld be collected an d tested for th e presen ce of cerebrosp in al flu id . Cerebrosp i- n al flu id co n tain s gluco se, an d if p ositive, th is wou ld in d icate th at th e d rain age is cerebrosp in al fluid. Th e h ead o f th e b ed sh ou ld rem ain elevated to p reven t in creased in tracran ial pres- sure. Clear n asal d rain age wo uld n o t in d icate th e n eed for a cul- tu re. Con tin u in g to o bserve th e drain age with ou t takin g action co uld resu lt in a serio u s com plicatio n . Test -Ta kin g Str a tegy: No te th e strategic wo rd , initial, an d d eterm in e if an ab n o rm ality exists. Th is in d icates th at an actio n is req uired . O p tio n 1 can be elim in ated first b y recallin g th at th is actio n can in crease in tracran ial p ressure. O ptio n 3 can be elim in ated also, b ecau se th e drain age is clear. Becau se an actio n is requ ired, elim in ate o ption 4. Review: Co m p licatio n s fo llowin g h yp o p h ysecto m y Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —En do crin e Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ign atavicius, Workm an (2016), p p. 1270–1271.

556. 1, 3, 5 Ra t ion a le: Clien ts with SIADH experien ce excess secretion of an tidiuretic h o rm on e (ADH), wh ich lead s to excess in travascu - lar volu m e, a d eclin in g serum osm o larity, an d dilu tio n al

h ypo n atrem ia. Man agem en t is directed at correctin g th e h ypo - n atrem ia an d p reven tin g cerebral edem a. Hyp erto n ic salin e is p rescrib ed wh en th e h ypo n atrem ia is severe, less th an 120 m Eq / L ( 120 m m o l/ L) . An in traven o u s ( IV) in fu sio n o f 3% salin e is h yp erton ic. Hyp erto n ic salin e m ust be in fused slowly as prescrib ed an d an in fu sio n pu m p m ust be used. Fluid restrictio n is a u seful strategy aim ed at correctin g d ilu tio n al h ypo n atrem ia. Vasop ressin is an ADH; vaso pressin an tago n ists are u sed to treat SIADH. Furosem id e m ay b e u sed to treat extra- vascular vo lu m e an d d ilu tio n al h yp o n atrem ia in SIADH, bu t it is on ly safe to u se if th e serum so d ium is at least 125 m Eq / L (125 m m ol/ L). Wh en furosem ide is used , po tassiu m sup p le- m en tation sh o uld also occu r an d seru m po tassium levels sh ou ld b e m on itored . To p ro m ote ven ou s retu rn , th e h ead o f th e b ed sh ou ld n o t be raised m o re th an 10 degrees fo r th e clien t with SIADH. Maxim izin g ven o us retu rn h elp s to avoid stim u latin g stretch recep tors in th e h eart th at sign al to th e p itu- itary th at m o re ADH is n eed ed. Test -Ta kin g St r a tegy: Fo cus on th e su b ject, treatm en t for SIADH. Th in k abo u t th e path op h ysio lo gy asso ciated with SIADH. Rem em b er th at SIADH is associated with th e in creased secretion of ADH, or vaso pressin . Excess vasop ressin lead s to in creased in travascular flu id vo lu m e, d ecreased seru m o sm o - lality, an d h yp on atrem ia. Wh en h ypo n atrem ia an d decreased seru m osm o lality beco m e severe, cerebral edem a o ccu rs. Review: Syn d ro m e o f in ap p ro p riate an tid iu retic h o rm o n e ( SIADH) Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cept s: Clin ical Ju d gm en t; Flu id an d Electrolyte Balan ce Refer en ce: Lewis et al. (2014), pp . 1156, 1194–1195.

557. 2 Ra t ion a le: Myxed em a com a is a rare b u t serio us disorder th at resu lts fro m persisten tly lo w th yroid p ro du ctio n . Co m a can b e p recip itated b y acu te illn ess, rap id with d rawal of th yro id m ed - icatio n , an esth esia an d su rgery, h ypo th erm ia, an d th e use o f sedatives an d op io id an algesics. In m yxed em a co m a, th e in itial n ursin g action is to m ain tain a p aten t airway. O xygen sh o uld b e adm in istered, followed b y flu id rep lacem en t, keep in g th e clien t warm , m o n ito rin g vital sign s, an d adm in isterin g th yro id h orm on es b y th e in traven o us rou te. Test -Ta kin g St r a t egy: No te th e strategic wo rd , initially. All th e o p tion s are app ro priate in terven tio n s, b ut use th e ABCs—air- way–b reath in g–circu latio n —in selectin g th e correct op tio n . Review: Myxed em a co m a Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cepts: Gas Exch an ge; Th erm oregulation Refer en ce: Ign atavicius, Workm an (2016), p . 1294.

558. 4 Ra t ion a le: Lack o f in sulin (ab solu te o r relative) is th e prim ary cause of DKA. Treatm en t co n sists of in su lin ad m in istratio n (sh ort- o r rapid -actin g), in traven o us fluid ad m in istratio n

A

d

u

l

t

E

n

d

o

c

r

i

n

e

649CHAPTER 50 Endocrine System

(n o rm al salin e in itially, n ot 5% dextro se), an d p otassiu m replacem en t, follo wed b y co rrectin g acid o sis. Card iac m on itor- in g is im po rtan t du e to alteration s in p otassiu m levels asso ci- ated with DKA an d its treatm en t, bu t ap plyin g an electrocard iogram m on itor is n o t th e priority action . Test-Ta kin g Str a tegy: Fo cu s on th e clien t’s d iagn o sis. No te th e strategic wo rd , priority. Rem em ber th at in DKA, th e in itial treatm en t is sh ort- or rapid-actin g in su lin . No rm al salin e is ad m in istered in itially; th erefore, o ptio n 2 is in co rrect. O p tion s 1 an d 3 m ay b e com p on en ts o f th e treatm en t plan b ut are n o t th e p rio rity. Review: Diab etic keto acid o sis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Glucose Regu latio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1334.

559. 2 Ra tion a le: Exercise is an im p ortan t p art of diab etes m an age- m en t. It p ro m otes weigh t loss, decreases in su lin resistan ce, an d h elps to co n tro l b lo od glu co se levels. A h ypo glycem ic reac- tio n m ay occu r in resp on se to in creased exercise, so clien ts sh o u ld exercise eith er an h ou r after m ealtim e or after con sum - in g a 10- to 15-gram carbo h yd rate sn ack, an d th ey sh ou ld ch eck th eir blo o d glu co se level b efore exercisin g. O p tio n 1 is in co rrect b ecau se clien ts with d iab etes sh o u ld exercise, th ou gh th ey sh o uld ch eck with th eir h ealth care p ro vider b efore start- in g a n ew exercise program . O ptio n 3 in in co rrect; clien ts sh o u ld avo id exercise d urin g th e p eak tim e of in su lin . NPH in sulin p eaks at 4 to 12 h o urs; th erefore, aftern o o n exercise takes place du rin g th e p eak o f th e m edicatio n . O p tio n 4 is in co rrect; NPH in su lin in an in term ed iate-actin g in su lin , n o t a basal in su lin . Test-Ta kin g St r a t egy: Focu s on th e su b ject, peak action of NPH in su lin . Recallin g th at NPH in su lin peaks at 4 to 12 h o urs an d th at exercise is b en eficial fo r clien ts with d iabetes will d irect yo u to th e co rrect o p tion . Review: Peak actio n o f NPH in su lin an d d iab etes m ellitu s Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regu lation Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1314, 1322.

560. 1, 3 Ra tion a le: Th e role of parath yroid h orm o n e (PTH) in th e body is to m ain tain serum calcium h om eo stasis. In h yp erparath yro id - ism , PTH levels are h igh , wh ich causes b on e resorp tion ( calcium is p ulled from the b on es). Hypercalcem ia o ccurs with h yp erpara- th yro idism . Elevated seru m calcium levels p ro du ce osm o tic d iuresis an d thu s p olyu ria. Th is diuresis leads to deh yd ratio n (weigh t loss rath er th an weigh t gain ). Loss o f calcium from th e b on es cau ses b on e pain . O ption s 2, 4, and 5 are n ot associated with h yperparathyroidism . Som e gastroin testin al sym ptom s in clu de ano rexia, n au sea, vom itin g, an d con stip ation . Test-Ta kin g Str a tegy: Focus o n th e su b ject, assessm en t fin d in gs in h yp erparath yro id ism . Thin k abo ut th e p ath oph ysiolo gy

associated with h yperparath yroidism . Rem em b er th at h yp ercal- cem ia is associated with this d isord er an d th at h yp ercalcem ia lead s to diu resis, an d th at calcium loss fro m bon e leads to b on e p ain . Review: Hyp erp arath yro id ism Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —En do crin e Pr ior it y Con cepts: Clin ical Ju dgm en t; Flu id an d Electro lyte Balan ce Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1296–1297.

561. 1 Ra tion a le: In h yp erp arath yroid ism , clien ts exp erien ce excess p arath yroid h o rm o n e (PTH) secretio n . A role of PTH in th e b od y is to m ain tain serum calciu m h om eostasis. Wh en PTH levels are h igh , th ere is excess b on e reso rp tion (calciu m is p ulled fro m th e b o n es). In clien ts with elevated serum calciu m levels, th ere is a risk of n ep h rolith iasis. O n e to 2 liters o f flu ids d aily sh o uld b e en co uraged to p rotect th e kidn eys an d d ecrease th e risk of n eph ro lith iasis. Mo derate ph ysical activity, p articu- larly weigh t-bearin g activity, m in im izes b on e reso rp tion an d h elps to p ro tect again st p ath o lo gical fractu re. Walkin g, as an exercise, sh o u ld b e en co u raged in th e clien t with h yperp arath y- roidism . Clien ts sh ould follo w a m oderate-calcium , h igh -fiber d iet. Even th ou gh seru m calcium is already h igh , clien ts sh o u ld fo llow a m o derate-calciu m d iet b ecau se a lo w-calcium d iet will su rge PTH. Calciu m causes co n stip ation , so a diet h igh in fib er is reco m m en ded . Alen dron ate is a b isph osp h ate th at in h ibits b on e reso rp tio n . In bo n e reso rp tion , b o n e is broken do wn an d calciu m is dep osited in to th e seru m . Test-Ta kin g Str a tegy: Note th e strategic wo rd s, need for addi- tional teaching. Th ese wo rd s in d icate a n egative even t q u ery an d th e n eed to select th e in correct statem en t. Con sider th e p ath op h ysio lo gy o f h yperparath yro id ism . Hyp erp arath yroid- ism leads to b o n e d em in eralizatio n , wh ich p laces th e clien t at risk fo r p ath o logical fracture, an d h igh seru m calciu m , wh ich p laces th e clien t at risk fo r n eph ro lith iasis. Kn owin g th at flu ids sh o u ld be en co uraged rath er th an lim ited to h elp p reven t n ep h rolith iasis sh ou ld direct yo u to th e correct o ptio n . Review: Hyp erp arath yro id ism Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —En do crin e Pr ior it y Con cept s: Clien t Ed ucation ; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p p. 1206–1207.

562. 1, 3 Ra tion a le: In Add iso n ’s d isease, also kn o wn as adren al in suf- ficien cy, d estru ction o f th e ad ren al glan d leads to d ecreased p ro du ctio n o f adren o co rtical h orm on es, in clud in g th e glu co - cortico id cortisol an d th e m in eralo co rtico id aldo stero n e. Ad di- so n ian crisis, also kn o wn as acute adren al in sufficien cy, o ccu rs wh en th ere is extrem e ph ysical or em otion al stress an d lack of su fficien t ad ren ocortical h o rm o n es to m an age th e stressor. Ad diso n ian crisis is a life-th reaten in g em ergen cy. O n e o f th e roles of en dogen ous cortisol is to en h an ce vascular to n e an d vascu lar respo n se to th e catech olam in es ep in ep h rin e an d

A

d

u

l

t

E

n

d

o

c

r

i

n

e

650 UNIT X Endocrine Disorders of the Adult Client

n orep in ep h rin e. Hypo ten sion o ccurs wh en vascular ton e is decreased an d blo od vessels can n ot respo n d to ep in ep h rin e an d n o repin eph rin e. Th e ro le of ald osteron e in th e b o dy is to sup po rt th e blo od p ressure b y h o ld in g salt an d water an d excretin g po tassium . Wh en th ere is in sufficien t aldo stero n e, salt an d water are lost an d po tassiu m bu ild s u p ; th is lead s to h ypo ten sion from d ecreased vascular vo lu m e, h yp on atrem ia, an d h yp erkalem ia. Th e rem ain in g op tio n s are n o t associated with add iso n ian crisis. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, ad d ison ian crisis. Th in k abo u t th e path o ph ysio logy associated with Add iso n ’s disease. Recallin g th at in Ad dison ’s d isease th ere is a decrease in th e glucoco rticoid cortiso l an d th e m in eralo cortico id aldo - stero n e will assist in determ in in g th e correct an swer. Review: Ad d iso n ian crisis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Ad ult Health —En do crin e Pr ior ity Con cepts: Clin ical Jud gm en t; Flu id an d Electro lytes Refer en ce: Lewis et al. (2014), p p. 1211–1212.

563. 1, 3, 4 Ra t ion a le: Decreased b lo od glucose levels p ro du ce au ton om ic n ervo u s system sym p tom s, wh ich are m an ifested classically as n ervo u sn ess, irritab ility, an d trem ors. O p tio n 5 is m o re likely to o ccu r with h yperglycem ia. O ption s 2 an d 6 are u n related to th e m an ifestatio n s of h yp oglycem ia. In h yp oglycem ia, u sually th e clien t feels h u n ger. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, a h yp oglycem ic reaction . Th in k about th e path oph ysiology an d m an ifestation s th at occur wh en th e bloo d glu co se is lo w. Recallin g th e sign s o f th is typ e of reaction will direct yo u easily to th e correct op tion s. Review: Man ifestatio n s of h yp o glycem ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —En do crin e Pr ior ity Con cepts: Clin ical Jud gm en t; Glu co se Regulatio n Refer en ce: Ign atavicius, Workm an (2016), p . 1330.

564. 3 Ra t ion a le: Ph eo ch ro m ocytom a is a catech o lam in e-p ro du cin g tu m or usu ally fo u n d in th e ad ren al m ed u lla, b ut extraad ren al location s in clu de th e ch est, blad der, ab do m en , an d b rain ; it is typ ically a b en ign tum o r b u t can b e m align an t. Excessive am o un ts of epin eph rin e an d n o rep in eph rin e are secreted . Th e com plicatio n s associated with ph eoch rom ocytom a in clud e h yp erten sive retin o path y an d n ep h rop ath y, m yo card i- tis, in creased platelet aggregatio n , an d stroke. Death can o ccur fro m sh o ck, stro ke, kid n ey failu re, d ysrh yth m ias, o r d issectin g ao rtic an eu rysm . An irregu lar h eart rate in dicates th e p resen ce of a d ysrh yth m ia. A co agulatio n tim e o f 5 m in utes is n orm al. A urin ary ou tpu t o f 50 m L/ h ou r is an adeq u ate o utp ut. A b lo od urea n itro gen level o f 20 m g/ dL (7.1 m m o l/ L) is a n o rm al fin d in g. Test -Ta kin g St r a t egy: Use th e ABCs—airway–b reath in g–cir- cu latio n . An irregu lar h eart rate is associated with circulatio n . In ad dition , kn owin g th e n o rm al h o urly expectatio n s asso ci- ated with urin ary o u tp u t an d th e n o rm al labo rato ry valu es

fo r coagu lation tim e an d bloo d u rea n itrogen level assists in selection o f th e correct o ptio n . Review: Co m p licatio n s asso ciated with p h eo ch ro m o cyto m a Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p p. 1282–1283.

565. 2, 4, 5 Ra t ion a le: Acrom egaly results fro m excess secretio n o f growth h orm on e, usu ally cau sed b y a b en ign tum o r on th e an terior p itu itary glan d . Treatm en t is su rgical rem oval o f th e tu m o r, u su ally with a su blin gual tran ssph en o idal co m plete o r partial h ypo ph ysecto m y. Th e su b lin gu al tran ssp h en oid al ap pro ach is o ften th rou gh an in cisio n in th e in n er up per lip at th e gum lin e. Tran ssp h en oid al su rgery is a typ e o f brain su rgery an d in fection is a p rim ary co n cern . Leu ko cyto sis, or an elevated wh ite co u n t, m ay in d icate in fectio n . Diab etes in sip id us is a p ossib le co m pli- catio n of tran ssph en o id al h ypo p h ysectom y. In d iab etes in sipi- d u s th ere is d ecreased secretion o f an tidiu retic h orm o n e an d clien ts excrete large am o un ts of dilute u rin e. Followin g tran s- sp h en oidal su rgery, th e n asal passages are packed an d a dripp er p ad is secured un d er th e n ares. Clear drain age o n th e dripp er p ad is su ggestive o f a cereb ro sp in al flu id leak. Th e surgeon sh ou ld b e n o tified an d th e d rain age sh ou ld b e tested for glu- co se. A cerebrosp in al flu id leak in creases th e p osto perative risk o f m en in gitis. An xiety is a n o n sp ecific fin din g th at is co m m o n to m an y d isorders. Ch vo stek’s sign is a test o f n erve h yp erexcit- ab ility asso ciated with h yp ocalcem ia an d is seen as grim acin g in resp on se to tap pin g on th e facial n erve. Ch vostek’s sign h as n o associatio n with co m plicatio n s of su blin gu al tran ssph en oi- d al h yp o ph ysecto m y. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, po stop erative co m p lication s o f sub lin gu al tran ssph en o idal h ypo ph ysec- to m y. Kn owin g th at in fectio n , diab etes in sipidu s, an d cerebro- sp in al flu id leak are po ssib le co m plicatio n s will assist in d eterm in in g th e co rrect an swer. Review: Acro m egaly an d su b lin gu al tran ssp h en o id al h yp o p h ysecto m y Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Lewis et al. (2014), pp . 1191, 1207.

566. 3 Ra t ion a le: In th e clien t with type 2 diabetes m ellitus, an ele- vated tem p eratu re m ay in d icate in fection . In fectio n is a lead in g cause of h yperosm o lar h yperglycem ic syn d ro m e in th e clien t with type 2 diabetes m ellitus. Th e oth er fin din gs are with in n orm al lim its. Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority. Use kn o wled ge o f th e n orm al valu es o f vital sign s to direct yo u to th e co rrect op tio n . Th e clien t’s tem perature is th e on ly ab n o rm al valu e. Rem em ber th at an elevated tem perature can in d icate an in fectiou s p ro cess th at can lead to co m p licatio n s in th e clien t with diab etes m ellitu s.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

651CHAPTER 50 Endocrine System

Review: Norm al an d ab n o rm al fin din gs fo r th e clien t with d ia- b etes m ellitu s Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Glucose Regulatio n ; In fection Refer en ce: Lewis et al. (2014), p p . 1184–1185.

567. 3, 4, 5, 6 Ra tion a le: Feelin g cold, h air loss, leth argy, an d facial p uffin ess are sign s o f h ypo th yro id ism . Trem o rs an d weigh t lo ss are sign s o f h yp erth yro id ism . Test-Ta kin g Str a tegy: Focus o n th e su b ject, sign s an d sym p - to m s asso ciated with h ypo th yro id ism . O p tio n s 1 an d 2 can b e elim in ated if you rem em b er th at in hypoth yroidism th ere is an undersecretio n of th yroid h o rm on e th at cau ses th e m etab - o lism to slow d o wn . Review: Hyp o th yro id ism Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Clien t Ed ucation ; Clin ical Jud gm en t Refer en ce: Lewis et al. (2014), p . 1202.

568. 3 Ra tion a le: Th yroidectom y is th e rem o val o f th e th yro id glan d , wh ich is located in th e an terior n eck. It is very im portan t to m on itor airway status, as an y swellin g to th e surgical site co u ld cause resp iratory d istress. Alth o ugh all of th e op tion s are im p ortan t fo r th e n urse to m o n ito r, th e priority n u rsin g actio n is to m on itor th e airway.

Test-Ta kin g St r a t egy: No te th e strategic wo rd , priority. Use th e ABCs—airway–b reath in g–circu latio n , to assist in d irectin g you to th e correct op tio n . Review: Th yro id ecto m y Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —En do crin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), p p. 1200–1201.

569. 1, 2, 4, 5 Ra tion a le: Th yro id sto rm is an acu te an d life-th reaten in g co m - p lication th at occu rs in a clien t with u n co n tro llab le h yperth y- roidism . Sign s an d sym pto m s of th yroid sto rm in clud e elevated tem p eratu re (fever) , n ausea, an d trem ors. In add itio n , as th e con dition progresses, th e clien t b eco m es co n fu sed. Th e clien t is restless an d an xiou s an d experien ces tach ycard ia. Test-Ta kin g Str a tegy: Focus o n th e su b ject, sign s an d sym p - tom s in d icatin g a co m plicatio n o f h yp erth yro idism . Recall th at th yroid storm is a co m p lication of h yp erth yro idism . O ption s 3 an d 6 can b e elim in ated if you rem em b er th at th yro id storm is cau sed by th e release of th yro id h orm o n es in to th e b loo d - stream , cau sin g u n con tro llab le hyperth yro idism . Leth argy an d b rad ycardia (th in k: slow d own ) are sign s o f hypoth yro id - ism (slo w m etab olism ). Review: Th yro id sto rm Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —En do crin e Pr ior it y Con cept s: Clin ical Ju dgm en t; Th erm o regu latio n Refer en ce: Lewis et al. (2014), p p. 1197–1198.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

652 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

C H A P T E R 51 Endocrine Medications

PRIORITY CONCEPTS Glucose Regulation; Hormonal Regulation

CRITICAL THINKING What Should You Do? The nurse is reviewing the medical record of a client sched- uled for a computerized tomography (CT) scan with an intra- venous iodine contrast dye and notes that the client has diabetes mellitus and is taking metformin. What should the nurse do? Answer located on p. 663.

I. Pituitary Medications A. Description

1. Th e an terior pituitary glan d secretes growth h orm on e (GH) , th yroid-stim ulatin g h orm on e (TSH ), adren o corticotro pic h orm on e (ACTH), prolactin , m elan ocyte-stim ulatin g h orm on e (MSH), an d gon ado tropin s (follicle-stim ulatin g h orm on e [FSH] an d lutein izin g h orm on e [LH ]).

2. Th e posterior pituitary glan d secretes an tidiuretic h orm on e (vasop ressin ) an d oxytocin .

B. Growth h orm on es an d related m edication s (Box 51-1) 1. Uses

a . Growth h orm on es are used to treat ped iatric or adult growth h orm on e deficien cy.

b . Growth h orm on e receptor an tagon ists are used to treat acrom egaly.

c. Growth h orm on e–releasin g facto r is used to evalu ate an terior pituitary fun ction .

2. Sid e an d ad verse effects a . May vary depen din g on th e m ed ication b . Developm en t of an tibod ies to growth

h orm on e c. Headach e, m uscle pain , weakn ess, vertigo d . Diarrh ea, n ausea, ab dom in al discom fort e. Mild hyperglycemia f. Hyperten sion g. Weigh t gain h . Allergic reaction (rash , swellin g), pain at

in jection site i. Elevated aspartate am in otran sferase (AST)

an d alan in e am in otran sferase (ALT)

3. In terven tion s a. Assess th e ch ild’s ph ysical growth an d

com pare growth with stan dard s. b . Recom m en d an n ual bon e age determ in ations

for ch ildren receivin g growth h orm on es. c. Mon itor vital sign s, blood gluco se levels, AST

an d ALT levels, an d th yroid fun ctio n tests. d . Teach th e clien t an d fam ily ab out th e clin ical

m an ifestation s of h yperglycem ia, oth er side an d adverse effects of th erap y, an d th e im portan ce of follow-up regardin g periodic blood tests.

II. Antidiuretic Hormones A. Desm o pressin acetate; vasopressin B. Description

1. An tidiu retic h orm on es en h an ce reabsorp tion of water in th e kidn eys, prom o tin g an an tidiuretic effect an d regulatin g fluid balan ce.

2. An tidiu retic h orm on es are used in diabetes insipidus.

3. Vasopressin is used less com m on ly th an desm o- pressin acetate to treat diabetes in sipidus; vaso- pressin is com m on ly used to treat septic sh o ck.

C. Side an d adverse effects 1. Flush in g 2. Headach e 3. Nausea an d abdom in al cram p s 4. Water in toxication 5. Hyperten sion with water in toxication 6. Nasal con gestion with n asal ad m in istration

D. In terven tion s 1. Mon itor weigh t. 2. Mon itor in take an d output an d urin e osm o lality. 3. Mon itor electrolyte levels. 4. Mon itor for sign s of deh ydration , in dicatin g th e

n eed to in crease th e dosage. 5. Mon itor for sign s of water in toxication (dro wsi-

n ess, listlessn ess, sh o rtn ess of breath , an d h ead- ach e), in dicatin g th e n eed to decrease dosage.

6. Mon itor blood pressure. 653

7. In struct th e clien t in h ow to use th e in tran asal m ed ication .

8. In struct th e clien t to weigh h im self or h erself daily to iden tify weigh t gain .

9. In struct th e clien t to report sign s of water in tox- ication or sym pto m s of h eadach e or sh o rtn ess of breath .

III. Thyroid Hormones (Box 51-2) A. Description

1. Th yroid h orm on es con trol th e m etabolic rate of tissues an d accelerate h eat productio n an d oxygen con sum p tion .

2. Th yroid h orm on es are used to replace th e th yroid h orm on e deficit in con dition s such as hypothyroidism an d myxedema coma.

3. Th yroid h orm on es en h an ce th e action of oral an ticoagulan ts, sym path om im etics, an d an tide- pressan ts an d decrease th e action of in sulin , oral h ypo glycem ics, an d digitalis preparation s; th e action of th yroid h orm on es is decreased by ph en ytoin an d carbam azep in e.

4. Th yroid h orm on es sh ould be given at least 4 h ou rs apart from m ultivitam in s, alum in um h ydroxide an d m agn esium h ydroxide, sim eth i- con e, calcium carbon ate, sevelam er, lan th an um , bile acid seq uestran ts, iron , an d sucralfate because th ese m ed ication s decrease th e absorp- tion of th yroid replacem en ts.

B. Side an d adverse effects 1. Nausea an d decreased appetite 2. Abdo m in al cram p s an d diarrh ea 3. Weigh t loss 4. Nervo usn ess an d trem o rs 5. In som n ia 6. Sweatin g

7. Heat in toleran ce 8. Tach ycardia, dysrh yth m ias, palp itation s, ch est

pain 9. Hyperten sion

10. Headach e 11. Toxicity: Hyperthyroidism

C. In terven tion s 1. Assess th e clien t for a h isto ry of m edication s cur-

ren tly bein g taken . 2. Mon itor vital sign s. 3. Mon itor weigh t. 4. Mon itor triiodo th yron in e, th yroxin e, an d TSH

levels. 5. In struct th e clien t to take th e m ed ication at

th e sam e tim e each day, in th e m orn in g with ou t food.

6. In struct th e clien t in h ow to m on itor th e pulse rate.

7. In form th e clien t th at it is im portan t to discuss wh ich foods to specifically avoid that m ay in h ibit th yroid secretion based on th e client’s in divi- dualized diet plan an d m edication regim en.

8. Advise th e clien t to avoid over-th e-coun ter m edication s.

9. In struct th e clien t to wear a MedicAlert bracelet.

Advise the client taking a thyroid hormone to report symptoms of hyperthyroidism, such as a fast heart beat (tachycardia), chest pain, palpitations, and excessive sweating. These indicate signs of toxicity.

IV. Antithyroid Medications (Box 51-3) A. Descrip tion

1. An tith yroid m edication s in h ibit th e syn th esis of th yroid h orm on e.

2. An tith yroid m ed ication s are used for h yperth y- roidism , or Graves’ disease.

B. Side an d adverse effects 1. Nausea an d vom itin g 2. Diarrh ea 3. Drowsin ess, h eadach e, fever 4. Hypersen sitivity with rash 5. Agran ulocytosis with leukopen ia an d th rom bo-

cytopen ia 6. Alopecia an d h yperp igm en tation 7. Toxicity: Hypoth yroidism 8. Iodism : Ch aracterized by vom itin g, ab dom in al

pain , m etallic or brassy taste in th e m ou th , rash , an d sore gum s an d salivary glan d s.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 51-1 Growth Hormones and Related Medications

Growth Hormones ▪ Somatropin ▪ Norditropin ▪ Mecasermin Growth Hormone Receptor Antagonists ▪ Octreotide acetate ▪ Lanreotide ▪ Pegvisomant

BOX 51-2 Thyroid Hormones ▪ Levothyroxine sodium ▪ Liothyronine sodium ▪ Liotrix ▪ Thyroid, dessicated

BOX 51-3 Antithyroid Medications ▪ Methimazole ▪ Propylthiouracil ▪ Potassium iodide and strong iodine solution

654 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

Iodism is a concern for clients taking strong iodine solution, also known as Lugol’s solution. Because of the risk of iodism, the use of strong iodine solution is limited to about 2 weeks, generally used for clients with hyper- thyroidism in preparation for thyroid surgery.

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor triiodo th yron in e, th yroxin e, an d TSH

levels. 3. Mon itor weigh t. 4. In struct th e clien t to take m ed ication with

m eals to avoid gastro in testin al (GI) upset. 5. In struct th e clien t in h ow to m on itor th e

pulse rate. 6. In form th e clien t of side an d adverse effects an d

wh en to n otify th e h ealth care provider (HCP) . 7. In struct th e clien t in th e sign s of

h ypo th yroidism . 8. In struct th e clien t regardin g th e im portan ce of

m ed ication com plian ce an d th at ab ruptly stopp in g th e m edication could cau se thyroid storm.

9. In struct th e clien t to m on itor for sign s an d sym pto m s of th yroid storm (fever, flush ed skin , con fusion an d beh avio ral ch an ges, tach ycardia, dysrh yth m ias, an d sign s of h eart failure).

10. In struct th e clien t to m on itor for sign s of iodism . 11. Advise th e clien t to con sult th e HCP before eat-

in g iodized salt an d io din e-rich food s. 12. In struct th e clien t to avoid acetylsalicylic acid

an d m edication s con tain in g iodin e.

Methimazole causes agranulocytosis. Therefore, advise the client to contact the HCP if a fever or sore throat develops. In pregnancy, propylthiouracil is usually used during the first trimester, then the woman is nor- mally switched to methimazole.

V. Parathyroid Medications (Box 51-4) A. Description

1. Parath yroid h orm on e regulates serum calcium levels.

2. Low serum levels of calcium stim ulate parath y- ro id h orm on e release.

3. Hyperparath yro idism results in a h igh serum calcium level an d bon e dem in eralization ; m edi- cation is used to lower th e serum calcium level.

4. Hypo parath yroidism results in a low serum calcium level, wh ich in creases n eurom uscular excitability; treatm en t in cludes calcium an d vitam in D supp lem en ts.

5. Calcium salts adm in istered with digo xin in crease th e risk of digoxin toxicity.

6. O ral calcium salts reduce th e absorption of tetracyclin e h ydroch loride.

B. In terven tion s 1. Mon itor electrolyte an d calcium levels.

2. Assess for sign s an d sym pto m s of h ypo calcem ia an d h ypercalcem ia.

3. Assess for sym pto m s of tetan y in th e clien t with h ypo calcem ia.

4. Assess for ren al calculi in th e clien t with h ypercalcem ia.

5. In struct th e clien t in th e sign s an d sym ptom s of h ypercalcem ia an d h ypo calcem ia.

6. In struct th e clien t to ch eck over-th e-cou n ter m edication labels for th e possibility of calcium con ten t.

7. In struct th e clien t receivin g oral calcium supple- m en ts to m ain tain an adequate in take of vitam in - D because vitam in D en h an ces absorption of calcium .

8. In struct th e clien t receivin g calcium regulators such as alendron ate sodium to swallow the tablet wh ole with water at least 30 m in utes before breakfast an d n ot to lie down for at least 30 m in utes.

9. In struct th e clien t usin g n asal spray of calcito- n in to altern ate n ares.

10. In struct th e clien t usin g an tih yp ercalcem ic agen ts to avoid foods rich in calcium such as green , leafy vegetables; dairy produ cts; sh ell- fish ; an d soy.

11. In struct th e clien t n ot to take oth er m ed ication s with in 1 h our of takin g a calcium supplem en t.

12. In struct th e clien t to in crease fluid an d fiber in th e diet to preven t con stipatio n associated with calcium supplem en ts.

VI. Corticosteroids: Mineralocorticoids A. Fludrocortison e acetate B. Description

1. Min eralocorticoids are steroid h orm on es th at en h an ce th e reabsorp tion of sodium an d

BOX 51-4 Medications to Treat Calcium Disorders

Oral Calcium Supplements ▪ Calcium acetate ▪ Calcium carbonate ▪ Calcium citrate ▪ Calcium glubionate ▪ Calcium gluconate ▪ Tribasic calcium phosphate Vitamin D Supplements ▪ Cholecalciferol (vitamin D3) ▪ Ergocalciferol (vitamin D2)

Bisphosphonates and Calcium Regulators ▪ Alendronate sodium ▪ Calcitonin salmon ▪ Etidronate disodium ▪ Ibandronate ▪ Pamidronate disodium ▪ Risedronate sodium ▪ Tiludronate disodium ▪ Zoledronic acid Medications to Treat Hypercalcemia ▪ Cinacalcet hydrochloride ▪ Doxercalciferol ▪ Calcitonin ▪ Paricalcitol

655CHAPTER 51 Endocrine Medications

A

d

u

l

t

E

n

d

o

c

r

i

n

e

ch loride an d prom o te th e excretion of potassium an d h ydrogen from th e ren al tubu les, th ereby h elp in g to m ain tain fluid an d electrolyte balan ce.

2. Min eralocorticoids are used for replacem en t th erap y in prim ary an d secon dary adren al in suf- ficien cy in Addison’s disease.

C. Side an d adverse effects 1. Sodium an d water retention , edem a, h yperten sion 2. Hypo kalem ia 3. Hypo calcem ia 4. O steoporo sis, com pression fractures 5. Weigh t gain 6. Heart failure

D. In terven tion s 1. Mon itor vital sign s. 2. Mon itor in take an d output, weigh t, an d

for edem a. 3. Mon itor electrolyte an d calcium levels. 4. In struct th e clien t to take m edication with food

or m ilk. 5. In struct th e clien t to con sum e a h igh -

potassium diet. 6. In struct th e clien t to report sign s of illn ess. 7. In struct th e clien t to n otify th e HCP if lo w blood

pressure, weakn ess, cram p in g, palpitation s, or ch an ges in m en tal status occur.

8. In struct th e clien t to wear a Med icAlert bracelet.

Instruct the client taking a corticosteroid not to stop the medication abruptly because this could result in adrenal insufficiency.

VII. Corticosteroids: Glucocorticoids (Box 51-5) A. Description

1. Glu cocorticoids affect gluco se, protein , an d bon e m etab olism ; alter th e n orm al im m un e respon se an d supp ress in flam m ation ; an d produ ce an tiin - flam m atory, an tiallergic, an d an tistress effects.

2. Glu cocorticoids m ay be used as a replacem en t in adren o cortical in sufficien cy.

3. Glu cocorticoids are used for th eir an tiin flam m a- tory an d im m un osuppressan t effects both sh ort- term an d lon g-term in th e treatm en t of several n on en docrin e disorders.

B. Side an d adverse effects 1. Adren al in sufficien cy 2. Hyperglycemia 3. Hypokalem ia 4. Hypocalcem ia, osteoporo sis 5. Sodium an d fluid reten tion 6. Weigh t gain an d edem a 7. Mood swin gs 8. Moon face, buffalo h um p, tru n cal obesity 9. In creased susceptibility to in fectio n an d m ask-

in g of th e sign s an d sym ptom s of in fection 10. Cataracts 11. Hirsutism , acn e, fragile skin , bruisin g 12. Growth retardation in ch ildren 13. GI irritation , peptic ulcer, pan creatitis 14. Seizures 15. Psych osis (usually occurs with h ydroco rtiso n e

an d dexam eth ason e in clien ts receivin g very h igh doses lon g-term an d is m ost likely due to th eir effects on blood gluco se)

C. Con train dication s an d cau tion s 1. Con train dicated in clien ts with h ypersen sitivity,

psych o sis, an d fun gal in fectio n s 2. Sh ould be used with cautio n in clien ts with dia-

betes mellitus 3. Sh ould be used with extrem e cautio n in clien ts

with in fectio n s because th ey m ask th e sign s an d sym ptom s of an in fectio n

4. Th ey can in crease th e poten cy of m ed ication s taken con cu rren tly, such as aspirin an d n on ste- roidal an tiin flam m atory drugs, th u s in creasin g th e risk of GI bleed in g an d ulceration .

5. Use of potassium -losin g diuretics in creases potassium loss, resultin g in h ypo kalem ia.

6. Dexam eth ason e decreases th e effects of orally adm in istered an ticoagulan ts an d an tidiabetic agen ts.

7. Barbiturates, ph en ytoin , an d rifam p in decrease th e effect of predn ison e.

D. In terven tion s 1. Mon itor vital sign s. 2. Mon itor serum electrolyte an d blood glucose

levels. 3. Mon itor for h ypo kalem ia an d h yperglycem ia. 4. Mon itor in take an d outp ut, weigh t, an d

for edem a. 5. Mon itor for h yperten sio n . 6. Assess m ed ical h isto ry for glaucom a, cataracts,

peptic ulcer, m en tal h ealth disorders, or diabe- tes m ellitus.

7. Mon itor th e older clien t for sign s an d sym p- tom s of in creased osteoporo sis.

8. Assess for ch an ges in m uscle stren gth . 9. Prepare a sch edule as n eeded for th e clien t, with

in form ation on sh ort-term tapered doses. 10. In struct th e clien t th at it is best to take m edica-

tion in th e early m orn in g with food or m ilk. 11. Advise th e clien t to eat food s h igh in potassium .

BOX 51-5 Corticosteroids: Glucocorticoids ▪ Betamethasone ▪ Cortisone acetate ▪ Dexamethasone ▪ Hydrocortisone ▪ Methylprednisolone ▪ Prednisolone ▪ Prednisone ▪ Triamcinolone

656 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

12. In struct th e clien t to avoid in dividuals with in fectio n s.

13. Advise th e clien t to in form all HCPs of th e m ed- ication regim en .

14. In struct th e clien t to report sign s an d sym pto m s of Cushing’s syndrome, in cludin g a m oon face, puffy eyelids, edem a in th e feet, in creased bruis- in g, dizzin ess, bleed in g, an d m en strual irregu- larities, wh ich often results from th e large doses of lon g-term gluco cortico ids th at m ay be used to treat n on en docrin e con dition s.

15. Note th at th e clien t m ay n eed addition al doses durin g periods of stress, such as surgery.

16. In struct th e clien t n ot to stop th e m ed ication abru ptly because ab rupt with drawal can result in severe adren al in sufficien cy.

17. Advise th e clien t to con sult with th e HCP before receivin g vaccin ation s; live virus vaccin es sh ould n ot be adm in istered to th e clien t takin g gluco cortico ids.

18. Advise th e clien t to wear a Med icAlert bracelet.

VIII. Androgens (Box 51-6) A. Description

1. Used to replace deficien t h orm on es or to treat h orm on e-sen sitive disorders

2. Can cause bleed in g if th e clien t is takin g oral an ticoagulan ts (in crease th e effect of an ticoagulan ts)

3. Can cau se decreased serum gluco se con cen tra- tio n , th ereby reducin g in sulin requirem en ts in th e clien t with diabetes m ellitus

4. Hepatotoxic m edication s are avoided with th e use of an drogen s because of th e risk of ad ditive dam age to th e liver.

5. An d rogen s usually are avoided in m en with kn own prostate or breast carcin om a because an drogen s often stim ulate growth of th ese tum o rs.

B. Side an d ad verse effects 1. Masculin e secon dary sexual ch aracteristics (body

h air growth , lowered voice, m uscle growth)

2. Bladder irritatio n an d urin ary tract in fectio n s 3. Breast ten dern ess 4. Gyn eco m astia 5. Priapism 6. Men strual irregularities 7. Virilism 8. Sodium an d water reten tion with edem a 9. Nausea, vom itin g, or diarrh ea

10. Acn e 11. Ch an ges in libido 12. Hepatoto xicity, jaun dice 13. Hypercalcem ia

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor for edem a, weigh t gain , an d skin

ch an ges. 3. Assess m en tal status an d n eurological fun ction . 4. Assess for sign s of liver dysfun ction , in cludin g

righ t upper quadran t abdom in al pain , m alaise, fever, jaun dice, an d pruritus.

5. Assess for th e developm en t of secon dary sexual ch aracteristics.

6. In struct th e clien t to take m ed ication with m eals or a sn ack.

7. In struct th e clien t to n otify th e HCP if priapism develops.

8. In struct th e clien t to n otify th e HCP if fluid reten tion occurs.

9. In struct wom en to use a n on h orm on al con tra- ceptive wh ile on th erap y.

10. For wom en , m on itor for m en strual irregulari- ties an d decreased breast size.

IX. Estrogens and Progestins A. Description

1. Estrogen s are steroids th at stim ulate fem ale reprodu ctive tissue.

2. Progestin s are steroids th at specifically stim ulate th e uterin e lin in g.

3. Estrogen an d progestin preparation s m ay be used to stim ulate th e en dogen ous h orm on es to restore h orm on al balan ce or to treat h orm on e- sen sitive tum o rs (suppress tum or growth ) or for con traception (Boxes 51-7 an d 51-8).

B. Con train dication s an d caution s 1. Estrogen s

a. Estrogen s are con train dicated in clien ts with breast can cer, en dom etrial h yperp lasia, en do- m etrial can cer, h isto ry of th rom boem bo lism , kn own or susp ected pregn an cy, or lactation .

BOX 51-6 Androgens ▪ Methyltestosterone Testosterone Preparations ▪ Testosterone, pellets ▪ Testosterone, transdermal ▪ Testosterone cypionate ▪ Testosterone enanthate ▪ Testosterone propionate ▪ Testosterone undecanoate ▪ Testosterone, buccal patch ▪ Testosterone, topical gel ▪ Testosterone, nasal gel

BOX 51-7 Estrogens

▪ Esterified estrogens ▪ Estradiol

▪ Estrogens, conjugated ▪ Ethinyl estradiol

657CHAPTER 51 Endocrine Medications

A

d

u

l

t

E

n

d

o

c

r

i

n

e

b . Use estrogen s with cau tion in clien ts with h yperten sion , gallblad der disease, or liver or kidn ey dysfun ction .

c. Estrogen s in crease th e risk of toxicity wh en used with h epatoto xic m edication s.

d . Barbiturates, ph en yto in , an d rifam pin decrease th e effectiven ess of estrogen .

2. Progestin s are con train dicated in clien ts with th rom boem bo lic disorders an d sh ould be avoided in clien ts with breast tum ors or h epatic disease.

C. Side an d adverse effects 1. Breast ten dern ess, m en strual ch an ges 2. Nausea, vo m itin g, an d diarrh ea 3. Malaise, depression , excessive irritability 4. Weigh t gain 5. Edem a an d flu id reten tion 6. Ath erosclerosis 7. Hyperten sion , stroke, m yocardial in farction 8. Th rom b oem bolism (estrogen ) 9. Migrain e h eadach es an d vom itin g (estrogen )

D. In terven tion s 1. Mon itor vital sign s. 2. Mon itor for h yperten sion . 3. Assess for edem a an d weigh t gain . 4. Advise th e clien t n ot to sm oke. 5. Advise th e clien t to un d ergo routin e breast an d

pelvic exam in ation s.

X. Contraceptives A. Description

1. Th ese m ed ication s con tain a com bin ation of estrogen an d a progestin or a progestin alon e.

2. Estrogen -progestin com bin ation s suppress ovu- lation an d ch an ge th e cervical m ucus, m akin g it difficu lt for sperm to en ter.

3. Medication s th at con tain on ly progestin s are less effective th an th e com bin ed m ed ication s.

4. Con traceptives usually are taken for 21 con sec- utive days an d stopped for 7 days; th e adm in is- tration cycle is th en repeated.

5. Con traceptives provide reversible preven tion of pregn an cy.

6. Con traceptives are useful in con trollin g irregu- lar or excessive m en strual cycles.

7. Risk factors associated with th e develop- m en t of com plication s related to th e use of con tracep tives in clude sm okin g, obesity, an d h yperten sion .

8. Con traceptives are con train dicated in wom en with h yperten sion , th rom boem bolic disease, cerebro vascu lar or coron ary artery disease, estrogen -depen d en t can cers, an d pregn an cy.

9. Con traceptives sh ould be avoided with th e use of h epatotoxic m edication s.

10. Con traceptives in terfere with th e activity of bro- m ocriptin e m esylate an d an ticoagulan ts an d in crease th e toxicity of tricyclic an tidepressan ts.

11. Con traceptives m ay alter blood gluco se levels. 12. An tibio tics m ay decrease th e absorption an d

effectiven ess of oral con tracep tives. B. Side an d adverse effects

1. Breakth rough bleedin g 2. Excessive cervical m ucus form ation 3. Breast ten dern ess 4. Hyperten sion 5. Nausea, vom itin g

C. In terven tion s 1. Mon itor vital sign s an d weigh t. 2. In struct th e clien t in th e ad m in istration of th e

m edication (it m ay take up to 1 week for full con tracep tive effect to occur wh en th e m edica- tion is begun ).

3. In struct th e clien t with diabetes m ellitus to m on itor blood gluco se levels carefully.

4. In struct th e clien t to report sign s of th rom bo- em bolic com plication s.

5. In struct th e clien t to n otify th e HCP if vagin al bleedin g or m en strual irregularities occur or if pregn an cy is suspected.

6. Advise th e clien t to use an altern ative m eth od of birth con tro l wh en takin g an tibiotics because th ese m ay decrease absorption of th e oral con tracep tive.

7. In struct th e clien t to perform breast self- exam in ation regularly an d about th e im por- tan ce of an n ual ph ysical exam in ation s.

8. Con traceptive patch es a . Design ed to be worn for 3 weeks an d

rem oved for a 1-week period b . Applied on clean , dry, in tact skin on th e but-

tocks, abdom en , upper outer arm , or upper torso

c. In struct th e clien t to peel away h alf of th e backin g on a patch , apply th e sticky surface to th e skin , rem ove th e oth er h alf of th e backin g, an d th en press down on th e patch with th e palm for 10 secon ds.

d . In struct th e clien t to ch an ge th e patch weekly, usin g a n ew location for each patch .

e. If th e patch falls off an d rem ain s off for less th an 24 h ou rs (such as wh en th e clien t is

BOX 51-8 Progestins

▪ Estradiol/ drospirenone ▪ Estradiol/ norgestimate ▪ Estradiol/ levonorgestrel ▪ Estradiol/ norethindrone ▪ Estradiol/ etonogestrel ▪ Medroxyprogesterone

acetate

▪ Medroxyprogesterone and conjugated estrogens

▪ Megestrol acetate ▪ Norethindrone acetate ▪ Levonorgestrel ▪ Progesterone

658 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

sleepin g or is un aware th at it h as fallen off) , it can be reapplied if still sticky, or it can be replaced with a n ew patch .

f. If the patch is off for m ore than 24 h ours, a n ew 4-week cycle m ust be started im m ediately.

9. Vagin al rin g a . In serted in to th e vagin a by th e clien t, left in

place for 3 weeks, an d rem oved for 1 week b . Th e m edication is ab sorbed th rough

m ucou s m em bran es of th e vagin a. c. Rem o ved rin gs sh ould be wrapped in a foil

pouch an d discarded, n ot flush ed down th e toilet.

10. Im p lan ts an d depot in jection s provide lon g- actin g form s of birth con trol, from 3 m on th s to 5 years in duration .

If the client decides to discontinue the contraceptive to become pregnant, recommend that the client use an alternative form of birth control for 2 months after dis- continuation to ensure more complete excretion of hor- monal agents before conception.

XI. Fertility Medications (Box 51-9) A. Description

1. Fertility m ed ication s act to stim ulate follicle developm en t an d ovulation in fun ction in g ova- ries an d are com bin ed with h um an ch orion ic go n adotropin to m ain tain th e follicles on ce ovu- lation h as occurred.

2. Fertility m ed ication s are con train d icated in th e presen ce of prim ary ovarian dysfun ction , th yroid or adren al dysfun ction , ovarian cysts, pregn an cy, or idio path ic uterin e bleed in g.

3. Fertility m edication s sh ould be used with cau- tio n in clien ts with th rom boem bolic or respira- tory disease.

B. Side an d ad verse effects 1. Risk of m ultiple birth s an d birth defects 2. O varian overstim u lation (abdom in al pain , dis-

ten tion , ascites, pleural effusion ) 3. Headach e, irritability 4. Fluid reten tion an d bloatin g 5. Nausea, vo m itin g 6. Uterin e bleedin g 7. O varian en largem en t

8. Gyn eco m astia 9. Rash

10. O rth o static h ypo ten sion 11. Febrile reaction s

C. In terven tion s 1. In struct th e clien t regardin g adm in istration of

th e m ed ication . 2. Provide a calen dar of treatm en t days an d

in struction s on wh en in tercourse sh o uld occur to in crease th erapeutic effectiven ess of th e m ed ication .

3. Provide in form ation about th e risks an d h azards of m ultiple birth s.

4. In struct th e clien t to n otify th e HCP if sign s of ovarian overstim ulation occur.

5. In form th e clien t about th e n eed for regular follo w-up for evaluatio n .

XII. Medications for Diabetes Mellitus A. In sulin an d oral an tidiabetic m edication s

1. Description a. In sulin in creases glucose tran spo rt in to cells

an d prom otes con version of gluco se to glyco- gen , decreasin g serum gluco se levels.

b . O ral an tidiabetic agen ts act in a n um ber of ways: stim ulate th e pan creas to produce m ore in sulin , in crease th e sen sitivity of periph eral receptors to in sulin , decrease h epatic gluco se output, delay in testin al absorption of glu- cose, en h an ce th e activity of in cretin s, an d prom o te gluco se loss th rough th e kidn ey.

2. Con train dication s an d con cern s a. O ral an tidiabetic agen ts, except th e sodium -

gluco se co-tran sporter 2 (SGLT-2) in h ibitors, are con train dicated in type 1 diabetes m ellitus.

b . β-Adren ergic blockin g agen ts m ay m ask sign s an d sym pto m s of h ypo glycem ia associated with h ypoglycem ia-prod ucin g m edication s.

c. An ticoagulan ts, ch loram ph en icol, salicylates, propran olol, m on oam in e oxidase in h ibitors, pen tam idin e, an d sulfon am ides m ay cau se h ypoglycem ia.

d . Corticosteroid s, sym path om im etics, th iazide diuretics, ph en yto in , th yroid preparation s, oral con traceptives, an d estrogen com po un ds m ay cau se h yperglycem ia.

e. Side an d adverse effects of th e sulfon ylureas in clude GI sym pto m s an d derm ato lo gical reactio n s; h ypoglycem ia can occur wh en an excessive dose is adm in istered or wh en m eals are om itted or delayed, food in take is decreased, or activity is in creased.

Sulfonylureas can cause a disulfiram type of reac- tion when alcohol is ingested.

BOX 51-9 Fertility Medications ▪ Chorionic gonadotropin ▪ Clomiphene citrate ▪ Follitropin alfa ▪ Follitropin beta ▪ Menotropins ▪ Urofollitropin ▪ Cetrorelix

659CHAPTER 51 Endocrine Medications

B. Medication s for type 2 diabetes m ellitus (Table 51-1) 1. In terven tion s

a. Assess th e clien t’s kn owledge of diabetes m ellitus an d th e use of oral an tidiabetic agen ts.

b . O btain a m ed ication h isto ry regardin g th e m edication s th at th e clien t is takin g curren tly.

c. Assess vital sign s an d blood glucose levels.

d . In struct th e clien t to recogn ize th e sign s an d sym ptom s of h ypo glycem ia an d h yperglycem ia.

e. In stru ct th e clien t to avo id o ver-th e- co u n ter m ed icatio n s u n less p rescrib ed b y th e H CP.

f. In struct th e clien t n ot to in gest alcoh ol with sulfon ylureas.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

TABLE 51-1 Medications for Type 2 Diabetes Class and Specific Agents Actions Major Adverse Effects

Oral Medications Bigua nide Metformin Decreases glucose production by the liver; increases tissue

response to insulin Gastrointestinal (GI) symptoms: decreased appetite, nausea, diarrhea Lactic acidosis (rarely)

Second-Genera tion Sulfonylurea s Glimepiride Glipizide Glyburide*

Promote insulin secretion by the pancreas; may also increase tissue response to insulin

Hypoglycemia Weight gain

Meglit inides (Glinides) Nateglinide Repaglinide

Promote insulin secretion by the pancreas Hypoglycemia Weight gain

Thia zolidinediones (Glita zones) Pioglitazone Rosiglitazone

Decrease insulin resistance, and thereby increase glucose uptake by muscle and adipose tissue and decrease glucose production by the liver

Hypoglycemia, but only in the presence of excessive insulin Heart failure Bladder cancer Fractures (in women) Ovulation, and thus possible unintended pregnancy

Alpha -Glucosida se Inhibit ors Acarbose Miglitol

Delay carbohydrate digestion and absorption, thereby decreasing the postprandial rise in blood glucose

GI symptoms: flatulence, cramps, abdominal distention, borborygmus

DPP-4 Inhibitors (Gliptins) Alogliptin Linagliptin Saxagliptin Sitagliptin

Enhance the activity of incretins (by inhibiting their breakdown by DPP-4), and thereby increase insulin release, reduce glucagon release, and decrease hepatic glucose production

Pancreatitis Hypersensitivity reactions

Sodium-Glucose Co-Tra nsporter 2 (SGLT-2) Inhibit ors Canagliflozin Dapagliflozin Empagliflozin

Increase glucose excretion via the urine by inhibiting SGLT-2 in the kidney tubules, decreasing glucose levels and inducing weight loss via caloric loss through the urine

Genital mycotic infections Orthostasis

Dopamine Agonist Bromocriptine Activates dopamine receptors in the central nervous system;

how it improves glycemic control is unknown Orthostatic hypotension Exacerbation of psychosis

Non-Insulin Injectable Medications Incretin Mimet ics Exenatide Exenatide extended-release Liraglutide Albiglutide

Lower blood glucose by slowing gastric emptying, stimulating glucose-dependent insulin release, suppressing postprandial glucagon release, and reducing appetite

Hypoglycemia GI symptoms: nausea, vomiting, diarrhea Pancreatitis Renal insufficiency

Amylin Mimetics Pramlintide Delays gastric emptying and suppresses glucagon secretion,

decreasing the postprandial rise in glucose Hypoglycemia Nausea Injection-site reactions

*Commonly known as glibenclamide outside the United States. Adapted from Burchum JR, Rosenthal RD: Lehne’s pharmacology for nursing care, ed 9, St. Louis, 20 16, Saunders.

660 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

g. In form th e clien t th at in sulin m ay be n eeded durin g tim es of in creased stress, surgery, or in fectio n .

h . In struct th e clien t on th e n ecessity for com pli- an ce with prescribed m ed ication .

i. In struct th e clien t about h ow to take each spe- cific m edication , such as with th e first bite of th e m eal for m eglitin ides an d α-glucosidase in h ib itors.

j. Advise th e clien t to wear a MedicAlert bracelet.

Metformin needs to be withheld temporarily before and for 48 hours after having any radiological study that involves the administration of intravenous contrast dye because of the risk of contrast-induced nephropathy and lactic acidosis. The HCP needs to be consulted for spe- cific prescriptions.

C. In sulin 1. In sulin acts prim arily in th e liver, m uscle, an d

ad ipose tissue by attach in g to receptors on cellu- lar m em bran es an d facilitatin g th e passage of gluco se, potassium , an d m agn esium .

2. In sulin is prescribed for clien ts with type 1 diabe- tes m ellitus an d for clien ts with type 2 diabetes m ellitus wh ose blood gluco se levels are n ot ade- quately con trolled with oral an tidiabetic agen ts.

3. Th e on set, peak, an d duration of action depen d on th e in sulin type (Tables 51-2 an d 51-3).

4. Storin g of in sulin ( Box 51-10) 5. In sulin in jection sites

a . Th e m ain areas for in jection s are th e ab do- m en , arm s (po sterior surface), th igh s (an te- rior surface) , an d h ips ( Fig. 51-1).

b . In sulin in jected in to th e abdom en m ay absorb m ore even ly an d rapidly th an at oth er sites.

c. System atic rotation with in 1 an atom ical area is recom m en ded to preven t lipodystrop h y an d to prom ote m ore even ab sorption ; cli- en ts sh ould be in structed n ot to use th e sam e site m ore th an on ce in a 2- to 3-week period.

d . In jection s sh ould be 1 to 1.5 in ch es (2.5 to 3.8 cm ) ap art with in th e an atom ical area.

e. Heat, m assage, an d exercise of th e in jected area can in crease absorption rates an d m ay result in h ypo glycem ia.

f. In jection in to scar tissue m ay delay absorp- tion of in sulin .

6. Adm in isterin g in sulin

Insulin glargine cannot be mixed with any other types of insulin.

a. To preven t dosage errors, be certain th at th ere is a m atch between th e in sulin con cen tration n oted on th e vial an d th e calibration of un its on th e in sulin syrin ge; th e usual con cen tra- tion of in sulin is U-100 (100 un its/ m L).

b . Th e Hu m ulin R bran d of regular in sulin is th e on ly in sulin th at is form ulated in a U-500 stren gth . U-500 stren gth in sulin is reserved for clien ts with severe in sulin resistan ce wh o require large doses of in sulin . A special syrin ge calibrated for use with U-500 in sulin is required .

c. Most in sulin syrin ges h ave a 27- to 29-gauge n eedle th at is about 12 -in ch lon g (1.3 cm ).

d . NPH in sulin is an in sulin suspen sion ; th e appearan ce is cloudy. All oth er in sulin typ es are solution s; th e appearan ce of all oth er in sulin products is clear.

TABLE 51-2 Types of Insulin: Time Course of Activity After Subcutaneous Injection

Time Course

Generic Name Onset (min) Peak (hr) Duration (hr)

Short Duration: Rapid Acting Insulin lispro 15–30 0.5–2.5 3–6

Insulin aspart 10–20 1–3 3–5

Insulin glulisine 10–15 1–1.5 3–5

Short Duration: Slower Acting Regular insulin 30–60 1–5 6–10

Intermediate Duration NPH insulin 60–120 6–14 16–24

Long Duration Insulin glargine 70 None 18–24

Insulin detemir 60–120 12–24 Varies

Adapted from Burchum JR, Rosenthal RD: Lehne’s pharmacology for nursing care, ed 9, St. Louis, 20 16, Saunders.

TABLE 51-3 Premixed Insulin Combinations* Time Course

Description Onset (min)

Peak (hr)

Duration (hr)

70% NPH insulin/ 30% regular insulin

30–60 1.5–16 10–16

30–60 2–12 10–16

50% NPH insulin/ 50% regular insulin

30–60 2–12 10–16

70% insulin aspart protamine/ 30% insulin aspart

10–20 1–4 15–18

75% insulin lispro protamine/ 25% insulin lispro

15–30 1–6.5 10–16

50% insulin lispro protamine/ 50% insulin lispro

15–30 0.8– 4.8

10–16

*Use only after the dosages and ratios of the components have been established as correct for the client. Adapted from Burchum JR, Rosenthal RD: Lehne’s pharmacology for nursing care, ed 9, St. Louis, 20 16, Saunders.

661CHAPTER 51 Endocrine Medications

e. Before use, NPH in sulin s m ust be rotated, or rolled, between th e palm s to en sure th at th e in sulin suspen sion is m ixed well; oth erwise, an in accurate dose will be drawn ; vigorou sly sh akin g th e bottle will cause bubbles to form . It is n ot n ecessary to rotate or roll clear in su- lin s before usin g.

f. In ject air in to th e in sulin bottle (a vacuum m akes it difficu lt to draw up th e in sulin ).

g. Wh en m ixin g in sulin s, draw up th e sh ortest- actin g in sulin first ( Fig. 51-2).

h . Sh ort-duration (i.e., regular, lisp ro, aspart, an d glulisin e) in sulin m ay be m ixed with NPH.

i. Adm in ister a m ixed dose of in sulin with in 5 to 15 m in utes of preparation ; after th is tim e, th e sh ort-actin g in sulin bin ds with th e NPH in sulin an d its action is reduced.

j. Aspiration after in sertio n of th e n eedle gen er- ally is n ot recom m en ded with self-in jectio n of in sulin .

k . Adm in ister in sulin at a 45- to 90-degree an gle in clien ts with n orm al subcu tan eous m ass an d at a 45- to 60-degree an gle in th in per- son s or th o se with a decreased am oun t of subcutan eous m ass.

Some rapid- and short-acting insulins can be admin- istered intravenously.

D. Glucagon -like pep tide (GLP-1) receptor agon ists 1. Non -in sulin in jectable agen ts th at are an alo gs of

h um an GLP-1 an d cause th e sam e effects as th e GLP-1 in cretin h orm on e in th e body, wh ich are to stim ulate th e gluco se level–dep en den t release of in sulin , to supp ress th e postp ran dial release of glucagon , to slow gastric em ptyin g, an d to supp ress appetite

2. Used for clien ts with type 2 diab etes m ellitus (n ot recom m en ded for clien ts takin g in sulin , n or sh o uld clien ts be taken off of in sulin an d given a GLP-1 receptor agon ist)

3. GLP-1 receptor agon ists restore th e first-ph ase in sulin respo n se (first 10 m in utes after food in gestion ), lo wer th e produ ction of glucagon after m eals, slow gastric em p tyin g (wh ich lim its th e rise in blood glucose level after a m eal), reduce fastin g an d postpran dial blood glucose levels, an d reduce caloric in take, resultin g in weigh t loss

A

d

u

l

t

E

n

d

o

c

r

i

n

e

BOX 51-10 Storing Insulin Avoid exposing insulin to extremes in temperature. Insulin should not be frozen or kept in direct sunlight or a hot

car. Before injection, insulin should be at room temperature. If a vial of insulin will be used up in 1 month, it may be kept at

room temperature; otherwise, the vial should be refrigerated.

1 Wa s h ha nds . 2 Ge ntly rota te NP H ins ulin bottle . 3 Wipe off tops of ins ulin via ls with a lcohol s wa b. 4 Dra w ba ck a mount of a ir into the s yringe tha t e qua ls tota l dos e .

5 Inje ct a ir e qua l to NP H dos e into NP H via l. Re move s yringe from via l taking c are no t to to uc h ne e dle tip to fluid. 36 units

36 U Air

Re gula r ins ulin (cle a r)

Re gula r ins ulin (cle a r)

NP H ins ulin (cloudy)

NP H ins ulin (cloudy)

Re gula r ins ulin 12 units

Re gula r ins ulin

36 units 48 units (tota l dos e )

NP H ins ulin

12 units

12 U Air

6 Inje ct a ir e qua l to re gula r dos e into re gula r via l.

7 Inve rt re gula r ins ulin bottle a nd withdra w re gula r ins ulin dos e .

8 Without a dding more a ir to NP H via l, ca re fully withdra w NP H dos e taking c are no t to pus h fluid bac k into c o ntaine r as this will c o ntaminate NPH ins ulin with Re g ular ins ulin.

FIGURE 51-2 Steps for mixing insulins. Note: Colors here are not representative of actual insulin. NPH is a cloudy white fluid and Regular is a clear fluid with no color.

Front Ba ck

FIGURE 51-1 Common insulin injection sites.

662 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

4. Packaged in prem easured doses (pen s) th at require refrigeration (can n ot be fro zen )

5. Adm in istered as a subcu tan eo us in jection in th e th igh , abdom en , or upper arm . Exen atide is ad m in istered twice daily with in 60 m in u tes befo re m orn in g an d even in g m eals (n ot taken after m eals) ; if a dose is m issed, th e treatm en t regim en is resum ed as prescribed with th e n ext sch eduled dose. Liraglutide is adm in istered sub- cutan eously on ce daily with ou t regard to m eals. Alb iglutide is in jected subcutan eously on ce weekly.

6. Can cau se m ild to m od erate n ausea th at abates with use.

7. Because delayed gastric em p tyin g slows th e ab sorption of oth er m edication s, oth er pre- scrib ed oral m ed ication s sh ould be given an h ou r before in jection of th ese m edication s.

E. Am ylin Mim etic: Pram lin tide 1. Syn th etic form of am ylin , a n aturally occurrin g

h orm on e secreted by th e pan creas 2. Used for clien ts with types 1 an d 2 diabetes

m ellitus wh o use in sulin ; adm in istered subcu ta- n eously before m eals to lower blood gluco se level after m eals, leadin g to less fluctuation durin g th e day an d better lon g-term gluco se con trol

3. Asso ciated with an in creased risk of in sulin - in du ced severe h ypo glycem ia, particularly in cli- en ts with type 1 diabetes m ellitus

4. GI effects, in cludin g n ausea, can occur. 5. Un open ed vials are refrigerated; open ed vials can

be refrigerated or kept at room tem perature for up to 28 days.

6. Redu ces postpran dial h yperglycem ia by delayin g gastric em p tyin g an d suppressin g postpran dial glucagon release

7. Because pram lin tide delays gastric em p tyin g, oth er prescribed oral m edication s sh ould be given 1 h ou r befo re or 2 h ours after an in jection of pram lin tide.

F. Glu cagon 1. Ho rm on e secreted by th e alph a cells of th e islets

of Lan gerh an s in th e pan creas 2. In creases blood glucose level by stim ulatin g gly-

cogen olysis in th e liver 3. Can be ad m in istered subcu tan eo usly, in tram us-

cularly, or in traven o usly 4. Used to treat in sulin -in du ced h ypo glycem ia

wh en th e clien t is sem icon sciou s or un co n sciou s an d is un able to in gest liqu ids

5. Th e blood gluco se level begin s to in crease with in 5 to 20 m in u tes after adm in istration .

6. In struct th e fam ily in th e proced ure for ad m in istration .

7. See Ch apter 50 for addition al in form ation regardin g in terven tion s for h ypo glycem ia.

CRITICAL THINKING What Should You Do? Answer: The nurse needs to plan to instruct the client to temporarily discontinue the metformin a day or 2 before the CT scan and for 48 hours after the scan. Health care provider prescriptions and agency procedures are followed regarding timelines for discontinuing the medication. Intravenous con- trast that contains iodine poses a risk for contrast-induced nephropathy. Lactic acidosis may result if metformin is administered to a client who is experiencing poor kidney function. The serum creatinine level may also be checked before allowing the client to resume the medication.

References: Ignatavicius, Workman (20 16), p. 1310 ; Pagana, Pagana, Pagana (20 15), p. 284.

P R A C T I C E Q U E S T I O N S 570. Th e n urse is teach in g a clien t h ow to m ix regular

in sulin an d NPH in sulin in th e sam e syrin ge. Wh ich action , if perform ed by th e clien t, in dicates th e n eed fo r fu rth er teach in g? 1. With draws th e NPH in sulin first 2. With draws th e regular in sulin first 3. In jects air in to NPH in sulin vial first 4. In jects an am oun t of air equal to th e desired

dose of in sulin in to each vial

571. Th e h om e care n urse visits a clien t recen tly diag- n osed with diab etes m ellitus wh o is takin g Hum u- lin NPH in sulin daily. Th e clien t asks th e n urse h ow to store th e un o pen ed vials of in sulin . Th e n urse sh o uld tell th e clien t to take wh ich action ? 1. Freeze th e in sulin . 2. Refrigerate th e in sulin . 3. Store th e in sulin in a dark, dry place. 4. Keep th e in sulin at room tem perature.

572. Glim epiride is prescribed for a clien t with diabetes m ellitus. Th e n urse in structs th e clien t th at wh ich food item s are m o st acceptable to con sum e wh ile takin g th is m edication ? Select all th at ap p ly.

1. Alcoh ol 2. Red m eats 3. Wh ole-grain cereals 4. Low-calorie desserts 5. Carb on ated beverages

573. Th e n urse is providin g disch arge teach in g for a cli- en t n ewly diagn osed with typ e 2 diabetes m ellitus wh o h as been prescribed m etform in . Wh ich clien t statem en t in dicates th e n eed fo r fu rth er teach in g? 1. “It is okay if I skip m eals n ow an d th en .” 2. “I n eed to con stan tly watch for sign s of low

blood sugar.”

663CHAPTER 51 Endocrine Medications

3. “I n eed to let m y h ealth care provider kn ow if I get un u sually tired.”

4. “I will be sure to n ot drin k alcoh ol excessively wh ile on th is m edication .”

574. Th e h ealth care provider (HCP) prescribes exen a- tid e for a clien t with type 1 diabetes m ellitus wh o takes in sulin . Th e n urse sh o uld plan to take wh ich m o st ap p ro p riate in terven tion ? 1. With h old th e m ed ication an d call th e HCP,

question in g th e prescription for th e clien t. 2. Adm in ister th e m ed ication with in 60 m in u tes

before th e m orn in g an d even in g m eal. 3. Mon itor th e clien t for gastro in testin al side

effects after adm in isterin g th e m ed ication . 4. With draw th e in sulin from th e prefilled pen

in to an in sulin syrin ge to prepare for adm in istration .

575. A clien t is takin g Hum ulin NPH in sulin an d regular in sulin every m orn in g. Th e n urse sh ould provid e wh ich in struction s to th e clien t? Select all th at ap p ly.

1. Hypoglycem ia m ay be experien ced before din n ertim e.

2. Th e in sulin dose sh ould be decreased if ill- n ess occurs.

3. Th e in sulin sh ould be adm in istered at ro om tem perature.

4. Th e in sulin vial n eeds to be sh aken vigor- ously to break up th e precipitates.

5. Th e NPH in sulin sh o uld be drawn in to th e syrin ge first, th en th e regular in sulin .

576. Th e h om e h ealth care n urse is visitin g a clien t wh o was recen tly diagn osed with typ e 2 diabetes m elli- tus. Th e clien t is prescribed repaglin ide an d m etfor- m in . Th e n urse sh o uld provid e wh ich in struction s to th e clien t? Select all th at ap p ly.

1. Diarrh ea m ay occur secon dary to th e m etform in .

2. Th e repaglin id e is n ot taken if a m eal is skipp ed.

3. Th e repaglin ide is taken 30 m in u tes before eatin g.

4. A sim ple sugar food item is carried an d used to treat m ild h ypo glycem ia episo des.

5. Muscle pain is an expected effect of m etfor- m in an d m ay be treated with acetam in oph en.

6. Metform in in creases h epatic gluco se produ c- tion to preven t h ypoglycem ia associated with repaglin ide.

577. Th e n urse is teach in g th e clien t about h is pre- scrib ed predn ison e. Wh ich statem en t, if m ade by th e clien t, in dicates th at fu rth er teach in g is n ecessary?

1. “I can take aspirin or m y an tih istam in e if I n eed it.”

2. “I n eed to take th e m ed ication every day at th e sam e tim e.”

3. “I n eed to avoid coffee, tea, cola, an d ch oco late in m y diet.”

4. “If I gain m ore th an 5 poun ds (2.25 kg) a week, I will call m y h ealth care provid er (HCP) .”

578. A clien t with h yperth yroidism h as been given m eth im azole. Wh ich n ursin g con sideration s are associated with th is m ed ication ? Select all th at ap p ly.

1. Adm in ister m eth im azole with food . 2. Place th e clien t on a low-calorie, low-

protein diet. 3. Assess th e clien t for un exp lain ed bruisin g or

bleedin g. 4. In stru ct th e clien t to rep o rt sid e an d ad verse

effects su ch as so re th ro at, fever, o r h ead ach es.

5. Use special radioactive precaution s wh en h an dlin g th e clien t’s urin e for th e first 24 h ours followin g in itial adm in istration .

579. Th e n urse is m on itorin g a clien t receivin g levoth y- roxin e sodium for h ypo th yroidism . Wh ich fin din gs in dicate th e presen ce of a side effect associated with th is m ed ication ? Select all th at ap p ly.

1. In som n ia 2. Weigh t loss 3. Bradycardia 4. Con stipation 5. Mild h eat in toleran ce

580. Th e n urse provides in struction s to a clien t wh o is takin g levo th yroxin e. Th e n urse sh ould tell th e cli- en t to take th e m ed ication in wh ich way? 1. With food 2. At lun ch tim e 3. O n an em p ty stom ach 4. At bedtim e with a sn ack

581. Th e n urse sh ould tell th e clien t, wh o is takin g levo th yroxin e, to n otify th e h ealth care provider (HCP) if wh ich problem occurs? 1. Fatigue 2. Trem ors 3. Cold in toleran ce 4. Excessively dry skin

582. Th e n urse is providin g in struction s to th e clien t n ewly diagn osed with diabetes m ellitus wh o h as been prescribed pram lin tide. Wh ich in struction sh ould th e n urse in clude in th e disch arge teach in g? 1. “In ject th e pram lin tide at th e sam e tim e you take

your oth er m edication s.”

A

d

u

l

t

E

n

d

o

c

r

i

n

e

664 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

E

n

d

o

c

r

i

n

e

2. “Take your prescribed pills 1 h ou r before or 2 h ours after th e in jection .”

3. “Be sure to take th e pram lin tide with food so you don ’t upset your stom ach .”

4. “Make sure you take your pram lin tide im m edi- ately after you eat so you don ’t experien ce a low blood sugar.”

583. Th e n urse teach es th e clien t, wh o is n ewly diag- n osed with diabetes in sipidu s, about th e pre- scrib ed in tran asal desm opressin . Wh ich statem en ts by th e clien t in dicate un derstan din g? Select all th at ap p ly.

1. “Th is m ed ication will turn m y urin e oran ge.” 2. “I sh ould decrease m y oral fluids wh en I start

th is m edication .” 3. “Th e am oun t of urin e I m ake sh ould in crease

if th is m edicin e is workin g.” 4. “I n eed to follow a low-fat diet to avoid pan -

creatitis wh en takin g th is m edicin e.” 5. “I sh ould report h eadach e an d drowsin ess to

m y h ealth care provid er sin ce th ese sym p- tom s could be related to m y desm op ressin .”

584. A daily dose of predn ison e is prescribed for a clien t. Th e n urse provides in struction s to th e clien t regardin g adm in istration of th e m ed ication an d sh ould in struct th e clien t th at wh ich tim e is b est to take th is m ed ication ? 1. At n oo n

2. At bed tim e 3. Early m orn in g 4. An y tim e, at th e sam e tim e, each day

585. Th e clien t with h yperparath yroidism is takin g alen - dron ate. Wh ich statem en ts by th e clien t in dicate un derstan din g of th e proper way to take th is m ed- ication ? Select all th at ap p ly.

1. “I sh ould take th is m edication with food.” 2. “I sh ould take th is m ed ication at bed tim e.” 3. “I sh ould sit up for at least 30 m in u tes after

takin g th is m ed ication .” 4. “I sh ould take th is m edication first th in g in

th e m orn in g on an em pty stom ach .” 5. “I can pick a tim e to take th is m edication th at

best fits m y lifestyle as lon g as I take it at th e sam e tim e each day.”

586. A clien t with diabetes m ellitus visits a h ealth care clin ic. Th e clien t’s diabetes m ellitus previously h ad been well con trolled with glyburide daily, but recen tly th e fastin g blood glucose level h as been 180 to 200 m g/ dL (10.2 to 11.4 m m o l/ L). Wh ich m edication , if added to th e clien t’s regim en , m ay h ave con tributed to th e h yperglycem ia? 1. Predn ison e 2. Aten olol 3. Ph en elzin e 4. Allop urin ol

A N S W E R S 570. 1 Ra t ion a le: Wh en preparin g a m ixture o f sh ort-actin g in sulin , such as regular in su lin , with an oth er in sulin p rep aratio n , th e sh ort-actin g in su lin is d rawn in to th e syrin ge first. Th is sequ en ce will avoid con tam in atin g th e vial o f sh o rt-actin g in su lin with in sulin o f an oth er type. O p tion s 2, 3, an d 4 id en - tify co rrect actio n s fo r prep arin g NPH an d sh o rt-actin g in su lin . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further teaching. Th ese wo rds in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in correct action . Rem em b er RN—d raw up th e Regu lar ( short-acting) in su lin befo re th e NPH in su lin . Review: Prep aratio n o f NPH an d sh o rt-actin g in su lin Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medicatio n s Pr ior ity Con cepts: Clien t Edu catio n ; Gluco se Regu latio n Refer en ce: Burch um , Rosen th al (2016), pp . 689–680.

571. 2 Ra t ion a le: In sulin in u no pen ed vials sh ould b e stored un d er refrigeration un til n eeded. Vials sh o uld n ot b e fro zen . Wh en stored u n open ed u n der refrigeratio n , in sulin can be used up to th e exp iration date on th e vial. O ption s 1, 3, and 4 are in co rrect.

Test -Ta kin g St r a t egy: Note th e su b ject, h ow to store un o- p en ed vials of in su lin . O ptio n s 3 an d 4 are co m p arab le o r alike regard in g wh ere to store th e in su lin an d sh ou ld b e elim - in ated . Rem em b erin g th at in su lin sh o uld n o t b e frozen will assist in elim in atin g op tio n 1. Review: Sto rage o f in su lin Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medication s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 681.

572. 2, 3, 5 Ra t ion a le: Wh en alco h o l is co m b in ed with glim ep irid e, a d isu lfiram -like reactio n m ay o ccu r. Th is syn d ro m e in clu d es flu sh in g, p alp itatio n s, an d n au sea. Alco h o l can also p o ten - tiate th e h yp o glycem ic effects o f th e m ed icatio n . Clien ts n eed to b e in stru cted to avo id alco h o l co n su m p tio n wh ile takin g th is m ed icatio n . Lo w-calo rie d esserts sh o u ld also b e avo id ed . Even th o u gh th e calo rie co n ten t m ay b e lo w, carb o - h yd rate co n ten t is m o st likely h igh an d can affect th e b lo o d glu co se. Th e item s in o p tio n s 2, 3, an d 5 are accep tab le to co n su m e. Test -Ta kin g St r a t egy: No te th e strategic wo rd , most. Rem em - b erin g th at alco h o l can affect th e action o f m an y m ed icatio n s will assist in elim in atin g option 1. Next, recallin g th at

665CHAPTER 51 Endocrine Medications

carb oh yd rates n eed to b e co n trolled in a d iabetic d iet will assist in elim in atin g op tion 4. Review: Glim ep irid e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—En do crin e Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regu lation Refer en ce: Bu rch u m , Ro sen th al (2016), p . 688.

573. 2 Ra tion a le: Metfo rm in is classified as a bigu an id e an d is th e m ost co m m o n ly u sed m ed ication fo r typ e 2 diab etes m ellitu s in itially. It is also o ften u sed as a p reven tive m ed ication fo r th o se at h igh risk for d evelo pin g d iab etes m ellitus. Wh en u sed alo n e, m etform in lo wers th e b lo od sugar after m eal in take as well as fastin g blood glucose levels. Metform in does n ot stim - u late in sulin release an d th erefore po ses little risk for h ypo gly- cem ia. For th is reaso n , m etfo rm in is well su ited fo r clien ts wh o skip m eals. Un u sual so m n olen ce, as well as h yp erven tilatio n , m yalgia, an d m alaise, are early sign s o f lactic acido sis, a toxic effect associated with m etfo rm in . If an y o f th ese sign s or sym p - to m s o ccur, th e clien t sh ou ld in form th e h ealth care p ro vider im m ediately. Wh ile it is b est to avoid con sum p tion o f alco h o l, it is n o t always realistic or feasible for clien ts to qu it d rin kin g alto geth er; fo r th is reaso n , clien ts sh o uld be in form ed th at excessive alco h o l in take can cau se an adverse reaction with m etform in . Test-Ta kin g St r a t egy: Note the strategic word s, need for further teaching. These words in dicate a n egative even t q uery and th e n eed to select th e in correct clien t statem en t as th e an swer. Recal- lin g th e adverse effects an d drug in teractio n s associated with this m edicatio n will assist you in elim in atin g o ptio n s 3 and 4. Next, recallin g th e m ech an ism o f action of th is m edicatio n will h elp you to determ in e th at th is m edication is suited for clien ts who skip m eals, th ereby leadin g you to th e correct option . Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—En do crin e Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regu lation Refer en ce: Bu rch u m , Ro sen th al (2016), p . 686.

574. 1 Ra tion a le: Exen atid e is an in cretin m im etic u sed fo r type 2 d ia- b etes m ellitu s on ly. It is n o t recom m en d ed for clien ts takin g in sulin . Hen ce, th e n u rse sh ou ld with h old th e m ed icatio n an d q uestio n th e HCP regard in g th is p rescription . Alth o u gh o ptio n s 2 an d 3 are co rrect statem en ts ab ou t th e m ed ication , in th is situatio n th e m ed ication sh ou ld n o t b e ad m in istered. Th e m edicatio n is p ackaged in prefilled p en s ready for in jec- tio n with ou t th e n eed for d rawin g it u p in to an oth er syrin ge. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Fo cus o n th e n am e of th e m edicatio n , recallin g th at it is u sed for th e treatm en t of type 2 d iab etes m ellitu s. Elim in ate o ptio n 4 becau se th e m ed icatio n is p ackaged in p refilled pen s ready fo r in jectio n . From th e rem ain in g o ption s, fo cu s o n th e d ata in th e q u estio n . Alth ou gh o ption s 2 an d 3 are ap prop ri- ate wh en adm in isterin g th is m ed icatio n , th is clien t sh o uld n o t receive th is m ed icatio n .

Review: Exen atid e Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Glu co se Regu latio n Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 692–693.

575. 1, 3 Ra tion a le: Hum u lin NPH is an in term ed iate-actin g in su lin . Th e o n set of actio n is 60 to 120 m in u tes, it peaks in 6 to 14 h o urs, an d its d uration o f action is 16 to 24 h o u rs. Regular in sulin is a sh o rt-actin g in su lin . Dep en d in g o n th e typ e, th e o n set o f actio n is 30 to 60 m in u tes, it p eaks in 1 to 5 h ou rs, an d its du ratio n is 6 to 10 h o urs. Hyp oglycem ic reactio n s m o st likely o ccur d u rin g peak tim e. In sulin sh o uld be at ro om tem - p eratu re wh en adm in istered. Clien ts m ay n eed th eir in sulin d osages in creased du rin g tim es of illn ess. In su lin vials sh o u ld n ever be sh aken vigo rou sly. Regu lar in sulin is always drawn u p b efore NPH. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, clien t in stru c- tio n s regard in g in su lin . Elim in ate o p tio n 4 b ecau se o f th e wo rd vigorously. Use kn o wled ge regard in g th e ch aracteristics o f in su lin ; p ro ced u res fo r ad m in istratio n ; an d th e o n set, p eak, an d d u ratio n o f actio n fo r in su lin an d in su lin ad m in is- tratio n to select fro m th e rem ain in g o p tio n s. Rem em b er th at NPH in su lin p eaks in 6 to 14 h o u rs an d regu lar in su lin p eaks in 1 to 5 h o u rs. Review: Regu lar an d NPH in su lin Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regulation Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 676–677.

576. 1, 2, 3, 4 Ra tion a le: Repaglin ide, a rapid-actin g o ral h ypo glycem ic agen t th at stim u lates p an creatic in su lin secretio n , sh o u ld b e taken befo re m eals (ap p ro xim ately 30 m in utes b efo re m eals) an d sh o u ld be with h eld if th e clien t d oes n ot eat. Hyp oglyce- m ia is a side effect of repaglin id e an d th e clien t sh o u ld always b e p rep ared b y carryin g a sim p le sugar at all tim es. Metfo rm in is an o ral h ypo glycem ic given in co m b in atio n with rep aglin ide an d wo rks b y d ecreasin g h ep atic glu co se prod uctio n . A co m - m on sid e effect o f m etform in is diarrh ea. Mu scle p ain m ay o ccur as an ad verse effect fro m m etfo rm in bu t it m igh t sign ify a m ore serious con dition th at warran ts h ealth care p rovider n o tification , n o t th e use of acetam in op h en . Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, oral m edicatio n s to treat diab etes m ellitu s. Th in kin g ab o ut th e p ath op h ysio lo gy o f diab etes m ellitus an d recallin g th e actio n s an d effects of th ese m edicatio n s are n eed ed to an swer correctly. Review: Rep aglin id e an d m etfo rm in Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regulation Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 700–701.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

666 UNIT X Endocrine Disorders of the Adult Client

577. 1 Ra t ion a le: Aspirin an d o th er o ver-th e-co u n ter m ed ication s sh ou ld n o t be taken u n less th e clien t co n su lts with th e HCP. Th e clien t n eeds to take th e m edicatio n at th e sam e tim e every day an d sh o u ld be in stru cted n o t to sto p th e m edication . A sligh t weigh t gain as a resu lt o f an im p ro ved ap p etite is expected ; h owever, after th e do sage is stab ilized , a weigh t gain of 5 po u n ds (2.25 kg) o r m o re weekly sh o uld b e rep o rted to th e HCP. Caffein e-con tain in g fo o ds an d fluid s n eed to b e avo id ed b ecause th ey m ay co n trib u te to stero id-u lcer develo p m en t. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, further teach- ing is necessary. Th ese wo rd s in d icate a n egative even t q u ery an d ask you to select an op tio n th at is an in co rrect statem en t. Rem em b er th at a clien t takin g p red n iso n e sh ou ld n ot take oth er m edicatio n s, especially over-th e-cou n ter m edicatio n s, with ou t first con sultin g with h is or h er HCP. Review: Teach in g p oin ts fo r th e clien t takin g p red n iso n e Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medicatio n s Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 877–878.

578. 1, 3, 4 Ra t ion a le: Co m m o n sid e effects o f m eth im azo le in clu d e n au - sea, vo m itin g, an d d iarrh ea. To ad d ress th ese sid e effects, th is m ed icatio n sh o u ld b e taken with fo o d . Becau se o f th e in crease in m etab o lism th at o ccu rs in h yp erth yro id ism , th e clien t sh o u ld co n su m e a h igh -calo rie d iet. An tith yro id m ed i- catio n s can cau se agran u lo cyto sis with leu ko p en ia an d th ro m b o cyto p en ia. So re th ro at, fever, h ead ach e, o r b leed in g m ay in d icate agran u lo cyto sis an d th e h ealth care p ro vid er sh o u ld b e n o tified im m ed iately. Meth im azo le is n o t rad io ac- tive an d sh o u ld n o t b e sto p p ed ab ru p tly, d u e to th e risk o f th yro id sto rm . Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, n ursin g con sider- ation s fo r adm in isterin g m eth im azole. Focus on th e clien t’s diagn o sis. Th in k ab o ut th e p ath o ph ysiolo gy asso ciated with th e d iagn o sis an d th e m edicatio n an d th e action s an d effects of an tith yroid m ed ication s to assist in an swerin g co rrectly. Review: Meth im azo le Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medicatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Bu rch u m , Rosen th al (2016), p p. 713–714; Skidm ore-Ro th ( 2014) , p . 792.

579. 1, 2, 5 Ra t ion a le: In so m n ia, weigh t lo ss, an d m ild h eat in to leran ce are sid e effects of levoth yro xin e so dium . Brad ycardia an d co n - stipatio n are n o t sid e effects associated with th is m edicatio n , an d rath er are asso ciated with h ypo th yro id ism , wh ich is th e diso rd er th at th is m ed ication is prescrib ed to treat. Test -Ta kin g St r a tegy: Fo cus on th e su b ject, side effects o f levoth yro xin e. Th in kin g ab ou t th e path op h ysio logy o f h ypo - th yro id ism an d th e action o f th e m edicatio n will assist yo u

in d eterm in in g th at in so m n ia, weigh t lo ss, an d m ild h eat in to l- eran ce are sid e effects o f th yro id h o rm o n es. Review: Levo th yro xin e so d iu m Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medication s Pr ior ity Con cepts: Clin ical Jud gm en t; Th erm oregu lation Refer en ce: Lilley et al. (2014), p. 503.

580. 3 Ra t ion a le: O ral d o ses o f levo th yroxin e sh o uld b e taken o n an em p ty stom ach to en h an ce ab sorption . Dosin g sh ou ld be d on e in th e m o rn in g before b reakfast. Test -Ta kin g Str a tegy: No te th at o ptio n s 1, 2, an d 4 are co m - p arab le o r alike in th at th ese o ptio n s add ress ad m in isterin g th e m ed ication with foo d. Review: Levo th yro xin e so d iu m Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medication s Pr ior ity Con cepts: Clien t Ed u catio n ; Th erm oregulation Refer en ce: Lilley et al. (2014), p. 508.

581. 2 Ra t ion a le: Excessive do ses of levo th yro xin e can prod uce sign s an d sym pto m s of h yperth yroid ism . Th ese in clu de tach ycard ia, ch est p ain , trem ors, n ervou sn ess, in som n ia, h yp erth erm ia, extrem e h eat in toleran ce, an d sweatin g. Th e clien t sh o uld b e in stru cted to n o tify th e HCP if th ese occur. O p tion s 1, 3, an d 4 are sign s of h yp oth yro idism . Test -Ta kin g St r a t egy: Fo cus on th e su b ject, th e n eed to n o tify th e HCP. Recall th e sym p tom s asso ciated with h yp oth yro id- ism , th e pu rp ose o f adm in isterin g levoth yro xin e, an d th e effects o f th e m ed ication . O p tio n s 1, 3, an d 4 are sym pto m s related to h yp oth yroidism . Review: Ad verse effects asso ciated with levo th yro xin e so d iu m Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medication s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 713.

582. 2 Ra t ion a le: Pram lin tid e is u sed for clien ts with typ es 1 an d 2 d iab etes m ellitus wh o use in sulin . It is adm in istered sub cuta- n eou sly b efore m eals to lo wer blo o d gluco se level after m eals, leadin g to less flu ctu ation du rin g th e day an d b etter lon g-term glucose co n trol. Because pram lin tid e delays gastric em p tyin g, o ral m ed ication s sh o u ld b e given 1 h o u r b efo re o r 2 h o urs after an in jection o f pram lin tid e; th erefo re, in stru ctin g th e clien t to take h is or h er pills 1 h ou r b efo re o r 2 h ou rs after th e in jection is co rrect. Pram lin tide sh ou ld n o t b e taken at th e sam e tim e as o th er m edicatio n s. Pram lin tid e is given im m ediately b efo re th e m eal in o rd er to con tro l po stpran d ial rise in b lo od glu cose, n ot n ecessarily to p reven t sto m ach up set. It is in correct to in stru ct th e clien t to take th e m ed ication after eatin g, as it will n ot ach ieve its fu ll th erapeu tic effect.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

667CHAPTER 51 Endocrine Medications

Test-Ta kin g Str a tegy: Fo cus on th e su b ject, clien t in structio n s regard in g p ram lin tide as it pertain s to adm in istratio n . Use kn owled ge regardin g th e actio n o f th e m edicatio n an d treat- m en t m easu res fo r d iabetes m ellitus to an swer th e q uestion . Rem em ber th at th is m ed icatio n is u sed in co n ju n ction with in sulin to preven t p o stp ran dial rise in bloo d gluco se, an d th at h yp oglycem ia is a po ten tial adverse effect. Also rem em b er th at th is m edicatio n cau ses d elayed gastric em p tyin g an d sh o u ld n o t be taken with oth er m ed ication s. Review: Pram lin tid e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—En do crin e Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 710.

583. 2, 5 Ra tion a le: In diabetes in sipidus, th ere is a deficien cy in an ti- d iuretic h o rm on e (ADH), resu ltin g in large urin ary lo sses. Des- m op ressin is an an alog of ADH. Clien ts with d iabetes in sip id us d rin k h igh volum es o f flu id (p olyd ip sia) as a co m p en sato ry m ech an ism to cou n teract urin ary lo sses an d m ain tain flu id b alan ce. O n ce desm o pressin is started , oral fluid s sh ou ld be d ecreased to p reven t water in toxicatio n . Th erefo re, clien ts with d iabetes in sip id us sh ou ld d ecrease th eir o ral flu id in take wh en th ey start desm o pressin . Head ach e an d d ro wsin ess are sign s of water in toxication in th e clien t takin g desm opressin an d sh o u ld b e repo rted to th e h ealth care p ro vider. Desm op ressin d oes n ot turn urin e o ran ge. Th e am o un t o f u rin e sh ou ld d ecrease, n o t in crease, wh en d esm op ressin is started . Desm o - p ressin do es n ot cau se p an creatitis. Test-Ta kin g Str a tegy: Focus o n th e su b ject, u n d erstan d in g o f d esm op ressin . Recall th at in d iabetes in sip idu s th ere is a d eficien cy o f ADH an d th at desm o pressin is an ADH an alo g. Recallin g th e path op h ysio lo gy o f th is d iso rd er will assist you in an swerin g correctly. Review: Desm o p ressin Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm aco logy—En do crin e Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Flu id an d Electrolytes Refer en ce: Skidm o re-Ro th (2014), pp . 383–384.

584. 3 Ra tion a le: Co rtico stero id s ( gluco co rtico ids) sh o uld b e ad m in - istered b efo re 9 a.m . Adm in istratio n at th is tim e h elps to m in - im ize adren al in sufficien cy an d m im ics th e b urst of glu co co rtico id s released n aturally b y th e adren al glan ds each m orn in g. O p tio n s 1, 2, an d 4 are in co rrect. Test-Ta kin g St r a t egy: No te th e strategic wo rd , best. No te th e su ffix -sone an d recall th at m edication n am es th at en d with th ese letters are cortico steroid s. Rem em b er th at a d aily d o se o f a co rticostero id sh o u ld be adm in istered in th e m orn in g.

Review: Pred n iso n e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Ho rm o n al Regu lation Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 877–878.

585. 3, 4 Ra tion a le: Alen d ro n ate is a b isp h o sp h o n ate u sed in h yp er- p arath yro id ism to in h ib it b o n e lo ss an d n o rm alize seru m cal- ciu m levels. Eso p h agitis is an ad verse effect o f p rim ary co n cern in clien ts takin g alen d ro n ate. Fo r th is reaso n th e cli- en t is in stru cted to take alen d ro n ate first th in g in th e m o rn in g with a fu ll glass o f water o n an em p ty sto m ach , n o t to eat o r d rin k an yth in g else fo r at least 30 m in u tes after takin g th e m ed icatio n , an d to rem ain sittin g u p righ t fo r at least 30 m in u tes after takin g it. A d aily d o sin g sch ed u le an d a o n ce-weekly d o sin g sch ed u le is availab le fo r clien ts takin g alen d ro n ate. Test-Ta kin g St r a t egy: Focus on th e su b ject, th e co rrect m eth o d to take alen d ro n ate. Recall th at th e p rim ary co n cern with alen d ro n ate is eso ph agitis. Elim in ate op tio n s 1 an d 2 sin ce takin g with foo d an d takin g at bed tim e will each p lace th e clien t at in creased risk of reflux. Elim in ate o p tion 5 b ecause alen dron ate sh ou ld be taken first th in g in th e m o rn in g on an em pty stom ach . Review: Bisp h o sp h o n ate ad m in istratio n Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 877–878.

586. 1 Ra tion a le: Predn iso n e m ay decrease th e effect o f oral h ypo gly- cem ics, in su lin , d iuretics, an d p otassiu m su pp lem en ts. O p tion 2, a b eta b lo cker, an d op tio n 3, a m o n o am in e o xid ase in h ib i- to r, h ave th eir o wn in trin sic h yp oglycem ic activity. O p tio n 4 d ecreases u rin ary excretio n o f su lfon ylurea agen ts, cau sin g in creased levels of th e o ral agen ts, wh ich can lead to h yp oglycem ia. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, an in crease in th e b loo d glu cose level. Recallin g th at pred n iso n e is a co rtico ste- roid an d th at corticosteroids d ecrease th e effects o f oral h yp o- glycem ics will d irect you to th e co rrect op tion . Review: Glyb u rid e an d p red n iso n e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Glu co se Regu latio n Refer en ce: Lilley et al. (2014), p p. 516, 540–541.

A

d

u

l

t

E

n

d

o

c

r

i

n

e

668 UNIT X Endocrine Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

UNIT XI

Gastrointestinal Disorders of the Adult Client

Pyramid to Success

Pyram id Poin ts focus on diagn ostic tests an d n ursin g care related to th e various gastric or in testin al tubes, gas- tric surgery, cirrh osis, h epatitis, pan creatitis, an d colos- tom y care. Focus on preprocedure an d postprocedure care of th e clien t un dergoin g a gastro in testin al diagn os- tic test. Rem em b er th at an in form ed con sen t is required for an y in vasive proced ure. Focus on diet restriction s before an d after th e diagn ostic test an d rem em ber th at th e gag reflex or bowel soun ds m ust return before allow- in g a clien t to con sum e food or flu ids. Pyram id Poin ts also in clude in struction s to th e clien t an d fam ily regard- in g th e preven tion of gastro in testin al disorders an d th e com plication s associated with th e disorder. Focus on teach in g th e clien t an d fam ily ab out diet an d n utrition specific to th e disorder, tube an d woun d care, preven tin g th e tran sm ission of in fectio n such as with h epatitis, an d care of a colosto m y or ileostom y. Rem em b er th at body im age disturban ces can occur in clien ts with a gastro in - testin al disorder. Specific focus relates to th e clien t with a diversion , such as an ileostom y or colosto m y; th e social isolatio n issues th at can occur; an d effective copin g strategies.

Client Needs: Learning Objectives Safe and Effective Care Environment Con sultin g with th e in terp rofession al team regardin g

th e clien t’s care an d n utrition al status En surin g th at co n fiden tiality issues related to th e gastro-

in testin al disorder are m ain tain ed En surin g th at in form ed con sen t for treatm en ts an d sur-

gical procedures h as been obtain ed Establish in g priorities of care

Han dlin g in fectio us drain age an d secretio n s safely Main tain in g stan dard precaution s an d oth er precaution s

as appropriate O btain in g referrals for h om e care an d com m un ity

services Preven tin g disease tran sm ission

Health Promotion and Maintenance Perform in g ph ysical assessm en t tech n iques of th e gas-

troin testin al system Preven tin g disease related to th e gastro in testin al system Providin g h ealth screen in g an d h ealth prom o tion pro-

gram s related to gastro in testin al disorders Teach in g related to colosto m y or ileostom y care Teach in g related to prescribed dietary an d oth er treat-

m en t m easures Teach in g related to preven tin g th e tran sm ission of

disease

Psychosocial Integrity Assessin g copin g m ech an ism s Con siderin g en d-of-life an d grief an d loss issues Iden tifyin g available supp ort system s Mon itorin g for co n cern s related to body im age ch an ges

Physiological Integrity Adm in isterin g m ed ication s as prescribed specific to th e

gastro in testin al disorder Assessin g for sign s an d sym pto m s of in fectio us diseases

of th e gastro in testin al tract Assistin g with person al h ygien e Mon itorin g elim in ation pattern s Mon itorin g for co m plication s related to tests, proce-

dures, an d surgical in terven tion s Mon itorin g for fluid an d electrolyte im balan ces

669

Mon itorin g laborato ry values related to gastro in testin al disorders

Mon itorin g paren terally adm in istered fluids, in cludin g total paren teral n utrition (TPN)

Provid in g ad equate n utrition an d oral h ydration

Providin g care for gastroin testin al tubes Providin g n on ph arm acological an d ph arm aco logical

com fort m easures Providin g preprocedure an d postprocedure care for diag-

n ostic tests related to th e gastro in testin al system

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

670 UNIT XI Gastrointestinal Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

C H A P T E R 52 Gastrointestinal System

PRIORITY CONCEPTS Elimination; Nutrition

CRITICAL THINKING What Should You Do? The nurse is preparing a client for a liver biopsy. On review of the client’s laboratory results, the nurse notes that the client’s prothrombin time is 35 seconds and platelet count is 10 0 ,0 0 0 mm 3 (10 0 Â 10 9/ L). What should the nurse do? Answer located on p. 690.

I. Anatomy and Physiology A. Fun ction s of th e gastroin testin al (GI) system

1. Process food substan ces 2. Abso rb th e products of digestion in to th e blood 3. Excrete un absorbed m aterials 4. Provide an en viron m en t for m icroorgan ism s to

syn th esize n utrien ts, such as vitam in K 5. For risk facto rs associated with th e GI system , see

Box 52-1. B. Mou th

1. Con tain s th e lips, ch eeks, palate, ton gue, teeth , salivary glan d s, m uscles, an d m axillary bon es

2. Saliva con tain s th e en zym e am ylase (ptyalin ), wh ich aids in digestion .

C. Esoph agus 1. Collap sible m uscu lar tube about 10 in ch es

(25 cm ) lo n g 2. Carries food fro m th e ph aryn x to th e stom ach

D. Stom ach 1. Con tain s th e cardia, fun dus, body, an d pylo rus 2. Mucou s glan ds are located in th e m ucosa an d

preven t autodigestion by providin g an alkalin e protective coverin g.

3. Th e lower esoph ageal (cardiac) sph in cter preven ts reflux of gastric conten ts in to th e esophagus.

4. Th e pyloric sph in cter regulates th e rate of stom - ach em ptyin g in to th e sm all in testin e.

5. Hydro ch loric acid kills m icroorgan ism s, breaks food in to sm all particles, an d provides a ch em i- cal en viron m en t th at facilitates gastric en zym e activation .

6. Pepsin is th e ch ief coen zym e of gastric juice, wh ich con verts protein s in to proteoses an d pepton es.

7. In trin sic facto r com es from parietal cells an d is n ecessary for th e absorption of vitam in B12.

8. Gastrin co n trols gastric acidity. E. Sm all in testin e

1. Th e duoden um con tain s th e open in gs of th e bile an d pan creatic ducts.

2. Th e jejun um is about 8 feet (2.4 m eters) lon g. 3. Th e ileu m is about 12 feet (3.7 m eters) lo n g. 4. Th e sm all in testin e term in ates in th e cecum .

F. Pan creatic in testin al juice en zym es 1. Am ylase digests starch to m altose. 2. Maltase reduces m altose to m on osacch aride

gluco se. 3. Lactase splits lactose in to galactose an d gluco se. 4. Sucrase reduces sucrose to fru ctose an d glucose. 5. Nucleases split n ucleic acids to n ucleotides. 6. En tero kin ase activates trypsin ogen to trypsin .

G. Large in testin e 1. Abou t 5 feet (1.5 m eters) lon g 2. Abso rbs water an d elim in ates wastes 3. In testin al bacteria play a vital role in th e syn th e-

sis of som e B vitam in s an d vitam in K. 4. Colon : In cludes th e ascen din g, tran sverse, des-

cen din g, an d sigm oid colon s an d rectum 5. Th e ileocecal valve preven ts con ten ts of th e large

in testin e from en terin g th e ileum . 6. Th e in tern al an d extern al an al sph in cters con trol

th e an al can al. H. Periton eum : Lin es th e ab dom in al cavity an d form s

th e m esen tery th at supports th e in testin es an d blood supply

I. Liver 1. Th e largest glan d in th e body, weigh in g 3 to 4

poun ds (1.4 to 1.8 kg) 2. Con tain s Kupffer cells, wh ich rem ove bacteria in

th e portal ven ous blood 3. Rem o ves excess glucose an d am in o acids from

th e portal blood 4. Syn th esizes gluco se, am in o acids, an d fats 671

5. Aids in th e digestion of fats, carboh ydrates, an d protein s

6. Stores an d filters blood (200 to 400 m L of blood stored )

7. Stores vitam in s A, D, an d B an d iron 8. Th e liver secretes bile to em u lsify fats (500 to

1000 m L of bile/ day). 9. Hepatic ducts

a. Deliver bile to th e gallbladder via th e cystic duct an d to th e duoden um via th e com m on bile duct

b . Th e com m on bile duct open s in to th e duod e- n um , with th e pan creatic duct at th e am pulla of Vater.

c. Th e sph in cter preven ts th e reflux of in testin al con ten ts in to th e com m on bile duct an d pan creatic duct.

J. Gallbladder 1. Stores an d con cen trates bile an d con tracts to

force bile in to th e duod en um durin g th e diges- tion of fats

2. Th e cystic duct join s th e h epatic duct to form th e com m on bile duct.

3. Th e sph in cter of O ddi is located at th e en tran ce to th e duoden um .

4. Th e presen ce of fatty m aterials in th e duoden um stim ulates th e liberation of ch olecystokin in , wh ich cau ses con traction of th e gallbladder an d relaxatio n of th e sph in cter of O ddi.

K. Pan creas 1. Exocrin e glan d

a. Secretes sodium bicarbo n ate to n eutralize th e acidity of th e stom ach con ten ts th at en ter th e duoden um

b . Pan creatic juices con tain en zym es for digest- in g carboh ydrates, fats, an d protein s.

2. En docrin e glan d a. Secretes glucagon to raise blood glucose

levels an d secretes som ato statin to exert a h ypoglycem ic effect

b . Th e islets of Lan gerh an s secrete in sulin . c. In sulin is secreted in to th e blood stream an d

is im portan t for carboh ydrate m etab olism .

II. Diagnostic Procedures (Box 52-2) A. Upp er GI tract study (barium swallow)

1. Descriptio n : Exam in ation of th e upper GI tract un d er flu oroscop y after th e clien t drin ks barium sulfate

2. Preprocedure: With h old food s an d fluids for 8 h ou rs prior to th e test.

3. Postp rocedu re a . A laxative m ay be prescribed. b . In struct th e clien t to in crease oral fluid in take

to h elp pass th e barium . c. Mon itor stools for th e passage of barium

(stools will appear ch alky wh ite for 24 to 72 h ours postp rocedu re) because barium can cause a bowel obstruction .

B. Cap sule en doscopy 1. Description : Aprocedure th at uses a sm all wireless

cam era shaped like a m edication capsule th at th e clien t swallows; th e test will detect bleedin g or ch an ges in th e lin in g of th e sm all in testin e.

2. Th e cam era travels th rou gh th e en tire digestive tract an d sen ds pictures to a sm all box th at th e clien t wears like a belt; th e sm all box saves th e pictures, wh ich are th en tran sferred to a com - puter for viewin g on ce th e test is com plete.

3. Th e clien t visits th e h ealth care provid er’s (HCP’s) office in th e m orn in g an d swallows

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

BOX 52-1 Risk Factors Associated with the Gastrointestinal System

▪ Allergic reactions to food or medications ▪ Cardiac, respiratory, and endocrine disorders that may

lead to slowed gastrointestinal (GI) movement or constipation

▪ Chronic alcohol use ▪ Chronic high stress levels ▪ Chronic laxative use ▪ Chronic use of aspirin or nonsteroidal antiinflammatory

drugs (NSAIDs) ▪ Diabetes mellitus, which may predispose to oral candidal

infections or other GI disorders ▪ Family history of GI disorders ▪ Long-term GI conditions, such as ulcerative colitis, that

may predispose to colorectal cancer ▪ Neurological disorders that can impair movement, partic-

ularly with chewing and swallowing ▪ Previous abdominal surgery or trauma, which may lead to

adhesions ▪ Tobacco use

BOX 52-2 Common Gastrointestinal System Diagnostic Studies*

▪ Capsule endoscopy ▪ Endoscopic retrograde cholangiopancreatography (ERCP) ▪ Endoscopic ultrasound ▪ Fiberoptic colonoscopy ▪ Gastric analysis ▪ Gastrointestinal motility studies ▪ Hydrogen and urea breath test ▪ Laparoscopy: Liver and pancreas laboratory studies ▪ Liver biopsy ▪ Paracentesis ▪ Stool specimens ▪ Upper gastrointestinal endoscopy or esophagogastro-

duodenoscopy ▪ Upper gastrointestinal tract study (barium swallow) ▪ Videofluoroscopic swallowing study

*Informed consent is obtained for a diagnostic study that is invasive.

672 UNIT XI Gastrointestinal Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

th e capsule, th e recordin g belt is applied by th e office staff, an d th en th e clien t return s at th e en d of th e day so th at pictures can be tran sferred to th e com pu ter.

4. Preprocedure: A bowel preparation will be pre- scribed. Th e clien t will n eed to m ain tain a clear liquid diet on th e even in g befo re th e exam ; addi- tion ally, NPO (n oth in g by m ou th ) status is m ain tain ed for 3 h ours befo re an d after swallow- in g th e capsule (tim e for NPO status is pre- scribed by th e HCP but is usually 2 to 3 h ours).

C. Gastric an alysis 1. Descrip tion

a. Gastric an alysis requires the passage of a n aso- gastric (NG) tube in to th e stom ach to aspirate gastric con ten ts for th e an alysis of acidity (pH), appearan ce, an d volum e; th e entire gastric con - ten ts are aspirated, an d th en specim en s are col- lected every 15 m in utes for 1 h our.

b . Medication , such as h istam in e or pen tagas- trin , m ay be ad m in istered subcutan eously to stim ulate gastric secretio n s; som e m ed ica- tion s m ay produ ce a flush ed feelin g.

c. Esoph ageal reflux of gastric acid m ay be diag- n osed by am bulatory pH m on itorin g; a probe is placed just above th e lower eso ph a- geal sph in cter an d con n ected to an extern al recordin g device. It provides a com puter an alysis an d graph ic display of results.

2. Preprocedure a. Fastin g for at least 12 h ours is required before

th e test. b . Use of tobacco an d ch ewin g gum is avoided

for 24 h ours before th e test. c. Medication s th at stim ulate gastric secretio n s

are with h eld for 24 to 48 h ours. 3. Postprocedure

a. Clien t m ay resum e n orm al activities. b . Refrigerate gastric sam ples if n ot tested

with in 4 h ours. D. Upper GI en dosco py

1. Descrip tion a. Also kn own as eso ph agogastroduoden o-

scopy b . Followin g sedation , an en dosco pe is passed

down th e esoph agus to view th e gastric wall, sph in cters, an d duoden um ; tissue specim en s can be obtain ed.

2. Preprocedure a. Th e clien t m ust be NPO for 6 to 8 h ours

before th e test. b . A lo cal an esth etic (spray or gargle) is ad m in -

istered alon g with m edication th at provides m oderate sed ation just befo re th e scope is in serted.

c. Medication m ay be adm in istered to reduce secretio n s, an d m ed ication m ay be adm in is- tered to relax sm ooth m uscle.

d . Th e clien t is position ed on th e left side to facilitate saliva drain age an d to provide easy access of th e en doscope.

e. Airway paten cy is m on itored durin g th e test an d pulse oxim etry is used to m on itor oxygen saturation ; em ergen cy equip m en t sh o uld be readily available.

3. Postprocedure a . Mon itor vital sign s. b . Clien t m ust be NPO un til th e gag reflex

return s (1 to 2 h ours). c. Mon itor for sign s of perforation (pain ,

bleedin g, un usual difficu lty in swallowin g, elevated tem p erature) .

d . Main tain bed rest for th e sed ated clien t un til alert.

e. Lozen ges, salin e gargles, or oral an algesics can relieve a m in o r sore th roat (n ot given to th e clien t un til th e gag reflex return s).

E. Fib eroptic colon o scopy 1. Description

a . Colon oscop y is a fib eroptic en doscopy study in wh ich th e lin in g of th e large in testin e is visu ally exam in ed ; biopsies an d polypec- tom ies can be perform ed.

b . Card iac an d respiratory fun ctio n is m on i- tored con tin uously durin g th e test.

c. Colon oscopy is perform ed with th e clien t lyin g on the left side with the kn ees drawn up to the ch est; position m ay be ch an ged dur- in g th e test to facilitate passing of th e scope.

2. Preprocedure a . Adeq uate clean sin g of th e colon is n ecessary,

as prescribed by th e HCP. b . A clear liquid diet is started on th e day before

th e test. Red, oran ge, an d purple (grap e) liq- uids are to be avoided.

c. Con sult with th e HCP regardin g m ed ication s th at m ust be with h eld before th e test.

d . Clien t is NPO for 4 to 6 h ours prior to th e test. e. Mod erate sed ation is ad m in istered in tra-

ven o usly. f. Med ication m ay be ad m in istered to relax

sm oo th m uscle. 3. Postprocedure

a . Mon itor vital sign s. b . Provide bed rest un til alert. c. Mon itor for sign s of bowel perforation an d

periton itis ( Box 52-3). d . Rem in d th e clien t th at passin g flatus, ab dom -

in al fulln ess, an d m ild cram pin g are expected for several h ours.

e. In struct th e clien t to report an y bleedin g to th e HCP.

The client receiving oral liquid bowel cleansing prep- arations or enemas is at risk for fluid and electrolyte imbalances.

673CHAPTER 52 Gastrointestinal System

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

F. Laparoscop y is perform ed with a fiberop tic laparo- scope th at allows direct visu alization of organ s an d structures with in th e abdom en ; biopsies m ay be obtain ed.

G. En do scopic retrograde ch olan giop an creatograph y (ERCP) 1. Descrip tion

a . Exam in ation of th e h epatobiliary system is perform ed via a flexible en doscope in serted in to th e eso ph agus to th e descen din g duod e- n um ; m ultiple position s are required durin g th e procedure to pass th e en doscope.

b . If m edication is ad m in istered befo re th e pro- cedu re, th e clien t is m on itored closely for sign s of respiratory an d cen tral n ervous sys- tem dep ression , h ypoten sion , oversedation , an d vom itin g.

2. Preprocedure a . Clien t is NPO for 6 to 8 h ours. b . In quire about previous exp osure to con trast

m ed ia an d an y sen sitivities or allergies. c. Mod erate sedation is adm in istered.

3. Postprocedure a . Mon itor vital sign s. b . Mon itor for th e return of th e gag reflex. c. Mon itor for sign s of perforation or periton itis

(see Box 52-3). H. En do scopic ultraso n ograph y

1. Descrip tion : Provides im ages of th e GI wall an d digestive organ s.

2. Preprocedure an d postp rocedure: Care is sim ilar to th at im plem en ted for en doscopy.

Following endoscopic procedures, monitor for the return of the gag reflex before giving the client any oral substance. If the gag reflex has not returned, the client could aspirate.

I. Com puted tom o graph y (CT) scan 1. Descrip tion

a . No n in vasive cro ss-section al view th at can detect tissue den sities in th e abdom en , in cludin g in th e liver, spleen , pan creas, an d biliary tree.

b . Can be perform ed with or with ou t con trast m ed ium .

2. Preprocedure a . Clien t is NPO for at least 4 h ou rs.

b . If con trast m ed ium will be used, assess for previous sen sitivities an d allergies.

3. Postp rocedu re a . No specific care is required .

J. Paracen tesis 1. Descriptio n an d preprocedure (see Priority

Nu rsin g Actio n s)

2. Postp rocedu re a . Mon itor vital sign s. b . Measure fluid collected, describe, an d record. c. Label fluid sam ples an d sen d to th e labora-

tory for an alysis.

BOX 52-3 Signs of Bowel Perforation and Peritonitis

▪ Guarding of the abdomen ▪ Increased temperature and chills ▪ Pallor ▪ Progressive abdominal distention and abdominal pain ▪ Restlessness ▪ Tachycardia and tachypnea

PRIORITY NURSING ACTIONS Paracentesis

1. Ensure that the client understands the procedure and that informed consent has been obtained.

2. Obtain vital signs, including weight, and assist the client to void.

3. Position the client upright. 4. Assist the health care provider (HCP), monitor vital signs,

and provide comfort and support during the procedure. 5. Apply a dressing to the site of puncture. 6. Monitor vital signs, especially blood pressure and pulse

because these parameters provide information on rapid vasodilation postparacentesis; weigh the client postpro- cedure, and maintain the client on bed rest.

7. Measure the amount of fluid removed. 8. Label and send the fluid for laboratory analysis. 9. Document the event, client’s response, and appearance

and amount of fluid removed.

Paracentesis is the transabdominal removal of fluid from the peritoneal cavity. The nurse first ensures that the client understands the procedure and that informed consent has been obtained, because the procedure is invasive. The nurse next obtains preprocedure vital signs, including weight, so that a baseline is obtained. Weight is taken before and after the procedure to provide an indication of the effectiveness of the procedure in fluid removal. The client is assisted to void to empty the bladder and to move the bladder out of the way of the paracentesis needle. The client is positioned upright on the edge of a bed with the back supported and the feet resting on a stool, or in a Fowler’s position in bed. The nurse assists the HCP, monitors vital signs per protocol, and provides com- fort and support to the client during the procedure. Once the procedure is complete, the nurse applies a dressing to the site of puncture and monitors for leakage or bleeding. The client is placed in a position of comfort, bed rest is maintained as pre- scribed, and vital signs are monitored to assess for complica- tions. The fluid removed from the client is measured, labeled, and sent to the laboratory for analysis. The nurse documents the event, the client’s response, the appearance and amount of fluid removed, and any additional pertinent data.

Reference Ignatavicius, Workman (2016), p. 1199.

674 UNIT XI Gastrointestinal Disorders of the Adult Client

d . Apply a dry sterile dressin g to th e in sertio n site; m on itor th e site for bleed in g.

e. Measure abdom in al girth an d weigh t. f. Mon itor for h ypo volem ia, electrolyte loss,

m en tal status ch an ges, or en ceph alopath y. g. Mon itor for h em aturia cau sed by bladder

traum a. h . In struct th e clien t to n otify th e HCP if th e

urin e beco m es blood y, pin k, or red.

The rapid removal of fluid from the abdominal cavity during paracentesis leads to decreased abdominal pressure, which can cause vasodilation and resultant shock; therefore, heart rate and blood pressure must be monitored closely.

K. Liver biopsy 1. Descrip tion : A n eedle is in serted th rou gh th e

abdom in al wall to th e liver to obtain a tissue sam ple for biopsy an d m icroscopic exam in ation .

2. Preprocedure a. Assess results of coagulation tests (pro th rom -

bin tim e, partial th rom boplastin tim e, platelet coun t).

b . Adm in ister a sed ative as prescribed. c. Note th at th e clien t is placed in th e supin e

or left lateral position durin g th e proce- dure to expose th e righ t side of th e upper abdom en .

3. Postprocedure a. Assess vital sign s. b . Assess biopsy site for bleedin g. c. Mon itor for periton itis (see Box 52-3). d . Main tain bed rest for several h ours as

prescribed. e. Place th e clien t on th e righ t side with a pillow

un der th e costal m argin for 2 h ours to decrease th e risk of bleedin g, an d in struct th e clien t to avoid cough in g an d strain in g.

f. In struct th e clien t to avoid h eavy liftin g an d stren uou s exercise for 1 week.

L. Stool specim en s 1. Testin g of stool specim en s in cludes in spectin g

th e specim en for con sisten cy an d color an d test- in g for occult blood .

2. Tests for fecal urobilin ogen , fat, n itrogen , para- sites, path ogen s, food substan ces, an d oth er sub- stan ces m ay be perform ed; th ese tests require th at th e specim en be sen t to th e laborato ry.

3. Ran do m specim en s are sen t prom ptly to th e laborato ry.

4. Q uan titative 24- to 72-h our collection s m ust be kept refrigerated un til th ey are taken to th e laborato ry.

5. Som e specim en s require th at a certain diet be fol- lowed or th at certain m edication s be with h eld; ch eck agen cy guidelin es regardin g specific proced ures.

M. Urea breath test 1. Th e urea breath test detects th e presen ce of Heli-

cobacter pylori, th e bacteria th at cause pep tic ulcer disease.

2. Th e clien t con sum es a capsule of carbon -labeled urea an d provides a breath sam ple 10 to 20 m in utes later.

3. Certain m edication s m ay n eed to be avoided before testin g. Th ese m ay in clude antibiotics or bism uth subsalicylate for 1 m on th before th e test; sucralfate an d om eprazole for 1 week before th e test; an d cim etidin e, fam otidin e, ran itidin e, an d n izatidin e for 24 h ours before breath testin g.

4. H. pylori can also be detected by assessin g serum an tibod y levels.

N. Liver an d pan creas labo ratory studies 1. Liver en zym e levels (alkalin e ph osph atase [ALP],

aspartate am in otran sferase [AST], an d alan in e am in otran sferase [ALT]) are elevated with liver dam age or bilary obstru ction . No rm al referen ce in tervals: ALP, 0.5 to 2.0 m ckat/ L (35 to 120 U/ L); AST, 0 to 35 U/ L(0 to 35 U/ L); ALT, 4 to 36 U/ L(4 to 36 U/ L).

2. Proth rom bin tim e is prolon ged with liver dam - age. Norm al referen ce in terval: 11 to 12.5 secon ds.

3. Th e serum am m on ia level assesses th e ability of th e liver to deam in ate protein byprodu cts. No r- m al referen ce in terval: 10 to 80 m cg/ dL (6 to 47 m cm o l/ L).

4. An in crease in ch olestero l level in dicates pancre- atitis or biliary obstru ction . Norm al referen ce in terval: < 200 m g/ dL ( < 5.0 m m ol/ L) .

5. An in crease in bilirubin level in dicates liver dam age or biliary obstru ction . Norm al referen ce in tervals: Total, 0.3 to 1.0 m g/ dL (5.1 to 17 m cm o l/ L); in direct, 0.2 to 0.8 m g/ dL (3.4 to 12 m cm o l/ L); direct, 0.1 to 0.3 m g/ dL (1.7 to 5.1 m cm o l/ L).

6. In creased values for am ylase an d lipase levels in dicate pan creatitis. No rm al referen ce in tervals: am ylase, 60 to 120 Som o gyi un its/ dL (30 to 220 U/ L); lipase, 0 to 160 U/ L (0 to 160 U/ L).

III. Assessment A. See Ch apter 15 for abdom in al assessm ent tech n iques.

IV. Gastrointestinal Tubes A. See Ch apter 20 for in form ation regardin g th ese

tubes.

V. Gastroesophageal Reflux Disease A. Description

1. Th e backflow of gastric an d duoden al con ten ts in to th e esoph agus.

2. Th e reflux is caused by an in com peten t lower eso ph ageal sph in cter (LES), pyloric sten osis, or m otility disorder.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

675CHAPTER 52 Gastrointestinal System

B. Assessm en t 1. Heartburn , epigastric pain 2. Dysp epsia 3. Nausea, regurgitation 4. Pain an d difficulty with swallowin g 5. Hypersalivation

C. In terven tion s 1. In struct th e clien t to avoid factors th at decrease

LES pressure or cause esoph ageal irritation , such as pep perm in t, ch oco late, coffee, fried or fatty food s, carbo n ated beverages, alcoh olic bever- ages, an d cigarette sm okin g.

2. In struct th e clien t to eat a low-fat, h igh -fib er diet an d to avoid eatin g an d drin kin g 2 h ours before bed tim e an d wearin g tigh t clo th es; also, elevate th e h ead of th e bed on 6- to 8-in ch (15 to 20 cm ) blocks.

3. Avoid th e use of an tich o lin ergics, wh ich delay stom ach em ptyin g; also , n on steroidal an tiin - flam m atory m edication s (NSAIDs) an d oth er m ed ication s th at con tain acetylsalicylic acid n eed to be avoided.

4. In struct th e clien t regardin g prescribed m edica- tion s, such as an tacids, H 2-receptor an tagon ists, or proton pum p in h ibitors.

5. In struct th e clien t regardin g th e ad m in istration of prokin etic m ed ication s, if prescribed, wh ich accelerate gastric em p tyin g.

6. Surgery m ay be required in extrem e cases wh en m ed ical m an agem en t is un successful; th is in volves a fun dop lication (wrappin g a portion of th e gastric fun dus arou n d th e sph in cter area of th e eso ph agus); surgery m ay be perform ed by laparoscopy.

VI. Gastritis A. Description

1. In flam m ation of th e stom ach or gastric m ucosa 2. Acute gastritis is cau sed by th e in gestion of food

con tam in ated with disease-causin g m icro organ - ism s or food th at is irritatin g or too h igh ly sea- son ed , th e overuse of aspirin or oth er NSAIDs, excessive alcoh ol in take, bile reflux, or radiation th erap y.

3. Ch ron ic gastritis is caused by ben ign or m align an t ulcers or by th e bacteria H. pylori, an d also m ay be caused by autoim m une diseases, dietary factors, m edication s, alcoh ol, sm oking, or reflux.

B. Assessm en t (Box 52-4) C. In terven tion s

1. Acute gastritis: Food an d fluid s m ay be with h eld un til sym ptom s subside; afterward, an d as pre- scrib ed, ice ch ips can be given , followed by clear liqu ids, an d th en solid food .

2. Mon itor for sign s of h em orrh agic gastritis such as h em atem esis, tach ycardia, an d h ypo ten sion , an d n otify th e HCP if th ese sign s occur.

3. In struct th e clien t to avoid irritatin g food s, fluids, an d oth er substan ces, such as spicy an d h igh ly seaso n ed food s, caffein e, alcoh ol, an d n icotin e.

4. In struct th e clien t in th e use of prescribed m ed i- cation s, such as an tibiotics to treat H. pylori, an d an tacids.

5. Provid e th e clien t with in form ation about th e im portan ce of vitam in B12 in jection s if a defi- cien cy is presen t.

VII. Peptic Ulcer Disease A. Description

1. A peptic ulcer is an ulceratio n in th e m ucosal wall of th e stom ach , pyloru s, duoden um , or esoph a- gu s in portion s accessible to gastric secretio n s; erosion m ay exten d th rou gh th e m uscle.

2. Th e ulcer m ay be referred to as gastric, duodenal, or esophageal, depen din g on its location .

3. Th e m ost com m on peptic ulcers are gastric ulcers an d duoden al ulcers.

B. Gastric ulcers 1. Description

a . A gastric ulcer in volves ulceration of th e m ucosal lin in g th at exten ds to th e subm uco- sal layer of th e stom ach .

b . Predisp osin g facto rs in clude stress, sm okin g, th e use of co rticosteroids, NSAIDs, alcoh ol, h isto ry of gastritis, fam ily h istory of gastric ulcers, or in fectio n with H. pylori.

c. Com p lication s in clude h em orrh age, perfora- tion , an d pyloric obstru ction .

2. Assessm en t ( Box 52-5) 3. In terven tion s

a . Mon itor vital sign s an d for sign s of bleedin g. b . Adm in ister sm all, frequen t blan d feedin gs

durin g th e active ph ase. c. Adm in ister H 2-receptor an tagon ists or proton

pum p in h ibito rs as prescribed to decrease th e secretio n of gastric acid.

d . Adm in ister an tacids as prescribed to n eutral- ize gastric secretio n s.

e. Adm in ister an tich olin ergics as prescribed to reduce gastric m otility.

f. Adm in ister m ucosal barrier protectan ts as prescribed 1 h our befo re each m eal.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

BOX 52-4 Assessment Findings in Acute and Chronic Gastritis

Acute ▪ Abdominal discomfort ▪ Anorexia, nausea, and

vomiting ▪ Headache ▪ Hiccupping ▪ Reflux

Chronic ▪ Anorexia, nausea, and

vomiting ▪ Belching ▪ Heartburn after eating ▪ Sour taste in the mouth ▪ Vitamin B12 deficiency

676 UNIT XI Gastrointestinal Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

g. Adm in ister prostaglan din s as prescribed for th eir protective an d an tisecretory action s.

4. Clien t edu cation a . Avo id con sum in g alcoh ol an d substan ces th at

con tain caffein e or ch ocolate. b . Avo id sm okin g. c. Avo id aspirin or NSAIDs. d . O btain ad equate rest an d reduce stress.

5. In terven tion s durin g active bleedin g a . Mon itor vital sign s closely. b . Assess for sign s of deh ydration , h ypo volem ic

sh o ck, sep sis, an d respiratory in sufficien cy. c. Main tain NPO status an d adm in ister in trave-

n ou s (IV) flu id replacem en t as prescribed ; m on itor in take an d outp ut.

d . Mon itor h em oglobin an d h em atocrit. e. Adm in ister blood tran sfusion s as prescribed. f. Prepare to assist with adm in isterin g m edica-

tio n s as prescribed to in duce vasocon striction an d reduce bleedin g.

6. Surgical in terven tion s a . To tal gastrectomy: Rem oval of th e stom ach

with attach m en t of th e esoph agus to th e jeju- n um or duod en um ; also called esophagojeju- nostomy or esophagoduodenostomy

b . Vagotomy: Surgical division of th e vagus n erve to elim in ate th e vagal im pulses th at stim ulate h ydroch loric acid secretio n in th e stom ach

c. Gastric resection: Rem o val of th e lower h alf of th e stom ach an d usually in cludes a vagot- om y; also called antrectomy

d . Gastroduo den ostom y: Partial gastrectom y, with th e rem ain in g segm en t an astom osed to th e duod en um ; also called Billroth I ( Fig. 52-1)

e. Gastrojejun ostom y: Partial gastrectom y, with th e rem ain in g segm en t anastom osed to the jejun um ; also called Billroth II (Fig. 52-2)

f. Pyloroplasty: En largem en t of th e pylorus to preven t or decrease pyloric obstru ction , th ereby en h an cin g gastric em ptyin g

7. Posto perative in terven tion s a. Mon itor vital sign s. b . Place in a Fowler’s position for com fort an d to

prom o te drain age. c. Adm in ister flu ids an d electrolyte replace-

m en ts in traven o usly as prescribed; m on itor in take an d outp ut.

d . Assess bowel soun ds. e. Mon itor NG suction as prescribed. f. Main tain NPO status as prescribed for 1 to

3 days un til peristalsis return s. g. Progress th e diet from NPO to sips of clear

water to 6 sm all blan d m eals a day, as pre- scrib ed wh en bowel soun ds return .

h . Mon itor for postoperative com plication s of h em orrh age, dumping syndrome, diarrh ea, h ypo glycem ia, an d vitam in B12 deficien cy.

BOX 52-5 Assessment: Gastric and Duodenal Ulcers

Gastric Gnawing, sharp pain in or to the left of the mid-epigastric

region occurs 30 to 60 minutes after a meal (food inges- tion accentuates the pain).

Hematemesis is more common than melena.

Duodenal Burning pain occurs in the mid-epigastric area 1½ to 3 hours

after a meal and during the night (often awakens the client).

Melena is more common than hematemesis. Pain is often relieved by the ingestion of food.

Fundus

Body

Duode num

Duode na l a na s tomos is

FIGURE 52-1 The Billroth I procedure (gastroduodenostomy). The distal portion of the stomach is removed, and the remainder is anastomosed to the duodenum.

Fundus

Body

J e junum

J e juna l a na s tomos is

FIGURE 52-2 The Billroth II procedure (gastrojejunostomy). The lower portion of the stomach is removed, and the remainder is anastomosed to the jejunum.

677CHAPTER 52 Gastrointestinal System

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

Following gastric surgery, do not irrigate or remove the NG tube unless specifically prescribed because of the risk for disruption of the gastric sutures. Monitor closely to ensure proper functioning of the NG tube to prevent strain on the anastomosis site. Contact the HCP if the tube is not functioning properly.

C. Du oden al ulcers 1. Descriptio n

a . A duod en al ulcer is a break in th e m ucosa of th e duod en um .

b . Risk factors an d cau ses in clude in fectio n with H. pylori; alcoh ol in take; sm okin g; stress; caf- fein e; an d th e use of aspirin , co rticosteroids, an d NSAIDs.

c. Com p lication s in clude bleed in g, perforation , gastric outlet obstruction , an d in tractable disease.

2. Assessm en t (see Box 52-5) 3. In terven tion s

a . Mon itor vital sign s. b . In struct th e clien t ab out a blan d diet, with

sm all, frequen t m eals. c. Provide for ad equate rest. d . En cou rage th e cessation of sm okin g. e. In struct th e clien t to avoid alcoh ol in take; caf-

fein e; an d th e use of aspirin , co rticosteroids, an d NSAIDs.

f. Adm in ister m edication s to treat H. pylori an d an tacids to n eutralize acid secretions as prescribed.

g. Adm in ister H 2-recep tor an tagon ists or proton pum p in h ibitors as prescribed to block th e secretio n of acid.

4. Surgical in terven tion s: Surgery is perform ed on ly if th e ulcer is un respo n sive to m edication s or if h em orrh age, obstru ction , or perforation occurs.

D. Dumping syndrome 1. Descriptio n : Th e rapid em ptyin g of th e gastric

co n ten ts in to th e sm all in testin e th at occurs fol- lo win g gastric resectio n

2. Assessm en t a . Sym ptom s occurrin g 30 m in utes after eatin g b . Nausea an d vom itin g c. Feelin gs of ab dom in al fulln ess an d abdom i-

n al cram p in g d . Diarrh ea e. Palp itation s an d tach ycardia f. Persp iration g. Weakn ess an d dizzin ess h . Borb orygm i (loud gu rglin g soun ds resultin g

from bowel h yperm otility) 3. Clien t edu cation (Box 52-6)

VIII. Vitamin B12 Deficiency A. Description

1. Vitam in B12 deficien cy results from an in - adequate in take of vitam in B12 or a lack of

absorption of in gested vitam in B12 from th e in testin al tract.

2. Pern iciou s an em ia results from a deficien cy of in trin sic facto r (n orm ally secreted by th e gastric m ucosa), n ecessary for in testin al absorption of vitam in B12; gastric disease or surgery can result in a lack of in trin sic factor.

B. Assessm en t 1. Severe pallor 2. Fatigue 3. Weigh t loss 4. Sm oo th , beefy red ton gue 5. Sligh t jaun dice 6. Paresth esias of th e h an ds an d feet 7. Distu rban ces with gait an d balan ce

C. In terven tion s 1. In crease dietary in take of foods rich in vitam in B12

such as citrus fruits, dried bean s, green leafy vege- tables, liver, n uts, organ m eats, an d brewer’s yeast if th e an em ia is th e result of a dietary deficien cy

2. Adm in ister vitam in B12 in jection s as prescribed, weekly in itially an d th en m on th ly for m ain te- n an ce (lifelon g) if th e an em ia is th e result of a deficien cy of in trin sic factor or disease or surgery of th e ileum .

IX. Bariatric Surgery A. Descrip tion

1. Surgical reduction of gastric capacity or absorp- tive ab ility th at m ay be perform ed on a clien t with m orbid obesity to produ ce lon g-term weigh t loss

2. Surgery m ay be perform ed by laparoscopy; th e decision is based on th e clien t’s weigh t, body build, h istory of abdom in al surgery, an d curren t m edical disorders.

3. O bese clien ts are at in creased postoperative risk for pulm o n ary an d th rom boem bolic com plica- tion s an d death .

4. Surgery can preven t th e com plication s of obesity, such as diabetes m ellitus, h yperten sion an d oth er cardiovascular disorders, or sleep ap n ea.

5. Th e clien t n eeds to agree to m od ify h is or h er life- style, lose weigh t an d keep th e weigh t off, an d obtain supp ort from available com m un ity resou rces such as th e Am erican O besity Associa- tion , Am erican Society of Bariatric Surgery, or O vereaters An o n ym ous.

BOX 52-6 Client Education: Preventing Dumping Syndrome

Avoid sugar, salt, and milk. Eat a high-protein, high-fat, low-carbohydrate diet. Eat small meals and avoid consuming fluids with meals. Lie down after meals. Take antispasmodic medications as prescribed to delay

gastric emptying.

678 UNIT XI Gastrointestinal Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

B. Types (Fig. 52-3) C. Posto perative in terven tion s

1. Care is sim ilar to th at for th e clien t un dergoin g laparoscopic or ab dom in al surgery.

2. As prescribed, if th e clien t can tolerate water, clear liquid s are in troduced slowly in 1-oun ce (30 m L) cu ps for each servin g on ce bowel soun ds h ave return ed an d th e clien t passes flatu s.

3. As prescribed, clear fluid s are follo wed by puréed food s, juices, th in soups, an d m ilk 24 to 48 h ours after clear fluid s are tolerated (th e diet is usually lim ited to liquid s or puréed food s for 6 weeks) ; th en th e diet is progressed to n utrien t-den se regular food .

D. Clien t teach in g poin ts about diet ( Box 52-7)

X. Gastric Cancer A. See Ch apter 48 for m ore in form ation .

XI. Hiatal Hernia A. Description

1. A hiatal hernia is also kn own as eso ph ageal or diaph ragm atic h ern ia.

2. A portion of th e stom ach h ern iates th rough th e diaph ragm an d in to th e th orax.

3. Hern iation results from weaken in g of th e m us- cles of th e diap h ragm an d is aggravated by factors

th at in crease abdom in al pressure such as preg- n an cy, ascites, obesity, tum o rs, an d h eavy liftin g.

4. Com p lication s in clude ulceratio n , h em orrh age, regurgitation an d aspiration of stom ach con - ten ts, stran gulation , an d in carceration of th e stom ach in th e ch est with possible n ecro sis, peri- ton itis, an d m ed iastin itis.

B. Assessm en t 1. Heartburn 2. Regurgitation or vom itin g 3. Dysp h agia 4. Feelin g of fulln ess

Pouch (15-30 mL ca pa city)

Polypropyle ne ba nd with ca libra te d s toma

Infla ta ble s ilicone ba nd

Pouch (10-15 mL ca pa city)

Pouch (100-200 mL ca pa city)

P ylorus

Ile um

Ce cum

Pouch (20-30 mL ca pa city)

S tomaDuode num

J e junum

Duode num

J e junum

Ga s tric s le e ve

S e lf-s e a ling re s e rvoir

Ve rtic al Bande d Gas tro plas ty

Bilio panc re atic Dive rs io n with Duo de nal S witc h Ro ux-e n-Y Gas tric Bypas s

Ve rtic al S le e ve Gas tro plas tyGas tric Banding

A B C

D E

FIGURE 52-3 Bariatric surgical procedures.

BOX 52-7 Dietary Measures for the Client Following Bariatric Surgery

Avoid alcohol, high-protein foods, and foods high in sugar and fat.

Eat slowly and chew food well. Progress food types and amounts as prescribed. Take nutritional supplements as prescribed, which may

include calcium, iron, multivitamins, and vitamin B12. Monitor and report signs and symptoms of complications,

such as dehydration and gastric leak (persistent abdomi- nal pain, nausea, vomiting).

679CHAPTER 52 Gastrointestinal System

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

C. In terven tion s 1. Med ical an d surgical m an agem en t are sim ilar to

th o se for gastro esoph ageal reflux disease. 2. Provide sm all frequen t m eals an d lim it th e

am oun t of liquid s taken with m eals. 3. Advise th e clien t n ot to reclin e for 1 h our after

eatin g. 4. Avoid an tich o lin ergics, wh ich delay stom ach

em p tyin g.

XII. Cholecystitis A. Description

1. In flam m ation of th e gallbladder th at m ay occur as an acute or ch ron ic process

2. Acute in flam m ation is associated with gallston es (ch olelith iasis) .

3. Ch ron ic cholecystitis results when in efficien t bile em ptyin g an d gallbladder m uscle wall disease cause a fibrotic and con tracted gallbladder.

4. Acalculou s ch olecystitis occurs in th e absen ce of gallston es an d is caused by bacterial in vasion via th e lym p h atic or vascular system .

B. Assessm en t 1. Nausea an d vom itin g 2. In digestion 3. Belch in g 4. Flatu len ce 5. Epigastric pain th at radiates to th e righ t sh oul-

der or scapula 6. Pain localized in righ t upper quadran t an d trig-

gered by h igh -fat or h igh -vo lum e m eal 7. Guardin g, rigidity, an d reboun d ten dern ess 8. Mass palpated in th e righ t upper quadran t 9. Murphy’s sign (can n ot take a deep breath wh en

th e exam in er’s fin gers are passed below th e h epatic m argin because of pain )

10. Elevated tem p erature 11. Tach ycardia 12. Sign s of deh ydration

C. Biliary obstru ctio n 1. Jaun d ice 2. Dark oran ge an d foam y urin e 3. Steatorrh ea an d clay-colored feces 4. Pruritus

D. In terven tion s 1. Main tain NPO status durin g n ausea an d vom it-

in g episo des. 2. Main tain NG deco m pression as prescribed for

severe vo m itin g. 3. Adm in ister an tiem etics as prescribed for n ausea

an d vom itin g. 4. Adm in ister an algesics as prescribed to relieve

pain an d reduce spasm . 5. Adm in ister an tispasm odics (an tich olin ergics) as

prescribed to relax sm ooth m uscle. 6. In struct th e clien t with ch ron ic ch olecystitis to

eat sm all, low-fat m eals. 7. In struct th e clien t to avoid gas-form in g food s.

8. Prepare th e clien t for n on su rgical an d surgical proced ures as prescribed.

E. Surgical in terven tion s 1. Cholecystectomyis th e rem oval of th e gallbladder. 2. Choledocholithotomy requires in cision in to th e

com m on bile duct to rem ove th e ston e. 3. Surgical proced ures m ay be perform ed by

laparoscopy. F. Postoperative in terven tion s

1. Mon itor for respiratory com plication s caused by pain at th e in cision al site.

2. En cou rage cough in g an d deep breath in g. 3. En cou rage early am bulation . 4. In struct th e clien t about splin tin g th e abdom en

to preven t discom fort durin g cough in g. 5. Adm in ister an tiem etics as prescribed for n ausea

an d vo m itin g. 6. Adm in ister an algesics as prescribed for pain relief. 7. Main tain NPO status an d NG tube suction as

prescribed. 8. Advan ce diet fro m clear liquids to solids wh en

prescribed an d as tolerated by th e clien t. 9. Main tain an d m on itor drain age from th e T-tu be,

if presen t (Box 52-8).

XIII. Cirrhosis A. Description

1. A ch ron ic, progressive disease of th e liver ch arac- terized by diffuse degen eration an d destruction of h epatocytes

2. Repeated destruction of h epatic cells cau ses th e form ation of scar tissue.

BOX 52-8 Care of a T-Tube Purpose and Description A T-tube is placed after surgical exploration of the common bile duct. The tube preserves the patency of the duct and ensures drainage of bile until edema resolves and bile is effec- tively draining into the duodenum. A gravity drainage bag is attached to the T-tube to collect the drainage.

Interventions Place the client in semi-Fowler’s position to facilitate

drainage. Monitor the output amount and the color, consistency, and

odor of the drainage. Report sudden increases in bile output to the health care pro-

vider (HCP). Monitor for inflammation and protect the skin from irritation. Keep the drainage system below the level of the gallbladder. Monitor for foul odor and purulent drainage and report its

presence to the HCP. Avoid irrigation, aspiration, or clamping of the T-tube without

an HCP’s prescription. As prescribed, clamp the tube before a meal and observe for

abdominal discomfort and distention, nausea, chills, or fever; unclamp the tube if nausea or vomiting occurs.

680 UNIT XI Gastrointestinal Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

3. Cirrh osis h as m an y causes an d is due to ch ron ic dam age an d in jury to liver cells; th e m ost com m on are ch ron ic h epatitis C, alcoh olism , nonalcoholic fatty liver disease (NAFLD), an d nonalcoholic steatohepatitis (NASH).

B. Com p lication s 1. Portal hypertension: A persisten t in crease in pres-

sure in th e portal vein th at develops as a result of obstru ction to flow

2. Ascites a. Accum u lation of fluid in th e periton eal cavity

th at results from ven ous con gestion of th e h epatic capillaries

b . Capillary congestion leads to plasm a leakin g directly from the liver surface an d portal vein .

3. Bleedin g esophageal varices: Fragile, th in -walled , disten ded esoph ageal vein s th at becom e irritated an d ru pture

4. Coagulation defects a. Decreased syn th esis of bile fats in th e liver

preven ts th e absorption of fat-solub le vitam in s.

b . With out vitam in K an d clottin g factors II, VII, IX, and X, th e clien t is pron e to bleedin g.

5. Jaun dice: O ccurs because th e liver is un able to m etab olize bilirubin an d because th e edem a, fibrosis, an d scarrin g of th e h epatic bile ducts in terfere with n o rm al b ile an d b iliru bin secretio n

6. Portal system ic en ceph alopath y: En d-stage h epatic failure ch aracterized by altered level of con scio usn ess, n eurological sym ptom s, im - paired th in kin g, an d n eurom uscular distur- ban ces; caused by failure of th e diseased liver to deto xify n eurotoxic agen ts such as am m on ia

7. Hepatoren al syn d rom e a. Progressive ren al failure associated with

h epatic failure b . Ch aracterized b y a su d d en d ecrease in u ri-

n ary o u tp u t, elevated b lo o d u rea n itro gen an d creatin in e levels, d ecreased u rin e so d iu m excretio n , an d in creased u rin e o sm o larity

C. Assessm en t ( Fig. 52-4) D. In terven tion s

1. Elevate th e h ead of th e bed to m in im ize sh ort- n ess of breath .

Fluid and Ele c tro lyte Dis turbanc e s

• As cite s • De cre a s e d

e ffe ctive blood volume

• Hypoka le mia • P e riphe ra l e de ma • Wa te r re te ntion

• Hypoca lce mia • Dilutiona l

hypona tre mia or hype rna tre mia

Gas tro inte s tinal (GI) Finding s

• Abdomina l pa in • Anore xia • As cite s • Cla y-colore d s tools • Dia rrhe a • Es opha ge a l va rice s

• Hia ta l he rnia • Hype rs ple nis m • Ma lnutrition • Na us e a • S ma ll nodula r live r • Vomiting

• Fe tor he pa ticus • Ga lls tone s • Ga s tritis • Ga s trointe s tina l ble e ding • He morrhoida l va rice s • He pa tome ga ly

He mato lo g ic al Finding s

• Ane mia • Dis s e mina te d intra va s cula r

coa gula tion

• Impa ire d coa gula tion • S ple nome ga ly • Thrombocytope nia

• As te rixis • P a re s the s ia s of fe e t • P e riphe ra l ne rve de ge ne ra tion • P orta l-s ys te mic e nce pha lopa thy • Re ve rs a l of s le e p-wa ke pa tte rn • S e ns ory dis turba nce s

Ne uro lo g ic al Finding s

• Axilla ry a nd pubic ha ir cha nge s • Ca put me dus a e (dila te d

a bdomina l ve ins )* • Ecchymos is ; pe te chia e * • Incre a s e d s kin pigme nta tion • J a undice • P a lma r e rythe ma * • P ruritus • S pide r a ngioma s (che s t a nd thora x)*

De rmato lo g ic al Finding s

• He pa tore na l s yndrome • Incre a s e d urine bilirubin

Re nal Finding s

• Incre a s e d a ldos te rone • Incre a s e d a ntidiure tic hormone • Incre a s e d circula ting e s troge ns • Incre a s e d glucocorticoids • Gyne coma s tia

Endo c rine Finding s

• Incre a s e d s us ce ptibility to infe ction • Le ukope nia

Immune S ys te m Dis turbanc e s

• Dys pne a • Hydrothora x • Hype rve ntila tion • Hypoxe mia

Pulmo nary Finding s

Cardio vas c ular Finding s

• Ca rdia c dys rhythmia s • De ve lopme nt of

colla te ra l circula tion • Fa tigue

• Hype rkine tic circula tion • P e riphe ra l e de ma • P orta l hype rte ns ion • S pide r a ngioma s

FIGURE 52-4 Clinical picture of a client with liver dysfunction. Manifestations vary according to the progression of the disease. Some dermatological manifestations are noted in color (and marked with asterisks).

681CHAPTER 52 Gastrointestinal System

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

2. If ascites an d edem a are absen t an d th e clien t does n ot exh ibit sign s of im pen din g com a, a h igh -protein diet supp lem en ted with vitam in s is prescribed.

3. Provide supplem en tal vitam in s (B com plex; vitam in s A, C, an d K; folic acid; an d th iam in e) as prescribed.

4. Restrict sodium in take an d fluid in take as prescribed.

5. In itiate en teral feedin gs or paren teral n utrition as prescribed.

6. Adm in ister diuretics as prescribed to treat ascites. 7. Mon itor in take an d outp ut an d electrolyte

balan ce. 8. Weigh clien t an d m easu re abdom in al girth

daily ( Fig. 52-5). 9. Mon itor level of con scio usn ess; assess for pre-

com a state (trem ors, delirium ). 10. Mon itor for asterixis, a coarse trem o r ch aracter-

ized by rapid, n on rh yth m ic exten sion s an d flex- io n s in th e wrist an d fin gers (Fig. 52-6).

11. Mon itor for fetor hepaticus, th e fruity, m usty breath odor of severe ch ron ic liver disease.

12. Main tain gastric in tubation to assess bleedin g or eso ph agogastric balloon tam pon ade to con - trol bleedin g varices if prescribed.

13. Adm in ister blood products as prescribed. 14. Mon itor coagulation labo ratory results; adm in -

ister vitam in K if prescribed. 15. Adm in ister an tacids as prescribed. 16. Adm in ister lactulose as prescribed, wh ich

decreases th e pH of th e bowel, decreases produ ction of am m on ia by bacteria in th e bowel, an d facilitates th e excretion of am m on ia.

17. Adm in ister an tibiotics as prescribed to in h ib it protein syn th esis in bacteria an d decrease th e produ ction of am m on ia.

18. Avoid m edication s such as opioids, sed atives, an d barbiturates an d an y h epatotoxic m edica- tion s or substan ces.

19. In struct th e clien t about th e im portan ce of abstin en ce of alcoh ol in take.

20. Prepare th e clien t for paracen tesis to rem ove abdom in al flu id.

21. Prepare th e clien t for surgical sh un tin g proce- dures if prescribed to divert fluid from ascites in to th e ven ous system .

XIV. Esophageal Varices A. Description

1. Dilated an d tortuous vein s in th e subm ucosa of th e eso ph agus.

2. Caused by portal h yperten sion , often associated with liver cirrhosis; are at h igh risk for ru pture if portal circulation pressure rises

3. Bleedin g varices are an em ergen cy. 4. Th e goal of treatm en t is to con tro l bleedin g, pre-

ven t com plication s, an d preven t th e recurren ce of bleedin g.

B. Assessm en t 1. Hem atem esis 2. Melena 3. Ascites 4. Jaun d ice 5. Hepatom egaly an d splen om egaly 6. Dilated abdom in al vein s 7. Sign s of sh ock

Rupture and resultant hemorrhage of esophageal varices is the primary concern because it is a life- threatening situation.

C. In terven tion s 1. Mon itor vital sign s. 2. Elevate th e h ead of th e bed . 3. Mon itor for orth ostatic h ypoten sion . 4. Mon itor lu n g soun ds an d for th e presen ce of

respiratory distress.

FIGURE 52-6 Eliciting asterixis (flapping tremor). Have the client extend the arm, dorsiflex the wrist, and extend the fingers. Observe for rapid, non- rhythmic extensions and flexions.

Ma rkings on a bdome n

La rge s t dia me te r

FIGURE 52-5 How to measure abdominal girth. With the client supine, bring the tape measure around the client and take a measurement at the level of the umbilicus. Before removing the tape, mark the client’s abdo- men along the sides of tape on the client’s flanks (sides) and midline to ensure that later measurements are taken at the same place.

682 UNIT XI Gastrointestinal Disorders of the Adult Client

5. Adm in ister oxygen as prescribed to preven t tis- sue h ypo xia.

6. Mon itor level of con scio usn ess. 7. Main tain NPO status. 8. Adm in ister fluids in traven o usly as prescribed to

restore fluid volum e an d electrolyte im bal- an ces; m on itor in take an d outp ut.

9. Mon itor h em oglobin an d h em atocrit values an d coagulation factors.

10. Adm in ister blood tran sfusion s or clottin g fac- tors as prescribed.

11. Assist in in sertin g an NG tube or a balloo n tam pon ade as prescribed; balloon tam pon ade is n ot used frequen tly because it is very un co m - fortable for th e clien t an d its use is associated with com plication s.

12. Prepare to assist with adm in isterin g m edication s to in duce vasocon striction an d reduce bleedin g.

13. In struct th e clien t to avoid activities th at will in itiate vasovagal respon ses.

14. Prepare th e clien t for en doscopic proced ures or surgical proced ures as prescribed.

D. En do scopic in jection (sclero th erapy) 1. Th e procedure in volves th e in jection of a scleros-

in g agen t in to an d arou n d bleedin g varices. 2. Com p lication s in clude ch est pain , pleural effu-

sion , aspiration pn eum on ia, esoph ageal stric- ture, an d perforation of th e eso ph agus.

E. En do scopic variceal ligation 1. Th e procedure in volves ligatio n of th e varices

with an elastic ru bber ban d . 2. Slo ugh in g, followed by superficial ulceration ,

occurs in th e area of ligation with in 3 to 7 days. F. Sh u n tin g procedures

1. Descriptio n : Sh u n t blood away from th e esoph - ageal varices

2. Portacaval sh un tin g in volves an astom osis of th e portal vein to th e in ferior ven a cava, divertin g blood from th e portal system to th e system ic circulation ( Fig. 52-7).

3. Distal splen oren al sh un t (see Fig. 52-7) a . Th e sh un t in volves an astom osis of th e splen ic

vein to th e left ren al vein . b . The spleen conducts blood from the high-

pressure varices to th e low-pressure renal vein. 4. Mesocaval sh un tin g in volves a side an astom osis

of th e superior m esen teric vein to th e proxim al en d of th e in ferior ven a cava.

5. Tran sjugular in trah epatic portosystem ic sh u n t (TIPS) a . Th is proced ure uses th e n orm al vascu lar

an atom y of th e liver to create a sh un t with th e use of a m etallic sten t.

b . Th e sh un t is between th e portal an d system ic ven ous system in th e liver an d is aim ed at relievin g portal h yperten sio n .

XV. Hepatitis A. Description

1. In flam m ation of th e liver caused by a virus, bac- teria, or exposu re to m ed ication s or h epatoto xin s

2. Th e goals of treatm en t in clude restin g th e in flam ed liver to reduce m etabolic dem an ds an d increas- ing th e blood supply, th us prom oting cellular regen eration an d preventin g com plication s.

B. Types of hepatitis in clude h epatitis Avirus (HAV), h ep- atitis B virus (HBV), h epatitis C virus (HCV), h epatitis D virus (HDV), and h epatitis E virus (HEV).

C. Assessm en t an d stages of viral h epatitis (Box 52-9)

XVI. Hepatitis A A. Description : Form erly kn own as infectious hepatitis

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

No rmal He patic Circ ulatio n

Porta l ve in

S ple e n

Le ft re na l ve in

Infe rior ve na ca va

S ple nic ve in

S ple nic ve in

Po rtac aval (End-to -s ide ) S hunt S ple no re nal (End-to -s ide ) S hunt

FIGURE 52-7 Surgical shunting diverts portal venous blood flow from the liver to decrease portal and esophageal pressure.

683CHAPTER 52 Gastrointestinal System

B. In divid uals at in creased risk 1. Crowded con d ition s (e.g., day care, n ursin g

h om e) 2. Expo sure to poor san itation

C. Tran sm issio n 1. Fecal-oral ro ute 2. Perso n -to-person con tact 3. Paren teral 4. Con tam in ated fru its or vegetables, or un cooked

sh ellfish 5. Con tam in ated water or m ilk 6. Poorly wash ed uten sils

D. In cubation an d in fectious period 1. In cubation period is 2 to 6 weeks. 2. In fectious period is 2 to 3 weeks before an d

1 week after developm en t of jaun dice. E. Testin g

1. In fection is establish ed by th e presen ce of HAV an tibod ies (an ti-HAV) in th e blood .

2. Im m un oglobulin M (IgM) an d im m un oglobu lin G (IgG) are n orm ally presen t in th e blood, an d in creased levels in dicate in fectio n an d in flam m ation .

3. O n goin g in flam m ation of th e liver is eviden ced by th e presen ce of elevated levels of IgM an tibo- dies, wh ich persist in th e blood for 4 to 6 weeks.

4. Previous in fectio n is in dicated by th e presen ce of elevated levels of IgG an tibodies.

F. Com p lication : Fulm in an t (severe acu te an d often fatal) h epatitis

G. Preven tion 1. Strict h an d wash in g 2. Stool an d n eedle precaution s 3. Treatm en t of m un icipal water supp lies

4. Serological screen in g of food h an dlers 5. Hepatitis A vaccin e: Two doses are n eeded at least

6 m on th s ap art for lastin g protectio n . For ad di- tion al in form ation , refer to h ttp:/ / www.cdc. gov/ vaccin es/ h cp/ vis/ vis-statem en ts/ h ep -a.h tm l

6. Im m une globulin : For in dividuals exposed to HAV wh o h ave n ever received the h epatitis A vaccin e; adm in ister im m un e globulin durin g the period of in cubation an d within 2 weeks of exposure.

7. Im m un e globulin an d h epatitis A vaccin e are recom m en ded for h ouseh old m em bers an d sex- ual con tacts of in dividuals with h epatitis A.

8. Preexposure proph ylaxis with im m un e globulin is recom m en ded to in dividuals travelin g to coun - tries with poor or un certain san itation con dition s.

Strict and frequent hand washing is key to prevent- ing the spread of all types of hepatitis.

XVII. Hepatitis B A. Descrip tion

1. Hepatitis B is n on season al. 2. All age grou ps can be affected.

B. In divid uals at in creased risk 1. IV drug users 2. Clien ts un d ergoin g lon g-term h em od ialysis 3. Health care perso n n el

C. Tran sm ission 1. Bloo d or body fluid con tact 2. In fected blood produ cts 3. In fected saliva or sem en 4. Con tam in ated n eedles 5. Sexual con tact 6. Paren teral 7. Perin atal period 8. Bloo d or body fluid con tact at birth

D. In cubation period: 6 to 24 weeks E. Testin g

1. In fection is establish ed by th e presen ce of h epa- titis B an tigen –an tibody system s in th e blood .

2. Th e presen ce of h epatitis B surface an tigen (HBsAg) is th e serological m arker establish in g th e diagn osis of h epatitis B.

3. Th e clien t is co n sidered in fectio us if th ese an ti- gen s are presen t in th e blood.

4. If th e serological m arker (HBsAg) is presen t after 6 m on th s, it in dicates a carrier state or ch ron ic h epatitis.

5. Norm ally, th e serological m arker (HBsAg) level declin es an d disappears after th e acute h epatitis B episo de.

6. Th e presen ce of an tibod ies to HBsAg (an ti-HBs) in dicates recovery an d im m un ity to h epatitis B.

7. Hepatitis B early an tigen (HBeAg) is detected in th e blood about 1 week after th e ap pearan ce of HBsAg, an d its presen ce determ in es th e in fective state of th e clien t.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

BOX 52-9 Stages and Assessment of Viral Hepatitis

Preicteric Stage The first stage of hepatitis, preceding the appearance of jaundice; includes flulike symptoms—malaise, fatigue; anorexia, nausea, vomiting, diarrhea; pain—headache, muscle aches, polyarthritis; and elevated serum bilirubin and enzyme levels.

Icteric Stage The second stage of hepatitis; includes the appearance of jaundice and associated symptoms such as elevated bilirubin levels, dark or tea-colored urine, and clay-colored stools; pru- ritus; and a decrease in preicteric-phase symptoms.

Posticteric Stage The convalescent stage of hepatitis, in which the jaundice decreases and the color of the urine and stool returns to nor- mal; energy increases, pain subsides, there is minimal to absent gastrointestinal symptoms, and bilirubin and enzyme levels return to normal.

684 UNIT XI Gastrointestinal Disorders of the Adult Client

F. Com p lication s 1. Fulm in an t h epatitis 2. Ch ron ic liver disease 3. Cirrh osis 4. Prim ary h epatocellular carcin om a

G. Preven tion 1. Strict h an d wash in g 2. Screen in g blood don ors 3. Testin g of all pregn an t wom en 4. Needle precaution s 5. Avoidin g in tim ate sexual con tact an d con tact

with body fluids if test for HBsAg is positive. 6. Hepatitis B vaccin e: Adult an d ped iatric form s;

th ere is also an ad ult vaccin e th at protects again st h epatitis A an d B.

7. Hepatitis B im m un e glob ulin is for in dividuals exposed to HBV th rou gh sexual co n tact or th rou gh th e percutan eous or tran sm u cosal routes wh o h ave n ever h ad h epatitis B an d h ave n ever received h epatitis B vaccin e.

XVIII. Hepatitis C A. Description

1. HCV in fectio n occurs year-rou n d. 2. In fection can occur in an y age group. 3. In fection with HCV is co m m on am on g IV drug

users an d is th e m ajo r cau se of posttran sfusion h epatitis.

4. Risk factors are sim ilar to th o se for HBV because h epatitis C is also tran sm itted paren terally.

B. In divid uals at in creased risk 1. Paren teral drug users 2. Clien ts receivin g frequen t tran sfusion s 3. Health care person n el

C. Tran sm issio n : Sam e as for HBV, prim arily th rou gh blood

D. In cubation period: 5 to 10 weeks E. Testin g: An ti-HCV is th e an tibod y to HCV an d is

m easu red to detect ch ron ic states of h epatitis C. F. Com p lication s

1. Ch ron ic liver disease 2. Cirrh osis 3. Prim ary h epatocellular carcin om a

G. Preven tion 1. Strict h an d wash in g 2. Needle precaution s 3. Screen in g of blood don ors

XIX. Hepatitis D A. Description

1. Hepatitis D is com m on in th e Mediterran ean an d Middle Eastern areas.

2. Hepatitis D occurs with h epatitis B an d causes in fectio n on ly in th e presen ce of active HBV in fectio n .

3. Coin fection with th e delta agen t (HDV) in ten - sifies th e acute sym pto m s of h epatitis B.

4. Tran sm issio n an d risk of in fectio n are th e sam e as for HBV, via co n tact with blood an d blood produ cts.

5. Preven tion of HBV in fection with vaccin e also preven ts HDV in fectio n , because HDV depen ds on HBV for replication .

B. High -risk in dividuals 1. Drug users 2. Clien ts receivin g h em odialysis 3. Clien ts receivin g frequen t blood tran sfusion s

C. Tran sm ission : Sam e as for HBV D. In cubation period: 7 to 8 weeks E. Testin g: Sero lo gical H DV d eterm in atio n is m ad e

b y d etectio n o f th e h ep atitis D an tigen ( H DAg) early in th e co u rse o f th e in fectio n an d b y d etec- tio n o f an ti-H DV an tib o d y in th e later d isease stages.

F. Com p lication s 1. Ch ron ic liver disease 2. Fulm in an t h epatitis

G. Preven tion : Because h epatitis D m ust coexist with h epatitis B, th e precaution s th at h elp to preven t h epatitis B are also useful in preven tin g delta h epatitis.

XX. Hepatitis E A. Description

1. Hepatitis E is a waterborn e virus. 2. Hepatitis E is prevalen t in areas wh ere sewage

disposal is in adeq uate or wh ere com m un al bath - in g in con tam in ated rivers is practiced.

3. Risk of in fection is th e sam e as for HAV. 4. In fection with HEVpresents as a m ild disease except

in in fected wom en in th e th ird trim ester of preg- nan cy, who h ave a h igh m ortality rate.

B. In divid uals with in creased risk 1. Travelers to coun tries th at h ave a h igh in ciden ce

of h epatitis E, such as In dia, Burm a (Myan m ar), Afgh an istan , Algeria, an d Mexico

2. Eatin g or drin kin g of food or water con tam i- n ated with th e virus

C. Tran sm ission : Sam e as for HAV D. In cubation period: 2 to 9 weeks E. Testin g: Specific serological tests for HEV in clude

detection of IgM an d IgG an tibod ies to h epatitis E (an ti-HEV) .

F. Com p lication s 1. High m ortality rate in pregn an t wom en 2. Fetal dem ise

G. Preven tion 1. Strict h an d wash in g 2. Treatm en t of water supp lies an d san itation

m easu res

XXI. Client and Family Home Care Instructions for Hepatitis

A. See Box 52-10.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

685CHAPTER 52 Gastrointestinal System

XXII. Pancreatitis A. Description

1. Acute or ch ron ic in flam m ation of th e pan creas, with associated escape of pan creatic en zym es in to surroun din g tissue

2. Acute pan creatitis occurs sudden ly as 1 attack or can be recurren t, with resolutio n s.

3. Ch ron ic pan creatitis is a con tin ual in flam m ation an d destructio n of th e pan creas, with scar tissue replacin g pan creatic tissue.

4. Precipitatin g factors in clude traum a, th e use of alcoh ol, biliary tract disease, viral or bacterial dis- ease, h yperlipidem ia, h ypercalcem ia, ch olelith i- asis, h yperparath yroidism , isch em ic vascu lar disease, an d peptic ulcer disease.

B. Acute pan creatitis 1. Assessm en t

a. Abdo m in al pain , in cludin g a sudden on set at a m id-epigastric or left upper quadran t lo ca- tion with radiation to th e back

b . Pain aggravated by a fatty m eal, alcoh ol, or lyin g in a recum ben t position

c. Abdo m in al ten dern ess an d guardin g d . Nausea an d vom itin g e. Weigh t loss f. Absen t or decreased bowel soun ds g. Elevated wh ite blood cell coun t, an d elevated

gluco se, bilirubin , alkalin e ph osph atase, an d urin ary am ylase levels

h . Elevated serum lipase an d am ylase levels i. Cullen’s sign j. Turner’s sign

Cullen’s sign is the discoloration of the abdomen and periumbilical area. Turner’s sign is the bluish discoloration of the flanks. Both signs are indicative of pancreatitis.

2. In terven tion s a . With h old food an d flu id durin g th e acute

period an d m ain tain h ydration with IV fluids as prescribed.

b . Adm in ister paren teral n utrition for severe n utrition al dep letion .

c. Adm in ister supplem en tal preparation s an d vitam in s an d m in erals to in crease caloric in take if prescribed.

d . An NG tube m ay be in serted if th e clien t is vom itin g or h as biliary obstruction or paralytic ileus.

e. Adm in ister opiates as prescribed for pain . f. Adm in ister H 2-receptor an tagon ists or pro-

ton pum p in h ibitors as prescribed to decrease h ydroch loric acid produ ction an d preven t activatio n of pan creatic en zym es.

g. In struct th e clien t in th e im portan ce of avoid- in g alcoh ol.

h . In struct th e clien t in th e im portan ce of follow-up visits with th e HCP.

i. In struct th e clien t to n otify th e HCP if acute abdom in al pain , jaun dice, clay-colored stools, or dark-colored urin e develops.

C. Ch ron ic pan creatitis 1. Assessm en t

a . Abdom in al pain an d ten dern ess b . Left upper quadran t m ass c. Steatorrh ea an d foul-sm ellin g stools th at m ay

in crease in volum e as pan creatic in sufficien cy in creases

d . Weigh t loss e. Muscle wastin g f. Jaun dice g. Sign s an d sym pto m s of diabetes m ellitus

2. In terven tion s a . In struct th e clien t in th e prescribed dietary

m easures (fat an d protein in take m ay be lim ited) .

b . In struct th e clien t to avoid h eavy m eals. c. In struct th e clien t about th e im portan ce of

avoidin g alcoh ol. d . Provide supplem en tal preparation s an d vita-

m in s an d m in erals to in crease caloric in take. e. Adm in ister pan creatic en zym es as prescribed

to aid in th e digestion an d absorption of fat an d protein .

f. Adm in ister in sulin or oral h ypo glycem ic m edication s as prescribed to con tro l diabetes m ellitus, if presen t.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

BOX 52-10 Home Care Instructions for the Client with Hepatitis

Hand washing must be strict and frequent. Do not share bathrooms unless the client strictly adheres to

personal hygiene measures. Individual washcloths, towels, drinking and eating utensils,

and toothbrushes and razors must be labeled and used only by the client.

The client must not prepare food for other family members. The client should avoid alcohol and over-the-counter medica-

tions, particularly acetaminophen and sedatives, because these medications are hepatotoxic.

The client should increase activity gradually to prevent fatigue. The client should consume small, frequent meals consisting

of high-carbohydrate, low-fat foods. The client is not to donate blood. The client may maintain normal contact with persons as long

as proper personal hygiene is maintained. Close personal contact such as kissing and sexual activity

should be discouraged with hepatitis B until surface anti- gen test results are negative.

The client needs to carry a MedicAlert card noting the date of hepatitis onset.

The client needs to inform other health professionals, such as medical or dental personnel, of the onset of hepatitis.

The client needs to keep follow-up appointments with the health care provider.

686 UNIT XI Gastrointestinal Disorders of the Adult Client

g. In struct th e clien t in th e use of pan creatic en zym e m edication s.

h . In struct th e clien t in th e treatm en t plan for gluco se m an agem en t.

i. In struct th e clien t to n otify the HCP if in creased steatorrh ea, abdom in al disten tion or cram pin g, or skin breakdown develops.

j. In struct th e clien t in th e im portan ce of follow-up visits.

XXIII. Pancreatic Tumors, Intestinal Tumors, and Bowel Obstructions

A. See Ch apter 48 for m ore in form ation .

XXIV. Irritable Bowel Syndrome (IBS) A. Description

1. Fun ction al disorder ch aracterized by ch ron ic or recurren t diarrh ea, con stipation , an d/ or abdom - in al pain an d bloatin g

2. Cau se is un clear but m ay be in fluen ced by en vi- ro n m en tal, im m un ological, gen etic, h orm on al, an d stress facto rs

B. In terven tion s 1. In crease dietary fiber. 2. Drin k 8 to 10 cups of liqu ids per day. 3. Med ication th erapy: Depen ds on th e predom i-

n an t sym pto m s of IBS (an tidiarrh eals versus bulk-form in g laxatives; lu biprosto n e or lin aclo- tid e for con stipatio n -predom in an t IBS an d alose- tro n for diarrh ea-pred om in an t IBS)

XXV. Ulcerative Colitis A. Description

1. An ulcerative an d in flam m atory disease of th e bowel th at results in poor absorption of n utrien ts.

2. Com m on ly begin s in th e rectum an d spreads upward toward th e cecum

3. Th e colon beco m es edem atous an d m ay develo p bleed in g lesion s an d ulcers; th e ulcers m ay lead to perforation .

4. Scar tissue develo ps an d cau ses loss of elasticity an d loss of th e ability to absorb n utrien ts.

5. Colitis is ch aracterized by various periods of rem ission s an d exacerbatio n s.

6. Acute ulcerative colitis results in vascu lar con ges- tion , h em orrh age, edem a, an d ulceration of th e bowel m ucosa.

7. Ch ron ic ulcerative colitis causes m uscular h yper- troph y, fat dep osits, an d fibrous tissue, with bowel th icken in g, sh orten in g, an d n arro win g.

B. Assessm en t 1. An o rexia 2. Weigh t loss 3. Malaise 4. Abdo m in al ten dern ess an d cram p in g 5. Severe diarrh ea th at m ay con tain blood an d

m ucus

6. Maln utrition , deh ydration , an d electrolyte im balan ces

7. An em ia 8. Vitam in K deficien cy

C. In terven tion s 1. Acute ph ase: Main tain NPO status an d adm in -

ister fluid s an d electrolytes in traven ously or via paren teral n utrition as prescribed.

2. Restrict th e clien t’s activity to reduce in testin al activity.

3. Mon itor bowel soun ds an d for ab dom in al ten - dern ess an d cram p in g.

4. Mon itor stools, n otin g color, con sisten cy, an d th e presen ce or absen ce of blood .

5. Mon itor for bowel perforation , periton itis (see Box 52-3), an d h em orrh age.

6. Follo win g th e acute ph ase, th e diet progres- ses from clear liquid s to a low-fiber diet as tolerated.

7. In struct th e clien t about diet. Usually a low- fiber is prescribed durin g an exacerb ation epi- sode; in ad dition , a h igh -p rotein diet with vita- m in s an d iron supplem en ts are prescribed.

8. In struct th e clien t to avoid gas-form in g food s, m ilk produ cts, an d food s such as wh ole-wh eat grain s, n uts, raw fruits an d vegetables, pepper, alcoh ol, an d caffein e-con tain in g products.

9. In struct th e clien t to avoid sm okin g. 10. Adm in ister m edication s as prescribed, wh ich

m ay in clude a com bin ation of m ed ication s such as salicylate com po un ds, corticostero id s, im m un osuppressan ts, an d an tidiarrh eals.

D. Surgical in terven tion s 1. Perform ed in extrem e cases if m ed ical m an age-

m en t is un successful 2. Min im ally in vasive proced ures are co n sidered as

a surgical option if th e clien t is a can didate; cli- en ts wh o are obese, h ave h ad previous abdom i- n al surgeries, or h ave adh esion s m ay n ot be can didates.

3. Min im ally in vasive proced ures can in clude lapa- roscopic procedures, ro botic-assisted surgery, an d n atural orifice tran slum in al en doscopic surgery (NO TES) .

4. Resto rative proctoco lectom y with ileal pouch – an al an astom osis (RPC-IPAA) a . Allows for bowel con tin en ce b . May be perform ed th rou gh laparoscopic

proced ure c. Involves a 2-stage procedure th at in cludes

rem oval of the colon an d m ost of th e rectum ; the an us an d an al sph in cter rem ain in tact.

d . An in tern al pouch kn own as a reservoir (J- pouch , S-pou ch , or pelvic pouch ) is created usin g th e sm all in testin e an d con n ected to th e an us, followed by creation of a tem p orary ileostom y th rou gh th e abdom in al skin to

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

687CHAPTER 52 Gastrointestinal System

allow h ealin g of th e in tern al pouch an d all an astom osis sites.

e. In th e secon d surgical proced ure (with in 1 to 2 m on th s), th e ileostom y is clo sed.

5. Total proctocolectom y with perm anent ileostom y a. Perform ed if th e clien t is n ot a can didate for

RPC-IPAA or if th e clien t prefers th is type of proced ure.

b . Th e proced ure in volves th e rem oval of th e en tire colon (colon , rectum , an d an us, with an al clo sure).

c. Th e en d of th e term in al ileum form s th e stom a or ostom y, wh ich is lo cated in th e righ t lower quadran t.

6. Preop erative in terven tion s a. Consult with the enterostom al therapist to help

identify optim al placem ent of the ostom y. b . In struct th e clien t on dietary restriction s; th e

clien t m ay n eed to follow a low-fiber diet for 1 to 2 days befo re surgery.

c. Paren teral an tibiotics are adm in istered 1 h our before th e surgical open in g.

d . Address body im age con cern s an d allow th e clien t to express con cern s; a visit fro m an ostom ate m ay be h elpful to th e clien t.

7. Posto perative in terven tion s a. A pouch system with a skin barrier is usually

placed on th e stom a postoperatively; if a pouch system is n ot co verin g th e stom a, a petrolatum gauze dressin g is placed over th e stom a as prescribed to keep it m oist, fol- lowed by a dry sterile dressin g.

b . Mon itor th e stom a for size, un usual bleed- in g, or n ecrotic tissue.

c. Mon itor for color ch an ges in th e stom a. d . Note th at th e n orm al stom a co lor is pin k to

brigh t red an d sh in y, in dicatin g h igh vascularity.

e. Note th at a pale pin k stom a in dicates low h em oglob in an d h em atocrit levels an d a purple-black stom a in dicates com prom ised circulation , requirin g HCP n otification .

f. Assess th e fun ction in g of th e ostom y. g. Expect th at stool is liquid in th e im m ediate

postoperative period but beco m es m ore solid depen din g on th e area of creatio n — ascen din g colon , liquid; tran sverse colon , loose to sem iform ed; an d descen din g colon , close to n orm al.

h . Mon itor th e pouch system for proper fit an d sign s of leakage; th e pouch is em ptied wh en it is on e-th ird full.

i. Fecal m atter sh ould n ot be allowed to rem ain on th e skin ; skin assessm en t an d care are a priority.

j. Mon itor for deh ydration an d electrolyte im balan ce.

k . Adm in ister an algesics an d an tibiotics as prescribed.

l. In struct th e clien t to avoid food s th at cause excess gas form ation an d odor.

m . In struct th e clien t about stom a care an d irri- gation s if prescribed (Box 52-11).

n . In struct th e clien t th at n orm al activities m ay be resum ed wh en approved by th e HCP.

A stoma that is purple-black in color indicates compromised circulation, requiring immediate HCP notification.

XXVI. Crohn’s Disease A. Descrip tion

1. An in flam m ato ry disease th at can occur an y- wh ere in th e gastroin testin al tract but m ost often affects th e term in al ileum an d lead s to th icken in g an d scarrin g, a n arrowed lum en , fistulas, ulcera- tion s, an d abscesses

2. Ch aracterized by rem ission s an d exacerbatio n s B. Assessm en t

1. Fever 2. Cram plike an d colicky pain after m eals 3. Diarrh ea (sem iso lid), wh ich m ay con tain

m ucus an d pus 4. Abdo m in al disten tion 5. An orexia, n ausea, an d vo m itin g 6. Weigh t loss 7. An em ia

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

BOX 52-11 Colostomy Irrigation Purpose An enema is given through the stoma to stimulate bowel emptying.

Description Irrigation is performed by instilling 50 0 to 100 0 mL of luke- warm tap water through the stoma and allowing the water and stool to drain into a collection bag.

Procedure If ambulatory, position the client sitting on the toilet. If on bed rest, position the client on his or her side. Hang the irrigation bag so that the bottom of the bag is at the

level of the client’s shoulder or slightly higher. Insert the irrigation tube carefully without force. Begin the flow of irrigation. Clamp the tubing if cramping occurs; release the tubing as

cramping subsides. Avoid frequent irrigations, which can lead to loss of fluids and

electrolytes. Perform irrigation at about the same time each day. Perform irrigation preferably 1 hour after a meal. To enhance effectiveness of the irrigation, massage the abdo-

men gently.

688 UNIT XI Gastrointestinal Disorders of the Adult Client

8. Deh ydration 9. Electrolyte im balan ces

10. Maln utrition (m ay be worse th an th at seen in ulcerative colitis)

C. In terven tion s: Care is sim ilar to th at for th e clien t with ulcerative colitis; h owever, surgery m ay be n ec- essary but is avoided for as lo n g as possib le because recurren ce of th e disease process in th e sam e region is likely to occur.

XXVII. Appendicitis A. Description

1. In flam m ation of th e ap pen dix 2. Wh en th e appen dix beco m es in flam ed or

in fected, rupture m ay occur with in a m atter of h ours, lead in g to periton itis an d sepsis.

B. Assessm en t 1. Pain in th e perium bilical area th at descen ds to

th e righ t lower quadran t 2. Abdo m in al pain th at is m ost in ten se at

McBurn ey’s poin t 3. Rebo un d ten dern ess an d abdom in al rigidity 4. Low-grade fever 5. Elevated wh ite blood cell coun t 6. An o rexia, n ausea, an d vo m itin g 7. Clien t in side-lyin g position , with abdom in al

guardin g an d legs flexed 8. Con stipation or diarrh ea

C. Periton itis: In flam m ation of th e periton eum (see Box 52-3)

D. Appen dectom y: Surgical rem oval of th e ap pen dix 1. Preop erative in terven tion s

a . Main tain NPO status. b . Adm in ister fluids in traven ously to preven t

deh ydration . c. Mon itor for ch an ges in level of pain . d . Mon itor for sign s of ruptured appen dix an d

periton itis (see Box 52-3). e. Position th e clien t in a righ t side-lyin g or low

to sem i-Fowler’s position to prom o te com fo rt.

f. Mon itor bowel soun ds. g. Apply ice packs to th e abdom en for 20 to

30 m in u tes every h ou r if prescribed. h . Adm in ister an tibiotics as prescribed. i. Avoid laxatives or en em as.

Avoid the application of heat to the abdomen of a client with appendicitis. Heat can cause rupture of the appendix leading to peritonitis, a life-threatening condition.

2. Posto perative in terven tion s a . Mon itor tem perature for sign s of in fection . b . Assess in cision for sign s of in fection such as

redn ess, swellin g, an d pain . c. Main tain NPO status un til bowel fun ctio n

h as return ed.

d . Advan ce diet gradually as tolerated an d as prescribed, wh en bowel soun ds return .

e. If rupture of th e appen dix occurred, expect a drain to be in serted, or th e in cision m ay be left open to h eal from th e in side out.

f. Expect th at drain age from th e drain m ay be profuse for th e first 12 h ou rs.

g. Position th e clien t in a righ t side-lyin g or low to sem i-Fowler’s position , with legs flexed, to facilitate drain age.

h . Ch an ge th e dressin g as prescribed an d record th e type an d am oun t of drain age.

i. Perform woun d irrigation s if prescribed. j. Main tain NG suction an d paten cy of th e NG

tube if presen t. k . Adm in ister an tibiotics an d an algesics as

prescribed.

XXVIII. Diverticulosis and Diverticulitis A. Description

1. Diverticulosis a . Diverticulosis is an outp ouch in g or h ern ia-

tion of th e in testin al m ucosa. b . The disorder can occur in an y part of th e in tes-

tin e but is m ost com m on in the sigm oid colon. 2. Diverticulitis

a . Diverticulitis is th e in flam m ation of 1 or m ore diverticu la th at occurs from pen etration of fecal m atter th rou gh th e th in -walled divertic- ula; it can result in local abscess form ation an d perforation .

b . A perforated diverticulu m can progress to in traab dom in al perforation with gen eralized periton itis.

B. Assessm en t 1. Left lower quadran t abdom in al pain th at

in creases with cough in g, strain in g, or liftin g 2. Elevated tem p erature 3. Nausea an d vom itin g 4. Flatu len ce 5. Cram plike pain 6. Abdo m in al disten tion an d ten dern ess 7. Palp able, ten der rectal m ass m ay be presen t. 8. Bloo d in th e stools

C. In terven tion s 1. Provide bed rest durin g th e acu te ph ase. 2. Main tain NPO status or provide clear liquids

durin g th e acu te ph ase as prescribed. 3. In tro duce a fiber-con tain in g diet gradually,

wh en th e in flam m ation h as resolved . 4. Adm in ister an tibiotics, an algesics, an d an tich o-

lin ergics to reduce bowel spasm s as prescribed. 5. In struct th e clien t to refrain from liftin g, strain -

in g, cough in g, or ben din g to avoid in creased in traabdom in al pressure.

6. Mon itor for perforation (see Box 52-3), h em or- rh age, fistulas, an d abscesses.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

689CHAPTER 52 Gastrointestinal System

7. In struct th e clien t to increase fluid in take to 2500 to 3000 m L daily, un less con train dicated.

8. In struct th e clien t to eat soft h igh -fiber food s, such as wh o le grain s; th e clien t sh ould avoid h igh -fiber food s wh en in flam m ation occurs because th ese foods will irritate th e m ucosa furth er.

9. In struct th e clien t to avoid gas-form in g food s or food s con tain in g in digestible ro ugh age, seeds, n uts, or popco rn because th ese food substan ces beco m e trapp ed in diverticula an d cau se in flam m ation .

10. In struct th e clien t to con sum e a sm all am oun t of bran daily an d to take bulk-form in g laxatives as prescribed to increase stool m ass.

D. Surgical in terven tion s 1. Colon resectio n with prim ary an astom osis m ay

be an option . 2. Tem po rary or perm an en t colosto m y m ay be

required for in creased bowel in flam m ation .

XXIX. Hemorrhoids A. Description

1. Dilated varicose vein s of th e an al can al 2. May be in tern al, extern al, or prolapsed 3. In tern al h em orrh oids lie above th e an al sph in c-

ter an d can n ot be seen on in spection of th e perian al area.

4. Extern al h em orrh oids lie below th e an al sph in c- ter an d can be seen on in spection .

5. Prolapsed h em orrh oids can becom e th rom - bosed or in flam ed.

6. Hem o rrh oids are cau sed fro m portal h yperten - sion , strain in g, irritatio n , or in creased ven ous or abdom in al pressure.

B. Assessm en t 1. Brigh t red bleedin g with defecation 2. Rectal pain 3. Rectal itch in g

C. In terven tion s 1. Apply cold packs to th e an al-rectal area follo wed

by sitz bath s as prescribed. 2. Apply witch h azel soaks an d topical an esth etics

as prescribed. 3. En cou rage a h igh -fib er diet an d flu ids to pro-

m ote bowel m ovem en ts with out strain in g. 4. Adm in ister stool soften ers as prescribed.

D. Surgical in terven tion s: May in clude ultrasoun d, scleroth erapy, circular staplin g, ban d ligation , or sim ple resectio n of th e h em orrh oids (h em orrh oidectom y)

E. Postoperative in terven tion s followin g h em orrh oi- decto m y 1. Assist th e clien t to a pron e or side-lyin g position

to preven t bleedin g. 2. Main tain ice packs over th e dressin g as pre-

scrib ed un til th e packin g is rem oved by th e HCP.

3. Mon itor for urin ary reten tion . 4. Adm in ister stool soften ers as prescribed. 5. In struct th e clien t to in crease fluid s an d h igh -

fiber food s. 6. In struct th e clien t to lim it sittin g to sh o rt periods

of tim e. 7. In struct th e clien t in th e use of sitz bath s 3 or 4

tim es a day as prescribed.

CRITICAL THINKING What Should You Do? Answer: Bleeding is a primary concern for a liver biopsy because of the high vascularity of the liver. Therefore, a pre- procedure assessment includes checking the client’s status related to the risk for bleeding. The normal prothrombin time ranges from 11 to 16 seconds (11 to 12.5 seconds). Since the client’s prothrombin time is prolonged, the client is at risk for bleeding. The normal platelet count is 150,0 00 to 400 ,00 0 mm3 (150 –40 0 Â 10 9/ L). A low platelet count places the cli- ent at risk for bleeding. Therefore, the nurse should immedi- ately notify the health care provider of these abnormal laboratory values.

References: Lewis et al. (20 14), pp. 882, 884; Pagana, Pagana, Pagana (20 15), p. 767.

P R A C T I C E Q U E S T I O N S 587. Th e n urse is m on itorin g a clien t adm itted to th e

h ospital with a diagn osis of ap pen dicitis wh o is sch eduled for surgery in 2 h ours. Th e clien t begin s to com plain of in creased abdom in al pain an d begin s to vom it. O n assessm en t, th e n urse n otes th at th e abdom en is disten ded an d bowel soun ds are dim in ish ed . Wh ich is th e m o st ap p ro p riate n ursin g in terven tion ? 1. No tify th e h ealth care provider (HCP). 2. Adm in ister th e prescribed pain m edication . 3. Call an d ask th e operatin g room team to per-

form surgery as soon as possible. 4. Repo sition th e clien t an d ap ply a h eatin g pad

on th e warm settin g to th e clien t’s abdom en .

588 A clien t adm itted to th e h ospital with a susp ected diagn osis of acute pan creatitis is bein g assessed by th e n urse. Wh ich assessm en t fin din gs would be con sisten t with acu te pan creatitis? Select all th at ap p ly.

1. Diarrh ea 2. Black, tarry stools 3. Hyperactive bowel soun ds 4. Gray-blue color at th e flan k 5. Abdom in al guardin g an d ten dern ess 6. Left upper quadran t pain with radiation to

th e back

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

690 UNIT XI Gastrointestinal Disorders of the Adult Client

589 Th e n urse is assessin g a clien t wh o is experien cin g an acute episo de of ch olecystitis. Wh ich of th ese clin ical m an ifestation s support th is diagn osis? Select all th at ap p ly.

1. Fever 2. Positive Cullen ’s sign 3. Com p lain ts of in digestion 4. Palpable m ass in th e left upper quadran t 5. Pain in th e upper righ t quadran t after a

fatty m eal 6. Vague lo wer righ t quadran t abdom in al

discom fort

590. A clien t is diagn osed with viral h epatitis, com plain - in g of “n o appetite” an d “losin g m y taste for food .” Wh at in struction sh ould th e n urse give th e clien t to provide adequate n utrition ? 1. Select food s h igh in fat. 2. In crease in take of fluids, in cludin g juices. 3. Eat a good supper wh en an orexia is n ot as severe. 4. Eat less often , preferably on ly 3 large m eals daily.

591. A clien t h as developed h epatitis A after eatin g con - tam in ated oysters. Th e n urse assesses th e clien t for wh ich expected assessm en t fin din g? 1. Malaise 2. Dark stools 3. Weigh t gain 4. Left upper quadran t discom fort

592 A clien t h as just h ad a h em orrh oidectom y. Wh ich n ursin g in terven tion s are appropriate for th is cli- en t? Select all th at ap p ly.

1. Adm in ister stool soften ers as prescribed. 2. In struct th e clien t to lim it fluid in take to avoid

urin ary reten tion . 3. En cou rage a h igh -fiber diet to prom o te bowel

m ovem en ts with ou t strain in g. 4. Apply cold packs to th e an al-rectal area over

th e dressin g un til th e packin g is rem oved. 5. Help th e client to a Fowler’s position to place

pressure on th e rectal area and decrease bleeding.

593 Th e n urse is plan n in g to teach a clien t with gastro- eso ph ageal reflux disease (GERD) ab out substan ces to avoid. Wh ich item s sh o uld th e n urse in clude on th is list? Select all th at ap p ly.

1. Coffee 2. Ch o colate 3. Pep perm in t 4. Non fat m ilk 5. Fried ch icken 6. Scram bled eggs

594. A clien t h as un d ergon e esoph agogastrod uoden os- copy. Th e n urse sh ould place h igh est p rio rity on wh ich item as part of th e clien t’s care plan ?

1. Mon itorin g th e tem p erature 2. Mon itorin g com plain ts of h eartb urn 3. Givin g warm gargles for a sore th roat 4. Assessin g for th e return of th e gag reflex

595. Th e n urse h as taugh t th e clien t about an upcom in g en doscopic retrograd e ch olan giopan creatograph y (ERCP) proced ure. Th e n urse determ in es th at th e clien t n eed s fu rth er in fo rm atio n if th e clien t m akes wh ich statem en t? 1. “I kn ow I m ust sign th e con sen t form .” 2. “I h ope th e th roat spray keeps m e fro m gaggin g.” 3. “I’m glad I don’t have to lie still for th is procedure.” 4. “I’m glad som e in traven o us m edication will be

given to relax m e.”

596. Th e h ealth care provider h as determ in ed th at a cli- en t h as con tracted h epatitis A based on flulike sym ptom s an d jaun dice. Wh ich statem en t m ade by th e clien t supp orts th is m edical diagn osis? 1. “I h ave h ad un protected sex with m ultiple

partn ers.” 2. “I ate sh ellfish about 2 weeks ago at a local

restauran t.” 3. “I was an in traven o us drug abuser in th e past

an d sh ared n eedles.” 4. “I h ad a blood tran sfusion 30 years ago after

m ajo r abdom in al surgery.”

597 Th e n urse is providin g dietary teach in g for a clien t with a diagn osis of ch ron ic gastritis. Th e n urse in structs th e clien t to in clude wh ich food s rich in vitam in B12 in th e diet? Select all th at ap p ly.

1. Nuts 2. Corn 3. Liver 4. Apples 5. Len tils 6. Ban an as

598. Th e n urse is assessin g a clien t 24 h ours followin g a ch olecystectom y. Th e n urse n otes th at th e T-tube h as drain ed 750 m L of green -brown drain age sin ce th e surgery. Wh ich n ursin g in terven tion is m o st ap p ro p riate? 1. Clam p th e T-tube. 2. Irrigate th e T-tube. 3. Docum en t th e fin din gs. 4. No tify th e h ealth care provider.

599. Th e n urse is m on itorin g a clien t with a diagn osis of pep tic ulcer. Wh ich assessm en t fin din g would m o st likely in dicate perforation of th e ulcer? 1. Bradycardia 2. Num bn ess in th e legs 3. Nausea an d vom itin g 4. A rigid, boardlike abdom en

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

691CHAPTER 52 Gastrointestinal System

600. Th e n urse is carin g for a clien t followin g a gastro - jejun ostom y (Billroth II procedure). Wh ich post- operative prescription sh o uld th e n urse question an d verify? 1. Leg exercises 2. Early am bulation 3. Irrigatin g th e n aso gastric tube 4. Cough in g an d deep-breath in g exercises

601. Th e n urse is providin g disch arge in struction s to a clien t followin g gastrectom y an d sh ould in struct th e clien t to take wh ich m easu re to assist in pre- ven tin g dum pin g syn drom e? 1. Am bu late follo win g a m eal. 2. Eat h igh -carboh ydrate food s. 3. Lim it th e fluids taken with m eals. 4. Sit in a h igh Fowler’s position durin g m eals.

602 Th e n urse is reviewin g th e prescription for a clien t adm itted to th e h ospital with a diagn osis of acu te pan creatitis. Wh ich in terven tion s would th e n urse expect to be prescribed for th e clien t? Select all th at ap p ly.

1. Main tain NPO (n oth in g by m outh ) status. 2. En cou rage cough in g an d deep breath in g. 3. Give sm all, frequen t h igh -calorie feed in gs. 4. Main tain th e clien t in a supin e an d flat

position . 5. Give h ydrom orph on e in traven ously as pre-

scribed for pain . 6. Main tain in traven o us fluid s at 10 m L/ h our to

keep th e vein open .

603. Th e n u rse is p ro vid in g d isch arge teach in g fo r a clien t with n ewly d iagn o sed Cro h n ’s d isease ab o u t d ietary m easu res to im p lem en t d u rin g exacerb atio n ep iso d es. Wh ich statem en t m ad e b y th e clien t in d icates a n eed fo r fu rth er in stru ctio n ? 1. “I sh ould in crease th e fib er in m y diet.” 2. “I will n eed to avoid caffein ated beverages.” 3. “I’m goin g to learn som e stress reduction

tech n iqu es.” 4. “I can h ave exacerbatio n s an d rem ission s with

Croh n ’s disease.”

604. Th e n urse is reviewin g th e record of a clien t with a diagn osis of cirrh o sis an d n otes th at th ere is docu- m en tation of th e presen ce of asterixis. How sh ould th e n urse assess for its presen ce? 1. Do rsiflex th e clien t’s foot. 2. Measure th e abdom in al girth . 3. Ask th e clien t to exten d th e arm s. 4. In struct th e clien t to lean forward .

605. Th e n u rse is reviewin g th e lab o rato ry resu lts fo r a clien t with cirrh o sis an d n o tes th at th e am m o n ia

level is 85 m cg/ d L ( 51 m cm o l/ L) . Wh ich d ietary selectio n d o es th e n u rse su ggest to th e clien t? 1. Roast pork 2. Ch eese om elet 3. Pasta with sauce 4. Tun a fish san dwich

606. Th e n urse is doin g an adm ission assessm en t on a clien t with a h istory of duod en al ulcer. To deter- m in e wh eth er th e problem is curren tly active, th e n urse sh ould assess th e clien t for wh ich sign ( s)/ sym pto m ( s) of duod en al ulcer? 1. Weigh t loss 2. Nausea an d vo m itin g 3. Pain relieved by food in take 4. Pain radiatin g down th e righ t arm

607. A clien t with h iatal h ern ia ch ron ically experi- en ces h eartb u rn fo llo win g m eals. Th e n u rse sh o u ld p lan to teach th e clien t to avo id wh ich actio n b ecau se it is co n train d icated with a h iatal h ern ia? 1. Lyin g recum b en t follo win g m eals 2. Con sum in g sm all, frequen t, blan d m eals 3. Takin g H 2-recep tor an tagon ist m edication 4. Raisin g th e h ead of th e bed on 6-in ch (15 cm )

blocks

608. Th e n urse is providin g care for a clien t with a recen t tran sverse colostom y. Wh ich observation requires im m ed iate n otification of th e h ealth care provider? 1. Stom a is beefy red an d sh in y 2. Purple discoloratio n of th e stom a 3. Skin excoriation aroun d th e stom a 4. Sem i-fo rm ed stool n oted in th e ostom y pouch

609. A clien t h ad a n ew colostom y created 2 days earlier an d is begin n in g to pass m alodorou s flatus from th e stom a. Wh at is th e correct in terp retatio n by th e n urse? 1. Th is is a n orm al, expected even t. 2. Th e clien t is experien cin g early sign s of

isch em ic bowel. 3. Th e clien t sh ould n ot h ave th e n aso gastric tube

rem oved. 4. Th is in dicates in adequate preoperative bowel

preparation .

610. A clien t h as just h ad surgery to create an ileostom y. Th e n urse assesses th e clien t in th e im m ediate post- operative period for wh ich m o st frequen t com pli- cation of th is typ e of surgery? 1. Folate deficien cy 2. Malabsorption of fat 3. In testin al obstruction 4. Fluid an d electrolyte im balan ce

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

692 UNIT XI Gastrointestinal Disorders of the Adult Client

611. Th e n urse provid es in struction s to a clien t ab out m easures to treat in flam m ato ry bowel syn dro m e (IBS). Wh ich statem en t by th e clien t in dicates a n eed fo r fu rth er teach in g? 1. “I n eed to lim it m y in take of dietary fib er.” 2. “I n eed to drin k plen ty, at least 8 to 10

cups daily.” 3. “I n eed to eat regular m eals an d ch ew m y

food well.” 4. “I will take th e prescribed m edication s because

th ey will regulate m y bowel pattern s.”

612. Th e n urse is m on itorin g a clien t for th e early sign s an d sym ptom s of dum pin g syn d rom e. Wh ich fin d- in gs in dicate th is occurren ce? 1. Sweatin g an d pallor 2. Bradycardia an d in digestion 3. Double vision an d ch est pain 4. Abdo m in al cram p in g an d pain

A N S W E R S 587. 1 Ra t ion a le: O n th e b asis of th e sign s an d sym pto m s presen ted in th e qu estio n , th e n urse sh ou ld susp ect p eriton itis an d n otify th e HCP. Ad m in isterin g p ain m ed ication is n o t an ap p ro priate in terven tio n . Heat sh o u ld n ever b e app lied to th e abd om en of a clien t with susp ected app en d icitis because o f th e risk o f rup tu re. Sch edu lin g surgical tim e is n ot with in th e sco pe of n u rsin g p ractice, alth o ugh th e HCP prob ably wou ld perform th e su rgery earlier th an th e presch edu led tim e. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Determ in e if an ab n o rm ality exists, focus on th e sign s an d sym p tom s in th e q u estion , an d con sider th e com plicatio n s th at can o ccur with app en d icitis. No tin g th at th e sign s p resen ted in th e qu estio n in dicate a com p lication will assist in d irectin g yo u to th e co rrect op tio n . Review: Care o f th e clien t with ap p en d icitis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; In flam m ation Refer en ce: Ign atavicius, Workm an (2016), p p. 1168–1169.

588. 4, 5, 6 Ra t ion a le: Grayish -blue d iscoloration at th e flan k is kn o wn as Grey-Turn er’s sign an d o ccu rs as a resu lt of pan creatic en zym e leakage to cutan eou s tissu e fro m th e p eriton eal cavity. Th e cli- en t m ay d em o n strate abd om in al guardin g an d m ay co m plain of ten d ern ess with palpatio n . Th e p ain asso ciated with acute pan creatitis is often su dd en in on set an d is lo cated in th e ep i- gastric regio n o r left u p per q uad ran t with rad iatio n to th e b ack. Th e oth er o p tion s are in co rrect. Test -Ta kin g Str a tegy: Notin g th at o ptio n s 1 an d 3 are co m p arab le o r alike will assist you in elim in atin g th ese op tion s first. Th en recall th at black, tarry stoo ls o ccu r wh en th ere is gastroin testin al b leed in g, so th is can also b e elim i- n ated. From th e rem ain in g o ptio n s, recall th e an ato m ical location of th e p an creas, th e pain ch aracteristics, an d th e effect o f en zym es leakin g in to th e tissu es to direct yo u to th e co rrect op tio n s. Review: Man ifestatio n s of acu te p an creatitis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t

Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: In flam m atio n ; Pain Refer en ce: Ign atavicius, Workm an (2016), p p. 1219–1221.

589. 1, 3, 5 Ra t ion a le: Durin g an acu te ep iso de o f ch olecystitis, th e clien t m ay co m p lain of severe righ t up p er qu adran t p ain th at radiates to th e righ t scapu la o r sh o ulder o r exp erien ce ep igastric pain after a fatty o r h igh -vo lu m e m eal. Fever an d sign s o f d eh ydra- tion wo uld also be expected, as well as co m plain ts o f in diges- tion , belch in g, flatu len ce, n ausea, an d vo m itin g. O p tio n s 4 an d 6 are in co rrect because th ey are in co n sisten t with th e an a- to m ical lo cation o f th e gallb lad der. O ption 2 (Cu llen ’s sign ) is asso ciated with p an creatitis. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, th e location an d ch aracteristics of pain asso ciated with ch o lecystitis. Recallin g th e an ato m ical lo catio n of th e gallb ladd er will also direct yo u to th e co rrect o ption . Review: Ch o lecystitis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: In flam m ation ; Pain Refer en ce: Lewis et al. (2014), p. 1037.

590. 2 Ra t ion a le: Alth o ugh n o special d iet is requ ired to treat viral h ep - atitis, it is gen erally recom m en ded th at clients con sum e a low-fat d iet, as fat m ay be tolerated poo rly b ecause of d ecreased b ile p ro - d uctio n . Sm all, frequ en t m eals are p referable and m ay even pre- ven t n au sea. Frequen tly, app etite is b etter in th e m orn in g, so it is easier to eat a good b reakfast. An adequ ate flu id in take o f 2500 to 3000 m L/ day that in clu des n utritio n al juices is also im p ortan t. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, a d iet for viral h ep - atitis. Th in k ab ou t th e p ath o ph ysiolo gy asso ciated with h ep a- titis an d fo cu s o n th e clien t’s co m plain ts to d irect you to th e co rrect o ption . Review: Measu res to provid e ad eq uate n utrition in th e clien t with h ep atitis Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clien t Ed u catio n ; In fection Refer en ces: Lewis et al. (2014), p. 1013; Nix (2013), pp. 371–372.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

693CHAPTER 52 Gastrointestinal System

591. 1 Ra tion a le: Hepatitis causes gastro in testin al sym p tom s su ch as an o rexia, n au sea, righ t up per q uad ran t disco m fo rt, an d weigh t lo ss. Fatigue an d m alaise are co m m o n . Stoo ls will b e ligh t- or clay-co lored if co n ju gated b iliru bin is un able to flo w o ut o f th e liver b ecau se o f in flam m ation or o b stru ctio n o f th e b ile du cts. Test-Ta kin g Str a tegy: Focus on th e sub ject, expected assessm en t fin din gs. Recallin g th e fun ction of the liver will direct you to th e correct optio n. Rem em b er that fatigue an d m alaise are com m on . Review: Th e sign s an d sym pto m s o f h ep atitis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Gastroin testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; In fection Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1205.

592. 1, 3, 4 Ra tion a le: Nu rsin g in terven tion s after a h em o rrh o idecto m y are aim ed at m an agem en t of p ain an d avo id an ce o f bleedin g an d in cisio n rup ture. Stoo l so ften ers an d a h igh -fib er d iet will h elp th e clien t to avo id strain in g, th ereby red ucin g th e ch an ces o f rup turin g th e in cisio n . An ice p ack will in crease co m fo rt an d d ecrease bleedin g. O p tio n s 2 an d 5 are in correct in terven tio n s. Test-Ta kin g St r a t egy: Focus o n th e su b ject, p osto p erative h em o rrh o idecto m y care. Recall th at decreasin g flu id in take will cause difficulty with defecation b ecause of h ard stool. Rec- o gn ize th at Fowler’s po sitio n will in crease pressu re in th e rectal area, causin g in creased bleedin g an d in creased p ain . Review: Care of th e clien t followin g h em o rrh o id ecto m y Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Gastroin testin al Pr ior it y Con cept s: Elim in ation ; Pain Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1164–1165.

593. 1, 2, 3, 5 Ra tion a le: Fo od s th at decrease lo wer esop h ageal sp h in cter (LES) p ressu re an d irritate th e esop h agu s will in crease reflu x an d exacerb ate th e sym pto m s of GERD an d th erefo re sh o u ld b e avoid ed . Aggravatin g su bstan ces in clud e coffee, ch o co late, p epp erm in t, fried o r fatty fo od s, carbo n ated beverages, an d alcoh ol. O ption s 4 an d 6 do n ot p ro m o te th is effect. Test-Ta kin g Str a tegy: Fo cus on th e su bject, substan ces th at in crease lower esoph ageal pressure. Use kn o wledge of th e effect of various foods on LES pressure an d GERD. However, if you are un sure, select th e option s th at iden tify th e m ost h ealth ful fo od item (s). Review: Th e d ietary regim en fo r a clien t with gastro eso p h a- geal reflu x d isease ( GERD) Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —Gastroin testin al Pr ior it y Con cept s: Clien t Ed ucation ; In flam m atio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1112–1113.

594. 4 Ra tion a le: Th e n u rse places h igh est p rio rity o n assessin g fo r return of th e gag reflex. Th is assessm en t ad d resses th e clien t’s

airway. Th e n urse also m o n ito rs th e clien t’s vital sign s an d fo r a sud den in crease in tem perature, wh ich cou ld in d icate p er- fo ratio n of th e gastro in testin al tract. Th is co m p lication wou ld b e acco m p an ied b y o th er sign s as well, su ch as p ain . Mon itor- in g for so re th roat an d h eartb urn are also im p ortan t; h owever, th e clien t’s airway is th e priority. Test-Ta kin g Str a tegy: No te th e strategic wo rd s, highest priority. Use th e ABCs—airway–b reath in g–circu latio n . Th e correct o ptio n add resses th e airway. Review: Care of th e clien t followin g eso p h ago gastro d u o - d en o sco p y Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad ult Health —Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1094.

595. 3 Ra tion a le: Th e clien t d o es h ave to lie still fo r ERCP, wh ich takes abo ut 1 h o ur to p erfo rm . Th e clien t also h as to sign a con - sen t form . In traven o u s sed ation is given to relax th e clien t, an d an an esth etic sp ray is used to h elp keep th e clien t from gaggin g as th e en d osco pe is passed . Test-Ta kin g Str a t egy: No te th e strategic wo rd s, needs further information. Th ese wo rd s in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is in co rrect. In vasive p ro ce- d ures requ ire co n sen t, so o ptio n 1 can be elim in ated. No tin g th e n am e o f th e p ro ced u re an d con siderin g th e an atom ical lo catio n will assist yo u in elim in atin g op tio n s 2 an d 4. Review: En d o sco p ic retro grad e ch o lan gio p an creato grap h y Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Gastro in testin al Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ces: Ign ataviciu s, Workm an ( 2016) , pp . 1094–1095; Pagan a, Pagan a, Pagan a (2015), p p . 384–385.

596. 2 Ra tion a le: Hepatitis A is tran sm itted b y th e fecal-o ral rou te via con tam in ated water o r fo od ( im p rop erly coo ked sh ellfish ) , or in fected fo od h an d lers. Hep atitis B, C, an d D are tran sm itted m ost co m m o n ly via in fected blo o d or bo dy fluid s, such as in th e cases of in traven o us dru g ab use, h istory of b loo d tran sfu- sio n , or un protected sex with m u ltip le partn ers. Test-Ta kin g Str a tegy: Focu s o n th e su b ject, h ep atitis A. Recal- lin g th e m od es o f tran sm ission of th e variou s typ es of h epatitis is requ ired to an swer th is q u estion . Rem em b er th at h ep atitis A is tran sm itted b y th e fecal-o ral rou te. Review: Meth od of tran sm ission o f h ep atitis A Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Gastro in testin al Pr ior it y Con cept s: In fection ; In flam m ation Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1203.

597. 1, 3, 5 Ra tion a le: Ch ron ic gastritis causes deterioration an d atroph y o f th e lin in g o f th e sto m ach , lead in g to th e loss of fu n ctio n

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

694 UNIT XI Gastrointestinal Disorders of the Adult Client

of th e p arietal cells. Th e sou rce of in trin sic facto r is lo st, wh ich results in an in ability to absorb vitam in B12, leadin g to devel- op m en t of p ern icio u s an em ia. Clien ts m ust in crease th eir in take o f vitam in B12 b y in creasin g co n su m ptio n o f fo od s rich in th is vitam in , su ch as n u ts, o rgan m eats, dried bean s, citrus fru its, green leafy vegetab les, an d yeast. Test -Ta kin g Str a tegy: Focus o n th e su b ject, fo o ds rich in vita- m in B12. Note th at app les an d ban an as are co m p arab le o r alike in th at th ey are n o t citru s fruits. Th is will h elp you to elim - in ate th ese op tion s first. O ption 2 can also b e elim in ated because it is n o t a green leafy vegetab le. Th e rem ain in g o ptio n s are th e co rrect o ption s. Review: Vitam in B12–rich fo o d s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clien t Edu catio n ; Nu tritio n Refer en ce: Ign atavicius, Workm an (2016), p p. 1126–1127.

598. 3 Ra t ion a le: Fo llo win g ch olecystectom y, d rain age fro m th e T- tu b e is in itially bloo dy an d th en tu rn s a green ish -bro wn co lor. Th e d rain age is m easu red as o utp u t. Th e am o un t of exp ected drain age will ran ge fro m 500 to 1000 m L/ day. Th e n u rse wo uld d ocum en t th e ou tpu t. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropriate. O ptio n s 1 an d 2 can b e elim in ated b ecau se a T-tu b e is n o t irrigated an d wo uld n o t b e clam ped with th is am o un t of d rain age. Fro m th e rem ain in g op tio n s, yo u m ust kn o w n o rm al exp ected fin d in gs fo llo win g th is su rgical procedu re. Review: Po stop erative assessm en t fin d in gs fo llo win g ch o lecys- tecto m y Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in atio n Refer en ces: Ign atavicius, Wo rkm an (2016), p p . 1217–1218; Lewis et al. (2014), p p. 361, 1040.

599. 4 Ra t ion a le: Perfo ration o f an u lcer is a su rgical em ergen cy an d is ch aracterized b y su d den , sh arp , in to lerable severe p ain begin n in g in th e m id-epigastric area an d sp readin g o ver th e ab d om en , wh ich b eco m es rigid an d b oardlike. Nau sea an d vo m itin g m ay o ccu r. Tach ycardia m ay occu r as h yp ovo lem ic sh ock develop s. Nu m b n ess in th e legs is n o t an associated fin d in g. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, p erfo ration . O p tion 2 can be elim in ated easily b ecause it is n ot related to perforation . Elim in ate op tio n 1 n ext b ecause tach ycard ia rath er th an b rad ycardia wo uld d evelo p if p erfo ratio n o ccu rs. Fro m th e rem ain in g o p tion s, n o te th e strategic wo rd s, most likely, to h elp direct you to th e correct o ptio n . Review: Sign s of a p erfo rated u lcer Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al

Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Ign atavicius, Workm an (2016), p p. 1130–1131.

600. 3 Ra t ion a le: In a gastro jejun o sto m y (Billro th II proced ure), th e proxim al rem n an t o f th e sto m ach is an astom o sed to th e p ro xim al jeju n u m . Paten cy o f th e n aso gastric tu be is critical fo r preven tin g th e reten tio n of gastric secretio n s. Th e n u rse sh ou ld n ever irrigate or rep osition th e gastric tu be after gastric su rgery, un less specifically prescrib ed b y th e h ealth care pro- vider. In th is situatio n , th e n u rse sh ou ld clarify th e prescrip - tion . O ptio n s 1, 2, an d 4 are app ro priate po stop erative in terven tio n s. Test -Ta kin g St r a t egy: No te th e words question and verify. Elim - in ate o p tion s 1, 2, an d 4 b ecau se th ey are co m p arab le o r alike an d are gen eral po stop erative m easures. Also , con sider th e an a- to m ical locatio n of th e surgical p ro cedu re to assist in directin g yo u to th e co rrect o ption . Review: Po stop erative m easures fo llo win g gastro jeju n o sto m y ( Billro th II p ro ced u re) Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Lewis et al. (2014), pp . 950–951.

601. 3 Ra t ion a le: Dumping syndrome is a term th at refers to a con stel- lation o f vaso m oto r sym pto m s th at o ccu rs after eatin g, espe- cially followin g a gastro jejun o sto m y ( Billro th II proced ure) . Early m an ifestatio n s u sually occur with in 30 m in u tes o f eatin g an d in clud e vertigo , tach ycard ia, syn cop e, sweatin g, p allor, p alp itation s, an d th e desire to lie do wn . Th e n u rse sh ou ld in stru ct th e clien t to decrease th e am ou n t of fluid taken at m eals an d to avoid h igh -carbo h yd rate fo od s, in clu din g fluid s su ch as fru it n ectars; to assu m e a lo w Fo wler’s po sitio n d urin g m eals; to lie d own for 30 m in u tes after eatin g to delay gastric em p tyin g; an d to take an tisp asm o dics as p rescrib ed . Test -Ta kin g St r a t egy: Elim in ate op tion s 1 an d 4 first becau se th ese m easures are co m p arab le o r alike an d will pro m o te gas- tric em ptyin g. Fro m th e rem ain in g o ption s, select th e m easure th at will d elay gastric em ptyin g. Review: Du m p in g syn d ro m e Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clien t Ed u catio n ; Nu tritio n Refer en ce: Lewis et al. (2014), p. 950.

602. 1, 2, 5 Ra t ion a le: Th e clien t with acute pan creatitis n o rm ally is placed o n NPO status to rest th e pan creas an d sup press gastroin testi- n al secretion s, so adeq uate in traven ou s h yd ratio n is n ecessary. Becau se ab d om in al pain is a p ro m in en t sym pto m of p an crea- titis, pain m edicatio n s su ch as m o rp h in e o r h yd ro m o rph o n e are prescrib ed. Mep eridin e is avoided , as it m ay cau se seizures. So m e clien ts exp erien ce lessen ed p ain b y assu m in g po sitio n s th at flex th e tru n k, with th e kn ees drawn u p to th e ch est. A side-lyin g p osition with th e h ead elevated 45 d egrees decreases

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

695CHAPTER 52 Gastrointestinal System

ten sion on th e ab do m en an d m ay h elp to ease th e p ain . Th e clien t is susceptible to resp irato ry in fection s because th e retro - p erito n eal flu id raises th e diap h ragm , wh ich cau ses th e clien t to take sh allow, gu ard ed abd om in al breath s. Th erefo re, m ea- su res su ch as turn in g, co u gh in g, an d deep breath in g are in stituted . Test-Ta kin g St r a tegy: Fo cu s on th e su b ject, care fo r th e clien t with acute p an creatitis. Th in k about th e path oph ysiology asso- ciated with p an creatitis an d n o te th e word acute. Th is will assist in selectin g th e correct op tio n s. Review: Acu te p an creatitis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Adu lt Health —Gastroin testin al Pr ior it y Con cept s: Pain ; In flam m atio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1222–1223.

603. 1 Ra tion a le: Cro h n ’s d isease is an in flam m atory disease th at can o ccur an ywh ere in th e gastro in testin al tract b u t m o st often affects th e term in al ileu m an d leads to th icken in g an d scarrin g, a n arrowed lu m en , fistu las, u lceratio n s, an d abscesses. It is ch aracterized b y exacerb atio n s an d rem issio n s. If stress in creases th e sym p tom s of th e disease, th e clien t is taugh t stress m an agem en t tech n iqu es an d m ay req uire ad d ition al cou n sel- in g. Th e clien t is tau gh t to avo id gastro in testin al stim ulan ts con tain in g caffein e an d to follow a h igh -calorie an d h igh - p ro tein d iet. A lo w-fib er diet m ay be p rescrib ed , esp ecially d ur- in g p eriod s of exacerb ation . Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an o ption th at is in co rrect. Also , fo cu s o n th e in fo r- m atio n in th e q u estio n an d th at th e q uestio n ad dresses exacer- b ation . Kn owin g th at th e clien t sh ou ld co n su m e a d iet h igh in p ro tein an d calo ries an d lo w in fiber will direct you to op tion 1. O ptio n s 2, 3, an d 4 are correct statem en ts. Review: Teach in g for Cro h n ’s d isease Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —Gastroin testin al Pr ior it y Con cept s: Clien t Ed ucation ; Elim in atio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1182–1183.

604. 3 Ra tion a le: Asterixis is irregu lar flapp in g m o vem en ts o f th e fin - gers an d wrists wh en th e h an d s an d arm s are o utstretch ed, with th e palm s d own , wrists ben t up , an d fin gers spread . Asterixis is th e m o st co m m o n an d reliab le sign th at h ep atic en ceph alop - ath y is develop in g. O p tion s 1, 2, an d 4 are in correct. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e proced ure fo r assessm en t o f asterixis. Rem em b er th at asterixis is irregular flap pin g m o vem en ts o f th e fin gers an d wrists. Th is will d irect yo u to th e correct o ptio n . Review: Asterixis Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Gastroin testin al

Pr ior it y Con cept s: Clin ical Ju dgm en t; In flam m atio n Refer en ce: Lewis et al. (2014), p . 1021.

605. 3 Ra tion a le: Cirrh osis is a ch ro n ic, p ro gressive disease of th e liver ch aracterized by d iffu se d egen eratio n an d d estruction of h ep atocytes. Th e serum am m on ia level assesses th e ab ility of th e liver to d eam in ate protein b yprod ucts. Norm al referen ce in terval is 10 to 80 m cg/ d L (6 to 47 m cm o l/ L). Most of th e am m o n ia in th e bo dy is fo un d in th e gastroin testin al tract. Pro tein p ro vid ed by th e d iet is tran spo rted to th e liver by th e p ortal vein . Th e liver breaks do wn protein , wh ich resu lts in th e form ation o f am m o n ia. Foo d s h igh in protein sh ou ld be avoided sin ce th e clien t’s am m on ia level is elevated ab ove th e n o rm al ran ge; th erefo re, p asta with sauce wou ld b e th e best selectio n . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, an am m o n ia level o f 85 m cg/ dL (51 m cm ol/ L). Realizin g th at th is resu lt is ab ove th e n o rm al ran ge will d irect yo u away fro m selectin g h igh - p ro tein fo od s, su ch as po rk, ch eese, eggs, an d fish . Review: Dietary m easu res for th e clien t with a h igh am m o n ia level Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad u lt Health —Gastro in testin al Pr ior it y Con cept s: In flam m atio n ; Nu trition Refer en ce: Lewis et al. (2014), p p. 1023–1024.

606. 3 Ra tion a le: A frequ en t sym pto m o f d uo d en al ulcer is p ain th at is relieved b y fo o d in take. Th ese clien ts gen erally describe th e p ain as a bu rn in g, h eavy, sh arp , or “h u n gry” p ain th at often lo calizes in th e m id -ep igastric area. Th e clien t with d uo d en al u lcer usu ally do es n o t experien ce weigh t lo ss or n ausea an d vom itin g. Th ese sym pto m s are m o re typ ical in th e clien t with a gastric ulcer. Test-Ta kin g St r a t egy: Elim in ate op tion s 1 an d 2 becau se th ey are co m p arab le o r alike; if th e clien t is vo m itin g, weigh t lo ss will occur. Next, th in k about th e sym ptom s of duoden al an d gastric ulcer. Ch o o se th e correct op tio n over o ptio n 4, kn owin g th at th e p ain d oes n o t rad iate d own th e righ t arm an d th at a p attern of pain -foo d-relief o ccurs with du od en al u lcer. Review: Clin ical m an ifestatio n s of a d u o d en al u lcer Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; In flam m atio n Refer en ce: Lewis et al. (2014), p . 943.

607. 1 Ra tion a le: Hiatal h ern ia is caused by a protrusion of a p ortio n o f th e sto m ach abo ve th e d iap h ragm wh ere th e eso ph agu s u su - ally is po sitio n ed . Th e clien t u sually experien ces pain from reflux caused by in gestion of irritatin g foo d s, lyin g flat follow- in g m eals o r at n igh t, an d eatin g large o r fatty m eals. Relief is o btain ed with th e in take of sm all, freq uen t, an d blan d m eals; u se of H 2-recep to r an tago n ists an d an tacids; an d elevatio n of th e th o rax fo llo win g m eals an d du rin g sleep .

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

696 UNIT XI Gastrointestinal Disorders of the Adult Client

Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e actio n co n tra- in d icated in h iatal h ern ia. Th in kin g abo ut th e p ath o ph ysiology th at occu rs in h iatal h ern ia will d irect you to th e correct op tio n . Review: Co n train dicatio n s associated with h iatal h ern ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clien t Edu catio n ; Pain Refer en ce: Ign atavicius, Workm an (2016), p . 1115.

608. 2 Ra t ion a le: Isch em ia o f th e sto m a wo uld b e associated with a du sky o r blu ish o r pu rp le co lo r. A b eefy red an d sh in y sto m a is n o rm al an d exp ected. Skin exco riatio n n eed s to b e ad dressed an d treated b ut d oes n ot requ ire as im m ed iate atten tio n as pu r- ple d iscolo ratio n of th e stom a. Sem i-fo rm ed sto ol is a n o rm al fin d in g. Test -Ta kin g St r a t egy: No te th e strategic wo rd , immediate, an d fo cus o n th e su b ject, th e o bservation th at req uires h ealth care provid er n otificatio n . Note th e wo rd s purple discoloration in op tion 2. Recall th at p urple in dicates isch em ia. Review: Com plicatio n s asso ciated with a co lo sto m y an d sto m a ch aracteristics Level of Cogn itive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1154.

609. 1 Ra t ion a le: As peristalsis retu rn s followin g creation o f a co lo s- to m y, th e clien t b egin s to p ass m alod o ro us flatus. Th is in dicates return in g b owel fun ction an d is an expected even t. With in 72 h o urs of su rgery, th e clien t sh o u ld b egin p assin g stoo l via th e co lo stom y. O ptio n s 2, 3, an d 4 are in co rrect in terp retatio n s. Test -Ta kin g St r a t egy: Focus on th e su b ject, th at th e clien t is passin g flatus fro m th e sto m a. Th in k ab ou t th e n o rm al fun c- tion in g of th e gastroin testin al tract an d n o te th e tim e fram e in th e qu estio n to assist in an swerin g co rrectly. Review: Th e exp ected fin din gs of a co lo sto m y Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in atio n Refer en ce: Lewis et al. (2014), p . 992.

610. 4 Ra t ion a le: A freq uen t co m p licatio n th at o ccurs fo llo win g ileo stom y is fluid an d electrolyte im balan ce. Th e clien t requ ires co n stan t m o n ito rin g o f in take an d ou tpu t to p reven t th is fro m occu rrin g. Losses requ ire rep lacem en t by in traven ou s in fusion un til th e clien t can to lerate a diet orally. In testin al ob stru ction

is a less frequ en t com p lication . Fat m alabso rp tio n an d fo late d eficien cy are co m plicatio n s th at cou ld o ccur later in th e p o stop erative p erio d . Test -Ta kin g Str a tegy: Note th e strategic wo rd , most. Also n o te th e su b ject, an ileo stom y. Rem em ber th at ileo stom y d rain age is liqu id , placin g th e clien t at risk fo r flu id an d electrolyte im b alan ce. Review: Po sto p erative co m p licatio n s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in ation Refer en ce: Lewis et al. (2014), p. 993.

611. 1 Ra t ion a le: IBS is a fun ction al gastroin testin al disorder th at causes ch ro n ic or recurren t d iarrh ea, co n stip ation , an d/ o r ab do m in al pain an d b lo atin g. Dietary fiber an d b ulk h elp to p ro d uce bu lky, so ft sto ols an d estab lish regu lar b owel elim in a- tion h ab its. Th erefo re, th e clien t sh o uld con sum e a h igh -fiber d iet. Eatin g regular m eals, d rin kin g 8 to 10 cup s of liq uid a day, an d ch ewin g foo d slo wly h elp to p ro m ote n o rm al b owel fun c- tion . Med ication th erap y d ep en d s o n th e m ain sym pto m s o f IBS. Bu lk-fo rm in g laxatives o r an tidiarrh eal agen ts o r o th er agen ts m ay b e prescrib ed. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further teaching. Th ese words in d icate a n egative even t q u ery an d th e n eed to select th e in co rrect clien t statem en t. Th in k abo ut th e p ath o ph ysiology asso ciated with IBS to an swer correctly. Also , n ote th e word limit in op tion 1. With IBS, d ietary fiber an d b u lk is im po rtan t to assist in co n trollin g sym p tom s. Review: In flam m ato ry b o wel syn d ro m e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clien t Ed u catio n ; In flam m ation Refer en ce: Lewis et al. (2014), pp . 993, 1097–1098.

612. 1 Ra t ion a le: Early m an ifestatio n s of d um pin g syn drom e o ccur 5 to 30 m in utes after eatin g. Sym p tom s in clud e vertigo, tach ycar- d ia, syn co pe, sweatin g, pallo r, p alp itation s, an d th e desire to lie do wn . Test -Ta kin g St r a t egy: Note th e strategic wo rd , early. Th in k ab ou t th e p ath op h ysio lo gy associated with d um pin g syn - d ro m e an d its etiolo gy to an swer correctly. Review: Early m an ifestatio n s of d u m p in g syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Elim in atio n ; Nu trition Refer en ce: Ign atavicius, Workm an (2016), p p. 1140–1141.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

697CHAPTER 52 Gastrointestinal System

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l C H A P T E R 53 Gastrointestinal Medications

PRIORITY CONCEPTS Inflammation; Tissue Integrity

CRITICAL THINKING What Should You Do? The nurse checks the ammonia level of a client with hepatic dysfunction who is receiving lactulose and notes that the level is 75 mcg/ dL (45 mcmol/ L). What should the nurse do? Answer located on p. 702.

I. Antacids (Table 53-1; Fig. 53-1) A. React with gastric acid to produce n eutral salts or

salts of low acidity B. In activate pepsin an d en h an ce m ucosal protection

but do n ot coat th e ulcer crater C. Th ese m edication s are used for peptic ulcer disease

an d gastroeso ph ageal reflux disease. D. Th ese m ed ication s sh ould be taken on a regular

sch edule; som e are prescribed to be taken 1 an d 3 h ours after each m eal an d at bedtim e.

E. To provid e m axim u m ben efit, treatm en t sh ould ele- vate th e gastric pH ab ove 5.

F. An tacid tablets sh ould be ch ewed th orough ly an d follo wed with a glass of water or m ilk.

G. Liquid preparation s sh ould be sh aken before dispen sin g.

To prevent interactions with other medications and interference with the action of other medications, allow 1 hour between antacid administration and the adminis- tration of other medications.

II. Gastric Protectants A. Misop rostol

1. An an tisecretory m edication th at en h an ces m ucosal defen ses

2. Supp resses secretion of gastric acid an d m ain - tain s subm ucosal blood flo w by prom o tin g vaso dilation

3. Used to preven t gastric ulcers cau sed by n on ste- roid al an tiin flam m atory drugs an d aspirin

4. Adm in istered with m eals 5. Causes diarrh ea an d abdom in al pain 6. Con train dicated for use in pregn an cy

B. Sucralfate 1. Creates a protective barrier again st acid an d

pepsin 2. Adm in istered orally; sh ould be taken on an

em pty stom ach 3. May cau se con stipation 4. May im ped e absorption of warfarin sodium ,

ph en ytoin , th eoph yllin e, digoxin , an d som e an tibiotics; sh o uld be adm in istered at least 2 h ours apart from th ese m ed ication s

III. Histamine (H2)-Receptor Antagonists A. Descrip tion

1. Supp ress secretio n of gastric acid 2. Alleviate sym ptom s of h eartburn an d assist in

preven tin g com plication s of peptic ulcer disease 3. Preven t stress ulcers an d reduce th e recurren ce of

all ulcers 4. Prom o te h ealin g in gastro esoph ageal reflux

disease 5. Are con train d icated in h ypersen sitive clien ts 6. Sh ould be used with cau tion in clien ts with

im paired ren al or h epatic fun ction B. Cim etidin e

1. Can be adm in istered orally, in tram uscularly, or in traven ously

2. Food reduces th e rate of absorption ; if taken orally with m eals, absorption will be slowed .

3. In traven ou s adm in istration can cause h ypo ten - sion an d dysrh yth m ias.

4. An tacids can decrease th e absorption of oral cim etidin e.

5. Cim etidin e an d an tacids sh ould be adm in istered at least 1 h our ap art from each oth er.

6. Cim etidin e passes th e blood -brain barrier, an d cen tral n ervous system side an d adverse effects can occur; it m ay cau se m en tal con fusion , agitation , psych osis, dep ression , an xiety, an d dis- orien tation .698

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

TABLE 53-1 Classification of Antacids and Considerations Classification Considerations

Aluminum compounds Aluminum hydroxide is used to treat hyperphosphatemia; therefore, it can cause hypophosphatemia

Aluminum hydroxide can reduce the effects of tetracyclines, warfarin sodium, and digoxin and can reduce phosphate absorption and thereby cause hypophosphatemia

Aluminum compounds contain significant amounts of sodium; they should be used with caution in clients with hypertension and heart failure

The most common side effect is constipation

Magnesium compounds

Magnesium hydroxide is also a saline laxative and the most prominent side effect is diarrhea; it is usually administered in combination with aluminum hydroxide, an antacid that assists in preventing diarrhea

Magnesium compounds are contraindicated in clients with intestinal obstruction, appendicitis, or undiagnosed abdominal pain

In clients with renal impairment, magnesium can accumulate to high levels, causing signs of toxicity

Calcium compounds Calcium carbonate can cause acid rebound

Calcium compounds are rapid-acting and release carbon dioxide in the stomach, causing belching and flatulence

A common side effect is constipation. Milk-alkali syndrome (headache, urinary frequency, anorexia, nausea/ vomiting, fatigue) can occur (the client should avoid milk products and vitamin D supplements)

Sodium bicarbonate Sodium bicarbonate has a rapid onset, liberates carbon dioxide, increases intraabdominal pressure, and promotes flatulence

Sodium bicarbonate should be used with caution in clients with hypertension and heart failure

Sodium bicarbonate can cause systemic alkalosis in clients with renal impairment

Sodium bicarbonate is useful for treating acidosis and elevating urinary pH to promote excretion of acidic medications following overdose

Gas tric Ulc e r

Duo de nal Ulc e r

Ga s tric mucos a De cre a s e dmucos a l de fe ns e s

Loca l mucos a l infla mma tion from NS AIDs

Norma l or de cre a s e d a cid s e cre tion a nd ga s tric e mptying

Ulce r • Fa ilure to inhibit a cid s e cre tion • Ina bility to form mucous ca p a fte r injury • ↓ Mucus a nd bica rbona te s e cre tion • ↓ Mucos a l blood flow

S ys te mic e ffe cts of NS AIDs

• Ba cte ria pe ne tra te s ga s tric ce lls a nd we a ke ns mucous la ye r • Cytotoxins ca us e e pithe lia l ce ll injury a nd de a th • Cytokine s ca us e infla mma tory cha nge s in mucos a • P rote a s e s de gra de mucus

Effe cts of H. pylori infe ction

Duode na l mucos a ↑ Acid loa d ↓ Mucos a l de fe ns e s

↑ Ra te of ga s tric e mptying

Norma l or incre a s e d ga s tric a cid s e cre tion pos tpra ndia lly a nd a t re s t

Ulce rP os s ible ↑ inpa rie ta l ce ll ma s s

• Ba cte ria pe ne tra te the ce lls a nd we a ke n the mucous la ye r • Ba cte ria trigge r me ta pla s tic cha nge s in ce lls tha t s upport ba cte ria l inva s ion • Cytotoxins ca us e e pithe lia l ce ll injury a nd de a th • Cytokine s ca us e infla mma tory cha nge s in mucos a • ↓ Duode na l bica rbona te s e cre tion • P rote a s e s de gra de mucus

Effe cts of H. pylori infe ction

FIGURE 53-1 Pathophysiological components of peptic ulcer. H. pylori, Helicobacter pylori; NSAIDs, nonsteroidal antiinflammatory drugs.

7. Dosage sh ould be reduced in clien ts with ren al im pairm en t.

8. Cim etidin e in h ibits h epatic drug-m etab olizin g en zym es an d can cause m an y m edication levels to rise; if adm in istered with warfarin sodium , ph en ytoin , th eoph yllin e, or lidocain e, th e dos- ages of th ese m ed ication s sh ould be reduced.

C. Ran itidin e 1. Can be adm in istered orally, in tram uscu larly, or

in traven ously 2. Side effects are un com m on an d it does n ot pen -

etrate th e blood-brain barrier as cim etidin e does. 3. Ran itidin e is n ot affected by food.

D. Fam otidin e an d n izatidin e 1. Fam otidin e an d n izatidin e are sim ilar to ran iti-

din e an d cim etidin e. 2. Th ese m edication s do n ot n eed to be adm in is-

tered with food .

IV. Proton Pump Inhibitors (Box 53-1) A. Supp ress gastric acid secretio n B. Used to treat active ulcer disease, erosive eso ph agitis,

an d path ological h ypersecretory con ditio n s C. Con train dicated in h ypersen sitivity D. Com m on side effects in clude h eadach e, diarrh ea,

abdom in al pain , an d n ausea.

V. Medication Regimens to Treat Helicoba ct er pylori Infections (Box 53-2)

A. An an tibacterial agen t alon e is n ot effective for erad- icatin g H. pylori because th e bacterium readily beco m es resistan t to th e agen t.

B. Triple or quadrup le th erap y with a variety of m ed i- cation com bin ation s is used (if triple th erap y fails, quadrup le th erap y is recom m en ded).

VI. Prokinetic Agent A. Medication : Meto clopram ide B. Stim ulates m otility of th e upper gastroin testin al tract

an d in creases th e rate of gastric em ptyin g with out stim ulatin g gastric, biliary, or pan creatic secretion s

C. Used to treat gastro esoph ageal reflux an d paralytic ileus

D. May cause restlessn ess, drowsin ess, extrapyram idal reactio n s, dizzin ess, in som n ia, an d h eadach e

E. Usually adm in istered 30 m in utes befo re m eals an d at bedtim e

F. Con train dicated in clien ts with sen sitivity an d in cli- en ts with m ech an ical obstru ction , perforation , or gastro in testin al h em orrh age

G. Can precipitate h yperten sive crisis in clien ts with ph eoch rom ocyto m a

H. Safety in pregn an cy h as n ot been establish ed I. Metoclo pram ide can cause parkin son ian reaction s; if

th is occurs, th e m edication will be discon tin ued by th e h ealth care provider.

J. An tich olin ergics, such as atropin e, an d opioid an al- gesics, such as m orph in e, an tagon ize th e effects of m etoclo pram ide.

K. Alcoh o l, sed atives, cyclosporin e, an d tran quilizers produ ce an additive effect.

VII. Bile Acid Sequestrants (Box 53-3) A. Act by absorbin g an d com bin in g with in testin al bile

salts, wh ich th en are secreted in th e feces, preven tin g in testin al reabsorp tion

B. Used to treat h yperch olesterolem ia in ad ults, biliary obstru ction , an d pruritu s associated with biliary disease

C. With powdered form s, taste an d palatability are often reason s for n on com plian ce an d can be im proved by th e use of flavored produ cts or m ixin g th e m edication with various juices.

D. Side an d adverse effects in clude n ausea, bloatin g, con stipation , fecal im paction , an d in testin al obstru ction .

E. Stool soften ers an d oth er sources of fiber can be used to ab ate th e gastro in testin al side effects.

Bile acid sequestrants should be used cautiously in clients with suspected bowel obstruction or severe con- stipation because they can worsen these conditions.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

BOX 53-1 Proton Pump Inhibitors ▪ Esomeprazole ▪ Lansoprazole ▪ Omeprazole ▪ Pantoprazole ▪ Rabeprazole

BOX 53-2 Medication Regimens to Treat Helicoba ct er pylori Infections

Triple Therapy ▪ Esomeprazole, amoxicillin, clarithromycin ▪ Lansoprazole, amoxicillin, clarithromycin ▪ Lansoprazole, amoxicillin, levofloxacin Quadruple Therapies ▪ Esomeprazole, metronidazole, tetracycline, bismuth

subsalicylate ▪ Ranitidine, metronidazole, tetracycline, bismuth

subsalicylate

Note: Additional medications may be prescribed for each level of therapy.

BOX 53-3 Bile Acid Sequestrants ▪ Colesevelam ▪ Cholestyramine

700 UNIT XI Gastrointestinal Disorders of the Adult Client

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

VIII. Treating Hepatic Encephalopathy A. Med ication : Lactulose B. Used in th e prevention an d treatm en t of portal

system ic en ceph alopath y, in cludin g h epatic precom a and com a; also used in th e treatm en t of ch ron ic con stipation

C. Prom otes in creased peristalsis an d bowel evacuation , expellin g am m on ia from th e colon an d th us lowerin g the am m on ia level (norm al am m on ia referen ce in ter- val is 10 to 80 m cg/ dL [6 to 47 m cm ol/ L])

D. Im pro ves protein toleran ce in clien ts with advan ced h epatic cirrhosis

E. Adm in istered orally in th e form of a syrup or rectally

IX. Pancreatic Enzyme Replacements A. Pan crelipase B. Used to supp lem en t or replace pan creatic en zym es

an d th u s im prove n utrition al status an d reduce th e am oun t of fatty stools (a deficien cy of pan creatic en zym es can com pro m ise digestion , esp ecially th e digestion of fats)

C. Sh ould be taken with all m eals an d sn acks D. Side an d ad verse effects in clude ab dom in al cram ps

or pain , n ausea, vom itin g, an d diarrh ea. E. Produ cts th at con tain calcium carbon ate or m agn e-

sium h ydroxide in terfere with th e action of th ese m ed ication s.

X. Treatment for InflammatoryBowel Disease (Box 53-4) A. In flam m atory bowel disease h as 2 form s, in cludin g

Crohn’s disease an d ulcerative colitis. B. An tim icrob ials: May be prescribed to preven t or treat

secon dary in fectio n (see Ch apter 67 for in form ation on an tim icrobials)

C. 5-Am in osalicylates (5-ASAs): Decrease gastroin testin al in flam m ation ; side an d adverse effects in clude n ausea, rash , arth ralgia, and h em atological disorders.

D. Corticostero ids: Act as an an tiin flam m atory to decrease gastroin testin al in flam m ation (see

Ch apter 51 for in form ation on gluco corticoids an d cortico steroids)

E. Im m un om odulators: Mon oclon al an tibod ies m od- ulate th e im m un e respo n se to in duce an d m ain tain rem ission (see Box 53-4 for specific im m un o- m od ulators).

XI. Treatment for Irritable Bowel Syndrome (IBS) A. Irritable bowel syn d rom e is a gastro in testin al disor-

der th at is ch aracterized by cram p y abdom in al pain accom pan ied by diarrh ea, con stipatio n , or both .

B. Ph arm aco lo gical treatm en t depen ds on th e m ain sym pto m , con stipatio n or diarrh ea.

C. Con stipation -predom in an t IBS (IBS-C) treatm en t 1. Bulk-form in g laxatives, usually taken at m eal-

tim es with a full glass of water. 2. Lubip roston e: Ch loride ch an n el activator th at

in creases fluid in th e in testin es to prom ote bowel elim in ation ; n eeds to be taken with food an d water.

3. Lin aclotide: Stim ulates receptors in th e in testin es to prom o te bowel tran sit tim e; taken daily 30 m in u tes befo re breakfast.

4. See Box 53-6 for a list of addition al m ed ication s to treat con stipation .

D. Diarrh ea-p redom in an t IBS (IBS-D) treatm en t 1. Alosetron

a . A selective seroto n in receptor an tagon ist b . Can cause ad verse effects such as con stipa-

tion , im paction , bowel obstru ctio n , perfora- tion of th e bowel, an d isch em ic colitis.

c. A strict risk m an agem en t procedure m ust be followed, includin g m on itorin g for serious adverse effects, reportin g th em , and im m ediate discontin uation of th e m edication if th ey arise.

2. An tidiarrh eal m ed ication s: See Box 53-7 for a list of addition al m ed ication s to treat diarrh ea.

XII. Antiemetics (Box 53-5) A. Medication s used to con trol vo m itin g an d m otion

sickn ess B. Th e ch oice of th e an tiem etic is determ in ed by th e

cause of th e n ausea an d vom itin g. C. Mon itor vital sign s an d in take an d output an d for sign s

of deh ydration an d fluid an d electrolyte im balan ces. D. Lim it odors in th e clien t’s room wh en th e clien t is

n auseated or vom itin g. E. Lim it oral in take to clear liqu ids wh en th e clien t is

n auseated or vom itin g.

Antiemetics can cause drowsiness; therefore, a pri- ority intervention is to protect the client from injury.

XIII. Laxatives (Box 53-6) A. Bulk-form in g

1. Description a . Absorb water in to th e feces an d in crease bulk

to produce large an d soft stools

BOX 53-4 Medications to Treat Inflammatory Bowel Disease

Antimicrobials ▪ Ciprofloxacin ▪ Metronidazole ▪ Rifaximin ▪ Clarithromycin 5-Aminosalicylates ▪ Balsalazide ▪ Mesalamine ▪ Sulfasalazine Corticosteroids ▪ Budesonide ▪ Prednisone ▪ Hydrocortisone

Immunosuppressants ▪ Azathioprine ▪ Cyclosporine ▪ Mercaptopurine ▪ Tacrolimus Immunomodulators ▪ Adalimumab ▪ Certolizumab ▪ Infliximab ▪ Natalizumab

701CHAPTER 53 Gastrointestinal Medications

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

b . Con train dicated in bowel obstru ctio n c. Depen den cy can occur with lon g-term use.

2. Side an d adverse effects in clude gastro in testin al disturban ces, deh ydration , an d electrolyte im balan ces.

B. Stim ulan ts: Stim ulate m otility of large in testin e C. Em ollien ts

1. In h ibit ab sorption of water so fecal m ass rem ain s large an d soft

2. Used to avoid strain in g D. O sm o tics: Attract water in to th e large in testin e to

produ ce bulk an d stim ulate peristalsis

The client receiving a laxative needs to increase fluid intake to prevent dehydration.

XIV. Medications to Control Diarrhea (Box 53-7) A. Iden tify an d treat th e un d erlyin g cause, treat deh y-

dratio n , replace fluids an d electrolytes, relieve abdom in al discom fort an d cram p in g, an d reduce th e passage of stool

B. O pioids 1. O pioids are effective an tidiarrh eal m edication s

th at decrease in testin al m otility an d peristalsis. 2. Wh en poison s, in fectio n s, or bacterial toxin s

are th e cause of th e diarrh ea, opioids worsen th e con dition by delayin g th e elim in ation of toxin s.

CRITICAL THINKING What Should You Do? Answer: Lactulose is used in the prevention and treatment of portal systemic encephalopathy including hepatic precoma and coma. It promotes increased peristalsis and bowel evacuation, expelling ammonia from the colon and thus lowering the ammo- nia level. The normal ammonia level is 10 to 80 mcg/ dL(6 to 47 mcmol/ L). If the level is 75 mcg/ dL (45 mcmol/ L), the nurse determines that the medication is effective in lowering the ammonia level. The nurse should contact the health care pro- vider regarding continuation of the medication.

Reference: Lewis et al. (2014), p. 10 23.

P R A C T I C E Q U E S T I O N S 613. A clien t with Croh n ’s disease is sch eduled to

receive an in fusion of in flixim ab. Wh at in terven - tion by th e n urse will determ in e th e effectiven ess of treatm en t? 1. Mon itorin g th e leukocyte co un t for 2 days after

th e in fusion 2. Ch eckin g th e frequen cy an d con sisten cy of

bowel m ovem en ts 3. Ch eckin g serum liver en zym e levels befo re an d

after th e in fusio n 4. Carryin g out a Hem atest on gastric fluids after

th e in fusion is com pleted

BOX 53-5 Commonly Administered Antiemetics Serotonin Antagonists ▪ Dolasetron ▪ Granisetron ▪ Ondansetron Glucocorticoids ▪ Dexamethasone ▪ Methylprednisolone Substance P/ Neurokinin-1 Antagonists ▪ Aprepitant ▪ Fosaprepitant Benzodiazepine ▪ Lorazepam Dopamine Antagonists Phenot hiazines ▪ Chlorpromazine ▪ Perphenazine ▪ Prochlorperazine ▪ Promethazine

But yrophenones ▪ Haloperidol ▪ Droperidol Others ▪ Metoclopramide ▪ Trimethobenzamide

Cannabinoids ▪ Dronabinol ▪ Nabilone Anticholinergics ▪ Scopolamine

transdermal

Antihistamines ▪ Cyclizine ▪ Dimenhydrinate ▪ Diphenhydramine ▪ Hydroxyzine ▪ Meclizine hydrochloride

Adapted from Burchum J, Rosenthal L: Pharmacology for nursing care, ed 9, St. Louis, 20 16, Saunders.

BOX 53-6 Laxatives Bulk-Forming ▪ Methylcellulose ▪ Polycarbophil ▪ Psyllium Stimulants ▪ Bisacodyl ▪ Senna Emollient ▪ Docusate sodium

Osmotics ▪ Magnesium hydroxide ▪ Magnesium citrate ▪ Sodium phosphates ▪ Polyethylene glycol and

electrolytes ▪ Lactulose

BOX 53-7 Medications to Control Diarrhea Opioids and Related Medications ▪ Diphenoxylate with atropine sulfate ▪ Loperamide Other Antidiarrheals ▪ Bismuth subsalicylate ▪ Bulk-forming medications ▪ Anticholinergic antispasmodics: dicyclomine, glycopyr-

rolate

702 UNIT XI Gastrointestinal Disorders of the Adult Client

614. A clien t h as an as n eeded prescription for lopera- m ide h ydroch loride. For wh ich con ditio n sh ould th e n urse adm in ister th is m ed ication ? 1. Con stipation 2. Abdom in al pain 3. An episo de of diarrh ea 4. Hem atest-positive n aso gastric tube drain age

615. A clien t h as an as n eeded prescription for on dan se- tron . For wh ich con ditio n (s) sh ould th e n urse adm in ister th is m ed ication ? 1. Paralytic ileu s 2. In cisio n al pain 3. Urin ary reten tion 4. Nausea an d vom itin g

616. A clien t h as begun m edication th erapy with pan - crelipase. Th e n urse evaluates th at th e m ed ication is h avin g th e optim al in ten ded ben efit if wh ich effect is observed? 1. Weigh t lo ss 2. Relief of h eartburn 3. Reduction of steato rrh ea 4. Absen ce of abdom in al pain

617. An older clien t recen tly h as been takin g cim etidin e. Th e n urse m on itors th e clien t for wh ich m o st fre- quen t cen tral n ervous system side effect of th is m edication ? 1. Trem ors 2. Dizzin ess 3. Con fusion 4. Hallucin ation s

618. A clien t with a gastric ulcer h as a prescription for sucralfate 1 gram by m ou th 4 tim es daily. Th e n urse sh o uld sch edule th e m edication for wh ich tim es? 1. With m eals an d at bedtim e 2. Every 6 h ou rs aroun d th e clo ck 3. O n e h our after m eals an d at bedtim e 4. O n e h ou r before m eals an d at bed tim e

619. A clien t wh o uses n onsteroidal an tiinflam m atory drugs (NSAIDs) h as been takin g m isoprostol. Th e nurse determ in es that th e m isoprostol is havin g the in ten ded therapeutic effect if which fin din g is n oted? 1. Reso lved diarrh ea 2. Relief of epigastric pain 3. Decreased platelet coun t 4. Decreased wh ite blood cell coun t

620. A clien t h as been takin g om eprazole for 4 weeks. Th e am bulatory care n urse evaluates th at th e clien t is receivin g th e optim al in ten ded effect of th e m ed- ication if th e clien t reports th e absen ce of wh ich sym ptom ?

1. Diarrh ea 2. Heartburn 3. Flatulen ce 4. Con stipation

621. A clien t with a peptic ulcer is diagn osed with a Heli- cobacter pylori in fectio n . Th e n urse is teach in g th e clien t about th e m edication s prescribed, in cludin g clarith rom ycin , eso m eprazole, an d am oxicillin . Wh ich statem en t by th e clien t in dicates th e b est un d erstan din g of th e m edication regim en ? 1. “My ulcer will h eal because th ese m ed ication s

will kill th e bacteria.” 2. “Th ese m edication s are on ly taken wh en I h ave

pain fro m m y ulcer.” 3. “Th e m edication s will kill th e bacteria an d stop

th e acid produ ction .” 4. “Th ese m edication s will coat th e ulcer an d

decrease th e acid produ ction in m y stom ach .”

622. A clien t h as a n ew prescription for m etoclopra- m ide. O n review of th e ch art, th e n urse id en tifies th at th is m edication can be safely ad m in istered with wh ich con dition ? 1. In testin al obstru ction 2. Peptic ulcer with m elen a 3. Diverticulitis with perforation 4. Vom itin g followin g can cer ch em oth erapy

623. Th e n urse determ in es th e clien t n eed s fu rth er in stru ctio n on cim etidin e if wh ich statem en ts were m ade? Select all th at ap p ly.

1. “I will take th e cim etidin e with m y m eals.” 2. “I’ll kn ow th e m edication is workin g if m y

diarrh ea stops.” 3. “My episo des of h eartburn will decrease if

th e m ed ication is effective.” 4. “Takin g th e cim etidin e with an an tacid will

in crease its effectiven ess.” 5. “I will n otify m y h ealth care provider if

I beco m e dep ressed or an xious.” 6. “Som e of m y blood levels will n eed to be

m on itored clo sely sin ce I also take warfarin for atrial fibrillation .”

624. Th e n urse h as given in struction s to a clien t wh o h as just been prescribed ch olestyram in e. Wh ich state- m en t by th e clien t in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I will con tin ue takin g vitam in supp lem en ts.” 2. “Th is m ed ication will h elp to lower m y

ch olestero l.” 3. “Th is m edication sh ould on ly be taken with

water.” 4. “A h igh -fib er diet is im portan t wh ile takin g th is

m ed ication .”

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

703CHAPTER 53 Gastrointestinal Medications

A N S W E R S 613. 2 Ra tion a le: Th e prin cipal m an ifestation s of Cro h n ’s d isease are d iarrh ea an d ab d om in al p ain . In flixim ab is an im m u n o m o d- u lator th at red uces th e degree of in flam m atio n in th e co lo n , th ereb y red u cin g th e d iarrh ea. O ptio n s 1, 3, an d 4 are u n re- lated to th is m ed icatio n . Test-Ta kin g Str a tegy: Focu s o n th e su b ject, treatm en t fo r Croh n ’s d isease, an d n o te th e strategic wo rd , effectiveness. Elim in ate op tion 4 b ecause gastric b leed in g is n o t a ch aracter- istic of Croh n ’s disease. Mo n itorin g th e leukocyte co un t an d liver en zym e levels is ap prop riate wh en in flixim ab is given b ut n o t to evaluate th e effectiven ess o f treatm en t, elim in atin g o ptio n s 1 an d 3. Review: Man ifestatio n s of Cro h n ’s d isease an d action s of in flixim ab Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm aco logy—Gastro in testin al Medicatio n s Pr ior it y Con cept s: Evid en ce; Im m u n ity Refer en ce: Hod gson , Kizio r (2015), p. 622.

614. 3 Ra tion a le: Loperam ide is an an tidiarrh eal agen t. It is used to m an age acu te an d ch ron ic d iarrh ea in con dition s su ch as in flam m atory b owel disease. Lo peram ide also can be u sed to redu ce th e vo lum e o f d rain age fro m an ileosto m y. It is n o t u sed fo r th e co n d itio n s in o ptio n s 1, 2, an d 4. Test-Ta kin g Str a tegy: Focus on th e su b ject, th e action of lo peram ide. Recallin g th at th is m ed ication is an an tid iarrh eal agen t will d irect yo u to th e co rrect o p tion . Review: Lo p eram id e h yd ro ch lo rid e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm aco logy—Gastro in testin al Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Lilley et al. (2014), p . 832.

615. 4 Ra tion a le: O n d an setron is an an tiem etic used to treat po stop - erative n au sea an d vom itin g, as well as n au sea an d vom itin g asso ciated with ch em o th erapy. Th e oth er o ptio n s are in co rrect reason s for ad m in isterin g th is m ed icatio n . Test-Ta kin g Str a tegy: Focus on th e su b ject, th e action of o n d an setro n . Recallin g th at th is m ed icatio n is an an tiem etic will direct you to th e correct option . Review: O n d an setro n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm aco logy—Gastro in testin al Medicatio n s Pr ior it y Con cepts: Clin ical Ju dgm en t; Flu id an d Electro lyte Balan ce Refer en ces: Hod gson , Kizio r (2015), pp . 889–890; Lilley et al. (2014), p. 850.

616. 3 Ra tion a le: Pan crelip ase is a pan creatic enzym e used in clien ts with pan creatitis as a d igestive aid . Th e m edication sh o uld reduce the am o un t o f fatty stools (steatorrh ea). An oth er in tend ed effect could b e im proved n utrition al statu s. It is n ot u sed to treat abdom in al pain o r h eartbu rn . Its use cou ld result in weigh t gain b ut sho uld n ot result in weigh t loss if it is aid in g in d igestion . Test-Ta kin g St r a tegy: Focus on th e su b ject, in ten ded ben efit o f th e m ed icatio n an d o n th e n am e of th e m edicatio n . Use kn owled ge of p h ysio logy of th e p an creas an d th e fu n ction of p an creatic en zym es to assist in d irectin g you to th e co rrect o ptio n . Review: Pan crelip ase Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm acolo gy—Gastro in testin al Medicatio n s Pr ior it y Con cept s: Elim in ation ; In flam m atio n Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 984–985.

617. 3 Ra tion a le: Cim etid in e is a h istam in e ( H2)-recep tor an tagon ist. O lder clien ts are esp ecially suscep tible to cen tral n ervou s system sid e effects of cim etid in e. Th e m o st freq uen t of th ese is co n fu sio n . Less co m m o n cen tral n ervo u s system sid e effects in clud e h eadach e, dizzin ess, drowsin ess, an d h allucin atio n s. Test-Ta kin g Str a tegy: No te th e strategic wo rd , most. Use kn owled ge o f th e o lder clien t an d m ed icatio n effects to d irect you to th e correct op tio n . Review: Sid e effects o f cim etid in e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Gastro in testin al Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 953.

618. 4 Ra tion a le: Su cralfate is a gastric protectan t. Th e m edicatio n sh o u ld be sch edu led for ad m in istration 1 h o ur b efo re m eals an d at b ed tim e. Th e m ed ication is tim ed to allow it to fo rm a p ro tective co atin g o ver th e ulcer b efore foo d in take stim ulates gastric acid prod u ctio n an d m ech an ical irritation . Th e oth er o ptio n s are in co rrect. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, tim es to adm in is- ter sucralfate. Note th e clien t’s d iagn osis an d th in k abo ut th e p ath op h ysio lo gy asso ciated with a gastric ulcer to assist in d irectin g yo u to th e correct o ptio n . Review: Su cralfate Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm acolo gy—Gastro in testin al Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Hod gson , Kizio r (2015), pp . 1131–1132.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

704 UNIT XI Gastrointestinal Disorders of the Adult Client

619. 2 Ra t ion a le: Th e clien t wh o uses NSAIDs is p ro n e to gastric m u co sal in ju ry. Misop ro sto l is a gastric p ro tectan t an d is given specifically to preven t th is occu rren ce in clien ts takin g NSAIDs freq uen tly. Diarrh ea can be a sid e effect o f th e m ed icatio n b ut is n ot an in ten d ed effect. O p tio n s 3 an d 4 are un related to th e pu rp ose of m isop ro sto l. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, th e in ten ded th er- ap eu tic effect of m isop ro stol for a clien t wh o ch ron ically uses NSAIDs. Th is in dicates th at th e m ed icatio n is bein g given to preven t th e o ccurren ce o f sp ecific sym p to m s. Recallin g th at NSAIDs can cause gastric m u cosal in ju ry will direct yo u to th e co rrect op tion . Review: Miso p ro sto l Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Gastroin testin al Med icatio n s Pr ior ity Con cepts: Eviden ce; Tissue In tegrity Refer en ce: Lilley et al. (2014), pp . 709, 824.

620. 2 Ra t ion a le: O m eprazole is a proto n p um p in h ib itor classified as an an tiu lcer agen t. Th e in ten d ed effect o f th e m ed ication is relief o f p ain fro m gastric irritation , o ften called heartburn by clien ts. O m ep razo le is n o t used to treat th e co n d itio n s id en - tified in o p tion s 1, 3, an d 4. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject, th e o ptim al in ten d ed effect of o m ep razo le. Recallin g th at th is m ed ication is a pro to n p um p in h ib itor will d irect yo u to th e correct op tio n . Review: O m ep razo le Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Gastroin testin al Med icatio n s Pr ior ity Con cepts: Eviden ce; Tissue In tegrity Refer en ce: Lilley et al. (2014), p. 823.

621. 3 Ra t ion a le: Triple th erapy fo r H. pylori in fection usually in clud es 2 an tib acterial m ed ication s an d a p ro ton pu m p in h ibito r. Clarith rom ycin an d am o xicillin are an tibacterials. Esom ep razo le is a p ro to n pu m p in h ib itor. Th ese m ed ication s will kill th e b acteria an d d ecrease acid p ro d uction . Test-Ta kin g Str a tegy: Focus on th e su bject, th e m edication s an d th eir action s, an d n ote th e strategic word, best. Elim in ate option 1 because th e m edicatio ns do m ore th an kill th e bacteria. Th ese m edication s are taken n ot on ly when th ere is pain but con tin ually un til go ne, usually for 1 to 2 weeks. Th is will elim in ate option 2. Th ese m edication s do n o t co at th e ulcer, elim in atin g option 4. Review: Med ication regim en s fo r th e treatm en t o f Helicoba cter pylori Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Gastroin testin al Med icatio n s Pr ior ity Con cepts: Clien t Edu catio n ; In fection Refer en ces: Lilley et al. ( 2014), p p. 817–818; Bu rch u m , Rosen th al (2016), p. 951.

622. 4 Ra t ion a le: Meto clo p ram ide is a gastroin testin al stim ulan t an d an tiem etic. Becau se it is a gastroin testin al stim u lan t, it is co n - train d icated with gastro in testin al ob struction , h em o rrh age, o r p erforation . It is u sed in th e treatm en t o f vo m itin g after su r- gery, ch em o th erapy, o r radiation . Test-Ta king Stra tegy: Focus on th e su bject, safe use of m etoclo- pram ide. Recallin g th e classification an d action of th is m edication an d th at it is an antiem etic will direct you to th e correct option . Review: Meto clo p ram id e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Gastroin testin al Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 983.

623. 1, 2, 4 Ra t ion a le: Cim etid in e, a h istam in e (H 2)-recep tor an tago n ist, h elp s to alleviate th e sym pto m of h eartbu rn , n ot d iarrh ea. Becau se cim etidin e crosses th e bloo d-b rain barrier, cen tral n er- vo us system sid e an d adverse effects, such as m en tal co n fu sio n , agitatio n , d ep ressio n , an d an xiety, can o ccur. Foo d redu ces th e rate of abso rp tio n , so if cim etid in e is taken with m eals, abso rp- tion will be slowed. An tacids d ecrease th e abso rptio n o f cim et- idin e an d sh ou ld be taken at least 1 h ou r ap art. If cim etid in e is co n co m itan tly ad m in istered with warfarin th erap y, warfarin d o ses m ay n eed to be red u ced , so p ro th rom b in an d in tern a- tion al n orm alized ratio resu lts m u st b e followed. Test -Ta kin g St r a t egy: Note th e strategic wo rd s, needs further instruction. Th ese words in dicate a n egative even t q u ery an d ask yo u to select th e op tio n s th at are in co rrect statem en ts. Th in k ab ou t th e th erap eu tic effect, adverse effects, an d p oten - tial m ed ication in teractio n s to direct you to th e correct o p tion s. Review: Cim etid in e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Gastroin testin al Med icatio n s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), pp . 960–961.

624. 3 Ra tion a le: Ch olestyram in e is a bile acid sequestran t used to lower th e ch olesterol level, an d clien t com plian ce is a problem because of its taste an d palatability. Th e use of flavored products or fruit juices can im prove th e taste. Som e side effects of bile acid seques- tran ts in clude con stipation an d decreased vitam in absorption . Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further instructions. Th ese words in dicate a n egative even t q u ery an d ask you to select an o ptio n th at is an in co rrect statem en t. Note th e clo sed -en d ed wo rd only in th e co rrect o p tion . Review: Th e action an d sid e effects o f ch o lestyram in e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Gastroin testin al Med icatio n s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 573.

A

d

u

l

t

G

a

s

t

r

o

i

n

t

e

s

t

i

n

a

l

705CHAPTER 53 Gastrointestinal Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y UNIT XII

Respiratory Disorders of the Adult Client

Pyramid to Success

Th e Pyram id to Success focuses on infectious diseases, particularly tuberculosis, an d respiratory care in relation to oxygen delivery system s an d m ech an ical ven tilation . Pyram id Poin ts focus on th e clien t with pn eum on ia, respi- ratory failure, ch ron ic obstructive pulm on ary disease, pn eum oth orax, in fluen za, an d tuberculosis. Th e Pyram id to Success in cludes the care of th e clien t with tuberculosis, especially regardin g th e im portan ce of th e m edication reg- im en , providin g adequate n utrition an d adequate rest to prom ote th e h ealin g process, an d prevention of progres- sion of th e disease. Focus on assistin g the clien t to cope with the social isolation issues th at exist durin g th e period of illn ess an d on teach in g the clien t an d fam ily th e critical m easures of screenin g, preven ting respiratory disease, an d th e tran sm ission of in fectious airborn e disease.

Client Needs: Learning Objectives Safe and Effective Care Environment Collab oratin g with th e in terp ro fession al team in th e

m an agem en t of th e respiratory disorder Discussin g con sultatio n s an d referrals related to th e

respiratory disorder En surin g th at in form ed con sen t related to in vasive pro-

cedures h as been obtain ed Establish in g prio rities Han dlin g in fectio us m aterials such as sputu m or body

fluids safely Main tain in g asepsis wh en carin g for woun ds or trach e-

ostom y sites an d durin g m ech an ical ven tilation or suction in g

Main tain in g co n fiden tiality related to th e respiratory disorder

Main tain in g respiratory precaution s, stan dard precau- tion s, an d oth er precaution s

Health Promotion and Maintenance Educatin g th e clien t about adequ ate fluid an d n utri-

tion al in take Educatin g th e clien t about breath in g exercises an d respi-

ratory th erap y an d care Educatin g th e clien t about m edication adm in istration Educatin g th e clien t about th e n eed for follo w-up care Educatin g th e clien t ab out th e preven tion of tran sm is-

sion of in fectio n In form in g th e clien t ab out h ealth prom otion program s Perform in g respiratory assessm en t tech n iques Preven tin g respiratory disorders an d in fectio us diseases Providin g h ealth screen in g related to risks for respiratory

disorders

Psychosocial Integrity Con siderin g religious, cultural, an d spiritual in fluen ces

wh en providin g care Discussin g body im age ch an ges related to respiratory

disorders Discussin g en d-of-life an d grief an d loss issues Discussin g situation al role ch an ges Iden tifyin g copin g strategies Iden tifyin g supp ort system s an d com m un ity resou rces

Physiological Integrity Adm in isterin g m edication s Carin g for th e clien t on m ech an ical ven tilation

706

Carin g for th e clien t receivin g respiratory th erapy an d supplem en tal oxygen

Man agin g respiratory illn esses Mon itorin g for acid –base im balan ces Mon itorin g for alteration s in body system s

Mon itorin g for in fectio us diseases Providin g n utrition an d oral h ygien e Providin g perso n al h ygien e an d prom o tin g rest an d

sleep Providin g rest an d com fort

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

707UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

C H A P T E R 54 Respiratory System

PRIORITY CONCEPTS Gas Exchange; Perfusion

CRITICAL THINKING What Should You Do? A victim of a gunshot wound to the chest sustained a pene- trating injury. The emergency medical response team applied a nonporous dressing over the victim’s sucking chest wound at the site of the accident. On arrival at the emergency depart- ment, the victim is cyanotic, and the nurse notes subcutane- ous emphysema (crepitus) and tracheal deviation away from the affected side. What should the nurse do? Answer located on p. 729.

I. Anatomy and Physiology A. Prim ary fun ction s of th e respiratory system

1. Provides oxygen for m etab olism in th e tissues 2. Rem o ves carbo n dioxide, th e waste produ ct of

m etab olism B. Secon dary fun ction s of th e respiratory system

1. Facilitates sen se of sm ell 2. Produ ces speech 3. Main tain s acid-b ase balan ce 4. Main tain s body water levels 5. Main tain s h eat balan ce

C. Upp er respiratory airway 1. Nose: Hum idifies, warm s, an d filters inspired air 2. Sin uses: Air-filled cavities with in th e h ollow

bon es th at surroun d th e n asal passages an d pro- vide reson an ce durin g speech

3. Ph aryn x a. Passageway for th e respiratory an d digestive

tracts located behind th e oral an d n asal cavities b . Divided in to th e n aso ph aryn x, oroph aryn x,

an d laryn goph aryn x 4. Laryn x

a. Located just below th e ph aryn x at th e root of th e ton gue; com m on ly called th e voice box

b . Con tain s 2 pairs of vocal cords, th e false an d true co rds

c. Th e open in g between th e true vocal co rds is th e glottis. Th e glottis plays an im portan t role

in cough in g, wh ich is th e m ost fun dam en tal defen se m ech an ism of th e lu n gs.

5. Epiglottis a. Leaf-sh aped elastic flap structure at th e top of

th e laryn x b . Preven ts food from en terin g th e trach eobro n -

ch ial tree by closin g over th e glottis durin g swallowin g

D. Lower respiratory airway 1. Trach ea: Located in fron t of th e esoph agus;

bran ch es in to th e righ t an d left m ain stem bron - ch i at th e carin a

2. Main stem bron ch i a. Begin at th e carin a b . Th e righ t bron ch us is sligh tly wider, sh o rter,

an d m ore vertical th an th e left bron ch us. c. Divide in to secon dary or lobar bron ch i th at

en ter each of th e 5 lobes of th e lun g d . Th e bron ch i are lin ed with cilia, wh ich propel

m ucus up an d away from th e lower airway to th e trach ea, wh ere it can be expecto rated or swallowed.

3. Bron ch ioles a. Bran ch fro m th e secon dary bron ch i an d sub-

divide in to th e sm all term in al an d respiratory bron ch ioles

b . Con tain n o cartilage an d dep en d on th e elas- tic recoil of th e lun g for paten cy

c. Th e term in al bron ch ioles con tain n o cilia an d do n ot participate in gas exch an ge.

4. Alveolar ducts an d alveo li a. Acinus (plural, acini) is a term used to in dicate

all structures distal to the term in al bron ch iole. b . Bran ch from th e respiratory bron ch ioles c. Alveolar sacs, wh ich arise fro m th e ducts, con -

tain clu sters of alveo li, wh ich are th e basic un its of gas exch an ge.

d . Type II alveolar cells in th e walls of th e alveoli secrete surfactan t, a ph osph olipid protein th at reduces the surface ten sion in the alveoli; with out surfactan t, the alveoli would collapse.

708

5. Lun gs a . Located in th e pleural cavity in th e th orax b . Exten d fro m just above th e clavicles to th e

diaph ragm , th e m ajor m uscle of in spiration c. Th e righ t lu n g, wh ich is larger th an th e left, is

divided in to 3 lobes: th e upper, m iddle, an d lower lobes.

d . Th e left lun g, wh ich is n arrower th an th e righ t lun g to accom m o date th e h eart, is divided in to 2 lo bes.

e. Th e respiratory structures are in n ervated by th e ph ren ic n erve, th e vagus n erve, an d th e th oracic n erves.

f. Th e parietal pleura lin es th e in side of th e th oracic cavity, in cludin g th e upper surface of th e diaph ragm .

g. Th e visceral pleura covers th e pulm o n ary surfaces.

h . A th in fluid layer, wh ich is produ ced by th e cells lin in g th e pleura, lubricates th e visceral pleura an d th e parietal pleura, allowin g th em to glide sm oo th ly an d pain lessly durin g respiration .

i. Bloo d flows th rou gh out th e lun gs via th e pul- m on ary circulation system .

6. Accessory m uscles of respiration in clude th e scalen e m uscles, wh ich elevate th e first 2 ribs; th e stern ocleidom astoid m uscles, wh ich raise th e stern um ; an d th e trapezius an d pecto ralis m uscles, wh ich fix th e sh oulders.

7. Th e respiratory process a . Th e diaph ragm descen ds in to th e abdom in al

cavity durin g in spiration , causin g n egative pressure in th e lun gs.

b . Th e n egative pressure draws air fro m th e area of greater pressure, th e atm osph ere, in to th e area of lesser pressure, th e lun gs.

c. In th e lun gs, air passes th rough th e term in al bron ch ioles in to th e alveoli an d diffuses in to surroun din g capillaries, th en travels to th e rest of th e body to oxygen ate th e body tissues.

d . At th e en d of in spiration , th e diaph ragm and in tercostal m uscles relax an d the lun gs recoil.

e. As the lungs recoil, pressure within the lungs becom es higher than atm ospheric pressure, causing the air, which now contains the cellular waste products carbon dioxide and water, to m ove from the alveoli in the lungs to the atm osphere.

f. Effective gas exch an ge depen ds on distri- bution of gas (ven tilation ) an d blood (perfu- sion ) in all portion s of th e lu n gs.

II. Diagnostic Tests A. Risk facto rs for respiratory disorders (Box 54-1) B. Ch est x-ray film (radiograp h )

1. Descrip tion : Provid es in form ation regardin g th e an atom ical location an d appearan ce of th e lu n gs

2. Preprocedure a . Rem o ve all jewelry an d oth er m etal objects

fro m th e ch est area. b . Assess th e clien t’s ability to in h ale an d h old

h is or h er breath . 3. Postprocedure: Help th e clien t to get dressed.

Question women regarding pregnancy or the possi- bility of pregnancy before performing radiography studies.

C. Sputu m specim en 1. Description : Specim en obtained by expectoration

or trach eal suctioning to assist in th e iden tification of organ ism s or abn orm al cells (see Priority Nursin g Actions)

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

PRIORITY NURSING ACTIONS Tracheal Suctioning

1. Assess the client and explain the procedure. 2. Assist the client to an upright position. 3. Perform hand hygiene and don protective garb. 4. Prepare suctioning equipment and turn on the suction. 5. Hyperoxygenate the client. 6. Insert the catheter without suction applied. 7. Once inserted, apply suction intermittently while rotat-

ing and withdrawing the catheter. 8. Hyperoxygenate the client. 9. Listen to breath sounds.

10. Document the procedure, client response, and effectiveness.

Once the nurse has assessed the client, the nurse explains the procedure. The client is assisted to a sitting upright position such as semi-Fowler’s with the head hyperextended (unless contraindicated). Hand hygiene is performed, and the nurse applies appropriate protective garb, using aseptic technique. The nurse prepares the needed suctioning equipment, turns on the suction device, and sets it to the appropriate pressure. The nurse hyperoxygenates the client with a resuscitation bag, increasing the oxygen flow rate, or asks the client to take deep breaths. The nurse dons sterile gloves and lubricates the cath- eter with sterile water or water-soluble lubricant (per agency procedure), inserts the catheter without the application of suction, and then applies intermittent suction for up to 10 sec- onds while rotating and withdrawing the catheter. After suctioning, the nurse hyperoxygenates the client and encourages the client to take deep breaths if possible. During the procedure, the nurse monitors the client for toleration of the procedure and the presence of complications. Finally, the nurse listens to breath sounds to assist in determining effectiveness and documents the procedure, the client’s response, and effectiveness.

Reference Ignatavicius, Workman (2016), p. 525. Perry, Potter, Ostendorf

(20 14), pp. 631–632, 637.

709CHAPTER 54 Respiratory System

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

2. Preprocedure a . Determ in e th e specific purpo se of collection

an d ch eck in stitutio n al policy for th e appro- priate m eth od for collection .

b . O btain an early m orn in g sterile specim en by suction in g or expecto ration after a respira- tory treatm en t if a treatm en t is prescribed .

c. In struct th e clien t to rin se th e m outh with water before collection .

d . O btain 15 m L of sputum . e. In struct th e clien t to take several deep breath s

an d th en cough deeply to obtain sputum . f. Always collect th e specim en befo re th e clien t

begin s an tibiotic th erapy. 3. Postprocedure

a . If a culture of sputu m is prescribed, tran spo rt th e specim en to th e laborato ry im m ediately.

b . Assist th e clien t with m outh care.

Ensure that an informed consent was obtained for any invasive procedure. Vital signs are measured before the procedure and monitored postprocedure to detect signs of complications.

D. Laryn goscop y an d bron ch oscopy 1. Descrip tion : Direct visu al exam in ation of th e

laryn x, trach ea, an d bron ch i with a fiberop tic bron ch oscope

2. Preprocedure a . Main tain NPO (n oth in g by m outh ) status as

prescribed . b . Assess th e results of coagulation studies. c. Rem o ve den tures an d eyeglasses. d . Establish an in traven ous (IV) access as n eces-

sary an d adm in ister m edication for sedation as prescribed.

e. Have em ergen cy resuscitation equ ipm en t readily available.

3. Postprocedure a . Main tain th e clien t in a sem i-Fowler’s position. b . Assess for th e return of th e gag reflex. c. Main tain NPO status un til th e gag reflex

return s. d . Mon itor for blood y sputum .

e. Mon itor respiratory status, particularly if sed ation h as been adm in istered.

f. Monitor for com plication s, such as bron - ch ospasm or bronch ial perforation, in dicated by facial or n eck crepitus, dysrh ythm ias, h em orrh age, h ypoxem ia, and pneumothorax.

g. No tify th e h ealth care provider (HCP) if sign s of com plication s occur.

E. En do bron ch ial ultraso un d (EBUS) 1. Tissue sam ples are obtain ed from cen tral lun g

m asses an d lym ph n odes, usin g a bron ch oscope with th e h elp of ultraso un d guidan ce.

2. Tissue sam ples are used for diagn osin g an d stagin g lun g can cer, detectin g in fectio n s, an d id en tifyin g in flam m ato ry diseases th at affect th e lun gs, such as sarcoidosis.

3. Postp rocedu re, th e clien t is m on itored for sign s of bleed in g an d respiratory distress.

F. Pulm o n ary an giograph y 1. Descriptio n

a . A fluoroscopic proced ure in wh ich a cath eter is in serted th rough th e an tecu bital or fem oral vein in to th e pulm on ary artery or 1 of its bran ch es

b . In vo lves an in jection of io din e or radiopaque con trast m aterial

2. Preprocedure a . Assess for allergies to iodin e, seafood, or

oth er radiop aque dyes. b . Main tain NPO status as prescribed. c. Assess results of co agulation studies. d . Establish an IV access. e. Adm in ister sedation as prescribed. f. In struct th e clien t to lie still durin g th e

proced ure. g. In struct th e clien t th at h e or sh e m ay feel an

urge to cough , flush in g, n ausea, or a salty taste followin g in jection of th e dye.

h . Have em ergen cy resuscitation equ ipm en t available.

3. Postp rocedu re a . Avoid takin g blood pressures for 24 h ours in

th e extrem ity used for th e in jection . b . Mon itor periph eral n eurovascular status of

th e affected extrem ity. c. Assess in sertion site for bleed in g. d . Mon itor for reactio n to th e dye.

G. Th oracen tesis 1. Descriptio n : Rem o val of flu id or air from th e

pleural space via tran sth oracic aspiration 2. Preprocedure

a . Prepare th e clien t for ultrasoun d or ch est radiograph , if prescribed, before proced ure.

b . Assess results of co agulation studies. c. No te th at th e clien t is position ed sittin g

uprigh t, with th e arm s an d sh oulders sup- ported by a table at th e bedside durin g th e proced ure (Fig. 54-1).

BOX 54-1 Risk Factors for Respiratory Disorders ▪ Allergies ▪ Chest injury ▪ Crowded living conditions ▪ Exposure to chemicals and environmental pollutants ▪ Family history of infectious disease ▪ Frequent respiratory illnesses ▪ Geographical residence and travel to foreign countries ▪ Smoking ▪ Surgery ▪ Use of chewing tobacco ▪ Viral syndromes

710 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

d . If th e clien t can n ot sit up, th e clien t is placed lyin g in bed toward th e un affected side, with th e h ead of th e bed elevated.

e. In struct th e clien t n ot to cough , breath e deeply, or m ove durin g th e procedure.

3. Postprocedure a. Mon itor respiratory status. b . Apply a pressure dressin g, an d assess th e

pun cture site for bleedin g an d crepitus. c. Mon itor for sign s of pn eum oth orax, air

em bolism , an d pulm o n ary edem a. H. Pulm on ary fun ctio n tests

1. Descrip tion : Tests used to evaluate lun g m ech an - ics, gas exch an ge, an d acid-b ase disturban ce th rough spirom etric m easu rem en ts, lun g vol- um es, an d arterial blood gas levels.

2. Preprocedure a. Determ in e wh eth er an an algesic th at m ay

depress th e respiratory fun ction is bein g adm in istered.

b . Con sult with th e HCP regardin g with h oldin g bron ch od ilators before testin g.

c. In struct th e clien t to void before th e proce- dure an d to wear loose cloth in g.

d . Rem ove den tures. e. In struct th e clien t to refrain from sm okin g or

eatin g a h eavy m eal for 4 to 6 h ours before th e test.

3. Postprocedure: Clien t m ay resum e a n orm al diet an d an y bron ch od ilators an d respiratory treat- m en ts th at were with h eld befo re th e proced ure.

I. Lun g biopsy 1. Descrip tion

a. A tran sbron ch ial biopsy an d a tran sbron ch ial n eedle aspiration m ay be perform ed to obtain tissue for an alysis by culture or cyto- logical exam in ation .

b . An open lun g biopsy is perform ed in th e operatin g room .

2. Preprocedure a. Main tain NPO status as prescribed. b . In form th e clien t th at a lo cal an esth etic will

be used for a n eedle biopsy but a sen sation

of pressure durin g n eedle in sertio n an d aspi- ration m ay be felt.

c. Adm in ister an algesics an d sedatives as prescribed.

3. Postprocedure a . Apply a dressin g to th e biopsy site an d m on -

ito r for drain age or bleed in g. b . Mon itor for sign s of respiratory distress, an d

n otify th e HCP if th ey occur. c. Mon itor for sign s of pn eum oth orax an d air

em b oli, an d n otify th e HCP if th ey occur. d . Prepare th e clien t for ch est radiograph y if

prescribed. J. Spiral (h elical) com pu ted tom o graph y (CT) scan

1. Frequen tly used test to diagn ose pulm o n ary em bolism

2. IV in jection of con trast m ed ium is used; if th e cli- en t can n ot h ave con trast m ed ium , a ven tilation - perfusio n (V/ Q ) scan will be don e.

3. Th e scan n er rotates aroun d th e body, allowin g for a 3-dim en sion al picture of all region s of the lun gs.

K. Ven tilation -perfu sion (V/ Q ) lun g scan 1. Description

a . Th e perfusion scan evaluates blood flow to th e lu n gs.

b . Th e ven tilation scan determ in es th e paten cy of th e pulm o n ary airways an d detects abn o r- m alities in ven tilation .

c. A radion uclide m ay be in jected for th e procedure.

2. Preprocedure a . Assess th e clien t for allergies to dye, iodin e,

or seafoo d. b . Rem o ve jewelry aroun d th e ch est area. c. Review breath in g m eth od s th at m ay be

required durin g testin g. d . Establish an IV access. e. Adm in ister sedation if prescribed . f. Have em ergen cy resuscitation equ ipm en t

available. 3. Postprocedure

a . Mon itor th e clien t for reactio n to th e radion uclide.

b . In struct th e clien t th at th e radion uclide clears fro m th e body in ab out 8 h ours.

L. Skin tests: A skin test uses an in traderm al injection to h elp diagn ose various in fectious diseases (Box 54-2).

M. Arterial blood gases (ABGs) 1. Description : Measu rem en t of th e dissolved oxy-

gen an d carbo n dioxide in th e arterial blood h elps to in dicate th e acid-b ase state an d h ow well oxygen is bein g carried to th e body.

2. Preprocedure an d postp rocedure care, n orm al results, an d an alysis of results: See Ch apter 9. Avoid suctioning the client before drawing an ABG

sample because the suctioning procedure will deplete the client’s oxygen, resulting in inaccurate ABG results.

FIGURE 54-1 Positions for thoracentesis.

711CHAPTER 54 Respiratory System

N. Pulse oxim etry: See Ch apter 10. O. D-d im er

1. A blood test th at m easures clo t form ation an d lysis th at results from th e degradatio n of fib rin

2. Helps to diagn ose (a positive test result) th e pres- en ce of th rom bus in con dition s such as deep vein th rom bosis, pulm o n ary em bolism , or stroke; it is also used to diagn ose dissem in ated in travascu lar co agulation (DIC) an d to m on itor th e effectiven ess of treatm en t.

3. Th e n orm al D-d im er level is less th an or equ al to 250 n g/ m L (250 m cg/ L) D-dim er un its (DDU) ; n orm al fibrin ogen is 200 to 400 m g/ dL (2 to 4 g/ L).

III. Respiratory Treatments A. Breath in g retrain in g ( Box 54-3) B. Ch est ph ysio th erap y (CPT) (Fig. 54-2)

1. Description : Percussion , vibration , an d postural drain age tech n iqu es are perform ed over th e th o- rax to lo osen secretio n s in th e affected area of th e lun gs an d m ove th em in to m ore cen tral airways.

2. In terven tion s (Box 54-4) 3. Con train dication s

a. Un stable vital sign s b . In creased in tracran ial pressure c. Bron ch ospasm d . History of path ological fractures e. Rib fractures f. Ch est in cision s

C. In cen tive spirom etry ( Box 54-5)

IV. Oxygen A. Supp lem en tal oxygen delivery system s (Table 54-1)

1. Nasal can n ula for low flow: Used for th e clien t with ch ron ic airflow lim itation an d for lon g- term oxygen use ( Fig. 54-3)

2. Nasal h igh -flo w (NHF) respiratory th erap y: Used for h ypo xem ic clien ts in m ild to m od erate respi- ratory distress (Box 54-6)

3. Sim ple face m ask: Used for sh ort-term oxygen th erap y or to deliver oxygen in an em ergen cy (Fig. 54-4)

4. Ven turi m ask: Used for clien ts at risk for or experien cin g acu te respiratory failure ( Fig. 54-5)

5. Partial rebreath er m ask: Useful wh en th e oxygen con cen tration n eeds to be raised; n ot usually pre- scrib ed for a clien t with ch ron ic obstru ctive pul- m on ary disease (CO PD)

6. Non reb reath er m ask: Most frequen tly used for th e clien t with a deterio ratin g respiratory status wh o m igh t require in tub ation (Fig. 54-6)

7. Trach eostom y collar and T-bar or T-piece: Trach e- ostom y collar is used to deliver h igh h um idity an d th e desired oxygen to th e clien t with a trach eo- stom y; the T-bar or T-piece is used to deliver th e desired FiO 2 to th e clien t with a trach eostom y, laryn gectom y, or en dotrach eal tube (Fig. 54-7).

8. Face ten t: Used in stead of a tigh t-fittin g m ask for th e clien t wh o h as facial traum a or burn s.

B. Con tin uo us positive airway pressure (CPAP) an d bilevel positive airway pressure (BiPAP) (see Section V, B, 1 in th is ch apter [Non in vasive positive pressure ven tilation or BiPAP] for m ore in form ation on BiPAP) 1. CPAP m ain tain s a set positive airway pressure

durin g in spiration an d expiration ; ben eficial in clien ts wh o h ave obstru ctive sleep apn ea or acute exacerbation s of CO PD.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

BOX 54-2 Skin Test Procedure 1. Determine hypersensitivity or previous reactions to skin

tests. 2. Use a skin site that is free of excessive body hair, dermati-

tis, and blemishes. 3. Apply the injection at the upper third of the inner surface

of the left arm. 4. Circle and mark the injection test site. 5. Document the date, time, and test site. 6. Advise the client not to scratch the test site to prevent infec-

tion and possible abscess formation. 7. Instruct the client to avoid washing the test site. 8. Interpret the reaction at the injection site 24 to 72 hours

after administration of the test antigen. 9. Assess the test site for the amount of induration (hard

swelling) in millimeters and for the presence of erythema and vesiculation (small blister-like elevations).

BOX 54-3 Client Education: Breathing Retraining and Huff Coughing

Breathing Retraining This includes exercises to decrease use of the accessory mus-

cles of breathing, to decrease fatigue, and to promote car- bon dioxide (CO2) elimination.

The main types of exercises include pursed-lip breathing and diaphragmatic breathing.

The client should inhale slowly through the nose. The client should place a hand over the abdomen while inhal-

ing; the abdomen should expand with inhalation and con- tract during exhalation.

The client should exhale 3 times longer than inhalation by blowing through pursed lips.

Huff Coughing This is an effective coughing technique that conserves energy,

reduces fatigue, and facilitates mobilization of secretions. The client should take 3 or 4 deep breaths using pursed-lip and

diaphragmatic breathing. Leaning slightly forward, the cli- ent should cough 3 or 4 times during exhalation.

The client may need to splint the thorax or abdomen to achieve a maximum cough.

712 UNIT XII Respiratory Disorders of the Adult Client

2. BiPAP provid es positive airway pressure durin g in spiration an d ceases airway supp ort durin g expiration ; th ere is on ly en ough pressure pro- vided durin g expiration to keep th e airways open ; usually used if CPAP is in effective.

3. Both CPAP an d BiPAP im prove oxygen atio n th rou gh airway supp ort.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

Po s tural Drainag e

Che s t Phys io the rapy (CPT)

FIGURE 54-2 Chest physiotherapy (CPT) and postural drainage. Top, Percussion and vibration techniques. The nurse may use 1 or 2 hands with vibration, which is performed when the client exhales or coughs. Bottom, Positions for postural drainage of respiratory secretions.

BOX 54-4 Chest Physiotherapy Procedure Perform chest physiotherapy (CPT) in the morning on arising,

1 hour before meals, or 2 to 3 hours after meals. Stop CPT if pain occurs. If the client is receiving a tube feeding, stop the feeding and

aspirate for residual before beginning CPT. Administer the bronchodilator (if prescribed) 15 minutes

before the procedure. Place a layer of material (gown or pajamas) between the hands

or percussion device and the client’s skin. Position the client for postural drainage based on assessment. Percuss the area for 1 to 2 minutes. Vibrate the same area while the client exhales 4 or 5 deep

breaths. Monitor for respiratory tolerance to the procedure. Stop the procedure if cyanosis or exhaustion occurs. Maintain the position for 5 to 20 minutes after the procedure. Repeat in all necessary positions until the client no longer

expectorates mucus. Dispose of sputum properly. Provide mouth care after the procedure.

BOX 54-5 Client Instructions for Incentive Spirometry

1. Instruct the client to assume a sitting or upright position. 2. Instruct the client to place the mouth tightly around the

mouthpiece of the device. 3. Instruct the client to inhale slowly to raise and maintain the

flow rate indicator between the 600 and 90 0 marks. 4. Instruct the client to hold the breath for 5 seconds and then

to exhale through pursed lips. 5. Instruct the client to repeat this process 10 times every

hour while awake.

713CHAPTER 54 Respiratory System

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

TABLE 54-1 Supplemental Oxygen Delivery Systems Device Oxygen Delivered Nursing Considerations

Nasal cannula (nasal prongs) (see Fig. 54-3)

1-6 L/ min for oxygen concentration (FiO2) of 24% (at 1 L/ min) to 44% (at 6 L/ min)

Easily tolerated Can dislodge easily. Doesn’t get in the way of eating or talking Effective oxygen concentration can be delivered. Allows the

client to breath through the nose or mouth Ensure that prongs are in the nares with openings facing

the client Assess nasal mucosa for irritation from drying effect of

higher flow rates Assess skin integrity, as tubing can irritate skin Add humidification as prescribed and check water levels

Simple face mask (see Fig. 54-4)

5-8 L/ min oxygen flow for FiO2 of 40 %-60% Minimum flow of 5 L/ min needed to flush CO2 from mask

Interferes with eating and talking Can be warm and confining Ensure that mask fits securely over nose and mouth Remove saliva and mucus from the mask Provide skin care to area covered by mask Provide emotional support to decrease anxiety in the client

who feels claustrophobic Monitor for risk of aspiration from inability of client to

clear mouth (i.e., if vomiting occurs)

Venturi mask (Ventimask) (see Fig. 54-5)

4-10 L/ min oxygen flow for FiO2 of 24%-55% Delivers exact desired selected concentrations of O2

Keep the air entrapment port for the adapter open and uncovered to ensure adequate oxygen delivery

Keep mask snug on the face and ensure tubing is free of kinks because the FiO2 is altered if kinking occurs or if the mask fits poorly

Assess nasal mucosa for irritation; humidity or aerosol can be added to the system as needed

Partial rebreather mask (mask with reservoir bag)

6-15 L/ min oxygen flow for FiO2 of 70%-90% The client rebreathes one-third of the exhaled tidal volume, which is high in oxygen, thus providing a high FiO2

Adjust flow rate to keep the reservoir bag two-thirds full during inspiration

Keep mask snug on face Make sure the reservoir bag does not twist or kink Deflation of the bag results in decreased oxygen delivered

and rebreathing of exhaled air

Nonrebreather mask (see Fig. 54-6)

FiO2 of 60%-100% at a rate of flow that maintains the bag two-thirds full

Adjust flow rate to keep the reservoir bag inflated. Keep mask snug on the face

Remove mucus and saliva from the mask Provide emotional support to decrease anxiety in the client

who feels claustrophobic Ensure that the valves and flaps are intact and functional

during each breath (valves should open during expiration and close during inhalation)

Make sure the reservoir bag does not twist or kink or that the oxygen source does not disconnect; otherwise, the client will suffocate

Tracheostomy collar and T-bar or T-piece (face tent; face shield) (see Fig. 54-7)

The tracheostomy collar can be used to deliver the desired amount of oxygen to a client with a tracheostomy

A special adaptor (T-bar or T-piece) can be used to deliver any desired FiO2 to client with tracheostomy, laryngectomy, or endotracheal tube

The face tent provides 8-12 L/ min and the FiO2 varies due to environmental loss

Ensure that aerosol mist escapes from the vents of the delivery system during inspiration and expiration

Empty condensation from the tubing to prevent the client from being lavaged with water and to promote an adequate oxygen flow rate (remove and clean the tubing at least every 4 hr)

Keep the exhalation port in the T-piece open and uncovered (if the port is occluded, the client can suffocate)

Position the T-piece so that it does not pull on the tracheostomy or endotracheal tube and cause erosion of the skin at the tracheostomy insertion site

CO2, Carbon dioxide; FiO2, fraction of inspired oxygen.

714 UNIT XII Respiratory Disorders of the Adult Client

C. Gen eral in terven tion s 1. Assess color, pulse oxim etry readin g, an d vital

sign s before an d durin g treatm en t. 2. Place an Oxygen in Use sign at th e clien t’s bed side. 3. Assess for th e presen ce of ch ron ic lun g problem s. 4. Hum idify th e oxygen if in dicated. 5. For specific in terven tion s for each supp lem en tal

oxygen delivery system , see Table 54-1.

A client who is hypoxemic and has chronic hypercapnia requires low levels of oxygen delivery at 1 to 2 L/ minute because a low arterial oxygen level is the client’s primary drive for breathing.

V. Mechanical Ventilation A. Types

1. Pressure-cycled ven tilator: Th e ven tilator push es air in to th e lu n gs un til a specific airway pressure

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

From oxyge n s ource

Na s a l prongs

FIGURE 54-3 A nasal cannula (prongs).

BOX 54-6 Nasal High-Flow (NHF) Respiratory Therapy

▪ Comfortably delivers high flows of heated and humidified oxygen through a wide-bore nasal cannula and humidifica- tion system

▪ Can deliver nasal flow rates up to 50 to 60 L/ minute to deliver humidified high-flow oxygen therapy

Me ta l pie ce conforms to s ha pe of nos e

From oxyge n s ource

Exha la tion ports

S tra p

FIGURE 54-4 A simple face mask used to deliver oxygen.

Fle xible tube

Re mova ble a da pte r

100% oxyge n

Air e ntra inme nt port

Entra pme nt room a ir

Inha le d mixture of 100% oxyge n a nd room a ir

Exha la tion ports

S tra p

FIGURE 54-5 A Venturi mask for precise oxygen delivery.

Fla ps ove r e xha la tion ports (one -wa y)

One -wa y va lve

FIGURE 54-6 A nonrebreather mask.

715CHAPTER 54 Respiratory System

is reach ed; it is used for sh o rt periods, as in th e postan esth esia care un it.

2. Tim e-cycled ven tilator: Th e ven tilator push es air in to th e lun gs un til a preset tim e h as elapsed; it is used for th e pediatric or n eon atal clien t.

3. Volum e-cycled ven tilator a . Th e ven tilator push es air in to th e lun gs un til

a preset volum e is delivered. b . A con stan t tid al volum e is delivered regard-

less of th e ch an gin g com plian ce of th e lu n gs an d ch est wall or th e airway resistan ce in th e clien t or ven tilator.

4. Microprocessor ven tilator a . A com pu ter or m icroprocessor is built in to

th e ven tilator to allow con tin uous m on itor- in g of ven tilatory fun ction s, alarm s, an d cli- en t param eters.

b . Th is typ e of ven tilator is m ore respo n sive to clien ts wh o h ave severe lun g disease or require prolon ged wean in g.

B. Mod es of ven tilation 1. Non in vasive positive pressure ven tilation or

BiPAP (Fig. 54-8) a . Ven tilatory support given with ou t usin g an

in vasive artificial airway (en d otrach eal tube or trach eo stom y tube); orofacial m asks an d n asal m asks are used in stead.

b . An in spiratory positive airway pressure (IPAP) an d an expiratory positive airway pressure (EPAP) are set on a large ven tilator or a sm all flow gen erator ven tilator with a desired pres- sure support an d positive en d-expiratory pres- sure (PEEP) level. Th is allows m ore air to m ove in to an d out of th e lun gs with out th e n orm al m uscular activity n eeded to do so.

c. Can be used in certain situation s of CO PD distress, h eart failure, asthma, pulm o n ary edem a, an d h ypercap n ic respiratory failure

A resuscitation bag should be available at the bed- side for all clients receiving mechanical ventilation.

2. Con trolled a . Th e clien t receives a set tidal volu m e at a

set rate. b . Used for clien ts wh o can n ot in itiate respira-

tory effort. c. Least used m od e; if th e clien t attem pts to in i-

tiate a breath , th e ven tilator lo cks out th e clien t’s in spiratory effort.

3. Assist-con trol a . Most com m on ly used m od e b . Tidal vo lum e an d ven tilatory rate are preset

on th e ven tilator. c. Th e ven tilator takes over th e work of breath -

in g for th e clien t. d . Th e ven tilator is program m ed to respo n d to

th e clien t’s in spiratory effort if th e clien t does in itiate a breath .

e. Th e ven tilator delivers th e preset tidal volu m e wh en th e clien t in itiates a breath wh ile allowin g th e clien t to con trol th e rate of breath in g.

f. If th e clien t’s spon tan eous ven tilatory rate in creases, th e ven tilator con tin ues to deliver a preset tidal volum e with each breath , wh ich m ay cau se h yperven tilation an d respiratory alkalosis.

4. Syn ch ron ized in term itten t m an d atory ven tila- tio n (SIMV) a . Sim ilar to assist-con trol ven tilation in th at

th e tidal volum e an d ven tilatory rate are pre- set on th e ven tilator

b . Allows th e clien t to breath e spon tan eously at h er or h is own rate an d tidal vo lum e between th e ven tilator breath s

c. Can be used as a prim ary ven tilatory m od e or as a wean in g m od e

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

Endotra che a l tube

15-mm a da pte r

Fle xible tubing from oxyge n s ource

T-pie ce a da pte r

Re s e rvoir tube

FIGURE 54-7 A T-piece apparatus for attachment to an endotracheal tube or tracheostomy tube.

FIGURE 54-8 A BiPAP (bilevel positive airway pressure) system using a nasal mask for pressure- and volume-controlled ventilation.

716 UNIT XII Respiratory Disorders of the Adult Client

d . Wh en SIMV is used as a wean in g m od e, th e n um ber of SIMV breath s is decreased gradu- ally, an d th e clien t gradually resum es spon ta- n eous breath in g.

C. Ven tilator con trols an d settin gs ( Table 54-2) D. In terven tion s

For a client receiving mechanical ventilation, always assess the client first and then assess the ventilator.

1. Assess vital sign s, lun g soun ds, respiratory sta- tus, an d breath in g pattern s (th e clien t will n ever breath e at a rate lower th an th e rate set on th e ven tilator).

2. Mon itor skin color, particularly in th e lips an d n ail beds.

3. Mon itor th e ch est for bilateral expan sio n . 4. O btain pulse oxim etry readin gs. 5. Mon itor ABG results. 6. Assess th e n eed for suction in g an d observe th e

type, color, an d am oun t of secretio n s. 7. Assess ven tilator settin gs. 8. Assess th e level of water in th e h um idifier an d

th e tem perature of th e h um idification system because extrem es in tem perature can dam age th e m ucosa in th e airway.

9. En sure th at th e alarm s are set. 10. If a cause for an alarm can n ot be determ in ed,

ven tilate th e clien t m an ually with a resuscita- tion bag un til th e problem is corrected.

11. Em pty th e ven tilator tubin g wh en m oisture collects.

12. Turn th e clien t at least every 2 h ours or get th e clien t out of bed , as prescribed , to preven t co m - plication s of im m ob ility.

13. Have resuscitation equ ipm en t available at th e bedside.

14. Refer to Ch apter 20 for en dotrach eal tube an d trach eo stom y tube care.

E. Causes of ven tilator alarm s ( Box 54-7) F. Alarm safety an d alarm fatigue

1. It is th e respon sibility of th e n urse to be alert to th e soun d of an alarm because th is sign als a cli- en t problem .

2. Th e n urse n eeds to respo n d prom ptly to an alarm an d im m ediately assess th e clien t.

3. Accordin g to Th e Join t Com m ission (TJC), th e m ost com m on con tribu tin g facto r related to alarm -related sen tin el even ts is alarm fatigue, wh ich results wh en th e n um erous alarm s an d th e resultin g n oise ten ds to desen sitize th e n urs- in g staff an d cause th em to ign ore alarm s or even disable th em .

4. Som e recom m en dation s of TJC in clude estab- lish in g alarm safety as a facility policy, iden tify- in g default alarm settin gs, iden tifyin g th e m ost im portan t alarm s to m an age, establish in g

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

TABLE 54-2 Ventilator Controls and Settings and Descriptions

Controls and Settings Descriptions

Tidal volume The volume of air that the client receives with each breath

Rate The number of ventilator breaths delivered per minute

Sighs The volumes of air that are 1.5 to 2 times the set tidal volume, delivered 6 to 10 times per hour; may be used to prevent atelectasis

Fraction of inspired oxygen (FiO2)

The oxygen concentration delivered to the client; determined by the client’s condition and ABG levels

Peak airway inspiratory pressure

The pressure needed by the ventilator to deliver a set tidal volume at a given compliance

Monitoring peak airway inspiratory pressure reflects changes in compliance of the lungs and resistance in the ventilator or client

Continuous positive airway pressure

The application of positive airway pressure throughout the entire respiratory cycle for spontaneously breathing clients

Keeps the alveoli open during inspiration and prevents alveolar collapse; used primarily as a weaning modality

No ventilator breaths are delivered, but the ventilator delivers oxygen and provides monitoring and an alarm system; the respiratory pattern is determined by the client’s efforts

Positive end-expiratory pressure (PEEP)

Positive pressure is exerted during the expiratory phase of ventilation, which improves oxygenation by enhancing gas exchange and preventing atelectasis

The need for PEEP indicates a severe gas exchange disturbance

Higher levels of PEEP (more than 15 cm H2O) increase the chance of complications, such as barotrauma tension pneumothorax

Pressure support The application of positive pressure on inspiration that eases the workload of breathing

May be used in combination with PEEP as a weaning method

As the weaning process continues, the amount of pressure applied to inspiration is gradually decreased

ABG, Arterial blood gas.

717CHAPTER 54 Respiratory System

policies an d proced ures for m an agin g alarm s, an d staff edu cation .

5. For addition al in form ation , refer to www. pwrn ewm edia.co m / 2013/ join t_co m m ission / m edical_alarm _safety/ down loads/ SEA_50_ alarm s.pdf.

Never set ventilator alarm controls to the off position.

G. Com plication s 1. Hypoten sion caused by th e application of posi-

tive pressure, wh ich in creases in trath o racic pressure an d in h ibits blood return to th e h eart

2. Respiratory com plication s such as pn eum oth o- rax or subcutan eous emphysema as a result of positive pressure

3. Gastroin testin al alteration s such as stress ulcers 4. Maln utrition if n utrition is n ot m ain tain ed 5. In fection s 6. Muscular deco n dition in g 7. Ven tilator dep en den ce or in ability to wean

H. Wean in g: Process of goin g from ven tilator dep en - den ce to spon tan eous breath in g 1. SIMV

a . Th e clien t breath es between th e preset breath s per m in ute rate of th e ven tilator.

b . Th e SIMV rate is decreased gradually un til th e clien t is breath in g on h is or h er own with out th e use of th e ven tilator.

2. T-piece a . Th e clien t is taken off th e ven tilator an d th e

ven tilator is replaced with a T-p iece or CPAP, wh ich delivers h um idified oxygen .

b . Th e clien t is taken off th e ven tilator for sh ort periods in itially an d allowed to breath e spon tan eously.

c. Wean in g progresses as th e clien t is able to tolerate progressively lon ger periods off th e ven tilator.

3. Pressure support a . Pressure supp ort is a predeterm in ed pressure

set on th e ven tilator to assist th e clien t in respiratory effort.

b . As wean in g con tin ues, th e am oun t of pres- sure is decreased gradually.

c. With pressure support, pressure m ay be m ain tain ed wh ile th e preset breath s per m in u te of th e ven tilator are decreased gradually.

VI. Chest Injuries A. Rib fracture

1. Description a . Resu lts from direct blun t ch est traum a

an d cau ses a poten tial for in trath o racic in jury, such as pn eum oth orax or pulm on ary con tusion

b . Pain with m ovem en t an d ch est splin tin g results in im paired ven tilation an d in ade- quate clearan ce of secretio n s.

2. Assessm en t a. Pain an d ten dern ess at th e in jury site th at

in creases with in spiration b . Sh allow respiration s c. Clien t splin ts ch est d . Fractures n oted on ch est x-ray

3. In terven tion s a. Note th at th e ribs usually reun ite spon tan e-

ously. b . Place th e clien t in a Fowler’s position . c. Adm in ister pain m ed ication as prescribed to

m ain tain adequate ven tilatory status. d . Mon itor for in creased respiratory distress. e. In struct th e clien t to self-sp lin t with th e

h an ds, arm s, or a pillow. f. Prepare th e clien t for an in tercostal n erve

block as prescribed if th e pain is severe. B. Flail ch est

1. Description a. Occurs from blun t ch est traum a associated with

accidents, wh ich m ay result in h em othorax an d rib fractures.

b . Th e loose segm en t of th e ch est wall beco m es paradoxical to th e expan sio n an d con traction of th e rest of th e ch est wall.

2. Assessm en t a. Paradoxical respiration s (in ward m ovem en t

of a segm en t of th e th o rax durin g in spiration with outward m ovem en t durin g expiration )

b . Severe pain in th e ch est c. Dyspn ea d . Cyan osis e. Tach ycardia f. Hypoten sion g. Tach ypn ea, sh allow respiration s h . Dim in ish ed breath soun ds

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

BOX 54-7 Causes of Ventilator Alarms High-Pressure Alarm ▪ Increased secretions are in the airway. ▪ Wheezing or bronchospasm is causing decreased airway

size. ▪ The endotracheal tube is displaced. ▪ The ventilator tube is obstructed because of water or a kink

in the tubing. ▪ Client coughs, gags, or bites on the oral endotracheal tube. ▪ Client is anxious or fights the ventilator. Low-Pressure Alarm ▪ Disconnection or leak in the ventilator or in the client’s air-

way cuff occurs. ▪ The client stops spontaneous breathing.

718 UNIT XII Respiratory Disorders of the Adult Client

3. In terven tion s a . Main tain th e clien t in a Fowler’s position . b . Adm in ister oxygen as prescribed. c. Mon itor for in creased respiratory distress. d . En cou rage cough in g an d deep breath in g. e. Adm in ister pain m edication as prescribed. f. Main tain bed rest an d lim it activity to reduce

oxygen dem an ds. g. Prepare for in tub ation with mechanical venti-

lation, with PEEP for severe flail ch est associ- ated with respiratory failure an d sh ock.

C. Pulm o n ary con tusion 1. Description

a . Ch aracterized by in terstitial h em orrh age asso- ciated with in traalveolar h em orrh age, result- in g in decreased pulm on ary com plian ce

b . Th e m ajo r com plication is acu te respiratory distress syn drom e.

2. Assessm en t a . Dysp n ea b . Restlessn ess c. In creased bron ch ial secretio n s d . Hypoxem ia e. Hem o ptysis f. Decreased breath soun ds g. Crackles an d wh eezes

3. In terven tion s a . Main tain a paten t airway an d adequate

ven tilation . b . Place th e clien t in a Fowler’s position . c. Adm in ister oxygen as prescribed. d . Mon itor for in creased respiratory distress. e. Main tain bed rest an d lim it activity to reduce

oxygen dem an ds. f. Prepare for m ech an ical ven tilation with PEEP

if required. D. Pneumothorax (Fig. 54-9)

1. Description a . Accum u lation of atm osp h eric air in th e pleu-

ral space, wh ich results in a rise in in trath o- racic pressure an d reduced vital cap acity

b . Th e loss of n egative in trapleural pressure results in collapse of th e lun g.

c. A spon tan eous pn eum oth orax occurs with th e rupture of a pulm o n ary bleb.

d . An open pn eum oth orax occurs wh en an open in g th rough th e ch est wall allows th e en tran ce of positive atm osp h eric air pressure in to th e pleural space.

e. A ten sion pn eum oth orax occurs fro m a blun t ch est in jury or fro m m ech an ical ven tilation with PEEP wh en a buildup of positive pres- sure occurs in th e pleural space.

f. Diagn osis of pn eum oth orax is m ade by ch est x-ray.

2. Assessm en t ( Box 54-8) 3. In terven tion s

a . Apply a n on po rous dressin g over an open ch est woun d.

b . Adm in ister oxygen as prescribed. c. Place th e clien t in a Fowler’s position . d . Prepare for ch est tube placem en t, wh ich

will rem ain in place un til th e lun g h as expan ded fully.

e. Mon itor th e ch est tube drain age system . f. Mon itor for subcu tan eo us em ph ysem a. g. See Ch apter 20 for in form ation on carin g for

a clien t with ch est tubes.

Clients with a respiratory disorder should be posi- tioned with the head of the bed elevated.

VII. Acute Respiratory Failure A. Description

1. O ccurs wh en in sufficien t oxygen is tran spo rted to th e blood or in adequate carbon dioxide is rem oved from th e lu n gs an d th e clien t’s com pen - satory m ech an ism s fail

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

Outs ide a ir e nte rs be ca us e of dis ruption of che s t wa ll a nd pa rie ta l ple ura

Lung a ir e nte rs be ca us e of

dis ruption of vis ce ra l ple ura

Norma l lung

Che s t wa ll

Dia phra gm Me dia s tinum

P le ura l s pa ce

FIGURE 54-9 Pneumothorax. Air in the pleural space causes the lungs to collapse around the hilus and may push the mediastinal contents (heart and great vessels) toward the other lung.

BOX 54-8 Assessment Findings: Pneumothorax ▪ Absent breath sounds on affected side ▪ Cyanosis ▪ Decreased chest expansion unilaterally ▪ Dyspnea ▪ Hypotension ▪ Sharp chest pain ▪ Subcutaneous emphysema as evidenced by crepitus on

palpation ▪ Sucking sound with open chest wound ▪ Tachycardia ▪ Tachypnea ▪ Tracheal deviation to the unaffected side with tension

pneumothorax

719CHAPTER 54 Respiratory System

2. Causes in clude a m ech an ical abn o rm ality of th e lun gs or ch est wall, a defect in th e respiratory con tro l cen ter in th e brain , or an im pairm en t in th e fun ction of th e respiratory m uscles.

3. In oxygen atio n failure, or h ypoxem ic respiratory failure, oxygen m ay reach th e alveo li but can n ot be ab sorbed or used properly, resultin g in a PaO 2 lower th an 60 m m Hg, arterial oxygen saturation (SaO 2) lower th an 90%, or partial pressure of arterial carbon dioxide (PaCo 2) greater th an 50 m m Hg occurrin g with acidem ia.

4. Man y clien ts exp erien ce both h ypoxem ic an d h ypercap n ic respiratory failure an d retain ed car- bon dioxide in th e alveo li displaces oxygen , con - tributin g to th e h ypoxem ia.

5. Man ifestation s of respiratory failure are related to th e exten t an d rapidity of ch an ge in PaO 2 an d PaCo 2.

B. Assessm en t 1. Dyspn ea 2. Headach e 3. Restlessn ess 4. Con fusion 5. Tach ycardia 6. Hyperten sion 7. Dysrh yth m ias 8. Decreased level of con sciousn ess 9. Alteration s in respiratio n s an d breath soun ds

C. In terven tion s 1. Iden tify an d treat th e cause of th e respiratory

failure. 2. Adm in ister oxygen to m ain tain th e PaO 2 level

h igh er th an 60 to 70 m m Hg. 3. Place th e clien t in a Fowler’s position . 4. En courage deep breath in g. 5. Adm in ister bron ch od ilators as prescribed . 6. Prepare th e clien t for m ech an ical ven tilation if

supplem en tal oxygen can n ot m ain tain accept- able PaO 2 an d PaCo 2 levels.

VIII. Acute Respiratory Distress Syndrome A. Description

1. A form of acute respiratory failure th at occurs as a com plication of som e oth er con ditio n ; it is caused by a diffuse lu n g in jury an d lead s to extra- vascular lun g fluid.

2. Th e m ajo r site of in jury is th e alveo lar cap illary m em bran e.

3. Th e in terstitial edem a causes com pression an d obliteration of th e term in al airways an d leads to reduced lun g vo lum e an d com plian ce.

4. Th e ABG levels iden tify respiratory acido sis an d h ypoxem ia th at do n ot respo n d to an in creased percen tage of oxygen .

5. Th e ch est x-ray shows bilateral in terstitial an d alveolar in filtrates; in terstitial edem a m ay n ot be n oted un til th ere is a 30% in crease in fluid con ten t.

6. Causes in clude sep sis, fluid overload, sh ock, traum a, n eurological in juries, burn s, DIC, drug in gestio n , aspiration , an d in h alation of toxic substan ces.

B. Assessm en t 1. Tach ypn ea 2. Dyspn ea 3. Decreased breath soun ds 4. Deterioratin g ABG levels 5. Hypoxem ia despite h igh con cen tration s of deliv-

ered oxygen 6. Decreased pulm on ary com plian ce 7. Pulm on ary in filtrates

C. In terven tion s 1. Iden tify an d treat th e cau se of th e acu te respira-

tory distress syn drom e. 2. Adm in ister oxygen as prescribed . 3. Place th e clien t in a Fowler’s position . 4. Restrict fluid in take as prescribed . 5. Provide respiratory treatm en ts as prescribed. 6. Adm in ister diuretics, an ticoagulan ts, or cortico -

steroids as prescribed. 7. Prepare th e clien t for in tub ation an d m ech an ical

ven tilation usin g PEEP.

IX. Asthma (Fig. 54-10) A. Descrip tion

1. Ch ron ic in flam m atory disorder of th e airways th at causes varyin g degrees of obstruction in th e airways

2. Marked by airway in flam m ation an d h yperre- spon siven ess to a variety of stim uli or triggers (Box 54-9).

3. Causes recurren t episo des of wh eezin g, breath - lessn ess, ch est tigh tn ess, an d cough in g associated with airflow obstru ction th at m ay resolve spon ta- n eously; it is often reversible with treatm en t.

4. Severity is classified based on th e clin ical features before treatm en t ( Box 54-10).

5. Status asth m aticus is a severe life-th reaten in g asthma episo de th at is refracto ry to treatm en t an d m ay result in pn eum oth orax, acute cor pul- m on ale, or respiratory arrest.

6. Refer to Ch apter 39 for addition al in form ation on asth m a.

B. Assessm en t 1. Restlessn ess 2. Wh eezin g or crackles 3. Absen t or dim in ish ed lun g soun ds 4. Hyperreson an ce 5. Use of accessory m uscles for breath in g 6. Tach ypn ea with h yperven tilation 7. Prolon ged exh alatio n 8. Tach ycardia 9. Pulsus paradoxu s

10. Diaph oresis 11. Cyan osis 12. Decreased oxygen saturatio n

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

720 UNIT XII Respiratory Disorders of the Adult Client

13. Pulm o n ary fun ction test results th at dem on - strate decreased airflow rates

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor pulse oxim etry. 3. Mon itor peak flow. 4. Du rin g an acute asth m a episo de, provide in ter-

ven tio n s to assist with breath in g (Box 54-11). D. Clien t education

1. O n th e in term itten t n ature of sym ptom s an d n eed for lon g-term m an agem en t

2. To id en tify possible triggers an d m easu res to pre- ven t episodes

3. Abou t th e m an agem en t of m edication an d proper adm in istration

4. Abou t th e correct use of a peak flowm eter 5. Abou t developin g an asth m a action plan with

th e prim ary HCP an d wh at to do if an asth m a episo de occurs

X. Chronic Obstructive Pulmonary Disease A. Description

1. Also kn own as ch ron ic obstru ctive lun g disease an d ch ron ic airflow lim itation

2. Chronic obstructive pulmonary disease is a disease state ch aracterized by airflow obstru ction cau sed by em ph ysem a or ch ron ic bron ch itis.

3. Progressive airflow lim itation occurs, associated with an abn orm al in flam m ato ry respo n se of th e lun gs th at is n ot co m pletely reversible.

4. CO PD leads to pulm o n ary in sufficien cy, pulm o- n ary h yperten sio n , an d cor pulm o n ale.

B. Assessm en t 1. Cough 2. Exertion al dyspn ea 3. Wh eezin g an d crackles 4. Sputu m produ ction 5. Weigh t loss 6. Barrel ch est (em ph ysem a) (Fig. 54-11)

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

BOX 54-9 Asthma Triggers Environmental Factors ▪ Animal dander ▪ Cockroaches ▪ Dust ▪ Exhaust fumes ▪ Fireplaces ▪ Molds ▪ Perfumes or other products with aerosol sprays ▪ Pollen ▪ Smoke, including cigarette or cigar smoke ▪ Sudden weather changes Physiological Factors ▪ Gastroesophageal reflux disease (GERD) ▪ Hormonal changes ▪ Sinusitis ▪ Stress ▪ Viral upper respiratory infection Medications ▪ Acetylsalicylic acid (aspirin) ▪ β-Adrenergic blockers ▪ Nonsteroidal antiinflammatory drugs Occupational Exposure Factors ▪ Metal salts ▪ Wood and vegetable dusts ▪ Industrial chemicals and plastics Food Additives ▪ Sulfites (bisulfites and metabisulfites) ▪ Beer, wine, dried fruit, shrimp, processed potatoes ▪ Monosodium glutamate

From Lewis S, Dirksen S, Heitkemper M, Bucher L, Camera I: Medical-surgical nurs- ing: assessment and management of clinical problems, ed 8, St. Louis, 20 11, Mosby.

Trig g e rs *

• Bronchia l hype rre a ctivity • Infiltra tion with e os inophils

a nd ne utrophils • Infla mma tion*

• Bronchia l s mooth mus cle cons triction*

• Mucos a l e de ma • Mucus s e cre tion • Va s cula r le a ka ge

• Air tra pping • Hypoxe mia • Obs truction of la rge a nd s ma ll a irwa ys • Re s pira tory a cidos is

IgE–ma s t ce ll me dia te d re s pons e

Re le a s e of me dia tors from ma s t ce lls , e os inophils , ma cropha ge s , lymphocyte s

Early-phas e re s po ns e Late -phas e re s po ns e

Infiltra tion with monocyte s a nd lymphocyte s

P e a ks in 5 to 6 hours

Within 1 to 2 da ys

P e a ks in 30 to 60 minute s

• Alle rge ns • Exe rcis e

• Infe ction • Irrita nts

FIGURE 54-10 Pathophysiology in asthma. Stems with asterisks are primary processes. IgE, Immunoglobulin E.

721CHAPTER 54 Respiratory System

7. Use of accesso ry m uscles for breath in g 8. Prolon ged exp iration 9. O rth o pn ea

10. Card iac dysrh yth m ias 11. Con gestion an d h yperin flation seen on ch est

x-ray (Fig. 54-12) 12. ABG levels th at in dicate respiratory acido sis

an d h ypo xem ia 13. Pulm o n ary fun ction tests th at dem on strate

decreased vital cap acity

C. In terven tion s 1. Mon itor vital sign s. 2. Adm in ister a con cen tration of oxygen based

on ABG values an d oxygen saturation by pulse oxim etry as prescribed.

3. Mon itor pulse oxim etry. 4. Provide respiratory treatm en ts an d CPT. 5. In struct th e clien t in diap h ragm atic or abdom -

in al breath in g tech n iqu es an d pursed-lip breath in g tech n iqu es, wh ich in crease airway pressure an d keep air passages open , prom o tin g m axim al carbo n dioxide expiration .

6. Record th e color, am oun t, an d con sisten cy of sputum .

7. Suction th e clien t’s lun gs, if n ecessary, to clear th e airway an d preven t in fectio n .

8. Mon itor weigh t. 9. En courage sm all, frequen t m eals to m ain tain

n utrition an d preven t dyspn ea. 10. Provide a h igh -calorie, h igh -protein diet with

supplem en ts. 11. En courage fluid in take up to 3000 m L/ day to

keep secretion s th in , un less con train d icated. 12. Place th e clien t in a Fowler’s position an d lean -

in g forward to aid in breath in g (Fig. 54-13). 13. Allow activity as tolerated. 14. Adm in ister bron ch od ilators as prescribed, an d

in struct th e clien t in th e use of oral an d in h alan t m edication s.

15. Adm in ister cortico steroids as prescribed for exacerb ation s.

16. Adm in ister m ucolytics as prescribed to th in secretio n s.

17. Adm in ister an tibiotics for in fection if prescribed. D. Clien t edu cation (Box 54-12)

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

BOX 54-10 Classification of Asthma Severity Severe Persistent ▪ Symptoms are continuous. ▪ Physical activity requires limitations. ▪ Frequent exacerbations occur. ▪ Nocturnal symptoms occur frequently. Moderate Persistent ▪ Daily symptoms occur. ▪ Daily use of inhaled short-acting β-agonist is needed. ▪ Exacerbations affect activity. ▪ Exacerbations occur at least twice weekly and may last for

days. ▪ Nocturnal symptoms occur more frequently than once

weekly.

Mild Persistent ▪ Symptoms occur more frequently than twice weekly but

less often than once daily. ▪ Exacerbations may affect activity. ▪ Nocturnal symptoms occur more frequently than twice a

month.

Mild Intermittent ▪ Symptoms occur twice weekly or less. ▪ Client is asymptomatic between exacerbations. ▪ Exacerbations are brief (hours to days). ▪ Intensity of exacerbations varies. ▪ Nocturnal symptoms occur twice a month or less.

From Ignatavicius D, Workm an M: Medical-surgical nursing: patient-centered collabo- rative care, ed 7, St. Louis, 20 13, Saunders.

BOX 54-11 Nursing Interventions During an Acute Asthma Episode

Position the client in a high Fowler’s position or sitting to aid in breathing.

Administer oxygen as prescribed. Stay with the client to decrease anxiety. Administer bronchodilators as prescribed. Record the color, amount, and consistency of sputum, if any. Administer corticosteroids as prescribed. Auscultate lung sounds before, during, and after treatments.

FIGURE 54-11 Typical barrel chest in a client with chronic obstructive pulmonary disease.

722 UNIT XII Respiratory Disorders of the Adult Client

XI. Severe Acute Respiratory Syndrome (SARS) A. Respiratory illn ess cau sed by a coron avirus, called

SARS-associated coronavirus B. Th e syn d rom e begin s with a fever, an overall feelin g

of discom fort, body ach es, an d m ild respiratory sym pto m s.

C. After 2 to 7 days, th e clien t m ay develop a dry co ugh an d dyspn ea.

D. In fection is spread by close person -to -perso n con tact by direct con tact with in fectio us m aterial (respirato ry secretio n s from in fected perso n s or con - tact with objects con tam in ated with in fectio us droplets).

E. Preven tion in cludes avoidin g con tact with th o se sus- pected of h avin g SARS, avoidin g travel to coun tries wh ere an outbreak of SARS exists, avoidin g clo se con tact with crowds in areas wh ere SARS exists, an d frequen t h an d wash in g if in an area wh ere SARS exists.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

No rmal

Norma l lung infla tion

Norma l dia phra gm curva ture

Chro nic Obs truc tive Pulmo nary Dis e as e

Hype rinfla tion of lungs

Fla tte ne d dia phra gm

FIGURE 54-12 Diaphragm shape and lung inflation in the normal client and in the client with chronic obstructive pulmonary disease.

S itting on the e dge of a be d with the a rms folde d a nd pla ce d on two or thre e pillows pos itione d ove r a nights ta nd.

S itting in a cha ir with the fe e t s pre a d s houlde r-width a pa rt a nd le a ning forwa rd with the e lbows on the kne e s . Arms a nd ha nds a re re la xe d.

FIGURE 54-13 Orthopnea positions that clients with chronic obstructive pulmonary disease can assume to ease the work of breathing.

BOX 54-12 Client Education: Chronic Obstructive Pulmonary Disease

Adhere to activitylimitations, alternating rest periods with activity. Avoid eating gas-producing foods, spicy foods, and extremely

hot or cold foods. Avoid exposure to individuals with infections and avoid crowds. Avoid extremes in temperature. Avoid fireplaces, pets, feather pillows, and other environmen-

tal allergens. Avoid powerful odors. Meet nutritional requirements. Receive immunizations as recommended. Recognize the signs and symptoms of respiratory infection and

hypoxia. Stop smoking. Use medications and inhalers as prescribed. Use oxygen therapy as prescribed. Use pursed-lip and diaphragmatic or abdominal breathing. When dusting, use a wet cloth.

723CHAPTER 54 Respiratory System

XII. Pneumonia A. Description

1. In fection of th e pulm onary tissue, in cludin g th e in terstitial spaces, the alveoli, an d the bron ch ioles.

2. Th e edem a associated with in flam m ation stiffen s th e lun g, decreases lun g com plian ce an d vital capacity, an d causes h ypo xem ia.

3. Pn eum on ia can be com m un ity-acquired or h ospital-acqu ired.

4. Th e ch est x-ray film sh ows lobar or segm en tal con solidatio n , pulm o n ary in filtrates, or pleural effusion s.

5. A sputum culture iden tifies th e organ ism . 6. Th e wh ite blood cell coun t an d th e eryth rocyte

sedim en tatio n rate are elevated. B. Assessm en t

1. Ch ills 2. Elevated tem p erature 3. Pleuritic pain 4. Tach ypn ea 5. Rh on ch i an d wh eezes 6. Use of accesso ry m uscles for breath in g 7. Men tal status ch an ges 8. Sputu m productio n

C. In terven tion s 1. Adm in ister oxygen as prescribed. 2. Mon itor respiratory status. 3. Mon itor for labo red respiration s, cyan osis, an d

cold an d clam m y skin . 4. En cou rage cough in g an d deep breath in g an d

use of th e in cen tive spirom eter. 5. Place th e clien t in a sem i-Fowler’s position to

facilitate breath in g an d lun g expan sio n . 6. Ch an ge th e clien t’s position frequen tly an d

am bulate as tolerated to m obilize secretio n s. 7. Provide CPT. 8. Perform n aso trach eal suction in g if th e clien t is

un ab le to clear secretio n s. 9. Mon itor pulse oxim etry.

10. Mon itor an d record color, con sisten cy, an d am oun t of sputu m .

11. Provide a h igh -calorie, h igh -protein diet with sm all frequen t m eals.

12. En cou rage fluids, up to 3 L/ day, to th in secre- tion s un less con train d icated.

13. Provide a balan ce of rest an d activity, in creasin g activity gradually.

14. Adm in ister an tibiotics as prescribed. 15. Adm in ister an tipyretics, bronch odilators, cough

suppressan ts, m ucolytic agen ts, an d expector- an ts as prescribed.

16. Preven t th e spread of in fectio n by h an d wash - in g an d th e proper disposal of secretio n s.

D. Clien t education 1. Abou t th e im portan ce of rest, proper n utrition ,

an d adequate fluid in take

2. To avoid ch illin g an d exp osure to in dividuals with respiratory in fectio n s or viruses

3. Regardin g m ed ication s an d th e use of in h alan ts as prescribed

4. To n otify th e HCP if ch ills, fever, dyspn ea, h em op tysis, or in creased fatigue occurs

5. To receive a pn eum ococcal vaccin e as recom - m en ded by th e HCP; refer to th e followin g Web site for in form ation about th is vaccin e: h ttp:/ / www. cdc.gov/ vaccin es/ vpd-vac/ pn eum o/ default.h tm .

Teach clients that using proper hand-washing tech- niques, disposing of respiratory secretions properly, and receiving vaccines will assist in preventing the spread of infection.

XIII. Influenza A. Descrip tion

1. Also kn own as th e flu; h igh ly con tagious acute viral respiratory in fectio n

2. May be caused by several viruses, usually kn own as types A, B, an d C

3. Yearly vaccination is recom m en ded to preven t th e disease, especially for th ose older th an 50 years of age, in dividuals with ch ron ic illn ess or who are im m un ocom prom ised, th ose livin g in in stitu- tion s, an d h ealth care person n el providin g direct care to clien ts (th e vaccin ation is con train dicated in th e in dividual with egg allergies).

4. Addition al preven tion m easu res in clude avoid- in g th ose wh o h ave develo ped in fluen za, fre- quen t an d proper h an d wash in g, an d clean in g an d disin fectin g surfaces th at h ave becom e co n - tam in ated with secretio n s.

5. Avian in fluen za A (H5N1) a. Affects birds; does n ot usually affect h um an s;

h owever, h um an cases h ave been reported in som e coun tries.

b . An H5N1 vaccin e h as been developed for use if a pan dem ic virus were to em erge.

c. Reported sym pto m s are sim ilar to th ose asso- ciated with in fluen za types A, B, an d C.

d . Preven tion m easures in clude th orough cook- in g of poultry products, avoidin g con tact with wild anim als, frequen t an d proper h an d wash - in g, an d clean in g an d disin fectin g surfaces th at h ave becom e con tam in ated with secretion s.

6. Swin e (H1N1) in fluen za a. A strain of flu th at con sists of gen etic m ate-

rials from swin e, avian , an d h um an in fluen za viruses

b . Sign s an d sym pto m s are sim ilar to th o se th at presen t with season al flu; in addition , vom it- in g an d diarrh ea com m on ly occur.

c. Preven tion m easu res an d treatm en t are th e sam e as for th e seaso n al flu.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

724 UNIT XII Respiratory Disorders of the Adult Client

B. Refer to Ch apter 55 for in form ation on vaccin es. C. Assessm en t

1. Acute on set of fever an d m uscle ach es 2. Headach e 3. Fatigue, weakn ess, an orexia 4. Sore th roat, cough , an d rh in orrh ea

D. In terven tion s 1. En cou rage rest. 2. En cou rage fluids to preven t pulm o n ary com pli-

cation s (un less con train d icated). 3. Mon itor lun g soun ds. 4. Provide supportive th erap y such as an tipyretics

or an titussives as in dicated. 5. Adm in ister an tiviral m edication s as prescribed for

th e curren t strain of in fluen za (see Ch apter 55).

XIV. Legionnaire’s Disease A. Description

1. Acute bacterial in fectio n caused by Legionella pneumophila

2. Sources of th e organ ism in clude co n tam in ated coolin g tower water an d warm stagn an t water supp lies, in cludin g water vaporizers, water son i- cato rs, wh irlpool spas, an d sh owers.

3. Perso n -to-person con tact does n ot occur; th e risk for in fectio n is in creased by th e presen ce of oth er con d ition s.

B. Assessm en t: In fluen za-like sym ptom s with a h igh fever, ch ills, m uscle ach es, an d h eadach e that m ay pro- gress to dry cough , pleurisy, an d som etim es diarrh ea.

C. In terven tion s: Treatm en t is supp ortive an d an tibi- otics m ay be prescribed.

XV. Pleural Effusion A. Description

1. Pleural effusion is th e collectio n of fluid in th e pleural space.

2. An y con d ition th at in terferes with secretio n or drain age of th is flu id will lead to pleural effusion .

B. Assessm en t 1. Pleuritic pain th at is sh arp an d in creases with

in spiration 2. Progressive dyspn ea with decreased m ovem en t

of th e ch est wall on th e affected side 3. Dry, n on pro ductive co ugh cau sed by bron ch ial

irritation or m ed iastin al sh ift 4. Tach ycardia 5. Elevated tem perature 6. Decreased breath soun ds over affected area 7. Ch est x-ray film th at sh o ws pleural effusion an d

a m ediastin al sh ift away fro m th e fluid if th e effu- sion is m ore th an 250 m L

C. In terven tion s 1. Iden tify an d treat th e un derlyin g cau se. 2. Mon itor breath soun ds. 3. Place th e clien t in a Fowler’s position . 4. En cou rage cough in g an d deep breath in g.

5. Prepare th e clien t for th oracen tesis. 6. If p leu ral effu sio n is recu rren t, p rep are th e

clien t fo r p leu recto m y o r p leu ro d esis as p rescrib ed .

D. Pleurectom y 1. Con sists of surgically strippin g th e parietal

pleura away fro m th e visceral pleura 2. Th is produces an in ten se in flam m atory reaction

th at prom otes adh esion form ation between th e 2 layers durin g h ealin g.

E. Pleurod esis 1. In vo lves th e in stillatio n o f a sclero sin g su b -

stan ce in to th e p leu ral sp ace via a th o raco to m y tu b e

2. Th e substan ce creates an in flam m atory respon se th at scleroses tissue togeth er.

XVI. Empyema A. Description

1. Collection of pus with in th e pleural cavity 2. Th e flu id is th ick, opaqu e, an d foul-sm ellin g. 3. Th e m ost co m m on cau se is pulm o n ary in fectio n

an d lun g abscess caused by th o racic surgery or ch est traum a, in wh ich bacteria are in troduced directly in to th e pleural space.

4. Treatm en t focuses on treatin g th e in fectio n , em p- tyin g th e em p yem a cavity, reexpan d in g th e lu n g, an d con trollin g th e in fectio n .

B. Assessm en t 1. Recen t febrile illn ess or traum a 2. Ch est pain 3. Cough 4. Dysp n ea 5. An o rexia an d weigh t loss 6. Malaise 7. Elevated tem p erature an d ch ills 8. Nigh t sweats 9. Pleural exudate on ch est x-ray

C. In terven tion s 1. Mon itor breath soun ds. 2. Place th e clien t in a sem i-Fowler’s or h igh

Fowler’s position . 3. En cou rage cough in g an d deep breath in g. 4. Adm in ister an tibiotics as prescribed. 5. In struct th e clien t to splin t th e ch est as n ecessary. 6. Assist with th oracen tesis or ch est tube in sertio n

to prom o te drain age an d lun g expan sion . 7. If m arked pleural th icken in g occurs, prepare th e

clien t for decortication , if prescribed ; th is surgi- cal proced ure in volves rem oval of th e restrictive m ass of fib rin an d in flam m ato ry cells.

XVII. Pleurisy A. Description

1. In flam m ation of th e visceral an d parietal m em - bran es; m ay be cau sed by pulm o n ary in farctio n or pn eum on ia.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

725CHAPTER 54 Respiratory System

2. Th e visceral an d parietal m em bran es rub togeth er durin g respiration an d cause pain .

3. Pleurisy usually occurs on 1 side of th e ch est, usually in th e lower lateral portion s in th e ch est wall.

B. Assessm en t 1. Kn ifelike pain aggravated on deep breath in g an d

cough in g 2. Dysp n ea 3. Pleural friction rub h eard on auscultation

C. In terven tion s 1. Iden tify an d treat th e cau se. 2. Mon itor lun g soun ds. 3. Adm in ister an algesics as prescribed . 4. Apply h ot or co ld ap plication s as prescribed. 5. En cou rage cough in g an d deep breath in g. 6. In struct th e clien t to lie on th e affected side to

splin t ch est.

XVIII. Pulmonary Embolism A. Description

1. O ccurs wh en a th rom bus form s (m ost com - m on ly in a deep vein ) , detach es, travels to th e righ t side of th e h eart, an d th en lodges in a bran ch of th e pulm o n ary artery

2. Clien ts pron e to pulm o n ary em bolism are th o se at risk for deep vein th rom bosis, in cludin g th o se with prolon ged im m ob ilization , surgery, obe- sity, pregn an cy, h eart failure, advan ced age, or a h isto ry of th rom boem bo lism .

3. Fat em b oli can occur as a com plication followin g fracture of a lon g bon e an d can cause pulm o n ary em b oli.

4. Treatm en t is aim ed at preven tion th rou gh risk facto r recogn ition an d elim in ation .

B. Assessm en t (Box 54-13) C. In terven tion s (see Priority Nursin g Action s)

XIX. Lung Cancer and Laryngeal Cancer A. See Ch apter 48 for m ore in form ation

XX. Carbon Monoxide Poisoning A. See Ch apter 46 for m ore in form ation

XXI. Histoplasmosis A. Descrip tion

1. Pulm o n ary fun gal in fectio n cau sed by spores of Histoplasma capsulatum

2. Tran sm ission occurs by th e in h alation of spores, wh ich com m on ly are foun d in con tam in ated soil.

3. Spores also are usually foun d in bird droppin gs. B. Assessm en t

1. Sim ilar to pn eum on ia 2. Positive skin test for h istoplasm osis 3. Positive agglutin ation test 4. Splen om egaly, h epatom egaly

C. In terven tion s 1. Adm in ister oxygen as prescribed. 2. Mon itor breath soun ds.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

BOX 54-13 Assessment Findings: Pulmonary Embolism

▪ Apprehension and restlessness ▪ Blood-tinged sputum ▪ Chest pain ▪ Cough ▪ Crackles and wheezes on auscultation ▪ Cyanosis ▪ Distended neck veins ▪ Dyspnea accompanied by anginal and pleuritic pain,

exacerbated by inspiration ▪ Feeling of impending doom ▪ Hypotension ▪ Petechiae over the chest and axilla ▪ Shallow respirations ▪ Tachypnea and tachycardia

PRIORITY NURSING ACTIONS Suspected Pulmonary Embolism

1. Notify the Rapid Response Team and health care provider (HCP).

2. Reassure the client and elevate the head of the bed. 3. Prepare to administer oxygen. 4. Obtain vital signs and check lung sounds. 5. Prepare to obtain an arterial blood gas. 6. Prepare for the administration of heparin therapy or other

therapies. 7. Document the event, interventions taken, and the client’s

response to treatment.

Signs and symptoms of a pulmonary embolism include the sudden onset of dyspnea, apprehension and restlessness, a feeling of impending doom, cough, hemoptysis, tachypnea, crackles, petechiae over the chest and axillae, and a decreased arterial oxygen saturation. If suspected, the nurse immediately notifies the Rapid Response Team and HCP. The nurse stays with the client, reassures the client, and ele- vates the head of the bed. The nurse prepares to administer oxygen and obtains the vital signs and checks lung sounds. The nurse continues to monitor the client closely, prepares the client for tests prescribed to confirm the diagnosis, and prepares to obtain an arterial blood gas. When pre- scribed, the client is prepared for the administration of hep- arin therapy or other therapies such as embolectomy or placement of a vena cava filter if necessary. Finally, the nurse documents the event, the interventions taken, and the client’s response to treatment.

Reference Ignatavicius, Workman (2016), p. 606.

726 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

3. Adm in ister an tiem etics, an tih istam in es, an tipy- retics, an d cortico steroids as prescribed.

4. Adm in ister fun gicidal m edication s as prescribed . 5. En cou rage co ugh in g an d deep breath in g. 6. Place th e clien t in a sem i-Fowler’s position . 7. Mon itor vital sign s. 8. Mon itor for n eph ro toxicity from fun gicidal

m ed ication s. 9. In struct th e clien t to wear a m ask an d spray th e

flo or with water befo re sweepin g barn an d ch icken coops.

XXII. Sarcoidosis A. Description

1. Presen ce of epith elioid cell tubercles in th e lu n g 2. Th e cause is un kn own , but a h igh titer of Epstein -

Barr virus m ay be n oted. 3. Viral in ciden ce is h igh est in African Am erican s

an d youn g adults. B. Assessm en t

1. Nigh t sweats 2. Fever 3. Weigh t loss 4. Cough an d dyspn ea 5. Skin n odules 6. Polyarth ritis 7. Kveim test: Sarcoid n ode an tigen is in jected in tra-

derm ally an d causes a local n odular lesion in ab out 1 m on th .

C. In terven tion s 1. Adm in ister cortico steroids to con trol sym pto m s. 2. Mon itor tem perature. 3. In crease flu id in take. 4. Provide frequen t periods of rest. 5. En cou rage sm all, frequen t, n utritiou s m eals.

XXIII. Occupational Lung Disease A. Description

1. Cau sed by exp osure to en viron m en tal or occupa- tio n al fum es, dust, vapors, gases, bacterial or fun - gal an tigen s, an d allergen s; can result in acu te reversible effects or ch ron ic lun g disease

2. Com m on disease classification s in clude occupa- tio n al asth m a pn eum ocon io sis (silicosis or coal m in er’s [black lun g] disease), diffuse in terstitial fib rosis (asbesto sis, talcosis, berylliosis), or extrin sic allergic alveolitis (farm er’s lun g, bird fan cier’s lun g, or m ach in e operato r’s lu n g).

B. Assessm en t: Man ifestation s depen d on th e type of disease an d respiratory sym pto m s.

C. In terven tion s 1. Preven tion th rough th e use of respiratory protec-

tive devices 2. Treatm en t is based on th e sym pto m s experien ced

by th e clien t.

XXIV. Tuberculosis A. Description

1. High ly com m un icable disease caused by Myco- bacterium tuberculosis

2. M. tuberculosis is a n on m otile, n on sp orulatin g, acid-fast ro d th at secretes n iacin ; wh en th e bacil- lus reach es a susceptible site, it m ultiplies freely.

3. Becau se M. tuberculosis is an aerobic bacterium , it prim arily affects th e pulm o n ary system , esp e- cially th e upper lobes, wh ere th e oxygen con ten t is h igh est, but also can affect oth er areas of th e body, such as th e brain , in testin es, periton eum , kidn ey, join ts, an d liver.

4. An exudative respon se cau ses a n on specific pn eum on itis an d th e developm en t of gran ulo- m as in th e lu n g tissue.

5. Tuberculosis h as an in sidiou s on set, an d m an y clien ts are n ot aware of sym pto m s un til th e dis- ease is well advan ced .

6. Im pro per or n on com plian t use of treatm en t pro- gram s m ay cau se th e develo pm en t of m utation s in th e tubercle bacilli, resultin g in a multidrug- resistant strain of tuberculosis (MDR-TB).

7. Th e go al of treatm en t is to preven t tran sm ission , con trol sym ptom s, an d preven t progression of th e disease.

B. Risk factors ( Box 54-14) C. Tran sm ission

1. Via th e airborn e route by droplet in fectio n . 2. Wh en an in fected in dividual cough s, laugh s,

sn eezes, or sin gs, droplet n uclei con tain in g tuberculosis bacteria en ter th e air an d m ay be in h aled by oth ers.

3. Iden tification of th ose in close co n tact with th e in fected in dividual is im portan t so th at th ey can be tested an d treated as n ecessary.

4. Wh en con tacts h ave been iden tified, th ese per- son s are assessed with a tuberculin skin test

BOX 54-14 Risk Factors for Tuberculosis ▪ Child younger than 5 years of age ▪ Drinking unpasteurized milk if the cow is infected with

bovine tuberculosis ▪ Homeless individuals or those from a lower socioeco-

nomic group, minority group, or refugee group ▪ Individuals in constant, frequent contact with an untreated

or undiagnosed individual ▪ Individuals living in crowded areas, such as long-term care

facilities, prisons, and mental health facilities ▪ Older client ▪ Individuals with malnutrition, infection, immune dysfunc-

tion, or human immunodeficiency virus infection; or immunosuppressed as a result of medication therapy

▪ Individuals who abuse alcohol or are intravenous drug users

727CHAPTER 54 Respiratory System

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

an d ch est x-rays to determ in e in fectio n with tuberculosis.

5. After th e in fected in dividual h as received tuber- culosis m edication for 2 to 3 weeks, th e risk of tran sm ission is reduced greatly.

D. Disease progression 1. Drop lets en ter th e lun gs, an d th e bacteria form a

tubercle lesion . 2. Th e defen se system s of th e body en capsulate th e

tubercle, leavin g a scar. 3. If en cap sulation does n ot occur, bacteria m ay

en ter th e lym p h system , travel to th e lym p h n odes, an d cause an in flam m atory respo n se term ed granulomatous inflammation.

4. Prim ary lesion s form ; th e prim ary lesion s m ay beco m e dorm an t but can be reactivated an d beco m e a secon dary in fectio n wh en reexposed to th e bacterium .

5. In an active ph ase, tubercu losis can cau se n ecro- sis an d cavitatio n in th e lesion s, leadin g to rup- ture, th e spread of n ecro tic tissue, an d dam age to various parts of th e body.

E. Clien t h istory 1. Past exposu re to tuberculosis 2. Clien t’s coun try of origin an d travel to foreign

coun tries in wh ich th e in ciden ce of tuberculosis is h igh

3. Recen t h istory of in fluen za, pn eum on ia, febrile ill- n ess, cough , or foul-sm ellin g sputum production

4. Previous tests for tubercu losis; results of th e testin g

5. Recen t bacillus Calmette-Guérin (BCG) vaccine (a vaccin e con tain in g atten uated tubercle bacilli th at m ay be given to perso n s in foreign coun tries or to person s travelin g to foreign coun tries to produ ce in creased resistan ce to tuberculo sis).

An individual who has received a BCG vaccine will have a positive tuberculin skin test result and should be evaluated for tuberculosis with a chest x-ray.

F. Clin ical m an ifestatio n s 1. May be asym ptom atic in prim ary in fection 2. Fatigue 3. Leth argy 4. An o rexia 5. Weigh t loss 6. Low-grade fever 7. Ch ills 8. Nigh t sweats 9. Persisten t cough an d th e produ ction of m ucoid

an d m ucop urulen t sputum , wh ich is occasion - ally streaked with blood

10. Ch est tigh tn ess an d a dull, ach in g ch est pain m ay acco m pan y th e cough .

G. Ch est assessm en t 1. A ph ysical exam in ation of th e ch est does n ot pro-

vide con clusive eviden ce of tubercu losis.

2. A ch est x-ray is n ot defin itive, but th e presen ce of m ultin o dular in filtrates with calcification in th e upper lo bes suggests tuberculosis.

3. If th e disease is active, caseation an d in flam m a- tion m ay be seen on th e ch est x-ray.

4. Advan ced disease a. Dulln ess with percussion over in volved

paren ch ym al areas, bron ch ial breath soun ds, rh on ch i, an d crackles in dicate advan ced disease.

b . Partial obstruction of a bron ch us caused by en dobro n ch ial disease or com pression by lym ph n odes m ay produ ce lo calized wh eez- in g an d dyspn ea.

H. Q uan tiFERO N-TB Gold test 1. A blood an alysis test by an en zym e-lin ked

im m un osorben t assay 2. A sen sitive an d rapid test (results can be avail-

able in 24 h ours) th at assists in diagn osin g th e clien t

I. Sputum cultures 1. Sputu m specim en s are obtain ed for an acid-

fast sm ear. 2. A sputum culture iden tifyin g M. tuberculosis co n -

firm s th e diagn osis. 3. After m ed ication s are started, sputu m sam ples

are obtain ed again to determ in e th e effectiven ess of th erapy.

4. Most clien ts h ave n egative cultures after 3 m on th s of treatm en t.

J. Tuberculin skin test (TST) (Table 54-3) 1. A positive reaction does n ot m ean th at active dis-

ease is presen t but in dicates previous exposu re to tubercu losis or th e presen ce of in active (do r- m an t) disease.

2. O n ce th e test result is positive, it will be positive in an y future tests.

3. Skin test in terp retation dep en ds on 2 facto rs: m easu rem en t in m illim eters of th e in dura- tion , an d th e perso n ’s risk of bein g in fected with tuberculosis an d progression to disease if in fected.

4. O n ce an in dividual’s skin test is positive, a ch est x-ray is n ecessary to rule out active tubercu losis or to detect old h ealed lesion s.

K. Th e h ospitalized clien t 1. Th e clien t with active tuberculosis is placed un der

airborn e isolation precautions in a n egative- pressure room ; to m ain tain n egative pressure, the door of the room m ust be tigh tly closed.

2. Th e room sh ould h ave at least 6 exch an ges of fresh air per h our an d sh ould be ven tilated to th e outsid e en viron m en t, if possible.

3. Th e n urse wears a particulate respirator (a special in dividually fitted m ask) wh en carin g for th e cli- en t an d a go wn wh en th e possibility of cloth in g con tam in ation exists.

728 UNIT XII Respiratory Disorders of the Adult Client

4. Th orou gh h an d wash in g is required before an d after carin g for th e clien t.

5. If th e clien t n eeds to leave th e ro om for a test or procedure, th e clien t is required to wear a surgical m ask.

6. Resp iratory isolation is discon tin ued wh en th e clien t is n o lon ger con sidered in fectio us.

7. After th e infected in dividual h as received tubercu- losis m edication for 2 to 3 weeks, th e risk of tran s- m ission is reduced greatly.

L. Clien t education ( Box 54-15)

CRITICAL THINKING What Should You Do? Answer: A tension pneumothorax can occur when there is a buildup of intrathoracic pressure in the pleural space and air cannot escape. One cause is the covering of an open chest wound. Manifestations include cyanosis, air hunger, agitation, tracheal deviation away from the affected side, subcutaneous emphysema, neck vein distention, and hyperresonance to per- cussion. The nurse should immediately release the chest wound dressing and contact the health care provider. This is a medical emergencyrequiring possible needle decompression followed by chest tube insertion with a chest drainage system.

Reference: Ignatavicius, Workman (20 16), p. 624.

P R A C T I C E Q U E S T I O N S 625. Th e em ergen cy departm en t n urse is assessin g a cli-

en t wh o h as sustain ed a blun t in jury to th e ch est wall. Wh ich fin din g in dicates th e presen ce of a pn eum oth orax in th is clien t? 1. A low respiratory rate 2. Dim in ish ed breath soun ds 3. Th e presen ce of a barrel ch est 4. A suckin g soun d at th e site of in jury

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

TABLE 54-3 Classification of the Tuberculin Skin Test Reaction Induration 5 5 or > 5 mm Considered Positive in:

Induration 5 10 or > 10 mm Considered Positive in:

Induration 5 15 or > 15 mm Considered Positive in:

HIV-infected persons Recent contact of a person with TB disease Persons with fibrotic changes on chest x-ray

consistent with prior TB Clients with organ transplants Persons immunosuppressed for other reasons

Recent immigrants from high-prevalence countries Injection drug users Residents and employees in high-risk congregate

settings Mycobacteriology laboratory personnel Persons with clinical conditions that place them at

high risk Children < 4 years of age Infants, children, and adolescents exposed to

adults in high-risk categories

Any person, including persons with no known risk factors for TB

HIV, Human immunodeficiency virus; TB, tuberculosis. From Centers for Disease Control and Prevention: Tuberculosis (TB) fact sheets (website): http:/ / www.cdc.gov/ tb/ publications/ factsheets/ testing/ skintesting.htm.

BOX 54-15 Client Education: Tuberculosis Provide the client and family with information about tubercu-

losis and allay concerns about the contagious aspect of the infection.

Instruct the client to follow the medication regimen exactly as prescribed and always to have a supply of the medication on hand.

Advise the client that the medication regimen is continued up to 12 months depending on the situation.

Advise the client of the side and adverse effects of the medication and ways of minimizing them to ensure compliance.

Reassure the client that after 2 to 3 weeks of medication ther- apy, it is unlikely that the client will infect anyone.

Advise the client to resume activities gradually. Instruct the client about the need for adequate nutrition and a

well-balanced diet (foods rich in iron, protein, and vitamin C) to promote healing and to prevent recurrence of the infection.

Inform the client and family that respiratory isolation is not necessary because family members already have been exposed.

Instruct the client to cover the mouth and nose when coughing or sneezing and to put used tissues into plastic bags.

Instruct the client and family about thorough hand washing. Inform the client that a sputum culture is needed every 2 to

4 weeks once medication therapy is initiated. Inform the client that when the results of 3 sputum cultures

are negative, the client is no longer considered infectious and usually can return to former employment.

Advise the client to avoid excessive exposure to silicone or dust because these substances can cause further lung damage.

Instruct the client regarding the importance of compliance with treatment, follow-up care, and sputum cultures, as prescribed.

729CHAPTER 54 Respiratory System

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

626. Th e n urse is carin g for a clien t h ospitalized with acu te exacerbatio n of ch ron ic obstru ctive pulm o - n ary disease. Wh ich fin din gs would th e n urse expect to n ote on assessm en t of th is clien t? Select all th at ap p ly.

1. A low arterial PCo 2 level 2. A h yperin flated chest n oted on th e ch est x-ray 3. Decreased oxygen saturation with m ild exercise 4. A widen ed diap h ragm n oted on th e ch est

x-ray 5. Pulm o n ary fun ctio n tests th at dem on strate

in creased vital capacity

627. Th e n urse in structs a clien t to use th e pursed-lip m eth od of breath in g an d evaluates th e teach in g by askin g th e clien t about th e purpo se of th is typ e of breath in g. Th e n urse determ in es th at th e clien t un d erstan ds if th e clien t states th at th e p rim ary purpose of pursed-lip breath in g is to prom ote wh ich outcom e? 1. Prom ote oxygen in take 2. Stren gth en th e diap h ragm 3. Stren gth en th e in tercostal m uscles 4. Prom o te carbo n dioxide elim in ation

628. Th e n urse is preparin g a list of h om e care in structions for a clien t who h as been h ospitalized an d treated for tuberculosis. Which in struction s sh ould th e n urse in clude on th e list? Select all th at app ly.

1. Activities sh ould be resum ed gradually. 2. Avo id con tact with oth er in dividuals, except

fam ily m em bers, for at least 6 m on th s. 3. A sputum culture is n eeded every 2 to 4 weeks

on ce m ed ication th erapy is in itiated. 4. Respiratory isolation is n ot n ecessary because

fam ily m em bers already h ave been exposed. 5. Cover th e m outh an d n ose wh en cough in g or

sn eezin g an d put used tissues in plastic bags. 6. Wh en 1 sputum culture is n egative, th e cli-

en t is n o lo n ger co n sidered in fectio us an d usually can return to form er em p loym en t.

629. Th e n urse is carin g for a clien t after a bron ch oscopy an d biopsy. Wh ich fin din g, if n oted in th e clien t, sh o uld be reported im m ed iately to th e h ealth care provider? 1. Dry cough 2. Hem aturia 3. Bron ch ospasm 4. Bloo d-streaked sputum

630. Th e n urse is preparin g to suction a clien t via a trach e- ostom y tube. Th e n urse sh ould plan to lim it th e suc- tionin g tim e to a m axim um of which tim e period? 1. 5 secon ds 2. 10 secon ds 3. 30 secon ds 4. 60 secon ds

631. Th e n urse is suction in g a clien t via an en dotrach eal tube. Durin g th e suction in g procedure, th e n urse n otes on th e m on itor th at th e h eart rate is decreas- in g. Wh ich n ursin g in terven tion is appropriate? 1. Con tin ue to suction . 2. No tify th e h ealth care provid er im m ediately. 3. Stop th e proced ure an d reoxygen ate th e clien t. 4. En sure th at th e suction is lim ited to 15 secon ds.

632. Th e n urse is assessin g th e respiratory status of a cli- en t wh o h as suffered a fractured rib. Th e n urse sh ould exp ect to n ote wh ich fin din g? 1. Slow, deep respiration s 2. Rap id, deep respiratio n s 3. Paradoxical respiration s 4. Pain , especially with in spiration

633. A clien t with a ch est in ju ry h as suffered flail ch est. Th e n urse assesses th e clien t for wh ich m o st dis- tin ctive sign of flail ch est? 1. Cyan osis 2. Hypo ten sion 3. Paradoxical ch est m ovem en t 4. Dysp n ea, especially on exh alatio n

634. A client h as been adm itted with ch est traum a after a m otor veh icle crash an d h as un dergon e subsequen t in tubation. Th e n urse ch ecks th e clien t wh en th e h igh -pressure alarm on the ven tilator soun ds, an d n otes th at th e clien t h as absen ce of breath soun ds in th e righ t upper lobe of th e lun g. Th e n urse im m ed iately assesses for oth er signs of wh ich con dition ? 1. Righ t pn eum oth orax 2. Pulm on ary em bolism 3. Disp laced en dotrach eal tube 4. Acute respiratory distress syn drom e

635. Th e n urse is assessin g a clien t with m ultiple traum a wh o is at risk for developin g acu te respiratory distress syn drom e. Th e n urse sh o uld assess for wh ich earliest sign of acu te respiratory distress syn d rom e? 1. Bilateral wh eezin g 2. In spiratory crackles 3. In tercostal retraction s 4. In creased respiratory rate

636. Th e n urse is discussin g th e tech n iqu es of ch est ph ysioth erapy an d postu ral drain age (respiratory treatm en ts) to a clien t h avin g expecto ration prob- lem s because of ch ron ic th ick, ten acio us m ucus produ ctio n in th e lo wer airway. Th e n urse exp lain s th at after th e clien t is position ed for postu ral drain - age th e n urse will perform wh ich action to h elp loosen secretio n s? 1. Palp ation an d clubbin g 2. Percussion an d vibration

730 UNIT XII Respiratory Disorders of the Adult Client

3. Hyperoxygen atio n an d suction in g 4. Adm in ister a bron ch odilator an d m on itor peak

flo w

637. Th e n urse h as con d ucted disch arge teach in g with a clien t diagn osed with tuberculosis wh o h as been receivin g m edication for 2 weeks. Th e n urse deter- m in es th at th e clien t h as un dersto od th e in form a- tion if th e clien t m akes wh ich statem en t? 1. “I n eed to con tin ue m ed ication th erap y for

1 m on th .” 2. “I can ’t sh o p at th e m all for th e n ext 6 m on th s.” 3. “I can return to work if a sputum culture com es

back n egative.” 4. “I sh ould n ot be con tagious after 2 to 3 weeks of

m ed ication th erap y.”

638. Th e n urse is preparin g to give a bed bath to an im m obilized clien t with tuberculosis. Th e n urse sh ould wear wh ich item s when perform in g this care? 1. Surgical m ask an d gloves 2. Particulate respirator, gown , an d gloves 3. Particulate respirator an d protective eyewear 4. Surgical m ask, go wn , an d protective eyewear

639. A clien t h as experien ced pulm o n ary em bolism . Th e n urse sh o uld assess for wh ich sym pto m , wh ich is m o st com m on ly reported? 1. Ho t, flu sh ed feelin g 2. Sudden ch ills an d fever 3. Ch est pain th at occurs sudd en ly 4. Dysp n ea wh en deep breath s are taken

640. A clien t wh o is h um an im m un odeficien cy virus (HIV) –positive h as h ad a tuberculin skin test (TST). Th e n urse n otes a 7-m m area of in du ration at th e site of th e skin test an d in terp rets th e result as wh ich fin din g? 1. Positive 2. Negative 3. In con clusive 4. Need for repeat testin g

641. A clien t with acq uired im m un od eficien cy syn - drom e (AIDS) h as h isto plasm osis. Th e n urse sh ould assess th e clien t for wh ich exp ected fin din g? 1. Dysp n ea 2. Headach e 3. Weigh t gain 4. Hypo th erm ia

642. Th e n urse is givin g disch arge in struction s to a clien t with pulm on ary sarcoid osis. Th e n urse con clud es th at th e clien t un derstan ds th e in form ation if th e clien t in dicates to report wh ich early sign of exacerbation ?

1. Fever 2. Fatigue 3. Weigh t loss 4. Sh o rtn ess of breath

643. Th e n urse is takin g th e h isto ry of a clien t with occu- pation al lu n g disease (silicosis). Th e n urse sh ould assess wh eth er th e clien t wears wh ich item durin g periods of exposure to silica particles? 1. Mask 2. Gown 3. Gloves 4. Eye protection

644. An oxygen delivery system is prescribed for a clien t with ch ron ic obstru ctive pulm o n ary disease to deliver a precise oxygen con cen tration . Wh ich oxy- gen delivery system would th e n urse prepare for th e clien t? 1. Face ten t 2. Ven turi m ask 3. Aerosol m ask 4. Trach eostom y collar

645. Th e n urse is in structin g a h ospitalized clien t with a diagn osis of em ph ysem a about m easures th at will en h an ce th e effectiven ess of breath in g durin g dys- pn eic periods. Wh ich position sh ould th e n urse in struct th e clien t to assum e? 1. Sittin g up in bed 2. Side-lyin g in bed 3. Sittin g in a reclin er ch air 4. Sittin g up an d lean in g on an overbed table

646. Th e com m un ity h ealth n urse is con ductin g an education al session with com m un ity m em bers regardin g th e sign s an d sym ptom s associated with tuberculosis. Th e n urse in form s th e participan ts that tuberculosis is con sidered as a diagn osis if wh ich sign s an d sym ptom s are presen t? Select all th at app ly.

1. Dysp n ea 2. Headach e 3. Nigh t sweats 4. A blood y, productive cough 5. A cough with th e expecto ration of m ucoid

sputum

647. Th e n urse perform s an ad m ission assessm en t on a clien t with a diagn osis of tubercu losis. Th e n urse sh o uld ch eck th e results of wh ich diagn ostic test th at will con firm th is diagn osis? 1. Ch est x-ray 2. Bron ch oscopy 3. Sputum culture 4. Tuberculin skin test

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

731CHAPTER 54 Respiratory System

648. Th e low-pressure alarm soun ds on a ven tilator. Th e n urse assesses th e clien t an d th en attem p ts to deter- m in e th e cause of th e alarm . If un successful in determ in in g th e cau se of th e alarm , th e n urse sh o uld take wh at in itial action ?

1. Adm in ister oxygen 2. Ch eck th e clien t’s vital sign s 3. Ven tilate th e clien t m an ually 4. Start cardiopulm on ary resuscitation

A N S W E R S

625. 2 Ra tion a le: Th is clien t h as su stain ed a b lu n t o r clo sed -ch est in ju ry. Basic sym pto m s of a clo sed p n eu m oth orax are sh o rt- n ess of breath an d ch est p ain . A larger p n eu m oth orax m ay cause tach ypn ea, cyan o sis, d im in ish ed breath so un ds, an d su b - cutan eou s em ph ysem a. Hyp erreso n an ce also m ay occu r on th e affected sid e. A su ckin g so un d at th e site of in jury wo u ld be n o ted with an op en ch est in ju ry. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, a blun t ch est in ju ry. No tin g th e wo rd blunt will assist in elim in atin g op tio n 4, wh ich d escrib es a su ckin g ch est wou n d in ju ry. Kn o win g th at in a respiratory in ju ry in creased respiration s will o ccu r will assist yo u in elim in atin g op tion 1. O p tion 3 can be elim in ated b ecau se a b arrel ch est is a ch aracteristic fin din g in a clien t with ch ro n ic o b stru ctive p ulm o n ary disease. Review: Th e sign s o f p n eu m o th o rax Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Resp irato ry Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Ign ataviciu s, Workm an ( 2016) , pp . 505, 623–624.

626. 2, 3 Ra tion a le: Clin ical m an ifestatio n s of ch ron ic o bstructive p u l- m on ary d isease (CO PD) in clud e h yp oxem ia, h yp ercapn ia, d yspn ea o n exertio n an d at rest, oxygen desatu ratio n with exer- cise, an d th e use o f accesso ry m u scles o f resp iratio n . Ch est x-rays reveal a h yp erin flated ch est an d a flatten ed diap h ragm if th e d isease is advan ced . Pulm o n ary fu n ctio n tests will d em - o n strate decreased vital cap acity. Test-Ta kin g St r a tegy: Focu s on th e su b ject, m an ifestatio n s of CO PD. Th in k abo ut th e p ath op h ysio lo gy asso ciated with th is d isorder. Rem em ber th at h yp ercapn ia, a h yp erin flated ch est, a flat diap h ragm , oxygen d esatu ratio n o n exercise, an d d ecreased vital cap acity are m an ifestatio n s. Review: Th e m an ifestation s associated with ch ro n ic o b stru c- tive p u lm o n ary d isease ( CO PD) Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Resp irato ry Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ces: Ign atavicius, Wo rkm an (2016), pp . 558–559; Lewis et al. (2014), pp . 586–587.

627. 4 Ra tion a le: Pu rsed -lip b reath in g facilitates m axim al exp iratio n fo r clien ts with ob stru ctive lu n g disease. Th is type o f breath in g allo ws b etter expiratio n b y in creasin g airway pressu re th at keeps air p assages o p en du rin g exh alation . O ptio n s 1, 2, an d 3 are n ot th e purposes of th is type of breath in g.

Test-Ta kin g Str a tegy: No te th e strategic wo rd , primary, an d th e su b ject, clien t un derstan d in g of p ursed-lip b reath in g, an d visu alize th e u se o f th is p ro cedu re to assist yo u in an swer- in g co rrectly. Kn owled ge o f th e resp iratory co n d itio n s in wh ich th is typ e o f breath in g is h elp ful also will assist in d irectin g you to th e correct o ptio n . Review: Th e p u rp ose of p u rsed -lip b reath in g Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ad ult Health —Respiratory Pr ior it y Con cept s: Clien t Ed ucation ; Gas Exch an ge Refer en ce: Lewis et al. (2014), p . 579.

628. 1, 3, 4, 5 Ra tion a le: Th e n urse sh ould provide th e clien t an d fam ily with in form ation about tuberculosis an d allay con cern s about th e con tagious aspect of th e in fection . Th e clien t n eeds to follow th e m edication regim en exactly as prescribed an d always h ave a supply of th e m edication on h an d. Side an d adverse effects of th e m edication an d ways of m in im izin g th em to en sure com pli- an ce sh ould be explain ed. After 2 to 3 weeks of m edication th er- apy, it is un likely th at th e clien t will in fect an yon e. Activities sh ould be resum ed gradually an d a well-balan ced diet th at is rich in iron , protein, an d vitam in C to prom ote h ealing an d preven t recurren ce of in fection sh ould be con sum ed. Respiratory isolation is n ot n ecessary because fam ily m em bers already h ave been exposed. In struct th e clien t about th orough h an d wash in g, to cover th e m outh an d n ose wh en cough in g or sn eezin g, an d to put used tissues in to plastic bags. Asputum culture is n eeded every 2 to 4 weeks on ce m edication th erapy is in itiated. Wh en th e results of 3 sputum cultures are n egative, th e clien t is n o lon ger con sid- ered in fectious an d can usually return to form er em ploym en t. Test-Ta kin g Stra tegy: Focus on th e su b ject, h om e care in struc- tion s for tuberculosis. Kn owledge regardin g th e path oph ysiology, tran sm issio n, an d treatm en t of tubercu losis is n eeded to an swer th is question . Read each option carefully to an swer correctly. Review: Hom e care in structio n s for th e clien t with tu b ercu lo sis Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Respiratory Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ces: Ign atavicius, Wo rkm an (2016), pp . 598–599; Lewis et al. (2014), p. 533.

629. 3 Ra tion a le: If a b iop sy was p erfo rm ed d urin g a b ro n ch o sco py, b loo d-streaked spu tu m is expected for several h o urs. Fran k b loo d in dicates h em orrh age. A d ry co ugh m ay be exp ected. Th e clien t sh o uld be assessed for sign s o f com p lication s, wh ich would in clude cyan osis, dyspn ea, stridor, bron ch ospasm , h em o ptysis, h ypo ten sio n , tach ycardia, an d dysrh yth m ias. Hem aturia is un related to th is proced ure.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

732 UNIT XII Respiratory Disorders of the Adult Client

Test -Ta kin g St r a t egy: Note th e strategic wo rd , immediately. Elim in ate o ption 2 first b ecau se it is un related to th e p ro cedu re. Next, elim in ate op tion 1 b ecau se a d ry cou gh m ay b e exp ected . Notin g th at a b io psy h as b een p erfo rm ed will assist in elim in at- in g op tion 4, b ecau se b lo od -streaked spu tum wo uld b e expected . No te th at th e co rrect op tio n relates to th e airway. Review: Po stp ro ced ure care followin g b ro n ch o sco p y with bio psy Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ces: Ign ataviciu s, Workm an ( 2016) , p p. 510–511; Pagan a, Pagan a, Pagan a (2015), p p. 192–194.

630. 2 Ra t ion a le: Hyp o xem ia can be cau sed b y p ro lo n ged suctio n in g, wh ich stim ulates th e p acem aker cells in th e h eart. A vaso vagal respon se m ay o ccur, causin g bradycardia. Th e n urse m ust pre- oxygen ate th e clien t befo re su ctio n in g an d lim it th e su ction in g pass to 10 seco n ds. Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, th e p ro cedu re for suction in g. Recall th at du rin g su ctio n in g, th e clien t’s airway is blo cked; th erefo re, yo u sh o uld b e able to elim in ate o ptio n s 3 an d 4 easily. From th e rem ain in g op tio n s, elim in ate o p tion 1 because of th e sh ort tim e fram e. Five secon ds do es n o t seem reason able to ach ieve rem o val of secretion s. Review: Th e p ro ced ure fo r su ctio n in g Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Respiratory Pr ior ity Con cepts: Gas Exch an ge; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 525.

631. 3 Ra t ion a le: Du rin g suctio n in g, th e n u rse sh o uld m o n ito r th e clien t clo sely fo r ad verse effects, in clu din g h ypo xem ia, cardiac irregularities su ch as a decrease in h eart rate resultin g fro m vagal stim ulation , m u co sal trau m a, h yp oten sio n , an d p aro xys- m al co u gh in g. If ad verse effects d evelo p, esp ecially cardiac irregularities, th e proced ure is sto pp ed an d th e clien t is reo xygen ated. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, a d ecreased h eart rate, an d recall th at suction in g can cause cardiac irregulari- ties. Also , use o f th e ABCs—airway–b reath in g–circu latio n — sh ou ld d irect you to th e co rrect op tion . Review: Co m p lication s an d in terven tio n s associated with su c- tio n in g proced ures Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Ign atavicius, Workm an (2016), p . 525.

632. 4 Ra t ion a le: Rib fractures result from a b lu n t in jury o r a fall. Typ- ical sign s an d sym p tom s in clu de p ain an d ten dern ess localized

at th e fractu re site th at is exacerb ated b y in sp iration an d palp a- tion , sh allow resp iratio n s, sp lin tin g o r gu ard in g th e ch est pro- tectively to m in im ize ch est m o vem en t, an d p ossible b ru isin g at th e fracture site. Parad o xical resp iratio n s are seen with flail ch est. Test -Ta kin g St r a t egy: Fo cus on th e su b ject, fin d in gs associ- ated with a rib fracture. Fo cu sin g o n th e an ato m ical lo catio n o f th e in jury will d irect yo u to th e co rrect o p tion . Review: Th e assessm en t fin din gs in rib fractu re Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Gas Exch an ge; Pain Refer en ce: Ign atavicius, Workm an (2016), p . 623.

633. 3 Ra t ion a le: Flail ch est resu lts fro m m ultiple rib fractures. Th is resu lts in a “flo atin g” section o f ribs. Because th is section is u n attach ed to th e rest o f th e b on y rib cage, th is segm en t resu lts in p arad oxical ch est m ovem en t. Th is m ean s th at th e fo rce o f in sp iratio n p ulls th e fractu red segm en t in ward, wh ile th e rest o f th e ch est exp an d s. Sim ilarly, d u rin g exh alatio n , th e segm en t b allo on s o u tward wh ile th e rest o f th e ch est m oves in ward. Th is is a ch aracteristic sign o f flail ch est. Test -Ta kin g St r a t egy: Note th e strategic wo rd , most. Cyan o sis an d h yp oten sio n occu r with m an y d ifferen t diso rd ers, so elim - in ate op tion s 1 an d 2 first. Fro m th e rem ain in g op tio n s, ch o ose p arad oxical ch est m o vem en t over d yspn ea o n exh alatio n by rem em berin g th at a flail ch est h as bro ken rib segm en ts th at m o ve in d epen den tly o f th e rest of th e rib cage. Review: Assessm en t fin din gs in flail ch est Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Gas Exch an ge; Pain Refer en ce: Ign atavicius, Workm an (2016), p . 623.

634. 1 Ra t ion a le: Pn eum o th orax is ch aracterized b y restlessn ess, tach ycard ia, d yspn ea, pain with resp iration , asym m etrical ch est exp an sio n , an d dim in ish ed or ab sen t b reath so un ds o n th e affected side. Pn eum o th o rax can cause in creased airway p ressure because of resistan ce to lu n g in flatio n . Acute respira- to ry distress syn d ro m e an d p ulm o n ary em b olism are n o t ch ar- acterized b y absen t b reath so un ds. An en do trach eal tub e th at is in serted to o far can cause ab sen t b reath sou n d s, bu t th e lack o f b reath so un ds m o st likely wo u ld b e o n th e left side becau se o f th e degree of curvature o f th e righ t an d left m ain stem b ro n ch i. Test -Ta kin g St r a t egy: Note th e strategic wo rd , immediately. Fo cu s on th e sym pto m s p resen ted in th e q uestion an d n o te th e relatio n sh ip b etween right up p er lob e an d right pn eum o - th orax in th e co rrect op tion . Review: Man ifestatio n s associated with p n eu m o th o rax Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Critical Care—Em ergency Situations/Managem ent

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

733CHAPTER 54 Respiratory System

Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 623–624.

635. 4 Ra tion a le: Th e earliest detectable sign of acute respiratory d istress syn d ro m e is an in creased respiratory rate, wh ich can b egin fro m 1 to 96 h o urs after th e in itial in sult to th e b o dy. Th is is fo llo wed by in creasin g dysp n ea, air h un ger, retractio n o f accesso ry m u scles, an d cyan o sis. Breath sou n d s m ay be clear o r co n sist o f fin e in spiratory crackles o r diffu se co arse crackles. Test-Ta kin g St r a t egy: No te th e strategic wo rd , earliest. Elim i- n ate op tio n 3 first b ecau se in tercostal retractio n is a later sign of respiratory d istress. O f th e rem ain in g o ptio n s, recall th at ad ven titio us b reath so un ds (op tio n s 1 an d 2) wo uld occu r later th an an in creased resp iratory rate. Review: Th e early sign s of acu te resp irato ry d istress syn d ro m e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Resp irato ry Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 612–614.

636. 2 Ra tion a le: Ch est p h ysio th erapy of percussio n an d vib ratio n h elps to lo osen secretion s in th e sm aller lower airways. Po s- tu ral drain age p osition s th e clien t so th at gravity can h elp m ucus m ove fro m sm aller airways to larger o n es to sup po rt exp ectoration of th e m u cus. O p tio n s 1, 3, an d 4 are n o t actio n s th at will lo osen secretion s. Test-Ta kin g St r a t egy: Focus on th e su b ject, loosen in g th e secretion s. Visu alize th e effects o f each actio n in th e op tion s o n lo o sen in g secretio n s. Th is will direct yo u to op tio n 2. Th e action s in o ption s 1, 3, an d 4 will n ot lo osen secretion s. Review: Th e tech n iqu es o f ch est p h ysio th erap y an d p o stu ral d rain age Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care: Skills Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ces: Lewis et al. (2014), p . 594; Perry, Po tter, O sten d orf (2014), pp . 615, 617–619.

637. 4 Ra tion a le: Th e clien t is co n tin u ed o n m ed icatio n th erapy fo r u p to 12 m on th s, d ep en d in g on th e situ ation . Th e clien t gen - erally is co n sid ered n o n con tagiou s after 2 to 3 weeks o f m ed - ication th erap y. Th e clien t is in structed to wear a m ask if th ere will b e expo sure to cro wds un til th e m edication is effective in p reven tin g tran sm issio n . Th e clien t is allowed to retu rn to work wh en th e results of 3 sp utum cultures are n egative. Test-Ta kin g St r a t egy: Focus on th e su b ject, clien t u n d erstan d- in g of m ed icatio n th erap y. Kn o win g th at th e m ed ication th er- ap y lasts fo r u p to 12 m o n th s h elp s yo u to elim in ate o ption 1 first. Kn owin g th at 3 spu tu m cu ltures m u st b e n egative h elp s yo u to elim in ate o p tion 3 n ext. Fro m th e rem ain in g o ptio n s, recallin g th at th e clien t is n o t co n tagiou s after 2 to 3 weeks o f th erapy will direct yo u to th e correct o ptio n .

Review: Tu b ercu lo sis Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ad ult Health —Respiratory Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 598.

638. 2 Ra tion a le: Th e n u rse wh o is in con tact with a clien t with tub er- culo sis sh ou ld wear an in divid u ally fitted particu late resp ira- to r. Th e n u rse also wo uld wear glo ves as p er stan d ard p recautio n s. Th e n urse wears a go wn wh en th e po ssib ility exists th at th e clo th in g cou ld beco m e co n tam in ated , su ch as wh en givin g a b ed b ath . Test-Ta kin g Str a tegy: Focus o n th e su b ject, precau tio n s wh en carin g for th e clien t with tub ercu losis. Th in k abo ut th e n urse’s task, a b ed bath . Kn owin g th at th e n u rse sh ou ld wear a p artic- u late respirator elim in ates o ption s 1 an d 4. Kn o wledge of basic stan d ard precau tio n s d irects you to th e co rrect op tio n . Review: Precau tion s related to th e care o f a clien t with tu b ercu lo sis Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n dam en tals o f Care—In fectio n Co n trol Pr ior it y Con cept s: In fection ; Safety Refer en ce: Ign atavicius, Workm an ( 2016) , pp . 403–404, 598.

639. 3 Ra tion a le: Th e m ost co m m o n in itial sym pto m in pu lm on ary em bo lism is ch est p ain th at is sud den in on set. Th e n ext m o st com m on ly rep orted sym p tom is d yspn ea, wh ich is acco m pa- n ied b y an in creased resp irato ry rate. O th er typ ical sym p tom s o f pu lm on ary em bo lism in clu de ap p reh en sio n an d restless- n ess, tach ycardia, co u gh , an d cyan osis. Test-Ta kin g St r a tegy: Note th e strategic wo rd , most. Because p ulm o n ary em bo lism d o es n o t resu lt fro m an in fectiou s pro - cess or an allergic reaction , elim in ate o p tion s 1 an d 2 first. To select between th e co rrect o ptio n an d op tio n 4, loo k at th em closely. O p tio n 4 states d yspn ea wh en d eep b reath s are taken . Alth ou gh dysp n ea com m on ly o ccurs with p ulm o n ary em bo - lism , dysp n ea is n o t asso ciated on ly with deep b reath in g. Th erefo re, elim in ate o ptio n 4. Review: Sign s o f p u lm o n ary em b o lism Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Respiratory Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 605.

640. 1 Ra tion a le: Th e clien t with HIV in fectio n is con sidered to h ave p ositive results o n tub ercu lin skin testin g with an area o f in d u- ration larger th an 5 m m . Th e clien t with o ut HIV is p ositive with an in duration larger th an 10 m m . Th e clien t with HIV is im m u n osup pressed , m akin g a sm aller area o f in du ratio n p ositive fo r th is typ e o f clien t. It is po ssib le fo r th e clien t in fected with HIV to h ave false-n egative readin gs because of

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

734 UNIT XII Respiratory Disorders of the Adult Client

th e im m un osu pp ression factor. O p tion s 2, 3, an d 4 are in co r- rect in terpretation s. Test -Ta kin g St r a tegy: Elim in ate op tion s 3 an d 4 first b ecau se th ey are co m p arab le o r alike. Fro m th e rem ain in g op tion s, recallin g th at th e clien t with HIV in fection is im m un osup- pressed will assist in d eterm in in g th e in terpretatio n o f th e area of in d uration . Review: Tu b ercu lo sis skin testin g Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Ad ult Health —Respiratory Pr ior ity Con cepts: Eviden ce; In fectio n Refer en ce: Ign atavicius, Workm an (2016), p . 596.

641. 1 Ra t ion a le: Histo plasm o sis is an o pp o rtu n istic fu n gal in fection th at can o ccur in th e clien t with AIDS. Th e in fectio n begin s as a respirato ry in fection an d can progress to dissem in ated in fec- tion . Typ ical sign s an d sym p tom s in clud e fever, d ysp n ea, co ugh , an d weigh t lo ss. En largem en t o f th e clien t’s lym p h n od es, liver, an d spleen m ay occur as well. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, m an ifestatio n s o f h isto plasm o sis. Recallin g th at h isto plasm o sis is an in fectio us process will h elp yo u to elim in ate op tio n 4. Becau se th e clien t h as AIDS an d an o th er in fection , weigh t gain is an un likely sym p tom an d can be elim in ated n ext. Kn o win g th at h istop las- m o sis b egin s as a respiratory in fectio n h elp s yo u to ch oo se d ys- pn ea o ver h eadach e as th e co rrect o ption . Review: Sign s of h isto p lasm o sis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Respiratory Pr ior ity Con cepts: Clin ical Jud gm en t; In fectio n Refer en ce: Ign atavicius, Workm an (2016), p . 334.

642. 4 Ra t ion a le: Dry co ugh an d d ysp n ea are typ ical early m an ifesta- tion s of p ulm o n ary sarco id osis. Later m an ifestatio n s in clu de n igh t sweats, fever, weigh t lo ss, an d skin n o du les. Test -Ta kin g Str a t egy: Note th e strategic wo rd , early. Because sarcoid osis is a p u lm o n ary prob lem , elim in ate o p tion s 1 an d 3 first. Select th e co rrect o ptio n over op tio n 2 becau se th e sh ort- n ess o f breath (an d im p aired ven tilatio n ) ap pears first an d wo uld cau se th e fatigue as a secon d ary sym p tom . Review: Th e early sign s of exacerb ation o f sarco id o sis Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ad ult Health —Respiratory Pr ior ity Con cepts: Clien t Edu catio n ; Gas Exch an ge Refer en ce: Ign atavicius, Workm an (2016), p . 571.

643. 1 Ra t ion a le: Silicosis results from ch ron ic, excessive in h alation of particles of free crystallin e silica d ust. Th e clien t sh ou ld wear a m ask to lim it in h alatio n o f th is su b stan ce, wh ich can cau se restrictive lun g disease after years of exposure. O ption s 2, 3, an d 4 are n ot n ecessary.

Test -Ta kin g St r a t egy: Focu s o n th e su b ject, p reven tion o f sil- ico sis. Recallin g th at expo sure to silica du st cau ses th e illn ess an d th at th e d u st is in h aled in to th e resp irato ry tract will direct yo u to th e co rrect o ption . Review: Protective m easures asso ciated with silico sis Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: In fectio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 573.

644. 2 Ra t ion a le: Th e Ven tu ri m ask d elivers th e m ost accurate o xygen co n cen tratio n . It is th e best o xygen d elivery system fo r th e cli- en t with ch ron ic airflo w lim itatio n su ch as ch ro n ic ob stru ctive p u lm o n ary disease, because it d elivers a precise o xygen con cen - tration . Th e face ten t, aero so l m ask, an d trach eo stom y co llar are also h igh -flow oxygen d elivery system s b ut m o st o ften are u sed to adm in ister h igh h u m id ity. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, d elivery of a p re- cise o xygen co n cen tration . Elim in ate o ptio n s 1, 3, an d 4 b ecause th ey are co m p arab le o r alike in th at th ey are used to p rovid e h igh h um id ity. Review: Variou s typ es o f o xygen d elivery system s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Gas Exch an ge; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 519.

645. 4 Ra t ion a le: Po sitio n s th at will assist th e clien t with em ph ysem a with breath in g in clude sittin g up an d lean in g on an overbed tab le, sittin g u p an d restin g th e elb ows on th e kn ees, an d stan d- in g an d lean in g again st th e wall. Test -Ta kin g St r a t egy: Elim in ate op tion s 1 an d 3 first becau se th ey are co m p arab le o r alike. Next, elim in ate op tio n 2 becau se th is p osition will n ot en h an ce b reath in g. Review: Po sitio n s th at d ecrease th e wo rk o f b reath in g with em p h ysem a Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Clien t Ed u catio n ; Gas Exch an ge Refer en ce: Ign atavicius, Workm an (2016), p p. 558–559.

646. 1, 3, 4, 5 Ra t ion a le: Tub ercu losis sh o uld b e co n sidered fo r an y clien ts with a persisten t cough , weigh t loss, an orexia, n igh t sweats, h em op tysis, sh o rtn ess of breath , fever, or ch ills. Th e clien t’s p reviou s exp osu re to tub ercu losis sh ou ld also b e assessed an d co rrelated with th e clin ical m an ifestatio n s. Test -Ta kin g St r a t egy: Note th e su b ject, clin ical m an ifestation s o f tu berculo sis. No te th at h eadach e is n o t specifically asso ci- ated with tub ercu losis, is n o t resp irato ry in n ature, an d is n ot associated with an in fectio n to assist in elim in atin g th is o p tion .

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

735CHAPTER 54 Respiratory System

Review: Man ifestation s asso ciated with tu b ercu lo sis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —Resp irato ry Pr ior it y Con cept s: Clien t Ed ucation ; In fectio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 596.

647. 3 Ra tion a le: Tub ercu lo sis is d efin itively d iagn o sed th ro ugh cu l- tu re an d isolatio n of Mycobacterium tuberculosis. A p resum p tive d iagn o sis is m ad e b ased o n a tub erculin skin test, a spu tum sm ear th at is p o sitive fo r acid -fast b acteria, a ch est x-ray, an d h istolo gical evid en ce o f gran u lom ato us disease o n b iop sy. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, con firm in g th e d iagn o sis o f tub ercu losis. Co n firm atio n is m ade by iden tifyin g th e b acteria, M. tuberculosis. Review: Diagn ostic p rocedu res related to tu b ercu lo sis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Resp irato ry

Pr ior it y Con cept s: Evid en ce; In fection Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 596.

648. 3 Ra tion a le: If at an y tim e an alarm is soun din g an d th e n urse can n o t q uickly ascertain th e p ro b lem , th e clien t is discon - n ected fro m th e ven tilato r an d m an ual resuscitatio n is u sed to su pp ort respiratio n s u n til th e p ro b lem can b e co rrected . No reaso n is given to b egin cardiop ulm o n ary resu scitation . Ch eckin g vital sign s is n ot th e in itial action . Alth o ugh o xygen is h elp ful, it will n o t p ro vid e ven tilatio n to th e clien t. Test-Ta kin g Str a tegy: No te th e strategic wo rd , initial, an d n o te th at th e su b ject relates to ad equ ate ven tilatio n o f th e cli- en t. Also, n o te th at th e n u rse is un su ccessfu l in d eterm in in g th e cau se o f th e alarm . Th is will direct yo u to th e correct o ptio n . Review: Man agem en t of ven tilato rs an d alarm s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nu rsin g Pro cess—Im p lem en tatio n Con ten t Area : Critical Care—Em ergen cy Situation s/ Man agem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 619.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

736 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

C H A P T E R 55 Respiratory Medications

PRIORITY CONCEPTS Gas Exchange; Infection

CRITICAL THINKING What Should You Do? A client who has been taking isoniazid for the past 4 months to treat tuberculosis complains to the nurse of experiencing a lack of appetite, nausea, and urine output that is dark in color. What should the nurse do? Answer located on p. 748.

I. Medication Inhalation Devices A. Metered-dose in h aler (MDI): Uses a ch em ical pro-

pellan t to push th e m edication out of th e in h aler ( Fig. 55-1)

B. Dry powder in h aler (DPI): Delivers m ed ication with ou t usin g ch em ical propellan ts, but it requires stron g an d fast in h alation (see Fig. 55-1).

C. Nebulizer: Delivers fin e liqu id m ists of m ed ication th rou gh a tube or a m ask th at fits over th e n ose an d m outh , usin g air or oxygen un d er pressure.

D. If 2 differen t in h aled m edication s are prescribed an d 1 of th e m edication s con tain s a glucocorticoid (cor- tico steroid), adm in ister th e bron ch od ilator first an d th e corticosteroid secon d.

If 2 different inhaled medications are prescribed, instruct the client to wait 5 minutes following adminis- tration of the first before inhaling the second. If a second dose of the same medication is needed, instruct the cli- ent to wait 1 to 2 minutes before taking the second dose.

II. Bronchodilators (Box 55-1) A. Description

1. Sym path om im etic bron ch odilators relax th e sm oo th m uscle of th e bron ch i an d dilate th e air- ways of th e respiratory tree, m akin g air exch an ge an d respiration easier for th e clien t.

2. Meth ylxan th in e bron ch odilators stim ulate th e cen tral n ervou s system (CNS) an d respiration , dilate coron ary an d pulm o n ary vessels, cau se diuresis, an d relax sm ooth m uscle.

3. Used to treat acute bron ch ospasm , acute an d ch ron ic asthma, bron ch itis, an d restrictive air- way diseases

4. Con train dicated in in dividuals with h ypersen si- tivity, peptic ulcer disease, severe cardiac disease an d cardiac dysrh yth m ias, h yperth yroidism , or un co n trolled seizu re disorders

5. Used with cau tion in clien ts with h yperten sion , diab etes m ellitus, or n arrow-an gle glaucom a

6. Th eoph yllin e in creases the risk of digoxin toxicity an d decreases th e effects of lith ium an d ph en ytoin .

7. If th eoph yllin e an d a β2-ad ren ergic agon ist are adm in istered togeth er, cardiac dysrh yth m ias m ay result.

8. Beta blockers, cim etidin e, an d eryth rom ycin in crease th e effects of th eoph yllin e.

9. Barbiturates an d carbam azepin e decrease th e effects of th eoph yllin e.

B. Side an d adverse effects 1. Palp itation s an d tach ycardia 2. Dysrh yth m ias 3. Restlessn ess, n ervou sn ess, trem o rs 4. An o rexia, n ausea, an d vo m itin g 5. Headach es an d dizzin ess 6. Hyperglycem ia 7. Mou th dryn ess an d th roat irritatio n with in h alers 8. Toleran ce an d paradoxical bron ch ocon striction

with in h alers C. In terven tion s

1. Assess lun g soun ds. 2. Mon itor for cardiac dysrh yth m ias. 3. Assess for cough , wh eezin g, decreased breath

soun ds, an d sputu m produ ction . 4. Mon itor for restlessn ess an d con fusion . 5. Provide adequ ate h ydration . 6. Adm in ister th e m edication at regular in tervals

arou n d th e clock to m ain tain a sustain ed th erap eutic level.

7. Adm in ister oral m edication s with or after m eals to decrease gastro in testin al irritatio n .

8. Mon itor for a th erapeutic serum theoph yllin e level of 10 to 20 m cg/ m L(55.5 to 111 m cm ol/ L). 737

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

9. In traven ously adm in istered th eoph yllin e prep- aration s sh ould be ad m in istered slowly an d always via an in fusio n pum p.

10. Clien t education a. No t to cru sh en teric-coated or sustain ed-

release tablets or capsules

b . To avoid caffein e-con tain in g produ cts such as coffee, tea, cola, an d ch oco late, an d over-th e-cou n ter m ed ication s

c. Abou t th e side an d adverse effects of bron ch odilators

d . Ho w to m on itor th e pulse an d to report an y ab n orm alities to th e h ealth care provider (HCP)

e. How to use an inhaler, spacer, or nebulizer (see Fig. 55-1) and how to m onitor the am ount of m edication rem aining in an inhaler canister

f. Th e im portan ce of sm okin g cessation an d in form ation regardin g supp ort resources

g. To m on itor blood gluco se levels if diabetes m ellitus is a coexistin g con d ition

h . To wear a Med icAlert bracelet, particularly if th e clien t h as asth m a

Theophylline toxicity is likely to occur when the serum level is higher than 20 mcg/ mL (111 mcmol/ L). Early signs of toxicity include restlessness, nervousness, tremors, palpitations, and tachycardia.

III. Anticholinergics (see Box 55-1) A. In h aled m ed ication s th at im prove lu n g fun ction by

blockin g m uscarin ic receptors in th e bron ch i, wh ich results in bron ch odilation

B. Effective for treatin g ch ron ic obstru ctive pulm on ary disease, allergy-in duced asth m a, an d exercise- in du ced bron ch ospasm

C. Side effects in clude dry m ou th an d irritatio n of th e ph aryn x; suckin g on sugarless can dy will h elp to relieve sym pto m s.

D. System ic an tich olin ergic effects rarely occur but can in clude in creased in traocular pressure, blurred vision , tach ycardia, cardiovascular even ts, urin ary reten tion , an d con stipation .

BOX 55-1 Medications to Treat Restrictive Airway Disorders

Bronchodilators β2-Adrenergic Agonist s Inha led: ▪ Albuterol ▪ Arformoterol ▪ Formoterol ▪ Levalbuterol ▪ Salmeterol Ora l: ▪ Albuterol ▪ Terbutaline Met hylxa nthines ▪ Theophylline, oral ▪ Aminophylline Ant icholinergics ▪ Ipratropium, inhaled ▪ Tiotropium, inhaled

Glucocorticoids (Corticosteroids) Inha led ▪ Beclomethasone

dipropionate

▪ Budesonide ▪ Ciclesonide ▪ Fluticasone propionate ▪ Mometasone furoate ▪ Triamcinolone acetonide Ora l ▪ Prednisone ▪ Prednisolone

Leukotriene Modifiers ▪ Montelukast, oral ▪ Zafirlukast, oral Inhaled Nonsteroidal Antiallergy Agent ▪ Cromolyn sodium,

inhaled

Monoclonal Antibody ▪ Omalizumab

Adapted from Burchum JR, Rosenthal LD: Lehne’s pharmacology for nursing care, ed 9, St. Louis, 20 16, Saunders.

Me te re d a e ros ol inha le r

A B

Inha le r with s pa ce r de vice

10%

81%

9%

57%

22%

21%

Inha le r de vice

With s pa ce r

Mouth/throa t

Lungs

Without s pa ce r

FIGURE 55-1 Inhaled medications commonly used in asthma treatment include β-adrenergic bronchodilators, cromolyn sodium, and aerosol gluco- corticoids. A, The metered-dose inhaler may be held about 2 fingerwidths (112 inches [4 cm]) in front of the mouth. B, Alternatively, an inhaler with a spacer device can be used. Clients should breathe deeply once before activating the inhaler and then continue breathing in for about 5 seconds. Clients then should hold their breath for 10 to 15 seconds before breathing out slowly. If a second dose is needed, clients should wait 1 to 2 minutes before taking the second dose.

738 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

The client with a peanut allergy should not take certain ipratropium products because they contain soy lecithin, which is in the same plant family as peanuts.

IV. Glucocorticoids (Corticosteroids) (see Box 55-1) A. Glu cocorticoids act as an tiin flam m ato ry agen ts

an d reduce edem a of th e airways; th ey are used to treat asth m a an d oth er in flam m atory respiratory con d ition s.

B. See Ch apter 51 for in form ation on gluco cortico ids.

V. Leukotriene Modifiers (see Box 55-1) A. Description

1. Used in th e proph ylaxis an d treatm en t of ch ron ic bron ch ial asth m a (n ot used for acute asth m a episo des)

2. In h ibit bron ch ocon striction caused by specific an tigen s an d reduce airway edem a an d sm oo th m uscle con striction

3. Con train dicated in clien ts with h ypersen sitivity an d in breast-feed in g m oth ers

4. Sh o uld be used with caution in clien ts with im paired h epatic fun ctio n

5. Coadm in istration of in h aled glucocorticoids in creases th e risk of upper respiratory in fectio n .

B. Sid e an d ad verse effects 1. Headach e 2. Nausea an d vo m itin g 3. Dysp epsia 4. Diarrh ea 5. Gen eralized pain , m yalgia 6. Fever 7. Dizzin ess

C. In terven tion s 1. Assess lu n g soun ds for rh on ch i an d wh eezin g. 2. Assess liver fun ction labo ratory values. 3. Mon itor for cyan osis.

D. Clien t education 1. To take m ed ication 1 h our before or 2 h ours

after m eals 2. To in crease fluid in take 3. No t to discon tin ue th e m edication an d to take it

as prescribed, even durin g sym pto m -free periods

VI. Inhaled Nonsteroidal Antiallergy Agent (see Box 55-1) A. Description

1. An tiasth m atic, an tiallergic, an d m ast cell stabilizers in h ibit m ast cell release after exposure to an tigen s.

2. Used to treat allergic rh in itis, bron ch ial asth m a, an d exercise-in duced bron ch ospasm

3. Con train dicated in clien ts with kn own h ypersen - sitivity

4. O rally adm in istered crom olyn sodium is used with cau tion in clien ts with im paired h epatic or ren al fun ction .

B. Sid e an d ad verse effects 1. Cough , sn eezin g, n asal stin g, or bron ch ospasm

followin g in h alation

2. Un pleasan t taste in th e m outh C. In terven tion s: Mon itor respiration s an d assess lun g

soun ds for rh on ch i or wh eezin g. D. Clien t education

1. To ad m in ister oral capsules at least 30 m in utes befo re m eals

2. No t to discon tin ue th e m ed ication abru ptly, because a reboun d asth m atic attack can occur

Instruct the client taking inhaled medications to drink a few sips of water before and after inhalation to prevent a cough and an unpleasant taste in the mouth.

VII. Monoclonal Antibody A. Description

1. O m alizum ab is a recom b in an t DNA-derived h um an ized im m un oglobu lin G (IgG) m urin e m on oclon al an tibody th at selectively bin ds to im m un oglobulin E (IgE) to lim it th e release of m ed iators in th e allergic respon se.

2. Used to treat allergy-related asth m a; adm in is- tered subcutan eously every 2 to 4 weeks

3. Do se is titrated on th e basis of th e serum IgE level an d body weigh t.

4. Con train dicated in th ose with h ypersen sitivity to th e m ed ication

B. Side an d adverse effects 1. In jection site reaction s 2. Viral in fectio n s 3. Upp er respiratory in fectio n s 4. Sin usitis 5. Headach e 6. Ph aryn gitis 7. An aph ylaxis 8. Malign an cies

C. In terven tion s 1. Assess respiratory rate, rh yth m , an d dep th , an d

auscultate lun g soun ds. 2. Assess for allergies an d/ o r allergic reactio n sym p-

tom s such as rash or urticaria. 3. Have m ed ication s for th e treatm en t of severe

h ypersen sitivity reaction s available durin g in itial adm in istration in case an aph ylaxis occurs.

D. Clien t education 1. Th at respiratory im provem en t will n ot be

im m ediate 2. No t to stop takin g or decrease th e curren tly pre-

scrib ed asth m a m edication s un less in structed 3. To avoid receivin g live virus vaccin es for th e

duration of treatm en t

VIII. Antihistamines (Box 55-2) A. Description

1. Called histamine antagonists or H1 blockers; th ese m edication s co m pete with h istam in e for receptor sites, th u s preven tin g a h istam in e respo n se.

739CHAPTER 55 Respiratory Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

2. Wh en th e H 1 receptor is stim ulated , th e extravas- cular sm ooth m uscles, in cludin g th ose lin in g th e n asal cavity, are con stricted.

3. Decrease n aso ph aryn geal, gastro in testin al, an d bron ch ial secretio n s by blockin g th e H 1 receptor

4. Used for th e com m on cold, rh in itis, n ausea an d vo m itin g, m otion sickn ess, urticaria, an d as a sleep aid

5. Can cau se CNS depression if taken with alcoh ol, opioids, h ypn otics, or barb iturates

6. Sh o uld be used with caution in clien ts with ch ron ic obstru ctive pulm o n ary disease because of th eir dryin g effect

7. Diph en h ydram in e h as an an tich olin ergic effect an d sh o uld be avoided in clien ts with n arrow- an gle glaucom a.

B. Side an d ad verse effects 1. Drowsin ess an d fatigue 2. Dizzin ess 3. Urin ary reten tion 4. Blurred vision 5. Wh eezin g 6. Con stipation 7. Dry m ou th 8. Gastroin testin al irritatio n 9. Hypo ten sion

10. Hearin g disturban ces 11. Ph o tosen sitivity 12. Nervousn ess an d irritability 13. Con fusion 14. Nigh tm ares

C. In terven tion s 1. Mon itor for sign s of urin ary dysfun ction . 2. Adm in ister with food or m ilk. 3. Avo id subcu tan eous in jection , an d ad m in ister by

in tram uscu lar in jection in a large m uscle if th e in tram uscu lar ro ute is prescribed.

D. Clien t education 1. To avoid h azardo us activities, alcoh ol, an d oth er

CNS depressan ts 2. If th e m edication is bein g taken for m otion sick-

n ess, take it 30 m in utes befo re th e even t an d th en befo re m eals an d at bedtim e durin g th e even t as prescribed.

3. To suck on h ard can dy or ice ch ips for dry m ou th

IX. Nasal Decongestants (Box 55-3) A. Description

1. In clude ad ren ergic, an tich olin ergic, an d cortico- steroid m edication s

2. Sh rin k n asal m ucosal m em bran es an d reduce fluid secretio n

3. Used for allergic rh in itis, h ay fever, an d acute coryza (profuse n asal disch arge)

4. Con train dicated or used with extrem e cau tion in clien ts with h yperten sio n , cardiac disease, h yper- th yroidism , or diab etes m ellitus

B. Side an d adverse effects 1. Nervo usn ess 2. Restlessn ess, in som n ia 3. Hyperten sion 4. Hyperglycem ia

Nasal decongestants can cause tolerance and rebound nasal congestion (vasodilation) caused by irri- tation of the nasal mucosa. Therefore, the client needs to be informed that these medications should not be used for longer than 48 hours.

C. In terven tion s 1. Mon itor for cardiac dysrh yth m ias. 2. Mon itor blood gluco se levels.

D. Clien t education 1. To avoid con sum in g caffeine in large am oun ts

because it can increase restlessness an d palpitations 2. Abou t th e im portan ce of lim itin g th e use of n asal

sprays an d drops to preven t rebou n d n asal con gestion

X. Expectorants and Mucolytic Agents (Box 55-4) A. Description

1. Expectoran ts loosen bron ch ial secretion s so th at th ey can be elim in ated with cough in g; th ey are used for a dry un produ ctive cough an d to stim u- late bron ch ial secretion s.

BOX 55-2 Antihistamines

▪ Brompheniramine ▪ Cetirizine ▪ Chlorpheniramine ▪ Clemastine ▪ Cyproheptadine ▪ Desloratadine

▪ Dimenhydrinate ▪ Diphenhydramine ▪ Fexofenadine ▪ Levocetirizine ▪ Loratadine ▪ Olopatadine

BOX 55-3 Nasal Decongestants Nonglucocorticoids ▪ Oxymetazoline ▪ Phenylephrine

hydrochloride ▪ Pseudoephedrine

hydrochloride

Glucocorticoids ▪ Beclomethasone ▪ Budesonide ▪ Ciclesonide ▪ Flunisolide ▪ Fluticasone propionate ▪ Fluticasone furoate ▪ Mometasone ▪ Triamcinolone

BOX 55-4 Expectorants and Mucolytic Agents Expectorant ▪ Guaifenesin

Mucolytic ▪ Acetylcysteine

740 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

2. Mucolytic agen ts th in m ucou s secretio n s to h elp m ake th e cough m ore produ ctive.

3. Mucolytic agen ts with dextrom eth orph an sh ould n ot be used by clien ts with ch ron ic obstructive pul- m on ary disease because they suppress th e cough .

4. Acetylcystein e can in crease airway resistan ce an d sh o uld n ot be used in clien ts with asth m a.

B. Sid e an d ad verse effects 1. Gastroin testin al irritatio n 2. Rash 3. O ro ph aryn geal irritation

C. In terven tion s 1. Acetylcystein e, adm in istered by n ebulization ,

sh o uld n ot be m ixed with an oth er m ed ication . 2. If acetylcystein e is ad m in istered with a bron ch o-

dilator, th e bron ch odilator sh ould be adm in is- tered 5 m in utes before th e acetylcystein e.

3. Mon itor for side effects of acetylcystein e such as n ausea an d vo m itin g, stom atitis, an d run n y n ose.

D. Clien t education 1. To take th e m ed ication with a full glass of water

to loosen m ucus 2. To m ain tain adequate fluid in take 3. To cough an d deep breath e

XI. Antitussives (Box 55-5) A. Description : Act on th e cough con tro l cen ter in th e

m ed ulla to suppress th e cough reflex; used for a cough th at is n on productive an d irritatin g

B. Sid e an d ad verse effects 1. Dizzin ess, drowsin ess, sedation 2. Gastroin testin al irritatio n , n ausea 3. Dry m ou th 4. Con stipation 5. Resp iratory dep ression

C. In terven tion s 1. En cou rage th e clien t to take adequate fluids with

th e m ed ication . 2. En cou rage th e clien t to sleep with th e h ead of th e

bed elevated . 3. No te th at m edication depen den cy can occur. 4. Avo id adm in istration to th e clien t with a h ead

in ju ry or a posto perative cran ial surgery clien t.

5. Avo id adm in istration to th e clien t usin g opioids, sed ative-h ypn otics, barb iturates, or an tidepres- san ts because CNS dep ression can occur.

D. Clien t education 1. If th e cough lasts lon ger th an 1 week an d a fever

or rash occurs, to n otify th e HCP 2. To avoid h azardo us activities 3. To avoid th e use of alcoh ol

XII. Opioid Antagonists (Box 55-6) A. Description

1. Reverses respiratory dep ression in opioid overdose

2. Avoid its use for n on opioid respiratory depres- sion .

3. Reoccurren ce of respiratory dep ression can occur if duration of opiate exceeds duration of opioid an tagon ist.

B. Side an d adverse effects 1. Nausea, vo m itin g 2. Trem ors 3. Sweatin g 4. In creased blood pressure 5. Tach ycardia

C. In terven tion s 1. Assess vital sign s, especially respiratio n s. 2. For in traven o us adm in istration , th e dose is

titrated every 2 to 5 m in u tes as prescribed. 3. Have oxygen an d resuscitative equ ipm en t avail-

able durin g adm in istration .

XIII. Tuberculosis Medications (Box 55-7) A. Description

1. O ffer th e m ost effective m eth od for treatin g th e disease an d preven tin g tran sm ission

BOX 55-5 Antitussives Opioids ▪ Codeine phosphate, codeine sulfate ▪ Hydrocodone Nonopioids ▪ Benzonatate ▪ Dextromethorphan ▪ Diphenhydramine hydrochloride

BOX 55-6 Opioid Antagonists ▪ Alvimopan ▪ Methylnaltrexone

▪ Naloxone ▪ Naltrexone

BOX 55-7 First-Line and Second-Line Medications for Tuberculosis

First-Line Agents ▪ Isoniazid ▪ Rifampin ▪ Ethambutol ▪ Pyrazinamide

Second-Line Agents ▪ Amikacin ▪ Capreomycin sulfate ▪ Cycloserine ▪ Ethionamide ▪ Levofloxacin ▪ Moxifloxacin ▪ p-Aminosalicylic acid ▪ Rifabutin ▪ Rifapentine ▪ Streptomycin

741CHAPTER 55 Respiratory Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

2. Treatm en t of iden tified lesion s depen ds on wh eth er th e in dividual h as active disease or h as on ly been exposed to th e disease.

3. Treatm en t is difficult because th e bacterium h as a waxy substan ce on th e cap sule th at m akes pen e- tration an d destru ction difficult.

4. Th e use of a m ultidrug regim en destroys organ - ism s as quickly as possible an d m in im izes th e em ergen ce of drug-resistan t organ ism s.

5. Active tuberculosis is treated with a com bin ation of m edication s to wh ich th e organ ism is susceptible.

6. In dividuals with active tubercu losis are treated for 6 to 9 m on th s; h owever, clien ts with h um an im m un od eficien cy virus (HIV) in fection are treated for a lon ger period of tim e.

7. After th e in fected in dividual h as received m edica- tio n for 2 to 3 weeks, th e risk of tran sm ission is greatly reduced.

8. Most clien ts h ave n egative sputum cultures after 3 m on th s of com plian ce with m ed ication th erapy.

9. In dividuals wh o h ave been exposed to active tuberculosis are treated with preven tive ison iazid for 9 to 12 m on th s.

B. First-lin e or secon d-lin e m ed ication s 1. First-lin e m ed ication s provide th e m ost effective

an tituberculo sis activity. 2. Secon d-lin e m ed ication s are used in com bin a-

tio n with first-lin e m edication s but are m ore toxic.

3. Curren t in fectin g organ ism s are provin g resistan t to stan dard first-lin e m edication s; th e resistan t organ ism s develop because in dividuals with th e disease fail to com plete th e course of treat- m en t, so survivin g bacteria ad apt to th e m edica- tio n an d beco m e resistan t.

4. Multidrug th erap ies are in stituted because of th e resistan t organ ism s.

C. Multidrug-resistant strain of tuberculosis (MDR-TB) 1. Resistan ce occurs wh en a clien t receivin g 2 m ed-

ication s (first-lin e an d secon d-lin e m edication s) discon tin u es 1 of th e m edication s.

2. Th e clien t briefly exp erien ces som e respo n se fro m th e sin gle m edication but th en large n um - bers of resistan t organ ism s begin to grow.

3. Th e clien t, in fectio us again , tran sm its th e drug- resistan t organ ism to oth er in dividuals.

4. As th is even t is repeated, an organ ism develo ps th at is resistan t to m an y of th e first-lin e tubercu- lo sis m ed ication s.

D. Gen eral clien t education poin ts for tuberculosis m ed ication s 1. No t to skip doses an d to take m ed ication for th e

full len gth of th e prescribed th erapy 2. No t to take an y oth er m edication with ou t con -

sultin g with th e HCP

3. Abou t th e im portan ce of follo w-up HCP visits an d laborato ry tests

4. To avoid alcoh ol 5. To take m ed ication on an em p ty stom ach with

8 oz of water 1 h ou r befo re or 2 h ours after m eals an d to avoid takin g an tacids with th e m edication

6. Abou t th e ad verse effects th at require HCP n otification

XIV. First-Line Medications for Tuberculosis (see Box 55-7)

A. Ison iazid 1. Description

a . Bactericidal b . In h ibits th e syn th esis of m ycolic acids an d

acts to kill actively growin g organ ism s in th e extracellular en viron m en t

c. In h ibits th e growth of dorm an t organ ism s in th e m acroph ages an d caseatin g gran ulom as

d . Is active on ly durin g cell division an d is used in com bin ation with oth er an titub ercular m edication s

2. Con train dication s an d cautio n s a . Con train dicated in clien ts with h ypersen sitiv-

ity or with acu te liver disease b . Use with cau tion in clien ts with ch ron ic liver

disease, alcoh olism , or ren al im pairm en t. c. Use with caution in clien ts takin g n icotin ic

acid. d . Use with cau tion in clien ts takin g h epatoto xic

m edication s because th e risk for h epatoto xic- ity in creases.

e. Alcoh o l in creases th e risk of h epatotoxicity. f. May in crease th e risk of toxicity of carbam az-

epin e an d ph en ytoin g. May decrease ketocon azole con cen tration s

3. Side an d ad verse effects a . Hypersen sitivity reaction s b . Periph eral n euritis c. Neurotoxicity d . Hepatoto xicity an d h epatitis; in creased liver

fun ctio n test levels e. Pyrido xin e deficien cy f. Irritation at in jection site with in tram uscular

adm in istration g. Nausea an d vom itin g h . Dry m outh i. Dizzin ess j. Hyperglycem ia

k . Vision ch an ges 4. In terven tion s

a . Assess for h ypersen sitivity. b . Assess for h epatic dysfun ction . c. Assess for sen sitivity to n icotin ic acid. d . Mon itor liver fun ction test results. e. Monitor for signs of hepatitis, such as anorexia,

nausea, vom iting, weakness, fatigue, dark urine,

742 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

or jaundice; if these sym ptom s occur, withhold the m edication and notify the HCP.

f. Mon itor for tin glin g, n um bn ess, or burn in g of th e extrem ities.

g. Assess m en tal status. h . Mon itor for visu al ch an ges, an d n otify th e

HCP if th ey occur. i. Assess for dizzin ess an d in itiate safety

precaution s. j. Mon itor com plete blood coun t (CBC) an d

blood glucose levels. k . Adm in ister ison iazid 1 h our before or

2 h ours after a m eal because food m ay delay absorption .

l. Adm in ister ison iazid at least 1 h our before an tacids.

m . Adm in ister pyrido xin e as prescribed to reduce th e risk of n eurotoxicity.

Many tuberculosis medications can cause toxic effects such as hepatotoxicity, nephrotoxicity, neurotox- icity, optic neuritis, or ototoxicity. Teach the client about the signs of toxicity and inform the client that the HCP needs to be notified if any signs arise.

5. Clien t edu cation a . To avoid tyram in e-con tain in g foods because

th ey m ay cause a reaction such as red an d itch in g skin , a poun din g h eartbeat, lightheadedness, a h ot or clam m y feeling, or a h eadach e; if this occurs, the client should n otify th e HCP.

b . To recogn ize th e sign s of n eurotoxicity, h epatitis, an d h epatotoxicity

c. To n otify the HCP if sign s of n eurotoxicity, h epatitis an d h epatotoxicity, or visual ch an ges occur

B. Rifam pin 1. Descriptio n

a . In h ibits bacterial RNA syn th esis b . Bin ds to DNA-depen den t RNA polym erase

an d blocks RNA tran scription c. Used with at least 1 oth er an titub ercular

m ed ication 2. Con train dication s an d cau tion s

a . Con train dicated in clien ts with h ypersensitivity b . Used with cau tion in clien ts with h epatic dys-

fun ction or alcoh olism c. Use of alcoh ol or h epatotoxic m ed ication s

m ay in crease th e risk of h epatoto xicity. d . Decreases th e effects of several m edication s,

in cludin g oral an ticoagulan ts, oral h ypoglyce- m ics, ch loram ph en icol, digoxin , disopyram ide ph osph ate, m exiletin e, quin idin e polygalactur- on ate, flucon azole, m eth adone h ydroch loride, ph en ytoin , an d verapam il h ydroch loride

3. Sid e an d adverse effects a . Hypersen sitivity reactio n , in cludin g fever,

ch ills, sh iverin g, h ead ach e, m uscle an d bon e pain , an d dyspn ea

b . Heartb urn , n ausea, vo m itin g, diarrh ea c. Red-o ran ge–colored body secretio n s d . Visio n ch an ges e. Hepatoto xicity an d h epatitis f. In creased uric acid levels g. Bloo d dyscrasias h . Colitis

4. In terven tion s a . Assess for h ypersen sitivity. b . Evaluate CBC, uric acid, an d liver fun ctio n

test results. c. Assess for sign s of h epatitis; if th ey occur,

with h o ld th e m ed icatio n an d n o tify th e H CP.

d . Mon itor for sign s of colitis. e. Assess for visual ch an ges.

5. Clien t education a. Th at urin e, feces, sweat, an d tears will be red-

oran ge an d th at soft con tact len s can beco m e perm an en tly discolored

b . To n otify th e HCP if jaun dice (yellow eyes or skin ) develops or if weakn ess, fatigue, n ausea, vo m itin g, sore th roat, fever, or un usual bleed- in g occurs

C. Eth am b utol 1. Description

a . Bacteriostatic b . In terferes with cell m etab olism an d m ultipli-

cation by in h ibitin g 1 or m ore m etab olites in susceptible organ ism s

c. In h ibits bacterial RNA syn th esis an d is active on ly durin g cell division

d . Slow-actin g an d m ust be used with oth er bac- tericid al agen ts

2. Con train dication s an d cautio n s a . Con train dicated in clien ts with h ypersen sitiv-

ity or optic n euritis an d in ch ildren youn ger th an 13 years

b . Used with cau tion in clien ts with ren al dys- fun ction , gout, ocular defects, diabetic reti- n opath y, cataracts, or ocular in flam m atory con dition s

c. Used with cau tion in clien ts takin g n euro- toxic m edication s because th e risk for n euro- toxicity in creases

3. Sid e an d ad verse effects a . Hypersen sitivity reaction s b . An orexia, n ausea, vom itin g c. Dizzin ess d . Malaise e. Men tal con fusion f. Join t pain g. Derm atitis h . O ptic n euritis i. Periph eral n euritis j. Th rom b ocytopen ia

k . In creased uric acid levels l. An aph ylactoid reaction

743CHAPTER 55 Respiratory Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

4. In terven tion s a. Assess th e clien t for h ypersen sitivity. b . Evaluate results of CBC, uric acid, an d ren al

an d liver fun ction tests. c. Mon itor for visu al ch an ges such as altered

color percep tion an d decreased visual acu ity; if ch an ges occur, with h old th e m ed ication an d n otify th e HCP.

d . Adm in ister on ce every 24 h ours an d adm in is- ter with food to decrease gastro in testin al upset.

e. Mon itor uric acid con cen tration an d assess for pain ful or swollen join ts or sign s of gout.

f. Mon itor in take an d outp ut an d for adequate ren al fun ction .

g. Assess m en tal status. h . Mon itor for dizzin ess an d in itiate safety

precaution s. i. Assess for periph eral n euritis (n um b n ess, tin -

glin g, or burn in g of th e extrem ities); if it occurs, n otify th e HCP.

5. Clien t education a. Th at n ausea, related to th e m edication , can

be preven ted by takin g th e daily dose at bed- tim e or by takin g th e prescribed an tin au sea m edication s

b . To n otify th e HCP im m ediately if an y visu al problem s occur or if a rash , swellin g an d pain in th e join ts, or n um bn ess, tin glin g, or burn - in g in th e h an ds or feet occurs

D. Pyrazin am ide 1. Description

a. Th e exact m ech an ism of action is un kn own . b . May be bacteriostatic or bactericidal, depen d-

in g on its con cen tration at th e in fectio n site an d on th e susceptibility of th e in fectin g organ ism

c. Used with at least 1 oth er an titubercular m ed- ication if in effectiven ess of th e prim ary m ed- ication (s) occurs

2. Con train dication s an d cautio n s a. Con train dicated in clien ts with h ypersen si-

tivity b . Used with cau tion in clien ts with diabetes

m ellitus, ren al im pairm en t, or go ut, an d in ch ildren

c. May decrease th e effects of allopu rin ol, col- ch icin e, an d proben ecid

d . Cross-sen sitivity is possible with ison iazid, eth ion am id e, or n icotin ic acid.

3. Sid e an d ad verse effects a. In creases liver fun ction tests an d uric acid

levels b . Arth ralgia, m yalgia c. Ph otosen sitivity d . Hepatoto xicity e. Th rom b ocytopen ia

4. In terven tion s a . Assess for h ypersen sitivity. b . Evaluate CBC, liver fun ction test results, an d

uric acid levels. c. O bserve for h epatotoxic effects; if th ey occur,

with h old th e m ed ication an d n otify th e HCP. d . Assess for pain ful or swollen join ts. e. Evaluate blood gluco se level because diabetes

m ellitus m ay be difficult to con trol wh ile cli- en t is takin g th e m edication .

5. Clien t education a . To take th e m ed ication with food to reduce

gastro in testin al distress b . To avoid sun ligh t or ultraviolet ligh t un til

ph otosen sitivity is determ in ed

Some tuberculosis medications can cause red- orange–colored body secretions. Inform the client that this is not a harmful effect but that the secretions can stain and permanently discolor items.

XV. Second-Line Medications for Tuberculosis (see Box 55-7)

A. Rifabu tin 1. Descriptio n

a. In h ibits m ycobacterial DNA-depen den t RNA polym erase an d supp resses protein syn th esis

b . Used to preven t dissem in ated Mycobacterium avium com plex (MAC) disease in clien ts with ad van ced HIV in fection

c. Used to treat active MAC disease an d tubercu- lo sis in clien ts with HIV in fectio n

2. Caution s a . Can affect blood levels of som e m ed ication s,

in cludin g oral con tracep tives an d som e m ed- ication s used to treat HIV in fectio n

b . A n on h orm onal m eth od of birth control sh ould be used in stead of an oral con traceptive.

3. Sid e an d adverse effects a . Rash b . Gastroin testin al disturban ces c. Neutropen ia d . Red-o ran ge–colored body secretio n s e. Uveitis f. Myositis g. Arth ralgia h . Hepatitis i. Ch est pain with dyspn ea j. Flulike syn drom e

4. In terven tion s a. O bserve for h epatotoxic effects; if th ey

occur, with h old th e m edication an d n otify th e HCP.

b . Assess for pain ful or swollen join ts. c. Assess for ocular pain or blurred vision .

5. Clien t education : Th at th e m ed ication can be taken with out regard to food

744 UNIT XII Respiratory Disorders of the Adult Client

B. Rifapen tin e 1. Description : Used on ly for pulm on ary tuberculosis 2. Caution s: Can affect blood levels of som e m edica-

tion s, in cludin g oral con traceptives an d warfarin , an d som e m edication s used to treat HIV in fection

3. Side an d adverse effects a . Red-oran ge–colored body secretion s b . Hepatoto xicity

4. In terven tion s a . O btain baselin e liver fun ction studies an d

assess th rou gh out th erap y. b . O bserve for h epatotoxic effects; if th ey occur,

with h old th e m ed ication an d n otify th e HCP. 5. Clien t education

a. Th at th e m edication can be taken with out regard to food

b . To avoid sun ligh t or ultraviolet ligh t un til ph otosen sitivity is determ in ed

c. Th at red-oran ge–colored body secretio n s m ay occur

C. Capreom ycin sulfate 1. Descrip tion

a. Mech an ism of action is un kn own . b . Used to treat MDR-TB wh en sign ifican t resis-

tan ce to oth er m edication s is expected c. Adm in istered in tram uscularly

2. Con train dication s an d caution s a. Th e risk of n eph ro toxicity, ototo xicity, an d

n eurom u scular blockade is in creased with th e use of am in oglycosides or loop diuretics.

b . Used with cau tion in clien ts with ren al in suf- ficien cy, acoustic n erve im pairm en t, h epatic disorder, m yasth en ia gravis, or parkin son ism

c. Not adm in istered to clien ts receivin g strepto- m ycin

3. Side an d adverse effects a. Neph rotoxicity b . O totoxicity c. Neurom u scular blockade

4. In terven tion s a. Perform baselin e audiom etric testin g. b . Assess ren al, h epatic, an d electrolyte levels

before adm in istration . c. Mon itor in take an d outp ut. d . Recon stituted m edication m ay be stored for

48 h ours at room tem perature. e. Adm in ister in tram uscu larly, deep in to a large

m uscle m ass. f. Rotate in jection sites. g. O bserve in jection site for redn ess, excessive

bleedin g, an d in flam m ation . 5. Clien t education

a. Not to perform tasks th at require m en tal alertn ess

b . To report an y h earin g lo ss, balan ce distur- ban ces, respiratory difficulty, weakn ess, or sign s of h ypersen sitivity reaction s

D. An tibiotics 1. Descrip tion

a . Am in oglycoside an tibiotics or flu oroquin o- lo n es are given with at least 1 oth er an titub er- cular m ed ication .

b . Bactericidal because of receptor-bin din g action in terferin g with protein synthesis in susceptible m icroorganism s

c. Gastroin testin al disturban ces are th e m ost com m on side effect.

d . Flu oroquin olon es are n ot recom m en ded for use in ch ildren .

2. Con train dication s an d cau tion s a . Con train dicated in clien ts with h ypersen si-

tivity, n eurom uscular disorders, or eigh th cran ial n erve dam age

b . Used with cautio n in th e older clien t, in n eo- n ates because of ren al in sufficien cy an d im m aturity, an d in yo un g in fan ts because it m ay cause CNS depression

c. Th e risk of toxicity in creases if taken with oth er am in oglycosides or n eph rotoxicity- or ototo xicity-p roducin g m ed ication s.

3. Side an d adverse effects a . Hypersen sitivity b . Pain an d irritatio n at th e in jection site c. Neph rotoxicity is in dicated by in creased

blood urea n itrogen an d serum creatin in e levels.

d . O toto xicity is in dicated by tin n itus, dizzi- n ess, rin gin g or roarin g in th e ears, an d reduced h earin g.

e. Neurotoxicity is in dicated by h ead ach e, dizzin ess, leth argy, trem o rs, an d visual disturban ces.

f. Superin fection s 4. In terven tion s

a . Assess for h ypersen sitivity. b . Mon itor for ototoxic, n eurotoxic, an d n eph -

ro toxic reaction s. c. Mon itor liver an d ren al fun ction test results. d . O btain baselin e audiom etric test an d repeat

every l to 2 m on th s because th e m edication im pairs th e eigh th cran ial n erve.

e. Assess acu ten ess of h earin g. f. Mon itor for visual ch an ges. g. Assess h ydration status an d m ain tain ade-

quate h ydration durin g th erap y. h . Mon itor in take an d outp ut. i. Assess urin alysis. j. Mon itor for superin fectio n .

5. Clien t edu cation : To n otify th e HCP if h earin g loss, ch an ges in vision , or urin ary problem s occur

E. Eth ion am ide 1. Descrip tion

a . Mech an ism of action is un kn own .

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

745CHAPTER 55 Respiratory Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

b . Used to treat MDR-TB wh en sign ifican t resis- tan ce to oth er m edication s is expected

2. Con train dication s an d cau tion s a . Con train dicated in clien ts with h ypersen -

sitivity b . Used with caution in clien ts with diabetes

m ellitus or ren al dysfun ction 3. Side an d adverse effects

a . An o rexia, n ausea, vom itin g b . Metallic taste in th e m outh c. O rth ostatic h ypoten sion d . Jau n dice e. Men tal ch an ges f. Periph eral n euritis g. Rash

4. In terven tion s a . Assess liver an d ren al fun ctio n test results. b . Mon itor gluco se levels in th e clien t with dia-

betes m ellitus. c. Adm in ister pyridoxin e as prescribed to

reduce th e risk of n eurotoxicity. 5. Clien t edu cation

a . To take m ed ication with food or m eals to m in im ize gastro in testin al irritatio n

b . To ch an ge position s slowly c. To report sign s of a rash , wh ich can progress

to exfoliative derm atitis if th e m ed ication is n ot discon tin ued

F. Am in osalicylic acid 1. Descrip tion

a . In h ibits folic acid m etabolism in m ycobacteria b . Used to treat MDR-TB wh en sign ifican t resis-

tan ce to oth er m edication s is exp ected 2. Con train dication s an d cau tion s

a . Con train dicated with h ypersen sitivity to am i- n osalicylates, salicylates, or com po un ds con - tain in g th e para-am in o ph en ol grou p

b . Am in oben zoates block th e absorption of am in osalicylate sodium .

3. Side an d adverse effects a . Hypersen sitivity b . Bitter taste in th e m ou th c. Gastroin testin al tract irritatio n d . Exfoliative derm atitis e. Bloo d dyscrasias f. Crystalluria g. Ch an ges in th yroid fun ction

4. In terven tion s a . Assess for h ypersen sitivity. b . O ffer water to rin se th e m outh and ch ewin g

gum or h ard can dy to alleviate the bitter taste. c. En cou rage fluid in take to preven t crystalluria. d . Mon itor in take an d outp ut.

5. Clien t edu cation a . To discard th e m edication an d obtain a n ew

supp ly if a purplish -brown discoloratio n occurs

b . To take th e m edication with food c. Th at urin e m ay turn red on con tact with

h ypo ch lorite bleach if bleach was used to clean a toilet

d . No t to take aspirin or over-th e-cou n ter m ed- ication s with out th e HCP’s ap proval

e. To report sign s of a blood dyscrasia, such as sore th roat or m ou th , m alaise, fatigue, bruis- in g, or bleedin g

G. Cycloserin e 1. Descriptio n

a . In terferes with cell wall biosyn th esis b . Used to treat MDR-TB wh en sign ifican t resis-

tan ce to oth er m edication s is expected 2. Con train dication s an d cau tion s

a . Use of alcoh ol or eth ion am ide in creases th e risk of seizures

b . Used with caution in clien ts with a seizu re disorder, depression , severe an xiety, psych o- sis, or ren al in sufficien cy, or in clien ts wh o use alcoh ol

3. Sid e an d adverse effects a . Hypersen sitivity b . CNS reaction s c. Neurotoxicity d . Seizu res e. Heart failure f. Headach e g. Vertigo h . Altered level of con scio usn ess i. Irritability, n ervou sn ess, an xiety j. Con fusion

k . Moo d ch an ges, dep ression , th ough ts of suicide

4. In terven tion s a . Mon itor level of con scio usn ess. b . Mon itor for ch an ges in m en tal status an d

th o ugh t processes. c. Mon itor ren al an d h epatic fun ction tests. d . Mon itor serum m ed ication level to avoid

th e risk of n eurotoxicity; th e peak con cen tra- tion , m easured 2 h ours after dosin g, sh ould be 25 to 35 m cg/ m L (140 to 195 m cm o l/ L).

5. Clien t edu cation a . To take th e m edication after m eals to preven t

gastro in testin al upset b . To report sign s of a rash or sign s of CNS

toxicity c. To avoid drivin g or perform in g tasks th at

require alertn ess un til th e reaction to th e m ed ication h as been determ in ed

d . Abou t th e n eed for m on itorin g serum m ed i- cation levels weekly, as prescribed

H. Strepto m ycin 1. Descriptio n

a. An am in oglycoside an tibiotic used with at least 1 oth er an titub ercular m edication

746 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

b . Bactericidal because of receptor-bin din g action th at in terferes with protein syn th esis in susceptible organ ism s

2. Con train dication s an d caution s a. Con train dicated in clien ts with h ypersen si-

tivity, m yasth en ia gravis, parkin son ism , or eigh th cran ial n erve dam age

b . Used with caution in the older client, in n eo- n ates because of ren al in sufficien cy an d organ im m aturity, an d in youn g in fan ts because the m edication m ay cause CNS depression

c. Th e risk of toxicity in creases wh en taken with oth er am in oglycosides or n eph rotoxicity- or ototoxicity-producin g m edication s.

3. Side an d adverse effects ( Box 55-8) 4. In terven tion s

a. Assess for h ypersen sitivity. b . Mon itor liver an d ren al fun ction test results. c. Mon itor for ototoxic, n eurotoxic, an d n eph -

rotoxic reaction s. d . Perform baselin e audiom etric testin g an d

repeat every l to 2 m on th s because th e m ed- ication im pairs th e eigh th cran ial n erve.

e. Mon itor for visu al ch an ges. f. Assess h ydration status an d m ain tain ad e-

quate h ydration durin g th erap y. g. Mon itor in take an d outp ut. h . Assess urin alysis results. i. Mon itor for sign s of periph eral n euritis.

5. Clien t education : To n otify th e HCP if h earin g loss, ch an ges in vision , or urin ary problem s occur

XVI. Influenza Medications A. Vaccin es (Box 55-9)

1. Description a. Because th e strain of in fluen za virus is

differen t every year, an n ual vaccin ation is recom m en ded (usually in O ctober or No vem ber); each tim e a flu vaccin e is adm in - istered , th e n urse sh ould in form th e clien t of an y updated in form ation regardin g th e vaccin e.

b . Vaccin e is available as in activated in fluen za vaccin e adm in istered in tram uscularly or as a live atten uated in fluen za vaccin e, wh ich is adm in istered n asally.

The trivalent influenza vaccine includes vaccina- tion against H1N1 and H3N2 strains (influenza A s trains) and an influenza B strain. Because the s train of influenza virus is different every year, vaccine com po- nents m ay change. The vaccine is recom m ended for all individuals unless a contraindication to receiving it exists.

2. Vaccin e a. Th e n asal spray (live) vaccin e is approved

on ly for h ealth y peo ple ages 2 th rou gh 49. b . Th e n asal spray vaccin e is n ot ap proved for

pregn an t wom en . c. Th e flu sh o ts (in activated vaccin e), depen d-

in g on th e m an ufacturer, are approved for ch ildren as youn g as 6 m on th s of age an d are safe for pregn an t wom en .

d . Th e n asal spray con tain s a live flu virus th at h as been weaken ed to th e poin t th at it can n ot cause th e flu; its advan tage is th at it m ay elicit a stron ger im m un e respon se th an th e flu sh ot in ch ildren wh o h ave n ever h ad th e flu or a flu vaccin e befo re.

e. Th e disadvan tage of th e n asal spray is th at it m ay n ot be quite as protective as th e flu sh ot for older people wh o h ave h ad th e flu or flu vaccin es befo re.

f. All in dividuals sh ould receive an in fluen za vaccin e. High -priority in dividuals in clude pregn an t wom en ; h ou seh old co n tacts an d caregivers of ch ildren youn ger th an 6 m on th s of age; peo ple ages 6 m on th s to 24 years; h ealth care workers an d em ergen cy m ed ical perso n n el; an d adults ages 25 to 64 with a ch ron ic m edical con dition , such as asth m a, or a weaken ed im m un e system , wh ich in creases th e risk of flu com plication s.

3. Con train dication s an d cautio n s a. Con train dication s of th e in activated vaccin e

in clude h ypersen sitivity, ch icken egg allergy, active in fectio n , Guillain -Barré syn dro m e, active febrile illn ess, an d ch ildren youn ger th an 6 m on th s.

BOX 55-9 Influenza Vaccines Inactivated (Intramuscular Administration) ▪ Afluria ▪ Fluarix ▪ FluLaval ▪ Flucelvax

▪ Flublok ▪ Fluvirin ▪ Fluzone Live, Attenuated (Nasal Administration) ▪ FluMist

BOX 55-8 Side and Adverse Effects of Streptomycin

Nephrotoxicity ▪ Changes in urine output ▪ Decreased appetite ▪ Increased thirst ▪ Nausea, vomiting Neurotoxicity ▪ Muscle numbness ▪ Seizures ▪ Tingling ▪ Twitching

Vestibular Toxicity ▪ Clumsiness ▪ Dizziness ▪ Unsteadiness Auditory Toxicity (Ototoxicity) ▪ A full feeling in the ears ▪ Ringing in the ears ▪ Loss of hearing

747CHAPTER 55 Respiratory Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

b . Con train dication s of th e live atten uated vac- cin e in clude age youn ger th an 2 years or adults 50 years or older; pregn an t wom en ; ch ildren or adolescen ts on lon g-term aspirin th erap y; an d th o se with severe n asal con ges- tion or lon g-term con dition s such as asth m a, diab etes m ellitus, an em ia or blood disorders, or h eart, kidn ey, or lun g disease.

4. Side an d ad verse effects a . In activated vaccin e: Localized pain an d swell-

in g at th e in jection site, gen eral body ach es an d pain s, m alaise, fever

b . Atten uated vaccin e: Run n y n ose or n asal con - gestion , co ugh , h eadach e, sore th roat

5. In terven tion s a. Th e in tram uscular route is recom m en ded for

th e in activated vaccin e; adults an d older ch il- dren sh ould be vaccin ated in th e deltoid m uscle.

b . Mon itor for side an d ad verse effects of th e vaccin e.

c. Mon itor for h ypersen sitivity reaction s in cli- en ts receivin g vaccin ation for th e first tim e.

6. Clien t education a. Abou t th e im portan ce of an an n ual

vaccin ation b . Th at th e in activated vaccin e con tain s n on in -

fectious, killed viruses an d can n ot cau se in fluen za

c. Th at an y respiratory disease un related to in fluen za can occur after th e vaccin ation

d . Th at if th e atten uated vaccin e is received, th e virus m ay be sh ed in secretio n s up to 2 days after vaccin ation

e. Th at develo pm en t of an tibod ies in adults takes approxim ately 2 weeks

7. Visit th e Cen ters for Disease Con trol an d Preven- tion for updates (h ttp:/ / www.cdc.gov/ flu/ protect/ vaccin e/ in dex.h tm ).

B. An tiviral m ed ication s (Table 55-1) 1. Description

a. Use durin g outb reaks of in fluen za depen ds on th e curren t strain of in fluen za

b . Diagn osis of in fluen za sh ould in clude rapid diagn ostic tests because in fection from oth er path o gen s m ay cause sym pto m s sim ilar to th ose of in fluen za in fection .

c. May also be adm in istered as proph ylaxis again st in fection but sh o uld n ot replace vaccin ation

2. Con train dicated in h ypersen sitive clien ts 3. Side an d ad verse effects (see Table 55-1) 4. In terven tion s

a. Adm in ister with in 2 days of onset of sym ptom s and con tin ue for th e en tire prescription .

b . Mon itor for side an d adverse effects of spe- cific m ed ication s.

5. Clien t education a . Th at th e m edication m ay n ot preven t th e

tran sm ission of in fluen za to oth ers b . About th e n eed to adju st activities if dizzin ess

or fatigue occur c. About m an agem en t of side an d adverse

effects of various m ed ication s d . To take m edication exactly as prescribed an d

for th e duration of prescription

XVII. Pneumococcal Conjugate Vaccine A. Pn eum ococcal co n jugate vaccin e is used for th e pre-

ven tio n of in vasive pn eum ococcal disease in in fan ts an d ch ildren .

B. Pn eum ococcal polysacch aride vaccin e is used for adults an d h igh -risk ch ildren older th an 2 years.

C. Side an d adverse effects m ay in clude eryth em a, swell- in g, pain , an d ten dern ess at th e in jection site; fever; irritab ility; drowsin ess; an d reduced ap petite.

D. See Ch apter 44 for addition al in form ation about vaccin es for pn eum on ia.

CRITICAL THINKING What Should You Do? Answer: A major adverse effect of isoniazid is nonviral hep- atitis. Signs include anorexia, nausea, vomiting, weakness, fatigue, dark urine, or jaundice. If these symptoms occur, the nurse should withhold the medication and notify the health care provider. The nurse should also check the client’s liver function test results for elevations, such as alanine aminotrans- ferase (ALT), the normal level being 4 to 36 U/ L (4 to 36 U/ L); aspartate aminotransferase (AST), the normal level being 0 to 35 U/ L (0 to 35 U/ L); and the total bilirubin level, the normal level being 0 .3 to 1.0 mg/ dL (5.1 to 17 mcmol/ L). If these are elevated, the client could be experiencing nonviral hepatitis.

References: Ignatavicius, Workman (20 16), p. 597; Burchum, Rosenthal (2016), p. 531.

TABLE 55-1 Side and Adverse Effects of Antiviral Influenza Medications

Antiviral Medication Side and Adverse Effects

Amantadine Drowsiness, anxiety, psychosis, depression, hallucinations, tremors, confusion, insomnia, orthostatic hypotension, heart failure, blurred vision, constipation, dry mouth, urinary frequency and retention, leukopenia, photosensitivity, dermatitis

Oseltamivir Insomnia, diarrhea, abdominal pain, cough

Rimantadine Depression, hallucinations, tremors, seizures, insomnia, poor concentration, asthenia, gait abnormalities, anxiety, confusion, pallor, palpitations, hypotension, edema, tinnitus, eye pain, constipation, dry mouth, anorexia, abdominal pain, diarrhea, dyspepsia, rash

Zanamivir Ear, nose, and throat infections; diarrhea; nasal symptoms; cough; sinusitis; bronchitis

748 UNIT XII Respiratory Disorders of the Adult Client

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

P R A C T I C E Q U E S T I O N S 649. A clien t h as a prescription to take guaifen esin . Th e

n urse determ in es th at th e clien t un derstan ds th e proper adm in istration of th is m ed ication if th e cli- en t states th at h e or sh e will perform wh ich action ? 1. Take an extra dose if fever develo ps 2. Take th e m edication with m eals on ly 3. Take th e tablet with a full glass of water 4. Decrease th e am oun t of daily flu id in take

650. Th e n urse is preparin g to adm in ister a dose of n al- oxon e in traven o usly to a clien t with an opioid overdose. Wh ich supportive m edical equipm en t sh ould th e n urse plan to h ave at th e clien t’s bed side if n eeded? 1. Naso gastric tube 2. Paracen tesis tray 3. Resuscitation equipm en t 4. Cen tral lin e in sertion tray

651. Th e n urse teach es a clien t about th e effects of diph en h ydram in e, wh ich h as been prescribed as a cough supp ressan t. Th e n urse determ in es th at th e clien t n eed s fu rth er in stru ctio n if th e clien t m akes wh ich statem en t? 1. “I will take th e m edication on an em pty stom ach .” 2. “I won ’t drin k alcoh ol wh ile takin g th is

m edication .” 3. “I won ’t do activities th at require m en tal alert-

n ess wh ile takin g th is m edication .” 4. “I will use sugarless gum , can dy, or oral rin ses to

decrease dryn ess in m y m outh .”

652. A crom olyn sodium in h aler is prescribed for a clien t with allergic asth m a. Th e n urse provides in struc- tion s regardin g the adverse effects of th is m edication an d sh ould tell th e clien t th at wh ich un desirable effect is associated with th is m edication ? 1. In som n ia 2. Con stipation 3. Hypoten sion 4. Bron ch ospasm

653. Terbutalin e is prescribed for a clien t with bron ch i- tis. Th e n urse ch ecks th e clien t’s m edical h isto ry for wh ich disorder in wh ich th e m ed ication sh ould be used with cau tion ? 1. O steoarth ritis 2. Hypoth yroidism 3. Diabetes m ellitus 4. Polycystic disease

654. Zafirlukast is prescribed for a clien t with bron ch ial asth m a. Wh ich laborato ry test does th e n urse expect to be prescribed before th e adm in istration of th is m edication ? 1. Platelet coun t

2. Neutroph il coun t 3. Liver fun ctio n tests 4. Com p lete blood coun t

655. A clien t h as been takin g ison iazid for 2 m on th s. Th e clien t com plain s to th e n urse about n um bn ess, paresth esias, an d tin glin g in th e extrem ities. Th e n urse in terprets th at th e clien t is experien cin g wh ich problem ? 1. Hypercalcem ia 2. Periph eral n euritis 3. Sm all blood vessel spasm 4. Im p aired periph eral circulation

656. A clien t is to begin a 6-m on th course of th erap y with ison iazid. Th e n urse sh ould plan to teach th e clien t to take wh ich action ? 1. Use alcoh ol in sm all am oun ts on ly. 2. Report yello w eyes or skin im m ediately. 3. In crease in take of Swiss or aged ch eeses. 4. Avoid vitam in supplem en ts durin g th erapy.

657. A clien t h as been started on lon g-term th erap y with rifam p in . Th e n urse sh ould provid e wh ich in for- m ation to th e clien t about th e m ed ication ? 1. Sh o uld always be taken with food or an tacids 2. Sh ould be doub le-dosed if 1 dose is forgotten 3. Causes oran ge discoloratio n of sweat, tears,

urin e, an d feces 4. May be discon tin ued in depen den tly if sym p-

tom s are gon e in 3 m on th s

658. Th e n urse h as given a clien t takin g eth am bu tol in form ation about th e m ed ication . Th e n urse determ in es th at th e clien t un derstan ds th e in struc- tio n s if th e clien t states th at h e or sh e will im m ed i- ately report wh ich fin din g? 1. Im p aired sen se of h earin g 2. Gastroin testin al side effects 3. O ran ge-red discoloration of body secretio n s 4. Difficulty in discrim in atin g th e color red

from green

659. A clien t with tubercu losis is bein g started on an ti- tuberculosis th erapy with ison iazid . Before givin g th e clien t th e first dose, th e n urse sh ould en sure th at wh ich baselin e study h as been com pleted? 1. Electrolyte levels 2. Coagulation tim es 3. Liver en zym e levels 4. Serum creatin in e level

660. Th e n urse h as a prescription to give a clien t salm e- terol, 2 puffs, an d beclom eth ason e dipropion ate, 2 puffs, by m etered-dose in h aler. Th e n urse sh ould ad m in ister th e m ed ication usin g wh ich proced ure? 1. Beclom eth aso n e first an d th en th e salm etero l 2. Salm eterol first an d th en th e beclom eth ason e

749CHAPTER 55 Respiratory Medications

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

3. Altern atin g a sin gle puff of each , begin n in g with th e salm eterol

4. Altern atin g a sin gle puff of each , begin n in g with th e beclom eth ason e

661. Rifabu tin is prescribed for a clien t with active Myco- bacterium avium com plex (MAC) disease an d tuber- culosis. For wh ich side an d adverse effects of th e m ed ication sh o uld th e n urse m on itor? Select all th at ap p ly.

1. Sign s of h epatitis 2. Flulike syn d rom e 3. Low n eutroph il coun t 4. Vitam in B6 deficien cy 5. O cular pain or blurred vision 6. Tin glin g an d n um bn ess of th e fin gers

662. A clien t h as begun th erap y with th eoph yllin e. Th e n urse sh ould plan to teach th e clien t to lim it th e in take of wh ich item s wh ile takin g th is m ed ication ? 1. Coffee, cola, an d ch oco late 2. O ysters, lo bster, an d sh rim p 3. Melon s, oran ges, an d pin eapple 4. Cottage ch eese, cream ch eese, and dairy cream ers

663. Th e n urse h as just adm in istered th e first dose of om alizum ab to a clien t. Wh ich statem en t by th e clien t would alert th e n urse th at th e clien t m ay be experien cin g a life-th reaten in g effect? 1. “I h ave a severe h eadach e.” 2. “My feet are quite swollen .” 3. “I am n auseated an d m ay vom it.” 4. “My lips an d ton gue are swollen .”

664. Th e n urse is carin g for a clien t with a diagn osis of in fluen za wh o first began to experien ce sym ptom s yesterday. An tiviral th erap y is prescribed an d th e n urse provides in struction s to th e clien t about th e th erapy. Wh ich statem en t by th e clien t in di- cates an un derstan din g of th e in struction s? 1. “I m ust take th e m ed ication exactly as

prescribed.” 2. “O n ce I start th e m edication , I will n o lon ger be

co n tagious.” 3. “I will n ot get an y colds or in fection s wh ile tak-

in g th is m edication .” 4. “Th is m ed ication h as m in im al side effects an d I

can return to n orm al activities.”

A N S W E R S 649. 3 Ra tion a le: Gu aifen esin is an exp ecto ran t an d sh ou ld b e taken with a fu ll glass of water to decrease th e viscosity of secretion s. Extra d oses sh o uld n ot b e taken . Th e clien t sh ou ld con tact th e h ealth care provider if th e cou gh lasts lo n ger th an 1 week o r is acco m p an ied by fever, rash , sore th roat, or p ersisten t h ead- ach e. Fluids are n eed ed to decrease th e visco sity o f secretion s. Th e m edicatio n do es n ot h ave to be taken with m eals. Test-Ta kin g Str a tegy: Begin to an swer th is q uestion by elim i- n atin g o ptio n 1 first, recallin g th at extra doses o f m ed icatio n sh o u ld n o t b e taken . Next, elim in ate op tio n 2 because o f th e clo sed -en d ed wo rd only. Next, kn o win g th at in creased flu id h elps to liqu efy secretio n s fo r m o re effective co u gh in g d irects yo u to th e correct o ptio n . Review: Gu aifen esin Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm aco logy—Respiratory Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ces: Lilley et al. (2014), p . 586; Skidm o re-Ro th (2014), p . 615.

650. 3 Ra tion a le: Th e n urse adm in isterin g n alo xon e for suspected o pio id o verd o se sh o uld h ave resu scitatio n eq uip m en t readily availab le to su p po rt n alo xon e th erapy if it is n eeded . O th er ad ju n cts th at m ay b e n eeded in clu de o xygen , a m ech an ical ven tilator, an d vasop ressors.

Test-Ta kin g St r a t egy: Focus on the sub ject, suppo rtive m edical equ ip m en t. Note the word s opioid overdose. Recallin g th e effects o f these types of m ed icatio n s will direct you to th e correct o ption . Th e correct optio n is also th e u m b rella o ptio n . Review: Nalo xo n e h yd ro ch lo rid e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm acolo gy—Resp iratory Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Gah art, Nazaren o (2015), p . 861; Skidm ore-Ro th (2014), p. 855.

651. 1 Ra tion a le: Dip h en h ydram in e h as several u ses, in clu din g as an an tih istam in e, an titu ssive, an tid yskin etic, an d sed ative- h yp n o tic. In stru ctio n s for use in clud e takin g with fo od o r m ilk to decrease gastro in testin al up set an d u sin g oral rin ses, sugar- less gum , or h ard can dy to m in im ize d ry m o uth . Because th e m edicatio n causes drowsin ess, th e clien t sh o uld avoid use of alcoh ol or cen tral n ervou s system dep ressan ts, op eratin g a car, or en gagin g in oth er activities req uirin g m en tal awaren ess d urin g use. Test-Ta kin g Str a t egy: No te th e strategic wo rd s, needs further instruction. Th ese words in dicate a n egative even t q u ery an d ask you to select an o p tion th at is in correct. Kn o win g th at th e m edicatio n h as a sed ative effect h elps you to elim in ate o ptio n s 2 an d 3 first becau se th ey are co m p arab le o r alike. Recallin g th at th e m ed ication cau ses a dry m o uth h elp s you to ch o ose th e correct op tion as th e an swer, acco rdin g to th e way th e question is stated.

750 UNIT XII Respiratory Disorders of the Adult Client

Review: Dip h en h yd ram in e Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Ho dgso n , Kizior (2015), p . 374.

652. 4 Ra t ion a le: Crom o lyn sod iu m is an in h aled n on stero id al an ti- allergy agen t an d a m ast cell stab ilizer. Un desirab le effects asso- ciated with in h alatio n th erap y o f crom o lyn sod iu m are bron ch o sp asm , co u gh , n asal co n gestio n , th roat irritatio n , an d wh eezin g. Clien ts receivin g th is m edicatio n o rally m ay experien ce pruritu s, n au sea, diarrh ea, an d m yalgia. Test -Ta kin g St r a tegy: Note th e wo rd s undesirable effect. Th is sh ou ld assist in d irectin g yo u to th e co rrect o ption . In ad dition , use th e ABCs—airway–b reath in g–circu latio n —to select th e co rrect o p tion . Th e correct op tio n add resses th e airway. Review: Cro m o lyn so d iu m Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clien t Edu catio n ; Gas Exch an ge Refer en ce: Burch um , Rosen th al (2016), p. 341.

653. 3 Ra t ion a le: Terbutalin e is a bron ch odilator an d is con train di- cated in clien ts with h yp ersen sitivity to sym p ath o m im etics. It sh ou ld b e used with cau tio n in clien ts with im p aired cardiac fu n ctio n , diab etes m ellitus, h yperten sio n , h yperth yroid ism , o r a h istory of seizu res. Th e m ed ication m ay in crease bloo d glu - co se levels. Test -Ta kin g St r a t egy: Fo cus on th e su b ject, cau tio n s fo r u sin g terb u talin e. Sp ecific kn o wled ge regard in g th e co n train d ica- tio n s an d cau tio n s asso ciated with th e u se o f th is m ed ica- tio n is n eed ed to an swer th is q u estio n . Rem em b er th at terb u talin e is u sed with cau tio n in th e clien t with d iab etes m ellitu s. Review: Terb u talin e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Burch um , Rosen th al (2016), p. 936.

654. 3 Ra t ion a le: Zafirlu kast is a leuko trien e recep tor an tago n ist used in th e prop h ylaxis an d lo n g-term treatm en t o f bron ch ial asth m a. Zafirlu kast is u sed with caution in clien ts with im p aired h ep atic fun ctio n . Liver fu n ction labo rato ry tests sh ou ld b e p erfo rm ed to o btain a b aselin e, an d th e levels sh ou ld be m on itored du rin g ad m in istration o f th e m edicatio n . It is n o t n ecessary to perform th e oth er labo rato ry tests b efore ad m in istration of th e m edicatio n . Test -Ta kin g St r a tegy: Elim in ate op tion s 2 an d 4 first b ecau se th ey are co m p arab le o r alike, n otin g th at a co m p lete b lo od co un t wou ld in clud e a n eutrop h il cou n t. Fro m th e rem ain in g

o p tion s, you wo u ld n eed to kn o w th at th is m edicatio n affects h ep atic fu n ction . Review: Zafirlu kast Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Cellu lar Regu latio n ; Gas Exch an ge Refer en ces: Ho dgso n , Kizior (2015), p p. 1291–1292; Burch um , Ro sen th al (2016), p p. 924–925.

655. 2 Ra t ion a le: Ison iazid is an an titubercular m edication . A com - m o n sid e effect of iso n iazid is p eriph eral n euritis, m an ifested b y n u m b n ess, tin glin g, an d p aresth esias in th e extrem ities. Th is can b e m in im ized with pyrido xin e ( vitam in B6) in take. O p tion s 1, 3, an d 4 are n ot asso ciated with th e in form ation in th e qu estio n . Test -Ta kin g St r a t egy: Fo cu s on th e in fo rm atio n in th e q u es- tio n , n u m b n ess, p aresth esias, an d tin glin g in th e extrem ities. O p tio n s 3 an d 4 wo u ld n o t cau se th e sym p to m s p resen ted in th e q u estio n b u t in stead wo u ld cau se p allo r an d co o ln ess. Fro m th e rem ain in g o p tio n s, yo u sh o u ld kn o w th at p erip h eral n eu ritis is an ad verse effect o f iso n iazid , an d th at th ese sign s an d sym p to m s d o n o t co rrelate with h yp ercalcem ia. Review: Ad verse effects asso ciated with iso n iazid Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Bu rch u m , Rosen th al (2016), p. 1084.

656. 2 Ra t ion a le: Iso n iazid is h ep atoto xic, an d th erefo re th e clien t is tau gh t to rep ort sign s an d sym pto m s of h ep atitis im m ediately, wh ich in clude yellow skin an d sclera. For th e sam e reason , alco h o l sh o uld b e avoided d u rin g th erap y. Th e clien t sh ou ld avo id in take o f Swiss ch eese, fish such as tu n a, an d fo od s co n - tain in g tyram in e b ecau se th ey m ay cau se a reactio n ch aracter- ized b y red n ess an d itch in g o f th e skin , flu sh in g, sweatin g, tach ycard ia, h eadach e, o r ligh th eaded n ess. Th e clien t can avo id d evelo pin g periph eral n euritis by in creasin g th e in take o f p yrid oxin e (vitam in B6) du rin g th e cou rse of ison iazid th erap y. Test -Ta kin g St r a t egy: Focus on th e su b ject, clien t teach in g for ison iazid . Because alco h o l in take is p ro h ib ited with th e use o f m an y m edication s, elim in ate o ptio n 1 first. Because th e clien t receivin g th is m edicatio n typically is given su pp lem en ts o f vita- m in B6, o ption 4 is in co rrect an d is elim in ated n ext. Recallin g th at th e m ed ication is h epato toxic will direct yo u to th e co rrect o p tion . Review: Iso n iazid Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 1084.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

751CHAPTER 55 Respiratory Medications

657. 3 Ra tion a le: Rifam p in cau ses oran ge-red d iscolo ratio n of b od y secretion s an d will stain soft co n tact len ses p erm an en tly. Rifam pin sh o u ld be taken exactly as d irected . Do ses sh o u ld n o t b e do ub led o r skipp ed. Th e clien t sh o uld n o t sto p th erap y u n til directed to do so b y a h ealth care p ro vider. It is b est to ad m in ister th e m ed ication o n an em p ty stom ach u n less it causes gastroin testin al u pset, an d th en it m ay be taken with fo od . An tacids, if p rescribed , sh o u ld b e taken at least 1 h o u r b efore th e m ed ication . Test-Ta kin g Str a tegy: O ption s 2 an d 4 are co m p arab le o r alike an d are in accurate, b ased on gen eral gu idelin es for m ed - ication adm in istratio n ; th e clien t sh o u ld n o t d ou ble-do se or d isco n tin ue m ed icatio n in d epen den tly. Elim in ate o ptio n 1 n ext becau se o f th e clo sed -en d ed wo rd always. Review: Rifam p in Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Respiratory Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p . 1084–1085.

658. 4 Ra tion a le: Eth am bu tol causes optic n euritis, wh ich decreases visu al acu ity an d th e ab ility to discrim in ate between th e co lors red an d green . Th is p oses a p oten tial safety h azard wh en a cli- en t is drivin g a m oto r veh icle. Th e clien t is tau gh t to rep ort th is sym pto m im m ed iately. Th e clien t also is tau gh t to take th e m edicatio n with foo d if gastro in testin al u p set o ccu rs. Im p aired h earin g resu lts fro m an titu bercu lar th erapy with strep tom ycin . O ran ge-red discoloration o f secretio n s o ccurs with rifam p in . Test-Ta kin g Str a tegy: No te th e strategic wo rd , immediately. O ptio n 2 is th e least likely sym p tom to repo rt; in stead , it sh o u ld b e m an aged by takin g th e m ed icatio n with fo od . To select am o n g th e o th er op tio n s, yo u m u st kn ow th at th is m ed - ication causes o ptic n euritis, resultin g in d ifficu lty with red - green d iscrim in atio n . Review: Eth am b u to l Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm aco logy—Respiratory Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1085.

659. 3 Ra tion a le: Iso n iazid th erap y can cau se an elevatio n o f h epatic en zym e levels an d h epatitis. Th erefore, liver en zym e levels are m on itored wh en th erap y is in itiated an d d u rin g th e first 3 m o n th s o f th erap y. Th ey m ay b e m o n itored lo n ger in th e cli- en t wh o is old er th an 50 years or ab u ses alco h ol. Th e labo ra- to ry tests in o p tion s 1, 2, an d 4 are n o t n ecessary. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e lab oratory valu e to m on itor. Recallin g th at th is m edicatio n can b e toxic to th e liver will direct yo u to th e co rrect o ption . Review: Iso n iazid Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n

Con ten t Ar ea : Ph arm acology—Resp iratory Medicatio n s Pr ior it y Con cept s: Cellular Regulation ; Safety Refer en ce: Hod gson , Kizio r (2015), p. 646.

660. 2 Ra tion a le: Salm etero l is an adren ergic typ e o f b ron ch o dilator an d b eclo m eth aso n e d ip ro pion ate is a gluco co rtico id. Bron - ch od ilato rs are always ad m in istered b efo re gluco co rticoids wh en both are to be given on th e sam e tim e sch edule. Th is allo ws for widen in g of th e air p assages b y th e bro n ch od ilato r, wh ich th en m akes th e glucocorticoid m ore effective. Test-Ta kin g St r a t egy: Focu s on th e su b ject, th e proced ure fo r adm in isterin g in h aled m edicatio n s. To an swer th is qu estio n correctly, you m ust kn o w two differen t th in gs. First, yo u m u st kn ow th at a bron ch od ilator is always given b efore a glucocor- ticoid . Th is wo uld allo w yo u to elim in ate o p tion s 3 an d 4 b ecau se you wou ld n ot altern ate th e m ed ication s. To select b etween th e rem ain in g o p tion an d th e correct o ptio n , you m ust kn o w th at salm eterol is a b ro n ch o dilato r, wh ereas beclo - m eth aso n e is a gluco co rticoid. Review: Beclo m eth aso n e d ip ro p io n ate Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm acolo gy—Resp iratory Medicatio n s Pr ior it y Con cept s: Gas Exch an ge; Safety Refer en ces: Ho dgso n , Kizior ( 2015), p p. 119, 1085; Lilley et al. (2014), p. 594.

661. 1, 2, 3, 5 Ra tion a le: Rifab utin m ay b e p rescrib ed fo r a clien t with active MAC disease an d tu berculo sis. It in h ibits m ycob acterial DNA-d epen den t RNA po lym erase an d sup presses protein syn - th esis. Sid e an d ad verse effects in clu d e rash , gastro in testin al d isturban ces, n eu tro p en ia (lo w n eu tro p h il co un t), red - o ran ge–co lo red bo d y secretio n s, u veitis (b lu rred visio n an d eye pain ), m yo sitis, arth ralgia, h epatitis, ch est p ain with d ys- p n ea, an d flu like syn drom e. Vitam in B6 deficien cy an d n um b- n ess an d tin glin g in th e extrem ities are associated with th e u se o f iso n iazid. Test-Ta kin g St r a t egy: Focus on th e su b ject, side an d adverse effects o f rifabu tin . Specific kn o wledge is n eed ed to an swer cor- rectly. Rem em ber th at h epatitis, flu like syn d rom e, n eutrope- n ia, an d uveitis can o ccu r. Review: Rifab u tin Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Resp iratory Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ces: Ho d gso n , Kizior ( 2015) , p. 1052; Lilley et al. (2014), p. 678.

662. 1 Ra tion a le: Th eoph yllin e is a m eth ylxan th in e bron ch odilator. Th e n u rse teach es th e clien t to lim it th e in take of xan th in e- con tain in g fo od s wh ile takin g th is m ed ication . Th ese fo od s in clu de coffee, co la, an d ch o co late. Test-Ta kin g Str a tegy: Focus on th e su b ject, fo od item s th at n eed to b e lim ited . Recall th at th eo ph yllin e is a xan th in e

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

752 UNIT XII Respiratory Disorders of the Adult Client

bron ch o d ilator an d th at in take of excessive am ou n ts o f foo ds n aturally h igh in xan th in es n eed s to b e lim ited. Also , recallin g th at th ese m edicatio n s cause card iac an d cen tral n ervou s sys- tem stim ulation will d irect you to th e co rrect op tio n . Review: Th eo p h yllin e Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 937–938.

663. 4 Ra t ion a le: O m alizum ab is an an tiin flam m atory u sed for lon g- term co n tro l of asth m a. An ap h ylactic reaction s can occur with th e ad m in istratio n o f o m alizu m ab . Th e n u rse ad m in isterin g th e m ed icatio n sh ou ld m on itor for adverse reactio n s of th e m ed ication . Swellin g o f th e lips an d to n gu e are an in dicatio n of an an aph ylaxis. Th e clien t statem en ts in op tio n s 1, 2, an d 3 are n ot in d icative o f an ad verse reactio n . Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, a life-th reaten in g effect. Recall th at an aph ylactic reaction s can o ccur with th e ad m in istration of o m alizum ab. Kn o win g th e sign s o f a reac- tion will direct yo u to th e co rrect o ption . Review: O m alizu m ab Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity

In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Bu rch u m , Rosen th al (2016), pp . 925–926.

664. 1 Ra t ion a le: An tiviral m edication s for in fluen za m ust be taken exactly as p rescrib ed. Th ese m edicatio n s d o n o t p reven t th e sp read o f in flu en za an d clien ts are u su ally co n tagio us fo r up to 2 d ays after th e in itiatio n o f an tiviral m edicatio n s. Seco n d - ary bacterial in fectio n s m ay o ccur desp ite an tiviral treatm en t. Sid e effects occur with th ese m ed icatio n s an d m ay n ecessitate a ch an ge in activities, especially wh en d rivin g o r op eratin g m ach in ery if d izzin ess o ccu rs. Test -Ta kin g St r a t egy: Focus on th e su b ject, clien t in stru ctio n s fo r an tiviral th erap y, an d n ote th e words indicates an under- standing. Usin g gen eral m ed ication gu idelin es will d irect yo u to th e co rrect op tion . Review: An tiviral th erap y Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Resp irato ry Med ication s Pr ior ity Con cepts: Clien t Ed u catio n ; In fection Refer en ces: Ign ataviciu s, Workm an (2016), p p. 586–587; Lilley et al. ( 2014) , pp . 669–670.

A

d

u

l

t

R

e

s

p

i

r

a

t

o

r

y

753CHAPTER 55 Respiratory Medications

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

UNIT XIII

Cardiovascular Disorders of the Adult Client

Pyramid to Success

Pyram id Poin ts focus on assessm en t data related to cardiovascular risks, h ealth screen in g an d prom o tion , com plication s of th e various cardiovascular disorders, em ergen cy m easures, an d clien t edu cation . Focus on th e assessm en t fin din gs an d treatm en t in an gin a, m yo- cardial in farction , h eart failure an d pulm o n ary edem a, pericarditis, an eurysm s, h yperten sion , an d arterial an d ven ous disorders. You m ust be ab le to iden tify th e m ost com m on dysrh yth m ias an d determ in e th e appropriate in terven tion s for th ese dysrh yth m ias, in cludin g th e use of a pacem aker. Focus also on th e care of th e clien t followin g diagn ostic treatm en ts an d surgical proced ures. Note appropriate an d th erap eutic clien t position s, particularly with arterial an d ven ous disorders of th e extrem ities. Focus on treatm en ts an d m edication s prescribed for th e various cardiovascular disorders an d clien t teach in g related to prescribed treatm en t plan s. Be fam iliar with th e co m pon en ts related to cardiac reh abilitation .

Client Needs: Learning Objectives Safe and Effective Care Environment Con sultin g with th e in terp rofession al h ealth care team Establish in g prio rities Main tain in g asepsis Main tain in g stan d ard an d oth er precaution s Recogn izin g th e n eed for con sultatio n s an d referrals Uph oldin g clien t righ ts Verifyin g th at in form ed con sen t related to treatm en ts

an d procedures h as been obtain ed

Health Promotion and Maintenance Discussin g alteration s in lifestyle Mobilizin g appropriate com m un ity resources Perform in g cardiovascu lar assessm en t tech n iqu es Preven tin g cardiovascular disease Prom otin g cardiac reh abilitation Providin g h ealth screen in g an d h ealth prom otion

program s Teach ing related to diet therapy, exercise, and m edication s

Psychosocial Integrity Assistin g th e clien t to accept lifestyle ch an ges Con siderin g religious, spiritual, an d cultural in fluen ces

on h ealth Discussin g grief an d loss an d en d-of-life issues Discussin g situation al role ch an ges Discussin g un exp ected body im age ch an ges Iden tifyin g copin g m ech an ism s Iden tifyin g fear, an xiety, an d den ial Iden tifyin g supp ort system s

Physiological Integrity Adm in isterin g in traven o us m ed ication s Discussin g activity lim itation s an d prom otin g rest

an d sleep Mon itorin g for com plication s related to cardiovascular

disorders Mon itorin g for th erapeutic effects of m ed ication s Mon itorin g h em odyn am ics Mon itorin g of cardiac en zym e an d tropon in levels an d

oth er cardiovascular-related laborato ry values Providin g in terven tion s required in em ergen cies Providin g n on ph arm acological an d ph arm aco logical

com fort in terven tion s Respon din g to m ed ical em ergen cies

754

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

C H A P T E R 56 Cardiovascular System

PRIORITY CONCEPTS Health Promotion; Perfusion

CRITICAL THINKING What Should You Do? A hospitalized client with a diagnosis of abdominal aortic aneurysm suddenly complains of severe back pain and short- ness of breath. What should the nurse do? Answer located on p. 789.

I. Anatomy and Physiology A. Heart an d h eart wall layers

1. Th e h eart is lo cated in th e left side of th e m ed iastin um .

2. Th e h eart con sists of 3 layers. a. Th e epicardium is th e outerm ost layer of

th e h eart. b . Th e m yocardium is th e m iddle layer an d is

th e actual co n tractin g m uscle of th e h eart. c. Th e en docardium is th e inn erm ost layer an d

lin es th e inn er ch am bers an d h eart valves. B. Pericardial sac

1. En cases an d protects th e h eart from traum a an d in fection

2. Has 2 layers a. Th e parietal pericardium is th e tough ,

fibrous outer m em bran e th at attach es an te- riorly to th e lower h alf of th e stern um , pos- teriorly to th e th oracic vertebrae, an d in feriorly to th e diap h ragm .

b . Th e visceral pericardium is th e th in , in n er layer th at clo sely adh eres to th e h eart.

3. Th e pericard ial space is between th e parietal an d visceral layers; it h old s 5 to 20 m L of pericardial flu id, lubricates th e pericardial surfaces, an d cush ion s th e h eart.

C. Th ere are 4 h eart ch am b ers. 1. Th e righ t atrium receives deoxygen ated blood

from th e body via th e superior and in ferior ven a cava.

2. Th e righ t ven tricle receives blood from th e righ t atrium an d pum ps it to th e lu n gs via th e pulm o- n ary artery.

3. Th e left atrium receives oxygen ated blood from th e lun gs via 4 pulm on ary vein s.

4. Th e left ven tricle is th e largest an d m ost m uscu- lar ch am b er; it receives oxygen ated blood from th e lun gs via th e left atrium an d pum ps blood in to th e system ic circulation via th e aorta.

D. Th ere are 4 valves in th e h eart. 1. Th ere are 2 atrioven tricular valves, th e tricuspid

an d th e m itral, wh ich lie between th e atria an d ven tricles. a. Th e tricuspid valve is lo cated on th e righ t

side of th e h eart. b . Th e bicuspid (m itral) valve is located on th e

left side of th e h eart. c. Th e atrioven tricular valves clo se at th e

begin n in g of ven tricular con traction an d preven t blood fro m flowin g back in to th e atria from th e ven tricles; th ese valves open wh en th e ven tricles relax.

2. Th ere are 2 sem ilun ar valves, th e pulm o n ic an d th e aortic. a. Th e pulm on ic sem ilun ar valve lies between

th e righ t ven tricle an d th e pulm on ary artery. b . Th e ao rtic sem ilun ar valve lies between th e

left ven tricle an d th e aorta. c. Th e sem ilun ar valves preven t blood from

flowin g back into th e ven tricles durin g relax- ation ; th ey open durin g ven tricular con trac- tion an d close wh en th e ven tricles begin to relax.

E. Sin oatrial (SA) n ode 1. Th e m ain pacem aker th at in itiates each h eartbeat 2. It is located at th e jun ction of th e superior ven a

cava an d th e righ t atrium . 3. Th e SA n ode gen erates electrical im pulses at 60 to

100 tim es per m in ute an d is con trolled by th e sym path etic an d parasym path etic n ervous system s.

F. Atrio ven tricular (AV) n ode 1. Located in th e lower aspect of th e atrial septum 2. Receives electrical im pulses from th e SA n od e 3. If th e SA n ode fails, th e AV n ode can in itiate an d

sustain a h eart rate of 40 to 60 beats/ m in u te. 755

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

G. Th e bun dle of His 1. A con tin uation of th e AV n od e; located at th e

in terven tricular sep tum 2. It bran ch es in to th e righ t bun dle bran ch , wh ich

exten ds down th e righ t side of th e in terven tricu- lar septum , an d th e left bun dle bran ch , wh ich exten ds in to th e left ven tricle.

3. Th e righ t an d left bun dle bran ch es term in ate in th e Purkin je fibers.

H. Purkin je fibers 1. Purkin je fibers are a diffuse n etwork of con duct-

in g stran ds located ben eath th e ven tricular en docardium .

2. Th ese fibers spread th e wave of depolarization th rou gh th e ven tricles.

3. Purkin je fib ers can act as th e pacem aker with a rate between 20 an d 40 beats/ m in ute wh en h igh er pacem akers (such as th e SA an d AV n odes) fail.

I. Coron ary arteries (Fig. 56-1) 1. Th e righ t m ain coron ary artery supp lies th e righ t

atrium an d ven tricle, th e in ferior portion of th e left ven tricle, th e posterio r sep tal wall, an d th e SA an d AV n od es.

2. Th e left m ain coron ary artery con sists of 2 m ajor bran ch es, th e left an terior descen din g (LAD) an d th e circum flex arteries.

3. Th e LAD artery supp lies blood to th e an terior wall of th e left ven tricle, th e an terior ven tricular sep tum , an d th e ap ex of th e left ven tricle.

4. Th e circum flex artery supp lies blood to th e left atrium an d th e lateral an d posterior surfaces of th e left ven tricle.

The coronary arteries supply the capillaries of the myocardium with blood. If blockage occurs in these arteries, the client is at risk for myocardial infarction (MI).

J. Heart soun ds 1. Th e first h eart soun d (S1) is h eard as th e atrio-

ven tricular valves close an d is h eard loudest at th e apex of th e h eart.

2. Th e secon d h eart soun d (S2) is h eard wh en th e sem ilun ar valves close an d is h eard loudest at th e base of th e h eart.

3. A th ird h eart soun d (S3) m ay be h eard if ven tric- ular wall com plian ce is decreased an d structures in th e ven tricular wall vibrate; th is can occur in con dition s such as h eart failure or valvular regurgitation . Ho wever, a th ird h eart soun d m ay be n orm al in in dividuals youn ger th an 30 years.

4. A fourth h eart soun d (S4) m ay be h eard on atrial systole if resistan ce to ven tricular fillin g is pre- sen t; th is is an ab n orm al fin din g, an d th e cau ses in clude cardiac h ypertroph y, disease, or in jury to th e ven tricular wall.

K. Heart rate 1. Th e faster th e h eart rate, th e less tim e th e h eart

h as for fillin g, an d th e cardiac output decreases. 2. Th e n orm al sin us h eart rate is 60 to 100 beats/

m in u te. 3. Sin us tach ycardia is a rate m ore th an 100 beats/

m in u te. 4. Sin us bradycardia is a rate less th an 60 beats/

m in u te. L. Auton om ic n ervou s system

1. Stim ulation of sym path etic n erve fibers releases th e n eurotran sm itter n orepin eph rin e, produ c- in g an in creased h eart rate, in creased co n duc- tion speed th rou gh th e AV n od e, in creased atrial an d ven tricular contractility, an d periph - eral vasocon striction . Stim ulation occurs wh en a decrease in pressure is detected.

2. Stim ulation of th e parasym pathetic n erve fibers releases the n eurotransm itter acetylch olin e, which decreases th e h eart rate an d lessen s atrial an d ven - tricular contractility an d conductivity. Stim ulation occurs when an in crease in pressure is detected.

M. Blood pressure (BP) con trol 1. Baroreceptors (specialized n erve en din gs

affected by ch an ges in th e arterial BP), also called pressoreceptors, are located in th e walls of th e ao rtic arch an d carotid sin uses.

2. In creases in arterial pressure stim ulate barore- ceptors, an d th e h eart rate an d arterial pressure decrease.

3. Decreases in arterial pressure reduce stim ula- tion of th e barorecep tors an d vaso con striction occurs, as does an in crease in h eart rate.

4. Stretch receptors, located in th e ven a cava an d th e righ t atrium , respo n d to pressure ch an ges th at affect circulatory blood volu m e.

5. Wh en th e BP decreases as a result of h ypo vo- lem ia, a sym path etic respo n se occurs, causin g an in creased h eart rate an d blood vessel

Aorta

Right ma in corona ry a rte ry

Le ft ma in corona ry a rte ry

Circumfle x corona ry a rte ry

Le ft a nte rior de s ce nding corona ry a rte ry

Pe riphe ra l bra nche s

Pos te rior de s ce nding corona ry a rte ry

Right ma rgina l corona ry a rte ry

FIGURE 56-1 Coronary arterial system.

756 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

con striction ; wh en th e BP in creases as a result of h ypervo lem ia, an opposite effect occurs.

6. Antidiuretic h orm on e (vasopressin ) in fluen ces BP in directly by regulatin g vascular volum e.

7. In creases in blood volum e result in decreased an tidiuretic horm on e release, in creasin g diure- sis, decreasing blood volum e, an d th us decreas- in g BP.

8. Decreases in blood vo lum e result in in creased an tidiuretic h orm on e release; th is prom o tes an in crease in blood volu m e an d th erefore BP.

9. Ren in , a poten t vaso con strictor, causes th e BP to in crease.

10. Ren in con verts an gio ten sin ogen to an gioten - sin I; an gioten sin I is th en con verted to an gio- ten sin II in th e lun gs.

11. An gioten sin II stim ulates th e release of aldo- steron e, wh ich prom o tes water an d sodium reten tion by th e kidn eys; th is action in creases blood volum e an d BP.

N. Th e vascu lar system 1. Arteries are vessels th rou gh wh ich th e blood

passes away from th e h eart to various parts of th e body; th ey con vey h igh ly oxygen ated blood fro m th e left side of h eart to th e tissues.

2. Arterioles con tro l th e blood flow in to th e cap illaries.

3. Capillaries allow th e exch an ge of fluid an d n utri- en ts between the blood and th e in terstitial spaces.

4. Ven ules receive blood from th e capillary bed an d m ove blood in to th e vein s.

5. Vein s tran spo rt deo xygen ated blood from th e tissues back to th e righ t h eart an d th en to th e lu n gs for oxygen ation .

6. Valves h elp return blood to th e h eart again st th e force of gravity.

7. Th e lym ph atics drain th e tissues an d return th e tissue fluid to th e blood.

II. Diagnostic Tests and Procedures (refer to Chapter 10 for further information on laboratory reference levels)

A. Card iac m arkers 1. CK-MB (creatin e kin ase, m yocardial m uscle)

a. An elevation in value in dicates m yocardial dam age.

b . An elevation occurs with in h ours an d peaks at 18 h ours followin g an acute isch em ic attack.

c. Norm al value for CK-MB (CK-2) is m ale: 2 to 6 n g/ m L (2 to 6 m cg/ L) ; fem ale: 2 to 5 n g/ m L (2 to 5 m cg/ L) .

2. Trop on in a. Tropon in is com posed of 3 protein s—

tropon in C, cardiac tropon in I, an d cardiac tropon in T.

b . Tropon in I especially h as a h igh affin ity for m yocardial in jury; it rises with in 3 h ours an d persists for up to 7 to 10 days.

c. Norm al values are low, with tropon in I bein g < 0.3 n g/ m L (< 0.03 m cg/ L) an d tropon in T bein g < 0.2 n g/ m L (< 0.02 m cg/ L); th us, an y rise can in dicate m yocardial cell dam age.

3. Myoglobin a . Myoglobin is an oxygen -bin d in g protein

foun d in cardiac an d skeletal m uscle. b . Th e level rises with in 2 h ours after cell

death , with a rapid declin e in th e level after 7 h ou rs; h owever, it is n ot cardiac specific.

B. Com p lete blood coun t 1. Th e red blood cell coun t decreases in rh eum atic

h eart disease an d in fective en docarditis an d in creases in con dition s ch aracterized by in ade- quate tissue oxygen ation .

2. Th e wh ite blood cell coun t in creases in in fec- tious an d in flam m atory diseases of th e h eart an d after MI because large n um bers of wh ite blood cells are n eeded to dispose of th e n ecro tic tissue resultin g from th e in farctio n .

3. An elevated h em atocrit level can result from vas- cular volum e depletion .

4. Decreases in h em oglob in an d h em atocrit levels can in dicate an em ia.

C. Bloo d coagulation facto rs: An in crease in coagu la- tion facto rs can occur durin g an d after MI, wh ich places th e clien t at greater risk for th rom boph leb itis an d form ation of clo ts in th e coron ary arteries.

D. Serum lipids (refer to Ch apter 10) 1. Th e lipid profile m easures serum ch olesterol,

triglyceride, an d lipo protein levels. 2. Th e lipid profile is used to assess th e risk of

developin g coron ary artery disease. 3. Lipop rotein -a or Lp( a) , a m odified form of low-

den sity lipoprotein (LDL), in creases ath ero scle- rotic plaques an d in creases clo ts; value sh ould be less th an 30 m g/ dL.

E. Hom ocystein e: Elevated levels m ay in crease th e risk of cardiovascular disease; n orm al value is 0.54 to 1.9 m g/ L (4 to14 m cm o l/ L).

F. High ly sen sitive C-reactive protein (h sCRP): Detects an inflam m atory process such as th at associated with th e developm en t of ath eroth rom bosis; a level less th an 1 m g/ dLis con sidered low risk an d a level greater th an 3 m g/ dL places th e clien t at h igh risk for h eart disease.

G. Micro album in u ria: A sm all am oun t of protein in th e urin e h as been a m arker for en doth elial dys- fun ction in cardiovascular disease.

H. Electro lytes (refer to Ch apters 8 an d 10) 1. Potassium

a. Hypokalem ia causes in creased cardiac elec- trical in stability, ven tricular dysrh yth m ias, an d in creased risk of digoxin toxicity.

b . In h ypokalem ia, th e electrocardiogram (ECG) shows flatten ing an d in version of th e T wave, th e appearan ce of a U wave, an d ST depression.

757CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

c. Hyperkalem ia cau ses asystole an d ven tricu- lar dysrh yth m ias.

d . In h yperkalem ia, th e ECG m ay sh ow tall, peaked T waves; widen ed Q RS com plexes; prolon ged PR in tervals; or flat P waves.

2. Sodium a. Th e serum sodium level decreases with th e

use of diuretics. b . Th e serum sodium level decreases in h eart

failure, in dicatin g water excess. I. Calcium

1. Hypo calcem ia can cau se ven tricular dysrh yth - m ias, prolon ged ST an d Q T in tervals, an d car- diac arrest.

2. Hypercalcem ia can cau se a sh orten ed ST seg- m en t an d widen ed T wave, atrioven tricular block, tach ycardia or bradycardia, digitalis h ypersen sitivity, an d cardiac arrest.

J. Ph osph orus level: Ph osph orus levels sh ould be in terp reted with calcium levels because th e kidn eys retain or excrete on e electrolyte in an in verse rela- tion sh ip to th e oth er.

K. Magn esium 1. A low m agn esium level can cau se ven tricular

tach ycardia an d fib rillation . 2. Electrocardio graph ic ch an ges th at m ay be

observed with h ypo m agn esem ia in clude tall T waves an d depressed ST segm en ts.

3. A h igh m agn esium level can cause m uscle weak- n ess, h ypoten sion , an d bradycardia.

4. Electrocardiograph ic chan ges that m ay be observed with h yperm agn esem ia in clude a pro- lon ged PR in terval and widen ed Q RS com plex.

Electrolyte and mineral imbalances can cause car- diac electrical instability that can result in life- threatening dysrhythmias.

L. Bloo d urea n itrogen : Th e blood urea n itrogen level is elevated in h eart disorders th at adversely affect ren al circulation , such as h eart failure an d cardiogen ic sh ock.

M. Bloo d gluco se: An acu te cardiac episo de can elevate th e blood glucose level.

N. B-type n atriuretic pep tide (BNP) 1. BNP is released in respon se to atrial an d ven tric-

ular stretch ; it serves as a m arker for h eart failure. 2. BNP levels sh ould be < 100 pg/ m L (< 100 ng/L);

th e h igh er th e level, th e m ore severe th e h eart failure.

O. Ch est x-ray 1. Description : Rad iograph y of th e ch est is don e to

determ in e an atom ical ch an ges such as th e size, silh ou ette, an d position of th e h eart.

2. In terven tion s a . Prepare th e clien t, explain in g th e purpo se

an d proced ure. b . Rem o ve jewelry. c. En su re th at th e clien t is n ot pregn an t.

P. Electro cardiograph y ( Box 56-1) 1. Description : Th is com m on n on in vasive diag-

n ostic test records th e electrical activity of th e h eart an d is useful for detectin g cardiac dys- rh yth m ias, location an d exten t of MI, an d car- diac h ypertroph y, an d for evalu ation of th e effectiven ess of cardiac m edication s.

2. In terven tion s a . Determ in e th e clien t’s ability to lie still;

ad vise th e clien t to lie still, breath e n or- m ally, an d refrain from talkin g durin g th e test.

b . Reassure th e clien t th at an electrical sh ock will n ot occur.

c. Do cum en t an y cardiac m edication s th e cli- en t is takin g.

BOX 56-1 Basics of Electrocardiography An electrocardiogram (ECG) reflects the electrical activity of

cardiac cells and records electrical activity at a speed of 25 mm/ second.

An electrocardiographic strip consists of horizontal lines representing seconds and vertical lines representing voltage.

Each small square represents 0.0 4 second. Each large square represents 0 .20 second. The P wave represents atrial depolarization. The PR interval represents the time it takes an impulse to

travel from the atria through the atrioventricular node, bun- dle of His, and bundle branches to the Purkinje fibers.

Normal PR interval duration ranges from 0 .12 to 0 .2 second. The PR interval is measured from the beginning of the P wave

to the end of the PR segment. The QRS complex represents ventricular depolarization. Normal QRS complex duration ranges from 0.0 4 to

0 .1 second. The Q wave appears as the first negative deflection in the QRS

complex and reflects initial ventricular septal depolarization.

The R wave is the first positive deflection in the QRS complex. The S wave appears as the second negative deflection in the

QRS complex. The J point marks the end of the QRS complex and the begin-

ning of the ST segment. The QRS duration is measured from the end of the PR seg-

ment to the J point. The ST segment represents early ventricular repolarization. The T wave represents ventricular repolarization and ventric-

ular diastole. The U wave may follow the T wave. A prominent U wave may indicate an electrolyte abnormality,

such as hypokalemia. The QT interval represents ventricular refractory time or the

total time required for ventricular depolarization and repolarization.

The QT interval is measured from the beginning of the QRS complex to the end of the T wave.

The QT interval normally lasts 0 .32 to 0 .4 second but varies with the client’s heart rate, age, and gender.

758 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

Q. Holter m on itorin g 1. Description

a. A n on in vasive test; th e clien t wears a m on - itor an d an electrocardiograph ic tracin g is recorded con tin uo usly over a period of 24 h ou rs or m ore wh ile th e clien t perform s h is or h er activities of daily livin g.

b . Th e m on itor iden tifies dysrh yth m ias if th ey occur an d evaluates th e effectiven ess of an ti- dysrh yth m ics or pacem aker therapy.

2. In terven tion s a. In struct th e clien t to resum e n orm al daily

activities an d to m ain tain a diary docu- m en tin g activities an d an y sym pto m s th at m ay develop for correlation with th e elec- trocardio graph ic tracin g.

b . In struct th e clien t to avoid tub bath s or sh owers because th ey will in terfere with th e electrocardiograp h ic recorder device.

R. Ech ocardiograph y 1. Description

a. Th is n on in vasive procedure is based on the prin ciples of ultrasoun d an d evaluates struc- tural an d fun ction al chan ges in th e h eart.

b . Used to detect valvular abn orm alities, con - gen ital h eart defects, wall m otion , ejection fraction , an d cardiac fun ctio n .

c. Tran sesoph ageal ech ocardiograph y m ay be perform ed, in wh ich th e ech ocardio gram is don e th rough th e esoph agus to view th e posterio r structures of th e h eart; th is is an in vasive exam an d requires preparation an d care sim ilar to en doscopy proced ures.

2. In terven tion s: Determ in e th e clien t’s ability to lie still, an d advise th e clien t to lie still, breath e n or- m ally, an d refrain from talkin g durin g th e test.

S. Exercise electrocardiograph y testin g (stress test) 1. Description

a. Th is n on in vasive test studies th e h eart dur- in g activity an d detects an d evaluates coro- n ary artery disease.

b . Treadm ill testin g is th e m ost com m on ly used m ode of stress testin g.

c. If th e clien t is un able to tolerate exercise, an in traven ous (IV) in fusion of dipyridam ole or dobutam in e h ydroch loride is given to dilate th e coron ary arteries an d sim ulate the effect of exercise; th e clien t m ay n eed to be NPO (noth in g by m outh ) for 3 to 6 h ours preprocedure.

2. Preprocedure in terven tion s a. En sure th at an in form ed con sen t is

obtain ed if required. b . En courage adequ ate rest th e n igh t before

th e procedure. c. Instruct th e clien t h avin g a n on in vasive test

to eat a ligh t m eal 1 to 2 h ours before the procedure.

d . In struct th e clien t to avoid sm okin g, alco- h ol, an d caffein e before th e proced ure.

e. Instruct the client to ask th e h ealth care provider (HCP) about takin g prescribed m ed- ication on th e day of the procedure; th eoph - yllin e products are usually withh eld 12 h ours before th e test an d calcium ch an n el blockers and beta blockers are usually with h eld on th e day of the test to allow the h eart rate to increase during th e stress portion of the test.

f. In struct th e clien t to wear n on con strictive, com fortable cloth in g an d supportive rubber-soled shoes for th e exercise stress test.

g. In struct th e clien t to n otify th e HCP if an y ch est pain , dizzin ess, or sh ortn ess of breath occurs durin g th e procedure.

3. Postp rocedu re in terven tion s: In struct th e clien t to avoid takin g a h ot bath or sh o wer for at least 1 to 2 h ours.

T. Myocardial n uclear perfusio n im agin g (MNPI) 1. Description

a. Nu clear cardiology in volves th e use of radion uclide tech n iqu es an d scan n in g for cardiovascular assessm en t.

b . Th e m ost com m on tests in clude tech n etium pyroph osph ate scan n in g, th alliu m im ag- in g, an d m ultigated cardiac blood pool im agin g; th ese tests can evaluate cardiac m otion an d calculate th e ejection fraction .

2. Preprocedure in terven tion s a. En sure that an in form ed con sent is obtained. b . In form th e clien t th at a sm all am oun t of

radioisotope will be in jected an d th at th e radiation exp osure an d risks are m in im al.

3. Postp rocedu re in terven tion s a. Assess vital sign s. b . Assess in jection site for bleedin g or

discom fort. c. In form th e clien t th at fatigue is possible.

U. Magn etic reson an ce im agin g (MRI) 1. Description

a. Th is is a n on in vasive diagn ostic test th at produces an im age of th e h eart or great ves- sels th rou gh th e in teraction of m agn etic fields, radio waves, an d ato m ic n uclei.

b . It provides in form ation on ch am b er size an d th ickn ess, valve an d ven tricular fun c- tio n , an d blood flow th rough th e great ves- sels an d coron ary arteries.

2. Preprocedure in terven tion s a. Evaluate th e clien t for th e presen ce of a

pacem aker or oth er im plan ted item s th at presen t a con train dication to th e test.

b . En sure that th e clien t h as rem oved all m etallic objects such as a watch , oth er jewelry, cloth in g with m etal fasten ers, an d m etal h air fasteners.

c. In form th e clien t th at sh e or h e m ay experi- en ce claustroph obia wh ile in th e scan n er.

759CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

V. Electro ph ysio logical studies: An in vasive procedure in wh ich a program m ed electrical stim ulation of th e h eart is in duced to cau se dysrh yth m ias an d con duc- tion defects; assists in fin din g an accurate diagn osis an d aids in determ in in g treatm en t.

W. Electro n -beam com pu ted tom ograph y (EBCT) scan : Determ in es wh eth er calcification s are presen t in th e arteries; a coron ary artery calcium (CAC) score is provided (a score h igh er th an 400 requires in ten sive preven tive treatm en t).

X. Card iac cath eterization (Fig. 56-2) 1. Description

a . An in vasive test in volvin g in sertion of a cath eter in to th e h eart an d surroun din g vessels

b . O btain s in form ation about th e structure an d perform an ce of th e h eart ch am bers an d valves an d th e coron ary circulation

2. Preprocedure in terven tion s a . En su re th at in form ed con sen t h as been

obtain ed. b . Assess for allergies to seafoo d, iodin e, or

radiop aque dyes; if allergic, th e clien t m ay be prem edicated with an tih istam in es an d co rticosteroids to preven t a reaction .

c. With h old solid food for 6 to 8 h ours an d liqu ids for 4 h ours as prescribed to preven t vo m itin g an d aspiration durin g th e procedure.

d . Do cum en t th e clien t’s h eigh t an d weigh t because th ese data will be n eeded to deter- m in e th e am oun t of dye to be ad m in istered.

e. Do cum en t baselin e vital sign s an d n ote th e quality an d presen ce of periph eral pulses for postp rocedu re com parison .

f. In form th e clien t th at a local an esth etic will be adm in istered befo re cath eter in sertion .

g. In form th e clien t th at h e or sh e m ay feel a flu ttery feelin g as th e cath eter passes th rou gh th e h eart, a flush ed an d warm feel- in g wh en th e dye is in jected, a desire to cough , an d palpitation s caused by h eart irritability.

h . Th e in sertion site is prepared by sh avin g an d clean in g with an an tiseptic solution .

i. Adm in ister preprocedure m ed ication s such as sed atives if prescribed.

j. In sert an IV lin e if prescribed.

If a client taking metformin is scheduled to undergo a procedure requiring the administration of iodine dye, the metformin is withheld for 24 hours prior to the pro- cedure because of the risk of lactic acidosis. The medi- cation is not resumed until prescribed by the HCP (usually 48 hours after the procedure or after renal func- tion studies are done and the results are evaluated).

3. Postp rocedure in terven tion s a . Mon itor vital sign s an d cardiac rh yth m for

dysrh yth m ias at least every 30 m in u tes for 2 h ours in itially.

b . Assess for ch est pain an d, if dysrh yth m ias or ch est pain occurs, n otify th e HCP.

c. Mon itor periph eral pulses an d th e co lor, warm th , an d sen sation of th e extrem ity dis- tal to th e in sertion site at least every 30 m in utes for 2 h ou rs in itially.

d . Notify the HCP if the client com plain s of n um bn ess an d tin glin g; if the extrem ity becom es cool, pale, or cyan otic; or if loss of th e peripheral pulses occurs. This could indi- cate clot form ation and is an em ergen cy.

e. Apply a san dbag or com pression device (if prescribed) to th e in sertion site to provide ad dition al pressure if required.

f. Mon itor for bleedin g; if bleed in g occurs, ap ply m an ual pressure im m ediately an d n otify th e HCP.

g. Mon itor for h em atom a; if a h em atom a develops, n otify th e HCP.

h . Keep th e extrem ity exten ded for 4 to 6 h ours, as prescribed, keepin g th e leg straigh t to preven t arterial occlusion .

S upe rior ve na ca va

Infe rior ve na ca va

P ulmona ry a rte ry

Fe mora l ve in

Right ve ntricle

FIGURE 56-2 Right-sided heart catheterization. The catheter is inserted into the femoral vein and advanced into the inferior vena cava (or, if into an antecubital or basilic vein, through the superior vena cava), right atrium, right ventricle, and pulmonary artery.

760 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

i. Main tain strict bed rest for 6 to 12 h ours, as prescribed; h owever, th e clien t m ay turn from side to side. Do n ot elevate th e h ead of th e bed m ore th an 15 degrees.

j. If th e an tecu bital vessel was used, im m ob i- lize th e arm with an arm b oard.

k . En courage fluid in take, if n ot con train d i- cated, to prom ote ren al excretion of th e dye an d to replace fluid loss caused by th e osm otic diuretic effect of th e dye.

l. Mon itor for n ausea, vom itin g, rash , or oth er sign s of h ypersen sitivity to th e dye.

Y. In travascular ultrason ograph y (IVUS) : A cath eter with a tran sducer is used as an altern ative to in ject- in g a dye in to th e coron ary arteries an d detects pla- que distribution an d com po sition ; it also detects arterial dissectio n an d th e degree of sten osis of an occlu ded artery.

III. Therapeutic Management A. Percutan eous tran slum in al coron ary an gio plasty

(PTCA) 1. Description ( Fig. 56-3)

a. An in vasive, n on su rgical tech n iqu e in wh ich 1 or m ore arteries are dilated with a balloon cath eter to open th e vessel lum en an d im prove arterial blood flo w

b . PTCA m ay be used for clien ts with an evolv- in g MI, alon e or in com bin ation with m ed- ication s to ach ieve reperfu sion .

c. Th e clien t can experien ce reocclusion after th e proced ure; th u s, th e proced ure m ay n eed to be repeated.

d . Com plication s can in clude arterial dissec- tion or ru pture, em bolization of plaq ue fragm en ts, spasm , an d acu te MI.

e. Firm com m itm en t is n eeded on th e clien t’s part to stop sm okin g, adh ere to diet restric- tion s, lose weigh t, alter h is or h er exercise

pattern , an d stop an y beh aviors th at lead to progression of artery occlusion .

2. Preprocedure in terven tion s a. Sim ilar to preprocedure in terven tion s for

cardiac cath eterization b . Th e HCP m ay prescribe preprocedure m ed-

ication s, in cludin g acetylsalicylic acid. c. In struct th e clien t th at ch est pain m ay occur

durin g balloo n in flation an d to report it if it does occur.

3. Postp rocedu re in terven tion s a. Sim ilar to postp rocedure in terven tion fol-

lo win g cardiac cath eterization b . Adm in ister an ticoagulan ts an d an tiplatelets

as prescribed to preven t throm bus form ation . c. IV n itroglycerin m ay be prescribed to pre-

ven t coron ary artery vaso spasm . d . En cou rage fluids, if n ot con train dicated, to

en h an ce ren al excretio n of dye. e. In struct th e clien t in th e adm in istration of

prescribed m edication s; daily acetylsalicylic acid (aspirin ) m ay be prescribed.

f. Assist th e clien t with plan n in g lifestyle m od ification s.

B. Laser-assisted an gioplasty 1. Description

a. A laser probe is advan ced th rou gh a can n ula sim ilar to th at used for PTCA.

b . Used also for clien ts with sm all occlu sion s in th e distal superficial fem oral, proxim al popliteal, an d com m on iliac arteries, an d in coron ary arteries.

c. Heat fro m th e laser vapo rizes th e plaque to open th e occlu ded artery.

2. Preprocedure an d postp rocedure in terven tion s a. Care is sim ilar to th at for PTCA. b . Mon itor for com plication s of co ron ary dis-

section , acute occlu sion , perforation , em b olism , an d MI.

1. The ba lloon-tippe d ca the te r is pos itione d in the a rte ry.

2. The uninfla te d ba lloon is ce nte re d in the obs truction.

3. The ba lloon is infla te d, which fla tte ns pla que a ga ins t the a rte ry wa ll.

4. The ba lloon is re move d, a nd the a rte ry is le ft unocclude d.

FIGURE 56-3 Percutaneous transluminal coronary angioplasty.

761CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

C. Coron ary artery sten ts 1. Description

a . Coron ary artery sten ts are used in con jun c- tio n with PTCA to provide a supportive scaf- fold to elim in ate th e risk of acute coron ary vessel clo sure an d to im prove lon g-term paten cy of th e vessel.

b . A balloo n cath eter bearin g th e sten t is in serted in to th e coron ary artery an d posi- tio n ed at th e site of occlusion ; balloo n in flation deploys th e sten t.

c. Wh en placed in th e coron ary artery, th e sten t reopen s th e blocked artery.

2. Preprocedure an d postp rocedu re in terven tion s a . Care is sim ilar to th at for PTCA. b . Acute th rom bosis is a m ajor con cern fol-

lo win g th e procedure; th e clien t is placed on an tiplatelet th erap y such as clopidogrel an d acetylsalicylic acid (aspirin ) for several m on th s followin g th e proced ure. Len gth of tim e of an tiplatelet th erapy is determ in ed by th e type of sten t (m etal or m edication - co ated) th at h as been dep loyed.

c. Mon itor for com plication s of th e procedure such as sten t m igration or occlu sion , coro- n ary artery dissection , an d bleedin g result- in g fro m an ticoagulation .

D. Ath erectom y 1. Description

a . Ath erectom y rem oves plaque from a coro- n ary artery by th e use of a cuttin g ch am b er on th e in serted cath eter or a ro tatin g blad e th at pulverizes th e plaque.

b . Ath erectom y is also used to im prove blood flo w to isch em ic lim b s in in dividuals with periph eral arterial disease.

2. Preprocedure an d postp rocedu re in terven tion s a . Care is sim ilar to th at for PTCA. b . Mon itor for co m plication s of perforation ,

em b olus, an d reocclusion . E. Tran sm yocardial revascularization

1. May be used for clien ts with widespread ath ero - sclerosis in volvin g vessels th at are too sm all an d n um erous for replacem en t or balloon cath eter- ization ; perform ed th rou gh a sm all ch est in cision

2. Tran sm yocardial revascularization uses a high - powered laser th at creates 20 to 24 ch an n els through th e ven tricular m uscle of th e left ven tricle; blood en ters these sm all ch ann els, providin g th e affected region of the h eart with oxygen ated blood.

3. Th e open in g on th e surface of th e h eart h eals; h owever, th e m ain ch an n els rem ain an d perfuse th e m yocardium .

F. Periph eral arterial revascularization 1. Description

a . Perform ed to in crease arterial blood flo w to th e affected lim b

b . In flow proced ures in volve bypassin g th e arterial occlu sion above th e superficial fem - oral arteries.

c. O utflow proced ures in volve bypassin g th e arterial occlusion s at or below th e superfi- cial fem o ral arteries.

d . Graft m aterial is sutured above an d below th e occlu sion to facilitate blood flo w arou n d th e occlusion .

2. Preop erative in terven tion s a . Assess baselin e vital sign s an d periph eral

pulses. b . In sert an IV lin e an d urin ary cath eter as

prescribed. c. Main tain a cen tral ven ous cath eter an d/ o r

arterial lin e if in serted. 3. Posto perative in terven tion s

a . Assess vital sign s an d n otify th e HCP if ch an ges occur.

b . Mon itor for h ypo ten sion , wh ich m ay in di- cate h ypo volem ia, an d h yperten sion , wh ich m ay place stress on th e graft an d cau se clot form ation .

c. Maintain bed rest for 24 h ours as prescribed. d . In struct th e clien t to keep th e affected

extrem ity straigh t, lim it m ovem en t, an d avoid ben din g th e kn ee an d h ip.

e. Mon itor for warm th , redn ess, an d edem a, wh ich often are expected outcom es because of in creased blood flow.

f. Mon itor for graft occlu sion , wh ich often occurs with in th e first 24 h ours.

g. Assess periph eral pulses an d for adverse ch an ges in color an d tem p erature of th e extrem ity.

h . Assess th e in cision for drain age, warm th , or swellin g.

i. Mon itor for excessive bleed in g (a sm all am oun t of blood y drain age is expected).

j. Mon itor th e area over th e graft for h ardn ess, ten dern ess, an d warm th , wh ich m ay in di- cate in fectio n ; if th is occurs, n otify th e HCP im m ediately.

k . In struct th e clien t about proper foot care an d m easures to preven t ulcer form ation .

l. Assist th e clien t in m od ifyin g lifestyle to preven t furth er plaq ue form ation .

Following arterial revascularization, monitor for a sharp increase in pain because pain is frequently the first indicator of postoperative graft occlusion. If signs of graft occlusion occur, notify the HCP immediately.

G. Coron ary artery bypass graftin g ( Fig. 56-4) 1. Description

a . Th e occluded coron ary arteries are bypassed with th e clien t’s own ven ous or arterial blood vessels.

762 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

b . Th e saph en ous vein , in tern al m am m ary artery, or oth er arteries m ay be used to bypass lesion s in th e coron ary arteries.

c. Coron ary artery bypass graftin g is perform ed wh en the clien t does n ot respon d to m edical m an agem en t of coron ary artery disease or wh en vessels are severely occluded.

d . A m in im ally in vasive direct coron ary artery bypass (MIDCAB) m ay be an option for som e clien ts wh o h ave a lesion in th e LAD artery; a stern al in cision is n ot required (usually a 2-in ch [5 cm ] left th oracoto m y in cision is don e) an d cardiop ulm on ary bypass is n ot required in th is procedure.

2. Preoperative in terven tion s a. Fam iliarize th e clien t an d fam ily with th e

cardiac surgical critical care un it. b . In form th e clien t to expect a stern al in ci-

sion , possib le arm or leg in cision (s), 1 or 2 ch est tubes, a Foley cath eter, an d several IV fluid cath eters.

c. In form th e clien t that an en dotrach eal tube will be in place for a sh ort period of tim e an d th at h e or sh e will be un able to speak.

d . Advise th e clien t th at h e or sh e will be on m ech an ical ven tilation an d to breath e with th e ven tilator an d n ot figh t it.

e. In struct th e clien t th at posto perative pain is expected an d th at pain m ed ication will be available.

f. In struct th e clien t in h ow to splin t th e ch est in cision , cough an d deep-breath e, use th e in cen tive spirom eter, an d perform arm an d leg exercises.

g. En courage th e clien t an d fam ily to discuss an xieties an d fears related to surgery.

h . Note th at prescribed m edication s m ay be discon tin ued preop eratively (usually,

diuretics 2 to 3 days befo re surgery, digo xin 12 h ou rs befo re surgery, an d aspirin an d an ticoagulan ts 1 week befo re surgery).

i. Adm in ister m edication s as prescribed, wh ich m ay in clude potassium ch loride, an tih yper- ten sives, an tidysrhyth m ics, an d an tibiotics.

3. Cardiac surgical unit postoperative in terven tion s a. Mech an ical ven tilation is m ain tain ed for 6

to 24 h ours as prescribed. b . Th e h eart rate an d rh yth m , pulm on ary artery

an d arterial pressures, urin ary output, and n eurological status are m on itored closely.

c. Med iastin al an d pleural ch est tubes to th e water seal drain age system with prescribed suction are presen t; drain age exceed in g 100 to 150 m L/ h ou r is reported to th e HCP.

d . Ep icardial pacin g wires are covered with sterile caps or con n ected to a tem p orary pacem aker gen erator; all equipm en t in use m ust be properly groun d ed to preven t m icrosh ock.

e. Fluid an d electrolyte balan ce is m on itored closely; fluids are usually restricted to 1500 to 2000 m L because the clien t usually h as edem a.

f. Th e blood pressure is m on itored clo sely because h ypo ten sion can cau se collapse of a vein graft; h yperten sion can cau se in creased pressure prom o tin g leakage from th e suture lin e, cau sin g bleedin g.

g. Tem peratu re is m on itored an d rewarm in g procedures are in itiated usin g warm or th er- m al blan kets if th e tem perature drops below 96.8 °F (36.0 °C); rewarm th e clien t n o faster th an 1.8 degrees/ h our to preven t sh iverin g, an d discon tin ue rewarm in g pro- cedu res wh en th e tem p erature approach es 98.6 °F (37.0 °C).

S aphe no us ve in g rafts

Inte rnal mammary arte ry g raft

As ce nding a orta

Right corona ry

a rte ry

Le ft corona ry

a rte ry

Circumfle x a rte ry

Le ft a nte rior de s ce nding

a rte ry

FIGURE 56-4 Two methods of coronary artery bypass grafting. The procedure used depends on the nature of the coronary disease, the condition of the vessels available for grafting, and the client’s health status.

763CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

h . Potassium is adm in istered in traven ously as prescribed to m ain tain th e potassium level between 4 an d 5 m Eq/ L (4 to 5 m m o l/ L) to preven t dysrh yth m ias.

i. Th e clien t is m on itored for sign s of cardiac tam pon ade, wh ich will in clude sudden ces- sation of previously h eavy m ed iastin al drain age, jugu lar vein disten tion with clear lu n g soun ds, equ alization of righ t atrial (RA) pressure an d pulm o n ary artery wedge pressure, an d pulsus paradoxu s.

j. Pain is m on itored, differen tiatin g stern ot- om y pain from an gin al pain , wh ich would in dicate graft failure.

4. Alarm safety an d alarm fatigue: Refer to Ch apter 54.

5. Tran sfer of th e clien t from th e cardiac surgical un it a . Mon itor vital sign s, level of con sciousn ess,

an d periph eral perfusion . b . Mon itor for dysrh yth m ias. c. Auscultate lungs and assess respiratory status. d . En cou rage th e clien t to splin t th e in cision ,

cough , deep-breath e, an d use th e in cen tive spirom eter to raise secretio n s an d preven t atelectasis.

e. Mon itor tem p erature an d wh ite blood cell coun t, wh ich , if elevated after 3 to 4 days, in dicate in fectio n .

f. Provide ad equate fluids an d h ydration as prescribed to liquefy secretio n s.

g. Assess suture lin e an d ch est tube in sertio n sites for redn ess, purulen t disch arge, an d sign s of in fectio n .

h . Assess stern al suture lin e for in stability, wh ich m ay in dicate an in fectio n .

i. Guide th e clien t to gradually resum e activity. j. Assess th e clien t for tach ycardia, postural

(orthostatic) hypotension, an d fatigue befo re, durin g, an d after activity.

k . Discon tin ue activities if th e BP drops m ore th an 10 to 20 m m Hg or if th e pulse in creases m ore th an 10 beats/ m in ute.

l. Mon itor episo des of pain clo sely. m . See Box 56-2 for h om e care in struction s.

H. Heart tran splan tation 1. A don or h eart from an in dividual with a com pa-

rable body weigh t an d ABO com patibility is tran splan ted in to a recipien t with in less th an 6 h ours of procurem en t.

2. Th e surgeon rem oves th e diseased h eart, leavin g th e posterior portion of th e atria to serve as an an ch or for th e n ew h eart.

3. Because a rem n an t of th e clien t’s atria rem ain s, 2 un related P waves are n oted on th e ECG.

4. Th e tran splanted h eart is den ervated an d un - respon sive to vagal stim ulation ; because the h eart is den ervated, clien ts do n ot experien ce angin a.

5. Sym pto m s of h eart rejection in clude h ypo ten - sion , dysrh yth m ias, weakn ess, fatigue, an d dizzin ess.

6. En dom yocardial biopsies are perform ed at reg- ularly sch eduled in tervals an d wh en ever rejec- tion is susp ected.

7. Th e clien t requires lifetim e im m un osuppressive th erap y.

8. Strict aseptic tech n iqu e an d vigilan t h an d wash - in g m ust be m ain tain ed wh en carin g for th e posttran splan tatio n clien t because of in creased risk for in fectio n fro m im m un osuppression .

9. Th e h eart rate approxim ates 100 beats/ m in ute an d respo n ds slowly to exercise or stress with regard to in creases in h eart rate, contractility, an d cardiac output.

IV. Cardiac Dysrhythmias A. No rm al sin us rh yth m ( Fig. 56-5)

1. Rh yth m origin ates from th e SA n ode. 2. Descriptio n

a. Atrial an d ven tricular rh yth m s are regular. b . Atrial an d ven tricular rates are 60 to 100

beats/ m in ute (Fig. 56-6 an d Box 56-3). c. PR in terval an d Q RS width are with in n or-

m al lim its. B. Sin us bradycardia

1. Descriptio n a. Atrial an d ven tricular rh yth m s are regular. b . Atrial an d ven tricular rates are less th an 60

beats/ m in ute. c. PR in terval an d Q RS width are with in n or-

m al lim its. d . Treatm en t m ay be n ecessary if th e clien t is

sym pto m atic (sign s of decreased cardiac output) .

e. Note th at a low h eart rate m ay be n orm al for som e in dividuals, such as in ath letes.

BOX 56-2 Home Care Instructions for the Client Who Has Had Cardiac Surgery

▪ Progressive return to activities at home ▪ Limiting of pushing or pulling activities for 6 weeks follow-

ing discharge ▪ Maintenance of incisional care and recording signs of red-

ness, swelling, or drainage ▪ Sternotomy incision heals in about 6 to 8 weeks ▪ Avoidance of crossing legs; wearing elastic hose as pre-

scribed until edema subsides, and elevating the surgical limb (if used to obtain the graft) when sitting in a chair

▪ Use of prescribed medications ▪ Dietary measures, including the avoidance of saturated

fats and cholesterol and the use of salt ▪ Resumption of sexual intercourse on the advice of the health

care provider after exercise tolerance is assessed (usually, if the client can walk 1 block or climb 2 flights of stairs without symptoms, he or she can resume sexual activity safely)

764 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

2. In terven tion s a . Attem pt to determ in e th e cause of sin us

bradycardia; if a m ed ication is susp ected of cau sin g th e bradycardia, with h old th e m edication an d n otify th e HCP.

b . Adm in ister oxygen as prescribed for sym p- tom atic clien t.

c. Adm in ister atropin e sulfate as prescribed to in crease th e h eart rate to 60 beats/ m in ute.

d . Be prepared to apply a n on in vasive (tran s- cutan eous) pacem aker in itially if th e atro- pin e sulfate does n ot in crease th e h eart rate sufficien tly.

e. Avoid addition al doses of atrop in e sulfate because th is will in du ce tach ycardia.

f. Mon itor for h ypoten sion an d adm in ister fluids in traven o usly as prescribed.

g. Depen din g on th e cause of th e bradycar- dia, th e clien t m ay n eed a perm an en t pacem aker.

C. Sin us tach ycardia 1. Description

a . Atrial an d ven tricular rates are 100 to 180 beats/ m in ute.

b . Atrial an d ven tricular rh yth m s are regular. c. PR in terval an d Q RS width are with in n or-

m al lim its. 2. In terven tion s

a . Iden tify th e cause of th e tach ycardia. b . Decrease th e h eart rate to n orm al by treat-

in g th e un d erlyin g cause. D. Atrial fibrillation (Fig. 56-7)

1. Description a . Mu ltip le rap id im p u lses fro m m an y fo ci

d ep o larize in th e atria in a to tally d is- o rgan ized m an n er at a rate o f 350 to 600 tim es/ m in u te.

b . Th e atria quiver, wh ich can lead to th e for- m ation of th rom bi.

FIGURE 56-5 Normal sinus rhythm. Both atrial and ventricular rhythms are essentially regular (a slight variation in rhythm is normal). Atrial and ven- tricular rates are both 83 beats/ minute. There is one P wave before each QRS complex, and all P waves are of a consistent morphology, or shape. The PR interval measures 0.18 seconds and is constant; the QRS complex measures 0.06 seconds and is constant.

1 2

3 s e conds 3 s e conds

3 4 5 6 7 8 9 10

FIGURE 56-6 Each segment between the dark lines (above the monitor strip) represents 3 seconds when the monitor is set at a speed of 25 mm/ second. To estimate the ventricular rate, count the QRS complexes in a 6-second strip and then multiply that number by 10 to estimate the heart rate for 1 minute. In this example, there are 9 QRS complexes in 6 seconds. Therefore, the heart rate can be estimated as 90 beats/ minute.

BOX 56-3 Determination of Heart Rate Using 6-Second Strip Method

The method can be used to determine heart rate for regular and irregular rhythms.

To determine atrial rate, count the number of P waves in 6 sec- onds and multiply by 10 to obtain a full minute rate.

To determine ventricular rate, count the number of R waves or QRS complexes in 6 seconds and multiply by 10 to obtain a full minute rate.

For accuracy, timing should begin on the P wave or the QRS complex and end exactly at 30 large blocks later.

FIGURE 56-7 Atrial dysrhythmias—atrial fibrillation.

765CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

c. Usually n o defin itive P wave can be observed, on ly fibrillatory waves before each Q RS.

2. In terven tion s a. Adm in ister oxygen . b . Adm in ister an ticoagulan ts as prescribed

because of th e risk of em b oli. c. Adm in ister cardiac m edication s as prescribed

to con trol th e ven tricular rh yth m an d assist in th e m ain ten an ce of cardiac output.

d . Prepare th e clien t for cardioversion as prescribed.

e. In struct th e clien t in th e use of m ed ication s as prescribed to con trol th e dysrh yth m ia.

E. Prem atu re ven tricular con traction s (PVCs; Fig. 56-8 an d Box 56-4) 1. Descrip tion

a. Early ven tricular con traction s result from in creased irritability of th e ven tricles.

b . PVCs frequen tly occur in repetitive pattern s such as bigem in y, trigem in y, an d quad- rigem in y.

c. Th e Q RS com plexes m ay be un ifo cal or m ultifocal.

2. In terven tion s a. Iden tify th e cau se an d treat on th e basis of

th e cause. b . Evaluate oxygen saturatio n to assess for h y-

poxem ia, wh ich can cause PVCs. c. Evaluate electrolytes, particularly th e potas-

sium level, because h ypokalem ia can cause PVCs.

d . O xygen an d m ed ication m ay be prescribed in th e case of acute m yocardial isch em ia or MI.

For the client experiencing PVCs, notify the HCP if the client complains of chest pain or if the PVCs increase in frequency, are multifocal, occur on the T wave (R-on- T), or occur in runs of ventricular tachycardia.

F. Ven tricular tach ycard ia (VT; Fig. 56-9) 1. Descrip tion

a. VT occurs because of a repetitive firin g of an irritable ven tricular ectop ic focus at a rate of 140 to 250 beats/ m in ute or m ore.

b . VT m ay presen t as a paroxysm of 3 self- lim itin g beats or m ore, or m ay be a sus- tain ed rh yth m .

c. VT can lead to cardiac arrest. 2. Stable clien t with sustain ed VT (with pulse an d n o

sign s or sym ptom s of decreased cardiac output) a. Adm in ister oxygen as prescribed. b . Adm in ister an tidysrh ythm ics as prescribed.

3. Un stable clien t with VT (with pulse an d sign s an d sym pto m s of decreased cardiac output) a. Adm in ister oxygen an d an tidysrh yth m ic

th erap y as prescribed. b . Prepare for syn ch ron ized cardioversion if

th e clien t is un stable. c. Th e HCP m ay attem pt cough cardiop ulm o-

n ary resuscitation (CPR) by askin g th e clien t to cough h ard every 1 to 3 secon ds.

4. Pulseless clien t with VT: Defibrillatio n an d CPR G. Ven tricular fib rillation (VF; Fig. 56-10)

1. Descriptio n a. Im p u lses fro m m an y irritab le fo ci in th e

ven tricles fire in a to tally d iso rgan ized m an n er.

BOX 56-4 Premature Ventricular Contractions Bigeminy: Premature ventricular contraction (PVC) every

other heartbeat Trigeminy: PVC every third heartbeat Qua drigeminy: PVC every fourth heartbeat Couplet or pa ir: Two sequential PVCs Unifoca l: Uniform upward or downward deflection, arising

from the same ectopic focus Multifoca l: Different shapes, with the impulse generation

from different sites R-on-T phenomenon: PVC falls on the T wave of the preceding

beat; may precipitate ventricular fibrillation

P VCP VCP VC P VCP VCP VC

FIGURE 56-8 Ventricular dysrhythmias—normal sinus rhythm with multifocal premature ventricular contractions (PVCs; one negative and the other positive).

766 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

b . VF is a ch aotic rapid rh yth m in wh ich th e ven tricles quiver an d th ere is n o cardiac outp ut.

c. VF is fatal if n ot successfully term in ated with in 3 to 5 m in u tes.

d . Clien t lacks a pulse, BP, respiratio n s, an d h eart soun ds, an d is un con scious.

2. In terven tion s a . In itiate CPR un til a defibrillator is available. b . Th e clien t is defibrillated im m ediately with

120 to 200 joules (biph asic defibrillator) or 360 joules (m on oph asic defibrillator); check the en tire len gth of the clien t 3 tim es to m ake sure n o on e is touch in g th e clien t or th e bed; when clear, proceed with defibrillation .

c. CPR is con tin ued for 2 m in utes an d th e car- diac rh yth m is reassessed to determ in e n eed for furth er coun tersh ock.

d . Adm in ister oxygen as prescribed. e. Adm in ister an tidysrh yth m ic th erap y as

prescribed. H. Guidelin es for perform in g adult CPR

1. If a victim is n oted not breath in g or on ly gaspin g, activate the em ergen cy respon se system an d obtain an autom ated extern al defibrillator (AED) or m on oph asic or biph asic defibrillator depen din g on the setting an d equipm ent available.

2. Ch eck th e carotid pulse for a m axim u m of 10 secon ds.

3. If n o pulse is felt, begin ch est com pression s (100 to 120 per m in ute) at a dep th of 2 in ch es (5 cm ) for 2 m in u tes or 5 cycles of 30 com pression s to 2 ven tilation s usin g a barrier device.

4. Ch eck rh yth m an d for presen ce of a pulse every 2 m in utes or after 5 cycles (depen din g on th e settin g an d equipm en t available, deliver a sh ock if in dicated ).

5. Switch com pression an d ven tilation roles if an oth er rescuer is available, to avoid fatigue.

6. Con tin ue th is process un til th e victim gain s con - sciousn ess, starts breath in g, or h as a pulse.

7. If th e victim h as a pulse but is n ot breath in g, con tin ue with rescue breath in g un til h elp arrives an d advan ced cardiovascular life supp ort m ea- sures are in stituted.

8. For updated in form ation , refer to Am erican Heart Association : Guidelines for CPR and ECC, 2015. Retrieved from h ttps:/ / eccguidelin es.h eart.org/ in dex.ph p/ circulation / cpr-ecc-guidelin es-2/

V. Management of Dysrhythmias A. Vagal m an euvers

1. Description : Vagal m an euvers in duce vagal stim ulation of th e cardiac con d uction system an d are used to term in ate supraven tricular tach ydysrh yth m ias.

2. Caro tid sin us m assage a. Th e HCP in structs th e clien t to turn th e h ead

away fro m th e side to be m assaged . b . Th e HCP m assages over 1 carotid artery for a

few secon ds to determ in e wh eth er a ch an ge in cardiac rh yth m occurs.

c. Th e clien t m ust be on a cardiac m on itor; an electrocardio graph ic rh yth m strip before, durin g, an d after th e proced ure sh o uld be docum en ted on th e ch art.

FIGURE 56-9 Ventricular dysrhythmias—sustained ventricular tachycardia at a rate of 166 beats/ minute.

FIGURE 56-10 Ventricular dysrhythmias—coarse ventricular fibrillation.

767CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

d . Have a defibrillator an d resuscitative equip- m en t available.

e. Mon itor vital sign s, cardiac rh yth m , an d level of con sciousn ess followin g th e procedure.

3. Valsalva m an euver a . Th e HCP in structs th e clien t to bear down or

in du ces a gag reflex in th e clien t to stim ulate a vagal respo n se.

b . Mon itor th e h eart rate, rh yth m , an d BP. c. O bserve th e cardiac m on itor for a ch an ge in

rh yth m . d . Record an electrocardiograph ic rh yth m strip

before, durin g, an d after th e procedure. e. Provide an em esis basin if th e gag reflex is

stim ulated , an d in itiate precaution s to pre- ven t aspiration .

f. Have a defibrillator an d resuscitative equip- m en t available.

B. Card ioversion 1. Description

a . Card ioversion is syn ch ron ized coun ter- sh o ck to con vert an un d esirable rh yth m to a stable rh yth m .

b . Card ioversion can be an elective procedure perform ed by th e HCP for stable tach ydys- rh yth m ias resistan t to m ed ical th erapies or an em ergen t procedure for h em od yn am i- cally un stable ven tricular or supraven tricu- lar tach ydysrh yth m ias.

c. A lo wer am oun t of en ergy is used th an with defibrillation .

d . Th e defibrillator is syn ch ron ized to th e clien t’s R wave to avoid disch argin g th e sh o ck durin g th e vuln erable period (T wave).

e. If th e defibrillator is n ot syn ch ron ized, it could disch arge on th e T wave an d cause VF.

2. Preprocedure in terven tion s a . If an elective procedure, en sure th at

in form ed con sen t is obtain ed. b . Adm in ister sedation as prescribed. c. If an elective procedure, h old digo xin for 48

h ou rs preprocedure as prescribed to preven t postcardioversion ven tricular irritab ility.

d . If an elective proced ure for atrial fibrillatio n or atrial flutter, th e clien t sh ould receive an ticoagulan t th erap y for 4 to 6 weeks pre- procedure an d a tran sesoph ageal ech ocar- diogram (TEE) sh o uld be perform ed to ru le out clo ts in th e atria prior to th e procedure.

3. Durin g th e proced ure a . En su re th at th e skin is clean an d dry in th e

area wh ere th e electrod e pads/ h an ds-off pads will be placed.

b . Stop th e oxygen durin g th e procedure to avoid th e h azard of fire.

c. Be sure th at n o on e is touch in g th e bed or th e clien t wh en deliverin g th e coun tersh ock (ch eck th e en tire len gth of th e clien t 3 tim es).

4. Postprocedure in terven tion s a . Prio rity assessm en t in cludes ability of th e

clien t to m ain tain th e airway an d breath in g. b . Resum e oxygen adm in istration as prescribed. c. Assess vital sign s. d . Assess level of con sciousn ess. e. Mon itor cardiac rh yth m . f. Mon itor for in dication s of successful

respo n se, such as con version to sin us rh yth m , stron g periph eral pulses, an ade- quate BP, an d adequ ate urin e outp ut.

g. Assess th e skin on th e ch est for eviden ce of burn s fro m th e edges of th e pads.

C. Defibrillation 1. Defibrillation is an asyn ch ro n ous coun tersh ock

used to term in ate pulseless VT or VF. 2. Th e defibrillator is ch arged to 120 to 200 joules

(biph asic) or 360 joules (m on oph asic) for 1 coun tersh ock from th e defibrillator, an d th en CPR is resum ed im m ediately an d con tin ued for 5 cycles or about 2 m in utes.

3. Reassess th e rh yth m after 2 m in u tes, an d if VF or pulseless VT con tin ues, th e defibrillator is ch arged to give a secon d sh ock at th e sam e en ergy level previously used.

4. Resu m e CPR after th e sh o ck, an d con tin ue with th e life support protocol.

Before defibrillating a client, be sure that the oxygen is shut off to avoid the hazard of fire and be sure that no one is touching the bed or the client.

D. Use of pad electrodes 1. O n e pad is placed at th e th ird in tercostal space

to th e righ t of th e stern um ; th e oth er is placed at th e fifth in tercostal space on th e left m idaxillary lin e.

2. Apply firm pressure of at least 25 lb to each of th e pads.

3. Be sure th at n o on e is touch in g th e bed or th e clien t wh en deliverin g th e coun tersh ock.

4. Pads for h an ds-off biph asic defibrillation m ay be applied in an an terior-posterior position or apex-posterior position , an d placem en t directly over breast tissue sh ould be avoided.

E. Autom ated extern al defibrillato r (AED) 1. An AED is u sed b y layp erso n s an d em ergen cy

m ed ical tech n ician s fo r p reh o sp ital card iac arrest.

2. Place th e clien t on a firm , dry surface. 3. Stop CPR. 4. En sure th at n o on e is touch in g th e clien t to

avoid m otion artifact durin g rh yth m an alysis. 5. Place th e electrod e patch es in th e correct posi-

tion on th e clien t’s ch est.

768 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

6. Press th e an alyzer button to iden tify th e rh yth m , wh ich m ay take 30 secon ds; th e m ach in e will advise wh eth er a sh o ck is n ecessary.

7. Sh o cks are recom m en ded for pulseless VT or VF on ly (usually 3 sh o cks are delivered).

8. If u n su ccessfu l, CPR is co n tin u ed fo r 1 m in u te an d th en an o th er series o f sh o cks is d elivered .

F. Autom ated im plan table cardioverter-defibrillato r (AICD) 1. Description

a . An AICD m on itors cardiac rh yth m an d detects an d term in ates episo des of VT an d VF by deliverin g 25 to 30 joules up to 4 tim es, if n ecessary.

b . An AICD is used in clien ts with episodes of spon tan eous sustain ed VT or VF un related to an MI or in clien ts wh ose m ed ication th erapy h as been un successful in con trollin g life-th reaten in g dysrh yth m ias.

c. Tran sven ous electrode leads are placed in th e righ t atrium an d ven tricle in con tact with th e en docardium ; leads are used for sen sin g, pacin g, an d delivery of cardiover- sion or defibrillation .

d . Th e gen erator is m ost com m on ly im plan ted in th e left pecto ral region .

2. Clien t education a. In struct th e clien t in th e basic fun ction s of

th e AICD. b . Kn o w th e rate cutoff of th e AICD an d th e

n um ber of con secutive sh ocks th at it will deliver.

c. Wear loose-fittin g cloth in g over th e AICD gen erator site.

d . In struct th e clien t on activities to avoid, in cludin g con tact sports, to prevent traum a to th e AICD gen erator an d lead wires.

e. Repo rt an y fever, redn ess, swellin g, or drain age from th e in sertio n site.

f. Repo rt sym ptom s of fain tin g, n ausea, weak- n ess, blackouts, an d rapid pulse rates to th e HCP.

g. Du rin g sh o ck disch arge, th e clien t m ay feel fain t or sh o rt of breath .

h . In struct th e clien t to sit or lie down if h e or sh e feels a sh o ck an d to n otify th e HCP.

i. Advise th e clien t to m ain tain a log of th e date, tim e, an d activity precedin g th e sh o ck; th e sym ptom s preced in g th e sh ock; an d postsh ock sen sation s.

j. In struct th e clien t an d fam ily in h ow to access th e em ergen cy m edical system .

k . En cou rage th e fam ily to learn CPR. l. In struct th e clien t to avoid electrom agn etic

fields directly over th e AICD because th ey can in activate th e device.

m . In struct th e clien t to m ove away fro m th e m agn etic field im m ediately if beepin g ton es are h eard, an d to n otify th e HCP.

n . Keep an AICD iden tification card in th e wallet an d obtain an d wear a MedicAlert bracelet.

o . In form all HCPs th at an AICD h as been in serted; certain diagn ostic tests, such as MRI, an d procedures usin g diath erm y or electrocautery in terfere with AICD fun ction.

VI. Pacemakers A. Descriptio n : Tem po rary or perm an en t device th at

provides electrical stim ulation an d m ain tain s th e h eart rate wh en th e clien t’s in trin sic pacem aker fails to provid e a perfusin g rh yth m

B. Settin gs 1. A syn ch ron ous (dem an d) pacem aker sen ses th e

clien t’s rh yth m an d paces on ly if th e clien t’s in trin sic rate falls below th e set pacem aker rate for stim ulatin g dep olarization .

2. An asyn ch ron ous (fixed rate) pacem aker paces at a preset rate regardless of th e clien t’s in trin sic rh yth m an d is used wh en th e clien t is asystolic or profoun d ly brad ycardic.

3. O verdrive pacin g suppresses th e un derlyin g rh yth m in tach ydysrh yth m ias so th at th e sin us n ode will regain con tro l of th e h eart.

C. Spikes 1. Wh en a pacin g stim ulus is delivered to th e h eart,

a spike (straigh t vertical lin e) is seen on th e m on itor or ECG strip.

2. Spikes precede th e ch am b er bein g paced; a spike precedin g a P wave in dicates th at th e atrium is paced an d a spike precedin g th e Q RS com plex in dicates th at th e ven tricle is bein g paced.

3. An atrial spike followed by a P wave in dicates atrial depolarization an d a ven tricular spike fol- lowed by a Q RS com plex represen ts ven tricular depolarization ; th is is referred to as capture.

D. Tem po rary pacem akers 1. Non in vasive tran scutan eous pacin g

a . Non in vasive tran scutan eous pacin g is used as a tem porary em ergen cy m easu re in th e profou n dly bradycardic or asystolic clien t un til in vasive pacin g can be in itiated.

b . Large electrode pads are placed on th e cli- en t’s ch est an d back an d con n ected to an extern al pulse gen erator.

c. Wash th e skin with soap an d water before applyin g electrod es.

d . It is n ot n ecessary to sh ave th e h air or ap ply alcoh ol or tin ctures to th e skin .

e. Place th e posterior electrode between th e spin e an d left scapula beh in d th e h eart, avoidin g placem en t over bon e.

f. Place th e an terior electrod e between V2 an d V5 position s over th e h eart.

769CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

g. Do n ot place th e an terior electrode over fem ale breast tissue; rath er, displace breast tis- sue and place th e electrode un der th e breast.

h . Do n ot take th e pulse or BP on th e left side; th e results will n ot be accu rate because of th e m uscle twitch in g an d electrical curren t.

i. En sure th at electrod es are in good con tact with th e skin .

j. Set pacin g rate as prescribed ; establish stim - ulatio n th resh o ld to en sure cap ture.

k . If lo ss of capture occurs, assess th e skin con - tact of th e electrod es an d in crease th e cur- ren t un til cap ture is regain ed.

l. Evaluate th e clien t for discom fort fro m cuta- n eous an d m uscle stim ulation ; adm in ister an algesics as n eeded.

2. In vasive tran sven ou s pacin g a. Pacin g lead wire is placed th rou gh th e an te-

cubital, fem o ral, jugular, or subclavian vein in to th e righ t atrium or righ t ven tricle, so th at it is in direct co n tact with th e en docardium .

b . Mon itor th e pacem aker in sertion site. c. Restrict clien t m ovem en t to preven t lead

wire displacem en t. 3. In vasive epicardial pacin g—applied by usin g a

tran sth oracic approach ; th e lead wires are th readed loosely on th e epicardial surface of th e h eart after cardiac surgery.

4. Reducin g th e risk of m icro sh ock a. Use only inspected an d approved equipm en t. b . In sulate th e exposed portion of wires with

plastic or rubber m aterial (fin gers of ru bber gloves) wh en wires are n ot attach ed to th e pulse gen erator; cover with n on con ductive tape.

c. Groun d all electrical equ ipm en t, usin g a 3-pron ged plug.

d . Wear gloves wh en h an dlin g exposed wires. e. Keep dressin gs dry.

Vital signs are monitored and cardiac monitoring is done continuously for the client with a pacemaker.

E. Perm an en t pacem akers 1. Pulse gen erator is in tern al an d surgically

im plan ted in a subcu tan eous pocket below th e clavicle.

2. Th e leads are passed tran sven ously via th e ceph alic or subclavian vein to th e en docardium on th e righ t side of th e h eart; posto peratively, lim itation of arm m ovem en t on th e operative side is required to preven t lead wire dis- lodgem en t.

3. Perm an en t pacem akers m ay be sin gle- ch am bered, in wh ich th e lead wire is placed in th e ch am ber to be paced, or dual-ch am bered, with lead wires placed in both th e righ t atrium an d th e righ t ven tricle.

4. Biven tricular pacin g of th e ven tricles allows for syn ch ron ized dep olarization an d is used for m od erate to severe h eart failure to im prove car- diac outp ut.

5. A perm an en t pacem aker is program m ed wh en in serted an d can be reprogram m ed if n ecessary by n on in vasive tran sm ission fro m an extern al program m er to th e im plan ted gen erator.

6. Pacem akers m ay be powered by a lith ium battery with an average life span of 10 years, n uclear- powered with a life span of 20 years or lon ger, or design ed to be rech arged extern ally.

7. Pacem aker fun ction can be ch ecked in th e HCP’s office or clin ic by a pacem aker in terroga- tor or program m er or from h om e, usin g a spe- cial telep h on e tran sm itter device.

8. Th e clien t m ay be provided with a device placed over th e pacem aker battery gen erator with an attach m en t to th e teleph o n e; th e h eart rate th en can be tran sm itted to th e clin ic.

9. Clien t teach in g (Box 56-5).

VII. Coronary Artery Disease A. Description

1. Coron ary artery disease is a n arrowin g or obstru ctio n of 1 or m ore coron ary arteries as a result of ath ero sclerosis, wh ich is an

BOX 56-5 Pacemakers: Client Education Instruct the client about the pacemaker, including the pro-

grammed rate. Instruct the client in the signs of battery failure and when to

notify the health care provider (HCP). Instruct the client to report any fever, redness, swelling, or

drainage from the insertion site. Report signs of dizziness, weakness or fatigue, swelling

of the ankles or legs, chest pain, or shortness of breath. Keep a pacemaker identification card in the wallet and obtain

and wear a MedicAlert bracelet. Instruct the client in how to take the pulse, to take the pulse

daily, and to maintain a diary of pulse rates. Wear loose-fitting clothing over the pulse generator site. Avoid contact sports. Inform all HCPs that a pacemaker has been inserted. Instruct the client to inform airport security that he or she has

a pacemaker because the pacemaker may set off the secu- rity detector.

Instruct the client that most electrical appliances can be used without any interference with the functioning of the pacemaker; however, advise the client not to operate electrical appliances directly over the pacemaker site.

Avoid transmitter towers and antitheft devices in stores. Instruct the client that if any unusual feelings occur when near

any electrical devices, to move 5 to 10 feet away and check the pulse.

Instruct the client about the methods of monitoring the func- tion of the device.

Emphasize the importance of follow-up with the HCP. Use cellphones on the side opposite the pacemaker.

770 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

accum ulation of lipid-co n tain in g plaque in th e arteries ( Fig. 56-11).

2. Th e disease causes decreased perfusion of m yo- cardial tissue an d in adequate m yocardial oxy- gen supp ly leadin g to h yperten sio n , an gin a, dysrh yth m ias, MI, h eart failure, an d death .

3. Collateral circulation , m ore th an 1 artery supplyin g a m uscle with blood, is n orm ally presen t in th e coron ary arteries, especially in older perso n s.

4. Th e developm en t of collateral circulation takes tim e an d develo ps wh en ch ron ic isch em ia occurs to m eet th e m etab olic dem an ds; th ere- fore, an occlusion of a coron ary artery in a youn - ger in dividual is m ore likely to be leth al th an on e in an older in dividual.

5. Sym pto m s occur wh en th e coron ary artery is occlu ded to th e poin t th at in adequate blood supply to th e m uscle occurs, causin g isch em ia.

6. Coron ary artery n arrowin g is sign ifican t if th e lu m en diam eter of th e left m ain artery is reduced at least 50%, or if an y m ajo r bran ch is reduced at least 75%.

7. Th e goal of treatm en t is to alter th e ath ero scle- ro tic progressio n .

B. Assessm en t 1. Possibly n orm al fin din gs durin g asym ptom atic

periods 2. Ch est pain 3. Palpitation s 4. Dysp n ea 5. Syn cope 6. Cough or h em op tysis 7. Excessive fatigue

C. Diagn ostic studies 1. Electrocardio graph y

a . Wh en blood flow is reduced an d isch em ia occurs, ST-segm en t depression , T-wave in ver- sion , or both is n oted; th e ST segm ent returns to n orm al wh en the blood flow returns.

b . With in farction , cell in jury results in ST- segm en t elevation , followed by T-wave in version an d an ab n orm al Q wave.

2. Card iac cath eterization : Cardiac cath eterization sh o ws th e presen ce of ath ero sclerotic lesion s.

3. Bloo d lipid levels a . Blood lipid levels m ay be elevated. b . Ch olesterol-lowerin g m edication s m ay be

prescribed to reduce th e developm en t of ath ero sclerotic plaq ues.

D. In terven tion s 1. Assist th e clien t to id en tify risk facto rs th at can

be m odified an d to set go als to prom ote lifestyle ch an ges to reduce th e im pact of risk factors.

2. Assist th e clien t to iden tify barriers to com pli- an ce with th e th erap eutic plan an d to iden tify m eth ods to overcom e barriers.

3. In struct th e clien t regardin g a low-calorie, low- sodium , lo w-ch o lesterol, an d lo w-fat diet, with an in crease in dietary fiber.

4. Stress to the clien t that dietary ch an ges are n ot tem - porary an d m ust be m ain tain ed for life; in struct the clien t regardin g prescribed m edication s.

5. Provide co m m un ity resou rces to th e clien t regardin g exercise, sm okin g cessation , an d stress reduction as appropriate.

E. Surgical proced ures 1. PTCA to com press th e plaque again st th e walls

of th e artery an d dilate th e vessel 2. Laser an gio plasty to vaporize th e plaque 3. Ath erectom y to rem ove th e plaque from th e artery 4. Vascular sten t to preven t th e artery from closin g

an d to preven t resten o sis 5. Coron ary artery bypass graftin g to im prove

blood flow to th e m yocardial tissue at risk for ischem ia or in farction because of th e occluded artery

Re s po ns e to injury

Chro nic Caus e s o f Endo the lial Injury:

Endothe lium

P la te le ts

Lipids

Monocyte

Ma cropha ge

P la te le ts a tta ch to e ndothe lium

Foa my ma cropha ge inge s ting lipids

Migra tion of s mooth mus cle into the intima

Lipid a ccumula tion

Fibrobla s t

Colla ge n ca p (fibrous tis s ue )

Fibrobla s t

Fis s ure in pla que

Lipid pool

Thrombus

Thinning colla ge n ca p

Lipid pool

Da ma ge d e ndothe lium

Tunica me dia

Adve ntitia

• He modyna mic fa ctors • Hype rhomocys te ine mia • Hype rlipide mia

• Hype rte ns ion • Immune re a ctions • S moking

• Toxins • Virus e s

Fatty s tre ak

Fibro us plaque

Co mplic ate d le s io n

Tunica intima

FIGURE 56-11 Cross-sections of an atherosclerotic coronary artery.

771CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

F. Med ication s 1. Nitrates to dilate th e coron ary arteries an d

decrease preload an d afterload 2. Calcium ch an n el blockers to dilate coron ary

arteries an d reduce vasospasm 3. Ch o lestero l-lowerin g m ed ication s to reduce th e

developm en t of ath erosclerotic plaq ues 4. Beta blockers to reduce th e BP in in dividuals

wh o are h yperten sive

VIII. Angina A. Description

1. An gin a is ch est pain resultin g from m yocardial isch em ia cau sed by in adeq uate m yocardial blood an d oxygen supply.

2. An gin a is caused by an im balan ce between oxy- gen supply an d dem an d.

3. Cau ses in clude obstru ction of coron ary blood flo w resultin g from ath ero sclerosis, coron ary artery spasm , or con d ition s in creasin g m yocar- dial oxygen con sum ptio n .

The goaloftreatment for angina is to provide relieffrom the acute attack, correct the imbalance between myocardial oxygen supply and demand, and prevent the progression of the disease and further attacks to reduce the risk of MI.

B. Pattern s of an gin a 1. Stable an gin a

a . Also called exertion al an gin a b . O ccurs with activities th at in volve exertio n

or em o tion al stress; relieved with rest or n itroglycerin

c. Usually h as a stable pattern of on set, dura- tion , severity, an d relievin g factors

2. Un stable an gin a a . Also called prein farction an gin a b . O ccurs with an un predictable degree of exer-

tion or em otion an d in creases in occurren ce, duration , an d severity over tim e

c. Pain m ay n ot be relieved with n itroglycerin . 3. Varian t an gin a

a . Also called Prin zm etal’s or vasospastic an gin a b . Results fro m coron ary artery spasm c. May occur at rest d . Attacks m ay be associated with ST-segm en t

elevation n oted on th e ECG. 4. In tractable an gin a is a ch ron ic, in capacitatin g

an gin a un respo n sive to in terven tion s. 5. Prein farction an gin a

a . Associated with acu te coron ary in sufficien cy

b . Lasts lon ger th an 15 m in utes c. Sym pto m of worsen in g cardiac isch em ia d . Ch aracterized by ch est pain th at occurs days

to weeks befo re an MI C. Assessm en t

1. Pain a . Pain can develop slowly or quickly.

b . Pain usually is described as m ild or m oderate.

c. Substern al, crush in g, squeezin g pain m ay occur.

d . Pain m ay radiate to th e sh oulders, arm s, jaw, n eck, or back.

e. Pain in ten sity is un affected by in spiration an d expiration .

f. Pain usually lasts less th an 5 m in utes; h ow- ever, pain can last up to 15 to 20 m in u tes.

g. Pain is relieved by n itroglycerin or rest. 2. Dysp n ea 3. Pallor 4. Sweatin g 5. Palp itation s an d tach ycardia 6. Dizzin ess an d syn cop e 7. Hyperten sion 8. Digestive disturban ces

D. Diagn ostic studies 1. Electrocardio graph y: Readin gs are n orm al dur-

in g rest, with ST depression or T-wave in version durin g an episo de of pain .

2. Stress testin g: Ch est pain or ch an ges in th e ECG or vital sign s durin g testin g m ay in dicate isch em ia.

3. Card iac en zym e an d tro pon in levels: Fin din gs are n orm al in an gin a.

4. Card iac cath eterization : Cath eterization pro- vides a defin itive diagn osis by providin g in for- m ation about th e paten cy of th e coron ary arteries.

E. In terven tion s 1. Im m ediate m an agem en t

a. Assess pain ; in stitute pain relief m easures. b . Adm in ister oxygen by n asal can n ula as

prescribed. c. Assess vital sign s an d provide con tin uous

cardiac m on itorin g an d n itroglycerin as pre- scribed to dilate th e coron ary arteries, reduce th e oxygen requirem en ts of th e m yo- cardium , an d relieve th e ch est pain .

d . En sure th at bed rest is m ain tain ed, place th e clien t in sem i-Fowler’s position , an d stay with th e clien t.

e. O btain a 12-lead ECG. f. Establish an IV access route.

2. Follo win g th e acute episode a. See section VII, D (Coron ary Artery Disease,

In terven tion s). b . Assist th e clien t to iden tify an gin a-

precipitatin g even ts. c. In struct th e clien t to stop activity an d rest if

ch est pain occurs an d to take n itroglycerin as prescribed; th e clien t is usually in structed to call em ergen cy m edical services if th e n itroglycerin does n ot relieve th e pain , an d m an y HCPs recom m en d th at th e clien t also take an aspirin .

772 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

F. Surgical procedures: See section VII, E (Co ron ary Artery Disease, Surgical procedures).

G. Med ication s 1. See section VII, F (Co ron ary Artery Disease,

Medication s). 2. An tiplatelet th erapy m ay be prescribed ; it

in h ibits platelet aggregation an d reduces th e risk of developin g an acu te MI.

IX. Myocardial Infarction A. Descriptio n

1. MI occurs wh en m yocardial tissue is ab ruptly an d severely deprived of oxygen .

2. Isch em ia can lead to n ecrosis of m yocardial tissue if blood flow is n ot restored.

3. In farction does n ot occur in stan tly but evolves over several h ours.

4. O bvious ph ysical ch an ges do n ot occur in th e h eart un til 6 h ours after th e in farction , wh en th e in farcted area ap pears blue an d swollen .

5. After 48 h ours, th e in farct turn s gray, with yel- low streaks developin g as n eutroph ils in vad e th e tissue.

6. By 8 to 10 days after in farction , gran ulatio n tissue form s.

7. O ver 2 to 3 m on th s, th e n ecrotic area develops in to a scar; scar tissue perm an en tly ch an ges th e size an d sh ap e of th e en tire left ven tricle.

8. No t all clien ts experien ce th e classic sym pto m s of an MI.

9. Wom en m ay experien ce atypical discom fort, sh ortn ess of breath , or fatigue an d often pre- sen t with n on –ST-elevation m yocardial in farc- tion (NSTEMI) or T-wave in version .

10. An older clien t m ay experien ce sh ortn ess of breath , pulm o n ary edem a, dizzin ess, altered m en tal status, or a dysrh yth m ia.

B. Location of MI (see Fig. 56-1) 1. O bstruction of th e LAD artery results in an terior

wall or septal MI, or both . 2. O bstruction of th e circum flex artery results in

posterior wall MI or lateral wall MI. 3. O bstruction of th e righ t coron ary artery results

in in ferior wall MI. C. Risk facto rs

1. Ath erosclerosis 2. Coron ary artery disease 3. Elevated ch olesterol levels 4. Sm okin g 5. Hyperten sion 6. O besity 7. Ph ysical in activity 8. Im paired gluco se toleran ce 9. Stress

D. Diagn ostic studies 1. Tropon in level: Level rises with in 3 h ours an d

rem ain s elevated for up to 7 to 10 days.

2. Total CK level: Level rises within 6 hours after the onset of ch est pain an d peaks with in 18 h ours after dam age an d death of cardiac tissue.

3. CK-MB isoen zym e: Peak elevation occurs 18 h ou rs after th e on set of ch est pain an d return s to n orm al 48 to 72 h ou rs later.

4. Myoglobin : Level rises with in 2 h ours after cell death , with a rapid declin e in th e level after 7 h ou rs.

5. Wh ite blood cell coun t: An elevated wh ite blood cell coun t appears on th e secon d day followin g th e MI an d lasts up to 1 week.

6. Electrocardio gram a . ECG sh ows eith er ST segm en t elevation

MI (STEMI), T-wave in version , or NSTEMI; an ab n orm al Q wave m ay also presen t.

b . Hours to days after th e MI, ST- an d T-wave ch an ges will return to n orm al, but th e Q -wave ch an ges usually rem ain perm an en tly.

7. Diagn ostic tests followin g th e acu te stage a . Exercise toleran ce test or stress test to assess

for electrocardio graph ic ch an ges an d isch e- m ia an d to evaluate for m ed ical th erap y or iden tify clien ts wh o m ay n eed in vasive th erap y.

b . Th allium scan s to assess for isch em ia or n ecrotic m uscle tissue.

c. Multigated cardiac blood pool im agin g scan s m ay be used to evaluate left ven tricu- lar fun ction .

d . Cardiac cath eterization to determ in e th e exten t an d lo cation of obstru ction s of th e coron ary arteries.

E. Assessm en t 1. Pain

a . Clien t m ay experien ce crush in g substern al pain .

b . Pain m ay radiate to th e jaw, back, an d left arm .

c. Pain m ay occur with ou t cause, prim arily early in th e m orn in g.

d . Pain is un relieved by rest or n itroglycerin an d is relieved on ly by opioids.

e. Pain lasts 30 m in utes or lon ger. 2. Nausea an d vo m itin g 3. Diaph oresis 4. Dysp n ea 5. Dysrh yth m ias 6. Feelin gs of fear an d an xiety 7. Pallor, cyan osis, cooln ess of extrem ities

F. Com p lication s of MI ( Box 56-6) G. In terven tion s, acu te stage

Pain relief increases oxygen supply to the myocar- dium; administer morphine as a priority in managing pain in the client having an MI.

773CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

1. O btain a description of th e ch est discom fort. 2. Adm in ister oxygen an d in stitute pain relief m ea-

sures (m orph in e, n itroglycerin as prescribed). 3. Assess vital sign s an d cardiovascular status an d

m ain tain cardiac m on itorin g. 4. Assess respiratory rate an d breath soun ds for

sign s of h eart failure, as in dicated by the presen ce of crackles or wheezes or depen den t edem a.

5. En sure bed rest an d place th e clien t in a sem i- Fowler’s position to en h an ce com fo rt an d tis- sue oxygen ation ; stay with th e clien t.

6. Establish an IV access route. 7. O btain a 12-lead ECG. 8. Mon itor laborato ry values. 9. Mon itor for cardiac dysrh yth m ias because

tach ycardia an d PVCs frequen tly occur in th e first few h ou rs after MI; adm in ister an tidysr- h yth m ics as prescribed .

10. Adm in ister th rom bolytic th erapy, wh ich m ay be prescribed with in th e first 6 h ours of th e coron ary even t; m on itor for sign s of bleedin g if th e clien t is receivin g th rom bolytic th erapy.

11. Assess distal periph eral pulses an d skin tem - perature because poor cardiac outp ut m ay be iden tified by cool diaph o retic skin an d dim in - ish ed or absen t pulses.

12. Mon itor th e BP clo sely after th e adm in istra- tion of m ed ication s; if th e systolic pressure is lower th an 100 m m Hg or 25 m m Hg lower th an th e previous readin g, lower th e h ead of th e bed an d n otify th e HCP.

13. Adm in ister beta blockers as prescribed to slow th e h eart rate an d in crease m yocardial per- fusion wh ile reducin g th e force of m yocardial con traction .

14. Provid e reassuran ce to th e clien t an d fam ily. H. In terven tion s followin g th e acu te episo de

1. Main tain bed rest as prescribed. 2. Allow th e clien t to stan d to void or use a bed side

com m ode if prescribed. 3. Provide ran ge-of-m otion exercises to preven t

th rom bus form ation an d m ain tain m uscle stren gth .

4. Progress to dan glin g legs at th e side of th e bed or out of bed to th e ch air for 30 m in utes 3 tim es a day as prescribed .

5. Progress to am bulation in the client’s room and to the bathroom and then in the hallway 3 tim es a day.

6. Mon itor for com plication s. 7. Adm in ister an giotensin -con vertin g en zym e

(ACE) inh ibitors, an gioten sin -II receptor blockers (ARBs), calcium ch an n el blockers, aspirin , th ie- n opyridin es (clopidogrel), an d lipid-lowerin g agen ts as prescribed.

8. En cou rage th e clien t to verbalize feelin gs regard- in g th e MI.

I. Card iac reh abilitation : Process of actively assistin g th e clien t with cardiac disease to ach ieve an d m ain - tain a vital an d produ ctive life with in th e lim itation s of th e h eart disease; also , refer to section VII, D (Co ron ary Artery Disease, In terven tion s).

X. Heart Failure A. Descriptio n

1. Heart failure is th e in ability of th e h eart to m ain - tain adequ ate cardiac outp ut to m eet th e m eta- bolic n eeds of th e body because of im paired pum pin g ability.

2. Dim in ish ed cardiac output results in in adequate periph eral tissue perfusion .

3. Con gestion of th e lun gs an d periph ery m ay occur; th e clien t can develop acute pulm on ary edem a.

B. Classification 1. Acute h eart failure occurs sudden ly. 2. Ch ron ic h eart failure develops over tim e; h ow-

ever, a clien t with ch ron ic h eart failure can develo p an acute episode.

C. Types of h eart failure 1. Righ t ven tricular failure, left ven tricular failure

a. Because th e 2 ven tricles of th e h eart represen t 2 separate pum pin g system s, it is possible for 1 to fail alon e for a sh ort period.

b . Most h eart failure begin s with left ven tricu- lar failure an d progresses to failure of both ven tricles.

c. Acute pulm o n ary edem a, a m edical em er- gen cy, results fro m left ven tricular failure.

d . If pulm o n ary edem a is n ot treated, death will occur from suffo cation because th e cli- en t literally drown s in h is or h er own fluids.

2. Forward failure, backward failure a. In forward failure, an in adequate output of

th e affected ven tricle causes decreased perfu- sion to vital organ s.

b . In backward failure, blood backs up beh in d th e affected ventricle, causing in creased pressure in th e atrium beh ind th e affected ven tricle.

3. Low outp ut, h igh output a. In low-outp ut failure, n ot en ough cardiac

outp ut is available to m eet th e dem an ds of th e body.

BOX 56-6 Complications of Myocardial Infarction ▪ Dysrhythmias ▪ Heart failure ▪ Pulmonary edema ▪ Cardiogenic shock ▪ Thrombophlebitis ▪ Pericarditis ▪ Mitral valve insufficiency ▪ Postinfarction angina ▪ Ventricular rupture ▪ Dressler’s syndrome (a combination of pericarditis, peri-

cardial effusion, and pleural effusion, which can occur sev- eral weeks to months following a myocardial infarction)

774 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

b . High -outp ut failure occurs wh en a con di- tio n causes th e h eart to work h arder to m eet th e dem an ds of th e body.

4. Systolic failure, diastolic failure a . Systolic failure leads to problem s with con -

traction an d ejection of blood. b . Diastolic failure leads to problem s with th e

h eart relaxin g an d fillin g with blood . D. Com pen satory m ech an ism s

1. Com p en satory m ech an ism s act to restore car- diac outp ut to n ear-n orm al levels.

2. In itially, th ese m ech an ism s in crease cardiac out- put; h owever, th ey even tually h ave a dam agin g effect on pum p action .

3. Com pensatory m echanism s con tribute to an in crease in m yocardial oxygen con sum ption; when th is occurs, m yocardial reserve is exh austed an d clin ical m an ifestations of heart failure develop.

4. Com p en satory m ech an ism s in clude in creased h eart rate, im proved stroke volume, arterial vaso- con striction , sodium an d water reten tion , an d m yocardial h ypertroph y.

E. Assessm en t ( Table 56-1) 1. Righ t- an d left-sided h eart failure

Signs of left ventricular failure are evident in the pulmonary system. Signs of right ventricular failure are evident in the systemic circulation.

2. Acute pulm on ary edem a a . Severe dyspn ea b . Tach ycardia, tach ypn ea c. Nasal flarin g; use of accesso ry breath in g

m uscles

d . Wh eezin g an d crackles on auscultation ; gur- glin g respiration s

e. Expectoratio n of large am oun ts of blood- tin ged , froth y sputu m

f. Acute an xiety, appreh en sion , restlessn ess g. Profuse sweatin g h . Cold, clam m y skin i. Cyan osis

F. Im m ed iate m an agem en t of acute episo de (see Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Pulmonary Edema

1. Place the client in a high Fowler’s position. 2. Administer oxygen. 3. Assess the client quickly, including assessing lung sounds. 4. Ensure that an intravenous (IV) access device is in place. 5. Prepare for the administration of a diuretic and morphine

sulfate. 6. Insert a Foley catheter as prescribed. 7. Prepare for intubation and ventilator support, if required. 8. Document the event, actions taken, and the client’s response.

Pulmonary edema is a life-threatening event that can result from severe heart failure. In pulmonary edema, the left ventricle fails to eject sufficient blood, and pressure increases in the lungs because of the accumulated blood. The client is immediately placed in a high Fowler’s position, with the legs in a dependent position, to reduce pulmonary congestion and relieve edema. Oxygen is always prescribed, usually in high concentrations by mask or cannula to improve gas exchange and pulmonary function. The client is then assessed quickly, including checking the lung sounds. Next it is important to ensure that an IV access device is in place for the administration of a diuretic and morphine sulfate. Furosemide, a rapid-acting diuretic, will eliminate accumu- lated fluid. Morphine sulfate reduces venous return (pre- load), decreases anxiety, and also reduces the work of breathing. A Foley catheter is inserted to measure output accurately. The nurse then prepares for intubation and ven- tilator support, if required. The nurse stays with the client and provides reassurance. Vital signs are monitored and a cardiac monitor is used to monitor the heart rate and for dys- rhythmias. The lung sounds are monitored for crackles, decreased breath sounds, and a response to treatment. A weight measurement will also determine a response to treatment. Other interventions may include the administra- tion of digoxin to increase ventricular contractility and improve cardiac output, bronchodilators for severe broncho- spasm or bronchoconstriction, medications to facilitate myo- cardial contractility and enhance stroke volume, and vasodilators to reduce afterload, increase the capacity of the systemic venous bed, and decrease venous return to the heart. The nurse finally documents the event, actions taken, and the client’s response.

Reference Ignatavicius, Workman (2016), pp. 688–689.

TABLE 56-1 Clinical Manifestations of Right-Sided and Left-Sided Heart Failure

Right-Sided Heart Failure Left-Sided Heart Failure

Dependent edema (legs and sacrum)

Signs of pulmonary congestion

Jugular venous distention Dyspnea

Abdominal distention Tachypnea

Hepatomegaly Crackles in the lungs

Splenomegaly Dry, hacking cough

Anorexia and nausea Paroxysmal nocturnal dyspnea

Weight gain Increased BP (from fluid volume excess) or decreased BP (from pump failure)

Nocturnal diuresis

Swelling of the fingers and hands

Increased BP (from fluid volume excess) or decreased BP (from pump failure)

BP, Blood pressure.

775CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

G. Followin g th e acu te episo de 1. Assist th e clien t to iden tify precipitatin g risk

factors of h eart failure an d m eth od s of elim i- n atin g th ese risk facto rs.

2. En cou rage th e clien t to verbalize feelin gs ab out th e lifestyle ch an ges required as a result of th e h eart failure.

3. In struct th e clien t in th e prescribed m ed ication regim en , wh ich m ay in clude digoxin , a diuretic, ACE in h ibito rs, low-dose beta blockers, an d vasodilators.

4. Advise th e clien t to n otify th e HCP if side effects occur fro m th e m ed ication s.

5. Advise th e clien t to avoid over-th e-cou n ter m edication s.

6. In struct th e clien t to con tact th e HCP if h e or sh e is un ab le to take m ed ication s because of illn ess.

7. In struct th e clien t to avoid large am oun ts of caffein e, foun d in coffee, tea, cocoa, ch oco late, an d som e carbon ated beverages.

8. In struct th e clien t about th e prescribed low- sodium , lo w-fat, an d low-ch olesterol diet.

9. Provid e th e clien t with a list of potassium -rich food s because diuretics can cau se h ypo kalem ia (excep t for potassium -retain in g diuretics) .

10. In struct th e clien t regardin g fluid restriction , if prescribed, advisin g th e clien t to spread th e fluid out durin g th e day an d to suck on h ard can dy to reduce th irst.

11. In struct th e clien t to balan ce periods of activity an d rest.

12. Advise th e clien t to avoid isom etric activities, wh ich in crease pressure in th e h eart.

13. In struct th e clien t to m on itor daily weigh t. 14. In struct th e clien t to report sign s of fluid reten -

tion such as edem a or weigh t gain .

XI. Cardiogenic Shock A. Descriptio n

1. Cardiogen ic sh ock is failure of th e h eart to pum p adequ ately, th ereby reducin g cardiac out- put an d com pro m isin g tissue perfusion .

2. Necrosis of m ore th an 40% of th e left ven tricle occurs, usually as a result of occlusion of m ajor coron ary vessels.

3. Th e goal of treatm en t is to m ain tain tissue oxy- gen ation an d perfusion an d im prove th e pum p- in g ability of th e h eart.

B. Assessm en t 1. Hypoten sion : BP lower th an 90 m m Hg systolic

or 30 m m Hg lower th an th e clien t’s baselin e 2. Urin e outp ut lo wer th an 30 m L/ h ou r 3. Cold, clam m y skin 4. Poor periph eral pulses 5. Tach ycardia, tach ypn ea 6. Pulm on ary con gestion 7. Disorien tation , restlessn ess, an d con fusion 8. Con tin uin g ch est discom fort

C. In terven tion s 1. Adm in ister oxygen as prescribed. 2. Adm in ister m orph in e sulfate in traven ously as

prescribed to decrease pulm on ary con gestion an d relieve pain .

3. Prepare for in tub ation an d m ech an ical ven ti- lation .

4. Adm in ister diuretics an d n itrates as prescribed wh ile m on itorin g th e BP con stan tly.

5. Adm in ister vasopressors an d positive in otropes as prescribed to m aintain organ perfusion .

6. Prepare the client for insertion of an intraaortic balloon pum p, if prescribed, to im prove coronary artery perfusion and im prove cardiac output.

7. Prepare th e clien t for im m ediate reperfusion proced ures such as PTCA or coron ary artery bypass graft.

8. Mon itor arterial blood gas levels an d prepare to treat im balan ces.

9. Mon itor urin ary outp ut. 10. Assist with th e in sertio n of a pulm o n ary artery

(Swan -Gan z) cath eter to assess degree of h eart failure ( Fig. 56-12).

11. Mon itor distal pulses an d m ain tain th e tran s- ducer at th e level of th e righ t atrium if th e clien t h as a pulm o n ary artery (Swan -Gan z) cath eter.

D. Hem o dyn am ic m on itorin g (see Fig. 56-12) 1. Cen tral venous pressure (CVP)

a. Th e CVP is th e pressure with in th e superior ven a cava; it reflects th e pressure un der wh ich blood is return ed to th e superior ven a cava an d righ t atrium .

b . Th e CVP is m easu red with a cen tral ven ous lin e in th e superior ven a cava.

c. Norm al CVP pressure is ab out 3 to 8 m m Hg. d . An elevated CVP in dicates an in crease in

blood volum e as a result of sodium an d water reten tion , excessive IV fluid s, alter- ation s in fluid balan ce, or kidn ey failure.

e. A decreased CVP in dicates a decrease in cir- culatin g blood volum e an d m ay be a result of fluid im balan ces, h em orrh age, or severe vasodilation , with poolin g of blood in th e extrem ities th at lim its ven o us return .

2. Measu rin g CVP a. Th e righ t atrium is located at th e m idaxillary

lin e at th e fourth in tercostal space; th e zero poin t on th e tran sdu cer n eeds to be at th e level of th e righ t atrium .

b . Th e clien t n eeds to be supin e, with th e h ead of th e bed at 45 degrees.

c. Th e clien t n eeds to be relaxed; n ote th at activity th at in creases in trath oracic pressure, such as co ugh in g or strain in g, will cause false in creases in th e readin gs.

d . If th e clien t is on a ven tilator, th e readin g sh ould be taken at th e poin t of en d- expiration .

776 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

e. To m ain tain paten cy of th e lin e, a con tin u- ous sm all am oun t of fluid is delivered un der pressure.

3. Pulm o n ary artery pressures a. Apulm onary artery catheter is used to m easure

right heart and indirect left heart pressures. b . Pulmonary artery wedge pressure (PAWP) is

also kn own as pulm o n ary artery occlusive pressure (PAO P) an d as PCWP.

c. Th e m easurem en t is obtain ed durin g m om en tary balloon in flatio n of th e pulm o- n ary artery cath eter an d is reflective of left ven tricular en d-diastolic pressure.

d . PAWP n orm ally ran ges between 4 and 12 m m Hg; elevation s m ay indicate left ventricular failure, hypervolem ia, m itral regurgitation , or intracardiac shun t, wh ereas decreases m ay indicate h ypovolem ia or afterload reduction .

e. Norm al RApressure ranges from 1 to 8 m m Hg; increases occur with right ventricular failure, whereas decreases may indicate hypovolem ia.

f. Norm al pulm o n ary artery pressure (PAP) ran ges fro m 15 to 26 m m Hg systolic/ 5 to 15 m m Hg diastolic.

4. Mean arterial pressure (MAP) a . An ap proxim ation of th e average pressure

in th e system ic circulation th rou gh out th e cardiac cycle.

b . MAP m ust be between 60 an d 70 m m Hg for adequ ate organ perfusio n .

XII. Inflammatory Diseases of the Heart A. Pericarditis

1. Description a . Pericarditis is an acu te or ch ron ic in flam m a-

tio n of th e pericard ium .

b . Ch ron ic pericarditis, a ch ron ic in flam m atory th icken in g of th e pericardium , con stricts th e h eart, causin g com pression .

c. Th e pericard ial sac becom es in flam ed. d . Pericarditis can result in loss of pericardial

elasticity or an accu m ulation of flu id with in th e sac.

e. Heart failure or cardiac tam pon ade m ay result. 2. Assessm en t

a. Precordial pain in th e an terior ch est th at radiates to th e left side of th e n eck, sh oulder, or back

b . Pain is gratin g an d is aggravated by breath - in g (particularly in spiration ), cough in g, an d swallowin g

c. Pain is worse wh en in th e supin e position an d m ay be relieved by lean in g forward.

d . Pericardial friction rub (scratch y, h igh - pitch ed soun d) is h eard on auscultation an d is produ ced by th e ru bbin g of th e in flam ed pericardial layers.

e. Fever an d ch ills f. Fatigue an d m alaise g. Elevated wh ite blood cell coun t h . Electrocardio graph ic ch an ges with acu te

pericarditis; ST-segm en t elevation with th e on set of in flam m ation ; atrial fibrillation is com m on .

i. Sign s of righ t ven tricular failure in clien ts with ch ron ic con strictive pericarditis

3. In terven tion s a. Assess th e n ature of th e pain . b . Place th e clien t in a h igh Fowler’s position ,

or uprigh t an d lean in g forward . c. Adm in ister oxygen .

4040

3030

2020

1010

Tricus pid va lve

Right ve ntricle

P ulmonic va lve

Ca the te r pla ce me nt for pulmona ry a rte ry

pre s s ure

Ca the te r pla ce me nt for pulmona ry a rte ry

we dge pre s s ure

Typica l pulmona ry a rte ry we dge pre s s ure tra cing

Typica l pulmona ry a rte ry pre s s ure tra cing

40

30

20

10

3030

2020

1010

30

20

10

FIGURE 56-12 Cardiac pressure waveforms can be visualized on the monitor.

777CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

d . Adm in ister an algesics, n on steroidal an tiin - flam m atory drugs (NSAIDs), or cortico ste- ro ids for pain as prescribed.

e. Auscu ltate for a pericardial friction rub. f. Ch eck results of blood culture to iden tify

cau sative organ ism . g. Adm in ister an tibiotics for bacterial in fectio n

as prescribed. h . Adm in ister diuretics an d digoxin as pre-

scrib ed to th e clien t with ch ron ic con stric- tive pericarditis; surgical in cision of th e pericardium (pericardial win do w) or peri- cardiectom y m ay be n ecessary.

i. Mon itor for sign s of cardiac tam pon ade. j. No tify th e HCP if sign s of cardiac tam po-

n ade occur. B. Myocarditis

1. Description : Acute or ch ron ic in flam m ation of th e m yocardium as a result of pericarditis, sys- tem ic in fectio n , or allergic respon se

2. Assessm en t a . Fever b . Dysp n ea c. Tach ycardia d . Ch est pain e. Pericardial friction rub f. Gallop rh yth m g. Murm u r th at soun ds like fluid passin g an

obstru ctio n h . Pulsus altern an s i. Sign s of h eart failure

3. In terven tion s a . Assist th e clien t to a position of com fo rt,

such as sittin g up an d lean in g forward . b . Adm in ister oxygen as prescribed. c. Adm in ister an algesics, salicylates, an d NSAIDs

as prescribed to reduce fever an d pain . d . Adm in ister digo xin as prescribed. e. Adm in ister an tidysrh yth m ics as prescribed. f. Adm in ister an tibiotics as prescribed to treat

th e cau sative organ ism . g. Mon itor for com plication s, wh ich can

in clude th rom bus, h eart failure, an d cardio- m yopath y.

C. En docarditis 1. Description

a . En do carditis is an in flam m ation of th e in n er lin in g of th e h eart an d valves.

b . O ccurs prim arily in clien ts wh o are IV drug ab users, h ave h ad valve replacem en ts or repair of valves with prosth etic m aterials, or h ave oth er structural cardiac defects

c. Ports of en try for th e in fectin g organ ism in clude th e oral cavity (especially if th e clien t h as h ad a den tal proced ure in th e previous 3 to 6 m on th s), in fectio n s (cutan eous, gen ito - urin ary, gastro in testin al, an d system ic), an d

surgery or in vasive procedures, in cludin g IV lin e placem en t.

2. Assessm en t a . Fever b . An o rexia, weigh t loss c. Fatigue d . Card iac m urm urs e. Heart failure f. Em bo lic com plication s from vegetation

fragm en ts travelin g th rou gh th e circulation g. Petech iae h . Splin ter h em orrh ages in th e n ail bed s i. O sler’s n odes (reddish , ten der lesion s) on

th e pads of th e fin gers, h an ds, an d toes j. Jan eway lesion s (n on ten der h em orrh agic

lesion s) on th e fin gers, toes, n ose, or earlobes k . Splen om egaly l. Clubbin g of th e fin gers

3. In terven tion s a . Provide adequate rest balan ced with activity

to preven t th rom bus form ation . b . Maintain antiem bolism stockings if prescribed. c. Mon itor for sign s of h eart failure. d . Mon itor for splen ic em b oli, as evid en ced by

sudd en abdom in al pain radiatin g to th e left sh oulder an d th e presen ce of rebou n d abdom in al ten dern ess on palpation .

e. Mon itor for ren al em boli, as evid en ced by flan k pain radiatin g to th e groin , h em atu- ria, an d pyuria.

f. Mon itor for con fusion , aph asia, or dysph a- sia, wh ich m ay in dicate cen tral n ervou s sys- tem em b oli.

g. Mo n ito r fo r p u lm o n ary em b o li as evi- d en ced b y p leu ritic ch est p ain , d ysp n ea, an d co u gh .

h . Assess skin , m ucous m em bran es, an d con - jun ctiva for petech iae.

i. Assess n ail bed s for splin ter h em orrh ages. j. Assess for O sler’s n odes on th e pads of th e

fin gers, h an ds, an d toes. k . Assess for Jan eway lesion s on th e fin gers,

toes, n ose, or earlobes. l. Assess for clubbin g of th e fin gers.

m . Evaluate blood culture results. n . Adm in ister an tibiotics in traven ously as

prescribed. o . Plan an d arran ge for disch arge, providin g

resou rces required for th e con tin ued adm in istration of IV an tibiotics.

4. Clien t education ( Box 56-7)

XIII. Cardiac Tamponade A. Descrip tion

1. A pericardial effusion occurs wh en th e space between th e parietal an d visceral layers of th e pericardium fills with flu id.

778 UNIT XIII Cardiovascular Disorders of the Adult Client

2. Pericardial effusion places th e clien t at risk for cardiac tam pon ade, an accu m ulation of fluid in th e pericardial cavity.

3. Tam pon ade restricts ven tricular fillin g, an d car- diac output drops.

Acute cardiac tamponade can occur when small vol- umes (20 to 50 mL) of fluid accumulate rapidly in the pericardium.

B. Assessm en t 1. Pulsus paradoxu s 2. In creased CVP 3. Jugular ven o us disten tion with clear lu n gs 4. Distan t, m uffled h eart soun ds 5. Decreased cardiac output 6. Narrowin g pulse pressure

C. In terven tion s 1. Th e clien t n eeds to be placed in a critical care

un it for h em od yn am ic m on itorin g. 2. Adm in ister fluids in traven ously as prescribed to

m an age decreased cardiac outp ut. 3. Prepare th e clien t for ch est x-ray or ech ocardiog-

raph y. 4. Prepare th e clien t for pericardiocen tesis to with -

draw pericardial fluid if prescribed. 5. Mon itor for recurren ce of tam pon ade followin g

pericardiocen tesis. 6. If th e clien t experien ces recurren t tam pon ade or

recurren t effusion s or develops adh esion s fro m ch ron ic pericard itis, a portion (pericardial win - dow) or all of th e pericardium (pericardiect- om y) m ay be rem oved to allow adequate ven tricular fillin g an d con traction .

XIV. Valvular Heart Disease A. Descrip tion

1. Valvular h eart disease occurs wh en th e h eart valves can n ot open fully (sten osis) or clo se com pletely (in sufficien cy or regurgitation ).

2. Valvular h eart disease preven ts efficien t blood flow th rou gh th e h eart.

B. Types 1. Mitral sten osis: Valvular tissue th icken s an d n ar-

rows th e valve open in g, preven tin g blood from flowin g from th e left atrium to th e left ven tricle.

2. Mitral in sufficien cy, regurgitation : Valve is in com peten t, preven tin g com plete valve closure durin g systole.

3. Mitral valve prolapse: Valve leaflets protrude in to th e left atrium durin g systole.

4. Aortic sten osis: Valvular tissue th icken s and n ar- rows th e valve open in g, preven tin g blood from flowin g from th e left ven tricle in to th e aorta.

5. Aortic in sufficien cy: Valve is in com peten t, pre- ven tin g com plete valve closure durin g diastole.

6. For aortic disorders, see Table 56-2. 7. For tricuspid disorders, see Table 56-3. 8. For pulm o n ary valve disorders, see Table 56-4.

C. Repair procedures 1. Balloon valvuloplasty

a . A balloo n cath eter is passed from th e fem o- ral vein th rou gh th e atrial sep tum to th e m itral valve or th rou gh th e fem oral artery to th e aortic valve.

b . Th e balloo n is in flated to en large th e orifice. c. In stitute precaution s for arterial pun cture if

appropriate. d . Mon itor for bleedin g fro m th e cath eter

in sertion site. e. Mon itor for sign s of system ic em boli. f. Mon itor for sign s of a regurgitan t valve by

m on itorin g cardiac rh yth m , h eart soun ds, an d cardiac outp ut.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 56-7 Home Care Instructions for the Client with Infective Endocarditis

Teach the client to maintain aseptic technique during setup and administration of intravenous (IV) antibiotics.

Instruct the client to administer IV antibiotics at scheduled times to maintain the blood level.

Instruct the client to monitor IV catheter sites for signs of infection and report this immediately to the health care provider (HCP).

Instruct the client to record the temperature daily for up to 6 weeks and to report fever.

Encourage oral hygiene at least twice a day with a soft tooth- brush and rinse well with water after brushing.

Client should avoid use of oral irrigation devices and flossing to avoid bacteremia.

Teach the client to cleanse any skin lacerations thoroughly and apply an antibiotic ointment as prescribed.

Client should inform all HCPs of history of endocarditis and ask about the use of prophylactic antibiotics prior to invasive respiratory procedures and dentistry.

Teach the client to observe for signs and symptoms of embolic conditions and heart failure.

TABLE 56-2 Aortic Valve Disorders Aortic Stenosis Aortic Insufficiency

Symptoms Dyspnea on exertion Angina Syncope on exertion Fatigue Orthopnea Paroxysmal nocturnal dyspnea Harsh systolic crescendo-

decrescendo murmur

Dyspnea Angina Tachycardia Fatigue Orthopnea Paroxysmal nocturnal dyspnea Blowing decrescendo diastolic

murmur

Interventions Refer to the section on repair procedures. Prepare the client for valve replacement as indicated.

779CHAPTER 56 Cardiovascular System

2. Mitral an n uloplasty: Tigh ten in g an d suturin g th e m alfun ction in g valve an n ulus to elim in ate or greatly reduce regurgitation

3. Com m issuroto m y, valvotom y a. Th e procedure is accom plish ed with cardio-

pulm on ary bypass durin g open h eart surgery. b . Th e valve is visualized, th rom bi are rem oved

from the atria, fused leaflets are in cised, and calcium is debrided from th e leaflets, th us widen in g th e orifice.

D. Valve replacem en t proced ures 1. Mech an ical prosth etic valves: Th ese prosth etic

valves are durable.

Thromboembolism can be a problem following valve replacement with a mechanical prosthetic valve, and lifetime anticoagulant therapy is required.

2. Biopro sth etic valves a. Biological grafts are xenografts (valves from

other species)—porcine valves (pig), bovine valves (cow), or hom ografts (hum an cadavers).

b . Th e risk of clot form ation is sm all; th erefore, lon g-term an ticoagulatio n m ay n ot be in dicated.

3. Preoperative in terven tion s: Con sult with th e HCP regardin g discon tin uin g an ticoagulan ts 72 h ours before surgery.

4. Postoperative in terven tion s a. Mon itor closely for sign s of bleed in g. b . Mon itor cardiac output an d for sign s of

h eart failure. c. Adm in ister digoxin as prescribed to m ain tain

cardiac output an d preven t atrial fibrillation . d . Clien t education (Box 56-8).

XV. Cardiomyopathy (Table 56-5) A. Description

1. Card iom yopath y is a subacute or ch ron ic disor- der of th e h eart m uscle.

2. Treatm en t is palliative, n ot curative, an d th e clien t n eeds to deal with n um erou s lifestyle ch an ges an d a sh orten ed life span .

B. Types, sign s an d sym pto m s, an d treatm en t (see Table 56-5)

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

TABLE 56-3 Tricuspid Valve Disorders Tricuspid Stenosis Tricuspid Insufficiency

Symptoms Easily fatigued Effort intolerance Complaints of fluttering sensations in

the neck (obstructed venous flow) Cyanosis Signs of right ventricular failure,

including ascites, hepatomegaly, peripheral edema, jugular vein distention with clear lung fields

Symptoms of decreased cardiac output

Rumbling diastolic murmur

Asymptomatic in mild situations

Signs of right ventricular failure, including ascites, hepatomegaly, peripheral edema

Pleural effusion Systolic murmur heard at the

left sternal border, fourth intercostal space

Interventions Refer to the section on repair procedures. Prepare the client for valve replacement as indicated.

TABLE 56-4 Pulmonary Valve Disorders Pulmonary Stenosis Pulmonary Insufficiency

Symptoms Asymptomatic in a mild condition Dyspnea Fatigue Syncope Signs of right ventricular failure,

including ascites, hepatomegaly, peripheral edema

Systolic thrill heard at left sternal border

Asymptomatic in mild condition Dyspnea Fatigue Syncope Signs of right ventricular failure,

including ascites, hepatomegaly, peripheral edema

Systolic thrill heard at left sternal border

Interventions Refer to the section on repair

procedures. Prepare the client for pulmonary

valve commissurotomy as indicated.

Refer to the section on repair procedures.

Prepare the client for pulmonary valve replacement as indicated.

BOX 56-8 Client Instructions Following Valve Replacement

Adequate rest is important, and fatigue is usual. Anticoagulant therapy is necessary if a mechanical prosthetic

valve has been inserted. Instruct the client concerning hazards related to anticoagulant

therapy and to notify the health care provider (HCP) if bleeding or excessive bruising occurs.

Instruct the client concerning the importance of good oral hygiene to reduce the risk of infective endocarditis.

Brush teeth twice daily with a soft toothbrush, followed by oral rinses.

Avoid irrigation devices, electric toothbrushes, and flossing because these activities can cause the gums to bleed, allowing bacteria to enter the mucous membranes and bloodstream.

Monitor incision and report any drainage or redness. Avoid any dental procedures for 6 months. Heavy lifting (more than 10 lb [4 . 5 kg]) is to be avoided, and

exercise caution when in an automobile to prevent injury to the sternal incision.

If a prosthetic valve was inserted, a soft, audible, clicking sound may be heard.

Instruct the client concerning the importance of prophylactic antibiotics before any invasive procedure and the impor- tance of informing all HCPs of history of valve replacement or repair.

Obtain and wear a MedicAlert bracelet.

780 UNIT XIII Cardiovascular Disorders of the Adult Client

XVI. Vascular Disorders A. Ven ous th rom bosis

1. Descrip tion a . Th rom b us can be associated with an in flam -

m atory process. b . Wh en a th rom bus develops, in flam m ation

occurs, th icken in g th e vein wall an d leadin g to em bolization .

2. Types a . Th rom boph lebitis: Th rom bus associated

with in flam m ation b . Ph leboth rom bo sis: Th rom bus with out

in flam m ation c. Ph lebitis: Vein in flam m ation associated

with in vasive procedures, such as IV lin es

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

TABLE 56-5 Pathophysiology, Signs and Symptoms, and Treatment of Cardiomyopathies Hypertrophic Cardiomyopathy

Dilated Cardiomyopathy Nonobstructed Obstructed Restrictive Cardiomyopathy

Pathophysiology Fibrosis of myocardium and

endocardium Dilated chambers Mural wall thrombi prevalent

Hypertrophy of the walls Hypertrophied septum Relatively small chamber size

Same as for nonobstructed except for obstruction of left ventricular outflow tract associated with the hypertrophied septum and mitral valve incompetence

Mimics constrictive pericarditis

Fibrosed walls cannot expand or contract

Chambers narrowed; emboli common

Signs and Symptoms Fatigue and weakness Heart failure (left side) Dysrhythmias or heart block Systemic or pulmonary

emboli S3 and S4 gallops Moderate to severe

cardiomegaly

Dyspnea Angina Fatigue, syncope, palpitations Mild cardiomegaly S4 gallop Ventricular dysrhythmias Sudden death common Heart failure

Same as for nonobstructed except with mitral regurgitation murmur

Atrial fibrillation

Dyspnea and fatigue Heart failure (right side) Mild to moderate cardiomegaly S3 and S4 gallops Heart block Emboli

Treatment Symptomatic treatment of

heart failure Vasodilators Control of dysrhythmias Surgery: Heart transplant

For both: Symptomatic treatment Beta blockers Conversion of atrial fibrillation Surgery: Ventriculomyotomy or muscle resection with mitral

valve replacement Digoxin, nitrates, and other vasodilators contraindicated

with the obstructed form

Supportive treatment of symptoms

Treatment of hypertension Conversion from dysrhythmias Exercise restrictions Emergency treatment of acute

pulmonary edema

Adapted from Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 7, Philadelphia, 20 13, Saunders.

781CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

d . Deep vein throm boph lebitis: More serious th an a superficial th rom boph lebitis because of the risk for pulm on ary em bolism

3. Risk facto rs for th rom bus form ation a. Ven ous stasis fro m varicose vein s, h eart fail-

ure, im m obility b . Hypercoagulab ility disorders c. In jury to th e ven ous wall from IV in jection s;

adm in istration of vessel irritan ts (ch em o- th erap y, h yperton ic solution s)

d . Followin g surgery, particularly orth oped ic an d ab dom in al surgery

e. Pregn an cy f. Ulcerative colitis g. Use of oral con traceptives h . Certain m align an cies i. Fractu res or oth er in juries of th e pelvis or

lower extrem ities B. Ph lebitis

1. Assessm en t a. Red, warm area radiatin g up th e vein an d

extrem ity b . Pain c. Swellin g

2. In terven tion s a. Apply warm , m oist soaks as prescribed

to dilate th e vein an d prom ote circulation (assess tem perature of soak before applyin g).

b . Assess for sign s of com plication s such as tissue n ecro sis, in fectio n , or pulm o n ary em bolus.

C. Deep vein th rom bop h lebitis 1. Assessm en t

a. Calf or groin ten dern ess or pain with or with ou t swellin g

b . Positive Ho m an s’ sign m ay be n oted; h owever, false-po sitive results are com m on , so th is is n ot a reliable assessm en t m easure.

c. Warm skin th at is ten der to touch 2. In terven tion s

a. Provid e bed rest as prescribed. b . Elevate th e affected extrem ity above th e

level of th e h eart as prescribed. c. Avoid usin g th e kn ee gatch or a pillow

un der th e kn ees. d . Do n ot m assage th e extrem ity. e. Provid e th igh -h igh or kn ee-h igh an tiem bo-

lism stockin gs as prescribed to reduce ven ous stasis an d assist in th e ven ous return of blood to th e h eart; teach h ow to ap ply an d rem ove stockin gs.

f. Adm in ister in term itten t or con tin uous warm , m oist com presses as prescribed.

g. Palpate th e site gen tly, m on itorin g for warm th an d edem a.

h . Measu re an d record th e circum feren ces of th e th igh s an d calves.

i. Mon itor for sh ortn ess of breath an d ch est pain , wh ich can in dicate pulm on ary em boli.

j. Adm in ister th rom bolytic th erapy (tissue plasm in o gen activator) if prescribed, wh ich m ust be in itiated with in 5 days after th e on set of sym pto m s.

k . Adm in ister h eparin th erap y as prescribed to preven t en largem en t of th e existin g clot an d preven t th e form ation of n ew clo ts.

l. Mon itor activated partial th rom boplastin tim e durin g h eparin th erap y.

m . Adm in ister warfarin as prescribed followin g h eparin th erapy when th e sym ptom s of deep vein throm boph lebitis h ave resolved.

n . Mon itor prothrom bin tim e an d in tern ation al n orm alized ratio durin g warfarin th erapy.

o . Mon itor for th e ad verse effects associated with an ticoagulan t th erapy.

p . Clien t edu cation (Box 56-9) D. Ven ous in sufficien cy

1. Descriptio n a. Ven ous in sufficien cy results from prolon ged

ven ous h yperten sion , wh ich stretch es th e vein s an d dam ages the valves.

b . Th e resultan t edem a an d ven ous stasis cause ven o us stasis ulcers, swellin g, an d cellulitis.

c. Treatm en t focuses on decreasin g edem a an d prom o tin g ven ous return from th e affected extrem ity.

d . Treatm en t for ven ous stasis ulcers focuses on h ealin g th e ulcer an d preven tin g stasis an d ulcer recurren ce.

2. Assessm en t a. Stasis derm atitis or brown discoloration

alon g th e an kles, exten din g up to th e calf b . Edem a

BOX 56-9 Instructions for the Client with Deep Vein Thrombophlebitis

Instruct the client concerning the hazards of anticoagulation therapy.

Recognize the signs and symptoms of bleeding. Avoid prolonged sitting or standing, constrictive clothing, or

crossing the legs when seated. Elevate the legs for 10 to 20 minutes every few hours each day. Plan a progressive walking program. Inspect the legs for edema, and measure the circumference of

the legs. Wear antiembolism stockings as prescribed. Avoid smoking. Avoid any medications unless prescribed by the health care

provider (HCP). Instruct the client concerning the importance of follow-up

HCP visits and laboratory studies. Obtain and wear a MedicAlert bracelet.

782 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

c. Ulcer form ation : Edges are un even , ulcer bed is pin k, an d gran ulation is presen t; usu- ally located on th e lateral m alleolus.

3. In terven tion s

For venous insufficiency, leg elevation is usually pre- scribed to assist with the return of blood to the heart.

a . In struct the clien t to wear elastic or com pres- sion stockin gs durin g the day an d even in g if prescribed (in struct the clien t to put on elastic stockin gs on awakenin g, before gettin g out of bed); it m ay be n ecessary to wear th e stockin gs for th e rem ain der of th e clien t’s life.

b . In struct th e clien t to avoid prolon ged sittin g or stan d in g, con strictive cloth in g, or cro ss- in g th e legs wh en seated.

c. In struct th e clien t to elevate th e legs above th e level of th e h eart for 10 to 20 m in u tes every few h ours each day.

d . In struct th e clien t in th e use of an in term it- ten t sequen tial pn eum atic com pression sys- tem , if prescribed (used twice daily for 1 h our in th e m orn in g an d even in g).

e. Advise the clien t with an open ulcer that the com pression system is applied over a dressin g.

4. Woun d care a . Provide care to th e woun d as prescribed by

th e HCP. b . Assess th e clien t’s ability to care for th e

woun d, an d in itiate h om e care resources as n ecessary.

c. If an Un n a boot (dressin g con structed of gauze m oisten ed with zin c oxide) is pre- scrib ed, th e HCP will ch an ge it weekly.

d . Th e woun d is clean sed with n orm al salin e before application of th e Un n a boot; povi- don e-iodine and h ydrogen peroxide are n ot used because th ey destroy gran ulation tissue.

e. Th e Un n a boot is covered with an elastic wrap th at h arden s to prom o te ven o us return an d preven t stasis.

f. Mon itor for sign s of arterial occlu sion fro m an Un n a boot th at m ay be too tigh t.

g. Keep tape off th e clien t’s skin . h . O cclu sive dressin gs such as polyeth ylen e

film or a h ydrocolloid dressin g m ay be used to cover th e ulcer.

5. Medication s a . Apply topical agen ts to th e woun d as pre-

scrib ed to debride th e ulcer, elim in ate n ecro tic tissue, an d prom o te h ealin g.

b . Wh en applyin g topical agen ts, apply an oil- based agen t such as petroleum jelly on sur- roun din g skin , because deb ridin g agen ts can in jure h ealth y tissue.

c. Adm in ister an tibiotics as prescribed if in fec- tion or cellulitis occurs.

E. Varicose vein s 1. Description

a . Disten d ed, protrudin g vein s th at appear darken ed an d tortuou s are eviden t.

b . Vein walls weaken an d dilate, an d valves beco m e in com peten t.

2. Assessm en t a . Pain in th e legs with dull achin g after standin g b . A feelin g of fulln ess in th e legs c. An kle edem a

3. Tren delen burg test a . Place th e clien t in a supin e position with th e

legs elevated . b . Wh en th e clien t sits up, if varicosities are

presen t, vein s fill fro m th e proxim al en d; vein s n orm ally fill from th e distal en d.

4. In terven tion s a . Em ph asize th e im portan ce of an tiem bolism

stockin gs as prescribed. b . In struct th e clien t to elevate th e legs as m uch

as possib le. c. In struct th e clien t to avoid con strictive

cloth in g an d pressure on th e legs. d . Prepare th e clien t for scleroth erapy or vein

strippin g as prescribed. 5. Scleroth erapy

a . A solution is in jected in to th e vein , followed by th e application of a pressure dressin g.

b . In cision an d drain age of th e trapped blood in the sclerosed vein is perform ed 14 to 21 days after the in jection , followed by th e applica- tion of a pressure dressin g for 12 to 18 h ours.

6. Laser th erapy: Alaser fiber is used to h eat and close th e m ain vessel con tributin g to the varicosity.

7. Vein strippin g: Varicose vein s m ay be rem oved if th ey are larger th an 4 m m in diam eter or if th ey are in clusters; oth er treatm en ts are usually tried before vein strippin g.

XVII. Arterial Disorders A. Periph eral arterial disease

1. Description a. Ch ron ic disorder in wh ich partial or total

arterial occlusion deprives th e lower extrem - ities of oxygen an d n utrien ts

b . Tissue dam age occurs below th e level of th e arterial occlusion .

c. Ath erosclerosis is th e m ost com m on cau se of periph eral arterial disease.

2. Assessm en t a. In term itten t claudication (pain in the m uscles

resulting from an in adequate blood supply) b . Rest pain , ch aracterized by n um bn ess, burn -

in g, or ach in g in th e distal portion of th e lo wer extrem ities, wh ich awaken s th e clien t at n igh t an d is relieved by placin g th e extrem - ity in a depen den t position

783CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

c. Lower back or buttock discom fort d . Loss of h air an d dry scaly skin on th e lower

extrem ities e. Th icken ed toen ails f. Cold an d gray-blue color of skin in th e lower

extrem ities g. Elevation al pallor an d dep en den t ru bor in

th e lo wer extrem ities h . Decreased or ab sen t periph eral pulses i. Sign s of arterial ulcer form ation occurrin g

on or between th e toes or on th e upper aspect of th e foot th at are ch aracterized as pain ful

j. BP m easurem en ts at th e th igh , calf, an d an kle are lower th an th e brach ial pressure (n orm ally, BP readin gs in th e th igh an d calf are h igh er th an th o se in th e upper extrem ities) .

3. In terven tion s

Because swelling in the extremities prevents arterial blood flow, the client with peripheral arterial disease is instructed to elevate the feet at rest but to refrain from ele- vating them above the level of the heart, because extreme elevation slows arterial blood flowto the feet. In severe cases of peripheral arterial disease, clients with edema may sleep with the affected limb hanging from the bed or they may sit upright (without leg elevation) in a chair for comfort.

a. Assess pain . b . Mon itor th e extrem ities for color, m otion

an d sen sation , an d pulses. c. O btain BP m easu rem en ts. d . Assess for sign s of ulcer form ation or sign s of

gan gren e. e. Assist in developin g an in dividualized exer-

cise program , wh ich is in itiated gradually an d in creased slowly an d will im prove arte- rial flow th rou gh th e developm en t of collat- eral circulation .

f. In struct th e clien t to walk to th e poin t of claud ication , stop an d rest, an d th en walk a little farth er.

g. In struct th e clien t with periph eral arterial disease to avoid crossin g th e legs, wh ich in terferes with blood flow.

h . In struct th e clien t to avoid exposu re to cold (causes vaso con striction ) to th e extrem ities an d to wear socks or in sulated sh oes for warm th at all tim es.

i. In struct th e clien t n ever to ap ply direct h eat to th e lim b , such as with a h eatin g pad or h ot water, because th e decreased sen sitivity in th e lim b can cau se burn in g.

j. In struct th e clien t to in spect th e skin on th e extrem ities daily an d to report an y sign s of skin breakdown .

k . In struct th e clien t to avoid tobacco and caf- fein e because of th eir vasocon strictive effects.

l. In struct th e clien t in th e use of h em orh eo- logical an d an tiplatelet m ed ication s as prescribed.

4. Proced ures to im prove arterial blood flo w a . Percutan eous tran slum in al an gioplasty, with

or with ou t in travascu lar sten t b . Laser-assisted an gioplasty c. Ath erectom y d . Bypass surgery: In flow proced ures bypass th e

occlusion above th e superficial fem oral arteries an d in clude ao rtoiliac, aorto fem oral, an d axillofem oral bypasses; outflow proce- dures bypass th e occlusion at or below th e superficial fem o ral arteries an d in clude fem o ropop liteal an d fem o rotibial bypass (Fig. 56-13).

B. Rayn aud’s disease 1. Description

a . Rayn aud’s disease is vasospasm of th e arteri- oles an d arteries of th e upper an d lo wer extrem ities.

b . Vasospasm cau ses con striction of th e cutan e- ous vessels.

c. Attacks are in term itten t an d occur with expo- sure to cold or stress.

d . Affects prim arily fin gers, toes, ears, an d ch eeks

2. Assessm en t a . Blan ch in g of th e extrem ity, follo wed by cya-

n osis durin g vasocon striction b . Redd en ed tissue wh en th e vaso spasm is

relieved c. Nu m bn ess, tin glin g, swellin g, an d a cold

tem p erature at th e affected body part

FIGURE 56-13 In aortoiliac and aortofemoral bypass surgery, a midline incision into the abdominal cavity is required, with an additional incision in each groin.

784 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

3. In terven tion s a . Mon itor pulses. b . Adm in ister vaso dilato rs as prescribed . c. In struct th e clien t regardin g m ed ication

th erapy. d . Assist th e clien t to iden tify an d avoid

precipitatin g factors such as cold an d stress. e. In struct th e clien t to avoid sm okin g. f. In struct th e clien t to wear warm clo th in g,

socks, an d gloves in cold weath er. g. Advise th e clien t to avoid in juries to fin gers

an d h an ds. C. Buerger’s disease (th rom b oan giitis obliteran s)

1. Description a . Buerger’s disease is an occlusive disease of

th e m edian an d sm all arteries an d vein s. b . Th e distal upper an d lo wer lim bs are affected

m ost com m on ly. 2. Assessm en t

a . In term itten t claud ication b . Isch em ic pain occurrin g in th e digits wh ile

at rest c. Ach in g pain th at is m ore severe at n igh t d . Cool, n um b, or tin glin g sen sation e. Dim in ish ed pulses in th e distal extrem ities f. Extrem ities th at are cool an d red in th e

depen den t position g. Developm en t of ulceration s in the extrem ities

3. In terven tion s: See Rayn aud’s disease

XVIII. Aortic Aneurysms A. Descrip tion

1. An aortic an eurysm is an abn o rm al dilation of th e arterial wall cau sed by localized weakn ess an d stretch in g in th e m ed ial layer or wall of th e aorta.

2. Th e an eu rysm can be located an ywh ere alon g th e abdom in al aorta.

3. The goal of treatm en t is to lim it th e progression of th e disease by m odifyin g risk factors, con trollin g th e BP to preven t strain on th e an eurysm , recog- n izin g sym ptom s early, an d preven tin g rupture.

B. Types of ao rtic an eu rysm 1. Fusiform : Diffuse dilation th at in volves th e

en tire circum feren ce of th e arterial segm en t 2. Saccu lar: Distin ct localized outp ouch in g of th e

artery wall 3. Dissectin g: Created wh en blood sep arates th e

layers of th e artery wall, form in g a cavity between th em

4. False (pseud oan eurysm ): O ccurs wh en th e clot an d co n n ective tissue are outsid e th e arterial wall as a result of vessel in jury or traum a to all 3 layers of th e arterial wall.

C. Assessm en t 1. Th oracic an eurysm

a . Pain exten din g to n eck, sh oulders, lower back, or abdom en

b . Syn cop e c. Dysp n ea d . In creased pulse e. Cyan osis f. Hoarsen ess, difficulty swallowin g because

of pressure from th e an eurysm 2. Abdom in al an eurysm

a . Prom in en t, pulsatin g m ass in ab dom en , at or above th e um b ilicus

b . Systolic bruit over th e aorta c. Ten d ern ess on deep palpation d . Abdo m in al or lower back pain

3. Ruptu rin g an eurysm a . Severe abdom in al or back pain b . Lum bar pain radiating to th e flan k an d groin c. Hypo ten sion d . In creased pulse rate e. Sign s of sh ock f. Hem atom a at flan k area

4. Diagn o stic tests a . Diagn ostic tests are don e to con firm th e pres-

en ce, size, an d location of th e an eurysm . b . Tests in clude abdom in al ultrasoun d, com -

puted tom ograph y scan , an d arteriography. 5. In terven tion s

a . Mon itor vital sign s. b . O btain in form ation regardin g back or

abdom in al pain . c. Q uestion th e clien t regardin g th e sen sation

of pulsation in th e abdom en . d . Ch eck periph eral circulation , in cludin g

pulses, tem p erature, an d color. e. O bserve for sign s of rupture. f. No te an y ten dern ess over th e abdom en . g. Mon itor for abdom in al disten tion .

6. Non su rgical in terven tion s a . Mod ify risk facto rs. b . In struct th e clien t regardin g th e procedure

for m on itorin g BP. c. In struct th e clien t on th e im portan ce of reg-

ular HCP visits to follow th e size of th e an eu rysm .

d . In struct th e clien t th at if severe back or abdom in al pain or fulln ess, soren ess over th e um b ilicus, sudd en developm en t of dis- coloration in th e extrem ities, or a persisten t elevation of BP occurs, to n otify th e HCP im m ediately.

Instruct the client with an aortic aneurysm to report immediately the occurrence of chest or back pain, short- ness of breath, difficulty swallowing, or hoarseness.

D. Ph arm aco logical in terven tion s 1. Adm in ister an tih yp erten sives to m ain tain th e

BP with in n orm al lim its an d to preven t strain on th e an eurysm .

2. In struct th e clien t about th e purpo se of th e m edication s.

785CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

3. In struct th e clien t ab out th e side effects an d sch edule of th e m ed ication .

E. Abdom in al aortic an eu rysm resectio n 1. Descrip tion : Surgical resectio n or excision of th e

an eurysm ; th e excised section is replaced with a graft th at is sewn en d to en d (Fig. 56-14).

2. Preop erative in terven tion s a. Assess all periph eral pulses as a baselin e for

posto perative com parison . b . In struct th e clien t in cough in g an d deep-

breath in g exercises. 3. Postoperative in terven tion s

a. Mon itor vital sign s. b . Mon itor periph eral pulses distal to th e graft

site. c. Mon itor for signs of graft occlusion , in clud-

in g ch an ges in pulses, cool to cold extrem ities below th e graft, wh ite or blue extrem ities or flan ks, severe pain , or abdom in al disten tion.

d . Lim it elevation of th e h ead of th e bed to 45 degrees to preven t flexion of th e graft.

e. Mon itor for h ypo volem ia an d kidn ey fail- ure resultin g fro m sign ifican t blood lo ss durin g surgery.

f. Mon itor urin e outp ut h ou rly, an d n otify th e HCP if it is lower th an 30 to 50 m L/ h our.

g. Mon itor serum creatin in e an d blood urea n itrogen levels daily.

h . Mon itor respiratory status an d auscultate breath soun ds to iden tify respiratory com plication s.

i. En cou rage turn in g, cough in g an d deep breath in g, an d splin tin g th e in cision .

j. Am bu late as prescribed. k . Prepare th e clien t for disch arge by provid-

in g in struction s regardin g pain m an age- m en t, woun d care, an d activity restriction s.

l. In struct th e clien t n ot to lift objects h eavier th an 15 to 20 lb for 6 to 12 weeks.

m . Advise th e clien t to avoid activities requir- in g push in g, pullin g, or strain in g.

n . In struct th e clien t n ot to drive a veh icle un til approved by th e HCP.

F. Th oracic an eu rysm repair 1. Descrip tion

a. A th oracoto m y or m ed ian stern otom y ap p ro ach is u sed to en ter th e th o racic cavity.

b . Th e an eu rysm is exposed an d excised, an d a graft or prosth esis is sewn on to th e aorta.

c. Total cardiopulm on ary bypass is n ecessary for excision of an eurysm s in th e ascen din g aorta.

d . Partial cardiop ulm on ary bypass is used for clien ts with an an eurysm in th e descen din g aorta.

2. Postoperative in terven tion s a. Mon itor vital sign s an d n eurological an d

ren al status. b . Mon itor for sign s of h em orrh age, such as a

drop in BP an d in creased pulse rate an d res- piration s, an d report th em to th e HCP im m ediately.

c. Mon itor ch est tubes for an in crease in ch est drain age, wh ich m ay in dicate bleed in g or separation at th e graft site.

d . Assess sen sation an d m otion of all extrem i- ties an d n otify th e HCP if deficits are n oted, wh ich can occur because of a lack of blood supply to th e spin al co rd durin g surgery.

e. Mon itor respiratory status an d au scultate breath soun ds to iden tify respiratory com - plication s.

f. En cou rage turn in g, cough in g, an d deep breath in g wh ile splin tin g th e in cision .

g. Prepare th e clien t for disch arge by provid in g in struction s regardin g pain m an - agem en t, woun d care, an d activity restriction s.

h . In struct th e clien t n ot to lift objects h eavier th an 15 to 20 lb for 6 to 12 weeks.

i. Advise th e clien t to avoid activities requirin g push in g, pullin g, or strain in g.

j. In struct th e clien t n ot to drive a veh icle un til approved by th e HCP.

XIX. Embolectomy A. Descriptio n

1. Em bolectom y is rem oval of an em b olus from an artery, usin g a cath eter.

2. A patch graft m ay be required to clo se th e artery. B. Preoperative in terven tion s

1. O btain a baselin e vascu lar assessm en t. 2. Adm in ister an ticoagulan ts as prescribed. 3. Adm in ister th rom bolytics as prescribed. 4. Place a bed cradle on th e bed. 5. Avoid bum pin g or jarrin g th e bed. 6. Main tain th e extrem ity in a sligh tly dep en den t

position .

Da cron gra ft

FIGURE 56-14 Surgical repair of an abdominal aortic aneurysm with a woven Dacron graft.

786 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

C. Postoperative in terven tion s 1. Assess cardiac, respiratory, an d n eurological

status. 2. Mon itor affected extrem ity for color, tem pera-

ture, an d pulse. 3. Assess sen sory an d m oto r fun ctio n of th e

affected extrem ity. 4. Mon itor for sign s an d sym pto m s of n ew

th rom bi or em boli. 5. Adm in ister oxygen as prescribed. 6. Mon itor pulse oxim etry. 7. Mon itor for co m plication s cau sed by reperfu-

sion of th e artery, such as spasm s an d swellin g of th e skeletal m uscles.

8. Mon itor for sign s of swollen skeletal m uscles such as edem a, pain on passive m ovem en t, poor capillary refill, n um bn ess, an d m uscle ten seness.

9. Main tain bed rest in itially, with th e clien t in a sem i-Fowler’s position .

10. Place a bed cradle on th e bed . 11. Ch eck th e in cision site for bleedin g or

h em atom a. 12. Adm in ister an ticoagulan ts as prescribed. 13. Mon itor laborato ry values related to an ticoag-

ulan t th erap y. 14. In struct th e clien t to recogn ize th e sign s an d

sym pto m s of in fectio n an d edem a. 15. In struct th e clien t to avoid prolon ged sittin g or

cro ssin g th e legs wh en sittin g. 16. In struct th e clien t to elevate th e legs wh en

sittin g. 17. In struct th e clien t to wear an tiem bolism stock-

in gs as prescribed an d h ow to rem ove an d reapply th e stockin gs.

18. In struct th e clien t to am bulate daily. 19. In struct th e client about anticoagulan t th erapy

an d th e h azards associated with anticoagulan ts.

XX. Vena Cava Filter and Ligation of Inferior Vena Cava A. Ven a cava filter: In sertion of an in tracaval filter

(um brella) th at partially occludes th e in ferior ven a cava an d traps em boli to preven t pulm o n ary em boli (Fig. 56-15)

B. Ligation : Suturin g or placin g clips on th e in ferior ven a cava to preven t pulm on ary em boli; don e via abdom in al laparoto m y

C. Preoperative in terven tion s: If th e clien t h as been takin g an an ticoagulan t, con sult with th e HCP regardin g discon tin uation of th e m edication preop- eratively to preven t h em orrh age.

D. Posto perative in terven tion s 1. Adm in ister oxygen as prescribed. 2. Main tain a sem i-Fowler’s position . 3. Avo id h ip flexion . 4. Provide activity as prescribed. 5. Ch eck th e in sertio n site for bleedin g or h em a-

tom a an d sign s or sym ptom s of in fection . 6. Assess for periph eral edem a.

7. Main tain an tiem bolism stockin gs as prescribed. 8. Mon itor laborato ry values related to an tico-

agulan t th erap y. 9. In struct th e clien t to recogn ize th e sign s an d

sym pto m s of in fectio n an d edem a. 10. In struct th e clien t to avoid prolon ged sittin g

or cro ssin g th e legs wh en sittin g. 11. In struct th e clien t to elevate th e legs wh en

sittin g. 12. In struct th e clien t to wear an tiem bolism

stockin gs as prescribed an d h ow to rem ove an d reapply th e stockin gs.

13. In struct th e clien t to am bulate daily. 14. In struct the clien t about an ticoagulan t th erapy

an d the h azards associated with an ticoagulan ts.

XXI. Hypertension A. Description

1. For an ad ult (ages 18 an d older), a n orm al BP is a systolic BP below 120 m m Hg an d a diastolic pressure below 80 m m Hg.

2. An in dividual classified with preh yperten sion h as a systolic BP between 120 an d 139 m m Hg or a diastolic pressure between 80 an d 89 m m Hg.

3. Stage 1 h yperten sion can be classified as a sys- tolic BP between 140 an d 159 m m Hg or a dia- stolic pressure between 90 an d 99 m m Hg.

4. Stage 2 h yperten sion can be classified as a systolic BP equal to or greater th an 160 m m Hg or a dia- stolic pressure equal to or greater th an 100 m m Hg.

5. Hyperten sion is a m ajo r risk factor for coron ary, cerebral, ren al, an d periph eral vascu lar disease.

Infe rior ve na ca va

Re na l ve in

Umbre lla filte r

FIGURE 56-15 An inferior vena cava filter.

787CHAPTER 56 Cardiovascular System

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

6. Th e disease is in itially asym ptom atic. 7. Th e goals of treatm en t in clude reduction of th e

BP an d preven tin g or lessen in g th e exten t of organ dam age.

8. No n ph arm acological approach es, such as life- style ch an ges, m ay be prescribed in itially; if th e BP can n ot be decreased after a reason able tim e period (1 to 3 m on th s), th e clien t m ay require ph arm acological treatm en t.

B. Prim ary or essen tial h yperten sion 1. Risk facto rs

a . Agin g b . Fam ily h istory c. African Am erican race d . O besity e. Sm okin g f. Stress g. Excessive alcoh ol h . Hyperlip idem ia i. In creased in take of salt or caffein e

C. Secon dary h yperten sion 1. Secon dary h yperten sio n occurs as a result of

oth er disorders or con d ition s. 2. Treatm en t dep en ds on th e cause an d th e organ s

in volved. 3. Precipitatin g disorders or con d ition s

a . Cardio vascular disorders b . Ren al disorders c. En docrin e system disorders d . Pregn an cy e. Medication s (e.g., estrogen s, glucocorti-

coids, m in eraloco rticoids) D. Assessm en t

1. May be asym ptom atic 2. Headach e 3. Visual disturban ces 4. Dizzin ess 5. Ch est pain 6. Tin n itus 7. Flu sh ed face 8. Epistaxis

E. In terven tion s 1. Goals: To reduce th e BP an d to preven t or

lessen th e exten t of organ dam age 2. Q uestion th e clien t regardin g th e sign s an d

sym ptom s in dicative of h yperten sio n . 3. O btain th e BP 2 or m ore tim es on both arm s,

with th e clien t supin e an d stan din g. 4. Com pare th e BP with prior docum en tatio n . 5. Determ in e fam ily h isto ry of h yperten sion . 6. Iden tify curren t m edication th erapy. 7. O btain weigh t. 8. Evaluate dietary pattern s an d sodium in take. 9. Assess for visu al ch an ges or retin al dam age.

10. Assess for cardiovascular ch an ges such as dis- ten ded n eck vein s, in creased h eart rate, an d dysrh yth m ias.

11. Evaluate ch est x-ray for h eart en largem en t. 12. Assess th e n eurological system . 13. Evaluate ren al fun ction . 14. Evaluate results of diagn ostic an d labo ratory

studies. F. Non p h arm acological in terven tion s

1. Weigh t reduction , if n ecessary, or m ain ten an ce of ideal weigh t

2. Dietary sodium restriction to 2 g daily as prescribed 3. Mod erate in take of alcoh ol an d caffein e-

con tain in g produ cts 4. In itiation of a regular exercise program 5. Avo idan ce of sm okin g 6. Relaxation tech n iqu es an d biofeedback th erap y 7. Elim in ation of un n ecessary m ed ication s th at

m ay con tribu te to th e h yperten sion G. Ph arm acological in terven tion s

1. Med ication th erap y is in dividualized for each clien t an d th e selectio n of th e m edication is based on such facto rs as th e clien t’s age, culture, presen ce of coexistin g con dition s, severity of th e h yperten sion , an d clien t’s preferen ces.

2. See Ch apter 57 for m ed ication s to treat h yper- ten sion .

H. See Box 56-10 for clien t edu cation .

XXII. Hypertensive Crisis A. Descrip tion

1. A h yperten sive crisis is an y clin ical con d ition requirin g im m ediate reduction in BP.

2. A h yperten sive crisis is an acu te an d life- th reaten in g con d ition .

3. Th e accelerated h yperten sio n requires em er- gen cy treatm en t because target organ dam age (brain , h eart, kidn eys, retin a of th e eye) can occur quickly.

4. Death can be caused by stroke, kidn ey failure, or cardiac disease.

B. Assessm en t 1. An extrem ely h igh BP; usually th e diastolic

pressure is h igh er th an 120 m m Hg 2. Headach e 3. Drowsin ess an d con fusion 4. Blurred vision 5. Ch an ges in n eurological status 6. Tach ycardia an d tach ypn ea 7. Dysp n ea 8. Cyan osis 9. Seizu res

C. In terven tion s 1. Main tain a paten t airway. 2. Adm in ister an tih yp erten sive m edication s

in traven ously as prescribed. 3. Mon itor vital sign s, assessin g th e BP every

5 m in utes. 4. Main tain bed rest, with th e h ead of th e bed ele-

vated at 45 degrees.

788 UNIT XIII Cardiovascular Disorders of the Adult Client

5. Assess for h ypo ten sion durin g th e ad m in istra- tio n of an tih yperten sives; place th e clien t in a supin e position if h ypoten sion occurs.

6. Have em ergen cy m ed ication s an d resuscitation equ ipm en t readily available.

7. Mon itor IV th erap y, assessin g for fluid overload. 8. In sert a Foley cath eter as prescribed. 9. Mon itor in take an d urin ary output; if oliguria or

an uria occurs, n otify th e HCP.

CRITICAL THINKING What Should You Do? Answer: If the client with an abdominal aortic aneurysm suddenly complains of severe back pain and shortness of breath, the nurse should suspect rupture (a surgical emer- gency) and should immediately contact the health care pro- vider (HCP). The nurse should also obtain information about the back pain, stay with the client while waiting for the arrival of the HCP, monitor vital signs and neurological status, and provide support to the client. Other signs of rupture include severe abdominal pain or fullness, soreness over the umbili- cus, and sudden development of discoloration in the extremities.

Reference: Ignatavicius, Workman (20 16), pp. 726–728.

P R A C T I C E Q U E S T I O N S 665. A clien t is ad m itted to th e em ergen cy d ep artm en t

with ch est p ain th at is co n sisten t with m yo card ial in farctio n b ased o n elevated tro p o n in levels. H eart so u n d s are n o rm al an d vital sign s are n o ted o n th e clien t’s ch art. Th e n u rse sh o u ld alert th e h ealth care p ro vid er b ecau se th ese ch an ges are m o st co n sisten t with wh ich co m p licatio n ? Refer to ch art.

1. Card iogen ic sh ock 2. Card iac tam pon ade 3. Pulm on ary em bolism 4. Dissectin g th o racic aortic an eurysm

666. A clien t adm itted to th e h ospital with ch est pain an d a h istory of type 2 diabetes m ellitus is sch eduled for cardiac cath eterization . Wh ich m ed- ication would n eed to be with h eld for 24 h ours befo re th e procedure an d for 48 h ours after th e procedure? 1. Glipizide 2. Metform in 3. Repaglin ide 4. Regular in sulin

667. A clien t in sin us brad ycardia, with a h eart rate of 45 beats/ m in u te, com plain s of dizzin ess an d h as a blood pressure of 82/ 60 m m Hg. Wh ich prescrip- tio n sh ould th e n urse an ticipate will be prescribed? 1. Adm in ister digoxin . 2. Defibrillate th e clien t. 3. Con tin ue to m on itor th e clien t. 4. Prepare for tran scutan eous pacin g.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

Client’s Chart Time: 11:00 a.m. 11:15 a.m. 11:30 a.m. 11:45 a.m.

Pulse: 92 beats/ min

96 beats/ min

104 beats/ min

118 beats/ min

Respiratory rate:

24 breaths/ min

26 breaths/ min

28 breaths/ min

32 breaths/ min

Blood pressure:

140 / 88 mm Hg

128/ 82 mm Hg

104/ 68 mm Hg

88/ 58 mm Hg

BOX 56-10 Education for the Client with Hypertension Describe the importance of compliance with the treatment

plan. Describe the disease process, explaining that symptoms usually

do not develop until organs have suffered damage. Initiate and assist the client in planning a regular exercise

program, avoiding heavy weight-lifting and isometric exercises.

Emphasize the importance of beginning the exercise program gradually.

Encourage the client to express feelings about daily stress. Assist the client to identify ways to reduce stress. Teach relaxation techniques. Instruct the client in how to incorporate relaxation techniques

into the daily living pattern. Instruct the client and family in the technique for monitoring

blood pressure (BP). Instruct the client to maintain a diary of BP readings. Emphasize the importance of lifelong medication.

Instruct the client and family about dietary restrictions, which may include sodium, fat, calories, and cholesterol.

Instruct the client in how to shop for and prepare low-sodium meals.

Provide a list of products that contain sodium. Instruct the client to read labels of products to determine

sodium content, focusing on substances listed as sodium, NaCl, or MSG (monosodium glutamate).

Instruct the client to bake, roast, or boil foods; avoid salt in preparation of foods; and avoid using salt at the table.

Instruct the client that fresh foods are best to consume, and to avoid canned foods.

Instruct the client about the actions, side effects, and schedul- ing of medications.

Advise the client that if uncomfortable side effects occur, to con- tact the health care provider and not to stop the medication.

Instruct the client to avoid over-the-counter medications. Stress the importance of follow-up care.

789CHAPTER 56 Cardiovascular System

668. Th e n urse in a m edical un it is carin g for a clien t with h eart failure. Th e clien t sudd en ly develops extrem e dyspn ea, tach ycardia, an d lu n g crackles an d th e n urse suspects pulm on ary edem a. Th e n urse im m ediately asks an oth er n urse to con tact th e h ealth care provid er an d prepares to im ple- m en t wh ich p rio rity in terven tion s? Select all th at ap p ly.

1. Adm in isterin g oxygen 2. In sertin g a Foley cath eter 3. Adm in isterin g furosem ide 4. Adm in isterin g m orph in e sulfate in trave-

n ously 5. Tran sportin g th e clien t to th e coron ary

care un it 6. Placin g th e clien t in a low Fowler’s side-lyin g

position

669. A clien t with m yocardial in farction sudden ly beco m es tach ycardic, sh ows sign s of air h un ger, an d begin s cough in g fro th y, pin k-tin ged sputu m . Wh ich fin din g would th e n urse an ticip ate wh en au scultatin g th e clien t’s breath soun ds? 1. Strid or 2. Crackles 3. Scattered rh on ch i 4. Dim in ish ed breath soun ds

670. A clien t with m yocardial in farction is developin g cardiogen ic sh o ck. Because of th e risk of m yocar- dial isch em ia, wh at con ditio n sh o uld th e n urse carefully assess th e clien t for? 1. Bradycardia 2. Ven tricular dysrh yth m ias 3. Risin g diastolic blood pressure 4. Fallin g cen tral ven ous pressure

671. A clien t wh o h ad cardiac surgery 24 h ou rs ago h as h ad a urin e outp ut averagin g 20 m L/ h ou r for 2 h ours. Th e clien t received a sin gle bolus of 500 m L of in traven o us fluid. Urin e outp ut for th e subsequen t h our was 25 m L. Daily labo ratory results in dicate th at th e blood urea n itrogen level is 45 m g/ dL (16 m m o l/ L) an d th e serum creatin in e level is 2.2 m g/ dL (194 m cm o l/ L). O n th e basis of th ese fin din gs, th e n urse would an ticipate th at th e clien t is at risk for wh ich problem ? 1. Hypo volem ia 2. Acute kidn ey in ju ry 3. Glom eru lon eph ritis 4. Urin ary tract in fectio n

672. Th e n urse is reviewin g an electrocardiogram rh yth m strip. Th e P waves an d Q RS com plexes are regular. Th e PR in terval is 0.16 secon ds, an d Q RS com plexes m easure 0.06 secon ds. Th e overall h eart rate is 64 beats/ m in ute. Which action sh ould th e n urse take?

1. Ch eck vital sign s. 2. Ch eck labo ratory test results. 3. No tify th e h ealth care provid er. 4. Con tin ue to m on itor for an y rh yth m ch an ge.

673. A clien t is wearin g a con tin uous cardiac m on itor, wh ich begin s to soun d its alarm . Th e n urse sees n o electrocardiograp h ic com plexes on th e screen . Wh ich is th e p rio rity n ursin g action ? 1. Call a code. 2. Call th e h ealth care provid er. 3. Ch eck th e clien t’s status an d lead placem en t. 4. Press th e recorder button on th e electrocardio-

gram con sole.

674. Th e n urse is watch in g th e cardiac m on itor an d n otices th at th e rh yth m sudd en ly ch an ges. Th ere are n o P waves, th e Q RS com plexes are wide, an d th e ven tricular rate is regular but m ore th an 140 beats/ m in u te. Th e n urse determ in es th at th e clien t is experien cin g wh ich dysrh yth m ia? 1. Sin us tach ycardia 2. Ven tricular fibrillation 3. Ven tricular tach ycardia 4. Prem atu re ven tricular con traction s

675. A clien t h as frequen t bursts of ven tricular tach ycar- dia on th e cardiac m on itor. Wh at sh ould th e n urse be m o st con cern ed about with th is dysrh yth m ia? 1. It can develo p in to ven tricular fibrillation at

an y tim e. 2. It is alm ost im possible to con vert to a n orm al

rh yth m . 3. It is un com fo rtable for th e clien t, givin g a sen se

of im pen din g doom . 4. It produ ces a h igh cardiac output th at quickly

leads to cerebral an d m yocardial isch em ia.

676. A clien t is h avin g frequen t prem atu re ven tricular con traction s. Th e n urse sh ould place p rio rity on assessm en t of wh ich item ? 1. Sen sation of palpitation s 2. Causative facto rs, such as caffein e 3. Bloo d pressure an d oxygen saturation 4. Precipitatin g facto rs, such as in fection

677. Th e clien t h as develo ped atrial fib rillation , with a ven tricular rate of 150 beats/ m in u te. Th e n urse sh ould assess th e clien t for wh ich associated sign s an d/ o r sym pto m s? 1. Flat n eck vein s 2. Nausea an d vo m itin g 3. Hypo ten sion an d dizzin ess 4. Hyperten sion an d h eadach e

678. Th e n urse is watch in g th e cardiac m on itor, an d a clien t’s rh yth m sudd en ly ch an ges. Th ere are n o P

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

790 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

waves; in stead, th ere are fibrillatory waves before each Q RS co m plex. How sh o uld th e n urse correctly in terpret th e clien t’s h eart rh yth m ? 1. Atrial fibrillation 2. Sin us tach ycardia 3. Ven tricular fibrillation 4. Ven tricular tach ycardia

679. Th e n urse is assistin g to defibrillate a clien t in ven tricular fib rillation . After placin g th e pad on th e clien t’s ch est an d before disch arge, wh ich in ter- ven tion is a p rio rity? 1. En su re th at th e clien t h as been in tub ated. 2. Set th e defibrillator to th e “syn ch ron ize” m od e. 3. Adm in ister an am iodaron e bolus in traven ously. 4. Con firm th at th e rh yth m is actually ven tricular

fib rillation .

680. A clien t in ven tricular fibrillation is about to be defibrillated. To con vert th is rh yth m effectively, th e m on oph asic defibrillator m ach in e sh ould be set at wh ich en ergy level (in joules, J) for th e first delivery? 1. 50 J 2. 120 J 3. 200 J 4. 360 J

681. Th e n urse sh ould evaluate th at defibrillation of a clien t was m o st successful if wh ich observation was m ade? 1. Aro usable, sin us rh yth m , blood pressure (BP)

116/ 72 m m Hg 2. Non arousable, sin us rh yth m , BP 88/ 60 m m Hg 3. Arousable, m arked bradycardia, BP 86/

54 m m Hg 4. No n arousable, supraven tricular tach ycardia, BP

122/ 60 m m Hg

682. Th e n urse is evaluatin g a clien t’s respon se to cardio- version . Wh ich assessm en t would be th e p riority? 1. Bloo d pressure 2. Status of airway 3. O xygen flow rate 4. Level of co n sciousn ess

683. Th e n urse is carin g for a clien t wh o h as just h ad im plan tation of an autom atic in tern al cardioverter-defibrillato r. Th e n urse sh ould assess wh ich item based on p rio rity? 1. An xiety level of th e clien t an d fam ily 2. Presen ce of a Med icAlert card for th e clien t

to carry 3. Kn owledge of restriction s on postd isch arge

ph ysical activity 4. Activation status of th e device, h eart rate cutoff,

an d n um ber of sh ocks it is program m ed to deliver

684. A clien t’s electrocardiogram strip sh ows atrial an d ven tricular rates of 110 beats/ m in ute. Th e PRin terval is 0.14 secon ds, the Q RS com plex m easures 0.08 sec- on ds, an d th e PP an d RR in tervals are regular. How sh ould th e n urse correctly in terpret this rh yth m ? 1. Sin us tach ycardia 2. Sin us bradycardia 3. Sin us dysrh yth m ia 4. No rm al sin us rh yth m

685. Th e n urse is assessin g th e n eurovascular status of a clien t wh o return ed to th e surgical n ursin g un it 4 h ou rs ago after un dergoin g aorto iliac bypass graft. Th e affected leg is warm , an d th e n urse n otes redn ess an d edem a. Th e pedal pulse is palpab le an d un ch an ged from adm ission . How sh ould th e n urse correctly in terpret th e clien t’s n eurovascular status? 1. Th e n eurovascular status is n orm al because of

in creased blood flow th rough th e leg. 2. Th e n eurovascular status is m oderately

im paired, an d th e surgeon sh ould be called . 3. Th e n eurovascular status is sligh tly deterioratin g

an d sh ould be m on itored for an oth er h our. 4. Th e n eurovascular status is ad equate from an

arterial ap proach , but ven ous com plication s are arisin g.

686. Th e n urse is evaluatin g th e con dition of a clien t after pericard iocen tesis perform ed to treat cardiac tam pon ade. Wh ich observation would in dicate th at th e proced ure was effective? 1. Muffled h eart soun ds 2. A rise in blood pressure 3. Jugular ven ous disten tion 4. Clien t expressio n s of dyspn ea

687. Th e n urse is carin g for a clien t wh o h ad a resectio n of an abdom in al aortic an eurysm yesterday. Th e clien t h as an in traven o us (IV) in fusion at a rate of 150 m L/ h ou r, un ch an ged for th e last 10 h ours. Th e clien t’s urin e outp ut for th e last 3 h ou rs h as been 90, 50, an d 28 m L (28 m L is m ost recen t). Th e clien t’s blood urea n itrogen level is 35 m g/ dL (12.6 m m o l/ L) an d th e serum creatin in e level is 1.8 m g/ dL (159 m cm o l/ L), m easu red th is m orn - in g. Wh ich n ursin g action is th e p rio rity? 1. Ch eck th e urin e specific gravity. 2. Call th e h ealth care provid er (HCP) . 3. Put th e IV lin e on a pum p so th at th e in fusio n

rate is sure to stay stable. 4. Ch eck to see if th e clien t h ad a blood sam ple for

a serum album in level drawn .

688. A clien t with varian t an gin a is sch eduled to receive an oral calcium ch an n el blocker twice daily. Wh ich statem en t by th e clien t in dicates th e n eed fo r fu r- th er teach in g?

791CHAPTER 56 Cardiovascular System

1. “I sh o uld n otify m y doctor if m y feet or legs start to swell.”

2. “My doctor told m e to call h is office if m y pulse rate decreases below 60.”

3. “Avoidin g grapefruit juice will defin itely be a ch allen ge for m e, sin ce I usually drin k it every m orn in g with breakfast.”

4. “My spou se told m e th at sin ce I h ave developed th is problem , we are goin g to stop walkin g in th e m all every m orn in g.”

689. Th e n urse n otes th at a clien t with sin us rh yth m h as a prem atu re ven tricular con traction th at falls on th e T wave of th e precedin g beat. Th e clien t’s rh yth m sudd en ly ch an ges to on e with n o P waves, n o defin able Q RS com plexes, an d coarse wavy lin es of varyin g am plitude. How sh ould th e n urse correctly in terp ret th is rh yth m ? 1. Asystole 2. Atrial fibrillation 3. Ven tricular fibrillation 4. Ven tricular tach ycardia

A N S W E R S 665. 1 Ra tion a le: Cardiogen ic sh ock o ccu rs with severe dam age (m ore th an 40%) to th e left ven tricle. Classic sign s in clud e h yp oten sio n ; a rap id p ulse th at b eco m es weaker; d ecreased u rin e o u tpu t; an d coo l, clam m y skin . Respirato ry rate in creases as th e bo d y d evelo ps m etabo lic acido sis fro m sh ock. Card iac tam po n ad e is acco m p an ied b y d istan t, m u ffled h eart so un ds an d p ro m in en t n eck vessels. Pu lm o n ary em bo lism p resen ts su dd en ly with severe d yspn ea acco m p an yin g th e ch est p ain . Dissectin g ao rtic an eurysm s u sually are acco m p an ied b y b ack pain . Test-Ta kin g Str a tegy: No te th e strategic wo rd , most. Recallin g th at th e early seriou s com p lication s of m yocard ial in farctio n in clu de dysrh yth m ias, cardio gen ic sh o ck, an d sud d en d eath will d irect you to th e co rrect option . No in form ation in th e q uestion is associated with th e rem ain in g op tio n s. Review: Com p lication s of m yo card ial in farctio n Level of Cogn it ive Abilit y: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Conten t Area : Critical Care—Em ergency Situations/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 741.

666. 2 Ra tion a le: Metfo rm in n eed s to be with h eld 24 h o urs befo re an d fo r 48 h ou rs after cardiac cath eterizatio n because o f th e in jection of co n trast m ed ium du rin g th e p ro cedu re. If th e con - trast m ed iu m affects kidn ey fu n ctio n , with m etfo rm in in th e system th e clien t wou ld b e at in creased risk for lactic acido sis. Th e m edication s in th e rem ain in g o p tion s d o n ot n eed to b e with h eld 24 h o u rs b efore an d 48 h ou rs after card iac cath eterization . Test-Ta kin g Str a tegy: Elim in ate glipizide and rep aglin ide first b ecau se they are com p arab le o r alike. Alth o ugh th ese m edica- tio n s m ay be withh eld o n th e m o rn in g o f th e procedure because o f th e clien t’s NPO (n o th in g b y m o uth ) statu s, there is n o in d i- catio n for with h old in g th e m ed ication o n th e d ay prior to th e p ro cedu re an d p ostp rocedure. Regular in su lin m ay b e adm in is- tered if elevated blo od glu co se levels from in fused in traven ou s solutio ns occur on th e d ay o f th e p rocedure. Review: Prep ro ced u re an d p ostp ro cedu re in terven tion s fo r card iac cath eterizatio n Level of Cogn it ive Abilit y: An alyzin g

Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad u lt Health —Card iovascular Pr ior it y Con cept s: Perfu sion ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 643, 1310.

667. 4 Ra tion a le: Sin u s b rad ycard ia is n o ted with a h eart rate less th an 60 beats per m in u te. Th is rh yth m beco m es a co n cern wh en th e clien t becom es sym ptom atic. Hypoten sion an d diz- zin ess are sign s o f d ecreased card iac ou tpu t. Tran scu tan eo us p acin g p ro vides a tem po rary m easu re to in crease th e h eart rate an d th u s perfusion in th e sym pto m atic clien t. Defib rillatio n is u sed fo r treatm en t o f p ulseless ven tricu lar tach ycard ia an d ven - tricu lar fib rillatio n . Digoxin will fu rth er d ecrease th e clien t’s h eart rate. Con tin u in g to m on itor th e clien t delays n ecessary in terven tion . Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, in terven tion s fo r sin us b rad ycard ia. Elim in ate th e o p tion in dicatin g to co n tin u e to m o n ito r th e clien t b ecau se th e clien t is sym p to m atic an d requires in terven tion . Digoxin is elim in ated because it will fur- th er decrease th e clien t’s h eart rate. Defib rillation is used fo r treatm en t o f p ulseless ven tricu lar tach ycard ia an d ven tricu lar fib rillation , so th at o ptio n can b e elim in ated . Review: In d ication s fo r tran scu tan eo u s p acin g Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Critical Care—Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 664.

668. 1, 2, 3, 4 Ra tion a le: Pulm o n ary edem a is a life-th reaten in g even t th at can resu lt from severe h eart failure. In p ulm o n ary edem a, th e left ven tricle fails to eject sufficien t b loo d, an d p ressure in creases in th e lu n gs b ecau se of th e accum u lated b loo d . O xy- gen is always p rescribed , an d th e clien t is p laced in a h igh Fowler’s po sitio n to ease th e work of breath in g. Furosem id e, a rapid -actin g d iuretic, will elim in ate accum u lated flu id . A Foley cath eter is in serted to m easu re ou tpu t accurately. In trave- n o usly ad m in istered m o rp h in e su lfate red u ces ven ou s return (prelo ad), decreases an xiety, an d also red u ces th e wo rk of b reath in g. Tran sp ortin g th e clien t to th e co ro n ary care u n it is n o t a p rio rity in terven tion . In fact, th is m ay n ot be n ecessary at all if th e clien t’s resp on se to treatm en t is su ccessfu l.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

792 UNIT XIII Cardiovascular Disorders of the Adult Client

Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority, an d fo cus on th e clien t’s d iagn o sis. Recall th e path o ph ysiology associated with pu lm on ary edem a an d u se th e ABCs—air- way–b reath in g–circu latio n —to h elp d eterm in e prio rity in terven tio n s. Review: Prio rity in terven tio n s for th e clien t with p u lm o n ary ed em a Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con tent Area : Critical Care—Em ergency Situation s/ Man agem en t Pr ior ity Con cepts: Gas Exch an ge; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p p. 688–689.

669. 2 Ra t ion a le: Pu lm o n ary edem a is ch aracterized b y extrem e breath lessn ess, d ysp n ea, air h u n ger, an d th e prod uctio n o f fro th y, pin k-tin ged sp u tu m . Auscultation of th e lu n gs reveals crackles. Rh on ch i an d dim in ish ed breath sou n d s are n o t asso- ciated with p ulm o n ary ed em a. Strido r is a crowin g so un d asso- ciated with laryn gosp asm o r edem a o f th e u p per airway. Test -Ta kin g St r a t egy: Focus on th e su b ject, b reath sou n d s ch aracteristic o f pu lm on ary edem a. Recallin g th at flu id pro- du ces sou n d s th at are called crackles will assist yo u in elim in at- in g th e in co rrect o p tion s. Review: Man ifestatio n s of p u lm o n ary ed em a Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con tent Area : Critical Care—Em ergency Situation s/ Man agem en t Pr ior ity Con cepts: Gas Exch an ge; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 699.

670. 2 Ra t ion a le: Classic signs of card io gen ic sh o ck as th ey relate to m yocardial isch em ia in clude low blood pressure an d tachycar- dia. The cen tral ven ous p ressure wou ld rise as th e backward effects of the severe left ven tricular failure becam e app aren t. Dysrh yth m ias com m on ly o ccur as a resu lt o f d ecreased oxygen ation and severe d am age to greater th an 40% o f th e m yocardium . Test -Ta kin g Str a tegy: Fo cus on th e su b ject, cardiogen ic sh o ck, an d n o te th e wo rd s myocardial ischemia. Recall th at isch em ia m akes th e m yo cardiu m irritable, p ro du cin g d ysrh yth m ias. Also, kn owled ge o f th e classic sign s of sh o ck h elp s to elim in ate th e in correct o ption s. Review: Man ifestatio n s associated with card io gen ic sh o ck Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con tent Area : Critical Care—Em ergency Situation s/ Man agem en t Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 759.

671. 2 Ra t ion a le: The clien t wh o un dergoes cardiac surgery is at risk for ren al in ju ry from p oor perfusion , h em olysis, low cardiac o ut- put, o r vasop ressor m ed icatio n th erapy. Ren al in ju ry is signaled by d ecreased u rin e o utput an d in creased b lood u rea n itro gen (BUN) and creatin in e levels. Norm al referen ce levels are BUN,

10 to 20 m g/ dL (3.6 to 7.1 m m ol/ L), an d creatin in e: m ale, 0.6–1.2 m g/ dL ( 53–106 m cm o l/ L) an d fem ale 0.5–1.1 m g/ d L (44–97 m cm o l/ L). Th e clien t m ay n eed m edication s to in crease ren al perfusion an d p ossibly could n eed p erito neal dialysis o r h em odialysis. No d ata in th e q uestion in dicate th e p resen ce o f h yp ovolem ia, glo m erulo n eph ritis, o r urin ary tract in fection . Test -Ta kin g St r a t egy: Elim in ate glom erulon eph ritis an d u ri- n ary tract in fection first b ecause th ey are co m p arab le o r alike in th at th ere are n o data in d icatin g in fectio n or in flam m ation . No tin g th at th e creatin in e level is elevated will assist you in elim in atin g h yp ovo lem ia. Review: Co m p lication s associated with card iac su rgery Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ad ult Health —Cardio vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ces: Ign ataviciu s, Workm an ( 2016) , p. 777; Lewis et al. (2014), p . 1102.

672. 4 Ra t ion a le: Norm al sin us rh yth m is defin ed as a regu lar rh yth m , with an o verall rate o f 60 to 100 beats/ m in ute. Th e PR an d Q RS m easurem en ts are n orm al, m easurin g between 0.12 an d 0.20 secon ds an d 0.04 an d 0.10 seco n d s, respectively. Th ere are n o irregu larities in th is rh yth m curren tly, so th ere is n o im m ed iate n eed to ch eck vital sign s o r labo rato ry resu lts, o r to n otify th e h ealth care provid er. Th erefore, th e n urse wo uld co n tin u e to m o n ito r th e clien t for an y rh yth m ch an ge. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, electro cardio gram rh yth m strip m easurem en ts. A b aselin e kn o wledge o f n o rm al electrocard io grap h ic m easu rem en ts is n eed ed to an swer th is q u estion . Focusin g o n th e d ata in th e q uestio n an d recallin g th e ch aracteristics o f n o rm al sin u s rh yth m will h elp you to p ri- o ritize you r action s. Review: Electro card io gram rh yth m strip m easurem en ts Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess: Im p lem en tation Con t en t Ar ea : Ad ult Health —Cardio vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 656.

673. 3 Ra tion a le: Sudden loss of electro card io graph ic com plexes in d i- cates ven tricular asystole o r possibly electro de displacem en t. Accurate assessm en t o f th e clien t an d equ ip m en t is n ecessary to determ in e the cause an d id en tify th e appro priate in terven - tion . Th e rem ain in g o ptio ns are secon dary to clien t assessm en t. Test -Ta kin g Str a tegy: Note th e strategic wo rd , priority. Use th e step s o f th e n u rsin g p ro cess. Always assess th e clien t d irectly b efo re takin g an y actio n . Th e correct op tio n is th e on ly on e th at ad dresses assessm en t. Review: Care o f th e clien t o n a card iac m o n ito r Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Cardio vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Lewis et al. (2014), p. 790.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

793CHAPTER 56 Cardiovascular System

674. 3 Ra tion a le: Ven tricular tach ycardia is ch aracterized b y th e ab sen ce of P waves, wid e Q RS com p lexes (lon ger th an 0.12 secon ds), an d typ ically a rate b etween 140 an d 180 im p ulses/ m in u te. Th e rh yth m is regular. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, th e ch aracteristics o f an electro cardiogram p attern , an d n ote th e d ata in th e q u es- tio n . Elim in ate sin us tach ycard ia first b ecause th ere are n o P waves. Prem ature ven tricular con traction s are isolated ectopic b eats sup erim p o sed on an u n d erlyin g rh yth m , so th at o p tion is elim in ated n ext. Recallin g th at th ere are n o tru e Q RS com - p lexes with ven tricular fibrillatio n will direct you to th e correct o ptio n fro m th ose rem ain in g. Review: Th e ch aracteristics o f ven tricu lar tach ycard ia Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Conten t Area : Critical Care—Em ergency Situations/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Lewis et al. (2014), p p . 794, 799–800.

675. 1 Ra tion a le: Ven tricu lar tach ycardia is a life-th reaten in g d ys- rh yth m ia th at results fro m an irritab le ecto p ic fo cu s th at takes o ver as th e p acem aker fo r th e h eart. Th e lo w cardiac ou tp ut th at results can lead q uickly to cerebral an d m yocard ial isch em ia. Clien ts freq uen tly experien ce a feelin g of im pen din g do o m . Ven tricular tach ycardia is treated with an tidysrh yth m ic m ed i- cation s, cardioversio n ( if th e clien t is awake) , or d efib rillation (lo ss of co n scio usn ess). Ven tricu lar tach ycardia can deterio rate in to ven tricu lar fib rillation at an y tim e. Test-Ta kin g St r a t egy: No te th e strategic wo rd , most. Th e o ptio n in dicatin g th at it is im po ssib le to con vert is in co rrect an d is elim in ated first. Fro m th e rem ain in g op tion s, fo cusin g o n th e strategic wo rd will d irect yo u to th e correct op tio n b ecau se th is o ptio n id en tifies th e life-th reaten in g co n d itio n . Review: Ven tricu lar tach ycard ia Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Conten t Area : Critical Care—Em ergency Situations/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 670.

676. 3 Ra tion a le: Prem atu re ven tricu lar co n tractio n s can cause h em o dyn am ic co m prom ise. Th erefo re, th e prio rity is to m o n - ito r th e b lo od pressure an d o xygen saturatio n . Th e sh orten ed ven tricular fillin g tim e can lead to d ecreased card iac o utp ut. Th e clien t m ay be asym p tom atic o r m ay feel p alp itation s. Pre- m ature ven tricular co n traction s can be cau sed by card iac disor- d ers; states o f h ypo xem ia; an y n u m b er o f p h ysio lo gical stressors, su ch as in fectio n , illn ess, surgery, o r traum a; an d in take of caffein e, n ico tin e, or alco h o l. Test-Ta kin g St r a t egy: Note th e strategic wo rd , priority. Use th e ABCs—airway–b reath in g–circu latio n —to direct yo u to th e correct op tio n . Review: Prem atu re ven tricu lar co n tractio n s ( PVCs) Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity

In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lewis et al. (2014), p . 799.

677. 3 Ra tion a le: Th e clien t with u n co n tro lled atrial fib rillatio n with a ven tricu lar rate m o re th an 100 b eats/ m in u te is at risk fo r lo w card iac o u tp u t b ecau se o f lo ss o f atrial kick. Th e n u rse assesses th e clien t fo r p alp itatio n s, ch est p ain o r d is- co m fo rt, h yp o ten sio n , p u lse d eficit, fatigu e, weakn ess, d izzi- n ess, syn co p e, sh o rtn ess o f b reath , an d d isten d ed n eck vein s. Test-Ta kin g St r a t egy: Focus o n th e su b ject, sign s an d / o r sym p to m s asso ciated with atrial fib rillatio n . Flat n eck vein s are n o rm al o r in d icate h yp o vo lem ia, so th is o p tio n can b e elim in ated . Nau sea an d vo m itin g are asso ciated with vagu s n erve activity an d d o n o t co rrelate with a tach ycard ic state. Fro m th e rem ain in g o p tio n s, th in k o f th e co n se- q u en ces o f a fallin g card iac o u tp u t to d irect yo u to th e co r- rect o p tio n . Review: Th e effects o f atrial fib rillatio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lewis et al. (2014), p . 707.

678. 1 Ra tion a le: Atrial fibrillation is ch aracterized by a loss of P waves an d fibrillatory waves before each Q RS com plex. Th e atria qu iver, wh ich can lead to th ro m bu s form atio n . Test-Ta kin g Str a tegy: .Fo cu s o n th e su b ject, in terp retin g a h eart rh yth m . No te th e d ata in th e q u estio n . No tin g th e wo rd s There are no P waves sh o u ld d irect yo u to th e co r- rect o p tio n . Lo ss o f P waves is ch aracteristic o f th is d ysrh yth m ia. Review: Atrial fib rillatio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 666–667.

679. 4 Ra tion a le: Un til th e d efibrillato r is attach ed an d ch arged , th e clien t is resuscitated b y u sin g cardiop ulm o n ary resu scitation . O n ce th e d efib rillato r h as been attach ed , th e electro cardiogram is ch ecked to verify th at th e rh yth m is ven tricu lar fibrillation or p ulseless ven tricu lar tach ycardia. Lead s also are ch ecked fo r an y lo ose co n n ectio n s. A n itroglycerin p atch , if presen t, is rem oved. Th e clien t does n ot h ave to be in tu bated to be defi- b rillated. Th e m ach in e is n ot set to th e syn ch ro n o us m o de b ecau se th ere is n o un derlyin g rh yth m with wh ich to syn ch ro - n ize. Am io daron e m ay be given su b sequ en tly bu t is n o t required before defibrillation . Test-Ta kin g St r a t egy: Note th e strategic wo rd , priority. Fo cu s o n th e su b ject, ven tricu lar fibrillatio n . Note th at th e co rrect

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

794 UNIT XIII Cardiovascular Disorders of the Adult Client

op tion directly add resses th is su bject an d also add resses assess- m en t o f th e clien t. Review: Defib rillatio n Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Critical Care—Basic Life Sup p ort/ Card io pu l- m o n ary Resu scitation Pr ior ity Con cepts: Perfusio n ; Safety Refer en ce: Lewis et al. (2014), p p. 801–802.

680. 4 Ra t ion a le: Th e en ergy level used for all defibrillatio n attem pts with a m o n o ph asic d efib rillator is 360 jo u les. Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, m o n oph asic defib rillation . As a gen eral rule, th ou gh , rem em b er th at lower levels o f en ergy are u sed for cardio version and biph asic d efib ril- lation . High er levels are u sed in m o no ph asic d efibrillation . Review: Defib rillatio n Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Basic Life Sup p ort/ Card io pu l- m o n ary Resu scitation Pr ior ity Con cepts: Perfusio n ; Safety Refer en ce: Lewis et al. (2014), p . 802.

681. 1 Ra t ion a le: After d efibrillation , th e clien t requires con tin uous m o n ito rin g of electro cardiograp h ic rh yth m , h em o dyn am ic statu s, an d n eu ro lo gical status. Resp irato ry an d m etabo lic acid osis develop d u rin g ven tricular fib rillatio n b ecau se o f lack of resp iration an d card iac o utp ut. Th ese can cause cereb ral an d card iop u lm o n ary co m plicatio n s. Arou sable statu s, ad e- qu ate BP, an d a sin us rh yth m in d icate su ccessful respo n se to defib rillatio n . Test -Ta kin g Str a tegy: No te th e strategic wo rd , most. Elim in ate th e op tion s th at co n tain th e word nonarousable. Fro m th e rem ain in g o ption s, select th e correct option because a sin us rh yth m is a m ore successful respon se com pared with m arked brad ycardia. Review: Th e exp ected effects of d efib rillatio n Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Critical Care—Basic Life Sup p ort/ Card io pu l- m o n ary Resu scitation Pr ior ity Con cepts: Eviden ce; Perfusio n Refer en ce: Ign atavicius, Workm an (2016), p . 672.

682. 2 Ra t ion a le: Nu rsin g respo n sibilities after cardioversio n in clu de m ain ten an ce first o f a paten t airway, an d th en o xygen adm in - istratio n , assessm en t of vital sign s an d level o f con sciou sn ess, an d dysrh yth m ia detectio n . Test -Ta kin g Str a tegy: No te th e strategic wo rd , priority. Use th e ABCs—airway–b reath in g–circu latio n —to d irect you to th e co rrect o p tion . Review: Care o f th e clien t fo llo win g card io versio n Level of Cogn it ive Ability: An alyzin g

Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Cardio vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 668.

683. 4 Ra t ion a le: Th e n urse wh o is carin g fo r th e clien t after in sertion o f an au tom atic in tern al card io verter-defib rillator n eeds to assess d evice settin gs, sim ilar to after in sertion o f a p erm an en t p acem aker. Specifically, th e n u rse n eeds to kn ow wh eth er th e d evice is activated , th e h eart rate cu to ff ab ove wh ich it will fire, an d th e n u m b er of sh o cks it is program m ed to deliver. Th e rem ain in g o ption s are also n u rsin g in terven tion s b ut are n ot th e priority. Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority. Use Maslo w’s Hierarch y o f Need s th eo ry. Th e correct o ptio n is th e on e th at iden tifies th e p h ysio lo gical n eed . Review: Care to th e clien t fo llo win g in sertio n of an au to m atic in tern al card io verter-d efib rillato r Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Cardio vascu lar Pr ior ity Con cepts: Perfusio n ; Safety Refer en ce: Lewis et al. (2014), p. 803.

684. 1 Ra t ion a le: Sin us tach ycard ia h as th e ch aracteristics o f n o rm al sin u s rh yth m , in clud in g a regular PP in terval an d n o rm al- width PR an d Q RS in tervals; h owever, th e rate is th e differen - tiatin g facto r. In sin us tach ycard ia, th e atrial an d ven tricular rates are greater th an 100 beats/ m in u te. Test -Ta kin g St r a t egy: Fo cus on th e su b ject, in terp retin g a car- d iac rh yth m . Elim in ate sin u s b rad ycard ia an d n orm al sin u s rh yth m first b ecau se th e ven tricu lar rate is 110 beats/ m in ute. Next elim in ate sin u s dysrh yth m ia because th is is an irregu lar rh yth m , with ch an gin g PP an d RR in tervals. Review: Th e ch aracteristics of sin u s tach ycard ia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Cardio vascu lar Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p p. 662–663.

685. 1 Ra t ion a le: An expected o utcom e of ao rto iliac byp ass graft su r- gery is warm th , red n ess, an d edem a in th e su rgical extrem ity b ecause o f in creased b lo od flo w. Th e rem ain in g op tion s are in correct in terp retatio n s. Test -Ta kin g St r a t egy: Focus on th e su b ject, exp ected o u t- co m es followin g aortoiliac byp ass graft surgery. Ven ou s com - p licatio n s from im m o bilizatio n resu ltin g from surgery wo uld n ot b e app aren t with in 4 h ou rs, so elim in ate op tion 4. Fro m th e rem ain in g o ption s, n o te th at th e p ed al pu lse is un ch an ged from ad m issio n an d th in k abo ut th e effects o f su dd en reperfu- sion in an isch em ic lim b . Th ere wo uld b e redn ess fro m n ew b lo od flow an d edem a from th e su dd en ch an ge in pressu re in th e blo o d vessels.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

795CHAPTER 56 Cardiovascular System

Review: Ao rto iliac b yp ass graft Level of Cogn it ive Abilit y: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Card io vascu lar Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfu sion Refer en ce: Lewis et al. (2014), p . 839.

686. 2 Ra tion a le: Fo llo win g pericard iocen tesis, th e clien t u su ally exp resses im m ediate relief. Heart so un d s are n o lo n ger m u ffled o r distan t an d b loo d pressu re in creases. Disten d ed n eck vein s are a sign o f in creased ven o us pressu re, wh ich occu rs with car- d iac tam p o n ade. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, exp ected o utcom e fo llo win g p ericardiocen tesis, an d n o te th e strategic wo rd , effective. Su ccessfu l th erap y is m easured b y th e disapp earan ce o f th e origin al sign s an d sym pto m s o f card iac tam p o n ade. Th is will direct you to th e correct option . Review: Sign s of card iac tam p o n ad e an d th e exp ected effects o f p ericard io cen tesis Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Card io vascu lar Pr ior it y Con cept s: Evid en ce; Perfu sio n Refer en ce: Lewis et al. (2014), p p . 815–816.

687. 2 Ra tion a le: Fo llo win g abd om in al ao rtic an eurysm resectio n or repair, th e n urse m on itors th e clien t fo r sign s of acu te kid n ey in ju ry. Acu te kidn ey in ju ry can o ccu r because o ften m uch bloo d is lo st d urin g th e su rgery an d , d ep en d in g o n th e an eurysm loca- tio n , th e ren al arteries m ay b e h ypo p erfu sed for a sh ort perio d d urin g su rgery. Norm al referen ce levels are BUN, 10 to 20 m g/ dL (3.6 to 7.1 m m o l/ L), an d creatin in e: m ale, 0.6–1.2 m g/ dL (53–106 m cm o l/ L) an d fem ale 0.5–1.1 m g/ d L (44–97 m cm o l/ L). O ption s 1 an d 4 are n ot asso ciated with th e d ata in th e qu estio n . Th e IV sh o uld h ave alread y been on a pu m p. Urin e o utp ut lo wer th an 30 m L/ h o ur is repo rted to th e HCP. Test-Ta kin g St r a t egy: Note th e strategic word , priority. Fo cu s o n th e d ata in th e q u estio n and th e abn orm al assessm en t data. Th is q uestion in dicates elevation s in b lo od u rea n itrogen an d creati- n in e levels and a significan t drop in h ou rly u rin e output. Th ese assessm en t fin din gs sh ould direct you to th e correct o ption . Review: Resection of an ab d o m in al ao rtic an eu rysm Level of Cogn it ive Abilit y: Syn th esizin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Conten t Area : Critical Care—Em ergency Situations/ Managem en t

Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Lewis et al. (2014), p p. 841–843.

688. 4 Ra tion a le: Varian t an gin a, o r Prin zm etal’s an gin a, is p ro - lo n ged an d severe an d o ccu rs at th e sam e tim e each d ay, m o st o ften at rest. Th e p ain is a result of co ro n ary artery sp asm . Th e treatm en t o f ch oice is usu ally a calciu m ch an n el b locker, wh ich relaxes an d dilates th e vascu lar sm ooth m uscle, th us relievin g th e coron ary artery sp asm in varian t an gin a. Ad verse effects can in clu de perip h eral ed em a, h yp oten sion , b rad ycard ia, an d h eart failure. Grap efru it juice in teracts with calcium ch an n el b lockers an d sh o uld b e avoid ed . If b rad ycardia o ccurs, th e cli- en t sh o uld con tact th e h ealth care provid er. Clien ts sh ou ld also b e taugh t to ch an ge p ositio n s slowly to p reven t orth o static h yp oten sio n . Ph ysical exertio n do es n o t cau se th is type of an gin a; th erefore, th e clien t sh o u ld be ab le to con tin u e m o rn - in g walks with h is o r h er sp ou se. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further teaching, an d fo cu s o n th e d ata in th e q u estio n . Th ese wo rd s in d icate a n egative even t q u ery an d th e n eed to select th e in cor- rect clien t statem en t. Recall th at walkin g is a lo w-im pact exercise an d is usu ally reco m m en ded fo r clien ts with h eart prob lem s. Review: Vario us typ es o f an gin a an d calciu m ch an n el b lo ckers Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Card iovascular Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 759, 763.

689. 3 Ra tion a le: Ven tricular fib rillation is ch aracterized by irregular ch aotic u n d ulatio n s o f varyin g am p litu des. Ven tricu lar fibrilla- tio n h as n o m easurable rate an d n o visible P waves o r Q RS com plexes an d results fro m electrical ch ao s in th e ven tricles. Test-Ta kin g Str a t egy: Fo cu s on th e su b ject, th e ch aracteristics o f ven tricu lar fib rillation . Note th e word s, no definable QRS complexes. Th e lack o f visible Q RS com p lexes elim in ates atrial fib rillation an d ven tricu lar tach ycardia. Recallin g th at asystole is lack o f an y electrical activity o f th e h eart will d irect you to th e correct op tio n . Review: Th e ch aracteristics o f ven tricu lar fib rillatio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Critical Care—Em ergen cy Situation s/ Managem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 670–671.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

796 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

C H A P T E R 57 Cardiovascular Medications

PRIORITY CONCEPTS Clotting; Perfusion

CRITICAL THINKING What Should You Do? The nurse notes that a client taking warfarin sodium has an international normalized ratio (INR) of 2.8. What should the nurse do? Answer located on p. 810.

I. Anticoagulants (Box 57-1) A. Description (Box 57-2)

1. An ticoagulan ts preven t th e exten sion an d form ation of clots by in h ib itin g facto rs in th e clo ttin g cascad e an d decreasin g blood coagulability.

2. An ticoagulan ts are adm in istered wh en th ere is evid en ce of or likelih ood of clot form ation — m yocardial in farction , un stable an gin a, atrial fib rillation , deep vein th rom bosis, pulm o n ary em b olism , an d th e presen ce of m ech an ical h eart valves.

3. An ticoagulan ts are con train d icated with active bleedin g (except for dissem in ated in travascular coagulation ), bleed in g disorders or blood dys- crasias, ulcers, liver an d kidn ey disease, an d h em - orrh agic brain in juries.

B. Sid e an d ad verse effects 1. Hem orrh age 2. Hem aturia 3. Epistaxis 4. Ecch ym osis 5. Bleedin g gum s 6. Th rom bocytopen ia 7. Hypo ten sion

C. Heparin sodium 1. Descriptio n

a . Heparin preven ts th rom bin from con vertin g fibrin ogen to fib rin .

b . Heparin preven ts th rom boem bolism . c. Th e th erapeutic dose does n ot dissolve clots

but preven ts n ew th rom bus form ation .

2. Bloo d levels a . Th e n orm al activated partial th rom boplastin

tim e (aPTT) is 30 to 40 seconds (conventional an d SI units) in m ost laboratories (values depend on reagen t an d in strum entation used).

b . To m ain tain a th erapeutic level of an ticoagula- tion wh en th e clien t is receivin g a contin uous in fusion of h eparin , th e aPTT should be 1.5 to 2.5 tim es th e n orm al value. Som e agen cies use 2 differen t protocols, a high -in ten sity proto- col such as for acute coron ary syn drom e an d a low-in ten sity protocol such as for ven ous th rom boem bolism proph ylaxis, an d th e dos- ages an d recom m en ded aPTTran ges are sligh tly different for th e differen t protocols.

c. Activated p artial th ro m b o p lastin tim e th er- ap y sh o u ld b e m easu red every 4 to 6 h o u rs d u rin g in itial co n tin u o u s in fu sio n th erap y o r u n til th e clien t h as b een th erap eu tic fo r a sp ecified tim e fram e an d th en d aily p er agen cy p o licy.

d . If th e aPTT is too lon g, lon ger th an 90 sec- on ds, th e dosage sh o uld be lowered .

e. If th e aPTT is too sh ort, less th an 60 secon ds, th e dosage sh ould be in creased.

3. In terven tion s a . Mon itor aPTT. b . Mon itor platelet coun t. c. O bserve for bleedin g gu m s, bruises, n ose-

bleeds, h em aturia, h em atem esis, occult blood in th e stool, an d petech iae.

d . In struct th e clien t regardin g m easu res to pre- ven t bleedin g.

e. Th e an tidote to h eparin is protam in e sulfate. f. Wh en adm in isterin g h eparin subcu tan e-

ously, in ject in to th e ab dom en with a ⅝-in ch (16 m m ) n eedle (25 to 28 gauge) at a 90-degree an gle an d do n ot aspirate or rub th e in jection site.

g. Co n tin u o u s in fu sio n s m u st b e ru n o n an in fu sio n p u m p to en su re a p recise rate o f d elivery. 797

D. En oxaparin —low-m o lecular-weigh t h eparin 1. Description : En oxaparin h as th e sam e m ech a-

n ism of action an d use as h eparin but is n ot in ter- ch an geable; it h as a lon ger h alf-life th an h eparin .

2. In terven tion s a. Adm in ister on ly to th e recum ben t clien t by

subcu tan eous in jection in to th e an tero lateral or posterolateral abdom in al wall; do n ot expel th e air bubble from th e prefilled syrin ge or aspirate durin g in jection .

b . Mon itor th e sam e labo ratory values as for h eparin an d observe for bleedin g.

c. Th e an tidote to en oxap arin is protam in e sulfate.

E. Warfarin sodium 1. Description

a. Warfarin supp resses coagulation by actin g as an an tagon ist of vitam in K by in h ib itin g 4 depen den t clo ttin g factors (X, IX, VII, an d II).

b . Warfarin prolon gs clottin g tim e an d is m on - itored by th e proth rom bin tim e (PT) an d th e INR.

c. It is used for lon g-term an ticoagulation and is used m ainly to preven t th rom boem bolic con - ditions such as throm boph lebitis, pulm on ary em bolism , an d em bolism form ation caused by atrial fibrillation , th rom bosis, m yocardial infarction , or h eart valve dam age.

2. Bloo d levels a. Th e n orm al PT is 11 to 12.5 secon ds (con ven -

tion al an d SI un its).

b . Warfarin so d iu m p ro lo n gs th e PT; th e th era- p eu tic ran ge is 1.5 to 2 tim es th e co n tro l valu e.

3. In tern ation al n orm alized ratio (INR) a. Th e n orm al INR is 0.81 to 1.2 (0.81–1.2). b . Th e INR is determ in ed by m ultiplyin g th e

observed PT ratio (th e ratio of th e clien t’s PT to a con trol PT) by a correction facto r spe- cific to a particular th rom boplastin prepara- tion used in th e testin g.

c. Th e treatm en t goal of warfarin sodium is to raise th e INR to an ap propriate value.

d . An INR of 2 to 3 is appropriate for stan dard warfarin th erap y; an INR of 3 to 4.5 is ap propriate for h igh -dose warfarin th erap y.

e. If th e PT value is lo n ger th an 30 secon ds an d th e INR is greater th an 3.0 in a clien t receivin g stan dard warfarin th erap y, in itiate bleed in g precaution s.

f. If th e INR is below th e recom m en ded ran ge, warfarin sodium sh o uld be in creased.

g. Clien ts m ay som etim es be prescribed “bridge th erapy,” wh ereby h eparin sodium is used con - curren tly with warfarin sodium un til th e INR reach es th e recom m en ded ran ge. O n ce th is occurs, th e h eparin is discon tin ued.

4. In terven tion s a . Mon itor PT an d INR. b . O bserve for bleedin g gum s, bruises, n ose-

bleeds, h em aturia, h em atem esis, occult blood in th e stool, an d petech iae.

c. In struct th e clien t regardin g diet an d m ea- sures to preven t bleed in g.

d . Th e an tidote for warfarin is ph yton adion e. F. Dabigatran etexilate

1. Description a . Dabigatran etexilate works th rough direct

in h ibitio n of th rom bin , preven tin g th e con - version of fibrin ogen in to fibrin an d activa- tion of factor XIII.

b . Curren t approved use is for clo t preven - tion associated with n on valvular atrial fibrillation .

c. It is ad m in istered in a fixed dose twice daily. 2. Bloo d levels: No blood testin g is required. 3. In terven tion s: Sam e as for warfarin , except n o

routin e m on itorin g is required. G. Rivaroxaban

1. Description a . Rivaroxaban works th rou gh in h ib ition of

factor Xa. b . Approved uses in clude for clot preven tion

associated with n on valvular atrial fib rillation an d after kn ee an d h ip replacem en t.

2. Bloo d levels: No blood testin g is required. 3. In terven tion s: Sam e as for dabigatran etexilate

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-1 Anticoagulants Oral ▪ Warfarin sodium ▪ Dabigatran etexilate

mesylate ▪ Rivaroxaban ▪ Apixaban

Parenteral ▪ Argatroban ▪ Bivalirudin ▪ Dalteparin ▪ Desirudin ▪ Enoxaparin ▪ Fondaparinux ▪ Heparin sodium

BOX 57-2 Substances to Avoid with Anticoagulants

▪ Allopurinol ▪ Cimetidine ▪ Corticosteroids ▪ Green, leafy vegetables and other foods high in vitamin K ▪ Nonsteroidal antiinflammatory drugs ▪ Oral hypoglycemic agents ▪ Phenytoin ▪ Salicylates ▪ Sulfonamides ▪ Ginkgo and ginseng (herbs)

798 UNIT XIII Cardiovascular Disorders of the Adult Client

II. Thrombolytic Medications (Box 57-3) A. Description

1. Th rom bolytic m ed ication s activate plasm in o- gen ; plasm in o gen gen erates plasm in (th e en zym e th at dissolves clots).

2. Th rom bolytic m ed ication s are used early in th e course of m yocardial in farction (with in 4 to 6 h ours of th e on set of th e in farct) to restore blood flow, lim it m yocardial dam age, preserve left ven tricular fun ction , an d preven t death .

3. Th rom bolytics are also used in arterial th rom bo- sis, deep vein th rom bosis, occluded sh un ts or cath eters, an d pulm o n ary em b oli.

B. Con train dication s 1. Active in tern al bleedin g 2. Histo ry of h em orrh agic stroke 3. In tracran ial problem s, in cludin g traum a 4. In tracran ial or in traspin al surgery with in th e pre-

viou s 2 m on th s 5. Histo ry of th o racic, pelvic, or abdom in al surgery

in th e previous 10 days 6. Histo ry of h epatic or ren al disease 7. Un con tro lled h yperten sion 8. Recen tly required , prolon ged cardiop ulm on ary

resuscitation 9. Kn o wn allergy to th e specific produ ct or an y of its

preservatives C. Sid e an d ad verse effects

1. Bleedin g 2. Dysrh yth m ias 3. Allergic reaction s

D. In terven tion s 1. Determ in e aPTT, PT, fibrin ogen level, h em ato-

crit, an d platelet coun t. 2. Mon itor vital sign s. 3. Assess pulses. 4. Mon itor for bleedin g an d ch eck all excretion s

for occult blood . 5. Mon itor for n eurological ch an ges such as slurred

speech , leth argy, con fusion , an d h em iparesis. 6. Mon itor for h ypo ten sion an d tach ycardia. 7. Avoid in jection s an d un n ecessary ven ipu n c-

tures if possible. 8. Apply direct pressure over a pun cture site for 20

to 30 m in u tes. 9. Han dle th e clien t as little as possib le wh en

m ovin g. 10. In struct th e clien t to use an electric razor for

sh avin g an d to brush teeth gen tly. 11. With h old th e m edication if bleed in g develops,

an d n otify th e h ealth care provider (HCP).

12. An tido te a . Am in o caproic acid is th e an tidote. b . Used on ly in acute, life-th reaten in g

con dition s

Bleeding is the primary concern for a client taking an anticoagulant, thrombolytic, or antiplatelet medication.

III. Antiplatelet Medications (Box 57-4) A. Description

1. An tiplatelet m ed ication s in h ib it th e aggregation of platelets in th e clottin g process, th ereby prolon gin g th e bleedin g tim e.

2. An tiplatelet m ed ication s m ay be used with an ticoagulan ts.

3. Used in th e proph ylaxis of lon g-term com plica- tion s followin g m yocardial in farction , coron ary revascularization , sten ts, an d stroke.

4. Th ese m ed ication s are con train dicated in th o se with bleedin g disorders an d kn own sen sitivity.

B. Side an d adverse effects 1. Bruisin g 2. Hem aturia 3. Gastroin testin al bleedin g 4. Tarry stools

C. In terven tion s 1. Determ in e sen sitivity befo re ad m in istration . 2. Mon itor vital sign s. 3. In struct th e clien t to take m ed ication with food if

gastro in testin al upset occurs. 4. Mon itor bleedin g tim e. 5. In struct th e clien t to m on itor for side an d adverse

effects an d in th e m easu res to preven t bleedin g.

IV. Positive Inotropic and Cardiotonic Medications (Box 57-5)

A. Description 1. Th ese m edication s stim ulate m yocardial contrac-

tility an d produce a positive in otrop ic effect. 2. Th ese m edication s are used for sh o rt-term m an -

agem en t of advan ced h eart failure; th e in crease in m yocardial con tractility im proves cardiac, periph eral, an d kidn ey fun ction by in creasin g cardiac output, decreasin g preload, im provin g

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-3 Thrombolytic Medications ▪ Alteplase ▪ Tenecteplase

BOX 57-4 Antiplatelet Medications Oral ▪ Acetylsalicylic acid ▪ Anagrelide ▪ Cilostazol ▪ Clopidogrel ▪ Dipyridamole ▪ Ticlopidine ▪ Ticagrelor ▪ Persantine

Parenteral ▪ Abciximab ▪ Eptifibatide ▪ Tirofiban

799CHAPTER 57 Cardiovascular Medications

blood flow to th e periph ery an d kidn eys, decreasin g edem a, an d in creasin g flu id excretion . As a result, fluid reten tion in th e lun gs an d extrem ities is decreased (Fig. 57-1).

B. Side an d adverse effects 1. Dysrh yth m ias 2. Hypo ten sion 3. Th rom b ocytopen ia 4. Hepatoto xicity m an ifested by elevated liver

en zym e levels 5. Hypersen sitivity m an ifested by wh eezin g, sh ort-

n ess of breath , pruritus, urticaria, clam m y skin , an d flush in g

C. In terven tion s 1. Positive in otrop ic an d cardioto n ic m ed ication s

are used for in traven ous (IV) adm in istration .

a . For co n tin uou s IV in fusio n , ad m in ister with an in fusion pum p.

b . Stop th e in fusion if th e clien t’s blood pressure (BP) drops or dysrh yth m ias occur.

c. In am rin on e sh o uld n ot be m ixed with gluco se-con tain in g solution s.

2. Mon itor th e apical pulse an d BP. 3. Mon itor for h ypersen sitivity. 4. Assess lun g soun ds for wh eezin g an d crackles. 5. Mon itor for edem a. 6. Mon itor for relief of h eart failure as n oted by

reduction in edem a an d lessen in g of dyspn ea, orth o pn ea, an d fatigue.

7. Mon itor electrolyte an d liver en zym e levels, plate- let coun t, an d ren al fun ction studies; th e m edica- tion s m ay decrease potassium an d in crease liver en zym e levels; con tin uous electrocardiograph ic m on itorin g is don e durin g ad m in istration .

V. Cardiac Glycosides A. Digoxin B. Description

1. Card iac glycosides in h ibit th e sodium -potassium pum p, th u s in creasin g in tracellular calcium , wh ich cau ses th e h eart m uscle fibers to co n tract m ore efficien tly.

2. Card iac glycosides produ ce a positive in otropic action , wh ich in creases th e force of m yocardial con traction s.

3. Card iac glycosides produ ce a n egative ch ron otro- pic action , wh ich slows th e h eart rate.

4. Card iac glycosides produ ce a n egative drom o tro- pic action th at slows con duction velocity th rou gh th e atrioven tricular (AV) n ode.

5. Th e in crease in m yocardial con tractility in creases cardiac, periph eral, an d kidn ey fun ction by in creasin g cardiac output, decreasin g preload, im provin g blood flow to th e periph ery an d kid- n eys, decreasin g edem a, an d in creasin g fluid excretion ; as a result, fluid reten tion in th e lun gs an d extrem ities is decreased.

6. Card iac glycosides are used secon d-lin e for h eart failure (m edication s affectin g th e ren in - an gio ten sin -aldo steron e system are used m ore often ) an d cardiogen ic sh ock, atrial tach ycardia, atrial fibrillation , an d atrial flu tter; th ey are used less frequen tly for rate con trol in atrial dysrh yth - m ias (beta blockers an d calcium ch an n el blockers are used m ore often ).

7. Th ese m ed ication s are con train dicated in th ose with ven tricular dysrh yth m ias an d secon d- or th ird-degree h eart block an d sh ould be used with cau tion in clien ts with ren al disease, h ypo th y- roid ism , an d h ypokalem ia.

C. Side an d adverse effects 1. An o rexia, n ausea, vom itin g, diarrh ea 2. Bradycardia

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-5 Positive Inotropic and Cardiotonic Medications

Dopamine ▪ Used as a short-term rescue measure for clients with

severe, acute heart failure ▪ Increases myocardial contractility, thereby improving car-

diac performance ▪ Dilates renal blood vessels and increases renal blood flow

and urine output

Dobutamine ▪ Used for short-term management of heart failure ▪ Increases myocardial contractility, thereby improving car-

diac performance

Milrinone Lactate ▪ Used for short-term management of heart failure; may be

given before heart transplantation

Ca rdia c re mode ling

Re duce d ca rdia c output

“Compe ns a tory” re s pons e s

↑ He a rt ra te ↑ Ve nous pre s s ure ↑ Arte ria l pre s s ure

Ca rdia c dila tion Activa tion of the s ympa the tic ne rvous s ys te m Activa tion of the re nin-a ngiote ns in-a ldos te rone s ys te m Re te ntion of wa te r a nd incre a s e d blood volume

1. 2.

3.

4.

FIGURE 57-1 The vicious cycle of maladaptive compensatory responses to a failing heart.

800 UNIT XIII Cardiovascular Disorders of the Adult Client

3. Visual disturban ces: Diplop ia, blurred vision , yello w vision , ph otop h obia

4. Headach e 5. Fatigue, weakn ess 6. Drowsin ess

Early signs of digoxin toxicity present as gastrointes- tinal manifestations (anorexia, nausea, vomiting, diar- rhea); then, heart rate abnormalities and visual disturbances appear.

D. In terven tion s 1. Mon itor for toxicity as eviden ced by an orexia,

n ausea, vo m itin g, visu al disturban ces (blurred or yello w vision ) , an d dysrh yth m ias.

2. Mon itor serum digo xin level, electrolyte levels, an d ren al fun ction test results.

3. Th e optim al th erapeutic ran ge for digoxin is 0.5 to 0.8 n g/ m L.

4. An in creased risk of toxicity exists in clien ts with h ypercalcem ia, h ypo kalem ia, h ypo m agn ese- m ia, or h ypoth yroidism .

5. Mon itor th e potassium level; if h ypo kalem ia occurs (po tassium lo wer th an 3.5 m Eq/ L [3.5 m m o l/ L]), n otify th e HCP.

6. In struct th e clien t to avoid over-th e-coun ter m ed ication s.

7. Monitor the clien t takin g a potassium -losing diuretic or corticosteroids closely for hypokalem ia, because the h ypokalem ia can cause digoxin toxicity.

8. No te th at older clien ts are m ore sen sitive to digoxin toxicity.

9. Advise th e clien t to eat food s h igh in potassiu m , such as fresh an d dried fruits, fruit juices, vege- tab les, an d potatoes.

10. Mon itor th e ap ical pulse for 1 full m in u te; if th e ap ical pulse rate is lower th an 60 beats/ m in u te, th e m ed ication sh ould be with h eld an d th e HCP n otified.

11. Teach th e clien t h ow to m easu re th e pulse an d to n otify th e HCP if th e pulse rate is lower th an 60 or m ore th an 100 beats/ m in ute.

12. Teach th e clien t th e sign s an d sym ptom s of toxicity.

13. An tidote: Digoxin im m un e Fab is used in extrem e toxicity.

VI. Antihypertensive Medications: Diuretics (Box 57-6) A. Th iazide diuretics (Box 57-7)

1. Descriptio n

a . Th iazide diuretics in crease sodium an d water excretion by in h ibitin g sodium reabsorptio n in th e distal tubu le of th e kidn ey.

b . Used for h yperten sio n an d periph eral edem a c. Not effective for im m ediate diuresis d . Used in clien ts with n orm al ren al

fun ction (con train dicated in clien ts with ren al failure)

e. Th iazide diuretics sh ould be used with cau- tion in th e clien t takin g lith iu m , because lith - ium toxicity can occur, an d in th e clien t takin g digo xin , cortico steroids, or h ypoglyce- m ic m ed ication s.

2. Sid e an d ad verse effects a . Hypercalcem ia, h yperglycem ia, h yperuricem ia b . Hypokalem ia, h ypon atrem ia c. Hypovolem ia d . Hypoten sion e. Rash es f. Ph otosen sitivity g. Deh ydration

3. In terven tion s a. Mon itor vital sign s. b . Mon itor weigh t. c. Mon itor urin e outp ut. d . Mon itor electrolytes, glucose, calcium , blood

urea n itrogen (BUN), creatin in e, an d uric acid levels.

e. Ch eck periph eral extrem ities for edem a. f. Mon itor for sign s of digoxin or lith ium

toxicity if th e clien t is takin g th ese m edication s.

g. In struct th e clien t to take th e m ed ication in th e m orn in g to avoid n octuria an d sleep in terrup tion .

h . In struct th e clien t in h ow to record th e BP. i. In struct th e clien t to eat food s h igh in

potassium . j. In struct th e clien t in h ow to take potassium

supplem en ts if prescribed. k . In struct th e clien t to take m ed ication with

food to avoid gastro in testin al upset. l. In struct th e clien t to ch an ge position s slowly

to preven t orthostatic hypotension. m . In struct th e clien t to use sun screen wh en in

direct sun ligh t because of in creased ph otosen sitivity.

n . In struct th e clien t with diabetes m ellitus to h ave th e blood gluco se level ch ecked periodically.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-6 Classifications of Diuretics

▪ Loop diuretics ▪ Osmotic diuretics

▪ Potassium-retaining diuretics

▪ Thiazide diuretics

BOX 57-7 Thiazide and Thiazide-Like Diuretics

▪ Chlorothiazide ▪ Chlorthalidone ▪ Hydrochlorothiazide

▪ Indapamide ▪ Metolazone

801CHAPTER 57 Cardiovascular Medications

B. Loo p diuretics ( Box 57-8) 1. Description

a. Loop diuretics in h ibit sodium an d ch loride reabsorp tio n from th e loop of Hen le an d th e distal tubule.

b . Loop diuretics h ave little effect on th e blood gluco se level; h owever, th ey cause depletion of water an d electrolytes, in creased uric acid levels, an d th e excretion of calcium .

c. Loop diuretics are m ore poten t th an th iazide diuretics, cau sin g rapid diuresis, an d th us decreasin g vascular fluid volum e, cardiac out- put, an d BP.

d . Used for h yperten sion , pulm o n ary edem a, edem a associated with h eart failure, h ypercal- cem ia, an d ren al disease

e. Use loop diuretics with cau tion in th e clien t takin g digoxin or lith ium an d in th e clien t takin g am in oglycosides, an ticoagulan ts, cor- ticosteroids, or am ph otericin B.

2. Sid e an d ad verse effects a. Hypo kalem ia, h ypo n atrem ia, h ypo calcem ia,

h ypo m agn esem ia b . Th rom b ocytopen ia c. Hyperuricem ia d . O rth o static h ypo ten sion e. Rash f. O toto xicity an d deafn ess g. Th iam in e deficien cy h . Deh ydration

3. In terven tion s: See section VI, A, 3 (In terven tion s for th iazide diuretics). a. Mon itor electrolytes, calcium , m agn esium ,

BUN, creatin in e, an d uric acid levels. b . Adm in ister IV furosem ide slowly over 1 to

2 m in utes because h earin g loss can occur if in jected rapidly.

C. O sm o tic diuretics: See Ch apter 63. D. Potassium -retain in g diuretics (Box 57-9)

1. Description a. Potassium -retain in g diuretics act on th e distal

tubu le to prom o te sodium an d water excre- tion an d potassium reten tion .

b . Used for edem a an d h yperten sion , to in crease urin e output, an d to treat fluid reten tion an d overload associated with h eart failure, ascites resultin g from cirrh osis or n eph rotic syn - drom e, an d diuretic-in duced h ypokalem ia.

c. Potassium -retain in g diuretics are co n train d i- cated in severe kidn ey or h epatic disease an d in severe h yperkalem ia.

d . Potassium -retain in g diuretics sh o uld be used with caution in th e clien t with diab etes m el- litus, takin g an tih yp erten sives or lith ium , or takin g an gio ten sin -co n vertin g en zym e in h ib- itors or potassium supp lem en ts because h yperkalem ia can result.

The primary concern with administering potassium- retaining diuretics is hyperkalemia.

2. Side an d ad verse effects a . Hyperkalem ia b . Nausea, vom itin g, diarrh ea c. Rash d . Dizzin ess, weakn ess e. Headach e f. Dry m outh g. Ph otosen sitivity h . An em ia i. Th rom b ocytopen ia

3. In terven tion s a . Mon itor vital sign s. b . Mon itor urin e outp ut. c. Mon itor for sign s an d sym pto m s of h yperka-

lem ia such as n ausea; diarrh ea; ab dom in al cram p s; tach ycardia followed by bradycardia; tall, peaked T waves on th e electrocardio- gram ; an d oliguria.

d . Mon itor for a potassium level greater th an 5.0 m Eq/ L (5.0 m m o l/ L), wh ich in dicates h yperkalem ia.

e. In struct th e clien t to avoid food s h igh in potassium .

f. In struct th e clien t to avoid exposure to direct sun ligh t.

g. In struct th e clien t to m on itor for sign s of h yperkalem ia.

h . In struct th e clien t to avoid salt substitutes because th ey co n tain potassium .

i. In struct th e clien t to take th e m edication with or after m eals to decrease gastro in testin al irritatio n .

VII. Peripherally Acting α-Adrenergic Blockers (Box 57-10)

A. Descrip tion 1. Th ese m ed ication s decrease sym path etic vaso-

con striction by reducin g th e effects of n orepi- n eph rin e at periph eral n erve en din gs, resultin g in vasodilation an d decreased BP.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-8 Loop Diuretics

▪ Bumetanide ▪ Ethacrynic acid

▪ Furosemide ▪ Torsemide

BOX 57-9 Potassium-Retaining Diuretics ▪ Amiloride hydrochloride; hydrochlorothiazide ▪ Eplerenone ▪ Spironolactone ▪ Spironolactone; hydrochlorothiazide ▪ Triamterene

802 UNIT XIII Cardiovascular Disorders of the Adult Client

2. Th ese m ed ication s are used to m ain tain ren al blood flow.

3. Th ese m edication s are used to treat h yperten sion . B. Side an d ad verse effects

1. O rth ostatic h ypoten sion 2. Reflex tach ycardia 3. Sodium an d water reten tion 4. Edem a 5. Weigh t gain 6. Gastroin testin al disturban ces 7. Drowsin ess 8. Nasal co n gestion

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor for fluid reten tion an d edem a. 3. In struct th e clien t to ch an ge position s slowly to

preven t orth ostatic h ypoten sion . 4. In struct th e clien t in h ow to m on itor th e BP. 5. In struct th e clien t to m on itor for edem a. 6. In struct th e clien t to decrease salt in take. 7. In struct th e clien t to avoid over-th e-coun ter

m ed ication s.

VIII. Centrally Acting Sympatholytics (Adrenergic Blockers) (Box 57-11)

A. Description 1. Cen trally actin g sym path olytics stim ulate

α-recep tors in th e cen tral n ervou s system to in h ibit vaso con striction , th us reducin g periph - eral resistan ce.

2. Used to treat h yperten sion 3. Con train dicated in im paired liver fun ction

B. Side an d ad verse effects 1. Sodium an d water reten tion 2. Edem a 3. Drowsin ess, dizzin ess 4. Dry m ou th 5. Hypo ten sion 6. Bradycardia 7. Im p oten ce 8. Depression

C. In terven tion s 1. Mon itor vital sign s. 2. In struct th e clien t n ot to discon tin ue m ed ication

because abrupt with drawal can cau se severe rebou n d h yperten sion .

3. Mon itor liver fun ction tests.

IX. Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) (Box 57-12)

A. Description 1. ACE in h ibitors preven t periph eral vaso con stric-

tion by blockin g con version of an gioten sin I to an gio ten sin II (AII).

2. ARBs preven t periph eral vasocon striction an d secretio n of aldo steron e an d block th e bin din g of AII to typ e 1 AII receptors.

3. Th ese m ed ication s are used to treat h yperten sion an d h eart failure; also, ACE in h ibitors are adm in - istered for th eir cardiop rotective effect after m yo- cardial in farction .

4. Avoid use with potassiu m supplem en ts an d potassium -retain in g diuretics.

B. Side an d adverse effects 1. Nausea, vo m itin g, diarrh ea 2. Persisten t dry co ugh (ACE in h ibito rs on ly) 3. Hypo ten sion 4. Hyperkalem ia 5. Tach ycardia 6. Headach e 7. Dizzin ess, fatigue 8. In som n ia 9. Hypo glycem ic reaction in th e clien t with diab e-

tes m ellitus 10. Bruisin g, petech iae, bleed in g 11. Dim in ish ed taste (ACE in h ibitors)

A persistent dry cough is a common complaint for those taking an ACE inhibitor, but this often subsides after a few weeks. Instruct the client to contact the HCP if this occurs and persists.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-10 Peripherally Acting α-Adrenergic Blockers

▪ Doxazosin ▪ Prazosin ▪ Terazosin

BOX 57-11 Centrally Acting Sympatholytics (Adrenergic Blockers)

▪ Clonidine ▪ Guanfacine ▪ Methyldopa

BOX 57-12 Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers

Angiotensin-Converting Enzyme Inhibitors ▪ Benazepril ▪ Captopril ▪ Fosinopril ▪ Enalapril ▪ Lisinopril ▪ Moexipril ▪ Perindopril ▪ Quinapril ▪ Ramipril ▪ Trandolapril

Angiotensin II Receptor Blockers ▪ Candesartan ▪ Eprosartan ▪ Irbesartan ▪ Losartan ▪ Olmesartan ▪ Telmisartan ▪ Valsartan

803CHAPTER 57 Cardiovascular Medications

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor wh ite blood cells, an d protein , albu-

m in , BUN, creatin in e, an d potassium levels. 3. Mon itor for h ypo glycem ic reactio n s in th e cli-

en t with diabetes m ellitus. 4. If cap topril is prescribed , in struct th e clien t to

take th e m edication 20 to 60 m in u tes before a m eal.

5. Mon itor for bruisin g, petech iae, or bleedin g with captopril.

6. In struct th e clien t n ot to discon tin u e m edica- tion s because rebou n d h yperten sio n can occur.

7. In struct th e clien t n ot to take over-th e-cou n ter m ed ication s.

8. In struct th e clien t in h ow to take th e BP. 9. In form th e clien t th at th e taste of food m ay be

dim in ish ed durin g th e first m on th of th erap y. 10. In struct th e clien t to report adverse effects to

th e HCP.

X. Antianginal Medications (Box 57-13) A. Nitrates (see Priority Nursin g Action s)

1. Description a. Nitrates produ ce vasodilation , decrease pre-

load an d afterload, an d reduce m yocardial oxygen con sum ption .

b . Con train dicated in th e clien t with sign ifican t h ypo ten sion , in creased in tracran ial pressure, or severe an em ia, an d in th o se takin g m edica- tion to treat erectile dysfun ction

c. Sh ould be used with cau tion with severe ren al or h epatic disease

d . Avoid ab rupt with drawal of lo n g-actin g prep- aration s to preven t th e rebou n d effect of severe pain from m yocardial isch em ia.

2. Side an d ad verse effects a. Headach e b . O rth o static h ypo ten sion c. Dizzin ess, weakn ess d . Fain tn ess e. Flush in g or pallor f. Dry m ou th g. Reflex tach ycardia

3. Sublin gu al m edication s a . Mon itor vital sign s. b . O ffer sips of water befo re givin g because dry-

n ess m ay in h ibit m ed ication ab sorption . c. In struct th e clien t to place un der th e ton gue

an d leave un til fully dissolved . d . In struct th e clien t n ot to swallow th e

m edication . e. In struct th e at-h om e clien t to take 1 tab let for

pain an d to im m ediately con tact em ergen cy m edical services if pain is n ot relieved; in th e h ospitalized clien t, 1 tablet is adm in is- tered every 5 m in utes for a total of 3 doses

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-13 Antianginal Medications (Organic Nitrates)

▪ Isosorbide dinitrate ▪ Isosorbide mononitrate ▪ Nitroglycerin, sublingual ▪ Nitroglycerin, translingual ▪ Nitroglycerin, transdermal patches ▪ Nitroglycerin ointment ▪ Intravenous nitroglycerin

PRIORITY NURSING ACTIONS Chest Pain in a Hospitalized Client with Cardiac Disease

1. Quickly assess the client, specifically characteristics of pain, heart rate and rhythm, and blood pressure (BP).

2. Administer a nitroglycerin tablet sublingually. 3. Stay with the client. 4. Reassess in 5 minutes. 5. Administer another nitroglycerin tablet sublingually if

pain is not relieved and the BP is stable. 6. Reassess in 5 minutes. 7. Administer a third nitroglycerin tablet sublingually if pain

is not relieved and the BP is stable. 8. Reassess in 5 minutes; contact the health care provider

(HCP) if the third nitroglycerin tablet does not relieve the pain.

9. Document the event, actions taken, and the client’s response to treatment.

The usual guidelines for administering nitroglycerin tab- lets for chest pain to a hospitalized client include administer- ing 1 tablet every 5 minutes PRN (as needed) for chest pain, for a total dose of 3 tablets. If the client does not obtain relief after taking a third dose of nitroglycerin, the HCP is notified. Before administering the first dose of nitroglycerin, the nurse quickly assesses the client, specifically the characteristics of the pain, the heart rate and rhythm, and BP. The nurse always stays with the client during the event to provide reassurance and to relieve anxiety. In addition, the nurse needs to be pre- sent if a life-threatening situation develops. The nurse assesses the client before administering each subsequent dose of nitroglycerin and pays particular attention to the BP, because nitroglycerin causes hypotension. The nurse needs to lower the head of the bed and contact the HCP before administering another nitroglycerin if hypotension occurs. Agency protocols for this type of event should also be followed. The nurse documents the event, actions taken, and the client’s response to treatment.

References Ignatavicius, Workman (2016), p. 764; Burchum, Rosenthal (2016),

pp. 586, 592–593.

804 UNIT XIII Cardiovascular Disorders of the Adult Client

an d th e HCP is n otified im m ediately if pain is n ot relieved followin g th e 3 doses (th e BP is ch ecked before each ad m in istration ).

f. In form th e clien t th at a stingin g or burn in g sen - sation m ay in dicate th at th e tablet is fresh .

g. In struct th e clien t to store m ed ication in a dark, tigh tly closed bottle.

h . In struct th e clien t to take acetam in oph en for a h ead ach e.

4. Tran slin gual m edication s (sp ray) a . In struct th e clien t to direct th e spray again st

th e oral m ucosa. b . In struct th e client to avoid in h aling th e spray.

5. Sustain ed-released m edication s: In struct th e cli- en t to swallow an d n ot to ch ew or crush th e m ed ication .

6. Tran sderm al patch a . In struct th e clien t to apply th e patch to a h air-

less area, usin g a n ew patch an d differen t site each day.

b . As prescribed, in struct th e clien t to rem ove th e patch after 12 to 14 h ours, allowin g 10 to 12 “patch -free” h ours each day to preven t toleran ce.

7. To pical oin tm en ts a . In struct th e clien t to rem ove th e oin tm en t on

th e skin from th e previous dose. b . In struct th e clien t to squeeze a ribbon of oin t-

m en t of th e prescribed len gth on to th e appli- cator or dose-m easurin g paper.

c. In struct th e clien t to spread th e oin tm en t over a 2.5- Â 3.5-in ch (6.5 x 9 cm ) area an d cover with plastic wrap, usin g th e ch est, back, ab do- m en , upper arm , or an terior th igh (avoid h airy areas).

d . In struct th e clien t to rotate sites an d to avoid touch in g th e oin tm en t wh en applyin g.

8. Patch es an d oin tm en ts a . Wear gloves wh en ap plyin g. b . Do n ot ap ply on th e ch est in th e area of

defibrillator-cardioverter pad placem en t because skin burn s can result if th e pads n eed to be used.

Instruct the client using nitroglycerin tablets to check the expiration date on the medication bottle because expiration may occur within 6 months of obtain- ing the medication. The tablets will not relieve chest pain if they have expired.

XI. β-Adrenergic Blockers (Box 57-14) A. Description

1. β-Adren ergic blockers in h ibit respo n se to β- ad ren ergic stim ulation , th u s decreasin g cardiac outp ut.

2. Th ey block th e release of catech o lam in es, epi- n eph rin e, an d n orepin eph rin e, th us decreasin g

th e h eart rate an d BP; th ey also decrease th e workload of th e h eart an d decrease oxygen dem an ds.

3. Used for an gin a, dysrh yth m ias, h yperten sion , m igrain e h eadach es, preven tion of m yocardial in farction , an d glaucom a

4. β-Adren ergic blockers are con train dicated in th e clien t with asth m a, bradycardia, h eart failure (with exception s), severe ren al or h epatic disease, h yperth yroidism , or stroke; carvedilol, m etopro- lol, an d bisopro lo l h ave been approved for use in h eart failure on ce th e clien t h as been stabilized by ACE in h ibitor an d diuretic th erap y.

5. β-Adren ergic blockers sh o uld be used with cau- tion in th e clien t with diabetes m ellitus because th e m ed ication m ay m ask sym ptom s of h ypo glycem ia.

6. β-Adrenergic blockers sh ould be used with caution in th e clien t takin g an tih yperten sive m edication s.

B. Side an d adverse effects 1. Bradycardia 2. Bron ch ospasm 3. Hypo ten sion 4. Weakn ess, fatigue 5. Nausea, vo m itin g 6. Dizzin ess 7. Hyperglycem ia 8. Agran ulocytosis 9. Beh avioral or psych otic respon se

10. Depression 11. Nigh tm ares

C. In terven tion s 1. Mon itor vital sign s. 2. With h old th e m ed ication if th e pulse or BP is

n ot with in th e prescribed param eters. 3. Mon itor for sign s of h eart failure or worsen in g

h eart failure. 4. Assess for respiratory distress an d for sign s of

wh eezin g an d dyspn ea. 5. In struct th e clien t to report dizzin ess, ligh th ead-

edn ess, or n asal con gestion . 6. In struct th e clien t n ot to stop th e m edication

because rebou n d h yperten sio n , rebou n d tach y- cardia, or an an gin al attack can occur.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-14 β-Adrenergic Blockers Nonselective (Block β1 and β2) ▪ Carvedilol ▪ Labetalol ▪ Nadolol ▪ Penbutolol ▪ Pindolol ▪ Propranolol ▪ Sotalol

Cardioselective (Block β1) ▪ Acebutolol ▪ Atenolol ▪ Betaxolol ▪ Bisoprolol ▪ Esmolol ▪ Metoprolol ▪ Nebivolol

805CHAPTER 57 Cardiovascular Medications

7. Advise th e clien t takin g in sulin th at th e β- adren ergic blocker can m ask early sign s of h ypo glycem ia, such as tach ycardia an d n ervou sn ess.

8. In struct th e clien t takin g in sulin to m on itor th e blood glucose level.

9. In struct th e clien t in h ow to take pulse an d BP. 10. In struct th e clien t to ch an ge position s slowly to

preven t orth ostatic h ypoten sion . 11. In struct th e clien t to avoid over-th e-cou n ter

m ed ication s, especially cold m ed ication s an d n asal deco n gestan ts.

XII. Calcium Channel Blockers (Box 57-15) A. Description

1. Calcium ch an n el blockers decrease cardiac co n - tractility (n egative in otrop ic effect by relaxin g sm oo th m uscle) an d th e workload of th e h eart, th u s decreasin g th e n eed for oxygen .

2. Calcium ch an n el blockers prom o te vaso dilation of th e coron ary an d periph eral vessels.

3. Used for an gin a, dysrh yth m ias, or h yperten sion 4. Sh o uld be used with caution in th e clien t with

h eart failure, bradycardia, or atrioven tricular block

B. Side an d adverse effects 1. Bradycardia 2. Hypo ten sion 3. Reflex tach ycardia as a result of h ypoten sion 4. Headach e 5. Dizzin ess, ligh th ead edn ess 6. Fatigue 7. Periph eral edem a 8. Con stipation 9. Flush in g of th e skin

10. Ch an ges in liver an d kidn ey fun ction C. In terven tion s

1. Mon itor vital sign s. 2. Mon itor for sign s of h eart failure. 3. Mon itor liver en zym e levels. 4. Mon itor kidn ey fun ction tests. 5. In struct th e clien t n ot to discon tin ue th e

m ed ication . 6. In struct th e clien t in h ow to take th e pulse. 7. In struct th e clien t to n otify th e HCP if dizzin ess

or fain tin g occurs. 8. In struct th e clien t n ot to crush or ch ew sustain ed-

release tablets.

XIII. Peripheral Vasodilators (Box 57-16) A. Descrip tion

1. Periph eral vaso dilators decrease periph eral resis- tan ce by exertin g a direct action on th e arteries or on th e arteries an d th e vein s.

2. Th ese m edication s in crease blood flow to th e extrem ities an d are used in periph eral vascu lar disorders of ven o us an d arterial vessels.

3. Periph eral vaso dilato rs are m ost effective for dis- orders resultin g from vaso spasm (Rayn aud’s disease).

4. Th ese m ed ication s m ay decrease som e sym p- tom s of cerebral vascular in sufficien cy.

B. Side an d adverse effects 1. Ligh th eadedn ess, dizzin ess 2. O rth o static h ypo ten sion 3. Tach ycardia 4. Palpitation s 5. Flush in g 6. Gastro in testin al distress

C. In terven tion s 1. Mon itor vital sign s, esp ecially th e BP an d th e

h eart rate. 2. Mon itor for orth o static h ypoten sion an d

tach ycardia. 3. Mon itor for sign s of in adequate blood flow to th e

extrem ities, such as pallor, feelin g cold, and pain . 4. In struct th e clien t th at it m ay take up to 3 m on th s

for a desired th erapeutic respo n se. 5. Advise th e clien t n ot to sm oke because sm okin g

in creases vasospasm . 6. In struct th e clien t to avoid aspirin or aspirin -like

com po un ds un less ap proved by th e HCP. 7. In struct th e clien t to take th e m ed ication with

m eals if gastro in testin al disturban ces occur. 8. In struct th e clien t to avoid alcoh ol because it

m ay cau se a h ypo ten sive reaction . 9. En cou rage th e clien t to ch an ge position s slowly

to avoid orth o static h ypo ten sion .

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-15 Calcium Channel Blockers

▪ Amlodipine ▪ Clevidipine ▪ Diltiazem ▪ Felodipine ▪ Isradipine

▪ Nicardipine ▪ Nifedipine ▪ Nimodipine ▪ Nisoldipine ▪ Verapamil

BOX 57-16 Peripheral Vasodilators α-Adrenergic Blockers ▪ Doxazosin ▪ Prazosin ▪ Terazosin Calcium Channel Blockers ▪ Diltiazem ▪ Nifedipine ▪ Nimodipine ▪ Verapamil Hemorheological ▪ Pentoxifylline (increases microcirculation and tissue

perfusion)

806 UNIT XIII Cardiovascular Disorders of the Adult Client

XIV. Direct-Acting Arteriolar Vasodilators (Box 57-17) A. Description

1. Direct-actin g vasodilato rs relax th e sm oo th m us- cles of th e blood vessels, m ain ly th e arteries, cau sin g vasodilation ; with vaso dilation , th e BP drops an d sodium an d water are retain ed , result- in g in periph eral edem a (diuretics m ay be given to decrease th e edem a).

2. Direct-actin g vasodilators prom o te an in crease in blood flow to th e brain an d kidn eys.

3. Th ese m ed ication s are used in th e clien t with m od erate to severe h yperten sio n an d for acu te h yperten sive em ergen cies.

B. Side an d ad verse effects 1. Hypo ten sion 2. Reflex tach ycardia caused by vasodilation an d

th e drop in BP 3. Palpitation s 4. Edem a 5. Dizzin ess 6. Headach es 7. Nasal con gestion 8. Gastroin testin al bleedin g 9. Neurological sym ptom s

10. Con fusion 11. With sodium n itroprusside, cyan id e toxicity

an d th iocyan ate toxicity can occur. C. In terven tion s

1. Mon itor vital sign s, especially BP. 2. Sodium n itroprusside

a . Mon itor cyan ide an d th iocyan ate levels. b . Protect fro m ligh t because th e m ed ication

deco m poses. c. Wh en adm in isterin g, solution m ust be cov-

ered by a dark bag provid ed by th e m an u fac- turer an d is stable for 24 h ou rs.

d . Discard if th e m edication is red, green , or blue.

Vasodilators cause orthostatic hypotension. Instruct the client about safety measures when taking these medications, such as the need to rise from a lying to a sitting or standing position slowly.

XV. Miscellaneous Vasodilator A. Description

1. Nesiritide a . Recom bin an t version of h um an B-type n atri-

uretic peptid e th at vaso dilates arteries an d vein s

b . Used for th e treatm en t of decom pen sated h eart failure

2. Side an d ad verse effects a. Hypoten sion b . Con fusion c. Dizzin ess d . Dysrh yth m ias

3. In terven tion s a. Adm in ister by con tin uous IV in fusion via

in fusio n device b . Mon itor BP, cardiac rh yth m , urin e output,

an d body weigh t. c. Mon itor for sign s of resolvin g h eart failure.

XVI. Antidysrhythmic Medications A. Description : An tidysrh yth m ic m edication s supp ress

dysrh yth m ias by in h ibitin g ab n orm al path ways of electrical con d uction th rou gh th e h eart.

B. Class I an tidysrh yth m ics are sodium ch an n el blockers, class II are beta blockers, class III are potas- sium ch an n el blockers (m edication s th at delay repo- larization ), an d class IV are calcium ch an n el blockers.

C. Class IA an tidysrh yth m ics 1. Diso pyram ide 2. Procain am ide 3. Q uin id in e sulfate

D. Class IB an tidysrh yth m ics 1. Lidocain e 2. Mexiletin e h ydroch loride 3. Ph en ytoin

E. Class IC an tidysrh yth m ics 1. Flecain ide acetate 2. Propafen on e h ydroch loride 3. Side an d adverse effects: Class I an tidysrh yth m ics

a . Hypoten sion b . Heart failure c. Worsen ed or n ew dysrh yth m ias d . Nausea, vom itin g, or diarrh ea

F. Class II an tidysrh yth m ics 1. Acebu tolol 2. Esm olo l 3. Propran olol 4. Meto prolol 5. Nado lol 6. Aten olol 7. Side an d adverse effects: Class II an tidys-

rh yth m ics a . Dizzin ess b . Fatigue c. Hypoten sion d . Bradycardia e. Heart failure f. Dysrh yth m ias g. Heart block h . Bron ch ospasm s i. Gastroin testin al distress

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-17 Direct-Acting Arteriolar Vasodilators

▪ Diazoxide ▪ Fenoldopam ▪ Hydralazine

▪ Nitroglycerin ▪ Sodium nitroprusside

807CHAPTER 57 Cardiovascular Medications

G. Class III an tidysrh yth m ics 1. Am iodaron e 2. Dofetilide 3. Ibu tilide 4. Sotalol 5. Side an d ad verse effects: Class III an tidys-

rh yth m ics a. Hypoten sion b . Bradycardia c. Nausea, vom itin g d . Am iodaron e h ydroch loride m ay cause pul-

m on ary fibrosis, ph otosen sitivity, bluish skin discoloration , corn eal dep osits, periph eral n europath y, trem o r, poor coordin ation , abn orm al gait, an d h ypo th yroidism .

e. Th e electrocardiogram sh ould be m on itored for clien ts receivin g am iodaron e or dofetilide because th ey m ay prolon g th e Q T in terval, poten tially leadin g to torsades de poin tes.

H. Class IV an tidysrh yth m ics 1. Verapam il 2. Diltiazem 3. Side an d ad verse effects: Class IV an tidys-

rh yth m ics a. Dizzin ess b . Hypoten sion c. Bradycardia d . Edem a e. Con stipation

I. O th er an tidysrh yth m ics 1. Aden osin e 2. Digoxin

J. In terven tion s for an tidysrh yth m ics 1. Mon itor h eart rate, respiratory rate, an d BP. 2. Mon itor electrocardiogram . 3. Provide con tin uo us cardiac m on itorin g. 4. Main tain th erapeutic serum m ed ication levels. 5. Before adm in isterin g lido cain e, always ch eck

th e vial label to preven t ad m in isterin g a form th at con tain s epin eph rin e or preservatives because th ese solution s are used for local an esth esia on ly.

6. Do n ot adm in ister an tidysrh yth m ics with food because food m ay affect absorption .

7. Mexiletin e m ay be ad m in istered with food or an tacids to reduce gastro in testin al distress.

8. Always ad m in ister IV an tidysrh yth m ics via an in fusion pum p.

9. Mon itor for sign s of fluid reten tion such as weigh t gain , periph eral edem a, or sh ortn ess of breath .

10. Advise th e clien t to lim it flu id an d salt in take to m in im ize fluid reten tion .

11. Mon itor respiratory, th yroid, an d n eurological fun ction s.

12. In struct th e clien t to ch an ge position s slowly to m in im ize orth ostatic h ypoten sion .

13. In struct th e clien t takin g am iodaron e to use sun screen an d protective clo th in g to preven t ph otosen sitivity reactio n s.

14. En cou rage th e clien t to in crease fiber in take to preven t con stipatio n .

XVII. Adrenergic Agonists (Box 57-18) A. Dobutam in e

1. In creases m yocardial force an d cardiac output th rou gh stim ulation of β-recep tors

2. Used in clien ts with h eart failure an d for clien ts un dergoin g cardiop ulm on ary bypass surgery

B. Dopam in e 1. In creases BP an d cardiac output th rough

positive in otrop ic action an d in creases ren al blood flo w th rough its action on α- an d β-recep tors

2. Used to treat m ild kidn ey failure caused by low cardiac outp ut

C. Epin eph rin e 1. Used for cardiac stim ulation in cardiac arrest 2. Used for bron ch od ilation in asth m a or allergic

reaction s 3. Produ ces m ydriasis 4. Produ ces local vasocon striction wh en com bin ed

with local an esth etics an d prolon gs an esth etic action by decreasin g blood flow to th e site

D. Isoproteren ol 1. Stim ulates β-receptors 2. Used for cardiac stim ulation an d bron ch o-

dilation E. Norepin eph rin e

1. Stim ulates th e h eart in cardiac arrest 2. Vasocon stricts an d in creases th e BP in h ypo ten -

sion an d sh ock F. Side an d adverse effects

1. Dysrh yth m ias 2. Tach ycardia 3. An gin a 4. Restlessn ess 5. Urgen cy or urin ary in con tin en ce

G. In terven tion s 1. Mon itor vital sign s. 2. Mon itor lun g soun ds. 3. Mon itor urin ary outp ut. 4. Mon itor electrocardiogram . 5. Adm in ister th e m ed ication th rou gh a large vein .

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

BOX 57-18 Adrenergic Agonists

▪ Dobutamine ▪ Dopamine ▪ Epinephrine

▪ Isoproterenol ▪ Norepinephrine

808 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

XVIII. Antilipemic Medications A. Description

1. An tilipem ic m ed ication s reduce serum levels of ch olesterol, triglycerides, or low-den sity lipo protein .

2. Wh en ch olesterol, triglycerid e, an d low-den sity lipo protein levels are elevated , th e clien t is at in creased risk for coron ary artery disease.

3. In m an y cases, diet alon e will n ot lower blood lipid levels; th erefore, an tilip em ic m ed ication s will be prescribed.

B. Bile sequestran ts (see Ch apter 53, Box 53-3) 1. Descriptio n

a . Bin d with acids in th e in testin es, wh ich pre- ven ts reabsorption of ch olestero l

b . Sh o uld n ot be used as th e on ly th erap y in cli- en ts with elevated triglyceride levels because th ey m ay raise triglyceride levels

2. Sid e an d adverse effects a . Con stipation b . Gastroin testin al disturban ces: Heartb urn ,

n ausea, belch in g, bloatin g 3. In terven tion s

a . Ch o lestyram in e com es in a gritty powder th at m ust be m ixed th orough ly in juice or water befo re ad m in istration .

b . Monitor the clien t for early sign s of peptic ulcer such as n ausea an d abdom in al discom fort followed by abdom in al pain an d disten tion .

c. In struct th e clien t th at th e m edication m ust be taken with an d followed by sufficien t fluids.

C. HMG-CoA reductase in h ibitors ( Box 57-19) 1. Descriptio n

a . Lovastatin is h igh ly protein-boun d an d sh ould n ot be adm in istered with anticoagulan ts.

b . Lovastatin sh ould n ot be ad m in istered with gem fibrozil.

c. Adm in ister lo vastatin with cau tion to th e cli- en t takin g im m un osuppressive m edication s.

2. Sid e an d adverse effects a . Nausea b . Diarrh ea or con stipation c. Abdo m in al pain or cram p s d . Flatu len ce e. Dizzin ess f. Headach e g. Blurred vision h . Rash

i. Pruritu s j. Elevated liver en zym e levels

k . Muscle cram ps an d fatigue 3. In terven tion s

a . Mon itor serum liver en zym e levels. b . In struct th e clien t to receive an an n ual eye

exam in ation because th e m edication s can cause cataract form ation .

c. If lovastatin is n ot effective in lowerin g th e lipid level after 3 m on th s, it sh o uld be discon tin ued.

Instruct the client who is taking an antilipemic med- ication to report any unexplained muscular pain to the HCP immediately.

D. O th er an tilipem ic m ed ication s (Box 57-20) 1. Description

a . Gem fib rozil sh o uld n ot be taken with an tico- agulan ts because th ey com pete for protein sites; if th e clien t is takin g an an ticoagulan t, th e an ticoagulan t dose sh ould be reduced durin g an tilip em ic th erap y an d th e INR sh ould be m on itored closely.

b . Do n ot adm in ister gem fibrozil with HMG-CoA reductase in h ibitors because it in creases th e risk for m yositis, m yalgias, an d rh abdo m yolysis.

c. Fish oil supplem en ts h ave been associated with a decreased risk for cardiovascu lar h eart disease; plan t stan o l an d sterol esters an d ch olestin h ave been associated with reducin g ch olesterol levels.

2. In terven tion s a . Mon itor vital sign s. b . Mon itor liver en zym e levels. c. Mon itor serum ch olestero l an d triglyceride

levels. d . In struct th e clien t to restrict in take of fats,

ch olesterol, carbo h ydrates, an d alcoh ol. e. In struct th e clien t to follow an exercise program . f. In struct th e clien t th at it will take several

weeks before th e lipid level declin es. g. In struct th e clien t to h ave an an n ual eye exam -

ination an d to report an y ch an ges in vision . h . In struct th e clien t with diabetes m ellitus wh o

is takin g gem fibrozil to m on itor blood glu- cose levels regularly.

i. In struct th e clien t to in crease fluid in take.

BOX 57-19 HMG-CoA Reductase Inhibitors

▪ Atorvastatin ▪ Fluvastatin ▪ Lovastatin ▪ Pitavastatin

▪ Pravastatin ▪ Rosuvastatin ▪ Simvastatin

BOX 57-20 Other Antilipemic Medications

▪ Cholestyramine ▪ Colesevelam ▪ Colestipol ▪ Ezetimibe ▪ Ezetimibe; simvastatin

▪ Lomitapide ▪ Fenofibrate ▪ Gemfibrozil ▪ Nicotinic acid

809CHAPTER 57 Cardiovascular Medications

j. Note th at n icotin ic acid h as n um erou s side an d ad verse effects, in cludin g gastro in testin al disturban ces, flush in g of th e skin , elevated liver en zym e levels, h yperglycem ia, an d h yperu ricem ia.

k . In struct th e clien t th at aspirin or n on steroidal an tiin flam m atory drugs taken 30 m in u tes before m ay assist in reducin g th e side effect of cutan eous flush in g from n icotin ic acid.

l. In struct th e clien t to take n icotin ic acid with m eals to reduce gastro in testin al discom fort.

CRITICAL THINKING What Should You Do? Answer: The normal INR is 0 .81 to 1.2 (0 .81–1.2). The treat- ment goal of warfarin sodium is to raise the INR to an appro- priate value. An INR of 2 to 3 is appropriate for most clients, although for some clients the target INR is 3 to 4.5, such as in the case of a mechanical heart valve. If the INR is below the recommended range, warfarin sodium should be increased. If the INR is above the recommended range, warfarin sodium should be reduced. If the INR is 2.8, the nurse should plan to administer the same dosage as prescribed.

Reference: Burchum, Rosenthal (2016), pp. 604–60 5, 622.

P R A C T I C E Q U E S T I O N S 690. A clien t with atrial fibrillatio n is receivin g a con tin -

uous h eparin in fusion at 1000 un its/ h our. Th e n urse determ in es th at th e clien t is receivin g th e th erapeutic effect based on wh ich results? 1. Proth rom bin tim e of 12.5 secon ds 2. Activated partial th rom boplastin tim e of

60 secon ds 3. Activated partial th rom boplastin tim e of

28 secon ds 4. Activated partial th rom bop lastin tim e lon ger

th an 120 secon ds

691. Th e n urse provides disch arge in struction s to a cli- en t wh o is takin g warfarin sodium . Wh ich state- m en t, by th e clien t, reflects th e n eed fo r fu rth er teach in g? 1. “I will avoid alcoh ol con sum p tion .” 2. “I will take m y pills every day at th e sam e tim e.” 3. “I h ave already called m y fam ily to pick up a

MedicAlert bracelet.” 4. “I will take coated aspirin for m y h eadach es

because it will coat m y stom ach .”

692. A clien t wh o is receivin g digo xin daily h as a serum potassium level of 3 m Eq/ L (3 m m ol/ L) an d is com plain in g of an orexia. Th e h ealth care provider prescribes a serum digoxin level to be don e. Th e n urse ch ecks th e results an d sh ould exp ect to n ote wh ich level th at is outsid e of th e th erap eutic ran ge?

1. 0.3 n g/ m L 2. 0.5 n g/ m L 3. 0.8 n g/ m L 4. 1.0 n g/ m L

693. A clien t is bein g treated with procain am ide for a cardiac dysrh yth m ia. Follo win g in traven ous adm in istration of th e m edication , th e clien t com - plain s of dizzin ess. Wh at in terven tion sh ould th e n urse take first? 1. Measu re th e h eart rate on th e rh yth m strip. 2. Adm in ister prescribed n itroglycerin tablets. 3. O btain a 12-lead electrocardiogram im m edi-

ately. 4. Auscu ltate th e clien t’s apical pulse an d obtain a

blood pressure.

694. Th e n urse is m on itorin g a clien t wh o is takin g pro- pran olol. Wh ich assessm en t fin din g in dicates a poten tial adverse com plication associated with th is m ed ication ? 1. Th e developm en t of com plain ts of in som n ia 2. Th e developm en t of au dible exp iratory wh eezes 3. A baselin e blood pressure of 150/ 80 m m Hg fol-

lo wed by a blood pressure of 138/ 72 m m Hg after 2 doses of th e m ed ication

4. A baselin e restin g h eart rate of 88 beats/ m in ute followed by a restin g h eart rate of 72 beats/ m in u te after 2 doses of th e m edication

695. A clien t with a clot in th e righ t atrium is receivin g a h eparin sodium in fusion at 1000 un its/ h our an d warfarin sodium 7.5 m g at 5:00 p.m . daily. Th e m orn in g labo ratory results are as follows: activated partial th rom boplastin tim e (aPTT), 32 secon ds; in tern ation al n orm alized ratio (INR) , 1.3. Th e n urse sh o uld take wh ich action based on th e cli- en t’s laborato ry results? 1. Collab orate with th e h ealth care provider (HCP)

to discon tin ue th e h eparin in fusion an d adm in - ister th e warfarin sodium as prescribed.

2. Collaborate with th e HCP to obtain a prescrip- tio n to in crease th e h eparin in fusion an d ad m in ister th e warfarin sodium as prescribed.

3. Collaborate with th e HCP to with h old th e war- farin sodium sin ce th e clien t is receivin g a h ep- arin in fusion an d th e aPTT is with in th e th erapeutic ran ge.

4. Collab orate with th e HCP to con tin ue th e h ep- arin in fusion at th e sam e rate an d to discuss use of dabigatran etexilate in place of warfarin sodium .

696. A clien t is diagn osed with an ST segm en t elevation m yocardial in farction (STEMI) an d is receivin g a tissue plasm in ogen activator, alteplase. Wh ich action is a p rio rity n ursin g in terven tion ?

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

810 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

1. Mon itor for kidn ey failure. 2. Mon itor psych osocial status. 3. Mon itor for sign s of bleedin g. 4. Have h eparin sodium available.

697. Th e n urse is plan n in g to adm in ister h ydroch loro- th iazide to a clien t. Th e n urse sh ould m on itor for wh ich adverse effects related to th e ad m in istra- tion of th is m ed ication ? 1. Hypo uricem ia, h yperkalem ia 2. In creased risk of osteoporo sis 3. Hypokalem ia, h yperglycem ia, sulfa allergy 4. Hyperkalem ia, h ypoglycem ia, pen icillin allergy

698. Th e h o m e h ealth care n u rse is visitin g a clien t with elevated triglycerid e levels an d a seru m ch o les- tero l level o f 398 m g/ d L ( 10 m m o l/ L) . Th e clien t is takin g ch o lestyram in e an d th e n u rse teach es th e clien t ab o u t th e m ed icatio n . Wh ich statem en t, b y th e clien t, in d icates th e n eed fo r fu rth er teach in g? 1. “Con stipation an d bloatin g m igh t be a

problem .” 2. “I’ll con tin ue to watch m y diet an d reduce

m y fats.” 3. “Walkin g a m ile each day will h elp th e wh ole

process.” 4. “I’ll con tin ue m y n icotin ic acid from th e h ealth

food store.”

699. Th e n urse is m on itorin g a clien t wh o is takin g digoxin for ad verse effects. Wh ich fin din gs are ch aracteristic of digoxin toxicity? Select all th at ap p ly.

1. Trem ors 2. Diarrh ea 3. Irritability 4. Blurred vision 5. Nausea an d vom itin g

700. Prior to adm in isterin g a clien t’s daily dose of digoxin , the n urse reviews th e clien t’s laboratory data an d notes th e following results: serum calci- um , 9.8 m g/ dL (2.45 m m ol/L); serum m agn esium , 1.0 m Eq/ L (0.5 m m ol/ L); serum potassium , 4.1 m Eq/ L (4.1 m m ol/ L); serum creatinine, 0.9 m g/ dL (79.5 m cm ol/ L). Which result sh ould alert the nurse th at th e clien t is at risk for digoxin toxicity? 1. Serum calcium level 2. Serum potassium level 3. Serum creatin in e level 4. Serum m agn esium level

701. A clien t bein g treated for h eart failure is adm in is- tered in traven o us bum etan id e. Wh ich outcom e

in dicates th at th e m ed ication h as ach ieved th e exp ected effect? 1. Cough becom es produ ctive of froth y pin k

sputu m . 2. Urin e output in creases from 10 m L/ h ou r to

greater th an 50 m L h ourly. 3. Th e serum potassium level ch an ges from 3.8 to

3.1 m Eq/ L (3.8 to 3.1 m m ol/ L) . 4. B-type n atriuretic peptid e (BNP) facto r in creases

from 200 to 262 pg/ m L (200 to 262 n g/ L).

702. In traven ou s h eparin th erap y is prescribed for a cli- en t. Wh ile im plem en tin g th is prescription , th e n urse en sures th at wh ich m ed ication is available on th e n ursin g un it? 1. Vitam in K 2. Protam in e sulfate 3. Potassiu m ch loride 4. Am in o capro ic acid

703. A clien t receivin g th rom bolytic th erap y with a con - tin uo us in fusion of alteplase sudden ly beco m es extrem ely an xious an d com plain s of itch in g. Th e n urse h ears strid or an d n otes gen eralized urticaria an d h ypoten sion . Wh ich n ursin g action is th e p rio rity? 1. Adm in ister oxygen an d protam in e sulfate. 2. Cut th e in fusion rate in h alf an d sit th e clien t up

in bed . 3. Stop th e in fusion an d call for th e Rapid

Respon se Team (RRT) . 4. Adm in ister diph en h ydram in e an d epin eph rin e

an d con tin ue th e in fusion .

704. Th e n urse sh ould report wh ich assessm en t fin din g to th e h ealth care provider (HCP) before in itiatin g th rom bolytic th erapy in a clien t with pulm on ary em b olism ? 1. Adven titious breath soun ds 2. Tem perature of 99.4 °F (37.4 °C) orally 3. Blood pressure of 198/ 110 m m Hg 4. Resp iratory rate of 28 breath s/ m in ute

705. A clien t is prescribed n icotin ic acid for h yperlipid- em ia an d th e n urse provides in struction s to th e cli- en t about th e m edication . Wh ich statem en t by th e clien t in dicates an un derstan din g of th e in struction s? 1. “It is n ot n ecessary to avoid th e use of alcoh ol.” 2. “Th e m edication sh ould be taken with m eals to

decrease flush in g.” 3. “Clay-co lored stools are a com m on side effect

an d sh ould n ot be of con cern .” 4. “Ib uprofen IB taken 30 m in utes before th e n ic-

otin ic acid sh ould decrease th e flush in g.”

811CHAPTER 57 Cardiovascular Medications

A N S W E R S 690. 2 Ra tion a le: Co m m o n labo rato ry ran ges fo r activated partial th rom b op lastin tim e (aPTT) are 30 to 40 seco n ds. Becau se th e aPTT sh ou ld be 1.5 to 2.5 tim es th e n orm al value, th e cli- en t’s aPTT wou ld be con sid ered th erapeutic if it was 60 secon ds. Pro th ro m bin tim e assesses resp o n se to warfarin th erapy. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e th erap eutic effect o f h ep arin . Pro th rom bin tim e is elim in ated because it assesses respo n se to warfarin th erap y. Th e aPTT o f 28 seco n d s is elim in ated becau se th is resu lt in d icates th at th e clien t is receivin g n o th erapeu tic effect fro m th e co n tin u o us h ep arin in fusio n . Fin ally, th e aPTT greater th an 120 secon ds can be elim in ated b ecau se th is valu e is b eyon d th e th erapeu tic ran ge an d th e clien t is at risk fo r bleedin g. Review: Lab o ratory tests to m on itor th e effectiven ess of h ep arin th erap y Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm aco logy—Card iovascular Medicatio n s Pr ior it y Con cept s: Clo ttin g; Safety Refer en ces: Gah art, Nazaren o ( 2015) , pp. 620–621, 624; Ign a- tavicius, Workm an (2016), p p. 607–608.

691. 4 Ra tion a le: Asp irin -co n tain in g p ro d ucts n eed to b e avoid ed wh en a clien t is takin g th is m ed icatio n . Alcoh ol con sum ption sh o u ld b e avo id ed b y a clien t takin g warfarin so diu m . Takin g th e p rescrib ed m edicatio n at th e sam e tim e each d ay in creases clien t com p lian ce. Th e MedicAlert bracelet provid es h ealth care p erso n n el with em ergen cy in fo rm atio n . Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further teaching. Th ese wo rd s in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in correct statem en t. Recallin g th at warfarin is an an tico agulan t an d th at co ated asp irin is an asp irin -co n tain in g p ro d uct will direct yo u to th e correct o ptio n . Review: Warfarin so d iu m Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Card iovascular Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hod gson , Kizio r (2015), pp . 89, 1289–1290.

692. 4 Ra tion a le: Th e o ptim al th erapeutic ran ge for digo xin is 0.5 to 0.8 n g/ m L. If th e clien t is exp erien cin g sym p tom s su ch as an o rexia an d is exp erien cin g h yp okalem ia as eviden ced b y a lo w p otassium level, digo xin toxicity is a co n cern . Th erefo re, o ptio n 4 is co rrect b ecause it is o u tside of th e th erapeu tic level an d an elevated level. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, a digoxin level o utsid e o f th e th erap eutic ran ge. Ad dition ally, d eterm in e if an ab n o rm ality exists. No te th at th e clien t is experien cin g an o rexia an d h as a low seru m p otassiu m level. Th erefo re, it is best to select th e o ption th at iden tifies th e h igh est level. Recall th at in h yp okalem ia, th e clien t is at greater risk fo r d igoxin to xicity.

Review: Th erap eu tic d igo xin level Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Cardiovascular Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 527.

693. 4 Ra tion a le: Sign s of to xicity fro m procain am id e in clud e con fu- sio n , d izzin ess, drowsin ess, d ecreased urin atio n , n au sea, vom itin g, an d tach yd ysrh yth m ias. If th e clien t com p lain s of d izzin ess, th e n urse sh o uld assess th e vital sign s first. Alth o u gh m easurin g th e h eart rate o n th e rh yth m strip an d o btain in g a 12-lead electro cardio gram m ay b e in terven tion s, th ese wou ld b e do n e after th e vital sign s are taken . Nitroglycerin is a vaso - d ilator an d will lo wer th e blo od pressure. Test-Ta kin g Str a tegy: Note th e strategic wo rd , first. Also u se th e step s o f th e n u rsin g p ro cess to an swer co rrectly. Rem em - b er to always assess th e clien t first, n ot th e m o n ito rin g devices. Th erefo re, au scu ltatin g th e ap ical p ulse an d takin g th e blo o d p ressu re are th e first actio n s. Review: Pro cain am id e an d related n u rsin g in terven tio n s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm acolo gy—Cardiovascular Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Perfusion Refer en ce: Gah art, Nazaren o (2015), p. 1021.

694. 2 Ra tion a le: Au dible exp irato ry wh eezes m ay in d icate a serio us adverse reaction , bron ch osp asm . Beta b lo ckers m ay in du ce th is reaction , particularly in clien ts with ch ro n ic obstructive pul- m on ary d isease or asth m a. Norm al d ecreases in blo od p ressure an d h eart rate are expected . In som n ia is a frequ en t m ild sid e effect an d sh o uld b e m o n ito red . Test-Ta kin g Str a tegy: Focus o n th e su b ject, a po ten tial adverse com plicatio n . Elim in ate op tion s in d icatin g a decrease in blo o d p ressu re an d a decrease in h eart rate first, because th ese are exp ected effects fro m th e m edicatio n . Next, focu sin g o n th e su b ject will direct yo u to th e correct o ptio n . Review: Ad verse effects o f p ro p ran o lo l Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Cardiovascular Medicatio n s Pr ior it y Con cept s: Gas Exch an ge; Perfusion Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 161, 163.

695. 2 Ra tion a le: Wh en a clien t is receivin g warfarin fo r clo t p reven - tio n du e to atrial fib rillatio n , an INR of 2 to 3 is ap p ro priate fo r m ost clien ts. Un til th e INR h as ach ieved a th erap eu tic ran ge, th e clien t sh ou ld b e m ain tain ed o n a co n tin uo us h ep arin in fu- sio n with th e aPTT ran gin g between 60 an d 80 seco n d s. Th ere- fo re, th e n u rse sh ou ld co llabo rate with th e HCP to ob tain a p rescrip tio n to in crease th e h ep arin in fusio n an d to ad m in ister th e warfarin as p rescribed. Test-Ta kin g Str a tegy: Focus on th e su b ject, lab orato ry result an alysis related to th ese m edicatio n s. First, elim in ate th e

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

812 UNIT XIII Cardiovascular Disorders of the Adult Client

op tion th at in dicates to d iscu ss use o f dab igatran etexilate, recallin g th at it is con train dicated for use in atrial fibrillation associated with valvular h eart d isease. Next, recall th at if th e warfarin sod iu m h as ach ieved th e th erap eu tic ran ge for th e INR fo r clo t preven tio n in atrial fib rillation , th e h ep arin in fu - sion is n o lo n ger n ecessary. Th is will h elp yo u to elim in ate th e op tion th at in d icates to with h old th e warfarin sod iu m b ecau se th e INR is n ot th erap eu tic. Last, keep in m in d th at if bo th th e aPTT an d th e INR are n o t with in th erapeu tic ran ge, th e clien t is left u n pro tected fro m clot fo rm ation . Review: Hep arin so d iu m an d warfarin so d iu m th erapy an d related laborato ry values Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Card io vascu lar Med ication s Pr ior ity Con cepts: Clottin g; Collab oratio n Refer en ce: Burch um , Rosen th al (2016), pp . 621–623.

696. 3 Ra t ion a le: Tissue plasm in ogen activato r is a th ro m bo lytic. Hem o rrh age is a com plicatio n o f an y type of th rom b olytic m ed ication . Th e clien t is m on itored fo r bleedin g. Mon ito rin g fo r ren al failure an d m o n ito rin g th e clien t’s psych o so cial status are im p ortan t b ut are n ot th e m ost critical in terven tion s. Hep- arin m ay b e adm in istered after th rom b olytic th erap y, bu t th e qu estio n is n ot askin g ab ou t follow-up m edicatio n s. Test -Ta kin g Str a tegy: Note th e strategic wo rd , priority. Rem em b er th at bleedin g is a priority for th rom b olytic m ed ication s. Review: Care o f th e clien t receivin g tissu e p lasm in o gen activato r Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Card io vascu lar Med ication s Pr ior ity Con cepts: Clottin g; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 617–618.

697. 3 Ra t ion a le: Th iazid e diu retics su ch as h ydroch lo ro th iazide are sulfa-b ased m edicatio n s, an d a clien t with a su lfa allergy is at risk for an allergic reaction . Also, clien ts are at risk for h ypoka- lem ia, h yperglycem ia, h ypercalcem ia, h yperlip id em ia, an d h yperu ricem ia. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, a co n cern related to ad m in istration of h ydroch lo ro th iazide. Recallin g th at th ia- zide d iuretics carry a sulfa rin g will direct you to th e co rrect op tion . Review: Hyd ro ch lo ro th iazid e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Card io vascu lar Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 452–453.

698. 4 Ra t ion a le: Nicotin ic acid, even an o ver-th e-co un ter fo rm , sh ou ld b e avoided because it m ay lead to liver ab n orm alities.

All lipid -lo werin g m ed icatio n s also can cause liver abn orm al- ities, so a co m b in ation of n ico tin ic acid an d ch o lestyram in e resin n eed s to b e avoided . Co n stip atio n an d blo atin g are th e 2 m o st co m m o n ad verse effects. Walkin g an d th e redu ctio n o f fats in th e d iet are th erapeu tic m easures to red u ce ch olestero l an d triglyceride levels. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further teaching. Th ese wo rd s in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in co rrect statem en t. Rem em - b erin g th at o ver-th e-co un ter m edicatio n s sh ou ld b e avo ided wh en a clien t is takin g a prescription m edication will direct yo u to th e co rrect o ption . Review: Ch o lestyram in e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Card io vascu lar Med icatio n s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ces: Hodgson , Kizior (2015), pp. 244–245; Bu rch u m , Rosen th al ( 2016) , p. 573.

699. 2, 4, 5 Ra t ion a le: Digoxin is a card iac glyco side. Th e risk o f to xicity can o ccur with th e u se o f th is m ed ication . To xicity can lead to life-th reaten in g even ts an d th e n urse n eeds to m o n ito r th e clien t clo sely fo r sign s o f to xicity. Early sign s o f toxicity in clu de gastroin testin al m an ifestation s such as an o rexia, n ausea, vo m itin g, an d d iarrh ea. Su b sequ en t m an ifestatio n s in clu de h eadach e; visual distu rban ces su ch as d ip lop ia, blurred visio n , yellow-green h alo s, an d p h o top h o b ia; dro wsin ess; fatigue; an d weakn ess. Cardiac rh yth m abn orm alities can also occur. Th e n urse also m on ito rs th e d igoxin level. Th e o p tim al th erap eu tic ran ge for d igo xin is 0.5 to 0.8 n g/ m L. Test -Ta kin g Str a tegy: Focus o n th e su b ject, digo xin toxicity. Sp ecific kn owled ge regardin g th e ch aracteristics o f d igoxin tox- icity is n eed ed to an swer th is q uestion . Recall th at th e early sign s are gastroin testin al m an ifestatio n s. Next, recall th at visu al d istu rb an ces can o ccu r. Review: Digo xin to xicity Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Card io vascu lar Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Ho dgso n , Kizior (2015), p. 363; Bu rch u m , Rosen th al ( 2016) , pp . 532–533.

700. 4 Ra t ion a le: An in creased risk of to xicity exists in clien ts with h ypercalcem ia, h ypo kalem ia, h yp om agn esem ia, h yp oth yro id- ism , an d im p aired ren al fu n ctio n . Th e calciu m , creatin in e, an d p o tassium levels are all with in n o rm al lim its. Th e n o rm al ran ge for m agn esium is 1.3 to 2.1 m Eq / L (0.65-1.05 m m o l/ L) an d th e resu lts in th e correct o ption are reflective of h ypom agn esem ia. Test -Ta kin g St r a t egy: Focus on th e su b ject, th e lab o rato ry resu lt th at p laces th e clien t at risk fo r d igoxin to xicity. Recallin g th e n orm al labo rato ry values fo r each electrolyte id en tified in th e op tion s will assist in an swerin g correctly. Review: Lab orato ry values related to d igo xin to xicity Level of Cogn it ive Ability: An alyzin g

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

813CHAPTER 57 Cardiovascular Medications

Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—Card iovascular Medicatio n s Pr ior it y Con cept s: Perfu sio n ; Safety Refer en ce: Hod gson , Kizio r (2015), p. 363.

701. 2 Ra tion a le: Bu m etan ide is a d iu retic an d expected ou tcom es in clu d e in creased u rin e ou tpu t, decreased crackles, an d d ecreased weigh t. O ption s 1, 3, an d 4 are in correct. Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, assessm en t fin d - in gs in dicative of th e exp ected effect of bu m etan id e. Keep in m in d wh en an swerin g th is qu estio n th at an expected effect o f a m ed ication refers to a p o sitive ou tcom e versu s a sid e or ad verse effect. Th is will h elp yo u to elim in ate th e o ption th at refers to th e p otassiu m lo ss. Fro th y p in k sp utu m in d icates p ro - gression to pu lm on ary ed em a. A BNP greater th an 100 p g/ m L (100 n g/ L) is in d icative o f h eart failure; th us, a rise from a pre- vio us level in dicates worsen in g o f th e co n d itio n . Review: Bu m etan id e Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm aco logy—Card iovascular Medicatio n s Pr ior it y Con cept s: Evid en ce; Perfu sio n Refer en ce: Gah art, Nazaren o (2015), pp . 191–192.

702. 2 Ra tion a le: Th e an tid ote to h eparin is p ro tam in e sulfate; it sh o u ld b e readily availab le fo r use if excessive b leed in g o r h em - o rrh age sh o uld o ccu r. Vitam in K is an an tido te for warfarin so diu m . Po tassiu m ch lo rid e is ad m in istered fo r a p otassiu m d eficit. Am in o cap ro ic acid is th e an tid o te fo r th ro m bo lytic th erapy. Test-Ta kin g St r a tegy: Fo cu s on th e su b ject, th e an tid ote fo r h eparin . Kn owled ge regard in g th e vario u s an tido tes is n eed ed to an swer th is qu estio n . Rem em ber th at th e an tid ote to h epa- rin is p ro tam in e su lfate. Review: Pro tam in e su lfate Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm aco logy—Card iovascular Medicatio n s Pr ior it y Con cept s: Clo ttin g; Safety Refer en ce: Gah art, Nazaren o (2015), p. 626.

703. 3 Ra tion a le: Th e clien t is exp erien cin g an an ap h ylactic reactio n . Th erefo re, th e priority action is to sto p th e in fu sion an d n otify th e RRT. Th e h ealth care provid er sh ou ld be co n tacted o n ce th e clien t h as been stab ilized. Th e clien t m ay b e treated with epi- n eph rin e, an tih istam in es, an d corticosteroids as prescrib ed , b ut th e in fu sion sh ou ld n o t be co n tin ued . Test-Ta kin g Str a tegy: No te th e strategic wo rd , priority. Recall th at an allergic reactio n an d p o ssible an aph ylaxis are risks associated with altep lase th erapy. Also , focusin g o n th e sign s an d sym p tom s in th e q uestio n will assist in an swerin g

correctly. Wh en a severe allergic reactio n o ccurs, th e offen din g su bstan ce sh o uld b e sto pp ed , an d lifesavin g treatm en t sh o u ld begin . Review: Adverse effects o f altep lase Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Area : Critical Care—Em ergen cy Situation s/ Man agem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ce: Ign ataviciu s, Wo rkm an (2016), p p. 352–353, 607, 939.

704. 3 Ra tion a le: Th rom bolytic th erapy is con train dicated in a n u m ber of p reexistin g con d itio n s in wh ich th ere is a risk of u n co n trolled bleedin g, sim ilar to th e case in an ticoagu lan t th erapy. Th ro m bo lytic th erap y also is co n train d icated in severe u n co n trolled h yp erten sion because of th e risk of cerebral h em o rrh age. Th erefo re, th e n u rse wo u ld repo rt th e results of th e b lo od p ressu re to th e HCP befo re in itiatin g th erap y. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, a co n train d ication for th e u se o f th ro m b olytic th erap y. Adven titio us breath so un ds, tem p eratu re o f 99.4 °F (37.4 °C), an d resp iratory rate o f 28 breath s/ m in u te m ay be p resen t in th e clien t with p u lm o - n ary em bo lism bu t are n ot n ecessarily sign s th at warran t reportin g before th rom bo lytic th erapy is in itiated. Review: Con train d ication s for th ro m b o lytic th erap y Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Area : Critical Care—Em ergen cy Situation s/ Man agem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 731–732.

705. 4 Ra tion a le: Flu sh in g is an ad verse effect of th is m ed ication . Asp irin or a n o n steroidal an tiin flam m atory drug can be taken 30 m in utes p rio r to takin g th e m ed icatio n to decrease flu sh in g. Alcoh ol con sum p tion n eed s to b e avoided because it will en h an ce th is effect. Th e m ed ication sh o uld b e taken with m eals to decrease gastroin testin al u pset; h owever, takin g th e m edica- tio n with m eals h as n o effect o n th e flu sh in g. Clay-colo red sto ols are a sign o f h ep atic d ysfu n ction an d sh o uld be repo rted to th e h ealth care p ro vider (HCP) im m ediately. Test-Ta kin g St r a t egy: Focus o n th e su b ject, clien t u n d erstan d- in g of th e m edicatio n . Alco h o l m ust b e abstain ed from , so th is o ptio n can be elim in ated. Takin g th e m ed ication with m eals h elps to d ecrease th e gastro in testin al sym pto m s rath er th an flu sh in g. Clay-co lo red sto ols are a sign o f h ep atic d ysfu n ctio n an d sh o u ld be rep o rted to th e HCP im m ed iately. Review: Nico tin ic acid Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm acolo gy—Cardiovascular Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 578–579.

A

d

u

l

t

C

a

r

d

i

o

v

a

s

c

u

l

a

r

814 UNIT XIII Cardiovascular Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

UNIT XIV

Renal and Urinary Disorders of the Adult Client

Pyramid to Success

Pyram id Po in ts fo cu s o n acu te kid n ey in ju ry an d ch ro n ic kid n ey d isease, d ialysis p ro ced u res, u rin ary d iversio n s, an d p o sto p erative care fo llo win g u rin ary o r ren al su rgery. Be fam iliar with m ed ical co n d itio n s an d d iagn o stic tests th at p lace th e clien t at risk fo r acu te kid n ey in ju ry. Fo cu s o n th e m ajo r p ro b lem s asso ciated with kid n ey failu re an d th e ratio n ale fo r th e p rescrib ed treatm en t m o d alities. Be fam iliar with th e co m p lica- tio n s asso ciated with h em o d ialysis an d p erito n eal d ialysis, th e sp ecific assessm en t d ata related to co m - p licatio n s, an d th e exp ected treatm en t. Fo cu s o n th e care o f a p erito n eal cath eter an d h em o d ialysis access d evices, th e co m p licatio n s asso ciated with th ese access d evices, an d th e ap p ro p riate n u rsin g in terven tio n s if a co m p licatio n is su sp ected . Review assessm en t d ata in d icatin g rejectio n fo llo win g kid n ey tran sp lan tatio n . Be fam iliar with care fo r th e clien t fo llo win g p ro statec- to m y, an d treatm en t m easu res fo r th e clien t with u rin ary o r ren al calcu li.

Client Needs: Learning Objectives Safe and Effective Care Environment Con sultin g with th e in terp rofession al h ealth care team Establish in g priorities Iden tifyin g con d ition s an d diagn ostic procedures th at

in crease th e risk of developin g ren al disorders Iden tifyin g th e gu idelin es related to kidn ey organ

don ation Main tain in g asepsis related to woun d care an d dialysis

access devices

Main tain in g con fiden tiality related to th e ren al disorder Main tain in g stan dard an d oth er precaution s related to

care for th e clien t Preven tin g in jury related to com plication s of th e disorder Uph oldin g clien t righ ts Verifyin g th at in form ed con sen t related to diagn ostic

an d surgical proced ures h as been obtain ed

Health Promotion and Maintenance Perform in g urin ary an d ren al ph ysical assessm en t

tech n iqu es Providin g clien t in struction s regardin g prescribed treat-

m en ts related to th e urin ary or ren al disorder Providin g clien t in struction s regardin g th e preven tion of

th e recurren ce of a urin ary or ren al disorder

Psychosocial Integrity Assistin g th e clien t to use appropriate copin g m ech an ism s Discussin g body im age disturban ces Discussin g th e lo ss of ren al fun ction Iden tifyin g cultural, religious, an d spiritual in fluen ces

on h ealth Iden tifyin g grief an d lo ss an d en d-of-life issues Iden tifyin g support system s an d appropriate com m un ity

resources

Physiological Integrity En surin g elim in ation m easures In form in g th e clien t about diagn ostic tests an d labora-

tory results Mon itorin g for fluid an d electrolyte im balan ces an d

acid-base disorders

815

O btain in g assessm en t data in dicatin g rejection of kid- n ey tran splan t

Preven tin g com plication s arisin g as a result of dialysis Provid in g ad equate rest an d sleep Provid in g care related to h em odialysis an d periton eal

dialysis an d dialysis access devices Provid in g care to th e clien t followin g prostatectom y

Providin g com fo rt in terven tion s Providin g ph arm acological th erapy Providin g treatm en t m easures for th e clien t with ren al or

urin ary calculi Teach in g th e clien t about th e prescribed n utrition an d

fluid m easu res

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

816 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

yC H A P T E R 58 Renal and Urinary System

PRIORITY CONCEPTS Fluids and Electrolytes; Elimination

CRITICAL THINKING What Should You Do? On assessment, the nurse notes that a client with acute kid- ney injury (AKI) has developed fine crackles in the lung bases bilaterally. What should the nurse do? Answer located on p. 843.

I. Anatomy and Physiology A. Kidn ey an atom y

1. Each person h as 2 kidn eys; 1 is attach ed to th e left abdom in al wall at th e level of th e last th o- racic an d first 3 lum bar vertebrae an d th e oth er is on th e righ t.

2. Th e kidn eys are en closed in th e ren al cap sule. 3. Th e ren al cortex is th e outer layer of th e ren al cap-

sule, wh ich con tain s blood-filterin g m ech an ism s (glom eruli).

4. Th e ren al m ed ulla is th e in n er region , wh ich con - tain s th e ren al pyram ids an d ren al tubu les.

5. Togeth er, th e ren al cortex, pyram ids, an d m ed ulla con stitute th e paren ch ym a.

6. Neph ron s a . Located with in th e paren ch ym a b . Com p osed of glom erulus an d tubu les c. Selectively secretes an d reabsorbs io n s an d fil-

trates, in cludin g fluid, wastes, electrolytes, acids, an d bases

The nephrons are the functional units of the kidney.

7. Glo m erulu s a . Each n eph ron con tain s tufts of cap illaries,

wh ich filter large plasm a protein s an d blood cells.

b . Bloo d flo ws in to th e glom erular cap illaries from th e afferen t arteriole an d flows out of th e glom erular cap illaries in to th e efferen t arteriole.

8. Bowm an ’s capsule a . Th in doub le-walled cap sule th at surroun ds

th e glom erulus b . Fluid an d particles from th e blood such as

electrolytes, gluco se, am in o acids, an d m eta- bolic waste (glom erular filtrate) are filtered th rough th e glom erular m em bran e in to a fluid-filled space in Bowm an ’s capsule (Bow- m an ’s space) an d th en en ter th e proxim al con vo luted tubu le (PCT).

9. Tubules a . The tubules include the PCT, the loop of Henle,

and the distal convoluted tubule (DCT). b . Th e PCT receives filtrate from th e glom erular

capsule an d reabsorb s water an d electrolytes th rough active an d passive tran sport.

c. Th e descen din g loop of Hen le passively reab- sorbs water from th e filtrate.

d . Th e ascen din g loop of Hen le passively reab- sorbs sodium an d ch loride from th e filtrate an d h elps to m ain tain osm o lality.

e. Th e DCT actively an d passively rem oves sodium an d water.

f. Th e filtered fluid is con verted to urin e in th e tubules, an d th en th e urin e m oves to th e pel- vis of th e kidn ey.

g. Th e urin e flows fro m th e pelvis of th e kidn eys th rough th e ureters an d em pties in to th e bladder.

B. Fun ction s of kidn eys 1. Main tain acid-b ase balan ce 2. Excrete en d products of body m etab olism 3. Con trol fluid an d electrolyte balan ce 4. Excrete bacterial toxin s, water-solub le m edica-

tion s, an d m edication m etabolites 5. Secrete ren in to regulate th e blood pressure (BP)

an d eryth rop oietin to stim ulate th e bon e m ar- row to produ ce red blood cells

6. Syn th esize vitam in D for calcium absorption an d regulation of th e parath yroid h orm on es

817

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

C. Urin e productio n 1. As flu id flo ws th rou gh th e tubu les, water, electro-

lytes, an d solutes are reabsorb ed an d oth er sol- utes such as creatin in e, h ydrogen io n s, an d potassium are secreted.

2. Water an d solutes th at are n ot reabsorbed beco m e urin e.

3. Th e process of selective reabsorptio n deter- m in es th e am oun t of water an d solutes to be secreted.

D. Hom eostasis of water 1. An tidiuretic h orm on e (ADH) is prim arily respon -

sible for th e reabsorp tion of water by th e kidn eys. 2. ADH is produ ced by th e h ypo th alam us an d

secreted fro m th e posterio r lobe of th e pituitary glan d .

3. Secretion of ADH is stim ulated by deh ydration or h igh sodium in take an d by a decrease in blood volu m e.

4. ADH m akes th e distal con vo luted tubules an d collectin g duct perm eable to water.

5. Water is drawn out of th e tubules by osm osis an d return s to th e blood ; con cen trated urin e rem ain s in th e tubule to be excreted.

6. Wh en ADH is lackin g, th e clien t develo ps diab e- tes in sipidus (DI).

7. Clien ts with DI produce large am oun ts of dilu te urin e; treatm en t is n ecessary because th e clien t can n ot drin k sufficien t water to survive.

E. Hom eostasis of sodium 1. Wh en th e am oun t of sodium in creases, extra

water is retain ed to preserve osm o tic pressure. 2. An in crease in sodium an d water produ ces an

in crease in blood volu m e an d BP. 3. Wh en th e BP in creases, glom erular filtration

in creases, an d extra water an d sodium are lost; blood vo lum e is reduced, return in g th e BP to n orm al.

4. Reabso rption of sodium in th e distal con volu ted tubu les is con tro lled by th e ren in -an gioten sin system .

5. Ren in , an en zym e, is released from th e n eph ron wh en th e BP or fluid con cen tration in th e distal con vo luted tubu le is low.

6. Ren in catalyzes th e splittin g of an giotensin I from angioten sin ogen ; an gioten sin I con verts to an gio- ten sin II as blood flows through th e lun g.

7. An gioten sin II, a poten t vasocon strictor, stim u- lates th e secretio n of aldostero n e.

8. Aldosteron e stim ulates the distal con voluted tubules to reabsorb sodium an d secrete potassium .

9. Th e addition al sodium in creases water reabsorp - tion an d in creases blood volum e an d BP, return - in g th e BP to n orm al; th e stim ulus for th e secretio n of ren in th en is rem oved.

F. Hom eostasis of potassium 1. In creases in th e serum potassium level stim ulate

th e secretio n of aldostero n e.

2. Aldosteron e stim ulates th e distal con vo luted tubu les to secrete potassium ; th is action return s th e serum potassium con cen tration to n orm al.

G. Hom eostasis of acidity (pH) 1. Bloo d pH is con tro lled by m ain tain in g th e con -

cen tration of buffer system s. 2. Carb on ic acid an d sodium bicarbo n ate form th e

m ost im portan t buffers for n eutralizin g acids in th e plasm a.

3. Th e con cen tration of carbon ic acid is con trolled by th e respiratory system .

4. Th e con cen tration of sodium bicarbon ate is co n - trolled by th e kidn eys.

5. Norm al arterial pH is 7.35 to 7.45, m ain tain ed by keepin g th e ratio of con cen tration s of sodium bicarbo n ate to carbon dioxide con stan t at 20:1.

6. Stron g acids are n eutralized by sodium bicarbo n - ate to produce carbo n ic acid an d th e sodium salts of th e stron g acid; th is process quickly restores th e ratio an d th us blood pH.

7. Th e carbo n ic acid dissociates in to carbon dioxide an d water; because th e con cen tration of carbo n dioxide is m ain tain ed at a con stan t level by th e respiratory system , th e excess carbo n ic acid is rapidly excreted.

8. Sodium com bin ed with th e stron g acid is actively reabsorb ed in th e distal con volu ted tubu les in exch an ge for h ydrogen or potassiu m ion s. Th e stron g acid is n eutralized by am m on ia an d is excreted as am m on ia or potassium salts.

H. Adren al glan ds (see Ch apter 50 for in form ation about th e ad ren al glan ds) 1. O n e adren al glan d is on top of each kidn ey. 2. Th e ad ren al glan ds in fluen ce BP an d sodium an d

water reten tion . I. Bladder

1. Th e blad der detrusor m uscle, com po sed of sm ooth m uscle, disten ds durin g blad der fillin g an d con tracts durin g bladder em ptyin g.

2. Th e ureterovesical sph in cter preven ts reflux of urin e fro m th e blad der to th e ureter.

3. Th e total bladder capacity is 1 L; n orm al adult urin e outp ut is 1500 m L/ d ay.

J. Prostate glan d 1. Th e prostate glan d surroun ds th e m ale ureth ra. 2. Th e prostate glan d con tains a duct th at opens in to

th e prostatic portion of th e ureth ra an d secretes the alkalin e portion of sem in al fluid, wh ich protects sperm .

K. Risk factors associated with ren al disorders (Box 58-1)

II. Diagnostic Tests A. See Ch apter 10 an d Box 58-2 for in form ation regard-

in g n orm al values for ren al fun ction studies. B. Determ in atio n of serum creatin in e level

1. Descriptio n : A test th at m easures th e am oun t of creatin in e in th e serum . Creatin in e is an en d product of protein an d m uscle m etab olism .

818 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

2. An alysis a. Creatin in e level reflects th e glom erular

filtration rate. b . Kidn ey disease is the on ly path ological con di-

tion that in creases the serum creatin in e level. c. Serum creatin in e level in creases on ly wh en at

least 50% of ren al fun ction is lost. C. Determ in ation of blood urea n itrogen (BUN) level

1. Descrip tion : A serum test th at m easu res th e am oun t of n itrogen ou s urea, a byprodu ct of pro- tein m etab olism in th e liver.

2. An alysis a. BUN levels in dicate th e exten t of ren al clear-

an ce of urea n itrogen ou s waste products. b . An elevation does n ot always m ean th at ren al

disease is presen t. c. Som e factors th at can elevate th e BUN level

in clude deh ydration , poor ren al perfusion , in take of a h igh -protein diet, in fection , stress, corticosteroid use, gastroin testin al (GI) bleed- in g, an d factors th at cause m uscle breakdown .

D. BUN/ creatin in e ratio 1. Th e BUN level is divided by th e creatin in e level

to obtain th e ratio. 2. Wh en th e BUN an d serum creatin in e levels

in crease at th e sam e rate, th e ratio of BUN to cre- atin in e rem ain s con stan t.

3. Elevated serum creatin in e an d BUN levels sug- gest ren al dysfun ction .

4. A decreased BUN/ creatin in e ratio occurs with fluid volu m e deficit, obstru ctive uropath y, cata- bolic state, an d a h igh -protein diet.

5. An in creased BUN/ creatin in e ratio occurs with fluid volum e excess.

E. Urin alysis 1. Descrip tion : A urin e test for evaluation of th e

ren al system an d ren al disease (see Table 58-1) 2. In terven tion s

a . Wash perin eal area an d use a clean con tain er for collection .

b . O btain 10 to 15 m L of th e first m orn in g void- in g if possible.

c. Refrigeratin g sam ples m ay alter th e specific gravity.

d . If th e clien t is m en struatin g, n ote th is on th e labo ratory requisition form .

F. A 24-h our urin e collection 1. Ch eck with th e labo ratory ab out specific in struc-

tion s for th e clien t to follow, such as dietary or m edication restriction s.

2. In struct th e clien t about th e urin e collection . 3. At th e start tim e, in struct th e clien t to void an d

discard th at sam ple. 4. Collect all urin e for th e prescribed tim e (24 h ours). 5. Keep th e urin e specim en on ice or refrigerated

an d ch eck with th e laborato ry regardin g addin g a preservative to th e specim en durin g collection .

6. At th e en d of th e prescribed tim e, in struct th e cli- en t to em p ty th e bladder an d ad d th at urin e to th e collectio n con tain er.

G. Specific gravity determ in ation 1. Descrip tion : A urin e test th at m easu res th e ab il-

ity of th e kidn eys to con cen trate urin e 2. In terven tion s

a . Specific gravity can be m easu red by a m ultiple-test dipstick m eth od (m ost com - m on m eth od ), refractom eter (an in strum en t used in th e laborato ry settin g), or urin om eter (least accu rate m eth od ).

BOX 58-1 Risk Factors Associated with Renal Disorders

▪ Chemical or environmental toxin exposure ▪ Contact sports ▪ Diabetes mellitus ▪ Family history of renal disease ▪ Frequent urinary tract infections ▪ Heart failure ▪ High-sodium diet ▪ Hypertension ▪ Medications ▪ Polycystic kidney disease ▪ Trauma ▪ Urolithiasis or nephrolithiasis

BOX 58-2 Normal Renal Function Values ▪ Blood urea nitrogen (BUN) level, 10 to 20 mg/ dL (3.6 to

7.1 mmol/ L) ▪ Serum creatinine level, male, 0 .6-1.2 mg/ dL (53-106

mcmol/ L); female 0 .5-1.1 mg/ dL (44-97 mcmol/ L) ▪ BUN/ creatinine ratio, 6-25

TABLE 58-1 Normal Urinalysis Values Color Amber yellow

Odor Specific aromatic odor, similar to ammonia

pH 4.6-8.0 (4.6-8.0)

Osmolality 300-1300 mOsm/ kg (300-1300 mmol/ kg)

Specific gravity 1.005-1.030

Glucose Negative

Ketones Negative

Protein Negative

Bilirubin Negative

Casts Negative

Bacteria None or < 10 00/ mL

Hemoglobin Negative

Myoglobin Negative

Culture for organisms Negative

819CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

b . Facto rs th at in terfere with an accurate readin g in clude radiop aque con trast agen ts, gluco se, an d protein s.

c. Cold specim en s m ay produce a false h igh readin g.

d . Norm al ran dom referen ce in terval is 1.005– 1.030 (m ay vary depen ding on the laboratory).

e. An in crease in specific gravity (m ore con - cen trated urin e) occurs with in sufficien t flu id in take, decreased ren al perfusion , or in creased ADH.

f. A decrease in specific gravity (less con cen - trated urin e) occurs with in creased fluid in take or diabetes in sipidu s; it m ay also in di- cate ren al disease or th e kidn eys’ in ability to con cen trate urin e.

H. Urin e culture an d sen sitivity testin g 1. Description : A urin e test that iden tifies th e pres-

ence of m icroorgan ism s (culture) an d determ in es th e specific an tibiotics to treat th e existin g m icro- organ ism (sen sitivity) appropriately

2. In terven tion s a . Clean th e perin eal area an d urin ary m eatu s

with a bacteriostatic solution . b . Collect th e m idstream sam ple in a sterile con -

tain er (clean catch specim en ); if th e clien t is un ab le to obtain a clean catch specim en , a specim en obtain ed by straigh t cath eteriza- tio n m ay be prescribed.

c. Sen d th e collected specim en to th e labo ratory im m ediately.

d . Iden tify an y sources of poten tial contam in an ts durin g th e collection of the specim en , such as the h an ds, skin , cloth in g, h air, or vagin al or rec- tal secretion s; if con tam in ation occurs, the specim en is discarded an d a n ew specim en n eeds to be collected. Urin e from th e clien t who dran k a very large am ount of fluids m ay be too dilute to provide a positive culture.

I. Creatin in e clearan ce test 1. Descrip tion

a . Th e creatin in e clearan ce test evaluates h ow well th e kidn eys rem ove creatin in e from th e blood, an d is an estim ate of glom erular filtration rate (GFR).

b . Th e test in cludes obtain in g a blood sam ple an d tim ed urin e specim en s.

c. Bloo d is drawn wh en th e urin e specim en col- lection is com plete.

d . Th e urin e specim en for th e creatin in e clear- an ce is usually collected for 24 h ou rs, but sh o rter periods such as 8 or 12 h ours could be prescribed.

The creatinine clearance test provides the best esti- mate of the GFR; the normal GFR is 125 mL/ minute in a young adult. The GFR decreases with age (10 % for each decade). By age 65 the GFR is 65 mL/ minute.

2. In terven tion s a . En cou rage flu ids befo re an d durin g th e test. b . In struct th e clien t to avoid caffein ated bever-

ages durin g testin g. c. Ch eck with th e h ealth care provider (HCP)

regardin g th e adm in istration of an y pre- scrib ed m ed ication s durin g testin g.

d . In struct th e clien t ab out th e urin e collection . e. At th e start tim e, ask th e clien t to void (or

em p ty th e tubin g an d drain age bag if th e cli- en t h as a urin ary cath eter) an d discard th e first sam ple.

f. Collect all urin e for th e prescribed tim e. g. Keep th e urin e specim en on ice or refriger-

ated an d ch eck with th e labo ratory regardin g addin g a preservative to th e specim en durin g collection .

h . At th e en d of th e prescribed tim e, ask th e cli- en t to em p ty th e bladder (or em p ty th e tub- in g an d drain age bag if th e clien t h as a urin ary cath eter) an d ad d th at fin al urin e to th e collection con tain er.

i. Sen d th e labeled urin e specim en to th e labo ratory.

j. Do cum en t specim en collectio n , tim e started an d com pleted, an d pertin en t assessm en ts.

J. KUB (kidn eys, ureters, an d bladder) radiograph y 1. Descriptio n : An x-ray of th e urin ary system an d

ad jacen t structures to detect urin ary calculi. 2. Interven tions: No specific preparation is n ecessary.

K. Bladder ultraso n ograph y (bladd er scan n in g) 1. Bladder ultrason ograph y is a n on in vasive

m eth od for m easurin g th e volum e of urin e in th e bladder.

2. Bladder ultrason o graph y m ay be perform ed to evaluate urin ary frequen cy, in ability to urin ate, or am oun t of residual urin e (th e am oun t of urin e rem ain in g in th e bladder after void in g).

L. In traven ou s urograph y 1. Descriptio n : An x-ray proced ure in wh ich an

in traven o us (IV) in jection of a radiop aque dye is used to visualize an d iden tify abn o rm alities in th e ren al system .

2. Preprocedure in terven tion s a . Verify th at an in form ed con sen t was

obtain ed. b . Assess th e clien t for allergies to iodin e, sea-

food , an d radiop aque dyes an d con train dica- tion s for th e test, in cludin g a positive pregn an cy test; cautio n s in clude m edical h is- tory of asth m a, sign ifican t cardiac disease, ren al in sufficien cy.

c. With h old food an d fluids for th e tim e prescribed.

d . Adm in ister laxatives if prescribed. e. In form th e clien t about possib le th roat irrita-

tion , flush in g of th e face, warm th , or a salty or m etallic taste durin g th e test.

820 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

3. Postprocedure in terven tion s a. Mon itor vital sign s. b . In struct th e clien t to drin k at least 1 L of fluid

un less con train d icated. c. Mon itor urin ary outp ut. d . Mon itor for sign s of a possible allergic reac-

tion to th e dye used durin g th e test an d in struct th e clien t to n otify th e HCP if an y sign s of an allergic reaction occur.

e. Con trast dye is poten tially dam agin g to kid- n eys; th e risk is greater in older clien ts an d th ose experien cin g deh ydratio n .

The dye (contrast media) used in IV urography may be nephrotoxic; therefore, encourage increased fluids unless contraindicated and monitor urinary output. It is essential that preprocedure BUN and creatinine levels are assessed on any client undergoing a procedure where dye might be injected. The HCP may institute pre- cautionary measures to prevent AKI or use smaller amounts of the dye.

M. Ren ograp h y (kidn ey scan ) 1. Descrip tion : An IV in jection of a radioiso tope for

visual im agin g of ren al blood flo w, glom erular filtration , tubular fun ction , an d excretion

2. Preprocedure in terven tion s a. Verify th at an in form ed con sen t was obtain ed. b . Assess for allergies. c. In form th e clien t th at th e test requires n o die-

tary or activity restriction s. d . In struct the client to rem ain m otion less dur-

in g th e test and that im agin g m ay be repeated at various intervals before th e test is com plete.

3. Postprocedure in terven tion s a. En courage fluid in take un less con train dicated. b . Assess th e clien t for sign s of an allergic

reaction . c. Th e radioiso tope is elim in ated in 24 h ours;

wear gloves for excretion precaution s. d . Follow stan dard precaution s wh en carin g for

in con tin en t clien ts an d double-bag clien t lin en s per agen cy policy.

e. If cap topril was ad m in istered durin g th e pro- cedure, th e clien t’s BP sh ould be ch ecked frequen tly.

N. Cystosco py an d biopsy of th e bladder 1. Descrip tion : Th e bladder m ucosa is exam in ed

for in flam m ation , calculi, or tum ors by m ean s of a cystoscope; a sam ple for biopsy m ay be obtain ed.

2. Preprocedure in terven tion s a. Verify th at an in form ed con sen t was

obtain ed. b . If a biopsy is plan n ed, with h old food an d

fluids for th e tim e prescribed. c. If a cystoscop y alon e is plan n ed, n o special

preparation is n ecessary, an d th e procedure m ay be perform ed in th e HCP’s office;

postp rocedu re in terven tion s in clude in creas- in g flu id in take.

3. Postprocedure in terven tion s followin g biopsy a . Mon itor vital sign s. b . In crease flu id in take as prescribed. c. Mon itor in take an d outp ut an d assess urin e

ch aracteristics. d . En cou rage deep-breath in g exercises to relieve

bladder spasm s an d adm in ister an algesics as prescribed.

e. Adm in ister sitz or tub bath s for back an d ab dom in al pain if prescribed .

f. No te th at leg cram p s are com m on because of th e lith otom y position m ain tain ed durin g th e procedure.

g. In form th e clien t th at burn in g on urin ation , pin k-tin ged or tea-colored urin e, an d urin ary frequen cy are com m on after cystoscopy an d resolve in a few days.

h . Mon itor for brigh t red urin e or clots, an d notify th e HCP if a fever occurs; an increase in wh ite blood cell (WBC) coun t suggests infection.

O. Ren al biopsy 1. Descrip tion : In sertion of a n eedle in to th e kid-

n ey to obtain a sam ple of tissue for exam in ation ; usually don e percutan eously

2. Preprocedure in terven tion s a . Assess vital sign s. b . Assess baselin e coagulation studies; n otify

th e HCP if ab n orm al results are n oted. c. Verify th at an in form ed con sen t was obtained. d . With h old food an d fluids as prescribed.

3. In terven tion durin g th e proced ure: Position th e clien t pron e with a pillow un der th e abdom en an d sh oulders.

4. Postprocedure in terven tion s a . Monitor vital signs, especially for hypotension

an d tachycardia, which could indicate bleedin g. b . Provide pressure to th e biopsy site for

30 m in utes or as prescribed. c. Mon itor th e h em oglobin an d h em atocrit

levels for decreases, wh ich could in dicate bleedin g.

d . Place th e clien t on strict bed rest in th e supin e position with a back roll for addition al sup- port for 2 to 6 h ours after th e biopsy.

e. Ch eck th e biopsy site an d un der th e clien t for bleedin g.

f. En cou rage flu id in take of 1500 to 2000 m L as prescribed.

g. O bserve th e urin e for gross an d m icroscopic bleedin g.

h . In struct th e clien t to avoid h eavy liftin g an d stren uous activity for 1 to 2 weeks.

i. In struct th e clien t to n otify th e HCP if eith er a tem p erature greater th an 100 °F (37.8 °C) or h em aturia occurs after th e first 24 h ours postp rocedu re.

821CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

III. Acute Kidney Injury A. Description

1. Acute kidney injury (AKI) is th e rapid lo ss of kid- n ey fun ction from ren al cell dam age.

2. O ccurs abruptly an d can be reversible 3. AKI leads to cell h ypo perfusion , cell death , an d

deco m pen sation of ren al fun ction . 4. Th e progn osis depen ds on th e cau se an d th e con -

dition of th e clien t. 5. Near-n orm al or n orm al kidn ey fun ction m ay

resum e gradually. B. Causes

1. Preren al: O utside th e kidn ey; cau sed by in travas- cular volum e depletion such as with blood loss associated with traum a or surgery, deh ydration , decreased cardiac output (as with cardiogen ic sh o ck), decreased periph eral vascular resistan ce, decreased ren ovascular blood flo w, an d preren al in fectio n or obstruction .

2. In traren al: With in th e paren ch ym a of th e kidn ey; cau sed by tubular n ecrosis, prolon ged preren al isch em ia, in traren al in fectio n or obstru ction , an d n eph ro toxicity ( Box 58-3)

3. Postren al: Between th e kidn ey an d ureth ral m ea- tus, such as bladder n eck obstru ction , bladder can cer, calculi, an d postren al in fectio n

C. Ph ases of AKI an d in terven tion s ( Box 58-4) 1. O n set: Begin s with precipitatin g even t 2. O liguric ph ase

a. For som e clien ts, oliguria does n ot occur an d th e urin e outp ut is n orm al; oth erwise, th e duration of oliguria is 8 to 15 days; th e lon ger th e duration , th e less ch an ce of recovery.

b . Sudd en decrease in urin e outp ut; urin e out- put is less th an 400 m L/ day.

c. Signs of excess fluid volum e: Hypertension, edem a, pleural and pericardial effusions, dys- rhythm ias, heart failure, and pulm onary edem a

d . Sign s of urem ia: An orexia, n ausea, vom itin g, an d pruritus

e. Sign s of m etab olic acidosis: Kussm aul’s respi- ration s

f. Sign s of n eurological ch an ges: Tin glin g of extrem ities, drowsin ess progressin g to disori- en tation , an d th en com a

g. Sign s of pericard itis: Friction ru b, ch est pain with in spiration , an d lo w-grade fever

h . Laboratory an alysis (see Box 58-4) i. With early recogn ition or poten tial for AKI,

clien t m ay be treated with flu id ch allen ges (IV boluses of 500 to 1000 m L over 1 h ou r).

j. Restrict flu id in take; if h yperten sion is pre- sen t, daily fluid allowan ces m ay be 400 to 1000 m L plus th e m easured urin ary outp ut.

k . Adm in ister m ed ication s, such as diuretics, as prescribed to in crease ren al blood flo w an d diuresis of retain ed fluid an d electrolytes.

3. Diuretic ph ase a. Urin e output rises slowly, followed by diure-

sis (4 to 5 L/ day) . b . Excessive urin e outp ut in dicates th at dam -

aged n eph ron s are recoverin g th eir ability to excrete wastes.

c. Deh ydration , h ypovo lem ia, h ypoten sion , an d tach ycardia can occur.

d . Level of con sciousn ess im proves. e. Laboratory an alysis (see Box 58-4) f. Adm in ister IV fluids as prescribed , wh ich m ay

con tain electrolytes to replace lo sses. 4. Recovery ph ase (con valescen t)

a. Recovery is a slow process; com plete recovery m ay take 1 to 2 years.

b . Urin e vo lum e return s to n orm al. c. Mem ory im proves. d . Stren gth in creases. e. Th e older ad ult is less likely th an a youn ger

adult to regain full kidn ey fun ction .

BOX 58-3 Potentially Nephrotoxic Substances Medications Ant ibiot ics: Antiinfect ives ▪ Amphotericin B ▪ Methicillin ▪ Polymyxin B ▪ Rifampin ▪ Sulfonamides ▪ Tetracycline

hydrochloride ▪ Vancomycin Aminoglycoside Ant ibiot ics ▪ Gentamicin ▪ Kanamycin ▪ Neomycin ▪ Tobramycin Ant ineopla st ics ▪ Cisplatin ▪ Cyclophosphamide ▪ Methotrexate Nonst eroida l Ant iinflammat ory Drugs (NSAIDs) ▪ Celecoxib ▪ Flurbiprofen ▪ Ibuprofen ▪ Indomethacin ▪ Ketorolac ▪ Meclofenamate ▪ Meloxicam ▪ Nabumetone ▪ Naproxen ▪ Oxaprozin

▪ Rofecoxib ▪ Tolmetin

Other Medications ▪ Acetaminophen ▪ Captopril ▪ Cyclosporine ▪ Fluorinate anesthetics ▪ D-Penicillamine ▪ Phenazopyridine

hydrochloride ▪ Quinine Other Substances ▪ Organic solvents ▪ Carbon tetrachloride ▪ Ethylene glycol Nonpharmacological Chemical Agents ▪ Radiographic contrast

dye ▪ Pesticides ▪ Fungicides ▪ Myoglobin (from break-

down of skeletal muscle)

Heavy Metals and Ions ▪ Arsenic ▪ Bismuth ▪ Copper sulfate ▪ Gold salts ▪ Lead ▪ Mercuric chloride

Adapted from Ignatavicius D, Workman ML: Medical-surgical nursing: patient- centered collaborative care, ed 7, Philadelphia, 20 13, Saunders.

822 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

f. Laboratory an alysis (see Box 58-4) g. AKI can progress to chronic kidney disease

(CKD).

The signs and symptoms of AKI are primarily caused by the retention of nitrogenous wastes, the reten- tion of fluids, and the inability of the kidneys to regulate electrolytes.

D. Assessm en t: Assess objective an d subjective data n oted in th e ph ases of AKI (see Box 58-4).

E. O th er in terven tion s 1. Mon itor vital sign s, esp ecially for sign s of

h yperten sio n , tach ycardia, tach ypn ea, an d an irregular h eart rate.

2. Mon itor urin e an d in take an d outp ut h ourly an d urin e color an d ch aracteristics.

3. Mon itor daily weigh t (sam e scale, sam e clo th es, sam e tim e of day), n otin g th at an in crease of ½ to 1 lb/ day (0.25 to 0.5 kg/ day) in dicates fluid reten tion .

4. Mon itor for ch an ges in th e BUN, serum creati- n in e, an d serum electrolyte levels.

5. Mon itor for acido sis (m ay n eed to be treated with sodium bicarbo n ate).

6. Mon itor urin alysis for protein level, h em aturia, casts, an d specific gravity.

7. Mon itor for altered level of con sciousn ess cau sed by urem ia.

8. Mon itor for sign s of in fectio n because th e clien t m ay n ot exh ibit an elevated tem perature or an in creased WBC coun t.

9. Mon itor th e lun gs for wh eezes an d rh on ch i an d m on itor for edem a, wh ich can in dicate fluid overload.

10. Adm in ister th e prescribed diet, wh ich is usually a low- to m oderate-pro tein (to decrease th e workload on th e kidn eys) an d h igh - carbo h ydrate diet; ill clien ts m ay require n utri- tio n al support with supp lem en ts, en teral feed- in gs, or paren teral n utrition .

11. Restrict potassium an d sodium in take as pre- scrib ed based on th e electrolyte level.

12. Adm in ister m edication s as prescribed; be alert to th e m ech an ism for m etabolism an d excre- tio n of all prescribed m ed ication s.

13. Be alert to n eph rotoxic m edication s, wh ich m ay be prescribed (see Box 58-3).

14. Be alert to th e HCP’s adju stm en t of m ed ication dosages for kidn ey in jury.

15. Prepare th e clien t for dialysis if prescribed; con - tin uo us ren al replacem en t th erap y m ay be used in AKI to treat fluid volum e overload or rapidly developin g azotemia an d m etab olic acidosis.

16. Provide em o tion al support by allowin g oppo r- tun ities for th e clien t to express con cern s an d fears an d by en couragin g fam ily in teraction s.

17. Prom ote con sisten cy in caregivers. 18. Also refer to Section IV, E in th is ch apter (Special

problem s in kidn ey disease an d in terven tion s).

IV. Chronic Kidney Disease (CKD) A. Description

1. CKD is a slow, progressive, irreversible loss in kidn ey fun ction , with a GFR less th an or equal to 60 m L/ m in ute for 3 m on th s or lon ger.

2. It occurs in stages (with loss of 75% of fun ction - in g n eph ro n s, th e clien t becom es sym pto m atic) an d even tually results in urem ia or en d-stage kid- n ey disease (with loss of 90% to 95% of fun ctio n - in g n eph ron s) (Table 58-2).

3. Hypervolem ia can occur because of th e kidn eys’ in ability to excrete sodium an d water; h ypo vole- m ia can occur because of th e kidn eys’ in ability to con serve sodium an d water.

CKD affects all major body systems and may require dialysis or kidney transplantation to maintain life.

B. Prim ary cau ses 1. May follow AKI 2. Diabetes m ellitus an d oth er m etabolic disorders 3. Hyperten sion

BOX 58-4 Acute Kidney Injury: Phases and Laboratory Findings

Onset ▪ Begins with precipitating event Oliguric Phase ▪ Elevated blood urea nitrogen (BUN) and serum creatinine

levels ▪ Decreased urine specific gravity (prerenal causes) or nor-

mal (intrarenal causes) ▪ Decreased glomerular filtration rate (GFR) and creatinine

clearance ▪ Hyperkalemia ▪ Normal or decreased serum sodium level ▪ Hypervolemia ▪ Hypocalcemia ▪ Hyperphosphatemia Diuretic Phase ▪ Gradual decline in BUN and serum creatinine levels, but

still elevated ▪ Continued low creatinine clearance with improving GFR ▪ Hypokalemia ▪ Hyponatremia ▪ Hypovolemia Recovery Phase (Convalescent) ▪ Increased GFR ▪ Stabilization or continual decline in BUN and serum creat-

inine levels toward normal ▪ Complete recovery (may take 1 to 2 years)

823CHAPTER 58 Renal and Urinary System

4. Ch ron ic urin ary obstru ction 5. Recurren t in fectio n s 6. Ren al artery occlu sion 7. Autoim m un e disorders

C. Assessm en t 1. Assess body system s for th e m an ifestatio n s of

CKD (Box 58-5). 2. Assess psych ological ch an ges, wh ich could

in clude em otion al lability, with drawal, depres- sion , an xiety, den ial, depen den ce-in depen den ce con flict, ch an ges in body im age, an d suicidal beh avior.

D. In terven tion s 1. Sam e as th e in terven tion s for AKI. 2. Adm in ister a prescribed diet, wh ich is usually a

m od erate-pro tein (to decrease th e workload on th e kidn eys) an d h igh -carboh ydrate, low-potas- sium , an d lo w-ph osp h orus diet.

3. Provide oral care to preven t stom atitis an d reduce discom fort from m outh sores.

4. Provide skin care to preven t pruritu s. 5. Teach th e clien t about fluid an d dietary restric-

tio n s an d th e im portan ce of daily weigh ts. 6. Provide support to prom o te acceptan ce of th e

ch ron ic illn ess an d prepare th e clien t for lon g- term dialysis an d tran splan tation , or explain to th e clien t about h is or h er ch oice to declin e dial- ysis or tran splan tatio n ; with elderly clien ts, pro- vide in form ation th at kidn ey fun ctio n is declin in g an d in tim e m ay reach en d-stage ren al disease an d require dialysis; en courage h ealth y lifestyle an d discuss ch oices.

E. Special problem s in kidn ey disease an d in terven tion s (Box 58-6)

1. Activity in toleran ce an d in som n ia a. Fatigue results from an em ia and th e buildup

of wastes from th e diseased kidn eys. b . Provide adequate rest periods.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y TABLE 58-2 Progression of Chronic Kidney Disease Stage of CKD Estimated GFR

At risk; normal kidney function (early kidney disease may or may not be present)

> 90 mL/ min

Mild CKD 60-89 mL/ min

Moderate CKD 30 -59 mL/ min

Severe CKD 15-29 mL/ min

ESKD < 15 mL/ min

CKD, Chronic kidney disease; ESKD, end-stage kidney disease; GFR, glomerular filtration rate. Data from Ignatavicius D, Workman ML: Medical-surgical nursing: patient-centered collaborative care, ed 7, Philadelphia, 20 13, Saunders.

BOX 58-5 Key Features of Chronic Kidney Disease

Neurological Manifestations ▪ Asterixis ▪ Ataxia (alteration in gait) ▪ Inability to concentrate

or decreased attention span

▪ Lethargy and daytime drowsiness

▪ Myoclonus ▪ Paresthesias ▪ Seizures ▪ Slurred speech ▪ Tremors, twitching, or

jerky movements ▪ Coma Cardiovascular Manifestations ▪ Hypertension ▪ Heart failure ▪ Peripheral edema ▪ Cardiomyopathy ▪ Pericardial effusion ▪ Pericardial friction rub ▪ Uremic pericarditis ▪ Cardiac tamponade Respiratory Manifestations ▪ Crackles ▪ Deep sighing, yawning ▪ Depressed cough reflex ▪ Shortness of breath ▪ Tachypnea ▪ Kussmaul’s respirations ▪ Pleural effusion ▪ Pulmonary edema ▪ Uremic halitosis ▪ Uremic pneumonia Hematological Manifestations ▪ Abnormal bleeding and

bruising ▪ Anemia

Gastrointestinal Manifestations ▪ Anorexia, nausea,

vomiting ▪ Changes in taste acuity

and sensation ▪ Constipation ▪ Diarrhea ▪ Metallic taste in the

mouth ▪ Stomatitis ▪ Uremic colitis (diarrhea) ▪ Uremic fetor ▪ Uremic gastritis (possible

gastrointestinal bleeding)

Urinary Manifestations ▪ Polyuria, nocturia (early) ▪ Proteinuria ▪ Diluted, straw-colored

appearance ▪ Hematuria ▪ Oliguria, anuria (later) Integumentary Manifestations ▪ Decreased skin turgor ▪ Dry skin ▪ Yellow-gray pallor ▪ Ecchymosis ▪ Pruritus ▪ Purpura ▪ Soft tissue calcifications ▪ Uremic frost (late,

premorbid)

Musculoskeletal Manifestations ▪ Bone pain ▪ Muscle weakness and

cramping ▪ Pathological fractures ▪ Renal osteodystrophy Reproductive Manifestations ▪ Decreased fertility ▪ Decreased libido ▪ Impotence ▪ Infrequent or absent

menses

From Ignatavicius D, Workm an ML: Medical-surgical nursing: patient-centered collab- orative care, ed 7, Philadelphia, 2013, Saunders.

824 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

c. Teach th e clien t to plan activities to avoid fatigue.

d . Mild cen tral n ervou s system (CNS) dep res- san ts m ay be prescribed to prom o te rest.

2. An em ia a. An em ia results from th e decreased secretio n

of eryth ropoietin by dam aged n eph ron s, resultin g in decreased produ ction of red blood cells.

b . Mon itor for decreased h em oglob in an d h em atocrit levels.

c. Adm in ister h em atop oietics such as epo etin alfa or darb epoetin alfa, as prescribed to prom o te m aturity of th e red blood cells.

d . Adm in ister folic acid as prescribed. e. Adm in ister iron orally as prescribed , but

n ot at th e sam e tim e as ph osph ate bin d ers. f. Adm in ister stool soften ers as prescribed

because of th e con stipatin g effects of iron . g. Note th at oral iron is n ot well absorbed by

th e GI tract in CKD an d causes n ausea an d vom itin g; paren teral iron m ay be used if iron deficien cies persist despite folic acid or oral iron adm in istration .

h . Adm in ister blood tran sfusion s; prescribed on ly wh en n ecessary (acute blood loss, sym ptom atic an em ia) because th ey decrease the stim ulus to produce red blood cells.

i. Blood tran sfusion s also cau se th e develop- m en t of an tibod ies again st h um an tissues, wh ich can m ake m atch in g for organ tran s- plan tation difficult.

3. Gastro in testin al bleedin g a. Urea is broken down by th e in testin al bac-

teria to am m on ia; am m on ia irritates th e GI m ucosa, cau sin g ulceratio n an d bleedin g.

b . Mon itor for decreasin g h em oglobin an d h em atocrit levels.

c. Mon itor stools for occult blood . d . Avoid th e ad m in istration of acetylsalicylic

acid because it is excreted by th e kidn eys; if adm in istered, aspirin toxicity can occur an d prolon g th e bleed in g tim e.

4. Hyperkalem ia a . Mon itor vital sign s for h yperten sion or h ypo-

ten sion an d th e apical h eart rate; an irregular h eart rate could in dicate dysrh ythm ias.

b . Mon itor the serum potassium level; an ele- vated serum potassium level can cause decreased cardiac output, h eart blocks, fibril- lation , or asystole (Fig. 58-1).

c. Provide a low-potassium diet (see Ch apter 11 for a list of foods th at are h igh in potassium ).

d . Adm in ister electrolyte-bin din g an d electrolyte-excretin g m edications such as oral or rectal sodium polystyren e sulfonate as pre- scribed to lower the serum potassium level.

e. Adm in ister prescribed m edication s: 50% dextrose an d regular in sulin IV m ay be pre- scribed to sh ift potassium in to th e cells; cal- ciu m gluco n ate IV m ay be prescribed to reduce m yocardial irritability from h yper- kalem ia; an d sodium bicarbon ate IV m ay be prescribed to correct acidosis.

f. Adm in ister prescribed loop diuretics to excrete potassium .

g. Avoid potassium -retain in g m ed ication s such as spiron olacto n e an d triam teren e because th ese m edication s will in crease th e potassium level.

BOX 58-6 Special Problems in Kidney Failure

▪ Activity intolerance and insomnia

▪ Anemia ▪ Gastrointestinal

bleeding ▪ Hyperkalemia ▪ Hypermagnesemia ▪ Hyperphosphatemia ▪ Hypertension ▪ Hypervolemia

▪ Hypocalcemia ▪ Hypovolemia ▪ Infection ▪ Metabolic acidosis ▪ Muscle cramps ▪ Neurological changes ▪ Ocular irritation ▪ Potential for injury ▪ Pruritus ▪ Psychosocial problems

QRSQRS

T

QRSQRS T

QRSQRS

T

P

QRSQRS T

P

QRS

T

QRS T

QRS

T

P

QRS T

P

A

B

C

D

Norma l (3.5-5.0 mEq/L)

S e rum Po tas s ium Le ve l

About 7.0 mEq/L

S e rum Po tas s ium Le ve l

8.0-9.0 mEq/L

S e rum Po tas s ium Le ve l

>10.0 mEq/L

S e rum Po tas s ium Le ve l

FIGURE 58-1 Cardiac rhythm changes with hyperkalemia.

825CHAPTER 58 Renal and Urinary System

h . Prepare th e clien t for periton eal dialysis (PD) or h em od ialysis as prescribed.

Place the client with kidney disease on continuous telemetry. The client can develop hyperkalemia, resulting in the risk for dysrhythmias.

5. Hyperm agn esem ia a. Results from decreased ren al excretion of

m agn esium . b . Mon itor for cardiac m an ifestation s such as

bradycardia, periph eral vaso dilation , an d h ypoten sion .

c. Mon itor CNS ch an ges, such as drowsin ess or leth argy.

d . Mon itor n eurom u scular m an ifestation s, such as reduced or absen t deep ten don reflexes or weak or ab sen t volun tary skeletal m uscle con traction s.

e. Adm in ister loop diuretics as prescribed to excrete m agn esium .

f. Adm in ister calcium as prescribed for result- in g cardiac problem s.

g. Avoid m edication s th at con tain m agn e- sium , such as an tacids; som e laxatives an d en em as m ay also con tain m agn esium .

h . Durin g severe elevation s, avoid foods that in crease m agn esium levels (see Ch apter 11 for a list of foods that are h igh in m agn esium ).

6. Hyperph osph atem ia a. As th e ph o sph orus level rises, th e calcium

level drops; th is leads to th e stim ulation of parath yro id h orm on e, causin g bon e dem in eralization .

b . Treatm en t is aim ed at lowerin g th e serum ph osph orus level.

c. Adm in ister ph osph ate bin ders as prescribed with m eals to lower serum ph osph ate levels.

d . Adm in ister stool soften ers an d laxatives as prescribed because ph osph ate bin d ers are con stipatin g.

e. Teach th e clien t about th e n eed to lim it th e in take of food s h igh in ph o sph orus (see Ch apter 11 for a list of food s th at are h igh in ph osph orus).

7. Hyperten sion a. Caused by failure of th e kidn eys to m ain -

tain BP h om eo stasis. b . Mon itor vital sign s for elevated BP. c. Main tain flu id an d sodium restriction s as

prescribed. d . Adm in ister diuretics an d an tih yp erten sives

as prescribed . 8. Hypervolem ia

a. Mon itor vital sign s for an elevated BP. b . Mon itor in take an d outp ut an d daily weigh t

for in dication s of fluid reten tion .

c. Mon itor for periorbital, sacral, an d periph - eral edem a.

d . Mon itor th e serum electrolyte levels. e. Mon itor for h yperten sio n an d n otify th e

HCP if th ere are sustain ed elevation s. f. Mon itor for sign s of h eart failure an d pul-

m on ary edem a, such as restlessn ess, h eigh t- en ed an xiety, tach ycardia, dyspn ea, basilar lu n g crackles, an d blood -tin ged sputum ; n otify th e HCP im m ediately if sign s occur.

g. Main tain fluid restriction . h . Avo id th e adm in istration of large am oun ts

of IV fluids. i. Adm in ister diuretics as prescribed. j. Teach th e clien t to m ain tain a low-sod ium

diet. k . Teach th e clien t to avoid over-th e-coun ter

m edication s with out ch eckin g with th e HCP. 9. Hypocalcem ia

a . Resu lts from a h igh ph o sph orus level an d th e in ability of th e diseased kidn ey to acti- vate vitam in D

b . Th e absen ce of vitam in D cau ses poor cal- ciu m ab sorption from th e in testin al tract.

c. Mon itor th e serum calcium level. d . Adm inister calcium supplem ents as prescribed. e. Adm in ister activated vitam in D as prescribed. f. See Ch apter 11 for a list of foods th at are

h igh in calcium . 10. Hypovolem ia

a. Mon itor th e vital sign s for h ypo ten sion an d tach ycardia.

b . Mon itor for decreasin g in take an d outp ut an d a reduction in th e daily weigh t.

c. Mon itor for deh ydration . d . Mon itor electrolyte levels. e. Provide replacem en t th erap y based on th e

serum electrolyte level values. 11. In fection

a. Th e clien t is at risk for in fection caused by a supp ressed im m un e system , dialysis access site, an d possible m aln utrition .

b . Mon itor for sign s of in fectio n . c. Avo id urin ary cath eters wh en possib le; if

used, provide cath eter care per protoco l. d . Provide strict asepsis durin g urin ary cath e-

ter in sertion an d oth er in vasive procedures. e. In struct th e clien t to avoid fatigue an d avoid

perso n s with in fectio n s. f. Adm in ister an tibiotics as prescribed , m on i-

torin g for n eph rotoxic effects. 12. Metabolic acido sis

a. Th e kidn eys are un ab le to excrete h ydrogen io n s or m an ufacture bicarbon ate, resultin g in acido sis.

b . Adm in ister alkalizers such as sodium bicar- bon ate as prescribed .

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

826 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

c. Note th at clien ts with CKD ad just to low bicarbo n ate levels an d as a result do n ot becom e acutely ill.

13. Muscle cram ps a. O ccur from electrolyte im balan ces an d th e

effects of urem ia on periph eral n erves b . Mon itor serum electrolyte levels. c. Adm in ister electrolyte replacem en ts an d

m edication s to con tro l m uscle cram p s as prescribed.

d . Adm in ister h eat an d m assage as prescribed . 14. Neurological ch an ges

a. Th e buildup of active particles an d fluid s causes ch an ges in th e brain cells an d lead s to con fusion an d im pairm en t in decision - m akin g ability.

b . Periph eral n europath y results from th e effects of urem ia on periph eral n erves.

c. Mon itor th e level of con sciousn ess an d for con fusion .

d . Mon itor for restless leg syn drom e, wh ich is also com m on durin g dialysis treatm en ts.

e. Teach th e clien t to exam in e areas of decreased sen sation for sign s of in jury.

15. O cular irritatio n a. Calcium deposits in th e con jun ctivae cau se

burn in g an d waterin g of th e eyes. b . Adm in ister m ed ication s to con trol th e cal-

cium an d ph osph ate levels as prescribed. c. Adm in ister lu bricatin g eye drops. d . Protect th e clien t fro m in jury.

16. Poten tial for in jury a. The client is at risk for fractures caused by alter-

ation s in th e absorption of calcium , excretion of ph osph ate, an d vitam in D m etabolism .

b . Provide for a safe en viron m en t. c. Avoid in jury; tissue breakdown causes

in creased serum potassium levels. 17. Pruritu s

a. To rid th e body of excess wastes, urate crys- tals are excreted th rough th e skin , causin g pruritus.

b . Th e deposit of urate crystals (urem ic frost) occurs in advan ced stages of kidn ey disease.

c. Mon itor for skin breakdown , rash , an d ure- m ic frost.

d . Provide m eticulo us skin care an d oral h ygien e.

e. Avoid th e use of soaps. f. Adm in ister an tih istam in es an d an tipru-

ritics as prescribed to relieve itch in g. g. Teach th e clien t to keep th e n ails trim m ed

to preven t local in fection from scratch in g. 18. Psych o social problem s

a. Listen to th e client’s con cern s to determ in e h ow the clien t is h an dlin g the situation .

b . Allow th e clien t tim e to m ourn th e loss of kidn ey fun ction .

c. With clien t perm ission , in clude the fam ily m em bers in discussion s of th e clien t’s con cerns.

d . Provide education about treatm en t option s an d support th e clien t’s decision ; elderly cli- en ts with CKD m ay progress slowly toward en d-stage kidn ey disease or require dialysis, an d clien ts m ay decide on n o treatm en t an d opt for en d-of-life care.

e. O ffer in form ation ab out support grou ps.

V. Uremic Syndrome A. Descriptio n : System ic clin ical an d laborato ry m an i-

festation s of severe an d/ o r en d-stage kidn ey disease due to accu m ulation of n itrogen ous waste produ cts in th e blood caused by th e kidn eys’ in ability to filter out th ese waste products.

B. Assessm en t 1. O liguria 2. Presen ce of protein , red blood cells, an d casts in

th e urin e 3. Elevated levels of urea, uric acid, potassium , an d

m agn esium in th e urin e 4. Hypoten sion or h yperten sion 5. Alteration s in th e level of con sciousn ess 6. Electrolyte im balan ces 7. Stom atitis 8. Nausea or vom itin g 9. Diarrh ea or con stipation

C. In terven tion s 1. Mon itor vital sign s for h yperten sion , tach ycardia,

an d an irregular h eart rate. 2. Mon itor serum electrolyte levels. 3. Mon itor in take an d outp ut an d for oliguria. 4. Provide a lim ited but h igh -quality protein diet as

prescribed. 5. Provide a lim ited sodium , n itrogen , potassium ,

an d ph osph ate diet as prescribed. 6. Assist th e clien t to cope with body im age distur-

ban ces caused by urem ic syn drom e.

VI. Hemodialysis A. Description

1. Hem o dialysis is an in term itten t ren al replace- m en t th erap y in volvin g th e process of clean sin g th e clien t’s blood .

2. It in volves th e diffusion of dissolved particles from 1 flu id com partm en t in to an oth er across a sem iperm eable m em bran e; th e clien t’s blood flows th rou gh 1 flu id com partm en t of a dialysis filter, an d th e dialysate is in an oth er fluid com - partm en t.

B. Fun ction s of h em odialysis 1. Clean ses th e blood of accum ulated waste products 2. Rem o ves th e byprodu cts of protein m etab olism

such as urea, creatin in e, an d uric acid from th e blood

3. Rem o ves excess body fluids

827CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

4. Main tain s or restores th e buffer system of th e body 5. Corrects electrolyte levels in th e body

C. Prin ciples of h em od ialysis 1. Th e sem iperm eable m em bran e is m ade of a th in ,

porou s celloph an e. 2. Th e pore size of th e m em bran e allows sm all par-

ticles to pass th rou gh , such as urea, creatin in e, uric acid, an d water m olecu les.

3. Protein s, bacteria, an d som e blood cells are too large to pass th rou gh th e m em bran e.

4. Th e clien t’s blood flo ws in to th e dialyzer; th e m ovem en t of substan ces occurs fro m th e blood to th e dialysate by th e prin ciples of osm o sis, dif- fusion , an d ultrafiltration .

5. O sm o sis is th e m ovem en t of fluids across a sem i- perm eable m em bran e fro m an area of lower con - cen tration of particles to an area of h igh er con cen tration of particles.

6. Diffusion is th e m ovem en t of particles from an area of h igh er con cen tration to on e of lower con cen tration .

7. Ultrafiltration is th e m ovem en t of flu id across a sem iperm eab le m em bran e as a result of an arti- ficially created pressure gradien t.

D. Dialysate bath 1. A dialysate bath is com posed of water an d m ajor

electrolytes. 2. Th e dialysate n eed n ot be sterile because bacteria

an d viruses are too large to pass th rough th e pores of th e sem iperm eab le m em bran e; h ow- ever, th e dialysate m ust m eet specific stan dards, an d water is treated to en sure a safe water supp ly.

E. In terven tion s 1. Mon itor vital sign s befo re, durin g, an d after dial-

ysis; th e clien t’s tem p erature m ay elevate because of sligh t warm in g of th e blood fro m th e dialysis m ach in e (n otify th e HCP about excessive tem - perature elevation s because th is could in dicate sepsis, requirin g blood cultures to be collected ).

2. Mon itor laborato ry values, specifically th e BUN, creatin in e, an d com plete blood cell coun ts befo re, durin g, an d after dialysis.

3. Assess th e clien t for flu id overload before dialysis an d fluid volum e deficit followin g dialysis.

4. Weigh th e clien t befo re an d after dialysis to determ in e fluid loss. Note th at th e clien t will n ot urin ate or will urin ate sm all am oun ts (m ay be less th an 30 m L per h ou r).

5. Assess th e paten cy of th e blood access device befo re, durin g, an d after dialysis.

6. Mon itor for bleed in g; h eparin is added to th e dialysis bath to preven t clo ts fro m form in g in th e dialyzer or th e blood tubin g.

7. Mon itor for h ypo volem ia durin g dialysis, wh ich can occur from blood loss or excess fluid an d electrolyte rem oval.

8. Provide ad equate n utrition ; th e clien t m ay eat befo re or durin g dialysis.

9. Iden tify th e clien t’s reaction s to th e treatm en t an d support copin g m ech an ism s; en courage in depen den ce an d in volvem en t in care.

Withhold antihypertensives and other medications that can affect the BP or result in hypotension until after hemodialysis treatment. Also withhold medications that could be removed by dialysis, such as water-soluble vita- mins, certain antibiotics, and digoxin.

VII. Access for Hemodialysis A. Subclavian an d fem o ral cath eters

1. Description a . A subclavian (subclavian vein ) or fem o ral

(fem oral vein ) cath eter m ay be in serted for sh ort-term or tem p orary use in AKI.

b . Th e cath eter is used un til a fistula or graft m atures or develops, wh ich is typically 6 weeks, or m ay be required wh en th e clien t’s fistula or graft access h as failed because of in fectio n or clo ttin g.

2. In terven tion s a . Assess in sertio n site for h em atom a, bleedin g,

cath eter dislodgem en t, an d in fectio n . b . Th ese cath eters sh ould on ly be used for dial-

ysis treatm en ts an d accessed by dialysis person n el.

c. Main tain an occlusive dressin g over th e cath - eter in sertion site.

3. Subclavian vein cath eter a . Th e cath eter is usually filled with h eparin an d

capped to m ain tain paten cy between dialysis treatm en ts. Heparin is aspirated from th e lin e before dialysis.

b . Th e cath eter sh ould n ot be un cap ped except for dialysis treatm en ts.

c. Th e cath eter m ay be left in place for up to 6 weeks if n o com plication s occur.

4. Fem o ral vein cath eter a . Assess th e extrem ity for circulation , tem p era-

ture, an d pulses. b . Preven t pullin g or discon n ectin g of th e cath -

eter wh en givin g care. c. Becau se th e groin is n ot a clean site, m eticu-

lous perin eal care is required . d . Use an IV in fusion pum p or con tro ller with

m icro drip tubin g if a h eparin in fusion th rough th e cath eter to m ain tain paten cy is prescribed.

The client with a femoral vein catheter should not sit up more than 45 degrees or lean forward, because the catheter may kink and occlude.

B. Extern al arterioven ous sh un t ( Fig. 58-2) 1. Description

a . Two Silastic can n ulas are surgically in serted in to an artery an d vein in th e forearm or leg to form an extern al blood path .

828 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

b . Th e can n ulas are co n n ected to form a U sh ap e; blood flo ws from th e clien t’s artery th rou gh th e sh u n t in to th e vein .

c. A tube leadin g to th e m em bran e com part- m en t of th e dialyzer is con n ected to th e arte- rial can n ula.

d . Bloo d fills th e m em bran e com partm en t, passes th rough th e dialyzer, an d is return ed to th e clien t th rou gh a tube con n ected to th e ven o us can n ula.

e. Wh en dialysis is com plete, th e can n ulas are clam p ed an d reattach ed, reform in g th e U sh ape.

2. Advan tages a . Th e extern al arterioven o us sh un t can be used

im m ediately followin g its creation . b . No ven ipu n ctu re is n ecessary for dialysis.

3. Disadvan tages a . Discon n ection or dislodgm en t of th e extern al

sh un t b . Risk of h em orrh age, in fectio n , or clottin g c. Poten tial for skin erosion arou n d th e

cath eter site 4. In terven tion s

a . Avoid gettin g th e sh u n t wet. b . Wrap a dressin g com pletely aroun d th e sh un t

an d keep it dry an d in tact. c. Keep can n ula clam ps at th e clien t’s bed side or

attach ed to th e arterioven ous dressin g for use in case of acciden tal discon n ection .

d . Teach th e clien t th at th e sh un t extrem ity sh ould n ot be used for m on itorin g BP, draw- in g blood , placin g IV lin es, or adm in isterin g in jection s.

e. Fold back th e dressin g to exp ose th e sh u n t tubin g an d assess for sign s of h em orrh age, in fectio n , or clo ttin g.

f. Mon itor skin in tegrity aroun d the insertion site. g. Auscu ltate for a bruit an d palp ate for a th rill,

alth ough a bruit m ay n ot be h eard with th e sh un t.

h . Notify th e HCP im m ediately if sign s of clot- tin g, h em orrh age, or in fectio n occur.

5. Sign s of clottin g a . Fibrin : Wh ite flecks in th e tubin g b . Separation of serum an d cells c. Absen ce of a previously h eard bruit; th rill

absen t on palp ation d . Cooln ess of th e tubin g or extrem ity e. Tin glin g sen sation at site or in extrem ity

C. In tern al arteriovenous fistula (see Fig. 58-2) 1. Description

a . A perm an en t access of ch oice for th e clien t with CKD requirin g dialysis.

b . Th e fistula is created surgically by an asto- m osis of a large artery an d large vein in th e arm .

c. Th e flo w of arterial blood in to th e ven o us sys- tem causes th e vein to becom e en gorged (m atu red or developed ).

d . Maturity takes ab out 4 to 6 weeks, dep en din g on th e clien t’s ability to do h an d-flexin g exer- cises such as ball squeezin g, wh ich h elp th e fistula to m ature.

e. Th e fistula is required to be m ature before it can be used because th e en gorged vein is pun ctured with a large-bo re n eedle for th e dialysis proced ure.

Te flon conne ctor

Ra dia l a rte ry

Te flon ve s s e l tip

Ba s ilic ve in

S ila s tic tubing (e xte rna l s e gme nt)

D

A

Loope d gra ft

Bra chia l a rte ry

Ante cubita l ve in

C

Blood s upply to dia lyze r

Blood re turn to pa tie nt

Ba s ilic ve in

Fis tula (a na s tomos is of a rte ry a nd ve in, s hunting a rte ria l blood into ve in)

Ra dia l a rte ry

B

FIGURE 58-2 Vascular access for hemodialysis. A, External shunt. B, Internal arteriovenous fistula. C, Internal arteriovenous graft. D, A hemodialysis graft while connected to a hemodialysis machine. (D, From Lewis et al., 20 11.)

829CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

f. Subclavian or fem oral cath eters, PD, or an extern al arterioven ous sh u n t can be used for dialysis wh ile th e fistula is m aturin g or developin g.

2. Advan tages a. Becau se th e fistula is in tern al, th e risk of clot-

tin g an d bleedin g is low. b . Th e fistula can be used in defin itely. c. Th e fistula h as a decreased in ciden ce of

in fectio n because it is in tern al an d is n ot exposed.

d . O n ce h ealin g h as occurred, n o extern al dress- in g is required .

e. Th e fistula allows freedom of m ovem en t. 3. Disadvan tages

a. Th e fistula can n ot be used im m ediately after in sertio n , so plan n in g ah ead for an altern a- tive access for dialysis is im portan t.

b . Needle in sertion s th rou gh th e skin an d tis- sues to th e fistula are required for dialysis.

c. In filtration of th e n eedles durin g dialysis can occur an d cause h em atom as.

d . An an eu rysm can form in th e fistula. e. Heart failure can occur fro m th e in creased

blood flow in th e ven o us system .

Arterial steal syndrome can develop in a client with an internal arteriovenous fistula. In this complication, too much blood is diverted to the vein, and arterial per- fusion to the hand is compromised.

D. In tern al arterioven o us graft (see Fig. 58-2) 1. Description

a. Th e in tern al graft m ay be used for ch ron ic dialysis clien ts wh o do n ot h ave adequate blood vessels for th e creation of a fistula.

b . An artificial graft m ade of Gore-Tex or a bovin e (cow) carotid artery is used to create an artificial vein for blood flo w.

c. Th e procedure in volves th e an astom osis of an artery to a vein , usin g an artificial graft.

d . Th e graft can be used 2 weeks after in sertio n . e. Com p lication s of th e graft in clude clottin g,

an eurysm s, an d in fectio n . 2. Advan tages an d disadvan tages: Sam e as for in ter-

n al arterioven o us fistula E. In terven tion s for an arterioven ous fistula an d arte-

rioven ous graft 1. Teach th e clien t th at th e extrem ity sh ould n ot be

used for m on itorin g BP, drawin g blood, placin g IV lin es, or ad m in isterin g in jection s, an d th at th e clien t sh o uld in form all h ealth care person n el of its presen ce.

2. Teach th e clien t with an arterioven ous fistula to perform h an d-flexin g exercises such as ball squeezin g (if prescribed) to prom o te graft m aturity.

3. No te th e tem perature an d capillary refill of th e extrem ity.

4. Palp ate pulses below th e fistula or graft, an d m on itor for h an d swellin g as an in dication of isch em ia.

5. Mon itor for clottin g. a . Com p lain ts of tin glin g or discom fort in th e

extrem ity b . In ab ility to palpate a th rill or auscultate a

bruit over th e fistula or graft 6. Mon itor for arterial steal syndrome. 7. Mon itor for in fectio n . 8. Mon itor lun g an d h eart soun ds for sign s of h eart

failure. 9. No tify th e HCP im m ediately if sign s of clottin g,

in fectio n , or arterial steal syn dro m e occur.

To ensure patency, palpate for a thrill or auscultate for a bruit over the fistula or graft. Notify the HCP if a thrill or bruit is absent.

VIII. Complications of Hemodialysis (Box 58-7) A. If sign s of co m plication s occur, th e dialysis is slowed

or stopp ed, dep en din g on th e com plication , an d th e HCP is n otified im m ediately.

B. Th e n urse stays with th e clien t an d m on itors th e cli- en t, in cludin g vital sign s, wh ile an oth er n urse obtain s in itial prescription s from th e HCP.

C. See Priority Nursin g Action s for air em bolism .

PRIORITY NURSING ACTIONS Air Embolism in a Client Receiving Hemodialysis 1. Stop the hemodialysis. 2. Turn the client on the left side, with the head down (Tren-

delenburg position). 3. Notify the health care provider (HCP) and Rapid

Response Team for the hospitalized client. 4. Administer oxygen. 5. Assess vital signs and pulse oximetry. 6. Document the event, actions taken, and the client’s

response.

Air embolism occurs when air enters the catheter system and is a complication of hemodialysis. The signs of air embo- lism include dyspnea, tachypnea, chest pain, hypotension, reduced oxygen saturation, cyanosis, anxiety, and changes in sensorium. Air embolism is a critical situation and if it is suspected, hemodialysis is stopped immediately and the client should be placed in a left side-lying position with the head lower than the feet. This position is used to try to pre- vent the air from traveling as a bolus to the lungs by trapping it in the right side of the heart. The HCP is notified immedi- ately and oxygen is administered. Vital signs, including pulse oximetry, are assessed and other prescribed interventions are done. The event, actions taken, and the client’s response are documented.

References Ignatavicius, Workman (2016), p. 20 2; Lewis et al. (20 16), p. 311.

830 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

IX. Peritoneal Dialysis A. Description

1. Th e periton eum acts as th e dialyzin g m em bran e (sem iperm eable m em bran e) to ach ieve dialysis an d th e m em bran e is accessed by in sertio n of a PD cath eter th rou gh th e ab dom en .

2. PD works on th e prin ciples of osm o sis, diffusion , an d ultrafiltration ; PD occurs via th e tran sfer of flu id an d solute fro m th e bloodstream th rough th e periton eum in to th e dialysate solution .

3. Th e periton eal m em bran e is large an d porou s, allowin g solutes an d fluid to m ove via osm osis fro m an area of h igh er con cen tration in th e body to an area of lower co n cen tration in th e dialyzin g flu id.

4. Th e periton eal cavity is rich in capillaries; th ere- fore, it provides a ready access to th e blood supp ly.

B. Con train dication s to PD 1. Periton itis 2. Recen t ab dom in al surgery 3. Abdo m in al ad h esion s 4. O th er GI problem s such as diverticulosis

C. Access for PD ( Fig. 58-3) 1. A silicon ized rubber cath eter such as a Ten ckh off

cath eter is surgically in serted in to th e clien t’s

periton eal cavity to allow in fusion of dialysis fluid ; th e cath eter site is co vered by a sterile dressin g th at is ch an ged daily an d wh en soiled or wet.

2. Th e preferred in sertion site is 3 to 5 cm below th e um b ilicus; th is area is relatively avascular an d h as less fascial resistan ce.

3. Th e cath eter is tun n eled un der th e skin , th rough th e fat an d m uscle tissue to th e periton eum ; it is stabilized with in flatable Dacron cuffs in th e m uscle an d un d er th e skin .

4. O ver a period of 1 to 2 weeks followin g in sertio n , fibro blasts an d blood vessels grow arou n d th e cuffs, fixin g th e cath eter in place an d providin g an extra barrier again st dialysate leakage an d bac- terial in vasion .

5. If th e clien t is sch eduled for tran splan t surgery, th e PD cath eter m ay be eith er rem oved or left in place if th e n eed for dialysis is susp ected posttran splan tation .

D. Dialysate solution 1. Th e solution is sterile. 2. All dialysis solution s are prescribed by th e HCP;

th e solution con tain s electrolytes an d m in erals an d h as a specific osm o larity, specific gluco se con cen tration , an d oth er m ed ication ad ditives as prescribed.

3. Th e h igh er th e glucose con cen tration , th e greater th e h yperton icity an d th e am oun t of fluid rem oved durin g a PD exch an ge.

4. In creasin g th e gluco se con cen tration in creases th e con cen tration of active particles th at cau se osm o sis, in creases th e rate of ultrafiltration , an d in creases th e am oun t of flu id rem oved.

5. If h yperkalem ia is n ot a problem , potassium m ay be added to each bag of dialysate solution .

Dia lys is

Outflow

Bowe l Pe ritone a l ca vity

Da cron cuff

Mus cle

Fa t

Pe ritone um

Da cron cuffS kin

Te nckhoff ca the te r

FIGURE 58-3 Manual peritoneal dialysis via an implanted abdominal catheter (Tenckhoff catheter).

BOX 58-7 Complications of Hemodialysis

▪ Air embolus ▪ Disequilibrium

syndrome ▪ Electrolyte alterations ▪ Encephalopathy

▪ Hemorrhage ▪ Hepatitis ▪ Hypotension ▪ Sepsis ▪ Shock

831CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

6. Heparin is added to th e dialysate solution to pre- ven t clottin g of th e cath eter.

7. Proph ylactic an tibiotics m ay be added to th e dialysate solution to preven t periton itis.

8. In sulin m ay be added to th e dialysate solution for th e clien t with diabetes m ellitus.

E. PD in fusion 1. Description

a. O n e in fusion (fill), dwell, an d drain is co n - sidered 1 exch an ge.

b . Fill: 1 to 2 L of dialysate as prescribed is in fused by gravity in to th e periton eal space, wh ich usually takes 10 to 20 m in utes.

c. Dwell tim e: Th e am oun t of tim e th at th e dialysate solution rem ain s in th e periton eal cavity is prescribed by th e HCP an d can last 20 to 30 m in u tes to 8 or m ore h ours, depen d- in g on th e type of dialysis used.

d . Drain (outflow): Fluid drain s out of body by gravity in to th e drain age bag.

2. In terven tion s before treatm en t a. Mon itor vital sign s. b . Mon itor daily weigh t on th e sam e scale. c. Have th e clien t vo id, if possible. d . Assess electrolyte an d glucose levels. e. Assess th e periton eal cath eter dressin g an d site.

3. In terven tion s durin g treatm en t a . Mon itor vital sign s. b . Mon itor for respiratory distress, pain , or

discom fort. c. Mon itor for sign s of pulm o n ary edem a. d . Mon itor for h ypoten sion an d h yperten sion . e. Mon itor for m alaise, n ausea, an d vom itin g. f. Assess th e cath eter site dressin g for wetn ess

or bleedin g. g. Mon itor dwell tim e as prescribed by th e HCP. h . Do n ot allow dwell tim e to exten d beyon d

th e HCP’s prescription because th is in creases th e risk for h yperglycem ia.

i. In itiate outflow; turn th e clien t fro m side to side if th e outflow is slow to start.

j. Mon itor outflow, wh ich sh ould be a con tin - uous stream after th e clam p is open ed.

k . Mon itor outflow for co lor an d clarity. l. Mon itor in take an d outp ut accu rately; if out-

flow is less th an in flow, th e differen ce is equal to th e am oun t absorbed or retain ed by th e clien t durin g dialysis an d sh ould be coun ted as in take.

m . An outflow greater th an in flow as well as th e appearan ce of fran k blood or clo udin ess in th e outflow sh ould be reported to th e HCP.

F. Types of PD 1. Con tin uous am bulatory periton eal dialysis

(CAPD) a. Closely resem bles ren al fun ction because it is

a con tin uous process b . Does n ot require a m ach in e for the procedure

c. Prom o tes clien t in depen den ce d . Th e clien t perform s self-dialysis 24 h ou rs a

day, 7 days a week. e. Four dialysis cycles are usually adm in istered

in a 24-h o ur period, in cludin g an overn igh t 8-h our dwell tim e.

f. Dialysate, 1.5 to 2 L, is in stilled in to th e abdo- m en 4 tim es daily an d allowed to dwell as prescribed (bags are weigh ed to determ in e output) ; th e cath eter is clam p ed an d th e bag is rolled up durin g dwell tim e.

g. After dwell, th e bag is placed lower th an th e in sertio n site an d th e clam p is open ed so th at fluid drain s out by gravity flo w.

h . After flu id is drain ed, th e bag is ch an ged, n ew dialysate is in stilled in to th e ab dom en , an d th e process con tin ues.

i. Between exch an ges, th e cath eter is clam p ed. 2. Autom ated periton eal dialysis ( Box 58-8)

a. Autom ated dialysis requires a periton eal cyclin g m ach in e.

b . Autom ated dialysis can be don e as in term itten t peritoneal dialysis, contin uous cyclin g perito- neal dialysis, or n igh tly periton eal dialysis.

c. Th e exch an ges are autom ated in stead of m an u al.

X. Complications of Peritoneal Dialysis

Infection is a concern with PD; sites of infection are either the catheter insertion site or the peritoneum, caus- ing peritonitis.

A. Periton itis 1. Mon itor for sign s an d sym pto m s of periton itis:

Fever, clo udy outflow, rebou n d abdom in al ten - dern ess, abdom in al pain , gen eral m alaise, n au- sea, an d vom itin g.

BOX58-8 Types of Automated Peritoneal Dialysis Continuous Cycling Peritoneal Dialysis Dialysis requires a peritoneal cycling machine. Dialysis usually consists of 3 cycles done at night and 1 cycle

with an 8-hour dwell done in the morning. The sterile catheter system is opened only for the on-and-off

procedures, which reduces the risk of infection. The client does not need to do exchanges during the day.

Intermittent Peritoneal Dialysis Dialysis requires a peritoneal cycling machine. Dialysis is not a continuous procedure. Dialysis is performed for 10 to 14 hours, 3 or 4 times a week.

Nightly Peritoneal Dialysis Dialysis requires a cycling machine. Dialysis is performed for 8 to 12 hours each night, with no day-

time exchanges or dwells.

832 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

2. Clo udy or opaqu e outflow is an early sign of periton itis.

3. If periton itis is susp ected, obtain a sam ple for culture an d sen sitivity of th e outflow to deter- m in e th e in fective organ ism .

4. An tibiotics m ay be added to th e dialysate. 5. Avo id in fectio n s by m ain tain in g m eticulous ster-

ile tech n ique wh en con n ectin g an d discon n ect- in g PD solution bags an d wh en carin g for th e cath eter in sertio n site.

6. Preven t th e cath eter in sertio n site dressin g from beco m in g wet durin g care of th e clien t or th e dialysis procedure; ch an ge th e dressin g if wet or soiled.

7. Follow in stitutio n al proced ure for con n ectin g an d discon n ectin g PD solution bags, wh ich m ay in clude scrubbin g th e con n ection sites with an an tiseptic solution .

B. Abdo m in al pain 1. Periton eal irritatio n durin g in flow com m on ly

cau ses abdom in al cram pin g an d discom fort dur- in g th e first few exch an ges; th e pain usually dis- ap pears after 1 to 2 weeks of dialysis treatm en ts.

2. Warm th e dialysate before adm in istration , usin g a special dialysate warm er pad, because th e cold tem perature of the dialysate can cause discom fort.

C. Abn orm al outflow ch aracteristics in dicative of com plication s 1. Bloo dy outflow after th e first few exch an ges in di-

cates vascular com plication s (th e outflow sh ould be clear after th e in itial exch an ges).

2. Brown outflow in dicates bowel perforation . 3. Urin e-colored outflow in dicates bladder perfora-

tion . 4. Clo udy outflow in dicates periton itis.

D. In sufficien t outflow 1. Th e m ain cause of in sufficien t outflow is a full

colon ; en courage a h igh -fiber diet, because con - stipation can cau se in flow an d outflow prob- lem s. Adm in ister stool soften ers as prescribed.

2. In sufficien t outflow m ay also be caused by cath e- ter m igration out of th e periton eal area; if this occurs, an x-ray will be prescribed to evaluate cath - eter position .

3. Main tain th e drain age bag below th e clien t’s ab dom en .

4. Ch eck for kin ks in th e tubin g. 5. Ch an ge th e clien t’s outflow position by turn in g

th e clien t to a side-lyin g position or am bulatin g th e clien t.

6. Ch eck for fib rin clots in th e tubin g an d m ilk th e tubin g to dislodge th e clot as prescribed.

E. Leakage aroun d th e cath eter site 1. Clear fluid th at leaks from th e cath eter exit site

will be n oted. 2. It takes 1 to 2 weeks follo win g in sertio n of th e

cath eter befo re fibroblasts an d blood vessels grow in to th e cath eter cuffs, wh ich fix it in place

an d provide an extra barrier again st dialysate leakage an d bacterial in vasion .

3. Sm aller am oun ts of dialysate n eed to be used; it m ay take up to 2 weeks for th e clien t to tolerate a full 2-L exch an ge with ou t leakin g aroun d th e cath eter site.

XI. Continuous Renal Replacement Therapy A. Contin uous ren al replacem en t th erapy (CRRT) pro-

vides contin uous ultrafiltration of extracellular fluid an d clearan ce of urin ary toxin s over a period of 8 to 24 h ours; used prim arily for clien ts in AKI or critically ill clien ts with CKD who can n ot tolerate h em odialysis.

B. Water, electrolytes, an d oth er solutes are rem oved as th e clien t’s blood passes th rou gh a h em ofilter.

C. Because rapid sh ifts in fluid s an d electrolytes typ i- cally do n ot occur, h em ofiltration is usually better tolerated by critically ill clien ts.

D. Th ere are 5 variatio n s of CRRT (Box 58-9), som e th at require a h em od ialysis m ach in e an d oth ers th at rely on th e clien t’s BP to power th e system .

E. If CRRT does n ot require a h em od ialysis m ach in e, th e clien t’s m ean arterial BP n eeds to be m ain tain ed above 60 m m Hg an d arterial an d ven ous access sites are n ecessary.

XII. Kidney Transplantation (Fig. 58-4) A. Description

1. A h um an kidn ey from a com patible don or is im plan ted in to a recipien t.

2. Kid n ey tran splan tation is perform ed for irrevers- ible kidn ey failure; specific criteria are estab- lish ed for eligibility for a tran splan t.

3. Th e recipien t m ust take im m un osuppressive m ed ication s for life.

B. Don o rs 1. Do n ors m ay be livin g don ors (related or un re-

lated to th e clien t) , n on -h eart-beatin g don ors (NH BDs), or cadaver don ors.

2. Th e m ost desirable source of kidn eys for tran s- plan tation is livin g related don ors wh o clo sely m atch th e clien t.

3. No n -h eart-beatin g don ors are th ose wh o h ave been declared dead by cardiop ulm on ary criteria an d h ave organ s h arvested im m ediately after death ; th ese perso n s h ave con sen ted previously to organ don ation .

BOX 58-9 Types of Continuous Renal Replacement Therapy

▪ Continuous venovenous hemofiltration (CVVH) ▪ Continuous arteriovenous hemofiltration (CAVH) ▪ Continuous venovenous hemodialysis (CVVHD) ▪ Continuous arteriovenous hemodialysis (CAVHD) ▪ Slow continuous ultrafiltration (SCUF)

833CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

4. Cad aver don ors are th ose wh o h ave suffered irre- versible brain in jury; th ese person s are m ain - tain ed with m ech an ical ven tilation an d m ust h ave adequ ate perfusion to th e kidn eys.

5. Ph ysical criteria for don ors in clude absen ce of system ic disease an d in fection , n o h isto ry of can - cer, n o kidn ey disease or h yperten sio n , an d ad e- quate kidn ey fun ction .

6. Do n ors are screen ed for ABO blood group, tissue-specific an tigen , h um an leukocyte an tigen suitability, an d m ixed lym p h ocyte culture in dex (h istocom patibility); don ors are also screen ed for th e presen ce of an y com m un icable diseases an d un dergo a com plete m ed ical evalu ation as well as a n eph ro logy con sultatio n .

7. Th e don or m ust be in excellen t h ealth , with 2 properly fun ctio n in g kidn eys.

8. Th e em otion al well-bein g of th e don or is determ in ed.

9. Com p lete un derstan din g of th e don ation process an d outcom e by th e don or is n ecessary; usually kidn ey rem oval from th e don or is don e usin g a laparoscopic procedure.

C. Preop erative in terven tion s 1. Verify h isto com patibility tests of don or, wh ich

will be don e by organ ban k person n el. 2. Adm in ister im m un osuppressive m edication s to

th e recipien t as prescribed. 3. Main tain strict aseptic tech n iqu e. 4. Verify th at h em od ialysis of th e recipien t was

com pleted 24 h ours before tran splan tation . 5. En su re th at th e recipien t is free of an y in fectio n s. 6. Assess ren al fun ction studies. 7. En cou rage discussion of feelin gs of th e live

don or an d th e recipien t. 8. Provide psych ological support to th e live don or,

NHBD, or cad aver don or fam ily an d to th e recipien t.

D. Postoperative in terven tion s for th e recipien t 1. Th e tran splan ted kidn ey is placed in th e an te-

rior iliac fossa; usually th e recipien t’s diseased kidn eys are left in place except for th ose with polycystic kidn ey disease in wh ich th e kidn eys are often very en larged an d pain ful.

2. Urin e output usually begin s im m ediately if th e don or was a livin g don or; it m ay be delayed for a few days or m ore with oth er don or types.

3. Hem o dialysis m ay be perform ed un til ad equate kidn ey fun ction is establish ed.

4. Mon itor vital sign s an d for sign s of com plica- tion s such as rejection , th rom bosis, ren al artery sten osis, or woun d problem s.

5. Mon itor urin e outp ut h ourly; im m ediately report an abrupt decrease in output.

6. Mon itor IV fluids closely; for th e first 12 to 24 h ours, IV fluid replacem en t is based on h ourly urin e output.

7. Adm in ister prescribed diuretics an d osm o tic agen ts.

8. Mon itor daily weigh t to evaluate fluid status. 9. Mon itor daily laborato ry results to evaluate

ren al fun ctio n , in cludin g h em atocrit, BUN, an d serum creatin in e levels, an d m on itor urin e for blood an d specific gravity.

10. Position th e clien t in a sem i-Fowler’s position to prom ote gas exch an ge, turn in g from th e back to th e n on operative side.

11. Mon itor urin ary cath eter paten cy; th e urinary cath eter usually rem ain s in the bladder for 3 to 5 days to allow for an astom osis h ealin g; it is rem oved as soon as possible to preven t in fection .

12. No te th at urin e is pin k an d m ay be blood y in i- tially but gradually return s to n orm al with in several days to weeks.

13. No tify th e HCP if gross h em aturia an d clo ts are n oted in th e urin e.

Bla dde r

S ymphys is pubis

BA

Tra ns pla nte d kidne y

Ilia c cre s t

Incis ion

Tra ns pla nte d kidne y

Inte rna l ilia c a rte ry a nd ve in Exte rna l ilia c

a rte ry a nd ve inGra fte d

ure te r

FIGURE 58-4 A, Surgical incision for renal transplantation. B, Surgical placement of transplanted kidney.

834 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

14. Mon itor th e 3-way bladder irrigation , if presen t, for clo ts; irrigate on ly if an HCP’s prescription is presen t.

15. Main tain aseptic tech n ique an d m on itor for in fection .

16. Main tain strict aseptic tech n iqu e with woun d care.

17. Mon itor for bowel soun ds an d for th e passage of flatu s; in itiate a specific diet an d oral fluids as prescribed wh en flatu s an d bowel soun ds return (usually, fluid s, sodium , an d potassium are restricted if th e clien t is oliguric).

18. Main tain good oral h ygien e, m on itorin g for stom atitis an d bacterial an d fun gal in fection s.

19. En cou rage cough in g an d deep-breath in g exercises.

20. Adm in ister im m un osuppressive m edication s as prescribed .

21. Assess for sign s of organ rejection . 22. Prom ote relation sh ip between th e live don or

an d recipien t. 23. Mon itor both th e don or an d th e recipien t for

dep ression . 24. Provide th e recipien t with in struction s followin g

th e kidn ey tran splantation (Box 58-10). 25. Assist th e recipien t to cope with th e body im age

disturban ces th at occur from lon g-term use of im m un osu ppressan ts.

26. Advise th e recipien t of available support groups. E. Graft rejection

1. Assessm en t ( Box 58-11) 2. Hyperacute rejection

a . Hyperacute rejection occurs with in 48 h ours after th e tran splan t.

b . In terven tion : Rem o val of rejected kidn ey 3. Acute rejection

a . O ccurs with in 1 week postoperatively, but can occur an y tim e posttran splan tation .

b . In terven tion : Poten tially reversible with in creased im m un osuppressive th erap y.

4. Ch ron ic rejection a . O ccurs slowly m on th s to years after

tran splan t.

b . In terven tion s: Im m un osuppressive m edica- tion s an d dialysis if n ecessary.

Except in identical twin donors and recipients, the major postoperative complication following renal trans- plant is graft rejection.

XIII. Cystitis (Urinary Tract Infection) A. Descriptio n

1. Cystitis (urinary tract in fection [UTI]) is an in flam - m ation of the bladder from an in fection , obstruc- tion of th e ureth ra, or oth er irritan ts (Box 58-12).

2. Th e m ost com m on cau sative organ ism s are Escherichia coli an d Enterobacter, Pseudomonas, an d Serratia species.

3. Cystitis is m ore com m on in wom en because wom en h ave a shorter urethra th an m en an d th e ureth ra in the wom an is located close to th e rectum .

4. Sexually active an d pregn an t wom en are m ost vuln erable to cystitis.

B. Assessm en t 1. Frequen cy an d urgen cy 2. Burn in g on urin ation 3. Voidin g in sm all am oun ts

BOX 58-10 Client Instructions Following Kidney Transplantation

Avoid prolonged periods of sitting. Monitor intake and output. Recognize the signs and symptoms of infection and rejection. Use medications as prescribed, and maintain immunosup-

pressive therapy for life. Avoid contact sports. Avoid exposure to persons with infections. Know the signs and symptoms that require the need to con-

tact the health care provider. Ensure follow-up care.

BOX 58-11 Clinical Signs of Renal Transplant (Graft) Rejection

▪ Temperature higher than 100 °F (37.8 °C) ▪ Pain or tenderness over the grafted kidney ▪ 2- to 3-lb (0 .9 to 1.4 kg) weight gain in 24 hours ▪ Edema ▪ Hypertension ▪ Malaise ▪ Elevated blood urea nitrogen and serum creatinine levels ▪ Decreased creatinine clearance ▪ Elevated white blood cell count ▪ Rejection indicated by ultrasound or biopsy

BOX 58-12 Causes of Cystitis ▪ Allergens or irritants, such as soaps, sprays, bubble bath,

perfumed sanitary napkins ▪ Bladder distention ▪ Calculus ▪ Hormonal changes, influencing alterations in vaginal flora ▪ Indwelling urinary catheters ▪ Invasive urinary tract procedures ▪ Loss of bactericidal properties of prostatic secretions in

the male ▪ Microorganisms ▪ Poor-fitting vaginal diaphragms ▪ Sexual intercourse ▪ Synthetic underwear and pantyhose ▪ Urinary stasis ▪ Use of spermicides ▪ Wet bathing suits

835CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

4. In ability to void 5. In com p lete em p tyin g of th e bladder 6. Lower abdom in al discom fort or back discom -

fort; bladder spasm s 7. Cloudy, dark, foul-sm ellin g urin e 8. Hem aturia 9. Malaise, ch ills, fever

10. WBC coun t greater th an 11,000 m m 3 (11.0 Â 109/ L) on urin alysis

Altered mentation is a sign of a UTI in older adults; frequency and urgency may not be specific symptoms of UTI because of urinary elimination changes that occur with aging.

C. In terven tion s 1. Before adm in isterin g prescribed an tibiotics,

obtain a urin e specim en for culture an d sen sitiv- ity, if prescribed, to id en tify bacterial growth .

2. En courage th e clien t to in crease fluid s up to 3000 m L/ day, especially if th e clien t is takin g a sulfon am ide; sulfon am ides can form crystals in con cen trated urin e.

3. Adm in ister prescribed m ed ication s, wh ich m ay in clude an algesics, an tiseptics, an tispasm odics, an tibiotics, an d an tim icrobials.

4. Main tain an acid urin e pH (5.5); in struct th e clien t about food s to con sum e to m ain tain acidic urin e.

5. Provide h eat to th e ab dom en or sitz bath s for com plain ts of discom fort.

6. Note th at if th e client is prescribed an am in oglyco- side, sulfon am ide, or n itrofuran toin , th e action s of these m edication s are decreased by acidic urin e.

7. Use sterile tech n iqu e wh en in sertin g a urin ary cath eter.

8. Provide m eticulous perin eal care for th e clien t with an in dwellin g cath eter.

9. Discourage caffein e produ cts such as coffee, tea, an d cola.

10. Clien t edu cation a. Avoid alcoh ol. b . Take m edication s as prescribed. c. Take an tibiotics on sch edule an d com plete

th e en tire course of m edication s as pre- scrib ed, wh ich m ay be 10 to 14 days.

d . Repeat the urin e culture followin g treatm en t. e. Preven t recurren ce of cystitis ( Box 58-13).

XIV. Urosepsis A. Description

1. Urosepsis is a gram -n egative bacterem ia origin at- in g in th e urin ary tract.

2. Th e m ost com m on cau sative organ ism is E. coli. 3. In a clien t wh o is im m un oco m prom ised, a com -

m on cause is in fectio n from an in dwellin g uri- n ary cath eter or an un treated UTI.

4. Th e m ajor problem is th e ability of th is bacterium to develop resistan t strain s.

5. Urosepsis can lead to sep tic sh ock if n ot treated aggressively.

B. Assessm en t: Fever is th e m ost com m on an d earliest m an ifestatio n .

C. In terven tion s 1. O btain a urin e specim en for urin e culture an d

sen sitivity befo re ad m in isterin g an tibiotics. 2. Adm in ister an tibiotics in traven ously as pre-

scribed, usually un til th e clien t h as been afebrile for 3 to 5 days.

3. Adm in ister oral an tibiotics as prescribed after th e 3- to 5-day afebrile period.

XV. Urethritis A. Descrip tion

1. In flam m ation of th e ureth ra com m on ly associ- ated with a sexually tran sm itted in fectio n (STI); m ay occur with cystitis.

2. In m en , ureth ritis m ost often is caused by gon o r- rh ea or ch lam ydial in fectio n .

3. In wom en , ureth ritis m ost often is caused by fem in in e h ygien e sprays, perfum ed toilet paper or san itary n apkin s, sperm icidal jelly, UTI, or ch an ges in th e vagin al m ucosal lin in g.

B. Assessm en t 1. Pain or burn in g on urin ation 2. Frequen cy an d urgen cy 3. Nocturia 4. Difficulty voidin g 5. Males m ay h ave clear to m ucop urulen t disch arge

from th e pen is. 6. Fem ales m ay h ave lower abdom in al discom fort.

C. In terven tion s 1. En cou rage fluid in take. 2. Prepare th e clien t for testin g to determ in e

wh eth er an STI is presen t. 3. Adm in ister an tibiotics as prescribed.

BOX 58-13 Client Instructions for Prevention of Cystitis

Use good perineal care, wiping front to back. Avoid bubble baths, tub baths, and vaginal deodorants or

sprays. Void every 2 to 3 hours. Wear cotton pants and avoid wearing tight clothes or panty-

hose with slacks. Avoid sitting in a wet bathing suit for prolonged periods of

time. If pregnant, void every 2 hours. If menopausal, use estrogen vaginal creams to restore pH. Use water-soluble lubricants for intercourse, especially after

menopause. Void and drink a glass of water after intercourse.

836 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

4. In struct th e clien t in th e ad m in istration of sitz or tub bath s.

5. If strictu re occurs, prepare th e clien t for dilation of th e ureth ra an d in stillation of an an tiseptic solution .

6. In struct th e fem ale clien t to avoid th e use of per- fum ed toilet paper or san itary n apkin s an d fem - in in e h ygien e sprays.

7. In struct th e clien t to avoid in tercou rse un til th e sym pto m s subside or treatm en t of th e STI is com plete.

8. In struct th e clien t about STIs if th is is th e cause. a . Preven t STIs by th e use of latex con dom s or

abstin en ce. b . All sexual partn ers durin g th e 30 days before

diagn osis with ch lam ydial in fection sh ould be n otified, exam in ed, an d treated if in dicated.

c. Ch lam ydial in fectio n often coexists with gon o rrh ea; diagn ostic testin g is don e for both STIs.

d . Treatm en t for STIs in cludes an tibiotics as pre- scrib ed to treat th e causative organ ism .

e. A serious prim ary com plication of ch lam yd- ial in fectio n is sterility.

f. Follow-up culture m ay be requested in 4 to 7 days to evalu ate th e effectiven ess of m edication s.

XVI. Ureteritis A. Descrip tion : An in flam m ation of th e ureter com -

m on ly associated with bacterial or viral in fectio n s an d pyelon eph ritis

B. Assessm en t 1. Dysu ria 2. Frequen t urin ation 3. Clear to m ucop urulen t pen ile disch arge in m ales

C. In terven tion s 1. Treatm en t in cludes iden tifyin g an d treatin g th e

un derlyin g cau se an d providin g sym pto m atic relief.

2. Metro n idazole or clotrim azole m ay be prescribed for treatin g Trichomonas in fection .

3. Nystatin or flucon azole m ay be prescribed for treatin g yeast in fectio n s.

4. Doxycyclin e or azith rom ycin m ay be prescribed for treatin g ch lam ydial in fectio n s.

XVII. Pyelonephritis A. Description

1. An in flam m ation of th e ren al pelvis an d th e paren ch ym a, com m on ly caused by bacterial in vasion

2. Acute pyelon ep h ritis often occurs after bacterial con tam in ation of th e ureth ra or followin g an in vasive proced ure of th e urin ary tract.

3. Ch ron ic pyelon eph ritis m ost com m on ly occurs follo win g ch ron ic urin ary flow obstru ctio n with reflux.

4. E. coli is th e m ost com m on causative bacterial organ ism .

B. Acute pyelon eph ritis 1. Acute pyelon ep h ritis occurs as a n ew in fectio n or

recurs as a relap se of a previous in fectio n . 2. It can progress to bacterem ia or ch ron ic pyelon e-

ph ritis. 3. Assessm en t

a . Fever an d ch ills b . Tach ycardia an d tach ypn ea c. Nausea d . Flan k pain on th e affected side e. Costovertebral an gle ten dern ess f. Headach e g. Dysuria h . Frequen cy an d urgen cy i. Cloudy, blood y, or foul-sm ellin g urin e j. In creased WBCs in th e urin e

C. Ch ron ic pyelon eph ritis 1. A slow, progressive disease usually associated

with recurren t acute attacks 2. Causes con traction of th e kidn ey an d dysfun c-

tion of th e n eph ron s, wh ich are replaced by scar tissue

3. Causes th e ureter to beco m e fibrotic an d n ar- rowed by strictures

4. Can lead to AKI or CKD 5. Assessm en t

a . Frequen tly diagn osed in ciden tally wh en a cli- en t is bein g evaluated for h yperten sion

b . In ability to con serve sodium c. Poor urin e-con cen tratin g ability d . Pyuria e. Azotem ia f. Protein uria

D. In terven tion s 1. Mon itor vital sign s, especially for elevated

tem p erature. 2. En cou rage fluid in take up to 3000 m L/ day to

reduce fever an d preven t deh ydration . 3. Mon itor in take an d outp ut (en sure th at output

is a m in im u m of 1500 m L/ 24 h our). 4. Mon itor weigh t. 5. En cou rage ad equate rest. 6. In struct th e clien t ab out a h igh -calorie, low-

protein diet. 7. Provide warm , m oist com presses to th e flan k

area to h elp relieve pain . 8. En cou rage th e clien t to take warm bath s for

pain relief. 9. Adm in ister an algesics, an tipyretics, an tibiotics,

urin ary an tiseptics, an d an tiem etics as pre- scrib ed.

10. Mon itor for sign s of AKI or CKD. 11. En cou rage follow-up urin e culture.

XVIII. Glomerulonephritis A. Refer to Ch apter 41.

837CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

XIX. Nephrotic Syndrome A. Refer to Ch apter 41.

XX. Polycystic Kidney Disease A. Description

1. Cyst form ation an d h ypertroph y of th e kidn eys, wh ich leads to cystic rupture, in fectio n , form a- tion of scar tissue, an d dam aged n eph ron s

2. Th ere is n o specific treatm en t to arrest th e pro- gress of th e destructive cysts.

3. Th e ultim ate result of th is disease is CKD. B. Types

1. In fan tile polycystic disease: An in h erited au toso- m al recessive trait th at results in th e death of th e in fan t with in a few m on th s after birth

2. Adult polycystic disease: An autoso m al dom i- n an t trait th at m an ifests between 30 an d 40 years of age an d results in en d-stage kidn ey disease.

C. Assessm en t 1. O ften asym ptom atic un til th e age of 30 to 40 years 2. Flan k, lu m bar, or ab dom in al pain th at worsen s

with activity an d is relieved wh en lyin g down 3. Fever an d ch ills 4. Recurren t UTIs 5. Hem aturia, protein uria, pyuria 6. Calculi 7. Hyperten sion 8. Palpable abdom in al m asses an d en larged kidn eys 9. In creased abdom in al girth

D. In terven tion s 1. Mon itor for gross h em aturia, wh ich in dicates

cyst ru pture. 2. In crease sodium an d water in take because

sodium loss rath er th an reten tion occurs. 3. Provide bed rest if ruptured cysts an d bleedin g

occur. 4. Mon itor pain , teach use of pain m ed ication s

(avoid n on steroidal an tiin flam m atory drugs [NSAIDs] an d aspirin because of th e risk for bleed in g), an d use dry h eat to abdom en an d flan k areas for com fort wh en cysts are in fected.

5. Preven t con stipatio n from pressure of cysts on colon by ad equate fiber in diet, stool soften ers, adequ ate fluid in take, an d exercise.

6. Prepare the clien t for percutan eous cyst pun cture for relief of obstruction or for drain in g an abscess.

7. Adm in ister an tih yp erten sives as prescribed. 8. Preven t an d/ o r treat UTIs. 9. Prepare th e clien t for dialysis or ren al tran splan -

tatio n . 10. En courage th e clien t to seek gen etic coun selin g. 11. Provide psych ological support to th e clien t an d

fam ily. 12. Provide psych osocial support an d gen etic

coun selin g for fam ily m em bers with out polycys- tic kidn ey disease wh o m ay wan t to don ate a kidn ey.

XXI. Hydronephrosis A. Descriptio n ( Fig. 58-5)

1. Disten tion of th e ren al pelvis an d calices cau sed by an obstru ction of n orm al urin e flow

2. Th e urin e becom es trapp ed proxim al to th e obstruction .

3. Th e causes in clude calculus, tum ors, scar tissue, ure- ter obstruction s, and hypertrophy of the prostate.

B. Assessm en t 1. Hyperten sion 2. Headach e 3. Colicky or dull flan k pain th at radiates to

th e groin C. In terven tion s

1. Mon itor vital sign s frequen tly. 2. Mon itor for fluid an d electrolyte im balan ces,

in cludin g deh ydration after th e obstru ctio n is relieved.

3. Mon itor for diuresis, wh ich can lead to flu id depletion .

4. Mon itor weigh t daily. 5. Mon itor urin e for specific gravity an d album in

an d gluco se levels. 6. Adm in ister fluid replacem en t as prescribed. 7. Prepare th e clien t for in sertion of a n eph rostom y

tube or a surgical proced ure to relieve th e obstruction if prescribed.

XXII. Renal Calculi A. Descrip tion

1. Calculi are ston es th at can form an ywh ere in th e urin ary tract; h owever, th e m ost frequen t site is th e kidn eys.

Urina ry bla dde r

Hydrone phros is Hydroure te r

S tone

S tone

FIGURE 58-5 Hydronephrosis and hydroureter.

838 UNIT XIV Renal and Urinary Disorders of the Adult Client

2. Problem s resultin g from calculi are severe in ter- m itten t pain , obstru ction , tissue traum a, secon d- ary h em orrh age, an d in fectio n .

3. Th e ston e can be located th rou gh radiograph y of th e kidn eys, ureters, an d bladder; IV pyelogra- ph y; com puted tom o graph y (CT) scan n in g; an d ren al ultrason o graph y.

4. A ston e an alysis is don e after passage to deter- m in e th e type of ston e an d assist in determ in in g treatm en t.

5. Urolithiasis refers to th e form ation of urin ary cal- culi; th ese form in th e ureters.

6. Nephrolithiasis refers to th e form ation of kidn ey calculi; th ese form in th e ren al paren ch ym a.

7. Wh en a calculus occludes th e ureter an d blocks th e flow of urin e, th e ureter dilates, produ cin g h ydrou reter (see Fig. 58-5).

8. If the obstruction is n ot rem oved, urin ary stasis results in in fection , im pairm en t of ren al fun ction on th e side of the blockage, h ydroneph rosis (see Fig. 58-5), an d irreversible kidn ey dam age.

B. Causes 1. Fam ily h isto ry of ston e form ation 2. Diet h igh in calcium , vitam in D, protein , oxalate,

purin es, or alkali 3. O bstructio n an d urin ary stasis 4. Deh ydration 5. Use of diuretics, wh ich can cau se vo lum e

dep letion 6. UTIs an d prolon ged urin ary cath eterization 7. Im m obilization 8. Hypercalcem ia an d h yperparath yroid ism 9. Elevated uric acid level, such as in go ut

C. Assessm en t 1. Ren al colic, which origin ates in the lum bar region

an d radiates aroun d th e side an d down to the tes- ticles in m en an d to th e bladder in wom en

2. Ureteral colic, wh ich radiates toward th e gen ita- lia an d th igh s

3. Sh arp, severe pain of sudden on set 4. Du ll, ach in g pain in th e kidn ey 5. Nausea an d vo m itin g, pallor, an d diap h oresis

durin g acu te pain 6. Urin ary frequen cy, with altern atin g reten tion 7. Sign s of a UTI 8. Low-grade fever 9. High n um bers of red blood cells, WBCs, an d

bacteria n oted in th e urin alysis report 10. Gro ss h em aturia

D. In terven tion s 1. Mon itor vital sign s, esp ecially tem perature, for

sign s of in fectio n . 2. Mon itor in take an d output. 3. Assess for fever, ch ills, an d in fectio n . 4. Mon itor for n ausea, vom itin g, an d diarrh ea. 5. En cou rage fluid in take up to 3000 m L/ d ay,

un less con train dicated, to facilitate th e passage

of th e ston e an d preven t in fectio n ; m on itor for obstru ction .

6. Adm in ister flu ids in traven ously as prescribed if un ab le to take fluids orally or in ad equate am oun ts to in crease th e flow of urin e an d facil- itate passage of th e ston e.

7. Provide warm bath s an d h eat to th e flan k area (m assage th erap y sh ould be avoided).

8. Adm in ister an algesics at regularly sch eduled in tervals as prescribed to relieve pain .

9. Assess th e clien t’s respo n se to pain m ed ication . 10. Assist th e clien t in perform in g relaxatio n tech -

n iqu es to assist in relievin g pain . 11. En cou rage clien t am bulation , if stable, to pro-

m ote th e passage of th e ston e. 12. Turn an d reposition th e im m ob ilized clien t to

prom o te passage of th e ston e. 13. In struct th e clien t in th e diet restriction s specific to

th e ston e com position if prescribed (Box 58-14). 14. Prepare th e clien t for surgical procedures if

prescribed.

For the client with renal calculi, strain all urine for the presence of stones and send the stones to the labo- ratory for analysis.

XXIII. Treatment Options for Renal Calculi (Fig. 58-6) A. Cystosco py

1. Cystosco py m ay be don e for ston es in th e blad- der or lower ureter.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

BOX 58-14 Nutritional Therapy for Calculi Note: Depending on the type of calculi, the diet is modified to decrease foods that are high in the substance that is the cause of the calculi.

Purine* ▪ High: Sardines, herring, mussels, liver, kidney, goose, ven-

ison, meat soups, sweetbreads ▪ Moderate: Chicken, salmon, crab, veal, mutton, bacon,

pork, beef, ham

Calcium ▪ High: Milk, cheese, ice cream, yogurt, sauces containing

milk; all beans (except green beans), lentils; fish with fine bones (e.g., sardines, kippers, herring, salmon); dried fruits, nuts; cocoa powder, chocolate, cocoa

Oxalate ▪ High: Dark roughage, spinach, rhubarb, asparagus, cab-

bage, tomatoes, beets, nuts, celery, parsley, runner beans; chocolate, cocoa, instant coffee, cocoa powder, tea; Wor- cestershire sauce

Adapted from Lewis SL, Dirksen SR, Heitkemper MM, Bucher L, Camera IA: Medical- surgical nursing: assessment and management of clinical problems, ed 8, St. Louis, 20 11, Mosby. *Uric acid is a waste product from purine in food.

839CHAPTER 58 Renal and Urinary System

2. O n e or two ureteral cath eters are in serted past th e ston e.

3. Th e cath eters are left in place for 24 h ours to drain th e urin e trapp ed proxim al to th e ston e an d to dilate th e ureter.

4. A con tin uo us ch em ical irrigation m ay be pre- scrib ed to dissolve th e ston e.

B. Extracorporeal sh ock wave lith otripsy (ESWL) 1. A n on in vasive m ech an ical procedure for break-

in g up ston es located in th e kidn ey or upper ure- ter so th at th ey can pass spon tan eously or be rem oved by oth er m eth od s

2. A sten t m ay be placed to facilitate passin g ston e fragm en ts.

3. Fluoroscopy is used to visualize th e ston e an d ultraso n ic waves are delivered to th e area of th e ston e to disin tegrate it.

4. Th e ston es are passed in th e urin e with in a few days.

5. Th e clien t is taugh t to watch for sign s of urin ary obstru ction , bleedin g, or h em atom a form ation .

6. In struct th e clien t to in crease fluid in take to flush out th e ston e fragm en ts.

C. Percutan eous lith otripsy 1. An in vasive procedure in wh ich a guide is

in serted un d er fluorosco py n ear th e area of th e ston e; an ultrason ic wave is aim ed at th e ston e to break it in to fragm en ts.

2. Percutan eous lith otripsy m ay be perform ed via cystoscopy or n eph roscopy (a sm all flan k in ci- sion is n eeded for n eph roscopy) .

3. Th e clien t m igh t h ave an in dwellin g urin ary cath eter.

4. A n eph ro stom y tube m ay be placed to adm in is- ter ch em ical irrigation s to break up th e ston e; th e n eph rostom y tube m ay rem ain in place for 1 to 5 days.

5. En cou rage th e clien t to drin k 3000 to 4000 m L of fluid/ day as prescribed followin g th e procedure.

6. In struct th e clien t to m on itor for com plication s of in fectio n , h em orrh age, an d extravasatio n of fluid in to th e retroperito n eal cavity.

D. Uretero lith otom y 1. An open surgical proced ure perform ed if lith o-

tripsy is n ot effective for rem oval of a ston e in th e ureter

2. An in cision is m ade th rou gh th e lower abdom en or flan k an d th en in to th e ureter to rem ove th e ston e.

3. Th e clien t m ay h ave a drain , ureteral sten t cath - eter, an d/ o r in dwellin g bladder cath eter.

E. Pyelolith otom y an d n eph rolith otom y 1. Pyelolith otom y is an in cision in to th e ren al pel-

vis to rem ove a ston e; a large flan k in cision is required an d th e clien t m ay h ave a drain an d in dwellin g blad der cath eter.

2. Neph rolith oto m y is an in cision in to th e kidn ey m ade to rem ove a ston e; a large flan k in cision is required , an d th e clien t m ay h ave a n eph ros- tom y tube an d an in dwellin g bladder cath eter.

F. Partial or total n eph rectom y 1. Perform ed for exten sive kidn ey dam age, ren al

in fectio n , severe obstru ction from ston es or tum o rs, an d preven tion of ston e recurren ce

2. Mon itor th e in cision , particularly if a drain is in place, because it will drain large am oun ts of urin e.

3. Protect th e skin from urin ary drain age, ch an gin g dressin gs frequen tly if n ecessary; place an ostom y pouch over th e drain to protect th e skin if urin ary drain age is excessive.

4. Mon itor th e n eph rostom y tube, wh ich m ay be attach ed to a drain age bag, for a con tin uo us flow of urin e.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

Midure te r

• Ante gra de ne phros to- ure te rolithotomy • ES WL • Ope n ure te rolithotomy • Re trogra de ure te ros copy

Pro ximal Ure te r

• Ante gra de ne phros toure te rolithotomy • ES WL • Pe rcuta ne ous ure te rolithotomy or ne phrolithotomy • Re trogra de ure te ros copy • S te nting a lone

Dis tal Ure te r

• Ante gra de ne phros toure te rolithotomy • ES WL/ure te ros copy • Ope n ure te rolithotomy • S te nting a lone

FIGURE 58-6 Treatment options for ureteral stones. ESWL, Extracorporeal shock wave lithotripsy.

840 UNIT XIV Renal and Urinary Disorders of the Adult Client

5. Do n ot irrigate th e n eph rostom y or bladder cath - eters un less specifically prescribed.

6. En cou rage fluid in take to en sure a urin e output of 2500 to 3000 m L/ day or m ore as prescribed.

XXIV. Kidney Tumors A. Descrip tion

1. Kidn ey tum ors m ay be ben ign or m align an t, bilateral or un ilateral.

2. Com m on sites of m etastasis of m align an t tum ors in clude bon e, lun gs, liver, spleen , an d th e oth er kidn ey.

3. Th e exact cause of ren al carcin om a is un kn own . B. Assessm en t

1. Dull flan k pain 2. Palpab le ren al m ass 3. Pain less gross h em aturia

C. Radical n eph rectom y 1. Description

a. Surgical rem oval of th e en tire kidn ey, adja- cen t adren al glan d, an d ren al artery an d vein

b . Radiation th erapy an d possibly ch em oth er- apy m ay follo w radical n eph rectom y.

c. Before surgery, radiation m ay be used to em bo- lize (occlude) th e arteries supplyin g th e kidn ey to reduce bleeding durin g n eph rectom y.

2. Postoperative in terven tion s a. Mon itor vital sign s for sign s of bleedin g

(h ypoten sion an d tach ycardia). b . Mon itor for abdom in al disten tion , decreases

in urin ary output, an d alteration s in level of con sciousn ess as sign s of bleedin g; ch eck the bed lin en s un der th e client for bleedin g.

c. Mon itor for sign s of adren al insufficien cy, wh ich in clude a large urin ary output followed by h ypoten sion an d subsequen t oliguria.

d . Adm in ister fluids an d packed red blood cells in traven o usly as prescribed.

e. Mon itor in take an d outp ut an d daily weigh t. f. Mon itor for a urin ary outp ut of 30 to 50 m L/

h our to en sure ad equate ren al fun ctio n . g. Main tain th e clien t in a sem i-Fowler’s position . h . If a n eph rostom y tube is in place, do n ot irri-

gate (un less specifically prescribed) or m an ip- ulate th e tube.

XXV. Epididymitis A. Descrip tion

1. Acute or ch ron ic in flam m ation of th e epididym is th at occurs as a result of a UTI, STI, prostatitis, or lon g-term use of a bladder cath eter

2. Th e in fective organ ism travels upward th rou gh th e ureth ra an d ejacu latory duct an d alon g th e vas deferen s to th e epididym is.

B. Assessm en t 1. Scrotal an d groin pain 2. Swellin g in th e scrotum an d groin

3. Pus an d bacteria in th e urin e 4. Fever an d ch ills 5. Abscess develo pm en t

C. In terven tion s 1. En courage fluid in take. 2. En courage bed rest with th e scro tum elevated to

preven t traction on th e sperm atic cord, facilitate drain age, an d relieve pain .

3. In struct th e clien t in th e in term itten t application of cold com presses to th e scrotum .

4. In struct th e clien t in th e use of tub or sitz bath s. 5. In struct th e clien t in th e adm in istration of an tibi-

otics for self an d sexual partn er if th e cause is ch lam ydial or gon o rrh eal in fectio n .

6. In struct th e clien t to avoid liftin g, strain in g, an d sexual con tact un til th e in fectio n subsides.

7. In struct th e clien t to lim it th e force of th e urin e stream because organ ism s can be forced in to th e vas deferen s an d epididym is fro m strain or pressure durin g void in g.

8. Teach th e clien t th at co n dom use can h elp to pre- ven t ureth ritis an d epididym itis.

9. Teach th e clien t m easures to preven t UTI or STI recurren ce.

XXVI. Prostatitis A. Description

1. In flam m ation of th e prostate glan d com m on ly caused by an in fectio us agen t; m ay be acu te or ch ron ic.

2. Th e bacterial typ e occurs as a result of th e organ - ism reach in g th e prostate via th e ureth ra, blad der, blood stream , or lym p h atic ch an n els.

3. Th e ab acterial typ e usually occurs followin g a viral illn ess or a decrease in sexual activity.

B. Assessm en t 1. Bacterial prostatitis

a. Clien t beco m es acutely ill. b . Fever an d ch ills c. Frequen cy an d urgen cy of urin ation ; dysuria d . Perin eal an d low back pain e. Ureth ral disch arge f. Prostate is ten der, in du rated, an d warm to

th e touch . g. Ureth ral disch arge on palp ation of prostate h . WBCs are foun d in prostatic secretio n s. i. Urin e culture is usually positive for gram -

n egative bacteria, esp ecially after prostate m assage.

2. Abacterial prostatitis (m ost com m on form of ch ron ic prostatitis) a. Backach e b . Dysu ria c. Perin eal pain d . Frequen cy e. Hem aturia f. Irregularly en larged, firm , an d ten der prostate

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

841CHAPTER 58 Renal and Urinary System

C. In terven tion s 1. En courage adequ ate flu id in take. 2. In struct th e clien t in th e use of tub or sitz bath s to

prom o te com fo rt. 3. Adm in ister an tibiotics, an algesics, an tispas-

m odics, an d stool soften ers as prescribed. 4. In form th e clien t of activities to drain th e pros-

tate, such as in tercourse, m asturbation , an d pros- tatic m assage.

5. In struct th e clien t to avoid spicy food s, coffee, alcoh ol, prolon ged autom obile rides, an d sexual in tercou rse durin g an acute in flam m ation .

XXVII. Benign Prostatic Hypertrophy (Hyperplasia) A. Description

1. Ben ign prostatic h ypertroph y (ben ign prostatic h yperplasia; BPH) is a slow en largem en t of th e prostate glan d, with h ypertroph y an d h yperpla- sia of n orm al tissue.

2. En largem en t com presses th e ureth ra, resultin g in partial or com plete obstru ction .

3. Usually occurs in m en older th an 50 years B. Assessm en t

1. Dim in ish ed size an d force of urin ary stream (early sign of BPH)

2. Urin ary urgen cy an d frequen cy 3. No cturia 4. In ab ility to start (h esitan cy) or con tin ue a uri-

n ary stream 5. Feelin gs of in com plete bladder em ptyin g 6. Postvo id drib blin g from overflow in con tin en ce

(later sign ) 7. Urin ary reten tion an d bladder disten tion 8. Hem aturia 9. Urin ary stasis an d UTIs

10. Dysu ria an d blad der pain C. In terven tion s

1. Encourage fluid in take of up to 2000 to 3000 m L/ day un less con train dicated.

2. Prepare for urin ary cath eterization to drain th e blad der an d preven t disten tion .

3. Avo id ad m in isterin g m ed icatio n s th at cau se u rin ary reten tio n , su ch as an tich o lin ergics, an tih istam in es, d eco n gestan ts, an d an tid e- p ressan ts.

4. Adm in ister m ed ication s as prescribed to sh rin k th e prostate glan d an d im prove urin e flow.

5. Adm in ister m edication s as prescribed to relax prostatic sm ooth m uscle an d im prove urin e flow.

6. In struct th e clien t to decrease in take of caffein e an d artificial sweeten ers an d lim it spicy or acidic food s.

7. In struct th e clien t to follo w a tim ed vo idin g sch edule.

8. Prepare th e clien t for surgery or in vasive proce- dures as prescribed ( Figs. 58-7 an d 58-8).

D. Surgical in terven tion s an d posto perative care (see Ch apter 48)

XXVIII. Bladder Cancer A. Refer to Ch apter 48.

XXIX. Bladder Trauma A. Descriptio n

1. O ccurs followin g a blun t or pen etratin g in jury to th e lo wer abdom en

2. Blun t traum a cau ses com pression of th e abdom - in al wall an d bladder.

3. Pen etratin g woun ds occur as a result of a stab- bin g, gu n sh ot woun d, or oth er objects piercin g th e ab dom in al wall.

4. A fractured pelvis th at cau ses bon e fragm en ts to pun cture th e blad der is a com m on cause of blad- der traum a.

B. Assessm en t 1. Anuria 2. Hem aturia 3. Pain below th e level of th e um b ilicus; can radiate

to th e sh oulders 4. Nausea an d vo m itin g

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor for h em aturia, bleed in g, an d sign s

of sh ock. 3. Main tain bed rest. 4. If blood is seen at th e m eatus, avoid urin ary cath -

eterization un til a retrograd e uretero gram can be obtain ed.

5. Prepare th e clien t for in sertio n of a suprapu bic cath eter to aid in urin ary drain age if prescribed.

6. Prepare th e clien t for surgical repair of th e lacer- ation if in dicated.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

S ymphys is pubis

Bla dde r

Re ctum

Re s e ctos cope in ure thra

Hype rpla s tic pros ta te

FIGURE 58-7 Transurethral resection of the prostate.

842 UNIT XIV Renal and Urinary Disorders of the Adult Client

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

CRITICAL THINKING What Should You Do? Answer: AKI is the sudden loss of kidney function caused by renal cell damage from ischemia or toxic substances. It occurs abruptly and can be reversible. AKI leads to hypoper- fusion, cell death, and decompensation in renal function. With this disorder, the nurse should monitor for complica- tions such as fluid overload, ascites, pulmonary edema, and heart failure. If fine crackles in the lung bases develop bilaterally, the nurse should notify the health care provider because this could be a sign of one of these complications.

Reference: Ignatavicius, Workman (20 16), p. 140 2.

P R A C T I C E Q U E S T I O N S 706. A clien t with acute kidn ey in jury h as a serum potas-

sium level of 7.0 m Eq/ L (7.0 m m o l/ L). Th e n urse sh o uld plan wh ich action s as a p rio rity? Select all th at ap p ly.

1. Place th e clien t on a cardiac m on itor. 2. Notify th e h ealth care provider (HCP). 3. Put th e clien t on NPO (n oth in g by m outh )

status except for ice ch ips. 4. Review th e clien t’s m ed ication s to determ in e

if an y con tain or retain potassium . 5. Allow an extra 500 m L of in traven ous fluid

in take to dilute th e electrolyte con cen tration .

707. A clien t bein g h em od ialyzed sudd en ly beco m es sh ort of breath an d com plain s of ch est pain . Th e clien t is tach ycardic, pale, an d an xiou s an d th e n urse suspects air em b olism . Wh at are th e p rio rity n ursin g action s? Select all th at ap p ly.

1. Adm in ister oxygen to th e clien t. 2. Con tin ue dialysis at a slower rate after ch eck-

in g th e lin es for air. 3. No tify th e h ealth care provider (HCP) an d

Rap id Respon se Team . 4. Stop dialysis, an d turn th e clien t on th e left

side with h ead lo wer th an feet. 5. Bolus th e clien t with 500 m L of n orm al

salin e to break up th e air em b olus.

708. A clien t arrives at th e em ergen cy departm en t with com plain ts of lo w ab dom in al pain an d h em aturia. Th e clien t is afebrile. Th e n urse n ext assesses th e cli- en t to determ in e a h isto ry of wh ich con d ition ? 1. Pyelon eph ritis 2. Glom eru lon eph ritis 3. Traum a to th e blad der or abdom en 4. Ren al can cer in th e clien t’s fam ily

709. Th e n u rse d iscu sses p lan s fo r fu tu re treatm en t o p tio n s with a clien t with sym p to m atic p o lycys- tic kid n ey d isease. Wh ich treatm en t sh o u ld b e in clu d ed in th is d iscu ssio n ? Select all th at ap p ly.

B C

A

Re tro pubic

Pe rine al S uprapubic

FIGURE 58-8 Surgical approaches for prostatectomy. A, Retropubic approach involves a low abdominal incision. B, Perineal approach involves an inci- sion between the scrotum and anus. C, Suprapubic approach involves a midline abdominal incision.

843CHAPTER 58 Renal and Urinary System

1. Hem o dialysis 2. Periton eal dialysis 3. Kid n ey tran splan t 4. Bilateral n eph rectom y 5. In ten se im m un osuppression th erap y

710. A clien t is adm itted to th e em ergen cy departm en t followin g a fall from a h orse an d th e h ealth care provider (HCP) prescribes in sertion of a urin ary cath eter. Wh ile preparin g for th e proced ure, th e n urse n otes blood at th e urin ary m eatu s. Th e n urse sh o uld take wh ich action ? 1. No tify th e HCP befo re perform in g th e

cath eterization . 2. Use a sm all-sized cath eter an d an an esth etic gel

as a lubrican t. 3. Adm in ister paren teral pain m edication before

in sertin g th e cath eter. 4. Clean th e m eatu s with soap an d water before

open in g th e cath eterization kit.

711. Th e n urse is assessin g th e paten cy of a clien t’s left arm arterioven o us fistula prio r to in itiatin g h em o- dialysis. Wh ich fin din g in dicates th at th e fistula is paten t? 1. Palpation of a th rill over th e fistula 2. Presen ce of a radial pulse in th e left wrist 3. Visualization of en larged blood vessels at th e

fistula site 4. Capillary refill less th an 3 secon ds in th e n ail

bed s of th e fin gers on th e left h an d

712. A m ale clien t h as a ten tative diagn osis of ureth ritis. Th e n urse sh ould assess th e clien t for wh ich m an - ifestation of th e disorder? 1. Hem aturia an d pyuria 2. Dysuria an d protein uria 3. Hem aturia an d urgen cy 4. Dysu ria an d pen ile disch arge

713. Th e n urse is assessin g a clien t with epididym itis. Th e n urse an ticipates wh ich fin din gs on ph ysical exam in ation ? 1. Fever, diarrh ea, groin pain , an d ecch ym osis 2. Nausea, pain ful scrotal edem a, an d ecch ym osis 3. Fever, n ausea, vom itin g, an d pain ful scrotal

edem a 4. Diarrh ea, groin pain , testicular torsion , an d

scrotal edem a

714. A clien t com plain s of fever, perin eal pain , an d uri- n ary urgen cy, frequen cy, an d dysuria. To assess wh eth er th e clien t’s problem is related to bacterial prostatitis, th e n urse reviews th e results of th e pros- tate exam in ation for wh ich ch aracteristic of th is disorder? 1. Soft an d swollen prostate glan d

2. Swollen , an d boggy prostate glan d 3. Ten der an d edem atous prostate glan d 4. Ten der, in durated prostate glan d th at is warm to

th e touch

715. Th e n urse is collectin g data from a clien t. Wh ich sym pto m described by th e clien t is ch aracter- istic of an early sym pto m of ben ign prostatic h yperplasia? 1. No cturia 2. Scrotal edem a 3. O ccasion al con stipatio n 4. Decreased force in th e stream of urin e

716. Th e n urse m on itorin g a clien t receivin g periton eal dialysis n otes th at th e clien t’s outflow is less th an th e in flow. Wh ich action s sh o uld th e n urse take? Select all th at ap p ly.

1. Ch eck th e level of th e drain age bag. 2. Repo sition th e clien t to h is or h er side. 3. Con tact th e h ealth care provider (HCP). 4. Place th e clien t in go od body align m en t. 5. Ch eck th e periton eal dialysis system for

kin ks. 6. In crease th e flow rate of th e periton eal dialy-

sis solution .

717. A h em odialysis clien t with a left arm fistula is at risk for arterial steal syn d rom e. Th e n urse sh ould assess for wh ich m an ifestation s of th is com plication ? 1. Warm th , redn ess, an d pain in th e left h an d 2. Ecch ym osis an d audible bruit over th e fistula 3. Ed em a an d reddish discoloration of th e left arm 4. Pallor, dim in ish ed pulse, an d pain in th e

left h an d

718. Th e n urse is reviewin g a clien t’s record an d n otes th at th e h ealth care provid er h as docum en ted th at th e clien t h as ch ron ic ren al disease. O n review of th e laborato ry results, th e n urse m o st likely would expect to n ote wh ich fin din g? 1. Elevated creatin in e level 2. Decreased h em oglobin level 3. Decreased red blood cell coun t 4. In creased n um ber of wh ite blood cells in

th e urin e

719. A clien t with ch ron ic kidn ey disease return s to th e n ursin g un it followin g a h em odialysis treatm en t. O n assessm en t, th e n urse n otes th at th e clien t’s tem p erature is 38.5 °C (101.2 °F). Wh ich n ursin g action is m o st ap p ro p riate? 1. En cou rage flu id in take. 2. No tify th e h ealth care provid er. 3. Con tin ue to m on itor vital sign s. 4. Mon itor th e site of th e sh un t for in fection .

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

844 UNIT XIV Renal and Urinary Disorders of the Adult Client

720. Th e n urse is perform in g an assessm en t on a clien t wh o h as return ed from th e dialysis un it followin g h em odialysis. Th e clien t is com plain in g of h ead- ach e an d n ausea an d is extrem ely restless. Wh ich is th e p rio rity n ursin g action ? 1. Mon itor th e clien t. 2. Elevate th e h ead of th e bed. 3. Assess th e fistula site an d dressin g. 4. No tify th e h ealth care provider (HCP) .

721. A clien t with severe back pain an d h em aturia is foun d to h ave h ydron ep h rosis due to urolith iasis. Th e n urse an ticipates wh ich treatm en t will be don e to relieve th e obstru ction ? Select all th at ap p ly.

1. Periton eal dialysis 2. An alysis of th e urin ary ston e 3. In traven ou s opioid an algesics 4. In sertion of a n eph rostom y tube 5. Placem en t of a ureteral sten t with ureteroscopy

722. Th e n urse is in structin g a clien t with diabetes m el- litus about periton eal dialysis. Th e n urse tells th e clien t th at it is im portan t to m ain tain th e pre- scribed dwell tim e for th e dialysis because of th e risk of wh ich com plication ? 1. Periton itis 2. Hyperglycem ia 3. Hyperph osph atem ia 4. Disequilibriu m syn dro m e

723. A week after kidn ey tran splan tation , a clien t develops a tem p erature of 101 °F (38.3 °C), th e blood pressure is elevated, an d th ere is ten dern ess

over th e tran splan ted kidn ey. Th e serum creatin in e is risin g an d urin e outp ut is decreased. Th e x-ray in dicates th at th e tran splan ted kidn ey is en larged. Based on th ese assessm en t fin din gs, th e n urse an ticipates wh ich treatm en t? 1. An tibio tic th erapy 2. Periton eal dialysis 3. Rem oval of th e tran splan ted kidn ey 4. In creased im m un osuppression th erapy

724. A clien t is adm itted to th e h ospital with a diagn osis of ben ign prostatic h yperplasia, an d a tran sureth ral resection of th e prostate is perform ed. Four h ours after surgery, th e n urse takes th e clien t’s vital sign s an d em p ties th e urin ary drain age bag. Wh ich assessm en t fin din g in dicates th e n eed to n otify th e h ealth care provid er (HCP) ? 1. Red, bloody urin e 2. Pain rated as 2 on a 0–10 pain scale 3. Urin ary output of 200 m L h igh er th an in take 4. Bloo d pressure, 100/ 50 m m Hg; pulse, 130

beats/ m in u te

725. Th e clien t n ewly diagn osed with ch ron ic kidn ey disease recen tly h as begun h em odialysis. Kn o win g th at th e clien t is at risk for diseq uilibrium syn - drom e, th e n urse sh o uld assess th e clien t durin g dialysis for wh ich associated m an ifestatio n s? 1. Hyperten sion , tach ycardia, an d fever 2. Hypoten sion , bradycardia, an d h ypo th erm ia 3. Restlessn ess, irritability, an d gen eralized weakn ess 4. Headach e, deterioratin g level of con sciousn ess,

an d twitch in g

A N S W E R S 706. 1, 2, 4 Ra t ion a le: Th e n orm al p otassiu m level is 3.5–5.0 m Eq/ L ( 3.5– 5.0 m m o l/ L) . A po tassium level o f 7.0 is elevated. Th e clien t with h yperkalem ia is at risk o f d evelo pin g card iac dysrh yth - m ias an d card iac arrest. Becau se o f th is, th e clien t sh ou ld b e placed o n a card iac m on itor. Th e n u rse sh ou ld n otify th e HCP an d also review m edication s to determ in e if an y co n tain po tassium o r are p otassium retain in g. Th e clien t do es n o t n eed to b e p ut on NPO statu s. Flu id in take is n o t in creased b ecau se it co n tribu tes to fluid overlo ad an d wou ld n ot affect th e seru m po tassium level sign ifican tly. Test -Ta kin g Str a tegy: No te th e strategic wo rd , priority. First, n ote th at th e po tassiu m level is sign ifican tly elevated to select op tion s 1 an d 4. Also , use th e ABCs—airway–b reath in g– circu latio n —to select o ptio n 2. Review: Care o f th e clien t with h yp erkalem ia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary

Pr ior ity Con cept s: Clin ical Ju d gm en t; Flu id an d Electrolyte Balan ce Refer en ce: Ign atavicius, Workm an (2016), p p. 166–167.

707. 1, 3, 4 Ra t ion a le: If th e clien t experien ces air em bo lu s du rin g h em o - d ialysis, th e n u rse sh ou ld term in ate d ialysis im m ediately, p o sitio n th e clien t so th e air em b olu s is in th e righ t sid e o f th e h eart, n o tify th e HCP an d Rapid Respo n se Team , an d ad m in ister o xygen as n eed ed. Slo win g th e dialysis treatm en t o r givin g an in traven o us bo lus will n ot co rrect th e air em b o - lism o r preven t co m plicatio n s. Test -Ta kin g St r a t egy: Note th e strategic wo rd , priority. Recall th at air em bo lism is an em ergen cy situ ation th at affects th e car- d io pu lm on ary system su dd en ly an d p ro fou n d ly. Select th e o p tion s th at deal with th e prob lem , su pp ly o xygen , an d get n eed ed assistan ce. Review: Em ergen cy care o f a clien t wh o d evelo ps air em b o lism Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

845CHAPTER 58 Renal and Urinary System

Conten t Area : Critical Care—Em ergen cy Situation s/Man agem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Gas Exch an ge Refer en ces: Ign atavicius, Wo rkm an ( 2016) , p . 202; Lewis et al. (2016), p. 311.

708. 3 Ra tion a le: Bladder traum a or in jury sh ould be con sidered or su spected in th e clien t with lo w abd om in al pain an d h em atu - ria. Glom erulon eph ritis an d pyelo n ep h ritis wou ld b e accom - p an ied b y fever an d are th us n o t ap plicab le to th e clien t d escrib ed in th is q uestio n . Ren al can cer wo uld n o t cau se p ain th at is felt in th e low abd om en ; rath er, th e p ain wo uld be in th e flan k area. Test-Ta kin g Str a tegy: Note th e strategic wo rd , next. Elim in ate o ptio n s 1 an d 2 b ecau se th ey are co m p arab le o r alike, kn o w- in g th at an y in flam m ato ry d isease o r in fectio n is accom pan ied b y fever. Becau se th is clien t is afebrile, th ese are n ot po ssib le o ptio n s. Use kn owledge of an ato m y an d p ain assessm en t to select th e co rrect op tio n . Pain fro m ren al can cer is a later fin d- in g an d is lo calized in th e flan k area. Review: Ren al assessm en t tech n iqu es Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Pain Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1391–1392.

709. 1, 3, 4 Ra tion a le: Po lycystic kid n ey disease is a gen etic fam ilial d is- ease in wh ich th e kid n eys en large with cysts th at rup ture an d scar th e kid n ey, even tually resu ltin g in en d -stage ren al disease. Treatm en t op tio n s in clu d e h em o dialysis or kid n ey tran sp lan t. Clien ts usu ally un dergo bilateral n ep h recto m y to rem o ve th e large, p ain fu l, cyst-filled kid n eys. Perito n eal dialysis is n o t a treatm en t o p tion du e to th e in fected cysts. Th e co n d itio n d o es n o t resp on d to im m u n osup pressio n . Test-Ta kin g Str a tegy: Fo cus on th e su b ject, treatm en t op tio n s fo r po lycystic kid n ey disease. Recall th at th e con dition results in en d-stage ren al disease. Th is will d irect you to th e correct o ptio n s. Review: Treatm en t for p o lycystic kid n ey d isease Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Adu lt Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Clien t Ed ucation Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1394, 1396.

710. 1 Ra tion a le: Th e p resen ce of blo o d at th e urin ary m eatus m ay in dicate u reth ral trau m a or d isru p tion . Th e n urse n o tifies th e HCP, kn o win g th at th e clien t sh ou ld n ot b e cath eterized un til th e cau se o f th e b leed in g is determ in ed b y d iagn o stic testin g. Th e o th er o p tion s in clu de p erfo rm in g th e cath eterizatio n p ro - cedu re an d th erefore are in correct. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, th e co m p lication s asso ciated with a trau m atic fall. No tin g th e wo rd s blood at the urinary meatus suggests m ore exten sive in tern al traum a th at cou ld b e fu rth er aggravated b y th e cath eterization .

Review: Assessm en t fin d in gs related to b lad d er trau m a Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Lewis et al. (2016), p p. 1081–1082.

711. 1 Ra tion a le: Th e n urse assesses th e p aten cy of th e fistula by p al- p atin g for th e p resen ce of a th rill o r auscultatin g for a bruit. Th e p resen ce o f a th rill an d bruit in dicate paten cy o f th e fistula. En larged visible b lo od vessels at th e fistula site are a n orm al o bservation bu t are n ot in dicative o f fistu la paten cy. Alth o u gh th e p resen ce o f a radial p ulse in th e left wrist an d capillary refill less th an 3 seco n d s in th e n ail b eds o f th e fin gers on th e left h an d in dicate ad equ ate circu latio n to th e h an d , th ey d o n o t assess fistula p aten cy. Test-Ta kin g Str a tegy: Elim in ate option s 2 an d 4 first because th ey are co m p arab le o r alike an d assess for adequ ate circulation in th e d istal p ortion of th e extrem ity (n ot the fistula). En larged b lood vessels o ccur wh en th e fistula is created. Select option 1 sin ce a th rill in dicates b lo od flow an d p aten cy o f th e fistu la. Review: Expected fin din gs related to arterio ven o u s fistu la Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1433.

712. 4 Ra tion a le: Ureth ritis in th e m ale clien t o ften resu lts from ch la- m ydial in fectio n an d is ch aracterized by dysu ria, wh ich is acco m p an ied by a clear to m ucop u ru len t d isch arge. Because th is diso rder o ften coexists with go n o rrh ea, diagn ostic tests are d on e for b oth an d in clu d e cultu re an d rap id assays. Hem a- tu ria is n o t associated with u reth ritis. Protein u ria is asso ciated with kidn ey dysfun ction . Test-Ta kin g St r a t egy: Focus on th e su b ject, m an ifestatio n s of u reth ritis. Recallin g th at ureth ritis gen erally is accom pan ied b y d ysu ria in th e m ale clien t will assist yo u in elim in atin g o p tion s 1 an d 3. Kn o win g th at th e prob lem origin ates in th e ureth ra, n o t th e kid n eys, will assist yo u in elim in atin g op tio n 2, b ecause p ro tein u ria in dicates a p rob lem with kid n ey fun ctio n . Review: Clin ical m an ifestatio n s of u reth ritis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior it y Con cept s: In fection ; Sexu ality Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1373.

713. 3 Ra tion a le: Typical sign s an d sym p tom s of ep ididym itis in clu de scro tal p ain an d edem a, wh ich often are acco m pan ied b y fever, n ausea an d vo m itin g, an d ch ills. Ep id idym itis m o st o ften is cau sed b y in fection , alth o ugh som etim es it can be cau sed by trau m a. Th e rem ain in g op tio n s d o n o t presen t all o f th e accu rate m an ifestatio n s.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

846 UNIT XIV Renal and Urinary Disorders of the Adult Client

Test -Ta kin g St r a t egy: An y d iso rd er th at en d s in -itis resu lts fro m in flam m atio n o r in fection . Th erefo re, an expected fin d - in g wou ld be elevated tem peratu re. With th is in m in d, elim i- n ate op tio n s 2 an d 4 b ecause th ey are co m p arab le o r alike an d d o n o t con tain fever as p art o f th e o ptio n . Kn o win g th at ecch ym osis resu lts from b leed in g, wh ich is n ot p art of th is clin - ical p icture, d irects yo u to th e correct o ptio n . Review: Clin ical m an ifestation s o f ep id id ym itis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: In fectio n ; In flam m atio n Refer en ce: Lewis et al. (2016), p . 1324.

714. 4 Ra t ion a le: Th e clien t with bacterial prostatitis h as a swollen an d ten d er p ro state glan d th at is also warm to th e to uch , firm , an d in du rated . System ic sym p tom s in clu d e fever with ch ills, perin eal an d low back p ain , an d sign s of urin ary tract in fectio n , wh ich often accom p an y th e d iso rd er. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, m an ifestatio n s o f bacterial p ro statitis. Begin to an swer th is qu estio n b y reaso n in g th at in flam m ation of th e prostate glan d wo uld cau se th e area to b e ten d er. Th is wou ld allow yo u to elim in ate o ptio n s 1 an d 2. Recallin g th at in flam m atio n is accom p an ied by lo cal warm th will direct yo u to th e correct o ptio n . Review: Sign s of p ro statitis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: In fectio n ; In flam m atio n Refer en ce: Ign atavicius, Workm an (2016), p . 1512.

715. 4 Ra t ion a le: Decreased force in th e stream o f u rin e is an early sym p tom o f b en ign p ro static h yp erp lasia. Th e stream later becom es weak an d d rib blin g. Th e clien t th en m ay develop h em aturia, freq uen cy, urgen cy, urge in co n tin en ce, an d n oc- tu ria. If un treated , com p lete ob stru ction an d u rin ary reten tion can occu r. Co n stip atio n o r scro tal ed em a is n o t asso ciated with ben ign p ro static h yp erp lasia. Test -Ta kin g Str a tegy: No te th e strategic wo rd , early. Also , if yo u kn o w th at b en ign prostatic h yp erp lasia can lead to urin ary ob stru ctio n , lo ok for th e o p tion th at iden tifies th e least severe sym p tom . Review: Early sign s an d sym ptom s of b en ign p ro static h yp ertro p h y Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Elim in atio n ; In flam m atio n Refer en ce: Lewis et al. (2016), p . 1308.

716. 1, 2, 4, 5 Ra t ion a le: If ou tflow drain age is in ad eq uate, th e n u rse attem p ts to stim ulate o u tflow by ch an gin g th e clien t’s p o sition . Turn in g th e clien t to th e sid e o r m akin g su re th at th e clien t is in

go o d bo dy align m en t m ay assist with o utflo w d rain age. Th e d rain age bag n eeds to b e lo wer th an th e clien t’s abd om en to en h an ce gravity drain age. Th e co n n ectin g tu bin g an d perito - n eal d ialysis system are also ch ecked for kin ks or twistin g an d th e clam ps on th e system are ch ecked to en su re th at th ey are o pen . Th ere is n o reaso n to co n tact th e HCP. In creasin g th e flow rate sh o uld n o t b e d on e an d also is n ot associated with th e am o un t o f o utflo w so lutio n . Test -Ta kin g Str a tegy: Focus o n th e su b ject, outflow is less th an in flo w, an d use th e p rin cip les related to gravity flo w an d preven tin g o bstructio n to flow to an swer th is qu estio n . Th is will assist in determ in in g th e correct in terven tio n s. Review: Perito n eal d ialysis an d in terven tion s related to in su f- ficien t flow of d ialysate Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in ation Refer en ce: Ign atavicius, Workm an (2016), p . 1441.

717. 4 Ra t ion a le: Steal syn drom e results from vascular in sufficien cy after creation of a fistu la. Th e clien t exh ibits pallo r an d a d im in ish ed p u lse d istal to th e fistu la. Th e clien t also com - p lain s of pain distal to th e fistula, caused b y tissue isch em ia. Warm th an d redn ess probably would ch aracterize a problem with in fection . Ecch ym osis an d a bruit are n orm al fin din gs for a fistu la. Test -Ta kin g Str a tegy: Focus o n th e su b ject, arterial steal syn - d ro m e. Elim in ate sign s associated with in fectio n o r n orm al fis- tu la fin d in gs. Recallin g th at steal syn d ro m e resu lts fro m vascular in sufficien cy after creation of a fistula will direct yo u to th e co rrect o ption . Review: Arterial steal syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Clin ical Jud gm en t; Perfu sio n Refer en ce: Ign atavicius, Workm an (2016), p . 1435.

718. 1 Ra t ion a le: Th e creatin in e level is th e m ost sp ecific lab o ratory test to determ in e ren al fun ctio n . Th e creatin in e level in creases wh en at least 50% of ren al fun ction is lost. A decreased h em o- glob in level an d red b lo od cell cou n t are asso ciated with an e- m ia o r blo o d lo ss an d n ot sp ecifically with decreased ren al fu n ctio n . In creased wh ite b lo od cells in th e urin e are n o ted with urin ary tract in fection . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most likely. Recallin g th e relatio n sh ip between th e creatin in e level an d ren al fun ctio n will d irect yo u to th e correct o ptio n . Review: Ren al fu n ctio n stu d ies Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Cellu lar Regu latio n ; Elim in atio n Refer en ce: Ign atavicius, Workm an (2016), p p. 224, 1354.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

847CHAPTER 58 Renal and Urinary System

719. 2 Ra tion a le: A tem perature of 101.2 °F (38.5 °C) is sign ifican tly elevated an d m ay in d icate in fection . Th e n u rse sh o uld n otify th e h ealth care p ro vid er (HCP). Dialysis clien ts can n o t h ave flu id in take en co uraged. Vital sign s an d th e sh u n t site sh o u ld b e m on itored , bu t th e HCP sh o uld be n o tified first. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Fo cu s o n th e d ata in th e q u estio n . Note th e tem perature elevatio n . Th is warran ts n o tification o f th e HCP, wh o m ay pre- scrib e d iagn o stic tests o r m ed icatio n s. Review: In terven tion s for tem p erature elevatio n followin g d ialysis Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1437.

720. 4 Ra tion a le: Disequ ilib rium syn drom e m ay be cau sed b y rapid rem o val of solu tes fro m th e b od y d urin g h em o dialysis. Th ese ch an ges can cau se cereb ral ed em a th at leads to in creased in tra- cran ial pressure. Th e clien t is exh ib itin g early sign s an d sym p - to m s of d iseq u ilib riu m syn d ro m e an d app ro p riate treatm en ts with an ticon vu lsive m edication s an d barbiturates m ay be n ec- essary to p reven t a life-th reaten in g situatio n . Th e HCP m u st be n o tified . Mon itorin g th e clien t, elevatin g th e h ead o f th e b ed, an d assessin g th e fistu la site are correct actio n s, b ut th e p rio rity action is to n o tify th e HCP. Test-Ta kin g Str a tegy: Note th e strategic wo rd , priority, an d fo cu s o n th e clien t’s sign s an d sym pto m s. Determ in e if an ab n o rm ality exists. Recallin g th e seriou s co m plicatio n s asso ci- ated with h em o dialysis such as d iseq uilibriu m syn d ro m e will d irect yo u to th e co rrect o p tion . Review: Sign s an d sym p tom s of d iseq u ilib riu m syn d ro m e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; In tracran ial Regulation Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1437.

721. 4, 5 Ra tion a le: Uro lith iasis is th e con d itio n th at occu rs wh en a sto n e form s in th e u rin ary system . Hydron eph ro sis d evelo ps wh en th e sto n e h as blocked th e ureter an d urin e backs up an d dilates an d d am ages th e kidn ey. Prio rity treatm en t is to allo w th e urin e to d rain an d relieve th e ob stru ction in th e ure- ter. Th is is acco m p lish ed b y placem en t of a percu tan eo us n eph ro stom y tu be to d rain urin e fro m th e kidn ey an d place- m en t o f a ureteral sten t to keep th e u reter o pen . Perito n eal d ialysis is n ot n eed ed sin ce th e kid n ey is fun ctio n in g. Ston e an alysis will b e d on e later wh en th e ston e h as b een retrieved an d an alyzed . O p ioid an algesics are n ecessary for p ain relief b ut d o n o t treat th e ob stru ction . Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, treatm en t to relieve th e o bstructio n . Th in k abo ut wh at each o ptio n will acco m p lish . Elim in ate th e o p tion s th at d o n ot add ress th e o bstructio n .

Review: Treatm en t for h yd ro n ep h ro sis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior it y Con cept s: Clin ical Ju dgm en t; Elim in atio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1397–1398.

722. 2 Ra tion a le: An exten d ed dwell tim e in creases th e risk of h yp er- glycem ia in th e clien t with diab etes m ellitus as a resu lt of abso rptio n o f glu co se from th e d ialysate an d electro lyte ch an ges. Diabetic clien ts m ay requ ire extra in sulin wh en receivin g periton eal dialysis. Periton itis is a risk asso ciated with breaks in aseptic tech n ique. Hyperph osph atem ia is an electro lyte im balan ce th at occurs with ren al dysfu n ction . Diseq u ilib riu m syn d ro m e is a co m plicatio n associated with h em o dialysis. Test-Ta kin g St r a tegy: Fo cu s o n th e su b ject, a co m p lication asso ciated with an exten d ed d well tim e. No tin g th e clien t’s d iagn osis an d recallin g th at th e d ialysate so lu tio n co n tain s glu - cose will direct yo u to th e co rrect o ptio n . Review: Com plicatio n s asso ciated with p erito n eal d ialysis Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior it y Con cept s: Elim in ation ; Glucose Regu latio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1441.

723. 4 Ra tion a le: Acu te rejection m o st often occu rs with in 1 week after tran sp lan tatio n bu t can o ccu r an y tim e p osttran splan ta- tio n . Clin ical m an ifestation s in clud e fever, m alaise, elevated wh ite blood cell coun t, acute h yperten sion , graft ten dern ess, an d m an ifestatio n s of d eterioratin g ren al fun ctio n . Treatm en t con sists of in creasin g im m u n o sup p ressive th erapy. An tib iotics are u sed to treat in fectio n . Perito n eal dialysis can n ot be u sed with a n ewly tran splan ted kidn ey due to th e recen t surgery. Rem o val of th e tran splan ted kid n ey is in d icated with h yp er- acu te rejectio n , wh ich o ccu rs with in 48 h ou rs of th e tran sp lan t su rgery. Test-Ta kin g Str a tegy: Note th e wo rd s A week after kidney trans- plantation. Fo cu s o n th e d ata in th e q u estio n an d th e tim e fram e an d sym p tom s, wh ich describe acu te rejection . Recall th e treatm en t for acute rejectio n to d irect you to th e correct o ptio n . Review: Sign s an d treatm en t o f acu te rejectio n in kid n ey tran s- p lan t clien ts Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nu rsin g Pro cess—An alysis Con ten t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior it y Con cept s: Elim in ation ; Im m u n ity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1444.

724. 4 Ra tion a le: Fran k bleedin g (arterial or ven ou s) m ay occur d ur- in g th e first day after surgery. So m e h em atu ria is u sual fo r sev- eral d ays after su rgery. A u rin ary o utp ut of 200 m L m o re th an

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

848 UNIT XIV Renal and Urinary Disorders of the Adult Client

in take is adeq u ate. A clien t p ain ratin g o f 2 o n a 0–10 scale in di- cates adeq u ate p ain co n trol. A rap id p u lse with a low b lo od pressure is a p oten tial sign of excessive blo od lo ss. Th e HCP sh ou ld b e n otified. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, th e n eed to n o tify th e HCP, an d d eterm in e if an ab n o rm ality exists. Th in k abo ut th e expected fin din gs fo llo win g th is proced ure an d n o te th at th e vital sign s are n o t with in th e n o rm al ran ge an d co uld in di- cate excessive b loo d lo ss. Review: Expected fin d in gs fo llo win g tran su reth ral resectio n o f th e p ro state Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Collabo ratio n ; Clo ttin g Refer en ce: Lewis et al. (2016), p p. 1311, 1313–1314.

725. 4 Ra t ion a le: Disequ ilib rium syn d ro m e is ch aracterized b y h ead - ach e, m en tal co n fu sio n , d ecreasin g level o f con sciou sn ess, n ausea, vom itin g, twitch in g, an d po ssib le seizu re activity. Dis- equ ilib rium syn drom e is caused b y rapid rem o val o f solutes

from th e b o dy du rin g h em o dialysis. At th e sam e tim e, th e b lo od -brain barrier in terferes with th e efficien t rem o val o f wastes from brain tissue. As a result, water goes in to cerebral cells b ecau se o f th e o sm otic grad ien t, causin g in creased in tra- cran ial p ressu re an d o n set o f sym p tom s. Th e syn drom e m ost o ften occu rs in clien ts wh o are n ew to d ialysis an d is preven ted b y dialyzin g for sh orter tim es o r at red uced b lo od flo w rates. Tach ycard ia an d fever are asso ciated with in fection . Gen eral- ized weakn ess is asso ciated with low blo od pressure an d an e- m ia. Restlessn ess an d irritability are n ot associated with d iseq u ilib riu m syn drom e. Test -Ta kin g Str a tegy: Focu s on th e su b ject, d iseq uilib riu m syn drom e. Th in k abo ut th e path o p h ysio logy an d th at b rain cells are respo n sive to ch an ges in osm o larity. Th is will assist yo u to ch oo se th e co rrect o p tion describin g n eu ro lo gical sym p tom s. Review: Diseq u ilib riu m syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Elim in atio n ; In tracran ial Regu latio n Refer en ce: Ign atavicius, Workm an (2016), p . 1437.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

849CHAPTER 58 Renal and Urinary System

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y C H A P T E R 59 Renal and Urinary Medications

PRIORITY CONCEPTS Elimination; Safety

CRITICAL THINKING What Should You Do? A client who is taking ciprofloxacin prescribed for a urinary tract infection complains of dizziness, blurred vision, and sensitivity to light. What should the nurse do? Answer located on p. 855.

I. Urinary Tract Antiseptics A. Description

1. Urin ary tract an tiseptics in h ib it th e growth of bacteria in th e urin e (Box 59-1).

2. Act as disin fectan ts with in th e urin ary tract 3. Used to treat acute cystitis or urin ary tract

in fectio n s (UTIs) 4. Urin ary tract an tiseptics do n ot ach ieve effective

an tibacterial con cen tration s in blood or tissues an d th erefore can n ot be used for in fectio n s out- side th e urin ary tract.

B. Side an d adverse effects an d n ursin g con sideration s 1. Fosfo m ycin

a. Th e m ed ication is available as gran ules th at m ust be dissolved ; in struct th e clien t to m ix th e con ten ts of a package in about ½ cup (120 m L) of cold water, stir well, an d drin k all of th e liquid.

b . Med ication s th at in crease gastro in testin al m otility reduce th e absorption of fosfo m ycin .

2. Meth en am in e a . Used to treat ch ron ic UTIs, but n ot recom -

m en ded for acute in fectio n s b . Adm in ister after m eals an d at bedtim e to

m in im ize gastric distress. c. Ch ron ic h igh -d ose th erap y can cau se blad-

der irritation . d . Methenam ine can cause crystalluria an d should

not be used in clients with renal im pairm ent. e. Decom position of th e m ed ication gen erates

am m on ia; th erefore, it sh ould n ot be used for clien ts with liver dysfun ction .

f. Meth en am in e requires acidic urin e with a pH of 5.5 or lower.

g. In creasin g fluid in take reduces an tibacterial effects by dilutin g th e m edication an d raisin g urin e pH.

h . Meth en am in e sh ould n ot be com bin ed with sulfon am ides because of th e risk of crystal- luria an d urin ary tract in ju ry.

i. Clien ts takin g th is m edication sh ould avoid alkalin izin g agen ts, in cludin g over-th e- coun ter an tacids con tain in g sodium bicar- bon ate or sodium carbon ate.

3. Nitrofu ran toin a . Gastroin testin al effects in clude an orexia,

n ausea, vom itin g, an d diarrh ea; adm in istra- tion with m ilk or m eals m in im izes gastro in - testin al distress.

b . Pulm o n ary reaction s in clude dyspn ea, ch est pain , ch ills, fever, cough , an d alveo lar in fil- trates; th ese resolve in 2 to 4 days follo win g cessation of treatm en t.

c. Hem atological effects in clude agran ulo cyto- sis, leukopen ia, th rom bocytop en ia, an d m egaloblastic an em ia.

d . Periph eral n europath y effects in clude m uscle weakn ess, tin glin g sen sation s, an d n um bn ess.

e. Neurological effects in clude h eadach e, ver- tigo, drowsin ess, an d n ystagm u s.

f. Allergic reaction s in clude an aph ylaxis, h ives, rash , an d tin glin g sen sation s aroun d th e m ou th .

g. Nitrofuran toin m ay im part a h arm less brown color to th e urin e.

h . Nitrofuran toin is con train d icated in clien ts with ren al im pairm en t.

i. In struct th e clien t in expected side an d adverse effects, sign s warran tin g n oti- fication of th e h ealth care provider (HCP) , an d n ot to take n itrofuran toin with an tacids.

850

II. Fluoroquinolones (Box 59-2) A. Description : Suppress bacterial growth by in h ibitin g

an en zym e n ecessary for DNA syn th esis; active again st a broad spectru m of m icro bes

B. Side an d ad verse effects an d n ursin g con sideration s 1. Can cause dizzin ess, drowsin ess, gastric distress,

diarrh ea, vagin itis, n ausea, an d vom itin g 2. Adverse effects in clude psych oses, h allucin a-

tio n s, con fusion , trem ors, h ypersen sitivity, an d in terstitial n eph ritis.

With fluoroquinolones, there is an increased risk for tendonitis and tendon rupture. The Achilles tendon is most often involved but the shoulder and hand tendons can also be affected. Clients at increased risk are those over the age of 60, those taking corticosteroids, and cli- ents who have undergone organ transplant.

3. Flu oroquin olon es sh ould be used with cau tion in clien ts with h epatic, ren al, or cen tral n ervou s system (CNS) disorders.

4. Mon itor clien t for side an d adverse effects. 5. Cip rofloxacin an d ofloxacin m ay be taken with

or with ou t food. 6. In traven ou sly adm in istered ciproflo xacin an d

ofloxacin are in fused slowly over 60 m in utes to m in im ize discom fort an d vein irritatio n .

7. Advise th e clien t to report dizzin ess, ligh th eaded- n ess, visual disturban ces, in creased ligh t sen sitiv- ity, an d feelin gs of depression , because th ese sign s could in dicate CNS toxicity.

8. In form th e clien t of sign s of h epatic an d ren al toxicity an d th e im portan ce of reportin g th ese sign s to th e HCP.

Administer oral fluoroquinolones with a full glass of water and ensure that the client maintains a urine output of at least 120 0 to 1500 mL daily to minimize the devel- opment of crystalluria.

III. Sulfonamides (Box 59-3) A. Description : Suppress bacterial growth by in h ib itin g

th e syn th esis of folic acid; active again st a broad spec- trum of m icrobes; used prim arily to treat acute UTIs

B. Side an d adverse effects an d n ursin g con sideration s 1. Hypersen sitivity reaction s in clude rash , fever,

an d ph otosen sitivity. 2. Steven s-Joh n son syn drom e, th e m ost severe

h ypersen sitivity respon se, produces sym ptom s that in clude widespread lesions of th e skin an d m ucous m em bran es, fever, m alaise, an d toxem ia.

3. Sulfon am ides can cause h em olytic an em ia, agran ulocytosis, leukopen ia, an d th rom bocyto- pen ia; in struct th e clien t to n otify th e HCP if sore th roat or fever occurs.

4. Adm in ister sulfon am ides with caution in cli- en ts with ren al im pairm en t.

5. Sulfon am ides are con train dicated if h ypersen - sitivity exists to sulfon am ides, sulfon ylureas, or th iazide or loop diuretics.

6. Sulfon am ides are con train dicated in in fan ts yo un ger th an 2 m on th s an d in pregn an t wom en or m oth ers wh o are breast-feedin g.

7. Sulfon am ides can poten tiate th e effects of warfa- rin sodium , ph en ytoin , an d orally adm in istered h ypoglycem ics (wh en com bin ed with sulfon - am ides, h ypoglycem ics m ay require a reduction in dosage).

8. In struct th e clien t to take th e m edication on an em p ty stom ach with a full glass of water.

9. In struct th e clien t to com plete th e en tire co urse of th e prescribed m edication .

10. In struct th e clien t to avoid prolon ged exp osure to sun ligh t, wear protective clo th in g, an d ap ply a sun screen to exp osed skin .

11. Adults sh ould m ain tain a daily urin e outp ut of at least 1200 m L by con sum in g 8 to 10 glasses of water each day to m in im ize th e risk of ren al dam age from th e m ed ication .

12. In form th e clien t th at som e com bin ation m ed- ication s of sulfon am ides can cau se th e urin e to turn dark brown or red.

13. Th e sulfon am ide com bination of trim eth oprim - sulfam eth oxazole is m ore effective than eith er m edication alon e because it in h ibits th e sequen - tial steps in bacterial folic acid syn th esis.

14. Trim eth oprim -sulfam eth oxazo le is used cau- tio usly with clien ts experien cin g im paired kid- n ey fun ction , folate deficien cy, severe allergy, or bron ch ial asth m a.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

yBOX 59-1 Urinary Tract Antiseptics ▪ Amoxicillin ▪ Cefixime ▪ Fosfomycin ▪ Methenamine ▪ Nitrofurantoin

BOX 59-2 Fluoroquinolones

▪ Ciprofloxacin ▪ Gemifloxacin ▪ Levofloxacin ▪ Moxifloxacin ▪ Ofloxacin ▪ Gatifloxacin

BOX 59-3 Sulfonamides ▪ Sulfadiazine ▪ Trimethoprim-sulfamethoxazole

851CHAPTER 59 Renal and Urinary Medications

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

15. An in traven o us (IV) dose of trim eth oprim - sulfam eth oxazole is ad m in istered over 60 to 90 m in utes an d is n ot m ixed with oth er m ed ication s.

Sulfonamides should be withheld if a rash is noted. Inform the client to contact the HCP if a rash appears.

IV. Urinary Tract Analgesics (Box 59-4) A. Description : A urin ary tract an algesic is ad m in istered

with an an tibiotic because th e an algesic on ly treats pain , n ot th e in fectio n .

B. Side an d adverse effects 1. Nausea 2. Headach e 3. Vertigo

C. Nursin g con sideration s 1. In struct th e clien t th at th e urin e will turn red or

oran ge an d could stain cloth in g; tears an d con - tact len ses will also becom e red or oran ge tin ged.

2. A urin ary tract an algesic is con train d icated in cli- en ts with ren al or h epatic disease.

3. Th e m edication in terferes with accu rate urin e testin g for glucose an d keton es.

V. Anticholinergics/ Antispasmodics (Box 59-5) A. Description : Used for overactive bladder (urge

in con tin en ce) B. Side an d adverse effects

1. An orexia, n ausea, vom itin g, an d dry m outh 2. Blurred vision 3. Con fusion in older clien ts 4. Con stipation 5. Decreased sweatin g 6. Dizzin ess 7. Drowsin ess 8. Dry eyes 9. Gastric distress

10. Headach e 11. Tach ycardia 12. Urin ary reten tion

C. Nursin g con sideration s 1. Exten ded-release capsules sh o uld n ot be split,

ch ewed, or crush ed. 2. Tolterodin e sh ould be used cau tiously in clien ts

with n arrow-an gle glaucom a. 3. Do n ot adm in ister oxybutyn in to clien ts with

kn own h ypersen sitivity, gastroin testin al or gen i- tourin ary obstru ction , glaucom a, severe colitis, or m yasth en ia gravis.

4. Do n ot adm in ister propan th elin e to clien ts with n arrow-an gle glaucom a, obstructive uropath y, gastro in testin al disease, or ulcerative colitis.

5. In struct th e clien t to avoid h azardo us activities because of th e effects of dizzin ess an d drowsi- n ess.

6. Mon itor in take an d outp ut. 7. Provid e gum or h ard can dy for dry m ou th . 8. Mon itor for sign s of toxicity (CNS stim ulation )

such as h ypoten sion or h yperten sion , con fusion , tach ycardia, flush ed or red face, sign s of respira- tory depression , n ervousn ess, restlessn ess, h allu- cin atio n s, an d irritability.

Antispasmodic medications used to treat overactive bladder (urge incontinence) should not be used by cli- ents diagnosed with open-angle glaucoma. These med- ications will block the flow of intraocular fluid and raise the intraocular pressure. This may cause permanent damage to the optic nerve.

VI. Cholinergic A. Descrip tion : Beth an ech ol ch loride is a ch olin ergic

used to in crease blad der ton e an d fun ction an d to treat n on ob structive urin ary reten tion an d n euro- gen ic bladder.

B. Side an d adverse effects 1. Headach e 2. Hypoten sion 3. Flush in g an d sweatin g 4. In creased salivatio n 5. Nausea an d vom itin g 6. Abdom in al cram ps 7. Diarrh ea 8. Urin ary urgen cy 9. Bron ch ocon striction

10. Tran sien t com plete h eart block C. Nursin g con sideration s

1. Adm in ister on an em p ty stom ach , 1 h our before or 2 h ours after m eals to lessen n ausea an d vom itin g.

2. Never adm in ister by th e in tram uscular or IVroute. 3. Mon itor in take an d outp ut. 4. Mon itor for in creased bladder ton e an d fun ction .

BOX 59-4 Urinary Tract Analgesics ▪ Pentosan polysulfate sodium ▪ Phenazopyridine

BOX 59-5 Anticholinergics/ Antispasmodics

▪ Darifenacin ▪ Dicyclomine ▪ Oxybutynin chloride ▪ Flavoxate ▪ Mirabegron ▪ Propantheline ▪ Solifenacin ▪ Tolterodine ▪ Trospium

852 UNIT XIV Renal and Urinary Disorders of the Adult Client

5. Mon itor for ch olin ergic overdose (excessive sali- vation , sweatin g, in volun tary urin ation and defe- cation , bradycardia, an d severe h ypoten sion ).

6. Have atrop in e sulfate (an tidote) readily available for IV or subcutan eous ad m in istration .

A cholinergic such as bethanechol chloride is not given to a client who has a urinary stricture or obstruction.

VII. Medications for Preventing Organ Rejection (Box 59-6)

A. Med ication s in clude im m un osuppressan ts, cortico- steroids, cytotoxic m edication s, an d an tibod ies.

B. Som e m edication s m ay be used in com bin ation to produ ce differen t action s on th e im m un e system ; com bin ation th erap y also allows for adm in istration of th e m edication s in lower doses, reducin g th e pos- sibility of adverse effects.

C. Cyclosporin e 1. Cyclosporin e in h ibits calcin eurin an d acts on

T lym p h ocytes to supp ress th e production of in terleu kin -2, in terferon -γ, an d oth er cyto kin es.

2. Cyclosporin e m ay be used to preven t rejection of allogen eic kidney, liver, an d h eart tran splan ts.

3. Predn ison e m ay be adm in istered con curren tly. 4. O ral adm in istration of cyclosporin e is pre-

ferred; IV adm in istration is reserved for clien ts wh o can n ot take th e m ed ication orally.

5. Bloo d levels of th e m edication sh ould be m easu red regularly because of its n eph rotoxic effects.

6. Th e m ost com m on adverse effects are n eph ro- toxicity, in fectio n , h yperten sion , trem o r, an d h irsutism .

7. Assure th e clien t th at h irsutism is reversible; instruct on depilatory (h air rem oval) m ethods.

8. O th er adverse effects in clude n eurotoxicity, gastro in testin al effects, h yperkalem ia, an d h yperglycem ia.

9. Th e risk of in fectio n an d lym p h om as is in creased with th e use of cyclosporin e.

10. Cyclosporin e is con train d icated in th e pres- en ce of h ypersen sitivity, pregn an cy an d breast-feedin g, recen t in oculation with live virus vaccin es, an d recen t con tact with an active in fectio n such as ch icken p ox or h erpes zoster.

11. Cyclosporin e is em bryo toxic, an d wom en of ch ildbearin g age sh ould use a m ech an ical form of con tracep tion an d avoid oral con traceptives.

12. Th e clien t sh ould be in form ed about th e pos- sibility of ren al dam age an d liver dam age an d th e n eed for periodic liver fun ctio n tests an d determ in ation of coagu lation factors an d blood urea n itrogen , serum creatin in e, serum potassium , an d blood glucose levels.

13. Th e clien t sh o uld be in structed to m on itor for early sign s of in fectio n an d to report th ese sign s im m ediately.

14. Available in a pill form ; if th e clien t is un able to swallow th e pill, in struct th e clien t to follow th e m edication adm in istration in struction s exactly; dispen se th e oral liqu id m edication in to a glass con tain er usin g a specially cali- brated pipette, m ix well, an d drin k im m edi- ately; rin se th e glass co n tain er with diluen t an d drin k it to en sure in gestion of th e com - plete dose; dry th e outsid e of th e pipette an d return to its cover for storage.

15. To prom o te palatability, in struct th e clien t to m ix th e liquid m edication with m ilk, ch oco - late m ilk, or oran ge juice just before adm in is- tration .

16. Con sum in g grapefruit juice is proh ibited because it raises cyclosporin e levels an d in creases th e risk of toxicity.

17. Keto con azole, eryth rom ycin , an d am ph oteri- cin B can elevate cyclosporin e levels.

18. Ph en ytoin , ph en obarbital, rifam pin , an d trim eth oprim -su lfam eth oxazole can decrease cyclosporin e levels.

19. Ren al dam age can be in ten sified by th e con - curren t use of oth er n eph rotoxic m ed ication s.

D. Sirolim u s 1. Sirolim u s is used for th e preven tion of ren al

tran splan t rejection by in h ibitin g th e respon se of h elp er T lym p h ocytes an d B lym p h ocytes to cyto kin esis.

2. It m ay be used with cyclosporin e or tacrolim us an d cortico steroids.

3. In creases th e risk of in fectio n , in creases th e risk of ren al in ju ry, in creases th e risk of lym p h ocele

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

yBOX 59-6 Medications for Preventing Organ Rejection

Immunosuppressants ▪ Cyclosporine ▪ Sirolimus ▪ Tacrolimus Glucocorticoid ▪ Prednisone Cytotoxic Medications ▪ Azathioprine ▪ Mercaptopurine ▪ Mycophenolate mofetil Antibodies ▪ Antithymocyte globulin, equine ▪ Basiliximab

853CHAPTER 59 Renal and Urinary Medications

(a com plication of ren al tran splan t surgery), an d raises ch olesterol an d triglyceride levels

4. Side an d adverse effects in clude rash , acn e, an e- m ia, th rom bocytop en ia, join t pain , diarrh ea, an d h ypokalem ia.

E. Tacrolim us 1. Tacrolim us in h ibits calcin eurin an d th ereby

preven ts T cells fro m produ cin g in terleu kin -2, in terferon -γ, an d oth er cyto kin es.

2. Tacrolim us is m ore effective th an cyclosporin e, but is m ore toxic.

3. Adverse effects are sim ilar to th ose of cyclosporin e an d in clude n eph rotoxicity, in fection , h yperten - sion , trem or, h irsutism , n eurotoxicity, gastroin tes- tin al effects, h yperkalem ia, an d h yperglycem ia.

4. Tacrolim us sh o uld be used cautiously in im m u- n osupp ressed clien ts an d th o se with ren al, h epatic, or pan creatic im pairm en t.

5. Tacrolim us is con train d icated for clien ts h yper- sen sitive to cyclosporin e.

6. Mon itor blood gluco se levels an d adm in ister prescribed in sulin or oral h ypo glycem ics.

F. Predn ison e 1. Predn ison e is a gluco cortico id th at in h ibits

accu m ulation of in flam m atory cells at in flam - m ation sites.

2. Hyperglycem ia an d h ypokalem ia can occur with predn ison e use; m on itor gluco se an d serum potassiu m levels.

3. See Ch apter 51 for addition al in form ation about predn ison e.

G. Azath ioprin e 1. Azath ioprin e suppresses cell-m ediated an d

h um oral im m un e respon ses by in h ibitin g th e proliferation of B an d T lym p h ocytes.

2. Can cause n eutropen ia an d th rom bocytop en ia from bon e m arro w suppressio n

3. Con train dicated in pregn an cy; associated with an in creased in ciden ce of n eoplasm s

4. Mon itor h em atocrit, wh ite blood cell coun t, platelet coun t, liver en zym e levels, an d coagu la- tion factors.

H. Mycoph en olate m ofetil 1. Mycoph en olate m ofetil causes selective in h ibi-

tion of B- an d T-lym p h ocyte proliferatio n . 2. May be used with cyclosporin e or tacrolim us

an d gluco cortico ids for proph ylaxis again st organ rejection

3. Adverse effects in clude diarrh ea, severe n eutro- pen ia, vom itin g, an d sep sis.

4. Mycoph en olate m ofetil is associated with an in creased risk of in fection an d m align an cies.

5. Abso rption is decreased by th e use of m agn e- sium an d alum in um an tacids an d by ch olestyram in e.

6. It is con train dicated in pregn an cy an d durin g breast-feedin g.

7. In struct th e clien t to take the m edication on an em pty stom ach an d n ot to open or crush capsules.

8. In struct th e clien t to con tact th e HCP for un usual bleedin g or bruisin g, sore th roat, m ou th sores, abdom in al pain , or fever.

Persons who have undergone organ transplant, such as a kidney, must take the prescribed immunosup- pressant medications at the same time each day to ensure that the immune system is sufficiently sup- pressed to prevent organ rejection.

I. Basilixim ab 1. Basilixim ab bin d s to in terleukin -2 receptors on

lym ph o cytes, resultin g in dim in ish ed cell- m ediated im m un e reaction s.

2. Used prim arily as an in duction agen t at th e tim e of tran splan tation ; m ay be used with oth er im m un osuppressan ts to preven t acute rejection of tran splan ted kidn eys

3. Adm in istered by th e IV route; initial dose is adm in istered with in 2 h ours before tran s- plan tation .

4. Side an d adverse effects in clude h eadach e, in som n ia, dizzin ess, an d trem o rs; ch est pain , gastro in testin al distress, edem a, sh ortn ess of breath , pain in th e join ts, an d slow woun d h eal- in g can also occur.

J. An tith ym ocyte glob ulin , equin e 1. An tith ym ocyte glob ulin , equin e, causes a

decrease in th e n um ber an d activity of th ym u s- derived lym ph o cytes an d is used to suppress organ rejection followin g ren al, liver, bon e m ar- row, an d h eart tran splan tation .

2. It is used prim arily to treat acute rejection episodes.

3. Before th e first in fusion , th e clien t sh ould un dergo in traderm al skin testin g to determ in e h ypersen sitivity.

4. Becau se th is product is m ade usin g equin e an d h um an blood com po n en ts, it m ay carry a risk of tran sm ittin g in fectious agen ts, such as viruses.

5. Mon itor th e platelet coun t an d report low coun ts to th e HCP per agen cy policy.

6. Arran ge for outpatien t referral for repeated in fu- sion s after disch arge.

VIII. Hematopoietic Growth Factors (Box 59-7) A. Eryth ropoietic growth factors

1. Stim ulate th e productio n of red blood cells 2. Used to treat an em ia of chronic kidney disease,

ch em oth erapy-in du ced an em ia, an em ia cau sed by zidovud in e, an d an em ia in clien ts requirin g surgery

3. In itial effects can be seen with in 1 to 2 weeks, an d th e h em atocrit reach es n orm al levels in 2 to 3 m on th s.

4. Majo r adverse effect is h yperten sion .

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

854 UNIT XIV Renal and Urinary Disorders of the Adult Client

5. Adverse effects can also in clude h eart failure, th rom botic effects such as stroke or m yocardial in farction , an d cardiac arrest.

B. Leuko poietic growth facto rs 1. Stim ulate th e produ ctio n of wh ite blood cells

(leu kocytes) 2. Used for clien ts un d ergoin g m yelosuppressive

ch em oth erapy or bon e m arrow tran splan tation an d th ose with severe ch ron ic n eutropen ia

3. Can cau se bon e pain , leuko cytosis, an d elevation of plasm a uric acid, lactate deh ydrogen ase, an d alkalin e ph osph atase levels; lon g-term th erap y h as caused splen om egaly.

C. Th rom b opoietic growth facto r 1. Stim ulates th e productio n of platelets 2. Used for clien ts un d ergoin g m yelosuppressive

ch em oth erapy to m in im ize th rom bocytopen ia an d to decrease th e n eed for platelet tran sfusion s

3. Adverse effects in clude flu id reten tion , cardiac dysrh yth m ias, con jun ctival in fection , visu al blurrin g, an d papilledem a.

CRITICAL THINKING What Should You Do? Answer: Ciprofloxacin is a fluoroquinolone that is used to treat urinary tract infections by suppressing bacterial growth. Com- plaints of dizziness, lightheadedness, visual disturbances, increased light sensitivity, and feelings of depression are signs of central nervous system toxicity. Therefore, the nurse should withhold the medication and notify the health care provider.

Reference: Burchum, Rosenthal (20 16), pp. 10 86–10 87.

P R A C T I C E Q U E S T I O N S 726. A clien t wh o h as a cold is seen in th e em ergen cy

departm en t with an in ability to void. Because th e clien t h as a h isto ry of ben ign prostatic h yperplasia, th e n urse determ in es th at th e clien t sh o uld be question ed about th e use of wh ich m edication ? 1. Diuretics 2. An tibio tics 3. An tilipem ics 4. Decon gestan ts

727. Nitrofuran toin is prescribed for a clien t with a uri- n ary tract in fectio n . Th e clien t con tacts th e n urse an d reports a cough , ch ills, fever, an d difficu lty breath in g. Th e n urse sh o uld m ake wh ich in terp re- tatio n about th e clien t’s com plain ts? 1. Th e clien t m ay h ave con tracted th e flu . 2. Th e clien t is experien cin g an aph ylaxis. 3. Th e clien t is experien cin g expected effects of th e

m edication . 4. Th e clien t is experien cin g a pulm on ary reaction

requirin g cessation of th e m edication .

728. Th e n urse is providin g disch arge in struction s to a clien t receivin g trim eth oprim -su lfam eth oxazole. Wh ich in struction sh ould be in cluded in th e list? 1. Advise th at sun screen is n ot n eeded. 2. Drin k 8 to 10 glasses of water per day. 3. If th e urin e turn s dark brown , call th e h ealth care

provider (HCP) im m ediately. 4. Decrease th e dosage wh en sym ptom s are

im provin g to preven t an allergic respo n se.

729. Trim eth oprim -sulfam eth oxazole is prescribed for a clien t. Th e n urse sh ould in struct th e clien t to report wh ich sym pto m if it develops durin g th e course of th is m edication th erap y? 1. Nausea 2. Diarrh ea 3. Headach e 4. Sore th roat

730. Phenazopyridin e is prescribed for a clien t with a uri- n ary tract in fection. Th e n urse evaluates th at th e m edication is effective based on which observation ? 1. Urin e is clear am ber. 2. Urin ation is n ot pain ful. 3. Urge in con tin en ce is n ot presen t. 4. A reddish -oran ge discoloration of th e urin e is

presen t.

731. Beth an ech ol ch loride is prescribed for a clien t with urin ary reten tion . Wh ich disorder would be a con train dication to th e adm in istration of th is m ed ication ? 1. Gastric ato n y 2. Urin ary strictures 3. Neurogen ic aton y 4. Gastroesoph ageal reflux

732. Th e n urse, wh o is adm in isterin g beth an ech ol ch lo- ride, is m on itorin g for ch olin ergic overdose associ- ated with th e m edication . Th e n urse sh ould ch eck th e clien t for wh ich sign of overdose? 1. Dry skin 2. Dry m outh 3. Bradycardia 4. Sign s of deh ydration

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

yBOX 59-7 Hematopoietic Growth Factors Erythropoietic Growth Factors ▪ Epoetin alfa ▪ Darbepoetin alfa ▪ Peginesatide Leukopoietic Growth Factors ▪ Filgrastim ▪ Pegfilgrastim ▪ Sargramostim

855CHAPTER 59 Renal and Urinary Medications

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

733. O xybutyn in ch loride is prescribed for a clien t with urge in con tin en ce. Wh ich sign would in dicate a possible toxic effect related to th is m ed ication ? 1. Pallor 2. Drowsin ess 3. Bradycardia 4. Restlessn ess

734. Followin g kidn ey tran splan tation , cyclosporin e is prescribed for a clien t. Wh ich laborato ry result would in dicate an ad verse effect from th e use of th is m edication ? 1. Hem o glob in level of 14.0 g/ d L (140 m m o l/ L) 2. Creatin in e level of 0.6 m g/ dL (53 m cm ol/ L) 3. Blood urea n itrogen level of 25 m g/ dL

(8.8 m m o l/ L) 4. Fastin g blood gluco se level of 99 m g/ dL

(5.5 m m o l/ L)

735. Th e n urse is provid in g dietary in struction s to a cli- en t wh o h as been prescribed cyclosporin e. Wh ich food item sh ould th e n urse in struct th e clien t to exclud e from th e diet? 1. Red m eats 2. O ran ge juice 3. Grapefruit juice 4. Green , leafy vegetables

736. Tacrolim us is prescribed for a clien t wh o un der- wen t a kidn ey tran splan t. Wh ich in struction sh o uld th e n urse in clude wh en teach in g th e clien t ab out th is m edication ? 1. Eat at frequen t in tervals to avoid h ypo glycem ia. 2. Take th e m edication with a full glass of

grapefru it juice. 3. Ch an ge position s carefully due to risk of orth o-

static h ypo ten sion . 4. Take th e oral m ed ication every 12 h ours at th e

sam e tim es every day.

737. Th e n urse is reviewin g th e laborato ry results for a clien t receivin g tacrolim us. Wh ich laborato ry result

would in dicate to th e n urse th at th e clien t is experien cin g an adverse effect of th e m edication ? 1. Potassium level of 3.8 m Eq/ L (3.8 m m o l/ L) 2. Platelet coun t of 300,000 m m 3 (300 Â 109/ L) 3. Fastin g blood gluco se of 200 m g/ dL (11.1

m m o l/ L) 4. Wh ite blood cell coun t of 6000 m m 3 (5 to

10 Â 109/ L)

738. Th e n urse receives a call from a clien t con cern ed about elim in atin g brown -colored urin e after takin g n itrofuran toin for a urin ary tract in fection . Th e n urse sh ould m ake wh ich appropriate respon se? 1. “Con tin ue takin g th e m edication ; th e brown

urin e occurs an d is n ot h arm ful.” 2. “Take m agn esium h ydroxide with your m edica-

tio n to ligh ten th e urin e color.” 3. “Discon tin ue takin g th e m edication an d m ake

an appoin tm en t for a urin e cu lture.” 4. “Decrease your m ed ication to h alf th e dose,

because your urin e is too con cen trated .”

739. A clien t with ch ron ic kidn ey disease is receivin g epo etin alfa. Wh ich labo ratory result would in di- cate a th erapeutic effect of th e m edication ? 1. Hem atocrit of 33% (0.33) 2. Platelet coun t of 400,000 m m 3 (400 Â 109/ L) 3. Wh ite blood cell coun t of 6000 m m 3

(6.0 Â 109/ L) 4. Bloo d urea n itrogen level of 15 m g/ dL

(5.25 m m o l/ L)

740. A clien t with a urin ary tract in fectio n is receivin g cip rofloxacin by th e in traven ous (IV) route. Th e n urse appropriately ad m in isters th e m edication by perform in g wh ich action ? 1. In fusin g slowly over 60 m in u tes 2. In fusin g in a ligh t-protective bag 3. In fusin g on ly th rou gh a cen tral lin e 4. In fusin g rapidly as a direct IV push m edication

A N S W E R S 726. 4 Ra tion a le: In th e clien t with ben ign prostatic h yperplasia, ep iso des o f urin ary reten tio n can b e triggered b y certain m ed - ication s, su ch as d econ gestan ts, an tich o lin ergics, an d an tide- p ressan ts. Th ese m edicatio n s lessen th e volun tary ability to con tract th e b ladd er. Th e clien t sh ou ld b e q uestion ed ab ou t th e use of th ese m ed icatio n s if h e h as u rin ary reten tion . Diu retics in crease u rin e o u tp u t. An tib io tics an d an tlip em ics d o n o t affect ab ility to u rin ate. Test-Ta kin g St r a t egy: Focus o n th e su b ject, m ed ication s th at cou ld exacerb ate o r con trib u te to u rin ary reten tion in th e clien t

with ben ign prostatic h yperplasia. Recallin g th at m edication s th at co n tain an tich olin ergics m ay cause u rin ary reten tion will d irect yo u to th e co rrect o ption . Review: Factors th at can p recipitate u rin ary reten tio n in th e clien t with b en ign p ro static h yp ertro p h y Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—Ren al an d Urin ary Medica- tio n s Pr ior it y Con cept s: Elim in ation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1378.

856 UNIT XIV Renal and Urinary Disorders of the Adult Client

727. 4 Ra t ion a le: Nitro furan to in can in d uce 2 kin ds of p ulm o n ary reaction s: acute an d subacute. Acute reaction s, wh ich are m ost co m m o n , m an ifest with d yspn ea, ch est pain , ch ills, fever, co ugh , an d alveo lar in filtrates. Th ese sym p tom s resolve 2 to 4 days after discon tin uin g th e m edication . Acute pulm on ary respon ses are th ough t to be h ypersen sitivity reaction s. Sub- acu te reactio n s are rare an d occu r d urin g prolon ged treatm en t. Sym pto m s ( e.g., d yspn ea, cou gh , m alaise) u sually regress o ver weeks to m o n th s fo llo win g n itro furan toin with drawal. How- ever, in so m e clien ts, perm an en t lu n g d am age m ay occu r. Th e rem ain in g op tio n s are in correct in terp retatio n s. Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, in terpretin g th e clien t’s co m p lain ts, an d th e in fo rm atio n in th e q u estio n . No te th e relation sh ip o f th e in fo rm atio n in th e qu estio n an d th e wo rd s pulmonary reaction in th e co rrect op tio n . Review: Th e adverse effects of n itro fu ran to in Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Clin ical Jud gm en t; In fectio n Refer en ce: Burch um , Rosen th al (2016), pp . 1068–1069.

728. 2 Ra t ion a le: Each d ose of trim eth oprim -sulfam eth oxazole sh ou ld b e ad m in istered with a full glass o f water, an d th e clien t sh ou ld m ain tain a h igh fluid in take to avo id crystalluria. Th e m edicatio n is m o re so lub le in alkalin e urin e. Th e clien t sh ou ld n o t b e in structed to taper or d iscon tin u e th e d ose. Clien ts sh o u ld b e ad vised to u se su n screen sin ce th e skin becom es sen sitive to th e sun . So m e fo rm s of trim eth o p rim - sulfam eth o xazo le cause urin e to turn dark brown or red . Th is do es n o t in d icate th e n eed to n otify th e HCP. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, clien t in stru ction s fo r trim eth o p rim -su lfam eth oxazo le. Recallin g th at th is m ed i- catio n is used to treat u rin ary tract in fection s will direct yo u to th e co rrect op tio n . Review: Trim eth o p rim -su lfam eth o xazo le Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Clien t Teach in g; In fectio n Refer en ce: Burch u m , Rosen th al (2016), pp . 1060, 1063–1064.

729. 4 Ra t ion a le: Clien ts takin g trim eth o prim -sulfam eth o xazo le sh ou ld b e in fo rm ed ab ou t early sign s an d sym pto m s o f b lo od diso rd ers th at can occur fro m th is m ed ication . Th ese in clu de sore th ro at, fever, an d pallor, an d th e clien t sh ou ld b e in structed to n o tify th e h ealth care provid er (HCP) if th ese occu r. Th e o th er o ptio n s d o n o t req uire HCP n otificatio n . Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e sym p to m s to rep ort. Kn o wledge th at th is m edication can cause blood dys- crasias will direct yo u to th e correct o ptio n . Review: Trim eth o p rim -su lfam eth o xazo le Level of Cogn it ive Ability: Ap plyin g

Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Clien t Ed u catio n ; In fection Refer en ce: Bu rch u m , Rosen th al ( 2016), pp . 1062, 1064–1065.

730. 2 Ra t ion a le: Ph en azo pyridin e is a urin ary an algesic. It is effec- tive wh en it elim in ates pain an d b urn in g with urin ation . It d o es n ot elim in ate th e bacteria cau sin g th e in fection , so it would n ot m ake th e urin e clear am ber. It does n ot treat urge in con tin en ce. It will cause th e clien t to h ave red dish -o ran ge d iscoloration of urin e b ut th is is a sid e effect of th e m edicatio n , n ot th e d esired effect. Test -Ta kin g Str a tegy: No te th e strategic wo rd , effective. Focus o n th e su b ject, effectiven ess of p h en azop yrid in e. Recallin g th e classificatio n of th is m ed ication an d th at it is a u rin ary an alge- sic will direct yo u to th e correct o ptio n . Review: Effectiven ess o f p h en azo p yrid in e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Elim in atio n ; Pain Refer en ce: Ho dgso n , Kizior (2015), p p. 949–950.

731. 2 Ra t ion a le: Beth an ech o l ch lo rid e can b e h azard ou s to clien ts with urin ary tract obstruction or weakn ess of th e bladder wall. Th e m ed ication h as th e ability to co n tract th e blad d er an d th ereb y in crease pressure with in th e u rin ary tract. Elevation o f pressure with in th e u rin ary tract co u ld dam age o r rup ture th e blad der in clien ts with th ese con ditio n s. Test -Ta kin g Str a tegy: Focus on th e su b ject, a con train dicatio n fo r th e use o f th e m ed icatio n . Notin g th at th e m ed ication is u sed fo r urin ary reten tio n m ay assist in directin g yo u to th e co r- rect op tio n . Review: Con train d ication s associated with b eth an ech o l ch lo rid e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con ten t Ar ea : Pharm aco logy—Ren al an d Urin ary Medication s Pr ior ity Con cepts: Elim in atio n ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), pp . 116–117, 125.

732. 3 Ra t ion a le: Ch olin ergic overdose of beth an ech ol ch loride pro- duces m an ifestation s of excessive m uscarin ic stim ulation such as salivation , sweatin g, in volun tary urin ation an d defecation , bra- dycardia, an d severe h ypoten sion . Rem em ber th at th e sym pa- th etic n ervous system speeds th e h eart rate an d th e ch olin ergic (parasym path etic) n ervous system slows th e h eart rate. Treatm en t in cludes supportive m easures an d th e adm in istration of atropin e sulfate (an tich olin ergic) subcutan eously or in traven ously. Test -Ta kin g St r a t egy: Focus on th e su b ject, sign s o f ch o lin er- gic overd ose. No tin g th at op tion s 1, 2, an d 4 are co m p arab le o r alike will assist in elim in atin g th ese o p tion s.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

857CHAPTER 59 Renal and Urinary Medications

Review: Sign s o f overdo se o f b eth an ech o l ch lo rid e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco lo gy—Ren al an d Urin ary Medica- tio n s Pr ior it y Con cept s: Elim in ation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 125.

733. 4 Ra tion a le: Toxicity ( o verd osage) of oxyb u tyn in p ro d uces cen - tral n ervou s system excitatio n , su ch as n ervou sn ess, restless- n ess, h allu cin atio n s, an d irritability. O th er sign s o f toxicity in clu d e h yp oten sio n o r h yp erten sion , con fusion , tach ycard ia, flu sh ed o r red face, an d sign s o f resp irato ry dep ression . Dro ws- in ess is a freq uen t sid e effect o f th e m ed ication bu t do es n o t in dicate overd osage. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, sign s of to xicity (overd osage) of o xyb utyn in . Rem em ber th at restlessn ess is a sign o f to xicity. Review: Sign s o f toxicity o f o xyb u tyn in Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco lo gy—Ren al an d Urin ary Medica- tio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Hod gson , Kizio r (2015), pp . 902–904.

734. 3 Ra tion a le: Cyclo sp orin e is an im m u n osupp ressan t. Neph ro to x- icity can occur fro m th e use of cyclo sp orin e. Nep hrotoxicity is evalu ated by m o nitorin g for elevated blood u rea n itrogen and serum creatin in e levels. The n orm al b lo od u rea n itrogen level is 10 to 20 m g/ dL (3.6 to 7.1 m m ol/ L). Th e n orm al creatin in e level for a m ale is 0.6 to 1.2 m g/d L ( 53 to 106 m cm o l/ L) an d for a fem ale 0.5 to 1.1 m g/ d L (44 to 97 m cm ol/ L). Cyclosporin e can lower com plete b lood cell coun t levels. A n orm al h em o glo- b in is Male: 14 to 18 g/ d L (140 to 180 m m o l/ L); Female: 12 to 16 g/ d L ( 120 to 160 m m ol/ L). A n orm al h em o glo bin is n ot an adverse effect. Cyclo sporin e does affect th e glu co se level. Th e n orm al fastin g gluco se is 70 to 110 m g/ dL ( 4 to 6 m m ol/ L) . Test-Ta kin g Str a tegy: Focus o n th e su b ject, th e adverse effects o f cyclo spo rin e. Recall th at cyclosp orin e can be n ep h roto xic. Th e correct o ptio n is th e o n ly on e th at in dicates an in creased level of a ren al fun ctio n test. Also , recallin g th e n orm al labo ra- to ry referen ce levels will d irect yo u to th e co rrect o ption , th e o n ly ab n o rm al level. Review: Adverse effects related to cyclo sp o rin e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm aco lo gy—Ren al an d Urin ary Medica- tio n s Pr ior it y Con cept s: Im m u n ity; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 840.

735. 3 Ra tion a le: A com po u n d p resen t in grap efru it ju ice in h ib its m etabo lism of cyclo sp orin e th rou gh th e cyto ch ro m e P450

system . As a resu lt, co n su m ptio n o f grap efru it ju ice can raise cyclo spo rin e levels by 50% to 100%, th ereb y greatly in creasin g th e risk of toxicity. Red m eats, o ran ge ju ice, an d green , leafy vegetables do n ot in teract with th e cytoch rom e P450 system . Test-Ta kin g Str a tegy: Fo cus on th e su b ject, th e item to exclu de fro m th e diet. Recall th at grap efru it juice is co n train d icated with m an y m ed ication s. Use o f gen eral ph arm aco logy gu id e- lin es will d irect yo u to th e correct o ptio n . Review: Cyclo sp o rin e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Ren al an d Urin ary Medica- tio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 840.

736. 4 Ra tion a le: Tacrolim u s is a p o ten t im m u n o sup pressan t u sed to p reven t organ rejection in tran splan t clien ts. It is im po rtan t th at th e m edicatio n b e taken at 12-h o ur in tervals to m ain tain a stab le bloo d level to p reven t o rgan rejectio n . Adverse effects in clu de h yp erglycem ia an d h yperten sion , so th e clien t d oes n o t eat freq uen tly to avoid h yp oglycem ia o r u se p recautio n s to avoid o rth o static h yp oten sio n . Tacro lim u s is m etabo lized th rou gh th e cyto ch ro m e P450 system , so grap efru it ju ice is n o t allowed . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, teach in g a tran s- p lan t clien t regardin g tacrolim u s. Focus o n th e go al o f avoid in g o rgan rejection by m ain tain in g a stable level o f tacro lim us in th e bloo d by takin g th e m ed ication at regu lar in tervals every day. Review: Tacro lim u s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Ren al an d Urin ary Medica- tio n s Pr ior it y Con cept s: Clien t Ed ucation ; Im m un ity Refer en ce: Bu rch u m , Ro sen th al (2016), p . 836.

737. 3 Ra tion a le: A fastin g blo o d glu co se level of 200 m g/ d L (11.1 m m ol/ L) is sign ifican tly elevated ab ove th e n orm al ran ge o f 70 to 110 m g/ dL (4 to 6 m m o l/ L) an d suggests an adverse effect. Recall th at fastin g blo od glu co se levels are so m etim es b ased o n h ealth care p ro vid er preferen ce. O th er ad verse effects in clu de n euroto xicity evid en ced by h eadach e, trem or, an d in som n ia; gastro in testin al effects su ch as diarrh ea, n au sea, an d vom itin g; h yp erten sio n ; an d h yp erkalem ia. Th e rem ain in g o ptio n s id en tify n o rm al referen ce levels. Th e n orm al po tas- siu m level is 3.5 to 5.0 m Eq / L (3.5 to 5.0 m m o l/ L). Th e n o rm al p latelet cou n t is 150,000 to 400,000 m m 3 (150 to 400 Â 109/ L). Th e n orm al wh ite bloo d cell co u n t is 5000 to 10,000 m m 3 (5 to 10 Â 109/ L). Test-Ta kin g Str a tegy: Focus o n th e su b ject, an ad verse effect. No te th at o ptio n s 1, 2, an d 4 are co m p arab le o r alike an d rep - resen t n orm al values. Th e co rrect optio n h as th e on ly abn o r- m al valu e, reflectin g an elevatio n . Review: Ad verse effects related to tacro lim u s

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

858 UNIT XIV Renal and Urinary Disorders of the Adult Client

Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Bu rch u m , Ro sen th al (2016), p . 836; Lilley et al. (2014) , p . 793.

738. 1 Ra t ion a le: Nitrofu ran toin im parts a h arm less brown co lo r to th e u rin e an d th e m ed ication sh ou ld n o t b e d iscon tin u ed u n til th e prescrib ed d ose is co m pleted. Magn esium h ydroxide will n ot affect u rin e co lo r. In ad d ition , an tacid s sh o uld b e avo id ed because th ey in terfere with m edicatio n effectiven ess. Test -Ta kin g Str a tegy: Fo cus on th e su b ject, brown -colo red urin e. O ptio n 2 can b e elim in ated becau se an tacids sh o uld be avo ided as a resu lt of th eir in terferen ce with th e effectiven ess of n itro furan toin . In ad d ition , m agn esiu m h ydroxide will n o t h ave an effect o n u rin e co lo r. Next, elim in ate op tion s 3 an d 4 because th e n u rse sh o u ld n ot tell th e clien t to disco n tin u e m ed- icatio n or alter th e d ose. Review: Nitro fu ran to in Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Elim in atio n ; Safety Refer en ce: Ho dgso n , Kizior (2015), p p. 856–857.

739. 1 Ra t ion a le: Epo etin alfa is synth etic eryth ropoietin , wh ich th e kidn eys pro duce to stim ulate red blood cell p ro duction in th e bon e m arrow. It is used to treat an em ia associated with ch ro nic kidn ey disease. Th e n orm al h em atocrit level is Male: 42% to 52% (0.42 to 0.52); Female: 37% to 47% (0.37 to 0.47). Th erapeutic effect is seen wh en th e h em ato crit reach es between 30% an d 33% (0.30 and 0.33). Th e n orm al platelet coun t is 150,000 to 400,000 m m 3 (150 to 400 Â 109/ L). Th e n orm al b lo od urea

n itrogen level is 10 to 20 m g/ dL (3.6 to 7.1 m m ol/ L). Th e n orm al wh ite blood cell count is 5000 to 10,000 m m 3 (5 to 10 Â 109/L). Platelet production , white blood cell production , an d blo od u rea n itrogen do n ot respon d to eryth ropo ietin . Test -Ta kin g Str a tegy: Fo cu s on th e su b ject, a th erap eu tic effect. Relate th e n am e o f th e m ed ication , epo etin alfa, to th e p o ten tial actio n o r effect o f eryth rop oietin . Th e o n ly lab o ratory test th at wo uld reflect th e effect o f th is m ed ication is a h em at- o crit o f 33% (0.33), fo un d in th e co rrect o p tion . Review: Ep o etin alfa Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con ten t Ar ea : Pharm aco logy—Ren al an d Urin ary Medication s Pr ior ity Con cepts: Clin ical Jud gm en t; Evid en ce Refer en ce: Bu rch u m , Rosen th al (2016), pp . 663–664.

740. 1 Ra t ion a le: Cip ro flo xacin is prescrib ed fo r treatm en t o f m ild , m o derate, severe, an d com p licated in fectio n s o f th e urin ary tract, lower resp irato ry tract, an d skin an d skin stru ctu re. A sin - gle d ose is adm in istered slowly o ver 60 m in u tes to m in im ize d iscom fo rt an d vein irritatio n . Ciproflo xacin is n o t ligh t- sen sitive, m ay be in fu sed th rou gh a p erip h eral IV access, an d is n o t given by IV pu sh m eth o d. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, th e app ro priate way to adm in ister an IV m edication ciprofloxacin . Recall th at th is m edicatio n h as ad verse effects, so IV p ush wou ld n ot b e th e reco m m en ded m eth od o f adm in istratio n . Elim in ate o p tion 3 b ecau se of th e clo sed -en d ed wo rd , only. Next, it is n ecessary th at th e p resen ce o f ligh t do es n o t affect th e in tegrity o f th is m ed ication . Review: Th e pro ced ure fo r adm in isterin g IV cip ro flo xacin Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ph arm acolo gy—Ren al an d Urin ary Med ica- tion s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Gah art, Nazaren o (2015), p p. 286–287.

A

d

u

l

t

R

e

n

a

l

a

n

d

U

r

i

n

a

r

y

859CHAPTER 59 Renal and Urinary Medications

A

d

u

l

t

E

y

e

/

E

a

r UNIT XV

Eye and Ear Disorders of the Adult Client

Pyramid to Success

Pyram id Poin ts focus on safety an d n ursin g in terven - tion s for clien ts with im pairm en t of sigh t or h earin g an d on th e n ursin g care related to disorders such as cat- aracts, glaucom a, an d retin al detach m en t. Com m un icat- in g with clien ts wh o are visually or h earin g im paired is also a priority. Em ergen cy in terven tion s for eye an d ear disorders an d in ju ries are a priority poin t. Pyram id Poin ts also focus on clien t in struction s related to m ed i- cation adm in istration , sen sory percep tual alteration s an d safety issues, an d available support system s.

Client Needs: Learning Objectives Safe and Effective Care Environment Carin g for th e recipien t of a tissue (corn eal) don ation Com m un icatin g with th e in terpro fession al h ealth

care team Establish in g prio rities Main tain in g asepsis with proced ures an d treatm en ts Main tain in g stan d ard an d oth er precaution s Preven tin g acciden ts th at can occur as a result of sen sory

im pairm en ts Uph oldin g clien t righ ts Verifyin g th at in form ed con sen t for in vasive proced ures

is obtain ed

Health Promotion and Maintenance Discussin g ch an ges th at occur with th e agin g process Discussin g exp ected body im age ch an ges an d self-care

deficits

Im plem en tin g m easu res for th e preven tion an d early detection of h ealth problem s an d diseases related to th e eye an d th e ear

Perform in g ph ysical assessm en ts of th e eye an d ear Providin g h om e care in struction s followin g procedures

related to th e eye an d ear Providin g in struction s regardin g activity lim itation s or

postoperative activities Providin g in struction s regardin g th e adm in istration of

eye an d ear m edication s Teach in g regardin g th e im portan ce of com plian ce with

th e prescribed th erapy

Psychosocial Integrity Assessin g th e clien t’s ability to cope with feelin gs of iso-

lation , fear, or an xiety regardin g a possible ch an ge in vision an d/ or h earin g status, an d loss of in depen - den ce

Discussin g role ch an ges Iden tifyin g fam ily supp ort system s In form in g th e clien t about available com m un ity

resources Mon itorin g for sen sory perceptual alteration s Usin g ap propriate com m un ication tech n iques for

im paired vision an d h earin g

Physiological Integrity Mon itorin g for co m plication s related to proced ures Mon itorin g for exp ected respo n ses to th erap y Providin g care for assistive devices such as eyeglasses,

con tact len ses, an d h earin g aids Takin g action in m edical em ergen cies

860

A

d

u

l

t

E

y

e

/

E

a

r

C H A P T E R 60 The Eye and the Ear

PRIORITY CONCEPTS Safety, Sensory Perception

CRITICAL THINKING What Should You Do? A client enters the emergency department and tells the triage nurse that he suddenly felt something hit his eye and has severe eye pain. The nurse notes an entrance wound and sus- pects a foreign body in the client’s affected eye. What should the nurse do? Answer located on p. 876.

I. Anatomy and Physiology of the Eye A. Th e eye

1. Th e eye is 1 in ch (2.5 cm ) in diam eter an d is lo cated in th e an terior portion of th e orbit.

2. Th e orbit is th e bon y structure of th e skull th at surroun ds th e eye an d offers protection to the eye.

B. Layers of th e eye 1. Extern al layer

a. Th e fibrous coat th at supports th e eye b . Con tain s th e corn ea, th e den se tran sparen t

outer layer c. Con tain s th e sclera, th e fibrous “wh ite of

th e eye” 2. Middle layer

a. Called th e uveal tract b . Con sists of th e ch oroid, ciliary body, an d iris c. Th e ch oroid is th e dark brown m em bran e

located between th e sclera an d th e retin a th at h as dark pigm en tation to preven t ligh t from reflectin g in tern ally.

d . Th e ch oroid lin es m ost of th e sclera an d is attach ed to th e retin a but can detach easily from th e sclera.

e. Th e ch oro id con tain s m an y blood vessels an d supp lies n utrien ts to th e retin a.

f. Th e ciliary body con n ects th e ch oro id with th e iris an d secretes aq ueous h um or th at h elps give th e eye its sh ap e; th e m uscles of th e ciliary body con tro l th e th ickn ess of th e len s.

g. Th e iris is th e colored portion of th e eye, lo cated in fron t of th e len s, an d it h as a cen - tral circular open in g called th e pupil. Th e pupil con trols th e am oun t of ligh t (dark- n ess produ ces dilation an d ligh t produces co n striction ) adm itted in to th e retin a.

3. In tern al layer a . Con sists of th e retin a, a th in , delicate struc-

ture in wh ich th e fibers of th e optic n erve are distributed.

b . Th e retin a is bordered extern ally by th e ch oro id an d sclera an d in tern ally by th e vitreous.

c. Th e retin a is th e visu al receptive layer of th e eye in wh ich ligh t waves are ch an ged in to n erve im pulses; it con tain s blood vessels an d ph otoreceptors called rods an d cones.

C. Vitreous body 1. Con tain s a gelatin ous substan ce th at occupies

th e vitreo us ch am b er, th e space between th e len s an d th e retin a

2. Th e vitreo us body tran sm its ligh t an d gives sh ap e to th e posterio r eye.

D. Vitreous 1. Gel-like substan ce th at m ain tain s th e sh ape of

th e eye 2. Provides addition al ph ysical support to th e

retin a E. Rods an d con es

1. Rods are respon sible for periph eral vision an d fun ction at reduced levels of illum in ation .

2. Con es fun ctio n at brigh t levels of illum in ation an d are respo n sible for color vision an d cen tral vision .

F. O ptic disc 1. It is a cream y pin k to wh ite depressed area in th e

retin a. 2. Th e optic n erve en ters an d exits th e eyeball at

th is area. 3. Th is area is called th e blind spot because it con -

tain s on ly n erve fibers, lacks ph otoreceptor cells, an d is in sen sitive to ligh t. 861

G. Macula lutea 1. Sm all, oval, yellowish -pin k area located later-

ally an d tem porally to th e optic disc 2. Th e cen tral dep ressed part of th e m acula is th e

fovea cen tralis, th e area of sh arpest an d keen est vision , wh ere m ost acute vision occurs.

3. Its fun ction s in clude cen tral vision , n igh t an d color vision , an d m otion detection .

H. Aqueous h um or 1. A clear, watery fluid th at fills th e an terior an d

posterior ch am b ers of th e eye 2. It is produced by th e ciliary processes, an d th e

fluid drain s in to th e can al of Sch lem m . 3. Th e an terior ch am b er lies between th e corn ea

an d th e iris. 4. Th e posterior ch am ber lies between th e iris an d

th e len s. I. Can al of Sch lem m : Passageway th at exten ds

com pletely arou n d th e eye; it perm its fluid to drain out of th e eye in to th e system ic circulation so th at a con stan t in traocular pressure (IO P) is m ain tain ed.

J. Len s 1. Tran sparen t con vex structure beh in d th e iris

an d in fro n t of th e vitreous body 2. Th e len s ben ds rays of ligh t so th at th e ligh t falls

on th e retin a. 3. Th e curve of th e len s ch an ges to focus on n ear or

distan t objects. K. Con ju n ctivae: Th in , tran sparen t m ucous m em -

bran es of th e eye th at lin e th e posterio r surface of each eyelid, lo cated over th e sclera

L. Lacrim al glan d : Produ ces tears th at are drain ed th rou gh th e pun ctum in to th e lacrim al duct an d sac

M. Eye m uscles 1. Muscles do n ot work in depen den tly; each m us-

cle works with th e m uscle th at produces th e oppo site m ovem en t.

2. Rectus m uscles exert th eir pull wh en th e eye turn s tem porally.

3. O blique m uscles exert th eir pull wh en th e eye turn s n asally.

N. Nerves 1. Cran ial n erve II: O ptic n erve (sigh t) 2. Cran ial n erve III: O culom o tor (eye m ovem en t) 3. Cran ial n erve IV: Troch lear (eye m ovem en t) 4. Cran ial n erve VI: Abdu cen s (eye m ovem en t)

O. Bloo d vessels 1. Th e oph th alm ic artery is th e m ajor artery sup-

plyin g th e structures in th e eye. 2. Th e oph th alm ic vein s drain th e blood from

th e eye.

II. Assessment of Vision (see Chapter 15)

III. Diagnostic Tests for the Eye A. Fluorescein an giograph y

1. Description

a . A detailed im agin g an d recordin g of ocular circulation by a series of ph o tograp h s taken after th e adm in istration of a dye

b . Used to assess problem s with retin al circu- lation , such as th ose th at occur in diabetic retin opath y, retin al bleedin g, an d macular degeneration, or to ru le out in traocular tum o rs

2. Preprocedure in terven tion s a . Assess th e clien t for allergies an d previous

reaction s to dyes. b . An in form ed con sen t is n ecessary. c. A mydriatic m edication , wh ich cau ses pupil

dilation , is in stilled in to th e eye 1 h ou r befo re th e test.

d . Th e dye is in jected in to a vein of th e clien t’s arm .

e. In form th e clien t that th e dye m ay cause th e skin to appear yellow for several h ours after the test an d is elim in ated gradually through the urin e. Urin e m ay be brigh t green or oran ge for up to 2 days followin g th e procedure.

f. Th e clien t m ay exp erien ce n ausea, vo m it- in g, sn eezin g, paresth esia of th e ton gue, or pain at th e in jection site.

g. If h ives appear, an tih istam in es such as diph en h ydram in e are ad m in istered as pre- scrib ed.

3. Postp rocedure in terven tion s a . En cou rage rest. b . En cou rage fluid in take to assist in elim in at-

in g th e dye. c. Rem in d th e clien t th at th e yellow skin

ap pearan ce will disappear. d . In form th e clien t th at th e urin e will appear

brigh t green or oran ge un til th e dye is excreted.

e. Advise th e clien t to avoid direct sun ligh t for a few h ours after th e test an d to wear sun - glasses, if stayin g in do ors is n ot possible.

f. In form th e clien t th at th e ph otoph obia will con tin ue un til pupil size return s to n orm al.

B. Com p uted tom ograph y (CT) 1. Description

a . Th e test is perform ed to exam in e th e eye, bon y structures aroun d th e eye, an d extrao- cular m uscles.

b . Con trast m aterial m ay be used un less eye traum a is suspected.

2. In terven tion s a. No special clien t preparatio n or follow-up

care is required . b . In struct th e clien t th at h e or sh e will be posi-

tion ed in a con fin ed space an d will n eed to keep th e h ead still durin g th e proced ure.

c. Ask about an d docum en t allergies an d/ o r previous exposure to con trast.

A

d

u

l

t

E

y

e

/

E

a

r

862 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

C. Slit lam p 1. Description

a. Allows exam in ation of th e an terior ocular structures un der m icroscop ic m agn ification

b . Th e clien t lean s on a ch in rest to stabilize th e h ead wh ile a n arrowed beam of ligh t is aim ed so th at it illum in ates on ly a n arrow segm en t of th e eye.

2. In terven tion s: Advise th e clien t about th e brigh tn ess of th e ligh t an d th e n eed to look for- ward at a poin t over th e exam in er’s ear.

D. Corn eal stain in g 1. Description

a. A topical dye is in stilled in to th e con jun cti- val sac to outlin e irregularities of th e cor- n eal surface th at are n ot easily visible.

b . Th e eye is viewed th rough a blue filter, an d a brigh t green co lor in dicates areas of a n on - in tact corn eal epith elium .

2. In terven tion s a. If th e clien t wears con tact len ses, th e len ses

m ust be rem oved. b . Th e clien t is in structed to blin k after th e dye

h as been applied to distribute th e dye even ly across th e corn ea.

E. Ton o m etry 1. Description : Th e test is used prim arily to assess

for an in crease in IO P an d poten tial glaucoma. 2. No n con tact ton om etry

a. No direct con tact with th e clien t’s corn ea is n eeded an d n o topical eye an esth etic is n eeded.

b . A puff of air is directed at th e co rn ea to in den t th e corn ea, wh ich can be un pleasan t an d m ay startle th e clien t.

c. It is a less accu rate m eth od of m easurem en t as com pared with con tact ton om etry.

3. Con tact ton om etry a. Requ ires a topical an esth etic b . A flatten ed con e is brough t in to con tact

with th e corn ea an d th e am oun t of pressure n eeded to flatten th e corn ea is m easu red.

c. Th e clien t m ust be in structed to avoid ru b- bin g th e eye followin g th e exam in ation if th e eye h as been an esth etized because of th e poten tial for scratch in g th e corn ea.

Normal IOP is 10 to 21 mm Hg; IOP varies through- out the day and is normally higher in the morning (always document the time of IOP measurement).

F. Ultrasoun d: Procedure is sim ilar to an ultrasoun d proced ure don e in oth er parts of th e body an d is don e to detect lesion s or tum o rs in th e eye.

G. Magn etic reson an ce im agin g (MRI): Sim ilar to an MRI don e in oth er parts of th e body; refer to Ch apter 62 for addition al in form ation on MRI.

IV. Disorders of the Eye A. Risk factors related to eye disorders ( Box 60-1) B. Refractive errors

1. Description a. Refraction is th e ben din g of ligh t rays; an y

problem associated with eye len gth or refraction can lead to refractive errors.

b . Myopia (n earsigh tedn ess): Refractive ability of th e eye is too stron g for th e eye len gth ; im ages are ben t an d fall in fron t of, n ot on , th e retin a.

c. Hyperopia (farsigh tedn ess): Refractive abil- ity of th e eye is too weak; im ages are focused beh in d th e retin a.

d . Presbyopia: Loss of len s elasticity because of agin g; less able to focus th e eye for clo se work an d im ages fall beh in d th e retin a.

e. Astigmatism: O ccurs because of th e irregu- lar curvatu re of th e corn ea; im age focuses at 2 differen t poin ts on th e retin a.

2. Assessm en t a . Refractive errors are diagn osed th rough a

process called refraction. b . Th e clien t views an eye ch art wh ile various

len ses of differen t stren gth s are system ati- cally placed in fron t of th e eye, an d is asked wh eth er th e len ses sh arpen or worsen th e vision .

3. No n surgical in terven tion s: Eyeglasses or con tact len ses

4. Surgical in terven tion s a. Rad ial keratoto m y: In cision s are m ade

th rou gh th e periph eral corn ea to flatten th e corn ea, wh ich allows th e im age to be focused closer to th e retin a; used to treat m yopia.

b . Ph o torefractive keratoto m y: A laser beam is used to rem ove sm all portion s of th e cor- n eal surface to resh ape th e co rn ea to focus an im age properly on th e retin a; used to treat m yopia an d astigm atism .

c. Laser-assisted in -situ keratom ileusis (LASIK): Th e superficial layers of th e corn ea are lifted as a flap, a laser resh apes th e dee- per corn eal layers, an d th en th e corn eal flap is replaced; used to treat h yperopia, m yo- pia, an d astigm atism .

d . Corn eal ring: Th e sh ape of th e cornea is chan ged by placing a flexible rin g in the outer edges of the corn ea; used to treat m yopia.

BOX 60-1 Risk Factors for Eye Disorders

▪ Aging process ▪ Congenital ▪ Diabetes mellitus

▪ Hereditary ▪ Medications ▪ Trauma

863CHAPTER 60 The Eye and the Ear

A

d

u

l

t

E

y

e

/

E

a

r

C. Legal blindness 1. Description : In th e clien t wh o is legally blind, th e

best visual acuity with corrective len ses in th e better eye is 20/ 200 or less, or th e visu al field is n o greater th an 20 degrees in its widest diam - eter in th e better eye.

2. In terven tion s a . Wh en speakin g to th e clien t wh o h as lim -

ited sigh t or is blin d, th e n urse sh ould use a n orm al ton e of voice.

b . Alert th e clien t wh en approach in g. c. O rien t th e clien t to th e en viron m en t. d . Use a focal point an d provide furth er orien -

tation to th e en viron m en t from th at focal poin t; en sure that the clien t h as a clear pathway.

e. Allow the clien t to touch objects in th e room . f. Use th e clo ck placem en t of food s on th e

m eal tray to orien t th e clien t. g. Prom ote in depen den ce as m uch as is

possible. h . Provide radios, television s, an d clocks th at

give th e tim e orally, or provide a Braille watch .

i. Wh en am bulatin g, allow th e clien t to grasp th e n urse’s arm at th e elbow; th e n urse keeps h is or h er arm close to th e body so th at th e clien t can detect th e direction of m ovem en t.

j. In struct th e clien t to rem ain 1 step beh in d th e n urse wh en am bulatin g.

k . In struct th e clien t in th e use of th e can e for th e blin d, wh ich is differen tiated from oth er can es by its straigh t sh ap e an d wh ite color with red tip .

l. In struct th e clien t th at th e can e is h eld in th e dom in an t h an d several in ch es (cen ti- m eters) off th e floor.

m . In struct th e client th at th e can e sweeps th e groun d wh ere th e clien t’s foot will be placed n ext to determ in e the presen ce of obstacles.

D. Cataracts (Fig. 60-1) 1. Description

a . A cataract is an opacity of th e len s th at dis- torts th e im age projected on to th e retin a an d th at can progress to blin dn ess.

b . Causes in clude th e agin g process (sen ile cat- aracts), h eredity (con gen ital cataracts), an d in ju ry (traum atic cataracts); cataracts also can result from an oth er eye disease (sec- on d ary cataracts) .

c. Cau ses of secon dary cataracts in clude dia- betes m ellitus, m atern al rubella, severe m yopia, ultraviolet ligh t exposure, an d m ed ication s such as corticosteroid s.

d . In terven tion is in dicated wh en visual acuity h as been reduced to a level th at th e clien t fin ds un acceptable or th at ad versely affects h is or h er lifestyle.

2. Assessm en t a . Blurred vision an d decreased color percep -

tio n are early sign s. b . Diplopia, reduced visual acuity, absen ce of th e

red reflex, an d th e presen ce of a wh ite pupil are late sign s. Pain or eye redn ess is associated with age-related cataract form ation .

c. Loss of vision is gradual. 3. In terven tion s

a . Surgical rem oval of th e len s, 1 eye at a tim e, is perform ed.

b . With extracapsular extraction , th e len s is lifted out with out rem ovin g th e len s capsule; th e procedure m ay be perform ed by ph acoe- m ulsification , in wh ich th e len s is broken up by ultrason ic vibration s an d extracted.

c. With in tracapsular extraction , th e len s an d cap sule are rem oved com pletely.

d . A partial iridectom y m ay be perform ed with th e len s extraction to preven t acu te secon d- ary glaucom a.

e. A len s im plan tation m ay be perform ed at th e tim e of th e surgical proced ure.

4. Preop erative in terven tion s a . In struct th e clien t regardin g th e posto pera-

tive m easures such as th e im portan ce of h an d wash in g an d m easures to preven t or decrease IO P, such as ben din g over, cough - in g, strain in g, an d rubbin g th e eye.

b . Stress to the clien t th at care after surgery requires instillation of various types of eye drops several tim es a day for 2 to 4 weeks.

c. Adm in ister eye m ed ication s preop eratively, in cludin g m ydriatics an d cyclop legics as prescribed.

5. Posto perative in terven tion s a . Elevate the h ead of th e bed 30 to 45 degrees. b . Tu rn th e clien t to th e back or n on operative

side. c. Main tain an eye patch as prescribed; orien t

th e clien t to th e en viron m en t. d . Position th e clien t’s person al belon gin gs to

th e n on op erative side. e. Use side rails for safety (per agency guidelines). f. Assist with am bulation .

6. Clien t education ( Box 60-2) E. Glauco m a

1. Description a . A group of ocular diseases resultin g in

in creased IO P FIGURE 60-1 The cloudy appearance of a lens affected by cataract. (From Patton, Thibodeau, 2010.)

864 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

b . IO P is th e fluid (aqueou s h um or) pressure with in th e eye (n orm al IO P is 10 to 21 m m Hg) .

c. In creased IO P results from in adequate drain age of aqueous h um or from th e can al of Sch lem m or overproduction of aqueous h um or.

d . Th e con d ition dam ages th e optic n erve an d can result in blin dn ess.

e. Th e gradual loss of visual fields m ay go un - n oticed because cen tral vision is un affected.

2. Types a. Prim ary open -an gle glaucom a (PO AG)

results from obstru ction to outflow of aque- ous h um or an d is th e m ost com m on type.

b . Prim ary an gle-closure glaucom a (PACG) results from blockin g th e outflow of aque- ous h um or in to th e trabecular m esh work; causes in clude len s or pupil dilation fro m m edication s or sym path etic stim ulation .

3. Assessm en t a. Early sign s in clude dim in ish ed accommoda-

tion an d in creased IO P. b . PO AG: Pain less, an d vision ch an ges are

slow; results in “tun n el” vision c. PACG: Blurred vision , h alos arou n d ligh ts,

an d ocular eryth em a 4. In terven tion s for acute an gle-closure glaucom a

Acute angle-closure glaucoma is a medical emer- gency that causes sudden eye pain and possible nausea and vomiting.

a. Treat acute an gle-closure glaucom a as a m ed ical em ergen cy.

b . Adm in ister m edication s as prescribed to lo wer IO P.

c. Prepare th e clien t for periph eral iridectom y, wh ich allows aqueo us h um or to flow from th e posterior to th e an terior ch am b er.

5. In terven tion s for th e clien t with glaucom a a. In struct th e clien t on the im portan ce of m ed-

ication s to con strict th e pupils (miotics), to decrease th e production of aqueous h um or (carbon ic anh ydrase inh ibitors), an d to decrease th e production of aqueous h um or an d IOP (beta blockers).

b . In struct th e clien t about th e n eed for life- lo n g m edication use, to wear a MedicAlert bracelet, to avoid an tich o lin ergic m edica- tio n s to preven t in creased IO P, an d to con - tact th e h ealth care provider (HCP) before takin g m edication s, in cludin g over-th e- co un ter m edication s.

c. In struct th e clien t to report eye pain , h alos arou n d th e eyes, an d ch an ges in vision to th e HCP.

d . In struct th e clien t th at wh en m axim al m ed- ical th erapy h as failed to h alt th e progres- sion of visual field loss an d optic n erve dam age, surgery will be recom m en ded.

e. Prepare th e clien t for trabeculectom y as pre- scrib ed, wh ich allows drain age of aqueous h um or in to th e con jun ctival spaces by th e creation of an open in g.

F. Retin al detach m en t 1. Description

a. Detach m en t or sep aration of th e retin a fro m th e epith elium

b . O ccurs wh en th e layers of th e retin a sep a- rate because of th e accu m ulation of fluid between th em , or wh en both retin al layers elevate away from th e ch oroid as a result of a tum o r

c. Partial detach m en t beco m es com plete if un treated.

d . Wh en detach m en t becom es com plete, blin dn ess occurs.

2. Assessm en t a. Flash es of ligh t b . Flo aters or black spots (sign s of bleedin g) c. In crease in blurred vision d . Sen se of a curtain bein g drawn over th e eye e. Loss of a portion of th e visu al field; pain less

lo ss of cen tral or periph eral vision 3. Im m ediate in terven tion s

a. Provide bed rest. b . Cover both eyes with patch es as prescribed

to preven t furth er detach m en t. c. Speak to th e clien t befo re approach in g. d . Position th e clien t’s h ead as prescribed.

BOX 60-2 Client Education Following Cataract Surgery

Avoid eye straining. Avoid rubbing or placing pressure on the eyes. Avoid rapid movements, straining, sneezing, coughing, bend-

ing, vomiting, or lifting objects heavier than 5 lb (2.25 kg). Take measures to prevent constipation. Follow instructions for dressing changes and prescribed eye

drops and medications. Wipe excess drainage or tearing with a sterile wet cotton ball

from the inner to the outer canthus. Use an eye shield at bedtime. If lens implantation is not performed, accommodation is

affected and glasses must be worn at all times. Cataract glasses act as magnifying glasses and replace central

vision only, and objects will appear closer; therefore, the client needs to accommodate, judge distance, and climb stairs carefully.

Contact lenses provide sharp visual acuity but dexterity is needed to insert them.

Eye itching and mild discomfort are normal for a few days after the procedure.

Contact the health care provider about any decrease in vision, severe eye pain, increase in redness, or increase in eye discharge.

865CHAPTER 60 The Eye and the Ear

e. Protect th e clien t from in jury. f. Avoid jerky h ead m ovem en ts. g. Min im ize eye stress. h . Prepare th e clien t for a surgical proced ure as

prescribed . 4. Surgical proced ures

a. Drain in g fluid from th e subretin al space so th at th e retin a can return to th e n orm al position

b . Sealin g retin al breaks by cryosurgery, a cold probe applied to th e sclera, to stim ulate an in flam m atory response leadin g to adh esions

c. Diath erm y, th e use of an electrode n eedle an d h eat th rou gh th e sclera, to stim ulate an in flam m ato ry respo n se

d . Laser th erap y, to stim ulate an in flam m ato ry respon se an d seal sm all retin al tears before th e detach m en t occurs

e. Scleral bucklin g, to h old th e ch oro id an d retin a togeth er with a splin t un til scar tissue form s, closin g th e tear ( Fig. 60-2)

f. In sertion of gas or silicon e oil to prom ote reattach m en t; these agen ts float again st th e retin a to h old it in place until h ealin g occurs.

5. Posto perative in terven tion s a . Main tain eye patch es as prescribed. b . Mon itor for h em orrh age.

c. Preven t n ausea an d vom itin g an d m on itor for restlessn ess, which can cause h em orrh age.

d . Mon itor for sudden , sh arp eye pain (n otify th e HCP).

e. En cou rage deep breath in g but avoid cough in g.

f. Provide bed rest as prescribed. g. Position the clien t as prescribed (position in g

depen ds on the location of th e detach m en t). h . Adm in ister eye m ed ication s as prescribed. i. Assist th e clien t with activities of daily

livin g. j. Avo id sudd en h ead m ovem en ts or an y-

th in g th at in creases IO P. k . In struct th e clien t to lim it readin g for 3 to

5 weeks. l. In struct th e clien t to avoid squin tin g,

strain in g an d con stipatio n , liftin g h eavy objects, an d ben din g fro m th e waist.

m . In struct th e clien t to wear dark glasses dur- in g th e day an d an eye patch at n igh t.

n . Encourage follow-up care because of the dan- ger of recurrence or occurrence in the other eye.

G. Macular degen eration 1. A deterioration of th e m acula, th e area of cen tral

vision 2. Can be atrop h ic (age-related or dry) or

exudative (wet) 3. Age-related: Caused by gradual blockin g of retin al

capillaries leading to an isch em ic an d n ecrotic m acula; rod an d con e ph otoreceptors die.

4. Exud ative: Serous detach m en t of pigm en t epi- th eliu m in th e m acula occurs; fluid an d blood collect un der th e m acula, resultin g in scar for- m ation an d visu al distortion .

5. In terven tion s are aim ed at m axim izin g th e rem ain in g vision .

6. Assessm en t a . A declin e in cen tral vision b . Blurred vision an d distortion

7. In terven tion s a . In itiate strategies to assist in m axim izin g

rem ain in g vision an d m ain tain in g in depen - den ce.

b . Provide referrals to com m un ity organ iza- tio n s.

c. Laser th erapy, ph otodyn am ic th erapy, or oth er th erapies m ay be prescribed to seal th e leaking blood vessels in or n ear th e m acula.

H. O cular m elan om a 1. Most com m on m align an t eye tum o r in adults 2. Tum or is usually foun d in th e uveal tract an d can

spread easily because of th e rich blood supply. 3. Assessm en t

a . Tu m or can be discovered durin g ro utin e exam in ation .

A

d

u

l

t

E

y

e

/

E

a

r

Re tina l te a r

S ilicone s ponge

Encircling ba nd

De ta che d re tina

FIGURE 60-2 The scleral buckling procedure for repair of retinal detachment.

866 UNIT XV Eye and Ear Disorders of the Adult Client

b . If m acular area is in vaded , blurrin g of vision occurs.

c. In creased IO P is presen t if th e can al of Sch lem m is in vaded .

d . Ch an ge of iris color is n oted if th e tum o r in vades th e iris.

e. Ultrason ograph y m ay be perform ed to determ in e tum o r size an d location .

4. In terven tion s a. Surgery: En ucleation b . Radiation m ay be given via a radioactive

plaque th at is sutured to the sclera; the radioactive plaque rem ain s in place un til the prescribed radiation dose is delivered.

I. En ucleation an d exen teratio n 1. Description

a. En ucleatio n is th e rem oval of th e en tire eyeball.

b . Exen teration is th e rem oval of th e eyeball an d surroun din g tissues an d bon e.

c. Th e proced ures are perform ed for th e rem oval of ocular tum ors.

d . After th e eye is rem oved, a ball im plan t is in serted to provid e a firm base for a socket prosth esis an d to facilitate th e best cosm etic result.

e. A prosth esis is fitted about 1 m on th after surgery.

2. Preoperative in terven tion s a. Provide em otion al supp ort to th e clien t. b . En courage th e clien t to verbalize feelin gs

related to lo ss. c. En courage fam ily support in care.

3. Posto perative in terven tion s a. Mon itor vital sign s. b . Assess a pressure patch or dressin g as

prescribed. c. Report ch an ges in vital sign s or th e presen ce

of brigh t red drain age on th e pressure patch or dressin g.

J. Hyph em a 1. Description : Presen ce of blood in th e an terior

ch am b er th at occurs as a result of an in jury; usu- ally resolves in 5 to 7 days.

2. In terven tion s a. En courage rest in a sem i-Fowler’s position . b . Avo id su d d en eye m o vem en ts fo r 3 to

5 d ays to d ecrease th e likelih o o d o f b leed in g.

c. Adm in ister cyclop legic eye drops as pre- scribed to relax th e eye m uscles an d place th e eye at rest.

d . In struct th e clien t in th e use of eye sh ields or eye patch es as prescribed.

e. In struct th e clien t to restrict readin g an d lim it watch in g television .

K. Con tusion s 1. Description

a. Bleedin g in to th e soft tissue as a result of an in ju ry.

b . A con tusion cau ses a black eye; th e discolor- ation disappears in about 10 days.

c. Pain , ph o toph ob ia, edem a, an d diplopia m ay occur.

2. In terven tion s a. Place ice on th e eye im m ediately. b . In struct th e clien t to receive a th o rough eye

exam in ation . L. Foreign bodies

1. Description : An object such as dust or dirt th at en ters th e eye an d causes irritatio n

2. In terven tion s a. Have the client look upward, expose th e

lower lid, wet a cotton-tipped applicator with sterile n orm al salin e, gen tly twist th e swab over th e particle, an d rem ove it.

b . If th e particle can n ot be seen , h ave th e clien t lo ok down ward, place a cotton applicato r h orizon tally on th e outer surface of th e upper eye lid, grasp th e lash es, an d pull th e upper lid outward an d over th e cotton ap plicator; if th e particle is seen , gen tly twist a swab over it to rem ove.

M. Pen etratin g objects 1. Description : An eye in jury in wh ich an object

pen etrates th e eye 2. In terven tion s

a. Never rem ove th e object, because it m ay be h old in g ocular structures in place; th e object m ust be rem oved by th e HCP.

b . Cover th e eye with a cup (pap er or plastic) an d tape in place.

c. Do n ot allow th e clien t to ben d over or lie flat; th ese position s m ay m ove th e object.

d . Do n ot place pressure on th e eye. e. Th e clien t is to be seen by th e HCP

im m ediately. f. X-rays an d CT scan s of th e orbit are usually

obtain ed. g. MRI is con train dicated because of th e possi-

bility of m etal-con tain in g projectile m ove- m en t durin g th e procedure.

N. Ch em ical burn s 1. Description : An eye in jury in wh ich a cau stic

substan ce en ters th e eye 2. In terven tion s (see Priority Nu rsin g Action s)

If a chemical splash to the eye occurs, treatment should begin immediately; immediatelyflush the eyes with water for at least 15 to 20 minutes at the scene of the injury and then the client is brought to the emergency depart- ment. If possible, obtain a sample of the chemical involved.

A

d

u

l

t

E

y

e

/

E

a

r

867CHAPTER 60 The Eye and the Ear

A

d

u

l

t

E

y

e

/

E

a

r

PRIORITY NURSING ACTIONS Chemical Eye Injury Interventions in the Emergency Department

1. Quickly assess the client and visual acuity. 2. Check the pH of the eye. 3. Irrigate the eye. 4. Document the event, actions taken, and the client’s

response.

Emergency care in the emergency department following a chemical burn to the eye includes quickly assessing the client and asking about allergies and the type of chemical splashed into the eye. The pH of the eye is checked by placing a strip of pH paper in the cul-de-sac of the affected eye; the pH mea- surement is used as a means of determining whether the chemical has been washed out. The eye is immediately irri- gated with sterile normal saline or ocular irrigating solution. During irrigation, the client is positioned supine with the head slightly toward the affected eye; the solution is directed across the cornea and toward the lateral canthus. In the emergency department, irrigation should be maintained for at least 10 minutes (and at least 1 L should be used to irri- gate). After irrigation, the pH of the eye is checked and, if a pH of 6 to 7 has not returned, the irrigation should be con- tinued. Some health care providers prefer the use of lactated Ringer’s solution for irrigation because its pH is 6 to 7.5, which is closer to the pH of tears (7.1) than that of normal saline, which may range from 4.5 to 7. Following this emer- gency treatment, visual acuity is assessed and the pH is rechecked. It is also important for the nurse to find out what chemical splashed into the eye. Finally, the event is docu- mented, as well as the actions taken and the client’s response. If the injury occurred outside the hospital, the eye is irrigated immediately with tap water and then the client is brought to the emergency department.

References Ignatavicius, Workman (2016), p. 991; Perry et al. (2014),

pp. 460 –462.

O. Eye (tissue) don ation 1. Do n or eyes

a . Do n or eyes are obtain ed from cadavers. b . Do n or eyes m ust be en ucleated soon after

death an d stored in a preservin g solution because of rapid en doth elial cell death .

c. Storage, h an dlin g, an d coordin ation of don or tissue with surgeon s is provid ed by a n etwork of state an d n ation al eye ban k associatio n s.

2. Care to th e deceased clien t as a poten tial eye don or a . Th e option of eye don ation is discussed

with th e fam ily. b . Raise th e h ead of th e bed 30 degrees. c. In still an tibiotic eye drops as prescribed. d . Close th e eyes an d apply a sm all ice pack as

prescribed to th e closed eyes.

3. Preop erative care to th e recip ien t of th e corn ea a . Th e recipien t m ay be told of th e tissue

(corn ea) availability on ly several h ours to 1 day before th e surgery.

b . Assist in alleviatin g clien t an xiety. c. Assess th e recipien t’s eye for sign s of

in fectio n . d . Repo rt th e presen ce of an y redn ess, watery

or purulen t drain age, or edem a arou n d th e recipien t’s eye to th e HCP.

e. In still an tibiotic drops in to th e recipien t’s eye as prescribed to reduce th e n um ber of m icroorgan ism s presen t.

f. Adm in ister fluids an d m edication s in trave- n ou sly as prescribed.

4. Posto perative care to th e recipien t a . Th e eye is covered with a patch an d

protective sh ield th at is left in place for 1 day. b . Do n ot rem ove or ch an ge th e dressin g with -

out an HCP’s prescription . c. Mon itor vital sign s. d . Mon itor level of con scio usn ess. e. Assess th e eye dressin g. f. Position th e clien t with th e h ead elevated

an d on th e n on op erative side to reduce IO P. g. O rien t th e clien t frequen tly. h . Mon itor for com plications of bleeding,

woun d leakage, in fection , an d tissue rejection .

i. In struct th e clien t h ow to apply a patch an d eye sh ield.

j. In struct th e clien t to wear th e eye sh ield at n igh t for 1 m on th an d wh en ever arou n d sm all ch ildren or pets.

k . Advise th e clien t n ot to rub th e eye. l. In struct th e clien t to avoid activities th at

in crease IO P. 5. Graft rejection ( Fig. 60-3)

a . Rejection can occur at an y tim e. b . In form th e clien t of th e sign s of rejection . c. Sign s in clude redn ess, swellin g, decreased

vision , an d pain (RSVP). d . Th e eye is treated with topical corticosteroids.

V. Anatomy and Physiology of the Ear A. Fun ction s

1. Hearin g 2. Main ten an ce of balan ce

B. Extern al ear (pin n a) 1. It is em bedded in th e tem p oral bon e bilaterally

at th e level of th e eyes. 2. It exten ds fro m th e au ricle th rou gh th e extern al

can al to th e tym pan ic m em bran e or eardrum an d in cludes th e m astoid process, th e bon y ridge located over th e tem p oral bon e.

C. Middle ear 1. Th e m iddle ear con sists of th e m ed ial side of th e

tym pan ic m em bran e.

868 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

2. It con tain s 3 bon y ossicles. a . Malleus b . In cus c. Stapes

3. Fun ction s of th e m iddle ear a . Con duct soun d vibration s fro m th e outer

ear to th e cen tral h earin g apparatu s in th e in n er ear

b . Protect th e in n er ear by reducin g th e am pli- tude of loud soun ds

c. Th e auditory can al (eustach ian tube) allows equ alization of air pressure on each side of th e tym pan ic m em bran e so th at th e m em - bran e does n ot rupture.

D. In n er ear 1. Th e in n er ear con tain s th e sem icircular can als,

coch lea, an d distal en d of th e eigh th cran ial n erve.

2. Th e sem icircular can als con tain flu id an d h air cells con n ected to sen sory n erve fib ers of th e ves- tibular portion of th e eigh th cran ial n erve.

3. Th e in n er ear m ain tain s th e sen se of balan ce or equilibrium .

4. Th e coch lea is th e spiral-sh aped organ of h earin g.

5. Th e organ of Corti (with in th e coch lea) is th e receptor an d organ of h earin g.

6. Eigh th cran ial n erve a . Th e coch lear bran ch of th e n erve tran sm its

n euroim pulses from th e coch lea to th e brain , wh ere th ey are in terp reted as soun d.

b . Th e vestibular bran ch m ain tain s balan ce an d equilibrium .

E. Hearin g an d equ ilibrium 1. Th e extern al ear con d ucts soun d waves to th e

m iddle ear. 2. Th e m iddle ear, also called th e tympanic cavity,

con ducts soun d waves to th e in n er ear.

3. Th e m iddle ear is filled with air, wh ich is kep t at atm osp h eric pressure by th e open in g of th e auditory can al.

4. Th e in n er ear con tain s sen sory receptors for soun d an d for equilibrium .

5. Th e receptors in th e in n er ear tran sm it soun d waves an d ch an ges in body position as n erve im pulses.

VI. Assessment of the Ear (see Chapter 15)

VII. Diagnostic Tests for the Ear A. Tom ograph y

1. Description a. To m ograph y m ay be perform ed with or

with out con trast m ediu m . b . To m ograph y assesses th e m astoid, m iddle

ear, an d in n er ear structures an d is esp ecially h elpful in th e diagn osis of aco ustic tum ors.

c. Multiple radiograph s of th e h ead are obtain ed.

2. In terven tion s a. All jewelry is rem oved. b . Lead eye sh ield s are used to cover th e corn ea

to dim in ish th e radiation dose to th e eyes. c. Th e clien t m ust rem ain still in a supin e

position . d . No follow-up care is required. e. If con trast is to be used, assess for allergies or

previous respo n se to co n trast. B. Audiom etry

1. Description a. Audiom etry m easu res h earin g acuity. b . Audiom etry uses 2 types, pure ton e audiom -

etry an d speech audiom etry. c. Pure ton e audiom etry is used to iden tify

problem s with h earin g, speech , m usic, an d oth er soun ds in th e en viron m en t.

BA

FIGURE 60-3 Graft rejection. A, Clinical appearance of the eye after keratoplasty. B, Acute graft rejection. (From Black, Hawks, 2009. Courtesy Ophthalmic Photography at the University of Michigan, W.K. Kellogg Eye Center, Ann Arbor, Mich.)

869CHAPTER 60 The Eye and the Ear

d . In speech au diom etry, th e clien t’s ability to h ear spoken words is m easu red.

e. After testin g, au diograp h ic pattern s are dep icted on a graph to determ in e th e type an d level of th e h earin g loss.

2. In terven tion s a. In form th e clien t regardin g th e proced ure. b . In struct th e clien t to iden tify th e soun ds as

th ey are h eard. C. Electro n ystagm o graph y (ENG)

1. Description a. ENG is a vestibular test th at evalu ates spon -

tan eo us an d in du ced eye m ovem en ts kn own as nystagmus.

b . ENG is used to distin guish between n orm al n ystagm us an d m ed ication -in duced n ystag- m us, or n ystagm u s caused by a lesion in th e cen tral or periph eral vestibular path way.

c. ENG records ch an gin g electrical fields with th e m ovem en t of th e eye, as m on itored by electrod es placed on th e skin arou n d th e eye.

2. In terven tion s a. Th e clien t is in structed to rem ain NPO

(n oth in g by m ou th ) for 3 h ours befo re test- in g, an d to avoid caffein e-con tain in g bever- ages for 24 to 48 h ou rs befo re th e test.

b . Un n ecessary m edication s are with h eld for 24 h ours before testin g.

c. In struct th e clien t th at th is is a lon g an d tirin g procedure.

d . Th e clien t sh o uld brin g prescription eye- glasses to th e exam in ation .

e. Th e clien t sits an d is in structed to gaze at ligh ts, focus on a m ovin g pattern , focus on a m ovin g poin t, an d th en close th e eyes.

f. Wh ile sittin g in a ch air, th e clien t m ay be rotated to obtain in form ation about vestibu- lar fun ction .

g. In addition , th e clien t’s ears are irrigated with cool an d warm water, wh ich m ay cause n au- sea an d vo m itin g.

h . Followin g th e proced ure, th e clien t begin s takin g clear fluids slowly an d cautio usly because n ausea an d vo m itin g m ay occur.

i. Assistan ce with am bulation m ay also be n ec- essary followin g th e proced ure.

D. MRI: Refer to Ch apter 62 for in form ation on MRI.

VIII. Disorders of the Ear A. Risk factors related to ear disorders (Box 60-3)

B. Conductive hearing loss (Fig. 60-4) 1. Description

a. O ccurs wh en soun d waves are blocked to th e in n er ear fibers because of extern al or m iddle ear disorders

b . Disorders often can be corrected with no dam age to hearing or m inim al perm an ent hearin g loss.

A

d

u

l

t

E

y

e

/

E

a

r

BOX 60-3 Risk Factors for Ear Disorders

▪ Aging process ▪ Infection ▪ Medications

▪ Ototoxicity ▪ Trauma ▪ Tumors

Eighth cra nia l (ve s tibulocochle a r)

ne rve

S e micircula r ca na ls

S ta pe s

Cochle a

Tympa nic me mbra ne

Ma lle us Incus

P inna

Os s icle s

Exte rna l e a r Inne r e a rMiddlee a r

S e ns orine ura l he a ring los sConductive he a ring los s

Mixe d conductive -s e ns orine ura l he a ring los s

FIGURE 60-4 Anatomy of hearing loss. Hearing loss can be divided into 3 types: (1) conductive (difficulty in the external or the middle ear); (2) sen- sorineural (difficulty in the inner ear or acoustic nerve); and (3) mixed conductive-sensorineural (a combination of the two).

870 UNIT XV Eye and Ear Disorders of the Adult Client

2. Cau ses a. An y in flam m ato ry process or obstru ction of

th e extern al or m iddle ear b . Tum ors c. O tosclerosis d . A buildup of scar tissue on th e ossicles fro m

previous m iddle ear surgery C. Sensorineural hearing loss (see Fig. 60-4)

1. Description a. A path o logical process of th e in n er ear or of

th e sen sory fib ers th at lead to th e cerebral cortex

b . Sen sorin eural h earin g loss is often perm a- n en t, an d m easu res m ust be taken to reduce furth er dam age.

2. Cau ses a. Dam age to th e in n er ear structures b . Dam age to th e eigh th cran ial n erve or th e

brain itself c. Prolon ged exposu re to lo ud n oise d . Medication s e. Traum a f. In h erited disorders g. Metabolic an d circulatory disorders h . In fection s i. Surgery j. Men iere’s syn d rom e

k . Diabetes m ellitus l. Myxedem a

D. Mixed h earin g lo ss (see Fig. 60-4) 1. Also kn own as con d uctive-sen sorin eu ral h ear-

in g lo ss 2. Th e clien t h as both sen sorin eural an d con duc-

tive h earin g lo ss. E. Cen tral h earin g loss: In volves th e in ability to in ter-

pret soun d, in cludin g speech , due to a problem in th e brain

F. Sign s of h earin g loss an d facilitatin g com m un ica- tion (Boxes 60-4 an d 60-5)

G. Coch lear im plan tation 1. Coch lear im plan ts are used for sen sorin eural

h earin g loss. 2. A sm all com pu ter con verts soun d waves in to

electrical im pulses. 3. Electrodes are placed by th e in tern al ear with a

com pu ter device attach ed to th e extern al ear. 4. Electron ic im pulses directly stim ulate n erve

fibers. H. Hearin g aids

1. Used for th e clien t with co n ductive h earin g lo ss 2. Have lim ited value for th e clien t with sen sori-

n eural h earin g loss, because th ey m ake soun ds on ly louder, n ot clearer

3. A difficulty th at exists in the use of h earin g aids is the am plification of backgroun d n oise an d voices.

4. Hearin g aids are costly an d often n ot covered by in suran ce. Som e clien ts can obtain h earin g aids th rou gh a reh abilitation facility or th rough oth er resou rces.

5. Clien t education ( Box 60-6) I. Presb ycusis

1. Description a. A sen sorin eural h earin g loss associated

with agin g b . Presbycusis leads to degen eration or atroph y

of th e gan glion cells in the coch lea an d a loss of elasticity of th e basilar m em bran es.

c. Presbycu sis leads to com pro m ise of th e vas- cu lar supply to th e in n er ear, with ch an ges in several areas of th e ear structure.

A

d

u

l

t

E

y

e

/

E

a

r

BOX 60-4 Signs of Hearing Loss

▪ Frequently asking others to repeat statements ▪ Straining to hear ▪ Turning the head or leaning forward to favor 1 ear ▪ Shouting in conversation ▪ Ringing in the ears ▪ Failing to respond when not looking in the direction of the

sound ▪ Answering questions incorrectly ▪ Raising the volume of the television or radio ▪ Avoiding large groups ▪ Better understanding of speech when in small groups ▪ Withdrawing from social interactions

BOX 60-5 Facilitating Communication ▪ Using written words if the client is able to see, read, and write ▪ Providing plenty of light in the room ▪ Getting the attention of the client before beginning to speak ▪ Facing the client when speaking ▪ Talking in a room without distracting noises ▪ Moving close to the client and speaking slowly and clearly ▪ Keeping hands and other objects away from the mouth

when talking to the client ▪ Talking in normal volume and at a lower pitch because shout-

ing is not helpful and higher frequencies are less easilyheard ▪ Rephrasing sentences and repeating information ▪ Validating with the client the understanding of statements

made by asking the client to repeat what was said ▪ Reading lips ▪ Encouraging the client to wear glasses when talking to

someone to improve vision for lip reading ▪ Using sign language, which combines speech with hand

movements that signify letters, words, or phrases ▪ Using telephone amplifiers ▪ Using flashing lights that are activated by ringing of the

telephone or doorbell ▪ Using specially trained dogs to help the client be aware of

sound and alert the client to potential danger

871CHAPTER 60 The Eye and the Ear

A

d

u

l

t

E

y

e

/

E

a

r

2. Assessm en t a . Hearin g loss is gradual an d bilateral. b . Clien t states th at h e or sh e h as n o problem

with h earin g but can n ot un derstan d wh at th e words are.

c. Clien t th in ks th at th e speaker is m um blin g.

Instruct the client that cotton-tipped applicators should not be inserted into the ear canal because their use can lead to trauma to the canal and puncture the tympanic membrane.

J. Extern al otitis 1. Description

a . An in fective in flam m ato ry or allergic respon se in volvin g th e structure of th e extern al auditory can al or auricles

b . An irritatin g or infective agen t com es in to con - tact with th e epith elial layer of th e extern al ear.

c. Con tact leads to an allergic respo n se or sign s an d sym pto m s of an in fectio n .

d . Th e skin beco m es red, swollen , an d ten der to touch on m ovem en t.

e. Th e exten sive swellin g of th e can al can lead to con d uctive h earin g loss because of obstru ction .

f. Extern al otitis is m ore com m on in ch ildren ; it is also term ed swimmer’s ear an d occurs m ore often in h ot, h um id en viron m en ts.

g. Preven tion in cludes th e elim in ation of irri- tatin g or in fectin g agen ts.

2. Assessm en t a . Pain b . Itch in g c. Plugged feelin g in th e ear d . Redn ess an d edem a

e. Exud ate f. Hearin g loss

3. In terven tion s a . Apply h eat lo cally for 20 m in utes, 3 tim es

a day. b . En cou rage rest to assist in reducin g pain . c. Adm in ister an tibiotics or cortico steroids as

prescribed. d . Adm in ister an algesics for th e pain as

prescribed. e. In struct th e clien t th at th e ears sh ould be

kep t clean an d dry. f. In struct th e clien t to use earplugs for

swim m in g. g. In struct th e clien t th at irritatin g agen ts such

as h air produ cts or h ead ph on es sh ould be discon tin u ed.

K. O titis m ed ia: See Ch apter 38. 1. Myrin gotom y: See Ch apter 38. 2. Clien t education ( Box 60-7)

L. Ch ron ic otitis m edia 1. Description

a . A ch ron ic in fective, in flam m ato ry, or aller- gic respo n se in volvin g th e structure of th e m iddle ear

b . Frequen t rem oval of debris from th e ear can al m ay be required.

c. Myrin goplasty can recon struct th e tym pan ic m em bran e an d ossicles an d im prove con - ductive h earin g lo ss.

d . Mastoidectom y m ay be perform ed if th e in fectio n h as spread to in volve th e m astoid bon e.

Monitor the client with otitis media closely for response to treatment. Otic and systemic antibiotics may be used to treat the infection, but often the organ- ism is resistant.

BOX 60-6 Client Education Regarding a Hearing Aid

Begin using the hearing aid slowly to adjust to the device. Adjust the volume to the minimal hearing level to prevent

feedback squealing. Concentrate on the sounds that are to be heard and to filter

out background noise. Clean the ear mold and cannula per manufacturer’s

instructions. Keep the hearing aid dry. Turn the hearing aid off before removing from the ear to

prevent squealing feedback; remove the battery when not in use.

Keep extra batteries on hand. Keep the hearing aid in a safe place. Prevent hairsprays, oils , or other hair and face products

from com ing into contact with the receiver of the hearing aid.

Instruct the client to keep the hearing aid in the proper envi- ronmental climate as recommended by the manufacturer in order to prolong the life of the device.

BOX 60-7 Client Education Following Myringotomy

Avoid strenuous activities. Avoid rapid head movements, bouncing, or bending. Avoid straining on bowel movement. Avoid drinking through a straw. Avoid traveling by air. Avoid forceful coughing. Avoid contact with persons with colds. Avoid washing hair, showering, or getting the head wet for

1 week as prescribed. Use proper hand hygiene to prevent infection. Instruct the client that if he or she needs to blow the nose, to

blow 1 side at a time with the mouth open. Instruct the client to keep ears dry by keeping a ball of cotton

coated with petroleum jelly in the ear and to change the cotton ball daily.

Instruct the client to report excessive ear drainage to the health care provider.

872 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

2. Preoperative in terven tion s a. Adm in ister an tibiotic drops as prescribed. b . Clean th e ear of deb ris as prescribed; irrigate

th e ear with a solution of equal parts vin e- gar an d sterile water as prescribed to restore th e n orm al pH of th e ear.

c. In struct th e clien t to avoid person s with upper respiratory in fection s, obtain ad e- quate rest, eat a balan ced diet, an d drin k adequate fluid s.

d . In struct th e clien t in deep breath in g an d cough in g; forceful cough in g, wh ich in creases pressure in th e m iddle ear, is to be avoided posto peratively.

3. Posto perative in terven tion s a. Inform th e clien t th at in itial h earin g after

surgery is dim in ish ed because of th e packin g in th e ear canal; h earin g im provem en t will occur after the ear can al packin g is rem oved.

b . Keep th e dressin g clean an d dry. c. Keep th e clien t flat as prescribed, with th e

operative ear up for at least 12 h ours. d . Adm in ister an tibiotics as prescribed.

M. Mastoiditis 1. Description

a. Mastoiditis m ay be acu te or ch ron ic an d results from un treated or in adequately trea- ted ch ron ic or acu te otitis m edia.

b . Th e pain is n ot relieved by m yrin gotom y. 2. Assessm en t

a. Swellin g beh in d th e ear an d pain with m in - im al m ovem en t of th e h ead

b . Cellulitis on th e skin or extern al scalp over th e m astoid process

c. A redden ed, dull, th ick, im m ob ile tym pan ic m em bran e, with or with ou t perforation

d . Ten der an d en larged postau ricular lym p h n odes

e. Low-grade fever 3. In terven tion s

a. Prepare th e clien t for surgical rem oval of in fected m aterial.

b . Sim ple or m odified radical m astoidectom y with tym pan oplasty is th e m ost com m on treatm en t.

c. O n ce in fected tissue is rem oved, th e tym pa- n oplasty is perform ed to recon struct th e ossicles an d tym pan ic m em bran e in an attem pt to restore n orm al h earin g.

4. Com p lication s a. Dam age to th e abducen s an d facial cran ial

n erves; exh ibited by an in ability to look lat- erally (cran ial n erve VI, abducen s) an d a droopin g of th e m ou th on th e affected side (cran ial n erve VII, facial)

b . Men in gitis c. Brain ab scess d . Ch ron ic purulen t otitis m edia e. Woun d in fectio n s

f. Vertigo, if th e in fectio n spreads in to th e labyrin th

5. Posto perative in terven tion s a. Mon itor for dizzin ess. b . Mon itor for sign s of m en in gitis, as evi-

den ced by a stiff n eck an d vom itin g, an d for oth er com plication s.

c. Prepare for a woun d dressin g ch an ge 24 h ours postoperatively.

d . Mon itor th e surgical in cision for edem a, drain age, an d redn ess.

e. Position th e clien t flat with th e operative side up as prescribed .

f. Restrict th e clien t to bed with bedside com - m od e privileges for 24 h ours as prescribed.

g. Assist th e clien t with gettin g out of bed to preven t fallin g or in juries from dizzin ess.

h . With recon struction of th e ossicles via a graft, take precaution s to preven t dislodgin g of th e graft.

N. O tosclerosis 1. Description

a. A gen etic disorder of th e labyrinthine capsule of the m iddle ear that results in a bon y over- growth of th e tissue surrounding th e ossicles

b . O tosclerosis causes th e developm en t of irregular areas of n ew bon e form ation an d cau ses th e fixatio n of th e bon es.

c. Stapes fixation lead s to a con d uctive h earin g lo ss.

d . If th e disease in volves th e in n er ear, sen so- rin eural h earin g loss is presen t.

e. Bilateral in volvem en t is com m on , although h earin g loss m ay be worse in 1 ear.

f. No n surgical in terven tion prom otes th e im provem en t of h earin g th rough am plifi- cation .

g. Surgical in terven tion in volves rem oval of th e bon y growth causin g th e h earin g loss.

h . A partial staped ectom y or com plete stape- decto m y with prosth esis (fen estration ) m ay be perform ed surgically.

2. Assessm en t a. Slo wly progressin g con ductive h earin g loss b . Bilateral h earin g loss c. A rin gin g or roarin g type of con stan t tin n itus d . Lou d soun ds h eard in th e ear wh en ch ewin g e. Pin kish discoloration (Sch wartze’s sign ) of

th e tym pan ic m em bran e, wh ich in dicates vascu lar ch an ges with in th e ear

f. Negative Rin n e test g. Weber’s test sh ows lateralization of soun d

to th e ear with th e greatest degree of co n - ductive h earin g lo ss.

O. Fen estration 1. Description

a. Rem o val of th e stapes, with a sm all h ole drilled in th e footplate; a prosth esis is con - n ected between th e in cus an d footplate.

873CHAPTER 60 The Eye and the Ear

b . Soun ds cause th e prosth esis to vibrate in th e sam e m an n er as th e stapes.

c. Com plication s in clude com plete h earin g lo ss, prolon ged vertigo, in fection , an d facial n erve dam age.

2. Preop erative in terven tion s a . In struct th e clien t in m easu res to preven t

m iddle ear or extern al ear in fectio n s. b . In struct th e clien t to avoid excessive n ose

blowin g. 3. Posto perative in terven tion s

a . In form th e clien t th at h earin g is in itially worse after th e surgical proced ure because of swellin g, an d th at n o n oticeable im pro- vem en t in h earin g m ay occur for as lon g as 6 weeks.

b . In form th e clien t th at th e Gelfoam ear pack- in g (if used) in terferes with h earin g but is used to decrease bleedin g.

c. Assist with am bulatin g durin g th e first 1 to 2 days after surgery.

d . Adm in ister an tibiotic, an tivertigin ous, an d pain m ed ication s as prescribed.

e. Assess for facial n erve dam age, weakn ess, ch an ges in tactile sen sation an d taste sen sa- tio n , vertigo, n ausea, an d vom itin g.

f. In struct th e clien t to m ove the h ead slowly wh en ch an gin g position s to prevent vertigo.

g. In struct th e clien t to avoid perso n s with upper respiratory in fectio n s.

h . In struct th e clien t to avoid sh owerin g an d gettin g th e h ead an d woun d wet.

i. In struct th e clien t to avoid rapid extrem e ch an ges in pressure cau sed by quick h ead m ovem en ts, sn eezin g, n ose blowin g, strain - in g, an d ch an ges in altitud e.

j. In struct th e clien t to avoid ch an ges in m id- dle ear pressure because th ey could dislodge th e graft or prosth esis.

P. Labyrin th itis 1. Description : In fection of th e labyrin th th at

occurs as a com plication of acute or ch ron ic otitis m ed ia

2. May result from growth of a ch olesteato m a, a ben ign overgrowth of squam ous cell epith elium in th e m iddle ear

3. Assessm en t a . Hearin g loss th at m ay be perm an en t on th e

affected side b . Tin n itus c. Spon tan eous n ystagm us to th e affected side d . Vertigo e. Nausea an d vo m itin g

4. In terven tion s a . Mon itor for sign s of m en in gitis, th e m ost

co m m on co m plication , as eviden ced by h eadach e, stiff n eck, an d leth argy.

b . Adm in ister system ic an tibiotics as prescribed. c. Advise th e clien t to rest in bed in a

darken ed room . d . Adm in ister an tiem etics an d an tivertigin ous

m ed ication s as prescribed. e. In struct th e clien t th at th e vertigo subsides

as th e in flam m ation resolves. f. In struct th e clien t th at balan ce problem s

th at persist m ay require gait train in g th rou gh ph ysical th erap y.

Q. Men iere’s syn d rom e 1. Description

a . Also called en dolym ph atic h ydrops; it refers to dilation of th e en dolym p h atic system by overproduction or decreased reabsorp tion of en dolym ph atic fluid.

b . The syndrom e is characterized by tinnitus, uni- lateral sen sorineural hearing loss, and vertigo.

c. Sym ptom s occur in attacks an d last for sev- eral days, an d th e clien t beco m es totally in capacitated durin g th e attacks.

d . In itial h earin g lo ss is reversible but as th e frequen cy of attacks in creases, h earin g loss beco m es perm an en t.

A priority nursing intervention in the care of a client with Meniere’s syndrome is instituting safety measures.

2. Causes a . An y factor th at in creases en dolym ph atic

secretio n in th e labyrin th b . Viral an d bacterial in fection s c. Allergic reactio n s d . Bioch em ical disturban ces e. Vascular disturban ce, produ cin g ch an ges in

th e m icrocirculation in th e labyrin th f. Long-term stress m ay be a con tributin g factor.

3. Assessm en t a . Feelin gs of fulln ess in th e ear b . Tin n itus, as a con tin uous low-pitch ed roar

or h um m in g soun d, th at is presen t m uch of th e tim e but worsen s just before an d dur- in g severe attacks

c. Hearin g loss th at is worse durin g an attack d . Vertigo; th at is, a sen sation of wh irlin g th at

m igh t cau se th e clien t to fall to th e grou n d e. Vertigo th at is so inten se th at even while lyin g

down , th e clien t h olds th e bed or groun d in an attem pt to prevent the wh irlin g

f. Nausea an d vom itin g g. Nystagm us h . Severe h eadach es

4. Non su rgical in terven tion s a . Preven t in ju ry durin g vertigo attacks. b . Provide bed rest in a quiet en viron m en t. c. Provide assistan ce with walkin g. d . In struct th e clien t to m ove th e h ead slowly

to preven t worsen in g of th e vertigo.

A

d

u

l

t

E

y

e

/

E

a

r

874 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

e. In itiate sodium an d fluid restrictio n s as prescribed.

f. In struct th e clien t to stop sm okin g. g. In struct th e clien t to avoid watch in g televi-

sion because th e flickerin g of ligh ts m ay exacerbate sym pto m s.

h . Adm in ister n icotin ic acid as prescribed for its vaso dilato ry effect.

i. Adm in ister an tih istam in es as prescribed to reduce th e productio n of h istam in e an d th e in flam m ation .

j. Adm in ister an tiem etics as prescribed. k . Adm inister tranquilizers and sedatives as pre-

scribed to calm the client; allow the client to rest; and control vertigo, nausea, and vom iting.

l. Mild diuretics m ay be prescribed to decrease en dolym p h vo lum e.

m . In form th e clien t about vestibular reh abil- itation as prescribed.

5. Surgical in terven tion s a. Surgery is perform ed wh en m edical th erap y

is in effective an d th e fun ction al level of th e clien t h as decreased sign ifican tly.

b . En dolym ph atic drain age an d in sertion of a sh un t m ay be an option early in th e course of th e disease to assist with th e drain age of excess flu ids.

c. A resection of the vestibular n erve or total rem oval of the labyrin th (i.e., a labyrin th ec- tom y) m ay be perform ed.

6. Posto perative in terven tion s a. Assess packin g an d dressin g on th e ear. b . Speak to th e clien t on th e side of th e

un affected ear. c. Perform n eurological assessm en ts. d . Main tain safety. e. Assist with am bulatin g. f. Encourage the client to use a bedside com m ode

rather than am bulating to the bathroom . g. Adm in ister an tivertigin ous an d an tiem etic

m edication s as prescribed. R. Acoustic n eurom a

1. Description a. A ben ign tum o r of th e vestibular or

acoustic n erve b . Th e tum o r m ay cause dam age to h earin g

an d to facial m ovem en ts an d sen sation s. c. Treatm en t in cludes surgical rem oval of th e

tum or via cran iotom y. d . Care is taken to preserve th e fun ction of th e

facial n erve. e. Th e tum or rarely recurs after surgical rem oval. f. Postoperative n ursin g care is sim ilar to post-

operative cran io tom y care. 2. Assessm en t

a . Sym ptom s usually begin with tin nitus an d progress to gradual sen sorin eural h earin g loss.

b . As th e tum o r en larges, dam age to adjacen t cran ial n erves occurs.

S. Traum a 1. Description

a. Th e tym pan ic m em bran e h as lim ited stretch - in g ability an d gives way un der h igh pressure.

b . Foreign objects placed in th e extern al can al m ay exert pressure on th e tym pan ic m em - bran e an d cau se perforation .

c. If th e object con tin ues th rou gh th e can al, th e bon y structure of th e stapes, in cus, an d m alleus m ay be dam aged.

d . A blun t in jury to th e basal skull an d ear can dam age th e m iddle ear structures th rough fractures exten din g to th e m iddle ear.

e. Excessive n ose blowin g an d rapid ch an ges of pressure th at occur with n on pressurized air fligh ts can in crease pressure in th e m iddle ear.

f. Depen din g on th e dam age to th e ossicles, h earin g lo ss m ay or m ay n ot be reversible.

2. In terven tion s a. Tym pan ic m em bran e perforation s usually

h eal with in 24 h ours. b . Surgical recon struction of th e ossicles an d

tym pan ic m em bran e th rough tym pan o- plasty or m yrin goplasty m ay be perform ed to im prove h earin g.

T. Cerum en an d foreign bodies 1. Description

a. Cerum en , or wax, is th e m ost com m on cau se of im pacted can als.

b . Foreign bodies can in clude vegetables, beads, pencil erasers, in sects, an d oth er objects.

2. Assessm en t a. Sen sation of fulln ess in th e ear with or with -

out h earin g loss b . Pain , itch in g, or bleedin g

3. Cerum en a. Rem o val of wax m ay be don e by irrigation . b . Irrigation is con train d icated in clien ts with

a h istory of tym pan ic m em bran e perfora- tio n or otitis m ed ia.

c. If prescribed to soften cerum en , glycerin or m in eral oil is placed in th e ear at bedtim e; h ydrogen peroxide m ay also be prescribed.

d . After several days, th e ear is irrigated. e. Th e m axim um am oun t of solution th at

sh ould be used for irrigation is 50 to 70 m L.

Inform the client that ear candles should never be used to remove cerumen. Their use can cause burns and a vacuum effect, causing a perforation in the tym- panic membrane.

4. Foreign bodies a. With a foreign object of vegetable m atter,

irrigation is used with care because th is m aterial expan d s with h ydration .

875CHAPTER 60 The Eye and the Ear

A

d

u

l

t

E

y

e

/

E

a

r

b . In sects are killed before rem oval, un less th ey can be coaxed out by flash ligh t or a h um m in g n oise; lido cain e m ay be placed in th e ear to relieve pain .

c. Min eral oil or diluted alcoh ol is in stilled to suffo cate th e in sect, wh ich th en is rem oved usin g ear forceps.

d . Use a sm all ear forceps to rem ove th e object; avoid push in g th e object farth er in to th e can al an d dam agin g th e tym pan ic m em bran e.

CRITICAL THINKING What Should You Do? Answer: This situation is an emergency. The nurse should immediately accompany the client to a room and notify the health care provider to assess the client. A penetrating eye wound is a serious injury that can cause loss of sight or require loss of the eye (surgical removal). The object is removed only by an ophthalmologist, because it may be hold- ing eye structures in place. X-rays and computed tomography (CT) scans of the orbit are usually obtained to ensure that the orbit of the eye is intact and to look for fractures that might entrap orbital muscles. Magnetic resonance imaging (MRI) is contraindicated because of the possibility of metal- containing projectile movement during the procedure. Sur- gery is usually needed to remove the foreign object.

Reference: Ignatavicius, Workman (20 16), p. 992.

P R A C T I C E Q U E S T I O N S 741. Du rin g th e early postoperative period, a clien t wh o

h as un dergon e a cataract extraction com plain s of n ausea an d severe eye pain over th e operative site. Wh at sh o uld be th e in itial n ursin g action ? 1. Call th e h ealth care provider (HCP) . 2. Reassu re th e clien t th at th is is n orm al. 3. Turn th e clien t on to h is or h er operative side. 4. Adm in ister th e prescribed pain m edication an d

an tiem etic.

742. Th e n urse is developin g a teach in g plan for a clien t with glaucom a. Wh ich in struction sh ould th e n urse in clude in th e plan of care? 1. Avo id overuse of th e eyes. 2. Decrease th e am oun t of salt in th e diet. 3. Eye m edication s will n eed to be adm in istered

for life. 4. Decrease fluid in take to con tro l th e in traocular

pressure.

743. Th e n urse is perform in g an ad m ission assessm en t on a clien t with a diagn osis of detach ed retin a. Wh ich sign or sym pto m is associated with th is eye disorder? 1. To tal loss of vision

2. Pain in th e affected eye 3. A yello w discoloration of th e sclera 4. A sen se of a curtain fallin g across th e field of

vision

744. Th e n urse is perform in g an otoscopic exam in ation on a clien t with m astoiditis. O n exam in ation of th e tym pan ic m em bran e, wh ich fin din g sh ould th e n urse exp ect to observe? 1. A pin k-colored tym pan ic m em bran e 2. A pearly colored tym pan ic m em bran e 3. A tran sparen t an d clear tym pan ic m em bran e 4. A red, dull, th ick, an d im m obile tym pan ic

m em bran e

745. A clien t is diagn osed with a disorder in volvin g th e in n er ear. Wh ich is th e m o st com m on clien t com - plain t associated with a disorder in volvin g th is part of th e ear? 1. Pruritus 2. Tin n itus 3. Hearin g loss 4. Burn in g in th e ear

746. Th e n urse is perform in g an assessm en t on a clien t with a susp ected diagn osis of cataract. Wh ich clin - ical m an ifestatio n sh ould th e n urse expect to n ote in th e early stages of cataract form ation ? 1. Diplop ia 2. Eye pain 3. Flo atin g spots 4. Blurred vision

747. A clien t arrives in th e em ergen cy departm ent follow- in g an autom obile crash . Th e clien t’s foreh ead h it th e steerin g wh eel an d a h yph em a is diagn osed. Th e n urse sh ould place the client in which position ? 1. Flat in bed 2. A sem i-Fowler’s position 3. Lateral on th e affected side 4. Lateral on th e un affected side

748. Th e clien t sustain s a con tusion of th e eyeball follow- in g a traum atic in jury with a blunt object. Wh ich in terven tion sh ould be in itiated im m ed iately? 1. Apply ice to th e affected eye. 2. Irrigate th e eye with cool water. 3. No tify th e h ealth care provid er (HCP) . 4. Accom p an y th e clien t to th e em ergen cy

departm en t.

749. A clien t arrives in th e em ergen cy departm en t with a pen etratin g eye in jury from wood ch ips th at occurred wh ile cu ttin g wood. Th e n urse assesses th e eye an d n otes a piece of wood protrudin g from th e eye. Wh at is th e in itial n ursin g action ?

876 UNIT XV Eye and Ear Disorders of the Adult Client

1. Apply an eye patch . 2. Perform visual acu ity tests. 3. Irrigate th e eye with sterile salin e. 4. Rem o ve th e piece of wood usin g a sterile

eye clam p.

750. Th e n urse is carin g for a clien t followin g en ucle- ation an d n otes th e presen ce of brigh t red drain age on th e dressin g. Wh ich action sh ould th e n urse take at th is tim e? 1. Do cum en t th e fin din g. 2. Con tin ue to m on itor th e drain age. 3. Notify th e h ealth care provider (HCP). 4. Mark th e drain age on th e dressin g an d m on itor

for an y in crease in bleedin g.

751. A wom an was workin g in h er garden . Sh e acciden - tally sprayed in secticide in to h er righ t eye. Sh e calls th e em ergen cy departm en t, fran tic an d scream in g for h elp. Th e n urse sh ould in struct th e wom an to take wh ich im m ed iate action ? 1. Irrigate th e eyes with water. 2. Com e to th e em ergen cy dep artm en t. 3. Call th e h ealth care provider (HCP). 4. Irrigate th e eyes with diluted h ydrogen

peroxide.

752. Th e n urse is preparin g a teach in g plan for a clien t who h ad a cataract extraction with in traocular im plan tation . Wh ich h om e care m easures sh ould th e n urse in clude in th e plan ? Select all th at app ly.

1. Avoid activities th at require ben din g over. 2. Con tact th e surgeon if eye scratch in ess occurs. 3. Take acetam in oph en for m in or eye discom fort. 4. Expect episo des of sudd en severe pain in

th e eye. 5. Place an eye sh ield on th e surgical eye at

bedtim e. 6. Con tact th e surgeon if a decrease in visu al

acuity occurs.

753. Ton om etry is perform ed on a clien t with a sus- pected diagn osis of glaucom a. Th e n urse lo oks at th e docum en ted test results an d n otes an in traocu- lar pressure (IO P) value of 23. Wh at sh o uld be th e n urse’s in itial action ? 1. Apply n orm al salin e drops. 2. Note th e tim e of day th e test was don e. 3. Con tact th e h ealth care provider (HCP). 4. In struct th e clien t to sleep with th e h ead of th e

bed flat.

754. Th e n urse is carin g for a clien t followin g cran iotom y for rem oval of an aco ustic n eurom a. Assessm en t of wh ich cran ial n erve would iden tify a com plication specifically associated with th is surgery? 1. Cran ial n erve I, olfacto ry

2. Cran ial n erve IV, troch lear 3. Cran ial n erve III, oculom otor 4. Cran ial n erve VII, facial n erve

755. Th e n urse n otes th at th e h ealth care provider h as docum en ted a diagn osis of presb ycusis on a clien t’s ch art. Based on th is in form ation , wh at action sh o uld th e n urse take? 1. Speak loudly, but m um ble or slur th e words. 2. Speak loudly an d clearly wh ile facin g th e clien t. 3. Speak at n orm al ton e an d pitch , slowly an d

clearly. 4. Speak loudly an d directly in to th e clien t’s

affected ear.

756. A clien t with Men iere’s disease is experien cin g severe vertigo. Wh ich in struction sh ould th e n urse give to th e clien t to assist in con trollin g th e vertigo? 1. In crease sodium in th e diet. 2. Avoid sudden h ead m ovem en ts. 3. Lie still an d watch th e television . 4. In crease fluid in take to 3000 m L a day.

757. Th e n urse is preparin g to test th e visual acu ity of a clien t, usin g a Sn ellen ch art. Wh ich iden tifies th e accu rate proced ure for th is visu al acuity test? 1. Th e righ t eye is tested, follo wed by th e left eye,

an d th en both eyes are tested. 2. Both eyes are assessed togeth er, followed by

an assessm en t of th e righ t eye an d th en th e left eye.

3. Th e clien t is asked to stan d at a distan ce of 40 feet (12 m eters) from th e ch art an d to read th e larg- est lin e on th e ch art.

4. Th e clien t is asked to stan d at a distan ce of 40 feet (12 m eters) fro m th e ch art an d to read th e lin e th at can be read 200 feet (60 m eters) away by an in dividual with un im paired vision .

758. Aclient’s vision is tested with a Snellen chart. The results of the tests are docum ented as 20/60. What action should the nurse im plem ent based on this finding? 1. Provide th e clien t with m aterials on legal

blin dn ess. 2. In struct th e clien t th at h e or sh e m ay n eed

glasses wh en drivin g. 3. In form th e clien t of wh ere h e or sh e can pur-

ch ase a wh ite can e with a red tip. 4. In form th e clien t th at it is best to sit n ear th e

back of th e room wh en atten din g lectures.

759. Th e n urse is carin g for a h earin g-im p aired clien t. Wh ich approach will facilitate com m un ication ? 1. Speak loudly. 2. Speak frequen tly. 3. Speak at a n orm al vo lum e. 4. Speak directly in to th e im paired ear.

A

d

u

l

t

E

y

e

/

E

a

r

877CHAPTER 60 The Eye and the Ear

A N S W E R S 741. 1 Ra tion a le: Severe p ain or pain acco m p an ied b y n au sea fo llow- in g a cataract extraction is an in d icator o f in creased in trao cu lar p ressu re an d sh ou ld b e rep orted to th e HCP im m ed iately. O ptio n s 2, 3, an d 4 are in app ro p riate actio n s. Test-Ta kin g St r a t egy: Note th e strategic wo rd , initial, an d th e word severe. Elim in ate o ption 2 b ecause th is is n ot a n orm al con ditio n . Th e clien t sh o uld n ot b e tu rn ed to th e o perative sid e; th erefore, elim in ate op tion 3. From th e rem ain in g o ptio n s, focusin g on th e strategic wo rd will direct yo u to th e correct o ptio n . Review: Po stop erative com plicatio n s of cataract su rgery Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Conten t Area : Critical Care—Em ergen cy Situation s/Man agem en t Pr ior it y Con cept s: Clin ical Ju dgm en t; Pain Refer en ce: Lewis et al. (2014), p . 395.

742. 3 Ra tion a le: Th e adm in istratio n o f eye d ro p s is a critical co m po - n en t of th e treatm en t p lan fo r th e clien t with glau co m a. Th e clien t n eed s to be in structed th at m ed icatio n s will n eed to be taken fo r th e rest o f h is o r h er life. O ption s 1, 2, an d 4 are n o t accurate in stru ction s. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, clien t teach in g fo r glau co m a. Recallin g th at m ed ication s are an in tegral co m p o - n en t of th e treatm en t p lan will assist in d irectin g you to th e cor- rect o ption . Review: Teach in g plan for th e clien t with glau co m a Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —Eye Pr ior it y Con cept s: Clien t Ed ucation ; Sen sory Perceptio n Refer en ce: Lewis et al. (2014), p . 401.

743. 4 Ra tion a le: A ch aracteristic m an ifestatio n o f retin al detach m en t d escrib ed b y th e clien t is th e feelin g th at a sh ado w or curtain is fallin g acro ss th e field of visio n . No p ain is associated with d etach m en t o f th e retin a. O ptio n s 1 an d 3 are n ot ch aracteris- tics of th is d iso rd er. A retin al d etach m en t is an o ph th alm ic em ergen cy an d even m ore so if visual acu ity is still n orm al. Test-Ta kin g Str a tegy: Focu s on th e su b ject, m an ifestatio n s o f retin al d etach m en t. Th in kin g ab o ut th e p ath op h ysio lo gy asso ciated with th is d isorder will d irect you to th e correct o ptio n . Review: Retin al d etach m en t Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Eye Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen so ry Perception Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 989–990.

744. 4 Ra tion a le: O to sco pic exam in ation in a clien t with m astoiditis reveals a red, d ull, th ick, an d im m o b ile tym pan ic m em b ran e, with or with out perforatio n . Postauricular lym ph n odes are

ten d er an d en larged . Clien ts also h ave a low-grad e fever, m al- aise, an orexia, swellin g beh in d th e ear, an d pain with m in im al m ovem en t of th e h ead . Test-Ta kin g Str a tegy: Focus o n th e su b ject, th e assessm en t fin d in gs in m asto id itis. Th in k abo ut th e p ath o ph ysiology asso - ciated with m asto iditis an d rem em b er th at m asto id itis reveals a red, dull, th ick, an d im m ob ile tym pan ic m em bran e. Review: Masto id itis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Ear Pr ior it y Con cept s: In fection ; In flam m ation Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1007.

745. 2 Ra tion a le: Tin n itu s is th e m ost co m m o n co m plain t o f clien ts with otological disorders, especially disorders in volvin g th e in n er ear. Sym p to m s o f tin n itu s ran ge from m ild rin gin g in th e ear, wh ich can go u n n oticed d urin g th e d ay, to a lo u d roar- in g in th e ear, wh ich can in terfere with th e clien t’s th in kin g p ro - cess an d atten tio n sp an . O p tio n s 1, 3, an d 4 are n o t asso ciated sp ecifically with d iso rd ers o f th e in n er ear. Test-Ta kin g Str a tegy: Note th e strategic wo rd , most. Recallin g th e an ato m y an d th e fu n ction o f th e in n er ear will d irect you to th e correct o ptio n . Review: In n er ear d iso rd ers Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Ear Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen sory Perceptio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1007–1008.

746. 4 Ra tion a le: A grad ual, pain less blu rrin g of cen tral visio n is th e ch ief clin ical m an ifestation o f a cataract. Early sym p tom s in clu de sligh tly b lurred vision an d a decrease in co lor percep - tio n . O ption s 1, 2, an d 3 are n o t ch aracteristics o f a cataract. Test-Ta kin g St r a t egy: Note th e strategic wo rd , early. Rem em ber th e path o ph ysio lo gy related to cataract develo pm en t. As a cata- ract d evelo ps, th e len s o f th e eye b ecom es o paqu e. Th is descrip- tion will assist in d irectin g you to th e correct o ption . Review: Cataracts Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Eye Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen sory Perceptio n Refer en ce: Lewis et al. (2014), p . 393.

747. 2 Ra tion a le: A h yph em a is th e p resen ce o f b lo od in th e an terio r ch am b er. Hyp h em a is prod uced wh en a force is sufficien t to b reak th e in tegrity o f th e b lo od vessels in th e eye an d can be cau sed by direct in ju ry, su ch as a p en etratin g in jury fro m a BB o r pellet, o r in directly, such as fro m strikin g th e foreh ead o n a steerin g wh eel d urin g an acciden t. Th e clien t is treated b y b ed rest in a sem i-Fowler’s po sitio n to assist gravity in keep- in g th e h yph em a away from th e op tical cen ter of th e corn ea.

A

d

u

l

t

E

y

e

/

E

a

r

878 UNIT XV Eye and Ear Disorders of the Adult Client

Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, care o f th e clien t wh o h as su stain ed a h yph em a. Rem em b er th at p lacin g th e cli- en t flat will p rod uce an in crease in p ressure at th e in ju red site. Also, n ote th at th e co rrect o p tion is th e on e th at id en tifies a po sitio n d ifferen t fro m th e o th er o ptio n s. Review: Hyp h em a Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Em ergen cy Situatio n s/ Man agem en t Pr ior ity Con cepts: Safety; Tissu e In tegrity Refer en ce: Jarvis (2016), p . 321.

748. 1 Ra t ion a le: Treatm en t for a con tusio n begin s at th e tim e o f in ju ry. Ice is ap plied im m ediately. Th e clien t th en sh ou ld b e seen by an HCP an d receive a th orou gh eye exam in atio n to rule ou t th e p resen ce of oth er eye in ju ries. Test -Ta kin g Str a t egy: Focus on th e strategic wo rd , immedi- ately. Recallin g th e prin cip les related to in itial treatm en t o f in ju ries an d n otin g th e typ e of in jury su stain ed will direct yo u to th e co rrect o p tion . Review: Em ergen cy treatm en t o f eye in ju ries Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Critical Care—Em ergen cy Situatio n s/ Man agem en t Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 992.

749. 2 Ra t ion a le: If th e eye in jury is th e resu lt of a p en etratin g ob ject, th e ob ject m ay b e n oted p ro tru din g from th e eye. Th is o bject m u st n ever be rem o ved excep t by th e o ph th alm olo gist b ecau se it m ay b e h oldin g o cu lar stru ctu res in place. Ap plicatio n o f an eye p atch o r irrigatio n o f th e eye m ay d isru pt th e fo reign b o dy an d cau se fu rth er tearin g o f th e co rn ea. Test -Ta kin g St r a t egy: No te th e strategic wo rd , initial, an d n o te th e wo rd penetrating. Th is sh ou ld in d icate th at a laceratio n h as occu rred an d th at in terven tion s are directed at p reven tin g fu r- th er disru ptio n o f th e in tegrity o f th e eye. Th e o n ly o ption th at will p reven t furth er disru ptio n is to assess visu al acuity. Review: Em ergen cy treatm en t o f eye in ju ries Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con tent Area : Critical Care—Em ergen cy Situation s/ Man agem en t Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 992.

750. 3 Ra t ion a le: If th e n u rse n o tes th e presen ce o f brigh t red drain - age o n th e dressin g, it m u st be rep orted to th e HCP, b ecau se th is in dicates h em o rrh age. O ptio n s 1, 2, an d 4 are in ap prop ri- ate at th is tim e. Test -Ta kin g St r a t egy: Determ in e if an ab n o rm ality exists. Note th e word s, bright red. Sin ce an ab n o rm ality do es exist, elim in ate o p tion s th at state to do cum en t an d co n tin u e to m on - itor b ecau se an actio n is n eed ed.

Review: Po sto perative co m p lication s followin g en u cleatio n Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Critical Care—Em ergen cy Situ atio n s/ Man agem en t Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Lewis et al. (2014), p. 402.

751. 1 Ra t ion a le: In th is typ e o f accid en t, th e clien t is in stru cted to irrigate th e eyes im m ed iately with run n in g water fo r at least 20 m in u tes, or u n til th e em ergen cy m ed ical services p erso n n el arrive. In th e em ergen cy d ep artm en t, th e clean sin g agen t o f ch o ice is u su ally n o rm al salin e. Callin g th e HCP an d goin g to th e em ergen cy d ep artm en t d elays n ecessary in terven tio n . Hyd ro gen peroxide is n ever p laced in th e eyes. Test -Ta kin g Str a tegy: No te th e strategic wo rd , immediate. Fo cu s o n th e type o f in jury an d elim in ate o ptio n s 2 an d 3 b ecause th ey d elay n ecessary in terven tio n . Next, elim in ate o p tion 4 becau se h yd ro gen peroxide is n ever placed in th e eyes. Review: Im m ed iate in terven tion s fo r a ch em ical eye in ju ry Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Critical Care—Em ergen cy Situ atio n s/ Man agem en t Pr ior ity Con cepts: Clien t Ed u catio n ; Tissu e In tegrity Refer en ces: Ign ataviciu s, Workm an ( 2016) , p. 991; Lewis et al. (2014), p . 390.

752. 1, 3, 5, 6 Ra t ion a le: Followin g eye surgery, so m e scratch in ess an d m ild eye d isco m fort m ay occu r in th e o p erative eye an d u su ally is relieved b y m ild an algesics. If th e eye p ain b eco m es severe, th e clien t sh o uld n o tify th e su rgeo n b ecau se th is m ay in dicate h em orrh age, in fectio n , o r in creased in trao cular pressu re (IO P). Th e n u rse also wou ld in stru ct th e clien t to n otify th e su r- geo n o f in creased pu ru len t drain age, in creased red n ess, o r an y d ecrease in visu al acu ity. Th e clien t is in stru cted to p lace an eye sh ield over th e o perative eye at b edtim e to p ro tect th e eye fro m in ju ry du rin g sleep an d to avo id activities th at in crease IO P, su ch as b en d in g o ver. Test -Ta kin g St r a t egy: Fo cus on th e su b ject, po stop erative care fo llo win g eye su rgery. Recallin g th at th e eye n eeds to be pro- tected an d th at in creased IO P is a co n cern will assist in deter- m in in g th e h om e care m easu res to b e in clud ed in th e p lan . Review: Cataract extractio n with in traocular im p lan t Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Adu lt Health —Eye Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Lewis et al. (2014), p. 395.

753. 2 Ra t ion a le: To n o m etry is a m eth od o f m easu rin g in traocular fluid pressu re. Pressu res b etween 10 an d 21 m m Hg are con sid- ered with in th e n orm al ran ge. Ho wever, IO P is sligh tly h igh er in th e m o rn in g. Th erefore, th e in itial action is to ch eck th e tim e

A

d

u

l

t

E

y

e

/

E

a

r

879CHAPTER 60 The Eye and the Ear

th e test was p erfo rm ed . No rm al salin e dro ps are n o t a specific treatm en t for glau co m a. It is n o t n ecessary to con tact th e HCP as an in itial action . Flat po sitio n s m ay in crease th e pressu re. Test-Ta kin g St r a t egy: Focu s o n th e su b ject, n orm al IO P, an d n o te th e strategic wo rd , initial. Rem em ber th at n orm al IO P is b etween 10 an d 21 m m Hg an d th e p ressure m ay b e h igh er in th e m o rn in g. Review: Norm al in trao cu lar p ressu re Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Eye Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen so ry Perception Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 974.

754. 4 Ra tion a le: An acou stic n eu ro m a (or vestib u lar sch wan n o m a) is a u n ilateral b en ign tu m o r th at o ccurs wh ere th e vestibu loco - ch lear or aco ustic n erve ( cran ial n erve VIII) en ters th e in tern al au dito ry can al. It is im po rtan t th at an early diagn osis be m ad e b ecau se th e tum o r can com press th e trigem in al an d facial n erves an d arteries with in th e in tern al aud ito ry can al. Treat- m en t fo r acou stic n eurom a is surgical rem o val via a cran io t- o m y. Assessm en t o f th e trigem in al an d facial n erves is im p ortan t. Extrem e care is taken to p reserve rem ain in g h earin g an d preserve th e fu n ctio n of th e facial n erve. Aco u stic n eu ro - m as rarely recu r fo llo win g su rgical rem o val. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, a co m p licatio n fo llo win g su rgery. Th in k abo ut th e an atom ical lo catio n o f an acou stic n eurom a an d th e n erves th at th e n eu ro m a can com - p ress to d irect yo u to th e co rrect o p tion . Review: Su rgical treatm en t fo r aco u stic n eu ro m a Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Ear Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen so ry Perception Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 958, 1009.

755. 3 Ra tion a le: Presbycusis is a typ e o f h earin g lo ss th at o ccu rs with agin g. Presb ycu sis is a grad ual sen sorin eural lo ss cau sed b y n erve d egen eration in th e in n er ear o r au dito ry n erve. Wh en com m un icatin g with a clien t with th is co n d itio n , th e n urse sh o u ld sp eak at a n orm al ton e an d pitch , slo wly an d clearly. It is n ot ap prop riate to speak lo ud ly, m u m b le o r slu r word s, o r sp eak in to th e clien t’s affected ear. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, presbycu sis an d th e effective m eth od to co m m u n icate. Visu alize each o f th e com m un icatio n tech n iqu es to d irect yo u to th e co rrect o ptio n . Review: Presb ycu sis Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Ear Pr ior it y Con cept s: Co m m u n ication ; Sen sory Perceptio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1010.

756. 2 Ra tion a le: Th e n u rse in structs th e clien t to m ake slo w h ead m ovem en ts to p reven t wo rsen in g of th e vertigo. Dietary

ch an ges su ch as salt an d fluid restriction s th at red uce th e am ou n t o f en do lym ph atic fluid are so m etim es prescrib ed . Lyin g still an d watch in g televisio n will n o t co n tro l vertigo . Test-Ta kin g Str a tegy: Fo cus on th e su b ject, p reven tin g vertigo . No te th e relatio n sh ip between vertigo an d avo idin g sud den h ead m ovem en ts in th e co rrect op tio n . Review: Measures th at red uce vertigo in th e clien t with Men iere’s d isease Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Ear Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an , (2016), p p. 1008–1009.

757. 1 Ra tion a le: Visu al acuity is assessed in 1 eye at a tim e, an d th en in bo th eyes to geth er, with th e clien t co m fortably stan d in g or sittin g. Th e righ t eye is tested with th e left eye covered; th en th e left eye is tested with th e righ t eye co vered. Both eyes are th en tested to geth er. Visu al acu ity is m easured with o r with ou t cor- rective len ses an d th e clien t stan d s at a distan ce of 20 feet (6 m eters) fro m th e ch art. Test-Ta kin g Str a tegy: Rem em ber th at n orm al visual acu ity as m easured b y a Sn ellen ch art is 20/ 20 visio n . Th is sh o uld assist in elim in atin g o ption s 3 an d 4 b ecause th ey are co m p arab le o r alike in th at th ey in d icate stan d in g at a d istan ce of 40 feet (12 m eters). From th e rem ain in g op tio n s, rem em b er th at it is best an d m ost accu rate to test each eye separately an d th en test b oth eyes to geth er. Review: Visual acu ity testin g with use o f a Sn ellen ch art Level of Cogn itive Ability: Ap plyin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen sory Perceptio n Refer en ce: Jarvis (2016), pp . 289–290, 303.

758. 2 Ra tion a le: Vision th at is 20/ 20 is n orm al—th at is, th e clien t is able to read from 20 feet (6 m eters) wh at a p erson with n o rm al visio n can read fro m 20 feet (6 m eters). A clien t with a visual acu ity of 20/ 60 can on ly read at a d istan ce o f 20 feet (6 m eters) wh at a person with n orm al vision can read at 60 feet (18 m eters). With th is vision , th e clien t m ay n eed glasses wh ile drivin g in order to read sign s an d to see far ah ead. Th e clien t sh o u ld b e in structed to sit in th e fron t of th e ro om fo r lectures to aid in visu alizatio n . Th is is n o t co n sid ered to be legal blin dn ess. Test-Ta kin g St r a tegy: Focus on th e su b ject, in terp retin g a Sn ellen ch art resu lt. No te th e test resu lt, 20/ 60, an d recall th e associated in terven tio n s fo r th is resu lt. Also, elim in ate o ptio n s 1 an d 3, as th ey are co m p arab le o r alike, im plyin g th at th e test resu lts in dicate b lin dn ess. Review: In terp retatio n of visu al acu ity test results Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nu rsin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Eye Pr ior it y Con cept s: Clin ical Ju dgm en t; Sen sory Perceptio n Refer en ce: Jarvis (2016), pp . 289–290, 303.

A

d

u

l

t

E

y

e

/

E

a

r

880 UNIT XV Eye and Ear Disorders of the Adult Client

759. 3 Ra t ion a le: Sp eakin g in a n orm al ton e to th e clien t with im p aired h earin g an d n ot sh o utin g are im po rtan t. Th e n u rse sh ou ld talk directly to th e clien t wh ile facin g th e clien t an d speak clearly. If th e clien t d oes n ot seem to u n d erstan d wh at is said , th e n urse sh ou ld express it d ifferen tly. Mo vin g clo ser to th e clien t an d to ward th e b etter ear m ay facilitate com m un icatio n , b ut th e n u rse sh o u ld avo id talkin g directly in to th e im p aired ear. Test -Ta kin g St r a tegy: Fo cus on th e su b ject, an effective co m - m u n ication tech n iqu e fo r th e h earin g im p aired . Rem em b er th at it is im p o rtan t to speak in a n o rm al to n e.

Review: Effective com m un ication tech n iq ues for th e h earin g im p aired Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Ad ult Health —Ear Pr ior ity Con cepts: Com m un icatio n ; Sen so ry Perception Refer en ce: Ign atavicius, Workm an (2016), p . 1014.

A

d

u

l

t

E

y

e

/

E

a

r

881CHAPTER 60 The Eye and the Ear

A

d

u

l

t

E

y

e

/

E

a

r

C H A P T E R 61 Eye and Ear Medications

PRIORITY CONCEPTS Safety; Sensory Perception

CRITICAL THINKING What Should You Do? Aclient who requires the instillation of eye drops 3 times daily tells the nurse that he lives alone and is concerned about the ability to administer the drops because his hands are shaky. What should the nurse do? Answer located on p. 889.

I. Ophthalmic Medication Administration A. Guidelin es for th e use of eye m edication s

1. Eye m ed ication s are usually in th e form of drops or oin tm en ts.

2. To preven t overflow of m edication in to th e n asal an d ph aryn geal passages, th us reducin g system ic absorption , in struct th e clien t to ap ply pressure over th e in n er can th us n ext to th e n ose for 30 to 60 secon ds followin g adm in istration of th e m ed ication ; in struct th e clien t to clo se th e eye gen tly to h elp distribute th e m ed ication (Fig. 61-1).

3. If both an eye drop an d eye oin tm en t are sch ed- uled to be adm in istered at th e sam e tim e, adm in ister th e eye drop first.

4. Wash h an ds an d don gloves before adm in ister- in g eye m edication s to avoid con tam in atin g th e eye or m ed ication dropp er or applicato r.

5. Use a sep arate bottle or tube of m edication for each clien t to avoid acciden tal cross- con tam in ation .

6. Place th e prescribed dose of eye m edication in th e lo wer con jun ctival sac, n ever directly on to th e corn ea.

7. Avoid touch in g an y part of th e eye with th e dropp er or ap plicator.

8. Adm in ister gluco cortico id preparation s before oth er m ed ication s.

9. Mon itor th e pulse an d blood pressure if receiv- in g an oph th alm ic beta blocker, an d in struct th e clien t to do th e sam e; th e n urse sh ould obtain pulse param eters from th e h ealth care provid er (HCP) .

10. In struct th e clien t h ow to in still m edication correctly an d supervise in stillation un til th e cli- en t can do it safely; adaptive devices th at posi- tion th e bottle of eye drops directly over th e eye can also be purch ased if in stillation is difficu lt for th e clien t.

11. In struct th e clien t to read th e m edication labels carefully to en sure ad m in istration of th e correct m edication an d correct stren gth .

12. Rem in d th e clien t to keep th ese m edication s out of th e reach of ch ildren .

13. In struct th e clien t to avoid drivin g or operatin g h azardo us equ ipm en t if vision is blurred.

14. Inform the clien t th at h e or sh e m ay be un able to drive h om e after eye exam in ation s wh en a m edication to dilate the pupil (mydriatic) or to paralyze the ciliary m uscle (cycloplegic) is used.

15. If ph o toph ob ia occurs, in struct th e clien t to wear sun glasses an d avoid brigh t ligh ts.

16. In struct th e clien t to adm in ister a m issed dose of th e eye m ed ication as soon as it is rem em - bered, un less th e n ext dose is sch eduled to be adm in istered in 1 to 2 h ou rs.

17. In form th e clien t with glaucoma th at th e disor- der can n ot be cured, on ly con trolled.

18. Rein force th e im portan ce of usin g m ed ication s to treat glaucom a as prescribed an d n ot to dis- con tin ue th ese m edication s with out con sultin g th e HCP.

19. In form th e clien t th at m ed ication s used to treat glaucom a m ay cause pain an d blurred vision , especially wh en th erapy is begun .

20. In struct th e clien t to report th e developm en t of an y eye irritation .

21. In form th e clien t usin g eye gel to store th e gel at room tem p erature or in th e refrigerator, but n ot to freeze it.

22. In struct th e clien t to discard un used eye gel kept at room tem p erature as recom m en ded by th e HCP an d/ or th e ph arm acist.

23. In form th e clien t th at soft con tact len ses m ay absorb certain eye m ed ication s an d th at882

preservatives in eye m edication s m ay discolor th e con tact len ses.

24. Advise th e clien t wearin g con tact len ses to question th e HCP carefully about special pre- caution s to observe with eye m ed ication s.

25. In form th e paren ts of in fan ts th at atropin e sul- fate eye drops m ay con tribute to abdom in al disten tion .

26. In struct th e paren ts to keep a record of th e in fan t’s bowel m ovem en ts if atropin e sulfate eye drops are bein g adm in istered.

27. Auscu ltate bowel soun ds of th e in fan t or ch ild receivin g atropin e sulfate eye drops.

Because the timing of medication administration is critical, administer eye medications at precise intervals as prescribed; separate the instillation by 3 to 5 minutes if two medications must be administered at the same time.

B. In stillation of eye m ed ication s 1. Drop s

a . Wash h an ds. b . Put gloves on . c. Ch eck th e n am e, stren gth , an d exp iration

date of th e m edication . d . In struct th e clien t to tilt th e h ead backward,

open th e eyes, an d look up. e. Pull th e lo wer lid down again st th e

ch eekbon e. f. Hold th e bottle like a pen cil, with th e tip

down ward. g. Holdin g th e bottle, gen tly rest th e wrist of th e

h an d on th e clien t’s ch eek. h . Squeeze th e bottle gen tly to allow th e drop to

fall in to th e con jun ctival sac. i. In struct th e clien t to clo se th e eyes gen tly an d

n ot to squeeze th e eyes sh ut. j. Wait 3 to 5 m in utes before in stillin g an oth er

drop, if m ore th an on e drop is prescribed, to prom ote m axim al absorption of th e m edication .

k . Do n ot allow th e m edication bottle, drop- per, or applicato r to com e in to con tact with th e eyelid or con jun ctival sac.

l. To preven t system ic ab sorption of th e m ed i- cation , apply gen tle pressure with a clean tis- sue to th e clien t’s n aso lacrim al duct for 30 to 60 secon ds (see Fig. 61-1).

2. O in tm en ts a. In struct th e clien t to lie down or tilt th e h ead

backward an d look up. b . Ho ld th e oin tm en t tube n ear, but n ot touch -

in g, th e eye or eyelash es. Th is action preven ts th e spread of con tam in an ts fro m 1 eye to th e oth er.

c. Squeeze a th in ribb on of oin tm en t alon g th e lin in g of th e lower co n jun ctival sac, from th e in n er to th e outer can th us.

d . In struct th e clien t to close th e eyes gen tly, ro llin g th e eyeb all in all direction s (in creases con tact area of m ed ication to eye).

e. In struct th e clien t th at vision m ay be blurred by th e oin tm en t.

f. If possible, apply oin tm en t just before bed tim e.

II. Mydriatic, Cycloplegic, and Anticholinergic Medica- tions (Box 61-1)

A. Descriptio n 1. Mydriatics an d cycloplegics dilate th e pupils

(mydriasis) an d relax th e ciliary m uscles (cycloplegia).

2. An tich olin ergics block respon ses of th e sph in c- ter m uscle in th e ciliary body, produ cin g m ydri- asis an d cyclop legia.

3. Th ese m edication s are used preoperatively or for eye exam in ation s to produ ce m ydriasis.

4. Mydriatics are con train dicated in glaucom a, cardiac dysrh yth m ias, an d cerebral ath ero sclero- sis an d sh o uld be used with caution in th e older clien t an d in clien ts with prostatic h ypertro ph y, diabetes m ellitus, or parkin son ism .

B. Sid e an d adverse effects 1. Tach ycardia 2. Ph otop h obia 3. Con jun ctivitis 4. Derm atitis 5. Elevated blood pressure

A

d

u

l

t

E

y

e

/

E

a

r

FIGURE 61-1 Applying punctual occlusion to prevent systemic absorp- tion of eye drops. (From Ignatavicius, Workman, 2013.)

BOX 61-1 Mydriatic, Cycloplegic, and Anticholinergic Medications

▪ Atropine ▪ Cyclopentolate ▪ Homatropine ▪ Phenylephrine ▪ Tropicamide

883CHAPTER 61 Eye and Ear Medications

C. Atropin e toxicity 1. Dry m ou th 2. Blurred vision 3. Ph o toph ob ia 4. Tach ycardia 5. Fever 6. Urin ary reten tion 7. Con stipation 8. Headach e, brow pain 9. Worsen in g of glaucoma

10. Con fusion 11. Hallucin ation s, delirium 12. Com a

D. System ic reaction s to an tich olin ergics 1. Dry m outh an d skin 2. Fever 3. Th irst 4. Hyperactivity 5. Con fusion

E. In terven tion s 1. Mon itor for allergic respo n se. 2. Assess for risk of in jury. 3. Assess for co n stipatio n an d urin ary reten tion . 4. In struct th e clien t th at a burn in g sen sation m ay

occur on in stillation . 5. In struct th e clien t n ot to drive or perform h az-

ardous activities for 24 h ours after in stillation of th e m edication un less oth erwise directed by th e HCP.

6. In struct th e clien t to wear sun glasses un til th e effects of th e m ed ication wear off.

7. In struct th e clien t to n otify th e HCP if blurrin g of vision , loss of sigh t, difficulty breath in g, sweatin g, or flush in g occurs.

8. In struct th e clien t to report eye pain to th e HCP.

Mydriatics are contraindicated in clients with glau- coma because of the risk of increased intraocular pressure.

III. Antiinfective Eye Medications (Box 61-2) A. Description : An tiin fective m edication s kill or in h ibit

th e growth of bacteria, fun gi, an d viruses. B. Side an d adverse effects

1. Superin fection 2. Glo bal irritatio n

C. In terven tion s 1. Assess for risk of in jury. 2. In struct th e clien t h ow to apply th e eye m edica-

tion ; rem in d th e clien t to clean exu dates from th e eyes befo re adm in isterin g th e m edication .

3. Rein fo rce th e im portan ce of com pletin g th e pre- scrib ed m ed ication regim en .

4. In struct th e clien t to wash th e h an ds th o rough ly an d frequen tly.

5. Advise th e clien t th at if im provem en t does n ot occur to n otify th e HCP.

IV. Antiinflammatory Eye Medications (Box 61-3) A. Descrip tion

1. Antiin flam m atory m edication s con trol in flam - m ation, th ereby reducin g vision loss an d scarrin g.

2. An tiin flam m atory m ed ication s are used for uve- itis, allergic con dition s, an d in flam m ation of th e con jun ctiva, corn ea, an d lids.

B. Side an d adverse effects 1. Cataracts 2. In creased in traocular pressure

A

d

u

l

t

E

y

e

/

E

a

r

BOX 61-2 Antiinfective Eye Medications Antibacterial ▪ Chloramphenicol ▪ Erythromycin ▪ Bacitracin Aminoglycosides ▪ Gentamicin sulfate ▪ Tobramycin Antifungal ▪ Natamycin Antiviral ▪ Ganciclovir ▪ Trifluridine Sulfonamide ▪ Sulfacetamide

BOX 61-3 Antiinflammatory Eye Medications Corticosteroids ▪ Dexamethasone ▪ Fluocinolone ▪ Fluorometholone; sulfacetamide ▪ Loteprednol etabonate ▪ Prednisolone, gentamicin Ophthalmic Immunosuppressant and Antiinflammatory Agent ▪ Cyclosporine Nonsteroidal Antiinflammatory Agents ▪ Bromfenac ▪ Diclofenac ▪ Flurbiprofen sodium ▪ Ketorolac tromethamine Mast Cell Stabilizers ▪ Azelastine hydrochloride ▪ Cromolyn sodium ▪ Epinastine ▪ Ketotifen fumarate ▪ Nedocromil sodium ▪ Olopatadine hydrochloride

884 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

3. Im p aired h ealin g 4. Maskin g sign s an d sym pto m s of in fectio n

C. In terven tion s 1. In terven tion s are th e sam e as for an tiin fective

m ed ication s. 2. No te th at dexam eth ason e sh ould n ot be used for

eye abrasio n s an d woun ds.

V. Topical Eye Anesthetics A. Description

1. To pical an esth etics produ ce corn eal an esth esia. 2. To pical an esth etics are used for an esth esia for eye

exam in ation s an d surgery or to rem ove foreign bodies from th e eye.

3. Do n ot use th e solution if it is discolored , an d store th e bottle tigh tly clo sed.

4. An exam ple is tetracain e B. Side an d ad verse effects

1. Tem po rary stin gin g or burn in g of th e eye 2. Tem po rary loss of co rn eal reflex

C. In terven tion s 1. Assess for risk of in jury. 2. No te th at th e m ed ication s sh ould n ot be given to

th e clien t for h om e use an d are n ot to be self- ad m in istered by th e clien t.

3. In struct th e clien t n ot to rub or touch th e eye wh ile it is an esth etized .

4. Note th at the blink reflex is lost tem porarily and th at th e corn eal epith elium n eeds to be protected.

5. Provide an eye patch to protect th e eye from in ju ry un til th e corn eal reflex return s.

VI. Eye Lubricants (Box 61-4) A. Description

1. Eye lubrican ts replace tears or ad d m oistu re to th e eyes.

2. Eye lubrican ts m oisten con tact len ses or an arti- ficial eye an d protect th e eyes durin g surgery or diagn ostic proced ures.

3. Eye lubrican ts are used for keratitis, durin g an es- th esia, or for a clien t wh o is un con scious or h as decreased blin kin g.

B. Side an d ad verse effects 1. Burn in g on in stillation 2. Discom fort or pain on in stillation 3. Allergic reactio n

C. In terven tion s 1. In form th e clien t th at burn in g m ay occur on

in stillation .

2. Be alert to allergic respo n ses to th e preservatives in th e lubrican ts.

VII. Medications to Treat Glaucoma (Box 61-5) A. Descrip tion

1. Th ese m edication s reduce in traocular pressure by con strictin g th e pupil an d con tractin g th e cil- iary m uscle, th ereby in creasin g th e blood flow to th e retin a an d decreasin g retin al dam age an d loss of vision .

2. Th ese m edication s open th e an terior ch am b er an gle an d in crease th e outflow of aqueous h um or.

3. Som e m ay be used to ach ieve miosis durin g eye surgery.

4. Con train dicated in clien ts with retin al detach - m en t, adh esion s between th e iris an d len s, or in flam m atory diseases.

5. Use with cautio n in clien ts with asth m a, h yper- ten sion , corn eal abrasio n , h yperth yroidism , cor- on ary vascu lar disease, urin ary tract obstruction , gastro in testin al obstru ction , ulcer disease, par- kin son ism , an d bradycardia.

B. Side effects 1. Myopia 2. Headach e

BOX 61-4 Eye Lubricants ▪ Carboxymethylcellulose ▪ Hydroxypropyl methylcellulose ▪ Petroleum-based ointment ▪ Polyvinyl alcohol

BOX 61-5 Medications to Treat Glaucoma Miotics ▪ Echothiophate ▪ Carbachol ▪ Pilocarpine hydrochloride β-Adrenergic Blocking Eye Medications ▪ Betaxolol hydrochloride ▪ Carteolol hydrochloride ▪ Levobunolol hydrochloride ▪ Metipranolol ▪ Timolol maleate α-Adrenergic Agonists ▪ Apraclonidine ▪ Brimonidine Prostaglandin Analogs ▪ Latanoprost ▪ Tafluprost ▪ Travoprost ▪ Bimatoprost Cholinergic Agonists ▪ Pilocarpine hydrochloride ▪ Echothiophate iodide Carbonic Anhydrase Inhibitors ▪ Dorzolamide ▪ Brinzolamide

885CHAPTER 61 Eye and Ear Medications

A

d

u

l

t

E

y

e

/

E

a

r

3. Eye pain 4. Decreased vision in poor ligh t 5. Local irritatio n

C. Adverse effects 1. Flush in g 2. Diaph oresis 3. Gastro in testin al upset an d diarrh ea 4. Frequen t urin ation 5. In creased salivation 6. Muscle weakn ess 7. Respiratory difficu lty

D. Toxicity 1. Vertigo an d syn cop e 2. Bradycardia or oth er dysrh yth m ias 3. Hypoten sion 4. Trem ors 5. Seizures

E. In terven tion s 1. Assess vital sign s. 2. Assess for risk of in jury. 3. Assess th e clien t for th e degree of dim in ish ed

vision . 4. Mon itor for side an d adverse effects an d toxic

effects. 5. Mon itor for postural h ypoten sion , and in struct

th e clien t to ch an ge position s slowly. 6. Assess breath soun ds for wh eezes an d rh on ch i

because som e m edication s can cau se bron ch o- spasm s an d in creased bron ch ial secretion s.

7. Main tain oral h ygien e because of th e in crease in salivation .

8. Have atropin e sulfate available as an an tidote for pilocarpin e.

9. In struct th e clien t or fam ily regardin g th e cor- rect adm in istration of eye m ed ication s.

10. In struct th e clien t n ot to stop th e m edication sudden ly.

11. In struct th e clien t to avoid activities such as drivin g wh ile vision is im paired.

Instruct the client with glaucoma to read labels on over-the-counter medications and to avoid atropine-like medications because atropine will increase intraocular pressure.

VIII. β-Adrenergic Blocker Eye Medications (see Box 61-5) A. Description

1. Th ese m edication s reduce in traocular pressure by decreasin g sym path etic im pulses an d decreas- in g aqueo us h um or produ ction with out affect- in g accommodation or pupil size.

2. Th ese m edication s are used to treat glaucom a. 3. Th ese m edication s are con train dicated in th e cli-

en t with asth m a or ch ron ic obstru ctive pulm o - n ary disease because system ic ab sorption can cau se in creased airway resistan ce.

4. Use th ese m edication s with cautio n in th e clien t receivin g oral beta blockers.

B. Side an d adverse effects 1. O cular irritatio n 2. Visual disturban ces 3. Bradycardia 4. Hypoten sion 5. Bron ch ospasm

C. In terven tion s 1. Mon itor vital sign s, especially blood pressure

an d pulse, befo re adm in isterin g m edication . 2. Usually if th e pulse is 60 beats/ m in ute or less or

if th e systolic blood pressure is less th an 90 m m Hg, th e m edication is with h eld an d th e HCP is con tacted. Th e n urse sh ould obtain pulse param eters from th e HCP for clien ts receivin g oph th alm ic beta blockers.

3. Mon itor for sh o rtn ess of breath . 4. Assess for risk of in jury. 5. Mon itor in take an d outp ut. 6. In struct th e clien t to n otify th e HCP if sh ortn ess

of breath occurs. 7. In struct th e clien t n ot to discon tin ue th e m ed-

ication abru ptly. 8. In struct th e clien t to ch an ge position s slowly

because of th e poten tial for orth ostatic h ypoten sion .

9. In struct th e clien t to avoid h azardous activities. 10. In struct th e clien t to avoid over-th e-coun ter

m edication s with out th e HCP’s ap proval. 11. In struct clien ts with diab etes m ellitus usin g β-

adren ergic blockers to m on itor blood glucose levels frequen tly.

IX. Carbonic Anhydrase Inhibitors (see Box 61-5) A. Descrip tion

1. Carb on ic an h yd rase in h ib itors in terfere with th e produ ction of carbon ic acid, wh ich leads to decreased aqueous h um or form ation an d decreased in traocular pressure.

2. Th ese m ed ication s are used for th e lon g-term treatm en t of glaucom a.

3. Th ese m edication s are con train dicated in th e cli- en t allergic to sulfon am ides.

4. Use with cau tion for clien ts with severe ren al or liver disease.

B. Side an d adverse effects 1. Appetite loss 2. Gastro in testin al upset 3. Paresth esias in th e fin gers, toes, an d face 4. Polyuria 5. Hypokalem ia 6. Ren al calculi 7. Ph otosen sitivity 8. Leth argy an d drowsin ess 9. Depression

886 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

C. In terven tion s 1. Mon itor vital sign s. 2. Assess visual acuity. 3. Assess for risk of in jury. 4. Mon itor in take an d output. 5. Mon itor weigh t. 6. Main tain oral h ygien e. 7. Mon itor for side effects such as lethargy, an orexia,

drowsin ess, polyuria, n ausea, an d vom iting. 8. Mon itor electrolyte levels for h ypo kalem ia. 9. In crease fluid in take un less con train d icated.

10. Advise th e clien t to avoid prolon ged exp osure to sun ligh t.

11. En cou rage th e use of artificial tears for dry eyes. 12. In struct th e clien t n ot to discon tin ue th e m ed-

ication ab ruptly. 13. In struct th e clien t to avoid h azardo us activities

wh ile vision is im paired. 14. Teach th e client n ot to wear con tact len ses

durin g or with in 15 m in utes of instillin g th ese m edication s.

X. Ocusert System A. Description

1. A th in eye wafer (disk) is im pregn ated with a tim e-release dose of pilocarpin e.

2. Th e O cusert system was devised to overcom e th e n eed for frequen t in stillation of pilocarpin e.

3. It is placed in th e upper or lo wer cul-de-sac of th e eye.

4. Th e pilocarpin e is released over 1 week. 5. Th e disk is replaced every 7 days. 6. Drawbacks of its use in clude sudden leakage of

pilocarpin e, m igration of th e system over th e corn ea, an d un n oticed loss of th e system .

B. In terven tion s 1. Assess th e clien t’s ability to in sert th e m ed ication

disk. 2. Store th e m ed ication in th e refrigerato r. 3. In struct th e clien t to discard dam aged or con -

tam in ated disks. 4. In form th e clien t th at tem p orary stin gin g is

exp ected but to n otify th e HCP if blurred vision or brow pain occurs.

5. In struct th e clien t to ch eck for th e presen ce of th e disk in th e upper or lower cu l-de-sac daily at bed- tim e an d on arisin g.

6. Because vision m ay ch an ge in th e first few h ours after th e eye system is in serted, in struct th e clien t to replace th e disk at bedtim e.

XI. Osmotic Medications A. Man n itol B. Description

1. O sm o tic m ed ication s lower in traocular pressure. 2. Th ey are used in em ergen cy treatm en t of glau-

com a an d are used preoperatively an d posto per- atively to decrease vitreous h um or volum e.

C. Side an d adverse effects 1. Headach e 2. Nausea, vo m itin g, diarrh ea, deh ydratio n 3. Diso rien tation 4. Electrolyte im balan ces

D. In terven tion s 1. Assess vital sign s. 2. Assess visual acuity. 3. Assess for risk of in jury. 4. Mon itor in take an d output. 5. Mon itor weigh t. 6. Mon itor for electrolyte im balan ces. 7. In crease fluid in take un less con train d icated. 8. Mon itor for ch an ges in level of orien tation .

XII. Medications to Treat Macular Degeneration A. Pegaptan ib, ran izum ab, bevacizum ab , aflibercept,

vertepo rfin B. Descrip tion

1. Age-related macular degen eration (ARMD) can be dry ARMD (atroph ic) or wet ARMD (n eovascu lar).

2. Dry ARMD is m ore com m on ; m acular ph otore- ceptors un d ergo gradual breakdown , lead in g to gradual blurrin g of cen tral vision .

3. Wet ARMD progresses faster an d m acular degen - eration is caused by th e growth of n ew subretinal blood vessels, wh ich leads to fluid leakage that lifts th e m acula an d causes perm an en t in jury.

4. Ch aracterized by th e presen ce of drusen (yellow deposits un der th e retin a) .

C. Side an d adverse effects 1. En doph th alm itis (eye in flam m ation caused by

bacterial, viral, or fun gal in fectio n ) 2. Blurred vision 3. Cataracts 4. Corn eal edem a 5. Eye discom fort an d disch arge 6. Con ju n ctival h em orrh age 7. In creased in traocular pressure 8. Reduced visual acuity

D. In terven tion s 1. Teach th e clien t about ad m in istration of th e

m edication s. 2. Teach th e clien t ab out th e side effects an d th e

n eed to n otify th e HCP.

XIII. Otic Medication Administration A. In stillation of ear drops

1. In an adult, pull th e pin n a up an d back to straigh ten th e extern al can al to in still ear drops.

2. Tilt th e clien t’s h ead in th e oppo site direction of th e affected ear an d apply th e drops in to th e ear.

3. With th e h ead tilted, gen tly m ove th e h ead back an d forth 5 tim es.

4. Pull th e pin n a down an d back for in fan ts an d ch ildren youn ger th an 3 years, up an d back for older ch ildren .

887CHAPTER 61 Eye and Ear Medications

A

d

u

l

t

E

y

e

/

E

a

r

B. Irrigation of th e ear (Fig. 61-2) 1. Irrigation of th e ear n eeds to be prescribed by

th e HCP. 2. En su re direct visu alization of th e tym pan ic

m em bran e. 3. Warm th e irrigatin g solution to 98.6 °F (37.0 °C)

because a solution tem p erature th at is n ot clo se to th e clien t’s body tem perature will cau se ear in jury, n ausea, vertigo, an d n ystagm us.

4. Irrigation m ust be don e gen tly to avoid dam age to th e eardrum .

5. Wh en irrigatin g, to preven t in jury, do n ot direct irrigation solution directly toward th e eardrum but rath er toward th e wall of th e ear can al. In addition , to rem ove cerum en , th e solution is directed above or below th e im paction toward th e wall of th e can al to allow back pressure to push th e im paction out.

6. Du rin g irrigation , th e clien t sh o uld be posi- tion ed with th e ear to be irrigated facin g up. Fall precaution s sh o uld be in stituted because th e cli- en t m ay get dizzy an d an em esis basin sh ould be available because vom itin g can occur.

C. System ic m edication s th at affect h earin g ( Box 61-6)

If a perforation of the eardrum is suspected, do not perform ear irrigation.

XIV. Antiinfective Ear Medications (Box 61-7) A. Description

1. An tiin fective m ed ication s kill or in h ib it th e growth of bacteria an d are used for otitis m edia or otitis extern a.

2. Th ese m edication s are co n train d icated if a prior h ypersen sitivity exists.

B. Side an d adverse effect: O vergrowth of n on suscep ti- ble organ ism s

C. In terven tion s 1. Mon itor vital sign s. 2. Assess for allergies. 3. Assess for pain . 4. Mon itor for sign s of secon dary in fectio n . 5. In struct th e clien t to report dizzin ess, fatigue,

fever, or sore th roat, wh ich m ay in dicate a super- im posed in fectio n .

6. In struct th e clien t to com plete th e en tire course of th e m edication .

7. In struct th e clien t to keep ear can als dry.

XV. Antihistamines and Decongestants (Box 61-8) A. Descrip tion

1. Th ese m edication s produce vaso con striction . 2. Th ese m edication s stim ulate th e receptors of th e

respiratory m ucosa.

Ce rume n Irriga tion s yringe

P inna

Tympa nic me mbra ne

FIGURE 61-2 Irrigation of the external canal. Cerumen and debris can be removed from the ear by irrigation with warm water. The stream of water is aimed above or below the impaction to allow back pressure to push it out rather than further down the canal.

BOX 61-6 Medications That Affect Hearing Antibiotics ▪ Amikacin ▪ Chloramphenicol ▪ Erythromycin ▪ Gentamicin ▪ Neomycin ▪ Streptomycin sulfate ▪ Tobramycin sulfate ▪ Vancomycin Diuretics ▪ Ethacrynic acid ▪ Furosemide

Others ▪ Cisplatin ▪ Nitrogen mustard ▪ Quinine ▪ Quinidine ▪ Aspirin ▪ Ibuprofen ▪ Naproxen

BOX 61-7 Antiinfective Ear Medications

▪ Acetic acid; aluminum acetate ▪ Amoxicillin ▪ Ampicillin ▪ Cefaclor ▪ Chloramphenicol ▪ Clarithromycin ▪ Clindamycin hydrochloride ▪ Erythromycin ▪ Gentamicin sulfate otic solution ▪ Penicillin V potassium ▪ Trimethoprim; sulfamethoxazole

BOX 61-8 Antihistamines and Decongestants ▪ Loratadine ▪ Cetirizine ▪ Diphenhydramine ▪ Fexofenadine ▪ Pseudoephedrine

888 UNIT XV Eye and Ear Disorders of the Adult Client

A

d

u

l

t

E

y

e

/

E

a

r

3. Th ese m ed ication s reduce respiratory tissue h yperem ia an d edem a to open obstru cted eusta- ch ian tubes.

4. Th ese m edication s are used for acute otitis m edia. B. Side an d ad verse effects

1. Drowsin ess 2. Blurred vision 3. Dry m ucou s m em bran es

C. In terven tion s 1. In form th e clien t th at drowsin ess, blurred vision ,

an d a dry m ou th m ay occur. 2. In struct th e clien t to in crease fluid in take un less

con train dicated an d to suck on h ard can dy to alleviate th e dry m ou th .

3. In struct th e clien t to avoid h azardo us activities if drowsin ess occurs.

4. In struct th e clien t with h yperten sion to con sult th e HCP prior to th e use of th ese m edication s.

XVI. Ceruminolytic Medication A. Carbam ide peroxide B. Descrip tion

1. Em ulsifies an d loosen s cerum en dep osits 2. Used to loosen an d rem ove im pacted wax fro m

th e ear can al C. Side an d adverse effects

1. Irritation 2. Redn ess or swellin g of th e ear can al

D. In terven tion s 1. In struct th e clien t n ot to use drops m ore often

th an prescribed. 2. Moisten a cotton plug with m edication and in sert

th e cotton plug after in stillin g th e ear drops. 3. Keep th e con tain er tigh tly closed an d away fro m

m oistu re. 4. Avoid touch in g th e ear with th e dropper. 5. Th irty m in u tes after in stillation , gen tly irrigate

th e ear as prescribed with warm water, usin g a soft ru bber bulb ear syrin ge.

6. Irrigation m ay be don e with h ydrogen peroxide solution as prescribed to flush cerum en deposits out of th e ear can al.

7. For a ch ron ic cerum en im paction , 1 or 2 drops of m in eral oil (if prescribed) will soften th e wax.

8. In struct th e clien t to n otify th e HCP if redn ess, pain , or swellin g persists.

CRITICAL THINKING What Should You Do? Answer: If the client lives alone and has a physical condition that may affect instilling the eye drops, the nurse should arrange for a home care nurse to assess the client and the home situation. If the client is unable to instill eye drops independently, a friend, neighbor, or family member can be taught the technique if pos- sible. In addition, adaptive equipment that positions the bottle of eye drops directly over the eye can be purchased and used by the client who has difficulty instilling eye drops.

References: Ignatavicius, Workman (20 16), pp. 970 , 975; Perry et al. (2014), p. 516.

P R A C T I C E Q U E S T I O N S 760. Betaxo lo l h yd ro ch lo rid e eye d ro p s h ave b een

p rescrib ed fo r a clien t with glau co m a. Wh ich n u rsin g actio n is m o st ap p ro p riate related to m o n ito rin g fo r sid e an d ad verse effects o f th is m ed icatio n ? 1. Assessin g for edem a 2. Mon itorin g tem perature 3. Mon itorin g blood pressure 4. Assessin g blood gluco se level

761. Th e n urse is preparin g to ad m in ister eye drops. Wh ich in terven tion s sh ould th e n urse take to adm in ister th e drops? Select all th at ap p ly.

1. Wash h an ds. 2. Put gloves on . 3. Place th e drop in th e con jun ctival sac. 4. Pull th e lower lid down again st th e

ch eekb on e. 5. In struct th e clien t to squeeze th e eyes sh ut

after in stillin g th e eye drop. 6. In struct th e clien t to tilt th e h ead forward,

open th e eyes, an d look down .

762. Th e n urse prepares a clien t for ear irrigation as prescribed by th e h ealth care provider. Wh ich action sh o uld th e n urse take wh en perform in g th e procedure? 1. Warm th e irrigatin g solution to 98.6 °F (37.0 °C). 2. Position th e clien t with th e affected side up

followin g th e irrigation . 3. Direct a slow, steady stream of irrigation solu-

tion toward th e eardrum . 4. Assist th e clien t to turn h is or h er h ead so th at

th e ear to be irrigated is facin g upward.

763. Th e n urse is providin g in struction s to a clien t wh o will be self-adm in isterin g eye drops. To m in im ize system ic absorption of th e eye drops, th e n urse sh o uld in struct th e clien t to take wh ich action ? 1. Eat before in stillin g th e drops. 2. Swallow several tim es after in stillin g th e drops. 3. Blin k vigorou sly to en courage tearin g after

in stillin g th e drops. 4. O cclude th e n asolacrim al duct with a fin ger

after in stillin g th e drops.

764. A clien t is prescribed an eye drop an d an eye oin t- m en t for th e righ t eye. Ho w sh o uld th e n urse b est ad m in ister th e m ed ication s? 1. Adm in ister th e eye drop first, followed by th e

eye oin tm en t. 2. Adm in ister th e eye oin tm en t first, followed by

th e eye drop. 3. Adm in ister th e eye drop, wait 15 m in utes, an d

adm in ister th e eye oin tm en t. 4. Adm in ister th e eye oin tm en t, wait 15 m in u tes,

an d adm in ister th e eye drop.

889CHAPTER 61 Eye and Ear Medications

A

d

u

l

t

E

y

e

/

E

a

r

765. Wh ich m ed ication , if prescribed for th e clien t with glaucom a, sh o uld th e n urse question ? 1. Betaxolol 2. Pilocarpin e 3. Eryth rom ycin 4. Atropin e sulfate

766. A m iotic m edication h as been prescribed for th e clien t with glaucom a an d th e clien t asks th e n urse ab out th e purpo se of th e m ed ication . Wh ich respo n se sh ould th e n urse provid e to th e clien t? 1. “Th e m edication will h elp dilate th e eye to pre-

ven t pressure from occurrin g.” 2. “Th e m edication will relax th e m uscles of th e

eyes an d preven t blurred vision .” 3. “Th e m edication causes th e pupil to con strict

an d will lower th e pressure in th e eye.” 4. “Th e m edication will h elp block th e respon ses

th at are sen t to th e m uscles in th e eye.”

767. A clien t was just adm itted to th e h ospital to ru le out a gastro in testin al (GI) bleed. Th e clien t h as brough t several bottles of m edication s prescribed by differen t specialists. Durin g th e adm ission

assessm en t, th e clien t states, “Lately, I h ave been h earin g som e roarin g soun ds in m y ears, especially wh en I am alon e.” Wh ich m ed ication would th e n urse iden tify as th e cau se of th e clien t’s com plain t? 1. Do xycyclin e 2. Atropin e sulfate 3. Acetylsalicylic acid 4. Diltiazem h ydroch loride

768. In preparation for cataract surgery, th e n urse is to adm in ister cyclop en tolate eye drops at 0900 for surgery th at is sch eduled for 0915. Wh at in itial action sh ould th e n urse take in relation to th e ch ar- acteristics of th e m edication action ? 1. Provide lubrication to th e operative eye prior to

givin g th e eye drops. 2. Call th e surgeon , as th is m ed ication will furth er

co n strict th e operative pupil. 3. Con sult th e surgeon , as th ere is n ot sufficien t

tim e for th e dilative effects to occur. 4. Give th e m ed ication as prescribed; th e surgeon

n eeds optim al con striction of th e pupil.

A N S W E R S 760. 3 Ra tion a le: Hypo ten sion , d izzin ess, n au sea, d iaph oresis, h ead- ach e, fatigue, co n stip ation , an d diarrh ea are side an d adverse effects o f th e m ed icatio n . Nursin g in terven tio n s in clu de m o n - ito rin g th e bloo d pressu re fo r h ypo ten sion an d assessin g th e p ulse fo r stren gth , weakn ess, irregular rate, an d bradycard ia. O ptio n s 1, 2, an d 4 are n ot sp ecifically associated with th is m edicatio n . Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Use th e ABCs—airway–b reath in g–circu latio n —to d irect yo u to th e correct o ptio n . Review: Betaxo lo l h yd ro ch lo rid e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm aco logy—Eye an d Ear Med icatio n s Pr ior it y Con cept s: Safety; Sen sory Perceptio n Refer en ces: Burch um , Rosen th al ( 2016) , p p. 1269–1270; Ign atavicius, Workm an ( 2016) , p . 988.

761. 1, 2, 3, 4 Ra tion a le: To adm in ister eye m edication s, th e n urse should wash h an ds and put glo ves on. The client is in structed to tilt th e h ead b ackward, op en th e eyes, an d look u p. The n urse pulls th e lo wer lid down again st the ch eekbo n e and h olds th e b ottle like a pen cil with th e tip d ownward . Holdin g the b ottle, th e n urse gen tly rests the wrist of th e h an d on th e clien t’s ch eek an d squeezes th e b ottle gen tly to allo w the d ro p to fall in to th e con - jun ctival sac. The clien t is in structed to close th e eyes gen tly and n ot to squeeze th e eyes shut to preven t the loss o f m edicatio n. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e proced ure fo r ad m in isterin g eye d ro p s. Use gu idelin es related to stan d ard

p recautio n s an d visualize th is proced ure. Th is will assist in d eterm in in g th e co rrect in terven tio n s. Review: Pro cedu re for ad m in isterin g eye m ed icatio n s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm acolo gy—Eye an d Ear Med icatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 975.

762. 1 Ra tion a le: Befo re ear irrigatio n , th e n urse sh ould in sp ect th e tym pan ic m em brane to en sure that it is in tact. Th e irrigatin g solution sh ould b e warm ed to 98.6 °F (37.0 °C) becau se a solu- tion tem p erature th at is n ot close to the clien t’s body tem p era- tu re will cause ear in jury, n au sea, an d vertigo. Th e affected side sho uld b e d own followin g th e irrigation to assist in drain age o f th e fluid. Wh en irrigatin g, a direct and slo w steady stream of irri- gatio n solution is directed toward th e wall of th e can al, n ot to ward th e eardru m . Th e clien t is position ed sittin g, facin g for- ward with the h ead in a n atural position; if the ear is faced u pward, th e n urse wou ld n ot b e able to visualize th e can al. Test-Ta kin g Stra tegy: Focus on th e su b ject, th e procedure for perform in g ear irrigation . Th in k abo ut th e purpose of th is p roce- dure and keep safety in m in d . Visualizin g each step and th e in for- m ation in th e option s will assist in elim in ating th e in correct on es. Review: Th e p ro cedu re for ear irrigatio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ph arm acolo gy—Eye an d Ear Med icatio n s Pr ior it y Con cept s: Safety; Sen sory Perceptio n Refer en ces: Ign ataviciu s, Wo rkm an (2016), p. 1005; Perry et al. ( 2014) , pp . 511–512.

890 UNIT XV Eye and Ear Disorders of the Adult Client

763. 4 Ra t ion a le: App lyin g p ressu re on th e n asolacrim al d uct p re- ven ts system ic ab sorptio n o f th e m ed ication . O p tio n s 1, 2, an d 3 will n ot preven t system ic abso rp tion . Test -Ta kin g St r a t egy: Focus on th e su b ject, system ic effects. Eatin g an d swallo win g are co m p arab le o r alike an d are n o t related to th e system ic absorption of eye drops. Blin kin g vigor- ou sly to prod u ce tearin g m ay resu lt in th e lo ss of th e ad m in is- tered m ed ication . Review: Th e p ro ced ure fo r adm in isterin g eye d ro p s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Eye an d Ear Med ication s Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Lilley et al. (2014), p. 128.

764. 1 Ra t ion a le: Wh en an eye drop an d an eye oin tm en t are sch ed- uled to b e adm in istered at th e sam e tim e, th e eye dro p is ad m in istered first. Th e in stillation of two m ed icatio n s is sep a- rated by 3 to 5 m in utes. Test -Ta kin g Str a tegy: Note th e strategic wo rd , best. Focu s o n th e su b ject, th e guid elin es for adm in isterin g eye m edicatio n s. Elim in ate o p tion s 3 an d 4 first because of th e words 15 minutes. Next, th in kin g ab ou t th e co n sisten cy an d ab so rp tion o f a d ro p versu s oin tm en t will direct yo u to th e correct o ptio n . Review: Gu idelin es for ad m in isterin g eye d ro p s an d eye o in tm en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Eye an d Ear Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry et al. (2014), p . 516.

765. 4 Ra t ion a le: O p tion s 1 an d 2 are m iotic agen ts used to treat glau- co m a. O ptio n 3 is an an tiin fective m edicatio n u sed to treat b ac- terial co n jun ctivitis. Atrop in e su lfate is a m yd riatic an d cyclop legic (also an tich o lin ergic) m edicatio n , an d its u se is co n train dicated in clien ts with glauco m a. Mydriatic m ed ica- tion s d ilate th e p up il an d can cause an in crease in in traocular pressure in th e eye. Test-Ta kin g Str a tegy: Focus o n th e su b ject, th e m ed icatio n th at th e n urse should question . Recallin g th e classificatio n s o f the m edicatio n s iden tified in th e o ptio n s will assist in an swerin g th e q uestion . Rem em ber th at m ydriatics dilate th e p up il an d th at th ese m ed icatio ns are con train dicated in glaucom a. Review: Mio tic agen ts u sed to treat glauco m a Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Ph arm aco lo gy—Eye an d Ear Med ication s Pr ior ity Con cepts: Collabo ratio n ; Safety Refer en ces: Bu rch u m , Ro sen th al ( 2016) , p p. 120, 1272–1273; Ign ataviciu s, Wo rkm an (2016), p. 662.

766. 3 Ra t ion a le: Mio tics cau se p up illary con strictio n an d are used to treat glau co m a. Th ey lower th e in traocular p ressu re, th ereby

in creasin g b loo d flo w to th e retin a an d d ecreasin g retin al d am - age an d loss o f vision . Miotics cau se a con traction of th e ciliary m u scle an d a wid en in g of th e trab ecu lar m esh work. O p tion s 1, 2, an d 4 are in co rrect. Test -Ta kin g Str a tegy: No te th at th e clien t h as glauco m a. Recall th at p reven tion of in creased in trao cu lar pressu re is th e go al in th e clien t with glaucom a. O p tio n s 1, 2, an d 4 are co m p arab le o r alike an d d escrib e action s related to m y- d riatic m ed icatio n s, wh ich p rim arily d ilate th e p up ils an d relax th e ciliary m uscles. Review: Th e actio n of a m io tic agen t Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Eye an d Ear Med ication s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ces: Ign ataviciu s, Workm an (2016), p p. 987–988; Lilley et al. ( 2014) , pp . 921–923.

767. 3 Ra t ion a le: Asp irin is co n train d icated for GI b leed in g an d is p o ten tially o toto xic. Th e clien t sh o uld b e ad vised to n otify th e p rescrib in g h ealth care provid er so th e m ed ication can be d iscon tin ued an d/ o r a su bstitu te th at is less to xic to th e ear can b e taken in stead . O p tio n s 1, 2, an d 4 d o n ot h ave effects th at are po ten tially associated with h earin g d ifficulties. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e m ed ication th at m ay b e causin g th e clien t’s com p lain t. Review th e classifi- catio n s an d / or th erapeu tic effects as well as th e sid e an d ad verse effects o f each m ed icatio n in th e o p tion s. O f th e m ed- icatio n s id en tified, o n ly aspirin can cau se oto toxicity. In add i- tion , it is co n train dicated fo r GI b leed . Review: Medicatio n s th at can cause o to to xicity Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ph arm aco lo gy—Eye an d Ear Med ication s Pr ior ity Con cepts: Safety; Sen so ry Percep tion Refer en ce: Ign atavicius, Workm an (2016), p . 765.

768. 3 Ra t ion a le: Cyclop en to late is a rapid ly actin g m yd riatic an d cyclop legic m edicatio n . Cyclop en to late is effective in 25 to 75 m in u tes, an d accom m od ation retu rn s in 6 to 24 h o urs. Cyclo pen tolate is used fo r preo perative m yd riasis, n ot p up il co n strictio n . Th e n u rse sh o uld con sult with th e su rgeo n abo ut th e tim e o f adm in istratio n o f th e eye d ro ps sin ce 15 m in utes is n ot ad equ ate tim e for d ilatio n to occur. Test -Ta kin g Str a tegy: No te th e strategic wo rd , initial. O ptio n s 2 an d 4 are co m p arab le o r alike an d are elim in ated first (m io - sis refers to a co n stricted p up il). No te th at th e q u estion iden - tifies a clien t b ein g p rep ared fo r eye su rgery. Th e p up il would n eed to be dilated for th e surgical procedure. Review: Th e actio n an d p urpo se o f cyclo p en to late Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Eye an d Ear Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Lilley et al. (2014), p. 933.

A

d

u

l

t

E

y

e

/

E

a

r

891CHAPTER 61 Eye and Ear Medications

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l UNIT XVI

Neurological Disorders of the Adult Client

Pyramid to Success

Pyram id Poin ts related to n eurological disorders focus on n ursin g care an d m on itorin g for in creased in tracra- n ial pressure, assessin g level of con sciousn ess, position - in g clien ts, h ead in juries, spin al cord in juries, spin al sh ock, auton om ic dysreflexia, in terven tion s durin g a sei- zure, stroke, Parkin son ’s disease, m yasth en ia gravis, an d th e edroph o n ium test. Focus on th e poin ts related to th e psych o social effects as a result of th e n eurological disor- der, such as an xiety, un expected body im age ch an ges, an d th e appropriate an d available support services n eeded for th e clien t.

Client Needs: Learning Objectives Safe and Effective Care Environment Actin g as a clien t advocate Collab oratin g with th e in terpro fession al h ealth

care team En surin g th at advan ce directives are in th e clien t’s

m edical record En surin g th at in form ed con sen t for in vasive proced ures

h as been obtain ed Establish in g prio rities In itiatin g referrals to appropriate services Main tain in g asepsis with proced ures an d treatm en ts Main tain in g con fiden tiality Main tain in g stan dard , tran sm ission -b ased, an d oth er

precaution s Preven tin g acciden ts th at can occur as a result of n euro-

logical deficits Uph oldin g clien t righ ts

Health Promotion and Maintenance Discussin g exp ected an d un exp ected body im age

ch an ges resultin g from n eurological deficits Perform in g n eurological assessm en t usin g various

tech n iqu es Preven tin g an d detectin g h ealth problem s associated

with n eurological deficits Providin g h om e care in struction s regardin g care related

to th e n eurological disorder Teach in g about th e im portan ce of prescribed th erap y

Psychosocial Integrity Addressin g grief an d loss issues Assessin g th e ability to cope with feelin gs of isolation

an d loss of in depen den ce Con siderin g th e cultural, religious, an d spiritual in flu-

en ces of th e clien t wh en plan n in g care Iden tifyin g sen sory an d percep tual alteration s Iden tifyin g supp ort system s an d en couragin g th e use of

com m un ity resou rces Mobilizin g copin g m ech an ism s

Physiological Integrity Adm in isterin g ph arm aco logical th erap y Main tain in g n utrition Mon itorin g for alteration s in body system s Mon itorin g for co m plication s related to proced ures Mon itorin g for fluid an d electrolyte im balan ces Prom otin g n orm al elim in ation pattern s Prom otin g self-care m easures Providin g assistive devices for m ob ility Providin g em ergen cy care Providin g m easu res to prom o te com fort

892

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

C H A P T E R 62 Neurological System

PRIORITY CONCEPTS Functional Ability; Intracranial Regulation

CRITICAL THINKING What Should You Do? The nurse notes that a client who experienced a stroke is sit- ting in a chair and is leaning to the left with the arm caught in the side of the chair seat. The nurse suspects unilateral body neglect syndrome. What should the nurse do? Answer located on p. 916.

I. Anatomy and Physiology of the Brain and Spinal Cord A. Cerebru m

1. Th e cerebru m co n sists of th e righ t an d left h em isph eres.

2. Each h em isph ere receives sen sory in form ation from th e opposite side of th e body an d con trols th e skeletal m uscles of th e opposite side.

3. Th e cerebrum go vern s sen sory an d m oto r activ- ity an d th ough t an d learn in g.

B. Cerebral cortex (Box 62-1) 1. Th e cerebral cortex is th e outer gray layer; it is

divided in to 5 lo bes. 2. It is respo n sible for th e con scious activities of th e

cerebru m . C. Basal gan glia: Cell bodies in wh ite m atter th at h elp

th e cerebral cortex to produ ce sm oo th vo lun tary m ovem en ts

D. Dien cep h alon 1. Th alam us

a. Relays sen sory im pulses to th e co rtex b . Provides a pain gate c. Part of th e reticular activatin g system

2. Hypoth alam u s a. Regulates auton om ic respon ses of th e sym pa-

th etic an d parasym path etic n ervous system s b . Regulates th e stress respon se, sleep, appetite,

body tem p erature, fluid balan ce, an d em otion s

c. Respon sible for th e production of h orm on es secreted by th e pituitary glan d an d th e h ypoth alam us

E. Brain stem 1. Midbrain

a . Resp on sible for m oto r coordin ation b . Con tain s th e visual reflex an d auditory relay

cen ters 2. Pon s: Con tain s th e respiratory cen ters an d regu-

lates breath in g 3. Medulla oblon gata

a . Con tain s all afferen t an d efferen t tracts an d cardiac, respiratory, vo m itin g, an d vasom o- tor cen ters

b . Con trols h eart rate, respiration , blood vessel diam eter, sn eezin g, swallowin g, vom itin g, an d cough in g

F. Cerebellum : Coordin ates m uscle m ovem en t, pos- ture, equilibrium , an d m uscle ton e

G. Spin al cord 1. Provides n euron an d syn apse n etworks to

produce in volun tary respo n ses to sen sory stim ulation

2. Con trols body m ovem en t an d regulates visceral fun ction

3. Carries sen sory in form ation to an d m otor in for- m ation fro m th e brain

4. Exten ds from th e first cervical to th e secon d lum - bar vertebra

5. Protected by th e m en in ges, cerebrospin al fluid (CSF), an d adipose tissue

6. Horn s a . In n er colum n of gray m atter; con tain s 2 an te-

rior an d 2 posterior h orn s b . Posterior h orn s con n ect with afferen t (sen -

sory) n erve fib ers. c. An terior h orn s co n tain efferen t (m otor)

n erve fibers. 7. Nerve tracts

a . Wh ite m atter con tain s th e n erve tracts. b . Ascen din g tracts (sen sory path way) c. Descen din g tracts (m otor path way)

H. Men in ges 1. Th e dura m ater is a tough an d fibrous

m em bran e. 893

2. Th e arach n oid m em bran e is a delicate m em - bran e an d con tain s CSF.

3. Th e pia m ater is a vascu lar m em bran e. 4. Th e subarach n oid space is form ed by th e arach -

n oid m em bran e an d th e pia m ater. I. Cerebrospin al flu id (CSF)

1. Secreted in th e ven tricles; circulates in th e sub- arach n oid space an d th rou gh th e ven tricles to th e subarach n oid space of th e m en in ges, wh ere it is reabsorb ed

2. Acts as a protective cush ion ; aids in th e exch an ge of n utrien ts an d wastes

3. Norm al pressure is 50 to 175 m m H 2O . 4. Norm al volum e is 125 to 150 m L.

J. Ven tricles 1. Four ven tricles 2. Th e ven tricles com m un icate between th e sub-

arach n oid spaces an d produce an d circulate CSF. K. Bloo d supply

1. Righ t an d left in tern al carotid arteries 2. Righ t an d left vertebral arteries 3. Th ese arteries supply th e brain via an an astom osis

at the base of th e brain called th e circle of Willis. L. Neurotran sm itters

1. Acetylch olin e 2. Norepin eph rin e 3. Dopam in e 4. Seroton in 5. Am in o acids 6. Polypep tides

M. Neuron s 1. Th e n euron con sists of th e cell body, axon , an d

den drites. 2. Th e cell body con tain s th e n ucleus.

3. Neuron s carryin g im pulses from th e periph eral n ervous system to th e cen tral n ervous system (CNS) are called sensory neurons.

4. Neuron s carryin g im pulses away from th e CNS are called motor neurons.

5. Syn apse is th e ch em ical tran sm ission of im pulses from 1 n euron to an oth er.

N. Axon s an d den drites 1. Th e axon con d ucts im pulses from th e cell body. 2. Th e den drites receive stim uli from th e body an d

tran sm it th em to th e axon . 3. Th e n euron s are protected an d in sulated by

Sch wan n cells. 4. Th e Sch wan n cell sh eath is called th e neurolemma. 5. Neuron s do n ot reproduce after th e n eon atal

period. 6. If an axon or den drite is dam aged, it will die an d

be replaced slowly on ly if th e n eurolem m a is in tact an d th e cell body h as n ot died.

O. Spin al n erves 1. Th ere are 31 pairs of spin al n erves. 2. Mixed n erve fibers are form ed by th e join in g of

th e an terior m otor an d posterior sen sory roots. 3. Posterior ro ots con tain afferen t (sen sory) n erve

fib ers. 4. Anterior roots contain efferent (m otor) n erve fibers.

P. Auton om ic n ervous system 1. Sym pathetic (adren ergic) fibers dilate pupils,

in crease h eart rate and rh ythm , con tract blood vessels, an d relax sm ooth m uscles of th e bronch i.

2. Parasym path etic (ch olin ergic) fibers produce th e oppo site effect.

II. Diagnostic Tests A. Skull an d spin al radiograph y

1. Description a . Radio graph s of th e sku ll reveal th e size an d

sh ape of th e skull bon es, suture separation in in fan ts, fractures or bon y defects, erosion , an d calcification .

b . Spin al radiograph s iden tify fractures, disloca- tion , com pression , curvature, erosion , n ar- rowed spin al cord, an d degen erative processes.

2. Preprocedure in terven tion s a . Provid e n ursin g support for th e con fused,

com bative, or ven tilator-depen den t clien t. b . Main tain im m ob ilization of th e n eck if a spi-

n al fracture is susp ected. c. Rem o ve m etal item s from th e clien t. d . If th e clien t h as th ick an d h eavy h air, th is

sh ould be docum en ted, because it could affect in terp retation of th e x-ray film .

3. Postp rocedure in terven tion : Main tain im m ob ili- zation un til results are kn own .

Always check with the client about the possibility of pregnancy before any radiographic procedures are done.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-1 Cerebral Cortex Frontal Lobe ▪ Broca’s area for production of speech ▪ Morals, emotions, reasoning and judgment, concentra-

tion, and abstraction

Parietal Lobe ▪ Interpretation of taste, pain, touch, temperature, and

pressure ▪ Spatial perception Temporal Lobe ▪ Auditory center ▪ Wernicke’s area for comprehension of speech Occipital Lobe ▪ Visual area Limbic System ▪ Emotional and visceral patterns for survival ▪ Learning and memory

894 UNIT XVI Neurological Disorders of the Adult Client

B. Com p uted tom o graph y (CT) 1. Descriptio n

a . A type of brain scan n in g th at m ay or m ay n ot require in jection of a dye.

b . It is used to detect in tracran ial bleedin g, space-o ccupyin g lesion s, cerebral edem a, in farction s, h ydroceph alus, cerebral atrop h y, an d sh ifts of brain structures.

An informed consent is needed for anyinvasive proce- dure, including those that use a contrast medium (dye).

2. Preprocedure in terven tion s a . Assess for allergies to iodin e, con trast dyes, or

sh ellfish if a dye is used. b . Assess ren al fun ctio n an d verify co n trast dose

with th e ph arm acy. c. In struct th e clien t of th e n eed to lie still an d

flat durin g th e test. d . In struct th e clien t to h old h is or h er breath

wh en requested. e. In itiate an in traven o us lin e with th e appropri-

ate gauge size if prescribed. f. Rem o ve objects from th e h ead, such as wigs,

barrettes, earrin gs, an d h airpin s. g. Assess for claustroph obia. h . In form th e clien t of possible m ech an ical

n oises as th e scan n in g occurs. i. In form th e clien t th at th ere m ay be a h ot,

flush ed sen sation an d a m etallic taste in th e m ou th wh en th e dye is in jected.

j. No te th at som e clien ts m ay be given th e dye even if th ey report an allergy; th ey m ay be treated with an an tih istam in e an d corticoster- oids before th e in jection to reduce th e severity of a reactio n .

Assess the need to withhold metformin if iodinated contrast dye is used for a diagnostic procedure because of the risk for metformin-induced lactic acidosis.

3. Postp rocedu re in terven tion s a . Provide replacem en t fluids because diuresis

from th e dye is expected. b . Mon itor for an allergic reaction to th e dye. c. Assess th e dye in jection site for bleedin g or

h em atom a, an d m on itor th e extrem ity for color, warm th , an d th e presen ce of distal pulses.

C. Magn etic reson an ce im agin g (MRI) 1. Descriptio n

a . A n on in vasive proced ure th at id en tifies tis- sues, tum o rs, an d vascu lar ab n orm alities.

b . It is sim ilar to CT scan n in g but provides m ore detailed pictures.

2. Preprocedure in terven tion s a . Rem o ve all m etal objects from th e clien t. b . Determ in e wh eth er th e clien t h as a pace-

m aker, im plan ted defibrillator, or oth er m etal im plan ts such as a h ip prosth esis or

vascu lar clips because th ese clien ts can n ot h ave th is test perform ed.

c. In sert an in term itten t in fusion device (salin e lock) to all in traven o us accesses prior to th e proced ure (in traven ou s flu id pum ps are n ot allowed in th e MRI room ).

d . Provid e precaution s for th e clien t wh o is attach ed to a pulse oxim eter because it can cause a burn durin g testin g if coiled arou n d th e body or a body part.

e. Provid e an assessm en t of th e clien t with claustroph obia (m ay n ot be n ecessary if an open MRI m ach in e is used).

f. Adm in ister m ed ication as prescribed for th e clien t with claustro ph obia.

g. Determ in e wh eth er a con trast agen t is to be used an d follo w th e prescription related to th e adm in istration of food , fluids, an d m ed- ication s. Verify allergies an d ren al fun ctio n prior to adm in istration .

h . In struct th e clien t th at h e or sh e will n eed to rem ain still durin g th e proced ure.

An MRI is contraindicated in a pregnant woman because the increase in amniotic fluid temperature that occurs during the procedure may be harmful to the fetus.

3. Postp rocedu re in terven tion s a . Th e clien t m ay resum e n orm al activities. b . In crease flu id in take an d expect diuresis if a

con trast agen t is used. D. Lum bar pun cture

1. Description a . In sertion of a spin al n eedle th rou gh th e

L3–L4 in tersp ace in to th e lu m bar subarach - n oid space to obtain CSF; m easu re CSF fluid or pressure; or in still air, dye, or m ed ication s

b . Th e test is con train dicated in clien ts with increased intracranial pressure (ICP) because th e procedure will cau se a rapid decrease in pressure in th e CSF arou n d th e spin al cord, leadin g to brain h ern iation .

2. Preprocedure in terven tion s: Have th e clien t em p ty th e bladder.

3. In terven tion s durin g th e procedure a . Position th e clien t in a lateral recum b en t

position an d h ave th e clien t draw th e kn ees up to th e ab dom en an d th e ch in on to th e ch est; th e pron e position m ay be required for radiolo gically guid ed pun ctures.

b . Assist with th e collection of specim en s (label th e specim en s in seq uen ce).

c. Main tain strict asepsis. 4. Postp rocedu re in terven tion s

a . Mon itor vital sign s an d n eurological sign s to ch eck for th e presen ce of leakage of CSF an d also m on itor for h eadach e.

b . Position th e clien t flat as prescribed.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

895CHAPTER 62 Neurological System

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

c. En courage fluids to replace CSF obtain ed from th e specim en collection or from leakage.

d . Mon itor in take an d output. E. Cereb ral an giograph y

1. Description : In jection of a con trast m aterial usu- ally th rou gh th e fem oral artery (or an oth er artery) in to th e carotid arteries to visualize th e cerebral arteries an d assess for lesion s

2. Preprocedure in terven tion s a. Assess th e clien t for allergies to iodin e an d

sh ellfish . Assess ren al fun ction . b . Assess for a m edication h isto ry of an ti-

coagu lation th erap y; with h old th e an ticoagu- lan t m ed ication prior to th e proced ure as prescribed.

c. En cou rage h ydration for 2 days before th e test.

d . Main tain th e clien t on NPO (n oth in g by m ou th ) status 4 to 6 h ours befo re th e test as prescribed.

e. Perform a n eurological assessm en t, wh ich will serve as a baselin e for postprocedure assessm en ts.

f. Mark th e periph eral pulses. g. Rem o ve m etal item s from th e h air. h . Adm in ister prem edication as prescribed .

3. Postp rocedu re in terven tion s a. Mon itor n eurological status, vital sign s, an d

n eurovascular status of th e affected extrem ity frequen tly un til stable.

b . Mon itor for swellin g in th e n eck an d for dif- ficulty swallowin g; n otify a h ealth care pro- vider (HCP) if th ese sym pto m s occur.

c. Main tain bed rest for 12 h ours as prescribed. d . Elevate th e h ead of th e bed 15 to 30 degrees

on ly if prescribed. e. Keep th e bed flat, as prescribed, if th e fem oral

artery is used. f. Assess periph eral pulses. g. Apply san dbags or an oth er device to im m obi-

lize th e lim b an d a pressure dressin g to the in jec- tion site to decrease bleedin g as prescribed.

h . Place ice on th e pun cture site as prescribed. i. En cou rage fluid in take.

F. Electroen cep h alograph y 1. Description : Graph ic recordin g of th e electrical

activity of th e superficial layers of th e cerebral cortex

2. Preprocedure in terven tion s a. Wash th e clien t’s h air. b . In form th e clien t th at electrodes are attach ed

to th e h ead an d th at electricity does n ot en ter th e h ead.

c. With h old stim ulan ts such as coffee, tea, an d caffein e beverages; an tidepressan ts; tran quil- izers; an d possib ly an tiseizure m edicato n s for 24 to 48 h ours before th e test as prescribed.

d . Allow th e clien t to h ave breakfast if prescribed.

e. Prem edicate for sedation as prescribed. 3. Postp rocedure in terven tion s

a . Wash th e clien t’s h air. b . Main tain safety precaution s, if th e clien t was

sedated. G. Calo ric testin g (oculovestibu lar reflex)

1. Description : Caloric testin g provides in form a- tion about th e fun ctio n of th e vestibular portion of cran ial n erve VIII an d aids in th e diagn osis of cerebellar an d brain stem lesion s.

2. Proced ure a . Paten cy of th e extern al auditory can al is

con firm ed. b . Th e clien t is position ed supin e with th e h ead

of th e bed elevated 30 degrees. c. Water th at is warm er or cooler th an body

tem perature is in fused in to th e ear. d . A n orm al respon se is th e on set of vertigo an d

n ystagm u s (in vo lun tary eye m ovem en ts) with in 20 to 30 secon ds.

e. Absen t or discon jugate eye m ovem en ts in di- cate brain stem dam age.

III. Neurological Assessment (see Chapter 15 for addi- tional information on neurological assessment)

A. Assessm en t of risk factors 1. Traum a 2. Hem orrh age 3. Tu m ors 4. In fection 5. To xicity 6. Metab olic disorders 7. Hypo xic con dition s 8. Hyperten sion 9. Cigarette sm okin g

10. Stress 11. Agin g process 12. Ch em icals, eith er in gestion or en viron m en tal

exp osure B. Assessm en t of cran ial n erves (see Ch apter 15) C. Assessm en t of level of con sciousn ess (LO C) (see

Ch apter 15)

Level of consciousness is the most sensitive indica- tor of neurological status.

D. Assessm en t of vital sign s: Mon itor for blood pressure or pulse ch an ges, wh ich m ay in dicate in creased ICP.

E. Assessm en t of respiration s ( Box 62-2) F. Assessm en t of tem perature

1. An elevated tem p erature in creases th e m etabolic rate of th e brain .

2. An elevation in tem perature m ay in dicate a dys- fun ction of th e h ypo th alam us or brain stem .

3. A slow rise in tem perature m ay in dicate in fection .

896 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

G. Assessm en t of pupils ( Fig. 62-1) 1. Un ilateral pupil dilation in dicates com pression

of cran ial n erve III. 2. Midpo sition fixed pupils in dicate m idbrain

in jury. 3. Pin poin t fixed pupils in dicate pon tin e dam age.

H. Assessm en t for postu rin g (see Ch apter 42, Fig. 42-3) 1. Posturin g in dicates a deterioration of th e

con ditio n . 2. Flexor ( decorticate posturing)

a . Clien t flexes 1 or both arm s on th e ch est an d m ay exten d th e legs stiffly.

b . Flexo r posturin g in dicates a n on fu n ction in g cortex.

3. Exten so r (decerebrate posturing) a . Clien t stiffly exten ds 1 or both arm s an d pos-

sibly th e legs. b . Exten sor postu rin g in dicates a brain stem

lesion . 4. Flaccid posturing: Clien t displays n o m oto r

respon se in an y extrem ity. I. Assessm en t of reflexes ( Box 62-3) J. Assessm en t of m en in geal irritatio n ( Box 62-4)

K. Assessm en t of th e auton om ic system 1. Sym path etic fun ctio n s, adren ergic respo n ses

a . In creased pulse an d blood pressure b . Dilated pupils c. Decreased peristalsis d . In creased persp iration

2. Parasym path etic fun ctio n , ch olin ergic respon ses a . Decreased pulse an d blood pressure b . Con stricted pupils c. In creased salivation d . In creased peristalsis e. Dilated blood vessels f. Bladder con traction

L. Assessm en t of sen sory fun ction : To uch , pressure, pain

M. Glasgow Com a Scale (Box 62-5) 1. Th e scale is a m eth od of assessin g a clien t’s n eu-

rological con d ition .

BOX 62-2 Assessment of Respirations Cheyne-Stokes ▪ Rhythmic, with periods of apnea ▪ Can indicate a metabolic dysfunction or dysfunction in the

cerebral hemisphere or basal ganglia

Neurogenic Hyperventilation ▪ Regular rapid and deep sustained respirations ▪ Indicates a dysfunction in the low midbrain and middle

pons

Apneustic ▪ Irregular respirations, with pauses at the end of inspiration

and expiration ▪ Indicates a dysfunction in the middle or caudal pons Ataxic ▪ Totally irregular in rhythm and depth ▪ Indicates a dysfunction in the medulla Cluster ▪ Clusters of breaths with irregularly spaced pauses ▪ Indicates a dysfunction in the medulla and pons

P upils e qua l a nd re a ct norma lly

P upil re a cts to light (bris kly or s lowly)

Dila te d pupil (compre s s e d cra nia l

ne rve III)

P inpoint pupils (pons da ma ge or drugs )

Bila te ra l dila te d, fixe d pupils

(ominous s ign)

FIGURE 62-1 Pupillary check for size and response.

BOX 62-3 Assessment of Reflexes Babinski Reflex ▪ Dorsiflexion of the big toe, and fanning of the other toes;

elicited by firmly stroking the lateral aspect of the sole of the foot

▪ Is a pathological or abnormal reflex in anyone older than 2 years and represents the presence of central nervous system (CNS) disease

Corneal (Blink) Reflex ▪ Involuntary closure of the eyelids in response to stimula-

tion of the cornea ▪ Loss of the blink reflex indicates a dysfunction of cranial

nerve V.

Gag Reflex ▪ Contraction of pharyngeal muscle, elicited by touching the

back of the throat ▪ Loss of the gag reflex indicates a dysfunction of cranial

nerves IX and X.

897CHAPTER 62 Neurological System

2. Th e scorin g system is based on a scale of 3 to 15 poin ts.

3. Ascore lower than 8 in dicates th at com a is presen t.

IV. The Unconscious Client A. Description

1. Th e un co n sciou s clien t is in a state of depressed cerebral fun ction in g with un respon siven ess to stim ulation of sen sory an d m otor fun ction .

2. Som e causes in clude h ead traum a, cerebral toxin s, sh ock, h em orrh age, tum or, an d in fectio n .

B. Assessm en t 1. Un arousable 2. Prim itive or n o respo n se to pain ful stim uli 3. Altered respiration s 4. Decreased cran ial n erve an d reflex activity

C. In terven tion s ( Box 62-6)

V. Increased Intracranial Pressure (ICP) A. Description

1. In creased ICP m ay be cau sed by traum a, h em or- rh age, growth s or tum o rs, h ydroceph alus, edem a, or in flam m ation .

2. In creased ICP can im pede circulation to th e brain , im pede th e absorption of CSF, affect th e fun ction in g of n erve cells, an d lead to brain stem com pression an d death .

B. Assessm en t 1. Altered level of con sciousn ess, wh ich is th e

m ost sen sitive an d earliest in dication of in creasin g ICP

2. Headach e 3. Abn orm al respiration s (see Box 62-2) 4. Rise in blood pressure with widen in g pulse

pressure 5. Slowin g of pulse 6. Elevated tem p erature 7. Vom itin g 8. Pupil ch an ges 9. Late sign s of in creased ICP in clude in creased

systolic blood pressure, widen ed pulse pressure, an d slowed h eart rate.

10. O th er late sign s in clude ch an ges in m otor fun c- tion from weakn ess to h em iplegia, a positive Babinski reflex, decorticate or decerebrate pos- turin g, an d seizures.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-4 Assessment of Meningeal Irritation General Findings ▪ Irritability ▪ Nuchal rigidity ▪ Severe, unrelenting headaches ▪ Generalized muscle aches and pains ▪ Nausea and vomiting ▪ Fever and chills ▪ Tachycardia ▪ Photophobia ▪ Nystagmus ▪ Abnormal pupil reaction and eye movement Brudzinski’s Sign ▪ Involuntary flexion of the hip and knee when the neck is pas-

sively flexed; indicates meningeal irritation

Kernig’s Sign ▪ Loss of the ability of a supine client to straighten the leg

completely when it is fully flexed at the knee and hip; indi- cates meningeal irritation

Motor Response ▪ Hemiparesis, hemiplegia, and decreased muscle tone ▪ Cranial nerve dysfunction, especially cranial nerves III, IV, VI,

VII, and VIII

Memory Changes ▪ Short attention span ▪ Personality and behavioral changes ▪ Bewilderment

BOX 62-5 Glasgow Coma Scale Score ▪ The lowest possible score is 3 points (deep coma or death). ▪ The highest possible score is 15 points (fully awake). Motor Response Points ▪ Obeys a simple response ¼6 ▪ Localizes painful stimuli¼5 ▪ Normal flexion (withdrawal) ¼4 ▪ Abnormal flexion (decorticate posturing) ¼3 ▪ Extensor response (decerebrate posturing) ¼2 ▪ No motor response to pain ¼1

Verbal Response Points ▪ Oriented ¼5 ▪ Confused conversation ¼4 ▪ Inappropriate words ¼3 ▪ Responds with incomprehensible sounds ¼2 ▪ No verbal response¼1 Eye-Opening Points ▪ Spontaneous ¼4 ▪ In response to sound ¼3 ▪ In response to pain ¼2 ▪ No response, even to painful stimuli¼1

Data from Ignatavicius D, Workman M: Medical-surgical nursing: patient-centered collaborative care, ed 7, St. Louis, 2013, Saunders.

898 UNIT XVI Neurological Disorders of the Adult Client

C. In terven tion s 1. Mon itor respiratory status an d preven t h ypoxia. 2. Avo id th e ad m in istration of m orph in e sulfate to

preven t th e occurren ce of h ypo xia. 3. Main tain m ech an ical ven tilation as prescribed;

m ain tain in g th e PaCO 2 at 30 to 35 m m Hg (30 to 35 m m Hg) will result in vaso con stric- tio n of th e cerebral blood vessels, decreased blood flow, an d th erefore decreased ICP.

4. Main tain body tem p erature. 5. Preven t sh iverin g, wh ich can in crease ICP. 6. Decrease en viron m en tal stim uli. 7. Mon itor electrolyte levels an d acid-b ase balan ce. 8. Mon itor in take an d outp ut. 9. Lim it flu id in take to 1200 m L/ d ay.

10. In struct th e clien t to avoid strain in g activities, such as cough in g an d sn eezin g.

11. In struct th e clien t to avoid Valsalva’s m an euver.

For the client with increased ICP, elevate the head of the bed 30 to 40 degrees, avoid the Trendelenburg posi- tion, and prevent flexion of the neck and hips.

D. Med ication s (Box 62-7) E. Surgical in terven tion : Also see Ch apter 42 for addi-

tion al in form ation on ven triculop eriton eal sh un ts ( Box 62-8)

VI. Hyperthermia A. Descrip tion

1. Tem perature h igh er th an 105 °F (40.6 °C), wh ich in creases th e cerebral m etab olism an d in creases th e risk of h ypo xia

2. Causes in clude in fectio n , h eat stroke, exposu re to h igh en viron m en tal tem p eratures, an d dys- fun ction of th e th erm oregulatory cen ter.

B. Assessm en t 1. Tem perature h igh er th an 105 °F (40.6 °C) 2. Sh iverin g 3. Nausea an d vom itin g

C. In terven tion s 1. Main tain a paten t airway. 2. In itiate seizu re precaution s. 3. Mon itor in take an d output an d assess th e

skin an d m ucous m em bran es for sign s of deh ydration .

4. Mon itor lun g soun ds. 5. Mon itor for dysrh yth m ias. 6. Assess p erip h eral p u lses fo r system ic b lo o d

flo w. 7. In duce n orm oth erm ia with fluid s, cool bath s,

fan s, or a h ypo th erm ia blan ket. D. In ducem en t of n orm oth erm ia

1. Preven t sh iverin g, wh ich will in crease ICP an d oxygen con sum p tion .

2. Adm in ister m ed ication s as prescribed to preven t sh iverin g an d to lower body tem perature.

3. Mon itor n eurological status. 4. Mon itor for in fectio n an d respiratory com plica-

tion s because h yperth erm ia m ay m ask th e sign s of in fectio n .

5. Mon itor for cardiac dysrh yth m ias. 6. Mon itor in take an d outp ut an d fluid balan ce. 7. Preven t traum a to th e skin an d tissues. 8. Apply lotion to th e skin frequen tly.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-6 Care of the Unconscious Client

Assess patency of the airway and keep airway and emergency equipment readily available.

Monitor blood pressure, pulse, and heart sounds. Assess respiratory and circulatory status. Do not leave the client unattended if unstable. Maintain a patent airway and ventilation because a high

carbon dioxide (CO2) level increases intracranial pressure. Assess lung sounds for the accumulation of secretions; suction

as needed. Assess neurological status, including level of consciousness,

pupillary reactions, and motor and sensory function, using a coma scale.

Place the client in a semi-Fowler’s position. Change position of the client every 2 hours, avoiding injury

when turning. Avoid Trendelenburg position. Use side rails unless contraindicated or according to agency

protocol. Assess for edema. Monitor for dehydration. Monitor intake and output and daily weight. Maintain NPO (nothing by mouth) status until consciousness

returns.

Maintain nutrition as prescribed (intravenous or enteral feedings), and monitor fluid and electrolyte balance (when consciousness returns, checkthe gag and swallowreflexbefore resuming a diet).

Assess bowel sounds. Monitor elimination patterns. Monitor for constipation, impaction, and paralytic ileus. Maintain urinary output to prevent stasis, infection, and calcu-

lus formation. Monitor the status of skin integrity. Initiate measures to prevent skin breakdown. Provide frequent mouth care. Remove dentures and contact lenses. Assess the eyes for the presence of a corneal reflex and irritation,

and instill artificial tears or cover the eyes with eye patches. Monitor drainage from the ears or nose for the presence of

cerebrospinal fluid. Assume that the unconscious client can hear. Avoid restraints. Initiate seizure precautions if necessary. Provide range-of-motion exercises to prevent contractures. Use a footboard or high-topped sneakers to prevent footdrop. Use splints to prevent wrist deformities. Initiate physical therapy as appropriate.

899CHAPTER 62 Neurological System

9. In spect for frostbite if a h ypo th erm ia blan ket is used.

VII. Traumatic Head Injury A. Descrip tion

1. Head in jury is traum a to th e skull, resultin g in m ild to exten sive dam age to th e brain .

2. Im m ed iate com plication s in clude cerebral bleed- in g, h em atom as, un con tro lled in creased ICP, in fectio n s, an d seizu res.

3. Ch an ges in perso n ality or beh avior, cran ial n erve deficits, an d an y oth er residual deficits dep en d on th e area of th e brain dam age an d th e exten t of th e dam age.

B. Types of h ead in ju ries (Box 62-9) 1. O pen

a . Scalp laceration s

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-7 Medications for Increased Intracranial Pressure

Antiseizure Seizures increase metabolic requirements and cerebral blood

flow and volume, thus increasing intracranial pressure (ICP).

Medications may be given prophylactically to prevent seizures.

Antipyretics and Muscle Relaxants Temperature reduction decreases metabolism, cerebral blood

flow, and thus ICP. Antipyretics prevent temperature elevations. Muscle relaxants prevent shivering.

Blood Pressure Medication Blood pressure medication may be required to maintain cere-

bral perfusion at a normal level. Notify the health care provider if the blood pressure range is

lower than 10 0 or higher than 150 mm Hg systolic.

Corticosteroids Corticosteroids stabilize the cell membrane and reduce leak-

iness of the blood-brain barrier. Corticosteroids decrease cerebral edema. A histamine blocker may be administered to counteract the

excess gastric secretion that occurs with the corticosteroid. Clients must be withdrawn slowly from corticosteroid therapy

to reduce the risk of adrenal crisis.

Intravenous Fluids Fluids are administered intravenously via an infusion pump to

control the amount administered. Infusions are monitored closely because of the risk of promot-

ing additional cerebral edema and fluid overload.

Hyperosmotic Agent A hyperosmotic agent increases intravascular pressure by

drawing fluid from the interstitial spaces and from the brain cells.

Monitor renal function. Diuresis is expected.

BOX 62-8 Surgical Intervention for Chronic Increased Intracranial Pressure: Ventriculoperitoneal Shunt

Description A ventriculoperitoneal shunt diverts cerebrospinal fluid from

the ventricles into the peritoneum.

Postprocedure Interventions Position the client supine and turn from the back to the non-

operative side. Monitor for signs of increasing intracranial pressure resulting

from shunt failure. Monitor for signs of infection.

BOX 62-9 Types of Head Injuries Concussion ▪ Concussion is a jarring of the brain within the skull; there

may or may not be a loss of consciousness.

Contusion ▪ Contusion is a bruising type of injury to the brain tissue. ▪ Contusion may occur along with other neurological injuries,

such as with subdural or extradural collections of blood.

Skull Fractures ▪ Linear ▪ Depressed ▪ Compound ▪ Comminuted Epidural Hematoma ▪ The most serious type of hematoma, epidural hematoma

forms rapidly and results from arterial bleeding. ▪ The hematoma forms between the dura and skull from a

tear in the meningeal artery. ▪ It is often associated with temporary loss of conscious-

ness, followed by a lucid period that then rapidly pro- gresses to coma.

▪ Epidural hematoma is a surgical emergency. Subdural Hematoma ▪ Subdural hematoma forms slowly and results from a

venous bleed. ▪ It occurs under the dura as a result of tears in the veins

crossing the subdural space.

Intracerebral Hemorrhage ▪ Intracerebral hemorrhage occurs when a blood vessel within

the brain ruptures, allowing blood to leak inside the brain.

Subarachnoid Hemorrhage ▪ A subarachnoid hemorrhage is bleeding into the subarach-

noid space. It may occur as a result of head trauma or spon- taneously, such as from a ruptured cerebral aneurysm.

900 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

b . Fractu res in th e sku ll c. In terruption of th e dura m ater

2. Clo sed a . Con cussion s b . Con tusion s c. Fractu res

C. Hem atom a 1. Description : A collectio n of blood in th e tissues

th at can occur as a result of a subarach n oid h em - orrh age or an in tracerebral h em orrh age.

2. Assessm en t a. Assessm en t fin din gs depen d on th e in jury. b . Clin ical m an ifestation s usually result from

in creased ICP. c. Ch an gin g n eurological sign s in th e clien t d . Ch an ges in level of co n sciousn ess e. Airway an d breath in g pattern ch an ges f. Vital sign s ch an ge, reflectin g in creased ICP. g. Headach e, n ausea, an d vo m itin g h . Visual disturban ces, pupillary ch an ges, an d

papilledem a i. Nuchal rigidity (n ot tested un til spin al cord

in jury is ruled out) j. CSF drain age fro m th e ears or n ose

k . Weakn ess an d paralysis l. Posturin g

m . Decreased sen sation or absen ce of feelin g n . Reflex activity ch an ges o . Seizu re activity

CSF can be distinguished from other fluids by the presence of concentric rings (bloody fluid surrounded by yellowish stain; halo sign) when the fluid is placed on a white sterile background, such as a gauze pad. CSF also tests positive for glucose when tested using a strip test.

3. In terven tion s a. Mon itor respiratory status an d m ain tain a

paten t airway because in creased carbo n diox- ide (CO 2) levels in crease cerebral edem a.

b . Mon itor n eurological status an d vital sign s, in cludin g tem p erature.

c. Mon itor for in creased ICP. d . Main tain h ead elevation to reduce ven o us

pressure. e. Preven t n eck flexion . f. In itiate n orm oth erm ia m easu res for

in creased tem p erature. g. Assess cran ial n erve fun ction , reflexes, an d

m oto r an d sen sory fun ction . h . In itiate seizure precaution s. i. Mon itor for pain an d restlessn ess. j. Morph in e sulfate m ay be prescribed to

decrease agitation an d con trol restlessn ess caused by pain for th e h ead-in jured clien t on a ven tilator; adm in ister with caution because it is a respiratory depressan t an d m ay in crease ICP.

k . Mon itor for drain age from th e n ose or ears because th is fluid m ay be CSF.

l. Do n ot attem pt to clean th e n ose, suction , or allow th e clien t to blow h is or h er n ose if drain age occurs.

m . Do n ot clean th e ear if drain age is n oted, but apply a lo ose, dry sterile dressin g.

n . Ch eck drain age for th e presen ce of CSF. o . Notify th e HCP if drain age from th e ears or

n ose is n oted an d if th e drain age tests posi- tive for CSF.

p . In struct th e clien t to avoid cough in g because th is in creases ICP.

q . Mon itor for sign s of in fectio n . r . Preven t com plication s of im m ob ility. s. In form th e clien t an d fam ily about th e possi-

ble beh avio r ch an ges th at m ay occur, in clud- in g th o se th at are expected an d th ose th at n eed to be reported.

D. Cran iotom y 1. Description

a. Surgical proced ure th at in volves an in cision th rou gh th e cran iu m to rem ove accum ulated blood or a tum o r

b . Com p lication s of th e procedure in clude in creased ICP fro m cerebral edem a, h em or- rh age, or obstru ction of th e n orm al flow of CSF.

c. Addition al com plication s in clude h em ato- m as, h ypo volem ic sh ock, h ydroceph alus, respiratory an d n eurogen ic com plication s, pulm o n ary edem a, an d woun d in fectio n s.

d . Com p lication s related to fluid an d electrolyte im balan ces in clude diabetes in sipidus an d in approp riate secretio n of an tidiuretic h orm on e.

e. Stereo tactic radiosurgery (SRS) m ay be an altern ative to tradition al surgery an d is usu- ally used to treat tum o rs an d arterioven ous m alform ation s.

2. Preop erative in terven tion s a. Explain th e proced ure to th e clien t an d

fam ily. b . Prepare to sh ave th e clien t’s h ead as pre-

scribed (usually don e in th e operatin g room ) an d cover th e h ead with an appropriate coverin g.

c. Stabilize th e clien t befo re surgery. 3. Posto perative in terven tion s ( Box 62-10) 4. Posto perative position in g (Box 62-11)

VIII. Spinal Cord Injury A. Descriptio n

1. Traum a to th e spin al cord cau ses partial or com - plete disruption of th e n erve tracts an d n euron s.

2. Th e in jury can in volve con tusion , laceration , or com pression of th e cord.

901CHAPTER 62 Neurological System

3. Spin al cord edem a develops; n ecrosis of th e spin al cord can develo p as a result of com - prom ised cap illary circulation an d ven ous return .

4. Loss of m otor fun ction , sen sation , reflex activity, an d bowel an d bladder con tro l m ay result.

5. Th e m ost com m on causes in clude m otor veh icle crash es, falls, sportin g an d in dustrial acciden ts, an d gun sh ot or stab woun ds.

6. Com plication s related to th e in jury in clude respiratory failure, autonomic dysreflexia, spin al sh ock, furth er cord dam age, an d death .

B. Most frequen tly in volved vertebrae 1. Cervical—C5, C6, an d C7

2. Th oracic—T12 3. Lum bar—L1

C. Tran section of th e cord 1. Com plete tran section of th e cord: Th e spin al

co rd is severed com pletely, with total loss of sen - sation , m ovem en t, an d reflex activity below th e level of in ju ry.

2. Partial tran section of th e cord a . Th e spin al cord is dam aged or severed partially. b . Th e sym pto m s dep en d on th e exten t an d

location of th e dam age. c. If th e cord h as n ot suffered irreparable dam -

age, early treatm en t is n eeded to preven t par- tial dam age from developin g in to total an d perm an en t dam age.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-10 Nursing Care Following Craniotomy

Monitor vital signs and neurological status every 30 to 60 minutes.

Monitor for increased intracranial pressure (ICP). Monitor for decreased level of consciousness, motor weakness

or paralysis, aphasia, visual changes, and personality changes.

Maintain mechanical ventilation and slight hyperventilation for the first 24 to 48 hours as prescribed to prevent increased ICP.

Assess the health care provider’s (HCP’s) prescription regard- ing client positioning.

Avoid extreme hip or neck flexion, and maintain the head in a midline neutral position.

Provide a quiet environment. Monitor the head dressing frequently for signs of drainage. Mark any area of drainage at least once each nursing shift for

baseline comparison. Monitor the drain, which may be in place for 24 hours; maintain

suction on the drain as prescribed.

Measure drainage from the drain every 8 hours, and record the amount and color.

Notify the HCP if drainage is more than the normal amount of 30 to 50 mL per shift.

Notify the HCP immediately of excessive amounts of drainage or a saturated head dressing.

Record strict measurement of hourly intake and output. Maintain fluid restriction at 150 0 mL/ day as prescribed. Monitor electrolyte levels. Monitor for dysrhythmias, which may occur as a result of fluid

or electrolyte imbalance. Apply ice packs or cool compresses as prescribed; expect peri-

orbital edema and ecchymosis of 1 or both eyes. Provide range-of-motion exercises every 8 hours. Place antiembolism stockings on the client as prescribed. Administer antiseizure medications, antacids, corticosteroids,

and antibiotics as prescribed. Administer analgesics such as codeine sulfate or acetamino-

phen as prescribed for pain.

BOX 62-11 Client Positioning Following Craniotomy

Positions prescribed following a craniotomy vary with the type of surgery and the specific postoperative health care pro- vider’s (HCP’s) prescription.

Always check the HCP’s prescription regarding client positioning.

Incorrect positioning may cause serious and possibly fatal complications.

Removal of a Bone Flap for Decompression To facilitate brain expansion, the client should be turned from

the back to the nonoperative side, but not to the side on which the operation was performed.

Posterior Fossa Surgery To protect the operative site from pressure and minimize ten-

sion on the suture line, position the client on the side, with a pillow under the head for support, and not on the back.

Infratentorial Surgery Infratentorial surgery involves surgery below the tentorium of

the brain. The HCP may prescribe a flat position without head elevation or

may prescribe that the head of the bed be elevated at 30 to 45 degrees.

Do not elevate the head of the bed in the acute phase of care following surgery without an HCP’s prescription.

Supratentorial Surgery Supratentorial surgery involves surgery above the tentorium of

the brain. The HCP may prescribe that the head of the bed be elevated at

30 degrees to promote venous outflow through the jugular veins.

Do not lower the head of the bed in the acute phase of care fol- lowing surgery without an HCP’s prescription.

902 UNIT XVI Neurological Disorders of the Adult Client

D. Spin al cord syn d rom es in in com plete in ju ry (Fig. 62-2) 1. Cen tral cord syn d rom e

a. O ccurs fro m a lesion in th e cen tral portion of th e spin al cord

b . Loss of m oto r fun ction is m ore pron oun ced in th e upper extrem ities, an d varyin g degrees an d pattern s of sen sation rem ain in tact.

2. An terio r cord syn dro m e a. Caused by dam age to th e an terior portion of

th e gray an d wh ite m atter of th e spin al cord b . Motor fun ction , pain , an d tem p erature sen -

sation are lost below th e level of in jury; h ow- ever, th e sen sation s of position , vibration , an d touch rem ain in tact.

3. Posterio r cord syn dro m e a. Caused by dam age to th e posterio r portion of

th e gray an d wh ite m atter of th e spin al cord b . Motor fun ction rem ain s in tact, but th e clien t

experien ces a lo ss of vibratory sen se, cru de touch , an d position sen sation .

4. Brown -S equ ard syn d rom e a . Resu lts from pen etratin g in juries th at cau se

h em isection of th e spin al cord or in juries th at affect h alf of th e cord

b . Moto r fun ction , vibration , proprioception , an d deep touch sen sation s are lo st on th e sam e side of th e body (ipsilateral) as th e lesion or cord dam age.

c. O n th e opposite side of th e body (con tralat- eral) fro m th e lesion or cord dam age, th e sen - sation s of pain , tem p erature, an d ligh t touch are affected.

5. Con us m edullaris syn d rom e a . Follows dam age to th e lum bar n erve roots

an d con us m edullaris in th e spin al cord b . Th e clien t experien ces bowel an d bladder are-

flexia an d flaccid lower extrem ities. c. If dam age is lim ited to th e upper sacral seg-

m en ts of th e spin al cord, bulbo spon giosus pen ile (erection ) an d m icturitio n reflexes will rem ain .

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

Co mple te Le s io n

Ante rio r Co rd S yndro me

Bro wn-S e quard S yndro me´ Ce ntral Co rd S yndro me

Are a of cord da ma ge

Are a of cord da ma ge

Are a of cord da ma ge

Are a of cord da ma ge

T11

T12

T1 2

L1

L1

L2 L2 L3 L4 L5

T11

C on u s

C a ud a e q uina

T12

L1

L2 C

S 5 S 4 S 3 S 2 S 1

Are a of cord da ma ge

Motor

P a in, te mpe ra ture

P os ition, vibra tion, a nd touch s e ns e

Tota l los s of motor, s e ns ory a nd re fle x a ctivity

Los s of motor function

Incomple te los s of motor function

Los s of pa in, te mpe ra ture , a nd light touch on oppos ite s ide

Los s of motor function a nd vibra tion, pos ition, a nd de e p touch s e ns a tion on s a me s ide a s the cord da ma ge

Los s of motor s e ns ory function in va rious pa tte rns , with pote ntia l for re cove ry of function with re ge ne ra tion of pe riphe ra l ne rve s ; ne uroge nic bowe l a nd bla dde r

Co nus Me dullaris and Cauda Equina S yndro me s

FIGURE 62-2 Common spinal cord syndromes.

903CHAPTER 62 Neurological System

6. Cauda equin a syn drom e a . O ccurs from in ju ry to th e lum bo sacral n erve

ro ots below th e con us m edullaris b . Th e clien t experien ces areflexia of th e bowel,

bladder, an d lower reflexes. E. Assessm en t of spin al cord in ju ries ( Box 62-12)

1. Depen den t on th e level of th e cord in jury 2. Level of spin al cord in ju ry: Lowest spin al cord

segm en t with in tact m oto r an d sen sory fun ction 3. Respiratory status ch an ges 4. Motor an d sen sory ch an ges below th e level of

in jury 5. Total sen sory loss an d m oto r paralysis below th e

level of in ju ry 6. Loss of reflexes below th e level of in jury 7. Loss of blad der an d bowel con trol 8. Urin ary reten tion an d bladder disten tion 9. Presen ce of sweat, wh ich does n ot occur on

paralyzed areas F. Cervical in juries

1. In jury at C2 to C3 is usually fatal. 2. C4 is th e m ajor in n ervatio n to th e diap h ragm by

th e ph ren ic n erve. 3. In volvem en t above C4 cau ses respiratory diffi-

culty an d paralysis of all four extrem ities. 4. Th e clien t m ay h ave m ovem en t in th e sh oulder if

th e in ju ry is at C5 th rou gh C8, an d m ay also h ave decreased respiratory reserve.

G. Th oracic level in juries 1. Loss of m ovem en t of th e ch est, trun k, bowel,

bladder, an d legs m ay occur, depen din g on th e level of in ju ry.

2. Leg paralysis (paraplegia) m ay occur. 3. Auton om ic dysreflexia with lesion s or in juries

above T6 an d in cervical lesion s m ay occur. 4. Visceral disten tion from n oxious stim uli such as

a disten ded blad der or an im pacted rectum m ay cause reaction s such as sweatin g, brad ycardia, h yperten sion , n asal stuffin ess, an d go ose flesh .

H. Lum bar an d sacral level in juries 1. Loss of m ovem en t an d sen sation of th e lower

extrem ities m ay occur. 2. S2 an d S3 cen ter on m icturition ; th erefore,

below th is level, th e bladder will con tract but n ot em pty (n eu rogen ic blad der).

3. In jury above S2 in m ales allows th em to h ave an erection , but th ey are un ab le to ejaculate because of sym path etic n erve dam age.

4. In jury between S2 an d S4 dam ages th e sym pa- th etic an d parasym path etic respon se, preven tin g erection or ejacu lation .

I. Em ergen cy in terven tion s

Always suspect spinal cord injury when trauma occurs until this injury is ruled out. Immobilize the client on a spinal backboard with the head in a neutral position to prevent an incomplete injury from becoming complete.

1. Em ergen cy m an agem en t is critical because im proper m ovem en t can cau se furth er dam age an d loss of n eurological fun ction .

2. Assess th e respiratory pattern an d m ain tain a paten t airway.

3. Preven t h ead flexion , rotation , or exten sion . 4. Du rin g im m ob ilization , m ain tain traction an d

align m en t on th e h ead by placin g h an ds on both sides of th e h ead by th e ears.

5. Main tain an exten ded position . 6. Logroll th e clien t. 7. No part of th e body sh ould be twisted or turn ed,

an d th e clien t is n ot allowed to assum e a sittin g position .

8. In th e em ergen cy departm en t, a client wh o h as sus- tain ed a cervical fracture sh ould be placed im m e- diately in skeletal traction via skull ton gs or h alo traction to im m obilize th e cervical spin e an d reduce the fracture an d dislocation (Fig. 62-3).

J. In terven tion s durin g h ospitalization 1. Resp iratory system

a . Assess respiratory status because paralysis of th e in tercostal an d ab dom in al m uscles occurs with C4 in juries.

b . Mon itor arterial blood gas levels an d m ain - tain m ech an ical ven tilation if prescribed to preven t respiratory arrest, especially with cer- vical in juries.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-12 Effects of Spinal Cord Injury Tetraplegia (Quadriplegia) ▪ Injury occurring between C1 and C8 ▪ Paralysis involving all four extremities Paraplegia ▪ Injury occurring between T1 and L4 ▪ Paralysis involving only the lower extremities

Gardne r-We lls To ng s Halo Fixatio nDe vic e with Jac ke t

FIGURE 62-3 Types of cervical spine traction.

904 UNIT XVI Neurological Disorders of the Adult Client

c. En courage deep breath in g an d th e use of an in cen tive spirom eter.

d . Mon itor for sign s of in fectio n , particularly pn eum on ia.

2. Cardio vascular system a. Mon itor for cardiac dysrh yth m ias. b . Assess for sign s of h em orrh age or bleedin g

aroun d th e fracture site. c. Assess for sign s of sh ock, such as h ypo ten sion ,

tach ycardia, an d a weak an d th read y pulse. d . Assess th e lower extrem ities for deep vein

th rom bosis. e. Measure circum feren ces of th e calf an d th igh

to iden tify in creases in size. f. Apply an tiem bolism stockin gs as prescribed ;

rem ove daily to assess skin in tegrity. g. Mon itor for orth ostatic h ypo ten sion wh en

repositio n in g th e clien t. 3. Neurom u scular system

a. Assess n eurological status. b . Assess m oto r an d sen sory status to determ in e

th e level of in ju ry. c. Assess m oto r ability by testin g th e clien t’s

ability to squeeze h an ds, spread th e fin gers, m ove th e toes, an d turn th e feet.

d . Assess absen ce of sen sation , h yposen sation , or h ypersen sation by pin ch in g th e skin or prickin g it with a pin , startin g at th e sh oul- ders an d workin g down th e extrem ities.

e. Mon itor for sign s of auton om ic dysreflexia an d spin al sh ock.

f. Im m obilize th e clien t to prom o te h ealin g an d preven t furth er in jury.

g. Assess pain . h . In itiate m easu res to reduce pain . i. Adm in ister an algesics as prescribed. j. Mon itor for com plication s of im m ob ility.

k . Prepare th e clien t for deco m pression lam in - ectom y, spin al fusion , or in sertion of in stru- m en tation or ro ds if prescribed.

l. Collaborate with th e ph ysical th erap ist an d occupation al th erapist to determ in e appro- priate exercise tech n iques, assess th e n eed for h an d an d wrist splin ts, an d develop an appropriate plan to preven t footd rop.

4. Gastroin testin al system a. Assess abdom en for disten tion an d

h em orrh age. b . Mon itor bowel soun ds an d assess for para-

lytic ileus. c. Preven t bowel reten tion . d . In itiate a bowel con trol program as

appropriate. e. Main tain adequ ate n utrition an d a h igh -

fiber diet. 5. Ren al system

a. Preven t urin ary reten tion .

b . In itiate a blad der con trol program as ap propriate.

c. Main tain fluid an d electrolyte balan ce. d . Main tain adequate fluid in take of 2000 m L/

day un less con train d icated. e. Mon itor for urin ary tract in fectio n an d

calculi. 6. In tegum en tary system

a . Assess skin in tegrity. b . Tu rn th e clien t every 2 h ours.

7. Psych osocial in tegrity a . Assess psych osocial status. b . En cou rage th e clien t to express feelin gs of

an ger, dep ression , an d lo ss. c. Discuss th e sexual con cern s of th e clien t. d . Prom ote reh abilitation with self-care m ea-

sures, settin g realistic goals based on th e cli- en t’s poten tial fun ction al level.

e. En cou rage con tact with appropriate com m u- n ity resou rces.

K. Spin al an d n eurogen ic sh o ck 1. Descrip tion

a . Spinal shock: A com plete but tem p orary lo ss of m otor, sen sory, reflex, an d auton om ic fun ction th at occurs im m ediately after in ju ry as th e cord’s respon se to th e in ju ry. It usually lasts less th an 48 h ours but can con tin ue for several weeks.

b . Neurogenic shock: O ccurs m ost com m on ly in clien ts with in juries above T6 an d usually is exp erien ced soon after th e in jury. Massive vaso dilation occurs, leadin g to poolin g of th e blood in blood vessels, tissue h ypoperfu - sion , an d im paired cellular m etab olism .

2. Assessm en t ( Box 62-13) 3. In terven tion s

a . Mon itor for sign s of sh ock followin g a spin al cord in ju ry.

b . Mon itor for h ypo ten sion an d bradycardia. c. Mon itor for reflex activity. d . Assess bowel soun ds. e. Mon itor for bowel an d urin ary reten tion . f. Provide supp ortive m easu res as prescribed,

based on th e presen ce of sym pto m s. g. Mon itor for th e return of reflexes.

L. Autonomic dysreflexia 1. Descrip tion

a . Also kn own as auton om ic h yperreflexia b . It gen erally occurs after th e period of spin al

sh o ck is resolved an d occurs with lesion s or in ju ries above T6 an d in cervical lesion s.

c. It is com m on ly cau sed by visceral disten tion fro m a disten ded blad der or im pacted rectum .

d . It is a n eurological em ergen cy an d m ust be treated im m ediately to preven t a h yperten - sive stroke.

2. Assessm en t (see Box 62-13)

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

905CHAPTER 62 Neurological System

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

3. In terven tion s (see Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Autonomic Dysreflexia in a Spinal Cord Injury Client

1. Raise the head of the bed and ask that the health care pro- vider (HCP) be notified.

2. Loosen tight clothing on the client. 3. Check for bladder distention or other noxious stimulus. 4. Administer an antihypertensive medication. 5. Document the occurrence, treatment, and response.

Autonomic dysreflexia is characterized by severe hyperten- sion, bradycardia, severe headache, nasal stuffiness, and flush- ing. The cause is a noxious stimulus, most often a distended bladder or constipation. Autonomic dysreflexia is a neurologi- cal emergency and must be treated promptly to prevent a hypertensive stroke. Immediate nursing actions are to contact the HCP, sit the client up in bed in a high Fowler’s position, and remove the noxious stimulus. The nurse would loosen anytight clothing and then check for bladder distention. If the client has a urinarycatheter, the nurse would check for kinks in the tubing. The nurse also would check for a fecal impaction and disimpact the client, if necessary. The nurse assesses the environment to ensure that it is not too cool or too drafty and also monitors vital signs, particularly the blood pressure, every 15 minutes. Antihypertensive medication may be prescribed by the HCP to minimize cerebral hypertension. Finally, the nurse docu- ments the occurrence, treatment, and client response.

Reference Ignatavicius, Workman (2016), p. 899.

M. Cervical spin e traction for cervical in juries (see Fig. 62-3) 1. Descriptio n

a . Skeletal traction is used to stabilize fractures or dislocation s of th e cervical or upper th o racic spin e.

b . Two types of equ ipm en t used for cervical traction are skull (cervical) ton gs an d h alo traction (h alo fixatio n device) .

2. Skull ton gs a . Skull ton gs are in serted in to th e outer aspect

of th e clien t’s skull, an d traction is applied. b . Weigh ts are attach ed to th e ton gs, an d th e cli-

en t is used as coun tertraction . Th e n urse sh ould n ot ad d or rem ove weigh ts.

c. Determ in e th e am oun t of weigh t prescribed to be added to th e traction .

d . En su re th at weigh ts h an g securely an d freely at all tim es.

e. En su re th at th e ropes for th e traction rem ain with in th e pulley.

f. Main tain body align m en t an d m ain tain care of th e clien t on a special bed (su ch as a RotoRest bed or Stryker or Foster fram e) as prescribed.

g. Turn th e clien t every 2 h ours. h . Assess th e in sertion site of th e ton gs for

in fectio n . i. Provide sterile pin site care as prescribed.

3. Halo traction a . Halo traction is a static traction device th at

con sists of a h eadpiece with 4 pin s, 2 an terior an d 2 posterior, in serted in to th e clien t’s sku ll.

b . Th e m etal h alo rin g m ay be attach ed to a vest (jacket) or cast wh en th e spin e is stable, allowin g in creased clien t m ob ility.

c. Mon itor th e clien t’s n eurological status for ch an ges in m ovem en t or decreased stren gth .

d . Never m ove or turn th e clien t by h old in g or pullin g on th e h alo traction device.

e. Assess for tigh tn ess of th e jacket by en surin g th at 1 fin ger can be placed un der th e jacket.

f. Assess skin in tegrity to en sure th at th e jacket or cast is n ot cau sin g pressure.

g. Provide sterile pin site care as prescribed. 4. Clien t education for h alo traction device

(Box 62-14) 5. In itiate in terven tion s in support of th e clien t’s

self-im age. 6. Teach th e clien t an d fam ily pin care, care of th e

vest, an d sign s an d sym pto m s of in fectio n to report to h is or h er HCP.

N. In terven tion s for th oracic, lum bar, an d sacral in ju ries 1. Bed rest 2. Im m obilization with a body cast if prescribed 3. Assess for respiratory im pairm en t an d paralytic

ileu s, possible com plication s of th e body cast.

BOX 62-13 Manifestations: Neurogenic Shock, Spinal Shock, and Autonomic Dysreflexia

Neurogenic Shock ▪ Hypotension ▪ Bradycardia Spinal Shock ▪ Flaccid paralysis ▪ Loss of reflex activity below the level of the injury ▪ Bradycardia ▪ Hypotension ▪ Paralytic ileus Autonomic Dysreflexia ▪ Sudden onset, severe throbbing headache ▪ Severe hypertension and bradycardia ▪ Flushing above the level of the injury ▪ Pale extremities below the level of the injury ▪ Nasal stuffiness ▪ Nausea ▪ Dilated pupils or blurred vision ▪ Sweating ▪ Piloerection (goose bumps) ▪ Restlessness and a feeling of apprehension

906 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

4. Use of a brace or corset wh en th e clien t is out of bed

O. Surgical in terven tion s for th oracic, lum bar, an d sacral in juries 1. Decom p ressive lam in ecto m y

a. Rem oval of 1 or m ore lam in ae b . Allows for cord exp an sion from edem a;

perform ed if con ven tion al m eth od s fail to preven t n eurological deterio ration

2. Spin al fusion a. Spin al fusion is used for th oracic spin al

in juries. b . Bon e is grafted between th e vertebrae for sup-

port an d to stren gth en th e back. 3. Postoperative in terven tion s

a. Mon itor for respiratory im pairm en t. b . Mon itor vital sign s, m oto r fun ction , sen sa-

tio n , an d circulatory status in th e lower extrem ities.

c. En cou rage breath in g exercises. d . Assess for sign s of fluid an d electrolyte

im balan ces. e. O bserve for com plication s of im m ob ility. f. Keep th e clien t in a flat position as prescribed. g. Provide cast care if th e clien t is in a full

body cast. h . Turn an d reposition frequen tly by logrollin g

side to back to side, usin g turn in g sheets an d pillows between th e legs to m ain tain align m en t.

i. Adm in ister pain m edication as prescribed. j. Main tain on NPO status un til th e clien t is

passin g flatu s. k . Mon itor bowel soun ds. l. Provide th e use of a fracture bedpan .

m . Mon itor in take an d outp ut. n . Main tain n utrition al status.

P. Medication s 1. Dexam eth ason e: Used for its antiin flam m atory

an d edem a-reducin g effects; m ay in terfere with h ealin g because it suppresses th e im m un e system

2. Dextran : Plasm a expan d er used to in crease cap- illary blood flow with in th e spin al cord an d to preven t or treat h ypo ten sion

3. Baclofen : Used for clien ts with upper m oto r n eu- ron in juries to con trol m uscle spasticity

IX. Cerebral Aneurysm A. Description : Dilation of th e walls of a weaken ed

cerebral artery; can lead to rupture B. Assessm en t

1. Headach e an d pain 2. Irritability 3. Visual ch an ges 4. Tin n itu s 5. Hem iparesis 6. Nu ch al rigidity 7. Seizu res

C. In terven tion s 1. Main tain a paten t airway (suctio n on ly with an

HCP’s prescription ). 2. Adm in ister oxygen as prescribed. 3. Mon itor vital sign s an d for h yperten sio n or

dysrh yth m ias. 4. Avoid takin g tem p eratures via th e rectum . 5. In itiate an eurysm precaution s ( Box 62-15).

X. Seizures A. Description

1. Seizu res are an abn o rm al, sudden , excessive dis- ch arge of electrical activity with in th e brain .

2. Epilepsy is a disorder ch aracterized by ch ron ic seizu re activity an d in dicates brain or CNS irritation .

3. Causes in clude gen etic factors, traum a, tum ors, circulatory or m etabolic disorders, toxicity, an d in fectio n s.

4. Status epilepticus in volves a rapid succession of epilep tic spasm s with ou t in tervals of con scious- n ess; it is a poten tial com plication th at can occur with an y type of seizure, an d brain dam age m ay result.

BOX 62-14 Client Education for a Halo Fixation Device

Notify the health care provider (HCP) if the halo vest (jacket) or ring bolts loosen.

Use fleece or foam inserts to relieve pressure points. Keep the vest lining dry. Clean the pin site daily. Notify the HCP if redness, swelling, drainage, open areas,

pain, tenderness, or a clicking sound occurs from the pin site.

A sponge bath or tub bath is allowed; showers are not allowed. Assess the skin under the vest daily for breakdown, using a

flashlight. Do not use any products other than shampoo on the hair. When shampooing the hair, cover the vest with plastic.

When getting out of bed, roll onto the side and push on the mat- tress with the arms.

Never use the metal frame for turning or lifting. Use a rolled towel or pillowcase between the back of the neck

and bed or next to the cheek when lying on the side, and raise the head of the bed to increase sleep comfort.

Adapt clothing to fit over the halo device. Eat foods high in protein and calcium to promote bone healing. Have the correct-sized wrench available at all times for an emer-

gency (tape the wrench to the vest). If cardiopulmonary resuscitation is required, the anterior por-

tion of the vest will be loosened and the posterior portion will remain in place to provide stability.

907CHAPTER 62 Neurological System

B. Types of seizu res (Box 62-16) C. Assessm en t

1. Seizu re h istory 2. Type of seizure 3. O ccurren ces befo re, durin g, an d after th e seizure 4. Prodrom al sign s, such as m oo d ch an ges, irrita-

bility, an d in som n ia 5. Aura: Sen sation th at warn s th e clien t of th e

im pen din g seizu re 6. Loss of m otor activity or bowel an d blad der fun c-

tion or loss of con sciousn ess durin g th e seizu re 7. O ccurren ces durin g th e postictal state, such as

h ead ach e, loss of con sciousn ess, sleepin ess, an d im paired speech or th in kin g

D. In terven tion s

If the client is having a seizure, maintain a patent airway. Do not force the jaws open or place anything in the client’s mouth.

1. Note th e tim e an d duration of th e seizure. 2. Assess beh avior at th e on set of th e seizure: If th e

clien t h as experien ced an aura, if a ch an ge in facial expressio n occurred, or if a soun d or cry occurred from th e clien t.

3. If th e clien t is stan din g or sittin g, place th e clien t on th e floor an d protect th e h ead an d body.

4. Supp ort airway, breath in g, an d circulation . 5. Adm in ister oxygen . 6. Prepare to suction secretio n s. 7. Turn th e clien t to th e side to allow secretio n s to

drain wh ile m ain tain in g th e airway. 8. Preven t in ju ry durin g th e seizu re. 9. Rem ain with th e clien t.

10. Do n ot restrain th e clien t. 11. Loosen restrictive clo th in g. 12. Note th e type, ch aracter, an d progression of th e

m ovem en ts durin g th e seizure.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-15 Aneurysm Precautions

Maintain the client on bed rest in a semi-Fowler’s or a side-lying position.

Maintain a darkened room (subdued lighting and avoid direct, bright, artificial lights) without stimulation (a private room is optimal).

Provide a quiet environment (avoid activities or startling noises); a telephone in the room is not usually allowed.

Reading, watching television, and listening to music are permit- ted, provided that they do not overstimulate the client.

Limit visitors. Maintain fluid restrictions. Provide diet as prescribed; avoid stimulants in the diet.

Prevent any activities that initiate the Valsalva maneuver (strain- ing at stool, coughing); provide stool softeners to prevent straining.

Administer care gently (such as the bath, back rub, range of motion).

Limit invasive procedures. Maintain normothermia. Prevent hypertension. Provide sedation. Provide pain control. Administer prophylactic antiseizure medications. Provide deep vein thrombosis (DVT) prophylaxis as prescribed.

BOX 62-16 Types of Seizures Generalized Seizures Tonic-Clonic Tonic-clonic seizures may begin with an aura. The tonic phase involves the stiffening or rigidity of the muscles

of the arms and legs and usually lasts 10 to 20 seconds, fol- lowed by loss of consciousness.

The clonic phase consists of hyperventilation and jerking of the extremities and usually lasts about 30 seconds.

Full recovery from the seizure may take several hours.

Absence Abrief seizure that lasts seconds, and the individual may or may

not lose consciousness. No loss or change in muscle tone occurs. Seizures may occur several times during a day. The victim appears to be daydreaming. This type of seizure is more common in children.

Myoclonic Myoclonic seizures present as a brief generalized jerking or stiff-

ening of extremities. The victim may fall from the seizure.

At onic or Akinet ic (Drop At t acks) An atonic seizure is a sudden momentary loss of muscle tone. The victim may fall as a result of the seizure.

Partial Seizures Simple Part ial The simple partial seizure produces sensory symptoms accom-

panied by motor symptoms that are localized or confined to a specific area.

The client remains conscious and may report an aura.

Complex Pa rtia l The complex partial seizure is a psychomotor seizure. The area of the brain most usually involved is the temporal lobe. The seizure is characterized by periods of altered behavior of

which the client is not aware. The client loses consciousness for a few seconds.

908 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

13. Mon itor for in con tin en ce. 14. Adm in ister in traven ous m ed ication s as pre-

scrib ed to stop th e seizu re. 15. Do cum en t th e ch aracteristics of th e seizure. 16. Provide privacy. 17. Mon itor beh avior follo win g th e seizure, such as

th e state of co n sciousn ess, m oto r ability, an d speech ability.

18. In struct th e clien t about th e im portan ce of life- lo n g m edication an d th e n eed for follow-up determ in ation of m ed ication blood levels.

19. In struct th e clien t to avoid alcoh ol, excessive stress, fatigue, an d strobe ligh ts.

20. En cou rage th e clien t to co n tact available co m - m un ity resou rces, such as th e Epilepsy Foun da- tio n of Am erica.

21. En cou rage th e clien t to wear a MedicAlert bracelet.

XI. Stroke (Brain Attack) A. Description

1. A stroke or brain attack m an ifests as a sudden focal n eurological deficit an d is cau sed by cere- brovascular disease.

2. Cereb ral an oxia lastin g lon ger th an 10 m in u tes cau ses cerebral in farction with irreversible ch an ge.

3. Cereb ral edem a an d con gestion cause furth er dysfun ction .

4. Diagn osis is determ in ed by a CT scan , electroen - ceph alograph y, cerebral arteriograph y, an d MRI. In m ost facilities, th e type of stroke n eeds to be determ in ed with in a certain tim e fram e after arrival in order for tim ely treatm en t to be in itiated.

5. Tran sien t isch em ic attack m ay be a warn in g sign of an im pen din g stroke.

6. Th e perm an en t disability can n ot be determ in ed un til th e cerebral edem a subsid es.

7. Th e order in wh ich fun ction m ay return is facial, swallowin g, lo wer lim bs, speech , an d arm s.

8. Caro tid en darterectom y is a surgical in terven tion used in stroke m an agem en t; it is targeted at stroke preven tion , especially in clien ts with sym ptom atic carotid sten osis.

9. Th e Nation al In stitutes of Health th rough th e Nation al In stitute of Neurological Diso rders an d Stroke (NINDS) develo ped th e Know Stroke: Know the Signs. Act in Time cam paign devised to h elp educate th e public ab out th e sym pto m s of stroke an d th e im portan ce of gettin g to th e h os- pital quickly ( h ttp:/ / stroke.n ih .gov).

B. Causes 1. Th rom bosis 2. Em bo lism 3. Th rom botic an d em b olic strokes are classified as

isch em ic strokes.

4. Hem o rrh age from rupture of a vessel; classified as a h em orrh agic stroke

5. Man ifestation s of differen t typ es of stroke are sim ilar an d th erefore it is critical to determ in e th e type of stroke occurrin g; th e type can n ot be determ in ed solely based on m an ifestatio n s an d th e correct an d ap propriate treatm en t for th e stroke typ e m ust be in itiated.

C. Risk factors 1. Ath erosclerosis 2. Hyperten sion 3. An ticoagulation th erap y 4. Diabetes m ellitus 5. Stress 6. O besity 7. O ral con traceptives

D. Assessm en t ( Fig. 62-4; Boxes 62-17 an d 62-18)

A critical factor in the early intervention and treat- ment of stroke is the accurate identification of stroke manifestations and establishing the onset of the mani- festations. Stroke screening scales may be used to iden- tify stroke manifestations quickly. Identification of the type of stroke occurring is critical in determining the appropriate treatment, and this is usually done using imaging such as a CT scan.

• Impa ire d judgme nt • Impa ire d time conce pts • Impuls ive , s a fe ty proble ms • Le ft-s ide d ne gle ct • P a ra lyze d le ft s ide :

he miple gia • Ra pid pe rforma nce ,

s hort a tte ntion s pa n • S pa tia l-pe rce ptua l de ficits • Te nds to de ny or minimize

proble ms

Rig ht-brain damag e (s troke on right s ide

of the bra in)

• Awa re of de ficits : de pre s s ion, a nxie ty

• Impa ire d compre he ns ion re la te d to la ngua ge , ma th

• Impa ire d right/le ft dis crimina tion

• Impa ire d s pe e ch/la ngua ge a pha s ia s

• P a ra lyze d right s ide : he miple gia

• S low pe rforma nce , ca utious

Le ft-brain damag e (s troke on le ft s ide

of the bra in)

FIGURE 62-4 Manifestations of right brain and left brain stroke.

909CHAPTER 62 Neurological System

1. Assessm en t fin din gs dep en d on th e area of th e brain affected ; stroke scales such as th e NIH Stroke Scale (stro ke.n ih .gov/ resou rces/ scale. h tm ) m ay be used by th e h ealth care facility for assessm en t.

2. Lesio n s in th e cerebral h em isph ere result in m an ifestatio n s on th e con tralateral side, wh ich is th e side of th e body opposite th e stroke.

3. Airway paten cy is always a priority.

4. Pulse (m ay be slow an d boun din g) 5. Resp iration s (Ch eyn e-Stokes) 6. Bloo d pressure (h yperten sion ) 7. Headach e, n ausea, an d vo m itin g 8. Facial droopin g 9. Nuch al rigidity

10. Visual ch an ges 11. Ataxia 12. Dysarth ria 13. Dysp h agia 14. Speech ch an ges 15. Decreased sen sation to pressure, h eat, an d cold 16. Bowel an d bladder dysfun ction s 17. Paralysis

E. Aph asia 1. Expressive

a . Dam age occurs in Broca’s area of th e fro n tal brain .

b . Th e clien t un derstan ds wh at is said but is un able to com m un icate verbally.

2. Recep tive a . In jury in volves Wern icke’s area in th e tem -

porop arietal area. b . Th e clien t is un ab le to un derstan d th e spoken

an d often th e written word. 3. Global or m ixed: Lan gu age dysfun ction occurs in

expressio n an d reception . 4. In terven tion s for aph asia

a . Provide repetitive direction s. b . Break tasks down to 1 step at a tim e. c. Repeat n am es of objects frequen tly used. d . Allow tim e for th e clien t to com m un icate. e. Use a picture board, com m un ication board,

or com puter tech n ology. F. In terven tion s durin g th e acu te ph ase of stroke

1. Main tain a paten t airway an d adm in ister oxy- gen as prescribed.

2. Mon itor vital sign s. 3. Usually a blood pressure of 150/ 100 m m Hg is

m ain tain ed to en sure cerebral perfusio n . 4. Suction secretio n s to preven t aspiration as

prescribed, but n ever suction n asally or for lon ger th an 10 secon ds to preven t in creased ICP.

5. Mon itor for in creased ICP because th e clien t is m ost at risk durin g th e first 72 h ours follo win g th e stroke.

6. Position th e clien t on th e side to preven t aspira- tion , with th e h ead of th e bed elevated 15 to 30 degrees as prescribed.

7. Mon itor level of con sciousn ess, pupillary respo n se, m oto r an d sen sory respo n se, cran ial n erve fun ction , an d reflexes.

8. Main tain a quiet en viron m en t. 9. In sert a urin ary cath eter as prescribed .

10. Adm in ister in traven o us fluid s as prescribed. 11. Main tain fluid an d electrolyte balan ce.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 62-17 Clinical Manifestations of Stroke Based on Type

Thrombotic Stroke Typically, there is no decreased level of consciousness within

the first 24 hours. Symptoms get progressively worse as the infarction and

edema increase.

Embolic Stroke Sudden, severe symptoms Warning signs are less common. Client remains conscious and may have a headache.

Hemorrhagic Stroke Sudden onset of symptoms Symptoms progress over minutes to hours due to ongoing

bleeding.

BOX 62-18 Assessment Findings in a Stroke Agnosia ▪ The inability to recognize familiar objects or persons Apraxia ▪ Called dyspraxia if the condition is mild ▪ Characterized by loss of ability to execute or carry out

skilled movements or gestures, despite having the desire and physical ability to perform them

Hemianopsia ▪ Blindness in half the visual field Homonymous Hemianopsia ▪ Loss of half of the field of view on the same side in both

eyes

Neglect Syndrome (Unilateral Neglect) ▪ Client unaware of the existence of his or her paralyzed side Proprioception Alterations ▪ Altered position sense that places the client at increased

risk of injury ▪ Pyramid Point: With visual problems, the client must turn

the head to scan the complete range of vision.

Data from U.S. Department of Health and Human Services, National Institutes of Health: Know stroke: know the signs. Act in time, NIH Publication # 10 -4872. Bethesda, Md., June 20 13, National Institutes of Health, http:/ / stroke.nih.gov.

910 UNIT XVI Neurological Disorders of the Adult Client

12. Prepare to adm in ister an ticoagulan ts, an tiplate- lets, diuretics, an tih yp erten sives, an d an tisei- zure m ed ication s as prescribed depen din g on th e typ e of stroke th at h as been diagn osed.

13. Establish a form of com m un ication . G. In terven tion s in th e postacu te ph ase of a stroke

1. Con tin ue with in terven tion s from th e acu te ph ase.

2. Position th e clien t 2 h ours on th e un affected side an d 20 m in utes on th e affected side; th e pron e position m ay also be prescribed.

3. Provide skin , m ou th , an d eye care. 4. Perform passive ran ge-of-m otion exercises to

preven t con tractures. 5. Place an tiem bolism stockin gs on th e clien t;

rem ove daily to ch eck skin . 6. Mon itor th e gag reflex an d ability to swallow. 7. Provide sips of flu ids an d slowly ad van ce diet to

food s th at are easy to ch ew an d swallow. 8. Provide soft an d sem isoft food s an d flavored,

cool or warm , th icken ed flu ids rath er th an th in liqu ids because th e stroke clien t can tolerate th ese types of food better; speech th erapists m ay do swallow studies to recom m en d con sis- ten cy of food an d flu ids.

9. Wh en th e client is eatin g, position th e client sit- tin g in a ch air or sitting up in bed, with th e h ead an d n eck position ed sligh tly forward an d flexed.

10. Place food in th e back of th e m outh on th e un af- fected side to preven t trappin g of food in th e affected ch eek.

H. In terven tion s in th e ch ron ic ph ase of stroke 1. Neglect syn d rom e

a. Th e clien t is un aware of th e existen ce of h is or h er paralyzed side ( unilateral neglect), wh ich places th e clien t at risk for in jury.

b . Teach th e clien t to touch an d use both sides of th e body.

2. Hemianopsia a. Th e clien t h as blin dn ess in h alf of th e

visual field. b . Homonymous hemianopsia is blin dn ess in

th e sam e visual field of both eyes. c. En cou rage th e clien t to turn th e h ead to scan

th e com plete ran ge of vision ; oth erwise, h e or sh e does n ot see h alf of th e visual field.

3. Approach th e clien t from th e un affected side. 4. Place th e clien t’s person al objects with in th e

visu al field. 5. Provide eye care for visu al deficits. 6. Place a patch over th e affected eye if th e clien t

h as diplopia. 7. In crease m ob ility as tolerated. 8. En cou rage flu id in take an d a h igh -fib er diet. 9. Adm in ister stool soften ers as prescribed.

10. En cou rage th e clien t to express h er or h is feelin gs.

11. En cou rage in depen den ce in activities of daily livin g.

12. Assess th e n eed for assistive devices such as a can e, walker, splin t, or braces.

13. Teach tran sfer tech n ique from bed to ch air an d from ch air to bed .

14. Provide gait train in g. 15. In itiate ph ysical an d occupation al th erap y for

assessm en t an d th e n eed for adap tive equ ip- m en t or oth er supports for self-care an d m ob ility.

16. Refer clien t to a speech an d lan gu age path olo- gist as prescribed .

17. En cou rage th e clien t an d fam ily to con tact avail- able com m un ity resou rces.

XII. Multiple Sclerosis A. Description

1. A ch ron ic, progressive, n on con tagious, degen er- ative disease of th e CNS ch aracterized by dem ye- lin ization of th e n euron s.

2. It usually occurs between th e ages of 20 an d 40 years an d con sists of periods of rem ission s an d exacerbation s.

3. Th e causes are un kn own , but th e disease is th o ugh t to be th e result of an autoim m un e respo n se or viral in fectio n .

4. Precipitatin g facto rs in clude pregn an cy, fatigue, stress, in fection , an d traum a.

5. Electroen cep h alograph ic fin din gs are abn orm al. 6. Assessm en t of a lum bar pun cture in dicates an

in creased gam m a globulin level, but th e serum glob ulin level is n orm al.

B. Assessm en t 1. Fatigue an d weakn ess 2. Ataxia an d vertigo 3. Trem ors an d spasticity of th e lo wer extrem ities 4. Paresth esias 5. Blurred vision , diplopia, an d tran sien t

blin dn ess 6. Nystagm us 7. Dysp h asia 8. Decreased perception to pain , touch , an d

tem p erature 9. Bladder and bowel disturban ces, in cludin g

urgen cy, frequen cy, reten tion , an d in con tinen ce 10. Abn orm al reflexes, in cludin g h yperreflexia,

absen t reflexes, an d a positive Babin ski reflex 11. Em otion al ch an ges such as apath y, eup h oria,

irritability, an d dep ression 12. Mem ory ch an ges an d con fusion

C. In terven tion s 1. Provide en ergy con servation m easures durin g

exacerbatio n . 2. Protect th e clien t from in jury by providin g

safety m easu res.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

911CHAPTER 62 Neurological System

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

3. Place an eye patch on th e eye for diplopia. 4. Mon itor for poten tial com plication s such as uri-

n ary tract in fectio n s, calculi, pressure ulcers, respiratory tract in fectio n s, an d con tractures.

5. Prom o te regular elim in ation by bladder an d bowel train in g.

6. En cou rage in depen den ce. 7. Assist th e clien t to establish a regular exercise

an d rest program an d to balan ce m od erate activity with rest periods.

8. Assess th e n eed for an d provide assistive devices. 9. In itiate ph ysical an d speech th erapy.

10. In struct th e clien t to avoid fatigue, stress, in fec- tion , overh eatin g, an d ch illin g.

11. In struct th e clien t to in crease fluid in take an d eat a balan ced diet, in cludin g low-fat, h igh -fiber food s an d foods h igh in potassium .

12. In struct th e clien t in safety m easu res related to sen sory loss, such as regulatin g th e tem p erature of bath water an d avoidin g h eatin g pads.

13. In struct th e clien t in safety m easu res related to m oto r loss, such as avoidin g th e use of scatter rugs an d usin g assistive devices.

14. In struct th e clien t in th e self-adm in istration of prescribed m edication s.

15. Provide in form ation about th e Nation al Multi- ple Sclerosis Society.

XIII. Myasthenia Gravis A. Descriptio n

1. A n eurom u scular disease ch aracterized by con - siderable weakn ess an d abn o rm al fatigue of th e volun tary m uscles

2. A defect in th e tran sm ission of n erve im pulses at th e m yon eural jun ction occurs.

3. Causes in clude in sufficien t secretio n of acetyl- ch olin e, excessive secretion of ch olin esterase, an d un respon siven ess of th e m uscle fibers to acetylch olin e.

B. Assessm en t 1. Weakn ess an d fatigue 2. Difficulty ch ewin g an d swallowin g 3. Dysph agia 4. Ptosis 5. Diplop ia 6. Weak, h oarse voice 7. Difficulty breath in g 8. Dim in ish ed breath soun ds 9. Respiratory paralysis an d failure

C. In terven tion s 1. Mon itor respiratory status an d ability to co ugh

an d deep-breath e adequately. 2. Mon itor for respiratory failure. 3. Main tain suction in g an d em ergen cy equ ipm en t

at th e bedside. 4. Mon itor vital sign s.

5. Mon itor speech an d swallowin g abilities to pre- ven t aspiration .

6. En cou rage th e clien t to sit up wh en eatin g. 7. Assess m uscle status. 8. In struct th e clien t to con serve stren gth . 9. Plan sh ort activities th at coin cide with tim es of

m axim al m uscle stren gth . 10. Mon itor for m yasth en ic an d ch olin ergic crises. 11. Adm in ister an tich o lin esterase m ed ication s as

prescribed . 12. In struct th e clien t to avoid stress, in fectio n ,

fatigue, an d over-th e-coun ter m ed ication s. 13. In struct th e clien t to wear a Med icAlert bracelet. 14. In form th e clien t about services from th e Myas-

th en ia Gravis Foun dation . D. An tich olin esterase m ed ication s: In crease levels

of acetylch olin e at th e m yon eural jun ction (see Ch apter 63)

E. Myasth en ic crisis 1. Descriptio n

a . An acu te exacerbatio n of th e disease b . Th e crisis is caused by a rapid, un recogn ized

progression of th e disease, in adequate am oun t of m edication , in fection , fatigue, or stress.

2. Assessm en t a . In creased pulse, respiration s, an d blood

pressure b . Dysp n ea, an oxia, an d cyan osis c. Bowel an d blad der in con tin en ce d . Decreased urin e output e. Absen t cough an d swallow reflex

3. In terven tion s a . Assess for sign s of m yasth en ic crisis. b . In crease an tich olin esterase m ed ication , as

prescribed. F. Ch o lin ergic crisis

1. Descriptio n a . Resu lts in dep olarization of th e m oto r en d

plates b . Th e crisis is cau sed by overm edication with

an tich olin esterase. 2. Assessm en t

a . Abdo m in al cram p s b . Nausea, vo m itin g, an d diarrh ea c. Blurred vision d . Pallor e. Facial m uscle twitch in g f. Hypo ten sion g. Pupillary m iosis

3. In terven tion s a . With h old an tich o lin esterase m ed ication . b . Prepare to adm in ister th e an tidote, atropin e

sulfate, if prescribed. G. Edrophonium (Tensilon) test

Have atropine sulfate available when performing the edrophonium test.

912 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

1. Descrip tion a. Th is test is perform ed by th e n eurologist to

diagn ose m yasth en ia gravis an d to differen ti- ate between m yasth en ic crisis an d ch olin er- gic crisis.

b . Th e test places th e clien t at risk for ven tricular fibrillation an d cardiac arrest; em ergen cy equipm en t n eeds to be available.

2. To diagn ose m yasth en ia gravis a. Edroph on ium in jection is adm in istered to

th e clien t. b . Positive for m yasth en ia gravis: Clien t sh ows

im provem en t in m uscle stren gth after th e adm in istration of edroph o n ium .

c. Negative for m yasth en ia gravis: Clien t sh ows n o im provem en t in m uscle stren gth , an d stren gth m ay even deterio rate after in jection of edrop h on ium .

3. To differen tiate crisis a. Myasth en ic crisis: Edroph on ium is adm in is-

tered an d, if stren gth im proves, th e clien t n eeds m ore m ed ication .

b . Ch olin ergic crisis: Edroph on ium is adm in - istered an d, if weakn ess is m ore severe, th e cli- en t is overm edicated; prepare to adm in ister atropin e sulfate, th e an tidote, as prescribed.

XIV. Parkinson’s Disease A. Description

1. A degen erative disease caused by th e dep letion of dopam in e, wh ich in terferes with th e in h ibitio n of excitatory im pulses, resultin g in a dysfun ction of th e extrapyram idal system .

2. It is a slow, progressive disease th at results in a cripp lin g disability.

3. Th e deb ilitation can result in falls, self-care defi- cits, failure of body system s, an d depression .

4. Men tal deterioration occurs late in th e disease. B. Assessm en t

1. Bradykinesia, abn orm al slown ess of m ovem en t, an d sluggish n ess of ph ysical an d m en tal respon ses

2. Akin esia 3. Mon oton ou s speech 4. Han dwritin g th at becom es progressively sm aller 5. Trem ors in h an ds an d fin gers at rest (pill rollin g) 6. Trem ors in creasin g wh en fatigued an d decreas-

in g with purpo seful activity or sleep 7. Rigidity with jerky m ovem en ts 8. Restlessn ess an d pacin g 9. Blan k facial expressio n ; m asklike faces

10. Droo lin g 11. Difficulty swallowin g an d speakin g 12. Loss of coordin ation an d balan ce 13. Sh u fflin g steps, stooped position , an d propu l-

sive gait C. In terven tion s

1. Assess n eurological status.

2. Assess ability to swallow an d ch ew. 3. Provide h igh -calorie, h igh -protein , h igh -fiber

soft diet with sm all, frequen t feed in gs. 4. In crease fluid in take to 2000 m L/ d ay. 5. Mon itor for con stipation . 6. Prom o te in depen den ce alon g with safety

m easu res. 7. Avoid ru sh in g th e clien t with activities. 8. Assist with am bulation an d provide assistive

devices. 9. In struct th e clien t to rock back an d forth to in i-

tiate m ovem en t. 10. In struct th e clien t to wear low-h eeled sh o es. 11. En cou rage th e clien t to lift th e feet wh en walk-

in g an d to avoid prolon ged sittin g. 12. Provide a firm m attress an d position th e clien t

pron e, with ou t a pillow, to facilitate proper postu re.

13. In struct in proper posture by teach in g th e clien t to h old th e h an ds beh in d th e back to keep th e spin e an d n eck erect.

14. Prom o te ph ysical th erap y an d reh abilitatio n . 15. Adm in ister an tiparkin son ian m edication s to

in crease th e level of dopam in e in th e CNS. 16. In struct th e clien t to avoid foods h igh in vita-

m in B6 because th ey block th e effects of an tipar- kin son ian m edication s.

17. Avoid th e use of m on oam in e oxidase in h ibitors because th ey will precipitate h yperten sive crisis.

18. See Ch apter 63 regardin g m edication to treat Parkin son ’s disease.

XV. Trigeminal Neuralgia A. Description

1. A sen sory disorder of th e trigem in al (fifth cran ial) n erve

2. It results in severe, recurren t, sh arp, facial pain alon g th e trigem in al n erve.

B. Assessm en t 1. Th e clien t h as severe pain on th e lips, gu m s, or

n ose, or across th e ch eeks. 2. Situ ation s th at stim ulate sym pto m s in clude cold,

wash in g th e face, ch ewin g, or food or fluid s of extrem e tem p eratures.

C. In terven tion s 1. In struct th e clien t to avoid h ot or co ld food s an d

fluid s. 2. Provide sm all feedin gs of liquid an d soft food s. 3. In struct th e clien t to ch ew food on th e

un affected side. 4. Adm in ister m edication s as prescribed (see

Ch apter 63). D. Surgical in terven tion s

1. Microvascu lar deco m pression : Surgical relo ca- tion of th e artery th at com presses th e trigem in al n erve as it en ters th e pon s, wh ich m ay relieve pain with ou t com pro m isin g facial sen sation

913CHAPTER 62 Neurological System

2. Rad iofrequ en cy waveform s: Create lesion s th at provide relief of pain with out com pro m isin g touch or m oto r fun ction

3. Rh izo tom y: Resection of th e root of th e n erve to relieve pain

4. Glycero l in jection : Destroys th e m yelin ated fib ers of th e trigem in al n erve (m ay take up to 3 weeks for pain relief to occur)

XVI. Bell’s Palsy (Facial Paralysis) A. Description

1. Caused by a lower m oto r n euron lesion of cra- n ial n erve VII th at m ay result from in fectio n , traum a, h em orrh age, m en in gitis, or tum o r.

2. It results in paralysis of 1 side of th e face. 3. Recovery usually occurs in a few weeks, with out

residual effects. B. Assessm en t

1. Flaccid facial m uscles 2. In ab ility to raise th e eyeb rows, frown , sm ile,

clo se th e eyelids, or puff out th e ch eeks 3. Upward m ovem en t of th e eye wh en attem p tin g

to close th e eyelid 4. Loss of taste

C. In terven tion s 1. En cou rage facial exercises to preven t th e loss of

m uscle ton e (a face slin g m ay be prescribed to preven t stretch in g of weak m uscles).

2. Pro tect th e eyes fro m d ryn ess an d p reven t in ju ry.

3. Prom o te frequen t oral care. 4. In struct th e clien t to ch ew on th e un affected side.

XVII. Guillain-Barr e Syndrome A. Description

1. An acute in fectio us n euron itis of th e cran ial an d periph eral n erves.

2. Th e im m un e system overreacts to th e in fectio n an d destroys th e m yelin sh eath .

3. Th e syn d rom e usually is preced ed by a m ild upper respiratory in fectio n or gastro en teritis.

4. Th e recovery is a slow process an d can take years.

The major concern in Guillain-Barr e syndrome is dif- ficulty breathing; monitor respiratory status closely.

B. Assessm en t 1. Paresth esias 2. Pain an d/ o r h ypersen sitivity such as with th e

weigh t of bed sh eets or oth er item s touch in g th e body

3. Weakn ess of lo wer extrem ities 4. Gradu al progressive weakn ess of th e upper

extrem ities an d facial m uscles 5. Possible progressio n to respiratory failure 6. Card iac dysrh yth m ias 7. CSF th at reveals an elevated protein level 8. Abn orm al electroen ceph alogram

C. In terven tion s 1. Care is directed toward th e treatm en t of sym p-

tom s, in cludin g pain m an agem en t. 2. Mon itor respiratory status closely. 3. Provid e respiratory treatm en ts. 4. Prepare to in itiate respiratory supp ort. 5. Mon itor cardiac status. 6. Assess for com plication s of im m ob ility. 7. Provid e th e clien t an d fam ily with supp ort.

XVIII. Amyotrophic Lateral Sclerosis A. Descrip tion

1. Also kn own as Lou Geh rig’s disease 2. It is a progressive degen erative disease in volvin g

th e m oto r system . 3. Th e sen sory an d auton om ic system s are n ot

in volved, an d m en tal status ch an ges do n ot result from th e disease.

4. Th e cause of th e disease m ay be related to an excess of glutam ate, a ch em ical respo n sible for relayin g m essages between th e m oto r n euron s.

5. As the disease progresses, m uscle weakn ess an d atroph y develop un til a flaccid tetraplegia develops.

6. Even tu ally, th e respiratory m uscles becom e affected , lead in g to respiratory com pro m ise, pn eum on ia, an d death .

7. No cure is kn own , an d th e treatm en t is sym pto m atic.

B. Assessm en t 1. Resp iratory difficu lty 2. Fatigue wh ile talkin g 3. Muscle weakn ess an d atroph y 4. Ton gue atrop h y 5. Dysp h agia 6. Weakn ess of th e h an ds an d arm s 7. Fascicu lation s of th e face 8. Nasal quality of speech 9. Dysarth ria

C. In terven tion s 1. Care is directed toward th e treatm en t of sym p-

tom s. 2. Mon itor respiratory status an d in stitute m easures

to preven t aspiration . 3. Provid e respiratory treatm en ts. 4. Prepare to in itiate respiratory supp ort. 5. Assess for com plication s of im m ob ility. 6. Address advan ce directives as appropriate. 7. Provid e th e clien t an d fam ily with psych osocial

support.

XIX. Encephalitis A. Description

1. An in flam m ation of th e brain paren ch ym a an d often of th e m en in ges.

2. It affects th e cerebrum , brain stem , an d cerebellum . 3. It m ost often is cau sed by a viral agen t, alth ough

bacteria, fun gi, or parasites also m ay be in volved.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

914 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

4. Viral en ceph alitis is alm ost always preceded by a viral in fectio n .

B. Tran sm issio n 1. Arb oviruses can be tran sm itted to h um an

bein gs th rou gh th e bite of an in fected m osquito or tick.

2. Ech ovirus, coxsackievirus, poliovirus, h erp es zos- ter virus, an d viruses th at cause m um ps an d ch icken pox are com m on en teroviruses associ- ated with en ceph alitis.

3. Herpes sim plex type 1 virus can cause viral en ceph alitis.

4. Th e organ ism th at cau ses am ebic m en in go en - ceph alitis can en ter th e n asal m ucosa of perso n s swim m in g in warm fresh water, such as a pon d or lake.

C. Assessm en t 1. Presen ce of cold sores, lesion s, or ulceration s of

th e oral cavity 2. Histo ry of in sect bites an d swim m in g in fresh

water 3. Expo sure to in fectio us diseases 4. Travel to areas wh ere th e disease is prevalen t 5. Fever 6. Nausea an d vo m itin g 7. Nu ch al rigidity 8. Ch an ges in level of con sciousn ess an d m en tal

status 9. Sign s of in creased ICP

10. Moto r dysfun ction an d focal n eurological deficits

D. In terven tion s 1. Mon itor vital an d n eurological sign s. 2. Assess level of con sciousn ess usin g th e Glasgow

Com a Scale. 3. Assess for m en tal status ch an ges an d person ality

an d beh avior ch an ges. 4. Assess for sign s of in creased ICP. 5. Assess for th e presen ce of n uch al rigidity an d a

positive Kernig’s sign or Brudzinski’s sign, in di- catin g m en in geal irritatio n (Fig. 62-5).

6. Assist th e clien t to turn , cough , an d deep- breath e frequen tly.

7. Elevate th e h ead of th e bed 30 to 45 degrees. 8. Assess for m uscle an d n eurological deficits. 9. Adm in ister acyclovir as prescribed (usually th e

m ed ication of ch oice for h erpes en ceph alitis) .

10. In itiate reh abilitation as n eeded for m oto r dys- fun ction or n eurological deficits.

XX. West Nile Virus Infection A. Description

1. A poten tially serious illn ess th at affects th e CNS 2. Th e virus is con tracted prim arily by th e bite of an

in fected m osq uito (m osquitoes becom e carriers wh en th ey feed on in fected birds).

3. Sym ptom s typically develop between 3 an d 14 days after bein g bitten by th e in fected m osq uito.

4. Neurological effects can be perm an en t. B. Assessm en t

1. Man y in dividuals will n ot experien ce an y sym pto m s.

2. Mild sym pto m s in clude fever; h ead ach e an d body ach es; n ausea; vom itin g; swollen glan ds; or a rash on th e ch est, stom ach , or back.

3. Severe sym pto m s in clude a h igh fever, h ead ach e, n eck stiffn ess, stupor, disorien tation , trem o rs, m uscle weakn ess, vision loss, n um bn ess, paraly- sis, seizures, or com a.

C. In terven tion s are supp ortive; th ere is n o specific treatm en t for th e virus.

D. Preven tion 1. Use in sect repellen ts con tain in g DEET (dieth yl-

toluam ide) wh en outd oors an d wear lon g sleeves an d pan ts an d ligh t-colored clo th in g.

2. Stay in doors at dusk an d dawn wh en m osq uitoes are m ost active.

3. En su re th at m osq uito breedin g sites are elim i- n ated , such as stan d in g water an d water in bird bath s, an d keep wadin g pools em p ty an d on th eir sides wh en n ot in use.

XXI. Meningitis A. Description

1. An in flam m ation of th e arach n oid an d pia m ater of th e brain an d spin al cord

2. It is caused by bacterial an d viral organ ism s, alth ough fun gal an d protozoan m en in gitis also occur.

3. Predisp osin g facto rs in clude skull fractures, brain or spin al surgery, sin us or upper respiratory in fectio n s, th e use of n asal sprays, an d a com pro - m ised im m un e system .

4. CSF is an alyzed to determ in e th e diagn osis an d typ e of m en in gitis. In m en in gitis, CSF is cloudy, with in creased protein , in creased wh ite blood cells, an d decreased gluco se coun ts.

B. Tran sm issio n : Tran sm issio n occurs in areas of h igh popu lation den sity, crowded livin g areas such as col- lege dorm itories, an d prison s.

Transmission of meningitis is by direct contact, including droplet spread.FIGURE 62-5 Kernig’s sign and Brudzinski’s sign.

915CHAPTER 62 Neurological System

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

C. Assessm en t (see Box 62-4) 1. Mild leth argy 2. Ph o toph ob ia 3. Deterioration in th e level of co n sciousn ess 4. Sign s of m en in geal irritation , such as n uch al rigid-

ity an d a positive Kern ig’s sign an d Brudzin ski’s sign 5. Red, m acular rash with m en in gococcal m en in gitis 6. Abdo m in al an d ch est pain with viral m en in gitis

D. In terven tion s 1. Mon itor vital sign s an d n eurological sign s. 2. Assess for sign s of in creased ICP. 3. In itiate seizu re precaution s. 4. Mon itor for seizure activity. 5. Mon itor for sign s of m en in geal irritatio n . 6. Perform cran ial n erve assessm en t. 7. Assess periph eral vascular status (septic em b oli

m ay block circulation ). 8. Main tain isolation precaution s as n ecessary

with bacterial m en in gitis. 9. Main tain urin e an d stool precaution s with viral

m en in gitis. 10. Main tain respiratory isolation for th e clien t with

pn eum ococcal m en in gitis. 11. Elevate th e h ead of th e bed 30 degrees, an d

avoid n eck flexion an d extrem e h ip flexion . 12. Preven t stim ulation an d restrict visitors. 13. Adm in ister an algesics an d/ o r an tibiotics as

prescribed.

CRITICAL THINKING What Should You Do? Answer: Unilateral body neglect syndrome is particularly common with strokes in the right cerebral hemisphere. In this syndrome, the client is unaware of his or her left or par- alyzed side and neglects that side. If the nurse makes this observation, the nurse should immediately assess the client for signs of injury and provide safety to the client. When assessed, the client with this syndrome often indicates that everything is fine and believes that he or she is sitting up straight in the chair. The client should be taught to use both sides of the body and to attend to the affected side first. If the client is experiencing visual problems, the client is taught to turn the head from side to side to expand the visual field.

Reference: Ignatavicius, Workman (20 16), pp. 936, 944.

P R A C T I C E Q U E S T I O N S 769. Th e n urse is assessin g th e m oto r an d sen sory fun c-

tio n of an un con scious clien t. Th e n urse sh ould use wh ich tech n iqu e to test th e clien t’s periph eral respo n se to pain ? 1. Stern al ru b 2. Nail bed pressure 3. Pressure on th e orbital rim 4. Squeezin g of th e stern ocleidom astoid m uscle

770. Th e n urse is carin g for th e clien t with in creased in tracran ial pressure. Th e n urse would n ote wh ich tren d in vital sign s if th e in tracran ial pressure is risin g? 1. In creasin g tem perature, in creasin g pulse, in creas-

in g respirations, decreasin g blood pressure 2. In creasin g tem perature, decreasin g pulse, de-

creasin g respiratio n s, in creasin g blood pressure 3. Decreasin g tem p erature, decreasin g pulse, in -

creasin g respiration s, decreasin g blood pressure 4. Decreasin g tem perature, in creasin g pulse, de-

creasin g respiration s, in creasin g blood pressure

771. A clien t recoverin g fro m a h ead in ju ry is participat- in g in care. Th e n urse determ in es th at th e clien t un d erstan ds m easu res to preven t elevation s in in tracran ial pressure if th e n urse observes th e clien t doin g wh ich activity? 1. Blowin g th e n ose 2. Iso m etric exercises 3. Cough in g vigorou sly 4. Exh alin g durin g reposition in g

772. A clien t h as clear flu id leakin g from th e n ose fol- lowin g a basilar skull fracture. Wh ich fin din g would alert th e n urse th at cerebro spin al fluid is presen t? 1. Fluid is clear an d tests n egative for glucose. 2. Fluid is grossly bloody in appearan ce an d h as a

pH of 6. 3. Flu id clum ps togeth er on th e dressin g an d h as a

pH of 7. 4. Fluid separates in to con cen tric rin gs an d tests

positive for gluco se.

773. A clien t with a spin al cord in jury is pron e to experien cin g auton om ic dysreflexia. Th e n urse sh ould in clude wh ich m easu res in th e plan of care to m in im ize th e risk of occurren ce? Select all th at ap p ly.

1. Keepin g th e lin en s wrin kle-free un der th e clien t

2. Preven tin g un n ecessary pressure on th e lower lim b s

3. Lim itin g blad der cath eterization to on ce every 12 h ou rs

4. Turn in g an d reposition in g th e clien t at least every 2 h ours

5. En su rin g th at th e clien t h as a bowel m ove- m en t at least on ce a week

774. Th e n urse is evalu atin g th e n eurological sign s of a clien t in spin al sh o ck follo win g spin al cord

916 UNIT XVI Neurological Disorders of the Adult Client

in jury. Wh ich observation in dicates th at spin al sh ock persists? 1. Hyperreflexia 2. Positive reflexes 3. Flaccid paralysis 4. Reflex em ptyin g of th e blad der

775. Th e n urse is carin g for a clien t wh o begin s to exp erien ce seizure activity wh ile in bed. Wh ich action s sh ould th e n urse take? Select all th at ap p ly.

1. Loo sen in g restrictive cloth in g 2. Restrain in g th e clien t’s lim b s 3. Rem o vin g th e pillow an d raisin g padded

side rails 4. Position in g th e clien t to th e side, if possib le,

with th e h ead flexed forward 5. Keepin g th e curtain aroun d th e clien t an d th e

room door open so wh en h elp arrives th ey can quickly en ter to assist

776. Th e n urse is assign ed to care for a clien t with com plete righ t-sided h em iparesis from a stroke (brain attack). Wh ich ch aracteristics are asso- ciated with th is con dition ? Select all th at ap p ly.

1. Th e clien t is aph asic. 2. Th e clien t h as weakn ess on th e righ t side of

th e body. 3. Th e clien t h as com plete bilateral paralysis of

th e arm s an d legs. 4. Th e clien t h as weakn ess on th e righ t side of

th e face an d ton gue. 5. Th e clien t h as lost th e ability to m ove th e righ t

arm but is able to walk in depen den tly. 6. Th e clien t h as lost th e ability to am bulate

in depen den tly but is able to feed an d bath e h im self or h erself with ou t assistan ce.

777. Th e n urse h as in structed th e fam ily of a clien t with stroke (brain attack) wh o h as h om on ym ous h em i- an opsia about m easures to h elp th e clien t over- com e th e deficit. Wh ich statem en t suggests th at th e fam ily un derstan ds th e m easu res to use wh en carin g for th e clien t? 1. “We n eed to discourage h im from wearin g

eyeglasses.” 2. “We n eed to place objects in h is im paired field

of vision .” 3. “We n eed to approach h im fro m th e im paired

field of vision .” 4. “We n eed to rem in d h im to turn h is h ead to

scan th e lost visual field.”

778. Th e n u rse is assessin g th e ad ap tatio n o f a clien t to ch an ges in fu n ctio n al statu s after a stro ke ( b rain attack) . Wh ich o b servatio n in d icates to th e n u rse th at th e clien t is ad ap tin g m o st su ccessfu lly?

1. Gets an gry with fam ily if th ey in terrup t a task 2. Experien ces bouts of depression an d irritability 3. Has difficulty with usin g m od ified feedin g

uten sils 4. Con sisten tly uses adap tive equipm en t in dress-

in g self

779. Th e n urse is teach in g a clien t with m yasth en ia gravis about th e preven tion of m yasth en ic an d ch olin ergic crises. Wh ich clien t activity suggests th at teach in g is m o st effective? 1. Takin g m edication s as sch eduled 2. Eatin g large, well-balan ced m eals 3. Doin g m uscle-stren gth en in g exercises 4. Do in g all ch ores early in th e day wh ile less

fatigued

780. Th e n urse is in structin g a clien t with Parkin son ’s disease about preven tin g falls. Wh ich clien t state- m en t reflects a n eed fo r fu rth er teach in g? 1. “I can sit down to put on m y pan ts an d sh oes.” 2. “I try to exercise every day an d rest when I’m tired.” 3. “My son rem oved all loose rugs from m y

bedroom .” 4. “I don ’t n eed to use m y walker to get to th e

bath roo m .”

781. Th e n urse h as given suggestio n s to a clien t with tri- gem in al n euralgia ab out strategies to m in im ize episo des of pain . Th e n urse determ in es th at th e cli- en t n eed s fu rth er teach in g if th e clien t m akes wh ich statem en t? 1. “I will wash m y face with cotton pads.” 2. “I’ll h ave to start ch ewin g on m y un affected

side.” 3. “I sh ould rin se m y m ou th if tooth brush in g is

pain ful.” 4. “I’ll try to eat m y food eith er very warm or

very cold.”

782. Th e clien t is adm itted to th e h ospital with a diagn o- sis of Guillain -Barr e syn drom e. Wh ich past m ed i- cal h istory fin din g m akes th e clien t m o st at risk for th is disease? 1. Men in gitis or en ceph alitis durin g th e last 5 years 2. Seizures or traum a to th e brain with in th e

last year 3. Back in ju ry or traum a to th e spin al cord durin g

th e last 2 years 4. Resp iratory or gastro in testin al in fectio n durin g

th e previous m on th

783. A clien t with Guillain -Barr e syn d rom e h as ascen d- in g paralysis an d is in tubated an d receivin g m ech an ical ven tilation . Wh ich strategy sh ould th e n urse in corporate in th e plan of care to h elp th e clien t cope with th is illn ess?

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

917CHAPTER 62 Neurological System

1. Givin g clien t full co n trol over care decision s an d restrictin g visitors

2. Providin g positive feed back an d en couragin g active ran ge of m otion

3. Providin g in form ation , givin g positive feed- back, an d en couragin g relaxation

4. Providin g in traven o usly adm in istered sed a- tives, reducin g distraction s, an d lim itin g visitors

784. A clien t h as a n eurological deficit in volvin g th e lim b ic system . O n assessm en t, wh ich fin din g is specific to th is type of deficit? 1. Is disorien ted to perso n , place, an d tim e 2. Affect is flat, with periods of em otion al lability 3. Can n ot recall wh at was eaten for breakfast today 4. Dem on strates in ability to ad d an d subtract;

does n ot kn ow wh o is th e presiden t of th e Un ited States

785. Th e n urse is in stitutin g seizure precaution s for a cli- en t wh o is bein g ad m itted from th e em ergen cy dep artm en t. Wh ich m easures sh ould th e n urse in clude in plan n in g for th e clien t’s safety? Select all th at ap p ly.

1. Paddin g th e side rails of th e bed 2. Placin g an airway at th e bedside 3. Placin g th e bed in th e h igh position 4. Puttin g a padded ton gue blad e at th e h ead of

th e bed 5. Placin g oxygen an d suction equ ipm en t at th e

bedside 6. Flush in g th e in traven o us cath eter to en sure

th at th e site is paten t

786. Th e n urse is evaluatin g th e status of a clien t wh o h ad a cran iotom y 3 days ago. Wh ich assess- m en t fin din g would in dicate th at th e clien t is developin g m en in gitis as a com plication of surgery? 1. A n egative Kern ig’s sign 2. Absen ce of n uch al rigidity 3. A positive Brud zin ski’s sign 4. A Glasgow Com a Scale score of 15

787. Th e n urse h as com pleted disch arge in struction s for a clien t with application of a h alo device. Wh ich statem en t in dicates th at th e clien t n eed s fu rth er clarificatio n of th e in struction s? 1. “I will use a straw for drin kin g.” 2. “I will drive on ly durin g th e daytim e.” 3. “I will be careful because th e device alters

balan ce.” 4. I will wash th e skin daily un der th e lam b’s wool

lin er of th e vest.”

788. Th e n urse is adm ittin g a clien t with Guillain -Barr e syn d rom e to th e n ursin g un it. Th e clien t h as ascen din g paralysis to th e level of th e waist. Kn o w- in g th e com plication s of th e disorder, th e n urse sh ould brin g wh ich m o st essen tial item s in to th e clien t’s ro om ? 1. Nebulizer an d pulse oxim eter 2. Bloo d pressure cuff an d flash ligh t 3. Flash ligh t an d in cen tive spirom eter 4. Electro cardiograph ic m on itorin g electrodes an d

in tub ation tray

A N S W E R S 769. 2 Ra tion a le: Nail b ed p ressu re tests a basic m oto r an d sen sory p erip h eral resp on se. Cerebral respo n ses to pain are tested u sin g a stern al ru b, p lacin g up ward p ressu re o n th e o rb ital rim , or sq ueezin g th e clavicle o r stern ocleido m asto id m uscle. Test-Ta kin g St r a tegy: Focu s on th e su b ject, testin g perip h eral respo n se to pain . Th e n ail bed s are th e m o st distal of all o ptio n s an d are th erefore th e m o st perip h eral. Each o f th e o th er op tio n s m ay elicit a gen eralized respo n se, bu t n o t a lo calized on e. Review: Th e tech n iq u e fo r testin g p erip h eral resp o n se to p ain Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Neu ro logical Pr ior it y Con cept s: In tracran ial Regu lation ; Pain Refer en ce: Lewis et al. (2014), p . 1360.

770. 2 Ra tion a le: A ch an ge in vital sign s m ay b e a late sign of in creased in tracran ial pressu re. Tren ds in clu de in creasin g

tem perature an d b lo od pressure an d d ecreasin g p ulse an d res- p iratio n s. Respiratory irregu larities also m ay o ccu r. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, sign s o f in creased in tracran ial p ressure. If yo u rem em ber th at th e tem perature rises, you are able to elim in ate option s 3 an d 4. If you kn ow th at th e clien t becom es bradycard ic, or kn ow th at th e blo o d p ressu re rises, you are ab le to select th e co rrect op tion . Review: Th e sign s o f in creased in tracran ial p ressu re Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Neurological Pr ior it y Con cept s: Clin ical Ju dgm en t; In tracran ial Regulation Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 939, 941.

771. 4 Ra tion a le: Activities th at in crease in trath o racic an d in traab - d om in al pressu res cau se an in direct elevatio n of th e in tracra- n ial pressure. So m e o f th ese activities in clu de iso m etric exercises, Valsalva’s m an eu ver, cou gh in g, sn eezin g, an d blo w- in g th e n o se. Exh alin g du rin g activities such as repo sitio n in g or p ullin g up in bed op en s th e glo ttis, wh ich preven ts in trath o- racic pressure from risin g.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

918 UNIT XVI Neurological Disorders of the Adult Client

Test -Ta kin g St r a tegy: Fo cus on th e su b ject, p reven tin g eleva- tion s in in tracran ial p ressu re. Evaluate each o p tion in term s o f th e ten sio n it p uts on th e b od y. Do in g so will h elp you to elim - in ate each in correct o p tion system atically. Review: Th e m easures th at will redu ce or preven t in creased in tracran ial p ressu re Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Clien t Edu catio n ; In tracran ial Regu lation Refer en ce: Lewis et al. (2014), p p. 1361, 1367–1368.

772. 4 Ra t ion a le: Leakage o f cereb ro spin al flu id ( CSF) fro m th e ears or n o se m ay acco m p an y b asilar sku ll fractu re. CSF can b e dis- tin guish ed fro m oth er b o dy flu ids b ecau se th e d rain age will separate in to b loo dy an d yellow con cen tric rin gs on d ressin g m aterial, called a halo sign. Th e flu id also tests p ositive for glucose. Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e ch aracteristics of CSF. Recall th at CSF con tain s gluco se, wh ereas o th er secre- tion s, such as m u cu s, do n o t. Kn owin g th at CSF sep arates in to rin gs also will h elp you to an swer th is question . Review: Testin g fo r cereb ro sp in al flu id Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ign atavicius, Workm an (2016), p . 952.

773. 1, 2, 4 Ra t ion a le: Th e m o st frequ en t cau se o f auto n o m ic d ysreflexia is a d isten d ed b ladd er. Straigh t cath eterizatio n sh ou ld b e d o n e every 4 to 6 h ou rs ( cath eterization every 12 h ou rs is to o in fre- qu en t), an d u rin ary cath eters sh o uld be ch ecked frequ en tly to preven t kin ks in th e tu b in g. Co n stipatio n an d fecal im p actio n are oth er causes, so m ain tain in g bo wel regu larity is im po rtan t. En surin g a b owel m ovem en t on ce a week is m uch too in fre- qu en t. O th er cau ses in clud e stim ulation o f th e skin from tac- tile, th erm al, or p ain fu l stim u li. Th e n urse ad m in isters care to m in im ize risk in th ese areas. Test -Ta kin g St r a t egy: Focu s on th e su b ject, p reven tin g auto- n om ic dysreflexia. Rem em b er th at au ton om ic dysreflexia is cau sed by n oxiou s stim u li to th e bo wel, b ladd er, or skin . With th is in m in d , yo u can elim in ate easily each o f th e in correct op tion s. Review: Th e m easu res to m in im ize th e risk of au to n o m ic d ysreflexia Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Caregivin g; In tracran ial Regulatio n Refer en ce: Ign atavicius, Workm an (2016), p . 899.

774. 3 Ra t ion a le: Reso lu tion o f sp in al sh ock is o ccu rrin g wh en th ere is return of reflexes (especially flexors to n o xio us cu tan eou s

stim u li) , a state o f h yp erreflexia rath er th an flaccidity, an d reflex em p tyin g of th e b ladd er. Test -Ta kin g Str a tegy: Recall th at sp in al sh o ck is ch aracterized b y th e lo ss o f m ovem en t of skeletal m u scles, loss o f b owel o r b lad der wall fun ctio n , an d d epressed reflex action . Return o f an y o f th ese in d icates th at sp in al sh o ck is begin n in g to resolve. Note th at op tio n s 1, 2, an d 4 are co m p arab le o r alike, in d icat- in g th e presen ce of reflexes. Review: Sign s of sp in al sh o ck Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Evid en ce; In tracran ial Regu latio n Refer en ce: Ign atavicius, Workm an (2016), p . 894.

775. 1, 3, 4 Ra t ion a le: Nu rsin g actio n s du rin g a seizure in clud e providin g fo r privacy, loo sen in g restrictive clo th in g, rem ovin g th e p illow an d raisin g pad ded side rails in th e bed , an d placin g th e clien t o n 1 sid e with th e h ead flexed forward, if po ssib le, to allo w th e to n gu e to fall forward an d facilitate d rain age. Th e lim b s are n ever restrain ed because th e stro n g m u scle con tractio n s cou ld cause th e clien t h arm . If th e clien t is n ot in b ed wh en seizu re activity begin s, th e n urse lowers th e clien t to th e floo r, if po s- sible; protects th e h ead from in ju ry; an d m o ves furn itu re th at m ay in jure th e clien t. Test -Ta kin g St r a t egy: Focus on th e su b ject, in terven tion s du r- in g a seizu re. Th in k abo u t eth ical an d legal issues to elim in ate o p tion 5. Next, evalu ate th is qu estio n fro m th e persp ective o f causin g p ossible h arm . No h arm can co m e to th e clien t fro m an y of th e o ptio n s excep t for restrain in g th e lim b s. Rem em b er to avo id restrain ts. Review: Care o f a clien t d urin g a seizu re Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: In tracran ial Regu latio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 861.

776. 1, 2, 4 Ra t ion a le: Hem ip aresis is a weakn ess o f o n e side of th e b o dy th at m ay o ccu r after a stroke. It in vo lves weakn ess of th e face an d ton gue, arm , an d leg on o n e sid e. Th ese clien ts are also ap h asic: u n ab le to discrim in ate wo rd s an d letters. Th ey are gen - erally very cautiou s an d get an xio us wh en attem p tin g a n ew task. Com p lete b ilateral paralysis d oes n o t o ccur in h em ipar- esis. Th e clien t with righ t-sid ed h em iparesis h as weakn ess o f th e righ t arm an d leg an d n eeds assistan ce with feedin g, bath - in g, an d am b ulatin g. Test -Ta kin g St r a t egy: Focus on th e su b ject, righ t-sided h em i- p aresis. Recallin g th at h em ip aresis in dicates weakn ess o n o n e side of th e b od y an d focu sin g o n th e su b ject will d irect yo u to th e co rrect o ptio n . Also , n o tin g th e wo rd complete in th e q ues- tion will assist yo u in an swerin g correctly. Review: Hem ip aresis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

919CHAPTER 62 Neurological System

Con ten t Ar ea : Adu lt Health —Neu ro logical Pr ior it y Con cept s: Fun ctio n al Ab ility; In tracran ial Regu lation Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 934.

777. 4 Ra tion a le: Ho m o n ym ou s h em ian o psia is loss of h alf of th e visu al field. Th e clien t with h o m on ym o us h em ian o psia sh ou ld h ave ob jects p laced in th e in tact field o f visio n , an d th e n urse also sh o uld app ro ach th e clien t from th e in tact sid e. Th e n urse in stru cts th e clien t to scan th e en viron m en t to o vercom e th e visu al d eficit an d d oes clien t teach in g fro m with in th e in tact field o f visio n . Th e n u rse en cou rages th e u se of p erso n al eye- glasses, if th ey are available. Test-Ta kin g St r a t egy: Focus on th e su b ject, h o m on ym o us h em ian op sia. Elim in ate op tio n s 2 an d 3 first because th ey are co m p arab le o r alike. Recallin g th e defin itio n o f h o m o n y- m ou s h em ian o psia will d irect yo u easily to th e correct o ption . Review: Ho m o n ym o u s h em ian o p sia Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Neu ro logical Pr ior it y Con cept s: In tracran ial Regu lation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 936.

778. 4 Ra tion a le: Clien ts are evaluated as cop in g su ccessfu lly with lifestyle ch an ges after a stroke if th ey m ake ap pro priate lifestyle alteration s, use th e assistan ce of oth ers, an d h ave ap prop riate so cial in teraction s. O p tio n s 1 an d 2 are n o t ad ap tive b eh avio rs; o ptio n 3 in dicates a n o t yet su ccessfu l attem p t to adap t. Test-Ta kin g St r a t egy: No te th e strategic wo rd , most, an d fo cus o n th e su b ject, in dication s th at a clien t wh o h as h ad a stroke is ad ap tin g m o st su ccessfu lly. O ptio n s 1 an d 2 are b eh avio rs th at m ay b e expected in th e clien t with a stroke, b ut th ey are n o t ad ap tive respo n ses. In stead , th ey are a resu lt o f th e in sult to th e b rain . O ptio n s 3 an d 4 in d icate th at th e clien t is tryin g to ad ap t, b ut th e co rrect o p tion h as th e best ou tcom e. Review: Care of th e clien t with a stro ke Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Neu ro logical Pr ior it y Con cept s: Co pin g; Fu n ction al Ab ility Refer en ce: Lewis et al. (2014), p . 1408.

779. 1 Ra tion a le: Clien ts with m yasth en ia gravis are taugh t to sp ace o ut activities o ver th e day to con serve en ergy an d resto re m u scle stren gth . Takin g m edicatio n s correctly to m ain tain blo o d levels th at are n ot too low or to o h igh is im po rtan t. Muscle- stren gth en in g exercises are n ot h elp ful an d can fatigue th e clien t. O vereatin g is a cau se o f exacerb ation of sym pto m s, as is exp o - su re to h eat, cro wds, erratic sleep h abits, an d em o tion al stress. Test-Ta kin g Str a tegy: No te th e strategic wo rd s, most effective. Recallin g th at th e co m m o n cau ses o f m yasth en ic an d ch o lin ergic crises are u n d erm ed ication an d o verm edicatio n , respectively, will assist yo u in elim in atin g each of th e in co rrect o ptio n s. No o th er op tio n wou ld preven t b oth of th ose com plicatio n s.

Review: Measu res to preven t m yasth en ic crisis an d ch o lin er- gic crisis Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ad ult Health —Neurological Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 920.

780. 4 Ra tion a le: Th e clien t with Parkin son ’s d isease sh o uld be in stru cted regard in g safety m easu res in th e h o m e. Th e clien t sh o u ld u se h is o r h er walker as su p po rt to get to th e b ath roo m b ecau se of b rad ykin esia. Th e clien t sh ou ld sit d own to pu t on p an ts an d sh o es to p reven t fallin g. Th e clien t sh ou ld exercise every day in th e m orn in g wh en en ergy levels are h igh est. Th e clien t sh o u ld h ave all lo ose ru gs in th e h o m e rem o ved to p re- ven t fallin g. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further teaching. Th ese wo rd s in dicate a n egative even t q u ery an d th e n eed to select th e in co rrect clien t statem en t as th e an swer. Recall th at clien ts with Parkin so n ’s d isease are at risk fo r falls. Review: Clien t teach in g po in ts for Parkin so n ’s d isease Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Neurological Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Lewis et al. (2014), p . 1437.

781. 4 Ra tion a le: Facial pain can be m in im ized by u sin g co tton pad s to wash th e face an d usin g roo m tem p eratu re water. Th e clien t sh o u ld ch ew o n th e u n affected sid e of th e m o u th , eat a soft d iet, an d take in fo od s an d b everages at roo m tem p eratu re. If b ru sh in g th e teeth triggers p ain , an oral rin se after m eals m ay b e h elp ful in stead. Test-Ta kin g Str a t egy: No te th e strategic wo rd s, needs further teaching. Th ese words in d icate a n egative even t q u ery an d ask yo u to select an o ptio n th at is in co rrect. Recall th at th e p ain o f trigem in al n euralgia is triggered by m ech an ical o r th erm al stim uli. Very h ot o r co ld foo ds are likely to trigger th e pain , n o t relieve it. Review: Clien t edu catio n p o in ts fo r trigem in al n eu ralgia Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Neurological Pr ior it y Con cept s: Clien t Ed ucation ; Pain Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 926–928.

782. 4 Ra tion a le: Guillain -Barr e syn drom e is a clin ical syn d ro m e of u n kn o wn origin th at in volves cran ial an d p eriph eral n erves. Man y clien ts rep ort a h isto ry o f respiratory o r gastro in testin al in fectio n in th e 1 to 4 weeks b efore th e on set o f n eurological d eficits. O n occasio n , th e syn d ro m e can be triggered b y vacci- n atio n or surgery. Test-Ta kin g Str a tegy: No te th e strategic wo rd , most. Use kn owled ge regard in g th e cau ses related to th is d iso rd er.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

920 UNIT XVI Neurological Disorders of the Adult Client

Rem em b er th at a recen t h isto ry of resp irato ry o r gastroin testi- n al in fectio n is a pred ispo sin g factor. Review: Gu illain -Barr e syn d ro m e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Clin ical Jud gm en t; In fectio n Refer en ce: Ign atavicius, Workm an (2016), p p. 913–914.

783. 3 Ra t ion a le: Th e clien t with Guillain -Barr e syn drom e experi- en ces fear an d an xiety fro m th e ascen din g p aralysis an d su dd en on set o f th e d isorder. Th e n urse can alleviate th ese fears b y pro- vidin g accurate in fo rm atio n ab ou t th e clien t’s con d itio n , giv- in g exp ert care an d po sitive feedb ack to th e clien t, an d en cou ragin g relaxation an d distraction . Th e fam ily can becom e in vo lved with selected care activities an d provid e diversio n for th e clien t as well. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, h elp in g a clien t co pe with illn ess. O p tio n 1 sh ou ld b e elim in ated first b ecau se it is n ot p ractical to th in k th at th e clien t wou ld wan t full co n trol over all care d ecision s. Th e clien t wh o is paralyzed can n ot par- ticip ate in active ran ge o f m o tion , wh ich elim in ates op tio n 2. From th e rem ain in g o p tion s, th e co rrect op tio n is m o re b en e- ficial in h elp in g th e clien t to cop e. Review: Care o f th e clien t with Gu illain -Barr e syn d ro m e Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Carin g Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Caregivin g; Cop in g Refer en ce: Ign atavicius, Workm an (2016), p . 917.

784. 2 Ra t ion a le: Th e lim bic system is respo n sib le fo r feelin gs (affect) an d em o tio n s. Calcu latio n ab ility an d kn o wledge o f cu rren t even ts relate to fun ction of th e fron tal lo be. Th e cereb ral h em i- sph eres, with sp ecific regio n al fu n ction s, co n trol o rien tation . Recall o f recen t even ts is co n tro lled b y th e h ip p ocam p us. Test -Ta kin g Str a tegy: Focus o n th e su b ject, n eu ro lo gical d ef- icit o f th e lim b ic system . It is n ecessary to recall th at th e lim bic system is respo n sible fo r feelin gs an d em otio n s to direct yo u to th e co rrect op tion . Review: Th e fu n ction o f th e lim b ic system Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Lewis et al. (2014), p . 1339.

785. 1, 2, 5, 6 Ra t ion a le: Seizure p recaution s m ay vary fro m agen cy to agen cy, but they gen erally h ave som e com m on featu res. Usu ally, an air- way, oxygen , an d suction in g equipm en t are kep t available at the bed side. Th e sid e rails o f th e b ed are p added, an d th e b ed is kept in th e lowest p ositio n . Th e clien t h as an in traven o us access in place to h ave a readily accessible route if an tiseizure m edication s m ust be adm in istered, an d as part of the routin e assessm en t th e n urse

should be ch eckin g p aten cy of th e catheter. The u se o f padded ton gu e b lades is h igh ly con troversial, an d th ey sh ould n ot be kep t at th e b edside. Fo rcin g a ton gue blade in to th e m ou th durin g a seizu re m o re likely will h arm th e clien t wh o bites d own d urin g seizu re activity. Risks in clud e b lo ckin g the airway fro m im p ro per p lacem en t, ch ip pin g th e clien t’s teeth , and sub sequen t risk o f asp iratin g tooth fragm en ts. If th e clien t h as an aura b efore th e sei- zure, it m ay give th e n urse eno ugh tim e to place an o ral airway b efore seizure activity begin s. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, seizu re precau - tion s. Evalu ate th is qu estio n from th e p erspective o f cau sin g p o ssible h arm . No h arm can com e to th e clien t from an y o f th e o ptio n s except fo r placin g th e b ed in th e h igh po sitio n an d usin g a to n gu e b lade. Review: Seizu re p recau tio n s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: In tracran ial Regu latio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p p. 860–862.

786. 3 Ra t ion a le: Sign s o f m en in geal irritation co m p atible with m en - in gitis in clu de n u ch al rigidity, a p ositive Bru dzin ski’s sign , an d p o sitive Kern ig’s sign . Nuch al rigid ity is ch aracterized b y a stiff n eck an d so ren ess, wh ich is esp ecially n o ticeab le wh en th e n eck is flexed . Kern ig’s sign is p ositive wh en th e clien t feels pain an d sp asm of th e h am strin g m u scles wh en th e leg is fu lly flexed at th e kn ee an d h ip. Bru dzin ski’s sign is po sitive wh en th e cli- en t flexes th e h ip s an d kn ees in resp o n se to th e n u rse gen tly flexin g th e h ead an d n eck o n to th e ch est. A Glasgow Co m a Scale sco re of 15 is a perfect sco re an d in dicates th at th e clien t is awake an d alert, with n o n eu ro lo gical d eficits. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, a clien t’s d iagn o sis o f m en in gitis. You can elim in ate o p tion s 1, 2, an d 4 becau se th ey are co m p arab le o r alike an d are n o rm al fin din gs. Review: Th e sign s o f m en in gitis Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: Clin ical Jud gm en t; In tracran ial Regu latio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p p. 863–864, 962.

787. 2 Ra t ion a le: Th e h alo d evice alters b alan ce an d can cau se fatigu e b ecause of its weigh t. Th e clien t sh ou ld clean se th e skin d aily u n d er th e vest to protect th e skin fro m u lceratio n an d sh o uld avo id th e u se o f po wd er o r lotio n s. Th e lin er sh o uld b e ch an - ged if o do r beco m es a p ro b lem . Th e clien t sh ou ld h ave foo d cu t in to sm all p ieces to facilitate ch ewin g an d u se a straw for d rin kin g. Pin care is d on e as in structed . Th e clien t can n ot d rive at all b ecause th e device im p airs th e ran ge o f visio n . Test -Ta kin g St r a t egy: Note th e strategic wo rd s, needs further clarification. Th ese wo rds in d icate a n egative even t q u ery an d ask yo u to select an op tion th at is in correct. Visualize th is d evice to an swer co rrectly. Th e in ability to tu rn th e h ead with - o u t turn in g th e torso wo uld con train dicate d rivin g. Also n o te th e clo sed -en d ed wo rd only in th e co rrect o p tion .

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

921CHAPTER 62 Neurological System

Review: Clien t edu catio n fo r a h alo d evice Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —Neu ro logical Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 897–898.

788. 4 Ra tion a le: Th e clien t with Gu illain -Barr e syn d ro m e is at risk fo r respirato ry failu re b ecau se o f ascen din g p aralysis. An in tu- b ation tray sh o uld b e available for use. An oth er co m p lication o f th is syn drom e is card iac d ysrh yth m ias, wh ich n ecessitates th e use o f electro card iograph ic m o n ito rin g. Becau se th e clien t is im m ob ilized, th e n urse sh ou ld assess for d eep vein th rom b o- sis an d p ulm o n ary em bo lism rou tin ely. Alth ou gh item s in th e

in co rrect o p tion s m ay be u sed in care, th ey are n ot th e m o st essen tial item s from th e o ptio n s p ro vided. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most essential. With an ascen d in g paralysis, th e clien t is at risk for in vo lve- m en t of resp irato ry m u scles an d su bsequ en t resp irato ry failure. Th e correct op tion is th e on ly o n e th at in clu des an in tub ation tray, wh ich wou ld be n eed ed if th e clien t’s statu s d eteriorated to n eedin g in tu batio n an d m ech an ical ven tilatio n . Th is op tion m ost directly add resses th e airway. Review: Care of th e clien t with Gu illain -Barr e syn d ro m e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Neurological Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 915–916.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

922 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

C H A P T E R 63 Neurological Medications

PRIORITY CONCEPTS Intracranial Regulation; Pain

CRITICAL THINKING What Should You Do? A client with a traumatic brain injury experiencing restless- ness and agitation due to the pain is receiving morphine. On assessment the nurse measures the respiratory rate and notes it to be 10 breaths/ minute. What should the nurse do? Answer located on p. 932.

I. Antimyasthenic Medications A. Description

1. An tim yasth en ic m edication s, also called an ti- ch olin esterase m edication s, relieve m uscle weakn ess associated with m yasth en ia gravis by blockin g acetylch olin e breakdown at th e n euro- m uscu lar jun ction .

2. Th ese are used to treat or diagn ose m yasth en ia gravis or to distin guish ch olin ergic crisis from m yasth en ic crisis.

3. Neostigm in e brom ide, pyridostigm in e, an d am ben on ium ch loride are used to con trol m yasth en ic sym pto m s.

4. Edroph on ium is used to diagn ose m yasth en ia gravis an d to distin guish ch olin ergic crisis fro m m yasth en ic crisis.

B. Med ication s (Box 63-1) C. Side an d adverse effects: Ch olin ergic crisis (Box 63-2) D. In terven tion s

1. Assess n eurom uscular status, in cludin g reflexes, m uscle stren gth , an d gait.

2. Mon itor th e clien t for sign s an d sym ptom s of m ed ication overdose (ch olin ergic crisis) an d un d erdose (m yasth en ic crisis).

3. In struct th e clien t to take m edication s on tim e to m ain tain th erap eutic blood level, th us preven tin g weakn ess, because weakn ess can im pair th e clien t’s ability to breath e an d swallow.

4. In struct th e clien t to take th e m edication with a sm all am oun t of food to preven t gastro in testi- n al sym ptom s.

5. In struct th e clien t to eat a m eal 45 to 60 m in u tes after takin g m ed ication s to decrease th e risk for aspiration .

6. In struct th e clien t to wear a Med icAlert bracelet. 7. No te th at an tim yasth en ic th erapy is lifelon g

th erap y. 8. Evaluate for m ed ication effectiven ess, wh ich is

based on th e im provem en t of n eurom u scular sym pto m s or stren gth with ou t ch olin ergic sign s an d sym pto m s.

9. Wh en ad m in isterin g edrop h on ium , h ave em er- gen cy resuscitation equ ipm en t on h an d an d atrop in e sulfate available for ch olin ergic crisis.

E. Edrophonium test (m ay be known as the Tensilon test) 1. Edroph on ium is in jected in traven o usly. 2. Th e edrop h on ium test can cau se bron ch o-

spasm , laryn gospasm , h ypo ten sion , bradycar- dia, an d cardiac arrest.

3. Atropin e sulfate is th e an tidote for overdose. 4. Diagn osis of m yasth en ia gravis: Most m yas-

th en ic clien ts will sh o w a sign ifican t im prove- m en t in m uscle ton e with in 30 to 60 secon ds after in jection , an d th e m uscle im provem en t lasts 4 to 5 m in utes.

5. Th e edrop h on ium test is also used to diagn ose ch olin ergic crisis (overdose with an tich olin es- terase) or m yasth en ic crisis (un derm edication ). a. In ch olin ergic crisis, m uscle ton e does n ot

im prove after th e adm in istration of edro- ph o n ium , an d m uscle twitch in g m ay be n oted arou n d th e eyes an d face.

b . An edroph on ium in jection tem porarily worsens th e con dition wh en a clien t is in ch o- lin ergic crisis (negative edroph on ium test).

c. An edroph onium in jection tem porarily im - proves the con dition when the client is in m yasthenic crisis (positive edrophonium test).

II. Multiple Sclerosis Medications A. Description

1. Med ication th erapy is aim ed at m od ifyin g th e disease, treatin g acute episo des or relap ses, an d treatin g sym ptom s.

923

2. Disease-m odifyin g m edication s decrease th e fre- quen cy an d severity of relapses, reduce brain lesion s, in crease future fun ction al cap ability, an d in crease overall quality of life.

3. Th e 2 m ain groups of disease-m o difyin g m edica- tion s are im m un om odulators an d im m un osup- pressan ts ( Box 63-3).

4. Treatin g acute episo des usually con sists of givin g a h igh -d ose gluco cortico id in traven o usly to sup- press in flam m ation or givin g gam m a globulin in traven ously.

5. Treatin g sym ptom s of m ultiple sclerosis can be don e with a variety of m edication s, an d the m edi- cation can be ch an ged if unfavorable effects occur.

6. Box 63-4 id en tifies m ed ication s com m on ly used to treat sym pto m s.

B. Side an d adverse effects 1. Im m un om o dulators: Flu-like reaction s, h epato-

toxicity, m yelosu ppression , in jection site reac- tion s, dep ression , an d n eutralizin g an tibod ies.

2. Im m un osuppressan ts: Myelosuppression, cardio- toxicity, fetal h arm , reversible h air loss, injury to th e gastroin testin al m ucosa, n ausea an d vom itin g, and m en strual irregularities.

III. Antiparkinsonian Medications A. Descrip tion

1. An tiparkin son ian m edication s restore th e bal- an ce of th e n eurotran sm itters acetylch olin e an d dopam in e in th e cen tral n ervous system (CNS), decreasin g th e sign s an d sym ptom s of Parkin - son ’s disease to m axim ize th e clien t’s fun ction al abilities.

2. Th ese m edication s in clude th e dopam in ergics, wh ich stim ulate th e dopam in e receptors; th e an tich o lin ergics, wh ich block th e ch olin ergic receptors; an d th e catech ol-O-m eth yltran sferase in h ib itors, wh ich in h ibit th e m etab olism of dopam in e in th e periph ery.

B. Dopam in ergic m edication s 1. Description

a . Do pam in ergic m ed ication s stim ulate th e dopam in e receptors an d in crease th e am oun t of dopam in e available in th e CNS or en h an ce n eurotran sm ission of dopam in e.

b . Do pam in ergic m edication s are con train d i- cated in clien ts with cardiac, ren al, or psych i- atric disorders.

Carbidopa-levodopa taken with a monoamine oxidase inhibitor antidepressant can cause a hyperten- sive crisis.

2. Medication s (Box 63-5) 3. Side an d adverse effects

a . Dyskin esia b . In vo lun tary body m ovem en ts c. Ch est pain d . Nausea an d vom itin g e. Urin ary reten tion f. Con stipation g. Sleep disturban ces, in som n ia, or periods

of sedation h . O rth ostatic h ypoten sion an d dizzin ess i. Con fusion

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 63-1 Antimyasthenic Medications

▪ Ambenonium chloride ▪ Edrophonium chloride

▪ Neostigmine bromide ▪ Pyridostigmine

BOX 63-2 Signs of Cholinergic Crisis ▪ Abdominal cramps ▪ Nausea, vomiting, and diarrhea ▪ Pupillary miosis ▪ Hypotension and dizziness ▪ Increased bronchial secretions ▪ Increased tearing and salivation ▪ Increased perspiration ▪ Bronchospasm, wheezing, and bradycardia

BOX 63-3 Medications for Multiple Sclerosis Immunomodulators Interferons (beta-1a, 1b, peginterferon beta-1a) Glatiramer acetate Fingolimod Teriflunomide Dimethyl fumarate

Immunosuppressant Mitoxantrone

Monoclonal antibodies Natalizumab Alemtuzumab

Potassium channel blockers Dalfampridine (used to improve walking)

BOX 63-4 Medications to Treat Symptoms of Multiple Sclerosis

Bladder and bowel dysfunction: psyllium, docusate Fatigue: amantadine, modafinil Depression: fluoxetine, sertraline Sexual dysfunction: sildenafil, vardenafil Neuropathic pain: gabapentin, carbamazepine

Adapted from Burchum JR, Rosenthal LD: Lehne’s pharmacology for nursing care, ed 9. St. Louis, 2016, Elsevier.

924 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

j. Mood ch an ges, especially depression k . Hallucin ation s l. Dry m outh

4. In terven tion s a . Assess vital sign s. b . Assess for risk of in jury. c. In struct th e clien t to take th e m ed ication

with food if n ausea or vom itin g occurs. d . Assess for sign s an d sym pto m s of parkin -

son ism such as rigidity, trem ors, akin esia, bradykin esia, a stoop ed forward posture, sh u fflin g gait, an d m asked facies.

e. Mon itor for sign s of dyskin esia. f. In struct th e clien t to report side an d adverse

effects an d sym pto m s of dyskin esia. g. Mon itor th e clien t for im provem en t in sign s

an d sym pto m s of parkin son ism . h . In struct the clien t to ch an ge position s slowly

to m in im ize orth ostatic h ypoten sion . i. In struct th e clien t n ot to discon tin ue th e

m ed ication abru ptly. j. In struct th e clien t to avoid alcoh ol.

k . In form th e clien t th at urin e or persp iration m ay be discolored an d th at th is is h arm less, but m ay stain th e cloth in g.

l. Ad vise th e clien t with d iab etes m ellitu s th at glu co se testin g sh o u ld n o t b e d o n e b y u rin e testin g b ecau se th e resu lts will n o t b e reliab le.

m . In struct th e clien t takin g carbido pa- levo dopa to divide th e total daily prescribed protein in take am on g all m eals of th e day; h igh -protein diets in terfere with m ed ication availability to th e CNS.

n . Wh en adm in isterin g carbido pa-levodo pa, in struct th e clien t to avoid excessive vitam in B6 in take to preven t m ed ication reaction s.

C. An tich olin ergic m ed ication s 1. Description

a. An tich olin ergic m edication s block th e ch o- lin ergic receptors in th e CNS, th ereby sup- pressin g acetylch olin e activity.

b . Th ey reduce th e trem o rs an d droolin g but h ave a m in im al effect on th e bradykin esia, rigidity, an d balan ce abn orm alities.

c. Th ey are con train dicated in clien ts with glaucom a.

d . Th e clien t with ch ron ic obstructive lun g dis- ease can develop dry, th ick m ucous secretion s.

2. Med ication s (see Box 63-5) 3. Side an d ad verse effects

a. Blurred vision b . Dryn ess of th e n ose, m outh , th roat, an d

respiratory secretio n s c. In creased pulse rate, palpitation s, an d

dysrh yth m ias d . Con stipation e. Urin ary reten tion f. Restlessn ess, con fusion , dep ression , an d

h allucin ation s g. Ph o toph ob ia

4. In terven tion s a. Mon itor vital sign s. b . Assess for risk of in jury. c. Mon itor th e clien t for im provem en t in sign s

an d sym pto m s. d . Assess th e clien t’s bowel an d urin ary fun c-

tio n an d m on itor for urin ary reten tion , con - stipation , an d paralytic ileus.

e. Mon itor for in volun tary m ovem en ts. f. En cou rage th e clien t to avoid alcoh ol, sm ok-

in g, caffein e, an d acetylsalicylic acid to decrease gastric acidity.

g. In struct th e clien t to con sult with a h ealth care provid er (HCP) before takin g an y n on - prescription m ed ication s.

h . In struct th e clien t to m in im ize dry m ou th by in creasin g fluid in take an d usin g ice ch ips, h ard can dy, or gum .

i. In struct th e clien t to preven t con stipation by in creasin g fluids an d fib er in th e diet.

j. In struct th e clien t to use sun glasses in direct sun ligh t because of possib le ph o toph ob ia.

k . In struct th e clien t to h ave routin e eye exam - in ation s to assess in traocular pressure.

If an anticholinergic medication is discontinued abruptly, the signs and symptoms of parkinsonism, such as rigidity, tremors, akinesia, bradykinesia, stooped for- ward posture, shuffling gait, and masked facies, may be intensified.

BOX 63-5 Medications to Treat Parkinson’s Disease

Medications Affecting the Amount of Dopamine ▪ Amantadine ▪ Apomorphine ▪ Bromocriptine ▪ Carbidopa-levodopa ▪ Pramipexole ▪ Rasagiline ▪ Ropinirole ▪ Selegiline hydrochloride Anticholinergics ▪ Benztropine mesylate ▪ Trihexyphenidyl hydrochloride Catechol-O-Methyltransferase (COMT) Inhibitors ▪ Carbidopa/ levodopa/ entacapone ▪ Entacapone ▪ Tolcapone

925CHAPTER 63 Neurological Medications

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

IV. Antiseizure Medications A. Description

1. An tiseizure m edication s are used to depress abn o rm al n euron al disch arges an d preven t th e spread of seizures to ad jacen t n euron s.

2. Th ese sh ould be used with caution in clien ts takin g an ticoagulan ts, acetylsalicylic acid, sul- fon am ides, cim etidin e, an d an tipsych otic m ed ication s.

3. Abso rption is decreased with th e use of an t- acids, calcium preparation s, an d an tin eop lastic m ed ication s.

B. In terven tion s for clien ts on an tiseizure m ed ication s 1. In itiate seizure precaution s. 2. Mon itor urin ary output. 3. Mon itor liver an d ren al fun ctio n tests an d m ed-

ication blood serum levels (Table 63-1). 4. Mon itor for sign s of m ed ication toxicity, wh ich

would in clude CNS dep ression , ataxia, n ausea, vom itin g, drowsin ess, dizzin ess, restlessn ess, an d visual disturban ces.

5. If a seizu re occurs, assess seizure activity, in clud- in g location an d duration (see Ch apter 62 for m an agem en t of seizures).

6. Protect th e clien t from h azards in th e en viron - m en t durin g a seizu re.

C. Clien t education ( Box 63-6) D. Hydan toin s: Fosph en ytoin , ph en ytoin

1. Hydan toin s are used to treat partial an d gen er- alized ton ic-clon ic seizu res.

2. Ph en ytoin is also used to treat dysrh yth m ias. 3. Side an d ad verse effects

a . Gin gival h yperplasia (red den ed gu m s th at bleed easily)

b . Slurred speech c. Con fusion d . Sedation an d drowsin ess e. Nausea an d vo m itin g f. Blurred vision an d n ystagm u s g. Headach es h . Bloo d dyscrasias: Decreased platelet coun t

an d decreased wh ite blood cell coun t i. Elevated blood gluco se level

j. Alo pecia or h irsutism k . Rash or pruritu s

4. In terven tion s a . Tu be feed in gs m ay in terfere with th e

ab sorption of th e en teral form of ph en ytoin an d dim in ish th e effectiven ess of th e m ed i- cation ; th erefore, feedin gs sh ould be sch ed- uled as far as possible away from th e tim e of ph en ytoin adm in istration .

b . Mon itor th erapeutic serum levels to assess for toxicity.

c. Mon itor for sign s of toxicity. d . Wh en adm in isterin g ph en yto in in trave-

n ou sly, dilute in n orm al salin e because dex- tro se causes th e m ed ication to precipitate.

e. Wh en adm in isterin g ph en yto in in trave- n ou sly, in fuse with an in lin e filter an d n o faster th an 25 to 50 m g/ m in ute; oth erwise, a decrease in blood pressure an d cardiac dysrh yth m ias could occur.

f. Assess for ataxia (staggerin g gait). g. In struct th e clien t to con sult with th e HCP

befo re takin g oth er m ed ication s to en sure com patibility with an ticon vulsan ts.

Phenytoin must be given slowly to prevent hypoten- sion and cardiac dysrythmias. Also, it may decrease the effectiveness of some birth control pills and may cause teratogenic effects, if taken during pregnancy.

E. Barbiturates: Am ob arbital, m ep h obarb ital, ph en o- barbital 1. Barbiturates are used for ton ic-clon ic seizures

an d acute episo des of seizu res caused by status epilep ticus.

TABLE 63-1 Antiseizure Medications Medication Therapeutic Serum Range

Carbamazepine 3-14 mcg/ mL (13-59 mcmol/ L)

Clonazepam 20-80 ng/ mL (0.02-0.0 8 mcg/ L)

Divalproex 50-100 mcg/ mL (347-693 mcmol/ L)

Ethosuximide 40-100 mcg/ mL (283-708 mcmol/ L)

Lorazepam 50-240 ng/ mL (156-746 nmol/ L)

Phenobarbital 15-40 mcg/ mL (65-172 mcmol/ L)

Phenytoin 10-20 mcg/ mL (40-79 mcmol/ L)

BOX 63-6 Client Education: Antiseizure Medications

Take the prescribed medication in the prescribed dose and frequency.

Take with food to decrease gastrointestinal irritation, but avoid milk and antacids, which impair absorption.

If taking liquid medication, shake well before ingesting. Do not discontinue the medications. Avoid alcohol. Avoid over-the-counter medications. Wear a MedicAlert bracelet. Use caution when performing activities that require alertness. Maintain good oral hygiene and use a soft toothbrush. Maintain preventive dental checkups. Maintain follow-up health care visits with periodic blood

studies related to determining toxicity. Monitor serum glucose levels (diabetes mellitus). Urine may be a harmless pink-red or red-brown color. Report symptoms of sore throat, bruising, and nosebleeds,

which may indicate a blood dyscrasia. Inform the health care provider if side and adverse effects

occur, such as bleeding gums, nausea, vomiting, blurred vision, slurred speech, rash, or dizziness.

926 UNIT XVI Neurological Disorders of the Adult Client

2. Barbiturates also m ay be used as ad jun cts to an esth esia.

3. Sid e an d adverse effects a. Sedation , ataxia, an d dizzin ess durin g in i-

tial treatm en t b . Mood ch an ges c. Hypoten sion d . Respiratory depression e. Toleran ce to th e m ed ication

F. Ben zodiazepin es: Clon azepam , clorazepate, diaze- pam , lorazepam 1. Ben zodiazepin es are used to treat absen ce

seizu res. 2. Diazepam an d lorazepam are used to treat status

epilepticus, an xiety, and skeletal m uscle spasm s. 3. Clo razepate is used as ad jun ctive th erapy for

partial seizures. 4. Sid e an d adverse effects

a. Sedation , drowsin ess, dizzin ess, blurred vision

b . For in traven ous in jection , adm in ister slowly to preven t brad ycardia.

c. Medication toleran ce an d depen den cy d . Blood dyscrasias: Decreased platelet coun t

an d decreased wh ite blood cell coun t e. Hepatoto xicity

Flumazenil reverses the effects of benzodiazepines. It should not be administered to clients with increased intracranial pressure or status epilepticus who were treated with benzodiazepines because these problems may recur with reversal.

G. Succin im ides: Eth o suxim id e, m eth su xim ide 1. Succin im ides are used to treat absen ce seizu res. 2. Sid e an d adverse effects

a. An orexia, n ausea, vo m itin g b . Blood dyscrasias

H. Valproates: Valproic acid, divalproex sodium 1. Valproates are used to treat ton ic-clon ic, partial,

an d m yoclon ic seizu res. 2. Sid e an d adverse effects

a. Tran sien t n ausea, vom itin g, an d in digestion b . Sedation , drowsin ess, an d dizzin ess c. Pan creatitis d . Blood dyscrasias: Decreased platelet coun t

an d decreased wh ite blood cell coun t e. Hepatoto xicity

I. Im in ostilben es 1. Im in ostilben es are used to treat seizure disor-

ders th at h ave n ot respon d ed to oth er an ticon - vu lsan ts ( Box 63-7).

2. Im in ostilben es are also used to treat trigem in al n euralgia.

3. Sid e an d adverse effects a. Drowsin ess b . Dizzin ess c. Nausea an d vom itin g, dry m ou th

d . Con stipation or diarrh ea e. Rash f. Visual abn o rm alities g. Bloo d dycrasias, agran u locytosis h . Headach e

V. Central Nervous System Stimulants A. Description

1. Am ph etam in es an d caffein e stim ulate th e cere- bral cortex of th e brain ( Box 63-8).

2. Am ph etam in es h ave a h igh poten tial for abuse. 3. An alep tics an d caffein e act on th e brain stem an d

m ed ulla to stim ulate respiration . 4. An o rexian ts act on th e cerebral cortex an d h ypo-

th alam us to suppress appetite ( Box 63-9). 5. CNS stim ulan ts are used to treat n arcolepsy an d

atten tion -deficit/ h yperactivity disorders an d are used as adjun ctive th erapy for exogen ous obesity.

B. Side an d adverse effects 1. Irritability 2. Restlessn ess 3. Trem ors 4. In som n ia 5. Heart palpitation s 6. Tach ycardia an d dysrh yth m ias 7. Hyperten sion 8. Dry m ou th 9. An orexia an d weigh t loss

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

BOX 63-7 Other Antiseizure Medications

▪ Carbamazepine ▪ Gabapentin ▪ Lacosamide ▪ Lamotrigine ▪ Levetiracetam ▪ Oxcarbazepine

▪ Pregabalin ▪ Tiagabine ▪ Topiramate ▪ Zonisamide ▪ Vigabatrin

BOX 63-8 Amphetamines ▪ Amphetamine sulfate ▪ Amphetamine/ dextroamphetamine ▪ Atomoxetine ▪ Dextroamphetamine sulfate ▪ Dexmethylphenidate ▪ Lisdexamfetamine ▪ Methylphenidate hydrochloride

BOX 63-9 Anorexiants ▪ Benzphetamine hydrochloride ▪ Diethylpropion ▪ Orlistat ▪ Phendimetrazine ▪ Phentermine hydrochloride ▪ Phentermine/ topiramate

927CHAPTER 63 Neurological Medications

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

10. Abdo m in al cram pin g 11. Diarrh ea or con stipatio n 12. Hepatic failure 13. Psych o ses 14. Im poten ce 15. Depen den ce an d toleran ce

C. In terven tion s 1. Mon itor vital sign s. 2. Assess m en tal status. 3. Docum en t th e degree of in atten tion , im pulsiv-

ity, h yperactivity, an d periods of sleepin ess. 4. Assess h eigh t, weigh t, an d growth of th e ch ild. 5. Mon itor com plete blood coun t an d wh ite blood

cell an d platelet coun ts before an d durin g th erapy. 6. Mon itor for side an d adverse effects. 7. Mon itor sleep pattern s. 8. Mon itor for with drawal sym pto m s such as n au-

sea, vo m itin g, weakn ess, an d h eadach e. 9. In struct th e clien t to take th e m ed ication

before m eals. 10. In struct th e clien t to avoid foods an d beverages

con tain in g caffein e to preven t ad dition al stim ulation .

11. In struct th e clien t n ot to ch ew or crush lon g- actin g form s of th e m edication s.

12. Instruct th e client to read labels on over-th e- counter products because they m an y con tain caffein e.

13. In struct th e clien t to avoid alcoh ol. 14. In struct th e clien t n ot to discon tin u e th e m ed-

ication abru ptly (can produ ce extrem e fatigue an d dep ression ) .

15. In struct th e clien t to take th e last daily dose of th e CNS stim ulan t at least 6 h ours before bed- tim e to preven t in som n ia.

16. Mon itor for m edication dep en den ce an d abuse with am ph etam in es.

17. If a ch ild is takin g a CNS stim ulan t, in struct th e paren ts to n otify th e sch ool n urse.

18. Mon itor for calm in g effects of CNS stim ulan ts with in 3 to 4 weeks on ch ildren with atten tion - deficit/ h yperactivity disorder.

19. Mon itor growth in th e ch ild on lon g-term th er- apy with m eth ylph en idate or oth er m edication s to treat atten tion -deficit/ h yperactivity disorder.

VI. Nonopioid Analgesics A. Non steroidal an tiin flam m atory drugs (NSAIDs;

Box 63-10) 1. Description

a. NSAIDs are acetylsalicylic acid an d acetylsal- icylic acid –like m ed ication s th at in h ibit th e syn th esis of prostaglan din s.

b . Th e m edication s act as an an algesic to relieve pain , an an tipyretic to reduce body tem p erature, an d an an ticoagulan t to in h ibit platelet aggregation .

c. NSAIDs are used to relieve in flam m ation an d pain an d to treat rh eum atoid arth ritis, bursi- tis, ten din itis, osteoarth ritis, an d acute gout.

d . NSAIDs are con train dicated in clien ts with h ypersen sitivity or liver or ren al disease.

e. Clien ts takin g an ticoagulan ts sh o uld n ot take acetylsalicylic acid or NSAIDs.

f. Acetylsalicylic acid and an NSAID sh ould n ot be taken togeth er because aspirin decreases the blood level an d effectiven ess of th e NSAID an d can in crease th e risk of bleedin g.

g. NSAIDs can in crease th e effects of warfarin , sulfon am ides, ceph alosporin s, an d ph en ytoin .

h . Hypo glycem ia can result if ibuprofen is taken with in sulin or an oral h ypo glycem ic m ed ication .

i. A h igh risk of toxicity exists if ibuprofen is taken con cu rren tly with calcium ch an n el blockers.

Adolescents and children with flu symptoms, viral illnesses, and varicella should not take acetylsalicylic acid because of the risk of Reye’s syndrome.

2. Side an d adverse effects ( Box 63-11) 3. In terven tion s

a . Assess clien t for allergies. b . O btain a m ed ication h isto ry on th e clien t.

BOX 63-10 Nonopioid Analgesics Acetaminophen ▪ Acetaminophen Aspirin ▪ Aspirin (acetylsalicylic acid; ASA) ▪ Aspirin (acetylsalicylic acid), buffered Nonsteroidal Antiinflammatory Drugs ▪ Ibuprofen ▪ Naproxen Cyclooxygenase-2 (COX-2) Inhibitor ▪ Celecoxib Other Nonsteroidal Antiinflammatory Drugs ▪ Diclofenac ▪ Diflunisal ▪ Etodolac ▪ Indomethacin ▪ Ketoprofen ▪ Ketorolac ▪ Meclofenamate ▪ Mefenamic acid ▪ Meloxicam ▪ Piroxicam ▪ Sulindac ▪ Tolmetin

928 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

c. Assess for h isto ry of gastric upset or bleedin g or liver or ren al disease.

d . Assess th e clien t for gastro in testin al upset durin g m edication ad m in istration .

e. Mon itor for edem a. f. Mon itor th e serum salicylate (acetylsalicylic

acid) level when th e clien t is takin g h igh doses.

g. Mon itor for sign s of bleedin g such as tarry stools, bleed in g gum s, petech iae, ecch ym o- sis, an d purpura.

h . In struct th e clien t to take th e m ed ication with m ilk, or food .

i. An en teric-coated or buffered form of acetyl- salicylic acid can be taken to decrease gastric distress.

j. In struct th e clien t th at en teric-coated tab lets can n ot be crush ed or broken .

k . Clien ts takin g acetylsalicylic acid sh o uld sit uprigh t for 20 to 30 m in u tes after takin g th e dose.

l. Advise th e clien t to in form oth er h ealth care profession als if th ey are takin g h igh doses of acetylsalicylic acid.

m . No te th at acetylsalicylic acid sh ould be dis- co n tin ued 3 to 7 days before surgery as pre- scribed to reduce th e risk of bleed in g.

n . In struct th e clien t to avoid alcoh olic beverages.

B. Acetam in oph en 1. Description

a. Acetam in oph en in h ibits prostaglan din syn th esis.

b . Used to decrease pain an d fever c. Sh o uld n ot be taken if liver dysfun ction

exists 2. Side an d ad verse effects

a. An o rexia, n ausea, vom itin g b . Rash c. Hypo glycem ia d . O liguria e. Hepatotoxicity

3. In terven tion s a. Mon itor vital sign s. b . Assess clien t for h isto ry of liver an d ren al dys-

fun ction , alcoh olism , an d m aln utrition . c. Mon itor for h epatic dam age, wh ich in cludes

n ausea, vom itin g, diarrh ea, an d abdom in al pain .

d . Mon itor liver en zym e test results. e. In struct th e clien t th at self-m edication

sh o uld n ot be used lon ger th an 10 days for an adult an d 5 days for a ch ild.

f. No te th at th e an tidote for acetam in o ph en is acetylcystein e.

g. Evaluate for th e effectiven ess of th e m edication .

Acetaminophen is contraindicated in clients with hepatic or renal disease, alcoholism, and/ or hypersensitivity.

VII. Opioid Analgesics A. Description

1. O pioid an algesics supp ress pain im pulses but can suppress respiration an d cough in g by actin g on th e respiratory an d co ugh cen ter in th e m ed ulla of th e brain stem .

2. Th ey can produce eup h oria an d sedation an d can cause ph ysical dep en den ce.

3. Used for relief of m ild, m od erate, or severe pain B. Medication s (Box 63-12)

1. Codein e

BOX 63-11 Side and Adverse Effects of Acetylsalicylic Acid and Nonsteroidal Antiinflammatory Drugs

Acetylsalicylic acid ▪ Allergic reactions (anaphylaxis, laryngeal edema) ▪ Bleeding (anemia, hemolysis, increased bleeding time) ▪ Dizziness ▪ Drowsiness ▪ Flushing ▪ Gastrointestinal symptoms (distress, heartburn, nausea,

vomiting) ▪ Headaches ▪ Decreased renal function ▪ Tinnitus ▪ Visual changes Nonsteroidal Antiinflammatory Drugs ▪ Dysrhythmias ▪ Blood dyscrasias ▪ Cardiovascular thrombotic events ▪ Dizziness ▪ Gastric irritation ▪ Hepatotoxicity ▪ Hypotension ▪ Pruritus ▪ Decreased renal function ▪ Sodium and water retention ▪ Tinnitus

BOX 63-12 Opioid Analgesics

▪ Acetaminophen/ hydrocodone

▪ Buprenorphine ▪ Butorphanol tartrate ▪ Codeine ▪ Fentanyl ▪ Hydrocodone ▪ Hydromorphone ▪ Levorphanol ▪ Meperidine ▪ Methadone

▪ Morphine ▪ Nalbuphine ▪ Oxycodone ▪ Oxycodone;

acetaminophen ▪ Oxycodone; aspirin ▪ Oxymorphone 10 ▪ Pentazocine ▪ Remifentanil ▪ Sufentanil ▪ Tramadol

929CHAPTER 63 Neurological Medications

a . Codein e also is an effective cough suppres- san t at low doses.

b . It can cause con stipation . 2. Hydro m orph on e

a . Hydro m orph on e can decrease respiration s. b . It can cause con stipation .

3. Mep eridin e a . Mep eridin e can cause h ypo ten sion , dizzi-

n ess, an d urin ary reten tion . b . May be used for acu te pain an d as a preop-

erative m ed ication c. May lead to increased intracranial pressure

(ICP) in clien ts with h ead in ju ries d . Con train dicated in clien ts with h ead in ju-

ries an d in creased ICP, respiratory disor- ders, h ypoten sion , sh ock, an d severe h epatic an d ren al disease an d in clien ts tak- in g m on oam in e oxidase in h ibito rs

e. Sh ould n ot be taken with alcoh ol or a sed ative-h ypn otic because it m ay in crease th e CNS depression

f. Sh ould be used cau tiously in ch ildren an d ad ults with a seizu re disorder or a h istory of seizures because it decreases th e seizure th resh old

4. Morph in e a . Mo rp h in e can cau se resp irato ry d ep res-

sio n , o rth o static h yp o ten sio n , an d co n sti- p atio n .

b . May cause n ausea an d vom itin g because of in creased vestibular sen sitivity

c. Used for acute pain caused by m yocardial in farction or can cer, for dyspn ea cau sed by pulm o n ary edem a, for surgery, an d as a preoperative m edication

d . Is con train dicated in clien ts with severe respiratory disorders; h ead in juries; in creased ICP; severe ren al, h epatic, or pul- m on ary disease; or seizure activity

e. Morph in e is used with caution in clien ts with blood loss or sh ock.

Respiratory depression is the priority concern with morphine.

5. O xycod on e with acetylsalicylic acid a . O xycodon e with acetylsalicylic acid sh ould

n ot be taken by a clien t allergic to acetylsa- licylic acid.

b . Can cause gastric irritatio n an d sh ould be taken with food or plen ty of liquid s

6. Nalbup h in e is preferable for treatin g th e pain of a m yocardial in farction because it reduces th e oxygen n eeds of th e h eart with ou t reducin g blood pressure.

7. Meth adon e a . Dilute doses of oral con cen trate with at least

90 m L of water.

b . Dilute dispersible tablets in at least 120 m Lof water, orange juice, or acidic fruit beverage.

c. Meth adon e is used as a replacem en t m ed i- cation for opiate depen den ce an d to facili- tate with drawal.

8. Hydro codon e/ h om atropin e frequen tly is used for cough suppressio n .

C. In terven tion s for opioid an algesics 1. Mon itor vital sign s. 2. Assess th e clien t th o rough ly before adm in is-

terin g pain m edication . 3. In itiate n ursin g m easu res such as m assage, dis-

traction , deep breath in g an d relaxation exer- cises, th e application of h eat or cold as prescribed, an d provid in g care an d com fo rt alon g with adm in isterin g th e opioid an algesic.

4. Adm in ister m edication s 30 to 60 m in utes before pain ful activities.

5. Mon itor respiratory rate an d, if th e rate is less th an 12 breath s/ m in ute in an adult, with h old th e m edication un less ventilatory support is bein g provided or the clien t h as term in al disease (as prescribed).

6. Mon itor pulse an d, if bradycardia develops, with h old th e dose an d n otify th e HCP.

7. Mon itor blood pressure for h ypo ten sion . 8. Auscu ltate breath soun ds because opioid an al-

gesics suppress th e cough reflex. 9. En courage activities such as turn in g, deep

breath in g, an d in cen tive spirom etry to preven t atelectasis an d pn eum on ia.

10. Mon itor level of con sciousn ess. 11. In itiate safety precaution s such as a n igh t ligh t

an d supervised am bulation . 12. Mon itor in take an d outp ut. 13. Assess for urin ary reten tion . 14. In struct th e clien t to take oral doses with m ilk

or a sn ack to reduce gastric irritation . 15. In struct th e clien t to avoid alcoh ol. 16. In struct th e clien t to avoid activities th at

require alertn ess. 17. Assess bowel fun ction for con stipation , abdom -

in al disten tion , and decreased peristalsis. 18. Evaluate th e effectiven ess of m ed ication . 19. Have an opioid an tagon ist, oxygen , an d resus-

citation equ ipm en t available. D. Morph in e

1. Side an d adverse effects a . Resp iratory dep ression b . O rth ostatic h ypoten sion c. Urin ary reten tion d . Nausea an d vom itin g e. Con stipation f. Sedation , con fusion , an d h allucin ation s g. Cough suppressio n h . Redu ction in pupillary size i. Miosis

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

930 UNIT XVI Neurological Disorders of the Adult Client

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

2. In terven tion s a. Have n aloxo n e available for overdose. b . Assess vital sign s an d level of con sciousn ess. c. Com pare rate an d depth of respiration s to

baselin e. d . With h old th e m edication if th e respiratory

rate is less th an 12 breath s/ m in ute; respira- tion s of less th an 10 breath s/ m in ute can in dicate respiratory distress.

e. Mon itor urin ary outp ut, wh ich sh ould be at least 30 m L/ h ou r.

f. Mon itor bowel soun ds for decreased peri- stalsis because con stipatio n can occur.

g. Mon itor for pupil ch an ges because pin - poin t pupils can in dicate m orph in e overdose.

h . Avoid alcoh ol or CNS depressan ts because th ey can cause respiratory depression .

i. In struct th e clien t to report dizzin ess or dif- ficulty breath in g.

j. If takin g sustain ed-release m orph in e, th e clien t m ay n eed sh ort-actin g opioid doses for breakth rough pain .

k . To adm in ister m orph in e in traven ously, dilute in at least 5 m L of sterile water (per agen cy procedure) for in jection an d ad m in - ister slowly over 4 to 5 m in utes.

l. Explain to th e clien t an d fam ily ab out adm in istration an d th e side an d adverse effects of th e m ed ication .

E. Mep eridin e 1. Sid e an d adverse effects

a. Respiratory depression b . Hypoten sion an d dizzin ess c. Tach ycardia d . Drowsin ess an d con fusion e. Con stipation f. Urin ary reten tion g. Nausea an d vom itin g h . Seizures i. Trem ors

2. In terven tion s a. Mon itor vital sign s. b . Mon itor for respiratory dep ression an d

h ypoten sion . c. Have n aloxo n e available for overdose. d . Mon itor for urin ary reten tion . e. Mon itor bowel soun ds and for con stipation . f. To adm in ister m eperidin e in traven ously,

dilute in at least 5 m L of sterile water or n or- m al salin e (per agen cy procedure) for in jec- tion an d adm in ister th e dose over 4 to 5 m in utes.

VIII. Opioid Antagonists A. O pioid an tagon ists ( Box 63-13) are used to treat

respiratory dep ression from opioid overdose.

B. In terven tion s 1. Mon itor blood pressure, pulse, an d respiratory

rate every 5 m in u tes in itially, taperin g to every 15 m in u tes, an d th en every 30 m in utes un til th e clien t is stable.

2. Place th e clien t on a cardiac m on itor an d m on i- tor cardiac rh yth m .

3. Auscu ltate breath soun ds. 4. Have resuscitation equipm en t available. 5. Do n ot leave th e clien t un atten ded. 6. Mon itor th e clien t clo sely for several h ours

because wh en th e effects of th e an tagon ist wear off, th e clien t m ay again display sign s of opioid overdose.

IX. Osmotic Diuretics A. Description

1. O sm o tic diuretics in crease osm o tic pressure of th e glom erular filtrate, in h ib itin g reabsorptio n of water an d electrolytes.

2. Th ey are used for oliguria an d to preven t kid- n ey failure, decrease ICP, an d decrease in traoc- ular pressure in clien ts with n arro w-an gle glaucom a.

3. Man n itol is used with ch em oth erapy to in duce diuresis.

B. Side an d adverse effects 1. Fluid an d electrolyte im balan ces 2. Pulm o n ary edem a from th e rapid sh ifts of fluid 3. Nausea an d vom itin g 4. Headach e 5. Tach ycardia from th e rapid fluid loss 6. Hypo n atrem ia an d deh ydration

C. In terven tion s 1. Mon itor vital sign s. 2. Mon itor weigh t. 3. Mon itor urin e outp ut. 4. Mon itor electrolyte levels. 5. Mon itor lun gs an d h eart soun ds for sign s of

pulm o n ary edem a. 6. Mon itor for sign s of deh ydration . 7. Mon itor n eurological status. 8. Mon itor for in creased in traocular pressure. 9. Assess for sign s of decreasin g ICP if ap propriate.

10. Ch an ge th e clien t’s position slowly to preven t orth o static h ypo ten sion .

11. Mon itor for crystallization in th e vial of m an n i- tol before adm in isterin g th e m edication ; if crys- tallization is n oted, do n ot adm in ister th e m edication from th at vial.

BOX 63-13 Opioid Antagonists

▪ Alvimopan ▪ Methylnaltrexone ▪ Naloxone

▪ Naltrexone ▪ Naloxegol

931CHAPTER 63 Neurological Medications

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

CRITICAL THINKING What Should You Do? Answer: Morphine is an opioid analgesic, and an adverse effect is respiratory depression. The nurse needs to monitor the respiratory rate closely and, if the rate is less than 12 breaths/ minute in an adult, the nurse needs to withhold the medication and contact the health care provider. The nurse needs to continue to monitor the client closely.

References: Burchum, Rosenthal (2016), pp. 261–262; Igna- tavicius, Workman (2016), p. 955.

P R A C T I C E Q U E S T I O N S 789. Carb idopa-levodopa is prescribed for a clien t with

Parkin son ’s disease. Th e n urse m on itors th e clien t for side an d adverse effects of th e m ed ication . Wh ich fin din g in dicates th at th e clien t is experien c- in g an adverse effect? 1. Pruritus 2. Tach ycardia 3. Hyperten sion 4. Im p aired volun tary m ovem en ts

790. Th e h om e h ealth n urse visits a clien t wh o is takin g ph en ytoin for con tro l of seizu res. Du rin g th e assessm en t, th e n urse n otes th at th e clien t is takin g birth con trol pills. Wh ich in form ation sh ould th e n urse in clude in th e teach in g plan ? 1. Pregn an cy m ust be avoided wh ile takin g

ph en ytoin . 2. Th e clien t m ay stop th e m edication if it is caus-

in g severe gastro in testin al effects. 3. Th ere is th e poten tial of decreased effectiven ess

of birth con trol pills wh ile takin g ph en ytoin . 4. Th ere is th e in creased risk of th rom boph leb itis

wh ile takin g ph en ytoin an d birth con trol pills togeth er.

791. Th e n urse is carin g for a clien t in th e em ergen cy dep artm en t wh o h as been diagn osed with Bell’s palsy. Th e clien t h as been takin g acetam in o ph en , an d acetam in o ph en overdose is susp ected. Wh ich an tidote sh ould th e n urse prepare for adm in istra- tio n if prescribed? 1. Pen tostatin 2. Auran o fin 3. Fludarabin e 4. Acetylcystein e

792. Mep eridin e h as been prescribed for a clien t to treat pain . Wh ich side an d ad verse effects sh ould th e n urse m on itor for? Select all th at ap p ly.

1. Diarrh ea 2. Trem ors 3. Drowsin ess 4. Hypoten sion

5. Urin ary frequen cy 6. In creased respiratory rate

793. A clien t is takin g th e prescribed dose of ph en ytoin to con trol seizures. Resu lts of a ph en ytoin blood level study reveal a level of 35 m cg/ m L (140 m cm o l/ L). Wh ich fin din g would be expected as a result of th is labo ratory result? 1. Hypo ten sion 2. Tach ycardia 3. Slu rred speech 4. No abn o rm al fin din g

794. Th e clien t arrives at th e em ergen cy departm en t com plain in g of back spasm s. Th e clien t states, “I h ave been takin g 2 to 3 aspirin every 4 h ours for th e last week, an d it h asn ’t h elped m y back.” Sin ce acetylsalicylic acid in toxication is suspected, th e n urse sh o uld assess th e clien t for wh ich m an ifestatio n ? 1. Tin n itu s 2. Diarrh ea 3. Con stipation 4. Ph otosen sitivity

795. A clien t with trigem in al n euralgia is bein g treated with carbam azepin e, 400 m g orally daily. Wh ich value in dicates th at th e clien t is experien cin g an adverse effect to th e m ed ication ? 1. Sodium level, 140 m Eq/ L (140 m m ol/ L) 2. Uric acid level, 4.0 m g/ dL (0.24 m m o l/ L) 3. Wh ite blood cell coun t, 3000 m m 3 (3.0 Â 109/ L) 4. Bloo d urea n itrogen level, 10 m g/ dL

(3.6 m m ol/ L)

796. Th e n urse is carin g for a clien t with ch ron ic back pain . Codein e h as been prescribed for th e clien t. Specific to th is m edication , wh ich in terven tion sh ould th e n urse in clude in th e plan of care wh ile th e clien t is takin g th is m edication ? 1. Mon itor radial pulse. 2. Mon itor bowel activity. 3. Mon itor apical h eart rate. 4. Mon itor periph eral pulses.

797. Th e n urse h as given m edication in struction s to a clien t receivin g ph en ytoin . Wh ich statem en t in di- cates th at th e clien t h as an ad equate un derstan din g of th e in struction s? 1. “Alcoh ol is n ot con train d icated wh ile takin g th is

m ed ication .” 2. “Good oral h ygien e is n eeded, in cludin g brush -

in g an d flossin g.” 3. “Th e m ed ication dose m ay be self-adjusted,

dep en din g on side effects.” 4. “Th e m orn in g dose of th e m ed ication sh ould

be taken before a serum m ed ication level is drawn .”

932 UNIT XVI Neurological Disorders of the Adult Client

798. A clien t with m yasth en ia gravis h as beco m e in creasin gly weaker. Th e h ealth care provid er pre- pares to iden tify wh eth er th e clien t is reactin g to an overdose of th e m edication (ch olin ergic crisis) or an in creasin g severity of th e disease (m yasth en ic crisis). An in jection of edroph o n ium is adm in is- tered. Wh ich fin din g would in dicate th at th e clien t is in ch olin ergic crisis? 1. No ch an ge in th e con ditio n 2. Com plain ts of m uscle spasm s 3. An im provem en t of th e weakn ess 4. A tem p orary worsen in g of th e con dition

799. A clien t with trigem in al n euralgia tells th e n urse th at acetam in oph en is taken daily for th e relief of gen eralized discom fort. Wh ich laborato ry value would in dicate toxicity associated with th e m ed ication ? 1. Sodium level of 140 m Eq/ L (140 m m ol/ L) 2. Platelet coun t of 400,000 m m 3 (400 Â 109/ L) 3. Proth ro m bin tim e of 12 secon ds (12 secon ds) 4. Direct bilirubin level of 2 m g/ dL (34 m cm ol/ L)

A N S W E R S 789. 4 Ra t ion a le: Dyskin esia an d im paired volu n tary m o vem en ts m ay occur with h igh carb ido p a-levod op a d osages. Nausea, an orexia, dizzin ess, o rth o static h ypo ten sio n , b rad ycardia, an d akin esia are freq uen t sid e effects o f th e m edication . Test -Ta kin g St r a t egy: Focu s o n th e su b ject, an adverse effect. O ption s 2 an d 3 are co m p arab le o r alike an d are card iac-related op tio n s, so th ese o ption s can b e elim in ated first. Next, fo cu s o n th e clien t’s d iagn o sis an d select th e co rrect op tion over o ptio n 1 because it relates to th e n eu rolo gical system . Review: Th e sid e an d adverse effects o f carb id o p a-levo d o p a Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Neu ro logical Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 182–183.

790. 3 Ra t ion a le: Ph en ytoin en h an ces th e rate o f estro gen m etabo - lism , wh ich can d ecrease th e effectiven ess of so m e birth co n trol pills. O p tio n s 1, 2, an d 4 are in ap prop riate in structio n s. Preg- n an cy do es n o t n eed to b e “avoid ed ” wh ile takin g ph en yto in ; h owever, because ph en yto in m ay cau se so m e risk to th e fetus (Pregn an cy Category D m edicatio n ) , co n su ltatio n with th e h ealth care provid er sh o uld b e do n e if p regn an cy is con sid ered . Tellin g a clien t th at th ere is an in creased risk of th rom b op h le- bitis is in correct an d in ap p ro priate an d cou ld cau se an xiety in th e clien t. A clien t sh o uld n ot b e in stru cted to sto p an tiseizu re m ed ication . Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, teach in g p oin ts for th e clien t takin g ph en ytoin . Elim in ate o ption 1 because of th e wo rd s must be avoided. Use gen eral m edication guidelin es to elim in ate o ptio n 2; th e clien t wo uld n ot b e advised to sto p a m ed ication . Fo r th e rem ain in g op tio n s, elim in ate o ptio n 4, as it will cau se an xiety in th e clien t. Review: Medicatio n in teractio n s related to p h en yto in Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Neu ro logical Med icatio n s Pr ior ity Con cepts: Clien t Edu catio n ; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 236–237.

791. 4 Ra t ion a le: Th e an tid o te fo r acetam in op h en is acetylcystein e. Th e n orm al th erap eu tic seru m level o f acetam in op h en is 10 to 20 m cg/ m L (40 to 79 m cm ol/ L). A to xic level is h igh er th an 50 m cg/ m L (200 m cm o l/ L), an d levels h igher th an 100 m cg/m L (400 m cm o l/ L) cou ld in dicate h epatotoxicity. Auran o fin is a gold p reparation that m ay b e used to treat rh eu m ato id arth ritis. Pen tostatin an d fludarabin e are antin eo plastic agents. Test -Ta kin g St r a t egy: Elim in ate op tion s 1 an d 3 first becau se th ey are co m p arab le o r alike (an tin eo plastic agen ts). Recallin g th at auran o fin is u sed to treat rh eum atoid arth ritis will direct yo u to th e co rrect o ption . Review: Th e an tid ote fo r acetam in o p h en Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Ph arm aco lo gy—Neu ro logical Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Ho dgso n , Kizior (2016), p . 11.

792. 2, 3, 4 Ra t ion a le: Meperid in e is an op io id an algesic. Sid e an d ad verse effects in clu de resp iratory dep ression , d rowsin ess, h ypo ten - sion , co n stipatio n , urin ary reten tion , n ausea, vom itin g, an d trem ors. Test -Ta kin g Str a tegy: No te th e su b ject, sid e an d ad verse effects o f m ep eridin e. Recallin g th at th is m edicatio n is an op i- o id an algesic an d recallin g th e effects o f an o pio id an algesic will assist you in iden tifyin g th e correct option s. Review: Side an d adverse effects of m ep erid in e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Neu ro logical Med icatio n s Pr ior ity Con cepts: Pain ; Safety Refer en ce: Bu rch u m , Rosen th al (2016), pp . 270, 284.

793. 3 Ra t ion a le: Th e th erapeu tic p h en ytoin level is 10 to 20 m cg/ m L (40-79 m cm ol/ L). At a level h igh er th an 20 m cg/ m L, in volun - tary m o vem en ts o f th e eyeballs (n ystagm u s) occu r. At a level h igh er th an 30 m cg/ m L (120 m cm ol/ L), ataxia an d slurred sp eech o ccur. Test -Ta kin g Str a t egy: Focus on th e su b ject, a ph en yto in level o f 35 m cg/ m L. Use kn o wledge regardin g th e th erap eutic ph e- n ytoin level. Fro m th is p oin t, yo u m u st kn o w th e sym pto m s

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

933CHAPTER 63 Neurological Medications

th at wou ld b e n oted in th e clien t wh en th e p h en ytoin level is 35 m cg/ m L. Rem em b er th at ataxia an d slurred sp eech occu r with levels h igh er th an 30 m cg/ m L. Review: Th e th erap eu tic level o f p h en yto in Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—Neurolo gical Medicatio n s Pr ior it y Con cept s: In tracran ial Regu lation ; Safety Refer en ce: Hod gson , Kizio r (2016), p. 986.

794. 1 Ra tion a le: Mild in to xicatio n with acetylsalicylic acid is called salicylism an d is exp erien ced com m on ly wh en th e d aily d osage is h igh er th an 4 g. Tin n itu s (rin gin g in th e ears) is th e m o st fre- q uen t effect n oted with in to xication . Hyp erven tilatio n m ay o ccur because salicylate stim ulates th e respiratory cen ter. Fever m ay result b ecau se salicylate in terferes with th e m etab o lic p ath ways co up lin g oxygen co n sum p tion an d h eat p ro d uction . O ptio n s 2, 3, an d 4 are n ot associated specifically with to xicity. Test-Ta kin g Str a tegy: Focu s on th e su b ject, acetylsalicylic acid in toxicatio n . O ptio n s 2 an d 3 relate to gastroin testin al sym p - to m s, are co m p arab le o r alike, an d are elim in ated first. From th e rem ain in g o ptio n s, you m u st kn o w th at tin n itus o ccurs. Review: Acetylsalicylic acid in to xicatio n Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—Neurolo gical Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p . 853–854.

795. 3 Ra tion a le: Ad verse effects of carb am azepin e app ear as bloo d d yscrasias, in clud in g ap lastic an em ia, agran u locytosis, th ro m - b ocytop en ia, an d leu ko pen ia; cardio vascu lar d istu rb an ces, in clu d in g th rom b op h leb itis an d d ysrh yth m ias; an d derm ato- lo gical effects. Th e low wh ite bloo d cell co un t reflects agran u- lo cyto sis. Th e labo rato ry valu es in o ptio n s 1, 2, an d 4 are n o rm al values. Test-Ta kin g Str a tegy: Focus on th e su b ject, an adverse effect of carb am azep in e. If yo u are fam iliar with n orm al labo rato ry valu es, yo u will n ote th at th e o n ly op tion th at in dicates an ab n orm al value is th e co rrect o ption . Review: Th e ad verse effects o f carb am azep in e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm aco logy—Neurolo gical Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Cellular Regulation Refer en ces: Burch um , Ro sen th al ( 2016) , p . 237; Lewis et al. (2014), p. 1424.

796. 2 Ra tion a le: Wh ile th e clien t is takin g co dein e, th e n u rse wou ld m on itor vital sign s an d assess fo r h yp oten sio n . Th e n urse also sh o u ld in crease fluid in take, palp ate th e bladd er for u rin ary reten tio n , auscultate b owel sou n d s, an d m o n ito r th e p attern o f d aily b owel activity an d sto ol co n sisten cy because th e m ed - ication cau ses con stipatio n . Th e n urse sh ou ld m o n ito r

respiratory status an d in itiate d eep -breath in g an d co ugh in g exercises. In ad d itio n , th e n u rse m o n ito rs th e effectiven ess of th e p ain m ed ication . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, a sp ecific n ursin g con sideration related to cod ein e. Elim in ate o ption s 1, 3, an d 4 b ecau se th ey are co m p arab le o r alike. In add itio n , relate cod ein e with co n stip ation . Review: Nu rsin g m easu res related to th e adm in istratio n of co d ein e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ph arm acolo gy—Neu ro lo gical Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Pain Refer en ce: Bu rch u m , Ro sen th al (2016), p . 284.

797. 2 Ra tion a le: Typical an tiseizu re m edicatio n in stru ctio n s in clud e takin g th e p rescribed d aily d osage to keep th e b lo od level of th e m edicatio n con stan t an d h avin g a sam ple d rawn fo r serum m edicatio n level d eterm in ation befo re takin g th e m o rn in g d ose. Th e clien t is tau gh t n ot to stop th e m edicatio n abrup tly, to avo id alco h o l, to ch eck with a h ealth care p ro vid er befo re takin g over-th e-cou n ter m edicatio n s, to avoid activities in wh ich alertn ess an d coordin ation are required un til m edica- tio n effects are kn own , to provid e goo d oral h ygien e, an d to o btain regu lar den tal care. Th e clien t sh o uld also wear a Med - icAlert bracelet. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, an u n derstan d in g o f m edicatio n in struction s for p h en yto in . Usin g kn owled ge of gen eral prin cip les related to m edication ad m in istration will assist you in elim in atin g o ptio n s 1 an d 3. Fro m th e rem ain in g o ptio n s, recall th at m edicatio n s gen erally are n o t taken just b efore determ in in g th erap eu tic seru m levels b ecau se th e results wo u ld b e artificially h igh . Th is leaves o ral h ygien e as th e co rrect o ptio n b ecau se o f th e risk of gin gival h yp erp lasia. Review: Clien t edu catio n related to p h en yto in Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm acolo gy—Neu ro lo gical Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hod gson , Kizio r (2016), p. 986.

798. 4 Ra tion a le: An edro ph o n ium in jection m akes th e clien t in ch o - lin ergic crisis tem p orarily wo rse. An im p ro vem en t in th e weak- n ess in dicates m yasth en ia crisis. Muscle sp asm s are n o t asso ciated with th is test. Test-Ta kin g Str a tegy: Focus on th e su bject, resu lts of an edro - ph o nium test. Recallin g th at a ch olin ergic crisis in d icates an over- dose of m ed ication , it seem s reaso nable th at a worsen in g of th e con dition will occur when addition al m edication is adm in istered. Review: Ch o lin ergic crisis Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm acolo gy—Neu ro lo gical Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Mo bility Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 131–132.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

934 UNIT XVI Neurological Disorders of the Adult Client

799. 4 Ra t ion a le: In adu lts, o verd ose o f acetam in oph en causes liver dam age. Th e correct o ptio n is an in dicator of liver fun ctio n an d is th e on ly option th at in d icates an abn orm al labo ratory value. Th e n orm al d irect b iliru bin level is 0.1 to 0.3 m g/ d L (1.7 to 5.1 m cm ol/ L). Th e n orm al sodium level is 135 to 145 m Eq/ L (135 to 145 m m ol/ L). The n orm al p ro th ro m bin tim e is 11 to 12.5 secon ds (11 to 12.5 secon ds). Th e n orm al p latelet cou nt is 150,000 to 400,000 m m 3 (150–400 Â 109/ L). Test -Ta kin g Str a tegy: Focu s on th e su b ject, acetam in op h en to xicity. Kn o wledge th at acetam in o ph en causes liver d am age an d kn o wledge o f n orm al lab oratory results will assist yo u

in an swerin g th is q uestion . Th e co rrect op tio n is th e on ly ab n o rm al valu e. Also, o f all th e op tion s, th e biliru bin level is th e labo rato ry value m ost d irectly related to liver fu n ctio n . Review: Th e effects o f toxicity fro m acetam in o p h en an d n o rm al lab o rato ry valu es Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ph arm aco lo gy—Neu ro logical Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Cellu lar Regu latio n Refer en ces: Burch um , Ro sen th al (2016), p . 868; Skid m ore- Roth ( 2014) , p. 66.

A

d

u

l

t

N

e

u

r

o

l

o

g

i

c

a

l

935CHAPTER 63 Neurological Medications

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

UNIT XVII

Musculoskeletal Disorders of the Adult Client

Pyramid to Success

Th e Pyram id to Success focuses on th e em ergen cy care for a clien t wh o sustain s a fracture or oth er m usculoskel- etal in jury, m on itorin g for com plication s, an d carryin g out in terven tion s if com plication s occur. Nu rsin g care related to casts an d traction is em ph asized. Skill related to in structin g th e clien t in th e use of an assistive device such as a can e, walker, or crutch es is a Pyram id Poin t. Pyram id Poin ts also in clude posto perative care follow- in g h ip surgery or am putation an d care of th e clien t with rh eum atoid arth ritis or osteopo rosis. Focus on th e poin ts related to th e psych o social effects as a result of th e m usculoskeletal disorder, such as un exp ected body im age ch an ges, an d th e appropriate an d available sup- port services n eeded for th e clien t.

Client Needs: Learning Objectives Safe and Effective Care Environment Com m un icatin g with th e in terpro fession al h ealth

care team En surin g th at in form ed con sen t is obtain ed for treat-

m en ts an d proced ures Establish in g prio rities Han dlin g h azardous an d in fectious m aterials safely Main tain in g asepsis related to woun ds Main tain in g con fiden tiality Main tain in g stan d ard an d oth er precaution s Preven tin g acciden ts an d in juries Provid in g ph ysical th erapy an d occupation al th erap y

referrals Uph oldin g clien t righ ts

Health Promotion and Maintenance Perform in g ph ysical assessm en t related to th e m uscu lo-

skeletal system Preven tin g diseases th at occur as a result of th e agin g

process Prom otin g h ealth related to diet an d activity Providin g h om e care in struction s regardin g care related

to a m uscu loskeletal disorder Rein forcin g th e im portan ce of prescribed th erap y

Psychosocial Integrity Assessin g available support system s an d use of com m un ity

resources Assessin g th e clien t’s ability to cope with m ob ility lim i-

tation s an d restrictio n s, feelin gs of isolatio n , an d loss of in depen den ce

Con siderin g cultural, religious, an d spiritual in fluen ces Discussin g situation al role ch an ges as a result of th e

m usculoskeletal disorder Discussin g un exp ected body im age ch an ges as a result of

in jury or disease Iden tifyin g sen sory an d percep tual alteration s Mobilizin g copin g m ech an ism s

Physiological Integrity Iden tifyin g com plication s of proced ures, in juries, or a

fracture Providin g care related to casts an d traction Prom otin g n orm al elim in ation pattern s Prom otin g self-care m easures Providin g em ergen cy care for a fracture or oth er in jury Providin g m easu res to prom o te com fort Teach in g about th e use of assistive devices for m ob ility

such as can es, walkers, an d crutch es Teach in g ph arm aco logical th erap y

936

C H A P T E R 64 Musculoskeletal System

PRIORITY CONCEPTS Functional Ability; Mobility

CRITICAL THINKING What Should You Do? The nurse employed in an industrial plant is called to an acci- dent site in the plant at which an employee amputated his index finger on a saw. What should the nurse do? Answer located on p. 952.

I. Anatomy and Physiology A. Skeleton

1. Axial portion a. Cran ium b . Vertebrae c. Ribs

2. Appen dicular portion a. Lim bs b . Sh oulders c. Hips

B. Types of bon es: Lon g, sh ort, flat, irregular 1. Spon gy bon e

a. Spon gy bon e is located in th e en ds of lo n g bon es an d th e cen ter of flat an d irregular bon es.

b . Spon gy bon e can with stan d forces applied in m an y direction s.

2. Den se (com pact) bon e a. Den se bon e covers spon gy bon e. b . Form s a cylin der aroun d a cen tral m arro w

cavity c. Better able to with stan d lo n gitudin al forces

th an h orizon tal forces 3. Ch aracteristics of bon es

a. Support an d protect structures of th e body b . Provide attach m en ts for m uscles, ten don s,

an d ligam en ts c. Con tain tissue in th e cen tral cavities, wh ich

aids in th e form ation of blood cells d . Assist in regulatin g calcium an d ph osph ate

con cen tration s

4. Bon e growth a . Th e len gth of bon e growth results fro m ossi-

fication of th e epiph yseal cartilage at th e en ds of bon es; bon e growth stops between th e ages of 18 an d 25 years.

b . Th e width of bon e growth results from th e activity of osteoblasts; it occurs th rou gh out life but slows down with agin g.

As aging occurs, bone resorption accelerates, decreasing bone mass and predisposing the client to injury.

C. Types of join ts (Table 64-1) 1. Ch aracteristics of join ts

a. Allow m ovem en t between bon es b . Form ed wh ere 2 bon es join c. Surfaces are covered with cartilage. d . En closed in a cap sule (syn ovial join ts) e. Con tain a cavity filled with syn o vial fluid

(syn ovial join ts) f. Ligam en ts h old th e bon e an d join t in th e

co rrect position . g. Articulation is th e m eetin g poin t of 2 or

m ore bon es. 2. Syn ovial fluid

a. Foun d in th e syn o vial join t capsule b . Form ed by th e syn ovial m em bran e, wh ich

lin es th e join t capsule c. Lub ricates th e cartilage d . Provides a cu sh ion again st sh ocks

D. Muscles 1. Ch aracteristics of m uscles

a. Made up of bun dles of m uscle fibers b . Provide th e force to m ove bon es c. Assist in m ain tain in g postu re d . Assist with h eat productio n

2. Process of con traction an d relaxation a. Muscle con traction an d relaxation require

large am oun ts of aden osin e triph osph ate. b . Con traction also requires calcium , wh ich

fun ction s as a catalyst.

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

937

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

c. Acetylch olin e released by th e m otor en d plate of th e m oto r n euron in itiates an action poten tial.

d . Acetylch olin e is th en destro yed by acetylch olin esterase.

e. Calcium is required for m uscle fiber con - traction an d acts as a catalyst for th e en zym e n eeded for th e slidin g-togeth er action of actin an d m yosin .

f. Followin g con traction, aden osin e triph os- phate tran sports calcium out to allow actin an d m yosin to separate an d allow the m uscle to relax.

3. Skeletal m uscles a. Skeletal m uscles are attach ed to 2 bon es by

cartilagin o us ten don s called en th uses (th e co n n ective tissue between ten don or liga- m en t an d bon e).

b . Th e poin t of origin is th e poin t of attach - m en t th at does n ot m ove.

c. Th e poin t of in sertion is th e point of attach- m en t that m oves wh en th e m uscle con tracts.

d . Skeletal m uscles act in groups. e. Prim e m overs con tract to produce

m ovem en t. f. An tagon ists relax. g. Syn ergists con tract to stabilize body

m ovem en t. h . Nerves activate an d con trol th e m uscles.

E. Bon e h ealin g 1. Description : Bon e un ion or h ealin g is th e

process th at occurs after th e in tegrity of a bon e is in terrup ted.

2. Stages ( Fig. 64-1)

II. Risk Factors Associated with Musculoskeletal Disorders

A. See Box 64-1 for m ore in form ation .

III. Diagnostic Tests A. Radio graph y an d m agn etic reson an ce im agin g

(MRI) (refer to Ch apter 62 for in form ation on MRI) 1. Description : Radiograph y an d MRI are com -

m on ly used proced ures to diagn ose disorders of th e m usculoskeletal system .

2. In terven tion s a . Han dle in ju red areas carefully an d supp ort

extrem ities above an d below th e join t. b . Adm in ister an algesics as prescribed befo re

th e proced ure, particularly if th e clien t is in pain .

c. Rem o ve an y radiop aque an d m etallic objects, such as jewelry.

d . Ask th e clien t if sh e is pregn an t; MRI m ay be con train dicated in pregn an cy.

e. Sh ield th e clien t’s testes, ovaries, or preg- n an t ab dom en .

f. Th e clien t m ust lie still durin g a procedure. g. In form th e clien t th at exposu re to radiation

fro m radiograph y is m in im al an d n ot dan gerous.

h . Th e h ealth care provider (HCP) wears a lead ap ron if stayin g in th e room with th e clien t h avin g radiograph y.

i. Com p lete screen in g process per agen cy policy.

B. Arth rocen tesis 1. Description : Arth rocen tesis is used to diagn ose

join t in flam m ation an d in fectio n . a . Arth rocen tesis in volves aspiratin g syn ovial

flu id, blood , or pus via a n eedle in serted in to a join t cavity.

TABLE 64-1 Types of Joints Type Description

Amphiarthrosis Cartilaginous joint

Slightly movable

Diarthrosis Synovial joint

Ball-and-socket joint Permit free movement

Synarthrosis Fibrous or fixed joint

No movement associated with these joints

He ma toma forma tion

He ma toma to gra nula tion

tis s ue

Ca llus forma tion

Os te obla s tic prolife ra tion

Bone re mode ling

Bone he a ling comple te

FIGURE 64-1 The stages of bone healing.

938 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

b . Medication , such as cortico steroids, m ay be in stilled in to th e join t if n ecessary to allevi- ate in flam m ation .

2. In terven tion s a. En sure th at in form ed con sen t h as been

obtain ed. b . Apply an elastic com pression ban d age post-

procedure as prescribed. c. Use ice to decrease pain an d swellin g. d . Pain m ay worsen after aspiratin g fluid fro m

th e join t; an algesics m ay be prescribed. e. Pain can con tin ue for up to 2 days after

adm in istration of corticosteroid s in to a join t.

f. In struct th e clien t to rest th e join t for 8 to 24 h ours postprocedure.

g. In struct th e clien t to n otify th e HCP if a fever or swellin g of th e join t occurs.

C. Arth roscopy 1. Description : Used to diagn ose an d treat acu te

an d ch ron ic disorders of th e join t. a. Arth roscopy provides an en doscopic exam -

in ation of various join ts. b . Articular cartilage abn o rm alities can be

assessed , lo ose bodies rem oved, an d th e cartilage trim m ed.

c. A biopsy m ay be perform ed durin g th e procedure.

2. In terven tion s a. In struct th e clien t to fast for 8 to 12 h ours

before th e proced ure. b . En sure th at in form ed con sen t was obtain ed. c. Adm in ister pain m ed ication as prescribed

postprocedure. d . Assess th e n eurovascular status of th e

affected extrem ity. e. An elastic com pression ban dage sh ould be

worn postprocedure for 2 to 4 days as prescribed.

f. In struct th e clien t th at walkin g with weigh t- bearin g usually is perm itted after sen sation return s but to lim it activity for 1 to 4 days as prescribed followin g th e proced ure.

g. In struct th e clien t to elevate th e extrem ity as often as possible for 24 h ou rs followin g th e procedure an d to place ice on th e site to m in im ize swellin g for 12 to 24 h ours postp rocedu re.

h . Advise th e clien t to n otify the HCP if fever or in creased kn ee pain occurs or if edem a con - tin ues for m ore th an 3 days postprocedure.

D. Bon e m in eral den sity m easu rem en ts 1. Du al-en ergy x-ray absorptiom etry

a. Du al-en ergy x-ray absorptiom etry m easures th e bon e m ass of th e spin e, wrist an d h ip bon es, an d total body.

b . Rad iation exposu re is m in im al. c. It is used to diagn ose m etab olic bon e dis-

ease an d to m on itor ch an ges in bon e den - sity with treatm en t.

d . In form th e clien t th at th e proced ure is pain less.

e. All m etallic objects are rem oved before th e test.

2. Q uan titative ultraso un d a. Q uan titative ultrasoun d evaluates stren gth ,

den sity, an d elasticity of various bon es, usin g ultraso un d rath er th an radiation .

b . In form th e clien t th at th e proced ure is pain less.

E. Bon e scan 1. Description : A bon e scan is used to iden tify,

evaluate, an d stage bon e can cer before an d after treatm en t; it is also used to detect fractures. a. Rad ioisotop e is in jected in traven ously an d

will collect in areas th at in dicate ab n orm al bon e m etab olism an d som e fractures, if th ey exist.

b . Th e isotope is excreted in th e urine an d feces within 48 h ours an d is n ot h arm ful to oth ers.

2. In terven tion s a. Food an d flu ids m ay be with h eld befo re th e

procedure. b . En su re th at in form ed con sen t h as been

obtain ed. c. Rem o ve all jewelry an d m etal objects. d . Followin g th e in jection of th e radioiso tope,

th e clien t m ust drin k 32 oz of water (if n ot co n train d icated) to prom ote ren al filterin g of th e excess isotop e.

e. Fro m 1 to 3 h ou rs after th e in jection , h ave th e clien t vo id to clear excess isotop e from th e bladder before th e scan n in g procedure is com pleted.

f. In form th e clien t of th e n eed to lie supin e durin g th e procedure an d th at th e proce- dure is n ot pain ful.

g. Mon itor th e in jection site for redn ess an d swellin g.

h . En cou rage oral fluid in take followin g th e procedure.

BOX 64-1 Risk Factors Associated with Musculoskeletal Disorders

▪ Autoimmune disorders ▪ Calcium deficiency ▪ Falls ▪ Hyperuricemia ▪ Infection ▪ Medications ▪ Metabolic disorders ▪ Neoplastic disorders ▪ Obesity ▪ Postmenopausal states ▪ Trauma and injury

939CHAPTER 64 Musculoskeletal System

No special precautions are required after a bone scan because only a minimal amount of radioactivity exists in the radioisotope used for the procedure.

F. Bon e or m uscle biopsy 1. Description : Biop sy m ay be don e durin g

surgery or th rou gh aspiration or pun ch or n ee- dle biopsy.

2. In terven tion s a . En su re th at in form ed con sen t was obtain ed. b . Mon itor for bleed in g, swellin g, h em atom a,

or severe pain . c. Elevate th e site for 24 h ours followin g th e

procedure to reduce edem a. d . Apply ice packs as prescribed follo win g

th e procedure to preven t th e develop- m en t of a h em atom a an d to decrease site discom fort.

e. Mon itor for sign s of in fectio n followin g th e procedure.

f. In form th e clien t th at m ild to m od erate dis- co m fort is n orm al followin g th e proced ure.

G. Electro m yograph y (EMG) 1. Description : EMG is used to evaluate m uscle

weakn ess. a . Electrom yograph y m easures electrical

poten tial associated with skeletal m uscle co n traction s.

b . Needles are in serted in to th e m uscle, an d recordin gs of m uscu lar electrical activity are traced on recordin g paper th rou gh an oscilloscope.

2. In terven tion s a . En su re th at in form ed con sen t was

obtain ed. b . In struct th e clien t th at th e n eedle in sertio n

is un co m fortable. c. In struct th e clien t n ot to take any stim ulan ts or

sedatives for 24 h ours before the procedure. d . In form th e clien t th at sligh t bruisin g m ay

occur at th e n eedle in sertion sites. e. Mild an algesics can be used for th e pain .

IV. Injuries A. Strain s

1. Strain s are an excessive stretch in g of a m uscle or ten don .

2. Man agem en t in volves cold an d h eat applica- tion s, exercise with activity lim itation s, an tiin - flam m atory m ed ication s, an d m uscle relaxan ts.

3. Surgical repair m ay be required for a severe strain (rup tured m uscle or ten don ) .

B. Sprain s 1. Sprain s are an excessive stretch in g of a ligam en t,

usually cau sed by a twistin g m otion , such as in a fall or steppin g on to an un even surface.

2. Sprain s are ch aracterized by pain an d swellin g.

3. Man agem en t in volves rest, ice, a com pression ban d age, an d elevation (RICE) to reduce swell- in g, as well as join t supp ort. RICE is con sidered a first-aid treatm en t, rath er th an a cure for soft tissue in ju ries.

4. Castin g m ay be required for m oderate sprain s to allow th e tear to h eal.

5. Surgery m ay be n ecessary for severe ligam en t dam age.

C. Rotator cuff in juries 1. Th e m usculoten din ous or rotator cuff of th e

sh oulder can sustain a tear, usually as a result of traum a.

2. In jury is ch aracterized by sh oulder pain an d th e in ability to m ain tain abduction of th e arm at th e sh oulder (dro p arm test).

3. Man agem en t in volves n on steroidal an tiin flam - m atory drugs (NSAIDs), ph ysical th erapy, slin g support, an d ice-h eat ap plication s.

4. Surgery m ay be required if m ed ical m an agem en t is un successful or a com plete tear is presen t.

V. Fractures A. Description : A break in th e con tin uity of th e bon e

caused by traum a, twistin g as a result of m uscle spasm or in direct loss of leverage, or bon e decalci- fication an d disease th at result in osteopen ia.

B. Types of fractures (Box 64-2) C. Assessm en t of a fracture of an extrem ity

1. Pain or ten dern ess over th e in volved area 2. Decrease or lo ss of m uscu lar stren gth or

fun ction

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

BOX 64-2 Types of Fractures Closed or Simple: Skin over the fractured area remains intact. Comminut ed: The bone is splintered or crushed, creating

numerous fragments. Complete: The bone is separated completely by a break into 2

parts. Compression: A fractured bone is compressed by other bone. Depressed: Bone fragments are driven inward. Greenst ick: One side of the bone is broken and the other is

bent; these fractures occur most commonly in children. Impa cted: A part of the fractured bone is driven into another

bone. Incomplet e: Fracture line does not extend through the full

transverse width of the bone. Oblique: The fracture line runs at an angle across the axis of

the bone. Open or Compound: The bone is exposed to air through a

break in the skin, and soft tissue injury and infection are common.

Pa t hologica l: The fracture results from weakening of the bone structure by pathological processes such as neoplasia; also called spontaneous fracture.

Spira l: The break partially encircles bone. Tra nsverse: The bone is fractured straight across.

940 UNIT XVII Musculoskeletal Disorders of the Adult Client

3. O bvious defo rm ity of th e affected area 4. Crepitation , eryth em a, edem a, or bruisin g 5. Muscle spasm an d n eurovascular im pairm en t

D. In itial care of a fracture of an extrem ity 1. Im m obilize th e affected extrem ity with a cast or

splin t. 2. Assess th e n eurovascular status of th e extrem ity. 3. In terven tion s for a fracture: Reduction, fixation,

traction, cast

If a compound (open) fracture exists, splint the extremity and cover the wound with a sterile dressing.

E. Reduction restores th e bon e to proper align m en t. 1. Clo sed reduction is a n on su rgical in terven tion

perform ed by m an ual m an ipu lation . a. Closed reduction m ay be perform ed un der

local or gen eral an esth esia. b . A cast m ay be ap plied followin g reduction .

2. O pen reduction in volves a surgical in terven - tio n ; th e fracture m ay be treated with internal fix- ation devices.

F. Fixation 1. In tern al fixation follows an open reduction

( Fig. 64-2). a. Intern al fixation in volves the application of

screws, plates, pin s, wires, or in tram edullary rods to h old th e fragm en ts in align m en t.

b . In tern al fixatio n m ay in volve th e rem oval of dam aged bon e an d replacem en t with a prosth esis.

c. In tern al fixation provides im m ediate bon e stabilization .

2. External fixation is th e use of an extern al fram e to stabilize a fracture by attach in g skeletal pin s

th rou gh bon e fragm en ts to a rigid extern al sup- port ( Fig. 64-3). a. Extern al fixation provides m ore freed om of

m ovem en t th an with traction . b . Mon itor pin stability an d provide pin care

to decrease in fectio n risks. c. Risk of in fectio n exists with both fixatio n

m eth ods. d . Extern al fixatio n is com m on ly used wh en

m assive tissue traum a is presen t. G. Traction (Fig. 64-4)

1. Description a. Traction is th e exertion of a pullin g force

ap plied in 2 direction s to reduce an d im m o- bilize a fracture.

b . It provid es proper bon e align m en t an d reduces m uscle spasm s.

2. In terven tion s a. Main tain proper body align m en t. b . En su re th at th e weigh ts h an g freely an d do

n ot touch th e floor. c. Do n ot rem ove or lift th e weigh ts with out

an HCP’s prescription . d . En su re th at pulleys are n ot obstru cted an d

th at ropes in th e pulleys m ove freely. e. Place kn ots in th e ropes to preven t slippin g. f. Ch eck th e ro pes for frayin g.

H. Skeletal traction 1. Description

a. Traction is applied m ech an ically to th e bon e with pin s, wires, or ton gs.

b . Typical weigh t for skeletal traction is 25 to 40 lb (11 to 18 kg).

2. In terven tion s a. Mon itor color, m otion , an d sen sation of

th e affected extrem ity. b . Mon itor th e in sertio n sites for redn ess,

swellin g, drain age, or in creased pain . c. Provide in sertio n site care as prescribed.

3. Cervical ton gs an d a h alo fixation device: See Ch apter 62 regardin g care of th e clien t with th ese types of devices.

I. Skin traction 1. Description : Skin traction is ap plied by usin g

elastic b an d ages o r ad h esive, fo am b o o t, o r slin g.

2. Cervical skin traction relieves m uscle spasm s an d com pression in th e upper extrem ities an d n eck (see Fig. 64-4). a. Cervical skin traction uses a h ead h alter an d

ch in pad to attach th e traction . b . Use powder to protect th e ears from

friction rub. c. Position th e clien t with th e h ead of th e bed

elevated 30 to 40 degrees, an d attach th e weigh ts to a pulley system over th e h ead of th e bed.

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

FIGURE 64-2 A compression hip screw used for open reduction with internal fixation.

941CHAPTER 64 Musculoskeletal System

3. Buck’s (exten sion ) skin traction is used to allevi- ate m uscle spasm s an d im m ob ilize a lower lim b by m ain tain in g a straigh t pull on th e lim b with th e use of weigh ts (see Fig. 64-4). a . A boot applian ce is applied to attach to th e

traction .

b . Th e weigh ts are attach ed to a pulley; allow th e weigh ts to h an g freely over th e edge of bed.

c. No t m ore th an 8 to 10 lb (3.5 to 4.5 kg) of weigh t sh ould be applied as prescribed.

d . Elevate th e foot of th e bed to provid e th e traction .

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

FIGURE 64-3 External fixators. A, Mini-Hoffman system in use on hand. B, Hoffman II on the tibia (standard system). (From Lewis et al., 2011.)

A B

C

30 de gre e s

D

2

1

1

E FIGURE 64-4 Types of traction. A, Buck’s traction. B, Russell’s traction. C, Head halter traction. D, Pelvic traction. E, Balanced suspension traction.

942 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

4. Russell’s skin (slin g) traction : See Figure 64-4 an d Ch apter 43 regardin g th is type of traction .

5. Pelvic skin traction is used to relieve low back, hip, or leg pain or to reduce m uscle spasm (see Fig. 64-4). a. Apply th e traction belt sn ugly over th e pel-

vis an d iliac crest an d attach to th e weigh ts. b . Use m easu res as prescribed to preven t th e

clien t from slippin g down in bed . J. Balan ced suspen sion traction (see Fig. 64-4)

1. Description a. Balan ced suspen sion traction is used with

skin or skeletal traction . b . Used to approxim ate fractures of th e fem ur,

tibia, or fibula c. Balan ced suspen sion traction is produ ced

by a coun terforce oth er th an th e clien t. 2. In terven tion s

a. Position th e clien t in a lo w Fowler’s posi- tion on eith er th e side or th e back.

b . Main tain a 20-degree an gle from th e th igh to th e bed .

c. Protect th e skin from breakdown . d . Provide pin care if pin s are used with th e

skeletal traction . e. Clean th e pin sites with sterile n orm al salin e

an d h ydrogen peroxide or povidon e-iod in e as prescribed or per agen cy policy.

K. Casts 1. Description : Plaster, fiberglass, or air casts are

used to im m ob ilize bon es an d join ts in to cor- rect align m en t after a fracture or in jury.

2. In terven tion s a. Keep th e cast an d extrem ity elevated. b . Allow a wet plaster cast 24 to 72 h ours to

dry (syn th etic casts dry in 20 m in utes). c. Han dle a wet plaster cast with th e palm s of

th e h an ds (n ot fin gertips) un til dry. d . Turn th e extrem ity every 1 to 2 h ours, un less

con train d icated, to allow air circulation an d prom ote dryin g of th e cast.

e. Ah air dryer can be used on a cool settin g to dry a plaster cast (h eat can n ot be used on a plaster cast because th e cast h eats up an d burn s th e skin ).

f. Mon itor closely for circulatory im pairm en t; prepare for bivalvin g or cuttin g th e cast if circulatory im pairm en t occurs.

g. Petal th e cast or ap ply m oleskin to th e edges to protect th e clien t’s skin ; m ain tain sm ooth edges aroun d th e cast to preven t crum blin g of th e cast m aterial.

h . Mon itor for sign s of in fectio n such as in creased tem p erature, h ot spots on th e cast, foul odor, or ch an ges in pain .

i. If an open drain in g area exists on th e affected extrem ity, th e HCP will m ake a cutout portion of th e cast kn own as a window, for assessm ent an d woun d care purposes.

j. In struct th e clien t n ot to stick objects in side th e cast.

k . Teach th e clien t to keep th e cast clean an d dry.

l. In struct th e clien t in isom etric exercises to preven t m uscle atrop h y.

Monitor a casted extremity for circulatory impair- ment such as pain, swelling, discoloration, tingling, numbness, coolness, or diminished pulse. Notify the HCP immediately if circulatory compromise occurs.

VI. Complications of Fractures (Box 64-3) A. Fat embolism (see Priority Nursin g Action s)

PRIORITY NURSING ACTIONS Fat Embolism in a Client Following a Fracture 1. Notify the health care provider (HCP). 2. Administer oxygen. 3. Administer intravenous (IV) fluids as prescribed. 4. Monitor vital signs and respiratory status. 5. Prepare for intubation and mechanical ventilation if nec-

essary as indicated by arterial blood gas values. 6. Follow up on results of diagnostic tests such as chest

x-ray or computed tomography (CT) scan. 7. Document the event, actions taken, and the client’s

response.

A fat embolism originates in the bone marrow and occurs after a fracture when a fat globule is released into the blood- stream. Fat embolism can occur within the first 48 to 72 hours following the injury and clients with long bone fractures are at the greatest risk for development of a fat embolism. Findings are similar to those noted with pulmonary embolism and include restlessness, hypoxemia, mental status changes, dyspnea, tachypnea, tachycardia, and hypotension. In addi- tion, a petechial rash may present over the upper chest and neck. The HCP is notified immediately while initiating emergency care. The client is maintained on bed rest and is repositioned only as necessary and gently. Oxygen is administered and IV hydration is administered to prevent hypovolemic shock. Vital signs and respiratory status are monitored closely and the client is prepared for intubation and mechanical ventilation if necessary. Medications may also be prescribed for the client. The nurse then documents the event, actions taken, and the client’s response.

Reference Ignatavicius, Workman (2016), pp. 1054–1055.

BOX 64-3 Complications of Fractures ▪ Avascular necrosis ▪ Compartment syndrome ▪ Fat embolism ▪ Infection and osteomyelitis ▪ Pulmonary embolism

943CHAPTER 64 Musculoskeletal System

B. Pulm o n ary em b olism 1. Description : Pulm o n ary em b olism is cau sed by

th e m ovem en t of foreign particles (blood clot, fat, or air) in to th e pulm o n ary circulation .

2. Assessm en t a . Restlessn ess an d appreh en sion b . Sudden on set of dyspn ea an d ch est pain c. Cough , h em op tysis, h ypo xem ia, or crackles

3. In terven tion s a . No tify th e HCP im m ediately if sign s of

em b oli are presen t. b . Adm in ister oxygen an d oth er prescription s;

in traven o us (IV) an ticoagulan t th erap y m ay be prescribed.

C. Compartment syndrome 1. Description

a . Tough fascia surroun ds m uscle groups, form - in g com partm en ts from wh ich arteries, vein s, an d n erves en ter an d exit at opposite ends.

b . Com partm en t syn drom e occurs when pressure in creases with in 1 or m ore com part- m en ts, leadin g to decreased blood flow, tissue isch em ia, an d n eurovascular im pairm en t.

c. Neurovascular dam age m ay be irreversible if n ot treated with in 4 to 6 h ours after th e on set of com partm en t syn d rom e.

2. Assessm en t a . Un relieved or in creased pain in th e lim b b . Tissue th at is distal to th e in volved area

beco m es pale, dusky, or edem atous. c. Pain with passive m ovem en t d . Loss of sen sation (paresth esia) e. Pulselessn ess (a late sign )

3. In terven tion s a . No tify th e HCP im m ediately an d prepare to

assist th e HCP. b . Con tin ue to elevate th e affected extrem ity. c. If severe, assist th e HCP with fascio tom y to

relieve pressure an d restore tissue perfusion . d . Loo sen tigh t dressin gs or bivalve restrictive

cast as prescribed. D. In fection an d osteom yelitis

1. Description : In fection and osteom yelitis (in flam m atory respon se in bon e tissue) can be caused by the in troduction of organ ism s in to bon es leadin g to localized bon e in fection .

2. Assessm en t a . Tach ycardia an d fever (usually above 101°F

[38.3°C]). b . Eryth em a an d pain in th e area surroun din g

th e in fection c. Leu kocytosis an d elevated eryth rocyte sed i-

m en tation rate (ESR) 3. In terven tion s

a . No tify th e HCP. b . Prepare to in itiate aggressive, lon g-term IV

an tibiotic th erap y.

c. Surgery is perform ed for resistan t osteom ye- litis with sequestrectom y an d/ or bon e grafts.

d . For un relen tin g in fectio n an d osteom yeli- tis, h yperbaric oxygen th erapy is used (if available) to prom o te h ealin g.

E. Avascu lar n ecrosis 1. Description : Avascular n ecrosis occurs wh en a

fracture in terrupts th e blood supp ly to a section of bon e, leadin g to bon e death .

2. Assessm en t a . Pain b . Decreased sen sation

3. In terven tion s a . No tify th e HCP if pain or n um bn ess occurs. b . Prepare th e clien t for rem oval of n ecrotic tis-

sue because it serves as a focus for in fection .

VII. Crutch Walking A. Descriptio n

1. An accu rate m easurem en t of th e clien t for crutch es is im portan t because an in correct m ea- surem en t could dam age th e brach ial plexus.

2. Th e distan ce between th e axillae an d th e arm pieces on th e crutch es sh ould be 2 to 3 fin ger- width s in th e axilla space.

3. Th e elbows sh ould be sligh tly flexed, 20 to 30 degrees, wh en th e clien t is walkin g.

4. Wh en am bulatin g with th e clien t, stan d on th e affected side.

5. In struct th e clien t n ever to rest th e axillae on th e axillary bars.

6. In struct th e clien t to look up an d outward wh en am bulatin g an d to place th e crutch es 6 to 10 in ch es (25.5 cm ) diagon ally in fron t of th e foot.

7. In struct th e clien t to stop am bulation if n um b- n ess or tin glin g in th e h an ds or arm s occurs.

B. Crutch gaits (Table 64-2) C. Assistin g th e clien t with cru tch es to sit an d stan d

1. Place th e un affected leg again st th e fron t of th e ch air.

2. Move th e cru tch es to th e affected side, an d grasp th e arm of th e ch air with th e h an d on th e un affected side.

3. Flex th e kn ee of th e un affected leg to lower self in to th e ch air wh ile placin g th e affected leg straigh t out in fro n t.

4. Reverse th e step s to m ove from a sittin g to stan d- in g position .

D. Goin g up an d down stairs 1. Up th e stairs

a. Th e clien t m oves th e un affected leg up first. b . Th e clien t m oves th e affected leg an d th e

crutch es up. 2. Down th e stairs

a. Th e clien t m oves th e cru tch es an d th e affected leg down .

b . Th e clien t m oves th e un affected leg down .

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

944 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

VIII. Canes and Walkers A. Descrip tion : Can es an d walkers are m ade of a ligh t-

weigh t m aterial with a rubber tip at th e bottom . B. In terven tion s

1. Stan d at th e affected side of th e clien t wh en am bulatin g; use of a gait or tran sfer belt m ay be n ecessary.

2. Th e h an dle sh ould be at th e level of th e clien t’s greater troch an ter.

3. Th e clien t’s elbow sh ould be flexed at a 15- to 30-degree an gle.

4. In struct th e clien t to h old th e can e 4 to 6 in ch es (10 to 15 cm ) to th e side of th e foot.

5. In struct th e clien t to h old th e can e in th e h an d on th e un affected side so th at th e can e an d weaker leg can work togeth er with each step .

6. In struct th e clien t to m ove th e can e at th e sam e tim e as th e affected leg.

7. In struct th e clien t to in spect th e ru bber tips reg- ularly for worn places.

C. Hem ican es or quadripod can es 1. Hem ican es or quadripod can es are used for cli-

en ts wh o h ave th e use of on ly 1 upper extrem ity. 2. Hem ican es provide m ore security th an a quadri-

pod can e; h owever, both types provide m ore security th an a sin gle-tipp ed can e.

3. Position th e can e at th e clien t’s un affected side, with th e straigh t, n on an gled side ad jacen t to th e body.

4. Position th e can e 6 in ch es (15 cm ) fro m th e un affected clien t’s side, with th e h an d grip level with th e greater troch an ter.

D. Walker 1. Stan d adjacen t to th e clien t on th e affected side. 2. In struct th e clien t to put all 4 poin ts of th e

walker flat on th e floor befo re puttin g weigh t on th e h an d pieces.

3. In struct th e clien t to m ove th e walker forward, followed by th e affected or weaker foot an d th en th e un affected foot.

Safety is the priority concern when the client uses an assistive device such as a cane, walker, or crutches. Be sure that the client demonstrates correct use of the device.

IX. Fractured Hip A. Types

1. In tracapsular (fem oral h ead is broken with in th e join t cap sule) a. Fem o ral h ead an d n eck receive decreased

blood supply an d h eal slowly. b . Skin traction is applied preoperatively to reduce

the fracture an d decrease m uscle spasm s. c. Treatm en t in cludes a total h ip replacem en t

or open reduction in tern al fixation (O RIF) with fem o ral h ead replacem en t.

d . To prevent h ip displacem en t postoperatively, avoid extrem e h ip flexion , an d ch eck the sur- geon ’s prescription s regarding positionin g.

2. Extracapsular (fracture is outsid e th e join t cap sule) a. Fractu re can occur at th e greater troch an ter

or can be an in tertroch an teric fracture. b . Preoperative treatm en t in cludes balan ced

susp en sion or skin traction to relieve m uscle spasm s an d reduce pain .

c. Surgical treatm en t in cludes O RIF with n ail plate, screws, pin s, or wires.

B. Postoperative in terven tion s 1. Mon itor for sign s of delirium an d in stitute

safety m easures. 2. Main tain leg an d h ip in proper align m en t an d

preven t in tern al or extern al rotation ; avoid extrem e h ip flexion .

3. Follow th e HCP’s prescription s regardin g turn - in g an d repositio n in g; usually, turn in g to th e un affected side is allowed.

TABLE 64-2 Crutch Gaits Type of Gait Use Procedure

Two-point gait Used with partial weight- bearing limitations and with bilateral lower extremity prostheses

The crutch on the affected side and the unaffected foot are advanced at the same time

Three-point gait

Used for partial weight- bearing or no weight- bearing on the affected leg; requires that the client have strength and balance

Both crutches and the foot of the affected extremity are advanced together, followed by the foot of the unaffected extremity

Four-point gait Used if weight-bearing is allowed and 1 foot can be placed in front of the other

The right crutch is advanced, then the left foot, then the left crutch, and then the right foot

Swing-to gait Used when there is adequate muscle power and balance in the arms and legs

Both crutches are advanced together, then both legs are lifted and placed down on a spot behind the crutches. The feet and crutches form a tripod

Swing-through gait

Used when there is adequate muscle power and balance in the arms and legs

Both crutches are advanced together; then both legs are lifted through and beyond the crutches and placed down again at a point in front of the crutches

Adapted from Linton AD: Introduction to medical-surgical nursing, ed 4, St. Louis, 20 07, Saunders.

945CHAPTER 64 Musculoskeletal System

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

4. Elevate th e h ead of th e bed 30 to 45 degrees for m eals on ly.

5. Assist th e clien t to am bulate as prescribed by th e HCP.

6. Avoid weigh t-bearin g on th e affected leg as prescribed; in struct th e clien t in th e use of a walker to avoid weigh t-bearin g.

7. Weigh t-b earin g is often restricted after O RIF an d m ay n ot be restricted after total h ip arth ro- plasty (THA); always refer to th e HCP’s prescription s.

8. Keep th e operative leg exten ded , supported, an d elevated (preven tin g h ip flexion ) wh en gettin g th e clien t out of bed.

9. Avoid h ip flexion greater th an 90 degrees an d avoid low ch airs wh en out of bed.

10. Mon itor for woun d in fection or h em orrh age. 11. Adm in ister an tibiotics if prescribed with in a

specified tim e fram e (an tib iotics also m ay be prescribed in th e preop erative period).

12. Neurovascular assessm en t of affected extrem - ity: Ch eck color, pulses, cap illary refill, m ove- m en t, an d sen sation .

13. Main tain th e com pression of th e drain to facil- itate woun d drain age.

14. Mon itor an d record drain age am oun t, wh ich decreases con sisten tly.

15. As prescribed, carry out postoperative blood salvage to collect, filter, an d rein fu se salvaged blood in to th e clien t.

16. Use an tiem bolism stockin gs or sequen tial com pression stockin gs as prescribed; en cour- age th e clien t to flex an d exten d th e feet to reduce th e risk of deep vein th rom bosis (DVT).

17. In struct th e clien t to avoid crossin g th e legs an d activities th at require ben din g over.

18. Ph ysical th erap y will be in stituted posto pera- tively with progressive am bulation as pre- scribed by th e HCP.

X. Total Knee Replacement A. Description : Total kn ee replacem en t is th e im plan ta-

tion of a device to substitute for th e fem o ral con dyles an d tib ial join t surfaces.

B. Postoperative in terven tion s 1. Mon itor surgical in cision for drain age an d

in fectio n . 2. If prescribed, con tin uo us passive m otion (CPM)

is started soon after th e clien t is adm itted to th e posto perative un it.

3. Adm in ister an algesics before CPM to decrease pain .

4. Prepare th e clien t for out-of-bed activities as pre- scrib ed; h ave th e clien t avoid leg dan glin g.

5. Weigh t-bearin g with an assistive device is pre- scrib ed as tolerated.

6. Postoperative blood salvage m ay be prescribed to collect, filter, an d rein fu se salvaged blood in to th e clien t.

7. Adm in ister an tibiotics if prescribed with in a specified tim e fram e (an tibiotics also m ay be pre- scrib ed in th e preoperative period).

XI. Joint Dislocation and Subluxation A. Dislocation : In jury of th e ligam en ts surroun din g a

join t, wh ich leads to displacem en t or separatin g of th e articular surfaces of th e join t

B. Subluxation : In com plete displacem en t of join t sur- faces wh en forces disrupt th e soft tissue th at sur- ro un ds th e join ts

C. Assessm en t 1. Asym m etry of th e con tour of affected body parts 2. Pain , ten dern ess, dysfun ction , an d swellin g 3. Com plication s in clude n eurovascular com pro -

m ise, avascular n ecrosis, an d open join t in juries. 4. X-rays are taken to determ in e join t sh iftin g.

D. In terven tion s 1. Focus of treatm en t in cludes pain relief, join t

support, an d join t protection . 2. Im m ed iate treatm en t is don e to reduce th e dis-

location an d realign th e dislocated join t. 3. O pen or clo sed reduction is don e with a post-

proced ural join t im m ob ilization . 4. Intraven ous con scious sedation , local, or gen eral

an esth esia is used durin g joint m an ipulation . 5. In itial activity restriction is followed by gen tle

ran ge-of-m otion activities an d a gradual return of activities to n orm al levels wh ile supp ortin g th e affected join t.

6. A weaken ed join t is pron e to recurren t disloca- tion an d m ay require exten ded activity restriction .

XII. Herniation: Intervertebral Disk A. Descrip tion : Th e n ucleus of th e disk protrudes in to

th e an n ulus, causin g n erve com pression . B. Cervical disk h ern iation occurs at th e C5 to C6 an d

C6 to C7 in tersp aces. 1. Cervical disk h ern iatio n cau ses pain radiation to

sh oulders, arm s, h an ds, scapulae, an d pecto ral m uscles.

2. Moto r an d sen sory deficits can in clude paresth e- sia, n um bn ess, an d weakn ess of th e upper extrem ities.

3. In terven tion s a . Con servative m an agem en t is used un less th e

clien t develops sign s of n eurological deterioration .

b . Bed rest is prescribed to decrease pressure, in flam m ation , an d pain .

c. Im m obilize th e cervical area with a cervical collar or brace.

946 UNIT XVII Musculoskeletal Disorders of the Adult Client

d . Apply h eat to reduce m uscle spasm s an d apply ice to reduce in flam m ation an d swellin g.

e. Main tain h ead an d spin e align m en t. f. In struct th e clien t in th e use of an algesics,

sedatives, an tiin flam m ato ry agen ts, an d cor- ticosteroid s as prescribed.

g. Prepare th e clien t for a cortico steroid in jec- tion in to th e epidural space if prescribed.

h . Assist an d in struct the clien t in the use of a cer- vical collar or cervical traction as prescribed.

4. Cervical collar is used for cervical disk h ern iation . a . A cervical collar lim its n eck m ovem en t an d

h olds th e h ead in a n eutral or sligh tly flexed position .

b . Th e cervical co llar m ay be worn in term it- ten tly or 24 h ou rs daily.

c. In spect th e skin un der th e collar for irritation . d . Wh en prescribed an d after pain decreases,

exercises are don e to stren gth en th e m uscles. 5. Clien t edu cation related to cervical disk

con d ition s a . Avoid flexin g, exten din g, an d rotatin g th e n eck. b . Avoid th e pron e position an d m ain tain th e

n eck, spin e, an d h ips in a n eutral position wh ile sleepin g.

c. Min im ize lon g periods of sittin g. d . In struct th e clien t regardin g m ed ication s

such as an algesics, sed atives, an tiin flam m a- tory agen ts, an d cortico steroids.

C. Lum bar disk h ern iatio n m ost often occurs at th e L4 to L5 or L5 to S1 in tersp ace. 1. Hern iation produ ces m uscle weakn ess, sen sory

deficits, an d dim in ish ed ten don reflexes. 2. Th e clien t experien ces pain an d m uscle spasm s

in th e lower back, with radiation of th e pain in to 1 h ip an d down th e leg (sciatica).

3. Pain is relieved by bed rest an d aggravated by m ovem en t, liftin g, strain in g, an d cough in g.

4. In terven tion s a . Con servative m an agem en t is in dicated

un less n eurological deterioration or bowel an d blad der dysfun ction occurs.

b . Apply heat to decrease m uscle spasm s and apply ice to decrease inflam m ation and swelling.

c. In struct th e clien t to sleep on th e side, with th e kn ees an d h ips flexed, an d place a pillow between th e legs.

d . Apply pelvic traction as prescribed to relieve m uscle spasm s an d decrease pain .

e. Begin progressive am bulation as in flam m a- tion , edem a, an d pain subside.

5. Clien t education related to lum bar disk con d ition s a . In struct th e clien t in th e use of prescribed m ed-

ication s such as analgesics, m uscle relaxan ts, an tiin flam m atory agen ts, or corticosteroids.

b . In struct th e clien t ab out ap plication tech - n iqu es for corsets or braces to m ain tain im m obilization an d proper spin e align m en t.

c. In struct th e clien t in co rrect postu re wh ile sit- tin g, stan d in g, walkin g, an d workin g.

d . In struct the clien t in the correct tech n ique to use wh en liftin g objects such as ben din g th e kn ees, m ain tain in g a straigh t back, an d avoid- in g liftin g objects above th e elbow level.

e. In struct in a weigh t con trol program as prescribed .

f. In struct th e clien t in an exercise program to stren gth en back an d abdom in al m uscles as prescribed .

D. Disk surgery is used wh en spin al cord com pression is suspected or sym pto m s do n ot respo n d to con serva- tive treatm en t; m in im ally in vasive tech n iqu es m ay be prescribed ( Box 64-4). 1. Posto perative in terven tion s: Cervical disk

a . Mon itor for respiratory difficulty from in flam m ation or h em atom a.

b . En cou rage cough in g, deep breath in g, an d early am bulation as prescribed .

c. Mon itor for h oarsen ess an d in ability to cough effectively because th is m ay in dicate laryn geal n erve dam age.

d . Use th roat sprays or lozen ges for sore th roat, avoidin g an esth etic lozen ges th at m ay n um b th e th roat an d in crease ch okin g risks.

e. Assess th e surgical dressin g; m on itor th e sur- gical woun d for in fectio n , swellin g, redn ess, drain age, or pain ; an d m an age surgical drain s acco rdin gly.

f. Provide a soft diet if th e clien t com plain s of dysph agia.

g. Mon itor for sudden return of radicular pain , wh ich m ay in dicate cervical spin e in stability.

2. Posto perative in terven tion s: Lum bar disk a . Assess th e surgical dressin g, m on itorin g for

woun d drain age an d bleedin g an d m on itor- in g surgical drain s acco rdin gly.

b . Mon itor lower extrem ities for sen sation , m ove- m en t, color, tem perature, an d paresth esia.

c. Mon itor for urin ary reten tion , paralytic ileu s, an d con stipatio n , wh ich can result from decreased m ovem en t, opioid adm in istra- tio n , or spin al cord com pression .

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

BOX 64-4 Types of Disk Surgery Diskect omy: Removal of herniated disk tissue and related

matter Diskect omy with Fusion: Fusion of vertebrae with bone graft La minect omy: Excision of part of the vertebrae (lamina) to

remove the disk La minot omy: Division of the lamina of a vertebra

947CHAPTER 64 Musculoskeletal System

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

d . Preven t co n stipatio n by en couragin g a h igh - fib er diet, in creased fluid in take, an d stool soften ers as prescribed.

e. Adm in ister opioids an d sedatives as pre- scrib ed to relieve pain an d an xiety.

f. Assist an d in struct th e clien t to use a pre- scrib ed back brace or corset an d to wear cotton un derwear to preven t skin irritation .

3. Posto perative lum bar disk position in g a. In th e im m ediate postoperative period, th e

clien t m ay be exp ected to lie supin e or h ave oth er activity restrictio n s, dep en din g on th e specific surgical in terven tion .

b . In struct th e clien t to avoid spinal flexion or twisting an d th at the spine should be kept aligned.

c. In struct th e clien t to m in im ize sittin g, wh ich m ay place a strain on th e surgical site.

d . Wh en th e clien t is lyin g supin e, place a pillow un der th e n eck an d sligh tly flex the knees.

e. Avo id extrem e h ip flexion wh en lyin g on th e side.

Following disk surgery, instruct the client in correct logrolling techniques for turning and repositioning and for getting out of bed.

XIII. Amputation of a Lower Extremity A. Description

1. Am pu tatio n ( Fig. 64-5) is th e surgical rem oval of a lim b or part of th e lim b.

2. Com p lication s in clude h em orrh age, in fectio n , ph an tom lim b pain , n eurom a, an d flexion con tractures.

B. Posto perative in terven tion s 1. Mon itor for sign s of com plication s. 2. Mark bleedin g an d drain age on th e dressin g if

it occurs.

3. Evaluate for ph an tom lim b sen sation an d pain ; explain sen sation an d pain to th e clien t, an d m ed icate th e clien t as prescribed.

4. To preven t h ip flexion con tractures, do n ot elevate th e residual lim b on a pillow.

5. First 24 h ours: Elevate th e foot of th e bed to reduce edem a; th en keep th e bed flat to pre- ven t h ip flexion con tractures, if prescribed by th e HCP.

6. After 24 to 48 h ours postoperatively, position th e clien t pron e to stretch th e m uscles an d pre- ven t h ip flexion con tractures, if prescribed.

7. Main tain surgical application of dressin g, elas- tic com pression wrap, or elastic stum p (resid- ual lim b) sh rin ker as prescribed to reduce swellin g, m in im ize pain , an d m old th e residual lim b in preparation for prosth esis (Fig. 64-6)

8. As prescribed, wash th e residual lim b with m ild soap an d water an d dry com pletely.

9. Massage th e skin toward th e suture lin e if pre- scribed, to m obilize scar an d preven t its ad h er- en ce to un d erlyin g bon e.

10. Prepare for th e prosth esis an d in struct th e cli- en t in progressive resistive tech n iques by gen tly push in g th e residual lim b again st pil- lows an d progressin g to firm er surfaces.

11. En courage verbalization regardin g lo ss of th e body part, an d assist th e clien t to iden tify cop- in g m ech an ism s to deal with th e loss.

C. In terven tion s for below-kn ee am putation 1. Preven t edem a. 2. Do n ot allow th e residual lim b to h an g over th e

edge of th e bed. 3. Discou rage lon g periods of sittin g to lessen

com plication s of kn ee flexion . 4. Place th e clien t in a pron e position th rough ou t

th e day as prescribed by th e HCP. D. In terven tion s for above-kn ee am putation

1. Preven t in tern al or extern al rotatio n of th e lim b. 2. Place a san dbag, rolled towel, or tro ch an ter roll

alon g th e outsid e of th e th igh to preven t exter- n al rotation .

3. Place th e clien t in a pron e position th rough ou t th e day as prescribed by th e HCP.

E. Reh ab ilitation 1. In struct th e clien t in th e use of a m obility aid

such as cru tch es or a walker. 2. Prepare th e residual lim b for a prosth esis. 3. Prepare th e clien t for fittin g of th e residual lim b

for a prosth esis. 4. In struct th e clien t in exercises to m ain tain ran ge

of m otion an d upper body stren gth en in g. 5. Provid e psych o social support to th e clien t.

F. Traum atic am putation : Em ergen cy care 1. O btain em ergen cy m edical assistan ce (call 911). 2. Stay with th e victim , ch eck th e am putation site,

apply direct pressure with gauze or clo th (do n ot

Mid-foot a mputa tion (e .g., Lis fra nc a nd Chopa rt proce dure s )

Above -kne e a mputa tion

Be low-kne e a mputa tion

S yme a mputa tion

Toe a mputa tion

FIGURE 64-5 Common levels of lower extremity amputation.

948 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

rem ove ap plied pressure dressin g to preven t dis- lo dgin g of a form ed clot).

3. Elevate th e extrem ity above h eart level. 4. If fin ger( s) were am putated, place th em in a

watertigh t, sealed plastic bag; place th e bag in ice water (n ot directly on ice); an d tran spo rt to th e em ergen cy dep artm en t with th e victim .

XIV. Rheumatoid Arthritis A. Description

1. Rh eum atoid arth ritis is a ch ron ic system ic in flam m atory disease (im m un e com plex disor- der) ; th e cau se m ay be related to a com bin ation of en viron m en tal an d gen etic facto rs.

2. Rh eum atoid arth ritis leads to destru ction of con n ective tissue an d syn o vial m em bran e with in th e join ts.

3. Rh eum atoid arth ritis weaken s th e join t, leadin g to dislocation an d perm an en t deform ity of th e join t.

4. Pan n us form s at th e jun ction of syn o vial tissue an d articular cartilage an d projects in to th e join t cavity, causin g n ecrosis.

5. Exacerbation s of disease m an ifestation s occur durin g periods of ph ysical or em otion al stress an d fatigue.

6. Vasculitis can im ped e blood flo w, lead in g to organ or organ system m alfun ction an d failure cau sed by tissue isch em ia.

B. Assessm en t 1. In flam m ation , ten dern ess, an d stiffn ess of th e

join ts 2. Mod erate to severe pain , with m orn in g stiffn ess

lastin g lon ger th an 30 m in u tes 3. Join t defo rm ities, m uscle atrop h y, an d

decreased ran ge of m otion in affected join ts 4. Spon gy, soft feelin g in th e join ts 5. Low-grade tem perature, fatigue, an d weakn ess 6. An o rexia, weigh t loss, an d an em ia 7. Elevated ESR an d positive rh eu m atoid factor 8. Rad iograph ic study sh owin g join t deterioration 9. Syn ovial tissue biopsy reveals in flam m ation

C. Rh eum atoid facto r 1. Bloo d test used to assist in diagn osin g rh eum a-

toid arth ritis 2. Referen ce in terval: Negative or < 60 un its/ m L

D. Medication s: Com b in ation of ph arm aco lo gical th erap ies in cludes NSAIDs, disease-m odifyin g an ti- rh eum atic drugs (DMARDs), an d gluco cortico ids

E. Ph ysical m obility 1. Preserve join t fun ction . 2. Provid e ran ge-of-m otion exercises to m ain tain

join t m otion an d m uscle stren gth en in g. 3. Balan ce rest an d activity. 4. Splin ts m ay be used durin g acu te in flam m a-

tion to preven t defo rm ity. 5. Preven t flexion co n tractures. 6. Apply h eat or cold therapy as prescribed to join ts. 7. Apply paraffin bath s an d m assage as

prescribed. 8. En cou rage con sisten cy with exercise program . 9. Use join t-protectin g devices.

10. Avoid weigh t-bearin g on in flam ed join ts. F. Self-care ( Box 64-5)

1. Assess th e n eed for assistive devices such as raised toilet seats, self-risin g ch airs, wh eelch airs, an d scooters to facilitate m ob ility.

2 3 41 2 3 41

Wrapping fo r Abo ve -kne e Amputatio n Wrapping fo r Be lo w-kne e Amputatio n

FIGURE 64-6 A common method of wrapping a residual limb. Left, Wrapping for above-knee amputation. Right, Wrapping for below-knee amputation.

BOX 64-5 Client Education for Rheumatoid Arthritis and Degenerative Joint Disease

Assist the client to identify and correct safety hazards in the home.

Instruct the client in the correct use of assistive or adaptive devices.

Instruct the client in energy conservation measures. Review the prescribed exercise program. Instruct the client to sit in a chair with a high, straight back. Instruct the client to use only a small pillow when lying down. Instruct the client in measures to protect the joints. Instruct the client regarding the prescribed medications. Stress the importance of follow-up visits with the health care

provider.

949CHAPTER 64 Musculoskeletal System

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

2. Work with an occupation al th erap ist or HCP to obtain assistive or ad aptive devices.

3. In struct th e clien t in altern ative strategies for providin g activities of daily livin g.

G. Fatigue 1. Iden tify facto rs th at m ay con tribute to fatigue. 2. Mon itor for sign s of an em ia an d adm in ister

iron , folic acid, an d vitam in s as prescribed. 3. Mon itor for m ed ication -related blood loss by

testin g th e stool for occult blood. 4. In struct th e clien t in m easures to con serve

en ergy, such as pacin g activities an d obtain in g assistan ce wh en possible.

H. Distu rbed body im age 1. Assess th e clien t’s reaction to th e body ch an ge. 2. En cou rage th e clien t to verbalize feelin gs. 3. Assist th e clien t with self-care activities an d

groo m in g. 4. En cou rage th e clien t to wear street cloth es.

I. Surgical in terven tion s 1. Syn ovectom y: Surgical rem oval of th e syn ovia

to h elp m ain tain join t fun ction 2. Arth rodesis: Bon y fusion of a join t to regain

som e m ob ility 3. Join t replacem en t (arth roplasty): Surgical

replacem en t of diseased join ts with artificial join ts; perform ed to restore m otion to a join t an d fun ctio n to th e m uscles, ligam en ts, an d oth er soft tissue structures th at con tro l a join t

XV. Osteoarthritis (Degenerative Joint Disease) A. Description

1. O steoarth ritis is m arked by progressive deterio- ration of th e articular cartilage.

2. O steoarth ritis causes bon e buildup an d th e lo ss of articular cartilage in periph eral an d axial join ts.

3. O steoarth ritis affects th e weigh t-bearin g join ts an d join ts that receive th e greatest stress, such as the h ips, kn ees, lower vertebral colum n , an d h an ds.

4. Th e cause of prim ary osteoarth ritis is n ot kn own . Risk factors in clude traum a, agin g, obe- sity, gen etic ch an ges, an d sm okin g.

B. Assessm en t 1. Th e clien t experien ces join t pain th at dim in -

ish es after rest an d in ten sifies after activity, n oted early in th e disease process.

2. As th e disease progresses, pain occurs with sligh t m otion or even at rest.

3. Sym pto m s are aggravated by tem p erature ch an ge an d clim ate h um idity.

4. Presen ce of Heberd en ’s n od es or Bouch ard’s n odes (h an d s)

5. Join t swellin g (m ay be m in im al), crepitus, an d lim ited ran ge of m otion

6. Difficulty gettin g up after prolon ged sittin g 7. Skeletal m uscle disuse atroph y

8. In ability to perform activities of daily livin g 9. Com p ression of th e spin e as m an ifested by radi-

atin g pain , stiffn ess, an d m uscle spasm s in 1 or both extrem ities

C. Pain 1. Adm in ister m edication s as prescribed, such as

acetam in oph en or topical application s; if acet- am in op h en or topical agen ts do n ot relieve pain , NSAIDs m ay be prescribed. Muscle relax- an ts m ay also be prescribed for m uscle spasm s, especially th ose occurrin g in th e back.

2. Prepare th e clien t for corticosteroid in jection s in to join ts as prescribed.

3. Position join ts in fun ction position an d avoid flexion of kn ees an d h ips.

4. Im m obilize th e affected join t with a splin t or brace un til in flam m ation subsides.

5. Avoid large pillows un der th e h ead or kn ees. 6. Provid e a bed or foot cradle to keep lin en off of

feet an d legs un til in flam m ation subsid es. 7. In struct th e clien t in th e im portan ce of m oist

h eat, h ot packs or co m presses, an d paraffin dips as prescribed.

8. Apply cold ap plication s as prescribed wh en th e join t is acutely in flam ed .

9. En cou rage adequ ate rest. D. Nutrition

1. En cou rage a well-balan ced diet. 2. Main tain weigh t with in n orm al ran ge to

decrease stress on th e join ts. E. Ph ysical m ob ility

1. In struct th e clien t to balan ce activity with rest an d to participate in an exercise program th at lim its stressin g affected join ts.

2. In struct th e clien t th at exercises sh ould be active rath er th an passive an d to stop exercise if pain occurs.

3. In struct th e clien t to lim it exercise wh en join t in flam m ation is severe.

F. Surgical m an agem en t 1. O steotom y: Th e bon e is resected to correct join t

deform ity, prom o te realign m en t, an d reduce join t stress.

2. Total join t replacem en t or arth roplasty a . To tal join t replacem en t is perform ed wh en

all m easu res of pain relief h ave failed. b . Hips an d kn ees are replaced m ost

com m on ly. c. To tal join t replacem en t is co n train d icated

in th e presen ce of in fectio n , ad van ced oste- oporo sis, or severe join t in flam m ation .

XVI. Osteoporosis A. Descrip tion

1. O steoporosis is a m etab olic disease ch aracterized by bon e dem in eralization , with loss of calcium an d ph o sph orus salts lead in g to fragile bon es an d th e subsequen t risk for fractures.

950 UNIT XVII Musculoskeletal Disorders of the Adult Client

2. Bon e resorptio n accelerates as bon e form ation slows.

3. O steoporo sis occurs m ost com m on ly in th e wrist, h ip, an d vertebral colum n .

4. O steoporo sis can occur postm en opausally or as a result of a m etab olic disorder or calcium deficien cy.

5. Th e clien t m ay be asym ptom atic un til th e bon es beco m e fragile an d a m in o r in ju ry or m ovem en t cau ses a fracture.

6. Prim ary osteopo rosis a . Most often occurs in postm en opausal

wom en ; occurs in m en with low testosteron e levels

b . Risk factors in clude decreased calcium in take, deficien t estrogen , an d seden tary lifestyle.

7. Secon dary osteoporo sis a . Causes in clude prolon ged th erapy with

corticostero ids, th yroid-reducin g m edica- tion s, alum in um -con tain in g an tacids, or an tiseizure m ed ication s.

b . Associated with im m ob ility, alcoh olism , m aln utrition , or m alabsorption

8. Risk facto rs (Box 64-6) B. Assessm en t

1. Possibly asym ptom atic 2. Back pain th at occurs after liftin g, ben din g, or

stoop in g 3. Back pain th at in creases with palpation 4. Pelvic or h ip pain , especially with weigh t-b earin g 5. Problem s with balan ce 6. Declin e in h eigh t from vertebral com pression 7. Kyp h osis of th e dorsal spin e, also kn own as

“dowager’s h um p” 8. Degen eration of lower th o rax an d lu m bar verte-

brae on radiograph ic studies

The client with osteoporosis is at risk for patholog- ical fractures.

C. In terven tion s 1. Assess risk for an d preven t in jury in th e clien t’s

perso n al en viron m en t. a . Assist th e clien t to iden tify an d correct h az-

ards in h is or h er en viron m en t.

b . Position h ou seh old item s an d furn iture to en sure an un obstru cted walkway.

c. Use side rails to preven t falls. d . In struct in use of assistive devices such as a

can e or walker. e. En cou rage th e use of a firm m attress.

2. Provide perso n al care to th e clien t to reduce in juries. a. Move th e clien t gen tly wh en turn in g an d

reposition in g. b . Assist with am bulation if the client is un steady. c. Provide gen tle ran ge-of-m otion exercises. d . Apply a back brace as prescribed durin g an

acu te ph ase to im m ob ilize th e spin e an d provide spin al colum n supp ort.

3. Provide th e clien t with in struction s to prom o te optim al level of h ealth an d fun ction . a. In struct th e clien t in th e use of correct body

m ech an ics. b . In struct th e clien t in exercises to stren gth en

ab dom in al an d back m uscles to im prove postu re an d provide supp ort for th e spin e.

c. In struct th e clien t to avoid activities th at can cau se vertebral com pression .

d . In struct th e clien t to eat a diet h igh in pro- tein , calcium , vitam in s C an d D, an d iron .

e. In struct the client to avoid alcoh ol an d coffee. f. In struct th e clien t to m ain tain an ad equate

flu id in take to preven t ren al calculi. 4. Adm in ister m ed ication s as prescribed to pro-

m ote bon e stren gth an d decrease pain .

XVII. Gout A. Descrip tion

1. Gout is a system ic disease in wh ich urate crystals deposit in join ts an d oth er body tissues.

2. Gout results fro m abn o rm al am oun ts of uric acid in th e body.

3. Prim ary gout results fro m a disorder of purin e m etab olism .

4. Secon dary gout in volves excessive uric acid in th e blood cau sed by an oth er disease.

B. Ph ases 1. Asym ptom atic: Clien t h as n o sym pto m s but

serum uric acid level is elevated. 2. Acute: Clien t h as excruciatin g pain an d in flam -

m ation of 1 or m ore sm all join ts, especially th e great toe.

3. In term itten t: Clien t h as in term itten t periods with ou t sym ptom s between acu te attacks.

4. Ch ron ic: Results fro m repeated episo des of acute gout a . Resu lts in deposits of urate crystals un der

th e skin b . Resu lts in deposits of urate crystals with in

m ajo r organ s, such as th e kidn eys, leadin g to organ dysfun ction

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

BOX 64-6 Risk Factors for Osteoporosis

▪ Cigarette smoking ▪ Early menopause ▪ Excessive use of alcohol ▪ Family history ▪ Female gender ▪ Increasing age ▪ Insufficient intake of calcium ▪ Sedentary lifestyle ▪ Thin, small frame ▪ White (European descent) or Asian race

951CHAPTER 64 Musculoskeletal System

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

C. Assessm en t 1. Swellin g an d in flam m ation of th e join ts, leadin g

to excruciatin g pain 2. Toph i: Hard, irregularly sh ap ed n od ules in th e

skin con tain in g ch alky deposits of sodium urate 3. Low-grade fever, m alaise, an d h eadach e 4. Pruritu s from urate crystals in th e skin 5. Presen ce of ren al ston es from elevated uric acid

levels D. In terven tion s

1. Provide a low-purin e diet as prescribed, avoid- in g foods such as organ m eats, win es, an d aged ch eese.

2. En courage a h igh flu id in take of 2000 m L/ d ay to preven t ston e form ation .

3. En courage a weigh t reduction diet if required. 4. In stru ct th e clien t to avo id alco h o l an d

starvatio n d iets b ecau se th ey m ay p recip itate a go u t attack.

5. In crease urin ary pH (above 6) by eatin g alka- lin e ash food s (i.e., green bean s, broccoli).

6. Provide bed rest durin g acute attacks, with th e affected extrem ity elevated.

7. Mon itor join t ran ge-of-m otion ab ility an d appearan ce of join ts.

8. Position th e join t in m ild flexion durin g acu te attack.

9. Protect the affected join t from excessive m ove- m en t or direct con tact with sh eets or blan kets.

10. Provide h eat or cold for local treatm en ts to affected join t as prescribed.

11. Adm inister m edications such as analgesic, antiin- flam m atory, and uricosuric agents as prescribed.

CRITICAL THINKING What Should You Do? Answer: In a traumatic amputation, the nurse should ask someone to call 911 to transport the victim to the hospital. While awaiting emergency medical assistance, the nurse should immediately check the amputation site and apply direct pressure with dry gauze. This pressure dressing is not removed, to prevent dislodgment of a formed clot. The extremity is elevated above heart level. The amputated finger is placed in a watertight, sealed plastic bag and the bag is placed in ice water (not directly on ice). The nurse stays with the victim until transport to the emergency department.

Reference: Ignatavicius, Workman (20 16), p. 10 72.

P R A C T I C E Q U E S T I O N S 800. Th e n urse is con d uctin g h ealth screen in g for oste-

oporo sis. Wh ich clien t is at greatest risk of develop- in g th is disorder? 1. A 25-year-old wom an wh o run s 2. A 36-year-o ld m an wh o h as asth m a 3. A 70-year-old m an wh o con sum es excess alcoh ol 4. A sed en tary 65-year-o ld wom an wh o sm okes

cigarettes

801. Th e n urse h as given in struction s to a clien t return - in g h om e after kn ee arth roscopy. Wh ich statem en t by th e clien t in dicates th at th e in struction s are un d erstood? 1. “I can resum e regular exercise tom orrow.” 2. “I can ’t eat food for th e rem ain der of th e day.” 3. “I n eed to stay off th e leg en tirely for th e rest of

th e day.” 4. “I n eed to report a fever or swellin g to m y h ealth

care provider.”

802. Th e n urse witn essed a veh icle h it a pedestrian . Th e victim is dazed and tries to get up. A leg appears fractured. Wh ich in terven tion sh ould th e n urse take? 1. Try to reduce th e fracture m an ually. 2. Assist th e victim to get up an d walk to th e

sidewalk. 3. Leave th e victim for a few m om en ts to call an

am bulan ce. 4. Stay with th e victim an d en courage h im or h er

to rem ain still.

803. Wh ich cast care in struction s sh ould th e n urse pro- vide to a clien t wh o just h ad a plaster cast applied to th e righ t forearm ? Select all th at ap p ly.

1. Keep th e cast clean an d dry. 2. Allow th e cast 24 to 72 h ours to dry. 3. Keep th e cast an d extrem ity elevated . 4. Expect tin glin g an d n um bn ess in th e

extrem ity. 5. Use a h air dryer set on a warm to h ot settin g

to dry th e cast. 6. Use a soft, padded object th at will fit

un d er th e cast to scratch th e skin un der th e cast.

804. Th e n urse is evalu atin g a clien t in skeletal traction . Wh en evaluatin g th e pin sites, th e n urse would be m o st con cern ed with wh ich fin din g? 1. Redn ess aroun d th e pin sites 2. Pain on palpatio n at th e pin sites 3. Th ick, yello w drain age fro m th e pin sites 4. Clear, watery drain age from th e pin sites

805. Th e n urse is assessin g th e casted extrem ity of a cli- en t. Wh ich sign is in dicative of in fectio n ? 1. Depen den t edem a 2. Dim in ish ed distal pulse 3. Presen ce of a “h ot spot” on th e cast 4. Cooln ess an d pallor of th e extrem ity

806. A clien t h as sustain ed a clo sed fracture an d h as just h ad a cast applied to th e affected arm . Th e clien t is com plain in g of in ten se pain . Th e n urse elevates th e lim b , applies an ice bag, an d ad m in isters an an al- gesic, with little relief. Wh ich problem m ay be cau sin g th is pain ?

952 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

1. In fection un der th e cast 2. Th e an xiety of th e clien t 3. Im paired tissue perfusion 4. Th e recen t occurren ce of th e fracture

807. Th e n urse is adm ittin g a clien t with m ultiple traum a in juries to th e n ursin g un it. Th e clien t h as a leg fracture an d h ad a plaster cast applied. Wh ich position would be b est for th e casted leg? 1. Elevated for 3 h ours, th en flat for 1 h our 2. Flat for 3 h ours, th en elevated for 1 h ou r 3. Flat for 12 h ou rs, th en elevated for 12 h ours 4. Elevated on pillows con tin uo usly for 24 to

48 h ou rs

808. A clien t is bein g disch arged to h om e after applica- tion of a plaster leg cast. Wh ich statem en t in dicates th at th e clien t un derstan ds proper care of th e cast? 1. “I n eed to avoid gettin g th e cast wet.” 2. “I n eed to cover th e casted leg with warm

blan kets.” 3. “I n eed to use m y fin gertips to lift an d m ove

m y leg.” 4. “I n eed to use som eth in g like a padded coat

h an ger en d to scratch un der th e cast if it itch es.”

809. A clien t bein g m easured for cru tch es asks th e n urse wh y th e crutch es can n ot rest up un dern eath th e arm for extra supp ort. Th e n urse respo n ds kn owin g th at wh ich would m o st likely result from th is im proper crutch m easu rem en t? 1. A fall an d furth er in jury 2. In jury to th e brach ial plexus n erves 3. Skin breakd own in th e area of th e axilla 4. Im p aired ran ge of m otion wh ile th e clien t

am bulates

810. Th e n urse h as given th e clien t in struction s ab out cru tch safety. Wh ich statem en t in dicates th at th e clien t un derstan ds th e in struction s? Select all th at ap p ly.

1. “I sh ould n ot use som eon e else’s crutch es.” 2. “I n eed to rem ove an y scatter rugs at h om e.” 3. “I can use crutch tips even wh en th ey are wet.” 4. “I n eed to h ave spare crutch es an d tips

available.” 5. “Wh en I’m usin g th e crutch es, m y arm s n eed

to be com pletely straigh t.”

811. Th e n urse is carin g for a clien t bein g treated for fat em bolus after m ultiple fractures. Wh ich data would th e n urse evaluate as th e m o st favorable in dication of resolution of th e fat em bolus? 1. Clear m en tation 2. Min im al dyspn ea 3. O xygen saturation of 85% 4. Arterial oxygen level of 78 m m Hg (10.3 kPa)

812. Th e n urse h as con d ucted teach in g with a clien t in an arm cast about th e sign s an d sym pto m s of com - partm en t syn d rom e. Th e n urse determ in es th at th e clien t un d erstan ds th e in form ation if th e clien t states th at h e or sh e sh ould report wh ich early sym ptom of co m partm en t syn d rom e? 1. Cold, bluish -colored fin gers 2. Num bn ess an d tin glin g in th e fin gers 3. Pain th at in creases wh en th e arm is depen den t 4. Pain th at is out of proportion to th e severity of

th e fracture

813. A clien t with diabetes m ellitus h as h ad a righ t below-kn ee am putation . Given th e clien t’s h isto ry of diabetes m ellitus, wh ich com plication is th e cli- en t at m o st risk for after surgery? 1. Hem o rrh age 2. Edem a of th e residual lim b 3. Sligh t redn ess of th e in cision 4. Separation of th e woun d edges

814. Th e n urse is carin g for a clien t wh o h ad an above- kn ee am putation 2 days ago. Th e residual lim b was wrapped with an elastic com pression ban dage, wh ich h as com e off. Wh ich im m ed iate action sh o uld th e n urse take? 1. Apply ice to th e site. 2. Call th e h ealth care provid er (HCP) . 3. Rewrap th e residual lim b with an elastic com -

pression ban dage. 4. Apply a dry, sterile dressin g an d elevate th e

residual lim b on 1 pillow.

815. A clien t is com plain in g of lo w back pain th at radi- ates down th e left posterior th igh . Th e n urse sh o uld ask th e clien t if th e pain is worsen ed or aggravated by wh ich factor? 1. Bed rest 2. Ibuprofen 3. Ben din g or liftin g 4. Application of h eat

816. Th e n urse is carin g for a clien t wh o h as h ad spin al fusion , with in sertion of h ardware. Th e n urse would be m o st con cern ed with which assessm en t fin din g? 1. Tem perature of 101.6°F (38.7°C) orally 2. Com plain ts of discom fort durin g reposition in g 3. O ld blood y drain age outlin ed on th e surgical

dressin g 4. Discom fort durin g cough in g an d deep-

breath in g exercises

817. Th e n urse is carin g for a clien t with a diagn osis of go ut. Wh ich labo ratory value would th e n urse exp ect to n ote in th e clien t? 1. Calcium level of 9.0 m g/ dL (2.25 m m ol/ L) 2. Uric acid level of 9.0 m g/ dL (0.54 m m o l/ L)

953CHAPTER 64 Musculoskeletal System

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

3. Potassiu m level of 4.1 m Eq/ L (4.1 m m o l/ L) 4. Ph osph orus level of 3.1 m g/ dL (1.0 m m ol/ L)

818. A clien t with a h ip fracture asks th e n urse about Buck’s (exten sio n ) traction th at is bein g applied befo re surgery an d wh at is in volved. Th e n urse sh o uld provide wh ich in form ation to th e clien t? 1. Allows bon y h ealin g to begin before surgery an d

in volves pin s an d screws

2. Provides rigid im m obilization of th e fracture site an d in volves pulleys an d wh eels

3. Len gth en s th e fractured leg to preven t severin g of blood vessels an d in volves pin s an d screws

4. Provid es com fo rt by reducin g m uscle spasm s, provid es fracture im m ob ilization , an d in volves pulleys an d wh eels

A N S W E R S 800. 4 Ra tion a le: Risk factors for o steop o ro sis in clu de fem ale gen der, b ein g p ostm en o pau sal, advan ced age, a lo w-calcium d iet, excessive alco h o l in take, b ein g seden tary, an d sm o kin g ciga- rettes. Lon g-term use of corticosteroid s, an ticon vu lsan ts, an d / o r furosem id e also in creases th e risk. Test-Ta kin g St r a t egy: Focus o n th e su b ject, risk facto rs for o ste- o poro sis. Th e 25-year-old wom an wh o run s (exercises u sin g th e lo n g bon es) h as n egligib le risk. The 36-year-old m an with asth m a is elim in ated n ext b ecause h is on ly risk facto r m igh t b e lon g-term corticostero id use (if prescribed ) to treat th e asth m a. O f th e rem ain in g option s, th e 65-year-o ld wom an h as h igher risk (age, gen der, postm en op au sal, seden tary, sm o k- in g) th an th e 70-year-old m an (age, alcoh ol con su m ptio n) . Review: Th e risk facto rs asso ciated with o steo p o ro sis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Mu sculo skeletal Pr ior it y Con cept s: Health Pro m otio n ; Mo bility Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1030.

801. 4 Ra tion a le: After arth rosco py, th e clien t u sually can walk care- fu lly o n th e leg o n ce sen sation h as return ed . Th e clien t is in stru cted to avo id stren u ou s exercise for at least a few d ays. Th e clien t m ay resum e th e usu al d iet. Sign s an d sym p tom s o f in fectio n sh o u ld be rep o rted to th e h ealth care provid er. Test-Ta kin g Str a tegy: Focus on th e su b ject, teach in g poin ts fol- lowin g kn ee arth roscopy. Recallin g th e gen eral clien t teach in g poin ts related to surgical procedures an d th at a risk for in fection exists after a surgical procedure will direct you to th e correct option . Review: Teach in g po in ts followin g arth ro sco p y Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Mu sculo skeletal Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Lewis et al. (2014), p . 1536.

802. 4 Ra tion a le: With a su sp ected fractu re, th e victim is n ot m o ved u n less it is d an gerou s to rem ain in th at spo t. Th e n u rse sh ou ld rem ain with th e victim an d h ave so m eon e else call fo r em er- gen cy h elp . A fractu re is n ot red u ced at th e scen e. Before th e

victim is m o ved , th e site o f fractu re is im m o b ilized to p reven t fu rth er in jury. Test-Ta king St r a t egy: Elim in ate o ptio n s 1 an d 2 first because th ey are co m p arab le o r alike in th at eith er o f th ese o ption s cou ld result in furth er in jury to th e victim . O f th e rem ain in g option s, th e m o re p ru den t action would be for the n urse to rem ain with th e victim an d h ave som eon e else call fo r em ergency assistan ce. Review: Im m ediate care o f th e victim with a fractu re Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Mu scu lo skeletal Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 1058.

803. 1, 2, 3 Ra tion a le: A plaster cast takes 24 to 72 h o urs to d ry (syn th etic casts d ry in 20 m in u tes) . Th e cast an d extrem ity sh o uld b e ele- vated to redu ce ed em a if p rescribed. A wet cast is h an dled with th e p alm s of th e h an d un til it is d ry, an d th e extrem ity is turn ed (un less con train d icated) so th at all sid es of th e wet cast will d ry. A co ol settin g o n th e h air d ryer can b e used to dry a p laster cast ( h eat can n o t b e used o n a p laster cast becau se th e cast h eats u p an d b u rn s th e skin ). Th e cast n eeds to be kep t clean an d d ry, an d th e clien t is in structed n o t to stick an yth in g u n d er th e cast b ecau se of th e risk o f b reakin g skin in tegrity. Th e clien t is in stru cted to m o n ito r th e extrem ity fo r circu lato ry im p airm en t, su ch as pain , swellin g, discoloration , tin glin g, n um b n ess, coo l- n ess, or d im in ish ed p ulse. Th e h ealth care p ro vid er is n otified im m ediately if circulato ry im pairm en t occu rs. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, a p laster cast. Recallin g th at ed em a o ccu rs fo llo win g a fracture an d recallin g th e com p lication s associated with a cast will assist you in an swerin g th e q uestion . Review: Cast care in structio n s Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ad ult Health —Mu scu lo skeletal Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1058–1059.

804. 3 Ra tion a le: Th e n urse sh o uld m o nitor for signs of in fection such as in flam m ation , purulen t d rain age, an d pain at th e pin site. Ho wever, som e d egree o f in flam m ation , pain at th e p in site, and serous drain age wou ld be exp ected; th e n urse sh o uld

954 UNIT XVII Musculoskeletal Disorders of the Adult Client

correlate assessm en t fin din gs with o th er clin ical fin din gs, such as fever, elevated wh ite b lo od cell coun t, and ch anges in vital sign s. Add itio n ally, th e n urse sh o uld com pare an y fin din gs to baselin e fin din gs to determ in e if th ere were an y ch anges. Test -Ta kin g Str a tegy: No te th e strategic wo rd , most. Deter- m in e if an ab n o rm ality exists. Recall th at p u ru len t drain age is in dicative of in fectio n , an d th at so m e d egree of p ain , in flam - m atio n , an d serou s d rain age sh o uld b e exp ected . Review: Exp ected fin d in gs in th e clien t with skeletal tractio n Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ad ult Health —Mu scu loskeletal Pr ior ity Con cepts: Clin ical Jud gm en t; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1062.

805. 3 Ra t ion a le: Sign s o f in fection un d er a casted area in clud e odor or purulent drain age from th e cast or th e presen ce of “h ot spo ts,” wh ich are areas o f th e cast th at are warm er th an o th ers. Th e h ealth care provider sh ould b e n otified if an y of th ese occur. Sign s of im paired circulation in th e distal lim b in clu de cooln ess an d p allor o f th e skin , d im in ish ed d istal pulse, an d edem a. Test-Ta kin g St ra tegy: Focus o n th e su b ject, signs o f in fection . Thin k abo ut wh at you would exp ect to n ote with in fectio n —red- n ess, swellin g, h eat, and purulen t d rain age. With th is in m in d, you can elim in ate option s 2 an d 4 easily. From th e rem ain in g option s, rem em ber that “depend en t edem a” is n ot n ecessarily in dicative of in fection . Swellin g wou ld b e con tin uo us. The h ot spo t o n th e cast cou ld signify in fection u nd ern eath that area. Review: Sign s of in fectio n in an extrem ity with a cast Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Mu scu loskeletal Pr ior ity Con cepts: In fectio n ; Tissu e In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1060.

806. 3 Ra tion a le: Most p ain associated with fractu res can be m in i- m ized with rest, elevation , application of cold , an d adm in istra- tion of analgesics. Pain that is n ot relieved b y th ese m easures sh ould be reported to th e h ealth care p rovid er b ecau se pain un relieved by m edicatio ns an d o th er m easu res m ay in d icate n eu rovascular com pro m ise. Becau se th is is a n ew closed fracture an d cast, in fection wou ld n ot h ave h ad tim e to set in . Inten se pain after castin g is n orm ally n ot associated with anxiety or th e recent occurren ce o f th e in jury. Treatm en t followin g th e frac- ture sho uld assist in relievin g th e p ain associated with th e in ju ry. Test -Ta kin g St r a t egy: Focus o n th e su b ject, in ten se p ain , an d fo cus o n th e d ata in th e q u estio n . Use o f th e ABCs—airway– b reath in g–circu latio n —will direct you to th e correct option . Review: Care o f th e clien t with a fractu re an d n ew cast Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Mu scu loskeletal Pr ior ity Con cepts: Pain ; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1064.

807. 4 Ra t ion a le: A casted extrem ity is elevated co n tin uo usly for th e first 24 to 48 h o urs to m in im ize swellin g an d p ro m o te ven o u s drain age. O p tio n s 1, 2, an d 3 are in co rrect.

Test -Ta kin g St r a t egy: Note th e strategic wo rd , best. Recallin g th at edem a is a co n cern fo llo win g an in ju ry an d kn o wledge o f th e effects o f gravity o n ed em a will d irect you to th e correct o p tion . Review: Care o f th e clien t with a n ew cast Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Muscu loskeletal Pr ior ity Con cepts: Perfusio n ; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1059.

808. 1 Ra t ion a le: A plaster cast m ust rem ain d ry to keep its stren gth. Th e cast sh ould be h an dled with th e palm s of th e h an ds, n ot th e fin gertips, un til fully d ry; u sin g th e fin gertips results in in dentatio n s in th e cast an d skin p ressure u n der th e cast. Air sh ould circulate freely aro un d the cast to h elp it dry; th e cast also gives o ff h eat as it dries. Th e clien t sho uld n ever scratch un der th e cast becau se of the risk o f altered skin in tegrity; th e clien t m ay u se a h air d ryer o n th e coo l settin g to relieve an itch. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, clien t un derstan d- in g abo u t cast care. Kn o win g th at a wet cast can b e d en ted with th e fin gertips, cau sin g pressure un dern eath , h elps to elim in ate o p tion 3 first. Kn o win g th at th e cast n eed s to dry h elps to elim - in ate o ptio n 2 n ext. O ption 4 is d an gero us to skin in tegrity an d is also elim in ated . Rem em ber th at p laster casts, on ce th ey h ave d ried after ap plicatio n , sh o uld n ot beco m e wet. Review: Care o f th e clien t with a cast Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ad ult Health —Muscu loskeletal Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p . 1059.

809. 2 Ra t ion a le: Cru tch es are m easu red so th at th e to ps are 2 to 3 fin gerwid th s fro m th e axillae. Th is en su res th at th e clien t’s axil- lae are n o t restin g on th e cru tch or b earin g th e weigh t o f th e cru tch , wh ich co uld resu lt in in ju ry to th e n erves o f th e b rach ial p lexu s. Alth o ugh th e co n d ition s in o p tion s 1, 3, an d 4 can o ccu r, th ey are n o t th e m ost likely resu lt fro m restin g th e axilla d irectly o n th e cru tch es. Test -Ta kin g St r a t egy: No te th e strategic wo rd s, most likely, an d fo cus o n th e d ata in th e q u estio n . Recallin g th e risk asso ciated with brach ial n erve plexus in jury will direct you to th e correct o p tion . Review: Th e com p licatio n s asso ciated with th e u se o f cru tch es Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Muscu loskeletal Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Perry et al. (2014), p p. 239–240.

810. 1, 2, 4 Ra t ion a le: Th e clien t sh o uld u se on ly cru tch es m easured for th e clien t. Wh en assessin g for h o m e safety, th e n u rse en su res th at th e clien t kn o ws to rem ove an y scatter rugs an d do es n ot walk on h igh ly waxed floo rs. Th e tip s sh o uld b e in sp ected fo r wear, an d spare cru tch es an d tips sh ou ld b e available if n eed ed. Cru tch tips sh ou ld rem ain dry. If cru tch tips get wet,

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

955CHAPTER 64 Musculoskeletal System

th e clien t sh o u ld d ry th em with a clo th o r pap er to wel. Wh en walkin g with crutch es, both elbows n eed to be flexed n ot m ore th an 30 d egrees wh en th e p alm s are on th e h an dle. Test-Ta kin g St r a t egy: Focus on th e su b ject, clien t u n d erstan d- in g of in stru ctio n s o f usin g cru tch es. Visualize each o ption an d th in k abo u t th e safety asso ciated with each in stru ctio n . Th is will assist in an swerin g correctly. Review: Clien t teach in g po in ts related to safety an d cru tch es Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Mu sculo skeletal Pr ior it y Con cept s: Mob ility; Safety Refer en ce: Perry et al. (2014), pp . 239–240.

811. 1 Ra tion a le: An altered m en tal state is an early in dication o f fat em boli; th erefore, clear m en tatio n is a goo d in dicator th at a fat em bolus is resolvin g. Eupn ea, n ot m in im al dyspn ea, is a n orm al sign. Arterial oxygen levels sh ould be 80–100 m m Hg (10.6–13.33 kPa). O xygen saturatio n sh ould be h igh er th an 95%. Test-Ta kin g St r a t egy: No te th e strategic wo rd , most. Kn owin g th at th e arterial o xygen an d oxygen satu ratio n levels are below n o rm al h elp s to elim in ate o ptio n s 3 an d 4. Dysp n ea, even at a m in im al level, is n ot n orm al, so elim in ate o ptio n 2. Review: Th e expected o utcom es in a clien t b ein g treated for fat em b o lism Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Mu sculo skeletal Pr ior it y Con cept s: Evid en ce; Perfu sio n Refer en ce: Lewis et al. (2014), p . 1523.

812. 2 Ra tion a le: Th e earliest sym p tom o f co m p artm en t syn drom e is p aresth esia (n u m bn ess an d tin glin g in th e fin gers). O th er sym pto m s in clu de pain un relieved by o pio id s, p ain th at in creases with lim b elevatio n , an d pallor an d co oln ess to th e d istal lim b. Cyan osis is a late sign . Pain th at is o u t of p ro p or- tio n to th e severity of th e fracture, alo n g with oth er sym p tom s asso ciated with th e p ain , is n o t an early m an ifestation . Test-Ta kin g Str a tegy: No te th e strategic wo rd , early. Kn owin g th at com partm en t syn d ro m e is ch aracterized by in su fficien t circulation an d isch em ia cau sed b y p ressure will direct you to th e correct o ptio n . Review: Th e early m an ifestation s o f co m p artm en t syn d ro m e Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Adu lt Health —Mu sculo skeletal Pr ior it y Con cept s: Clien t Ed ucation ; Perfusion Refer en ce: Lewis et al. (2014), p . 1523.

813. 4 Ra tion a le: Clien ts with d iab etes m ellitus are m o re pron e to woun d in fection an d delayed woun d h ealin g because of th e d isease. Posto p erative h em o rrh age an d edem a of th e resid ual lim b are co m plicatio n s in th e im m ediate p o stop erative perio d th at app ly to an y clien t with an am p utatio n . Sligh t red n ess of th e in cisio n is co n sid ered n o rm al, as lo n g as th e in cisio n is dry an d in tact.

Test-Ta kin g St r a t egy: Note th e strategic wo rd , most, an d fo cus o n th e su b ject, com p licatio n s followin g surgery fo r th e clien t with diabetes m ellitus. Recallin g th at diabetes m ellitus in creases th e clien t’s ch an ces o f develop in g in fectio n an d d elayed wou n d h ealin g will direct yo u to th e correct o ptio n . Review: Th e co m p lication s asso ciated with an am p u tatio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Mu scu lo skeletal Pr ior it y Con cept s: Glucose Regu latio n ; Tissu e In tegrity Refer en ce: Lewis et al. (2014), p p. 1530–1531.

814. 3 Ra tion a le: If the clien t with an am putation h as a cast or elastic com p ression b an dage th at slip s off, th e n urse m ust wrap th e residual lim b im m ediately with an oth er elastic com pression b an dage. O th erwise, excessive edem a will form rapidly, which could cau se a sign ifican t d elay in reh abilitatio n . If th e clien t h ad a cast th at slipped o ff, th e n urse would h ave to call th e HCP so th at a n ew o ne could b e applied . Elevation o n 1 p illow is n ot goin g to im pede the d evelop m en t o f edem a greatly o nce com pression is released. Ice wou ld be of lim ited value in con trollin g edem a from th is cau se. If th e HCP were called , th e p rescription likely wou ld be to reapply th e com pression d ressin g anyway. Test-Ta kin g Str a tegy: Note th e strategic wo rd , immediate, an d fo cu s o n th e d ata in th e q u estio n . Recallin g th at excessive ed em a can fo rm rap id ly in th e resid ual lim b will direct you to th e correct o ptio n . Review: Care of th e clien t after am p u tatio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Mu scu lo skeletal Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ce: Lewis et al. (2014), p . 1532.

815. 3 Ra tion a le: Low back p ain th at radiates in to 1 leg (sciatica) is con sisten t with h ern iated lum b ar d isk. Th e n urse assesses th e cli- en t to see wh eth er th e p ain is aggravated by even ts that in crease in traspin al pressure, such as b en din g, liftin g, sn eezin g, and cough in g, o r by liftin g th e leg straigh t up wh ile sup in e (straigh t leg-raisin g test) . Bed rest, h eat (or som etim es ice), an d n on steroi- d al antiin flam m atory d ru gs (NSAIDs) usu ally relieve b ack pain . Test-Ta kin g Str a t egy: Fo cu s o n th e su b ject, factors th at aggra- vate back p ain . Th in k abo ut h o w each item in th e op tion s wo u ld relieve or exacerb ate back p ain . Recall th at b ed rest, h eat (or so m etim es ice), an d NSAIDs usu ally relieve back pain , wh ereas ben din g, liftin g, an d strain in g aggravate it. Review: Th e causes o f b ack p ain Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Mu scu lo skeletal Pr ior it y Con cept s: Mob ility; Pain Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 885–886.

816. 1 Ra tion a le: Th e n ursin g assessm en t con du cted after spin al sur- gery is sim ilar to th at d on e after oth er surgical pro cedu res. For th is specific typ e of surgery, th e n urse assesses th e n eu ro vascular

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

956 UNIT XVII Musculoskeletal Disorders of the Adult Client

statu s o f th e lo wer extrem ities, watch es for signs an d sym pto m s o f in fectio n, and in sp ects th e surgical site for evidence of cerebrosp i- n al flu id leakage (d rain age is clear an d tests positive for glu cose). A m ild tem perature is exp ected after in sertion o f h ardware, b ut a tem p erature of 101.6 °F ( 38.7 °C) sh o uld b e reported. Test -Ta kin g Str a tegy: Note th e strategic wo rd , most. Deter- m in e if an ab n o rm ality exists. Th us, you are lo okin g fo r th e op tion th at h as th e greatest d eviation from n o rm al. O ptio n s 2 an d 4 are exp ected after su rgery an d , alth o ugh th e n u rse tries to m in im ize discom fo rt, th e clien t is likely to h ave so m e dis- co m fo rt, even with p ro per an algesic use. Th e words old an d out- lined in o ptio n 3 in dicate th at th is is n o t a n ew o ccu rren ce. Th is leaves th e tem p eratu re o f 101.6 °F (38.7 °C) , wh ich is excessive an d sh o uld b e rep orted. Review: Th e sign s of co m plicatio n s fo llo win g sp in al fu sio n Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Mu scu loskeletal Pr ior ity Con cepts: Clin ical Jud gm en t; In fectio n Refer en ce: Ign atavicius, Workm an (2016), p p. 888–889.

817. 2 Ra t ion a le: In add itio n to th e p resen ce of clin ical m an ifesta- tion s, go u t is diagn osed b y th e p resen ce of p ersisten t h yperu ri- cem ia, with a uric acid level h igh er th an 8 m g/ dL (0.48 m m ol/ L); a n o rm al value fo r a m ale ran ges from 4.0 to 8.5 m g/ dL (0.24 to 0.51 m m o l/ L) an d for a fem ale, fro m 2.7 to 7.3 m g/ dL (0.16 to 0.43 m m ol/ L). O p tion s 1, 3, an d 4 in d icate n o rm al labo rato ry values. In ad ditio n , th e presen ce o f uric acid in an asp irated sam p le of syn o vial flu id co n firm s th e d iagn osis. Test -Ta kin g St r a t egy: Focus on th e su b ject, m an ifestation of go u t. Use kn o wledge of n o rm al labo rato ry valu es. Recallin g th at in creased uric acid levels o ccur in gou t an d n o tin g th at

th e co rrect o ption h as th e on ly abn orm al value will assist yo u in an swerin g th e q u estion . Review: Th e m an ifestatio n s o f go u t an d th e n orm al u ric acid level Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Muscu loskeletal Pr ior ity Con cepts: Cellu lar Regu latio n ; Clin ical Ju dgm en t Refer en ces: Ign ataviciu s, Workm an (2016), p p. 319–320; Pagan a et al. (2015), p. 949.

818. 4 Ra t ion a le: Buck’s (exten sio n ) tractio n is a typ e o f skin tractio n o ften app lied after h ip fractu re b efo re th e fractu re is redu ced in su rgery. Traction redu ces m uscle spasm s an d h elp s to im m ob i- lize th e fractu re. Tractio n d o es n o t allo w fo r bo n y h ealin g to b egin o r provid e rigid im m o bilizatio n . Tractio n d o es n ot len gth en th e leg fo r th e p urpo se o f p reven tin g bloo d vessel sev- eran ce. Th is typ e of tractio n in vo lves pu lleys an d wh eels, n ot p in s an d screws. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, u se of tractio n fo l- lowin g a h ip fracture. Read each o p tion carefu lly an d n o te th at each op tion h as m o re th an on e p art. All parts o f th e o ptio n n eed to b e correct in o rd er fo r th e an swer to be co rrect. Notin g th e wo rd s provides comfort an d fracture immobilization will direct yo u to th e co rrect o ption . Review: Bu ck’s (exten sio n ) tractio n Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Muscu loskeletal Pr ior ity Con cepts: Clin ical Jud gm en t; Mo bility Refer en ce: Ign atavicius, Workm an (2016), p . 1061.

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

957CHAPTER 64 Musculoskeletal System

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l C H A P T E R 65 Musculoskeletal Medications

PRIORITY CONCEPTS Inflammation; Safety

CRITICAL THINKING What Should You Do? Cyclobenzaprine is prescribed for a client experiencing mus- cle spasms. The nurse reviews the client’s record and notes that the client is currently taking phenelzine. What should the nurse do? Answer located on p. 962.

I. Skeletal Muscle Relaxants A. Description

1. Skeletal m uscle relaxan ts ( Box 65-1) act directly on th e n eurom u scular jun ction or act in directly on th e cen tral n ervous system (CNS) .

2. Cen trally actin g m uscle relaxan ts dep ress n eu- ron activity in th e spin al cord or brain .

3. Periph erally actin g m uscle relaxan ts act directly on th e skeletal m uscles, in terferin g with calcium release from m uscle tubu les an d th us preven t- in g th e fibers from con tractin g.

4. Skeletal m uscle relaxan ts are used to preven t or relieve m uscle spasm s an d treat spasticity associated with spin al cord disease or lesion s, acu te pain ful m uscu loskeletal con ditio n s, an d ch ron ic deb ilitatin g disorders such as m ultiple sclerosis, stroke (brain attacks) , or cerebral palsy.

5. Skeletal m uscle relaxan ts are con train d icated in clien ts with severe liver, ren al, or h eart disease; th ese m edication s are often m etab olized in th e liver or excreted by th e kidn eys.

6. Skeletal m uscle relaxan ts sh ould n ot be taken with CNS depressan ts, such as barbiturates, opi- oids, alcoh ol, sedatives, h ypn otics, or tricyclic an tidepressan ts, un less specifically prescribed.

B. Side an d adverse effects 1. Dizzin ess an d h ypo ten sion 2. Drowsin ess an d m uscle weakn ess 3. Dry m ou th 4. Gastroin testin al upset 5. Ph otosen sitivity 6. Liver toxicity

C. In terven tion s 1. O btain a m edical h isto ry an d ask about cur-

ren t m ed ication s bein g taken . 2. Mon itor vital sign s. 3. Mon itor for CNS effects. 4. Assess for risk of in ju ry. 5. Assess in volved join ts an d m uscles for pain

an d m ob ility. 6. Mon itor ren al fun ction studies. 7. In struct th e clien t to take th e m ed ication with

food to decrease gastro in testin al upset. 8. In struct th e clien t to report ad verse effects. 9. In struct th e clien t to avoid alcoh ol an d CNS

depressan ts. 10. In struct th e clien t to avoid activities requir-

in g alertn ess, such as drivin g or operatin g equipm en t.

Monitor liver function tests when a client is taking a skeletal muscle relaxant because hepatotoxicity can occur.

D. Nursin g co n sideration s 1. Baclofen

a . Baclofen causes CNS effects such as drows- in ess, dizzin ess, weakn ess, an d fatigue; an d n ausea, co n stipatio n , an d urin ary reten tion .

b . Adm in ister with caution in th e clien t with ren al or h epatic dysfun ction or a seizu re disorder.

c. Baclofen can be ad m in istered by th e h ealth care provider (HCP) th rou gh in trath ecal in fusion usin g an im plan table pum p or by direct in trath ecal adm in istration over 1 m in u te.

d . In struct th e clien t with an im plan table pum p to m ain tain m edication refill appoin tm en ts to preven t the pum p from em ptyin g an d experien cin g sudden withdrawal sym ptom s, wh ich could be life-th reatenin g.

2. Cariso prodo l a . Advise th e clien t to take th e m edication

with food to preven t gastro in testin al upset.958

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

b . In struct th e clien t to report an y rash or h ypersen sitivity to th e HCP.

3. Ch lorzoxazon e a. Mon itor th e clien t for h ypersen sitivity reac-

tion s such as urticaria, redn ess or itch in g, an d possibly an gioedem a.

b . Ch lorzoxazon e m ay cau se m alaise an d m ay cause th e urin e to turn oran ge or red.

c. Can cau se h epatitis an d h epatic n ecro sis. 4. Cyclob en zaprin e

a. Cycloben zaprin e is con train dicated in cli- en ts wh o h ave received m on oam in e oxi- dase in h ibito rs (MAO Is) with in 14 days of in itiation of cyclob en zaprin e th erapy an d in clien ts with cardiac disorders.

b . Cycloben zaprin e h as sign ifican t an tich olin - ergic (atropin e-like) effects an d sh ould be used with cautio n in clien ts with a h isto ry of urin ary reten tion , an gle-closure glau- com a, or in creased in traocular pressure.

c. Cycloben zaprin e sh ould be used on ly for sh ort-term th erap y (2 to 3 weeks) .

5. Dan trolen e a. Dan trolen e acts directly on skeletal m uscles

to relieve spasticity. b . Liver dam age is th e m ost serious adverse

effect. c. Liver fun ction values sh ould be m on itored

before th e in itiation of treatm en t an d dur- in g treatm en t.

d . Dan trolen e can cause gastroin testin al bleed- in g, urin ary frequen cy, im poten ce, ph oto- sen sitivity, rash , an d m uscle weakn ess.

e. In struct th e clien t to wear protective clo th - in g wh en in th e sun .

f. In struct th e clien t to n otify th e HCP if rash , bloody or tarry stools, or yello w discolor- ation of th e skin or eyes occurs.

6. Diazepam a. Acts on th e CNS to supp ress spasticity; does

n ot affect skeletal m uscle directly b . Sedation com m on ly occurs.

7. Meth ocarbam ol a. Th e paren teral form is con train d icated in

clien ts with ren al im pairm en t.

b . Th e paren teral form can cau se h ypo ten sion , bradycardia, an aph ylaxis, an d seizures, esp ecially wh en th e m ed ication is given too rapidly.

c. Mon itor site for extravasatio n , wh ich can result in th rom boph lebitis an d tissue slough in g.

d . Meth ocarbam ol m ay cau se th e urin e to turn brown , black, or green .

e. In form th e clien t to n otify th e HCP if blurred vision , n asal con gestion , urticaria, or rash occurs.

8. Tizan idin e an d m etaxalon e: Can cau se liver dam age

9. O rph en adrin e h as sign ifican t an tich olin ergic (atropin e-like) effects an d sh o uld be used with cau tion in clien ts with a h isto ry of urin ary reten - tion , an gle-closu re glaucom a, or in creased in tra- ocular pressure.

Safety is a primary concern when the client is taking a skeletal muscle relaxant because these medications cause drowsiness.

II. Antigout Medications A. Description

1. An tigou t m edication s (allopurin ol, colch icin e, proben ecid ) reduce uric acid produ ction an d in crease uric acid excretion (uricosu ric) to pre- ven t or relieve gout or to m an age h yperuricem ia.

2. No n steroidal an tiin flam m atory drugs (NSAIDs) are used for th eir an tiin flam m atory effects an d to relieve pain durin g an acute gouty attack (see Ch apter 63 for in form ation on NSAIDs) .

3. Glu cocorticoids m ay be prescribed to reduce in flam m ation durin g an acu te gout attack (see Ch apter 51 for in form ation on glucocorti- coids).

4. An tigou t m edication s sh o uld be used cau tiously in clien ts with gastro in testin al, ren al, cardiac, or h epatic disease.

B. Side an d adverse effects 1. Headach es 2. Nausea, vo m itin g, an d diarrh ea 3. Bloo d dyscrasias, such as bon e m arro w

dep ression 4. Flush ed skin an d rash 5. Uric acid kidn ey ston es 6. Sore gum s 7. Metallic taste

C. In terven tion s 1. Assess serum uric acid levels. 2. Mon itor in take an d outp ut. 3. Main tain a fluid in take of at least 2000 to

3000 m L/ day to preven t kidn ey ston es. 4. Mon itor co m plete blood cell co un t an d ren al

an d liver fun ction studies.

BOX 65-1 Skeletal Muscle Relaxants ▪ Baclofen ▪ Carisoprodol ▪ Chlorzoxazone ▪ Cyclobenzaprine ▪ Dantrolene ▪ Diazepam ▪ Metaxalone ▪ Methocarbamol ▪ Orphenadrine ▪ Tizanidine

959CHAPTER 65 Musculoskeletal Medications

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

5. In struct th e clien t to avoid alcoh ol an d caf- fein e because th ese products can in crease uric acid levels.

6. En cou rage th e clien t to com ply with th erap y to preven t elevated uric acid levels, wh ich can trigger a gout attack.

7. In struct th e client to avoid foods h igh in purin e as prescribed, such as win e, alcoh ol, organ m eats, sardin es, salm on , scallops, an d gravy.

8. In struct th e clien t to take th e m edication with food to decrease gastric irritatio n .

9. In struct th e clien t to report adverse effects to th e HCP.

10. Caution th e clien t n ot to take aspirin with th ese m ed ication s because th is could trigger a gout attack.

D. Nursin g con sideration s 1. Allop urin ol

a . Can in crease th e effect of warfarin an d oral h ypo glycem ic agen ts

b . In struct th e clien t n ot to take large doses of vitam in C wh ile takin g allopurin ol because kidn ey ston es m ay occur.

c. Hypersen sitivity syn drom e (rare) can occur, ch aracterized by rash , fever, eosin oph ilia, an d liver an d kidn ey alteration s (m edica- tio n is with h eld an d th e HCP is n otified).

d . Advise th e clien t to m in im ize exp osure to sun ligh t an d h ave an an n ual eye exam in a- tio n because visu al ch an ges can occur from prolon ged use of allopurin ol.

2. Colch icin e a . Used with caution in older clien ts, debili-

tated clien ts, an d clien ts with cardiac, ren al, an d/ o r gastro in testin al disease.

b . If gastroin testin al sym ptom s occur (n ausea, vom itin g, diarrh ea, an d abdom in al pain ), th e m edication is with h eld and the HCP is n otified.

3. Proben ecid a . Mild gastro in testin al effects can occur an d

can be reduced by takin g th e m edication with food .

b . Aspirin an d oth er salicylates in terfere with th e uricosuric action of th e m ed ication .

The concurrent use of antigout medications and aspirin causes elevated uric acid levels; the client should be instructed to take acetaminophen if prescribed rather than aspirin.

III. Antiarthritic Medications (Box 65-2) A. Description ( Fig. 65-1)

1. Rh eum atoid arth ritis occurs as in flam m ation progresses in to th e syn o via, cartilage, an d bon e; if th is in flam m ation is n ot con trolled, it will lead to join t destruction , th u s affectin g clien t m ob ility an d co m fort.

2. Th e focus of treatm en t is early diagn osis an d aggressive treatm en t in order to preserve join t fun ction .

3. Medication th erapy in cludes NSAIDs, gluco - cortico ids, an d disease-m o difyin g an tirh eu- m atic drugs (DMARDs) .

4. Gold salts: Use of gold salts h as decreased, but th eir purpo se is to reduce th e progression of join t dam age caused by arth ritic processes. Gold toxicity, ch aracterized by pruritus, rash , m etallic taste, stom atitis, an d diarrh ea, can occur; if tox- icity occurs, dim ercaprol m ay be prescribed to en h an ce go ld excretion .

B. DMARDs 1. Descrip tion

a. DMARDs are effective an tirh eum atic m ed- ication s th at are used to slow th e degen er- ative effects of th e disorder.

b . DMARDs are usually prescribed secon d- ary to NSAIDs but are often th e first ch oice in th e treatm en t of severe arth ritis.

2. Com m on side an d adverse effects of DMARDs in clude in jection site in flam m ation an d pain , ecch ym osis, an d edem a; pan cytop en ia an d in fectio n ; fatigue, h eadach e, n ausea, vo m it- in g, an d flulike sym pto m s; an d allergic respon se.

3. In terven tion s a. In struct th e clien t to m on itor for sign s of

in fectio n an d report sign s to th e HCP. b . Mon itor th e in jection site for sign s of irri-

tatio n , pain , in flam m ation , an d swellin g. c. In struct th e clien t to con sult with th e HCP

befo re receivin g live vaccin es an d to avoid exposu re to in fection s.

d . In form th e clien t about th e im portan ce of labo ratory tests for n eutroph il coun ts, wh ite blood cell coun ts, an d platelet coun ts befo re in itiation of treatm en t an d durin g treatm en t.

4. An akin ra: In jection site reactio n s are com m on (pruritus, eryth em a, rash , pain ).

BOX 65-2 Antiarthritic Medications ▪ Anakinra ▪ Adalimumab ▪ Azathioprine ▪ Cyclosporine ▪ Etanercept ▪ Hydroxychloroquine ▪ Infliximab ▪ Leflunomide ▪ Methotrexate ▪ Penicillamine ▪ Rituximab ▪ Sulfasalazine

960 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

5. Adalim um ab a . In jection site reaction s are com m on . b . Has been associated with n eurological

in ju ry (n um b n ess, tin glin g, dizzin ess, visu al disturban ces, weakn ess in th e legs)

6. Azath ioprin e: Im m un osuppressive an d an ti- in flam m ato ry action s; toxic effects in clude h epatitis an d blood dyscrasias.

7. Cyclosporin e: Im m un osuppressive action s; can cause n eph ro toxicity

8. Etan ercept a . In jection site reaction s are com m on . b . Poses a risk for h eart failure; h as been

associated with CNS dem yelin atin g disor- ders an d h em atological disorders

9. Hydro xych loro quin e: Asso ciated with retin al dam age; in form th e clien t to con tact th e HCP if visu al disturban ces occur.

10. Leflun om ide: Sid e an d adverse effects in clude diarrh ea, respiratory in fectio n , reversible alop ecia, rash , an d n ausea; m edication is h epatotoxic.

11. Meth otrexate: Can cause h epatic fibrosis, bon e m arro w suppressio n , gastro in testin al ulceration , an d pn eum on itis

12. Pen icillam in e: Can cau se bon e m arro w sup- pression an d autoim m un e disorders

13. In flixim ab: Can cau se in fusion reaction s (fever, ch ills, pruritus, urticaria, ch est pain ); m ed ication is h epatoto xic.

14. Sulfasalazin e: Can cause gastro in testin al an d derm ato logical reaction s, bon e m arro w sup- pression , an d h epatitis

C. NSAIDs m ay be prescribed for th eir an tiin flam m a- tory an d an algesic effects (see Ch apter 63 for in for- m ation on NSAIDs).

D. Glu cocorticoids m ay be prescribed for th eir an tiin - flam m atory effects (see Ch apter 51 for in form ation on gluco cortico ids).

IV. Medications to Prevent and Treat Osteoporosis A. Description

1. O steoporo sis is ch aracterized by decreased bon e m ass an d in creased bon e fragility.

2. Calcium an d vitam in D supplem en tation can reduce th e risk of osteopo rosis; calcium m axi- m izes bon e growth early in life an d m ain tain s bon e in tegrity later in life, an d vitam in D en sures calcium ab sorption (see Ch apter 51 for in form ation on calcium an d vitam in D supp lem en ts).

3. Treatm en t is aim ed at reducin g th e occurren ce of fractures by m ain tain in g or in creasin g bon e stren gth .

4. Med ication s th at decrease bon e resorptio n (an ti- resorptive) an d m edication s th at prom ote bon e form ation are used ( Box 65-3).

5. An tiresorptive m edication s in clude raloxifen e, calciton in , an d bisph osp h on ates.

6. Teriparatide prom otes bon e growth . B. In terven tion s

1. Calciton in -salm o n a. Calciton in is secreted by th e th yroid glan d

an d in h ib its osteoclastic bon e resorptio n .

Pa nnus forma tion a nd e ros ion of ca rtila ge Bone fus ion

Infla mma tion of s ynovia l me mbra ne

Bone

B C D EA

Articula r ca rtila ge

S ynovia l ca vity a nd me mbra ne

FIGURE 65-1 Progressive joint degeneration in rheumatoid arthritis. A, Healthy joint. B, Inflammation of synovial membrane. C, Onset of pannus for- mation and cartilage erosion. D, Pannus formation progresses and cartilage deteriorates further. E, Complete destruction of joint cavity, together with fusion of articulating bones.

BOX 65-3 Medications to Prevent or Treat Osteoporosis

▪ Calcium and vitamin D ▪ Alendronate ▪ Calcitonin-salmon ▪ Denosumab ▪ Ibandronate ▪ Raloxifene ▪ Risedronate ▪ Teriparatide

961CHAPTER 65 Musculoskeletal Medications

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

b . In struct th e clien t on h ow to adm in ister th e in tran asal or subcutan eous form , dep en din g on th e route prescribed.

c. In tran asal route: Exam in e th e n ares for irrita- tio n ; altern ate n ostrils for doses.

d . Wh en calciton in is taken , it is im portan t to m on itor for h ypo calcem ia.

2. Bisph osph on ates a. Bisph osph on ates in h ibit osteoclast-m edi-

ated bon e resorption , th ereby in creasin g total bon e m ass.

b . Bisph osph on ates in clude alen dro n ate, rise- dron ate, an d iban dron ate.

c. Con train dicated for clien ts with eso ph ageal disorders th at can im ped e swallowin g an d for clien ts wh o can n ot sit or stan d for at least 30 m in utes (60 m in utes with iban dron ate)

d . Adverse effects in clude esoph agitis, m uscle pain , an d ocular problem s; th e clien t is in structed to con tact th e HCP if adverse effects occur.

Because of the risk of esophagitis, bisphosphonates must be administered in the morning before eating or drinking with a full glass of water; the client must then remain sitting or standing and postpone ingesting anything for at least 30 minutes (60 minutes with ibandronate).

3. Raloxifen e a. An tiresorptive m edication (non bisphospho-

nate) b . Con train dicated in clien ts wh o h ave a h is-

tory of ven o us th rom botic even ts c. Needs to be discon tinued 72 hours prior to pro-

lon ged im m obilization periods (such as with periods of extended bed rest)

d . In struct th e clien t to avoid exten ded periods of restricted activity (such as wh en travelin g).

4. Teriparatide a. Teriparatide stim ulates n ew bon e form ation ,

th u s in creasin g bon e m ass. b . Teriparatide is a portion of th e h um an para-

th yroid h orm on e an d works by in creasin g th e action of osteoblasts.

c. Is usually reserved for clien ts at h igh risk for fractures

d . Has been associated with th e developm en t of bon e can cer

CRITICAL THINKING What Should You Do? Answer: Cyclobenzaprine is a muscle relaxant and is contra- indicated in clients who have received monoamine oxidase inhibitors (MAOIs) within 14 days of initiation of cyclobenzapr- ine therapy and in clients with cardiac disorders. The nurse should contact the health care provider and question the cyclo- benzaprine prescription before the initiation of therapy.

Reference: Hodgson, Kizior (2016), pp. 30 2–303.

P R A C T I C E Q U E S T I O N S 819. A clien t h as been on treatm en t for rh eu m atoid

arth ritis for 3 weeks. Durin g th e adm in istration of etan ercept, wh ich is m o st im p o rtan t for th e n urse to assess? 1. Th e in jection site for itch in g an d edem a 2. Th e wh ite blood cell coun ts an d platelet coun ts 3. Wh eth er th e clien t is experien cin g fatigue an d

join t pain 4. Wh eth er th e clien t is experien cin g a m etallic

taste in th e m ou th , an d a loss of appetite

820. Allop urin ol is prescribed for a clien t an d th e n urse provides m edication in struction s to th e clien t. Wh ich in struction sh o uld th e n urse provide? 1. Drin k 3000 m L of fluid a day. 2. Take th e m ed ication on an em pty stom ach . 3. Th e effect of th e m ed ication will occur

im m ediately. 4. An y swellin g of th e lips is a n orm al expected

respo n se.

821. Colch icin e is prescribed for a clien t with a diagn o- sis of go ut. Th e n urse reviews th e clien t’s record, kn owin g th at th is m ed ication would be used with cau tion in wh ich disorder? 1. Myxedem a 2. Kidn ey disease 3. Hypo th yroidism 4. Diabetes m ellitus

822. Alen dron ate is prescribed for a clien t with osteopo- rosis an d th e n urse is providin g in struction s on adm in istration of th e m ed ication . Wh ich in struc- tion sh ould th e n urse provid e? 1. Take th e m edication at bedtim e. 2. Take th e m edication in th e m orn in g with

breakfast. 3. Lie down for 30 m in utes after takin g th e

m ed ication . 4. Take th e m edication with a full glass of water

after risin g in th e m orn in g.

823. Th e n urse is preparin g disch arge in struction s for a clien t receivin g baclofen . Wh ich in struction sh ould be in cluded in th e teach in g plan ? 1. Restrict fluid in take. 2. Avoid th e use of alcoh ol. 3. Stop th e m edication if diarrh ea occurs. 4. Notify th e h ealth care provider (HCP) if fatigue

occurs.

824. Th e n urse is an alyzin g th e laborato ry studies on a clien t receivin g dan trolen e. Wh ich laborato ry test would iden tify an adverse effect associated with th e adm in istration of th is m edication ? 1. Platelet coun t 2. Creatin in e level

962 UNIT XVII Musculoskeletal Disorders of the Adult Client

3. Liver fun ction tests 4. Bloo d urea n itrogen level

825. Cycloben zaprin e is prescribed for a clien t for m us- cle spasm s an d th e n urse is reviewin g th e clien t’s record. Wh ich disorder, if n oted in th e record, would in dicate a n eed to con tact th e h ealth care provider about th e ad m in istration of th is m edication ? 1. Glaucom a 2. Em ph ysem a 3. Hypoth yroidism 4. Diabetes m ellitus

826. In m on itorin g a clien t’s respon se to disease- m od ifyin g an tirh eum atic drugs (DMARDs) , wh ich assessm en t fin din gs would th e n urse co n sider acceptable respon ses? Select all th at ap p ly.

1. Con trol of sym pto m s durin g periods of em o tion al stress

2. No rm al wh ite blood cell, platelet, an d n eu- tro ph il coun ts

3. Rad iological fin din gs th at sh o w n o progres- sion of join t degen eration

4. An in creased ran ge of m otion in th e affected join ts 3 m on th s in to th erap y

5. In flam m ation an d irritatio n at th e in jection site 3 days after th e in jection is given

6. A low-grade tem perature on risin g in th e m orn in g th at rem ain s th rough ou t th e day

827. Th e n urse is adm in isterin g an in traven ous dose of m eth ocarbam ol to a clien t with m ultiple sclerosis. For wh ich adverse effect sh ould th e n urse m on itor? 1. Tach ycardia 2. Rapid pulse 3. Bradycardia 4. Hyperten sion

A N S W E R S 819. 2 Ra t ion a le: In fectio n an d pan cyto pen ia are ad verse effects o f etan ercep t. Lab oratory stud ies are p erform ed prio r to an d du r- in g m ed ication treatm en t. Th e ap p earan ce of ab n o rm al wh ite blo od cell co un ts an d abn o rm al p latelet co u n ts can alert th e n urse to a p oten tially life-th reaten in g in fectio n . In jection site itch in g is a co m m o n occu rren ce fo llo win g adm in istratio n . A m etallic taste an d lo ss o f ap petite are n ot com m on sign s o f ad verse effects o f th is m edicatio n . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most impor- tant. O ptio n 4 can be elim in ated, because th is is n o t a co m m o n ad verse effect. In early treatm en t, resid ual fatigu e an d join t pain m ay still b e app aren t. Fo r th e rem ain in g o ption s, th e co r- rect option m on itors for a h em atological disorder, wh ich could in d icate a reaso n fo r discon tin u in g th is m edicatio n an d sh o uld be rep orted . Review: Ad verse effects of etan ercep t Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Musculoskeletal Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 884–885, 889.

820. 1 Ra t ion a le: Clien ts takin g allo p urin o l are en cou raged to drin k 3000 m L o f fluid a d ay, un less oth erwise co n train d icated . A full th erap eu tic effect m ay take 1 week o r lon ger. Allo p urin o l is to be given with , o r im m ediately after, m eals o r m ilk. A clien t wh o develo p s a rash , irritatio n of th e eyes, o r swellin g o f th e lips o r m o uth sh ou ld co n tact th e h ealth care p ro vider b ecau se th is m ay in d icate h yp ersen sitivity. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, clien t in stru ction s fo r allo pu rin o l. O ptio n 4 can b e elim in ated easily becau se it in d icates h ypersen sitivity, wh ich is n ot a n o rm al exp ected

resp on se. From th e rem ain in g o p tion s, recallin g th at th is m ed- icatio n is used to treat gou t an d recallin g th e p ath o ph ysiology o f th is d iso rd er will direct yo u to th e correct o ptio n . Review: Th e clien t in struction s related to allo p u rin o l Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—Mu sculo skeletal Med ication s Pr ior ity Con cepts: Clien t Ed u catio n ; Safety Refer en ce: Ho dgso n , Kizior (2016), p . 43.

821. 2 Ra t ion a le: Colch icin e is used with cau tio n in o ld er clien ts, d eb ilitated clien ts, an d clien ts with cardiac, kid n ey, or gastro- in testin al disease. Th e d iso rd ers in op tio n s 1, 3, an d 4 are n ot con cern s with ad m in istration of th is m ed ication . Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, th e cau tion s asso- ciated with colch icin e. No te th at op tio n s 1, 3, an d 4 are co m - p arab le o r alike an d are en d ocrin e-related d iso rd ers. Th e co rrect o ption is d ifferen t fro m th e o th ers. Review: Th e cau tio n s asso ciated with co lch icin e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ph arm aco lo gy—Mu sculo skeletal Med ication s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Bu rch u m , Rosen th al (2016), p. 892.

822. 4 Ra t ion a le: Precautio n s n eed to b e taken with th e adm in istra- tion of alen d ro n ate to p reven t gastroin testin al ad verse effects (esp ecially eso ph ageal irritation ) an d to in crease ab sorptio n o f th e m ed ication . Th e m ed ication n eed s to be taken with a fu ll glass o f water after risin g in th e m o rn in g. Th e clien t sh ou ld n o t eat or drin k an yth in g fo r 30 m in u tes fo llo win g ad m in istration an d sh o uld n ot lie d own after takin g th e m ed ication .

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

963CHAPTER 65 Musculoskeletal Medications

Test-Ta kin g Str a tegy: Fo cus on th e su b ject, th e adm in istratio n o f alen d ro n ate. Recallin g th at th is m ed ication can cau se eso ph - ageal irritatio n will d irect yo u to th e co rrect o p tion . Review: Clien t teach in g po in ts for alen d ro n ate Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Mu scu lo skeletal Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Tissue In tegrity Refer en ce: Hod gson , Kizio r (2016), pp . 38–39.

823. 2 Ra tion a le: Baclofen is a skeletal m u scle relaxan t. Th e clien t sh o u ld b e cau tion ed again st th e u se o f alco h o l an d o th er cen - tral n ervou s system depressan ts b ecause baclo fen po ten tiates th e d epressan t activity o f th ese agen ts. Co n stipatio n rath er th an diarrh ea is a sid e effect. Restrictio n o f fluid s is n o t n eces- sary, bu t th e clien t sh o uld b e warn ed th at urin ary reten tio n can o ccur. Fatigu e is related to a cen tral n ervou s system effect th at is m ost in ten se d urin g th e early p h ase of th erap y an d dim in ish es with con tin ued m edicatio n use. Th e clien t does n ot n eed to n o tify th e HCP abo ut fatigu e. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, teach in g po in ts fo r b aclo fen . Recallin g th at b aclofen is a skeletal m uscle relaxan t will direct yo u easily to th e co rrect option . If you were un sure o f th e co rrect op tion , u se gen eral p rin cip les related to m edica- tio n adm in istratio n . Alco h o l sh o uld b e avo id ed with th e use of m edicatio n s. Review: Clien t teach in g po in ts related to b aclo fen Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Mu scu lo skeletal Medicatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p . 243–244.

824. 3 Ra tion a le: Dose-related liver d am age is th e m o st serio u s ad verse effect of d an tro len e. To redu ce th e risk of liver d am age, liver fu n ctio n tests sh o uld be p erform ed b efore treatm en t an d th rou gh o ut th e treatm en t in terval. Dan tro len e is adm in istered at th e lowest effective d o sage fo r th e sh ortest tim e n ecessary. Test-Ta kin g Str a tegy: Elim in ate op tio n s 2 an d 4 b ecau se th ese tests assess kidn ey fu n ction an d are co m p arab le o r alike. From th e rem ain in g op tio n s, yo u m u st recall th at th is m edicatio n affects liver fu n ction . Review: Adverse effects o f d an tro len e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm aco logy—Mu scu lo skeletal Medicatio n s Pr ior it y Con cept s: Cellular Regu lation ; Tissue In tegrity Refer en ce: Bu rch u m , Ro sen th al (2016), p p . 242, 244.

825. 1 Ra tion a le: Because cyclo ben zaprin e h as an tich o lin ergic effects, it sh o uld be u sed with cautio n in clien ts with a h istory

o f u rin ary reten tio n , glaucom a, an d in creased in trao cular p res- su re. Cyclo ben zaprin e sh o uld b e u sed on ly fo r a sh o rt tim e (2 to 3 weeks). Th e co n d itio n s in o ption s 2, 3, an d 4 are n o t a co n cern with th is m ed ication . Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, a co n train d ication to cyclo ben zaprin e. Recallin g th at th is m edicatio n h as an tich o- lin ergic effects will d irect yo u to th e co rrect o p tion . Review: Th e co n train dicatio n s of cyclo b en zap rin e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm acolo gy—Muscu loskeletal Medicatio n s Pr ior it y Con cept s: Co llab oration ; Safety Refer en ce: Hod gson , Kizio r (2016), p. 303.

826. 1, 2, 3, 4 Ra tion a le: Because em otio n al stress freq uen tly exacerbates th e sym pto m s o f rh eum ato id arth ritis, th e absen ce o f sym p tom s is a po sitive fin d in g. DMARDs are given to slow th e p ro gressio n o f jo in t d egen eration . In ad dition , an im p rovem en t in th e ran ge of m otion after 3 m o n th s o f th erap y with n orm al blo od work is a positive fin din g. Tem perature elevation an d in flam - m ation an d irritation at th e m edicatio n in jection site co u ld in dicate sign s o f in fection . Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, acceptable respon ses to th erapy. Recallin g th at sign s o f an in fectio n can in d icate an u n exp ected an d un wan ted fin din g will assist in elim in atin g o p tion s 5 an d 6. Review: Th e expected effects o f d isease-m o d ifyin g an tirh eu - m atic d ru gs ( DMARDs) Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Ph arm acolo gy—Muscu loskeletal Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Eviden ce Refer en ce: Lewis et al. (2014), p p. 1566–1568.

827. 3 Ra tion a le: In traven o us adm in istratio n of m eth o carb am ol can cau se h yp o ten sio n an d bradycard ia. Th e n urse n eeds to m o n - ito r fo r th ese ad verse effects. O ption s 1, 2, an d 4 are n o t effects with adm in istration of th is m edication . Test-Ta kin g Str a tegy: Elim in ate o ptio n s 1 an d 2 first b ecause th ey are co m p arab le o r alike. Kn owled ge ab o ut th e sp ecific adverse effects related to th e in traven o u s u se o f th is m edicatio n will direct yo u to th e co rrect op tion . Rem em b er th at h yp oten - sio n an d brad ycardia can o ccur with in traven o us ad m in istra- tio n of m eth o carbam ol. Review: Ad verse effects o f m eth o carb am o l Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Muscu loskeletal Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Hod gson , Kizio r (2016), p. 778.

A

d

u

l

t

M

u

s

c

u

l

o

s

k

e

l

e

t

a

l

964 UNIT XVII Musculoskeletal Disorders of the Adult Client

A

d

u

l

t

I

m

m

u

n

eUNIT XVIII

Immune Disorders of the Adult Client

Pyramid to Success

Pyram id Poin ts focus on th e effects of an d com plication s associated with an im m un e deficien cy. Specific focus relates to th e n ursin g care related to th e disorder, th e im pact of th e treatm en t or disorder, an d clien t ad apta- tion . Hum an im m un od eficien cy virus an d acquired im m un odeficien cy syn drom e is a Pyram id focus, alon g with protectin g th e clien t from in fectio n an d preven tin g th e tran sm issio n of in fectio n to oth er in dividuals. Psy- ch osocial issues relate to social isolatio n an d th e body im age disturban ces th at can occur as a result of th e im m un e disorder.

Client Needs: Learning Objectives Safe and Effective Care Environment Actin g as an advocate related to th e clien t’s decision s Addressin g ad van ce directives Co n su ltin g with th e in terp ro fessio n al h ealth care

team En surin g th at in form ed con sen t for treatm en ts an d pro-

cedu res h as been obtain ed Establish in g priorities Han dlin g h azardous an d in fectious m aterials safely Im plem en tin g stan dard an d oth er precaution s Main tain in g asepsis Main tain in g con fiden tiality regardin g diagn osis Preven tin g in fection Uph oldin g clien t righ ts

Health Promotion and Maintenance En surin g th at th e clien t receives recom m en ded

im m un ization s Im plem en tin g h ealth screen in g m easu res Mon itorin g for expected body im age ch an ges Perform in g ph ysical assessm en t tech n iqu es related to

th e im m un e system Preven tin g disease related to in fection Providin g h ealth prom o tion program s Respectin g clien t lifestyle ch oices

Psychosocial Integrity Assistin g in m ob ilizin g appropriate supp ort an d

resource system s Assistin g th e clien t an d fam ily to cope Assistin g th e clien t to co pe, adapt, an d solve problem s

durin g illn ess or stressful even ts Con siderin g religious, spiritual, an d cultural preferen ces Discussin g grief an d lo ss related to death an d th e dyin g

process Prom o tin g a positive en viron m en t to m ain tain optim al

quality of life

Physiological Integrity Man agin g m ed ical em ergen cies Man agin g pain Mon itorin g for th e expected an d un exp ected respon ses

to treatm en ts Prom o tin g n utrition Protectin g th e clien t from in fectio n Providin g basic care an d com fo rt Reviewin g diagn ostic test an d laborato ry test results

965

A

d

u

l

t

I

m

m

u

n

e

C H A P T E R 66 Immune Disorders

PRIORITY CONCEPTS Immunity; Infection

CRITICAL THINKING What Should You Do? The nurse notes that a client with scleroderma (systemic sclerosis) is having difficulty swallowing. What should the nurse do? Answer located on p. 975.

I. Functions of the Immune System (Fig. 66-1) A. Provid es protectio n again st in vasion by m icroorgan -

ism s from outside th e body B. Protects th e body from in tern al th reats an d m ain -

tain s th e in tern al en viron m en t by rem ovin g dead or dam aged cells

II. Immune Response A. T lym p h ocytes an d B lym ph ocytes

1. Lym ph ocytes are produ ced in th e bon e m arro w an d m igrate to lym p h oid tissue, wh ere th ey rem ain dorm an t un til th ey n eed to form sen si- tized lym ph o cytes for cellular im m un ity or an ti- bodies for h um oral im m un ity.

2. Som e B lym p h ocytes lie dorm an t un til a specific an tigen en ters th e body, at wh ich tim e th ey greatly in crease in n um ber an d are available for defen se.

3. Types of T lym ph o cytes in clude h elper/ in ducer, supp ressor, an d cytotoxic/ cytolytic.

4. T an d B lym p h ocytes are n ecessary for a n orm al im m un e respo n se.

B. Humoral response 1. Hum oral respo n se is im m ediate. 2. Th is type of respo n se provides protectio n again st

acu te, rapidly developin g bacterial an d viral in fectio n s.

C. Cellular response 1. Cellular respon se is delayed; th is is also called

delayed hypersensitivity. 2. Th is type of respo n se is active again st slowly

developin g bacterial in fectio n s an d is in volved in autoim m un e respon ses, som e allergic reac- tion s, an d rejection of foreign cells.

III. Immunity A. Innate immunity

1. In n ate im m un ity is also called native or natural immunity.

2. It is presen t at birth an d in cludes bioch em ical, ph ysical, an d m ech an ical barriers of defen se, as well as th e in flam m ato ry respo n se.

B. Acquired immunity 1. Acquired or adap tive im m un ity is received pas-

sively from th e m oth er’s an tibod ies, an im al serum , or an tibod ies produced in respo n se to a disease.

2. Im m un izatio n produ ces active acq uired im - m un ity.

IV. Immunizations A. See Ch apter 44 for in form ation ab out im m u-

n ization s.

V. Laboratory Studies A. An tin uclear an tibod y (ANA) determ in ation

1. Th e ANA determ in ation is a blood test used for th e differen tial diagn osis of rh eu m atic diseases an d for th e detection of an tin u cleoprotein fac- tors an d pattern s associated with certain auto- im m un e diseases.

2. Th e test is n egative at a 1:40 dilutio n , dep en din g on th e labo ratory.

3. A positive result does n ot n ecessarily con firm a disease.

4. Th e ANA is positive in m ost in dividuals diag- n osed with system ic lupus eryth em atosus (SLE); it m ay also be positive in in dividuals with system ic sclerosis (scleroderm a) or rh eu m atoid arth ritis.

5. An ANA result can be false positive in som e in dividuals.

B. An ti-d sDNA an tibody test 1. Th e an ti-dsDNA (double-stran ded DNA) an ti-

body test is a blood test don e specifically to iden tify or differen tiate DNA an tibod ies foun d in SLE.966

2. Th e test supp orts a diagn osis, m on itors disease activity an d respo n se to th erap y, an d establish es a progn osis for SLE.

3. Values: n egative, lower th an 70 IU/ m L by en zym e-lin ked im m un osorben t assay (ELISA)

C. Hum an im m un od eficien cy virus (HIV) testin g 1. CD4 + T-cell coun t

a. Mon itors th e progression of HIV b . As th e disease progresses, usually th e n um -

ber of CD4 + T cells decreases, with a resul- tan t decrease in im m un ity.

c. Th e n orm al CD4 + T-cell coun t is between 500 an d 1600 cells/ L.

d . In gen eral, th e im m un e system rem ain s h ealth y with CD4 + T-cell coun ts h igh er th an 500 cells/ L.

e. Im m un e system problem s occur wh en th e CD4 + T-cell coun t is between 200 an d 499 cells/ L.

f. Severe im m un e system problem s occur wh en th e CD4 + T-cell co un t is lower th an 200 cells/ L.

2. CD4-to-CD8 ratio a. Mon itors progression of HIV b . Norm al ratio is ap proxim ately 2:1.

3. Viral culture in volves placin g th e in fected cli- en t’s blood cells in a culture m ediu m an d m ea- surin g th e am oun t of reverse tran scriptase activity over a specified period of tim e.

4. Viral lo ad testin g m easu res th e presen ce of HIV viral gen etic m aterial (RNA) or an oth er viral protein in th e clien t’s blood.

5. Th e p24 an tigen assay quan tifies th e am oun t of HIV viral core protein in th e clien t’s serum .

6. O ral testin g for HIV a . Uses a device th at is placed again st th e gum

an d ch eek for 2 m in utes b . Flu id (n ot saliva) is drawn in to an absorb-

ab le pad, wh ich , in an HIV-po sitive in divid- ual, con tain s an tibod ies.

c. Th e pad is placed in a solution an d a spec- ified observab le ch an ge is n oted if th e test result is positive.

d . If th e result is positive, a blood test is n eeded to con firm th e results.

7. Hom e test kits for HIV a . In on e at-h om e test kit, a drop of blood is

placed on a test card with a special code n um ber; th e card is m ailed to a labo ratory for testin g for HIV an tibod ies.

b . Th e in dividual receives the results by callin g a special teleph one n um ber an d en terin g th e special code n um ber; test results are th en given .

8. Nu rsin g con sideration s a . Main tain issues of con fid en tiality surroun d-

in g HIV an d acquired im m un od eficien cy syn d rom e (AIDS) testin g.

A

d

u

l

t

I

m

m

u

n

e

Immune s ys te m

Nons pe cificS pe cific

Ce ll me dia te d

T lymphocyte Comple me nt B lymphocyte

T he lpe r T s uppre s s or

T cytotoxic Lymphokine s

De a th of a ntige n

Antibodie s

IgA IgD

Humora l Monocyte s

Ma cropha ge s Ne utrophils

P ha gocytos is S kin a nd mucous me mbra ne s

Che mica l ba rrie r Infla mma tory re s pons e

Inte rfe ron

Vira l, funga l, protozoa n, a nd s ome ba cte ria l prote ction

Gra ft re je ction S kin hype rs e ns itivity Immune s urve illa nce Vira l

prote ction Function unknown

IgE

Involve d in a lle rgy

a nd pa ra s itic infe s ta tion

IgG

S e conda ry a ntibody

prote ction

IgM

P rima ry a ntibody

prote ction

FIGURE 66-1 Components of the immune system. Ig, Immunoglobulin.

967CHAPTER 66 Immune Disorders

b . Follow prescribed state regulation s an d pro- tocols related to reportin g positive test results.

D. Skin testin g 1. Description

a . Th e adm in istration of an allergen to th e sur- face of th e skin or in to th e derm is

b . Adm in istered by patch , scratch , or in trader- m al tech n iqu es

2. Preprocedure in terven tion s a . Discon tin ue system ic corticosteroid s or

an tih istam in e th erap y 5 days befo re th e test as prescribed .

b . En su re th at in form ed con sen t was obtain ed.

3. Postp rocedu re in terven tion s a . Record th e site, date, an d tim e of th e test. b . Record th e date an d tim e for follow-up site

readin g. c. Have th e clien t rem ain in th e waitin g ro om

or office for at least 30 m in utes after th e in jection s to m on itor for ad verse effects.

d . In spect th e site for eryth em a, papules, vesi- cles, edem a, an d wh eal (Fig. 66-2).

e. Measu re flare alon g with th e wh eal, an d docum en t th e size an d oth er fin din gs.

f. Provide th e clien t with a list of poten tial allergen s, if iden tified.

Have resuscitation equipment available if skin test- ing is performed because the allergen may induce an anaphylactic reaction.

VI. Hypersensitivity and Allergy A. Description

1. An abn orm al, in dividual respo n se to certain sub- stan ces th at n orm ally do n ot trigger such an exag- gerated reaction .

2. In som e types of allergies, a reaction occurs on a secon d an d subsequ en t con tact with th e allergen .

3. Skin testin g m ay be don e to determ in e th e allergen .

B. Assessm en t 1. History of exposure to allergen s 2. Itch in g, tearin g, an d burn in g of eyes an d skin 3. Rash es 4. Nose twitch in g, n asal stuffin ess

C. In terven tion s 1. Iden tification of th e specific allergen 2. Man agem en t of th e sym ptom s with an ti-

h istam in es, an tiin flam m ato ry agen ts, an d/ o r cortico steroids

3. O in tm en ts, cream s, wet com presses, an d sooth - in g bath s for lo cal reaction s

4. Desen sitization program s m ay be recom - m en ded.

VII. Anaphylaxis A. Descrip tion

1. A serious an d im m ediate h ypersen sitivity reac- tion th at releases h istam in e from th e dam aged cells

2. An aph ylaxis can be system ic or cutan eous (localized).

B. Assessm en t (Fig. 66-3) C. In terven tion s (see Priority Nursin g Action s)

A

d

u

l

t

I

m

m

u

n

e

Whe a l is le s s tha n 0.5 cm in dia me te r

Pos itive Pos itive

Pos itive Pos itive

Whe a l is 1.0 cm in dia me te r (2+)

Whe a l is 1.5 cm in dia me te r (3+)

Whe a l is 2.0 cm in dia me te r (4+)

Ne ga tive

Whe a l is 0.5 cm in dia me te r (1+)

FIGURE 66-2 Interpretation of intradermal test results, based on the size of the wheal after 15 to 30 minutes.

He a da che , dizzine s s , pa re s the s ia , fe e ling of impe nding doom

Ne uro lo g ic

P ruritus , a ngioe de ma , e rythe ma , urtica ria

S kin

Cra mping, a bdomina l pa in,

na us e a , vomiting, dia rrhe a

Gas tro inte s tinal

Hoa rs e ne s s , coughing, whe e zing, s tridor, dys pne a ,

ta chypne a , s e ns a tion of na rrowe d a irwa y,

re s pira tory a rre s t

Re s pirato ry

Hypote ns ion, dys rhythmia s , ta chyca rdia ,

ca rdia c a rre s t

Cardio vas c ular

FIGURE 66-3 Clinical manifestations of a systemic anaphylactic reaction.

968 UNIT XVIII Immune Disorders of the Adult Client

A

d

u

l

t

I

m

m

u

n

e

PRIORITY NURSING ACTIONS Anaphylactic Reaction

1. Quickly assess respiratory status and maintain a patent airway.

2. Call the health care provider (HCP) or Rapid Response Team.

3. Administer oxygen. 4. Start an intravenous (IV) line and infuse normal saline. 5. Prepare to administer diphenhydramine and epinephrine. 6. Document the event, actions taken, and the client’s

response.

If the client experiences an anaphylactic reaction, the immediate action would be to assess the respiratory status quickly and maintain a patent airway. The HCP or Rapid Response Team is called. In the meantime, the nurse stays with the client and monitors the client’s vital signs and for signs of shock. An IV device is inserted if one is not already in place and normal saline is infused. The nurse then pre- pares for the administration of diphenhydramine and epi- nephrine and other medications as prescribed. The head of the bed is elevated if the client’s blood pressure is normal. The client’s feet and legs may be raised if the blood pressure is low. The nurse documents the event, actions taken, and the client’s response.

Reference Ignatavicius, Workman (2016), p. 353.

VIII. Latex Allergy A. Descrip tion

1. Latex allergy is a h ypersen sitivity to latex. 2. Th e source of th e allergic reaction is th o ugh t to

be th e protein s in th e n atural ru bber latex or th e various ch em icals used in th e m an ufacturin g process of latex gloves.

3. Sym ptom s of th e allergy can ran ge from m ild con tact derm atitis to m oderately severe sym p- tom s of rh in itis, con jun ctivitis, urticaria, and bron ch ospasm to severe life-th reaten in g an aph ylaxis.

B. Com m on routes of exposu re ( Box 66-1) 1. Cutan eous: Natural latex gloves an d latex

balloo n s 2. Percutan eous an d paren teral: In traven ous lin es

an d cath eters; h em od ialysis equip m en t 3. Mucosal: Use of latex con dom s, cath eters, air-

ways, an d n ipples 4. Aeroso l: Aerosolization of powder fro m latex

gloves can occur wh en gloves are dispen sed from th e box or wh en gloves are rem oved fro m th e h an ds.

C. At-risk in dividuals 1. Health care workers 2. In divid uals wh o work in th e rubber in dustry 3. In divid uals h avin g m ultiple surgeries

4. In divid uals with spin a bifida 5. In divid uals wh o wear gloves frequen tly, such as

food h an dlers, h airdressers, an d auto m ech an ics 6. In divid uals allergic to kiwis, ban an as, pin eap-

ples, tropical fruits, grapes, avocado s, potatoes, h azeln u ts, an d water ch estn uts

D. Assessm en t 1. An aph ylaxis or type I h ypersen sitivity is a

respon se to n atural rubber latex (Fig. 66-4; also see Fig. 66-3).

2. A delayed type IV h ypersen sitivity reaction can occur; sym pto m s of con tact derm atitis in clude pruritu s, edem a, eryth em a, vesicles, papules, an d crustin g an d th icken in g of th e skin an d can occur with in 6 to 48 h ours followin g exposu re.

E. In terven tion s ( Box 66-2)

IX. Immunodeficiency A. Description

1. Immunodeficiency is th e absen ce or in adequate produ ction of im m un e bodies.

2. Th e disorder can be co n gen ital (prim ary) or acq uired (secon dary) .

3. Treatm en t dep en ds on th e in adequacy of im m un e bodies an d its prim ary cau se.

B. Assessm en t 1. Facto rs th at decrease im m un e fun ctio n 2. Frequen t in fectio n s

BOX 66-1 Products That May Contain Natural Rubber Latex

▪ ACE bandages (brown) ▪ Adhesive or elastic bandages ▪ Ambu bag ▪ Balloons ▪ Blood pressure cuff (tubing and bladder) ▪ Catheter leg bag straps ▪ Catheters ▪ Condoms ▪ Diaphragms ▪ Elastic pressure stockings ▪ Electrocardiographic pads ▪ Feminine hygiene pads ▪ Gloves ▪ Intravenous catheters, tubing, and rubber injection ports ▪ Nasogastric tubes ▪ Pads for crutches ▪ Prepackaged enema kits ▪ Rubber stoppers on medication vials ▪ Stethoscopes ▪ Syringes

Note: Health care agencies use as many nonlatex products as possible and have nonlatex supplies available for clients with a latex allergy.

969CHAPTER 66 Immune Disorders

A

d

u

l

t

I

m

m

u

n

e

3. Nu trition al status 4. Med ication h isto ry, such as use of corticostero ids

for lon g periods 5. Histo ry of alcoh ol or drug abuse

C. In terven tion s 1. Protect th e clien t from in fection . 2. Prom o te a balan ced diet with adequ ate

n utrition . 3. Use strict aseptic tech n iqu e for all proced ures. 4. Provid e psych osocial care regardin g lifestyle

ch an ges an d role ch an ges. 5. In struct th e clien t in m easu res to preven t

in fectio n . 6. In struct th e clien t to wear a MedicAlert bracelet.

The priority concern for a client with immunodefi- ciency is infection.

X. Autoimmune Disease A. Descriptio n

1. Body is un ab le to recogn ize its own cells as a part of itself.

2. Autoim m un e disease can affect collagen ou s tissue.

B. System ic lupus eryth em atosus (SLE) 1. Descrip tion

a. Ch ron ic, progressive, system ic in flam m a- tory disease th at can cause m ajor organ s an d system s to fail

b . Con n ective tissue an d fib rin dep osits co llect in blood vessels on collagen fibers an d on organ s.

c. Th e deposits lead to n ecrosis an d in flam m a- tion in blood vessels, lym ph n odes, gastro - in testin al tract, an d pleura.

d . No cure for th e disease is kn own but rem is- sion s are frequen tly exp erien ced by clien ts wh o m an age th eir care well.

2. Causes a. Th e cau se of SLE is un kn own , but is believed

to be a defect in im m un ological m ech a- n ism s, with a gen etic origin .

b . Precipitatin g facto rs in clude m ed ication s, stress, gen etic factors, sun ligh t or ultraviolet ligh t, an d pregn an cy.

c. Discoid lupus eryth em atosus is possible with som e m edication s but totally disappears after th e m edication is stopped; th e on ly m an ifes- tation is th e skin rash th at occurs in lupus.

3. Assessm en t a . Assess for precipitatin g factors. b . Eryth em a of th e face (m alar rash ; also

called a butterfly rash ) c. Dry, scaly, raised rash on th e face or upper

body d . Fever e. Weakn ess, m alaise, an d fatigue f. An orexia g. Weigh t loss h . Ph otosen sitivity i. Join t pain

IgE A la rge a mount of IgE a ntibody

is ma de .

Ra gwe e d polle n

B ce ll

P la s ma ce ll

Ma s t ce ll

Che mica l me dia tors As thma

Rhinitis

Angioe de ma Atopic de rma titis

Urtica ria Whe a l-fla re re a ction

Cra mping pa in Dia rrhe a Na us e a Vomiting

Ana phyla ctic s hock

Intra va s cula r compa rtme nt

Re s pira tory s ys te m

GI s ys te m

S kin

The s e IgE a ntibodie s a tta ch to

ma s t ce lls .

The firs t time a pe rs on is e xpos e d to a n a lle rge n

(e .g., ra gwe e d)

Ma s t ce ll

The ne xt time the pe rs on is e xpos e d to the a lle rge n (e .g., ra gwe e d), it binds to the IgE

a ntibodie s tha t a re a tta che d to the ma s t ce lls . This trigge rs the re le a s e of che mica l

me dia tors from the ma s t ce ll.

FIGURE 66-4 Steps in a type I allergic reaction. GI, Gastrointestinal; IgE, immunoglobulin E.

BOX66-2 Interventions for the Client with a Latex Allergy

Ask the client about a known allergy to latex when performing the initial assessment.

Identify risk factors for a latex allergy in the client. Use nonlatex gloves and all latex-safe supplies. Keep a latex-safe supply cart near the client’s room. Applya cloth barrier to the client’s arm under a blood pressure cuff. Use latex-free syringes and medication containers (glass

ampules), and latex-safe intravenous equipment. Instruct the client to wear a MedicAlert bracelet. Instruct the client about the importance of informing health

care providers and local and paramedic ambulance com- panies about the allergy.

970 UNIT XVIII Immune Disorders of the Adult Client

A

d

u

l

t

I

m

m

u

n

e

j. Eryth em a of th e palm s k . An em ia l. Positive ANA test an d lupus eryth em atosu s

preparation m . Elevated eryth rocyte sed im en tation rate

(ESR) an d C-reactive protein level 4. In terven tion s

a. Mon itor skin in tegrity an d provide frequen t oral care.

b . In struct th e clien t to clean th e skin with a m ild soap, avoidin g h arsh an d perfum ed substan ces.

c. Assist with th e use of oin tm en ts an d cream s for th e rash as prescribed.

d . Iden tify facto rs con tributin g to fatigue. e. Adm in ister iron , folic acid, or vitam in sup-

plem en ts as prescribed if an em ia occurs. f. Provide a h igh -vitam in an d h igh -iron diet. g. Provide a h igh -protein diet if th ere is n o evi-

den ce of kidn ey disease. h . In struct in m easures to con serve en ergy,

such as pacin g activities an d balan cin g rest with exercise.

i. Adm in ister topical or system ic cortico ste- roid s, salicylates, an d n on steroidal an tiin - flam m atory drugs as prescribed for pain an d in flam m ation .

j. Adm in ister m edication s to decrease th e in flam m ato ry respo n se as prescribed.

k . Mon itor in take an d outp ut, as well as daily weigh t for sign s of fluid overload if cortico- steroids are used.

l. In struct th e clien t to avoid exposu re to sun - ligh t an d ultraviolet ligh t.

m . Mon itor for protein uria an d red cell casts in th e urin e.

n . Mon itor for bruisin g, bleedin g, an d in jury. o . Assist with plasm apheresis as prescribed to

rem ove autoantibodies and im m une com - plexes from the blood before organ dam age occurs.

p . Mon itor for sign s of organ in volvem en t such as pleuritis, n eph ritis, pericarditis, cor- on ary artery disease, h yperten sion , n euritis, an em ia, an d periton itis.

q . No te th at lupus n eph ritis occurs early in th e disease process.

r . Provide supp ortive th erap y as m ajor organ s beco m e affected .

s. Provide em otion al supp ort an d en courage th e clien t to verbalize feelin gs.

t . Provide in form ation regardin g support grou ps an d en courage th e use of com m u- n ity resou rces.

For the client with SLE, monitor the blood urea nitro- gen and creatinine levels frequently for signs of renal impairment.

C. Scleroderm a (system ic sclerosis) 1. Descrip tion

a . Scleroderm a is a ch ron ic con n ective tissue disease, sim ilar to SLE, th at is ch aracterized by in flam m ation , fibro sis, an d sclerosis.

b . Th is disorder affects th e con n ective tissue th rou gh out th e body.

c. It cau ses fibrotic ch an ges in volvin g th e skin , syn o vial m em bran es, eso ph agus, h eart, lun gs, kidn eys, an d gastro in testin al tract.

d . Treatm en t is directed toward forcin g th e dis- ease in to rem ission an d slowin g its progress.

2. Assessm en t a . Pain b . Stiffn ess an d m uscle weakn ess c. Pittin g edem a of th e h an ds an d fin gers th at

progresses to th e rest of th e body d . Taut an d sh in y skin th at is free from wrin kles e. Skin tissue is tigh t, h ard, an d th ick; loses its

elasticity; an d adh eres to un derlyin g struc- tures.

f. Dysp h agia g. Decreased ran ge of m otion h . Join t con tractures i. In ab ility to perform activities of daily livin g

3. In terven tion s a . En cou rage activity as tolerated. b . Main tain a con stan t ro om tem p erature. c. Provide sm all frequen t m eals, elim in atin g

food s th at stim ulate gastric secretio n s, such as spicy food s, caffein e, an d alcoh ol.

d . Mon itor for esoph ageal in volvem en t; if pre- sen t, advise th e clien t to sit up for 1 to 2 h ours after m eals. Usin g ad dition al pil- lows an d raisin g th e h ead of th e bed on blocks m ay h elp to reduce n octurn al reflux.

e. Provide supportive th erap y as th e m ajo r organ s beco m e affected .

f. Adm in ister cortico steroids as prescribed for in flam m ation .

g. Provide em otion al supp ort an d en courage th e use of resources as n ecessary.

D. Polyarteritis n odosa 1. Descrip tion

a . Polyarteritis n odosa is a collagen disease; it is a form of system ic vascu litis th at cau ses in flam m ation of th e arteries in visceral organ s, brain , an d skin .

b . Treatm en t is sim ilar to th e treatm en t for SLE.

c. Polyarteritis n odosa affects m iddle-aged m en. d . Th e cau se is un kn own an d th e progn osis

is poor. e. Ren al disorders an d cardiac in volvem en t are

th e m ost frequen t cau ses of death . 2. Assessm en t

a . Malaise an d weakn ess b . Low-grade fever

971CHAPTER 66 Immune Disorders

A

d

u

l

t

I

m

m

u

n

e

c. Severe abdom in al pain d . Bloo dy diarrh ea e. Weigh t loss f. Elevated ESR

3. In terven tion s: Refer to in terven tion s for SLE. E. Pem ph igus

1. Descrip tion a. Pem ph igus is a rare autoim m un e disease

th at occurs predom in an tly between m iddle age an d old age.

b . Th e cau se is un kn own , an d th e disorder is poten tially fatal.

c. Treatm en t is aim ed at suppressin g th e im m un e respo n se an d blister form ation .

2. Assessm en t a. Fragile, partial-th ickn ess lesion s bleed,

weep , an d form cru sts wh en bullae are disrupted.

b . Debilitation , m alaise, pain , an d dysph agia c. Niko lsky’s sign : Separation of th e epiderm is

cau sed by rubbin g th e skin d . Leuko cytosis, eosin op h ilia, foul-sm ellin g

disch arge fro m skin 3. In terven tion s

a. Provide supp ortive care. b . Provide oral h ygien e an d in crease fluid

in take. c. Sooth e oral lesion s. d . Assist with sooth in g bath s, as prescribed for

relief of sym pto m s. e. Adm in ister topical or system ic an tibiotics as

prescribed for secon dary in fectio n s. f. Adm in ister corticosteroids and cytotoxic

agen ts as prescribed to brin g about rem ission .

XI. Goodpasture’s Syndrome A. Description

1. An au toim m u n e disorder; autoan tibodies are m ade again st th e glom erular basem en t m em - bran e an d alveo lar basem en t m em bran e.

2. It is m ost com m on in m ales an d youn g adults wh o sm oke; th e exact cause is un kn own .

3. Th e lun gs an d th e kidn eys are affected prim arily, an d th e disorder usually is n ot diagn osed un til sign ifican t pulm o n ary or ren al in volvem en t occurs.

B. Assessm en t 1. Clin ical m an ifestation s in dicatin g pulm o n ary

an d ren al in volvem en t 2. Sh o rtn ess of breath 3. Hem o ptysis 4. Decreased urin e output 5. Edem a an d weigh t gain 6. Hyperten sion an d tach ycardia

C. In terven tion s 1. Focus on suppressin g th e autoim m un e respon se

with m edication s such as cortico steroids, an d on

plasm aph eresis (filtration of th e plasm a to rem ove som e protein s an d au toan tib odies).

2. Provid e supportive th erapy for pulm o n ary an d ren al in volvem en t.

XII. Lyme Disease A. Descrip tion

1. An in fectio n caused by th e spiroch ete Borrelia burgdorferi, acq uired from a tick bite (ticks live in wooded areas an d survive by attach in g to a h ost).

2. In fection with th e spiroch ete stim ulates in flam - m atory cytokin es an d autoim m un e m ech a- n ism s.

B. Assessm en t (Box 66-3; Fig. 66-5) 1. Th e typical rin g-sh ap ed rash of Lym e disease

does n ot occur in all clien ts. Man y clien ts n ever develop a rash . In addition , if a rash does occur, it can occur an ywh ere on th e body, n ot on ly at th e site of th e bite.

BOX 66-3 Assessment and Stages of Lyme Disease

First Stage Symptoms can occur several days to months following the

bite. A small red pimple develops that may spread into a ring-

shaped rash; it may occur anywhere on the body. Ring-shaped rash may be large or small, or may not occur

at all. Flulike symptoms occur, such as headaches, stiff neck,

muscle aches, and fatigue.

Second Stage This stage occurs several weeks following the bite. Joint pain occurs. Neurological complications occur. Cardiac complications occur.

Third Stage Large joints become involved. Arthritis progresses.

FIGURE 66-5 Erythema migrans of Lyme disease. (From Swartz, 2010 .)

972 UNIT XVIII Immune Disorders of the Adult Client

C. In terven tion s 1. Gen tly rem ove th e tick with tweezers, wash th e

skin with an tiseptic, an d dispose of th e tick by flu sh in g it down th e toilet; th e tick m ay also be placed in a sealed jar so th at th e h ealth care pro- vider can in spect it an d determ in e its type.

2. Perform a blood test 4 to 6 weeks after a bite to detect th e presen ce of th e disease (testin g before th is tim e is n ot reliable).

3. In struct th e clien t in th e adm in istration of an tibi- otics as prescribed; th ese are in itiated im m edi- ately (even before th e blood testin g results are kn own ).

4. In struct th e clien t to avoid areas th at con tain ticks, such as wooded grassy areas, esp ecially in th e sum m er m on th s.

5. In struct th e clien t to wear lon g-sleeved tops, lo n g pan ts, closed sh oes, an d h ats wh ile outsid e.

6. In struct th e clien t to spray th e body with tick repellen t before goin g outsid e.

7. In struct th e clien t to exam in e th e body wh en return in g in side for th e presen ce of ticks.

XIII. Immunodeficiency Syndrome A. Acquired immunodeficiency syndrome (AIDS)

1. AIDS is a viral disease caused by HIV, wh ich destro ys T cells, th ereby in creasin g susceptibility to in fectio n an d m align an cy ( Fig. 66-6).

2. Th e syn dro m e is m an ifested clin ically by oppor- tun istic in fectio n s an d un usual n eoplasm s.

3. AIDS is con sid ered a ch ron ic illn ess. 4. Th e disease h as a lon g in cubation period, som e-

tim es 10 years or lon ger.

5. Man ifestation s m ay n ot appear un til late in th e in fectio n .

B. Diagn o sis an d m on itorin g of th e clien t with AIDS 1. Refer to Box 66-4 for tests used to evaluate th e

progressio n of HIV in fectio n . 2. Refer to Box 66-5 for in form ation used to

diagn ose AIDS. C. High -risk grou ps

1. Heterosexual or h om osexual con tact with h igh - risk in dividuals

2. In traven ou s drug abusers 3. Person s receivin g blood produ cts 4. Health care workers 5. Babies born to in fected m oth ers

D. Assessm en t 1. Malaise, fever, an orexia, weigh t lo ss,

in fluen za-like sym pto m s 2. Lym ph aden opath y for at least 3 m on th s 3. Leukopen ia 4. Diarrh ea 5. Fatigue 6. Nigh t sweats 7. Presen ce of opportun istic in fectio n s 8. Protozoan in fectio n s ( Pneumocystis jiroveci

pn eum on ia, a m ajo r source of m ortality) 9. Neoplasm s ( Kaposi’s sarcoma, purplish -red

lesion s of in tern al organ s an d skin , B-cell n on -Hod gkin ’s lym ph o m a, cervical can cer)

10. Fun gal in fectio n s (can didiasis, h istoplasm osis)

11. Viral in fection s (cytom egalovirus, h erpes sim plex)

12. Bacterial in fectio n s

A

d

u

l

t

I

m

m

u

n

e

Virion

Nucle us

Inte rve ntio n

c. b.

a .

f.

e . d.

i. h. g.

HIV life c yc le

9. Tra ns la tion 10. P rote in modifica tion 11. As s e mbly of core

3. Uncoa ting 2. Inje ction of core 1. Atta chme nt a nd fus ion

6. Entra nce into nucle us 5. Circula r DNA 4. Conve rs ion to DNA

12. Budding

8. Tra ns cription 7. Inte gra tion

a

c

e b

d f

g

h

i

2

1

4

3

65

8 7

10

9

12

11

Block binding a nd e ntra nce Inhibit uncoa ting Inhibit re ve rs e tra ns cripta s e Inhibit inte gra s e Block tra ns cription Block tra ns la tion Inhibit prote a s e Inhibit a s s e mbly Inhibit budding

FIGURE 66-6 The life cycle of human immunodeficiency virus (HIV).

973CHAPTER 66 Immune Disorders

E. In terven tion s 1. Provide respiratory support. 2. Adm in ister oxygen an d respiratory treatm en ts

as prescribed. 3. Provide psych o social support an d support ser-

vices as n eeded. 4. Main tain fluid an d electrolyte balan ce. 5. Mon itor for sign s of in fectio n an d in stitute

protective isolatio n precaution s as n ecessary. 6. Preven t th e spread of in fectio n .

7. In itiate stan d ard an d oth er n ecessary pre- cau tion s.

8. Provide com fort as n ecessary. 9. Provide m eticulo us skin care.

10. Provide adequ ate n utrition al support as prescribed .

F. Kaposi’s sarcoma 1. Descrip tion : Skin lesion s th at occur prim arily in

in dividuals with a com pro m ised im m un e system

2. Assessm en t a. Kaposi’s sarcom a is a slow-growin g tum o r

th at appears as raised, oblon g, purplish , reddish -brown lesion s; m ay be ten der or n on ten der.

b . O rgan in volvem en t in cludes th e lym ph n odes, airways or lun gs, or any part of th e gas- troin testin al tract from the m outh to an us.

3. In terven tion s a . Main tain stan dard precaution s. b . Provide protective isolation if th e im m un e

system is depressed. c. Prepare th e clien t for radiation th erap y or

ch em oth erapy as prescribed. d . Adm in ister im m un oth erapy, as prescribed,

to stabilize th e im m un e system .

XIV. Posttransplantation Immunodeficiency A. Descriptio n

1. Secon dary im m un od eficien cy is im m un osup- pressio n caused by th erapeutic agen ts.

2. Th e clien t m ust take im m un osuppressive agen ts for th e rest of h is or h er life posttran splan tatio n to decrease rejection of th e tran splan ted organ or tissue.

A

d

u

l

t

I

m

m

u

n

e

BOX 66-4 Tests Used to Evaluate Progression of Human Immunodeficiency Virus (HIV) Infection Complete Blood Cell Count ▪ WBC count (normal to decreased) ▪ Lymphopenia (< 30% of the normal number of WBCs) ▪ Thrombocytopenia (decreased platelet count) Lymphocyte Screen ▪ Reduced CD4 +/ CD8 + T-cell ratio ▪ CD4 + (helper) lymphocytes decreased ▪ CD8 + lymphocytes increased Quantitative Immunoglobulin ▪ IgG level increased ▪ IgA level frequently increased Chemistry Panel ▪ Lactate dehydrogenase level increased (all fractions) ▪ Serum albumin level decreased

▪ Total protein increased ▪ Cholesterol level decreased ▪ AST and ALT levels elevated Anergy Panel ▪ Nonreactive (anergic) or poorly reactive to infectious agents

or environmental materials (e.g., pokeweed, phytohemag- glutinin mitogens and antigens, mumps, Candida)

Hepatitis B Surface Antigen Testing ▪ To detect the presence of hepatitis B Blood Cultures ▪ To detect septicemia Chest Radiography ▪ To detect Pneumocystis jiroveci infection or tuberculosis

Data from Copstead-Kirkhorn L, Banasik J: Pathophysiology, ed 5, St. Louis, 20 14, Mosby. ALT, Alanine aminotransferase; AST, aspartate aminotransferase; Ig, immunoglobulin; WBC, white blood cell.

BOX 66-5 Diagnostic Criteria for Acquired Immunodeficiency Syndrome (AIDS)

CD4 + T-cell count drops below 20 0 cells/ L Presence of a fungal, viral, protozoal, or bacterial infection

Candidiasis of bronchi, trachea, lungs, or esophagus Pneumocystis jiroveci pneumonia Disseminated or extrapulmonary coccidiomycosis Disseminated or extrapulmonary histoplasmosis Cytomegalovirus Herpes simplex Progressive multifocal leukoencephalopathy Toxoplasmosis Mycobacterium tuberculosis Recurrent pneumonia Recurrent salmonella septicemia

Presence of an opportunistic cancer Invasive cervical cancer Kaposi’s sarcoma Burkitt’s lymphoma Immunoblastic lymphoma Primary lymphoma of the brain

Wasting syndrome (10 % or more of ideal body mass) AIDS dementia complex

Adapted from Lewis S, Dirksen S, Heitkemper M, Bucher L: Medical-surgical nursing: assessment and management of clinical problems, ed 9, St. Louis, 20 14, Mosby.

974 UNIT XVIII Immune Disorders of the Adult Client

A

d

u

l

t

I

m

m

u

n

e

B. Diagn o sis an d m on itorin g of posttran splan tation clien ts 1. Ch eck ren al an d h epatic fun ction . 2. Mon itor th e com plete cell co un t with differen -

tial to determ in e sign s of in fectio n . 3. Assess all body secretio n s periodically for blood .

C. High -risk clien ts 1. Clien ts with a h isto ry of m align an cy or prem a-

lign an cy h ave an in creased susceptibility to m align an cy if im m un osuppressed.

2. Clien ts with recen t in fectio n or exposu re to tubercu losis, h erp es zoster, or ch icken p ox h ave a h igh risk for severe gen eralized disease wh en on im m un osuppressive agen ts.

D. Assessm en t 1. Assess for sign s of oppo rtun istic in fectio n s. 2. Assess n utrition al status. 3. Assess for sign s of rejection (sign s will depen d

on th e organ or tissue tran splan t). E. In terven tion s

1. Strict aseptic tech n iqu e is n ecessary. 2. Provid e teach in g regardin g asepsis an d th e sign s

of in fectio n an d rejection . 3. In stitute protective isolatio n precaution s as

n ecessary. 4. Provid e psych o social support as n eeded. 5. Provid e clien t teach in g about im m un o-

suppressan ts.

CRITICAL THINKING What Should You Do? Answer: Major organ damage can occur with diffuse sclero- derma, with esophageal involvement being one complication. The nurse should continuouslyassess the client’s abilityto swal- low. If esophageal involvement is suspected, the nurse should collaborate with the health care provider about scheduling a swallowing study. The nurse should also collaborate with the nutritionist about dietary changes, such as the need for small, frequent meals and minimizing the intake of foods and liquids that stimulate gastric secretion (spicy foods, caffeine, alcohol). The client should also sit up for 1 to 2 hours after meals.

Reference: Ignatavicius, Workman (20 16), p. 317.

P R A C T I C E Q U E S T I O N S 828. Th e n urse prepares to give a bath an d ch an ge th e

bed lin en s of a clien t with cutan eous Kaposi’s sar- com a lesion s. Th e lesion s are open an d drain in g a scan t am oun t of serou s fluid. Wh ich would th e n urse in corporate in to th e plan durin g th e bath in g of th is clien t? 1. Wearin g gloves 2. Wearin g a gown an d gloves 3. Wearin g a go wn , gloves, an d a m ask 4. Wearin g a gown an d gloves to ch an ge th e bed

lin en s, an d gloves on ly for th e bath

829. Th e n urse provid es h om e care in struction s to a cli- en t with system ic lupus eryth em atosus an d tells th e clien t about m eth od s to m an age fatigue. Wh ich statem en t by th e clien t in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I sh ould take h ot bath s because th ey are relaxing.” 2. “I sh ould sit wh en ever possible to con serve m y

en ergy.” 3. “I sh o uld avoid lon g periods of rest because it

causes join t stiffn ess.” 4. “I sh o uld do som e exercises, such as walkin g,

wh en I am n ot fatigued.”

830. A clien t develops an an aph ylactic reaction after receivin g m orph in e. Th e n urse sh ould plan to in stitute wh ich action s? Select all th at ap p ly.

1. Adm in ister oxygen . 2. Q uickly assess th e clien t’s respiratory status. 3. Do cum en t th e even t, in terven tion s, an d cli-

en t’s respon se. 4. Leave th e clien t briefly to con tact a h ealth

care provider (HCP). 5. Keep th e clien t supin e regardless of th e blood

pressure readin gs. 6. Start an in traven o us (IV) in fusion of D5W

an d adm in ister a 500-m L bolus.

831. Th e n urse is con d uctin g a teach in g session with a clien t on th eir diagn osis of pem ph igus. Wh ich statem en t by th e clien t in dicates th at th e clien t un d erstan ds th e diagn osis? 1. “My skin will h ave tin y red vesicles.” 2. “Th e presen ce of th e skin vesicles is caused by

a virus.” 3. “I h ave an autoim m un e disease th at cau ses blis-

terin g in th e epiderm is.” 4. “Th e presen ce of red, raised papules an d large

plaq ues covered by silvery scales will be presen t on m y skin .”

832. Th e n urse is assistin g in plan n in g care for a clien t with a diagn osis of im m un od eficien cy an d sh ould in corporate wh ich action as a p rio rity in th e plan ? 1. Protectin g th e clien t from in fectio n 2. Providin g em o tion al support to decrease fear 3. En couragin g discussion about lifestyle ch an ges 4. Iden tifyin g factors th at decreased th e im m un e

fun ction

833. A clien t calls th e n urse in the em ergen cy departm en t an d states th at h e was just stung by a bum blebee while gardenin g. Th e clien t is afraid of a severe reac- tion because th e clien t’s n eigh bor experien ced such a reaction just 1 week ago. Which action sh ould th e n urse take? 1. Advise th e clien t to soak th e site in h ydrogen

peroxide.

975CHAPTER 66 Immune Disorders

A

d

u

l

t

I

m

m

u

n

e

2. Ask th e clien t if h e ever sustain ed a bee stin g in th e past.

3. Tell th e clien t to call an am bulan ce for tran spo rt to th e em ergen cy departm en t.

4. Tell th e clien t n ot to worry about th e stin g un less difficu lty with breath in g occurs.

834. Th e com m un ity h ealth n urse is con ductin g a research study an d is iden tifyin g clien ts in th e com - m un ity at risk for latex allergy. Wh ich clien t population is m o st at risk for developin g this type of allergy? 1. Hairdressers 2. Th e h om eless 3. Ch ildren in day care cen ters 4. In dividuals livin g in a grou p h om e

835. Wh ich in terven tion s apply in th e care of a clien t at h igh risk for an allergic respon se to a latex allergy? Select all th at ap p ly.

1. Use n on latex gloves. 2. Use m ed ication s from glass am pules. 3. Place th e clien t in a private room on ly. 4. Keep a latex-safe supply cart available in th e

clien t’s area. 5. Avoid th e use of m edication vials th at h ave

rubber stopp ers. 6. Use a b lo o d p ressu re cu ff fro m an elec-

tro n ic d evice o n ly to m easu re th e b lo o d p ressu re.

836. A clien t presen ts at th e h ealth care provider’s office with com plain ts of a rin g-like rash on h is upper leg. Wh ich question sh ould th e n urse ask first? 1. “Do yo u h ave an y cats in your h om e?” 2. “Have you been cam pin g in th e last m on th ?” 3. “Have yo u or close con tacts h ad an y flu-like

sym pto m s with in th e last few weeks?” 4. “Have you been in ph ysical con tact with an yon e

wh o h as th e sam e type of rash ?”

837. A clien t is diagn osed with scleroderm a. Wh ich inter- ven tion sh ould the n urse an ticipate to be prescribed? 1. Main tain bed rest as m uch as possible. 2. Adm in ister co rticosteroids as prescribed for

in flam m ation . 3. Advise th e clien t to rem ain supin e for 1 to

2 h ours after m eals. 4. Keep th e room tem perature warm durin g th e

day an d cool at n igh t.

838. A clien t arrives at th e h ealth care clin ic an d tells th e n urse th at sh e was just bitten by a tick an d would like to be tested for Lym e disease. Th e clien t tells th e n urse th at sh e rem oved th e tick an d flush ed it down th e toilet. Wh ich action s are m o st ap p ro - p riate? Select all th at ap p ly.

1. Tell th e clien t th at testin g is n ot n ecessary un less arth ralgia develops.

2. Tell th e clien t to avoid an y woody, grassy areas th at m ay co n tain ticks.

3. In struct th e clien t to im m ediately start to take th e an tibiotics th at are prescribed .

4. In form th e clien t to plan to h ave a blood test 4 to 6 weeks after a bite to detect th e presen ce of th e disease.

5. Tell th e clien t th at if th is h appen s again , to n ever rem ove th e tick but vigorously scrub th e area with an an tiseptic.

839. Th e n urse is preparin g a grou p of Cub Scouts for an overn igh t cam pin g trip an d in structs th e Scouts about th e m eth od s to preven t Lym e disease. Wh ich statem en t by on e of th e Scouts in dicates a n eed fo r fu rth er in stru ctio n ? 1. “I n eed to brin g a h at to wear durin g th e trip.” 2. “I should wear lon g-sleeved tops an d lon g pan ts.” 3. “I sh o uld n ot use in sect repellen ts because it will

attract th e ticks.” 4. “I n eed to wear clo sed sh oes an d socks th at can

be pulled up over m y pan ts.”

840. The clien t with acquired im m unodeficiency syn- drom e is diagn osed with cutan eous Kaposi’s sarcom a. Based on th is diagn osis, the n urse understan ds th at th is has been con firm ed by wh ich fin ding? 1. Swellin g in th e gen ital area 2. Swellin g in th e lower extrem ities 3. Positive pun ch biopsy of th e cutan eous lesion s 4. Appearan ce of reddish -blue lesion s n oted on

th e skin

841. Th e n urse is con d uctin g allergy skin testin g on a cli- en t. Wh ich postp rocedure in terven tion s are m o st ap p ro p riate? Select all th at ap p ly.

1. Record site, date, an d tim e of th e test. 2. Give th e clien t a list of poten tial allergen s if

iden tified. 3. Estim ate th e size of th e wh eal an d docum en t

th e fin din g. 4. Tell th e clien t to return to h ave th e site

in spected on ly if th ere is a reaction . 5. Have th e clien t wait in th e waitin g room for

at least 1 to 2 h ours after in jection .

842. The nurse is perform ing an assessm ent on a client who has been diagnosed with an allergy to latex. In deter- m ining th e clien t’s risk factors, th e n urse should ques- tion the client about an allergy to wh ich food item ? 1. Eggs 2. Milk 3. Yogurt 4. Ban an as

976 UNIT XVIII Immune Disorders of the Adult Client

A N S W E R S 828. 2 Ra t ion a le: Gown s an d gloves are req uired if th e n urse an tici- pates co n tact with so iled item s su ch as th o se with wou n d drain age, or is carin g for a clien t wh o is in co n tin en t with d iar- rh ea or a clien t wh o h as an ileostom y or colostom y. Masks are n ot req uired u n less d ro plet o r airb orn e p recautio n s are n eces- sary. Regard less of th e am o un t o f wo un d drain age, a go wn an d gloves m u st b e wo rn . Test -Ta kin g St r a t egy: Fo cus on th e su b ject, th e m eth od o f tran sm issio n of in fectio n fro m Kap osi’s sarco m a. Read th e qu estio n , n o tin g th e task th at is p resen ted; in th is case, it is bath in g an d ch an gin g lin en s. Elim in ate op tion 3 b ecause th e m eth od o f tran sm issio n is n ot resp irato ry. Elim in ate o ptio n s 1 an d 4 because n eith er provides adequate protection based on th e m eth od o f tran sm issio n . Review: Stan d ard an d tran sm issio n -b ased p recau tio n s Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Fun dam en tals of Care—In fection Co n tro l Pr ior ity Con cepts: In fectio n ; Safety Refer en ce: Perry et al. (2014), p . 173.

829. 1 Ra t ion a le: To h elp red uce fatigue in th e clien t with system ic lup us eryth em ato sus, th e n u rse sh ou ld in stru ct th e clien t to sit wh en ever po ssib le, avoid h ot bath s (b ecau se th ey exacerbate fatigu e) , sch ed ule m o derate lo w-im p act exercises wh en n ot fatigu ed , an d m ain tain a b alan ced d iet. Th e clien t is in stru cted to avo id lon g perio ds o f rest b ecause it prom o tes jo in t stiffn ess. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further instruction. Th ese words in d icate a n egative even t q u ery an d th e n eed to select th e in co rrect clien t statem en t. Also , focus on th e su b ject, fatigu e. Th is will assist in directin g yo u to th e co rrect o p tion as th e actio n th at wo uld exacerb ate fatigue. Review: Measu res to p reven t fatigu e in a clien t with system ic lu p u s eryth em ato su s Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Im m u n e Pr ior ity Con cepts: Clien t Edu catio n ; Im m u n ity Refer en ces: Ign ataviciu s, Workm an ( 2016), p . 316; Lewis et al. (2014) , p . 1586.

830. 1, 2, 3 Ra t ion a le: An an aph ylactic reaction req uires im m ediate actio n , startin g with q u ickly assessin g th e clien t’s respiratory statu s. Alth o ugh th e HCP an d th e Rap id Respo n se Team m u st be n otified im m ediately, th e n urse m u st stay with th e clien t. O xygen is ad m in istered an d an IV o f n o rm al salin e is started an d in fu sed p er HCP p rescrip tio n . Do cu m en tatio n of th e even t, actio n s taken , an d clien t ou tco m es n eed s to b e d on e. Th e h ead o f th e bed sh ou ld b e elevated if th e clien t’s b lo od pressure is n orm al. Test -Ta kin g St r a t egy: Focu s on th e su b ject, in terven tio n s th e n urse takes for an an aph ylactic reactio n . Read each o ption care- fu lly an d rem em ber th at th is is an em ergen cy. Th in k abo u t th e path o ph ysiology th at o ccurs in th is reactio n to an swer co rrectly. Review: In terven tion s for a clien t with an an ap h ylactic reactio n

Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Critical Care—Em ergency Situations/Managem en t Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ce: Ign atavicius, Workm an (2016), p . 353.

831. 3 Ra t ion a le: Pem phigus is an autoim m un e disease th at causes b listerin g in th e epiderm is. The clien t h as large flaccid blisters (bullae). Becau se th e blisters are in th e epiderm is, th ey h ave a thin coverin g of skin and b reak easily, leavin g large d en ud ed areas o f skin . O n in itial exam in atio n , clien ts m ay h ave crustin g areas in stead o f in tact blisters. O ption 1 d escribes eczem a, option 2 d escribes h erpes zoster, an d optio n 4 d escribes p so riasis. Test -Ta kin g Str a tegy: Focus o n th e su b ject, th e ch aracteristics o f pem p h igu s. Th in k abo ut th e path o ph ysio logy asso ciated with th is disorder an d recall th at pem ph igus vulgaris is an au toim m u n e disorder. Review: Th e ch aracteristics of p em p h igu s Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ad ult Health —Im m u n e Pr ior ity Con cepts: Clien t Ed u catio n ; Im m u n ity Refer en ces: Ign atavicius, Wo rkm an ( 2016) , p. 455; Mosby’s dictionary of medicine, nursing, & health professions ( 2013) , p . 1356.

832. 1 Ra t ion a le: Th e clien t with im m u n o deficien cy h as in adequ ate o r ab sen ce o f im m u n e bo dies an d is at risk fo r in fectio n . Th e p riority n u rsin g in terven tion wo uld b e to protect th e clien t from in fectio n . O ptio n s 2, 3, an d 4 m ay b e co m p on en ts o f care b u t are n ot th e p rio rity. Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority. Use Maslo w’s Hierarch y o f Need s th eo ry to an swer th e qu estio n . Rem em b er th at ph ysiological n eed s are th e p rio rity. Th is will d irect you to th e co rrect op tio n . Review: Th e care of a clien t with im m u n o d eficien cy Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Ad ult Health —Im m u n e Pr ior ity Con cepts: Im m un ity; Safety Refer en ce: Ign atavicius, Workm an (2016), p p. 326, 338.

833. 2 Ra t ion a le: In so m e typ es of allergies, a reaction o ccurs on ly o n seco n d an d sub seq uen t co n tacts with th e allergen . Th e ap pro- p riate action , th erefo re, wou ld be to ask th e clien t if h e ever experien ced a bee stin g in th e past. O ptio n 1 is n o t ap p ro priate ad vice. O p tio n 3 is u n n ecessary. Th e clien t sh o uld n ot b e told “n o t to wo rry.” Test -Ta kin g Str a tegy: Use th e step s o f th e n u rsin g p ro cess to an swer th e q uestio n . Th e co rrect op tio n is th e o n ly on e th at ad dresses assessm en t. Review: In form ation related to h yp ersen sitivity an d allergy Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity

A

d

u

l

t

I

m

m

u

n

e

977CHAPTER 66 Immune Disorders

In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Im m un e Pr ior it y Con cept s: Clin ical Ju dgm en t; Im m u n ity Refer en ce: Ign ataviciu s, Workm an ( 2016) , pp . 128–129, 348.

834. 1 Ra tion a le: In d ivid uals m ost at risk for develop in g a latex allergy in clud e h ealth care workers; in dividu als wh o work in th e ru b ber in d u stry; or th ose wh o h ave h ad m ultiple surgeries, h ave sp in a bifida, wear gloves freq uen tly ( su ch as fo od h an - d lers, h airdressers, an d au to m ech an ics), or are allergic to kiwis, b an an as, pin eap ples, tro pical fruits, grapes, avocado s, p otato es, h azeln u ts, o r water ch estn u ts. Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, a latex allergy, an d n o te th e strategic wo rd , most. Recallin g th e so u rces o f latex an d o f th e allergic reaction will d irect yo u easily to th e correct o ptio n . Review: Th e cau se o f latex allergy an d th e in dividu als at risk Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Im m un e Pr ior it y Con cept s: Health Pro m otio n ; Im m u n ity Refer en ces: Ign atavicius, Wo rkm an (2016), pp . 354–355; Perry et al. (2014), p. 191.

835. 1, 2, 4, 5 Ra tion a le: If a clien t is allergic to latex an d is at h igh risk fo r an allergic respo n se, th e n urse wo uld use n o n latex glo ves an d latex- safe sup plies, an d wo uld keep a latex-safe su p ply cart available in th e clien t’s area. An y sup plies o r m aterials th at con tain latex would be avoided. Th ese in clude blo od pressure cuffs an d m ed- ication vials with ru bb er sto pp ers th at req uire pu n cture with a n eedle. It is n o t n ecessary to place th e clien t in a private ro om . Test-Ta kin g St r a t egy: Focu s o n th e su b ject, th e clien t at h igh risk fo r an allergic resp on se to latex. Recallin g th at item s th at con tain rub ber are likely to con tain latex will d irect yo u to th e co rrect in terven tio n s. Also, n otin g th e clo sed -en d ed wo rd only in op tio n s 3 an d 6 will assist in elim in atin g th ese o ptio n s. Review: Care of th e clien t with a latex allergy Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Im m un e Pr ior it y Con cept s: Clin ical Ju dgm en t; Im m u n ity Refer en ces: Lewis et al. ( 2014) , p . 216; Perry et al. ( 2014) , p p. 191–192.

836. 2 Ra tion a le: Th e n u rse sh o u ld ask q u estion s to assist in iden ti- fyin g a cau se o f Lym e d isease, wh ich is a m u ltisystem in fectio n th at resu lts fro m a bite b y a tick carried b y several sp ecies of d eer. Th e rash fro m a tick b ite can be a rin g-like rash o ccu rrin g 3 to 4 weeks after a bite an d is co m m o n ly seen on th e groin , b utto cks, axillae, tru n k, an d u pp er arm s o r legs. O ption 1 is referrin g to toxo plasm o sis, wh ich is caused by th e in h alatio n o f cysts fro m co n tam in ated cat feces. Lym e d isease can n o t be tran sm itted from on e p erson to an o th er. Test-Ta kin g Str a tegy: Focus on th e strategic wo rd , first. Also fo cu s o n th e d ata in th e q u estio n . Elim in ate option s 3 an d

4 becau se th ey are co m p arab le o r alike. It is im portan t in th e in itial assessm en t fo r th e n u rse to d eterm in e th e cau se of th e rash . If th e clien t su stain ed a bite wh ile ou t in th e wo od s, Lym e disease sh ou ld b e su spected . Review: Th e cause o f Lym e d isease Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ad ult Health —Im m un e Pr ior it y Con cept s: Clin ical Ju dgm en t; In fectio n Refer en ce: Lewis et al. (2014), p . 1578.

837. 2 Ra tion a le: Scleroderm a is a ch ron ic con n ective tissue disease sim ilar to system ic lu p us eryth em ato sus. Co rtico stero ids m ay b e prescrib ed to treat in flam m ation . Top ical agen ts m ay p ro - vid e so m e relief from join t pain . Activity is en cou raged as tol- erated an d th e roo m tem p eratu re n eed s to be con stan t. Clien ts n eed to sit u p for 1 to 2 h o urs after m eals if esop h ageal in vo lve- m en t is presen t. Test-Ta kin g Str a tegy: Fo cus o n th e su b ject, sclero derm a. Th in k abo u t th e p ath op h ysio lo gy associated with th is co n d itio n an d read each op tion carefully to assist in an swerin g correctly. Review: Nu rsin g in terven tio n s fo r th e clien t with sclero d erm a Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad ult Health —Im m un e Pr ior it y Con cept s: Caregivin g; Im m u n ity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 317.

838. 2, 3, 4 Ra tion a le: A b loo d test is availab le to detect Lym e disease; h o wever, th e test is n ot reliab le if p erfo rm ed b efore 4 to 6 weeks fo llowin g th e tick b ite. An tib od y fo rm atio n takes p lace in th e fo llowin g m an n er. Im m u n o glo bu lin M is d etected 3 to 4 weeks after Lym e disease o n set, peaks at 6 to 8 weeks, an d th en grad - u ally d isap pears; im m u n o glob u lin G is detected 2 to 3 m o n th s after in fectio n an d m ay rem ain elevated for years. Areas th at ticks in h ab it n eed to b e avo ided . Ticks sh ou ld b e rem o ved with tweezers an d th en th e area is wash ed with an an tisep tic. O ptio n s 1 an d 5 are in co rrect. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, m easu res to take if Lym e d isease is su spected . Also n ote th e strategic wo rd s, most appropriate. Elim in ate o p tion 1 because treatm en t sh ou ld begin b efore th e arth ralgia d evelo p s. Elim in ate o ptio n 5 b ecause ticks n eed to b e rem oved . Review: Th e m eth od of diagn osin g Lym e d isease Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Im m un e Pr ior it y Con cept s: Caregivin g; Im m u n ity Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 320–321.

839. 3 Ra tion a le: In th e preven tio n o f Lym e disease, in d ivid uals n eed to b e in stru cted to u se an in sect rep ellen t on th e skin an d cloth es wh en in an area wh ere ticks are likely to be fo un d. Lo n g-sleeved to ps an d lon g p an ts, clo sed sh o es, an d a h at or

A

d

u

l

t

I

m

m

u

n

e

978 UNIT XVIII Immune Disorders of the Adult Client

cap sh o uld b e worn . If p o ssible, h eavily wo o ded areas or areas with th ick u n d erb ru sh sh o uld be avoid ed . Socks can be pu lled up an d o ver th e p an t legs to p reven t ticks from en terin g un der clo th in g. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further instruction. Th ese words in d icate a n egative even t q u ery an d ask yo u to select an o ptio n th at is in correct. No te th at th e co r- rect op tion uses th e words should not. Read in g carefu lly will assist in d irectin g you to th is o p tion . Review: Th e m easures to preven t co n tact with ticks Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun dam en tals of Care—In fection Co n tro l Pr ior ity Con cepts: Clien t Edu catio n ; In fection Refer en ce: Ign atavicius, Workm an (2016), p . 321.

840. 3 Ra t ion a le: Kap o si’s sarco m a lesio n s b egin as red , d ark blue, o r pu rp le m acu les on th e lower legs th at ch an ge in to plaqu es. Th ese large plaq ues ulcerate o r o pen an d d rain . Th e lesio n s spread by m etastasis th rou gh th e up p er bo dy an d th en to th e face an d oral m u co sa. Th ey can m ove to th e lym p h atic sys- tem , lu n gs, an d gastro in testin al tract. Late d isease results in swellin g an d pain in th e lower extrem ities, pen is, scro tum , o r face. Diagn osis is m ad e b y p un ch b io psy o f cu tan eo us lesio n s an d biop sy o f p ulm o n ary an d gastro in testin al lesion s. Test -Ta kin g Str a tegy: Focu s on th e su b ject, d iagn o sin g Kapo - si’s sarco m a. Elim in ate o ptio n s 1 an d 2 first b ecause th ese sym p tom s occur late in th e develop m en t of Kap osi’s sarcom a. Th en , n ote th e wo rd confirmed in th e qu estio n . Th is wo rd will assist in d irectin g yo u to th e o ptio n th at will co n firm th e diag- n osis, th e bio p sy of th e lesion s. Review: Diagn o stic m easures fo r Kap o si’s sarco m a Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Im m u n e Pr ior ity Con cepts: Eviden ce; Im m un ity Refer en ce: Ign atavicius, Workm an (2016), p . 335.

841. 1, 2 Ra t ion a le: Skin testin g in vo lves adm in istratio n o f an allergen to th e surface o f th e skin o r in to th e d erm is. Site, d ate, an d tim e o f th e test m u st b e recorded , an d th e clien t m ust retu rn at a sp e- cific d ate an d tim e fo r a fo llo w-u p site evaluatio n , even if n o reaction is su spected ; a list of po ten tial allergen s is iden tified . Fo r th e follow-up evaluatio n , th e size of th e site h as to b e m ea- su red an d n o t estim ated . After in jection , clien ts on ly n eed to b e m o n ito red fo r abo ut 30 m in u tes to assess for an y ad verse effects. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Elim in ate o p tion 3 because an y results m ust be accu rately m easu red an d n ot estim ated. Elim in ate op tion 4 b ecau se o f th e clo sed -en d ed wo rd only. Elim in ate o ption 5 b ecau se it is u n reason able to h ave th e clien t wait 1 to 2 h o urs. Review: In terven tio n s for clien ts receivin g skin testin g Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Im m u n e Pr ior ity Con cepts: Clien t Ed u catio n ; Im m u n ity Refer en ce: Pagan a et al. (2015), p p. 34–36.

842. 4 Ra t ion a le: In d ivid uals wh o are allergic to kiwis, b an an as, pin e- ap ples, tro pical fru its, grapes, avocado s, po tato es, h azeln uts, o r water ch estn uts are at risk for developin g a latex allergy. Th is is th ou gh t to be th e resu lt o f a po ssib le cro ss-reaction between th e foo d an d th e latex allergen . O p tion s 1, 2, an d 3 are u n re- lated to latex allergy. Test -Ta kin g St r a t egy: Recall kn owledge regardin g th e food item s related to a latex allergy. Elim in ate option s 1, 2, an d 3 because th ey are com p arab le o r alike an d relate to dairy products. Review: Th e fo o d item s asso ciated with a risk for latex allergy Level of Cogn it ive Ability: An alyzin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Im m u n e Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ce: Ign atavicius, Workm an (2016), p p. 402–403.

A

d

u

l

t

I

m

m

u

n

e

979CHAPTER 66 Immune Disorders

A

d

u

l

t

I

m

m

u

n

e

C H A P T E R 67 Immunological Medications

PRIORITY CONCEPTS Immunity; Safety

CRITICAL THINKING What Should You Do? A hospitalized client who is receiving ceftriaxone to treat an infection develops severe diarrhea. What should the nurse do? Answer located on p. 984.

I. Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)

A. Medication s in clude n ucleoside-n u cleotide reverse tran scriptase in h ib itors (NRTIs), n on n ucleoside reverse tran scriptase in h ib itors (NNRTIs), protease in h ib itors (PIs), an d fusion in h ibito rs ( Box 67-1).

B. NRTIs an d NNRTIs work by in h ib itin g th e activity of reverse tran scriptase.

C. PIs work by in terferin g with th e activity of th e en zym e protease.

D. Fusion in h ibitors work by in h ibitin g th e bin d in g of HIV to cells.

E. Stan dard treatm en t con sists of usin g 3 or 4 m edica- tion s in regim en s kn own as h igh ly active an tiretro- viral th erapy (HAART); th is th erap y is n ot curative but can delay or reverse lo ss of im m un e fun ction , preserve h ealth , an d prolon g life.

F. O th er m edication s in clude th ose th at are used to treat com plication s or oppo rtun istic in fectio n s th at develop (see Box 67-1).

G. Nucleoside-n u cleotide reverse tran scriptase in h ibi- tors (NRTIs)

1. Abacavir: Can cause n ausea; m on itor for h ypersen sitivity reaction , in cludin g fever, n au- sea, vo m itin g, diarrh ea, leth argy, m alaise, sore th roat, sh ortn ess of breath , cough , an d rash .

2. Abacavir/ lam ivudin e: In addition to th e effects th at can occur from abacavir an d lam i- vudin e, h ypersen sitivity reaction s, lactic aci- dosis, an d severe h epatom egaly can occur.

3. Didan osin e: Can cause n ausea, diarrh ea, periph eral n europath y, h epatotoxicity, an d pan creatitis

4. Em tricitabin e: Can cause h eadach e, diarrh ea, n ausea, rash , h yperp igm en tation of th e palm s an d soles, lactic acidosis, an d severe h epatom - egaly

5. Em tricitabin e/ ten ofo vir: In addition to th e effects th at can occur from em tricitabin e an d ten ofovir (see below) , lactic acidosis an d severe h epatom egaly can occur.

6. Lam ivudin e: Causes n ausea an d n asal con ges- tion

7. Lam ivudin e/ zido vudin e: Can cause an em ia an d n eutropen ia an d lactic acido sis with h epatom egaly

8. Lam ivudin e/ zidovudin e/ abacavir: In addition to th e effects th at can occur from lam ivudin e, zidovudin e (see below), an d abacavir, h yper- sen sitivity reaction s, an em ia, neutropen ia, lactic acidosis, an d severe h epatom egaly can occur.

9. Stavudin e: Can cau se periph eral n europath y an d pan creatitis

10. Ten ofovir: Can cau se n ausea an d vom itin g 11. Zidovu din e: Can cau se n ausea, vom itin g, an e-

m ia, leuko pen ia, m yopath y, fatigue, an d h eadach e

H. Non n ucleoside reverse tran scriptase in h ibito rs (NNRTIs) 1. Delavirdin e: Can cause rash , liver fun ction

ch an ges, an d pruritus 2. Efaviren z: Can cause rash , dizzin ess, con fusion ,

difficu lty con cen tratin g, dream s, an d en ceph a- lopath y

3. Etravirin e: Can cause rash , gastro in testin al dis- turban ces, h eadach e, h yperten sio n , an d periph - eral n europath y

4. Nevirapin e: Can cau se rash , Steven s-Joh n son syn d rom e, h epatitis, an d in creased tran sam i- n ase levels

I. Protease in h ibitors (PIs) 1. Atazan avir: Can cau se n ausea, h eadach e, in fec-

tion , vom itin g, diarrh ea, drowsin ess, in som n ia, fever, h yperglycem ia, h yperlipidem ia, an d in creased bleedin g in clien ts with h em oph ilia980

2. Fosam p ren avir: Can cau se n ausea, vom itin g, h eadach e, altered taste sen sation s, perioral par- esth esia, rash es, an d altered liver fun ction

3. In din avir: Can cause n ausea, diarrh ea, h yperbi- lirubin em ia, n eph ritis, an d kidn ey ston es

4. Lop in avir/ riton avir Can cause n ausea, diarrh ea, altered taste sen sation s, circum oral paresth esia, an d h epatitis

5. Nelfin avir: Can cause n ausea, flatu len ce, an d diarrh ea

6. Rito n avir: Can cau se n ausea, vom itin g, diar- rh ea, altered taste sen sation s, circum oral pares- th esia, h epatitis, an d in creased triglycerid e levels

7. Saq uin avir: Can cause n ausea, diarrh ea, ph o to- sen sitivity, an d h ead ach e

8. Tipran avir: Hepatotoxicity (liver dam age) ; can also cause n ausea, vo m itin g, diarrh ea, h ead- ach e, an d fatigue

J. In tegrase in h ibitor: Raltegravir 1. Stops HIV replication an d is used in com bin a-

tio n with oth er an tiretroviral m edication s

2. Com m on side an d ad verse effects in clude n au- sea, diarrh ea, fatigue, h eadach e, an d itch in g.

K. Chem okin e receptor 5 (CCR5) an tagonist: Maraviroc 1. Bin ds with CCR5 an d blocks viral en try 2. Most com m on side an d adverse effects are

cough , dizzin ess, pyrexia, rash , ab dom in al pain , m uscu loskeletal sym pto m s, an d upper respira- tory tract in fectio n s; liver in jury an d cardiovas- cular even ts h ave occurred in som e clien ts.

L. Fusion in h ib itor: En fu virtide can cau se skin irrita- tion at in jection site, fatigue, n ausea, in som n ia, an d periph eral n europath y.

M. An tiin fective an d an tiin flam m atory m edication s: Used to treat opportun istic in fection s such as Pneumo- cystis jiroveci pneum on ia; Toxoplasma en cephalitis is treated with sulfam ethoxazole/ trim ethoprim (see Box 67-1).

N. An tifu n gal m edication s: Used to treat can didiasis an d crypto coccal m en in gitis (see Box 67-1)

O. An tiviral m edication s: Used to treat cyto m egalovi- rus retin itis, h erpes sim plex, an d varicella-zoster virus (see Box 67-1)

A

d

u

l

t

I

m

m

u

n

e

BOX 67-1 Medications for Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS)

Nucleoside-Nucleotide Reverse Transcriptase Inhibitors (NRTIs) ▪ Abacavir ▪ Abacavir/ lamivudine ▪ Didanosine ▪ Emtricitabine ▪ Emtricitabine/ tenofovir ▪ Emtricitabine/ tenofovir/ efavirenz ▪ Lamivudine ▪ Lamivudine/ zidovudine ▪ Lamivudine/ zidovudine/ abacavir ▪ Stavudine ▪ Tenofovir ▪ Zidovudine Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) ▪ Delavirdine ▪ Efavirenz ▪ Etravirine ▪ Nevirapine Protease Inhibitors (PIs) ▪ Atazanavir ▪ Darunavir ▪ Fosamprenavir ▪ Indinavir ▪ Lopinavir/ ritonavir ▪ Nelfinavir ▪ Ritonavir ▪ Saquinavir ▪ Tipranavir

Integrase Inhibitor ▪ Raltegravir ▪ Dolutegravir ▪ Elvitegravir Fusion Inhibitor ▪ Enfuvirtide Chemokine Receptor 5 (CCR5) Antagonist ▪ Maraviroc Antiinflammatory Medication ▪ Sulfasalazine Antiinfective Medications ▪ Atovaquone ▪ Metronidazole ▪ Pentamidine isethionate ▪ Sulfamethoxazole/ trimethoprim Antifungal Medications ▪ Amphotericin B ▪ Fluconazole ▪ Itraconazole ▪ Ketoconazole ▪ Voriconazole Antiviral Medications ▪ Acyclovir ▪ Foscarnet ▪ Ganciclovir ▪ Valacyclovir

981CHAPTER 67 Immunological Medications

A

d

u

l

t

I

m

m

u

n

e

The client with HIV or AIDS is at high risk for the development of opportunistic infections.

II. Immunosuppressants (Box 67-2) A. Description : Im m un osuppressan ts are used for

tran splan t recipien ts to preven t organ or tissue rejection an d to treat au toim m un e disorders such as system ic lupus eryth em atosu s.

B. Cyclosporin e 1. Used for preven tion of rejection followin g allo-

gen eic organ tran splan tation 2. Usually adm in istered with a gluco cortico id an d

an oth er im m un osuppressan t 3. Th e m ost com m on adverse effects are n eph ro-

toxicity, in fectio n , h yperten sion , an d h irsutism . C. Tacrolim us

1. Used for preven tion of rejection followin g liver or kidn ey tran splan tation

2. Adverse effects in clude n eph rotoxicity, n euro- toxicity, gastro in testin al effects, h yperten sion , h yperkalem ia, h yperglycem ia, h irsutism , an d gum h yperplasia.

D. Azath ioprin e 1. Gen erally used with ren al tran splan t recipien ts 2. Can cause n eutropen ia an d th rom bocytop en ia

E. Cyclop h osph am ide 1. Used for its im m un osuppressan t action to treat

autoim m un e disorders 2. Can cause n eutropen ia an d h em orrh agic cystitis

F. Meth otrexate 1. Used for its im m un osuppressan t action to treat

autoim m un e disorders 2. Can cause h epatic fibro sis an d cirrh osis, bon e

m arro w supp ression , ulcerative stom atitis, an d ren al dam age

G. Mycoph en olate m ofetil an d m ycoph en olic acid 1. Used to preven t rejection followin g kidn ey,

h eart, an d liver tran splan tation 2. Can cau se diarrh ea, vom itin g, n eutropen ia, an d

sepsis; in creases th e risk of in fectio n an d m alig- n an cies, esp ecially lym ph o m as

H. Basilixim ab 1. Used to preven t rejection follo win g kidn ey

tran splan tation 2. Can cau se severe acute h ypersen sitivity reac-

tion s, in cludin g an aph ylaxis I. Lym ph ocyte im m un e glob ulin , an tith ym ocyte

globulin 1. Used to preven t rejection followin g kidn ey,

h eart, liver, an d bon e m arrow tran splan tation 2. Side an d adverse effects in clude fever, ch ills, leu-

kopen ia, an d skin reactio n s. 3. Can cause an aph ylactoid reaction s

J. Sirolim u s 1. Used to preven t ren al tran splan t rejection 2. In creases th e risk of in fectio n ; raises

ch olesterol an d triglyceride levels; can cause ren al in jury

3. O th er side an d ad verse effects in clude rash , acn e, an em ia, th rom bocytop en ia, join t pain , diarrh ea, an d h ypo kalem ia.

Monitor the client taking an immunosuppressant closely for signs of infection.

III. Immunizations A. See Ch apter 44 for m ore in form ation .

IV. Antibiotics (Box 67-3) A. In h ibit th e growth of bacteria B. In clude m ed ication classification s of am in oglyco-

sides, ceph alosporin s, flu oroqu in olon es, m acro- lides, lin cosam ides, m on ob actam s, pen icillin s an d pen icillin ase-resistan t pen icillin s, sulfon am ides, tetracyclin es, an tim ycobacterials, an d oth ers (see Box 67-3)

C. Adverse effects (Table 67-1) D. Nursin g co n sideration s

1. Assess for allergies. 2. Mon itor appropriate laborato ry values before

th erap y as appropriate an d durin g th erapy to assess for adverse effects.

3. Mon itor for adverse effects an d report to th e h ealth care provider if an y occur.

BOX 67-2 Immunosuppressants Calcineurin Inhibitors ▪ Cyclosporine ▪ Tacrolimus Cytotoxic Medications ▪ Azathioprine ▪ Cyclophosphamide ▪ Methotrexate ▪ Mycophenolate mofetil ▪ Mycophenolic acid Antibodies ▪ Basiliximab ▪ Lymphocyte immune globulin, antithymocyte globulin ▪ Muromonab-CD3 ▪ Rho(D) immune globulin Other ▪ Sirolimus ▪ Everolimus Glucocorticoids ▪ See Chapter 51

982 UNIT XVIII Immune Disorders of the Adult Client

A

d

u

l

t

I

m

m

u

n

e

4. Determ in e th e ap propriate m eth od of adm in is- tration an d provide in struction s to th e clien t.

5. Mon itor in take an d outp ut. 6. En courage fluid in take (un less con train dicated). 7. In itiate safety precaution s because of possible

cen tral n ervous system effects. 8. Teach th e clien t about th e m ed ication an d h ow

to take it; em p h asize th e im portan ce of com - pletin g th e full prescribed course.

BOX 67-3 Antibiotics Aminoglycosides ▪ Amikacin ▪ Gentamicin ▪ Neomycin ▪ Streptomycin ▪ Tobramycin Cephalosporins ▪ Cefaclor ▪ Cefadroxil ▪ Cefazolin ▪ Cefdinir ▪ Cefditoren ▪ Cefepime ▪ Cefotaxime ▪ Cefotetan ▪ Cefoxitin ▪ Cefpodoxime ▪ Cefprozil ▪ Ceftazidime ▪ Ceftibuten ▪ Ceftriaxone ▪ Cefuroxime ▪ Cephalexin Fluoroquinolones ▪ Ciprofloxacin ▪ Gemifloxacin ▪ Levofloxacin ▪ Moxifloxacin ▪ Norfloxacin ▪ Ofloxacin Macrolides ▪ Azithromycin ▪ Clarithromycin ▪ Erythromycin Lincosamides ▪ Clindamycin ▪ Lincomycin Monobactam ▪ Aztreonam

Penicillins ▪ Amoxicillin ▪ Ampicillin ▪ Penicillin G ▪ Penicillin V ▪ Piperacillin Penicillinase-Resistant Penicillins ▪ Dicloxacillin ▪ Nafcillin ▪ Oxacillin Sulfonamides ▪ Sulfamethoxazole ▪ Sulfadiazine ▪ Sulfasalazine ▪ Sulfisoxazole ▪ Trimethoprim/

sulfamethoxazole

Tetracyclines ▪ Demeclocycline ▪ Doxycycline ▪ Minocycline ▪ Tetracycline Antimycobacterials ▪ Antituberculosis agents

(see Chapter 55) ▪ Leprostatics: Clofazimine,

Thalidomide

Antifungal Medications ▪ Amphotericin B ▪ Fluconazole ▪ Itraconazole ▪ Ketoconazole ▪ Voriconazole Antiviral Medications ▪ Acyclovir ▪ Foscarnet ▪ Ganciclovir ▪ Valacyclovir

TABLE 67-1 Antibiotics and Their Adverse Effects Classification Adverse Effects

Aminoglycosides Ototoxicity

Confusion, disorientation

Renal toxicity

Gastrointestinal irritation

Palpitations, blood pressure changes

Hypersensitivity reactions

Cephalosporins Gastrointestinal disturbances

Pseudomembranous colitis

Headache, dizziness, lethargy, paresthesias

Nephrotoxicity

Superinfections

Fluoroquinolones Headache, dizziness, insomnia, depression

Gastrointestinal effects

Bone marrow depression

Fever, rash, photosensitivity

Macrolides Gastrointestinal effects

Pseudomembranous colitis

Confusion, abnormal thinking

Superinfections

Hypersensitivity reactions

Lincosamides Gastrointestinal effects

Pseudomembranous colitis

Bone marrow depression

Monobactams Gastrointestinal effects

Hepatotoxicity

Allergic reactions

Penicillins and penicillinase-resistant penicillins

Gastrointestinal effects, including sore mouth and furry tongue

Superinfections

Hypersensitivity reactions, including anaphylaxis

Sulfonamides Gastrointestinal effects

Hepatotoxicity

Nephrotoxicity

Bone marrow depression

Dermatological effects, including hypersensitivity and photosensitivity

Headache, dizziness, vertigo, ataxia, depression, seizures

Continued

983CHAPTER 67 Immunological Medications

CRITICAL THINKING What Should You Do? Answer: Ceftriaxone is a cephalosporin. Some adverse effects include gastrointestinal disturbances, pseudomembranous colitis, and superinfections. If the client develops severe diar- rhea, the nurse should contact the health care provider immediately because of the potential development of an adverse effect. In some situations, antibiotic-associated gas- trointestinal disturbances such as diarrhea may require con- tact precautions.

Reference: Lilley et al. (2014), pp. 622, 631.

P R A C T I C E Q U E S T I O N S 843. Th e clien t with acq uired im m un od eficien cy syn -

drom e an d Pneumocystis jiroveci in fectio n h as been receivin g pen tam idin e. Th e clien t develops a tem - perature of 101 °F (38.3 °C). Th e n urse con tin ues to assess th e clien t, kn owin g th at th is sign m o st likely in dicates wh ich con dition ? 1. Th at th e dose of th e m edication is too low 2. Th at th e clien t is exp erien cin g toxic effects of th e

m edication 3. Th at th e clien t h as developed in adequacy of

th erm oregu lation 4. Th at th e clien t h as developed an oth er in fectio n

cau sed by leukopen ic effects of th e m ed ication

844. Th e n urse carin g for a clien t wh o is takin g an am i- n oglycoside sh ould m on itor th e clien t for wh ich adverse effects of th e m edication ? Select all th at ap p ly.

1. Seizu res 2. O toto xicity 3. Ren al toxicity 4. Dysrh yth m ias 5. Hepatoto xicity

845. Keto con azole is prescribed for a clien t with a diag- n osis of can didiasis. Wh ich in terven tion s sh ould th e n urse in clude wh en adm in isterin g th is m edica- tion ? Select all th at ap p ly.

1. Restrict flu id in take. 2. Mon itor liver fun ctio n studies. 3. In struct th e clien t to avoid alcoh ol. 4. Adm in ister th e m edication with an an tacid. 5. Instruct th e clien t to avoid exposure to the sun . 6. Adm in ister th e m ed ication on an em p ty

stom ach .

846. Th e n urse is carin g for a clien t wh o h as been takin g a sulfon am ide an d sh o uld m on itor for sign s an d sym pto m s of wh ich ad verse effects of th e m edica- tion ? Select all th at ap p ly.

1. O toto xicity 2. Palpitation s 3. Neph rotoxicity 4. Bon e m arro w suppression 5. Gastroin testin al (GI) effects 6. In creased wh ite blood cell (WBC) co un t

847. Th e n urse is reviewin g th e results of serum laboratory studies drawn on a clien t with acquired im m un ode- ficien cy syn drom e wh o is receivin g didan osin e. Th e n urse in terprets that th e clien t m ay h ave th e m edica- tion discon tin ued by the h ealth care provider if wh ich elevated result is n oted? 1. Serum protein level 2. Bloo d glucose level 3. Serum am ylase level 4. Serum creatin in e level

848. Th e n urse is carin g for a postren al tran splan tatio n clien t takin g cyclosporin e. Th e n urse n otes an in crease in on e of th e clien t’s vital sign s an d th e cli- en t is com plain in g of a h eadach e. Wh at vital sign is m o st likely in creased? 1. Pulse 2. Resp iration s 3. Bloo d pressure 4. Pulse oxim etry

849. Am ikacin is prescribed for a client with a bacterial infec- tion. The nurse instructs the client to contact the health care provider (HCP) im m ediately if which occurs? 1. Nausea 2. Leth argy 3. Hearin g loss 4. Muscle ach es

A

d

u

l

t

I

m

m

u

n

e

TABLE 67-1 Antibiotics and Their Adverse Effects—cont’d Classification Adverse Effects

Tetracyclines Gastrointestinal effects

Hepatotoxicity

Teeth (staining) and bone damage

Superinfections

Dermatological reactions, including rash and photosensitivity

Hypersensitivity reactions

Antimycobacterials, leprostatics

Gastrointestinal effects

Neuritis, dizziness, headache, malaise, drowsiness, hallucinations

Antifungals Gastrointestinal effects

Headache, rash, anemia, hepatotoxicity

Hearing loss, peripheral neuritis

984 UNIT XVIII Immune Disorders of the Adult Client

A

d

u

l

t

I

m

m

u

n

e

850. Th e n urse is assign ed to care for a clien t with cyto- m egalovirus retin itis an d acq uired im m un od efi- cien cy syn dro m e wh o is receivin g foscarn et, an an tiviral m ed ication . Th e n urse sh ould m on itor th e results of wh ich labo ratory study wh ile th e cli- en t is takin g th is m edication ? 1. CD4+ T cell coun t 2. Lym ph ocyte coun t 3. Serum albu m in level 4. Serum creatin in e level

851. A clien t wh o is h um an im m un od eficien cy virus serop ositive h as been takin g stavudin e. Th e n urse sh o uld m on itor wh ich m o st clo sely wh ile th e cli- en t is takin g th is m edication ? 1. Gait 2. Appetite 3. Level of con scio usn ess 4. Gastroin testin al fun ctio n

A N S W E R S 843. 4 Ra t ion a le: Freq u en t ad verse effects o f th is m ed icatio n in clu de leukop en ia, th ro m b ocytop en ia, an d an em ia. Th e clien t sh o uld be m on ito red ro utin ely for sign s an d sym p tom s o f in fectio n . O p tion s 1, 2, an d 3 are in accu rate in terp retatio n s. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most likely. Fo cu s o n th e d ata in th e q u estio n . Notin g th at th e tem perature is elevated will d irect you to th e co rrect op tio n . Review: Th e adverse effects of p en tam id in e Level of Cogn it ive Ability: Syn th esizin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Ph arm aco lo gy—Im m u n e Med icatio n s Pr ior ity Con cepts: In fectio n ; Im m u n ity Refer en ces: Burch um , Ro sen th al ( 2016) , p. 1198; Ho dgso n , Kizio r (2016), p. 974.

844. 2, 3, 4 Ra t ion a le: Am in o glyco sid es are adm in istered to in h ibit th e growth of b acteria. Ad verse effects o f th is m edicatio n in clu de co n fu sion , o to to xicity, ren al to xicity, gastroin testin al irritatio n , palp itation s o r dysrh yth m ias, b lo od pressu re ch an ges, an d h ypersen sitivity reactio n s. Th erefo re, th e rem ain in g o ptio n s are in co rrect. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, ad verse effects o f am in oglycosides. It is n ecessary to kn ow th e ad verse effects asso ciated with th is m edicatio n to an swer correctly. Rem em b er th at o toto xicity, ren al toxicity, an d d ysrh yth m ias are ad verse effects. Review: Th e adverse effects of am in o glyco sid es Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Im m u n e Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ce: Burch um , Rosen th al (2016), pp . 1056–1057.

845. 2, 3, 5 Ra t ion a le: Keto co n azo le is an an tifu n gal m edicatio n . Th ere is n o reason fo r th e clien t to restrict fluid in take; in fact, th is co uld be h arm fu l to th e clien t. Th e m edication is h epato toxic, an d th e n u rse m on itors liver fun ctio n . It is adm in istered with foo d (n ot o n an em p ty stom ach ) an d an tacid s are avo ided for 2 h o u rs after takin g th e m ed icatio n to en sure abso rp tio n . Th e clien t is also in structed to avoid alcoh o l. In ad dition , th e clien t is in structed to avoid expo sure to th e sun b ecau se th e m ed ication in creases ph oto sen sitivity.

Test -Ta kin g Str a tegy: Focus on th e su b ject, ad m in istration p ro cedu res, an d recall th at keto co n azo le is an an tifun gal m ed - icatio n . Next, u se gen eral m edicatio n guid elin es to select th e co rrect in terven tion s. Also, rem em b er th at th is m edicatio n is ad m in istered with foo d an d th at it is h epato toxic. Review: Ad m in istratio n p ro ced u res fo r keto co n azo le Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Im m un e Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ces: Bu rch u m , Ro sen th al ( 2016) , p p . 1097–1098; Ho dgso n , Kizior (2016) , p p. 671–672.

846. 3, 4, 5 Ra t ion a le: Ad verse effects of su lfon am ides in clud e n eph ro tox- icity, b o n e m arrow su p pressio n , GI effects, h ep ato toxicity, d erm ato lo gical effects, an d som e n eurolo gical sym p tom s, in clud in g h ead ach e, d izzin ess, vertigo , ataxia, d epressio n , an d seizures. O p tion s 1, 2, an d 6 are u n related to th ese m ed ication s. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, ad verse effects o f su lfo n am ides. It is n ecessary to kn ow th e ad verse effects asso- ciated with th ese m edicatio n s to an swer co rrectly. Rem em b er th at n ep h ro to xicity, bo n e m arro w su pp ression , an d GI sym p- to m s are ad verse effects of sulfo n am id es. Review: Th e adverse effects of su lfo n am id es Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Im m un e Med icatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Im m u n ity Refer en ce: Bu rch u m , Rosen th al (2016), pp . 1063–1064.

847. 3 Ra t ion a le: Did an o sin e can cau se p an creatitis. A seru m am y- lase level th at is in creased to 1.5 to 2 tim es n o rm al m ay sign ify p an creatitis in th e clien t with acqu ired im m un o d eficien cy syn - d ro m e an d is p o ten tially fatal. Th e m ed ication m ay h ave to b e d iscon tin u ed. Th e m ed ication is also h ep atoto xic an d can resu lt in liver failu re. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, ad verse effects o f d id an o sin e. Recallin g th at th is m ed ication can cause d am age to th e p an creas an d is h epato toxic will direct you to th e correct o p tion . Review: Ad verse effects o f d id an o sin e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t

985CHAPTER 67 Immunological Medications

Con ten t Ar ea : Ph arm aco logy—Im m un e Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p . 1132–1133.

848. 3 Ra tion a le: Hyp erten sion can o ccur in a clien t takin g cyclosp or- in e, an d because th is clien t is also com plain in g o f a h ead ach e, th e b loo d p ressu re is th e vital sign to be m on itored m ost closely. O th er ad verse effects in clu d e in fection , n ep h roto xicity, an d h irsu tism . O p tion s 1, 2, an d 4 are u n related to th e use of th is m edicatio n . Test-Ta kin g St r a t egy: Note th e strategic wo rd s, most likely. Focus o n th e n am e o f th e m ed icatio n an d recall th at th is m ed - ication can cause h yperten sio n . Also , n o tin g th at th e clien t h as a h eadach e will assist yo u in an swerin g co rrectly. Review: Th e ad verse effects o f cyclo sp o rin e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm aco logy—Im m un e Medicatio n s Pr ior it y Con cept s: Clin ical Ju dgm en t; Im m u n ity Refer en ce: Hod gson , Kizio r (2016), p. 308.

849. 3 Ra tion a le: Am ikacin is an am in oglycoside. Adverse effects of am in o glyco sid es in clud e o toto xicity (h earin g prob lem s), con - fu sion , diso rien tatio n , gastroin testin al irritation , palp itatio n s, b loo d pressu re ch an ges, n ep h roto xicity, an d h ypersen sitivity. Th e n u rse in structs th e clien t to repo rt h earin g lo ss to th e HCP im m ed iately. Leth argy an d m uscle ach es are n o t asso ci- ated with th e use o f th is m ed ication . It is n o t n ecessary to con - tact th e HCP im m ediately if n ausea occurs. If n au sea p ersists or results in vom itin g, th e HCP sh ou ld b e n otified . Test-Ta kin g Str a tegy: No te th e strategic wo rd , immediately. Recallin g th at th is m edication is an am in o glyco sid e (m o st am i- n o glycosid e m edicatio n n am es en d in -cin) an d th at am in ogly- cosid es are oto toxic will direct yo u to th e co rrect o ption . Review: Th e ad verse effects o f am in o glyco sid es Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity

In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acology—Im m u n e Medication s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 1052–1053.

850. 4 Ra tion a le: Foscarn et is to xic to th e kidn eys. Th e seru m creati- n in e level is m on itored b efore th erapy, two o r th ree tim es p er week durin g in duction th erapy, an d at least weekly durin g m ain ten an ce th erapy. Fo scarn et also m ay cau se d ecreased levels o f calciu m , m agn esiu m , ph osp h o ru s, an d p o tassium . Th u s, th ese levels also are m easu red with th e sam e frequ en cy. Test-Ta kin g Str a tegy: Focus on th e su b ject, th e labo rato ry valu e to be m on itored. Recallin g th at th is m ed icatio n is n ep h - rotoxic will direct you to th e co rrect op tion . Review: Th e ad verse effects o f fo scarn et Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Im m u n e Med ication s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p p. 1111–1112.

851. 1 Ra tion a le: Stavu din e is an an tiretroviral u sed to m an age h um an im m u no deficiency virus in fectio n in clien ts wh o d o n ot resp on d to o r wh o can n o t tolerate con ven tio n al th erapy. The m edication can cause p erip h eral n eu ropath y, an d the n urse sh ould m o n itor th e client’s gait clo sely and ask th e clien t abo ut p aresth esia. O ption s 2, 3, and 4 are u nrelated to this m edication . Test-Ta kin g Str a tegy: Note th e strategic wo rd , most. Focus o n th e n am e o f the m edication . Recallin g th at th is m ed icatio n causes p erip h eral n europath y will d irect you to th e co rrect option . Review: Th e ad verse effects o f stavu d in e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Im m u n e Med ication s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 1133.

A

d

u

l

t

I

m

m

u

n

e

986 UNIT XVIII Immune Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

UNIT XIX

Mental Health Disorders of the Adult Client

Pyramid to Success

Th e Pyram id to Success focuses on th e th erapeutic n urse- clien t relation sh ip, clien t righ ts, h ospital ad m ission pro- cedu res, th e eth ical an d legal issues related to th e care of a clien t with a m en tal h ealth disorder, an d grief an d loss. Pyram id Poin ts also focus on th e use of restrain ts (secu- rity devices), seclusion , an d electroco n vulsive th erapy. Care for a clien t with an addiction , such as an eatin g dis- order, substan ce abuse disorder, or gam blin g disorder, is an oth er focus area. Addition al areas of focus in clude an xiety, depression , suicide, abuse an d n eglect, violen ce, rape crisis in terven tion s, posttraum atic stress disorders, obsessive-com pulsive disorders, sch izoph ren ia, an d bipolar disorders. Pyram id Poin ts also address th e use of m edication s prescribed for a clien t with a m en tal h ealth disorder.

Client Needs: Learning Objectives Safe and Effective Care Environment En surin g clien t advocacy En surin g th at in form ed con sen t related to treatm en ts,

such as restrain ts (security devices), seclusio n , an d electroco n vulsive th erapy, h as been obtain ed

Im plem en tin g legal respon sibilities related to reportin g in ciden ces of abuse, n eglect, or violen ce

Main tain in g con fiden tiality Provid in g psych iatric con sultation s an d oth er in terp ro-

fessio n al referrals Provid in g safety to th e clien t an d oth ers Uph oldin g clien t righ ts Usin g restrain ts (security devices) an d seclusion appro-

priately an d safely

Health Promotion and Maintenance Iden tifyin g com m un ity resou rces for th e clien t Iden tifyin g in dividual lifestyle ch oices Perform in g psych o social assessm en t tech n iqu es Providin g h ealth prom otio n program s related to

addictio n s

Psychosocial Integrity Addressin g grief an d lo ss issues Assessin g for abuse an d n eglect situation s Assessin g for addiction s Assessin g for dom estic violen ce Carin g for the clien t wh o h as been sexually abused or raped Con siderin g religious, cultural, an d spiritual in fluen ces

on h ealth Developin g a th erapeutic n urse-clien t relation sh ip Iden tifyin g copin g m ech an ism s Iden tifyin g supp ort system s Im plem en tin g beh avioral in terven tion s Providin g crisis in terven tion Providin g a th erapeutic m ilieu Teach in g stress-m an agem en t tech n iqu es

Physiological Integrity Assessin g for abusive an d self-destructive beh avior Mon itorin g elim in ation pattern s Mon itorin g for alteration s in body system s related to

substan ce abuse Mon itorin g for expected an d un toward effects of

m edication s Mon itorin g for poten tial com plication s related to m edica-

tion s an d treatm en ts, such as electrocon vulsive th erapy Monitorin g laboratory values related to m edication th erapy Mon itorin g rest an d sleep pattern s Providin g ad equate n utrition Providin g perso n al h ygien e m easu res

987

M

e

n

t

a

l

H

e

a

l

t

h

C H A P T E R 68 Foundations of Psychiatric Mental Health Nursing

PRIORITY CONCEPTS Caregiving; Coping

CRITICAL THINKING What Should You Do? A client needs assistance in using coping mechanisms to decrease anxiety. What should the nurse do? Answer located on p. 994.

I. Nurse-Client Relationship A. Prin ciples

1. Gen uin en ess, respect, an d em path ic un der- stan din g are ch aracteristics im portan t to th e developm en t of a th erap eutic n urse-clien t relation sh ip.

2. Th e clien t sh ould be cared for in a h olistic m an n er.

3. Th e n urse con sid ers th e clien t’s cultural an d spir- itu al beliefs an d values in assessin g th e clien t’s respo n se to th e n urse-clien t relation sh ip an d h is or h er adap tation to stressors.

4. Appropriate lim its an d boun daries defin e an d facilitate a th erap eutic n urse-clien t relation sh ip.

5. Ho n est an d open co m m un ication is im portan t for th e developm en t of trust, an un d erpin n in g of th e th erap eutic n urse-clien t relation sh ip.

6. Th e n urse uses th erapeutic com m un ication tech n iques to en courage th e clien t to express th o ugh ts an d feelin gs as th ey address id en tified problem areas.

7. Th e n urse respects th e clien t’s con fiden tiality an d lim its discussion of th e clien t to th e in terpro fes- sion al h ealth care team .

8. Th e goal of th e n urse-clien t relation sh ip is to assist th e clien t to develop problem -solvin g ab il- ities an d coping mechanisms.

The nurse needs to consider the cultural, religious, and spiritual practices of the client and whether these practices may give the client hope, comfort, and support while healing.

B. Ph ases of a th erapeutic n urse-clien t relation sh ip 1. Prein teraction ph ase

a . Begin s before th e n urse’s first con tact with th e clien t

b . Th e n urse’s task is to focus on h is or h er own precon ceived ideas, stereotypes, biases, an d values th at m ay im pin ge on th e n urse-clien t relation sh ip.

2. O rien tation or in trodu ctory ph ase a . Acceptan ce, rapport, tru st, an d boun daries

are establish ed. b . Expectations an d th e tim e fram e of th e relation -

sh ip are iden tified (establish in g a con tract). c. Clien t-cen tered goals are defin ed. d . Term in ation an d sep aration of th e relation -

sh ip are discussed in an ticip ation of th e tim e-lim ited n ature of th e relation sh ip.

3. Workin g ph ase a . Explorin g, focusin g on , an d evaluating the cli-

en t’s con cern s an d problem s occur; an attitude of acceptance an d active listen in g assists the cli- en t to express th ough ts an d feelin gs.

b . En cou ragin g in depen den ce in th e clien t facil- itates recovery an d leads to readin ess for term in ation .

4. Term in ation or sep aration ph ase a . Prepare th e clien t for term in ation an d separa-

tion on in itial con tact. b . Evaluate progress an d ach ievem en t of goals. c. Iden tify respon ses related to term in ation an d

sep aration , such as an ger, distan cin g from th e relation sh ip, a return of sym ptom s, an d dep en den cy.

d . En cou rage th e clien t to express feelin gs about term in ation .

e. Iden tify th e clien t’s stren gth s an d an ticipated n eeds for follow-up care.

f. Refer th e clien t to com m un ity resou rces an d oth er supp ort system s.

988

C. Fam ily as an exten sion of th e clien t 1. Fam ily m em bers sh ould be viewed as collabora-

tors in th e m an agem en t of a clien t’s m en tal h ealth n eeds (m ain tain con fiden tiality as n ecessary).

2. Com peten ce an d carin g focused toward fam ily m em bers en h an ce th e n urse’s ability to iden tify clien t an d fam ily n eeds an d to select an d im ple- m en t effective in terven tion s directed toward pro- m otin g adap tive fun ction in g.

3. Nu rses h ave a profession al obligation to be aware of an d sen sitive to th e cu ltural, eth n ic, reli- giou s, an d spiritu al factors th at affect th e struc- ture an d resultin g n eeds of th e clien t an d h is or h er fam ily.

4. Ed ucatin g fam ily m em bers regardin g th e clien t’s illn ess, iden tification of sym pto m s, an d effective m an agem en t of m alad aptive beh aviors plays a vital role in th e clien t’s quality of life.

D. Im p act of culture, eth n icity, religion , an d spirituality on clien t care 1. Cultural com peten cy allows th e n urse to recogn ize

th e un iqueness of each clien t an d the im pact th at culture, values, an d religious and spiritual beliefs h ave on an in dividual’s m en tal h ealth as well as th e treatm en t required for existin g m en tal illn ess.

2. A clien t’s culture, eth n icity, value, an d religious an d spiritual belief system s can affect all aspects of m en tal h ealth care, in cludin g m edication th erapies, an d can act as eith er protective or risk facto rs wh en dealin g with th e developm en t an d/ o r treatm en t of psych iatric disorders.

3. Nurses m ust be aware of th e im pact th at th eir own culture, religious an d spiritual beliefs, an d values h ave on the care they provide an d to avoid biases.

4. Th e treatm en t plan m ust be agreed upon by both clien t an d n urse an d take in to con sideration th e n eeds of th e clien t wh en ever possib le.

II. Therapeutic Communication Process A. Prin ciples

1. Com m un ication in cludes verbal an d n on verbal exp ression (Fig. 68-1).

2. Successful com m un ication in cludes appropriate- n ess, efficien cy, flexibility, an d feed back.

3. An xiety in th e n urse or clien t im pedes com m un i- cation .

4. Com m un ication n eeds to be goal-d irected with in a profession al fram ework.

B. Th erapeutic an d n on th erapeu tic com m un ication tech n iqu es ( Box 68-1)

M

e

n

t

a

l

H

e

a

l

t

h

(ne e d for informa tion, comfort, a dvice , e tc.)

S TIMULUS

FORMULATION OF FEEDBACK

PERS ON(S ) RECEIVING THE MES S AGE

• Amount of input • Cla rity of input • Re le va nce of input

MES S AGE INFLUENCED BY TRANS MIS S ION

QUALITY

Can be • Ve rba l • Nonve rba l

- Vis ua l (e .g., body la ngua ge ) - Ta ctile (e .g., hug) - S me ll (e .g., body odor) - S ile nce

• Both ve rba l a nd nonve rba l - Ma y contra dict - Ma y s ubs ta ntia te

MES S AGE

S ENDER

Me s s ag e filte rs thro ug h pe rs o nal fac to rs • Ability to re la te to othe rs • Culture • Environme nta l fa ctors • Ge nde r role s • Knowle dge • Mood/a ttitude

• Pa s t e xpe rie nce • Pe rs ona l a ge nda /goa ls • Pe rs ona l bia s • Pe rs ona l re la tions hip • Va lue s ys te m

Re c e ive r • Agre e s with me s s a ge • Dis a gre e s with me s s a ge • Ne e ds cla rifica tion:

“Is this wha t you me a n? ” • P rovide s informa tion • Re que s ts informa tion

• Give s fe e dba ck, which

ta ke s ma ny forms - Ve rba l - Nonve rba l - Both ve rba l a nd

nonve rba l

Me s s ag e e valuate d thro ug h pe rs o nal filte rs • Inte rpre ta tions of me s s a ge s e nt a re influe nce d

by the s a me common fa ctors a s for the s e nde r - Ability to re la te to othe rs - Culture - Environme nta l fa ctors - Ge nde r role s - Knowle dge - Mood/a ttitude

- Pa s t e xpe rie nce - Pe rs ona l a ge nda /goa ls - Pe rs ona l bia s - Pe rs ona l re la tions hips - Va lue s ys te m

FIGURE 68-1 Operational definition of communication.

989CHAPTER 68 Foundations of Psychiatric Mental Health Nursing

III. Mental Health A. Men tal h ealth is a lifelon g process of successful

adaptation to ch an gin g in tern al an d extern al en viron m en ts.

B. A m en tally h ealth y in dividual is in contact with reality, can relate to peo ple an d situation s in th eir en viron m en t, an d can resolve con flicts with in a problem -solvin g fram ework.

C. A m en tally h ealth y in dividual h as psych obiological resilien ce.

IV. Psychiatric–Mental Health Illness A. Description

1. Psych iatric illn ess is th e lo ss of th e ab ility to respo n d to th e in tern al an d extern al en viron - m en t in ways th at are in h arm on y with on eself or th e exp ectation s of society.

2. It is ch aracterized by th o ugh t or beh avior pattern s th at im pair fun ction in g an d cau se distress.

B. Perso n ality ch aracteristics 1. Self-con cept is distorted. 2. Percep tion of stren gth s an d weakn esses is

un realistic. 3. Th ou gh ts an d perception s m ay n ot be reality-

based. 4. Th e ability to fin d m ean in g an d purpo se in life

m ay be im paired.

5. Life direction an d produ ctivity m ay be disturbed. 6. Meetin g on e’s own n eeds m ay be problem atic. 7. Excessive relian ce or preoccu patio n on th e

th o ugh ts, opin ion s, an d action s of self or oth ers m ay be presen t.

C. Adaptation s to stress 1. Th e in dividual’s sen se of self-con trol m ay be

affected . 2. Percep tion of th e en viron m en t m ay be distorted. 3. Copin g m ech an ism s m ay n ot exist or m ay be

in effective. D. In terperson al relation sh ips

1. In terperson al relation sh ips m ay be m in im ally existen t or m ay be n egatively affected.

2. Th e ability to en jo y sustain ed in tim acy in rela- tion sh ips is im paired.

V. Coping and Defense Mechanisms A. Coping mechanisms

1. Copin g in volves an y effort to decrease an xiety. 2. Copin g m ech an ism s can be con structive or

destructive, task- or problem -orien ted in relation to direct problem solvin g, cogn itively orien ted in an attem pt to n eutralize th e m ean in g of th e problem , or defen se- or em o tion -o rien ted, th us regulatin g th e respo n se to protect on eself.

B. Defense mechanisms 1. As an xiety in creases, th e in dividual copes by

usin g defen se m ech an ism s. 2. A defen se m ech an ism is a copin g m ech an ism

used in an effort to protect th e individual from feelings of an xiety; as an xiety increases an d becom es overwh elm in g, th e in dividual copes by usin g defen se m ech an ism s to protect th e ego an d decrease an xiety (Box 68-2).

Coping mechanisms and defense mechanisms are used by the client to decrease anxiety.

C. In terven tion s 1. Assist th e clien t to iden tify th e source of an xiety

an d to exp lore m eth ods to reduce an xiety. 2. Assess th e clien t’s use of defen se m ech an ism s. 3. Facilitate appropriate use of defen se m ech an ism s. 4. Determ in e wh eth er th e defen se m ech an ism s

used by th e clien t are effective for h im or h er or create addition al distress.

5. Avoid criticizin g th e clien t’s beh avior an d th e use of defen se m ech an ism s.

VI. Dia gnost ic a nd St a t ist ica l Ma nua l of Ment a l Hea lt h Disorders

A. Th e Diagnostic and Statistical Manual of Mental Health Disorders, publish ed by th e Am erican Psych iatric Association , provides gu idelin es for h ealth care per- son n el for iden tifyin g an d categorizin g m en tal disorders.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 68-1 Therapeutic and Nontherapeutic Communication Techniques

Therapeutic Techniques ▪ Clarifying and validating ▪ Encouraging formulation of a plan of action ▪ Focusing and refocusing ▪ Giving information and presenting reality ▪ Listening ▪ Maintaining neutral responses ▪ Maintaining silence ▪ Providing acknowledgment and feedback ▪ Providing nonverbal encouragement ▪ Reflecting ▪ Restating ▪ Sharing perceptions ▪ Summarizing ▪ Using broad openings and open-ended questions Nontherapeutic Techniques ▪ Asking the client “Why?” ▪ Being defensive or challenging the client ▪ Changing the subject ▪ Giving advice or approval or disapproval ▪ Making stereotypical comments ▪ Making value judgments ▪ Placing the client’s feelings on hold ▪ Providing false reassurance

990 UNIT XIX Mental Health Disorders of the Adult Client

B. Th e m an u al is a system used in clin ical, research , an d edu cation al settin gs, in wh ich diagn ostic criteria are in cluded for each m en tal h ealth disorder.

C. Th e m an u al addresses culturally diverse population s an d illn ess th at m ay be associated with a particular culture.

D. Dual diagn osis: Refers to th e clien t wh o h as both a m en tal h ealth disorder an d a substan ce related disorder; also kn own as com orb idity or co-occurrin g disorders

E. See Am erican Psych iatric Association for updates: h ttp:/ / www.dsm 5.org/ Pages/ Default.aspx.

VII. Types of Mental Health Admissions and Discharges

A. Volun tary adm ission 1. Th e clien t (or th e clien t’s guardian ) seeks adm is-

sion for care. 2. Th e vo lun tary clien t is free to sign out of th e h os-

pital with psych iatrist (h ealth care provider [HCP]) n otification an d prescription .

3. Detain in g a volu n tary clien t again st h er or h is will is term ed false imprisonment.

4. Th e clien t retain s full civil righ ts (Box 68-3). B. Righ t to con fid en tiality

1. A clien t h as a righ t to con fiden tiality of h is or h er m ed ical in form ation ; th e Health In suran ce Por- tab ility an d Accoun tability Act (HIPAA) of 1996 en sures clien t con fiden tiality with regard to th e release an d electron ic tran sm ission of data.

2. In form ation som etim es m ust be released in life-th reaten in g situation s with ou t th e clien t’s con sen t.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 68-2 Types of Defense Mechanisms Compensa tion: Putting forth extra effort to achieve in areas

where one has a real or imagined deficiency Conversion: The expression of emotional conflicts through

physical symptoms Denia l: Disowning consciously intolerable thoughts and

impulses Displa cement : Feelings about one person are directed to

another who is less threatening, satisfying an impulse with a substitute object

Dissocia tion: The blocking of an anxiety-provoking event or period of time from the conscious mind

Fa nt a sy: Gratification by imaginary achievements and wishful thinking

Fixa t ion: Never advancing to the next level of emotional devel- opment and organization; persistence in later life of inter- ests and behavior patterns appropriate to an earlier age

Ident ifica t ion: The unconscious attempt to change oneself to resemble an admired person

Insula t ion: Withdrawing into passivity and becoming inacces- sible so as to avoid further threatening situations

Intellectua liza tion: Excessive reasoning to avoid feelings; the thinking is disconnected from feelings, and situations are dealt with at a cognitive level

Introjection: Atype of identification in which the individual incor- porates the traits or values of another into himself or herself

Isola tion: Response in which a person blocks feelings associ- ated with an unpleasant experience

Project ion: Transferring one’s internal feelings, thoughts, and unacceptable ideas and traits to someone else

Ra t iona liza tion: An attempt to make unacceptable feelings and behaviors acceptable by justifying the behavior

Rea ct ion Forma t ion: Developing conscious attitudes and behaviors and acting out behaviors opposite to what one really feels

Regression: Returning to an earlier developmental stage to express an impulse to deal with anxiety

Repression: An unconscious process in which the client blocks undesirable and unacceptable thoughts from conscious expression

Sublima t ion: Replacement of an unacceptable need, attitude, or emotion with one more socially acceptable

Substitut ion: The replacement of a valued unacceptable object with an object more acceptable to the ego

Suppression: The conscious, deliberate forgetting of unaccept- able or painful thoughts, ideas, and feelings

Symboliza tion: The conscious use of an idea or object to rep- resent another actual event or object; often, the meaning is unclear because the symbol may be representative of something unconscious

Undoing: Engaging in behavior considered to be the opposite of a previous unacceptable behavior, thought, or feeling

BOX 68-3 Client Rights ▪ Right to accessible health care ▪ Right to coordination and continuity of health care ▪ Right to courteous and individualized health care ▪ Right to information about the qualifications, names, and

titles of personnel delivering care ▪ Right to refuse observation by individuals not directly

involved in care ▪ Right to privacy and confidentiality ▪ Right to informed consent ▪ Right to treatment and to refuse treatment ▪ Right to treatment in the least restrictive setting ▪ Right not to be subjected to unnecessary restraints ▪ Right to habeas corpus; may request a hearing at any time

to be released from the hospital ▪ Right to information about diagnosis, prognosis, and

treatment ▪ Right to information on the charges of service ▪ Right to communicate with people outside the hospital

through written correspondence, telephone, and personal visits

▪ Right to keep clothing and personal effects ▪ Right to be employed ▪ Right to religious freedom ▪ Right to execute wills ▪ Right to retain licenses, privileges, or permits established

by the law, such as a driver’s or professional license

From Stuart G: Principles and practice of psychiatric nursing, ed 9, St. Louis, 20 0 9, Mosby.

991CHAPTER 68 Foundations of Psychiatric Mental Health Nursing

3. In th e even t of a specific th reat again st an id en ti- fied in dividual, th e h ealth care profession al h as a legal obligation to warn th e in ten ded victim of a clien t’s th reats of h arm .

Except in an emergency situation, client information can be released only with the client’s informed consent, which specifies the information that can be released and the time frame for which the release is valid.

C. In volu n tary adm ission 1. In volun tary adm ission m ay be n ecessary wh en

a perso n is m en tally ill, is a dan ger to self or oth ers, or is in n eed of psych iatric treatm en t or ph ysical care.

2. In volun tary adm ission occurs wh en a person is adm itted or detain ed in volun tarily for m en tal h ealth treatm en t because of actu al or im m in en t dan ger to self or oth ers.

3. A clien t wh o is ad m itted in volun tarily retain s h is or h er righ t for in form ed con sen t.

4. Th e client retain s th e right to refuse treatm en ts, in cludin g m edication s, un less a separate an d spe- cific treatm ent order is obtain ed from th e court.

5. Th e clien t lo ses th e righ t to refuse treatm en t wh en h e or sh e poses an im m ediate dan ger to self or oth ers, requirin g im m ediate action by th e in terp rofessio n al h ealth care team .

6. An order from a judge is required for in volun - tary ad m ission s except in th e case of em ergen cy, wh ich allows tim e to obtain th e n ecessary order from a judge; in th e case of all in volun tary adm ission s, legal coun sel m ust be provid ed for th e clien t.

7. A court h earin g is h eld by a judge with in a spec- ified tim e period for a clien t adm itted in volun - tarily; th e specific tim e period varies by state.

8. In m ost states, a clien t can in stitute a co urt h ear- in g to seek an exped ien t judicial disch arge (a writ of h abeas corpus).

9. At th e court h earin g, a determ in ation is m ade as to wh eth er th e clien t m ay be released from th e h ospital or detain ed for furth er treatm en t an d evalu ation , or com m itted to a m en tal h ealth facility for an un determ in ed period.

10. A clien t h as th e righ t to treatm en t in th e least restrictive treatm en t en viron m en t; if treatm en t objectives can be ach ieved by court-ordered treatm en t to an outp atien t facility as oppo sed to an in patien t facility, th e clien t h as th e righ t to be treated in th e outp atien t settin g.

11. A clien t is con sid ered legally co m peten t un less h e or sh e h as been declared in com peten t th rou gh a legal h earin g sep arate from th e in vol- un tary com m itm en t h earin g.

12. In th e course of providin g n ursin g care an d car- ryin g out m ed ical prescription s, if th e n urse believes th at a clien t lacks com peten cy to m ake

in form ed decision s, action sh o uld be in itiated to determ in e wh eth er a legal guardian n eeds to be appoin ted by th e court.

D. Release fro m th e h ospital 1. Description

a . A clien t m ay be released volun tarily, again st m ed ical advice, or with con d ition s (con di- tion al release).

b . A clien t wh o h as sough t volu n tary adm ission h as th e righ t to receive release upon request.

2. Volun tary release a . In th e ab sen ce of an act of self-h arm or dan ger

to oth ers, a volu n tary clien t sh ould n ever be detain ed.

b . If a volun tary clien t wish es to be disch arged from treatm en t, but is con sidered poten tially dan gerous to self or oth ers, th e HCP can order th e clien t to be detain ed wh ile legal proceed- in gs for in volun tary status are sough t.

c. Som e states provid e for con d ition al release of in volun tarily h ospitalized clien ts; th is en ab les th e treatin g HCP to prescribe con tin - ued treatm en t on an outp atien t basis as oppo sed to disch argin g th e clien t to follow up on h is or h er own in itiative.

d . Con dition al release usually in volves outp a- tien t treatm en t for a specified period to deter- m in e th e clien t’s com plian ce with m edication protoco l, ability to m eet basic n eeds, an d abil- ity to rein tegrate in to th e com m un ity.

e. An in volun tary clien t wh o is released con d i- tion ally m ay be rein stitution alized wh ile th e com m itm en t is still in effect with out recom - m en cem en t of form al adm ission procedures.

3. Disch arge plan n in g an d follow-up care a . Disch arge (un con dition al release) is th e term i-

n ation of th e clien t-in stitution relation sh ip. b . Th is un co n dition al release m ay be ordered by

th e psych iatrist, co urt, or adm in istration for in volun tarily adm itted clien ts an d m ay be requested by volun tary clien ts at an y tim e.

c. In m ost states, th e clien t can in stitute a court h earin g to seek an exped ien t judicial dis- ch arge (writ of h abeas corpus).

d . Disch arge plan n in g an d follow-up care are im portan t for th e con tin ued well-bein g of th e clien t with a m en tal h ealth disorder.

e. Aftercare case m an agers are used to facilitate th e clien t’s adaptatio n back in to th e com m u- n ity an d to provide early referral if th e treat- m en t plan is un successful.

VIII. Types of Therapy for Care A. Milieu th erap y

1. Th e milieu refers to th e safe ph ysical an d social en viron m en t in wh ich an in dividual is receivin g treatm en t.

M

e

n

t

a

l

H

e

a

l

t

h

992 UNIT XIX Mental Health Disorders of the Adult Client

2. Safety is th e m ost im portan t priority in m an agin g th e m ilieu, an d all en coun ters with th e clien t h ave th e goal of bein g “th erapeutic.”

3. All m em bers of th e in terp rofession al h ealth care team con tribu te to th e plan n in g an d fun ctio n in g of th e m ilieu an d are sign ifican t an d valuable to th e clien t’s successful treatm en t outcom es; the team gen erally in cludes a registered n urse, social worker, exercise th erapist, recreation al th erapist, psych ologist, psych iatrist, occupational th erapist, an d clin ical n urse specialist or n urse practition er.

4. Com m un ity m eetin gs, activity grou ps, social skills grou ps, an d ph ysical exercise program s are in cluded to accom plish treatm en t go als.

5. O n e-to-on e relation sh ips are used to exam in e clien t beh aviors, feelin gs, an d in teraction s within th e con text of th e th erapeutic group activities.

The focus of milieu therapy is to empower the client through involvement in setting his or her own goals and to develop purposeful relationships with the staff to assist in meeting these goals.

B. In terperson al psych o th erap y 1. A treatm en t m odality th at uses a th erap eutic rela-

tion sh ip to m odify th e clien t’s feelin gs, attitudes, an d beh aviors an d work with in an agreed-up on tim e fram e to h elp m eet th e clien t’s go als

2. Th erapeutic com m un ication form s th e foun da- tion of th e th erap ist-clien t relation sh ip, an d th is relation sh ip is used as a way for th e clien t to exam in e oth er relation sh ips in h is or h er life.

3. Supportive level of psych oth erap y a . Brief th erapy or m ay exten d over a period of

years, allowin g th e clien t to express feelin gs, explore altern atives, an d m ake decision s in a safe, carin g en viron m en t

b . No plan exists to in trodu ce n ew m eth od s of copin g; in stead, th e th erapist rein fo rces th e clien t’s existin g coping mechanisms.

4. Re-ed ucative level of psych oth erap y a. Th e clien t explores altern atives in a plan n ed,

system atic way; th is requires a lon ger period of th erap y th an supp ortive th erap y.

b . Th e clien t agrees upon an d specifies desired ch an ges of beh avior an d learn in g n ew ways of perceivin g an d beh avin g.

c. Tech n iques m ay in clude sh ort-term psych o- therapy, reality th erapy, cogn itive restructurin g, beh avior m odification , an d developm en t of copin g skills.

5. Recon structive level of psych oth erap y a. Em otion al an d cogn itive restructurin g of self

takes place. b . Positive outcom es in clude a greater un der-

stan din g of self an d oth ers, m ore em o tion al freedom , an d th e developm en t of poten tial abilities.

C. Beh avior th erap y 1. A treatm en t ap proach th at uses th e prin ciples of

Skin n erian (op eran t con d ition in g) or Pavlovian (classical con dition in g) beh avior th eory to brin g ab out beh avioral ch an ge; th e belief is th at m ost beh aviors are learn ed.

2. Operant conditioning refers to th e m an ipulation of selected rein fo rcers to elicit an d stren gth en desired beh avioral respo n ses; th e reinforcer refers to th e con sequ en ce of th e beh avio r, wh ich is defin ed as an yth in g th at in creases th e occurren ce of a beh avior ( Fig. 68-2).

3. In classical con d ition in g (respon den t con ditio n - in g), th e in dividual respo n ds to a stim ulus but is basically a passive agen t (see Fig. 68-2).

4. Desen sitization is a form of beh avior th erap y wh ereby exp osure to in creasin g in crem en ts of a feared stim ulus is paired with in creasin g levels of relaxation , wh ich h elp s to reduce th e in ten sity of fear to a m ore tolerable level.

5. Aversion th erapy is a form of beh avior th erapy wh ereby n egative rein forcem en t is used to ch an ge beh avior; for exam ple, a stim ulus attractive to th e clien t is paired with an un pleasan t event in h opes of en dowin g th e stim ulus with n egative proper- ties, th ereby dissuadin g th e beh avior.

6. Mod elin g is beh avioral th erapy wh ereby th e th er- ap ist acts as a role m od el for specific id en tified beh aviors so th at th e clien t learn s th rough im itation .

D. Cogn itive th erapy 1. An active, directive, tim e-lim ited , structured

ap proach used to treat various disorders, in clud- in g an xiety an d depressive disorders

2. It is based on th e prin ciple th at h ow in dividuals feel an d beh ave is determ in ed by h ow th ey th in k ab out th e world an d th eir place in it; th eir cogn i- tio n s are based on th e attitudes or assum ption s developed fro m previous experien ces.

3. Th erapeutic tech n iques are design ed to iden tify, reality-test, an d correct distorted con ceptu aliza- tio n s an d th e dysfun ction al beliefs un derlyin g th ese cogn ition s.

4. Th e th erap ist h elps th e in dividual to ch an ge th e way h e or sh e th in ks, th ereby reducin g sym ptom s.

M

e

n

t

a

l

H

e

a

l

t

h

Pa s s ive a ge nt

Active a ge nt

Re inforce r

Re s ponde nt conditioning

Ope ra nt conditioning

Re s pons e

S timulus

FIGURE 68-2 Respondent versus operant conditioning.

993CHAPTER 68 Foundations of Psychiatric Mental Health Nursing

E. Group developm en t an d group th erap y 1. In volves a th erapist an d, id eally, 5 to 8 m em bers

workin g on th eir in dividual go als with in th e con - text of a group, wh ich presu m ably in creases th e oppo rtun ity for feedback an d support

2. In itial develo pm en t of th e group a . In vo lves superficial rath er th an open an d

tru stin g co m m un ication b . Mem bers beco m e acquain ted with each oth er

an d search for sim ilarities am on g th em selves. c. Mem bers m ay be un clear about th e purpo se

or go als of th e grou p. d . Gro up n orm s, roles, an d respo n sibilities are

establish ed. e. Th e work of term in ation begin s an d is

exp an ded upon th rough ou t th e duration of th e grou p.

3. Workin g in th e grou p a . Th e real work of th e grou p is acco m plish ed. b . Mem bers are fam iliar with on e an oth er, th e

grou p leader, an d th e grou p roles an d feel free to address an d attem p t to solve th eir problem s.

c. Both con flict an d co operation surface durin g th e grou p’s work as th e m em bers learn to work with on e an oth er.

4. Term in ation of th e group a . Begin s with th e in itial m eetin g b . Mem bers’ feelin gs are exp lored regardin g

th eir acco m plish m en ts an d th e im pen din g term in ation of th e group.

c. Th e term in ation stage provides an oppo rtu- n ity for m em bers to learn to deal m ore realis- tically an d com fo rtably with th is n orm al part of h um an experien ce.

5. Self-h elp or support grou ps ( Box 68-4)

Support groups are based on the premise that individuals who have experienced and are insightful concerning a problem are able to help others who have a similar problem.

F. Fam ily th erap y 1. Fam ily th erap y is a specific in terven tion m ode

based on th e prem ise th at th e m em ber with th e presen tin g sym pto m s sign als th e presen ce of problem s in th e en tire fam ily; th is prem ise also assum es th at a ch an ge in 1 m em ber will brin g about ch an ges in oth er m em bers.

2. Th e th erapist works to assist fam ily m em bers to iden tify an d express th eir th ough ts an d feelin gs; defin e fam ily roles an d rules; try n ew, m ore pro- ductive styles of relatin g; an d restore stren gth to th e fam ily.

CRITICAL THINKING What Should You Do? Answer: A coping mechanism involves any effort to decrease anxiety and can be constructive or destructive, task-oriented, or defense-oriented. The nurse should first help the client to iden- tify the source of anxiety. Next, the nurse should explore with the client various methods to reduce anxiety, such as relaxation methods. The client may use a defense mechanism to protect himself or herself from anxiety. A defense mechanism is a cop- ing mechanism used in an effort to protect the individual from feelings of anxiety; as anxiety increases and becomes over- whelming, the individual copes by using defense mechanisms to protect the ego and decrease anxiety. If this occurs, the nurse should facilitate appropriate and constructive use of the defense mechanism, and determine whether the defense mech- anism used by the client is effective for him or her or creates additional distress. The nurse should never criticize the client’s behavior or the use of defense mechanisms.

Reference: Stuart (2013), pp. 224–227.

P R A C T I C E Q U E S T I O N S 852. A clien t with a diagn osis of dep ression wh o h as

attem p ted suicide says to th e n urse, “I sh ould h ave died. I’ve always been a failure. No th in g ever go es righ t for m e.” Wh ich respo n se by th e n urse dem on - strates th erap eutic com m un ication ? 1. “You h ave everyth in g to live for.” 2. “Wh y do you see yo urself as a failure?” 3. “Feelin g like th is is all part of bein g depressed.” 4. “You’ve been feelin g like a failure for a wh ile?”

853. Th e n urse visits a clien t at h om e. Th e clien t states, “I h aven ’t slept at all th e last couple of n igh ts.” Wh ich respo n se by th e n urse dem on strates th era- peu tic com m un ication ? 1. “I see.” 2. “Really?”

M

e

n

t

a

l

H

e

a

l

t

h

BOX 68-4 Self-Help and Support Groups ▪ Adult Children of Alcoholics ▪ Al-Anon ▪ Alcoholics Anonymous ▪ Bereavement groups ▪ Cancer support groups ▪ Co-Dependents Anonymous ▪ Gamblers Anonymous ▪ Groups to help deal with caring for family members ▪ Groups to help deal with unexpected body image changes,

such as mastectomy or colostomy ▪ Mental illness support groups ▪ Narcotics Anonymous ▪ Overeaters Anonymous ▪ Parents without Partners ▪ Recovery groups, such as for those who have experienced

trauma ▪ Smoking cessation groups

994 UNIT XIX Mental Health Disorders of the Adult Client

3. “You’re h avin g difficu lty sleepin g?” 4. “Som etim es I h ave tro uble sleep in g too.”

854. A clien t experien cin g disturbed th ough t processes believes th at h is food is bein g poison ed. Wh ich com m un ication tech n iqu e sh ould th e n urse use to en courage th e clien t to eat? 1. Usin g open -en ded question s an d silen ce 2. Sh arin g perso n al preferen ce regardin g food

ch oices 3. Docum en tin g reason s wh y th e clien t does n ot

wan t to eat 4. O fferin g opin io n s about th e n ecessity of ad e-

quate n utrition

855. Th e n urse sh ould plan wh ich goals of th e term in a- tio n stage of group developm en t? Select all th at ap p ly.

1. Th e group evaluates th e experien ce. 2. Th e real work of th e group is accom plish ed. 3. Group in teraction in volves superficial

con versation . 4. Gro up m em bers beco m e acq uain ted with

on e an oth er. 5. Som e structurin g of grou p n orm s, roles, an d

respo n sibilities takes place. 6. Th e grou p explores m em bers’ feelin gs ab out

th e group an d th e im pen din g sep aration .

856. A clien t diagn osed with term in al can cer says to th e n urse, “I’m go in g to die, an d I wish m y fam ily would stop h opin g for a cure! I get so an gry wh en th ey carry on like th is. After all, I’m th e on e wh o’s dyin g.” Wh ich respo n se by th e n urse is th erap eutic? 1. “Have you sh ared your feelin gs with your fam ily?” 2. “I th in k we sh ould talk m ore about yo ur an ger

with your fam ily.” 3. “You’re feelin g an gry th at yo ur fam ily co n tin ues

to h op e for you to be cured?” 4. “You are probably very depressed, wh ich is

un d erstan dable with such a diagn osis.”

857. O n review of th e clien t’s record, th e n urse n otes th at th e adm ission was volun tary. Based on th is in form ation , th e n urse plan s care an ticip atin g wh ich clien t beh avior? 1. Fearfuln ess regardin g treatm en t m easu res 2. An ger an d aggressiven ess directed toward oth ers 3. An un d erstan din g of th e path olo gy an d sym p-

tom s of th e diagn osis 4. A willin gn ess to participate in th e plan n in g of

th e care an d treatm en t plan

858. A clien t adm itted volun tarily for treatm en t of an an xiety disorder dem an ds to be released fro m th e h ospital. Wh ich action sh ould th e n urse take in itially?

1. Con tact th e clien t’s h ealth care provider (HCP). 2. Call th e clien t’s fam ily to arran ge for

tran spo rtation . 3. Attem pt to persu ade th e clien t to stay “for on ly a

few m ore days.” 4. Tell th e clien t th at leavin g would likely result in

an in volun tary co m m itm en t.

859. Wh en reviewin g th e ad m ission assessm en t, th e n urse n otes th at a clien t was adm itted to th e m en tal h ealth un it in volun tarily. Based on th is type of ad m ission , th e n urse sh ould provide wh ich in ter- ven tio n for th is clien t? 1. Mon itor closely for h arm to self or oth ers. 2. Assist in com pletin g an application for

adm ission . 3. Supply th e clien t with written in form ation

about h is or h er m en tal illn ess. 4. Provide an opportun ity for th e fam ily to discuss

wh y th ey felt th e adm ission was n eeded.

860. Wh en a clien t is adm itted to an in patien t m en tal h ealth un it with th e diagn osis of an orexia n ervosa, a cogn itive beh avioral approach is used as part of th e treatm en t plan . Th e n urse plan s care based on wh ich purpo se of th is ap proach ? 1. Providin g a supp ortive en viron m en t 2. Exam in in g in trapsych ic con flicts an d past issues 3. Em ph asizin g social in teraction with clien ts wh o

with draw 4. Helpin g th e clien t to exam in e dysfun ction al

th o ugh ts an d beliefs

861. A clien t is preparin g to atten d a Gam blers An on y- m ou s m eetin g for th e first tim e. Th e n urse sh ould tell th e clien t th at wh ich is th e first step in th is 12-step program ? 1. Adm ittin g to h avin g a problem 2. Substitu tin g oth er activities for gam b lin g 3. Statin g th at th e gam blin g will be stopped 4. Discon tin uin g relation sh ips with people wh o

gam b le

862. Th e n urse em ployed in a m en tal h ealth clin ic is greeted by a n eigh bor in a local grocery store. Th e n eigh bor says to th e n urse, “H ow is Caro l doin g? Sh e is m y best frien d an d is seen at your clin ic every week.” Wh ich is th e m o st ap p ro p riate n ursin g respo n se? 1. “I can n ot discuss an y clien t situation with yo u.” 2. “If you wan t to kn ow about Caro l, you n eed to

ask h er yourself.” 3. “O n ly because you’re worried ab out a frien d , I’ll

tell you th at sh e is im provin g.” 4. “Bein g h er frien d , yo u kn ow sh e is h avin g a

difficu lt tim e an d deserves h er privacy.”

M

e

n

t

a

l

H

e

a

l

t

h

995CHAPTER 68 Foundations of Psychiatric Mental Health Nursing

863. Th e n urse calls security an d h as ph ysical restrain ts applied to a clien t wh o was ad m itted vo lun tarily wh en th e clien t beco m es verbally abusive, dem an din g to be disch arged fro m th e h ospital. Wh ich represen ts th e possible legal ram ification s for th e n urse associated with th ese in terven tion s? Select all th at ap p ly.

1. Libel 2. Battery 3. Assault 4. Slan der 5. False im prison m en t

864. Th e n urse in th e m en tal h ealth un it plan s to use wh ich th erap eutic co m m un ication tech n iqu es wh en com m un icatin g with a clien t? Select all th at ap p ly.

1. Restatin g 2. Listen in g 3. Askin g th e clien t “Wh y?” 4. Main tain in g n eutral respo n ses 5. Providin g ackn owledgm en t an d feedback 6. Givin g advice an d approval or disapproval

865. Wh at is th e m o st ap p ro p riate n ursin g action to h elp m an age a m an ic clien t wh o is m on op olizin g a grou p th erapy session ? 1. Ask th e clien t to leave th e grou p for th is

session on ly. 2. Refer th e clien t to an oth er group th at in cludes

oth er m an ic clien ts. 3. Tell th e clien t to stop m on opolizin g in a firm

but com passion ate m an n er. 4. Th an k th e clien t for th e in pu t, but in form th e

clien t th at oth ers n ow n eed a ch an ce to con tribute.

866. A clien t is participatin g in a th erap y group an d focuses on viewin g all team m em bers as equ ally im portan t in h elpin g th e clien ts to m eet th eir go als. Th e n urse is im plem en tin g wh ich th erap eutic approach ? 1. Milieu th erapy 2. In terperson al th erapy 3. Beh avior m od ification 4. Supp ort group th erap y

867. Th e n urse is workin g with a clien t wh o despite m akin g a h ero ic effort was un ab le to rescue a n eigh bor trapp ed in a h ouse fire. Wh ich clien t- focused action sh ould th e n urse en gage in durin g th e workin g ph ase of th e n urse-clien t relation sh ip? 1. Explorin g th e clien t’s ability to fun ctio n 2. Explorin g th e clien t’s poten tial for self-h arm 3. In quirin g about th e clien t’s perception or

ap praisal of wh y th e rescue was un successful 4. In quirin g about an d exam in in g th e clien t’s feel-

in gs for an y th at m ay block ad aptive copin g

868. Th e n urse provides an edu cation al session on cli- en t righ ts. Wh ich statem en t by a m em ber of th e session dem on strates th e b est un derstan din g of th e n urse’s role regardin g en surin g th at each cli- en t’s righ ts are respected? 1. “Auto n om y is th e fun dam en tal righ t of each an d

every clien t.” 2. “A clien t’s righ ts are gu aran teed by both state

an d federal laws.” 3. “Bein g respectful an d con cern ed will en sure th at

I’m atten tive to m y clien ts’ righ ts.” 4. “Regardless of th e clien t’s con d ition , all n urses

h ave th e duty to value clien t righ ts.”

A N S W E R S

852. 4 Ra tion a le: Respo n d in g to th e feelin gs expressed by a clien t is an effective th erap eutic com m un icatio n tech n iq u e. Th e correct o ptio n is an exam p le o f th e u se o f restatin g. Th e rem ain in g o ptio n s b lock co m m u n icatio n b ecau se th ey m in im ize th e cli- en t’s experien ce an d do n o t facilitate explo ratio n o f th e clien t’s exp ressed feelin gs. In ad dition , u se o f th e wo rd why is n o n th erap eutic. Test-Ta kin g St r a t egy: Use th erap eu tic co m m u n icatio n tech - n iq u es to d irect yo u to th e o ptio n th at directly add resses th e clien t’s feelin gs an d co n cern s. Also , th e co rrect op tio n is th e o n ly o n e stated in th e fo rm o f a qu estio n th at is op en -en ded , wh ich will en courage th e verbalizatio n of feelin gs. Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Com m un icatio n an d Docum en tation Con ten t Ar ea : Men tal Health

Pr ior it y Con cept s: Co m m u n ication ; Mo od an d Affect Refer en ce: Varcaro lis (2013), pp . 121–123.

853. 3 Ra tion a le: The correct option u ses th e th erapeutic com m un ica- tion tech n iq ue o f restatem ent. Alth ough restatem en t is a tech - n iq ue th at h as a p ro m ptin g com p on en t to it, it repeats th e clien t’s m ajo r th em e, which assists th e n urse to o btain a m ore specific perception o f th e problem from th e clien t. The rem ain - in g option s are n ot th erapeutic respo nses sin ce n on e en courages th e clien t to expan d o n th e p ro blem . O fferin g p erson al exp eri- en ces m oves th e fo cus away fro m the clien t an d on to th e n urse. Test-Ta kin g St r a t egy: Use th erap eu tic co m m u n icatio n tech - n iq u es. “I see” is a gen eral lead b u t d oes n ot provid e th e clien t with th e opportun ity to con tin ue th e discussion . “Really?” is a respon se th at m ay m ake th e clien t feel th at h e o r sh e is n o t b elieved . Provid in g person al experien ces fo cuses on th e n urse’s p ro blem an d th u s m in im izes th e clien t’s co n cern s. Th e co rrect o ptio n will provide in form ation abo u t th e p erception o f th e p ro blem fro m th e clien t’s persp ective.

M

e

n

t

a

l

H

e

a

l

t

h

996 UNIT XIX Mental Health Disorders of the Adult Client

Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Com m un icatio n ; Sleep Refer en ce: Varcarolis (2013), p p. 121–123.

854. 1 Ra t ion a le: O pen -en d ed question s an d silen ce are strategies used to en cou rage clien ts to d iscuss th eir p ro blem s. Sh arin g person al foo d p referen ces is n o t a clien t-cen tered in terven tion . Th e rem ain in g o p tion s are n o t h elp ful to th e clien t b ecau se th ey d o n o t en cou rage th e clien t to exp ress feelin gs. Th e n u rse sh ou ld n o t offer o p in io n s an d sh o uld en co urage th e clien t to iden tify th e reason s for th e beh avior. Test -Ta kin g Str a tegy: Use th erap eu tic co m m u n icatio n tech - n iq u es. First elim in ate op tion s th at do n o t su pp ort th e clien t’s expressio n o f feelin gs. An y op tio n th at is n o t clien t-cen tered sh ou ld be elim in ated n ext. Focusin g on th e clien t’s feelin gs will direct yo u to th e correct o ptio n . Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Com m un icatio n ; Psych o sis Refer en ce: Stuart (2013), pp . 17, 27.

855. 1, 6 Ra t ion a le: Th e stages of grou p develop m en t in clu d e th e in itial stage, th e workin g stage, an d th e term in atio n stage. Du rin g th e in itial stage, th e gro up m em bers b eco m e acq uain ted with on e an oth er, an d so m e stru ctu rin g of gro up n orm s, ro les, an d resp on sibilities takes p lace. Du rin g th e in itial stage, gro up in teractio n in volves sup erficial con versatio n . Du rin g th e work- in g stage, th e real wo rk o f th e gro up is accom p lish ed. Durin g th e term in ation stage, th e gro up evalu ates th e exp erien ce an d explores m em b ers’ feelin gs abo ut th e grou p an d th e im pen din g separation . Test -Ta kin g St r a t egy: Focus on th e su b ject, th e term in atio n stage. Read in g each item presen ted an d recallin g th e stages of grou p d evelo pm en t an d th e d efin itio n o f term in ation will assist yo u in an swerin g th is qu estio n . Review: Stages of gro u p d evelo p m en t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Collabo ratio n ; Co m m u n ication Refer en ce: Stuart (2013), pp . 624–625.

856. 3 Ra t ion a le: Restatin g is a th erapeutic co m m u n ication tech - n iq ue in wh ich th e n u rse repeats wh at th e clien t says to sh ow un d erstan din g an d to review wh at was said . Wh ile it is ap pro - priate for th e n urse to attem pt to assess th e clien t’s ab ility to discuss feelin gs o pen ly with fam ily m em b ers, it d oes n ot h elp th e clien t to d iscu ss th e feelin gs cau sin g th e an ger. Th e n u rse’s direct attem p t to exp ect th e clien t to talk m o re abo u t th e an ger

is p rem ature. Th e n u rse wou ld n ever m ake a ju d gm en t regard - in g th e reaso n fo r th e clien t’s feelin g; th is is n o n th erap eutic in th e on e-to-o n e relation sh ip . Test -Ta kin g Str a tegy: Use th erap eu tic co m m u n icatio n tech - n iq u es. Th e correct op tion is th e on ly on e th at id en tifies th e u se o f a th erap eutic tech n iq ue (restatem en t) an d fo cu ses o n th e clien t’s feelin gs. Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Com m un icatio n ; Fam ily Dyn am ics Refer en ce: Varcarolis (2013), p p. 122, 124.

857. 4 Ra t ion a le: In gen eral, clien ts seek vo lun tary ad m ission . If a cli- en t seeks volu n tary ad m issio n , th e m ost likely exp ectatio n is th at th e clien t will participate in th e treatm en t p ro gram sin ce h e or sh e is actively seekin g h elp . Th e rem ain in g o p tion s are n ot ch aracteristics of th is type of adm issio n . Fearfu ln ess, an ger, an d aggressiven ess are m o re ch aracteristic o f an in vo lun tary ad m issio n . Volun tary ad m issio n d o es n o t guaran tee th at a cli- en t u n d erstan ds h is or h er illn ess, on ly th e clien t’s desire fo r h elp. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject, vo lu n tary adm is- sion . Th is sh o u ld d irect yo u to th e co rrect o ptio n . No te th e rela- tion sh ip b etween th e wo rd voluntary an d th e correct o ptio n . Review: Vo lu n tary ad m issio n p ro cess Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Ad h eren ce; Caregivin g Refer en ce: Varcarolis (2013), p . 81.

858. 1 Ra t ion a le: In gen eral, clients seek volu n tary adm ission . Volun - tary clien ts h ave th e righ t to d em an d an d o btain release. Th e n urse n eeds to b e fam iliar with th e state an d facility policies an d pro cedu res. The in itial n ursin g action is to con tact th e HCP, who h as th e auth ority to d iscu ss disch arge with th e clien t. While arrangin g for safe tran sportation is appropriate, it is pre- m atu re in th is situation an d sh o uld be d on e o n ly with th e clien t’s p erm issio n . Wh ile it is appro priate to d iscu ss why th e clien t feels th e n eed to leave an d the p ossible outcom es of leavin g again st m edical advice, attem ptin g to get th e clien t to agree to stayin g “fo r on ly a few m ore days” h as little value an d will n ot likely b e successfu l. Man y states require th at th e clien t subm it a written release n otice to th e facility psych iatrist, wh o reevaluates th e cli- ent’s con ditio n for possib le con versio n to in vo lu n tary status if n ecessary, accordin g to criteria establish ed by law. While th is is a possib ility, it sh ould n ot b e u sed as a th reat with the clien t. Test -Ta kin g St r a t egy: No te th e strategic wo rd , initially. Notin g th e typ e o f h o spital adm ission will assist in directin g yo u to th e co rrect o ptio n wh ile elim in atin g th ose th at are u n likely to o ccu r. Callin g th e fam ily sh o uld b e elim in ated , b ased o n th e issues o f clien t righ ts an d co n fid en tiality. To “persu ade” a clien t to stay in th e h o sp ital is in ap prop riate. Th reaten in g th e clien t is in ap prop riate an d illegal.

M

e

n

t

a

l

H

e

a

l

t

h

997CHAPTER 68 Foundations of Psychiatric Mental Health Nursing

Review: Variou s typ es of h o sp ital ad m issio n an d d isch arge p ro cesses Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip/ Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Clin ical Ju dgm en t; Health Care Law Refer en ce: Varcaro lis (2013), pp . 81–82.

859. 1 Ra tion a le: In vo lu n tary ad m issio n is n ecessary wh en a p erson is a d an ger to self or o th ers or is in n eed o f psych iatric treatm en t regard less o f th e clien t’s willin gn ess to co n sen t to th e h o spital- izatio n . A written requ est is a com p on en t o f a volu n tary ad m is- sio n . Pro vid in g written in fo rm atio n regardin g th e illn ess is likely p rem ature in itially. Th e fam ily m ay h ave h ad n o ro le to p lay in th e clien t’s adm issio n . Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, in volu n tary ad m ission . Use Maslo w’s Hierarch y o f Need s th eo ry. Safety is th e p rio rity if a p h ysio lo gical n eed do es n o t exist. Th is sh ou ld d irect you to th e co rrect op tion . Also, n o te th at th e rem ain in g o ptio n s are n o t always true of an in vo lu n tary ad m issio n . Review: In vo lu n tary ad m issio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: In terperson al Violen ce; Safety Refer en ce: Varcaro lis (2013), pp . 81–82.

860. 4 Ra tion a le: Cogn itive b eh avio ral th erapy is u sed to h elp th e clien t identify and exam in e dysfun ction al th o ugh ts an d to iden - tify an d exam in e values an d beliefs th at m ain tain th ese th ough ts. Th e rem ain in g o ptio n s, wh ile th erapeutic in certain situation s, are n ot th e focus o f cogn itive b eh avioral th erapy. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e purpo se of a cognitive b eh avioral app ro ach . Note the relatio n ship o f th e word cognitive in the q uestio n and thoughts in th e correct option . Review: Co gn itive b eh avio ral th erap y Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Caregivin g; Co gn itio n Refer en ce: Varcaro lis (2013), p. 236.

861. 1 Ra tion a le: Th e first step in th e 12-step program is to adm it th at a problem exists. Substitu tin g o th er activities for gam blin g m ay b e a strategy b ut it is n ot th e first step. The rem ain in g optio ns are n ot realistic strategies for th e in itial step in a 12-step p ro gram . Test-Ta kin g St r a t egy: Focus o n th e su b ject, th e first step in th e 12-step program . Th is will assist in d irectin g yo u to th e correct o ptio n . Review: 12-step p ro gram Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health

Pr ior it y Con cept s: Ad dictio n ; Caregivin g Refer en ce: Stu art (2013), p . 467.

862. 1 Ra tion a le: Th e n u rse is req uired to m ain tain co n fid en tiality regardin g th e clien t an d th e clien t’s care. Co n fiden tiality is b asic to th e th erap eu tic relatio n sh ip an d is a clien t’s righ t. Th e m o st ap prop riate resp on se to th e n eigh b or is th e statem en t o f th at respo n sib ility in a direct, b ut po lite m an n er. A blu n t statem en t th at do es n o t ackn o wled ge wh y th e n u rse can n o t reveal clien t in form ation m ay b e taken as d isrespectful an d u n carin g. Th e rem ain in g o ption s id en tify statem en ts th at d o n o t m ain tain clien t co n fid en tiality. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Fo cu sin g on m ain tain in g co n fid en tiality will d irect yo u to th e correct o ptio n . Th is fo cus will also assist yo u in elim in atin g o ptio n s th at in app ro p riately give such in fo rm atio n with o u t b ein g u n n ecessarily b lu n t o r rud e. Review: Co n fid en tiality issu es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Com m un icatio n an d Docum en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Eth ics; Health Care Law Refer en ce: Varcaro lis (2013), p. 144.

863. 2, 3, 5 Ra tion a le: False im prison m en t is an act with th e in ten t to con - fin e a person to a specific area. Th e n u rse can be ch arged with false im priso n m en t if th e n urse proh ibits a clien t from leavin g th e h osp ital if th e clien t h as been ad m itted volun tarily an d if n o agen cy o r legal p olicies exist for detain in g th e clien t. Assault an d b attery are related to th e act o f restrain in g th e clien t in a situ ation th at d id n ot m eet criteria fo r su ch an in terven tio n . Lib el an d slan der are n o t ap p licab le h ere sin ce th e n u rse d id n o t write o r verb ally m ake u n true statem en ts ab ou t th e clien t. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, legal ram ificatio n s o f n u rsin g actio n s related to h osp ital ad m issio n . No tin g th e wo rds admitted voluntarily will assist you in selectin g th e o ptio n s related to in app rop riately p reven tin g th e clien t from leavin g th e h o spital, a righ t to wh ich a volu n tarily co m m itted clien t is en titled . Th e rem ain in g op tio n s do n o t relate to acts th at p reven t th e clien t fro m leavin g th e h o spital. Review: Clien t righ ts related to h osp ital adm issio n Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Health Care Law; Safety Refer en ce: Varcaro lis (2013), pp . 87–88.

864. 1, 2, 4, 5 Ra tion a le: Th erapeu tic co m m u n icatio n tech n iq u es in clud e lis- ten in g, m ain tain in g silen ce, m ain tain in g n eutral resp on ses, u sin g broad o pen in gs an d op en -en ded qu estio n s, fo cu sin g an d refo cusin g, restatin g, clarifyin g an d valid atin g, sh arin g p er- ceptio n s, reflectin g, p ro vid in g ackn owled gm en t an d feedb ack, givin g in fo rm atio n , p resen tin g reality, en cou ragin g fo rm u la- tio n o f a p lan o f action , p ro vidin g n on verb al en co uragem en t, an d su m m arizin g. Askin g “Wh y” is often in terpreted as bein g

M

e

n

t

a

l

H

e

a

l

t

h

998 UNIT XIX Mental Health Disorders of the Adult Client

accusato ry b y th e clien t an d sh ou ld also b e avoid ed . Pro vidin g ad vice or givin g ap proval o r disap p ro val are barriers to co m m u n ication . Test -Ta kin g Str a tegy: Use th erap eu tic co m m u n icatio n tech - n iq u es. Th is will assist yo u in b o th selectin g th e co rrect an swers an d elim in atin g th e exam p les o f n on th erap eu tic co m m u n ication . Review: Th erap eu tic an d n o n th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Caregivin g; Com m un icatio n Refer en ce: Varcarolis (2013), p p. 121–123.

865. 4 Ra t ion a le: If a clien t is m o no po lizin g th e group, th e n urse m ust be d irect an d d ecisive. Th e best action is to th an k the clien t an d suggest that th e clien t sto p talkin g an d try listen in g to o th ers. Alth o ugh tellin g th e clien t to sto p m on op olizin g in a firm b ut com passion ate m an ner m ay b e a direct resp on se, th e correct option is m ore specific an d p ro vid es d irection for the clien t. The rem ain in g optio n s are in appropriate sin ce th ey are n ot directed toward h elpin g th e clien t in a therapeutic m an n er. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Use th erap eu tic co m m u n icatio n tech n iq u es to assist in directin g yo u to th e co rrect o p tion . Note th at th e co rrect o ptio n is sp ecific an d provid es d irectio n fo r th e clien t. Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Com m un icatio n ; Moo d an d Affect Refer en ce: Varcarolis (2013), p p. 40, 121–123.

866. 1 Ra t ion a le: All treatm en t team m em b ers are viewed as significant an d valu able to th e clien t’s successful treatm en t o utcom es in m ilieu th erapy. Interp erson al th erapy is b ased o n a on e-to-o ne or group therapy app roach in wh ich the th erapist-clien t relatio n- ship is o ften used as a way for th e clien t to exam in e other relatio n- ships in h is or h er life. Beh avior m o dification is based on reward s an d p un ishm en t. Support groups are b ased on th e prem ise th at in divid uals who h ave experien ced an d are in sightfu l con cern in g a problem are able to h elp oth ers who h ave a sim ilar problem . Test -Ta kin g St r a t egy: Focus o n th e su b ject, ch aracteristics of a typ e of th erapy. No te th e relatio n sh ip b etween th e words helping the clients to meet their goals an d th e correct o ptio n .

Review: Typ es o f th erap y Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Care Coo rd in ation ; Caregivin g Refer en ce: Varcarolis (2013), p . 41.

867. 4 Ra t ion a le: Th e clien t m ust first d eal with feelin gs an d n egative resp on ses b efore th e clien t can wo rk th ro ugh th e m ean in g o f th e crisis. Th e co rrect o p tion pertain s d irectly to th e clien t’s feelin gs an d is clien t-focu sed. Th e rem ain in g o ptio n s do n ot d irectly fo cu s on or add ress th e clien t’s feelin gs. Test -Ta kin g Str a tegy: Focu s on th e su b ject, th e wo rkin g p h ase o f th e n u rse-clien t relatio n sh ip . Also , n o te th e wo rd s client- focused action. Th in k abo ut th e in terven tio n s th at o ccu r in th is p h ase. Select th e op tio n th at focuses on th e feelin gs o f th e clien t. Review: Ph ases o f th e n u rse-clien t relatio n sh ip Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess: Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Com m un icatio n ; Co pin g Refer en ce: Stuart (2013), pp . 19, 21.

868. 3 Ra t ion a le: Th e n u rse n eed s to respect an d h ave co n cern fo r th e clien t; th is is vital to protectin g th e clien t’s righ ts. Wh ile it is true th at au ton om y is a basic clien t righ t, th ere are o th er righ ts th at m u st also b e bo th resp ected an d facilitated . State an d fed- eral laws d o p rotect a clien t’s righ ts, bu t it is sen sitivity to th o se righ ts th at will en su re th at th e n u rse secures th ese righ ts fo r th e clien t. It is a fact th at safegu ardin g a clien t’s righ ts is a n u rsin g resp on sibility, b ut statin g th at fact d o es n o t sh o w un derstan d - in g or resp ect for th e co n cept. Test -Ta kin g St r a t egy: Note the strategic word, best. Focus on th e broad issue o f clien t rights an d h ow th e n urse will respect an d pre- serve th ese rights. Th is is th e u m b rella o ptio n . Also n o te th e word respected in th e qu estion and respectful in th e correct o ption . Review: Th e n u rse’s role with regard to clien t righ ts Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Lead ersh ip/ Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Caregivin g; Eth ics Refer en ce: Stuart (2013), pp . 32, 38.

M

e

n

t

a

l

H

e

a

l

t

h

999CHAPTER 68 Foundations of Psychiatric Mental Health Nursing

M

e

n

t

a

l

H

e

a

l

t

h

C H A P T E R 69 Mental Health Disorders

PRIORITY CONCEPTS Mood and Affect; Safety

CRITICAL THINKING What Should You Do? A client is experiencing visual hallucinations. What should the nurse do? Answer located on p. 1014.

I. Anxiety A. Descrip tion

1. A n orm al respon se to stress 2. A subjective experien ce th at in cludes feelin gs of

appreh en sion , un easin ess, un certain ty, or dread 3. O ccurs as a result of a th reat th at m ay be m isper-

ceived or m isin terpreted or a th reat to iden tity or self-esteem

4. An xiety m ay result wh en values are th reaten ed, or precedin g n ew experien ces.

B. Types of an xiety 1. Norm al: A h ealth y type of an xiety 2. Acute: Precipitated by im m in en t lo ss or ch an ge

th at th reaten s on e’s sen se of security 3. Ch ron ic: An xiety th at persists as a ch aracteristic

respon se to daily activities C. Levels of an xiety

1. Mild a. Mild an xiety is associated with ten se experi-

en ces th at occur in everyday life. b . Th e in dividual is alert. c. Th e perceptual field is in creased. d . Mild an xiety can be m otivatin g, produce

growth , en h an ce creativity, an d in crease learn in g.

2. Moderate a. Th e focus is on im m ediate con cern s. b . Mod erate an xiety n arrows th e percep tual

field. c. Selective in atten tiven ess occurs. d . Learn in g an d problem solvin g still occur.

3. Severe a. Severe an xiety is a feelin g th at som eth in g

bad is about to h app en .

b . A sign ifican t n arrowin g in th e perceptual field occurs.

c. Focus is on m in ute or scattered details. d . All beh avior is aim ed at relievin g the an xiety. e. Learn in g an d problem solvin g are n ot

possib le. f. Th e in dividual n eeds direction to focus.

4. Pan ic a . Pan ic is associated with dread an d terror an d

a sen se of im pen din g doom . b . Th e perso n ality is disorgan ized. c. Th e in dividual is un ab le to com m un icate or

fun ction effectively. d . In creased m oto r activity occurs. e. Loss of ration al th ough ts with distorted

percep tion occurs. f. In ability to con cen trate occurs. g. If prolon ged, pan ic can lead to exh austion

an d death . D. In terven tion s: Gen eral n ursin g m easu res (see-

Priority Nursin g Action s) 1. Recogn ize th e an xiety. 2. Establish trust. 3. Protect th e clien t. 4. Modify th e en viron m en t by settin g lim its or

lim itin g in teraction with oth ers. 5. Do n ot criticize coping mechanisms. 6. Provid e creative outlets. 7. Mon itor for sign s of im pen din g destructive

beh avior. 8. Prom o te relaxatio n tech n iqu es, such as breath -

in g exercises or guided im agery. 9. Mon itor vital sign s, an d adm in ister an tian xiety

m edication s as prescribed . 10. Do n ot force th e clien t in to situation s th at pro-

voke an xiety.

The immediate nursing action for a client with anx- iety is to decrease stimuli in the environment and pro- vide a calm and quiet environment.

E. In terven tion s: Mild to m od erate levels 1. Help th e clien t to iden tify th e an xiety.1000

M

e

n

t

a

l

H

e

a

l

t

h

2. En cou rage th e clien t to talk about feelin gs an d con cern s.

3. Help th e clien t to iden tify th ough ts an d feelin gs th at occurred before th e on set of an xiety.

4. En cou rage problem solvin g. 5. En cou rage gross m oto r exercise.

F. In terven tion s: Severe to pan ic levels 1. Redu ce th e an xiety quickly. 2. Use a calm m an n er. 3. Always rem ain with th e clien t. 4. Min im ize en viron m en tal stim uli. 5. Provid e clear, sim ple statem en ts. 6. Use a low-pitch ed voice. 7. Atten d to th e ph ysical n eeds of th e clien t. 8. Provid e gross m oto r activity. 9. Adm in ister an tian xiety m edication s as pre-

scrib ed.

II. Generalized Anxiety Disorder A. Description

1. Gen eralized an xiety disorder is an un realistic an xiety about everyday worries th at persists over tim e an d is n ot associated with an oth er psych i- atric or m ed ical disorder.

2. Ph ysical sym pto m s occur.

B. Assessm en t 1. Restlessn ess an d in ability to relax 2. Episodes of trem b lin g an d sh akin ess 3. Ch ron ic m uscular ten sion 4. Dizzin ess 5. In ab ility to con cen trate 6. Ch ron ic fatigue an d sleep problem s 7. In ab ility to recogn ize th e con n ection between

th e an xiety an d ph ysical sym pto m s 8. Clien t is focused on th e ph ysical discom fort.

C. Un exp ected an d exp ected pan ic attacks 1. Description

a. Produces a sudd en on set of feelin gs of in ten se appreh en sion an d dread.

b . Cau se usually can n ot be id en tified. c. Severe, recurren t, in term itten t an xiety attacks

lastin g 5 to 30 m in utes occur. 2. Assessm en t

a. Ch o kin g sen sation b . Labored breath in g c. Poun din g h eart d . Ch est pain e. Dizzin ess f. Nausea g. Blurred vision h . Nu m bn ess or tin glin g of th e extrem ities i. Sen se of un reality an d h elplessn ess j. Fear of bein g trapped

k . Fear of dyin g 3. In terven tion s

a. Rem ain with th e clien t. b . Atten d to ph ysical sym ptom s. c. Assist th e clien t to iden tify th e th o ugh ts th at

arou sed th e an xiety an d iden tify th e basis for th ese th ough ts.

d . Assist th e clien t to ch an ge th e un realistic th o ugh ts to m ore realistic th ough ts.

e. Use cogn itive restructurin g to replace dis- torted th in kin g.

f. Adm in ister an tian xiety m edication s if pre- scrib ed.

III. Posttraumatic Stress Disorder A. Description : After exp erien cin g a psych o logically

traum atic even t, th e in dividual is pron e to reexperi- en ce th e even t an d h ave recurren t an d in trusive dream s or flash backs.

B. Stresso rs 1. Natural disaster 2. Terrorist attack 3. Com b at experien ces 4. Acciden ts 5. Rap e 6. Crim e or violen ce 7. Sexual, ph ysical, an d em otion al abuse 8. Reexperien cin g th e even t as flash backs

PRIORITY NURSING ACTIONS Anxiety in a Client

1. Provide a calm environment, decrease environmental stimuli, and stay with the client.

2. Ask the client to identify what and how he or she feels. 3. Encourage the client to describe and discuss his or her

feelings. 4. Help the client to identify the causes of the feelings if he or

she is having difficulty doing so. 5. Listen to the client for expressions of helplessness and

hopelessness. 6. Document the event, significant information, actions

taken and follow-up actions, and the client’s response.

If a client experiences anxiety, immediate actions are to pro- vide a calm environment, decrease environmental stimuli, and stay with the client. Excess stimulation would escalate the anxiety. Next, asking the client to identify what and how he or she feels and helping the client to identifythe causes of the feel- ings increase the client’s awareness of the connection between behaviors and feelings. This awareness helps to decrease the anxiety. While listening to the client, the nurse observes for expressions of helplessness and hopelessness that could indi- cate self-harm intentions. The nurse provides follow-up care as needed, based on observations and assessments. Finally, the nurse documents the event, significant information, actions taken and follow-up actions, and the client’s response.

Reference Varcarolis (20 13), p. 169.

1001CHAPTER 69 Mental Health Disorders

C. Assessm en t 1. Em otion al n um bn ess 2. Detach m en t 3. Depression 4. An xiety 5. Sleep disturban ces an d n igh tm ares 6. Flash backs of even t 7. Hypervigilan ce 8. Guilt about survivin g th e even t 9. Poor con cen tration an d avoidan ce of activities

th at trigger th e m em ory of th e even t D. In terven tion s ( Box 69-1)

Clients dealing with cancer may develop posttrau- matic stress (PTS). Cancer-related PTS can occur any- time during or after treatment. The symptoms of PTS are similar to those of posttraumatic stress disorder but are generally not as severe.

IV. Specific Phobia A. Description

1. Irration al fear of an object or situation th at persists

2. Asso ciated with pan ic-level an xiety if th e object, situation , or activity can n ot be avoided

3. Defense mechanisms com m on ly used in clude repression an d displacem en t.

B. Types (Box 69-2) C. In terven tion s

1. Iden tify th e basis of th e an xiety. 2. Allow th e clien t to verbalize feelin gs about th e

an xiety-produ cin g object or situation ; talkin g frequen tly about th e feared object is th e first step in th e desen sitizatio n process.

3. Teach relaxatio n tech n iques, such as breath in g exercises, m uscle relaxation exercises, an d visu- alization of pleasan t situation s.

4. Prom o te desen sitizatio n by gradually in trodu c- in g th e in dividual to th e feared object or situa- tion in sm all doses.

Always stay with the client who is experiencing anx- iety to promote safety and security. Never force the client to have contact with the phobic object or situation.

V. Obsessive-Compulsive and Related Disorders A. O bsession s: Preoccu pation with persisten tly in tru-

sive th ough ts an d ideas B. Com p ulsion s

1. Th e perform an ce of rituals or repetitive beh av- iors design ed to preven t som e even t, divert un acceptable th ough ts, an d decrease an xiety.

2. O bsession s an d com pulsion s often occur togeth er an d can disrupt n orm al daily activities.

3. An xiety occurs wh en on e resists obsession s or com pu lsion s an d from bein g powerless to resist th e th ough ts or rituals.

4. O bsessive th o ugh ts can in volve issues of vio- len ce, aggression , sexual beh avior, orderlin ess, or religion an d un con tro llably can in terrup t con scious th ough ts an d th e ability to fun ction .

C. Related disorders 1. Hoard in g disorder 2. Excoriation (skin -pickin g) disorder 3. Substan ce or m edication -in du ced obsessive-

com pu lsive an d related disorder 4. O bsessive-com pulsive an d related disorder due

to an oth er m edical con d ition 5. Trich o tillom an ia (h air-pu llin g disorder)

D. Com pulsive beh avior pattern s (beh aviors or rituals) 1. Com p ulsive beh avior pattern s decrease th e

an xiety. 2. Th e pattern s are associated with th e obsessive

th ough ts. 3. Th e pattern s n eutralize th e th o ugh t. 4. Durin g stressful tim es, th e ritualistic beh avio r

in creases.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 69-1 Interventions for Posttraumatic Stress Disorder

Be nonjudgmental and supportive. Assure the client that his or her feelings and behaviors are nor-

mal reactions. Assist the client to recognize the association between his or

her feelings and behaviors and the trauma experience. Encourage the client to express his or her feelings; provide

individual therapy that addresses loss of control or anger issues.

Assist the client to develop adaptive coping mechanisms and to use relaxation techniques.

Encourage use of support groups. Facilitate a progressive review of the trauma experience. Encourage the client to establish and reestablish relationships. Inform the client that hypnotherapy or systematic desensitiza-

tion may be recommended as a form of treatment.

BOX 69-2 Some Types of Phobias Acrophobia : Fear of heights Agora phobia : Fear of open spaces Astra phobia : Fear of electrical storms Cla ustrophobia : Fear of closed spaces Hema tophobia : Fear of blood Hydrophobia : Fear of water Monophobia : Fear of being alone Mysophobia : Fear of dirt or germs Nyct ophobia : Fear of darkness Pyrophobia : Fear of fires Socia l Phobia : Fear of situations in which one might be embar-

rassed or criticized; fear of making a fool of oneself Xenophobia : Fear of strangers Zoophobia : Fear of animals

1002 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

5. Defen se m ech an ism s in clude repression , dis- placem en t, an d un doin g.

E. In terven tion s ( Box 69-3)

VI. Somatic Symptom and Related Disorders A. Description

1. Som atic sym ptom disorders are ch aracterized by persisten t worry or com plain ts regardin g ph ysi- cal illn ess with ou t supp ortive ph ysical fin din gs.

2. Th e clien t focuses on th e ph ysical sign s an d sym ptom s an d is un able to con trol th e sign s an d sym pto m s.

3. Th e ph ysical sign s an d sym pto m s in crease with psych osocial stressors.

4. Th e an xiety is redirected in to a som atic con cern . 5. Th e clien t m ay un con sciously som atize for sec-

on d ary gain s, such as in creased atten tion an d decreased respon sibilities.

B. Con version disorder (fu n ction al n eurological sym pto m disorder) 1. Description

a. Th e sudden on set of a ph ysical sym pto m or a deficit suggestin g loss of or altered body fun ction related to psych ological con flict or a n eurological disorder

b . Con version disorder is an expressio n of a psych ological con flict or n eed.

c. Th e m ost com m on con version sym pto m s are blin dn ess, deafn ess, paralysis, an d th e in ability to talk.

d . Con version disorder h as n o organ ic cau se. e. Sym ptom s are beyond the con scious control

of th e clien t an d are directly related to conflict. f. Th e developm en t of ph ysical sym pto m s

reduces an xiety.

2. Assessm en t a . Ru le out a ph ysiolo gical cause for sym p-

tom s or deficits. b . “La belle indifference”: Un con cern ed with

sym ptom s c. Ph ysical lim itation or disability d . Feelin gs of guilt, an xiety, or frustration e. Low self-esteem an d feelin gs of in adequacy f. Un expressed an ger or con flict g. Secon dary gain

C. In terven tion s 1. O btain a n ursin g h isto ry an d assess for ph ysi-

cal problem s. 2. Explore th e n eeds bein g m et by th e ph ysical

sym ptom s with th e clien t. 3. Assist th e clien t to iden tify altern ative ways of

m eetin g n eeds. 4. Assist th e clien t to relate feelin gs an d con flicts

to th e ph ysical sym ptom s. 5. Con vey un derstan din g th at th e ph ysical sym p-

tom s are real to th e clien t. 6. Assu re th e clien t th at ph ysical illn ess h as been

ru led out. 7. Repo rt an d assess an y n ew ph ysical com plain t. 8. Use a pain assessm en t scale if th e clien t com -

plain s of pain , an d im plem en t pain reduction m easu res as required .

9. Explore th e source of an xiety an d stim ulate verbalizatio n of an xiety.

10. Assist th e clien t in recogn izin g h is or h er own feelin gs an d em o tion s.

11. En cou rage th e use of relaxation tech n iqu es as th e an xiety in creases.

12. En cou rage diversion al activities. 13. Provide positive feedback. 14. Adm in ister an tian xiety m edication s if pre-

scrib ed.

For a client with a somatic symptom disorder, allow a specific time period for the client to discuss physical complaints because the client will feel less threatened if this behavior is limited rather than stopped completely. Avoid responding with positive reinforce- ment about the physical complaints.

VII. Dissociative Disorder A. Description

1. Disso ciative disorder is a disruption in in tegra- tive fun ction s of m em ory, con scio usn ess, or iden tity.

2. It is associated with exposu re to an extrem ely traum atic even t.

B. Dissociative id en tity disorder (DID) , form erly called multiple personality disorder 1. Description

a. Two or m ore fully developed , distin ct, an d un iq ue perso n alities exist with in th e clien t.

BOX 69-3 Interventions for Obsessive- Compulsive and Related Disorders

Ensure that basic needs (food, rest, hygiene) are met. Identify situations that precipitate compulsive behavior;

encourage the client to verbalize concerns and feelings. Be empathetic toward the client and aware of his or her need

to perform the compulsive behavior. Do not interrupt compulsive behaviors unless they jeopardize

the safety of the client or others (provide for client safety related to the behavior).

Allow time for the client to perform the compulsive behavior, but set limits on behaviors that may interfere with the cli- ent’s physical well-being to protect the client from physical harm.

Implement a schedule for the client that distracts from the behaviors (structure simple activities, games, or tasks for the client).

Establish a written contract that assists the client to decrease the frequency of compulsive behaviors gradually.

Recognize and reinforce positive nonritualistic behaviors.

1003CHAPTER 69 Mental Health Disorders

b . Th e h ost is th e prim ary person ality, an d th e oth er person alities are referred to as alters.

c. Alter perso n alities m ay take full con trol of th e clien t, 1 at a tim e, an d m ay or m ay n ot be aware of on e an oth er.

d . Th e alters m ay be aware of th e h ost, but th e h ost is n ot usually aware of th e alters.

2. Assessm en t a . Th e clien t m ay h ave an in ability to recall

im portan t in form ation (un related to ordi- n ary forgetfuln ess).

b . Tran sition from 1 perso n ality to th e oth er is related to stress or a traum atic even t an d is sudd en .

c. Disso ciation is used as a m eth od of distan c- in g an d defen d in g on e’s self fro m an xiety an d traum atizin g experien ces.

C. Disso ciative am n esia 1. Description

a . In ability to recall im portan t person al in for- m ation because it provokes an xiety

b . Mem ory im pairm en t m ay ran ge from par- tial to alm ost com plete.

c. Th e clien t m ay assum e a n ew id en tity in a n ew en viron m en t, drift fro m place to place, develop few relation sh ips, an d th en return h om e un ab le to rem em ber th e am n esia.

2. Assessm en t a . Localized: Th e clien t blocks out all m em o-

ries ab out a specified period. b . Selective: Th e clien t recalls som e but n ot all

m em ories about a specified period. c. Gen eralized: Th e clien t h as a loss of all

m em ory ab out past life. D. Deperso n alization / derealization disorder

1. Description : An altered self-perception in wh ich on e’s own reality is tem porarily lost or ch an ged

2. Assessm en t a . Feelin gs of detach m en t b . In tact reality testin g

E. In terven tion s 1. O rien t th e clien t. 2. Develop a trustin g relation sh ip with th e clien t. 3. En cou rage verbal expressio n of pain ful experi-

en ces, an xieties, an d con cern s. 4. Explore m eth od s of copin g. 5. Iden tify sources of con flict. 6. Focus on th e clien t’s stren gth s an d skills. 7. Provide n on dem an d in g, sim ple ro utin es. 8. Allow th e clien t to progress at h is or h er

own pace. 9. Im p lem en t stress reduction tech n iqu es.

10. Plan for in dividual, group, or fam ily psych o- th erapy to in tegrate dissociated aspects of perso n ality or m em ory an d to exp an d self- awaren ess.

VIII. Mood Disorders A. Bipolar an d related disorders

1. Description ( Box 69-4) a . Bipo lar disorder is ch aracterized by epi-

sodes of m an ia an d depression with periods of n orm al m oo d an d activity in between .

b . Th e m edication of ch oice h as tradition ally been lith ium carbon ate, wh ich can be toxic an d requires regular m on itorin g of serum lith ium levels to h elp keep th e m edication ’s th erapeutic in dex level appropriate; a stable in take of adequ ate dietary sodium an d fluid (2 to 3 L daily) m ust be m ain tain ed to avoid toxicity.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 69-4 Assessment of Bipolar and Related Disorders

Mania ▪ Becomes angry quickly ▪ Delusional self-confidence ▪ Constantly pushing limits, manipulating, and finding fault ▪ Euphoric with intense feelings of well-being ▪ Demonstrates little or no inhibition ▪ Distracted by environmental stimuli ▪ Extroverted personality ▪ Flight of ideas ▪ Grandiose and persecutory delusions ▪ High and unstable affect ▪ Significant decrease in appetite ▪ Inability to eat or sleep because of involvement in more

important things ▪ Unlimited energy ▪ Inappropriate affect ▪ Dress that is inappropriately bizarre, loud, and/ or colorful ▪ Makeup is colorful and overdone ▪ Initiation of activity ▪ Pressured and/ or clanging speech ▪ Restlessness ▪ Sexually promiscuous ▪ Urgent motor activity Depression ▪ Increased or decreased appetite ▪ Decrease in activities of daily living ▪ Decreased emotion and physical activity ▪ Easily fatigued ▪ Inability to make decisions ▪ Poor concentration ▪ Internalizing hostility ▪ Introverted personality ▪ Social isolation and withdrawn from groups ▪ Lack of energy ▪ Lack of initiative ▪ Lack of self-confidence and low self-esteem ▪ Lack of sexual interest ▪ Psychomotor retardation ▪ Suicidal thinking

1004 UNIT XIX Mental Health Disorders of the Adult Client

c. O th er m ed ication s m ay be prescribed both to reduce th e sym ptom s of acu te bipolar m an ic episo des an d for m ain ten an ce th erapy.

d . An tian xiety agen ts m ay be prescribed to assist in m an agin g th e psych o m otor agita- tion ch aracteristic of m an ia; th ese m edica- tion s sh ould be avoided in clien ts with a h istory of substan ce ab use.

e. Atypical an tipsych otic m edication s m ay be prescribed for both th eir sedative an d m ood-stabilizin g effects.

2. In terven tion s for m an ia (Box 69-5) a. Rem ove h azardo us objects from th e en vi-

ron m en t (th is sh ould be don e for all clien ts).

b . Assess th e clien t clo sely for fatigue.

c. Provide frequen t rest periods an d m on itor th e clien t’s sleep pattern s; use com fo rt m ea- sures to prom ote sleep.

d . Provide a private ro om if possible. e. En cou rage th e clien t to ven tilate feelin gs. f. Use calm , slow in teraction s. g. Help th e clien t to focus on 1 topic durin g

th e con versation . h . Ign o re or distract th e clien t from gran diose

th in kin g; presen t reality to th e clien t. i. Do n ot argue with th e clien t. j. Lim it group activities an d assess th e clien t’s

toleran ce level; solitary activities m ay be n ecessary.

k . Provide h igh -calorie fin ger foods an d fluids. l. Supervise th e clien t’s ch oice of cloth in g.

m . Redu ce en viron m en tal stim uli. n . Set lim its on in approp riate beh aviors. o . Provide ph ysical activities an d outlets for

ten sion . p . Avo id com petitive gam es. q . Provide gross m oto r activities such as

walkin g. r . Provide structured activities or on e-to-on e

activities with th e n urse. s. Provide sim ple an d direct exp lan atio n s for

ro utin e proced ures. t . Supervise the adm in istration of m edication .

3. Depression : See Section IX.

IX. Depressive Disorders A. Description

1. Depression affects feelin gs, th o ugh ts, an d beh a- viors.

2. It can occur after a loss, in cludin g loss of self- esteem , th e en d of a sign ifican t relation sh ip, th e death of a loved on e, or a traum atic even t.

3. Th e loss is followed by grief an d m ou rn in g; if th is process does n ot resolve, depression results.

4. Depression m ay be m ild , m od erate, or severe. 5. Treatm en t in cludes coun selin g, an tidepressant

m edication, an d electroconvulsive therapy (ECT). 6. See Box 69-4 for gen eral assessm en t fin din gs.

B. Mild dep ression 1. Mild dep ression is triggered by an extern al

even t an d follows th e n orm al grief reactio n . 2. Mild depression lasts less th an 2 weeks. 3. Feelin g sad 4. Feelin g let down or disappoin ted 5. Mild alteration s in sleep pattern s 6. Feelin g less alert 7. Irritability 8. Disin terested in spen din g tim e with oth ers 9. In creased or decreased appetite

10. In creased use of substan ces such as alcoh ol or drugs

M

e

n

t

a

l

H

e

a

l

t

h

BOX 69-5 Dealing with Inappropriate Behaviors Associated with Bipolar Disorder

Aggressive Behavior Assist the client in identifying feelings of frustration and

aggression. Encourage the client to talk out instead of acting out feelings

of frustration. Assist the client in identifying precipitating events or situa-

tions that lead to aggressive behavior. Describe the consequences of the behavior for self and others. Assist the client in identifying previous coping mechanisms. Assist the client in problem-solving techniques to cope with

frustration or aggression.

Deescalation Techniques Maintain safety for the client, other clients, and self. Maintain a large personal space and use a nonaggressive

posture. Use a calm approach and communicate with a calm, clear

tone of voice (be assertive, not aggressive). Determine what the client considers to be his or her need. Avoid verbal struggles. Provide the client with clear options that deal with the client’s

behavior. Assist the client with problem solving and decision making

regarding options.

Manipulative Behavior Set clear, consistent, realistic, and enforceable limits, and

communicate expected behaviors. Be clear about consequences associated with exceeding set

limits and follow through with consequences in a nonpu- nitive manner, if necessary.

Discuss the client’s behavior in a nonjudgmental and non- threatening manner.

Avoid power struggles with the client (avoid arguing with the client).

Assist the client in developing means of setting limits on own behavior.

1005CHAPTER 69 Mental Health Disorders

C. Mod erate depression 1. Mod erate depression persists over tim e. 2. Th e person exp erien ces a sen se of ch an ge an d

often seeks h elp. 3. Despon den t an d gloo m y 4. Dejected 5. Low self-esteem 6. Helplessn ess an d powerlessn ess 7. May experien ce in ten se an xiety an d an ger 8. Diurn al variation : Th e perso n m ay feel better

at a certain tim e of th e day. 9. Slo w th ough t processes an d difficu lty in

con cen tratin g 10. Rum in ation : Persisten t th in kin g about an d

discussion of a particular subject 11. Negative th in kin g an d suicidal th ough ts (see

Ch apter 71) 12. Sleep disturban ces 13. Social with drawal 14. An o rexia, weigh t loss, an d fatigue 15. Som atic com plain ts 16. Men strual ch an ges 17. In creased use of substan ces such as alcoh ol

or drugs D. Majo r depressive disorder

1. In ten se an d pervasive 2. Despair an d h opelessn ess 3. Guilt an d worth lessn ess 4. Flat affect 5. May sh ow agitation an d pace about

6. Poor posture an d un kem pt appearan ce 7. Decreased speech 8. Self-destructive th ough ts; h owever, th e perso n

m ay lack en ergy to act on th e th ough ts. 9. Social with drawal

10. Poor con cen tration an d overwh elm ed by sim - ple tasks

11. Severe psych om o tor retardatio n 12. An o rexia an d con siderable weigh t loss 13. Con stipation an d urin ary reten tion 14. Lack of sexual in terest 15. Term in al in som n ia 16. Diurn al variation : Th e person m ay feel better

at a certain tim e of th e day. 17. Delu sion s an d h allucin ation s

E. In terven tion s ( Box 69-6)

For a client at risk for self-harm, ask the client directly, “Have you thought of hurting yourself?”

X. Electroconvulsive Therapy (ECT) A. Description

1. ECT is an effective treatm en t for depression (n ot a cure) ; a sm all am oun t of an electrical curren t is delivered th rou gh electrod es attach ed to th e tem ples th at cause a brief seizure with in th e brain ; outward m ovem en t is usually a sligh t m ovem en t of th e h an ds, feet, or a toe because prem edication is given to relax th e m uscles. In addition , a sh ort-actin g an esth etic is given .

M

e

n

t

a

l

H

e

a

l

t

h

BOX 69-6 Interventions for Depressed Clients Risk for Harm Assess for homicidal and suicidal ideation. Provide safety from suicidal actions (be certain that there are no

harmful objects in the environment). Do not leave the client alone for extended periods. If the client has a suicidal plan, place on one-to-one supervision. Form a “no-suicide contract” with the client as appropriate.

Activities Use gentle encouragement to participate in activities of daily liv-

ing and unit therapies. Do not push decision making or the making of complex choices

or decisions that the client is not ready for. Provide achievable activities in which the client can achieve suc-

cess (focus on strengths). Begin the client with one-to-one activities. Provide activities for easy mastery to increase self-esteem and

help in alleviating guilt feelings and activities that do not require a great deal of concentration (simple card games, drawing).

Engage the client in gross motor activities (walking). Eventually bring the client into small group activities and then

into large groups.

Nutrition Monitor nutritional intake and weight. Offer small, high-calorie,

high-protein snacks and fluids throughout the day. Stay with the client during meals.

Hygiene Care Monitor for general hygiene and self-care deficits; deficits may

indicate worsening depression. Assist with activities of daily living.

Sleep Patterns Monitor sleep patterns. Decrease environmental stimuli at bedtime. Spend time with the client before bedtime.

Altered Thought Processes Remind the client of times when he or she felt better and was

successful. Spend time with the client to convey the client’s worth and

value. Encourage the client to discuss losses or changes in the life

situation. Encourage the client to express sadness or anger and allow ade-

quate time for verbal responses. Respond to anger therapeutically.

1006 UNIT XIX Mental Health Disorders of the Adult Client

2. Th e usual course is 6 to 12 treatm en ts given every 2 to 5 days; m ain ten an ce ECT on ce a m on th m ay h elp to decrease th e relapse rate for a clien t with recurren t depression .

3. ECT is n ot always effective in clien ts with dysth ym ic depression , dep ression an d perso n - ality disorders, drug depen den ce, or dep ression secon dary to situation al or social difficu lties.

4. At-risk clien ts in clude clien ts with recen t m yo- cardial in farction , stroke (brain attack), or in tra- cran ial m ass lesion s.

B. Uses (Box 69-7) 1. Clien ts with severe dep ressive an d bipolar

dep ressive disorders, esp ecially wh en psych o tic sym ptom s are presen t, such as delusion s of gu ilt, som atic delusion s, an d delusion s of in fidelity

2. Clien ts wh o h ave depression with m arked psy- ch om otor retardation an d stupor

3. Man ic clien ts wh o se con d ition s are resistan t to lith ium an d an tipsych otic m ed ication s an d cli- en ts wh o are rapid cyclers (a clien t with a bipo- lar disorder wh o h as m an y episo des of m oo d swin gs clo se togeth er)

4. Clien ts with sch izoph ren ia (especially catato - n ia), clien ts with sch izoaffective syn d rom es, an d psych o tic clien ts

C. Preprocedure 1. Explain th e procedure to th e clien t. 2. En courage th e clien t to discuss feelin gs,

in cludin g m yth s regardin g ECT. 3. Teach th e clien t an d fam ily wh at to exp ect. 4. In form ed con sen t m ust be obtain ed wh en vol-

un tary clien ts are bein g treated. 5. For in volun tary clien ts, wh en in form ed con -

sen t can n ot be obtain ed, perm ission m ay be obtain ed from th e n ext of kin , alth ough in som e states th e perm ission for ECT m ust be obtain ed from th e court.

6. Main tain NPO (n oth in g by m ou th ) status after m idn igh t or at least 4 h ou rs before treat- m en t as prescribed.

7. Baselin e vital sign s are taken . 8. Th e clien t is requested to void. 9. Hairpin s, con tact len ses, an d den tures are

rem oved. 10. Adm in ister preprocedure m edication as pre-

scrib ed. D. Durin g th e proced ure

1. As th e in traven ous lin e is in serted, electroen - ceph alograph ic an d electrocardiograph ic elec- trodes are attach ed .

2. Th e blood pressure, pulse, an d oxygen satura- tion are m on itored th rou gh out th e treatm en t.

3. A blood pressure cuff is placed arou n d 1 an kle an d in flated to block th e m edication from en terin g th e foot. Wh en th e procedure begin s, seizu re activity can be m on itored by watch in g for m ovem en t in th at foot.

4. Med ication s adm in istered m ay in clude a sh ort- actin g an esth etic an d a m uscle relaxan t.

5. O xygen is adm in istered by face m ask. 6. An airway or m ou th guard is placed to preven t

th e clien t bitin g th e ton gue. 7. An electrical stim ulus is ad m in istered; a brief

seizu re occurs. E. Postprocedure

1. Th e clien t is tran sported to a recovery area with th e blood pressure cuff an d oxim eter in place, wh ere oxygen , suction , an d oth er em ergen cy equ ipm en t are available.

2. Wh en th e clien t is awake, talk to th e clien t an d take vital sign s.

3. Th e clien t m ay be con fused; provid e frequen t orien tation (brief, distin ct, an d sim ple) an d reassuran ce.

4. Th e clien t return s to th e n ursin g un it wh en at least a 90% oxygen saturation level is m ain - tain ed , vital sign s are stable, an d m en tal status is satisfactory.

5. Assess for a gag reflex before givin g th e clien t fluid s, food , or m ed ication .

F. Poten tial side effects 1. Con fusion , disorien tation , an d sh o rt-term

m em ory loss 2. Th e clien t m ay be con fused an d disorien ted on

awaken in g. 3. O th er side effects in clude h ead ach e, h ypo ten -

sion , m uscle soren ess, n ausea, an d tach ycardia. 4. Mem ory deficits m ay occur, but m em ory usu-

ally recovers com pletely, alth ough som e clien ts h ave m em ory loss lastin g 6 m on th s.

Monitor both a depressed client and a client who has recently been prescribed an antidepressant medica- tion closely for signs of suicidal ideation. If the client pre- sents with increased energy, monitor closely because it could mean that the client now has the energy to perform the suicide act.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 69-7 Electroconvulsive Therapy (ECT): Indications for Use

▪ When antidepressant medications have no effect ▪ When there is a need for a rapid definitive response, such

as when a client is suicidal or homicidal ▪ When the client is in extreme agitation or stupor ▪ When the risks of other treatments outweigh the risk of

ECT ▪ When the client has a history of poor medication response,

a history of good ECT response, or both ▪ When the client prefers ECT as a treatment

1007CHAPTER 69 Mental Health Disorders

XI. Schizophrenia A. Description

1. Sch izoph ren ia is a group of m en tal disorders ch ar- acterized by psych otic features (h allucin ation s an d delusion s), disordered though t processes, an d disrupted in terperson al relation sh ips.

2. Distu rban ces in affect, m ood, beh avio r, an d th o ugh t processes occur.

3. Treatm en t with m edication con trols sym pto m s associated with th e disorder.

B. Assessm en t ( Fig. 69-1) 1. Ph ysical ch aracteristics

a . Un kem pt appearan ce; m ay n eglect h ygien e, eatin g, sleepin g, an d elim in ation

b . Bod y im age distortion s c. May be preoccupied with som atic com -

plain ts 2. Moto r activity (Box 69-8)

a . Cataton ic postu rin g: Hold in g bizarre pos- tures for lon g periods

b . Cataton ic excitem en t: Movin g excitedly, with n o en viron m en tal stim uli presen t

c. Possible total im m obilization d . In ability to respon d to com m an ds or

respon din g on ly to com m an ds e. Waxy flexibility f. Repetitive or stereotyped m ovem en ts g. Moto r activity th at m ay be in creased, as

eviden ced by agitation , pacin g, in ability to sleep, loss of appetite an d weigh t, an d im pulsiven ess

h . Possible in ability to in itiate activity (an ergia)

3. Em otion al ch aracteristics a . Mistrust b . View of th e world as th reaten in g an d un safe c. Affect blun ted, flat, or in approp riate d . May display feelin gs of am bivalen ce, h elp-

lessn ess, an xiety, an ger, guilt, or dep ression in respo n se to h allucin ation s or delusio n s or as a result of grief related to losses im posed by th e illn ess

4. Com p ulsive rituals: Con stan t repetitive activity perform ed as an attem pt to solve con flictin g feelin gs

5. O vercom plian ce: Attem pt to den y respo n sibil- ity for an y action by doin g on ly wh at an oth er perso n in structs exactly

6. Affective disturban ces a . Flat or in con gruen t affect or in approp riate

affect b . Altered th ough t processes

M

e

n

t

a

l

H

e

a

l

t

h

• Biza rre be ha vior • De lus ions • Dis orga nize d s pe e ch (LOA) • Ha llucina tions

Po s itive S ympto ms

• Dys phoria • Hope le s s ne s s • S uicida lity

De pre s s ive and Othe r Mo o d S ympto ms

• Ability to work • Inte rpe rs ona l re la tions hips • Qua lity of life • S e lf-ca re a bilitie s • S ocia l functioning

All dime ns io ns alte r the individual's

• Blunte d a ffe ct • Ina bility to e xpe rie nce

ple a s ure or joy (a nhe donia ) • Los s of motiva tion (a volition) • Pove rty of thought (a logia )

Ne g ative S ympto ms

• Illogica l thinking • Impa ire d judgme nt • Impa ire d me mory • Ina tte ntion, e a s ily dis tra cte d • Poor de cis ion-ma king s kills • Poor proble m-s olving s kills

Co g nitive S ympto ms

FIGURE 69-1 Treatment-relevant dimensions of schizophrenia. LOA, Looseness of association.

BOX 69-8 Abnormal Motor Behaviors Description Abnormal motor behavior or activity displayed by a mentally ill

client that occurs as a result of a psychiatric disorder

Types Echola lia : Repeating the speech of another person Echopra xia : Repeating the movements of another person Wa xy Flexibilit y: Having one’s arms or legs placed in a certain

position and holding that same position for hours

1008 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

7. Abn orm al th o ugh t processes ( Box 69-9) a. Im paired reality testin g b . Fragm en tatio n of th o ugh ts c. Th ough t blockin g d . Loose association s e. Ech olalia f. Distorted percep tion of th e en viron m en t g. Neologism s h . Magical th in kin g i. In ability to con ceptu alize m ean in g in

words or th o ugh ts j. In ability to organ ize facts logically

k . Delusion s associated with th ough t pro- cesses or co n ten t

8. Types of delusio n s ( Box 69-10) a. Loss of referen ce, in wh ich th e clien t

believes th at certain even ts, situation s, or in teraction s are related directly to self

b . Delusion s of persecution , in wh ich th e clien t believes th at h e or sh e is bein g h ar- assed, th reaten ed, or persecuted by som e powerfu l force

c. Delusion s of gran deur, in wh ich th e clien t attach es special sign ifican ce to self in relation to oth ers or th e un iverse an d h as an exagger- ated sen se of self th at h as n o basis in reality

d . Som atic delusion s, in wh ich th e clien t believes th at h is or h er body is ch an gin g or respo n din g in an un usual way, wh ich h as n o basis in reality

9. Percep tual distortion s a . Illu sion s, wh ich m ay be brief experien ces

with a m isin terpretation or m isperception of reality

b . Hallucin ation s (5 sen ses) with n o basis in reality (Box 69-11), such as perceivin g objects, sen sation s, or im ages

10. Lan gu age an d com m un ication disturban ces ( Box 69-12) a. Related to disorders in th o ugh t process b . In ability to organ ize lan guage c. Difficulty com m un icatin g clearly d . In appropriate respo n ses to a situation e. A sin gle word or ph rase m ay represen t th e

wh ole m ean in g of th e con versation such th at th e clien t m ay feel th at h e or sh e h as co m m un icated adequ ately.

f. Developm en t of a private lan gu age C. In terven tion s: Sch izo ph ren ia ( Box 69-13) D. In terven tion s: Active h allucin ation s

1. Mon itor for h allucin ation cues an d assess con ten t of h allucin ation s.

2. In terven e with on e-on -on e con tact. 3. Decrease stim uli or m ove th e clien t to

an oth er area. 4. Avo id con veyin g to th e clien t th at oth ers also

are exp erien cin g th e h allucin ation . 5. Resp on d verbally to an yth in g real th at th e

clien t talks about. 6. Avo id touch in g th e clien t. 7. En cou rage th e clien t to express feelin gs.

BOX 69-9 Abnormal Thought Processes Description Abnormal thought processes displayed by a mentally ill client

that occur as a result of a psychiatric disorder

Types Circumst a nt ia lity: Before getting to the point or answering a

question, the client gets caught up in countless details and explanations.

Confa bula tion: Filling a memory gap with detailed fantasy believed by the teller; the purpose of confabulation is to maintain self-esteem; seen in organic conditions such as Korsakoff’s psychosis

Flight of Idea s: Constant flow of speech in which the client jumps from 1 topic to another in rapid succession; a con- nection between topics exists, although it is sometimes dif- ficult to identify; seen in manic states

Looseness of Associa t ion: Haphazard, illogical, and confused thinking and interrupted connections in thought; seen mostly in schizophrenic disorders

Neologisms: Client makes up words that have meaning only to the individual; often part of a delusional system

Thought Blocking: Sudden cessation of a thought in the middle ofa sentence; client is unable to continue the train ofthought; often, sudden new thoughts unrelated to the topic come up

Word Sa la d: Mixture of words and phrases that has no meaning

BOX 69-10 Delusions Description A false belief held to be true, even when there is evidence to

the contrary

Types Gra ndeur: False belief that one is a powerful and important

person Jea lousy: False belief that one’s partner or mate is going out

with other persons Persecut ion: Thought that one is being singled out for harm by

others

Interventions Ask the client to describe the delusion. Be open and honest in interactions to reduce suspiciousness. Focus conversation on reality-based topics, rather than on the

delusion. Encourage the client to express feelings and focus on feelings

that the delusions generate. If the client obsesses on the delusion, set firm limits on the

amount of time spent talking about the delusion. Do not argue with the client or try to convince the client that

the delusions are false. Validate if part of the delusion is real.

1009CHAPTER 69 Mental Health Disorders

8. Du rin g a h allu cin ation , attem p t to en gage th e clien t’s atten tio n th rough a con crete activity.

9. Accept an d do n ot joke about or judge th e cli- en t’s beh avior.

10. Provide easy activities an d a structured en vi- ro n m en t with routin e activities of daily livin g.

11. Mon itor for sign s of in creasin g fear, an xiety, or agitation .

12. Decrease stim uli as n eeded. 13. Adm in ister m ed ication s as prescribed.

For a client with hallucinations, safety is the first pri- ority; ensure that the client does not have an auditory command telling him or her to harm self or others.

E. In terven tion s: Delu sion s 1. In teract based on reality.

2. En cou rage th e clien t to express feelin gs. 3. Do n ot dispute th e clien t or try to con vin ce th e

clien t th at delusion s are false. 4. In itiate activities on a on e-on -on e basis. 5. Alter h ospital routin es as n ecessary, such as by

usin g can n ed or packaged food or food from h om e.

6. Recogn ize acco m plish m en ts an d provide posi- tive feedback for successes.

XII. Personality Disorders A. Description

1. Perso n ality disorders in clude various in flexible m alad aptive beh avior pattern s or traits th at m ay im pair fun ction in g an d relation sh ips.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 69-13 Interventions for Schizophrenia Assess the client’s physical needs. Set limits on the client’s behavior if the client is unable to do

so, especially when it interferes with others and becomes disruptive.

Maintain a safe environment. Initiate one-on-one interaction and progress to small groups

as tolerated. Spend time with the client, even ifthe client is unable to respond. Monitor for altered thought processes. Maintain ego boundaries and avoid touching the client. Avoid an overly warm approach; a neutral approach is less

threatening. Do not make promises to that client that cannot be kept. Establish daily routines. Assist the client to improve grooming and accept responsibil-

ity for personal care. Sit with the client in silence if necessary. Provide brief, frequent contact with the client; limit time of

interaction with the client. Tell the client when you are leaving. Tell the client when you do not understand what he or she is

saying. Do not “go along” with the client’s delusions or hallucinations. Provide simple, concrete activities, such as puzzles or word games. Reorient the client as necessary. Help the client to establish what is real and unreal. Stay with the client if he or she is frightened. Speak to the client in a simple, direct, and concise manner. Reassure the client that the environment is safe. Remove the client from group situations if the client’s behav-

ior is too bizarre, disturbing, or dangerous to others. Set realistic goals. Initially, do not offer choices to the client; then gradually assist

the client in making his or her own decisions. Use canned or packaged food, especially with a paranoid

schizophrenic client. Provide a radio or tape player at night for insomnia. Decrease excessive stimuli in the environment. Monitor for suicide risk. Assist the client to use alternative means to express feelings,

such as through music, art therapy, or writing.

BOX 69-11 Hallucinations Description Sense perception (occurs with 1of the 5 senses) for which no ex-

ternal stimuli exist; can have an organic or functional cause

Types Audit ory: Hearing voices when none are present Gust a t ory: Experiencing taste in the absence of stimuli Olfa ct ory: Smelling smells that do not exist Ta ctile: Feeling touch sensations in the absence of stimuli Visua l: Seeing things that are not there

Interventions Ask the client directly about the hallucination. Avoid reacting to the hallucination as if it were real. Decrease stimuli or move the client to another area. Do not negate the client’s experience. Focus on reality-based topics. Attempt to engage the client’s attention through a concrete

activity. Respond verbally to anything real that the client talks about. Avoid touching the client. Monitor for signs of increasing anxiety or agitation, which may

indicate that hallucinations are increasing.

BOX 69-12 Language and Communication Disturbances

Cla ng Associa t ion: Repetition of words or phrases that are similar in sound but in no other way

Echola lia : Repetition of words or phrases heard from another person

Mut ism: Absence of verbal speech Neologism: A newly devised word that has special meaning

only to the client Pressured Speech: Speaking as if the words are being forced

out quickly Verbigera t ion: Purposeless repetition of words or phrases Word Sa la d: Form of speech in which words or phrases are

connected meaninglessly

1010 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

2. Th e clien t usually rem ain s in touch with reality an d typically h as a lack of in sigh t on h is or h er beh avior.

3. Stress exacerbates m an ifestation s of th e perso n - ality disorder.

4. In severe cases, th e perso n ality disorder m ay deteriorate to a psych o tic state.

B. Ch aracteristics 1. Poor im pulse con tro l

a. Actin g out to m an age in tern al pain b . Form s of actin g out in clude ph ysical an d

verbal attacks, such as yellin g an d swearin g, an d self-in jurious beh aviors, such as cuttin g own skin , ban gin g th e h ead , pun ch in g self, m an ipu lation , substan ce abuse, prom iscu- ous sexual beh aviors, an d suicide attempts.

c. Th e clien t m ay be preoccu pied with such th in gs as self, religion , or sex.

2. Moo d ch aracteristics a. May experien ce abandonm ent and depression b . Moods m ay in clude rage, guilt, fear, an d

em ptin ess. 3. Im p aired judgm en t

a. Difficulty with problem solvin g b . In ability to perceive th e con sequ en ces of

beh avio r 4. Im paired reality testin g: Distortion of reality an d

often projection of own feelin gs on to oth ers 5. Im p aired object relation s: Rigid an d in flexible,

with difficu lty in in tim ate relation sh ips 6. Im p aired self-perception : Disto rted self-

percep tion an d exp erien ce of self-h ate or self- id ealizatio n

7. Im p aired th o ugh t processes a. Con crete or diffuse th in kin g b . Difficulty co n cen tratin g c. Im paired m em ory

8. Im p aired stim ulus barrier a. In ability to regulate in com in g sen sory

stim uli b . In creased excitability c. Excessive respo n se to n oise an d ligh t d . Poor atten tion span e. Agitated f. In som n ia

C. Cluster A perso n ality disorder types in clude th e odd disorders—sch izoid, sch izotypal, an d paran oid. 1. Schizoid personality disorder is characterized by an

inability to form warm , close social relationships. a. Social detach m en t an d lack of close rela-

tion sh ips b . In terest in solitary activities c. Aloof an d in differen t d . Restricted expressio n of em otion s e. Lack of in terest in oth ers

2. Sch izotypal perso n ality disorder is ch aracter- ized by th e display of abn o rm al or h igh ly

un usual th o ugh ts, perception s, speech , an d beh avior pattern s. a. Susp iciou s b . Paran oia c. Magical th in kin g d . O dd th in kin g an d speech e. Relation sh ip deficits

3. Paran oid perso n ality disorder is ch aracterized by susp iciou sn ess an d m istrust of oth ers (para- n oia) (Box 69-14). a. May be susp icious an d distrustin g b . May be argum en tative c. May be h ostile or aloo f d . May be rigid, critical, an d con trollin g of others e. May h ave th o ugh ts of gran diosity

Do not whisper or laugh in front of a client with a paranoid personality disorder because the client will think that you are talking about or laughing at him or her; this increases the paranoia.

D. Cluster B perso n ality disorders in clude th e dra- m atic, em o tion al, erratic types—h istrion ic, n arcis- sistic, an tisocial, an d borderlin e. 1. Histrion ic perso n ality disorder is ch aracterized

by overly dram atic an d in ten sely expressive beh avior.

BOX 69-14 Interventions for Paranoia Assess for suicide risk. Diminish suspicious behavior. Avoid direct eye contact. Establish a trusting relationship. Promote increased self-esteem. Remain calm, nonthreatening, and nonjudgmental. Provide continuity of care. Respond honestly to the client. Follow through on commitments made to the client. Acknowledge the client’s feelings, but tell the client that you

do not share his or her interpretation of an event. Provide a daily schedule of activities. Assist the client to identify diversionary activities. Gradually introduce the client to groups. Refocus conversation to reality-based topics. Use role playing to help the client identifythoughts and feelings. Provide positive reinforcement for successes. Do not argue with delusions. Use concrete, specific words. Do not be secretive with the client. Do not whisper in the client’s presence. Assure the client that he or she will be safe. Involve the client in noncompetitive tasks. Provide the client with the opportunity to complete small tasks. Monitor eating, drinking, sleeping, and elimination patterns. Limit physical contact. Monitor for agitation, and decrease stimuli as needed.

1011CHAPTER 69 Mental Health Disorders

M

e

n

t

a

l

H

e

a

l

t

h

a . Lively an d dram atic an d en joys bein g th e cen ter of atten tion

b . Has poor an d sh allow in terp erson al relation s

c. May be sexually sed uctive or provocative d . Dram atizes h is or h er life an d m ay appear

th eatrical e. O verly con cern ed with appearan ce f. Easily bored

2. Narcissistic perso n ality disorder is ch aracterized by an in creased sen se of self-im portan ce an d preoccu pation with fan tasies an d un lim ited success. a . Need for adm iration an d in flatio n of

acco m plish m en ts b . O verestim ation of ab ilities an d un deresti-

m ation of con tribu tion s of oth ers c. Lack of em path y an d sen sitivity to n eeds of

oth ers 3. An tiso cial person ality disorder com prises a pat-

tern of irrespon sible an d an tisocial beh avior, selfish n ess, an in ability to m ain tain lastin g rela- tion sh ips, poor sexual adjustm en t, a failure to accept social n orm s, an d a ten den cy toward irri- tability an d aggressiven ess. a . Perceives th e world as h ostile b . Superficial ch arm , yet can beco m e h ostile c. No sh am e or guilt d . Self-cen tered e. Un reliable f. Easily bored g. Poor work h isto ry h . In ability to tolerate frustration i. Views oth ers as objects to be m an ipu lated j. Poor judgm en t

k . Im p ulsive 4. Bord erlin e person ality disorder is ch aracterized

by in stability in in terp erson al relation sh ips, un stable m oo d an d self-im age, an d im pulsive an d un predictable beh avior. a . Un clear iden tity b . Un stable an d in ten se c. Extrem e sh ifts in m ood d . Easily an gered e. Easily bored f. Argum en tative g. Depressio n h . Self-destructive beh avio r i. Man ipulation j. In ability to tolerate an xiety

k . Ch ron ic feelin gs of em ptin ess an d fear of bein g alon e

l. Splittin g—sees oth ers as all good or all bad; creates con flict between in dividuals by playin g 1 perso n again st an oth er

E. Cluster C perso n ality disorders in clude th e an xiou s, fearful types of person ality disorders—obsessive- com pu lsive perso n ality, avoidan t, an d dep en den t.

1. O bsessive-com pulsive perso n ality disorder is ch aracterized by difficulty expressin g warm an d ten der em o tion s, perfection ism , stubborn - n ess, th e n eed to con trol oth ers, an d a devotio n to work. a . O verly con scien tiou s b . In flexible an d preoccupied with details

an d rules c. Extrem ely devoted to work to th e exclusio n

of leisure activities an d frien dsh ip s d . Miserly an d stubb orn e. Ho ardin g beh avior f. En gages in rituals

2. Avoidan t perso n ality disorder is ch aracterized by social with drawal an d extrem e sen sitivity to poten tial rejection . a . Feelin gs of in adequacy b . Hypersen sitive to reaction s of oth ers an d

poor reaction to criticism c. Social isolation d . Lack of support system

3. Depen dent person ality disorder is ch aracterized by an in ten se lack of self-con fiden ce, low self-esteem , and in ability to fun ction in depen - den tly, such that the in dividual passively allows oth ers to m ake decision s an d assum e respon sibil- ity for m ajor areas in the person ’s life; th e depen - den t client h as great difficulty m akin g decision s.

F. Gen eral in terven tion s for a clien t with a perso n ality disorder

1. Main tain safety again st self-destructive beh a- viors.

2. Allow th e clien t to m ake ch oices an d be as in depen den t as possible.

3. En cou rage th e clien t to discuss feelin gs rath er th an act th em out.

4. Provide con sisten cy in respo n se to th e clien t’s actin g-out beh avio rs.

5. Discuss expectation s an d respon sibilities with th e clien t.

6. Discuss th e con sequ en ces th at will follow cer- tain beh aviors.

7. In form th e clien t th at h arm to self, oth ers, an d property is un acceptable.

8. Iden tify splittin g beh avior. 9. Assist th e clien t to deal directly with an ger.

10. Develop a written safety or beh avioral con tract with th e clien t.

11. En cou rage th e clien t to keep a journ al record- in g daily feelin gs.

12. En courage the client to participate in group activities, an d praise n on m an ipulative behavior.

13. Set an d m ain tain lim its to decrease m an ipula- tive beh avior.

14. Rem o ve th e clien t fro m group situation s in wh ich atten tio n -seekin g beh aviors occur.

15. Provide realistic praise for positive beh aviors in social situation s.

1012 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

XIII. Neurodevelopmental Disorders A. Autism spectrum disorder: See Ch apter 42. B. Atten tion-deficit/hyperactivity disorder: See

Chapter 42.

XIV. Neurocognitive Disorders A. Dem en tia an d Alzh eim er’s disease

1. Dem en tia a. Dem en tia is a syn drom e with progressive

deterioration in intellectual fun ction in g secon dary to structural or fun ction al ch an ges.

b . Lon g-term an d sh ort-term m em ory lo ss occurs, with im pairm en t in judgm en t, abstract th in kin g, problem -solvin g ability, an d beh avior.

c. Dem en tia results in a self-care deficit. d . Dem en tia-like sym pto m s can be a result of

ph ysiolo gical co n dition s, an d such con d i- tion s m ust be ruled out in itially.

e. Th e m ost co m m on type of dem en tia is Alzh eim er’s disease.

2. Alzh eim er’s disease ( Box 69-15) a. Alzh eim er’s disease is an irreversib le form

of sen ile dem en tia cau sed by n erve cell deterioration .

b . In divid uals with Alzh eim er’s disease experi- en ce cogn itive deterio ration an d progres- sive loss of ability to carry out activities of daily livin g.

c. Th e clien t experien ces a steady declin e in ph ysical an d m en tal fun ction in g an d usu- ally requires lo n g-term care in a specialized facility in th e fin al stages of th e illn ess.

d . Stages and m ajor ch aracteristics of Alzh ei- m er’s disease: Stage 1 (m ild): forgetfuln ess; stage 2 (m oderate): con fusion ; stage 3 (m od- erate to severe): am bulatory dem en tia; and stage 4 (late): en d stage.

3. In terven tion s a. Iden tify an d rein fo rce retain ed skills. b . Provide con tin uity of care. c. O rien t th e clien t to th e en viron m en t. d . Furn ish th e en viron m en t with fam iliar

possessio n s. e. Ackn owled ge th e clien t’s feelin gs. f. Assist th e clien t an d fam ily m em bers to

m an age m em ory deficits an d beh avior ch an ges.

g. En cou rage fam ily m em bers to express feel- in gs about caregivin g.

h . Provide th e caregiver with support and iden tify th e resources an d support groups available.

i. Mon itor th e clien t’s activities of daily livin g. j. Rem in d th e clien t h ow to perform self-care

activities. k . Help th e clien t to m ain tain in depen den ce. l. Provide th e clien t with con sisten t routin es.

m . Provide th e clien t with exercise, such as walkin g with an escort.

n . Avo id activities th at tax th e m em ory. o . Allow th e clien t plen ty of tim e to com plete

a task. p . Use con stan t en couragem en t with th e cli-

en t with a sim ple step-by-step approach . q . Provide th e clien t with activities th at dis-

tract an d occupy tim e, such as listen in g to m usic, colorin g, an d watch in g television .

r . Provide th e clien t with m en tal stim ulation with sim ple gam es or activities.

4. Wan derin g a. Provide th e clien t with a safe en viron m en t. b . Preven t un safe wan derin g. c. Provide th e clien t with clo se supervision . d . Clo se an d secure doors. e. Use iden tification bracelets an d electron ic

surveillan ce. f. Sundown syndrom e (sun down ing) is ch arac-

terized by a pronounced increase in sym ptom s and problem beh aviors in th e even in g.

Providing a safe environment is a priority in the care of a client with Alzheimer’s disease.

5. Com m un ication disorders a. Disorders in clude lan guage disorder (expres-

sive–receptive disorder), speech soun d disor- der (phonological disorder), ch ildhood- onset fluen cy disorder (stutterin g disorder), an d social com m un ication disorder (im paired social com m unication ).

b . Adapt to the com m un ication level of the client.

c. Use a firm volum e an d a low-pitch ed voice to com m un icate.

d . Stan d directly in fro n t of th e clien t an d m ain tain eye con tact.

e. Call th e clien t by n am e an d iden tify self; wait for a respo n se.

f. Use a calm an d reassurin g voice. g. Use pan to m im e gestures if th e clien t is

un ab le to un d erstan d spoken words. h . Speak slowly an d clearly, usin g sh ort words

an d sim ple sen ten ces. i. Ask on ly 1 question at a tim e an d give 1

direction at a tim e. j. Repeat question s if n ecessary, but do n ot

reph rase.

BOX 69-15 Alzheimer’s Disease Agnosia : Failure to recognize or identify familiar objects

despite intact sensory function Amnesia : Loss of memory caused by brain degeneration Apha sia : Language disturbance in understanding and expres-

sing spoken words Apra xia : Inability to perform motor activities, despite intact

motor function

1013CHAPTER 69 Mental Health Disorders

M

e

n

t

a

l

H

e

a

l

t

h

6. Im p aired judgm en t a. Rem o ve th row rugs, toxic substan ces, an d

dan gerous electrical applian ces from th e en viron m en t.

b . Redu ce h ot water h eater tem perature. 7. Altered th ough t processes

a. Call th e clien t by n am e. b . O rien t th e clien t frequen tly. c. Use fam iliar objects in th e room . d . Place a calen dar an d clo ck in a visible place. e. Main tain fam iliar ro utin es. f. Allow th e clien t to rem in isce. g. Make tasks sim ple. h . Allow tim e for th e clien t to com plete a task. i. Provide positive rein fo rcem en t for positive

beh aviors. 8. Altered sleep pattern s

a. Allow th e clien t to wan der in a safe place un til h e or sh e beco m es tired.

b . Preven t sh ad ows in th e room by usin g in direct ligh t.

c. Avo id th e use of h ypn otics because th ey cau se con fusion an d aggravate th e sun down effect.

9. Agitation a. Assess th e precipitan t of th e agitation . b . Reassure th e clien t. c. Rem o ve item s th at can be h azardous wh en

th e clien t is agitated. d . Approach th e clien t slowly an d calm ly from

th e fron t, an d speak, gesture, an d m ove slowly.

e. Rem o ve th e clien t to a less stressful en viron - m en t; decrease excess stim uli.

f. Use touch gen tly. g. Do n ot argue with or force th e clien t to do

som eth in g.

P R A C T I C E Q U E S T I O N S 869. A clien t says to th e n urse, “Th e federal guards were

sen t to kill m e.” Wh ich is th e b est respo n se by th e n urse to th e clien t’s con cern ? 1. “I don ’t believe th is is true.” 2. “Th e guards are n ot out to kill you.” 3. “Do you feel afraid th at peo ple are tryin g to

h urt you?” 4. “Wh at m akes you th in k th e guards were sen t to

h urt yo u?”

870. A clien t diagn osed with delirium beco m es disor- ien ted an d con fused at n igh t. Wh ich in terven tion sh ould th e n urse im plem en t in itially? 1. Move th e clien t n ext to th e n urses’ statio n . 2. Use an in direct ligh t source an d turn off th e

television . 3. Keep th e television an d a soft ligh t on durin g

th e n igh t. 4. Play soft m usic durin g th e n igh t, an d m ain tain a

well-lit room .

871. A clien t is adm itted to th e m en tal h ealth un it with a diagn osis of dep ression . Th e n urse sh o uld develop a plan of care for th e clien t th at in cludes wh ich in terven tion ? 1. En cou ragin g quiet readin g an d writin g for th e

first few days 2. Iden tification of ph ysical activities th at will pro-

vide exercise 3. No socializin g activities, un til th e clien t asks to

participate in m ilieu 4. A structured program of activities in wh ich th e

clien t can participate

872. Wh en plan n in g th e disch arge of a clien t with ch ron ic an xiety, th e n urse directs th e goals at pro- m otin g a safe en viron m en t at h om e. Wh ich is th e m o st ap p ro p riate m ain ten an ce goal? 1. Supp ressin g feelin gs of an xiety 2. Iden tifyin g an xiety-produ cin g situation s 3. Con tin uin g con tact with a crisis coun selor 4. Elim in atin g all an xiety from daily situation s

873. A clien t is un willin g to go to h is ch urch because h is ex-girlfrien d goes th ere an d h e feels th at sh e will laugh at h im if sh e sees h im . Because of th is h yper- sen sitivity to a reactio n fro m h er, th e clien t rem ain s h om eboun d. Th e h om e care n urse develops a plan of care th at ad dresses wh ich person ality disorder? 1. Avoidan t 2. Bord erlin e 3. Sch izotypal 4. O bsessive-com pulsive

874. Th e n urse is con d uctin g a grou p th erapy session . Du rin g th e session , a clien t diagn osed with m an ia

CRITICAL THINKING What Should You Do? Answer: If a client is actively hallucinating, the nurse should intervene with one-on-one contact. The nurse should ask the client directly about the hallucination and avoid reacting to the hallucination as if it were real. The nurse should decrease stimuli or move the client to another area and avoid indicat- ing to the client that others also are experiencing the halluci- nation. The nurse should encourage the client to express feelings, focus on reality-based topics, and respond verbally to anything real that the client talks about. The nurse also should avoid touching the client. During a hallucination, the nurse should attempt to engage the client’s attention through a concrete activity and monitor for signs of increas- ing anxiety or agitation, which may indicate that the halluci- nations are increasing.

Reference: Varcarolis (2013), pp. 312, 318.

1014 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

con sisten tly disrupts th e grou p’s in teraction s. Wh ich in terven tion sh ould th e n urse in itially im plem en t? 1. Settin g lim its on th e clien t’s beh avior 2. Askin g th e clien t to leave th e group session 3. Askin g an oth er n urse to escort th e clien t out of

th e group session 4. Tellin g th e clien t th at th ey will n ot be ab le to

atten d an y future grou p session s

875. A clien t is adm itted to a m edical n ursin g un it with a diagn osis of acute blin dn ess after bein g in volved in a h it-an d-run acciden t. Wh en diagn ostic testin g can n ot iden tify an y organ ic reason wh y th is clien t can n ot see, a m en tal h ealth con sult is prescribed . Th e n urse plan s care based on wh ich con dition th at sh ould be th e focus of th is con sult? 1. Psych osis 2. Repression 3. Con version disorder 4. Disso ciative disorder

876. A m an ic clien t begin s to m ake sexual advan ces toward visitors in th e dayroo m . Wh en th e n urse firm ly states th at th is is in approp riate an d will n ot be allowed, th e clien t beco m es verbally abusive an d th reaten s ph ysical violen ce to th e n urse. Based on th e an alysis of th is situation , wh ich in terven - tion sh ould th e n urse im plem en t? 1. Place th e clien t in seclusion for 30 m in utes. 2. Tell th e clien t th at th e beh avior is in approp riate. 3. Escort th e clien t to th eir room , with th e assis-

tan ce of oth er staff. 4. Tell th e clien t th at th eir telep h on e privileges are

revoked for 24 h ours.

877. Wh ich n ursin g in terven tion s are ap propriate for a h ospitalized clien t with m an ia wh o is exh ibitin g m an ipulative beh avior? Select all th at ap p ly.

1. Com m un icate expected beh aviors to th e clien t.

2. En sure th at th e clien t kn ows th at th ey are n ot in ch arge of th e n ursin g un it.

3. Assist th e clien t in iden tifyin g ways of settin g lim its on person al beh aviors.

4. Follow th rough about th e con sequ en ces of beh avior in a n on pu n itive m an n er.

5. En fo rce rules by in form in g th e clien t th at h e/ sh e will n ot be allowed to atten d th erapy grou ps.

6. Have th e clien t state th e con sequen ces for beh avin g in ways th at are viewed as un acceptable.

878. Th e n urse observes th at a clien t is pacin g, agitated , an d presen tin g aggressive gestures. Th e clien t’s speech pattern is rapid, an d affect is belligeren t. Based on th ese observation s, wh ich is th e n urse’s im m ed iate p rio rity of care?

1. Provide safety for th e clien t an d oth er clien ts on th e un it.

2. Provide th e clien ts on th e un it with a sen se of com fort an d safety.

3. Assist th e staff in carin g for th e clien t in a co n - trolled en viron m en t.

4. O ffer th e clien t a less stim ulatin g area in wh ich to calm down an d gain con trol.

879. Th e n u rse is p rep arin g a clien t with a h isto ry o f co m m an d h allu cin atio n s fo r d isch arge b y p ro vid - in g in stru ctio n s o n in terven tio n s fo r m an agin g h allu cin atio n s an d an xiety. Wh ich statem en t in resp o n se to th ese in stru ctio n s su ggests to th e n u rse th at th e clien t h as a n eed fo r ad d itio n al in fo rm atio n ? 1. “My m edication s will h elp m y an xious feelin gs.” 2. “I’ll go to support grou p an d talk about wh at I

am feelin g.” 3. “I n eed to get en ough sleep an d eat well to h elp

preven t feelin g an xious.” 4. “Wh en I h ave com m an d h allu cin ation s, I’ll call

a frien d an d ask h im wh at I sh ould do.”

880. Th e n urse is carin g for a clien t just adm itted to th e m en tal h ealth un it an d diagn osed with catato n ic stupo r. Th e clien t is lyin g on th e bed in a fetal posi- tio n . Wh ich is th e m o st ap p ro p riate n ursin g in terven tion ? 1. Ask direct question s to en courage talkin g. 2. Leave th e clien t alon e so as to m in im ize extern al

stim uli. 3. Sit beside th e clien t in silen ce with occasion al

open -en d ed question s. 4. Take th e clien t in to th e dayroom with oth er cli-

en ts so th at th ey can h elp watch th em .

881. Th e n urse is carin g for a clien t diagn osed with para- n oid person ality disorder wh o is exp erien cin g dis- turbed th ough t processes. In form ulatin g a n ursin g plan of care, wh ich b est in terven tion sh o uld th e n urse in clude? 1. In crease socialization of th e clien t with peers. 2. Avoid usin g a wh isper voice in fro n t of th e

clien t. 3. Begin to edu cate th e clien t about social supports

in th e com m un ity. 4. Have th e clien t sign a release of in form ation to

appropriate parties for assessm en t purposes.

882. Th e n urse is plan n in g activities for a clien t diag- n osed with bipolar disorder with aggressive social beh avior. Wh ich activity would be m o st ap p ro p ri- ate for th is clien t? 1. Ch ess 2. Writin g 3. Pin g pon g 4. Basketball

1015CHAPTER 69 Mental Health Disorders

A N S W E R S 869. 3 Ra tion a le: It is m ost th erap eutic fo r th e n urse to em path ize with th e clien t’s experien ce. Th e rem ain in g option s lack th is con n ection with th e clien t. Disagreein g with d elu sio n s m ay m ake th e clien t m ore d efen sive, an d th e clien t m ay clin g to th e d elu sio n s even m ore. En co uragin g d iscu ssio n regard in g th e d elu sio n is in app ro p riate. Test-Ta kin g Str a tegy: Note th e strategic wo rd , best. Use th er- ap eu tic co m m u n icatio n tech n iq u es. Elim in ate o p tion s th at sh o w disagreem en t with th e clien t o r en co urage an y discu ssion regard in g th e delu sio n . Review: Th erap eu tic co m m u n icatio n tech n iq u es fo r th e cli- en t with d elu sio n s Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Com m un icatio n an d Docum en tation Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Co m m u n ication ; Psych o sis Refer en ce: Varcaro lis (2013), pp . 121–123.

870. 2 Ra tion a le: Provisio n o f a con sisten t daily ro utin e an d a lo w stim - u latin g en viro nm en t is im portan t wh en a clien t is d isorien ted. Noise, in cludin g radio an d televisio n , m ay add to th e con fu sio n and d isorien tation . Mo vin g th e client n ext to th e n urses’ statio n m ay becom e n ecessary but is n ot th e in itial action . Test-Ta kin g St r a t egy: No te th e strategic wo rd , initially. Elim - in ate o ptio n s th at are in app ro priate o r prem atu re actio n s an d m ay in crease stim u latio n an d ad d to th e co n fusion . Th is will d irect yo u to th e co rrect o p tion . Review: Care for th e clien t wh o is co n fu sed o r d iso rien ted Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Co gn itio n ; Safety Refer en ce: Varcaro lis (2013), pp . 340–341.

871. 4 Ra tion a le: A clien t with depression often is with drawn wh ile exp erien cin g difficu lty co n cen tratin g, loss of in terest or plea- su re, lo w en ergy, fatigu e, an d feelin gs of worth lessn ess an d p oo r self-esteem . Th e p lan of care n eeds to p ro vide su ccessfu l exp erien ces in a stim u latin g yet structu red en viro n m en t. Th e rem ain in g o p tion s are eith er to o “restrictive” o r o ffer little or n o structure an d stim ulation . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e plan for a cli- en t with depressio n . Recall th at a d ep ressed clien t req u ires a structured an d stim u latin g p ro gram in a safe en viron m en t. Th e correct o ptio n is th e on ly o n e th at will provide a safe an d effective en viron m en t. Review: Care for th e clien t with d ep ressio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Moo d an d Affect; Safety Refer en ce: Stu art (2013), p p . 312–313.

872. 2 Ra tion a le: Reco gn izin g situ ation s th at p ro d uce an xiety allo ws th e clien t to p rep are to co p e with an xiety o r avo id a sp ecific stim ulus. Co un selors will n ot be available for all an xiety- p ro du cin g situ atio n s, an d th is o ptio n d oes n ot en co urage th e d evelop m en t of in tern al stren gth s. Su pp ressin g feelin gs will n o t resolve an xiety. Elim in ation of all an xiety from life is im po ssib le. Test-Ta kin g Str a tegy: Focus on th e strategic wo rd s, most appropriate. Elim in ate an y o ptio n th at co n tain s th e clo sed - en d ed wo rd all o r su ggests th at feelin gs sh ou ld be su pp ressed. No te th at th e correct o ptio n is m o re clien t-cen tered an d h elp s p rep are th e clien t to d eal with an xiety sh ou ld it occur. Review: Ho m e care in structio n s for a clien t with ch ro n ic an xiety Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Health Pro m otio n Refer en ce: Varcaro lis (2013), p. 180.

873. 1 Ra tion a le: Th e avo id an t person ality disorder is ch aracterized b y so cial with d rawal an d extrem e sen sitivity to p o ten tial rejec- tio n . Th e p erson retreats to so cial iso latio n . Bo rd erlin e person - ality d iso rd er is ch aracterized by u n stable m oo d an d self-im age an d im p u lsive an d u n p red ictab le beh avior. Sch izo typal p er- so n ality d iso rd er is ch aracterized by th e disp lay of abn orm al th o ugh ts, p ercep tion s, speech , an d b eh avio rs. O bsessive- com pu lsive p erso n ality d iso rd er is ch aracterized by perfection - ism , th e n eed to co n trol o th ers, an d a d evotion to work. Test-Ta kin g St r a t egy: Fo cu s on th e su b ject, a type of person - ality disorder. Fo cu sin g on th e wo rd s hypersensitivity to a reaction will d irect you to th e co rrect op tion . Review: Perso n ality d iso rd er Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Caregivin g Refer en ce: Keltn er, Steele (2015), pp . 364–365.

874. 1 Ra tion a le: Man ic clien ts m ay be talkative an d can d om in ate gro u p m eetin gs o r th erap y sessio n s by th eir excessive talkin g. If th is occu rs, th e n u rse in itially wo u ld set lim its o n th e clien t’s b eh avio r. In itially, askin g th e clien t to leave th e sessio n or ask- in g an oth er p erso n to escort th e clien t ou t of th e sessio n is in ap p ro priate. Th is m ay agitate th e clien t an d escalate th e cli- en t’s b eh avio r fu rth er. Barrin g th e clien t fro m grou p session s is also an in app ro priate action because it vio lates th e clien t’s righ t to receive treatm en t an d is a th reaten in g actio n . Test-Ta kin g Str a tegy: No te th e strategic wo rd , initially. Elim - in ate op tio n s th at are co m p arab le o r alike an d relate to th e clien t leavin g th e session . Next, elim in ate th e op tion th at vio - lates th e clien t’s righ t to receive treatm en t an d is a th reaten in g action . Rem em b er th at settin g firm lim its with th e clien t in i- tially is b est. Review: Care for th e clien t with m an ia

M

e

n

t

a

l

H

e

a

l

t

h

1016 UNIT XIX Mental Health Disorders of the Adult Client

Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Caregivin g; Psych o sis Refer en ce: Varcarolis (2013), p . 40.

875. 3 Ra t ion a le: A co n version d isorder is th e alteratio n or lo ss of a ph ysical fun ction th at can n ot be explain ed b y an y kn own path - op h ysio logical m ech an ism . A con version disorder is th o u gh t to be an expressio n o f a p sych olo gical n eed or co n flict. In th is situatio n , th e clien t witn essed an accid en t th at was so p sych o- logically pain ful th at th e clien t becam e b lin d . Psych o sis is a state in wh ich a person ’s m en tal cap acity to reco gn ize reality, co m m u n icate, an d relate to o th ers is im paired, in terferin g with th e person ’s ab ility to d eal with life’s d em an ds. Rep ression is a co pin g m ech an ism in wh ich u n accep tab le feelin gs are kept o ut of awaren ess. A d isso ciative d iso rd er is a d istu rb an ce o r alter- ation in th e n o rm ally in tegrative fun ctio n s of iden tity, m em - ory, o r con scio u sn ess. Test -Ta kin g Str a tegy: Focu s on th e su b ject, th e cau se o f acu te blin dn ess. Th e key to th e co rrect o p tion lies in th e fact th at th e clien t presen ts n o o rgan ic reason to acco un t fo r th e blin dn ess—h en ce, a con version disorder. Review: Defen se m ech an ism s associated with co n versio n d iso rd ers Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Caregivin g; Psych o sis Refer en ce: Varcarolis (2013), p p. 196, 201.

876. 3 Ra t ion a le: Th e clien t is at risk for in ju ry to self an d o th ers an d sh ou ld be escorted ou t o f th e d ayro om . Seclusion is prem atu re in th is situ ation . Tellin g th e clien t th at th e beh avior is in ap pro- priate h as already been attem p ted by th e n urse. Den yin g p riv- ileges m ay in crease th e agitatio n th at already exists in th is clien t. Test -Ta kin g St r a t egy: Elim in ate o ption 2 because th is in ter- ven tio n h as alread y b een attem p ted. Next, u se Maslo w’s Hier- arch y o f Need s th eo ry to an swer th e q uestion . Rem em ber th at if a ph ysiological n eed is n o t p resen t, fo cu s o n safety. Lo o k for th e op tio n th at p ro m o tes safety o f th e clien t, o th er clien ts, an d staff. Review: App ro priate in terven tion s wh en d ealin g with a m an ic clien t Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Mo od an d Affect; Safety Refer en ce: Varcarolis (2013), p p. 284, 290–291.

877. 1, 3, 4, 6 Ra t ion a le: In terven tio n s fo r d ealin g with th e clien t exh ibitin g m an ipu lative b eh avio r in clu d e settin g clear, co n sisten t, an d en fo rceable lim its on m an ipu lative beh aviors; b ein g clear

with th e clien t regardin g th e con sequen ces of exceedin g th e lim its set; followin g th ro u gh with th e co n seq u en ces in a n on pu n itive m an n er; an d assistin g th e clien t in iden tifyin g a m ean s o f settin g lim its on perso n al beh aviors. En surin g th at th e clien t kn o ws th at h e o r sh e is n ot in ch arge o f th e n u rsin g u n it is in app ro priate; p ower stru ggles n eed to be avoid ed . En forcin g rules an d in form in g th e clien t th at h e or sh e will n ot b e allo wed to atten d th erapy grou ps is a vio latio n o f a clien t’s righ ts. Test -Ta kin g St r a t egy: Focus on th e su b ject, m an ipulative b eh avio r. Recallin g clien ts’righ ts an d th at p ower struggles n eed to b e avo id ed will assist in selectin g th e correct in terven tio n s. Review: Care fo r th e clien t with m an ip u lative b eh avio r Level of Cogn it ive Ability: An alyzin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Clin ical Jud gm en t; Mo od an d Affect Refer en ce: Varcarolis (2013), p p. 288–289.

878. 1 Ra t ion a le: Safety of th e clien t an d oth er clien ts is th e im m ed i- ate p riority. Th e co rrect op tio n is th e on ly o n e th at ad dresses th e safety n eed s of th e clien t as well as th o se o f th e oth er clien ts. Test -Ta kin g St r a t egy: Note th e strategic wo rd s, immediate pri- ority, an d use Maslo w’s Hierarch y o f Need s th eo ry to priori- tize. Note th e words agitated, aggressive, an d belligerent. Safety is th e p rio rity fo cu s if a p h ysio lo gical n eed d oes n o t exist. Also , th e correct o ptio n is th e u m b rella o p tio n an d ad d resses th e safety o f all. Review: Nursin g in terven tio n s fo r aggressive b eh avio r Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Mo od an d Affect; Safety Refer en ce: Varcarolis (2013), p . 291.

879. 4 Ra t ion a le: Th e risk fo r im p ulsive an d aggressive b eh avio r m ay in crease if a clien t is receivin g com m an d h allu cin ation s to h arm self o r o th ers. If th e clien t is exp erien cin g a h allu cin atio n , th e n u rse o r h ealth care co un selo r, n ot a frien d, sh ou ld b e co n - tacted to d iscu ss wh eth er th e clien t h as in ten tion s to h u rt h im - self o r h erself o r o th ers. Talkin g ab ou t aud itory h allucin atio n s can in terfere with su b vo cal m uscular activity associated with a h allu cin ation . Th e clien t statem en ts in th e rem ain in g op tio n s will aid in welln ess, but are n ot specific in terven tion s for h al- lucin atio n s, if th ey occu r. Test -Ta kin g St r a t egy: No te th e strategic wo rd s, need for addi- tional information. Th ese wo rd s in d icate a n egative even t q u ery an d th e n eed to select th e in correct statem en t as th e an swer. Fo cu s o n th e su b ject, m an agin g h allu cin atio n s an d an xiety. Th e co rrect o p tion is a sp ecific agreem en t to seek ap p ro priate h elp . Th e rem ain in g op tion s are in terven tion s th at a clien t can carry o ut to aid welln ess. Review: Teach in g poin ts for a clien t with a h istory of h allu cin atio n s Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Psych oso cial In tegrity

M

e

n

t

a

l

H

e

a

l

t

h

1017CHAPTER 69 Mental Health Disorders

In tegr a t ed Pr ocess: Nursin g Pro cess—Teach in g an d Learn in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Varcaro lis (2013), p. 316.

880. 3 Ra tion a le: Clien ts wh o are with drawn m ay b e im m o bile an d m ute an d m ay req uire con sisten t, rep eated ap proach es. Com - m un icatio n with with drawn clien ts req uires m uch p atien ce from th e n u rse. In terven tion s in clud e th e estab lish m en t of in terp erso n al con tact. Th e n urse facilitates com m un ication with th e clien t by sittin g in silen ce, askin g open -en ded ques- tio n s rath er th an d irect qu estio n s, an d p au sin g to provid e o pp ortun ities fo r th e clien t to resp o n d . Wh ile o verstim u latio n is n o t app ro p riate, th ere is n o th erap eutic valu e in ign o rin g th e clien t. Th e clien t’s safety is n o t th e respo n sibility of o th er clien ts. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Elim in ate o ptio n s eith er th at are n o n th erap eutic or th at p lace th e resp on sibility of clien t care an d safety o n so m eon e o th er th an app ro priate staff. Also elim in ate op tio n s th at are n o t exam ples of th erapeu tic co m m u n ication . Th e correct o ptio n p ro vides fo r clien t sup ervision an d com m un ication as app ro priate. Review: Care for th e clien t with catato n ic stu p o r Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Caregivin g; Psych osis Refer en ce: Keltn er, Steele (2015), p. 273.

881. 2 Ra tion a le: Disturbed th ou gh t process related to paran oid per- so n ality disorder is th e clien t’s p ro blem , an d th e p lan of care m ust add ress th is p ro blem . Th e clien t is distru stful an d su spi- ciou s of oth ers. Th e m em b ers of th e h ealth care team n eed to

estab lish a rap p ort an d trust with th e clien t. Laugh in g o r wh is- p erin g in fro n t o f th e clien t wo uld b e co un terp ro du ctive. Th e rem ain in g option s ask th e clien t to tru st on a m u ltitud e of levels. Th ese op tion s are action s th at are to o in tru sive fo r a cli- en t with th is d iso rd er. Test-Ta kin g St r a t egy: Focus o n th e su b ject, in terven tion s fo r p aran o id person ality diso rder, an d n o te th e strategic wo rd , best. No te th at th e clien t h as paran o ia; th in kin g ab o ut its d ef- in ition will d irect you to th e co rrect op tion . Review: Paran o ia Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Caregivin g; Psych o sis Refer en ce: Varcaro lis (2013), p. 317.

882. 2 Ra tion a le: Solitary activities th at req uire a sh o rt atten tio n sp an with m ild ph ysical exertion are th e m ost appropriate activities fo r a clien t wh o is exh ib itin g aggressive beh avior. Writin g (jo urn alin g), walks with staff, an d fin ger p ain tin g are activities th at m in im ize stim uli an d p ro vide a con stru ctive release fo r ten sion . Th e rem ain in g op tio n s h ave a com p etitive elem en t to th em an d sh o uld be avo ided because th ey can stim ulate aggression an d in crease psych o m o tor activity. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Elim in ate op tion s th at in clu de activities th at th e clien t can - n o t d o alo n e an d are co m petitive in n ature. Th e correct op tion id en tifies a solitary activity. Review: Care for th e aggressive clien t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Moo d an d Affect; Safety Refer en ce: Stu art (2013), p . 373.

M

e

n

t

a

l

H

e

a

l

t

h

1018 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

C H A P T E R 70 Addictions

PRIORITY CONCEPTS Addiction; Coping

CRITICAL THINKING What Should You Do? The nurse notes that a client is experiencing signs of alcohol withdrawal delirium. What should the nurse do? Answer located on p. 1026.

I. Eating Disorders A. Description : Eatin g disorders are ch aracterized by

un sure self-iden tification an d grossly disturbed eat- in g h abits (Fig. 70-1).

B. Com p ulsive overeatin g 1. Com p ulsive overeatin g is bin ge-like overeatin g

with out purgin g. 2. Food con sum p tion is out of th e in dividual’s con -

tro l an d occurs in a stereotyped fash ion . 3. Repu lsed by eatin g, th at is, th e eatin g relieves

ten sion but does n ot produce pleasure 4. Aware th at eatin g pattern s are ab n orm al an d

feels depressed after eatin g 5. Eats secretly durin g a bin ge an d con sum es h igh -

calorie an d easily digestible food 6. Repeatedly tries to diet, but with ou t success 7. Feels h elpless an d h opeless about weigh t 8. Resp on ds to feelin gs of guilt, an ger, dep ression ,

bored om , lo n elin ess, in adeq uacy, or am biva- len ce by eatin g

C. An o rexia n ervosa 1. Description

a. O n set often is associated with a stressful life even t.

b . In ten sely fears obesity c. Bod y im age is distorted an d a disturbed self-

con cept is com m on . d . Preoccupied with foods th at preven t weigh t

gain an d h as a ph o bia again st food s th at pro- duce weigh t gain

e. Th e eatin g disorder can be life-th reaten in g. f. Death can occur from starvation , suicide,

cardiom yopath ies, or electrolyte im balan ces.

2. Assessm en t a. Appetite lo ss an d refusal to eat b . Appetite den ial c. Feelin gs of lack of con trol d . Com p ulsive exercisin g e. O verach iever an d perfection ist f. Ph ysical alteration s: Man y occur an d can

in clude decreased tem perature, pulse, an d blood pressure; weight loss; gastroin testin al dis- turban ces such as con stipation; teeth an d gum deterioration ; esoph ageal varices from in duced vom itin g; electrolyte im balan ces; dry, scaly skin ; presen ce of lanugo on extrem ities; sleep disturban ces; horm on e deficien cies; am en or- rh ea for at least 3 con secutive m en strual periods; cyan osis an d n um bn ess of extrem ities; an d bon e degen eration .

D. Bulim ia n ervosa 1. Description

a. In dulges in eatin g bin ges followed by purgin g beh aviors.

b . Most clien ts rem ain with in a n orm al weigh t ran ge, but th in k th at th eir lives are dom in ated by th e eatin g-related con flict.

2. Assessm en t a. Preoccu pied with body sh ap e an d weigh t b . Con sum ption of h igh -calorie food in secret;

guilt about secretive eatin g c. Bin ge-purge syn drom e d . Attem pts to lo se weigh t th rough diets, vom it-

in g, en em as, cath artics, an d am ph etam in es or diuretics

e. Has a n eed to con trol, yet experien ces feelin gs of powerlessn ess or loss of co n trol

f. Low self-esteem g. Poor in terp erson al relation sh ips h . Decreased in terest, or absen ce of in terest,

in sex i. Moo d swin gs j. Electrolyte im balan ces k . Ph ysical alteration s: Sim ilar to th ose th at

occur with an orexia n ervosa 1019

E. In terven tion s: Clien ts with an eatin g disorder 1. Assess n utrition al status an d th e severity of an y

m ed ical problem s. 2. Establish a on e-to-on e th erapeutic relation sh ip

with th e clien t; th e n urse n eeds to establish trust an d recogn ize an y clien t relu ctan ce to establish a relation sh ip.

3. Establish a plan con cern in g th e n utrition al plan for th e day.

4. Assist to iden tify precipitan ts to th e eatin g disorder.

5. En cou rage th e clien t to exp ress feelin gs about th e eatin g beh avior an d h ow th e clien t feels about h is or h er body.

6. Be acceptin g an d n on judgm en tal. 7. Work on explorin g self-con cep t an d establish in g

iden tity. 8. Im p lem en t beh avio r m odification tech n iques. 9. If in a h ealth care facility, supervise durin g m eal-

tim es an d for a specified period after m eals an d m on itor in take an d outp ut; set a tim e lim it for each m eal an d provide a pleasan t, relaxed en vi- ron m en t for eatin g.

10. Mon itor for sign s of ph ysical co m plication s related to th e eatin g disorder.

11. Weigh daily at th e sam e tim e, usin g th e sam e scale, after th e clien t voids (weigh in g each day m ay decrease an xiety in som e clien ts); wh en weigh in g th e clien t, en sure th at th e clien t is wear- in g th e sam e clo th in g as wh en th e previous weigh t was taken .

12. Mon itor an d restore fluid an d electrolyte balance.

13. Mon itor elim in ation pattern s. 14. Assess an d lim it th e clien t’s activity level

(an orexia n ervosa an d bulim ia n ervosa). 15. En cou rage th e clien t to participate in diversion al

activities. 16. Assess suicide poten tial. 17. Adm in ister an tidepressan t m ed ication if

prescribed. 18. En cou rage psych o th erap y. 19. Refer to supp ort groups.

II. Substance Abuse Disorders A. Descrip tion : Substan ce ab use disorders cause beh av-

ioral an d ph ysiological ch an ges ( Box 70-1). B. Substan ce depen den ce

1. Substan ce depen den ce is a pattern of repeated use of a substan ce, wh ich usually results in toler- an ce, with drawal sym ptom s, an d com pulsive drug-takin g beh avio r.

M

e

n

t

a

l

H

e

a

l

t

h

plus

o r

Hunge r, a nge r (re la te d to de priva tion)

Binge e a ting (numbing of pa in, the n guilt, fe a r of we ight ga in)

Re s urge nce of fe e ling out of control

P urging to re ga in a s e ns e of control

More we ight los s

Fe e ling powe r a nd control

More we ight los s

Die ting a s a n a tte mpte d s olution to ge t “in control”

We ight los s

Pos itive re inforce me nt from othe rs

More die ting

• Biologica l pre dis pos ition • P s ychologica l pre dis pos ition • Fa mily dys function

• De ve lopme nta l pre s s ure (a dole s ce nce )

• S ociocultura l pre s s ure

Ano re xia ne rvo s a Bulimia ne rvo s a

FIGURE 70-1 Cycle of eating disorders.

BOX 70-1 CAGE Screening Questionnaire C Have you ever felt the need to cut down on your drinking/

drug use? A Have you ever been annoyed at criticism of your drinking/

drug use? G Have you ever felt guilty about something that you have

done when you have been drinking or taking drugs? E Have you ever had an eye opener—drinking or taking drugs

first thing in the morning to get going or to avoid with- drawal symptoms?

1020 UNIT XIX Mental Health Disorders of the Adult Client

2. Substan ces are taken in larger am oun ts an d over lo n ger periods th an was in ten ded.

3. Th ere is a desire to cut down , but efforts to decrease or discon tin ue use are un successful.

4. Daily activities revolve aroun d th e use of a substan ce.

Screening tools are available to assess a substance abuse disorder; some are Michigan Alcohol Screening Test (MAST), Drug Abuse Screening Test (DAST), and CAGE screening questionnaire.

C. Substan ce toleran ce is th e n eed for in creased am oun ts of th e substan ce to ach ieve th e desired effect.

D. Substan ce ab use 1. Uses substan ces recurren tly 2. Recurren t, sign ificant h arm ful con sequen ces

related to the use of substan ces are experien ced. 3. In volvem en t with th e legal system is com m on ;

th e clien t m ay h ave legal issues to deal with an d resolve.

E. Substan ce with drawal 1. Ph ysiological an d substan ce-specific cogn itive

sym ptom s occur. 2. Substan ce with drawal occurs wh en an in dividual

exp erien ces a decrease in blood levels of a sub- stan ce on wh ich th e in dividual is ph ysiologically dep en den t.

F. O th er factors to con sider in a clien t with a substan ce- related disorder 1. Rebellion an d peer grou p pressure in adoles-

cen ce m ay con tribute to th e on set of substan ce use.

2. Substan ce use m ay beco m e a coping mechanism used to decrease ph ysical an d em otion al pain .

3. Depression m ay precede or occur as a result of or in association with substan ce use.

4. Grief an d lo ss m ay be associated with substan ce use.

G. Dysfu n ction al beh aviors related to substan ce ab use 1. Preoccupation with obtain in g an d usin g

substan ce 2. Man ipulation to avoid con sequen ces of beh avior 3. Im p ulsiven ess 4. An ger, in cludin g ph ysical an d verbal abuse 5. Avo idan ce of relation sh ips outsid e th e

fam ily un it 6. Relation sh ips with in th e fam ily becom e dysfun c-

tio n al as th e ch ildren take on atypical roles to protect th e fam ily un it

7. Sen se of self-im portan ce an d requirin g special treatm en t

8. Den ial—blam in g everyth in g but th e substan ce use for problem s

9. Use of ration alization an d projection to justify un acceptable beh avior

10. Low self-esteem

11. Depression 12. Codepen den cy issues

a. Codependency refers to the presen ce of coexist- in g beh aviors present in a sign ifican t oth er, which serves to enable the addict or alcoh olic to contin ue the irrespon sible pattern s of use with out experiencing con sequences.

b . Exam ples of codepen den cy: Payin g bills for wh ich th e ad dict or alcoh olic is respo n sible, bailin g th e addict or alcoh olic out of jail, an d h elpin g th e addict or alcoh olic to call in sick to em p loym en t agen cy.

c. It is im portan t to address codepen den cy issues with th e fam ily to m axim ize th e ch an ce for recovery of th e clien t with th e addiction an d th e perso n with th e codepen den t beh aviors.

III. Alcohol Abuse A. Description

1. Alco h ol is a cen tral n ervou s system (CNS) dep ressan t affectin g all body tissues.

2. Ph ysical dep en den ce is a biological n eed for alcoh ol to avoid ph ysical with drawal sym pto m s, wh ereas psych o logical depen den ce refers to crav- in g for th e subjective effect of alcoh ol.

B. Risk factors 1. Biological predisp osition ; gen etic an d fam ilial

predisp osition m ay also be a risk facto r. 2. Depressed an d h igh ly an xiou s ch aracteristics 3. Low self-esteem 4. Poor self-con trol 5. Histo ry of rebelliousn ess, poor sch o ol perfor-

m an ce, an d delin q uen cy 6. Poor paren tal relation sh ips

C. Assessm en t 1. Slurred speech 2. Un coordin ated m ovem en ts 3. Un steady gait 4. Restlessn ess 5. Con fusion 6. Sn eakin g drin ks, drin kin g in th e m orn in g, an d

experien cin g blackouts 7. Bin ge drin kin g 8. Argu m en ts ab out drin kin g 9. Missin g work 10. In creased toleran ce to alcoh ol 11. In toxication , with blood alcoh ol con ten t (BAC)

of 0.1% (100 m g alcoh ol/ dL blood ) or greater (legal BAC m ay vary state to state)

Part of the assessment should include the type of alco- hol, how much, for how long, and when last consumed.

D. Psych o logical sym pto m s 1. Depression 2. Irritable, belligeren t, an d h ostile

M

e

n

t

a

l

H

e

a

l

t

h

1021CHAPTER 70 Addictions

3. Susp iciousn ess 4. Ration alization 5. Iso lation 6. Decrease in in h ib ition s 7. Decrease in self-esteem 8. Den ial th at a problem exists

E. Com p lication s associated with ch ron ic alcoh ol use 1. Vitam in deficien cies

a . Vitam in B deficien cy causin g periph eral n europath ies

b . Th iam in e deficien cy, causin g Korsako ff’s syn d rom e

2. Alco h ol-in duced persisten t am n esic disorder, cau sin g severe m em ory problem s

3. Wern icke’s en ceph alopath y, cau sin g con fusion , ataxia, an d ab n orm al eye m ovem en ts

4. Hepatitis; cirrh osis of th e liver 5. Esoph agitis an d gastritis 6. Pan creatitis 7. An em ias 8. Im m un e system dysfun ction s 9. Brain dam age 10. Periph eral n europath y 11. Card iac disorders

IV. Alcohol Withdrawal A. Description

1. Early sign s develo p with in a few h ours after ces- satio n of alcoh ol in take.

2. Th ese sign s peak after 24 to 48 h ou rs an d th en rapidly disappear, un less th e with drawal pro- gresses to alcoh ol with drawal deliriu m .

3. At th e on set of with drawal ( Box 70-2), follow un it or agen cy protoco l usin g specified with - drawal assessm en t scales.

4. Ch lordiazepoxide m ay be prescribed for acu te alcoh ol with drawal an d is usually given orally, un less a m ore im m ediate on set is required (ben zodiazepin e m edication s would decrease

th e with drawal sym pto m s because of cross- toleran ce; see Ch apter 72 for a list of ben zo diazep in es).

5. An in tram uscular in jection of vitam in B1 (th ia- m in e) followed by several days of oral adm in is- tration is usually prescribed to preven t Wern icke’s en ceph alopath y.

B. With drawal (see Box 70-2) C. With drawal delirium : Th e state of delirium usually

peaks 48 to 72 h ours after cessation or reduction of in take (alth o ugh it can occur later) an d lasts 2 to 3 days (Box 70-3).

Withdrawal delirium is a medical emergency. Death can occur from myocardial infarction, fat emboli, periph- eral vascular collapse, electrolyte imbalance, aspiration pneumonia, or suicide.

D. In terven tion s 1. Provid e care in a n on judgm en tal m an n er. 2. Ch eck th e clien t frequen tly. 3. Mon itor vital sign s an d n eurological sign s (every

15 m in utes) an d provide on e-to-on e supervision . 4. Provid e a quiet, n on stim ulatin g en viron m en t;

en courage a fam ily m em ber (1 at a tim e) to stay with th e clien t to m in im ize an xiety.

5. O rien t frequen tly. 6. Explain all treatm en ts an d proced ures in a quiet

an d sim ple m an n er. 7. In itiate seizure precaution s. 8. Adm in ister sedatin g or an ticon vulsan t m edica-

tion as prescribed . 9. Provide sm all, frequen t, h igh -carboh ydrate foods

(adm in ister an tiem etic before m eals as n eeded). 10. Mon itor in take an d outp ut. 11. Adm in ister vitam in s (m ultivitam in , vitam in B

com plex in cludin g th iam in e, an d vitam in C). 12. Assist with activities of daily livin g an d assist with

am bulation if stable. 13. Allow to express fears.

E. Medication th erapy for alcoh ol abuse an d alcoh ol depen den ce 1. Description : Med ication is prescribed on ly for

th ose in dividuals wh o h ave stopped drin kin g.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 70-2 Early Signs of Alcohol Withdrawal

▪ Anorexia (nausea and vomiting may occur) ▪ Anxiety ▪ Easily startled ▪ Hyperalertness ▪ Hypertension ▪ Insomnia ▪ Irritability ▪ Jerky movements ▪ Possibly experiences hallucinations, illusions, delusions,

or vivid nightmares ▪ Possibly reports a feeling of “shaking inside” ▪ Seizures (usually appear 7 to 48 hours after cessation of

alcohol) ▪ Tachycardia ▪ Tremors

BOX 70-3 Manifestations of Alcohol Withdrawal Delirium

▪ Agitation ▪ Anorexia ▪ Anxiety ▪ Delirium ▪ Diaphoresis ▪ Disorientation with fluctuating levels of consciousness ▪ Fever (temperature of 100 °F [37.8°C] to 103°F [39.4°C]) ▪ Hallucinations and delusions ▪ Insomnia ▪ Tachycardia and hypertension

1022 UNIT XIX Mental Health Disorders of the Adult Client

2. Naltrexon e: Works by blockin g in th e brain th e “h igh ” feelin g th at people experien ce wh en th ey drin k alcoh ol

3. Acam prosate: Works by reducin g th e ph ysical distress an d em o tion al discom fort peo ple usu- ally exp erien ce wh en th ey quit drin kin g

4. Disu lfiram : Works by causin g a severe adverse reaction wh en som eon e takin g th e m ed ication con sum es alcoh ol

F. Disu lfiram th erap y 1. Description

a. Th e clien t m ust ab stain from alcoh ol for at least 12 h ou rs before th e in itial dose is ad m in istered.

b . Adverse effects usually begin with in several m in utes to 30 m in u tes after con sum in g alco- h ol an d m ay last 30 m in u tes to 2 h ou rs.

c. Th e clien t m ust avoid drin kin g alcoh ol for 14 days after disulfiram th erapy h as been dis- con tin ued; oth erwise, th e clien t is at risk for a disulfiram -alcoh ol reaction .

2. Adverse effects a. Facial flush in g b . Sweatin g c. Th robbin g h ead ach e d . Neck pain e. Nausea an d vom itin g f. Hypo ten sion g. Tach ycardia h . Resp iratory distress

3. Clien t education a. Educate about th e effects of th e m edication . b . En su re agreem en t to ab stain from alcoh ol

an d an y alcoh ol-con tain in g substan ces. c. In form th e clien t th at effects of th e m edica-

tio n m ay occur for several days after it is discon tin u ed.

G. Dealin g with th e clien t wh o h as a substan ce abuse disorder ( Boxes 70-4 an d 70-5)

Instruct the client who is on disulfiram therapy to avoid the use of substances that contain alcohol, such as cough medicines, rubbing compounds, vinegar, mouthwashes, and aftershave lotions. The client needs to read the labels of all products.

V. Drug Dependency A. CNS dep ressan ts

1. CNS depressan ts in clude alcoh ol, ben zodiaze- pin es, an d barb iturates an d act as a dep ressan t, sed ative, or h ypn otic.

2. In toxication (Box 70-6) 3. Overdose can produce cardiovascular or respira-

tory depression , com a, sh ock, seizures, an d death . 4. O verdose: If th e clien t is awake, vom itin g is

in du ced an d activated ch arcoal is adm in istered; if th e clien t is com atose, establish m en t an d

m ain ten an ce of an airway an d gastric lavage with activated ch arcoal are th e priorities; seizu re pre- cau tion s are in dicated.

5. Flum azen il in traven ously m ay be used for ben - zod iazepin e overdose to reverse th e effects.

6. With drawal effects in clude n ausea, vom itin g, tach ycardia, diap h oresis, irritab ility, trem o rs, in som n ia, an d seizu res; with drawal m ust be treated with a carefully titrated sim ilar drug (abrup t with drawal can lead to death ).

M

e

n

t

a

l

H

e

a

l

t

h

BOX 70-4 Dealing with the Client Who Abuses Alcohol

Direct the client’s focus to the substance abuse problem. Identify situations that precipitate angry feelings with the

client. Set limits on manipulative behavior and verbal and physical

abuse. Hold the client firmly to reasonable limits, consistently rein-

forcing rules, with reasonable consequences for breaking rules.

Hold the client accountable for all behaviors. Assist the client to explore strengths and weaknesses. Encourage the client to focus on strengths if the client is los-

ing control. Encourage the client to participate in group therapy and sup-

port groups.

BOX 70-5 Therapies for Clients with Substance Abuse and for Their Families

▪ Behavior therapy, aversion conditioning with medication ▪ Hospitalization ▪ Psychotherapy (individual, group, family) ▪ 12-Step support groups such as Alcoholics Anonymous;

Narcotics Anonymous; Pills Anonymous; Al-Anon, Al- a-Teen, or Narc-Anon (for family members and friends of alcoholics or addicts); and Adult Children of Alcoholics

▪ Transitional living programs (halfway houses)

BOX 70-6 Intoxication: Central Nervous System Depressants

▪ Drowsiness ▪ Hypotension ▪ Impairment of memory, attention, judgment, and social or

occupational functioning ▪ Incoordination and unsteady gait ▪ Irritability ▪ Slurred speech

1023CHAPTER 70 Addictions

7. With d rawal fro m CNS d ep ressan ts su ch as b ar- b itu rates is gen erally treated with a b arb itu rate su ch as p h en o b arb ital o r a lo n g-actin g b en zo d iazep in e.

B. CNS stim ulan ts 1. CNS stim ulan ts in clude substan ces such as

am ph etam in es, cocain e, an d crack. 2. In toxication (Box 70-7) 3. O verdose can produ ce respiratory distress,

ataxia, h yperpyrexia, seizures, co m a, stroke, m yocardial in farction , an d death .

4. O verdose is treated with an tipsych otics an d m an agem en t of associated effects.

5. With drawal effects in clude fatigue, dep ression , agitation , apath y, an xiety, in som n ia, disorien ta- tion , leth argy, an d cravin g.

6. With drawal is treated with an tidepressan ts, a dopam in e agon ist, or brom ocriptin e; with - drawal is prim arily supp ortive, particularly wh en dealin g with th e severe dep ression an d suicidal ideation th at accom pan ies stim ulan t with drawal.

C. O pioids 1. O pioids in clude substan ces such as opium , h er-

oin , m eperidin e, m orph in e, codein e sulfate, m eth adon e, h ydrom orph on e, oxycod on e, h ydroco don e, an d fen tan yl.

2. In toxication (Box 70-8) 3. O verdose can produ ce respiratory dep ression ,

sh ock, com a, seizures, an d death .

4. O verdose is treated with an opioid an tagon ist such as n aloxo n e.

5. With drawal effects in clude yawn in g, in som n ia, irritab ility, rh in o rrh ea, diaph o resis, cram p s, n au- sea an d vo m itin g, m uscle ach es, ch ills, fever, lac- rim ation , an d diarrh ea.

6. With drawal m ay be treated by m eth adon e detox- ification or taperin g dosage with oth er opioids.

7. Clon idin e, an α-adren ergic blocker, assists in reducin g th e severity of sym path etic n ervous sys- tem –gen erated with drawal discom fort.

8. Specific m easures for sym pto m m an agem en t m ay also be used, such as an tidiarrh eal agen ts an d acetam in o ph en for m uscle ach es.

D. Hallucin ogen s 1. Hallucinogen s in clude substan ces such as lysergic

acid dieth ylam ide (LSD), m escalin e (peyote), psilocybin (m ush room s), an d ph en cyclidin e (PCP).

2. In toxication (Box 70-9) 3. O verdose effects of LSD, peyote, an d psilocybin

in clude psych osis, brain dam age, an d death ; effects of PCP in clude psych osis, h yperten sive crisis, h yperth erm ia, seizures, an d respiratory arrest.

4. Treatm en t (LSD, peyote, psilocybin ) in volves low en viron m en tal stim uli (speak slowly, clearly, an d in a low vo ice) an d m ed ication s to treat an xiety.

5. Treatm en t (PCP) in volves possible gastric lavage (if alert); treatm en t to acidify the urin e to assist in excretin g th e drug; an d in terven tion s to treat beh avioral disturban ces, h yperth erm ia, h yperten - sion , an d respiratory distress.

6. Man agem en t of withdrawal is prim arily support- ive an d m ay in clude m edication s to target partic- ular problem beh aviors, such as agitation .

M

e

n

t

a

l

H

e

a

l

t

h

BOX 70-7 Intoxication: Central Nervous System Stimulants

▪ Dilated pupils ▪ Euphoria ▪ Hypertension ▪ Impairment of judgment and social or occupational

functioning ▪ Insomnia ▪ Nausea and vomiting ▪ Paranoia, delusions, hallucinations ▪ Potential for violence ▪ Tachycardia

BOX 70-8 Intoxication: Opioids ▪ Constricted pupils ▪ Decreased respirations ▪ Drowsiness ▪ Euphoria ▪ Hypotension ▪ Impairment of memory, attention, and judgment ▪ Psychomotor retardation ▪ Slurred speech

BOX 70-9 Intoxication: Hallucinogens ▪ Agitation and belligerence ▪ Anxiety and depression ▪ Bizarre behavior, regressive behavior, or violent behavior ▪ Blank stare ▪ Diaphoresis ▪ Dilated pupils ▪ Elevated vital signs, including blood pressure ▪ Hallucinations ▪ Impairment of judgment and social and occupational

functioning ▪ Incoordination ▪ Muscular rigidity and chronic jerking ▪ Paranoia ▪ Seizures ▪ Tachycardia ▪ Tremors

1024 UNIT XIX Mental Health Disorders of the Adult Client

Flashbacks, which are unexpected reexperiences of the effects of taking a hallucinogenic drug, can occur for extended periods of time after its original use. Safety dur- ing flashbacks is a priority.

E. In h alan ts 1. In h alan ts in clude gases or liquids such as butan e,

pain t th in n er, pain t an d wax rem overs, airplan e glue, n ail polish rem over, an d n itrous oxide.

2. In toxication (Box 70-10) 3. O verdose can cause dam age to th e n ervou s sys-

tem an d death . 4. Man agem en t of with drawal is m ain ly support-

ive, in cludin g th e treatm en t of affected body system s.

F. Marijuan a (Can n abis sativa) 1. Gen erally is sm oked , but can be in gested; m ay be

legally prescribed in certain states. 2. Cau ses euph oria, detach m en t, relaxation , talka-

tiven ess, slowed perception of tim e, an xiety, an d paran oia.

3. Lon g-term dep en den ce can result in leth argy, dif- ficu lty con cen tratin g, m em ory loss, an d possibly ch ron ic respiratory disorders.

4. With drawal m an agem en t is m ain ly supp ortive. G. O th er recreation al an d club drugs

There are many types of illegal street drugs that are harmful. The nurse needs to be knowledgeable about the physiological effects of these various drugs, be able to recognize the signs associated with their use, and be pre- pared to provide immediate treatment.

1. Can in clude m eth ylen edioxym eth am ph etam in e (MDMA, ecstasy), γ-h ydroxybutyrate (GHB), m eth am ph etam in e (cran k, m eth , crystal m eth ) , an d ketam in e (special K)

2. Effects in clude euph o ria, in creased en ergy, in creased self-con fiden ce, an d in creased sociability.

3. Adverse effects in clude h yperth erm ia, rh abdo- m yolysis, kidn ey failure, h epatotoxicity, depres- sion , pan ic attacks, psych o sis, cardiovascu lar collapse, an d death .

4. Program s for addictio n also address n icotin e with drawal an d th e ph arm acological an d psy- ch oth erapeutic in terven tion s for th is problem ,

such as n icotin e patch es, n icotin e in h alers, an d bupro pion for th e reduction of with drawal sym pto m s an d cravin gs.

5. An abo lic steroids h ave also gain ed in creased atten tion as in creasin gly adverse even ts, in clud- in g death , h ave beco m e m ore widely publicized.

H. In terven tion s: With drawal ( Box 70-11) 1. In itiate seizure precaution s. 2. Hydrate th e clien t. 3. Mon itor vital sign s every h our. 4. Mon itor in take an d output. 5. O rien t th e clien t frequen tly. 6. Main tain m in im al stim uli. 7. Approach th e clien t in an acceptin g an d

n on judgm en tal m an n er. 8. Direct focus to th e substan ce abuse problem . 9. Assist th e clien t with iden tifyin g situation s th at

precipitate an gry feelin gs. 10. Assist th e clien t to deal with em o tion s. 11. Lim it placin g blam e or ration alizin g to explain

th e substan ce abuse problem . 12. Assist th e clien t to use assertive tech n iques rath er

th an m an ipulation to m eet n eeds. 13. Set lim its on m an ipulative beh avior an d verbal

an d ph ysical abuse. 14. Main tain firm an d reason able lim its, con sis-

ten tly rein fo rcin g ru les, with reason able con se- quen ces for breakin g rules.

15. Hold th e client accoun table for all beh aviors. 16. Assist th e clien t to exp lore stren gth s an d

weakn esses. 17. En cou rage th e clien t to focus on stren gth s if th e

clien t is losin g con trol. 18. En cou rage th e clien t to participate in un it

activities. 19. En cou rage th e clien t to participate in grou p th er-

apy an d support grou ps.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 70-10 Intoxication: Inhalants ▪ Enhancement of sexual pleasure ▪ Euphoria ▪ Excitation followed by drowsiness, lightheadedness, disin-

hibition, and agitation ▪ Giggling and laughter

BOX 70-11 Withdrawal: Nursing Care Obtain information regarding the type of drug and amount

consumed. Assess vital signs. Remove unnecessary objects from the environment. Provide one-to-one supervision if necessary. Provide a quiet, calm environment with minimal stimuli. Maintain client orientation. Ensure the client’s safety by implementing seizure

precautions. Use security devices if necessary and as prescribed to prevent

the client from harming self and others. Provide for physical needs. Provide food and fluids as tolerated. Administer medications as prescribed to decrease withdrawal

symptoms. Collect blood and urine samples for drug screening.

1025CHAPTER 70 Addictions

I. Dual diagn oses 1. Som etim es th e use of alcoh ol an d drugs m asks

un derlyin g psych iatric path ology. 2. Psych iatric path o logy m ay also be precipitated

by substan ce use an d abuse. 3. Wh en psych iatric disorders an d substan ce abuse

are presen t togeth er, it is often referred to as dual diagnosis.

4. Separatin g psych iatric diagn osis fro m substan ce dep en den ce can be don e on ly over tim e after a sustain ed period of abstin en ce.

J. Addiction an d abuse in h ealth care profession als: Susp icious sign s 1. Frequen tly reportin g th at drugs h ave been

wasted with ou t bein g witn essed by an oth er n urse

2. Reportin g adm in isterin g m axim um dosages of con trolled substan ces to clien ts wh en oth er n urses do n ot adm in ister the m axim um dose

3. A varian ce in usual pain relief in th e absen ce of a ch an ge in dosage or frequen cy of adm in istration in th eir clien ts

4. Work pattern s in clude th e followin g: Always volu n teerin g to carry n arcotic (opioids) keys (or oth er opioid access devices per agen cy proce- dure); ch oosin g sh ifts in wh ich less supervision is presen t; ch oo sin g work areas wh ere th e use of con trolled substan ces is h igh , such as critical care un its, operatin g room , an esth esia, an d traum a un its.

5. Nu rses h ave a profession al an d eth ical obligation to report im paired co-workers.

6. Most im paired nurses are able to return to work through th e State Board of Nursing assistan ce and m on itoring program s; such program s usually require strict adh erence to clearly stated rules an d regular reports an d drug screen s.

CRITICAL THINKING What Should You Do? Answer: The nurse should immediately contact the health care provider if signs of alcohol withdrawal delirium occur, and the nurse should follow agency protocol using specified assessment scales. One-to-one supervision needs to be pro- vided to ensure safety. The nurse should provide care in a nonjudgmental manner and monitor vital signs and neuro- logical signs (every 15 minutes). The environment should be quiet and nonstimulating, and a family member should be encouraged to stay with the client to minimize anxiety. The nurse should orient the client frequently, explain all treat- ments and procedures in a quiet and simple manner, initiate seizure precautions, and administer sedating or anticonvul- sant medication as prescribed. In addition, the nurse should provide small, frequent, high-carbohydrate foods (administer antiemetic before meals as needed).

Reference: Stuart (2013), p. 454.

P R A C T I C E Q U E S T I O N S 883. Th e h om e h ealth n urse visits a clien t at h om e

an d determ in es th at th e clien t is dep en den t on drugs. Durin g th e assessm en t, wh ich action sh ould th e n urse take to plan ap propriate n ursin g care? 1. Ask th e clien t wh y h e started takin g illegal drugs. 2. Ask th e clien t about th e am oun t of drug use an d

its effect. 3. Ask th e clien t h ow lo n g h e th ough t th at h e could

take drugs with ou t som eon e fin din g out. 4. Not ask an y question s for fear th at th e clien t is

in den ial an d will th row th e n urse out of th e h om e.

884. Wh ich in terven tion s are m o st ap p ro p riate for car- in g for a clien t in alcoh ol with drawal? Select all th at ap p ly.

1. Mon itor vital sign s. 2. Provide a safe en viron m en t. 3. Address h allucin ation s th erap eutically. 4. Provide stim ulation in th e en viron m en t. 5. Provide reality orien tation as appropriate. 6. Main tain NPO (n oth in g by m ou th ) status.

885. Th e n urse determ in es th at th e wife of an alcoh olic clien t is ben efitin g fro m atten din g an Al-An on grou p if th e n urse h ears th e wife m ake wh ich statem en t? 1. “I n o lo n ger feel th at I deserve th e beatin gs m y

h usban d in flicts on m e.” 2. “My atten dan ce at th e m eetin gs h as h elped m e

to see th at I provoke m y h usban d’s violen ce.” 3. “I en jo y atten din g th e m eetin gs because th ey get

m e out of th e h ouse an d away from m y h usban d.”

4. “I can tolerate m y h usban d’s destru ctive beh av- iors n ow th at I kn ow th ey are com m on am on g alcoh olics.”

886. A h ospitalized clien t with a h isto ry of alcoh ol abuse tells th e n urse, “I am leavin g n ow. I h ave to go . I don ’t wan t an y m ore treatm en t. I h ave th in gs th at I h ave to do righ t away.” Th e clien t h as n ot been disch arged an d is sch eduled for an im portan t diagn ostic test to be perform ed in 1 h ou r. After th e n urse discusses th e clien t’s con - cern s with th e clien t, th e clien t dresses an d begin s to walk out of th e h ospital room . Wh at action sh ould th e n urse take? 1. Call th e n ursin g superviso r. 2. Call security to block all exit areas. 3. Restrain th e clien t un til th e h ealth care provider

(HCP) can be reach ed. 4. Tell th e clien t th at th e clien t can n ot return to

th is h ospital again if th e clien t leaves n ow.

M

e

n

t

a

l

H

e

a

l

t

h

1026 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

887. Th e n urse is preparin g to perform an ad m ission assessm en t on a clien t with a diagn osis of bulim ia n ervosa. Wh ich assessm en t fin din gs sh ould th e n urse exp ect to n ote? Select all th at ap p ly.

1. Den tal decay 2. Moist, oily skin 3. Loss of tooth en am el 4. Electrolyte im balan ces 5. Body weigh t well below id eal ran ge

888. Th e n urse is carin g for a fem ale clien t wh o was adm itted to th e m en tal h ealth un it recen tly for an orexia n ervosa. Th e n urse en ters th e clien t’s room an d n otes th at th e clien t is en gaged in rigor- ous push -up s. Wh ich n ursin g action is m o st ap p ro p riate? 1. In terrupt th e clien t an d weigh h er im m ediately. 2. In terrupt th e clien t an d offer to take h er for

a walk. 3. Allow th e clien t to com plete h er exercise

program . 4. Tell th e clien t th at sh e is n ot allowed to exercise

rigorously.

889. A clien t with a diagn osis of an orexia n ervosa, wh o is in a state of starvation , is in a 2-bed ro om . A n ewly ad m itted clien t will be assign ed to th is cli- en t’s room . Wh ich clien t would be th e b est ch oice as a ro om m ate for th e clien t with an orexia n ervosa? 1. A clien t with pn eum on ia 2. A clien t un d ergoin g diagn ostic tests 3. A clien t wh o th rives on m an agin g oth ers 4. A clien t wh o could ben efit fro m th e clien t’s

assistan ce at m ealtim e

890. Th e n urse is m on itorin g a h ospitalized clien t wh o ab uses alcoh ol. Wh ich fin din gs sh ould alert th e n urse to th e poten tial for alcoh ol with drawal delirium ? 1. Hypo ten sion , ataxia, h un ger 2. Stupor, leth argy, m uscu lar rigidity 3. Hypoten sion , coarse h an d trem o rs, leth argy 4. Hyperten sion , ch an ges in level of con scious-

n ess, h allucin ation s

891. Th e spou se of a clien t adm itted to th e m en tal h ealth un it for alcoh ol with drawal says to th e n urse, “I sh ould get out of th is bad situation .” Wh ich is th e m o st h elpful respo n se by th e n urse? 1. “Wh y don ’t you tell your spouse ab out th is?” 2. “Wh at do yo u fin d difficult about th is situation ?” 3. “Th is is n ot th e best tim e to m ake th at decision .” 4. “I agree with yo u. You sh ould get out of th is

situation .”

892. A clien t with an orexia n ervosa is a m em ber of a pre- disch arge support grou p. Th e clien t verbalizes th at sh e would like to buy som e n ew cloth es, but h er fin an ces are lim ited. Group m em bers h ave brough t som e used clo th es to th e clien t to replace th e cli- en t’s old cloth es. Th e clien t believes th at th e n ew clo th es are m uch too tigh t an d h as reduced h er cal- orie in take to 800 calories daily. How sh ould th e n urse evaluate th is beh avior? 1. No rm al beh avior 2. Eviden ce of th e clien t’s disturbed body im age 3. Regression as th e clien t is m ovin g toward th e

com m un ity 4. In dicative of th e clien t’s am bivalen ce about h os-

pital disch arge

A N S W E R S 883. 2 Ra t ion a le: Wh en ever th e n u rse carries ou t an assessm en t fo r a clien t wh o is d epen den t o n drugs, it is b est fo r th e n urse to attem p t to elicit in fo rm atio n b y bein g n on ju dgm en tal an d direct. O p tio n 1 is in co rrect b ecau se it is ju dgm en tal an d o ff- fo cus, an d reflects th e n urse’s bias. O p tio n 3 is in correct because it is ju d gm en tal, in sen sitive, an d aggressive, wh ich is n on th erapeu tic. O ption 4 is in correct because it in d icates pas- sivity on th e n u rse’s p art an d u ses ration alizatio n to avo id th e th erap eu tic n ursin g in terven tio n . Test -Ta kin g St r a tegy: Fo cu s on th e su b ject, p ro vid in g ap p ro - priate n u rsin g care. Use of th erap eu tic co m m u n icatio n tech - n iq u es will assist in d irectin g yo u to th e co rrect o p tion . Review: Assessm en t o f a clien t wh o is d epen den t on d ru gs Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Men tal Health

Pr ior ity Con cepts: Ad d iction ; Com m un icatio n Refer en ces: Keltn er, Steele ( 2015) , p p. 80–81; Stu art ( 2013) , p . 226.

884. 1, 2, 3, 5 Ra t ion a le: Wh en th e clien t is exp erien cin g with d rawal fro m alco h o l, th e p rio rity for care is to preven t th e clien t fro m h arm - in g self o r o th ers. Th e n urse wo uld m on itor th e vital sign s clo sely an d rep ort abn orm al fin din gs. Th e n u rse wo uld pro vide a low-stim ulatio n en viron m en t to m ain tain th e clien t in as calm a state as p ossible. Th e n u rse wou ld reorien t th e clien t to reality frequ en tly an d wo u ld ad d ress h allu cin atio n s th era- p eu tically. Adeq u ate n u trition al an d flu id in take n eed to b e m ain tain ed . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. Th in kin g ab ou t th e n eeds o f th e clien t in alco h o l with - d rawal an d recallin g th e ch aracteristics asso ciated with alco h o l with d rawal will assist in an swerin g correctly. Also , u se th erap eu tic co m m u n icatio n tech n iq u es to assist in selectin g th e correct in terven tion s.

1027CHAPTER 70 Addictions

Review: In terven tio n s for th e clien t exp erien cin g alco h o l with d rawal Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Ad dictio n ; Caregivin g Refer en ce: Varcaro lis (2013), pp . 370, 372.

885. 1 Ra tion a le: Al-An o n sup po rt gro up s are a p ro tected , sup po rtive o pp ortun ity fo r sp ou ses an d sign ifican t o th ers to learn wh at to exp ect an d to o btain excellen t p oin ters abo ut su ccessfu l b eh av- io ral ch an ges. Th e correct o ptio n is th e h ealth iest resp on se b ecau se it exem plifies an u n d erstan d in g th at th e alcoh olic p art- n er is resp on sible fo r h is beh avior an d can n o t b e allowed to b lam e fam ily m em bers for lo ss of co n tro l. O ption 2 is in co rrect b ecau se th e n o n alco h o lic partn er sh ou ld n ot feel respo n sib le wh en th e spou se loses con trol. O ption 3 in dicates th at th e gro u p is viewed as an escap e, n o t as a p lace to work o n issues. O ptio n 4 in dicates th at th e wife rem ain s co dep en d en t. Test-Ta kin g Str a tegy: Focus o n th e su b ject, th e th erapeutic effect o f atten din g an Al-An on gro up . Notin g th e words benefiting from attending an Al-Anon group will direct you to th e correct o ption . Review: Th e pu rp ose of specific su p p o rt gro u p s Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Evaluatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Ad dictio n ; Fam ily Dyn am ics Refer en ce: Varcaro lis (2013), p. 391.

886. 1 Ra tion a le: Mo st h ealth care facilities h ave do cum en ts th at th e clien t is asked to sign relatin g to th e clien t’s resp o n sib ilities wh en th e clien t leaves again st m edical advice. Th e clien t sh ould b e asked to wait to sp eak to th e HCP befo re leavin g an d to sign th e “again st m ed ical advice” d ocum en t b efo re leavin g. If th e clien t refuses to d o so , th e n urse can n o t h old th e clien t again st th e clien t’s will. Th erefore, in th is situ atio n , th e n urse sh ou ld call th e n ursin g su perviso r. Th e n urse can b e ch arged with false im p riso n m en t if a clien t is m ade to believe wro n gfully th at h e o r sh e can n ot leave th e h o sp ital. Restrain in g th e clien t an d call- in g security to block exits co n stitu tes false im p riso n m en t. All clien ts h ave a righ t to h ealth care an d can n o t b e to ld oth erwise. Test-Ta kin g Str a tegy: Keepin g th e co n cept o f false im p rison - m en t in m in d, elim in ate op tion s 2 an d 3 because th ey are co m - p arab le o r alike. Elim in ate op tio n 4, kn o win g th at all clien ts h ave a righ t to h ealth care. Fro m th e op tion s p resen ted , th e best action is presen ted in th e co rrect o p tion . Review: Po in ts related to false im p riso n m en t Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Clin ical Ju dgm en t; Health Care Law Refer en ce: Varcaro lis (2013), pp . 87–88.

887. 1, 3, 4 Ra tion a le: Clien ts with bu lim ia n ervosa in itially m ay n o t ap pear to be ph ysically or em o tio n ally ill. Th ey are often at

o r sligh tly belo w ideal bo dy weigh t. O n fu rth er in sp ection , a clien t exh ib its d en tal d ecay an d loss of too th en am el if th e cli- en t h as b een in d u cin g vo m itin g. Electro lyte im b alan ces are p resen t. Dry, scaly skin (rath er th an m oist, o ily skin ) is p resen t. Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, assessm en t fin d- in gs in b ulim ia n ervo sa. It is n ecessary to recall th at in an orexia n ervosa th e b od y weigh t is n o rm ally well below id eal bo dy weigh t an d th at clien ts with b ulim ia n ervo sa are o ften at or sligh tly belo w ideal b o dy weigh t. Also , rem em b er th at skin tex- ture will be dry an d scaly. Review: Ch aracteristics of an o rexia n ervo sa an d b u lim ia n ervo sa Level of Cogn itive Ability: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Nutritio n Refer en ce: Varcaro lis (2013), pp . 230, 240.

888. 2 Ra tion a le: Clien ts with an o rexia n ervo sa freq uen tly are p reoc- cup ied with rigo ro u s exercise an d p u sh th em selves beyo n d n o rm al lim its to wo rk o ff caloric in take. Th e n urse m ust pro - vid e for ap prop riate exercise an d place lim its o n rigoro us activ- ities. Th e correct o ptio n sto ps th e h arm ful beh avior yet p ro vides th e clien t with an activity to d ecrease an xiety th at is n o t h arm fu l. Weigh in g th e clien t im m ed iately rein forces th e clien t’s p reoccu pation with weigh t. Allo win g th e clien t to co m - p lete th e exercise program can be h arm fu l to th e clien t. Tellin g th e clien t th at sh e is n o t allowed to co m p lete th e exercise p ro - gram will in crease th e clien t’s an xiety. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate, an d focus on th e clien t’s d iagn o sis. Also, fo cu s o n th e n eed fo r th e n urse to m ain tain safety an d to set firm lim its with cli- en ts wh o h ave th is disorder. Review: In terven tion s fo r th e clien t with an o rexia n ervo sa Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Safety Refer en ce: Stu art (2013), p . 490.

889. 2 Ra tion a le: Th e clien t un dergoin g d iagn o stic tests is an accep t- able ro om m ate. Th e clien t with an o rexia n ervo sa is m o st likely exp erien cin g h em ato logical co m plicatio n s, such as leu kop e- n ia. Havin g a ro om m ate with p n eu m on ia wo uld p lace th e cli- en t with an orexia n ervo sa at risk for in fectio n . Th e clien t with an o rexia n ervo sa sh ou ld n o t b e p ut in a situ ation in wh ich th e clien t can focus on th e n u trition al n eed s of oth ers o r be m an - aged by o th ers b ecause th is m ay co n tribu te to su blim atio n an d su pp ression o f p erso n al h u n ger. Test-Ta kin g St r a t egy: Note th e strategic wo rd , best, an d n ote th e words in a state of starvation in th e q u estion . Recallin g th e ch aracteristics o f an o rexia n ervosa an d th at th e clien t is im m u- n o co m prom ised as a result o f starvatio n will direct you to th e correct op tio n . Review: Care of th e clien t with an o rexia n ervo sa Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t

M

e

n

t

a

l

H

e

a

l

t

h

1028 UNIT XIX Mental Health Disorders of the Adult Client

In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Care Co ordin ation ; Safety Refer en ce: Varcarolis (2013), p . 235.

890. 4 Ra t ion a le: Sym pto m s associated with alcoh ol with d rawal deliriu m typ ically in clu de an xiety, in so m n ia, an o rexia, h yp er- ten sio n , d isorien tatio n , h allucin ation s, ch an ges in level of co n - scio usn ess, agitation , fever, an d delusion s. Test -Ta kin g Str a tegy: Fo cus o n th e su b ject, fin d in gs associ- ated with with d rawal d eliriu m . Review each o ptio n carefu lly to en su re th at all sym p tom s in th e o ptio n are co rrect. Elim in ate o p tion s 1 an d 3 first, kn o win g th at h yp erten sio n rath er th an h ypoten sion occurs. From th e rem ain in g option s, recallin g th at th e clien t wh o is stuporous is n ot likely to exh ibit with drawal deliriu m will d irect you to th e co rrect op tion . Review: Sym p tom s associated with with d rawal d eliriu m Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Add iction ; Clin ical Jud gm en t Refer en ce: Stuart (2013), p. 454.

891. 2 Ra t ion a le: Th e m o st h elpfu l resp on se is on e th at en cou rages th e clien t to so lve p ro b lem s. Givin g ad vice im p lies th at th e n urse kn o ws wh at is b est an d can fo ster d ep en d en cy. Th e n u rse sh ou ld n o t agree with th e clien t, an d th e n urse sh ou ld n ot req uest th at th e clien t provide explan ation s.

Test -Ta kin g St r a t egy: No te th e strategic wo rd , most. Use th er- ap eu tic co m m u n icatio n tech n iq u es. Elim in ate option 1 b ecause o f th e wo rd why, wh ich sh ou ld be avo ided in co m m u - n ication . Elim in ate o ptio n 3 b ecau se th is o ption places th e cli- en t’s feelin gs o n h old. Elim in ate op tio n 4 b ecau se th e n u rse is agreein g with th e clien t. Th e correct o ption is th e o n ly on e th at ad dresses th e clien t’s feelin gs. Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Caregivin g; Com m un icatio n Refer en ce: Varcarolis (2013), p p. 121–123, 372.

892. 2 Ra t ion a le: Disturbed bo dy im age is a co n cern with clien ts with an orexia n ervo sa. Alth ou gh th e clien t m ay stru ggle with am biv- alen ce an d sh ow regressed beh avior, th e clien t’s cop in g pattern relates to th e basic issu e o f d istu rb ed b od y im age. Th e n u rse sh ou ld ad dress th is n eed in th e sup p ort gro up . Test -Ta kin g Str a tegy: No te th e su b ject, sign s o f d istu rb ed b o dy im age. Note th e relation sh ip b etween th e in form ation in th e qu estio n an d th e correct op tio n . Review: Need s o f a clien t with an o rexia n ervo sa Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: An xiety; Cop in g Refer en ce: Stuart (2013), pp . 486, 492–493.

M

e

n

t

a

l

H

e

a

l

t

h

1029CHAPTER 70 Addictions

M

e

n

t

a

l

H

e

a

l

t

h

C H A P T E R 71 Crisis Theory and Intervention

PRIORITY CONCEPTS Coping; Interpersonal Violence

CRITICAL THINKING What Should You Do? A female victim of rape has just arrived at the emergency department. What should the nurse do? Answer located on p. 1038.

I. Crisis Intervention A. Description

1. Crisis is a tem porary state of severe em o tion al disorgan ization caused by an even t th at presen ts a th reat.

2. Everyo n e experien ces crises; th e outcom e dep en ds on copin g m ech an ism s an d supp ort sys- tem s available at th e tim e of th e crisis.

3. Th e ability for decision m akin g an d problem solvin g is in adequate.

4. Treatm en t is aim ed at assistin g th e clien t an d th e fam ily th rou gh th e stressful situation .

B. Ph ases of a crisis 1. Ph ase 1: Extern al precipitatin g even t (cou ld be

situation al, developm en tal, cultural, or societal) 2. Ph ase 2

a. Percep tion of th e th reat b . In crease in an xiety c. Clien t m ay cope or resolve th e crisis.

3. Ph ase 3 a. Failure of copin g b . In creasin g disorgan ization c. Em ergen ce of ph ysical sym ptom s d . Relation sh ip problem s

4. Ph ase 4 a. Mob ilization of in tern al an d extern al

resou rces b . Goal is to return th e clien t to at least a precri-

sis level of fun ction in g. C. Types of crises (Box 71-1) D. Crisis in terven tion

1. Treatm en t is im m ediate, supp ortive, an d directly respo n sive to th e im m ediate crisis.

2. Th e in terp rofessio n al h ealth care team assists in dividuals in crisis to co pe; in terven tion s are goal directed .

3. Feelin gs of th e clien t are ackn o wledged . 4. In terven tion provides opportun ities for expres-

sion an d validation of feelin gs. 5. Con n ection s are m ade between th e m ean in g of

th e even t an d th e crisis. 6. Th e clien t exp lores altern ative copin g m ech a-

n ism s an d tries out n ew beh aviors.

II. Grief A. Grief is a n atural em o tion al respo n se to loss th at

in dividuals m ust experien ce as th ey attem p t to accept th e loss.

B. Grief usually in volves m ovin g th rough a series of stages or tasks to h elp resolve th e grief ( Box 71-2).

C. Depen din g on th e type of loss, feelin gs associated with grief in clude an ger, fru stration , lo n elin ess, sad- n ess, gu ilt, regret, an d peace.

D. Healin g can occur wh en th e pain of th e lo ss h as less- en ed an d th e in dividual h as adapted to th e loss; if th e grief is th e result of th e loss of a loved on e, th e in di- vidual con tin ues to experien ce m em ories of th e deceased .

E. Types of grief 1. Norm al grief: Ph ysical, em otion al, cogn itive, or

beh avioral reaction s can occur; th e process of res- olution can take m on th s to years.

2. An ticipatory grief occurs before th e loss of a loved on e an d is associated with an acu te, ch ron ic, or term in al illn ess.

3. Disen fran ch ised grief occurs wh en a loss of a loved on e is experien ced an d can n ot be ackn o wl- edged open ly (societal n orm s do n ot defin e th e loss as a loss with in its tradition al defin ition ).

4. Dysfu n ction al grief occurs with prolon ged em o- tion al in stability an d a lack of progressio n to suc- cessful copin g with th e lo ss.

5. Grief in ch ildren is based on th e developm en tal level of th e ch ild (Box 71-3).

1030

III. Loss A. Loss is th e ab sen ce of som eth in g desired or previ-

ously th o ugh t to be available. B. Actual loss can be iden tified by oth ers an d can arise

in respon se to or in an ticipation of a situation . C. Perceived loss is experien ced by 1 perso n an d can n ot

be verified by oth ers. D. An ticipatory loss is experien ced before th e lo ss

occurs. E. Mou rn in g

1. Mou rn in g is th e outward an d social expressio n of loss.

2. Mou rn in g m ay be dictated by cu ltural, spiritual, an d religious beliefs.

F. Bereavem en t 1. Bereavem en t in cludes th e in n er feelin gs an d th e

outward reaction s of th e in dividual experien cin g th e loss.

2. Bereavem en t in cludes grief an d m ou rn in g.

IV. Nurse’s Role: Grief and Loss (Box 71-4) A. Allow on go in g oppo rtun ities for fully in form ed

ch oices. B. Facilitate th e grief process; assess th e in dividual’s

grief, an d assist th e in dividual to feel th e loss an d com plete th e tasks of th e grief process.

C. Grief affects in dividuals ph ysically, psych o logically, socially, an d spiritually; an in terp rofession al team approach , in cludin g a bereavem en t specialist, facili- tates th e grief process.

The nurse’s role in the grief and loss process includes communicating with the client, family members, and significant other. The nurse must consider the individ- ual’s culture, spirituality, religion, family structure, life experiences, coping skills, and support systems.

V. Suicidal Behavior A. Description

1. Suicidal clien ts ch aracteristically h ave feelin gs of worth lessn ess, guilt, an d h op elessn ess th at are so overwh elm in g th at th ey feel un able to go on with life an d feel un fit to live.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 71-1 Types of Crises Maturational ▪ Relates to developmental stages and associated role

changes; examples include marriage, birth of a child, and retirement

Situational ▪ Arises from an external source, is often unanticipated, and

is associated with a life event that upsets an individual’s or group’s psychological equilibrium; examples include loss of a job or a change in job, change in financial status, death of a loved one, divorce, abortion, addition of new family members, pregnancy, and severe physical or mental illness

Adventitious ▪ Relates to a crisis of disaster, is not a part of everyday life; it

is unplanned and accidental. Adventitious crises may result from a natural disaster (e.g., floods, fires, tornadoes, earthquakes), a national disaster (e.g., war, riots, airplane crashes), or a crime of violence (e.g., rape, assault, murder in the workplace or school, bombings, or spousal or child abuse).

From Varcarolis E: Essentials of psychiatric mental health nursing, revised reprint, ed 2, Philadelphia, 20 13, Saunders.

BOX 71-2 The Grief Response Stage 1: Shock and Disbelief Individual may have feelings of numbness, difficulties with

decision making, emotional outbursts, denial, and isolation.

Stage 2: Experiencing the Loss If the grief response is the result of a loss of a loved one, the

individual may feel angry at the loved one who died or may feel guilt about the death.

Bargaining or depression or both also may occur in this stage.

Stage 3: Reintegration Individual begins to reorganize his or her life and accepts the

reality of the loss.

BOX 71-3 Grief in Children Birth to 1 Year Infant has no concept of death. Infant reacts to the loss of mother or caregiver.

1 to 2 Years Toddler may see death as reversible. Toddler may scream, withdraw, or become disinterested in the

environment. Grief response occurs only to the death of the significant per-

son in the toddler’s life.

2 to 5 Years Child may see death as reversible. Regressive or aggressive behavior may occur. Child has a sense of loss and is concerned about who will pro-

vide care.

5 to 9 Years Child has difficulty concentrating. Child begins to see death as permanent. Child may feel responsible for the occurrence.

Preadolescent Through Adolescent Adolescent may regress. Adolescent sees death as permanent. Adolescent experiences a strong emotional reaction.

1031CHAPTER 71 Crisis Theory and Intervention

2. Th e n urse carin g for a dep ressed clien t always con siders th e possibility of suicide.

B. In divid uals at risk 1. Clien ts with a h istory of previous suicide

attempts 2. Fam ily h isto ry of suicide attem p ts 3. Adolescen ts 4. O lder adults 5. Disabled or term in ally ill clien ts 6. Clien ts with person ality disorders 7. Clien ts with organ ic brain syn drom e or dem en tia 8. Depressed or psych o tic clien ts (see Ch apter 69

for in form ation on dep ression ) 9. Substan ce ab users

10. Th ose wh o h ave been con sisten tly bullied or rejected by peers or society

C. Cues ( Box 71-5) D. Assessm en t (Box 71-6) E. In terven tion s

1. Assess for suicidal in ten t or ideation an d in itiate suicide precaution s.

2. Rem o ve h arm fu l objects. 3. Do n ot leave th e clien t alon e. 4. Provid e a n on judgm en tal, carin g attitu de.

5. Per agen cy procedure an d policy, develo p a n o- suicide con tract th at is written , dated, an d sign ed an d in dicates altern ative beh avior at tim es of suicidal th o ugh ts.

6. En cou rage th e clien t to talk about feelin gs an d to iden tify positive aspects ab out self.

7. En cou rage active participation in own care. 8. Keep the client active by assignin g achievable tasks. 9. Ch eck th at visitors do n ot leave h arm fu l objects

in th e clien t’s room . 10. Iden tify supp ort system s. 11. Do n ot allow th e clien t to leave th e un it un less

acco m pan ied by a staff m em ber. 12. Continue to assess the client’s suicide potential.

Provide one-to-one supervision at all times for the client at risk for suicide.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 71-4 Communication During Grief and Loss

Determine how much the client and family want to know about the situation.

Determine whether there is a spokesperson for the family. Be aware of cultural, spiritual, and religious beliefs and how they

may affect the communication process; consider personal space issues, eye contact, and touch.

Obtain an interpreter, if necessary. Allow opportunity for informed choices. Assist with the decision-making process if asked; use problem

solving to assist in decision making, and avoid interjecting personal views or opinions.

Encourage expression of feelings, concerns, and fears. Be honest, and let the client and family know that you will not

abandon them. Ask the client and family about their expectations and needs.

Be a sensitive listener; sit in silence if necessary and appropriate. Extend touch and hold the client’s or family member’s hand if

appropriate. Encourage reminiscing. If you do not know what to do in a particular situation, seek

assistance. If you do not know what to say to a client or family who is talking

about death or another loss, listen attentively and use ther- apeutic communication techniques, such as open-ended questions or reflection.

Acknowledge your own feelings; let the client and family know that the topic of conversation is a difficult one and that you do not know what to say.

Realize that it is acceptable to cry with the client and family dur- ing the grief process.

BOX 71-5 Suicidal Cues ▪ Giving away personal, special, and prized possessions ▪ Canceling social engagements ▪ Making out or changing a will ▪ Taking out or changing insurance policies ▪ Positive or negative changes in behavior ▪ Poor appetite ▪ Sleeping difficulties ▪ Feelings of hopelessness ▪ Difficulty in concentrating ▪ Loss of interest in activities ▪ Client statements indicating an intent to attempt suicide ▪ Sudden calmness or improvement in a depressed client ▪ Client inquiries about poisons, guns, or other lethal items

or objects

BOX 71-6 Suicidal Client: Assessment Plan Does the client have a plan? What is the plan, how lethal is the plan, and how likely is death

to occur? Does the client have the means to carry out the plan?

Client History of Attempts What suicide attempts occurred in the past and what harm

occurred? Was the client accidentally rescued? Have the past attempts and methods been the same, or have

methods increased in lethality?

Psychosocial Factors Is the client alone or alienated from others? Is hostility or depression present? Do hallucinations exist? Is substance abuse present? Has the client had any recent losses or physical illness? Has the client had any environmental or lifestyle changes?

1032 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

VI. Abusive Behaviors A. An ger

1. An ger is a feelin g of an n oyan ce th at m ay be dis- placed on to an object or perso n .

2. An ger is used to avoid an xiety an d gives a feelin g of power in situation s in wh ich th e perso n feels out of con trol.

B. Aggression can be h arm fu l an d destructive wh en n ot con trolled.

C. Vio len ce is ph ysical force th at is th reaten in g to th e safety of self an d oth ers.

D. Assessm en t 1. Histo ry of violen ce or self-h arm 2. Poor im pulse con trol an d low toleran ce of

fru stration 3. Defian t an d argum en tative 4. Raisin g of voice 5. Makin g verbal th reats 6. Pacin g an d agitation 7. Muscle rigidity 8. Flu sh ed face 9. Glarin g at oth ers

E. In terven tion s 1. Main tain safety. 2. Use a calm approach an d com m un icate with a

calm , clear ton e of voice (be assertive, n ot aggres- sive, an d avoid verbal struggles).

3. Main tain a large person al space an d use a n on ag- gressive postu re (e.g., arm s an d h an ds at th e side rath er th an folded across th e ch est or placed on th e h ips).

4. Listen actively an d ackn owledge th e clien t’s anger. 5. Determ in e wh at th e clien t con siders to be h is or

h er n eed. 6. Provide th e clien t with clear option s th at deal

with th e clien t’s beh avior, set lim its on beh avior, an d m ake th e clien t aware of th e con sequen ces of an ger an d violen ce.

7. Discuss th e use of restraints (security devices) or seclusion if th e clien t is un able to con tro l an gry beh avior th at m ay lead to violen ce.

8. Assist th e clien t with problem solvin g an d deci- sion m akin g regardin g th e option s.

F. Restraints (security devices) an d seclusion 1. Description

a . Ph ysical restrain ts: An y m an u al m eth od or m ech an ical device, m aterial, or equipm en t th at in h ibits free m ovem en t

b . Seclusion : A process in wh ich a clien t is placed alon e in a specially design ed room for protectio n an d close supervisio n

c. Ch em ical restrain ts: Medication s given for a specific purpose of in h ibitin g a specific beh avior or m ovem en t an d th at h ave an im pact on th e clien t’s ability to relate to th e en viron m en t

2. Use of restrain ts an d seclusion

Restraints require a written prescription by a health care provider, which must be reviewed and renewed per agency policy; the prescription must specify the type of restraint to be used, the duration of the restraint or seclu- sion, and the criteria for release (agency policy and procedures need to be followed).

a. Restrain ts an d seclusio n sh o uld n ever be used as pun ish m en t or for th e con ven ien ce of th e h ealth care staff.

b . Restrain ts an d seclusion are used wh en beh avior is ph ysically h arm fu l to th e clien t or oth ers an d wh en altern ative or less restric- tive m easu res are in sufficien t in protectin g th e clien t or oth ers from h arm .

c. Restrain ts an d seclusion are used wh en th e clien t an ticip ates th at a con trolled en viron - m en t would be h elpful an d requests restrain ts or seclusion .

d . Th e n urse m ust docum en t th e beh avior lead- in g to th e use of restrain ts or seclusion .

e. In an em ergen cy, a qualified n urse m ay place a clien t in restrain ts or seclusion an d obtain a written or verbal prescription as soon as possib le th ereafter.

f. Per state gu idelin es, with in 1 h our of th e in itiation of restrain ts or seclusion , th e psy- ch iatrist m ust m ake a face-to-face assessm en t an d evaluatio n of th e clien t an d m ust con tin - uously reevaluate th e n eed for con tin ued restrain ts or seclusion .

g. Wh ile in restrain ts or seclusion , th e clien t m ust be protected from all sources of h arm .

h . Th e clien t in restrain ts or seclusion n eeds con stan t on e-to-on e supervision ; ph ysical, safety, an d co m fort n eeds m ust be assessed every 15 to 30 m in utes, an d th ese observa- tion s are also docum en ted (e.g., food, fluid s, bath roo m n eeds, ran ge-of-m otion exercise, an d am bulation ).

i. Th e n urse m ust always follo w agen cy proce- dures an d policies regardin g th e use of restrain ts an d m ust also be fam iliar with th eir use for th e older clien t an d juven iles.

VII. Bullying A. Bullyin g is th e abuse of power by an in dividual

toward an oth er th rou gh repeated aggressive acts. B. It m ost often occurs in ch ildren an d in h igh sch ool or

college en viron m en ts but can also occur in th e work- place or oth er en viron m en ts.

C. Th e bully feels power from sources such as ph ysical stren gth , m aturity, or a h igh er status with in a peer group; from kn owin g th e victim ’s weakn esses; or from support of oth ers.

1033CHAPTER 71 Crisis Theory and Intervention

D. Bullyin g can occur in th e form of ph ysical h arm , rela- tion al aggression , isolatio n an d exclusion , an d ver- bal h arm such as slan der, rum ors, or th reats; it is both in ten tion ally cru el an d un provoked.

E. Cyberbu llyin g is also a form of bullyin g an d occurs in th e form of In tern et m essages on social m edia n et- works, text m essages, em ails, ph o tos bein g posted, an d ru m ors.

F. Th e bullied perso n repeatedly exp erien ces n egative action s from th e bully(s).

G. Th ese bullyin g acts can lead to depression , low self- esteem , h um iliation , isolatio n , an d social with - drawal in th e victim ; th ey could result in self-h arm such as cuttin g, suicide, an d m urder.

H. Th e n urse’s respo n sibility is to observe for sign s of bullyin g an d to educate teach ers, sch o ol ad m in istra- tors, an d paren ts ab out bullyin g beh aviors an d sign s th at bullyin g m ay be occurrin g.

VIII. Family Violence A. Description (Fig. 71-1)

1. Vio len ce begin s with th reats or verbal or ph ysical m in o r assaults (ten sio n buildin g), an d th e victim attem p ts to com ply with th e requests of th e abuser.

2. Th e abuser loses con tro l an d becom es destru ctive an d h arm fu l (acute batterin g), wh ile th e victim attem p ts to protect h im self or h erself.

3. After th e batterin g, th e abuser becom es lovin g and attem pts to m ake peace (calm n ess and diffusion of ten sion ); un doin g beh avior is ch aracteristic in wh ich th e abuser gives gifts an d positive atten - tion to th e victim to un do th e n egative beh avior

4. Th e abuser justifies th at violen ce is n orm al an d th e victim is respon sible for th e abuse.

5. O utsiders are usually un aware of wh at is h app en - in g in th e fam ily.

6. Fam ily m em bers are isolated socially an d lack auton om y an d trust am on g each oth er; carin g an d in tim acy in th e fam ily are absen t.

7. Fam ily m em bers exp ect oth er m em bers of th e fam ily to m eet th eir n eeds, but n on e is ab le to do so.

8. Th e ab user th reaten s to ab an don th e fam ily. B. Types of violen ce ( Box 71-7) C. Th e vuln erable perso n (victim )

1. Th e vuln erable perso n is th e on e in th e fam ily un it again st wh o m violen ce is perpetrated.

2. Th e m ost vuln erable in dividuals are ch ildren an d older adults.

3. Th e perpetrato r of violen ce an d th e perso n tar- geted by th e violen ce can be m ale or fem ale.

4. Batterin g is a crim e. D. Ch aracteristics of abusers

1. Im paired self-esteem 2. Stron g depen den cy n eeds 3. Narcissistic an d suspiciou s 4. History of abuse durin g ch ildh ood 5. Perceive victim s as th eir property an d believe th at

th ey are en titled to ab use th em E. Ch aracteristics of victim s

1. Som e m ay h ave a depen den t perso n ality disorder

2. Feel trapped , depen den t, h elpless, an d powerless 3. May beco m e depressed as th ey are trapped in th e

abusers’ power an d con trol cycle (see Fig. 71-1) 4. As victim s’ self-esteem becom es dim in ish ed with

ch ron ic abuse, th ey m ay blam e th em selves for th e violen ce an d be un able to see a way out of th e situation .

F. In terven tion s 1. Report suspected or actual cases of ch ild abuse

or abuse of an older adult to appropriate auth or- ities (follow state an d agency guidelines).

2. Assess for evid en ce of ph ysical in juries.

M

e

n

t

a

l

H

e

a

l

t

h

• The te ns ion be come s unbe a ra ble ; the victim ma y provoke a n incide nt to ge t it ove r with

• The victim ma y try to cove r up the injury or ma y look for he lp

S e rio us batte ring inc ide nt

The Cyc le o f Vio le nc e

• Loving be ha vior, s uch a s bringing gifts a nd flowe rs a nd doing s pe cia l things for the victim

• Fe e ls he lple s s , be come s complia nt, a cce pts bla me

• Trus ting, hoping for cha nge , wa nts to be lie ve pa rtne r’s promis e s

Abus e r

H o

n e y

m o

o n

p h a s e

Te n

s io

n -b

u ild

in g

p

h a

s e

S e rio us batte ring pha s e

• Edgy, ha s minor e xplos ions

• Ma y be come ve rba lly a bus ive ; minor hitting, s la pping, a nd othe r incide nts be gin

Vic tim • Fe e ls te ns e a nd a fra id,

like “wa lking on e ggs ”Vic tim

Abus e r • Contrite , s orry,

ma ke s promis e s to cha nge

FIGURE 71-1 The cycle of violence.

BOX 71-7 Types of Violence Physica l Violence: Infliction of physical pain or bodily harm Sexua l Violence: Any form of sexual contact without consent Emot iona l Violence: Infliction of mental anguish Physica l Neglect: Failure to provide health care to prevent or

treat physical or emotional illnesses Developmenta l Neglect: Failure to provide physical and cogni-

tive stimulation needed to prevent developmental deficits Educa t iona l Neglect: Depriving a child of education Economic Exploita tion: Illegal or improper exploitation of

money, funds, or other resources for one’s personal gain

1034 UNIT XIX Mental Health Disorders of the Adult Client

3. En sure privacy an d con fiden tiality durin g th e assessm en t, an d provide a n on judgm en tal an d em p ath etic approach to foster trust; reas- sure th e victim th at h e or sh e h as n ot don e an y- th in g wron g. Box 71-8 lists sam ple assessm en t question s.

4. Assist th e victim to develop self-pro tective an d oth er problem -solvin g ab ilities.

5. Even if th e victim is n ot ready to leave th e situ- ation , en courage th e victim to develop a spe- cific safety plan (a fast escape if th e violen ce return s) an d provide in form ation on wh ere to obtain h elp (h otlin es, safe h ouses, an d sh el- ters); an abused person is usually reluctan t to call th e police.

6. Assess suicidal poten tial of th e victim . 7. Assess th e poten tial for h om icide. 8. Assess for th e use of drugs an d alcoh ol. 9. Determ in e fam ily copin g pattern s an d support

system s. 10. Provide support an d assistan ce in copin g with

con tactin g th e legal system . 11. Assist in resolvin g fam ily dysfun ction with pre-

scribed th erapies. 12. En courage in dividual th erapy for th e victim

th at prom o tes copin g with th e traum a an d pre- ven ts furth er psych ological con flict.

13. En courage in dividual th erap y for th e ab user th at focuses on preven tin g violen t beh avior an d repairin g relation sh ips.

14. En courage psych oth erapy, coun selin g, group th erapy, an d support groups to assist fam ily m em bers to develop copin g strategies.

15. Assist th e fam ily to iden tify an access to com - m un ity an d perso n al resources.

16. Main tain accu rate an d th oro ugh m edical h ealth records.

IX. Child Abduction A. Description

1. Ch ild abduction is th e kidn appin g of a ch ild (or in fan t) by an older perso n .

2. O ccurren ces a. A stran ger m ay kidn ap a ch ild for crim in al

or m isch ievous purpo ses. b . A stran ger m ay kidn ap a ch ild (or in fan t)

to brin g up h im or h er as th at perso n ’s own ch ild.

c. A paren t rem oves or retain s a ch ild from th e oth er paren t’s care (often in th e course of or after divorce proceedin gs) .

3. Because of th e in creased in depen den ce th at occurs in th e presch oo l-age ch ild, paren ts are less able to provid e th e con stan t protectio n th ey on ce did wh en th e ch ild reach es th is age; in terven tion s th at en sure protection (in cludin g teach in g th e ch ild) are n ecessary.

B. In terven tion s 1. In struct th e paren ts to teach a ch ild basic guid e-

lin es about perso n al safety th at in clude th e follo win g: a. Do n ot go an ywh ere alon e. b . Always tell an adult wh ere h e or sh e is goin g

an d wh en h e or sh e will return . c. Say no if h e or sh e feels un com fo rtable with a

situation . d . Do n ot talk with stran gers or get in to

th eir cars. e. Do n ot h elp an yon e look for a lo st dog or cat

an d do n ot accept can dy from a stran ger. f. If lost in a store, do n ot wan der aroun d lo ok-

in g for th e paren t; go at on ce to a clerk or guard.

2. Ch ildren n eed to learn th eir full n am e, ad dress, an d paren ts’ n am es.

3. Watch for posttraum atic stress disorder in an y ch ild wh o h as experien ced an abduction .

X. Child Abuse A. Description

1. Abuse is th e n on acciden tal ph ysical in ju ry or th e n on acciden tal act of om ission of care by a paren t or perso n respo n sible for a ch ild; abuse com prises n eglect an d ph ysical, sexual, an d em o tion al m altreatm en t.

2. Neglect can be in th e form of ph ysical or em o- tion al n eglect an d in volves th e dep rivatio n of basic n eeds, supervisio n , m edical care, or edu cation an d failure to m eet a ch ild’s n eeds for atten tion an d affection .

3. Sexual abuse can in volve in cest, m olestation , exh ibition ism , porn ograph y, prostitution , or ped oph ilia; fin din gs associated with sexual abuse m ay n ot be easily apparen t in a ch ild.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 71-8 Assessment Questions for Violence and Abuse

“Has anyone ever touched you in a way that made you uncomfortable?”

“Is anyone hurting you now?” “How do you and your partner deal with anger (or

disagreement)?” “Has your partner ever hit you?” “Have you ever been threatened by _____?” “Does your partner prevent you from seeing family or

friends?” “Does your partner ever use the children to manipulate you?” “Did (or does) anyone in your family deal with anger by

hitting?” “Who do you play with most often? Is there anyone you do

not like playing with? Are there games you don’t like playing?”

1035CHAPTER 71 Crisis Theory and Intervention

4. Sh aken baby syn d rom e is cau sed by th e violen t sh akin g of an in fan t an d results in in tracran ial (usually subd ural h em orrh age) traum a; th is can lead to cerebral edem a an d death .

B. Assessm en t (Box 71-9) C. In terven tion s

1. Supp ort th e ch ild durin g a th o rough ph ysical assessm en t.

2. Assess in juries. 3. If sh aken baby syn d rom e is susp ected, m on itor

th e in fan t for a decrease in level of co n scious- n ess, wh ich can in dicate in creased in tracran ial pressure (ICP).

4. Repo rt a case of susp ected abuse; n urses are legally required to report all cases of susp ected ch ild abuse to th e appropriate lo cal or state agen cy.

5. Place th e ch ild in an en viron m en t th at is safe, preven tin g furth er in ju ry.

6. Do cum en t in form ation related to th e susp ected abuse in an objective m an n er.

7. Assess paren ts’ stren gth s an d weakn esses, n orm al copin g m ech an ism s, an d presen ce or absen ce of supp ort system s.

8. Assist th e fam ily in iden tifyin g stressors, support system s, an d resources.

9. Refer th e fam ily to ap propriate supp ort groups.

Nurses are legally required to report all cases of sus- pected child abuse or elder abuse to the appropriate local or state agency; state laws and procedures may vary and are always followed.

XI. Latchkey Children A. Descrip tion

1. Ch ildren wh o do n ot h ave adult supervision before or after sch o ol h ours; th ey are left to care for th em selves durin g th ese tim es.

2. O ccurs wh en ch ildren are m em bers of a sin gle- paren t fam ily or wh en both paren ts work an d n eed to leave th e h om e before ch ildren are brough t to sch o ol

3. Th is situation in du ces a stress-provokin g en vi- ron m en t for th e ch ildren an d places th e ch ildren at risk for an un safe situation , in jury, an d delin - quen t beh avior.

B. In terven tion s 1. Iden tify th e latch key ch ild. 2. En cou rage th e paren t to teach th e ch ild about

self-care an d self-h elp skills. 3. Assist th e paren t to id en tify possib le altern atives

to leavin g th e ch ild alon e. 4. In form th e paren t about available com m un ity

resou rces such as after-sch ool program s for ch ildren .

XII. Abuse of the Older Adult A. Descrip tion

1. Abuse of an older adult in volves ph ysical, em o - tion al, or sexual ab use; n eglect; an d econ om ic exploitation .

2. O lder adults at m ost risk in clude in dividuals wh o are depen den t because of illn ess, im m obil- ity, or altered m en tal status.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 71-9 Child Neglect and Abuse: Assessment Findings Neglect ▪ Inadequate weight gain ▪ Poor hygiene ▪ Consistent hunger ▪ Inconsistent school attendance ▪ Constant fatigue ▪ Reports of lack of child supervision ▪ Delinquency Physical Abuse ▪ Unexplained bruises, burns, or fractures ▪ Bald spots on the scalp ▪ Apprehensive child ▪ Extreme aggressiveness or withdrawal ▪ Fear of parents ▪ Lack of crying (older infant, toddler, or young preschool

child) when approached by a stranger ▪ Spiral fractures without history of trauma from a sports

injury

Emotional Abuse ▪ Speech disorders ▪ Habit disorders such as sucking, biting, and rocking ▪ Psychoneurotic reactions ▪ Learning disorders ▪ Suicide attempts Sexual Abuse ▪ Difficulty walking or sitting ▪ Torn, stained, or bloody underclothing ▪ Pain, swelling, or itching of genitals ▪ Bruises, bleeding, or lacerations in genital or anal area ▪ Unwillingness to change clothes or unwillingness to partic-

ipate in gym activities ▪ Poor peer relations Shaken Baby Syndrome ▪ External signs of trauma are usually absent ▪ Ophthalmoscopic examination reveals retinal hemorrhages ▪ Full bulging fontanels and head circumference greater than

expected

1036 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

3. Facto rs th at con tribute to abuse an d n eglect in clude lo n g-stan din g fam ily violen ce, caregiver stress, an d th e older adult’s in creasin g depen - den ce on oth ers.

4. Victim s m ay attem p t to dism iss in juries as acciden tal, an d abusers m ay preven t victim s from receivin g proper m edical care to avoid discovery.

5. Victim s often are isolated socially by their abusers. B. Assessm en t

1. Ph ysical abuse a . Sprain s, dislocation s, or fractures b . Abrasion s, bruises, or laceration s c. Pressure sores d . Pun cture woun ds e. Burn s f. Skin tears

2. Sexual abuse a . Torn or stain ed un d ercloth in g b . Discom fort or bleedin g in th e gen ital area c. Difficulty in walkin g or sittin g d . Un exp lain ed gen ital in fectio n s or disease

3. Em otion al ab use a . Con fusion b . Fearful an d agitated c. Ch an ges in appetite an d weigh t d . With drawn an d lo ss of in terest in self an d

social activities 4. Neglect

a . Dish eveled appearan ce b . Dressed in adequately or in approp riately c. Deh ydration an d m aln utrition d . Lackin g ph ysical n eeds, such as glasses, h ear-

in g aids, an d den tures 5. Sign s of m edication overdose 6. Eco n om ic explo itation

a . In ability to pay bills an d fearful wh en discuss- in g fin an ces

b . Con fused, in accurate, or n o kn owledge of fin an ces

C. In terven tion s 1. Assess for ph ysical in juries an d treat ph ysical

in ju ries. 2. Repo rt cases of susp ected abuse to ap propriate

au th orities (follow state an d agen cy guid elin es). 3. Separate th e older adult from th e abusive en vi-

ro n m en t, if possible, an d con tact ad ult protective services for assistan ce in placem en t wh ile th e ab use is bein g in vestigated .

4. Explore altern ative livin g arran gem en ts th at are least restrictive an d disruptive to th e victim .

5. Th e older adult wh o h as been abused m ay n eed assistan ce for fin an cial or legal m atters.

6. Provide referrals to em ergen cy com m un ity resou rces.

7. Wh en workin g with caregivers, assess th e n eed for respite care or coun selin g to deal with care- giver stress (see Priority Nu rsin g Action s).

PRIORITY NURSING ACTIONS Physical Abuse of an Older Client

1. Assess and treat the wounds. 2. Ensure that the victim is removed from the threatening

environment. 3. Adhere to mandatory abuse reporting laws. 4. Notify the caseworker of the situation. 5. Document the occurrence, findings, actions taken, and

the victim’s response.

When a victim is abused, the priority is to assess and treat any physical injuries. The nurse stays with the victim and provides comfort and support. After physical injuries are treated, the nurse ensures that the client is safe and is removed from the threatening environment. Elder abuse needs to be reported, so the nurse would adhere to the mandatory abuse reporting laws of the state. The nurse also contacts the caseworker of the situation so that the incident is reported and follow-up can occur. If there is no caseworker, the nurse contacts social services or the appropriate service to initiate this process. Finally, the nurse documents the occurrence, findings, actions taken, and the victim’s response.

References Keltner, Steele (2015), pp. 438–439; Varcarolis (20 13), p. 428.

XIII. Rape and Sexual Assault A. Description

1. Rape is en gagin g an oth er person in a sexual act or sexual in tercourse th rough th e use of force or coercion an d without the con sen t of th e sexual partn er.

2. Th e victim is n ot required by law to report th e rape or assault.

3. O ften , th e victim is blam ed by oth ers an d receives n o supp ort from sign ifican t oth ers.

4. Acquain tan ce rape in volves som eon e kn own to th e victim .

5. Statutory rape is th e act of sexual in tercourse with a perso n yo un ger th an th e age of legal con sen t, even if th e m in o r con sen ts.

6. Marital rape a. Th e belief th at m arriage bestows righ ts to sex

wh en ever wan ted an d with out con sen t of th e partn er con tribu tes to th e occurren ce of m arital rape.

b . Victim s of m arital rape describe bein g forced to perform acts th ey did n ot wish to perform an d bein g ph ysically abused durin g sex.

1037CHAPTER 71 Crisis Theory and Intervention

B. Assessm en t 1. Fem ale clien t

a. O btain th e date of th e last m en strual period. b . Determ in e th e form of birth con trol used an d

th e last act of in tercou rse before rape. c. Determ in e th e duration of in tercourse,

orifices violated, an d wh eth er pen ile pen etra- tion occurred.

d . Determ in e wh eth er a con dom was used by th e perpetrator.

2. Sh am e, em b arrassm en t, an d h um iliation 3. An ger an d reven ge 4. Afraid to tell oth ers because of fear of n ot bein g

believed C. Males m ay be sexually abused as ch ildren an d as

adults, an d are th e usual targeted victim of pedo- ph iles; m ales m ay h ave m ore difficu lty with disclos- in g th eir abuse.

D. Rape traum a syn drom e 1. Sleep disturban ces, n igh tm ares 2. Loss of appetite 3. Fears, an xiety, ph obias, suspicion 4. Decrease in activities an d m otivation 5. Disrup tion s in relation sh ips with partn er, fam -

ily, frien d s 6. Self-blam e, guilt, sh am e 7. Lowered self-esteem , feelin gs of worth lessn ess 8. Som atic com plain ts 9. See Ch apter 69 for in form ation on posttraum atic

stress disorder. E. In terven tion s

1. Perform th e assessm en t in a quiet, private area. 2. Stay with th e victim . 3. Assess th e victim ’s stress level befo re perform in g

treatm en ts an d procedures. 4. Victim sh ould n ot sh o wer, bath e, douch e

(fem ale), or ch an ge cloth in g un til an exam in a- tion is perform ed.

5. O btain written con sen t for th e exam in ation , ph otograph s, labo ratory tests, release of in for- m ation , an d laborato ry sam ples.

6. Assist with th e fem ale pelvic exam in ation and obtain specim en s to detect sem en (th e pelvic exa- m in ation m ay trigger a flash back of th e attack); a sh ower an d fresh cloth in g sh ould be m ade avail- able to th e clien t after th e exam ination .

7. Preserve an y evid en ce. 8. Treat ph ysical in juries an d provid e clien t safety. 9. Docum en t all even ts in th e care of th e victim .

10. Rein force to th e victim th at survivin g th e assault is m ost im portan t; if th e victim survived th e rape, h e or sh e did exactly wh at was n eces- sary to stay alive.

11. Refer th e victim to crisis in terven tion an d support grou ps.

P R A C T I C E Q U E S T I O N S

893. Th e n urse observes th at a clien t with a poten tial for violen ce is agitated , pacin g up an d down th e h all- way, an d is m akin g aggressive an d belligeren t ges- tures at oth er clien ts. Wh ich statem en t would be m o st ap p ro p riate to m ake to th is clien t? 1. “You n eed to stop th at beh avior n ow.” 2. “You will n eed to be placed in seclusion .” 3. “You seem restless; tell m e wh at is h app en in g.” 4. “You will n eed to be restrain ed if yo u do n ot

ch an ge yo ur beh avio r.”

894. Th e n urse is reviewin g th e assessm en t data of a cli- en t adm itted to th e m en tal h ealth un it. Th e n urse n otes th at th e adm ission n urse docum en ted th at th e clien t is experien cin g an xiety as a result of a sit- uatio n al crisis. Th e n urse plan s care for th e clien t, determ in in g th at th is type of crisis could be cau sed by wh ich even t? 1. Witn essin g a m urder 2. Th e death of a loved on e 3. A fire th at destro yed th e clien t’s h om e 4. A recen t rape episo de experien ced by th e clien t

895. Th e n urse is con d uctin g an in itial assessm en t of a clien t in crisis. Wh en assessin g th e clien t’s percep- tion of th e precipitatin g even t th at led to th e crisis, wh ich is th e m o st ap p ro p riate question ? 1. “With wh om do you live?” 2. “Wh o is available to h elp you?”

M

e

n

t

a

l

H

e

a

l

t

h

CRITICAL THINKING What Should You Do? Answer: The nurse should first take the victim to a quiet and private room and assess the victim’s stress level before per- forming treatments and procedures. The nurse needs to stay with the victim. The victim should not shower, bathe, douche (female), or change clothing until an examination is per- formed. The nurse should obtain consent for an examination, photographs, laboratory tests, release of information, and laboratory samples. The nurse should assist with the female pelvic examination (the pelvic examination may trigger a flashback of the attack). A shower and fresh clothing should be made available to the client after the examination. Any evi- dence needs to be preserved and physical injuries need to be treated. The nurse should provide for client safety, document all events in the care of the victim, and reinforce to the victim that surviving the assault is most important; if the victim sur- vived the rape, she did exactly what was necessary to stay alive. When appropriate, the nurse should refer the victim to crisis intervention and support groups.

Reference: Varcarolis (2013), pp. 439–440 .

1038 UNIT XIX Mental Health Disorders of the Adult Client

3. “Wh at leads yo u to seek h elp n ow?” 4. “Wh at do yo u usually do to feel better?”

896. Th e n urse is creatin g a plan of care for a clien t in a crisis state. Wh en develo pin g th e plan , th e n urse sh ould con sider wh ich factor? 1. A crisis state in dicates th at th e clien t h as a m en -

tal illn ess. 2. A crisis state in dicates th at th e clien t h as an em o-

tion al illn ess. 3. Presen tin g sym pto m s in a crisis situation are

sim ilar for all clien ts experien cin g a crisis. 4. A clien t’s respo n se to a crisis is in dividualized

an d wh at co n stitutes a crisis for on e clien t m ay n ot con stitute a crisis for an oth er clien t.

897. Th e n urse in th e em ergen cy departm en t is carin g for a youn g fem ale victim of sexual assault. Th e cli- en t’s ph ysical assessm en t is com plete, an d ph ysical eviden ce h as been collected. Th e n urse n otes th at th e clien t is with drawn , con fused, an d at tim es ph ysically im m obile. How sh ould th e n urse in ter- pret th ese beh aviors? 1. Sign s of depression 2. Reaction s to a devastatin g even t 3. Eviden ce th at th e clien t is a h igh suicide risk 4. In dicative of th e n eed for h ospital adm ission

898. A depressed clien t on an in patien t un it says to th e n urse, “My fam ily would be better off with ou t m e.” Wh ich is th e n urse’s b est respo n se? 1. “H ave you talked to your fam ily ab out th is?” 2. “Everyon e feels th is way when th ey are depressed.” 3. “You will feel better on ce yo ur m ed ication

begin s to work.” 4. “You soun d very upset. Are yo u th in kin g of

h urtin g yourself?”

899. Th e n urse h as been clo sely observin g a clien t wh o h as been displayin g aggressive beh aviors. Th e n urse observes th at th e beh avio r displayed by th e clien t is escalatin g. Wh ich n ursin g in terven tion is m o st h elpful to th is clien t at th is tim e? Select all th at ap p ly.

1. In itiate con fin em en t m easu res. 2. Ackn owledge th e clien t’s beh avior. 3. Assist th e clien t to an area th at is quiet. 4. Main tain a safe distan ce from th e clien t. 5. Allow th e clien t to take con trol of the situation.

900. Wh ich beh avior observed by th e n urse in dicates a suspicion th at a depressed ad olescen t clien t m ay be suicidal? 1. Th e adolescen t gives away a DVD an d a ch er-

ish ed au tograp h ed picture of a perform er.

2. Th e adolescen t ru n s out of th e th erapy group, swearin g at th e grou p lead er, an d to h er room .

3. Th e ad olescen t beco m es an gry wh ile speakin g on th e teleph o n e an d slam s down th e receiver.

4. Th e adolescen t gets an gry with h er room m ate wh en th e ro om m ate borrows th e clien t’s cloth es with ou t askin g.

901. Th e police arrive at th e em ergen cy departm en t with a clien t wh o h as lacerated both wrists. Wh ich is th e in itial n ursin g action ? 1. Adm in ister an an tian xiety agen t. 2. Assess an d treat th e woun d sites. 3. Secure an d record a detailed h istory. 4. En courage an d assist the client to ven tilate feelin gs.

902. A m od erately depressed clien t wh o was h ospital- ized 2 days ago sudden ly begin s sm ilin g an d reportin g th at th e crisis is over. Th e clien t says to th e n urse, “I’m fin ally cured.” Ho w sh ould th e n urse in terpret th is beh avior as a cue to m odify th e treatm en t plan ? 1. Suggestin g a reduction of m edication 2. Allowin g in creased “in -roo m ” activities 3. In creasin g th e level of suicide precaution s 4. Allowin g th e clien t off-un it privileges as n eeded

903. Th e n urse is plan n in g care for a clien t bein g adm it- ted to th e n ursin g un it wh o attem p ted suicide. Wh ich p rio rity n ursin g in terven tion sh ould th e n urse in clude in th e plan of care? 1. O n e-to-on e suicide precaution s 2. Suicide precaution s with 30-m in ute ch ecks 3. Ch eckin g th e wh ereabouts of th e clien t every

15 m in utes 4. Askin g th e clien t to report suicidal th ough ts

im m ediately

904. Th e em ergen cy dep artm en t n urse is carin g for an ad ult clien t wh o is a victim of fam ily violen ce. Wh ich p rio rity in struction sh ould be in cluded in th e disch arge in struction s? 1. In form ation regardin g sh elters 2. In struction s regardin g callin g th e police 3. In struction s regardin g self-defen se classes 4. Explain in g th e im portan ce of leavin g th e violen t

situation

905. A fem ale victim of a sexual assault is bein g seen in the crisis cen ter. Th e clien t states th at sh e still feels “as th ough th e rape just h appened yesterday,” even th ough it h as been a few m on th s sin ce th e in ciden t. Wh ich is the m o st app ro p riate n ursin g respon se? 1. “You n eed to try to be realistic. Th e rape did n ot

just occur.”

M

e

n

t

a

l

H

e

a

l

t

h

1039CHAPTER 71 Crisis Theory and Intervention

M

e

n

t

a

l

H

e

a

l

t

h

2. “It will take som e tim e to get over th ese feelin gs ab out your rape.”

3. “Tell m e m ore about th e in ciden t th at cau ses yo u to feel like th e rape just occurred.”

4. “Wh at do you th in k th at you can do to alleviate som e of your fears about bein g raped again ?”

906. A clien t is adm itted to th e m en tal h ealth un it after an attem p ted suicide by h an gin g. Th e n urse can b est en sure clien t safety by wh ich action ? 1. Requ estin g th at a peer rem ain with th e clien t at

all tim es 2. Rem ovin g th e clien t’s cloth in g an d placin g th e

clien t in a h ospital gown 3. Assign in g to th e clien t a staff m em ber wh o will

rem ain with th e clien t at all tim es 4. Adm ittin g th e clien t to a seclusion room wh ere

all poten tially dan gerous articles are rem oved

907. A clien t is adm itted with a recen t h istory of severe an xiety followin g a h om e in vasion an d robbery. Durin g th e in itial assessm en t in terview, wh ich statem en t by th e clien t sh o uld in dicate to th e n urse th e possible diagn osis of posttraum atic stress dis- order? Select all th at ap p ly.

1. “I’m afraid of spiders.” 2. “I keep relivin g th e ro bbery.” 3. “I see h is face everywh ere I go.” 4. “I don ’t wan t an yth in g to eat n ow.” 5. “I m igh t h ave died over a few dollars in m y

pocket.” 6. “I h ave to wash m y h an ds over an d over

again m an y tim es.”

A N S W E R S 893. 3 Ra tion a le: Th e best statem en t is to ask th e clien t wh at is caus- in g th e agitation . Th is will assist th e clien t to b ecom e aware of th e b eh avio r an d m ay assist th e n u rse in p lan n in g ap prop riate in terven tion s for th e clien t. O ptio n 1 is dem an d in g b eh avio r th at cou ld cau se in creased agitation in th e clien t. O p tio n s 2 an d 4 are th reats to th e clien t an d are in app ro p riate. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Elim in ate op tio n 1 b ecau se of th e d em an d th at it p laces on th e clien t. Elim in ate op tio n s 2 an d 4 becau se th ey in d icate th reats to th e clien t. Review: Ap pro priate n ursin g action s for th e clien t experien cin g agitatio n Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Com m un icatio n an d Docum en tation Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Co m m u n icatio n Refer en ce: Varcaro lis (2013), pp . 121–123, 313.

894. 2 Ra tion a le: A situatio n al crisis arises from extern al rath er th an in tern al sou rces. Extern al situ ation s th at co uld p recip itate a cri- sis in clu de loss o r ch an ge o f a job , th e d eath o f a lo ved on e, ab ortion , ch an ge in fin an cial status, divo rce, ad d ition o f n ew fam ily m em bers, p regn an cy, an d severe illn ess. O ption s 1, 3, an d 4 iden tify adven titiou s crises. An ad ven titiou s crisis refers to a crisis of d isaster, is n ot a part of everyd ay life, an d is u n p lan n ed an d acciden tal. Adven titiou s crises m ay resu lt from a n atu ral d isaster (e.g., flo od s, fires, to rn ado es, earth q u akes), a n atio n al disaster ( e.g., war, riots, airplan e crash es) , o r a crim e o f vio len ce (e.g., rap e, assault, m u rd er in th e wo rkplace or sch o ol, b om bin gs, o r sp ou sal o r ch ild abu se). Test-Ta kin g Str a tegy: Note th e su b ject, situ ation al crisis. Recall th at th is type of crisis arises fro m an extern al sou rce, is o ften u n an ticip ated , an d is associated with a life even t th at u psets an in dividu al’s or grou p’s psych o lo gical eq uilibrium . Th is will d irect you to th e co rrect op tion .

Review: Typ es o f crises Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Co pin g Refer en ce: Varcaro lis (2013), p. 400.

895. 3 Ra tion a le: Th e n u rse’s in itial task wh en assessin g a clien t in cri- sis is to assess th e in d ivid ual o r fam ily an d th e pro blem . Th e m ore clearly th e p ro b lem can b e d efin ed, th e b etter th e ch an ce a so lu tion can be fou n d . Th e co rrect op tion wo uld assist in d eterm in in g d ata related to th e p recip itatin g even t th at led to th e crisis. O p tio n s 1 an d 2 assess situ ation al sup po rts. O p tion 4 assesses person al co pin g skills. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Also n o te th e su b ject, assessm en t tech n iqu es fo r th e clien t in crisis, an d n ote th e wo rd s precipitating event an d led to the cri- sis. Elim in ate op tion s 1 an d 2 becau se th ese data wou ld d eter- m in e su pp o rt system s. Elim in ate o ption 4 becau se th is q uestio n wo u ld b e asked wh en d eterm in in g cop in g skills. Review: Assessm en t tech n iq u es for th e clien t in crisis Level of Cogn itive Ability: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Co pin g Refer en ce: Varcaro lis (2013), pp . 402, 405.

896. 4 Ra tion a le: Alth o u gh each crisis resp o n se can b e d escrib ed in sim ilar term s as far as presen tin g sym pto m s are co n cern ed, wh at con stitutes a crisis for on e clien t m ay n ot con stitute a cri- sis for an o th er clien t b ecau se each is a un iqu e in d ivid ual. Bein g in th e crisis state d oes n ot m ean th at th e clien t h as a m en tal or em otion al illn ess. Test-Ta kin g Str a tegy: Elim in ate op tio n 3 b ecau se of th e clo sed -en d ed wo rd all. Next, elim in ate o p tion s 1 an d 2 b ecau se a crisis d oes n o t in dicate “illn ess.”

1040 UNIT XIX Mental Health Disorders of the Adult Client

Review: Th e ch aracteristics of a crisis state Level of Cogn it ive Ability: Creatin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Caregivin g; Cop in g Refer en ce: Stuart (2013), p. 186.

897. 2 Ra t ion a le: Du rin g th e acute p h ase o f th e rape crisis, th e clien t can d isplay a wid e ran ge of em otion al an d som atic respo n ses. Th e sym pto m s n oted in dicate an exp ected reactio n . O ptio n s 1, 3, an d 4 are in co rrect in terpretation s. Test -Ta kin g St r a t egy: Note th e su b ject, clien t respo n se to a cri- sis. Use kn owled ge regard in g clien t respo n ses to d evastatin g even ts an d focus o n th e sym p tom s n o ted in th e qu estio n to direct yo u to th e correct o ptio n . Review: Norm al an d ab n o rm al clien t respo n ses to d ealin g with a crisis Level of Cogn it ive Ability: An alyzin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Caregivin g; Cop in g Refer en ce: Varcarolis (2013), p . 438.

898. 4 Ra t ion a le: Clien ts wh o are d epressed m ay b e at risk for su icide. It is critical fo r th e n urse to assess su icidal id eation an d p lan . Th e n urse sh ou ld ask th e clien t d irectly wh eth er a plan for self-h arm exists. O p tio n s 1, 2, an d 3 do n o t d eal d irectly with th e clien t’s feelin gs. Test -Ta kin g St r a tegy: Note th e strategic wo rd , best. Recallin g th erap eu tic co m m u n icatio n tech n iq u es will assist in d irect- in g you to th e co rrect op tio n . O ption 4 is th e on ly o ptio n th at deals d irectly with th e clien t’s feelin gs. In add itio n , clien ts at risk for suicide n eed to be assessed directly regardin g th e poten - tial for self-h arm . Review: Care o f th e clien t at risk fo r su icid e Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Co m m u n ication an d Do cu m en tatio n Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Stu art ( 2013), pp. 25–29; Varcarolis ( 2013) , p . 452.

899. 2, 3, 4 Ra t ion a le: Du rin g th e escalatio n period , th e clien t’s b eh avior is m o vin g to ward lo ss o f co n tro l. Nursin g actio n s in clu de tak- in g co n tro l, m ain tain in g a safe distan ce, ackn o wledgin g beh av- ior, m o vin g th e clien t to a q uiet area, an d m ed icatin g th e clien t if ap p ro priate. To in itiate co n fin em en t m easu res du rin g th is period is in ap prop riate. In itiation of co n fin em en t m easu res, if n eed ed , is m ost ap prop riate du rin g th e crisis p eriod . Test -Ta kin g Str a tegy: Fo cu s o n th e strategic wo rd , most, an d fo cus on th e su bject, th e m o st h elp ful n ursin g in terven tio n s. Also n o te th e words aggressive behaviors an d escalating. Recallin g th at, du rin g th e escalation p eriod , th e clien t’s b eh avio r is m o v- in g to ward loss o f co n trol an d th at th e least restrictive m easu res sh ou ld b e u sed will d irect you to th e co rrect op tio n s.

Review: Care o f th e clien t with aggressive beh avior Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Stuart (2013), pp . 427, 588.

900. 1 Ra t ion a le: A d epressed su icidal clien t often gives away th at wh ich is of value as a way of sayin g goodbye an d wan tin g to b e rem em bered. O p tion s 2, 3, an d 4 d eal with an ger an d actin g-o ut b eh avio rs th at are often typical of an ado lescen t. Test -Ta kin g Str a tegy: Elim in ate o ption s 2, 3, an d 4 becau se th ey are co m p arab le o r alike. Th e correct op tio n is d ifferen t an d is an action th at cou ld in dicate th at th e clien t m ay be “say- in g goo db ye.” Review: Beh aviors in dicative o f su icid e in ten t Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Mo od an d Affect; Safety Refer en ce: Varcarolis (2013), p p. 449, 451.

901. 2 Ra t ion a le: Th e in itial n ursin g actio n is to assess and treat th e self-in flicted in juries. In juries from lacerated wrists can lead to a life-th reaten in g situation . O th er in terven tion s, such as o ption s 1, 3, and 4, m ay follow after th e clien t h as b een treated m edically. Test -Ta kin g Str a tegy: No te th e strategic wo rd , initial. Use Maslo w’s Hierarch y o f Need s th eo ry to p rioritize. Ph ysiolo g- ical n eed s co m e first. Th e co rrect op tio n ad dresses th e p h ysio lo gical n eed. Review: Care o f th e clien t wh o h as attem pted su icid e Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Content Area : Critical Care: Em ergency Situations—Managem ent Pr ior ity Con cepts: Caregivin g; Safety Refer en ce: Varcarolis (2013), p . 452.

902. 3 Ra t ion a le: A clien t wh o is m od erately d ep ressed an d h as on ly b een in th e h osp ital 2 days is u n likely to h ave such a d ram atic cu re. Wh en a dep ression su dd en ly lifts, it is likely th at th e clien t m ay h ave m ade th e decisio n to h arm h im self o r h erself. Suicid e p recau tion s are n ecessary to keep th e clien t safe. Th e rem ain in g o p tion s are th erefo re in correct in terp retatio n s. Test -Ta kin g St r a t egy: Focus on th e su b ject, su icid e precau - tion s. O ptio n s 1 an d 4 sup p ort th e clien t’s n o tion th at a cu re h as occurred . O ptio n 2 allows th e clien t to in crease self- isolatio n an d wou ld presen t a th reat to th e clien t’s safety. Kn owin g th at safety is o f th e u tm ost im p ortan ce will direct yo u to th e co rrect o ption . Review: Su icid e p recau tio n s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Men tal Health

M

e

n

t

a

l

H

e

a

l

t

h

1041CHAPTER 71 Crisis Theory and Intervention

Pr ior it y Con cept s: Caregivin g; Safety Refer en ce: Stu art (2013), p . 337.

903. 1 Ra tion a le: O n e-to-o n e suicide p recaution s are requ ired for a clien t wh o h as attem pted suicide. O ption s 2 and 3 m ay be appro priate, but n ot at th e presen t tim e, con siderin g th e situation . O ptio n 4 also m ay b e an app ro priate n ursin g in terven - tio n , b ut th e priority is id en tified in th e correct option . Th e best in terven tion is con stan t sup ervision so th at th e n urse m ay in ter- ven e as n eeded if th e clien t attem p ts to h arm h im self or h erself. Test-Ta kin g St r a t egy: Fo cu s o n th e strategic wo rd , priority, n o tin g th e wo rd s attempted suicide. Th e correct option is th e o n ly o n e th at p ro vid es a safe en viro n m en t. Review: In terven tion s fo r th e su icid al clien t Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Content Area : Critical Care: Em ergency Situations—Managem ent Pr ior it y Con cept s: Caregivin g; Safety Refer en ce: Stu art (2013), p . 337.

904. 1 Ra tion a le: Tertiary preven tio n o f fam ily vio len ce in clud es assistin g th e victim after th e abu se h as alread y occu rred . Th e n u rse sh ou ld provid e th e clien t with in form atio n regard in g wh ere to obtain h elp, in cludin g a specific plan for rem ovin g th e self from th e abu ser an d in form atio n regardin g escape, h o tlin es, an d th e locatio n o f sh elters. An ab used p erson is u su - ally reluctan t to call th e po lice. Teach in g th e victim to figh t b ack is n o t th e app rop riate actio n for th e victim wh en d ealin g with a violen t p erson . Explain in g th e im portan ce of leavin g th e vio len t situatio n is im p ortan t, bu t a specific plan is n ecessary. Test-Ta kin g St r a t egy: No te th e strategic wo rd , priority. Fo cu s o n th e su b ject o f th e q uestio n , wh ich relates to p rovid in g th e clien t with a safe en viron m en t. Th e correct o ptio n p ro vid es a specific plan fo r safety. Review: Nursin g m easures for a victim of fam ily vio len ce Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: In terperson al Violen ce; Safety Refer en ce: Varcaro lis (2013), pp . 425–426.

905. 3 Ra tion a le: Th e co rrect op tio n allo ws th e clien t to exp ress h er id eas an d feelin gs m o re fu lly an d po rtrays a n on h u rried , n o n - ju d gm en tal, sup po rtive attitu de o n th e p art o f th e n urse. Cli- en ts n eed to b e reassured th at th eir feelin gs are n orm al an d th at th ey m ay express th eir con cern s freely in a safe, carin g en vi- ron m en t. O p tion 1 im m ed iately blocks co m m u n icatio n . O ptio n 2 p laces th e clien t’s feelin gs o n h old. O ptio n 4 p laces th e p ro blem so lvin g totally o n th e clien t. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Also, focus on th e su b ject, th e m o st ap prop riate resp on se to th e clien t. Use th erap eu tic co m m u n icatio n tech n iq u es. Th e correct o ption is th e on ly o n e th at add resses th e clien t’s feelin gs. Always add ress th e clien t’s feelin gs first.

Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Co m m u n ication ; Cop in g Refer en ces: Keltn er, Steele (2015), pp . 80–81; Stuart ( 2013) , p . 748.

906. 3 Ra tion a le: Han gin g is a serio us suicid e attem p t. Th e p lan of care m ust reflect actio n th at en sures th e clien t’s safety. Co n stan t o bservation status (o n e-to -on e) with a staff m em ber is th e best ch oice. Placin g th e clien t in a h osp ital go wn an d req uestin g th at a p eer rem ain with th e clien t wou ld n o t en su re a safe en vi- ron m en t. Seclusion sh ou ld n ot be th e in itial in terven tio n , an d th e least restrictive m easure sh ou ld b e u sed. Test-Ta kin g Str a tegy: Note th e strategic wo rd , best. Focus on th e su b ject, care of the clien t at risk for suicide. Elim in ate option 4 b ecau se seclusio n should n ot be the in itial in terven tion . Elim - in ate o ptio n 1 n ext b ecause safeguardin g a clien t is n ot th e peer’s respon sibility. Elim in ate o ptio n 2 because rem o vin g o n e’s clo th - in g would n ot m axim ize all p ossible safety strategies. Review: Nursin g in terven tio n s for th e clien t at risk for su icid e Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Caregivin g; Safety Refer en ce: Varcaro lis (2013), pp . 451–452.

907. 2, 3, 5 Ra tion a le: Relivin g an even t, exp erien cin g em o tio n al n um b- n ess ( facin g po ssib le d eath ) , an d h avin g flash b acks o f th e even t (seein g th e sam e face everywh ere) are all co m m o n occurren ces with posttraum atic stress disorder. Th e statem ent “I’m afraid of sp iders” relates m ore to h avin g a p hobia. The statem en t “I h ave to wash m y h ands over an d over again m an y tim es” describes ritual com pulsive behaviors to decrease an xiety for som eon e with obsessive-com pu lsive disorder. Statin g “I do n’t want an yth in g to eat n ow” is vague an d could relate to n um erous con ditio ns. Test-Ta kin g Str a tegy: Focus o n th e su b ject, p o sttraum atic stress d iso rd er. Th ere is n o in d ication abo ut a fear of sp id ers b ein g p art of th e p ro blem . Th ere is n o in fo rm ation in th e qu es- tio n to su pp ort th at th e clien t h as ritual b eh avio rs. Th e clien t statin g th at th ey do n ’t wan t an yth in g to eat at th e tim e is n o t relevan t to th is clien t’s situ ation . Respo n ses 2, 3, an d 5 all in di- cate th at th e clien t is experien cin g po sttrau m atic stress d isorder fro m a recen t h om e in vasio n an d rob bery even t. Review: Po sttrau m atic stress d iso rd er Level of Cogn itive Ability: An alyzin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Co pin g Refer en ces: Keltn er, Steele (2015), p p. 480–481; Varcaro lis (2013), p. 160.

M

e

n

t

a

l

H

e

a

l

t

h

1042 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

C H A P T E R 72 Psychiatric Medications

PRIORITY CONCEPTS Anxiety; Mood and Affect

CRITICAL THINKING What Should You Do? A client has been taking alprazolam on a long-term basis for the treatment of anxiety. The health care provider has informed the nurse that the medication will be discontinued and the client needs instructions about tapering off of the medication. What should the nurse do? Answer located on p. 1052.

I. Selective Serotonin Reuptake Inhibitors (SSRIs) (Box 72-1)

A. Description 1. In h ibit seroto n in uptake an d elicit an an tidepres-

san t respon se 2. Th e poten tial for m edication in teraction s is h igh ,

an d com plete m edication assessm en ts m ust be obtain ed an d evaluated; in qu ire about th e use of h erbal th erap ies, esp ecially St. Joh n ’s wort.

B. Side an d ad verse effects 1. Nausea, vom itin g, cram p in g, an d diarrh ea 2. Dry m outh 3. Cen tral n ervou s system (CNS) stim ulation ,

in cludin g akath isia (restlessn ess, agitation ) 4. In creased sweatin g 5. Blood pressure ch an ges 6. Ph otosen sitivity 7. In som n ia, som n olen ce (sleepy, drowsy), apath y 8. Nervo usn ess 9. Headach e, dizzin ess

10. Weigh t loss or gain 11. Decreased libido 12. Apath y 13. Trem ors 14. Seizure activity

C. In terven tion s 1. SSRIs in teract with n um erous m ed ication s. 2. Mon itor vital sign s because SSRIs can poten -

tially lo wer or elevate blood pressure.

3. Mon itor weigh t. 4. In itiate safety precaution s, particularly if dizzi-

n ess occurs. 5. In struct th e clien t to avoid alcoh ol. 6. Adm in ister with a sn ack or m eal to reduce th e

risk of dizzin ess an d ligh th ead edn ess. 7. Mon itor th e suicidal clien t, especially durin g

im proved m ood an d in creased en ergy levels. 8. In struct th e clien t takin g fluoxetin e or bupro -

pion to take th e m edication early in th e day to preven t in terferen ce with sleep.

9. For th e client on lon g-term therapy, m on itor liver an d ren al fun ction test results; altered values m ay occur, requirin g dosage adjustm en ts.

10. Mon itor wh ite blood cell an d n eutroph il coun ts; th e m ed ication m ay be discon tin ued if levels decrease below n orm al.

11. If priapism (pain ful, prolon ged pen ile erec- tion ) occurs, th e m ed ication is with h eld an d th e h ealth care provider (HCP) is n otified.

12. Inform about th e possibility of decreased libido. 13. In struct to ch an ge position s slowly to avoid a

h ypoten sive effect. 14. Caution th e clien t about ph o tosen sitivity an d to

take m easu res to preven t exp osure to sun ligh t. 15. Educate about th e poten tial for discon tin u a-

tion syn drom e if m edication is stopp ed abruptly rath er th an tapered; th e syn d rom e is ch aracterized by gastro in testin al distress, pecu- liar beh avioral or perceptual presen tation s, m ovem en t problem s, an d sleep disturban ces.

16. Be aware of th e poten tial for seroto n in syn - drom e, ch aracterized by elevated tem perature, m uscle rigidity, an d elevated creatin e ph osph o- kin ase levels; th is risk is greatly in creased wh en SSRIs are given with m on oam in e oxidase in h ibito rs (MAO Is). Th is m ed ication com bin a- tion n eeds to be avoided.

17. In struct th at over-th e-coun ter (O TC) cold m ed- icin es can in crease th e likelih oo d of seroto n in syn dro m e.

1043

18. In pregn an cy, con sultation with an obstetrician is recom m en ded regardin g takin g th ese m edication s.

19. Mon itor th e m edication respon se in ch ildren, adolescen ts, and older adults closely because th e respon se m ay be differen t th an in an adult clien t.

20. En courage psych o th erapy.

II. Tricyclic Antidepressants (Box 72-2) A. Description

1. Block th e reuptake of n orepin eph rin e (an d sero- ton in ) at th e presyn aptic jun ction ; used to treat dep ression

2. May reduce seizure th resh old 3. May reduce effectiven ess of an tih yp erten sive

agen ts 4. Con curren t use with alcoh ol or an tih istam in es

can cause CNS depression . 5. Con curren t use with MAO Is can cause h yperten -

sive crisis. 6. Card iac toxicity can occur, an d all clien ts sh ould

receive an electrocardiogram (ECG) before treat- m en t an d periodically th ereafter.

7. O verdose is life-th reaten in g, n ecessitatin g im m e- diate treatm en t (see Priority Nu rsin g Action s).

8. Th e tricyclic an tidepressan t clo m ipram in e m ay be used to treat obsessive-com pulsive disorder.

B. Side an d adverse effects 1. An tich olin ergic effects: Dry m ou th , difficulty

voidin g, dilated pupils an d blurred vision , decreased gastro in testin al m otility, con stipatio n

2. Ph otosen sitivity 3. Card iovascular disturban ces such as tach ycardia

or dysrh yth m ias; orth o static h ypo ten sion 4. Sedation 5. Seizu res (with bupropion ) 6. Weigh t gain 7. An xiety, restlessn ess, irritability 8. Decreased or in creased libido with ejacu latory

an d erection disturban ces C. In terven tion s

1. Mon itor th e suicidal clien t, esp ecially durin g im proved m ood an d in creased en ergy levels.

2. In struct th e clien t to ch an ge position s slowly to avoid a h ypo ten sive effect.

3. Mon itor pattern of daily bowel activity. 4. Assess for urin ary reten tion . 5. For th e clien t on lon g-term th erap y, m on itor

liver an d ren al fun ction test results.

M

e

n

t

a

l

H

e

a

l

t

h

BOX 72-1 Reuptake Inhibitors Selective Serotonin Reuptake Inhibitors ▪ Citalopram ▪ Escitalopram ▪ Fluoxetine ▪ Fluvoxamine ▪ Paroxetine ▪ Sertraline ▪ Vilazodone Serotonin-Norepinephrine Reuptake Inhibitors ▪ Desvenlafaxine ▪ Duloxetine ▪ Levomilnacipran ▪ Venlafaxine Atypical Antidepressants ▪ Bupropion ▪ Mirtazapine ▪ Nefazodone ▪ Trazodone ▪ Vortioxetine

BOX 72-2 Tricyclic Antidepressants

▪ Amitriptyline ▪ Amoxapine ▪ Clomipramine ▪ Desipramine ▪ Doxepin

▪ Imipramine ▪ Nortriptyline ▪ Protriptyline ▪ Trimipramine

PRIORITY NURSING ACTIONS Tricyclic Antidepressant Overdose 1. Check airway and maintain a patent airway. 2. Administer oxygen. 3. Check vital signs. 4. Obtain an electrocardiogram. 5. Prepare for gastric lavage with activated charcoal. 6. Prepare to administer physostigmine (a cholinesterase

inhibitor) and antidysrhythmic medications. 7. Document the event, actions taken, and the client’s

response.

A tricyclic antidepressant overdose can be life- threatening. Signs and symptoms include dysrhythmias, including tachycardia, intraventricular blocks, complete atrioventricular block, and ventricular fibrillation; hypother- mia; flushing; dry mouth; dilation of the pupils; confusion, agitation, and hallucinations; and seizures followed by coma. The immediate action is to check the airway and institute measures such as oxygen to maintain an adequate oxygena- tion level. Vital signs are checked and monitored, and an electrocardiogram is obtained to check for dysrhythmias. Gastric lavage with activated charcoal is done to prevent fur- ther absorption of the medication. Physostigmine (a cholin- esterase inhibitor) is given to counteract anticholinergic effects, and antidysrhythmics are administered as needed. The nurse documents the event, actions taken, and the cli- ent’s response.

Reference Lewis et al. (2014), p. 1689.

1044 UNIT XIX Mental Health Disorders of the Adult Client

6. Adm in ister with food or m ilk if gastro in testin al distress occurs.

7. Adm in ister th e en tire daily oral dose at 1 tim e, preferably at bed tim e because of th e sed ative effect.

8. In struct th e clien t to avoid alcoh ol an d n on pre- scriptio n m ed ication s to preven t adverse m ed- ication in teraction s.

9. In struct th e clien t to avoid drivin g an d oth er activities requirin g alertn ess un til th e respon se is kn own ; sed ation is expected in early th erap y an d m ay subside with tim e.

10. Wh en th e m ed ication is discon tin ued by th e HCP, it sh ould be tapered gradually.

11. Th e poten tial for m ed ication in teraction s with O TC cold m ed ication s exists.

12. Caution th e clien t about ph otosen sitivity an d to take m easures to preven t exp osure to sun ligh t.

13. En cou rage oral h ygien e an d th e use of h ard can dies an d m ou th rin ses to relieve dry m ou th .

14. En cou rage psych o th erap y.

Inform the client that antidepressant medication may take several weeks to produce the desired effect (cli- ent response may not occur until 2 to 4 weeks after the first dose).

III. Monoamine Oxidase Inhibitors (MAOIs) (Box 72-3) A. Description

1. In h ibit th e en zym e m on oam in e oxidase, wh ich is presen t in th e brain , blood platelets, liver, spleen , an d kidn eys

2. Mon oam in e oxidase m etab olizes am in es, n or- epin eph rin e, an d seroto n in , so th e con cen tration of th ese am in es in creases with MAO Is.

3. Clien ts wh o h ave dep ression an d h ave n ot respo n ded to oth er an tidepressan t th erap ies, in cludin g electrocon vulsive th erap y, m ay be given MAO Is. Th ese m ed ication s are n ot th e first ch oice because of oth er available m ed ication s an d th e possible serious side an d adverse effects th at can occur.

4. Con curren t use with am ph etam in es, an tidepres- san ts, dopam in e, epin eph rin e, levodop a/ carbi- dopa, m eth yldop a, n asal decon gestan ts, n orepin eph rin e, reserp in e, tyram in e-con tain in g food s, or vasocon stricto rs m ay cause h yperten - sive crisis.

5. Con curren t use with opioid an algesics m ay cau se h yperten sion or h ypo ten sion , com a, or seizu res.

B. Side an d adverse effects 1. O rth o static h ypo ten sion 2. Restlessn ess 3. In som n ia 4. Dizzin ess 5. Weakn ess, leth argy 6. Gastroin testin al upset 7. Dry m outh 8. Weigh t gain 9. Periph eral edem a

10. An tich olin ergic effects 11. CNS stim ulation (an xiety, agitation , m an ia) 12. Delay in ejaculation

C. Hyperten sive crisis 1. Hyperten sion 2. O ccipital h ead ach e radiatin g fro n tally 3. Neck stiffn ess an d soren ess 4. Nausea an d vom itin g 5. Sweatin g 6. Fever an d ch ills 7. Clam m y skin 8. Dilated pupils 9. Palpitation s, tach ycardia, or bradycardia

10. Con strictin g ch est pain 11. An tidote for h yperten sive crisis: Ph en tolam in e

by in traven o us in jection D. In terven tion s

1. Mon itor blood pressure frequen tly for h yperten sion .

2. Mon itor for sign s of h yperten sive crisis. 3. If palpitation s or frequen t h ead ach es occur,

with h old th e m ed ication an d n otify th e HCP. 4. Adm in ister with food if gastro in testin al distress

occurs. 5. In struct th e clien t th at th e m edication effect

m ay be n oted durin g th e first week of th erap y, but m axim u m ben efit m ay take 3 weeks.

6. In struct th e clien t to report h eadach e, n eck stiffn ess, or n eck soren ess im m ediately.

7. In struct th e clien t to ch an ge position s slowly to preven t orth o static h ypo ten sion .

8. In struct th e clien t to avoid caffein e or O TC preparation s such as weigh t-reducin g pills or m edication s for h ay fever an d colds.

9. Mon itor com plian ce with m ed ication adm in is- tration .

10. In struct th e clien t to carry a Med icAlert card in dicatin g th at an MAO I m edication is bein g taken .

11. Avoid adm in isterin g th e m ed ication in th e eve- n in g because in som n ia m ay result.

12. Wh en th e m edication is discon tin ued by th e HCP, it sh ould be discon tin ued gradually.

13. In struct th e clien t to avoid food s th at require bacteria or m olds for th eir preparation or preservation an d foods th at con tain tyram in e (Fig. 72-1; Box 72-4).

M

e

n

t

a

l

H

e

a

l

t

h

BOX 72-3 Monoamine Oxidase Inhibitors (MAOIs)

▪ Isocarboxazid ▪ Phenelzine

▪ Selegiline ▪ Tranylcypromine

1045CHAPTER 72 Psychiatric Medications

Teach the client about foods that contain tyramine. Consuming tyramine-containing foods when taking an MAOI can cause hypertensive crisis.

IV. Mood Stabilizers (Box 72-5) A. Description : Affect cellular transport m ech an ism an d

en h an ce seroton in or γ-am in obutyric acid (GABA) fun ction , or both , wh ich are associated with m ood

B. Lith iu m 1. Con curren t use with diuretics, flu oxetin e, m eth -

yldopa, or n on steroidal an tiin flam m ato ry drugs in creases lith ium reabsorp tion by th e kidn eys or in h ib its lith ium excretion , eith er of wh ich in creases th e risk of lith iu m toxicity.

2. Acetazo lam id e, th eoph yllin e, ph en oth iazin es, or sodium bicarbo n ate m ay in crease ren al excretio n of lith ium , reducin g its effectiven ess.

3. Th e th erap eutic dose is on ly sligh tly less th an th e am oun t produ cin g toxicity.

4. Th e th erap eutic m ed ication serum level of lith - ium is 0.6 to 1.2 m Eq/ L (0.6 to 1.2 m m o l/ L); th e actual dose at wh ich th e th erap eutic effect is ach ieved an d th e levels at wh ich toxicity occurs are h igh ly variable am on g in dividual clien ts.

5. Th e cau ses of an in crease in th e lith ium level in clude decreased sodium in take; fluid an d elec- trolyte lo ss associated with excessive sweatin g, deh ydration , diarrh ea, or diuretic th erapy; an d illn ess or overdose.

6. Serum lith ium levels sh ould be ch ecked fre- quen tly after in itiation of th erap y an d th en every 1 to 2 m on th s or wh en ever an y beh avioral ch an ge suggests an altered serum level.

7. Bloo d sam ples to ch eck serum lith ium levels sh ould be drawn in th e m orn in g, 12 h ou rs after th e last dose was taken .

M

e

n

t

a

l

H

e

a

l

t

h

MAO

MAO Arte riole s or he a rt

NE

1

3

2

Inte s tine

TYRAMINE

TYRAMINE

INACTIVE METABOLITES

Live r

Ne rve te rmina l

NE

A B

Influe nc e o f Die tary Tyramine in the Pre s e nc e

o f MAO Inhibito rs

R MAO

Arte riole s or he a rt

NE

TYRAMINE

TYRAMINE

R

Influe nc e o f Die tary Tyramine in the Abs e nc e

o f MAO Inhibito rs

MAO

FIGURE 72-1 Interaction between dietary tyramine and monoamine oxi- dase inhibitors (MAOIs). A, In the absence of MAOIs, much of the ingested tyramine is inactivated by MAO in the intestinal wall (not shown in the figure). Any dietary tyramine that is not metabolized in the intestinal wall is transported directly to the liver, where it undergoes immediate inactiva- tion byhepatic MAO. No tyramine reaches the general circulation. B, Three events occur in the presence of MAOIs: (1) inhibition of neuronal MAO increases levels of norepinephrine (NE) in sympathetic nerve terminals; (2) inhibition of intestinal and hepatic MAO allows dietarytyramine to pass through the intestinal wall and liver and enter the systemic circulation intact; (3) on reaching peripheral sympathetic nerve terminals, tyramine promotes the release of accumulated NE stores, causing massive vaso- constriction and excessive stimulation of the heart. R, Receptor for NE.

BOX 72-4 Foods That Contain Tyramine ▪ Avocados ▪ Bananas ▪ Beef or chicken liver ▪ Brewer’s yeast ▪ Broad beans ▪ Caffeine, such as in coffee, tea, or chocolate ▪ Cheese, especially aged, except cottage cheese ▪ Eggplant ▪ Figs ▪ Meat extracts and tenderizers ▪ Overripe fruit ▪ Papaya ▪ Pickled herring ▪ Raisins ▪ Red wine, beer, sherry ▪ Sauerkraut ▪ Sausage, bologna, pepperoni, salami ▪ Sour cream ▪ Soy sauce ▪ Yogurt

Note: These foods need to be avoided by the client taking an MAOI. Even a small amount of tyramine can increase the blood pressure and the force and/ or rate of heart contractions.

BOX 72-5 Mood Stabilizers Lithium Preparations ▪ Lithium carbonate ▪ Lithium citrate Other Mood Stabilizers ▪ Aripiprazole ▪ Carbamazepine ▪ Clozapine ▪ Gabapentin ▪ Lamotrigine ▪ Olanzapine ▪ Olanzapine/ fluoxetine ▪ Oxcarbazepine ▪ Paliperidone ▪ Quetiapine ▪ Risperidone ▪ Valproate ▪ Ziprasidone

1046 UNIT XIX Mental Health Disorders of the Adult Client

8. Lith iu m is classified as pregn an cy category D; it cro sses th e placen tal barrier freely an d h as been associated with fetal toxicity.

C. Side an d ad verse effects 1. Polyuria 2. Polydipsia 3. An orexia, n ausea 4. Dry m outh , m ild th irst 5. Weigh t gain 6. Abdo m in al bloatin g 7. Soft stools or diarrh ea 8. Fin e h an d trem o rs 9. In ability to con cen trate

10. Muscle weakn ess 11. Leth argy, fatigue 12. Headach e 13. Hair loss 14. Hypoth yroidism

D. In terven tion s 1. Mon itor th e suicidal clien t, especially durin g

im proved m ood an d in creased en ergy levels. 2. Adm in ister th e m edication with food to m in i-

m ize gastro in testin al irritatio n . 3. In struct th e clien t to avoid excessive am oun ts of

coffee, tea, or cola, wh ich h ave a diuretic effect. 4. Do n ot adm in ister diuretics wh ile th e clien t is

takin g lith ium . 5. In struct th e clien t to avoid alcoh ol. 6. In struct th e clien t to avoid O TC m ed ication s. 7. In struct th e clien t th at h e or sh e m ay take a

m issed dose with in 2 h ours of th e sch eduled tim e; oth erwise, th e clien t sh o uld skip th e m issed dose an d take th e n ext dose at th e sch eduled tim e.

8. In struct th e clien t n ot to adju st th e dosage or stop th e m edication with ou t con sultin g th e HCP because lith ium sh o uld be tapered an d n ot discon tin ued abruptly.

9. In struct th e clien t about th e sign s an d sym p- tom s of lith ium toxicity.

10. In struct th e clien t to n otify th e HCP if polyuria, prolon ged vo m itin g, diarrh ea, or fever occurs.

11. In struct th e clien t th at th e th erap eutic respon se to th e m ed ication is n oted in 1 to 3 weeks.

12. Mon itor th e ECG, ren al fun ctio n tests, an d th y- roid tests (en sure th at th ese tests are perform ed before th e start of th erap y).

13. Mon itor weigh t.

Instruct the client taking lithium to maintain a fluid intake of 6 to 8 glasses of water a day and an adequate salt intake to prevent lithium toxicity.

E. Lith iu m toxicity 1. Description

a . O ccurs wh en in gested lith iu m can n ot be detoxified an d excreted by th e kidn eys

b . Sym ptom s of toxicity begin to appear wh en th e serum lith ium level is 1.5 to 2 m Eq/ L (1.5 to 2 m m ol/ L) .

2. Mild toxicity a. Serum lithium level of 1.5 m Eq/L (1.5 m m ol/L) b . Apath y c. Leth argy d . Dim in ish ed con cen tration e. Mild ataxia f. Coarse h an d trem o rs g. Sligh t m uscle weakn ess

3. Mod erate toxicity a. Serum lith ium level of 1.5 to 2.5 m Eq/ L (1.5

to 2.5 m m o l/ L) b . Nausea, vom itin g c. Severe diarrh ea d . Mild to m od erate ataxia an d in coord in ation e. Slu rred speech f. Tin n itus g. Blurred vision h . Muscle twitch in g i. Irregular trem or

4. Severe toxicity a. Serum lith iu m level greater th an 2.5 m Eq/ L

(2.5 m m o l/ L) b . Nystagm us c. Muscle fascicu lation s d . Deep ten don h yperreflexia e. Visual or tactile h allucin ation s f. O liguria or an uria g. Im p aired level of con sciousn ess h . To n ic-clon ic seizures or com a, leadin g

to death 5. In terven tion s for lith ium toxicity

a. With h old lith ium an d n otify th e HCP. b . Mon itor vital sign s an d level of co n scious-

n ess. c. Mon itor cardiac status. d . Prepare to obtain sam ples to m on itor lithium ,

electrolyte, blood urea nitrogen, and creatinine levels an d perform a com plete blood cell coun t.

e. Mon itor for suicidal ten den cies an d in stitute suicide precaution s.

V. Antianxiety or Anxiolytic Medications A. Description

1. An tian xiety m edication s depress th e CNS, in creasin g th e effects of GABA, wh ich produ ces relaxation an d m ay dep ress th e lim b ic system .

2. Ben zodiazepin es h ave an xiety-reducin g (an xio- lytic), sedative-h ypn otic, m uscle-relaxin g, an d an ticon vulsan t action s ( Box 72-6).

3. Ben zodiazepines are con train dicated in clien ts with acute n arrow-an gle glaucom a an d should be used cautiously in ch ildren an d older adults.

4. Ben zodiazepin es in teract with oth er CNS m ed i- cation s, produ cin g an additive effect.

M

e

n

t

a

l

H

e

a

l

t

h

1047CHAPTER 72 Psychiatric Medications

5. Abrupt with drawal of ben zodiazepin es can be poten tially life-th reaten in g, an d with drawal sh ould occur on ly un d er m ed ical supervisio n .

B. Side an d adverse effects 1. Daytim e sedation 2. Ataxia 3. Dizzin ess 4. Headach es 5. Blurred or doub le vision 6. Hypoten sion 7. Trem or 8. Am n esia 9. Slurred speech

10. Urin ary in con tin en ce 11. Con stipation 12. Paradoxical CNS excitem en t 13. Leth argy 14. Beh avioral ch an ge

C. Acute toxicity 1. Som n olen ce 2. Con fusion 3. Dim in ish ed reflexes an d co m a 4. Flum azen il, a ben zodiazepin e an tagon ist ad m in -

istered in traven ously, reverses ben zo diazep in e in toxication in 5 m in utes.

5. A clien t bein g treated for an overdose of a ben zo- diazep in e m ay experien ce agitation , restlessn ess, discom fort, an d an xiety.

D. In terven tion s 1. Mon itor for m oto r respo n ses such as agitation ,

trem b lin g, an d ten sion . 2. Mon itor for auton om ic respo n ses such as cold,

clam m y h an ds an d sweatin g. 3. Mon itor for parado xical CNS excitem en t dur-

in g early th erapy, particularly in older adults an d deb ilitated clien ts.

4. Mon itor for visu al disturban ces because th e m edication s can worsen glaucom a.

5. Mon itor liver an d ren al fun ction test results an d com plete blood cell coun ts.

6. Reduce th e m edication dose as prescribed for th e older adult clien t an d for th e clien t with im paired liver fun ction .

7. In itiate safety precaution s because th e older adult clien t is at risk for fallin g wh en takin g th e m ed ication for sleep or an xiety.

8. Assist with am bulation if drowsin ess or ligh t- h eaded n ess occurs.

9. In struct th e clien t th at drowsin ess usually dis- appears durin g con tin ued th erapy.

10. In struct th e clien t to avoid tasks th at require alertn ess un til th e respo n se to th e m edication is establish ed.

11. In struct th e clien t to avoid alcoh ol. 12. In struct th e clien t n ot to take oth er m ed ication s

with out con sultin g th e HCP. 13. In struct th e clien t n ot to stop th e m edication

abruptly (can result in seizu re activity). E. With drawal

1. To lessen with drawal sym pto m s, th e dosage of a ben zo diazep in e sh ould be tapered gradually over 2 to 6 weeks.

2. Abrupt or too rapid with drawal results in th e followin g: a . Restlessn ess b . Irritability c. In som n ia d . Han d trem o rs e. Abdo m in al or m uscle cram ps f. Sweatin g g. Vom itin g h . Seizu res

VI. Barbiturates and Sedative-Hypnotics (Box 72-7) A. Descrip tion

1. Depress th e reticular activatin g system by pro- m otin g th e in h ib itory syn aptic action of th e n eurotran sm itter GABA

2. Used for sh ort-term treatm en t of in som n ia or for sedation to relieve an xiety, ten sion , an d appreh en sion

M

e

n

t

a

l

H

e

a

l

t

h

BOX 72-6 Benzodiazepines ▪ Alprazolam ▪ Chlordiazepoxide ▪ Clonazepam ▪ Clorazepate ▪ Diazepam ▪ Estazolam ▪ Flurazepam ▪ Lorazepam ▪ Midazolam ▪ Oxazepam ▪ Quazepam ▪ Temazepam ▪ Triazolam Nonbenzodiazepine Anxiolytic ▪ Buspirone

BOX 72-7 Barbiturates and Sedative-Hypnotics Barbiturates ▪ Amobarbital ▪ Butabarbital ▪ Pentobarbital ▪ Phenobarbital ▪ Secobarbital

Sedative-Hypnotics ▪ Chloral hydrate ▪ Eszopiclone ▪ Meprobamate ▪ Ramelteon ▪ Suvorexant ▪ Zaleplon ▪ Zolpidem

1048 UNIT XIX Mental Health Disorders of the Adult Client

B. Side an d ad verse effects 1. Dizzin ess an d drowsin ess 2. Con fusion 3. Irritability 4. Allergic reactio n s 5. Agran ulocytosis 6. Th rom bocytopen ic purpu ra 7. Megaloblastic an em ia

C. O verdose 1. Tach ycardia 2. Hypo ten sion 3. Cold an d clam m y skin 4. Dilated pupils 5. Weak an d rapid pulse 6. Sign s of sh ock 7. Depressed respiratio n s 8. Absen t reflexes 9. Com a an d death m ay result from respiratory an d

cardiovascular collapse. D. With drawal

1. Severe with drawal sym pto m s begin with in 24 h ours after th e m edication is discon tin ued in an in dividual with severe m ed ication depen den ce.

2. Gradu al with drawal is used to detoxify a depen den t clien t.

3. An xiety 4. Beh avioral ch an ges 5. In som n ia 6. Nigh tm ares 7. Daytim e agitation 8. Trem ors 9. Delirium

10. Seizures E. In terven tion s

1. Adm in ister lower doses as prescribed for th e older clien t.

2. Medication s sh ould be used with caution in th e clien t wh o h as suicidal ten den cies or h as a h is- tory of drug addiction.

3. Main tain safety by supervisin g am bulation an d usin g side rails at n igh t as appropriate.

4. In struct th e clien t to take th e m edication as directed .

5. In struct th e clien t to avoid drivin g or operatin g h azardo us equip m en t if drowsin ess, dizzin ess, or un steadin ess occurs.

6. In struct th e clien t to avoid alcoh ol because th is allows m ore m edication to en ter th e brain , causin g feelin gs of dep ression an d drowsin ess, dizzin ess, slow an d difficult breath in g, con fu- sion , an d com a.

7. For clien ts with in som n ia, in struct th e clien t to take th e m ed ication 30 m in u tes befo re bed- tim e; avoid takin g with a large am oun t of food to h elp absorption .

8. In struct th e clien t th at a h an gover effect m ay occur in th e m orn in g.

9. In struct th e clien t n ot to discon tin ue th e m ed- ication abru ptly.

10. In struct clien ts takin g ch loral h ydrate to take the m edication with food an d a full glass of water, fruit juice, or ginger ale to prevent gastric irritation.

VII. Antipsychotic Medications (Box 72-8) A. Description

1. Im p rove th e th ough t processes an d beh avior of th e clien t with psych otic sym pto m s, esp ecially clien ts with sch izoph ren ia

2. Affect dopam in e receptors in th e brain , reducin g psych o tic sym pto m s

3. Typical an tipsych otics are m ore effective for pos- itive sym pto m s of sch izoph ren ia, such as h allu- cin ation s, aggression , an d delusion s; th ese m ed ication s also block th e ch em oreceptor trig- ger zon e an d vom itin g cen ter in th e brain , pro- ducin g an an tiem etic effect.

4. Atypical an tipsych otics are m ore effective for th e n egative sym ptom s of sch izoph ren ia, such as avolition , apath y, an d alogia.

5. Th e effects of an tipsych otic m ed ication s are poten tiated wh en given with oth er m ed ication s actin g on th e CNS.

B. Side an d adverse effects ( Box 72-9) C. Extrapyram id al syn d rom e: Can in clude parkin son -

ism , dyston ia, akath isia, or tardive dyskin esia (see Box 72-9)

D. In terven tion s 1. Mon itor vital sign s. 2. Mon itor for sym ptom s of n eurolep tic m alig-

n an t syn d rom e (can occur with an tipsych otic m edication s); refer to Section VIII.

3. Mon itor urin e output. 4. Mon itor serum glucose level. 5. Adm in ister th e m edication with food or m ilk

to decrease gastric irritatio n .

M

e

n

t

a

l

H

e

a

l

t

h

BOX 72-8 Antipsychotic Medications Typical Antipsychotics ▪ Chlorpromazine ▪ Fluphenazine decanoate ▪ Haloperidol ▪ Loxapine ▪ Molindone ▪ Perphenazine ▪ Pimozide ▪ Thioridazine ▪ Thiothixene ▪ Trifluoperazine

Atypical Antipsychotics ▪ Aripiprazole ▪ Asenapine ▪ Clozapine ▪ Lurasidone ▪ Olanzapine ▪ Paliperidone ▪ Quetiapine ▪ Risperidone ▪ Ziprasidone

1049CHAPTER 72 Psychiatric Medications

6. For oral use, th e liquid form m igh t be preferred because som e clien ts h ide tablets in th eir m outh s to avoid takin g th em .

7. Th e ab sorption rate is faster with th e liqu id form of oral m edication .

8. Avoid skin con tact with th e liqu id con cen trate to preven t con tact derm atitis.

9. Protect th e liqu id con cen trate from ligh t. 10. Dilute th e liqu id con cen trate with fruit juice. 11. In form th e clien t th at a full th erap eutic effect of

th e m ed ication m ay n ot be eviden t for 3 to 6 weeks after in itiation of th erapy; h owever, an observab le th erap eutic respo n se m ay be apparen t after 7 to 10 days.

12. In form th e clien t th at som e m ed ication s m ay cause a h arm less ch an ge in urin e color to pin k- ish to red-bro wn .

13. In struct th e clien t to use sun screen , h ats, an d protective cloth in g wh en outdoors.

14. In struct th e clien t to avoid alcoh ol or oth er CNS depressan ts because th ese substan ces will allow m ore of th e m ed ication to en ter th e brain , causin g feelin gs of depression an d drowsin ess, dizzin ess, slow an d difficu lt breath in g, con fusion , an d com a.

15. In struct th e clien t to ch an ge position s slowly to avoid orth o static h ypo ten sion .

16. Instruct the client to report signs of agran u- locytosis, including sore throat, fever, and m alaise.

17. In struct th e clien t to report sign s of liver dys- fun ctio n , in cludin g jaun dice, m alaise, fever, an d righ t upper abdom in al pain .

18. When discon tin uin g an tipsych otics, the m edica- tion dosage sh ould be reduced gradually to avoid sudden recurren ce of psychotic sym ptom s.

Monitor for extrapyramidal side and adverse effects in the client taking an antipsychotic medication.

VIII. Neuroleptic Malignant Syndrome A. Descrip tion

1. A poten tially fatal syn d rom e th at m ay occur at an y tim e durin g th erapy with n euroleptic (an ti- psych o tic) m ed ication s.

2. Alth ou gh rare, n eurolep tic m align an t syn dro m e m ore com m on ly occurs at th e in itiation of th er- apy, after th e clien t h as ch an ged from 1 m edica- tion to an oth er, after a dosage in crease, or wh en a com bin ation of m ed ication s is used.

B. Assessm en t 1. Dyspn ea or tach ypn ea 2. Tach ycardia or irregular pulse rate 3. Fever 4. High or low blood pressure 5. In creased sweatin g 6. Loss of blad der con trol 7. Skeletal m uscle rigidity 8. Pale skin 9. Excessive weakn ess or fatigue

10. Altered level of con sciousn ess 11. Seizures 12. Severe extrapyram idal side an d adverse effects 13. Difficulty swallowin g 14. Excessive salivation

M

e

n

t

a

l

H

e

a

l

t

h

BOX 72-9 Side and Adverse Effects of Antipsychotic Medications Anticholinergic Effects ▪ Dry mouth ▪ Increased heart rate ▪ Urinary retention ▪ Constipation ▪ Hypotension Extrapyramidal Effects ▪ Parkinsonism ▪ Tremors ▪ Masklike facies ▪ Rigidity ▪ Shuffling gait ▪ Dysphagia ▪ Drooling Dystonias ▪ Abnormal or involuntary eye movements, including oculogy-

ric crisis ▪ Facial grimacing ▪ Twisting of the torso or other muscle groups

Akathisia ▪ Restlessness ▪ Constant moving about Tardive Dyskinesia ▪ Protrusion of the tongue ▪ Chewing motion ▪ Involuntary movements of the body and extremities Other Side and Adverse Effects ▪ Drowsiness ▪ Blood dyscrasias ▪ Pruritus ▪ Photosensitivity ▪ Elevated blood glucose level ▪ Increased weight ▪ Impaired body temperature regulation ▪ Gynecomastia ▪ Lactation

1050 UNIT XIX Mental Health Disorders of the Adult Client

M

e

n

t

a

l

H

e

a

l

t

h

15. O culogyric crisis 16. Dyskin esia 17. Elevated wh ite blood cell coun t, liver fun ction

results, an d creatin e ph osph okin ase level C. In terven tion s

1. No tify th e HCP. 2. Mon itor vital sign s. 3. In itiate safety an d seizure precaution s. 4. Prepare to discon tin ue th e m edication . 5. Mon itor level of con scio usn ess. 6. Adm in ister an tipyretics as prescribed. 7. Use a coolin g blan ket to lower th e body

tem p erature. 8. Mon itor electrolyte levels an d adm in ister fluid s

in traven ously as prescribed.

IX. Medications to Treat Attention-Deficit/ Hyperactivity Disorder (Box 72-10)

A. Ch ildren with atten tion -deficit/ h yperactivity disor- der m ay require m edication to reduce h yperactive beh avior an d len gth en atten tion span .

B. Med ication s th at are m ost effective in co n trollin g th is disorder are CNS stim ulan ts.

C. CNS stim ulan ts, wh ich in crease agitation an d activ- ity in adults, h ave a calm in g effect on ch ildren with atten tion -deficit/ h yperactivity disorder an d in crease alertn ess an d sen sitivity to stim uli.

D. Side an d ad verse effects 1. Tach ycardia 2. An o rexia an d weigh t lo ss 3. Elevated blood pressure 4. Dizzin ess 5. Agitation

E. In terven tion s 1. Mon itor for CNS side an d adverse effects. 2. O btain a baselin e ECG. 3. Mon itor th e blood pressure. 4. In struct th e ch ild an d paren ts th at O TC m ed ica-

tio n s n eed to be avoided. 5. In struct th e ch ild an d paren ts th at th e last dose of

th e day sh o uld be taken at least 6 h ours before bed tim e (14 h ours for exten ded -release form s) to preven t in som n ia.

6. Mon itor h eigh t an d weigh t (particularly in ch ildren ).

7. Rein fo rce th at several weeks of th erap y m ay be n ecessary before th e th erap eutic effect is n oted.

8. In struct th e clien t an d paren ts th at a m ed ication - free period m ay be prescribed to allow growth of th e ch ild if th e m edication h as cau sed growth retardation .

X. Medications to Treat Alzheimer’s Disease (Box 72-11)

A. Acetylch olin esterase in h ibitors m ay be used in cli- en ts with Alzh eim er’s disease to im prove cogn itive fun ction s in th e early stages.

B. Don epezil 1. An in h ibitor of acetylch olin esterase used to treat

m ild to m oderate dem en tia of Alzh eim er’s disease 2. Side an d adverse effects in clude n ausea an d

diarrh ea. 3. Do n epezil can slow th e h eart rate th rou gh its

vagoto n ic effect. C. Galan tam in e

1. An in h ibitor of ch olin esterase used to treat m ild to m oderate dem en tia of Alzh eim er’s disease

2. Side an d adverse effects in clude n ausea, vom it- in g, diarrh ea, an orexia, an d weigh t loss.

3. Galan tam in e can cause bron chocon striction ; it sh ould be used with caution in clients with asth m a an d ch ron ic obstructive pulm on ary disease.

D. Mem an tin e 1. N-Meth yl-D-aspartate (NMDA) receptor an tago-

n ist in dicated for treatm en t of m od erate to severe dem en tia of Alzh eim er’s disease

2. Side an d adverse effects in clude dizzin ess, h ead ach e, con fusion , an d gastro in testin al disturban ces.

3. Mem an tin e sh ould n ot be used in com bin ation with oth er NMDA receptor an tagon ists such as am an tadin e or ketam in e; such com bin ation s produ ce un desirable additive effects.

4. Sodium bicarbon ate an d oth er m edication s th at alkalin ize th e urin e can decrease ren al excretion of m em an tin e; accu m ulation to toxic levels can result.

E. Rivastigm in e 1. Ch o lin esterase in h ibito r used to treat m ild to

m od erate dem en tia of Alzh eim er’s disease 2. Side an d adverse effects in clude n ausea, vom it-

in g, diarrh ea, ab dom in al pain , an d an orexia.

BOX 72-10 Medications to Treat Attention- Deficit/ Hyperactivity Disorder

▪ Amphetamine ▪ Atomoxetine ▪ Dexmethylphenidate ▪ Dextroamphetamine ▪ Dextroamphetamine and amphetamine ▪ Lisdexamfetamine ▪ Methamphetamine ▪ Methylphenidate

BOX 72-11 Medications to Treat Alzheimer’s Disease

▪ Donepezil ▪ Galantamine

▪ Memantine ▪ Rivastigmine

1051CHAPTER 72 Psychiatric Medications

3. Rivastigm in e sh ould be used with cau tion in cli- en ts with pep tic ulcer disease, bradycardia, sick sin us syn d rom e, urin ary obstru ction , an d lun g disease because it en h an ces ch olin ergic tran sm is- sion , in ten sifyin g sym pto m s of th ese disorders.

CRITICAL THINKING What Should You Do? Answer: Alprazolam is a benzodiazepine and to prevent withdrawal or lessen withdrawal symptoms, the nurse should instruct the client to taper the dose gradually over 2 to 6 weeks as specifically prescribed by the health care provider. The nurse should inform the client that abrupt or too rapid withdrawal can result in restlessness, irritability, insomnia, hand tremors, abdominal or muscle cramps, sweating, vomiting, and seizures. The nurse informs the client that if any of these manifestations occur during tapering, they should be reported immediately to the health care provider.

Reference: Hodgson, Kizior (2016), p. 48.

P R A C T I C E Q U E S T I O N S 908. A clien t’s m edication sh eet con tain s a prescription

for sertralin e. To en sure safe adm in istration of th e m ed ication , h ow sh o uld th e n urse adm in ister th e dose? 1. O n an em p ty stom ach 2. At th e sam e tim e each even in g 3. Even ly spaced arou n d th e clock 4. As n eeded wh en th e clien t com plain s of

dep ression

909. A clien t with sch izoph ren ia h as been started on m ed ication th erap y with clo zapin e. Th e n urse sh o uld assess th e results of wh ich laborato ry study to m on itor for adverse effects from th is m ed ication ? 1. Platelet coun t 2. Blood gluco se level 3. Liver fun ctio n studies 4. Wh ite blood cell coun t

910. A clien t is sch eduled for disch arge an d will be tak- in g ph en obarbital for an exten ded period. Th e n urse would place h igh est p rio rity on teach in g th e clien t wh ich poin t th at directly relates to clien t safety? 1. Take th e m ed ication on ly with m eals. 2. Take th e m ed ication at th e sam e tim e each day. 3. Use a dose con tain er to h elp preven t

m issed doses. 4. Avoid drin kin g alcoh ol wh ile takin g th is

m ed ication .

911. Th e n urse is describin g th e m edication side an d ad verse effects to a clien t wh o is takin g oxazepam .

Wh ich in form ation sh o uld th e n urse in corpo rate in th e discussion ? 1. Con sum e a low-fiber diet. 2. In crease fluids an d bulk in th e diet. 3. Rest if th e h eart begin s to beat rapidly. 4. Take an tidiarrh eal agen ts if diarrh ea occurs.

912. Th e nurse is adm in istering risperidone to a clien t wh o is sch eduled to be disch arged. Before disch arge, wh ich in struction sh ould th e n urse provide to the clien t? 1. Get adequate sun ligh t. 2. Con tin ue drivin g as usual. 3. Avoid foods rich in potassium . 4. Get up slowly wh en ch an gin g position s.

913. Th e n urse is teach in g a clien t wh o is bein g started on im ip ram in e ab out th e m edication . Th e n urse sh ould in form th e clien t to expect m axim u m desired effects at wh ich tim e period follo win g in i- tiation of th e m ed ication ? 1. In 2 m on th s 2. In 2 to 3 weeks 3. Du rin g th e first week 4. Durin g th e sixth week of adm in istration

914. A h ospitalized clien t is started on ph en elzin e for th e treatm en t of dep ression . Th e n urse sh ould in struct th e clien t th at wh ich food s are acceptable to con sum e wh ile takin g th is m ed ication ? Select all th at ap p ly.

1. Figs 2. Yogurt 3. Crackers 4. Aged ch eese 5. Tossed salad 6. O atm eal raisin cookies

915. Th e n urse n otes that a clien t with sch izoph renia an d receivin g an an tipsych otic m edication is m ovin g h er m outh , protrudin g h er ton gue, an d grim acin g as she watch es television . Th e n urse determ in es that the cli- en t is experien cin g wh ich m edication com plication ? 1. Parkin son ism 2. Tardive dyskin esia 3. Hyperten sive crisis 4. Neuroleptic m align an t syn d rom e

916. Th e n urse is perform in g a follo w-up teach in g session with a clien t disch arged 1 m on th ago. Th e clien t is takin g fluoxetin e. Wh ich in form ation would be im portan t for th e n urse to obtain durin g th is clien t visit regardin g th e side an d adverse effects of th e m edication ? 1. Card iovascu lar sym ptom s 2. Gastroin testin al dysfun ction s 3. Problem s with m outh dryn ess 4. Problem s with excessive sweatin g

M

e

n

t

a

l

H

e

a

l

t

h

1052 UNIT XIX Mental Health Disorders of the Adult Client

917. A clien t wh o h as been takin g busp iron e for 1 m on th return s to th e clin ic for a follo w-up assess- m en t. Th e n urse determ in es th at th e m edication is effective if th e absen ce of wh ich m an ifestation h as occurred? 1. Paran oid th ough t process 2. Rapid h eartb eat or an xiety 3. Alcoh o l with drawal sym pto m s 4. Th ou gh t broadcastin g or delusion s

918. A clien t takin g lith iu m reports vo m itin g, abdom i- n al pain , diarrh ea, blurred vision , tin n itu s, an d trem ors. Th e lith ium level is 2.5 m Eq/ L (2.5 m m o l/ L). Th e n urse plan s care based on wh ich represen tation of th is level? 1. To xic 2. Norm al 3. Sligh tly above n orm al 4. Excessively below n orm al

919. A clien t gives th e h om e h ealth n urse a bottle of clo- m ipram in e. Th e n urse n otes th at th e m ed ication h as n ot been taken by th e clien t in 2 m on th s. Wh ich beh avior observed in th e clien t would vali- date n on com plian ce with th is m edication ? 1. Com plain ts of in som n ia

2. Com plain ts of h un ger an d fatigue 3. A pulse rate less th an 60 beats/ m in ute 4. Frequen t h an d wash in g with h ot, soapy water

920. A h ospitalized clien t h as begun takin g bupropion as an an tidepressan t agen t. Th e n urse determ in es th at wh ich is an adverse effect, in dicatin g th at th e clien t is takin g an excessive am oun t of m edication ? 1. Con stipation 2. Seizure activity 3. In creased weigh t 4. Dizzin ess wh en gettin g uprigh t

921. A clien t receivin g tricyclic an tidepressan ts arrives at th e m en tal h ealth clin ic. Wh ich observation would in dicate th at th e clien t is follo win g th e m ed ication plan correctly? 1. Clien t reports n ot goin g to work for th e

past week. 2. Clien t com plain s of n ot bein g able to “do an y-

th in g” an ym ore. 3. Clien t arrives at th e clin ic n eat an d appropriate

in appearan ce. 4. Clien t reports sleepin g 12 h ours per n igh t an d 3

to 4 h ours durin g th e day.

A N S W E R S 908. 2 Ra t ion a le: Sertralin e is classified as an an tid ep ressan t. Sertra- lin e gen erally is adm in istered o n ce every 24 h ou rs. It m ay b e ad m in istered in th e m o rn in g o r even in g, bu t even in g ad m in is- tratio n m ay be preferab le b ecau se d ro wsin ess is a sid e effect. Th e m ed icatio n m ay b e ad m in istered with ou t fo o d o r with fo o d if gastro in testin al d istress occu rs. Sertralin e is n o t p re- scribed for u se as n eeded. Test -Ta kin g Str a tegy: Focu s on th e su b ject, ad m in istration o f sertralin e. Recallin g th at th is m edicatio n is an an tid epressan t ad m in istered daily will d irect you to th e co rrect op tion . Review: Sertralin e Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Mo od an d Affect; Safety Refer en ce: Burch um , Rosen th al (2016), pp . 346–347.

909. 4 Ra tion a le: A client takin g clozapin e m ay experien ce agran ulocy- tosis, wh ich is m on itored by reviewin g th e results of th e wh ite blo od cell coun t. Treatm en t is in terrupted if th e wh ite b lo od cell cou nt d ecreases to less th an 3000 m m 3 (3 Â 109/ L). Agran ulocy- tosis could b e fatal if u n detected and u n treated. Th e oth er lab - orato ry stu dies are n ot related specifically to th e u se o f th is m edicatio n . Test -Ta kin g Str a tegy: Focu s on th e su b ject, co m plicatio n s asso ciated with clo zapin e. It is n ecessary to recall th at th is

m ed ication cau ses agran ulo cyto sis; th is will direct you to th e co rrect o ption . Review: Ad verse effects o f clo zap in e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Cellu lar Regu latio n ; Psych o sis Refer en ce: Ho dgso n , Kizior (2016), p p. 285–286.

910. 4 Ra t ion a le: Ph en ob arb ital is an an tico n vu lsan t an d h ypn otic agen t. Th e clien t sh ou ld avoid takin g an y o th er cen tral n ervo u s system d epressan ts su ch as alcoh ol wh ile takin g th is m ed ica- tion . Th e m ed ication m ay b e given with ou t regard to m eals. Takin g th e m ed ication at th e sam e tim e each d ay en h an ces co m p lian ce an d m ain tain s m ore stable bloo d levels o f th e m ed ication . Usin g a d ose con tain er o r “pillb ox” m ay b e h elp - fu l for so m e clien ts. Test -Ta kin g Str a tegy: Focus o n th e su b ject, clien t safety, an d n ote th e strategic wo rd s, highest priority. Elim in ate option 1 b ecause o f th e clo sed -en d ed wo rd only. Alth ough option s 2 an d 3 are co rrect teach in g p oin ts, th ese are n o t th e h igh est p ri- o rity from th e o ptio n s provid ed. Rem em b er th at alco h o l sh ou ld n ot be con sum ed wh en a h yp n otic is taken becau se o f its adverse effects. Review: Clien t teach in g p oin t related to p h en o b arb ital Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g

M

e

n

t

a

l

H

e

a

l

t

h

1053CHAPTER 72 Psychiatric Medications

Con ten t Ar ea : Ph arm aco logy—Psych iatric Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hod gson , Kizio r (2016), p. 982.

911. 2 Ra tion a le: O xazep am cau ses con stipatio n , an d th e clien t is in stru cted to in crease fluid in take an d bu lk (h igh fib er) in th e d iet. If th e h eart b egin s to beat fast, th e h ealth care p ro vider (HCP) is n o tified because th is co u ld in d icate overd ose. In ad di- tio n , d iarrh ea cou ld in dicate an in com p lete in testin al o bstruc- tio n an d , if th is occu rs, th e HCP is n o tified . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, side an d adverse effects of o xazep am . Recallin g th at co n stip ation is a side effect o f th is m edicatio n will d irect you to th e co rrect op tion . Review: Sid e an d ad verse effects o f o xazep am Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Psych iatric Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 263.

912. 4 Ra tion a le: Risp erido n e can cause orth o static h yp o ten sio n . Sun ligh t sh ou ld be avoided by th e clien t takin g th is m edica- tio n . With an y psych o tro pic m ed icatio n , cau tio n n eed s to be taken (such as with d rivin g o r oth er activities req u irin g alert- n ess) un til th e in divid u al can d eterm in e wh eth er h is or h er level o f alertn ess is affected . Foo d in teractio n is n o t a co n cern . Test-Ta kin g St r a t egy: Focus o n th e su b ject, p aram eters to m on itor for th e clien t takin g risperid on e. It is n ecessary to kn o w th e n ursin g co n sid eratio n s related to th e ad m in istra- tio n o f risperid on e an d th at risperid on e can cause orth o static h yp oten sio n . Also, use of th e ABCs—airway–b reath in g– circu latio n —will d irect you to th e correct op tio n . Review: Risp erid o n e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Psych iatric Med ication s Pr ior it y Con cept s: Clien t Ed ucation ; Safety Refer en ce: Hod gson , Kizio r (2016), p. 1089.

913. 2 Ra tion a le: Th e m axim u m th erap eu tic effects of im ipram in e m ay n o t o ccu r fo r 2 to 3 weeks after an tidep ressan t th erap y h as b een in itiated . O p tio n s 1, 3, an d 4 are in correct tim e p erio d s. Test-Ta kin g Str a tegy: Note th e su b ject, th e d esired effect of th is m ed ication , an d fo cu s o n th e word maximum. Recallin g th at it takes 2 to 3 weeks fo r a m axim u m th erap eu tic effect to occur with m o st an tidep ressan ts will direct you to th e correct o ptio n . Review: Im ip ram in e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm aco logy—Psych iatric Med ication s Pr ior it y Con cept s: An xiety; Clien t Ed ucation Refer en ce: Hod gson , Kizio r (2016), pp . 624–625.

914. 3, 5 Ra tion a le: Ph en elzin e is a m o n o am in e o xid ase in h ib ito r (MAO I). Th e clien t sh ou ld avoid in gestin g fo od s th at are h igh in tyram in e. In gestion of th ese foo d s cou ld trigger a po ten tially fatal h yp erten sive crisis. Foo ds to avoid in clu d e yo gu rt; aged ch eeses; sm oked or p ro cessed m eats; red win es; an d fru its su ch as avo cad o s, raisin s, o r figs. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, accep table fo o d item s wh ile takin g MAO Is. Recall th at p h en elzin e is an MAO I an d th at fo od s h igh in tyram in e n eed ed to be avo id ed. Next, fro m th e fo od item s listed in th e q uestion , id en tify th e fo od s th at are tyram in e-free. Review: Foo d item s co n tain in g tyram in e an d m o n o am in e o xi- d ase in h ib ito rs ( MAO Is) Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acolo gy—Psych iatric Med ication s Pr ior it y Con cept s: Nu tritio n ; Safety Refer en ce: Varcaro lis (2013), p. 272.

915. 2 Ra tion a le: Tard ive d yskin esia is a reaction th at can occu r from an tip sych otic m ed icatio n . It is ch aracterized b y u n con tro llable in vo lu n tary m ovem en ts o f th e bo dy an d extrem ities, p articu- larly th e ton gu e. Parkin so n ism is ch aracterized b y trem ors, m asklike facies, rigid ity, an d a sh u fflin g gait. Hyp erten sive cri- sis can o ccur from th e u se o f m o n o am in e oxidase in h ib itors an d is ch aracterized by h yp erten sio n , o ccip ital h ead ach e rad i- atin g fro n tally, n eck stiffn ess an d so ren ess, n au sea, an d vom it- in g. Neu ro lep tic m align an t syn dro m e is a p o ten tially fatal syn d ro m e th at m ay occur at an y tim e d urin g th erap y with n eu- roleptic (an tipsych otic) m ed ication s. It is ch aracterized by dys- p n ea or tach yp n ea, tach ycard ia or irregu lar p ulse rate, fever, b loo d pressu re ch an ges, in creased sweatin g, lo ss o f b lad der con trol, an d skeletal m uscle rigid ity. Test-Ta kin g St r a t egy: Fo cu s o n th e su b ject, a co m p lication of an tip sych otic m ed ication s. To d irect yo u to th e co rrect o ptio n , rem em ber th at tardive d yskin esia is ch aracterized by u n con - tro llab le in vo lun tary m ovem en ts o f th e bo dy an d extrem ities, p articularly th e to n gu e. Review: Extrap yram id al sid e effects an d tard ive d yskin esia Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ph arm acolo gy—Psych iatric Med ication s Pr ior it y Con cept s: Clin ical Ju dgm en t; Psych o sis Refer en ce: Varcaro lis (2013), p. 326.

916. 2 Ra tion a le: Th e m o st co m m o n sid e an d adverse effects related to flu oxetin e in clud e cen tral n ervo u s system an d gastro in testin al system d ysfun ctio n . Fluo xetin e affects th e gastro in testin al sys- tem by cau sin g n ausea an d vo m itin g, cram pin g, an d d iarrh ea. Cardio vascu lar sym pto m s, d ry m ou th , an d excessive sweatin g are n ot side an d ad verse effects associated with th is m ed ication . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, co m m o n sid e an d adverse effects o f fluo xetin e. It is n ecessary to rem em ber th at th is m ed ication cau ses gastro in testin al prob lem s. Th is will d irect yo u to th e co rrect o ption .

M

e

n

t

a

l

H

e

a

l

t

h

1054 UNIT XIX Mental Health Disorders of the Adult Client

Review: Side an d adverse effects of flu o xetin e Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ces: Burch um , Rosenthal (2016), pp. 360–361; Hodgson, Kizior (2016), p. 518.

917. 2 Ra t ion a le: Bu spiro n e is n ot reco m m en ded fo r th e treatm en t o f paran oid th o u gh t disorders, drug o r alcoh ol with d rawal, o r sch izop h ren ia. Bu spiro n e m o st o ften is in dicated for th e treat- m en t o f an xiety. Test -Ta kin g Str a tegy: Note th e strategic wo rd , effective. No te th e wo rds absence of which manifestation in th e qu estio n . Recall- in g th at bu spiro n e is an an tian xiety m ed ication will d irect yo u to th e co rrect op tio n . Review: Th e action an d u se o f b u sp iro n e Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: An xiety; Eviden ce Refer en ce: Ho dgso n , Kizior (2016), p p. 173–174.

918. 1 Ra t ion a le: Main ten an ce seru m levels of lith iu m are 0.6 to 1.2 m Eq / L ( 0.6 to 1.2 m m o l/ L) . Sym pto m s of toxicity b egin to ap pear at levels o f 1.5 to 2 m Eq/ L (1.5 to 2 m m o l/ L) . Lith - ium toxicity req uires im m ediate m ed ical atten tio n with lavage an d po ssib le perito n eal dialysis o r h em od ialysis. Test -Ta kin g St r a t egy: Focu s on th e su b ject, th erapeu tic seru m m ed ication level of lith ium . Recallin g th at th e h igh en d of th e m ain ten an ce level is 1.2 m Eq / L (1.2 m m o l/ L) will d irect yo u to th e co rrect op tio n . Review: Th e th erapeu tic seru m level o f lith iu m Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Varcarolis (2013), p p. 294–295.

919. 4 Ra t ion a le: Clo m ipram in e is a tricyclic an tidep ressan t used to treat o bsessive-co m pu lsive d iso rd er. Sed ation som etim es occu rs. In so m n ia seld o m is a sid e effect. Weigh t gain an d tach y- card ia are side an d ad verse effects o f th is m edicatio n .

Test -Ta kin g St r a t egy: Fo cus on th e su b ject, n o n com p lian ce with clom ipram in e. Recallin g th at th is m edication is a tricyclic an tidepressan t used to treat o bsessive-co m pu lsive d isorder will d irect you to th e co rrect op tio n . Review: Th e pu rpo se o f clo m ip ram in e Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Ad h eren ce; Evid en ce Refer en ce: Ho dgso n , Kizior (2016), p . 275.

920. 2 Ra t ion a le: Seizure activity can occu r in clien ts takin g b up ro - p io n d o sages greater th an 450 m g d aily. Weigh t gain is an occa- sion al sid e effect, wh ereas co n stip ation is a co m m o n sid e effect o f th is m edicatio n . Th is m ed icatio n d oes n o t cau se sign ifican t o rth ostatic b lo od p ressure ch an ges. Test -Ta kin g Str a t egy: Fo cus o n th e su b ject, sign s of to xicity asso ciated with b up ro p ion . Note th e wo rd s excessive amount. Th ese wo rd s will direct yo u to th e co rrect o p tion , th e on e th at iden tifies th e m ost seriou s con cern . Review: Bu p ro p io n Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Ho dgso n , Kizior (2016), p . 173.

921. 3 Ra t ion a le: Depressed in d ividu als sleep fo r lo n g p erio d s, are u n ab le to go to work, an d feel as if th ey can n o t “d o an yth in g.” Wh en th ese clien ts h ave h ad som e th erapeutic effect from th eir m ed ication , th ey rep ort reso lu tio n of m an y o f th ese com - p lain ts an d exh ib it an im p ro vem en t in th eir ap pearan ce. O p tion s 1, 2, an d 4 id en tify co n tin u ed dep ressio n . Test -Ta kin g St r a t egy: Th e clien t’s b eh avio rs or repo rts id en ti- fied in o ption s 1, 2, an d 4 are co m p arab le o r alike an d are sym p tom s o f d ep ression . Th e im p ro vem en t in ap p earan ce in d icates a th erap eu tic respo n se to th e m edicatio n , in dicatin g co m p lian ce with th e m ed icatio n regim en . Review: Exp ected effects of tricyclic an tid ep ressan ts Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—Psych iatric Medicatio n s Pr ior ity Con cepts: Ad h eren ce; Evid en ce Refer en ce: Varcarolis (2013), p p. 262, 267.

M

e

n

t

a

l

H

e

a

l

t

h

1055CHAPTER 72 Psychiatric Medications

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t UNIT XX

Comprehensive Test

P R A C T I C E Q U E S T I O N S 922. Th e em ergen cy departm en t n urse is carin g for a cli-

en t wh o h as been iden tified as a victim of ph ysical ab use. In plan n in g care for th e clien t, wh ich is th e p rio rity n ursin g action ? 1. Adh erin g to th e m an datory abuse-reportin g laws 2. Notifyin g th e caseworker of th e fam ily situation 3. Rem ovin g th e clien t from an y im m ediate

dan ger 4. O btain in g treatm en t for th e abusin g fam ily

m em ber

923. Th e nurse assesses a clien t with the adm ittin g diagn o- sis of bipolar affective disorder, m an ia. Wh ich clien t sym ptom s require the n urse’s im m ed iate action ? 1. In cessan t talkin g an d sexual in n uen do es 2. Gran diose delusio n s an d poor con cen tration 3. O utlan d ish beh aviors an d in approp riate dress 4. No n stop ph ysical activity an d poor n utrition al

in take

924. Th e n urse is carin g for a clien t wh o was in volun tarily h ospitalized to a m en tal h ealth un it an d is sch ed- uled for electroconvulsive therapy. Th e n urse n otes th at an inform ed con sent h as n ot been obtained for th e procedure. Based on this in form ation , wh at is th e n urse’s b est determ ination in plan n in g care? 1. Th e in form ed con sen t does n ot n eed to be

obtain ed. 2. Th e in form ed con sen t sh ould be obtain ed from

th e fam ily. 3. Th e in form ed con sen t n eeds to be obtain ed

from th e clien t. 4. Th e h ealth care provider will provide th e

in form ed con sen t.

925. A clien t n ewly diagn osed with diabetes m ellitus is in structed by th e h ealth care provid er to obtain glu- cagon for em ergen cy h om e use. Th e clien t asks a

h om e care n urse ab out th e purpo se of th e m edica- tion . Wh at is th e n urse’s b est respo n se to th e cli- en t’s question ? 1. “It will boost th e cells in your pan creas if you

h ave in sufficien t in sulin .” 2. “It will h elp to prom o te in sulin absorption

wh en yo ur glucose levels are h igh .” 3. “It is for th e tim es wh en yo ur blood glucose is

too low fro m too m uch in sulin .” 4. “It will h elp to preven t lipoatro ph y from th e

m ultiple in sulin in jection s over th e years.”

926. Th e n urse is providin g care to a Puerto Rican – Am erican clien t wh o is term in ally ill. Nu m erous fam ily m em bers are presen t m ost of th e tim e, an d m an y of th e fam ily m em bers are very em o - tion al. Wh at is th e m o st ap p ro p riate n ursin g action for th is clien t? 1. Restrict th e n um ber of fam ily m em bers visitin g

at on e tim e. 2. In form th e fam ily th at em otion al outb ursts are

to be avoided. 3. Make th e n ecessary arran gem en ts so th at fam ily

m em bers can visit. 4. Con tact th e h ealth care provider to speak to th e

fam ily regardin g th eir beh aviors.

927. A clien t presen ts to th e em ergen cy dep artm en t with upper gastro in testin al bleedin g an d is in m od erate distress. In plan n in g care, wh at is th e p rio rity n urs- in g action for th is clien t? 1. Assessm en t of vital sign s 2. Com pletion of ab dom in al exam in ation 3. In sertion of th e prescribed n asogastric tube 4. Th orou gh in vestigation of precipitatin g even ts

928. Th e n urse is perform in g an assessm en t on a clien t with dem en tia. Wh ich piece of data gath ered dur- in g th e assessm en t in dicates a m an ifestation asso- ciated with dem en tia?

1056

1. Use of con fabulation 2. Im pro vem en t in sleep in g 3. Absen ce of sun down syn dro m e 4. Presen ce of person al h ygien ic care

929. Th e n urse is carin g for a clien t with an orexia n er- vosa. Wh ich beh avior is ch aracteristic of th is disor- der an d reflects an xiety m an agem en t? 1. En gagin g in im m oral acts 2. Always rein fo rcin g self-approval 3. O bservin g rigid rules an d regulatio n s 4. Havin g th e n eed always to m ake th e righ t

decision

930. Th e n urse provides in struction s to a m aln ou rish ed pregn an t clien t regardin g iron supplem en tation . Wh ich clien t statem en t in dicates an un derstan din g of th e in struction s? 1. “Iron supplem en ts will give m e diarrh ea.” 2. “Meat does n ot provide iron an d sh ould be

avoided.” 3. “Th e iron is best absorbed if taken on an em pty

stom ach .” 4. “O n th e days th at I eat green leafy vegetables

or calf liver I can om it takin g th e iron supp lem en t.”

931. Levoth yroxin e is prescribed for a clien t diagn osed with h ypo th yroidism . Upo n review of th e clien t’s record, th e n urse n otes th at th e clien t is takin g war- farin . Wh ich m od ification to th e plan of care sh ould th e n urse review with th e clien t’s h ealth care provid er? 1. A decreased dosage of levoth yroxin e 2. An in creased dosage of levo th yroxin e 3. A decreased dosage of warfarin sodium 4. An in creased dosage of warfarin sodium

932. Th e n urse is teach in g a clien t with em p h ysem a ab out position s th at h elp breath in g durin g dys- pn eic episo des. Th e n urse in structs th e clien t th at wh ich position s alleviate dyspn ea? Select all th at ap p ly.

1. Sittin g up an d lean in g on a table 2. Stan din g an d lean in g again st a wall 3. Lyin g supin e with th e feet elevated 4. Sittin g up with th e elbows restin g on kn ees 5. Lyin g on th e back in a lo w Fowler’s position

933. A clien t is about to un dergo a lum bar pun cture. Th e n urse describes to th e clien t th at wh ich posi- tion will be used durin g th e procedure? 1. Side-lyin g with a pillow un der th e h ip 2. Pron e with a pillow un der th e abdom en 3. Pron e in sligh t Tren d elen burg position 4. Sid e-lyin g with th e legs pulled up an d th e h ead

ben t down on to th e ch est

934. Th e n urse recogn izes th at wh ich interven tion s are likely to facilitate effective com m un ication between a dyin g client an d fam ily? Select all th at app ly.

1. Th e n urse en courages th e clien t an d fam ily to id en tify an d discuss feelin gs open ly.

2. Th e n urse assists th e clien t an d fam ily in car- ryin g out spiritu ally m ean in gful practices.

3. Th e n urse rem oves auton om y from th e clien t to alleviate an y un n ecessary stress for th e clien t.

4. Th e n urse m akes decision s for th e clien t an d fam ily to relieve th em of un n ecessary dem an ds.

5. Th e n urse m ain tain s a calm attitude an d on e of acceptan ce wh en th e fam ily or clien t expresses an ger.

935. A dep ressed clien t verbalizes feelin gs of low self- esteem an d self-worth typified by statem en ts such as “I’m such a failure. I can ’t do an yth in g righ t.” Ho w sh o uld th e n urse plan to respo n d to th e cli- en t’s statem en t? 1. Reassure th e clien t th at th in gs will get better. 2. Tell th e clien t th at th is is n ot true an d th at we all

h ave a purpose in life. 3. Iden tify recen t beh aviors or accom plish m en ts

th at dem on strate th e clien t’s skills. 4. Rem ain with th e clien t an d sit in silen ce; th is

will en courage th e clien t to verbalize feelin gs.

936. Th e n urse h as just ad m itted to th e n ursin g un it a clien t with a basilar skull fracture wh o is at risk for in creased in tracran ial pressure. Pen din g spe- cific h ealth care provider prescription s, th e n urse sh ould safely place th e clien t in wh ich position s? Select all th at ap p ly.

1. Head m idlin e 2. Neck in n eutral position 3. Head of bed elevated 30 to 45 degrees 4. Head turn ed to th e side wh en flat in bed 5. Neck an d jaw flexed forward wh en open in g

th e m ou th

937. Th e n urse reviews th e arterial blood gas results of an assign ed clien t an d n otes th at th e labo ratory report in dicates a pH of 7.30, PaCO 2 of 58 m m Hg, PaO 2 of 80 m m Hg, an d HCO 3 of 27 m Eq/ L (27 m m o l/ L). Th e n urse in terp rets th at th e clien t h as wh ich acid –base disturban ce? 1. Metab olic acidosis 2. Metab olic alkalosis 3. Respiratory acidosis 4. Resp iratory alkalosis

938. Th e nurse has adm itted a clien t to th e clin ical n ursin g un it after un dergoin g a righ t m astectom y. Th e n urse sh ould plan to place th e righ t arm in wh ich position ?

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1057UNIT XX Comprehensive Test

1. Elevated on a pillow 2. Level with th e righ t atrium 3. Depen den t to th e righ t atrium 4. Elevated above sh oulder level

939. O n th e secon d postpartu m day, a clien t com plain s of burn in g on urin ation , urgen cy, an d frequen cy of urin ation . A urin alysis in dicates th e presen ce of a urin ary tract in fectio n . Th e n urse in structs th e clien t regardin g m easu res to take for th e treat- m en t of th e in fectio n . Wh ich clien t statem en t in di- cates to th e n urse th e n eed fo r fu rth er in stru ctio n ? 1. “I n eed to urinate frequen tly th rough out th e day.” 2. “Th e prescribed m ed ication m ust be taken un til

it is fin ish ed.” 3. “My fluid in take sh ould be in creased to at least

3000 m L daily.” 4. “Foo ds an d fluids th at will in crease urin e alka-

lin ity sh ould be con sum ed.”

940. A clien t received 20 un its of Hum ulin N in sulin sub- cutan eously at 08:00. At wh at tim e sh ould the n urse plan to assess th e client for a h ypoglycem ic reaction ? 1. 10:00 2. 11:00 3. 17:00 4. 24:00

941. Th e n urse is th e first respo n der after a torn ado h as destroyed m an y h om es in th e com m un ity. Wh ich victim sh o uld th e n urse atten d to first? 1. A pregn an t wom an wh o exclaim s, “My baby is

n ot m ovin g.” 2. A ch ild wh o is com plain in g, “My leg is bleedin g

so bad, I am afraid it is go in g to fall off!” 3. A youn g ch ild stan din g n ext to an adult fam ily

m em ber wh o is scream in g, “I wan t m y m om m y!” 4. An older victim wh o is sittin g n ext to h er h us-

ban d sobbin g, “My h usban d is dead. My h us- ban d is dead.”

942. A pregn an t clien t at 10 weeks’ gestation calls th e pren atal clin ic to report a recen t exp osure to a ch ild with rubella. Th e n urse reviews th e clien t’s ch art. Wh at is th e n urse’s b est respo n se to th e clien t? Refer to ch art.

1. “You sh ould avoid all sch ool-age ch ildren dur- in g pregn an cy.”

2. “Th ere is n o n eed to be con cern ed if you don ’t h ave a fever or rash with in th e n ext 2 days.”

3. “You were wise to call. Your rubella titer in di- cates th at you are im m un e an d your baby is n ot at risk.”

4. “Be sure to tell th e h ealth care provid er in 2 weeks, as ad dition al screen in g will be pre- scrib ed durin g your secon d trim ester.”

943. A breast-feedin g m oth er of an in fan t with lactose in toleran ce asks th e n urse about dietary m easures. Wh at food s sh ould th e n urse tell th e m oth er are acceptable to con sum e wh ile breast-feedin g? Select all th at ap p ly.

1. 1% m ilk 2. Egg yolk 3. Dried bean s 4. Hard ch eeses 5. Green leafy vegetables

944. A clien t with diabetes m ellitus is told th at am puta- tion of th e leg is n ecessary to sustain life. Th e clien t is very upset an d tells th e n urse, “Th is is all m y h ealth care provid er’s fau lt. I h ave don e everyth in g I’ve been asked to do!” Wh ich n ursin g in terp reta- tion is b est for th is situation ? 1. An expected copin g m ech an ism 2. An in effective defen se m ech an ism 3. A n eed to n otify th e h ospital lawyer 4. An exp ression of guilt on th e part of th e clien t

945. A clien t with term in al can cer arrives at th e em er- gen cy departm en t dead on arrival (DO A). After an autopsy is prescribed, th e clien t’s fam ily requests th at n o autopsy be perform ed. Wh ich respo n se to th e fam ily is m o st ap p ro p riate? 1. “Th e decision is m ade by th e m edical exam in er.” 2. “An au topsy is m an datory for an y clien t wh o

is DO A.” 3. “I will con tact th e m ed ical exam in er regardin g

your request.” 4. “It is required by federal law. Tell m e wh y you

don ’t wan t th e autopsy don e.”

946. A clien t wh o is positive for h um an im m un od efi- cien cy virus (HIV) delivers a n ewborn in fan t. Th e n urse provides in struction s to h elp th e clien t with care of h er in fan t. Wh ich clien t statem en t in dicates th e n eed fo r fu rth er in stru ctio n ? 1. “I will be sure to wash m y h an ds before an d after

bath room use.” 2. “I n eed to breast-feed, especially for th e first

6 weeks postp artum .” 3. “Support grou ps are available to assist m e with

un derstan din g m y diagn osis of HIV.”

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

History and Physical Laboratory and Diagnostic Results Medications

Gravida, Term Births, Preterm Births, Abortions, Living Children (GTPAL) 1,0,0,0,0

Venereal Disease Research Laboratory (VDRL) nonreactive

Prenatal vitamins

Weight 135 lb (61 kg) Rubella immune

Positive Goodell and Chadwick

Rh positive, Type O

1058 UNIT XX Comprehensive Test

4. “My n ewb o rn in fan t sh o u ld b e o n an tiviral m ed icatio n s fo r th e first 6 weeks after d elivery.”

947. An adolescen t clien t is diagn osed with con jun ctivi- tis, an d th e n urse provid es in form ation to th e cli- en t about th e use of con tact len ses. Wh ich clien t statem en t in dicates th e n eed fo r fu rth er in fo rm atio n ? 1. “I sh ould obtain n ew con tact len ses.” 2. “I sh ould n ot wear m y con tact len ses.” 3. “My old con tact len ses sh o uld be discard ed.” 4. “My con tact len ses can be worn if th ey are

clean ed as directed .”

948. Th e n u rse teach es a clien t n ewly d iagn o sed with typ e 1 d iab etes ab o u t sto rin g H u m u lin N in su lin . Wh ich statem en t in d icates to th e n u rse th at th e clien t u n d ersto o d th e d isch arge teach in g? 1. “I sh o uld keep th e in sulin in th e cabin et durin g

th e day on ly.” 2. “I kn ow I h ave to keep m y in sulin in th e refrig-

erator at all tim es.” 3. “I can store th e open in sulin bottle in th e

kitch en cabin et for 1 m on th .” 4. “Th e best place for m y in sulin is on th e win dow

sill, but in th e cupbo ard is just as good.”

949. Th e n urse is carin g for a clien t sch eduled for a tran ssph en oidal h ypoph ysectom y. Th e preop era- tive teach in g in struction s sh ould in clude wh ich statem en t? 1. “Your h air will n eed to be sh aved .” 2. “You will receive spin al an esth esia.” 3. “You will n eed to am bulate after surgery.” 4. “Bru sh in g your teeth n eeds to be avoided for at

least 2 weeks after surgery.”

950. Durin g a ro utin e pren atal visit, a clien t com plain s of gum s th at bleed easily with brush in g. Th e n urse perform s an assessm en t an d teach es th e clien t about proper n utrition to m in im ize th is problem . Wh ich clien t statem en t in dicates an un d erstan d- in g of th e proper n utrition to m in im ize th is problem ? 1. “I will drin k 8 oz of water with each m eal.” 2. “I will eat 3 servin gs of cracked wh eat bread

each day.” 3. “I will eat 2 saltin e crackers befo re I get up each

m orn in g.” 4. “I will eat fresh fru its an d vegetables for sn acks

an d for dessert each day.”

951. A 6-year-old ch ild h as just been diagn osed with localized Hodgkin ’s disease, an d ch em oth erapy is plan n ed to begin im m ediately. Th e m oth er of

th e ch ild asks th e n urse wh y radiation th erap y was n ot prescribed as a part of th e treatm en t. Wh at is th e n urse’s b est respo n se? 1. “It’s very costly, an d ch em oth erapy works just

as well.” 2. “I’m n ot sure. I’ll discuss it with th e h ealth care

provider.” 3. “Som etim es age h as to do with th e decision for

radiation th erapy.” 4. “Th e h ealth care provid er would prefer th at

yo u discuss treatm en t option s with th e on co logist.”

952. An in fan t born with an im perforate an us return s fro m surgery after requirin g a colostom y. Th e n urse assesses th e stom a an d n otes th at it is red an d edem atous. Based on th is fin din g, wh ich action sh o uld th e n urse take? 1. Elevate th e buttocks. 2. Docum en t th e fin din gs. 3. Apply ice im m ediately. 4. Call th e h ealth care provider.

953. Th e n urse is perform in g an in itial assessm en t on a n ewborn in fan t. Wh en assessin g th e in fan t’s h ead, th e n urse n otes th at th e ears are low-set. Wh ich n ursin g action is m o st ap p ro p riate? 1. Do cum en t th e fin din gs. 2. Arran ge for h earin g testin g. 3. Notify th e h ealth care provider. 4. Cover th e ears with gauze pads.

954. Th e clin ic n urse is assessin g jaun dice in a ch ild with h epatitis. Wh ich an atom ical area would provide th e b est data regardin g th e presen ce of jaun dice? 1. Th e n ail bed s 2. Th e skin in th e sacral area 3. Th e skin in th e abdom in al area 4. Th e m em bran es in th e ear can al

955. Th e n urse is assign ed to care for a clien t in traction . Th e n urse creates a plan of care for th e clien t an d sh o uld in clude wh ich action in th e plan ? 1. En su re th at th e kn ots are at th e pulleys. 2. Ch eck th e weigh ts to en sure th at th ey are off of

th e floor. 3. En sure th at th e h ead of th e bed is kept at a 45- to

90-degree an gle. 4. Mon itor th e weigh ts to en sure th at th ey are rest-

in g on a firm surface.

956. Th e n urse is settin g up th e ph ysical en viron m en t for an in terview with a clien t an d plan s to obtain subjective data regardin g th e clien t’s h ealth . Wh ich in terven tion s are appropriate? Select all th at ap p ly.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1059UNIT XX Comprehensive Test

1. Set th e room tem p erature at a com fo rtable level.

2. Rem ove distractin g objects from th e in ter- viewin g area.

3. Place a ch air for th e clien t across from th e n urse’s desk.

4. En su re com fortab le seatin g at eye level for th e clien t an d n urse.

5. Provid e seatin g for th e clien t so th at th e clien t faces a stron g ligh t.

6. En sure th at th e distan ce between th e clien t an d n urse is at least 7 feet (2.1 m eters).

957. Th e n u rse is carin g fo r an o ld er ad u lt wh o h as b een p laced in Bu ck’s exten sio n tractio n after a h ip fractu re. O n assessm en t o f th e clien t, th e n u rse n o tes th at th e clien t is d iso rien ted . Wh at is th e b est n u rsin g actio n b ased o n th is in fo rm atio n ? 1. Apply restrain ts to th e clien t. 2. Ask th e fam ily to stay with th e clien t. 3. Place a clock an d calen dar in th e clien t’s ro om . 4. Ask th e laborato ry to perform electrolyte

studies.

958. Th e n urse is creatin g a plan of care for a clien t in skin traction . Th e n urse sh o uld m on itor for wh ich p rio rity fin din g in th is clien t? 1. Urin ary in con tin en ce 2. Sign s of skin breakdown 3. Th e presen ce of bowel soun ds 4. Sign s of in fectio n arou n d th e pin sites

959. Th e h om e care n urse is visitin g a clien t wh o is in a body cast. Wh ile perform in g an assessm en t, th e n urse plan s to evaluate th e psych o social adjust- m en t of th e clien t to th e cast. Wh at is th e m o st ap p ro p riate assessm en t for th is clien t? 1. Th e n eed for sen sory stim ulation 2. Th e am oun t of h om e care supp ort available 3. Th e ability to perform activities of daily livin g 4. Th e type of tran sportation available for follow-

up care

960. Wh at action sh ould th e n urse con sider wh en coun selin g a clien t of th e Am ish tradition ? 1. Speak on ly to th e h usban d. 2. Use com plex m ed ical term in ology. 3. Avoid usin g scien tific or m edical jargon . 4. Stan d close to th e clien t an d speak loudly.

961. A clien t h as refused to eat m ore th an a few spoo n - fuls of breakfast. Th e h ealth care provider h as pre- scrib ed th at tube feed in gs be in itiated if th e clien t fails to eat at least h alf of a m eal because th e clien t h as lost a sign ifican t am oun t of weigh t durin g th e previous 2 m on th s. Th e n urse en ters th e room ,

looks at th e tray, an d states, “If yo u don ’t eat an y m ore th an th at, I’m goin g to h ave to put a tube down your th roat an d get a feedin g in th at way.” Th e clien t begin s cryin g an d tries to eat m ore. Based on th e n urse’s action s, th e n urse m ay be accu sed of wh ich violation ? 1. Assault 2. Battery 3. Slan der 4. In vasio n of privacy

962. Wh en creatin g an assign m en t for a team con sistin g of a registered n urse (RN), 1 licen sed practical n urse (LPN), an d 2 un licen sed assistive perso n n el (UAP), wh ich is th e b est clien t for th e LPN? 1. A clien t requirin g frequen t tem p erature ch ecks 2. A clien t requirin g assistan ce with am bulation

every 4 h ours 3. A clien t on a m ech an ical ven tilator requirin g

frequen t assessm en t an d suction in g 4. A clien t with a spin al co rd in ju ry requirin g uri-

n ary cath eterization every 6 h ou rs

963. To perform cardiop ulm on ary resuscitation (CPR), th e n urse sh ould use th e m eth od pictured to open th e airway in wh ich situation ? Refer to figu re.

1. If n eck traum a is susp ected 2. In all situation s requirin g CPR 3. If th e clien t h as a h isto ry of seizu res 4. If th e clien t h as a h isto ry of h eadach es

964. Th e n urse teach es skin care to a clien t receivin g extern al radiation th erap y. Wh ich clien t statem en t in dicates th e n eed fo r fu rth er in stru ctio n ? 1. “I will h an dle th e area gen tly.” 2. “I will wear loose-fittin g clo th in g.” 3. “I will avoid th e use of deo doran ts.” 4. “I will lim it sun exposu re to 1 h ou r daily.”

965. Th e h ealth care provid er’s prescription reads levoth yroxin e, 150 m cg orally daily. Th e m edica- tion label reads levoth yroxin e, 0.1 m g per tablet. Th e n urse sh o uld adm in ister h ow m an y tablet( s) to th e clien t? Fill in th e b lan k. An swer: _____ tablet(s)

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1060 UNIT XX Comprehensive Test

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

966. Metform in is prescribed for a clien t with type 2 dia- betes m ellitus. Wh at is th e m o st com m on side effect th at th e n urse sh o uld in clude in th e clien t’s teach in g plan ? 1. Weigh t gain 2. Hypoglycem ia 3. Flush in g an d palp itation s 4. Gastroin testin al disturban ces

967. Wh ich n ursin g action s ap ply to th e care of a ch ild wh o is h avin g a seizure? Select all th at ap p ly.

1. Tim e th e seizu re. 2. Restrain th e ch ild. 3. Stay with th e ch ild. 4. In sert an oral airway. 5. Loo sen clo th in g arou n d th e ch ild’s n eck. 6. Place the child in a lateral side-lyin g position .

968. Th e n urse is con ductin g an in terview of an older clien t an d is con cern ed ab out th e possibility of ben ign prostatic h yperplasia (BPH). Wh ich are ch aracteristics of th is disorder? Select all th at ap p ly.

1. No cturia 2. In con tin en ce 3. En larged prostate 4. No cturn al em ission s 5. Decreased desire for sexual in tercou rse

969. Th e n ursin g in structo r asks a n ursin g studen t to iden tify th e priorities of care for an assign ed clien t. Wh ich statem en t in dicates th at th e studen t cor- rectly iden tifies th e p rio rity clien t n eeds? 1. Actual or life-th reaten in g con cern s 2. Com p letin g care in a reason able tim e fram e 3. Tim e con strain ts related to th e clien t’s n eeds 4. O btain in g n eeded supp lies to care for th e clien t

970. A clien t arrives at th e clin ic com plain in g of fatigue, lack of en ergy, con stipatio n , an d depression . Hypoth yroidism is diagn osed, an d levoth yroxin e is prescribed. Wh at is an exp ected outcom e of th e m edication ? 1. Alleviate depression 2. In crease en ergy levels 3. In crease blood glucose levels 4. Ach ieve n orm al th yroid h orm on e levels

971. Th e com m un ity h ealth n urse is creatin g a poster for an education al session for a grou p of wom en an d will be discussin g th e risk facto rs associated with breast can cer. Wh ich risk facto rs for breast can cer sh o uld th e n urse list on th e poster? Select all th at ap p ly.

1. Multiparity 2. Early m en arch e 3. Early m en op ause

4. Fam ily h isto ry of breast can cer 5. High -dose radiation exp osure to ch est 6. Previous can cer of th e breast, uterus, or

ovaries

972. Th e n urse is carin g for a clien t with acute pan crea- titis an d is m on itorin g th e clien t for paralytic ileu s. Wh ich piece of assessm en t data sh ould alert th e n urse to th is occurren ce? 1. In ability to pass flatu s 2. Loss of an al sph in cter con trol 3. Severe, con stan t pain with rapid on set 4. Firm , n on ten d er m ass palp able at th e lower

righ t costal m argin

973. Th e n urse in spects th e color of th e drain age from a n aso gastric tube on a posto perative clien t approx- im ately 24 h ours after gastric surgery. Wh ich fin d- in g in dicates th e n eed to n otify th e h ealth care provider (HCP)? 1. Dark red drain age 2. Dark brown drain age 3. Green -tin ged drain age 4. Ligh t yello wish -bro wn drain age

974. Th e n u rse is p rep arin g to d isco n tin u e a clien t’s n aso gastric tu be. Th e clien t is po sitio n ed prop - erly, an d th e tu be h as b een flu sh ed with 15 m L o f air to clear secretion s. Befo re rem o vin g th e tu b e, th e n u rse sh ou ld m ake wh ich statem en t to th e clien t? 1. “Take a deep breath wh en I tell you, an d h old it

wh ile I rem ove th e tube.” 2. “Take a deep breath wh en I tell yo u, an d bear

down wh ile I rem ove th e tube.” 3. “Take a deep breath wh en I tell you, an d slowly

exh ale wh ile I rem ove th e tube.” 4. “Take a deep breath wh en I tell you, an d breath e

n orm ally wh ile I rem ove th e tube.”

975. A clien t with a h istory of lun g disease is at risk for developin g respiratory acido sis. Th e n urse sh ould assess th e clien t for wh ich sign s an d sym ptom s ch aracteristic of th is disorder? 1. Bradycardia an d h yperactivity 2. Decreased respiratory rate an d depth 3. Headach e, restlessn ess, an d con fusion 4. Bradypn ea, dizzin ess, an d paresth esias

976. Th e n urse is carin g for a clien t with a resolved in tes- tin al obstru ctio n wh o h as a n asogastric tube in place. Th e h ealth care provider h as n ow prescribed th at th e n asogastric tube be rem oved. Wh at is th e p rio rity n ursin g assessm en t prio r to rem ovin g th e tube? 1. Ch eckin g for n orm al serum electrolyte levels 2. Ch eckin g for n orm al pH of th e gastric aspirate

1061UNIT XX Comprehensive Test

3. Ch eckin g for proper n aso gastric tube placem en t 4. Ch eckin g for th e presen ce of bowel soun ds in

all 4 quadran ts

977. Th e n urse h as reviewed with th e preoperative clien t th e proced ure for th e adm in istration of an en em a. Wh ich statem en t by th e clien t would in dicate th e n eed fo r fu rth er in stru ctio n ? 1. “Th e en em a will be given wh ile I am sittin g on

th e toilet.” 2. “I sh ould try an d h old th e fluid as lo n g as pos-

sible after it is in stilled.” 3. “I kn ow th at th ere will be som e cram p in g after

th e en em a adm in istration .” 4. “I sh ould tell th e n urse if cram p in g occurs dur-

in g th e in stillation of th e fluid.”

978. A clien t exp erien cin g a great deal of stress an d an x- iety is bein g tau gh t to use self-con trol th erap y. Wh ich statem en t by th e clien t in dicates a n eed fo r fu rth er teach in g about th e th erap y? 1. “Th is form of th erapy can be ap plied to n ew

situation s.” 2. “An advan tage of th is tech n iqu e is th at ch an ge is

likely to last.” 3. “Talkin g to on eself is a basic com po n en t of th is

form of th erapy.” 4. “Th is form of th erap y provides a n egative rein -

forcem en t wh en th e stim ulus is produ ced.”

979. Th e n urse is preparin g a list of h om e care in struc- tion s regardin g stom a an d laryn gecto m y care for a clien t with laryn geal can cer wh o h ad a laryn gec- tom y. Wh ich in struction s sh o uld be in cluded in th e list? Select all th at ap p ly.

1. Restrict fluid in take. 2. O btain a MedicAlert bracelet. 3. Keep th e h um idity in th e h om e low. 4. Preven t deb ris from en terin g th e stom a. 5. Avoid exp osure to peo ple with in fection s. 6. Avoid swim m in g an d use care wh en

sh owerin g.

980. Th e h ealth care provider prescribes 2000 m L of 5% dextrose an d h alf-n orm al salin e to in fuse over 24 h ours. Th e drop facto r is 15 drops (gtt) / m L. Th e n urse sh ould set th e flow rate at h ow m an y drops per m in u te? Fill in th e b lan k. Reco rd yo u r an swer to th e n earest wh o le n u m b er. An swer: _____ gtt/ m in u te

981. A clien t is return ed to th e n ursin g un it after th o- racic surgery with ch est tubes in place. Durin g th e first few h ours postoperatively, wh at type of drain age sh ould th e n urse expect? 1. Serous

2. Bloody 3. Serosan guin eous 4. Bloo dy, with frequen t sm all clots

982. A clien t h as h ad radical n eck dissectio n an d begin s to h em orrh age at th e in cision site. Th e n urse sh ould take wh ich action s in th is situation ? Select all th at ap p ly.

1. Mon itor vital sign s. 2. Mon itor th e clien t’s airway. 3. Apply m an ual pressure over th e site. 4. Lower th e h ead of th e bed to a flat position . 5. Call th e h ealth care provider (HCP)

im m ediately.

983. A sexually active youn g ad ult clien t h as develo ped viral h epatitis. Wh ich clien t statem en t in dicates th e n eed fo r fu rth er teach in g? 1. “I sh ould avoid drin kin g alcoh ol.” 2. “I can go back to work righ t away.” 3. “My partn er sh o uld get th e vaccin e.” 4. “A con d om sh o uld be used for sexual

in tercou rse.”

984. Th e n urse sh ould in clude wh ich in terven tion s in th e plan of care for a clien t with h ypo th yroidism ? Select all th at ap p ly.

1. Provide a cool en viron m en t for th e clien t. 2. In struct th e clien t to con sum e a h igh -fat diet. 3. In struct th e clien t about th yroid replacem en t

th erapy. 4. En cou rage th e clien t to con sum e flu ids an d

h igh -fiber foods in th e diet. 5. In form th e clien t th at iodin e preparatio n s

will be prescribed to treat th e disorder. 6. In struct th e clien t to con tact th e h ealth care pro-

vider (HCP) if episodes of ch est pain occur.

985. Th e n urse is preparin g to care for a clien t wh o will be wean ed from a cu ffed trach eostom y tube. Th e n urse is plan n in g to use a trach eostom y plug an d plan s to in sert it in to th e open in g in th e outer can - n ula. Wh ich n ursin g action is required before plug- gin g th e tube? 1. Deflate th e cuff on th e tube. 2. Place th e in n er can n ula in to th e tube. 3. En sure th at th e clien t is ab le to speak. 4. En su re th at th e clien t is able to swallow.

986. A clien t is diagn osed with glaucom a. Wh ich piece of n ursin g assessm en t data iden tifies a risk facto r associated with th is eye disorder? 1. Card iovascu lar disease 2. Frequen t urin ary tract in fectio n s 3. A h isto ry of m igrain e h eadach es 4. Frequen t upper respiratory in fectio n s

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1062 UNIT XX Comprehensive Test

987. A clien t with retin al detach m en t is ad m itted to th e n ursin g un it in preparatio n for a repair proced ure. Wh ich prescription sh ould th e n urse an ticipate? 1. Allowin g bath room privileges on ly 2. Elevatin g th e h ead of th e bed to 45 degrees 3. Wearin g dark glasses to read or watch television 4. Placin g an eye patch over th e clien t’s

affected eye

988. Th e n urse is carin g for a clien t wh o is on strict bed rest an d creates a plan of care with go als related to th e preven tion of deep vein th rom bosis an d pul- m on ary em boli. Wh ich n ursin g action is m o st h elpful in preven tin g th ese disorders from developin g? 1. Restrictin g flu ids 2. Placin g a pillow un der th e kn ees 3. En cou ragin g active ran ge-of-m otion exercises 4. Ap p lyin g a h eatin g p ad to th e lo wer

extrem ities

989. Th e n urse is carin g for a clien t wh o is at risk for sui- cide. Wh at is th e p rio rity n ursin g action for th is clien t? 1. Provide auth ority, action , an d participation . 2. Disp lay an attitu de of detach m en t, con fron ta-

tion , an d efficien cy. 3. Dem on strate con fiden ce in th e clien t’s ab ility to

deal with stressors. 4. Provide h op e an d reassuran ce th at th e prob-

lem s will resolve th em selves.

990. A clien t with tuberculo sis wh ose status is bein g m on itored in an am bulatory care clin ic asks th e n urse wh en it is perm issible to return to work. Wh at factor sh ould th e n urse in clude wh en respon d in g to th e clien t? 1. Five blood cultures are n egative. 2. Th ree sputu m cu ltures are n egative. 3. A blood culture an d a ch est x-ray are n egative. 4. A sputum culture an d a tuberculin skin test are

n egative.

991. A clien t com es to th e em ergen cy departm en t after an assault an d is extrem ely agitated, trem b lin g, an d h yperven tilatin g. Wh at is th e p rio rity n ursin g action for th is clien t? 1. Begin to teach relaxation tech n iques. 2. En cou rage th e clien t to discuss th e assault. 3. Rem ain with th e clien t un til th e an xiety

decreases.

4. Place th e clien t in a quiet room alon e to decrease stim ulation .

992. Th e n urse is carin g for a clien t adm itted to th e h ospital with a suspected diagn osis of acu te ap- pen dicitis. Wh ich laborato ry result sh o uld th e n urse expect to n ote if th e clien t does h ave ap pen dicitis? 1. Leu kopen ia with a sh ift to th e left 2. Leuko cytosis with a sh ift to th e left 3. Leuko pen ia with a sh ift to th e righ t 4. Leu kocytosis with a sh ift to th e righ t

993. Th e n urse is creatin g a plan of care for a clien t wh o was experien cin g an xiety after th e loss of a job . Th e clien t is n ow verbalizin g co n cern s regard- in g th e ab ility to m eet role expectation s an d fin an - cial obligation s. Wh at is th e p rio rity n ursin g problem for th is clien t? 1. An xiety 2. Un realistic outlook 3. Lack of ability to cope effectively 4. Distu rban ces in th o ugh ts an d id eas

994. Th e n urse is m on itorin g th e ch est tube drain age system in a clien t with a ch est tube. Th e n urse n otes in term itten t bubb lin g in th e water seal ch am ber. Wh ich is th e m o st ap p ro p riate n ursin g action ? 1. Ch eck for an air leak. 2. Docum en t th e fin din gs. 3. Notify th e h ealth care provider. 4. Ch an ge th e ch est tube drain age system .

995. After perform in g an in itial abdom in al assessm en t on a clien t with n ausea an d vo m itin g, th e n urse sh o uld exp ect to n ote wh ich fin din g? 1. Waves of loud gurgles auscultated in all 4

quadran ts 2. Low-pitch ed swish in g auscultated in 1 or 2

quadran ts 3. Relatively h igh -pitch ed clicks or gurgles auscul-

tated in all 4 quadran ts 4. Very h igh -pitch ed, loud rush es auscultated

esp ecially in 1 or 2 quadran ts

996. Th e h ealth care provider prescribes eryth rom ycin susp en sion 800 m g by m outh . After recon stitu- tion , h ow m an y m illiliters sh ould th e n urse pour in to th e m ed icin e cup to deliver th e prescribed dose? Refer to figu re. Fill in th e b lan k. An swer: _____ m L

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1063UNIT XX Comprehensive Test

A N S W E R S

922. 3 Ra tion a le: Wh en ever an ab u sed clien t rem ain s in th e abu sive en viro n m en t, p riority m ust b e p laced on ascertain in g wh eth er th e clien t is in an y im m ed iate d an ger. If so, em ergen cy actio n m ust be taken to rem o ve th e clien t fro m th e abu sin g situ atio n . O ptio n s 1, 2, an d 4 m ay b e app ro priate in terven tio n s, bu t are n o t th e prio rity. Test-Ta kin g Str a tegy: Note th e strategic wo rd , priority. Use Maslo w’s Hierarch y o f Need s th eo ry, rem em b erin g th at if a p h ysio logical n eed is n o t p resen t, safety is th e p rio rity. Th is will d irect you to th e correct o ptio n , th e o n ly on e th at d irectly ad dresses clien t safety. Review: Care of th e clien t wh o is a victim of p h ysical ab u se Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: In terperson al Violen ce; Safety Refer en ce: Varcaro lis (2013), pp . 425–426.

923. 4 Ra tion a le: Man ia is a m ood ch aracterized by excitem en t, eu ph oria, h yperactivity, excessive en ergy, d ecreased n eed fo r sleep, an d im paired ab ility to con cen trate o r co m plete a sin gle train o f th ou gh t. Th e clien t’s m oo d is pred om in an tly elevated , exp an sive, o r irritab le. All of th e o ptio n s reflect a clien t’s p o s- sib le sym p to m s. Ho wever, th e correct op tion clearly presen ts a p ro blem th at com prom ises ph ysiological in tegrity an d n eeds to b e ad dressed im m ed iately. Test-Ta kin g Str a tegy: Note th e strategic wo rd , immediate, an d u se Maslo w’s Hierarch y o f Need s th eo ry to assist you in an swerin g th e qu estio n . Th e co rrect o ptio n is th e on ly o n e th at reflects a p h ysio lo gical n eed. Review: Care of th e clien t with m an ia Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Men tal Health

Pr ior it y Con cept s: Psych o sis; Safety Refer en ce: Keltn er, Steele (2015), p. 174.

924. 3 Ra tion a le: Clien ts wh o are ad m itted in vo lun tarily to a m en tal h ealth u n it do n o t lose th eir righ t to in form ed co n sen t. Clien ts m ust be co n sid ered legally co m p eten t un til th ey h ave b een d eclared in co m peten t th rou gh a legal proceed in g. Th e best d eterm in ation for th e n u rse to m ake is to ob tain th e in fo rm ed con sen t from th e clien t. Test-Ta kin g Str a tegy: Focus on th e su b ject, in form ed con sen t fo r an in vo lun tarily adm itted clien t, an d n o te th e stra- tegic wo rd , best. Kn o wledge regard in g th e h o spital adm ission p ro cesses an d clien t’s righ ts will d irect you to th e correct o ptio n . Review: Clien t righ ts an d in fo rm ed co n sen t Level of Cogn itive Ability: Ap plyin g Clien t Need s: Safe an d Effective Care En viro n m en t In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Leadersh ip / Man agem en t—Eth ical/ Legal Pr ior it y Con cept s: Eth ics; Health Care Law Refer en ce: Varcaro lis (2013), pp . 83–84.

925. 3 Ra tion a le: Glucagon is u sed to treat h yp oglycem ia resultin g fro m in sulin o verd ose. Th e fam ily of th e clien t is in structed in h o w to ad m in ister th e m edicatio n . In an u n con scio us clien t, aro u sal usu ally o ccurs with in 20 m in u tes of glucagon in jec- tio n . Wh en co n scio usn ess h as been regain ed , oral carb oh y- d rates sh ou ld b e given . Lip oatrop h y an d lip oh yp ertro ph y result from in sulin in jection s. Test-Ta kin g Str a tegy: Focus o n th e su b ject, th e pu rp o se of glu - cago n . Also n o te th e strategic wo rd , best. No tin g th e word glu - cago n will assist yo u in d eterm in in g th at th e m edicatio n con tain s som e fo rm o f gluco se. Th is relation sh ip will d irect you to th e correct op tio n . Review: Th e p u rp ose of glu cago n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

Figure from Brown, Mulholland (2012).

1064 UNIT XX Comprehensive Test

In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medicatio n s Pr ior ity Con cepts: Clien t Edu catio n ; Gluco se Regu latio n Refer en ce: Burch um , Rosen th al (2016), p. 696.

926. 3 Ra t ion a le: In th e Puerto Rican –Am erican cultu re, lo ud cryin g an d oth er ph ysical m an ifestation s o f grief are co n sid ered socially accep table. O f th e o p tion s provid ed , th e co rrect o ptio n is th e o n ly o n e th at id en tifies a culturally sen sitive ap proach o n th e p art of th e n urse. O p tio n s 1, 2, an d 4 are in ap pro priate n ursin g in terven tion s. Test -Ta kin g Str a tegy: Note th e strategic wo rd s, most appropri- ate. Fo cu s o n th e clien ts o f th e qu estio n , th e fam ily m em b ers. Use th erap eu tic n ursin g in terven tio n s, recallin g th e ch aracter- istics o f th e cultu re an d th e im po rtan ce of cu ltu ral sen sitivity. Th is will direct yo u to th e correct o ptio n . Review: Th e n urse’s role an d resp on sibilities regard in g cu ltu ral awaren ess Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Cu lture an d Sp iritu ality Con t en t Ar ea : Fun dam en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Cultu re; Fam ily Dyn am ics Refer en ces: Giger (2013), p. 582; Lewis et al. (2014), p . 145.

927. 1 Ra t ion a le: Th e priority n ursin g action is to assess th e vital sign s. Th is wou ld p ro vid e in form atio n ab ou t th e am ou n t o f blo od lo ss th at h as o ccurred an d p ro vid e a baselin e by wh ich to m on itor th e progress of treatm en t. Th e clien t m ay be u n ab le to p ro vid e sub jective data un til th e im m ed iate p h ysical n eed s are m et. Alth o ugh an ab do m in al exam in ation an d an assess- m en t o f th e precipitatin g even ts m ay b e n ecessary, th ese actio n s are n o t th e p riority. In sertio n o f a n aso gastric tub e is n ot th e p rio rity an d will requ ire a h ealth care provid er’s p re- scription ; in add itio n , th e vital sign s sh ou ld be ch ecked b efore perform in g th is pro ced ure. Test -Ta kin g St r a t egy: Note th e strategic wo rd , priority, an d u se th e ABCs—airway–b reath in g–circu latio n . Th is will direct you to th e co rrect op tio n . Review: Care fo r th e clien t with gastro in testin al b leed in g Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Care Co ordin ation ; Clin ical Jud gm en t Refer en ce: Ign atavicius, Workm an (2016), p . 1180.

928. 1 Ra t ion a le: Th e clin ical pictu re of dem en tia ran ges from m ild co gn itive d eficits to severe, life-th reaten in g alteration s in n eu - ro logical fu n ction in g. For th e clien t to use con fabulation or th e fab ricatio n of even ts or experien ces to fill in m em o ry gaps is n ot un u su al. O ften , lack o f in h ibition s on th e part of th e clien t m ay co n stitute th e first in d ication of som eth in g bein g “wro n g” to th e clien t’s sign ifican t oth ers ( e.g., th e clien t m ay un dress in fro n t o f oth ers, or th e fo rm erly well-m an n ered clien t m ay exh ib it slo ven ly table m an n ers) . As th e dem en tia p ro gresses,

th e clien t will h ave difficu lty sleep in g an d ep iso des of wan d er- in g or sun do wn in g. Test -Ta kin g St r a t egy: Fo cu s on th e clien t’s d iagn o sis an d n o te th e su b ject, a m an ifestation of dem en tia. Th in k about th e ch ar- acteristics o f d em en tia to d irect you to th e co rrect op tio n . Review: Man ifestatio n s associated with d em en tia Level of Cogn it ive Ability: An alyzin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Cogn ition ; Cop in g Refer en ce: Ign atavicius, Workm an (2016), p p. 871, 873.

929. 3 Ra t ion a le: Clien ts with an o rexia n ervosa h ave th e d esire to p lease o th ers. Th eir n eed to b e correct o r perfect in terferes with ration al decision -m akin g processes. Th ese clien ts are m o ralistic. Ru les an d rituals h elp th ese clien ts to m an age th eir an xiety. Test -Ta kin g Str a tegy: Focu s o n th e su b ject, m an agin g an xi- ety. Elim in ate o p tion s 2 an d 4 because of th e clo sed -en d ed wo rd always. O ption 1 is n ot ch aracteristic of a clien t with an orexia. Review: Care fo r th e clien t with an o rexia n ervo sa Level of Cogn it ive Ability: An alyzin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: An xiety; Cop in g Refer en ce: Stuart (2013), p. 483.

930. 3 Ra t ion a le: Iro n is n eeded to allow for tran sfer of ad eq uate iro n to th e fetus an d to perm it expan sion o f th e m atern al red b loo d cell m ass. Du rin g p regn an cy, th e relative excess o f p lasm a causes a decrease in th e h em oglo bin con cen tratio n an d h em at- o crit, kn own as physiological anemia of pregnancy. Th is is a n o r- m al adap tation d urin g p regn an cy. Iro n is b est ab so rb ed if taken o n an em p ty stom ach . Takin g it with a fluid h igh in asco rb ic acid such as to m ato ju ice en h an ces ab so rp tion . Iron su p plem en ts u sually cau se con stipation . Meats are an excellen t so u rce of iro n . Th e clien t n eed s to take th e iro n sup plem en ts regard less o f fo od in take. Test -Ta kin g St r a t egy: Note th e su b ject, iron su pp lem en tatio n d u rin g p regn an cy. Fo cu s on th e words understanding of the instructions. Kn o wled ge o f basic prin cip les related to n utritio n d u rin g p regn an cy will assist in elim in atin g o p tion s 2 an d 4. From th e rem ain in g o p tion s, rem em b er th at iron cau ses co n stip ation . Review: Clien t teach in g p oin ts related to iro n sup plem en tatio n Level of Cogn it ive Abilit y: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clien t Ed u catio n ; Nu tritio n Refer en ce: Lo wd erm ilk et al. (2016), p . 361.

931. 3 Ra t ion a le: Levo th yro xin e accelerates th e degradatio n o f vita- m in K–dep en d en t clo ttin g facto rs. As a resu lt, th e effects o f

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1065UNIT XX Comprehensive Test

warfarin are en h an ced. If th yroid h orm on e replacem en t th er- ap y is in stitu ted in a clien t wh o h as b een takin g warfarin , th e d osage o f warfarin sh o uld b e red uced . Test-Ta kin g St r a t egy: Fo cus o n th e su b ject, th e use of levo th yroxin e co n curren tly with warfarin . Recallin g th at levo th yroxin e en h an ces th e effects o f warfarin will d irect yo u to th e correct o ptio n . Review: Levo th yro xin e Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—An alysis Con ten t Ar ea : Ph arm aco logy—En do crin e Med ication s Pr ior it y Con cept s: Co llab oration ; Safety Refer en ce: Bu rch u m , Ro sen th al (2016), p . 713.

932. 1, 2, 4 Ra tion a le: Th e clien t sh o u ld u se th e p ositio n s o utlin ed in o ptio n s 1, 2, an d 4. Th ese allow fo r m axim al ch est exp an sio n . Th e clien t sh o uld n ot lie o n th e b ack b ecau se it red uces m ove- m en t o f a large area o f th e clien t’s ch est wall. Sittin g is b etter th an stan din g, wh en ever p ossible. If n o ch air is availab le, lean - in g again st a wall wh ile stan d in g allows accesso ry m uscles to be u sed fo r b reath in g an d n o t po stu re co n tro l. Test-Ta kin g St r a t egy: Focus o n th e su b ject, th e p ositio n s th at cou ld alleviate d yspn ea. Rem em b er th at u prigh t p osition s are best. Also , n o te th at o p tion s 1, 2, an d 4 are co m p arab le o r alike in th at th ey all add ress up righ t p o sitio n s. Review: Clien t teach in g po in ts related to em p h ysem a Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —Resp irato ry Pr ior it y Con cept s: Clien t Ed ucation ; Gas Exch an ge Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 559.

933. 4 Ra tion a le: A clien t u n d ergo in g lu m b ar p un ctu re is po sitio n ed lyin g on th e sid e, with th e legs pu lled up to th e ab d om en an d th e h ead ben t do wn o n to th e ch est. Th is p osition h elps to o pen th e spaces b etween th e verteb rae an d allo ws for easier n eed le in sertio n b y th e h ealth care provid er. Th e n u rse rem ain s with th e clien t du rin g th e p ro cedu re to h elp th e clien t m ain tain th is p osition . Th e o th er op tion s id en tify in correct p o sitio n s fo r th is p ro ced u re. Test-Ta kin g Str a tegy: Focu s on th e su b ject, lu m b ar p un ctu re. Recallin g th at a lu m bar pu n cture is th e in trod u ctio n of a n eedle in to th e sub arach n o id sp ace will d irect you to th e correct o ptio n . It is reaso n able th at th e po sitio n o f th e clien t m u st facilitate th is, an d th e co rrect o ptio n is th e o n ly p osition th at flexes th e verteb rae an d wid en s th e sp aces b etween th em . Review: Care of th e clien t un dergoin g lu m b ar p u n ctu re Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Diagn ostic Tests Pr ior it y Con cept s: In tracran ial Regu lation ; Safety Refer en ces: Lewis et al. (2014), pp . 1349, 1352; Pagan a et al. (2015), pp . 600–601.

934. 1, 2, 5 Ra tion a le: Main tain in g effective an d open com m un ication am on g fam ily m em bers affected by death an d grief is o f th e greatest im po rtan ce. O p tion 1 d escrib es en co u ragin g d iscu s- sio n o f feelin gs an d is likely to en h an ce co m m u n icatio n . O ptio n 2 is also an effective in terven tion b ecau se sp iritual p ractices give m ean in g to life an d h ave an im p act o n h ow peo- p le react to crisis. O ption 5 is also an effective tech n iq ue b ecau se th e clien t an d fam ily n eed to kn o w th at som eo n e will b e th ere wh o is su p po rtive an d n o n jud gm en tal. Th e rem ain in g o ptio n s describe th e n u rse rem o vin g auto n o m y an d d ecisio n m akin g fro m th e clien t an d fam ily, wh o are alread y experien c- in g feelin gs o f lo ss of co n trol in th at th ey can n o t ch an ge th e p ro cess o f d yin g. Th ese are in effective in terven tio n s th at co u ld im pair com m un icatio n furth er. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e in terven tio n s th at will facilitate effective co m m u n ication . Use of th erap eu tic co m m u n icatio n tech n iq u es an d fo cu sin g o n th e su b ject will assist you in an swerin g correctly. Th e in co rrect o ptio n s rem ove con trol from th e clien t an d fam ily. Review: Th erap eu tic co m m u n icatio n tech n iq u es Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Develop m en tal Stages—En d -of-Life Care Pr ior it y Con cept s: Caregivin g; Fam ily Dyn am ics Refer en ce: Lewis et al. (2014), p p. 145, 147.

935. 3 Ra tion a le: Feelin gs o f lo w self-esteem an d worth lessn ess are com m on sym pto m s of a dep ressed clien t. An effective p lan o f care to en h an ce th e clien t’s perso n al self-esteem is to p rovid e exp erien ces for th e clien t th at are ch allen gin g, b u t th at will n o t b e m et with failure. Rem in ders o f th e clien t’s p ast accom plish - m en ts o r perso n al successes are ways to in terrup t th e clien t’s n egative self-talk an d d istorted cogn itive view o f self. O p tion s 1 an d 2 give advice an d devalue th e clien t’s feelin gs. Silen ce m ay b e in terpreted as agreem en t. Test-Ta kin g St r a t egy: Use th erap eu tic co m m u n icatio n tech - n iq u es an d fo cu s o n th e clien t’s d iagn o sis. Yo u can elim in ate o ptio n s 1 an d 2 easily becau se th ey are n on th erap eu tic. From th e rem ain in g op tio n s, focusin g o n th e clien t’s diagn osis will d irect yo u to th e co rrect o ption . Review: Care of th e clien t with d ep ressio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: Caregivin g; Moo d an d Affect Refer en ce: Stu art (2013), p p . 266–267.

936. 1, 2, 3 Ra tion a le: Use of p ro per po sitio n s p ro m otes ven o us d rain age fro m th e cran ium to keep in tracran ial p ressu re from elevatin g. Th e h ead of th e clien t at risk fo r o r with in creased in tracran ial p ressu re sh o uld be p osition ed so th at it is in a n eu tral, m idlin e p ositio n . Th e h ead of th e b ed sh ou ld be raised to 30 to 45 d egrees. Th e n u rse sh o uld avo id flexin g o r exten din g th e cli- en t’s n eck or turn in g th e clien t’s h ead from side to sid e.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1066 UNIT XX Comprehensive Test

Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, care o f th e clien t with in creased in tracran ial p ressure. Visualize each of th e po si- tion s id en tified in th e o ptio n s an d id en tify th o se th at will pro- m o te ven o u s d rain age fro m th e cran iu m . Review: Care o f th e clien t with in creased in tracran ial p ressu re Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Ad ult Health —Neu ro lo gical Pr ior ity Con cepts: In tracran ial Regulatio n ; Safety Refer en ce: Lewis et al. (2014), p p. 1367–1368.

937. 3 Ra t ion a le: Th e n orm al pH is 7.35 to 7.45. No rm al PaCO 2 is 35 to 45 m m Hg. In resp irato ry acid osis, th e pH is low an d PaCO 2 is elevated. O p tion s 1, 2, an d 4 are in co rrect in terpretation s o f th e values iden tified in th e q uestion . Test -Ta kin g St r a t egy: Focu s on th e su b ject, in terpretation of arterial bloo d gas levels. Rem em ber th at in a resp iratory im bal- an ce yo u will fin d an o pp osite resp o n se b etween th e pH an d PaCO 2. Also , rem em b er th at th e p H is lo w in an acido tic con di- tion . Recallin g th is in form ation will allow yo u to elim in ate each of th e in correct o ption s. Review: In terpretation o f arterial b lo o d gas resu lts Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—An alysis Con t en t Ar ea : Fun dam en tals of Care—Acid –b ase Pr ior ity Con cepts: Acid –base Balan ce; Clin ical Jud gm en t Refer en ce: Ign atavicius, Workm an (2016), p p. 180, 182.

938. 1 Ra t ion a le: Th e clien t’s op erative arm sh o uld be p osition ed so th at it is elevated o n a pillow an d n o t exceed in g sh ou ld er ele- vatio n . Th is po sitio n p rom otes o ptim al d rain age from th e lim b, with ou t im p airin g th e circulation to th e arm . If th e arm is p osition ed flat (o ptio n 2) or d ep en d en t (o ptio n 3), th is co uld in crease th e ed em a in th e arm , wh ich is co n train dicated because of lym ph atic d isru ption cau sed by su rgery. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, care o f th e clien t fo llo win g m astectom y. Read each o p tion carefu lly an d attem p t to visu alize th e p o sitio n id en tified in th e op tion . Usin g th e prin ciples o f circulation an d gravity will d irect you to th e co r- rect optio n . Th e correct option avoids th e two extrem es of h eigh t ( d ep en d en t, abo ve sh ou ld er level) in po sitio n in g th e lim b affected b y surgery. Review: Care o f th e clien t wh o h as u n dergo n e m astecto m y Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Plan n in g Con t en t Ar ea : Ad ult Health —O n cology Pr ior ity Con cepts: Perfusio n ; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1474.

939. 4 Ra t ion a le: A clien t with a u rin ary tract in fectio n m u st b e en co u raged to take th e p rescrib ed m ed icatio n fo r th e en tire tim e it is p rescrib ed . Th e clien t sh o u ld also b e in stru cted to d rin k at least 3000 m L o f flu id each d ay to flu sh th e in fectio n

fro m th e b lad d er an d to u rin ate freq u en tly th ro u gh o u t th e d ay. Fo o d s an d flu id s th at acid ify th e u rin e n eed to b e en co u raged . Test -Ta kin g Str a tegy: Note th e strategic wo rd s, need for further instruction. Th ese words in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is in correct. Recall th at foo ds an d fluid s th at acid ify th e u rin e sh o uld b e co n sum ed , rath er th an foo ds an d flu id s th at cause urin e alkalin ity. Review: Nu rsin g co n sid eratio n s fo r a clien t with u rin ary tract in fectio n Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Po stpartum Pr ior ity Con cepts: Clien t Ed u catio n ; In fection Refer en ce: Lo wd erm ilk et al. (2016), p p. 813–814.

940. 3 Ra t ion a le: Hum ulin N is an in term ediate-actin g in sulin . Th e o n set of action is 60 to 120 m in utes, it peaks in 6 to 14 h o urs, an d th e du ratio n of actio n is 16 to 24 h o urs. Hyp oglycem ic reaction s m o st likely occu r du rin g peak tim e. Test -Ta kin g St r a t egy: Focus on th e su b ject, ch aracteristics of Hu m ulin N in su lin , an d u se kn o wled ge regard in g th e o n set, p eak, an d du ratio n of actio n . Recallin g th at it is an in term ed iate-actin g in sulin an d recallin g th at p eak action is b etween 6 an d 14 h o urs will d irect you to th e co rrect op tion . Review: Ch aracteristics o f Hu m u lin N in su lin Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medication s Pr ior ity Con cepts: Glu co se Regulation ; Safety Refer en ces: Ign ataviciu s, Workm an (2016), p. 1314; Lilley et al. (2014), p p. 517, 519.

941. 2 Ra t ion a le: Prio rity n ursin g care in disaster situ ation s n eeds to b e d elivered to th e livin g an d n o t th e dead . Th e ch ild wh o is b leed in g bad ly is th e prio rity. Th e b leed in g co uld b e fro m an arterial vessel; if th e b leed in g is n o t stop ped, th e ch ild is at risk for sh ock an d death . Th e p regn an t clien t is th e n ext p ri- o rity, bu t th e ab sen ce o f fetal m o vem en t m ay or m ay n ot b e in d icative o f fetal d em ise. Th e yo u n g ch ild is with a fam ily m em b er an d is safe at th is tim e. Th e o ld er victim will n eed co m fo rt m easures; th ere is n o in form atio n in dicatin g sh e is p h ysically h u rt. Test -Ta kin g St r a t egy: No te th e strategic wo rd , first. Use Maslo w’s Hierarch y o f Need s th eo ry wh en an swerin g th is q u estion . Rem em b er th at ph ysical n eed s sh o uld b e ad dressed b efo re psych o social n eeds an d u se th e ABCs—airway–b reath - in g–circu latio n . Bleed in g is th e priority. Review: Disasters an d triage Level of Cogn it ive Ability: Syn th esizin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Lead ersh ip/ Man agem en t—Disasters Pr ior ity Con cepts: Care Coo rd in ation ; Clin ical Ju d gm en t Refer en ce: Ign atavicius, Workm an (2016), p p. 140–141.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1067UNIT XX Comprehensive Test

942. 3 Ra tion a le: Ru bella viru s is spread b y aero sol drop let tran sm is- sio n th rou gh th e u pp er resp irato ry tract an d h as an in cu batio n p erio d o f 14 to 21 days. Th e risks o f m atern al an d su bseq u en t fetal in fectio n d u rin g th e seco n d trim ester in clud e h earin g lo ss an d con gen ital an o m alies; th ese risks decrease after th e first 12 weeks of p regn an cy. Ru bella titer d eterm in ation is a stan - d ard p ren atal test fo r pregn an t wom en du rin g th eir in itial screen in g an d en try in to th e h ealth care d elivery system . As n o ted in th is clien t’s ch art, sh e is im m u n e to rub ella. Th e cor- rect op tio n is th e o n ly o ption th at h elp s to clarify m atern al con - cern s with accurate in form ation . Test-Ta kin g St r a t egy: Note th e strategic wo rd , best, an d recall kn owled ge regard in g th e tran sm issio n of ru bella virus to th e fetu s. Also , u se of th erap eu tic co m m u n icatio n tech n iq u es will direct you to th e correct o ption . Th e correct option ad dresses th e clien t’s co n cern s. Review: Ru b ella in pregn an cy Level of Cogn it ive Abilit y: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Matern ity—An tepartum Pr ior it y Con cept s: Im m u n ity; Safety Refer en ce: Lo wd erm ilk et al. (2016), p. 166.

943. 2, 3, 5 Ra tion a le: Breast-feedin g m oth ers with lacto se-in toleran t in fan ts n eed to be en co uraged to lim it d airy prod ucts. Milk an d ch eese are dairy prod u cts. Altern ative calciu m sou rces th at can be co n su m ed b y th e m oth er in clu d e egg yolk, dried b ean s, green leafy vegetab les, cau liflo wer, an d m olasses. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, foo d s accep tab le fo r a b reast-feedin g m oth er with a lacto se-in to leran t in fan t. Recall th at lacto se is th e su gar fou n d in d airy p ro du cts. Also n o te th at op tion s 1 an d 4 are co m p arab le o r alike an d are d airy p ro d ucts. Review: Dietary m an agem en t fo r an in fan t with lacto se in to leran ce Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n d am en tals o f Care—Nutrition Pr ior it y Con cept s: Clien t Ed ucation ; Nutritio n Refer en ce: Lo wd erm ilk et al. (2016), pp . 352–353.

944. 1 Ra tion a le: Th e n u rse n eeds to be aware of th e effective an d in effective co pin g m ech an ism s th at can occu r in a clien t wh en lo ss is an ticipated . Th e exp ression o f an ger is kn o wn to b e a n o rm al resp on se to im pen din g loss, an d th e an ger m ay be d irected to ward th e self, God o r oth er sp iritual bein g, or care- givers. Notifyin g th e h o spital lawyer is in ap prop riate. Gu ilt m ay o r m ay n ot b e a co m p o n en t o f th e clien t’s feelin gs, an d th e data in th e qu estio n do n ot in dicate th at gu ilt is p resen t. Test-Ta kin g St r a t egy: Note th e su b ject, p sych oso cial care o f a clien t n eedin g am p utatio n . Also n o te th e strategic wo rd , best. No te th at th e correct op tion an d op tio n 2 add ress co pin g an d d efen se m ech an ism s. Th is provid es you with th e clu e th at o n e o f th ese o ption s m ay b e th e co rrect respo n se. In add itio n ,

kn owled ge o f th e stages of grief asso ciated with lo ss will d irect you to th e correct op tio n . Review: Stages o f grief an d expected clien t resp on ses Level of Cogn itive Ability: An alyzin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Co pin g Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1071–1072.

945. 3 Ra tion a le: An au top sy is req uired by state law in certain cir- cum stan ces, in clud in g th e su dd en death o f a clien t an d a d eath th at o ccu rs u n d er susp iciou s circu m stan ces. A clien t m ay h ave p ro vided o ral o r written in stru ctio n s regard in g an au top sy after d eath . If an au to psy is n o t requ ired by law, th ese oral or written requests will be gran ted. If n o o ral o r written in struction s were p ro vided , state law determ in es wh o h as th e auth ority to co n - sen t for an au top sy. Mo st often , th e decisio n rests with th e su r- vivin g relative o r n ext o f kin . Test-Ta kin g St r a t egy: No te th e strategic wo rd s, most appropri- ate. Use kn o wledge regard in g th e laws an d issu es su rrou n d in g auto p sy an d th erap eu tic co m m u n icatio n tech n iq u es to an swer th e q uestion . Elim in ate o ptio n s 2 an d 4 becau se th ese statem en ts are n o t co m pletely accu rate an d are n o t th erapeutic in th is situatio n . From th e rem ain in g o p tion s, th e co rrect o ptio n is th e th erapeutic an d ap prop riate resp on se to th e fam ily. Review: Issu es an d laws surro un din g au to p sy Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Carin g Con ten t Ar ea : Develop m en tal Stages—En d -of-Life Care Pr ior it y Con cept s: Health Care Law; Pro fessio n al Iden tity Refer en ce: Perry et al. (2014), p. 385.

946. 2 Ra tion a le: Th e m ode of perin atal tran sm ission of HIV to th e fetu s or n eon ate o f an HIV-po sitive wo m an can o ccur du rin g th e pren atal, in trap artal, o r po stpartum perio d. HIV tran sm is- sio n can o ccur du rin g b reast-feed in g. In th e Un ited States an d m ost develo p ed co un tries, HIV-po sitive clien ts are en co uraged to bo ttle-feed th eir in fan ts (th e h ealth care p ro vider’s p rescrip- tio n is always fo llo wed ). Freq uen t h an d wash in g is en cou r- aged. Su pp ort gro up s an d com m un ity agen cies can be id en tified to assist th e paren ts with th e n ewb orn in fan t’s h om e care, th e im p act o f th e diagn osis o f HIV in fectio n , an d availab le fin an cial resou rces. It is reco m m en ded th at in fan ts of HIV- p ositive clien ts receive an tiviral m edication s for th e first 6 weeks of life. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further instruction. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an op tion th at is in correct. Recallin g th e m eth o ds o f tran sm issio n o f HIV an d th at breast-feed in g is d is- cou raged in th e HIV-p ositive wom an will d irect you to th e cor- rect option . Review: Ho m e care m easures fo r th e clien t with h u m an im m u - n o d eficien cy viru s ( HIV) Level of Cogn itive Ability: Evalu atin g Clien t Need s: Safe an d Effective Care En viro n m en t

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1068 UNIT XX Comprehensive Test

In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Matern ity—Newbo rn Pr ior ity Con cepts: Clien t Edu catio n ; In fection Refer en ce: Lo wderm ilk et al. (2016), p . 161.

947. 4 Ra t ion a le: If th e ad olescen t wears co n tact len ses, th e ado les- cen t sh ou ld b e in structed to d iscon tin u e wearin g th em u n til th e in fection h as cleared co m p letely. O b tain in g n ew co n tact len ses wo uld elim in ate th e ch an ce o f rein fectio n fro m con tam - in ated con tact len ses an d wo uld lessen th e risk of a co rn eal ulceration . Test -Ta kin g Str a tegy: No te th e strategic wo rd s, need for further information. Th ese wo rd s in d icate a n egative even t q u ery an d ask yo u to select an op tio n th at is in correct. O ptio n s 1, 2, an d 3 are co m p arab le o r alike in th at th ey relate to avo id in g th e use o f con tact len ses d u rin g in fection . Review: Treatm en t m easu res for co n ju n ctivitis Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Pediatrics—Eye/ Ear Pr ior ity Con cepts: Clien t Edu catio n ; In fection Refer en ce: McKin n ey et al. (2013), p . 1509.

948. 3 Ra t ion a le: An in sulin vial in cu rren t use can b e kep t at ro om tem p eratu re for 1 m o n th with o ut sign ifican t lo ss of activity. Direct sun ligh t an d h eat m ust b e avo id ed. Th erefo re, o ptio n s 1, 2, an d 4 are in correct. Test -Ta kin g St r a t egy: No te th e su b ject, clien t u n d erstan din g of d isch arge in struction s related to storage of in su lin . Notin g th e clo sed -en d ed wo rd s only in op tion 1 an d all in op tio n 2 will assist you in elim in atin g th ese op tio n s. Recallin g th at direct su n ligh t an d h eat n eed to be avo ided will assist yo u in elim in atin g o ptio n 4. Review: Storage o f in su lin Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medicatio n s Pr ior ity Con cepts: Clien t Edu catio n ; Gluco se Regu latio n Refer en ce: Burch um , Rosen th al (2016), p. 681.

949. 4 Ra t ion a le: A tran ssp h en oidal h ypoph ysectom y is a surgical ap p ro ach th at uses th e n asal sin u ses an d n o se fo r access to th e pituitary glan d . Based o n th e locatio n o f th e surgical pro- ced ure, spin al an esth esia wo u ld n o t b e used . In ad ditio n , th e h air wo uld n ot b e sh aved . Alth ou gh am bu latin g is im po rtan t, specific to th is p rocedu re is avo id in g b ru sh in g th e teeth to p re- ven t disru ptio n of th e su rgical site. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, a p reop erative in struction . Co n sid er th e an atom ical locatio n an d th e surgical procedu re itself to elim in ate o ptio n s 1 an d 2. Alth ou gh yo u m ay b e tem p ted to select op tion 3, n ote th e location of th e sur- gery to d irect you to th e correct op tio n . Review: Tran ssp h en o id al h yp o p h ysecto m y Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity

In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —En d o crin e Pr ior ity Con cepts: Safety; Tissu e In tegrity Refer en ce: Ign atavicius, Workm an (2016), p p. 1270–1271.

950. 4 Ra t ion a le: Fresh fruits an d vegetab les p ro vid e vitam in s an d m in erals n eeded for h ealth y gum s. Drin kin g water with m eals h as n o direct effect o n gu m s. Cracked wh eat bread m ay ab rad e th e ten d er gu m s. Eatin g saltin e crackers can also abrade th e ten der gum s. Test -Ta kin g St r a t egy: Focu s o n th e su b ject, den tal h ealth du r- in g pregn an cy. Elim in ate o ptio n s 2 an d 3 first because th ese m easu res co u ld irritate fragile gum s. Fro m th e rem ain in g o p tion s, elim in ate op tio n 1 by rem em b erin g th at drin kin g water with m eals h as n o direct effect on gum s an d does n ot p ro vid e n eed ed vitam in s an d m in erals. Review: Measures to p ro m o te d en tal h ealth du rin g p regn an cy Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Evalu ation Con t en t Ar ea : Matern ity—An tep artu m Pr ior ity Con cepts: Clien t Ed u catio n ; Nu tritio n Refer en ce: Lo wd erm ilk et al. (2016), p p. 317, 320, 358.

951. 3 Ra t ion a le: Radiatio n th erap y is usu ally delayed un til a ch ild is 8 years old, wh en ever p ossible, to p reven t retard ation o f b on e growth an d so ft tissu e d evelo pm en t. O p tion s 1, 2, an d 4 are in app ro p riate respo n ses to th e m oth er an d p lace th e m o th er’s q u estion o n h old. Test -Ta kin g St r a t egy: No te th e strategic wo rd , best. Also , n o te th e su b ject, effects of radiation th erapy, an d th e age o f th e ch ild. In add itio n , use th erap eu tic co m m u n icatio n tech - n iq u es an d kn o wledge regard in g th e effects o f radiatio n to an swer th is qu estio n . O p tion s 1, 2, an d 4 are n on th erap eu tic an d place th e m oth er’s in q uiry o n h old. Also use th e ch ild ’s age as a guide in directin g you to th e correct op tio n . Review: Effects of rad iatio n th erap y Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Pediatrics—O n co lo gical Pr ior ity Con cepts: Develop m en t; Safety Refer en ce: Ho cken berry, Wilson (2015), p p. 1384–1385.

952. 2 Ra t ion a le: A fresh colo sto m y stom a wo uld b e red an d ed em - ato us, b ut th is wo uld d ecrease with tim e. Th e co lo stom y site th en b ecom es p in k with o u t eviden ce of ab n orm al drain age, swellin g, or skin breakd own . Th e n u rse sh o u ld d ocum en t th ese fin din gs becau se th is is a n o rm al exp ectatio n . O p tio n s 1, 3, an d 4 are in appropriate an d un n ecessary in terven tion s. Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, po stop erative co losto m y assessm en t. No te th e words returns from surgery. Th e n urse sh o uld expect red n ess an d ed em a at th is tim e. Review: Po sto perative co lo sto m y assessm en t Level of Cogn it ive Abilit y: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1069UNIT XX Comprehensive Test

Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; Tissu e In tegrity Refer en ces: Ho cken b erry, Wilso n (2015), p p. 940–941, 1118; Potter, Perry, Sto ckert, Hall (2013), p. 873.

953. 3 Ra tion a le: Low or oddly placed ears are associated with vari- o us co n gen ital d efects an d sh ou ld be repo rted im m ed iately. Alth ou gh th e fin din gs sh o u ld be do cum en ted , th e m ost app ro - p riate action wo uld b e to n otify th e h ealth care provid er. O ptio n s 2 an d 4 are in accu rate an d in ap p ro priate n ursin g action s. Test-Ta kin g St r a tegy: No te th e strategic wo rd s, most appropri- ate. Focus o n th e su b ject, n orm al assessm en t fin d in gs in a n ew- b orn . Use kn o wledge regardin g th e n orm al assessm en t fin din gs in a n ewbo rn in fan t to an swer th is qu estio n . Recallin g th at lo w-set ears are an ab n o rm al fin d in g will d irect yo u to th e correct op tio n . Review: Norm al assessm en t fin d in gs in a n ewb o rn Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Matern ity—Newb orn Pr ior it y Con cept s: Clin ical Ju dgm en t; Develo pm en t Refer en ce: Hocken b erry, Wilso n (2015), p. 255.

954. 1 Ra tion a le: Jaun dice, if presen t, is b est assessed in th e sclera, n ail bed s, an d m ucou s m em b ran es. Gen eralized jau n dice ap pears in th e skin th ro ugh ou t th e bo dy. O p tion 4 is an in ap - p ro priate area to assess fo r th e p resen ce of jau n d ice. Test-Ta kin g Str a tegy: No te th e strategic wo rd , best. O ptio n s 2 an d 3 can be elim in ated first b ecau se jau n d ice presen t in th e skin is kn own as gen eralized jau n d ice. Fro m th e rem ain in g o ptio n s, recallin g th at skin disco lo ratio n can best be assessed in th e n ail bed s will direct yo u to th e correct o ptio n . Review: Assessm en t fin d in gs related to jau n d ice Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Ped iatrics—Gastro in testin al Pr ior it y Con cept s: Clin ical Ju dgm en t; Develo pm en t Refer en ce: Hocken b erry, Wilso n (2015), p. 1102.

955. 2 Ra tion a le: To ach ieve p ro per tractio n , weigh ts n eed to be free- h an gin g, with kn o ts kept away fro m th e p ulleys. Weigh ts sh o u ld n o t be kept restin g on a firm su rface. Th e h ead o f th e b ed is u sually kept lo w to provid e co u n tertractio n . Test-Ta kin g Str a tegy: Focu s o n th e su b ject, care fo r a clien t in tractio n . Attem pt to visu alize th e traction , recallin g th at th ere m ust b e weigh t to exert th e p ull from th e tractio n setu p . Th is con cep t will assist in elim in atin g o ptio n s 1 an d 4. Recallin g th at co un tertractio n is n eed ed will assist in elim in atin g o ptio n 3. Review: Care for a clien t in tractio n Level of Cogn it ive Abilit y: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Adu lt Health —Mu sculo skeletal

Pr ior it y Con cept s: Mob ility; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 1060–1061.

956. 1, 2, 4 Ra tion a le: Wh en preparin g th e p hysical en viron m ent for an in terview, th e n urse sh ould set th e room tem p erature at a com - fo rtable level. Th e n urse should p ro vide sufficient ligh tin g for th e clien t an d n urse to see each o th er. The n urse sh o uld avo id h avin g th e clien t face a stro n g ligh t b ecau se th e clien t wou ld h ave to squin t in to th e full ligh t. Distractin g o bjects and equipm en t sho uld be rem o ved fro m th e in terview area. Th e n urse sh o uld arran ge seatin g so th at the n urse an d clien t are seated com fort- ably at eye level, and th e n urse avo id s facin g th e clien t across a d esk or table b ecause th is creates a barrier. The d istan ce between th e n urse an d th e clien t sh ould be set b y the n urse at 4 to 5 feet (1.2 to 1.5 m eters). If th e n urse places th e clien t an y clo ser, th e n urse will b e in vadin g th e clien t’s p rivate space and m ay create anxiety in th e clien t. If the n urse p laces th e clien t farth er away, th e n urse m ay b e seen as distant an d alo of by th e clien t. Test-Ta kin g Str a tegy: Focus on th e su b ject, in terviewin g tech - n iq u es. Read each in terven tio n carefu lly an d th in k abo ut a con d u cive en viro n m en t. Use th e gu id elin es fo r p reparin g th e p h ysical en viro n m en t fo r con du ctin g an in terview to select th e ap prop riate in terven tio n s. Review: Gu idelin es fo r clien t in terview Level of Cogn itive Ability: An alyzin g Clien t Need s: Health Pro m otio n an d Main ten an ce In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Develo p m en tal Stages—Health Assessm en t/ Ph ysical Exam Pr ior it y Con cept s: Co m m u n ication ; Health Prom o tion Refer en ce: Jarvis (2016), pp . 29–30.

957. 3 Ra tion a le: An in active older ad ult m ay b eco m e d iso rien ted b ecau se of lack of sen sory stim u lation . Th e m o st ap prop riate n u rsin g in terven tion wo uld be to reorien t th e clien t frequ en tly an d to place o bjects su ch as a clock an d a calen d ar in th e cli- en t’s roo m to m ain tain o rien tatio n . Restrain ts m ay cau se fu r- th er disorien tatio n an d sh ou ld n ot b e ap plied u n less sp ecifically p rescribed; agen cy po licies an d p ro ced u res sh o u ld b e fo llo wed befo re th e ap plicatio n o f restrain ts. Th e fam ily can assist with o rien tation o f th e clien t, b ut it is in ap prop riate to ask th e fam ily to stay with th e clien t. It is n ot with in th e scop e o f n u rsin g practice to p rescribe labo rato ry stud ies. Test-Ta kin g St r a t egy: No te th e strategic wo rd , best, an d elim - in ate o p tion 4 first b ecau se it is n ot with in th e realm o f n u rsin g p ractice to prescrib e labo rato ry stu dies. Next, elim in ate op tion 1 b ecau se restrain ts m ay ad d to th e d isorien tation th at th e cli- en t is exp erien cin g. It is in ap pro priate to place th e resp o n sib il- ity o f th e clien t o n th e fam ily, so elim in ate o p tion 2. Also, n ote th e relatio n sh ip b etween th e wo rd s disoriented in th e q uestio n an d th e im p lication s of reorien tatio n in th e correct o ptio n . Review: Care for th e clien t with d iso rien tatio n Level of Cogn itive Ability: Ap plyin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ad ult Health —Mu scu lo skeletal Pr ior it y Con cept s: Co gn itio n ; Sen so ry Perception Refer en ce: Lewis et al. (2014), p p. 1460, 1527.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1070 UNIT XX Comprehensive Test

958. 2 Ra t ion a le: Skin traction is ach ieved b y Ace wraps, bo ots, o r slin gs th at app ly a d irect force o n th e clien t’s skin . Traction is m ain tain ed with 5 to 8 lb (2.3 to 3.6 kg) of weigh t, an d th is typ e of traction can cau se skin breakd own . Urin ary in co n ti- n en ce is n ot related to th e use of skin traction . Alth ou gh co n - stipatio n can occu r as a resu lt of im m o bility an d m on ito rin g bo wel so un ds m ay b e a com po n en t of th e assessm en t, th is in terven tio n is n o t th e p riority assessm en t. Th ere are n o p in sites with skin tractio n . Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority. Elim i- n ate o p tion 4 first becau se th ere are n o pin sites with skin trac- tion . Visu alizin g th e tractio n setu p an d kn o wled ge o f th e co m p lication s associated with th is type o f tractio n will direct yo u to th e co rrect o p tion . Review: Co m p licatio n s asso ciated with skin tractio n Level of Cogn it ive Ability: Creatin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Mu scu loskeletal Pr ior ity Con cepts: Mo bility; Tissue In tegrity Refer en ce: Ign atavicius, Workm an (2016), p . 1060.

959. 1 Ra t ion a le: A p sych o so cial assessm en t o f a clien t wh o is im m o - bilized wo uld m ost app ro priately in clud e th e n eed fo r sen so ry stim u latio n . Th is assessm en t sh ou ld also in clu de su ch facto rs as bo d y im age, past an d presen t cop in g skills, an d co pin g m eth od s u sed d urin g th e perio d o f im m o bilizatio n . Alth ou gh h om e care su pp ort, th e ab ility to perform activities of d aily livin g, an d tran sp ortation are com p on en ts of an assessm en t, th ey are n ot as sp ecifically related to p sych o so cial ad ju stm en t as is th e n eed for sen sory stim ulatio n . Test -Ta kin g St r a t egy: Focus on th e strategic wo rd s, most appropriate, an d n ote th e su b ject, p sych oso cial adjustm en t. O p tion 3 can b e elim in ated first b ecau se it relates to p h ysio - logical in tegrity rath er th an p sych o so cial in tegrity. Next, elim - in ate op tio n s 2 an d 4 becau se th ey are m ost clo sely related to ph ysical su p po rts, rath er th an psych o social n eeds of th e clien t. Review: A p sych o so cial assessm en t for a clien t in a b od y cast Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Muscu loskeletal Pr ior ity Con cepts: Mo bility; Sen sory Perceptio n Refer en ce: Lewis et al. (2014), p p. 1520–1521.

960. 3 Ra t ion a le: Com p lex scien tific o r m edical term in o lo gy sh o uld be avo id ed wh en co un selin g an Am ish clien t (o r an y clien t). Wh en cou n selin g a fem ale Am ish clien t, m ost often th e h us- ban d an d wife will wan t to d iscuss h ealth care op tio n s to geth er. Stan d in g close an d sp eakin g lo ud ly is in app ro p riate in m o st co un selin g situatio n s. Test -Ta kin g Str a tegy: Use kn o wled ge of th e Am ish so ciety an d th erap eu tic co m m u n icatio n tech n iq u es to an swer th is q ues- tion . O p tion s 2 an d 4 can be elim in ated first b ecau se o ptio n 4 is in appropriate an d option 2 is n ot a th erapeutic in terven - tion . In ad dition , n o te th at o ptio n s 2 an d 3 are o pp osite, wh ich

m ay in d icate th at o n e of th ese o ptio n s is co rrect. O p tion 1 can b e elim in ated b ecau se o f Am ish cu ltural h ab its. Review: Cu ltu ral con sid eratio n s in th e care o f th e clien t wh o is Am ish Level of Cogn it ive Ability: App lyin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Cu lture an d Spiritu ality Con t en t Ar ea : Fun d am en tals of Care—Cu ltural Awaren ess Pr ior ity Con cepts: Com m un icatio n ; Cu lture Refer en ce: Giger (2013), p p . 665–666.

961. 1 Ra t ion a le: Assault o ccu rs wh en a p erso n p uts an oth er perso n in fear o f h arm fu l o r o ffen sive co n tact an d th e victim fears an d b elieves th at h arm will resu lt as a resu lt o f th e th reat. In th is situatio n , th e n u rse cou ld be accu sed o f th e tort o f assault. Bat- tery is th e in ten tion al to uch in g of an oth er’s b o dy with o ut th e p erson ’s con sen t. Slan d er is verbal co m m u n icatio n th at is false an d h arm s th e rep utatio n o f an oth er. In vasion of privacy is co m m itted wh en th e n urse in trud es in to th e clien t’s p erson al affairs o r vio lates co n fid en tiality. Test -Ta kin g St r a t egy: No te th e su b ject, legal im plicatio n s for n ursin g care. Focusin g o n th e word s u sed by th e n urse an d n o t- in g th at th e n u rse th reaten s th e clien t will d irect you to th e co r- rect op tion . Review: Legal im plicatio n s fo r th e n urse in th e care o f clien ts an d assau lt Level of Cogn it ive Ability: App lyin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Lead ersh ip/ Man agem en t—Eth ical/ Legal Pr ior ity Con cepts: Eth ics; Health Care Law Refer en ce: Zerwekh , Zerwekh (2015), p . 472.

962. 4 Ra t ion a le: Wh en creatin g n ursin g assign m en ts, th e n u rse n eed s to co n sid er th e skills an d ed ucation al level of th e n u rsin g staff. Frequ en t tem p eratu re ch ecks an d am bu latio n can m ost ap pro priately be p ro vid ed b y th e UAP, co n sid erin g th e clien ts iden tified in each o ptio n . Th e clien t on th e m ech an ical ven ti- lato r requ irin g frequ en t assessm en t an d suctio n in g sh ou ld m o st ap prop riately be cared fo r b y th e RN. Th e LPN is skilled in urin ary cath eterizatio n , so th e clien t in o ptio n 4 wou ld b e assign ed to th is staff m em ber. Test -Ta kin g Str a tegy: Note th e strategic wo rd , best; focus on th e su b ject, th e prin ciples related to delegation an d assign - m en ts; an d co n sid er th e ed ucation an d job p o sition as d escrib ed b y th e Nurse Practice Act an d em p lo yee gu id elin es. Note th e word assessment in o ptio n 3. Th is sh ou ld alert yo u th at th is clien t sh o u ld b e assign ed to th e RN. O p tion s 1 an d 2 can b e elim in ated b ecau se a UAP can perform th ese tasks. Review: Prin ciples related to d elegatio n an d assign m en t m akin g Level of Cogn it ive Ability: Creatin g Clien t Need s: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Lead ersh ip/ Man agem en t—Delegatin g Pr ior ity Con cepts: Care Coo rd in ation ; Safety Refer en ces: Yod er-Wise ( 2015) , p p. 489, 496; Zerwekh , Zerwekh (2015), p . 305.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1071UNIT XX Comprehensive Test

963. 1 Ra tion a le: Th e jaw th ru st with o ut th e h ead tilt m an euver is u sed wh en h ead o r n eck traum a is su spected . Th is m an euver o pen s th e airway wh ile m ain tain in g p ro per h ead an d n eck align m en t, redu cin g th e risk of fu rth er d am age to th e n eck. O ptio n s 2, 3, an d 4 are in co rrect. In ad dition , it is un likely th at th e n urse wo u ld be able to ob tain d ata ab o ut th e clien t’s h istory. Test-Ta kin g Str a tegy: Fo cu s o n th e figure an d n ote th at it is a jaw th rust m an eu ver. Elim in ate o p tion 2 becau se of th e clo sed - en d ed wo rd all. Notin g th at th e clien t req u ires CPR an d th at th e figu re illu strates th at th e clien t’s n eck rem ain s stable will assist in elim in atin g o p tion s 3 an d 4. Review: Card io p u lm o n ary resu scitatio n gu idelin es Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Critical Care—Basic Life Su pp o rt/ Cardiop ul- m on ary Resuscitatio n Pr ior it y Con cept s: Gas Exch an ge; Safety Refer en ce: Lewis et al. (2014), p p . 1520–1521.

964. 4 Ra tion a le: Th e clien t n eeds to b e in stru cted to avo id expo sure to th e su n . Becau se o f th e risk o f altered skin in tegrity, op tion s 1, 2, an d 3 are accurate m easu res in th e care of a clien t receivin g extern al radiation th erap y. Test-Ta kin g St r a t egy: Note th e strategic wo rd s, need for further instruction. Th ese words in dicate a n egative even t q u ery an d ask yo u to select an o ptio n th at is an in co rrect statem en t. Elim - in ate op tio n 1 because o f th e wo rd gently an d op tio n 2 because o f th e wo rd loose. Fro m th e rem ain in g op tion s, recallin g th at su n exp osu re is to be avo id ed will assist in an swerin g th e q uestion . Review: Skin care m easu res for th e clien t receivin g extern al rad iatio n th erap y Level of Cogn it ive Abilit y: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Adu lt Health —O n co lo gy Pr ior it y Con cept s: Clien t Ed ucation ; Tissue In tegrity Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 377.

965. 1.5 Ra tion a le: It is n ecessary to con vert 150 m cg to m g. In th e m et- ric system , to con vert sm aller to larger, d ivid e b y 1000 or m o ve th e d ecim al 3 p laces to th e left: 150 m cg¼0.15 m g. Next, use th e fo rm u la to calcu late th e co rrect do se. For mu la :

Desired Available

 Quantity¼ tabletðsÞ

0:15 mg 0:1 mg

 1 tablet ¼ 1:5 tablets

Test-Ta kin g Str a tegy: Fo cus on th e su b ject, a m ed ication cal- culatio n prob lem . In th is m edicatio n calcu lation p ro blem , it is n ecessary first to co n vert m icro gram s to m illigram s. Next, u se th e fo rm ula to calculate th e co rrect d ose. Rech eck yo ur work u sin g a calcu lato r, an d m ake sure th at th e an swer m akes sen se.

Review: Med icatio n calcu latio n p ro b lem s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fun dam en tals o f Care—Medication /IV Calcu - lation s Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), pp . 486–487.

966. 4 Ra tion a le: Th e m o st co m m o n sid e effect o f m etfo rm in is gas- tro in testin al d istu rb an ces, in clu d in g d ecreased ap p etite, n au sea, an d d iarrh ea. Th ese gen erally su b sid e o ver tim e. Th is m ed icatio n d o es n o t cau se weigh t gain ; clien ts lo se an aver- age o f 7 to 8 lb ( 3.2 to 3.6 kg) b ecau se th e m ed icatio n cau ses n au sea an d d ecreased ap p etite. Alth o u gh h yp o glycem ia can o ccu r, it is n o t th e m o st co m m o n sid e effect. Flu sh in g an d p alp itatio n s are n o t sp ecifically asso ciated with th is m ed icatio n . Test-Ta kin g Str a tegy: Note th e strategic wo rd , most. To an swer correctly, it is n ecessary to recall th at th e m ost co m m o n sid e effect of m etfo rm in is gastroin testin al d istu rb an ces. Review: Sid e effects o f m etfo rm in Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Ph arm acolo gy—En do crin e Med icatio n s Pr ior it y Con cept s: Clien t Ed ucation ; Glu co se Regulation Refer en ce: Bu rch u m , Ro sen th al (2016), p . 700.

967. 1, 3, 5, 6 Ra tion a le: Du rin g a seizure, th e n u rse sh o u ld stay with th e ch ild to redu ce th e risk of in jury an d allow fo r o bservation an d tim in g o f th e seizure. Th e ch ild is n o t restrain ed b ecause th is co uld cau se in jury to th e ch ild . Th e ch ild is p laced on h is o r h er sid e in a lateral po sitio n . No th in g is placed in th e ch ild ’s m o uth du rin g a seizure b ecau se th is cou ld in jure th e ch ild ’s m o uth , gum s, o r teeth . Po sitio n in g o n th e sid e preven ts aspiratio n because saliva drain s ou t o f th e corn er of th e ch ild’s m ou th . Th e n u rse sh o uld lo o sen clo th in g arou n d th e ch ild’s n eck an d en su re a p aten t airway. Test-Ta kin g Str a tegy: Fo cus on th e su b ject, care o f th e ch ild exp erien cin g seizures, an d visualize th is clin ical situ ation . Recallin g th at airway p aten cy an d safety are th e prio rities will assist in determ in in g th e correct in terven tion s. Review: Care of th e ch ild experien cin g seizu res Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Ped iatrics—Neu ro lo gical Pr ior it y Con cept s: In tracran ial Regu lation ; Safety Refer en ce: Hocken b erry, Wilso n (2015), pp . 1477–1478.

968. 1, 2, 3 Ra tion a le: No ctu ria, in con tin en ce, an d an en larged p ro state are ch aracteristics o f BPH an d n eed to b e assessed for in all m ale clien ts o ver 50 years of age. No ctu rn al em ission s are co m - m on ly associated with prepu b escen t m ales. Lo w testostero n e levels (n ot BPH) m ay be asso ciated with a d ecreased desire fo r sexual in tercou rse.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1072 UNIT XX Comprehensive Test

Test -Ta kin g St r a t egy: Focus on th e su b ject, ch aracteristics of BPH. Th in kin g ab ou t th e path o p h ysio logy associated with th is diso rd er will assist yo u in an swerin g correctly. Review: Ben ign p ro static h yp ertro p h y ( BPH) Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Assessm en t Con t en t Ar ea : Ad ult Health —Ren al an d Urin ary Pr ior ity Con cepts: Clin ical Jud gm en t; Elim in atio n Refer en ce: Ign atavicius, Workm an (2016), p . 1500.

969. 1 Ra t ion a le: Settin g priorities m ean s d ecid in g wh ich clien t n eeds or problem s requ ire im m ed iate action and wh ich can be d elayed un til a later tim e because th ey are n ot urgen t. Clien t pro blem s th at in vo lve actual o r life-th reaten in g con cern s are always co n - sid ered first. Alth o ugh com p letin g care in a reason able tim e fram e, tim e con strain ts, an d o btain in g n eeded supplies are com - pon en ts of tim e m an agem en t, th ese item s are n ot th e p rio rity in plan n in g care for th e clien t, based on th e o ptio n s p rovid ed. Test -Ta kin g St r a tegy: Note th e strategic wo rd , priority. Recall th e prin ciples related to prio ritizin g to an swer th e qu estio n . Notin g th e wo rd s life-threatening in th e correct o ptio n will assist in d irectin g you to th is o p tion . Review: Prio ritizatio n prin ciples Level of Cogn it ive Ability: Evaluatin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Lead ersh ip / Man agem en t—Prio ritizin g Pr ior ity Con cepts: Care Co ordin ation ; Clin ical Jud gm en t Refer en ce: Zerwekh , Zerwekh Garn eau (2015), pp . 35–36.

970. 4 Ra t ion a le: Lab oratory determ in atio n s o f th e seru m th yroid - stim u latin g h orm o n e (TSH) level are an im p ortan t m ean s o f evaluatio n . Successfu l th erapy cau ses elevated TSH levels to declin e. Th ese levels begin th eir d eclin e with in h ou rs o f th e on set o f th erap y an d co n tin ue to d ecrease as plasm a levels o f th yro id h o rm o n e bu ild up . If an adequ ate do sage is ad m in is- tered , TSH levels rem ain sup pressed fo r th e du ratio n o f th er- ap y. Alth ou gh en ergy levels m ay in crease an d th e clien t’s m o od m ay im prove follo win g effective treatm en t, th ese are n ot n oted un til n o rm al th yro id h orm o n e levels are ach ieved with m ed ication th erapy. An in crease in th e b loo d glucose level is n o t associated with th is co n d itio n . Test -Ta kin g St r a t egy: Focu s o n th e su b ject, th erap eu tic effects of th is m edicatio n . Note th e wo rd s expected outcome. Relate th e diagn o sis o f h ypo th yro id ism with th yroid h orm o n e levels in th e co rrect op tion . Review: Th erapeutic effects o f levo th yro xin e Level of Cogn it ive Ability: Evaluatio n Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Evalu ation Con t en t Ar ea : Ph arm aco lo gy—En d ocrin e Medicatio n s Pr ior ity Con cepts: Cellu lar Regu latio n ; Evid en ce Refer en ce: Burch um , Rosen th al (2016), p. 713.

971. 2, 4, 5, 6 Ra t ion a le: Risk factors fo r b reast can cer in clu de n u llip arity o r first ch ild bo rn after age 30 years; early m en arch e; late

m en op ause; fam ily h isto ry o f breast can cer; h igh -d ose radia- tion exp osu re to th e ch est; an d p revio u s can cer of th e b reast, u terus, or o varies. In ad ditio n , sp ecific in h erited m u tation s in BReast CAn cer ( BRCA) 1 an d BRCA2 in crease th e risk o f fem ale breast can cer; th ese m utatio n s are also associated with an in creased risk fo r ovarian can cer. Test -Ta kin g St r a t egy: Focu s on th e su b ject, th e risk facto rs asso ciated with breast can cer. Th in kin g abo u t th e ph ysio logy asso ciated with th e reprod uctive system an d th e m o st co m m o n causes o f can cer will assist in an swerin g th e q uestio n . Review: Risk facto rs asso ciated with b reast can cer Level of Cogn it ive Ability: An alyzin g Clien t Need s: Health Prom o tion an d Main ten an ce In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —O n colo gy Pr ior ity Con cepts: Cellu lar Regu latio n ; Clien t Ed ucation Refer en ce: Lewis et al. (2014), p. 1243.

972. 1 Ra t ion a le: An in flam m ato ry reactio n su ch as acute pan creatitis can cause p aralytic ileu s, th e m o st com m on form of n on m e- ch an ical o b stru ctio n . In ab ility to pass flatu s is a clin ical m an - ifestation o f p aralytic ileus. Lo ss o f sp h in cter co n trol is n ot a sign o f p aralytic ileu s. Pain is associated with p aralytic ileus, b u t th e p ain u sually m an ifests as a m o re co n stan t gen eralized d iscom fo rt. O ption 4 is th e d escrip tion of th e ph ysical fin din g o f liver en largem en t. Th e liver m ay b e en larged in cases o f cir- rh o sis o r h ep atitis. Alth o ugh th is clien t m ay h ave an en larged liver, an en larged liver is n ot a sign of p aralytic ileu s o r in testi- n al ob stru ction . Test -Ta kin g Str a tegy: Fo cu s o n th e su b ject, clin ical m an ifesta- tion s o f p aralytic ileus. No tin g th e wo rd paralytic will assist in d irectin g you to th e co rrect op tio n . Review: Clin ical m an ifestatio n s o f p aralytic ileu s Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Elim in atio n ; In flam m ation Refer en ce: Ign atavicius, Workm an (2016), p . 1219.

973. 1 Ra t ion a le: Fo r th e first 12 h ou rs after gastric surgery, th e n aso- gastric tub e d rain age m ay b e dark b ro wn to dark red. Later, th e d rain age sh o uld ch an ge to a ligh t yello wish -b ro wn co lor. Th e p resen ce o f bile m ay cau se a green tin ge. Th e HCP sh o u ld b e n otified if d ark red drain age, a sign of h em o rrh age, is n o ted 24 h ou rs po sto peratively. Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, th e n eed to n o tify th e H CP. Recall th at b leed in g is a co n cern in th e p o st- o p erative clien t. Th is co n cep t will d irect yo u to th e co rrect o p tio n . Review: Sign s o f po sto perative com plicatio n s fo llo win g gastric su rgery Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—An alysis Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clin ical Jud gm en t; Co llab oratio n Refer en ce: Ign atavicius, Workm an (2016), p p. 262–263.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1073UNIT XX Comprehensive Test

974. 1 Ra tion a le: Th e clien t sh ou ld take a deep breath b ecau se th e cli- en t’s airway will be tem p orarily ob stru cted du rin g tub e rem o val. Th e clien t is th en to ld to h old th e b reath an d th e tub e is with d rawn slowly an d even ly over th e cou rse o f 3 to 6 sec- o n d s (co il th e tub e aro u n d th e h an d wh ile rem ovin g it) wh ile th e breath is h eld . Bearin g d own co uld in h ib it th e rem oval of th e tu be. Exh alin g is n o t p ossible d urin g rem o val b ecause th e airway is tem po rarily o b stru cted d urin g rem o val. Breath in g n o rm ally co u ld resu lt in asp iratio n of gastric secretio n s du rin g in h alatio n . Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, th e proced ure fo r rem o val o f a n aso gastric tub e, an d attem p t to visu alize th e p ro - cess of tub e rem o val to d irect you to th e correct o ption . Rem em ber, h o ld in g th e b reath facilitates th e process of rem o val. Review: Th e procedu re for rem oval o f a n aso gastric tu b e Level of Cogn it ive Abilit y: Ap p lyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Fu n d am en tals o f Care—Skills Pr ior it y Con cept s: Gas Exch an ge; Safety Refer en ce: Perry et al. (2014), pp . 781, 862.

975. 3 Ra tion a le: Wh en a clien t is experien cin g respiratory acidosis, th e resp irato ry rate an d dep th in crease in an attem p t to com - p en sate. Th e clien t also exp erien ces h ead ach e; restlessn ess; m en tal statu s ch an ges, su ch as drowsin ess an d co n fusion ; visu al d isturban ces; d iaph oresis; cyan o sis as th e h ypo xia b eco m es m ore acu te; h yperkalem ia; rap id , irregu lar pu lse; an d d ysrh yth m ias. O p tio n s 1, 2, an d 4 are n o t sp ecifically asso - ciated with th is d iso rd er. Test-Ta kin g St r a t egy: Focus on th e su b ject, clin ical m an ifesta- tio n s asso ciated with resp iratory acido sis, an d use kn owled ge o f th e sign s an d sym p to m s o f resp irato ry acido sis to an swer th is q uestio n . Elim in ate op tio n s 2 an d 4 first b ecau se th ey are co m p arab le o r alike an d ad dress a d ecreased resp iratory rate. Rem em ber th at h ead ach e, restlessn ess, an d con fu sio n o ccur in resp irato ry acid osis. Review: Clin ical m an ifestatio n s associated with resp irato ry acid o sis Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n d am en tals o f Care—Acid–base Pr ior it y Con cept s: Acid –b ase Balan ce; Clin ical Ju dgm en t Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 180–181.

976. 4 Ra tion a le: Disten tion , vo m itin g, an d ab do m in al p ain are a few of th e sym p to m s asso ciated with in testin al ob stru ction . Naso gastric tub es m ay be u sed to rem o ve gas an d flu id from th e sto m ach , relievin g d isten tio n an d vo m itin g. Bo wel so un ds return to n orm al as th e ob stru ctio n is reso lved an d n orm al b owel fun ction is resto red . Disco n tin uin g th e n aso gastric tub e b efore n orm al bo wel fu n ction m ay resu lt in a return o f th e sym pto m s, n ecessitatin g rein sertio n o f th e n asogastric tu be. Seru m electro lyte levels, p H o f th e gastric asp irate, an d tub e

p lacem en t are im po rtan t assessm en ts for th e clien t with a n aso - gastric tu be in p lace, bu t wou ld n o t assist in determ in in g th e readin ess for rem ovin g th e n asogastric tub e. Test-Ta kin g Str a tegy: Elim in ate o ptio n s 2 an d 3 first b ecause th ey are co m p arab le o r alike. Assessin g th e pH of th e gastric aspirate is o n e m eth od of assessin g tub e placem en t. Also , n ote th e strategic wo rd , priority. Fo cu s o n th e clien t’s diagn osis to d irect yo u to th e co rrect o ption . Review: Care of th e clien t with a n aso gastric tu b e Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Fu n dam en tals o f Care—Skills Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), p. 862.

977. 1 Ra tion a le: Th e en em a is n ever ad m in istered wh ile on a to ilet d ue to safety. Th e en em a is ad m in istered wh ile th e clien t is in a left sid e-lyin g ( Sim s’) p osition with th e righ t kn ee flexed . Th is allows en em a solu tio n to flo w do wn ward by gravity alo n g th e n atu ral curve of th e sigm oid co lo n an d rectum . It is im p ortan t for th e clien t to retain th e flu id fo r as lo n g as p o s- sib le sin ce th is will prom o te peristalsis an d defecation . If th e clien t com p lain s of fu lln ess o r p ain , th e flo w is sto pp ed fo r 30 secon ds an d restarted at a slo wer rate. Th e h igh er th e so lu- tio n con tain er is h eld ab ove th e rectum , th e faster th e flow an d th e greater th e fo rce in th e rectum ; th is co uld in crease cram pin g. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further instruction. Th is in d icates a n egative even t q u ery, an d th e n eed to select th e op tion th at is in co rrect. Elim in ate op tion s 3 an d 4 first b ecau se th ey are co m p arab le o r alike. Fro m th e rem ain in g o ptio n s, fo cusin g on th e su b ject, safety, will direct yo u to th e correct op tio n . Review: Th e p ro cedu re for ad m in isterin g an en em a Level of Cogn itive Ability: Evalu atin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Fu n dam en tals o f Care—Elim in atio n Pr ior it y Con cept s: Clien t Ed ucation ; Elim in atio n Refer en ce: Perry et al. (2014), p. 855.

978. 4 Ra tion a le: Negative rein fo rcem en t wh en th e stim u lu s is p ro - d uced is descriptive o f aversio n th erap y. O p tio n s 1, 2, an d 3 are ch aracteristics o f self-co n trol th erap y. Test-Ta kin g St r a t egy: No te th e strategic wo rd s, need for further teaching. Th ese words in d icate a n egative even t q u ery an d ask you to select an o p tion th at is in co rrect. Th in k abo ut th e su b ject, self-con tro l. Th is su b ject will assist yo u in an swerin g correctly. Review: Self-co n tro l th erap y Level of Cogn itive Ability: Evalu atin g Clien t Need s: Psych o so cial In tegrity In tegr a t ed Pr ocess: Teach in g an d Learn in g Con ten t Ar ea : Men tal Health Pr ior it y Con cept s: An xiety; Stress Refer en ce: Stu art (2013), p p . 225–226.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1074 UNIT XX Comprehensive Test

979. 2, 4, 5, 6 Ra t ion a le: Th e n urse sh o uld teach th e clien t h o w to care for th e stom a, d epen din g o n th e typ e o f laryn gecto m y p erfo rm ed . Mo st in terven tion s focu s o n protectio n o f th e sto m a an d th e preven tio n of in fection . In terven tio n s in clud e o btain in g a Med icAlert b racelet, p reven tin g deb ris fro m en terin g th e stom a, avoidin g exp osu re to peop le with in fection s, an d avo id - in g swim m in g an d u sin g care wh en sh owerin g. Add itio n al in terven tio n s in clu de wearin g a sto m a gu ard or h igh -co llared clo th in g to protect th e sto m a, in creasin g th e h u m id ity in th e h om e, an d in creasin g flu id in take to 3000 m L/ d ay to keep th e secretio n s th in . Test -Ta kin g St r a t egy: Fo cu s o n th e su b ject, clien t in stru ction s regard in g stom a care. Recallin g th at m ost in terven tion s focus on protectio n of th e sto m a an d th e p reven tion of in fectio n will assist in iden tifyin g th e clien t in stru ction s for h om e care. Review: Sto m a care Level of Cogn it ive Ability: An alyzin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —O n cology Pr ior ity Con cepts: Clien t Edu catio n ; Gas Exch an ge Refer en ce: Lewis et al. (2014), p . 993.

980. 21 Ra t ion a le: Use th e in traven ou s flow rate form ula. For mu la :

Total volume prescribed  Drop factor Time in minutes

¼ gtt=minute

2000 mLÂ 15 gtt=mL 1440 minutes

¼ 20:8 gtt=minute¼ 21 gtt=minute

Test -Ta kin g St r a t egy: Focu s o n th e su b ject, a m edicatio n cal- cu lation . Use th e fo rm ula fo r calcu latin g in traven o u s flo w rates wh en an swerin g th e qu estio n . Verify th e an swer usin g a calcu - lator, an d be su re to ro un d th e an swer to th e n earest wh o le n u m ber. Review: In traven o u s in fu sio n rates Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Ph ysiolo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Content Area: Fundamentals of Care—Medication/IV Calculations Pr ior ity Con cepts: Clin ical Jud gm en t; Safety Refer en ce: Perry et al. (2014), p p. 710–711.

981. 2 Ra t ion a le: In th e first few h ou rs after su rgery, th e drain age fro m th e ch est tub e is b loo d y. After several h o urs, it b ecom es sero san gu in eo us. Th e clien t sh ou ld n o t exp erien ce frequ en t clo ttin g. Pro per ch est tub e fun ction sh o uld allow fo r d rain age of b loo d befo re it h as th e ch an ce to clo t in th e ch est or th e tu b in g. Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, expected fin d in gs after th oracic su rgery. Recall th at after th o racic surgery, th ere m ay b e co n siderable capillary o ozin g for h o urs in th e p osto p- erative p eriod . Th is will lead yo u to ch o ose th e blo o dy d rain age op tion over th e sero us or serosan gu in eou s drain age op tion s. Kn o win g th at paten t ch est tub es d o n o t allo w blo od to collect in th e pleu ral sp ace elim in ates th e o p tion of b lo od with clo ts.

Review: Assessm en t m easu res for th e clien t with a ch est tu b e Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), p. 546.

982. 1, 2, 3, 5 Ra t ion a le: If th e clien t b egin s to h em o rrh age from th e su rgical site after rad ical n eck d issection , th e n urse elevates th e h ead o f th e b ed to m ain tain airway paten cy an d preven t aspiratio n . Th e n urse ap plies p ressu re o ver th e b leedin g site an d calls th e HCP im m ed iately. Th e n urse also m o n ito rs th e clien t’s airway an d vital sign s. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject, n u rsin g actio n s for h em orrh age, an d on th e clien t situ ation . Use th e ABCs—air- way–b reath in g–circu latio n —to assist yo u in an swerin g th e q u estion . Note th at lowerin g th e h ead of th e b ed to a flat po si- tion in creases th e clien t’s risk fo r asp iratio n . Review: Nu rsin g actio n s if th e clien t begin s to h em o rrh age Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Content Area: Critical Care—Emergency Situations/Management Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), p. 516.

983. 2 Ra tion a le: To preven t transm issio n of h epatitis, vaccin ation o f th e partner is advised. In additio n, a con do m is advised d urin g sexual in tercou rse. Alcoh ol sh o uld be avoided because it is d etoxified in th e liver and m ay in terfere with recovery. Rest is especially im po rtan t un til lab oratory studies sh ow th at liver fun ctio n h as return ed to n orm al. Th e clien t’s activity is in creased gradually, an d th e clien t sh ould n ot retu rn to work righ t away. Test -Ta kin g Str a tegy: Fo cu s o n th e strategic wo rd s, need for further teaching. Th ese words in d icate a n egative even t q u ery an d ask yo u to select an o ption th at is in co rrect. Th in k abo ut th e path o p h ysio logy associated with h ep atitis to direct yo u to th e in co rrect clien t statem en t. Rem em b er th at rest is n eeded fo r th e liver to h eal. Review: Clien t in stru ctio n s regard in g h ep atitis Level of Cogn it ive Ability: Evaluatin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Clien t Ed u catio n ; In fection Refer en ce: Lewis et al. (2014), p. 1014.

984. 3, 4, 6 Ra t ion a le: Th e clin ical m an ifestation s o f h yp oth yroidism are th e resu lt of decreased m etabo lism fro m low levels of th yro id h orm on e. In terven tio n s are aim ed at rep lacem en t o f th e h o r- m o n e an d p ro vidin g m easures to sup po rt th e sign s an d sym p- to m s related to d ecreased m etab olism . Th e clien t o ften h as co ld in to leran ce an d req u ires a warm en viron m en t. Th e n u rse en co u rages th e clien t to co n su m e a well-b alan ced d iet th at is low in fat for weigh t red uctio n an d h igh in flu ids an d h igh -fiber

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1075UNIT XX Comprehensive Test

fo od s to p reven t co n stip ation . Io din e p reparation s m ay be u sed to treat h yperth yroidism . Io d in e p reparation s d ecrease b loo d flow th rou gh th e th yro id glan d an d redu ce th e prod u c- tio n an d release o f th yroid h orm on e; th ey are n o t u sed to treat h yp oth yro idism . Th e clien t is in structed to n otify th e HCP if ch est pain occurs b ecau se it co uld be an in dication o f o verre- p lacem en t o f th yro id h o rm o n e. Test-Ta kin g Str a tegy: Fo cu s on th e su b ject, h yp oth yroidism . Recallin g th e m an ifestatio n s of th is d isord er an d th at in th is d isorder th e clien t h as a d ecreased m etab olic rate will assist in d eterm in in g th e app ro priate in terven tion s. Review: In terven tion s fo r th e clien t with h yp o th yro id ism Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —En d ocrin e Pr ior it y Con cept s: Caregivin g; Th erm oregulation Refer en ce: Lewis et al. (2014), p p . 1203–1204.

985. 1 Ra tion a le: Plu ggin g a trach eo sto m y tu b e is usu ally do n e b y in sertin g th e trach eo stom y p lu g (d ecan n ulation stop p er) in to th e op en in g of th e o uter can n u la. Th is closes o ff th e trach eo s- to m y, an d airflo w an d resp iratio n occu r n o rm ally th ro u gh th e n o se an d m o u th . Wh en p lu ggin g a cuffed trach eo stom y tu be, th e cuff m ust be deflated. If it rem ain s in flated, ven tilation can - n o t occur, an d respiratory arrest cou ld result. A trach eo sto m y p lug cou ld n ot b e placed in a trach eo stom y if an in n er can n ula was in p lace. Th e ability to swallow or speak is un related to wean in g an d plu ggin g th e tube. Test-Ta kin g St r a t egy: Focus o n th e su b ject, care of th e clien t with a trach eosto m y, an d n ote th e word required in th e ques- tio n . Th in k ab ou t th e structure an d fun ctio n o f a trach eo sto m y tu be. Recallin g th at an in flated cu ff wou ld cause airway o bstructio n will assist in directin g you to th e op tio n th at ad dresses a priority p h ysio lo gical n eed. Review: Care of th e clien t with a trach eo sto m y Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Con ten t Ar ea : Adu lt Health —Resp irato ry Pr ior it y Con cept s: Gas Exch an ge; Safety Refer en ces: Lewis et al. (2014), p. 512.

986. 1 Ra tion a le: Hyp erten sion , card iovascular disease, d iab etes m el- litu s, an d o besity are associated with th e d evelo p m en t o f glau - com a. O p tion s 2, 3, an d 4 d o n ot iden tify risk facto rs asso ciated with th is eye d iso rder. Test-Ta kin g Str a tegy: Fo cu s o n th e su b ject, a risk facto r asso - ciated with glau co m a. Recall th at glaucom a is asso ciated with in creased p ressure in th e eye. Th is will assist to direct yo u to th e correct op tio n . Review: Risk factors associated with glau co m a Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Eye Pr ior it y Con cept s: Health Pro m otio n ; Sen so ry Percep tio n Refer en ce: Ign ataviciu s, Wo rkm an (2016), p. 985.

987. 4 Ra tion a le: Th e n urse places an eye p atch o ver th e clien t’s affected eye to red uce eye m o vem en t. So m e clien ts m ay n eed b ilateral p atch in g. Depen din g on th e lo cation an d size o f th e retin al break, activity restriction s m ay be n eeded im m ed iately. Th ese restrictio n s are n ecessary to p reven t fu rth er tearin g or d etach m en t an d to prom o te d rain age o f an y sub retin al fluid. Th erefo re, readin g an d watch in g television are n ot allo wed . Th e clien t’s po sitio n is prescrib ed by th e h ealth care p rovid er; n o rm ally, th e prescrip tion is to lie flat. Test-Ta kin g St r a t egy: Focus on th e su b ject, retin al detach - m en t. Rem em b er th at th e eye n eeds to b e protected an d rested. Th is sh o uld d irect you to th e co rrect op tion . Review: Care of th e clien t with retin al d etach m en t Level of Cogn itive Ability: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad ult Health —Eye Pr ior it y Con cept s: Sen so ry Perception ; Safety Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 989–990.

988. 3 Ra tion a le: Clien ts at greatest risk for deep vein th ro m b osis an d p ulm o n ary em b o li are im m ob ilized clien ts. Basic p reven tive m easures in clud e early am bu lation , leg elevation , active leg exercises, elastic stockin gs, an d in term itten t pn eum atic calf com pressio n . Keep in g th e clien t well h yd rated is essen tial b ecau se d eh ydratio n predispo ses to clo ttin g. A pillo w u n d er th e kn ees m ay cause ven ou s stasis. Heat sh ou ld n o t be app lied with out a h ealth care provider’s prescription . Test-Ta kin g Str a t egy: No te th e strategic wo rd , most. Fo cu s on th e su b ject, m easures to preven t deep vein th ro m bo sis an d p ulm o n ary em bo li. Use b asic prin ciples related to th e care of th e im m ob ile clien t to an swer th is q uestion . Review: Preven tio n m easu res fo r d eep vein th ro m b o sis an d p u lm o n ary em b o lu s Level of Cogn itive Ability: Creatin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Plan n in g Con ten t Ar ea : Ad ult Health —Respiratory Pr ior it y Con cept s: Clin ical Ju dgm en t; Clo ttin g Refer en ce: Ign ataviciu s, Wo rkm an (2016), pp . 730–731.

989. 1 Ra tion a le: A crisis is an acute, tim e-lim ited state of disequ ilib - rium resultin g from situatio n al, develop m en tal, o r so cietal so urces o f stress. A p erson in th is state is tem p orarily u n ab le to co pe with o r ad apt to th e stresso r b y u sin g p reviou s cop in g m ech an ism s. Th e p erson wh o in terven es in th is situatio n (th e n u rse) “takes over” fo r th e clien t ( au th ority) wh o is n o t in con - tro l an d devises a plan (actio n ) to secu re an d m ain tain th e cli- en t’s safety. Wh en th is h as occurred , th e n u rse wo rks collab o ratively with th e clien t ( p articipates) in d evelo p in g n ew cop in g an d pro blem -so lvin g strategies. Test-Ta kin g Str a tegy: No te th e strategic wo rd , priority. A clien t wh o exp erien ces a suicid al crisis is in a state of acute d iseq ui- lib rium . Rem em ber th at in a crisis an au th o rity figu re m u st em erge to take actio n . Review: Care of th e su icid al clien t Level of Cogn itive Ability: Ap plyin g

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1076 UNIT XX Comprehensive Test

Clien t Needs: Psych o social In tegrity In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: Mo od an d Affect; Safety Refer en ce: Stuart (2013), pp . 335–336.

990. 2 Ra t ion a le: Th e clien t with tu berculo sis m u st h ave sp utu m cul- tu res p erfo rm ed every 2 to 4 weeks after in itiatio n of an titu - bercu lo sis m edication th erapy. Th e clien t m ay return to wo rk wh en th e results of th ree sp utu m cultu res are n egative because th e clien t is con sidered n o n in fectio us at th at po in t. O p tion s 1, 3, an d 4 are n o t reliable determ in an ts of a n on in - fectio us statu s. Test -Ta kin g St r a t egy: Fo cu s on th e su b ject, co n cep ts related to tu b erculosis. Kn o win g th at a po sitive tu b erculin skin test n ever reverts to n egative h elps you to elim in ate option 4. From th e rem ain in g option s, th in k about th e m ode of tran sm ission of tu b erculosis to direct yo u to th e correct o ption . Rem em b er, th ree n egative spu tum cu ltures are requ ired. Review: Co n cepts related to tu b ercu lo sis Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Teach in g an d Learn in g Con t en t Ar ea : Fun dam en tals of Care—In fection Co n tro l Pr ior ity Con cepts: In fectio n ; Safety Refer en ce: Ign atavicius, Workm an (2016), p p. 596, 598.

991. 3 Ra t ion a le: Th is clien t is in a severe state o f an xiety. Wh en a cli- en t is in a severe o r pan ic state of an xiety, it is cru cial fo r th e n urse to rem ain with th e clien t. Th e clien t in a severe state o f an xiety wo u ld be un able to learn relaxatio n tech n iq ues. Dis- cu ssin g th e assau lt at th is p oin t wo uld in crease th e clien t’s level of an xiety fu rth er. Placin g th e clien t in a q uiet roo m alon e m ay also in crease th e an xiety level. Test -Ta kin g St r a t egy: No te th e strategic wo rd , priority. Th e pri- ority actio n in th is situ atio n is to rem ain with th e clien t. Review: In terven tio n s for th e clien t exp erien cin g an xiety Level of Cogn it ive Ability: Ap plyin g Clien t Needs: Safe an d Effective Care En viron m en t In t egr a ted Pr ocess: Nu rsin g Process—Im plem en tation Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: An xiety; Caregivin g Refer en ce: Varcarolis (2013), p p. 168–169.

992. 2 Ra t ion a le: Labo rato ry fin din gs do n o t estab lish th e d iagn o sis of app en d icitis, b ut th ere is o ften an elevatio n o f th e wh ite blo od cell co u n t (leu ko cyto sis) with a sh ift to th e left (an in creased n u m b er of im m atu re wh ite blo o d cells). O ptio n s 1, 3, an d 4 are in co rrect because th ey are n ot asso ciated fin d - in gs in acute app en ditis. Test -Ta kin g St r a t egy: Fo cus o n th e su b ject, ap pen d icitis. Kn o wled ge th at an in flam m atory process cau ses an in crease in th e wh ite b lo od cell co un t will assist you in elim in atin g op tion s 1 an d 3. Fro m th e rem ain in g op tio n s, it is n ecessary to un d erstan d th e sign ifican ce of a sh ift to th e left. Review: Ap p en d icitis

Level of Cogn it ive Ability: An alyzin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Assessm en t Con t en t Ar ea : Ad ult Health —Gastro in testin al Pr ior ity Con cepts: Cellu lar Regu latio n ; In flam m atio n Refer en ce: Ign atavicius, Workm an (2016), p . 1169.

993. 3 Ra t ion a le: Lack of ab ility to co pe effectively m ay be eviden ced b y a clien t’s in ab ility to m eet b asic n eed s, in ab ility to m eet role expectatio n s, alteratio n in social p articipatio n , u se o f in app ro - p riate d efen se m ech an ism s, o r im p airm en t of usu al p attern s o f co m m u n ication . An xiety is a b ro ad d escrip tio n an d can o ccur as a result of m an y triggers; alth ou gh th e clien t was exp erien c- in g an xiety, th e clien t’s co n cern n o w is th e ability to m eet role expectatio n s an d fin an cial o b ligation s. Th ere is n o in form ation in th e qu estio n th at in d icates an un realistic o utlo ok o r distu r- b an ces in th ou gh ts an d id eas. Test -Ta kin g Str a tegy: No te th e strategic wo rd , priority. Focus o n th e su b ject, con cern s regard in g th e ability to m eet role expectatio n s an d fin an cial o bligation s. O p tion 1 can b e elim - in ated becau se th e clien t was previou sly exp erien cin g an xiety. Elim in ate op tio n s 2 an d 4 because th ere are n o d ata in th e q u estion th at add ress th ese pro blem s. Review: An xiety Level of Cogn it ive Ability: Creatin g Clien t Need s: Psych oso cial In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Plan n in g Con t en t Ar ea : Men tal Health Pr ior ity Con cepts: An xiety; Cop in g Refer en ce: Varcarolis (2013), p . 181.

994. 2 Ra t ion a le: Bub b lin g in th e water seal ch am b er is cau sed by air p assin g ou t o f th e p leu ral sp ace in to th e fluid in th e ch am b er. In term itten t ( n o t co n stan t) b ub blin g is n o rm al. It in dicates th at th e system is accom p lish in g on e of its pu rp oses, rem o vin g air fro m th e p leu ral space. Con tin u ou s b ub blin g d urin g in spi- ratio n an d expiratio n in dicates th at an air leak exists. If th is o ccu rs, it m u st b e co rrected. Notifyin g th e h ealth care p rovid er an d ch an gin g th e ch est tub e d rain age system are n ot in dicated at th is tim e. Test -Ta kin g Str a tegy: No te th e strategic wo rd s, most appropri- ate. No te th e su b ject, ch est tube drain age system s, an d focus on th e wo rd s intermittent bubbling an d water seal chamber. Recallin g th at in term itten t (n ot con stan t) bu b blin g is n orm al in th is ch am b er will d irect yo u to th e co rrect o p tion . Review: Ch est tu b e d rain age system s Level of Cogn it ive Ability: App lyin g Clien t Need s: Ph ysio lo gical In tegrity In t egr a ted Pr ocess: Nu rsin g Pro cess—Im plem en tation Con t en t Ar ea : Ad ult Health —Resp iratory Pr ior ity Con cepts: Clin ical Jud gm en t; Gas Exch an ge Refer en ce: Lewis et al. (2014), p. 546.

995. 1 Ra t ion a le: Alth o u gh freq u en cy an d in ten sity o f b owel sou n d s vary depen din g o n th e p h ase o f digestion , n orm al b owel so u n d s are relatively h igh -p itch ed clicks or gu rgles. Lou d

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1077UNIT XX Comprehensive Test

gu rgles (bo rb orygm i) in dicate h yperperistalsis an d are com - m on ly associated with n ausea an d vo m itin g. A swish in g or b uzzin g sou n d represen ts turbu len t b lo od flo w asso ciated with a b ru it. Bruits are n o t n o rm al so un ds. Bo wel sou n d s are very h igh -pitch ed an d lo ud ( h yp erreson an ce) wh en th e in testin es are un der ten sion , such as in in testin al o bstructio n . Th erefo re, o ptio n s 2, 3, an d 4 are in co rrect. Test-Ta kin g Str a tegy: Note th e su b ject, tech n iq u es fo r abd om - in al assessm en t. Norm ally, bo wel sou n d s are au d ible in all fo ur qu adran ts, so o ptio n s 2 an d 4 can b e elim in ated . From th e rem ain in g op tio n s, focus o n th e d ata in th e q u estio n an d n o te th at th e clien t h as n ausea an d vo m itin g; th is will d irect yo u to th e correct o ptio n . Review: Ab d o m in al assessm en t fin d in gs Level of Cogn it ive Abilit y: An alyzin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Assessm en t Con ten t Ar ea : Adu lt Health —Gastroin testin al Pr ior it y Con cept s: Elim in ation ; Health Pro m otio n Refer en ce: Jarvis (2016), pp . 548–549, 572.

996. 20 Ra tion a le: Use th e m edicatio n calculation fo rm u la. For mu la :

Prescribed Available

 Quantity¼ mL=dose

800 mg 200 mg

 5 mL¼ 20 mL

Test-Ta kin g St r a t egy: No te th e su b ject, m edicatio n calcu la- tio n s. Review th e lab el fo r th e co rrect reco n stitu tio n , wh ich states 200 m g in 5 m L. Calcu late th e p rescribed n u m b er of m il- ligram s p er m illiliter. Use a calcu lator to verify th e an swer an d m ake su re th at th e an swer m akes sen se. Review: Med icatio n calcu latio n s Level of Cogn itive Ability: Ap plyin g Clien t Need s: Ph ysio logical In tegrity In tegr a t ed Pr ocess: Nursin g Pro cess—Im p lem en tatio n Content Area : Fundamentals of Care—Medication/IV Calculations Pr ior it y Con cept s: Clin ical Ju dgm en t; Safety Refer en ce: Perry et al. (2014), pp . 486–487.

C

o

m

p

r

e

h

e

n

s

i

v

e

T

e

s

t

1078 UNIT XX Comprehensive Test

References

Am erican Heart Association . (2015) . HIGHLIGHTS of the 2015 guidelines update for CPR and ECC. Am erican Heart Association .

Brown , M., & Mulh ollan d, J. ( 2012). Drug calculations: ratio and propor- tion: problems for clinical practice ( ed 9). St. Louis: Saun ders.

Burch um , J., & Rosen th al, L. ( 2016) . Pharmacology for nursing care. Ph iladelph ia: Saun d ers.

Calen, J. P., Greer, K. E., Ho od, A. F., Paller, A. S., & Swin yer, L. J. ( 1993) . Color atlas of dermatology. Ph iladelph ia: Saun ders.

Ch ern ecky, C., & Berger, B. ( 2013). Laboratory tests and diagnostic proce- dures ( ed 6) . Ph ilad elph ia: Saun ders.

Ch risten sen , B., & Ko ckrow, E. ( 2010). Foundations of nursing ( ed 6) . St. Louis: Mosby.

Dolan , B., & H olt, L. (2013) . Accident & emergency theory into practice ( ed 3). St. Louis: Elsevier.

Gah art, B., & Nazaren o, A. ( 2015) . 2015 intravenous medications ( ed 31) . St. Louis: Mosby.

Gidden s, J. F. ( 2013) . Concepts for nursing practice. St. Louis: Elsevier. Giger, J. (2013) . Transcultural nursing assessment & intervention ( ed 6) .

St. Louis: Mosby. Habif, T. P. ( 2004) . Clinical dermatology: a color guide to diagnosis and

therapy ( ed 4) . St. Lou is: Mosb y. Ham m on d, B., & Zim m erm an n , P. ( 2013). Sheehy’s manual of emergency

care ( ed 7). St. Louis: Elsevier. Hocken berry, M., & Wilson , D. ( 2015) . Wong’s nursing care of infants

and children ( ed 10) . St. Louis: Mosby. Hocken berry, M., & Wilson , D. ( 2013). Wong’s essentials of pediatric

nursing ( ed 9) . St. Lou is: Mosb y. Hodgson , B., & Kizior, R. ( 2016). Saunders nursing drug handbook 2016.

St. Louis: Saun ders. Hodgson , B., & Kizior, R. ( 2015). Saunders nursing drug handbook 2015.

St. Louis: Saun ders. Huber, D. ( 2014) . Leadership and nursing care management ( ed 5) .

St. Louis: Saun ders. Ign atavicius, D., & Workm an , M. ( 2016). Medical-surgical nursing: patient-

centered collaborative care (ed 8). St. Louis: Saunders. Ign atavicius, D., & Workm an , M. (2013) . Medical-surgical nursing:

patient-centered collaborative care ( ed 7). St. Louis: Saun ders. Jarvis, C. ( 2016). Physical examination and health assessment ( ed 7) .

St. Louis: Saun ders. Keltn er, N., & Steele, D. ( 2015) . Psychiatric nursing (ed 7) . St. Louis:

Elsevier. Kirton , C. ( 1996). Assessin g edem a. Nursing, 26( 7), 54. 96. Kristen , G., et al. (2013) . Com p arison of BMI an d p h ysical activity

between old order Am ish ch ildren an d n on -Am ish ch ildren . Diabetes Care, 36(4), 873–878. h ttp:/ /dx.do i.org/ 10.2337/ dc12-0934. Pub- lish ed ahead o f prin t O cto ber 23, 2012.

Leh n e, R. ( 2013) . Pharmacology for nursing care (ed 8) . St. Louis: Saun ders.

Lewis, S., Dirksen , S., Heitkem per, M., & Buch er, L. ( 2014). Medical- surgical nursing: assessment and management of clinical problems ( ed 9). St. Louis: Mo sby.

Lilley, L., Rain forth Collin s, S., Harrin gton , S., & Sn yd er, J. ( 2014) . Pharmacology and the nursing process (ed 7) . St. Lo uis: Mosby.

Lo wderm ilk, D., Perry, S., Cash ion , K., & Alden , K. (2016) . Maternity & women’s health care ( ed 11). St. Louis: Elsevier.

Markiewicz, M., & Abrah am son , E. ( 1999) . Diagnosis in color: neonatol- ogy. St. Louis: Mosby.

McKin n ey, E., Jam es, S., Murray, S., Nelson , K., & Ash will, J. ( 2013) . Maternal-child nursing ( ed 4) . St. Louis: Elsevier.

Mosby’s dictionary of medicine, nursing, & health professions. ( 2013) . ( ed 9). St. Louis: Elsevier.

National Council of State Boards of Nursin g. (2016). Detailed test plan for the National Council Licensure Examination for Registered Nurses. NCSBN.

Nix, S. ( 2013). Williams’ basic nutrition and diet therapy ( ed 14). St. Louis: Mosby.

Pagan a, K., Pagan a, T., & Pagan a, T. N. ( 2015) . Mosby’s diagnostic and laboratory tests reference ( ed 12) . St. Lo uis: Mosby.

Perry, A., Potter, P., & O sten dorf, W. ( 2014) . Clinical nursing skills & techniques (ed 8) . St. Louis: Mosby.

Potter, A., Perry, P., Stockert, P., & Hall, A. ( 2013). Fundamentals of nurs- ing ( ed 8) . St. Lou is: Mosb y.

Skid m ore-Roth , L. ( 2014). Mosby’s nursing drug reference ( ed 27). St. Louis: Mosby.

Stuart, G. (2013) . Principles & practice of psychiatric nursing (ed 10). St. Louis: Mosby.

Swartz, M. ( 2010) . Textbook of physical diagnosis ( ed 6). Ph iladelp h ia: Saun ders.

Touh y, T., & Jett, K. ( 2012). Ebersole and Hess’ toward healthy aging ( ed 8) . St. Louis: Mo sby.

Varcarolis, E. (2013) . Essentials of psychiatric mental health nursing: a communication approach to evidence-based care ( ed 2) . St. Louis: Saun ders. Revised reprin t.

Weston , W. L., & Lan e, A. T. ( 2007) . Color textbook of pediatricdermatology ( ed 4). St. Louis: Mosby.

Wilso n , A. F., & Gidden s, J. F. ( 2013). Health assessment for nursing practice (ed 5) . St. Lo uis: Mosby.

Won g-Baker FACES® Fo un d ation , Co pyrigh t 1983, www. Won gBakerFACES.org. Used with perm ission . O rigin ally pub lish ed in Whaley & Wong’s nursing care of infants and children. ©Elsevier In c.

Yoder-Wise, P. ( 2015) . Leading and managing in nursing ( ed 6) . St. Louis: Elsevier.

Zerwekh , J., & Zerwekh Garn eau, A. (2015) . Nursing today: transition and trends ( ed 8) . St. Louis: Elsevier.

Zitelli, B. J., & Davis, H. W. ( 2007) . Atlas of pediatric physical diagnosis ( ed 5). St. Louis: Mo sby.

Online References AIDS.gov: CD4 coun t ( website): www.aid s.gov/ h iv-aids-basics/ just-

diagn osed-with -h iv-aids/ un d erstan d-your-test-results/ cd4-coun t/ . Am erican Academ y of Pediatrics: Car seats: Inform ation for fam ilies fo r

2015 (website): www.health ychildren .o rg/ En glish /safety-prevention / on-th e-go/ Pages/ Car-Safety-Seats-Inform ation -for-Fam ilies.aspx.

1079

Am erican Diabetes Associatio n, DiabetesPro : Estim ated average glucose, eAG/ A1C Con version Calculator ( website): h ttp:/ / profession al. diabetes.org/ diap ro /glucose_calc.

Am erican Diabetes Association , Diab etesProSM: Profession al Reso urces On lin e (website): h ttp:/ / professional.diabetes.org/ .

Am erican H eart Asso ciatio n . ( 2015) . Guidelin es for CPR an d ECC (website) . h ttp s:/ / eccguidelin es.h eart.org/ in dex.ph p / circulation / cpr-ecc-guidelin es-2/ .

Am erican Heart Associatio n : Classes o f h eart failure ( website) : www. h eart.org/ HEARTO RG/ Con dition s/ HeartFailure/ Abo utHeartFailure/ Classes-of-Heart-Failure_UCM_306328_Article. jsp#.VpSRvE9KWSp.

Am erican Hosp ital Association : Th e p atien t care p artn ersh ip : Un der- stan din g expectatio n s, righ ts an d resp on sibilities ( website): h ttp:/ / www.ah a.org/ advocacy-issues/ com m un icatin gpts/ pt-care- partn ersh ip.sh tm l.

Am erican Nurses Association : Code o f eth ics fo r n urses ( web site) : www.n ursin gworld.org/ codeo feth ics.

Am erican Nurses Association : Social n etworkin g prin ciples too lkit (website) : www.n ursin gworld.o rg/ socialn etworkin gtoolkit.

Am erican Psych iatric Asso ciation : DSM (website) : www.psych iatry. org/ p sych iatrists/ practice/ dsm .

Am erican Psych iatric Associatio n : High ligh ts of ch an ges from DSM-IV- TR to DSM-5 ( website): www.dsm 5.o rg/ Docum en ts/ ch an ges% 20from %20dsm -iv-tr%20to %20dsm -5.pdf.

Cen ters for Disease Con trol an d Preven tion (CDC): Guid an ce o n per- sonal protective equipm en t (PPE) to be used by h ealthcare workers durin g m an agem en t of patients with con firm ed Ebola or person s un der in vestigation (PUIs) for Ebola who are clin ically un stable or h ave bleedin g, vom itin g, or diarrhea in U.S. h osp itals, includin g pro - cedures for don n in g an d do ffin g PPE (website): www.cdc.gov/ vh f/ ebola/h ealth care-us/ ppe/ guidan ce.h tm l.

Cen ters fo r Disease Con tro l an d Preven tio n ( CDC): Han d h ygien e in h ealth care settin gs (website) : www.cdc.gov/ h an dh ygien e/ .

Centers for Disease Control and Prevention (CDC): Identify, isolate, inform : Em ergency departm ent evaluation and m anagem ent for patients under investigation (PUIs) for Ebola virus disease (EVD) (website): www.cdc.gov/vhf/ebola/healthcare-us/em ergency-services/em ergency- departm ents.htm l.

Cen ters for Disease Con trol an d Preven tion ( CDC) : Im m un ization sch edules ( website) : www.cdc.gov/ vaccin es/ sch ed ules/ .

Cen ters for Disease Con trol an d Preven tion (CDC) : In terim guidan ce fo r en viron m en tal in fection con trol in h ospitals for Ebola virus ( website): www.cdc.gov/ vh f/ ebola/ h ealth care-u s/ clean in g/ h ospitals.h tm l.

Cen ters for Disease Con trol an d Preven tion (CDC) : Ph o n e n um b ers fo r state an d lo cal h ealth d epartm en ts (website) : www.cdc.gov/ vh f/ ebola/ ou tbreaks/ state-local-h ealth -dep artm en t-con tacts.h tm l.

Cen ters for Disease Control and Preven tion (CDC): Sm allpox: Diagn osis an d evaluation (website): h ttp:/ / em ergency.cdc.gov/ agent/ sm allpox/ diagn osis/ .

Th e Guttm ach er In stitute. ( Augu st 2000) . Min o rs an d th e righ t to con sen t to h ealth care. Th e Guttm ach er Report on Public Policy, 3(4). (serial onlin e): www.guttm ach er.o rg/ pubs/ tgr/03/ 4/gr030404. h tm l.

Im m un ization Action Co alition ( website) : www.im m un ize.org. Th e In tern ation al Coun cil o f Nurses ( ICN) : Th e ICN code of eth ics for

n urses (website): www.icn .ch /about-icn/code-of-ethics-for-nurses/ an d www.icn .ch/ im ages/ stories/ docum en ts/about/icn code_en glish.pdf.

Th e Join t Com m ission . (2015) . Nation al patien t safety goals: facts about th e official “do n ot use” list o f ab breviation s ( website). www.join tco m m ission .org/ stan dards_in form atio n / n p sgs.aspx.

Livestron g.com : The con sisten t carb oh ydrate diet for diabetics (website): www.livestron g.com / article/ 436101-th e-con sisten t-carboh ydrate- d iet-for-diab etics/ .

Nation al Cou n cil of State Boards of Nursin g. ( 2016) . NCLEX-RN®

exam in ation test plan for th e Nation al Coun cil Licen sure Exam in a- tion for Registered Nurses ( website). ( 2016). h ttps:/ / www.n csbn . o rg/ RN_Test_Plan _2016_Fin al.pdf.

Nation al In stitutes of Health , Kn ow Stroke ( website): h ttp:/ / stroke. n ih .gov.

Postp artum Support In tern ation al ( website) : www.p ostpartum .n et. Spector, N., & Kapp el, D. (2012) . Guidelines for using electronic and

social m edia: the regulatory perspective. Online JIssuesNurs, 17(3) (serial on line): (2012). www.nursingworld.org/ Main Men uCategories/ ANAMarketplace/ANAPeriodicals/ OJIN/ TableofConten ts/ Vol-17- 2012/ No3-Sept-2012/ Guidelines-for-Electron ic-and-Social-Media. h tm l.

Un ited States Cen sus Bureau. ( 2010) . Un ited States Cen sus. ( website) : www.cen sus.gov/ 2010cen sus/ .

U.S. Departm en t of Agriculture, Ch ooseMyPlate.go v: Pregn an cy & b reastfeedin g (website): www.ch oosem yplate.gov/ m om s-pregn an cy- b reastfeedin g.

U.S. Departm en t of Health an d Hum an Services, O ffice fo r Civil Righ ts: Health in form ation privacy ( web site) : www.h h s.go v/ ocr/ privacy/ .

U.S. Departm en t of Health an d Hum an Services, Natio n al In stitutes of Health : Kn ow stroke. Kn ow th e sign s. Act in tim e., NIH Publication #10-4872, Jun e 2013. Retrieved from h ttp:/ / stro ke.n ih .gov/ .

U.S. Departm en t of Health an d Hum an Services, Nation al In stitutes o f Health , Natio n al In stitute of Neurological Disorders an d Stroke: NIH stroke scale ( website): h ttp:// stro ke.n ih .gov/ resources/ scale.htm .

U.S. Departm en t of State: U.S. m in orities will be th e m ajo rity by 2042, U.S. Cen sus Bureau says ( website) : h ttp:/ / iipdigital.usem bassy.go v/ st/ en glish / article/ 2008/ 08/ 20080815140005xlren n ef0.1078106. h tm l#axzz3lTh Gs4XZ.

U.S. Food an d Drug Ad m in istration : iPLEDGE in form ation ( web site) : www.fda.go v/ Drugs/ Dru gSafety/ Postm arketDrugSafetyIn fo rm ation forPatien tsan dProviders/ u cm 094307.h tm .

1080 REFERENCES

Glossary

ABO A type of antigen system. The ABO type of the donor should be compatible with the recipient’s. Type A can match with type A or O; type B can match with type B or O; type O can match only with type O; type AB can match with type A, B, AB, or O.

abuse When directed toward another, includes acts such as neglect, mis- use, deceit, or exploitation. It is the wrongful or improper use or action toward another that results in willful infliction of pain, injury, maltreat- ment, mental anguish, or unreasonable confinement. Abuse can include verbal assaults, the demand to perform demeaning tasks, theft, or mis- management of personal belongings (exploitation). Abuse inflicted can be physical, emotional, or sexual.

accommodation Process whereby a clear visual image is maintained as the gaze is shifted from a distant to a near point.

accountability Moral concept that involves acceptance by a professional nurse of the consequences of a decision or action.

acculturation Process of learning norms, beliefs, and behavioral expec- tations of a group other than one’s own group.

active immunity A form of long-term acquired antibody protection that develops naturally after an initial infection or exposure to antigens, or artificially after a vaccination.

acute kidney injury (AKI) The sudden loss of kidney function caused by renal cell damage from ischemia or toxic substances. It occurs abruptly and can be reversible. Acute kidney injury leads to hypoperfusion, cell death, and decompensation in renal function. The prognosis depends on the cause and condition of the client.

addiction State of dependence or compulsive use. In relation to sub- stance dependence, addiction incorporates the concepts of loss of con- trol with respect to the use of a substance, consuming the substance despite related problems and complications, and a tendency to relapse.

addisonian crisis Alife-threatening disorder caused by adrenal hormone insufficiency. Crisis is precipitated by infection, trauma, stress, or sur- gery. Death can occur from shock, vascular collapse, or hyperkalemia.

Addison’s disease Hyposecretion of adrenal cortex hormones (gluco- corticoids and mineralocorticoids) from the adrenal gland, resulting in deficiency of the corticosteroid hormones. The condition is fatal if left untreated.

adenocarcinoma A tumor that arises from glandular epithelial tissue. adrenalectomy The surgical removal of an adrenal gland. Lifelong

replacement of glucocorticoids and mineralocorticoids is necessary with a bilateral adrenalectomy. Temporary replacement may be neces- sary for a unilateral adrenalectomy.

advance directive Written document recognized by state law that pro- vides directions concerning the provision of care when a client is unable to make his or her own treatment choices; the 2 basic types of advance directives include instructional directives such as a living will and dura- ble power of attorney for health care.

advocacy Acting on behalf of the client and protecting the client’s right to make his or her own decisions.

afterload The force against which the heart has to pump (peripheral resistance) to eject blood from the left ventricle. Factors and conditions that would impede blood flow increase left ventricular afterload.

air embolism An obstruction caused by a bolus of air that enters the vein through an inadequately primed intravenous (IV) line, from a loose con- nection, during a tubing change, or during removal of an IV line.

Allen’s test A test to assess for collateral circulation to the hand by eval- uating the patency of the radial and ulnar arteries.

amniotic fluid Pale, straw-colored fluid in which the fetus floats. It serves as a cushion against injury from sudden blows or movements and helps to maintain a constant body temperature for the fetus. The fetus mod- ifies the amniotic fluid through the processes of swallowing, urinating, and movement through the respiratory tract.

anuria Urine output of less than 100 mL/ day. arterial pressure The pressure of the blood against the arterial walls.

Pressure can be measured indirectly by sphygmomanometer or directly by arterial catheter. Readings are expressed as systolic over diastolic. Arterial pressure increases when the cardiac output, peripheral resis- tance, or blood volume increases.

arterial steal syndrome A set of symptoms that can develop following the insertion of an arteriovenous fistula when too much blood is diverted to the vein and arterial perfusion to the hand is compromised.

arteriovenous fistula Surgical creation by anastomosis of an opening between a large artery and a large vein to provide an access for hemo- dialysis. The flow of arterial blood into the venous system causes the vein to become engorged (maturity). Maturity is necessary so that the engorged vein can be punctured using a large-bore needle for hemodialysis.

ascites The accumulation of fluid within the peritoneal cavity that results from venous congestion of the hepatic capillaries, which leads to plasma leaking directly from the liver surface and portal vein.

asterixis Asign that occurs in liver disease. Causes a coarse tremor char- acterized by rapid, nonrhythmic extensions and flexions in the wrist and fingers; also termed liver flap.

asthma (reactive airway disease) A chronic inflammatory disorder of the airways marked by airway hyperresponsiveness. Asthma causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing associated with airflow obstruction that is often reversible with treatment.

astigmatism Visual distortion that results from an uneven curvature of the cornea or lens, in which light rays focus on 2 different points on the retina.

atresia Congenital absence or closure of a body orifice. attenuated vaccines Vaccines derived from microorganisms or viruses;

their virulence has been weakened as a result of passage through another host.

auscultation The physical assessment technique that involves listening to sounds within the body. Special equipment such as a stethoscope may be needed to perform this technique. 1081

autonomic dysreflexia Syndrome characterized by hypertension, brady- cardia, excessive sweating, facial flushing, nasal congestion, pilomotor responses, and headache. Occurs with spinal lesions above T6. Triggers include visceral stimulation from a distended bladder or impacted rec- tum. It is a neurological emergency and must be treated immediately to prevent a hypertensive stroke; also known as autonomic hyperreflexia.

autonomy An ethical principle; respecting the client’s right to make deci- sions about self and health care.

Babinski reflex Dorsiflexion of the big toe with extension; elicited by firmly stroking the lateral aspect of the sole of the foot.

bacille Calmette-Gu erin vaccine (BCG) Avaccine containing attenuated tubercle bacilli that may be given to persons in foreign countries or to those traveling to foreign countries to produce increased resistance to tuberculosis.

ballottement Rebounding of the fetus against the examiner’s finger on palpation. When the examiner taps the cervix, the fetus floats upward in the amniotic fluid. The examiner feels a rebound when the fetus falls back.

bariatric surgery A surgical procedure used to treat severe obesity. baroreceptors Specialized nerve endings (also called pressoreceptors)

located in the walls of the aortic arch and carotid sinuses. They are affected by changes in the arterial blood pressure (BP). Increases in arte- rial pressure stimulate baroreceptors and the heart rate and arterial pressure decrease. Decreases in arterial pressure lead to a lessened stimulation of the baroreceptors, vasoconstriction occurs, and the heart rate increases.

beneficence An ethical principle; the responsibility of the nurse to take positive actions to help the client.

benign Usually refers to growths that are encapsulated, remain localized, and are slow growing.

Billroth I Partial gastrectomy with the remaining segment being anasto- mosed to the duodenum; also termed gastroduodenostomy.

Billroth II Partial gastrectomy with the remaining segment being anasto- mosed to the jejunum; also termed gastrojejunostomy.

birth The expulsion or extraction of the neonate. blood The liquid pumped by the heart through the arteries, veins, and

capillaries. Blood is composed of a clear yellow fluid (plasma), formed elements, and cell types with various functions.

blood cell Any of the formed elements of the blood, including red cells (erythrocytes), white cells (leukocytes), and platelets (thrombocytes).

blood pressure (BP) The force exerted by the blood against the walls of the blood vessels. If the blood pressure falls too low, blood flow to the tissues, heart, brain, and other organs becomes inadequate. If the blood pressure becomes too high, the risk of vessel rupture and damage increases.

body mechanics The coordinated efforts of the musculoskeletal and nervous systems to maintain balance, posture, and body alignment dur- ing lifting, bending, and moving to perform activities safely.

Brudzinski’s sign Involuntary flexion of the hip and knee when the neck is passively flexed; indicates meningeal irritation.

burn Cell destruction of the layers of the skin caused by heat, friction, electricity, radiation, or chemicals.

calcium A mineral element needed for the process of bone formation, coagulation of blood, excitation of cardiac and skeletal muscle, mainte- nance of muscle tone, conduction of neuromuscular impulses, and the synthesis and regulation of the endocrine and exocrine glands. The nor- mal adult reference range is 9.0–10.5 mg/ dL (2.25–2.75 mmol/ L).

cancer A neoplastic disorder that can involve all body organs. Cells lose their normal growth-controlling mechanism, and the growth of cells is uncontrolled.

carbon monoxide poisoning Carbon monoxide is a colorless, odorless, and tasteless gas that has an affinity for hemoglobin 200 times greater than that of oxygen. Poisoning occurs from the inhalation of carbon monoxide. Oxygen molecules are displaced and carbon monoxide

reversibly binds to hemoglobin to form carboxyhemoglobin. Tissue hyp- oxia results.

carcinogen A physical, chemical, or biological stressor that causes neo- plastic changes in normal cells.

carcinoma A new growth or malignant tumor that originates from epi- thelial cells, the skin, gastrointestinal tract, lungs, uterus, breast, or other organ.

carcinoma in situ A premalignant lesion with all of the histological char- acteristics of cancer except invasion of the basement membrane.

cardiac output The total volume of blood pumped through the heart in 1 minute. The normal cardiac output is 4 to 7 L/ minute. Cardiac output equals stroke volume multiplied by heart rate. Cardiac output can be calculated via the thermodilution method when the client has a pulmo- nary artery catheter (Swan-Ganz catheter).

cast Stiff dressing or casting, made of plaster of Paris or synthetic mate- rial, to stabilize a part or parts of the body until healing occurs.

cataract An opacity of the lens that distorts the image projected onto the retina and that can progress to blindness.

catheter embolism An obstruction caused by breakage of the catheter tip during intravenous line insertion or removal.

Chadwick’s sign Violet coloration of the mucous membranes of the cer- vix, vagina, and vulva that is one of the earliest signs of pregnancy; caused by increased vascularity. This is considered a probable sign of pregnancy.

chest tube Tube that returns negative pressure to the intrapleural space; used to remove abnormal accumulations of air and fluid from the pleural space.

cholecystectomy Removal of the gallbladder. cholecystitis An inflammation of the gallbladder that may occur as an

acute or chronic process. Acute inflammation is associated with gall- stones (cholelithiasis). Chronic cholecystitis results when inefficient bile emptying and gallbladder muscle wall disease cause a fibrotic and con- tracted gallbladder.

choledocholithotomy Incision into the common bile duct to remove a gallstone.

chronic kidney disease (CKD) The progressive loss and ongoing dete- rioration in kidney function. It is characterized by a glomerular filtration rate of less than 60 mL/ minute for a period of 3 months or longer. It is irreversible and eventually results in uremia or end-stage kidney disease. Chronic kidney disease requires dialysis or kidney transplantation to maintain life.

chronic obstructive pulmonary disease A disease state characterized by pulmonary airflow obstruction that is usually progressive, not fully reversible, and sometimes accompanied by airway hyperreactivity. Air- flow obstruction may be caused by chronic bronchitis and/ or emphy- sema. In chronic hypercapnia, the stimulus to breathe is a low PaO2 instead of an increased PaCo2.

chronological age Age in years. Chvostek’s sign A sign of hypocalcemia. A spasm of the facial muscles

elicited by tapping the facial nerve just anterior to the ear. circulatory overload Acomplication resulting from the infusion of blood

or intravenous solutions at a rate too rapid for the size, age, physiolog- ical status, or clinical condition of the recipient.

cirrhosis A chronic progressive disease of the liver characterized by dif- fuse degeneration and destruction of hepatocytes. Repeated destruc- tion of hepatic cells causes the formation of scar tissue.

Client’s (Patient’s) Bill of Rights The rights and responsibilities of cli- ents receiving care. These rights acknowledge the client’s right to par- ticipate in her or his health care with an emphasis on autonomy.

compartment syndrome Condition in which pressure increases in a confined anatomical space, leading to decreased blood flow, ischemia, and dysfunction of these tissues. Initial ischemia with pain, pallor, par- esthesia, muscle weakness, and loss of pulses may progress to necrosis and permanent muscle cell dysfunction.

1082 GLOSSARY

compatibility Matching of blood from 2 persons by 2 different types of antigen systems, ABO and Rh, present on the membrane surface of the red blood cells, to prevent a transfusion reaction.

compensation Compensation refers to the body processes that occur to counterbalance a physiological disturbance such as an acid-base distur- bance or other disturbance such as that which occurs in heart failure.

conductive hearing loss Amechanical dysfunction or blockage of sound waves to the inner ear fibers because of external ear or middle ear dis- orders. Disorders often can be corrected with no damage to hearing or minimal permanent hearing loss.

conductivity The ability of the heart muscle fibers to propagate electrical impulses along and across cell membranes.

confidentiality The nurse’s responsibility of keeping a client’s informa- tion private.

confidentiality/ information security In the health care system, refers to the protection of privacy of the client’s personal health information.

consent Voluntary act whereby a person agrees to allow someone else to do something.

contractility The inherent ability of the myocardium to alter contractile force and velocity. Sympathetic stimulation increases myocardial con- tractility, so stroke volume increases. Conditions that decrease myocar- dial contractility reduce stroke volume.

conversion The first step in the calculation of a medication problem. Conversion is necessary when a medication prescribed is written in one system but the medication label is stated in another system.

coping mechanism Method used to decrease anxiety. crackles Audible high-pitched crackling or popping sounds heard during

lung auscultation; result from fluid in the airways, and are not cleared by coughing.

crisis Temporary state of disequilibrium that can be physiological or psy- chological. An individual’s usual compensatory or coping mechanisms and problem-solving methods fail. Crisis can result in further physiolog- ical disturbance, personality growth, or personality disorganization if left untreated.

Crohn’s disease An inflammatory disease that can occur anywhere in the gastrointestinal tract but most often affects the terminal ileum; leads to thickening and scarring, narrowed lumen, fistulas, ulcerations, and abscesses. The disease is characterized by remissions and exacerbations.

crossmatching The testing of the donor’s blood and the recipient’s blood for compatibility.

Cullen’s sign Bluish discoloration of the abdomen and periumbilical area seen in acute hemorrhagic pancreatitis.

cultural assimilation Process in which individuals from a minority group are absorbed by the dominant culture and take on the character- istics of the dominant culture.

cultural awareness Learning about the cultures of clients being cared for; this includes a self-examination of one’s own background, recognizing biases, prejudices, and assumptions about other people. The nurse is also responsible for asking clients about their health care practices and preferences.

cultural competence Continued pursuit of acquisition of awareness, skill, and knowledge of a culture and its practices that facilitates provi- sion of culturally appropriate health care.

cultural diversity Differences among groups of people that result from ethnic, racial, and cultural variables.

cultural imposition Tendency to impose one’s own beliefs, values, and patterns of behavior on individuals from another culture.

culture The knowledge, beliefs, patterns of behavior, ideas, attitudes, values, and norms that are unique to a particular group of people.

Cushing’s disease A metabolic disorder characterized by abnormally increased secretion (endogenous) of cortisol, caused by increased amounts of adrenocorticotropic hormone (ACTH) secreted by the pitu- itary gland.

Cushing’s syndrome A metabolic disorder resulting from the chronic and excessive production of cortisol by the adrenal cortex or by the administration of glucocorticoids in large doses for several weeks or longer (exogenous or iatrogenic).

Cushing’s triad A classic, late sign of increased intracranial pressure; the triad includes hypertension, bradycardia, and widened pulse pressure.

cyanosis The bluish color that results in tissues, such as the nail beds and mucous membranes, when tissues are deprived of adequate amounts of oxygen.

cycloplegia Paralysis of the ciliary muscles by medications that block muscarinic receptors. Cycloplegia causes blurred vision because the shape of the lens can no longer be adjusted for near-vision.

dawn phenomenon A nocturnal release of growth hormone, which may cause blood glucose level elevations before breakfast in the client with diabetes mellitus. Treatment includes administering an evening dose of intermediate-acting insulin at 10 p.m.

decerebrate (extensor) posturing Stiff extension of 1 or both arms and possibly the legs; indicates a brainstem lesion.

decorticate (flexor) posturing Flexure of 1or both arms on the chest and possibly stiff extension of the legs; indicates damaged cortex.

deep full-thickness burn Injury extends beyond the skin into underlying fascia and tissues, and muscle, bone, and tendons are damaged.

deep partial-thickness burn Injury extends deep into the dermis and few healthy cells remain.

defense mechanism Coping mechanism used in an effort to protect the individual from feelings of anxiety. As anxiety increases and becomes overwhelming, the individual copes by using defense mechanisms to protect the ego and decrease anxiety.

delegation Process of transferring a selected nursing task in a situation to an individual who is competent to perform that specific task.

delivery Actual event of birth; the expulsion or extraction of the neonate. dementia An organic syndrome identified by gradual and progressive

deterioration in intellectual functioning. Long- and short-term memory losses occur with impairment in judgment, abstract thinking, problem- solving ability, and behavior, resulting in a self-care deficit. A common type of dementia is Alzheimer’s disease.

depression A mood disorder that can be identified by feelings of sad- ness, hopelessness, and worthlessness, and a decreased interest in activities.

developmental age Age based on a child’s maturational progress. It is determined by standardized resources such as body size, physical and psychological functioning, motor skills, and aptitude tests.

diabetes insipidus The hyposecretion of antidiuretic hormone from the posterior pituitary gland, resulting in failure of tubular reabsorption of water in the kidneys and diuresis.

diabetes mellitus A chronic disorder of glucose intolerance and impaired carbohydrate, protein, and lipid metabolism caused by a defi- ciency of insulin or resistance to the action of insulin. A deficiency of insulin results in hyperglycemia.

diabetic ketoacidosis A life-threatening complication of diabetes melli- tus that develops when a severe insulin deficiency occurs, resulting in hyperglycemia. Hyperglycemia progresses to ketoacidosis over a period of several hours to several days. Acidosis occurs in clients with type 1 diabetes mellitus, persons with undiagnosed diabetes, and persons who stop prescribed treatment for diabetes.

dialysis A blood filtering procedure that is indicated when kidney func- tion deteriorates and the accumulation of water and waste products interferes with life functions. Dialysis is performed via the bloodstream (hemodialysis) or through the peritoneal cavity (peritoneal dialysis).

diastole The phase of the cardiac cycle in which the heart relaxes between contractions. Diastole represents the period of time when the 2 ventri- cles are dilated by the blood flowing into them.

diastolic pressure The force of the blood exerted against the artery walls when the heart relaxes or fills.

1083GLOSSARY

disaster Any human-made or natural event that causes destruction and devastation that cannot be alleviated without assistance; internal disas- ters are events that occur within a health care agency, whereas external disasters are events that occur outside the health care agency.

diverticulitis Inflammation of 1 or more diverticula from penetration of fecal matter through the thin-walled diverticula, resulting in local abscess formation. A perforated diverticulum can progress to intraab- dominal perforation with generalized peritonitis.

diverticulosis Outpouching or herniations of the intestinal mucosa that can occur in any part of the intestine but are most common in the sig- moid colon.

dumping syndrome Rapid emptying of the gastric contents into the small intestine, which occurs following gastric resection.

edrophonium test Test used to diagnose myasthenia gravis and to dif- ferentiate between myasthenic crisis and cholinergic crisis; may also be called the Tensilon test.

embryo The earliest stage of fetal development beginning day 15 through approximately week 8 after conception. Then, the unborn baby is usually referred to as the fetus.

emergency response plan A health care agency’s preparedness and response plan in the event of a disaster.

emphysema Abnormal permanent enlargement of air spaces distal to the terminal bronchioles in the lungs, with destruction of alveolar walls.

endotracheal tube Tube used to maintain a patent airway; indicated when a client needs mechanical ventilation.

enteral nutrition Administration of nutrition with liquefied foods into the gastrointestinal tract via a tube.

ergonomic principles The anatomical, physiological, psychological, and mechanical principles used to ensure the efficient and safe use of an individual’s energy.

esophageal varices Dilated and tortuous veins in the submucosa of the esophagus caused by portal hypertension, often associated with liver cirrhosis; at high risk for rupture if portal circulation pressure rises.

ethical principles Set of guidelines or codes that direct or govern actions for health care providers. The guidelines and codes identify the expec- tations of a profession and the standards of behavior for its members.

ethics The ideals of right and wrong; guiding principles that individuals may use to make decisions.

ethnic group People within a culture who share characteristics based on race, religion, color, national origin, or language.

ethnicity An individual’s identification of self as part of an ethnic group. evidence-based practice Approach to client care in which the nurse inte-

grates the client’s preferences, clinical expertise, and the best research evidence to deliver quality care.

external fixation Stabilization of a fracture by the use of an external frame, with multiple pins applied through the bone.

fat embolism Sudden dislodgment of a fat globule that is freed into the circulation, where it can lodge in a blood vessel and obstruct blood flow to tissue distal to the obstruction.

fat emulsion (lipids) A solution administered intravenously with paren- teral nutrition therapy to prevent fatty acid deficiency.

fertilization Uniting of the sperm and ovum, which occurs within 12 hours of ovulation and within 2 to 3 days of insemination, the average duration of viability for the ovum and sperm.

fetor hepaticus The fruity, musty breath odor associated with severe chronic liver disease.

fidelity An ethical principle; the nurse’s responsibility to keep promises by following through with nursing actions and interventions.

flaccid posturing No motor response display in any extremity. fluid volume deficit Dehydration, in which the fluid intake of the body is

not sufficient to meet the fluid needs of the body. fluid volume excess Fluid intake or fluid retention that exceeds the fluid

needs of the body. Also called overhydration or fluid overload.

Fowler’s position The client is supine and the head of the bed is elevated to 45 to 90 degrees.

fresh-frozen plasma A blood product administered to increase the level of clotting factors in clients with such a deficiency.

full-thickness burn Involves injury and destruction of the entire epider- mis and the dermis; there are no skin cells to repopulate.

functional age The age equivalent at which a child actually is able to per- form specific self-care or related tasks.

gastrectomy Removal of the stomach with attachment of the esophagus to the jejunum or duodenum; also termed esophagojejunostomy or esophagoduodenostomy.

gastric resection Removal of the lower half of the stomach, usually including a vagotomy; also termed antrectomy.

generic name Also known as the nonproprietary name of a medica- tion, or the U.S. adopted name; each medication has only 1 generic name. The generic name will be identified in a medication question on the NCLEX®.

glaucoma Increased intraocular pressure as a result of inadequate drain- age of aqueous humor from the canal of Schlemm or from overproduc- tion of aqueous humor. If untreated, the condition damages the optic nerve and can result in blindness.

glomerulonephritis An immunological condition causing proliferative and inflammatory changes within the glomeruli of the kidneys that results in sclerosis (hardening) and loss of function.

Goodell’s sign Softening ofthe cervixthat occurs at the beginning ofthe sec- ond month of gestation. This is considered a probable sign of pregnancy.

gravida A pregnant woman; called gravida I (primigravida) during the first pregnancy, gravida II during the second pregnancy, and so on.

growth Measurable physical and physiological body changes that occur over time.

grunting The sound made by forced expiration, which is the body’s attempt to improve oxygenation when hypoxemia is present.

health care–associated (nosocomial) infections Infections acquired in the hospital or other health care facility that were not present or incu- bating at the time of the client’s admission; also referred to as hospital-acquired infections.

health history The collection of subjective data when interviewing the client. It includes information such as the client’s current state of health, the medications taken, previous illnesses and surgeries, family histo- ries, and a review of systems.

Hegar’s sign Compressibility and softening of the lower uterine seg- ment that occurs at about week 6 of gestation. This is considered a probable sign of pregnancy.

hemianopsia Blindness in half of the visual field. hemiparesis Weakness affecting 1 side of the body. hemiplegia Paralysis affecting 1 side of the body. hemoglobin A1c A blood test that measures the amount of glycosylated

hemoglobin as a percentage of total hemoglobin. When glucose levels are elevated over time, a higher percentage of hemoglobin is glycosylated. When hemoglobin is glycosylated, the glucose remains attached for the life of the red blood cell, approximately120 days. The hemoglobin A1c level is reflective of the degree of glycemic control over the previous 2 to 3 months. An estimated average daily glucose can be calculated from the hemoglobin A1c.

hepatitis Inflammation of the liver caused by a virus, bacteria, or expo- sure to medications or hepatotoxins.

hereditary Refers to the transmission of genetic characteristics from par- ent to offspring.

herpes zoster (shingles) An acute viral infection of the nerve structure caused by varicella-zoster (chickenpox). Reactivation of the virus can occur in those who previously had chickenpox and is commonly seen in the older adult; a vaccine is available to prevent this occurrence. Her- pes zoster is contagious to individuals who never had chickenpox and have not been vaccinated against the disease.

1084 GLOSSARY

hiatal hernia A portion of the stomach that herniates through the dia- phragm and into the thorax. Herniation results from weakening of the muscles of the diaphragm and is aggravated by factors that increase abdominal pressure, such as pregnancy, ascites, obesity, tumors, and heavy lifting; also termed esophageal or diaphragmatic hernia.

high Fowler’s position The client is supine and the head of the bed is elevated to 90 degrees.

home safety Removing items from the home environment and avoiding situations or events that place the client at risk for accident or injury.

homeostasis The tendency of a biological system to maintain relatively constant conditions in the internal environment while continuously interacting with and adjusting to changes originating within or outside the system.

homonymous hemianopsia Loss of half of the field of view on the same side in both eyes.

hyperglycemia Elevated blood glucose as a result of too little insulin or the inability of the body to use insulin properly.

hyperopia Farsightedness; objects converge to a point behind the retina. Vision beyond 20 feet is normal, but near-vision is poor. The condition is corrected by a convex lens.

hyperosmolar hyperglycemic syndrome (HHS) Extreme hyperglyce- mia without acidosis. A complication of type 2 diabetes mellitus, which may result in dehydration or vascular collapse but does not include the acidosis component of diabetic ketoacidosis. Onset is usually slow, tak- ing from hours to days.

hyperparathyroidism A condition resulting in the excess secretion of parathyroid hormone (PTH). Parathyroid hormone is responsible for calcium homeostasis in the body.

hyperthyroidism A condition that occurs as a result of excessive thyroid hormone secretion.

hypoglycemia Low blood glucose level that results from too much insu- lin, not enough food, or excess activity.

hypothyroidism A hypothyroid state resulting from a hyposecretion of thyroid hormone.

implantation Embedding of the fertilized ovum in the uterine mucosa 6 to 10 days after conception.

inactivated vaccines Vaccines that contain killed microorganisms. increased intracranial pressure Increased pressure within the skull

caused by trauma, hemorrhage, growths or tumors, hydrocephalus, edema, or inflammation. Increased pressure can impede circulation to the brain and absorption of cerebrospinal fluid and can affect nerve cell functioning, leading to brainstem compression and death.

infant A human born alive; also, a human from 28 days of age until the first birthday.

infiltration Seepage of intravenous fluid out of the vein and into the sur- rounding interstitial spaces.

informed consent A client’s understanding of the reason for the pro- posed intervention, with its benefits and risks, and agreement with the treatment by signing a consent form.

inspection The first physical assessment technique, which begins the moment the examiner meets the client. It involves a visual assessment of the client during the health history and making observations during the physical examination of specific body systems.

internal fixation Stabilization of a fracture that involves the application of screws, plates, pins, wire, or nails to hold the fragments in alignment.

interprofessional collaboration Involves teamwork among health care professionals that promotes sharing of expertise to create a plan of care that will restore and maintain a client’s health.

irritable bowel syndrome (IBS) A functional gastrointestinal disorder characterized by chronic or recurrent diarrhea, constipation, and/ or abdominal pain, and bloating.

justice An ethical principle; refers to fairness when providing care to clients.

Kernig’s sign Loss of the ability of a supine client to straighten the leg completely when it is fully flexed at the knee and hip; indicates menin- geal irritation.

labor Coordinated sequence of rhythmic involuntary uterine contractions resulting in effacement and dilation of the cervix, followed by expulsion of the products of conception.

lateral (side-lying) position The client is lying on the side and the head and shoulders are aligned with the hips and the spine and are parallel to the edge of the mattress. The head, neck, and upper arm are supported by a pillow. The lower shoulder is pulled forward slightly and, along with the elbow, flexed at 90 degrees. The legs are flexed or extended. A pillow is placed to support the back.

leadership Interpersonal process that involves influencing others (fol- lowers) to achieve goals.

lecithin-to-sphingomyelin (L/ S) ratio Ratio of two components of amniotic fluid, used for predicting fetal lung maturity; normal L/ S ratio in amniotic fluid is 2:1 or greater when the fetal lungs are mature.

legally blind The best visual acuity with corrective lenses in the better eye of 20 / 200 or less, or the visual field is no greater than 20 degrees in its widest diameter in the better eye.

leukemia Neoplasm involving abnormal overproduction of leukocytes, usually at an immature stage, in the bone marrow.

lithotomy position The client is lying on the back with the hips and knees flexed at right angles and the feet in stirrups.

lochia Discharge from the uterus that consists of blood from the vessels of the placental site and debris from the decidua; lasts for 2 to 6 weeks after delivery.

lymphoma Neoplasm that originates from lymphoid tissue. macular degeneration Blurred central vision caused by progressive

degeneration of the center of the retina. The condition may be atrophic or age-related, or dry or exudative (wet).

magnesium Concentrated in the bone, cartilage, and within the cell itself; required for the use of adenosine triphosphate as a source of energy. It is necessary for the action of numerous enzyme systems such as those involved in carbohydrate metabolism, protein synthesis, nucleic acid synthesis, and contraction of muscular tissue. It also reg- ulates neuromuscular activity and the clotting mechanism. The normal adult level is 1.3–2.1 mEq/ L (0.65–1.05 mmol/ L).

malignant Term for growths that are not encapsulated but grow and metastasize. These growths are cancerous lesions having the character- istics of disorderly, uncontrolled, and chaotically proliferating cells.

malnutrition Deficiency of the nutrients required for development and maintenance of the human body.

malpractice Type of negligence; failure to meet the standards of accept- able care, which results in harm to another person.

management Accomplishment of tasks or goals by oneself or by direct- ing others.

mass casualty event Involves a number of casualties that exceeds the resource capabilities of the hospital, and is also known as a disaster.

mean arterial pressure (MAP) An approximation of the average pres- sure in the systemic circulation throughout the cardiac cycle; used in hemodynamic monitoring. Mean arterial pressure must be between 60 and 70 mm Hg for adequate organ perfusion.

mechanical ventilation The us e of a ventilator to m ove room air or oxygen-enriched air into and out of the lungs mechanically to m ain- tain proper levels of oxygen and carbon dioxide in the blood. Types of ventilators include negative-pressure and positive-pressure ventila- tors . Various ventilator m odes are adjusted to the client’s individual needs .

medication reconciliation An organized process to avoid medication errors by comparing the client’s medication prescriptions when hospi- talized with all medications that the client was previously taking.

melena Black, tarry stools as a result of bleeding in the upper gastroin- testinal tract.

1085GLOSSARY

metabolic acidosis A total concentration of buffer base that is lower than normal, with a relative increase in the hydrogen ion concentration. This results from loss of buffer bases or retention of too many acids without sufficient bases, and occurs in conditions such as kidney failure and diabetic ketoacidosis, from the production of lactic acid, and from the ingestion of toxins, such as acetylsalicylic acid.

metabolic alkalosis Adeficit or loss of hydrogen ions or acids or an excess of base (bicarbonate) that results from the accumulation of base or from a loss of acid without a comparable loss of base in the body fluids. This occurs in conditions resulting in hypovolemia, the loss of gastric fluid, excessive bicarbonate intake, the massive transfusion of whole blood, and hyperaldosteronism.

metabolism Ongoing chemical process within the body that converts digested nutrients into energy for the functioning of body cells.

metastasis The transfer of disease from 1 organ or part to another not directly connected with it. Secondary malignant lesions, originating from the primary tumor, are located in anatomically distant places.

milieu The safe physical and social environment in which an individual receives treatment.

minority group Ethnic, cultural, racial, or religious group that consti- tutes less than a numerical majority of the population.

miosis Constriction of the pupil, which occurs primarily by stimulation of the muscarinic receptors of the sphincter muscles. It is seen with the use of pilocarpine drops when treating glaucoma, when using opioids, or when there is brain damage of the pons.

miotic A medication that causes constriction of the pupil. morality Behavior that is in accordance with customs or traditions and

usually reflects personal or religious beliefs. multicasualty event Involves a limited number of victims or casualties

and can be managed by a hospital with available resources. multidrug-resistant strain of tuberculosis (MDR-TB) A multidrug-

resistant strain of tuberculosis can occur as a result of improper or non- compliant use of treatment programs and the development of muta- tions in the tubercle bacilli.

Murphy’s sign A sign of gallbladder disease consisting of pain on taking a deep breath when the examiner’s fingers are on the approximate loca- tion of the gallbladder.

mydriasis A dilated pupil that occurs because of blockage of the musca- rinic receptors of the sphincter muscles or by stimulation of the α- receptors of the dilator muscles. Enlarged pupils occur with stimulation of the sympathetic nervous system, use of dilating drops, acute glau- coma, or past or recent trauma.

mydriatic A medication that causes dilation of the pupil. myeloma A malignant proliferation of plasma cells within the bone. myopia Nearsightedness; rays coming from an object are focused in

front of the retina. Near vision is normal, but distant vision is defective. A biconcave lens is used for correction.

myxedema coma A rare but serious disorder that results from persis- tently low thyroid production. Coma can be precipitated by acute illness, rapid withdrawal of thyroid medication, anesthesia and surgery, hypo- thermia, and the use of sedatives and opioid analgesics.

nadir The period of time during which an antineoplastic medication has its most profound effects on the bone marrow.

Nägele’s rule Determines the estimated date of birth based on the pre- mise that the woman has a 28-day menstrual cycle. Subtract 3 months and add 7 days to the first day of the last menstrual period; then add 1 year if appropriate. Alternatively, add 7 days to the last menstrual period and count forward 9 months.

nasal flaring A widening of the nares to enable an infant or child to take in more oxygen; a serious indicator of air hunger.

neglect The failure to provide services necessary for physical or mental health; includes failure to prevent injury.

negligence Conduct that falls below a standard of care; failure to meet a client’s needs either willfully or by omission or failure to act.

neoplasm An abnormal growth, which may be benign or malignant. nephrolithiasis The formation of kidney stones. Kidney stones are

formed in the renal parenchyma. nephrotic syndrome A set of manifestations characterized by protein

wasting and diffuse glomerular damage in which the client has severe diffuse edema.

neurogenic shock Occurs most commonly in clients with injuries above T6 and usually is experienced soon after the injury. Massive vasodilation occurs, leading to pooling of blood in the blood vessels, tissue hypoper- fusion, and impaired cellular metabolism.

newborn; neonate A human from the time of birth to the twenty-eighth day of life.

nonmaleficence An ethical principle; the obligation to do no harm or cause no harm to another.

nuchal rigidity Stiff neck; flexion of the neck onto the chest causes intense pain.

nutrients Carbohydrates, fats or lipids, proteins, vitamins, minerals, electrolytes, and water that must be supplied in adequate amounts to provide energy, growth, development, and maintenance of the human body.

objective data Information about the client that is obtained by the exam- iner through the physical examination and the review of results of lab- oratory, radiological, or other diagnostic studies.

oliguria Urine output of less than 400 mL/ day. packed red blood cells Ablood product used to replace erythrocytes lost

as a result of trauma or surgical interventions or in clients with bone marrow suppression.

palpation A physical assessment technique that involves using the hands to feel certain parts of the client’s body, including some organs. The examiner uses this technique to assess texture, size, and consis- tency of the body part being examined.

pancreatitis An acute or chronic inflammation of the pancreas, with associated escape of pancreatic enzymes into surrounding tissue. Acute pancreatitis can occur suddenly as 1 attack or can be recurrent with res- olution. Chronic pancreatitis is a continual inflammation and destruc- tion of the pancreas, with scar tissue replacing pancreatic tissue.

para Number of pregnancies that have ended at 20 or more weeks, regardless of whether the infant was born alive or was stillborn.

parenteral Given by injection, such as by the intravenous, intramuscular, subcutaneous, or intradermal route.

parenteral nutrition (PN) A nutritional formula administered through a central or peripheral intravenous catheter. In the clinical setting, the term parenteral nutrition may be used interchangeably with the term hyperalimentation.

partial parenteral nutrition A nutritional alternative to total parenteral nutrition that is usually administered through a peripheral intravenous access device or a peripherally inserted central catheter. It is used for clients who are still able to eat but are not able to take in enough nutri- ents to meet their needs.

passive immunity A form of acquired immunity that occurs artificially through injection or is acquired naturally as the result of antibody trans- fer through the placenta to a fetus or through colostrum to an infant; is not permanent and does not last as long as active immunity.

percussion A physical assessment technique that involves tapping the body to assess the size, borders, and consistency of some organs and to assess for the presence of fluid within body cavities. Direct percussion is performed by striking the fingers directly on the body surface. Indirect percussion is performed by striking a finger of 1 hand on a finger of the other hand as it is placed on the body surface, such as over an organ.

perinatal nursing practice Perinatal nurses provide nursing care to women during pregnancy, childbirth, and postpartum. These nurses are sometimes referred to as obstetric nurses or prenatal nurses, and work in both inpatient and outpatient settings, including the private practices of midwives or obstetricians, hospitals, birth centers, or com- munity health centers.

1086 GLOSSARY

perioperative nursing Nursing care given before (preoperative), during (intraoperative), and after (postoperative) surgery.

peristalsis Wavelike rhythmic contractions that propel material through the gastrointestinal tract.

phlebitis An inflammation of the vein that can occur from mechanical or chemical (medication) trauma or from a local infection.

phosphorus (phosphate) Needed for generation of bony tissue. It func- tions in the metabolism of glucose and lipids, in the maintenance of acid-base balance, and in the storage and transfer of energy from 1 site in the body to another. Phosphorus levels are evaluated in relation to calcium levels because of their inverse relationship; when calcium levels are decreased, phosphorus levels are increased, and when phosphorus levels are decreased, calcium levels are increased. The normal adult level is 3.0–4.5 mg/ dL (0.97–1.45 mmol/ L).

physical hazard Any situation or event that places the client at risk for accident, injury, or death.

placenta Organ that provides for the exchange of nutrients and waste products between the fetus and the mother and produces hormones to maintain pregnancy. The placenta develops by the third month of ges- tation. Also called afterbirth.

plasma The watery, straw-colored, fluid part of lymph and the blood in which the formed elements (blood cells) are suspended. Plasma is made up of water, electrolytes, protein, glucose, fats, bilirubin, and gases and is essential for carrying the cellular elements of the blood through the circulation.

platelet transfusion A blood product administered to clients with low platelet counts and to thrombocytopenic clients who are bleeding actively or are scheduled for an invasive procedure.

play An activity that is spontaneous or organized and provides entertain- ment or diversion. It is a part of childhood that is necessary for the devel- opment of a normal personalityand social, physical, and intellectual skills.

pneumothorax The accumulation of atmospheric air in the pleural space caused by a rupture in the visceral or parietal pleura. The loss of negative intrapleural pressure results in collapse of the lung. Diagnosis of pneu- mothorax is made by chest radiography.

poison Any substance that impairs health or destroys life when ingested, inhaled, or otherwise absorbed by the body.

polypharmacy Taking multiple prescription and/ or over-the-counter medications together.

portal hypertension A persistent increase in pressure within the portal vein that develops as a result of obstruction to flow.

postural (orthostatic) hypotension A blood pressure decrease of more than 10 to 15 mm Hg of the systolic pressure or a decrease of more than 10 mm Hg of the diastolic pressure and a 10% to 20% increase in heart rate. Postural hypotension occurs when the client’s blood pressure is not maintained adequately when moving from a lying to a sitting or standing position.

potassium A principal electrolyte of intracellular fluid and the primary buffer within the cell itself. It is needed for nerve conduction, muscle function, acid-base balance, and osmotic pressure. Along with calcium and magnesium, potassium controls the rate and force of contraction of the heart and thus cardiac output. The normal adult level is 3.5–5.0 mEq/ L (3.5–5.0 mmol/ L).

preload The volume of blood stretching the left ventricle at the end of diastole. Preload is determined by the total circulating blood volume and is increased by an increase in venous return to the heart.

presbycusis Gradual nerve degeneration associated with aging; a com- mon cause of sensorineural hearing loss.

pressure ulcer Area of tissue damage that occurs as a result of skin and underlying soft tissue compression from pressure between a surface and a bony prominence.

prioritizing Deciding which needs or problems require immediate action and which ones could tolerate a delay in action until a later time because they are not urgent.

prodromal Pertaining to early symptoms that mark the onset of a disease.

prone position The client is lying on the abdomen with the head turned to the side.

puberty The period of time during which the adolescent experiences a growth spurt, develops secondary sex characteristics, and achieves reproductive maturity.

pulmonary artery wedge pressure (PAWP) The measurement obtained during momentary balloon inflation of a pulmonary artery catheter; it is reflective of left ventricular end-diastolic pressure. The PAWP normally ranges between 4 and 12 mm Hg. Decreased PAWP indicates hypovole- mia, whereas increased PAWP indicates hypervolemia, left ventricular failure, or mitral regurgitation.

pulse pressure The difference between the systolic and diastolic pres- sure. Normal pulse pressure is 30 to 40 mm Hg.

pyelonephritis An inflammation of the renal pelvis and the parenchyma, commonly caused by bacterial invasion.

pyloroplasty Enlarging the pylorus to prevent or decrease pyloric obstruction, thereby enhancing gastric emptying.

quickening Maternal perception of fetal movement for the first time, occurring usually in the sixteenth to twentieth week of pregnancy.

race A grouping of people based on biological similarities; members of a racial group may have similar physical characteristics, such as blood group; facial features; and color of skin, hair, and eyes.

racism Discrimination directed toward individuals or groups who are perceived to be inferior.

reduction Correction or realignment of a bone fracture or joint dislocation.

regurgitation An abnormal backward flow of body fluid. respiratory acidosis A total concentration of buffer base that is lower

than normal, with a relative increase in hydrogen ion concentration; thus a greater number of hydrogen ions is circulating in the blood than the buffer system can absorb. This is caused by primary defects in the function of the lungs or by changes in normal respiratory patterns as a result of secondary problems. Any condition that causes an obstruction of the airway or depresses respiratory status can cause respiratory acidosis.

respiratory alkalosis A deficit of carbonic acid or a decrease in hydrogen ion concentration that results from the accumulation of base or from a loss of acid without a comparable loss of base in the body fluids. This occurs in conditions that cause overstimulation of the respiratory system.

restraints (security/ safety devices) Physical restraints include any manual method or mechanical device, material, or equipment that inhibits free movement. Chemical restraints include the administration of medications for the specific purpose of inhibiting a specific behavior or movement.

retraction An abnormal movement of the chest wall during inspiration in which the skin appears to be drawn in between the ribs, and above and/ or below the clavicle, and scapula; indicates respiratory difficulty.

reverse Trendelenburg position The entire bed is tilted so that the cli- ent’s foot of the bed is down. Position in which the lower extremities are low and the body and head are elevated on an inclined plane.

Rh factor Rh stands for rhesus factor. A person having the factor is Rh positive; a person lacking the factor is Rh negative. The presence or absence of Rh antigens on the surface of red blood cells determines the classification as Rh positive or Rh negative.

safety measures Interventions that ensure protection of the client and the prevention of an accident or injury.

sarcoma Neoplasm that originates from muscle, bone, fat, the lymph system, or connective tissue.

seclusion Placing a client alone in a specially designed room that pro- tects the client and allows for close supervision. Seclusion is the last selected measure in a process to maximize safety to the client and others.

1087GLOSSARY

self-neglect The choice to avoid medical care or other services that could improve optimal function. Unless declared legally incompetent, an indi- vidual has the right to refuse care.

semi-Fowler’s position (low Fowler’s) The client is supine and the head of the bed is elevated about 30 to 45 degrees.

sensorineural hearing loss A pathological process of the inner ear or of the sensory fibers that lead to the cerebral cortex. Such hearing loss often is permanent, and measures must be taken to reduce further dam- age or to attempt to amplify sound as a means of improving hearing to some degree.

septicemia The presence of infective agents or their toxins in the blood- stream. Septicemia is a serious infection and must be treated promptly; otherwise, the infection leads to circulatory collapse, profound shock, and death.

serum The clear and thin fluid part of blood that remains after coagula- tion. Serum contains no blood cells, platelets, or fibrinogen.

shunt Movement of blood or body fluid through an abnormal anatomical or surgically created opening.

Sims’ position The client is lying on the side with the body turned prone at 45 degrees. The lower leg is extended, with the upper leg flexed at the hip and knee to a 45- to 90-degree angle.

skin cancer A malignant lesion of the skin that may or may not metastasize.

smoke inhalation injury Respiratory injury that occurs due to inhalation of products of combustion during a fire.

sodium An abundant electrolyte that maintains osmotic pressure and acid-base balance and transmits nerve impulses. The normal adult level is 135–145 mEq/ L (135–145 mmol/ L).

Somogyi phenomenon A rebound phenomenon that occurs in clients with type 1 diabetes mellitus. Normal or elevated blood glucose levels are present at bedtime; hypoglycemia occurs at about 2 to 3 a.m. Counter- regulatory hormones, produced to prevent further hypoglycemia, result in hyperglycemia (evident in the prebreakfast blood glucose level). Treat- ment includes decreasing the evening (predinner or bedtime) dose of intermediate-acting insulin or increasing the bedtime snack.

spinal shock Also known as spinal shock syndrome. It is a complete but temporary loss of motor, sensory, reflex, and autonomic function that occurs soon after the injury as the cord’s response to the injury. It usu- ally lasts less than 48 hours but can continue for several weeks.

spirituality A broad concept that may have different perspectives for individuals. It can relate to religious beliefs and values and to the soul or human spirit, rather than to material and physical things.

staging A method of classifying malignancies on the basis of the pres- ence and extent of the tumor within the body.

standard precautions Guidelines used by all health care providers for all clients to reduce the risk of infection for clients and caregivers.

stenosis The narrowing or constriction of an opening. stereotyping Expectation that all people within the same racial, ethnic,

or cultural group act alike and share the same beliefs and attitudes. stretch receptors Nerve endings located in the vena cava and the right

atrium that respond to pressure changes affecting circulatory blood vol- ume. When the blood pressure decreases because of hypovolemia, a sympathetic response occurs, causing an increased heart rate and blood vessel constriction. When the blood pressure increases because of hypervolemia, an opposite effect occurs.

stridor Ashrill, harsh sound heard during inspiration, expiration, or both, produced by the flow of air through a narrowed segment of the respira- tory tract.

stroke volume The amount of blood ejected from the left ventricle with each contraction. The normal stroke volume is 70 to 130 mL/ heartbeat. The stroke volume can be affected by preload, afterload, contractility, and the Frank–Starling law.

subjective data Information obtained from the client during history- taking. It is what the client says about himself or herself.

suctioning Asterile procedure involving the removal of respiratory secre- tions that accumulate in the tracheobronchial airway when the client is unable to expectorate secretions; performed to maintain a patent airway.

suicide The ultimate act of self-destruction in which an individual pur- posefully ends his or her own life.

suicide attempt Any willful, self-inflicted, or life-threatening attempt by an individual that has not led to death.

superficial partial-thickness burn Involves injury to the upper third of the dermis; an adequate blood supply remains.

superficial-thickness burn Involves injury to the epidermis; cells and membranes needed for total regrowth remain.

supine position The client is lying on the back. The head and shoulders usually are elevated slightly (depending on the client’s condition) with a small pillow. The arms and legs are extended, and the legs are slightly abducted.

surfactant Phospholipid that is necessary to keep the fetal lung alveoli from collapsing; amount is usually sufficient after 32 weeks’ gestation.

syndrome of inappropriate antidiuretic hormone The hypersecretion of antidiuretic hormone from the posterior pituitary gland resulting in increased intravascular volume, serum hypoosmolality, and dilutional hyponatremia.

systole The phase of contraction of the heart, especially of the ventricles, during which blood is forced into the aorta and pulmonary artery.

systolic pressure The maximum pressure of blood exerted against the artery walls when the heart contracts.

thyroid storm An acute, potentially fatal exacerbation of hyperthyroidism that may result from manipulation of the thyroid gland during surgery, severe infection, or stress.

thyroidectomy Surgical removal of the thyroid gland to treat persistent hyperthyroidism or thyroid tumors.

total parenteral nutrition A nutritional solution administered through either a peripherally inserted central catheter or the subclavian or inter- nal jugular veins via a central line. It is used when the client requires intensive nutritional support for an extended period of time.

tracheostomy An opening made surgically directly into the trachea to establish an airway. A tracheostomy tube is inserted into the opening and the tube attaches to the mechanical ventilator or another type of oxygen delivery device.

traction Exertion of a pulling force to a fractured bone or dislocated joint to establish and maintain correct alignment for healing and to decrease muscle spasms and pain.

trade name Also known as the proprietary or brand name of a medication. The trade name is the name under which a medication is marketed. A medication can have many trade names; therefore, trade names must be approved by the U.S. Food and Drug Administration (FDA) to ensure that no 2 trade names are alike. Trade names may be used in clinical prac- tice settings but will not likely be identified in a medication question on the NCLEX®.

transfusion reaction A hemolytic reaction caused by blood type or Rh incompatibility. An allergic transfusion reaction most often occurs in cli- ents with a history of an allergy. Afebrile transfusion reaction most com- monly occurs in clients with antibodies directed against the transfused white blood cells. A bacterial transfusion reaction occurs after transfu- sion of contaminated blood products.

transmission-based precautions Guidelines used in addition to stan- dard precautions for specific syndromes that are highly suggestive of specific infections until a diagnosis is confirmed.

Trendelenburg position The entire bed frame is tilted so that the client’s head of the bed is low and the bodyand legs are elevated. This position is contraindicated in clients with head injuries, increased intracranial pres- sure, spinal cord injuries, and certain respiratory and cardiac disorders.

triage Classifying procedure that ranks clients according to their need for medical care.

1088 GLOSSARY

Trousseau’s sign A sign of hypocalcemia. Carpal spasm can be elicited by compressing the brachial artery with a blood pressure cuff for 3 minutes.

tuberculin skin test (TST) Test used to determine infection with tuber- culosis. The TST is performed by injecting 0 .1 mL of tuberculin purified protein derivative (PPD) intradermally in the forearm. The skin test reac- tion is read between 48 and 72 hours later. The reaction is measured in millimeters of the induration (raised, hardened area).

tuberculosis A highly communicable disease caused by Mycobacterium tuberculosis, an acid-fast rod bacterium. Tuberculosis is transmitted by the airborne route via droplet infection.

tumor marker Substances that are produced by cancer or by normal cells of the body in response to cancer or certain benign (noncancerous) conditions.

Turner’s sign A gray-blue discoloration of the flanks seen in acute hem- orrhagic pancreatitis.

ulcerative colitis Ulcerative and inflammatory disease of the bowel that results in poor absorption of nutrients. Acute ulcerative colitis results in vascular congestion, hemorrhage, edema, and ulceration of the bowel mucosa. Chronic ulcerative colitis causes muscular hypertrophy, fat deposits, and fibrous tissue with bowel thickening, shortening, and narrowing.

unconscious client A state of depressed cerebral functioning with unre- sponsiveness to sensory and motor function. Causes include head trauma, cerebral toxins, shock, hemorrhage, tumor, or infections.

undifferentiated cells Cells that have lost the capacity for specialized functions.

unilateral neglect An inability to recognize a physical impairment on 1 side of the body. Also known as neglect syndrome.

unit A measurement of a medication in terms of its action, not its phys- ical weight.

urolithiasis The formation of urinary stones or calculi. Urinary calculi are formed in the ureter.

uterus Organ located behind the symphysis pubis, between the bladder and the rectum. It has 4 parts: fundus (upper part), corpus (body), isth- mus (lower segment), and cervix.

vaccine A suspension of attenuated or killed microorganisms adminis- tered to induce active immunity to infectious disease.

vagina Tubular structure located behind the bladder and in front of the rectum; it extends from the cervix to the vaginal opening in the peri- neum. It functions as the outflow tract for menstrual fluid and for vag- inal and cervical secretions, as the birth canal, and as the organ for coitus.

vagotomy Surgical division of the vagus nerve to eliminate the vagal impulses that stimulate hydrochloric acid secretion in the stomach.

venipuncture Puncture into a vein to obtain a blood specim en for test- ing; the antecubital veins are the veins of choice because of ease of access .

venous pressure The force exerted by the blood against the vein walls. Normal venous pressures are highest in the extremities (5 to 14 cm H2O in the arm), and lowest closest to the heart (6 to 8 cm H2O in the inferior vena cava).

veracity An ethical principle; the responsibility and obligation to tell the truth.

warfare agent Biological or chemical substance that can cause mass destruction or fatality.

wheezing High-pitched musical whistle sounds heard with or without a stethoscope as air is compressed through narrowed or obstructed air- ways because of swelling, secretions, or tumors.

1089GLOSSARY

Index

A Abacavir, 980 Abacavir/ lam ivudin e, 980 Abbreviation s, co m m on m easurem en t,

538b ABCs

ph ysiological in tegrity question s an d, 27 prioritizin g n ursin g action s an d, 23, 23b,

68b in triage, 71

Abdom en assessm en t of, 182

in n ewborn , 375 wall defects of, 447

Abdom in al an eurysm , resection of, position in g clien ts in , 233

Abdom in al aortic an eurysm , 785 resection of, 786, 786f

Abdom in al girth , m easurem en t in cirrh osis, 682f

Abdom in al pain , in rh eum atic fever, 486f Abducen s n erve, 184t Abduction

ch ild, 1035 of n ewborn , 379, 379b

ABGs. See Arterial blood gases (ABGs) Abn orm al th ough t processes

in dem en tia an d Alzh eim er’s disease, 1014

in sch izoph ren ia, 1009, 1009b ABO typin g, 305 Abortion , 314, 315b, 367 Abruptio placen tae, in labor an d birth , 348,

348f Absen ce seizure, 908b Absorptiom etry, dual-en ergy x-ray, 939 Abuse

assessm en t question s for, 1035b ch ild, 1035, 1036b older adult, 285, 285b, 1036, 1037b

Abusive beh aviors, 1033 Acceleration s, in fetal h eart rate, 335 Accep tan ce, pregn an cy an d, 302 Accessory m uscles of resp iration , 709 Acciden ts, o lder clien t an d, 193, 193b Accom m odation

in con flict resolution , 64 ocular, assessm en t of, 175b

Accoun tability, 60 Acetabular dysplasia, developm en tal

dysplasia o f h ip, 512b Acetam in oph en , 113, 928b, 929

p oison in g in ch ildren , 452 Acetylch olin e, 938 Acetylsalicylic acid, 113

side an d adverse effects of, 113b Acid-base balan ce, 97–107, 97b, 98f

arterial blood gases an d, 102, 102–103t, 102–104b

com pen sation in , 103 h ydrogen ion s, acids, an d bases in , 97 m etabolic acidosis an d, 100t, 101, 101b m etabolic alkalosis an d, 101, 101t, 102b regulatory system s for, 97, 98–99f respiratory acidosis an d, 99, 99b, 100t respiratory alkalo sis an d, 100, 100b, 101t

Acidity, h om eostasis of, 818 Acidosis

kidn eys an d, 98 m etabolic, 100t, 101, 101b, 103, 103t

with ch ron ic kidn ey disease, 826 potassium respon se to, 98, 99f respiratory, 99, 99b, 100t, 103, 103t

ro le of lun gs in , 98 Acids, 97 Acin us, 708 Acitretin , 571b, 572 Acn e vulgaris, 550 Aco ustic n erve, 184t Aco ustic n eurom a, 875 Acq uain tan ce rape, 1037 Acq uired im m u n ity, 966 Acq uired im m u n odeficien cy syn drom e

( AIDS) , 973, 973f, 974b in ch ildren , 520, 521f, 521b m edication s for, 980, 981b in pregn an cy, 319

Acrocyan o sis, in n ewborn , 374, 374f Acrom egaly, 629 Actin ic keratosis, 570, 570b Activated partial th rom boplastin tim e

( aPTT) , 116 an d h eparin adm in istration , 797

Active ph ase, of labor, 337, 338t Active tran sport, 81 Activity in toleran ce, with ch ron ic kidn ey

disease, 824

Acute kidn ey in jury ( AKI), 822, 822–823b Acute lym ph ocytic leukem ia, 419 Acute pan creatitis, 686 Acute respiratory distress syn drom e, 720 Acute respiratory failure, 719 Acyclovir, 323, 524 Adalim um ab, 961 Adam ’s test, 513 Adapalen e, 574 Addicted n ewborn , 384 Addiction s, 1019–1029

alcoh o l abuse, 1021, 1023b alcoh o l with drawal, 1022, 1022b drug depen den cy, 1023, 1023–1024b eatin g disorders, 1019, 1020f in h ealth care profession als, 1026 sub stan ce abuse disorders, 1020, 1020b,

1023b Addison ian crisis, 631, 632b Addison ’s disease, 631, 631t Aden ocarcin om a, esoph ageal, 593 Aden oiditis, 458–459, 459f Adh esive tran sparen t film , 553t Adm in istration

of m edication s, oph th alm ic, 882, 883f of otic m edication , 887 pediatric, 536–542 of vaccin es, 529b

Adm in istrative staff, roles of, 65 Adm ission

clien t righ ts an d, 991b in volun tary, 992 volun tary, 991

Adm ission agreem en t, 49b Adolescen ce, growth an d developm en t of

Erikson ’s th eory of, 258b, 258t Freud’s th eory of, 261b

Adolescen t developm en tal con sideration s for

ad m in isterin g m edication s to, 540b developm en tal stages of

ch aracteristics of, 273 com m un ication approach es in , 268 h ospitalized, 267 vital sign s of, 273b

eczem a in , 405b HIV in , 522 recom m en ded ch ildh ood an d adolescen t

vaccin es for, 528, 529b

Note: Page n um bers follo wed by f in d icate figures, t in dicate tables, an d b in dicate boxes.1090

Adren al cortex an atom y an d ph ysiology of, 626, 628b in sufficien cy of, 631

Adren al glan ds, 818 an atom y an d ph ysiology of, 626 disorders of, 631, 631–632b, 631t, 632f,

634b in fluid an d electrolyte balan ce, 81

Adren al m edulla, an atom y an d ph ysiology of, 626

Adren alectom y, 632–633, 634b Adren ergic ago n ists, 808, 808b α-Adren ergic agon ists, 885b β-Adren ergic blocker, for eye disorders,

885b, 886 Adren ergic blockers, 803, 803b α-Adren ergic blockers, periph erally actin g,

802, 803b β-Adren ergic blockers, for cardiac disorders,

805, 805b Advan ce directives, 48, 53 Adven titious crisis, 1031b Adven titious soun ds, 178, 180t Advocate, 44 AED. See Autom ated extern al defibrillator

( AED) African Am erican s, 32

en d-of-life care an d, 38 Afterbirth pain s, 358 Aftern oon body tem perature, 108 Agan glion ic m egacolon , 446 Age

burn in jury an d, 556 can cer develo pm en t an d, 580 developm en tal, oral m edication

adm in istration an d, 536, 537f tem perature an d, 109

Age-related m acular degen eration , 866, 887 Agen cies of th e m in d, in Freud’s th eory, of

psych osexual developm en t, 259 Aggression , 1033 Aggressive beh avior, 1005b Agin g, defin ition o f, 281 Agitation , in dem en tia an d Alzh eim er’s

disease, 1014 Agn osia, in stroke, 910b AICD. See Autom ated im plan table

cardioverter-defibrillato r ( AICD) AIDS. See Acquired im m un odeficien cy

syn drom e ( AIDS) Air em bolism

as com plication in h em odialysis, 830b in in traven ous th erapy, 149, 149t

in paren teral n utrition , 136, 137t Airborn e precaution s, 196 Airway

obstruction , with ep iglottitis, 464f suction of, in n ewborn , 376

AKI. See Acute kidn ey in jury (AKI) Akin etic seizure, 908b Alba, 356 Albiglutide, 663 Alcoh ol abuse, 1021, 1023b Alcoh ol with drawal, 1022, 1022b Aldosteron e, 628b

Ald osteron e ( Continued) in fluid an d electrolyte balan ce, 81, 818 h ypersecretion of, 632

Alertn ess, in differen tiatin g delirium , depression , an d dem en tia, 283t

Algin ate dressin g, 553t Alike option s, elim in ation of, 27, 27b Alkalosis

kidn eys an d, 98 m etabolic, 101, 101t, 102b, 103, 103t potassium respon se to, 98, 99f respiratory, 100, 100b, 101t, 103, 103t

role of lun gs in , 98 Alkylatin g m edication s, 616, 616b Allen ’s test, 102, 102b Allergic reaction s, to in sulin th erapy, 638 Allergy, 968

latex, 969, 969–970b, 970f in traven ous th erapy an d, 147

Allis sign , 511 Allogen eic, stem cell don ation , 584 Allograft, fo r burn in jury care, 561b Allop urin ol, 959–960 Alo e, 39b Alo pecia, 422t Alo setron , 701 Alp h a ad ren ergic blockers, periph erally

actin g, 802, 803b Altered th ough t processes

in dem en tia an d Alzh eim er’s disease, 1014

depression an d, 1006b Altretam in e, 619 Alu m in um com poun ds, as an tacids, 699t Alveolar ducts, 708 Alveoli, 708 Alzh eim er’s disease, 1013, 1013b

m edication s for, 1051, 1051b Am an tadin e, 748t Am b en on ium ch loride, 924b Am b ivalen ce, pregn an cy an d, 302 Am b ulation , safety durin g, 193 Am b ulatory care, 224, 225b Am erican Hospital Association , Clien t’s

(Patien t’s) Bill of Righ ts, 48b Am erican Nurses Association Code of

Eth ics, 44, 48b Am erican Red Cross (ARC) , 68 Am in o acids, 124

in paren teral n utrition , 135 Am in oglycosid es

adverse effects of, 983t poten tially n eph rotoxic, 822b

Am in olevulin ic acid, 570 5-Am in osalicylates (5-ASAs) , for

in flam m atory bowel disease, 701, 701b

Am in osalicylic acid, 746 Am ish , 37 Am n esia, dissociative, 1004 Am n iocen tesis, 307 Am n ion , 293 Am n iotic fluid, 294

test of, in pregn an cy, 307 Am n iotic fluid em bolism , in labor an d

birth , 350

Am n iotic fluid in dex, 307 Am n iotic m em bran es, for burn in jury care,

561b Am n iotom y, 340 Am obarbital, 926 Am ph etam in es, 927, 927b Am ph iarth rosis, 938t Am ylin m im etic, 663 Am yotroph ic lateral sclerosis, 914 An al stage, of psych osexual developm en t,

261b An algesia, patien t-con trolled, 146 An algesics

epidural cath eter for, 153, 153f in trath ecal opioid, for labor an d birth ,

339 n on opioid, 928, 928–929b opioid, 929, 929b

for m atern ity an d n ewborn m edication s, 395

urin ary tract, 852, 852b An alysis, question s o n exam in ation

asso ciated with , 25, 25b An aph ylactic reaction

to an tin eoplastic m edication s, 616, 616b

to vaccin e, 531 An aph ylaxis, 968, 968f, 969b An asarca, 78 An drogen s, 657, 657b An droid pelvis, 292 An em ia

aplastic, 413 in ch ron ic kidn ey disease, 825 h igh -iron diet for, 129 iron deficien cy, in pediatric patien t, 412,

413b pern icious, 678 in pregn an cy, 314 sickle cell, 411, 412b, 412f

screen in g of, in pregn an cy, 306 An ergy pan el, 974b An esth esia, for labor an d birth , 339 An esth etics, topical, oph th alm ic, 885 An eurysm

abdom in al, resection of, 233 aortic, 785, 786f cerebral, 907, 908b cerebral, position in g clien ts with , 234

An ger, 1033 An gin a, 772

m edication s for, 804, 804b An giograph y

cerebral, 896 position in g clien ts in , 234

fluorescein , 862 pulm on ary, 710

An gioplasty laser-assisted, 761 percutan eous tran slum in al coron ary,

761, 761f An gioten sin -con vertin g en zym e (ACE)

in h ibitors, 480, 803, 803b An gioten sin II, 818 An gioten sin II receptor blockers (ARBs) ,

803, 803b

1091INDEX

An gles of in jection , 206, 206f An im al tissue, for burn in jury care, 561b An ion , 79b An kle edem a, in p regn an cy, 303 An n uloplasty, m itral, 780 An orexia

in dyin g clien t, 276b as radiation th erapy side effect, 422t

An orexia n ervosa, 1019 An orexian ts, 927, 927b An tacids, 698, 699f, 699t An terior cord syn drom e, 903, 903f An terior fon tan el, in deh yd ration , pediatric,

431t An th rax, 197, 197b, 197f An th ropoid pelvis, 292 An tian drogen s, for m align an cy, 618b An tian gin al m edication s, 804, 804b An tian xiety agen ts, for bipolar disorder,

1005 An tian xiety/ an xiolytic m edicatio n s, 1047 An tiarth ritic m edication s, 960, 960b, 961f An tibiotics, 982, 983b

for acn e vulgaris, 574 adverse effects of, 983t effects in surgical patien t, 218b h earin g loss due to, 888b secon d-lin e m edication s for tuberculosis,

745 An tibod ies, for organ rejection preven tion ,

853b An tich olin ergics, 738, 738b, 852, 852b

effects in surgical patien t, 218b for eye disorders, 883, 883b for Parkin son ’s disease, 925, 925b

An tich olin esterase m edication s, 923 An ticipato ry grief, 1030 An ticoagulan ts, effects in su rgical patien t,

218b An ticon vulsan ts, effects in surgical p atien t,

218b An tidepressan ts

effects in surgical patien t, 218b tricyclic, 1044, 1044b

An tidiarrh eal m edication s, 702b An tidiuretic h orm on e ( ADH)

in fluid an d electrolyte balan ce, 818 syn drom e of in appropriate, 630

as on cological em ergen cy, 604 An tidotes, for opioids, 395 An ti-dsDNA an tibody test, 966 An tidysrh yth m ic m edication s, 807

effects in surgical patien t, 218b An tiem etics, 701, 702b An tiestro gen s, for m align an cy, 618b An tifun gals

adverse effects of, 983t for HIV, 981

An tih istam in es, 739, 740b, 888, 888b An tih yperten sive m edication s, 801,

801–802b effects in surgical patien t, 218b

An tiin fective m edication s for ears, 888, 888b for eyes, 884, 884b for HIV, 981

An tiin flam m atory m edication s for eyes, 884, 884b for HIV, 981

An tilipem ic m edication s, 809, 809b An tim etab olite m edication s, 617, 617b An tim icrobials, for in flam m atory bowel

disease, 701, 701b An tim yasth en ic m edication s, 923, 924b An tim ycobacterials, adverse effects of, 983t An tin eoplastic m edication s, 614, 614b,

619b adverse effects of, 614 alkylatin g, 616, 616b an aph ylactic reaction to, 616 an tim etabolite m edication s, 617, 617b an titum or an tibio tic m edication s, 617,

617b descriptio n of, 614, 615f h ealth prom otion an d m ain ten an ce

an d, 615 h orm on al m edication s an d en zym es,

618, 618b im m un om odulator agen ts: biological

respon se m odifiers, 619, 619b m itotic in h ibitor m edication s, 618, 618b ph ysiological in tegrity an d, 614 poten tially n eph rotoxic, 822b psych osocial in tegrity an d, 615 safe an d effective care en viron m en t

an d, 615 targeted th erapy, 619 topoisom erase in h ibitors, 618, 618b

An tin uclear an tibody (ANA) determ in ation , 966

An tiparkin son ian m edication s, 924, 925b An tiplatelet th erapy, for an gin a, 773 An tipsych otic m edication s, 1049, 1049b

n euroleptic m align an t syn dro m e due to, 1050

side an d adverse effects of, 1050b An tipyretics, for in creased in tracran ial

pressure, 900b An tiretroviral m edication s, for HIV/ AIDS,

520 An tirh eum atic drugs, 514b An tiseizure m edication s, 926, 926–927b,

926t for in creased in tracran ial pressure,

900b An tiseptics, urin ary tract, 850, 851b An tisocial person ality disorder, 1012 An tispasm odics, 852, 852b An tith ym ocyte globulin , 982

equin e, 854 An tith yroid m edication s, 654, 654b An titum or an tibiotic m edication s, 617,

617b An titussives, 741, 741b An tiviral m edication s

for HIV, 981 for in fluen za, 748, 748t

An trectom y, 677 An us

assessm en t of, 187 in n ewborn , 375

im perforate, 449, 449b

An xiety, 1000, 1001b in Freud’s th eory, of psych osexual

developm en t, 260 gen eralized an xiety disorder, 1001 separation of

in h ospitalized adolescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch oo l-age ch ild, 266

Aorta, coarctation of, 482 Aortic an eurysm s, 785, 786f Aortic in sufficien cy, 779, 779t Aortic sem ilun ar valve, 755 Aortic sten osis, 481, 779, 779t Apgar scorin g system , 372, 373t Aph asia, in stroke, 910 Aph eresis, for stem cell h arvestin g, 584 Apical h eart rate

of adolescen t, 273b of n ewborn an d in fan t, 268b of presch oo ler, 271b of sch oo l-age ch ild, 272b of toddler, 270b

Aplastic an em ia, 413 Aplastic crisis, in sickle cell an em ia, 412b Apn eustic respiration , 897b Appearan ce, in m en tal status exam , 171 Appen dectom y, 445 Appen dicitis, 689

in ch ildren , 445 Appen dicular skeleton , 937 Apraxia, in stroke, 910b aPTT. See Activated partial th rom boplastin

tim e ( aPTT) Aqueous h um or, 862 ARBs. See An gioten sin II receptor b lockers

( ARBs) ARC. See Am erican Red Cross ( ARC) Arm , periph eral sites in , 147, 147f Arom ath erapy, 39b Arterial blood gases ( ABGs), 102, 711

in acid-base im balan ces, 103, 103t an alysis of resu lts in , 104b co m pen sation an d, 103 n orm al values for, 102t specim en collection fo r, 102, 102b

Arterial disease, periph eral, position in g clien ts in , 233

Arterial disorders, 783, 784f Arterial pressure, 756 Arterial vascular graftin g, positio n in g clien ts

in , 233 Arteries

an atom y an d ph ysiology of, 757 co ron ary

an atom y an d ph ysiology of, 756, 756f ath erectom y of, 762 bypass graftin g of, 762, 763f disease of, 770, 771f laser-assisted an gioplasty, 761 percutan eous tran slum in al coron ary

an gioplasty of, 761, 761f sten ts, 762

periph eral assessm en t of, 181b disease of, 783, 784f

1092 INDEX

Arteries ( Continued) revascularization , 762

Arteriolar vasodilators, direct-actin g, 807, 807b

Arterioles, 757 Arterioven ous fistula, for h em odialysis,

829–830, 829f Arterioven ous graft, for h em odialysis, 829f,

830 Arterioven ous sh un t, extern al, for

h em odialysis, 828, 829f Arth ritis, rh eum atoid, 949, 949b, 961f

m edication s for, 960, 960b, 961f Arth rocen tesis, 938 Arth rodesis, 950 Arth roplasty, 950 Arth roscopy, 939 Artificial skin , for burn in jury care, 561b Asch off bodies, with rh eum atic fever, 485 Ascites, 681 ASD. See Atrial septal defect ( ASD) ASDs. See Autism spectrum disorders

( ASDs) Asian Am erican s, 34

en d-o f-life care an d, 38 Asperger syn drom e, 505 Aspiration

as com plication , of gastroin testin al tube feedin gs, 241

m econ ium , in n ewborn , 381 n eedle, of th yroid tissu e, 628 pn eum on ia associated with , 466

Aspirin , 928b poison in g in ch ildren , 452 Reye’s syn drom e an d, 503 side/ adverse effects of, 929b

Assault as legal risk, 47 sexual, 1037

Assem bly of God, dietary preferen ces in , 33b

Assessm en t of adult clien t, 171–191, 171b body system s assessm en t, 172.

See also Body system s assessm en t docum en tation of fin din gs, 187,

188b in em ergen cy departm en t, 71 en viron m en t/ settin g fo r, 171 h ealth h istory in , 171 m en tal status exam in , 171, 172b ph ysical exam in , 172

tech n iques for, 172 vital sign s in , 172

question s on exam in ation asso ciated with , 24, 24b

strategic words associated with , 22b types of, 172b words, on exam in ation , 22b

Assign m en ts process of, 66 qu estion s on exam in ation regardin g, 28,

28b Assim ilation , in Piaget’s th eory, 257 Assist-con trol ven tilation , 716 Asterixis, 682, 682f

Asth m a, 720, 721f, 722b in ch ildren , 467, 468–469b laboratory tests in diagn osis of, 468b precipitan ts triggerin g, 468b respiratory acidosis due to, 99b triggers of, 721b

Astigm atism , 863 Ataxic respiration , 897b Atazan avir, 980 Atelectasis

postoperative, 220, 221f respiratory acidosis due to, 99b

Ath erectom y, 762 Ath erosclerotic coron ary artery, 771f Ato m , 79b Ato n ic seizure, 908b Ato p ic derm atitis, in ch ild, 404, 405b Atresia

esoph ageal, 441, 442f tricuspid, 483

Atrial fibrillatio n , 765, 765f Atrial septal defect ( ASD) , 481, 481b Atrioven tricular ( AV) can al defect, 481 Atrioven tricular ( AV) n ode, 755 Atrioven tricular valves, 755 Atrium , 755 Atropin e toxicity, 884 ATT. See Auth orization to Test (ATT) Atten tion , in differen tiatin g delirium ,

depression , an d dem en tia, 283t Atten tion -deficit/ h yperactivity disorder

(ADHD) , 505 m edication s for, 1051, 1051b

Atten tion span , in m en tal status exam , 172b Attitud e, in labor an d birth , 332 Audio question s, 8–9, 10f Audiom etry, 869 Audit, in quality im provem en t, 63 Auditory assessm en t, 176 Auscultation , 172

abdom in al, 182 in h eart assessm en t, 181, 181f in lun g assessm en t, 178, 179f

Auth orization to Test ( ATT) , 18 form , 10

Autism spectrum disorders ( ASDs) , 505 Autocratic leadersh ip, 60 Autogen ic train in g, 38 Autograft, position in g clien ts with , 230 Autograftin g, for b urn in jury, 561, 561b Autoim m un e disease

pem ph igus, 972 polyarteritis n odosa, 971 scleroderm a, 971 system ic lupus eryth em atosus, 970 system ic sclerosis, 971

Autologous, for stem cell h arvestin g, 584 Autologous blood don ation , 159 Autom ated extern al defibrillator ( AED),

768 Autom ated im plan table cardioverter-

defibrillator (AICD) , 769 Autom ated periton eal dialysis, 832, 832b Auton om ic dysreflexia, 905

m an ifestatio n of, 906b position in g clien ts with , 233

Au ton om ic dysreflexia ( Continued) in spin al cord in jury, 906b

Au ton om ic n ervous system , 894 assessm en t of, 897 role in cardiovascular fun ction , 756

Au ton om y, 45 Avascular n ecrosis, 944 Aversion th erapy, 993 Avian in fluen za A ( H5N1), 724 Avoidan ce, in con flict resolution , 64 Avoidan t person ality disorder, 1012 Awaren ess, in Freud’s th eory, of

psych osexual developm en t, 259 Axial skeleton , 937 Axillary lym ph n odes, 182 Axon s, 894 Ayurved a, 38 Azath ioprin e, 854, 961, 982

for atopic derm atitis, 570b Azelaic acid, 574

B Babin ski reflex, 897b Babin ski sign , in n ewborn , 378 Bach elor of Scien ce in Nursin g ( BSN), 18 Bacillus anthracis, 197 Bacillus Calm ette-Gu erin ( BCG) vaccin e,

728 Backach e, in pregn an cy, 304 Backward failure, of h eart, 774 Baclofen , 907, 958, 959b Bacteria, urin ary, an tiseptics for growth

in h ibition of, 850, 851b Bacterial in fection

of am n iotic cavity, 315 croup, 463, 464f im petigo, 404 m en in gitis, 502 pn eum on ia, 466–467 pyelon eph ritis, durin g pregn an cy, 324

Bacterial vagin osis, durin g pregn an cy, 325 Balan ced suspen sion traction , 942f, 943 Ballard scale, 372 Balloon valvu loplasty, 779 Barbiturates, 926, 1048, 1048b Bariatric surgery, 678, 679b, 679f Barium swallow, 672 Barlow’s test, 511 Baroreceptors, 756 Barrier protection , 196 Basal cell carcin om a, 549, 549t Basal gan glia, 893 Bases, 97. See also Acid-base balan ce Basic care an d com fort, subcategories on

exam in ation , 4t, 5–6, 6b Basilixim ab, 854, 982 Bath in g, o f n ewborn , 379 Battery, as legal risk, 47 Baxter resuscitation form ula, 558t Bed boards, for proper position in g, 235b Bed position s, 230f Beh avior th erapy, 993 Beh aviors

abusive, 1033 in atten tion -deficit/ h yperactivity

disorder, 505

1093INDEX

Beh aviors ( Continued) with bipolar disorder, 1005b in deh ydration , pediatric, 431t of effective leader an d m an ager, 61b in m en tal status exam , 171 substan ce abuse disorders, 1021 suicidal, 1031, 1032b

Bell’s palsy, 914 Ben eficen ce, 45 Ben ign prostatic h ypertroph y, 842,

842–843f Ben zodiazepin es, 927, 1047, 1048b Ben zoyl peroxide, 573, 573b Betam eth ason e, 394 Beth an ech ol ch loride, 852 Bexaroten e, 619 Bicarbon ate

in acid-base balan ce, 97, 98f n orm al values of, 102t ren al regulation of, 98 value ch an ges in acid-base im balan ces,

103, 103t Biceps reflex, durin g pregn an cy, 322b Bicuspid ( m itral) valve, 755 Bile acid sequestran ts, 700, 700b Bile duct, com m on , 672 Bile sequestran ts, 809 Bilevel positive airway pressure ( BiPAP),

712, 716, 716f Biliary obstruction , 680 Bilirubin

assessm en t of, in n ewborn , 376 in h yperbilirubin em ia, 382

Bill of Righ ts, Clien t’s, 47, 48b Billroth I pro cedure, 594b, 677, 677f Billroth II procedure, 594b, 677, 677f Biofeedback, 38 Biological dressin g, 553t Biological respon se m odifiers, 619, 619b Biological warfare agen ts, 197, 197–198f,

197b Biologically based practices, 38, 39b Bioph ysical profile, in pregn an cy, 307 Bioprosth etic valves, 780 Biopsy

of bladder, 821 bon e or m uscle, 940 for can cer diagn o sis, 581 liver, 675

position in g clien ts an d, 232, 232b lun g, 711 ren al, 821 skin , 545

Biosyn th etic, for burn in jury, 561b Bioterrorism , 199 BiPAP. See Bilevel positive airway pressure

(BiPAP) Bipolar disord er, 1004, 1004b Birth can al, 291 Birth co n trol, 295 Birth traum a, 373 Birth m arks, 375, 375t Bish op score, 340, 340t, 395–396 Bisph osph on ates, 962 Bites an d stin gs, 547 Black coh osh , 39b

Black widow spider bite, 547 Bladder

an atom y an d ph ysiology of, 818 can cer o f, 600

m etastatic, 581b con tin uous irrigation , 599 en uresis an d, 493 exstroph y, 495 as radiation th erapy side effect, 422t traum a of, 842

Bladder con trol in presch ooler, 271 in toddler, 270, 270b

Bladder exstroph y, 495 Bladder ultrason ograph y, 820 Bleed in g

assessm en t in dark-skin n ed clien t, 173 gastroin testin al, with ch ron ic kidn ey

disease, 824b, 825 with leukem ia, 420, 421b, 580b, 586,

606b postoperative, 221 postpartum , 364, 365b, 365f from woun d, 545b

Bleedin g disord ers h em oph ilia, 413, 414–415b von Willebran d’s disease, 414

Bleom ycin , 617 Blin d spot, 861 Blin dn ess, legal, 864 Block

lum bar epidural, 339 subarach n oid, 339

Blood clean in g spills of, 196 pediatric disorders of

aplastic an em ia, 413 β-Th alassem ia, 414, 414b h em oph ilia, 413, 414–415b iron deficien cy an em ia, 412, 413b sickle cell an em ia, 411, 412b, 412f von Willebran d’s disease, 414

Blood ban k precaution s, 160b Blood coagulation factors, 757

h em oph ilia due to deficien cy of, 413 Blood glucose

cardio vascular testin g of, 758 in diabetes m ellitus, pediatric, 433 in diabetic keto acidosis, 435 in h yperglycem ia, pediatric, 434 in h ypoglycem ia, pediatric, 434 in n ewborn , with h yp oglycem ia, 386

Blood glucose level, self-m on itorin g of, 639, 639b

Blood glucose m on itorin g in diabetes m ellitus, 433, 433b lessen in g pain of, 433b

Blood pressure (BP) , 110 of adolescen t, 273b cardiac surgical un it postoperative

m on itorin g of, 763 con trol of, 756 in deh ydration , pediatric, 431t factors affectin g, 111 in h yperten sion , 787 of n ewborn , 373

Blood pressure ( BP) ( Continued) of n ewborn an d in fan t, 268b in postpartum vital sign s, 357t in preeclam psia, 321t of presch ooler, 271b of sch oo l-age ch ild, 272b of toddler, 270b

Blood pressure m edication s, for in creased in tracran ial pressure, 900b

Blood products adm in istration , 158–168, 158b

blood warm ers in , 159 co m patibility in , 159, 159t, 160b co m plication s of, 160, 161–163b cryoprecipitates, 158 fresh -frozen plasm a, 158 gran ulocytes, 159 in fusion pum ps for, 159 packed red blood cells, 158 platelet, 158 precautio n s an d n ursin g respon sibilities

in , 160, 160b, 161f reaction s to, 160, 162b types of don ation s, 159

Blood salvage, 159 Blood specim en collection , potassiu m

im balan ces an d, 84 Blood supply, to brain , 894 Blood tran sfusion , con sen t for, 49b Blood type, in an tepartum diagn ostic

testin g, 305 Blood urea n itrogen (BUN) , 118, 758, 819 Blood vessels, ocular, 862 Blood warm ers, 159 Bloodborn e m etastasis, 580 Blue spells, 482, 484b BMI. See Body m ass in dex ( BMI) BMT. See Bon e m arrow tran splan tation

(BMT) BNP. See B-type n atriuretic peptide ( BNP) Body-based practices, 38 Body fluid , 79. See also Fluid an d electrolyte

balan ce co m partm en ts of, 78, 79f co n stituen ts of, 79 in take an d output of, 81, 81f m o vem en t of, 80 th ird-spacin g of, 78 tran sport of, 79

Body im age ch an ges in , durin g pregn an cy, 302 disturb ed, with rh eum atoid arth ritis, 950

Body lan guage, in m en tal status exam , 171 Body m ass in dex ( BMI) , 130 Body m easurem en ts, of n ewborn , 373 Body m ech an ics, position in g clien ts an d,

230b Body surface area ( BSA)

calculatin g ped iatric, 538–539, 539b, 539f

ch em oth erapy dosin g based on , 614 Body system s assessm en t, 172

abdom en , 182 breasts, 181 ears, 175, 177b eyes, 174, 175f, 175b

1094 INDEX

Body system s assessm en t ( Continued) fem ale gen italia an d reproductive tract,

186 h ead, n eck, an d lym ph n odes, 173 h eart an d periph eral vascular system ,

180, 181f, 181b in tegum en tary system , 172, 173t, 173b lun gs, 178, 178b, 179f, 180b, 180t m ale gen italia, 186 m usculoskeletal system , 183, 183t, 183b n eurological system , 183, 184t, 186b in n ewborn , 376, 378f n ose, m outh , an d th roat, 177 rectum an d an us, 187

Body tem p erature, 108 con version of, 109b

Body weigh t calculatin g pediatric dosages by, 538,

538b percen tage of body fluid, 79

Bon e m arrow suppression , as radiation th erapy side effect, 422t

Bon e m arrow tran splan tation (BMT) , 584 Bon e m in eral den sity m easurem en t, 939 Bon e scan , 939 Bon es

biopsy of, 940 ch aracteristics of, 937 growth o f, 937 h ealin g of, 938, 938f osteosarcom a of, 424 types, 937

Borderlin e person ality disorder, 1012 Bordetella pertussis, 524 Borrelia burgdorferi, 972 Botulism , 198 Bowel, perforation of, 674b Bowel con trol

in presch ooler, 271 in toddler, 270, 270b

Bowel elim in ation , in dyin g clien t, 276b Bowel soun ds, assessm en t of, 182 Bowm an ’s capsule, 817 Bracelets, in form ation , in n ewborn , 379 Braces, for scoliosis, 513 Brach yth erapy, 583 Bradycardia

fetal, 335 sin us, 756, 764

Brain an atom y an d ph ysiology of, 893 can cer of, m etastatic, 581b tum ors of, pediatric, 424, 425b

Brain attack, 909, 909f, 910b position in g clien ts in , 234

Brain traum a, respiratory acidosis due to, 99b

Brain stem , 893 in volvem en t in pediatric h ead in jury,

501b Breach of duty, 46 Breast

can cer of, 591, 592f m etastatic, 581b

discom fort, from en gorgem en t, 358 m astitis, 366, 366f

Breast ( Continued) ph ysiological m atern al ch an ges of, 302

in postp artum period, 356, 357b ten dern ess, 303

Breast-feedin g en gorgem en t in , 357, 357b in n ewborn , 377

paren t teach in g, 379, 379f n utrition an d, 268 in postpartum period, 358 procedure in , 359b

Breast self-exam in ation ( BSE) , 591, 592f Breasts, assessm en t of, 181 Breath so un ds

abn orm al, 178, 180t in asth m a, 468 n orm al, 178

Breath in g, preoperative, 216, 216b Breath in g retrain in g, 712b Breath in g tech n iques, fo r labor an d

delivery, 335, 335b Breech presen tation , in labor an d birth , 332 Bricker’s procedure, 601 Bron ch i, m ain stem , 708 Bron ch iectasis, 99b Bron ch ioles, 708 Bron ch iolitis, 465 Bron ch itis

in ch ildren , 465 respiratory acidosis due to, 99b

Bron ch odilators, 737, 738b for cystic fibrosis, 471

Bron ch ogen ic can cer, 596 Bron ch oph on y, 180b Bron ch oprovocation testin g, 468b Bron ch opulm on ary dysplasia, in n ewborn ,

381 Bron ch oscopy, 232, 710 Bron ze baby syn drom e, 383 Brown recluse spider b ite, 547 Brown -S equard syn drom e, 903, 903f Brudzin ski’s sign , 186, 502, 898b, 915, 915f BSA. See Body surface area ( BSA) BSE. See Breast self-exam in ation ( BSE) BSN. See Bach elor of Scien ce in Nursin g

(BSN) B-type n atriuretic peptide ( BNP), 758 Bubon ic plague, 198 Buck’s traction , 942, 942f Buddh ism

dietary preferen ces in , 33b en d-of-life care an d, 37

Buerger’s disease, 785 Bulim ia n ervosa, 1019 Bulk-form in g laxatives, 701, 702b Bullyin g, 1033 BUN. See Blood u rea n itrogen ( BUN) BUN/ creatin in e ratio, 819 Bun dle of His, 756 Bureaucratic leadersh ip, 61 Burn in jury, 544b, 554, 554b, 562b

age an d gen eral h ealth an d, 556 ch em ical, ocular, 867, 868b in ch ild, 407, 407b, 408f full-th ickn ess, 555, 556f

deep, 556, 556f

Burn in jury ( Continued) in h alation in juries, 556 locatio n of, 556 m an agem en t of, 557, 558t path oph ysiology of, 557 position in g clien ts with , 230 priority n u rsin g action s, 554b rule of 9 for estim ation , of burn

percen tage, 555f size of, 554 superficial partial-th ickn ess, 554, 555f superficial-th ickn ess, 554, 555f

Busulfan , 616 Butorph an ol tartrate, 395 Butterfly sets, 144 Bypass graftin g, coron ary artery, 762, 763f Bypass surgery, for periph eral arterial

disease, 784f

C Cadaver don ors, kidn ey, 834 Calcipotrien e, 571, 571b Calciton in -salm on , for osteoporosis, 961 Calcium

as an tacids, 699t cardiovascular testin g of, 758 diet for h igh in take of, 129 disorders in , m edication to, 655b food sources of, 87b, 125b h ypocalcem ia an d, 86, 87b, 88t, 88f.

See also Hypocalcem ia n orm al value of, 87b for osteoporosis, 961

Calcium can aliculi, 839b Calcium ch an n el blockers, 806, 806b Calculation

of correct dosage, 207 of pediatric body surface area, 538, 539b,

539f pediatric m edication , 536–542 percen tage an d ratio solution s in , 208 ph arm acological, 29 stan dard fo rm ula for, 208b

Caloric testin g, of n euro logical system , 896 Calorie, d iet for h igh in take of, 128 Calorie in take, postpartum , 358 CAM. See Com plem en tary an d altern ative

m edicin e ( CAM) Can al of Sch lem m , 862 Can alicu li, ren al, 838, 839b

treatm en t option s for, 839, 840f Can cer, 580

an tin eoplastic m edication s for, 614 bladder, 600 breast, 591, 592b, 592f cervical, 589, 589b ch em oth erapy for, 582 classification of, 580 colorectal, 595 diagn ostic testin g of, 581, 581b early detection of, 581, 581b en dom etrial, 591 esoph ageal, 593 factors in fluen cin g developm en t of, 580 gastric, 593, 594b gradin g an d stagin g of, 580, 581b

1095INDEX

Can cer ( Continued) laryn geal, 597, 597f lun g, 596 m etastatic, 580, 581b ovarian , 591 pain con trol in , 582 pan creatic, 594, 595f preven tion of, 581, 581b prostate, 598 radiation th erapy for, 583, 583b skin , 549, 549t surgery in , 582 testicular, 588, 589f uterin e, 591 warn in g sign s of, 581b

Candida albicans in tegum en tary, 545 in vagin al can didiasis, 325

Can didate perform an ce report, followin g failure of exam in ation , 13

Can didiasis, vagin al, durin g pregn an cy, 325 Can es, 945 Can n ulas

in traven ous, 144 n asal, 465t

Can tor tube, 240f, 242 CAPD. See Con tin u ous am bulato ry

periton eal dialysis ( CAPD) Capillaries, 757 Capillary fillin g tim e, 173b Capreom ycin sulfate, 745 Capsule en doscopy, 672 Capsules, 206 Caput succedan eum , 373 Car safety seats, guidelin es an d, 268 Carbam ide peroxide, 889 Carbidopa-levodopa, 925 Carboh ydrates

diet for co n sisten t in take of, 128 m etabolic acidosis due to in sufficien t

m etabolism of, 101b n utrition an d, 124 in paren teral n utrition , 134

Carbon dioxide ( CO 2), partial pressure of n orm al ran ge of, 102t value ch an ges in acid-base im balan ces,

103, 103t Carbon m on oxide poison in g, 556, 557t Carbon ic acid, 818 Carbon ic acid-bicarbon ate system

in acid-base balan ce, 97 m etabolic alkalosis an d, 101 respiratory alkalosis an d, 100

Carbon ic an h ydrase in h ibitors, 885b, 886 Carboprost trom eth am in e, 398 Carcin ogen , 580 Cardiac cath eterization , 760, 760f

in an gin a, 772 in ch ildren , 484 in coron ary artery disease, 771 position in g clien ts in , 233

Cardiac diet, 127, 127b Cardiac disease, in p regn an cy, 314, 315b Cardiac dysrh yth m ias, 764, 765–766b,

765–767f m an agem en t of, 767

Cardiac dysrh yth m ias ( Continued) m edication s for, 807

Cardiac glycosides, 800 Cardiac m arkers, 757 Cardiac output

in atrial septal defect, 481b h eart rate an d, 756, 764 sign s an d sym ptom s of, 481b

Cardiac tam pon ade, 764, 778 Cardiogen ic sh ock, 776, 777f Cardiom yopath y, 780, 781t Cardiopulm on ary resuscitation (CPR)

for adults, 767 guidelin es of, for in fan ts, 387

Cardioton ic m edication s, 799, 800f, 800b Cardiovascular defects, in terven tion s for,

484 Cardiovascular disorders

o f adult clien t, 754 in ch ildren , 479–490

aortic sten osis, 481 atrial septal defect, 481, 481b atrioven tricular can al defect, 481 cardiac cath eterization , 484 coarctation of aorta, 482 defects with decreased pulm on ary

blood flow, 482 defects with in creased pulm on ary

blood flow, 481 h eart failure, 479, 480b h ypoplastic left h eart syn drom e, 483 in terven tion s for, 484 Kawasaki disease, 486, 487b m ixed defects, 483 obstructive defects, 481 paten t ductus arteriosus, 481 pulm on ary sten osis, 482 rh eum atic fever, 485, 486b, 486f surgery for, 485 tetralogy of Fallot, 482 total an om alous pulm on ary ven ous

con n ection , 483 tran sposition of great arteries/ vessels,

483 tricuspid atresia, 483 trun cus arteriosu s, 483 ven tricular septal defect, 481

Cardiovascular fin din gs, in liver dysfun ction , 681f

Cardiovascular m edication s, 797–814, 810b

adren ergic agon ists, 808, 808b adren ergic blockers, 803, 803b β-adren ergic blockers, 805, 805b an gioten sin -con vertin g en zym e (ACE)

in h ibitors, 803, 803b an gioten sin II receptor blockers (ARBs),

803, 803b an tian gin al m edication s, 804, 804b an ticoagu lan ts, 797, 798b an tidysrh yth m ic m edication s, 807 an tih yperten sive m edication s, 801,

801–802b an tilip em ic m edication s, 809, 809b an tiplatelet m edication s, 799, 799b calcium ch an n el blockers, 806, 806b

Cardiovascular m edication s ( Continued) cardiac glycosides, 800 cen trally actin g sym path olytics, 803,

803b diuretics, 801, 801–802b periph erally actin g α-adren ergic blockers,

802, 803b positive in otropic an d cardioton ic

m edication s, 799, 800f, 800b th rom b olytic m edication s, 799, 799b vasod ilators

direct-actin g, arteriolar, 807, 807b m iscellan eous, 807 periph eral, 806, 806b

Cardiovascular system , 755–796 acidosis m an ifestation s in , 100t alkalosis m an ifestation s in , 101t an aph ylaxis m an ifestation s in , 968f an atom y an d ph ysiology of, 755 assessm en t of, in n ewborn , 376 ch an ges in , with agin g, 281 ch ron ic kidn ey disease m an ifestation in ,

824b diagn ostic tests an d procedures, 757 disorders of

an gin a, 772 aortic an eurysm s, 785, 786f arterial, 783, 784f cardiac dysrh yth m ias, 764, 765–766b,

765–767f cardiac tam pon ade, 764, 778 cardiogen ic sh ock, 776, 777f cardiom yopath y, 780, 781t coron ary artery disease, 770, 771f diagn ostic tests an d procedures, 757 em bolectom y for, 786 h eart failure, 774, 775b, 775t h yperten sion , 787, 789b h yperten sive crisis, 788 in flam m atory, 777, 779b m yocardial in farction , 773, 774b pacem akers for, 769, 770b th erapeutic m an agem en t of, 758b, 761,

761f, 763f, 764b valvular, 779, 779–780t, 780b vascular, 781, 782b ven a cava filter an d ligation for, 787,

787f fluid volum e deficit an d excess fin din gs

in , 82t h ypocalcem ia an d h ypercalcem ia

fin din gs in , 88t h ypokalem ia an d h yperkalem ia fin din gs

in , 84t h ypom agn esem ia an d h yperm agn esem ia

fin din gs in , 90t h ypon atrem ia an d h ypern atrem ia

fin din gs in , 87t in terven tion s in spin al cord in jury, 905 m edication s for, 797–814, 810b ph ysiological m atern al ch an ges in , 300,

301f position in g clien ts in , 233 postoperative care of, 219, 219f

Cardioversion , 768 Carditis, in rh eum atic fever, 486f

1096 INDEX

Carin g, as In tegrated Process subcategories, 6–7

Cariso prodol, 958, 959b Carotid artery, assessm en t of, 181 Carotid sin us m assage, 767 Cartridge, prefilled m edication , 207 Case m an agem en t, 59 Case m an ager, 59 Case m eth od, n ursin g, 60 Casts, 943

in ch ildren , 516 CAT. See Com puter adaptive testin g ( CAT) Cataracts, 864, 864f, 865b

surgery for, position in g clien ts in , 233 Catato n ic posturin g, in sch izoph ren ia,

1008 Catech ol-O-Meth yltran sferase ( CO MT)

in h ibitors, for Parkin so n ’s disease, 925b

Catech olam in es, urin ary, n orm al values of, 629

Cath eter/ cath eterization cardiac, 760, 760f

in an gin a, 772 in ch ild ren , 484 in coron ary artery disease, 771 position in g clien ts in , 233

epidural, 153, 153b, 153f fem oral, 152f for h em odialysis, 828 Hickm an , 152f in fection at site of, 136b for paren teral n utrition , 134, 135f for periton eal dialysis, 831f subclavian , 152f urin ary, 243, 244b of urin ary stom a, 603b

Cath eter em bolism , 149, 149t Cath olic Ch urch , organ don ation an d

tran splan tation an d, 49 Cath olicism

dietary preferen ces in , 33b en d-o f-life care an d, 37b

Cation , 79b Caucasian Am erican , 36 Cauda equin a syn d rom e, 903f, 904 CBI. See Con tin uo us b ladder irrigation

( CBI) CD4+ lym ph ocyte coun t, in HIV/ AIDS, 522t Celiac crisis, 445 Celiac disease, 444 Cell cycle, an tin eoplastic m edication s, 614,

615f Cellular respon se, 966 Cellulitis, 547 Cen tral cord syn drom e, 903, 903f Cen tral n ervous system

h ypom agn esem ia an d h yperm agn esem ia fin din gs in , 90t

h ypon atrem ia an d h ypern atrem ia fin din gs in , 87t

Cen tral n ervous system depressan ts, 1023 in toxication , 1023b respiratory acidosis due to, 99b

Cen tral n ervous system stim ulan ts, 927, 927b, 1024

Cen tral n ervous system stim ulan ts ( Continued)

in toxication , 1024b Cen tral ven ous cath eters

access sites for, 152f in fection at site of, 136b for in traven ous th erapy, 152, 152f for paren teral n utrition adm in istration ,

134, 135f periph erally in serted, 134, 135f, 152f,

153 tun n eled, 152, 153f vascular access ports for, 153

Cen tral ven ous pressure (CVP) , 776 Cen tralization , 62 Cen trally actin g sym path olytics, 803, 803b Ceph alh em atom a, 373 Ceph alic presen tation , in labor an d birth ,

332 Ceph alosporin s, adverse effects of, 983t Cerebellar fun ction , assessm en t of, 185 Cerebellum , 893 Cerebral an eurysm , 907, 908b

position in g clien ts with , 234 Cerebral an giograph y, 896

position in g clien ts in , 234 Cerebral cortex, 893, 894b Cerebral palsy, 499, 500f Cerebrospin al fluid ( CSF) , 894

im balan ce in h ydroceph alus, 501 Cerebrum , 893 Cerum en , 875 Cerum in olytic m ed ication , 889 Cervical cerclage, 323 Cervical co llar, 947 Cervical disk h ern iation , 946 Cervical in traepith elial n eoplasia, 589b Cervical skin traction , 941 Cervical spin e in juries, 904

in terven tion s for, 906 traction for, 904, 904f, 906, 907b

Cervix, 291 can cer of, 589 dilation of, in labor an d birth , 337, 338t in com peten t, in pregn an cy, 323 ph ysiological m atern al ch an ges of, 301

in postpartum period, 356 ripen in g of, prostaglan din s for, 395

Cesarean delivery, 341 CF. See Cystic fibrosis ( CF) Ch an ge

process of, 63, 63f, 64b of sh ift report, 65

Ch aplain , roles of, 65 Ch arism atic th eory, of leadersh ip an d

m an agem en t, 60b Ch art/ exh ibit question s, 8, 9b, 20 Ch ecklist, preo perative, 216, 217b Ch elation th erapy, 452 Ch em ical burn , ocular, 867, 868b Ch em ical carcin ogen s, 580 Ch em ical restrain ts, 194 Ch em ical warfare agen ts, 199 Ch em istry pan el, 974b Ch em okin e recepto r 5 (CCR5) an tagon ist,

981

Ch em oth erapy, 582 for bladder can cer, 601 for leukem ia, in ch ildren , 421

Ch est assessm en t of, of n ewborn , 374 exam in ation of

in h eart assessm en t, 180 in lun g assessm en t, 178, 178b

Ch est in juries, 718 Ch est pain , 804b

m edication s for, 804, 804b Ch est ph ysioth erapy ( CPT), 712, 713f

for asth m a, 469 for cystic fibrosis, 471

Ch est radiograph , in asth m a, 468b Ch est tube, 246, 249–250f Ch est x-ray, in cardiovascular assessm en t,

758 Ch est x-ray film , 709 Ch eyn e-Stokes respiration , 897b Ch icken pox, 524, 524f Ch ief com plain t, 171 Ch ild abduction , 1035 Ch ild abuse, 1035, 1036b Ch ildren

eczem a in , 405b grief in , 1031b in creased in tracran ial pressure in , 420b protection from bleedin g, 421b

Ch iropractic m an ipulation , 38 Chlamydia, in fection of, pregn an cy an d, 324 Chlamydia pneumoniae, 466 Chlamydia trachomatis, 399 Ch lam ydial in fection , in pregn an cy, 305,

306t Ch loasm a, 302 Ch loram bucil, 616, 616b Ch lordiazepoxide, 1022 Ch loride

food sources of, 125b quan titative sweat test, 470b sh ift, 97

Ch lorzoxazon e, 959, 959b Ch olan giopan creatograp h y, en doscopic

retrograde, 674 Ch olecystectom y, 680 Ch olecystitis, 680, 680b Ch oledoch olith otom y, 680 Ch olelith iasis, 680 Ch olesteatom a, 874 Ch olesterol, m edication s for reduction of,

809 Ch olin ergic agon ists, for eye disorders,

885b Ch olin ergic crisis, 924b

in m yasth en ia gravis, 912 Ch olin ergics, 852 Ch orea, in rh eum atic fever, 486f Ch orioam n ion itis, in p regn an cy, 315 Ch orion , 294 Ch orion ic villus sam plin g, 307 Ch oroid, 861 Ch ristian ity, en d-of-life care an d , 37b Ch ristm as disease, 413 Ch ron ic kidn ey disease, 823, 824b, 824t,

825f

1097INDEX

Ch ron ic obstructive pulm on ary disease, 721, 722–723f

clien t education in , 723b clien t position in g, 723f position in g clien ts with , 232

Ch ron ic pan creatitis, 686 Ch urch of God, dietary preferen ces in , 33b Ch urch of Jesus Ch rist of Latter-day Sain ts

dietary preferen ces in , 33b en d-of-life care an d, 38

Ch vostek’s sign , 88f, 636 Ciliary body, 861 Cim etidin e, 698 Ciprofloxacin , 851, 851b Circle of Willis, 894 Circulation

fetal, 294, 294f n ear-death ph ysiolo gical m an ifestation s

in , 275 Circulatory overload, 83

in blood products adm in istration , 162 in in traven ous th erapy, 149, 149t, 150f

Circum cision , care of, in n ewborn , 377, 380 Circum flex artery, 756, 756f Cirrh osis, 680, 681–682f Cisplatin , 616, 616b Citrate toxicity, 163 Civil law, 46b CK-MB ( creatin e kin ase, m yocardial

m uscle), 757 in m yocardial in farction , 773

Classical con dition in g, 993 Clean sin g breath , in labor an d birth , 335b Clear liquid diet, 126 Cleft lip an d palate, 440f Clien t an d fam ily teach in g

disch arge, 66, 66b as legal safegu ards, 53 settin g priorities for, 67

Clien t care, prioritizin g, 59–75, 59b Clien t education

in Addison ’s disease, 631 in autom ated im plan table cardioverter-

defibrillator ( AICD) , 769 in cardiac surgery, 764b in cataract su rgery, 865b in ch ron ic obstructive pulm on ary

disease, 723b in degen erative join t disease, 949b, 950 in dum pin g syn dro m e, 678b in guidelin es durin g illn ess, 642b in h alo fixation device, 907b in h earin g aids, 872b in h yperten sion , 789b in m yrin gotom y, 872b in pacem akers, 770b in rh eum atoid arth ritis, 949b in self-m on itorin g of bloo d glucose level,

639b in th rom boph lebitis, 367b in tuberculosis, 729b

Clien t h istory, of tuberculosis, 728 Clien t iden tity, in blood prod ucts

adm in istration , 160b Clien t in stru ction s

for cystitis, 836, 836b

Clien t in struction s ( Continued) for kidn ey tran splan tation , 835b

Clien t n eeds, question s on exam in ation an d, 4–6, 4t, 5–6b

test-takin g strategies, 26, 27b Clien t righ ts, 991b Clien t (Patien t) Self-Determ in ation Act, 53 Clien t teach in g

p ostpartum , 358 p reoperative, 216, 216b

Clien t-focused care, 60 Clien t’s righ ts/ Bill of Righ ts, 47, 48b, 50 Clin dam ycin , 573, 573b Clon azepam , 926t, 927 Clon us reflex, durin g p regn an cy, 322b Clorazepate, 927 Closed fracture, 940b Closed h ead in jury, 499, 500f, 901 Closed reduction , of fracture, 515 Closed-en ded word s, elim in ation of

option s co n tain in g, 28, 28b Clostridium difficile, h ealth care-associated,

195 Cloth in g, in n ewborn , 380 Clubfoot, con gen ital, 511, 511b, 513f Cluster respiration , 897b Coagulation factors, assessm en t of, 757 Coal tar, 571, 571b Coarctation of aorta, 482 Coch lea, 869 Coch lear im plan tatio n , 871 Code of Eth ics for Nurses, 44 Codein e, 929 Codein e sulfate, 114 Codepen den cy, 1021 Codes, eth ical, 44 Coercive power, 62b Cogn itive ability, exam in ation question s

an d, 4, 4b Cogn itive ch an ges

in early adulth ood, 274 in m iddle adulth ood, 274

Cogn itive developm en t, Piaget’s th eory of, 257

Cogn itive disorders, pediatric, 499–510 Cogn itive level of fun ction in g, assessm en t

of, 172b Cogn itive th erapy, 993 Cogn itive-beh avioral th erapies, 38 Colch icin e, 959–960 Cold stress, in n ewborn , 377, 378f Colitis, ulcerative, 687, 688b Collaboration , h ealth care team , 65 Collar, cervical, 947 Collateral circulation , 771 Collective bargain in g, 47 Colloids, 144, 145t Colon , 671 Colon ization , 527 Colon oscopy, fibero ptic, 673, 674b Colon y-stim ulatin g factors for m align an cy,

619, 619b Color vision , assessm en t of, 175 Colorectal can cer, 595

m etastatic, 581b Colostom y, 595

Colostom y irrigation , 688b Com a, m yxedem a, 634, 635b Com edon es, 550 Com fort, position in g clien ts for, 230 Com m in uted fracture, 940b Com m issurotom y, 780 Com m on bile duct, 672 Com m un icatin g h ydrocele, 448 Com m un ication

in African Am erican s, 32 in Am ish society, 34 approach es in , 267, 267b in Asian Am erican culture, 34 in autism spectrum disorders, 506 in dem en tia an d Alzh eim er’s disease,

1013 disturban ces in sch izoph ren ia, 1009,

1010b an d docum en tation , as in tegrated pro cess

subcategories, 6–7 facilitatin g with h earin g loss, 871b in Hispan ic an d Latin o Am erican

culture, 35 in m en tal h ealth n ursin g, 989 in Native Am erican cu lture, 36 operation al defin ition of, 989f question s about, 27, 27b th erapeutic an d n on th erapeutic

tech n iques in , 990b in wh ite Am erican culture, 36

Com m un ity-associated m eth icillin - resistan t Staphylococcus aureus ( CA-MRSA) , 527

Com pact bon e, 937 Com parable option s, elim in ation of, 27,

27b Com partm en t syn drom e, 516b, 944 Com patibility, in blood tran sfusion , 159,

159t, 160b Com pen sation

in acid-base balan ce, 98 in arterial blood gases, 103

Com pen sation defen se m ech an ism s, 991b

Com pen satory m ech an ism s, in h eart failure, 775

Com petition , in con flict resolution , 64 Com plem en tary an d altern ative m edicin e

(CAM), 38, 38–39b Com plem en tary an d altern ative th erapies,

for pain , 113, 113b Com plete abortio n , 315b Com plete assessm en t, 172b Com plete blood coun t, 757, 974b Com plete fracture, 940b Com plex partial seizure, 908b Com poun d fracture, 940b Com pression fracture, 940b Com prom ise, in con flict resolution , 64 Com pulsion s, 1002 Com pulsive beh avior, 1002, 1003b

in sch izoph ren ia, 1008 Com pulsive overeatin g, 1019 Com puted tom ograph y ( CT) , 674

electron -beam , of cardiovascular system , 760

1098 INDEX

Com puted tom ograph y ( CT) ( Continued) of eye, 862 of n euro logical system , 895 spiral ( h elical), 711

Com puter adaptive testin g (CAT) , 3–4 Com puterized m edical records,

con fiden tiality of, 52 Con crete operation al stage, of cogn itive

developm en t, 259 Con curren t ( “at th e sam e tim e”) audit, in

quality im provem en t, 63 Con cussion , 900b Con dition in g, in bon e m arrow

tran splan tation , 584 Con ductive h earin g loss, 176, 870, 870f Con ductivity, 756 Con dylom a acum in atum , in pregn an cy,

305, 306t, 325 Con es, ocular, 861 Con fiden tiality, 50, 51b

righ t to, 991 Con flict, 64 Con fron tation test, 174 Con gen ital agan glion osis, 446 Con gen ital clubfoot, 511, 511b, 513f Con gen ital h eart defects, 479b

cardiac cath eterization for diagn osis of, 484, 487b

Con ization , for cervical can cer, 590 Con jun ctivae, 862 Con n ’s syn drom e, 632 Con sciousn ess, in differen tiatin g delirium ,

depression , an d dem en tia, 283t Con sen t, 49, 49b

m in ors an d, 50 for organ don ation an d

tran splan tation , 48 before surgery, 215 types of, 49b

Con stipation in ch ildren , 448, 449b in irritable bowel syn drom e, treatm en t

for, 701, 702b postoperative, 222 in postpartum period, 358 in pregn an cy, 301, 304

Con sultation , with h ealth care team , 65 Con tact precautio n s, 197 Con tain ers, in traven ous, 145 Con tin uin g care n urse, 64 Con tin uous am bulatory periton eal dialysis

( CAPD) , 832 Con tin uous bladder irrigation ( CBI) , 599,

600b Con tin uous positive airway pressure

( CPAP) , 712, 717t Con tin uous ren al replacem en t th erapy

( CRRT) , 833, 833b Con traception , 295 Con traceptive patch es, 658 Con traceptives, 658

oral, for acn e vulgaris, 573 Con tract law, 46b Con tractility, 756, 764

m yocardial, m edication s for stim ulation of, 799

Con traction stress test, 309b Con traction s

in lab or an d birth , 332 of m uscle, 937

Con tracts, em ployee, 45 Con trol, loss of

in h ospitalized adolescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch oo l-age ch ild, 266

Con trol surgery, for can cer, 582 Con trolled substan ces, legal liability an d,

47 Con trolled ven tilation , 716 Con trollin g, as fun ction of m an agem en t,

61b Con tusion

cerebral, 900b ocular, 867

Con us m edullaris syn drom e, 903, 903f Con version defen se m ech an ism s, 991b Con version disorder, 1003 Con version s, drug m easurem en t system s,

204, 205b Coordin ation , assessm en t of, 185 Copin g m ech an ism s, 988, 990, 993 Corn ea, 861

assessm en t o f, 175 stain in g of, 863 tran splan tation of, 868

Corn eal reflex, 174, 897b Corn eal rin g, 863 Coron ary arteries

an atom y an d ph ysiology of, 756, 756f an gioplasty of

laser-assisted, 761 percu tan eous tran slum in al, 761, 761f

bypass graftin g of, 762, 763f disease of, 770, 771f sten ts, 762

Corrosives, poison in g, 452 Corticosteroids

effects in surgical patien t, 218b as en docrin e m edication , 655–656b for eye disorders, 884b for in creased in tracran ial pressure, 900b for in flam m atory bowel disease, 701,

701b for juven ile idiopath ic arth ritis, 514b for n eph rotic syn drom e, 493 for poison ivy, 569 as respiratory m edication s, 738b, 739

Corticosteron e, 628b Cortisol, 628b Cortison e, 628b Corynebacterium diphtheriae, 525 Cotton gauze dressin g, 553t Cough , wh oopin g, 524 Cough in g, preoperative, 216, 216b, 217f Cover test, 174 CPAP. See Con tin u ous positive airway

pressure ( CPAP) CPR. See Cardiopulm on ary resuscitation

(CPR) CPT. See Ch est ph ysioth erapy ( CPT) Crackles, 180t

Cran ial n erves assessm en t of, 173, 184t in fun ction of ears, 869

Cran iotom y, 901 clien t position in g after, 902b n ursin g care followin g, 902b position in g after, 425b position in g clien ts for, 234

Crawlin g, in n ewborn , 379 Creatin e kin ase, in m yocard ial in farction ,

773 Creatin in e, serum , 818

in preeclam psia, 321t Creatin in e clearan ce test, 820 Creden tialin g agen cy, for foreign -educated

n urse, 13 Crim in al law, 46b Crisis

ph ases of, 1030 types of, 1030, 1031b

Crisis th eory an d in terven tion , 1030–1042, 1038b

abuse of older adult, 1036, 1037b abusive beh avio rs, 1033 bullyin g, 1033 ch ild ab duction , 1035 ch ild ab use, 1035, 1036b fam ily violen ce, 1034, 1034f grief an d loss

com m un ication durin g, 1032b n urse’s role in , 1031

latch key ch ild, 1036 rape an d sexual assault, 1037 suicidal beh avior, 1031, 1032b

Critical path way, 59 Croh n ’s disease, 688 "Cross-eye," 457 Crossm atch in g, 158–159 Croup, bacterial, 463, 464f CRRT. See Con tin uous ren al replacem en t

th erapy ( CRRT) Crutch walkin g, 944 Cryoprecipitates, 158 Cryosurgery, for cervical can cer, 590 Cryptorch idism , 494 CSF. See Cerebrospin al fluid ( CSF) Cuff

en dotrach eal tubes, 245, 245f trach eostom y tubes, 247b

Cuffed fen estrated tube, 247b Cullen ’s sign , 686 Cultural assessm en t, in p erioperative

n ursin g care, 217b Cultural awaren ess an d h ealth practices,

32–43, 32–33b, 33f of African Am erican s, 32 of Am ish , 32 of Asian Am erican s, 34 com plem en tary an d altern ative m edicin e

an d, 38, 38–39b en d-of-life care an d, 37, 37b of Hispan ic an d Latin o Am erican s, 35 low-risk th erapies an d, 39, 40b of Native Am erican s, 36 religion s an d dietary preferen ces, 33b of wh ite Am erican s, 36

1099INDEX

Cultural com peten cy, in m en tal h ealth n ursin g, 989

Culture skin / woun d, 545 urin e, 820

in pregn an cy, 307 Cultured skin , for burn in jury care, 561b Cush in g’s disease, 628, 631t, 632, 632f Cush in g’s syn drom e, 631t, 632, 632f, 657 CVP. See Cen tral ven ous pressure ( CVP) Cyan osis, 173b

assessm en t in dark-skin n ed clien t, 173 in n ewborn , 374 tetralogy of Fallot, 482

Cyberbullyin g, 1034 Cycloben zaprin e, 959, 959b Cyclooxygen ase-2 ( CO X-2) in h ibitors, 928b Cycloph osph am ide, 617, 982 Cycloplegic, 883, 883b Cycloserin e, 746 Cyclosporin e, 853, 961, 982

for atopic derm atitis, 570b for psoriasis, 572

Cystectom y, for bladd er can cer, 601 Cystic fibrosis ( CF) , 470, 470b, 470f Cystitis, 835, 835–836b

postpartum , 364 as radiation th erapy side effect, 422t

Cystoscopy, 839 of bladd er, 821

Cytarabin e, 617 Cytom egalovirus, durin g pregn an cy, 323 Cytoreductive surgery, for can cer, 582

D Dabigatran etexilate, 798, 798b Dam age, in proof of liability, 47 Dan trolen e, 959, 959b Dapson e, 573, 573b Daun orubicin , 617 Dawn ph en om en on , 639 DCT. See Distal con voluted tubule ( DCT) D-dim er, 712 Death , 275

fetal, in utero, 318 postm ortem care in , 275, 276b

Debridem en t, of burn in ju ry, 560, 560b "Debulkin g" surgery, for can cer, 582 Deceleration s, in fetal h eart rate, 336, 336f Decen tralization , 62 Decerebrate ( exten sor) posturin g, 897

in h ead in jury, 500, 500f Decision m akin g, 61 Decom pressive lam in ectom y, 907 Decon gestan ts, 888, 888b Decorticate (flexor) posturin g, 897

in h ead in jury, 500, 500f Deep full-th ickn ess b urn , 556, 556f Deep ten don reflexes, assessm en t of, 185,

186b m agn esium sulfate in , 394t

Deep vein th rom boph lebitis, 782, 782b Deep vein th rom bosis, 233 Deep-breath in g, preop erative, 216, 216b Deer fly fever, 198 Deescalation tech n iques, 1005b

Defam atio n , 47 Defen se m ech an ism s, 990, 991b

in Freud’s th eory, of psych osexual developm en t, 260

Deferoxam in e, for iron overload, 162 Defibrillation , 768 Defibrillator

autom ated extern al, 768 autom ated im plan table cardioverter-,

769 Degen erative join t disease, 949b, 950 Deh iscen ce, woun d, postoperative, 224,

224f Deh ydration , 81

in ch ildren , 430–431, 431t in dyin g clien t, 276b h yperton ic, 82 h ypoton ic, 82 isoton ic, 81

Deh ydroepian drosteron e ( DH EA) , 39b Delavirdin e, 980 Delayed h ypersen sitivity, 966 Delegation

prin ciples an d guidelin es of, 66b process of, 66 question s on exam in ation associated

with , 28, 28b Delirium , 283t

with drawal, 1022, 1022b Delivery

cesarean , 341 forceps, 341

Delivery system s h ealth care, 59 n ursin g, 60

Delusion s, in sch izoph ren ia, 1009–1010, 1009b

Dem en tia, 283t, 1013 Dem ocratic leadersh ip, 60 Den drites, 894 Den ial defen se m ech an ism s, 991b Den ileukin diftitox, 619 Den se bon e, 937 Den tal care

for presch ooler, 271 for toddler, 270

Deoxyribon ucleic acid ( DNA) gen etic testin g, 307

Depen den t person ality disorder, 1012 Deperson alization / derealization disorder,

1004 Depressan ts, cen tral n ervous system ,

respiratory acidosis due to, 99b Depressed fracture, 940b Depression , 1005, 1006b

in b ipolar disorder, 1004b in o lder clien t, 282, 283t po stpartum , 359b

Derm atitis, atopic in ch ild, 404, 405b m edication s to treat, 569, 570b

Derm atological fin din gs, in liver dysfun ction , 681f

Descen t, in labo r, 334b Desen sitization , 993 Design ated don ation , 159

Despair in h ospitalized in fan t an d toddler,

265 in h ospitalized presch ooler, 266

Desquam ation , dry or m oist, as radiation th erapy side effect, 422t

Detach m en t in h o spitalized in fan t an d toddler, 265 in h o spitalized p resch ooler, 266

Developm en tal age, oral m edication ad m in istration an d, 536

Developm en tal dysp lasia of h ip, 511, 512f, 512b

Devices in traven ous th erapy, 144, 145–146f for proper position in g, 235b

Dexam eth ason e, 394, 628, 907 Dextran , 907 DHEA. See Deh ydroepian drosteron e

( DHEA) Diabetes, m oth er with , n ewborn of, 386 Diabetes in sipidus, 630, 818 Diabetes m ellitus, 637

acute com plicatio n s of, 640, 640–642b, 641t, 641f

in ch ildren , 432, 432f, 433b sick day rules for, 435b

ch ron ic co m plication s of, 642, 644b diet an d, 638 exercise an d, 638 gestation al, 316 m edication s for, 659, 660–661t, 662f,

662b m etabolic acidosis in , 101, 101b perioperative care of clien t with , 644 in pregn an cy, 315

Diabetic ketoacidosis (DKA) , 101, 101b, 638, 641, 641t, 641f

in ch ildren , 434 Diabetic m oth er, n ewborn of, 386 Diabetic n eph ropath y, 643, 644b Diabetic retin o path y, 642 Diagnostic and Statistical Manual of Mental

Health Disorders, 990 Dialysate bath , 828 Dialysate solutio n , 831 Dialysis

h em o dialysis, 827 access for, 828, 829f com plication s of, 830, 831b prin ciples of, 828

periton eal, 831, 831f com plication s of, 832

ren al diet an d, 129, 129b Diarrh ea

in ch ildren , 430, 439 as com plication , of gastroin testin al tube

feedin gs, 241 fluid an d electrolyte im balan ce due

to, 81 in irritable bowel syn drom e, treatm en t

for, 701, 702b m edication s to con trol, 702, 702b m etabolic acidosis due to, 101b as radiation th erapy side effect, 422t

Diarth rosis, 938t

1100 INDEX

Diascopy, 545 Diastolic blood pressure, in preeclam psia,

321t Diastolic failure, 775 Diastolic pressure, in h yperten sion , 787 Diazepam , 927, 959, 959b DIC. See Dissem in ated in travascular

coagulation ( DIC) Diclofen ac sodium , 570, 570b DID. See Dissociative iden tity disorder

( DID) Didan osin e, 980 Dien ceph alon , 893 Diet

carboh ydrate-con sisten t, 128 cardiac, 127, 127b for ch ild with diab etes m ellitus, 432 for ch ild with gastroesoph ageal reflux

disease, 443 diabetes m ellitus an d, 638 fat-restricted, 127 followin g bariatric surgery, 679, 679b gluten -free, 128, 445, 445b h igh -calcium , 129 h igh -calorie, h igh -protein , 128 h igh -iron , 129 h igh -residue, h igh -fiber, 127, 127b liquid

clear, 126 full, 126

low-purin e, 129 low-residue, low-fiber, 127 m acrobiotic, 39b m ech an ical soft, 126 potassium -m odified , 129 protein -restricted, 128 religious preferen ces in , 33b ren al, 129, 129b sodium -restricted, 127b, 128 soft, 126 vegan an d vegetarian , 129

durin g pregn an cy, 309 Diffusion , 79 Digoxin , 479, 800 Dilatio n of cervix, in labor an d birth , 337,

338t Diph th eria, 525 Diph th eria, tetan us, acellular pertussis

( DTaP) vaccin e, 530 Direct-actin g arteriolar vasodilators, 807,

807b Directin g, as fun ction of m an agem en t,

61b Disasters, in safe an d effective care

en viron m en t, 197 Disasters an d em ergen cy respon se

plan n in g Am erican Red Cross an d, 68 description of, 68 levels of, 69, 69b n urse’s role in , 70 ph ases of, 69 triage in , 70, 70–71b types of, 68b

Disch arge plan n in g, 66, 66b in m en tal h ealth n ursin g, 992

Disch arge teach in g in pediatric cardiac cath eterization ,

485 postoperative, 224, 225b

Disciplin ary action , 45 Discom forts, postpartum , 358, 359b Disease progression , of tuberculosis, 728 Disease-m odifyin g an tirh eum atic dru gs

(DMARDs) , 960 Disen fran ch ised grief, 1030 Disk h ern iatio n , 946 Dislocatio n

developm en tal dysplasia of h ip, 512b of join t, 946

Displacem en t defen se m ech an ism s, 991b Disposal, of in fectious wastes, 193 Dissectin g, aortic an eurysm s, 785 Dissem in ated in travascular coagulation

(DIC) as on cological em ergen cy, 604 in pregn an cy, 316, 317b, 317f

Dissociation defen se m ech an ism s, 991b Dissociative am n esia, 1004 Dissociative disorder, 1003 Dissociative iden tity disorder ( DID) ,

1003 Distal con voluted tubule ( DCT) , 817 Distal splen oren al sh un t, for esoph ageal

varices, 683, 683f Distress

fetal, in labor an d birth , 350 respiratory, in n ewbo rn , 381

Disulfiram , 1023 Diuretic ph ase of acute kidn ey in jury, 822,

823b Diuretics, 801, 801–802b

effects in surgical patien t, 218b h earin g loss due to, 888b m etabolic alkalosis due to, 102b osm otic, 931

Divalproex sodium , 926t, 927 Diverticulitis, 689 Diverticulosis, 689 Dix-Hallpike m an euver, 177b DKA. See Diabetic ketoacidosis ( DKA) DMARDs. See Disease-m odifyin g

an tirh eum atic drugs (DMARDs) Do n ot resuscitate (DNR) orders, 53 Dobu tam in e, 800b, 808 Docum en tation

do’s an d don ’ts of, 53b of h ealth an d ph ysical assessm en t

fin din gs, 187, 188b as legal safeguards, 52 with use of safety devices, 194, 195b

Do cum en ts, n eeded by foreign -educated n urse, 13, 13b

Dom estic vio len ce screen in g, 171 Don ep ezil, 1051 Don or

of eyes, 868 of h eart, 764 of kidn ey, 833 of organ , 48

Dop am in e, 800b, 808 Do pam in ergic m edication s, 924, 925b

Doppler blood flow an alysis, in pregn an cy, 307

Dosage calculation of, 207, 208b calculation of, pediatric, 538, 538b in fusion prescribed by un it dosage per

h our, 208, 209b Double lum en urin ary cath eter, 243 Double-lu m en tube, of trach eostom y, 247b Dowager’s h um p, 282f Down syn dro m e, 506 Doxo rubicin , 617 Doxycyclin e, 573b DPI. See Dry powder in h aler ( DPI) Drag-an d-drop question , 20 Drain age

postural, position in g clien ts for, 233 woun d, 545

Drain age system , ch est tu be, 246, 249f Drain s, woun d, 220 Dressin gs

m aterials used for, 553t postoperative care of, 219 types of, 552–553t

Drip ch am bers, in in terven ous th erapy, 146, 146f

Drop arm test, 940 Drop attacks seizure, 908b Droplet precaution s, 196 Droppin g, in labor an d birth , 333 Drops

ear, in stillation of, 887 eyes, 883

Drug depen den cy, 1023, 1023–1024b Dry powder in h aler (DPI) , 737, 738f Dual-en ergy x-ray absorptio m etry, 939 Dum pin g syn drom e, 678, 678b Duoden al ulcers, 677b, 678

path oph ysio logical com po n en ts of, 699t

Duoden um , 671 Dura m ater, 893 Durable power of attorn ey, 53 Duration , in differen tiatin g delirium ,

depression , an d dem en tia, 283t Duty, in proof of liability, 46 Dysfun ction al grief, 1030 Dysplasia, bron ch opulm on ary, in

n ewborn , 381 Dyspn ea, in dyin g clien t, 276b Dyspraxia, in stro ke, 910b Dysreflexia, auton om ic, 905

m an ifestation of, 906b position in g clien ts with , 233 in spin al cord in jury, 906b

Dysrh yth m ias, cardiac, 764, 765–766b, 765–767f

m an agem en t of, 767 m edication s for, 807

Dystocia, in labor an d birth , 349

E Ear disorders, 870

acoustic n eurom a as, 875 cerum en an d foreign bodies in , 875 extern al o titis, 872

1101INDEX

Ear disorders ( Continued) fen estratio n , 873 h earin g loss

con ductive, 870, 870f facilitatin g com m un ication in ,

871b h earin g aids for, 871 m ixed, 871 sen sorin eural, 870f, 871 sign s of, 871b

labyrin th itis, 874 m astoid itis, 873 m edication s for

adm in istration of, 887 an tih istam in es an d decon gestan ts for,

888, 888b an tiin fective, 888, 888b cerum in olytic, 889

Men iere’s syn drom e, 874 otitis m edia, 458

ch ron ic, 872, 872b otosclerosis, 873 presbycusis, 871 risk factors for, 870b traum a as, 875

Ear drops, in stillation of, 887 Early adulth ood

developm en t in , Erikson ’s stages of, 258b, 258t

developm en tal stages of, 273 Early deceleration s, in fetal h eart rate, 336,

336f Ears

an atom y an d ph ysiology of, 868 assessm en t of, 175, 177b

in n ewborn , 374 diagn ostic tests for, 869 irrigation of, 888, 888f

Eastern O rth odox dietary preferen ces in , 33b en d-of-life care an d, 37

Eatin g d isorders, 1019, 1020f Eatin g h abits, exam in ation an d, 16 EBCT. See Electron -beam com puted

tom ograph y ( EBCT) Ebola virus disease ( EVD), 198 EBUS. See En dobron ch ial ultrasoun d

(EBUS) Ech in acea, 39b Ech ocardiograph y, 759 Eclam psia, 320, 321t, 322, 322–323b Econ om ic exploitation , 1034b ECT. See Electrocon vu lsive th erapy ( ECT) Ectopic pregn an cy, 317, 317f Eczem a, 569

in ch ild, 404, 405b Edem a

an kle, in pregn an cy, 303 of croup, 464f fluid an d electrolyte balan ce an d, 78 pulm on ary

with h eart failure, 775, 775b position in g clien ts with , 233 resp iratory acidosis due to, 99b

Edroph on ium , 923 Edroph on ium ch loride, 924b

Edroph on iu m (Ten silon ) test, 912, 923 Efaviren z, 980 Ego, in Freud’s th eory, of psych o sexual

developm en t, 259 Egoph on y, 180b Eigh th cran ial n erve, 869 Electrical safety, 192 Electrocardiograph y, 758, 758b

in an gin a, 772 ch an ges in electrolyte im balan ces, 85t in coron ary artery disease, 771 in m yocardial in farction , 773 stress test, 759

Electrocon vulsive th erapy ( ECT), 1006, 1007b

Electroen ceph alograph y, of n eurological system , 896

Electrolytes, 78–96, 78–79b. See also Fluid an d electrolyte balan ce

cardiovascular testin g of, 757 defin ed, 78 overload of in traven ous th erapy, 149t,

150 in paren teral n utrition , 136

Electrom yograph y ( EMG), 940 Electron -beam com puted tom ograph y

( EBCT) , 760 Electron ic IV in fusion devices, 146 Electron s, 79b Electron ystagm ograph y ( ENG) , 870 Electroph ysiological studies, 760 Elim in ation

in dyin g clien t, 276b preoperative, 215

ELISA. See En zym e-lin ked im m un osorben t assay ( ELISA)

Em an cipated m in or, 50 Em bolectom y, 786 Em boli, pulm on ary, respiratory acidosis

due to, 99b Em bolism

air as com plication , in h em odialysis,

830b with in traven ous th erapy, 149, 149t in paren teral n utrition , 136, 137t

o f am n iotic fluid , in labor an d birth , 350 cath eter, 149, 149t fat, 943, 943b p ulm on ary

with fractures, 944 postoperative, 221 postpartum , 366

Em bryon ic period, in fetal developm en t, 293b

Em ergen cies o n cological, 604 spin al cord in jury, 904

Em ergen cy departm en t triage, 71, 71b Em ergen cy respon se plan n in g, 68, 68–70b,

197 EMG. See Electrom yograph y ( EMG) Em ollien ts, as laxatives, 702, 702b Em otion al ch an ges, postpartum , 358, 359b Em otion al ch aracteristics, in sch izoph ren ia,

1008

Em o tion al lability, pregn an cy an d, 302 Em o tion al violen ce, 1034b Em o tion ally in com peten t clien ts, in form ed

con sen t issues with , 49, 49b Em p h ysem a, 99b Em p loyee guidelin es, 45 Em p owerm en t, 62 Em p yem a, 725 Em tricitabin e, 980 Em tricitabin e/ ten ofovir, 980 En ceph alitis, 914 En ceph alopath y, portal system ic, 681 En copresis, 448 En d -of-life care, 275, 276b

cu ltural/ religious beliefs con cern in g, 37, 37b

En d arterectom y, carotid artery, for stroke, 909

En d obron ch ial ultrasoun d ( EBUS) , 710 En d ocarditis, 778, 779b En d ocardium , 755 En d ocrin e disorders

of adren al glan d, 631, 631–632b, 631t, 632f, 634b

of pan creas, 637, 639b of parath yroid glan ds, 636 of pituitary glan d, 629, 629b risk factors of, 627b of th yroid glan d, 634, 634t, 635–636b,

635f En d ocrin e fin din gs, in liver dysfun ctio n ,

681f En d ocrin e glan ds

an atom y an d ph ysiology of, 626, 627b pan creatic, 672

En d ocrin e m edication s, 653–668 an drogen s, 657, 657b an tidiuretic h orm on es, 653 an tith yroid, 654, 654b co n traceptives, 658 co rticosteroids as, 655–656b for diabetes m ellitus, 659, 660–661t,

662f, 662b fertility m edication s, 659, 659b parath yroid, 655, 655b pituitary, 653, 654b progestin s, 657, 658b th yroid h orm on es, 654, 654b

En d ocrin e system , 626–652 an atom y an d ph ysiology of, 626,

627–628b, 627f ch an ges in , with agin g, 282 diagn ostic tests of, 627 disorders, pediatric, 430–438 ph ysiological m atern al ch an ges in , 301 position in g clien ts in , 232 pyram id p oin ts, 625

En dolym ph atic h ydrops, 874 En dom etrial can cer, 591 En dom etritis, in pregn an cy, 317 En dorsem en t, in terstate, 13 En doscopic in jection , for esoph ageal

varices, 683 En doscopic retrograde

ch olan giopan creatograph y ( ERCP), 674

1102 INDEX

En doscopic ultrason ograph y, gastroin testin al, 674

En doscopic variceal ligation , esoph ageal, 683

En doscopy capsule, 672 upper gastroin testin al, 673

En dotrach eal tubes, 245, 245f En em a

for con stipation an d en copresis in ch ildren , 448

position in g clien ts with , 232 En ergy m edicin e, 38 En fuvirtide, 981 ENG. See Electron ystagm ograph y (ENG) En gagem en t, in labor an d birth , 333, 334b En go rgem en t, in breast, 357–358, 357b En oxaparin , 798, 798b En teral n utrition , 130, 130b En teric-coated tablets, 206 En tero colitis, n ecrotizin g, in n ewborn , 382 En ucleation , ocular, 867 En uresis, 493 En viro n m en t, for h ealth an d ph ysical

assessm en t, 171 En viro n m en tal factors, in can cer

developm en t, 419 En viro n m en tal safety, 192, 192b, 193t En viro n m en tal tem perature, 109 En zym atic debridem en t, for burn in jury,

560b En zym e-lin ked im m un osorben t assay

( ELISA), 319, 522t En zym es

for can cer, 618, 618b liver, in preeclam psia, 321t pan creatic

for cystic fibrosis, 472 in testin al juice, 671

Epicardial pacin g in vasive, 770 wires, 763

Epicardium , 755 Epididym itis, 841 Epidural block, lum bar, for labor an d birth ,

339 Epidural cath eter, 153, 153b, 153f Epidural h em atom a, 900b Epiglottis, 708 Epiglottitis, 463, 464f Epilepsy, 907 Epin eph rin e, 808 Episiotom y, 358

in labor an d birth , 341 Episodic/ follow-up assessm en t, 172b Epispadias, 494, 494f Epistaxis, 459 Epstein -Barr virus, 526 Equilibrium , 869 Equivalen ts, 205b ERCP. See En doscopic retrograde

ch olan giopan creatograph y ( ERCP) Ergon om ic prin ciples, 230, 230b Ergot alkaloid, 397 Erikson ’s th eory, of psych osocial

developm en t, 257, 258b, 258t Erysipelas, 547

Eryth em a, 173b Eryth em a in fectiosum (fifth disease), 526,

526f Eryth em a m argin atum , of rh eum atic fever,

486f Eryth em a m igran s, of Lym e disease,

972f Eryth roblastosis fetalis, in n ewborn , 383,

383f Eryth rocyte protoporph yrin test, 451 Eryth rom ycin , 573 Eryth ropoietic growth factors, 854, 855b Eryth ropoietin , for colon y-stim ulatin g

factors, 619b Esch arotom y, for burn in jury, 559 Eso p h ageal atresia, 441, 442f Eso p h ageal tube, 243 Eso p h ageal varices, 681–682, 683f Eso p h agod uoden ostom y, 677 Eso p h agogastroduoden oscopy, 673 Eso p h agojejun ostom y, 594b, 677 Eso ph agus, 671

can cer of, 593 Essen tial fatty acids, 124 Essen tial h yperten sion , 788 ESSR m eth o d of feedin g, 441 Estrogen s, 657, 657b

for m align an cy, 618b ESWL. See Extracorporeal sh ock wave

lith otripsy ( ESWL) Etan ercept, 961 Eth am butol, 743 Eth ical an d legal issues, 44–58, 44b

advan ce directives, 53 clien t’s righ ts, 47, 48b collective bargain in g, 47 con fiden tiality/ in form ation security, 50,

51b Health In suran ce Portability an d

Accoun tability Act an d, 50, 51b in form ed con sen t, 49, 49b legal liability, 46, 46f, 46–47b legal risk areas, 47 legal safeguards, 52, 52–53b regulation of n ursin g practice, 44 reportin g respon sibilities, 54, 54b

Eth ical practices, in n u rsin g, 30 Eth ical reason in g, 44 Eth ics, 44

codes of, 44 dilem m a, 44 prin ciples of, 44, 45b

Eth ion am ide, 745 Eth n icity, in m en tal h ealth n ursin g, 989 Eth osuxim ide, 926t, 927 Etravirin e, 980 Evaluation , question s on exam in ation

associated with , 26, 26b EVD. See Ebola virus d isease ( EVD) Even t, as in gredien ts of question , 20, 21b Even t query

as in gredien ts of question , 20, 21b positive an d n egative, 22, 23b

Eviden ce-based practice, 62, 63t Evisceration , woun d, postoperative, 224,

224f, 224b Ewald tube, 243

Exan th em a sub itum , 523, 523f Excision al biopsy, 581 Exen atide, 663 Exen teration

ocular, 867 pelvic, 590, 590b

Exercise ch allen ges, in asth m a, 468b diabetes m ellitus an d, 638

in ch ildren , 433 preoperative, 216, 216b

Exercise electrocardiograph y testin g ( stress test) , 759

Exh ibit question s, 8, 9b, 20 Exocrin e glan d, 672

dysfun ction in cystic fibrosis, 470, 470f Exoph th alm os, 635f Expectoran ts an d m ucolytic agen ts, 740,

740b Expert power, 62b Expulsion , in labor, 334b Exten sion , in labor, 334b Exten sor posturin g, 897 Exten sor posturin g

in h ead in jury, 500, 500f Extern al b eam radiatio n , 583, 583b Extern al d isasters, 197 Extern al ear, 868 Extern al fixation , of fracture, 941, 942f Extern al jugular vein , in deh ydration ,

ped iatric, 431t Extern al otitis, 872 Extern al rotation , in labor, 334b Extern al version , in fetus, 340 Extracellular com partm en t, 78, 79f Extracellular fluid, buffer system s in , 97 Extracorporeal m em bran e oxygen ation ,

381 Extracorporeal sh ock wave lith otripsy

( ESWL), 840 Extraocular m uscle, assessm en t of, 174,

175f Extrem ities

assessm en t of, in n ewborn , 376 lower

am putation of, position in g clien ts for, 233

periph eral sites in , 147, 147f Extubation , of en dotrach eal tubes, 246 Exudate, from woun ds, 545b Exudative m acular degen eration , 866 Eye( s)

an atom y an d ph ysiology of, 861 assessm en t of, 174, 175f, 175b

of n ewborn , 374 diagn ostic tests for, 862 don ation of, 868 an d ear disorders, pyram id poin ts, 860 irritation of, with ch ron ic kidn ey disease,

827 m uscles of, 862 proph ylaxis o f, for n ewborn , 399

Eye disorders, 863 cataracts as, 864, 864f, 865b ch em ical burn s, 867, 868b con tusion s, 867 don ation in , 868

1103INDEX

Eye disorders ( Continued) en ucleation an d exen teration , 867 foreign bodies, 867 glaucom a, 864 h yph em a, 867 legal blin dn ess, 864 m acular degen eration , 866 ocular m elan om a, 866 pediatric

con jun ctivitis, 457, 457b, 459b strabism us, 457

pen etratin g objects, 867 refractive errors, 863 retin al detach m en t, 865, 866f risk factors for, 863b

F Face, assessm en t of, 173 Face ten t, 712

for oxygen adm in istration , 465t Facial ch an ges, in fetal alcoh ol spectrum

disorders, 385, 385f Facial expression , in m en tal status exam ,

171 Facial n erve, 184t Facial paralysis, 914 Failure of exam in ation , can didate

perform an ce report followin g, 13 Fallin g test, in vestibular assessm en t, 177b Fallopian tubes, 291 Falls, preven tion of, 193, 194b False im prison m en t, 47, 991 False labor, 334, 334b False pelvis, 291 Fam ily, as exten sion of m en tal h ealth clien t,

989 Fam ily h istory, 171 Fam ily plan n in g, 295 Fam ily th erapy, 994 Fam ily violen ce, 1034, 1034f Fam o tidin e, 700 Fan tasy defen se m ech an ism s, 991b Farsigh tedn ess, 863 Fascial tech n ique, for burn in jury

debridem en t, 560b Fasciotom y, for burn in jury, 560 FASDs. See Fetal alcoh ol spectrum disorders

(FASDs) Fastin g blood glucose, 117 Fat, m etabolic acidosis due to h igh in take

of, 101b Fat em bolism , 943, 943b Fat em ulsion , in p aren teral n utrition , 135,

135b Fat-soluble vitam in s, 124, 125b Fatigue

in dyin g clien t, 276b with leukem ia, pediatric, 420 in pregn an cy, 303 with rh eum atoid arth ritis, 950

Fats diet for restriction of, 127 n utrition an d, 124

Fear associated with dyin g, 276b of in jury, pain an d

in h ospitalized adolescen t, 267

Fear ( Continued) in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch ool-age ch ild, 266

Federal Em ergen cy Man agem en t Agen cy ( FEMA) , 69, 69b

Feedin g in n ewborn , 379 of p ediatric patien t

with cleft lip an d palate, 441 ESSR m eth od of, 441

Feet, periph eral sites in , 147, 147f FEMA. See Federal Em ergen cy Man agem en t

Agen cy ( FEMA) Fem ale gen italia, assessm en t of, 186

in n ewborn , 375 Fem ale reproductive

fam ily plan n in g, 295, 295b fertilization an d im plan tation , 292 fetal circulation , 294, 294f fetal developm en t, 293, 293b fetal en viron m en t, 293 in fertility, 295 m en stru al cycle, 291, 292b p elvis an d m easurem en ts, 291 structures of, 291

Fem oral cath eter, 152f, 828 Fem oral th rom boph lebitis, 367b Fen cin g, in n ewborn , 378 Fen estrated tube, of trach eosto m y, 247b Fen tan yl, 395 Fern test, 308 Fertility m edication s, 659, 659b Fertilization , 292 Fetal alcoh ol spectrum disorders ( FASDs),

385, 385f Fetal circulation , 294, 294f Fetal circulation bypass, 294, 294f Fetal death in utero, 318 Fetal dem ise, in trauterin e, in labor an d

birth , 350 Fetal distress, in labor an d birth , 350 Fetal h eart rate (FHR) , 294

fetal distress an d, 350 m on itorin g, in labor an d birth , 335 n on reassurin g, durin g oxyto cin in fusion ,

396, 397b n on reassurin g, pattern s of, 336, 337b variability in , 335b

Fetal lie, 332, 333f Fetal m ovem en t coun tin g, 308 Fetal period, in fetal developm en t, 293b Fetal presen tation , 332, 333f, 334b α-Fetoprotein screen in g, 307 Fetor h epaticus, 682 Fetus

bioph ysical profile of, 307 developm en t of, 293, 293b en viron m en t of, 293 extern al version in , 340 m on itorin g, in labor an d birth , 335,

335b, 336f, 337b po sition of, 332, 333f, 334b relation sh ip with , in pregn an cy, 302

Fever in ch ildren , 430 deer fly, 198

Fever ( Continued) h em o rrh agic, 198 rabb it, 198 respiratory alkalosis due to, 100b in rh eum atic fever, 485, 486f Rocky Moun tain spotted, 527, 527b in roseola, 523 scarlet, 525, 526f

FH R. See Fetal h eart rate ( FHR) Fiber, in h igh -residue, h igh -fiber diet,

127 Fiberoptic colon oscopy, 673, 674b Fibrillation

atrial, 765, 765f ven tricular, 766, 767f

Fibroblastic ph ase, of woun d h ealin g, 544 Fibron ectin test, in pregn an cy, 308 Fidelity, eth ical, 45 Fifth disease, 526, 526f Figure questio n s, 8, 9b Fill-in -th e-blan k q uestion s, 7, 7b, 20 Filters

in in traven ous th erapy, 146 ven a cava, 787, 787f

Filtration , 80 Fire extin guish ers, 193t Fire safety, 192, 193t First-lin e m edication s, for tuberculosis,

741b, 742 Fistula

arterioven ous, fo r h em odialysis, 829–830, 829f

trach ea-in n om in ate artery, 248t trach eoesoph ageal, 248t, 441, 442f

Fixation , of fracture, 941 extern al, 941, 942f in tern al, 941, 941f

Fixation defen se m ech an ism s, 991b Flaccid posturin g, 897 Flail ch est, 718 Flatulen ce, in pregn an cy, 301 Flexion , in labor, 334b Flexor posturin g, 897

in h ead in jury, 500, 500f Floatin g, 45 Flow rates, 208, 208b Flu sh ots, 747 Flu vaccin e, 528 Fludrocortison e acetate, 655 Fluid an d electrolyte balan ce

in cardiac surgical un it p ostoperative in terven tion s, 763

co n cep ts of, 78, 79f, 79b, 81f deh ydration in ch ildren an d, 431t electrocardiograph ic ch an ges in , 85t fluid volum e excess, 82t, 83 h ypercalcem ia, 88t, 89 h yperkalem ia, 84, 84t h yperm agn esem ia, 89, 90t h ypern atrem ia, 86, 87t h yperph osph atem ia, 91, 91b h ypocalcem ia, 86, 87b, 88t, 88f h ypokalem ia, 83, 83b, 84–85t h ypom agn esem ia, 89, 89b, 90t h ypon atrem ia, 85, 86b, 87t h ypoph o sph atem ia, 90, 90b postoperative, 220

1104 INDEX

Fluid an d electro lyte disturban ces, in liver dysfun ction , 681f

Fluid overload, 83. See also Circulatory overload

Fluid volum e deficit, 81, 82t Fluid volum e excess, 82t, 83 Fluids, 78–96, 78b Fluoride supplem en tatio n , fo r in fan t, 268 Fluoroquin olon es

adverse effects of, 983t as ren al m edication s, 851, 851b

Fluorouracil, 570 Flutter m ucus clearan ce device, 471 Foam dressin g, 553t Focused assessm en t, 172b Folic acid supplem en ts, in pregn an cy, 308 Follicle-stim ulatin g h orm on e ( FSH) , in

m en strual cycle, 291 Folliculitis, 546 Fon tan els, 373, 373t Food

calcium in , 87b gas-form in g, 127, 127b h igh -fiber, 449b for h yp oglycem ia, in ch ildren , 434 iron -rich , 125b, 413b m agn esium in , 89b n utrien ts in , 125b in n utrition , for in fan t, 268 ph osph orus in , 90b potassium in , 83b sodium in , 86b

Foot boots, for proper positio n in g, 235b Foot care, preven tive, 643, 644b Forceps delivery, in labor an d birth , 341 Foreign bodies

aspiration in ch ildren , 473, 473f in ears, 875 ocular, 867

Foreign -educated n urse creden tialin g agen cy for, 13 docum en ts n eeded by, 13, 13b licen sure requirem en ts for, 13, 13b Nation al Coun cil of State Boards of

Nursin g an d, 13 work visa for, 13

Form al operation s, of cogn itive developm en t, 259

Form al organ ization s, 62 Form ula feedin g, of n ewborn , 379 Forward failure, of h eart, 774 Forward side-lyin g position , 231f Fosam pren avir, 981 Fosfom ycin , 850, 851b Fosph en ytoin , 926 Foun dation , of path ways to success, 14 Fowler’s position , 232

h igh , 232 sem i, 230

Fraction of in sp ired oxygen ( FiO 2) , in m ech an ical ven tilation , 717t

Fractures, 940, 940b casts for, 943 in ch ildren , 515, 515b com plication s of, 943, 943b fixation of, 941, 941–942f

Fractures ( Continued) in itial care of, 941 reduction of, 941 of skull, 900b traction for, 941, 942f types of, 940b

Fraud, 47 Frem itus, tactile an d vocal, 178 Fresh -frozen plasm a, 158 Freud’s th eory, of psych osexual

developm en t, 259, 260–261b Friedm an curve, 337, 338f Fron tal lobe, 894b Fron tlin e m an ager, 61 Frostbite, 548 Full liquid diet, 126 Full-th ickn ess burn , 555, 556f

deep, 556, 556f Fun ction al n ursin g, 60 Fun dal h eigh t, ph ysiological m atern al

ch an ges in , 356, 357f Fun dal m assage, for uterin e aton y, 364,

365f Furu n cles, 546 Fusiform , aortic an eurysm s, 785 Fusion in h ibitors, 981

G Gag reflex, 178, 897b Gait belt, 194 Gaits, crutch , 944, 945t Galan tam in e, 1051 Galeazzi sign , 511 Gallbladder

an atom y an d ph ysiology of, 672 in flam m ation of, 680 surgical rem oval of, 680

Gallston es, 680 Garlic, 39b Gas-form in g foods, 127, 127b Gastrectom y, 677

subtotal, 594b Gastric an alysis, 673 Gastric can cer, 593 Gastric protectan ts, 698 Gastric resection , 677 Gastric tube, 243 Gastric ulcers, 676, 677b

path op h ysiological com pon en ts of, 699t Gastrin , 671 Gastritis, 676, 676b Gastroduoden ostom y, 594b, 677, 677f Gastroesoph ageal reflux disease ( GERD) ,

675 in ch ildren , 442 position in g clien ts with , 232

Gastroin testin al disorders abdom in al wall defects, 447 of adult clien t, 669 appen dicitis, 445 celiac disease, 444 cleft lip an d cleft palate, 440, 440f con stipation an d en co presis, 448, 449b diarrh ea, 439 esop h ageal atresia, 441, 442f gastroesoph ageal reflux disease, 442

Gastroin testin al disorders ( Continued) h epatitis, 449, 450b Hirsch sprun g’s disease, 446, 446f h ypertroph ic pyloric sten osis, 443, 443f im perforate an us, 449, 449b in testin al parasites, 453 in tussusception , 447, 447f irritable b owel syn drom e, 448 lactose in toleran ce, 444 poison in gestion , 451, 451t, 451b trach eoesoph ageal fistula, 441, 442f um bilical h ern ia, 448 vom itin g, 439, 439b, 453b

Gastroin testin al (GI) fin din gs, in liver dysfun ction , 681f

Gastroin testin al m ed ication s, 698–705 an tacids, 698, 699f, 699t an tiem etics, 701, 702b bile acid sequestran ts, 700, 700b to con trol diarrh ea, 702, 702b gastric protectan ts, 698 for Helicobacter pylori in fection , 700, 700b for h epatic en ceph alopath y, 701 h istam in e ( H2) -receptor an tagon ists, 698 for in flam m atory bowel disease, 701,

701b for irritable bowel syn drom e, 701, 702b laxatives, 701, 702b pan creatic en zym e replacem en ts as, 701 prokin etic agen t, 700 proton pum p in h ibitors, 700, 700b

Gastroin testin al system , 671–697 acidosis m an ifestation s in , 100t alkalosis m an ifestation s in , 101t an aph ylaxis m an ifestation s in , 968f an atom y an d ph ysiology o f, 671, 672b an th rax tran sm issio n an d sym ptom s in ,

197b assessm en t of, in n ewborn , 375, 377 bleedin g in , with ch ron ic kidn ey disease,

825 ch an ges in , with agin g, 282 ch ron ic kidn ey disease m an ifestation in ,

824b cystic fibrosis m an ifestation s in , 471 disorders of

appen dicitis, 689 bariatric surgery for, 678, 679b, 679f cirrh osis, 680, 681–682f Cro h n ’s disease, 688 diagn ostic procedures in , 672, 672b,

674b diverticulosis an d diverticulitis, 689 dum pin g syn drom e, 678, 678b esoph ageal varices, 681–682, 683f gastritis, 676, 676b gastroesoph ageal reflux disease, 675 h em orrh oids, 690 h epatitis, 683, 684b, 686b h iatal h ern ia, 679 irritable bowel syn drom e, 687 pan creatitis, 686 peptic ulcer disease, 676, 677f, 677b risk factors of, 672b ulcerative colitis, 687, 688b vitam in B12 deficien cy, 678

1105INDEX

Gastroin testin al system ( Continued) fluid volum e deficit an d excess fin din gs

in , 82t h ypocalcem ia an d h ypercalcem ia

fin din gs in , 88t h ypokalem ia an d h yperkalem ia fin din gs

in , 84t h ypon atrem ia an d h ypern atrem ia

fin din gs in , 87t in terven tion s in spin al cord in jury, 905 ph ysiological m atern al ch an ges in , 301 position in g clien ts in , 232, 232b posto perative care of, 220

Gastroin testin al tract ph ysiological m atern al ch an ges of, in

postpartu m period, 357 radiation th erapy side effect in , 422t

Gastroin testin al tube feedin gs, 239 Gastrojejun ostom y, 594b, 677, 677f Gastrosch isis, 447 Gastrostom y tube

adm in isterin g m edication s via, 242b esoph ageal atresia an d trach eoesoph ageal

fistula repair an d , 442 Gauges, in traven ous, 144 Gauze d ressin g, cotton , 553t Gaze, six cardin al position s of, 174, 175f Gaze n ystagm us evaluation , 177b Gem fibrozil, 809 Gen eral an esth esia, for labor an d birth , 340 Gen eralized an xiety disorder, 1001 Gen eralized seizures, 908b Gen eric n am e, 205 Gen etic predisposition , in can cer

developm en t, 580 Gen ital h erpes sim plex virus ( HSV-2) , in

pregn an cy, 305, 306t Gen ital stage, of psych osexual

developm en t, 261b Gen itals, assessm en t of, in n ewborn , 375 Gen itou rin ary system , ch an ges in older

clien ts, 193b Geron tology, 281 Gestation , m ultiple, 324 Gestation al diabetes m ellitus, 316 Gestation al h yperten sion , in pregn an cy,

320, 321t, 322–323b GFR. See Glom erular filtration rate ( GFR) Giardiasis, in ch ildren , 453 Giger an d Davidh izar’s Tran scultural

Assessm en t Mod el, 33f Gin ger, 39b Gin kgo biloba, 39b Gin sen g, 39b Glasgow Com a Scale, 897, 898b Glaucom a, 864

m edicatio n s for, 885, 885b ton om etry for diagn osis of, 863

Glom erular filtration rate ( GFR), 820, 824t Glom erulon eph ritis, 491, 491b, 837 Glom erulus, 817 Glossoph aryn geal n erve, 184t Gloves, in stan d ard precaution s, 195 Glucagon , 663 Glucagon -like peptide (GLP-1) receptor

agon ists, 662

Glucocorticoids, 628b, 961 as en docrin e m edication , 656, 656b as respiratory m edication s, 738b, 739 topical, 569, 569b, 575b

Glucosam in e, 39b Glucose

blood cardiovascular testin g of, 758 in diabetes m ellitus, pediatric, 433 in diabetic ketoacidosis, 435 in h ypo glycem ia, 434 in n ewb orn , with h ypoglycem ia, 386

urin alysis for, in pregn an cy, 307 Gluteal folds, asym m etry of, in

developm en tal dysplasia of h ip, 511 Gluten -free diet, 128, 445, 445b Glycosides, cardiac, 800 Glycosuria, in pregn an cy, 307 Glycosylated h em oglobin ( HgbA1C) , 118,

118t diagn ostic testin g of, 628

Gold salts, 960 Gon orrh ea, in pregn an cy, 305, 306t, 325 Good Sam aritan laws, 47 Goodpastu re’s syn drom e, 972 Gout, 951

m edication s for, 959 Gown s, in stan dard precautio n s, 195 Gradin g, of can cers, 580, 581b Graduate’s perspective, 18–19 Graft(in g)

arterial vascular, position in g clien ts in , 233

arterioven ous, for h em odialysis, 829f, 830

coron ary artery bypass, 762, 763f skin , position in g clien ts with , 230

Graft rejectio n of d on or eye, 868, 869f of d on or kidn ey, 835, 835b

Gran u locyte colon y-stim ulatin g factor, 619b

Gran u locyte-m acroph age colon y- stim ulatin g factor, 619b

Gran u locytes, 159 Gran u lom atous in flam m ation , 728 Graph ic option question s, 8, 9b Grasp, palm ar-plan tar, in n ewborn , 378 Green stick fracture, 940b Grief, 1030, 1031b

in ch ildren , 1031b in o lder clien t, 282

Group A β-h em olytic streptococci, 525 Group B Streptococcus (GBS), durin g

pregn an cy, 323 Group developm en t an d group th erapy,

994 Group of clien ts, prioritizin g wh en carin g

for, 67, 68b Group suppo rts, 38 Growth , of bon e, 937 Growth an d developm en t

ch aracteristics of stages of in adolescen t, 273, 273b in early adulth ood, 273 in in fan t, 268, 268–269b

Growth an d developm en t ( Continued) in later adulth ood, 274 in m iddle adulth ood, 274 in presch ooler, 271, 271b in sch ool-age ch ild, 272, 272b in toddler, 269, 270b

pyram id to success, 255 stages of, 265–280, 265b, 276b

ch aracteristics of, 268 com m un ication approach es in , 267,

267b en d-of-life care in , 275, 276b in h ospitalized adolescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch oo l-age ch ild, 266

th eories of, 257–264, 257b, 261b Erikson ’s th eory, of psych osocial

developm en t, 257, 258b, 258t Freud’s th eory, of psych osexu al

developm en t, 259, 260–261b Koh lberg’s th eory, of m oral

developm en t, 259, 260b Piaget’s th eory, of cogn itive

developm en t, 257 Growth h orm on es, as en docrin e

m ed ication , 653, 654b Guillain -Barr e syn drom e, 914 Gum s, 177 Gun s, safety in , for presch ooler, 272 Gyn ecoid pelvis, 291

H H 1 blockers, 739 HAART. See High ly active an tiretroviral

th erapy (HAART) Habitual abortion , 315b Haemophilus influenzae type b (H ib) , 502

co n jugate vaccin e, 530 Haemophilus vaginalis, 325 Hair

assessm en t of, 172 loss of, as radiation th erapy side effect,

422t pediculosis capitis in , 405

Hallucin ation s, in sch izoph ren ia, 1009, 1010b

Hallucin ogen s, 1024 in toxication , 1024b

Halo traction , 906 Han d, periph eral sites in , 147, 147f Han d h ygien e, in stan dard precaution s,

196 Han d rolls, for proper position in g,

235b Han d wash in g, in stan dard precaution s,

195 Han d-wrist splin ts, for proper position in g,

235b Han ds, assessm en t of arteries in , 181b Harassm en t, sexu al, 54 Hard palates, 177 Harlequin sign , 375 Harn ess, Pavlik, 511, 513f Harvestin g, in bon e m arrow

tran splan tation , 584

1106 INDEX

HBsAG. See Hepatitis B surface an tigen ( HBsAG)

HDAg. See Hepatitis D an tigen (HDAg) Head

assessm en t of, 173 of n ewborn , 373, 373t, 373f

lice in , 405 Head circum feren ce

of in fan t, 268 of n ewborn , 373 of toddler, 269

Head h alter traction , 942f Head in jury

in ch ildren , 499, 500f traum atic, 900b

Head lag, of n ewborn , 374 Headach es, in pregn an cy, 304 Healin g

of bon e, 938, 938f woun d

com plication s of, 224f by in ten tion , 545 ph ases of, 544

Health an d illn ess in African Am erican culture, 32 in Am ish society, 34 in Asian Am erican culture, 34 in Hisp an ic an d Latin o Am erican culture,

35 in Native Am erican culture, 36 in wh ite Am erican culture, 37

Health care delivery system s, 59 Health care provider ( HCP) , roles of, 64 Health care provider ( HCP) assistan t, roles

of, 64 Health care team

collaboration am on g, 65 con sultation with , 65 roles of, 64

Health care workers, body m ech an ics for, 230b

Health care-associated ( n osocom ial) in fection s, 195

Health h istory, 171 Health In suran ce Portability an d

Accoun tability Act (HIPAA), 50 Health prom otion an d m ain ten an ce

in an tin eoplastic m edication s adm in istration , 615

question s on exam in ation asso ciated with , 4t, 5, 5b, 27

Health risks in African Am erican population , 32 in Am ish population , 34 in Asian Am erican population , 35 in Hisp an ic an d Latin o Am erican

population , 35 in Native Am erican popu lation , 36 in wh ite Am erican population , 37

Hearin g an atom y an d ph ysiology of, 869 assessm en t of, 175

Hearin g aids, 871, 872b Hearin g loss, 176

coch lear im plan tation , 871 con ductive, 870, 870f

Hearin g loss ( Continued) facilitatin g com m un ication in , 871b h earin g aids for, 871 m ixed, 871 presbycusis, 871 sen sorin eural, 870f, 871 sign s of, 871b

Heart an atom y an d ph ysiology of, 755 assessm en t of, 180, 181f, 181b ch an ges in , durin g pregn an cy, 301, 301f tran splan tation of, 764

Heart ch am bers, 755 Heart failure ( HF) , 774, 775b, 775t

in ch ildren , 479, 480b position in g clien ts with , 233

Heart rate, 756 in Apgar scorin g, 373t apical

of adolescen t, 273b of n ewborn an d in fan t, 268b of presch ooler, 271b of sch ool-age ch ild, 272b of toddler, 270b

determ in ation usin g 6-secon d strip m eth od, 765b

fetal, 294 m on itorin g, in labor an d birth , 335 n on reassurin g, pattern s of, 336, 337b variability in , 335b

in n ewborn , 372 Heart sou n ds, 181, 756 Heartburn , in pregn an cy, 301, 303 Heat loss, in n ewborn , 377, 380 Heavy m etals, poten tially n eph rotoxic, 822b Heel-to-sh in test, 185 Heigh t

ch an ges in , with agin g, 281, 282f of in fan t, 268 of presch ooler, 271 of sch ool-age ch ild, 272 of toddler, 269

Helicobacter pylori gastric can cer associated with , 580 in fection , m edication s for, 700, 700b

HELLP syn drom e, 321 Hem atocrit, 117, 117t

assessm en t of, in pregn an cy, 314 burn in jury an d, 557 levels of, in an tepartum diagn ostic

testin g, 306 Hem atological disorders, p ediatric,

411–418 aplastic an em ia, 413 β-Th alassem ia m ajor, 414, 414b h em oph ilia, 413, 414–415b iron deficien cy an em ia, 412, 413b sickle cell an em ia, 411, 412b, 412f von Willebran d’s disease, 414

Hem atological fin din gs, in liver dysfun ction , 681f

Hem atological system , ch an ges in , with agin g, 282

Hem atological system disorders. See also O n cological disorders

bon e m arrow tran splan tation for, 584

Hem atological system disorders ( Continued)

leukem ia, 419, 419b lym ph om a, 587 m ultiple m yelom a, 587

Hem atom a cerebral, 901 as com plication , in in traven ous th erapy,

149t, 150 postpartu m , 364, 365f in pregn an cy, 318, 318b

Hem atopoietic growth factors, 854, 855b Hem ian opsia, in stroke, 910b, 911 Hem ican e, 945 Hem odialysis, 827

access for, 828, 829f com plication s of, 830, 831b prin ciples of, 828

Hem odyn am ic m on itorin g, 776, 777f Hem oglobin , 117, 117t

assessm en t of, in pregn an cy, 314 levels of, in an tepartum diagn ostic

testin g, 306 Hem oglobin system , in acid-base balan ce,

97 Hem olytic-urem ic syn drom e, 493, 493b Hem oph ilia, 413, 414–415b Hem orrh age

in tracerebral, 900b in traven tricular, in n ewborn , 382 postoperative, 221 postpartum , 364, 365b

m edication s used to, 397, 397b subarach n oid, 900b from woun d, 545b

Hem o rrh agic fever, 198 Hem o rrh oidectom y, 232 Hem o rrh oids, 690

in pregn an cy, 301, 304 HepA. See Hepatitis A vaccin e ( HepA) Heparin , in paren teral n utrition , 136 Heparin sodium , 797, 798b Hepatic ducts, 672 Hepatic en ceph alopath y, m edication s for,

701 Hepatic system , assessm en t of, in n ewborn ,

376 Hepatitis, 683, 684b

in ch ildren , 449, 450b h om e care in struction s, 686b

Hepatitis A, 683 in ch ildren , 450

Hepatitis A vaccin e ( HepA) , 530 Hepatitis B, 684

in ch ildren , 450 in pregn an cy, 318 pregn an cy an d, 306

Hepatitis B surface an tigen (HBsAG) , 684 Hepatitis B surface an tigen testin g, 974b Hepatitis B vaccin e, 307

for ch ildren an d adolescen ts, 529 for n ewborn , 399

Hepatitis C, 685 in ch ildren , 450 tran sm ission by blood tran sfusio n ,

163

1107INDEX

Hepatitis D, 685 in ch ildren , 450

Hepatitis D an tigen (HDAg) , 685 Hepatitis E, 685

in ch ildren , 450 Hepatoren al syn drom e, 681 Herbal substan ces, effects in surgical

patien t, 218b Herbal th erapies, 39, 39b Hern ia

h iatal, 679 in tervertebral disc, 946 um bilical, 448

Herpes sim plex virus (HSV) , 546 in pregn an cy, 306t, 323

Herpes zoster (sh in gles) , 546 HESI/Saunders Online Review for the NCLEX-

RN ®

Examination, 2 Heterograft, for burn in jury care, 561b HHS. See Hyperosm olar h yperglycem ic

syn drom e ( HHS) Hiatal h ern ia, 679 Hickm an cath eter, 152f High -calcium diet, 129 High -calorie, h igh -protein diet, 128 High -fat diet, m etabolic acidosis due to

h igh in take of, 101b High -fiber (h igh -residue) diet, 127, 127b High -fiber foods, 449b High Fowler’s position , 232 High -iron diet, 129 High -output failure, of h eart, 775 High -risk th erapies, 38 High ly active an tiretroviral th erapy

(HAART), 980 High ly sen sitive C-reactive pro tein ( h sCRP) ,

757 Hin duism

dietary preferen ces in , 33b en d-of-life care an d, 38

Hip developm en tal dysplasia of, 511, 512f,

512b fractured, 945 replacem en t of, position in g clien ts for,

234 HIPAA. See Health In suran ce Portability

an d Accou n tability Act ( HIPAA) Hirsch sprun g’s disease, 446, 446f Hispan ic Am erican s, 35, 38 Histam in e (H2)-receptor an tagon ists, 698 Histam in e an tagon ists, 739 Histoplasm osis, 726 Histrion ic perso n ality disorder, 1011 HMG-CoA reductase in h ibitors, 809, 809b Hodgkin ’s disease, 587

in ch ildren , 421, 421f, 422t Hoffm an II, 942f Holter m on itorin g, 759 Hom e care in struction s

after cardiac surgery, 485b cystic fibrosis, 472 digoxin adm in istration in ch ildren , 480b for h epatitis, 686b in n eural tu be defects, 505 in paren teral n utrition , 138, 138b

Hom e care m easures, for asth m a, 469 Hom eo path y, 38 Hom eo stasis

of acidity, 818 fluid an d electrolyte, 78, 81 of potassium , 818 of sodium , 818 of water, 818

Hom ocystein e, 757 Hom ograft, for burn in jury care, 561b Hom on ym ous h em ian opsia, in stroke,

910b, 911 Horizon tal lie, in labor an d birth , 332, 333f Horm on al m edication s

for acn e vulgaris, 573 for can cer, 618, 618b

Horm on es, ovarian , 291 Horn s, of spin al cord, 893 Hospice care, 275 Hospital staffin g, 45 Hospital-acq uired in fection s, 195 Hospitalization

clien t’s righ ts durin g, 48b developm en tal stages in

of adolescen t, 267 of in fan t an d todd ler, 265 of presch ooler, 266 of sch oo l-age ch ild, 266

Hospitalized clien t, with tuberculosis, 728 24-h our urin e collection , 819 Househ old system s, 204, 205b h sCRP. See High ly sen sitive C-reactive

protein ( h sCRP) HSV. See Herpes sim plex virus ( HSV) Huff cough in g, 712b Hum an im m un odeficien cy virus ( HIV)

in fection , in ch ildren , 520, 521b, 521f life cycle of, 973f m edication s for, 980, 981b m oth er with , n ewborn of, 385 in p regn an cy, 305, 306t, 319 progression of, tests for, 974b

Hum an im m un odeficien cy virus (HIV) testin g, 967

Hum an papillom avirus, durin g pregn an cy, 306t, 325

Hum an papillom avirus vaccin e, 530 Hum oral respon se, 966 Hun ch b ack, 183b Hydan toin s, 926 Hydatidiform m ole, in pregn an cy, 320 Hydrocele

com m un icatin g, 448 n on com m un icatin g, 448

Hydroceph alus, 501, 502f Hydroch loric acid, 671 Hydrocodon e/ h om atropin e, 930 Hydrocolloidal dressin g, 553t Hydrogel dressin g, 553t Hydrogen ion s, 97

con cen tration in blo od regulatory system s for, 97, 98–99f in respiratory acido sis, 99 in respiratory alkalosis, 100

Hydrom orph on e, 114, 930 Hydrom orph on e h ydroch loride, 395

Hydron eph rosis, 838, 838f Hydrostatic pressure, 80 Hydroth erapy, for burn in jury, 560 Hydroxych loroquin e, 961 Hygien e care, depression an d, 1006b Hyperaldosteron ism , 102b

prim ary, 632 Hyperbilirubin em ia, in n ewb orn , 382 Hypercalcem ia, 88t, 89

cardiac ch an ges with , 758 electrocardiograph ic ch an ges in , 85t as on cological em ergen cies, 605

Hypercortisolism , 632, 632f Hypercyan otic sp ell, 482 Hyperem esis gravidarum , in pregn an cy,

320 Hyperglycem ia, 637

as com plication of paren teral n utrition , 136, 137t

in diabetic ch ild, 434, 434b Hyperh em olytic crisis, 412b Hyperkalem ia, 84, 84t

cardiac ch an ges with , 758 with ch ron ic kidn ey disease, 825, 825f as com plication of blood tran sfusion ,

163 electrocardiograph ic ch an ges in , 85t potassium -m odified diet for, 129

Hyperm agn esem ia, 89, 90t with ch ron ic kidn ey disease, 826 electrocardiograph ic ch an ges in , 85t

Hypern atrem ia, 86, 87t Hyperopia, 863 Hyperosm olar h yperglycem ic syn drom e

(HH S), 641t, 642 Hyperosm otic agen t, for in creased

in tracran ial pressure, 900b Hyperparath yroidism , 636 Hyperph osph atem ia, 91, 91b

with ch ron ic kidn ey disease, 826 Hyperpituitarism , 629 Hyperplasia, 842, 842–843f Hypersen sitivity, 968

delayed, 966 Hyperten sion , 787, 789b

with ch ron ic kidn ey disease, 826 classification s of, 111, 111b gestation al, in pregn an cy, 320, 321t,

322–323b m edication s fo r, 801, 801–802b portal, 681

Hyperten sive crisis, 788 Hyperth erm ia, 899 Hyperth yroidism , 628, 634t, 635, 635f Hyperton ic con tractio n s, durin g oxytocin

in fusion , 396, 397b Hyperton ic deh ydration , 82 Hyperton ic overh yd ration , 83 Hyperton ic solution s, 80, 144, 145t Hyperton ic uterin e activity, in fetal h eart

rate, 336 Hypertroph ic pyloric sten osis, 443, 443f Hypertroph y, ben ign prostatic, 842,

842–843f Hyperven tilation

n eurogen ic, 897b

1108 INDEX

Hyperven tilation ( Continued) respiratory alkalosis due to, 100b

Hypervolem ia, 83 with ch ron ic kidn ey disease, 826 as com plication of paren teral n utrition ,

136, 137t Hyph em a, 867 Hypn osis, 38 Hypocalcem ia, 86, 87b, 88t, 88f

cardiac ch an ges with , 758 with ch ron ic kidn ey disease, 826 as com plication of blood tran sfusion ,

163 electro cardio graph ic ch an ges in , 85t

Hypoglossal n erve, 184t Hypoglycem ia, 640, 640–641b

as com plication of paren teral n utrition , 136, 137t

in diabetes m ellitus, in ch ildren , 434, 434b

food item s for treatm en t of, 434b in n ewborn , 386

Hypoglycem ic m edication s, oral, 638 Hypokalem ia, 83, 83b, 84–85t, 85b

cardiac ch an ges with , 757 electro cardio graph ic ch an ges in , 85t

Hypom agn esem ia, 89, 89b, 90t electrocardiograph ic ch an ges in , 85t

Hypon atrem ia, 85, 86b, 87t Hypoparath yroidism , 636 Hypoph osph atem ia, 90, 90b Hypoph ysectom y, 629

position in g clien ts in , 232 Hypopituitarism , 629 Hypoplastic left h eart syn drom e, 483 Hypospadias, 491b, 494, 494f, 495b Hypoten sion

in cardiogen ic sh ock, 776 postural ( orth ostatic) , 764 supin e, in labor an d birth , 348

Hypoth alam us, 893 an atom y an d ph ysiology of, 626 h orm on es of, 627b

Hypoth yroidism , 628, 634, 634t in n ewborn , 386

Hypoton ic deh ydration , 82 Hypoton ic overh yd ration , 83 Hypoton ic solution s, 80, 144, 145t Hypoven tilation , respiratory acidosis due

to, 99b Hypovolem ia, with ch ron ic kidn ey disease,

826 Hypoxem ia

in n ewborn , 376 postoperative, 221

Hypoxia respiratory alkalosis due to, 100b tetralogy of Fallot, 482

Hysterectom y, 590 Hysteria, respiratory alkalosis d ue to, 100b

I IBS. See Irritable bowel syn drom e ( IBS) ICP. See In creased in tracran ial pressure

( ICP) Icteric stage, of h epatitis, 684b

Id, in Freud’s th eory, of psych osexual developm en t, 259

Iden tification ( ID) , 18–19 n eeded for takin g exam in ation , 11 of n ewborn , 379

Iden tification defen se m ech an ism s, 991b Iden tity, of clien t, in blood products

adm in istration , 160b Idiopath ic scoliosis, 512 Ileal con duit, 601, 603b Ileocecal valve, 671 Ileostom y, 595

perm an en t, total proctocolectom y with , 688

Ileum , 671 Ileus, postoperative paralytic, 222 Illn ess, tem perature an d, 109 Illu sion s, in sch izoph ren ia, 1009 Im in ostilben es, 927 Im m ediate postoperative period, 219 Im m un e disorders, pyram id poin ts, 965 Im m un e globulin

h epatitis A, 684 h epatitis B, 685

Im m un e system assessm en t of, in n ewborn , 376 ch an ges in , with agin g, 282 fun ction s of, 966, 967f im m un e respon se, 966 laboratory testin g in , 966, 968f T lym ph ocytes an d B lym ph ocytes in ,

966 Im m un e system disorders

acquired im m un o deficien cy syn drom e, 973, 973f, 974b

in ch ildren , 520, 521f, 521b an aph ylaxis, 968, 968f, 969b autoim m un e disease, 970

pem ph igus, 972 polyarteritis n odosa, 971 scleroderm a, 971 system ic lupus eryth em atosus, 970 system ic sclerosis, 971

com pon en ts of, 521f Go odpasture’s syn drom e, 972 h ypersen sitivity an d allergy, 968 im m un odeficien cy syn drom e, 973 Kap osi’s sarcom a, 974 latex allergy as, 969, 969–970b, 970f Lym e disease, 972, 972b, 972f m edication s fo r, 980–986 posttran splan tation im m un odeficien cy,

974 Im m un e system disturban ces, in liver

dysfun ction , 681f Im m un ity

acquired, 966 in n ate, 966

Im m un ization s/ vaccin es adm in istration guidelin es for, 529b con sen t for, 49b gen eral con train dicatio n s an d

precaution s, 528 guidelin es for, 529b in pediatric HIV/ AIDS, 528 reaction s to, 530

Im m u n ization s/ vaccin es ( Continued) recom m en ded ch ildh oo d an d

adolescen t, 528, 529b Im m u n odeficien cy, 973

posttran splan tation , 974 Im m u n oglobulin

for h epatitis in ch ildren , 450 quan titative, 974b

Im m u n ological m edication s, 980–986 an tibiotics as, 982, 983t, 983b h um an im m un odeficien cy virus an d

acquired im m un odeficien cy syn drom e, 980, 981b

im m un osuppressan ts, 982, 982b Im m un om odulator agen ts, 619, 619b Im m un om odulators, for in flam m atory

bowel disease, 701, 701b Im m un osuppressan t th erapy, for n eph ro tic

syn drom e, 493 Im m un osuppressan ts, 982, 982b

for atop ic derm atitis, 569, 570b oph th alm ic, 884b posttran splan t im m un odeficien cy due to,

974 Im pacted fracture, 940b Im paired n urse, repo rtin g of, 54 Im perforate an us, 449, 449b Im petigo, in ch ild, 404, 405f Im plan table port, for in traven ous th erapy,

152f, 153 Im plan tation , 292 Im plem en tation , question s on exam in ation

associated with , 25, 25b In activated polio vaccin e, 521 In carcerated h ern ia, 448 In cen tive sp irom etry, 216, 713b In ciden t reports, 52, 52b In cision

for kidn ey tran splan tation , 834f postoperative care of, 219 preoperative splin tin g of, 216, 217f

In cision al biopsy, 581 In com peten t cervix, in pregn an cy, 323 In com plete abortion , 315b In com plete fracture, 940b In creased in tracran ial pressure ( ICP) , 895,

898, 900b in leukem ia, pediatric, 419, 420b position in g clien ts in , 234

In cus, 869 In dian a pouch , 602 In din avir, 981 In dom eth acin , 481 In duced abortion , 315b In duction , in labor an d birth , 340 In evitable abortion , 315b In fan cy, growth an d developm en t of

Erikson ’s th eory of, 258b, 258t Freud’s th eory of, 261b Koh lberg’s th eory of, 260b

In fan t cardiopulm on ary resuscitation ( CPR) for,

387 ch okin g, 386, 387b, 387f developm en tal con sideration s for

adm in isterin g m edication s to, 540b

1109INDEX

In fan t ( Continued) developm en tal stages of

ch aracteristics of, 268 com m un ication approach es in , 267 h ospitalized, 265 skills of, 269b vital sign s of, 268b

eczem a in , 405b in creased in tracran ial pressure in , 420b

In farction , m yocardial, 773, 774b In fection s

of am n iotic cavity, 315 at cen tral ven ous cath eter site, 136b with ch ron ic kidn ey disease, 826 as com plicatio n of paren teral n utrition ,

136, 137t with fractures, 944 h ealth care-associated ( n osocom ial), 195 as in traven ou s th erapy com plication s,

149t, 150 with leukem ia, pediatric, 419, 420b in older clien t, 283, 283b opportu n istic, in pediatric, HIV/ AIDS,

520 postpartum , 365 in pregn an cy, 323 sexually tran sm itted, pregn an cy an d,

305–306, 306t, 324 stan dard precaution s for preven tion of,

195 TO RCH, in n ewborn , 384 tran sm ission -based precautio n s for

preven tion of, 196 urin ary tract, 835, 835–836b

in pregn an cy, 326 West Nile virus, 915 woun d, 223, 223b

In fectious an d com m un icable diseases, 520–535

care of ch ild with HIV an d AIDS, 520 ch icken pox ( varicella) , 524, 524f com m un ity-associated m eth icillin -

resistan t Staphylococcus aureus (CA- MRSA) , 527

diph th eria, 525 eryth em a in fectiosum ( fifth disease), 526,

526f in fectious m on on ucleo sis, 526 in fluen za, 527 m um ps, 520b, 524, 531b pertussis ( wh oopin g cough ) , 524 poliom yelitis, 525 Rocky Moun tain spo tted fever,

527, 527b roseola ( exan th em a subitum ) , 523,

523f rubella ( Germ an m easles), 523, 523f rubeola ( m easles) , 522, 523f scarlet fever, 525, 526f

In fectious h epatitis, 683 In fectious m on on ucleosis, 526 In fectious wastes, disposal of, 193 In fective en docarditis, 779b In fertility, 295 In filtration , preven tion an d in terven tion

for, 149t, 151

In flam m ation assessm en t in dark-skin n ed clien t, 173 in woun d h ealin g, 544

In flam m atory bowel disease, m edication s for, 701, 701b

In flam m atory diseases of th e h eart, 777, 779b

In flixim ab, 961 In fluen za, 724

in ch ildren , 527 m edication s for, 747, 747b, 748t

In form ation bracelets, of n ewborn , 379 In form ation security, 50, 51b In form ation tech n ology, security an d, 52 In form ation al po wer, 62b In form ed con sen t, 48–49, 49b

before surgery, 215 In fusio n pum ps, for blood produ cts

adm in istration , 159 In fusio n tim e, 208b In fusio n s, prescribed by un it dosage per

h our, 208, 209b In guin al h ern ia, 448 In h alan ts, 1025

in toxication , 1025b In h alation

an th rax tran sm ission an d sym ptom s, 197b

in jury due to, 556 In h alation devices, respiratory, 737, 738f In h aled n o n steroidal an tiallergy agen t,

738b, 739 In jectab le m edication s, in po wder form ,

207, 207b In jection

an gles of, 206, 206f en doscopic, for esoph ageal varices, 683 for paren teral m edication , 206 for paren teral m edication

adm in istration , in pediatric patien t, 536

In jection site, for pediatric paren teral m edication ad m in istration , 536, 538f, 538t

In jury fear of, pain an d

in h ospitalized adolescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch ool-age ch ild, 266

to h ealth care worker, preven tion of, 194, 194b

m usculoskeletal, 940 in p roof of liability, 47 in spin al cord, position in g clien ts with ,

234 In n ate im m un ity, 966 In n er ear, 869 INR. See In tern ation al n orm alized ratio

( INR) In sen sible loss, 81 In som n ia, with ch ron ic kidn ey disease, 824 In spection , 172

of abdom en , 182 of breast, 181 of ch est in lun g assessm en t, 178

In stitution al policies, 45 In sulation defen se m ech an ism s, 991b In sulin / in sulin th erapy, 638

adm in istration of, 639, 661 in ch ildren , 433 co m plication s of, 638 deficien cy of, in diabetes m ellitus, 433 effects in surgical patien t, 218b in jection sites for, 661, 662f m edication s for, 661 in paren teral n utrition , 136 storin g for, 662b tim e activity of, 661t

In sulin lipodystroph y, 638 In sulin pum ps, 639 In sulin syrin ge, 207, 207f In suran ce, liability, 47 In take an d output, 81, 81f In tegrase in h ibitor, 981 In tegrated process, 6–7, 7b In tegum en tary disorders

pediatric, 404–410, 404b, 407b burn in juries, 407, 407b eczem a ( atopic d erm atitis) , 404, 405b im petigo, 404, 405f pediculosis capitis ( lice), 405, 406b scabies, 406, 406f, 406b

pyram id poin ts, 543 In tegum en tary m edication s, 569–577

for acn e vu lgaris, 573f for actin ic keratosis, 570 for atopic derm atitis, 570, 570b for burn products, 574, 574b for poison ivy, 569, 570b for psoriasis, 571, 571b sun screen s, 570 topical glucocorticoids, 569, 569b, 575b

In tegum en tary system , 544–568 acn e vulgaris, 550 actin ic keratoses, 548 an atom y an d ph ysiology of, 544 assessm en t of, 172, 173t, 173b bites an d stin gs, 547 burn in jury, 554b, 555–556f Candida albicans, 545 cellulitis, 547 ch an ges in , with agin g, 281 ch ron ic kid n ey disease m an ifestation s in ,

824b cystic fibrosis m an ifestation s in , 471 erysipelas, 547 fluid volum e deficit an d excess fin din gs

in , 82t frostb ite, 548 h erp es zoster ( sh in gles), 546 h ypon atrem ia an d h ypern atrem ia

fin din gs in , 87t in h alation in juries, 556 in terven tion s in spin al cord in jury, 905 m eth icillin -resistan t Staphylococcus

aureus, 546 poison ivy, poison oak, an d poison

sum ac, 547, 547f position in g clien ts in , 230 postoperative care of, 219 pressure ulcer, 551, 551t

1110 INDEX

In tegum en tary system ( Continued) psoriasis, 550 psych osocial im pact of, 544 risk factors for, 544 skin can cer, 549, 549t woun d h ealin g ph ases in , 544

In tellectual disability ( m en tal retard ation ) , 506

In tellectualization defen se m ech an ism s, 991b

In ten tion , woun d h ealin g by, 545 In terferon s, for m align an cy, 619 In terleukin s, for m align an cy, 619 In term itten t in fusion devices, 146 In term itten t sequen tial com pression , 219f,

222 In tern al disasters, 197 In tern al fixation of fracture, 941, 941f In tern al jugular vein s, cath eterization for

paren teral n utrition , 134, 135f In tern al rotation , in labor, 334b In tern ation al n orm alized ratio ( INR) , 116,

798 In terp erson al con flict, 64 In terp erson al psych oth erapy, 993 In terstate en dorsem en t, 13 In terstitial fluid, 79f In terven tion s

African Am erican culture an d, 32 Am ish an d, 34 Asian Am erican culture an d, 35 Hispan ic an d Latin o Am erican culture

an d, 35 in h ospitalized ad olescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch ool-age ch ild, 266 Native Am erican culture an d, 36 wh ite Am erican culture an d, 37

In tervertebral disc h ern iation , 946 In testin al obstruction , in cystic fibrosis, 471 In testin al tubes, 242 In testin al tum ors, 595 In toxication , water, 83 In tracellular com partm en t, 78, 79b In tracerebral h em orrh age, 900b In tracran ial pressure

in creased, 895, 898, 900b in leukem ia, pediatric, 419, 420b position in g clien ts in , 234

leukem ia an d, 420b In tractable an gin a, 772 In traderm al in jection , of paren teral

m edication , 206, 206f In tram uscular in jection , of paren teral

m edication , 206, 206f in pediatric patien t, 536, 538f, 538t

In traoperative pressure, 863 In traperson al con flict, 64 In trath ecal opioid an algesics, for labor an d

birth , 339 In trauterin e fetal d em ise, in labor an d birth ,

350 In travascular com partm en t, 78 In travascular fluid, 79f In travascular ultrason ograph y ( IVUS) , 761

In traven o us (IV) can n ulas, 144 In traven o us (IV) con tain ers, 145 In traven o us fluids, for in creased

in tracran ial pressu re, 900b In traven o us (IV) gauges, 144 In traven o us (IV) m ed ication s

adm in istration of, 206, 206f calculation s an d adm in istration of,

pediatric, 536, 540b calculation s of

dosage, 208b flow rates, 208, 208b

potassium , 85b In traven o us (IV) th erapy, 144, 144b

cen tral ven ous cath eters for, 152, 152f com plication s of, 149, 149t devices for, 144, 145–146f epidural cath eter for, 153, 153b, 153f in itiation an d ad m in istration of, 147,

148b latex allergy an d, 147 periph eral sites for, 147, 147f, 147b precaution s in , 149 purpose an d uses of, 144 types of solution s an d, 144, 145t

In traven o us (IV) tubin g, 145, 145–146f In traven o us tubin g, flow rates an d,

208 In traven o us urograph y, 820 In traven o usly adm in istered m edication s,

536 In traven tricular h em orrh age, in n ewborn ,

382 In trin sic factor, 671 In trojection defen se m ech an ism s, 991b In tubation procedures, 239, 241b In tussusception , 447, 447f In vasion of privacy, 47 In vasive epicardial pacin g, 770 In vasive pacin g

epicardial, 770 tran sven ous, 770

In vasive tran sven ou s pacin g, 770 In versio n , uterin e, in labor an d birth , 351 In vo lun tary adm ission , 992 In vo lution , of uterus, 356, 357f Iodin e, radioactive, uptake, 628 Ion , 79b Ion izin g radiation , as warfare agen t, 199 Ion otroic an d cardioton ic m edication s,

799, 800f, 800b Ion s, poten tially n eph rotoxic, 822b iPLEDGE program , 574 Irin otecan , 618b Iris, 861 Iron

diet for h igh in take of, 129 food sou rces of, 413b overload, due to blood tran sfu sion ,

162 supplem en tation of, for in fan t, 268

Iron deficien cy an em ia in pediatric patien t, 412, 413b in pregn an cy, 314

Irrigatio n of ch em ical eye in jury, 868b

Irrigation ( Continued) con tin uous bladder, 599 of ear, 888, 888f in n asogastric tube, 232 n asogastric tubes, 239 self-irrigation of urin ary stom a, 603b

Irritability, reflex, in Apgar scorin g, 373t Irritable bowel syn drom e ( IBS) , 448, 687

m edication s for, 701, 702b Ish ih ara ch art, 175 Islam

dietary preferen ces in , 33b en d-of-life care an d, 37 organ don ation an d tran splan tation an d,

49 Isolatio n

defen se m ech an ism s, 991b in older clien t, 283

Ison iazid, 326, 742 Isoproteren ol, 808 Isoton ic deh ydration , 81 Isoton ic overh ydration , 83 Isoton ic solution s, 80, 144, 145t Isotretin oin , 573

for acn e vulgaris, 574 Itch m ite, 406 IVUS. See In travascular ultrason ograph y

( IVUS)

J J poin t, 758b Jackson -Pratt device, 592, 593f Jaun dice, 173b

assessm en t in dark-skin n ed clien t, 173 with cirrh osis, 681 in h yperbilirubin em ia, 382 in n ewborn , 376

Jeh ovah ’s Witn esses dietary preferen ces in , 33b organ don ation an d tran splan tation an d,

49 Jeju n ostom y tube, adm in isterin g

m edication s via, 242b Jejun um , 671 Join ts

degen erative disease of, 949b, 950 dislocation an d subluxatio n of, 946 juven ile idiopath ic arth ritis of, 514 rh eum atoid arth ritis of, 949, 949b types of, 937, 938t

Jon es criteria for diagn osis of rh eu m atic fever, 486b

Judaism dietary preferen ces in , 33b en d-of-life care an d, 37 organ d on ation an d tran splan tation an d,

49 Judgm en t, in m en tal status exam , 172b Justice, 45 Juven ile idiopath ic arth ritis, 514, 514b

K Kaposi’s sarcom a, 974 Kawasaki disease, 486, 487b Keratolytics, 571 Keratom ileusis, laser-assisted in -situ, 863

1111INDEX

Keratosis, actin ic, 548 Keratotom y

ph otorefractive, 863 radial, 863

Kern ig’s sign , 186, 502, 898b, 915, 915f Ketoacidosis, diabetic, 101, 101b

in ch ildren , 432f, 434 Kick coun ts, 308 Kidn ey, 817

acute in jury of, 822, 822–823b ch ron ic disease of, 823, 824b, 824t, 825f fun ction s of, 817 polycystic disease of, 838 tran splan tation of, 833, 834f, 835b tum ors of, 841

Kidn ey, ureters, an d bladder ( KUB) rad iograph y, 820

Kidn eys, excretion of acids from , 97 Kn ee, total replacem en t, 946 Kn ee jerk reflex, 394 Kock p ouch , 601 Koebn er ph en om en on , 550 Koh lberg’s th eory, of m oral developm en t,

259, 260b Koplik’s spots, 523 Kupffer cells, 671 Kyph osis, 183b

L Labels

IV bag, 149, 150f m edicatio n , 205

Labor an d birth , 332–345, 332b, 341b 4 P’s of, 332 an esth esia for, 339 breath in g tech n iques for, 335, 335b defin ition of, 332 fetal m on itorin g in , 335, 335b, 336f,

337b four stages of, 337, 338f, 338t in terven tion s durin g, in diab etes

m ellitus, 316 Leopold ’s m an euvers durin g, 334 m ech an ism s of, 333, 334b obstetrical proced ures in , 340, 340t problem s with , 346–355, 346b, 351b

abruptio placen tae, 348, 348f am n iotic fluid em bolism , 350 dystocia, 349 fetal d istress, 350 in trauterin e fetal dem ise, 350 placen ta previa, 346, 347f placen tal abn orm alities, 348 precipitous lab or an d delivery, 349 prem ature ruptu re of th e m em bran es,

346 preterm labor, 349 prolapsed um bilical cord, 346, 347b,

347f rupture of th e uterus, 350 supin e h ypoten sio n (ven a cava

syn drom e) , 348 uterin e in version , 351

process of, 332, 333f, 334b true versus false, 334b

Labor curve, 337, 338f

Laboratory fin din gs fluid volum e deficit an d excess fin din gs

in , 82t in h ypocalcem ia an d h ypercalcem ia,

88t in h ypokalem ia an d h yperkalem ia, 84t in h ypom agn esem ia an d

h yperm agn esem ia, 90t in h ypon atrem ia an d h ypern atrem ia, 87t

Laboratory referen ce in tervals, 114, 115t, 115f, 119b

Laboratory value, in acid-base im balan ces, 103t

Laboratory values/ tests, in asth m a, 468b Labyrin th itis, 874 Laceration s, perin eal, 358 Lacrim al glan d, 862 Lactose in toleran ce

in ch ildren , 444 in pregn an cy, 309

Lactulose, 682 Laissez-faire leadersh ip, 61 Lam in ectom y

decom pressive, 907 position in g clien ts in , 234

Lam ivudin e, 980 Lam ivudin e/ zidovudin e, 980 Lam ivudin e/ zidovudin e/ abacavir, 980 Lan guage disturban ces, in sch izoph ren ia,

1009, 1010b Lan ugo, in n ewborn , 374 Laparoscopy, 674 Large for gestation al age, 380 Large in testin e, 671 Laryn gectom y, 597

position in g clien ts in , 232 speech reh abilitation followin g, 598b

Laryn gectom y stom a, 597 Laryn goscop y, 710 Laryn gotrach eobron ch itis, 464, 464b, 465t Laryn x, 708

can cer of, 597, 597f Laser-assisted an gioplasty, 761 Laser-assisted in -situ keratom ileusis

( LASIK), 863 Laser th erapy

for cervical can cer, 596 for lun g can cer, 596 for varicose vein s, 783

LASIK. See Laser-assisted in -situ keratom ileusis (LASIK)

LATCH, assessin g, 359 Latch key ch ild, 1036 Late deceleration s, in fetal h eart rate, 336,

336f Laten cy stage, of psych osexual

developm en t, 261b Laten t ph ase, of labor, 337, 338f, 338t Later ad ulth ood

d evelopm en t in , Erikson ’s stages of, 258b, 258t

developm en tal stages of, 274 Lateral ( side-lyin g) position , 231f, 232 Latex allergy, 147, 969, 969–970b, 970f Latin o Am erican s, 35, 38 Lavacuator tube, 240f, 243

Lavage tubes, 243 Laws, 46

clien t’s righ ts an d, 48, 48b Good Sam aritan , 47 types of, 46, 46b, 46f

Laxatives, 701, 702b Lead poison in g, 451 Leadersh ip, 60, 60–61b Leflun om ide, 961 Left atrium , 755 Left ven tricle, 755 Left ven tricular failure, 774 Leg cram ps, in pregn an cy, 304 Leg exercises, preop erative, 216 Legal an d eth ical issues, in en d-of-life care,

275 Legal blin dn ess, 864 Legal liability, 46, 46f, 46–47b Legal risk, areas of, 47 Legal safeguards, 52, 52–53b Legg-Calve-Perth es disease, 515 Legion n aire’s disease, 725 Legitim ate power, 62b Legs

assessm en t of arteries in , 181b periph eral sites in , 147, 147f

Len gth , in n ewborn , 373 Len s, 862

cataracts of, 864, 864f, 865b Leopold’s m an euvers, for labor an d

delivery, 334 Leprostatics, adverse effects of, 983t Leukaph eresis, for stem cell h arvestin g, 584 Leukem ia, 585b Leukem ia, in ch ildren , 419, 419–420b Leukopoietic growth factors, 855, 855b Leukotrien e m odifiers, 738b, 739 Level of con sciousn ess

in m en tal status exam , 171 in n euro logical system assessm en t, 183

Levin tube, 239, 240f Lewin ’s b asic con cept of th e ch an ge process,

63, 63f Liability, legal, 46, 46f, 46–47b

proof of, 46 Liability in suran ce, 47 Libel, 47 Lice, in ch ild, 405 Licen sure requirem en ts, for foreign -

educated n urse, 13, 13b Ligation

en doscopic variceal, esoph ageal, 683 of in ferior ven a cava, 787

Ligh t reflex co rn eal, 174 pupillary, 175b

Ligh t touch , assessm en t of, 185 Ligh ten in g, in labor an d birth , 333 Lim bic system , 894b Lin cosam ides, adverse effects of, 983t Lin dan e, 406 Lin ea n igra, 302 Lip, cleft, 440, 440f Lipids, 117, 118t

levels, in coron ary artery disease, 771 m edication s for reduction of, 809

1112 INDEX

Lipids ( Continued) in paren teral n utrition , 135, 135b serum , 757

Lipodystroph y, in sulin , 638 Lipoprotein -a, 757 Lips, assessm en t of, 177 Liquid diet, 126 Liraglutid e, 663 List, in path ways to success, 14 Lith ium , 1046, 1046b

toxicity, 1047 h ypon atrem ia an d, 86

Lith ium carbon ate, for bipolar disorder, 1004

Lith otom y position , 231, 231f Lith otripsy

extracorporeal sh ock wave, 840 percutan eous, 840

Liver an atom y an d ph ysiology of, 671 laboratory stu dies of, 675

Liver biopsy, 675 position in g clien ts an d, 232

clien t un dergoin g, 232b Liver en zym es, in preeclam psia, 321t Lobectom y, for lun g can cer, 596 Local an esth esia, for labor an d birth , 339 Loch ia, 356, 357b Lon gitudin al lie, in labor an d birth , 332,

333f Loop diuretics, 801–802b, 802 Lopin avir/ riton avir, 981 Lorazepam , 926t, 927 Lordosis, 183b Loss, 1031

n urse’s role in , 1031 perin atal, postpartum , 367

Loss of con trol in h ospitalized ad olescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch ool-age ch ild, 266

Lou Geh rig’s disease, 914 Lovastatin , 809, 809b Low-output failure, of h eart, 774 Low-purin e diet, 129 Low-risk th erapies, 38–39, 40b Lower extrem ities

am putation of, 233 periph eral sites in , 147, 147f

Lower respiratory airway, 708 Lubrican ts, oph th alm ic, 885, 885b Lum b ar disk h ern iation , 947 Lum b ar epidural block, for labor an d birth ,

339 Lum b ar pun cture, 895

position in g clien ts in , 234 Lum b ar spin e in juries, 904

in terven tion s for, 906 Lum p ectom y, 592b Lun g biopsy, 711 Lun g scan , ven tilatio n -perfusion , 711 Lun g surfactan ts, 398 Lun gs

in acid-base balan ce, 97–98 an atom y an d ph ysiology of, 709

Lun gs ( Continued) assessm en t of, 178, 178b, 179f, 180b,

180t can cer of, 596

m etastatic, 581b ph ysiological m atern al ch an ges in , 301f water loss from , 81

Lupus, 970 Luteal ph ase, of m en strual cycle, 292b Lutein izin g h orm o n e (LH) , in m en strual

cycle, 291 Lym e disease, 972, 972b, 972f Lym ph n odes

assessm en t of, 174 Hodgkin ’s disease an d, 421, 421f

Lym ph ocyte im m un e globulin , 982 Lym ph ocyte screen , 974b Lym ph ocytic leukem ia, acute, 419 Lym ph om a, 421

M Macewen ’s sign , 500 Macrobiotic diet, 39b Macrodrip ch am ber, in in traven ous

th erapy, 146, 146f Macrodrip set, in in traven ous th erapy, 208 Macrolides, adverse effects of, 983t Macula lutea, 862 Macular degen eration , 866

m edication s for, 887 Mafen ide acetate, for burn in jury, 575 Magn esium

as an tacids, 699t cardiovascular testin g of, 758 com m on food sources of, 89b food sou rces of, 125b h yperm agn esem ia an d, 89, 90t h ypom agn esem ia an d, 89, 89b n orm al value for, 89b

Magn esium sulfate, 393, 394t for preeclam psia, 322

Magn etic reson an ce im agin g ( MRI) of cardiovascular system , 759 in m usculoskeletal disorders, 938 of n eurological system , 895 ocular, 863

Main stem bron ch i, 708 Male gen italia, assessm en t of, 186

in n ewborn , 375 Male reproductive structu res, 291 Malleu s, 869 Maln utrition , m etabolic acidosis due to,

101b Malpractice, 45–46 Man aged care, 59 Man agem en t

of care sub categories on exam in ation , 4, 4t

fun ction s of, 61b leadersh ip an d, 60, 60–61b

Man ia, in bipolar disorder, 1005, 1005b Man ipulative beh avior, with bipolar

disorder, 1005b Man ipulative practices, 38 Man n itol, 887, 931 Man tou x test in terpretation , 474, 474b

MAO Is. See Mon oam in e oxidase in h ibitors ( MAO Is)

MAP. See Mean arterial pressure (MAP) Maraviroc, 981 Marfan syn drom e, 514 Marijuan a ( Cannabis sativa) , 1025 Marital rape, 1037 Mask

oxygen , 465t of pregn an cy, 302 in stan dard precaution s, 195

Maslow’s Hierarch y of Needs th eory, 23, 24f, 24b

Massage, fun dal, for uterin e aton y, 364, 365f

Massage th erapy, 38 Mast cell stabilizers, oph th alm ic, 884b Mastectom y, 230, 593b Mastitis, p ostpartum , 366, 366f Masto idectom y, 872 Masto iditis, 873 Matern ity n ursin g

care of th e n ewborn , 372–392, 372b, 388b

labor an d birth , 332–345 problem s with , 346–355

m atern ity an d n ewborn m edication s, 393–402, 393b

postpartum period, 356–363 co m plication s of, 364–371

pren atal period , 299–313, 299b pyram id poin ts, 289 reproductive system , 291–298, 291b risk con dition s related to pregn an cy,

314–331 Maturation al crisis, 1031b MCV. See Men in gococcal vaccin e ( MCV) MDI. See Metered-dose in h aler ( MDI) MDR-TB. See Multidrug-resistan t strain of

tub erculosis ( MDR-TB) Mean arterial pressure (MAP), 777 Measles, 522 Measles, m um ps, rubella ( MMR) vaccin e,

530 Measurem en t abbreviation s, 538b Measurem en t system s, for drug

adm in istration , 204, 205b Mech an ical prosth etic valves, 780 Mech an ical soft diet, 126 Mech an ical ven tilatio n , 715, 716f, 717t,

718b Mech an ical ven tilators, respiratory

alkalosis due to overven tilation by, 100b

Mech loreth am in e, 616, 616b Mecon ium aspiration syn drom e, in

n ewborn , 381 Mecon ium stool, 377 Medical records, con fiden tiality of, 51 Medication cartridge, prefilled, 207 Medication label, 205 Medication recon ciliation , process of, 65b Medication s

adm in isterin g, via n asogastric, gastrostom y, or jejun ostom y tube, 242b

1113INDEX

Medication s ( Continued) adm in istration an d calculation of,

pediatric, 536, 536b, 540b adm in istration of, 204, 205b an tin eoplastic, 614, 614b, 619b for asth m a, 469, 469b calculation of, 204–214, 204b

con version s in , 204, 205b dosage calculation in , 207, 208b in fusion s prescribed by un it dosage per

h our in , 208, 209b of in jectable m edication s in powder

form , 207, 207b in traven ous flow rate in , 208, 208b m easurem en t system s in , 204, 205b m ed ication labels in , 205 of oral m edication s, 206 of paren teral m edication s, 206,

206–207f percen tage an d ratio solution s in , 208 prescription s for, 206, 206b

cardiovascular, 797–814, 810b h earin g loss due to, 888b in tegu m en tary, 569–577 in traven ous, 145

in term itten t in fusion devices for adm in istration of, 146

m atern ity an d n ewborn , 393–402, 393b

m usculoskeletal, 958–964 n euro logical, 923–935 in older clien t, 284, 284–285b oph th alm ic, 882, 883f paren teral, 206 pediatric, 536–542 poten tially n eph rotoxic, 822b preoperative adm in istration of, 218 preoperative precautio n s, 218, 218b prescriptio n for

com pon en ts of, 53b legal safeguards, 52, 53b

psych iatric, 1043–1055 question s about, 29, 29b ren al, 850–859 for spin al co rd in juries, 907 Steven s-Joh n son syn drom e, 550

Medicin e cup, 206 Meditation , 38 Medulla oblon gata, 893 Melan om a, 549, 549t

ocular, 866 Melaton in , 39b Mem an tin e, 1051 Mem ory, in m en tal status exam , 172b Mem ory ch an ges, 898b Men iere’s syn drom e, 874 Men in geal irritation , 186, 898b Men in ges, 893 Men in gitis, 915

in ch ildren , 502 Men in gocele, 504 Men in gococcal vaccin e ( MCV) , 530 Men strual cycle, 291, 292b

tem perature an d, 109 Men strual ph ase, of m en strual cycle, 292b Men struation , in postpartum period, 356

Men tal h ealth , 990 assessm en t of, 171, 172b con cern s, in older clien t, 282, 283t

Men tal h ealth disorders, 1000–1018 an xiety, 1000, 1001b depression , 1005, 1006b dissociative disorder, 1003 electrocon vulsive th erapy for, 1006,

1007b gen eralized an xiety disorder, 1001 m ood disorders, 1004 o bsessive-com pulsive disorder, 1002,

1003b p aran oid person ality disorder, 1011,

1011b person ality diso rders, 1010 ph obia, 1002, 1002b posttraum atic stress disorder, 1001,

1002b pyram id poin ts, 987 sch izoph ren ia, 1008, 1008f, 1008b,

1010b Men tal h ealth n ursin g, 988–999

copin g an d defen se m ech an ism s in , 990, 991b

Diagnostic and Statistical Manual of Mental Health Disorders, 990

m en tal h ealth in , 990 n urse-clien t relation sh ip in , 988 psych iatric-m en tal h ealth illn ess in ,

990 th erapeutic com m un ication process in ,

989, 989f, 990b types of m en tal h ealth adm ission s an d

disch arges clien t righ ts an d, 991b disch arge plan n in g an d follow-up,

992 in vo lun tary adm ission , 992 righ t to con fiden tiality, 991 volun tary adm ission , 991 volun tary release, 992

Men tal Health System s Act, 48, 48b Men tally ill

in form ed con sen t issues with , 49, 49b righ ts for, 48, 48b

Meperidin e, 930–931 Meperidin e h ydroch loride, 395 Meph obarb ital, 926 Mercapto purin e, 617 Mesocaval sh un tin g, for esop h ageal varices,

683 Metabo lic acidosis, 100t, 101, 101b

with ch ron ic kidn ey disease, 826 Metabo lic alkalo sis, 101, 101t, 102b Metabo lic syn drom e, 637 Metabo lic system

assessm en t of, in n ewborn , 377 pediatric disorders of, 430–438

Metastasis, 580 Metaxalon e, 959, 959b Metered -dose in h aler (MDI) , 737, 738f

for asth m a, 469 Metform in , 760 Meth adon e, 930 Meth en am in e, 850, 851b

Meth icillin -resistan t Staphylococcus aureus (MRSA)

co m m u n ity-associated, pediatric, 527 in tegum en tary, 546

Meth im azole, 655 Meth ocarbam ol, 959, 959b Meth otrexate, 961, 982

for atopic derm atitis, 570b for juven ile idiopath ic arth ritis, 514b for m align an cy, 617 for psoriasis, 571

Meth suxim ide, 927 Meth ylergon ovin e m aleate, 397 Meth ylxan th in e bron ch odilators, 737 Metoclopram ide, 700 Metric system

co n version between , 204, 205b for drug calculation , 204, 205b for m easurem en ts of fluids, 78

Microalbum in uria, 757 Microdrip ch am ber, in in traven ous th erapy,

146, 146f Microdrip set, in in traven ous th erapy,

208 Microprocessor ven tilator, 716 Microsh ock, risk reduction of, 770 Midbrain , 893 MIDCAB. See Min im ally in vasive direct

coron ary artery bypass ( MIDCAB) Middle adulth ood

developm en t in , Erikson ’s stages of, 258b, 258t

developm en tal stages of, 274 Middle ear, 868 Middle m an ager, 61 Milieu th erapy, 992 Milk th istle, 39b Miller-Abbott tube, 240f, 242 Milliequivalen t ( m Eq) , 78, 204 Milliliters per h our, 208, 208b Milrin on e lactate, 800b Min d-body m edicin e, 38 Min eralocorticoids, 628b

as en docrin e m edication , 655 h ypersecretion of, 632

Min erals, 124 den sity m easurem en t in bon e, 939 food sources of, 125b in paren teral n utrition , 135

Min i-Hoffm an system , 942f Min idrip set, in in traven ous th erapy,

208 Min im ally in vasive direct coron ary artery

byp ass ( MIDCAB) , 763 Min n esota tubes, 232, 243 Min ocyclin e, 574 Min ors, con sen t an d, 50 Miotics, 865

for eye disorders, 885b Misoprostol, 698 Missed abortion , 315b Mitigation , in disaster m an agem en t, 69 Mitotic in h ibitor m edication s, 618, 618b Mitral an n uloplasty, 780 Mitral in su fficien cy, 779 Mitral sten osis, 779

1114 INDEX

Mitral valve, 755 prolapse of, 779

Mixed h earin g loss, 871 3-m L syrin ge, 206 5-m L syrin ge, 207, 207f Mn em on ics

PERRLA, 175b REEDA, 223

MNPI. See Myocardial n uclear perfusion im agin g ( MNPI)

Modelin g, 993 Modified Brooke resuscitation fo rm ula,

558t Modified Parklan d resuscitation form ula,

558t Modified-paced breath in g, in labor an d

birth , 335b Modular n ursin g, 60 Moldin g, of h ead, in n ewborn , 373, 373f Molecule, 79b Mon golian spots, as birth m ark, 375t Mon oam in e oxidase in h ibitors ( MAO Is) ,

1045, 1045b, 1046f Mon obactam s, adverse effects of, 983t Mon oclon al an tibodies, for m align an cy,

619, 619b Mon oclon al an tibody, as respiratory

m edication s, 739 Mon on ucleosis, 526 Mood disorders, 1004 Mood stabilizers, 1046, 1046b Moral developm en t, Koh lberg’s th eo ry of,

259, 260b Morals, 44 Morm on

dietary preferen ces in , 33b en d-of-life care an d, 38

Moro reflex, in n ewborn , 378 Morph in e, 930 Morph in e sulfate, 114

for h ead in jury, 901 Motor activity, in sch izoph ren ia, 1008,

1008b Motor fun ction , assessm en t of, 185 Motor n euron s, 894 Motor respon se, in m en in geal irritation ,

898b Mourn in g, 1031 Mouth

an atom y an d ph ysiology of, 671 assessm en t of, 177

of n ewborn , 374 care o f, in clien t with m ucositis, 586b

Movin g, in ch an ge process, 63, 63f MRI. See Magn etic reson an ce im agin g

( MRI) Mucocutan eous lym ph n ode syn drom e,

486 Mucosal ulceration , as rad iation th erapy

side effect, 422t Mucositis, with leukem ia, 421 Mucous m em bran es, in deh ydration ,

pediatric, 431t Multidrug-resistan t strain of tuberculosis

( MDR-TB) , 742 Multiple gestation , in pregn an cy, 324

Multiple m yelom a, 587 Multiple person ality disorder.

See Dissociative iden tity diso rder (DID)

Multiple-respon se question s, 7, 8b, 20 Multiple sclerosis, 911

m edication s for, 923, 924b Multiple-ch oice question s, 7, 20 Mum ps, 520b, 524, 531b Murph y’s sign , 680 Muscle cram ps, with ch ron ic kidn ey

disease, 827 Muscle relaxan ts, 958, 959b

for in creased in tracran ial pressure, 900b

Muscle stren gth , 183, 183t Muscle ton e

in Apgar scorin g, 373t assessm en t of, 183

Muscles an atom y an d p h ysiology of, 937, 938t,

938f biopsy of, 940 of eye, 862 skeletal, 938 strain of, 940

Musculoskeletal disord ers pediatric, 511–519

con gen ital clubfoot, 511, 511b, 513f developm en tal dysplasia of h ip, 511,

512f, 512b fractures, 515, 515b idiopath ic scoliosis, 512 juven ile idiopath ic arth ritis, 514, 514b Legg-Calve-Perth es disease, 515 Marfan syn drom e, 514

pyram id poin ts, 936 Musculoskeletal system

an atom y an d ph ysiology of, 937 assessm en t of, 183, 183t, 183b ch an ges in

with agin g, 281, 282f older clien ts, 193b

with ch ron ic kidn ey disease, 824b ph ysiological m atern al ch an ges in , 302 position in g clien ts in , 234 postoperative care of, 219

Musculoskeletal system disorders am putation of a lower extrem ity, 948,

948–949f can es an d walkers for, 945 crutch walkin g for, 944, 945t diagn ostic tests for, 938 fractures, 940, 940b

com plication s of, 943, 943b h ip, 945

gout, 951 in juries, 940 in tervertebral disc h ern iation , 946 join t dislocation an d sublu xation , 946 m edication s for, 958–964 osteoarth ritis, 950 osteoporosis, 950, 951b osteosarcom a, 424 risk factors for, 939b total kn ee replacem en t for, 946

Musculoskeletal system m edication s, 958–964

an tiarth ritic, 960, 960b, 961f an tigout, 959 to preven t an d treat osteoporosis, 961,

961b skeletal m uscle relaxan ts, 958, 959b

Mustard gas, 199 Myasth en ia gravis, 912 Myasth en ic crisis, in m yasth en ia gravis,

912 Mycobacterium tuberculosis, 326, 473 Mycoph en olate m ofetil, 854, 982 Mycoph en olic acid, 982 Mycoplasma pneumoniae, 466 Mydriatic, 863, 883, 883b Myelom en in gocele, 504 Myelosuppression , as radiation th erapy side

effect, 421f Myocardial in farction , 773, 774b Myocardial m uscle, 757

in m yocardial in farction , 773 Myocardial n uclear perfusion im agin g

( MNPI), 759 Myocarditis, 778 Myocardium

an atom y of, 755 tran sm yocardial revascularization , 762

Myocardium , con tractility of, m edication s for stim ulation of, 799

Myoclon ic seizure, 908b Myoglobin , 757

in m yocardial in farction , 773 Myopia, 863 MyPlate, 125, 125f Myrin goplasty, 872 Myrin goto m y, 458, 872 Myxed em a com a, 634, 635b

N Nadir, 421 Nails, assessm en t of, 172 Nalbuph in e, 395, 930 Naloxon e, 395 Narcissistic person ality disorder, 1012 Nasal can n ula, 712, 714t, 715f

for ch ildren , 465t Nasal decon gestan ts, 740, 740b Nasal h igh -flow ( NHF) respiratory th erapy,

712, 715b Nasal spray vaccin e, for in fluen za, 747 Nasal stuffin ess, in pregn an cy, 303 Nasogastric tubes, 239, 240f, 241b

adm in isterin g m edication s via, 242b position in g clien ts in , 232

Nasotrach eal tubes, 245 Nation al Coun cil of State Boards of Nursin g

( NCSBN) developm en t of test plan by, 4 foreign -educated n urse an d, 13 pass-or-fail decision s by, 12 Web site for, 3, 13

Native Am erican s, 36, 38 Native im m un ity, 966 Natural disasters, 68b Natural im m un ity, 966

1115INDEX

Natu ropath y, 38 Nausea

in dyin g clien t, 276b in h yperem esis gravidarum , 320 in pregn an cy, 301–302 as radiation th erapy side effect, 421f

NCLEX-RN ®

exam in ation , 1–13 addition al in form ation regardin g, 12 Auth orization to Test (ATT) form for, 10 can didate perform an ce report followin g

failure of, 13 ch an gin g of appoin tm en t for, 10–11 com p letion of, 12 com p uter adaptive testin g in , 3–4 day of, 11, 16–17, 16b fin al preparation for, 16 from graduate’s perspective, 18–19 iden tification n eeded for takin g, 11 in terstate en dorsem en t an d, 13 len gth of, 12 Nurse Licen sure Com pact an d, 13 pass-or-fail decision s followin g, 12 path ways to success for, 14–15, 15b process of, 3 processin g results of, 12–13 Pyram id to Success, 2–3, 14, 15f registerin g to take, 10 sch edulin g appoin tm en t for, 10 test plan for, 4–7

clien t n eeds categories in , 4–6, 4t developm en t of, 4 h ealth prom otion an d m ain ten an ce

category in , 5, 5b in tegrated process in , 6–7, 7b level of cogn itive ability an d, 4, 4b ph ysiological in tegrity category in , 5–6,

6b psych osocial in tegrity category in ,

5, 5b safe an d effective care en viron m en t

category in , 4, 5b testin g accom m odation s for, 11 testin g cen ter for, 11–12 testin g tim e for, 12 test-takin g strategies for, 20–29.

See also Test-takin g strategies types o f question s on , 7–10

NCSBN. See Nation al Coun cil of State Boards of Nursin g (NCSBN)

Near-death ph ysiological m an ifestation s, 275

Near vision , assessm en t of, 174 Nearsigh tedn ess, 863 Nebulizer, 737 Neck, assessm en t of, 173

of n ewborn , 374 Necrosis, avascular, 944 Necrotizin g en terocolitis (NEC) , in

n ewborn , 382 Needle aspiration , o f th yroid tissue, 628 Needle biopsy, 581 Needleless in fusion devices, 146 Needles

disposal of, 193 safety, 207 stan dard precaution s an d, 196

Negative even t queries, 22, 23b Negative-feedback loop, 626 Neglect, 1036b

developm en tal, 1034b education al, 1034b older adult, 1037 ph ysical, 1034b

Neglect syn drom e, in stroke, 910b, 911 Negligen ce, 46, 47b Neisseria gonorrhoeae, 325, 399 Neisseria meningitidis

in m en in gitis, 502 vaccin e for protection again st, 530

Nelfin avir, 981 Neobladder, 602 Neoderm is, 561b Neostigm in e b rom ide, 924b Neph recto m y

radical, for kidn ey tum ors, 841 for ren al can aliculi, 840

Neph roblastom a ( Wilm s’ tum or) , 422 Neph rolith iasis, 839 Neph rolith otom y, 840 Neph ron s, 817 Neph rostom y, percutan eous, 602 Neph rostom y tube, 243, 243f Neph rotic syn drom e, 492, 492f, 493b,

838 Neph rotoxic substan ces, 822b Nerve tracts, 893 Nerves

o cular, 862 spin al, 894

Nervous system , ch an ges in older clien ts, 193b

Nesiritide, 807 Nestin g, in labor, 333 Neural tube defects, 504 Neuralgia, trigem in al, 913 Neuro blastom a, 423 Neuro cogn itive disorders, 1013 Neuro gen ic h yperven tilation , 897b Neuro gen ic sh ock, 905, 906b Neuro lem m a, 894 Neuro lep tic m align an t syn dro m e, 1050 Neuro logic system , an aph ylaxis

m an ifestation s in , 968f Neuro logic system disorders

Bell’s palsy (facial p aralysis) , 914 m en in gitis, 915 m yasth en ia gravis, 912 un con scious clien t, 898, 899b West Nile virus in fection , 915

Neuro logical ch an ges, with ch ron ic kidn ey disease, 827

Neuro logical disorders, pyram id poin ts, 892

Neuro logical fin din gs, in liver dysfun ction , 681f

Neuro logical lateral sclerosis, h yperth erm ia, 899

Neuro logical m edication s, 923–935 Neurological system , 893–922

acidosis m an ifestation s in , 100t alkalosis m an ifestation s in , 101t an atom y an d ph ysiology of, 893, 894b

Neurological system ( Continued) assessm en t of, 183, 184t, 186b, 897f,

897–900b in n ewborn , 377 in stroke, 910b

botulism m an ifestatio n s in , 198 ch an ges in , with agin g, 281 with ch ron ic kidn ey disease, 824b diagn ostic tests for, 894 position in g clien ts in , 233 postoperative care of, 219

Neurological system disorders am yotrop h ic lateral sclerosis, 914 cerebral an eurysm , 907, 908b cran iotom y for, 901, 902b en cep h alitis as, 914 Gu illain -Barr e syn drom e, 914 in creased in tracran ial pressure, 895, 898,

900b m edication s for, 923–935 m u ltip le sclerosis, 911 n euroblastom a, 423 Parkin son ’s disease, 913 pediatric, 499–510

atten tion -deficit/ h yperactivity disorder, 505

autism spectrum disorders, 505 cerebral palsy, 499, 500f h ead in jury, 499, 500f h ydroceph alus, 501, 502f in tellectual disability ( m en tal

retardation ) , 506 m en in gitis, 502 n eural tube defects, 504 Reye’s syn drom e, 503 seizure disorders, 501b, 504, 504b subm ersion in jury, 503

seizures as, 907 spin al cord in jury, 901 stroke ( brain attack) , 909, 909f, 910b traum atic h ead in jury, 900, 900b trigem in al n euralgia, 913

Neurological system m edication s an tim yasth en ic m edication s, 923, 924b an tiparkin son ian m edication s, 924, 925b an tiseizure m edication s, 926, 926–927b,

926t n o n opioid an algesics, 928, 928–929b opioid an algesics, 929, 929b opioid an tagon ists, 931, 931b osm otic diuretics, 931

Neurom a, acoustic, 875 Neurom uscular system

acidosis m an ifestation s in , 100t alkalosis m an ifestation s in , 101t fluid volum e deficit an d excess fin din gs

in , 82t h ypocalcem ia an d h ypercalcem ia

fin din gs in , 88t h ypokalem ia an d h yperkalem ia fin din gs

in , 84t h ypom agn esem ia an d h yperm agn esem ia

fin din gs in , 90t h ypon atrem ia an d h ypern atrem ia

fin din gs in , 87t in terven tion s in spin al cord in jury, 905

1116 INDEX

Neuron s, 894 Neurotran sm itters, 894 Neutron s, 79b Nevirapin e, 980 Nevus flam m eu s, as birth m ark, 375t Nevus vasculosus, as birth m ark, 375t New learn in g, in m en tal status exam , 172b Newborn

abduction of, 379, 379b addicted, 384 Apgar scorin g system in , 372, 373t birth m arks in , 375, 375t body system s assessm en t of, 376, 378f bron ch opulm on ary dysplasia in , 381 cardiopulm on ary resuscitation ( CPR)

guidelin es for, 387 ch okin g, 386, 387b of diabetic m oth er, 316, 386 eryth roblastosis fetalis in , 383, 383f eye proph ylaxis for, 399 feedin g of, 379, 379f fetal alcoh ol spectrum disorders in , 385,

385f HIV an d, 319 h yperbilirubin em ia in , 382 h ypoglycem ia in , 386 h ypoth yroidism in , 386 iden tification , 379 in itial care of, 372 in traven tricular h em orrh age in , 382 large for gestation al age, 380 m econ ium aspiration syn drom e in , 381 m edication s for, 393–402, 393b, 399b of m oth er with h um an

im m un odeficien cy virus, 385 n ecrotizin g en terocolitis in , 382 paren t teach in g in , 379, 379f ph ysical assessm en t of, 372, 373t,

373–374f, 375t postterm , 380 preterm , 380 respiratory distress syn drom e in , 381 retin opath y of prem aturity in , 382 safety, 379 sepsis, 384 sm all for gestation al age, 380 syph ilis in , 384, 384f TO RCH in fection s in , 384 tran sien t tach ypn ea in , 381 tuberculosis in , 326 un circum cised, 380 vital sign s, 268b, 372

Nifedipin e, 394t 90-degree–90-d egree traction , 516 Nitrates, 804, 804b Nitrazin e test, 308 Nitrofuran toin , 850, 851b Nits, 405, 406b Nizatidin e, 700 NNRTIs. See Non n ucleoside reverse

tran scriptase in h ibitors ( NNRTIs) Nocturn al en uresis, prim ary, 493 Nom ogram , for estim ation of bod y surface

area in in fan ts an d ch ildren , 538, 539b, 539f

Non com m un icatin g h ydrocele, 448

Non -h eart -beatin g don ors, kidn ey, 833 Non in vasive positive pressure ven tilation ,

716, 716f No n in vasive tran scutan eous pacin g, 769 No n m aleficen ce, 45 No n n ucleoside reverse tran scriptase

in h ibitors ( NNRTIs), 980 No n opio id an algesics, 113, 928, 928–929b No n reassurin g fetal h eart rate

durin g oxytocin in fusion , 396, 397b pattern , 337b

Non reb reath er m ask, 712, 714t, 715f Non steroid al an tiin flam m atory drugs

(NSAIDs) , 113, 928, 928–929b for gout, 959 for juven ile idiopath ic arth ritis, 514b oph th alm ic, 884b poten tially n eph rotoxic, 822b for rh eum atoid arth ritis, 961 side an d adverse effects of, 113b, 929b

Non stress test, in pregn an cy, 309b Norepin eph rin e, 808 Norm al sin us rh yth m , 764, 765f, 765b Norm oth erm ia, in ducem en t of, 899 Nose, 708

assessm en t of, 177 of n ewborn , 374

Nosebleed, 459, 460b Nosocom ial in fection s, 195 NRTIs. See Nucleoside-n ucleotide reverse

tran scriptase in h ibitors ( NRTIs) NSAIDs. See Non steroidal

an tiin flam m atory dru gs ( NSAIDs) Nuch al rigidity, 901 Nucleoside-n ucleotide reverse tran scriptase

in h ibitors ( NRTIs) , 980 Nurse Licen sure Com pact, 13 Nurse Practice Act, 28, 44 Nurse practition er, roles of, 64 Nurse’s ro le

in advan ce directives, 53 in disaster plan n in g, 70, 70b in exposure to warfare agen ts, 199, 199b in grief an d loss, 1031

Nursin g process as In tegrated Process subcategories, 6–7 prioritizin g n ursin g action s an d, 24,

24–26b, 68b Nursin g sch ool, graduatin g from , 18 Nutrien ts, 124, 125b Nutrition , 124–133, 124b

for adolescen t, 273 burn in jury an d, 559 in degen erative join t disease, 950 depression an d, 1006b en teral, 130, 130b for in fan t, 268 in leukem ia, 420 MyPlate, 125, 125f n utrien ts, 124, 125b in postpartum period, 358 in pregn an cy, 308 preoperative, 215 for presch ooler, 271 for sch ool-age ch ild, 272 th erapeutic diets, 126, 127b, 129b

Nutrition ( Continued) for toddler, 270 vegan an d vegetarian diets, 129

Nutrition ist, 64 Nystagm us, 870

O O besity, in pregn an cy, 326 O blique fracture, 940b O bsessive-com pulsive disorder, 1002,

1003b, 1012 O bstruction

in testin al, in cystic fibrosis, 471 tube, of trach eostom y, 248t

O ccipital lobe, 894b O ccupatio n al lun g disease, 727 O ccupatio n al Safety an d Health Act

( O SHA) , 54 O ccupatio n al th erapist, 64 O cular irritation , with ch ron ic kidn ey

disease, 827 O cular m elan om a, 866 O culom otor n erve, 184t O culovestibular reflex, of n eurological

system , 896 O cusert system , 887 O floxacin , 851, 851b O in tm en ts, for eyes, 883 O lder adult

abuse of, 1036, 1037b acciden ts an d, 193, 193b

O lder clien t abuse of, 285, 285b care of, 281–288, 281b in fection in , 283, 283b m edication s in , 284, 284–285b m en tal h ealth con cern s in , 282, 283t pain in , 283 ph ysiological ch an ges in , 281, 282f psych osocial con cern s in , 282

O lfactory n erve, 184t O liguria, in acute kidn ey in jury, 822 O liguric ph ase of acute kidn ey in jury, 822 O m alizum ab, 739 O m ph alocele, 447 O n cological disorders, 580–613

bladder can cer, 600 bon e m arrow tran splan tation for, 584 breast can cer, 591, 592f cervical can cer, 589, 589b ch em oth erapy for, 582 classification of, 580 diagn ostic testin g of, 581, 581b early detection of, 581, 581b en dom etrial can cer, 591 factors in fluen cin g developm en t of, 580 gradin g an d stagin g of, 580, 581b in testin al tum ors, 595 laryn geal can cer, 597, 597f leukem ia, 585, 585b lym ph om a, 587 m etastatic, 580, 581b ovarian can cer, 591 pain con trol in , 582 pan creatic can cer, 594, 595f pediatric, 419–429

1117INDEX

O n cological disorders ( Continued) brain tum ors, 424, 425b Hodgkin ’s disease, 421, 421f, 422t leukem ia, 419, 419–420b lym ph om a, 421 n eph roblastom a ( Wilm s’ tum or) , 422 n euroblastom a, 423 osteosarcom a, 424

pelvic exen teration for, 590, 590b preven tion of, 581, 581b pyram id poin ts, 578 radiation th erapy for, 583, 583b surgery in , 582 uterin e can cer, 591 warn in g sign s of, 581b

O pen fracture, 940b O pen h ead in jury, 900 O pen reduction , of fracture, 515 O peran t con dition in g, in beh avio r th erapy,

993, 993f O peratin g room , arrival in , 218 O ph th alm ia n eon atorum , preven tion of,

376, 399 O ph th alm ic m edication s

adm in istration of, 882, 883f β-adren ergic blockers, 885b, 886 an esth etic, topical, 885 an tich olin ergics, 883, 883b an tiin fective, 884, 884b an tiin flam m atory, 884, 884b carbon ic an h yd rase in h ibitors, 885b, 886 cycloplegic, 883, 883b for glaucom a, 885, 885b lubrican ts, 885, 885b m ydriatic, 883b O cusert system , 887 osm otic, 887

O ph th alm oscopy, 175 O pioid an algesics, 114, 929, 929b

in trath ecal, for labor an d birth , 339 for m atern ity an d n ewborn m edication s,

395 O pioid an tagon ists, 741, 741b, 931, 931b O pioids, 1024

for can cer pain , 582 in toxication , 1024b

O pisth oton os, 499, 500f O pportun istic in fection , in HIV/ AIDS, 520 O ptic disc, 861 O ptic n erve, 184t O ral con traceptives, 573 O ral h ypoglycem ic m edication s, 638 O ral m edication s

adm in istration of, 206 dosage calculation for, 207, 208b pediatric m easu rem en t an d

adm in istration of, 536, 536–537b, 537f

O rbit, 861 O rdered-respon se question s, 7–8, 8f, 20 O rgan , don ation

clien t’s righ ts an d, 48 religious b eliefs regardin g, 49

O rgan of Corti, 869 O rgan rejection , m edication s for

preven tin g, 853, 853b

O rgan ization al con flict, 64 O rgan ization s, form al, 62 O rgan izin g, as fun ction of m an agem en t,

61b O rien tation

in differen tiatin g delirium , depression , an d dem en tia, 283t

in m en tal statu s exam , 172b O rotrach eal tubes, 245 O rph en adrin e, 959, 959b O rth odox

dietary preferen ces in , 33b en d-of-life care an d, 37

O rth odox Ch urch , organ don ation an d tran splan tation an d, 49

O rth om olecular th erapy, 39b O rth ostatic h ypoten sion , 764 O rtolan i click, 512f O rtolan i’s m an euver, 511 O seltam ivir, 748t O SHA. See O ccupation al Safety an d Health

Act ( O SH A) O sm olality, 80 O sm osis, 80 O sm otic diuretics, 801–802b, 802, 931 O sm otic m edication s, for eye disorders, 887 O sm otic pressure, 80 O sm otics, as laxatives, 702, 702b O steoarth ritis, 950 O steom yelitis, with fractures, 944 O steopath ic m an ipulation , 38 O steoporosis, 950, 951b

m edication s to preven t an d treat, 961, 961b

O steosarcom a, 424 O stium prim um , 481 O stium secun dum , 481 O tic m edication s

adm in istration of, 887 an tih istam in es an d d econ gestan ts for,

888, 888b an tiin fective, 888, 888b cerum in olytic, 889

O titis, extern al, 872 O titis m edia, 458, 872, 872b O tosclerosis, 873 O toscopic exam , 176 O varian fun ction , in postpartum period,

356 O varian h orm on es, 291 O varies, 291

an atom y an d ph ysiology of, 626 can cer of, 591 ch an ges in , durin g m en strual cycle,

292b ph ysiological m atern al ch an ges in , 302

O vercom plian ce, in sch izoph ren ia, 1008 O verdose, tricyclic an tidepressan ts, 1044b O vereatin g, com pulsive, 1019 O verh ydration , 83 O vern igh t dexam eth ason e suppression test,

628 O xalate can aliculi, 839b O xycodon e, with acetylsalicylic acid, 930 O xygen

partial pressure of, 102t

O xygen ( Continued) for respiratory system disorders, 712,

714t, 715–716f, 715b O xygen h ood, 465t O xygen m ask, 465t O xygen ten t, 465t O xytocin , 340, 396, 397b

P P wave, 758b, 765f p24 an tigen testin g, 522t Pacem akers, 769, 770b PACG. See Prim ary an gle-closure glaucom a

(PACG) Packed red bloo d cells ( PRBCs) , 158 Paclitaxel, 618b PaCO 2. See Partial pressure of carbon

dioxide ( PaCO 2) Pad electrodes, 768 Pain , 112

abdom in al with periton eal dialysis, 833 in rh eum atic fever, 486f

afterb irth , 358 in an gin a, 772 assessm en t of, 112, 112f

in n eurological exam in ation , 185 care of, in dyin g clien t, 276b ch est, 804b

m edication s for, 804, 804b fear of in jury an d

in h ospitalized adolescen t, 267 in h ospitalized in fan t an d toddler, 265 in h ospitalized presch ooler, 266 in h ospitalized sch oo l-age ch ild, 266

in m yocardial in farction , 773 n on verbal in dicators of, 112b in older clien t, 283 respiratory alkalosis due to, 100b types of, 112

Pain m an agem en t in burn in jury, 559 in degen erative join t disease, 950 in on cological disorders, 582 postoperative, 220

Palate, cleft, 440, 440f Palates, assessm en t of, 177 Palliative care, in en d-of-life care, 275 Palliative surgery, for can cer, 582 Pallor, 173b Palm ar-plan tar grasp, in n ewborn , 378 Palpation , 172

abdom in al, 182 of breasts, 182 of ch est

in h eart assessm en t, 180 in lun g assessm en t, 178, 178b

Pam p erin g, positive, 15–16 Pan creas

an atom y an d ph ysiology of, 626, 672 can cer of, 594, 595f diabetes m ellitus an d, 637

acute com plicatio n s of, 640, 640–642b, 641t, 641f

ch ron ic com plication s of, 642, 644b diet an d, 638

1118 INDEX

Pan creas ( Continued) exercise an d, 638 perio perative care of clien t with , 644

disorders of, 637, 639b laboratory studies of, 675

Pan creas tran splan ts, 639 Pan creatic en zym e

for cystic fibro sis, 472 in testin al juice, 671 replacem en ts for, 701

Pan creatic in sufficien cy, in cystic fibrosis, 472

Pan creatitis, 686 Pan crelipase, 701 Pan ic, 1000 PaO 2. See Partial pressure of oxygen ( PaO 2) Papan icolaou ( Pap) sm ear ( test), 186, 306 Paracen tesis, 232, 674, 674b Paralysis, facial, 914 Paralytic ileus, postoperative, 222 Paran oid person ality disorder, 1011, 1011b Paraplegia, 904b Parasites, in testin al, 453 Parath yroid glan d s

an atom y an d ph ysiology of, 626 disorders of, 636

Parath yroid m edication s, 655, 655b Parath yroidectom y, 637 Paren t teach in g, of n ewborn , 379, 379f Paren teral m edication s

calculation an d adm in istration of, 206, 206–207f

pediatric, 536, 538f, 538t Paren teral n utrition ( PN) , 134

adm in istration of, 134, 135f, 136 com plication s of, 136, 137t com pon en ts of, 134, 135b description of, 134 discon tin uation of, 136 h om e care in struction s in , 138, 138b in dication s for, 134 n ursin g con sideration s of, 136

Parietal lobe, 894b Parietal pericardium , 755 Parkin son ’s disease, 913

m edication for, 924, 925b Parklan d resuscitation form ula, 558t Partial pressure of carbon dioxide ( PaCO 2)

n orm al ran ge of, 102t value ch an ges in acid-base im balan ces,

103t Partial pressure of oxygen ( PaO 2) ,

102–103t Partial rebreath er m ask, 712, 714t Partial-th ickn ess burn

deep, 555, 555f superficial, 554, 555f

Participative m an agem en t, 60 PASS m n em on ic, 192b Password, in form ation security an d, 52 Past poin tin g, test for, 177b Pastia’s sign , 525 Patellar reflex

m agn esium sulfate in , 394, 394t durin g pregn an cy, 322b

Paten t ductus arteriosus, 481

Path ological fracture, 940b Patien t-con trolled an algesia ( PCA) , 146 Pattern -paced breath in g, in labor an d birth ,

335b PAWP. See Pulm o n ary artery wedge

pressure ( PAWP) PCA. See Patien t-con trolled an algesia ( PCA) PCT. See Proxim al con voluted tubule ( PCT) Peak airway in spirato ry pressure, 717t Peak expiratory flow rate m easurem en t,

468b Pediatric disorders

acquired im m un odeficien cy syn drom e, 520, 521f, 521b

cardiovascular, 479–490 aortic sten osis, 481 atrial septal defect, 481, 481b atrioven tricular can al defect, 481 cardiac cath eterization fo r diagn osis of,

484 coarctation of aorta, 482 defects with decreased pulm on ary

blood flow, 482 defects with in creased pulm on ary

blood flow, 481, 481b h eart failure, 479, 480b h ypoplastic left h eart syn drom e, 483 in terven tion s for, 484 Kawasaki disease, 486, 487b m ixed defects, 483 obstructive defects, 481 paten t ductus arteriosus, 481 pulm on ary sten osis, 482 rh eum atic fever, 485, 486b, 486f tetralogy of Fallot, 482 total an om alous p ulm on ary ven ous

con n ection , 483 tran sposition of great arteries/ vessels,

483 tricuspid atresia, 483 trun cus arteriosus, 483 ven tricular septal defect, 481

of eyes, ears, an d th roat, 457–462 con jun ctivitis, 457, 457b, 459b epistaxis, 459 otitis m edia, 458 strabism us, 457 ton sillitis an d aden oiditis, 458, 459f

gastroin testin al, 439–456 abdom in al wall defects, 447 appen dicitis, 445 celiac disease, 444 cleft lip an d cleft p alate, 440, 440f con stipation an d en copresis, 448, 449b diarrh ea, 439 esoph ageal atresia, 441, 442f gastroesoph ageal reflux disease, 442 h epatitis, 449, 450b Hirsch sprun g’s disease, 446, 446f h ypertroph ic pyloric sten osis, 443,

443f im perforate an us, 449, 449b in testin al parasites, 453 in tussusception , 447, 447f irritable bowel syn dro m e, 448 lactose in toleran ce, 444

Pediatric disorders ( Continued) poison in gestion , 451, 451t, 451b trach eoesoph ageal fistula, 441, 442f um bilical h ern ia, 448 vom itin g, 439, 439b, 453b

h em atological, 411–418 aplastic an em ia, 413 β-Th alassem ia, 414, 414b h em oph ilia, 413, 414–415b iron deficien cy an em ia, 412, 413b sickle cell an em ia, 411, 412b, 412f von Willebran d’s d isease, 414

in fectious an d com m un icab le diseases, 520–535

care of ch ild with HIV or AIDS, 520 ch icken pox (varicella) , 524, 524f com m u n ity-associated m eth icillin -

resistan t Staphylococcus aureus ( CA- MRSA), 527

diph th eria, 525 eryth em a in fectiosum ( fifth disease) ,

526, 526f in fectious m on on ucleosis, 526 in fluen za, 527 m um ps, 520b, 524, 531b pertussis ( wh oopin g cough ) , 524 poliom yelitis, 525 Rocky Moun tain spotted fever, 527,

527b ro seola (exan th em a subitum ) , 523,

523f rubella ( Germ an m easles) , 523, 523f rubeola ( m easles) , 522, 523f scarlet fever, 525, 526f

in tegum en tary, 404–410, 404b, 407b burn in juries, 407, 407b eczem a (atopic derm atitis) , 404, 405b im petigo, 404, 405f pediculosis capitis ( lice) , 405, 406b scabies, 406, 406f, 406b

m etabolic an d en docrin e, 430–438 m usculoskeletal, 511–519

co n gen ital clubfoot, 511, 511b, 513f develo pm en tal dysplasia of h ip, 511,

512f, 512b fractures, 515, 515b idiopath ic scoliosis, 512 Legg-Calve-Perth es disease, 515 Marfan syn drom e, 514

n eurological an d cogn itive, 499–510 atten tion -deficit/ h yperactivity

disorder, 505 autism spectrum disorders, 505 cerebral palsy, 499, 500f h ead in jury, 499, 500f h ydroceph alus, 501, 502f in tellectual disability ( m en tal

retardation ) , 506 m en in gitis, 502 n eural tube defects, 504 Reye’s syn drom e, 503 seizure disorders, 501b, 504, 504b subm ersion in jury, 503

on cological, 419–429 brain tum ors, 424, 425b Hodgkin ’s disease, 421, 421f, 422t

1119INDEX

Pediatric disorders ( Continued) leukem ia, 419, 419–420b lym ph om a, 421 n eph roblastom a ( Wilm s’ tum or) , 422 n euroblastom a, 423 osteosarcom a, 424

ren al an d urin ary, 491–498 bladder exstroph y, 495 cryptorch idism , 494 en uresis, 493 epispadias an d h ypospadias, 494, 494f,

495b glom erulon eph ritis, 491, 491b h em olytic-urem ic syn drom e, 493,

493b n ep h rotic syn drom e, 492, 492f, 493b

respiratory, 463–478 asth m a, 467, 468–469b bron ch iolitis, 465 bron ch itis, 465 cystic fibrosis, 470, 470b, 470f epiglottitis, 463, 464f foreign body aspiratio n , 473, 473f laryn gotrach eobron ch itis, 464, 464b,

465t pn eum on ia, 463b, 466, 474b resp iratory syn cytial virus, 465, 466b sudden in fan t death syn drom e, 472 tuberculosis, 473, 474b

Pediatric m edication adm in istration an d calculation , 536–542

calculation of body surface area, 538, 539b, 539f

developm en tal con sideration s in , 539, 540b

oral m ed ication s, 536, 537b, 537f paren teral m edication s, 536

Pediatric n u rsin g, pyram id poin ts, 403 Pediculosis capitis, in ch ild, 405, 406b PEEP. See Positive en d-expiratory pressure

(PEEP) Peer review, 63 Pegaspargase, 619 Pelvic exen teration , 590, 590b Pelvic in let diam eters, 292 Pelvic m idplan e diam eters, 292 Pelvic outlet diam eters, 292 Pelvic th rom boph lebitis, 367b Pelvic traction , 942f, 943 Pelvis, fem ale, m easurem en t an d, 291 Pem ph igus, 972 Pen etratin g objects, ocular, 867 Pen icillam in e, 961 Pen icillin ase-resistan t pen icillin s, adverse

effects of, 983t Pen icillin s, adverse effects o f, 983t Pen is, 291

assessm en t of, 187 epispadias an d h ypospadias of, 494, 494f

Pen tecostal, dietary preferen ces in , 33b Pepp erm in t oil, 39b Pepsin , 671 Peptic ulcer disease, 676, 677f, 677b Percen tage an d ratio solution s, 208 Perception s, in m en tal status exam , 172b Percussion , 172

Percussion ( Continued) abdom in al, 182 ch est

in h eart assessm en t, 181 in lun g assessm en t, 178, 179f

Percutan eous lith otripsy, 840 Percutan eous tran slum in al coron ary

an gioplasty ( PTCA) , 761, 761f Percutan eous um bilical blood sam plin g,

307 Perforatio n , bowel, 674b Perform an ce im provem en t, 62 Pericardial effusion , 778 Pericardial friction rub, 777 Pericardial sac, 755 Pericardial space, 755 Pericarditis, 777 Perin atal loss, postpartum , 367 Perin eal discom fo rt, postpartum , 358 Perin eal laceration s, 358 Perin eal procedu re, position in g clien ts in ,

231 Perin eal prostatectom y, 599 Perioperative n ursin g care, 215–229, 215b

am bulatory care or 1-day stay surgical un its, 224, 225b

p ostoperative care in , 219, 219f p ostoperative com plication s in , 220b

con stipation , 222 h em orrh age, 221 h ypoxem ia, 221 paralytic ileus, 222 pn eum on ia an d atelectasis, 220, 221f pulm on ary em bo lism , 221 sh ock, 221 th rom boph leb itis, 222 urin ary reten tion , 222 woun d deh iscen ce an d evisceration ,

224, 224f, 224b woun d in fection , 223, 223b

p reoperative care in , 215, 216–218b, 217f wron g site an d wron g procedure surgery

in , 218 Periph eral arterial disease, 233, 783, 784f Periph eral arterial revascularization , 762 Periph eral b lood stem cell tran splan tation ,

584 Periph eral in traven ous lin e

in sertion of, 148b rem oval of, 148b site selection for, 147, 147f, 147b

Periph eral vascular system , 181, 181b Periph eral vasodilators, 806, 806b Periph eral vision , assessm en t of, 174 Periph erally in serted cen tral cath eter

( PICC) , 152f, 153 Periton eal dialysis, 831, 831f

autom ated, 832, 832b com plication of, 832 in fusion , 832

Periton eum , 671 Periton itis, 674b

due to p erforated ap pen dix, 445 with periton eal dialysis, 832

Perm an en t pacem akers, 770 Perm eth rin , 406

Pern icious an em ia, 678 Person al h ealth in form ation ( PHI)

Health In suran ce Portability an d Accoun tab ility Act an d, 50

uses or disclosures of, 50, 51b Person al power, 62b Person al protective equipm en t (PPE) , 196,

196t Person al space preferen ces

in African Am erican culture, 32 in Am ish society, 34 in Asian Am erican culture, 34 in Hisp an ic an d Latin o Am erican culture,

35 in Native Am erican cu lture, 36 in wh ite Am erican culture, 36

Person ality ch aracteristics, in psych iatric- m en tal h ealth illn ess, 990

Person ality disorders, 1010 Perspiration , water loss by, 81 Pertussis ( wh oopin g cough ) , 524 pH

carbon ic acid-bicarbon ate system in regulation of, 97, 98f

n o rm al ran ge of, 102t Ph allic stage, of psych osexual developm en t,

261b Ph arm acist, roles of, 64 Ph arm acological an d paren teral th erapies,

subcategories on exam in ation , 4t, 5–6, 6b

Ph aryn x, an atom y an d ph ysiology of, 708 Ph en obarbital, 926, 926t Ph en ylketon uria, 377, 430b, 431, 435b Ph en ytoin , 926, 926t Ph eoch rom ocytom a, 633 PHI. See Person al h ealth in form ation ( PHI) Ph lebitis, 782

as in traven ous th erapy co m plication s, 149t, 151

Ph leboth rom bosis, 781 Ph obia, 1002, 1002b Ph osgen e, 199 Ph osph ate buffer system , 98 Ph osph orus

cardiovascular testin g of, 758 food sources of, 90b, 125b h yperph osph atem ia an d, 91 h ypoph o sph atem ia an d, 90, 90b n orm al values of, 90b

Ph otoch em oth erapy, 573 Ph otom eter, 383 Ph otorefractive keratotom y, 863 Ph ototh erapy

for h yperbiliru bin em ia, 382 for psoriasis, 571b, 572

Ph ysical abuse, of older adult, 1037b Ph ysical ch an ges

in early adulth ood, 273 in m iddle adulth ood, 274

Ph ysical developm en t of adolescen t, 273 of in fan t, 268 of presch ooler, 271 of sch oo l-age ch ild, 272 of toddler, 269

1120 INDEX

Ph ysical exam in ation , 172 of n ewborn , 372, 373t, 373–374f, 375t tech n iques for, 172 vital sign s in , 172

Ph ysical exercise, tem perature an d, 109 Ph ysical restrain ts, 194 Ph ysical th erapist, 64 Ph ysical th erapy, for bum in jury, 562 Ph ysical violen ce, 1034b Ph ysiological adaptation , subcategories on

exam in ation , 4t, 5–6, 6b Ph ysiological in tegrity, question s on

exam in ation associated with , 4t, 5–6, 6b, 27

Ph ysiological m atern al ch an ges , in pren atal period, 300, 301f

Ph yton adion e, 399 PI. See Protease in h ibitors ( PI) Piaget’s th eo ry, of cogn itive developm en t,

257 Pica, pregn an cy an d, 310 PICC. See Periph erally in serted cen tral

cath eter ( PICC) Pillows, for proper position in g, 235b Pilocarpin e, 887 Pilot balloon , en dotrach eal tubes, 245 "Pin k eye," 457 Pin n a, 868 Pin worm , in festation in ch ildren , 453 Pittin g edem a scale, 173t Pituitary aden ectom y, 629 Pituitary glan d

an atom y an d ph ysiology of, 626 disorders of, 629, 629b h orm on es of, 627b, 627f

Pituitary m edication s, 653, 654b Placen ta, 294

abn orm alities of, in labor an d birth , 348

abruptio placen tae, 348 placen ta previa, 346, 347f

Placen ta accreta, 348 Placen ta previa, 346, 347f Plague, 198 Plan

for preparation , 14–15, 15b for study, 14, 15b

Plan n ed ch an ge, 63 Plan n in g

disch arge, 66, 66b em ergen cy respon se, 68, 68–70b as fun ction of m an agem en t, 61b question s on exam in ation asso ciated

with , 25, 25b Plan tar reflex

assessm en t of, 185 in n ewborn , 378

Plasm a fresh -frozen , adm in istration of, 158 osm olality of, 80

Plasm a cells, abn orm al in m ultiple m yelom a, 588

Plasm a expan ders, 144 Plasm a protein system , in acid-base

balan ce, 97 Plastic can n ulas, 144

Platelet coun t, 117 an tin eoplastic m edication s an d, 614 followin g platelet tran sfusion , 158 in leukem ia, 419

Platelets in preeclam psia, 321t tran sfusion , 158

Platypelloid pelvis, 292 Play

adolescen t, 273 in fan t, 269 presch ooler, 271 sch ool-age ch ild, 272 toddler, 270

Pleural effusion , 725 Pleural friction rub, 180t Pleurectom y, 725 Pleurisy, 725 Pleurodesis, 596, 725 PN. See Paren teral n utrition ( PN) Pn eum ococcal con jugate vaccin e, 503, 748 Pneumocystis jiroveci pn eum on ia, 520 Pn eum on ia, 724

in ch ildren , 466 Pneumocystis jiroveci, 520 postoperative, 220, 221f respiratory acidosis due to, 99b

Pn eum on ic plague, 198 Pn eum oth orax, 719, 719b, 719f

in paren teral n utrition , 136, 137t PO AG. See Prim ary open -an gle glaucom a

(PO AG) Poison Con trol Cen ter, 195 Poison ivy, p oison oak, an d poison sum ac,

547, 547f Poison s

in gestion by ch ildren , 451, 451t, 451b safety m easures in , 195

Policies of form al organ ization s, 62 in stitution al, 45

Polio vaccin e, in activated, 521 Poliom yelitis, 525 Polyarteritis n odosa, 971 Polyarth ritis, in rh eum atic fever, 486f Polycystic kidn ey disease, 838 Polym erase ch ain reaction , 522t Polyp h arm acy, 284 Pon s, 893 Portacaval sh un t, for esoph ageal varices,

683, 683f Portal h yperten sion , 681 Portal system ic en ceph alopath y, 681 Port-win e stain , 375t Position in g

after cran iotom y, 902b clien t, with gastroesoph ageal reflux

disease, 443 tripod, 463

Position in g clien ts, 230–238, 230b, 231f, 234b

in bed, 230f in cardiovascular system , 233 devices for, 235b in en docrin e system , 232 ergon om ic prin ciples in , 230, 230b

Position in g clien ts ( Continued) in gastroin testin al system , 232, 232b guidelin es for, 230 in in tegum en tary system , 230 lateral ( side-lyin g) p osition , 231f lith otom y positio n , 231f in m usculoskeletal system , 234 in n eurological system , 233 pressure poin ts in , 231f pron e position , 231f in reproductive system , 230 in respiratory system , 232 in sen sory system , 233 Sim s’ position , 231f supin e position , 231f

Positive en d-expiratory pressure ( PEEP) , 717t

Positive even t qu eries, 22, 23b Positive in otropic an d cardioton ic

m edication s, 799, 800f, 800b Positive m om en tum , 15–16 Positive pam perin g, 15–16 Posterior cord syn drom e, 903, 903f Posticteric stage, of h epatitis, 684b Postm ortem care, 275, 276b Postoperative care, 219, 219f Postoperative com plication s, 220b

con stipation , 222 h em orrh age, 221 h ypoxem ia, 221 paralytic ileus, 222 pn eum on ia an d atelectasis, 220, 221f pulm on ary em bolism , 221 sh ock, 221 th rom boph lebitis, 222 urin ary reten tion , 222 woun d deh iscen ce an d evisceration , 224,

224f, 224b woun d in fection , 223, 223b

Postoperative in terven tion s in appen dicitis, 445 bladder can cer surgery, 604 in cardiac surgical un it, 763 in esoph ageal atresia an d

trach eoesoph ageal fistula, 442 in Hirsch sprun g’s disease repair, 446 in h ydrocele, 448 ileostom y, 595 in im perforate an us, 449 for kidn ey tran splan tation , 834 prostate can cer surgery, 599 in ton sillectom y, 459 in um bilical h ern ia, 448

Postpartum blues, 359b Postpartum depression , 359b Postpartum h em orrh age, m edication s for,

397, 397b Postpartum period, 356–363, 356b, 360b

breast-feedin g in , 358, 359b com plication s of, 364–371, 364b, 368b

cystitis, 364 h em atom a, 364, 365f h em orrh age an d sh ock, 364, 365b in fection , 365 m astitis, 366, 366f perin atal lo ss, 367

1121INDEX

Postpartum period ( Continued) pulm on ary em bolism , 366 subin volution , 366 th rom boph lebitis, 367, 367b uterin e aton y, 364, 365f

discom fo rts in , 358, 359b in terven tion s in , 357, 357f n utrition al coun selin g in , 358 ph ysiological m atern al ch an ges in , 356,

357f, 357t, 357b Postpartum psych osis, 359b Postterm n ewborn , 380 Posttran splan tation im m un odeficien cy,

974 Posttraum atic stress disorder, 1001, 1002b Postural drain age, 233 Postural (orth ostatic) h ypoten sion , 764 Posture

abn orm alities of, 183b in cerebral palsy, 499, 500f

assessm en t of, in n eurologic system , 897 ch an ges of, with agin g, 281, 282f decerebrate, 897 decorticate, 897 flaccid, 897

Potassium cardiovascular testin g of, 757 com m on fo od sources of, 83b diet for m odified in take of, 129 food sou rces of, 125b h om eostasis of, 818 h yperkalem ia an d, 84, 85t.

See also Hyperkalem ia h ypokalem ia an d, 83, 83b, 85b, 85t.

See also Hypokalem ia in traven ously adm in istered, precaution s

with , 85b as o ral supplem en tation , 84 oral supplem en tation , in h eart failure,

pediatric, 480 Potassium -retain in g diuretics, 801–802b,

802 Poten tial for in jury, with ch ron ic kidn ey

disease, 827 Pouch , Kock, 601 Powder form , in jectable m edication s in ,

207, 207b Power, 62, 62b PPE. See Person al protective equipm en t

(PPE) PR in terval, 758b Pram lin tide, 663 PRBCs. See Packed red blood cells ( PRBCs) Preadolescen t, eczem a in , 405b Precipitous labor an d delivery, 349 Predn ison e, 854 Preeclam psia, 320, 321t, 322 Preem bryon ic p eriod, in fetal developm en t,

293b Prefilled m edication cartridge, 207 Pregn an cy

adolescen t, 304 discom fo rts of, 302 ectopic, 317, 317f m atern al risk factors, 304 ph ysiological ch an ges durin g, 300, 301f

Pregn an cy ( Continued) psych ological ch an ges du rin g, 302 risk con dition s related to, 314–331, 314b,

327b abortion , 314, 315b acquired im m un odeficien cy syn drom e

( AIDS) , 319 an em ia, 314 card iac disease, 314, 315b ch orioam n ion itis, 315 diabetes m ellitus, 315 dissem in ated in travascular

coagulation , 316, 317b, 317f en dom etritis, 317 fetal death in utero, 318 gestation al h yperten sion , 320, 321t,

322–323b h em atom a, 318, 318b h epatitis B, 318 h um an im m un odeficien cy virus ( HIV) ,

319 h ydatid iform m ole, 320 h yperem esis gravidarum , 320 in com peten t cervix, 323 in fection s, 323 m ultiple gestation , 324 obesity, 326 pyelon eph ritis, 324 sexually tran sm itted in fection s, 324,

325b tuberculosis, 326 urin ary tract in fection , 326

sign s of, 299 tem perature an d, 109

Preh yperten sion , classification s of, 111, 111b

Preicteric stage, of h epatitis, 684b Prein farction an gin a, 772 Preluxation , developm en tal dysplasia of

h ip, 512b Prem ature rupture, of m em bran es, in lab or

an d birth , 346 Prem ature ven tricular con traction s, 766,

766b, 766f Prem aturity, retin opath y of, 382 Pren atal period, 299–313, 299b, 310b

an tepartum diagn ostic testin g, 305, 306t d iscom forts of pregn an cy, 302 fun dal h eigh t, 300, 300f, 300b gestation , 299, 300b gravidity an d parity, 299, 300b m atern al risk factors, 304 n utrition , 308 p h ysiological m atern al ch an ges, 300,

301f pregn an cy sign s, 299 psych ological m atern al ch an ges, 302

Preoperation al stage, of cogn itive developm en t, 257

Preoperative care, 215, 216–218b, 217f Preoperative ch ecklist, 216, 217b Preoperative in terven tion s

in esoph ageal atresia an d trach eoesoph ageal fistula, 441

in Hirsch sprun g’s disease repair, 446 in im perforate an us, 449

Preoperative in terven tion s ( Continued) for kidn ey tran splan tation , 834 in ton sillecto m y, 459

Preovulato ry ph ase, of m en strual cycle, 292b

Preparedn ess, in disaster m an agem en t, 69

n urse’s role in , 70, 70b Presbycusis, 871 Presbyopia, 863 Presch ooler

developm en tal con sideration s for adm in isterin g m edication s to, 540b

developm en tal stages of ch aracteristics of, 271 com m un ication approach es in , 267 h ospitalized, 266 vital sign s of, 271b

Prescription s, 206, 206b co m pon en ts of, 53b legal safeguards, 52, 52–53b

Pressoreceptors, 756 Pressure poin ts, in sittin g position s, 231f Pressure support, 717t, 718 Pressure ulcer, 551, 551t Pressure-cycled ven tilator, 715 Preterm labor, 349

preven tion of, 393 Preterm n ewborn , 380 Prim ary adren al in sufficien cy, 631 Prim ary an gle-closure glaucom a (PACG),

865 Prim ary assessm en t, in em ergen cy

departm en t, 71 Prim ary h yperaldosteron ism , 632 Prim ary h yperten sion , 788 Prim ary n ursin g, 60 Prim ary open -an gle glaucom a (PO AG) , 865 Prioritizin g, 67, 67–68b

exam in ation question s associated with , 20, 23, 23–26b, 24f

strategic words associated with , 22b Privacy, in vasion of, 47 Proben ecid, 959–960 Problem -solvin g process, 61, 61t Procedures, of form al organ ization s, 62 Proctocolectom y, with perm an en t

ileostom y, 688 Prodrom al labor, 334 Profession al liability in suran ce, 47 Profession al respon sibilities, 60 Progestin s, 657, 658b

for m align an cy, 618b Projection defen se m ech an ism s, 991b Prokin etic agen t, 700 Prolapsed um bilical co rd, in labor an d

birth , 346, 347b, 347f Proliferative ph ase, of m en strual cycle, 292b Pron e position , 231f, 233 Proof of liability, 46 Proph ylactic surgery, for can cer, 582 Proph ylaxis, for care of ch ild with HIV

in fection an d AIDS, 520 Propionibacterium acn es, 550 Propo rtion , 205b Proprioception alteration s, in stroke, 910b

1122 INDEX

Prostaglan din an alogs, for eye disorders, 885b

Prostaglan din s, 395, 395b con train dication s of, 396b for postpartum h em o rrh age, 398

Prostate glan d, 291, 818 can cer of, m etastatic, 581b tran sureth ral resection of, 599

Prostatectom y perin eal, 599 retropubic, 599 suprapubic, 599

Prostatitis, 841 Protease in h ibitors (PI) , 980 Protein s

diet for h igh in take of, 128 diet for restricted in take of, 128 n utrition an d, 124 in paren teral n utrition , 135 urin alysis for, in pregn an cy, 307

Protestan t, en d-of-life care an d, 37b Proth rom bin tim e ( PT) , 116, 798 Protocols, of form al organ ization s, 62 Proton pum p in h ibitors, 700, 700b Proton s, 79b Proxim al con voluted tubule ( PCT), 817 Proxim ate cause, in n egligen ce an d

m alpractice, 46 Pruritus, 406b

with ch ron ic kidn ey disease, 827 Pseudoan eurysm , 785 Pseudoh yperkalem ia, 84 Psoriasis, 550 Psych iatric m edication s, 1043–1055, 1052b

for Alzh eim er’s d isease, 1051, 1051b an tian xiety or an xiolytic m edication s,

1047 an tipsych otic m edication s, 1049, 1049b for atten tion -deficit/ h yperactivity

disorder, 1051, 1051b barbitu rates, 1048, 1048b m on oam in e oxidase in h ibitors ( MAO Is) ,

1045, 1045b, 1046f m ood stabilizers, 1046, 1046b sedative-h ypn otics, 1048, 1048b selective seroto n in reuptake in h ibitors

( SSRIs) , 1043 tricyclic an tidepressan ts, 1044, 1044b

Psych iatric-m en tal h ealth illn ess, 990 Psych ological ch an ges

in early adulth ood, 274 in m iddle adulth ood, 274

Psych ological m atern al ch an ges, in pren atal period, 302

Psych om otor activity, in differen tiatin g delirium , depression , an d dem en tia, 283t

Psych osexual developm en t, Freud’s th eory of, 259, 260–261b

Psych osis, postpartum , 359b Psych osocial care, of d yin g clien t, 275, 276b Psych osocial con cern s, in older clien t, 282 Psych osocial develop m en t, Erikson ’s th eory

of, 257, 258b, 258t Psych osocial im pact, with in tegum en tary

system disorders, 544

Psych osocial in tegrity with an tin eoplastic m edication

adm in istration , 615 question s on exam in ation associated

with , 4t, 5, 5b, 27, 27b with spin al cord in jury, 905

Psych osocial preparation , preoperative, 216, 217b

Psych osocial problem s, with ch ron ic kidn ey disease, 827

Psych oth erapy, in terperson al, 993 PT. See Proth rom bin tim e ( PT) PTCA. See Percutan eous tran slum in al

coron ary an gioplasty (PTCA) Ptyalism , in pregn an cy, 301 Pull-to-sit respon se, in n ewborn , 378 Pulm on ary an giograph y, 710 Pulm on ary artery, (Swan -Gan z) cath eter, in

cardiogen ic sh ock, 776, 777f Pulm on ary artery pressures, in cardio gen ic

sh ock, 777 Pulm on ary artery wedge pressure ( PAWP) ,

777 Pulm on ary blood flow, defects with

decreased, 482 Pulm on ary con tusion , 719 Pulm on ary edem a

with h eart failure, 775, 775b position in g clien ts with , 233 respiratory acidosis due to, 99b

Pulm on ary em boli, respiratory acidosis due to, 99b

Pulm on ary em bolism , 726, 726b with fractures, 944 postoperative, 221 postpartum , 366

Pulm on ary fin din gs, in liver dysfun ction , 681f

Pulm on ary fun ction tests, 468b, 711 Pulm on ary sten osis, 482 Pulm on ary valve disorders, 780t Pulm on ary ven ous con n ection , total

an om alous, 483 Pulm on ic sem ilun ar valve, 755 Pulse, 109

in deh ydration , pediatric, 431t gradin g scale for, 110b in postpartum vital sign s, 357t

Pulse deficit, 110 Pulse oxim etry, 111

procedure of, 111 Pulse poin ts, 110 Pulse qualities, 110 Pupillary ligh t reflex, 175b Pupils, 861

assessm en t of, 175, 175b in n eurological system exam in ation ,

185, 897, 897f Purin e

calculi, 839b diet for low in take of, 129

Purkin je fibers, 756 Purulen t exudate from woun d, 552 Pustules, of acn e vulgaris, 550 Pyelolith otom y, 840 Pyelon eph ritis, 837

Pyelon eph ritis ( Continued) acute, 837 ch ron ic, 837 in pregn an cy, 324

Pyelostom y, percutan eous, 602 Pyloric sph in cter, 671 Pyloric sten osis, h ypertroph ic, 443, 443f Pylorom yotom y, 444 Pyloroplasty, 677 Pyram id Poin t bu llets, 2 Pyram id Poin ts, 76 Pyram id to Success, 2–3, 14, 15f Pyrazin am ide, 744 Pyridostigm in e, 924b Pyridoxin e, 326

Q Q wave, 758b Q igon g, 38 Q RS com plex, 758b, 765f Q T in terval, 758b Q uadriplegia, 904b Q uadripod can e, 945 Q uadruple th erap ies, for Helicobacter pylori

in fection , 700, 700b Q ualities, of effective leader an d m an ager,

61b Q uality im provem en t, 62 Q uality study tim e, 14–15 Q uan tiFERO N-TB Gold test, 728 Q uan titative im m un oglobulin , 974b Q uan titative ultrasoun d for b on e m in eral

den sity m easurem en t, 939 Q uan tum th eory, of leadersh ip an d

m an agem en t, 60b Q uestion s

avoidin g readin g in to, 20, 21b on clien t n eeds, 4, 4t, 26, 27b cogn itive ability an d, 4, 4b in gredien ts of, 20, 21b on in tegrated process of carin g, 6–7 ph arm acological, 29, 29b on ph ysiological in tegrity, 5–6, 6b on prioritizin g n ursin g action s, 23,

23–26b, 24f on psych osocial in tegrity, 5, 5b on safe an d effective care en viron m en t, 4,

5b subject of, 22, 22b

R Rabbit fever, 198 RACE m n em on ic, 192b Radial artery pun cture, Allen ’s test b efore,

102b Radial keratotom y, 863 Radiation

ion izin g, as warfare agen t, 199 safety, 193

Radiation th erapy, 583, 583b for bladder can cer, 601 side effects in ch ild ren , 422t

Radioactive iodin e uptake, 628 Radioallergosorben t test, 468b Radiograph y

ch est, in asth m a, 468b

1123INDEX

Radiograph y ( Continued) in traven ous urograph y, 820 kidn ey, ureters, an d bladder, 820 in m usculoskeletal disorders, 938 skull an d spin al, 894

Radiosurgery, stereotactic, 901 Rales, 180t Raloxifen e, 962 Raltegravir, 981 Ran ge of m otio n , 183 Ran itidin e, 700 Rape, 1037 Rape traum a syn drom e, 1038 Rapid respon se team s, 65 Rash

eryth em a in fectiosum ( fifth disease), 526, 526f

of Lym e disease, 972f roseola, 523 rubella, 523, 523f rubeola ( m easles) , 523, 523f scabies, 406f scarlet fever, 525

Rate, in m ech an ical ven tilation , 717t Ratio an d proportion , 205b Ratio solution s, 208 Ration alization defen se m ech an ism s, 991b Rayn aud’s disease, 784 Reaction form ation defen se m ech an ism s,

991b Reason in g, eth ical, 44 Recen t m em ory, in m en tal status exam ,

172b Reco n stitution , of powder m edication , 207,

207b Reco n structive level, in psych oth erap y,

993 Reco n structive surgery, in can cer treatm en t,

582 Reco very

in disaster m an agem en t, 69 ph ase, of acute kidn ey in jury, 822, 823b

Rectal en em a, irrigation s an d, 232 Rectal tem peratures, 108 Rectum , assessm en t of, 187 Red blood cell coun t, 757 Red blood cells, packed, 158 Red reflex, 175 Reduction

of fractures, 941 in ch ildren , 515

of risk poten tial subcategories on exam in ation , 4t, 5–6, 6b

Reed-Stern berg cells, 422 REEDA, m n em on ics, 223 Re-educative level, in psych oth erapy, 993 Referen t power, 62b Reflex

corn eal ligh t, 174 deep ten don , 185, 186b gag, 178 patellar, m agn esium sulfate in , 394, 394t plan tar, 185 pupillary ligh t, 175b red, 175

Reflex irritability, in Apgar scorin g, 373t

Reflexes assessm en t of

in n euro logic system , 897b in n ewborn , 378 durin g pregn an cy, 322, 322b

Babin ski, 897b corn eal ( blin k) , 897b gag, 897b

Reflexology, 38 Reflux, gastroesoph ageal, 675 Refraction , 863 Refractive errors, 863 Refreezin g, in ch an ge process, 63, 63f Registerin g, to take exam in ation , 10 Regression defen se m ech an ism s, 991b Regulation , of n ursin g practice, 44 Reh abilitation , in burn in jury, 562 Reh abilitative surgery, in can cer treatm en t,

582 Rein fo rcer, in beh avior th erapy, 993 Rejection

of don or eye, 868, 869f of don or kidn ey, 835, 835b

Relation al th eory, of leadersh ip an d m an agem en t, 60b

Relation sh ip-based practice, 60 Relaxation , of m uscle, 937 Relaxation th erapy, 38 Religion s

Am ish , 32 in Asian Am erican population , 34 dietary preferen ces an d, 33b organ don ation an d tran splan tation an d,

49 Rem ote m em ory, in m en tal status exam ,

172b Ren al an d urin ary disorders, pyram id

poin ts, 815 Ren al biopsy, 821 Ren al calculi, 838, 839b

treatm en t option s for, 839, 840f Ren al cortex, 817 Ren al disorders, pediatric

bladder exstroph y, 495 cryptorch idism , 494 en uresis, 493 epispadias an d h yp ospadias, 494, 494f,

495b glom erulon eph ritis, 491, 491b h em olytic-urem ic syn drom e, 493, 493b n eph rotic syn drom e, 492, 492f, 493b

Ren al fun ction studies, 118 Ren al in sufficien cy, m etabolic acidosis

with , 101b Ren al m edulla, 817 Ren al system

an atom y an d ph ysiology of, 817 assessm en t of, in n ewbo rn , 376 ch an ges in , with agin g, 282 diagn ostic tests for, 818, 819t fluid volum e deficit an d excess fin din gs

in , 82t h ypocalcem ia an d h ypercalcem ia

fin din gs in , 88t h ypon atrem ia an d h ypern atrem ia

fin din gs in , 87t

Ren al system ( Continued) in terven tion s in spin al cord in jury, 905 n orm al fun ction values for, 819b ph ysiological m atern al ch an ges in , 301 postoperative care of, 220

Ren al system disorders acute kidn ey in jury, 822, 822–823b ben ign prostatic h ypertroph y, 842,

842–843f bladd er traum a, 842 ch ron ic kidn ey disease, 823, 824b, 824t,

825f co n tin uous am bulatory periton eal

dialysis ( CAPD) for, 832 co n tin uous ren al replacem en t th erapy

( CRRT) for, 833, 833b cystitis, 835, 835–836b epididym itis, 841 glom erulon eph ritis, 837 h em o dialysis for, 827, 830b h ydron eph rosis, 838, 838f h yperplasia, 842, 842–843f kidn ey tran splan tation for, 833, 834f,

835b kidn ey tum ors, 841 m edication s for, 850–859 n eph rotic syn drom e, 838 periton eal dialysis, 831, 831f, 832b polycystic kidn ey disease, 838 prostatitis, 841 pyelon eph ritis as, 837 ren al calculi, 838, 839b risk factors for, 819b urem ic syn d rom e, 827 ureteritis, 837 ureth ritis, 836 urin ary tract in fection , 835, 835–836b urosepsis, 836

Ren al system m edication s, 850–859 an tich olin ergics, 852, 852b an tispasm odics, 852, 852b ch olin ergics, 852 fluoroquin olon es, 851, 851b h em atopo ietic growth factors, 854, 855b organ rejection preven tion , m edication s

for, 853, 853b sulfon am ides, 851, 851b urin ary tract an algesics, 852, 852b urin ary tract an tiseptics, 850, 851b

Ren al tube, 243 Ren in , 818 Ren ograph y, 821 Repo rtin g

of in ciden t, 52, 52b n urse’s respon sibilities in , 54

Repo rts, types of, 65, 65b Repression defen se m ech an ism s, 991b Reproductive system , 291–298, 291b

ch an ges in , with agin g, 282 ch ron ic kidn ey disease m an ifestation s in ,

824b in cystic fibrosis, 471 ph ysiological m atern al ch an ges in , 301 position in g clien ts in , 230

Rep roductive tract, assessm en t of, 186 Research con sen t, 49b

1124 INDEX

Resin uptake test, T3 an d T4, 628 Resistan ce, to ch an ge, 63, 64b Respiration s, 110

of adolescen t, 273b assessm en t of, 897b n ear-death ph ysiological m an ifestation s

in , 275 of n ewborn , 373

an d in fan t, 268b in postpartum vital sign s, 357t of presch ooler, 271b of sch oo l-age ch ild, 272b of toddler, 270b

Respiratory acidosis, 99, 99b, 100t, 103, 103t

Respiratory alkalosis, 100, 100b, 101t, 103, 103t

Respiratory disorders of adult clien t, 706 pediatric, 463–478

asth m a, 467, 468–469b bron ch iolitis, 465 bron ch itis, 465 cystic fibrosis, 470, 470b, 470f epiglottitis, 463, 464f foreign b ody aspiration , 473, 473f laryn gotrach eobron ch itis, 464, 464b,

465t pn eum on ia, 463b, 466, 474b respiratory syn cytial virus, 465, 466b sud den in fan t death syn d ro m e, 472

Respiratory distress, in n ewborn , 376 Respiratory distress syn drom e, 394

in n ewborn , 381 Respiratory m edication s, 737–753

an tich olin ergics, 738, 738b an tih istam in es, 739, 740b an titussives, 741, 741b bron ch odilators, 737, 738b expectoran ts an d m ucolytic agen ts, 740,

740b glucocorticoids, 738b, 739 for in fluen za, 747, 747b in h alation devices for, 737, 738f in h aled n on steroidal an tiallergy agen t,

738b, 739 leukotrien e m odifiers, 738b, 739 m on oclo n al an tibody, 739 m ultidrug-resistan t strain of tuberculo sis

( MDR-TB) , 742 n asal decon gestan ts, 740, 740b opioid an tagon ists, 741, 741b pn eum ococcal con jugate vaccin e, 748 for tuberculosis, 741, 741b

Respiratory process, 709 Respiratory rate, 110

in Apgar scorin g, 373t in deh ydration . pediatric, 431t

Respiratory syn cytial virus ( RSV) , 465, 466b Respiratory system , 708–736

acidosis m an ifestation s in , 100t alkalosis m an ifestation s in , 101t an aph ylaxis m an ifestation s in , 968f an atom y an d ph ysiology of, 708 assessm en t of, in n ewborn , 376 ch an ges in , with agin g, 281

Respiratory system ( Continued) cystic fibrosis m an ifestation s in , 470 fluid volum e deficit an d excess fin din gs

in , 82t h ypocalcem ia an d h ypercalcem ia

fin din gs in , 88t h ypokalem ia an d h yperkalem ia fin din gs

in , 84t h ypom agn esem ia an d h yperm agn esem ia

fin din gs in , 90t h ypon atrem ia an d h ypern atrem ia

fin din gs in , 87t in terven tion s in spin al cord in jury, 904 ph ysiological m atern al ch an ges in , 301,

301f position in g clien ts in , 232 postoperative care of, 219 tubes for

en dotrach eal, 245, 245f trach eostom y, 246, 247b, 247f, 248t

Respiratory system disorders acute respiratory distress syn drom e, 720 acute respiratory failure, 719 asth m a, 720, 721f, 721–722b carbon m on oxide poison in g, 556, 557t ch est in juries in , 718 ch ron ic obstructive pulm on ary disease,

721, 722–723f, 723b diagn ostic tests in , 709, 709b, 711f, 712b em pyem a, 725 h istoplasm osis, 726 in fluen za, 724 Legion n aire’s disease, 725 m ech an ical ven tilation for, 715, 716f,

717t, 718b occupation al lun g disease, 727 oxygen for, 712, 714t, 715–716f, 715b pleural effusion , 725 pleurisy, 725 pn eum on ia, 724 pn eum oth orax, 719, 719b, 719f pulm on ary em bolism , 726, 726b risk factors for, 710b sarcoidosis, 727 severe acute respiratory syn drom e

(SARS) , 723 sm oke in h alation in jury, 556 treatm en ts fo r, 712, 712–713b, 713f tuberculosis, 727, 727b, 729b, 729t

Respiratory th erapist, roles of, 64 Respon deat superior, 45 Respon den t con dition in g, in beh avior

th erapy, 993, 993f Respon se, in disaster m an agem en t, 69 Respon sib ilities, profession al, 60 Restitution , in labor, 334b Restlessn ess, in dyin g clien t, 276b Restorative proctocolectom y with ileal

pouch -an al an astom osis ( RPC- IPAA) , 687

Restrain ts, 194, 195b for in fan t followin g cleft lip an d palate

repair, 441 an d seclusion , 1033

Restrictive airway disorders, m edication s for, 738b

Resuscitation / em ergen t ph ase, for burn in jury, 557, 558t

Retin a, 861 Retin al detach m en t, 233, 865, 866f Retin oids, for acn e vulgaris, 573 Retin opath y, of prem aturity, 382 Retraction ( s) , in epiglottitis, 463, 464f Retropub ic prostatectom y, 599 Retrospective ( “lookin g back”) audit, 63 Rett syn drom e, 505 Reuptake in h ibitors, 1044b Revascularization

periph eral arterial, 762 tran sm yocardial, 762

Reverse Tren delen burg’s position , 232 Reward power, 62b Reye’s syn drom e, 503 Rh an tigen s, in eryth roblastosis fetalis, 383,

383f Rh factor, in an tepartum diagn ostic testin g,

305 Rh eum atic fever, 485, 486b, 486f Rh eum atoid arth ritis, 949, 949b, 961f

m edication s for, 960, 960b, 961f Rh eum atoid factor, 949 Rh o(D) im m un e globu lin , 383, 398 Rh on ch i, 180t Rib fracture, 718 Rickettsia rickettsii, 527 Rifab utin , 744 Rifam pin , 743 Rifap en tin e, 745 Righ t atrium , 755 Righ t ven tricle, 755 Righ t ven tricular failure, 774 Rim an tadin e, 748t Rin n e test, 176 Risk factors

for alcoh ol abuse, 1021 for can cer

breast, 591 cervical, 589 en dom etrial, 591 laryn geal, 597

for eye disorders, 863b, 870b for in tegum en tary system , 544 for m usculoskeletal system disorders,

939b for osteoporosis, 951b for ren al system disorders, 819b for sudden in fan t death syn drom e, 472

Risk m an agem en t, 52 Riton avir, 981 Rivaroxaban , 798, 798b Rivastigm in e, 1051 Rocky Moun tain spotted fever, 527, 527b Rods an d con es, 861 Roles

of h ealth care team m em bers, 64 n urse’s

in advan ce directives, 53 in disaster plan n in g, 70, 70b in reportin g, 54

social in African Am erican culture, 32 in Am ish society, 34

1125INDEX

Roles ( Continued) in Asian Am erican culture, 34 in Hispan ic an d Latin o Am erican

culture, 35 in Native Am erican culture, 36

Rom an Cath olicism , dietary preferen ces in , 33b

Rom b erg test, 185 Rootin g, in n ewbo rn , 378 Roseola ( exan th em a subitum ), 523, 523f Rotation , in labor, 334b Rotator cuff in jury, 940 Rotavirus, 439 Rotavirus vaccin e ( RV) , 529 RSV. See Respiratory syn cytial virus ( RSV) Rubella

in ch ildren , 523 durin g pregn an cy, 323

Rubella titer, in an tepartum diagn ostic testin g, 305

Rubella vaccin e, 306 for m atern ity an d n ewborn m edication s,

398 Rubeola ( m easles) , 522, 523f Rubra, 356 Rule of 9 for estim ation , of burn percen tage,

555f Run -O ut-O f-Tim e ( R.O .O .T) Rule, 12 Rupture, of uterus, in labor an d birth , 350 Rupturin g an eurysm , 785 Russell skin traction , 515 Russell’s traction , 942f, 943

S Saccular, aortic an eurysm s, 785 Sacral spin e in juries, 904

in terven tion s for, 906 Safe en viron m en t

em ergen cy respon se plan an d disasters, 197

en viron m en tal safety, 192, 192b, 193t h ealth care-associated ( n osocom ial)

in fection s an d, 195 provision of, 192–203, 192b question s on exam in ation associated

with , 4, 5b, 26 stan dard precaution s in , 195 tran sm ission -based precautio n s in , 196 warfare agen ts

biological, 197, 197–198f, 197b ch em ical, 199 n urse’s role in exposure to, 199, 199b

Safeguards, legal, 52, 52–53b Safety

acciden ts an d, 193, 193b adolescen t, 273 durin g am bulation , 193 with an tin eoplastic m edication

adm in istration , 615 electrical, 192 falls an d, 193, 194b fire, 192, 193t for h ealth care worker, 194b in fan t, 269 an d in fection con tro l, 169

subcategories on exam in ation , 4, 4t

Safety ( Continued) n ewborn , 379, 379b for poison s, 195 p osition in g clien ts for, 230 p resch ooler, 272 radiation , 193 for restrain ts, 194, 195b sch oo l-age ch ild, 272 toddler, 271

Safety n eedles, 207 Salem sum p tube, 239, 240f San dbags, for proper positio n in g, 235b San guin eous exudate from woun d, 552 Saquin avir, 981 Sarcoidosis, 727 Sarcom a

Kaposi’s, 974 o steogen ic, 424

Sarcoptes scabiei, 406 Sarin , 199 SARS. See Severe acute respiratory syn drom e

( SARS) Saunders Comprehensive Review for the

NCLEX-RN ®

Examination, 2, 18 Saunders Q&A Review Cards for the NCLEX-

RN ®

Exam, 3 Saunders Q&A Review for the NCLEX-RN

®

Examination, 2 Saunders RNtertainment for the NCLEX-RN

®

Exam, 3 Saunders Strategies for Test Success: Passing

Nursing School and the NCLEX ®

Exam, 2–3

Savan t, 505 Saw palm etto, 39b Scabies, in ch ild, 406, 406f, 406b Scalp, pediculosis capitis in , 405 Scan

bo n e, 939 kidn ey, 821 th yroid, 628

Scarrin g, bum in jury, 562 Sch edulin g appoin tm en t, for exam in ation ,

10 ch an gin g of, 10–11

Sch em ata, in Piaget’s th eory, of cogn itive developm en t, 257

Sch izoid p erson ality disorder, 1011 Sch izoph ren ia, 1008, 1008f, 1008b, 1010b Sch izotypal person ality disorder, 1011 Sch ool age, growth an d developm en t of,

Erikson ’s th eory of, 258b, 258t Sch ool-age ch ild

developm en tal con sideration s for adm in isterin g m edication s to, 540b

developm en tal stages o f ch aracteristics of, 272 co m m u n ication approach es in , 267 h ospitalized, 266 vital sign s of, 272b

Sch ultz-Ch arlton reaction , 525 Sch wan n cells, 894 SCLC. See Sm all cell lun g can cer ( SCLC) Sclera, 861

assessm en t of, 175 Scleral bucklin g procedure, 866, 866f

Scleroderm a, 971 Sclerosis, am yotroph ic lateral, 914 Scleroth erapy, 783

for esoph ageal varices, 683 Scoliosis

assessm en t of, 183b in ch ildren , idiopath ic, 512

Scored tablets, 206 Scorpion stin gs, 548 Screen in g

sickle cell, 306 targeted , 451 un iversal, 451

Scrotum , 291 assessm en t of, 187

Sealed radiation im p lan t, 584b Seclusion , restrain ts an d, 1033 Secon d-lin e m edication s, for tuberculosis,

741b, 742, 744 Secon dary assessm en t, in em ergen cy

departm en t, 71 Secon dary h yperten sion , 788 Secretory ph ase, of m en strual cycle, 292b Secukin um ab, 572 Security, in form ation , 50, 51b Security devices, 1033 Sedative-h ypn otics, 1048, 1048b Seizures, 907

disorders in ch ildren , 501b, 504, 504b with eclam psia, 322, 323b

Selective seroton in reuptake in h ibitors (SSRIs) , 1043, 1044b

Self-exam in ation breast, 591, 592f testicular, 187, 588, 589f

Self-h elp, 994b Self-irrigation o f urin ary stom a, 603b Self-m on itorin g, of blood glucose level,

639, 639b Self-n eglect, in older adult, 285 Sem icircular can als, 869 Sem i-Fo wler’s position , 230, 232–233 Sem ilun ar valves, 755 Sem ipron e position , 231f Sen gstaken -Blakem ore tube, 232, 240f,

243 Sen ses, ch an ges in , with agin g, 282 Sen sitivity testin g, urin ary, 820 Sen so rim otor stage, of cogn itive

developm en t, 257 Sen so rin eural h earin g loss, 176, 870f, 871 Sen so ry, n ear-death ph ysiological

m an ifestation s in , 275 Sen so ry fun ction , assessm en t of, 185 Sen so ry n euron s, 894 Sen so ry system

ch an ges in older clien ts, 193b position in g clien ts in , 233

Separation an xiety in h o spitalized adolescen t, 267 in h o spitalized in fan t an d to ddler, 265 in h o spitalized presch ooler, 266 in h o spitalized sch ool-age ch ild , 266

Sepsis in n ewborn , 384 as on cological em ergen cies, 604

1126 INDEX

Septal defect atrial, 481, 481b ven tricular, 481

Septicem ia, due to blood tran sfusion , 162 Septicem ic plagu e, 198 Serosa, 356 Serosan guin eous exudate, 552 Serum calcium , 86 Serum creatin in e, 118, 818 Serum lipids, 757 Serum m agn esium , 89 Serum ph osph orus, 90–91 Serum potassium , 83–84, 114 Serum sodium , 85, 114

in syn drom e of in appropriate an tidiuretic h orm on e, 604

Servan t th eory, of leadersh ip an d m an agem en t, 60b

Settin gs for h ealth an d ph ysical assessm en t, 171 of pacem akers, 769

Seven th -Day Adven tist, dietary preferen ces in , 33b

Severe acute respiratory syn drom e ( SARS) , 723

Sexual abuse ch ild, 1035 older adult, 1037

Sexual h arassm en t, 54 Sexual violen ce, 1034b Sexuality

in early adulth ood, 274 in m iddle adulth ood, 274

Sexually tran sm itted in fection s, pregn an cy an d, 305–306, 306t, 324

Sh aken baby syn drom e, 1036, 1036b Sh ared th eory, o f leadersh ip an d

m an agem en t, 60b Sh arps, disposal of, 193 Sh avin g, of surgical site, 215 Sh in gles, 546 Sh ock

postoperative, 221 postpartum , 364, 365b spin al an d n euro gen ic, 905, 906b

Sh ortn ess of breath , in pregn an cy, 304 Sh oulder presen tation , in labo r an d birth ,

332 Sh un t

arterioven ous, for h em odialysis, 828, 829f

ven triculoperiton eal, in creased in tracran ial pressure, 900b

Sh un tin g proced ures, for esoph ageal varices, 683, 683f

SIADH. See Syn drom e of in appropriate an tidiuretic h orm on e ( SIADH)

Sibilan t wh eeze, 180t Sick day rules for diabetic ch ild, 435b Sickle cell an em ia, 411, 412b, 412f Sickle cell crisis, 412b Sickle cell screen in g, in pregn an cy, 306 Side rails, for proper position in g, 235b Side-lyin g position , 231f, 232, 234 SIDS. See Sudden in fan t death syn drom e

( SIDS)

Sigh s, in m ech an ical ven tilation , 717t Silver sulfadiazin e, for burn in jury, 574 Sim ple face m ask, 712, 714t, 715f Sim ple fracture, 940b Sim ple partial seizure, 908b Sim s’ position , 231f SIMV. See Syn ch ron ized in term itten t

m an datory ven tilation ( SIMV) Sin gle lum en urin ary cath eter, 243 Sin gle-lum en tube, of trach eo stom y, 247b Sin o atrial ( SA) n ode, 755 Sin u s bradycardia, 756, 764 Sin u s rh yth m , n orm al, 764, 765f, 765b Sin u s tach ycardia, 756, 765 Sin u ses

an atom y an d ph ysiology of, 708 assessm en t of, 177

Sirolim us, 853, 982 Situation al crisis, 1031b Situation al leadersh ip, 61 Skeletal m uscle relaxan ts, 958, 959b Skeletal m uscles, 938 Skeletal traction , 906, 941 Skills

adolescen t, 273 in fan t, 269b presch ooler, 271 sch ool-age ch ild, 272 toddler, 270

Skin an aph ylaxis m an ifestation s in , 968f an th rax tran sm ission an d sym ptom s in ,

197b assessm en t of, 172

of n ewborn , 374, 374f care of, in dyin g clien t, 276b ch an ges in , with agin g, 281 color, in Apgar scorin g, 373t cultured, for burn in jury care, 561b in deh yd ration , pediatric, 431t ph ysiological m atern al ch an ges in , 302 self-care with radiatio n th erapy, 583

Skin biopsy, 545 Skin can cer, 549, 549t Skin color,ch aracteristics of, 173b Skin culture, 545 Skin graft, position in g clien ts with , 230 Skin sen sor, in sulin pum p an d, 639 Skin tests, 711, 712b

in asth m a, 468b in im m un e disorders, 968, 968f tuberculin , in pregn an cy, 306

Skin traction , 941 Russell, 515

Skin turgor, 173 Skull

fractures of, 900b radiograph y of, 894

Skull ton gs, 906 Slan der, 47 Sleep pattern s

of adolescen t, 273 in dem en tia an d Alzh eim er’s disease,

1014 depression an d, 1006b of in fan t, 268

Sleep pattern s ( Continued) of sch ool-age ch ild, 272 of toddler, 270–271

Slit lam p, 863 Slow-paced breath in g, in labor an d birth ,

335b Sm all cell lun g can cer ( SCLC) , 596 Sm all for gestatio n al age, 380 Sm all in testin e, 671 Sm allpox, 198, 198f Sm oke in h alation in jury, 556 Sn ake bites, 548 Sn ellen eye ch art, 174 Social h istory, 171 Social n etworks, co n fiden tiality an d

in form ation security an d, 51 Social roles

in African Am erican culture, 32 in Am ish society, 34 in Asian Am erican culture, 34 in Hispan ic an d Latin o Am erican culture,

35 in Native Am erican culture, 36 in wh ite Am erican culture, 36

Social worker, roles of, 64 Sodium

cardiovascular testin g of, 758 diet for restricted in take o f, 127b, 128 food sources of, 86b, 125b h om eostasis of, 818 h ypern atrem ia an d, 86, 87t h ypon atrem ia an d, 85, 86b n orm al value of, 86b restriction of, in glom erulon eph ritis,

492 Sodium bicarbon ate, 818

as an tacids, 699t m etabolic alkalosis due to excess

in gestion / in fusion of, 102b Soft diet, 126 Soft palates, 177 Solid tum or, 580 Som ogyi ph en om en on , 639 Son orous wh eeze, 180t Special con sen ts, 49b Specific gravity, 819

in deh ydration , pediatric, 431t Specim en collection , for arterial b lood

gases, 102, 102b Speculum exam in ation , of in tern al

gen italia, 186 Speech

in differen tiatin g delirium , depression , an d dem en tia, 283t

in m en tal status exam , 171 reh abilitation followin g laryn gectom y,

598b Spider bites, 547 Spikes, of pacem akers, 769 Spin a bifida occulta, 504 Spin al accesso ry n erve, 173, 184t Spin al b lock, for labor an d birth , 339 Spin al cord

an atom y an d ph ysiology o f, 893 com pression with can cer, 604 tran section , 902

1127INDEX

Spin al cord in juries, 901 assessm en t of, 904 auton om ic dysreflexia in , 906b cervical, 904, 904f descrip tion of, 901 effects of, 904b in terven tion s for, 904 lum bar, 904 m edicatio n s for, 907 position in g clien ts with , 234 sacral, 904 spin al an d n eurogen ic sh ock in , 905,

906b surgical in terven tion s for, 907 syn drom es in in com plete in jury, 903,

903f th oracic, 904 tran section of cord in , 902 vertebrae in volved in , 902

Spin al fusion , 907 Spin al n erves, 894 Spin al sh ock, 905, 906b Spin e

assessm en t of, in n ewborn , 375 ch an ges of, with agin g, 282f radiograph y of, 894

Spiral ( h elical) com puted tom ograph y ( CT) scan , 711

Spiral fracture, 940b Spirituality, 38

m en tal h ealth n ursin g an d, 989 Spirom etry, in cen tive, 216 Spiron olacton e, for acn e vulgaris, 574 Splen ic sequestration , in sickle cell crisis,

412b Splen oren al sh un t, distal, for eso ph ageal

varices, 683f Splin t/ splin tin g

h an d-wrist, for proper position in g, 235b in cision , 216, 217f with Pavlik h arn ess, 511

Spon ge bath , for pediatric fever, 430 Spon gy bon e, 937 Spon tan eous abortion , 315b Sprain , 940 Sputum cultures, 728 Sputum specim en , 709 Squam ous cell carcin om a, 549, 549t "Squin t," 457 SRS. See Stereotactic radiosurgery ( SRS) SSRIs. See Selective seroton in reuptake

in h ibitors ( SSRIs) St. Joh n ’s wort, 39b Stable an gin a, 772 Staffin g, h osp ital, 45 Stagin g of can cers, 580

biopsy, 581 Stan dard precaution s, 195 Stan dards

of care, 45 for clien t’s righ ts, 48, 48b

Stapes, 869 Staphylococcus aureus, m eth icillin -resistan t

in tegu m en tary, 546 Staphylococcus aureus, m eth icillin -resistan t,

com m un ity-acquired, pediatric, 527

Startle reflex, in n ewborn , 378 State Board of Nursin g, 18 Station , in labor an d birth , 332 Stature ch an ges, with agin g, 281, 282f Status asth m aticus, 467 Status ep ilep ticus, 907 Statuto ry rape, 1037 Stavudin e, 980 Stem cell tran splan tation , 419 Sten osis

aortic, 481, 779, 779t h ypertroph ic pyloric, 443, 443f pulm on ary, 482 trach eal, 248t

Sten ts, coron ary arteries, 762 Steppin g, in n ewborn , 379 Stereotactic radiosurgery (SRS), 901 Steven s-Joh n son syn drom e, 550, 851 Stillbirth , 367 Stim ulan ts

cen tral n ervous system , 927, 927b as laxatives, 702, 702b

Stim ulation tests, of en docrin e system , 627 Stin gs an d bites, 547 Stom a

care followin g laryn gecto m y, 598b laryn gectom y, 597 urin ary, 603b

Stom ach an alysis, 673 an atom y an d ph ysiology of, 671 can cer of, 593, 594b resection of, 677 ulcers of, 676, 677b

Stool assessm en t of, in n ewbo rn , 377 specim en s, testin g of, 675

Stork bites, 375t Strabism us, 457 Strain , 940 Strategic words, on exam in ation , 20–21,

22b Strawberry m ark, 375t Strawberry ton gue, in scarlet fever, 525,

526f Stren gth , assessm en t of, 183, 183t Streptococcus, group B, durin g pregn an cy,

323 Streptococcus pneumoniae, 466

in m en in gitis, 502 Streptom ycin , 746, 747b Stress

adaptation to, in psych iatric-m en tal h ealth illn ess, 990

tem perature an d, 109 Stress test

cardiovascular, 759 in an gin a, 772

con traction , 309b Stretch receptors, 756 Striae gravidarum , 302 Stroke, 234, 909, 909f

m an ifestation of, 910b Study, plan for, 14, 15b Study session , len gth of, 14 Study tim e, q uality, 14–15

Sub arach n oid (spin al) block, for labor an d birth , 339

Sub arach n oid h em orrh age, 900b Sub clavian cath eter, 152f, 828 Sub clavian vein , cath eterization for

paren teral n utrition , 134, 135f Sub cutan eous in jection , of paren teral

m edication , 206, 206f in pediatric patien t, 536

Subcutan eous n odules, in rh eum atic fever, 486f

Subd ural h em atom a, 900b Subin volution , postpartum , 366 Subject, of question , 22, 22b Sublabial tran ssph en oidal pituitary surgery,

629 Sublim ation defen se m ech an ism s, 991b Sublin gual n itrates, 804 Subluxation , 946

developm en tal dysplasia of h ip, 512b Subm ersion in jury, 503 Substan ce abuse disorders, 1020, 1020b,

1023b Sub stan ces, poten tially n eph rotoxic, 822b Sub stitution defen se m ech an ism s, 991b Succin im ides, 927 Suckin g, in n ewborn , 378 Sud den in fan t death syn drom e ( SIDS) , 472 Sufen tan il, 395 Suicidal beh avior, 1031, 1032b

assessm en t, 1032b Suicide, in older clien t, 283 Sulfasalazin e, 961 Sulfon am ides, 851, 851b

adverse effects of, 983t Sulfur, for psoriasis, 571 Sup erego, in Freud’s th eory, of

psych osexual developm en t, 259 Sup erficial partial-th ickn ess burn , 554, 555f Sup erficial th ro m boph lebitis, 367b Sup erficial-th ickn ess burn , 554, 555f Sup erior ven a cava syn drom e, 605 Sup in e h ypoten sion , in labor an d birth , 348 Sup in e position , 231f, 234 Sup plem en tal oxygen delivery system s, 712,

714t Supp lies, for disaster preparedn ess, 70b Supp ort groups, 994b Supp ortive level, in psych oth erapy, 993 Supp ression defen se m ech an ism s, 991b Supp ression tests, of en docrin e system , 627 Suprapubic p rostatectom y, 599 Surfactan ts

lun g, 398 in respiratory d istress syn drom e, 381

Surgery am bu latory, 224, 225b appen decto m y, 445 bariatric, 678, 679b, 679f for bladder can cer, 601 for breast can cer, 592, 592b for burn in jury debridem en t, 560b for colorectal can cer, 596 co n sen t for, 49b cran iotom y, 901, 902b for Hirsch sprun g’s disease, 446

1128 INDEX

Surgery ( Continued) for h yd roceph alus, 501 for idiopath ic scoliosis, 513 for in creased in tracran ial pressure, 900b kidn ey tran splan tation , 834f for laryn geal can cer, 597 for lun g can cer, 596 for pro state can cer, 599 for refractive errors, 863 for spin al co rd in jury, 907 of ulcerative colitis, 687

Surgical site postoperative care of, 219 preoperative preparation , 215

Suspected h ypoglycem ic reaction , 640b Sutures, in n ewborn , 373 Swallowin g reflex, in n ewb orn , 378 Swayback, 183b Sweat ch loride test, in cystic fibrosis, 470,

470b Swim m er’s ear, 872 Sym bolization defen se m ech an ism s, 991b Sym path olytics, cen trally actin g, 803, 803b Sym path om im etic bron ch odilators, 737 Syn arth rosis, 938t Syn ch ron ized in term itten t m an datory

ven tilation (SIMV), 716 in wean in g, 718

Syn cope, in pregn an cy, 303 Syn drom e of in appropriate an tidiuretic

h o rm on e ( SIADH) , 630 as on cological em ergen cies, 604

Syn drom e X, 637 Syn gen eic, stem cell don ation , 584 Syn ovectom y, 950 Syn ovial fluid, 937 Syn th etic, for burn in jury, 561b Syph ilis

in n ewborn , 384, 384f in pregn an cy, 305, 306t, 324 stages of, 325b

Syrin ge in sulin , 207, 207f 5-m L, 207, 207f for paren teral m edication

adm in istration , 206 parts of, 206f tuberculin , 207, 207f

Syrin ge pum p, 146 System ic lupus eryth em atosus, 970 System ic sclerosis, 971 Systole, 756 Systolic bloo d pressure, in preeclam psia,

321t Systolic failure, 775 Systolic pressure, in m yocardial in farction ,

774

T T lym ph ocytes coun t, 522t T wave, 758b Tablets, 206 Tach ycardia

fetal, 335 sin us, 756, 765 ven tricular, 766, 767f

Tach ypn ea, tran sien t, of n ewborn , 381 Tacrolim us, 570b, 854, 982 Tactile frem itus, 178 Tai ch i, 38 Talipes calcan eus, 512 Talipes equin us, 512 Talipes valgus, 512 Talipes varus, 512 Tam oxifen citrate, 619 Tam pon ade, cardiac, 764, 778 Tan gen tial tech n ique, for burn in jury

debridem en t, 560b Taran tula spider bite, 547 Targeted th erapy, for can cer, 619 Taxan es, 618b Tazaroten e, 571, 574 T-bar, 712, 714t, 715f TCM. See Tradition al Ch in ese m edicin e

(TCM) Teach in g an d Learn in g, as In tegrated

Process sub categories, 6–7 Team , h ealth care

collaboration am on g, 65 con sultation with , 65 rapid respon se, 65 roles of, 64

Team leader, 60 Team n ursin g, 60 Tears, in deh ydratio n , pediatric, 431t Teeth , assessm en t of, 177 TEF. See Trach eoesoph ageal fistula ( TEF) Telan giectatic n evi, as birth m ark, 375t Teleph on e prescription guidelin es, 52, 52b Teleph on e reports, 65 Teleth erapy, 583, 583b Tem perature, 108, 109b

of adolescen t, 273b in h yperth erm ia, 899 in n eurological assessm en t, 896 of n ewborn , 373 of n ewborn an d in fan t, 268b pediatric n orm al values, 430 postoperative assessm en t o f, in cardiac

surgical un it, 763 postoperative care of, 219 in postpartum vital sign s, 357t of presch oo ler, 271b of sch ool-age ch ild, 272b of toddler, 270b

Tem poral arteries, palpation of, 173 Tem poral lobe, 894b Tem porary pacem akers, 769 Tem porom an dibular join t, 173 Ten ofovir, 980 Ten silon test, 912, 923 Teriparatid e, 962 Test an xiety, 18–19 Test-takin g strategies, 2, 18, 20–29, 21b

avoidin g readin g in to question , 20, 21b for clien t n eeds, 26, 27b elim in ation of com parable or alike

option s, 27, 27b elim in ation of option s con tain in g close-

en ded words, 28, 28b look for um brella option , 28, 28b for ph arm acology question s, 29, 29b

Test-takin g strategies ( Continued) for positive an d n egative even t queries,

22, 23b for prioritizin g n ursin g action s question s,

23, 23–26b, 24f strategic words an d, 21, 22b subject of question an d, 22, 22b usin g guidelin es for d elegatin g an d

assign m en t m akin g, 28 Testes

an atom y an d ph ysiology o f, 626 can cer of, 588, 589f

m etastatic, 581b cryptorch idism of, 494

Testicular self-exam in ation (TSE) , 187, 588, 589f

Testin g cen ter, 11–12 Tet spell, 482, 484b Tetan us toxoid vaccin e, 530 Tetan us-diph th eria-acellular pertussis

( Tdap) vaccin e, 525 Tetan y, sign s of, 636b Tetracyclin es

for acn e vulgaris, 574 adverse effects of, 983t

Tetralogy of Fallot, 482 Tetraplegia, 904b Th alam us, 893 β-Th alassem ia m ajor, 414, 414b Th e Join t Com m ission

abbreviation s an d docum en tation guidelin es, 53

righ ts of m en tally ill policies, 48 Th eoph yllin e, 737–738 Th eories, of leadersh ip an d m an agem en t,

60, 60b Th erapeutic diets, 126

carboh ydrate-con sisten t, 128 cardiac diet, 127, 127b fat-restricted, 127 h igh -calcium , 129 h igh -calorie, h igh -protein , 128 h igh -iron , 129 h igh -residue, h igh -fiber, 127, 127b liquid diet

clear, 126 full, 126

low-purin e, 129 low-residue, low-fiber, 127 m ech an ical soft, 126 potassium -m odified, 129 protein -restricted, 128 ren al, 129, 129b sodium -restricted, 127b, 128 soft, 126

Th erm al h eat in jury, 556 Th erm al regulatory system , assessm en t of,

in n ewb orn , 377, 378f Th iazide diuretics, 801, 801b Th ird-spacin g, 78 Th irst

in deh ydration , pediatric, 431t m easures to relieve, 129b

Th oracen tesis, 710, 711f for lun g can cer, 596 position in g clien ts in , 233

1129INDEX

Th o racic an eurysm , 785 repair of, 786

Th o racic spin e in juries, 904 in terven tion s for, 906

Th o racotom y, 596 Th o ugh t processes

abn orm al/ altered in dem en tia an d Alzh eim er’s disease,

1014 depression an d, 1006b in sch izoph ren ia, 1009, 1009b

in m en tal status exam , 172b Th reaten ed abortion , 315b Th roat

assessm en t of, 177 ton sillitis an d aden oiditis, 458

Th rom boan giitis obliteran s, 785 Th rom boem bolism , in m ech an ical

prosth etic valves, 780 Th rom boph lebitis, 781

as com plicatio n , in in traven ou s th erapy, 149t, 151

deep vein , 782, 782b postop erative, 222 postpartum , 367, 367b

Th rom bopoietic growth factor, 619b, 855 Th rom bosis

deep vein , position in g clien ts in , 233 ven ous, 781

Th yroid glan d an atom y an d ph ysiolo gy of, 626 assessm en t of, 173 disorders of, 634, 634t, 635–636b, 635f

Th yroid h o rm on es, as en docrin e m edication s, 654, 654b

Th yroid scan , 628 Th yroid storm , 635, 635b Th yroidectom y, 636

position in g clien t in , 232 Th yroid-stim u latin g h orm on e, diagn ostic

testin g of, 628 Th yrotoxicosis, 635 Th yroxin e

diagn ostic testin g of, 628 h ypersecretion of, 635

Tick bites protectin g ch ildren from , 527b Rocky Moun tain spo tted fever du e to,

527 Tidal volum e, in m ech an ical ven tilation ,

717t Tim e m an agem en t, 67 Tim e orien tation

in African Am erican culture, 32 in Am ish society, 34 in Asian Am erican culture, 34 in Hispan ic an d Latin o Am erican culture,

35 in Native Am erican culture, 36 in wh ite Am erican culture, 36

Tim e tape label, for IV bag, 149, 150f Tim e-cycled ven tilator, 716 Tin n itus, 874 Tipran avir, 981 TIPS. See Tran sjugular in trah epatic

portosystem ic sh un t (TIPS)

Tissue dam age due to in traven ous th erapy, 149t,

151 exam in atio n for can cer diagn osis, 582

Tizan idin e, 959, 959b TMP-SMZ. See Trim eth oprim -

sulfam eth oxazole ( TMP-SMZ) Tocolytics, 393, 394t Toddler

developm en tal con sideration s for adm in isterin g m edication s to, 540b

developm en tal stages of ch aracteristics of, 269 com m un ication approach es in , 267 h ospitalized, 265 vital sign s o f, 270b

Toilet train in g, 270, 270b Tom ograph y, 869 Ton gs, skull, 906 Ton gue

assessm en t of, 177 strawberry, in scarlet fever, 525, 526f

Ton ic n eck, in n ewborn , 378 Ton ic-clon ic seizure, 908b Ton om etry, 863 Ton sillectom y, 459 Ton sillitis, 458, 459f Topical an esth etics, oph th alm ic, 885 Topical an tibiotics, for acn e vulgaris, 573b Topical glucocorticoids, 569, 569b, 575b Topical im m un osuppressan ts, for atopic

derm atitis, 569, 570b Topical oin tm en ts, n itrate, 805 Topical retin oids, for acn e vulgaris, 573,

573b Topoisom erase in h ibitors, 618, 618b Topotecan , 618b TO RCH in fection s, in n ewborn , 384 Tort law, 46b Total body fluid, 79 Total care, n ursin g, 60 Total h ip replacem en t, 234 Total kn ee replacem en t, 946 Total proctocolectom y, with perm an en t

ileostom y, 688 Toxicity

acetam in o ph en , 452 acetylsalicylic acid, 452 atropin e, 884 ben zodiazepin es, 1047 carbon m on oxide, 556, 557t citrate, 163 lith ium , 1047 n eph rotoxic substan ces, 822b

Toxoplasm osis, durin g pregn an cy, 323 T-piece, 712, 714t, 715f

in wean in g, 718 Trace elem en ts, in paren teral n utrition , 135 Trach ea

an atom y an d ph ysiology of, 708 assessm en t of, 173

Trach ea-in n om in ate artery fistula, 248t Trach eal sten osis, 248t Trach eobron ch itis, 465 Trach eoesoph ageal fistula ( TEF), 248t, 441,

442f

Trach eom alacia, 248t Trach eostom y, 246

co m plication s of, 248t tubes for, 247b, 247f

Trach eostom y collar, 712, 714t, 715f Traction

balan ced suspen sion , 942f, 943 for cervical spin e, 904, 904f, 906, 907b for fractures, 941, 942f

in ch ildren , 515 skeletal, 941 skin , 941

Trade n am e, 205 Tradition al Ch in ese m edicin e ( TCM) , 38 Tran saction al th eory, of leadersh ip an d

m an agem en t, 60b Tran scellular fluid, 79f Tran scultural Assessm en t Model, 33f Tran scutan eous pacin g, n on in vasive, 769 Tran sderm al patch , n itrate, 805 Tran sesoph ageal ech ocardiograph y, 759 Tran sfer reports, 65, 65b Tran sform ation al th eo ry, of leadersh ip an d

m an agem en t, 60b Tran sfusion reaction s, 160, 162b Tran sien t tach ypn ea, of n ewbo rn , 381 Tran sition ph ase, of labor, 337, 338t Tran sjugular in trah epatic portosystem ic

sh un t ( TIPS) , 683, 683f Tran slin gual m edication s, n itrate, 805 Tran sm yocardial revascularization , 762 Tran splan tation

bon e m arrow, 584 clien t’s righ ts an d, 48 h eart, 764 im m un odeficien cy after, 974 of kidn ey, 833, 834f, 835b periph eral blood stem cell, 584 religious beliefs regardin g, 49

Tran sposition of great arteries/ vessels, 483 Tran sureth ral resection of bladd er tum or,

601 Tran sureth ral resection of th e prostate

(TURP) , 599 Tran sven ous pacin g, in vasive, 770 Tran sverse fracture, 940b Tran sverse lie, in labor an d birth , 332, 333f Trapeze bar, for proper position in g, 235b Trastuzum ab, 619 Traum a

birth , 373 of bladder, 842 in ear disorders, 875 spin al cord, 901

Traum atic h ead in jury, 900, 900b Treadm ill testin g, 759 Tren delen burg test, 783 Tren delen burg’s positio n , 233

reverse, 232 Tren delen burg’s sign , 511, 512f Treponema pallidum, 324 Tretin oin , 573 Triage, 70, 70–71b Trich om on iasis, in pregn an cy, 305, 306t,

325 Tricuspid atresia, 483

1130 INDEX

Tricuspid valve, 755 disorders of, 780t

Tricyclic an tidepressan ts, 1044, 1044b Trigem in al n erve, 184t Trigem in al n euralgia, 913 Triiodoth yron in e

diagn ostic testin g of, 628 h ypersecretio n of, 635

Trim eth oprim -sulfam eth oxazole ( TMP- SMZ) , 851, 851b

Trip le lum en urin ary cath eter, 243 Trip le th erapy, for Helicobacter pylori

in fection , 700, 700b Trip od position in g, 463 Troch an ter rolls, for proper position in g,

235b Troch lear n erve, 184t Tropon in , 757

in an gin a, 772 in m yocardial in farction , 773

Trousseau’s sign , 636 True labor, 334, 334b True pelvis, 291 Trun cus arteriosus, 483 TSE. See Testicular self-exam in atio n ( TSE) TST. See Tuberculin skin test ( TST) T-tube, 680b Tub al ectopic pregn an cy, 317, 317f Tub e( s) , 239b, 251b

ch est, 246, 249–250f en dotrach eal, 245, 245f esoph ageal, 243 gastric, 243 gastroin testin al, 239 gastrostom y

adm in isterin g m edication s via, 242b esoph ageal atresia an d

trach eoesoph ageal fistula repair an d, 442

in testin al, 242 jejun ostom y, 242b lavage, 243 Levin , 239, 240f n asogastric, 232, 239, 240f, 241–242b respiratory system , 245 Salem sum p, 239, 240f trach eostom y, 246, 247b, 247f, 248t urin ary an d ren al, 243, 243f

Tu be dislodgm en t, of trach eostom y, 248t Tu be feedin gs

gastroin testin al, 239 position in g clien ts for, 232

Tu be obstruction , o f trach eosto m y, 248t Tu berculin skin test ( TST) , 474, 474b, 728,

729t in pregn an cy, 306

Tu berculin syrin ge, 207, 207f Tu berculosis, 727, 727b, 729b, 729t

in ch ildren , 473 m edication s for, 741, 741b in pregn an cy, 326

Tubin g for blood products adm in istration , 160b,

161f in traven ou s, 145, 145–146f

flow rates an d, 208

Tubules, 817 Tularem ia, 198 Tum or( s)

brain , pediatric, 424 gradin g an d stagin g of, 580 in testin al, 595 n euroblastom a, 423 solid, 580 Wilm s’, 422

Tum or lysis syn drom e, 605 Tum or m arker, in ovarian can cer, 591 Tun in g fork tests, for h earin g assessm en t,

176 Tun n eled cen tral ven ous cath eters, 152,

153f Turn er’s sign , 686 TURP. See Tran sureth ral resection of th e

prostate ( TURP) Tym pan ic cavity, 869 Tym pan ic m em bran e

assessm en t of, 176 in ju ry to, 875

Type 1 diabetes m ellitus, 637 Type 2 diabetes m ellitus, 637

m edication s for, 660, 660t Tyram in e, 1045, 1046b, 1046f

U U wave, 758b Ulcerative colitis, 687, 688b Ulcers

duoden al, 677b, 678 gastric, 676, 677b peptic, 676, 677f, 677b pressure, 551, 551t

Ultrason ograph y bladder, 820 en doscopic, gastroin testin al, 674 ocular, 863 in pregn an cy, 307 quan titative, for bon e m in eral den sity

m easurem en t, 939 Um b ilical blood sam plin g, percutan eous,

307 Um b ilical cord

assessm en t of, in n ewborn , 375 in fetal circulatio n , 294, 294f prolapsed, in labo r an d birth , 346, 347b,

347f Um b ilical h ern ia, 448 Um b rella option , 28, 28b Un circu m cised n ewborn , 380 Un con scious clien t, 898, 899b Un d oin g defen se m ech an ism s, 991b Un freezin g, in ch an ge process, 63, 63f Un iform An atom ical Gift Act, 48 Un ilateral n eglect, 911 Un it, in drug m easurem en t, 204 Un it dosage per h our, in fusion prescribed

by, 208, 209b 100-un it in sulin syrin ge, 207, 207f Un p lan n ed ch an ge, 63 Un stable an gin a, 772 Upper gastroin testin al en doscopy, 673 Upper gastroin testin al tract study, 672 Upper resp iratory airway, 708

Urea breath test, 675 Urea n itrogen , 819 Urem ic syn drom e, 827 Ureteral tube, 243, 243f Ureteritis, 837 Ureterolith otom y, 840 Ureterostom y, 603 Ureth ral orifice, epispadias an d

h ypo spadias of, 494 Ureth ritis, 836 Urin alysis, 819, 819t

in pregn an cy, 307 Urin ary cath eters, 243, 244b Urin ary diversion , for bladder can cer, 601,

602f Urin ary elim in ation , in dyin g clien t,

276b Urin ary reten tion , p ostoperative, 222 Urin ary tract

bladder, as radiation th erapy side effect, 422t

ch ro n ic kidn ey disease m an ifestation s in , 824b

ph ysiological m atern al ch an ges o f, in postpartum period, 357

Urin ary tract an tiseptics, 850, 851b Urin ary tract in fection , 835, 835–836b

in pregn an cy, 326 Urin ary urgen cy an d frequen cy, in

pregn an cy, 303 Urin e

24-h our collection of, 819 culture an d sen sitivity testin g, 820 production of, 818

Urin e culture, in pregn an cy, 307 Urin e output

in acute kidn ey in jury, 822 in cardiogen ic sh ock, 776 postoperative, 220 in preeclam psia, 321t

Urin e specific gravity, 819 in deh ydration , pediatric, 431t

Urin e tests/ testin g, in diabetes m ellitus, 639 pediatric, 433

Urograph y, in traven ous, 820 Urolith iasis, 839 Urosepsis, 836 Ustekin um ab, 571b, 572 Uterin e activity, suppressin g, tocolytics in ,

393, 394t Uterin e aton y, p ostpartum , 364, 365f Uterin e con tractio n s, in labor an d birth ,

332 Uterus, 291

can cer o f, 591 ch an ges in , durin g m en strual cycle, 292b in version of, in labor an d birth , 351 in volu tion o f, in postpartum period, 356,

357f lin in g of, in fection in , 317 ph ysiological m atern al ch an ges in , 301 rupture o f, in labor an d birth , 350 subin volution of, in postpartum period,

366 Uveal tract, 861 Uvula, 178

1131INDEX

V Vaccin e

h epatitis A, 684 h epatitis B, 685

for n ewborn , 399 for in fluen za, 747 paren teral, 528b pn eum ococcal con jugate, 748 reaction s to, 530 rubella

for m atern ity an d n ewborn m edication s, 398

pregn an cy an d, 306 Vacuum extraction , in labo r an d birth , 341 Vagal m an euvers, 767 Vagin a, 291

ph ysiological m atern al ch an ges of, 302 in postpartum period, 356

Vagin al can didiasis, durin g pregn an cy, 325 Vagin al disch arge, in pregn an cy, 303 Vagin al procedure, position in g clien ts in ,

231 Vagin al rin g, 659 Vagin osis, bacterial, durin g pregn an cy, 325 Vago tom y, 677 Vagu s n erve, 184t Valerian , 39b Valproates, 927 Valproic acid, 927 Valsalva m an euver, 768 Valuables, safeguardin g of clien t’s, 52 Values, 44 Values clarification , 44 Valves, h eart, an atom y an d ph ysiology of,

755 Valvotom y, 780 Valvular h eart disease, 779, 779–780t, 780b Valvuloplasty, balloon , 779 Van illylm an delic acid ( VMA) , 24-h our

urin e collection for, 629 Variability, in fetal h eart rate, 335, 335b Variable deceleration s, in fetal h eart rate,

336, 336f Varian t an gin a, 772 Variceal ligation , en doscopic, esoph ageal,

683 Varicella ( ch icken pox) , 524, 524f Varicella vaccin e, 530 Varicose vein s, 783

position in g clien ts with , 233 in pregn an cy, 303

Vascular access port, for in traven ous th erapy, 152f, 153

Vascular system an atom y an d ph ysiology of, 757 disorders of, 781, 782b periph eral, assessm en t of, 181, 181b

Vasodilators direct-actin g, arteriolar, 807, 807b m iscellan eous, 807 periph eral, 806, 806b

Vaso-occlusive crisis, in sickle cell an em ia, 412b

Vastus lateralis m uscle, pediatric in jection in , 538f, 538t

Vegan an d vegetarian diets, 129, 309

Vein strippin g, fo r varicose vein s, 783 Vein s

an atom y an d ph ysiology of, 757 varicose

position in g clien ts with , 233 in pregn an cy, 303

Ven a cava filter, 787, 787f Ven a cava syn drom e, in labor an d birth ,

348 Ven ipun cture, h em atom a at site of, 150 Ven o-occlusive disease, h epatic, 585 Ven ous in sufficien cy, 782

po sition in g clien ts with , 233 Ven ous pressure, in cardiogen ic sh ock, 776 Ven ous th rom bosis, 781 Ven ted tubin g, 145 Ven tilation -perfusion ( V/ Q ) lun g scan , 711 Ven tilator alarm s, causes of, 718b Ven tilators, m ech an ical, respiratory

alkalosis due to overven tilation by, 100b

Ven tricles of b rain , 894 of h eart, 755

Ven tricular con traction s, prem ature, 766, 766b, 766f

Ven tricular fibrillation , 766, 767f Ven tricular septal defect ( VSD), 481 Ven tricular tach ycardia, 766, 767f Ven triculoatrial sh un t, for h ydroceph alus,

499b, 501 Ven triculop eriton eal sh un t

for h ydroceph alus, 501, 502f, 506b in creased in tracran ial pressure, 900b

Ven trogluteal m uscle, pediatric in jectio n in , 538t

Ven turi m ask, 712, 714t, 715f Ven ules, 757 Veracity, 45 Vern ix caseosa, in n ewborn , 374 Vertical lie, in labor an d birth , 332, 333f Vesicostom y, 603 Vestibular assessm en t, 177b Vestibulococh lear n erve, 184t Video question s, 9–10, 11f Vin ca alkaloids, 618, 618b Vin cristin e, 618 Violen ce, 1033

assessm en t question s for, 1035b cycle of, 1034f fam ily, 1034 types of, 1034b

Viral carcin ogen , 580 Viral in fection

en ceph alitis, 914 in m en in gitis, 502 pn eum on ia, 466 respiratory syn cytial virus, 465

Visa, work, 13 Visceral pericardium , 755 Vision , assessm en t of, 174 Visual im agery, 38 Vital sign s, 108, 108b

of adolescen t, 273b guidelin es for m easurin g, 108 in h ealth an d ph ysical assessm en t, 172

Vital sign s ( Continued) of n eurological system , 183

of n ewborn , 372 of presch ooler, 271b of sch oo l-age ch ild, 272b of toddler, 268b, 270b

Vitam in B12 deficien cy, 678 Vitam in D

for osteoporosis, 961 sup plem en tation of, for in fan t, 268

Vitam in K, for n ewborn , 399 Vitam in s, 124

food sources of, 125b in paren teral n utrition , 135

Vitreous, 861 Vitreous body, 861 Vocal frem itus, 178 Voice soun ds, 178, 180b Voice ( wh isper) test, for h earin g

assessm en t, 176 Volum e-cycled ven tilator, 716 Volum e per h our, 208 Volun tary adm ission , 991 Vom itin g

in ch ildren , 439, 439b, 453b as com plication , of gastroin testin al tube

feedin gs, 242 in dyin g clien t, 276b in h yperem esis gravidaru m , 320 m etabolic alkalosis due to, 102b in pregn an cy, 301–302 as radiation th erapy side effect, 421f

von Willebran d’s disease, 414 VSD. See Ven tricular septal defect ( VSD) Vulvar h em atom a, 364, 365f

W Walkers, 945 Walkin g, in n ewborn , 379 Wan derin g, in dem en tia an d Alzh eim er’s

disease, 1013 Warfare agen ts

biological, 197, 197–198f, 197b ch em ical, 199 n urse’s role in exp osure to, 199, 199b

Warfarin sodium , 798, 798b Warm in g, of blood before blood

tran sfusion , 159 Wasp stin g, 548 Wastes, disposal of in fectious, 193 Watch test, for h earin g assessm en t, 176 Water

h om eostasis of, 818 in take of, 81, 81f output of, 81, 81f in paren teral n utrition , 136

Water in toxication , 83 Water-soluble vitam in s, 124, 125b Weakn ess, in dyin g clien t, 276b Wean in g, 718 Weber test, 176 Wedge pillow, for prop er position in g, 235b Weigh t

of adolescen t, 273 calculatin g pediatric dosages by, 538,

538b

1132 INDEX

Weigh t ( Continued) of in fan t, 268 of n ewborn , 373 percen tage of body fluid, 79 of presch ooler, 271 of sch oo l-age ch ild, 272 of toddler, 269

Weigh t gain , du rin g pregn an cy, 308 Weigh t loss

in deh ydration , pediatric, 431t in labor, 333 in n ewborn , 376

Weigh ted flexible feedin g tube with stylet, 240f

West Nile virus in fection , 915 West n om ogram , for estim ation of body

surface area in in fan ts an d ch ildren , 539f

Western blot, 522t Wh eeze, 180t Wh ipple procedure, 594, 595f Wh ispered pectoriloquy, 180b

Wh ite Am erican s, 36 Wh ite blood cell ( WBC) coun t, 118, 757

in m yocardial in farction , 773 Wh ite blood cells ( WBCs), leukem ia an d,

419, 425b Wh iteh eads, 550 Wh oopin g cough , 524 Wilm s’ tu m or, 422 With drawal

alcoh ol, 1022 ben zodiazepin e, 1022 n ursin g care, 1025b

With drawal delirium , 1022, 1022b Woo d’s ligh t exam in ation , 545 Work visa, for foreign -educated n urse, 13 Wou n d

care in burn in jury, 560, 560t culture of, 545 drain age from , 545 postoperative care of, 219 postoperative deh iscen ce an d

evisceration , 224, 224f, 224b

Woun d ( Continued) postoperative in fection of, 223, 223b

Woun d dressin g m aterials used for, 553t types of, 552–553t

Woun d h ealin g com plication s of, 224f ph ases of, 544

X Xen ograft, for burn in jury care, 561b

Y Yeast in fection , 545 Yersinia pestis, 198 Yin an d yan g, 34 Yoga, 38

Z Zan am ivir, 748t Zidovudin e, 319, 980 Zin c, food sources of, 125b

1133INDEX

This pa ge inte ntiona lly le ft bla nk

This pa ge inte ntiona lly le ft bla nk

United States (U.S.) Top 100 Prescription Medications (By Generic Name)* Adalimubab Adapalene/ benzoyl

peroxide Albuterol (Proventil HFA) Albuterol (Ventolin HFA) Amlodipine/ olmesartan

medoxomil Amlodipine/ valsartan Aripiprazole Aspirin/ dipyradimole Atomoxetine Atorvastatin Bimatoprost Brimonidine Brimonidine/ timolol Budesonide/ formoterol Buprenorphine/

naloxone Canagliflozin Celecoxib Colesevelam Conjugated estrogens/

medroxyprogesterone acetate

Dabigatran Desvenlafaxine Dexlansoprazole Dexmethylphenidate Diclofenac sodium Duloxetine Dutasteride

Efavirenz/ emtricitabine/ tenofovir disoproxil fumarate

Emtricitabine/ tenofovir Esomeprazole Estrogens, conjugated

(Premarin Vaginal) Estrogens, conjugated

(Premarin) Eszopiclone Etanercept Ethinyl estradiol/

etonogestrel Ezetimibe Ezetimibe/ simvastatin Febuxostat Fluticasone Fluticasone/ salmeterol

(Advair Diskus) Fluticasone/ salmeterol

(Advair HFA) Formoterol/ mometasone Influenza vaccine (Afluria) Insulin aspart (Novolog

Flexpen) Insulin aspart (Novolog

Flexpen Mix 70/ 30) Insulin aspart (Novolog) Insulin detemir Insulin glargine (Lantus

solostar)

Insulin lispro Insulin lispro (Humalog

Kwikpen) Insulin, isophane

suspension (NPH) Insuline glargine (Lantus) Ipratropium bromide/

albuterol Levalbuterol Levothyroxine (Synthroid) Levothyroxine (Thyroid) Linagliptin Liraglutide Lisdexamfetamine Loteprednol Lubiprostone Lurasidone Memantine Memantine Metformin/ sitagliptin Metoprolol Mometasone furoate Mometasone furoate Nebivolol Norethindrone acetate/

ethinyl estradiol/ ferrous fumarate

Norethindrone/ ethinyl estradiol

Norgestim ate/ ethinyl estradiol

Olmesartan medoxomil Olmesartan medoxomil-

hydrochlorothiazide Olopatadine Olopatadine Oseltamivir Oxycodone hydrochloride Prasugrel Pregabalin Quetiapine Raloxifene Ranolazine Risedronate Ritonavir Rivaroxaban Rivastagmine Rosuvastatin Saxagliptin Sildenafil Sitagliptin Solfenacin Tadalafil Tiotropium Tolterodine Travoprost Valsartan Vardenafil Varenicline Vilazodone Zoster vaccine

(Zostavax) *Data are based on the volume of prescriptions dispensed from U.S. retail pharmacies. This listing identifies in alphabetical order the

top 100 medications dispensed from U.S. retail pharmacies. Informa t ion Sources: Mayo Clinic. (20 16). Drugs and Supplements. Retrieved from http:/ / www.mayoclinc.org/ drugs-supplements Medscape News and Perspective. (20 14). Top 100 Most-Prescribed, Best-Selling Drugs. Retrieved from http:/ / www.medscape.com/

viewarticle/ 884317 Skidmore-Roth, L. (2016). Mosby’s 2016 Nursing Drug Reference (29th ed.). St. Louis: Elsevier Mosby.

l Acute Asthma Attack, 469 l Administering a Parenteral Vaccine, 528 l Administering Medications via a Nasogastric, Gastrostomy, or Jejunostomy Tube, 242 l Administering Oral Medications to a Client at Risk for Aspiration, 285 l Air Embolism in a Client Receiving Hemodialysis, 830 l Anaphylactic Reaction Occurring from Medication, 616 l Anaphylaxis Reaction, 969 l Anxiety in a Client, 1001 l Assessing a Group of Clients in Order of Priority, 68 l Autonomic Dysreflexia in a Spinal Cord Injury Client, 906 l Burn Injury: Care in the Emergency Department, 554 l Central Venous Catheter Site with a Suspected Infection, 136 l Chemical Eye Injury Interventions in the Emergency Department, 868 l Chest Pain in a Hospitalized Client with Cardiac Disease, 804 l Child Has a Nosebleed, 460 l Choking Infant, 387 l Eclampsia Event, 322 l Event of a Fire, 192 l Evisceration in a Wound, 224 l Extremity Fracture in a Child, 515 l Fat Embolism in a Client Following a Fracture, 943 l Fluid Volume Overload in a Child with Glomerulonephritis, 491 l Hemorrhage and Shock in the Postpartum Client, 365 l Hypercyanotic Spell Occurring in an Infant, 484 l Hypertonic Contractions or a Nonreassuring Fetal Heart Rate during Oxytocin Infusion, 397 l Hypoglycemia in a Hospitalized Child with Diabetes Mellitus, 434 l Inserting a Peripheral Intravenous Line, 148 l Liver Biopsy, 232 l Major Burn Injury in the Child, 407 l Nonreassuring Fetal Heart Rate Pattern, 337 l Paracentesis, 674 l Performing the Allen’s Test Before Radial Artery Puncture, 102 l Physical Abuse of an Older Client, 1037 l Poisoning Treatment in the Emergency Department, 451 l Pulmonary Edema, 775 l Removing a Peripheral Intravenous Line, 148 l Sealed Radiation Implant that Dislodges, 584 l Suspected Hypoglycemic Reaction (the 15/ 15 rule), 640 l Suspected Pulmonary Embolism, 726 l Tracheal Suctioning, 709 l Transfusion Reaction: Nursing Interventions, 162 l Triaging Victims at the Site of an Accident, 70 l Tricyclic Antidepressant Overdose, 1044 l Umbilical Cord Prolapse, 347